PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Boursault, L; Haddad, V; Vergier, B; Cappellen, D; Verdon, S; Bellocq, JP; Jouary, T; Merlio, JP				Boursault, Lucile; Haddad, Veronique; Vergier, Beatrice; Cappellen, David; Verdon, Severine; Bellocq, Jean-Pierre; Jouary, Thomas; Merlio, Jean-Philippe			Tumor Homogeneity between Primary and Metastatic Sites for BRAF Status in Metastatic Melanoma Determined by Immunohistochemical and Molecular Testing	PLOS ONE			English	Article							PARAFFIN-EMBEDDED TISSUE; IMPROVED SURVIVAL; V600E MUTATIONS; MEK INHIBITION; MAPK PATHWAY; OPEN-LABEL; PHASE-III; MULTICENTER; DABRAFENIB; EXPRESSION	BRAF inhibitors have demonstrated improvement of overall survival in patients with metastatic melanoma and BRAF(V600) mutations. In order to evaluate BRAF tumor heterogeneity between primary and metastatic site, we have evaluated the performance of immunohistochemistry (IHC) with an anti-BRAF(V600E) antibody in both localization by comparison with high resolution melting analysis followed by Sanger sequencing in a parallel blinded study. A total of 230 samples distributed as primary melanoma (n = 88) and different types of metastatic samples (n = 142) were studied in 99 patients with advanced or metastatic melanoma (stage III or IV). The prevalence of each BRAF mutation was c.1799T>A, BRAF(V600E) (45.2%), c.1799_1800TG>AA, BRAF(V600E2) (3.0%), c.1798_1799GT>AA, BRAF(V600K) (3.0%), c.1801 A>G, BRAF(K601E) (1.3%), c.1789_1790CT>TC, BRAF(L597S) (0.4%), c.1780G>A, BRAF(D594N) (0.9%) respectively. IHC was positive in 109/112 samples harboring BRAF(V600E/E2) mutations and negative in other cases. The cytoplasmic staining was either strongly positive in tumor cells of BRAFV600E mutated cases. It appeared strong brown, different from the vesicular grey cytoplasmic pigmentation of melanophages. Concordance between the two techniques was 96.4%. Sensitivity of IHC for detecting the BRAF(V600E/E2) mutations was 97.3%, while specificity was 100%. Both our IHC and molecular study demonstrated homogeneity between primary and metastatic sites for BRAF status in melanoma. This study also provides evidence that IHC may be a cost-effective first-line method for BRAF(V600E) detection. Thereafter, molecular techniques should be used in negative, ambiguous or non-contributive cases.	[Boursault, Lucile; Jouary, Thomas] CHU Bordeaux, Dept Dermatol, Pessac, France; [Haddad, Veronique; Cappellen, David; Verdon, Severine; Merlio, Jean-Philippe] CHU Bordeaux, Tumor Bank & Tumor Biol Lab, Pessac, France; [Vergier, Beatrice] CHU Bordeaux, Dept Pathol, Pessac, France; [Bellocq, Jean-Pierre] CHU Strasbourg, Dept Pathol, F-67000 Strasbourg, France	CHU Bordeaux; CHU Bordeaux; CHU Bordeaux; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Merlio, JP (corresponding author), CHU Bordeaux, Tumor Bank & Tumor Biol Lab, Pessac, France.	jp.merlio@u-bordeaux2.fr						Anderson S, 2012, ARCH PATHOL LAB MED, V136, P1385, DOI 10.5858/arpa.2011-0505-OA; Atkins MB, 1999, J CLIN ONCOL, V17, P2105, DOI 10.1200/JCO.1999.17.7.2105; Busam KJ, 2013, AM J SURG PATHOL, V37, P413, DOI 10.1097/PAS.0b013e318271249e; Capper D, 2012, ACTA NEUROPATHOL, V123, P223, DOI 10.1007/s00401-011-0887-y; Capper D, 2011, ACTA NEUROPATHOL, V122, P11, DOI 10.1007/s00401-011-0841-z; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chapman PB, 1999, J CLIN ONCOL, V17, P2745, DOI 10.1200/JCO.1999.17.9.2745; Colomba E, 2013, J MOL DIAGN, V15, P94, DOI 10.1016/j.jmoldx.2012.09.001; Colombino M, 2012, J CLIN ONCOL, V30, P2522, DOI 10.1200/JCO.2011.41.2452; Cousins MM, 2013, J MOL DIAGN, V15, P130, DOI 10.1016/j.jmoldx.2012.08.008; Curry JL, 2012, SEMIN CUTAN MED SURG, V31, P267, DOI 10.1016/j.sder.2012.07.007; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Dahlman KB, 2012, CANCER DISCOV, V2, P791, DOI 10.1158/2159-8290.CD-12-0097; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Fecher LA, 2008, CURR OPIN ONCOL, V20, P183, DOI 10.1097/CCO.0b013e3282f5271c; Feller JK, 2013, MODERN PATHOL, V26, P414, DOI 10.1038/modpathol.2012.168; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Forsea AM, 2012, BRIT J DERMATOL, V167, P1124, DOI 10.1111/j.1365-2133.2012.11125.x; Hacker E, 2013, J INVEST DERMATOL, V133, P1027, DOI 10.1038/jid.2012.385; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Ilie M, 2013, ANN ONCOL, V24, P742, DOI 10.1093/annonc/mds534; Jaeger J, 2007, CLIN CANCER RES, V13, P806, DOI 10.1158/1078-0432.CCR-06-1820; Klein O, 2013, EUR J CANCER, V49, P1073, DOI 10.1016/j.ejca.2012.11.004; Lade-Keller J, 2012, J MOL DIAGNOSTICS; Lee JH, 2011, BRIT J DERMATOL, V164, P776, DOI 10.1111/j.1365-2133.2010.10185.x; Lin J, 2011, BRIT J CANCER, V104, P464, DOI 10.1038/sj.bjc.6606072; Long GV, 2013, AM J SURG PATHOL, V37, P61, DOI 10.1097/PAS.0b013e31826485c0; Long GV, 2012, LANCET ONCOL, V13, P1087, DOI 10.1016/S1470-2045(12)70431-X; Long GV, 2011, J CLIN ONCOL, V29, P1239, DOI 10.1200/JCO.2010.32.4327; Menzies AM, 2012, DRUG DES DEV THER, V6, P391, DOI 10.2147/DDDT.S38998; Middleton MR, 2000, J CLIN ONCOL, V18, P158, DOI 10.1200/JCO.2000.18.1.158; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Paternoster SF, 2002, AM J PATHOL, V160, P1967, DOI 10.1016/S0002-9440(10)61146-7; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Richtig E, 2013, BRIT J DERMATOL, V168, P428, DOI 10.1111/j.1365-2133.2012.11121.x; Rubinstein JC, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-67; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Skorokhod A, 2012, J AM ACAD DERMATOL, V67, P488, DOI 10.1016/j.jaad.2012.03.022; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Spittle C, 2007, J MOL DIAGN, V9, P464, DOI 10.2353/jmoldx.2007.060191; Tan YH, 2008, PATHOLOGY, V40, P295, DOI 10.1080/00313020801911512; Wilmott JS, 2013, BRIT J CANCER, V108, P924, DOI 10.1038/bjc.2013.29; Yancovitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029336; Yazdi AS, 2003, J INVEST DERMATOL, V121, P1160, DOI 10.1046/j.1523-1747.2003.12559.x	47	92	95	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e70826	10.1371/journal.pone.0070826	http://dx.doi.org/10.1371/journal.pone.0070826			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23976959	Green Submitted, Green Published, gold			2022-12-25	WOS:000324527300004
J	Kostic, C; Lillico, SG; Crippa, SV; Grandchamp, N; Pilet, H; Philippe, S; Lu, Z; King, TJ; Mallet, J; Sarkis, C; Arsenijevic, Y; Whitelaw, CBA				Kostic, Corinne; Lillico, Simon Geoffrey; Crippa, Sylvain Vincent; Grandchamp, Nicolas; Pilet, Heloise; Philippe, Stephanie; Lu, Zen; King, Tim James; Mallet, Jacques; Sarkis, Chamsy; Arsenijevic, Yvan; Whitelaw, Christopher Bruce Alexander			Rapid Cohort Generation and Analysis of Disease Spectrum of Large Animal Model of Cone Dystrophy	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT CONE; ARRESTIN GENE; LENTIVIRAL VECTORS; MUTATION ANALYSIS; ROD; EXPRESSION; CYCLASE; PIGS; GUCY2D; DEGENERATION	Large animal models are an important resource for the understanding of human disease and for evaluating the applicability of new therapies to human patients. For many diseases, such as cone dystrophy, research effort is hampered by the lack of such models. Lentiviral transgenesis is a methodology broadly applicable to animals from many different species. When conjugated to the expression of a dominant mutant protein, this technology offers an attractive approach to generate new large animal models in a heterogeneous background. We adopted this strategy to mimic the phenotype diversity encounter in humans and generate a cohort of pigs for cone dystrophy by expressing a dominant mutant allele of the guanylate cyclase 2D (GUCY2D) gene. Sixty percent of the piglets were transgenic, with mutant GUCY2D mRNA detected in the retina of all animals tested. Functional impairment of vision was observed among the transgenic pigs at 3 months of age, with a follow-up at 1 year indicating a subsequent slower progression of phenotype. Abnormal retina morphology, notably among the cone photoreceptor cell population, was observed exclusively amongst the transgenic animals. Of particular note, these transgenic animals were characterized by a range in the severity of the phenotype, reflecting the human clinical situation. We demonstrate that a transgenic approach using lentiviral vectors offers a powerful tool for large animal model development. Not only is the efficiency of transgenesis higher than conventional transgenic methodology but this technique also produces a heterogeneous cohort of transgenic animals that mimics the genetic variation encountered in human patients.	[Kostic, Corinne; Crippa, Sylvain Vincent; Philippe, Stephanie; Arsenijevic, Yvan] Univ Lausanne, Unit Gene Therapy & Stem Cell Biol, Jules Gonin Eye Hosp, Lausanne, Switzerland; [Lillico, Simon Geoffrey; Lu, Zen; King, Tim James; Whitelaw, Christopher Bruce Alexander] Univ Edinburgh, Roslin Inst, Edinburgh EH8 9YL, Midlothian, Scotland; [Lillico, Simon Geoffrey; Lu, Zen; King, Tim James; Whitelaw, Christopher Bruce Alexander] Univ Edinburgh, R D SVS, Edinburgh EH8 9YL, Midlothian, Scotland; [Grandchamp, Nicolas; Pilet, Heloise; Mallet, Jacques; Sarkis, Chamsy] Univ Paris 06, Unit Biotechnol & Biotherapy, Inst Cerveau & Moelle Epiniere, Ctr Rech,CNRS,Inst Natl Sante Rech Med,UMR7225,UM, Paris, France; [Grandchamp, Nicolas; Pilet, Heloise; Philippe, Stephanie; Sarkis, Chamsy] NewVectys, Villebon Sur Yvette, France	University of Lausanne; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Sarkis, C (corresponding author), Univ Paris 06, Unit Biotechnol & Biotherapy, Inst Cerveau & Moelle Epiniere, Ctr Rech,CNRS,Inst Natl Sante Rech Med,UMR7225,UM, Paris, France.	chamsy.sarkis@newvectys.com; yvan.arsenijevic@fa2.ch; bruce.whitelaw@roslin.ed.ac.uk	Lillico, Simon/X-6233-2019	Lillico, Simon/0000-0002-5101-2277; Kostic, Corinne/0000-0003-1006-9733; Lu, Zen H./0000-0002-9408-0579; Arsenijevic, Yvan/0000-0001-6960-1291; Crippa, Sylvain Vincent/0000-0002-4677-2642; Whitelaw, Bruce/0000-0002-2918-1605	EC FP6 INTEGRA program [29025]; FP6 NEST Adventure (European Commission); Retina France association (France); Loterie Romande (Switzerland); Biotechnology and Biological Sciences Research Council ISPG (United Kingdom) [BBS/E/D/07731442]; BBSRC [BBS/E/D/05251442, BBS/E/D/05251445, BBS/E/D/05251443, BBS/E/D/20221658, BBS/E/D/05251444] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/05251445, BBS/E/D/20221658, BBS/E/D/05251443, BBS/E/D/05251444, BBS/E/D/05251442] Funding Source: researchfish	EC FP6 INTEGRA program; FP6 NEST Adventure (European Commission); Retina France association (France); Loterie Romande (Switzerland); Biotechnology and Biological Sciences Research Council ISPG (United Kingdom)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the EC FP6 INTEGRA program, 29025, FP6 NEST Adventure (European Commission), Retina France association (France), Loterie Romande (Switzerland), Biotechnology and Biological Sciences Research Council ISPG, BBS/E/D/07731442 (United Kingdom). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arts JWM, 2009, BEHAV BRAIN RES, V205, P303, DOI 10.1016/j.bbr.2009.06.014; Beltran WA, 2012, P NATL ACAD SCI USA, V109, P2132, DOI 10.1073/pnas.1118847109; Bretaud S, 2011, ZEBRAFISH, V8, P103, DOI 10.1089/zeb.2011.0697; Cachafeiro M, 2010, INVEST OPHTHALMOLVIS; Carlson GA, 1997, HUM MOL GENET, V6, P1951, DOI 10.1093/hmg/6.11.1951; Carvalho LS, 2011, HUM MOL GENET, V20, P3161, DOI 10.1093/hmg/ddr218; COLEMAN DL, 1973, DIABETOLOGIA, V9, P287, DOI 10.1007/BF01221856; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; Collery RF, 2013, EXP EYE RES; Dang RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024086; Davidson D J, 2001, Trends Genet, V17, pS29, DOI 10.1016/S0168-9525(01)02452-0; Downes SM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1667; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eloholma M, 2006, LEUKOS, V2, P263, DOI 10.1582/LEUKOS.2006.02.04.002; Fujimaki T, 2004, GENE, V339, P139, DOI 10.1016/j.gene.2004.06.032; Garcia-Hoyos M, 2011, MOL VIS, V17, P1103; Gieling ET, 2011, CURR TOP BEHAV NEURO, V7, P359, DOI 10.1007/7854_2010_112; Gorodkin J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r45; Gregory-Evans K, 2000, OPHTHALMOLOGY, V107, P55, DOI 10.1016/S0161-6420(99)00038-X; Hamel CP, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-7; Harris R. S., 2007, THESIS PENNSYLVANIA; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hendrickson A, 2002, EXP EYE RES, V74, P435, DOI 10.1006/exer.2002.1181; Hiripi L, 2010, TRANSGENIC RES, V19, P799, DOI 10.1007/s11248-009-9356-y; John SK, 2000, MOL VIS, V6, P204; Karlstam L, 2011, VET OPHTHALMOL, V14, P227, DOI 10.1111/j.1463-5224.2010.00866.x; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kelsell RE, 1998, HUM MOL GENET, V7, P1179, DOI 10.1093/hmg/7.7.1179; Kim Ben J, 2011, Retin Cases Brief Rep, V5, P56, DOI 10.1097/ICB.0b013e3181cc21ae; Kitiratschky VBD, 2008, INVEST OPHTH VIS SCI, V49, P5015, DOI 10.1167/iovs.08-1901; Koba Y, 2001, APPL ANIM BEHAV SCI, V73, P45, DOI 10.1016/S0168-1591(01)00106-X; Kornum BR, 2011, NEUROSCI BIOBEHAV R, V35, P437, DOI 10.1016/j.neubiorev.2010.05.004; Lillico SG, 2007, P NATL ACAD SCI USA, V104, P1771, DOI 10.1073/pnas.0610401104; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Marmor MF, 2011, DOC OPHTHALMOL, V122, P1, DOI 10.1007/s10633-011-9259-0; Marmorstein AD, 2007, TRENDS GENET, V23, P225, DOI 10.1016/j.tig.2007.03.001; MOSER AR, 1992, J CELL BIOL, V116, P1517, DOI 10.1083/jcb.116.6.1517; Niu YY, 2010, P NATL ACAD SCI USA, V107, P17663, DOI 10.1073/pnas.1006563107; Ovcharenko I, 2004, GENOME RES, V14, P472, DOI 10.1101/gr.2129504; Pacal M, 2006, CURR MOL MED, V6, P759; Park F, 2007, PHYSIOL GENOMICS, V31, P159, DOI 10.1152/physiolgenomics.00069.2007; Peshenko IV, 2004, BIOCHEMISTRY-US, V43, P13796, DOI 10.1021/bi048943m; Petters RM, 1997, NAT BIOTECHNOL, V15, P965, DOI 10.1038/nbt1097-965; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; Pickrell SW, 2004, INVEST OPHTH VIS SCI, V45, P3877, DOI 10.1167/iovs.04-0663; Ritchie WA, 2009, MOL REPROD DEV, V76, P61, DOI 10.1002/mrd.20930; Robert L, 2011, OPHTHALMIC RES, V45, P155, DOI 10.1159/000313992; Ropstad EO, 2008, INVEST OPHTH VIS SCI, V49, P1106, DOI 10.1167/iovs.07-0848; Rozmahel R, 1996, NAT GENET, V12, P280, DOI 10.1038/ng0396-280; Samardzija M, 2009, HUM MOL GENET, V18, P1266, DOI 10.1093/hmg/ddp026; Schook L, 2005, ANIM BIOTECHNOL, V16, P183, DOI 10.1080/10495390500265034; Srivastava B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004857; Tsai KL, 2007, MAMM GENOME, V18, P444, DOI 10.1007/s00335-007-9037-1; Whitelaw CBA, 2004, FEBS LETT, V571, P233, DOI 10.1016/j.febslet.2004.06.076; Wilkie SE, 2000, HUM MOL GENET, V9, P3065, DOI 10.1093/hmg/9.20.3065; Xiao XS, 2011, MOL VIS, V17, P3271; Yang SH, 2008, NATURE, V453, P921, DOI 10.1038/nature06975; Zhu XM, 2002, MOL VIS, V8, P462; Zhu XM, 2002, FEBS LETT, V524, P116, DOI 10.1016/S0014-5793(02)03014-4; Zonderland JJ, 2008, APPL ANIM BEHAV SCI, V111, P28, DOI 10.1016/j.applanim.2007.05.010	60	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71363	10.1371/journal.pone.0071363	http://dx.doi.org/10.1371/journal.pone.0071363			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977029	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700041
J	Sung, SY; Liao, CH; Wu, HP; Hsiao, WC; Wu, IH; Yu, JP; Lin, SH; Hsieh, CL				Sung, Shian-Ying; Liao, Chia-Hui; Wu, Hsun-Pai; Hsiao, Wan-Chi; Wu, I-Hui; Yu, Jinpu; Lin, Sue-Hwa; Hsieh, Chia-Ling			Loss of Let-7 MicroRNA Upregulates IL-6 in Bone Marrow-Derived Mesenchymal Stem Cells Triggering a Reactive Stromal Response to Prostate Cancer	PLOS ONE			English	Article							TUMOR STROMA; METASTATIC PATTERNS; IN-VIVO; INTERLEUKIN-6; GROWTH; CARCINOMA; EXPRESSION; DELIVERY; DIFFERENTIATION; PROLIFERATION	Bone marrow-derived mesenchymal stem cells (MSCs) are able to migrate to tumors, where they promote tumorigenesis and cancer metastasis. However, the molecular phenotype of the recruited MSCs at the tumor microenvironment and the genetic programs underlying their role in cancer progression remains largely unknown. By using a three-dimensional rotary wall vessel coculture system in which human MSCs were grown alone or in close contact with LNCaP, C4-2 or PC3 prostate cancer cell lines, we established in vitro matched pairs of normal and cancer-associated MSC derivatives to study the stromal response of MSCs to prostate cancer. We observed that prostate cancer-associated MSCs acquired a higher potential for adipogenic differentiation and exhibited a stronger ability to promote prostate cancer cell migration and invasion compared with normal MSCs both in vitro and in experimental animal models. The enhanced adipogenesis and the pro-metastatic properties were conferred by the high levels of IL-6 secretion by cancer-associated MSCs and were reversible by functionally inhibiting of IL-6. We also found that IL-6 is a direct target gene for the let-7 microRNA, which was downregulated in cancer-associated MSCs. The overexpression of let-7 via the transfection of let-7 precursors decreased IL-6 expression and repressed the adipogenic potential and metastasis-promoting activity of cancer-associated MSCs, which was consistent with the inhibition of IL-6 3'UTR luciferase activity. Conversely, the treatment of normal MSCs with let-7 inhibitors resulted in effects similar to those seen with IL-6. Taken together, our data demonstrated that MSCs co-evolve with prostate cancer cells in the tumor microenvironment, and the downregulation of let-7 by cancer-associated MSCs upregulates IL-6 expression. This upregulation triggers adipogenesis and facilitates prostate cancer progression. These findings not only provide key insights into the molecular basis of tumor-stroma interactions but also pave the way for new treatments for metastatic prostate cancer.	[Sung, Shian-Ying; Hsiao, Wan-Chi; Wu, I-Hui; Hsieh, Chia-Ling] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan; [Sung, Shian-Ying; Liao, Chia-Hui; Hsieh, Chia-Ling] China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan; [Wu, Hsun-Pai] China Med Univ, Sch Med, Taichung, Taiwan; [Yu, Jinpu] Tianjin Med Univ Canc Inst & Hosp, Tianjin, Peoples R China; [Lin, Sue-Hwa] Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA; [Hsieh, Chia-Ling] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Sung, Shian-Ying; Hsieh, Chia-Ling] Taipei Med Univ, Inst Translat Med, Taipei, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Tianjin Medical University; University of Texas System; UTMD Anderson Cancer Center; Asia University Taiwan; Taipei Medical University	Hsieh, CL (corresponding author), China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan.	chsieh2@mail.cmu.edu.tw		Wu, I-Hui/0000-0002-7115-239X	National Science Council in Taiwan [NSC 101-2314-B-039-007, NSC 99-2320-B-039-029-MY3, NSC 99-2632-B-039-001-MY3]; Taiwan Department of Health [DOH102-TD-C-111-005]; University Cancer Foundation via SINF of MD Anderson Cancer Center, USA	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); Taiwan Department of Health; University Cancer Foundation via SINF of MD Anderson Cancer Center, USA	This work was supported by grants NSC 101-2314-B-039-007, NSC 99-2320-B-039-029-MY3 and NSC 99-2632-B-039-001-MY3 from the National Science Council in Taiwan, grant DOH102-TD-C-111-005 from the Taiwan Department of Health, and the University Cancer Foundation via SINF of MD Anderson Cancer Center, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala G, 2003, CLIN CANCER RES, V9, P4792; Ayala GE, 2011, AM J PATHOL, V178, P79, DOI 10.1016/j.ajpath.2010.09.042; Barh D, 2010, CURR ONCOL, V17, P70; Barron DA, 2012, ENDOCR-RELAT CANCER, V19, pR187, DOI 10.1530/ERC-12-0085; Bobis S, 2006, FOLIA HISTOCHEM CYTO, V44, P215; Bubendorf L, 2000, HUM PATHOL, V31, P578, DOI 10.1053/hp.2000.6698; Cavarretta IT, 2007, ONCOGENE, V26, P2822, DOI 10.1038/sj.onc.1210097; CHUNG LWK, 1991, CANCER METAST REV, V10, P263, DOI 10.1007/BF00050797; Coleman RE, 2001, CANCER TREAT REV, V27, P165, DOI 10.1053/ctrv.2000.0210; Dakhova O, 2009, CLIN CANCER RES, V15, P3979, DOI 10.1158/1078-0432.CCR-08-1899; Djouad F, 2006, TRANSPLANTATION, V82, P1060, DOI 10.1097/01.tp.0000236098.13804.0b; Drachenberg DE, 1999, PROSTATE, V41, P127, DOI 10.1002/(SICI)1097-0045(19991001)41:2<127::AID-PROS7>3.0.CO;2-H; Feng ST, 2009, MOL CANCER THER, V8, P665, DOI 10.1158/1535-7163.MCT-08-0823; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Giatromanolaki A, 2007, CANC BIOL THER, V6; Giri D, 2001, AM J PATHOL, V159, P2159, DOI 10.1016/S0002-9440(10)63067-2; Hall B., 2007, V180, P263; Hess KR, 2006, CANCER, V106, P1624, DOI 10.1002/cncr.21778; Hsiao WC, 2012, MOL PHARMACEUT, V9, P1396, DOI 10.1021/mp200649g; Huang J, 2010, STEM CELLS, V28, P357, DOI 10.1002/stem.288; Huang WH, 2012, ONCOGENE; Hung SC, 2004, INT J CANCER, V110, P313, DOI 10.1002/ijc.20126; Hung SC, 2010, MOL PHARMACEUT, V7, P2312, DOI 10.1021/mp1002834; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Johnson NA, 2010, J GENE MED, V12, P892, DOI 10.1002/jgm.1516; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kim YJ, 2009, STEM CELLS, V27, P3093, DOI 10.1002/stem.235; Lee SO, 2003, CLIN CANCER RES, V9, P370; Liu CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053795; Malinowska K, 2009, ENDOCR-RELAT CANCER, V16, P155, DOI 10.1677/ERC-08-0174; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; McMurtry CT, 2003, J AM GERIATR SOC, V51, P1136, DOI 10.1046/j.1532-5415.2003.51367.x; Mishra PJ, 2008, CANCER RES, V68, P4331, DOI 10.1158/0008-5472.CAN-08-0943; Moinfar F, 2000, CANCER RES, V60, P2562; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Nakashima J, 2000, CLIN CANCER RES, V6, P2702; Nemeth JA, 1999, CANCER RES, V59, P1987; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Paget S., 1889, LANCET, V1, P571, DOI DOI 10.1016/S0140-6736(00)49915-0; Pascal LE, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-46; Potapova IA, 2007, STEM CELLS, V25, P1761, DOI 10.1634/stemcells.2007-0022; Ramasamy R, 2007, LEUKEMIA, V21, P304, DOI 10.1038/sj.leu.2404489; Rhee HW, 2001, IN VITRO CELL DEV-AN, V37, P127; Rojas A, 2011, ONCOGENE, V30, P2345, DOI 10.1038/onc.2010.605; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Roorda BD, 2009, CRIT REV ONCOL HEMAT, V69, P187, DOI 10.1016/j.critrevonc.2008.06.004; Rowley DR, 1998, CANCER METAST REV, V17, P411, DOI 10.1023/A:1006129420005; Studeny M, 2004, JNCI-J NATL CANCER I, V96, P1593, DOI 10.1093/jnci/djh299; Su YW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019412; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Sung SY, 2008, CANCER RES, V68, P9996, DOI 10.1158/0008-5472.CAN-08-2492; Tsai KS, 2011, GASTROENTEROLOGY, V141, P1046, DOI 10.1053/j.gastro.2011.05.045; Tuxhorn JA, 2001, J UROLOGY, V166, P2472, DOI 10.1016/S0022-5347(05)65620-0; Tuxhorn JA, 2002, CANCER RES, V62, P3298; Verma S, 2002, J CLIN PATHOL, V55, P693, DOI 10.1136/jcp.55.9.693; VILLAVICENCIO H, 1993, EUR UROL, V24, P118; Wu TT, 1998, INT J CANCER, V77, P887, DOI 10.1002/(SICI)1097-0215(19980911)77:6<887::AID-IJC15>3.0.CO;2-Z; Yadav A, 2011, MOL CANCER RES, V9, P1658, DOI 10.1158/1541-7786.MCR-11-0271; Yang L, 2003, BIOCHEM BIOPH RES CO, V305, P462, DOI 10.1016/S0006-291X(03)00792-7; Zhau HYE, 2011, CLIN CANCER RES, V17, P2159, DOI 10.1158/1078-0432.CCR-10-2523; Zhu W, 2006, EXP MOL PATHOL, V80, P267, DOI 10.1016/j.yexmp.2005.07.004	61	72	74	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71637	10.1371/journal.pone.0071637	http://dx.doi.org/10.1371/journal.pone.0071637			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977098	gold, Green Published, Green Submitted			2022-12-25	WOS:000323425700077
J	Dhruv, HD; Winslow, WSM; Armstrong, B; Tuncali, S; Eschbacher, J; Kislin, K; Loftus, JC; Tran, NL; Berens, ME				Dhruv, Harshil D.; Winslow, Wendy S. McDonough; Armstrong, Brock; Tuncali, Serdar; Eschbacher, Jenny; Kislin, Kerri; Loftus, Joseph C.; Tran, Nhan L.; Berens, Michael E.			Reciprocal Activation of Transcription Factors Underlies the Dichotomy between Proliferation and Invasion of Glioma Cells	PLOS ONE			English	Article							NF-KAPPA-B; C-MYC; CYCLIN-A; ASTROCYTOMA MIGRATION; NUCLEAR-LOCALIZATION; CANCER; PHOSPHORYLATION; EXPRESSION; TARGETS; GROWTH	Histology of malignant glioma depicts dense proliferative areas rich in angiogenesis as well as dissemination of neoplastic cells into adjacent brain tissue. Although the mechanisms that trigger transition from proliferative to invasive phenotypes are complex, the dichotomy of cell proliferation and migration, the "Go or Grow'' hypothesis, argues for specific and coordinated regulation of these phenotypes. We investigated transcriptional elements that accompany the phenotypes of migration and proliferation, and consider the therapeutic significance of the "Go or Grow'' hypothesis. Interrogation of matched core and rim regions from human glioblastoma biopsy specimens in situ (n = 44) revealed higher proliferation (Ki67 labeling index) in cells residing at the core compared to the rim. Profiling activated transcription factors in a panel of migration-activated versus migration-restricted GBM cells portrayed strong NF-kappa B activity in the migratory cell population. In contrast, increased c-Myc activity was found in migration-restricted proliferative cells. Validation of transcriptional activity by NF-kappa B- or c-Myc-driven GFP or RFP, respectively, showed an increased NF-kappa B activity in the active migrating cells, whereas the proliferative, migration restricted cells displayed increased c-Myc activity. Immunohistochemistry on clinical specimens validated a robust phosphorylated c-Myc staining in tumor cells at the core, whereas increased phosphorylated NF-kappa B staining was detected in the invasive tumor cells at the rim. Functional genomics revealed that depletion of c-Myc expression by siRNA oligonucleotides reduced cell proliferation in vitro, but surprisingly, cell migration was enhanced significantly. Conversely, inhibition of NF-kappa B by pharmacological inhibitors, SN50 or BAY-11, decreased both cell migration in vitro and invasion ex vivo. Notably, inhibition of NF-kappa B was found to have no effect on the proliferation rate of glioma cells. These findings suggest that the reciprocal and coordinated suppression/activation of transcription factors, such as c-Myc and NF-kappa B may underlie the shift of glioma cells from a "growing-to-going'' phenotype.	[Dhruv, Harshil D.; Winslow, Wendy S. McDonough; Armstrong, Brock; Tuncali, Serdar; Kislin, Kerri; Tran, Nhan L.; Berens, Michael E.] Translat Genom Res Inst, Phoenix, AZ USA; [Eschbacher, Jenny] St Josephs Hosp, Phoenix, AZ USA; [Loftus, Joseph C.] Mayo Clin Arizona, Scottsdale, AZ USA	Translational Genomics Research Institute; St. Joseph's Hospital and Medical Center; Mayo Clinic; Mayo Clinic Phoenix	Tran, NL (corresponding author), Translat Genom Res Inst, Phoenix, AZ USA.	ntran@tgen.org; mberens@tgen.org		Berens, Michael/0000-0002-3382-6787	Ben & Catherine Ivy Foundation [P50 CA108961]; NIH [R01 CA130940]; NATIONAL CANCER INSTITUTE [P50CA108961, R01CA130940] Funding Source: NIH RePORTER	Ben & Catherine Ivy Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was funded by the Ben & Catherine Ivy Foundation (MEB), P50 CA108961 (JCL), and NIH R01 CA130940 (NLT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amati Bruno, 1998, Frontiers in Bioscience, V3, pD250; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; BERENS ME, 1994, CLIN EXP METASTAS, V12, P405, DOI 10.1007/BF01755884; Berens ME, 2004, METH MOLEC MED, V88, P219; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; [CBTRUS C.B.T.R.o.t.U. States], 2010, CBTRUS STAT REP PRIM; Chuang YY, 2004, CANCER RES, V64, P8271, DOI 10.1158/0008-5472.CAN-04-2097; Claes A, 2007, ACTA NEUROPATHOL, V114, P443, DOI 10.1007/s00401-007-0293-7; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dang CV, 1999, MOL CELL BIOL, V19, P1; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; Demuth T, 2004, J NEURO-ONCOL, V70, P217, DOI 10.1007/s11060-004-2751-6; Dobson A. J, 2002, INTRO GEN LINEAR MOD; Dolled-Filhart M, 2006, CANCER RES, V66, P5487, DOI 10.1158/0008-5472.CAN-06-0100; Erlandsson F, 2000, EXP CELL RES, V259, P86, DOI 10.1006/excr.2000.4889; FIRTH D, 1991, STAT THEORY MODELLIN, P55; Fortin SP, 2009, MOL CANCER RES, V7, P1871, DOI 10.1158/1541-7786.MCR-09-0194; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; Giese A, 1996, INT J CANCER, V67, P275, DOI 10.1002/(SICI)1097-0215(19960717)67:2<275::AID-IJC20>3.0.CO;2-9; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; GIESE A, 1995, NEUROSURGERY, V37, P294, DOI 10.1227/00006123-199508000-00015; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Hatzikirou H, 2010, MATH MED BIOL; Hoelzinger DB, 2005, NEOPLASIA, V7, P7, DOI 10.1593/neo.04535; Hoelzinger DB, 2007, J NATL CANCER I, V99, P1583, DOI 10.1093/jnci/djm187; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Jin X, 2011, CANCER RES, V71, P3066, DOI 10.1158/0008-5472.CAN-10-1495; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kislin KL, 2009, NEOPLASIA, V11, P377, DOI 10.1593/neo.81572; Larsson LG, 2010, EXP CELL RES, V316, P1429, DOI 10.1016/j.yexcr.2010.03.025; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Loftus JC, 2009, MOL CANCER THER, V8, P1505, DOI 10.1158/1535-7163.MCT-08-1055; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Maggirwar SB, 1998, J NEUROSCI, V18, P10356; Mariani L, 2001, J NEURO-ONCOL, V53, P161, DOI 10.1023/A:1012253317934; McCullagh P, 1989, GEN LINEAR MODELS; McDonough WS, 2005, NEOPLASIA, V7, P862, DOI 10.1593/neo.05190; Nakada M, 2007, CELL MOL LIFE SCI, V64, P458, DOI 10.1007/s00018-007-6342-5; Nakada M, 2005, AM J PATHOL, V167, P565, DOI 10.1016/S0002-9440(10)62998-7; Nakada M, 2004, CANCER RES, V64, P3179, DOI 10.1158/0008-5472.CAN-03-3667; Nakano I, 2006, PEDIATR RES, V59, p54R, DOI 10.1203/01.pdr.0000203568.63482.f9; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Norden AD, 2009, NAT REV NEUROL, V5, P610, DOI 10.1038/nrneurol.2009.159; Obaya AJ, 1999, ONCOGENE, V18, P2934, DOI 10.1038/sj.onc.1202749; Oliver RJ, 2000, J ORAL PATHOL MED, V29, P426, DOI 10.1034/j.1600-0714.2000.290902.x; Paulino VM, 2010, MOL CANCER RES, V8, P1558, DOI 10.1158/1541-7786.MCR-10-0334; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Salhia B, 2006, EXPERT REV MOL DIAGN, V6, P613, DOI 10.1586/14737159.6.4.613; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Shishodia S, 2004, BIOCHEM PHARMACOL, V68, P1071, DOI 10.1016/j.bcp.2004.04.026; Soldani C, 2002, EUR J HISTOCHEM, V46, P377; Tate MC, 2009, NEUROTHERAPEUTICS, V6, P447, DOI 10.1016/j.nurt.2009.04.001; Tran NL, 2006, CANCER RES, V66, P9535, DOI 10.1158/0008-5472.CAN-06-0418; Yam CH, 2002, CELL MOL LIFE SCI, V59, P1317, DOI 10.1007/s00018-002-8510-y; Zanotto A, 2011, BIOCHEM PHARMACOL, V81, P412, DOI 10.1016/j.bcp.2010.10.014	56	44	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e72134	10.1371/journal.pone.0072134	http://dx.doi.org/10.1371/journal.pone.0072134			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967279	gold, Green Published, Green Submitted			2022-12-25	WOS:000323378000081
J	Kwon, MS; Park, KR; Kim, YD; Na, BR; Kim, HR; Choi, HJ; Piragyte, I; Jeon, H; Chung, KH; Song, WK; Eom, SH; Jun, CD				Kwon, Min-Sung; Park, Kyoung Ryoung; Kim, Young-Dae; Na, Bo-Ra; Kim, Hye-Ran; Choi, Hak-Jong; Piragyte, Indre; Jeon, Hyesung; Chung, Kyung Hwun; Song, Woo Keun; Eom, Soo Hyun; Jun, Chang-Duk			Swiprosin-1 Is a Novel Actin Bundling Protein That Regulates Cell Spreading and Migration	PLOS ONE			English	Article							CROSS-LINKING; BINDING PROTEIN; ARP2/3 COMPLEX; MEMBRANE PROTRUSION; HUMAN FASCIN; EF-HAND; F-ACTIN; PHOSPHORYLATION; IDENTIFICATION; DOMAIN	Protein functions are often revealed by their localization to specialized cellular sites. Recent reports demonstrated that swiprosin-1 is found together with actin and actin-binding proteins in the cytoskeleton fraction of human mast cells and NK-like cells. However, direct evidence of whether swiprosin-1 regulates actin dynamics is currently lacking. We found that swiprosin-1 localizes to microvilli-like membrane protrusions and lamellipodia and exhibits actin-binding activity. Overexpression of swiprosin-1 enhanced lamellipodia formation and cell spreading. In contrast, swiprosin-1 knockdown showed reduced cell spreading and migration. Swiprosin-1 induced actin bundling in the presence of Ca2+, and deletion of the EF-hand motifs partially reduced bundling activity. Swiprosin-1 dimerized in the presence of Ca2+ via its coiled-coil domain, and a lysine (Lys)-rich region in the coiled-coil domain was essential for regulation of actin bundling. Consistent with these observations, mutations of the EF-hand motifs and coiled-coil region significantly reduced cell spreading and lamellipodia formation. We provide new evidence of how swiprosin-1 influences cytoskeleton reorganization and cell spreading.	[Kwon, Min-Sung; Park, Kyoung Ryoung; Kim, Young-Dae; Na, Bo-Ra; Kim, Hye-Ran; Choi, Hak-Jong; Piragyte, Indre; Chung, Kyung Hwun; Song, Woo Keun; Eom, Soo Hyun; Jun, Chang-Duk] Gwangju Inst Sci & Technol, Sch Life Sci, Immune Synapse Res Ctr, Kwangju, South Korea; [Kwon, Min-Sung; Park, Kyoung Ryoung; Kim, Young-Dae; Na, Bo-Ra; Kim, Hye-Ran; Choi, Hak-Jong; Piragyte, Indre; Chung, Kyung Hwun; Song, Woo Keun; Eom, Soo Hyun; Jun, Chang-Duk] Gwangju Inst Sci & Technol, Cell Dynam Res Ctr, Kwangju, South Korea; [Jeon, Hyesung] Korea Inst Sci & Technol, Biomed Res Ctr, Seoul, South Korea	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Korea Institute of Science & Technology (KIST)	Jun, CD (corresponding author), Gwangju Inst Sci & Technol, Sch Life Sci, Immune Synapse Res Ctr, Kwangju, South Korea.	cdjun@gist.ac.kr	Choi, Hak-Jong/I-5640-2019	Piragyte-Langa Oliva, Indre/0000-0002-5963-6711	Cell Dynamics Research Center through National Research Foundation (NRF) [2012 0000766]; Bio & Medical Technology Development Program through National Research Foundation (NRF) [2011 0030157]; Basic Research Program through National Research Foundation (NRF) [2012R1A2A1A03002115]; Ministry of Education, Science and Technology (MEST)	Cell Dynamics Research Center through National Research Foundation (NRF); Bio & Medical Technology Development Program through National Research Foundation (NRF); Basic Research Program through National Research Foundation (NRF); Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Cell Dynamics Research Center (2012 0000766), Bio & Medical Technology Development Program (2011 0030157), and Basic Research Program (2012R1A2A1A03002115) through a National Research Foundation (NRF) grant funded by the Ministry of Education, Science and Technology (MEST). Image acquisition was performed using the imaging facility of the BioImaging Research Center at GIST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1970, EXP CELL RES, V60, P437, DOI 10.1016/0014-4827(70)90537-9; Adams JC, 1999, MOL BIOL CELL, V10, P4177, DOI 10.1091/mbc.10.12.4177; Altman A, 2003, IMMUNOL REV, V192, P53, DOI 10.1034/j.1600-065X.2003.00027.x; Avramidou A, 2007, CELL DEATH DIFFER, V14, P1936, DOI 10.1038/sj.cdd.4402206; Ayscough KR, 1998, CURR OPIN CELL BIOL, V10, P102, DOI 10.1016/S0955-0674(98)80092-6; Ballif BA, 2008, J PROTEOME RES, V7, P311, DOI 10.1021/pr0701254; Bartles JR, 2000, CURR OPIN CELL BIOL, V12, P72, DOI 10.1016/S0955-0674(99)00059-9; Bellanger JM, 2000, NAT CELL BIOL, V2, P888, DOI 10.1038/35046533; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Blethrow JD, 2008, P NATL ACAD SCI USA, V105, P1442, DOI 10.1073/pnas.0708966105; Checinska A, 2009, J PROTEOMICS, V72, P575, DOI 10.1016/j.jprot.2008.11.016; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Cox EA, 2001, MOL BIOL CELL, V12, P265, DOI 10.1091/mbc.12.2.265; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; Dutting S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-2; FECHHEIMER M, 1984, J BIOL CHEM, V259, P4514; Ferrer-Acosta Y, 2013, J NEUROCHEM, V125, P921, DOI 10.1111/jnc.12155; Ferrer-Acosta Y, 2013, PROTEIN PEPTIDE LETT, V20, P573; Fontao L, 2001, J CELL SCI, V114, P2065; Furukawa R, 2003, J CELL SCI, V116, P187, DOI 10.1242/jcs.00220; George SP, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703617200; Gimona M, 2002, FEBS LETT, V513, P98, DOI 10.1016/S0014-5793(01)03240-9; Hagen S, 2012, CELL CALCIUM, V51, P411, DOI 10.1016/j.ceca.2012.01.004; HARTWIG JH, 1994, PROTEIN PROFILE, V1, P711; Hornbruch-Freitag C, 2011, J CELL SCI, V124, P3266, DOI 10.1242/jcs.083907; Kim HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059793; Kim HR, 2011, J EXP MED, V208, P2545, DOI 10.1084/jem.20110853; Kroczek C, 2010, J IMMUNOL, V184, P3665, DOI 10.4049/jimmunol.0903642; MATSUDAIRA P, 1991, TRENDS BIOCHEM SCI, V16, P87, DOI 10.1016/0968-0004(91)90039-X; Matsudaira Paul, 1994, Seminars in Cell Biology, V5, P165, DOI 10.1006/scel.1994.1021; Meng XB, 2005, J PROTEOME RES, V4, P2081, DOI 10.1021/pr0502121; Mielenz D, 2005, J IMMUNOL, V174, P3508, DOI 10.4049/jimmunol.174.6.3508; NOEGEL A, 1987, FEBS LETT, V221, P391, DOI 10.1016/0014-5793(87)80962-6; Okamoto KI, 2007, P NATL ACAD SCI USA, V104, P6418, DOI 10.1073/pnas.0701656104; Ono S, 1997, J BIOL CHEM, V272, P2527; Park SJ, 2007, GENES CELLS, V12, P611, DOI 10.1111/j.1365-2443.2007.01081.x; Puius YA, 1998, CURR OPIN CELL BIOL, V10, P23, DOI 10.1016/S0955-0674(98)80083-5; Ramesh T P, 2009, Immune Netw, V9, P274, DOI 10.4110/in.2009.9.6.274; Rivera J, 2001, INT ARCH ALLERGY IMM, V124, P137, DOI 10.1159/000053692; Shaffer JF, 2009, J BIOL CHEM, V284, P12318, DOI 10.1074/jbc.M808850200; Silverman MA, 2006, MOL CELL BIOL, V26, P1826, DOI 10.1128/MCB.26.5.1826-1838.2006; SMALL JV, 1978, NATURE, V272, P638, DOI 10.1038/272638a0; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Thylur RP, 2009, J CELL BIOCHEM, V108, P705, DOI 10.1002/jcb.22307; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; Vega IE, 2008, J NEUROCHEM, V106, P96, DOI 10.1111/j.1471-4159.2008.05339.x; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Vuadens F, 2004, PROTEOMICS, V4, P2216, DOI 10.1002/pmic.200300779; WINDER SJ, 1995, J CELL SCI, V108, P63; Yamakita Y, 1996, J BIOL CHEM, V271, P12632, DOI 10.1074/jbc.271.21.12632; Zanivan S, 2008, J PROTEOME RES, V7, P5314, DOI 10.1021/pr800599n	54	122	125	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71626	10.1371/journal.pone.0071626	http://dx.doi.org/10.1371/journal.pone.0071626			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977092	Green Published, Green Submitted, gold			2022-12-25	WOS:000323378000061
J	Rask-Andersen, M; Moschonis, G; Chrousos, GP; Marcus, C; Dedoussis, GV; Fredriksson, R; Schioth, HB				Rask-Andersen, Mathias; Moschonis, George; Chrousos, George P.; Marcus, Claude; Dedoussis, George V.; Fredriksson, Robert; Schioth, Helgi B.			The STK33-Linked SNP rs4929949 Is Associated with Obesity and BMI in Two Independent Cohorts of Swedish and Greek Children	PLOS ONE			English	Article							SERINE/THREONINE KINASE; CANDIDATE GENE; BODY-WEIGHT; STK33; OVERWEIGHT; TUB	Recent genome wide association studies (GWAS) have identified a locus on chromosome 11p15.5, closely associated with serine/threonine kinase 33 (STK33), to be associated with body mass. STK33, a relatively understudied protein, has been linked to KRAS mutation-driven cancers and explored as a potential antineoplastic drug target. The strongest association with body mass observed at this loci in GWAS was rs4929949, a single nucleotide polymorphism located within intron 1 of the gene encoding STK33. The functional implications of rs4929949 or related variants have not been explored as of yet. We have genotyped rs4929949 in two cohorts, an obesity case-control cohort of 991 Swedish children, and a cross-sectional cohort of 2308 Greek school children. We found that the minor allele of rs4929949 was associated with obesity in the cohort of Swedish children and adolescents (OR = 1.199 (95%CI: 1.002-1.434), p = 0.047), and with body mass in the cross-sectional cohort of Greek children (beta = 0.08147 (95% CI: 0.1345-0.1618), p = 0.021). We observe the effects of rs4929949 on body mass to be detectable already at adolescence. Subsequent analysis did not detect any association of rs4929949 to phenotypic measurements describing body adiposity or to metabolic factors such as insulin levels, triglycerides and insulin resistance (HOMA).	[Rask-Andersen, Mathias; Fredriksson, Robert; Schioth, Helgi B.] Uppsala Univ BMC, Dept Neurosci, Uppsala, Sweden; [Moschonis, George; Dedoussis, George V.] Harokopio Univ Athens, Dept Nutr & Dietet, Athens, Greece; [Marcus, Claude] Karolinska Inst, Dept Pediat, Dept Clin Sci Intervent & Technol CLINTEC, Karolinska Univ Hosp, Huddinge, Sweden; [Chrousos, George P.] Univ Athens, Sch Med, Dept Pediat 1, Aghia Sophia Childrens Hosp, GR-11527 Athens, Greece	Uppsala University; Harokopio University Athens; Karolinska Institutet; Karolinska University Hospital; Athens Medical School; National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital	Schioth, HB (corresponding author), Uppsala Univ BMC, Dept Neurosci, Uppsala, Sweden.	Helgi.Schioth@neuro.uu.se	Dedoussis, George/AAN-7252-2021; Marcus, Claude/ABE-1177-2020; Fredriksson, Robert/AAH-3921-2019; Schioth, Helgi/AAQ-7239-2020; Moschonis, George/AAM-9616-2021	Dedoussis, George/0000-0002-7798-6221; Marcus, Claude/0000-0003-0890-2650; Fredriksson, Robert/0000-0002-2810-3226; Moschonis, George/0000-0003-3009-6675; Rask-Andersen, Mathias/0000-0002-8008-4659	Swedish Research Council; Brain Research Foundation; Novo Nordisk Foundation; Tore Nilsons foundation; Ahlens foundation; Goran Gustafsson foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Brain Research Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Tore Nilsons foundation; Ahlens foundation; Goran Gustafsson foundation	The study was supported by the Swedish Research Council, Brain Research Foundation, Novo Nordisk Foundation, Tore Nilsons foundation and Ahlens foundation. R.F. was supported by the Goran Gustafsson foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2009, COLD SPRING HARB PRO; Brauksiepe Bastienne, 2008, BMC Biochemistry, V9, P25, DOI 10.1186/1471-2091-9-25; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Farooqi IS, 2005, ANNU REV MED, V56, P443, DOI 10.1146/annurev.med.56.062904.144924; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Jacobsson JA, 2012, OBES REV, V13, P1096, DOI 10.1111/j.1467-789X.2012.01025.x; Jacobsson JA, 2012, INT J OBESITY, V36, P119, DOI 10.1038/ijo.2011.11; Kranenburg O, 2005, BBA-REV CANCER, V1756, P81, DOI 10.1016/j.bbcan.2005.10.001; Luo TP, 2012, P NATL ACAD SCI USA, V109, P2860, DOI 10.1073/pnas.1120589109; Moschonis G, 2010, PUBLIC HEALTH NUTR, V13, P1693, DOI 10.1017/S1368980010002247; Mujica AO, 2005, FEBS J, V272, P4884, DOI 10.1111/j.1742-4658.2005.04900.x; Mujica AO, 2001, GENE, V280, P175, DOI 10.1016/S0378-1119(01)00780-6; OECD, 2010, OB EC PREV FIT FAT; Prada PO, 2013, DIABETES, V62, P137, DOI 10.2337/db11-1388; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Shiri-Sverdlov R, 2006, DIABETES, V55, P385, DOI 10.2337/diabetes.55.02.06.db05-0997; Sjoberg A, 2011, OBES REV, V12, P305, DOI 10.1111/j.1467-789X.2010.00838.x; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Snieder H, 2008, DIABETOLOGIA, V51, P54, DOI 10.1007/s00125-007-0851-5; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Tanner JM, 1955, GROWTH ADOLESCENCE; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287	24	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71353	10.1371/journal.pone.0071353	http://dx.doi.org/10.1371/journal.pone.0071353			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967198	Green Published, Green Submitted, gold			2022-12-25	WOS:000323378000046
J	Silva, A; Sampaio-Marques, B; Fernandes, A; Carreto, L; Rodrigues, F; Holcik, M; Santos, MAS; Ludovico, P				Silva, Alexandra; Sampaio-Marques, Belem; Fernandes, Angela; Carreto, Laura; Rodrigues, Fernando; Holcik, Martin; Santos, Manuel A. S.; Ludovico, Paula			Involvement of Yeast HSP90 Isoforms in Response to Stress and Cell Death Induced by Acetic Acid	PLOS ONE			English	Article							PROTEIN-KINASE GCN2; HEAT-SHOCK PROTEINS; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; INITIATION-FACTOR; 5'-UNTRANSLATED REGION; TRANSLATIONAL CONTROL; MINIMUM INFORMATION; MICROARRAY DATA; APOPTOSIS	Acetic acid-induced apoptosis in yeast is accompanied by an impairment of the general protein synthesis machinery, yet paradoxically also by the up-regulation of the two isoforms of the heat shock protein 90 (HSP90) chaperone family, Hsc82p and Hsp82p. Herein, we show that impairment of cap-dependent translation initiation induced by acetic acid is caused by the phosphorylation and inactivation of eIF2 alpha by Gcn2p kinase. A microarray analysis of polysome-associated mRNAs engaged in translation in acetic acid challenged cells further revealed that HSP90 mRNAs are over-represented in this polysome fraction suggesting preferential translation of HSP90 upon acetic acid treatment. The relevance of HSP90 isoform translation during programmed cell death (PCD) was unveiled using genetic and pharmacological abrogation of HSP90, which suggests opposing roles for HSP90 isoforms in cell survival and death. Hsc82p appears to promote survival and its deletion leads to necrotic cell death, while Hsp82p is a pro-death molecule involved in acetic acid-induced apoptosis. Therefore, HSP90 isoforms have distinct roles in the control of cell fate during PCD and their selective translation regulates cellular response to acetic acid stress.	[Silva, Alexandra; Sampaio-Marques, Belem; Fernandes, Angela; Rodrigues, Fernando; Ludovico, Paula] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst, Braga, Portugal; [Silva, Alexandra; Sampaio-Marques, Belem; Fernandes, Angela; Rodrigues, Fernando; Ludovico, Paula] 3Bs PT Govt Assoc Lab, Life & Hlth Sci Res Inst, Braga, Portugal; [Carreto, Laura; Santos, Manuel A. S.] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Carreto, Laura; Santos, Manuel A. S.] Univ Aveiro, Ctr Enseignement Stat Appl Med, P-3800 Aveiro, Portugal; [Holcik, Martin] Childrens Hosp Eastern Ontario, Res Inst, Apoptosis Res Ctr, Ottawa, ON K1H 8L1, Canada	Universidade do Minho; Universidade de Aveiro; Universidade de Aveiro; University of Ottawa; Children's Hospital of Eastern Ontario	Ludovico, P (corresponding author), Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst, Braga, Portugal.	pludovico@ecsaude.uminho.pt	Ludovico, Paula/B-4338-2011; Silva, Alexandra/J-9833-2013; Sampaio-Marques, B./M-4758-2013; Fernandes, Ângela/C-1592-2014; Rodrigues, Fernando/T-5299-2018; Sampaio-Marques, Belém/GPG-0757-2022; Rodrigues, Fernando/A-3123-2011; Holcik, Martin/AAC-6660-2019; Santos, Manuel/E-6704-2010	Ludovico, Paula/0000-0003-4130-7167; Silva, Alexandra/0000-0001-7604-792X; Sampaio-Marques, B./0000-0001-6580-0971; Fernandes, Ângela/0000-0003-4528-4951; Rodrigues, Fernando/0000-0001-8436-9398; Holcik, Martin/0000-0002-1922-5299; Santos, Manuel/0000-0002-0437-1146; Fernandes, Angela/0000-0002-8255-5602	Fundacao para a Ciencia e Tecnologia; COMPETE/QREN/EU [PTDC/BIA-MIC/114116/2009]; Canadian Institute for Health Research [MOP 89737]; Fundação para a Ciência e a Tecnologia [PTDC/BIA-MIC/114116/2009] Funding Source: FCT	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); COMPETE/QREN/EU(European Commission); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Fundação para a Ciência e a Tecnologia	This work was supported by Fundacao para a Ciencia e Tecnologia and COMPETE/QREN/EU (PTDC/BIA-MIC/114116/2009), and by the Canadian Institute for Health Research (MOP 89737 to MH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 2004, J BIOL CHEM, V279, P49919, DOI 10.1074/jbc.M404681200; Almeida B, 2009, PROTEOMICS, V9, P720, DOI 10.1002/pmic.200700816; Ayrault O, 2009, P NATL ACAD SCI USA, V106, P17037, DOI 10.1073/pnas.0902880106; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chiosis G., 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P1, DOI 10.2174/187152006774755483; Chiosis G, 2006, EXPERT OPIN THER TAR, V10, P37, DOI 10.1517/14728222.10.1.37; Chiosis G, 2006, ACS CHEM BIOL, V1, P279, DOI 10.1021/cb600224w; Clemens MJ, 2000, CELL DEATH DIFFER, V7, P603, DOI 10.1038/sj.cdd.4400695; CRAIG EA, 1993, MICROBIOL REV, V57, P402, DOI 10.1128/MMBR.57.2.402-414.1993; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; De Quinto SL, 2000, RNA, V6, P1380, DOI 10.1017/S1355838200000753; deHaro C, 1996, FASEB J, V10, P1378, DOI 10.1096/fasebj.10.12.8903508; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Donze O, 1999, MOL CELL BIOL, V19, P8422, DOI 10.1128/mcb.19.12.8422; Dudgeon DD, 2008, EUKARYOT CELL, V7, P2037, DOI 10.1128/EC.00291-08; Eisenberg T, 2010, APOPTOSIS, V15, P257, DOI 10.1007/s10495-009-0453-4; ERKINE AM, 1995, YEAST, V11, P573, DOI 10.1002/yea.320110607; Franzosa EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028211; Gilbert WV, 2007, SCIENCE, V317, P1224, DOI 10.1126/science.1144467; Graber TE, 2007, MOL BIOSYST, V3, P825, DOI 10.1039/b708867a; Hinnebusch Alan G., 1994, Seminars in Cell Biology, V5, P417, DOI 10.1006/scel.1994.1049; Holcik M, 2000, TRENDS GENET, V16, P469, DOI 10.1016/S0168-9525(00)02106-5; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hueso G, 2012, BIOCHEM J, V441, P255, DOI 10.1042/BJ20111264; Lanneau D, 2008, J CELL MOL MED, V12, P743, DOI 10.1111/j.1582-4934.2008.00273.x; Lewis J, 2000, J BIOL CHEM, V275, P10519, DOI 10.1074/jbc.275.14.10519; Ludovico P, 2005, IUBMB LIFE, V57, P129, DOI 10.1080/15216540500090553; Ludovico P, 2001, MICROBIOL-SGM, V147, P2409, DOI 10.1099/00221287-147-9-2409; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Mazzoni C, 2005, FEMS YEAST RES, V5, P1229, DOI 10.1016/j.femsyr.2005.07.007; Mazzoni C, 2003, MOL BIOL CELL, V14, P721, DOI 10.1091/mbc.E02-05-0258; Mazzoni C, 2011, BIOCHEM SOC T, V39, P1461, DOI 10.1042/BST0391461; Mroczek S, 2008, NUCLEIC ACIDS RES, V36, P2874, DOI 10.1093/nar/gkm1100; Neckers L, 2002, TRENDS MOL MED, V8, pS55, DOI 10.1016/S1471-4914(02)02316-X; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Reikvam H, 2009, CURR CANCER DRUG TAR, V9, P761, DOI 10.2174/156800909789271486; Richardson PG, 2011, BRIT J HAEMATOL, V152, P367, DOI 10.1111/j.1365-2141.2010.08360.x; Rubtsova MP, 2003, J BIOL CHEM, V278, P22350, DOI 10.1074/jbc.M303213200; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Shenton D, 2006, J BIOL CHEM, V281, P29011, DOI 10.1074/jbc.M601545200; Sreedhar AS, 2004, FEBS LETT, V562, P11; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Tesic M, 2003, J BIOL CHEM, V278, P32692, DOI 10.1074/jbc.M304315200; Vanden Berghe T, 2004, J BIOL CHEM, V279, P7925, DOI 10.1074/jbc.M307807200; Vanden Berghe T, 2003, J BIOL CHEM, V278, P5622, DOI 10.1074/jbc.M208925200; WEK RC, 1990, MOL CELL BIOL, V10, P2820, DOI 10.1128/MCB.10.6.2820	49	18	19	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71294	10.1371/journal.pone.0071294	http://dx.doi.org/10.1371/journal.pone.0071294			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967187	Green Published, gold			2022-12-25	WOS:000323378000038
J	Arounleut, P; Bowser, M; Upadhyay, S; Shi, XM; Fulzele, S; Johnson, MH; Stranahan, AM; Hill, WD; Isales, CM; Hamrick, MW				Arounleut, Phonepasong; Bowser, Matthew; Upadhyay, Sunil; Shi, Xing-Ming; Fulzele, Sadanand; Johnson, Maribeth H.; Stranahan, Alexis M.; Hill, William D.; Isales, Carlos M.; Hamrick, Mark W.			Absence of Functional Leptin Receptor Isoforms in the POUND (Lepr(db/lb)) Mouse Is Associated with Muscle Atrophy and Altered Myoblast Proliferation and Differentiation	PLOS ONE			English	Article							INCREASES BONE-FORMATION; SKELETAL-MUSCLE; GENE-EXPRESSION; MASS; OB/OB; MYOSTATIN; HYPERTROPHY; CELLS; IGF	Objective: Leptin receptors are abundant in human skeletal muscle, but the role of leptin in muscle growth, development and aging is not well understood. Here we utilized a novel mouse model lacking all functional leptin receptor isoforms (POUND mouse, Lepr(db/lb)) to determine the role of leptin in skeletal muscle. Methods and Findings: Skeletal muscle mass and fiber diameters were examined in POUND mice, and primary myoblast cultures were used to determine the effects of altered leptin signaling on myoblast proliferation and differentiation. ELISA assays, integrated pathway analysis of mRNA microarrays, and reverse phase protein analysis were performed to identify signaling pathways impacted by leptin receptor deficiency. Results show that skeletal muscle mass and fiber diameter are reduced 30-40% in POUND mice relative to wild-type controls. Primary myoblast cultures demonstrate decreased proliferation and decreased expression of both MyoD and myogenin in POUND mice compared to normal mice. Leptin treatment increased proliferation in primary myoblasts from muscles of both adult (12 months) and aged (24 months) wild-type mice, and leptin increased expression of MyoD and myogenin in aged primary myoblasts. ELISA assays and protein arrays revealed altered expression of molecules associated with the IGF-1/Akt and MAPK/MEK signaling pathways in muscle from the hindlimbs of mice lacking functional leptin receptors. Conclusion: These data support the hypothesis that the adipokine leptin is a key factor important for the regulation of skeletal muscle mass, and that leptin can act directly on its receptors in peripheral tissues to regulate cell proliferation and differentiation.	[Arounleut, Phonepasong; Bowser, Matthew; Upadhyay, Sunil; Shi, Xing-Ming; Fulzele, Sadanand; Johnson, Maribeth H.; Stranahan, Alexis M.; Hill, William D.; Isales, Carlos M.; Hamrick, Mark W.] Georgia Regents Univ, Georgia Hlth Sci Univ, Augusta, GA USA	University System of Georgia; Augusta University	Hamrick, MW (corresponding author), Georgia Regents Univ, Georgia Hlth Sci Univ, Augusta, GA USA.	mhamrick@gru.edu	Isales, Carlos/J-9902-2013; Hamrick, Mark/K-1131-2016; Stranahan, Alexis/AAF-3559-2020	Isales, Carlos/0000-0002-4480-3484; 	National Institute on Aging [P01 AG036675]; NATIONAL INSTITUTE ON AGING [P01AG036675] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding for this research was provided by the National Institute on Aging (P01 AG036675). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 2008, AM J PHYSIOL-ENDOC M, V294, pE918, DOI 10.1152/ajpendo.00798.2007; Amirouche A, 2009, ENDOCRINOLOGY, V150, P286, DOI 10.1210/en.2008-0959; [Anonymous], ANN LONG TERM CARE; Baldwin W, 2011, DIABETES, V60, P1258, DOI 10.2337/db10-0916; Bartell SM, 2011, J BONE MINER RES, V26, P1710, DOI 10.1002/jbmr.406; Bowser M, 2013, EXP GERONTOL, V48, P290, DOI 10.1016/j.exger.2012.11.004; Chan JL, 2008, J CLIN ENDOCR METAB, V93, P2819, DOI 10.1210/jc.2008-0056; Charles River Informational Resources, 2008, CHARLES RIVER INFORM; Chen YW, 2007, PHYSIOL GENOMICS, V31, P510, DOI 10.1152/physiolgenomics.00115.2006; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; Crespi EJ, 2006, P NATL ACAD SCI USA, V103, P10092, DOI 10.1073/pnas.0507519103; Fernandez-Real JM, 2000, EUR J ENDOCRINOL, V142, P25, DOI 10.1530/eje.0.1420025; Flier JS, 1998, J CLIN ENDOCR METAB, V83, P1407, DOI 10.1210/jc.83.5.1407; Gat-Yablonski G, 2008, CURR OPIN CLIN NUTR, V11, P303, DOI 10.1097/MCO.0b013e3282f795cf; Glass DJ, 2010, CURR TOP MICROBIOL, V346, P267, DOI 10.1007/82_2010_78; Guerra B, 2007, J APPL PHYSIOL, V102, P1786, DOI 10.1152/japplphysiol.01313.2006; Hamrick MW, 2008, J BONE MINER RES, V23, P870, DOI [10.1359/jbmr.080213, 10.1359/JBMR.080213]; Hamrick MW, 2006, BONE, V39, P845, DOI 10.1016/j.bone.2006.04.011; Hamrick MW, 2010, BIOCHEM BIOPH RES CO, V400, P379, DOI 10.1016/j.bbrc.2010.08.079; Hamrick MW, 2005, J BONE MINER RES, V20, P994, DOI 10.1359/JBMR.050103; Hamrick MW, 2004, J BONE MINER RES, V19, P1607, DOI 10.1359/JBMR.040712; Hamrick MW, 2004, BONE, V34, P376, DOI 10.1016/j.bone.2003.11.020; Liu P, 2012, J ANIM PHYSL ANIM NU; Nguyen MH, 2011, THESCIENTIFICWORLDJO, V11, P1525, DOI 10.1100/tsw.2011.137; Margetic S, 2002, INT J OBESITY, V26, P1407, DOI 10.1038/sj.ijo.0802142; Maroni P, 2005, CELL BIOL INT, V29, P542, DOI 10.1016/j.cellbi.2005.03.008; Maroni P, 2003, MOL CELL ENDOCRINOL, V201, P109, DOI 10.1016/S0303-7207(02)00427-6; Mathey J, 2002, CALCIFIED TISSUE INT, V70, P305, DOI 10.1007/s00223-001-2077-8; Narici MV, 2010, BRIT MED BULL, V95, P139, DOI 10.1093/bmb/ldq008; Olmedillas H, 2010, EUR J APPL PHYSIOL, V108, P749, DOI 10.1007/s00421-009-1281-5; Pijet M, 2013, CYTOKINE, V61, P445, DOI 10.1016/j.cyto.2012.11.002; Rando TA, 1997, METHOD CELL BIOL, V52, P261, DOI 10.1016/S0091-679X(08)60382-9; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Sainz N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006808; Solberg R, 2005, J CELL BIOCHEM, V96, P89, DOI 10.1002/jcb.20521; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009; Turner RT, 2013, J BONE MINER RES, V28, P22, DOI 10.1002/jbmr.1734; Wang JL, 1998, NATURE, V393, P684, DOI 10.1038/31474; Warmington SA, 2000, INT J OBESITY, V24, P1040, DOI 10.1038/sj.ijo.0801357; Welt CK, 2004, NEW ENGL J MED, V351, P987, DOI 10.1056/NEJMoa040388; White MF, 2003, SCIENCE, V302, P1710, DOI 10.1126/science.1092952; Willard M, 1991, JAMA-J AM MED ASSOC, V243, P1720; Williams NG, 2011, ENDOCRINOLOGY, V152, P172, DOI 10.1210/en.2010-0488; Yu TY, 2008, BIOSCI BIOTECH BIOCH, V72, P13, DOI 10.1271/bbb.70244	45	39	40	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e72330	10.1371/journal.pone.0072330	http://dx.doi.org/10.1371/journal.pone.0072330			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967295	Green Submitted, gold, Green Published			2022-12-25	WOS:000323221500128
J	Fralick, M; Denny, CJ; Redelmeier, DA				Fralick, Michael; Denny, Christopher J.; Redelmeier, Donald A.			Drowning and the Influence of Hot Weather	PLOS ONE			English	Article							RISK-FACTORS; MORTALITY	Background: Drowning deaths are devastating and preventable. Public perception does not regard hot weather as a common scenario for drowning deaths. The objective of our study was to test the association between hot weather and drowning risk. Materials and Methods: We conducted a retrospective case-crossover analysis of all unintentional drowning deaths in Ontario, Canada from 1999 to 2009. Demographic data were obtained from the Office of the Chief Coroner. Weather data were obtained from Environment Canada. We used the pair-matched analytic approach for the case-crossover design to contrast the weather on the date of the drowning with the weather at the same location one week prior (control period). Results: We identified 1243 drowning deaths. The mean age was 40 years, 82% were male, and most events (71%) occurred in open water. The pair-matched analytic approach indicated that temperatures exceeding 30 degrees C were associated with a 69% increase in the risk of outdoor drowning (OR = 1.69, 95% CI 1.23-2.25, p = 0.001). For indoor drowning, however, temperatures exceeding 30 degrees C were not associated with a statistically significant increase in the risk of drowning (OR = 1.50, 95% CI 0.53-4.21, p = 0.442). Adult men were specifically prone to drown in hot weather (OR 1.67, 95% CI 1.19-2.34, p = 0.003) yet an apparent increase in risk extended to both genders and all age groups. Conclusion: Contrary to popular belief, hot weather rather than cold stormy weather increases the risk of drowning. An awareness of this risk might encourage greater use of drowning prevention strategies known to save lives.	[Fralick, Michael; Redelmeier, Donald A.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Denny, Christopher J.] Univ Toronto, Dept Emergency Med, Toronto, ON, Canada; [Denny, Christopher J.] Auckland Dist Hlth Board, Dept Emergency Med, Auckland, New Zealand; [Redelmeier, Donald A.] Sunnybrook Hlth Sci Ctr, Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada	University of Toronto; University of Toronto; Auckland District Health Board; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Fralick, M (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	mike.fralick@mail.utoronto.ca						Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08; Barker R, 2008, INJURY B, V104, P1; Branche CM, 2001, LIFEGUARD EFFECTIVEN; Burford AE, 2005, PEDIATR EMERG CARE, V21, P610, DOI 10.1097/01.pec.0000177204.21774.35; Centers for Disease Control and Prevention National Center for Injury Prevention and Control, 2012, UNINT DROWN FACT SHE; Cummings P, 2011, INJURY PREV, V17, P156, DOI 10.1136/ip.2010.028688; Danet S, 1999, CIRCULATION, V100, pE11, DOI 10.1161/01.CIR.100.1.e1; Environment Canada, 2012, NAT CLIM DAT INF ARC; Gulliver P, 2005, AUST NZ J PUBL HEAL, V29, P238, DOI 10.1111/j.1467-842X.2005.tb00761.x; Homer, 1871, ODYSSEY; Howland J, 1986, AM J PUBLIC HEALTH, V86, P93; Jani AA, 2006, J PUBLIC HEALTH MAN, V12, P97; Junger P, 1997, PERFECT STORM; Lauwers B, 2011, REV ALL ACCIDENTAL D; Layon AJ, 2009, ANESTHESIOLOGY, V110, P1390, DOI 10.1097/ALN.0b013e3181a4c3b8; Lifesaving Society, 2003, NAT DROWN TRENDS REP; Lifesaving Society, 2012, NAT DROWN PREV WEEK; Lifesaving society, 2012, CAN DROWN REP; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Melville Herman, 1851, MOBY DICK; O'Connor PJ, 2006, ACCIDENT ANAL PREV, V38, P737, DOI 10.1016/j.aap.2006.01.004; Ontario Government, 2010, GEOGR ONT ITS BIG PL; Ontario Government, 2012, ONT NAT RES WAT LAK; Pearn JH, 2008, INT J INJ CONTROL SA, V15, P122, DOI 10.1080/17457300802150587; Petronis KA, 2009, CLIN PEDIATR, V48, P534, DOI 10.1177/0009922808330108; Queensland Government, 2007, ES INJ PREV; Rahman A, 2006, Int J Inj Contr Saf Promot, V13, P101, DOI 10.1080/17457300500172941; Shakespeare W, 1864, TEMPEST; *SMARTRISK, 2009, EC BURD INJ CAN; Smith G S, 1995, Inj Prev, V1, P216, DOI 10.1136/ip.1.4.216; Szpilman D, 2012, NEW ENGL J MED, V366, P2102, DOI 10.1056/NEJMra1013317; Thompson DC, 2001, POOL FENCING PREVENT; Van Beeck EFBCM, 2005, B WORLD HEALTH ORGAN, V83, P801; World Health Organization, 2012, FACTS INJ DROWN; Yang L, 2007, INJURY PREV, V13, P178, DOI 10.1136/ip.2006.013409; Zanobetti A, 2012, P NATL ACAD SCI USA, V109, P6608, DOI 10.1073/pnas.1113070109	36	22	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71689	10.1371/journal.pone.0071689	http://dx.doi.org/10.1371/journal.pone.0071689			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23977112	Green Published, gold			2022-12-25	WOS:000323221500095
J	Spirig, R; Schaub, A; Kropf, A; Miescher, S; Spycher, MO; Rieben, R				Spirig, Rolf; Schaub, Alexander; Kropf, Alain; Miescher, Sylvia; Spycher, Martin O.; Rieben, Robert			Reconstituted High-Density Lipoprotein Modulates Activation of Human Leukocytes	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; APOLIPOPROTEIN-A-I; TOLL-LIKE RECEPTORS; DENDRITIC CELLS; ISCHEMIA/REPERFUSION INJURY; NEUTROPHIL ACTIVATION; LIPOTEICHOIC ACID; HEPARAN-SULFATE; HUMAN MONOCYTES; HYALURONAN	An anti-inflammatory effect of reconstituted High Density Lipoprotein (rHDL) has been demonstrated in atherosclerosis and in sepsis models. An increase of adhesion molecules as well as tissue factor expression on endothelial cells in response to inflammatory or danger signals are attenuated by the treatment with rHDL. Here we show the inhibitory effect of rHDL on the activation of human leukocytes in a whole blood assay as well as on monocyte-derived human dendritic cells (DC). Multiplex analysis of human whole blood showed that phytohaemagglutinin (PHA)-induced secretion of the cytokines IL-1 beta, IL-1RA, IL-2R, IL-6, IL-7, IL-12(p40), IL-15 and IFN-alpha was inhibited. Furthermore, an inhibitory effect on the production of the chemokines CCL-2, CCL-4, CCL-5, CXCL-9 and CXCL-10 was observed. Activation of granulocytes and CD14(+) monocytes by PHA is inhibited dose-dependently by rHDL shown as decreased up-regulation of ICAM-1 surface expression. In addition, we found a strong inhibitory effect of rHDL on toll-like receptor 2 (TLR2)- and TLR4-mediated maturation of DC. Treatment of DC with rHDL prevented the up-regulation of cell surface molecules CD80, CD83 and CD86 and it inhibited the TLR-driven activation of inflammatory transcription factor NF-kappa B. These findings suggest that rHDL prevents activation of crucial cellular players of cellular immunity and could therefore be a useful reagent to impede inflammation as well as the link between innate and adaptive immunity.	[Spirig, Rolf; Rieben, Robert] Univ Bern, Cardiovasc Res Lab, Dept Clin Res, Bern, Switzerland; [Spirig, Rolf; Schaub, Alexander; Kropf, Alain; Miescher, Sylvia; Spycher, Martin O.] CSL Behring AG, Bern, Switzerland	University of Bern; CSL	Rieben, R (corresponding author), Univ Bern, Cardiovasc Res Lab, Dept Clin Res, Bern, Switzerland.	robert.rieben@dkf.unibe.ch	Rieben, Robert/D-7044-2017	Rieben, Robert/0000-0003-4179-8891	EU; Swiss National Science Foundation [3200B0-116618, 32003B_135272]	EU(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the EU 6th Framework Integrated Research Project "Reprogramming the Immune System for the Establishment of Tolerance'' (RISET) and the Swiss National Science Foundation (grants no. 3200B0-116618 and 32003B_135272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A-Gonzalez N, 2009, IMMUNITY, V31, P245, DOI 10.1016/j.immuni.2009.06.018; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; [Anonymous], J EXP MED, V171, P1363; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bayry J, 2003, BLOOD, V101, P758, DOI 10.1182/blood-2002-05-1447; BELL D, 1990, BRIT HEART J, V63, P82; Braunersreuther V, 2010, J MOL CELL CARDIOL, V48, P789, DOI 10.1016/j.yjmcc.2009.07.029; Bursill CA, 2010, ARTERIOSCL THROM VAS, V30, P1773, DOI 10.1161/ATVBAHA.110.211342; Calabresi L, 2003, CIRC RES, V92, P330, DOI 10.1161/01.RES.0000054201.60308.1A; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chen Z, 2012, J CARDIOVASC PHARM T, V17, P315, DOI 10.1177/1074248411426144; Curtsinger JM, 2010, CURR OPIN IMMUNOL, V22, P333, DOI 10.1016/j.coi.2010.02.013; DEKIMPE SJ, 1995, P NATL ACAD SCI USA, V92, P10359, DOI 10.1073/pnas.92.22.10359; Dewald O, 2005, CIRC RES, V96, P881, DOI 10.1161/01.RES.0000163017.13772.3a; DOUGHERTY GJ, 1988, EUR J IMMUNOL, V18, P35, DOI 10.1002/eji.1830180107; Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037; Franchimont D, 1999, J CLIN ENDOCR METAB, V84, P2834, DOI 10.1210/jc.84.8.2834; Freitas MCS, 2011, TRANSPLANTATION, V92, P131, DOI 10.1097/TP.0b013e318220586e; Goossens P, 2010, CELL METAB, V12, P142, DOI 10.1016/j.cmet.2010.06.008; Grunfeld C, 1999, J LIPID RES, V40, P245; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Hyka N, 2001, BLOOD, V97, P2381, DOI 10.1182/blood.V97.8.2381; Ihrcke NS, 1996, J CELL PHYSIOL, V168, P625, DOI 10.1002/(SICI)1097-4652(199609)168:3<625::AID-JCP15>3.3.CO;2-A; Kim KD, 2005, BIOCHEM BIOPH RES CO, V338, P1126, DOI 10.1016/j.bbrc.2005.10.065; Kiya Y, 2009, ATHEROSCLEROSIS, V203, P137, DOI 10.1016/j.atherosclerosis.2008.05.056; Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832; Lerch PG, 1996, VOX SANG, V71, P155, DOI 10.1046/j.1423-0410.1996.7130155.x; Lories RJ, 2004, ANN RHEUM DIS, V63, P747, DOI 10.1136/ard.2003.007138; Luke HJ, 1999, BIOCHEM J, V343, P71, DOI 10.1042/0264-6021:3430071; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; MENTZER SJ, 1986, CELL IMMUNOL, V101, P312, DOI 10.1016/0008-8749(86)90144-9; Michelsen KS, 2004, J IMMUNOL, V173, P5901, DOI 10.4049/jimmunol.173.10.5901; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Murphy AJ, 2008, ARTERIOSCL THROM VAS, V28, P2071, DOI 10.1161/ATVBAHA.108.168690; Murphy AJ, 2012, BBA-MOL CELL BIOL L, V1821, P513, DOI 10.1016/j.bbalip.2011.08.003; Murphy AJ, 2011, ARTERIOSCL THROM VAS, V31, P1333, DOI 10.1161/ATVBAHA.111.226258; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nicholls SJ, 2005, CIRCULATION, V111, P1543, DOI 10.1161/01.CIR.0000159351.95399.50; Norata GD, 2012, ATHEROSCLEROSIS, V220, P11, DOI 10.1016/j.atherosclerosis.2011.06.045; Obregon C, 2003, INFECT IMMUN, V71, P4382, DOI 10.1128/IAI.71.8.4382-4388.2003; Obregon C, 2006, AM J PATHOL, V169, P2127, DOI 10.2353/ajpath.2006.060453; Pajkrt D, 1996, J EXP MED, V184, P1601, DOI 10.1084/jem.184.5.1601; Palucka K, 2010, IMMUNITY, V33, P464, DOI 10.1016/j.immuni.2010.10.007; Perrin-Cocon L, 2012, IMMUNOBIOLOGY, V217, P91, DOI 10.1016/j.imbio.2011.07.030; PLATT JL, 1991, EUR J IMMUNOL, V21, P2887, DOI 10.1002/eji.1830211135; Randolph GJ, 2008, CURR OPIN IMMUNOL, V20, P52, DOI 10.1016/j.coi.2007.10.010; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; Roebuck KA, 1999, J LEUKOCYTE BIOL, V66, P876, DOI 10.1002/jlb.66.6.876; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Shaw JA, 2008, CIRC RES, V103, P1084, DOI 10.1161/CIRCRESAHA.108.182063; Spieker LE, 2002, CIRCULATION, V105, P1399, DOI 10.1161/01.CIR.0000013424.28206.8F; Spirig R, 2008, J IMMUNOL, V181, P878, DOI 10.4049/jimmunol.181.2.878; Spirig R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010983; Sun Y, 2009, CIRC RES, V104, P455, DOI 10.1161/CIRCRESAHA.108.182568; Sung FL, 2002, KIDNEY INT, V62, P1160, DOI 10.1111/j.1523-1755.2002.kid577.x; Tardif JC, 2007, JAMA-J AM MED ASSOC, V297, P1675, DOI 10.1001/jama.297.15.jpc70004; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Tolle M, 2008, ARTERIOSCL THROM VAS, V28, P1542, DOI 10.1161/ATVBAHA.107.161042; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Veillard NR, 2004, CIRC RES, V94, P253, DOI 10.1161/01.RES.0000109793.17591.4E; Viswambharan H, 2004, CIRC RES, V94, P918, DOI 10.1161/01.RES.0000124302.20396.B7; Wadham C, 2004, CIRCULATION, V109, P2116, DOI 10.1161/01.CIR.0000127419.45975.26; Woltman AM, 2000, EUR J IMMUNOL, V30, P1807, DOI 10.1002/1521-4141(200007)30:7<1807::AID-IMMU1807>3.0.CO;2-N; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Wyss CA, 2010, EUR HEART J, V31, P1457, DOI 10.1093/eurheartj/ehq084; Yasunami Y, 2005, J EXP MED, V202, P913, DOI 10.1084/jem.20050448; Yue TL, 2001, CIRCULATION, V104, P2588, DOI 10.1161/hc4601.099403; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731; Zhu XW, 2012, CIRC RES, V111, P1398, DOI 10.1161/CIRCRESAHA.112.269043	72	10	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71235	10.1371/journal.pone.0071235	http://dx.doi.org/10.1371/journal.pone.0071235			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967171	Green Submitted, Green Published, gold			2022-12-25	WOS:000323221500060
J	Wang, YK; Hurley, DG; Schnell, S; Print, CG; Crampin, EJ				Wang, Yi Kan; Hurley, Daniel G.; Schnell, Santiago; Print, Cristin G.; Crampin, Edmund J.			Integration of Steady-State and Temporal Gene Expression Data for the Inference of Gene Regulatory Networks	PLOS ONE			English	Article							BAYESIAN NETWORKS; SYSTEMS; INFORMATION; SIMULATION	We develop a new regression algorithm, cMIKANA, for inference of gene regulatory networks from combinations of steady-state and time-series gene expression data. Using simulated gene expression datasets to assess the accuracy of reconstructing gene regulatory networks, we show that steady-state and time-series data sets can successfully be combined to identify gene regulatory interactions using the new algorithm. Inferring gene networks from combined data sets was found to be advantageous when using noisy measurements collected with either lower sampling rates or a limited number of experimental replicates. We illustrate our method by applying it to a microarray gene expression dataset from human umbilical vein endothelial cells (HUVECs) which combines time series data from treatment with growth factor TNF and steady state data from siRNA knockdown treatments. Our results suggest that the combination of steady-state and time-series datasets may provide better prediction of RNA-to-RNA interactions, and may also reveal biological features that cannot be identified from dynamic or steady state information alone. Finally, we consider the experimental design of genomics experiments for gene regulatory network inference and show that network inference can be improved by incorporating steady-state measurements with time-series data.	[Wang, Yi Kan; Hurley, Daniel G.; Crampin, Edmund J.] Univ Auckland, Auckland Bioengn Inst, Auckland 1, New Zealand; [Hurley, Daniel G.; Print, Cristin G.] Univ Auckland, Dept Mol Med & Pathol, Auckland 1, New Zealand; [Schnell, Santiago] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI USA; [Schnell, Santiago] Univ Michigan, Sch Med, Dept Computat Med & Bioinformat, Ann Arbor, MI USA; [Print, Cristin G.] New Zealand Bioinformat Inst, Auckland, New Zealand; [Print, Cristin G.; Crampin, Edmund J.] Maurice Wilkins Ctr Mol Biodiscovery, Auckland, New Zealand; [Crampin, Edmund J.] Univ Auckland, Dept Engn Sci, Auckland 1, New Zealand; [Crampin, Edmund J.] Univ Melbourne, Melbourne Sch Engn, Melbourne, Vic, Australia; [Crampin, Edmund J.] Natl ICT Australia Victoria Res Lab, Canberra, ACT, Australia	University of Auckland; University of Auckland; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Auckland; University of Auckland; University of Melbourne; NICTA	Wang, YK (corresponding author), Univ Auckland, Auckland Bioengn Inst, Auckland 1, New Zealand.	yikan.wang@auckland.ac.nz; edmund.crampin@unimelb.edu.au	Schnell, Santiago/B-8682-2008	Schnell, Santiago/0000-0002-9477-3914; Print, Cristin/0000-0001-8345-7812; Hurley, Daniel Glyn/0000-0003-0171-1982	Royal Society of New Zealand [06UOA182]; University of Cambridge; GNI Ltd.;  [UOAX0810];  [06/581];  [2010021]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	Royal Society of New Zealand(Royal Society of New Zealand); University of Cambridge(University of Cambridge); GNI Ltd.; ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The list of funders is: Royal Society of New Zealand - Marsden Fund. URL: http://www.royalsociety.org.nz/programmes/funds/marsden. Grant number 06UOA182. Foundation for Research Science and Technology (FRST) URL: Foundation for Research Science and Technology (FRST) - NERF scheme URL:http://www.msi.govt.nz/update-me/who-got-funded/. Grant number UOAX0810. The Breast Cancer Research Trust URL: http://www.breastcancercure.org.nz Health Research Council of New Zealand - International Investment Opportunities Fund URL: http://www.hrc.govt.nz/funding-opportunities/recipients/associate-professor-cristin-print. Grant reference 06/581. James S. McDonnell Foundation - 21st Century Science Initiative: Studying Complex Systems Program URL: http://www.jsmf.org/grants/2010021/. The previously published microarray data used in this study was generated at Cambridge University, supported by research collaboration agreements between the University of Cambridge and GNI Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, INTRO SYSTEM BIOL DE; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Berkman O, 2007, LECT NOTES COMPUT SC, V4472, P479; Bonneau R, 2008, NAT CHEM BIOL, V4, P658, DOI 10.1038/nchembio.122; Bonneau R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r36; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Christley S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006799; Crampin EJ, 2004, PROG BIOPHYS MOL BIO, V86, P77, DOI 10.1016/j.pbiomolbio.2004.04.002; Crampin EJ, 2004, LECT NOTES COMPUT SC, V3214, P329; D'Haeseleer P, 1999, LINEAR MODELING MRNA, P41; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Dojer N, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-249; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; HECKERMAN D, 1995, MACH LEARN, V20, P197, DOI 10.1007/BF00994016; Hurley D, 2012, NUCLEIC ACIDS RES, V40, P2377, DOI 10.1093/nar/gkr902; JUDD K, 1995, PHYSICA D, V82, P426, DOI 10.1016/0167-2789(95)00050-E; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Mourao MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027534; Penfold CA, 2011, INTERFACE FOCUS, V1, P857, DOI 10.1098/rsfs.2011.0053; Rawool SB, 2007, BIOSYSTEMS, V90, P636, DOI 10.1016/j.biosystems.2007.02.003; Srividhya J, 2009, COMPUTATIONAL BIOL C, V34, P11; Srividhya J, 2007, PROTEOMICS, V7, P828, DOI 10.1002/pmic.200600428; Tegner J, 2003, P NATL ACAD SCI USA, V100, P5944, DOI 10.1073/pnas.0933416100; van Someren EP, 2006, BIOINFORMATICS, V22, P477, DOI 10.1093/bioinformatics/bti816; Wildenhain J, 2006, IEE P SYST BIOL, V153, P247, DOI 10.1049/ip-syb:20050092; Xiong J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043819; Zhao YG, 2012, STRUCT INFRASTRUCT E, V8, P517, DOI 10.1080/15732479.2010.539072; Zoppoli P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-154; Zou M, 2005, BIOINFORMATICS, V21, P71, DOI 10.1093/bioinformatics/bth463	31	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e72103	10.1371/journal.pone.0072103	http://dx.doi.org/10.1371/journal.pone.0072103			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967277	Green Published, gold			2022-12-25	WOS:000323221500120
J	Hall, D; Kuhlmann, L				Hall, David; Kuhlmann, Levin			Mechanisms of Seizure Propagation in 2-Dimensional Centre-Surround Recurrent Networks	PLOS ONE			English	Article							SPINY STELLATE NEURONS; EPILEPTIFORM ACTIVITY; VISUAL-CORTEX; FUNCTIONAL CONNECTIVITY; DYNAMICS; MODEL; OSCILLATIONS; WAVES; HIPPOCAMPUS; DISCHARGES	Understanding how seizures spread throughout the brain is an important problem in the treatment of epilepsy, especially for implantable devices that aim to avert focal seizures before they spread to, and overwhelm, the rest of the brain. This paper presents an analysis of the speed of propagation in a computational model of seizure-like activity in a 2-dimensional recurrent network of integrate-and-fire neurons containing both excitatory and inhibitory populations and having a difference of Gaussians connectivity structure, an approximation to that observed in cerebral cortex. In the same computational model network, alternative mechanisms are explored in order to simulate the range of seizure-like activity propagation speeds (0.1-100 mm/s) observed in two animal-slice-based models of epilepsy: (1) low extracellular [Mg2+], which creates excess excitation and (2) introduction of gamma-aminobutyric acid (GABA) antagonists, which reduce inhibition. Moreover, two alternative connection topologies are considered: excitation broader than inhibition, and inhibition broader than excitation. It was found that the empirically observed range of propagation velocities can be obtained for both connection topologies. For the case of the GABA antagonist model simulation, consistent with other studies, it was found that there is an effective threshold in the degree of inhibition below which waves begin to propagate. For the case of the low extracellular [Mg2+] model simulation, it was found that activity-dependent reductions in inhibition provide a potential explanation for the emergence of slowly propagating waves. This was simulated as a depression of inhibitory synapses, but it may also be achieved by other mechanisms. This work provides a localised network understanding of the propagation of seizures in 2-dimensional centre-surround networks that can be tested empirically.	[Hall, David] Natl ICT Australia, Victoria Res Labs, Parkville, Vic, Australia; [Hall, David; Kuhlmann, Levin] Univ Melbourne, Dept Elect & Elect Engn, Parkville, Vic 3052, Australia	NICTA; University of Melbourne	Kuhlmann, L (corresponding author), Univ Melbourne, Dept Elect & Elect Engn, Parkville, Vic 3052, Australia.	levink@unimelb.edu.au	Kuhlmann, Levin/N-7418-2015; Kuhlmann, Levin/P-8769-2019	Kuhlmann, Levin/0000-0002-5108-6348; Kuhlmann, Levin/0000-0002-5108-6348; Hall, David/0000-0003-3244-5744	National ICT Australia (NICTA); Australian Government	National ICT Australia (NICTA); Australian Government(Australian GovernmentCGIAR)	The authors thank National ICT Australia (NICTA) for their financial support and the Bio21 Undergraduate Research Opportunities Program for making this project possible. NICTA is funded by the Australian Government as represented by the Department of Broadband, Communications and the Digital Economy and the Australian Research Council through the ICT Centre of Excellence program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed B, 1997, J COMP NEUROL, V380, P230; AHMED B, 1994, J COMP NEUROL, V341, P39, DOI 10.1002/cne.903410105; Akiyama T, 2011, EPILEPSIA, V52, P75, DOI 10.1111/j.1528-1167.2010.02776.x; ANDERSON JC, 1994, J COMP NEUROL, V341, P25, DOI 10.1002/cne.903410104; [Anonymous], 1998, NEURAL NETWORKS BRAI; Bausch SB, 2000, J NEUROPHYSIOL, V84, P2918, DOI 10.1152/jn.2000.84.6.2918; Bazhenov M, 2002, J NEUROSCI, V22, P8691; Bazhenov M., 2008, DRUG DISCOV TODAY DI, V5, P45, DOI [DOI 10.1016/J.DDM0D.2008.07.005, 10.1016/j.ddmod.2008.07.005, DOI 10.1016/J.DDMOD.2008.07.005]; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; Berretta N, 1996, NEUROSCIENCE, V75, P339, DOI 10.1016/0306-4522(96)00301-6; BERTASHIUS KM, 1991, ELECTROEN CLIN NEURO, V78, P333, DOI 10.1016/0013-4694(91)90095-L; BOYD SG, 1986, J NEUROL NEUROSUR PS, V49, P251, DOI 10.1136/jnnp.49.3.251; Bragin A, 2009, J NEUROSCI, V29, P3660, DOI 10.1523/JNEUROSCI.5309-08.2009; Breakspear M, 2003, NEUROCOMPUTING, V52-4, P151, DOI 10.1016/S0925-2312(02)00740-3; Browne TR, 2001, NEW ENGL J MED, V344, P1145, DOI 10.1056/NEJM200104123441507; Cammarota M, 2013, J PHYSIOL-LONDON, V591, P807, DOI 10.1113/jphysiol.2012.238154; CHAGNACAMITAI Y, 1989, J NEUROPHYSIOL, V61, P747, DOI 10.1152/jn.1989.61.4.747; Chen W, 2012, NETWORK-COMP NEURAL, V23, P59, DOI 10.3109/0954898X.2012.678463; CHERVIN RD, 1988, J NEUROPHYSIOL, V60, P1695, DOI 10.1152/jn.1988.60.5.1695; Compte A, 2003, J NEUROPHYSIOL, V89, P2707, DOI 10.1152/jn.00845.2002; CONNORS BW, 1982, J NEUROPHYSIOL, V48, P1302, DOI 10.1152/jn.1982.48.6.1302; Cressman JR, 2009, J COMPUT NEUROSCI, V26, P159, DOI 10.1007/s10827-008-0132-4; Dayan P., 2001, THEORETICAL NEUROSCI, P178; Dayan P., 2001, THEORETICAL NEUROSCI; de la Prida LM, 2004, J NEUROSCI, V24, P5525, DOI 10.1523/JNEUROSCI.0309-04.2004; de la Prida LM, 2006, NEURON, V49, P131, DOI 10.1016/j.neuron.2005.10.034; de la Prida LM, 2002, BRAIN RES, V940, P27, DOI 10.1016/S0006-8993(02)02564-7; DeBiasi S, 1996, NEUROREPORT, V7, P2773, DOI 10.1097/00001756-199611040-00073; DELANEY KR, 1994, P NATL ACAD SCI USA, V91, P669, DOI 10.1073/pnas.91.2.669; Destexhe A, 1999, EUR J NEUROSCI, V11, P2175, DOI 10.1046/j.1460-9568.1999.00660.x; Destexhe A, 1998, J NEUROSCI, V18, P9099; Destexhe A, 2009, J COMPUT NEUROSCI, V27, P493, DOI 10.1007/s10827-009-0164-4; Dittman JS, 2000, J NEUROSCI, V20, P1374; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Ermentrout GB, 2001, NEURON, V29, P33, DOI 10.1016/S0896-6273(01)00178-7; FINCH DM, 1983, BRAIN RES, V271, P201, DOI 10.1016/0006-8993(83)90283-4; Foldvary N, 2001, NEUROL CLIN, V19, P491, DOI 10.1016/S0733-8619(05)70028-1; GABBOTT PLA, 1986, EXP BRAIN RES, V61, P323; Giustizieri M, 2005, J NEUROPHYSIOL, V94, P1992, DOI 10.1152/jn.00171.2005; Golomb D, 1997, J NEUROPHYSIOL, V78, P1199, DOI 10.1152/jn.1997.78.3.1199; Golomb D, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.061911; Golomb D, 2001, PHYS REV LETT, V86, P4179, DOI 10.1103/PhysRevLett.86.4179; Graben PB, 2008, NEUROCOMPUTING, V71, P999, DOI 10.1016/j.neucom.2007.02.007; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Haglund MM, 2012, EPILEPSIA, V53, P87, DOI 10.1111/j.1528-1167.2012.03479.x; Heiss JE, 2008, J NEUROSCI, V28, P13320, DOI 10.1523/JNEUROSCI.2646-08.2008; Hertz JA, 2018, INTRO THEORY NEURAL; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Huang XY, 2010, NEURON, V68, P978, DOI 10.1016/j.neuron.2010.11.007; INGHILLERI M, 1989, J NEUROL NEUROSUR PS, V52, P970, DOI 10.1136/jnnp.52.8.970; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; JAHR CE, 1990, J NEUROSCI, V10, P3178; Jasper H, 1969, BASIC MECH EPILEPSIE, P100; Jenssen S, 2011, EPILEPSY RES, V93, P25, DOI 10.1016/j.eplepsyres.2010.10.008; Jing Q, 2006, J NEUROSCI, V26, P6089, DOI 10.1523/JNEUROSCI.0475-06.2006; Jouny C, 2009, ENCY BASIC EPILEPSY; Kim JW, 2009, J THEOR BIOL, V257, P527, DOI 10.1016/j.jtbi.2008.12.009; Kramer MA, 2005, J R SOC INTERFACE, V2, P113, DOI 10.1098/rsif.2004.0028; Kramer MA, 2007, J COMPUT NEUROSCI, V22, P63, DOI 10.1007/s10827-006-9508-5; LARKMAN AU, 1995, CURR OPIN NEUROBIOL, V5, P324, DOI 10.1016/0959-4388(95)80045-X; Le Van Quyen M, 2001, LANCET, V357, P183, DOI 10.1016/S0140-6736(00)03591-1; Loscher W, 2002, TRENDS PHARMACOL SCI, V23, P113, DOI 10.1016/S0165-6147(00)01974-X; Lytton WW, 2008, NAT REV NEUROSCI, V9, P626, DOI 10.1038/nrn2416; Lytton WW, 2005, EPILEPSY BEHAV, V7, P336, DOI 10.1016/j.yebeh.2005.06.011; MacDermott AB, 1999, ANNU REV NEUROSCI, V22, P443, DOI 10.1146/annurev.neuro.22.1.443; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; MILES R, 1988, J NEUROPHYSIOL, V60, P1481, DOI 10.1152/jn.1988.60.4.1481; Miles R, 1983, NATURE, V306, P1; MODY I, 1987, J NEUROPHYSIOL, V57, P869, DOI 10.1152/jn.1987.57.3.869; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Ohara S, 2004, EPILEPSY RES, V62, P179, DOI 10.1016/j.eplepsyres.2004.09.002; Osorio I, 1998, EPILEPSIA, V39, P615, DOI 10.1111/j.1528-1157.1998.tb01430.x; Pinto DJ, 2005, J NEUROSCI, V25, P8131, DOI 10.1523/JNEUROSCI.2278-05.2005; Prechtl JC, 1997, P NATL ACAD SCI USA, V94, P7621, DOI 10.1073/pnas.94.14.7621; Prinz AA, 2003, J NEUROSCI, V23, P943; Regesta G, 1999, EPILEPSY RES, V34, P109, DOI 10.1016/S0920-1211(98)00106-5; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; Rothkegel A, 2011, EPILEPSY INTERSECTIO; Rothkegel A, 2009, CHAOS, V19, DOI 10.1063/1.3087432; Rubino D, 2006, NAT NEUROSCI, V9, P1549, DOI 10.1038/nn1802; Saab ME, 2005, CLIN NEUROPHYSIOL, V116, P427, DOI 10.1016/j.clinph.2004.08.004; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Santhakumar V, 2005, J NEUROPHYSIOL, V93, P437, DOI 10.1152/jn.00777.2004; Santhakumar V, 2008, COMPUTATIONAL NEUROSCIENCE IN EPILEPSY, P89, DOI 10.1016/B978-012373649-9.50010-7; Schevon CA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2056; SERESS L, 1985, J NEUROCYTOL, V14, P717, DOI 10.1007/BF01170824; SILVA LR, 1991, SCIENCE, V251, P432, DOI 10.1126/science.1824881; SOFRONOV GA, 1992, B EXP BIOL MED+, V113, P73, DOI 10.1007/BF00787750; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Staley K, 1995, SCIENCE, V269; Stratton P, 2010, NEUROIMAGE, V52, P1070, DOI 10.1016/j.neuroimage.2010.01.027; Tabak J, 2000, J NEUROSCI, V20, P3041; TAMAMAKI N, 1984, BRAIN RES, V307, P336, DOI 10.1016/0006-8993(84)90489-X; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P501, DOI 10.1152/jn.1989.61.3.501; Timofeev I, 2000, CEREB CORTEX, V10, P1185, DOI 10.1093/cercor/10.12.1185; Traub R.D., 1991, NEURONAL NETWORKS HI; TRAUB RD, 1982, SCIENCE, V216, P745, DOI 10.1126/science.7079735; TRAUB RD, 1994, J PHYSIOL-LONDON, V478, P379, DOI 10.1113/jphysiol.1994.sp020259; Trevelyan AJ, 2007, J NEUROSCI, V27, P3383, DOI 10.1523/JNEUROSCI.0145-07.2007; Trevelyan AJ, 2006, J NEUROSCI, V26, P12447, DOI 10.1523/JNEUROSCI.2787-06.2006; Trevelyan AJ, 2013, NEUROPHARMACOLOGY, V69, P45, DOI 10.1016/j.neuropharm.2012.06.015; Trevelyan AJ, 2009, J NEUROSCI, V29, P15299, DOI 10.1523/JNEUROSCI.2019-09.2009; Troyer TW, 1998, J NEUROSCI, V18, P5908; Ullah G, 2009, J COMPUT NEUROSCI, V26, P171, DOI 10.1007/s10827-008-0130-6; Ursino M, 2006, J THEOR BIOL, V242, P171, DOI 10.1016/j.jtbi.2006.02.012; Velasco M, 2000, EPILEPSIA, V41, P158, DOI 10.1111/j.1528-1157.2000.tb00135.x; WADMAN WJ, 1993, NEUROSCIENCE, V52, P255, DOI 10.1016/0306-4522(93)90154-8; WALTHER H, 1986, NEUROSCI LETT, V69, P156, DOI 10.1016/0304-3940(86)90595-1; Wilke C, 2011, EPILEPSIA, V52, P84, DOI 10.1111/j.1528-1167.2010.02785.x; WONG BY, 1990, EPILEPSY RES, V7, P29, DOI 10.1016/0920-1211(90)90051-V; Woodhall G, 2001, J NEUROPHYSIOL, V86, P1644, DOI 10.1152/jn.2001.86.4.1644; Wright JJ, 1996, BEHAV BRAIN SCI, V19, P285, DOI 10.1017/S0140525X00042679	112	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71369	10.1371/journal.pone.0071369	http://dx.doi.org/10.1371/journal.pone.0071369			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967201	Green Published, gold			2022-12-25	WOS:000323115800053
J	Lian, Y; Zhao, J; Xu, PY; Wang, YM; Zhao, J; Jia, L; Fu, Z; Jing, L; Liu, G; Peng, SQ				Lian, Yong; Zhao, Jing; Xu, Peiyu; Wang, Yimei; Zhao, Jun; Jia, Li; Fu, Ze; Jing, Li; Liu, Gang; Peng, Shuangqing			Protective Effects of Metallothionein on Isoniazid and Rifampicin-Induced Hepatotoxicity in Mice	PLOS ONE			English	Article							DRUG-INDUCED HEPATOTOXICITY; INDUCED OXIDATIVE STRESS; CARBON-TETRACHLORIDE; ANTITUBERCULOSIS DRUGS; INDUCED TOXICITY; HEPATIC-INJURY; LIVER-INJURY; EXPRESSION; CYTOCHROME-P450; INHIBITION	Isoniazid (INH) and Rifampicin (RFP) are widely used in the world for the treatment of tuberculosis, but the hepatotoxicity is a major concern during clinical therapy. Previous studies showed that these drugs induced oxidative stress in liver, and several antioxidants abated this effect. Metallothionein (MT), a member of cysteine-rich protein, has been proposed as a potent antioxidant. This study attempts to determine whether endogenous expression of MT protects against INH and RFP-induced hepatic oxidative stress in mice. Wild type (MT+/+) and MT-null (MT-/-) mice were treated intragastrically with INH (150 mg/kg), RFP (300 mg/kg), or the combination (150 mg/kg INH + 300 mg/kg RFP) for 21 days. The results showed that MT-/- mice were more sensitive than MT+/+ mice to INH and RFP-induced hepatic injuries as evidenced by hepatic histopathological alterations, increased serum AST levels and liver index, and hepatic oxidative stress as evidenced by the increase of MDA production and the change of liver antioxidant status. Furthermore, INH increased the protein expression of hepatic CYP2E1 and INH/RFP (alone or in combination) decreased the expression of hepatic CYP1A2. These findings clearly demonstrate that basal MT provides protection against INH and RFP-induced toxicity in hepatocytes. The CYP2E1 and CYP1A2 were involved in the pathogenesis of INH and RFP-induced hepatotoxicity.	[Lian, Yong; Zhao, Jing; Wang, Yimei; Zhao, Jun; Jia, Li; Fu, Ze; Jing, Li; Liu, Gang; Peng, Shuangqing] Acad Mil Med Sci, Inst Dis Control & Prevent, Evaluat & Res Ctr Toxicol, Beijing, Peoples R China; [Lian, Yong; Xu, Peiyu] Sichuan Univ, Dept Toxicol, West China Sch Publ Hlth, Chengdu 610064, Peoples R China	Academy of Military Medical Sciences - China; Sichuan University	Wang, YM (corresponding author), Acad Mil Med Sci, Inst Dis Control & Prevent, Evaluat & Res Ctr Toxicol, Beijing, Peoples R China.	wangyimei2006@126.com; pengsq@hotmail.com			National Natural Science Foundation of China [81273602, 30701063]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Natural Science Foundation of China (81273602, 30701063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attri S, 2000, HUM EXP TOXICOL, V19, P517, DOI 10.1191/096032700674230830; Baird L, 2011, ARCH TOXICOL, V85, P241, DOI 10.1007/s00204-011-0674-5; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; Cai L, 2005, DIABETES, V54, P1829, DOI 10.2337/diabetes.54.6.1829; Cai L, 2000, J BIOL CHEM, V275, P38957, DOI 10.1074/jbc.C000593200; Caro AA, 2003, J BIOL CHEM, V278, P33866, DOI 10.1074/jbc.M300408200; Cederbaum A, 2009, EXPERT OPIN DRUG MET, V5, P1223, DOI 10.1517/17425250903143769; Chen Jiezhong, 2006, Ann Clin Microbiol Antimicrob, V5, P3, DOI 10.1186/1476-0711-5-3; Chen X, 2011, EUR J PHARMACOL, V659, P53, DOI 10.1016/j.ejphar.2011.03.007; Cheng J, 2013, TOXICOL APPL PHARM, V266, P245, DOI 10.1016/j.taap.2012.10.024; Chowdhury A, 2001, Indian J Gastroenterol, V20, P97; Conrad CC, 2000, FREE RADICAL BIO MED, V28, P447, DOI 10.1016/S0891-5849(99)00263-4; Coyle P, 2002, CELL MOL LIFE SCI, V59, P627, DOI 10.1007/s00018-002-8454-2; Davis SR, 2001, J NUTR, V131, P215, DOI 10.1093/jn/131.2.215; Desta Z, 2001, ANTIMICROB AGENTS CH, V45, P382, DOI 10.1128/AAC.45.2.382-392.2001; Ebadi M, 2006, EXP BIOL MED, V231, P1576, DOI 10.1177/153537020623100919; ELLARD GA, 1978, AM REV RESPIR DIS, V118, P628; Georgieva N, 2004, TJS, V2, P37, DOI DOI 10.1016/j.ecoenv.2013.09.022; GIRLING DJ, 1992, AM REV RESPIR DIS, V145, P36; Glickman SW, 2006, SCIENCE, V311, P1246, DOI 10.1126/science.1119299; Haq F, 2003, MUTAT RES-FUND MOL M, V533, P211, DOI 10.1016/j.mrfmmm.2003.07.014; Huang RB, 1995, JPN J PHARMACOL, V69, P325, DOI 10.1254/jjp.69.325; JENNER AM, 1994, ARCH TOXICOL, V68, P349, DOI 10.1007/s002040050081; Jia G, 2004, INT J ONCOL, V25, P325; Kumari MVR, 1998, FREE RADICAL RES, V29, P93, DOI 10.1080/10715769800300111; Leiro-Fernandez V, 2011, INT J TUBERC LUNG D, V15, P1403, DOI 10.5588/ijtld.10.0648; Liu J, 1999, J PHARMACOL EXP THER, V289, P580; Liu J, 2008, BIOCHEM PHARMACOL, V76, P922, DOI 10.1016/j.bcp.2008.07.021; Liu YP, 1995, TOXICOL APPL PHARM, V135, P222, DOI 10.1006/taap.1995.1227; Mao H, 2012, AQUAT TOXICOL, V110, P208, DOI 10.1016/j.aquatox.2012.01.018; MASTERS BA, 1994, P NATL ACAD SCI USA, V91, P584, DOI 10.1073/pnas.91.2.584; Metushi IG, 2012, CHEM RES TOXICOL, V25, P2567, DOI 10.1021/tx300341r; MICHALSKA AE, 1993, P NATL ACAD SCI USA, V90, P8088, DOI 10.1073/pnas.90.17.8088; Miura T, 1997, LIFE SCI, V60, pPL301; Nanashima K, 2012, TUBERCULOSIS, V92, P253, DOI 10.1016/j.tube.2011.12.004; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Ohtsuji M, 2008, J BIOL CHEM, V283, P33554, DOI 10.1074/jbc.M804597200; ONOSAKA S, 1982, TOXICOL APPL PHARM, V63, P270, DOI 10.1016/0041-008X(82)90049-7; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Pal R, 2006, WORLD J GASTROENTERO, V12, P636, DOI 10.3748/wjg.v12.i4.636; Possuelo LG, 2008, EUR J CLIN PHARMACOL, V64, P673, DOI 10.1007/s00228-008-0484-8; Preziosi P, 2007, CURR DRUG METAB, V8, P839, DOI 10.2174/138920007782798216; Saad EI, 2010, FOOD CHEM TOXICOL, V48, P1869, DOI 10.1016/j.fct.2010.04.026; Santhosh S, 2007, EUR J PHARMACOL, V572, P69, DOI 10.1016/j.ejphar.2007.05.059; Serafim A, 2009, ENVIRON RES, V109, P390, DOI 10.1016/j.envres.2009.03.001; Shen C, 2008, BRIT J PHARMACOL, V153, P784, DOI 10.1038/sj.bjp.0707611; Shuai Y, 2011, TOXICOL LETT, V200, P77, DOI 10.1016/j.toxlet.2010.10.017; SKAKUN NP, 1985, ANTIBIOT MED BIOTEK, V30, P185; SMITH IK, 1988, ANAL BIOCHEM, V175, P408, DOI 10.1016/0003-2697(88)90564-7; Takeda K, 2000, ALCOHOL CLIN EXP RES, V24, p87S, DOI 10.1111/j.1530-0277.2000.tb00019.x; Tasduq SA, 2005, HEPATOL RES, V31, P132, DOI 10.1016/j.hepres.2005.01.005; Tostmann A, 2008, INT J ANTIMICROB AG, V31, P577, DOI 10.1016/j.ijantimicag.2008.01.022; Tostmann A, 2008, J GASTROEN HEPATOL, V23, P192, DOI 10.1111/j.1440-1746.2007.05207.x; Upadhyay G, 2007, EUR J PHARMACOL, V565, P190, DOI 10.1016/j.ejphar.2007.03.004; Vasak M, 2005, J TRACE ELEM MED BIO, V19, P13, DOI 10.1016/j.jtemb.2005.03.003; Viarengo A, 2000, CELL MOL BIOL, V46, P407; Vuilleumier Nicolas, 2006, Eur J Clin Pharmacol, V62, P423; Wang T, 2010, J INT MED RES, V38, P977, DOI 10.1177/147323001003800324; Weng CJ, 2011, NEW BIOTECHNOL, V28, P767, DOI 10.1016/j.nbt.2011.05.003; Yang HY, 2009, TOXICON, V53, P246, DOI 10.1016/j.toxicon.2008.11.008; Yew WW, 2006, RESPIROLOGY, V11, P699, DOI 10.1111/j.1440-1843.2006.00941.x; Yue J, 2004, ACTA PHARMACOL SIN, V25, P699; Yue J, 2009, PHARMACOL RES, V59, P112, DOI 10.1016/j.phrs.2008.10.006; Yuhas Y, 2011, ANTIMICROB AGENTS CH, V55, P5541, DOI 10.1128/AAC.05149-11; Zhang ZH, 2012, ASIAN PAC J TROP MED, V5, P306, DOI 10.1016/S1995-7645(12)60044-3; Zhou ZX, 2002, EXP BIOL MED, V227, P214, DOI 10.1177/153537020222700310	66	35	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e72058	10.1371/journal.pone.0072058	http://dx.doi.org/10.1371/journal.pone.0072058			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967274	Green Published, Green Submitted, gold			2022-12-25	WOS:000323115800096
J	Chen, CC; Liu, HP; Chao, M; Liang, Y; Tsang, NM; Huang, HY; Wu, CC; Chang, YS				Chen, C-C; Liu, H-P; Chao, M.; Liang, Y.; Tsang, N-M; Huang, H-Y; Wu, C-C; Chang, Y-S			NF-kappa B-mediated transcriptional upregulation of TNFAIP2 by the Epstein-Barr virus oncoprotein, LMP1, promotes cell motility in nasopharyngeal carcinoma	ONCOGENE			English	Article						TNFAIP2; LMP1; NPC; NF-kappa B; actin; migration	LYMPH-NODE METASTASIS; PRIMARY RESPONSE GENE; NECROSIS-FACTOR-ALPHA; MEMBRANE-PROTEIN 1; EBV LATENT-MEMBRANE-PROTEIN-1; LATENT MEMBRANE-PROTEIN-1; TUNNELING NANOTUBULES; ORGANELLE TRANSFER; EPITHELIAL-CELLS; FILOPODIA	Nasopharyngeal carcinoma (NPC), which is closely associated with Epstein-Barr virus (EBV), is a metastasis-prone epithelial cancer. We previously showed that tumor necrosis factor alpha-induced protein 2 (TNFAIP2) is highly expressed in NPC tumor tissues and is correlated with metastasis and poor survival in NPC patients. However, the underlying mechanism remains unclear. In this study, we demonstrate that the EBV oncoprotein, latent membrane protein 1 (LMP1), can transcriptionally induce TNFAIP2 expression via NF-kappa B. Quantitative RT-PCR and western blotting revealed that LMP1 induces TNFAIP2 expression through its C-terminal- activating region (CTAR2) domain, which is required for transduction of NF-kappa B (nuclear factor kappa-light-chain-enhancer of activated B cells) signaling. Inhibition of NF-kappa B activation or depletion of p65 (a component of NF-kappa B) by RNA interference abolished the LMP1-induced expression of TNFAIP2, whereas ectopic expression of p65 was sufficient to induce TNFAIP2 expression. Luciferase reporter assays showed that LMP1 transcriptionally induces TNFAIP2 expression through a newly identified NF-kappa B-binding site within the TNFAIP2 promoter (- 3.869 to - 3.860 bp). Immunohistochemical analysis of NPC biopsy specimens further revealed a significant correlation between the protein levels of TNFAIP2 and activated p65 (R = 0.689, P < 0.001), indicating that our findings are clinically relevant. Immunofluorescence microscopy and co-immunoprecipitation assays showed that TNFAIP2 associates with actin and is involved in the formation of actin-based membrane protrusions. Furthermore, transwell migration assays demonstrated that TNFAIP2 contributes to LMP1-induced cell motility. Collectively, these findings provide novel insights into the regulation of TNFAIP2 and its role in promoting NPC tumor progression.	[Chen, C-C; Liu, H-P; Liang, Y.; Chang, Y-S] Chang Gung Univ, Grad Inst Biomed Sci, Chang Gung Mol Med Res Ctr, Taoyuan 333, Taiwan; [Chao, M.; Huang, H-Y] Chang Gung Univ, Grad Inst Biomed Sci, Taoyuan 333, Taiwan; [Tsang, N-M] Chang Gung Mem Hosp Lin Kou, Dept Radiat Oncol, Kwei Shan, Taiwan; [Wu, C-C] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Taoyuan 333, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Chang, YS (corresponding author), Chang Gung Univ, Grad Inst Biomed Sci, Chang Gung Mol Med Res Ctr, 259,Wen Hwa 1st Rd, Taoyuan 333, Taiwan.	ysc@mail.cgu.edu.tw	Liu, Hao-Ping/AAJ-3038-2020	Liu, Hao-Ping/0000-0001-5915-5128; Chao, Mei/0000-0002-2143-0531; Chang, Yu-Sun/0000-0002-6457-3890; Wu, Chih-Ching/0000-0002-7264-9672	Ministry of Education of Taiwan	Ministry of Education of Taiwan(Ministry of Education, Taiwan)	We are grateful to Ms Jennifer Cheng for her technical assistance in image acquisition and analysis using the IN Cell Analyzer 2000. This work was supported by the grant from the Ministry of Education of Taiwan (to Chang Gung University).	Abounit S, 2012, J CELL SCI, V125, P1089, DOI 10.1242/jcs.083279; Arjonen A, 2011, CELL ADHES MIGR, V5, P421, DOI 10.4161/cam.5.5.17723; Beckers J, 2005, INT J CANCER, V114, P590, DOI 10.1002/ijc.20798; Chen CC, 2010, CELL SIGNAL, V22, P1132, DOI 10.1016/j.cellsig.2010.03.008; Chen HL, 2010, EXP MOL PATHOL, V89, P367, DOI 10.1016/j.yexmp.2010.09.004; Chen LC, 2011, MODERN PATHOL, V24, P175, DOI 10.1038/modpathol.2010.193; Chen MC, 2008, ANN ONCOL, V19, P1180, DOI 10.1093/annonc/mdn003; Chen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056929; Cheng YH, 2011, J MOL ENDOCRINOL, V46, P139, DOI 10.1530/JME-10-0064; Chevrier N, 2011, CELL, V147, P853, DOI 10.1016/j.cell.2011.10.022; Chinnery HR, 2008, J IMMUNOL, V180, P5779, DOI 10.4049/jimmunol.180.9.5779; Davis DM, 2008, NAT REV MOL CELL BIO, V9, P431, DOI 10.1038/nrm2399; Faix J, 2006, CURR OPIN CELL BIOL, V18, P18, DOI 10.1016/j.ceb.2005.11.002; Gourzones C, 2012, SEMIN CANCER BIOL, V22, P127, DOI 10.1016/j.semcancer.2012.01.002; Hase K, 2009, NAT CELL BIOL, V11, P1427, DOI 10.1038/ncb1990; Ho FCH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-98; Hong EJ, 2011, MOL ENDOCRINOL, V25, P269, DOI 10.1210/me.2010-0483; Hui EP, 2002, CLIN CANCER RES, V8, P2595; Zheng H, 2007, CELL MOL IMMUNOL, V4, P185; Jia WH, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-178; KAYE KM, 1993, P NATL ACAD SCI USA, V90, P9150, DOI 10.1073/pnas.90.19.9150; Kimura S, 2012, EXP CELL RES, V318, P1699, DOI 10.1016/j.yexcr.2012.05.013; Kondratiev S, 2011, AM J SURG PATHOL, V35, P1531, DOI 10.1097/PAS.0b013e31822bd476; Larkin JD, 2012, MOL CELL BIOL, V32, P2738, DOI 10.1128/MCB.00179-12; LEE AWM, 1992, INT J RADIAT ONCOL, V23, P261, DOI 10.1016/0360-3016(92)90740-9; Li HP, 2003, J BIOMED SCI, V10, P490, DOI 10.1159/000072376; Lin SY, 2001, HEAD NECK-J SCI SPEC, V23, P194, DOI 10.1002/1097-0347(200103)23:3<194::AID-HED1018>3.0.CO;2-X; Liu HP, 2006, EMBO J, V25, P4120, DOI 10.1038/sj.emboj.7601282; Liu HP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002690; Liu ZS, 2011, CARCINOGENESIS, V32, P1668, DOI 10.1093/carcin/bgr209; Lo AKF, 2006, NEOPLASIA, V8, P173, DOI 10.1593/neo.05625; Lui VWY, 2011, ONCOGENE, V30, P1518, DOI 10.1038/onc.2010.529; Ma Y, 2003, ONCOGENE, V22, P4924, DOI 10.1038/sj.onc.1206728; Marsman J, 2012, BBA-GENE REGUL MECH, V1819, P1217, DOI 10.1016/j.bbagrm.2012.10.008; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Mookherjee N, 2006, J IMMUNOL, V176, P2455, DOI 10.4049/jimmunol.176.4.2455; Mothes W, 2010, J VIROL, V84, P8360, DOI 10.1128/JVI.00443-10; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Ranzinger J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029537; Rusiniak ME, 2000, CANCER RES, V60, P1824; SARMA V, 1992, J IMMUNOL, V148, P3302; Sherer NM, 2008, TRENDS CELL BIOL, V18, P414, DOI 10.1016/j.tcb.2008.07.003; Sherer NM, 2010, J VIROL, V84, P3248, DOI 10.1128/JVI.02155-09; Singh SK, 2010, FASEB J, V24, P3756, DOI 10.1096/fj.10-159046; Slaby O, 2013, NUTR CANCER, V65, P247, DOI 10.1080/01635581.2013.756530; Smith IF, 2011, BIOPHYS J, V100, pL37, DOI 10.1016/j.bpj.2011.03.007; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Spano JP, 2003, EUR J CANCER, V39, P2121, DOI 10.1016/S0959-8049(03)00367-8; Tsai CL, 2006, CANCER RES, V66, P11668, DOI 10.1158/0008-5472.CAN-06-2194; Tsuji A, 2008, CLIN CANCER RES, V14, P5368, DOI 10.1158/1078-0432.CCR-08-0198; Van Prooyen N, 2010, P NATL ACAD SCI USA, V107, P20738, DOI 10.1073/pnas.1009635107; WANG D, 1985, CELL, V43, P831, DOI 10.1016/0092-8674(85)90256-9; Wang Y, 2011, CELL DEATH DIFFER, V18, P732, DOI 10.1038/cdd.2010.147; Watkins SC, 2005, IMMUNITY, V23, P309, DOI 10.1016/j.immuni.2005.08.009; WOLF FW, 1994, J BIOL CHEM, V269, P3633; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452	56	41	43	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 10	2014	33	28					3648	3659		10.1038/onc.2013.345	http://dx.doi.org/10.1038/onc.2013.345			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AL2GC	23975427				2022-12-25	WOS:000338942900004
J	Horta, BL; Bas, A; Bhargava, SK; Fall, CHD; Feranil, A; de Kadt, J; Martorell, R; Richter, LM; Stein, AD; Victora, CG				Horta, Bernardo L.; Bas, Abet; Bhargava, Santosh K.; Fall, Caroline H. D.; Feranil, Alan; de Kadt, Julia; Martorell, Reynaldo; Richter, Linda M.; Stein, Aryeh D.; Victora, Cesar G.		COHORTS Grp	Infant Feeding and School Attainment in Five Cohorts from Low- and Middle-Income Countries	PLOS ONE			English	Article							COGNITIVE-DEVELOPMENT; BIRTH COHORT; CHILD-DEVELOPMENT; YOUNG ADULTHOOD; RISK-FACTORS; INTELLIGENCE; OUTCOMES; PROFILE; LIFE; DURATION	Background: Performance in intelligence tests tends to be higher among individuals breastfed as infants, but little is known about the association between breastfeeding and achieved schooling. We assessed the association of infant feeding with school achievement in five cohorts from low- and middle-income countries. Unlike high-income country settings where most previous studies come from, breastfeeding is not positively associated with socioeconomic position in our cohorts, thus reducing the likelihood of a spurious positive association. Methodology and Principal Findings: Participants included 10,082 young adults from five birth cohorts (Brazil, India, Guatemala, the Philippines, and South Africa). The exposures variables were whether the subject was ever breastfed, total duration of breastfeeding, and age at introduction of complementary foods. We adjusted the estimates for age at follow up, sex, maternal age, smoking during pregnancy, birthweight and socioeconomic position at birth. The key outcome was the highest grade achieved at school. In unadjusted analyses, the association between ever breastfeeding and schooling was positive in Brazil, inverse in the Philippines, and null in South Africa; in adjusted analyses, these associations were attenuated. In Brazil, schooling was highest among individuals breastfed for 3-12 months whereas in the Philippines duration of breastfeeding was inversely associated with schooling; and null associations were observed in South Africa and Guatemala. These associations were attenuated in adjusted models. Late introduction of solid foods was associated with lower schooling achievement in Brazil and South Africa. Conclusion: Measures of breastfeeding are not consistently related to schooling achievement in contemporary cohorts of young adults in lower and middle-income countries.	[Horta, Bernardo L.; Victora, Cesar G.] Univ Fed Pelotas, Postgrad Programme Epidemiol, Pelotas, Brazil; [Bas, Abet; Feranil, Alan] Univ San Carlos, Off Populat Studies Fdn, Cebu, Philippines; [Bhargava, Santosh K.] Sunderlal Jain Hosp, New Delhi, India; [Fall, Caroline H. D.] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [de Kadt, Julia; Richter, Linda M.] Univ Witwatersrand, Dev Pathways Hlth Res Unit, Johannesburg, South Africa; [Martorell, Reynaldo; Stein, Aryeh D.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Richter, Linda M.] Human Sci Res Council, Pretoria, South Africa	Universidade Federal de Pelotas; University of San Carlos; University of Southampton; University of Witwatersrand; Emory University; Rollins School Public Health; Human Sciences Research Council-South Africa	Horta, BL (corresponding author), Univ Fed Pelotas, Postgrad Programme Epidemiol, Pelotas, Brazil.	blhorta@gmail.com	Victora, Cesar Gomes/Y-2455-2019; Victora, Cesar G/D-4476-2013; Hallal, Pedro C/A-3249-2011; Martorell, Reynaldo/I-2539-2012; Horta, Bernardo/A-7604-2008	Victora, Cesar Gomes/0000-0002-2465-2180; Victora, Cesar G/0000-0002-2465-2180; Hallal, Pedro C/0000-0003-1470-6461; Horta, Bernardo/0000-0001-9843-412X; de Kadt, Julia/0000-0002-8063-8914; Fall, Caroline/0000-0003-4402-5552; Osmond, Clive/0000-0002-9054-4655; Stein, Aryeh/0000-0003-1138-6458	Wellcome Trust (U.K.); Bill and Melinda Gates Foundation; INTCS (Guatemala) United States National Institutes of Health (NIH); United States National Science Foundation; Pelotas Birth Cohort (Brazil) Wellcome Trust; New Delhi Birth Cohort Study (India) Indian Council of Medical Research; United States National Center for Health Statistics; Medical Research Council (U.K.); British Heart Foundation; BTT (South Africa) Wellcome Trust; Human Sciences Research Council; South African Medical Research Council; South-African Netherlands Programme on Alternative Development; Anglo American Chairman's Fund; University of the Witwatersrand; CLHNS (the Philippines) NIH; Medical Research Council [G0400519, MC_UU_12011/3, MC_UP_A620_1016] Funding Source: researchfish; MRC [MC_UU_12011/3, MC_UP_A620_1016, G0400519] Funding Source: UKRI	Wellcome Trust (U.K.)(Wellcome Trust); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); INTCS (Guatemala) United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States National Science Foundation(National Science Foundation (NSF)); Pelotas Birth Cohort (Brazil) Wellcome Trust; New Delhi Birth Cohort Study (India) Indian Council of Medical Research; United States National Center for Health Statistics; Medical Research Council (U.K.)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); BTT (South Africa) Wellcome Trust; Human Sciences Research Council; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); South-African Netherlands Programme on Alternative Development; Anglo American Chairman's Fund; University of the Witwatersrand; CLHNS (the Philippines) NIH; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	COHORTS is supported by Wellcome Trust (U.K.) and the Bill and Melinda Gates Foundation. Funding for the individual cohorts was as follows: INTCS (Guatemala) United States National Institutes of Health (NIH) and United States National Science Foundation; Pelotas Birth Cohort (Brazil) Wellcome Trust; New Delhi Birth Cohort Study (India) Indian Council of Medical Research, United States National Center for Health Statistics, Medical Research Council (U.K.), and British Heart Foundation; BTT (South Africa) Wellcome Trust, Human Sciences Research Council, South African Medical Research Council, South-African Netherlands Programme on Alternative Development, Anglo American Chairman's Fund, and University of the Witwatersrand; and CLHNS (the Philippines) NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair LS, 2007, AM J HUM BIOL, V19, P327, DOI 10.1002/ajhb.20587; Anderson JW, 1999, AM J CLIN NUTR, V70, P525; Angelsen NK, 2001, ARCH DIS CHILD, V85, P183, DOI 10.1136/adc.85.3.183; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Barros AJD, 2010, INT J EPIDEMIOL, V39, P285, DOI 10.1093/ije/dyp272; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; BJERVE KS, 1993, AM J CLIN NUTR, V57, P801, DOI 10.1093/ajcn/57.5.801S; Bouchard TJ, 2003, J NEUROBIOL, V54, P4, DOI 10.1002/neu.10160; Brion MJA, 2011, INT J EPIDEMIOL, V40, P670, DOI 10.1093/ije/dyr020; Callen J, 2004, BIRTH-ISS PERINAT C, V31, P285, DOI 10.1111/j.0730-7659.2004.00321.x; Clark KM, 2006, AMBUL PEDIATR, V6, P65, DOI 10.1016/j.ambp.2005.11.003; Dahly DL, 2007, SOC SCI MED, V64, P1407, DOI 10.1016/j.socscimed.2006.11.019; Daniels MC, 2005, J NUTR, V135, P2589, DOI 10.1093/jn/135.11.2589; Der G, 2006, BMJ-BRIT MED J, V333, P945, DOI 10.1136/bmj.38978.699583.55; Duazo P, 2010, AM J HUM BIOL, V22, P725, DOI 10.1002/ajhb.21073; Fall CHD, 2011, INT J EPIDEMIOL, V40, P47, DOI 10.1093/ije/dyq155; FERGUSSON DM, 1982, SOC SCI MED, V16, P1705, DOI 10.1016/0277-9536(82)90096-X; Gibson-Davis CM, 2006, PEDIATRICS, V118, pE1444, DOI 10.1542/peds.2006-0072; Hoefer C, 1929, J AMER MED ASSOC, V92, P615, DOI 10.1001/jama.1929.02700340015006; Horta BL, 2007, EVIDENCE LONG TERM E; Horwood LJ, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.1.e9; Kramer MS, 2008, ARCH GEN PSYCHIAT, V65, P578, DOI 10.1001/archpsyc.65.5.578; Lawlor DA, 2006, PAEDIATR PERINAT EP, V20, P148, DOI 10.1111/j.1365-3016.2006.00704.x; LUCAS A, 1992, LANCET, V339, P261, DOI 10.1016/0140-6736(92)91329-7; McCrory C, 2011, SOC SCI MED, V72, P1515, DOI 10.1016/j.socscimed.2011.03.002; MORROWTLUCAK M, 1988, SOC SCI MED, V26, P635, DOI 10.1016/0277-9536(88)90028-7; Mortensen EL, 2002, JAMA-J AM MED ASSOC, V287, P2365, DOI 10.1001/jama.287.18.2365; Oddy WH, 2003, PAEDIATR PERINAT EP, V17, P81, DOI 10.1046/j.1365-3016.2003.00464.x; Quinn PJ, 2001, J PAEDIATR CHILD H, V37, P465, DOI 10.1046/j.1440-1754.2001.00702.x; Richards M, 2002, PUBLIC HEALTH NUTR, V5, P631, DOI 10.1079/PHN2002338; Richter L, 2007, INT J EPIDEMIOL, V36, P504, DOI 10.1093/ije/dym016; Richter LM, 2011, INT J EPIDEMIOL, P1; Stein AD, 2008, INT J EPIDEMIOL, V37, P716, DOI 10.1093/ije/dyn028; Victora CG, 2006, INT J EPIDEMIOL, V35, P237, DOI 10.1093/ije/dyi290; Victora CG, 2005, ACTA PAEDIATR, V94, P1656, DOI 10.1080/08035250500252658; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2	36	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71548	10.1371/journal.pone.0071548	http://dx.doi.org/10.1371/journal.pone.0071548			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219RU	23977075	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000324527300022
J	Liu, G; Yin, Y; Liu, HY; Hao, Q				Liu, Guo; Yin, Yi; Liu, Hongyan; Hao, Qian			Quantifying Regional Vegetation Cover Variability in North China during the Holocene: Implications for Climate Feedback	PLOS ONE			English	Article							RELEVANT SOURCE AREA; POLLEN DATA; ASIAN MONSOON; LOESS PLATEAU; LAND-SURFACE; SCALE DEFORESTATION; HIGH-RESOLUTION; MODERN ANALOGS; GRAIN-SIZE; RECONSTRUCTION	Validating model simulations of vegetation-climate feedback needs information not only on changes in past vegetation types as reconstructed by palynologists, but also on other proxies such as vegetation cover. We present here a quantitative regional vegetation cover reconstruction for North China during the Holocene. The reconstruction was based on 15 high-quality lake sediment profiles selected from 55 published sites in North China, along with their modern remote sensing vegetation index. We used the surface soil pollen percentage to build three pollen-vegetation cover transfer models, and used lake surface sediment pollen data to validate their accuracy. Our results showed that vegetation cover in North China increased slightly before its maximum at 6.5 cal ka BP and has since declined significantly. The vegetation decline since 6.5 cal ka BP has likely induced a regional albedo change and aerosol increase. Further comparison with paleoclimate and paleovegetation dynamics in South China reproduced the regional cooling effect of vegetation cover decline in North China modelled in previous work. Our discussion demonstrates that, instead of reconstructing vegetation type from a single site, reconstructing quantitative regional vegetation cover could offer a broader understanding of regional vegetation-climate feedback.	[Liu, Guo; Yin, Yi; Liu, Hongyan; Hao, Qian] Peking Univ, Coll Urban & Environm Sci, Beijing 100871, Peoples R China	Peking University	Liu, HY (corresponding author), Peking Univ, Coll Urban & Environm Sci, Beijing 100871, Peoples R China.	lhy@urban.pku.edu.cn	Yin, Yi/U-9952-2019	Yin, Yi/0000-0003-4750-4997	National Natural Science Foundation of China (NSFC) [41071124, 31021001, J1103406]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study is granted by National Natural Science Foundation of China (NSFC, numbers 41071124, 31021001 and J1103406). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON PM, 1989, J BIOGEOGR, V16, P573, DOI 10.2307/2845212; Bala G, 2007, P NATL ACAD SCI USA, V104, P6550, DOI 10.1073/pnas.0608998104; Betts RA, 2000, NATURE, V408, P187, DOI 10.1038/35041545; Birks HJB, 2009, HOLOCENE CLIMATE RES, P7; Blok D, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/035502; BOYLE EA, 1985, EARTH PLANET SC LETT, V76, P135, DOI 10.1016/0012-821X(85)90154-2; Cheddadi R, 1998, CLIM DYNAM, V14, P883, DOI 10.1007/s003820050262; Chuai X, 2012, INT J CLIM; Dallmeyer A, 2011, BIOGEOSCIENCES, V8, P1499, DOI 10.5194/bg-8-1499-2011; Davin EL, 2010, J CLIMATE, V23, P97, DOI 10.1175/2009JCLI3102.1; Delcourt H. R., 1991, QUATERNARY ECOLOGY P; Dykoski CA, 2005, EARTH PLANET SC LETT, V233, P71, DOI 10.1016/j.epsl.2005.01.036; Edwards ME, 2000, J BIOGEOGR, V27, P521, DOI 10.1046/j.1365-2699.2000.00426.x; [方修琦 Fang Xiuqi], 2011, [地理科学, Scientia Geographica Sinica], V31, P385; FIELD CB, 1995, REMOTE SENS ENVIRON, V51, P74, DOI 10.1016/0034-4257(94)00066-V; Francois L, 2011, PALAEOGEOGR PALAEOCL, V304, P359, DOI 10.1016/j.palaeo.2011.01.012; Frumkin A, 2004, EARTH PLANET SC LETT, V217, P451, DOI 10.1016/S0012-821X(03)00589-2; Gaillard MJ, 2008, VEG HIST ARCHAEOBOT, V17, P415, DOI [10.1007/s00334-008-0170-x, 10.1007/s00334-008-0169-3]; Gao YX., 1962, SOME PROBLEMS E ASIA; Glantz M.H., 1983, DESERT CONTROL B, V9, P15, DOI 10.1007/BF00140520; Glenn EP, 2008, SENSORS-BASEL, V8, P2136, DOI 10.3390/s8042136; Guiot J, 2009, CLIM PAST, V5, P571, DOI 10.5194/cp-5-571-2009; Hellman S, 2009, REV PALAEOBOT PALYNO, V153, P259, DOI 10.1016/j.revpalbo.2008.08.008; Herzschuh U, 2006, QUATERNARY SCI REV, V25, P163, DOI 10.1016/j.quascirev.2005.02.006; Herzschuh U, 2004, PALAEOGEOGR PALAEOCL, V211, P1, DOI 10.1016/j.palaeo.2004.04.001; Herzschuh U, 2010, HOLOCENE, V20, P91, DOI 10.1177/0959683609348882; Hu CY, 2008, EARTH PLANET SC LETT, V266, P221, DOI 10.1016/j.epsl.2007.10.015; Irvine PJ, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016281; Juang JY, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031296; Kellogg CA, 2006, TRENDS ECOL EVOL, V21, P638, DOI 10.1016/j.tree.2006.07.004; Lang G., 1994, QUARTARE VEGETATIONS; Lau KM, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031538; Lee X, 2011, NATURE, V479, P384, DOI 10.1038/nature10588; Li ZG, 2008, J ARID ENVIRON, V72, P974, DOI 10.1016/j.jaridenv.2007.11.014; [刘鸿雁 LIU Hong-yan], 2009, [古生物学报, Acta Palaeontologica Sinica], V48, P211; Loarie SR, 2011, EARTH INTERACT, V15, DOI 10.1175/2010EI342.1; Lu HY, 1998, SCI CHINA SER D, V41, P626, DOI 10.1007/BF02878745; McDermott F, 2004, QUATERNARY SCI REV, V23, P901, DOI 10.1016/j.quascirev.2003.06.021; Miller RL, 1998, J CLIMATE, V11, P3247, DOI 10.1175/1520-0442(1998)011<3247:CRTSDA>2.0.CO;2; NAKICENOVIC N, 1993, ENERGY, V18, P401, DOI 10.1016/0360-5442(93)90019-A; Nielsen AB, 2005, HOLOCENE, V15, P1006, DOI 10.1191/0959683605hl874ra; Ornstein L, 2009, CLIMATIC CHANGE, V97, P409, DOI 10.1007/s10584-009-9626-y; OVERPECK JT, 1985, QUATERNARY RES, V23, P87, DOI 10.1016/0033-5894(85)90074-2; OVERPECK JT, 1992, GEOLOGY, V20, P1071, DOI 10.1130/0091-7613(1992)020<1071:MENAVC>2.3.CO;2; PARSONS RW, 1981, REV PALAEOBOT PALYNO, V32, P127, DOI 10.1016/0034-6667(81)90001-4; Peng CH, 2011, ECOL LETT, V14, P522, DOI 10.1111/j.1461-0248.2011.01603.x; Piao SL, 2006, GLOBAL ENVIRON CHANG, V16, P340, DOI 10.1016/j.gloenvcha.2006.02.002; Pinzon J., 2005, HILBERT HUANG TRANSF; Prell W.L, 1985, STABILITY LOW LATITU; Prentice IC, 1996, CLIM DYNAM, V12, P185, DOI 10.1007/BF00211617; Reichstein M, 2011, ILEAPS NEWSLETTER, V11, P14; Rotenberg E, 2010, SCIENCE, V327, P451, DOI 10.1126/science.1179998; SELLERS PJ, 1995, REMOTE SENS ENVIRON, V51, P3, DOI 10.1016/0034-4257(94)00061-Q; SUGITA S, 1994, J ECOL, V82, P881, DOI 10.2307/2261452; Sun P.S., 2012, HYDROL EARTH SYST SC, V9, P6649; Tarasov P, 2007, EARTH PLANET SC LETT, V264, P284, DOI 10.1016/j.epsl.2007.10.007; Tarasov PE, 1999, EARTH PLANET SC LETT, V171, P635, DOI 10.1016/S0012-821X(99)00171-5; Tegen I, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000963; Tucker C.J., 2004, GLOBAL INVENTORY MOD; Tucker CJ, 2005, INT J REMOTE SENS, V26, P4485, DOI 10.1080/01431160500168686; Velichko A.A., 1984, LATE QUATERNARY ENV, P87; Wang S., 2000, PROGR NATURAL SCI, V10, P325; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Widmann M, 2010, CLIM PAST, V6, P627, DOI 10.5194/cp-6-627-2010; WIERINGA J, 1986, Q J ROY METEOR SOC, V112, P867, DOI 10.1002/qj.49711247316; Wight Jr HE, 1994, GLOBAL CLIMATES LAST, P169; Williams JW, 2008, QUATERNARY SCI REV, V27, P669, DOI 10.1016/j.quascirev.2008.01.004; Williams JW, 2008, GLOBAL ECOL BIOGEOGR, V17, P122, DOI 10.1111/j.1466-8238.2007.00349.x; Williams JW, 2003, HOLOCENE, V13, P485, DOI 10.1191/0959683603hl613rp; Williams M, 2009, BIOGEOSCIENCES, V6, P1341, DOI 10.5194/bg-6-1341-2009; Wilmshurst JM, 2005, REV PALAEOBOT PALYNO, V136, P1, DOI 10.1016/j.revpalbo.2005.03.007; Wishart David J., 2004, ENCY GREAT PLAINS, pxiii; WOLFE SA, 1993, PROG PHYS GEOG, V17, P50, DOI 10.1177/030913339301700104; Wu HB, 2009, GLOBAL CHANGE BIOL, V15, P82, DOI 10.1111/j.1365-2486.2008.01712.x; Wu XC, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036940; Xu QH, 2009, REV PALAEOBOT PALYNO, V153, P86, DOI 10.1016/j.revpalbo.2008.07.003; Yin Y, 2012, AGR FOREST IN PRESS, DOI [10.1016/j.agrformet.2012.10.005., DOI 10.1016/J.AGRF0RMET.2012.10.005.IN]; Yin Y, 2011, PALAEOGEOGR PALAEOCL, V307, P168, DOI 10.1016/j.palaeo.2011.05.011; Yuan DX, 2004, SCIENCE, V304, P575, DOI 10.1126/science.1091220; Zhang ZH, 2003, EARTH PLANET SC LETT, V214, P467, DOI 10.1016/S0012-821X(03)00387-X; Zhao Y, 2009, EARTH-SCI REV, V97, P242, DOI 10.1016/j.earscirev.2009.10.007; Zou XK, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021853	83	10	11	5	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71681	10.1371/journal.pone.0071681	http://dx.doi.org/10.1371/journal.pone.0071681			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977110	Green Published, gold, Green Submitted			2022-12-25	WOS:000324527300030
J	Luo, WT; Jiang, Y; Lu, XT; Wang, X; Li, MH; Bai, E; Han, XG; Xu, ZW				Luo, Wentao; Jiang, Yong; Lu, Xiaotao; Wang, Xue; Li, Mai-He; Bai, Edith; Han, Xingguo; Xu, Zhuwen			Patterns of Plant Biomass Allocation in Temperate Grasslands across a 2500-km Transect in Northern China	PLOS ONE			English	Article							NET PRIMARY PRODUCTIVITY; WATER AVAILABILITY; ATMOSPHERIC CO2; SHOOT BIOMASS; C-4; ROOT; ALLOMETRY; PRECIPITATION; RESPONSES; NITROGEN	Plant biomass allocation between below- and above-ground parts can actively adapt to the ambient growth conditions and is a key parameter for estimating terrestrial ecosystem carbon (C) stocks. To investigate how climatic variations affect patterns of plant biomass allocation, we sampled 548 plants belonging to four dominant genera (Stipa spp., Cleistogenes spp., Agropyron spp., and Leymus spp.) along a large-scale (2500 km) climatic gradient across the temperate grasslands from west to east in northern China. Our results showed that Leymus spp. had the lowest root/shoot ratios among the each genus. Root/shoot ratios of each genera were positively correlated with mean annual temperature (MAT), and negatively correlated with mean annual precipitation (MAP) across the transect. Temperature contributed more to the variation of root/shoot ratios than precipitation for Cleistogenes spp. (C4 plants), whereas precipitation exerted a stronger influence than temperature on their variations for the other three genera (C3 plants). From east to west, investment of C into the belowground parts increased as precipitation decreased while temperature increased. Such changes in biomass allocation patterns in response to climatic factors may alter the competition regimes among co-existing plants, resulting in changes in community composition, structure and ecosystem functions. Our results suggested that future climate change would have great impact on C allocation and storage, as well as C turnover in the grassland ecosystems in northern China.	[Luo, Wentao; Jiang, Yong; Lu, Xiaotao; Wang, Xue; Li, Mai-He; Bai, Edith; Han, Xingguo; Xu, Zhuwen] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [Li, Mai-He] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland; [Han, Xingguo] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Luo, Wentao; Wang, Xue] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xu, ZW (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China.	zwxu@iae.ac.cn	Lu (ü), Xiao-Tao/B-3905-2008; Li, Mai-He/L-6390-2013; Jiang, Yong/A-2263-2012; Xu, ZhuWen/O-3635-2015; Han, Xingguo/K-7552-2016; Xu, Zhuwen/GLS-8029-2022; Luo, Wentao/J-7634-2015	Lu (ü), Xiao-Tao/0000-0001-5571-1895; Li, Mai-He/0000-0002-7029-2841; Jiang, Yong/0000-0001-7518-5810; Xu, ZhuWen/0000-0002-8898-6577; Han, Xingguo/0000-0002-1836-975X; Luo, Wentao/0000-0002-9543-1123	National Basic Research Program of China [2011CB403204]; National Natural Science Foundation of China [31000200]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Basic Research Program of China (2011CB403204) and by the National Natural Science Foundation of China (31000200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auerswald K, 2012, BASIC APPL ECOL, V13, P67, DOI 10.1016/j.baae.2011.11.004; Barboni D, 2009, J VEG SCI, V15, P635; Bhattachan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033996; CHAPIN FS, 1981, ECOLOGY, V62, P1000, DOI 10.2307/1936999; CHAPIN FS, 1993, AM NAT, V142, pS78, DOI 10.1086/285524; Ehleringer JR, 1997, OECOLOGIA, V112, P285, DOI 10.1007/s004420050311; Enquist BJ, 2002, SCIENCE, V295, P1517, DOI 10.1126/science.1066360; Falster DS, SMATR STANDARDIZED M; Fan JW, 2008, CLIMATIC CHANGE, V86, P375, DOI 10.1007/s10584-007-9316-6; Griffith DA, 1993, PAP REG SCI, V72, P283, DOI DOI 10.1007/BF01434277; Henry HAL, 2002, AM J BOT, V89, P1609, DOI 10.3732/ajb.89.10.1609; Hobbie SE, 2002, PLANT SOIL, V242, P163, DOI 10.1023/A:1019670731128; Jackson RB, 1996, OECOLOGIA, V108, P389, DOI 10.1007/BF00333714; Kang L, 2007, PHILOS T R SOC B, V362, P997, DOI 10.1098/rstb.2007.2029; Kerkhoff AJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P585, DOI 10.1111/j.1466-822x.2005.00187.x; KUMMEROW J, 1984, CAN J BOT, V62, P2150, DOI 10.1139/b84-294; Li X, 1995, J BIOGEOGR, V22, P515, DOI 10.2307/2845949; Li Y, 2008, J VEG SCI, V19, P245, DOI 10.3170/2007-8-18365; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Liu YS, 2012, ACTA OECOL, V44, P2, DOI 10.1016/j.actao.2012.01.005; Lu XT, 2012, OECOLOGIA, V168, P301, DOI 10.1007/s00442-011-2097-7; Luo YJ, 2012, FOREST ECOL MANAG, V269, P19, DOI 10.1016/j.foreco.2012.01.005; Milchunas DG, 2009, ECOSYSTEMS, V12, P1381, DOI 10.1007/s10021-009-9295-8; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; Muller Ivo, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P115, DOI 10.1078/1433-8319-00007; Ni J, 2007, J ARID ENVIRON, V68, P132, DOI 10.1016/j.jaridenv.2006.05.003; Niklas K.J., 1994, PLANT ALLOMETRY SCAL; Niklas KJ, 2006, NEW PHYTOL, V171, P27, DOI 10.1111/j.1469-8137.2006.01760.x; Pau S, 2013, GLOBAL CHANGE BIOL, V19, P184, DOI 10.1111/gcb.12037; Pinheiro J, 2001, MIXED EFFECTS MODELS; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; Sack L, 2002, SCIENCE, V296, pA1923, DOI 10.1126/science.296.5575.1923a; Sage RF, 2003, PHOTOSYNTH RES, V77, P209, DOI 10.1023/A:1025882003661; Sage RF, 2007, PLANT CELL ENVIRON, V30, P1086, DOI 10.1111/j.1365-3040.2007.01682.x; Saugier B., 2001, TERRESTRIAL GLOBAL P, P543, DOI [10.1016/B978-0-12-505290-0.X5000-5, DOI 10.1016/B978-012505290-0/50024-7]; Scurlock JMO, 2002, GLOBAL CHANGE BIOL, V8, P736, DOI 10.1046/j.1365-2486.2002.00512.x; Shipley B, 2002, FUNCT ECOL, V16, P326, DOI 10.1046/j.1365-2435.2002.00626.x; Snowdon P., 2000, 17 NCAS AUSTR GREENH; Swemmer AM, 2007, J ECOL, V95, P780, DOI 10.1111/j.1365-2745.2007.01237.x; Szabo ND, 2009, GLOBAL ECOL BIOGEOGR, V18, P735, DOI 10.1111/j.1466-8238.2009.00479.x; Vogan PJ, 2012, OECOLOGIA, V169, P341, DOI 10.1007/s00442-011-2201-z; Wang LA, 2010, SCI CHINA LIFE SCI, V53, P851, DOI 10.1007/s11427-010-4027-z; Wang RZ, 2004, PHOTOSYNTHETICA, V42, P71, DOI 10.1023/B:PHOT.0000040572.95053.76; Wang RZ, 2003, GLOBAL ECOL BIOGEOGR, V12, P249, DOI 10.1046/j.1466-822X.2003.00027.x; Wei XR, 2006, SOIL TILL RES, V91, P120, DOI 10.1016/j.still.2005.11.009; Xu X, 2012, GLOBAL CHANGE BIOL, V18, P1648, DOI 10.1111/j.1365-2486.2012.02651.x; Xu ZZ, 2006, PLANTA, V224, P1080, DOI 10.1007/s00425-006-0281-5; Yang HJ, 2011, GLOBAL CHANGE BIOL, V17, P2936, DOI 10.1111/j.1365-2486.2011.02423.x; Yang YH, 2012, GLOBAL CHANGE BIOL, V18, P3672, DOI 10.1111/gcb.12025; Yang YH, 2010, GLOBAL ECOL BIOGEOGR, V19, P268, DOI 10.1111/j.1466-8238.2009.00502.x; Zhao W, 2008, PLANT ECOL, V196, P85, DOI 10.1007/s11258-007-9336-3	52	42	48	6	139	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71749	10.1371/journal.pone.0071749	http://dx.doi.org/10.1371/journal.pone.0071749			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977135	Green Published, Green Submitted, gold			2022-12-25	WOS:000324527300036
J	Krebs, TS; Johansen, PO				Krebs, Teri S.; Johansen, Pal-Orjan			Psychedelics and Mental Health: A Population Study	PLOS ONE			English	Article							GENERAL-POPULATION; JERUSALEM-SYNDROME; PEYOTE USE; FOLLOW-UP; LSD USE; ASSOCIATIONS; EXPERIENCES; PREVALENCE; SAMPLE; DRUGS	Background: The classical serotonergic psychedelics LSD, psilocybin, mescaline are not known to cause brain damage and are regarded as non-addictive. Clinical studies do not suggest that psychedelics cause long-term mental health problems. Psychedelics have been used in the Americas for thousands of years. Over 30 million people currently living in the US have used LSD, psilocybin, or mescaline. Objective: To evaluate the association between the lifetime use of psychedelics and current mental health in the adult population. Method: Data drawn from years 2001 to 2004 of the National Survey on Drug Use and Health consisted of 130,152 respondents, randomly selected to be representative of the adult population in the United States. Standardized screening measures for past year mental health included serious psychological distress (K6 scale), mental health treatment (inpatient, outpatient, medication, needed but did not receive), symptoms of eight psychiatric disorders (panic disorder, major depressive episode, mania, social phobia, general anxiety disorder, agoraphobia, posttraumatic stress disorder, and non-affective psychosis), and seven specific symptoms of non-affective psychosis. We calculated weighted odds ratios by multivariate logistic regression controlling for a range of sociodemographic variables, use of illicit drugs, risk taking behavior, and exposure to traumatic events. Results: 21,967 respondents (13.4% weighted) reported lifetime psychedelic use. There were no significant associations between lifetime use of any psychedelics, lifetime use of specific psychedelics (LSD, psilocybin, mescaline, peyote), or past year use of LSD and increased rate of any of the mental health outcomes. Rather, in several cases psychedelic use was associated with lower rate of mental health problems. Conclusion: We did not find use of psychedelics to be an independent risk factor for mental health problems.	[Krebs, Teri S.; Johansen, Pal-Orjan] Norwegian Univ Sci & Technol NTNU, Fac Med, Dept Neurosci, Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Krebs, TS (corresponding author), Norwegian Univ Sci & Technol NTNU, Fac Med, Dept Neurosci, Trondheim, Norway.	krebs@ntnu.no			Research Council of Norway [185924]	Research Council of Norway(Research Council of Norway)	Both authors were supported by the Research Council of Norway (grant 185924). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle David F., 1991, PEYOTE RELIG NAVAHO; ABRAHAM HD, 1983, ARCH GEN PSYCHIAT, V40, P884; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Andersson C, 2009, OCCURANCE USE HALLUC; Bar-El Y, 2000, BRIT J PSYCHIAT, V176, P86, DOI 10.1192/bjp.176.1.86; Batzer W, 1999, J ADDICT DIS, V18, P57, DOI 10.1300/J069v18n02_06; BERGMAN RL, 1971, AM J PSYCHIAT, V128, P695, DOI 10.1176/ajp.128.6.695; Bonn-Miller MO, 2007, J ANXIETY DISORD, V21, P730, DOI 10.1016/j.janxdis.2006.09.014; Briggs GG., 2017, DRUGS PREGNANCY LACT; Bruhn JG, 2002, LANCET, V359, P1866, DOI 10.1016/S0140-6736(02)08701-9; Caputo GB, 2010, PERCEPT MOTOR SKILL, V110, P1125, DOI 10.2466/02.09.24.PMS.110.C.1125-1138; Carhart-Harris RL, 2010, J SUBST USE, V15, P283, DOI 10.3109/14659890903271624; Bouso JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042421; Catts VS, 2010, SECONDARY SCHIZOPHRE, P141, DOI DOI 10.1017/CBO9780511789977.011; Department of Health and the Home Office, 2012, LSD; Department of Health and the Home Office, 2012, MAG MUSHR; DOBLIN R, 1991, J TRANSPERSONAL PSY, V23, P1; European Monitoring Centre for Drugs and Drug Addiction, 2011, DRUG PROF HALL MUSHR; European Monitoring Centre for Drugs and Drug Addiction, 2011, DRUG PROF LYS LSD; Garden M, 2007, HUMANIST; Genova P, 2002, PERMANENT TRIP THAW, P17; Gonzalez-Maeso J, 2007, NEURON, V53, P439, DOI 10.1016/j.neuron.2007.01.008; Griffiths RR, 2008, J PSYCHOPHARMACOL, V22, P621, DOI 10.1177/0269881108094300; Griffiths RR, 2011, PSYCHOPHARMACOLOGY, V218, P649, DOI 10.1007/s00213-011-2358-5; Hallock RM, 2013, DRUG ALCOHOL DEPEN, V130, P245, DOI 10.1016/j.drugalcdep.2012.11.010; Halpern JH, 2005, BIOL PSYCHIAT, V58, P624, DOI 10.1016/j.biopsych.2005.06.038; Halpern JH, 2003, DRUG ALCOHOL DEPEN, V69, P109, DOI 10.1016/S0376-8716(02)00306-X; Henderson LA, 1998, ADVERSE REACTION LSD, P55; Hoaken PNS, 2003, ADDICT BEHAV, V28, P1533, DOI 10.1016/j.addbeh.2003.08.033; International Consortium in Psychiatric Epidemiology, 2005, APP NEW SCAL SCREEN; Johnston L D, 1997, NIDA Res Monogr, V167, P59; Kalian M, 2000, BRIT J PSYCHIAT, V176, P492, DOI 10.1192/bjp.176.5.492-a; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Krebs TS, 2013, F1000 RES IN PRESS; Kuijpers HJH, 2007, PSYCHOPATHOLOGY, V40, P461, DOI 10.1159/000108125; Kuzenko N, 2011, ACTA PSYCHIAT SCAND, V123, P466, DOI 10.1111/j.1600-0447.2010.01633.x; Lang R, 2003, HALLUCINOGENS FORENS; Lee S, 2001, BRIT J PSYCHIAT, V179, P178, DOI 10.1192/bjp.179.2.178-a; Lyons D, 2001, BRIT J PSYCHIAT, V178, P380, DOI 10.1192/bjp.178.4.380-b; Marona-Lewicka D, 2007, PHARMACOL BIOCHEM BE, V87, P453, DOI 10.1016/j.pbb.2007.06.001; McGlothlin W. H., 1964, HALLUCINOGENIC DRUGS; MCGLOTHLIN WH, 1971, ARCH GEN PSYCHIAT, V24, P35; MCWILLIAMS SA, 1973, PSYCHOL BULL, V79, P341, DOI 10.1037/h0034411; Morgan CJA, 2010, J PSYCHOPHARMACOL, V24, P147, DOI 10.1177/0269881109106915; Nichols DE, 2004, PHARMACOL THERAPEUT, V101, P131, DOI 10.1016/j.pharmthera.2003.11.002; Nicholson TRJ, 2009, BMJ CASE REPORTS; Nutt D, 2007, LANCET, V369, P1047, DOI 10.1016/S0140-6736(07)60464-4; Nutt DJ, 2010, LANCET, V376, P1558, DOI 10.1016/S0140-6736(10)61462-6; Ohayon MM, 2000, PSYCHIAT RES, V97, P153, DOI 10.1016/S0165-1781(00)00227-4; Patel V, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P115; Pechey R, 2012, PSYCHOL PSYCHOTHER-T, V85, P150, DOI 10.1111/j.2044-8341.2011.02024.x; Perala J, 2007, ARCH GEN PSYCHIAT, V64, P19, DOI 10.1001/archpsyc.64.1.19; Schankin CJ, 2012, F1000 POSTERS; Shapiro D H Jr, 1992, Int J Psychosom, V39, P62; Studerus E, 2011, J PSYCHOPHARMACOL, V25, P1434, DOI 10.1177/0269881110382466; Sunderland M, 2011, SOC PSYCH PSYCH EPID, V46, P775, DOI 10.1007/s00127-010-0247-6; Taylor M, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000774; United Nations Office on Drugs and Crime, 2012, GET FACTS HALL; van Amsterdam J, 2011, REGUL TOXICOL PHARM, V59, P423, DOI 10.1016/j.yrtph.2011.01.006; van Amsterdam J, 2010, EUR ADDICT RES, V16, P202, DOI 10.1159/000317249; VARDY MM, 1983, ARCH GEN PSYCHIAT, V40, P877; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Voigt K, 2012, J PSYCHOSOM RES, V73, P345, DOI 10.1016/j.jpsychores.2012.08.020	63	145	146	5	133	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e63972	10.1371/journal.pone.0063972	http://dx.doi.org/10.1371/journal.pone.0063972			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	205ER	23976938	Green Submitted, Green Published, gold			2022-12-25	WOS:000323425700001
J	Zhang, JY; Wang, JHC				Zhang, Jianying; Wang, James H-C.			The Effects of Mechanical Loading on Tendons - An In Vivo and In Vitro Model Study	PLOS ONE			English	Article							ACHILLES-TENDON; IGF-I; GENE-EXPRESSION; STEM-CELLS; BIOCHEMICAL-PROPERTIES; COLLAGEN-SYNTHESIS; MESSENGER-RNA; GROWTH-FACTOR; RAT TENDON; EXERCISE	Mechanical loading constantly acts on tendons, and a better understanding of its effects on the tendons is essential to gain more insights into tendon patho-physiology. This study aims to investigate tendon mechanobiological responses through the use of mouse treadmill running as an in vivo model and mechanical stretching of tendon cells as an in vitro model. In the in vivo study, mice underwent moderate treadmill running (MTR) and intensive treadmill running (ITR) regimens. Treadmill running elevated the expression of mechanical growth factors (MGF) and enhanced the proliferative potential of tendon stem cells (TSCs) in both patellar and Achilles tendons. In both tendons, MTR upregulated tenocyte-related genes: collagen type I (Coll. I similar to 10 fold) and tenomodulin (similar to 3-4 fold), but did not affect non-tenocyte-related genes: LPL (adipocyte), Sox9 (chondrocyte), Runx2 and Osterix (both osteocyte). However, ITR upregulated both tenocyte (Coll. I similar to 7-11 fold; tenomodulin similar to 4-5 fold) and non-tenocyte-related genes (similar to 3-8 fold). In the in vitro study, TSCs and tenocytes were stretched to 4% and 8% using a custom made mechanical loading system. Low mechanical stretching (4%) of TSCs from both patellar and Achilles tendons increased the expression of only the tenocyte-related genes (Coll. I similar to 5-6 fold; tenomodulin similar to 6-13 fold), but high mechanical stretching (8%) increased the expression of both tenocyte (Coll. I similar to 28-50 fold; tenomodulin similar to 14-48 fold) and non-tenocyte-related genes (2-5-fold). However, in tenocytes, non-tenocyte related gene expression was not altered by the application of either low or high mechanical stretching. These findings indicate that appropriate mechanical loading could be beneficial to tendons because of their potential to induce anabolic changes in tendon cells. However, while excessive mechanical loading caused anabolic changes in tendons, it also induced differentiation of TSCs into non-tenocytes, which may lead to the development of degenerative tendinopathy frequently seen in clinical settings.	[Wang, James H-C.] Univ Pittsburgh, MechanoBiol Lab, Dept Orthopaed Surg Bioengn Mech Engn & Mat Sci, Pittsburgh, PA 15260 USA; Univ Pittsburgh, MechanoBiol Lab, Dept Phys Med & Rehabil, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wang, JHC (corresponding author), Univ Pittsburgh, MechanoBiol Lab, Dept Orthopaed Surg Bioengn Mech Engn & Mat Sci, Pittsburgh, PA 15260 USA.	wanghc@pitt.edu			NIH [AR061395, AR060920, AR049921]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049921, R21AR060920, R01AR061395] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by NIH AR061395, AR060920, and AR049921(JHW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archambault JM, 2007, J ORTHOP RES, V25, P617, DOI 10.1002/jor.20347; Ates K, 2007, FEBS LETT, V581, P2727, DOI 10.1016/j.febslet.2007.05.030; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Buchanan CI, 2001, J APPL PHYSIOL, V90, P164, DOI 10.1152/jappl.2001.90.1.164; Couppe C, 2008, J APPL PHYSIOL, V105, P805, DOI 10.1152/japplphysiol.90361.2008; Docheva D, 2005, MOL CELL BIOL, V25, P699, DOI 10.1128/MCB.25.2.699-705.2005; Dook JE, 1997, MED SCI SPORT EXER, V29, P291, DOI 10.1097/00005768-199703000-00002; Eliasson P, 2009, J APPL PHYSIOL, V107, P399, DOI 10.1152/japplphysiol.91563.2008; Endo T, 2010, MOL ENDOCRINOL, V24, P1267, DOI 10.1210/me.2010-0056; Fontana K, 2010, CELL TISSUE RES, V339, P411, DOI 10.1007/s00441-009-0894-7; Glazebrook MA, 2008, J ORTHOP RES, V26, P840, DOI 10.1002/jor.20546; Heinemeier KM, 2007, J PHYSIOL-LONDON, V582, P1303, DOI 10.1113/jphysiol.2007.127639; Heinemeier KM, 2007, J APPL PHYSIOL, V102, P573, DOI 10.1152/japplphysiol.00866.2006; Heinemeier KM, 2012, J APPL PHYSIOL, V113, P827, DOI 10.1152/japplphysiol.00401.2012; Imanaka Mari, 2008, Kobe J Med Sci, V54, pE46; Inoue M, 2005, BIOCHEM BIOPH RES CO, V336, P215, DOI 10.1016/j.bbrc.2005.08.070; Kalliokoski KK, 2005, J APPL PHYSIOL, V99, P1189, DOI 10.1152/japplphysiol.00283.2005; Kanai Y, 1999, HUM MOL GENET, V8, P691, DOI 10.1093/hmg/8.4.691; KANNUS P, 1991, J BONE JOINT SURG AM, V73A, P1507, DOI 10.2106/00004623-199173100-00009; Kjaer M., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P41; Langberg H, 2007, SCAND J MED SCI SPOR, V17, P61, DOI 10.1111/j.1600-0838.2006.00522.x; Langberg H, 1999, J PHYSIOL-LONDON, V521, P299, DOI 10.1111/j.1469-7793.1999.00299.x; Legerlotz K, 2007, J APPL PHYSIOL, V102, P564, DOI 10.1152/japplphysiol.00767.2006; Marqueti RD, 2012, EUR J APPL PHYSIOL, V112, P1505, DOI 10.1007/s00421-011-2114-x; Matheny RW, 2010, ENDOCRINOLOGY, V151, P865, DOI 10.1210/en.2009-1217; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Mendias CL, 2008, P NATL ACAD SCI USA, V105, P388, DOI 10.1073/pnas.0707069105; Nakama LH, 2005, J ORTHOP RES, V23, P1199, DOI 10.1016/j.orthres.2005.03.006; Nishioka T, 2007, J CARDIOVASC PHARM, V49, P261, DOI 10.1097/FJC.0b013e318033dfd4; Olesen JL, 2007, J APPL PHYSIOL, V102, P214, DOI 10.1152/japplphysiol.01205.2005; Olesen JL, 2006, J APPL PHYSIOL, V101, P183, DOI 10.1152/japplphysiol.00636.2005; Perry SM, 2005, J SHOULDER ELB SURG, V14, p79S, DOI 10.1016/j.jse.2004.09.020; Riley G, 2004, RHEUMATOLOGY, V43, P131, DOI 10.1093/rheumatology/keg448; Ruge T, 2004, AM J PHYSIOL-RENAL, V287, pF1131, DOI 10.1152/ajprenal.00089.2004; Rui YF, 2010, TISSUE ENG PT A, V16, P1549, DOI 10.1089/ten.TEA.2009.0529; Scott A, 2007, ARTHRITIS RHEUM-US, V56, P871, DOI 10.1002/art.22426; Shukunami C, 2006, DEV BIOL, V298, P234, DOI 10.1016/j.ydbio.2006.06.036; SKOVGAARD D, 2010, MOL IMAGING BIOL, P52235; Tallon C, 2001, MED SCI SPORT EXER, V33, P1983, DOI 10.1097/00005768-200112000-00002; Tentori L, 2007, PHARMACOL RES, V55, P359, DOI 10.1016/j.phrs.2007.01.020; Viidik A, 1967, Scand J Plast Reconstr Surg, V1, P141; Wang JHC, 2006, CLIN ORTHOP RELAT R, P320, DOI 10.1097/01.blo.0000195927.81845.46; Wang JHC, 2003, CONNECT TISSUE RES, V44, P128, DOI 10.1080/03008200390223909; Wang JHC, 2004, J BIOMECH, V37, P573, DOI 10.1016/j.jbiomech.2003.09.011; WOO SLY, 1980, CONNECT TISSUE RES, V7, P177, DOI 10.3109/03008208009152109; Zhang JY, 2010, J ORTHOP RES, V28, P639, DOI 10.1002/jor.21046; Zhang JY, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-10; Zhang JY, 2010, J ORTHOP RES, V28, P198, DOI 10.1002/jor.20962; Zhou ZP, 2010, AGING CELL, V9, P911, DOI 10.1111/j.1474-9726.2010.00598.x	49	89	94	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71740	10.1371/journal.pone.0071740	http://dx.doi.org/10.1371/journal.pone.0071740			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977130	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000323425700092
J	Haanstra, KG; Wubben, JAM; Jonker, M; 't Hart, BA				Haanstra, Krista G.; Wubben, Jacqueline A. M.; Jonker, Margreet; 't Hart, Bert A.			Induction of Encephalitis in Rhesus Monkeys Infused with Lymphocryptovirus-Infected B-Cells Presenting MOG(34-56) Peptide	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; HUMAN CYTOMEGALOVIRUS; HERPESVIRUS PAPIO; T-CELLS; MYELIN; IDENTIFICATION; LYMPHOCYTES; ADJUVANT	The overlapping epidemiology of multiple sclerosis (MS) and Epstein-Barr virus (EBV), the increased risk to develop MS after infectious mononucleosis (IM) and the localization of EBV-infected B-cells within the MS brain suggest a causal link between EBV and MS. However, the underlying mechanism is unknown. We hypothesize that EBV-infected B-cells are capable of eliciting a central nervous system (CNS) targeting autoimmune reaction. To test this hypothesis we have developed a novel experimental model in rhesus monkeys of IM-like disease induced by infusing autologous B-lymphoblastoid cells (B-LCL). Herpesvirus papio (HVP) is a lymphocryptovirus related to EBV and was used to generate rhesus monkey B-LCL. Three groups of five animals were included; each group received three intravenous infusions of B-LCL that were either pulsed with the encephalitogenic self peptide MOG(34-56) (group A), a mimicry peptide (981-1003) of the major capsid protein of cytomegalovirus (CMVmcp(981-1003); group B) or the citrullinated MOG(34-56) (cMOG(34-56); group C). Groups A and B received on day 98 a single immunization with MOG(34-56) in incomplete Freund's adjuvant (IFA). Group C monkeys were euthanized just prior to day 98 without booster immunization. We observed self-peptide-specific proliferation of T-cells, superimposed on similar strong proliferation of CD3(+)CD8(+) T-cells against the B-LCL as observed in IM. The brains of several monkeys contained perivascular inflammatory lesions of variable size, comprising CD3(+) and CD68(+) cells. Moreover, clusters of CD3(+) and CD20(+) cells were detected in the meninges. The only evident clinical sign was substantial loss of bodyweight (>15%), a symptom observed both in early autoimmune encephalitis and IM. In conclusion, this model suggests that EBV-induced B-LCL can elicit a CNS targeting inflammatory (auto)immune reaction.	[Haanstra, Krista G.; Wubben, Jacqueline A. M.; Jonker, Margreet; 't Hart, Bert A.] Biomed Primate Res Ctr, Dept Immunobiol, Rijswijk, Netherlands; ['t Hart, Bert A.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, NL-9713 AV Groningen, Netherlands	University of Groningen	Haanstra, KG (corresponding author), Biomed Primate Res Ctr, Dept Immunobiol, Rijswijk, Netherlands.	haanstra@bprc.nl		Jonker, Margreet/0000-0003-0045-6107	Biomedical Primate Research Centre	Biomedical Primate Research Centre	Funding was obtained from Biomedical Primate Research Centre. BPRC had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alotaibi S, 2004, JAMA-J AM MED ASSOC, V291, P1875, DOI 10.1001/jama.291.15.1875; Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Boven LA, 2006, BRAIN, V129, P517, DOI 10.1093/brain/awh707; Brok HPM, 2007, J NEUROIMMUNOL, V182, P135, DOI 10.1016/j.jneuroim.2006.10.010; Carrillo-Vico A, 2010, J IMMUNOL, V184, P2839, DOI 10.4049/jimmunol.0903639; Casiraghi C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002715; Cohen JI, 2000, NEW ENGL J MED, V343, P481, DOI 10.1056/NEJM200008173430707; Dolan A, 2004, J GEN VIROL, V85, P1301, DOI 10.1099/vir.0.79888-0; Flano E, 2002, IMMUNOL RES, V25, P201, DOI 10.1385/IR:25:3:201; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Geurts JJG, 2008, LANCET NEUROL, V7, P841, DOI 10.1016/S1474-4422(08)70191-1; Hayashi K, 2002, HISTOL HISTOPATHOL, V17, P1293, DOI 10.14670/HH-17.1293; HELLER M, 1981, J VIROL, V37, P821, DOI 10.1128/JVI.37.2.821-826.1981; Jagessar AS, 2013, J NEUROIMMUNE PHARM; Jagessar SA, 2012, EUR J IMMUNOL, V42, P217, DOI 10.1002/eji.201141863; Jagessar SA, 2010, J NEUROPATH EXP NEUR, V69, P372, DOI 10.1097/NEN.0b013e3181d5d053; Jenson HB, 2000, J INFECT DIS, V181, P1462, DOI 10.1086/315385; Kap YS, 2008, J IMMUNOL, V180, P1326, DOI 10.4049/jimmunol.180.3.1326; Kostich M, 2000, J CELL SCI, V113, P2595; Lacoste V, 2010, INFECT GENET EVOL, V10, P1, DOI 10.1016/j.meegid.2009.10.009; Lunemann JD, 2009, TRENDS IMMUNOL, V30, P243, DOI 10.1016/j.it.2009.03.007; Mazzarino P, 2005, EUR J IMMUNOL, V35, P3240, DOI 10.1002/eji.200535343; Moghaddam A, 1998, J VIROL, V72, P3205, DOI 10.1128/JVI.72.4.3205-3212.1998; Moretta L, 2003, TRENDS IMMUNOL, V24, P136, DOI 10.1016/S1471-4906(03)00031-0; Nash AA, 2001, PHILOS T R SOC B, V356, P569, DOI 10.1098/rstb.2000.0779; Oguz KK, 2009, AM J NEURORADIOL, V30, P716, DOI 10.3174/ajnr.A1425; Ohga S, 2002, CRIT REV ONCOL HEMAT, V44, P203, DOI 10.1016/S1040-8428(02)00112-9; Pohl D, 2006, NEUROLOGY, V67, P2063, DOI 10.1212/01.wnl.0000247665.94088.8d; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; 't Hart BA, 2005, J NEUROIMMUNOL, V168, P1, DOI 10.1016/j.jneuroim.2005.05.017; van Leeuwen EM, 2006, IMMUNOL REV, V211, P225; VOSS G, 1992, J VIROL METHODS, V39, P185, DOI 10.1016/0166-0934(92)90137-3; Wang F, 2001, PHILOS T ROY SOC B, V356, P489, DOI 10.1098/rstb.2000.0776	35	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71549	10.1371/journal.pone.0071549	http://dx.doi.org/10.1371/journal.pone.0071549			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977076	Green Published, Green Submitted, gold			2022-12-25	WOS:000323378000059
J	Rueda, CM; Velilla, PA; Chougnet, CA; Rugeles, MT				Rueda, Cesar M.; Velilla, Paula A.; Chougnet, Claire A.; Rugeles, Maria T.			Incomplete Normalization of Regulatory T-Cell Frequency in the Gut Mucosa of Colombian HIV-Infected Patients Receiving Long-Term Antiretroviral Treatment	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; IMMUNE ACTIVATION; LYMPHOID-TISSUE; MICROBIAL TRANSLOCATION; COLLAGEN DEPOSITION; RESTORATION; RESPONSES; RECONSTITUTION; SUPPRESS; THERAPY	Introduction: To evaluate the effect of late initiation of HAART and poor immune reconstitution on the frequency of regulatory T-cells (Treg) in the peripheral blood and gut of HIV-infected patients, we studied Colombian HIV-infected patients who had been on suppressive HAART for at least one year. They had undetectable viremia but were either immunological responders (HIR); (CD4 counts >500 cells/mu l) or non-immunological responders (NIR); (CD4 T-cell count <300 cells/mu l). Untreated HIV-infected patients and uninfected controls from the same region were also evaluated. Methods: Frequency and phenotype of regulatory T-cells (Treg) were analyzed in gut biopsies and blood samples. The functional effect of Treg depletion on CMV and HIV responses was determined. Markers of immune activation and circulating LPS levels were quantified. Results: Untreated patients exhibited high Treg frequency in PBMC and gut, and their Treg express high levels of CTLA-4 and PD-1. Although HAART significantly decreased mucosal Treg frequency, it did not normalize it in any of the treated groups (HIR and NIR patients). Treg normalization was observed in the blood of HIR patients following HAART, but did not occur in NIR patients. Treg from HIV-infected patients (treated or not) suppressed HIV and hCMV-specific T-cells from gut and blood. Plasma LPS levels and percentage of HLA-DR+CD38+ T-cells were significantly elevated in all infected groups compared to controls. Conclusions: These findings suggest that control of viral replication is not sufficient to normalize gut Treg frequency in patients, independent of their response to HAART. Furthermore, persistence of functional Treg in the gut appears to be associated with the failure of HAART to repair mucosal damage.	[Rueda, Cesar M.; Velilla, Paula A.; Rugeles, Maria T.] Univ Antioquia, Grp Inmunovirol, Medellin, Antioquia, Colombia; [Chougnet, Claire A.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati Childrens Hosp Res Fdn,Div Cellular &, Cincinnati, OH USA	Universidad de Antioquia; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati	Rugeles, MT (corresponding author), Univ Antioquia, Grp Inmunovirol, Medellin, Antioquia, Colombia.	mtrugel@udea.edu.co		Velilla, Paula A/0000-0003-0885-1320; Rugeles, Maria T./0000-0001-7855-1409	Colciencias [111540820490-1]; Programa Estrategia de Sostenibilidad; Universidad de Antioquia; NIH [R01 AI068524]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR047363] Funding Source: NIH RePORTER	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Programa Estrategia de Sostenibilidad; Universidad de Antioquia; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by Colciencias (grant 111540820490-1), "Programa Estrategia de Sostenibilidad 2013-2014'', Universidad de Antioquia and NIH R01 AI068524 (to CAC). CMR is a recipient of a doctoral scholarship from Colciencias. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aandahl EM, 2004, J VIROL, V78, P2454, DOI 10.1128/JVI.78.5.2454-2459.2004; Aiuti F, 2006, AIDS REV, V8, P88; Andersson J, 2005, J IMMUNOL, V174, P3143, DOI 10.4049/jimmunol.174.6.3143; Autran B, 1999, IMMUNOL LETT, V66, P207, DOI 10.1016/S0165-2478(98)00159-X; Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; Bedke T, 2010, J IMMUNOL, V184, P5562, DOI 10.4049/jimmunol.0902458; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Crabtree-Ramirez B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020272; Critchfield JW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003577; d'Ettorre G, 2011, CURR HIV RES, V9, P148, DOI 10.2174/157016211795945296; *EACS, 2009, CLIN MAN TREATM HIV; Elahi S, 2011, NAT MED, V17, P989, DOI 10.1038/nm.2422; Epple HJ, 2006, BLOOD, V108, P3072, DOI 10.1182/blood-2006-04-016923; Estes J, 2008, J INFECT DIS, V198, P456, DOI 10.1086/590112; Estes JD, 2008, SEMIN IMMUNOL, V20, P181, DOI 10.1016/j.smim.2008.04.002; Estes JD, 2007, J INFECT DIS, V195, P551, DOI 10.1086/510852; Estes Jacob D, 2009, Curr HIV/AIDS Rep, V6, P29, DOI 10.1007/s11904-009-0005-0; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; Grabar S, 2000, ANN INTERN MED, V133, P401, DOI 10.7326/0003-4819-133-6-200009190-00007; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Julg B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031161; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Kinter AL, 2007, AIDS RES HUM RETROV, V23, P438, DOI 10.1089/aid.2006.0162; Legrand FA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000102; Macal M, 2008, MUCOSAL IMMUNOL, V1, P475, DOI 10.1038/mi.2008.35; Marchetti G, 2008, AIDS, V22, P2035, DOI 10.1097/QAD.0b013e3283112d29; Rueda CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030307; Mendez-Lagares G, 2012, J INFECT DIS, V205, P1501, DOI 10.1093/infdis/jis230; Moreno-Fernandez ME, 2011, BLOOD, V117, P5372, DOI 10.1182/blood-2010-12-323162; Nash D, 2008, AIDS, V22, P2291, DOI 10.1097/QAD.0b013e3283121ca9; Nemes E, 2010, AIDS, V24, P947, DOI 10.1097/QAD.0b013e328337b144; Nilsson J, 2006, BLOOD, V108, P3808, DOI 10.1182/blood-2006-05-021576; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; Presicce P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028118; Presicce P, 2010, CYTOM PART A, V77A, P571, DOI 10.1002/cyto.a.20875; Rios Cesar Mauricio Rueda, 2012, Open Virol J, V6, P49, DOI 10.2174/1874357901206010049; Sachdeva N, 2010, VIRAL IMMUNOL, V23, P49, DOI 10.1089/vim.2009.0069; Sakaguchi S, 2009, INT IMMUNOL, V21, P1105, DOI 10.1093/intimm/dxp095; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Shaw JM, 2011, J VIROL, V85, P11422, DOI 10.1128/JVI.05608-11; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Weiss L, 2004, BLOOD, V104, P3249, DOI 10.1182/blood-2004-01-0365; WHO, 2010, ANT THER HIV INF AD; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062	45	16	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71062	10.1371/journal.pone.0071062	http://dx.doi.org/10.1371/journal.pone.0071062			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967152	Green Submitted, gold, Green Published			2022-12-25	WOS:000323378000029
J	Di Minin, E; Hunter, LTB; Balme, GA; Smith, RJ; Goodman, PS; Slotow, R				Di Minin, Enrico; Hunter, Luke T. B.; Balme, Guy A.; Smith, Robert J.; Goodman, Peter S.; Slotow, Rob			Creating Larger and Better Connected Protected Areas Enhances the Persistence of Big Game Species in the Maputaland-Pondoland-Albany Biodiversity Hotspot	PLOS ONE			English	Article							POPULATION VIABILITY ANALYSIS; WILD DOGS; CONSERVATION; REINTRODUCTION; CONSERVANCIES; DISTRIBUTIONS; VULNERABILITY; UNCERTAINTY; EXTINCTION; CARNIVORES	The ideal conservation planning approach would enable decision-makers to use population viability analysis to assess the effects of management strategies and threats on all species at the landscape level. However, the lack of high-quality data derived from long-term studies, and uncertainty in model parameters and/or structure, often limit the use of population models to only a few species of conservation concern. We used spatially explicit metapopulation models in conjunction with multi-criteria decision analysis to assess how species-specific threats and management interventions would affect the persistence of African wild dog, black rhino, cheetah, elephant, leopard and lion, under six reserve scenarios, thereby providing the basis for deciding on a best course of conservation action in the South African province of KwaZulu-Natal, which forms the central component of the Maputaland-Pondoland-Albany biodiversity hotspot. Overall, the results suggest that current strategies of managing populations within individual, small, fenced reserves are unlikely to enhance metapopulation persistence should catastrophic events affect populations in the future. Creating larger and better-connected protected areas would ensure that threats can be better mitigated in the future for both African wild dog and leopard, which can disperse naturally, and black rhino, cheetah, elephant, and lion, which are constrained by electric fences but can be managed using translocation. The importance of both size and connectivity should inform endangered megafauna conservation and management, especially in the context of restoration efforts in increasingly human-dominated landscapes.	[Di Minin, Enrico; Smith, Robert J.] Univ Kent, Sch Anthropol & Conservat, Durrell Inst Conservat & Ecol, Canterbury, Kent, England; [Di Minin, Enrico] Univ Helsinki, Finnish Ctr Excellence Metapopulat Biol, Dept Biosci, Helsinki, Finland; [Hunter, Luke T. B.; Balme, Guy A.] Panthera, New York, NY USA; [Hunter, Luke T. B.; Slotow, Rob] Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa; [Balme, Guy A.] Univ Cape Town, Dept Biol Sci, ZA-7925 Cape Town, South Africa; [Goodman, Peter S.] Ezemvelo KwaZulu Natal Wildlife, Cascades, South Africa	University of Kent; University of Helsinki; University of Kwazulu Natal; University of Cape Town	Di Minin, E (corresponding author), Univ Kent, Sch Anthropol & Conservat, Durrell Inst Conservat & Ecol, Canterbury, Kent, England.	enrico.di.minin@helsinki.fi	Slotow, Rob/AAM-9053-2020; Di Minin, Enrico/J-6904-2013; Smith, Robert J/D-9660-2011; Hunter, Luke T.B./H-3324-2019	Di Minin, Enrico/0000-0002-5562-318X; Smith, Robert J/0000-0003-1599-9171; Hunter, Luke T.B./0000-0001-9653-6544; Slotow, Rob/0000-0001-9469-1508	Panthera Kaplan Graduate Award; US Fish & Wildlife Service Rhinoceros grant	Panthera Kaplan Graduate Award; US Fish & Wildlife Service Rhinoceros grant(US Fish & Wildlife Service)	The study was funded through a Panthera Kaplan Graduate Award and a US Fish & Wildlife Service Rhinoceros grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarde RJV, 2006, BIOL CONSERV, V134, P289; Akcakaya H. Resit, 2006, P64; Akcakaya HR, 2000, POPUL ECOL, V42, P45, DOI 10.1007/s101440050008; Bach LA, 2010, J NAT CONSERV, V18, P237, DOI 10.1016/j.jnc.2009.09.001; Balme GA, 2014, CONSERV LETT, V7, P3, DOI 10.1111/conl.12028; Balme GA, 2009, BIOL CONSERV, V142, P2681, DOI 10.1016/j.biocon.2009.06.020; Balmford A, 2004, P NATL ACAD SCI USA, V101, P9694, DOI 10.1073/pnas.0403239101; Baret F, 2006, VGT4AFRICA USER MANU; Batjes NH, 2004, 200404 ISRIC WORLD S; Beissinger SR, 2009, MODELS FOR PLANNING WILDLIFE CONSERVATION IN LARGE LANDSCAPES, P33, DOI 10.1016/B978-0-12-373631-4.00002-2; Blach-Overgaard A, 2010, ECOGRAPHY, V33, P380, DOI 10.1111/j.1600-0587.2010.06273.x; Bottrill MC, 2008, TRENDS ECOL EVOL, V23, P649, DOI 10.1016/j.tree.2008.07.007; Bruner AG, 2004, BIOSCIENCE, V54, P1119, DOI 10.1641/0006-3568(2004)054[1119:FCASOM]2.0.CO;2; Burgman MA, 2005, ECOLOGY, V86, P2007, DOI 10.1890/04-0906; Burgman MA, 2001, CONSERV BIOL, V15, P603, DOI 10.1046/j.1523-1739.2001.015003603.x; BURKEY TV, 1989, OIKOS, V55, P75, DOI 10.2307/3565875; Carroll C, 2003, ECOL APPL, V13, P1773, DOI 10.1890/02-5195; Consortium for Spatial Information website, SHUTTL RAD TOP MISS; Cowling RM, 2003, BIOL CONSERV, V112, P191, DOI 10.1016/S0006-3207(02)00425-1; Davies-Mostert HT, 2012, AFR J ECOL, V50, P500, DOI 10.1111/j.1365-2028.2012.01335.x; Davies-Mostert HT, 2009, REINTRODUCTION TOP O; Department of Environmental Affairs and Tourism (DEAT), 2007, ENV MAN BIOD ACT LIS; Di Minin E, 2013, ANIM CONSERV, V16, P263, DOI 10.1111/acv.12060; Di Minin E, 2013, ANIM CONSERV, V16, P249, DOI 10.1111/j.1469-1795.2012.00595.x; DI MININ E., 2013, CONSERV BIOL, DOI [10.1111/cobi.12048, DOI 10.1111/C0BI.12048]; Di Minin E, 2011, ECOGRAPHY, V34, P162, DOI 10.1111/j.1600-0587.2010.06263.x; Downsborough L, 2011, ORYX, V45, P357, DOI 10.1017/S0030605310001559; Drechsler M, 2004, BIODIVERS CONSERV, V13, P115, DOI 10.1023/B:BIOC.0000004315.09433.f6; Drechsler M, 2003, ECOL APPL, V13, P990, DOI 10.1890/1051-0761(2003)13[990:RMERFP]2.0.CO;2; EAST R, 1984, AFR J ECOL, V22, P245, DOI 10.1111/j.1365-2028.1984.tb00700.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elmhagen B, 2001, OIKOS, V94, P89, DOI 10.1034/j.1600-0706.2001.11316.x; Emslie R., 2009, GUIDELINES IN SITU R; ESRI, 2009, ARCEDITOR 9 2; Ezemvelo KwaZulu-Natal Wildlife, 2008, KWAZULU NAT LAND COV; Fagan WF, 2001, ECOL LETT, V4, P132, DOI 10.1046/j.1461-0248.2001.00206.x; Goodman PS, 2010, KWAZULU NATAL BIODIV; Guisan A, 2007, DIVERS DISTRIB, V13, P332, DOI 10.1111/j.1472-4642.2007.00342.x; Gusset M, 2008, J APPL ECOL, V45, P100, DOI 10.1111/j.1365-2664.2007.01357.x; Gusset M, 2009, BIOL CONSERV, V142, P2774, DOI 10.1016/j.biocon.2009.07.007; Haight RG, 2007, ENVIRON MODEL ASSESS, V13, P243; Hayward MW, 2007, BIOL CONSERV, V139, P219, DOI 10.1016/j.biocon.2007.06.018; Hayward MW, 2007, AFR J ECOL, V45, P103, DOI 10.1111/j.1365-2028.2006.00673.x; Hayward MW, 2009, BIOL CONSERV, V142, P1, DOI 10.1016/j.biocon.2008.09.022; HESS GR, 1994, CONSERV BIOL, V8, P256, DOI 10.1046/j.1523-1739.1994.08010256.x; Hunter LTB, 2007, ORYX, V41, P196, DOI 10.1017/S003060530700172X; Jooste E, 2013, EUR J WILDLIFE RES, V59, P487, DOI 10.1007/s10344-013-0696-9; Joseph LN, 2009, CONSERV BIOL, V23, P328, DOI 10.1111/j.1523-1739.2008.01124.x; Knight AT, 2011, BIOL CONSERV, V144, P2623, DOI 10.1016/j.biocon.2011.07.013; Laliberte AS, 2004, BIOSCIENCE, V54, P123, DOI 10.1641/0006-3568(2004)054[0123:RCONAC]2.0.CO;2; Leuteritz T., 2008, IUCN RED LIST THREAT; Lindsey P, 2011, ORYX, V45, P587, DOI 10.1017/S003060531000150X; Lindsey PA, 2009, J ZOOL, V277, P99, DOI 10.1111/j.1469-7998.2008.00529.x; Linkie M, 2006, J APPL ECOL, V43, P576, DOI 10.1111/j.1365-2664.2006.01153.x; Maddock A, 2013, CONSERV BIOL, V14, P155; McCracken Donald P, 2008, SAVING ZULULAND WILD; Milliken BT, 2012, S AFRICA VIET NAM RH; Moilanen A, 2002, ECOL APPL, V12, P913, DOI 10.1890/1051-0761(2002)012[0913:SSDSS]2.0.CO;2; Morgan S, 2009, BIOL CONSERV, V142, P384, DOI 10.1016/j.biocon.2008.10.033; Nalle D. J., 2004, Journal of Environmental Economics and Management, V48, P997, DOI 10.1016/j.jeem.2004.01.001; Nicholson E, 2007, ECOL APPL, V17, P251, DOI 10.1890/1051-0761(2007)017[0251:MCDUUF]2.0.CO;2; Nicholson E, 2006, ECOL LETT, V9, P1049, DOI 10.1111/j.1461-0248.2006.00956.x; Nilsen EB, 2007, P ROY SOC B-BIOL SCI, V274, P995, DOI 10.1098/rspb.2006.0369; Noon BR, 2003, BIOSCIENCE, V53, P1217, DOI 10.1641/0006-3568(2003)053[1217:CPFUNF]2.0.CO;2; Noss RF, 2002, CONSERV BIOL, V16, P895, DOI 10.1046/j.1523-1739.2002.01405.x; Packer C, 2013, ECOL LETT, V16, P635, DOI 10.1111/ele.12091; Parks SA, 2002, CONSERV BIOL, V16, P800, DOI 10.1046/j.1523-1739.2002.00288.x; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; R Core Development Tem, 2011, R LANG ENV STAT COMP; Rabinowitz A, 2010, BIOL CONSERV, V143, P939, DOI 10.1016/j.biocon.2010.01.002; Regan HM, 2002, ECOL APPL, V12, P618, DOI 10.2307/3060967; Root KV, 2003, CONSERV BIOL, V17, P196, DOI 10.1046/j.1523-1739.2003.00447.x; Root W.T., 2005, APPL BIOMATHEMATICS; SIMBERLOFF D, 1992, CONSERV BIOL, V6, P493, DOI 10.1046/j.1523-1739.1992.06040493.x; Slotow R, 2005, S AFR J WILDL RES, V35, P23; Snyman SL, 2012, J SUSTAIN TOUR, V20, P395, DOI 10.1080/09669582.2012.657202; Somers MJ, 2008, OECOLOGIA, V158, P239, DOI 10.1007/s00442-008-1134-7; Steenkamp Y., 2004, HOTSPOTS REVISITED E; Stuart C, 2000, FIELD GUIDE LARGER M; Thomas CD, 2000, J ANIM ECOL, V6, P647; Trinkel M, 2008, ANIM CONSERV, V11, P138, DOI 10.1111/j.1469-1795.2008.00163.x; van Kooten GC, 2008, BIOL CONSERV, V141, P2012, DOI 10.1016/j.biocon.2008.05.016; Wensing D, 2006, BASELINE EC STUDY GU; Wikramanayake E, 2004, CONSERV BIOL, V18, P839, DOI 10.1111/j.1523-1739.2004.00145.x; Wintle BA, 2005, J WILDLIFE MANAGE, V69, P905, DOI 10.2193/0022-541X(2005)069[0905:EADWDI]2.0.CO;2	86	40	41	2	145	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71788	10.1371/journal.pone.0071788	http://dx.doi.org/10.1371/journal.pone.0071788			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23977144	Green Published, Green Submitted, gold			2022-12-25	WOS:000323221500105
J	Ricotti, L; Fujie, T; Vazao, H; Ciofani, G; Marotta, R; Brescia, R; Filippeschi, C; Corradini, I; Matteoli, M; Mattoli, V; Ferreira, L; Menciassi, A				Ricotti, Leonardo; Fujie, Toshinori; Vazao, Helena; Ciofani, Gianni; Marotta, Roberto; Brescia, Rosaria; Filippeschi, Carlo; Corradini, Irene; Matteoli, Michela; Mattoli, Virgilio; Ferreira, Lino; Menciassi, Arianna			Boron Nitride Nanotube-Mediated Stimulation of Cell Co-Culture on Micro-Engineered Hydrogels	PLOS ONE			English	Article							SKELETAL-MUSCLE CELLS; C2C12 MOUSE MYOTUBES; MYOGENIC DIFFERENTIATION; ELECTRICAL-STIMULATION; THIN-FILMS; SUBSTRATE; STIFFNESS; ALIGNMENT; ACTIVATION; MYOBLASTS	In this paper, we describe the effects of the combination of topographical, mechanical, chemical and intracellular electrical stimuli on a co-culture of fibroblasts and skeletal muscle cells. The co-culture was anisotropically grown onto an engineered micro-grooved (10 mm-wide grooves) polyacrylamide substrate, showing a precisely tuned Young's modulus (similar to 14 kPa) and a small thickness (similar to 12 mm). We enhanced the co-culture properties through intracellular stimulation produced by piezoelectric nanostructures (i.e., boron nitride nanotubes) activated by ultrasounds, thus exploiting the ability of boron nitride nanotubes to convert outer mechanical waves (such as ultrasounds) in intracellular electrical stimuli, by exploiting the direct piezoelectric effect. We demonstrated that nanotubes were internalized by muscle cells and localized in both early and late endosomes, while they were not internalized by the underneath fibroblast layer. Muscle cell differentiation benefited from the synergic combination of topographical, mechanical, chemical and nanoparticle-based stimuli, showing good myotube development and alignment towards a preferential direction, as well as high expression of genes encoding key proteins for muscle contraction (i.e., actin and myosin). We also clarified the possible role of fibroblasts in this process, highlighting their response to the above mentioned physical stimuli in terms of gene expression and cytokine production. Finally, calcium imaging-based experiments demonstrated a higher functionality of the stimulated co-cultures.	[Ricotti, Leonardo; Filippeschi, Carlo; Menciassi, Arianna] Scuola Superiore St Anna, BioRobot Inst, Pisa, Italy; [Fujie, Toshinori; Ciofani, Gianni; Filippeschi, Carlo; Mattoli, Virgilio] Ist Italiano Tecnol, Ctr MicroBioRobot SSSA, Pisa, Italy; [Vazao, Helena; Ferreira, Lino] Biocant Ctr Biotechnol Innovat Ctr, Coimbra, Portugal; [Vazao, Helena; Ferreira, Lino] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Fujie, Toshinori] Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 980, Japan; [Corradini, Irene] Fdn Filarete, Milan, Italy; [Corradini, Irene; Matteoli, Michela] Univ Milan, Dipartimento Biotecnol Med & Med Traslaz, Milan, Italy; [Matteoli, Michela] Humanitas Clin & Res Ctr, Rozzano, Italy; [Marotta, Roberto; Brescia, Rosaria] Ist Italiano Tecnol, Genoa, Italy	Scuola Superiore Sant'Anna; Istituto Italiano di Tecnologia - IIT; Universidade de Coimbra; Universidade de Coimbra; Tohoku University; University of Milan; IRCCS Humanitas Research Hospital; Istituto Italiano di Tecnologia - IIT	Ricotti, L (corresponding author), Scuola Superiore St Anna, BioRobot Inst, Pisa, Italy.	l.ricotti@sssup.it	Fujie, Toshinori/O-1493-2018; Ciofani, Gianni/D-3761-2009; Brescia, Rosaria/D-9507-2011; Marotta, Roberto/HGV-1599-2022; Mattoli, Virgilio/A-6744-2017; Matteoli, Michela/K-4526-2018; Ricotti, Leonardo/J-5592-2013; Marotta, Roberto/B-5382-2014; Corradini, Irene/J-5320-2018	Fujie, Toshinori/0000-0003-1417-8670; Ciofani, Gianni/0000-0003-1192-3647; Mattoli, Virgilio/0000-0002-4715-8353; Matteoli, Michela/0000-0002-3569-7843; Corradini, Irene/0000-0001-7128-9209; Ricotti, Leonardo/0000-0001-8797-3742; Brescia, Rosaria/0000-0003-0607-0627; Marotta, Roberto/0000-0003-0634-5483; Vazao, Helena/0000-0002-5955-4804; ferreira, lino/0000-0001-8985-9302	Fondazione Cassa di Risparmio di Pisa	Fondazione Cassa di Risparmio di Pisa	This work was supported in part by the Fondazione Cassa di Risparmio di Pisa in the framework of the project Micro-VAST (microsystem for vascular diagnostics and intervention). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare L, 2010, ACTA BIOMATER, V6, P1948, DOI 10.1016/j.actbio.2009.12.040; Bach AD, 2004, J CELL MOL MED, V8, P413, DOI 10.1111/j.1582-4934.2004.tb00466.x; Boonen KJM, 2010, J BIOMECH, V43, P1514, DOI 10.1016/j.jbiomech.2010.01.039; Capes EM, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-18; Charest JL, 2007, BIOMATERIALS, V28, P2202, DOI 10.1016/j.biomaterials.2007.01.020; Chen SE, 2007, AM J PHYSIOL-CELL PH, V292, pC1660, DOI 10.1152/ajpcell.00486.2006; Ciofani G, 2010, INT J NANOMED, V5, P285; Ciofani G, 2012, PIEZOELECTRIC NANOMA, pCh 8; Ciofani G, 2008, BIOTECHNOL BIOENG, V101, P850, DOI 10.1002/bit.21952; Ciofani G, 2012, INT J NANOMED, V7, P19, DOI 10.2147/IJN.S28144; Ciofani G, 2011, BIOMED MICRODEVICES, V13, P255, DOI 10.1007/s10544-010-9490-6; Ciofani G, 2011, CURR NANOSCI, V7, P94, DOI 10.2174/157341311794480345; Ciofani G, 2010, ACS NANO, V4, P6267, DOI 10.1021/nn101985a; Cooper ST, 2004, CELL MOTIL CYTOSKEL, V58, P200, DOI 10.1002/cm.20010; Cronin EM, 2004, J BIOMED MATER RES A, V69A, P373, DOI 10.1002/jbm.a.30009; Dennis R. G., 2005, BIOMIMETICS BIOL INS; DiEdwardo CA, 1999, CLIN PLAST SURG, V26, P647; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Feinberg AW, 2007, SCIENCE, V317, P1366, DOI 10.1126/science.1146885; Flaibani M, 2009, TISSUE ENG PT A, V15, P2447, DOI 10.1089/ten.tea.2008.0301; Furlan I, 2005, BRIT J PHARMACOL, V146, P389, DOI 10.1038/sj.bjp.0706329; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Golberg D, 2007, ADV MATER, V19, P2413, DOI 10.1002/adma.200700179; GRASSI F, 1993, PFLUG ARCH EUR J PHY, V422, P591, DOI 10.1007/BF00374007; Hastings NE, 2009, ARTERIOSCL THROM VAS, V29, P725, DOI 10.1161/ATVBAHA.109.184382; Hinds S, 2011, BIOMATERIALS, V32, P3575, DOI 10.1016/j.biomaterials.2011.01.062; Hoene M, 2013, AM J PHYSIOL-CELL PH, V304, pC128, DOI 10.1152/ajpcell.00025.2012; Huang NF, 2006, NANO LETT, V6, P537, DOI 10.1021/nl060060o; Jiang ZL, 2006, FASEB J, V20, P2570, DOI 10.1096/fj.06-6347fje; Kawahara Y, 2006, PATHOBIOLOGY, V73, P288, DOI 10.1159/000099123; Kim TG, 2012, ADV FUNCT MATER, V22, P2446, DOI 10.1002/adfm.201103083; Koning M, 2009, J TISSUE ENG REGEN M, V3, P407, DOI 10.1002/term.190; Lam MT, 2006, BIOMATERIALS, V27, P4340, DOI 10.1016/j.biomaterials.2006.04.012; Langelaan MLP, 2010, TRENDS FOOD SCI TECH, V21, P59, DOI 10.1016/j.tifs.2009.11.001; Langen RCJ, 2001, FASEB J, V15, P1169, DOI 10.1096/fj.00-0463; Levy-Mishali M, 2009, TISSUE ENG PT A, V15, P935, DOI 10.1089/ten.tea.2008.0111; Liao IC, 2008, CELL MOL BIOENG, V1, P133, DOI 10.1007/s12195-008-0021-y; Liu WF, 2005, MATER TODAY, V8, P28, DOI 10.1016/S1369-7021(05)71222-0; Lorenzon P, 1997, EUR J NEUROSCI, V9, P800, DOI 10.1111/j.1460-9568.1997.tb01429.x; Molnar P, 2007, BIOTECHNOL PROGR, V23, P265, DOI 10.1021/bp060302q; Monge C, 2012, TISSUE ENG PT A, V18, P1664, DOI [10.1089/ten.tea.2012.0079, 10.1089/ten.TEA.2012.0079]; Nikkhah M, 2012, BIOMATERIALS, V33, P5230, DOI 10.1016/j.biomaterials.2012.03.079; Pedrotty DM, 2005, AM J PHYSIOL-HEART C, V288, pH1620, DOI 10.1152/ajpheart.00610.2003; Razal JM, 2009, ADV FUNCT MATER, V19, P3381, DOI 10.1002/adfm.200900464; Ren KF, 2008, ADV FUNCT MATER, V18, P1378, DOI 10.1002/adfm.200701297; Riboldi SA, 2008, J BIOMED MATER RES A, V84A, P1094, DOI 10.1002/jbm.a.31534; Ricotti L, 2013, IEEE T BIO-MED ENG, V60, P727, DOI 10.1109/TBME.2013.2244093; Ricotti L, 2012, BIOMED MICRODEVICES, V14, P987, DOI 10.1007/s10544-012-9697-9; Ricotti L, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/3/035010; Ricotti L, 2010, BIOMED MICRODEVICES, V12, P809, DOI 10.1007/s10544-010-9435-0; Wang PY, 2010, BIOTECHNOL BIOENG, V106, P285, DOI 10.1002/bit.22697; Wang YL, 1998, METHOD ENZYMOL, V298, P489, DOI 10.1016/S0076-6879(98)98041-7; Yeung T, CELL MOT CYTOSKEL, V60, P24; Zhao Y, 2009, BIOTECHNOL BIOENG, V102, P624, DOI 10.1002/bit.22080	55	50	50	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71707	10.1371/journal.pone.0071707	http://dx.doi.org/10.1371/journal.pone.0071707			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23977119	Green Published, gold, Green Submitted			2022-12-25	WOS:000323221500096
J	Wang, Q; Shih, CK; Ren, D				Wang, Qi; Shih, Chungkun; Ren, Dong			The Earliest Case of Extreme Sexual Display with Exaggerated Male Organs by Two Middle Jurassic Mecopterans	PLOS ONE			English	Article							INNER-MONGOLIA; INSECTA MECOPTERA; BRITISH-COLUMBIA; HYMENOPTERA; PROCTOTRUPOIDEA; AGE	Background: Many extant male animals exhibit exaggerated body parts for display, defense or offence in sexual selection, such as male birds of paradise showing off colorful and elegant feathers and male moose and reindeers bearing large structured antlers. For insects, male rhinoceros and stag beetles have huge horn-like structure for fighting and competition and some male Leptopanorpa scorpionflies have very long abdominal terminal segments for sexual display and competition. Fossil records of insects having exaggerated body parts for sexual display are fairly rare. One example is two male holcorpids with elongate abdominal segments from sixth (A6) to eighth (A8) and enlarged male genitalia from Eocene, suggesting evolution of these characters occurred fairly late. Principal Findings: We document two mecopterans with exaggerated male body parts from the late Middle Jurassic Jiulongshan Formation in northeastern China. Both have extremely extended abdominal segments from A6 to A8 and enlarged genitalia, which might have been used for sexual display and, to less extent, for fighting with other males in the competition for mates. Although Fortiholcorpa paradoxa gen. et sp. nov. and Miriholcorpa forcipata gen. et sp. nov. seem to have affinities with Holcorpidae, we deem both as Family Incertae sedis mainly due to significant differences in branching pattern of Media (M) veins and relative length of A8 for F. paradoxa, and indiscernible preservation of 5-branched M veins in hind wing for M. forcipata. Conclusions/Significance: These two new taxa have extended the records of exaggerated male body parts of mecopterans for sexual display and/or selection from the Early Eocene to the late Middle Jurassic. The similar character present in some Leptopanorpa of Panorpidae suggests that the sexual display and/or sexual selection due to extremely elongated male abdominal and sexual organs outweigh the negative impact of bulky body and poor mobility in the evolutionary process.	[Wang, Qi; Shih, Chungkun; Ren, Dong] Capital Normal Univ, Coll Life Sci, Key Lab Insect Evolut & Environm Change, Beijing, Peoples R China	Capital Normal University	Ren, D (corresponding author), Capital Normal Univ, Coll Life Sci, Key Lab Insect Evolut & Environm Change, Beijing, Peoples R China.	rendong@mail.cnu.edu.cn			National Basic Research Program of China (973 Program) [2012CB821906]; National Natural Science Foundation of China [31071964, 31172143, 31230065, 41272006]; PHR Project of the Beijing Municipal Commission of Education [201207120]; China Geological Survey [1212011120116]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); PHR Project of the Beijing Municipal Commission of Education; China Geological Survey(China Geological Survey)	This research is supported by the National Basic Research Program of China (973 Program) (grant 2012CB821906), the National Natural Science Foundation of China (grants 31071964, 31172143, 31230065 and 41272006), PHR Project of the Beijing Municipal Commission of Education (grants 201207120), and China Geological Survey (grant 1212011120116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibald SB, 2010, ANN SOC ENTOMOL FR, V46, P173, DOI 10.1080/00379271.2010.10697654; Archibald SB, 2005, CAN J EARTH SCI, V42, P119, DOI 10.1139/E04-073; CARPENTER F. M., 1931, JOUR NEW YORK ENT SOC, V39, P405; Gao KQ, 2006, ACTA GEOL SIN-ENGL, V80, P42; Gao TP, 2009, ZOOTAXA, P52, DOI 10.11646/zootaxa.2094.1.6; Gao TP, 2009, ANN ENTOMOL SOC AM, V102, P588, DOI 10.1603/008.102.0402; Hong You-Chong, 2007, Entomotaxonomia, V29, P26; [洪友崇 Hong Youchong], 2004, [地质通报, Geological Bulletin of China], V23, P802; Huang DY, 2006, PROG NAT SCI-MATER, V16, P308; ICZN, 1999, INT CODE ZOOLOGICAL; Ji Q, 2006, SCIENCE, V311, P1123, DOI 10.1126/science.1123026; LIEFTINCK M. A., 1936, TREUBIA, V15, P271; Ma N, 2010, MICRON, V41, P931, DOI 10.1016/j.micron.2010.07.008; Martuinov A. V., 1937, Trav Inst paleontol Acad Sci URSS Moscow, V7, P1; Martynova OM, 1962, FUNDAMENTALS PALEONT, P283; Ogg J.G., 2008, CONCISE GEOLOGIC TIM; Ohm P., 1961, Zoologischer Anzeiger Leipzig, V166, P1; PENNY N D, 1975, Journal of the Kansas Entomological Society, V48, P331; Petrulevicius Julian F., 2012, Revue de Paleobiologie, P311; Qiao X, 2012, ALCHERINGA, V36, P467, DOI 10.1080/03115518.2012.671689; Qiao X, 2012, CRETACEOUS RES, V36, P146, DOI 10.1016/j.cretres.2012.03.004; Ren D, 2011, ZOOKEYS, P17, DOI 10.3897/zookeys.129.1282; Ren D, 2010, ACTA GEOL SIN-ENGL, V84, P720; Ren D, 2010, ACTA GEOL SIN-ENGL, V84, P22, DOI 10.1111/j.1755-6724.2010.00166.x; Ren D, 2009, SCIENCE, V326, P840, DOI 10.1126/science.1178338; Ren Dong, 2005, Acta Zootaxonomica Sinica, V30, P275; Scudder S.H., 1878, B US GEOLOGICAL GEOG, V4, P519; Shih CK, 2011, ANN ENTOMOL SOC AM, V104, P1334, DOI 10.1603/AN10194; Shih CK, 2011, ZOOKEYS, P281, DOI 10.3897/zookeys.130.1641; Shih CK, 2009, ANN ENTOMOL SOC AM, V102, P20, DOI 10.1603/008.102.0103; THORNHILL R, 1981, ANNU REV ECOL SYST, V12, P355, DOI 10.1146/annurev.es.12.110181.002035; Wang YJ, 2012, P NATL ACAD SCI USA, V109, P20514, DOI 10.1073/pnas.1205517109; WILLMANN R, 1987, SYST ENTOMOL, V12, P519, DOI 10.1111/j.1365-3113.1987.tb00222.x; Willmann R, 1989, ABH SENCKENB NAT, V544, P1; Willmann Rainer, 1998, Palaeontologische Zeitschrift, V72, P281; Yang XG, 2012, ALCHERINGA, V36, P195, DOI 10.1080/03115518.2012.622143	36	16	18	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71378	10.1371/journal.pone.0071378	http://dx.doi.org/10.1371/journal.pone.0071378			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23977031	Green Submitted, Green Published, gold			2022-12-25	WOS:000323221500081
J	Gamisch, A; Staedler, YM; Schonenberger, J; Fischer, GA; Comes, HP				Gamisch, Alexander; Staedler, Yannick M.; Schoenenberger, Juerg; Fischer, Gunter A.; Comes, Hans Peter			Histological and Micro-CT Evidence of Stigmatic Rostellum Receptivity Promoting Auto-Pollination in the Madagascan Orchid Bulbophyllum bicoloratum	PLOS ONE			English	Article							CONSEQUENCES; MORPHOLOGY; EVOLUTION; ECOLOGY	Background: The rostellum, a projecting part of the gynostemium in orchid flowers, separates the anther(s) from the stigma and thus commonly prevents auto-pollination. Nonetheless, as a modified (usually distal) portion of the median stigma lobe, the rostellum has been frequently invoked of having re-gained a stigmatic function in rare cases of orchid auto-pollination. Here it is shown that a newly discovered selfing variant of Madagascan Bulbophyllum bicoloratum has evolved a modified rostellum allowing the penetration of pollen tubes from in situ pollinia. Methods: Gynostemium micro-morphology and anatomy of selfing and outcrossing variants of B. bicoloratum was studied by using light and scanning electron microscopy and histological sections. Pollen tube growth in the selfing variant was further observed via X-ray computed microtomography (micro-CT), providing 3D reconstructions of floral tissues at a micron scale. Findings: Selfing variants possess a suberect ('displaced') rostellum rather than the conventional, erect type. Very early in anthesis, the pollinia of selfers are released from the anther and slide down onto the suberect rostellum, where pollen tube growth preferentially occurs through the non-vascularized, i.e. rear (adaxial) and (semi-) lateral parts. This penetrated tissue is comprised of a thin layer of elongate and loosely arranged cells, embedded in stigmatic exudates, as also observed in the stigmatic cavity of both selfing and outcrossing variants. Conclusions: Our results provide the first solid evidence of a stigmatic function for the rostellum in orchid flowers, thereby demonstrating for the first time the feasibility of the micro-CT technique for accurately visualizing pollen tube growth in flowering plants. Rostellum receptivity in B. bicoloratum probably uniquely evolved as an adaptation for reproductive assurance from an outcrossing ancestor possessing an erect (non-receptive) rostellum. These findings open up new avenues in the investigation of an organ that apparently re-gained its 'primordial function' of being penetrated by pollen tubes.	[Gamisch, Alexander; Comes, Hans Peter] Salzburg Univ, Dept Organism Biol, A-5020 Salzburg, Austria; [Staedler, Yannick M.; Schoenenberger, Juerg] Univ Vienna, Dept Struct & Funct Bot, Vienna, Austria; [Fischer, Gunter A.] Kadoorie Farm & Bot Garden Corp, Flora Conservat Dept, Hong Kong, Hong Kong, Peoples R China	Salzburg University; University of Vienna	Gamisch, A (corresponding author), Salzburg Univ, Dept Organism Biol, A-5020 Salzburg, Austria.	alexander.gamisch@gmx.at	Schönenberger, Jürg/AAE-6479-2020; Schönenberger, Jürg/D-3413-2014	Schönenberger, Jürg/0000-0001-6791-2731; Schönenberger, Jürg/0000-0001-6791-2731; Staedler, Yannick/0000-0002-5962-7313; Stadler, Yannick/0000-0002-6328-1503; Staedler, Yannick Marc/0000-0002-0688-6995	FWF (Austrian Science Fund) [P20726-B03, P17124-B0]; Austrian Science Fund (FWF) [P 20726] Funding Source: researchfish	FWF (Austrian Science Fund)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the FWF (Austrian Science Fund, http://www.fwf.ac.at/) (P20726-B03 and P17124-B0 to H.P.C and G.A.F., respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceto S, 2011, CURR GENOMICS, V12, P342, DOI 10.2174/138920211796429754; Arditti J., 1992, FUNDAMENTALS ORCHID, P691; Boavida LC, 2011, PLANT PHYSIOL, V155, P2066, DOI 10.1104/pp.110.169813; Borba EL, 1999, PLANT SYST EVOL, V217, P205, DOI 10.1007/BF00984366; Borba EL, 1999, PLANT SYST EVOL, V217, P197, DOI 10.1007/BF00984365; Burney DA, 2004, J HUM EVOL, V47, P25, DOI 10.1016/j.jhevol.2004.05.005; Cable S., 2011, The biology of island floras, P425; CALDER DM, 1985, ANN BOT-LONDON, V55, P297, DOI 10.1093/oxfordjournals.aob.a086906; Catling P., 1990, ORCHID BIOL REV PERS, P121; CATLING P M, 1983, Naturaliste Canadien (Quebec), V110, P37; Charlesworth D, 2006, CURR BIOL, V16, pR726, DOI 10.1016/j.cub.2006.07.068; Chen Ling-Ling, 2011, Chinese Journal of Plant Ecology, V35, P1202, DOI 10.3724/SP.J.1258.2011.01202; CLIFFORD SC, 1990, BOT GAZ, V151, P440, DOI 10.1086/337844; Cribb P, 2009, FIELD GUIDE ORCHIDS, P440; CRIVELLATO E, 1990, Z MIKROSK ANAT FORSC, V104, P769; Darwin C., 1862, VARIOUS CONTRIVANCES, P365; Darwin C, 1903, MORE LETT C DA UNPUB, V2; Darwin C. R., 1904, VARIOUS CONTRIVANCES; Dressler R.L, 1993, PHYLOGENY CLASSIFICA, P314; Dressler RL, 1981, ORCHIDS NATURAL HIST, P394; Eckert CG, 2010, TRENDS ECOL EVOL, V25, P35, DOI 10.1016/j.tree.2009.06.013; EFIMOV PG, 2011, EUR J ENVIRON SCI, V1, P125; Fischer GA, 2007, MOL PHYLOGENET EVOL, V45, P358, DOI 10.1016/j.ympev.2007.06.023; Gray Asa, 1862, AM J SCI ARTS, V34, P420; HAGERUP O, 1952, PHYTOMORPHOLOGY, V2, P51; Harper GJ, 2007, ENVIRON CONSERV, V34, P325, DOI 10.1017/S0376892907004262; Hawes C, 2001, PLANT CELL BIOL PRAC, P358; Hayat MA, 1993, STAINS CYTOCHEMICAL, P455; Heslop-Harrison Y., 1981, Nordic Journal of Botany, V1, P401, DOI 10.1111/j.1756-1051.1981.tb00707.x; HESLOPHARRISON Y, 1977, ANN BOT-LONDON, V41, P1233, DOI 10.1093/oxfordjournals.aob.a085414; Igersheim A, 1996, REV PALAEOBOT PALYNO, V92, P389, DOI 10.1016/0034-6667(96)00110-8; Jackman WR, 2006, P NATL ACAD SCI USA, V103, P19390, DOI 10.1073/pnas.0609575103; Kiehn M., 2007, CITES CHECKLIST BULB, P319; Kurzweil H., 2005, Telopea, V11, P11; Kurzweil H, 2002, ORCHID BIOLOGY: REVIEWS AND PERSPECTIVES, VIII, P83; LLOYD DG, 1979, AM NAT, V113, P67, DOI 10.1086/283365; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Margonska HB, 2012, ACTA SOC BOT POL, V81, P11, DOI 10.5586/asbp.2011.034; Pacini E, 2002, ANN BOT-LONDON, V89, P653, DOI 10.1093/aob/mcf138; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Peter CI, 2009, S AFR J BOT, V75, P791, DOI 10.1016/j.sajb.2009.07.007; PETER CI, 2009, THESIS U KWAZULUNATA; Pridgeon AM, 1999, GENERA ORCHIDACEARUM, V1, P240; Prutsch J, 2000, BIBLIOTH BOT, V151, P1; Rasmussen F. N., 1986, Lindleyana, V1, P21; Rasmussen FN, 1982, OPERA BOT, V65, P1; Rasmussen FN, 1985, FAMILIES MONOCOTYLED, P249; Rudall PJ, 2013, PEERJ, V1, DOI 10.7717/peerj.26; SLATER AT, 1990, SEX PLANT REPROD, V3, P61, DOI 10.1007/BF00189953; SLATER AT, 1991, AUST J BOT, V39, P273, DOI 10.1071/BT9910273; Smith JJ, 1907, B DEP AGR INDES NEER, P1; Sridharan Gokul, 2012, J Oral Maxillofac Pathol, V16, P251, DOI 10.4103/0973-029X.99081; Stpiczynska M, 2003, ACTA BIOL CRACOV BOT, V45, P37; Stuppy WH, 2003, TRENDS PLANT SCI, V8, P2, DOI 10.1016/S1360-1385(02)00004-3; Suetsugu K, 2013, PLANT SYST EVOL, V299, P481, DOI 10.1007/s00606-012-0736-z; Tan KH, 2005, J CHEM ECOL, V31, P497, DOI 10.1007/s10886-005-2023-8; Tremblay RL, 2005, BIOL J LINN SOC, V84, P1, DOI 10.1111/j.1095-8312.2004.00400.x; van der Cingel NA, 2001, ATLAS ORCHID POLLINA, P260; van der Niet T, 2010, TRENDS PLANT SCI, V15, P423, DOI 10.1016/j.tplants.2010.05.005; van der Pijl L, 1966, ORCHID FLOWERS THEIR, P214; VERMEULEN P, 1966, ACTA BOT NEERL, V15, P224; Vermeulen P, 1959, ACTA BOT NEERL, V8, P338; Von Kirchner O., 1922, FLORA, V115, P103; WILLIAMSON G, 1984, Journal of South African Botany, V50, P417; Yam TW, 2009, AM J BOT, V96, P2128, DOI 10.3732/ajb.0900122; YEUNG EC, 1987, BOT GAZ, V148, P149, DOI 10.1086/337642; Zheden V, 2012, BIOL BULL-US, V223, P192, DOI 10.1086/BBLv223n2p192	67	16	18	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e72688	10.1371/journal.pone.0072688	http://dx.doi.org/10.1371/journal.pone.0072688			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967332	Green Published, gold, Green Submitted			2022-12-25	WOS:000323115800115
J	Maas, H; Baan, GC; Huijing, PA				Maas, Huub; Baan, Guus C.; Huijing, Peter A.			Dissection of a Single Rat Muscle-Tendon Complex Changes Joint Moments Exerted by Neighboring Muscles: Implications for Invasive Surgical Interventions	PLOS ONE			English	Article							MYOFASCIAL FORCE TRANSMISSION; UPPER-EXTREMITY SURGERY; PATIENT SATISFACTION; RELATIVE POSITION; WRIST EXTENSION; SOLEUS MUSCLE; HAND FUNCTION; GASTROCNEMIUS; GENERATE; PATTERN	The aim of this paper is to investigate mechanical functioning of a single skeletal muscle, active within a group of (previously) synergistic muscles. For this purpose, we assessed wrist angle-active moment characteristics exerted by a group of wrist flexion muscles in the rat for three conditions: (i) after resection of the upper arm skin; (ii) after subsequent distal tenotomy of flexor carpi ulnaris muscle (FCU); and (iii) after subsequent freeing of FCU distal tendon and muscle belly from surrounding tissues (MT dissection). Measurements were performed for a control group and for an experimental group after recovery (5 weeks) from tendon transfer of FCU to extensor carpi radialis (ECR) insertion. To assess if FCU tenotomy and MT dissection affects FCU contributions to wrist moments exclusively or also those of neighboring wrist flexion muscles, these data were compared to wrist angle-moment characteristics of selectively activated FCU. FCU tenotomy and MT dissection decreased wrist moments of the control group at all wrist angles tested, including also angles for which no or minimal wrist moments were measured when activating FCU exclusively. For the tendon transfer group, wrist flexion moment increased after FCU tenotomy, but to a greater extent than can be expected based on wrist extension moments exerted by selectively excited transferred FCU. We conclude that dissection of a single muscle in any surgical treatment does not only affect mechanical characteristics of the target muscle, but also those of other muscles within the same compartment. Our results demonstrate also that even after agonistic-to-antagonistic tendon transfer, mechanical interactions with previously synergistic muscles do remain present.	[Maas, Huub; Baan, Guus C.; Huijing, Peter A.] Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Maas, H (corresponding author), Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands.	h.maas@vu.nl		Maas, Huub/0000-0002-2304-2735	European Community's Seventh Framework Programme [MIRG-CT-2007-203846]; Division for Earth and Life Sciences; Netherlands Organization for Scientific Research [864-10-011]	European Community's Seventh Framework Programme; Division for Earth and Life Sciences; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	The research yielding these results was supported in part by the European Community's Seventh Framework Programme (grant MIRG-CT-2007-203846) and in part by the Division for Earth and Life Sciences with financial aid from the Netherlands Organization for Scientific Research (grant 864-10-011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Bruin M, 2011, CLIN BIOMECH BRISTOL; Focks-Feenstra JHJ, 2011, SPINAL CORD, V49, P903, DOI 10.1038/sc.2011.21; FORSSBERG H, 1983, NEUROSCI LETT, V41, P283, DOI 10.1016/0304-3940(83)90464-0; Friden J, 2006, J HAND SURG-AM, V31A, P1105, DOI 10.1016/j.jhsa.2006.05.014; Friden J, 2012, PHYS MED REH CLIN N, V23, P33, DOI 10.1016/j.pmr.2011.11.002; GAGE JR, 1987, DEV MED CHILD NEUROL, V29, P159; GARFIN SR, 1981, J APPL PHYSIOL, V51, P317, DOI 10.1152/jappl.1981.51.2.317; Huijing PA, 2003, J MORPHOL, V256, P306, DOI 10.1002/jmor.10097; Huijing PA, 2003, J APPL PHYSIOL, V94, P1092, DOI 10.1152/japplphysiol.00173.2002; Huijing PA, 2009, J BIOMECH, V42, P9, DOI 10.1016/j.jbiomech.2008.09.027; Khanna A, 2009, BRIT MED BULL, V90, P85, DOI 10.1093/bmb/ldp013; Kreulen M, 2003, J BONE JOINT SURG BR, V85B, P856, DOI 10.1302/0301-620X.85B6.14071; Kreulen M, 2008, J BIOMECH, V41, P2130, DOI 10.1016/j.jbiomech.2008.04.030; Libberecht K, 2011, J HAND SURG-EUR VOL, V36E, P141, DOI 10.1177/1753193410384691; Maas H, 2005, CELLS TISSUES ORGANS, V181, P38, DOI 10.1159/000089967; Maas H, 2004, J BIOMECH, V37, P99, DOI 10.1016/S0021-9290(03)00235-5; Maas H, 2011, MUSCLES LIGAMENTS TE, V1, P126; Maas H, 18 C INT SOC EL KIN, P2010; Maas H, 2008, J APPL PHYSIOL, V104, P1557, DOI 10.1152/japplphysiol.01208.2007; Maas H, 2012, J APPL PHYSIOL, V112, P607, DOI 10.1152/japplphysiol.01275.2011; Maas H, 2012, J BIOMECH, V45, P289, DOI 10.1016/j.jbiomech.2011.10.026; Maas H, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/575672; Maas H, 2009, J APPL PHYSIOL, V107, P1453, DOI 10.1152/japplphysiol.00328.2009; Murray WM, 2002, J BONE JOINT SURG AM, V84A, P2203, DOI 10.2106/00004623-200212000-00012; Riewald SA, 1997, DEV MED CHILD NEUROL, V39, P99, DOI 10.1111/j.1469-8749.1997.tb07391.x; Rijkelijkhuizen JM, 2005, J EXP BIOL, V208, P129, DOI 10.1242/jeb.01360; Slawinska U, 2002, J NEUROSCI, V22, P5808; Smeulders MJC, 2007, J ELECTROMYOGR KINES, V17, P644, DOI 10.1016/j.jelekin.2007.02.002; Smeulders MJC, 2002, J ORTHOP RES, V20, P863, DOI 10.1016/S0736-0266(01)00181-4; SPERRY RW, 1945, Q REV BIOL, V20, P311, DOI 10.1086/394990; Strickland JW, 2000, J HAND SURG-AM, V25A, P214; van Alphen NA, 2013, J PEDIATR REHAB MED, V6, P53, DOI 10.3233/PRM-130237; Van Heest A, 2010, J HAND SURG-AM, V35A, P284, DOI 10.1016/j.jhsa.2009.10.004; Wuolle KS, 2003, ARCH PHYS MED REHAB, V84, P1145, DOI 10.1016/S0003-9993(03)00292-2; Yucesoy CA, 2010, J BIOMECH, V43, P2665, DOI 10.1016/j.jbiomech.2010.06.002; Yucesoy CA, 2010, EXERC SPORT SCI REV, V38, P128, DOI 10.1097/JES.0b013e3181e372ef	36	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e73510	10.1371/journal.pone.0073510	http://dx.doi.org/10.1371/journal.pone.0073510			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967344	Green Published, gold, Green Submitted			2022-12-25	WOS:000323115800121
J	Yao, FY; Walker, PD; MacKenzie, RG				Yao, Fayi; Walker, Paul D.; MacKenzie, Robert G.			A Tet-On System for DRD1-Expressing Cells	PLOS ONE			English	Article							MEDIUM SPINY NEURONS; DOPA-INDUCED DYSKINESIA; GENE-EXPRESSION; CRE RECOMBINASE; TRANSGENIC MICE; COCAINE; PHARMACOLOGY; PHYSIOLOGY; RECEPTORS; PATHWAYS	Cells expressing the dopamine D1 receptor (DRD1) have significant functional roles in diverse physiological processes including locomotion and drug addiction. The present work presents a novel in vivo DRD1-Bacterial Artificial Chromosome (BAC) Tet-on system allowing for the inducible activation of tet-operated transgenes specifically within DRD1-expressing cells of transgenic mice. It is shown that the DRD1-rtTA BAC-driven expression of a tet-operated reporter is under tight regulation by doxycycline and is restricted to DRD1-expressing brain regions. The model will be a useful research tool in studies of movement and reward and associated pathologies such as Parkinson's disease and addiction.	[Yao, Fayi; MacKenzie, Robert G.] Wayne State Univ, Dept Psychiat & Behav Neurosci, Sch Med, Detroit, MI 48207 USA; [Yao, Fayi] Wayne State Univ, Ctr Mol Med & Genet, Sch Med, Detroit, MI 48207 USA; [Walker, Paul D.] Wayne State Univ, Dept Anat & Cell Biol, Sch Med, Detroit, MI 48207 USA	Wayne State University; Wayne State University; Wayne State University	MacKenzie, RG (corresponding author), Wayne State Univ, Dept Psychiat & Behav Neurosci, Sch Med, Detroit, MI 48207 USA.	rmackenz@med.wayne.edu			National Institutes of Health [DA023015-01A2, DK089167-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA023015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding provided by National Institutes of Health Grants DA023015-01A2 and DK089167-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ade KK, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00032; Baron U, 2000, METHOD ENZYMOL, V327, P401, DOI 10.1016/S0076-6879(00)27292-3; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Chuhma N, 2011, J NEUROSCI, V31, P1183, DOI 10.1523/JNEUROSCI.3833-10.2011; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Feyder M, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00071; Fleming MD, 2001, GENE DEV, V15, P652, DOI 10.1101/gad.873001; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; GERFEN CR, 1992, TRENDS NEUROSCI, V15, P133, DOI 10.1016/0166-2236(92)90355-C; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Murer MG, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00051; Heusner CL, 2008, GENESIS, V46, P357, DOI 10.1002/dvg.20405; Heusner CL, 2005, J NEUROSCI, V25, P6651, DOI 10.1523/JNEUROSCI.1474-05.2005; Hikida T, 2010, NEURON, V66, P896, DOI 10.1016/j.neuron.2010.05.011; KEBABIAN JW, 1979, NATURE, V277, P93, DOI 10.1038/277093a0; Kreitzer AC, 2009, ANNU REV NEUROSCI, V32, P127, DOI 10.1146/annurev.neuro.051508.135422; Leshan RL, 2010, J NEUROSCI, V30, P5713, DOI 10.1523/JNEUROSCI.1001-10.2010; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Parkitna JR, 2010, FASEB J, V24, P2427, DOI 10.1096/fj.09-151423; Parkitna Jan Rodriguez, 2009, V530, P325, DOI 10.1007/978-1-59745-471-1_17; Shuen JA, 2008, J NEUROSCI, V28, P2681, DOI 10.1523/JNEUROSCI.5492-07.2008; Taniguchi M, 2012, NEURON, V73, P108, DOI 10.1016/j.neuron.2011.10.032; Taverna S, 2008, J NEUROSCI, V28, P5504, DOI 10.1523/JNEUROSCI.5493-07.2008; Valjent E, 2009, TRENDS NEUROSCI, V32, P538, DOI 10.1016/j.tins.2009.06.005; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; Zhu PX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000533	28	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e72681	10.1371/journal.pone.0072681	http://dx.doi.org/10.1371/journal.pone.0072681			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967330	Green Submitted, gold, Green Published			2022-12-25	WOS:000323115800113
J	Zhao, CJ; Eisinger, B; Gammie, SC				Zhao, Changjiu; Eisinger, Brian; Gammie, Stephen C.			Characterization of GABAergic Neurons in the Mouse Lateral Septum: A Double Fluorescence In Situ Hybridization and Immunohistochemical Study Using Tyramide Signal Amplification	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; CALCIUM-BINDING PROTEINS; GAMMA-AMINOBUTYRIC-ACID; REGULATES MATERNAL AGGRESSION; GABA-IMMUNOREACTIVE NEURONS; MESSENGER-RNA EXPRESSION; FEMALE MICE LACKING; RAT HIPPOCAMPUS; IMMUNOCYTOCHEMICAL LOCALIZATION; GUINEA-PIG	Gamma-aminobutyric acid (GABA) neurotransmission in the lateral septum (LS) is implicated in modulating various behavioral processes, including emotional reactivity and maternal behavior. However, identifying the phenotype of GABAergic neurons in the CNS has been hampered by the longstanding inability to reliably detect somal immunoreactivity for GABA or glutamic acid decarboxylase (GAD), the enzyme that produces GABA. In this study, we designed unique probes for both GAD65 (GAD2) and GAD67 (GAD1), and used fluorescence in Situ hybridization (FISH) with tyramide signal amplification (TSA) to achieve unequivocal detection of cell bodies of GABAergic neurons by GAD mRNAs. We quantitatively characterized the expression and chemical phenotype of GABAergic neurons across each subdivision of LS and in cingulate cortex (Cg) and medial preoptic area (MPOA) in female mice. Across LS, almost all GAD65 mRNA-expressing neurons were found to contain GAD67 mRNA (approximately 95-98%), while a small proportion of GAD67 mRNA-containing neurons did not express GAD65 mRNA (5-14%). Using the neuronal marker NeuN, almost every neuron in LS (> 90%) was also found to be GABA-positive. Interneuron markers using calcium-binding proteins showed that LS GABAergic neurons displayed immunoreactivity for calbindin (CB) or calretinin (CR), but not parvalbumin (PV); almost all CB-or CR-immunoreactive neurons (98-100%) were GABAergic. The proportion of GABAergic neurons immunoreactive for CB or CR varied depending on the subdivisions examined, with the highest percentage of colocalization in the caudal intermediate LS (LSI) (approximately 58% for CB and 35% for CR). These findings suggest that the vast majority of GABAergic neurons within the LS have the potential for synthesizing GABA via the dual enzyme systems GAD65 and GAD67, and each subtype of GABAergic neurons identified by distinct calcium-binding proteins may exert unique roles in the physiological function and neuronal circuitry of the LS.	[Zhao, Changjiu; Eisinger, Brian; Gammie, Stephen C.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Gammie, Stephen C.] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Zhao, CJ (corresponding author), Univ Wisconsin, Dept Zool, Madison, WI 53706 USA.	czhou23@wisc.edu	Zhao, Changjiu/M-8263-2014		National Institutes of Health [R01 MH 085642]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health Grant R01 MH 085642 to Stephen Gammie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acsady L, 1997, J COMP NEUROL, V378, P320; ANDRESSEN C, 1993, CELL TISSUE RES, V271, P181, DOI 10.1007/BF00318606; BALDINO FJ, 1989, NONRADIOACTIVE IN SI, P282; Bang SJ, 2012, J COMP NEUROL, V520, P4157, DOI 10.1002/cne.23146; Barroso-Chinea P, 2007, J NEUROSCI METH, V162, P119, DOI 10.1016/j.jneumeth.2006.12.017; BEAUVILLAIN JC, 1991, J COMP NEUROL, V308, P103, DOI 10.1002/cne.903080110; BOBROW MN, 1989, J IMMUNOL METHODS, V125, P279, DOI 10.1016/0022-1759(89)90104-X; Breininger JF, 2000, J HISTOCHEM CYTOCHEM, V48, P1593, DOI 10.1177/002215540004801202; Brown RE, 2008, EUR J NEUROSCI, V27, P352, DOI 10.1111/j.1460-9568.2008.06024.x; Castaneda MT, 2005, NEUROSCI RES, V52, P107, DOI 10.1016/j.neures.2005.02.003; CELIO MR, 1986, SCIENCE, V231, P995, DOI 10.1126/science.3945815; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; Chao J, 1996, CYTOMETRY, V23, P48, DOI 10.1002/(SICI)1097-0320(19960101)23:1<48::AID-CYTO7>3.0.CO;2-I; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; delRio MR, 1996, J COMP NEUROL, V369, P472, DOI 10.1002/(SICI)1096-9861(19960603)369:3<472::AID-CNE11>3.0.CO;2-K; DEMEULEMEESTER H, 1988, J NEUROSCI, V8, P988; DEMEULEMEESTER H, 1991, EXP BRAIN RES, V84, P538; Denkers N, 2004, DEV DYNAM, V229, P651, DOI 10.1002/dvdy.20005; DOUTRELANT O, 1993, BRAIN RES, V615, P335, DOI 10.1016/0006-8993(93)90046-P; DoutrelantViltart O, 1996, J CHEM NEUROANAT, V11, P199, DOI 10.1016/0891-0618(96)00160-3; Drazen DL, 1999, NITRIC OXIDE-BIOL CH, V3, P366, DOI 10.1006/niox.1999.0251; ERLANDER MG, 1991, NEUROCHEM RES, V16, P215, DOI 10.1007/BF00966084; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; ESCLAPEZ M, 1993, J COMP NEUROL, V331, P339, DOI 10.1002/cne.903310305; Everts HGJ, 1999, BEHAV BRAIN RES, V99, P7, DOI 10.1016/S0166-4328(98)00004-7; FELDBLUM S, 1993, J NEUROSCI RES, V34, P689, DOI 10.1002/jnr.490340612; FREUND TF, 1989, BRAIN RES, V478, P375, DOI 10.1016/0006-8993(89)91520-5; FREUND TF, 1990, P NATL ACAD SCI USA, V87, P8501, DOI 10.1073/pnas.87.21.8501; Fung SJ, 2010, AM J PSYCHIAT, V167, P1479, DOI 10.1176/appi.ajp.2010.09060784; Galle AA, 2013, BRAIN RES, V1498, P1, DOI 10.1016/j.brainres.2012.12.026; Gao B, 1996, BRAIN RES, V742, P163, DOI 10.1016/S0006-8993(96)01005-0; Goodson JL, 2004, J COMP NEUROL, V473, P293, DOI 10.1002/cne.20061; Grana P, 2012, J COMP NEUROL, V520, P2086, DOI 10.1002/cne.23030; Grimes JM, 2003, HORM BEHAV, V44, P271, DOI 10.1016/S0018-506X(03)00138-7; HENDRY SHC, 1987, J NEUROSCI, V7, P1503; HENDRY SHC, 1989, EXP BRAIN RES, V76, P467; Herman JP, 2004, ANN NY ACAD SCI, V1018, P35, DOI 10.1196/annals.1296.004; Holderith N, 1998, EXP BRAIN RES, V119, P65, DOI 10.1007/s002210050320; Huesa G, 2002, CELL TISSUE RES, V309, P355, DOI 10.1007/s00441-002-0608-x; Ito T, 2007, J COMP NEUROL, V502, P113, DOI 10.1002/cne.21309; Jarvie BC, 2012, J COMP NEUROL, V520, P3863, DOI 10.1002/cne.23127; Kalueff AV, 2007, DEPRESS ANXIETY, V24, P495, DOI 10.1002/da.20262; KAWAGUCHI Y, 1987, BRAIN RES, V416, P369, DOI 10.1016/0006-8993(87)90921-8; Kemppainen S, 2000, J COMP NEUROL, V426, P441, DOI 10.1002/1096-9861(20001023)426:3<441::AID-CNE8>3.0.CO;2-7; KOHLER C, 1983, ANAT EMBRYOL, V167, P53, DOI 10.1007/BF00304600; KOSAKA T, 1987, BRAIN RES, V419, P119, DOI 10.1016/0006-8993(87)90575-0; KUBOTA Y, 1994, BRAIN RES, V649, P159, DOI 10.1016/0006-8993(94)91060-X; KUBOTA Y, 1993, BRAIN RES, V600, P339, DOI 10.1016/0006-8993(93)91394-8; Kusnoor SV, 2010, J COMP NEUROL, V518, P2525, DOI 10.1002/cne.22350; Lee G, 2010, BEHAV BRAIN RES, V213, P230, DOI 10.1016/j.bbr.2010.05.001; Lee G, 2009, BEHAV NEUROSCI, V123, P1169, DOI 10.1037/a0017535; LEWIS ME, 1988, SYNAPSE, V2, P308, DOI 10.1002/syn.890020321; Liu S, 2007, NEUROSCIENCE, V146, P1677, DOI 10.1016/j.neuroscience.2007.02.064; Liu SH, 2003, J NEUROSCI, V23, P732; Lonstein JS, 2007, FRONT NEUROENDOCRIN, V28, P115, DOI 10.1016/j.yfrne.2007.05.002; Lukas M, 2011, PSYCHONEUROENDOCRINO, V36, P843, DOI 10.1016/j.psyneuen.2010.11.007; Macechko PT, 1997, J HISTOCHEM CYTOCHEM, V45, P359, DOI 10.1177/002215549704500303; MARCONDES F. K., 2002, Braz. J. Biol., V62, P609, DOI 10.1590/S1519-69842002000400008; Martijena ID, 2002, SYNAPSE, V45, P86, DOI 10.1002/syn.10085; MARTINEZGUIJARRO FJ, 1992, J COMP NEUROL, V322, P449, DOI 10.1002/cne.903220311; McDonald AJ, 2001, NEUROSCIENCE, V105, P681, DOI 10.1016/S0306-4522(01)00214-7; McDonald MM, 2012, BRAIN RES, V1439, P27, DOI 10.1016/j.brainres.2011.12.042; MERCUGLIANO M, 1992, J COMP NEUROL, V318, P245, DOI 10.1002/cne.903180302; Meszar Z, 2012, J COMP NEUROL, V520, P798, DOI 10.1002/cne.22789; MIETTINEN R, 1992, NEUROSCIENCE, V48, P29, DOI 10.1016/0306-4522(92)90335-Y; Mohler H, 2012, NEUROPHARMACOLOGY, V62, P42, DOI 10.1016/j.neuropharm.2011.08.040; MUGNAINI E, 1985, ATLAS DISTRIBUTION G; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; ONTENIENTE B, 1987, J NEUROSCI, V7, P48; ONTENIENTE B, 1986, J COMP NEUROL, V248, P422, DOI 10.1002/cne.902480310; PANULA P, 1984, J COMP NEUROL, V222, P69, DOI 10.1002/cne.902220107; Paxinos G., 2001, MOUSE BRAIN STEREOTA; RAAP AK, 1995, HUM MOL GENET, V4, P529, DOI 10.1093/hmg/4.4.529; RIBAK CE, 1978, BRAIN RES, V140, P315, DOI 10.1016/0006-8993(78)90463-8; Ricci LA, 2005, BRAIN RES, V1035, P131, DOI 10.1016/j.brainres.2004.11.049; Riedel A, 2008, J CHEM NEUROANAT, V36, P177, DOI 10.1016/j.jchemneu.2008.06.003; Risold PY, 1997, BRAIN RES REV, V24, P115, DOI 10.1016/S0165-0173(97)00009-X; Risold PY, 1996, SCIENCE, V272, P1484, DOI 10.1126/science.272.5267.1484; Risold PY, 1997, BRAIN RES REV, V24, P91, DOI 10.1016/S0165-0173(97)00008-8; SANABRIA G, 2006, NEUROSCIENCE, V142, P871, DOI DOI 10.1016/J.NEUR0SCIENCE.2006.06.057.PUBMED:16934946; Sheehan TP, 2004, BRAIN RES REV, V46, P71, DOI 10.1016/j.brainresrev.2004.04.009; Singewald GM, 2011, NEUROPSYCHOPHARMACOL, V36, P793, DOI 10.1038/npp.2010.213; SLOVITER RS, 1989, J COMP NEUROL, V280, P183, DOI 10.1002/cne.902800203; SLOVITER RS, 1987, J COMP NEUROL, V256, P42, DOI 10.1002/cne.902560105; Sloviter RS, 2001, J COMP NEUROL, V430, P283; Smith KS, 2012, NEUROPHARMACOLOGY, V62, P54, DOI 10.1016/j.neuropharm.2011.07.026; Soghomonian JJ, 1998, TRENDS PHARMACOL SCI, V19, P500, DOI 10.1016/S0165-6147(98)01270-X; Stephenson DT, 2005, NEUROBIOL DIS, V20, P347, DOI 10.1016/j.nbd.2005.03.016; Sui Y, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00013; Suzuki N, 2007, CLIN EXP PHARMACOL P, V34, P1064, DOI 10.1111/j.1440-1681.2007.04723.x; SZEIDEMANN Z, 1995, J COMP NEUROL, V358, P573, DOI 10.1002/cne.903580410; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Tobiansky DJ, 2013, BEHAV NEUROSCI, V127, P293, DOI 10.1037/a0031949; TOTH K, 1992, NEUROSCIENCE, V49, P793, DOI 10.1016/0306-4522(92)90357-8; TREMBLEAU A, 1995, J HISTOCHEM CYTOCHEM, V43, P829, DOI 10.1177/43.8.7622844; Trifonov S, 2012, EUR J NEUROSCI, V35, P711, DOI 10.1111/j.1460-9568.2012.08001.x; Tsuneoka Y, 2013, J COMP NEUROL, V521, P1633, DOI 10.1002/cne.23251; VANBREDERODE JFM, 1990, J COMP NEUROL, V298, P1, DOI 10.1002/cne.902980102; vanGijlswijk RPM, 1997, J HISTOCHEM CYTOCHEM, V45, P375, DOI 10.1177/002215549704500305; WENTHOLD RJ, 1986, BRAIN RES, V380, P7, DOI 10.1016/0006-8993(86)91423-X; WINSKY L, 1989, P NATL ACAD SCI USA, V86, P10139, DOI 10.1073/pnas.86.24.10139; Wolf HK, 1996, J HISTOCHEM CYTOCHEM, V44, P1167, DOI 10.1177/44.10.8813082; Xi X, 2003, BIOTECHNIQUES, V34, P914, DOI 10.2144/03345bm03; Zaidi AU, 2000, J HISTOCHEM CYTOCHEM, V48, P1369, DOI 10.1177/002215540004801007; Zhao C, 2008, CELL TISSUE RES, V332, P381, DOI 10.1007/s00441-008-0606-8; Zhao CJ, 2012, BRAIN RES, V1470, P35, DOI 10.1016/j.brainres.2012.06.002	108	55	55	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e73750	10.1371/journal.pone.0073750	http://dx.doi.org/10.1371/journal.pone.0073750			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967349	Green Submitted, Green Published, gold			2022-12-25	WOS:000323115800124
J	Keenholtz, RA; Mouw, KW; Boocock, MR; Li, NS; Piccirilli, JA; Rice, PA				Keenholtz, Ross A.; Mouw, Kent W.; Boocock, Martin R.; Li, Nan-Sheng; Piccirilli, Joseph A.; Rice, Phoebe A.			Arginine as a General Acid Catalyst in Serine Recombinase-mediated DNA Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Recombination; Enzyme Catalysis; Enzyme Mechanisms; Nucleic Acid Enzymology; Protein-DNA Interaction; Arginine; General Acid; Phosphotransfer; Serine Recombinase; Site-specific Recombination	GAMMA-DELTA-RESOLVASE; PHOSPHORYL-TRANSFER; TN3 RESOLVASE; 2-METAL-ION MECHANISM; STRUCTURAL BASIS; MUTANTS; HYDROLYSIS; ACTIVATION; BASE; SIN	Members of the serine family of site-specific DNA recombinases use an unusual constellation of amino acids to catalyze the formation and resolution of a covalent protein-DNA intermediate. A recent high resolution structure of the catalytic domain of Sin, a particularly well characterized family member, provided a detailed view of the catalytic site. To determine how the enzyme might protonate and stabilize the 3O leaving group in the strand cleavage reaction, we examined how replacing this oxygen with a sulfur affected the cleavage rate by WT and mutant enzymes. To facilitate direct comparison of the cleavage rates, key experiments used suicide substrates that prevented religation after cleavage. The catalytic defect associated with mutation of one of six highly conserved arginine residues, Arg-69 in Sin, was partially rescued by a 3 phosphorothiolate substrate. We conclude that Arg-69 has an important role in stabilizing the 3O leaving group and is the prime candidate for the general acid that protonates the 3O, in good agreement with the position it occupies in the high resolution structure of the active site of Sin.	[Keenholtz, Ross A.; Mouw, Kent W.; Li, Nan-Sheng; Piccirilli, Joseph A.; Rice, Phoebe A.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Piccirilli, Joseph A.] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Boocock, Martin R.] Univ Glasgow, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland	University of Chicago; University of Chicago; University of Glasgow	Rice, PA (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 929 E 57th St, Chicago, IL 60637 USA.	price@uchicago.edu		Mouw, Kent/0000-0001-7939-7343	National Institutes of Health [R01GM086826, R01GM088656, T32GM007183]; Medical Scientist National Research Service [T32 G07281]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086826, T32GM007183, R01GM088656] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Scientist National Research Service; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM086826 (to P. A. R.) and R01GM088656 (to J. A. P.).; Supported by National Institutes of Health Training Grant T32GM007183.; Supported by Medical Scientist National Research Service Award T32 G07281.	Arnold PH, 1999, EMBO J, V18, P1407, DOI 10.1093/emboj/18.5.1407; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; COSSTICK R, 1990, NUCLEIC ACIDS RES, V18, P829, DOI 10.1093/nar/18.4.829; Das SR, 2005, NAT CHEM BIOL, V1, P45, DOI 10.1038/nchembio703; DERBISE A, 1995, MOL MICROBIOL, V17, P769, DOI 10.1111/j.1365-2958.1995.mmi_17040769.x; Deweese JE, 2008, NUCLEIC ACIDS RES, V36, P4883, DOI 10.1093/nar/gkn466; Deweese JE, 2008, BIOCHEMISTRY-US, V47, P4129, DOI 10.1021/bi702194x; Deweese JE, 2009, BIOCHEMISTRY-US, V48, P1862, DOI 10.1021/bi8023256; Dhar G, 2009, NUCLEIC ACIDS RES, V37, P4743, DOI 10.1093/nar/gkp466; Gibb B, 2010, NUCLEIC ACIDS RES, V38, P5817, DOI 10.1093/nar/gkq384; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; HAFFTER P, 1988, EMBO J, V7, P3991, DOI 10.1002/j.1460-2075.1988.tb03287.x; HATFULL GF, 1986, P NATL ACAD SCI USA, V83, P5429, DOI 10.1073/pnas.83.15.5429; Haykinson MJ, 1996, CURR BIOL, V6, P163, DOI 10.1016/S0960-9822(02)00449-9; Highbarger LA, 1996, BIOCHEMISTRY-US, V35, P41, DOI 10.1021/bi9518306; Highlander SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99; Ho MC, 2009, NATURE, V459, P393, DOI 10.1038/nature07938; Kamtekar S, 2006, P NATL ACAD SCI USA, V103, P10642, DOI 10.1073/pnas.0604062103; Keenholtz RA, 2011, STRUCTURE, V19, P799, DOI 10.1016/j.str.2011.03.017; KIM EE, 1991, J MOL BIOL, V218, P449, DOI 10.1016/0022-2836(91)90724-K; KLIPPEL A, 1988, EMBO J, V7, P3983, DOI 10.1002/j.1460-2075.1988.tb03286.x; Krogh BO, 2000, MOL CELL, V5, P1035, DOI 10.1016/S1097-2765(00)80268-3; Krogh BO, 2002, J BIOL CHEM, V277, P5711, DOI 10.1074/jbc.C100681200; Lassila JK, 2011, ANNU REV BIOCHEM, V80, P669, DOI 10.1146/annurev-biochem-060409-092741; Li NS, 2011, ACCOUNTS CHEM RES, V44, P1257, DOI 10.1021/ar200131t; Li WK, 2005, SCIENCE, V309, P1210, DOI 10.1126/science.1112064; Mouw KW, 2010, J MOL BIOL, V404, P16, DOI 10.1016/j.jmb.2010.08.057; O'Brien PJ, 2008, BIOCHEMISTRY-US, V47, P7663, DOI 10.1021/bi800545n; O'Brien PJ, 2002, BIOCHEMISTRY-US, V41, P3207, DOI 10.1021/bi012166y; Olorunniji FJ, 2009, NUCLEIC ACIDS RES, V37, P7590, DOI 10.1093/nar/gkp797; Olorunniji FJ, 2008, NUCLEIC ACIDS RES, V36, P7181, DOI 10.1093/nar/gkn885; PAULSEN IT, 1994, GENE, V141, P109, DOI 10.1016/0378-1119(94)90136-8; Pinard R, 2001, EMBO J, V20, P6434, DOI 10.1093/emboj/20.22.6434; Rowland SJ, 2009, MOL MICROBIOL, V74, P282, DOI 10.1111/j.1365-2958.2009.06756.x; ROWLAND SJ, 1989, EMBO J, V8, P2761, DOI 10.1002/j.1460-2075.1989.tb08418.x; Schlippe YVG, 2005, BIOCHEMISTRY-US, V44, P11700, DOI 10.1021/bi048342v; Schlippe YVG, 2005, ARCH BIOCHEM BIOPHYS, V433, P266, DOI 10.1016/j.abb.2004.09.018; STARK WM, 1989, CELL, V58, P779, DOI 10.1016/0092-8674(89)90111-6; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Sun SG, 1997, RNA, V3, P1352; VYLE JS, 1992, BIOCHEMISTRY-US, V31, P3012, DOI 10.1021/bi00126a024; WEBER DJ, 1992, PROTEINS, V13, P275, DOI 10.1002/prot.340130402; Whiteson KL, 2007, CHEM BIOL, V14, P121, DOI 10.1016/j.chembiol.2007.01.011; YANG W, 1995, CELL, V82, P193, DOI 10.1016/0092-8674(95)90307-0	44	23	24	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					29206	29214		10.1074/jbc.M113.508028	http://dx.doi.org/10.1074/jbc.M113.508028			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23970547	Green Published, hybrid			2022-12-25	WOS:000330298800073
J	Boruah, BM; Liu, DW; Ye, D; Gu, TJ; Jiang, CL; Qu, MS; Wright, E; Wang, W; He, W; Liu, CZ; Gao, B				Boruah, Bhargavi M.; Liu, Dawei; Ye, Duan; Gu, Tie-jun; Jiang, Chun-lai; Qu, Mingsheng; Wright, Edward; Wang, Wei; He, Wen; Liu, Changzhen; Gao, Bin			Single Domain Antibody Multimers Confer Protection against Rabies Infection	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODY; ALPHA-HELICAL PROTEIN; VIRUS GLYCOPROTEIN; ACETYLCHOLINE-RECEPTOR; FUSION ACTIVITY; COILED COILS; IN-VITRO; FRAGMENTS; NEUTRALIZATION; AVIDITY	Post-exposure prophylactic (PEP) neutralizing antibodies against Rabies are the most effective way to prevent infection-related fatality. The outer envelope glycoprotein of the Rabies virus (RABV) is the most significant surface antigen for generating virus-neutralizing antibodies. The small size and uncompromised functional specificity of single domain antibodies (sdAbs) can be exploited in the fields of experimental therapeutic applications for infectious diseases through formatting flexibilities to increase their avidity towards target antigens. In this study, we used phage display technique to select and identify sdAbs that were specific for the RABV glycoprotein from a naive llama-derived antibody library. To increase their neutralizing potencies, the sdAbs were fused with a coiled-coil peptide derived from the human cartilage oligomeric matrix protein (COMP48) to form homogenous pentavalent multimers, known as combodies. Compared to monovalent sdAbs, the combodies, namely 26424 and 26434, exhibited high avidity and were able to neutralize 85-fold higher input of RABV (CVS-11 strain) pseudotypes in vitro, as a result of multimerization, while retaining their specificities for target antigen. 26424 and 26434 were capable of neutralizing CVS-11 pseudotypes in vitro by 90-95% as compared to human rabies immunoglobulin (HRIG), currently used for PEP in Rabies. The multimeric sdAbs were also demonstrated to be partially protective for mice that were infected with lethal doses of rabies virus in vivo. The results demonstrate that the combodies could be valuable tools in understanding viral mechanisms, diagnosis and possible anti-viral candidate for RABV infection.	[Boruah, Bhargavi M.; Liu, Dawei; Qu, Mingsheng; Wang, Wei; He, Wen; Liu, Changzhen; Gao, Bin] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol CASPMI, Beijing, Peoples R China; [Boruah, Bhargavi M.; Qu, Mingsheng; He, Wen] Univ Chinese Acad Sci, Beijing, Peoples R China; [Ye, Duan; Gu, Tie-jun; Jiang, Chun-lai] Jilin Univ, Coll Life Sci, Natl Engn Lab AIDS Vaccine, Changchun 130023, Peoples R China; [Wright, Edward] Univ Westminster, Sch Life Sci, Viral Pseudotype Unit, London W1R 8AL, England; [He, Wen] Hebei Med Univ, Biochem Teaching & Res Off, Shijiazhuang, Peoples R China; [Gao, Bin] Chinese Acad Sci, Inst Microbiol, China Japan Joint Lab Mol Immunol & Microbiol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Jilin University; University of Westminster; Hebei Medical University; Chinese Academy of Sciences; Institute of Microbiology, CAS	Gao, B (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol CASPMI, Beijing, Peoples R China.	bgao2004@gmail.com		Wright, Edward/0000-0001-7041-5138; Boruah, Bhargavi/0000-0002-3645-785X	Ministry of Science and Technology of China (S & T Major Program) [2012ZX10004701-001-002, 2009ZX10004103-002, 2008ZX10003012-002-008, 2009ZX10004101-003-002, 2009ZX09503-007, 2009ZX10004-305]; National Natural Science Foundation of China [30771953, 31070783, 81021003]	Ministry of Science and Technology of China (S & T Major Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Ministry of Science and Technology of China (S & T Major Program: No. 2012ZX10004701-001-002, 2009ZX10004103-002, 2008ZX10003012-002-008, 2009ZX10004101-003-002, 2009ZX09503-007, 2009ZX10004-305) and the National Natural Science Foundation of China (No. 30771953, 31070783, 81021003). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker ABH, 2005, J VIROL, V79, P9062, DOI 10.1128/JVI.79.14.9062-9068.2005; COHEN C, 1990, PROTEINS, V7, P1, DOI 10.1002/prot.340070102; Conrath KE, 2001, J BIOL CHEM, V276, P7346, DOI 10.1074/jbc.M007734200; Cortez-Retamozo V, 2004, CANCER RES, V64, P2853, DOI 10.1158/0008-5472.CAN-03-3935; Cortez-Retamozo V, 2002, INT J CANCER, V98, P456, DOI 10.1002/ijc.10212; de Kruif J, 2007, ANNU REV MED, V58, P359, DOI 10.1146/annurev.med.58.061705.145053; Deyev SM, 2008, BIOESSAYS, V30, P904, DOI 10.1002/bies.20805; Dietzschold B, 1978, Dev Biol Stand, V40, P45; Duan Y, 2012, MOL IMMUNOL, V51, P188, DOI 10.1016/j.molimm.2012.03.015; Dumoulin M, 2003, NATURE, V424, P783, DOI 10.1038/nature01870; Finke S, 2005, VIRUS RES, V111, P120, DOI 10.1016/j.virusres.2005.04.004; Forsman A, 2008, J VIROL, V82, P12069, DOI 10.1128/JVI.01379-08; Garaicoechea L, 2008, J VIROL, V82, P9753, DOI 10.1128/JVI.00436-08; Gastka M, 1996, J GEN VIROL, V77, P2437, DOI 10.1099/0022-1317-77-10-2437; GAUDIN Y, 1991, J VIROL, V65, P4853, DOI 10.1128/JVI.65.9.4853-4859.1991; GOLDSTEI.MA, 1970, APPL MICROBIOL, V19, P290, DOI 10.1128/AEM.19.2.290-294.1970; HAASE M, 1985, J BIOL STAND, V13, P123, DOI 10.1016/S0092-1157(85)80017-2; He W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060413; Holler N, 2000, J IMMUNOL METHODS, V237, P159, DOI 10.1016/S0022-1759(99)00239-2; Houimel M, 2009, J VIROL METHODS, V161, P205, DOI 10.1016/j.jviromet.2009.06.018; Hultberg A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017665; Jiao WQ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-521; Kammerer RA, 1997, MATRIX BIOL, V15, P555, DOI 10.1016/S0945-053X(97)90031-7; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kohn WD, 1997, J BIOL CHEM, V272, P2583, DOI 10.1074/jbc.272.5.2583; Lee CMY, 2007, NAT PROTOC, V2, P3001, DOI 10.1038/nprot.2007.448; LENTZ TL, 1983, YALE J BIOL MED, V56, P315; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Malashkevich VN, 1996, SCIENCE, V274, P761, DOI 10.1126/science.274.5288.761; MIFUNE K, 1982, FEBS LETT, V137, P293, DOI 10.1016/0014-5793(82)80370-0; Muyldermans S, 2001, J Biotechnol, V74, P277; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; Roovers RC, 2007, CANCER IMMUNOL IMMUN, V56, P303, DOI 10.1007/s00262-006-0180-4; Serruys B, 2009, HEPATOLOGY, V49, P39, DOI 10.1002/hep.22609; Sloan SE, 2007, VACCINE, V25, P2800, DOI 10.1016/j.vaccine.2006.12.031; Terskikh AV, 1997, P NATL ACAD SCI USA, V94, P1663, DOI 10.1073/pnas.94.5.1663; Thoulouze MI, 1998, J VIROL, V72, P7181, DOI 10.1128/JVI.72.9.7181-7190.1998; Tomschy A, 1996, EMBO J, V15, P3507, DOI 10.1002/j.1460-2075.1996.tb00719.x; Tuffereau C, 1998, EMBO J, V17, P7250, DOI 10.1093/emboj/17.24.7250; Tuffereau C, 2007, J VIROL, V81, P13622, DOI 10.1128/JVI.02368-06; van der Vaart JM, 2006, VACCINE, V24, P4130, DOI 10.1016/j.vaccine.2006.02.045; Wenqiang J, 2013, ARCH VIROL, P1; WHITT MA, 1991, VIROLOGY, V185, P681, DOI 10.1016/0042-6822(91)90539-N; Wright E, 2008, J GEN VIROL, V89, P2204, DOI 10.1099/vir.0.2008/000349-0; Wright E, 2009, VACCINE, V27, P7178, DOI 10.1016/j.vaccine.2009.09.024; Zhang JB, 2004, J MOL BIOL, V335, P49, DOI 10.1016/j.jmb.2003.09.034; Zhu XK, 2010, IMMUNOL CELL BIOL, V88, P667, DOI 10.1038/icb.2010.21	47	12	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71383	10.1371/journal.pone.0071383	http://dx.doi.org/10.1371/journal.pone.0071383			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977032	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000324527300013
J	Ficklin, DL; Stewart, IT; Maurer, EP				Ficklin, Darren L.; Stewart, Iris T.; Maurer, Edwin P.			Climate Change Impacts on Streamflow and Subbasin-Scale Hydrology in the Upper Colorado River Basin	PLOS ONE			English	Article							SOUTHWESTERN NORTH-AMERICA; WATER ASSESSMENT-TOOL; UNITED-STATES; SIERRA-NEVADA; COUPLED MODEL; WARMING CLIMATE; CHANGE SCENARIO; CALIFORNIA; SIMULATIONS; CIRCULATION	In the Upper Colorado River Basin (UCRB), the principal source of water in the southwestern U.S., demand exceeds supply in most years, and will likely continue to rise. While General Circulation Models (GCMs) project surface temperature warming by 3.5 to 5.6 degrees C for the area, precipitation projections are variable, with no wetter or drier consensus. We assess the impacts of projected 21st century climatic changes on subbasins in the UCRB using the Soil and Water Assessment Tool, for all hydrologic components (snowmelt, evapotranspiration, surface runoff, subsurface runoff, and streamflow), and for 16 GCMs under the A2 emission scenario. Over the GCM ensemble, our simulations project median Spring streamflow declines of 36% by the end of the 21 st century, with increases more likely at higher elevations, and an overall range of -100 to +68%. Additionally, our results indicated Summer streamflow declines with median decreases of 46%, and an overall range of -100 to +22%. Analysis of hydrologic components indicates large spatial and temporal changes throughout the UCRB, with large snowmelt declines and temporal shifts in most hydrologic components. Warmer temperatures increase average annual evapotranspiration by similar to 23%, with shifting seasonal soil moisture availability driving these increases in late Winter and early Spring. For the high-elevation water-generating regions, modest precipitation decreases result in an even greater water yield decrease with less available snowmelt. Precipitation increases with modest warming do not translate into the same magnitude of water-yield increases due to slight decreases in snowmelt and increases in evapotranspiration. For these basins, whether modest warming is associated with precipitation decreases or increases, continued rising temperatures may make drier futures. Subsequently, many subbasins are projected to turn from semi-arid to arid conditions by the 2080 s. In conclusion, water availability in the UCRB could significantly decline with adverse consequences for water supplies, agriculture, and ecosystem health.	[Ficklin, Darren L.] Indiana Univ, Dept Geog, Bloomington, IN 47405 USA; [Stewart, Iris T.] Santa Clara Univ, Dept Environm Studies & Sci, Santa Clara, CA 95053 USA; [Maurer, Edwin P.] Santa Clara Univ, Dept Civil Engn, Santa Clara, CA 95053 USA	Indiana University System; Indiana University Bloomington; Santa Clara University; Santa Clara University	Ficklin, DL (corresponding author), Indiana Univ, Dept Geog, Bloomington, IN 47405 USA.	dficklin@indiana.edu	Maurer, Edwin P/C-7190-2009	Maurer, Edwin P/0000-0001-7134-487X; Ficklin, Darren/0000-0003-3736-7407	U.S. Environmental Protection Agency through EPA STAR Grant [RD-83419101-0]	U.S. Environmental Protection Agency through EPA STAR Grant	The authors gratefully acknowledge financial support for this work from the U.S. Environmental Protection Agency through EPA STAR Grant No. RD-83419101-0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbaspour KC, 2007, J HYDROL, V333, P413, DOI 10.1016/j.jhydrol.2006.09.014; Arnold JG, 1998, J AM WATER RESOUR AS, V34, P73, DOI 10.1111/j.1752-1688.1998.tb05961.x; Barnett TP, 2008, SCIENCE, V319, P1080, DOI 10.1126/science.1152538; Barnett TP, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006704; Barnett TP, 2009, P NATL ACAD SCI USA, V106, P7334, DOI 10.1073/pnas.0812762106; Barnett TP, 2005, NATURE, V438, P303, DOI 10.1038/nature04141; Barsugli JJ, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007627; Cayan DR, 2008, CLIMATIC CHANGE, V87, pS21, DOI 10.1007/s10584-007-9377-6; Christensen NS, 2007, HYDROL EARTH SYST SC, V11, P1417, DOI 10.5194/hess-11-1417-2007; Christensen NS, 2004, CLIMATIC CHANGE, V62, P337, DOI 10.1023/B:CLIM.0000013684.13621.1f; Clow DW, 2010, J CLIMATE, V23, P2293, DOI 10.1175/2009JCLI2951.1; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Delworth TL, 2006, J CLIMATE, V19, P643, DOI 10.1175/JCLI3629.1; Dettinger MD, 2004, CLIMATIC CHANGE, V62, P283, DOI 10.1023/B:CLIM.0000013683.13346.4f; Diansky NA, 2002, IZV ATMOS OCEAN PHY+, V38, P732; Dyer J, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010031; Ficklin DL, 2013, CLIMATIC CHANGE, V116, P111, DOI 10.1007/s10584-012-0566-6; Ficklin DL, 2012, J AM WATER RESOUR AS, V48, P1104, DOI 10.1111/j.1752-1688.2012.00675.x; Ficklin DL, 2009, J HYDROL, V374, P16, DOI 10.1016/j.jhydrol.2009.05.016; Flato GM, 2001, GEOPHYS RES LETT, V28, P195, DOI 10.1029/2000GL012121; Fontaine TA, 2002, J HYDROL, V262, P209, DOI 10.1016/S0022-1694(02)00029-X; Furevik T, 2003, CLIM DYNAM, V21, P27, DOI 10.1007/s00382-003-0317-5; Gassman PW, 2007, T ASABE, V50, P1211, DOI 10.13031/2013.23637; Gesch D., 2002, PHOTOGRAMMETRIC ENG, P68; Gordon C, 2000, CLIM DYNAM, V16, P147, DOI 10.1007/s003820050010; Gordon H, 2002, CSIRO MK3 CLIMATE SY; Harding BL, 2012, HYDROL EARTH SYST SC, V16, P3989, DOI 10.5194/hess-16-3989-2012; Hay LE, 2000, J AM WATER RESOUR AS, V36, P387, DOI 10.1111/j.1752-1688.2000.tb04276.x; Hayhoe K, 2004, P NATL ACAD SCI USA, V101, P12422, DOI 10.1073/pnas.0404500101; Hidalgo HG, 2009, J CLIMATE, V22, P3838, DOI 10.1175/2009JCLI2470.1; Hoerling M., 2007, PEAK WATER SW; Homer C, 2004, PHOTOGRAMM ENG REM S, V70, P829, DOI 10.14358/PERS.70.7.829; IPCC, 2007, CONTRIBUTION WORKING; IPSL, 2005, NEW IPSL CLIM SYST M; Jungclaus JH, 2006, J CLIMATE, V19, P3952, DOI 10.1175/JCLI3827.1; K-1 model developers, 2004, 1 K1 MOD DEV; Krause P., 2005, ADV GEOSCI, V5, P89, DOI [10.5194/adgeo-5-89-2005, DOI 10.5194/ADGEO-5-89-2005, DOI 10.5194/ADGE0-5-89-2005]; Landwehr JM, 1993, HYDROCLIMATIC DATA N; Legutke S, 1999, 18 DKRZ GERM CLIM CO; Luo YZ, 2013, SCI TOTAL ENVIRON, V450, P72, DOI 10.1016/j.scitotenv.2013.02.004; Maloney ED, 2013, J CLIMATE IN PRESS; Maurer EP, 2010, HYDROL EARTH SYST SC, V14, P1125, DOI 10.5194/hess-14-1125-2010; Maurer EP, 2007, CLIMATIC CHANGE, V82, P309, DOI 10.1007/s10584-006-9180-9; Maurer EP, 2002, J CLIMATE, V15, P3237, DOI [10.1175/1520-0442(2002)015<3237:ALTHBD>2.0.CO;2, 10.1175/1520-0442(2002)015&lt;3237:ALTHBD&gt;2.0.CO;2]; McCabe GJ, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031764; Medlyn B. E., 2001, The impact of carbon dioxide and other greenhouse gases on forest ecosystems. Report No.3 of the IUFRO task force on environmental change, P127, DOI 10.1079/9780851995519.0127; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Milly PCD, 2005, NATURE, V438, P347, DOI 10.1038/nature04312; Monteith J. I. L., 1965, EVAPORATION ENV; Moriasi DN, 2007, T ASABE, V50, P885, DOI 10.13031/2013.23153; MORISON JIL, 1983, PLANT PHYSIOL, V71, P789, DOI 10.1104/pp.71.4.789; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Nash J.E., 1970, J HYDROL, V10, P282, DOI [DOI 10.1016/0022-1694(70)90255-6, 10.1016/0022-1694(70)90255-6]; NASH LL, 1991, J HYDROL, V125, P221, DOI 10.1016/0022-1694(91)90030-L; Neitsch S.L., 2005, SOIL WATER ASSESSMEN; NOAA, 2008, COL CLIM SUMM; Painter TH, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030284; Painter TH, 2010, P NATL ACAD SCI USA, V107, P17125, DOI 10.1073/pnas.0913139107; Penman H.L., 1956, NETH J AGR SCI, V4, P9; Raupach MR, 2007, P NATL ACAD SCI USA, V104, P10288, DOI 10.1073/pnas.0700609104; Russell GL, 2000, J GEOPHYS RES-ATMOS, V105, P14891, DOI 10.1029/2000JD900156; Russell GL, 1999, J CLIMATE, V12, P531, DOI 10.1175/1520-0442(1999)012<0531:RTCTII>2.0.CO;2; Salas-Melia D., 2005, 103 CNRM; Seager R, 2007, SCIENCE, V316, P1181, DOI 10.1126/science.1139601; Seager R, 2010, P NATL ACAD SCI USA, V107, P21277, DOI 10.1073/pnas.0910856107; Soil Conservation Service (SCS), 1971, NAT ENG HDB; Stewart IT, 2004, CLIMATIC CHANGE, V62, P217, DOI 10.1023/B:CLIM.0000013702.22656.e8; Stewart IT, 2005, J CLIMATE, V18, P1136, DOI 10.1175/JCLI3321.1; Stockton C, 1979, ECOHYDROLOGICAL IMPL; United States Bureau of Reclamation (USBR), 2005, NAT FLOW SALT COMP M; USBR, 2009, COL RIV BAS WAT SUPP; USBR, 2011, W WID CLIM RISK ASS; Vanrheenen NT, 2004, CLIMATIC CHANGE, V62, P257, DOI 10.1023/B:CLIM.0000013686.97342.55; Wang GQ, 2014, HYDROL PROCESS, V28, P1032, DOI 10.1002/hyp.9645; Washington WM, 2000, CLIM DYNAM, V16, P755, DOI 10.1007/s003820000079; Wolock D. M, 1997, STATSGO SOIL CHARACT; Wood AW, 2004, CLIMATIC CHANGE, V62, P189, DOI 10.1023/B:CLIM.0000013685.99609.9e; Wood AW, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000659; Yukimoto S., 2001, PAP METEOROL GEOPHYS, V51, P47, DOI DOI 10.2467/MRIPAPERS.51.47	79	91	91	1	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71297	10.1371/journal.pone.0071297	http://dx.doi.org/10.1371/journal.pone.0071297			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977011	gold, Green Published, Green Submitted			2022-12-25	WOS:000323425700035
J	Ghyselinck, J; Pfeiffer, S; Heylen, K; Sessitsch, A; De Vos, P				Ghyselinck, Jonas; Pfeiffer, Stefan; Heylen, Kim; Sessitsch, Angela; De Vos, Paul			The Effect of Primer Choice and Short Read Sequences on the Outcome of 16S rRNA Gene Based Diversity Studies	PLOS ONE			English	Article							COMMUNITY STRUCTURE; SOFTWARE; TOOLS; RATES	Different regions of the bacterial 16S rRNA gene evolve at different evolutionary rates. The scientific outcome of short read sequencing studies therefore alters with the gene region sequenced. We wanted to gain insight in the impact of primer choice on the outcome of short read sequencing efforts. All the unknowns associated with sequencing data, i.e. primer coverage rate, phylogeny, OTU-richness and taxonomic assignment, were therefore implemented in one study for ten well established universal primers (338f/r, 518f/r, 799f/r, 926f/r and 1062f/r) targeting dispersed regions of the bacterial 16S rRNA gene. All analyses were performed on nearly full length and in silico generated short read sequence libraries containing 1175 sequences that were carefully chosen as to present a representative substitute of the SILVA SSU database. The 518f and 799r primers, targeting the V4 region of the 16S rRNA gene, were found to be particularly suited for short read sequencing studies, while the primer 1062r, targeting V6, seemed to be least reliable. Our results will assist scientists in considering whether the best option for their study is to select the most informative primer, or the primer that excludes interferences by host-organelle DNA. The methodology followed can be extrapolated to other primers, allowing their evaluation prior to the experiment.	[Ghyselinck, Jonas; Heylen, Kim; De Vos, Paul] Univ Ghent, Microbiol Lab, Dept Biochem & Microbiol, B-9000 Ghent, Belgium; [Pfeiffer, Stefan; Sessitsch, Angela] AIT Austrian Inst Technol GmbH, Dept Hlth & Environm, Bioresources Unit, Tulln, Austria	Ghent University; Austrian Institute of Technology (AIT)	Ghyselinck, J (corresponding author), Univ Ghent, Microbiol Lab, Dept Biochem & Microbiol, B-9000 Ghent, Belgium.	jonas_ghyselinck@hotmail.com; stefan.pfeiffer.fl@ait.ac.at	Sessitsch, Angela/AAW-3191-2020; Heylen, Kim/G-4085-2011	Sessitsch, Angela/0000-0003-0137-930X; 	European Commission 's Seventh Framework Programme FP7 [27552]	European Commission 's Seventh Framework Programme FP7	The work was supported by the European Commission's Seventh Framework Programme FP7/2007-2013 [grant number 27552]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AE, 2005, AQUAT MICROB ECOL, V39, P247, DOI 10.3354/ame039247; Berry D, 2012, APPL ENVIRON MICROB, V78, P612, DOI 10.1128/AEM.07448-11; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; Choi K, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-423; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gilbert J.A., 2010, 1 EMP M SAMPL SEL AC; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Jeraldo P, 2011, ENVIRON MICROBIOL, V13, P3000, DOI 10.1111/j.1462-2920.2011.02577.x; Klindworth A., 2012, NUCL ACIDS RES; Kumar PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020956; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Larsen PE, 2012, FEMS MICROBIOL LETT, V332, P91, DOI 10.1111/j.1574-6968.2012.02588.x; Liu Z, 2008, NUCLEIC ACIDS RES, V36; Lombard N, 2011, FEMS MICROBIOL ECOL, V78, P31, DOI 10.1111/j.1574-6941.2011.01140.x; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Ludwig W., 2001, BERGEYS MANUAL SYSTE, P49; Mao DP, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-66; Moret BME, 2002, LECT NOTES COMPUT SC, V2452, P343; Munoz R, 2011, SYST APPL MICROBIOL, V34, P169, DOI 10.1016/j.syapm.2011.03.001; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quast C, 2012, NUCL ACIDS RES; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; ROBINSON DF, 1979, LECT NOTES MATH, V748, P119, DOI [10.1007/bfb0102690, DOI 10.1007/BFB0102690, DOI 10.1007/BFB0102678]; Rokas A, 2011, CURR PROTOC MOL BIOL, V19; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Soergel DAW, 2012, ISME J, V6, P1440, DOI 10.1038/ismej.2011.208; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stamatakis A, 2006, PHYLOGENETIC MODELS, P25; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; VandePeer Y, 1996, NUCLEIC ACIDS RES, V24, P3381, DOI 10.1093/nar/24.17.3381; Wang YF, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0005368, 10.1371/journal.pone.0007401]; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Wu JY, 2010, BMC MICROBIOL, V10, P7; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yarza P, 2010, SYST APPL MICROBIOL, V33, P291, DOI 10.1016/j.syapm.2010.08.001; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09	47	94	96	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71360	10.1371/journal.pone.0071360	http://dx.doi.org/10.1371/journal.pone.0071360			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977026	Green Published, gold, Green Submitted			2022-12-25	WOS:000323425700040
J	Eldevik, MF; Flo, E; Moen, BE; Pallesen, S; Bjorvatn, B				Eldevik, Maria Fagerbakke; Flo, Elisabeth; Moen, Bente Elisabeth; Pallesen, Stale; Bjorvatn, Bjorn			Insomnia, Excessive Sleepiness, Excessive Fatigue, Anxiety, Depression and Shift Work Disorder in Nurses Having Less than 11 Hours in-Between Shifts	PLOS ONE			English	Article							HOSPITAL ANXIETY; HEALTH; SCALE; POPULATION; SYSTEMS; RISK; CANCER	Study objective: To assess if less than 11 hours off work between work shifts (quick returns) was related to insomnia, sleepiness, fatigue, anxiety, depression and shift work disorder among nurses. Methods: A questionnaire including established instruments measuring insomnia (Bergen Insomnia Scale), sleepiness (Epworth Sleepiness Scale), fatigue (Fatigue Questionnaire), anxiety/depression (Hospital Anxiety and Depression Scale) and shift work disorder was administered. Among the 1990 Norwegian nurses who participated in the study; 264 nurses had no quick returns, 724 had 1-30 quick returns and 892 had more than 30 quick returns during the past year. 110 nurses did not report the number of quick returns during the past year. The prevalence of insomnia, excessive sleepiness, excessive fatigue, anxiety, depression and shift work disorder was calculated within the three groups of nurses. Crude and adjusted logistic regression analyses were performed to assess the relation between quick returns and such complaints. Results: We found a significant positive association between quick returns and insomnia, excessive sleepiness, excessive fatigue and shift work disorder. Anxiety and depression were not related to working quick returns. Conclusions: There is a health hazard associated with quick returns. Further research should aim to investigate if workplace strategies aimed at reducing the number of quick returns may reduce complaints among workers.	[Eldevik, Maria Fagerbakke; Flo, Elisabeth; Pallesen, Stale; Bjorvatn, Bjorn] Haukeland Hosp, Norwegian Competence Ctr Sleep Disorders, N-5021 Bergen, Norway; [Eldevik, Maria Fagerbakke; Moen, Bente Elisabeth; Bjorvatn, Bjorn] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway; [Flo, Elisabeth; Pallesen, Stale] Univ Bergen, Dept Psychosocial Sci, Bergen, Norway; [Moen, Bente Elisabeth] Haukeland Hosp, Dept Occupat Med, N-5021 Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital	Eldevik, MF (corresponding author), Haukeland Hosp, Norwegian Competence Ctr Sleep Disorders, N-5021 Bergen, Norway.	mel077@uib.no	Moen, BE/P-9329-2017	Flo, Elisabeth/0000-0003-4312-3855	Western Norway Regional Health Authority	Western Norway Regional Health Authority	The project generating the data analyzed in the present study received a grant for practical administration and data collection from The Western Norway Regional Health Authority (no personal payment/salary). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AASM, 2005, INT CLASS SLEEP DIS; Akerstedt T, 2003, OCCUP MED-OXFORD, V53, P89, DOI 10.1093/occmed/kqg046; AKERSTEDT T, 1988, SLEEP, V11, P17, DOI 10.1093/sleep/11.1.17; American Psychiatric Association (APA), 2000, DIAGN STAT MAN MENT; Axelsson J, 2004, INT ARCH OCC ENV HEA, V77, P121, DOI 10.1007/s00420-003-0482-1; Bara AC, 2009, SCAND J WORK ENV HEA, V35, P361, DOI 10.5271/sjweh.1344; BARTON J, 1993, ERGONOMICS, V36, P59, DOI 10.1080/00140139308967855; Baruch Y, 1999, HUM RELAT, V52, P421, DOI 10.1023/A:1016905407491; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bjorvatn B, 1998, J OCCUP ENVIRON MED, V40, P601, DOI 10.1097/00043764-199807000-00004; Bjorvatn B, 2012, NURS CRIT CARE, V17, P180, DOI 10.1111/j.1478-5153.2012.00504.x; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Costa G, 2010, SCAND J WORK ENV HEA, V36, P163, DOI 10.5271/sjweh.2899; Flo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033981; Geiger-Brown J, 2011, J OCCUP ENVIRON MED, V53, P303, DOI 10.1097/JOM.0b013e31820c3f87; Gumenyuk V, 2012, CHRONOBIOL INT, V29, P928, DOI 10.3109/07420528.2012.699356; Hakola T, 2010, IND HEALTH, V48, P390, DOI 10.2486/indhealth.MSSW-02; Harma M, 1998, SCAND J WORK ENV HLT, V24; Harma M, 2010, SCAND J WORK ENV HEA, V36, P81; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; KAWACHI I, 1995, CIRCULATION, V92, P3178, DOI 10.1161/01.CIR.92.11.3178; Kecklund G, 1995, J SLEEP RES, V4, P47, DOI 10.1111/j.1365-2869.1995.tb00226.x; Knudsen AK, 2010, AM J EPIDEMIOL, V172, P1306, DOI 10.1093/aje/kwq257; Knutson A, 2010, SCAND J WORK ENV HEA, V36, P85, DOI 10.5271/sjweh.2897; Knutsson A, 2003, OCCUP MED-OXFORD, V53, P103, DOI 10.1093/occmed/kqg048; Kober T, 2010, ARBEIDSTID BLANT HEL; Kolstad HA, 2008, SCAND J WORK ENV HEA, V34, P5, DOI 10.5271/sjweh.1194; Loge JH, 1998, J PSYCHOSOM RES, V45, P53, DOI 10.1016/S0022-3999(97)00291-2; Pallesen S, 2007, SLEEP, V30, P619, DOI 10.1093/sleep/30.5.619; Pallesen S, 2008, PERCEPT MOTOR SKILL, V107, P691, DOI 10.2466/PMS.107.3.691-706; Parent-Thiron A FE, 2007, 4 EUROPEAN WORKING C; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Puttonen S, 2010, ANN RHEUM DIS, V69, P779, DOI 10.1136/ard.2008.099184; Sallinen M, 2010, SCAND J WORK ENV HEA, V36, P121, DOI 10.5271/sjweh.2900; Statistics Norway, 2011, LAB FORC SURV PATT W; The European Parliament and the Council of the European Union, 2003, OFFICIAL J EUROPEAN, V299, P9; Tucker P, 2000, OCCUP ENVIRON MED, V57, P678, DOI 10.1136/oem.57.10.678; Vyas MV, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4800; Waage S, 2009, SLEEP, V32, P558, DOI 10.1093/sleep/32.4.558; Wright KP, 2013, SLEEP MED REV, V17, P41, DOI 10.1016/j.smrv.2012.02.002; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	41	124	126	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e70882	10.1371/journal.pone.0070882	http://dx.doi.org/10.1371/journal.pone.0070882			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	204OU	23976964	Green Published, gold			2022-12-25	WOS:000323378000018
J	Guo, WC; Liu, RW; Bhardwaj, G; Ma, AH; Changou, C; Yang, JC; Li, YP; Feng, CH; Luo, Y; Mazloom, A; Sanchez, E; Wang, Y; Huang, WZ; Patterson, R; Evans, CP; Lam, KS; Kung, HJ				Guo, Wenchang; Liu, Ruiwu; Bhardwaj, Gaurav; Ma, Ai-Hong; Changou, Chun; Yang, Joy C.; Li, Yuanpei; Feng, Caihong; Luo, Yan; Mazloom, Anisha; Sanchez, Eduardo; Wang, Yan; Huang, Wenzhe; Patterson, Randen; Evans, Christopher P.; Lam, Kit S.; Kung, Hsing-Jien			CTA095, a Novel Etk and Src Dual Inhibitor, Induces Apoptosis in Prostate Cancer Cells and Overcomes Resistance to Src Inhibitors	PLOS ONE			English	Article							TYROSINE KINASE ETK/BMX; PROTEIN HOMOLOGY DETECTION; CROSS-LINKED MICELLES; MOLECULAR-DYNAMICS; UP-REGULATION; FORCE-FIELD; PH-DOMAIN; ACTIVATION; ANGIOGENESIS; DISCOVERY	Etk is a non-receptor tyrosine kinase, which provides a strong survival signal in human prostate cancer cells. Src, another tyrosine kinase that cross-activates with Etk, has been shown to play an important role in prostate cancer metastasis. Herein, we discovered a new class of Etk inhibitors. Within those inhibitors, CTA095 was identified as a potent Etk and Src dual inhibitor. CTA095 was found to induce autophagy as well as apoptosis in human prostate cancer cells. In addition, CTA095 inhibited HUVEC cell tube formation and "wound healing" of human prostate cancer cells, implying its role in inhibition of angiogenesis and metastasis of human prostate cancer. More interestingly, CTA095 could overcome Src inhibitor resistance in prostate cancer cells. It induces apoptosis in Src inhibitor resistant prostate cancer cells, likely through a mechanism of down regulation of Myc and BCL2. This finding indicates that simultaneously targeting Etk and Src could be a promising approach to overcome drug resistance in prostate cancer.	[Guo, Wenchang; Liu, Ruiwu; Bhardwaj, Gaurav; Ma, Ai-Hong; Changou, Chun; Yang, Joy C.; Li, Yuanpei; Feng, Caihong; Luo, Yan; Mazloom, Anisha; Sanchez, Eduardo; Wang, Yan; Huang, Wenzhe; Patterson, Randen; Lam, Kit S.; Kung, Hsing-Jien] Univ Calif Davis, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Patterson, Randen] Univ Calif Davis, Dept Physiol & Membrane Biol, Sacramento, CA 95817 USA; [Evans, Christopher P.] Univ Calif Davis, Dept Urol, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Liu, RW (corresponding author), Univ Calif Davis, Dept Biochem & Mol Med, Sacramento, CA 95817 USA.	rwliu@ucdavis.edu; hkung@ucdavis.edu	Kung, Hsing-Jien/C-7651-2013	Bhardwaj, Gaurav/0000-0001-6554-2335	C-Tag Bioscience Inc; NIH [DK52659 CA150197, CA098116]; DOD Postdoctoral Training Award [PC080859]; Auburn Community Cancer Endowment Fund; NATIONAL CANCER INSTITUTE [P30CA093373, R01CA150197, R01CA165263, R01CA098116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052659] Funding Source: NIH RePORTER	C-Tag Bioscience Inc; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD Postdoctoral Training Award; Auburn Community Cancer Endowment Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was in part supported by C-Tag Bioscience Inc (Research grant to RL); NIH grants DK52659 CA150197 (to HJK), and CA098116 (to KSL); and DOD Postdoctoral Training Award PC080859 and Auburn Community Cancer Endowment Fund (to WG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang YM, 2007, NEOPLASIA, V9, P90, DOI 10.1593/neo.06694; Chau CH, 2002, ONCOGENE, V21, P8817, DOI 10.1038/sj.onc.1206032; Chen RY, 2001, NAT CELL BIOL, V3, P439, DOI 10.1038/35074500; Dai BJ, 2006, CANCER RES, V66, P8058, DOI 10.1158/0008-5472.CAN-06-1364; Dai BJ, 2010, CANCER RES, V70, P5587, DOI 10.1158/0008-5472.CAN-09-4610; Grasso AW, 1997, ONCOGENE, V15, P2705, DOI 10.1038/sj.onc.1201447; Grosdidier A., 2011, J COMPUT CHEM; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Guo LL, 2010, EUR J CANCER, V46, P636, DOI 10.1016/j.ejca.2009.11.009; Guo WC, 2012, MOL PHARMACOL, V82, P938, DOI 10.1124/mol.112.079889; Guryanova OA, 2011, CANCER CELL, V19, P498, DOI 10.1016/j.ccr.2011.03.004; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; He Y, 2006, J CLIN INVEST, V116, P2344, DOI 10.1172/JCI28123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kato J, 2012, MOL PHARMACEUT, V9, P1727, DOI 10.1021/mp300128b; Kim RH, 2009, CANCER RES, V69, P700, DOI 10.1158/0008-5472.CAN-08-3157; LAM KS, 1991, NATURE, V354, P82, DOI 10.1038/354082a0; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Li YP, 2011, BIOMATERIALS, V32, P6633, DOI 10.1016/j.biomaterials.2011.05.050; Lou Q, 1996, ANAL BIOCHEM, V235, P107, DOI 10.1006/abio.1996.0100; Lou Y, 2012, J MED CHEM, V55, P4539, DOI 10.1021/jm300035p; McDonald OB, 1999, ANAL BIOCHEM, V268, P318, DOI 10.1006/abio.1998.3030; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Pan S, 2002, MOL CELL BIOL, V22, P7512, DOI 10.1128/MCB.22.21.7512-7523.2002; Pan ZY, 2007, CHEMMEDCHEM, V2, P58, DOI 10.1002/cmdc.200600221; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Su GH, 2000, CANCER RES, V60, P3137; Tsai YT, 2000, MOL CELL BIOL, V20, P2043, DOI 10.1128/MCB.20.6.2043-2054.2000; Wilhelm S, 2006, NAT REV DRUG DISCOV, V5, P835, DOI 10.1038/nrd2130; Wu YM, 2001, J BIOL CHEM, V276, P17672, DOI 10.1074/jbc.M010964200; Wu Zhaoju, 2010, Genes Cancer, V1, P40, DOI 10.1177/1947601909358324; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Xue LY, 1999, ONCOGENE, V18, P3391, DOI 10.1038/sj.onc.1202687; Zhang ZH, 2011, CANCER BIOL THER, V11, P690, DOI 10.4161/cbt.11.7.15060; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816	39	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e70910	10.1371/journal.pone.0070910	http://dx.doi.org/10.1371/journal.pone.0070910			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967135	gold, Green Published, Green Submitted			2022-12-25	WOS:000323378000023
J	Islam, A; Deuster, PA; Devaney, JM; Ghimbovschi, S; Chen, YF				Islam, Aminul; Deuster, Patricia A.; Devaney, Joseph M.; Ghimbovschi, Svetlana; Chen, Yifan			An Exploration of Heat Tolerance in Mice Utilizing mRNA and microRNA Expression Analysis	PLOS ONE			English	Article							SHOCK TRANSCRIPTION FACTOR-1; CELLULAR THERMOTOLERANCE; MICROARRAY ANALYSIS; SKELETAL-MUSCLE; GENE-EXPRESSION; IN-VIVO; STRESS; HSP70; HEAT-SHOCK-PROTEIN-70; PROTEINS	Background: Individuals who rapidly develop hyperthermia during heat exposure (heat-intolerant) are vulnerable to heat associated illness and injury. We recently reported that heat intolerant mice exhibit complex alterations in stress proteins in response to heat exposure. In the present study, we further explored the role of genes and molecular networks associated with heat tolerance in mice. Methodology: Heat-induced physiological and biochemical changes were assessed to determine heat tolerance levels in mice. We performed RNA and microRNA expression profiling on mouse gastrocnemius muscle tissue samples to determine novel biological pathways associated with heat tolerance. Principal Findings: Mice (n = 18) were assigned to heat-tolerant (TOL) and heat-intolerant (INT) groups based on peak core temperatures during heat exposures. This was followed by biochemical assessments (Hsp40, Hsp72, Hsp90 and Hsf1 protein levels). Microarray analysis identified a total of 3,081 mRNA transcripts that were significantly misregulated in INT compared to TOL mice (p<0.05). Among them, Hspa1a, Dnajb1 and Hspb7 were differentially expressed by more than two-fold under these conditions. Furthermore, we identified 61 distinct microRNA (miRNA) sequences significantly associated with TOL compared to INT mice; eight miRNAs corresponded to target sites in seven genes identified as being associated with heat tolerance pathways (Hspa1a, Dnajb1, Dnajb4, Dnajb6, Hspa2, Hspb3 and Hspb7). Conclusions: The combination of mRNA and miRNA data from the skeletal muscle of adult mice following heat stress provides new insights into the pathophysiology of thermoregulatory disturbances of heat intolerance.	[Islam, Aminul; Deuster, Patricia A.; Chen, Yifan] Uniformed Serv Univ Hlth Sci, Dept Mil & Emergency Med, Bethesda, MD 20814 USA; [Devaney, Joseph M.; Ghimbovschi, Svetlana] Childrens Natl Med Ctr, Dept Integrat Syst Biol, Washington, DC 20010 USA	Uniformed Services University of the Health Sciences - USA; Children's National Health System	Islam, A (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Mil & Emergency Med, Bethesda, MD 20814 USA.	aminul.islam@usuhs.edu	Deuster, Patricia A/G-3838-2015; Chen, Yifan/K-1235-2019	Deuster, Patricia A/0000-0002-7895-0888; Chen, Yifan/0000-0003-1388-9200	USUHS [R091EH]; Office of Naval Research [N0001411MP20025]	USUHS; Office of Naval Research(Office of Naval Research)	This work was supported by USUHS Grant R091EH and the Office of Naval Research Grant N0001411MP20025. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anckar J, 2007, ADV EXP MED BIOL, V594, P78; Beckham JT, 2010, LASER SURG MED, V42, P752, DOI 10.1002/lsm.20983; Beckham JT, 2008, LASER SURG MED, V40, P704, DOI 10.1002/lsm.20713; Bryantsev AL, 2007, BIOCHEM J, V407, P407, DOI 10.1042/BJ20070195; Carra S, 2008, AUTOPHAGY, V4, P237, DOI 10.4161/auto.5407; Chiu TF, 2012, CIRC J, V76, P2226, DOI 10.1253/circj.CJ-12-0238; Doran P, 2007, EUR J CELL BIOL, V86, P629, DOI 10.1016/j.ejcb.2007.07.003; EPSTEIN Y, 1995, ISRAEL J MED SCI, V31, P454; Ferron C, 2006, PRESSE MED, V35, P196, DOI 10.1016/S0755-4982(06)74553-5; Golenhofen N, 2004, HISTOCHEM CELL BIOL, V122, P415, DOI 10.1007/s00418-004-0711-z; Greco S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039732; Hashim IA, 2010, ANN CLIN BIOCHEM, V47, P516, DOI 10.1258/acb.2010.010186; He MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004851; Henry JC, 2010, BIOCHEM BIOPH RES CO, V403, P120, DOI 10.1016/j.bbrc.2010.10.130; Hill OT, 2012, MED SCI SPORT EXER, V44, P442, DOI 10.1249/MSS.0b013e3182312745; Huang L, 2001, MOL CELL BIOL, V21, P8575, DOI 10.1128/MCB.21.24.8575-8591.2001; Islam A, 2013, STRESS, V16, P244, DOI 10.3109/10253890.2012.696754; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jubrias SA, 2008, J PHYSIOL-LONDON, V586, P1993, DOI 10.1113/jphysiol.2007.146829; Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001; Kukreti H, 2013, J BIOL CHEM, V288, P6663, DOI 10.1074/jbc.M112.390369; Lau P, 2010, BRAIN RES, V1338, P14, DOI 10.1016/j.brainres.2010.04.002; Lee CG, 2012, GASTROENTEROLOGY, V142, P1206, DOI 10.1053/j.gastro.2012.01.007; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li JX, 2009, CELL STRESS CHAPERON, V14, P355, DOI 10.1007/s12192-008-0089-2; Liu CM, 2009, NEUROMOL MED, V11, P141, DOI 10.1007/s12017-009-8077-y; Liu JP, 2007, CLIN CHIM ACTA, V384, P64, DOI 10.1016/j.cca.2007.05.021; Luber G. E., 2006, Morbidity and Mortality Weekly Report, V55, P796; Minami Y, 1996, J BIOL CHEM, V271, P19617, DOI 10.1074/jbc.271.32.19617; Morrison SF, 2008, EXP PHYSIOL, V93, P773, DOI 10.1113/expphysiol.2007.041848; Nollen EAA, 1999, MOL CELL BIOL, V19, P2069; O'Connell-Rodwell CE, 2004, FASEB J, V18, P264, DOI 10.1096/fj.03-0585com; O'Connor FG, 2012, MED SCI SPORT EXER, V44, P2045, DOI 10.1249/MSS.0b013e31826851c2; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Rylander MN, 2005, J BIOMECH ENG-T ASME, V127, P751, DOI 10.1115/1.1993661; Seo J, 2006, BIOINFORMATICS, V22, P808, DOI 10.1093/bioinformatics/btk052; Shan ZX, 2010, FEBS LETT, V584, P3592, DOI 10.1016/j.febslet.2010.07.027; Shatseva T, 2011, J CELL SCI, V124, P2826, DOI 10.1242/jcs.077529; Sonna LA, 2004, J APPL PHYSIOL, V96, P1943, DOI 10.1152/japplphysiol.00886.2003; Tabuchi Y, 2012, INT J MOL MED, V29, P380, DOI 10.3892/ijmm.2011.862; Tomanek L, 2002, J EXP BIOL, V205, P677; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Tsai MF, 2006, JNCI-J NATL CANCER I, V98, P825, DOI 10.1093/jnci/djj229; Uchiyama Y, 2006, J BIOCHEM, V140, P805, DOI 10.1093/jb/mvj212; Villard E, 2011, EUR HEART J, V32, P1065, DOI 10.1093/eurheartj/ehr105; Vos MJ, 2008, BIOCHEMISTRY-US, V47, P7001, DOI 10.1021/bi800639z	47	32	34	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e72258	10.1371/journal.pone.0072258	http://dx.doi.org/10.1371/journal.pone.0072258			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967293	Green Published, gold, Green Submitted			2022-12-25	WOS:000323378000089
J	Sarajlic, A; Janjic, V; Stojkovic, N; Radak, D; Przulj, N				Sarajlic, Anida; Janjic, Vuk; Stojkovic, Neda; Radak, Djordje; Przulj, Natasa			Network Topology Reveals Key Cardiovascular Disease Genes	PLOS ONE			English	Article							INTEGRATED APPROACH; CANCER DRIVER; EXPRESSION; DISCOVERY; ALIGNMENT; DYSREGULATION; MECHANISMS; PROTEOMICS; PRESSURE; ONTOLOGY	The structure of protein-protein interaction (PPI) networks has already been successfully used as a source of new biological information. Even though cardiovascular diseases (CVDs) are a major global cause of death, many CVD genes still await discovery. We explore ways to utilize the structure of the human PPI network to find important genes for CVDs that should be targeted by drugs. The hope is to use the properties of such important genes to predict new ones, which would in turn improve a choice of therapy. We propose a methodology that examines the PPI network wiring around genes involved in CVDs. We use the methodology to identify a subset of CVD-related genes that are statistically significantly enriched in drug targets and "driver genes.'' We seek such genes, since driver genes have been proposed to drive onset and progression of a disease. Our identified subset of CVD genes has a large overlap with the Core Diseasome, which has been postulated to be the key to disease formation and hence should be the primary object of therapeutic intervention. This indicates that our methodology identifies "key'' genes responsible for CVDs. Thus, we use it to predict new CVD genes and we validate over 70% of our predictions in the literature. Finally, we show that our predicted genes are functionally similar to currently known CVD drug targets, which confirms a potential utility of our methodology towards improving therapy for CVDs.	[Sarajlic, Anida; Janjic, Vuk; Przulj, Natasa] Univ London Imperial Coll Sci Technol & Med, Dept Comp, London, England; [Stojkovic, Neda; Radak, Djordje] Univ Belgrade, Inst Cardiovasc Dis Dedinje, Belgrade, Serbia	Imperial College London; University of Belgrade	Przulj, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Comp, London, England.	n.przulj@imperial.ac.uk	Przulj, Natasa/AAO-2850-2020	Przulj, Natasa/0000-0002-1290-853X	European Research Council [278212]; National Science Foundation Cyber-Enabled Cover Letter Discovery and Innovation [OIA-1028394]; Serbian Ministry of Education and Science [III44006]	European Research Council(European Research Council (ERC)European Commission); National Science Foundation Cyber-Enabled Cover Letter Discovery and Innovation(National Science Foundation (NSF)); Serbian Ministry of Education and Science(Ministry of Education, Science & Technological Development, Serbia)	This work was supported by the European Research Council Starting Independent Researcher Grant 278212, the National Science Foundation Cyber-Enabled Cover Letter Discovery and Innovation OIA-1028394, and the Serbian Ministry of Education and Science Project III44006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens I, 2010, THROMB HAEMOSTASIS, V104, P49, DOI 10.1160/TH09-05-0327; Akavia UD, 2010, CELL, V143, P1005, DOI 10.1016/j.cell.2010.11.013; Aragues R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-172; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashworth A, 2011, CELL, V145, P30, DOI 10.1016/j.cell.2011.03.020; Batagelj V., 2003, ARXIV, V1, P1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birks EJ, 2008, CARDIOVASC RES, V79, P472, DOI 10.1093/cvr/cvn083; Bjornstad JL, 2012, CARDIOVASC RES, V93, P100, DOI 10.1093/cvr/cvr294; Burnier M, 2000, LANCET, V355, P637, DOI 10.1016/S0140-6736(99)10365-9; Camargo A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001347; Camargo A, 2008, GENOMICS, V92, P404, DOI 10.1016/j.ygeno.2008.05.007; Chang C, 2012, J SURG RES; Chen KC, 2012, J MOL CELL CARDIOL, V52, P587, DOI 10.1016/j.yjmcc.2011.12.005; Cui ZY, 2011, AM J CARDIOVASC DIS, V1, P274; Du P, 2009, BIOINFORMATICS, V25, pI63, DOI 10.1093/bioinformatics/btp193; Gabay MP, 2002, ANN PHARMACOTHER, V36, P1629; Gerzanich V, 2003, CLIN HEMORHEOL MICRO, V29, P291; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Goldenberg A, 2011, BIOINFORMATICS, V27, P3166, DOI 10.1093/bioinformatics/btr533; Gomez D, 2011, CARDIOVASC RES, V89, P446, DOI 10.1093/cvr/cvq291; Guerrero C, 2008, P NATL ACAD SCI USA, V105, P13333, DOI 10.1073/pnas.0801870105; Haldar SM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000502; Ho HA, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-84; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Janjic V, 2012, MOL BIOSYST, V8, P2614, DOI 10.1039/c2mb25230a; Ji XL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-426; Jin GX, 2008, J PROTEOME RES, V7, P4013, DOI 10.1021/pr8002886; Jonsson PF, 2006, BIOINFORMATICS, V22, P2291, DOI 10.1093/bioinformatics/btl390; Ju HS, 1996, J MOL CELL CARDIOL, V28, P1119, DOI 10.1006/jmcc.1996.0103; King AD, 2004, BIOINFORMATICS, V20, P3013, DOI 10.1093/bioinformatics/bth351; Kuchaiev O, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-24; Kuchaiev O, 2010, J R SOC INTERFACE, V7, P1341, DOI 10.1098/rsif.2010.0063; Maier M, 2012, ESAIM PROBABILITY ST; Mallick P, 2010, NAT BIOTECHNOL, V28, P695, DOI 10.1038/nbt.1658; Memisevic V, 2012, INTEGR BIOL-UK, V4, P734, DOI 10.1039/c2ib00140c; Milenkovic T, 2010, J ROYAL SOC INTERFAC, V44, P353; Milenkovic T, 2008, CANCER INFORM, V6, P257; Milenkovic T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-70; Milenkovic T, 2010, CANCER INFORM, V9, P121, DOI 10.4137/CIN.S4744; Min JH, 2012, J CELL PHYSIOL, V227, P3585, DOI 10.1002/jcp.24062; Ping PP, 2010, CIRCULATION, V121, P2326, DOI 10.1161/CIRCULATIONAHA.110.949230; Przulj N, 2004, BIOINFORMATICS, V20, P3508, DOI 10.1093/bioinformatics/bth436; Przulj N, 2007, BIOINFORMATICS, V23, pE177, DOI 10.1093/bioinformatics/btl301; Radivojac P, 2008, PROTEINS, V72, P1030, DOI 10.1002/prot.21989; Reiling E, 2012, EUR J HUM GENET, V20, P696, DOI 10.1038/ejhg.2011.240; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Schnabel RB, 2012, CLIN CHEM, V58, P113, DOI 10.1373/clinchem.2011.170423; SEIDMAN SB, 1983, SOC NETWORKS, V5, P269, DOI 10.1016/0378-8733(83)90028-X; Seo D, 2006, J AM COLL CARDIOL, V48, P227, DOI 10.1016/j.jacc.2006.02.070; Shukla PC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1601; Souders CA, 2012, ARTERIOSCL THROM VAS, V32, P1308, DOI 10.1161/ATVBAHA.111.244590; van de Laar IMBH, 2012, J MED GENET, V49, P47, DOI 10.1136/jmedgenet-2011-100382; van der Linde D, 2012, J AM COLL CARDIOL, V60, P397, DOI 10.1016/j.jacc.2011.12.052; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Youn A, 2011, BIOINFORMATICS, V27, P175, DOI 10.1093/bioinformatics/btq630; Zawada AM, 2012, CIRC-CARDIOVASC GENE, V5, P611, DOI 10.1161/CIRCGENETICS.112.963207; Zhang LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037865; Zhang Q, 2012, J PATHOL, V228, P416, DOI 10.1002/path.4077; Zhang SS, 2003, J CLIN INVEST, V111, P833, DOI 10.1172/JCI200316290	60	35	36	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71537	10.1371/journal.pone.0071537	http://dx.doi.org/10.1371/journal.pone.0071537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977067	Green Submitted, Green Published, gold			2022-12-25	WOS:000323378000057
J	Buss, LW; Anderson, C; Bolton, EW				Buss, Leo W.; Anderson, Christopher; Bolton, Edward W.			Muscular Anatomy of the Podocoryna carnea Hydrorhiza	PLOS ONE			English	Article							STEADY STATE GROWTH; COLONIAL HYDROIDS; HYDRA LITTORALIS; TISSUE DYNAMICS; CELL MOVEMENTS; HYDRACTINIID HYDROIDS; EXTRACELLULAR-MATRIX; GASTROVASCULAR FLOW; ADHERENS JUNCTIONS; MORPHOGENESIS	The muscular anatomy of the athecate hydroid Podocoryna carnea hydrorhiza is elucidated. The polyp-stolon junction is characterized by an opening, here called the chloe, in the otherwise continuous hydrorhizal perisarc. The chloe is elliptical when the polyp first arises, but takes on a more complex outline as multiple stolons anastomose to communicate with that polyp. Surrounding the polyp base are spots, here called anchors, which autofluoresce at the same wavelengths as perisarc and which, like perisarc, contain chitin as assessed by Calcofluor White, Congo Red and wheat germ agglutinin staining. Anchors remain after living tissues are digested using KOH. Collagen IV staining indicates that the mesoglea is pegged to the anchors and rhodamine phallodin staining detects cytoskeletal F-actin fibers of the basal epidermis surrounding the anchors. Longitudinal muscle fibers of the polyp broaden at the polyp base and are inserted into the mesoglea of the underlying stolon, but were neither observed to extend along the stolonal axis nor to attach to the anchors. Circular muscular fibers of the polyp extend into stolons as a dense collection of strands running along the proximal-distal axis of the stolon. These gastrodermal axial muscular fibers extend to the stolon tip. Epidermal cells at the stolon tip and the polyp bud display a regular apical latticework of F-actin staining. A similar meshwork of F-actin staining was found in the extreme basal epidermis of all stolons. Immunohistochemical staining for tubulin revealed nerves at stolon tips, but at no other hydrorhizal locations. These studies bear on the mechanisms by which the stolon tip and polyp bud pulsate, the manner in which the stolon lumen closes, and on the developmental origin of the basal epidermis of the hydrorhiza.	[Buss, Leo W.; Anderson, Christopher] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Bolton, Edward W.] Yale Univ, Dept Geol & Geophys, New Haven, CT USA	Yale University; Yale University	Buss, LW (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	leo.buss@yale.edu			National Science Foundation [OCE-0818295]	National Science Foundation(National Science Foundation (NSF))	Funded by the National Science Foundation (www.nsf.gov) OCE-0818295. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman G. J., 1854, PHIL T R SOC LOND B, V143, P367, DOI DOI 10.1098/RSTL.1853.0015; Azevedo D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023964; Beloussov L.V., 1973, Publications Seto Mar Biol Lab, V20, P315; BELOUSSOV LV, 1989, J EXP ZOOL, V249, P258, DOI 10.1002/jez.1402490304; BELOUSSOV LV, 1972, J EMBRYOL EXP MORPH, V27, P317; Bely M, 2006, ACTA HISTOCHEM, V108, P175, DOI 10.1016/j.acthis.2006.03.017; BERRILL NJ, 1949, Q J MICROSC SCI, V90, P235; BERRILL NJ, 1949, J MORPHOL, V84, P1, DOI 10.1002/jmor.1050840102; Blackstone NW, 1998, J EXP BIOL, V201, P2821; Blackstone NW, 1996, BIOL BULL, V190, P56, DOI 10.2307/1542675; BLACKSTONE NW, 1991, BIOL BULL, V180, P394, DOI 10.2307/1542340; BOUILLON J, 1971, Z ZELLFORSCH MIK ANA, V121, P218, DOI 10.1007/BF00340673; Brown C. H., 1975, STRUCTURAL MAT ANIMA; BUSS LW, 1984, BIOL BULL, V167, P139, DOI 10.2307/1541343; CAMPBELL RD, 1967, J EXP ZOOL, V164, P379, DOI 10.1002/jez.1401640308; CAMPBELL RD, 1968, BIOL BULL, V134, P26, DOI 10.2307/1539964; CAMPBELL RD, 1967, DEV BIOL, V15, P487, DOI 10.1016/0012-1606(67)90039-5; CAMPBELL RD, 1967, J MORPHOL, V121, P19, DOI 10.1002/jmor.1051210103; Carthew RW, 2005, CURR OPIN GENET DEV, V15, P358, DOI 10.1016/j.gde.2005.06.002; CHAPMAN D M, 1969, Tissue and Cell, V1, P619, DOI 10.1016/S0040-8166(69)80036-4; CHAPMAN G, 1973, COMP BIOCHEM PHYSIOL, V45, P279, DOI 10.1016/0305-0491(73)90308-8; Citron E, 1902, ARCH NATURGESCH, V68, P1; DONALDSON S, 1974, AM ZOOL, V14, P735; Dudgeon S, 1999, BIOL BULL, V196, P1, DOI 10.2307/1543161; Dudgeon SR, 2011, ADV MAR BIOL, V59, P107, DOI 10.1016/B978-0-12-385536-7.00003-0; ELGHETANY MT, 1989, ANN CLIN LAB SCI, V19, P190; Fernandez-Gonzalez R, 2009, DEV CELL, V17, P736, DOI 10.1016/j.devcel.2009.09.003; Fulton C, 1963, J CELLULAR COMP PHYS, V61, P339; HALE LJ, 1964, J EMBRYOL EXP MORPH, V12, P517; Hale LJ, 1963, Q J MICROSCOPICAL SC, V101, P39; Hamann O, 1882, JENA Z NATURISS, V15, P473; HAMMETT FREDERICK S., 1935, PROTOPLASMA, V23, P81, DOI 10.1007/BF01603333; Homem CCF, 2008, DEVELOPMENT, V135, P1005, DOI 10.1242/dev.016337; HUGHES J, 1975, STAIN TECHNOL, V50, P319, DOI 10.3109/10520297509117082; LANGE R, 1989, J EXP ZOOL, V249, P284, DOI 10.1002/jez.1402490307; MAEDA H, 1967, J BIOCHEM-TOKYO, V62, P276, DOI 10.1093/oxfordjournals.jbchem.a128660; Magie CR, 2008, BIOL BULL-US, V214, P218, DOI 10.2307/25470665; Mali B, 2004, DEV COMP IMMUNOL, V28, P973, DOI 10.1016/j.dci.2004.04.002; MARCUM BA, 1978, TISSUE CELL, V10, P113, DOI 10.1016/0040-8166(78)90010-1; MCFADDEN CS, 1986, BIOL BULL, V171, P161, DOI 10.2307/1541914; Michels J, 2009, J MICROSCOPY, V238, P95; Monier B, 2010, NAT CELL BIOL, V12, P60, DOI 10.1038/ncb2005; OVERTON J, 1963, J CELL BIOL, V17, P661, DOI 10.1083/jcb.17.3.661; Sawyer JK, 2011, MOL BIOL CELL, V22, P2491, DOI 10.1091/mbc.E11-05-0411; SCHIERWATER B, 1992, J EXP BIOL, V162, P1; Schneider SQ, 2003, J EXP ZOOL PART B, V295B, P25, DOI 10.1002/jez.b.00006; Schulze FE, 1873, BAU SYNCORYNE SARSII; Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330; Shimizu H, 2008, ZOOLOGY, V111, P410, DOI 10.1016/j.zool.2007.11.004; SLAUTTERBACK DB, 1967, J CELL SCI, V2, P563; Smutny M, 2010, NAT CELL BIOL, V12, P696, DOI 10.1038/ncb2072; TADDEIFERRETTI C, 1976, J EXP BIOL, V65, P737; Tidball JG, 1984, BIOL INTEGUMENT, V1, P69; VanWinkle DH, 1997, INVERTEBR BIOL, V116, P6; WYTTENBACH CR, 1973, J EXP ZOOL, V186, P79, DOI 10.1002/jez.1401860111; WYTTENBACH CR, 1968, J EXP ZOOL, V167, P333, DOI 10.1002/jez.1401670306; WYTTENBACH CR, 1974, AM ZOOL, V14, P699; ZHANG XM, 1994, DEVELOPMENT, V120, P425	58	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e72221	10.1371/journal.pone.0072221	http://dx.doi.org/10.1371/journal.pone.0072221			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967288	Green Published, gold, Green Submitted			2022-12-25	WOS:000323221500124
J	Maheu-Giroux, M; Castro, MC				Maheu-Giroux, Mathieu; Castro, Marcia C.			Impact of Community-Based Larviciding on the Prevalence of Malaria Infection in Dar es Salaam, Tanzania	PLOS ONE			English	Article							LARVAL SOURCE MANAGEMENT; BACILLUS-SPHAERICUS; VECTOR CONTROL; ENVIRONMENTAL-MANAGEMENT; ECOLOGICAL REGRESSION; CONTROL PROGRAM; LARGE-SCALE; AFRICA; PREVENTION; PRECIPITATION	Background: The use of larval source management is not prioritized by contemporary malaria control programs in sub-Saharan Africa despite historical success. Larviciding, in particular, could be effective in urban areas where transmission is focal and accessibility to Anopheles breeding habitats is generally easier than in rural settings. The objective of this study is to assess the effectiveness of a community-based microbial larviciding intervention to reduce the prevalence of malaria infection in Dar es Salaam, United Republic of Tanzania. Methods and Findings: Larviciding was implemented in 3 out of 15 targeted wards of Dar es Salaam in 2006 after two years of baseline data collection. This intervention was subsequently scaled up to 9 wards a year later, and to all 15 targeted wards in 2008. Continuous randomized cluster sampling of malaria prevalence and socio-demographic characteristics was carried out during 6 survey rounds (2004-2008), which included both cross-sectional and longitudinal data (N = 64,537). Bayesian random effects logistic regression models were used to quantify the effect of the intervention on malaria prevalence at the individual level. Effect size estimates suggest a significant protective effect of the larviciding intervention. After adjustment for confounders, the odds of individuals living in areas treated with larviciding being infected with malaria were 21% lower (Odds Ratio = 0.79; 95% Credible Intervals: 0.66-0.93) than those who lived in areas not treated. The larviciding intervention was most effective during dry seasons and had synergistic effects with other protective measures such as use of insecticide-treated bed nets and house proofing (i.e., complete ceiling or window screens). Conclusion: A large-scale community-based larviciding intervention significantly reduced the prevalence of malaria infection in urban Dar es Salaam.	[Maheu-Giroux, Mathieu; Castro, Marcia C.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Castro, MC (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, 665 Huntington Ave, Boston, MA 02115 USA.	mcastro@hsph.harvard.edu	Maheu-Giroux, Mathieu/R-4034-2019; Castro, Marcia/S-2681-2019	Maheu-Giroux, Mathieu/0000-0002-8363-4388; Castro, Marcia/0000-0003-4606-2795	National Institute of Allergy and Infectious Diseases [R03AI094401-01]; International Fulbright Science & Technology Award; Bureau of Educational and Cultural Affairs of the U.S. Department of State; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI094401] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); International Fulbright Science & Technology Award; Bureau of Educational and Cultural Affairs of the U.S. Department of State; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by Award Number R03AI094401-01 (PI MCC) from the National Institute of Allergy and Infectious Diseases. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. MMG was supported by an International Fulbright Science & Technology Award sponsored by the Bureau of Educational and Cultural Affairs of the U.S. Department of State, and a Doctoral Foreign Study Award from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; [Anonymous], 1985, THEORETICAL EPIDEMIO; Baer F McGahey C, 1999, SUMMARY EHP ACTIVITI; Barbazan P, 1998, J AM MOSQUITO CONTR, V14, P33; Beguin J, 2012, METHODS ECOL EVOL, V3, P921, DOI 10.1111/j.2041-210X.2012.00211.x; Cameron AC, 2008, REV ECON STAT, V90, P414, DOI 10.1162/rest.90.3.414; Castro MC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000693; Castro MC, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-57; Chaki PP, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-21; Chaki PP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-311; Congdon P., 2006, BAYESIAN STAT MODELL; Cuamba N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011010; De Castro MC, 2004, AM J TROP MED HYG, V71, P103, DOI 10.4269/ajtmh.2004.71.103; DERRYBERRY OM, 1952, AM J TROP MED HYG, V1, P500, DOI 10.4269/ajtmh.1952.1.500; Dongus S, 2011, GEOTECH ENVIRON, V4, P321, DOI 10.1007/978-94-007-0329-2_16; Dongus S, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-37; Ferguson HM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000303; Fillinger U, 2003, TROP MED INT HEALTH, V8, P37, DOI 10.1046/j.1365-3156.2003.00979.x; Fillinger U, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-20; Fillinger U, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-353; Fillinger U, 2009, B WORLD HEALTH ORGAN, V87, P655, DOI 10.2471/BLT.08.055632; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003; Geissbuhler Y, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-126; Geissbuhler Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005107; Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324; Gu WD, 2008, AM J TROP MED HYG, V78, P2, DOI 10.4269/ajtmh.2008.78.2; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; Howard SC, 2000, T ROY SOC TROP MED H, V94, P357, DOI 10.1016/S0035-9203(00)90103-2; Imbahale SS, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-130; Keiser J, 2004, AM J TROP MED HYG, V71, P118, DOI 10.4269/ajtmh.2004.71.118; Keiser J, 2005, LANCET INFECT DIS, V5, P695, DOI 10.1016/S1473-3099(05)70268-1; Killeen GF, 2002, LANCET INFECT DIS, V2, P618, DOI 10.1016/S1473-3099(02)00397-3; Krefis AC, 2011, AM J TROP MED HYG, V84, P285, DOI 10.4269/ajtmh.2011.10-0381; Kristan M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-231; Lindsay SW, 2004, COMMUNITY BASED ENV; LOEVINSOHN ME, 1994, LANCET, V343, P714, DOI 10.1016/S0140-6736(94)91586-5; Majambere S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-76; Majambere S, 2010, AM J TROP MED HYG, V82, P176, DOI 10.4269/ajtmh.2010.09-0373; *MALERA CONS GROUP, 2011, PLOS MED, V0008; Morgan JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011872; Munhenga G, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-247; Najera JA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000412; Natario I, 2003, BIOMETRICAL J, V45, P670, DOI 10.1002/bimj.200390041; R Development Core Team, 2012, R LANG ENV STAT COMP; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Robert V, 2003, AM J TROP MED HYG, V68, P169, DOI 10.4269/ajtmh.2003.68.169; Ross R, 1907, LANCET, V2, P879; Rue H, 2009, INLA FUNCTIONS WHICH; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Schrodle B, 2011, COMPUTATION STAT, V26, P241, DOI 10.1007/s00180-010-0208-2; Shililu JI, 2003, J AM MOSQUITO CONTR, V19, P251; SHOUSHA A. T., 1948, BULL WORLD HEALTH ORGAN, V1, P309; Soper FL, 1943, ANOPHELES GAMBIAE BR; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; UN-HABITAT, 2010, STAT AFR CIT 2010 GO; United Nations, 2007, WORLD POP PROSP 2006; Vanek MJ, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-154; Walker K, 2007, MED VET ENTOMOL, V21, P2, DOI 10.1111/j.1365-2915.2007.00674.x; Watson, 2001, BATTLE BANNOCKBURN; WHO, 2012, INT POS STAT ROL LAR; WHO, 2004, WHOCDSCPEPVC200410; World Health Organization, 2012, HDB INT VECT MAN; World Health Organization (WHO), 2008, WHO POS STAT INT VEC; Worrall E, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-338; Xie PP, 1996, J CLIMATE, V9, P840, DOI 10.1175/1520-0442(1996)009<0840:AOGMPU>2.0.CO;2; YHDEGO M, 1988, ENVIRON INT, V14, P479, DOI 10.1016/0160-4120(88)90408-4; Zhou G, 2004, P NATL ACAD SCI USA, V101, P2375, DOI 10.1073/pnas.0308714100	67	54	54	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71638	10.1371/journal.pone.0071638	http://dx.doi.org/10.1371/journal.pone.0071638			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23977099	Green Published, gold			2022-12-25	WOS:000323221500094
J	Gabler, CA; Siemann, E				Gabler, Christopher A.; Siemann, Evan			Timing of Favorable Conditions, Competition and Fertility Interact to Govern Recruitment of Invasive Chinese Tallow Tree in Stressful Environments	PLOS ONE			English	Article								The rate of new exotic recruitment following removal of adult invaders (reinvasion pressure) influences restoration outcomes and costs but is highly variable and poorly understood. We hypothesize that broad variation in average reinvasion pressure of Triadica sebifera (Chinese tallow tree, a major invader) arises from differences among habitats in spatiotemporal availability of realized recruitment windows. These windows are periods of variable duration long enough to permit establishment given local environmental conditions. We tested this hypothesis via a greenhouse mesocosm experiment that quantified how the duration of favorable moisture conditions prior to flood or drought stress (window duration), competition and nutrient availability influenced Triadica success in high stress environments. Window duration influenced pre-stress seedling abundance and size, growth during stress and final abundance; it interacted with other factors to affect final biomass and germination during stress. Stress type and competition impacted final size and biomass, plus germination, mortality and changes in size during stress. Final abundance also depended on competition and the interaction of window duration, stress type and competition. Fertilization interacted with competition and stress to influence biomass and changes in height, respectively, but did not affect Triadica abundance. Overall, longer window durations promoted Triadica establishment, competition and drought (relative to flood) suppressed establishment, and fertilization had weak effects. Interactions among factors frequently produced different effects in specific contexts. Results support our 'outgrow the stress' hypothesis and show that temporal availability of abiotic windows and factors that influence growth rates govern Triadica recruitment in stressful environments. These findings suggest that native seed addition can effectively suppress superior competitors in stressful environments. We also describe environmental scenarios where specific management methods may be more or less effective. Our results enable better niche-based estimates of local reinvasion pressure, which can improve restoration efficacy and efficiency by informing site selection and optimal management.	[Gabler, Christopher A.; Siemann, Evan] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77251 USA; [Gabler, Christopher A.] Univ Houston, Dept Biol & Biochem, Houston, TX USA	Rice University; University of Houston System; University of Houston	Gabler, CA (corresponding author), Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77251 USA.	cagabler@uh.edu		Gabler, Christopher/0000-0001-9311-7248	US National Science Foundation (DDIG) [DEB-0910361]; Garden Club of America; Society of Wetland Scientists; Native Plant Society of Texas; Wintermann Research Fund; University of Houston Coastal Center and Lodieska Stockbridge Vaughn Fellowship; Houston Livestock Show and Rodeo Fellowship; Wray-Todd Fellowship	US National Science Foundation (DDIG)(National Science Foundation (NSF)); Garden Club of America; Society of Wetland Scientists; Native Plant Society of Texas; Wintermann Research Fund; University of Houston Coastal Center and Lodieska Stockbridge Vaughn Fellowship; Houston Livestock Show and Rodeo Fellowship; Wray-Todd Fellowship	This work was supported by the US National Science Foundation (DDIG, DEB-0910361), Garden Club of America (Fellowship in Ecological Restoration), Society of Wetland Scientists (Student Research Grant), Native Plant Society of Texas (A. M. Gonzalez Grant), Wintermann Research Fund, University of Houston Coastal Center and Lodieska Stockbridge Vaughn, Houston Livestock Show and Rodeo and Wray-Todd Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arredondo-Nunez A, 2009, COMMUNITY ECOL, V10, P1, DOI 10.1556/ComEc.10.2009.1.1; Aslan CE, 2011, BIOL INVASIONS, V13, P2829, DOI 10.1007/s10530-011-9966-1; Balke T, 2011, MAR ECOL PROG SER, V440, P1, DOI 10.3354/meps09364; Bartha S, 2003, APPL VEG SCI, V6, P205, DOI 10.1111/j.1654-109X.2003.tb00581.x; Brewer JS, 2003, PLANT ECOL, V167, P237, DOI 10.1023/A:1023984214512; Bruce KA, 1997, NAT AREA J, V17, P255; Buckley YM, 2007, ECOL LETT, V10, P809, DOI 10.1111/j.1461-0248.2007.01067.x; Busey P, 2003, CROP SCI, V43, P1899, DOI 10.2135/cropsci2003.1899; Butterfield BJ, 2004, TEX J SCI, V56, P335; Casper BB, 1997, ANNU REV ECOL SYST, V28, P545, DOI 10.1146/annurev.ecolsys.28.1.545; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CRAWLEY MJ, 1990, J APPL ECOL, V27, P803, DOI 10.2307/2404378; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Donahue C, 2004, TEX J SCI, V56, P347; Donahue C, 2006, NAT AREA J, V26, P244, DOI 10.3375/0885-8608(2006)26[244:RAIPBM]2.0.CO;2; Epanchin-Niell RS, 2010, ECOL LETT, V13, P528, DOI 10.1111/j.1461-0248.2010.01440.x; Firn J, 2010, J APPL ECOL, V47, P96, DOI 10.1111/j.1365-2664.2009.01741.x; Gabler CA, 2013, J APPL ECOL, V50, P748, DOI 10.1111/1365-2664.12071; Gabler CA, 2012, RESTOR ECOL, V20, P545, DOI 10.1111/j.1526-100X.2012.00901.x; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; Hall RBW, 1998, ECOLOGY, V79, P847, DOI 10.1890/0012-9658(1998)079[0847:FAAPOF]2.0.CO;2; Harcombe PA, 1999, SENSITIVITY GULF COA, P45; Harper J. L, 1977, POPULATION BIOL PLAN; Holmgren M, 2006, GLOBAL CHANGE BIOL, V12, P2263, DOI 10.1111/j.1365-2486.2006.01261.x; JOHNSTONE IM, 1986, BIOL REV, V61, P369, DOI 10.1111/j.1469-185X.1986.tb00659.x; JONES RH, 1989, B TORREY BOT CLUB, V116, P371, DOI 10.2307/2996627; Kettenring KM, 2011, J APPL ECOL, V48, P970, DOI 10.1111/j.1365-2664.2011.01979.x; Kunstler G, 2009, J ECOL, V97, P685, DOI 10.1111/j.1365-2745.2009.01482.x; Lin J, 2004, OECOLOGIA, V139, P399, DOI 10.1007/s00442-004-1522-6; Nijjer S, 2002, TEX J SCI, V54, P63; Peringer A, 2011, ECOL MODEL, V222, P3120, DOI 10.1016/j.ecolmodel.2011.05.025; Renne IJ, 2000, AM MIDL NAT, V144, P202, DOI 10.1674/0003-0031(2000)144[0202:SDOTCT]2.0.CO;2; Rinella MJ, 2009, ECOL APPL, V19, P155, DOI 10.1890/07-1482.1; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Siemann E, 2003, ECOLOGY, V84, P1489, DOI 10.1890/0012-9658(2003)084[1489:HDRLAS]2.0.CO;2; Siemann E, 2007, GLOBAL CHANGE BIOL, V13, P2184, DOI 10.1111/j.1365-2486.2007.01425.x; Siemann E, 2007, J ECOL, V95, P689, DOI 10.1111/j.1365-2745.2007.01253.x; Stokes KE, 2008, PLANT ECOL, V197, P91, DOI 10.1007/s11258-007-9363-0; Tomassen HBM, 2004, J APPL ECOL, V41, P139, DOI 10.1111/j.1365-2664.2004.00870.x; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Young TP, 2005, ECOL LETT, V8, P662, DOI 10.1111/j.1461-0248.2005.00764.x	42	7	7	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71446	10.1371/journal.pone.0071446	http://dx.doi.org/10.1371/journal.pone.0071446			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967212	Green Published, Green Submitted, gold			2022-12-25	WOS:000323115800061
J	Meyer, S; Maufort, JP; Nie, J; Stewart, R; McIntosh, BE; Conti, LR; Ahmad, KM; Soh, HT; Thomson, JA				Meyer, Susanne; Maufort, John P.; Nie, Jeff; Stewart, Ron; McIntosh, Brian E.; Conti, Lisa R.; Ahmad, Kareem M.; Soh, H. Tom; Thomson, James A.			Development of an Efficient Targeted Cell-SELEX Procedure for DNA Aptamer Reagents	PLOS ONE			English	Article							SYSTEMATIC EVOLUTION; LIGANDS; TOOLS	Background: DNA aptamers generated by cell-SELEX offer an attractive alternative to antibodies, but generating aptamers to specific, known membrane protein targets has proven challenging, and has severely limited the use of aptamers as affinity reagents for cell identification and purification. Methodology: We modified the BJAB lymphoblastoma cell line to over-express the murine c-kit cell surface receptor. After six rounds of cell-SELEX, high-throughput sequencing and bioinformatics analysis, we identified aptamers that bound BJAB cells expressing c-kit but not wild-type BJAB controls. One of these aptamers also recognizes c-kit endogenously expressed by a mast cell line or hematopoietic progenitor cells, and specifically blocks binding of the c-kit ligand stem cell factor (SCF). This aptamer enables better separation by fluorescence-activated cell sorting (FACS) of c-kit(+) hematopoietic progenitor cells from mixed bone marrow populations than a commercially available antibody, suggesting that this approach may be broadly useful for rapid isolation of affinity reagents suitable for purification of other specific cell types. Conclusions/Significance: Here we describe a novel procedure for the efficient generation of DNA aptamers that bind to specific cell membrane proteins and can be used as high affinity reagents. We have named the procedure STACS (Specific TArget Cell-SELEX).	[Meyer, Susanne; Conti, Lisa R.; Thomson, James A.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Maufort, John P.; Nie, Jeff; Stewart, Ron; McIntosh, Brian E.; Thomson, James A.] Morgridge Inst Res, Madison, WI USA; [Thomson, James A.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Cell & Regenerat Biol, Madison, WI USA; [Soh, H. Tom] Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA; [Soh, H. Tom] Univ Calif Santa Barbara, Dept Mech Engn, Santa Barbara, CA 93106 USA; [Ahmad, Kareem M.] Univ Calif Santa Barbara, Interdept Program Biomol Sci & Engn, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Thomson, JA (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	jthomson@morgridgeinstitute.org			National Institutes of Health (NIH) [UO1HL099773-01]; NIH [U54 DK093467, R01EB009764]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK093467] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) grant UO1HL099773-01 (to JAT) and NIH grant U54 DK093467, R01EB009764 (to HTS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avci-Adali M, 2010, MOLECULES, V15, P1, DOI 10.3390/molecules15010001; BERARDI AC, 1995, SCIENCE, V267, P104, DOI 10.1126/science.7528940; Berezhnoy A, 2012, MOL THER, V20, P1242, DOI 10.1038/mt.2012.18; Blank M, 2001, J BIOL CHEM, P276; Breaker RR, 2004, NATURE, V432, P838, DOI 10.1038/nature03195; Cerchia L, 2005, PLOS BIOL, V3, P697, DOI 10.1371/journal.pbio.0030123; Cerchia L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007971; Chen HW, 2008, CHEMMEDCHEM, V3, P991, DOI 10.1002/cmdc.200800030; Cho M, 2010, PNAS, V107, P7; Daniels DA, 2003, P NATL ACAD SCI USA, V100, P15416, DOI 10.1073/pnas.2136683100; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Ke-Tai Guo AP, 2008, INT J MOL SCI, V9, P11; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kunii T, 2011, ANALYST, V136, P1310, DOI 10.1039/c0an00962h; LI N., 2011, PLOS ONE, V6, P1; Liu YM, 2009, BIOL CHEM, V390, P137, DOI 10.1515/BC.2009.022; Mayer G, 2010, NAT PROTOC, V5, P1993, DOI 10.1038/nprot.2010.163; Meyer C, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/904750; Pestourie C, 2006, OLIGONUCLEOTIDES, V16, P323, DOI 10.1089/oli.2006.16.323; Sefah K, 2010, PLOS ONE, V5, P14; Sefah K, 2010, NAT PROTOC, V5, P1169, DOI 10.1038/nprot.2010.66; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; STEINITZ M, 1975, P NATL ACAD SCI USA, V72, P3518, DOI 10.1073/pnas.72.9.3518; Tang Z, 2007, ANAL CHEM; Thiel KW, 2012, NUCLEIC ACIDS RES, V40, P6319, DOI 10.1093/nar/gks294; Thiel WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043836; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Uhlen M, 2009, J MOL RECOGNIT, V22, P57, DOI 10.1002/jmr.891	30	35	37	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71798	10.1371/journal.pone.0071798	http://dx.doi.org/10.1371/journal.pone.0071798			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967247	gold, Green Published, Green Submitted			2022-12-25	WOS:000323115800082
J	Schulze, MSED; Anders, AK; Sethi, DK; Call, MJ				Schulze, Monika-Sarah E. D.; Anders, Anne-Kathrin; Sethi, Dhruv K.; Call, Melissa J.			Disruption of Hydrogen Bonds between Major Histocompatibility Complex Class II and the Peptide N-Terminus Is Not Sufficient to Form a Human Leukocyte Antigen-DM Receptive State of Major Histocompatibility Complex Class II	PLOS ONE			English	Article							HLA-DR MOLECULES; HIGH-AFFINITY BINDING; CRYSTAL-STRUCTURE; MHC; DISSOCIATION; HLA-DR1; EXCHANGE; SUSCEPTIBILITY; CONFORMATION; ASSOCIATION	Peptide presentation by MHC class II is of critical importance to the function of CD4+ T cells. HLA-DM resides in the endosomal pathway and edits the peptide repertoire of newly synthesized MHC class II molecules before they are exported to the cell surface. HLA-DM ensures MHC class II molecules bind high affinity peptides by targeting unstable MHC class II: peptide complexes for peptide exchange. Research over the past decade has implicated the peptide N-terminus in modulating the ability of HLA-DM to target a given MHC class II: peptide combination. In particular, attention has been focused on both the hydrogen bonds between MHC class II and peptide, and the occupancy of the P1 anchor pocket. We sought to solve the crystal structure of a HLA-DR1 molecule containing a truncated hemagglutinin peptide missing three N-terminal residues compared to the full-length sequence (residues 306-318) to determine the nature of the MHC class II: peptide species that binds HLA-DM. Here we present structural evidence that HLA-DR1 that is loaded with a peptide truncated to the P1 anchor residue such that it cannot make select hydrogen bonds with the peptide N-terminus, adopts the same conformation as molecules loaded with full-length peptide. HLA-DR1: peptide combinations that were unable to engage up to four key hydrogen bonds were also unable to bind HLA-DM, while those truncated to the P2 residue bound well. These results indicate that the conformational changes in MHC class II molecules that are recognized by HLA-DM occur after disengagement of the P1 anchor residue.	[Schulze, Monika-Sarah E. D.; Anders, Anne-Kathrin; Sethi, Dhruv K.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Anders, Anne-Kathrin] Harvard Univ, Sch Med, Program Immunol, Boston, MA USA; [Call, Melissa J.] Univ Melbourne, Struct Biol Div, Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Melbourne; Walter & Eliza Hall Institute	Call, MJ (corresponding author), Univ Melbourne, Struct Biol Div, Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia.	call@wehi.edu.au	Call, Melissa/HHZ-6671-2022	Call, Melissa/0000-0001-7684-5841	Australian Research Council Future Fellowship [FT120100145]; National Multiple Sclerosis Society; National Institutes of Health [5R01NS044914]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104]; U.S. DOE [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044914] Funding Source: NIH RePORTER	Australian Research Council Future Fellowship(Australian Research Council); National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. DOE(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	MJC is supported by an Australian Research Council Future Fellowship (FT120100145) and DKS is supported by a Postdoctoral Fellowship from The National Multiple Sclerosis Society. This work was supported by the National Institutes of Health (5R01NS044914). Diffraction data were collected at the Advanced Photon Source using beamline 23-ID-D of the General Medicine and Cancer Institutes Collaborative Access Team, which is supported by grants from the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Sciences (Y1-GM-1104). Use of the Advanced Photon Source, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under Contract No. DE-AC02-06CH11357. We thank the Dana-Farber Molecular Biology Core Facility for Mass Spectrometry measurements. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anders AK, 2011, NAT IMMUNOL, V12, P54, DOI 10.1038/ni.1967; AVVA RR, 1994, IMMUNITY, V1, P763, DOI 10.1016/S1074-7613(94)80018-9; Belmares MP, 2002, J IMMUNOL, V169, P5109, DOI 10.4049/jimmunol.169.9.5109; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chou CL, 2000, J EXP MED, V192, P1697, DOI 10.1084/jem.192.12.1697; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Denzin LK, 1996, J EXP MED, V184, P2153, DOI 10.1084/jem.184.6.2153; Doebele RC, 2000, IMMUNITY, V13, P517, DOI 10.1016/S1074-7613(00)00051-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferrante A, 2010, J IMMUNOL, V184, P1153, DOI 10.4049/jimmunol.0902878; GERMAIN RN, 1993, NATURE, V363, P725, DOI 10.1038/363725a0; HAMMER J, 1994, P NATL ACAD SCI USA, V91, P4456, DOI 10.1073/pnas.91.10.4456; Jardetzky TS, 1996, P NATL ACAD SCI USA, V93, P734, DOI 10.1073/pnas.93.2.734; Kaiko GE, 2008, IMMUNOLOGY, V123, P326, DOI 10.1111/j.1365-2567.2007.02719.x; Kropshofer H, 1996, EMBO J, V15, P6144, DOI 10.1002/j.1460-2075.1996.tb01002.x; LANZAVECCHIA A, 1992, NATURE, V357, P249, DOI 10.1038/357249a0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McFarland BJ, 2001, P NATL ACAD SCI USA, V98, P9231, DOI 10.1073/pnas.151131498; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; MORRIS P, 1994, NATURE, V368, P551, DOI 10.1038/368551a0; Narayan K, 2007, NAT IMMUNOL, V8, P92, DOI 10.1038/ni1414; Natarajan SK, 1999, J IMMUNOL, V162, P3463; Nicholson MJ, 2006, J IMMUNOL, V176, P4208, DOI 10.4049/jimmunol.176.7.4208; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter CA, 2011, P NATL ACAD SCI USA, V108, P19329, DOI 10.1073/pnas.1108074108; Pashine A, 2003, IMMUNITY, V19, P183, DOI 10.1016/S1074-7613(03)00200-0; Pos W, 2012, CELL, V151, P1557, DOI 10.1016/j.cell.2012.11.025; Rabinowitz JD, 1998, IMMUNITY, V9, P699, DOI 10.1016/S1074-7613(00)80667-6; ROCHE PA, 1990, J IMMUNOL, V144, P1849; ROCHE PA, 1990, NATURE, V345, P615, DOI 10.1038/345615a0; SADEGHNASSERI S, 1991, NATURE, V353, P167, DOI 10.1038/353167a0; Sato AK, 2000, J BIOL CHEM, V275, P2165, DOI 10.1074/jbc.275.3.2165; SHERMAN MA, 1995, IMMUNITY, V3, P197, DOI 10.1016/1074-7613(95)90089-6; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Stratikos E, 2002, J EXP MED, V196, P173, DOI 10.1084/jem.20020117; Stratikos E, 2004, J IMMUNOL, V172, P1109, DOI 10.4049/jimmunol.172.2.1109; Ullrich HJ, 1997, P NATL ACAD SCI USA, V94, P13163, DOI 10.1073/pnas.94.24.13163; vanHam SM, 1996, J EXP MED, V184, P2019, DOI 10.1084/jem.184.5.2019; Vogt AB, 1996, P NATL ACAD SCI USA, V93, P9724, DOI 10.1073/pnas.93.18.9724; Weber DA, 1996, SCIENCE, V274, P618, DOI 10.1126/science.274.5287.618; Zarutskie JA, 2001, P NATL ACAD SCI USA, V98, P12450, DOI 10.1073/pnas.211439398; Zhou ZM, 2009, J IMMUNOL, V183, P4187, DOI 10.4049/jimmunol.0901663	46	9	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69228	10.1371/journal.pone.0069228	http://dx.doi.org/10.1371/journal.pone.0069228			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23976922	Green Published, gold			2022-12-25	WOS:000322433300028
J	Chen, Z; Chen, J; Gu, Y; Hu, C; Li, JL; Lin, S; Shen, H; Cao, C; Gao, R; Li, J; Ha, PK; Kaye, FJ; Griffin, JD; Wu, L				Chen, Z.; Chen, J.; Gu, Y.; Hu, C.; Li, J-L; Lin, S.; Shen, H.; Cao, C.; Gao, R.; Li, J.; Ha, P. K.; Kaye, F. J.; Griffin, J. D.; Wu, L.			Aberrantly activated AREG-EGFR signaling is required for the growth and survival of CRTC1-MAML2 fusion-positive mucoepidermoid carcinoma cells	ONCOGENE			English	Article						salivary gland tumors; mucoepidermoid carcinoma; CRTC1-MAML2; AREG; EGFR	TRANSCRIPTIONAL COACTIVATORS; T(11/19) TRANSLOCATION; NOTCH RECEPTORS; LUNG-CANCER; WILD-TYPE; TUMORS; ONCOGENE; MASTERMIND; CETUXIMAB; CREB	Salivary gland tumors (SGT) are a group of highly heterogeneous head and neck malignancies with widely varied clinical outcomes and no standard effective treatments. The CRTC1-MAML2 fusion oncogene, encoded by a recurring chromosomal translocation t(11; 19)(q14-21; p12-13), is a frequent genetic alteration found in > 50% of mucoepidermoid carcinomas (MEC), the most common malignant SGT. In this study, we aimed to define the role of the CRTC1-MAML2 oncogene in the maintenance of MEC tumor growth and to investigate critical downstream target genes and pathways for therapeutic targeting of MEC. By performing gene expression analyses and functional studies via RNA interference and pharmacological modulation, we determined the importance of the CRTC1-MAML2 fusion gene and its downstream AREG-EGFR signaling in human MEC cancer cell growth and survival in vitro and in vivo using human MEC xenograft models. We found that CRTC1-MAML2 fusion oncogene was required for the growth and survival of fusion-positive human MEC cancer cells in vitro and in vivo. The CRTC1-MAML2 oncoprotein induced the upregulation of the epidermal growth factor receptor (EGFR) ligand Amphiregulin (AREG) by co-activating the transcription factor CREB, and AREG subsequently activated EGFR signaling in an autocrine manner that promoted MEC cell growth and survival. Importantly, CRTC1-MAML2-positive MEC cells were highly sensitive to EGFR signaling inhibition. Therefore, our study revealed that aberrantly activated AREG-EGFR signaling is required for CRTC1-MAML2-positive MEC cell growth and survival, suggesting that EGFR-targeted therapies will benefit patients with advanced, unresectable CRTC1-MAML2-positive MEC.	[Chen, Z.; Gu, Y.; Hu, C.; Lin, S.; Wu, L.] Univ Florida, Shands Canc Ctr, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; [Chen, J.; Griffin, J. D.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Li, J-L] Sanford Burnham Med Res Inst Lake Nona, Orlando, FL USA; [Shen, H.] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Cao, C.; Gao, R.; Kaye, F. J.] Univ Florida, Shands Canc Ctr, Dept Med, Gainesville, FL USA; [Li, J.] Fujian Med Univ, Fujian Prov Tumor Hosp, Teaching Hosp, Fuzhou, Fujian, Peoples R China; [Ha, P. K.] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD USA	State University System of Florida; University of Florida; Harvard University; Dana-Farber Cancer Institute; Sanford Burnham Prebys Medical Discovery Institute; Sun Yat Sen University; State University System of Florida; University of Florida; Fujian Medical University; Johns Hopkins University	Wu, L (corresponding author), Univ Florida, Shands Canc Ctr, Dept Mol Genet & Microbiol, 2033 Mowry Rd, Gainesville, FL 32610 USA.	lzwu@ufl.edu	Li, Jian-Liang/AAE-9315-2019; chen, zirong/S-4042-2016; Li, J L/E-6100-2018	Li, Jian-Liang/0000-0002-6487-081X; chen, zirong/0000-0002-0589-4619; Li, J L/0000-0002-6487-081X	University of Florida Shands Cancer Center Startup fund; Bankhead Coley Cancer Research Program; V foundation for Cancer Research	University of Florida Shands Cancer Center Startup fund; Bankhead Coley Cancer Research Program; V foundation for Cancer Research	We thank Marda Jorgensen for helping with immunohistochemical staining, Mei Zhang for helping with FACS analysis, and the Salivary Gland Tumor Biorepository (SGTB) for providing tumor specimens for this study. L Wu was supported by the University of Florida Shands Cancer Center Startup fund, Bankhead Coley Cancer Research Program, and the V foundation for Cancer Research.	Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Anzick SL, 2010, GENE CHROMOSOME CANC, V49, P59, DOI 10.1002/gcc.20719; Behboudi A, 2006, GENE CHROMOSOME CANC, V45, P470, DOI 10.1002/gcc.20306; Bell D, 2012, CURR ONCOL REP, V14, P166, DOI 10.1007/s11912-012-0220-5; Busser B, 2011, BBA-REV CANCER, V1816, P119, DOI 10.1016/j.bbcan.2011.05.003; Canettieri G, 2009, P NATL ACAD SCI USA, V106, P1445, DOI 10.1073/pnas.0808749106; Chiosea SI, 2012, LARYNGOSCOPE, V122, P1690, DOI 10.1002/lary.22419; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Coxon A, 2005, CANCER RES, V65, P7137, DOI 10.1158/0008-5472.CAN-05-1125; Enlund F, 2004, EXP CELL RES, V292, P21, DOI 10.1016/j.yexcr.2003.09.007; Eveson JW, 2011, PERIODONTOL 2000, V57, P150, DOI 10.1111/j.1600-0757.2011.00385.x; Fehr A, 2008, CANCER GENET CYTOGEN, V180, P135, DOI 10.1016/j.cancergencyto.2007.10.007; Grisanti Salvatore, 2008, J Med Case Rep, V2, P320, DOI 10.1186/1752-1947-2-320; Gu Y, 2012, ONCOGENE, V31, P469, DOI 10.1038/onc.2011.247; Han SW, 2008, LUNG CANCER, V61, P30, DOI 10.1016/j.lungcan.2007.11.014; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Komiya T, 2006, ONCOGENE, V25, P6128, DOI 10.1038/sj.onc.1209627; Komiya T, 2010, ONCOGENE, V29, P1672, DOI 10.1038/onc.2009.453; Kumar V, 2014, ROBBINS COTRAN PATHO; Lujan B, 2010, BRIT J CANCER, V103, P510, DOI 10.1038/sj.bjc.6605788; McElhinny AS, 2008, ONCOGENE, V27, P5138, DOI 10.1038/onc.2008.228; O'Neill ID, 2009, LUNG CANCER, V64, P129, DOI 10.1016/j.lungcan.2009.01.003; O'Neill ID, 2009, ORAL ONCOL, V45, P2, DOI 10.1016/j.oraloncology.2008.03.012; O'Neill ID, 2009, J ORAL PATHOL MED, V38, P145, DOI 10.1111/j.1600-0714.2008.00676.x; Persson M, 2009, P NATL ACAD SCI USA, V106, P18740, DOI 10.1073/pnas.0909114106; Raben D, 2005, CLIN CANCER RES, V11, P795; Seethala RR, 2010, AM J SURG PATHOL, V34, P1106, DOI 10.1097/PAS.0b013e3181de3021; Steiner P, 2007, CLIN CANCER RES, V13, P1540, DOI 10.1158/1078-0432.CCR-06-1887; Stenman G, 2005, SEMIN CANCER BIOL, V15, P224, DOI 10.1016/j.semcancer.2005.01.002; Tonon G, 2003, NAT GENET, V33, P208, DOI 10.1038/ng1083; Wu L, 2002, MOL CELL BIOL, V22, P7688, DOI 10.1128/MCB.22.21.7688-7700.2002; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Wu LZ, 2005, EMBO J, V24, P2391, DOI 10.1038/sj.emboj.7600719; Yonesaka K, 2008, CLIN CANCER RES, V14, P6963, DOI 10.1158/1078-0432.CCR-08-0957	34	53	54	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 17	2014	33	29					3869	3877		10.1038/onc.2013.348	http://dx.doi.org/10.1038/onc.2013.348			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AL8MU	23975434				2022-12-25	WOS:000339394100013
J	Roy, SS; Gonugunta, VK; Bandyopadhyay, A; Rao, MK; Goodall, GJ; Sun, LZ; Tekmal, RR; Vadlamudi, RK				Roy, S. S.; Gonugunta, V. K.; Bandyopadhyay, A.; Rao, M. K.; Goodall, G. J.; Sun, L-Z; Tekmal, R. R.; Vadlamudi, R. K.			Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer	ONCOGENE			English	Article						ER coactivators; PELP1; breast cancer; metastasis; EMT; miR	EPITHELIAL-MESENCHYMAL TRANSITION; LEUCINE-RICH PROTEIN-1/MODULATOR; GLUTAMIC ACID-RICH; ESTROGEN-RECEPTOR; TUMOR-METASTASIS; MIR-200 FAMILY; PROLINE-RICH; PELP1; EXPRESSION; COREPRESSOR	Tumor metastasis is the leading cause of death among breast cancer patients. PELP1 (proline, glutamic acid and leucine rich protein 1) is a nuclear receptor coregulator that is upregulated during breast cancer progression to metastasis and is an independent prognostic predictor of shorter survival of breast cancer patients. Here, we show that PELP1 modulates expression of metastasis-influencing microRNAs (miRs) to promote cancer metastasis. Whole genome miR array analysis using PELP1-overexpressing and PELP1-underexpressing model cells revealed that miR-200 and miR-141 levels inversely correlated with PELP1 expression. Consistent with this, PELP1 knockdown resulted in lower expression of miR-200a target genes ZEB1 and ZEB2. PELP1 knockdown significantly reduced tumor growth and metastasis compared with parental cells in an orthotopic xenograft tumor model. Furthermore, re-introduction of miR-200a and miR-141 mimetics into PELP1-overexpressing cells reversed PELP1 target gene expression, decreased PELP1-driven migration/invasion in vitro and significantly reduced in vivo metastatic potential in a preclinical model of experimental metastasis. Our results demonstrated that PELP1 binds to miR-200a and miR-141 promoters and regulates their expression by recruiting chromatin modifier histone deacetylase 2 (HDAC2) as revealed by chromatin immunoprecipitation, small interfering RNA and HDAC inhibitor assays. Taken together, our results suggest that PELP1 regulates tumor metastasis by controlling the expression and functions of the tumor metastasis suppressors miR-200a and miR-141.	[Roy, S. S.; Gonugunta, V. K.; Tekmal, R. R.; Vadlamudi, R. K.] UT Hlth Sci Ctr, Dept Obstet & Gynecol, San Antonio, TX USA; [Bandyopadhyay, A.; Rao, M. K.; Sun, L-Z] UT Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX USA; [Rao, M. K.; Sun, L-Z; Tekmal, R. R.; Vadlamudi, R. K.] UT Hlth Sci Ctr, Canc Therapy & Res Ctr, San Antonio, TX USA; [Goodall, G. J.] Univ Adelaide, Dept Med, Ctr Canc Biol, SA Pathol,Sch Mol & Biomed Sci, Adelaide, SA 5001, Australia	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; Centre for Cancer Biology; SA Pathology; University of Adelaide	Vadlamudi, RK (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Obstet & Gynecol, Div Reprod Res, San Antonio, TX 78229 USA.	vadlamudi@uthscsa.edu	, LuZhe/AAW-4095-2021	Goodall, Gregory/0000-0003-1294-0692	NIH/NCI [CA095681]; T32 training [CA148724]; William and Ella Owens foundation grant; Cancer Therapy and Research Center at the University of Texas Health Science Center at San Antonio through the NCI Cancer Center [P30CA054174-17]; NATIONAL CANCER INSTITUTE [T32CA148724, R01CA095681, P30CA054174] Funding Source: NIH RePORTER; National Breast Cancer Foundation [CG-10-04] Funding Source: researchfish	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); T32 training; William and Ella Owens foundation grant; Cancer Therapy and Research Center at the University of Texas Health Science Center at San Antonio through the NCI Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Breast Cancer Foundation	This study was supported by the NIH/NCI Grant CA095681 (R.K.V.) T32 training grant CA148724 (SSR), William and Ella Owens foundation grant (MKR) and the Cancer Therapy and Research Center at the University of Texas Health Science Center at San Antonio through the NCI Cancer Center Support Grant P30CA054174-17.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Bandyopadhyay A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010365; Beavon IRG, 2000, EUR J CANCER, V36, P1607, DOI 10.1016/S0959-8049(00)00158-1; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Chakravarty D, 2011, CLIN CANCER RES, V17, P2250, DOI 10.1158/1078-0432.CCR-10-2718; Chakravarty D, 2010, CANCER RES, V70, P4092, DOI 10.1158/0008-5472.CAN-09-3834; Chakravarty D, 2010, IUBMB LIFE, V62, P163, DOI 10.1002/iub.287; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Choi YB, 2004, J BIOL CHEM, V279, P50930, DOI 10.1074/jbc.M406831200; Cortez V, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3229; Eckhardt BL, 2012, NAT REV DRUG DISCOV, V11, P479, DOI 10.1038/nrd2372; Goldshaid L, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2579; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Habashy HO, 2010, BREAST CANCER RES TR, V120, P603, DOI 10.1007/s10549-009-0419-9; Hurst DR, 2009, CANCER RES, V69, P7495, DOI 10.1158/0008-5472.CAN-09-2111; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jenkins DE, 2005, BREAST CANCER RES, V7, pR444, DOI 10.1186/bcr1026; Khoshnaw SM, 2009, J CLIN PATHOL, V62, P422, DOI 10.1136/jcp.2008.060681; Mann M, 2012, Minerva Ginecol, V64, P75; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; Nair BC, 2010, CANCER RES, V70, P7166, DOI 10.1158/0008-5472.CAN-10-0628; Nair SS, 2007, MOL ENDOCRINOL, V21, P613, DOI 10.1210/me.2006-0269; Nair SS, 2010, EMBO REP, V11, P438, DOI 10.1038/embor.2010.62; O'Malley BW, 2007, MOL ENDOCRINOL, V21, P1009, DOI 10.1210/me.2007-0012; O'Malley BW, 2006, SCIENCE, V313, P1749, DOI 10.1126/science.1132509; O'Malley BW, 2009, CANCER RES, V69, P8217, DOI 10.1158/0008-5472.CAN-09-2223; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Qin L, 2008, MOL CELL BIOL, V28, P5937, DOI 10.1128/MCB.00579-08; Qin L, 2009, CANCER RES, V69, P3819, DOI 10.1158/0008-5472.CAN-08-4389; Rajhans R, 2007, CANCER RES, V67, P5505, DOI 10.1158/0008-5472.CAN-06-3647; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Roy S, 2012, MOL CANCER RES, V10, P25, DOI 10.1158/1541-7786.MCR-11-0456; Saha RS, 2012, INT J BREAST CANC, V2012; Schiff R, 2005, CANC CHEMOTHER PH S1, V56; Shi M, 2010, CANCER METAST REV, V29, P785, DOI 10.1007/s10555-010-9265-9; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; STETLERSTEVENSON WG, 1993, FASEB J, V7, P1434, DOI 10.1096/fasebj.7.15.8262328; Vadlamudi Ratna K, 2007, Nucl Recept Signal, V5, pe004; Wang L, 2012, ONCOGENE, V31, P2499, DOI 10.1038/onc.2011.444; Wiklund ED, 2011, INT J CANCER, V128, P1327, DOI 10.1002/ijc.25461; Yang YN, 2011, J CLIN INVEST, V121, P1373, DOI 10.1172/JCI42579	42	75	79	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 10	2014	33	28					3707	3716		10.1038/onc.2013.332	http://dx.doi.org/10.1038/onc.2013.332			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AL2GC	23975430	Green Accepted			2022-12-25	WOS:000338942900010
J	Feng, JJ; Jiang, DC; Shang, HY; Dong, M; Wang, GN; He, XY; Zhao, CN; Mao, KS				Feng, Jianju; Jiang, Dechun; Shang, Huiying; Dong, Miao; Wang, Gaini; He, Xinyu; Zhao, Changming; Mao, Kangshan			Barcoding Poplars (Populus L.) from Western China	PLOS ONE			English	Article							DNA BARCODE; GENE FLOW; LAND PLANTS; SPECIES IDENTIFICATION; NIGRA L.; MARKERS; GENOME; DIFFERENTIATION; INTROGRESSION; HYBRIDIZATION	Background: Populus is an ecologically and economically important genus of trees, but distinguishing between wild species is relatively difficult due to extensive interspecific hybridization and introgression, and the high level of intraspecific morphological variation. The DNA barcoding approach is a potential solution to this problem. Methodology/Principal Findings: Here, we tested the discrimination power of five chloroplast barcodes and one nuclear barcode (ITS) among 95 trees that represent 21 Populus species from western China. Among all single barcode candidates, the discrimination power is highest for the nuclear ITS, progressively lower for chloroplast barcodes matK (M), trnG-psbK (G) and psbK-psbI (P), and trnH-psbA (H) and rbcL (R); the discrimination efficiency of the nuclear ITS (I) is also higher than any two-, three-, or even the five-locus combination of chloroplast barcodes. Among the five combinations of a single chloroplast barcode plus the nuclear ITS, H+I and P+I differentiated the highest and lowest portion of species, respectively. The highest discrimination rate for the barcodes or barcode combinations examined here is 55.0% (H+I), and usually discrimination failures occurred among species from sympatric or parapatric areas. Conclusions/Significance: In this case study, we showed that when discriminating Populus species from western China, the nuclear ITS region represents a more promising barcode than any maternally inherited chloroplast region or combination of chloroplast regions. Meanwhile, combining the ITS region with chloroplast regions may improve the barcoding success rate and assist in detecting recent interspecific hybridizations. Failure to discriminate among several groups of Populus species from sympatric or parapatric areas may have been the result of incomplete lineage sorting, frequent interspecific hybridizations and introgressions. We agree with a previous proposal for constructing a tiered barcoding system in plants, especially for taxonomic groups that have complex evolutionary histories (e.g. Populus).	[Feng, Jianju; Jiang, Dechun; Shang, Huiying; Dong, Miao; Wang, Gaini; He, Xinyu; Zhao, Changming; Mao, Kangshan] Lanzhou Univ, Sch Earth & Environm Sci, Lanzhou 730000, Gansu, Peoples R China; [Feng, Jianju; Jiang, Dechun; Shang, Huiying; Dong, Miao; Wang, Gaini; He, Xinyu; Zhao, Changming; Mao, Kangshan] Lanzhou Univ, State Key Lab Grassland Agroecosyst, Sch Life Sci, Lanzhou 730000, Gansu, Peoples R China; [Feng, Jianju] Tarimu Univ, Xinjiang Prod & Construct Corps Key Lab Protect &, Coll Plant Sci, Alar, Xinjiang, Peoples R China	Lanzhou University; Lanzhou University	Mao, KS (corresponding author), Lanzhou Univ, Sch Earth & Environm Sci, Lanzhou 730000, Gansu, Peoples R China.	maokangshan@163.com		Mao, Kangshan/0000-0002-0071-1844	Ministry of Science and Technology(National Key Project for Basic Research) [2012CB114504]; Ministry of Science and Technology(National High Technology Research and Development Program of China) [2013AA102605]; International Collaboration 111 Projects of China; Fundamental Research Funds for the Central Universities [lzujbky-2009-k05]; National Natural Science Foundation of China [31260051]	Ministry of Science and Technology(National Key Project for Basic Research); Ministry of Science and Technology(National High Technology Research and Development Program of China); International Collaboration 111 Projects of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Financial support was provided by the Ministry of Science and Technology(National Key Project for Basic Research 2012CB114504 and the National High Technology Research and Development Program of China No. 2013AA102605), the International Collaboration 111 Projects of China, the Fundamental Research Funds for the Central Universities (lzujbky-2009-k05) and the National Natural Science Foundation of China (Grant number 31260051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Benetka V, 1999, SILVAE GENET, V48, P218; Bradshaw HD, 2000, J PLANT GROWTH REGUL, V19, P306, DOI 10.1007/s003440000030; Cervera MT, 2005, THEOR APPL GENET, V111, P1440, DOI 10.1007/s00122-005-0076-2; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Cho Y, 2004, P NATL ACAD SCI USA, V101, P17741, DOI 10.1073/pnas.0408302101; Cho Y, 1998, P NATL ACAD SCI USA, V95, P14244, DOI 10.1073/pnas.95.24.14244; Cowan RS, 2006, TAXON, V55, P611, DOI 10.2307/25065638; De-Lucas AI, 2008, ANN FOREST SCI, V65, DOI 10.1051/forest:2007079; Dickman D.L., 1983, CULTURE POPLARS E N; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Du FK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061337; Du FK, 2009, MOL ECOL, V18, P1396, DOI 10.1111/j.1365-294X.2009.04107.x; Eckenwalder James E., 1996, P7; Eckenwalder JE, 1977, SYSTEMATICS POPULUS; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellis B, 2010, PLANT GENET GENOMICS, V8, P3, DOI 10.1007/978-1-4419-1541-2_1; Fang CF, 1999, FLORA CHINA, V4, P139; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Feliner GN, 2007, MOL PHYLOGENET EVOL, V44, P911, DOI 10.1016/j.ympev.2007.01.013; Fladung M, 2009, TREES-STRUCT FUNCT, V23, P1199, DOI 10.1007/s00468-009-0359-3; Fossati T, 2005, TREE GENET GENOMES, V1, P11, DOI 10.1007/s11295-004-0002-9; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hamzeh M, 2004, AM J BOT, V91, P1398, DOI 10.3732/ajb.91.9.1398; Hamzeh M, 2007, CAN J BOT, V85, P1227, DOI 10.1139/B07-105; He CY, 2010, TREE PHYSIOL, V30, P1383, DOI 10.1093/treephys/tpq083; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heilman PE, 1999, NEW FOREST, V17, P89, DOI 10.1023/A:1006515204167; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Hollingsworth PM, 2011, P NATL ACAD SCI USA, V108, P19451, DOI 10.1073/pnas.1116812108; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Jansson S, 2007, ANNU REV PLANT BIOL, V58, P435, DOI 10.1146/annurev.arplant.58.032806.103956; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0013102, 10.1371/journal.pone.0011875]; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lexer C, 2005, MOL ECOL, V14, P1045, DOI 10.1111/j.1365-294X.2005.02469.x; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liesebach H, 2010, TREE GENET GENOMES, V6, P259, DOI 10.1007/s11295-009-0246-5; Meirmans PG, 2007, CAN J BOT, V85, P1082, DOI 10.1139/B07-069; Meirmans PG, 2010, AM J BOT, V97, P1688, DOI 10.3732/ajb.0900271; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; Pennisi E, 2007, SCIENCE, V318, P190, DOI 10.1126/science.318.5848.190; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Qiu Q, 2011, TREE PHYSIOL, V31, P452, DOI 10.1093/treephys/tpr015; Rahman MH, 2002, GENOME, V45, P1083, DOI [10.1139/g02-077, 10.1139/G02-077]; RAJORA OP, 1990, CAN J BOT, V68, P990, DOI 10.1139/b90-125; Ran JH, 2010, J INTEGR PLANT BIOL, V52, P1109, DOI 10.1111/j.1744-7909.2010.00995.x; Ren BQ, 2010, MOL ECOL RESOUR, V10, P594, DOI 10.1111/j.1755-0998.2009.02815.x; Sass C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001154; Schroeder H, 2012, PLANT BIOLOGY, V14, P374, DOI 10.1111/j.1438-8677.2011.00502.x; Schroeder H, 2010, SILVAE GENET, V59, P257, DOI 10.1515/sg-2010-0036; Slavov GT, 2012, NEW PHYTOL, V196, P713, DOI 10.1111/j.1469-8137.2012.04258.x; Stettler R.F., 1996, BIOL POPULUS ITS IMP; Stolting KN, 2013, MOL ECOL, V22, P842, DOI 10.1111/mec.12011; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson SL, 2010, MOL ECOL, V19, P132, DOI 10.1111/j.1365-294X.2009.04442.x; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; van Loo M, 2008, NEW PHYTOL, V177, P506, DOI 10.1111/j.1469-8137.2007.02266.x; Vanden Broeck A, 2004, FOREST ECOL MANAG, V197, P307, DOI 10.1016/j.foreco.2004.05.021; Vences M, 2005, PHILOS T R SOC B, V360, P1859, DOI 10.1098/rstb.2005.1717; Wang C, 1984, FLORA REPUBLICAE POP, V20, P1; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026530; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Xiang XG, 2011, MOL ECOL RESOUR, V11, P1012, DOI 10.1111/j.1755-0998.2011.03044.x; Xu F, 2013, MOL ECOL RESOUR, V13, P144, DOI 10.1111/1755-0998.12030; Yang CY, 1992, FLORA XINJIANGENSIS, V1, P122	72	33	36	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71710	10.1371/journal.pone.0071710	http://dx.doi.org/10.1371/journal.pone.0071710			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977122	Green Submitted, gold, Green Published			2022-12-25	WOS:000323425700089
J	Hahn, J; Seeber, F; Kolodziej, H; Ignatius, R; Laue, M; Aebischer, T; Klotz, C				Hahn, Juliane; Seeber, Frank; Kolodziej, Herbert; Ignatius, Ralf; Laue, Michael; Aebischer, Toni; Klotz, Christian			High Sensitivity of Giardia duodenalis to Tetrahydrolipstatin (Orlistat) In Vitro	PLOS ONE			English	Article							FATTY-ACID SYNTHASE; PANCREATIC LIPASE; DRUG-INTERACTIONS; LIPID-METABOLISM; AXENIC CULTURE; LAMBLIA; INHIBITOR; SUSCEPTIBILITY; RESISTANCE; 5-NITROIMIDAZOLE	Giardiasis, a gastrointestinal disease caused by Giardia duodenalis, is currently treated mainly with nitroimidazoles, primarily metronidazole (MTZ). Treatment failure rates of up to 20 percent reflect the compelling need for alternative treatment options. Here, we investigated whether orlistat, a drug approved to treat obesity, represents a potential therapeutic agent against giardiasis. We compared the growth inhibitory effects of orlistat and MTZ on a long-term in vitro culture adapted G. duodenalis strain, WB-C6, and on a new isolate, 14-03/F7, from a patient refractory to MTZ treatment using a resazurin assay. The giardiacidal concentration of the drugs and their combined in vitro efficacy was determined by median-effect analysis. Morphological changes after treatment were analysed by light and electron microscopy. Orlistat inhibited the in vitro growth of G. duodenalis at low micromolar concentrations, with isolate 14-03/F7 (IC50(24h) = 2.8 mu M) being more sensitive than WB-C6 (IC50(24h) = 6.2 mu M). The effect was significantly more potent compared to MTZ (IC50(24h) = 4.3 mu M and 11.0 mu M, respectively) and led to specific undulated morphological alterations on the parasite surface. The giardiacidal concentration of orlistat was >14 mu M for 14-03/F7 and >43 mu M for WB-C6, respectively. Importantly, the combination of both drugs revealed no interaction on their inhibitory effects. We demonstrate that orlistat is a potent inhibitor of G. duodenalis growth in vitro and kills parasites at concentrations achievable in the gut by approved treatment regimens for obesity. We therefore propose to investigate orlistat in controlled clinical studies as a new drug in giardiasis.	[Hahn, Juliane; Kolodziej, Herbert] Free Univ Berlin, Inst Pharm, Berlin, Germany; [Seeber, Frank; Aebischer, Toni; Klotz, Christian] Robert Koch Inst, Dept Infect Dis, Berlin, Germany; [Ignatius, Ralf] Charite, Inst Trop Med & Int Hlth, D-13353 Berlin, Germany; [Laue, Michael] Robert Koch Inst, Ctr Biol Threats & Special Pathogens, Berlin, Germany	Free University of Berlin; Robert Koch Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Robert Koch Institute	Klotz, C (corresponding author), Robert Koch Inst, Dept Infect Dis, Berlin, Germany.	KlotzC@rki.de		Aebischer, Toni/0000-0002-4875-8457; Seeber, Frank/0000-0002-2271-3699	National Research Platform for Zoonosis; German Federal Ministry of Education and Research (BMBF) [01KI1019]	National Research Platform for Zoonosis; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the "National Research Platform for Zoonosis" that is funded by the German Federal Ministry of Education and Research (BMBF) (Grant# 01KI1019 to TA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankarklev J, 2010, NAT REV MICROBIOL, V8, P413, DOI 10.1038/nrmicro2317; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Benere E, 2011, PARASITOLOGY, V138, P1354, DOI 10.1017/S0031182011001223; Benere E, 2007, J MICROBIOL METH, V71, P101, DOI 10.1016/j.mimet.2007.07.014; Bijnsdorp IV, 2011, METHODS MOL BIOL, V731, P421, DOI 10.1007/978-1-61779-080-5_34; Bogarin R, 2009, THERAPY, V6, P23, DOI DOI 10.2217/14750708.6.1.23; BORGSTROM B, 1988, BIOCHIM BIOPHYS ACTA, V962, P308, DOI 10.1016/0005-2760(88)90260-3; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Cruz A, 2003, J ANTIMICROB CHEMOTH, V51, P1017, DOI 10.1093/jac/dkg150; Das S, 2002, INT J PARASITOL, V32, P655, DOI 10.1016/S0020-7519(02)00006-1; Derosa G, 2012, EXPERT OPIN DRUG SAF, V11, P459, DOI 10.1517/14740338.2012.675326; Filippatos TD, 2008, DRUG SAFETY, V31, P53, DOI 10.2165/00002018-200831010-00005; Flavin R, 2010, FUTURE ONCOL, V6, P551, DOI [10.2217/fon.10.11, 10.2217/FON.10.11]; Gardner TB, 2001, CLIN MICROBIOL REV, V14, P114, DOI 10.1128/CMR.14.1.114-128.2001; Gibson GR, 1999, EXP PARASITOL, V92, P1, DOI 10.1006/expr.1999.4389; Gloeckner C, 2010, P NATL ACAD SCI USA, V107, P3424, DOI 10.1073/pnas.0915125107; HADVARY P, 1991, J BIOL CHEM, V266, P2021; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; Kent SJ, 2012, AIDS RES HUM RETROV, V28, P761, DOI [10.1089/aid.2012.0017, 10.1089/AID.2012.0017]; Kremer L, 2005, MOL MICROBIOL, V57, P1113, DOI 10.1111/j.1365-2958.2005.04717.x; Kridel SJ, 2004, CANCER RES, V64, P2070, DOI 10.1158/0008-5472.can-03-3645; Lalle Marco, 2010, Infectious Disorders - Drug Targets, V10, P283; Laue M, 2010, METHOD CELL BIOL, V96, P1, DOI 10.1016/S0091-679X(10)96001-9; Leitsch D, 2011, J ANTIMICROB CHEMOTH, V66, P1756, DOI 10.1093/jac/dkr192; Lopez-Velez R, 2010, AM J TROP MED HYG, V83, P171, DOI 10.4269/ajtmh.2010.09-0742; MAJEWSKA AC, 1991, T ROY SOC TROP MED H, V85, P67, DOI 10.1016/0035-9203(91)90161-Q; McClendon KS, 2009, EXPERT OPIN DRUG SAF, V8, P727, DOI 10.1517/14740330903321485; MCINTYRE P, 1986, J PEDIATR-US, V108, P1005, DOI 10.1016/S0022-3476(86)80950-7; Miculka C., 2011, Apicomplexan parasites: molecular approaches toward targeted drug development, P481; Nillius D, 2011, J ANTIMICROB CHEMOTH, V66, P1029, DOI 10.1093/jac/dkr029; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Parker SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004281; RICE EW, 1981, J CLIN MICROBIOL, V14, P709, DOI 10.1128/JCM.14.6.709-710.1981; Robertson LJ, 2010, TRENDS PARASITOL, V26, P75, DOI 10.1016/j.pt.2009.11.010; Savioli L, 2006, TRENDS PARASITOL, V22, P203, DOI 10.1016/j.pt.2006.02.015; Solaymani-Mohammadi S, 2011, J IMMUNOL, V187, P3769, DOI 10.4049/jimmunol.1100606; Sprong H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000558; Sterk M, 2007, MICROBIOL-SGM, V153, P4150, DOI 10.1099/mic.0.2007/010041-0; Sulaiman IM, 2003, EMERG INFECT DIS, V9, P1444, DOI 10.3201/eid0911.030084; Townson SM, 1996, MOL BIOCHEM PARASIT, V79, P183, DOI 10.1016/0166-6851(96)02661-8; Upcroft P, 2001, CLIN MICROBIOL REV, V14, P150, DOI 10.1128/CMR.14.1.150-164.2001; Valdez CA, 2009, J MED CHEM, V52, P4038, DOI 10.1021/jm900356n; Vargas-Villarreal J, 2007, J PARASITOL, V93, P979, DOI 10.1645/GE-1038R3.1; WEIBEL EK, 1987, J ANTIBIOT, V40, P1081, DOI 10.7164/antibiotics.40.1081; Xiao D, 2013, BIOCHEM PHARMACOL, V85, P439, DOI 10.1016/j.bcp.2012.11.026; Yang PY, 2012, CHEM-EUR J, V18, P8403, DOI 10.1002/chem.201200482; Yichoy M, 2011, PARASITOLOGY, V138, P267, DOI 10.1017/S0031182010001277; Yuan J, 2011, SCIENCE, V333, P724, DOI 10.1126/science.1205216	48	19	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71597	10.1371/journal.pone.0071597	http://dx.doi.org/10.1371/journal.pone.0071597			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977083	gold, Green Published, Green Submitted			2022-12-25	WOS:000323425700073
J	Schuster, C; Brosi, H; Stifter, K; Boehm, BO; Schirmbeck, R				Schuster, Cornelia; Brosi, Helen; Stifter, Katja; Boehm, Bernhard O.; Schirmbeck, Reinhold			A Missing PD-L1/PD-1 Coinhibition Regulates Diabetes Induction by Preproinsulin-Specific CD8 T-Cells in an Epitope-Specific Manner	PLOS ONE			English	Article							NOD MICE; BETA-CELLS; RIP-B7.1 MICE; PD-1 GENE; INSULIN; TOLERANCE; RESPONSES; LIGANDS; PEPTIDE; PATHWAY	Coinhibitory PD-1/PD-L1 (B7-H1) interactions provide critical signals for the regulation of autoreactive T-cell responses. We established mouse models, expressing the costimulator molecule B7.1 (CD80) on pancreatic beta cells (RIP-B7.1 tg mice) or are deficient in coinhibitory PD-L1 or PD-1 molecules (PD-L1(-/-) and PD-1(-/-) mice), to study induction of preproinsulin (ppins)-specific CD8 T-cell responses and experimental autoimmune diabetes (EAD) by DNA-based immunization. RIPB7.1 tg mice allowed us to identify two CD8 T-cell specificities: pCI/ppins DNA exclusively induced K-b/A(12-21)-specific CD8 T-cells and EAD, whereas pCI/ppins Delta A(12-21) DNA (encoding ppins without the COOH-terminal A(12-21) epitope) elicited K-b/B22-29-specific CD8 T-cells and EAD. Specific expression/processing of mutant ppins Delta A(12-21) (but not ppins) in non-beta cells, targeted by intramuscular DNA-injection, thus facilitated induction of (K)b/B22-29-specific CD8 T-cells. The A(12-21) epitope binds K-b molecules with a very low avidity as compared with B22-29. Interestingly, immunization of coinhibition-deficient PD-L1(-/-) or PD-1(-/-) mice with pCI/ppins induced K-b/A(12-21)-monospecific CD8 T-cells and EAD but injections with pCI/ppins Delta A(12-21) did neither recruit K-b/B22-29-specific CD8 T-cells into the pancreatic target tissue nor induce EAD. Ppins Delta A(12-21)/(K-b/B22-29)-mediated EAD was efficiently restored in RIP-B7.1(+)/PD-L1(-/-) mice, differing from PD-L1(-/-) mice only in the tg B7.1 expression in beta cells. Alternatively, an ongoing beta cell destruction and tissue inflammation, initiated by ppins/(K-b/A(12-21))-specific CD8 T-cells in pCI/ppins+pCI/ppins Delta A(12-21) co-immunized PD-L1(-/-) mice, facilitated the expansion of ppins Delta A(12-21)/(K-b/B22-29)-specific CD8 T-cells. CD8 T-cells specific for the high-affinity K-b/B22-29-(but not the low-affinity K-b/A(12-21))-epitope thus require stimulatory help from beta cells or inflamed islets to expand in PD-L1-deficient mice. The new PD-1/PD-L1 diabetes models may be valuable tools to study under well controlled experimental conditions distinct hierarchies of autoreactive CD8 T-cell responses, which trigger the initial steps of beta cell destruction or emerge during the pathogenic progression of EAD.	[Schuster, Cornelia; Brosi, Helen; Stifter, Katja; Boehm, Bernhard O.; Schirmbeck, Reinhold] Ulm Univ Hosp, Dept Internal Med 1, Ulm, Germany	Ulm University	Schirmbeck, R (corresponding author), Ulm Univ Hosp, Dept Internal Med 1, Ulm, Germany.	reinhold.schirmbeck@uni-ulm.de	Boehm, Bernhard Otto/F-8750-2015		Deutsche Forschungsgemeinschaft [GRK-1041]; DFG [SCHI-505/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft: GRK-1041 (to R.S. and B.O.B.) and DFG SCHI-505/4-1 (to R.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Ansari MJI, 2003, J EXP MED, V198, P63, DOI 10.1084/jem.20022125; Brosi H, 2009, J IMMUNOL, V183, P7187, DOI 10.4049/jimmunol.0901573; Calderon B, 2012, CURR OPIN IMMUNOL, V24, P119, DOI 10.1016/j.coi.2011.11.005; Dong HD, 2004, IMMUNITY, V20, P327, DOI 10.1016/S1074-7613(04)00050-0; Fife BT, 2006, J EXP MED, V203, P2737, DOI 10.1084/jem.20061577; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Guleria I, 2007, CLIN IMMUNOL, V125, P16, DOI 10.1016/j.clim.2007.05.013; HARLAN DM, 1994, P NATL ACAD SCI USA, V91, P3137, DOI 10.1073/pnas.91.8.3137; Jeker LT, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007807; Karges W, 2002, DIABETES, V51, P3237, DOI 10.2337/diabetes.51.11.3237; Karges W, 2007, EUR J IMMUNOL, V37, P2097, DOI 10.1002/eji.200737222; Kedl RM, 2003, CURR OPIN IMMUNOL, V15, P120, DOI 10.1016/S0952-7915(02)00009-2; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Krishnamurthy B, 2006, J CLIN INVEST, V116, P3258, DOI 10.1172/JCI29602; Lang KS, 2005, NAT MED, V11, P138, DOI 10.1038/nm1176; Lennon GP, 2009, IMMUNITY, V31, P643, DOI 10.1016/j.immuni.2009.07.008; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; Luo XR, 2010, IMMUNITY, V32, P488, DOI 10.1016/j.immuni.2010.04.002; Mallone R, 2007, DIABETES, V56, P613, DOI 10.2337/db06-1419; Mohan JF, 2011, J EXP MED, V208, P2375, DOI 10.1084/jem.20111502; Moser A, 2010, BIOL REP, V2, P75; Nakayama M, 2005, NATURE, V435, P220, DOI 10.1038/nature03523; Ni RH, 2007, HUM GENET, V121, P223, DOI 10.1007/s00439-006-0309-8; Nielsen C, 2003, TISSUE ANTIGENS, V62, P492, DOI 10.1046/j.1399-0039.2003.00136.x; Nishimura H, 1998, INT IMMUNOL, V10, P1563, DOI 10.1093/intimm/10.10.1563; Paterson AM, 2011, J IMMUNOL, V187, P1097, DOI 10.4049/jimmunol.1003496; Pinkse GGM, 2005, P NATL ACAD SCI USA, V102, P18425, DOI 10.1073/pnas.0508621102; Prasad S, 2012, J AUTOIMMUN, V39, P347, DOI 10.1016/j.jaut.2012.04.005; Rajasalu T, 2010, DIABETES, V59, P1966, DOI 10.2337/db09-1135; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Santamaria P, 2010, IMMUNITY, V32, P437, DOI 10.1016/j.immuni.2010.04.003; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Skowera A, 2008, J CLIN INVEST, V118, P3390, DOI 10.1172/JCI35449; SMEEKENS SP, 1992, P NATL ACAD SCI USA, V89, P8822, DOI 10.1073/pnas.89.18.8822; Stadinski B, 2010, IMMUNITY, V32, P446, DOI 10.1016/j.immuni.2010.04.008; Stadinski BD, 2010, P NATL ACAD SCI USA, V107, P10978, DOI 10.1073/pnas.1006545107; Turley S, 2003, J EXP MED, V198, P1527, DOI 10.1084/jem.20030966; von Herrath M, 2009, NAT IMMUNOL, V10, P129, DOI 10.1038/ni0209-129; Wong FS, 2008, BIOCHEM SOC T, V36, P316, DOI 10.1042/BST0360316; Wong FS, 2009, DIABETES, V58, P1156, DOI 10.2337/db08-0800; Wong FS, 2002, P NATL ACAD SCI USA, V99, P5551, DOI 10.1073/pnas.072037299; Zhang L, 2008, CURR OPIN IMMUNOL, V20, P111, DOI 10.1016/j.coi.2007.11.005	47	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71746	10.1371/journal.pone.0071746	http://dx.doi.org/10.1371/journal.pone.0071746			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977133	Green Submitted, Green Published, gold			2022-12-25	WOS:000323425700095
J	Lin, C; Karlson, EW; Canhao, H; Miller, TA; Dligach, D; Chen, PJ; Perez, RNG; Shen, YY; Weinblatt, ME; Shadick, NA; Plenge, RM; Savova, GK				Lin, Chen; Karlson, Elizabeth W.; Canhao, Helena; Miller, Timothy A.; Dligach, Dmitriy; Chen, Pei Jun; Perez, Raul Natanael Guzman; Shen, Yuanyan; Weinblatt, Michael E.; Shadick, Nancy A.; Plenge, Robert M.; Savova, Guergana K.			Automatic Prediction of Rheumatoid Arthritis Disease Activity from the Electronic Medical Records	PLOS ONE			English	Article							COLLEGE-OF-RHEUMATOLOGY; CLINICAL-PRACTICE; RELIABILITY; PNEUMONIA; ALGORITHM; CRITERIA; AGENTS; TEXT	Objective: We aimed to mine the data in the Electronic Medical Record to automatically discover patients' Rheumatoid Arthritis disease activity at discrete rheumatology clinic visits. We cast the problem as a document classification task where the feature space includes concepts from the clinical narrative and lab values as stored in the Electronic Medical Record. Materials and Methods: The Training Set consisted of 2792 clinical notes and associated lab values. Test Set 1 included 1749 clinical notes and associated lab values. Test Set 2 included 344 clinical notes for which there were no associated lab values. The Apache clinical Text Analysis and Knowledge Extraction System was used to analyze the text and transform it into informative features to be combined with relevant lab values. Results: Experiments over a range of machine learning algorithms and features were conducted. The best performing combination was linear kernel Support Vector Machines with Unified Medical Language System Concept Unique Identifier features with feature selection and lab values. The Area Under the Receiver Operating Characteristic Curve (AUC) is 0.831 (sigma = 0.0317), statistically significant as compared to two baselines (AUC = 0.758, sigma = 0.0291). Algorithms demonstrated superior performance on cases clinically defined as extreme categories of disease activity (Remission and High) compared to those defined as intermediate categories (Moderate and Low) and included laboratory data on inflammatory markers. Conclusion: Automatic Rheumatoid Arthritis disease activity discovery from Electronic Medical Record data is a learnable task approximating human performance. As a result, this approach might have several research applications, such as the identification of patients for genome-wide pharmacogenetic studies that require large sample sizes with precise definitions of disease activity and response to therapies.	[Lin, Chen; Miller, Timothy A.; Dligach, Dmitriy; Chen, Pei Jun; Savova, Guergana K.] Boston Childrens Hosp, Informat Program, Boston, MA USA; [Karlson, Elizabeth W.; Perez, Raul Natanael Guzman; Weinblatt, Michael E.; Shadick, Nancy A.; Plenge, Robert M.] Brigham & Womens Hosp, Dept Rheumatol & Immunol, Boston, MA 02115 USA; [Karlson, Elizabeth W.; Miller, Timothy A.; Dligach, Dmitriy; Weinblatt, Michael E.; Shadick, Nancy A.; Plenge, Robert M.; Savova, Guergana K.] Harvard Univ, Sch Med, Boston, MA USA; [Canhao, Helena] Univ Lisbon, Fac Med, Inst Mol Med, Rheumatol Res Unit, P-1699 Lisbon, Portugal; [Shen, Yuanyan] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Universidade de Lisboa; Harvard University; Harvard T.H. Chan School of Public Health	Lin, C (corresponding author), Boston Childrens Hosp, Informat Program, Boston, MA USA.	Chen.lin@childrens.harvard.edu	Canhao, Helena/C-9611-2018	Canhao, Helena/0000-0003-1894-4870; Canhao, Helena/0000-0002-3239-2809	NIH, NIH Pharmacogenomics Research Network (PGRN) [U01GM092691-01]; Bristol Myers Squibb; Mediummune; Crescendo Bioscience; Harvard-Portugal Program [HMSP-ICS/SAU-ICT/0002/2010]; Abbott; AMGEN; Genentech Pharmaceuticals;  [U54LM008748];  [R0149880];  [K240524030];  [P60477820]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092691] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [U54LM008748] Funding Source: NIH RePORTER	NIH, NIH Pharmacogenomics Research Network (PGRN)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bristol Myers Squibb(Bristol-Myers Squibb); Mediummune; Crescendo Bioscience; Harvard-Portugal Program; Abbott(Abbott Laboratories); AMGEN(Amgen); Genentech Pharmaceuticals(Roche HoldingGenentech); ; ; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by NIH grants: U01GM092691-01 (PI: Plenge), which is part of the NIH Pharmacogenomics Research Network (PGRN); U54LM008748 (PI: Kohane), R0149880 (PI: Karlson), K240524030 (PI: Karlson), and P60477820 (PI: Katz). BRASS registry is supported by grants from Bristol Myers Squibb, Mediummune and Crescendo Bioscience. HC was supported by a grant from Harvard-Portugal Program HMSP-ICS/SAU-ICT/0002/2010. NS received grant funding from Abbott, AMGEN and Genentech Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson AR, 2001, J AM MED INFORM ASSN, P17; Beigman E, 2009, LEARNING ANNOTATION, P280; Bejan CA, 2012, J AM MED INFORM ASS; Bishara A. J., 2012, PSYCHOL METHODS; Carroll RJ, 2012, J AM MED INFORM ASSN, V19, pE162, DOI 10.1136/amiajnl-2011-000583; Collier DS, 2009, ARTHRIT RHEUM-ARTHR, V61, P495, DOI 10.1002/art.24335; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Demner-Fushman D, 2009, J BIOMED INFORM, V42, P760, DOI 10.1016/j.jbi.2009.08.007; Fiszman M, 2000, J AM MED INFORM ASSN, V7, P593, DOI 10.1136/jamia.2000.0070593; Fiszman M, 1999, J AM MED INFORM ASSN, P67; Garla V, 2012, J BIOMEDICA IN PRESS; Goldberg D. E., 1989, GENETIC ALGORITHMS S; Greenwood P. E., 1996, GUIDE CHI SQUARED TE, V280; Hall M., 2009, SIGKDD EXPLOR, V11, P10, DOI [DOI 10.1145/1656274.1656278, 10.1145/1656274.1656278]; Hall M.A, 1999, CORRELATION BASED FE; Hastie T., 2009, ELEMENTS STAT LEARNI, Vxxii; Hripcsak G, 2005, J AM MED INFORM ASSN, V12, P296, DOI 10.1197/jamia.M1733; HRIPCSAK G, 1995, ANN INTERN MED, V122, P681, DOI 10.7326/0003-4819-122-9-199505010-00007; Iannaccone CK, 2011, RHEUMATOLOGY, V50, P40, DOI 10.1093/rheumatology/keq263; Joachims T., 1998, Machine Learning: ECML-98. 10th European Conference on Machine Learning. Proceedings, P137, DOI 10.1007/BFb0026683; John G. H., 1995, Uncertainty in Artificial Intelligence. Proceedings of the Eleventh Conference (1995), P338; Jurafsky D., 2009, SPEECH LANGUAGE PROC; Keerthi SS, 2001, NEURAL COMPUT, V13, P637, DOI 10.1162/089976601300014493; LECESSIE S, 1992, APPL STAT-J ROY ST C, V41, P191; Liao KP, 2010, ARTHRIT CARE RES, V62, P1120, DOI 10.1002/acr.20184; Lin C., 2012, ICML WORKSH MACH LEA; Ma S, 2008, BRIEF BIOINFORM, V9, P392, DOI 10.1093/bib/bbn027; Meystre S, 2006, J BIOMED INFORM, V39, P589, DOI 10.1016/j.jbi.2005.11.004; Mooijaart A, 2009, PSYCHOMETRIKA, V74, P443, DOI 10.1007/s11336-009-9112-5; Orme ME, 2012, BIOL-TARGETS THER, V6, P429, DOI 10.2147/BTT.S36707; Pierreisnard A, 2012, JOINT BONE SPINE; Platt J C, 1999, ADV KERNEL METHODS S; Quinlan J.R, 2014, C4 5 PROGRAMS MACHIN; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Savova GK, 2010, J AM MED INFORM ASSN, V17, P507, DOI 10.1136/jamia.2009.001560; Schmitz S, 2012, ANN RHEUM DIS, V71, P225, DOI 10.1136/annrheumdis-2011-200228; Singh Jasvinder A, 2012, J Manag Care Pharm, V18, pS1; Singh JA, 2012, ARTHRIT CARE RES, V64, P625, DOI 10.1002/acr.21641; SMOLEN JS, 1995, ARTHRITIS RHEUM, V38, P38, DOI 10.1002/art.1780380106; Ustun B, 2006, CHEMOMETR INTELL LAB, V81, P29, DOI 10.1016/j.chemolab.2005.09.003; Uzuner O, 2009, J AM MED INFORM ASSN, V16, P561, DOI 10.1197/jamia.M3115; VANDERHEIJDE DMFM, 1990, ANN RHEUM DIS, V49, P916, DOI 10.1136/ard.49.11.916; VANDERHEIJDE DMFM, 1993, J RHEUMATOL, V20, P579; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; Witten I. H., 2005, DATA MINING PRACTICA; Yang Y, 1997, ICML, P412, DOI DOI 10.1093/BI0INF0RMATICS/BTH267; Zhao Z, 2010, TR10007	48	26	27	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e69932	10.1371/journal.pone.0069932	http://dx.doi.org/10.1371/journal.pone.0069932			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	207BA	23976944	gold, Green Published			2022-12-25	WOS:000323570200003
J	Villegas-Amtmann, S; Jeglinski, JWE; Costa, DP; Robinson, PW; Trillmich, F				Villegas-Amtmann, Stella; Jeglinski, Jana W. E.; Costa, Daniel P.; Robinson, Patrick W.; Trillmich, Fritz			Individual Foraging Strategies Reveal Niche Overlap between Endangered Galapagos Pinnipeds	PLOS ONE			English	Article							NORTHERN FUR SEALS; INTRA-SPECIFIC COMPETITION; INTERSPECIFIC COMPETITION; CALLORHINUS-URSINUS; CHINSTRAP PENGUINS; OXYGEN STORES; LIONS; BEHAVIOR; DIET; PREY	Most competition studies between species are conducted from a population-level approach. Few studies have examined inter-specific competition in conjunction with intra-specific competition, with an individual-based approach. To our knowledge, none has been conducted on marine top predators. Sympatric Galapagos fur seals (Arctocephalus galapagoensis) and sea lions (Zalophus wollebaeki) share similar geographic habitats and potentially compete. We studied their foraging niche overlap at Cabo Douglas, Fernandina Island from simultaneously collected dive and movement data to examine spatial and temporal inter-and intra-specific competition. Sea lions exhibited 3 foraging strategies (shallow, intermediate and deep) indicating intra-specific competition. Fur seals exhibited one foraging strategy, diving predominantly at night, between 0-80 m depth and mostly at 19-22 h. Most sea lion dives also occurred at night (63%), between 0-40 m, within fur seals' diving depth range. 34% of sea lions night dives occurred at 19-22 h, when fur seals dived the most, but most of them occurred at dawn and dusk, when fur seals exhibited the least amount of dives. Fur seals and sea lions foraging behavior overlapped at 19 and 21 h between 0-30 m depths. Sea lions from the deep diving strategy exhibited the greatest foraging overlap with fur seals, in time (19 h), depth during overlapping time (21-24 m), and foraging range (37.7%). Fur seals foraging range was larger. Cabo Douglas northwest coastal area, region of highest diving density, is a foraging "hot spot" for both species. Fur seals and sea lions foraging niche overlap occurred, but segregation also occurred; fur seals primarily dived at night, while sea lions exhibited night and day diving. Both species exploited depths and areas exclusive to their species. Niche breadth generally increases with environmental uncertainty and decreased productivity. Potential competition between these species could be greater during warmer periods when prey availability is reduced.	[Villegas-Amtmann, Stella; Jeglinski, Jana W. E.; Trillmich, Fritz] Univ Bielefeld, Dept Behav Biol, D-33615 Bielefeld, North Rhine Wes, Germany; [Villegas-Amtmann, Stella; Costa, Daniel P.; Robinson, Patrick W.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA	University of Bielefeld; University of California System; University of California Santa Cruz	Villegas-Amtmann, S (corresponding author), Univ Bielefeld, Dept Behav Biol, D-33615 Bielefeld, North Rhine Wes, Germany.	stella.villegas@gmail.com	Costa, Daniel/E-2616-2013	Costa, Daniel/0000-0002-0233-5782	German Science Foundation [TR 105/19-1]; National Geographic [8682-09]; Office of Naval Research [N00014-08-1-1195]; E&P Sound and Marine Life Joint Industry Project of the International Association of Oil and Gas Producers; UC Santa Cruz Open Access Fund	German Science Foundation(German Research Foundation (DFG)); National Geographic(National Geographic Society); Office of Naval Research(Office of Naval Research); E&P Sound and Marine Life Joint Industry Project of the International Association of Oil and Gas Producers; UC Santa Cruz Open Access Fund	This work was funded by the German Science Foundation (grant No TR 105/19-1), National Geographic (grant No 8682-09), the Office of Naval Research grant N00014-08-1-1195 and the E&P Sound and Marine Life Joint Industry Project of the International Association of Oil and Gas Producers. Funding for Open Access provided by the UC Santa Cruz Open Access Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONELIS GA, 1990, CAN J ZOOL, V68, P150, DOI 10.1139/z90-022; Aumann T, 2001, WILDLIFE RES, V28, P379, DOI 10.1071/WR99092; Aurioles D., 2008, ZALOPHUS WOLLEBAEKI; Aurioles-Gamboa David, 2007, Aquatic Mammals, V33, P315, DOI 10.1578/AM.33.3.2007.315; Barlow KE, 2002, MAR BIOL, V140, P205, DOI 10.1007/s00227-001-0691-7; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; Begon M, 1996, POPULATION ECOLOGY U; Blanchet MA, 2013, MAR ECOL PROG SER, V477, P285, DOI 10.3354/meps10110; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Calder WA., 1984, SIZE FUNCTION LIFE H; Chase JM, 2002, ECOL LETT, V5, P302, DOI 10.1046/j.1461-0248.2002.00315.x; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CLARKE MR, 1980, J ZOOL, V190, P211, DOI 10.1111/j.1469-7998.1980.tb07767.x; Cody M. L., 1975, ECOLOGY EVOLUTION CO; Costa Daniel P., 1993, Symposia of the Zoological Society of London, V66, P293; Costa DP, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P344; Costa DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008677; COSTA DP, 1991, AM ZOOL, V31, P111; Costa DP, 2003, ECOL MONOGR, V73, P27, DOI 10.1890/0012-9615(2003)073[0027:EOABDS]2.0.CO;2; Costa DP, 2004, INT CONGR SER, V1275, P359, DOI 10.1016/j.ics.2004.08.058; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; Dellinger T, 1999, CAN J ZOOL, V77, P1204, DOI 10.1139/cjz-77-8-1204; Edwards JW, 1998, J WILDLIFE MANAGE, V62, P354, DOI 10.2307/3802299; Friedlaender AS, 2011, DEEP-SEA RES PT II, V58, P1729, DOI 10.1016/j.dsr2.2010.11.018; Himes JG, 2003, J HERPETOL, V37, P126, DOI 10.1670/0022-1511(2003)037[0126:IAICAT]2.0.CO;2; Horning M, 1997, BEHAVIOUR, V134, P1211, DOI 10.1163/156853997X00133; Horning M, 1999, P ROY SOC B-BIOL SCI, V266, P1127, DOI 10.1098/rspb.1999.0753; Hutchinson G.E., 1978, INTRO POPULATION ECO; Jeglinski JWE, 2013, J ANIM ECOL, V82, P694, DOI 10.1111/1365-2656.12019; Jeglinski JWE, 2013, J ANIM ECOL; Johannesen E, 2003, ANN ZOOL FENN, V40, P35; Kooijman S.A.L.M., 2010, DYNAMIC ENERGY BUDGE; Kooyman G.L., 1986, P186; Kooyman G.L, 1986, DIVING BEHAV GALAPAG; KREBS RA, 1991, AUST J ZOOL, V39, P579, DOI 10.1071/ZO9910579; KUHN CE, 2006, MEASURING FEEDING RA; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; MARTIN JH, 1994, NATURE, V371, P123, DOI 10.1038/371123a0; Miller AK, 2010, CONDOR, V112, P683, DOI 10.1525/cond.2010.090221; Morin P., 1999, COMMUNITY ECOL; Paez-Rosas D, 2012, J EXP MAR BIOL ECOL, V424, P44, DOI 10.1016/j.jembe.2012.05.001; Paez-Rosas D, 2010, MAR BIOL, V157, P2769, DOI 10.1007/s00227-010-1535-0; Pegg J, 2011, FISH RES, V112, P8, DOI 10.1016/j.fishres.2011.08.003; Ronconi RA, 2011, CAN J ZOOL, V89, P356, DOI 10.1139/Z11-006; Roughgarden J, 1986, COMMUNITY ECOL, P333; Sakamoto CM, 1998, DEEP-SEA RES PT II, V45, P1055, DOI 10.1016/S0967-0645(98)00013-7; SALAZAR SK, 2005, VARIACION TEMPORAL E; Schmitt RJ, 2003, ECOL LETT, V6, P898, DOI 10.1046/j.1461-0248.2003.00514.x; SCHOLANDER PF, 1950, BIOL BULL, V99, P237, DOI 10.2307/1538741; Schwartzlose RA, 1999, S AFR J MARINE SCI, V21, P289; Spitz J, 2006, ESTUAR COAST SHELF S, V70, P259, DOI 10.1016/j.ecss.2006.04.020; Szteren Diana, 2004, Latin American Journal of Aquatic Mammals, V3, P119; Tremblay Y, 2003, MAR ECOL PROG SER, V251, P279, DOI 10.3354/meps251279; Trillmich F., 1986, P196; Trillmich F., 1986, P168; Trillmich F., 1991, EFFECTS EL NINO PINN; TRIVELPIECE WZ, 1987, ECOLOGY, V68, P351, DOI 10.2307/1939266; Villegas-Amtmann S, 2008, MAR ECOL PROG SER, V363, P299, DOI 10.3354/meps07457; Villegas-Amtmann S, 2010, FUNCT ECOL, V24, P785, DOI 10.1111/j.1365-2435.2009.01685.x; Waite JN, 2012, CAN J ZOOL, V90, P110, DOI 10.1139/Z11-117; Waite JN, 2012, J EXP MAR BIOL ECOL, V416, P41, DOI 10.1016/j.jembe.2012.02.009; Weise MJ, 2007, J EXP BIOL, V210, P278, DOI 10.1242/jeb.02643; Wilson RP, 2010, FUNCT ECOL, V24, P646, DOI 10.1111/j.1365-2435.2009.01654.x; Wolf JBW, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-150; Young HS, 2010, MAR ECOL PROG SER, V416, P285, DOI 10.3354/meps08756	66	30	30	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e70748	10.1371/journal.pone.0070748	http://dx.doi.org/10.1371/journal.pone.0070748			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967096	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000323378000014
J	Aravindan, S; Natarajan, M; Awasthi, V; Herman, TS; Aravindan, N				Aravindan, Sheeja; Natarajan, Mohan; Awasthi, Vibhudutta; Herman, Terence S.; Aravindan, Natarajan			Novel Synthetic Monoketone Transmute Radiation-Triggered NF kappa B-Dependent TNF alpha Cross-Signaling Feedback Maintained NF kappa B and Favors Neuroblastoma Regression	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; ANTICANCER ACTIVITY; INDUCED APOPTOSIS; CANCER-CELLS; CURCUMIN; INHIBITION; RATS; SENSITIZATION; IRRADIATION; RELAPSE	Recently, we demonstrated that radiation (IR) instigates the occurrence of a NF kappa B-TNF alpha feedback cycle which sustains persistent NF kappa B activation in neuroblastoma (NB) cells and favors survival advantage and clonal expansion. Further, we reported that curcumin targets IR-induced survival signaling and NF kappa B dependent hTERT mediated clonal expansion in human NB cells. Herein, we investigated the efficacy of a novel synthetic monoketone, EF24, a curcumin analog in inhibiting persistent NF kappa B activation by disrupting the IR-induced NF kappa B-TNF alpha-NF kappa B feedback signaling in NB and subsequent mitigation of survival advantage and clonal expansion. EF24 profoundly suppressed the IR-induced NF kappa B-DNA binding activity/promoter activation and, maintained the NF kappa B repression by deterring NF kappa B-dependent TNF alpha transactivation/intercellular secretion in genetically varied human NB (SH-SY5Y, IMR-32, SK-PN-DW, MC-IXC and SK-N-MC) cell types. Further, EF24 completely suppressed IR-induced NF kappa B-TNF alpha cross-signaling dependent transactivation/translation of pro-survival IAP1, IAP2 and Survivin and subsequent cell survival. In corroboration, EF24 treatment maximally blocked IR-induced NF kappa B dependent hTERT transactivation/promoter activation, telomerase activation and consequent clonal expansion. EF24 displayed significant regulation of IR-induced feedback dependent NF kappa B and NF kappa B mediated survival signaling and complete regression of NB xenograft. Together, the results demonstrate for the first time that, novel synthetic monoketone EF24 potentiates radiotherapy and mitigates NB progression by selectively targeting IR-triggered NF kappa B-dependent TNF alpha-NF kappa B cross-signaling maintained NF kappa B mediated survival advantage and clonal expansion.	[Aravindan, Sheeja; Herman, Terence S.; Aravindan, Natarajan] Univ Oklahoma, Hlth Sci Ctr, Dept Radiat Oncol, Oklahoma City, OK 73190 USA; [Aravindan, Sheeja] Annamalai Univ, Ctr Adv Study, Parangipettai, Tamil Nadu, India; [Aravindan, Sheeja] Stephenson Canc Ctr, Oklahoma City, OK USA; [Natarajan, Mohan] Univ Texas San Antonio, Hlth Sci Ctr, Dept Pathol, San Antonio, TX 78284 USA; [Awasthi, Vibhudutta] Univ Oklahoma, Hlth Sci Ctr, Dept Pharmaceut Sci, Oklahoma City, OK USA; [Aravindan, Natarajan] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; [Aravindan, Natarajan] Univ Oklahoma, Hlth Sci Ctr, Dept Anesthesiol, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Annamalai University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas Health San Antonio; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Aravindan, N (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Radiat Oncol, Oklahoma City, OK 73190 USA.	naravind@ouhsc.edu	Aravindan, Natarajan/M-3203-2013	Aravindan, Natarajan/0000-0001-9150-3911; Aravindan, Sheeja/0000-0002-4810-789X	National Institutes of Health [COBRE-P20-PAR-09-079-PJI, R01 CA112175]; American Cancer Society [ACS-IRG-05-066-01]; U.S. Department of Energy [DE-FG02-03ER63449]; NATIONAL CANCER INSTITUTE [R01CA112175] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Institutes of Health (COBRE-P20-PAR-09-079-PJI), American Cancer Society (Grant ACS-IRG-05-066-01), National Institutes of Health (Grant R01 CA112175) and U.S. Department of Energy Grant DE-FG02-03ER63449. The funders had no role in study design, data collection and analysis.	Abal M, 2006, HISTOL HISTOPATHOL, V21, P197, DOI 10.14670/HH-21.197; Adams BK, 2005, ANTI-CANCER DRUG, V16, P263, DOI 10.1097/00001813-200503000-00005; Adams BK, 2004, BIOORGAN MED CHEM, V12, P3871, DOI 10.1016/j.bmc.2004.05.006; Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Aravindan N, 2008, CANCER BIOL THER, V7, P569, DOI 10.4161/cbt.7.4.5534; Aravindan N, 2008, MOL CELL BIOCHEM, V310, P167, DOI 10.1007/s11010-007-9678-0; Aravindan N, 2007, MOL CELL BIOCHEM, V302, P51, DOI 10.1007/s11010-007-9424-7; Aravindan N, 2011, INT J RADIAT ONCOL, V79, P1206, DOI 10.1016/j.ijrobp.2010.10.058; Aravindan N, 2009, J CELL BIOCHEM, V106, P999, DOI 10.1002/jcb.22079; BIELAMOWICZ SA, 1994, HEAD NECK-J SCI SPEC, V16, P383, DOI 10.1002/hed.2880160415; Bolignano D, 2010, CANCER LETT, V288, P10, DOI 10.1016/j.canlet.2009.05.027; BRONNER G, 1994, NATURE, V369, P664, DOI 10.1038/369664a0; Calaf GM, 2011, ONCOL REP, V26, P1029, DOI 10.3892/or.2011.1386; CASTLEBERRY RP, 1991, J CLIN ONCOL, V9, P789, DOI 10.1200/JCO.1991.9.5.789; Chuah TL, 2012, INT J ONCOL, V40, P1963, DOI 10.3892/ijo.2012.1409; DELAMAZA MS, 1994, OPHTHALMOLOGY, V101, P1281; Gao Ren-li, 2011, Chinese Journal of Pathology, V40, P775, DOI 10.3760/cma.j.issn.0529-5807.2011.11.014; Giagkousiklidis S, 2005, CANCER RES, V65, P10502, DOI 10.1158/0008-5472.CAN-05-0866; HENDERSON AS, 1994, BRIT J PSYCHIAT, V165, P273, DOI 10.1192/bjp.165.2.273b; IKEDA H, 1992, J PEDIATR SURG, V27, P1438, DOI 10.1016/0022-3468(92)90195-D; JACCARD A, 1994, AM J HEMATOL, V46, P256, DOI 10.1002/ajh.2830460329; JACINTO SM, 1994, ANN NY ACAD SCI, V723, P345, DOI 10.1111/j.1749-6632.1994.tb36743.x; JACINTO SM, 1994, ANN NY ACAD SCI, V723, P349, DOI 10.1111/j.1749-6632.1994.tb36744.x; JACK RM, 1994, J IMMUNOL, V153, P262; Kamer S, 2009, ARCH GYNECOL OBSTET, V279, P41, DOI 10.1007/s00404-008-0667-7; Kasinski AL, 2008, MOL PHARMACOL, V74, P654, DOI 10.1124/mol.108.046201; Kaushal M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043789; Kenny SL, 2012, AM J SURG PATHOL, V36, P799, DOI 10.1097/PAS.0b013e31824a72c6; Kwon O, 2006, CARCINOGENESIS, V27, P2258, DOI 10.1093/carcin/bgl097; Liu Zheng-cao, 2010, Chinese Journal of Pathology, V39, P338, DOI 10.3760/cma.j.issn.0529-5807.2010.05.010; Madhusoodhanan R, 2009, J RADIAT RES, V50, P311, DOI 10.1269/jrr.08110; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Maroni P, 2007, CARCINOGENESIS, V28, P267, DOI 10.1093/carcin/bgl129; MATTHAY KK, 1993, J CLIN ONCOL, V11, P2226, DOI 10.1200/JCO.1993.11.11.2226; MCGINN CJ, 1992, SEMIN ONCOL, V19, P21; Natarajan M, 2002, RADIAT ENVIRON BIOPH, V41, P139, DOI 10.1007/s00411-002-0143-x; RAVINDRANATH V, 1980, TOXICOLOGY, V16, P259, DOI 10.1016/0300-483X(80)90122-5; Saab MB, 2011, J BIOPHOTONICS, V4, P533, DOI 10.1002/jbio.201000119; Scherbakov AM, 2009, STEROIDS, V74, P535, DOI 10.1016/j.steroids.2009.02.003; Subramaniam D, 2008, CANCER RES, V68, P1962, DOI 10.1158/0008-5472.CAN-07-6011; Sun XN, 2012, INT J RADIAT ONCOL, V84, P1212, DOI 10.1016/j.ijrobp.2012.01.092; Veeraraghavan J, 2011, J BIOL CHEM, V286, P21588, DOI 10.1074/jbc.M110.193755; Weng HR, 2005, NEUROSCI LETT, V386, P18, DOI 10.1016/j.neulet.2005.05.049; Wu LX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018447; Yin L, 2000, J BIOL CHEM, V275, P36671, DOI 10.1074/jbc.M007378200; Zhang CZ, 2011, INT J RADIAT ONCOL, V80, P240, DOI 10.1016/j.ijrobp.2010.12.049; Zhang F, 2011, J PHARM SCI-US, V100, P2778, DOI 10.1002/jps.22512	48	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e72464	10.1371/journal.pone.0072464	http://dx.doi.org/10.1371/journal.pone.0072464			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967300	Green Submitted, Green Published, gold			2022-12-25	WOS:000323221500130
J	Rodger, IW; Dilar, D; Dwyer, J; Bienenstock, J; Coret, A; Coret-Simon, J; Foster, G; Franchetto, A; Franic, S; Goldsmith, CH; Koff, D; Konyer, NB; Levine, M; McDonald, E; Noseworthy, MD; Paulseth, J; Ribeiro, L; Sayles, MJ; Thabane, L				Rodger, Ian W.; Dilar, Dorothy; Dwyer, Janet; Bienenstock, John; Coret, Andu; Coret-Simon, Judith; Foster, Gary; Franchetto, Arlene; Franic, Slobodan; Goldsmith, Charles H.; Koff, David; Konyer, Norman B.; Levine, Mitchell; McDonald, Ellen; Noseworthy, Michael D.; Paulseth, John; Ribeiro, Luciana; Sayles, Mary Jane; Thabane, Lehana			Evidence against the Involvement of Chronic Cerebrospinal Venous Abnormalities in Multiple Sclerosis. A Case-Control Study	PLOS ONE			English	Article							DIAGNOSTIC-CRITERIA; MEDICAL PROGRESS; INSUFFICIENCY; DOPPLER; CCSVI; FLOW; MRI; MS	Objective: Multiple sclerosis (MS) is a chronic neurodegenerative disease of the CNS. Recently a controversial vascular hypothesis for MS, termed chronic cerebrospinal venous insufficiency (CCSVI), has been advanced. The objective of this study was to evaluate the relative prevalence of the venous abnormalities that define CCSVI. Methods: A case-control study was conducted in which 100 MS patients aged between 18-65 y meeting the revised McDonald criteria were randomly selected and stratified into one of four MS subtypes: relapsing/remitting, secondary progressive, primary progressive and benign. Control subjects (16-70 y) with no known history of MS or other neurological condition were matched with the MS cases. All cases and controls underwent ultrasound imaging of the veins of the neck plus the deep cerebral veins, and magnetic resonance imaging of the neck veins and brain. These procedures were performed on each participant on the same day. Results: On ultrasound we found no evidence of reflux, stenosis or blockage in the internal jugular veins (IJV) or vertebral veins (VV) in any study participant. Similarly, there was no evidence of either reflux or cessation of flow in the deep cerebral veins in any subject. Flow was detected in the IJV and VV in all study participants. Amongst 199 participants there was one MS subject who fulfilled the minimum two ultrasound criteria for CCSVI. Using MRI we found no significant differences in either the intra- or extra-cranial venous flow velocity or venous architecture between cases and controls. Conclusion: This case-control study provides compelling evidence against the involvement of CCSVI in multiple sclerosis.	[Rodger, Ian W.; Bienenstock, John] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Levine, Mitchell; Thabane, Lehana] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Noseworthy, Michael D.] McMaster Univ, Dept Elect & Comp Engn, Hamilton, ON, Canada; [Bienenstock, John] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Paulseth, John] McMaster Univ, Dept Neurol, Hamilton, ON, Canada; [Koff, David] McMaster Univ, Dept Radiol, Hamilton, ON, Canada; [Franchetto, Arlene; Ribeiro, Luciana] Hamilton Hlth Sci, Diagnost Imaging, Hamilton, ON, Canada; [McDonald, Ellen] Hamilton Hlth Sci, Clin Res, Hamilton, ON, Canada; [Dilar, Dorothy; Dwyer, Janet; Coret, Andu; Coret-Simon, Judith; Franic, Slobodan] St Josephs Healthcare, Diagnost Imaging, Hamilton, ON, Canada; [Foster, Gary] St Josephs Healthcare, Biostat, Hamilton, ON, Canada; [Sayles, Mary Jane] St Josephs Healthcare, Res Adm, Hamilton, ON, Canada; [Konyer, Norman B.; Noseworthy, Michael D.] St Josephs Healthcare, Imaging Res Ctr, Hamilton, ON, Canada; [Goldsmith, Charles H.] Simon Fraser Univ, Fac Hlth Sci, Vancouver, BC, Canada	McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; Simon Fraser University	Rodger, IW (corresponding author), McMaster Univ, Dept Med, Hamilton, ON, Canada.	rodgeri@mcmaster.ca	Noseworthy, Michael/B-2957-2011	Noseworthy, Michael/0000-0003-1464-159X	Harrison McCain Foundation; W Garfield Weston Foundation; Charity Intelligence; St Joseph's Healthcare Foundation	Harrison McCain Foundation; W Garfield Weston Foundation; Charity Intelligence; St Joseph's Healthcare Foundation	This study was funded entirely by private donations. These came from the Harrison McCain Foundation, the W Garfield Weston Foundation, Charity Intelligence, the St Joseph's Healthcare Foundation, and individuals in the community. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baracchini C, 2011, NEUROLOGY, V77, P844, DOI 10.1212/WNL.0b013e31822c6208; Baracchini C, 2013, NEUROL SCI, V34, P269, DOI 10.1007/s10072-012-1101-2; Baracchini C, 2012, J NEUROL, V259, P2585, DOI 10.1007/s00415-012-6541-3; Barreto AD, 2013, ANN NEUROL, V73, P721, DOI 10.1002/ana.23839; Bergan JJ, 2006, NEW ENGL J MED, V355, P488, DOI 10.1056/NEJMra055289; Blinkenberg M, 2012, ACTA NEUROL SCAND, V126, P421, DOI 10.1111/j.1600-0404.2012.01671.x; Chambers B, 2013, MULT SCLER J, V19, P749, DOI 10.1177/1352458512459986; Doepp F, 2011, NEUROLOGY, V77, P1745, DOI 10.1212/WNL.0b013e318236f0ea; Doepp F, 2010, ANN NEUROL, V68, P173, DOI 10.1002/ana.22085; Farb RI, 2001, RADIOLOGY, V220, P244, DOI 10.1148/radiology.220.1.r01jn15244; Fox RJ, 2011, CAN MED ASSOC J, V183, P1824, DOI 10.1503/cmaj.111506; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Imperiale D, 2013, CLIN NEUROL NEUROSUR, DOI [10.1016/j.clineuro.2013.01.003, DOI 10.1016/J.CLINEUR0.2013.01.003]; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lanzillo R, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-20; Laupacis A, 2011, CAN MED ASSOC J, V183, pE1203, DOI 10.1503/cmaj.111074; Leone MA, 2013, PLOS ONE, DOI [10.1371/journal.-pone.0056031, DOI 10.1371/J0URNAL.-P0NE.0056031]; Mayer C, 2011, INT J CLIN REV, V12, P04; Mayer CA, 2011, J NEUROL NEUROSUR PS, V82, P436, DOI 10.1136/jnnp.2010.231613; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; SAS Institute Inc, 2008, SAS VERS 9 2; SCHELLING F, 1986, MED HYPOTHESES, V21, P141, DOI 10.1016/0306-9877(86)90003-4; Singh AV, 2009, J CEREBR BLOOD F MET, V29, P1867, DOI 10.1038/jcbfm.2009.180; Sundstrom P, 2010, ANN NEUROL, V68, P255, DOI 10.1002/ana.22132; Valdueza JM, 2013, J CEREBR BLOOD F MET, V33, P657, DOI 10.1038/jcbfm.2013.31; Van den Berg PJ, 2012, PHLEBOLOGY, V27, P107, DOI [10.1258/phleb.2011.012s04, 10.1258/phleb.2011.012S04]; Wahlin A, 2012, J MAGN RESON IMAGING, V35, P1055, DOI 10.1002/jmri.23527; Wattjes MP, 2011, J NEUROL NEUROSUR PS, V82, P429, DOI 10.1136/jnnp.2010.223479; Yamout B, 2010, MULT SCLER, V16, P1341, DOI 10.1177/1352458510385268; Zamboni P, 2009, J NEUROL NEUROSUR PS, V80, P392, DOI 10.1136/jnnp.2008.157164; Zamboni P, 2009, FUNCT NEUROL, V24, P133; Zamboni P, 2009, J VASC SURG, V50, P1348, DOI 10.1016/j.jvs.2009.07.096; Zamboni P, 2009, J NEUROL SCI, V282, P21, DOI 10.1016/j.jns.2008.11.027; Zivadinov R, 2011, NEUROLOGY, V77, P138, DOI 10.1212/WNL.0b013e318212a901	36	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e72495	10.1371/journal.pone.0072495	http://dx.doi.org/10.1371/journal.pone.0072495			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967312	gold, Green Published, Green Submitted			2022-12-25	WOS:000323221500136
J	Snelling, EP; Becker, CL; Seymour, RS				Snelling, Edward P.; Becker, Christie L.; Seymour, Roger S.			The Effects of Temperature and Body Mass on Jump Performance of the Locust Locusta migratoria	PLOS ONE			English	Article								Locusts jump by rapidly releasing energy from cuticular springs built into the hind femur that deform when the femur muscle contracts. This study is the first to examine the effect of temperature on jump energy at each life stage of any orthopteran. Ballistics and high-speed cinematography were used to quantify the energy, distance, and take-off angle of the jump at 15, 25, and 35 degrees C in the locust Locusta migratoria. Allometric analysis across the five juvenile stages at 35 degrees C reveals that jump distance (D; m) scales with body mass (M; g) according to the power equation D = 0.35M(0.17 +/- 0.08) ((95%CI)), jump take-off angle (A; degrees) scales as A = 52.5M(0.00 +/- 0.06), and jump energy (E; mJ per jump) scales as E = 1.91M(1.14 +/- 0.09). Temperature has no significant effect on the exponent of these relationships, and only a modest effect on the elevation, with an overall Q(10) of 1.08 for jump distance and 1.09 for jump energy. On average, adults jump 87% farther and with 74% more energy than predicted based on juvenile scaling data. The positive allometric scaling of jump distance and jump energy across the juvenile life stages is likely facilitated by the concomitant relative increase in the total length (Lf+t; mm) of the femur and tibia of the hind leg, Lf+t = 34.9M(0.37 +/- 0.02). The weak temperature-dependence of jump performance can be traced to the maximum tension of the hind femur muscle and the energy storage capacity of the femur's cuticular springs. The disproportionately greater jump energy and jump distance of adults is associated with relatively longer (12%) legs and a relatively larger (11%) femur muscle cross-sectional area, which could allow more strain loading into the femur's cuticular springs. Augmented jump performance in volant adult locusts achieves the take-off velocity required to initiate flight.	[Snelling, Edward P.; Becker, Christie L.; Seymour, Roger S.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia	University of Adelaide	Snelling, EP (corresponding author), Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia.	edward.snelling@adelaide.edu.au			University of Adelaide	University of Adelaide	This study was financially assisted by the University of Adelaide. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETCLARK HC, 1979, J EXP BIOL, V82, P105; BENNETCLARK HC, 1975, J EXP BIOL, V63, P53; BENNETT AF, 1985, J EXP BIOL, V115, P333; BENNETT AF, 1984, AM J PHYSIOL, V247, pR217, DOI 10.1152/ajpregu.1984.247.2.R217; Burrows M, 2011, J EXP BIOL, V214, P2362, DOI 10.1242/jeb.056689; Calder WAI., 1996, SIZE FUNCTION LIFE H; Chown S.L., 2004, INSECT PHYSL ECOLOGY, DOI DOI 10.1002/joc.5086; Fleming PA, 2007, J EXP BIOL, V210, P1446, DOI 10.1242/jeb.02757; Forsman A, 1999, J EVOLUTION BIOL, V12, P869, DOI 10.1046/j.1420-9101.1999.00084.x; FULL RJ, 1990, J COMP PHYSIOL B, V160, P573, DOI 10.1007/BF00258985; GABRIEL JM, 1984, J ZOOL, V204, P533; GABRIEL JM, 1985, J EXP BIOL, V118, P327; HARRISON JF, 1991, PHYSIOL ZOOL, V64, P451, DOI 10.1086/physzool.64.2.30158185; Heinrich B., 1993, HOT BLOODED INSECTS; HEITLER WJ, 1977, J EXP BIOL, V66, P203; HEITLER WJ, 1977, J EXP BIOL, V67, P29; HEPBURN HR, 1974, J INSECT PHYSIOL, V20, P631, DOI 10.1016/0022-1910(74)90183-8; Hill A. V., 1950, Science Progress London, V38, P209; James RS, 2007, J EXP BIOL, V210, P923, DOI 10.1242/jeb.02731; KATZ SL, 1993, J EXP BIOL, V177, P81; Kirkton SD, 2006, ANIM BEHAV, V71, P925, DOI 10.1016/j.anbehav.2005.09.010; Lachenicht MW, 2010, J INSECT PHYSIOL, V56, P822, DOI 10.1016/j.jinsphys.2010.02.010; Lease HM, 2006, J EXP BIOL, V209, P3476, DOI 10.1242/jeb.02343; LIGHTON JRB, 1989, NATURE, V342, P174, DOI 10.1038/342174a0; QUEATHEM E, 1991, J INSECT PHYSIOL, V37, P129, DOI 10.1016/0022-1910(91)90098-K; QUEATHEM EJ, 1995, J ZOOL, V235, P605, DOI 10.1111/j.1469-7998.1995.tb01772.x; RALL JA, 1990, AM J PHYSIOL, V259, pR197, DOI 10.1152/ajpregu.1990.259.2.R197; SCOTT PD, 1976, J INSECT PHYSIOL, V22, P913, DOI 10.1016/0022-1910(76)90070-6; Snelling EP, 2012, J EXP BIOL, V215, P3324, DOI 10.1242/jeb.072975; Snelling EP, 2011, J EXP BIOL, V214, P3225, DOI 10.1242/jeb.058438; Snelling EP, 2011, J EXP BIOL, V214, P3218, DOI 10.1242/jeb.058420; WEISFOGH T, 1956, PHILOS T ROY SOC B, V239, P459, DOI 10.1098/rstb.1956.0008; Zar, 2011, BIOSTAT ANAL	33	8	8	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e72471	10.1371/journal.pone.0072471	http://dx.doi.org/10.1371/journal.pone.0072471			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967304	Green Published, Green Submitted, gold			2022-12-25	WOS:000323115800100
J	Franzosa, JA; Bugel, SM; Tal, TL; La Du, JK; Tilton, SC; Waters, KM; Tanguay, RL				Franzosa, Jill A.; Bugel, Sean M.; Tal, Tamara L.; La Du, Jane K.; Tilton, Susan C.; Waters, Katrina M.; Tanguay, Robert L.			Retinoic acid-dependent regulation of miR-19 expression elicits vertebrate axis defects	FASEB JOURNAL			English	Article						microRNAs; somitogenesis; zebrafish	LEFT-RIGHT ASYMMETRY; CYP26 ENZYMES; METABOLIZING ENZYME; MICRORNA EXPRESSION; GENOME DUPLICATION; SEGMENTATION; SKELETAL; SOMITOGENESIS; HINDBRAIN; CLUSTER	Retinoic acid (RA) is involved in multifarious and complex functions necessary for vertebrate development. RA signaling is reliant on strict enzymatic regulation of RA synthesis and metabolism. Improper spatiotemporal expression of RA during development can result in vertebrate axis defects. microRNAs (miRNAs) are also pivotal in orchestrating developmental processes. While mechanistic links between miRNAs and axial development are established, the role of miRNAs in regulating metabolic enzymes responsible for RA abundance during axis formation has yet to be elucidated. Our results uncovered a role of miR-19 family members in controlling RA metabolism through the regulation of CYP26A1 during vertebrate axis formation. Global miRNA expression profiling showed that developmental RA exposure suppressed the expression of miR-19 family members during zebrafish somitogenesis. A reporter assay confirmed that cyp26a1 is a bona fide target of miR-19 in vivo. Transient knockdown of miR-19 phenocopied axis defects caused by RA exposure. Exogenous miR-19 rescued the axis defects induced by RA exposure. Taken together, these results indicate that the teratogenic effects of RA exposure result, in part, from repression of miR-19 expression and subsequent misregulation of cyp26a1. This highlights a previously unidentified role of miR-19 in facilitating vertebrate axis development via regulation of RA signaling.	[Franzosa, Jill A.; Bugel, Sean M.; Tal, Tamara L.; La Du, Jane K.; Tanguay, Robert L.] Oregon State Univ, Dept Environm & Mol Toxicol, Corvallis, OR 97333 USA; [Franzosa, Jill A.; Bugel, Sean M.; Tal, Tamara L.; La Du, Jane K.; Tanguay, Robert L.] Oregon State Univ, Environm Hlth Sci Ctr, Corvallis, OR 97333 USA; [Tilton, Susan C.; Waters, Katrina M.] Pacific NW Natl Lab, Richland, WA USA	Oregon State University; Oregon State University; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Tanguay, RL (corresponding author), Oregon State Univ, Dept Environm & Mol Toxicol, 28645 East HWY 34, Corvallis, OR 97333 USA.	robert.tanguay@oregonstate.edu	Tal, Tamara/O-5414-2019	Tal, Tamara/0000-0001-8365-9385; Waters, Katrina/0000-0003-4696-5396	U.S. National Institute of Environmental Health Sciences (NIEHS) Environmental Health Sciences Core Center [P30 ES000210]; NIEHS [T32 ES007060, P42 ES016465]; Oregon State University Linus Pauling Institute; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210, T32ES007060, P42ES016465] Funding Source: NIH RePORTER	U.S. National Institute of Environmental Health Sciences (NIEHS) Environmental Health Sciences Core Center; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Oregon State University Linus Pauling Institute; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Leah Wehmas for her experimental and technical assistance. The authors are grateful to Cari Buchner, Carrie Barton, and the staff at the Sinnhuber Aquatic Research Laboratory (Oregon State University) for exemplary fish husbandry and technical expertise. The authors thank Dr. James Patton (Vanderbilt University, Nashville, TN, USA) for sharing the pCS2-GFP vector. The authors appreciate the critical comments on the manuscript provided by Britton Goodale, Katerine Saili, Michael Simonich, and R. L. T. laboratory members. This work was supported by U.S. National Institute of Environmental Health Sciences (NIEHS) Environmental Health Sciences Core Center grant P30 ES000210, NIEHS Training grant T32 ES007060, and an Oregon State University Linus Pauling Institute grant to R. L. T., and by NIEHS Superfund Basic Research Program grant P42 ES016465 to R. L. T. and K. M. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest. J.A.F., S. M. B., T. L. T., and R. L. T designed the research; J.A.F., S. M. B., J.K.L., and T. L. T. performed the research; S. C. T. and K. M. W. contributed analytic tools; J.A.F., S. M. B., T. L. T., S. C. T., K. M. W., and R. L. T. analyzed data; and J.A.F. and R. L. T. wrote the paper.	Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aulehla A, 2004, GENE DEV, V18, P2060, DOI 10.1101/gad.1217404; Aulehla A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000869; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonauer A, 2009, CELL CYCLE, V8, P3866, DOI 10.4161/cc.8.23.9994; Brend T, 2009, SEMIN CELL DEV BIOL, V20, P472, DOI 10.1016/j.semcdb.2008.11.009; Campo-Paysaa F, 2011, EVOL DEV, V13, P15, DOI 10.1111/j.1525-142X.2010.00452.x; Campo-Paysaa F, 2008, GENESIS, V46, P640, DOI 10.1002/dvg.20444; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chaulk SG, 2011, RNA BIOL, V8, P1105, DOI 10.4161/rna.8.6.17410; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Collins MD, 1999, ANNU REV PHARMACOL, V39, P399, DOI 10.1146/annurev.pharmtox.39.1.399; COOKE J, 1975, NATURE, V254, P196, DOI 10.1038/254196a0; Cordes R, 2004, DEVELOPMENT, V131, P1221, DOI 10.1242/dev.01030; Crist CG, 2009, P NATL ACAD SCI USA, V106, P13383, DOI 10.1073/pnas.0900210106; Darnell DK, 2006, DEV DYNAM, V235, P3156, DOI 10.1002/dvdy.20956; de Pontual L, 2011, NAT GENET, V43, P1026, DOI 10.1038/ng.915; Dequeant ML, 2008, NAT REV GENET, V9, P370, DOI 10.1038/nrg2320; Diez del Corral R, 2003, NEURON, V40, P65; Diez del Corral R, 2004, BIOESSAYS, V26, P857, DOI 10.1002/bies.20080; Dubrulle J, 2004, DEVELOPMENT, V131, P5783, DOI 10.1242/dev.01519; Duester Gregg, 2007, Birth Defects Research, V81, P84, DOI 10.1002/bdrc.20092; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Eckalbar WL, 2012, WIRES DEV BIOL, V1, P401, DOI 10.1002/wdev.34; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Emoto Y, 2005, DEV BIOL, V278, P415, DOI 10.1016/j.ydbio.2004.11.023; FELL HB, 1952, J PHYSIOL-LONDON, V116, P320, DOI 10.1113/jphysiol.1952.sp004708; Flynt AS, 2007, NAT GENET, V39, P259, DOI 10.1038/ng1953; Giampietro PF, 2009, ANN NY ACAD SCI, V1151, P38, DOI 10.1111/j.1749-6632.2008.03452.x; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Goljanek-Whysall K, 2011, P NATL ACAD SCI USA, V108, P11936, DOI 10.1073/pnas.1105362108; Halilagic A, 2007, DEV BIOL, V303, P362, DOI 10.1016/j.ydbio.2006.11.021; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; HE L, 2004, NAT REV GENET, V5, P522; He XJ, 2011, DEV BIOL, V357, P463, DOI 10.1016/j.ydbio.2011.07.014; Heimberg AM, 2008, P NATL ACAD SCI USA, V105, P2946, DOI 10.1073/pnas.0712259105; Hernandez RE, 2007, DEVELOPMENT, V134, P177, DOI 10.1242/dev.02706; Hoesel B, 2010, GENE EXPR PATTERNS, V10, P265, DOI 10.1016/j.gep.2010.06.002; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Hsu RJ, 2010, NUCLEIC ACIDS RES, V38, P4384, DOI 10.1093/nar/gkq148; Hu P, 2008, DEV DYNAM, V237, P3798, DOI 10.1002/dvdy.21801; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jevnaker AM, 2011, J CELL PHYSIOL, V226, P2257, DOI 10.1002/jcp.22562; Kawakami Y, 2005, NATURE, V435, P165, DOI 10.1038/nature03512; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee LMY, 2012, P NATL ACAD SCI USA, V109, P13668, DOI 10.1073/pnas.1200872109; Levin M, 2005, MECH DEVELOP, V122, P3, DOI 10.1016/j.mod.2004.08.006; Li N, 2011, DEVELOPMENT, V138, P1817, DOI 10.1242/dev.056697; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; LOHNES D, 1994, DEVELOPMENT, V120, P2723; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Mathew LK, 2007, J BIOL CHEM, V282, P35202, DOI 10.1074/jbc.M706640200; McGlinn E, 2009, P NATL ACAD SCI USA, V106, P18610, DOI 10.1073/pnas.0910374106; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Mishima Y, 2009, GENE DEV, V23, P619, DOI 10.1101/gad.1760209; Niederreither K, 2002, NAT GENET, V31, P84, DOI 10.1038/ng876; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; O'Rourke JR, 2007, DEV BIOL, V311, P359, DOI 10.1016/j.ydbio.2007.08.032; Pennimpede T, 2010, BIRTH DEFECTS RES A, V88, P883, DOI 10.1002/bdra.20709; Peterson KJ, 2009, BIOESSAYS, V31, P736, DOI 10.1002/bies.200900033; Pourquie O, 2011, CELL, V145, P650, DOI 10.1016/j.cell.2011.05.011; Rathjen T, 2009, FEBS LETT, V583, P1422, DOI 10.1016/j.febslet.2009.03.048; Raya A, 2004, CURR OPIN GENET DEV, V14, P575, DOI 10.1016/j.gde.2004.07.011; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Saga Y, 2001, NAT REV GENET, V2, P835, DOI 10.1038/35098552; Sakai Y, 2001, GENE DEV, V15, P213, DOI 10.1101/gad.851501; Sempere LF, 2006, J EXP ZOOL PART B, V306B, P575, DOI 10.1002/jez.b.21118; Shah AR, 2007, BIOINFORMATICS, V23, P906, DOI 10.1093/bioinformatics/btm031; Shkumatava A, 2009, GENE DEV, V23, P466, DOI 10.1101/gad.1745709; Sirbu IO, 2006, NAT CELL BIOL, V8, P271, DOI 10.1038/ncb1374; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; Spoorendonk KM, 2008, DEVELOPMENT, V135, P3765, DOI 10.1242/dev.024034; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Sweetman D, 2006, DEV DYNAM, V235, P2185, DOI 10.1002/dvdy.20881; Tal TL, 2012, FASEB J, V26, P1452, DOI 10.1096/fj.11-194464; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Thatcher JE, 2009, EXPERT OPIN DRUG MET, V5, P875, DOI 10.1517/17425250903032681; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Vermot J, 2005, SCIENCE, V308, P563, DOI 10.1126/science.1108363; Vermot J, 2005, NATURE, V435, P215, DOI 10.1038/nature03488; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; WILSON JG, 1953, AM J ANAT, V92, P189, DOI 10.1002/aja.1000920202; Woltering JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001396; Yekta S, 2008, NAT REV GENET, V9, P789, DOI 10.1038/nrg2400; Zakany J, 2001, CELL, V106, P207, DOI 10.1016/S0092-8674(01)00436-6; Zhang Z, 2011, DEV BIOL, V351, P254, DOI 10.1016/j.ydbio.2011.01.005	96	10	11	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2013	27	12					4866	4876		10.1096/fj.12-225524	http://dx.doi.org/10.1096/fj.12-225524			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	293UK	23975936	Green Published			2022-12-25	WOS:000329999000021
J	Spitali, P; van den Bergen, JC; Verhaart, IEC; Wokke, B; Janson, AAM; van den Eijnde, R; den Dunnen, JT; Laros, JFJ; Verschuuren, JJGM; 't Hoen, PAC; Aartsma-Rus, A				Spitali, Pietro; van den Bergen, Janneke C.; Verhaart, Ingrid E. C.; Wokke, Beatrijs; Janson, Anneke A. M.; van den Eijnde, Rani; den Dunnen, Johan T.; Laros, Jeroen F. J.; Verschuuren, Jan J. G. M.; 't Hoen, Peter A. C.; Aartsma-Rus, Annemieke			DMD transcript imbalance determines dystrophin levels	FASEB JOURNAL			English	Article						Duchenne muscular dystrophy; exon skipping; antisense oligonucleotides; transcript stability	DUCHENNE MUSCULAR-DYSTROPHY; MESSENGER-RNA; NONSENSE MUTATIONS; SKELETAL-MUSCLE; GENE; DISEASE; PTC124	Duchenne and Becker muscular dystrophies are caused by out-of-frame and in-frame mutations, respectively, in the dystrophin encoding DMD gene. Molecular therapies targeting the precursor-mRNA are in clinical trials and show promising results. These approaches will depend on the stability and expression levels of dystrophin mRNA in skeletal muscles and heart. We report that the DMD gene is more highly expressed in heart than in skeletal muscles, in mice and humans. The transcript mutated in the mdx mouse model shows a 5' to 3' imbalance compared with that of its wild-type counterpart and reading frame restoration via antisense-mediated exon skipping does not correct this event. We also report significant transcript instability in 22 patients with Becker dystrophy, clarifying the fact that transcript imbalance is not caused by premature nonsense mutations. Finally, we demonstrate that transcript stability, rather than transcriptional rate, is an important determinant of dystrophin protein levels in patients with Becker dystrophy. We suggest that the availability of the complete transcript is a key factor to determine protein abundance and thus will influence the outcome of mRNA-targeting therapies.	[Spitali, Pietro; Verhaart, Ingrid E. C.; den Dunnen, Johan T.; Laros, Jeroen F. J.; 't Hoen, Peter A. C.; Aartsma-Rus, Annemieke] Leiden Univ, Med Ctr, Dept Human Genet, NL-2300 RC Leiden, Netherlands; [van den Bergen, Janneke C.; Wokke, Beatrijs; Verschuuren, Jan J. G. M.] Leiden Univ, Med Ctr, Dept Neurol, NL-2300 RC Leiden, Netherlands; [Janson, Anneke A. M.; van den Eijnde, Rani] Prosensa Therapeut, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; BioMarin Pharmaceutical Inc.; Prosensa	Aartsma-Rus, A (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, POB 9600, NL-2300 RC Leiden, Netherlands.	a.m.rus@lumc.nl	dunnen, johan den/ABH-4228-2020; Hoen, Peter A 't/D-3950-2018; Verhaart, Ingrid/Y-2588-2018; Spitali, Pietro/Y-2948-2018	dunnen, johan den/0000-0002-6304-1710; Hoen, Peter A 't/0000-0003-4450-3112; Verhaart, Ingrid/0000-0001-7348-7989; Spitali, Pietro/0000-0003-2783-688X; Laros, Jeroen F.J./0000-0002-8715-7371; Verschuuren, Jan/0000-0002-4572-1501; Aartsma-Rus, Annemieke/0000-0003-1565-654X	Prinses Beatrix Foundation; ZonMw	Prinses Beatrix Foundation; ZonMw(Netherlands Organization for Health Research and Development)	The authors acknowledge Ron Wolterbeek for help with statistical analysis and Maarten van Iterson for helping with the Affy probe mapping. This work was supported by the Prinses Beatrix Foundation and ZonMw.	Aartsma-Rus A, 2004, GENE THER, V11, P1391, DOI 10.1038/sj.gt.3302313; Aartsma-Rus A, 2009, HUM MUTAT, V30, P293, DOI 10.1002/humu.20918; Arechavala-Gomeza V, 2007, HUM GENE THER, V18, P798, DOI 10.1089/hum.2006.061; Arechavala-Gomeza V, 2010, NEUROMUSCULAR DISORD, V20, P295, DOI 10.1016/j.nmd.2010.03.007; Bakay M, 2002, NEUROMUSCULAR DISORD, V12, pS125, DOI 10.1016/S0960-8966(02)00093-7; Bakay M, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-4; Bovolenta M, 2012, HUM MUTAT, V33, P572, DOI 10.1002/humu.22017; CHELLY J, 1990, CELL, V63, P1239, DOI 10.1016/0092-8674(90)90419-F; Chen YW, 2000, J CELL BIOL, V151, P1321, DOI 10.1083/jcb.151.6.1321; Finkel RS, 2010, J CHILD NEUROL, V25, P1158, DOI 10.1177/0883073810371129; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Hamed SA, 2006, AM J MED GENET B, V141B, P44, DOI 10.1002/ajmg.b.30234; Hamed SA, 2005, CLIN GENET, V68, P69, DOI 10.1111/j.1399-0004.2005.00455.x; Haslett JN, 2003, NEUROGENETICS, V4, P163, DOI 10.1007/s10048-003-0148-x; Haslett JN, 2002, P NATL ACAD SCI USA, V99, P15000, DOI 10.1073/pnas.192571199; Heemskerk H, 2009, ANN NY ACAD SCI, V1175, P71, DOI 10.1111/j.1749-6632.2009.04973.x; HOFFMAN EP, 1988, NEW ENGL J MED, V318, P1363, DOI 10.1056/NEJM198805263182104; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; Norwood FLM, 2009, BRAIN, V132, P3175, DOI 10.1093/brain/awp236; Pescatori M, 2007, FASEB J, V21, P1210, DOI 10.1096/fj.06-7285com; Spitali P, 2010, LAB INVEST, V90, P1396, DOI [10.1038/labinvest.2010.98, 10.1038/labinvest.labinvest201098]; Tennyson CN, 1996, NUCLEIC ACIDS RES, V24, P3059, DOI 10.1093/nar/24.15.3059; TENNYSON CN, 1995, NAT GENET, V9, P184, DOI 10.1038/ng0295-184; Tuffery-Giraud S, 2009, HUM MUTAT, V30, P934, DOI 10.1002/humu.20976; van Putten M, 2010, NEUROMUSCULAR DISORD, V20, P273, DOI 10.1016/j.nmd.2010.02.004; Verhaart I. E. C., 2012, PLOS CURR, V4, DOI 10.1371/currents.md.597d7 00f92eaa70de261ea0d91821377.; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756	27	19	20	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2013	27	12					4909	4916		10.1096/fj.13-232025	http://dx.doi.org/10.1096/fj.13-232025			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	293UK	23975932				2022-12-25	WOS:000329999000025
J	Ferreira, E; Porter, RM; Wehling, N; O'Sullivan, RP; Liu, FJ; Boskey, A; Estok, DM; Harris, MB; Vrahas, MS; Evans, CH; Wells, JW				Ferreira, Elisabeth; Porter, Ryan M.; Wehling, Nathalie; O'Sullivan, Regina P.; Liu, Fangjun; Boskey, Adele; Estok, Daniel M.; Harris, Mitchell B.; Vrahas, Mark S.; Evans, Christopher H.; Wells, James W.			Inflammatory Cytokines Induce a Unique Mineralizing Phenotype in Mesenchymal Stem Cells Derived from Human Bone Marrow	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; NONSPECIFIC ALKALINE-PHOSPHATASE; INORGANIC PYROPHOSPHATE; OSTEOBLASTS; DIFFERENTIATION; CALCIFICATION; CARTILAGE; MODEL; INTERLEUKIN-1-BETA; EXPRESSION	Bone marrow contains mesenchymal stem cells (MSCs) that can differentiate along multiple mesenchymal lineages. In this capacity they are thought to be important in the intrinsic turnover and repair of connective tissues while also serving as a basis for tissue engineering and regenerative medicine. However, little is known of the biological responses of human MSCs to inflammatory conditions. When cultured with IL-1 beta, marrow-derived MSCs from 8 of 10 human subjects deposited copious hydroxyapatite, in which authenticity was confirmed by Fourier transform infrared spectroscopy. Transmission electron microscopy revealed the production of fine needles of hydroxyapatite in conjunction with matrix vesicles. Alkaline phosphatase activity did not increase in response to inflammatory mediators, but PPi production fell, reflecting lower ectonucleotide pyrophosphatase activity in cells and matrix vesicles. Because PPi is the major physiological inhibitor of mineralization, its decline generated permissive conditions for hydroxyapatite formation. This is in contrast to MSCs treated with dexamethasone, where PPi levels did not fall and mineralization was fuelled by a large and rapid increase in alkaline phosphatase activity. Bone sialoprotein was the only osteoblast marker strongly induced by IL-1 beta; thus these cells do not become osteoblasts despite depositing abundant mineral. RT-PCR did not detect transcripts indicative of alternative mesenchymal lineages, including chondrocytes, myoblasts, adipocytes, ligament, tendon, or vascular smooth muscle cells. IL-1 beta phosphorylated multiple MAPKs and activated nuclear factor-kappa B (NF-kappa B). Certain inhibitors of MAPK and PI3K, but not NF-kappa B, prevented mineralization. The findings are of importance to soft tissue mineralization, tissue engineering, and regenerative medicine.	[Ferreira, Elisabeth; Porter, Ryan M.; O'Sullivan, Regina P.; Liu, Fangjun; Evans, Christopher H.; Wells, James W.] Beth Israel Deaconess Med Ctr, Ctr Adv Orthopaed Studies, Boston, MA 02215 USA; [Ferreira, Elisabeth; Porter, Ryan M.; Vrahas, Mark S.; Evans, Christopher H.; Wells, James W.] AO Fdn, Collaborat Res Ctr, CH-7270 Davos, Switzerland; [Wehling, Nathalie] Asklepios Stadtklin, Dept Surg, D-83646 Bad Tolz, Germany; [Boskey, Adele] Hosp Special Surg, New York, NY 10021 USA; [Estok, Daniel M.; Harris, Mitchell B.] Brigham & Womens Hosp, Dept Orthopaed Surg, Boston, MA 02115 USA; [Vrahas, Mark S.] Massachusetts Gen Hosp, Dept Orthopaed Surg, Boston, MA 02114 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital	Evans, CH (corresponding author), Beth Israel Deaconess Med Ctr, Ctr Adv Orthopaed Studies, RN-115,330 Brookline Ave, Boston, MA 02215 USA.	cevans@bidmc.harvard.edu	Wells, James W./C-7480-2011; Porter, Ryan M./AAU-9182-2020	Wells, James W./0000-0002-9618-6940; Porter, Ryan M./0000-0002-0246-5747; Boskey, Adele/0000-0002-6181-2219	National Institutes of Health [AR050243]; AO Foundation [S-10-72F]; GENDEF	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AO Foundation; GENDEF	This work was supported, in whole or in part, by National Institutes of Health Grant AR050243 (NIAMS). This work was also supported by AO Foundation Grants S-10-72F and GENDEF.	ANDERSON HC, 1995, CLIN ORTHOP RELAT R, P266; Arthur A, 2009, J CELL PHYSIOL, V218, P237, DOI 10.1002/jcp.21592; Bastian O, 2011, J LEUKOCYTE BIOL, V89, P669, DOI 10.1189/jlb.0810446; BELLOWS CG, 1992, BONE MINER, V17, P15, DOI 10.1016/0169-6009(92)90707-K; Bonewald LF, 2003, CALCIFIED TISSUE INT, V72, P537, DOI 10.1007/s00223-002-1057-y; BOSKEY AL, 1992, CLIN ORTHOP RELAT R, P244; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Choileain NN, 2006, ARCH SURG-CHICAGO, V141, P1132, DOI 10.1001/archsurg.141.11.1132; Diefenderfer DL, 2003, J BONE JOINT SURG AM, V85A, P19, DOI 10.2106/00004623-200300003-00005; Ding J, 2009, LIFE SCI, V84, P499, DOI 10.1016/j.lfs.2009.01.013; FLEISCH H, 1966, NATURE, V212, P901, DOI 10.1038/212901a0; Gilbert L, 2000, ENDOCRINOLOGY, V141, P3956, DOI 10.1210/en.141.11.3956; GOWEN M, 1988, ARTHRITIS RHEUM, V31, P1500, DOI 10.1002/art.1780311206; Guardavaccaro D, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002921; Harmey D, 2004, AM J PATHOL, V164, P1199, DOI 10.1016/S0002-9440(10)63208-7; Hessle L, 2002, P NATL ACAD SCI USA, V99, P9445, DOI 10.1073/pnas.142063399; Johnson K, 2005, FRONT BIOSCI-LANDMRK, V10, P988, DOI 10.2741/1593; Johnson KA, 2000, AM J PHYSIOL-REG I, V279, pR1365, DOI 10.1152/ajpregu.2000.279.4.R1365; Kaneki H, 2006, J BIOL CHEM, V281, P4326, DOI 10.1074/jbc.M509430200; KUROKI T, 1994, BRIT J RHEUMATOL, V33, P224; Lacey DC, 2009, OSTEOARTHR CARTILAGE, V17, P735, DOI 10.1016/j.joca.2008.11.011; McNamara CR, 2011, FUTURE MED CHEM, V3, P549, DOI [10.4155/fmc.11.12, 10.4155/FMC.11.12]; Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205; Okawa A, 1998, NAT GENET, V19, P271, DOI 10.1038/956; Pape HC, 2010, J ORTHOP TRAUMA, V24, P522, DOI 10.1097/BOT.0b013e3181ed1361; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Porter RM, 2009, J ORTHOP RES, V27, P42, DOI 10.1002/jor.20715; Rutsch F, 2001, AM J PATHOL, V158, P543, DOI 10.1016/S0002-9440(10)63996-X; Scrivo R, 2011, AUTOIMMUN REV, V10, P369, DOI 10.1016/j.autrev.2010.12.006; Sonomoto K, 2012, ARTHRITIS RHEUM-US, V64, P3355, DOI 10.1002/art.34555; Southerland JH, 2006, PERIODONTOL 2000, V40, P130, DOI 10.1111/j.1600-0757.2005.00138.x; Terkeltaub RA, 1998, J BONE MINER RES, V13, P931, DOI 10.1359/jbmr.1998.13.6.931; Wehling N, 2009, ARTHRITIS RHEUM-US, V60, P801, DOI 10.1002/art.24352; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Xiao Z, 2007, J CELL PHYSIOL, V210, P325, DOI 10.1002/jcp.20826; Yao Z, 2004, ANN RHEUM DIS, V63, P252, DOI 10.1136/ard.2003.008045	36	51	52	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29494	29505		10.1074/jbc.M113.471268	http://dx.doi.org/10.1074/jbc.M113.471268			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23970554	hybrid, Green Published			2022-12-25	WOS:000330615300026
J	Qiu, YX; Fakas, S; Han, GS; Barbosa, AD; Siniossoglou, S; Carman, GM				Qiu, Yixuan; Fakas, Stylianos; Han, Gil-Soo; Barbosa, Antonio Daniel; Siniossoglou, Symeon; Carman, George M.			Transcription Factor Reb1p Regulates DGK1-encoded Diacylglycerol Kinase and Lipid Metabolism in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diacylglycerol; Glycerolipid; Phosphatidate; Phospholipid; Phospholipid Metabolism; Phospholipid Turnover; Diacylglycerol Kinase	FATTY-ACID SYNTHASE; DNA-BINDING PROTEIN; MG2+-DEPENDENT PHOSPHATIDATE PHOSPHATASE; NUCLEAR-MEMBRANE GROWTH; ACETYL-COA CARBOXYLASE; PHOSPHOLIPID-SYNTHESIS; SIGNALING FUNCTIONS; NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; ORTHOLOGUE PAH1P	In the yeast Saccharomyces cerevisiae, the DGK1-encoded diacylglycerol kinase catalyzes the CTP-dependent phosphorylation of diacylglycerol to form phosphatidate. This enzyme, in conjunction with PAH1-encoded phosphatidate phosphatase, controls the levels of phosphatidate and diacylglycerol for phospholipid synthesis, membrane growth, and lipid droplet formation. In this work, we showed that a functional level of diacylglycerol kinase is regulated by the Reb1p transcription factor. In the electrophoretic mobility shift assay, purified recombinant Reb1p was shown to specifically bind its consensus recognition sequence (CGGGTAA, -166 to -160) in the DGK1 promoter. Analysis of cells expressing the P-DGK1-lacZ reporter gene showed that mutations (GTTG) in the Reb1p-binding sequence caused an 8.6-fold reduction in -galactosidase activity. The expression of DGK1(reb1), a DGK1 allele containing the Reb1p-binding site mutation, was greatly lower than that of the wild type allele, as indicated by analyses of DGK1 mRNA, Dgk1p, and diacylglycerol kinase activity. In the presence of cerulenin, an inhibitor of de novo fatty acid synthesis, the dgk1 mutant expressing DGK1(reb1) exhibited a significant defect in growth as well as in the synthesis of phospholipids from triacylglycerol mobilization. Unlike DGK1, the DGK1(reb1) expressed in the dgk1 pah1 mutant did not result in the nuclear/endoplasmic reticulum membrane expansion, which occurs in cells lacking phosphatidate phosphatase activity. Taken together, these results indicate that the Reb1p-mediated regulation of diacylglycerol kinase plays a major role in its in vivo functions in lipid metabolism.	[Qiu, Yixuan; Fakas, Stylianos; Han, Gil-Soo; Carman, George M.] Rutgers State Univ, Dept Food Sci, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; [Qiu, Yixuan; Fakas, Stylianos; Han, Gil-Soo; Carman, George M.] Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, New Brunswick, NJ 08901 USA; [Barbosa, Antonio Daniel; Siniossoglou, Symeon] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England	Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Cambridge	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu	Fakas, Stylianos/AAQ-7594-2020; Barbosa, Antonio Daniel/N-8248-2019; Fakas, Stylianos/R-9908-2019	Fakas, Stylianos/0000-0001-8692-1326; Barbosa, Antonio Daniel/0000-0002-5555-3230; Fakas, Stylianos/0000-0001-8692-1326	National Institutes of Health [GM-28140]; Medical Research Council [G0701446]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028140, R01GM028140] Funding Source: NIH RePORTER; MRC [G0701446] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-28140. This work was also supported by Medical Research Council Grant G0701446 (to S. S.).	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; ALFEEL W, 1992, P NATL ACAD SCI USA, V89, P4534, DOI 10.1073/pnas.89.10.4534; Angermayr M, 1997, MOL GEN GENET, V256, P682, DOI 10.1007/s004380050616; Athenstaedt K, 2005, J BIOL CHEM, V280, P37301, DOI 10.1074/jbc.M507261200; Athenstaedt K, 2003, J BIOL CHEM, V278, P23317, DOI 10.1074/jbc.M302577200; BISHOP WR, 1986, J BIOL CHEM, V261, P6993; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brindley DN, 2004, J CELL BIOCHEM, V92, P900, DOI 10.1002/jcb.20126; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Cai JJ, 2009, BBA-MOL CELL BIOL L, V1791, P942, DOI 10.1016/j.bbalip.2009.02.010; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; CARMEN AA, 1994, J BIOL CHEM, V269, P9790; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; CHASMAN DI, 1990, GENE DEV, V4, P503, DOI 10.1101/gad.4.4.503; CHIRALA SS, 1987, J BIOL CHEM, V262, P4231; CRAVEN GR, 1965, J BIOL CHEM, V240, P2468; Dominguez CL, 2013, CANCER DISCOV, V3, P782, DOI 10.1158/2159-8290.CD-12-0215; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Fakas S, 2011, J BIOL CHEM, V286, P1464, DOI 10.1074/jbc.M110.194308; Foster DA, 2007, CANCER RES, V67, P1, DOI 10.1158/0008-5472.CAN-06-3016; GAIGG B, 1995, BBA-BIOMEMBRANES, V1234, P214, DOI 10.1016/0005-2736(94)00287-Y; Garbarino J, 2009, J BIOL CHEM, V284, P30994, DOI 10.1074/jbc.M109.050443; Gnad F, 2009, PROTEOMICS, V9, P4642, DOI 10.1002/pmic.200900144; Goto K, 1999, CHEM PHYS LIPIDS, V98, P109, DOI 10.1016/S0009-3084(99)00023-7; GRAHAM IR, 1994, MOL MICROBIOL, V12, P931, DOI 10.1111/j.1365-2958.1994.tb01081.x; HAID A, 1983, METHOD ENZYMOL, V96, P192; Han GS, 2008, J BIOL CHEM, V283, P20443, DOI 10.1074/jbc.M802866200; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han GS, 2005, J BIOL CHEM, V280, P38328, DOI 10.1074/jbc.M509622200; HASSLACHER M, 1993, J BIOL CHEM, V268, P10946; Helbig AO, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-685; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; HERRICK D, 1990, MOL CELL BIOL, V10, P2269, DOI 10.1128/MCB.10.5.2269; Howe AG, 2006, CAN J PHYSIOL PHARM, V84, P29, DOI 10.1139/Y05-138; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; INOKOSHI J, 1994, MOL GEN GENET, V244, P90, DOI 10.1007/BF00280191; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JU QD, 1990, MOL CELL BIOL, V10, P5226, DOI 10.1128/MCB.10.10.5226; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kearns BG, 1997, NATURE, V387, P101, DOI 10.1038/387101a0; Kohlwein SD, 2010, J BIOL CHEM, V285, P15663, DOI 10.1074/jbc.R110.118356; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; KRATZER S, 1995, GENE, V161, P75, DOI 10.1016/0378-1119(95)00289-I; Krishna S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00178; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; KUZIORA MA, 1983, J BIOL CHEM, V258, P1648; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANG WH, 1993, MOL CELL BIOL, V13, P649, DOI 10.1128/MCB.13.1.649; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; LIAW PCY, 1994, YEAST, V10, P771, DOI 10.1002/yea.320100608; McLean M, 1995, MOL MICROBIOL, V18, P605, DOI 10.1111/j.1365-2958.1995.mmi_18040605.x; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; MORROW BE, 1990, J BIOL CHEM, V265, P20778; Muller MO, 2000, J BIOL CHEM, V275, P19475, DOI 10.1074/jbc.M002575200; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Omura S, 1981, Methods Enzymol, V72, P520; Oshiro J, 2000, J BIOL CHEM, V275, P40887, DOI 10.1074/jbc.M008144200; Packham EA, 1996, MOL GEN GENET, V250, P348; Pascual F, 2013, BBA-MOL CELL BIOL L, V1831, P514, DOI 10.1016/j.bbalip.2012.08.006; Raben DM, 2008, FRONT BIOSCI-LANDMRK, V13, P590, DOI 10.2741/2704; RAETZ CRH, 1990, J BIOL CHEM, V265, P1235; Rajakumari S, 2008, PROG LIPID RES, V47, P157, DOI 10.1016/j.plipres.2008.01.001; REMACLE JE, 1992, MOL CELL BIOL, V12, P5516, DOI 10.1128/MCB.12.12.5516; Rijken PJ, 2009, J BIOL CHEM, V284, P27609, DOI 10.1074/jbc.M109.016311; Rincon E, 2012, PROG LIPID RES, V51, P1, DOI 10.1016/j.plipres.2011.10.001; Rose MD., 1990, METHODS YEAST GENETI; Sakane F, 2008, CURR DRUG TARGETS, V9, P626, DOI 10.2174/138945008785132394; Sakane F, 2007, BBA-MOL CELL BIOL L, V1771, P793, DOI 10.1016/j.bbalip.2007.04.006; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; Schjerling P, 1996, NUCLEIC ACIDS RES, V24, P4599, DOI 10.1093/nar/24.23.4599; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SCHULLER HJ, 1994, EUR J BIOCHEM, V225, P213, DOI 10.1111/j.1432-1033.1994.00213.x; SCHWEIZER M, 1986, MOL GEN GENET, V203, P479, DOI 10.1007/BF00422073; Sciorra VA, 2002, BBA-MOL CELL BIOL L, V1582, P45, DOI 10.1016/S1388-1981(02)00136-1; Shulga YV, 2011, CHEM REV, V111, P6186, DOI 10.1021/cr1004106; SIKORSKI RS, 1989, GENETICS, V122, P19; Siniossoglou S, 2013, BBA-MOL CELL BIOL L, V1831, P575, DOI 10.1016/j.bbalip.2012.09.014; Soto A, 2008, J BIOL CHEM, V283, P10079, DOI 10.1074/jbc.M800502200; Soufi B, 2009, MOL BIOSYST, V5, P1337, DOI 10.1039/b902256b; Tehlivets O, 2007, BBA-MOL CELL BIOL L, V1771, P255, DOI 10.1016/j.bbalip.2006.07.004; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; Topham MK, 1999, J BIOL CHEM, V274, P11447, DOI 10.1074/jbc.274.17.11447; Tu-Sekine B, 2011, CRIT REV BIOCHEM MOL, V46, P353, DOI 10.3109/10409238.2011.577761; Verschuur AC, 2001, LEUKEMIA RES, V25, P891, DOI 10.1016/S0145-2126(01)00047-9; Waggoner DW, 1999, BBA-MOL CELL BIOL L, V1439, P299, DOI 10.1016/S1388-1981(99)00102-X; WANG HM, 1990, MOL CELL BIOL, V10, P1743, DOI 10.1128/MCB.10.4.1743; Wang KLC, 1998, MOL CELL BIOL, V18, P4368, DOI 10.1128/MCB.18.7.4368; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; WIMMER C, 1992, EMBO J, V11, P5051, DOI 10.1002/j.1460-2075.1992.tb05612.x; Zanghellini J, 2008, FEBS J, V275, P5552, DOI 10.1111/j.1742-4658.2008.06681.x; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	101	10	10	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					29124	29133		10.1074/jbc.M113.507392	http://dx.doi.org/10.1074/jbc.M113.507392			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23970552	Green Published, hybrid			2022-12-25	WOS:000330298800065
J	Barbieri, M; Esposito, A; Angellotti, E; Rizzo, MR; Marfella, R; Paolisso, G				Barbieri, Michelangela; Esposito, Antonietta; Angellotti, Edith; Rizzo, Maria Rosaria; Marfella, Raffaele; Paolisso, Giuseppe			Association of Genetic Variation in Adaptor Protein APPL1/APPL2 Loci with Non-Alcoholic Fatty Liver Disease	PLOS ONE			English	Article							HOMEOSTASIS MODEL ASSESSMENT; INSULIN-RESISTANCE; ADIPONECTIN RECEPTORS; NITRIC-OXIDE; APPL1; GLUCOSE; POPULATION; ACTIVATION; STEATOSIS; DIAGNOSIS	The importance of genetics and epigenetic changes in the pathogenesis of non alcoholic fatty liver disease (NAFLD) has been increasingly recognized. Adiponectin has a central role in regulating glucose and lipid metabolism and controlling inflammation in insulin-sensitive tissues and low adiponectin levels have been linked to NAFLD. APPL1 and APPL2 are adaptor proteins that interact with the intracellular region of adiponectin receptors and mediate adiponectin signaling and its effects on metabolism. The aim of our study was the evaluation of a potential association between variants at APPL1 and APPL2 loci and NAFLD occurrence. The impact on liver damage and hepatic steatosis severity has been also evaluated. To this aim allele frequency and genotype distribution of APPL1-rs3806622 and -rs4640525 and APPL2-rs 11112412 variants were evaluated in 223 subjects with clinical diagnosis of NAFLD and compared with 231 healthy subjects. The impact of APPL1 and APPL2 SNPs on liver damage and hepatic steatosis severity has been also evaluated. The minor-allele combination APPL1-C/APPL2-A was associated with an increased risk of NAFLD (OR = 2.50 95% CI 1.45-4.32; p < 0.001) even after adjustment for age, sex, body mass index, insulin resistance (HOMA-IR), triglycerides and adiponectin levels. This allele combination carrier had higher plasma alanine aminotransferase levels (Diff = 15.08 [7.60-22.57] p = 0.001) and an increased frequency of severe steatosis compared to the reference allele combination (OR = 3.88; 95% CI 1.582-9.531; p < 0.001). In conclusion, C-APPL1/A-APPL2 allele combination is associated with NAFLD occurrence, with a more severe hepatic steatosis grade and with a reduced adiponectin cytoprotective effect on liver.	[Barbieri, Michelangela; Esposito, Antonietta; Angellotti, Edith; Rizzo, Maria Rosaria; Marfella, Raffaele; Paolisso, Giuseppe] Univ Naples 2, Dept Med Surg Neurol Metab & Geriatr Sci, Naples, Italy	Universita della Campania Vanvitelli	Paolisso, G (corresponding author), Univ Naples 2, Dept Med Surg Neurol Metab & Geriatr Sci, Naples, Italy.	giuseppe.paolisso@unina2.it	Marfella, Raffaele/AAH-2595-2019; paolisso, giuseppe/AAP-8516-2020; rizzo, maria rosaria R/J-1968-2016; Rizzo, Maria Rosaria/AHH-3649-2022; Rizzo, Maria/HGD-6576-2022; Barbieri, Michelangela/K-2192-2016	Marfella, Raffaele/0000-0003-3960-9270; paolisso, giuseppe/0000-0002-2137-455X; rizzo, maria rosaria R/0000-0002-1023-4260; Rizzo, Maria Rosaria/0000-0002-1023-4260; Barbieri, Michelangela/0000-0002-9223-5792	Second University of Naples	Second University of Naples	This work was supported by the Second University of Naples. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Cheng KKY, 2007, DIABETES, V56, P1387, DOI 10.2337/db06-1580; Cheng KKY, 2009, CELL METAB, V9, P417, DOI 10.1016/j.cmet.2009.03.013; Chial HJ, 2008, TRAFFIC, V9, P215, DOI 10.1111/j.1600-0854.2007.00680.x; Choudhury Jayanta, 2004, Clin Liver Dis, V8, P575, DOI 10.1016/j.cld.2004.04.006; Deepa SS, 2009, AM J PHYSIOL-ENDOC M, V296, pE22, DOI 10.1152/ajpendo.90731.2008; Fang Qi-Chen, 2008, Zhonghua Yi Xue Za Zhi, V88, P369; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Hosch SE, 2006, CELL METAB, V4, P5, DOI 10.1016/j.cmet.2006.06.003; Jiang S, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-22; Li YL, 2012, HEPATOLOGY, V55, P327, DOI 10.1002/hep.24659; Li YY, 2012, WORLD J GASTROENTERO, V18, P6546, DOI 10.3748/wjg.v18.i45.6546; Loria P, 2010, DIGEST LIVER DIS, V42, P272, DOI 10.1016/j.dld.2010.01.021; Ma XW, 2011, CHINESE MED J-PEKING, V124, P3618, DOI 10.3760/cma.j.issn.0366-6999.2011.22.004; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Musso G, 2005, HEPATOLOGY, V42, P1175, DOI 10.1002/hep.20896; Nechamen CA, 2007, MOL CELL ENDOCRINOL, V260, P93, DOI 10.1016/j.mce.2006.08.014; Polyzos SA, 2010, DIABETES OBES METAB, V12, P365, DOI 10.1111/j.1463-1326.2009.01176.x; Polyzos SA, 2009, CURR MOL MED, V9, P299, DOI 10.2174/156652409787847191; Puppala J, 2013, J GENET GENOMICS, V40, P15, DOI 10.1016/j.jgg.2012.12.001; Saito T, 2007, J BIOL CHEM, V282, P32280, DOI 10.1074/jbc.M704150200; SAVERYMUTTU SH, 1986, BRIT MED J, V292, P13, DOI 10.1136/bmj.292.6512.13; Song JN, 2005, FASEB J, V19, P1266, DOI 10.1096/fj.04-3580com; Sookoian S, 2008, CYTOKINE, V44, P201, DOI 10.1016/j.cyto.2008.08.001; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Staiger H, 2007, DIABETIC MED, V24, P817, DOI 10.1111/j.1464-5491.2007.02166.x; Suzuki A, 2005, J HEPATOL, V43, P1060, DOI 10.1016/j.jhep.2005.06.008; Targher G, 2006, CLIN ENDOCRINOL, V64, P679, DOI 10.1111/j.1365-2265.2006.02527.x; Tokushige K, 2009, J GASTROENTEROL, V44, P976, DOI 10.1007/s00535-009-0085-z; Tregouet DA, 2004, ANN HUM GENET, V68, P165, DOI 10.1046/j.1529-8817.2003.00085.x; Wang CH, 2009, J BIOL CHEM, V284, P31608, DOI 10.1074/jbc.M109.010355; Wang Y, 2011, DIABETES, V60, P3044, DOI 10.2337/db11-0666; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Zeng MD, 2008, J DIGEST DIS, V9, P108, DOI 10.1111/j.1751-2980.2008.00331.x	38	12	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71391	10.1371/journal.pone.0071391	http://dx.doi.org/10.1371/journal.pone.0071391			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977033	gold, Green Submitted, Green Published			2022-12-25	WOS:000323425700044
J	Burgmer, M; Rehbein, MA; Wrenger, M; Kandil, J; Heuft, G; Steinberg, C; Pfleiderer, B; Junghofer, M				Burgmer, Markus; Rehbein, Maimu Alissa; Wrenger, Marco; Kandil, Judith; Heuft, Gereon; Steinberg, Christian; Pfleiderer, Bettina; Junghoefer, Markus			Early Affective Processing in Patients with Acute Posttraumatic Stress Disorder: Magnetoencephalographic Correlates	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; CHILDHOOD SEXUAL-ABUSE; CEREBRAL-BLOOD-FLOW; ORBITOFRONTAL CORTEX; AMYGDALA RESPONSE; NEURAL MECHANISMS; FLEETING IMAGES; BRAIN; PTSD; ACTIVATION	Background: In chronic PTSD, a preattentive neural alarm system responds rapidly to emotional information, leading to increased prefrontal cortex (PFC) activation at early processing stages (< 100 ms). Enhanced PFC responses are followed by a reduction in occipito-temporal activity during later processing stages. However, it remains unknown if this neuronal pattern is a result of a long lasting mental disorder or if it represents changes in brain function as direct consequences of severe trauma. Methodology: The present study investigates early fear network activity in acutely traumatized patients with PTSD. It focuses on the question whether dysfunctions previously observed in chronic PTSD patients are already present shortly after trauma exposure. We recorded neuromagnetic activity towards emotional pictures in seven acutely traumatized PTSD patients between one and seven weeks after trauma exposure and compared brain responses to a balanced healthy control sample. Inverse modelling served for mapping sources of differential activation in the brain. Principal Findings: Compared to the control group, acutely traumatized PTSD patients showed an enhanced PFC response to high-arousing pictures between 60 to 80 ms. This rapid prefrontal hypervigilance towards arousing pictorial stimuli was sustained during 120-300 ms, where it was accompanied by a reduced affective modulation of occipito-temporal neural processing. Conclusions: Our findings indicate that the hypervigilance-avoidance pattern seen in chronic PTSD is not necessarily a product of an endured mental disorder, but arises as an almost immediate result of severe traumatisation. Thus, traumatic experiences can influence emotion processing strongly, leading to long-lasting changes in trauma network activation and expediting a chronic manifestation of maladaptive cognitive and behavioral symptoms.	[Rehbein, Maimu Alissa; Steinberg, Christian; Junghoefer, Markus] Univ Hosp Munster, Inst Biomagnetism & Biosignalanal, Munster, Germany; [Burgmer, Markus; Wrenger, Marco; Heuft, Gereon] Univ Hosp Munster, Dept Psychosomat & Psychotherapy, Munster, Germany; [Kandil, Judith] Asklepios Hosp Teupitz, Teupitz, Germany; [Pfleiderer, Bettina] Univ Hosp Munster, Dept Clin Radiol, Munster, Germany	University of Munster; University of Munster; University of Munster	Junghofer, M (corresponding author), Univ Hosp Munster, Inst Biomagnetism & Biosignalanal, Munster, Germany.	markus.junghoefer@uni-muenster.de	Junghoefer, Markus/AAA-2892-2021	Junghoefer, Markus/0000-0002-8532-2986	Deutsche Forschungsgemeinschaft [JU-445/4-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	MAR was supported by the Deutsche Forschungsgemeinschaft grant JU-445/4-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adenauer H, 2010, BIOL PSYCHIAT, V68, P451, DOI 10.1016/j.biopsych.2010.05.015; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Armony JL, 2005, AM J PSYCHIAT, V162, P1961, DOI 10.1176/appi.ajp.162.10.1961; Attias J, 1996, BIOL PSYCHIAT, V40, P373, DOI 10.1016/0006-3223(95)00419-X; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bremner JD, 2003, AM J PSYCHIAT, V160, P924, DOI 10.1176/appi.ajp.160.5.924; Bremner JD, 2003, BIOL PSYCHIAT, V53, P879, DOI 10.1016/S0006-3223(02)01891-7; Brewin CR, 2003, CLIN PSYCHOL REV, V23, P339, DOI 10.1016/S0272-7358(03)00033-3; Brockelmann AK, 2013, EUR J NEUROSCI, V37, P303, DOI 10.1111/ejn.12043; Carstensen LL, 1999, AM PSYCHOL, V54, P165, DOI 10.1037/0003-066X.54.3.165; Catani C, 2009, EUR ARCH PSY CLIN N, V259, P340, DOI 10.1007/s00406-009-0006-4; CHARLES G, 1995, NEUROPSYCHOBIOLOGY, V32, P72, DOI 10.1159/000119216; Driessen M, 2004, BIOL PSYCHIAT, V55, P603, DOI 10.1016/j.biopsych.2003.08.018; Ehlers CL, 2006, ANN NY ACAD SCI, V1071, P125, DOI 10.1196/annals.1364.011; Elbert T, 2002, NATURE, V419, P883, DOI 10.1038/419883a; Elbert T, 2011, Z PSYCHOL, V219, P167, DOI 10.1027/2151-2604/a000064; Felmingham KL, 2003, NEUROREPORT, V14, P777, DOI 10.1097/00001756-200304150-00024; FOA EB, 1986, PSYCHOL BULL, V99, P20, DOI 10.1037/0033-2909.99.1.20; Francati V, 2007, DEPRESS ANXIETY, V24, P202, DOI 10.1002/da.20208; Gillette GM, 1997, LIFE SCI, V61, P1421, DOI 10.1016/S0024-3205(97)00688-7; Gottfried JA, 2004, NAT NEUROSCI, V7, P1145, DOI 10.1038/nn1314; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Hauk O, 2004, NEUROIMAGE, V21, P1612, DOI 10.1016/j.neuroimage.2003.12.018; Holstein DH, 2010, J AFFECT DISORDERS, V126, P188, DOI 10.1016/j.jad.2010.02.122; Javanbakht A, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-5; Junghofer M, 2000, PSYCHOPHYSIOLOGY, V37, P523, DOI 10.1111/1469-8986.3740523; Junghofer M, 2006, NEUROREPORT, V17, P225, DOI 10.1097/01.wnr.0000198437.59883.bb; Junghofer M, 2003, PSYCHOPHYSIOLOGY, V40, pS51; Junghofer M, 2001, PSYCHOPHYSIOLOGY, V38, P175, DOI 10.1017/S0048577201000762; Karl A, 2006, BIOL PSYCHOL, V71, P123, DOI 10.1016/j.biopsycho.2005.03.004; Kisley MA, 2007, PSYCHOL SCI, V18, P838, DOI 10.1111/j.1467-9280.2007.01988.x; Kounios J, 1997, ANN NY ACAD SCI, V821, P504, DOI 10.1111/j.1749-6632.1997.tb48316.x; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Lang P, 1980, TECHNOLOGY MENTAL HL, P119, DOI DOI 10.1016/J.LINDIF.2013.01.005; Lang P.J., 2008, TECHNICAL REPORT; Lang PJ, 1997, ATTENTION AND ORIENTING: SENSORY AND MOTIVATIONAL PROCESSES, P97; LANG PJ, 1979, PSYCHOPHYSIOLOGY, V16, P495, DOI 10.1111/j.1469-8986.1979.tb01511.x; Lanius RA, 2001, AM J PSYCHIAT, V158, P1920, DOI 10.1176/appi.ajp.158.11.1920; Leclerc CM, 2008, COGN AFFECT BEHAV NE, V8, P153, DOI 10.3758/CABN.8.2.153; Lewine JD, 2002, AM J PSYCHIAT, V159, P1689, DOI 10.1176/appi.ajp.159.10.1689; Liberzon I, 1999, BIOL PSYCHIAT, V45, P817, DOI 10.1016/S0006-3223(98)00246-7; Liddell BJ, 2005, NEUROIMAGE, V24, P235, DOI 10.1016/j.neuroimage.2004.08.016; Lui S, 2009, P NATL ACAD SCI USA, V106, P15412, DOI 10.1073/pnas.0812751106; Maercker A, 1998, DIAGNOSTICA, V44, P130; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Metzger LJ, 1997, INTEGR PHYS BEH SCI, V32, P43, DOI 10.1007/BF02688612; Moratti S, 2008, ARCH GEN PSYCHIAT, V65, P532, DOI 10.1001/archpsyc.65.5.532; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P1390, DOI 10.1176/appi.ajp.161.8.1390; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Osuch EA, 2008, BIOL PSYCHIAT, V64, P327, DOI 10.1016/j.biopsych.2008.03.010; PAIGE SR, 1990, BIOL PSYCHIAT, V27, P419, DOI 10.1016/0006-3223(90)90552-D; Peyk P, 2008, BRAIN TOPOGR, V20, P205, DOI 10.1007/s10548-008-0052-7; Peyk P, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/861705; Rauch SL, 1996, ARCH GEN PSYCHIAT, V53, P380; Rauch SL, 2000, BIOL PSYCHIAT, V47, P769, DOI 10.1016/S0006-3223(00)00828-3; Rehbein M, 2011, 2 INT S SFB TRR 58 F; Rockstroh B, 2010, INT J PSYCHOPHYSIOL, V78, P14, DOI 10.1016/j.ijpsycho.2010.01.012; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Schupp HT, 2006, PROG BRAIN RES, V156, P31, DOI 10.1016/S0079-6123(06)56002-9; SEMPLE WE, 1993, BIOL PSYCHIAT, V34, P115, DOI 10.1016/0006-3223(93)90264-E; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Shin LM, 2005, ARCH GEN PSYCHIAT, V62, P273, DOI 10.1001/archpsyc.62.3.273; Shin LM, 1999, AM J PSYCHIAT, V156, P575; Shin LM, 2004, ARCH GEN PSYCHIAT, V61, P168, DOI 10.1001/archpsyc.61.2.168; Skinner R D, 1999, Depress Anxiety, V9, P122, DOI 10.1002/(SICI)1520-6394(1999)9:3<122::AID-DA4>3.0.CO;2-M; Steinberg C, 2013, BIOL PSYCHOL; Steinberg C, 2013, PSYCHOPHYSIOLOGY, V50, P230, DOI 10.1111/psyp.12005; Steinberg C, 2012, J COGNITIVE NEUROSCI, V24, P17, DOI 10.1162/jocn_a_00067; THORPE SJ, 1983, EXP BRAIN RES, V49, P93; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Weber K, 2009, PSYCHOPHYSIOLOGY, V46, P1234, DOI 10.1111/j.1469-8986.2009.00871.x; Wessa M, 2005, EXP BRAIN RES, V167, P56, DOI 10.1007/s00221-005-0007-0; Williams LM, 2006, J NEUROSCI, V26, P6422, DOI 10.1523/JNEUROSCI.0022-06.2006; Wood S, 2006, PSYCHOL AGING, V21, P815, DOI 10.1037/0882-7974.21.4.815; Yun XY, 2011, NEUROSCI LETT, V498, P10, DOI 10.1016/j.neulet.2011.04.040; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	78	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71289	10.1371/journal.pone.0071289	http://dx.doi.org/10.1371/journal.pone.0071289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977010	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700034
J	de Leon, N; Sharifmoghadam, MR; Hoya, M; Curto, MA; Doncel, C; Valdivieso, MH				de Leon, Nagore; Sharifmoghadam, Mohammad Reza; Hoya, Marta; -Angeles Curto, M.; Doncel, Cristina; -Henar Valdivieso, M.			Regulation of Cell Wall Synthesis by the Clathrin Light Chain Is Essential for Viability in Schizosaccharomyces pombe	PLOS ONE			English	Article							FISSION YEAST; SACCHAROMYCES-CEREVISIAE; ACTIN CYTOSKELETON; SYNTHASE SUBUNIT; CHITIN SYNTHESIS; PRIMARY SEPTUM; GROWTH; ENDOCYTOSIS; SEPARATION; SECRETION	The regulation of cell wall synthesis by the clathrin light chain has been addressed. Schizosaccharomyces pombe clc1 Delta mutant was inviable in the absence of osmotic stabilization; when grown in sorbitol-supplemented medium clc1 Delta cells grew slowly, formed aggregates, and had strong defects in morphology. Additionally, clc1 Delta cells exhibited an altered cell wall composition. A mutant that allowed modulating the amount of Clc1p was created to analyze in more detail the dependence of cell wall synthesis on clathrin. A 40% reduction in the amount of Clc1p did not affect acid phosphatase secretion and bulk lipid internalization. Under these conditions, beta(1,3)glucan synthase activity and cell wall synthesis were reduced. Also, the delivery of glucan synthases to the cell surface, and the secretion of the Eng1p glucanase were defective. These results suggest that the defects in the cell wall observed in the conditional mutant were due to a defective secretion of enzymes involved in the synthesis/remodelling of this structure, rather than to their endocytosis. Our results show that a reduction in the amount of clathrin that has minor effects on general vesicle trafficking has a strong impact on cell wall synthesis, and suggest that this is the reason for the lethality of clc1 Delta cells in the absence of osmotic stabilization.	[de Leon, Nagore; Hoya, Marta; -Angeles Curto, M.; Doncel, Cristina; -Henar Valdivieso, M.] Univ Salamanca, CSIC, Dept Microbiol & Genet IBFG, E-37008 Salamanca, Spain; [Sharifmoghadam, Mohammad Reza] Ferdowsi Univ Mashhad, Fac Sci, Dept Biol, Mashhad, Iran	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca; Ferdowsi University Mashhad	Valdivieso, MH (corresponding author), Univ Salamanca, CSIC, Dept Microbiol & Genet IBFG, E-37008 Salamanca, Spain.	henar@usal.es	Sharifmoghadam, Mohammad Reza/AAI-8210-2021; Angeles, Maria/HCH-1574-2022; Valdivieso, M.-Henar/B-5199-2017	Sharifmoghadam, Mohammad Reza/0000-0002-3638-0653; Valdivieso, M.-Henar/0000-0002-6857-7493; Doncel, Cristina/0000-0002-1592-3583; Curto, Maria Angeles/0000-0002-0306-382X; Hoya, Marta/0000-0002-3186-2514	MICINN/European Union FEDER program [BFU2010-15085]; FPU fellowships from the Ministry of Science; JAE-PREDOC fellowship from Consejo Superior de Investigaciones Cientificas, Spain	MICINN/European Union FEDER program; FPU fellowships from the Ministry of Science; JAE-PREDOC fellowship from Consejo Superior de Investigaciones Cientificas, Spain	Financial support to our group from the MICINN (http://www.idi.mineco.gob.es/.Spain)/European Union FEDER program (grant BFU2010-15085) made this work possible. NdL and MAC were supported by FPU fellowships from the Ministry of Science, and MH was supported by a JAE-PREDOC fellowship from Consejo Superior de Investigaciones Cientificas, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghamohammadzadeh S, 2009, NAT CELL BIOL, V11, P1039, DOI 10.1038/ncb1918; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bendezu FO, 2011, MOL BIOL CELL, V22, P44, DOI 10.1091/mbc.E10-08-0720; Boettner DR, 2012, NAT CELL BIOL, V14, P2, DOI 10.1038/ncb2403; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; Castagnetti S, 2005, J CELL SCI, V118, P1843, DOI 10.1242/jcs.02311; Chu DS, 1996, J BIOL CHEM, V271, P33123, DOI 10.1074/jbc.271.51.33123; Cortes JCG, 2005, J CELL SCI, V118, P157, DOI 10.1242/jcs.01585; Cortes JCG, 2007, MOL MICROBIOL, V65, P201, DOI 10.1111/j.1365-2958.2007.05784.x; Duran A, 2003, MOLECULAR BIOLOGY OF SCHIZOSACCHAROMYCES POMBE, P269; Fischer R, 2008, MOL MICROBIOL, V68, P813, DOI 10.1111/j.1365-2958.2008.06193.x; Gachet Y, 2005, J CELL SCI, V118, P4231, DOI 10.1242/jcs.02530; Garcia I, 2005, BIOL CELL, V97, P569; Garcia-Rodriguez LJ, 2000, FEBS LETT, V478, P84, DOI 10.1016/S0014-5793(00)01835-4; Gurunathan S, 2002, EMBO J, V21, P602, DOI 10.1093/emboj/21.4.602; HARSAY E, 1995, J CELL BIOL, V131, P297, DOI 10.1083/jcb.131.2.297; Hirst J, 1998, BBA-MOL CELL RES, V1404, P173, DOI 10.1016/S0167-4889(98)00056-1; HORISBERGER M, 1978, ARCH MICROBIOL, V119, P107, DOI 10.1007/BF00964260; Huang KM, 1997, J CELL SCI, V110, P899; Ishiguro J, 1997, J BACTERIOL, V179, P7653, DOI 10.1128/jb.179.24.7653-7662.1997; Iwaki T, 2004, YEAST, V21, P867, DOI 10.1002/yea.1134; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kita A, 2004, MOL BIOL CELL, V15, P2920, DOI 10.1091/mbc.E03-09-0659; KREGER DR, 1954, BIOCHIM BIOPHYS ACTA, V13, P1, DOI 10.1016/0006-3002(54)90264-4; La Carbona S, 2006, BIOL CELL, V98, P619, DOI 10.1042/BC20060048; LEMMON SK, 1987, SCIENCE, V238, P504, DOI 10.1126/science.3116672; Martin V, 2003, EUKARYOT CELL, V2, P159, DOI 10.1128/EC.2.1.159-169.2003; Martin-Cuadrado AB, 2003, J CELL SCI, V116, P1689, DOI 10.1242/jcs.00377; MIYATA M, 1978, J BACTERIOL, V136, P558, DOI 10.1128/JB.136.2.558-564.1978; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mulholland J, 1997, MOL BIOL CELL, V8, P1481, DOI 10.1091/mbc.8.8.1481; MUNN AL, 1991, MOL CELL BIOL, V11, P3868, DOI 10.1128/MCB.11.8.3868; Nakano K, 2002, J CELL SCI, V115, P4629, DOI 10.1242/jcs.00150; Neiman AM, 1998, J CELL BIOL, V140, P29, DOI 10.1083/jcb.140.1.29; Newpher TM, 2006, MOL BIOL CELL, V17, P4343, DOI 10.1091/mbc.E06-07-0606; Newpher TM, 2006, TRAFFIC, V7, P574, DOI 10.1111/j.1600-0854.2006.00410.x; PAYNE GS, 1987, MOL CELL BIOL, V7, P3888, DOI 10.1128/MCB.7.11.3888; PAYNE GS, 1985, SCIENCE, V230, P1009, DOI 10.1126/science.2865811; Prosser DC, 2011, J CELL BIOL, V195, P657, DOI 10.1083/jcb.201104045; RIBAS JC, 1991, J BACTERIOL, V173, P3456, DOI 10.1128/jb.173.11.3456-3462.1991; Rodriguez-Pena JM, 2008, J BIOTECHNOL, V133, P311, DOI 10.1016/j.jbiotec.2007.10.006; Roncero C, 2002, CURR GENET, V41, P367, DOI 10.1007/s00294-002-0318-7; RUSCETTI T, 1994, J CELL BIOL, V126, P343, DOI 10.1083/jcb.126.2.343; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sanchatjate S, 2006, MOL BIOL CELL, V17, P4157, DOI 10.1091/mbc.E06-03-0210; SCHWEINGRUBER ME, 1992, CURR GENET, V22, P289, DOI 10.1007/BF00317923; Sharifmoghadam MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042726; Sharifmoghadam MR, 2009, J BIOL CHEM, V284, P11070, DOI 10.1074/jbc.M808353200; SILVEIRA LA, 1990, J CELL BIOL, V111, P1437, DOI 10.1083/jcb.111.4.1437; Sipiczki M, 2000, ARCH MICROBIOL, V174, P386, DOI 10.1007/s002030000214; Sipiczki M, 2000, GENOME BIOL, V1, DOI [10.1186/gb-2000-1-2-reviews1011, DOI 10.1186/GB-2000-1-2-REVIEWS1011]; Sirotkin V, 2010, MOL BIOL CELL, V21, P2894, DOI 10.1091/mbc.E10-02-0157; Trautwein M, 2006, EMBO J, V25, P943, DOI 10.1038/sj.emboj.7601007; Valdivia RH, 2002, DEV CELL, V2, P283, DOI 10.1016/S1534-5807(02)00127-2; Valdivieso MH, 2000, J BACTERIOL, V182, P4752, DOI 10.1128/JB.182.17.4752-4757.2000; Walker LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000040; Wang JS, 2003, TRAFFIC, V4, P891, DOI 10.1046/j.1600-0854.2003.00144.x; Weinberg J, 2012, TRENDS CELL BIOL, V22, P1, DOI 10.1016/j.tcb.2011.09.001; Yu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045324	59	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71510	10.1371/journal.pone.0071510	http://dx.doi.org/10.1371/journal.pone.0071510			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977061	Green Published, gold, Green Submitted			2022-12-25	WOS:000323425700063
J	Justumus, P; Colby, D; Anh, TMD; Balestre, E; Becquet, R; Orne-Gliemann, J				Justumus, Pauline; Colby, Donn; Thi Mai Doan Anh; Balestre, Eric; Becquet, Renaud; Orne-Gliemann, Joanna			Willingness to Use the Internet to Seek Information on HIV Prevention and Care among Men Who Have Sex with Men in Ho Chi Minh City, Vietnam	PLOS ONE			English	Article							RISK BEHAVIORS; UNITED-STATES; INFECTION; MSM; DISCRIMINATION; INTERVENTION; EPIDEMIOLOGY; KNOWLEDGE	Background: In Vietnam, men who have sex with men (MSM) are highly affected by HIV and need new targeted HIV prevention strategies. Objectives: To assess the willingness to use the Internet to seek information on HIV prevention and care and associated factors among MSM in Ho Chi Minh City. Methods: A descriptive cross-sectional study was conducted in 2012. Participants were recruited using a convenience sampling method in venues most frequented by MSM and completed a self-administered questionnaire. Logistic regression models were performed to estimate factors associated with the willingness to use the Internet to seek information on HIV prevention and care. Results: A total of 358 MSM were approached for the survey and 222 questionnaires (62.0%) were eligible for analyses. Overall, 76.1% of the respondents reported that they were willing to use the Internet to seek information on HIV prevention and care. A number of male partners in last year less than or equal to 3 (Adjusted Odds Ratio: 3.07, 95% Confidence interval: 1.40-6.73), a history of STI screening (4.10, 1.02-16.48) and HIV testing (3.23, 1.20-8.64) and having ever sought a male sexual partner through the Internet (3.56, 1.55-8.18) were significantly positively associated with the willingness to use the Internet to seek information on HIV prevention and care. Conclusion: The MSM interviewed in Ho Chi Minh City reported a high willingness to use the Internet to seek information on HIV prevention and care. In a context where new media are increasingly considered as promising options for reaching this HIV risk group, further research should be conducted on developing and testing tailored online tools adapted to the needs of Vietnamese MSM.	[Justumus, Pauline; Colby, Donn; Thi Mai Doan Anh] Harvard Med Sch AIDS Initiat Vietnam, Ho Chi Minh City, Vietnam; [Justumus, Pauline; Balestre, Eric; Becquet, Renaud; Orne-Gliemann, Joanna] Univ Bordeaux, ISPED, Ctr Inserm Epidemiol Biostat U897, Bordeaux, France; [Justumus, Pauline; Balestre, Eric; Becquet, Renaud; Orne-Gliemann, Joanna] INSERM, ISPED, Ctr Inserm Epidemiol Biostat U897, Bordeaux, France; [Colby, Donn] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Harvard University; Beth Israel Deaconess Medical Center	Orne-Gliemann, J (corresponding author), Univ Bordeaux, ISPED, Ctr Inserm Epidemiol Biostat U897, Bordeaux, France.	Joanna.Orne-Gliemann@isped.u-bordeaux2.fr	Orne-Gliemann, Joanna/T-2787-2019; Becquet, Renaud/F-4837-2013	Becquet, Renaud/0000-0003-3277-0985; colby, donn j./0000-0003-3931-5926				Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Berry MC, 2013, AIDS CARE, V25, P38, DOI 10.1080/09540121.2012.687808; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Blanc ME, 2005, INT SOC SCI J, V57, P661, DOI 10.1111/j.1468-2451.2005.583.x; Blas MM, 2007, SEX TRANSM INFECT, V83, P567, DOI 10.1136/sti.2007.027276; Blas MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054012; Bowen AM, 2008, J BEHAV MED, V31, P463, DOI 10.1007/s10865-008-9171-6; Bowen AM, 2007, HEALTH EDUC RES, V22, P120, DOI 10.1093/her/cyl057; Carpenter KM, 2010, AIDS BEHAV, V14, P549, DOI 10.1007/s10461-009-9578-2; Chiasson MA, 2010, JAIDS-J ACQ IMM DEF, V55, pS94, DOI 10.1097/QAI.0b013e3181fcb878; Cimigo, 2011, 2011 VIETN NETCITIZE; Colby D, 2004, AIDS EDUC PREV, V16, P45, DOI 10.1521/aeap.16.1.45.27722; Colby D, 2007, 8 INT C AIDS AS PAC; Colby DJ, 2003, JAIDS-J ACQ IMM DEF, V32, P80, DOI 10.1097/00126334-200301010-00012; Fay H, 2011, AIDS BEHAV, V15, P1088, DOI 10.1007/s10461-010-9861-2; Garcia MC, 2012, BMJ OPEN, V2; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hottes TS, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1948; Joint United Nations Programme on HIV/AIDS, 2002, HIV VOL COUNS TEST G; Koopman C, 1990, AIDS Educ Prev, V2, P58; Liu JX, 2006, AIDS BEHAV, V10, pS25, DOI 10.1007/s10461-006-9123-5; Liu SY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-250; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Mettey A, 2003, SEX TRANSM INFECT, V79, P466, DOI 10.1136/sti.79.6.466; Mikolajczak J, 2008, APPL PSYCHOL-INT REV, V57, P681, DOI 10.1111/j.1464-0597.2008.00342.x; Mimiaga MJ, 2012, AIDS CARE, P1; Ministry of Public Health Vietnam, 2009, VIETN HIV AIDS EST P; Mumtaz G, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000444; National Committee for AIDS Drugs and Prostitution prevention and control, 2012, VIETN AIDS RESP PROG; Ngo DA, 2009, AIDS EDUC PREV, V21, P251, DOI 10.1521/aeap.2009.21.3.251; Nguyen TA, 2008, AIDS BEHAV, V12, P476, DOI 10.1007/s10461-007-9267-y; Noar SA, 2009, AIDS, V23, P107, DOI 10.1097/QAD.0b013e32831c5500; Pequegnat W, 2007, AIDS BEHAV, V11, P505, DOI 10.1007/s10461-006-9172-9; Rhodes SD, 2008, HEALTH EDUC RES, V23, P180, DOI 10.1093/her/cym015; Rhodes SD, 2011, HEALTH EDUC BEHAV, V38, P311, DOI 10.1177/1090198110379572; Rosser BRS, 2010, AIDS, V24, P2099, DOI 10.1097/QAD.0b013e32833c4ac7; Saavedra Jorge, 2008, J Int AIDS Soc, V11, P9, DOI 10.1186/1758-2652-11-9; Sadler GR, 2010, NURS HEALTH SCI, V12, P369, DOI 10.1111/j.1442-2018.2010.00541.x; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; Sullivan PS, 2009, ANN EPIDEMIOL, V19, P423, DOI 10.1016/j.annepidem.2009.03.004; The Socialist Republic of Vietnam, 2010, DECL COMM HIV AIDS A; Thi MDA, 2008, AIDS BEHAV, V12, pS63, DOI 10.1007/s10461-008-9374-4; United Nations Programme on HIV/AIDS, 2010, GLOB REP UNAIDS REP; United Nations Programme on HIV/AIDS, 2008, REP GLOB AIDS EP; van Griensven F, 2009, CURR OPIN HIV AIDS, V4, P300, DOI 10.1097/COH.0b013e32832c3bb3; van Wijngaarden JWD, 2009, SEX TRANSM DIS, V36, P319, DOI 10.1097/OLQ.0b013e318195c302; Vu BN, 2008, SEX HEALTH, V5, P83, DOI 10.1071/SH07064; Wohlfeiler D, 2010, AIDS BEHAV, P1	48	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71471	10.1371/journal.pone.0071471	http://dx.doi.org/10.1371/journal.pone.0071471			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	205ER	23977048	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700055
J	Lin, SW; Chen, YL; Kao, KC; Yang, CT; Chuang, LP; Chou, YT; Lai, SC; Chen, RS; Chen, NH				Lin, Shih-Wei; Chen, Yen-Lung; Kao, Kuo-Chin; Yang, Cheng-Ta; Chuang, Li-Pang; Chou, Yu-Ting; Lai, Szu-Chia; Chen, Rou-Shayn; Chen, Ning-Hung			Diseases in Patients Coming to a Sleep Center with Symptoms Related to Restless Legs Syndrome	PLOS ONE			English	Article							DIAGNOSTIC-CRITERIA; GENERAL-POPULATION; KOREAN ADULTS; PREVALENCE; EPIDEMIOLOGY; ASSOCIATION; COMMUNITY; IMPACT; IRON	Study Objective: To explore the profile of patients who visit a sleep center with symptoms that fulfill the four essential criteria for restless legs syndrome (RLS). Design: A prospective study. Setting: Outpatients from one sleep disorders clinic in Taiwan. Participants: 1,200 consecutive patients visit sleep disorders clinic with any sleep complaints. Interventions: After completing a history and physical examination, all participants answered the RLS questionnaire. Subjects who fulfilled the four essential criteria for RLS were referred to a special clinic. A work-up including blood tests, polysomnography, and specialized neurological tests etc. was performed to make the final diagnosis. Measurements and Results: A total of 1,185 participants were enrolled, and, of these, 131(11.1%) fulfilled the four essential criteria for RLS, and 121 completed the supplemental work-up. Their mean age was 47.6 +/- 13.3 and 52.9% were male. Insomnia and snoring were the most common chief complaints. Obstructive sleep apnea syndrome and other diseases were found in 103 patients. Only 18 (14.9%) patients had no comorbid condition and were diagnosed with primary RLS. Conclusions: Symptoms of RLS are common in patients with sleep complaints. Even in a sleep clinic, using a questionnaire approach for identification of RLS has a low positive predictive value. Clinicians should pay attention to the limitations of the 4-item questionnaire in diagnosis of RLS and also the importance of a careful differential diagnosis to identify possible secondary causes of RLS.	[Lin, Shih-Wei; Chuang, Li-Pang; Chen, Ning-Hung] Chang Gung Mem Hosp, Sleep Ctr, Tao Yuan, Taiwan; [Chen, Yen-Lung] Chang Gung Univ, Chang Gung Mem Hosp, Ctr Tradit Chinese Med, Tao Yuan, Taiwan; [Kao, Kuo-Chin; Yang, Cheng-Ta] Chang Gung Mem Hosp, Dept Thorac Med & Resp Therapy, Tao Yuan, Taiwan; [Lai, Szu-Chia; Chen, Rou-Shayn] Chang Gung Mem Hosp, Sleep Ctr, Movement Disorder Sect, Dept Neurol, Tao Yuan, Taiwan; [Chen, Yen-Lung] Chang Gung Univ, Grad Inst Tradit Chinese Med, Tao Yuan, Taiwan; [Chuang, Li-Pang; Chou, Yu-Ting] Chang Gung Univ, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Kao, Kuo-Chin; Yang, Cheng-Ta] Chang Gung Univ, Dept Resp Therapy, Tao Yuan, Taiwan; [Chou, Yu-Ting] Chang Gung Mem Hosp, Chiayi, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Chen, NH (corresponding author), Chang Gung Mem Hosp, Sleep Ctr, Tao Yuan, Taiwan.	ninghung@yahoo.com.tw	Chuang, Li-Pang/L-8929-2019; Lin, Shih-Wei/I-9294-2019	Chuang, Li-Pang/0000-0001-5466-8995; Lin, Shih-Wei/0000-0002-7915-0014; Yang, Cheng-Ta/0000-0003-1846-1027	Department of Industrial Technology of the Ministry of Economic Affairs, R.O.C. [100-EC-17-A-19-S1-163]; National Science Council [NSC 101-2325-B-182 -012]; Chang Gung Medical Foundation [CMRPG391251]; GlaxoSmithKline [XMRPG380121]; GlaxoSmithKline company	Department of Industrial Technology of the Ministry of Economic Affairs, R.O.C.; National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Medical Foundation; GlaxoSmithKline(GlaxoSmithKline); GlaxoSmithKline company(GlaxoSmithKline)	This study was supported by the Department of Industrial Technology of the Ministry of Economic Affairs, R.O.C. (100-EC-17-A-19-S1-163), National Science Council (NSC 101-2325-B-182 -012). Chang Gung Medical Foundation supports the funding for language editing this manuscript (CMRPG391251). This study is also partly sponsored by GlaxoSmithKline (XMRPG380121). The GlaxoSmithKline company sponsored man power of a research assistant for 6 months which cost around 8,000 USD. However, they have no role in study design and conduct, collection, analysis, and interpretation of the data, or writing or approval of the manuscript.	Allen RP, 2011, MOVEMENT DISORD, V26, P114, DOI 10.1002/mds.23430; Allen RP, 2010, SLEEP MED, V11, P31, DOI 10.1016/j.sleep.2009.03.007; Allen RP, 2009, SLEEP MED, V10, P1097, DOI 10.1016/j.sleep.2008.10.007; Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Allen RP, 2005, ARCH INTERN MED, V165, P1286, DOI 10.1001/archinte.165.11.1286; Benediktsdottir B, 2010, SLEEP MED, V11, P1043, DOI 10.1016/j.sleep.2010.08.006; Benes H, 2009, SLEEP MED, V10, P524, DOI 10.1016/j.sleep.2008.06.007; Berger K, 2004, ARCH INTERN MED, V164, P196, DOI 10.1001/archinte.164.2.196; Chen NH, 2010, PSYCHIAT CLIN NEUROS, V64, P170, DOI 10.1111/j.1440-1819.2010.02067.x; Chen YL, 2013, THORACIC MED, V28, P65; Cho SJ, 2009, SLEEP, V32, P1069; Cho YW, 2008, SLEEP, V31, P219, DOI 10.1093/sleep/31.2.219; Gamaldo CE, 2006, CHEST, V130, P1596, DOI 10.1378/chest.130.5.1596; Innes KE, 2011, SLEEP MED, V12, P623, DOI 10.1016/j.sleep.2010.12.018; Lakshminarayanan S, 2005, MOVEMENT DISORD, V20, P501, DOI 10.1002/mds.20366; Montplaisir J, 1997, MOVEMENT DISORD, V12, P61, DOI 10.1002/mds.870120111; Nichols DA, 2003, ARCH INTERN MED, V163, P2323, DOI 10.1001/archinte.163.19.2323; Nomura T, 2008, MOVEMENT DISORD, V23, P2363, DOI 10.1002/mds.22274; OKEEFFE ST, 1994, AGE AGEING, V23, P200, DOI 10.1093/ageing/23.3.200; Rodrigues RND, 2006, SLEEP MED, V7, P235, DOI 10.1016/j.sleep.2005.06.009; Sun ER, 1998, SLEEP, V21, P371, DOI 10.1093/sleep/21.4.381; Tasdemir M, 2010, SLEEP MED, V11, P82, DOI 10.1016/j.sleep.2008.10.008; Ulfberg J, 2001, EUR NEUROL, V46, P17, DOI 10.1159/000050750	23	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71499	10.1371/journal.pone.0071499	http://dx.doi.org/10.1371/journal.pone.0071499			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977057	gold, Green Published, Green Submitted			2022-12-25	WOS:000323425700060
J	Lu, Q; Harris, VA; Sun, XT; Hou, YL; Black, SM				Lu, Qing; Harris, Valerie A.; Sun, Xutong; Hou, Yali; Black, Stephen M.			Ca2+/Calmodulin-Dependent Protein Kinase II Contributes to Hypoxic Ischemic Cell Death in Neonatal Hippocampal Slice Cultures	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; FOCAL CEREBRAL-ISCHEMIA; TRANSIENT FOREBRAIN ISCHEMIA; BRAIN-INJURY; CALMODULIN ANTAGONIST; OXIDATIVE STRESS; MOUSE-BRAIN; RAT-BRAIN; DEVELOPMENTAL-CHANGES; SIGNALING PATHWAY	We have recently shown that p38MAP kinase (p38MAPK) stimulates ROS generation via the activation of NADPH oxidase during neonatal hypoxia-ischemia (HI) brain injury. However, how p38MAPK is activated during HI remains unresolved and was the focus of this study. Ca2+/calmodulin-dependent protein kinase II (CaMKII) plays a key role in brain synapse development, neural transduction and synaptic plasticity. Here we show that CaMKII activity is stimulated in rat hippocampal slice culture exposed to oxygen glucose deprivation (OGD) to mimic the condition of HI. Further, the elevation of CaMKII activity, correlated with enhanced p38MAPK activity, increased superoxide generation from NADPH oxidase as well as necrotic and apoptotic cell death. All of these events were prevented when CaMKII activity was inhibited with KN93. In a neonatal rat model of HI, KN93 also reduced brain injury. Our results suggest that CaMKII activation contributes to the oxidative stress associated with neural cell death after HI.	[Lu, Qing; Harris, Valerie A.; Sun, Xutong; Hou, Yali; Black, Stephen M.] Georgia Regents Univ, Vasc Biol Ctr, Augusta, GA USA	University System of Georgia; Augusta University	Black, SM (corresponding author), Georgia Regents Univ, Vasc Biol Ctr, Augusta, GA USA.	sblack@gru.edu			National Institute of Child Health and Human Development [039110]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039110] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded in part by National Institute of Child Health and Human Development grant number 039110 to SMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ARONOWSKI J, 1992, J NEUROCHEM, V58, P1743, DOI 10.1111/j.1471-4159.1992.tb10049.x; Ashpole NM, 2012, J BIOL CHEM, V287, P8495, DOI 10.1074/jbc.M111.323915; Ashpole NM, 2011, MOL CELL NEUROSCI, V46, P720, DOI 10.1016/j.mcn.2011.02.003; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Black SM, 1995, NEUROBIOL DIS, V2, P145, DOI 10.1006/nbdi.1995.0016; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bracewell M, 2002, MENT RETARD DEV D R, V8, P241, DOI 10.1002/mrdd.10049; Chaudhari T, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006817.pub2; Cronberg T, 2004, STROKE, V35, P753, DOI 10.1161/01.STR.0000117576.09512.32; Davies KD, 2007, BRAIN RES, V1158, P39, DOI 10.1016/j.brainres.2007.05.008; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Enslen H, 1998, J BIOL CHEM, V273, P1741, DOI 10.1074/jbc.273.3.1741; Fabian RH, 2008, AM J PHYSIOL-HEART C, V295, pH1809, DOI 10.1152/ajpheart.00301.2007; Ferrer I, 2003, ACTA NEUROPATHOL, V105, P425, DOI 10.1007/s00401-002-0661-2; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; Ferriero DM, 2001, DEV NEUROSCI-BASEL, V23, P198, DOI 10.1159/000046143; Gao J, 2005, NEURON, V48, P635, DOI 10.1016/j.neuron.2005.10.011; GIDDAY JM, 1995, PEDIATR RES, V38, P306, DOI 10.1203/00006450-199509000-00006; GIDDAY JM, 1994, NEUROSCI LETT, V168, P221, DOI 10.1016/0304-3940(94)90455-3; Glass HC, 2011, PEDIATR RES, V70, P535, DOI 10.1203/PDR.0b013e31822f24c7; HAGBERG H, 1992, DEV PHARMACOL THERAP, V18, P139, DOI 10.1159/000480613; HAJIMOHAMMADREZA I, 1995, J NEUROSCI, V15, P4093; HASHIMOTO Y, 1987, ARCH BIOCHEM BIOPHYS, V252, P418, DOI 10.1016/0003-9861(87)90048-8; He XQ, 2012, INT J NEUROSCI, V122, P532, DOI 10.3109/00207454.2012.686544; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Ingram AJ, 2000, AM J PHYSIOL-RENAL, V279, pF243, DOI 10.1152/ajprenal.2000.279.2.F243; Ishida A, 2001, BRAIN DEV-JPN, V23, P349, DOI 10.1016/S0387-7604(01)00237-6; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Jiang Y, 1997, J BIOL CHEM, V272, P30122, DOI 10.1074/jbc.272.48.30122; Johnston MV, 2002, NEUROSCIENTIST, V8, P212, DOI 10.1177/1073858402008003007; Johnston MV, 2001, PEDIATR RES, V49, P735, DOI 10.1203/00006450-200106000-00003; Jourdain P, 2003, J NEUROSCI, V23, P10645; Katsura KI, 2003, ACT NEUR S, V86, P113; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Khan JY, 2003, PEDIATR RES, V54, P77, DOI 10.1203/01.PDR.0000065736.69214.20; KOLB B, 1989, PROG NEUROBIOL, V32, P235, DOI 10.1016/0301-0082(89)90023-3; Kuroda S, 1997, STROKE, V28, P2539, DOI 10.1161/01.STR.28.12.2539; Lafemina MJ, 2006, PEDIATR RES, V59, P680, DOI 10.1203/01.pdr.0000214891.35363.6a; Lennmyr F, 2002, ACTA NEUROL SCAND, V106, P333, DOI 10.1034/j.1600-0404.2002.01313.x; LIN TN, 1993, STROKE, V24, P117, DOI 10.1161/01.STR.24.1.117; Lu Q, 2012, FREE RADIC BIOL MED; Lu Q, 2011, EUR J NEUROSCI, V34, P1093, DOI 10.1111/j.1460-9568.2011.07786.x; MacDonnell SM, 2009, CIRC RES, V105, P316, DOI 10.1161/CIRCRESAHA.109.194035; McLean CW, 2005, DEV NEUROSCI-BASEL, V27, P169, DOI 10.1159/000085989; Mengesdorf T, 2002, NEUROCHEM RES, V27, P477, DOI 10.1023/A:1019844518704; Mishra OP, 2006, NEUROSCIENCE, V140, P857, DOI 10.1016/j.neuroscience.2006.02.060; Muramatsu K, 2000, DEV BRAIN RES, V123, P119, DOI 10.1016/S0165-3806(00)00088-2; Nito C, 2008, J CEREBR BLOOD F MET, V28, P1686, DOI 10.1038/jcbfm.2008.60; Nozaki K, 2001, MOL NEUROBIOL, V23, P1, DOI 10.1385/MN:23:1:01; Ochiishi T, 1998, BRAIN RES, V790, P129, DOI 10.1016/S0006-8993(98)00058-4; Osuka K, 2002, J CEREBR BLOOD F MET, V22, P1098, DOI 10.1097/00004647-200209000-00007; Pfeilschifter J, 1996, FEBS LETT, V396, P67, DOI 10.1016/0014-5793(96)01070-8; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Rao SM, 2011, DEV NEUROSCI-BASEL, V33, P288, DOI 10.1159/000327241; Rau TF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047877, 10.1371/journal.pone.0040881]; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Saeed SA, 2007, EXP BRAIN RES, V182, P1, DOI 10.1007/s00221-007-1050-9; Salas MA, 2010, J MOL CELL CARDIOL, V48, P1298, DOI 10.1016/j.yjmcc.2009.12.015; Sato T, 1999, EUR J PHARMACOL, V370, P117, DOI 10.1016/S0014-2999(99)00133-8; Schumacher AM, 2002, BBA-PROTEINS PROTEOM, V1600, P128, DOI 10.1016/S1570-9639(02)00453-3; Sebeo J, 2009, J NEUROSCI, V29, P9778, DOI 10.1523/JNEUROSCI.2613-09.2009; Siesjo BK, 1999, ACTA NEUROCHIR SUPPL, V73, P7; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; Stack EC, 2010, J NEUROCHEM, V112, P271, DOI 10.1111/j.1471-4159.2009.06452.x; Sugino T, 2000, J NEUROSCI, V20, P4506, DOI 10.1523/JNEUROSCI.20-12-04506.2000; SUGIURA H, 1992, BRAIN RES, V593, P97, DOI 10.1016/0006-8993(92)91269-K; Taha S, 2002, NEURON, V36, P483, DOI 10.1016/S0896-6273(02)00966-2; Takagi K, 2001, NEUROL RES, V23, P662, DOI 10.1179/016164101101198992; Takeda K, 2004, EMBO REP, V5, P161, DOI 10.1038/sj.embor.7400072; Tang KX, 2004, J NEUROCHEM, V91, P429, DOI 10.1111/j.1471-4159.2004.02733.x; Ten VS, 2010, J NEUROSCI, V30, P2077, DOI 10.1523/JNEUROSCI.5249-09.2010; Uto Takuhiro, 2008, Dev Neurosci, V30, P410, DOI 10.1159/000191212; Vest RS, 2010, J BIOL CHEM, V285, P20675, DOI 10.1074/jbc.M109.088617; Viberg H, 2008, NEUROTOXICOLOGY, V29, P152, DOI 10.1016/j.neuro.2007.10.007; Vila-Petroff M, 2007, CARDIOVASC RES, V73, P689, DOI 10.1016/j.cardiores.2006.12.003; Wallace BK, 2012, AM J PHYSIOL-CELL PH, V302, pC505, DOI 10.1152/ajpcell.00261.2011; Waxham MN, 1996, J CEREBR BLOOD F MET, V16, P1, DOI 10.1097/00004647-199601000-00001; Yu L, 2011, DEV NEUROSCI-BASEL, V33, P312, DOI 10.1159/000327244; Yu Z, 2009, AM J PHYSIOL-HEART C, V297, pH735, DOI 10.1152/ajpheart.01164.2008	79	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e70750	10.1371/journal.pone.0070750	http://dx.doi.org/10.1371/journal.pone.0070750			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23976956	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700008
J	Neergaard-Petersen, S; Ajjan, R; Hvas, AM; Hess, K; Larsen, SB; Kristensen, SD; Grove, EL				Neergaard-Petersen, Sos; Ajjan, Ramzi; Hvas, Anne-Mette; Hess, Katharina; Larsen, Sanne Bojet; Kristensen, Steen Dalby; Grove, Erik Lerkevang			Fibrin Clot Structure and Platelet Aggregation in Patients with Aspirin Treatment Failure	PLOS ONE			English	Article							ORAL ANTIPLATELET DRUGS; C-REACTIVE PROTEIN; INTERINDIVIDUAL VARIABILITY; CORONARY; RESISTANCE; NETWORK; LYSIS; INFLAMMATION; MECHANISMS; COUNT	Background: Aspirin is a cornerstone in prevention of cardiovascular events and modulates both platelet aggregation and fibrin clot formation. Some patients experience cardiovascular events whilst on aspirin, often termed aspirin treatment failure (ATF). This study evaluated both platelet aggregation and fibrin clot structure in patients with ATF. Methods: We included 177 stable coronary artery disease patients on aspirin monotherapy. Among these, 116 (66%) had ATF defined as myocardial infarction (MI) whilst on aspirin. Platelet aggregation was assessed by Multiplate (R) aggregometry and VerifyNow (R), whereas turbidimetric assays and scanning electron microscopy were employed to study fibrin clot characteristics. Results: Enhanced platelet aggregation was observed in patients with ATF compared with non-MI patients following stimulation with arachidonic acid 1.0 mM (median 161 (IQR 95; 222) vs. 97 (60; 1776) AU*min, p = 0.005) and collagen 1.0 mu g/mL (293 (198; 427) vs. 220 (165; 370) AU*min, p = 0.03). Similarly, clot maximum absorbance, a measure of fibrin network density, was increased in patients with ATF (0.48 (0.41; 0.52) vs. 0.42 (0.38; 0.50), p = 0.02), and this was associated with thinner fibres (mean +/- SD: 119.7 +/- 27.5 vs. 127.8 +/- 31.1 nm, p = 0.003) and prolonged lysis time (552 (498; 756) vs. 519 (468; 633) seconds; p = 0.02). Patients with ATF also had increased levels of C-reactive protein (CRP) (1.34 (0.48; 2.94) and 0.88 (0.32; 1.77) mg/L, p = 0.01) compared with the non-MI group. Clot maximum absorbance correlated with platelet aggregation (r = 0.31-0.35, p-values<0.001) and CRP levels (r = 0.60, p<0.001). Conclusions: Patients with aspirin treatment failure showed increased platelet aggregation and altered clot structure with impaired fibrinolysis compared with stable CAD patients without previous MI. These findings suggest that an increased risk of aspirin treatment failure may be identified by measuring both platelet function and fibrin clot structure.	[Neergaard-Petersen, Sos; Larsen, Sanne Bojet; Kristensen, Steen Dalby; Grove, Erik Lerkevang] Aarhus Univ Hosp, Dept Cardiol, DK-8000 Aarhus, Denmark; [Neergaard-Petersen, Sos; Ajjan, Ramzi; Grove, Erik Lerkevang] Univ Leeds, Div Cardiovasc & Diabet Res, Leeds Inst Genet Hlth & Therapeut, Leeds, W Yorkshire, England; [Hvas, Anne-Mette] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark; [Hess, Katharina] Univ Hosp Aachen, Dept Internal Med, Aachen, Germany	Aarhus University; University of Leeds; Aarhus University; RWTH Aachen University; RWTH Aachen University Hospital	Grove, EL (corresponding author), Aarhus Univ Hosp, Dept Cardiol, DK-8000 Aarhus, Denmark.	erikgrove@dadlnet.dk		Grove, Erik/0000-0002-1466-0865	Danish Agency for Science, Technology and Innovation [2101-05-0052]; Aarhus University; AstraZeneca; British Heart Foundation [PG/09/020/26305] Funding Source: researchfish	Danish Agency for Science, Technology and Innovation; Aarhus University; AstraZeneca(AstraZeneca); British Heart Foundation(British Heart Foundation)	The study was financially supported be the Danish Agency for Science, Technology and Innovation (grant number 2101-05-0052), Aarhus University and a travel grant from AstraZeneca to ELG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajjan R, 2005, THROMB HAEMOSTASIS, V94, P1048, DOI 10.1160/TH05-06-0384; Ajjan RA, 2009, ARTERIOSCL THROM VAS, V29, P712, DOI 10.1161/ATVBAHA.109.183707; Ajjan R, 2006, ATHEROSCLEROSIS, V186, P240, DOI 10.1016/j.atherosclerosis.2005.10.042; Al-Barjas HS, 2006, ANGIOLOGY, V57, P607, DOI 10.1177/0003319706293132; Amelot AA, 2007, J BIOL CHEM, V282, P710, DOI 10.1074/jbc.M606650200; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Barua RS, 2010, ARTERIOSCL THROM VAS, V30, P75, DOI 10.1161/ATVBAHA.109.195024; Carter AM, 2007, ARTERIOSCL THROM VAS, V27, P2783, DOI 10.1161/ATVBAHA.107.153221; Collet JP, 2006, ARTERIOSCL THROM VAS, V26, P2567, DOI 10.1161/01.ATV.0000241589.52950.4c; Collet JP, 2000, ARTERIOSCL THROM VAS, V20, P1354, DOI 10.1161/01.ATV.20.5.1354; Corrado E, 2010, J ATHEROSCLER THROMB, V17, P1, DOI 10.5551/jat.2600; Dunn EJ, 2005, DIABETOLOGIA, V48, P1198, DOI 10.1007/s00125-005-1742-2; Dunn EJ, 2006, DIABETOLOGIA, V49, P1071, DOI 10.1007/s00125-006-0197-4; Freynhofer MK, 2012, CURR PHARM DESIGN, V18, P5197; Gajos G, 2011, ARTERIOSCL THROM VAS, V31, P1696, DOI 10.1161/ATVBAHA.111.228593; Grove EL, 2011, J THROMB HAEMOST, V9, P185, DOI 10.1111/j.1538-7836.2010.04115.x; Grove EL, 2012, CURR PHARM DESIGN, V18, P5379; Grove EL, 2010, THROMB HAEMOSTASIS, V103, P1245, DOI 10.1160/TH09-08-0527; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; He S, 2009, J CARDIOVASC PHARM, V53, P24, DOI 10.1097/FJC.0b013e3181953e0f; Hooper JMW, 2012, J CLIN ENDOCR METAB, V97, P1463, DOI 10.1210/jc.2011-2894; Krasopoulos G, 2008, BMJ-BRIT MED J, V336, P195, DOI 10.1136/bmj.39430.529549.BE; Kuliczkowski W, 2009, EUR HEART J, V30, P426, DOI 10.1093/eurheartj/ehn562; Larsen SB, 2012, THROMB HAEMOSTASIS, V108, P140, DOI 10.1160/TH12-01-0026; Leander K, 2012, THROMB HAEMOSTASIS, V107, P1092, DOI 10.1160/TH11-11-0760; Margolis DJ, 2008, PHARMACOEPIDEM DR S, V17, P753, DOI 10.1002/pds.1630; Mills JD, 2002, CIRCULATION, V106, P1938, DOI 10.1161/01.CIR.0000033221.73082.06; Mortensen SB, 2010, THROMB RES, V126, pE318, DOI 10.1016/j.thromres.2010.03.013; Mutch NJ, 2010, BLOOD, V115, P3980, DOI 10.1182/blood-2009-11-254029; Osmancik P, 2012, J THROMB THROMBOLYS, V33, P349, DOI 10.1007/s11239-011-0659-5; PATRONO C, 1980, THROMB RES, V17, P317, DOI 10.1016/0049-3848(80)90066-3; Patrono C, 2007, NAT CLIN PRACT CARD, V4, P42, DOI 10.1038/ncpcardio0728; Scott EM, 2004, ARTERIOSCL THROM VAS, V24, P1558, DOI 10.1161/01.ATV.0000136649.83297.bf; Undas A, 2007, J THROMB HAEMOST, V5, P1988, DOI 10.1111/j.1538-7836.2007.02637.x; Undas A, 2008, NEPHROL DIAL TRANSPL, V23, P2010, DOI 10.1093/ndt/gfm884; Undas A, 2008, ATHEROSCLEROSIS, V196, P551, DOI 10.1016/j.atherosclerosis.2007.05.028; Wurtz M, 2012, CURR PHARM DESIGN, V18, P5344, DOI 10.2174/138161212803251925; Wurtz M, 2012, THROMB RES, V129, P56, DOI 10.1016/j.thromres.2011.08.019	38	27	27	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71150	10.1371/journal.pone.0071150	http://dx.doi.org/10.1371/journal.pone.0071150			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23976993	gold, Green Published, Green Submitted			2022-12-25	WOS:000323425700023
J	Schock-Kusch, D; Geraci, S; Ermeling, E; Shulhevich, Y; Sticht, C; Hesser, J; Stsepankou, D; Neudecker, S; Pill, J; Schmitt, R; Melk, A				Schock-Kusch, Daniel; Geraci, Stefania; Ermeling, Esther; Shulhevich, Yury; Sticht, Carsten; Hesser, Juergen; Stsepankou, Dzmitry; Neudecker, Sabine; Pill, Johannes; Schmitt, Roland; Melk, Anette			Reliability of Transcutaneous Measurement of Renal Function in Various Strains of Conscious Mice	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; FLUORESCEIN-LABELED SINISTRIN; CR-51-EDTA PLASMA; FITC-SINISTRIN; GFR-ESTIMATION; CLEARANCE; MARKER; RATS; PRECISION; DISEASE	Measuring renal function in laboratory animals using blood and/or urine sampling is not only labor-intensive but puts also a strain on the animal. Several approaches for fluorescence based transcutaneous measurement of the glomerular filtration rate (GFR) in laboratory animals have been developed. They allow the measurement of GFR based on the elimination kinetics of fluorescent exogenous markers. None of the studies dealt with the reproducibility of the measurements in the same animals. Therefore, the reproducibility of a transcutaneous GFR assessment method was investigated using the fluorescent renal marker FITC-Sinistrin in conscious mice in the present study. We performed two transcutaneous GFR measurements within three days in five groups of mice (Balb/c, C57BL/6, SV129, NMRI at 3-4 months of age, and a group of 24 months old C57BL/6). Data were evaluated regarding day-to-day reproducibility as well as intra- and inter-strain variability of GFR and the impact of age on these parameters. No significant differences between the two subsequent GFR measurements were detected. Fastest elimination for FITC-Sinistrin was detected in Balb/c with significant differences to C57BL/6 and SV129 mice. GFR decreased significantly with age in C57BL/6 mice. Evaluation of GFR in cohorts of young and old C57BL/6 mice from the same supplier showed high consistency of GFR values between groups. Our study shows that the investigated technique is a highly reproducible and reliable method for repeated GFR measurements in conscious mice. This gentle method is easily used even in old mice and can be used to monitor the age-related decline in GFR.	[Schock-Kusch, Daniel; Geraci, Stefania; Sticht, Carsten; Neudecker, Sabine] Heidelberg Univ, Med Fac Mannheim, Med Res Ctr, Mannheim, Germany; [Ermeling, Esther; Schmitt, Roland] Hannover Med Sch, Dept Nephrol, Hannover, Germany; [Ermeling, Esther; Melk, Anette] Hannover Med Sch, Childrens Hosp, Dept Kidney Liver & Metab Dis, Hannover, Germany; [Shulhevich, Yury; Hesser, Juergen; Stsepankou, Dzmitry] Heidelberg Univ, Med Fac Mannheim, Mannheim, Germany; [Pill, Johannes] Mannheim Pharma & Diagnost GmbH Mannheim, Mannheim, Germany	Ruprecht Karls University Heidelberg; Hannover Medical School; Hannover Medical School; Ruprecht Karls University Heidelberg	Schock-Kusch, D (corresponding author), Heidelberg Univ, Med Fac Mannheim, Med Res Ctr, Mannheim, Germany.	d.schock-kusch@hs-mannheim.de	Neudecker, Sabine/E-4771-2011; Schmitt, Roland/AAP-4609-2021	Schmitt, Roland/0000-0003-4415-8355	Fresenius Medical Care AG Co. KGaA; ITN Marie-Curie EU-Framework Programme 7: NephroTools; EU-Framework Programme 7: PLACE-it; Deutsche Forschungsgemeinschaft [Sonderforschungsbereich SFB 738, C8]	Fresenius Medical Care AG Co. KGaA; ITN Marie-Curie EU-Framework Programme 7: NephroTools; EU-Framework Programme 7: PLACE-it; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	YS was supported by a grant (nephrocore) from Fresenius Medical Care AG & Co. KGaA. SG was supported by ITN Marie-Curie EU-Framework Programme 7: NephroTools. D S-K was supported by the EU-Framework Programme 7: PLACE-it. Anette Melk and Roland Schmitt were supported by a grant from the Deutsche Forschungsgemeinschaft (Sonderforschungsbereich SFB 738, project C8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blake GM, 1997, NUCL MED COMMUN, V18, P776, DOI 10.1097/00006231-199708000-00012; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Chinen LK, 2008, J MED CHEM, V51, P957, DOI 10.1021/jm070842+; Dorshow RB, 1998, J BIOMED OPT, V3, P340, DOI 10.1117/1.429854; Eisner C, 2010, KIDNEY INT, V77, P519, DOI 10.1038/ki.2009.501; FLORIJN KW, 1994, KIDNEY INT, V46, P252, DOI 10.1038/ki.1994.267; Gaspari F, 1998, J AM SOC NEPHROL, V9, P310; HACKBARTH H, 1981, LAB ANIM, V15, P267, DOI 10.1258/002367781780893731; HACKBARTH H, 1982, J GERONTOL, V37, P540, DOI 10.1093/geronj/37.5.540; Kampa N, 2003, J VET MED A, V50, P37, DOI 10.1046/j.1439-0442.2003.00494.x; Kjaergaard KD, 2011, SCAND J CLIN LAB INV, V71, P663, DOI 10.3109/00365513.2011.619565; Pill J, 2005, EUR J MED CHEM, V40, P1056, DOI 10.1016/j.ejmech.2005.03.020; Pill J, 2005, ANAL BIOANAL CHEM, V382, P59, DOI 10.1007/s00216-005-3155-y; Pill J, 2006, N-S ARCH PHARMACOL, V373, P204, DOI 10.1007/s00210-006-0067-0; Poreddy AR, 2012, BIOORGAN MED CHEM, V20, P2490, DOI 10.1016/j.bmc.2012.03.015; Rabito CA, 2005, APPL OPTICS, V44, P5956, DOI 10.1364/AO.44.005956; Rajagopalan R, 2011, J MED CHEM, V54, P5048, DOI 10.1021/jm200257k; Sadick M, 2011, NEPHROL DIAL TRANSPL, V26, P3101, DOI 10.1093/ndt/gfr148; Schock-Kusch D, 2012, KIDNEY INT, V82, P314, DOI 10.1038/ki.2012.117; Schock-Kusch D, 2011, KIDNEY INT, V79, P1254, DOI 10.1038/ki.2011.31; Schock-Kusch D, 2009, NEPHROL DIAL TRANSPL, V24, P2997, DOI 10.1093/ndt/gfp225; Schreiber A, 2012, AM J PHYSIOL-RENAL, V303, pF783, DOI 10.1152/ajprenal.00279.2012; Wang E, 2012, KIDNEY INT, V81, P112, DOI 10.1038/ki.2011.294; WILKINSON J, 1990, NUCL MED COMMUN, V11, P697, DOI 10.1097/00006231-199010000-00005; Yu WM, 2007, AM J PHYSIOL-RENAL, V292, pF1873, DOI 10.1152/ajprenal.00218.2006	25	41	42	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71519	10.1371/journal.pone.0071519	http://dx.doi.org/10.1371/journal.pone.0071519			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977062	gold, Green Published, Green Submitted			2022-12-25	WOS:000323425700064
J	Syrogiannopoulos, GA; Grivea, IN; Al-Lahham, A; Panagiotou, M; Tsantouli, AG; Reinert, ANMRR; van der Linden, M				Syrogiannopoulos, George A.; Grivea, Ioanna N.; Al-Lahham, Adnan; Panagiotou, Maria; Tsantouli, Alexandra G.; Reinert, Aspasia N. Michoula Ralf Rene; van der Linden, Mark			Seven-Year Surveillance of emm Types of Pediatric Group A Streptococcal Pharyngitis Isolates in Western Greece	PLOS ONE			English	Article							MACROLIDE-RESISTANT; ERYTHROMYCIN-RESISTANT; VACCINE IMPLICATIONS; PYOGENES STRAINS; UNITED-STATES; IMMUNOGENICITY; EPIDEMIOLOGY; INFECTION; SPAIN; SUSCEPTIBILITIES	Background: An experimental 26-valent M protein Group A streptococcal (GAS) vaccine has entered clinical studies. Pharyngeal GAS emm type surveillances in different areas and time-periods enhance the understanding of the epidemiology of GAS pharyngitis. Moreover, these surveillances, combined with the data on GAS invasive disease, can play a significant role in the formulation of multivalent type-specific vaccines. Methods: During a 7-year period (1999-2005), 2408 GAS isolates were recovered from consecutive children with pharyngitis in Western Greece. The overall macrolide resistance rate was 22.8%. Along the study period we noted a tendency towards significantly decreased rates of resistance, with the lowest rates occurring in 2002 (15.3%), 2003 (15%) and 2004 (16.7%). A random sample of isolates from each year, 338 (61.7%) of the 548 macrolide-resistant and 205 (11%) of the macrolide-susceptible, underwent molecular analysis, including emm typing. Results: The 543 typed isolates had 28 different emm types. A statistically significant association was found between macrolide resistance and emm4, emm22 and emm77, whereas emm1, emm3, emm6, emm12, emm87 and emm89 were associated with macrolide susceptibility. A significant yearly fluctuation was observed in emm4, emm28 and emm77. The most common macrolide-resistant GAS were emm77 isolates harboring erm(A), either alone or in combination with mef(A), emm4 carrying mef(A), emm28 possessing erm(B), emm75 carrying mef(A), emm12 harboring mef(A) and emm22 carrying erm(A). We estimated that 82.8% of the isolates belonged to emm types included in the novel 26-valent M protein vaccine. The vaccine coverage rate was determined mainly by the increased frequency of nonvaccine emm4 isolates. Conclusions: A limited number of emm types dominated among macrolide-susceptible and macrolide-resistant GAS isolates. We observed seasonal fluctuations, which were significant for emm4, emm28 and emm77. This type of data can serve as baseline information if the novel 26-valent M protein GAS vaccine is introduced into practice.	[Syrogiannopoulos, George A.; Grivea, Ioanna N.; Panagiotou, Maria; Tsantouli, Alexandra G.; Reinert, Aspasia N. Michoula Ralf Rene] Univ Thessaly, Sch Hlth Sci, Fac Med, Gen Univ Hosp Larissa, Biopolis, Larissa, Greece; [Al-Lahham, Adnan; Reinert, Aspasia N. Michoula Ralf Rene; van der Linden, Mark] Univ Hosp, Inst Med Microbiol, Aachen, Germany; [Al-Lahham, Adnan; Reinert, Aspasia N. Michoula Ralf Rene; van der Linden, Mark] Univ Hosp, Natl Reference Ctr Streptococci, Aachen, Germany; [Al-Lahham, Adnan] German Jordanian Univ, Sch Appl Med Sci, Amman, Jordan; [Panagiotou, Maria] Univ Patras, Sch Hlth Sci, Fac Med, Gen Univ Hosp Patras, Patras, Greece	General University Hospital of Larissa; University of Thessaly; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; German-Jordanian University; University of Patras	Syrogiannopoulos, GA (corresponding author), Univ Thessaly, Sch Hlth Sci, Fac Med, Gen Univ Hosp Larissa, Biopolis, Larissa, Greece.	syrogian@otenet.gr	van der Linden, Mark/B-9305-2009	van der Linden, Mark/0000-0002-6574-4313	German Ministry of Health (Bundesministerium fur Gesundheit); Research Committee of the University of Thessaly [3089]	German Ministry of Health (Bundesministerium fur Gesundheit); Research Committee of the University of Thessaly	This study was supported by a grant from the German Ministry of Health (Bundesministerium fur Gesundheit) and the 3089 grant from the Research Committee of the University of Thessaly. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2003, J CLIN MICROBIOL, V41, P2385, DOI 10.1128/JCM.41.6.2385-2390.2003; Ardanuy C, 2010, J ANTIMICROB CHEMOTH, V65, P634, DOI 10.1093/jac/dkq006; BEACHEY EH, 1981, NATURE, V292, P457, DOI 10.1038/292457a0; Beall B, 1996, J CLIN MICROBIOL, V34, P953, DOI 10.1128/JCM.34.4.953-958.1996; Bingen E, 2004, ANTIMICROB AGENTS CH, V48, P3559, DOI 10.1128/AAC.48.9.3559-3562.2004; Bisno AL, 2003, LANCET INFECT DIS, V3, P191, DOI 10.1016/S1473-3099(03)00576-0; Brandt CM, 2001, MICROB DRUG RESIST, V7, P165, DOI 10.1089/10766290152045039; Cohen-Poradosu R, 2007, CLIN INFECT DIS, V45, P863, DOI 10.1086/521263; Daikos GL, 2008, DIAGN MICR INFEC DIS, V60, P393, DOI 10.1016/j.diagmicrobio.2007.10.020; Dale JB, 2011, VACCINE, V29, P8175, DOI 10.1016/j.vaccine.2011.09.005; Dale JB, 1999, VACCINE, V17, P193, DOI 10.1016/S0264-410X(98)00150-9; DALE JB, 1986, J EXP MED, V163, P1191, DOI 10.1084/jem.163.5.1191; Dale JB, 1996, VACCINE, V14, P944, DOI 10.1016/0264-410X(96)00050-3; Darenberg J, 2007, CLIN INFECT DIS, V45, P450, DOI 10.1086/519936; Dicuonzo G, 2002, ANTIMICROB AGENTS CH, V46, P3987, DOI 10.1128/AAC.46.12.3987-3990.2002; Giovanetti E, 1999, ANTIMICROB AGENTS CH, V43, P1935, DOI 10.1128/AAC.43.8.1935; Grivea IN, 2006, ANTIMICROB AGENTS CH, V50, P256, DOI 10.1128/AAC.50.1.256-261.2006; Hu MC, 2002, INFECT IMMUN, V70, P2171, DOI 10.1128/IAI.70.4.2171-2177.2002; Jaggi P, 2005, PEDIATR INFECT DIS J, V24, P1089, DOI 10.1097/01.inf.0000190023.89759.96; Jaggi P, 2009, EUR J PEDIATR, V168, P679, DOI 10.1007/s00431-008-0819-6; JONES KF, 1985, J EXP MED, V161, P623, DOI 10.1084/jem.161.3.623; Kafetzis DA, 2005, EUR J CLIN MICROBIOL, V24, P68, DOI 10.1007/s10096-004-1274-6; LANCEFIELD RC, 1962, J IMMUNOL, V89, P307; Luca-Harari B, 2009, J CLIN MICROBIOL, V47, P1155, DOI 10.1128/JCM.02155-08; Malli E, 2010, INT J ANTIMICROB AG, V35, P614, DOI 10.1016/j.ijantimicag.2010.01.025; Mazzariol A, 2007, J CHEMOTHERAPY, V19, P500, DOI 10.1179/joc.2007.19.5.500; McNeil SA, 2005, CLIN INFECT DIS, V41, P1114, DOI 10.1086/444458; Michos AG, 2009, DIAGN MICR INFEC DIS, V64, P295, DOI 10.1016/j.diagmicrobio.2009.03.004; O'Loughlin RE, 2007, CLIN INFECT DIS, V45, P853, DOI 10.1086/521264; PODBIELSKI A, 1991, MED MICROBIOL IMMUN, V180, P213; Rivera A, 2006, J MED MICROBIOL, V55, P1115, DOI 10.1099/jmm.0.46481-0; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Rubio-Lopez V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-215; Safar A, 2011, EMERG INFECT DIS, V17, P983, DOI [10.3201/eid1706.100804, 10.3201/eid/1706.100804]; Shea PR, 2011, EMERG INFECT DIS, V17, P2010, DOI 10.3201/eid1711.110159; Shulman ST, 2009, CLIN INFECT DIS, V49, P78, DOI 10.1086/599344; Silva-Costa C, 2008, CLIN MICROBIOL INFEC, V14, P1152, DOI 10.1111/j.1469-0691.2008.02104.x; Silva-Costa C, 2005, ANTIMICROB AGENTS CH, V49, P2109, DOI 10.1128/AAC.49.5.2109-2111.2005; Silva-Costa C, 2012, ANTIMICROB AGENTS CH, V56, P5661, DOI 10.1128/AAC.01133-12; Steer AC, 2009, LANCET INFECT DIS, V9, P611, DOI 10.1016/S1473-3099(09)70178-1; Stevens DL, 1999, STREPTOCOCCAL INFECTIONS, P19; Syrogiannopoulos GA, 2004, PEDIATR INFECT DIS J, V23, P857, DOI 10.1097/01.inf.0000138080.74674.a2; Tanz RR, 2004, CLIN INFECT DIS, V39, P1794, DOI 10.1086/426025; Van Heirstraeten L, 2012, EMERG INFECT DIS, V18, P1515, DOI 10.3201/eid1809.120049; Zampaloni C, 2003, J CLIN MICROBIOL, V41, P1307, DOI 10.1128/JCM.41.3.1307-1310.2003	45	20	23	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71558	10.1371/journal.pone.0071558	http://dx.doi.org/10.1371/journal.pone.0071558			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977078	Green Published, gold, Green Submitted			2022-12-25	WOS:000323425700070
J	Guo, YJ; Liu, YW; Huang, XJ; Rong, Y; He, MA; Wang, YJ; Yuan, J; Wu, TC; Chen, WH				Guo, Yanjun; Liu, Yuewei; Huang, Xiji; Rong, Yi; He, Meian; Wang, Youjie; Yuan, Jing; Wu, Tangchun; Chen, Weihong			The Effects of Shift Work on Sleeping Quality, Hypertension and Diabetes in Retired Workers	PLOS ONE			English	Article							NIGHT-SHIFT; ROTATING SHIFTS; BLOOD-PRESSURE; RISK; MELLITUS; NURSES; DEPRIVATION; DISORDERS; SCHEDULES; DURATION	Background: Shift work has been associated with adverse health effects by disturbing circadian rhythms. However, its potential long-term health effects and the persistent effects after leaving shifts have not been well established. Methods and Results: We studied 26,463 workers from Tongji-Dongfeng Cohort in China. All the participants are retired employees of Dongfeng Motor Company. Information on demographics, occupational history and medical history were gathered through questionnaires. After adjusting potential confounders in the logistic regression models, shift work was associated with poor sleeping quality, diabetes and hypertension independently. We observed significant effects of shift work on poor sleeping quality, diabetes and hypertension; the ORs (95%CI) are 1.18 (1.09-1.27), 1.10 (1.03-1.17) and 1.05 (1.01-1.09) respectively. In the further analysis, we found elevated ORs (95%CI) for participants with poor sleeping quality, the ORs (95%CI) are 1.34 (1.08-1.60), 1.13 (1.05-1.21), 1.05 (1.03-1.07) and 1.05 (1.01-1.09) for 1-4, 5-9, 10-19, >= 20 years of shift work respectively. However, with the extension of leaving shift work duration, the effects of shift work on sleep quality gradually reduced. Conclusions: Shift work may be an independent risk factor for sleeping quality, diabetes and hypertension even in retired workers. Applicable intervention strategies are needed for prevention of sleep loss, diabetes, and hypertension for shift workers.	[Guo, Yanjun; Liu, Yuewei; Huang, Xiji; Rong, Yi; He, Meian; Wang, Youjie; Yuan, Jing; Wu, Tangchun; Chen, Weihong] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Occupat & Environm Hlth, Wuhan 430074, Peoples R China; [Guo, Yanjun; Liu, Yuewei; Huang, Xiji; Rong, Yi; He, Meian; Wang, Youjie; Yuan, Jing; Wu, Tangchun; Chen, Weihong] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Key Lab Environm & Hlth,Minist Educ, Wuhan 430074, Peoples R China; [Guo, Yanjun; Liu, Yuewei; Huang, Xiji; Rong, Yi; He, Meian; Wang, Youjie; Yuan, Jing; Wu, Tangchun; Chen, Weihong] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Minist Environm Protect, Wuhan 430074, Peoples R China; [Guo, Yanjun; Liu, Yuewei; Huang, Xiji; Rong, Yi; He, Meian; Wang, Youjie; Yuan, Jing; Wu, Tangchun; Chen, Weihong] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, State Key Lab Environm Hlth Incubating, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Chen, WH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Occupat & Environm Hlth, Wuhan 430074, Peoples R China.	wchen@mails.tjmu.edu.cn	Chen, Weihong/D-2177-2011; Liu, Yuewei/J-5147-2019	Chen, Weihong/0000-0001-8689-7311; Liu, Yuewei/0000-0001-5970-4262	National Basic Research Program [2011CB503800, 2011CB503804]	National Basic Research Program(National Basic Research Program of China)	Funding was provided by the National Basic Research Program (2011CB503800) and the National Basic Research Program (2011CB503804). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes LC, 2010, NUTR RES REV, V23, P155, DOI 10.1017/S0954422410000016; Bjorvatn B, 2009, SLEEP MED REV, V13, P47, DOI 10.1016/j.smrv.2008.04.009; Chan MF, 2009, J CLIN NURS, V18, P285, DOI 10.1111/j.1365-2702.2008.02583.x; Chen HL, 2006, AM J EPIDEMIOL, V163, P726, DOI 10.1093/aje/kwj096; Copertaro A, 2011, IND HEALTH, V49, P597; De Bacquer D, 2009, INT J EPIDEMIOL, V38, P848, DOI 10.1093/ije/dyn360; Gangwisch JE, 2013, AM J HYPERTENS; Gumenyuk V, 2012, CHRONOBIOL INT, V29, P928, DOI 10.3109/07420528.2012.699356; Haus E, 2012, SLEEP MED REV; Ika K, 2013, ACTA MED OKAYAMA, V67, P25; Ioja S, 2012, POSTGRAD MED, V124, P119, DOI 10.3810/pgm.2012.07.2573; Islam Shariful, 2013, Perm J, V17, P37, DOI 10.7812/TPP/12-126; Itani O, 2011, SLEEP MED, V12, P341, DOI 10.1016/j.sleep.2010.09.007; John Axelsson SP, 2012, EVIDENCE BASED MED, V17; Juda M, 2013, J BIOL RHYTHM, V28, P141, DOI 10.1177/0748730412475042; Khabour O.F., 2012, CLIN EXP HYPERTENS; Lieu SJ, 2012, J HYPERTENS, V30, P61, DOI 10.1097/HJH.0b013e32834e1ea3; Liu YW, 2012, J HUAZHONG U SCI-MED, V32, P130, DOI 10.1007/s11596-012-0023-9; Mansukhani MP, 2012, POSTGRAD MED, V124, P241, DOI 10.3810/pgm.2012.07.2583; McCubbin JA, 2011, INT J BEHAV MED, V17, P314, DOI 10.1007/s12529-010-9117-6; Monk TH, 2012, J SLEEP RES; Morikawa Y, 2005, SCAND J WORK ENV HEA, V31, P179, DOI 10.5271/sjweh.867; Niu S. F., 2012, BIOL RES NURS; Pan A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001141; Pilcher JJ, 2000, SLEEP, V23, P155; Sallinen M, 2010, SCAND J WORK ENV HEA, V36, P121, DOI 10.5271/sjweh.2900; Santorek-Strumillo Edyta, 2012, Przegl Lek, V69, P103; Sfreddo C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015250; SmithCoggins R, 1997, ACAD EMERG MED, V4, P951, DOI 10.1111/j.1553-2712.1997.tb03658.x; Stang MND Andreas, 2007, SLEEP MED, V30, P9; Suwazono Y, 2008, HYPERTENSION, V52, P581, DOI 10.1161/HYPERTENSIONAHA.108.114553; Suwazono Y, 2006, J OCCUP ENVIRON MED, V48, P455, DOI 10.1097/01.jom.0000214355.69182.fa; TO EIICHI MIKUNI, 1983, TOHOKU J EXP MED; Ulas T, 2012, EUR REV MED PHARMACO, V16, P594; Vyas MV, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4800; Wagstaff AS, 2011, SCAND J WORK ENV HEA, V37, P173, DOI 10.5271/sjweh.3146; Wang F, 2012, INT J EPIDEMIOL; Wang XS, 2011, OCCUP MED-OXFORD, V61, P78, DOI 10.1093/occmed/kqr001; Wehrens SMT, 2010, J ENDOCRINOL, V206, P205, DOI 10.1677/JOE-10-0077; WHO, 2003, GUIDELINES; Yong M, 2012, ARH HIG RADA TOKSIKO, V63, P153, DOI 10.2478/10004-1254-63-2012-2209	41	86	89	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e71107	10.1371/journal.pone.0071107	http://dx.doi.org/10.1371/journal.pone.0071107			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23976988	Green Submitted, Green Published, gold			2022-12-25	WOS:000323570200028
J	Hao, HF; Maeda, Y; Fukazawa, T; Yamatsuji, T; Takaoka, M; Bao, XH; Matsuoka, J; Okui, T; Shimo, T; Takigawa, N; Tomono, Y; Nakajima, M; Fink-Baldauf, IM; Nelson, S; Seibel, W; Papoian, R; Whitsett, JA; Naomoto, Y				Hao, Huifang; Maeda, Yutaka; Fukazawa, Takuya; Yamatsuji, Tomoki; Takaoka, Munenori; Bao, Xiao-Hong; Matsuoka, Junji; Okui, Tatsuo; Shimo, Tsuyoshi; Takigawa, Nagio; Tomono, Yasuko; Nakajima, Motowo; Fink-Baldauf, Iris M.; Nelson, Sandra; Seibel, William; Papoian, Ruben; Whitsett, Jeffrey A.; Naomoto, Yoshio			Inhibition of the Growth Factor MDK/Midkine by a Novel Small Molecule Compound to Treat Non-Small Cell Lung Cancer	PLOS ONE			English	Article							MIDKINE GENE; KINASE; RESISTANCE; CARCINOMA; APOPTOSIS; DIFFERENTIATION; EXPRESSION; MUTATIONS; PROMOTER; FAMILY	Midkine (MDK) is a heparin-binding growth factor that is highly expressed in many malignant tumors, including lung cancers. MDK activates the PI3K pathway and induces anti-apoptotic activity, in turn enhancing the survival of tumors. Therefore, the inhibition of MDK is considered a potential strategy for cancer therapy. In the present study, we demonstrate a novel small molecule compound (iMDK) that targets MDK. iMDK inhibited the cell growth of MDK-positive H441 lung adenocarcinoma cells that harbor an oncogenic KRAS mutation and H520 squamous cell lung cancer cells, both of which are types of untreatable lung cancer. However, iMDK did not reduce the cell viability of MDK-negative A549 lung adenocarcinoma cells or normal human lung fibroblast (NHLF) cells indicating its specificity. iMDK suppressed the endogenous expression of MDK but not that of other growth factors such as PTN or VEGF. iMDK suppressed the growth of H441 cells by inhibiting the PI3K pathway and inducing apoptosis. Systemic administration of iMDK significantly inhibited tumor growth in a xenograft mouse model in vivo. Inhibition of MDK with iMDK provides a potential therapeutic approach for the treatment of lung cancers that are driven by MDK.	[Hao, Huifang; Bao, Xiao-Hong] Kawasaki Med Sch, Kawasaki Hosp, Res Ctr, Okayama, Japan; [Fukazawa, Takuya; Yamatsuji, Tomoki; Takaoka, Munenori; Naomoto, Yoshio] Kawasaki Med Sch, Dept Gen Surg, Okayama, Japan; [Maeda, Yutaka; Takigawa, Nagio] Kawasaki Med Sch, Dept Gen Internal Med 4, Okayama, Japan; [Maeda, Yutaka; Fink-Baldauf, Iris M.; Whitsett, Jeffrey A.] Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH 45229 USA; [Matsuoka, Junji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Palliat Care & Canc Survivorship, Okayama, Japan; [Okui, Tatsuo; Shimo, Tsuyoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral & Maxillofacial Surg, Okayama, Japan; [Tomono, Yasuko] Shigei Med Res Inst, Okayama, Japan; [Nakajima, Motowo] SBI Pharmaceut Co Ltd, Tokyo, Japan; [Nelson, Sandra; Seibel, William; Papoian, Ruben] Univ Cincinnati, Ctr Drug Discovery, Cincinnati, OH USA; [Bao, Xiao-Hong] Liaoning Med Univ, Sch Basical Med, Dept Biochem, Jinzhou, Peoples R China	Kawasaki Medical School; Kawasaki Medical School; Kawasaki Medical School; Cincinnati Children's Hospital Medical Center; Okayama University; Okayama University; SBI Pharmaceuticals; University System of Ohio; University of Cincinnati; Jinzhou Medical University	Fukazawa, T (corresponding author), Kawasaki Med Sch, Dept Gen Surg, Okayama, Japan.	FukazawaT@aol.com	Shimo, Tsuyoshi/AAT-8358-2020; Fukazawa, Takuya/GLR-7099-2022	Shimo, Tsuyoshi/0000-0002-7811-2366; Hao, Huifang/0000-0002-9680-8308	National Institutes of Health (NIH) [HL095580, HL108907, HL110964]; Ministry of Education, Science, and Culture, Japan [23591950]; University of Cincinnati Postdoctoral Fellow Research Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL110964, R01HL095580, R01HL108907] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Science, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); University of Cincinnati Postdoctoral Fellow Research Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institutes of Health (NIH) grants to JAW (http://report.nih.gov/index.aspx, grant number: HL095580, HL108907, HL110964), the Ministry of Education, Science, and Culture, Japan, to YN (http://www.jsps.go.jp/english/index.html, grant number: 23591950) and the University of Cincinnati Postdoctoral Fellow Research Program to YM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayoola A, 2012, CANCER INVEST, V30, P433, DOI 10.3109/07357907.2012.666691; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Ezquerra L, 2005, BIOCHEM BIOPH RES CO, V333, P636, DOI 10.1016/j.bbrc.2005.05.113; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Heist RS, 2012, J THORAC ONCOL, V7, P924, DOI 10.1097/JTO.0b013e31824cc334; Horiba M, 2000, J CLIN INVEST, V105, P489, DOI 10.1172/JCI7208; Ikematsu S, 2000, BRIT J CANCER, V83, P701, DOI 10.1054/bjoc.2000.1339; Jazirehi AR, 2012, AM J CANCER RES, V2, P178; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jin Z, 2008, CLIN CANCER RES, V14, P5033, DOI 10.1158/1078-0432.CCR-08-0092; Kaneko R, 2007, J BIOL CHEM, V282, P19273, DOI 10.1074/jbc.M610350200; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Maruyama K, 2004, ARTHRITIS RHEUM-US, V50, P1420, DOI 10.1002/art.20175; Matsui Takashi, 2010, Int Arch Med, V3, P12, DOI 10.1186/1755-7682-3-12; Matsushita A, 1999, ACTA MED OKAYAMA, V53, P67; Miyauchi M, 2001, INT J CANCER, V91, P723, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1112>3.0.CO;2-X; Muramatsu T, 2002, J BIOCHEM, V132, P359, DOI 10.1093/oxfordjournals.jbchem.a003231; Ogawa N, 1997, INT J CANCER, V73, P367, DOI 10.1002/(SICI)1097-0215(19971104)73:3<367::AID-IJC11>3.0.CO;2-A; Owada K, 1999, J NEUROCHEM, V73, P2084; Perez-Moreno P, 2012, CLIN CANCER RES, V18, P2443, DOI 10.1158/1078-0432.CCR-11-2370; Raica M, 2009, EUR J CANCER, V45, P1924, DOI 10.1016/j.ejca.2009.04.007; Reidy KJ, 2009, DEVELOPMENT, V136, P3979, DOI 10.1242/dev.037267; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Shimada H, 2003, CANCER SCI, V94, P628, DOI 10.1111/j.1349-7006.2003.tb01494.x; Sumida A, 2010, CARDIOVASC RES, V86, P113, DOI 10.1093/cvr/cvp386; Takei Y, 2002, J BIOL CHEM, V277, P23800, DOI 10.1074/jbc.M112100200; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Tomizawa M, 2003, BRIT J CANCER, V89, P1086, DOI 10.1038/sj.bjc.6601246; TSUTSUI J, 1993, CANCER RES, V53, P1281; Uddin S, 2005, CLIN CANCER RES, V11, P3102, DOI 10.1158/1078-0432.CCR-04-1857; Watanabe N, 2008, CLIN CANCER RES, V14, P4631, DOI 10.1158/1078-0432.CCR-07-4755; Zakowski MF, 2006, NEW ENGL J MED, V355, P213, DOI 10.1056/NEJMc053610; Zhang N, 1999, Curr Opin Hematol, V6, P44, DOI 10.1097/00062752-199901000-00008	34	37	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e71093	10.1371/journal.pone.0071093	http://dx.doi.org/10.1371/journal.pone.0071093			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23976985	gold, Green Published, Green Submitted			2022-12-25	WOS:000323570200026
J	Madan, E; Gogna, R; Keppler, B; Pati, U				Madan, Esha; Gogna, Rajan; Keppler, Bernhard; Pati, Uttam			p53 Increases Intra-Cellular Calcium Release by Transcriptional Regulation of Calcium Channel TRPC6 in GaQ(3)-Treated Cancer Cells	PLOS ONE			English	Article							GALLIUM NITRATE; APOPTOSIS; ACTIVATION; RECEPTOR; STIMULATION; COMPOUND; LYMPHOMA; COMPLEX; PROTEIN; DEATH	p53 and calcium signaling are inter-dependent and are known to show both synergistic and antagonistic effects on each other in the cellular environment. However, no molecular mechanism or cellular pathway is known which shows direct regulation between these important cellular signaling molecules. Here we have shown that in cancer cells treated with anti-neoplastic drug GaQ(3), p53, there is an increase in intracellular calcium levels by transcriptional regulation of a novel calcium channel gene TRPC6. p53 directly binds to a 22 bp response element in the TRPC6 gene promoter and increase its mRNA and protein expression. Over-expression of TRPC6 results in calcium-dependent apoptotic death and activation of apoptotic genes in a variety of cancer cells. This research work shows that p53 and its transcriptional activity is critical in regulation of calcium signaling and an increase in the intracellular calcium level might be one of the anti-cancer strategies to induce apoptosis in cancer cells.	[Madan, Esha; Gogna, Rajan; Pati, Uttam] Jawaharlal Nehru Univ, Sch Biotechnol, Transcript & Human Biol Lab, New Delhi 110067, Delhi, India; [Keppler, Bernhard] Univ Vienna, Inst Inorgan Chem, Vienna, Austria	Jawaharlal Nehru University, New Delhi; University of Vienna	Gogna, R (corresponding author), Univ Bern, Inst Cell Biol, Bern, Switzerland.	rajan.gogna@izb.unibe.ch; uttam@mail.jnu.ac.in	Pati, Uttam/L-9345-2019	MADAN, ESHA/0000-0002-4941-0612; GOGNA, RAJAN/0000-0001-7304-7692; Keppler, Bernhard/0000-0003-0877-1822	Swiss Cancer League; Josheph Steiner grants award; Indian council of Mecical Research (ICMR)	Swiss Cancer League; Josheph Steiner grants award; Indian council of Mecical Research (ICMR)	Swiss Cancer League, Josheph Steiner grants award and Indian council of Mecical Research (ICMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn BY, 2010, ONCOGENE, V29, P1155, DOI 10.1038/onc.2009.413; Cayouette S, 2004, J BIOL CHEM, V279, P7241, DOI 10.1074/jbc.M312042200; Chitambar CR, 2007, J PHARMACOL EXP THER, V322, P1228, DOI 10.1124/jpet.107.126342; Einhorn L, 2003, SEMIN ONCOL, V30, P34, DOI 10.1016/S0093-7754(03)00174-X; Estacion M, 2004, J BIOL CHEM, V279, P22047, DOI 10.1074/jbc.M402320200; Giorgi C, 2008, CURR MOL MED, V8, P119; Gogna R, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.15; Gogna R, 2012, BRIT J PHARMACOL, V166, P617, DOI 10.1111/j.1476-5381.2011.01780.x; Graham S, 2010, J BIOL CHEM, V285, P23464, DOI 10.1074/jbc.M109.093500; Inoue R, 2009, CIRC RES, V104, P1399, DOI 10.1161/CIRCRESAHA.108.193227; Jakupec MA, 2004, MET IONS BIOL SYST, V42, P425; Kumar S, 2011, J CELL PHYSL; Li DWC, 2005, MOL BIOL CELL, V16, P4437, DOI 10.1091/mbc.E05-01-0010; Madan E, 2012, BRIT J CANCER, V107, P516, DOI 10.1038/bjc.2012.260; Madan E, 2013, MOL CELL BIOL; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Straus DJ, 2003, SEMIN ONCOL, V30, P25, DOI 10.1016/S0093-7754(03)00173-8; Swami M, 2010, NAT REV CANCER, V10, P738, DOI 10.1038/nrc2956; Tripathi V, 2007, J BIOL CHEM, V282, P28441, DOI 10.1074/jbc.M703698200; Valiahdi SM, 2009, MELANOMA RES, V19, P283, DOI 10.1097/CMR.0b013e32832b272d; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Wang ZY, 2009, CELL PHYSIOL BIOCHEM, V24, P619, DOI 10.1159/000257517; Woelfle U, 2010, J INVEST DERMATOL, V130, P113, DOI 10.1038/jid.2009.248; Wu X, 2010, P NATL ACAD SCI USA, V107, P7000, DOI 10.1073/pnas.1001825107; Wu XY, 2004, J BIOL CHEM, V279, P43392, DOI 10.1074/jbc.M408959200; Xie J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2240	27	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e71016	10.1371/journal.pone.0071016	http://dx.doi.org/10.1371/journal.pone.0071016			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23976973	Green Published, gold, Green Submitted			2022-12-25	WOS:000323570200015
J	Sarkar, R; Kang, G; Naumova, EN				Sarkar, Rajiv; Kang, Gagandeep; Naumova, Elena N.			Rotavirus Seasonality and Age Effects in a Birth Cohort Study of Southern India	PLOS ONE			English	Article							LESS-THAN-5 YEARS; NATURAL-HISTORY; UNITED-STATES; CHILDREN; INFECTION; DIARRHEA; DISEASE; EPIDEMIOLOGY; SURVEILLANCE; VACCINE	Introduction: Understanding the temporal patterns in disease occurrence is valuable for formulating effective disease preventive programs. Cohort studies present a unique opportunity to explore complex interactions associated with emergence of seasonal patterns of infectious diseases. Methods: We used data from 452 children participating in a birth cohort study to assess the seasonal patterns of rotavirus diarrhea by creating a weekly time series of rotavirus incidence and fitting a Poisson harmonic regression with biannual peaks. Age and cohort effects were adjusted for by including the weekly counts of number of children in the study and the median age of cohort in a given week. Weekly average temperature, humidity and an interaction term to reflect the joint effect of temperature and humidity were included to consider the effects of meteorological variables. Results: In the overall rotavirus time series, two significant peaks within a single year were observed - one in winter and the other in summer. The effect of age was found to be the most significant contributor for rotavirus incidence, showing a strong negative association. Seasonality remained a significant factor, even after adjusting for meteorological parameters, and the age and cohort effects. Conclusions: The methodology for assessing seasonality in cohort studies is not yet developed. This is the first attempt to explore seasonal patterns in a cohort study with a dynamic denominator and rapidly changing immune response on individual and group levels, and provides a highly promising approach for a better understanding of the seasonal patterns of infectious diseases, tracking emergence of pathogenic strains and evaluating the efficacy of intervention programs.	[Sarkar, Rajiv; Kang, Gagandeep; Naumova, Elena N.] Christian Med Coll & Hosp, Dept Gastrointestinal Sci, Vellore, TN, India; [Naumova, Elena N.] Tufts Univ, Sch Engn, Dept Civil & Environm Engn, Boston, MA 02111 USA	Christian Medical College & Hospital (CMCH) Vellore; Tufts University	Naumova, EN (corresponding author), Christian Med Coll & Hosp, Dept Gastrointestinal Sci, Vellore, TN, India.	Elena.Naumova@tufts.edu	Sarkar, Rajiv/AAU-7203-2021; Naumova, Elena/AAP-3395-2020	Sarkar, Rajiv/0000-0003-0616-3129; Naumova, Elena/0000-0002-9562-4734; Kang, Gagandeep/0000-0002-3656-564X	PHS [R01 A1075452]; CDC/Indo-US Concept "Environmental Indicators for Diarrheal Infections in South India"; Global Infectious Disease Research Training Grant [D43TW007392]; Wellcome Trust Trilateral Initiative for Infectious Diseases [063144]; FOGARTY INTERNATIONAL CENTER [D43TW007392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075452] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); CDC/Indo-US Concept "Environmental Indicators for Diarrheal Infections in South India"; Global Infectious Disease Research Training Grant; Wellcome Trust Trilateral Initiative for Infectious Diseases(Wellcome Trust); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by PHS grant R01 A1075452 "Transmission Dynamics of Cryptosporidial Infections in India" (PI - GK); CDC/Indo-US Concept "Environmental Indicators for Diarrheal Infections in South India" (PI - ENN). RS was supported by the Global Infectious Disease Research Training Grant (D43TW007392; PI - GK). The data used in this study was collected from a rotavirus birth cohort study supported by the Wellcome Trust Trilateral Initiative for Infectious Diseases (Grant No.: 063144). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMAH GE, 1994, ANN TROP PAEDIATR, V14, P223, DOI 10.1080/02724936.1994.11747721; Atchison CJ, 2009, EPIDEMIOL INFECT, V137, P957, DOI 10.1017/S0950268808001933; Banerjee I, 2006, J CLIN MICROBIOL, V44, P2468, DOI 10.1128/JCM.01882-05; Buttery JP, 2011, PEDIATR INFECT DIS J, V30, pS25, DOI 10.1097/INF.0b013e3181fefdee; Chang T., 2013, EPIDEMIOL INFECT, V22, P1; Chui KKH, 2011, AM J PUBLIC HEALTH, V101, P2082, DOI 10.2105/AJPH.2010.300096; Chui KKH, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-447; COOK SM, 1990, B WORLD HEALTH ORGAN, V68, P171; Fischer TK, 2002, J INFECT DIS, V186, P593, DOI 10.1086/342294; Fisman DN, 2007, ANNU REV PUBL HEALTH, V28, P127, DOI 10.1146/annurev.publhealth.28.021406.144128; Fraser D, 1997, AM J TROP MED HYG, V57, P544, DOI 10.4269/ajtmh.1997.57.544; Gladstone BP, 2008, ARCH DIS CHILD, V93, P479, DOI 10.1136/adc.2006.114546; Gladstone BP, 2011, NEW ENGL J MED, V365, P337, DOI 10.1056/NEJMoa1006261; Gladstone BP, 2010, J TROP PEDIATRICS, V56, P221, DOI 10.1093/tropej/fmp116; Greene SK, 2006, AM J EPIDEMIOL, V163, P316, DOI 10.1093/aje/kwj040; Jagai JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038168; Jagai JS, 2012, INT J ENV RES PUB HE, V9, P1771, DOI 10.3390/ijerph9051771; Jagai JS, 2009, ENVIRON RES, V109, P465, DOI 10.1016/j.envres.2009.02.008; Kahn G, 2012, INDIAN PEDIATR, V49, P467, DOI 10.1007/s13312-012-0076-7; Kang G, 2009, J INFECT DIS, V200, pS147, DOI 10.1086/605031; Kiulia NM, 2008, J TROP PEDIATRICS, V54, P401, DOI 10.1093/tropej/fmn052; Levy K, 2009, INT J EPIDEMIOL, V38, P1487, DOI 10.1093/ije/dyn260; Moorthy M, 2012, CLIN MICROBIOL INFEC, V18, P955, DOI 10.1111/j.1469-0691.2012.03959.x; Naumova EN, 2007, EPIDEMIOL INFECT, V135, P281, DOI 10.1017/S0950268806006698; NAUMOVA EN, 2006, ADV STAT METHODS HLT; Ohuma EO, 2012, AM J EPIDEMIOL, V176, P794, DOI 10.1093/aje/kws257; Parashar UD, 1998, J INFECT DIS, V177, P13, DOI 10.1086/513808; Rahman M, 2007, EMERG INFECT DIS, V13, P18, DOI 10.3201/eid1301.060910; Ramani S, 2007, J CLIN MICROBIOL, V45, P432, DOI 10.1128/JCM.01710-06; Sarkar R, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-1; Soenarto Yati, 2009, J Infect Dis, V200 Suppl 1, pS188, DOI 10.1086/605338; Tate JE, 2009, PEDIATRICS, V124, P465, DOI 10.1542/peds.2008-3528; Velazquez FR, 1996, NEW ENGL J MED, V335, P1022, DOI 10.1056/NEJM199610033351404; Wenger JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010187; Yokoo M, 2004, JPN J INFECT DIS, V57, P166; Zaman K, 2009, VACCINE, V27, pF31, DOI 10.1016/j.vaccine.2009.08.063; Zeller M, 2010, VACCINE, V28, P7507, DOI 10.1016/j.vaccine.2010.09.004	37	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e71616	10.1371/journal.pone.0071616	http://dx.doi.org/10.1371/journal.pone.0071616			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977089	Green Published, gold, Green Submitted			2022-12-25	WOS:000323570200037
J	Sharaf, A; Bock, HH; Spittau, B; Bouche, E; Krieglstein, K				Sharaf, Ahmed; Bock, Hans H.; Spittau, Bjoern; Bouche, Elisabeth; Krieglstein, Kerstin			ApoER2 and VLDLr Are Required for Mediating Reelin Signalling Pathway for Normal Migration and Positioning of Mesencephalic Dopaminergic Neurons	PLOS ONE			English	Article							BRAIN-DEVELOPMENT; LIPOPROTEIN RECEPTORS; NERVOUS-SYSTEM; CAJAL-RETZIUS; KNOCKOUT MICE; CELLS; DISABLED-1; RAT; NEUROGENESIS; LOCALIZATION	The migration of mesencephalic dopaminergic (mDA) neurons from the subventricular zone to their final positions in the substantia nigra compacta (SNc), ventral tegmental area (VTA), and retrorubral field (RRF) is controlled by signalling from neurotrophic factors, cell adhesion molecules (CAMs) and extracellular matrix molecules (ECM). Reelin and the cytoplasmic adaptor protein Disabled-1 (Dab1) have been shown to play important roles in the migration and positioning of mDA neurons. Mice lacking Reelin and Dab1 both display phenotypes characterised by the failure of nigral mDA neurons to migrate properly. ApoER2 and VLDLr are receptors for Reelin signalling and are therefore part of the same signal transduction pathway as Dab1. Here we describe the roles of ApoER2 and VLDLr in the proper migration and positioning of mDA neurons in mice. Our results demonstrate that VLDLr- and ApoER2-mutant mice have both a reduction in and abnormal positioning of mDA neurons. This phenotype was more pronounced in VLDLr-mutant mice. Moreover, we provide evidence that ApoER2/VLDLr double-knockout mice show a phenotype comparable with the phenotypes observed for Reelin-and Dab1-mutant mice. Taken together, our results demonstrate that the Reelin receptors ApoER2 and VLDLr play essential roles in Reelin-mediated migration and positioning of mDA neurons.	[Sharaf, Ahmed; Spittau, Bjoern; Krieglstein, Kerstin] Univ Freiburg, Inst Anat & Cell Biol, Dept Mol Embryol, D-79106 Freiburg, Germany; [Bock, Hans H.; Bouche, Elisabeth] Univ Freiburg, Ctr Neurosci, D-79106 Freiburg, Germany; [Bock, Hans H.] Univ Freiburg, Dept Med 2, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Krieglstein, K (corresponding author), Univ Freiburg, Inst Anat & Cell Biol, Dept Mol Embryol, Hugstetter Str 55, D-79106 Freiburg, Germany.	kerstin.krieglstein@anat.uni-freiburg.de	Spittau, Björn/AGZ-8396-2022; Bock, Hans/AAF-2635-2021		Deutsche Forschungsgemeinschaft [Kr1477/10-3]; Ministry of Higher Education in Egypt	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ministry of Higher Education in Egypt(Ministry of Higher Education & Scientific Research (MHESR))	The current work was funded by the Deutsche Forschungsgemeinschaft (Kr1477/10-3). AS was funded by Ministry of Higher Education in Egypt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud L, 2003, CURR BIOL, V13, P9, DOI 10.1016/S0960-9822(02)01397-0; Bock HH, 2003, CURR BIOL, V13, P18, DOI 10.1016/S0960-9822(02)01403-3; Curran T, 1998, BRAIN RES REV, V26, P285, DOI 10.1016/S0165-0173(97)00035-0; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DAHLSTROM A, 1964, EXPERIENTIA, V20, P398, DOI 10.1007/BF02147990; Demyanenko GP, 2001, DEV BRAIN RES, V126, P21, DOI 10.1016/S0165-3806(00)00129-2; Drakew A, 2002, EXP NEUROL, V176, P12, DOI 10.1006/exnr.2002.7918; Forster E, 2006, EUR J NEUROSCI, V23, P901, DOI 10.1111/j.1460-9568.2006.04612.x; Forster E, 2002, P NATL ACAD SCI USA, V99, P13178, DOI 10.1073/pnas.202035899; Frotscher M, 1998, CURR OPIN NEUROBIOL, V8, P570, DOI 10.1016/S0959-4388(98)80082-2; FRYKMAN PK, 1995, P NATL ACAD SCI USA, V92, P8453, DOI 10.1073/pnas.92.18.8453; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Jossin Y, 2004, J NEUROSCI, V24, P514, DOI 10.1523/JNEUROSCI.3408-03.2004; Kang WY, 2010, ANAT CELL BIOL, V43, P241, DOI 10.5115/acb.2010.43.3.241; KAWANO H, 1995, DEV BRAIN RES, V86, P101, DOI 10.1016/0165-3806(95)00018-9; Komuro H, 1998, J NEUROSCI, V18, P1478; KORNACK DR, 1995, NEURON, V15, P311, DOI 10.1016/0896-6273(95)90036-5; MARCHAND R, 1983, NEUROSCIENCE, V9, P373, DOI 10.1016/0306-4522(83)90300-7; Nishikawa S, 2003, J COMP NEUROL, V461, P166, DOI 10.1002/cne.10610; Niu S, 2004, NEURON, V41, P71, DOI 10.1016/S0896-6273(03)00819-5; Oberle S, 2006, J NEUROSCI, V26, P1823, DOI 10.1523/JNEUROSCI.4127-05.2006; Ohyama K, 1998, DEV BRAIN RES, V107, P219, DOI 10.1016/S0165-3806(97)00220-4; Pearlman AL, 1998, CURR OPIN NEUROBIOL, V8, P45, DOI 10.1016/S0959-4388(98)80007-X; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Riddle R, 2003, DEV BRAIN RES, V147, P3, DOI 10.1016/j.devbrainres.2003.09.010; Rogers J, 2007, INT REV NEUROBIOL, V82, P235, DOI 10.1016/S0074-7742(07)82012-5; Rossel M, 2005, DEVELOPMENT, V132, P1175, DOI 10.1242/dev.01683; SAUER H, 1995, P NATL ACAD SCI USA, V92, P8935, DOI 10.1073/pnas.92.19.8935; SHULTS CW, 1990, NEUROSCIENCE, V38, P427, DOI 10.1016/0306-4522(90)90039-7; Soriano E, 2005, NEURON, V46, P389, DOI 10.1016/j.neuron.2005.04.019; SPECHT LA, 1981, BRAIN RES, V218, P49, DOI 10.1016/0006-8993(81)90988-4; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Won SJ, 2006, EXP NEUROL, V198, P250, DOI 10.1016/j.expneurol.2005.12.008; Zhao S, 2007, DEV NEUROSCI-BASEL, V29, P84, DOI 10.1159/000096213	38	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e71091	10.1371/journal.pone.0071091	http://dx.doi.org/10.1371/journal.pone.0071091			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23976984	Green Published, Green Submitted, gold			2022-12-25	WOS:000323570200025
J	Zhang, YN; Fu, DZ; Chen, H; Zhang, ZT; Shi, QQ; Elsayed, AK; Li, BC				Zhang, Yani; Fu, Dezhi; Chen, Hao; Zhang, Zhentao; Shi, Qingqing; Elsayed, Ahmed Kamel; Li, Bichun			Partial Antiviral Activities Detection of Chicken Mx Jointing with Neuraminidase Gene (NA) against Newcastle Disease Virus	PLOS ONE			English	Article							INFLUENZA-VIRUS; DYNAMIN FAMILY; PROTEIN	As an attempt to increase the resistance to Newcastle Disease Virus (NDV) and so further reduction of its risk on the poultry industry. This work aimed to build the eukaryotic gene co-expression plasmid of neuraminidase (NA) gene and myxo-virus resistance (Mx) and detect the gene expression in transfected mouse fibroblasts (NIH-3T3) cells, it is most important to investigate the influence of the recombinant plasmid on the chicken embryonic fibroblasts (CEF) cells. cDNA fragment of NA and mutant Mx gene were derived from pcDNA3.0-NA and pcDNA3.0-Mx plasmid via PCR, respectively, then NA and Mx cDNA fragment were inserted into the multiple cloning sites of pVITRO(2) to generate the eukaryotic co-expression plasmid pVITRO(2)-Mx-NA. The recombinant plasmid was confirmed by restriction endonuclease treatment and sequencing, and it was transfected into the mouse fibroblasts (NIH-3T3) cells. The expression of genes in pVITRO(2)-Mx-NA were measured by RT-PCR and indirect immunofluorescence assay (IFA). The recombinant plasmid was transfected into CEF cells then RT-PCR and the micro-cell inhibition tests were used to test the antiviral activity for NDV. Our results showed that co-expression vector pVITRO(2)-Mx-NA was constructed successfully; the expression of Mx and NA could be detected in both NIH-3T3 and CEF cells. The recombinant proteins of Mx and NA protect CEF cells from NDV infection until after 72 h of incubation but the individually mutagenic Mx protein or NA protein protects CEF cells from NDV infection till 48 h post-infection, and co-transfection group decreased significantly NDV infection compared with single-gene transfection group (P<0. 05), indicating that Mx-NA jointing contributed to delaying the infection of NDV in single-cell level and the co-transfection of the jointed genes was more powerful than single one due to their synergistic effects.	[Zhang, Yani; Fu, Dezhi; Zhang, Zhentao; Shi, Qingqing; Li, Bichun] Yangzhou Univ, Inst Anim Breeding & Genet, Prov Key Lab Mol Design, Coll Anim Sci & Technol, Yangzhou, Peoples R China; [Chen, Hao] Soochow Univ, Affiliated Hosp 1, Suzhou, Peoples R China; [Elsayed, Ahmed Kamel] Suez Canal Univ, Coll Vet Med, Ismailia, Egypt	Yangzhou University; Soochow University - China; Egyptian Knowledge Bank (EKB); Suez Canal University	Li, BC (corresponding author), Yangzhou Univ, Inst Anim Breeding & Genet, Prov Key Lab Mol Design, Coll Anim Sci & Technol, Yangzhou, Peoples R China.	yubcli@yzu.edu.cn	Elsayed, Ahmed/AAC-9689-2020	Kamel, Ahmed/0000-0002-2519-1531	National Natural Science Foundation of China [31272429, 330871791]; Research and Innovation Program for Graduate Cultivation of Jiangsu Proviance; Major Basic Research Program for Natural Science of Jiangsu Province Jiangsu Province; Specialized Research Grant for Doctoral Program [20103250110006]; "Six personal peak" grant; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research and Innovation Program for Graduate Cultivation of Jiangsu Proviance; Major Basic Research Program for Natural Science of Jiangsu Province Jiangsu Province; Specialized Research Grant for Doctoral Program; "Six personal peak" grant; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by National Natural Science Foundation of China (31272429, 330871791); Research and Innovation Program for Graduate Cultivation of Jiangsu Proviance in 2010; Major Basic Research Program for Natural Science of Jiangsu Province Jiangsu Province; Specialized Research Grant for Doctoral Program (20103250110006); "Six personal peak" grant; "A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions". There are no any conflicts for above grant numbers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Z, 2003, J MICROBIOL, V23, P1; Christensen JP, 1998, AVIAN PATHOL, V27, P373, DOI 10.1080/03079459808419354; Danino D, 2001, CURR OPIN CELL BIOL, V13, P454, DOI 10.1016/S0955-0674(00)00236-2; Haller O, 2007, MICROBES INFECT, V9, P1636, DOI 10.1016/j.micinf.2007.09.010; Johansson BE, 1998, VACCINE, V16, P1009, DOI 10.1016/S0264-410X(97)00279-X; Li BC, 2012, MOL BIOL REP, V39, P8415, DOI 10.1007/s11033-012-1694-9; McCullers JA, 2003, J INFECT DIS, V187, P1000, DOI 10.1086/368163; McNiven MA, 2000, TRENDS BIOCHEM SCI, V25, P115, DOI 10.1016/S0968-0004(99)01538-8; NAKAYAMA M, 1991, J BIOL CHEM, V266, P21404; PITOSSI F, 1993, J VIROL, V67, P6726, DOI 10.1128/JVI.67.11.6726-6732.1993; [乔传玲 Qiao Chuanling], 2003, [免疫学杂志, Immunological Journal], V19, P46; Smee DF, 2001, ANTIMICROB AGENTS CH, V45, P743, DOI 10.1128/AAC.45.3.743-748.2001; Tian ZQ, 2010, J ANIM VET ADV, V9, P402; Wang L, 2006, MICROBIOL IMMUNOL, V34, P54; Weber F, 2000, J VIROL, V74, P560, DOI 10.1128/JVI.74.1.560-563.2000; WEBSTER RG, 1988, VIROLOGY, V164, P230, DOI 10.1016/0042-6822(88)90640-X; Zhang Y, 2012, AFRICAN J BIOTECHNOL, V11, P10675; Zhao XD, 2003, CHINA VIROLOGY, V18, P213; Zhao Xiao-dong, 2003, Virologica Sinica, V18, P213; Zhou X, 2001, PROGR MICROBIOLOGY I, V29, P15; ZURCHER T, 1992, EMBO J, V11, P1657, DOI 10.1002/j.1460-2075.1992.tb05212.x	21	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e71688	10.1371/journal.pone.0071688	http://dx.doi.org/10.1371/journal.pone.0071688			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977111	gold, Green Submitted, Green Published			2022-12-25	WOS:000323570200043
J	Castaldo, C; Ciambellotti, S; de Pablo-Latorre, R; Lalli, D; Porcari, V; Turano, P				Castaldo, Cristiana; Ciambellotti, Silvia; de Pablo-Latorre, Raquel; Lalli, Daniela; Porcari, Valentina; Turano, Paola			Soluble Variants of Human Recombinant Glutaminyl Cyclase	PLOS ONE			English	Article							PROTEIN SOLUBILITY; NMR; EXPRESSION; GLYCOSYLATION; INHIBITION; HADDOCK; BOND	Recombinant human Glutaminyl Cyclase expressed in E. coli is produced as inclusion bodies. Lack of glycosylation is the main origin of its accumulation in insoluble aggregates. Mutation of single isolated hydrophobic amino acids into negative amino acids was not able to circumvent inclusion bodies formation. On the contrary, substitution with carboxyl-terminal residues of two or three aromatic residues belonging to extended hydrophobic patches on the protein surface provided soluble but still active forms of the protein. These mutants could be expressed in isotopically enriched forms for NMR studies and the maximal attainable concentration was sufficient for the acquisition of H-1-N-15 HSQC spectra that represent the starting point for future drug development projects targeting Alzheimer's disease.	[Castaldo, Cristiana; Porcari, Valentina] Siena Biotech, Dept Pharmacol, Siena, Italy; [Ciambellotti, Silvia; de Pablo-Latorre, Raquel; Turano, Paola] Univ Florence, Magnet Resonance Ctr CERM, Florence, Italy; [Lalli, Daniela; Turano, Paola] Univ Florence, Dept Chem, Florence, Italy	Siena Biotech; University of Florence; University of Florence	Turano, P (corresponding author), Univ Florence, Magnet Resonance Ctr CERM, Florence, Italy.	turano@cerm.unifi.it	Turano, Paola/F-9089-2011; Ciambellotti, Silvia/ABA-8496-2021	Turano, Paola/0000-0002-7683-8614; Ciambellotti, Silvia/0000-0002-1924-5046	POR CReO FESR	POR CReO FESR	The work was funded by POR CReO FESR 2007-2013, project FINDING (Farmaci innovativi per malattie neurodegenerative). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banci L, 2005, J BIOL CHEM, V280, P35815, DOI 10.1074/jbc.M506637200; Banci L, 2003, J MOL CATAL A-CHEM, V204, P401, DOI 10.1016/S1381-1169(03)00493-X; Baneyx F, 1999, CURR OPIN BIOTECH, V10, P411, DOI 10.1016/S0958-1669(99)00003-8; Buchholz M, 2006, J MED CHEM, V49, P664, DOI 10.1021/jm050756e; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Ferella L., 2012, NMR BIOMOLECULES MEC, P53; FISCHER WH, 1987, P NATL ACAD SCI USA, V84, P3628, DOI 10.1073/pnas.84.11.3628; Golovanov AP, 2004, J AM CHEM SOC, V126, P8933, DOI 10.1021/ja049297h; Huang KF, 2008, BIOCHEM J, V411, P181, DOI 10.1042/BJ20071073; Huang KF, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208595; Huang KF, 2005, P NATL ACAD SCI USA, V102, P13117, DOI 10.1073/pnas.0504184102; Huang KF, 2005, PROTEIN EXPRES PURIF, V43, P65, DOI 10.1016/j.pep.2005.02.020; Huang WL, 2010, J MOL BIOL, V401, P374, DOI 10.1016/j.jmb.2010.06.012; Hubbard S. J., 1993, NACCESS; Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233; OTTING G, 1993, CURR OPIN STRUC BIOL, V3, P760, DOI 10.1016/0959-440X(93)90061-O; Pellecchia M, 2008, NAT REV DRUG DISCOV, V7, P738, DOI 10.1038/nrd2606; Ruiz-Carrillo D, 2011, BIOCHEMISTRY-US, V50, P6280, DOI 10.1021/bi200249h; Schilling S, 2003, J BIOL CHEM, V278, P49773, DOI 10.1074/jbc.M309077200; Schilling S, 2002, BIOCHEMISTRY-US, V41, P10849, DOI 10.1021/bi0260381; Schilling S, 2002, ANAL BIOCHEM, V303, P49, DOI 10.1006/abio.2001.5560; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Schule N, 1998, J BIOL CHEM, V263, P8832; Sinclair AM, 2005, J PHARM SCI-US, V94, P1626, DOI 10.1002/jps.20319; Tams JW, 1999, BBA-PROTEIN STRUCT M, V1432, P214, DOI 10.1016/S0167-4838(99)00103-X; Tsitrin Y, 2002, NAT STRUCT BIOL, V9, P729, DOI 10.1038/nsb839; Zanzoni S, 2012, BIOCHEM BIOPH RES CO, V427, P677, DOI 10.1016/j.bbrc.2012.09.121; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	29	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71657	10.1371/journal.pone.0071657	http://dx.doi.org/10.1371/journal.pone.0071657			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977104	Green Submitted, Green Published, gold			2022-12-25	WOS:000323378000062
J	Colley, SM; Wintle, L; Searles, R; Russell, V; Firman, RC; Smith, S; DeBoer, K; Merriner, DJ; Genevieve, B; Bentel, JM; Stuckey, BGA; Phillips, MR; Simmons, LW; de Kretser, DM; O'Bryan, MK; Leedman, PJ				Colley, Shane M.; Wintle, Larissa; Searles, Richelle; Russell, Victoria; Firman, Renee C.; Smith, Stephanie; DeBoer, Kathleen; Merriner, D. Jo; Genevieve, Ben; Bentel, Jacqueline M.; Stuckey, Bronwyn G. A.; Phillips, Michael R.; Simmons, Leigh W.; de Kretser, David M.; O'Bryan, Moira K.; Leedman, Peter J.			Loss of the Nuclear Receptor Corepressor SLIRP Compromises Male Fertility	PLOS ONE			English	Article							MALE-INFERTILITY; RNA ACTIVATOR; HUMAN ASTHENOZOOSPERMIA; MOUSE MODELS; SPERM; PROTEIN; SPERMATOGENESIS; MITOCHONDRIA; BINDING; SRC-1	Nuclear receptors (NRs) and their coregulators play fundamental roles in initiating and directing gene expression influencing mammalian reproduction, development and metabolism. SRA stem Loop Interacting RNA-binding Protein (SLIRP) is a Steroid receptor RNA Activator (SRA) RNA-binding protein that is a potent repressor of NR activity. SLIRP is present in complexes associated with NR target genes in the nucleus; however, it is also abundant in mitochondria where it affects mitochondrial mRNA transcription and energy turnover. In further characterisation studies, we observed SLIRP protein in the testis where its localization pattern changes from mitochondrial in diploid cells to peri-acrosomal and the tail in mature sperm. To investigate the in vivo effects of SLIRP, we generated a SLIRP knockout (KO) mouse. This animal is viable, but sub-fertile. Specifically, when homozygous KO males are crossed with wild type (WT) females the resultant average litter size is reduced by approximately one third compared with those produced by WT males and females. Further, SLIRP KO mice produced significantly fewer progressively motile sperm than WT animals. Electron microscopy identified disruption of the mid-piece/annulus junction in homozygous KO sperm and altered mitochondrial morphology. In sum, our data implicates SLIRP in regulating male fertility, wherein its loss results in asthenozoospermia associated with compromised sperm structure and mitochondrial morphology.	[Colley, Shane M.; Wintle, Larissa; Russell, Victoria; Phillips, Michael R.; Leedman, Peter J.] Univ Western Australia, Med Res Ctr, Western Australian Inst Med Res, Lab Canc Med, Perth, WA 6009, Australia; [Searles, Richelle] Royal Perth Hosp, Res Ctr, Perth, WA, Australia; [Firman, Renee C.; Simmons, Leigh W.] Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Crawley, Australia; [Smith, Stephanie; DeBoer, Kathleen; Merriner, D. Jo; de Kretser, David M.; O'Bryan, Moira K.] Monash Univ, Dept Anat & Dev Biol, Male Infertil & Germ Cell Biol Lab, Clayton, Vic, Australia; [Genevieve, Ben; Stuckey, Bronwyn G. A.] Sir Charles Gairdner Hosp, Keogh Inst Med Res, Nedlands, WA 6009, Australia; [Bentel, Jacqueline M.] Royal Perth Hosp, PathWest Lab Med, Perth, WA, Australia; [Bentel, Jacqueline M.] Univ Western Australia, Sch Pathol & Lab Med, Crawley, Australia; [Stuckey, Bronwyn G. A.; Phillips, Michael R.; Leedman, Peter J.] Univ Western Australia, Sch Med & Pharmacol, Crawley, Australia	University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Western Australia; Monash University; University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Western Australia; University of Western Australia	Leedman, PJ (corresponding author), Univ Western Australia, Med Res Ctr, Western Australian Inst Med Res, Lab Canc Med, Perth, WA 6009, Australia.	peter.leedman@waimr.uwa.edu.au	Simmons, Leigh W/B-1815-2011; Leedman, Peter J/O-4044-2014; O'Bryan, Moira K/F-8256-2012	Simmons, Leigh W/0000-0003-0562-1474; O'Bryan, Moira K/0000-0001-7298-4940; Phillips, Michael/0000-0002-0252-9085; Wintle, Larissa/0000-0003-3834-950X; Colley, Shane/0000-0002-5792-7005	Royal Perth Hospital (RPH) Medical Research Foundation (MRF)	Royal Perth Hospital (RPH) Medical Research Foundation (MRF)	The authors thank the Royal Perth Hospital (RPH) Medical Research Foundation (MRF) for partially funding this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aitken RJ, 2008, ADV EXP MED BIOL, V636, P154, DOI 10.1007/978-0-387-09597-4_9; Arsov T, 2006, MOL ENDOCRINOL, V20, P1610, DOI 10.1210/me.2005-0494; Baughman JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000590; Bettegowda A, 2010, PHILOS T R SOC B, V365, P1637, DOI 10.1098/rstb.2009.0196; Borg CL, 2010, HUM REPROD UPDATE, V16, P205, DOI 10.1093/humupd/dmp032; Chujo T., 2012, NUCL ACIDS RES; Colley SM, 2011, BIOCHIMIE, V93, P1966, DOI 10.1016/j.biochi.2011.07.004; Cotton L, 2006, J CELL SCI, V119, P75, DOI 10.1242/jcs.02704; Escalier D, 2006, HUM REPROD UPDATE, V12, P449, DOI 10.1093/humupd/dml013; Fujita K, 2005, ACTA HISTOCHEM CYTOC, V38, P31, DOI 10.1267/ahc.38.31; Gallon F, 2006, FERTIL STERIL, V86, P1526, DOI 10.1016/j.fertnstert.2006.03.055; Gehin M, 2002, MOL CELL BIOL, V22, P5923, DOI 10.1128/MCB.22.16.5923-5937.2002; Gibbs GM, 2011, P NATL ACAD SCI USA, V108, P7034, DOI 10.1073/pnas.1015935108; Giles KM, 2003, J BIOL CHEM, V278, P2937, DOI 10.1074/jbc.M208439200; Guan J, 2010, REPROD DOMEST ANIM, V45, P992, DOI 10.1111/j.1439-0531.2009.01473.x; Hatchell EC, 2006, MOL CELL, V22, P657, DOI 10.1016/j.molcel.2006.05.024; Hung PH, 2008, BIOL REPROD, V79, P367, DOI 10.1095/biolreprod.107.066357; Ihara M, 2005, DEV CELL, V8, P343, DOI 10.1016/j.devcel.2004.12.005; Jamsai D, 2011, ASIAN J ANDROL, V13, P139, DOI 10.1038/aja.2010.101; Kefer JC, 2009, INT J UROL, V16, P449, DOI 10.1111/j.1442-2042.2009.02280.x; Kerkhofs S, 2009, J MOL ENDOCRINOL, V42, P11, DOI 10.1677/JME-08-0122; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Lanz RB, 2003, MOL CELL BIOL, V23, P7163, DOI 10.1128/MCB.23.20.7163-7176.2003; Lanz RB, 2002, P NATL ACAD SCI USA, V99, P16081, DOI 10.1073/pnas.192571399; Lanz RB, 1999, CELL, V97, P17, DOI 10.1016/S0092-8674(00)80711-4; Lhuillier P, 2009, HUM REPROD, V24, P1296, DOI 10.1093/humrep/dep020; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; McLachlan RI, 2010, J CLIN ENDOCR METAB, V95, P1013, DOI 10.1210/jc.2009-1925; Molenda HA, 2003, BIOL REPROD, V69, P1449, DOI 10.1095/biolreprod.103.019364; Nakada K, 2006, P NATL ACAD SCI USA, V103, P15148, DOI 10.1073/pnas.0604641103; O'Brien KLO, 2010, FERTIL STERIL, V93, P1, DOI 10.1016/j.fertnstert.2009.10.045; O'Donnell L, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1017; O'Malley BW, 2007, MOL ENDOCRINOL, V21, P1009, DOI 10.1210/me.2007-0012; Platts AE, 2007, HUM MOL GENET, V16, P763, DOI 10.1093/hmg/ddm012; Sasarman F, 2010, MOL BIOL CELL, V21, P1315, DOI 10.1091/mbc.E10-01-0047; Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100; Shamsi MB, 2008, INDIAN J UROL, V24, P150, DOI 10.4103/0970-1591.40606; Sugino Y, 2008, J UROLOGY, V180, P2706, DOI 10.1016/j.juro.2008.08.005; Toure A, 2007, HUM MOL GENET, V16, P1783, DOI 10.1093/hmg/ddm117; Toure A, 2011, BIOL CHEM, V392, P799, DOI 10.1515/BC.2011.074; Yan W, 2009, MOL CELL ENDOCRINOL, V306, P24, DOI 10.1016/j.mce.2009.03.003	41	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e70700	10.1371/journal.pone.0070700	http://dx.doi.org/10.1371/journal.pone.0070700			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23976951	Green Published, gold, Green Submitted			2022-12-25	WOS:000323378000011
J	Cramer, MD; Barger, NN				Cramer, Michael D.; Barger, Nichole N.			Are Namibian "Fairy Circles" the Consequence of Self-Organizing Spatial Vegetation Patterning?	PLOS ONE			English	Article							MYSTERIOUS CIRCLES; CLIMATE; DESERT; CARBON; PLANTS; KAOKOLAND; DYNAMICS; PATCHES; ANTS; FORM	Causes of over-dispersed barren "fairy circles" that are often surrounded by ca. 0.5 m tall peripheral grasses in a matrix of shorter (ca. 0.2 m tall) grasses in Namibian grasslands remain mysterious. It was hypothesized that the fairy circles are the consequence of self-organizing spatial vegetation patterning arising from resource competition and facilitation. We examined the edaphic properties of fairy circles and variation in fairy circle size, density and landscape occupancy (% land surface) with edaphic properties and water availability at a local scale (<50 km) and with climate and vegetation characteristics at a regional scale. Soil moisture in the barren fairy circles declines from the center towards the periphery and is inversely correlated with soil organic carbon, possibly indicating that the peripheral grass roots access soil moisture that persists into the dry season within fairy circles. Fairy circle landscape occupancy is negatively correlated with precipitation and soil [N], consistent with fairy circles being the product of resource-competition. Regional fairy circle presence/absence is highly predictable using an empirical model that includes narrow ranges of vegetation biomass, precipitation and temperature seasonality as predictor variables, indicating that fairy circles are likely a climate-dependent emergent phenomenon. This dependence of fairy circle occurrence on climate explains why fairy circles in some locations may appear and disappear over time. Fairy circles are only over-dispersed at high landscape occupancies, indicating that inter-circle competition may determine their spacing. We conclude that fairy circles are likely to be an emergent arid-grassland phenomenon that forms as a consequence of peripheral grass resource-competition and that the consequent barren circle may provide a resource-reservoir essential for the survival of the larger peripheral grasses and provides a habitat for fossicking fauna.	[Cramer, Michael D.] Univ Cape Town, Dept Biol Sci, ZA-7925 Cape Town, South Africa; [Barger, Nichole N.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA	University of Cape Town; University of Colorado System; University of Colorado Boulder	Cramer, MD (corresponding author), Univ Cape Town, Dept Biol Sci, ZA-7925 Cape Town, South Africa.	michael.cramer@uct.ac.za	Cramer, Michael D/A-3213-2013	Cramer, Michael D/0000-0003-0989-3266	University of Cape Town	University of Cape Town	Funding was from the University of Cape Town. MDC received sabbatical support from the Oppenheimer Memorial Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar MR, 1999, TRENDS ECOL EVOL, V14, P273, DOI 10.1016/S0169-5347(99)01612-2; Albrecht CF, 2001, S AFR J SCI, V97, P23; Batjes N.H., 2004, 200404 ISRIC WORLD S; Becker T, 2007, BASIC APPL DRYLAND R, V2, P121; Becker T, 2000, BASIC APPL ECOL, V1, P149, DOI 10.1078/1439-1791-00021; Bengough AG, 2000, ROOT METHODS: A HANDBOOK, P147; Carteni F, 2012, J THEOR BIOL, V313, P153, DOI 10.1016/j.jtbi.2012.08.008; CLAPP RB, 1978, WATER RESOUR RES, V14, P601, DOI 10.1029/WR014i004p00601; CLARK PJ, 1954, ECOLOGY, V35, P445, DOI 10.2307/1931034; Couteron P, 2001, J ECOL, V89, P616, DOI 10.1046/j.0022-0477.2001.00588.x; Cramer MD, 2009, OECOLOGIA, V161, P15, DOI 10.1007/s00442-009-1364-3; DANIN A, 1995, J ARID ENVIRON, V30, P307, DOI 10.1016/S0140-1963(05)80005-9; DOUST LL, 1981, J ECOL, V69, P743, DOI 10.2307/2259633; EICKER A, 1982, S AFR J BOT, V1, P69, DOI 10.1016/S0022-4618(16)30180-2; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; GARCIAMOYA E, 1970, ECOLOGY, V51, P81, DOI 10.2307/1933601; Grube S, 2002, BASIC APPL ECOL, V3, P367, DOI 10.1078/1439-1791-00138; Hengl T, 2009, PRACTICAL GUIDE GEOS, P2; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HilleRisLambers R, 2001, ECOLOGY, V82, P50, DOI 10.1890/0012-9658(2001)082[0050:VPFISA]2.0.CO;2; Hirosawa Y, 1996, REMOTE SENS ENVIRON, V58, P267, DOI 10.1016/S0034-4257(96)00068-5; Jankowitz WJ, 2008, S AFR J BOT, V74, P332, DOI 10.1016/j.sajb.2007.10.010; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Joubert A, 2008, THESIS U PRETORIA; Juergens N, 2013, SCIENCE, V339, P1618, DOI 10.1126/science.1222999; Koenker R, 1996, J ECONOMETRICS, V71, P265, DOI 10.1016/0304-4076(96)84507-6; Lambers H, 2010, PLANT SOIL, V334, P11, DOI 10.1007/s11104-010-0444-9; Lejeune O, 1999, ACTA OECOL, V20, P171, DOI 10.1016/S1146-609X(99)80030-7; MacMahon JA, 2000, ANNU REV ECOL SYST, V31, P265, DOI 10.1146/annurev.ecolsys.31.1.265; Meron E, 2012, ECOL MODEL, V234, P70, DOI 10.1016/j.ecolmodel.2011.05.035; Moll E.J., 1994, P 13 PLEN M AETFAT M, P1203; Naude Y, 2011, J ARID ENVIRON, V75, P446, DOI 10.1016/j.jaridenv.2010.12.018; OLEARY MH, 1988, BIOSCIENCE, V38, P328, DOI 10.2307/1310735; Picker MD, 2012, ECOL ENTOMOL, V37, P33, DOI 10.1111/j.1365-2311.2011.01332.x; Ravi S, 2008, OECOLOGIA, V158, P545, DOI 10.1007/s00442-008-1164-1; Reynard N, 1997, IAHS-AISH P, P23; Ridgeway G, 2010, GEN BOOSTED REGRESSI; Rietkerk M, 2002, AM NAT, V160, P524, DOI 10.1086/342078; Rietkerk M, 2008, TRENDS ECOL EVOL, V23, P169, DOI 10.1016/j.tree.2007.10.013; Rommerskirchen F, 2006, ORG GEOCHEM, V37, P1303, DOI 10.1016/j.orggeochem.2005.12.013; Schenk HJ, 2002, J ECOL, V90, P480, DOI 10.1046/j.1365-2745.2002.00682.x; SCHULTEN HR, 1992, BIOL FERT SOILS, V14, P237, DOI 10.1007/BF00395458; Sheffer E, 2007, ECOL COMPLEX, V4, P192, DOI 10.1016/j.ecocom.2007.06.008; Smith KA, 2000, SOIL ENV ANAL PHYS M, P453; Soil Science Society of South Africa, 1990, HDB STAND SOIL TEST; Tlidi M., 2008, Dissipative Solitons: From Optics to Biology and Medicine, P381, DOI 10.1007/978-3-540-78217-9_15; Tschinkel WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038056; Tschinkel WR, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.21; TSCHINKEL WR, 2010, J INSECT SCI, V10; van der Meer F, 2002, TERRA NOVA, V14, P1, DOI 10.1046/j.1365-3121.2002.00390.x; van Rooyen MW, 2004, J ARID ENVIRON, V57, P467, DOI 10.1016/S0140-1963(03)00111-3; Wood MK, 1998, J RANGE MANAGE, V51, P91, DOI 10.2307/4003570	52	50	52	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e70876	10.1371/journal.pone.0070876	http://dx.doi.org/10.1371/journal.pone.0070876			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23976962	Green Submitted, Green Published, gold			2022-12-25	WOS:000323378000017
J	Holzhutter, HG; Lock, JF; Taheri, P; Bulik, S; Goede, A; Stockmann, M				Holzhuetter, Hermann-Georg; Lock, Johan Friso; Taheri, Pouria; Bulik, Sascha; Goede, Andrean; Stockmann, Martin			Assessment of Hepatic Detoxification Activity: Proposal of an Improved Variant of the C-13-Methacetin Breath Test	PLOS ONE			English	Article							CHRONIC LIVER-DISEASE; LIMAX TEST; KINETICS; TRANSPLANTATION; METABOLISM; PREDICTION; FIBROSIS; EXERCISE; HUMANS; CO2	Breath tests based on the administration of a C-13-labeled drug and subsequent monitoring of (CO2)-C-13 in the breath (quantified as DOB - delta over baseline) liberated from the drug during hepatic CPY-dependent detoxification are important tools in liver function diagnostics. The capability of such breath tests to reliably indicate hepatic CYP performance is limited by the fact that (CO2)-C-13 is not exclusively exhaled but also exchanged with other compartments of the body. In order to assess this bias caused by variations of individual systemic CO2 kinetics we administered intravenously the test drug C-13-methacetin to 25 clinically liver-healthy individuals and monitored progress curves of DOB and the plasma concentration of C-13-methacetin. Applying compartment modelling we estimated for each individual a set of kinetic parameters characterizing the time-dependent exchange of the drug and of CO2 with the liver and non-hepatic body compartments. This analysis revealed that individual variations in the kinetics of CO2 may account for up to 30% deviation of DOB curve parameters from their mean at otherwise identical C-13-methacetin metabolization rates. In order to correct for this bias we introduced a novel detoxification score which ideally should be assessed from the DOB curve of a 2-step test ("2DOB") which is initialized with the injection of a standard dose of C-13-labeled bicarbonate (in order to provide information on the actual CO2 status of the individual) followed by injection of the C-13-labeled test drug (the common procedure). Computer simulations suggest that the predictive power of the proposed 2DOB breath test to reliably quantity the CYP-specific hepatic detoxification activity should be significantly higher compared to the conventional breath test.	[Holzhuetter, Hermann-Georg; Bulik, Sascha; Goede, Andrean] Charite, Inst Biochem, Computat Biochem Grp, D-13353 Berlin, Germany; [Lock, Johan Friso; Taheri, Pouria; Stockmann, Martin] Charite, Dept Gen Visceral & Transplantat Surg, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Holzhutter, HG (corresponding author), Charite, Inst Biochem, Computat Biochem Grp, D-13353 Berlin, Germany.	hergo@charite.de	Lock, Johan/AAA-8114-2020; Goede, Andrean/A-6652-2013	Lock, Johan/0000-0002-9007-3937; Holzhutter, Hermann-Georg/0000-0002-5054-6023; Goede, Andrean/0000-0002-9044-9869	BMBF-systems biology program "Virtual Liver" [FKZ 0315742]	BMBF-systems biology program "Virtual Liver"	This work was in part supported by the BMBF-systems biology program "Virtual Liver" (FKZ 0315742). No further funding was received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afolabi P, 2013, DIGEST DIS SCI, V58, P33, DOI 10.1007/s10620-012-2340-z; BARSTOW TJ, 1990, AM J PHYSIOL, V259, pR163, DOI 10.1152/ajpregu.1990.259.1.R163; BARSTOW TJ, 1989, J APPL PHYSIOL, V66, P936, DOI 10.1152/jappl.1989.66.2.936; Braden B, 2007, DIGEST LIVER DIS, V39, P795, DOI 10.1016/j.dld.2007.06.012; Braden B, 2005, ALIMENT PHARM THER, V21, P179, DOI 10.1111/j.1365-2036.2005.02317.x; Chowdhury RS, 2003, ALIMENT PHARM THER, V17, P733, DOI 10.1046/j.1365-2036.2003.01495.x; Cucchetti A, 2007, ANN SURG, V245, P902, DOI 10.1097/01.sla.0000256356.23026.9f; FELDSCHUH J, 1977, CIRCULATION, V56, P605, DOI 10.1161/01.CIR.56.4.605; Festi D, 2005, WORLD J GASTROENTERO, V11, P142, DOI 10.3748/wjg.v11.i1.142; Giannini EG, 2005, CLIN GASTROENTEROL H, V3, P279, DOI 10.1016/S1542-3565(04)00720-7; GRAHAM DY, 1987, LANCET, V1, P1174; Ilan Y, 2007, ALIMENT PHARM THER, V26, P1293, DOI 10.1111/j.1365-2036.2007.03519.x; IRVING CS, 1982, J LAB CLIN MED, V100, P356; IRVING CS, 1983, AM J PHYSIOL, V245, pR190, DOI 10.1152/ajpregu.1983.245.2.R190; Kasicka-Jonderko A, 2013, DIGEST DIS SCI, V58, P579, DOI 10.1007/s10620-012-2529-1; LIPSEN B, 1988, J APPL PHYSIOL, V65, P2736, DOI 10.1152/jappl.1988.65.6.2736; Lock JF, 2009, EUR J MED RES, V14, P547, DOI 10.1186/2047-783X-14-12-547; Lock JF, 2010, LIVER TRANSPLANT, V16, P172, DOI 10.1002/lt.21973; Mion F, 1999, EUR J CLIN INVEST, V29, P624; Mion F, 1995, HEPATO-GASTROENTEROL, V42, P931; Modak AS, 2007, J BREATH RES, V1, DOI 10.1088/1752-7155/1/1/014003; PRESCOTT LF, 1980, BRIT J CLIN PHARMACO, V10, pS291, DOI 10.1111/j.1365-2125.1980.tb01812.x; Razlan H, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/235796; Schneider A, 2007, J CLIN GASTROENTEROL, V41, P33, DOI 10.1097/MCG.0b013e31802dd4b9; Stibbe KJM, 2011, SCAND J GASTROENTERO, V46, P962, DOI 10.3109/00365521.2011.574725; Stockmann M, 2010, TRANSPL INT, V23, P1023, DOI 10.1111/j.1432-2277.2010.01089.x; Stockmann M, 2010, HPB, V12, P139, DOI 10.1111/j.1477-2574.2009.00151.x; Stockmann M, 2009, ANN SURG, V250, P119, DOI 10.1097/SLA.0b013e3181ad85b5; THORNHILL DP, 1984, EUR J DRUG METAB PH, V9, P161, DOI 10.1007/BF03189620; Yunoki T, 1999, JPN J PHYSIOL, V49, P139, DOI 10.2170/jjphysiol.49.139	30	5	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e70780	10.1371/journal.pone.0070780	http://dx.doi.org/10.1371/journal.pone.0070780			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967104	Green Published, gold, Green Submitted			2022-12-25	WOS:000323378000015
J	Lenassi, M; Gostincar, C; Jackman, S; Turk, M; Sadowski, I; Nislow, C; Jones, S; Birol, I; Cimerman, NG; Plemenitas, A				Lenassi, Metka; Gostincar, Cene; Jackman, Shaun; Turk, Martina; Sadowski, Ivan; Nislow, Corey; Jones, Steven; Birol, Inanc; Cimerman, Nina Gunde; Plemenitas, Ana			Whole Genome Duplication and Enrichment of Metal Cation Transporters Revealed by De Novo Genome Sequencing of Extremely Halotolerant Black Yeast Hortaea werneckii	PLOS ONE			English	Article							P-TYPE ATPASE; SACCHAROMYCES-CEREVISIAE; SALT TOLERANCE; PHYSCOMITRELLA-PATENS; ARABIDOPSIS-THALIANA; POTASSIUM-TRANSPORT; MAXIMUM-LIKELIHOOD; MEMBRANE-FLUIDITY; NA+/H+-ANTIPORTER; FUNGI EVOLUTION	Hortaea werneckii, ascomycetous yeast from the order Capnodiales, shows an exceptional adaptability to osmotically stressful conditions. To investigate this unusual phenotype we obtained a draft genomic sequence of a H. werneckii strain isolated from hypersaline water of solar saltern. Two of its most striking characteristics that may be associated with a halotolerant lifestyle are the large genetic redundancy and the expansion of genes encoding metal cation transporters. Although no sexual state of H. werneckii has yet been described, a mating locus with characteristics of heterothallic fungi was found. The total assembly size of the genome is 51.6 Mb, larger than most phylogenetically related fungi, coding for almost twice the usual number of predicted genes (23333). The genome appears to have experienced a relatively recent whole genome duplication, and contains two highly identical gene copies of almost every protein. This is consistent with some previous studies that reported increases in genomic DNA content triggered by exposure to salt stress. In hypersaline conditions transmembrane ion transport is of utmost importance. The analysis of predicted metal cation transporters showed that most types of transporters experienced several gene duplications at various points during their evolution. Consequently they are present in much higher numbers than expected. The resulting diversity of transporters presents interesting biotechnological opportunities for improvement of halotolerance of salt-sensitive species. The involvement of plasma P-type H+ ATPases in adaptation to different concentrations of salt was indicated by their salt dependent transcription. This was not the case with vacuolar H+ ATPases, which were transcribed constitutively. The availability of this genomic sequence is expected to promote the research of H. werneckii. Studying its extreme halotolerance will not only contribute to our understanding of life in hypersaline environments, but should also identify targets for improving the salt- and osmotolerance of economically important plants and microorganisms.	[Lenassi, Metka; Plemenitas, Ana] Univ Ljubljana, Fac Med, Inst Biochem, Ljubljana 61000, Slovenia; [Lenassi, Metka; Gostincar, Cene; Cimerman, Nina Gunde] Ctr Excellence Integrated Approaches Chem & Biol, Ljubljana, Slovenia; [Gostincar, Cene; Turk, Martina; Cimerman, Nina Gunde] Univ Ljubljana, Dept Biol, Biotech Fac, Ljubljana, Slovenia; [Jackman, Shaun; Jones, Steven; Birol, Inanc] BC Canc Agcy Genome Sci Ctr, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC, Canada; [Sadowski, Ivan] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada; [Nislow, Corey] Univ British Columbia, Dept Pharmaceut Sci, Vancouver, BC V5Z 1M9, Canada	University of Ljubljana; University of Ljubljana; University of British Columbia; University of British Columbia	Lenassi, M (corresponding author), Univ Ljubljana, Fac Med, Inst Biochem, Ljubljana 61000, Slovenia.	metka.lenassi@mf.uni-lj.si	Birol, Inanc/G-5440-2011; Jones, Steven J/C-3621-2009; Jackman, Shaun/G-9622-2013	Birol, Inanc/0000-0003-0950-7839; Jones, Steven J/0000-0003-3394-2208; Jackman, Shaun/0000-0002-9275-5966; Lenassi, Metka/0000-0002-9488-6855; Nislow, Corey/0000-0002-4016-8874; Gostincar, Cene/0000-0002-0149-3674	Slovenian Research Agency [P1-170]; Centre of excellence for integrated approaches in chemistry and biology of proteins [OP13.1.1.2.02.0005]; European regional development fund; Slovenian Ministry of Higher Education, Science and Technology; state budget by the Slovenian Research Agency (Infrastructural Centre Mycosmo)	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Centre of excellence for integrated approaches in chemistry and biology of proteins; European regional development fund(European Commission); Slovenian Ministry of Higher Education, Science and Technology; state budget by the Slovenian Research Agency (Infrastructural Centre Mycosmo)	This study was supported by the Slovenian Research Agency Grant P1-170 and by the "Centre of excellence for integrated approaches in chemistry and biology of proteins" (no. OP13.1.1.2.02.0005), financed by the European regional development fund (85% share of financing) and by the Slovenian Ministry of Higher Education, Science and Technology (15% share of financing). The authors acknowledge the financial support from the state budget by the Slovenian Research Agency (Infrastructural Centre Mycosmo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertin W, 2012, P ROY SOC B-BIOL SCI, V279, P2497, DOI 10.1098/rspb.2012.0434; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ambesi A, 2000, J EXP BIOL, V203, P155; Arango M, 2003, PLANTA, V216, P355, DOI 10.1007/s00425-002-0856-8; Arino J, 2010, MICROBIOL MOL BIOL R, V74, P95, DOI 10.1128/MMBR.00042-09; Ashraf M, 2009, BIOTECHNOL ADV, V27, P744, DOI 10.1016/j.biotechadv.2009.05.026; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Banuelos MA, 1998, MICROBIOL-UK, V144, P2749, DOI 10.1099/00221287-144-10-2749; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Benito B, 2002, MICROBIOL-SGM, V148, P933, DOI 10.1099/00221287-148-4-933; Benito B, 2012, PLANT CELL PHYSIOL, V53, P1117, DOI 10.1093/pcp/pcs056; Benito B, 2011, FUNGAL GENET BIOL, V48, P812, DOI 10.1016/j.fgb.2011.03.002; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bonifaz A, 2010, CLIN DERMATOL, V28, P140, DOI 10.1016/j.clindermatol.2009.12.004; Brock T, 1979, STRATEGIES MICROBIAL; Cagnac O, 2007, J BIOL CHEM, V282, P24284, DOI 10.1074/jbc.M703116200; Cantrell SA, 2006, MYCOL RES, V110, P962, DOI 10.1016/j.mycres.2006.06.005; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; De Hertogh B, 2006, GENETICS, V172, P771, DOI 10.1534/genetics.105.046813; Debuchy R, 2006, MYCOTA, P293, DOI DOI 10.1007/3-540-28135-5_15; Dhar R, 2011, J EVOLUTION BIOL, V24, P1135, DOI 10.1111/j.1420-9101.2011.02249.x; Ezov TK, 2006, GENETICS, V174, P1455, DOI 10.1534/genetics.106.062745; Fettich M, 2011, FUNGAL GENET BIOL, V48, P475, DOI 10.1016/j.fgb.2011.01.011; Field D, 2006, NAT BIOTECHNOL, V24, P801, DOI 10.1038/nbt0706-801; Flowers TJ, 2004, J EXP BOT, V55, P307, DOI 10.1093/jxb/erh003; Galitski T, 1999, SCIENCE, V285, P251, DOI 10.1126/science.285.5425.251; GARCIADEBLAS B, 1993, MOL GEN GENET, V236, P363, DOI 10.1007/BF00277134; Garciadeblas B, 2001, PLANT SOIL, V235, P181, DOI 10.1023/A:1011949626191; Gerstein AC, 2011, J EVOLUTION BIOL, V24, P531, DOI 10.1111/j.1420-9101.2010.02188.x; Gerstein AC, 2006, PLOS GENET, V2, P1396, DOI 10.1371/journal.pgen.0020145; Gerstein AC, 2009, J HERED, V100, P571, DOI 10.1093/jhered/esp057; Gioti A, 2012, MOL BIOL EVOL, V29, P3215, DOI 10.1093/molbev/mss132; Goodwin SB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002070; GORHAM J, 1991, THEOR APPL GENET, V82, P729, DOI 10.1007/BF00227318; Gorjan A, 2006, FEMS MICROBIOL LETT, V265, P41, DOI 10.1111/j.1574-6968.2006.00473.x; Gostincar C, 2012, BIORESOURCE TECHNOL, V111, P360, DOI 10.1016/j.biortech.2012.02.039; Gostincar C, 2011, ADV APPL MICROBIOL, V77, P71, DOI 10.1016/B978-0-12-387044-5.00003-0; Gostincar C, 2010, FEMS MICROBIOL ECOL, V71, P2, DOI 10.1111/j.1574-6941.2009.00794.x; Gostincar C, 2009, FEMS YEAST RES, V9, P247, DOI 10.1111/j.1567-1364.2009.00481.x; Graham LA, 2000, J EXP BIOL, V203, P61; Grant WD, 2004, PHILOS T R SOC B, V359, P1249, DOI 10.1098/rstb.2004.1502; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gunde-Cimerman N, 2000, FEMS MICROBIOL ECOL, V32, P235; HARDCASTLE RV, 1974, J BACTERIOL, V119, P294, DOI 10.1128/JB.119.1.294-302.1974; HARO R, 1991, FEBS LETT, V291, P189, DOI 10.1016/0014-5793(91)81280-L; Hay R.J., 1998, TOPLEY WILSONS MICRO, V4, P191; Hernandez A, 2009, J BIOL CHEM, V284, P14276, DOI 10.1074/jbc.M806203200; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Holt C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-491; Horie T, 2011, J BIOSCI BIOENG, V111, P346, DOI 10.1016/j.jbiosc.2010.10.014; Isidoro D, 2011, IRRIGATION SCI, V29, P197, DOI 10.1007/s00271-010-0223-7; Iwatsu T., 1988, Japanese Journal of Medical Mycology, V29, P142; KANE PM, 1990, SCIENCE, V250, P651, DOI 10.1126/science.2146742; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; KETCHUM KA, 1995, NATURE, V376, P690, DOI 10.1038/376690a0; Kinclova O, 2001, J BIOTECHNOL, V88, P151, DOI 10.1016/S0168-1656(01)00274-7; Kinclova-Zimmermannova O, 2006, FEMS YEAST RES, V6, P792, DOI 10.1111/j.1567-1364.2006.00062.x; KO CH, 1991, MOL CELL BIOL, V11, P4266, DOI 10.1128/MCB.11.8.4266; Kogej T, 2005, APPL ENVIRON MICROB, V71, P6600, DOI 10.1128/AEM.71.11.6600-6605.2005; Kogej T, 2004, FEMS MICROBIOL LETT, V232, P203, DOI 10.1016/S0378-1097(04)00073-4; Kogej T, 2007, MICROBIOL-SGM, V153, P4261, DOI 10.1099/mic.0.2007/010751-0; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Lenassi Metka, 2007, Saline Syst, V3, P3, DOI 10.1186/1746-1448-3-3; Lenassi M, 2007, CURR GENET, V51, P393, DOI 10.1007/s00294-007-0131-4; Lenassi M, 2011, FUNGAL BIOL-UK, V115, P959, DOI 10.1016/j.funbio.2011.04.001; Lidzbarsky GA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005914; Lunde C, 2007, PLANT PHYSIOL, V144, P1786, DOI 10.1104/pp.106.094946; Maathuis FJM, 2006, J EXP BOT, V57, P1137, DOI 10.1093/jxb/erj001; Maresova L, 2005, MOL MICROBIOL, V55, P588, DOI 10.1111/j.1365-2958.2004.04410.x; Maresova L, 2006, FEMS YEAST RES, V6, P1039, DOI 10.1111/j.1567-1364.2006.00140.x; Marschner H., 1995, MINERAL NUTR HIGHER, Vsecond, DOI DOI 10.1016/B978-0-12-473542-2.X5000-7; Martinez P, 1998, MOL GEN GENET, V258, P628, DOI 10.1007/s004380050776; MENDOZA I, 1994, J BIOL CHEM, V269, P8792; MOK WY, 1981, J FOOD TECHNOL, V16, P505, DOI 10.1089/thy.2006.16.505; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Mussatto SI, 2010, BIOTECHNOL ADV, V28, P817, DOI 10.1016/j.biotechadv.2010.07.001; Nass R, 1999, MICROBIOL-SGM, V145, P3221, DOI 10.1099/00221287-145-11-3221; Nowikovsky K, 2004, J BIOL CHEM, V279, P30307, DOI 10.1074/jbc.M403607200; Nowrousian M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000891; Ohm RA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003037; Oren A., 2002, HALOPHILIC MICROORGA; Palmgren MG, 1998, BBA-BIOENERGETICS, V1365, P37, DOI 10.1016/S0005-2728(98)00041-3; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Persson BL, 1998, BBA-BIOENERGETICS, V1365, P23, DOI 10.1016/S0005-2728(98)00037-1; Petrovic U, 2002, MOL MICROBIOL, V45, P665, DOI 10.1046/j.1365-2958.2002.03021.x; Petrovic U, 1999, FEMS MICROBIOL LETT, V180, P325, DOI 10.1111/j.1574-6968.1999.tb08813.x; Pisinaras V, 2010, ENVIRON MONIT ASSESS, V166, P79, DOI 10.1007/s10661-009-0986-6; Plett Darren, 2010, GM Crops, V1, P273, DOI 10.4161/gmcr.1.5.14200; Prior C, 1996, FEBS LETT, V387, P89, DOI 10.1016/0014-5793(96)00470-X; Prista C, 2005, FEMS YEAST RES, V5, P693, DOI 10.1016/j.femsyr.2004.12.009; Quintero FJ, 2002, P NATL ACAD SCI USA, V99, P9061, DOI 10.1073/pnas.132092099; Quintero FJ, 2000, FEBS LETT, V471, P224, DOI 10.1016/S0014-5793(00)01412-5; Ramos J, 2011, FEMS MICROBIOL LETT, V317, P1, DOI 10.1111/j.1574-6968.2011.02214.x; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rodriguez-Navarro A, 2000, BBA-REV BIOMEMBRANES, V1469, P1, DOI 10.1016/S0304-4157(99)00013-1; ROZMAN D, 1994, BIOTECHNIQUES, V16, P382; SCHLESSER A, 1988, J BIOL CHEM, V263, P19480; Schoustra SE, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030068; SERRANO R, 1986, NATURE, V319, P689, DOI 10.1038/319689a0; Serrano R, 2002, MOL MICROBIOL, V46, P1319, DOI 10.1046/j.1365-2958.2002.03246.x; Shabala L, 2005, PLANTA, V222, P1041, DOI 10.1007/s00425-005-0074-2; Shabala S, 2008, PHYSIOL PLANTARUM, V133, P651, DOI 10.1111/j.1399-3054.2007.01008.x; Shi HZ, 2003, NAT BIOTECHNOL, V21, P81, DOI 10.1038/nbt766; Simon E, 2001, J BIOL CHEM, V276, P29740, DOI 10.1074/jbc.M101992200; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Somvanshi Vishal S, 2009, Recent Pat DNA Gene Seq, V3, P16; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Turk M, 2004, EXTREMOPHILES, V8, P53, DOI 10.1007/s00792-003-0360-5; Turk M, 2002, FEMS MICROBIOL LETT, V216, P193, DOI 10.1111/j.1574-6968.2002.tb11435.x; Turk M, 2007, FEMS YEAST RES, V7, P550, DOI 10.1111/j.1567-1364.2007.00209.x; Unk I, 2000, J BIOL CHEM, V275, P22427, DOI 10.1074/jbc.M002845200; Vaupotic T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-280; Vaupotic T, 2007, FUNGAL GENET BIOL, V44, P1109, DOI 10.1016/j.fgb.2007.02.005; Vaupotic T, 2007, FEBS LETT, V581, P3391, DOI 10.1016/j.febslet.2007.06.038; Viladevall L, 2004, J BIOL CHEM, V279, P43614, DOI 10.1074/jbc.M403606200; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; Volkov V, 2004, PLANT CELL ENVIRON, V27, P1, DOI 10.1046/j.0016-8025.2003.01116.x; Waalwijk C, 2002, FUNGAL GENET BIOL, V35, P277, DOI 10.1006/fgbi.2001.1322; WIELAND J, 1995, EMBO J, V14, P3870, DOI 10.1002/j.1460-2075.1995.tb00059.x; WOLLENZIEN U, 1995, SCI TOTAL ENVIRON, V167, P287, DOI 10.1016/0048-9697(95)04589-S; Wong S, 2002, P NATL ACAD SCI USA, V99, P9272, DOI 10.1073/pnas.142101099; Yale J, 2001, J BIOL CHEM, V276, P15996, DOI 10.1074/jbc.M008209200; Zalar P, 2005, BOT MAR, V48, P323, DOI 10.1515/BOT.2005.042; Zalar P, 1999, STUD MYCOL, P38; Zotova L, 2010, J BIOL CHEM, V285, P14399, DOI 10.1074/jbc.M109.059956	128	61	61	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71328	10.1371/journal.pone.0071328	http://dx.doi.org/10.1371/journal.pone.0071328			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977017	gold, Green Published, Green Submitted			2022-12-25	WOS:000323378000041
J	Miwa, S; Takeuchi, A; Ikeda, H; Shirai, T; Yamamoto, N; Nishida, H; Hayashi, K; Tanzawa, Y; Kimura, H; Igarashi, K; Tsuchiya, H				Miwa, Shinji; Takeuchi, Akihiko; Ikeda, Hiroko; Shirai, Toshiharu; Yamamoto, Norio; Nishida, Hideji; Hayashi, Katsuhiro; Tanzawa, Yoshikazu; Kimura, Hiroaki; Igarashi, Kentaro; Tsuchiya, Hiroyuki			Prognostic Value of Histological Response to Chemotherapy in Osteosarcoma Patients Receiving Tumor-Bearing Frozen Autograft	PLOS ONE			English	Article							HIGH-GRADE OSTEOSARCOMA; MALIGNANT BONE-TUMORS; NEOADJUVANT CHEMOTHERAPY; LIQUID-NITROGEN; NONMETASTATIC OSTEOSARCOMA; PREOPERATIVE CHEMOTHERAPY; SINGLE INSTITUTION; EXTREMITIES; RECONSTRUCTION; SURVIVAL	Background: A variety of surgical procedures are now available for tissue reconstruction after osteosarcoma excision, and an important prognostic factor is the evaluation of response to chemotherapy using histology. Although tumor-bearing autografts are useful tools for reconstruction, re-use of the primary tumor may make it difficult to assess the histological response to chemotherapy, since the entire tumor cannot be analyzed. Here, we analyzed the prognostic value of the histological response in the patients who received frozen tumor-bearing autografts for reconstruction. Method: Retrospective analysis of the medical records of 51 patients with high-grade osteosarcoma of the extremities was performed. All patients received reconstruction using frozen tumor-bearing autografts. Tumor necrosis was evaluated in extraskeletal masses and cancellous bone. Results: Five-year overall survival of patients with good and poor response to chemotherapy was 82.9% and 46.4%, respectively (P = 0.044), and 5-year event-free survival was 57.7% and 36.0%, respectively (P = 0.329). Multivariate analysis revealed that a poor histological response to chemotherapy was a significant prognostic factor for overall survival (P = 0.033). Conclusion: Histological response is an important and reliable prognostic factor in patients undergoing reconstruction using frozen tumor-bearing autografts.	[Miwa, Shinji; Takeuchi, Akihiko; Shirai, Toshiharu; Yamamoto, Norio; Nishida, Hideji; Hayashi, Katsuhiro; Tanzawa, Yoshikazu; Kimura, Hiroaki; Igarashi, Kentaro; Tsuchiya, Hiroyuki] Kanazawa Univ, Sch Med, Dept Orthopaed Surg, Kanazawa, Ishikawa 920, Japan; [Ikeda, Hiroko] Kanazawa Univ Hosp, Sect Diagnost Pathol, Kanazawa, Ishikawa, Japan	Kanazawa University; Kanazawa University	Tsuchiya, H (corresponding author), Kanazawa Univ, Sch Med, Dept Orthopaed Surg, Kanazawa, Ishikawa 920, Japan.	tsuchi@med.kanazawa-u.ac.jp	Hayashi, K/C-4685-2015; Takeuchi, Akihiko/AAJ-1563-2020; Miwa, Shinji/AAI-9309-2020	Hayashi, K/0000-0001-8665-2154; Takeuchi, Akihiko/0000-0002-4071-5620; Miwa, Shinji/0000-0002-5962-8287; Igarashi, Kentaro/0000-0003-2278-1736				Bacci G, 2003, CANCER, V97, P3068, DOI 10.1002/cncr.11456; Bacci G, 2006, CANCER-AM CANCER SOC, V106, P1154, DOI 10.1002/cncr.21724; Bacci G, 2005, EUR J CANCER, V41, P2079, DOI 10.1016/j.ejca.2005.03.036; Bacci G, 2001, EUR J CANCER, V37, P2030, DOI 10.1016/S0959-8049(01)00229-5; Bielack SS, 2002, J CLIN ONCOL, V20, P776, DOI 10.1200/JCO.20.3.776; Bielack SS, 2004, EXPERT OPIN PHARMACO, V5, P1243, DOI 10.1517/14656566.5.6.1243; Chen WM, 2012, J SURG ONCOL, V105, P825, DOI 10.1002/jso.23005; Chen WM, 2002, J BONE JOINT SURG BR, V84B, P1156, DOI 10.1302/0301-620X.84B8.13508; Chen WM, 2000, J ORTHOP SURG, V17, P11; DAVIS AM, 1994, J CLIN ONCOL, V12, P423, DOI 10.1200/JCO.1994.12.2.423; Ehara S, 2000, SKELETAL RADIOL, V29, P335, DOI 10.1007/s002560000205; ENNEKING WF, 1980, CLIN ORTHOP RELAT R, P106; Ferrari S, 1997, ANN ONCOL, V8, P765, DOI 10.1023/A:1008221713505; Ford Samuel, 2004, Sarcoma, V8, P13, DOI 10.1080/13577140410001679202; FREEMAN AE, 1986, P NATL ACAD SCI USA, V83, P2694, DOI 10.1073/pnas.83.8.2694; FURUKAWA T, 1995, CLIN CANCER RES, V1, P305; Grimer RJ, 2005, LANCET ONCOL, V6, P85, DOI 10.1016/S1470-2045(05)01734-1; Harting MT, 2010, J CANCER RES CLIN, V136, P561, DOI 10.1007/s00432-009-0690-5; Hoffman R. M., 2010, HISTOCULTURES THEIR; Kubota T, 1995, CLIN CANCER RES, V1, P1537; LAURITZEN C, 1991, SCAND J PLAST RECONS, V25, P161, DOI 10.3109/02844319109111277; Le Deley MC, 2007, EUR J CANCER, V43, P752, DOI 10.1016/j.ejca.2006.10.023; Lewis IJ, 2007, JNCI-J NATL CANCER I, V99, P112, DOI 10.1093/jnci/djk015; Li X, 2011, INT ORTHOP, V35, P1847, DOI 10.1007/s00264-011-1209-7; Manabe J, 2004, CLIN ORTHOP RELAT R, P258, DOI 10.1097/01.blo.0000122665.47154.8f; Miwa S, PLOS ONE IN PRESS; Miwa S, 2012, J SURG ONCOL, V106, P273, DOI 10.1002/jso.23074; Miwa S, 2011, INT J CLIN ONCOL, V16, P373, DOI 10.1007/s10147-011-0194-6; Nishida H, 2008, J BONE JOINT SURG BR, V90B, P1249, DOI 10.1302/0301-620X.90B9.20671; Pakos EE, 2009, EUR J CANCER, V45, P2367, DOI 10.1016/j.ejca.2009.03.005; ROSEN G, 1982, CANCER-AM CANCER SOC, V49, P1221, DOI 10.1002/1097-0142(19820315)49:6<1221::AID-CNCR2820490625>3.0.CO;2-E; Takata M, 2011, CRYOBIOLOGY, V63, P235, DOI 10.1016/j.cryobiol.2011.09.001; Tanzawa Y, 2008, J ORTHOP SCI, V13, P259, DOI 10.1007/s00776-007-1222-2; Tanzawa Y, 2009, J ORTHOP SCI, V14, P761, DOI 10.1007/s00776-009-1392-1; Tsuboyama T, 2000, INT ORTHOP, V24, P202, DOI 10.1007/s002640000154; Tsuchiya H, 2005, J BONE JOINT SURG BR, V87B, P218, DOI 10.1302/0301-620X.87B2.15325; Tsuchiya H, 1999, CLIN ORTHOP RELAT R, P27; Tsuchiya H, 1997, J BONE JOINT SURG BR, V79B, P403, DOI 10.1302/0301-620X.79B3.7198; Tsuchiya H, 2010, J ORTHOP SCI, V15, P340, DOI 10.1007/s00776-010-1458-0; VESCIO RA, 1987, P NATL ACAD SCI USA, V84, P5029, DOI 10.1073/pnas.84.14.5029	40	28	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71362	10.1371/journal.pone.0071362	http://dx.doi.org/10.1371/journal.pone.0071362			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977028	Green Published, gold, Green Submitted			2022-12-25	WOS:000323378000048
J	Wang, XJ; Zhang, AH; Yan, GL; Sun, WJ; Han, Y; Sun, H				Wang, Xijun; Zhang, Aihua; Yan, Guangli; Sun, Wenjun; Han, Ying; Sun, Hui			Metabolomics and Proteomics Annotate Therapeutic Properties of Geniposide: Targeting and Regulating Multiple Perturbed Pathways	PLOS ONE			English	Article							CHEN-HAO-TANG; MASS-SPECTROMETRY; NATURAL-PRODUCTS; TIME	Geniposide is an important constituent of Gardenia jasminoides Ellis, a famous Chinese medicinal plant, and has displayed bright prospects in prevention and therapy of hepatic injury (HI). Unfortunately, the working mechanisms of this compound are difficult to determine and thus remain unknown. To determine the mechanisms that underlie this compound, we conducted a systematic analysis of the therapeutic effects of geniposide using biochemistry, metabolomics and proteomics. Geniposide significantly intensified the therapeutic efficacy as indicated by our modern biochemical analysis. Metabolomics results indicate 9 ions in the positive mode as differentiating metabolites which were associated with perturbations in primary bile acid biosynthesis, butanoate metabolism, citrate cycle (TCA cycle), alanine, aspartate and glutamate metabolism. Of note, geniposide has potential pharmacological effect through regulating multiple perturbed pathways to normal state. In an attempt to address the benefits of geniposide based on the proteomics approaches, the protein-interacting networks were constructed to aid identifying the drug targets of geniposide. Six identified differential proteins appear to be involved in antioxidation and signal transduction, energy production, immunity, metabolism, chaperoning. These proteins were closely related in the protein-protein interaction network and the modulation of multiple vital physiological pathways. These data will help to understand the molecular therapeutic mechanisms of geniposide on hepatic damage rats. We also conclude that metabolomics and proteomics are powerful and versatile tools for both biomarker discovery and exploring the complex relationships between biological pathways and drug response, highlighting insights into drug discovery.	[Wang, Xijun] Heilongjiang Univ Chinese Med, Key Lab Chinmed, Natl TCM Key Lab Serum Pharmacochem, Harbin, Peoples R China; Heilongjiang Univ Chinese Med, Key Pharmacometabol Platform Chinese Med, Harbin, Peoples R China	Heilongjiang University of Chinese Medicine; Heilongjiang University of Chinese Medicine	Wang, XJ (corresponding author), Heilongjiang Univ Chinese Med, Key Lab Chinmed, Natl TCM Key Lab Serum Pharmacochem, Harbin, Peoples R China.	casciences@163.com; metabolomics@126.com	Wang, Xijun/C-4477-2014	Wang, Xijun/0000-0002-0949-3492	Natural Science Foundation of State [90709019, 81173500, 81202639]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2011BAI03B03, 2011BAI03B06, 2011BAI03B08]; Key Science and Technology Program of Heilongjiang Province, China [GC06C501, GA08C303, GA06C30101]; National Specific Program on the Subject of Public Welfare [200807014]; National Key Subject of Drug Innovation [2009ZX09502-005]; Foundation of Heilongjiang University of Chinese Medicine [201209]; Chinese Ministry of Education [212044]	Natural Science Foundation of State; National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Key Science and Technology Program of Heilongjiang Province, China; National Specific Program on the Subject of Public Welfare; National Key Subject of Drug Innovation; Foundation of Heilongjiang University of Chinese Medicine; Chinese Ministry of Education(Ministry of Education, China)	This work was supported by grants from the Key Program of Natural Science Foundation of State (Grant Nos. 90709019, 81173500, 81202639), National Key Technology Research and Development Program of the Ministry of Science and Technology of China (Grant Nos. 2011BAI03B03, 2011BAI03B06, 2011BAI03B08), Key Science and Technology Program of Heilongjiang Province, China (Grant Nos. GC06C501, GA08C303, GA06C30101), the National Specific Program on the Subject of Public Welfare (Grant No. 200807014), National Key Subject of Drug Innovation (Grant No. 2009ZX09502-005), Foundation of Heilongjiang University of Chinese Medicine (Grant no. 201209), Key Project of Chinese Ministry of Education (Grant no. 212044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakal C, 2008, SCIENCE, V322, P453, DOI 10.1126/science.1158739; Gersch M, 2012, NAT PROD REP, V29, P659, DOI 10.1039/c2np20012k; Ioannidis JPA, 2011, SCIENCE, V334, P1230, DOI 10.1126/science.1211811; Jemal M, 2003, RAPID COMMUN MASS SP, V17, P2732, DOI 10.1002/rcm.1256; Pan X, 2011, NAT MED, V17, P708, DOI 10.1038/nm.2369; Price JV, 2012, NAT MED, V18, P1434, DOI 10.1038/nm.2913; Rix U, 2009, NAT CHEM BIOL, V5, P616, DOI 10.1038/nchembio.216; Sun H, 2013, MOL CELL PROTEOMICS, V12, P710, DOI 10.1074/mcp.M112.019141; Tran JC, 2011, NATURE, V480, P254, DOI 10.1038/nature10575; Wang L, 2008, P NATL ACAD SCI USA, V105, P4826, DOI 10.1073/pnas.0712365105; Wang XJ, 2013, MOL CELL PROTEOMICS, V12, P1226, DOI 10.1074/mcp.M112.021683; Wang XJ, 2013, J PHARMACEUT BIOMED, V74, P22, DOI 10.1016/j.jpba.2012.10.009; Wang XJ, 2012, ANALYST, V137, P4703, DOI 10.1039/c2an35891c; Wang XJ, 2012, OMICS, V16, P414, DOI 10.1089/omi.2011.0138; Wang XJ, 2011, ANALYST, V136, P5068, DOI 10.1039/c1an15752c; Yang DF, 2011, BRIT J PHARMACOL, V164, P1547, DOI 10.1111/j.1476-5381.2011.01522.x; Yeoman CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056111; Zhang A, 2013, OBES REV, V14, P344, DOI 10.1111/obr.12011; Zhang AH, 2013, CLIN CHIM ACTA, V424, P3, DOI 10.1016/j.cca.2013.05.003; Zhang AH, 2013, MAGN RESON CHEM, V51, P549, DOI 10.1002/mrc.3985; Zhang AH, 2013, MOL BIOSYST, V9, P2259, DOI 10.1039/c3mb70171a; Zhang AH, 2013, APPL BIOCHEM BIOTECH, V170, P774, DOI 10.1007/s12010-013-0238-7; Zhang AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064381; Zhang AH, 2013, EUR J MED CHEM, V63, P570, DOI 10.1016/j.ejmech.2012.12.062; Zhang AH, 2013, OMICS, V17, P224, DOI 10.1089/omi.2012.0064; Zhang AH, 2013, ANALYST, V138, P353, DOI 10.1039/c2an36382h; Zhang AH, 2011, FITOTERAPIA, V82, P1160, DOI 10.1016/j.fitote.2011.07.014	27	31	34	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71403	10.1371/journal.pone.0071403	http://dx.doi.org/10.1371/journal.pone.0071403			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967205	Green Published, gold, Green Submitted			2022-12-25	WOS:000323378000051
J	Flanagan, TP; Pinter-Wollman, NM; Moses, ME; Gordon, DM				Flanagan, Tatiana P.; Pinter-Wollman, Noa M.; Moses, Melanie E.; Gordon, Deborah M.			Fast and Flexible: Argentine Ants Recruit from Nearby Trails	PLOS ONE			English	Article							FORAGING STRATEGIES; FOOD RECRUITMENT; LAYING BEHAVIOR; COLONY; HYMENOPTERA; FORMICIDAE; DYNAMICS; INVASION	Argentine ants (Linepithema humile) live in groups of nests connected by trails to each other and to stable food sources. In a field study, we investigated whether some ants recruit directly from established, persistent trails to food sources, thus accelerating food collection. Our results indicate that Argentine ants recruit nestmates to food directly from persistent trails, and that the exponential increase in the arrival rate of ants at baits is faster than would be possible if recruited ants traveled from distant nests. Once ants find a new food source, they walk back and forth between the bait and sometimes share food by trophallaxis with nestmates on the trail. Recruiting ants from nearby persistent trails creates a dynamic circuit, like those found in other distributed systems, which facilitates a quick response to changes in available resources.	[Flanagan, Tatiana P.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Flanagan, Tatiana P.; Moses, Melanie E.] Univ New Mexico, Dept Comp Sci, Albuquerque, NM 87131 USA; [Pinter-Wollman, Noa M.; Gordon, Deborah M.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	University of New Mexico; University of New Mexico; Stanford University	Flanagan, TP (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	tpaz@unm.edu			Defense Advanced Research Projects Agency [P-1070-113237]; National Institutes of Health [P20 RR-018754]; National Science Foundation EF [1038682]; University of New Mexico; Emerging Frontiers [1038708] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018754] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation EF; University of New Mexico; Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by a Defense Advanced Research Projects Agency grant P-1070-113237, www.darpa.mil, and a National Institutes of Health grant P20 RR-018754 www.nih.gov. The authors also received a National Science Foundation EF grant 1038682, www.nsf.gov, and a Gift from Microsoft Research, research.microsoft.com. TPF is supported by the Program in Interdisciplinary Biomedical and Biological Sciences at the University of New Mexico. pibbs.unm.edu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2010, ANT ENCOUNTERS INTER; ARON S, 1989, BIOL BEHAV, V14, P207; Banavar JR, 2010, P NATL ACAD SCI USA, V107, P15816, DOI 10.1073/pnas.1009974107; BECKERS R, 1992, INSECT SOC, V39, P59, DOI 10.1007/BF01240531; BECKERS R, 1989, Psyche (Cambridge), V96, P239, DOI 10.1155/1989/94279; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; CAMAZINE S, 2001, SELF ORG COMPLEX SYS; CHERIX D, 1980, REV SUISSE ZOOL, V87, P955, DOI 10.5962/bhl.part.85566; Czaczkes TJ, 2012, BEHAV ECOL SOCIOBIOL, P1; Debout G, 2007, BIOL J LINN SOC, V90, P319, DOI 10.1111/j.1095-8312.2007.00728.x; Detrain C., 1999, INFORM PROCESSING SO; Detrain C, 2009, CONTEMP TOP ENTOMOL, P29; Dorigo M, 2006, ANT COL OPT SWARM IN; Dussutour A, 2009, J EXP BIOL, V212, P2337, DOI 10.1242/jeb.029827; Fernandez AA, 2011, J THEOR BIOL, V284, P7, DOI 10.1016/j.jtbi.2011.06.001; FOURCASSIE V, 1994, PHYSIOL ENTOMOL, V19, P291, DOI 10.1111/j.1365-3032.1994.tb01055.x; Franks NR, 2006, NATURE, V439, P153, DOI 10.1038/439153a; GORDON DM, 1995, ANIM BEHAV, V49, P649, DOI 10.1016/0003-3472(95)80198-7; Heller NE, 2008, INSECT SOC, V55, P397, DOI 10.1007/s00040-008-1019-0; Heller NE, 2006, ECOL ENTOMOL, V31, P499, DOI 10.1111/j.1365-2311.2006.00806.x; HOLLDOBLER B, 1980, SCIENCE, V210, P732, DOI 10.1126/science.210.4471.732; HOLLDOBLER B, 1976, BEHAV ECOL SOCIOBIOL, V1, P3, DOI 10.1007/BF00299951; Holldobler B., 1990, pi; Holway DA, 1999, TRENDS ECOL EVOL, V14, P328, DOI 10.1016/S0169-5347(99)01636-5; Holway DA, 1999, ECOLOGY, V80, P238, DOI 10.1890/0012-9658(1999)080[0238:CMUTDO]2.0.CO;2; Human KG, 1999, INSECT SOC, V46, P159, DOI 10.1007/s000400050127; KNIGHT RL, 1990, J ECON ENTOMOL, V83, P1402, DOI 10.1093/jee/83.4.1402; Latty T, 2011, J R SOC INTERFACE, V8, P1298, DOI 10.1098/rsif.2010.0612; Lizon a l'Allemand S, 2010, BIOL INVASIONS, V12, P3551, DOI 10.1007/s10530-010-9750-7; MARKIN G P, 1968, Journal of the Kansas Entomological Society, V41, P511; MARKIN GP, 1970, ANN ENTOMOL SOC AM, V63, P1238, DOI 10.1093/aesa/63.5.1238; MASCHWITZ U, 1975, OECOLOGIA, V20, P65, DOI 10.1007/BF00364322; Moses ME, 2005, THESIS U NEW MEXICO; NELSON CR, 1991, INSECT SOC, V38, P221, DOI 10.1007/BF01314908; Newell W., 1913, THE ARGENTINE ANT; Prabhakar B, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002670; Pratt SC, 2002, BEHAV ECOL SOCIOBIOL, V52, P117, DOI 10.1007/s00265-002-0487-x; Rowles AD, 2009, OECOLOGIA, V161, P161, DOI 10.1007/s00442-009-1368-z; Samaniego H, 2008, J TRANSPORT LAND USE, V1; Sanders NJ, 2001, OECOLOGIA, V127, P123, DOI 10.1007/s004420000572; Suarez AV, 2001, P NATL ACAD SCI USA, V98, P1095, DOI 10.1073/pnas.98.3.1095; TRANIELLO JFA, 1989, ANNU REV ENTOMOL, V34, P191, DOI 10.1146/annurev.en.34.010189.001203; TREMPER BS, 1976, DISTRIBUTION ARGENTI; WILSON EDWARD O., 1962, ANIMAL BEHAVIOUR, V10, P148, DOI 10.1016/0003-3472(62)90142-2; Witte V, 2007, CHEMOECOLOGY, V17, P57, DOI 10.1007/s00049-006-0364-6	46	32	32	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e70888	10.1371/journal.pone.0070888	http://dx.doi.org/10.1371/journal.pone.0070888			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967129	Green Published, Green Submitted, gold			2022-12-25	WOS:000323221500044
J	Hu, RK; Yan, H; Hao, XJ; Liu, HY; Wu, JR				Hu, Rongkuan; Yan, Huan; Hao, Xiaojiang; Liu, Haiyang; Wu, Jiarui			Shizukaol D Isolated from Chloranthus japonicas Inhibits AMPK-Dependent Lipid Content in Hepatic Cells by Inducing Mitochondrial Dysfunction	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; FATTY-ACID OXIDATION; RESPIRATORY COMPLEX-I; INSULIN-RESISTANCE; MALONYL-COA; SIGNALING PATHWAYS; GLUCOSE-UPTAKE; L6 MYOTUBES; HEPG2 CELLS; METFORMIN	This study is the first to demonstrate that shizukaol D, a natural compound isolated from Chloranthus japonicus, can activate AMP-activated protein kinase (AMPK), a key sensor and regulator of intracellular energy metabolism, leading to a decrease in triglyceride and cholesterol levels in HepG2 cells. Furthermore, we found that shizukaol D induces mitochondrial dysfunction by depolarizing the mitochondrial membrane and suppressing energy production, which may result in AMPK activation. Our results provide a possible link between mitochondrial dysfunction and AMPK activation and suggest that shizukaol D might be used to treat metabolic syndrome.	[Hu, Rongkuan; Wu, Jiarui] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Hu, Rongkuan; Wu, Jiarui] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Yan, Huan; Hao, Xiaojiang; Liu, Haiyang] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming, Yunnan, Peoples R China; [Wu, Jiarui] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Key Lab Syst Biol, Shanghai, Peoples R China; [Wu, Jiarui] Chinese Acad Sci, Shanghai Adv Res Inst, Shanghai, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Advanced Research Institute, CAS	Liu, HY (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.	haiyangliu@mail.kib.ac.cn; wujr@sibs.ac.cn	Hu, Rongkuan/M-8781-2018	Hu, Rongkuan/0000-0001-6293-2004	Ministry of Science and Technology [2010CB912102, 2011CB910200]; National Natural Science Foundation of China [31130034]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-Q-10]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences)	This work was supported in part by grants from Ministry of Science and Technology (#2010CB912102, 2011CB910200), a grant from the National Natural Science Foundation of China (#31130034) (to JRW); and a grant from the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-Q-10) (to HL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anurag P, 2002, DIABETES OBES METAB, V4, P36, DOI 10.1046/j.1463-1326.2002.00178.x; Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052; Cao CM, 2008, CHEM BIODIVERS, V5, P219, DOI 10.1002/cbdv.200890020; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Caton PW, 2010, J ENDOCRINOL, V205, P97, DOI 10.1677/JOE-09-0345; Cheng Z, 2006, BBA-GEN SUBJECTS, V1760, P1682, DOI 10.1016/j.bbagen.2006.09.007; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; COONEY GJ, 1977, BIOCHEM PHARMACOL, V26, P2463, DOI 10.1016/0006-2952(77)90462-2; COONEY GJ, 1979, BIOCHEM PHARMACOL, V28, P1067, DOI 10.1016/0006-2952(79)90305-8; Davidson MB, 1997, AM J MED, V102, P99, DOI 10.1016/S0002-9343(96)00353-1; de Graaf AO, 2004, EXP CELL RES, V299, P533, DOI 10.1016/j.yexcr.2004.06.024; Deng WJ, 2010, MOL CELL PROTEOMICS, V9, P100, DOI 10.1074/mcp.M900020-MCP200; Fang PL, 2011, J NAT PROD, V74, P1408, DOI 10.1021/np200087d; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Fujii N, 2000, BIOCHEM BIOPH RES CO, V273, P1150, DOI 10.1006/bbrc.2000.3073; Fujimoto S, 2007, DIABETES RES CLIN PR, V77, pS2, DOI 10.1016/j.diabres.2007.01.026; GLOCKLIN VC, 1952, J CELL COMPAR PHYSL, V39, P341, DOI 10.1002/jcp.1030390302; Hagen RM, 2010, FEBS LETT, V584, P2689, DOI 10.1016/j.febslet.2010.04.004; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Harvatine KJ, 2006, J NUTR, V136, P2468, DOI 10.1093/jn/136.10.2468; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Huang SL, 2012, DIABETOLOGIA, V55, P1469, DOI 10.1007/s00125-011-2366-3; Janovska A, 2008, MOL CELL ENDOCRINOL, V284, P1, DOI 10.1016/j.mce.2007.12.013; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim MK, 2012, INT J NEUROPSYCHOPH, V15, P907, DOI 10.1017/S1461145711000976; Kim MS, 2012, MOL CELL ENDOCRINOL, V358, P127, DOI 10.1016/j.mce.2012.03.013; Kraegen EW, 2006, AM J PHYSIOL-ENDOC M, V290, pE471, DOI 10.1152/ajpendo.00316.2005; Kuang HX, 2008, CHEM BIODIVERS, V5, P1736, DOI 10.1002/cbdv.200890162; Kwon KY, 2011, BIOCHEM BIOPH RES CO, V416, P343, DOI 10.1016/j.bbrc.2011.11.038; Kwon OE, 2006, J ETHNOPHARMACOL, V104, P270, DOI 10.1016/j.jep.2005.09.018; Lochhead PA, 2000, DIABETES, V49, P896, DOI 10.2337/diabetes.49.6.896; McCullough LD, 2005, J BIOL CHEM, V280, P20493, DOI 10.1074/jbc.M409985200; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Nachbur U, 2006, BLOOD, V107, P2790, DOI 10.1182/blood-2005-07-2744; Nelson BA, 2000, DIABETES, V49, P981, DOI 10.2337/diabetes.49.6.981; Peterson JM, 2012, J BIOL CHEM, V287, P1576, DOI 10.1074/jbc.M111.278333; Qiu BY, 2010, DIABETES, V59, P256, DOI 10.2337/db09-0223; Ruderman NB, 2003, BIOCHEM SOC T, V31, P202, DOI 10.1042/bst0310202; Sambandam N, 2004, EUR J BIOCHEM, V271, P2831, DOI 10.1111/j.1432-1033.2004.04218.x; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Turner N, 2008, DIABETES, V57, P1414, DOI 10.2337/db07-1552; Wang QH, 2011, J NAT PROD, V74, P16, DOI 10.1021/np100504m; Wen JP, 2010, MOL CELL BIOCHEM, V344, P109, DOI 10.1007/s11010-010-0534-2; Xiong L, 2007, J CELL BIOL, V178, P995, DOI 10.1083/jcb.200703044; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yim NH, 2008, BIOL PHARM BULL, V31, P1041, DOI 10.1248/bpb.31.1041; Yonemitsu S, 2001, DIABETES, V50, P1093, DOI 10.2337/diabetes.50.5.1093; Zammit VA, 2008, CELL METAB, V8, P175, DOI 10.1016/j.cmet.2008.07.009; Zang MW, 2004, J BIOL CHEM, V279, P47898, DOI 10.1074/jbc.M408149200; Zhan ZJ, 2011, NAT PROD REP, V28, P594, DOI 10.1039/c0np00050g; Zhang M, 2012, J NAT PROD, V75, P694, DOI 10.1021/np200968p; Zhang WY, 2010, HORM METAB RES, V42, P930, DOI 10.1055/s-0030-1265219; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	59	26	27	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e73527	10.1371/journal.pone.0073527	http://dx.doi.org/10.1371/journal.pone.0073527			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967345	Green Submitted, gold, Green Published			2022-12-25	WOS:000323221500147
J	Kurosawa, A; Saito, S; So, S; Hashimoto, M; Iwabuchi, K; Watabe, H; Adachi, N				Kurosawa, Aya; Saito, Shinta; So, Sairei; Hashimoto, Mitsumasa; Iwabuchi, Kuniyoshi; Watabe, Haruka; Adachi, Noritaka			DNA Ligase IV and Artemis Act Cooperatively to Suppress Homologous Recombination in Human Cells: Implications for DNA Double-Strand Break Repair	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; END-JOINING PATHWAY; HUMAN SOMATIC-CELLS; TOPOISOMERASE-II; VERTEBRATE CELLS; V(D)J RECOMBINATION; GENOME INTEGRITY; X-RAY; DAMAGE; ATM	Nonhomologous end-joining (NHEJ) and homologous recombination (HR) are two major pathways for repairing DNA double-strand breaks (DSBs); however, their respective roles in human somatic cells remain to be elucidated. Here we show using a series of human gene-knockout cell lines that NHEJ repairs nearly all of the topoisomerase II- and low-dose radiation-induced DNA damage, while it negatively affects survival of cells harbouring replication-associated DSBs. Intriguingly, we find that loss of DNA ligase IV, a critical NHEJ ligase, and Artemis, an NHEJ factor with endonuclease activity, independently contribute to increased resistance to replication-associated DSBs. We also show that loss of Artemis alleviates hypersensitivity of DNA ligase IV-null cells to low-dose radiation-and topoisomerase II-induced DSBs. Finally, we demonstrate that Artemis-null human cells display increased gene-targeting efficiencies, particularly in the absence of DNA ligase IV. Collectively, these data suggest that DNA ligase IV and Artemis act cooperatively to promote NHEJ, thereby suppressing HR. Our results point to the possibility that HR can only operate on accidental DSBs when NHEJ is missing or abortive, and Artemis may be involved in pathway switching from incomplete NHEJ to HR.	[Kurosawa, Aya; Saito, Shinta; So, Sairei; Watabe, Haruka; Adachi, Noritaka] Yokohama City Univ, Grad Sch Nanobiosci, Yokohama, Kanagawa 232, Japan; [Hashimoto, Mitsumasa; Iwabuchi, Kuniyoshi] Kanazawa Med Univ, Dept Biochem, Kanazawa, Ishikawa, Japan; [Adachi, Noritaka] Yokohama City Univ, Adv Med Res Ctr, Yokohama, Kanagawa 232, Japan	Yokohama City University; Kanazawa Medical University; Yokohama City University	Adachi, N (corresponding author), Yokohama City Univ, Grad Sch Nanobiosci, Yokohama, Kanagawa 232, Japan.	nadachi@yokohama-cu.ac.jp	Kurosawa, Aya/O-5165-2018	Kurosawa, Aya/0000-0001-8909-2789	Yokohama City University [G2201/G2301/G2401]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan	Yokohama City University; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from Yokohama City University (Strategic Research Promotion G2201/G2301/G2401) and by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi N, 2006, DNA CELL BIOL, V25, P19, DOI 10.1089/dna.2006.25.19; Adachi N, 2004, J BIOL CHEM, V279, P37343, DOI 10.1074/jbc.M313910200; Adachi N, 2003, J BIOL CHEM, V278, P35897, DOI 10.1074/jbc.M306500200; Adachi N, 2001, P NATL ACAD SCI USA, V98, P12109, DOI 10.1073/pnas.201271098; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Ceballos SJ, 2011, BBA-GENE REGUL MECH, V1809, P509, DOI 10.1016/j.bbagrm.2011.06.006; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chen BPC, 2007, J BIOL CHEM, V282, P6582, DOI 10.1074/jbc.M611605200; Chen L, 2005, CANCER SCI, V96, P134, DOI 10.1111/j.1349-7006.2005.00019.x; Corneo B, 2007, NATURE, V449, P483, DOI 10.1038/nature06168; Cui XP, 2005, MOL CELL BIOL, V25, P10842, DOI 10.1128/MCB.25.24.10842-10852.2005; Dobbs TA, 2010, DNA REPAIR, V9, P1307, DOI 10.1016/j.dnarep.2010.09.019; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fattah FJ, 2008, P NATL ACAD SCI USA, V105, P8703, DOI 10.1073/pnas.0712060105; Furuta T, 2003, J BIOL CHEM, V278, P20303, DOI 10.1074/jbc.M300198200; Germe T, 2005, EMBO REP, V6, P729, DOI 10.1038/sj.embor.7400465; Grawunder U, 1998, MOL CELL, V2, P477, DOI 10.1016/S1097-2765(00)80147-1; Hochegger H, 2006, EMBO J, V25, P1305, DOI 10.1038/sj.emboj.7601015; Iiizumi S, 2008, NUCLEIC ACIDS RES, V36, P6333, DOI 10.1093/nar/gkn649; Iiizumi S, 2006, BIOTECHNIQUES, V41, P311, DOI 10.2144/000112233; Iwabuchi K, 2008, BIOCHEM BIOPH RES CO, V372, P662, DOI 10.1016/j.bbrc.2008.05.147; Iwabuchi K, 2006, GENES CELLS, V11, P935, DOI 10.1111/j.1365-2443.2006.00989.x; Jeggo PA, 2011, RADIOTHER ONCOL, V101, P7, DOI 10.1016/j.radonc.2011.06.019; Karanjawala ZE, 2002, DNA REPAIR, V1, P1017, DOI 10.1016/S1568-7864(02)00151-9; Karpenshif Y, 2012, DNA REPAIR, V11, P781, DOI 10.1016/j.dnarep.2012.07.001; Kass EM, 2010, FEBS LETT, V584, P3703, DOI 10.1016/j.febslet.2010.07.057; Krejci L, 2012, NUCLEIC ACIDS RES, V40, P5975; Kurosawa A, 2008, DNA CELL BIOL, V27, P55, DOI 10.1089/dna.2007.0649; Kurosawa A, 2010, J RADIAT RES, V51, P503, DOI 10.1269/jrr.10017; Li G, 2002, P NATL ACAD SCI USA, V99, P832, DOI 10.1073/pnas.022649699; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031; Lobrich M, 2005, DNA REPAIR, V4, P749, DOI 10.1016/j.dnarep.2004.12.008; Ma YM, 2005, DNA REPAIR, V4, P845, DOI 10.1016/j.dnarep.2005.04.013; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Mills KD, 2004, GENE DEV, V18, P1283, DOI 10.1101/gad.1204304; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; Pannicke U, 2004, EMBO J, V23, P1987, DOI 10.1038/sj.emboj.7600206; Pommier Y, 2009, CHEM REV, V109, P2894, DOI 10.1021/cr900097c; Povirk LR, 2006, DNA REPAIR, V5, P1199, DOI 10.1016/j.dnarep.2006.05.016; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Saberi A, 2007, MOL CELL BIOL, V27, P2562, DOI 10.1128/MCB.01243-06; Sabourin M, 2003, NUCLEIC ACIDS RES, V31, P4373, DOI 10.1093/nar/gkg497; Sekiguchi J, 2001, P NATL ACAD SCI USA, V98, P3243, DOI 10.1073/pnas.051632098; Sekiguchi JM, 2006, CELL, V124, P260, DOI 10.1016/j.cell.2006.01.010; Shao RG, 1999, EMBO J, V18, P1397, DOI 10.1093/emboj/18.5.1397; Shibata A, 2011, EMBO J, V30, P1079, DOI 10.1038/emboj.2011.27; Simsek D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002080; Soutoglou E, 2007, CURR OPIN GENET DEV, V17, P435, DOI 10.1016/j.gde.2007.08.004; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Tomimatsu N, 2007, J BIOL CHEM, V282, P10138, DOI 10.1074/jbc.M611880200; Toyoda E, 2008, J BIOL CHEM, V283, P23711, DOI 10.1074/jbc.M803936200; Uegaki K, 2006, DNA REPAIR, V5, P303, DOI 10.1016/j.dnarep.2005.10.008; Van Dyck E, 1999, NATURE, V398, P728, DOI 10.1038/43942; Wang Zhifeng, 2012, Front Med, V6, P156, DOI 10.1007/s11684-012-0197-3; Yamaguchi-Iwai Y, 1998, MOL CELL BIOL, V18, P6430, DOI 10.1128/MCB.18.11.6430; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020; Yano KI, 2008, EMBO REP, V9, P91, DOI 10.1038/sj.embor.7401137; Zhang XS, 2004, MOL CELL BIOL, V24, P9207, DOI 10.1128/MCB.24.20.9207-9220.2004	62	16	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e72253	10.1371/journal.pone.0072253	http://dx.doi.org/10.1371/journal.pone.0072253			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967291	Green Submitted, Green Published, gold			2022-12-25	WOS:000323221500126
J	Lv, J; Cui, W; Liu, HB; He, HJ; Xiu, YC; Guo, J; Liu, H; Liu, Q; Zeng, TB; Chen, Y; Zhang, Y; Wu, Q				Lv, Jie; Cui, Wei; Liu, Hongbo; He, Hongjuan; Xiu, Youcheng; Guo, Jing; Liu, Hui; Liu, Qi; Zeng, Tiebo; Chen, Yan; Zhang, Yan; Wu, Qiong			Identification and Characterization of Long Non-Coding RNAs Related to Mouse Embryonic Brain Development from Available Transcriptomic Data	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; HUMAN CELL-LINES; GENE-EXPRESSION; STEM-CELLS; ANTISENSE TRANSCRIPTION; INTEGRATIVE ANNOTATION; FUNCTIONAL-ANALYSIS; ANALYSIS REVEALS; SEQ; CHROMATIN	Long non-coding RNAs (lncRNAs) as a key group of non-coding RNAs have gained widely attention. Though lncRNAs have been functionally annotated and systematic explored in higher mammals, few are under systematical identification and annotation. Owing to the expression specificity, known lncRNAs expressed in embryonic brain tissues remain still limited. Considering a large number of lncRNAs are only transcribed in brain tissues, studies of lncRNAs in developmental brain are therefore of special interest. Here, publicly available RNA-sequencing (RNA-seq) data in embryonic brain are integrated to identify thousands of embryonic brain lncRNAs by a customized pipeline. A significant proportion of novel transcripts have not been annotated by available genomic resources. The putative embryonic brain lncRNAs are shorter in length, less spliced and show less conservation than known genes. The expression of putative lncRNAs is in one tenth on average of known coding genes, while comparable with known lncRNAs. From chromatin data, putative embryonic brain lncRNAs are associated with active chromatin marks, comparable with known lncRNAs. Embryonic brain expressed lncRNAs are also indicated to have expression though not evident in adult brain. Gene Ontology analysis of putative embryonic brain lncRNAs suggests that they are associated with brain development. The putative lncRNAs are shown to be related to possible cis-regulatory roles in imprinting even themselves are deemed to be imprinted lncRNAs. Re-analysis of one knockdown data suggests that four regulators are associated with lncRNAs. Taken together, the identification and systematic analysis of putative lncRNAs would provide novel insights into uncharacterized mouse non-coding regions and the relationships with mammalian embryonic brain development.	[Lv, Jie; Cui, Wei; Liu, Hongbo; He, Hongjuan; Xiu, Youcheng; Guo, Jing; Liu, Hui; Liu, Qi; Zeng, Tiebo; Chen, Yan; Wu, Qiong] Harbin Inst Technol, Sch Life Sci & Technol, State Key Lab Urban Water Resource & Environm, Harbin 150006, Peoples R China; [Zhang, Yan] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China	Harbin Institute of Technology; Harbin Medical University	Wu, Q (corresponding author), Harbin Inst Technol, Sch Life Sci & Technol, State Key Lab Urban Water Resource & Environm, Harbin 150006, Peoples R China.	kigo@hit.edu.cn	Lyu, Jie/AAP-4077-2020; cui, wei/GQB-0382-2022; Liu, Hongbo/M-2162-2015; wu, qiong/GRY-4672-2022	Lyu, Jie/0000-0002-6530-5257; cui, wei/0000-0002-4660-2766; Liu, Hongbo/0000-0002-0733-8616; 	National Natural Science Foundation of China [31171383, 31271558]; Fundamental Research Funds for the Central Universities [HIT.NSRIF.2010027]; Natural Science Foundation of Heilongjiang Province [201217]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province)	The National Natural Science Foundation of China [No. 31171383, No. 31271558]; The Fundamental Research Funds for the Central Universities [No. HIT.NSRIF.2010027]; Natural Science Foundation of Heilongjiang Province [No. 201217]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano G, 2005, HUM MOL GENET, V14, P913, DOI 10.1093/hmg/ddi084; Amaral PP, 2011, NUCLEIC ACIDS RES, V39, pD146, DOI 10.1093/nar/gkq1138; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Banfai B, 2012, GENOME RES, V22, P1646, DOI 10.1101/gr.134767.111; Barlow DP, 2011, ANNU REV GENET, V45, P379, DOI 10.1146/annurev-genet-110410-132459; Belgard TG, 2011, NEURON, V71, P605, DOI 10.1016/j.neuron.2011.06.039; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boerner S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043047; Bu DC, 2012, NUCLEIC ACIDS RES, V40, pD210, DOI 10.1093/nar/gkr1175; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chodroff RA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r72; Chotalia M, 2009, GENE DEV, V23, P105, DOI 10.1101/gad.495809; Clark MB, 2012, GENOME RES, V22, P885, DOI 10.1101/gr.131037.111; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Da Sacco L, 2012, INT J MOL SCI, V13, P97, DOI 10.3390/ijms13010097; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; DeVeale B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002600; Dimmer EC, 2012, NUCLEIC ACIDS RES, V40, pD565, DOI 10.1093/nar/gkr1048; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055; Enerly Espen, 2005, In Silico Biology, V5, P367; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Giannopoulou EG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-277; Grabowski P, 2011, CURR OPIN GENET DEV, V21, P388, DOI 10.1016/j.gde.2011.03.005; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902; Gu TT, 2012, ACTA HISTOCHEM, V114, P392, DOI 10.1016/j.acthis.2011.07.009; Gu TT, 2011, J MOL HISTOL, V42, P105, DOI 10.1007/s10735-011-9312-z; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Han XW, 2009, P NATL ACAD SCI USA, V106, P12741, DOI 10.1073/pnas.0902417106; Han ZB, 2012, J MOL HISTOL, V43, P1, DOI 10.1007/s10735-011-9367-x; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Hatada I, 2001, J BIOCHEM, V130, P187, DOI 10.1093/oxfordjournals.jbchem.a002971; Hebenstreit D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.28; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027288; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Jia H, 2010, RNA, V16, P1478, DOI 10.1261/rna.1951310; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Kanaumi T, 2008, BRAIN DEV-JPN, V30, P362, DOI 10.1016/j.braindev.2007.11.003; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kawaji H, 2011, NUCLEIC ACIDS RES, V39, pD856, DOI 10.1093/nar/gkq1112; Kelley D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r107; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Klattenhoff CA, 2013, CELL, V152, P570, DOI 10.1016/j.cell.2013.01.003; Klevebring D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009762; Knowling S, 2011, BIOCHIMIE, V93, P1922, DOI 10.1016/j.biochi.2011.07.031; Koerner MV, 2009, DEVELOPMENT, V136, P1771, DOI 10.1242/dev.030403; Komine Y, 2006, MOL CELL NEUROSCI, V31, P273, DOI 10.1016/j.mcn.2005.09.017; Kondo T, 2010, SCIENCE, V329, P336, DOI 10.1126/science.1188158; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Korostowski L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002956; Kutter C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002841; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Latos PA, 2012, SCIENCE, V338, P1469, DOI 10.1126/science.1228110; Lee JH, 2011, CIRC RES, V109, P1332, DOI 10.1161/CIRCRESAHA.111.249433; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Li TT, 2012, GENOMICS, V99, P292, DOI 10.1016/j.ygeno.2012.02.003; Liao Q, 2011, NUCLEIC ACIDS RES, V39, P3864, DOI 10.1093/nar/gkq1348; Lin MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023356; Lipman D, 2011, GENOME BIOL, V12, DOI [10.1186/gb-2011-12-3-402, 10.1186/gb-2010-12-3-402]; Liu J, 2012, PLANT CELL, V24, P4333, DOI 10.1105/tpc.112.102855; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Louro R, 2009, GENOMICS, V93, P291, DOI 10.1016/j.ygeno.2008.11.009; Massone S, 2011, NEUROBIOL DIS, V41, P308, DOI 10.1016/j.nbd.2010.09.019; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Nam JW, 2012, GENOME RES, V22, P2529, DOI 10.1101/gr.140475.112; Noguer-Dance M, 2010, HUM MOL GENET, V19, P3566, DOI 10.1093/hmg/ddq272; Ogawa Y, 2002, CYTOGENET GENOME RES, V99, P59, DOI 10.1159/000071575; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pal S, 2011, GENOME RES, V21, P1260, DOI 10.1101/gr.120535.111; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; Ponjavic J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000617; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sati S, 2012, NUCLEIC ACIDS RES, V40, P10018, DOI 10.1093/nar/gks776; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; Stamatoyannopoulos JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-418; Sun L, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-331; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilkinson LS, 2007, NAT REV NEUROSCI, V8, P832, DOI 10.1038/nrn2235; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Wu CL, 2013, NUCLEIC ACIDS RES, V41, pD561, DOI 10.1093/nar/gks1114; Young RS, 2012, GENOME BIOL EVOL, V4, P427, DOI 10.1093/gbe/evs020	111	38	42	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71152	10.1371/journal.pone.0071152	http://dx.doi.org/10.1371/journal.pone.0071152			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967161	gold, Green Submitted, Green Published			2022-12-25	WOS:000323221500054
J	Rieg, S; Jonas, D; Kaasch, AJ; Porzelius, C; Peyerl-Hoffmann, G; Theilacker, C; Kupper, MF; Schneider, C; Seifert, H; Kern, WV				Rieg, Siegbert; Jonas, Daniel; Kaasch, Achim J.; Porzelius, Christine; Peyerl-Hoffmann, Gabriele; Theilacker, Christian; Kuepper, Marc-Fabian; Schneider, Christian; Seifert, Harald; Kern, Winfried V.			Microarray-Based Genotyping and Clinical Outcomes of Staphylococcus aureus Bloodstream Infection: An Exploratory Study	PLOS ONE			English	Article							HEMATOGENOUS COMPLICATIONS; SUPERANTIGEN GENES; BACTEREMIA; MORTALITY; ASSOCIATIONS; VIRULENCE; STRAINS	The clinical course of Staphylococcus aureus bacteremia varies extensively. We sought to determine the relationship between genetic characteristics of the infecting pathogen and clinical outcomes in an exploratory study. In two study centers, 317 blood culture isolates were analyzed by DNA microarray and spa genotyping. By uni- and multivariate regression analyses associations of genotype data with 30-day all-cause mortality, severe sepsis/septic shock, disseminated disease, endocarditis, and osteoarticular infection were investigated. Univariate analysis showed significant association between S. aureus genes/gene-clusters or clonal complexes and clinical endpoints. For example CC15 was associated with 30-day mortality and CC22 with osteoarticular infection. In multivariate analysis methicillin resistance (mecA, OR 4.8 [1.43-16.06]) and the beta-lactamase-gene (bla, OR 3.12 [1.17-8.30]) remained independently associated with 30-day mortality. The presence of genes for enterotoxins (sed/sej/ser) was associated with endocarditis (OR 5.11 [1.14-18.62]). Host factors such as McCabe classification (OR 4.52 [2.09-9.79] for mortality), age (OR 1.06 [1.03-1.10] per year), and community-acquisition (OR 3.40 [1.31-8.81]) had a major influence on disease severity, dissemination and mortality. Individual genotypes and clonal complexes of S. aureus can only partially explain clinical features and outcomes of S. aureus bacteremia. Genotype-phenotype association studies need to include adjustments for host factors like age, comorbidity and community-acquisition.	[Rieg, Siegbert; Peyerl-Hoffmann, Gabriele; Theilacker, Christian; Kuepper, Marc-Fabian; Kern, Winfried V.] Univ Med Ctr Freiburg, Ctr Infect Dis & Travel Med, Dept Med, Freiburg, Germany; [Rieg, Siegbert; Peyerl-Hoffmann, Gabriele; Theilacker, Christian; Kuepper, Marc-Fabian; Kern, Winfried V.] Univ Med Ctr Freiburg, IFB Ctr Chron Immunodeficiency, Freiburg, Germany; [Jonas, Daniel] Univ Med Ctr Freiburg, Dept Environm Hlth Sci, Freiburg, Germany; [Kaasch, Achim J.; Seifert, Harald] Univ Cologne, Inst Med Microbiol Immunol & Hyg, D-50931 Cologne, Germany; [Porzelius, Christine] Univ Med Ctr Freiburg, Inst Med Biometry & Med Informat, Freiburg, Germany; [Porzelius, Christine] Univ Leipzig, Inst Med Informat Stat & Epidemiol, D-04109 Leipzig, Germany; [Schneider, Christian] Univ Med Ctr Freiburg, Inst Med Microbiol & Hyg, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Cologne; University of Freiburg; Leipzig University; University of Freiburg	Rieg, S (corresponding author), Univ Med Ctr Freiburg, Ctr Infect Dis & Travel Med, Dept Med, Freiburg, Germany.	siegbert.rieg@uniklinik-freiburg.de	Rieg, Siegbert/ABB-7954-2020; Kaasch, Achim J/F-8414-2012	Rieg, Siegbert/0000-0001-7493-7080; Kaasch, Achim/0000-0002-6659-6738; Theilacker, Christian/0000-0003-0821-9202	Federal Ministry of Education and Research (BMBF) [01EO0803]; IFB-Center for Chronic Immunodeficiency at the University Medical Center Freiburg; BMBF [01KI1017]; Paul-Ehrlich-Society of Chemotherapy	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); IFB-Center for Chronic Immunodeficiency at the University Medical Center Freiburg; BMBF(Federal Ministry of Education & Research (BMBF)); Paul-Ehrlich-Society of Chemotherapy	The study was supported in part by the Federal Ministry of Education and Research (BMBF, http://www.bmbf.de/) grant 01EO0803 to the IFB-Center for Chronic Immunodeficiency at the University Medical Center Freiburg, the BMBF grant 01KI1017 (to A.J.K.), and by the Paul-Ehrlich-Society of Chemotherapy (http://www.p-e-g.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chi Chia-Yu, 2010, J Clin Microbiol, V48, P292, DOI 10.1128/JCM.01788-09; Desachy A, 2007, CLIN MICROBIOL INFEC, V13, P1131, DOI 10.1111/j.1469-0691.2007.01810.x; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Ferry T, 2005, CLIN INFECT DIS, V41, P771, DOI 10.1086/432798; Fowler VG, 2007, J INFECT DIS, V196, P738, DOI 10.1086/520088; Fowler VG, 2003, ARCH INTERN MED, V163, P2066, DOI 10.1001/archinte.163.17.2066; Fowler VG, 2005, CLIN INFECT DIS, V40, P695, DOI 10.1086/427806; Gill SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018673; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Holtfreter S, 2007, J CLIN MICROBIOL, V45, P2669, DOI 10.1128/JCM.00204-07; Kaasch AJ, 2011, INFECTION, V39, P281, DOI 10.1007/s15010-011-0104-x; Kaech C, 2006, CLIN MICROBIOL INFEC, V12, P345, DOI 10.1111/j.1469-0691.2005.01359.x; Kechrid A, 2011, CLIN MICROBIOL INFEC, V17, P1020, DOI 10.1111/j.1469-0691.2010.03367.x; Kern WV, 2010, CURR OPIN INFECT DIS, V23, P346, DOI 10.1097/QCO.0b013e32833bcc8a; Lindsay JA, 2006, J BACTERIOL, V188, P669, DOI 10.1128/JB.188.2.669-676.2006; Luedicke C, 2010, EUR J CLIN MICROBIOL, V29, P457, DOI 10.1007/s10096-010-0884-4; Melles DC, 2004, J CLIN INVEST, V114, P1732, DOI 10.1172/JCI200423083; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Monecke S, 2009, EUR J CLIN MICROBIOL, V28, P1159, DOI 10.1007/s10096-009-0752-2; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Nienaber JJC, 2011, J INFECT DIS, V204, P704, DOI 10.1093/infdis/jir389; Peacock SJ, 2002, INFECT IMMUN, V70, P4987, DOI 10.1128/IAI.70.9.4987-4996.2002; Priest NK, 2012, NAT REV MICROBIOL, V10, P791, DOI 10.1038/nrmicro2880; Rieg S, 2009, J INFECTION, V59, P232, DOI 10.1016/j.jinf.2009.07.015; van Hal SJ, 2012, CLIN MICROBIOL REV, V25, P362, DOI 10.1128/CMR.05022-11; Wehrhahn MC, 2012, J INFECT DIS, V205, P1840, DOI 10.1093/infdis/jis279; Wertheim HFL, 2005, J INFECT DIS, V192, P1196, DOI 10.1086/444427; Xiong YQ, 2009, J INFECT DIS, V199, P201, DOI 10.1086/595738; Ziebandt AK, 2010, PROTEOMICS, V10, P1634, DOI 10.1002/pmic.200900313	30	22	23	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71259	10.1371/journal.pone.0071259	http://dx.doi.org/10.1371/journal.pone.0071259			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967176	gold, Green Published, Green Submitted			2022-12-25	WOS:000323221500064
J	Sanzari, JK; Romero-Weaver, AL; James, G; Krigsfeld, G; Lin, LY; Diffenderfer, ES; Kennedy, AR				Sanzari, Jenine K.; Romero-Weaver, Ana L.; James, Gabrielle; Krigsfeld, Gabriel; Lin, Liyong; Diffenderfer, Eric S.; Kennedy, Ann R.			Leukocyte Activity Is Altered in a Ground Based Murine Model of Microgravity and Proton Radiation Exposure	PLOS ONE			English	Article							HINDLIMB-UNLOADING MODEL; IONIZING-RADIATION; BODY IRRADIATION; DOSE-RATE; CELL; SPACEFLIGHT; SPACE; MICE; HYPOGRAVITY; RESISTANCE	Immune system adaptation during spaceflight is a concern in space medicine. Decreased circulating leukocytes observed during and after space flight infer suppressed immune responses and susceptibility to infection. The microgravity aspect of the space environment has been simulated on Earth to study adverse biological effects in astronauts. In this report, the hindlimb unloading (HU) model was employed to investigate the combined effects of solar particle event-like proton radiation and simulated microgravity on immune cell parameters including lymphocyte subtype populations and activity. Lymphocytes are a type of white blood cell critical for adaptive immune responses and T lymphocytes are regulators of cell-mediated immunity, controlling the entire immune response. Mice were suspended prior to and after proton radiation exposure (2 Gy dose) and total leukocyte numbers and splenic lymphocyte functionality were evaluated on days 4 or 21 after combined HU and radiation exposure. Total white blood cell (WBC), lymphocyte, neutrophil, and monocyte counts are reduced by approximately 65%, 70%, 55%, and 70%, respectively, compared to the non-treated control group at 4 days after combined exposure. Splenic lymphocyte subpopulations are altered at both time points investigated. At 21 days post-exposure to combined HU and proton radiation, T cell activation and proliferation were assessed in isolated lymphocytes. Cell surface expression of the Early Activation Marker, CD69, is decreased by 30% in the combined treatment group, compared to the non-treated control group and cell proliferation was suppressed by approximately 50%, compared to the non-treated control group. These findings reveal that the combined stressors (HU and proton radiation exposure) result in decreased leukocyte numbers and function, which could contribute to immune system dysfunction in crew members. This investigation is one of the first to report on combined proton radiation and simulated microgravity effects on hematopoietic, specifically immune cells.	[Sanzari, Jenine K.; Romero-Weaver, Ana L.; James, Gabrielle; Krigsfeld, Gabriel; Lin, Liyong; Diffenderfer, Eric S.; Kennedy, Ann R.] Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Kennedy, AR (corresponding author), Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA.	akennedy@mail.med.upenn.edu	Lin, Liyong/I-1195-2019	Lin, Liyong/0000-0002-0820-8063	NIH [2T32CAO9677]; National Space Biomedical Research Institute (NSBRI) Center of Acute Radiation Research (CARR) grant; National Aeronautics and Space Administration (NASA) Class Code (NCC) [9-58]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Space Biomedical Research Institute (NSBRI) Center of Acute Radiation Research (CARR) grant; National Aeronautics and Space Administration (NASA) Class Code (NCC)	This research was supported by the NIH Radiation Biology Training Grant 2T32CAO9677 and the National Space Biomedical Research Institute (NSBRI) Center of Acute Radiation Research (CARR) grant. The NSBRI is funded through the National Aeronautics and Space Administration (NASA) Class Code (NCC) 9-58. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG JW, 1993, J APPL PHYSIOL, V75, P2734, DOI 10.1152/jappl.1993.75.6.2734; Aviles H, 2003, J APPL PHYSIOL, V95, P491, DOI 10.1152/japplphysiol.00259.2003; Belay T, 2002, J ALLERGY CLIN IMMUN, V110, P262, DOI 10.1067/mai.2002.126459; Boonyaratanakornkit JB, 2005, FASEB J, V19, P2020, DOI 10.1096/fj.05-3778fje; Canova S, 2005, RADIAT RES, V163, P191, DOI 10.1667/RR3304; Chang TT, 2012, J LEUKOCYTE BIOL, V92, P1133, DOI 10.1189/jlb.0312157; CHAPES SK, 1993, J LEUKOCYTE BIOL, V54, P227, DOI 10.1002/jlb.54.3.227; COGOLI A, 1980, AVIAT SPACE ENVIR MD, V51, P29; COGOLI A, 1993, J LEUKOCYTE BIOL, V54, P259, DOI 10.1002/jlb.54.3.259; COGOLI A, 1981, ACTA ASTRONAUT, V8, P995, DOI 10.1016/0094-5765(81)90070-9; COGOLI A, 1984, SCIENCE, V225, P228, DOI 10.1126/science.6729481; Czarnik T, 1988, MED EMERGENCIES SPAC; De Santo NG, 2005, J RENAL NUTR, V15, P183, DOI 10.1053/j.jrn.2004.09.011; Fuse Akira, 2004, J Gravit Physiol, V11, pP65; Girardi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031293; Gridley DS, 2006, IN VIVO, V20, P781; Hu SW, 2009, HEALTH PHYS, V96, P465, DOI 10.1097/01.HP.0000339020.92837.61; Ichiki AT, 1996, J LEUKOCYTE BIOL, V60, P37, DOI 10.1002/jlb.60.1.37; Johnston R.S., 1975, BIOMEDICAL RESULTS A; KONSTANTINOVA IV, 1993, J LEUKOCYTE BIOL, V54, P189, DOI 10.1002/jlb.54.3.189; LANGE RD, 1987, AM J PHYSIOL, V252, pR216, DOI 10.1152/ajpregu.1987.252.2.R216; Lebsack TW, 2005, AVIAT SPACE ENVIR MD, V76, P11; Maks CJ, 2011, RADIAT RES, V176, P170, DOI 10.1667/RR2413.1; Morey-Holton ER, 1998, BONE, V22, p83S, DOI 10.1016/S8756-3282(98)00019-2; Morey-Holton ER, 2002, J APPL PHYSIOL, V92, P1367, DOI 10.1152/japplphysiol.00969.2001; Musacchia X J, 1997, J Gravit Physiol, V4, P49; Ni H, 2011, RADIAT RES, V175, P485, DOI 10.1667/RR2373.1; Pecaut MJ, 2002, IMMUNOL LETT, V80, P67, DOI 10.1016/S0165-2478(01)00307-8; Risin D, 2001, IN VITRO CELL DEV-AN, V37, P66; Sanzari JK, 2011, INT J RADIAT BIOL, V87, P1033, DOI 10.3109/09553002.2011.595875; Schwarz R P, 1992, J Tissue Cult Methods, V14, P51, DOI 10.1007/BF01404744; Sonnenfeld G, 1996, J INTERF CYTOK RES, V16, P409, DOI 10.1089/jir.1996.16.409; Sonnenfeld G, 2002, NUTRITION, V18, P899, DOI 10.1016/S0899-9007(02)00903-6; Sonnenfeld G, 1993, Physiologist, V36, pS68; SONNENFELD G, 1990, AVIAT SPACE ENVIR MD, V61, P648; SONNENFELD G, 1992, J APPL PHYSIOL, V73, pS191, DOI 10.1152/jappl.1992.73.2.S191; Sonnenfeld G, 1998, J APPL PHYSIOL, V85, P1429, DOI 10.1152/jappl.1998.85.4.1429; Sonnenfeld Gerald, 2003, Rev Environ Health, V18, P1; Sonnenfeld Gerald, 2005, Gravit Space Biol Bull, V18, P31; Tipton CM, 1996, MED SCI SPORT EXER, V28, P988, DOI 10.1097/00005768-199608000-00009; Townsend LW, 2005, RADIAT PROT DOSIM, V115, P44, DOI 10.1093/rpd/nci141; Walther I, 1998, FEBS LETT, V436, P115, DOI 10.1016/S0014-5793(98)01107-7; Wambi CO, 2009, RADIAT RES, V172, P175, DOI 10.1667/RR1589.1; Ware JH, 2010, RADIAT RES, V174, P325, DOI 10.1667/RR1979.1; Wei LX, 2003, CELL RES, V13, P465, DOI 10.1038/sj.cr.7290189; Wilson JM, 2012, ADV SPACE RES, V49, P237, DOI 10.1016/j.asr.2011.09.019; Zhou Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044329	47	23	25	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71757	10.1371/journal.pone.0071757	http://dx.doi.org/10.1371/journal.pone.0071757			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23977138	gold, Green Published, Green Submitted			2022-12-25	WOS:000323221500102
J	Varela, M; Verschoor, E; Lai, RPJ; Hughes, J; Mooj, P; McKinley, TJ; Fitzmaurice, TJ; Landskron, L; Willett, BJ; Frost, SDW; Bogers, WM; Heeney, JL				Varela, Mariana; Verschoor, Ernst; Lai, Rachel P. J.; Hughes, Joseph; Mooj, Petra; McKinley, Trevelyan J.; Fitzmaurice, Timothy J.; Landskron, Lisa; Willett, Brian J.; Frost, Simon D. W.; Bogers, Willy M.; Heeney, Jonathan L.			Genetic Imprint of Vaccination on Simian/Human Immunodeficiency Virus Type 1 Transmitted Viral Genomes in Rhesus Macaques	PLOS ONE			English	Article							NEUTRALIZING ANTIBODY-RESPONSES; HIV-1/SIV CHIMERIC VIRUS; SUBTYPE-C INFECTION; MONOCLONAL-ANTIBODIES; ENVELOPE; PROTECTION; CHALLENGE; EVOLUTION; HIV; IMMUNIZATION	Understanding the genetic, antigenic and structural changes that occur during HIV-1 infection in response to pre-existing immunity will facilitate current efforts to develop an HIV-1 vaccine. Much is known about HIV-1 variation at the population level but little with regard to specific changes occurring in the envelope glycoprotein within a host in response to immune pressure elicited by antibodies. The aim of this study was to track and map specific early genetic changes occurring in the viral envelope gene following vaccination using a highly controlled viral challenge setting in the SHIV macaque model. We generated 449 full-length env sequences from vaccinees, and 63 from the virus inoculum. Analysis revealed a different pattern in the distribution and frequency of mutations in the regions of the envelope gene targeted by the vaccine as well as different patterns of diversification between animals in the naive control group and vaccinees. Given the high stringency of the model it is remarkable that we were able to identify genetic changes associated with the vaccination. This work provides insight into the characterization of breakthrough viral populations in less than fully efficacious vaccines and illustrates the value of HIV-1 Env SHIV challenge model in macaques to unravel the mechanisms driving HIV-1 envelope genetic diversity in the presence of vaccine induced-responses.	[Varela, Mariana; Lai, Rachel P. J.; McKinley, Trevelyan J.; Fitzmaurice, Timothy J.; Landskron, Lisa; Frost, Simon D. W.; Heeney, Jonathan L.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Verschoor, Ernst; Hughes, Joseph; Mooj, Petra; Bogers, Willy M.] BPRC, Dept Virol, Rijswijk, Netherlands; [Varela, Mariana; Willett, Brian J.] MRC Univ Glasgow, Ctr Virus Res, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland	University of Cambridge; University of Glasgow	Varela, M (corresponding author), MRC Univ Glasgow, Ctr Virus Res, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	Mariana.varela@glasgow.ac.uk	Frost, Simon/F-3648-2010; Hughes, Joseph/B-7711-2009	Frost, Simon/0000-0002-5207-9879; Hughes, Joseph/0000-0003-2556-2563; Fitzmaurice, Tim/0000-0003-1403-2495; Landskron, Lisa/0000-0003-0405-2046; Lai, Rachel/0000-0003-3418-850X; Heeney, Jonathan/0000-0003-2702-1621	National Institutes of Health (NIH) [1P01AI06628]; Medical Research Council [G0801822] Funding Source: researchfish; MRC [G0801822] Funding Source: UKRI	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Evolutionary analysis was supported by a Wellcome Intermediate Clinical Fellowship while the animal work by National Institutes of Health (NIH) grant 1P01AI06628. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Bar KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002721; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; Basavapathruni A, 2010, J VIROL, V84, P953, DOI 10.1128/JVI.01679-09; Blay WM, 2006, J VIROL, V80, P999, DOI 10.1128/JVI.80.2.999-1014.2006; Bogers WMJM, 2008, VIROLOGY, V382, P217, DOI 10.1016/j.virol.2008.09.016; Boots LJ, 1997, AIDS RES HUM RETROV, V13, P1549, DOI 10.1089/aid.1997.13.1549; Bunnik EM, 2008, J VIROL, V82, P7932, DOI 10.1128/JVI.00757-08; Burton DR, 2005, P NATL ACAD SCI USA, V102, P14943, DOI 10.1073/pnas.0505126102; CAO YZ, 1995, NEW ENGL J MED, V332, P201, DOI 10.1056/NEJM199501263320401; Davis D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028974; Decks SG, 2006, J VIROL, V80, P6155, DOI 10.1128/JVI.00093-06; Delport W, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000242; Deng WJ, 2010, BIOTECHNIQUES, V48, P405, DOI 10.2144/000113370; Draenert R, 2006, J EXP MED, V203, P529, DOI 10.1084/jem.20052116; Frost SDW, 2005, J VIROL, V79, P6523, DOI 10.1128/JVI.79.10.6523-6527.2005; Gauduin MC, 1997, NAT MED, V3, P1389, DOI 10.1038/nm1297-1389; Gray ES, 2007, J VIROL, V81, P6187, DOI 10.1128/JVI.00239-07; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harouse JM, 1999, SCIENCE, V284, P816, DOI 10.1126/science.284.5415.816; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Karasavvas N, 2012, AIDS RES HUM RETROV, V28, P1444, DOI 10.1089/aid.2012.0103; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Koopman G, 2008, J GEN VIROL, V89, P540, DOI 10.1099/vir.0.83384-0; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; McKinley TJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002027; Montefiori D, 2007, PLOS MED, V4, P1867, DOI 10.1371/journal.pmed.0040348; Moore PL, 2008, J VIROL, V82, P1860, DOI 10.1128/JVI.02187-07; Murcia PR, 2010, J VIROL, V84, P6943, DOI 10.1128/JVI.00112-10; Parker CE, 2001, J VIROL, V75, P10906, DOI 10.1128/JVI.75.22.10906-10911.2001; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Rolland M, 2012, NATURE; Rolland M, 2011, NAT MED, V17, P366, DOI 10.1038/nm.2316; Rong R, 2007, J VIROL, V81, P5658, DOI 10.1128/JVI.00257-07; Rong R, 2007, J VIROL, V81, P1350, DOI 10.1128/JVI.01839-06; Rong R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000594; Saphire EO, 2007, J MOL BIOL, V369, P696, DOI 10.1016/j.jmb.2007.01.060; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Tamura K, 2011, MOL BIOL EVOLUTION; Team R. D. C, 2011, R LANG ENV STAT COMP; ten Haaft P, 2004, J GEN VIROL, V85, P3735, DOI 10.1099/vir.0.80223-0; Varela M, 2011, J VIROL, V85, P10332, DOI 10.1128/JVI.05290-11; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wood N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000414; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106; Zwick MB, 2001, J VIROL, V75, P6692, DOI 10.1128/JVI.75.14.6692-6699.2001	56	1	1	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e70814	10.1371/journal.pone.0070814	http://dx.doi.org/10.1371/journal.pone.0070814			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967111	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000323221500035
J	Breen, MJ; Moran, DM; Liu, WZ; Huang, XK; Vary, CPH; Bergan, RC				Breen, Michael J.; Moran, Diarmuid M.; Liu, Wenzhe; Huang, Xiaoke; Vary, Calvin P. H.; Bergan, Raymond C.			Endoglin-Mediated Suppression of Prostate Cancer Invasion Is Regulated by Activin and Bone Morphogenetic Protein Type II Receptors	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; PRIMARY PULMONARY-HYPERTENSION; TGF-BETA; BMPR-II; CORECEPTOR ENDOGLIN; CELLULAR-RESPONSES; GERMLINE MUTATIONS; ENDOTHELIAL-CELLS; OVER-EXPRESSION; BREAST-CANCER	Mortality from prostate cancer (PCa) is due to the formation of metastatic disease. Understanding how that process is regulated is therefore critical. We previously demonstrated that endoglin, a type III transforming growth factor beta (TGFb) superfamily receptor, suppresses human PCa cell invasion and metastasis. Endoglin-mediated suppression of invasion was also shown by us to be dependent upon the type I TGFb receptor, activin receptor-like kinase 2 (ALK2), and the downstream effector, Smad1. In this study we demonstrate for the first time that two type II TGFb receptors are required for endoglinmediated suppression of invasion: activin A receptor type IIA (ActRIIA) and bone morphogenetic protein receptor type II (BMPRII). Downstream signaling through these receptors is predominantly mediated by Smad1. ActRIIA stimulates Smad1 activation in a kinase-dependent manner, and this is required for suppression of invasion. In contrast BMPRII regulates Smad1 in a biphasic manner, promoting Smad1 signaling through its kinase domain but suppressing it through its cytoplasmic tail. BMPRII's Smad1-regulatory effects are dependent upon its expression level. Further, its ability to suppress invasion is independent of either kinase function or tail domain. We demonstrate that ActRIIA and BMPRII physically interact, and that each also interacts with endoglin. The current findings demonstrate that both BMPRII and ActRIIA are necessary for endoglin-mediated suppression of human PCa cell invasion, that they have differential effects on Smad1 signaling, that they make separate contributions to regulation of invasion, and that they functionally and physically interact.	[Breen, Michael J.; Moran, Diarmuid M.; Liu, Wenzhe; Huang, Xiaoke; Bergan, Raymond C.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Bergan, Raymond C.] Northwestern Univ, Robert H Lurie Canc Ctr, Chicago, IL 60611 USA; [Bergan, Raymond C.] Northwestern Univ, Ctr Mol Innovat & Drug Discovery, Chicago, IL 60611 USA; [Vary, Calvin P. H.] Maine Med Ctr Res Inst, Ctr Mol Med, Scarborough, ME USA	Northwestern University; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Maine Medical Center	Bergan, RC (corresponding author), Northwestern Univ, Dept Med, Chicago, IL 60611 USA.	r-bergan@northwestern.edu			National Institutes of Health [CA122985]; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; NATIONAL CANCER INSTITUTE [R01CA122985] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert H. Lurie Comprehensive Cancer Center of Northwestern University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institutes of Health to R.C.B., CA122985. This work is supported in part by the Malkin Scholars Programs from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University via an award to MB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATCC, 2007, ATCC TECHN B, V8, P1; ATTISANO L, 1992, CELL, V68, P97, DOI 10.1016/0092-8674(92)90209-U; Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; Beppu H, 2004, AM J PHYSIOL-LUNG C, V287, pL1241, DOI 10.1152/ajplung.00239.2004; Bernabeu C, 2009, BBA-MOL BASIS DIS, V1792, P954, DOI 10.1016/j.bbadis.2009.07.003; Blanco FJ, 2005, J CELL PHYSIOL, V204, P574, DOI 10.1002/jcp.20311; Buijs JT, 2007, AM J PATHOL, V171, P1047, DOI 10.2353/ajpath.2007.070168; Chan MC, 2007, MOL CELL BIOL, V27, P5776, DOI 10.1128/MCB.00218-07; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; Conley BA, 2004, J BIOL CHEM, V279, P27440, DOI 10.1074/jbc.M312561200; Craft CS, 2007, ONCOGENE, V26, P7240, DOI 10.1038/sj.onc.1210533; Craft CS, 2008, MOL PHARMACOL, V73, P235, DOI 10.1124/mol.107.038935; Darby S, 2008, J PATHOL, V214, P394, DOI 10.1002/path.2292; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; El-Gohary YM, 2007, AM J CLIN PATHOL, V127, P572, DOI 10.1309/X6NXYE57DLUE2NQ8; Feeley BT, 2006, BONE, V38, P154, DOI 10.1016/j.bone.2005.07.015; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Foletta VC, 2003, J CELL BIOL, V162, P1089, DOI 10.1083/jcb.200212060; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Gray PC, 2000, J BIOL CHEM, V275, P3206, DOI 10.1074/jbc.275.5.3206; Grijelmo C, 2007, CELL SIGNAL, V19, P1722, DOI 10.1016/j.cellsig.2007.03.008; Guerrero-Esteo M, 2002, J BIOL CHEM, V277, P29197, DOI 10.1074/jbc.M111991200; Hayes SA, 2003, ONCOGENE, V22, P4841, DOI 10.1038/sj.onc.1206730; Heldin Carl-Henrik, 2008, P259; Huang XK, 2005, CANCER RES, V65, P3470, DOI 10.1158/0008-5472.CAN-04-2807; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kassouf W, 2004, PROSTATE CANCER P D, V7, P105, DOI 10.1038/sj.pcan.4500716; Katagiri Takenobu, 2008, P121; Katsuno Y, 2008, ONCOGENE, V27, P6322, DOI 10.1038/onc.2008.232; Kawabata M, 1998, CYTOKINE GROWTH F R, V9, P49, DOI 10.1016/S1359-6101(97)00036-1; Kim IY, 2004, ONCOGENE, V23, P7651, DOI 10.1038/sj.onc.1207924; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Lakshman M, 2008, CANCER RES, V68, P2024, DOI 10.1158/0008-5472.CAN-07-1246; Lakshman M, 2011, CLIN EXP METASTAS, V28, P39, DOI 10.1007/s10585-010-9356-6; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Lastres P, 1996, J CELL BIOL, V133, P1109, DOI 10.1083/jcb.133.5.1109; Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036; Lee-Hoeflich ST, 2004, EMBO J, V23, P4792, DOI 10.1038/sj.emboj.7600418; Letamendia A, 1998, J BIOL CHEM, V273, P33011, DOI 10.1074/jbc.273.49.33011; Liu YQ, 2002, ONCOGENE, V21, P8272, DOI 10.1038/sj.onc.1206117; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Machado RD, 2003, HUM MOL GENET, V12, P3277, DOI 10.1093/hmg/ddg365; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Meng QJ, 2006, J BIOL CHEM, V281, P37069, DOI 10.1074/jbc.M608614200; Muenzner P, 2005, J CELL BIOL, V170, P825, DOI 10.1083/jcb.200412151; Muenzner P, 2010, SCIENCE, V329, P1197, DOI 10.1126/science.1190892; Neuman NA, 2009, J BIOL CHEM, V284, P13202, DOI 10.1074/jbc.M900282200; Nishihara A, 2002, MOL BIOL CELL, V13, P3055, DOI 10.1091/mbc.E02-02-0063; Owens P, 2012, P NATL ACAD SCI USA, V109, P2814, DOI 10.1073/pnas.1101139108; Pardali E, 2011, ONCOGENE, V30, P334, DOI 10.1038/onc.2010.418; Pavese JM, 2010, CANCER METAST REV, V29, P465, DOI 10.1007/s10555-010-9238-z; Perez-Gomez E, 2010, THESCIENTIFICWORLDJO, V10, P2367, DOI 10.1100/tsw.2010.230; Perron JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008198; Rivera LB, 2011, J CELL BIOL, V193, P1305, DOI 10.1083/jcb.201011143; Romero D, 2009, CARCINOGENESIS; Romero D, 2011, CANCER RES, V71, P3482, DOI 10.1158/0008-5472.CAN-10-2665; Rudarakanchana N, 2002, HUM MOL GENET, V11, P1517, DOI 10.1093/hmg/11.13.1517; Santibanez JF, 2010, CARCINOGENESIS, V31, P2145, DOI 10.1093/carcin/bgq199; Sanz-Rodriguez F, 2004, J BIOL CHEM, V279, P32858, DOI 10.1074/jbc.M400843200; Scherner O, 2007, J BIOL CHEM, V282, P13934, DOI 10.1074/jbc.M611062200; Schwappacher R, 2009, EMBO J, V28, P1537, DOI 10.1038/emboj.2009.103; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Spanjol J, 2010, COLLEGIUM ANTROPOL, V34, P119; Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741; Tian HY, 2012, EMBO J, V31, P3885, DOI 10.1038/emboj.2012.246; West J, 2004, CIRC RES, V94, P1109, DOI 10.1161/01.RES.0000126047.82846.20; West J, 2008, AM J PHYSIOL-LUNG C, V295, pL744, DOI 10.1152/ajplung.90255.2008; Wikstrom P, 2002, PROSTATE, V51, P268, DOI 10.1002/pros.10083; Wong WKP, 2005, AM J RESP CELL MOL, V33, P438, DOI 10.1165/rcmb.2005-0103OC; Xu L, 2009, JNCI-J NATL CANCER I, V101, P1141, DOI 10.1093/jnci/djp227; Yang SX, 2005, CANCER RES, V65, P5769, DOI 10.1158/0008-5472.CAN-05-0289; Ye L, 2008, MOL CANCER RES, V6, P1594, DOI 10.1158/1541-7786.MCR-08-0171; Ye L, 2010, CANCER SCI, V101, P2137, DOI 10.1111/j.1349-7006.2010.01648.x; Ye L, 2009, J UROLOGY, V181, P2749, DOI 10.1016/j.juro.2009.01.098; Yu PB, 2008, J BIOL CHEM, V283, P3877, DOI 10.1074/jbc.M706797200; Yu PB, 2005, J BIOL CHEM, V280, P24443, DOI 10.1074/jbc.M502825200; Zelefsky MJ, 2008, CANC PRINCIPLES PRAC, P1392	80	15	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e72407	10.1371/journal.pone.0072407	http://dx.doi.org/10.1371/journal.pone.0072407			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967299	Green Published, Green Submitted, gold			2022-12-25	WOS:000323115800099
J	Guo, J; Zhang, X; Luo, S; He, F; Chen, Z; Wen, Y; Li, JL				Guo, Jia; Zhang, Xuan; Luo, Shuai; He, Fei; Chen, Zhi; Wen, Ying; Li, Jilun			A Novel TetR Family Transcriptional Regulator, SAV576, Negatively Controls Avermectin Biosynthesis in Streptomyces avermitilis	PLOS ONE			English	Article							SECONDARY METABOLISM; ANTIBIOTIC PRODUCTION; PHOSPHATE CONTROL; GENOME SEQUENCE; GENE-CLUSTER; DNA; DIFFERENTIATION; CLONING; ORGANIZATION; EXPRESSION	Avermectins produced by Streptomyces avermitilis are potent anti-parasitic agents that are useful in animal health care, agriculture, and the treatment of human infections. In a search for novel regulators that affect avermectin biosynthesis, comparative transcriptome analysis was performed between wild-type strain ATCC31267 and avermectin overproducing strain 76-02-e, revealing some differentially expressed genes. SAV576, which is downregulated in 76-02-e and encodes a TetR family transcriptional regulator (TFR), was shown to inhibit avermectin production by indirectly affecting the expression of ave genes. SAV576 directly repressed the transcription of its gene SAV576 and of adjacent genes SAV575 (encodes cytochrome P450/NADPH-ferrihemoprotein reductase) and SAV574. The SAV576-binding sites within the bidirectional SAV575-SAV576 promoter region were determined by DNase I footprinting assays. A consensus 15-bp palindromic sequence CCRTACRVYGTATGS was found in these binding sites and shown to be important for SAV576-binding activity. SAV575, an important target gene of SAV576, was shown to exert a positive effect on avermectin production. The study findings extend our limited knowledge of the complex regulation of avermectin biosynthesis and provide a basis for rational genetic manipulation of S. avermitilis to improve avermectin production through control of SAV576 and its target gene.	[Wen, Ying] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; China Agr Univ, Coll Biol Sci, MOA Key Lab Soil Microbiol, Beijing 100094, Peoples R China	China Agricultural University; China Agricultural University	Wen, Y (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	wen@cau.edu.cn			National Natural Science Foundation of China [31170045]; National Basic Research Program of China [2009CB118905]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by grants from the National Natural Science Foundation of China (Grant No. 31170045) and the National Basic Research Program of China (Grant No. 2009CB118905). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHARONOWITZ Y, 1980, ANNU REV MICROBIOL, V34, P209, DOI 10.1146/annurev.mi.34.100180.001233; Axarli I, 2010, ENZYME RES, V2010; Bibb MJ, 2005, CURR OPIN MICROBIOL, V8, P208, DOI 10.1016/j.mib.2005.02.016; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; BURG RW, 1979, ANTIMICROB AGENTS CH, V15, P361, DOI 10.1128/AAC.15.3.361; Challis GL, 2003, P NATL ACAD SCI USA, V100, P14555, DOI 10.1073/pnas.1934677100; Chen L, 2008, APPL MICROBIOL BIOT, V80, P277, DOI 10.1007/s00253-008-1545-8; Chen L, 2009, FEMS MICROBIOL LETT, V298, P199, DOI 10.1111/j.1574-6968.2009.01721.x; Chen Z, 2007, CHINESE SCI BULL, V52, P616, DOI 10.1007/s11434-007-0119-y; Choi KY, 2012, FEBS J, V279, P1650, DOI 10.1111/j.1742-4658.2011.08462.x; Demain AL, 2002, NAT BIOTECHNOL, V20, P331, DOI 10.1038/nbt0402-331; Duong CTP, 2009, J MICROBIOL BIOTECHN, V19, P136, DOI 10.4014/jmb.0806.387; Gomez-Escribano JP, 2008, MICROBIOL-SGM, V154, P744, DOI 10.1099/mic.0.2007/011890-0; Guo J, 2010, MOL GENET GENOMICS, V283, P123, DOI 10.1007/s00438-009-0502-2; Hesketh A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r161; HORINOUCHI S, 1994, MOL MICROBIOL, V12, P859, DOI 10.1111/j.1365-2958.1994.tb01073.x; Hwang YS, 2003, APPL ENVIRON MICROB, V69, P1263, DOI 10.1128/AEM.69.2.1263-1269.2003; IKEDA H, 1993, J BACTERIOL, V175, P2077, DOI 10.1128/JB.175.7.2077-2082.1993; Ikeda H, 1999, P NATL ACAD SCI USA, V96, P9509, DOI 10.1073/pnas.96.17.9509; IKEDA H, 1988, ANTIMICROB AGENTS CH, V32, P282, DOI 10.1128/AAC.32.2.282; Ikeda H, 2001, J IND MICROBIOL BIOT, V27, P170, DOI 10.1038/sj.jim.7000092; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Ikeda H, 1997, CHEM REV, V97, P2591, DOI 10.1021/cr960023p; Im JH, 2007, J MICROBIOL BIOTECHN, V17, P534; Kang SH, 2007, J BACTERIOL, V189, P4315, DOI 10.1128/JB.01789-06; Kato JY, 2007, P NATL ACAD SCI USA, V104, P2378, DOI 10.1073/pnas.0607472104; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kitani S, 2009, APPL MICROBIOL BIOT, V82, P1089, DOI 10.1007/s00253-008-1850-2; Lamb DC, 2003, BIOCHEM BIOPH RES CO, V307, P610, DOI 10.1016/S0006-291X(03)01231-2; Li LL, 2010, J IND MICROBIOL BIOT, V37, P673, DOI 10.1007/s10295-010-0710-0; Lum AM, 2004, METAB ENG, V6, P186, DOI 10.1016/j.ymben.2003.12.001; MACNEIL DJ, 1987, J IND MICROBIOL, V2, P209, DOI 10.1007/BF01569542; Martin JF, 2004, J BACTERIOL, V186, P5197, DOI 10.1128/JB.186.16.5197-5201.2004; Martin JF, 2012, APPL MICROBIOL BIOT, V95, P61, DOI 10.1007/s00253-012-4129-6; Miyamoto KT, 2011, MICROBIOL-SGM, V157, P2266, DOI 10.1099/mic.0.048371-0; Omura S, 2001, P NATL ACAD SCI USA, V98, P12215, DOI 10.1073/pnas.211433198; Rajkarnikar A, 2006, CURR MICROBIOL, V53, P204, DOI 10.1007/s00284-006-0062-1; Sambrook J, 2001, MOL CLONING LAB MANU; Sanchez S, 2010, J ANTIBIOT, V63, P442, DOI 10.1038/ja.2010.78; STRAUCH E, 1991, MOL MICROBIOL, V5, P289, DOI 10.1111/j.1365-2958.1991.tb02109.x; Stutzman-Engwall KJ, 2001, USA patent, Patent No. [US 6197591, 6197591]; Uguru GC, 2005, MOL MICROBIOL, V58, P131, DOI 10.1111/j.1365-2958.2005.04817.x; van Wezel GP, 2011, NAT PROD REP, V28, P1311, DOI 10.1039/c1np00003a; Xu GM, 2010, J BIOL CHEM, V285, P27440, DOI 10.1074/jbc.M110.143081; Yu Z, 2010, J MOL BIOL, V400, P847, DOI 10.1016/j.jmb.2010.05.062; Zhao JL, 2007, CHINESE SCI BULL, V52, P623, DOI 10.1007/s11434-007-0105-4; Zhuo Y, 2010, P NATL ACAD SCI USA, V107, P11250, DOI 10.1073/pnas.1006085107; Zianni Michael, 2006, J Biomol Tech, V17, P103	49	32	40	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71330	10.1371/journal.pone.0071330	http://dx.doi.org/10.1371/journal.pone.0071330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967193	Green Published, gold, Green Submitted			2022-12-25	WOS:000323115800050
J	Kovarova, N; Mracek, T; Nuskova, H; Holzerova, E; Vrbacky, M; Pecina, P; Hejzlarova, K; Kl'uckova, K; Rohlena, J; Neuzil, J; Houstek, J				Kovarova, Nikola; Mracek, Tomas; Nuskova, Hana; Holzerova, Eliska; Vrbacky, Marek; Pecina, Petr; Hejzlarova, Katerina; Kl'uckova, Katarina; Rohlena, Jakub; Neuzil, Jiri; Houstek, Josef			High Molecular Weight Forms of Mammalian Respiratory Chain Complex II	PLOS ONE			English	Article								Mitochondrial respiratory chain is organised into supramolecular structures that can be preserved in mild detergent solubilisates and resolved by native electrophoretic systems. Supercomplexes of respiratory complexes I, III and IV as well as multimeric forms of ATP synthase are well established. However, the involvement of complex II, linking respiratory chain with tricarboxylic acid cycle, in mitochondrial supercomplexes is questionable. Here we show that digitonin-solubilised complex II quantitatively forms high molecular weight structures (CIIhmw) that can be resolved by clear native electrophoresis. CIIhmw structures are enzymatically active and differ in electrophoretic mobility between tissues (500 - over 1000 kDa) and cultured cells (400-670 kDa). While their formation is unaffected by isolated defects in other respiratory chain complexes, they are destabilised in mtDNA-depleted, rho0 cells. Molecular interactions responsible for the assembly of CIIhmw are rather weak with the complexes being more stable in tissues than in cultured cells. While electrophoretic studies and immunoprecipitation experiments of CIIhmw do not indicate specific interactions with the respiratory chain complexes I, III or IV or enzymes of the tricarboxylic acid cycle, they point out to a specific interaction between CII and ATP synthase.	[Kovarova, Nikola; Mracek, Tomas; Nuskova, Hana; Holzerova, Eliska; Vrbacky, Marek; Pecina, Petr; Hejzlarova, Katerina; Houstek, Josef] Acad Sci Czech Republic, Inst Physiol, Dept Bioenerget, Prague, Czech Republic; [Kl'uckova, Katarina; Rohlena, Jakub; Neuzil, Jiri] Acad Sci Czech Republic, Inst Biotechnol, Lab Mol Therapy, Prague, Czech Republic; [Neuzil, Jiri] Griffith Univ, Apoptosis Res Grp, Sch Med Sci, Southport, Qld 4215, Australia; [Neuzil, Jiri] Griffith Univ, Griffith Hlth Inst, Southport, Qld 4215, Australia	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Griffith University; Griffith University; Menzies Health Institute Queensland	Houstek, J (corresponding author), Acad Sci Czech Republic, Inst Physiol, Dept Bioenerget, Prague, Czech Republic.	houstek@biomed.cas.cz	Kovarova, Nikola/D-1129-2014; Cermakova, Nikola/S-9044-2019; Kluckova, Katarina/ABF-2155-2020; Kluckova, Katarina/H-4802-2014; Neuzil, Jiri/H-7204-2014; Mracek, Tomas/C-5003-2012; Nuskova, Hana/A-4059-2010; Pecina, Petr/A-9396-2010; Tauchmannova, Katerina/G-1023-2014; Houstek, Josef/C-5019-2012; Vrbacky, Marek/A-1044-2010; Rohlena, Jakub/H-6699-2014	Kluckova, Katarina/0000-0002-9693-7708; Neuzil, Jiri/0000-0002-2478-2460; Mracek, Tomas/0000-0002-9492-0718; Nuskova, Hana/0000-0002-5562-9207; Pecina, Petr/0000-0003-0641-2834; Tauchmannova, Katerina/0000-0002-3745-8790; Houstek, Josef/0000-0002-8413-4772; Vrbacky, Marek/0000-0001-7218-8370; Rohlena, Jakub/0000-0001-5427-6502; Konarikova, Eliska/0000-0001-7365-5006	Grant Agency of the Czech Republic [P303/10/P227, P301/10/1937]; Ministry of Education, Youth and Sports of the Czech Republic [ERC CZ LL1204, RVO: 67985823]; Ministry of Health of the Czech Republic [NT12370-5]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic)	This work was supported by the Grant Agency of the Czech Republic (P303/10/P227, P301/10/1937), Ministry of Education, Youth and Sports of the Czech Republic (ERC CZ LL1204 and RVO: 67985823) and Ministry of Health of the Czech Republic (NT12370-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Ardehali H, 2004, P NATL ACAD SCI USA, V101, P11880, DOI 10.1073/pnas.0401703101; Bardella C, 2011, BBA-BIOENERGETICS, V1807, P1432, DOI 10.1016/j.bbabio.2011.07.003; Benard G, 2006, AM J PHYSIOL-CELL PH, V291, pC1172, DOI 10.1152/ajpcell.00195.2006; Bentlage HACM, 1996, NEUROLOGY, V47, P243, DOI 10.1212/WNL.47.1.243; Bianchi C, 2004, J BIOL CHEM, V279, P36562, DOI 10.1074/jbc.M405135200; Briere JJ, 2005, CELL MOL LIFE SCI, V62, P2317, DOI 10.1007/s00018-005-5237-6; Buchet K, 1998, J BIOL CHEM, V273, P22983, DOI 10.1074/jbc.273.36.22983; Burnichon N, 2010, HUM MOL GENET, V19, P3011, DOI 10.1093/hmg/ddq206; Carrozzo R, 2006, ANN NEUROL, V59, P265, DOI 10.1002/ana.20729; Cecchini G, 2003, ANNU REV BIOCHEM, V72, P77, DOI 10.1146/annurev.biochem.72.121801.161700; Chevallet M, 2006, ELECTROPHORESIS, V27, P1574, DOI 10.1002/elps.200500704; Dudkina NV, 2005, P NATL ACAD SCI USA, V102, P3225, DOI 10.1073/pnas.0408870102; Garcia JJ, 2000, J BIOL CHEM, V275, P11075, DOI 10.1074/jbc.275.15.11075; Gebert N, 2011, MOL CELL, V44, P811, DOI 10.1016/j.molcel.2011.09.025; Ghezzi D, 2009, NAT GENET, V41, P654, DOI 10.1038/ng.378; Haggie PM, 2002, J BIOL CHEM, V277, P40782, DOI 10.1074/jbc.M207456200; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Honzik T, 2010, ARCH DIS CHILD, V95, P296, DOI 10.1136/adc.2009.168096; King M P, 1996, Methods Enzymol, V264, P304, DOI 10.1016/S0076-6879(96)64029-4; Kluckova K, 2013, BBA-BIOENERGETICS, V1827, P552, DOI 10.1016/j.bbabio.2012.10.015; Ko YH, 2003, J BIOL CHEM, V278, P12305, DOI 10.1074/jbc.C200703200; Kovarova N, 2012, BBA-MOL BASIS DIS, V1822, P1114, DOI 10.1016/j.bbadis.2012.03.007; Lenaz G, 2012, ADV EXP MED BIOL, V748, P107, DOI 10.1007/978-1-4614-3573-0_5; Mercy L, 2005, FEBS J, V272, P5031, DOI 10.1111/j.1742-4658.2005.04913.x; Meyer FM, 2011, METAB ENG, V13, P18, DOI 10.1016/j.ymben.2010.10.001; MORADIAMELI M, 1983, P NATL ACAD SCI-BIOL, V80, P6167, DOI 10.1073/pnas.80.20.6167; Moreno-Lastres D, 2012, CELL METAB, V15, P324, DOI 10.1016/j.cmet.2012.01.015; Mracek T, 2009, ARCH BIOCHEM BIOPHYS, V481, P30, DOI 10.1016/j.abb.2008.10.011; Mueller EE, 2012, BIOCHEM BIOPH RES CO, V417, P1052, DOI 10.1016/j.bbrc.2011.12.093; Perry CG, 2006, AM J SURG PATHOL, V30, P42, DOI 10.1097/01.pas.0000178087.69394.9f; Piekutowska-Abramczuk D, 2009, CLIN GENET, V76, P195, DOI 10.1111/j.1399-0004.2009.01195.x; Ricketts C, 2008, J NATL CANCER I, V100, P1260, DOI 10.1093/jnci/djn254; ROBINSON JB, 1987, J BIOL CHEM, V262, P1786; Rosca M, 2011, BBA-BIOENERGETICS, V1807, P1373, DOI 10.1016/j.bbabio.2011.02.003; Schafer E, 2006, J BIOL CHEM, V281, P15370, DOI 10.1074/jbc.M513525200; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Shi YB, 2009, HUM MOL GENET, V18, P3014, DOI 10.1093/hmg/ddp239; Shibata Noriyuki, 2008, Brain and Nerve (Tokyo), V60, P157; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Velot C, 1997, BIOCHEMISTRY-US, V36, P14271, DOI 10.1021/bi972011j; Wittig I, 2005, PROTEOMICS, V5, P4338, DOI 10.1002/pmic.200500081; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wittig I, 2009, PROTEOMICS, V9, P5214, DOI 10.1002/pmic.200900151; Wojtovich AP, 2013, BBA-BIOENERGETICS, V1827, P598, DOI 10.1016/j.bbabio.2012.12.007; Wojtovich AP, 2010, ACTA BIOCHIM POL, V57, P431	49	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71869	10.1371/journal.pone.0071869	http://dx.doi.org/10.1371/journal.pone.0071869			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967256	Green Published, gold			2022-12-25	WOS:000323115800089
J	Pastushkova, LK; Kireev, KS; Kononikhin, AS; Tiys, ES; Popov, IA; Starodubtseva, NL; Dobrokhotov, IV; Ivanisenko, VA; Larina, IM; Kolchanov, NA; Nikolaev, EN				Pastushkova, Lyudmila Kh.; Kireev, Kirill S.; Kononikhin, Alexey S.; Tiys, Evgeny S.; Popov, Igor A.; Starodubtseva, Natalia L.; Dobrokhotov, Igor V.; Ivanisenko, Vladimir A.; Larina, Irina M.; Kolchanov, Nicolay A.; Nikolaev, Evgeny N.			Detection of Renal Tissue and Urinary Tract Proteins in the Human Urine after Space Flight	PLOS ONE			English	Article							WATER; AQUAPORIN-2; EXCRETION; KALLIKREIN; RESPONSES; PROTEOME; RECEPTOR; MEGALIN; CELLS; RAT	The urine protein composition samples of ten Russian cosmonauts (male, aged of 35 up to 51) performed long flight missions and varied from 169 up to 199 days on the International Space Station (ISS) were analyzed. As a control group, urine samples of six back-up cosmonauts were analyzed. We used proteomic techniques to obtain data and contemporary bioinformatics approaches to perform the analysis. From the total number of identified proteins (238) in our data set, 129 were associated with a known tissue origin. Preflight samples contained 92 tissue-specific proteins, samples obtained on Day 1 after landing had 90 such proteins, while Day 7 samples offered 95 tissue-specific proteins. Analysis showed that consistently present proteins in urine (under physiological conditions and after space flight) are cubilin, epidermal growth factor, kallikrein-1, kininogen-1, megalin, osteopontin, vitamin K-dependent protein Z, uromodulin. Variably present proteins consists of: Na(+)/K(+) ATPase subunit gamma, beta-defensin-1, dipeptidyl peptidase 4, maltasa-glucoamilasa, cadherin-like protein, neutral endopeptidase and vascular cell adhesion protein 1. And only three renal proteins were related to the space flight factors. They were not found in the pre-flight samples and in the back-up cosmonaut urine, but were found in the urine samples after space flight: AFAM (afamin), AMPE (aminopeptidase A) and AQP2 (aquaporin-2). This data related with physiological readaptation of water-salt balance. The proteomic analysis of urine samples in different phases of space missions with bioinformation approach to protein identification provides new data relative to biomechemical mechanism of kidney functioning after space flight.	[Pastushkova, Lyudmila Kh.; Kireev, Kirill S.; Dobrokhotov, Igor V.; Larina, Irina M.] RAS, Russian Federat State Sci Res Ctr, Inst Biomed Problems, Moscow 117901, Russia; [Kireev, Kirill S.] Gagarin Cosmonauts Training Ctr, Star City, Russia; [Kononikhin, Alexey S.; Popov, Igor A.; Nikolaev, Evgeny N.] RAS, Emanuel Inst Biochem Phys, Moscow 117901, Russia; [Kononikhin, Alexey S.; Popov, Igor A.; Starodubtseva, Natalia L.; Nikolaev, Evgeny N.] RAS, Inst Energy Problems Chem Phys, Moscow 117901, Russia; [Kononikhin, Alexey S.; Popov, Igor A.; Starodubtseva, Natalia L.] Moscow Inst Phys & Technol, Moscow, Russia; [Tiys, Evgeny S.; Ivanisenko, Vladimir A.; Kolchanov, Nicolay A.] SB RAS, Inst Cytol & Genet, Novosibirsk, Russia; [Starodubtseva, Natalia L.] Res Ctr Obstet, Moscow, Russia; [Nikolaev, Evgeny N.] Russian Acad Med Sci, Orekhovich Inst Biomed Chem, Moscow, Russia	Russian Academy of Sciences; Institute of Biomedical Problems of the Russian Academy of Sciences; Roscosmos; Gagarin Cosmonaut Training Center; Russian Academy of Sciences; Emanuel Institute of Biochemical Physics; Russian Academy of Sciences; N.N. Semenov Federal Research Centre for Chemical Physics, Russian Academy of Sciences; Moscow Institute of Physics & Technology; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Russian Academy of Medical Sciences; Research Center for Obstetrics, Gynecology & Perinatology; Russian Academy of Medical Sciences; Institute of Biomedical Chemistry	Kireev, KS (corresponding author), Gagarin Cosmonauts Training Ctr, Star City, Russia.	kir-kireev@yandex.ru	Kireev, Kirill/ABF-2466-2021; Pastushkova, Liudmila/T-5421-2017; Tiys, Evgeny S/G-1146-2016; Popov, Igor A/O-4615-2014; Kononikhin, Alexey/L-3171-2013; Ivanisenko, Vladimir/J-7832-2018; Popov, Igor/G-7795-2014; Starodubtseva, Natalia/Y-6378-2019; Kolchanov, Nikolay/A-9916-2014; Nikolaev, Eugene N/N-4498-2013; Dobrokhotov, Igor/AAB-1623-2020	Kireev, Kirill/0000-0002-0381-9164; Tiys, Evgeny S/0000-0001-5820-8646; Popov, Igor A/0000-0002-5904-2470; Nikolaev, Eugene N/0000-0001-6209-2068; Dobrokhotov, Igor/0000-0001-8831-4781; Kolchanov, Nikolay/0000-0001-6800-8787; Ivanisenko, Vladimir/0000-0002-1859-4631	Russian Foundation for Basic Research [10-04-13306-RT_ofi]; Russian Ministry of Science and Education [14.740.11.0755, 16.740.11.0369]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Ministry of Science and Education(Ministry of Education and Science, Russian Federation)	This research has been supported by the Russian Foundation for Basic Research (project 10-04-13306-RT_ofi), a program of the Russian Ministry of Science and Education (project 14.740.11.0755 and 16.740.11.0369). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agron IA, 2010, BIOCHEMISTRY-MOSCOW+, V75, P636, DOI 10.1134/S0006297910050147; Avtonomov D M, 2011, Bioorg Khim, V37, P165; Barratt J, 2007, CAN MED ASSOC J, V177, P361, DOI 10.1503/cmaj.061590; Bouley R, 2011, J AM SOC NEPHROL, V22, P59, DOI 10.1681/ASN.2009121267; Brown D, 2003, AM J PHYSIOL-RENAL, V284, pF893, DOI 10.1152/ajprenal.00387.2002; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Carretero OA, 2005, J CLIN INVEST, V115, P588, DOI 10.1172/JCI200524567; Christensen B, 2008, BIOCHEM J, V411, P53, DOI 10.1042/BJ20071021; CHRISTENSEN EI, 1992, J HISTOCHEM CYTOCHEM, V40, P1481, DOI 10.1177/40.10.1382088; Cirillo M., 2003, NEPHRON PHYSIOL, V93, P102, DOI DOI 10.1159/000070243; Coon JJ, 2008, PROTEOM CLIN APPL, V2, P964, DOI 10.1002/prca.200800024; Drummer C, 2000, EUR J CLIN INVEST, V30, P1066, DOI 10.1046/j.1365-2362.2000.00766.x; Frohlich Martina, 2010, Genome Inform, V24, P42; Fusaro M, 2011, CURR VASC PHARMACOL, V9, P763, DOI 10.2174/157016111797484134; Gazenko O G, 1986, Probl Kosm Biol, V54, P1; GRIGORIEV AI, 1994, CLIN INVESTIGATOR, V72, P169; He JC, 2012, KIDNEY INT, V81, P22, DOI 10.1038/ki.2011.314; Herrera GM, 2005, AM J PHYSIOL-REG I, V289, pR402, DOI 10.1152/ajpregu.00488.2004; Herrera GM, 2003, J PHYSIOL-LONDON, V551, P893, DOI 10.1113/jphysiol.2003.045914; Ishihama Y, 2002, J CHROMATOGR A, V979, P233, DOI 10.1016/S0021-9673(02)01402-4; Ishikawa S, 2000, ANN MED, V32, P90, DOI 10.3109/07853890009011757; KANNO K, 1995, NEW ENGL J MED, V332, P1540, DOI 10.1056/NEJM199506083322303; Kramer HJ, 2001, AM J KIDNEY DIS, V38, P675, DOI 10.1053/ajkd.2001.27754; Kratzer I, 2009, J NEUROCHEM, V108, P707, DOI 10.1111/j.1471-4159.2008.05796.x; Motoyoshi Y, 2008, KIDNEY INT, V74, P1262, DOI 10.1038/ki.2008.405; Norsk P, 2000, LANCET, V356, P1577, DOI 10.1016/S0140-6736(00)03135-4; NORSK P, 1995, J APPL PHYSIOL, V78, P2253, DOI 10.1152/jappl.1995.78.6.2253; Puliyanda DP, 2003, BIOCHEM BIOPH RES CO, V303, P52, DOI 10.1016/S0006-291X(03)00215-8; Riccardi D, 1998, AM J PHYSIOL-RENAL, V274, pF611, DOI 10.1152/ajprenal.1998.274.3.F611; Sands JM, 1997, J CLIN INVEST, V99, P1399, DOI 10.1172/JCI119299; Schmid M, 2010, CELL PHYSIOL BIOCHEM, V26, P311, DOI 10.1159/000320554; Song Q, 1996, IMMUNOPHARMACOLOGY, V32, P105, DOI 10.1016/0162-3109(95)00065-8; Thebault S, 2009, J AM SOC NEPHROL, V20, P78, DOI 10.1681/ASN.2008030327; Thongboonkerd V, 2005, EXPERT REV PROTEOMIC, V2, P349, DOI 10.1586/14789450.2.3.349; Thongboonkerd V, 2007, J PROTEOME RES, V6, P3881, DOI 10.1021/pr070328s; Valenti G, 2000, J AM SOC NEPHROL, V11, P1873, DOI 10.1681/ASN.V11101873; Valenti G, 2002, AM J PHYSIOL-RENAL, V283, pF895, DOI 10.1152/ajprenal.00354.2001; Verroust PJ, 2002, KIDNEY INT, V62, P745, DOI 10.1046/j.1523-1755.2002.00501.x; Wen HJ, 1999, J AM SOC NEPHROL, V10, P1416; Whedon G D, 1974, Trans Assoc Am Physicians, V87, P95	40	19	22	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71652	10.1371/journal.pone.0071652	http://dx.doi.org/10.1371/journal.pone.0071652			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967230	Green Published, Green Submitted, gold			2022-12-25	WOS:000323115800071
J	Qamra, R; Hubbard, SR				Qamra, Rohini; Hubbard, Stevan R.			Structural Basis for the Interaction of the Adaptor Protein Grb14 with Activated Ras	PLOS ONE			English	Article								Grb14, a member of the Grb7-10-14 family of cytoplasmic adaptor proteins, is a tissue-specific negative regulator of insulin signaling. Grb7-10-14 contain several signaling modules, including a Ras-associating (RA) domain, a pleckstrin-homology (PH) domain, a family-specific BPS (between PH and SH2) region, and a C-terminal Srchomology-2 (SH2) domain. We showed previously that the RA and PH domains, along with the BPS region and SH2 domain, are necessary for downregulation of insulin signaling. Here, we report the crystal structure at 2.4-angstrom resolution of the Grb14 RA and PH domains in complex with GTP-loaded H-Ras (G12V). The structure reveals that the Grb14 RA and PH domains form an integrated structural unit capable of binding simultaneously to small GTPases and phosphoinositide lipids. The overall mode of binding of the Grb14 RA domain to activated H-Ras is similar to that of the RA domains of RalGDS and Raf1 but with important distinctions. The integrated RA-PH structural unit in Grb7-10-14 is also found in a second adaptor family that includes Rap1-interacting adaptor molecule (RIAM) and lamellipodin, proteins involved in actin-cytoskeleton rearrangement. The structure of Grb14 RA-PH in complex with H-Ras represents the first detailed molecular characterization of tandem RA-PH domains bound to a small GTPase and provides insights into the molecular basis for specificity.	[Hubbard, Stevan R.] NYU, Sch Med, Skirball Inst, Kimmel Ctr Biol & Med, New York, NY 10003 USA; NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY USA	New York University; New York University	Hubbard, SR (corresponding author), NYU, Sch Med, Skirball Inst, Kimmel Ctr Biol & Med, New York, NY 10003 USA.	stevan.hubbard@med.nyu.edu		Hubbard, Stevan/0000-0002-2707-9383; Qamra, Rohini/0000-0002-6105-3558	National Institutes of Health [R01 DK052916, P41 GM103473]; National Center for Research Resources [P41 RR012408]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103473] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this study was provided by the National Institutes of Health (R01 DK052916 to S.R.H.; P41 GM103473) and the National Center for Research Resources (P41 RR012408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bereziat V, 2002, J BIOL CHEM, V277, P4845, DOI 10.1074/jbc.M106574200; Blagitko N, 2000, HUM MOL GENET, V9, P1587, DOI 10.1093/hmg/9.11.1587; Bunney TD, 2006, MOL CELL, V21, P495, DOI 10.1016/j.molcel.2006.01.008; Cariou B, 2004, FASEB J, V18, P965, DOI 10.1096/fj.03-0824fje; Chang YC, 2012, PROTEIN CELL; Chang YC, 2013, PROTEIN CELL, V4, P211, DOI 10.1007/s13238-013-2082-5; Charalambous M, 2003, P NATL ACAD SCI USA, V100, P8292, DOI 10.1073/pnas.1532175100; Cooney GJ, 2004, EMBO J, V23, P582, DOI 10.1038/sj.emboj.7600082; Depetris RS, 2009, NAT STRUCT MOL BIOL, V16, P833, DOI 10.1038/nsmb.1642; Depetris RS, 2005, MOL CELL, V20, P325, DOI 10.1016/j.molcel.2005.09.001; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filchtinski D, 2010, J MOL BIOL, V399, P422, DOI 10.1016/j.jmb.2010.03.046; Garfield AS, 2011, NATURE, V469, P534, DOI 10.1038/nature09651; Holt LJ, 2005, GROWTH FACTORS, V23, P193, DOI 10.1080/08977190500196267; Holt LJ, 2005, BIOCHEM J, V388, P393, DOI 10.1042/BJ20050216; Holt LJ, 2009, MOL ENDOCRINOL, V23, P1406, DOI 10.1210/me.2008-0386; Huang L, 1998, NAT STRUCT BIOL, V5, P422, DOI 10.1038/nsb0698-422; Kiel C, 2004, P NATL ACAD SCI USA, V101, P9223, DOI 10.1073/pnas.0401160101; Krause M, 2004, DEV CELL, V7, P571, DOI 10.1016/j.devcel.2004.07.024; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lafuente EM, 2004, DEV CELL, V7, P585, DOI 10.1016/j.devcel.2004.07.021; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Nassar N, 1996, NAT STRUCT BIOL, V3, P723, DOI 10.1038/nsb0896-723; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Rudolph MG, 2001, J BIOL CHEM, V276, P23914, DOI 10.1074/jbc.M011600200; Shiura H, 2005, BIOCHEM BIOPH RES CO, V329, P909, DOI 10.1016/j.bbrc.2005.02.047; Smith FM, 2007, MOL CELL BIOL, V27, P5871, DOI 10.1128/MCB.02087-06; Stieglitz B, 2008, EMBO J, V27, P1995, DOI 10.1038/emboj.2008.125; WIGLEY DB, 1987, BIOCHEM BIOPH RES CO, V149, P927, DOI 10.1016/0006-291X(87)90497-9; Wright LP, 2006, J LIPID RES, V47, P883, DOI 10.1194/jlr.R600004-JLR200; Wynne JP, 2012, J CELL BIOL, V199, P317, DOI 10.1083/jcb.201201157; Young A, 2009, ADV CANCER RES, V102, P1, DOI 10.1016/S0065-230X(09)02001-6	36	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e72473	10.1371/journal.pone.0072473	http://dx.doi.org/10.1371/journal.pone.0072473			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967305	Green Published, gold, Green Submitted			2022-12-25	WOS:000323115800101
J	Ma, H; Qazi, S; Ozer, Z; Zhang, J; Ishkhanian, R; Uckun, FM				Ma, Hong; Qazi, Sanjive; Ozer, Zahide; Zhang, Jian; Ishkhanian, Rita; Uckun, Fatih M.			Regulatory Phosphorylation of Ikaros by Bruton's Tyrosine Kinase	PLOS ONE			English	Article							PROTEIN; BTK; EXPRESSION; DIFFERENTIATION; LOCALIZATION; ACTIVATION; MECHANISM; DELETION; SYK	Diminished Ikaros function has been implicated in the pathogenesis of acute lymphoblastic leukemia (ALL), the most common form of childhood cancer. Therefore, a stringent regulation of Ikaros is of paramount importance for normal lymphocyte ontogeny. Here we provide genetic and biochemical evidence for a previously unknown function of Bruton's tyrosine kinase (BTK) as a partner and posttranslational regulator of Ikaros, a zinc finger-containing DNA-binding protein that plays a pivotal role in immune homeostasis. We demonstrate that BTK phosphorylates Ikaros at unique phosphorylation sites S214 and S215 in the close vicinity of its zinc finger 4 (ZF4) within the DNA binding domain, thereby augmenting its nuclear localization and sequence-specific DNA binding activity. Our results further demonstrate that BTK-induced activating phosphorylation is critical for the optimal transcription factor function of Ikaros.	[Ma, Hong; Qazi, Sanjive; Ozer, Zahide; Ishkhanian, Rita; Uckun, Fatih M.] Childrens Hosp Los Angeles, Syst Immunobiol Lab, Childrens Ctr Canc & Blood Dis, Los Angeles, CA 90027 USA; [Qazi, Sanjive] Gustavus Adolphus Coll, Dept Biol, St Peter, MN 56082 USA; [Qazi, Sanjive] Gustavus Adolphus Coll, Bioinformat Program, St Peter, MN 56082 USA; [Ozer, Zahide] Parker Hughes Inst, Mol Oncol Program, St Paul, MN USA; [Zhang, Jian] Shanghai Jiao Tong Univ, Med Bioinformat Ctr, Shanghai 200030, Peoples R China; [Uckun, Fatih M.] Univ So Calif, Keck Sch Med, Dept Pediat, Los Angeles, CA 90033 USA	Children's Hospital Los Angeles; Gustavus Adolphus College; Gustavus Adolphus College; Shanghai Jiao Tong University; University of Southern California	Uckun, FM (corresponding author), Childrens Hosp Los Angeles, Syst Immunobiol Lab, Childrens Ctr Canc & Blood Dis, Los Angeles, CA 90027 USA.	fmuckun@chla.usc.edu	Zhang, Jian/GXA-1303-2022	Zhang, Jian/0000-0002-6558-791X; Uckun, Fatih M./0000-0001-9334-183X	DHHS grants from National Cancer Institute [P30CA014089, U01-CA-151837, R01CA-154471, R21-CA-164098]; Children's Hospital Los Angeles; Ronald McDonald House Charities of Southern California; Couples Against Leukemia Foundation; William Lawrence & Blanche Hughes Foundation; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Nautica Triathalon; NATIONAL CANCER INSTITUTE [U01CA151837, R21CA164098, P30CA014089, R01CA154471] Funding Source: NIH RePORTER	DHHS grants from National Cancer Institute; Children's Hospital Los Angeles; Ronald McDonald House Charities of Southern California; Couples Against Leukemia Foundation; William Lawrence & Blanche Hughes Foundation; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Nautica Triathalon; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The project described was supported in part by DHHS grants P30CA014089, U01-CA-151837, R01CA-154471 and R21-CA-164098 (FMU) from the National Cancer Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. This work was supported in part by Children's Hospital Los Angeles Institutional Endowment and Special Funds (FMU), Ronald McDonald House Charities of Southern California (FMU), Couples Against Leukemia Foundation (FMU), a William Lawrence & Blanche Hughes Foundation grant (FMU), Nautica Triathalon and its producer Michael Epstein (FMU). JZ was supported by the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba Y, 2001, P NATL ACAD SCI USA, V98, P2582, DOI 10.1073/pnas.051626198; Buggy JJ, 2012, INT REV IMMUNOL, V31, P119, DOI 10.3109/08830185.2012.664797; Cobb BS, 2000, GENE DEV, V14, P2146, DOI 10.1101/gad.816400; Conklin DS, 2012, US patent application, Patent No. 20120165395; Dovat S, 2002, GENE DEV, V16, P2985, DOI 10.1101/gad.1040502; Dovat S, 2011, MOL CELL BIOCHEM, V356, P201, DOI 10.1007/s11010-011-0964-5; Eifert C, 2009, DISSERTATION PUBLICA, VAAT 3354648; Goodman PA, 2003, LEUKEMIA LYMPHOMA, V44, P1011, DOI 10.1080/1042819031000067576; Huang ZM, 2011, NUCLEIC ACIDS RES, V39, pD663, DOI 10.1093/nar/gkq1022; Kitanaka A, 1998, BLOOD, V91, P940, DOI 10.1182/blood.V91.3.940.940_940_948; Kuglstatter A, 2011, PROTEIN SCI, V20, P428, DOI 10.1002/pro.575; Lavitrano M, 2012, US patent, Patent No. [8,232,085, 8232085]; Mahajan S, 1999, J BIOL CHEM, V274, P9587, DOI 10.1074/jbc.274.14.9587; Mahajan S, 2001, J BIOL CHEM, V276, P31216, DOI 10.1074/jbc.M104874200; Mao C, 2001, J BIOL CHEM, V276, P41435, DOI 10.1074/jbc.M104828200; Merkenschlager M, 2010, FEBS LETT, V584, P4910, DOI 10.1016/j.febslet.2010.09.042; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Payne Marvin A, 2011, World J Biol Chem, V2, P161; Popescu M, 2009, J BIOL CHEM, V284, P13869, DOI 10.1074/jbc.M900209200; Qiu Y, 2000, ONCOGENE, V19, P5651, DOI 10.1038/sj.onc.1203958; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Satterthwaite AB, 2000, IMMUNOL REV, V175, P120, DOI 10.1034/j.1600-065X.2000.017504.x; Sun L, 1999, P NATL ACAD SCI USA, V96, P680, DOI 10.1073/pnas.96.2.680; Thompson EC, 2007, IMMUNITY, V26, P335, DOI 10.1016/j.immuni.2007.02.010; Tovchigrechko A, 2005, PROTEINS, V60, P296, DOI 10.1002/prot.20573; Uckun FM, 2012, P NATL ACAD SCI USA, V109, P18072, DOI 10.1073/pnas.1209828109; Uckun FM, 2010, EXPERT OPIN THER PAT, V20, P1457, DOI 10.1517/13543776.2010.517750; Uckun FM, 2010, P NATL ACAD SCI USA, V107, P16852, DOI 10.1073/pnas.1007896107; Uckun FM, 1996, SCIENCE, V273, P1096, DOI 10.1126/science.273.5278.1096; Yang EJ, 2004, J BIOL CHEM, V279, P1827, DOI 10.1074/jbc.M308722200; Yoshida T, 2010, CURR OPIN IMMUNOL, V22, P154, DOI 10.1016/j.coi.2010.02.011; Zhang JW, 2012, NAT IMMUNOL, V13, P86, DOI 10.1038/ni.2150	33	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71302	10.1371/journal.pone.0071302	http://dx.doi.org/10.1371/journal.pone.0071302			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977012	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700036
J	Teravainen, TP; Myllymaki, SM; Friedrichs, J; Strohmeyer, N; Moyano, JV; Wu, CY; Matlin, KS; Muller, DJ; Manninen, A				Teravainen, Terhi P.; Myllymaki, Satu M.; Friedrichs, Jens; Strohmeyer, Nico; Moyano, Jose V.; Wu, Chuanyue; Matlin, Karl S.; Muller, Daniel J.; Manninen, Aki			alpha V-Integrins Are Required for Mechanotransduction in MDCK Epithelial Cells	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; FORCE SPECTROSCOPY; FOCAL ADHESIONS; APICAL POLARITY; PROTEIN-KINASE; LINKED KINASE; CROSS-TALK; FIBRONECTIN; COLLAGEN; LAMININ	The properties of epithelial cells within tissues are regulated by their immediate microenvironment, which consists of neighboring cells and the extracellular matrix (ECM). Integrin heterodimers orchestrate dynamic assembly and disassembly of cell-ECM connections and thereby convey biochemical and mechanical information from the ECM into cells. However, the specific contributions and functional hierarchy between different integrin heterodimers in the regulation of focal adhesion dynamics in epithelial cells are incompletely understood. Here, we have studied the functions of RGD-binding alpha V-integrins in a Madin Darby Canine Kidney (MDCK) cell model and found that alpha V-integrins regulate the maturation of focal adhesions (FAs) and cell spreading. alpha V-integrin-deficient MDCK cells bound collagen I (Col I) substrate via alpha 2 beta 1-integrins but failed to efficiently recruit FA components such as talin, focal adhesion kinase (FAK), vinculin and integrin-linked kinase (ILK). The apparent inability to mature alpha 2 beta 1-integrin-mediated FAs and link them to cellular actin cytoskeleton led to disrupted mechanotransduction in alpha V-integrin deficient cells seeded onto Col I substrate.	[Teravainen, Terhi P.; Myllymaki, Satu M.; Manninen, Aki] Univ Oulu, Bioctr Oulu, Oulu Ctr Cell Matrix Res, Dept Med Biochem & Mol Biol, Oulu, Finland; [Friedrichs, Jens] Leibniz Inst Polymer Res Dresden, Inst Biofunct Polymer Mat, Dresden, Germany; [Strohmeyer, Nico; Muller, Daniel J.] ETH, Dept Biosyst Sci & Engn, Basel, Switzerland; [Friedrichs, Jens] Tech Univ Dresden, Ctr Biotechnol, Dresden, Germany; [Wu, Chuanyue] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Moyano, Jose V.; Matlin, Karl S.] Univ Chicago, Dept Surg, Comm Cell Physiol, Chicago, IL 60637 USA; [Moyano, Jose V.; Matlin, Karl S.] Univ Chicago, Comm Mol Pathogenesis & Mol Med, Chicago, IL 60637 USA	University of Oulu; Leibniz Institut fur Polymerforschung Dresden; Swiss Federal Institutes of Technology Domain; ETH Zurich; Technische Universitat Dresden; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Chicago; University of Chicago	Manninen, A (corresponding author), Univ Oulu, Bioctr Oulu, Oulu Ctr Cell Matrix Res, Dept Med Biochem & Mol Biol, Oulu, Finland.	aki.manninen@oulu.fi	Manninen, Aki/AAC-8067-2019; Müller, Daniel J./A-5967-2010; Friedrichs, Jens/D-4833-2015	Manninen, Aki/0000-0002-6263-8101; Müller, Daniel J./0000-0003-3075-0665; Strohmeyer, Nico/0000-0002-5985-9800; Myllymaki, Satu-Marja/0000-0003-0521-5062	Academy of Finland Grants [114330, 135560, 140974]; Federal Ministry of Education and Research, Germany; Biocenter Finland; Sigrid Juselius Foundation	Academy of Finland Grants(Academy of Finland); Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF)); Biocenter Finland; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work was supported by Academy of Finland Grants (114330, 135560 and 140974), by Federal Ministry of Education and Research, Germany, by Biocenter Finland, and by the Sigrid Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abair TD, 2008, EXP CELL RES, V314, P3593, DOI 10.1016/j.yexcr.2008.08.014; AUMAILLEY M, 1990, FEBS LETT, V262, P82, DOI 10.1016/0014-5793(90)80159-G; Blystone SD, 1999, J CELL BIOL, V145, P889, DOI 10.1083/jcb.145.4.889; BUSK M, 1992, J BIOL CHEM, V267, P5790; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Caswell PT, 2008, J CELL BIOL, V183, P143, DOI 10.1083/jcb.200804140; CHEN FA, 1991, J EXP MED, V173, P1111, DOI 10.1084/jem.173.5.1111; Cooke ME, 2000, J CELL SCI, V113, P2375; DAVIS GE, 1992, BIOCHEM BIOPH RES CO, V182, P1025, DOI 10.1016/0006-291X(92)91834-D; EIDE BL, 1995, MOL CELL BIOL, V15, P2819; Ferletta M, 1999, J CELL SCI, V112, P1; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Friedrichs J, 2008, J BIOL CHEM, V283, P32264, DOI 10.1074/jbc.M803634200; Friedrichs J, 2007, J BIOL CHEM, V282, P29375, DOI 10.1074/jbc.M701867200; Friedrichs J, 2010, NAT PROTOC, V5, P1353, DOI 10.1038/nprot.2010.89; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; GOTTARDI CJ, 1995, AM J PHYSIOL-RENAL, V268, pF285, DOI 10.1152/ajprenal.1995.268.2.F285; Grundstrom G, 2003, EXP CELL RES, V291, P463, DOI 10.1016/j.yexcr.2003.07.010; HALL DE, 1990, J CELL BIOL, V110, P2175, DOI 10.1083/jcb.110.6.2175; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Helenius J, 2008, J CELL SCI, V121, P1785, DOI 10.1242/jcs.030999; Hirata H, 2008, J CELL SCI, V121, P2795, DOI 10.1242/jcs.030320; HOWLETT AR, 1995, J CELL SCI, V108, P1945; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970; Kadler KE, 2008, CURR OPIN CELL BIOL, V20, P495, DOI 10.1016/j.ceb.2008.06.008; KORNBERG L, 1992, J BIOL CHEM, V267, P23439; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Krieg M, 2008, ANGEW CHEM INT EDIT, V47, P9775, DOI 10.1002/anie.200803552; Leiss M, 2008, CURR OPIN CELL BIOL, V20, P502, DOI 10.1016/j.ceb.2008.06.001; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li S, 2002, J CELL BIOL, V157, P1279, DOI 10.1083/jcb.200203073; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Lohikangas L, 2001, EXP CELL RES, V265, P135, DOI 10.1006/excr.2001.5170; Mak GZ, 2006, MOL BIOL CELL, V17, P3664, DOI 10.1091/mbc.E05-11-1070; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Matlin KS, 2003, METHODS, V30, P235, DOI 10.1016/S1046-2023(03)00030-6; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; MONTGOMERY AMP, 1994, P NATL ACAD SCI USA, V91, P8856, DOI 10.1073/pnas.91.19.8856; Myllymaki SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019453; O'Brien LE, 2001, NAT CELL BIOL, V3, P831, DOI 10.1038/ncb0901-831; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Pietila R, 2012, J CELL SCI, V125, P2212, DOI 10.1242/jcs.098020; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Rasband W., 2006, IMAGEJ; Reinhart-King CA, 2003, LANGMUIR, V19, P1573, DOI 10.1021/la026142j; Retta SF, 2001, MOL BIOL CELL, V12, P3126, DOI 10.1091/mbc.12.10.3126; Roca-Cusachs P, 2009, P NATL ACAD SCI USA, V106, P16245, DOI 10.1073/pnas.0902818106; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Saez A, 2007, P NATL ACAD SCI USA, V104, P8281, DOI 10.1073/pnas.0702259104; SCHOENENBERGER CA, 1994, J CELL SCI, V107, P527; Schuck S, 2004, P NATL ACAD SCI USA, V101, P4912, DOI 10.1073/pnas.0401285101; Schwarz DS, 2006, PLOS GENET, V2, P1307, DOI 10.1371/journal.pgen.0020140; Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386; Stanchi F, 2009, J CELL SCI, V122, P1800, DOI 10.1242/jcs.044602; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; TAKADA Y, 1993, J BIOL CHEM, V268, P17597; Valerius M. Todd, 2002, Mechanisms of Development, V112, P219, DOI 10.1016/S0925-4773(02)00008-4; Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200; Wang PB, 2011, J CELL BIOL, V195, P499, DOI 10.1083/jcb.201104128; White DP, 2007, J CELL BIOL, V177, P515, DOI 10.1083/jcb.200609004; Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670; Wu CY, 2001, J CELL BIOL, V155, P505, DOI 10.1083/jcb.200108077; Yoshigi M, 2005, J CELL BIOL, V171, P209, DOI 10.1083/jcb.200505018; Yu W, 2005, MOL BIOL CELL, V16, P433, DOI 10.1091/mbc.e04-05-0435; Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416; Zervas CG, 2001, J CELL BIOL, V152, P1007, DOI 10.1083/jcb.152.5.1007; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765; Zhang YJ, 2002, J CELL SCI, V115, P4777, DOI 10.1242/jcs.00166	72	20	20	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71485	10.1371/journal.pone.0071485	http://dx.doi.org/10.1371/journal.pone.0071485			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977051	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000323425700057
J	Zhan, QL; Tsai, SN; Lu, YH; Wang, CM; Kwan, YW; Ngai, SM				Zhan, Qinglei; Tsai, Sauna; Lu, Yonghai; Wang, Chunmei; Kwan, Yiuwa; Ngai, Saiming			RuvBL2 Is Involved in Histone Deacetylase Inhibitor PCI-24781-Induced Cell Death in SK-N-DZ Neuroblastoma Cells	PLOS ONE			English	Article							IN-VITRO; PROTEOMIC ANALYSIS; ANTITUMOR-ACTIVITY; APOPTOSIS; ACETYLATION; VORINOSTAT; EXPRESSION; VIVO; MECHANISMS; AUTOPHAGY	Neuroblastoma is the second most common solid tumor diagnosed during infancy. The survival rate among children with high-risk neuroblastoma is less than 40%, highlighting the urgent needs for new treatment strategies. PCI-24781 is a novel hydroxamic acid-based histone deacetylase (HDAC) inhibitor that has high efficacy and safety for cancer treatment. However, the underlying mechanisms of PCI-24781 are not clearly elucidated in neuroblastoma cells. In the present study, we demonstrated that PCI-24781 treatment significantly inhibited tumor growth at very low doses in neuroblastoma cells SK-N-DZ, not in normal cell line HS-68. However, PCI-24781 caused the accumulation of acetylated histone H3 both in SK-N-DZ and HS-68 cell line. Treatment of SK-N-DZ with PCI-24781 also induced cell cycle arrest in G2/M phase and activated apoptosis signaling pathways via the up-regulation of DR4, p21, p53 and caspase 3. Further proteomic analysis revealed differential protein expression profiles between non-treated and PCI-24781 treated SK-N-DZ cells. Totally 42 differentially expressed proteins were identified by MALDI-TOF MS system. Western blotting confirmed the expression level of five candidate proteins including prohibitin, hHR23a, RuvBL2, TRAP1 and PDCD6IP. Selective knockdown of RuvBL2 rescued cells from PCI-24781-induced cell death, implying that RuvBL2 might play an important role in anti-tumor activity of PCI-24781 in SK-N-DZ cells. The present results provide a new insight into the potential mechanism of PCI-24781 in SK-N-DZ cell line.	[Zhan, Qinglei; Tsai, Sauna; Lu, Yonghai; Wang, Chunmei; Ngai, Saiming] Chinese Univ Hong Kong, Ctr Soybean Res, Partner State Key Lab Agrobiotechnol, Shatin, Hong Kong, Peoples R China; [Zhan, Qinglei; Tsai, Sauna; Lu, Yonghai; Wang, Chunmei; Ngai, Saiming] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China; [Kwan, Yiuwa] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Ngai, SM (corresponding author), Chinese Univ Hong Kong, Ctr Soybean Res, Partner State Key Lab Agrobiotechnol, Shatin, Hong Kong, Peoples R China.	smngai@cuhk.edu.hk	Kwan, Yiu Wa/R-6468-2018; Ngai, Sai Ming/S-4898-2018	Kwan, Yiu Wa/0000-0002-9024-1275; Ngai, Sai Ming/0000-0002-4484-2483	Hong Kong RGC Collaborative Research Fund [CUHK3/CRF/11G]; ITC ITF for the Partner State Key Laboratories Hong Kong	Hong Kong RGC Collaborative Research Fund; ITC ITF for the Partner State Key Laboratories Hong Kong	This work was supported by the grant from the Hong Kong RGC Collaborative Research Fund (CUHK3/CRF/11G) and ITC ITF for the Partner State Key Laboratories Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Adimoolam S, 2007, P NATL ACAD SCI USA, V104, P19482, DOI 10.1073/pnas.0707828104; Bhalla S, 2009, CLIN CANCER RES, V15, P3354, DOI 10.1158/1078-0432.CCR-08-2365; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Buggy JJ, 2006, MOL CANCER THER, V5, P1309, DOI 10.1158/1535-7163.MCT-05-0442; Cayo MA, 2009, AM J TRANSL RES, V1, P178; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chakrabarti M, 2013, J MOL NEUROSCI, V51, P187, DOI 10.1007/s12031-013-9975-x; Chatellard-Causse C, 2002, J BIOL CHEM, V277, P29108, DOI 10.1074/jbc.M204019200; Chen GZ, 2008, J PROTEOME RES, V7, P2733, DOI 10.1021/pr7008753; Coffey DC, 2000, MED PEDIATR ONCOL, V35, P577, DOI 10.1002/1096-911X(20001201)35:6<577::AID-MPO18>3.0.CO;2-3; Coffey DC, 2001, CANCER RES, V61, P3591; Dantuma NP, 2009, DNA REPAIR, V8, P449, DOI 10.1016/j.dnarep.2009.01.005; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Francisco R, 2012, CANCER LETT, V318, P42, DOI 10.1016/j.canlet.2011.11.036; Gospodinov A, 2009, INT J BIOCHEM CELL B, V41, P925, DOI 10.1016/j.biocel.2008.09.004; Grimwood J, 2004, NATURE, V428, P529, DOI 10.1038/nature02399; Hrzenjak A, 2008, J PATHOL, V216, P495, DOI 10.1002/path.2434; Hua GQ, 2007, J BIOL CHEM, V282, P20553, DOI 10.1074/jbc.M703196200; Insinga A, 2005, NAT MED, V11, P71, DOI 10.1038/nm1160; Jaboin J, 2002, CANCER RES, V62, P6108; Janoueix-Lerosey I, 2009, J CLIN ONCOL, V27, P1026, DOI 10.1200/JCO.2008.16.0630; Jha S, 2013, MOL CELL BIOL, V33, P1164, DOI 10.1128/MCB.01567-12; Jha S, 2009, MOL CELL, V34, P521, DOI 10.1016/j.molcel.2009.05.016; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Li JY, 2010, AUTOPHAGY, V6, P711, DOI 10.4161/auto.6.6.12397; Li Y, 2006, GENE DEV, V20, P2566, DOI 10.1101/gad.1455006; Lopez G, 2009, CLIN CANCER RES, V15, P3472, DOI 10.1158/1078-0432.CCR-08-2714; Loprevite M, 2005, ONCOL RES, V15, P39; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; More SS, 2011, CLIN CANCER RES, V17, P2339, DOI 10.1158/1078-0432.CCR-10-2949; Muhlethaler-Mottet A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-55; Ouwehand K, 2005, FEBS LETT, V579, P1523, DOI 10.1016/j.febslet.2005.01.058; Qiu L, 2000, MOL BIOL CELL, V11, P2069, DOI 10.1091/mbc.11.6.2069; Rao R, 2010, MOL CANCER THER, V9, P942, DOI 10.1158/1535-7163.MCT-09-0988; Rivera-Del Valle N, 2010, INT J CELL BIOL; Rodriguez-Collazo P, 2009, NUCLEIC ACIDS RES, V37, P11; Shah RD, 2013, J CELL BIOCHEM, V114, P854, DOI 10.1002/jcb.24422; Smith KT, 2009, INT J BIOCHEM CELL B, V41, P21, DOI 10.1016/j.biocel.2008.09.008; Subramanian C, 2005, P NATL ACAD SCI USA, V102, P4842, DOI 10.1073/pnas.0408351102; Subramanian C, 2011, NEOPLASIA, V13, P726, DOI 10.1593/neo.11558; Tang XX, 2004, CLIN CANCER RES, V10, P5837, DOI 10.1158/1078-0432.CCR-04-0395; Theiss AL, 2011, BBA-MOL CELL RES, V1813, P1137, DOI 10.1016/j.bbamcr.2011.01.033; Tong AQ, 2008, CANCER CHEMOTH PHARM, V61, P791, DOI 10.1007/s00280-007-0536-2; Venteicher AS, 2008, CELL, V132, P945, DOI 10.1016/j.cell.2008.01.019; Wanczyk M, 2011, FRONT BIOSCI-LANDMRK, V16, P340, DOI 10.2741/3691; Wang S, 2002, ONCOGENE, V21, P8388, DOI 10.1038/sj.onc.1205944; Wiegmans AP, 2011, CANCER RES, V71, P3603, DOI 10.1158/0008-5472.CAN-10-3289; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yang YH, 2008, CANCER RES, V68, P4833, DOI 10.1158/0008-5472.CAN-08-0644	54	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e71663	10.1371/journal.pone.0071663	http://dx.doi.org/10.1371/journal.pone.0071663			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977108	Green Submitted, gold, Green Published			2022-12-25	WOS:000323570200041
J	Chen, GW; Song, B; Li, ZL; Yuan, Y				Chen, Guang-wen; Song, Bin; Li, Zhen-lin; Yuan, Yuan			Ectopic Blood Supply of Hepatocellular Carcinoma as Depicted by Angiography with Computed Tomography: Associations with Morphological Features and Therapeutic History	PLOS ONE			English	Article							MULTIDETECTOR ROW CT; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; DONOR LIVER-TRANSPLANTATION; SUPERIOR MESENTERIC-ARTERY; INTERNAL MAMMARY ARTERY; INFERIOR PHRENIC ARTERY; HEPATIC-ARTERY; ANATOMY; PSEUDOCAPSULE; PREDICTION	Objective: To investigate the associations of ectopic blood supply of hepatocellular carcinoma (HCC) with its morphological features and therapeutic history. Methods: Three hundred and six patients with 373 HCC lesions were enrolled in this study, and underwent biphasic contrast-enhanced scans on a 64-section MDCT. The anatomy of ectopic blood supply, morphological characteristics of HCC including the size, location and pseudocapsule, and history of transcatheter arterial chemoembolization (TACE) therapy were quantitively assessed and statistically analyzed. Results: Ectopic blood supply was found in 30.8% (115/373) lesions. The ectopic arteries were predominantly composed of inferior phrenic artery (86/115) followed by left and right gastric artery (25/115). Tumor size, location, status of pseudocapsule, and history of TACE therapy could impact the origination of ectopic arteries (all p<0.05). Conclusion: The ectopic feeding arteries of HCC predominantly composed of the perihepatic arteries are associated with the morphological features of the tumor and therapeutic history.	[Chen, Guang-wen] Sichuan Prov Peoples Hosp, Dept Radiol, Chengdu, Sichuan, Peoples R China; [Chen, Guang-wen; Song, Bin; Li, Zhen-lin; Yuan, Yuan] Sichuan Univ, West China Hosp, Dept Radiol, Chengdu 610064, Sichuan, Peoples R China	Sichuan Provincial People's Hospital; Sichuan University	Song, B (corresponding author), Sichuan Univ, West China Hosp, Dept Radiol, Chengdu 610064, Sichuan, Peoples R China.	cjr.songbin@vip163.com	Song, Bin/AAD-3670-2020	Song, Bin/0000-0002-7269-2101				Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cademartiri F, 2008, RADIOL MED, V113, P1135, DOI 10.1007/s11547-008-0330-1; Cheng LF, 2010, J MED IMAG RADIAT ON, V54, P26, DOI 10.1111/j.1754-9485.2010.02134.x; Coskun M, 2005, TRANSPL P, V37, P1070, DOI 10.1016/j.transproceed.2005.01.019; Duran C, 2009, J COMPUT ASSIST TOMO, V33, P618, DOI 10.1097/RCT.0b013e31818d814b; Frauenfelder T, 2004, RADIOGRAPHICS, V24, P481, DOI 10.1148/rg.242025714; Grazioli L, 1999, EUR RADIOL, V9, P62, DOI 10.1007/s003300050629; Il Gwon D, 2007, RADIOGRAPHICS, V27, P687, DOI 10.1148/rg.273065036; Ishigami K, 2004, AM J ROENTGENOL, V183, P1577, DOI 10.2214/ajr.183.6.01831577; Ishigami K, 2009, RADIOLOGY, V250, P435, DOI 10.1148/radiol.2501071702; Kim HC, 2005, RADIOGRAPHICS, V25, pS25, DOI 10.1148/rg.25si055508; Kim HC, 2008, J VASC INTERV RADIOL, V19, P1551, DOI 10.1016/j.jvir.2008.08.005; Kim HC, 2008, J VASC INTERV RADIOL, V19, P1419, DOI 10.1016/j.jvir.2008.06.015; Kim HC, 2011, CARDIOVASC INTER RAD, V34, P87, DOI 10.1007/s00270-010-9883-1; Kim HC, 2009, J VASC INTERV RADIOL, V20, P888, DOI 10.1016/j.jvir.2009.03.036; Kim MU, 2011, J VASC INTERV RADIOL, V22, P1403, DOI 10.1016/j.jvir.2011.05.009; Klok FA, 2011, CURR OPIN PULM MED, V17, P380, DOI 10.1097/MCP.0b013e328348b3de; Ko HK, 2007, KOREAN J RADIOL, V8, P320, DOI 10.3348/kjr.2007.8.4.320; Lee KH, 2002, RADIOGRAPHICS, V22, P1077, DOI 10.1148/radiographics.22.5.g02se191077; Loukas M, 2005, CLIN ANAT, V18, P357, DOI 10.1002/ca.20112; Lu WP, 2008, J GASTROEN HEPATOL, V23, P1874, DOI 10.1111/j.1440-1746.2008.05527.x; MICHELS NA, 1953, CANCER, V6, P708, DOI 10.1002/1097-0142(195307)6:4<708::AID-CNCR2820060411>3.0.CO;2-A; Miyayama S, 2010, CARDIOVASC INTER RAD, V33, P53, DOI 10.1007/s00270-009-9595-6; Mizouni Habiba, 2012, Tunis Med, V90, P201; Nakai M, 2001, RADIOLOGY, V219, P147, DOI 10.1148/radiology.219.1.r01mr28147; Okumura Yusuke, 2007, Nihon Hoshasen Gijutsu Gakkai Zasshi, V63, P1152; Park SI, 2003, J VASC INTERV RADIOL, V14, P461, DOI 10.1097/01.RVI.0000064856.87207.1E; Rajan DK, 2005, CLIN RADIOL, V60, P723, DOI 10.1016/j.crad.2005.01.013; Sacco R, 2009, WORLD J GASTROENTERO, V15, P1843, DOI 10.3748/wjg.15.1843; Shibata T, 1998, Radiat Med, V16, P251; Shin SW, 2009, KOREAN J RADIOL, V10, P425, DOI 10.3348/kjr.2009.10.5.425; Sneag DB, 2011, AM J ROENTGENOL, V197, pW658, DOI 10.2214/AJR.10.6402; Sosnowski M, 2009, CARDIOL J, V16, P413; Wang YL, 2005, WORLD J GASTROENTERO, V11, P2637, DOI 10.3748/wjg.v11.i17.2637; YAMADA R, 1983, RADIOLOGY, V148, P397, DOI 10.1148/radiology.148.2.6306721	35	8	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71942	10.1371/journal.pone.0071942	http://dx.doi.org/10.1371/journal.pone.0071942			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967266	Green Submitted, Green Published, gold			2022-12-25	WOS:000323378000074
J	Cheng, Y; Cawley, NX; Loh, YP				Cheng, Yong; Cawley, Niamh X.; Loh, Y. Peng			Carboxypeptidase E/NF alpha 1: A New Neurotrophic Factor against Oxidative Stress-Induced Apoptotic Cell Death Mediated by ERK and PI3-K/AKT Pathways	PLOS ONE			English	Article							NEUROPEPTIDE-PROCESSING ENZYME; REGULATED SECRETORY PATHWAY; HIPPOCAMPAL-NEURONS; NEURODEGENERATIVE DISEASES; ENKEPHALIN CONVERTASE; INDUCED NEUROTOXICITY; BRAIN; BDNF; SURVIVAL; MITOCHONDRIA	Mice lacking Carboxypeptidase E (CPE) exhibit degeneration of hippocampal neurons caused by stress at weaning while over-expression of CPE in hippocampal neurons protect them against hydrogen peroxide-induced cell death. Here we demonstrate that CPE acts as an extracellular trophic factor to protect neurons. Rat hippocampal neurons pretreated with purified CPE protected the cells against hydrogen peroxide-, staurosporine- and glutamate-induced cell death. This protection was observed even when hippocampal neurons were treated with an enzymatically inactive mutant CPE or with CPE in the presence of its inhibitor, GEMSA. Purified CPE added to the culture medium rescued CPE knock-out hippocampal neurons from cell death. Both ERK and AKT were phosphorylated within 15 min after CPE treatment of hippocampal neurons and, using specific inhibitors, both signaling pathways were shown to be required for the neuroprotective effect. The expression of the anti-apoptotic protein, B-cell lymphoma 2 (BCL-2), was up-regulated after hippocampal neurons were treated with CPE. Furthermore, hydrogen peroxide induced down-regulation of BCL-2 protein and subsequent activation of caspase-3 were inhibited by CPE treatment. Thus, this study has identified CPE as a new neurotrophic factor that can protect neurons against degeneration through the activation of ERK and AKT signaling pathways to up-regulate expression of BCL-2.	[Cheng, Yong; Cawley, Niamh X.; Loh, Y. Peng] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cellular Neurobiol Sect, Program Dev Neurosci, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Loh, YP (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cellular Neurobiol Sect, Program Dev Neurosci, NIH, Bethesda, MD USA.	lohp@mail.nih.gov		Cheng, Yong/0000-0002-7529-4408	Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000056] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham Istvan M., 2006, Dose-Response, V4, P38, DOI 10.2203/dose-response.004.01.004.Abraham; Almeida RD, 2005, CELL DEATH DIFFER, V12, P1329, DOI 10.1038/sj.cdd.4401662; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Cawley NX, 2012, ENDOCR REV, V33, P216, DOI 10.1210/er.2011-1039; Cawley NX, 2004, ENDOCRINOLOGY, V145, P5807, DOI 10.1210/en.2004-0847; Cheng Y, 2012, SOC NEUR ABSTR; Cheng Y, 2011, CARBOXYPEPTIDASE E N; Cheng Y, 2010, J ALZHEIMERS DIS, V20, P1143, DOI 10.3233/JAD-2010-091234; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Cool DR, 1997, CELL, V88, P73, DOI 10.1016/S0092-8674(00)81860-7; Deng YB, 2000, P NATL ACAD SCI USA, V97, P12050, DOI 10.1073/pnas.97.22.12050; Du J, 2003, J CELL BIOL, V163, P385, DOI 10.1083/jcb.200305134; FRICKER LD, 1983, BIOCHEM BIOPH RES CO, V111, P994, DOI 10.1016/0006-291X(83)91398-0; FRICKER LD, 1982, P NATL ACAD SCI-BIOL, V79, P3886, DOI 10.1073/pnas.79.12.3886; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Horing E, 2012, ACTA NEUROPATHOL, V124, P83, DOI 10.1007/s00401-011-0940-x; HOOK VYH, 1982, NATURE, V295, P341, DOI 10.1038/295341a0; Jin KL, 2001, J CEREBR BLOOD F MET, V21, P1422, DOI 10.1097/00004647-200112000-00006; Johnson-Farley NN, 2007, BRAIN RES, V1154, P40, DOI 10.1016/j.brainres.2007.04.026; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Koks S, 2004, GENES BRAIN BEHAV, V3, P80, DOI 10.1046/j.1601-183x.2003.00047.x; Koshimizu H, 2009, J MOL NEUROSCI, V39, P1, DOI 10.1007/s12031-008-9164-5; Lee C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050501; Lou H, 2005, NEURON, V45, P245, DOI 10.1016/j.neuron.2004.12.037; Lou H, 2010, J NEUROCHEM, V114, P886, DOI 10.1111/j.1471-4159.2010.06820.x; Murthy SRK, 2013, ENDOCRINOLO IN PRESS; Park JJ, 2008, MOL CELL NEUROSCI, V39, P63, DOI 10.1016/j.mcn.2008.05.016; Pla V, 2012, BRAIN PATHOL; Poletto R, 2006, BRAIN RES, V1068, P7, DOI 10.1016/j.brainres.2005.11.012; Qian YM, 1999, J BIOL CHEM, V274, P11582, DOI 10.1074/jbc.274.17.11582; Shibata Noriyuki, 2008, Brain and Nerve (Tokyo), V60, P157; Skalka N, 2012, ONCOGENE; Stahl S, 2007, BBA-PROTEINS PROTEOM, V1774, P1237, DOI 10.1016/j.bbapap.2007.07.004; VILIJN MH, 1989, J NEUROCHEM, V53, P1487, DOI 10.1111/j.1471-4159.1989.tb08542.x; Woronowicz A, 2013, CLIN PHARM IN PRESS; Woronowicz A, 2008, HIPPOCAMPUS, V18, P1051, DOI 10.1002/hipo.20462; Yan MH, 2012, FREE RADIC BIOL MED; Zhang XM, 2011, CURR NEUROPHARMACOL, V9, P388, DOI 10.2174/157015911795596540; Zhou A, 2004, J CEREBR BLOOD F MET, V24, P612, DOI 10.1097/01.WCB.0000118959.03453.17; Ziemka-Nalecz M, 2012, ACTA NEUROBIOL EXP, V72, P309	40	37	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71578	10.1371/journal.pone.0071578	http://dx.doi.org/10.1371/journal.pone.0071578			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977080	Green Submitted, Green Published, gold			2022-12-25	WOS:000323378000060
J	Helleberg, M; Haggblom, A; Sonnerborg, A; Obel, N				Helleberg, Marie; Haggblom, Amanda; Sonnerborg, Anders; Obel, Niels			HIV Care in the Swedish-Danish HIV Cohort 1995-2010, Closing the Gaps	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT; INFECTION; PREVENTION; ENGAGEMENT; DENMARK	Background: Successful treatment reduces morbidity, mortality and transmission of HIV. We evaluated trends in the treatment status of HIV infected individuals enrolled in care in Sweden and Denmark during the years 1995-2010. Our aim was to assess the proportion of HIV-infected individuals who received services along the continuum of care in Denmark in 2010, and to discuss the findings in relation to the organization of the health care system. Methods: We analyzed CD4 counts and viral loads (VL) among all HIV patients enrolled in the cohort. For each month of the study period we estimated the proportions of patients who 1) had initiated highly active antiretroviral treatment (HAART) and had VL<500 copies/mL, 2) were not eligible for HAART, 3) had initiated HAART but had VL >= 500 copies/mL, 4) were eligible for, but had not initiated HAART and 5) had initiated HAART but no VL monitoring for >13 months or 6) no HAART or monitoring of CD4 for >13 months. Patients fulfilling criteria 1 or 2 were considered successfully managed. Results: The proportion of successfully managed patients continued to increase throughout the study period and reached 83% in 2010, 92% of Swedish/Danish men who have sex with men and heterosexual patients, but only 74% of immigrants and 78% of injection drug users were successfully managed due to higher rates of inadequate monitoring in the latter two groups. In 2010, 70% of all individuals diagnosed with HIV in Denmark were virally suppressed. Conclusion: In a public health care system with free access to specialized care, successful management of the majority of HIV patients is achievable. Interventions tailored to retain immigrants and injection drug users in care are needed to further reduce the proportion of sub-optimally treated HIV patients.	[Helleberg, Marie; Obel, Niels] Rigshosp, Copenhagen Univ Hosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [Helleberg, Marie] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Haggblom, Amanda; Sonnerborg, Anders] Karolinska Inst, Dept Med, Infect Dis Unit, Solna, Sweden; [Haggblom, Amanda] Cty Council Gavleborg, Dept Infect Dis, Gavle, Sweden; [Sonnerborg, Anders] Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Solna, Sweden	Rigshospitalet; University of Copenhagen; University of Copenhagen; Karolinska Institutet; Karolinska Institutet	Helleberg, M (corresponding author), Rigshosp, Copenhagen Univ Hosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark.	mhelleberg@sund.ku.dk	Sönnerborg, Anders/W-2011-2019; Helleberg, Marie/ABC-8199-2020	Sönnerborg, Anders/0000-0001-8928-3374; Helleberg, Marie/0000-0002-2370-1657; Obel, Niels/0000-0002-5031-0045	Swedish Research Council; Swedish Physicians Against AIDS Research Fund; University of Copenhagen	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Physicians Against AIDS Research Fund; University of Copenhagen	The study was supported by the Swedish Research Council, the Swedish Physicians Against AIDS Research Fund and University of Copenhagen. The funders had no role in study design, data collection, analysis, report writing, or the decision to submit the paper.	Anell Anders, 2012, Health Syst Transit, V14, P1; Audelin AM, 2011, AIDS RES HUM RETROV, V27, P1284, DOI 10.1089/aid.2010.0368; Burns DN, 2010, CLIN INFECT DIS, V51, P725, DOI 10.1086/655889; Cabral HJ, 2007, AIDS PATIENT CARE ST, V21, pS59, DOI 10.1089/apc.2007.9986; Christiansen T, 2002, HEALTH POLICY, V59, P107, DOI 10.1016/S0168-8510(01)00201-9; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; Cowan SA, 2012, JAIDS-J ACQ IMM DEF, V61, P106, DOI 10.1097/QAI.0b013e31825af890; Engsig FN, 2010, AIDS, V24, P457, DOI 10.1097/QAD.0b013e328332828d; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Hamlyn E, 2010, CURR OPIN HIV AIDS, V5, P283, DOI 10.1097/COH.0b013e32833a6b11; Helleberg M, 2012, INFECTION, V40, P627, DOI 10.1007/s15010-012-0293-y; Helleberg M, 2012, SCAND J INFECT DIS, V44, P282, DOI 10.3109/00365548.2011.626440; Jensen-Fangel S, 2002, CLIN INFECT DIS, V35, P1541, DOI 10.1086/344769; Josephson F, 2009, SCAND J INFECT DIS, V41, P788, DOI 10.3109/00365540903214322; Laffoon B., 2011, Morbidity and Mortality Weekly Report, V60, P93; Larsen MV, 2010, SCAND J INFECT DIS, V42, P917, DOI 10.3109/00365548.2010.511258; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; Mayer KH, 2011, CLIN INFECT DIS, V52, pS205, DOI 10.1093/cid/ciq043; MULTINGHAM D, 2013, J AQUIR IMMUNE DEFIC, V63, P112, DOI DOI 10.1097/QAI.0B013E3182894555.PUBMED:23392459; Obel N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022698; Obel N, 2009, INT J EPIDEMIOL, V38, P1202, DOI 10.1093/ije/dyn192; PIOT P, 2013, NEW ENGL J MED, DOI DOI 10.1056/NEJMRA1201533.PUBMED:23738546; Presanis AM, 2010, AIDS, V24, P2849, DOI 10.1097/QAD.0b013e32834021ed; Sarmento-Castro Rui, 2011, Curr Opin HIV AIDS, V6 Suppl 1, pS12, DOI 10.1097/01.COH.0000410240.65647.23; Wilson DP, 2009, SEX HEALTH, V6, P19, DOI 10.1071/SH08081	27	39	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e72257	10.1371/journal.pone.0072257	http://dx.doi.org/10.1371/journal.pone.0072257			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967292	Green Published, Green Submitted, gold			2022-12-25	WOS:000323378000088
J	Hong, JS; Zhang, ZH; Lv, WL; Zhang, M; Chen, C; Yang, SM; Li, S; Zhang, LR; Han, DP; Zhang, WJ				Hong, Jinsheng; Zhang, Zhenhuan; Lv, Wenlong; Zhang, Mei; Chen, Chun; Yang, Shanmin; Li, Shan; Zhang, Lurong; Han, Deping; Zhang, Weijian			Icaritin Synergistically Enhances the Radiosensitivity of 4T1 Breast Cancer Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; ESTROGEN-RECEPTOR; SOLID TUMORS; IN-VITRO; RADIATION; GROWTH; PROLIFERATION; INHIBITION; MECHANISMS; FLAVONOIDS	Icaritin (ICT) is a hydrolytic form of icariin isolated from plants of the genus Epimedium. This study was to investigate the radiosensitization effect of icaritin and its possible underlying mechanism using murine 4T1 breast cancer cells. The combination of Icaritin at 3 mu M or 6 mu M with 6 or 8 Gy of ionizing radiation (IR) in the clonogenic assay yielded an ER (enhancement ratio) of 1.18 or 1.28, CI (combination index) of 0.38 or 0.19 and DRI (dose reducing index) of 2.51 or 5.07, respectively. These strongly suggest that Icaritin exerted a synergistic killing (?) effect with radiation on the tumor cells. This effect might relate with bioactivities of ICT: 1) exert an anti-proliferative effect in a dose- and time-dependent manner, which is different from IR killing effect but likely work together with the IR effect; 2) suppress the IR-induced activation of two survival paths, ERK1/2 and AKT; 3) induce the G2/M blockage, enhancing IR killing effect; and 4) synergize with IR to enhance cell apoptosis. In addition, ICT suppressed angiogenesis in chick embryo chorioallantoic membrane (CAM) assay. Taken together, ICT is a new radiosensitizer and can enhance anti-cancer effect of IR or other therapies.	[Hong, Jinsheng; Lv, Wenlong; Li, Shan; Zhang, Weijian] Fujian Med Univ, Dept Radiat Oncol, Affiliated Hosp 1, Fuzhou, Fujian, Peoples R China; [Zhang, Zhenhuan; Zhang, Mei; Yang, Shanmin; Zhang, Lurong] UF Shands Canc Ctr, Dept Radiat Oncol, Gainesville, FL USA; [Hong, Jinsheng; Han, Deping; Zhang, Weijian] Fujian Med Univ, Div Radiat Biol, Affiliated Hosp 1, Cent Res Lab, Fuzhou, Fujian, Peoples R China; [Chen, Chun] Fujian Med Univ, Sch Pharm, Dept Pharmacol, Fuzhou, Fujian, Peoples R China	Fujian Medical University; State University System of Florida; University of Florida; Fujian Medical University; Fujian Medical University	Han, DP (corresponding author), Fujian Med Univ, Div Radiat Biol, Affiliated Hosp 1, Cent Res Lab, Fuzhou, Fujian, Peoples R China.	hdp20012004@163.com; zwj9090@126.com						Bartelink H, 2007, J CLIN ONCOL, V25, P3259, DOI 10.1200/JCO.2007.11.4991; Caron RW, 2005, CELL CYCLE, V4, P456, DOI 10.4161/cc.4.3.1249; Chen MF, 2010, AMINO ACIDS, V38, P1505, DOI 10.1007/s00726-009-0366-0; Chen Y, 2008, PHARM RES-DORDR, V25, P2190, DOI 10.1007/s11095-008-9602-7; Frings PWH, 2011, BREAST CANCER RES TR, V130, P773, DOI 10.1007/s10549-011-1355-z; Guo YM, 2011, EUR J PHARMACOL, V658, P114, DOI 10.1016/j.ejphar.2011.02.005; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; He J, 2010, PLANTA MED, V76, P1834, DOI 10.1055/s-0030-1250042; Hooning MJ, 2007, JNCI-J NATL CANCER I, V99, P365, DOI 10.1093/jnci/djk064; Huang H, 2007, J SEP SCI, V30, P3207, DOI 10.1002/jssc.200700262; Huang X, 2007, EUR J PHARMACOL, V564, P26, DOI 10.1016/j.ejphar.2007.02.039; King TC, 1999, SEMIN RADIAT ONCOL, V9, P4; Larici AR, 2011, RADIOGRAPHICS, V31, P771, DOI 10.1148/rg.313105096; Li J, 2011, J ETHNOPHARMACOL, V137, P714, DOI 10.1016/j.jep.2011.06.030; Lobrich M, 2007, NAT REV CANCER, V7, P861, DOI 10.1038/nrc2248; Ning SC, 1998, INT J RADIAT ONCOL, V40, P177, DOI 10.1016/S0360-3016(97)00561-0; Ohri N, 2012, INT J RADIAT ONCOL, V83, P385, DOI 10.1016/j.ijrobp.2011.06.1990; Shen P, 2007, PHYTOCHEMISTRY, V68, P1448, DOI 10.1016/j.phytochem.2007.03.001; Tao K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-228; Tong JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016781; van Werkhoven E, 2011, RADIOTHER ONCOL, V100, P101, DOI 10.1016/j.radonc.2011.07.004; Wang W, 2007, CLIN CANCER RES, V13, P4891, DOI 10.1158/1078-0432.CCR-07-0416; Wang Z, 2007, NEUROSCIENCE, V145, P911, DOI 10.1016/j.neuroscience.2006.12.059; Wang ZQ, 2009, CHEM-BIOL INTERACT, V179, P375, DOI 10.1016/j.cbi.2008.12.007; Wang ZQ, 2004, EUR J PHARMACOL, V504, P147, DOI 10.1016/j.ejphar.2004.10.002; Wo YB, 2008, J CELL BIOCHEM, V103, P1536, DOI 10.1002/jcb.21541; Wu H, 2003, PROG DRUG RES, V60, P1; Yang SM, 2003, MOL CANCER THER, V2, P65; Zhang G, 2009, BONE, V44, P345, DOI 10.1016/j.bone.2008.10.035; Zhu Dan-yan, 2007, Zhejiang Da Xue Xue Bao Yi Xue Ban, V36, P217; Zhu JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023720; Zviahintseva T V, 1998, Fiziol Zh, V44, P106	32	31	33	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71347	10.1371/journal.pone.0071347	http://dx.doi.org/10.1371/journal.pone.0071347			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977023	Green Submitted, Green Published, gold			2022-12-25	WOS:000323378000045
J	Zamarbide, M; Martinez-Pinilla, E; Ricobaraza, A; Aragon, T; Franco, R; Perez-Mediavilla, A				Zamarbide, Marta; Martinez-Pinilla, Eva; Ricobaraza, Ana; Aragon, Tomas; Franco, Rafael; Perez-Mediavilla, Alberto			Phenyl Acyl Acids Attenuate the Unfolded Protein Response in Tunicamycin-Treated Neuroblastoma Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ORAL SODIUM PHENYLBUTYRATE; DISEASE MOUSE MODEL; ALZHEIMERS-DISEASE; ER STRESS; HISTONE ACETYLATION; CLINICAL-TRIAL; 4-PHENYLBUTYRATE; APOPTOSIS; THERAPY	Understanding how neural cells handle proteostasis stress in the endoplasmic reticulum (ER) is important to decipher the mechanisms that underlie the cell death associated with neurodegenerative diseases and to design appropriate therapeutic tools. Here we have compared the sensitivity of a human neuroblastoma cell line (SH-SY5H) to the ER stress caused by an inhibitor of protein glycosylation with that observed in human embryonic kidney (HEK-293T) cells. In response to stress, SH-SY5H cells increase the expression of mRNA encoding downstream effectors of ER stress sensors and transcription factors related to the unfolded protein response (the spliced X-box binding protein 1, CCAAT-enhancer-binding protein homologous protein, endoplasmic reticulum-localized DnaJ homologue 4 and asparagine synthetase). Tunicamycin-induced death of SH-SY5H cells was prevented by terminal aromatic substituted butyric or valeric acids, in association with a decrease in the mRNA expression of stress-related factors, and in the accumulation of the ATF4 protein. Interestingly, this decrease in ATF4 protein occurs without modifying the phosphorylation of the translation initiation factor eIF2 alpha. Together, these results show that when short chain phenyl acyl acids alleviate ER stress in SH-SY5H cells their survival is enhanced.	[Zamarbide, Marta; Martinez-Pinilla, Eva; Ricobaraza, Ana; Franco, Rafael; Perez-Mediavilla, Alberto] Univ Navarra, Ctr Appl Med Res CIMA, Div Neurosci, Cell & Mol Neuropharmacol Lab, E-31080 Pamplona, Spain; [Perez-Mediavilla, Alberto] Univ Navarra, Dept Biochem & Genet, E-31080 Pamplona, Spain; [Aragon, Tomas] Univ Navarra, Ctr Appl Med Res CIMA, Gene Therapy Div, E-31080 Pamplona, Spain; [Franco, Rafael] Univ Barcelona, Dept Biochem & Mol Biol, Barcelona, Spain; [Ricobaraza, Ana] ESPCI ParisTech, ESPCI CNRS UMR 7637, Neurobiol Lab, Paris, France	University of Navarra; University of Navarra; University of Navarra; University of Barcelona; UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI)	Perez-Mediavilla, A (corresponding author), Univ Navarra, Ctr Appl Med Res CIMA, Div Neurosci, Cell & Mol Neuropharmacol Lab, E-31080 Pamplona, Spain.	lamediav@unav.es	Aragon, Tomas/ABH-4616-2020; Martínez-Pinilla, Eva/C-7907-2013; Franco, Rafael/C-3694-2015; Perez-Mediavilla, Alberto/A-5246-2011; Zamarbide, Marta/AAG-8876-2019; Ricobaraza, Ana L/Q-8835-2018	Aragon, Tomas/0000-0002-1700-2729; Martínez-Pinilla, Eva/0000-0002-0572-0926; Franco, Rafael/0000-0003-2549-4919; Perez-Mediavilla, Alberto/0000-0003-1926-0972; Ricobaraza, Ana L/0000-0001-7587-7657; Zamarbide, Marta/0000-0002-4449-1345	Foundation for Applied Medical Research (UTE project FIMA), Spain	Foundation for Applied Medical Research (UTE project FIMA), Spain	This study was supported by the Foundation for Applied Medical Research (UTE project FIMA), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon T, 2009, NATURE, V457, P736, DOI 10.1038/nature07641; BIEDLER JL, 1978, CANCER RES, V38, P3751; BRUSILOW SW, 1991, PEDIATR RES, V29, P147, DOI 10.1203/00006450-199102000-00009; Camacho LH, 2007, INVEST NEW DRUG, V25, P131, DOI 10.1007/s10637-006-9017-4; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLLINS AF, 1995, BLOOD, V85, P43, DOI 10.1182/blood.V85.1.43.bloodjournal85143; Cuadrado-Tejedor M, 2011, CURR MED CHEM, V18, P5545, DOI 10.2174/092986711798347315; Cudkowicz ME, 2009, AMYOTROPH LATERAL SC, V10, P99, DOI 10.1080/17482960802320487; Dash PK, 2009, NEUROSCIENCE, V163, P1, DOI 10.1016/j.neuroscience.2009.06.028; DOVER GJ, 1994, BLOOD, V84, P339; Fontan-Lozano A, 2008, MOL CELL NEUROSCI, V39, P193, DOI 10.1016/j.mcn.2008.06.009; Francis YI, 2009, J ALZHEIMERS DIS, V18, P131, DOI 10.3233/JAD-2009-1134; Gardian G, 2005, J BIOL CHEM, V280, P556, DOI 10.1074/jbc.M410210200; Gjymishka A, 2009, BIOCHEM J, V417, P695, DOI 10.1042/BJ20081706; Glabe CG, 2006, NEUROLOGY, V66, pS74, DOI 10.1212/01.wnl.0000192103.24796.42; Govindarajan N, 2011, J ALZHEIMERS DIS, V26, P187, DOI 10.3233/JAD-2011-110080; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; He Y, 2010, GENE EXPRESSION, V15, P13, DOI 10.3727/105221610X12819686555051; JAMES MO, 1972, PROC R SOC SER B-BIO, V182, P25, DOI 10.1098/rspb.1972.0064; Kilgore M, 2010, NEUROPSYCHOPHARMACOL, V35, P870, DOI 10.1038/npp.2009.197; KIM YK, 1987, J CELL PHYSIOL, V133, P553, DOI 10.1002/jcp.1041330317; Kogel D, 2012, NEUROBIOL AGING, V33, P2200, DOI 10.1016/j.neurobiolaging.2011.06.012; Li XQ, 2013, BIOCHEMISTRY-MOSCOW+, V78, P102, DOI 10.1134/S0006297913010136; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Mimori S, 2012, BIOL PHARM BULL, V35, P84, DOI 10.1248/bpb.35.84; Naidoo N, 2009, REV NEUROSCIENCE, V20, P23; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Okada T, 2002, BIOCHEM J, V366, P585, DOI 10.1042/BJ20020391; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Ricobaraza A, 2012, HIPPOCAMPUS, V22, P1040, DOI 10.1002/hipo.20883; Ricobaraza A, 2009, NEUROPSYCHOPHARMACOL, V34, P1721, DOI 10.1038/npp.2008.229; Wiley JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009135; Wirth Brunhilde, 2006, Semin Pediatr Neurol, V13, P121, DOI 10.1016/j.spen.2006.06.008; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Zeitlin PL, 2002, MOL THER, V6, P119, DOI 10.1006/mthe.2002.0639; Zhou WB, 2011, J BIOL CHEM, V286, P14941, DOI 10.1074/jbc.M110.211029	37	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71082	10.1371/journal.pone.0071082	http://dx.doi.org/10.1371/journal.pone.0071082			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23976981	Green Published, Green Submitted, gold			2022-12-25	WOS:000323378000031
J	Greig, JE; du Cros, PA; Mills, C; Ugwoeruchukwu, W; Etsetowaghan, A; Grillo, A; Tayo-Adetoro, A; Omiyale, K; Spelman, T; O'Brien, DP				Greig, Jane E.; du Cros, Philipp A.; Mills, Clair; Ugwoeruchukwu, Wilfred; Etsetowaghan, Andrew; Grillo, Adetola; Tayo-Adetoro, Adetoro; Omiyale, Kunle; Spelman, Tim; O'Brien, Daniel P.			Predictors of Raised Viral Load during Antiretroviral Therapy in Patients with and without Prior Antiretroviral Use: A Cross-Sectional Study	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; SUB-SAHARAN AFRICA; SOUTH-AFRICA; TREATMENT INTERRUPTIONS; DRUG-RESISTANCE; VIROLOGICAL FAILURE; TREATMENT PROGRAM; ADHERENCE; KHAYELITSHA; EXPERIENCE	Objectives: In Lagos, Nigeria, Medecins Sans Frontieres (MSF) and the Ministry of Health (MoH) commenced free antiretroviral treatment (ART) in a hospital-based clinic. We performed a cross-sectional study to compare factors associated with raised viral load between patients with ("experienced") and without ("naive") prior antiretroviral (ARV) exposure at commencement of ART at the clinic. We also examined factors influencing ARV adherence in experienced patients prior to clinic entry. Methods: We included adult patients receiving ART from MSF who answered a questionnaire about previous antiretroviral use. Multivariate logistic regression was used to estimate odds ratios (OR) for raised viral load (>= 1000 copies/mL). Results: 1246 (96%) patients answered: 1075 (86%) reported no, and 171 (14%) some, prior ARV exposure. ARV-naive patients were more immunosuppressed at baseline: 65% vs 37% (p<0.001) had CD4<200; 17% vs 9% (p=0.013) were WHO stage 4. Proportionately more experienced than naive patients had raised viral loads (20% vs 9%, p<0.001) on ART in the MSF/MoH clinic. Raised viral load was associated with prior ARV experience (adjusted OR=3.74, 95% CI 2.09-6.70, p<0.001) and complete interruption of current ART (adjusted OR=3.71, 95% CI 2.06-6.68, p<0.001). Higher CD4 at time of VL and a higher self-rated score of recent adherence were associated with lower OR of a raised viral load. Among experienced patients who missed pills before joining MSF/MoH, most common reasons were because ARVS were not affordable (58%) or available (33%), with raised viral load associated with being unsure how to take them (OR=3.16, 95% CI 1.10-9.12, p=0.033). Conclusions: Patients previously exposed to ARVs had increased OR of raised viral load. The cost and availability of ARVs were common reasons for missing ARVs before joining the MSF/MoH clinic, and inadequate patient knowledge was associated with raised viral load.	[Greig, Jane E.; du Cros, Philipp A.] Medecins Sans Frontieres, Manson Unit, London, England; [Mills, Clair; O'Brien, Daniel P.] Medecins Sans Frontieres, Dept Publ Hlth, Amsterdam, Netherlands; [Ugwoeruchukwu, Wilfred; Etsetowaghan, Andrew; Grillo, Adetola; Tayo-Adetoro, Adetoro; Omiyale, Kunle] Medecins Sans Frontieres, Lagos, Nigeria; [Spelman, Tim] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia; [O'Brien, Daniel P.] Univ Melbourne, Royal Melbourne Hosp, Dept Med & Infect Dis, Melbourne, Vic 3050, Australia	Doctors Without Borders; Doctors Without Borders; Burnet Institute; Royal Melbourne Hospital; University of Melbourne	Greig, JE (corresponding author), Medecins Sans Frontieres, Manson Unit, London, England.	jane.greig@london.msf.org	O'Brien, Daniel/ABE-9658-2020	O'Brien, Daniel/0000-0001-5418-3330; du Cros, Philipp/0000-0002-3599-029X; Greig, Jane/0000-0003-2732-0023	M�decins Sans Fronti�res [OCA_pilot_00_Greig, OCA_ERB_009_12_Greig] Funding Source: researchfish	M�decins Sans Fronti�res		Adams J, 2010, ANN PHARMACOTHER, V44, P157, DOI 10.1345/aph.1M359; Amberbir A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-265; Anderson J, 2008, AIDS, V22, P349, DOI 10.1097/QAD.0b013e3282f4709a; Bangsberg DR, 2000, AIDS, V14, P357, DOI 10.1097/00002030-200003100-00008; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Burnham GM, 2004, B WORLD HEALTH ORGAN, V82, P187; Chung MH, 2009, CURR HIV RES, V7, P441, DOI 10.2174/157016209788680552; Coetzee D, 2004, AIDS, V18, pS27, DOI 10.1097/00002030-200406003-00006; Datay MI, 2010, JAIDS-J ACQ IMM DEF, V54, P489, DOI 10.1097/QAI.0b013e3181d91788; El-Khatib Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017518; El-Khatib Z, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-88; El-Khatib Z, 2010, AIDS, V24, P1679, DOI 10.1097/QAD.0b013e32833a097b; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Elema Riekje, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P60, DOI 10.1177/1545109709331472; Fielding KL, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-93; Ford N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010460; Garcia R, 2006, AIDS RES HUM RETROV, V22, P1248, DOI 10.1089/aid.2006.22.1248; Hamers RL, 2012, LANCET INFECT DIS, V12, P307, DOI 10.1016/S1473-3099(11)70255-9; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Kambugu A, 2012, LANCET INFECT DIS, V12, P261, DOI 10.1016/S1473-3099(11)70280-8; Keiser O, 2010, TROP MED INT HEALTH, V15, P251, DOI 10.1111/j.1365-3156.2009.02445.x; Martinez-Picado J, 2002, AIDS, V16, P895, DOI 10.1097/00002030-200204120-00009; Merten S, 2010, TROP MED INT HEALTH, V15, P16, DOI 10.1111/j.1365-3156.2010.02510.x; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Oyugi JH, 2004, JAIDS-J ACQ IMM DEF, V36, P1100, DOI 10.1097/00126334-200408150-00014; Parienti JJ, 2004, CLIN INFECT DIS, V38, P1311, DOI 10.1086/383572; Ramadhani HO, 2007, CLIN INFECT DIS, V45, P1492, DOI 10.1086/522991; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Segeral O, 2011, AIDS RES HUM RETROV, V27, P597, DOI [10.1089/AID.2010.0125, 10.1089/aid.2010.0125]; Stringer JSA, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000233; van Sighem A, 2008, JAIDS-J ACQ IMM DEF, V48, P104, DOI 10.1097/QAI.0b013e31816a1d4f; Weiser S, 2003, JAIDS-J ACQ IMM DEF, V34, P281, DOI 10.1097/00126334-200311010-00004; WHO, 2010, ANT THER HIV INF AD; World Health Organisation, 2006, ANT THER AD AD RES L	37	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71407	10.1371/journal.pone.0071407	http://dx.doi.org/10.1371/journal.pone.0071407			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967207	Green Published, gold, Green Submitted			2022-12-25	WOS:000323221500082
J	Hall, RJ; Leblanc-Maridor, M; Wang, J; Ren, XY; Moore, NE; Brooks, CR; Peacey, M; Douwes, J; McLean, DJ				Hall, Richard J.; Leblanc-Maridor, Mily; Wang, Jing; Ren, Xiaoyun; Moore, Nicole E.; Brooks, Collin R.; Peacey, Matthew; Douwes, Jeroen; McLean, David J.			Metagenomic Detection of Viruses in Aerosol Samples from Workers in Animal Slaughterhouses	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; CANCER INCIDENCE; CUTANEOUS WARTS; MEAT INDUSTRY; LUNG-CANCER; MERKEL CELL; WU; KI; MORTALITY; DNA	Published studies have shown that workers in animal slaughterhouses are at a higher risk of lung cancers as compared to the general population. No specific causal agents have been identified, and exposures to several chemicals have been examined and found to be unrelated. Evidence suggests a biological aetiology as the risk is highest for workers who are exposed to live animals or to biological material containing animal faeces, urine or blood. To investigate possible biological exposures in animal slaughterhouses, we used a metagenomic approach to characterise the profile of organisms present within an aerosol sample. An assessment of aerosol exposures for individual workers was achieved by the collection of personal samples that represent the inhalable fraction of dust/bioaerosol in workplace air in both cattle and sheep slaughterhouses. Two sets of nine personal aerosol samples were pooled for the cattle processing and sheep processing areas respectively, with a total of 332,677,346 sequence reads and 250,144,492 sequence reads of 85 bp in length produced for each. Eukaryotic genome sequence was found in both sampling locations, and bovine, ovine and human sequences were common. Sequences from WU polyomavirus and human papillomavirus 120 were detected in the metagenomic dataset from the cattle processing area, and these sequences were confirmed as being present in the original personal aerosol samples. This study presents the first metagenomic description of personal aerosol exposure and this methodology could be applied to a variety of environments. Also, the detection of two candidate viruses warrants further investigation in the setting of occupational exposures in animal slaughterhouses.	[Hall, Richard J.; Wang, Jing; Ren, Xiaoyun; Moore, Nicole E.; Peacey, Matthew] Natl Ctr Biosecur & Infect Dis, Inst Environm Sci & Res, Upper Hutt, New Zealand; [Leblanc-Maridor, Mily; Brooks, Collin R.; Douwes, Jeroen; McLean, David J.] Massey Univ, Ctr Publ Hlth Res, Wellington, New Zealand	Institute of Environmental Science & Research (ESR) - New Zealand; Massey University	Hall, RJ (corresponding author), Natl Ctr Biosecur & Infect Dis, Inst Environm Sci & Res, Upper Hutt, New Zealand.	richard.hall@esr.cri.nz	McLean, David J/F-3686-2015	McLean, David J/0000-0001-7147-2003; Peacey, Matthew/0000-0002-4312-8085; Brooks, Collin/0000-0002-3947-2246; Moore, Nicole/0000-0001-9826-7392; Hall, Richard/0000-0002-9879-9476; Douwes, Jeroen/0000-0003-3599-4036; Ren, Xiaoyun/0000-0002-5163-9715	Health Research Council of New Zealand	Health Research Council of New Zealand(Health Research Council of New Zealand)	The Centre for Public Health Research at Massey University is supported by a Programme Grant from the Health Research Council of New Zealand. This study was funded by a grant from the Health Research Council of New Zealand (http://www.hrc.govt.nz/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baydar DE, 2013, UROLOGY, V81, DOI 10.1016/j.urology.2012.09.009; Benschop J, 2009, NEW ZEAL MED J, V122, P39; Bethwaite P, 2001, CANCER CAUSE CONTROL, V12, P635, DOI 10.1023/A:1011203809049; Bialasiewicza S, 2007, J CLIN VIROL, V40, P9, DOI 10.1016/j.jcv.2007.07.015; Bjorge T, 2002, BRIT J CANCER, V87, P61, DOI 10.1038/sj.bjc.6600350; Blomberg M, 2012, J INFECT DIS, V205, P1544, DOI 10.1093/infdis/jis228; Bofill-Mas S, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-141; Bottalico D, 2012, J GEN VIROL, V93, P1774, DOI 10.1099/vir.0.041897-0; Bottalico D, 2011, J INFECT DIS, V204, P787, DOI 10.1093/infdis/jir383; Broutian TR, 2011, J CLIN VIROL, V50, P270, DOI 10.1016/j.jcv.2010.12.005; COGGON D, 1989, BRIT J IND MED, V46, P188; Daly DJ, 2002, APPL ENVIRON MICROB, V68, P791, DOI 10.1128/AEM.68.2.791-798.2002; Desai N, 2012, CURR OPIN BIOTECH, V23, P72, DOI 10.1016/j.copbio.2011.12.017; Durusoy R, 2006, INT J CANCER, V118, P2543, DOI 10.1002/ijc.21690; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Fancello L, 2012, VIROLOGY, V434, P162, DOI 10.1016/j.virol.2012.09.025; FERENCZY A, 1990, OBSTET GYNECOL, V75, P114; Fritschi L, 2003, OCCUP ENVIRON MED, V60, DOI 10.1136/oem.60.9.e4; Gallo RC, 2011, BEST PRACT RES CL HA, V24, P559, DOI 10.1016/j.beha.2011.09.012; Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064; Giuliano AR, 2008, VACCINE, V26, pK17, DOI 10.1016/j.vaccine.2008.06.021; GUBERAN E, 1993, BRIT J IND MED, V50, P1008; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; JENNINGS LC, 1984, NEW ZEAL MED J, V97, P473; Jiang MX, 2009, VIROLOGY, V384, P266, DOI 10.1016/j.virol.2008.09.027; JOHNSON ES, 1995, AM J IND MED, V27, P389, DOI 10.1002/ajim.4700270308; KASHIMA HK, 1991, OTOLARYNG HEAD NECK, V104, P191, DOI 10.1177/019459989110400206; KEEFE M, 1994, BRIT J DERMATOL, V130, P9, DOI 10.1111/j.1365-2133.1994.tb06874.x; Kiasari BA, 2008, J CLIN VIROL, V43, P123, DOI 10.1016/j.jcv.2008.05.003; Kijas JW, 2006, ANIM GENET, V37, P171, DOI 10.1111/j.1365-2052.2005.01399.x; Kocjan Bogtjan J., 2005, Infection Genetics and Evolution, V5, P255, DOI 10.1016/j.meegid.2004.05.009; La Rosa G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052391; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lazarevic V, 2009, J MICROBIOL METH, V79, P266, DOI 10.1016/j.mimet.2009.09.012; Lipkin WI, 2010, MICROBIOL MOL BIOL R, V74, P363, DOI 10.1128/MMBR.00007-10; Majd NS, 2012, ASIAN PAC J TROP S2, V2, pS550; Makiyama K, 2013, J VOICE, V27, P230, DOI 10.1016/j.jvoice.2012.10.014; McLean D, 2004, SCAND J WORK ENV HEA, V30, P425, DOI 10.5271/sjweh.831; McLean D, 2004, OCCUP ENVIRON MED, V61, P541, DOI 10.1136/oem.2003.010587; MELCHERS W, 1993, J CLIN MICROBIOL, V31, P2547, DOI 10.1128/JCM.31.9.2547-2549.1993; Metayer C, 1998, AM J EPIDEMIOL, V147, P727, DOI 10.1093/oxfordjournals.aje.a009517; Mohammed MH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S3-S4; Mokili JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058404; Mokili JL, 2012, CURR OPIN VIROL, V2, P63, DOI 10.1016/j.coviro.2011.12.004; Nakamura S, 2011, EXP BIOL MED, V236, P968, DOI 10.1258/ebm.2011.010378; Neske F, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-215; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; Rahkio TM, 1997, J FOOD PROTECT, V60, P38, DOI 10.4315/0362-028X-60.1.38; REIF JS, 1989, SCAND J WORK ENV HEA, V15, P24, DOI 10.5271/sjweh.1886; ROBINSON AJ, 1983, NEW ZEAL MED J, V96, P81; Roh SW, 2010, TRENDS BIOTECHNOL, V28, P291, DOI 10.1016/j.tibtech.2010.03.001; Roschewski M, 2012, BEST PRACT RES CL HA, V25, P75, DOI 10.1016/j.beha.2012.01.005; Rumbold AR, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-243; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; Sharp CP, 2009, J INFECT DIS, V199, P398, DOI 10.1086/596062; Terry J, 2000, Commun Dis Intell, V24, P158; Tringe SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001862; Tselis A, 2012, CURR OPIN RHEUMATOL, V24, P424, DOI 10.1097/BOR.0b013e3283542cf8; Usachev EV, 2012, J ENVIRON MONITOR, V14, P1631, DOI 10.1039/c2em30019b; Weyandt GH, 2011, ARCH DERMATOL RES, V303, P141, DOI 10.1007/s00403-010-1119-3; Whon TW, 2012, J VIROL, V86, P8221, DOI 10.1128/JVI.00293-12; Wilkins D, 2013, ENVIRON MICROBIOL, V15, P1318, DOI 10.1111/1462-2920.12035; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	64	18	18	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e72226	10.1371/journal.pone.0072226	http://dx.doi.org/10.1371/journal.pone.0072226			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967289	Green Published, Green Submitted, gold			2022-12-25	WOS:000323221500125
J	Hwang, H; Yoon, J; Kim, HY; Min, MK; Kim, JA; Choi, EH; Lan, WZ; Bae, YM; Luan, S; Cho, H; Kim, BG				Hwang, Hyunsik; Yoon, Jinyoung; Kim, Hyun Yeong; Min, Myung Ki; Kim, Jin-Ae; Choi, Eun-Hye; Lan, Wenzhi; Bae, Young-Min; Luan, Sheng; Cho, Hana; Kim, Beom-Gi			Unique Features of Two Potassium Channels, OsKAT2 and OsKAT3, Expressed in Rice Guard Cells	PLOS ONE			English	Article							K+ UPTAKE CHANNEL; FUNCTIONAL-CHARACTERIZATION; XENOPUS OOCYTES; ARABIDOPSIS; TRANSPORT; CLONING; YEAST; GENE; KAT1; TRANSFORMATION	Potassium is the most abundant cation and a myriad of transporters regulate K+ homeostasis in plant. Potassium plays a role as a major osmolyte to regulate stomatal movements that control water utility of land plants. Here we report the characterization of two inward rectifying shaker-like potassium channels, OsKAT2 and OsKAT3, expressed in guard cell of rice plants. While OsKAT2 showed typical potassium channel activity, like that of Arabidopsis KAT1, OsKAT3 did not despite high sequence similarity between the two channel proteins. Interestingly, the two potassium channels physically interacted with each other and such interaction negatively regulated the OsKAT2 channel activity in CHO cell system. Furthermore, deletion of the C-terminal domain recovered the channel activity of OsKAT3, suggesting that the C-terminal region was regulatory domain that inhibited channel activity. Two homologous channels with antagonistic interaction has not been previously reported and presents new information for potassium channel regulation in plants, especially in stomatal regulation.	[Hwang, Hyunsik; Yoon, Jinyoung; Kim, Hyun Yeong; Min, Myung Ki; Kim, Jin-Ae; Choi, Eun-Hye; Kim, Beom-Gi] Rural Dev Adm, Natl Acad Agr Sci, Dept Mol Breeding, Suwon, South Korea; [Lan, Wenzhi; Luan, Sheng] Nanjing Univ, Sch Life Sci, NJU NJFU Joint Inst Plant Mol Biol, Nanjing 210008, Jiangsu, Peoples R China; [Bae, Young-Min] Konkuk Univ, Sch Med, Dept Physiol, Choongju, South Korea; [Luan, Sheng] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Cho, Hana] Sungkyunkwan Univ, Sch Med, Dept Physiol, Suwon, South Korea	Rural Development Administration (RDA); Nanjing University; Konkuk University; University of California System; University of California Berkeley; Sungkyunkwan University (SKKU)	Kim, BG (corresponding author), Rural Dev Adm, Natl Acad Agr Sci, Dept Mol Breeding, Suwon, South Korea.	bgkimpeace@gmail.com		Yoon, Jin-Young/0000-0002-5707-3636; Cho, Hana/0000-0002-9394-8671; Bae, Young Min/0000-0002-0635-0787	National Academy of Agricultural Science [PJ008598]; Rural Development Administration, Republic of Korea [PJ009106]; National Academy of Agricultural Science	National Academy of Agricultural Science; Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); National Academy of Agricultural Science	This work was supported by a grant from Research Program for Agricultural Science & Technology Development (Project No. PJ008598) of National Academy of Agricultural Science and by the Woo Jang Chun Special Project (PJ009106) funded by the Rural Development Administration, Republic of Korea. Hyunsik Hwang, Hyun Yeong Kim and Myung Ki Min were supported by Post-doctoral fellowship program of National Academy of Agricultural Science. The funders had no role in study design, data collection and analysis decision to publish or preparation of the manuscript.	ANDERSON JA, 1992, P NATL ACAD SCI USA, V89, P3736, DOI 10.1073/pnas.89.9.3736; Boscari A, 2009, PLANT CELL ENVIRON, V32, P1761, DOI 10.1111/j.1365-3040.2009.02033.x; Buchsenschutz K, 2005, PLANTA, V222, P968, DOI 10.1007/s00425-005-0038-6; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; Cherel I, 2002, PLANT CELL, V14, P1133, DOI 10.1105/tpc.000943; Daram P, 1997, EMBO J, V16, P3455, DOI 10.1093/emboj/16.12.3455; Downey P, 2000, J BIOL CHEM, V275, P39420, DOI 10.1074/jbc.M002962200; Formentin E, 2004, FEBS LETT, V573, P61, DOI 10.1016/j.febslet.2004.07.052; Fuchs I, 2005, PLANTA, V221, P212, DOI 10.1007/s00425-004-1437-9; Gambale F, 2006, J MEMBRANE BIOL, V210, P1, DOI [10.1007/s00232-006-0856-x, 10.1007/S00232-006-0856-X]; Gaymard F, 1996, J BIOL CHEM, V271, P22863, DOI 10.1074/jbc.271.37.22863; Harmon Alice C, 2003, Gravit Space Biol Bull, V16, P83; Hartje S, 2000, PLANTA, V210, P723, DOI 10.1007/s004250050673; Hosy E, 2003, P NATL ACAD SCI USA, V100, P5549, DOI 10.1073/pnas.0733970100; Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kim DH, 2001, PLANT CELL, V13, P287, DOI 10.1105/tpc.13.2.287; Kim H, 2012, J EXP BOT, V63, P1013, DOI 10.1093/jxb/err338; Kwak JM, 2001, PLANT PHYSIOL, V127, P473, DOI 10.1104/pp.010428; Lagarde D, 1996, PLANT J, V9, P195, DOI 10.1046/j.1365-313X.1996.09020195.x; Lebaudy A, 2007, FEBS LETT, V581, P2357, DOI 10.1016/j.febslet.2007.03.058; Lebaudy A, 2010, J BIOL CHEM, V285, P6265, DOI 10.1074/jbc.M109.068445; Lee SC, 2007, P NATL ACAD SCI USA, V104, P15959, DOI 10.1073/pnas.0707912104; NAKAMURA RL, 1995, PLANT PHYSIOL, V109, P371, DOI 10.1104/pp.109.2.371; Obata T, 2007, PLANT PHYSIOL, V144, P1978, DOI 10.1104/pp.107.101154; Philippar K, 2003, J BIOL CHEM, V278, P16973, DOI 10.1074/jbc.M212720200; Pilot G, 2001, J BIOL CHEM, V276, P3215, DOI 10.1074/jbc.M007303200; Pittman JK, 2002, J BIOL CHEM, V277, P26452, DOI 10.1074/jbc.M202563200; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; SCHACHTMAN DP, 1992, SCIENCE, V258, P1654, DOI 10.1126/science.8966547; SCHACHTMAN DP, 1994, NATURE, V370, P655, DOI 10.1038/370655a0; SENTENAC H, 1992, SCIENCE, V256, P663, DOI 10.1126/science.1585180; Su YH, 2005, PLANT CELL, V17, P1532, DOI 10.1105/tpc.104.030551; Szyroki A, 2001, P NATL ACAD SCI USA, V98, P2917, DOI 10.1073/pnas.051616698; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Very AA, 2003, ANNU REV PLANT BIOL, V54, P575, DOI 10.1146/annurev.arplant.54.031902.134831; VERY AA, 1995, PLANT J, V7, P321, DOI 10.1046/j.1365-313X.1995.7020321.x; Yoshida S, 1976, LAB MANUAL PHYSL STU, V83; Zhang Y, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-30; Zimmermann S, 1998, PLANT PHYSIOL, V116, P879, DOI 10.1104/pp.116.3.879	41	34	39	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e72541	10.1371/journal.pone.0072541	http://dx.doi.org/10.1371/journal.pone.0072541			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967316	Green Published, gold, Green Submitted			2022-12-25	WOS:000323115800108
J	Liao, QH; Bai, T; Zhou, L; Vong, S; Guo, JQ; Lv, W; Dong, LB; Xiang, NJ; Li, Z; Huai, Y; Zhou, JF; Li, XD; Chen, RY; Xu, Z; Uyeki, TM; Shu, YL; Yu, H				Liao, Qiaohong; Bai, Tian; Zhou, Lei; Vong, Sirenda; Guo, Junqiao; Lv, Wei; Dong, Libo; Xiang, Nijuan; Li, Zi; Huai, Yang; Zhou, Jianfang; Li, Xiaodan; Chen, Ray Y.; Xu, Zhen; Uyeki, Timothy M.; Shu, Yuelong; Yu, Hongjie			Seroprevalence of Antibodies to Highly Pathogenic Avian Influenza A (H5N1) Virus among Close Contacts Exposed to H5N1 Cases, China, 2005-2008	PLOS ONE			English	Article								To assess the extent of highly pathogenic avian influenza (HPAI) A (H5N1) virus transmission, we conducted sero-epidemiologic studies among close contacts exposed to H5N1 cases in mainland China during 2005-2008. Blood specimens were collected from 87 household members and 332 social contacts of 23 H5N1 index cases for HPAI H5N1 serological testing by modified horse red-blood-cell hemagglutinin inhibition and microneutralization assays. All participants were interviewed with a standardized questionnaire to collect information about the use of personal protective equipment, illness symptoms, exposure to an H5N1 case during the infectious period, and poultry exposures. Two (2.3%) household contacts tested positive for HPAI H5N1 virus antibody, and all social contacts tested negative. Both seropositive cases had prolonged, unprotected, close contact with a different H5N1 index case, including days of bed-care or sleeping together during the index case's infectious period, and did not develop any illness. None of the 419 close contacts used appropriate personal protective equipment including 17% who reported providing bedside care or having physical contact with an H5N1 case for at least 12 hours. Our findings suggest that HPAI H5N1 viruses that circulated among poultry in mainland China from 2005-2008 were not easily transmitted to close contacts of H5N1 cases.	[Liao, Qiaohong; Xu, Zhen; Yu, Hongjie] Chinese Ctr Dis Control & Prevent China CDC, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China; [Bai, Tian; Dong, Libo; Li, Zi; Zhou, Jianfang; Li, Xiaodan; Shu, Yuelong] Natl Hlth & Family Planning Commiss, Natl Inst Viral Dis Control & Prevent Chinese, Chinese Ctr Dis Control & Prevent, Key Lab Med Virol, Beijing, Peoples R China; [Zhou, Lei; Xiang, Nijuan] China CDC, Publ Hlth Emergency Ctr, Beijing, Peoples R China; [Vong, Sirenda] World Hlth Org WHO Beijing Off, Beijing, Peoples R China; [Guo, Junqiao] Liaoning Ctr Dis Control & Prevent, Shenyang, Liaoning, Peoples R China; [Lv, Wei] Guangxi Ctr Dis Control & Prevent, Nanning, Guangxi, Peoples R China; [Huai, Yang] US Ctr Dis Control & Prevent, Int Emerging Infect Program, Beijing, Peoples R China; [Chen, Ray Y.] NIAID, NIH, Bethesda, MD 20892 USA; [Uyeki, Timothy M.] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; World Health Organization; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Centers for Disease Control & Prevention - USA	Shu, YL (corresponding author), Natl Hlth & Family Planning Commiss, Natl Inst Viral Dis Control & Prevent Chinese, Chinese Ctr Dis Control & Prevent, Key Lab Med Virol, Beijing, Peoples R China.	yshu@cnic.org.cn; yuhj@chinacdc.cn	Chen, Ray/GRJ-6736-2022; Chen, Ray/T-5102-2019; Yu, Hongjie/GZK-5351-2022	Chen, Ray/0000-0001-6344-1442	National Institute of Allergy and Infectious Diseases (NIAID); U.S. National Institutes of Health [U19 AI51915]; Ministry of Science and Technology (MOST) of the People's Republic of China [2004BA519A71, 2006BAD06A02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051915] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology (MOST) of the People's Republic of China(Ministry of Science and Technology, China); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grants from the National Institute of Allergy and Infectious Diseases (NIAID), U.S. National Institutes of Health (Comprehensive International Program for Research on AIDS grant U19 AI51915, http://www.niaid.nih.gov/Pages/default.aspx), and from the Ministry of Science and Technology (MOST) of the People's Republic of China (2004BA519A71 and 2006BAD06A02, http://www.most.gov.cn/). The NIAID was involved in the study design, data interpretation, and review and approval of the manuscript. The China MOST had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this study are those of the authors and do not represent the policy of their institutions.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P359; Apisarnthanarak A, 2005, CLIN INFECT DIS, V40, pE16, DOI 10.1086/427034; Buchy P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010864; CALLOW KA, 1976, INFECT IMMUN, V13, P1; Cavailler P, 2010, J CLIN VIROL, V48, P123, DOI 10.1016/j.jcv.2010.02.021; de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; Dejpichai R, 2009, EMERG INFECT DIS, V15, P756, DOI 10.3201/eid1505.080316; Dinh PN, 2006, EMERG INFECT DIS, V12, P1841; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Horby P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033180; Horm SV, 2012, INFLUENZA OTHER RESP, V6, P442, DOI 10.1111/j.1750-2659.2012.00338.x; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Kandun IN, 2008, LANCET, V372, P744, DOI 10.1016/S0140-6736(08)61125-3; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; Katz JM, 1999, J INFECT DIS, V180, P1763, DOI 10.1086/315137; Khuntirat BP, 2011, CLIN INFECT DIS, V53, pE107, DOI 10.1093/cid/cir525; Li YB, 2010, J VIROL, V84, P8389, DOI 10.1128/JVI.00413-10; Liem NT, 2005, EMERG INFECT DIS, V11, P210, DOI 10.3201/eid1102.041075; Lu CT, 2008, INT J ARTIF INTELL T, V17, P1; Neumann G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002932; Neumann G, 2010, J GEN VIROL, V91, P1984, DOI 10.1099/vir.0.020750-0; Oner AF, 2006, NEW ENGL J MED, V355, P2179, DOI 10.1056/NEJMoa060601; Ortiz JR, 2007, EMERG INFECT, V7, P1; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; Schultsz C, 2005, EMERG INFECT DIS, V11, P1158; Schultsz C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007948; Sedyaningsih ER, 2007, J INFECT DIS, V196, P522, DOI 10.1086/519692; Stephenson I, 2004, VIRUS RES, V103, P91, DOI 10.1016/j.virusres.2004.02.019; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; Vong S, 2008, EMERG INFECT DIS, V14, P1303, DOI 10.3201/eid1408.070912; Vong S, 2009, J INFECT DIS, V199, P1744, DOI 10.1086/599208; Wang H, 2008, LANCET, V371, P1427, DOI 10.1016/S0140-6736(08)60493-6; Wang TT, 2012, SCIENCE, V335, P1463, DOI 10.1126/science.1218888; *WHO, 2006, WHO CAS DEF HUM INF; WHO, 2013, CUM NUMB CONF HUM CA; World Health Organization, 2011, MAN LAB DIAGN VIR SU; World Organization for Animal Health, 2012, UPD HIGHL PATH AV IN; Yu HJ, 2006, LANCET, V367, P84, DOI 10.1016/S0140-6736(05)67894-4; Yu HJ, 2007, EMERG INFECT DIS, V13, P1061, DOI 10.3201/eid1307.061557; Yu HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002985; Zhou L, 2009, J INFECT DIS, V199, P1726, DOI 10.1086/599206	45	9	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71765	10.1371/journal.pone.0071765	http://dx.doi.org/10.1371/journal.pone.0071765			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967241	gold, Green Submitted, Green Published			2022-12-25	WOS:000323115800078
J	Yokoi, F; Cheetham, CC; Campbell, SL; Sweatt, JD; Li, YQ				Yokoi, Fumiaki; Cheetham, Chad C.; Campbell, Susan L.; Sweatt, J. David; Li, Yuqing			Pre-Synaptic Release Deficits in a DYT1 Dystonia Mouse Model	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; ONSET DYSTONIA; MOTOR DEFICITS; TORSINA; PROTEIN; GENE; MUTATIONS; CELL; HYPERACTIVITY; ENHANCEMENT	DYT1 early-onset generalized torsion dystonia (DYT1 dystonia) is an inherited movement disorder caused by mutations in one allele of DYT1 (TOR1A), coding for torsinA. The most common mutation is a trinucleotide deletion (Delta GAG), which causes a deletion of a glutamic acid residue (Delta E) in the C-terminal region of torsinA. Although recent studies using cultured cells suggest that torsinA contributes to protein processing in the secretory pathway, endocytosis, and the stability of synaptic proteins, the nature of how this mutation affects synaptic transmission remains unclear. We previously reported that theta-burst-induced long-term potentiation (LTP) in the CA1 region of the hippocampal slice is not altered in Dyt1 Delta GAG heterozygous knock-in (KI) mice. Here, we examined short-term synaptic plasticity and synaptic transmission in the hippocampal slices. Field recordings in the hippocampal Schaffer collaterals (SC) pathway revealed significantly enhanced paired pulse ratios (PPRs) in Dyt1 Delta GAG heterozygous KI mice, suggesting an impaired synaptic vesicle release. Whole-cell recordings from the CA1 neurons showed that Dyt1 Delta GAG heterozygous KI mice exhibited normal miniature excitatory post-synaptic currents (mEPSC), suggesting that action-potential independent spontaneous pre-synaptic release was normal. On the other hand, there was a significant decrease in the frequency, but not amplitude or kinetics, of spontaneous excitatory post-synaptic currents (sEPSC) in Dyt1 Delta GAG heterozygous KI mice, suggesting that the action-potential dependent pre-synaptic release was impaired. Moreover, hippocampal torsinA was significantly reduced in Dyt1 Delta GAG heterozygous KI mice. Although the hippocampal slice model may not represent the neurons directly associated with dystonic symptoms, impaired release of neurotransmitters caused by partial dysfunction of torsinA in other brain regions may contribute to the pathophysiology of DYT1 dystonia.	[Yokoi, Fumiaki; Li, Yuqing] Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA; [Cheetham, Chad C.] Univ Alabama Birmingham, Dept Neurol, Sch Med, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA; [Cheetham, Chad C.; Campbell, Susan L.; Sweatt, J. David] Univ Alabama Birmingham, Sch Med, Dept Neurobiol, Birmingham, AL USA	State University System of Florida; University of Florida; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Li, YQ (corresponding author), Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA.	yuqing.li@neurology.ufl.edu	Li, Yuqing/G-1596-2011; Li, Yuqing/AAR-9383-2021	Li, Yuqing/0000-0003-1211-5529; Li, Yuqing/0000-0003-1211-5529; Sweatt, J. David/0000-0003-3567-485X	Tyler's Hope for a Dystonia Cure, Inc.; National Institutes of Health [NS37409, NS47466, NS47692, NS54246, NS57098, NS65273, NS72872, NS 74423]; Howard Hughes Med-Grad Graduate Fellowship (CCC); Lucille P. Markey Charitable Trust (UIUC); Department of Neurology (UAB); University of Florida Open-Access Publishing Fund; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS047692, P30NS047466, R21NS072872, R03NS074423, P30NS057098, P50NS037409, R01NS054246, P01NS037409, R21NS065273] Funding Source: NIH RePORTER	Tyler's Hope for a Dystonia Cure, Inc.; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Med-Grad Graduate Fellowship (CCC); Lucille P. Markey Charitable Trust (UIUC); Department of Neurology (UAB); University of Florida Open-Access Publishing Fund; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Tyler's Hope for a Dystonia Cure, Inc., National Institutes of Health grants (NS37409, NS47466, NS47692, NS54246, NS57098, NS65273, NS72872, and NS 74423), Howard Hughes Med-Grad Graduate Fellowship (CCC), and startup funds from the Lucille P. Markey Charitable Trust (UIUC) and Department of Neurology (UAB). Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese A, 2013, MOVEMENT DISORD, V28, P863, DOI 10.1002/mds.25475; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breakefield XO, 2008, NAT REV NEUROSCI, V9, P222, DOI 10.1038/nrn2337; Bressman SB, 2000, NEUROLOGY, V54, P1746, DOI 10.1212/WNL.54.9.1746; Brunger AT, 2001, CURR OPIN STRUC BIOL, V11, P163, DOI 10.1016/S0959-440X(00)00186-X; Burdette AJ, 2010, CELL STRESS CHAPERON, V15, P605, DOI 10.1007/s12192-010-0173-2; Caldwell GA, 2003, HUM MOL GENET, V12, P307, DOI 10.1093/hmg/ddg027; Camargos S, 2008, LANCET NEUROL, V7, P207, DOI 10.1016/S1474-4422(08)70022-X; Campbell SL, 2004, NEUROSCIENCE, V127, P625, DOI 10.1016/j.neuroscience.2004.05.030; Cao SS, 2010, DIS MODEL MECH, V3, P386, DOI 10.1242/dmm.003715; Dang MT, 2006, NEUROSCI RES, V56, P470, DOI 10.1016/j.neures.2006.09.005; Dang MT, 2012, BEHAV BRAIN RES, V226, P465, DOI 10.1016/j.bbr.2011.10.002; Dang MT, 2005, EXP NEUROL, V196, P452, DOI 10.1016/j.expneurol.2005.08.025; DeAndrade MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035518; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; Doheny D, 2002, NEUROLOGY, V59, P1244, DOI 10.1212/WNL.59.8.1244; Fahn S, 1988, Adv Neurol, V50, P1; Ferguson GD, 2004, HIPPOCAMPUS, V14, P964, DOI 10.1002/hipo.20013; Fuchs T, 2009, NAT GENET, V41, P286, DOI 10.1038/ng.304; Gengler S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009764; Giles LM, 2008, HUM MOL GENET, V17, P2712, DOI 10.1093/hmg/ddn173; Goodchild RE, 2005, NEURON, V48, P923, DOI 10.1016/j.neuron.2005.11.010; Gordon KL, 2008, NEUROSCIENCE, V157, P588, DOI 10.1016/j.neuroscience.2008.09.028; Granata A, 2008, J BIOL CHEM, V283, P7568, DOI 10.1074/jbc.M704097200; Granata A, 2011, EMBO J, V30, P181, DOI 10.1038/emboj.2010.285; Grundmann K, 2007, NEUROBIOL DIS, V27, P190, DOI 10.1016/j.nbd.2007.04.015; Hanley JG, 2002, NEURON, V34, P53, DOI 10.1016/S0896-6273(02)00638-4; Hewett JW, 2007, P NATL ACAD SCI USA, V104, P7271, DOI 10.1073/pnas.0701185104; Kakazu Y, 2012, SYNAPSE, V66, P807, DOI 10.1002/syn.21571; Kakazu Y, 2012, SYNAPSE, V66, P453, DOI 10.1002/syn.21534; Kandel EC, 2013, PRINCIPLES NEURAL SC, V5th; Klein C, 2002, ANN NEUROL, V52, P675, DOI 10.1002/ana.10358; Leung JC, 2001, NEUROGENETICS, V3, P133, DOI 10.1007/s100480100111; Lovinger DM, 2010, NEUROPHARMACOLOGY, V58, P951, DOI 10.1016/j.neuropharm.2010.01.008; Martella G, 2009, BRAIN, V132, P2336, DOI 10.1093/brain/awp194; Martin JN, 2009, NEUROSCIENCE, V164, P563, DOI 10.1016/j.neuroscience.2009.07.068; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; Muller U, 2009, BRAIN, V132, P2005, DOI 10.1093/brain/awp172; Napolitano F, 2010, NEUROBIOL DIS, V38, P434, DOI 10.1016/j.nbd.2010.03.003; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Pan PY, 2009, NEURON, V61, P412, DOI 10.1016/j.neuron.2008.12.029; Pham P, 2006, NEUROREPORT, V17, P1725, DOI 10.1097/WNR.0b013e3280101220; Ramirez DMO, 2011, CURR OPIN NEUROBIOL, V21, P275, DOI 10.1016/j.conb.2011.01.007; Ritz K, 2009, J NEUROL NEUROSUR PS, V80, P653, DOI 10.1136/jnnp.2008.162099; Tan DP, 2006, P NATL ACAD SCI USA, V103, P5125, DOI 10.1073/pnas.0601043103; Torres GE, 2004, P NATL ACAD SCI USA, V101, P15650, DOI 10.1073/pnas.0308088101; Yokoi F, 2008, J BIOCHEM, V143, P39, DOI 10.1093/jb/mvm191; Yokoi F, 2012, BEHAV BRAIN RES, V230, P389, DOI 10.1016/j.bbr.2012.02.029; Yokoi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024539; Yokoi F, 2010, J BIOCHEM, V148, P459, DOI 10.1093/jb/mvq078; Yokoi F, 2009, NEUROSCI RES, V65, P228, DOI 10.1016/j.neures.2009.07.004; Zhang JM, 2011, CELL, V145, P284, DOI 10.1016/j.cell.2011.03.016; Zhang L, 2011, PLOS ONE, V6, DOI DOI 10.1371/J0URNAL.P0NE.0018357.PUBMED:21479250; Zim B, 2008, J NEUROL NEUROSUR PS, V79, P1327, DOI 10.1136/jnnp.2008.148270	54	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e72491	10.1371/journal.pone.0072491	http://dx.doi.org/10.1371/journal.pone.0072491			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967309	Green Submitted, Green Published, gold			2022-12-25	WOS:000323115800103
J	Garrido, G; Rabasa, A; Garrido, C; Lopez, A; Chao, L; Garcia-Lora, AM; Garrido, F; Fernandez, LE; Sanchez, B				Garrido, G.; Rabasa, A.; Garrido, C.; Lopez, A.; Chao, L.; Garcia-Lora, A. M.; Garrido, F.; Fernandez, L. E.; Sanchez, B.			Preclinical modeling of EGFR-specific antibody resistance: oncogenic and immune-associated escape mechanisms	ONCOGENE			English	Article						EGFR; monoclonal antibodies; resistance; MHC-I alterations	MHC CLASS-I; METASTATIC COLORECTAL-CANCER; COORDINATED DOWN-REGULATION; SQUAMOUS-CELL CARCINOMA; ACQUIRED-RESISTANCE; 1ST-LINE TREATMENT; LUNG-CANCER; TUMOR-CELLS; PHASE-III; CETUXIMAB	To define the molecular basis of secondary resistance to epidermal growth factor receptor (EGFR)-specific antibodies is crucial to increase clinical benefit in patients. The limited access to posttreatment tumor samples constitutes the major barrier to conduct these studies, representing preclinical experimentation as a useful alternative. Anti-EGFR antibody-based therapy has been reported to mediate tumor regression by interrupting oncogenic signals and, more recently, by inducing antitumor immunological responses. However, resistance models have been focused only on tumor escape associated with EGFR blockade, whereas studies describing immune-associated escape mechanisms have not been reported thus far. To address this idea, we modeled resistance induction in D122 metastasis-bearing C57BL/6 mice treated with 7A7 (an anti-murine EGFR antibody). Similarly to patients receiving EGFR-specific antibodies, 7A7 resistance promotion represents an important drawback to successful therapy. Characterization of primary cultures derived from metastasis in 7A7-treated mice revealed a high frequency of tumor variants resistant to in vivo and in vitro antibody treatment. We showed, for the first time, the convergence of alterations in oncogenic and immunological pathways in 7A7-resistant variants. To identify key molecules behind resistance, seven 7A7-resistant variants were screened. HER3 overexpression and PTEN deficiency leading to hyperactivation of protumoral downstream signaling were found in these variants as a consequence of 7A7-mediated EGFR inhibition. Concomitantly, we found a high percentage of resistant variants carrying abnormalities in the constitutive and/or interferon gamma (IFN-gamma)-inducible major histocompatibility complex I (MHC-I) expression. A significant decrease in mRNA levels for MHC-I heavy chains, beta(2)-microglogulin and antigen processing machinery genes as well as transcriptional alterations in IFN-gamma pathway components were identified as the main mechanisms underlying MHC-I expression defects in 7A7-resistant variants. Notably, these defects have not been previously associated with EGFR-specific antibody resistance, providing novel immunological escape mechanisms. This study has strong implications for the development of new combination strategies to overcome anti-EGFR antibodies refractoriness.	[Garrido, G.; Rabasa, A.; Chao, L.; Sanchez, B.] Ctr Mol Immunol, Tumor Immunol Direct, Inst Mol Immunol, Havana 11600, Cuba; [Garrido, C.; Garcia-Lora, A. M.; Garrido, F.] Hosp Univ VirgenNieves, Dept Anal Clin & Inmunol, Granada, Spain; [Garrido, C.; Garrido, F.] Univ Granada, Fac Med, Dept Bioquim Biol Mol & Inmunol 3, Granada, Spain; [Lopez, A.] Ctr Mol Immunol, Syst Biol Direct, Inst Mol Immunol, Havana 11600, Cuba; [Fernandez, L. E.] Ctr Mol Immunol, Innovat Direct, Inst Mol Immunol, Havana 11600, Cuba	University of Granada	Sanchez, B (corresponding author), Ctr Mol Immunol, Tumor Immunol Direct, Inst Mol Immunol, 216 St & 15th Ave,POB 16040, Havana 11600, Cuba.	belinda@cim.sld.cu	Garrido, Cristina/H-5974-2015	Garrido, Cristina/0000-0002-6277-4920; Garcia Lora, Angel Miguel/0000-0002-8248-8235; Garrido Torres-Puchol, Federico/0000-0003-4770-9685; RABASA CAPOTE, AILEM/0000-0002-4250-2725	Cuban Government; Boehringer Ingelheim Fonds; Instituto de Salud Carlos III [CP03/0111, P112/02031, PI 08/1265, PI 11/01022, RETIC RD 06/020]; Junta de Andalucia, Spain [CTS-143, CTS-695, CTS-3952, CVI-4740]; MEC (FPU) [1631]; FPS [CP03/0111, I3]; ISCIII, Spain	Cuban Government; Boehringer Ingelheim Fonds(Boehringer Ingelheim); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Junta de Andalucia, Spain(Junta de AndaluciaEuropean Commission); MEC (FPU)(Spanish Government); FPS; ISCIII, Spain(Instituto de Salud Carlos III)	We thank Isabel Linares and Ignacio Algarra for technical assistance. This work was partially supported by Cuban Government, a grant from Boehringer Ingelheim Fonds and by grants from the Instituto de Salud Carlos III (CP03/0111, P112/02031, PI 08/1265, PI 11/01022, RETIC RD 06/020); Junta de Andalucia (Group CTS-143 and CTS-695, CTS-3952, CVI-4740 grants), Spain. CG was supported by the MEC (FPU, 1631). AMGL was supported by Miguel Servet Contract CP03/0111 and Contract I3 from FPS and ISCIII, Spain.	Abril E, 1998, CANCER IMMUNOL IMMUN, V47, P113, DOI 10.1007/s002620050511; AKIYAMA T, 1991, MOL CELL BIOL, V11, P833, DOI 10.1128/MCB.11.2.833; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Aptsiauri N, 2007, INT REV CYTOL, V256, P139, DOI 10.1016/S0074-7696(07)56005-5; Bianchi F, 2006, P NATL ACAD SCI USA, V103, P18981, DOI 10.1073/pnas.0605821103; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Brand TM, 2011, CANCER BIOL THER, V11, P777, DOI 10.4161/cbt.11.9.15050; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Correale P, 2012, INT J CANCER, V130, P1577, DOI 10.1002/ijc.26181; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Duncan TJ, 2007, CLIN CANCER RES, V13, P4139, DOI 10.1158/1078-0432.CCR-06-2833; EISENBACH L, 1984, INT J CANCER, V34, P567, DOI 10.1002/ijc.2910340421; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Erjala K, 2006, CLIN CANCER RES, V12, P4103, DOI 10.1158/1078-0432.CCR-05-2404; Garcia-Lora A, 2003, INT J CANCER, V106, P521, DOI 10.1002/ijc.11241; Garrido C, 2012, CARCINOGENESIS, V33, P687, DOI 10.1093/carcin/bgr318; Garrido C, 2010, CANCER IMMUNOL IMMUN, V59, P13, DOI 10.1007/s00262-009-0716-5; Garrido F, 1997, IMMUNOL TODAY, V18, P89, DOI 10.1016/S0167-5699(96)10075-X; Garrido F, 2010, INT J CANCER, V127, P249, DOI 10.1002/ijc.25270; Garrido G, 2004, HYBRIDOMA HYBRIDOM, V23, P168, DOI 10.1089/1536859041224280; Garrido G, 2007, CANCER IMMUNOL IMMUN, V56, P1701, DOI 10.1007/s00262-007-0313-4; Garrido G, 2011, J IMMUNOL, V187, P4954, DOI 10.4049/jimmunol.1003477; Groettrup M, 1997, P NATL ACAD SCI USA, V94, P8970, DOI 10.1073/pnas.94.17.8970; Herrmann F, 2004, CANCER RES, V64, P215, DOI 10.1158/0008-5472.CAN-2522-2; Ishizawar RC, 2007, ONCOGENE, V26, P3503, DOI 10.1038/sj.onc.1210138; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kelly-Spratt KS, 2009, ONCOGENE, V28, P3652, DOI 10.1038/onc.2009.226; Kim SM, 2010, CANCER LETT, V296, P150, DOI 10.1016/j.canlet.2010.04.006; Meissner M, 2005, CLIN CANCER RES, V11, P2552, DOI 10.1158/1078-0432.CCR-04-2146; Peeters M, 2010, J CLIN ONCOL, V28, P4706, DOI 10.1200/JCO.2009.27.6055; Perez Rolando, 2011, Cancers (Basel), V3, P2014, DOI 10.3390/cancers3022014; Pollack BP, 2011, CLIN CANCER RES, V17, P4400, DOI 10.1158/1078-0432.CCR-10-3283; PORGADOR A, 1991, INT J CANCER, P54; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Reichert JM, 2012, DRUG DISCOV TODAY, V17, P954, DOI 10.1016/j.drudis.2012.04.006; Romero I, 2012, J PATHOL, V227, P367, DOI 10.1002/path.4029; Romero JM, 2005, INT J CANCER, V113, P605, DOI 10.1002/ijc.20499; Seliger B, 2008, ADV CANCER RES, V101, P249, DOI 10.1016/S0065-230X(08)00407-7; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Srivastava RM, 2013, CLIN CANCER RES, V19, P1858, DOI 10.1158/1078-0432.CCR-12-2426; Talavera A, 2011, MOL IMMUNOL, V48, P1578, DOI 10.1016/j.molimm.2011.03.016; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Wheeler DL, 2008, ONCOGENE, V27, P3944, DOI 10.1038/onc.2008.19; Wheeler DL, 2009, ONCOLOGIST, V14, P667, DOI 10.1634/theoncologist.2009-0009; Xi SC, 2006, JNCI-J NATL CANCER I, V98, P181, DOI 10.1093/jnci/djj020; Yang XM, 2013, MOL THER, V21, P91, DOI 10.1038/mt.2012.184; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309	48	22	22	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 12	2014	33	24					3129	3139		10.1038/onc.2013.288	http://dx.doi.org/10.1038/onc.2013.288			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AK4QU	23975426	Bronze			2022-12-25	WOS:000338410000006
J	Magnifico, S; Saias, L; Deleglise, B; Duplus, E; Kilinc, D; Miquel, MC; Viovy, JL; Brugg, B; Peyrin, JM				Magnifico, Sebastien; Saias, Laure; Deleglise, Berangere; Duplus, Eric; Kilinc, Devrim; Miquel, Marie-Christine; Viovy, Jean-Louis; Brugg, Bernard; Peyrin, Jean-Michel			NAD(+) acts on mitochondrial SirT3 to prevent axonal caspase activation and axonal degeneration	FASEB JOURNAL			English	Article						microfluidic; apoptosis; sirtuin	WALLERIAN DEGENERATION; SIRT3-MEDIATED DEACETYLATION; LYSINE ACETYLATION; SELF-DESTRUCTION; DNA-DAMAGE; IN-VIVO; APOPTOSIS; SYNAPSES; SIRTUINS; WLD(S)	In chronic degenerative syndromes, neuronal death occurs over long periods, during which cells progressively lose their axons and, ultimately, their cell bodies. Although apoptosis is recognized as a key event in neuronal death, the molecular mechanisms involved in CNS axons degeneration are poorly understood. Due to the highly polarized phenotypes of CNS neurons, the different neuronal subcompartments are likely to be targeted by light repetitive and localized aggression. Such locally initiated deleterious signal transduction pathways could theoretically spread through the cytoplasm. However, where axon-degenerative signals initiate, what these early signals are, and how they lead to axon degeneration are unanswered questions that limit our understanding of neurodegenerative diseases and our ability to identify novel therapeutic targets. Using a microfluidic culture device adapted to CNS primary neurons, allowing specific access to the axonal and somatodendritic compartments, we analyzed the molecular pathways involved in axonal degeneration of differentiated neurons. We show here that local application of proapoptotic stimuli on the somatodentritic compartment triggers a dying-back pattern involving caspase-dependent axonal degeneration. Using complementary pharmacological and genetic approaches, we further demonstrate that NAD(+) and grape wine polyphenols prevent axonal apoptosis and act via mitochondrial SirT3 activation in axons.	[Magnifico, Sebastien; Deleglise, Berangere; Duplus, Eric; Kilinc, Devrim; Brugg, Bernard; Peyrin, Jean-Michel] CNRS, Unite Mixte Rech UMR 7102, Paris, France; [Magnifico, Sebastien; Saias, Laure; Deleglise, Berangere; Duplus, Eric; Kilinc, Devrim; Miquel, Marie-Christine; Viovy, Jean-Louis; Brugg, Bernard; Peyrin, Jean-Michel] Univ Paris 06, F-75005 Paris, France; [Saias, Laure; Viovy, Jean-Louis] Inst Curie, CNRS, UMR 168, F-75231 Paris, France; [Miquel, Marie-Christine] Toulouse Univ, CNRS, UMR 5541, Ctr Dev Biol, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Universite Federale Toulouse Midi-Pyrenees (ComUE)	Peyrin, JM (corresponding author), Univ Paris 06, CNRS, UMR 7102, 9 Quai St Bernard,Bat B,6Eme Etage, F-75005 Paris, France.	jean-michel.peyrin@upmc.fr	Kilinc, Devrim/E-8733-2011; Kilinc, Devrim/I-4180-2019; DUPLUS, Eric/F-2969-2013	Kilinc, Devrim/0000-0003-3321-5203; Kilinc, Devrim/0000-0003-3321-5203; Peyrin, Jean-Michel/0000-0002-8705-8672; Peyrin, Jean-Michel/0000-0002-0108-1266; Miquel, Marie-Christine/0000-0002-9332-2572; Viovy, Jean-Louis/0000-0002-8223-4040; DUPLUS, Eric/0000-0003-1954-4836	Agence Nationale de la Recherche (ANR) Neuroscience research grant, ANR Bornaphosphopath, Plan Alzheimer; French Ministere de l'Enseignement Superieur et de la Recherche	Agence Nationale de la Recherche (ANR) Neuroscience research grant, ANR Bornaphosphopath, Plan Alzheimer(French National Research Agency (ANR)); French Ministere de l'Enseignement Superieur et de la Recherche	The authors thank Vincent Setola and Etienne Jacotot for critical reading of the manuscript. This project was funded by the Agence Nationale de la Recherche (ANR) Neuroscience research grant, ANR Bornaphosphopath, Plan Alzheimer. B. D., S. M., and M. S. received Ph.D. fellowships from the French Ministere de l'Enseignement Superieur et de la Recherche. The authors declare no conflicts of interest.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Alvarez S, 2008, EXP NEUROL, V212, P166, DOI 10.1016/j.expneurol.2008.03.022; Arendt T, 2009, ACTA NEUROPATHOL, V118, P167, DOI 10.1007/s00401-009-0536-x; Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Babetto E, 2010, J NEUROSCI, V30, P13291, DOI 10.1523/JNEUROSCI.1189-10.2010; Bao JJ, 2010, J CELL BIOCHEM, V110, P238, DOI 10.1002/jcb.22531; Barnat M, 2010, J NEUROSCI, V30, P7804, DOI 10.1523/JNEUROSCI.0372-10.2010; Barrientos SA, 2011, J NEUROSCI, V31, P966, DOI 10.1523/JNEUROSCI.4065-10.2011; Beirowski B, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-6; Beirowski B, 2009, J NEUROSCI, V29, P653, DOI 10.1523/JNEUROSCI.3814-08.2009; Benn SC, 2004, NAT REV NEUROSCI, V5, P686, DOI 10.1038/nrn1477; Borsello T, 2000, NEUROSCIENCE, V95, P163; Brichese L, 2004, CELL CYCLE, V3, P1312, DOI 10.4161/cc.3.10.1166; Brooks C, 2007, P NATL ACAD SCI USA, V104, P11649, DOI 10.1073/pnas.0703976104; Coleman M, 2011, ADV GENET, V73, P185, DOI 10.1016/B978-0-12-380860-8.00005-7; Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248; Courchesne SL, 2011, J NEUROSCI, V31, P1624, DOI 10.1523/JNEUROSCI.3347-10.2011; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; Eminel S, 2004, J BIOL CHEM, V279, P55385, DOI 10.1074/jbc.M405858200; Feng Y, 2010, PROTEIN CELL, V1, P237, DOI 10.1007/s13238-010-0021-2; Finn JT, 2000, J NEUROSCI, V20, P1333; Fritz KS, 2012, J PROTEOME RES, V11, P1633, DOI 10.1021/pr2008384; Gilley J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000300; Glass JD, 2002, J NEUROL SCI, V196, P9, DOI 10.1016/S0022-510X(02)00013-8; Hafner AV, 2010, AGING-US, V2, P914, DOI 10.18632/aging.100252; Hirschey MD, 2011, COLD SH Q B, V76, P267, DOI 10.1101/sqb.2011.76.010850; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; JACOBSON MD, 1994, EMBO J, V13, P1899, DOI 10.1002/j.1460-2075.1994.tb06459.x; Karbowski M, 2010, ADV EXP MED BIOL, V687, P131; Kharbanda S, 2000, J BIOL CHEM, V275, P322, DOI 10.1074/jbc.275.1.322; Kilinc D, 2011, NEUROTOX RES, V19, P149, DOI 10.1007/s12640-010-9152-8; Kim SH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014731, 10.1371/journal.pone.0026214]; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kuo CT, 2006, NEURON, V51, P283, DOI 10.1016/j.neuron.2006.07.014; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Louneva N, 2008, AM J PATHOL, V173, P1488, DOI 10.2353/ajpath.2008.080434; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Mattson MP, 1998, EXP NEUROL, V153, P35, DOI 10.1006/exnr.1998.6863; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Miller BR, 2009, NAT NEUROSCI, V12, P387, DOI 10.1038/nn.2290; Nakagawa T, 2011, J CELL SCI, V124, P833, DOI 10.1242/jcs.081067; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Park SH, 2011, INT J MOL SCI, V12, P6226, DOI 10.3390/ijms12096226; Paul D, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3569946; Pfister JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004090; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Sasaki Y, 2006, J NEUROSCI, V26, P8484, DOI 10.1523/JNEUROSCI.2320-06.2006; Schoenmann Z, 2010, J NEUROSCI, V30, P6375, DOI 10.1523/JNEUROSCI.0922-10.2010; Song WJ, 2013, NEUROBIOL DIS, V51, P72, DOI 10.1016/j.nbd.2012.07.004; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Wang J, 2009, CELL ADHES MIGR, V3, P77, DOI 10.4161/cam.3.1.7483; Wen YH, 2011, MOL CELL NEUROSCI, V48, P1, DOI 10.1016/j.mcn.2011.05.002; Whitmore AV, 2003, CELL DEATH DIFFER, V10, P260, DOI 10.1038/sj.cdd.4401147; Yahata N, 2009, J NEUROSCI, V29, P6276, DOI 10.1523/JNEUROSCI.4304-08.2009; Yankner BA, 2009, J BIOL CHEM, V284, P4754, DOI 10.1074/jbc.R800018200; Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206; Zhang L, 2007, DRUG RESIST UPDATE, V10, P207, DOI 10.1016/j.drup.2007.08.002	59	32	35	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2013	27	12					4712	4722		10.1096/fj.13-229781	http://dx.doi.org/10.1096/fj.13-229781			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	293UK	23975935				2022-12-25	WOS:000329999000007
J	Zhang, ZH; Zhang, Y; Wang, F; Wang, XH; Xu, YY; Yang, HY; Yu, GH; Yuan, CG; Ma, JY				Zhang, Zhihong; Zhang, Yi; Wang, Fei; Wang, Xinhe; Xu, Yuanyuan; Yang, Huaiyi; Yu, Guohua; Yuan, Chonggang; Ma, Jiyan			De novo generation of infectious prions with bacterially expressed recombinant prion protein	FASEB JOURNAL			English	Article						sPMCA; recombinant PrP; bioassay	MISFOLDING CYCLIC AMPLIFICATION; IN-VITRO; NEURODEGENERATIVE DISEASES; LIPID INTERACTION; MAMMALIAN PRIONS; CONFORMATION; FIBRILLIZATION; AGGREGATION; REPLICATION; MEMBRANES	The prion hypothesis is strongly supported by the fact that prion infectivity and the pathogenic conformer of prion protein (PrP) are simultaneously propagated in vitro by the serial protein misfolding cyclic amplification (sPMCA). However, due to sPMCA's enormous amplification power, whether an infectious prion can be formed de novo with bacterially expressed recombinant PrP (rPrP) remains to be satisfactorily resolved. To address this question, we performed unseeded sPMCA with rPrP in a laboratory that has never been exposed to any native prions. Two types of proteinase K (PK)-resistant and self-perpetuating recombinant PrP conformers (rPrP-res) with PK-resistant cores of 17 or 14 kDa were generated. A bioassay revealed that rPrP-res(17kDa) was highly infectious, causing prion disease in wild-type mice with an average survival time of about 172 d. In contrast, rPrP-res(14kDa) completely failed to induce any disease. Our findings reveal that sPMCA is sufficient to initiate various self-perpetuating PK-resistant rPrP conformers, but not all of them possess in vivo infectivity. Moreover, generating an infectious prion in a prion-free environment establishes that an infectious prion can be formed de novo with bacterially expressed rPrP.	[Zhang, Zhihong; Zhang, Yi; Xu, Yuanyuan; Yu, Guohua; Yuan, Chonggang; Ma, Jiyan] E China Normal Univ, Sch Life Sci, Shanghai Key Lab Brain Funct Genom, Key Lab Brain Funct Genom,Minist Educ, Shanghai 200062, Peoples R China; [Zhang, Yi; Wang, Fei; Wang, Xinhe; Ma, Jiyan] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Yang, Huaiyi] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China	East China Normal University; University System of Ohio; Ohio State University; Chinese Academy of Sciences; Institute of Microbiology, CAS	Ma, JY (corresponding author), Ohio State Univ, Dept Mol & Cellular Biochem, 1645 Neil Ave,Rm 457A Hamilton Hall, Columbus, OH 43210 USA.	ma.131@osu.edu	zhang, zh/GWV-4677-2022	Ma, Jiyan/0000-0001-7150-1898	National Natural Science Foundation of China [31172347, 30871369]; Ministry of Education of China [985]; U.S. National Institutes of Health [R01 NS071035, R01 NS 060729]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071035, R01NS060729] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Dr. Man-Sun Sy (Case Western Reserve University, Cleveland, OH, USA) and Dr. Surachai Supattapone (Dartmouth Medical School, Hanover, NH, USA) for providing reagents used in this study. Financial support for this study was provided by the National Natural Science Foundation of China, projects 31172347 and 30871369; the Ministry of Education of China, project 985; and the U.S. National Institutes of Health, grants R01 NS071035 and R01 NS 060729.	Adler V, 2003, J MOL BIOL, V332, P47, DOI 10.1016/S0022-2836(03)00919-7; Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Aguzzi A, 2009, NATURE, V459, P924, DOI 10.1038/459924a; Barria MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000421; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2005, NAT MED, V11, P982, DOI 10.1038/nm1286; Caughey B, 1997, TRENDS CELL BIOL, V7, P56, DOI 10.1016/S0962-8924(96)10054-4; Closewood L. C., 2009, BIOSAFETY MICROBIOLO, P282; Colby DW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000736; Cosseddu GM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002370; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2012, P NATL ACAD SCI USA, V109, pE1938, DOI 10.1073/pnas.1206999109; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Geoghegan JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000535; Gomes MPB, 2008, J BIOL CHEM, V283, P19616, DOI 10.1074/jbc.M802102200; Gonzalez-Romero D, 2008, FEBS LETT, V582, P3161, DOI 10.1016/j.febslet.2008.08.003; Imamura M, 2011, J VIROL, V85, P2582, DOI 10.1128/JVI.02098-10; Kang HE, 2012, J BIOL CHEM, V287, P37219, DOI 10.1074/jbc.M112.395921; Kazlauskaite J, 2005, BIOCHEM SOC SYMP, V72, P211, DOI 10.1042/bss0720211; Kazlauskaite J, 2003, BIOCHEMISTRY-US, V42, P3295, DOI 10.1021/bi026872q; Kim JI, 2010, J BIOL CHEM, V285, P14083, DOI 10.1074/jbc.C110.113464; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Li RL, 2000, J MOL BIOL, V301, P567, DOI 10.1006/jmbi.2000.3986; Ma JY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002589; Makarava N, 2008, J BIOL CHEM, V283, P15988, DOI 10.1074/jbc.M800562200; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; Morales R, 2012, NAT PROTOC, V7, P1397, DOI 10.1038/nprot.2012.067; Morillas M, 1999, J BIOL CHEM, V274, P36859, DOI 10.1074/jbc.274.52.36859; Parchi P, 2000, P NATL ACAD SCI USA, V97, P10168, DOI 10.1073/pnas.97.18.10168; Polymenidou M, 2012, J EXP MED, V209, P889, DOI 10.1084/jem.20120741; Polymenidou M, 2011, CELL, V147, P498, DOI 10.1016/j.cell.2011.10.011; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Prusiner SB, 2012, SCIENCE, V336, P1511, DOI 10.1126/science.1222951; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Saa P, 2006, SCIENCE, V313, P92, DOI 10.1126/science.1129051; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Soto C, 2012, CELL, V149, P968, DOI 10.1016/j.cell.2012.05.007; Tamguney G, 2008, J GEN VIROL, V89, P1777, DOI 10.1099/vir.0.2008/001255-0; Wang F, 2007, BIOCHEMISTRY-US, V46, P7045, DOI 10.1021/bi700299h; Wang F, 2013, ACTA BIOCH BIOPH SIN, V45, P485, DOI 10.1093/abbs/gmt038; Wang F, 2012, J VIROL, V86, P1874, DOI 10.1128/JVI.06216-11; Wang F, 2011, METHODS, V53, P208, DOI 10.1016/j.ymeth.2010.12.013; Wang F, 2010, BIOCHEMISTRY-US, V49, P8169, DOI 10.1021/bi101146v; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wang XH, 2009, BBA-MOL BASIS DIS, V1792, P555, DOI 10.1016/j.bbadis.2009.02.014; Yin SM, 2007, P NATL ACAD SCI USA, V104, P7546, DOI 10.1073/pnas.0610827104	48	46	46	0	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2013	27	12					4768	4775		10.1096/fj.13-233965	http://dx.doi.org/10.1096/fj.13-233965			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	293UK	23970796	Green Published			2022-12-25	WOS:000329999000012
J	Besprozvannaya, M; Pivorunas, VL; Feldman, Z; Burton, BM				Besprozvannaya, Marina; Pivorunas, Valerie L.; Feldman, Zachary; Burton, Briana M.			SpoIIIE Protein Achieves Directional DNA Translocation through Allosteric Regulation of ATPase Activity by an Accessory Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; ATPases; Chromosomes; DNA-Protein Interaction; Molecular Motors	BACILLUS-SUBTILIS; FTSK-TRANSLOCASE; CHROMOSOME ORIENTATION; CELL-DIVISION; STRANDED-DNA; KOPS; MECHANISM; COLI; SEGREGATION; SPORULATION	Bacterial chromosome segregation utilizes highly conserved directional translocases of the SpoIIIE/FtsK family. These proteins employ an accessory DNA-binding domain () to dictate directionality of DNA transport. It remains unclear how the interaction of with specific recognition sequences coordinates directional DNA translocation. We demonstrate that the domain of SpoIIIE inhibits ATPase activity of the motor domain in the absence of DNA but stimulates ATPase activity through sequence-specific DNA recognition. Furthermore, we observe that communication between subunits is necessary for both regulatory roles. Consistent with these findings, the domain is necessary for robust DNA transport along the length of the chromosome in vivo. Together, our data reveal that directional activation involves allosteric regulation of ATP turnover through coordinated action of domains. Thus, we propose a coordinated stimulation model in which - communication is required to translate DNA sequence information from each to its respective motor domain.	[Besprozvannaya, Marina; Pivorunas, Valerie L.; Feldman, Zachary; Burton, Briana M.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Burton, BM (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.	bburton@mcb.harvard.edu			Massachusetts Life Science Foundation; National Institutes of Health [GM-07598]; National Science Foundation [DGE-1144152, DGE-0946799]	Massachusetts Life Science Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	This work was supported in part by the Massachusetts Life Science Foundation (to B. M. B.).; Supported by National Institutes of Health Training Grant GM-07598 (Molecules Cells and Organisms) and National Science Foundation Graduate Research Fellowship Program Grant DGE-1144152.; Supported by National Science Foundation Graduate Research Fellowship Program Grants DGE-0946799 and DGE-1144152.	Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; Barre FX, 2007, MOL MICROBIOL, V66, P1051, DOI 10.1111/j.1365-2958.2007.05981.x; Bath J, 2000, SCIENCE, V290, P995, DOI 10.1126/science.290.5493.995; Becker EC, 2007, MOL MICROBIOL, V66, P1066, DOI 10.1111/j.1365-2958.2007.05992.x; BERMAN J, 1987, METHOD ENZYMOL, V155, P528; Bigot S, 2005, EMBO J, V24, P3770, DOI 10.1038/sj.emboj.7600835; Bigot S, 2006, NAT STRUCT MOL BIOL, V13, P1026, DOI 10.1038/nsmb1159; Buckstein MH, 2008, J BACTERIOL, V190, P718, DOI 10.1128/JB.01020-07; Burton BM, 2007, CELL, V131, P1301, DOI 10.1016/j.cell.2007.11.009; Cattoni DI, 2013, EMBO REP, V14, P473, DOI 10.1038/embor.2013.39; Graham JE, 2010, P NATL ACAD SCI USA, V107, P20263, DOI 10.1073/pnas.1007518107; Grainge I, 2008, CURR BIOL, V18, pR871, DOI 10.1016/j.cub.2008.07.047; Harwood C. R., 1990, MOL BIOL METHODS BAC, p[393, 432]; Ishikawa T, 2012, J STRUCT BIOL, V179, P229, DOI 10.1016/j.jsb.2012.05.016; Iyer LM, 2004, NUCLEIC ACIDS RES, V32, P5260, DOI 10.1093/nar/gkh828; Lee JY, 2012, P NATL ACAD SCI USA, V109, P6531, DOI 10.1073/pnas.1201613109; Levy O, 2005, P NATL ACAD SCI USA, V102, P17618, DOI 10.1073/pnas.0508932102; Lowe J, 2008, MOL CELL, V31, P498, DOI 10.1016/j.molcel.2008.05.027; Massey TH, 2006, MOL CELL, V23, P457, DOI 10.1016/j.molcel.2006.06.019; Masson P, 2002, BBA-PROTEIN STRUCT M, V1594, P313, DOI 10.1016/S0167-4838(01)00323-5; MORRICAL SW, 1986, BIOCHEMISTRY-US, V25, P1482, DOI 10.1021/bi00355a003; MURAKAMI A, 1991, NUCLEIC ACIDS RES, V19, P4097, DOI 10.1093/nar/19.15.4097; Nolivos S, 2012, NUCLEIC ACIDS RES, V40, P5535, DOI 10.1093/nar/gks171; Pease PJ, 2005, SCIENCE, V307, P586, DOI 10.1126/science.1104885; Ptacin JL, 2008, NAT STRUCT MOL BIOL, V15, P485, DOI 10.1038/nsmb.1412; Ptacin JL, 2006, NAT STRUCT MOL BIOL, V13, P1023, DOI 10.1038/nsmb1157; Saha A, 2002, GENE DEV, V16, P2120, DOI 10.1101/gad.995002; Sambrook J, 1989, MOL CLONING LAB MANU, P174; Sharp MD, 2002, SCIENCE, V295, P137, DOI 10.1126/science.1066274; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Sivanathan V, 2006, NAT STRUCT MOL BIOL, V13, P965, DOI 10.1038/nsmb1158; WILSON GA, 1968, J BACTERIOL, V95, P1439, DOI 10.1128/JB.95.4.1439-1449.1968; Wu LJ, 1998, MOL MICROBIOL, V27, P777, DOI 10.1046/j.1365-2958.1998.00724.x; YOUNGMAN PJ, 1983, P NATL ACAD SCI-BIOL, V80, P2305, DOI 10.1073/pnas.80.8.2305	34	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28962	28974		10.1074/jbc.M113.484055	http://dx.doi.org/10.1074/jbc.M113.484055			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23974211	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000330298800051
J	Arya, MA; Tai, AK; Wooten, EC; Parkin, CD; Kudryavtseva, E; Huggins, GS				Arya, Michelle A.; Tai, Albert K.; Wooten, Eric C.; Parkin, Christopher D.; Kudryavtseva, Elena; Huggins, Gordon S.			Notch Pathway Activation Contributes to Inhibition of C2C12 Myoblast Differentiation by Ethanol	PLOS ONE			English	Article							MUSCLE-CELL-PROLIFERATION; NUTRITIONAL-STATUS; SKELETAL; ALCOHOL; MYOGENESIS; MYOD; EXPRESSION; EVENTS; MODEL	The loss of muscle mass in alcoholic myopathy may reflect alcohol inhibition of myogenic cell differentiation into myotubes. Here, using a high content imaging system we show that ethanol inhibits C2C12 myoblast differentiation by reducing myogenic fusion, creating smaller and less complex myotubes compared with controls. Ethanol administration during C2C12 differentiation reduced MyoD and myogenin expression, and microarray analysis identified ethanol activation of the Notch signaling pathway target genes Hes1 and Hey1. A reporter plasmid regulated by the Hes1 proximal promoter was activated by alcohol treatment in C2C12 cells. Treatment of differentiating C2C12 cells with a gamma secretase inhibitor (GSI) abrogated induction of Hes1. On a morphological level GSI treatment completely rescued myogenic fusion defects and partially restored other myotube parameters in response to alcohol. We conclude that alcohol inhibits C2C12 myoblast differentiation and the inhibition of myogenic fusion is mediated by Notch pathway activation.	[Arya, Michelle A.; Wooten, Eric C.; Parkin, Christopher D.; Kudryavtseva, Elena; Huggins, Gordon S.] Tufts Med Ctr, Mol Cardiol Res Inst, Ctr Translat Gen, Boston, MA USA; [Arya, Michelle A.; Huggins, Gordon S.] Tufts Univ, Sackler Sch Biomed Sci, Genet Program, Boston, MA 02111 USA; [Tai, Albert K.] Tufts Univ, Study Ctr Immunogenet Infect Dis, Boston, MA 02111 USA	Tufts Medical Center; Tufts University; Tufts University	Huggins, GS (corresponding author), Tufts Med Ctr, Mol Cardiol Res Inst, Ctr Translat Gen, Boston, MA USA.	ghuggins@tuftsmedicalcenter.org		Wooten, Eric/0000-0002-8403-8668	National Institutes of Health [R01-AA014140, P30 NS047243]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA014140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the National Institutes of Health (R01-AA014140, G.S.H.) and P30 NS047243 for support of microarray analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657; BERILD D, 1981, LANCET, V2, P363; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Buas MF, 2010, EXP CELL RES, V316, P3028, DOI 10.1016/j.yexcr.2010.05.002; Buas MF, 2010, J BIOL CHEM, V285, P1249, DOI 10.1074/jbc.M109.046441; Buas MF, 2009, J CELL PHYSIOL, V218, P84, DOI 10.1002/jcp.21571; Burattini S, 2004, EUR J HISTOCHEM, V48, P223; Choi MR, 2011, ARCH TOXICOL, V85, P293, DOI 10.1007/s00204-010-0591-z; Chu JL, 2002, J BIOL CHEM, V277, P7587, DOI 10.1074/jbc.M111044200; Cofan M, 2000, ALCOHOL ALCOHOLISM, V35, P134, DOI 10.1093/alcalc/35.2.134; Dahlqvist C, 2003, DEVELOPMENT, V130, P6089, DOI 10.1242/dev.00834; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; ESTRUCH R, 1993, ALCOHOL ALCOHOLISM, V28, P543; Fernandez-Sola J, 2003, HUM PATHOL, V34, P1247, DOI 10.1016/j.humpath.2003.07.017; Fernandez-Sola J, 1998, ALCOHOL CLIN EXP RES, V22, P422, DOI 10.1097/00000374-199804000-00019; Fernandez-Sola J, 2007, ALCOHOL CLIN EXP RES, V31, P1953, DOI 10.1111/j.1530-0277.2007.00530.x; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Garriga J, 2000, ALCOHOL ALCOHOLISM, V35, P236, DOI 10.1093/alcalc/35.3.236; Hong-Brown LQ, 2001, ALCOHOL CLIN EXP RES, V25, P1373; Hong-Brown LQ, 2011, ALCOHOL CLIN EXP RES, V35, P1445, DOI 10.1111/j.1530-0277.2011.01480.x; Imbimbo BP, 2011, CURR TOP MED CHEM, V11, P1555; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; KOPAN R, 1994, DEVELOPMENT, V120, P2385; Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; LINDBLAD B, 1976, JAMA-J AM MED ASSOC, V236, P1600, DOI 10.1001/jama.236.14.1600; Morrow D, 2008, CARDIOVASC RES, V79, P313, DOI 10.1093/cvr/cvn108; Morrow D, 2010, ARTERIOSCL THROM VAS, V30, P2597, DOI 10.1161/ATVBAHA.110.215681; Nicolas JM, 2003, AM J CLIN NUTR, V78, P326, DOI 10.1093/ajcn/78.2.326; Nofziger D, 1999, DEVELOPMENT, V126, P1689; Ponnappa BC, 2000, ALCOHOL RES HEALTH, V24, P93; Porter GA, 2002, J BIOL CHEM, V277, P28942, DOI 10.1074/jbc.M203961200; Preedy Victor R, 2007, Novartis Found Symp, V285, P158; PURI EC, 1980, P NATL ACAD SCI-BIOL, V77, P5297, DOI 10.1073/pnas.77.9.5297; Shawber C, 1996, DEVELOPMENT, V122, P3765; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; SONG SK, 1972, SCIENCE, V175, P327, DOI 10.1126/science.175.4019.327; Sun JX, 2001, J BIOL CHEM, V276, P18591, DOI 10.1074/jbc.M101163200; URBANOMARQUEZ A, 1989, NEW ENGL J MED, V320, P409, DOI 10.1056/NEJM198902163200701; Vasyutina E, 2007, P NATL ACAD SCI USA, V104, P4443, DOI 10.1073/pnas.0610647104; Velica P, 2011, MUSCLE NERVE, V44, P366, DOI 10.1002/mus.22056; Wijnia JW, 2013, ALCOHOL CLIN EXP RES, V37, pE209, DOI 10.1111/j.1530-0277.2012.01902.x; Yoon MS, 2008, J CELL SCI, V121, P282, DOI 10.1242/jcs.022566; Yoshida N, 1998, J CELL SCI, V111, P769	45	14	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71632	10.1371/journal.pone.0071632	http://dx.doi.org/10.1371/journal.pone.0071632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977095	Green Submitted, Green Published, gold			2022-12-25	WOS:000324527300027
J	Kim, JH; Park, HY; Bae, S; Lim, YH; Hong, YC				Kim, Jin Hee; Park, Hye Yin; Bae, Sanghyuk; Lim, Youn-Hee; Hong, Yun-Chul			Diethylhexyl Phthalates Is Associated with Insulin Resistance via Oxidative Stress in the Elderly: A Panel Study	PLOS ONE			English	Article							IN-UTERO EXPOSURE; DI(2-ETHYLHEXYL) PHTHALATE; TEMPORAL VARIABILITY; METABOLIC SYNDROME; NATIONAL-HEALTH; URINE SAMPLES; MISSING DATA; INDOOR AIR; MALE RATS; GLUCOSE	Background: Insulin resistance (IR) is believed to be the underlying mechanism of metabolic syndrome and type 2 diabetes mellitus (DM). Recently, a few studies have demonstrated that phthalates could cause oxidative stress which would contribute to the development of IR. Therefore, we evaluated whether exposure to phthalates affects IR, and oxidative stress is involved in the phthalates-IR pathway. Methods: We recruited 560 elderly participants, and obtained blood and urine samples during repeated medical examinations. For the determination of phthalate exposure, we measured urinary levels of mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP) and mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP) as metabolites of diethylhexyl phthalates (DEHP), and mono-n-butyl phthalate (MnBP) as a metabolite of di-butyl phthalate (DBP). Malondialdehyde (MDA), an oxidative stress biomarker, was also measured in urine samples. We measured serum levels of fasting glucose and insulin, and derived the homeostatic model assessment (HOMA) index to assess IR. A mixed-effect model and penalized regression spline were used to estimate the associations among phthalate metabolites, MDA, and IR. Results: The molar sum of MEHHP and MEOHP (Sigma DEHP) were significantly associated with HOMA (beta = 0.26, P = 0.040), and the association was apparent among participants with a history of DM (beta = 0.88, P = 0.037) and among females (beta = 0.30, P = 0.022). However, the relation between MnBP and HOMA was not found. When we evaluated whether oxidative stress is involved in increases of HOMA by Sigma DEHP, MDA levels were significantly associated with increases of Sigma DEHP (beta = 0.11, P < 0.001) and HOMA (beta = 0.49, P = 0.049). Conclusions: Our study results suggest that exposure to DEHP in the elderly population increases IR, which is related with oxidative stress, and that participants with a history of DM and females are more susceptible to DEHP exposure.	[Kim, Jin Hee; Hong, Yun-Chul] Seoul Natl Univ, Inst Environm Med, Med Res Ctr, Seoul, South Korea; [Kim, Jin Hee; Bae, Sanghyuk; Hong, Yun-Chul] Seoul Natl Univ, Coll Med, Ctr Environm Hlth, Seoul, South Korea; [Park, Hye Yin; Bae, Sanghyuk; Hong, Yun-Chul] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Lim, Youn-Hee] Seoul Natl Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Hong, YC (corresponding author), Seoul Natl Univ, Inst Environm Med, Med Res Ctr, Seoul, South Korea.	ychong1@snu.ac.kr	Hong, Yun-Chul/J-5725-2012; Bae, Sanghyuk/AAQ-6635-2020	Bae, Sanghyuk/0000-0002-4995-6543; Lim, Youn-Hee/0000-0002-1290-5814; KIM, JIN HEE/0000-0003-1204-7079	Ministry of Environment, Republic of Korea	Ministry of Environment, Republic of Korea	This study was supported by the Susceptible Population Research Program (2008-2010) of the Ministry of Environment, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749; ALBRO PW, 1974, J CHROMATOGR, V94, P209, DOI 10.1016/S0021-9673(01)92368-4; Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074; Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309; Brasche S, 2005, INT J HYG ENVIR HEAL, V208, P247, DOI 10.1016/j.ijheh.2005.03.003; Eckardt Kristin, 2008, Archives of Physiology and Biochemistry, V114, P287, DOI [10.1080/13813450802404761, 10.1080/13813450802404761 ]; Eriksson JW, 2007, FEBS LETT, V581, P3734, DOI 10.1016/j.febslet.2007.06.044; Fischer P, 2003, EUR RESPIR J, V21, p34S, DOI 10.1183/09031936.03.00402503; Fisher JS, 2003, HUM REPROD, V18, P1383, DOI 10.1093/humrep/deg273; Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x; Frederiksen H, 2007, MOL NUTR FOOD RES, V51, P899, DOI 10.1002/mnfr.200600243; Frojdo S, 2009, BBA-MOL BASIS DIS, V1792, P83, DOI 10.1016/j.bbadis.2008.10.019; Fromme H, 2004, INDOOR AIR, V14, P188, DOI 10.1111/j.1600-0668.2004.00223.x; Goldstein BJ, 2005, DIABETES, V54, P311, DOI 10.2337/diabetes.54.2.311; Grattagliano I, 2008, J NUTR BIOCHEM, V19, P491, DOI 10.1016/j.jnutbio.2007.06.011; Hauser R, 2005, OCCUP ENVIRON MED, V62, DOI 10.1136/oem.2004.017590; Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212; Healey N, 2009, RADIAT PROT DOSIM, V134, P143, DOI 10.1093/rpd/ncp068; Hoang Khiet C, 2007, J Cardiometab Syndr, V2, P276, DOI 10.1111/j.1559-4564.2007.07491.x; Hong YC, 2009, TOXICOL LETT, V184, P139, DOI 10.1016/j.toxlet.2008.11.001; Hoppin JA, 2004, ENVIRON HEALTH PERSP, V112, P571, DOI 10.1289/ehp.6564; Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515, DOI 10.1289/ehp.02110515; James-Todd T, 2012, ENVIRON HEALTH PERSP, V120, P1307, DOI 10.1289/ehp.1104717; JANERO DR, 1990, FREE RADICAL BIO MED, V9, P515, DOI 10.1016/0891-5849(90)90131-2; Jarfelt K, 2005, REPROD TOXICOL, V19, P505, DOI 10.1016/j.reprotox.2004.11.005; Kim JH, 2012, TOXICOL LETT, V214, P263, DOI 10.1016/j.toxlet.2012.09.006; Kim JH, 2012, ENVIRON HEALTH PERSP, V120, P1378, DOI 10.1289/ehp.1104406; Kimber I, 2010, TOXICOLOGY, V271, P73, DOI 10.1016/j.tox.2010.03.020; Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3; Lamb RE, 2008, INT J CLIN PRACT, V62, P1087, DOI 10.1111/j.1742-1241.2008.01789.x; Lara-Castro C, 2008, ENDOCRIN METAB CLIN, V37, P841, DOI 10.1016/j.ecl.2008.09.002; Latini G, 2006, TOXICOLOGY, V226, P90, DOI 10.1016/j.tox.2006.07.011; Lim S, 2010, ANN NY ACAD SCI, V1201, P166, DOI 10.1111/j.1749-6632.2010.05622.x; Lind PM, 2012, DIABETES CARE, V35, P1519, DOI 10.2337/dc11-2396; Marx J, 2002, SCIENCE, V296, P686, DOI 10.1126/science.296.5568.686; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McKee RH, 2004, REPROD TOXICOL, V18, P1, DOI 10.1016/j.reprotox.2003.09.002; Moore RW, 2001, ENVIRON HEALTH PERSP, V109, P229, DOI 10.2307/3434690; Pereira C, 2006, REGUL TOXICOL PHARM, V45, P169, DOI 10.1016/j.yrtph.2006.04.006; Petersen KF, 2002, AM J CARDIOL, V90, p11G; Preuss R, 2005, J CHROMATOGR B, V816, P269, DOI 10.1016/j.jchromb.2004.11.048; ROBINS JM, 1995, J AM STAT ASSOC, V90, P122, DOI 10.2307/2291135; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Rudel RA, 2003, ENVIRON SCI TECHNOL, V37, P4543, DOI 10.1021/es0264596; Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Silva MJ, 2006, BIOMARKERS, V11, P1, DOI 10.1080/13547500500382868; Silva MJ, 2004, B ENVIRON CONTAM TOX, V72, P1226, DOI 10.1007/s00128-004-0374-4; Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723; Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882; Svensson K, 2011, ENVIRON RES, V111, P792, DOI 10.1016/j.envres.2011.05.015; Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100; Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010; WILLIAMS DT, 1975, J AGR FOOD CHEM, V23, P854, DOI 10.1021/jf60201a047; Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x; Zarich S W, 2006, Minerva Cardioangiol, V54, P195	56	82	88	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71392	10.1371/journal.pone.0071392	http://dx.doi.org/10.1371/journal.pone.0071392			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977034	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700045
J	Kosters, A; Sun, DQ; Wu, H; Tian, F; Felix, JC; Li, W; Karpen, SJ				Kosters, Astrid; Sun, Deqiang; Wu, Hao; Tian, Feng; Felix, Julio C.; Li, Wei; Karpen, Saul J.			Sexually Dimorphic Genome-Wide Binding of Retinoid X Receptor alpha (RXR alpha) Determines Male-Female Differences in the Expression of Hepatic Lipid Processing Genes in Mice	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; GROWTH-HORMONE; MOUSE-LIVER; GENDER-DIFFERENCES; METABOLIC SYNDROME; SEX-DIFFERENCES; NUCLEAR FACTOR-4-ALPHA; NUTRITIONAL REGULATION; MICROARRAY ANALYSIS; INSULIN-RESISTANCE	Many hepatic functions including lipid metabolism, drug metabolism, and inflammatory responses are regulated in a sex-specific manner due to distinct patterns of hepatic gene expression between males and females. Regulation for the majority of these genes is under control of Nuclear Receptors (NRs). Retinoid X Receptor alpha (RXR alpha) is an obligate partner for multiple NRs and considered a master regulator of hepatic gene expression, yet the full extent of RXRa chromatin binding in male and female livers is unclear. ChIP-Seq analysis of RXR alpha and RNA Polymerase2 (Pol2) binding was performed livers of both genders and combined with microarray analysis. Mice were gavage-fed with the RXR ligand LG268 for 5 days (30 mg/kg/day) and RXR alpha-binding and RNA levels were determined by ChIP-qPCR and qPCR, respectively. ChIP-Seq revealed 47,845 (male) and 46,877 (female) RXR alpha binding sites (BS), associated with similar to 12,700 unique genes in livers of both genders, with 91% shared between sexes. RXR alpha-binding showed significant enrichment for 2227 and 1498 unique genes in male and female livers, respectively. Correlating RXR alpha binding strength with Pol2-binding revealed 44 genes being male-dominant and 43 female-dominant, many previously unknown to be sexually-dimorphic. Surprisingly, genes fundamental to lipid metabolism, including Scd1, Fasn, Elovl6, and Pnpla3-implicated in Fatty Liver Disease pathogenesis, were predominant in females. RXR alpha activation using LG268 confirmed RXR alpha-binding was 2-3 fold increased in female livers at multiple newly identified RXR alpha BS including for Pnpla3 and Elovl6, with corresponding similar to 10-fold and similar to 2-fold increases in Pnpla3 and Elovl6 RNA respectively in LG268-treated female livers, supporting a role for RXR alpha regulation of sexually-dimorphic responses for these genes. RXR alpha appears to be one of the most widely distributed transcriptional regulators in mouse liver and is engaged in determining sexually-dimorphic expression of key lipid-processing genes, suggesting novel gender- and gene-specific responses to NR-based treatments for lipid-related liver diseases.	[Kosters, Astrid; Karpen, Saul J.] Emory Univ, Sch Med, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Atlanta, GA 30322 USA; [Sun, Deqiang; Li, Wei] Baylor Coll Med, Dept Mol & Cellular Biol, Div Biostat, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Wu, Hao] Emory Univ, Sch Publ Hlth, Dept Biostat, Atlanta, GA USA; [Tian, Feng; Felix, Julio C.] Baylor Coll Med, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA	Emory University; Baylor College of Medicine; Emory University; Baylor College of Medicine	Karpen, SJ (corresponding author), Emory Univ, Sch Med, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Atlanta, GA 30322 USA.	saul.karpen@emory.edu	Wu, Hao/H-3899-2017	Wu, Hao/0000-0003-1269-7354; sun, deqiang/0000-0002-5806-7289	NIH [RC1-DK86577]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK086577, R01DK056239] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by NIH RC1-DK86577 to SJK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argo CK, 2009, J HEPATOL, V51, P371, DOI 10.1016/j.jhep.2009.03.019; Atshaves BP, 2004, J LIPID RES, V45, P812, DOI 10.1194/jlr.M300408-JLR200; Basantani MK, 2011, J LIPID RES, V52, P318, DOI 10.1194/jlr.M011205; Baulande S, 2001, J BIOL CHEM, V276, P33336, DOI 10.1074/jbc.M105193200; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Boergesen M, 2012, MOL CELL BIOL, V32, P852, DOI 10.1128/MCB.06175-11; BOOKOUT AL, 2006, CURR PROTOC MOL BIOL; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Bouchard-Mercier A, 2012, J NUTRIGENET NUTRIGE, V5, P1, DOI 10.1159/000336511; Bugianesi E, 2006, HEPATOLOGY, V44, P1648, DOI 10.1002/hep.21429; Cai Y, 2003, ENDOCRINOLOGY, V144, P2311, DOI 10.1210/en.2002-0129; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chen WQ, 2010, HEPATOLOGY, V52, P1134, DOI 10.1002/hep.23812; Clodfelter KH, 2007, PHYSIOL GENOMICS, V31, P63, DOI 10.1152/physiolgenomics.00055.2007; Clodfelter KH, 2006, MOL ENDOCRINOL, V20, P1333, DOI 10.1210/me.2005-0489; Costet P, 1998, J BIOL CHEM, V273, P29577, DOI 10.1074/jbc.273.45.29577; Dolley G, 2011, J NUTRIGENET NUTRIGE, V4, P137, DOI 10.1159/000327778; Donkor J, 2009, J BIOL CHEM, V284, P29968, DOI 10.1074/jbc.M109.023663; Duma D, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001077; Franconi F, 2008, PHARMACOL RES, V57, P6, DOI 10.1016/j.phrs.2007.11.007; Fraser A, 2007, GASTROENTEROLOGY, V133, P1814, DOI 10.1053/j.gastro.2007.08.077; Gandhi M, 2004, ANNU REV PHARMACOL, V44, P499, DOI [10.1146/annurev.pharmtox.44.101802.121453, 10.2165/00003088-200948030-00001]; Gong J, 2011, J NUTR, V141, P2211, DOI 10.3945/jn.111.143503; Hernandez JP, 2009, TOXICOLOGY, V256, P53, DOI 10.1016/j.tox.2008.11.002; Hoekstra M, 2010, J HEPATOL, V52, P244, DOI 10.1016/j.jhep.2009.11.004; Holloway MG, 2006, MOL ENDOCRINOL, V20, P647, DOI 10.1210/me.2005-0328; Holloway MG, 2008, MOL ENDOCRINOL, V22, P1274, DOI 10.1210/me.2007-0564; Holloway MG, 2007, ENDOCRINOLOGY, V148, P1977, DOI 10.1210/en.2006-1419; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang Jie, 2006, Comp Hepatol, V5, P8, DOI 10.1186/1476-5926-5-8; Huang YC, 2010, P NATL ACAD SCI USA, V107, P7892, DOI 10.1073/pnas.1003585107; JANSSON JO, 1985, ENDOCR REV, V6, P128, DOI 10.1210/edrv-6-2-128; Johansson LE, 2006, DIABETES, V55, P826, DOI 10.2337/diabetes.55.03.06.db05-1075; Kang ES, 2008, MOL GENET METAB, V95, P96, DOI 10.1016/j.ymgme.2008.06.011; Kantartzis K, 2009, DIABETES, V58, P2616, DOI 10.2337/db09-0279; Kosters A, 2012, LIVER INT, V32, P321, DOI 10.1111/j.1478-3231.2011.02664.x; Kosters A, 2009, J HEPATOL, V51, P898, DOI 10.1016/j.jhep.2009.06.029; Kotronen A, 2009, DIABETOLOGIA, V52, P1056, DOI 10.1007/s00125-009-1285-z; Kumadaki S, 2008, BIOCHEM BIOPH RES CO, V368, P261, DOI 10.1016/j.bbrc.2008.01.075; Kumari M, 2012, CELL METAB, V15, P691, DOI 10.1016/j.cmet.2012.04.008; Laz EV, 2007, ENDOCRINOLOGY, V148, P3327, DOI 10.1210/en.2006-1192; Ledda-Columbano GM, 2003, CARCINOGENESIS, V24, P1059, DOI 10.1093/carcin/bgg063; Leuenberger N, 2009, J CLIN INVEST, V119, P3138, DOI 10.1172/JCI39019; Lichanska AM, 2008, TRENDS GENET, V24, P41, DOI 10.1016/j.tig.2007.10.006; Liu YM, 2004, J CLIN ENDOCR METAB, V89, P2684, DOI 10.1210/jc.2003-031978; Magkos F, 2009, OBSTET GYN CLIN N AM, V36, P245, DOI 10.1016/j.ogc.2009.03.001; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Mauvoisin D, 2011, BIOCHIMIE, V93, P78, DOI 10.1016/j.biochi.2010.08.001; Meyer RD, 2009, MOL ENDOCRINOL, V23, P1914, DOI 10.1210/me.2009-0242; Moon YA, 2001, J BIOL CHEM, V276, P45358, DOI 10.1074/jbc.M108413200; Morcillo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021198; Morise A, 2009, EUR J NUTR, V48, P465, DOI 10.1007/s00394-009-0037-7; Nadal-Casellas A, 2012, BIOCH CELL BIOL; Nadeau KJ, 2009, PEDIATR DIABETES, V10, P5, DOI 10.1111/j.1399-5448.2008.00450.x; Pashkov V, 2011, J BIOL CHEM, V286, P15116, DOI 10.1074/jbc.M110.216234; Perez E, 2012, BBA-MOL CELL BIOL L, V1821, P57, DOI 10.1016/j.bbalip.2011.04.003; Petta S, 2010, CURR PHARM DESIGN, V16, P741, DOI 10.2174/138161210790883787; Pirooznia M, 2007, BIOINFORMATION, V1, P420, DOI 10.6026/97320630001420; Priego T, 2008, OBESITY, V16, P819, DOI 10.1038/oby.2007.117; Qiao AJ, 2011, HEPATOLOGY, V54, P509, DOI 10.1002/hep.24402; Rando G, 2011, BBA-MOL BASIS DIS, V1812, P964, DOI 10.1016/j.bbadis.2010.12.023; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; ROY AK, 1983, ANNU REV PHYSIOL, V45, P37, DOI 10.1146/annurev.ph.45.030183.000345; Sartorio A, 2007, EUR J CLIN NUTR, V61, P877, DOI 10.1038/sj.ejcn.1602588; Schwimmer JB, 2005, PEDIATRICS, V115, pE561, DOI 10.1542/peds.2004-1832; Schwinnner JB, 2005, HEPATOLOGY, V42, P641, DOI 10.1002/hep.20842; SHAPIRO BH, 1995, INT J BIOCHEM CELL B, V27, P9, DOI 10.1016/1357-2725(94)00056-5; Shulman AI, 2005, NEW ENGL J MED, V353, P604, DOI 10.1056/NEJMra043590; Siersbaek R, 2012, TRENDS ENDOCRIN MET, V23, P56, DOI 10.1016/j.tem.2011.10.001; Sookoian S, 2011, HEPATOLOGY, V53, P1883, DOI 10.1002/hep.24283; Spitzer JA, 1999, LUPUS, V8, P380, DOI 10.1177/096120339900800510; Stryjecki C, 2012, MOL GENET METAB, V105, P421, DOI 10.1016/j.ymgme.2011.12.003; Thomas AM, 2010, HEPATOLOGY, V51, P1410, DOI 10.1002/hep.23450; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; Valenti L, 2012, J PEDIATR GASTR NUTR, V54, P588, DOI 10.1097/MPG.0b013e3182442a55; Wan YJY, 2000, J BIOL CHEM, V275, P28285; Wan YJY, 2000, MOL CELL BIOL, V20, P4436, DOI 10.1128/MCB.20.12.4436-4444.2000; Wauthier V, 2008, MOL ENDOCRINOL, V22, P1962, DOI 10.1210/me.2007-0549; Wauthier Valerie, 2010, Mol Endocrinol, V24, P667, DOI 10.1210/me.2009-0454; Waxman D J, 2000, Novartis Found Symp, V227, P61; Waxman DJ, 2006, MOL ENDOCRINOL, V20, P2613, DOI 10.1210/me.2006-0007; Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705; Wiwi CA, 2004, MOL ENDOCRINOL, V18, P1975, DOI 10.1210/me.2004-0129; Wiwi CA, 2004, GROWTH FACTORS, V22, P79, DOI 10.1080/08977190410001715172; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Zhang YJ, 2012, MOL CELL BIOL, V32, P880, DOI 10.1128/MCB.06312-11; Zhang YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023506; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	90	17	17	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71538	10.1371/journal.pone.0071538	http://dx.doi.org/10.1371/journal.pone.0071538			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977068	Green Submitted, Green Published, gold			2022-12-25	WOS:000323425700065
J	Liu, YL; Yan, XY; Zhou, TH				Liu, Yueli; Yan, Xiaoyi; Zhou, Tianhua			TBCK Influences Cell Proliferation, Cell Size and mTOR Signaling Pathway	PLOS ONE			English	Article							TSC1-TSC2 COMPLEX; PROTEIN-KINASE; RAB GTPASES; HEPATOCELLULAR-CARCINOMA; CATALYTIC DOMAIN; BINDING PARTNER; DOWN-REGULATION; GROWTH-CONTROL; RAPAMYCIN TOR; TARGET	Mammalian target of rapamycin (mTOR) is a central regulator for both cell proliferation and cell growth; however, little is known about the regulation of mTOR expression at the transcriptional level. Here, we provide evidences that a conserved human protein TBCK (TBC1 domain containing kinase) is involved in the regulation of mTOR signaling pathway. Depletion of TBCK significantly inhibits cell proliferation, reduces cell size, and disrupts the organization of actin, but not microtubule. Knockdown of TBCK induces a significant decrease in the protein levels of components of mTOR complex (mTORC), and suppresses the activity of mTOR signaling, but not MAPK or PDK1/Akt pathway. Further results show that TBCK influences the expression of mTORC components at the transcriptional level. Thus, these data suggest that TBCK may play an important role in cell proliferation, cell growth and actin organization possibly by modulating mTOR pathway.	[Zhou, Tianhua] Zhejiang Univ, Sch Med, Dept Cell Biol, Hangzhou 310003, Zhejiang, Peoples R China; Zhejiang Univ, Sch Med, Program Mol Cell Biol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Zhou, TH (corresponding author), Zhejiang Univ, Sch Med, Dept Cell Biol, Hangzhou 310003, Zhejiang, Peoples R China.	tzhou@zju.edu.cn	zhou, tianhua/K-4908-2013	zhou, tianhua/0000-0002-1791-2124	Ministry of Science and Technology of China [2012CB945004, 2013CB945603, 2011CBA01001]; Natural Scientific Foundation of China [31125017, 31190063, 31071221, 30771107]; Doctoral Fund of Ministry of Education of China [20110101110103]; Natural Scientific Foundation of Zhejiang Province, China [Z2100247, Y2100106]; 111 Project [B13026]; Department of Science and Technology of Zhejiang Province [2009C03012-3, 2009F80005]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Natural Scientific Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province); 111 Project(Ministry of Education, China - 111 Project); Department of Science and Technology of Zhejiang Province; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents	This study was funded by grants from the Ministry of Science and Technology of China (2012CB945004, 2013CB945603 and 2011CBA01001), the Natural Scientific Foundation of China (31125017, 31190063, 31071221 and 30771107), Doctoral Fund of Ministry of Education of China (20110101110103), the Natural Scientific Foundation of Zhejiang Province, China (Z2100247 and Y2100106), the 111 Project (B13026), the Department of Science and Technology of Zhejiang Province (2009C03012-3 and 2009F80005) and Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Dibble CC, 2012, MOL CELL, V47, P535, DOI 10.1016/j.molcel.2012.06.009; Fang YX, 2012, HEPATOLOGY, V55, P1852, DOI 10.1002/hep.25576; Faridi J, 2003, AM J PHYSIOL-ENDOC M, V285, pE964, DOI 10.1152/ajpendo.00239.2003; Fornari F, 2010, CANCER RES, V70, P5184, DOI 10.1158/0008-5472.CAN-10-0145; Frasa MAM, 2012, NAT REV MOL CELL BIO, V13, P67, DOI 10.1038/nrm3267; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hofmann K, 1998, J MOL BIOL, V282, P195, DOI 10.1006/jmbi.1998.1998; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Itoh T, 2006, GENES CELLS, V11, P1023, DOI 10.1111/j.1365-2443.2006.00997.x; Iwaya T, 2012, CARCINOGENESIS, V33, P2391, DOI 10.1093/carcin/bgs288; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kaizuka T, 2010, J BIOL CHEM, V285, P20109, DOI 10.1074/jbc.M110.121699; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim J, 2011, ANNU REV BIOCHEM, V80, P1001, DOI 10.1146/annurev-biochem-062209-094414; Kong J, 2012, NAT REV GENET, V13, P383, DOI 10.1038/nrg3184; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Leite KRM, 2011, J UROLOGY, V185, P1118, DOI 10.1016/j.juro.2010.10.035; Li D, 2011, J BIOL CHEM, V286, P36677, DOI 10.1074/jbc.M111.270561; Liu G, 2012, EXP NEUROL, V233, P447, DOI 10.1016/j.expneurol.2011.11.018; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Nakashima A, 2007, BIOCHEM BIOPH RES CO, V361, P218, DOI 10.1016/j.bbrc.2007.07.011; Okano H, 2002, J CELL SCI, V115, P1355; Oneyama C, 2011, ONCOGENE, V30, P3489, DOI 10.1038/onc.2011.63; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540; Pearce LR, 2011, BIOCHEM J, V436, P169, DOI 10.1042/BJ20102103; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Robertson G, 2006, NUCLEIC ACIDS RES, V34, pD68, DOI 10.1093/nar/gkj075; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sato N, 2010, GENE CHROMOSOME CANC, V49, P353, DOI 10.1002/gcc.20747; Scheeff ED, 2009, STRUCTURE, V17, P128, DOI 10.1016/j.str.2008.10.018; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Thedieck K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001217; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	52	30	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71349	10.1371/journal.pone.0071349	http://dx.doi.org/10.1371/journal.pone.0071349			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977024	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700039
J	Muramatsu, M; Yoshida, R; Miyamoto, H; Tomabechi, D; Kajihara, M; Maruyama, J; Kimura, T; Manzoor, R; Ito, K; Takada, A				Muramatsu, Mieko; Yoshida, Reiko; Miyamoto, Hiroko; Tomabechi, Daisuke; Kajihara, Masahiro; Maruyama, Junki; Kimura, Takashi; Manzoor, Rashid; Ito, Kimihito; Takada, Ayato			Heterosubtypic Antiviral Activity of Hemagglutinin-Specific Antibodies Induced by Intranasal Immunization with Inactivated Influenza Viruses in Mice	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; INTRACELLULAR NEUTRALIZATION; LETHAL INFLUENZA; CROSS-PROTECTION; BROAD-SPECTRUM; M2 PROTEIN; REPLICATION; INFECTION; H5N1; NUCLEOPROTEIN	Influenza A virus subtypes are classified on the basis of the antigenicity of their envelope glycoproteins, hemagglutinin (HA; H1-H17) and neuraminidase. Since HA-specific neutralizing antibodies are predominantly specific for a single HA subtype, the contribution of antibodies to the heterosubtypic immunity is not fully understood. In this study, mice were immunized intranasally or subcutaneously with viruses having the H1, H3, H5, H7, H9, or H13 HA subtype, and cross-reactivities of induced IgG and IgA antibodies to recombinant HAs of the H1-H16 subtypes were analyzed. We found that both subcutaneous and intranasal immunizations induced antibody responses to multiple HAs of different subtypes, whereas IgA was not detected remarkably in mice immunized subcutaneously. Using serum, nasal wash, and trachea-lung wash samples of H9 virus-immunized mice, neutralizing activities of cross-reactive antibodies were then evaluated by plaque-reduction assays. As expected, no heterosubtypic neutralizing activity was detected by a standard neutralization test in which viruses were mixed with antibodies prior to inoculation into cultured cells. Interestingly, however, a remarkable reduction of plaque formation and extracellular release of the H12 virus, which was bound by the H9-induced cross-reactive antibodies, was observed when infected cells were subsequently cultured with the samples containing HA-specific cross-reactive IgA. This heterosubtypic plaque reduction was interfered when the samples were pretreated with anti-mouse IgA polyclonal serum. These results suggest that the majority of HA-specific cross-reactive IgG and IgA antibodies produced by immunization do not block cellular entry of viruses, but cross-reactive IgA may have the potential to inhibit viral egress from infected cells and thus to play a role in heterosubtypic immunity against influenza A viruses.	[Muramatsu, Mieko; Yoshida, Reiko; Miyamoto, Hiroko; Tomabechi, Daisuke; Kajihara, Masahiro; Maruyama, Junki; Manzoor, Rashid; Takada, Ayato] Hokkaido Univ, Res Ctr Zoonosis Control, Div Global Epidemiol, Sapporo, Hokkaido, Japan; [Kimura, Takashi] Hokkaido Univ, Res Ctr Zoonosis Control, Div Mol Pathobiol, Sapporo, Hokkaido, Japan; [Ito, Kimihito] Hokkaido Univ, Res Ctr Zoonosis Control, Div Bioinformat, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Takada, A (corresponding author), Hokkaido Univ, Res Ctr Zoonosis Control, Div Global Epidemiol, Sapporo, Hokkaido, Japan.	atakada@czc.hokudai.ac.jp	Manzoor, Rashid/ABB-8209-2020; Maruyama, Junki/H-7993-2013; Maruyama, Junki/M-4735-2019; Ito, Kimihito/E-9975-2012; Kajihara, Masahiro/AAF-5724-2020; YOSHIDA, Reiko/F-6883-2012	Maruyama, Junki/0000-0003-0088-4793; Maruyama, Junki/0000-0003-0088-4793; Ito, Kimihito/0000-0003-4986-1795; 	Japan Initiative for the Global Research Network on Infectious Diseases (J-GRID); Global COE Program; Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [25280080] Funding Source: KAKEN	Japan Initiative for the Global Research Network on Infectious Diseases (J-GRID); Global COE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by the Japan Initiative for the Global Research Network on Infectious Diseases (J-GRID) (http://www.crnid.riken.jp/jgrid/en/), the Global COE Program (http://www.jsps.go.jp/english/index.html), the Japan Science and Technology Agency Basic Research Programs (http://www.jst.go.jp/EN/), and the Ministry of Education, Culture, Sports, Science and Technology (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADA GL, 1986, CURR TOP MICROBIOL, V128, P1; AYMARDHENRY M, 1973, B WORLD HEALTH ORGAN, V48, P199; Corthesy B, 2006, J VIROL, V80, P10692, DOI 10.1128/JVI.00927-06; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Gerhard W, 1997, IMMUNOL REV, V159, P95, DOI 10.1111/j.1600-065X.1997.tb01009.x; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; HUGHEY PG, 1995, VIROLOGY, V212, P411, DOI 10.1006/viro.1995.1498; Ichinohe T, 2007, J INFECT DIS, V196, P1313, DOI 10.1086/521304; Kajihara M, 2012, J VIROL, V86, P13467, DOI 10.1128/JVI.01896-12; KILBOURNE ED, 1973, J INFECT DIS, V127, P478, DOI 10.1093/infdis/127.4.478; Lamm ME, 1997, ANNU REV MICROBIOL, V51, P311, DOI 10.1146/annurev.micro.51.1.311; Manley K, 2011, CELL HOST MICROBE, V10, P197, DOI 10.1016/j.chom.2011.07.010; MAZANEC MB, 1995, J VIROL, V69, P1339, DOI 10.1128/JVI.69.2.1339-1343.1995; Muto NA, 2012, JPN J VET RES, V60, P71; Nakayama E, 2010, CLIN VACCINE IMMUNOL, V17, P1723, DOI 10.1128/CVI.00170-10; Nguyen HH, 2001, J INFECT DIS, V183, P368, DOI 10.1086/318084; Ohshima N, 2011, J VIROL, V85, P11048, DOI 10.1128/JVI.05397-11; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; RENEGAR KB, 1991, J VIROL, V65, P2146, DOI 10.1128/JVI.65.4.2146-2148.1991; Rohm C, 1996, VIROLOGY, V217, P508, DOI 10.1006/viro.1996.0145; Russell RJ, 2004, VIROLOGY, V325, P287, DOI 10.1016/j.virol.2004.04.040; Sakabe S, 2010, ANTIVIR RES, V88, P249, DOI 10.1016/j.antiviral.2010.09.007; Science Council of Japan, 2006, GUID PROP COND AN EX, P1; Stropkovska A, 2009, ACTA VIROL, V53, P15, DOI 10.4149/av_2009_01_15; Subbarao K, 2007, NAT REV IMMUNOL, V7, P267, DOI 10.1038/nri2054; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Takada A, 1999, J VIROL, V73, P8303, DOI 10.1128/JVI.73.10.8303-8307.1999; Takada A, 2003, VACCINE, V21, P3212, DOI 10.1016/S0264-410X(03)00234-2; TAKADA A, 1994, J VET MED SCI, V56, P633, DOI 10.1292/jvms.56.633; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; TOWNSEND ARM, 1984, CELL, V39, P13, DOI 10.1016/0092-8674(84)90187-9; TREANOR JJ, 1990, J VIROL, V64, P1375, DOI 10.1128/JVI.64.3.1375-1377.1990; Tumpey TM, 2001, J VIROL, V75, P5141, DOI 10.1128/JVI.75.11.5141-5150.2001; Wang TT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000796; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WEBSTER RG, 1988, VIROLOGY, V164, P230, DOI 10.1016/0042-6822(88)90640-X; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Wright A, 2006, VIROLOGY, V356, P165, DOI 10.1016/j.virol.2006.08.006; YEWDELL JW, 1985, P NATL ACAD SCI USA, V82, P1785, DOI 10.1073/pnas.82.6.1785; Yoshida R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000350; ZEBEDEE SL, 1988, J VIROL, V62, P2762, DOI 10.1128/JVI.62.8.2762-2772.1988; Zhou DH, 2011, J VIROL, V85, P11090, DOI 10.1128/JVI.00768-11	46	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e71534	10.1371/journal.pone.0071534	http://dx.doi.org/10.1371/journal.pone.0071534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977065	Green Published, gold			2022-12-25	WOS:000323570200034
J	Robinson, KG; Mendonca, JL; Militar, JL; Theroux, MC; Dabney, KW; Shah, SA; Miller, F; Akins, RE				Robinson, Karyn G.; Mendonca, Janet L.; Militar, Jaimee L.; Theroux, Mary C.; Dabney, Kirk W.; Shah, Suken A.; Miller, Freeman; Akins, Robert E.			Disruption of Basal Lamina Components in Neuromotor Synapses of Children with Spastic Quadriplegic Cerebral Palsy	PLOS ONE			English	Article							EXTRAJUNCTIONAL ACETYLCHOLINE-RECEPTORS; VERTEBRATE NEUROMUSCULAR-JUNCTION; UTROPHIN-DEFICIENT MICE; MEDIATED GENE-THERAPY; HUMAN SKELETAL-MUSCLE; POSTSYNAPTIC ABNORMALITIES; EXTRACELLULAR-MATRIX; MUSCULAR-DYSTROPHY; MAMMALIAN MUSCLE; ACTIVE ZONES	Cerebral palsy (CP) is a static encephalopathy occurring when a lesion to the developing brain results in disordered movement and posture. Patients present with sometimes overlapping spastic, athetoid/dyskinetic, and ataxic symptoms. Spastic CP, which is characterized by stiff muscles, weakness, and poor motor control, accounts for,similar to 80% of cases. The detailed mechanisms leading to disordered movement in spastic CP are not completely understood, but clinical experience and recent studies suggest involvement of peripheral motor synapses. For example, it is recognized that CP patients have altered sensitivities to drugs that target neuromuscular junctions (NMJs), and protein localization studies suggest that NMJ microanatomy is disrupted in CP. Since CP originates during maturation, we hypothesized that NMJ disruption in spastic CP is associated with retention of an immature neuromotor phenotype later in life. Scoliosis patients with spastic CP or idiopathic disease were enrolled in a prospective, partially-blinded study to evaluate NMJ organization and neuromotor maturation. The localization of synaptic acetylcholine esterase (AChE) relative to postsynaptic acetylcholine receptor (AChR), synaptic laminin beta 2, and presynaptic vesicle protein 2 (SV2) appeared mismatched in the CP samples; whereas, no significant disruption was found between AChR and SV2. These data suggest that pre- and postsynaptic NMJ components in CP children were appropriately distributed even though AChE and laminin beta 2 within the synaptic basal lamina appeared disrupted. Follow up electron microscopy indicated that NMJs from CP patients appeared generally mature and similar to controls with some differences present, including deeper postsynaptic folds and reduced presynaptic mitochondria. Analysis of maturational markers, including myosin, syntrophin, myogenin, and AChR subunit expression, and telomere lengths, all indicated similar levels of motor maturation in the two groups. Thus, NMJ disruption in CP was found to principally involve components of the synaptic basal lamina and subtle ultra-structural modifications but appeared unrelated to neuromotor maturational status.	[Robinson, Karyn G.; Mendonca, Janet L.; Militar, Jaimee L.; Akins, Robert E.] Alfred I duPont Hosp Children, Wilmington, DE USA; [Theroux, Mary C.] Alfred I duPont Hosp Children, Dept Anesthesiol & Crit Care, Wilmington, DE USA; [Dabney, Kirk W.; Shah, Suken A.; Miller, Freeman] Alfred I duPont Hosp Children, Dept Orthoped Surg, Wilmington, DE USA	Nemours Alfred I. duPont Hospital for Children; Nemours Alfred I. duPont Hospital for Children; Nemours Alfred I. duPont Hospital for Children	Akins, RE (corresponding author), Alfred I duPont Hosp Children, Wilmington, DE USA.	robert.akins@nemours.org	Shah, Suken/AAC-9857-2022; Akins, Robert/AEU-9620-2022	Akins, Robert/0000-0001-9706-0752; Robinson, Karyn/0000-0002-1735-8469	NICHD [HD051738]; NCRR [RR016472]; NIGMS [GM103464]; Nemours Foundation; Swank Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD051738] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103464] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Nemours Foundation; Swank Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funds from NICHD - HD051738 (Akins); NCRR - RR016472 (Akins); NIGMS - GM103464 (Theroux and Akins); Nemours Foundation (Akins); and Swank Foundation (Akins). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badawi N, 1998, DEV MED CHILD NEUROL, V40, P520; Banks GB, 2009, MOL CELL NEUROSCI, V40, P433, DOI 10.1016/j.mcn.2008.12.011; BEWICK GS, 1992, NEUROREPORT, V3, P857, DOI 10.1097/00001756-199210000-00009; BIRAL D, 1988, BIOCHEM J, V250, P307, DOI 10.1042/bj2500307; BROOKE MH, 1970, J HISTOCHEM CYTOCHEM, V18, P670, DOI 10.1177/18.9.670; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chen J, 2011, J NEUROSCI, V31, P512, DOI 10.1523/JNEUROSCI.3771-10.2011; Cho SI, 1998, J NEUROBIOL, V37, P339, DOI 10.1002/(SICI)1097-4695(19981115)37:3<339::AID-NEU1>3.3.CO;2-0; COERS C, 1977, ARCH NEUROL-CHICAGO, V34, P396, DOI 10.1001/archneur.1977.00500190030004; Compton AG, 2005, J NEUROPATH EXP NEUR, V64, P350, DOI 10.1093/jnen/64.4.350; Decary S, 2000, NEUROMUSCULAR DISORD, V10, P113, DOI 10.1016/S0960-8966(99)00093-0; Decary S, 1997, HUM GENE THER, V8, P1429, DOI 10.1089/hum.1997.8.12-1429; Deconinck AE, 1997, J CELL BIOL, V136, P883, DOI 10.1083/jcb.136.4.883; Fischer U, 1999, EUR J NEUROSCI, V11, P2856, DOI 10.1046/j.1460-9568.1999.00703.x; Foran JRH, 2005, DEV MED CHILD NEUROL, V47, P713, DOI 10.1017/S0012162205001465; Grady RM, 1997, J CELL BIOL, V136, P871, DOI 10.1083/jcb.136.4.871; GU Y, 1988, NEURON, V1, P117, DOI 10.1016/0896-6273(88)90195-X; Hepaguslar H, 1999, ANAESTHESIA, V54, P593, DOI 10.1046/j.1365-2044.1999.00799.x; Ito J, 1996, BRAIN DEV-JPN, V18, P299, DOI 10.1016/0387-7604(96)00006-X; Johnson DL, 2009, J PEDIATR-US, V154, P715, DOI 10.1016/j.jpeds.2008.10.046; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; KARPATI G, 1968, AM J ANAT, V122, P145, DOI 10.1002/aja.1001220109; KARSCHMIZRACHI I, 1989, NUCLEIC ACIDS RES, V17, P6167, DOI 10.1093/nar/17.15.6167; KIHIRA S, 1985, J NEUROL SCI, V70, P139, DOI 10.1016/0022-510X(85)90083-8; Knight D, 2003, J PHYSIOL-LONDON, V546, P789, DOI 10.1113/jphysiol.2002.030924; Koman LA, 2004, LANCET, V363, P1619, DOI 10.1016/S0140-6736(04)16207-7; Kramarcy NR, 2000, MOL CELL NEUROSCI, V15, P262, DOI 10.1006/mcne.1999.0823; Lee CW, 2008, MOL BIOL CELL, V19, P150, DOI 10.1091/mbc.E07-05-0515; Lee CW, 2006, J NEUROBIOL, V66, P522, DOI 10.1002/neu.20245; LEINWAND LA, 1983, P NATL ACAD SCI-BIOL, V80, P3716, DOI 10.1073/pnas.80.12.3716; LEVITTGILMOUR TA, 1986, J NEUROSCI, V6, P1606; Marbini A, 2002, BRAIN DEV-JPN, V24, P63, DOI 10.1016/S0387-7604(01)00394-1; Marinou M, 2003, BIOCHEM J, V372, P543, DOI 10.1042/BJ20021537; Maselli RA, 2009, J MED GENET, V46, P203, DOI 10.1136/jmg.2008.063693; Miner JH, 1998, J CELL BIOL, V143, P1713, DOI 10.1083/jcb.143.6.1713; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; Missias AC, 1996, DEV BIOL, V179, P223, DOI 10.1006/dbio.1996.0253; Modla S, 2010, J NEUROSCI METH, V191, P158, DOI 10.1016/j.jneumeth.2010.06.015; Mouly V, 2005, ACTA PHYSIOL SCAND, V184, P3, DOI 10.1111/j.1365-201X.2005.01417.x; NELSON PG, 1993, J NEUROBIOL, V24, P1517, DOI 10.1002/neu.480241106; Nishimune H, 2004, NATURE, V432, P580, DOI 10.1038/nature03112; Nishimune H, 2008, J CELL BIOL, V182, P1201, DOI 10.1083/jcb.200805095; Nishizawa T, 2003, J MUSCLE RES CELL M, V24, P527, DOI 10.1023/B:JURE.0000009905.89618.33; Nizri E, 2007, DRUG NEWS PERSPECT, V20, P421, DOI 10.1358/dnp.2007.20.7.1149629; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; O'Shea TM, 2008, CLIN OBSTET GYNECOL, V51, P816, DOI 10.1097/GRF.0b013e3181870ba7; Odding E, 2006, DISABIL REHABIL, V28, P183, DOI 10.1080/09638280500158422; Ohno K, 1998, P NATL ACAD SCI USA, V95, P9654, DOI 10.1073/pnas.95.16.9654; Okuhira K, J BIOL CHEM, V285, P16369; Patton BL, 2000, MICROSC RES TECHNIQ, V51, P247, DOI 10.1002/1097-0029(20001101)51:3<247::AID-JEMT5>3.0.CO;2-Z; Patton BL, 2003, J NEUROCYTOL, V32, P883, DOI 10.1023/B:NEUR.0000020630.74955.19; Patton BL, 1999, NEUROMUSCULAR DISORD, V9, P423, DOI 10.1016/S0960-8966(99)00033-4; Patton BL, 2001, NAT NEUROSCI, V4, P597, DOI 10.1038/88414; Patton BL, 1998, NATURE, V393, P698, DOI 10.1038/31502; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; Peters MF, 1998, J CELL BIOL, V142, P1269, DOI 10.1083/jcb.142.5.1269; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rasband Wayne, 2010, IMAGEJ; ROSE J, 1994, J ORTHOP RES, V12, P758, DOI 10.1002/jor.1100120603; Rotundo RL, 2005, CHEM-BIOL INTERACT, V157, P15, DOI 10.1016/j.cbi.2005.10.007; Rotundo RL, 2003, J NEUROCYTOL, V32, P743, DOI 10.1023/B:NEUR.0000020621.58197.d4; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Slater CR, 2006, BRAIN, V129, P2061, DOI 10.1093/brain/awl200; SLATER CR, 1992, BRAIN, V115, P451; Smith LR, 2011, J PHYSIOL-LONDON, V589, P2625, DOI 10.1113/jphysiol.2010.203364; Smith LR, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-44; Stackhouse SK, 2007, NEUROREHAB NEURAL RE, V21, P475, DOI 10.1177/1545968306298932; Stackhouse SK, 2005, MUSCLE NERVE, V31, P594, DOI 10.1002/mus.20302; Strochlic L, 2004, P NATL ACAD SCI USA, V101, P18189, DOI 10.1073/pnas.0406905102; Taniguchi M, 2006, HUM MOL GENET, V15, P1279, DOI 10.1093/hmg/ddl045; Theroux MC, 2005, MUSCLE NERVE, V32, P626, DOI 10.1002/mus.20401; Theroux MC, 2002, ANESTHESIOLOGY, V96, P330, DOI 10.1097/00000542-200202000-00017; THEROUX MC, 1994, ANESTH ANALG, V79, P761; Todd KJ, 2006, PFLUG ARCH EUR J PHY, V452, P608, DOI 10.1007/s00424-006-0068-3; Tsuneki H, 2003, J PHYSIOL-LONDON, V547, P169, DOI 10.1113/jphysiol.2002.036368; WALLACE BG, 1989, J NEUROSCI, V9, P1294; Wewer UM, 1997, AM J PATHOL, V151, P621; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; Yang YM, 2003, BIOMED ENVIRON SCI, V16, P256	80	16	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e70288	10.1371/journal.pone.0070288	http://dx.doi.org/10.1371/journal.pone.0070288			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23976945	Green Published, gold, Green Submitted			2022-12-25	WOS:000323570200004
J	Artells, E; Issartel, J; Auffan, M; Borschneck, D; Thill, A; Tella, M; Brousset, L; Rose, J; Bottero, JY; Thiery, A				Artells, Ester; Issartel, Julien; Auffan, Melanie; Borschneck, Daniel; Thill, Antoine; Tella, Marie; Brousset, Lenka; Rose, Jerome; Bottero, Jean-Yves; Thiery, Alain			Exposure to Cerium Dioxide Nanoparticles Differently Affect Swimming Performance and Survival in Two Daphnid Species	PLOS ONE			English	Article							MEDAKA ORYZIAS-LATIPES; NANO-SCALE TIO2; TITANIUM-DIOXIDE; OXIDATIVE STRESS; OXIDE NANOPARTICLES; MANUFACTURED NANOPARTICLES; CEO2 NANOPARTICLES; LIPID-PEROXIDATION; TOXICITY; MAGNA	The CeO2 NPs are increasingly used in industry but the environmental release of these NPs and their subsequent behavior and biological effects are currently unclear. This study evaluates for the first time the effects of CeO2 NPs on the survival and the swimming performance of two cladoceran species, Daphnia similis and Daphnia pulex after 1, 10 and 100 mg.L-1 CeO2 exposures for 48 h. Acute toxicity bioassays were performed to determine EC50 of exposed daphnids. Video-recorded swimming behavior of both daphnids was used to measure swimming speeds after various exposures to aggregated CeO2 NPs. The acute ecotoxicity showed that D. similis is 350 times more sensitive to CeO2 NPs than D. pulex, showing 48-h EC50 of 0.26 mg.L-1 and 91.79 mg.L-1, respectively. Both species interacted with CeO2 NPs (adsorption), but much more strongly in the case of D. similis. Swimming velocities (SV) were differently and significantly affected by CeO2 NPs for both species. A 48-h exposure to 1 mg.L-1 induced a decrease of 30% and 40% of the SV in D. pulex and D. similis, respectively. However at higher concentrations, the SV of D. similis was more impacted (60% off for 10 mg.L-1 and 100 mg.L-1) than the one of D. pulex. These interspecific toxic effects of CeO2 NPs are explained by morphological variations such as the presence of reliefs on the cuticle and a longer distal spine in D. similis acting as traps for the CeO2 aggregates. In addition, D. similis has a mean SV double that of D. pulex and thus initially collides with twice more NPs aggregates. The ecotoxicological consequences on the behavior and physiology of a CeO2 NPs exposure in daphnids are discussed.	[Artells, Ester; Issartel, Julien; Thiery, Alain] Aix Marseille Univ, IMBE UMR CNRS 7263, Inst Mediterraneen Biodivers & Ecol Marine & Cont, Marseille, France; [Artells, Ester; Brousset, Lenka] Aix Marseille Univ, IMBE UMR CNRS 7263, Inst Mediterraneen Biodivers & Ecol Marine & Cont, Aix En Provence, France; [Auffan, Melanie; Borschneck, Daniel; Tella, Marie; Rose, Jerome; Bottero, Jean-Yves] Aix Marseille Univ, CEREGE UMR CNRS 7330, Ctr Europeen Rech & Enseignement Geosci Environm, Aix En Provence, France; [Artells, Ester; Issartel, Julien; Auffan, Melanie; Borschneck, Daniel; Thill, Antoine; Tella, Marie; Brousset, Lenka; Rose, Jerome; Bottero, Jean-Yves; Thiery, Alain] Int Consortium Environm Implicat Nanotechnol, iCEINT, Aix En Provence, France; [Thill, Antoine] Comissariat Energie Atom & Energies Alternat, CEA Saclay, IRAMIS,UMR 3299, Lab Interdisciplinaire Org Nanometr & Supramol, Gif Sur Yvette, France; [Issartel, Julien; Auffan, Melanie; Tella, Marie; Rose, Jerome; Bottero, Jean-Yves; Thiery, Alain] Labex SERENADE 2012 Safer Ecodesign Res & Educ, Aix En Provence, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; PSL Research University Paris; College de France; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Thiery, A (corresponding author), Aix Marseille Univ, IMBE UMR CNRS 7263, Inst Mediterraneen Biodivers & Ecol Marine & Cont, Marseille, France.	alain.thiery@imbe.fr	auffan, melanie/B-7022-2009; ROSE, Jerome/J-5063-2017; BORSCHNECK, Daniel/AAA-7461-2021; Artells, Ester/B-7193-2014	ROSE, Jerome/0000-0003-3071-8147; BORSCHNECK, Daniel/0000-0003-1655-1977; Artells, Ester/0000-0002-7068-145X; Thill, Antoine/0000-0003-0163-3638	French Agence Nationale de la Recherche; Post-Grenelle (French Ministry of Ecology and Sustainable Development) via the Antiopes (INERIS) network	French Agence Nationale de la Recherche(French National Research Agency (ANR)); Post-Grenelle (French Ministry of Ecology and Sustainable Development) via the Antiopes (INERIS) network	Financial supports were provided by the French Agence Nationale de la Recherche (ANR P2N 2010, MESONNET project), and the Post-Grenelle (French Ministry of Ecology and Sustainable Development) via the Antiopes (INERIS) network (IMPECNANO project). The authors also acknowledge the FR-ECCOREV research federation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arzate-Cardenas MA, 2011, AQUAT TOXICOL, V105, P528, DOI 10.1016/j.aquatox.2011.08.006; Amiano I, 2012, ENVIRON TOXICOL CHEM, V31, P2564, DOI 10.1002/etc.1981; Asghari S, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-14; Auffan DM., 2012, ENCY NANOTECHNOLOGY, P623, DOI DOI 10.1007/978-94-017-9780-1_332; Auffan M, 2013, WATER RES, V47, P3921, DOI 10.1016/j.watres.2012.11.063; Baillieul M, 1999, AQUAT TOXICOL, V44, P245, DOI 10.1016/S0166-445X(98)00080-0; Barata C, 2000, AQUAT TOXICOL, V48, P195, DOI 10.1016/S0166-445X(99)00038-7; Baun A, 2008, AQUAT TOXICOL, V86, P379, DOI 10.1016/j.aquatox.2007.11.019; Brausch KA, 2011, ENVIRON TOXICOL CHEM, V30, P878, DOI 10.1002/etc.442; Buffet PE, 2011, CHEMOSPHERE, V84, P166, DOI 10.1016/j.chemosphere.2011.02.003; Canesi L, 2010, AQUAT TOXICOL, V100, P168, DOI 10.1016/j.aquatox.2010.04.009; Chae YJ, 2009, AQUAT TOXICOL, V94, P320, DOI 10.1016/j.aquatox.2009.07.019; Christensen BT, 2005, AQUAT TOXICOL, V73, P210, DOI 10.1016/j.aquatox.2005.03.011; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Dabrunz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020112; Diot M.-A, 2012, ETUDE VIEILLISSEMENT; Ebert D., 2005, ECOLOGY EPIDEMIOLOGY; Fan WH, 2012, WATER RES, V46, P5981, DOI 10.1016/j.watres.2012.08.019; Federici G, 2007, AQUAT TOXICOL, V84, P415, DOI 10.1016/j.aquatox.2007.07.009; Ferrao AD, 2008, ENVIRON TOXICOL, V23, P161, DOI 10.1002/tox.20320; Ferreira JLR, 2012, ENVIRON TOXICOL CHEM, V31, P961, DOI 10.1002/etc.1792; Gaiser BK, 2011, J ENVIRON MONITOR, V13, P1227, DOI 10.1039/c1em10060b; Garaventa F, 2010, ECOTOXICOLOGY, V19, P512, DOI 10.1007/s10646-010-0461-8; Garcia A, 2011, DESALINATION, V269, P136, DOI 10.1016/j.desal.2010.10.052; Gerhardt A, 1995, ENVIRON SCI POLLUT R, V2, P15, DOI 10.1007/BF02987506; Goto T, 2003, MAR POLLUT BULL, V47, P139, DOI 10.1016/S0025-326X(03)00052-3; Gould P, 2006, NANO TODAY, V1, P19; Griffitt RJ, 2008, ENVIRON TOXICOL CHEM, V27, P1972, DOI 10.1897/08-002.1; Hall S, 2009, NANOTOXICOLOGY, V3, P91, DOI 10.1080/17435390902788078; Hamza W, 2000, INT REV HYDROBIOL, V85, P157, DOI 10.1002/(SICI)1522-2632(200004)85:2/3<157::AID-IROH157>3.0.CO;2-Y; HANEY JF, 1995, LIMNOL OCEANOGR, V40, P263, DOI 10.4319/lo.1995.40.2.0263; Heinlaan M, 2008, CHEMOSPHERE, V71, P1308, DOI 10.1016/j.chemosphere.2007.11.047; Hund-Rinke K, 2006, ENVIRON SCI POLLUT R, V13, P225, DOI 10.1065/espr2006.06.311; Ingle TM, 2008, B ENVIRON CONTAM TOX, V81, P249, DOI 10.1007/s00128-008-9481-y; Jensen KH, 2001, LIMNOL OCEANOGR, V46, P1013, DOI 10.4319/lo.2001.46.5.1013; Kim KT, 2010, SCI TOTAL ENVIRON, V408, P2268, DOI 10.1016/j.scitotenv.2010.01.041; Klaine SJ, 2008, ENVIRON TOXICOL CHEM, V27, P1825, DOI 10.1897/08-090.1; Klaper R, 2009, ENVIRON POLLUT, V157, P1152, DOI 10.1016/j.envpol.2008.11.010; LAGADIC L, 1994, ECOTOXICOLOGY, V3, P193, DOI 10.1007/BF00117084; Lagergren R, 2000, FUNCT ECOL, V14, P380, DOI 10.1046/j.1365-2435.2000.00433.x; Larsen PS, 2008, AQUAT BIOL, V4, P47, DOI 10.3354/ab00093; Lee SW, 2009, ENVIRON TOXICOL PHAR, V28, P86, DOI 10.1016/j.etap.2009.03.001; Li HC, 2009, ECOTOX ENVIRON SAFE, V72, P684, DOI 10.1016/j.ecoenv.2008.09.027; Lin WS, 2006, INT J TOXICOL, V25, P451, DOI 10.1080/10915810600959543; Lovern SB, 2007, ENVIRON SCI TECHNOL, V41, P4465, DOI 10.1021/es062146p; Lovern SB, 2006, ENVIRON TOXICOL CHEM, V25, P1132, DOI 10.1897/05-278R.1; Marcone GPS, 2012, J HAZARD MATER, V211, P436, DOI 10.1016/j.jhazmat.2011.12.075; Menard A, 2011, ENVIRON POLLUT, V159, P677, DOI 10.1016/j.envpol.2010.11.027; OECD, 2004, GUID TEST CHEM; OECD, 2010, SER SAF MAN NAN, V27; Park EJ, 2008, TOXICOL LETT, V180, P222, DOI 10.1016/j.toxlet.2008.06.869; Pirow R, 1999, J EXP BIOL, V202, P3089; Saez G, 2010, NANO TODAY, V5, P251, DOI 10.1016/j.nantod.2010.06.002; Schmidt K, 2005, ACTA HYDROCH HYDROB, V33, P287, DOI 10.1002/aheh.200400579; Seidl MD, 2002, ZOOLOGY, V105, P15, DOI 10.1078/0944-2006-00050; Shaw JR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-477; Som C, 2013, ACCOUNTS CHEM RES, V46, P863, DOI 10.1021/ar3000458; Tao XJ, 2011, J ENVIRON SCI-CHINA, V23, P322, DOI 10.1016/S1001-0742(10)60409-3; Thiery A, 2012, INT J NANOTECHNOL, V9, P181, DOI 10.1504/IJNT.2012.045326; Untersteiner H, 2003, AQUAT TOXICOL, V65, P435, DOI 10.1016/S0166-445X(03)00157-7; US EPA, 2002, METH MEAS AC TOX EFF, V5th ed; Van Hoecke K, 2009, ENVIRON SCI TECHNOL, V43, P4537, DOI 10.1021/es9002444; Vincent JFV, 2002, COMPOS PART A-APPL S, V33, P1311, DOI 10.1016/S1359-835X(02)00167-7; Warheit DB, 2007, TOXICOL LETT, V171, P99, DOI 10.1016/j.toxlet.2007.04.008; Wiench K, 2009, CHEMOSPHERE, V76, P1356, DOI 10.1016/j.chemosphere.2009.06.025; Wolf G, 1998, COMP BIOCHEM PHYS A, V120, P99, DOI 10.1016/S1095-6433(98)10016-8; Wu Y, 2013, ENVIRON TOXICOL CHEM, V32, P165, DOI 10.1002/etc.2038; Xia T, 2008, ACS NANO, V2, P2121, DOI 10.1021/nn800511k; Xia T, 2006, NANO LETT, V6, P1794, DOI 10.1021/nl061025k; Zhu SQ, 2006, MAR ENVIRON RES, V62, pS5, DOI 10.1016/j.marenvres.2006.04.059; Zhu XS, 2010, CHEMOSPHERE, V78, P209, DOI 10.1016/j.chemosphere.2009.11.013; Zhu XS, 2009, J NANOPART RES, V11, P67, DOI 10.1007/s11051-008-9426-8	72	62	64	0	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71260	10.1371/journal.pone.0071260	http://dx.doi.org/10.1371/journal.pone.0071260			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977004	Green Published, gold, Green Submitted			2022-12-25	WOS:000323378000036
J	Iacobino, A; Scalfaro, C; Franciosa, G				Iacobino, Angelo; Scalfaro, Concetta; Franciosa, Giovanna			Structure and Genetic Content of the Megaplasmids of Neurotoxigenic Clostridium butyricum Type E Strains from Italy	PLOS ONE			English	Article							INFANT BOTULISM; TOXIN; SYSTEM; TOOL	We determined the genetic maps of the megaplasmids of six neutoroxigenic Clostridium butyricum type E strains from Italy using molecular and bioinformatics techniques. The megaplasmids are circular, not linear as we had previously proposed. The differently-sized megaplasmids share a genetic region that includes structural, metabolic and regulatory genes. In addition, we found that a 168 kb genetic region is present only in the larger megaplasmids of two tested strains, whereas it is absent from the smaller megaplasmids of the four remaining strains. The genetic region unique to the larger megaplasmids contains, among other features, a locus for clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR associated (cas) genes, i.e. a bacterial adaptive immune system providing sequence-specific protection from invading genetic elements. Some CRISPR spacer sequences of the neurotoxigenic C. butyricum type E strains showed homology to prophage, phage and plasmid sequences from closely related clostridia species or from distant species, all sharing the intestinal habitat, suggesting that the CRISPR locus might be involved in the microorganism adaptation to the human or animal intestinal environment. Besides, we report here that each of four distinct CRISPR spacers partially matched DNA sequences of different prophages and phages, at identical nucleotide locations. This suggests that, at least in neurotoxigenic C. butyricum type E, the CRISPR locus is potentially able to recognize the same conserved DNA sequence of different invading genetic elements, besides targeting sequences unique to previously encountered invading DNA, as currently predicted for a CRISPR locus. Thus, the results of this study introduce the possibility that CRISPR loci can provide resistance to a wider range of invading DNA elements than previously appreciated. Whether it is more advantageous for the peculiar neurotoxigenic C. butyricum type E strains to maintain or to lose the CRISPR-cas system remains an open question.	[Iacobino, Angelo; Scalfaro, Concetta; Franciosa, Giovanna] Ist Super Sanita, Dept Food Safety & Vet Publ Hlth, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS)	Franciosa, G (corresponding author), Ist Super Sanita, Dept Food Safety & Vet Publ Hlth, Viale Regina Elena 299, I-00161 Rome, Italy.	giovanna.franciosa@iss.it	Iacobino, Angelo/K-5805-2016; SCALFARO, CONCETTA/C-7041-2015; FRANCIOSA, GIOVANNA/C-7040-2015; Iacobino, Angelo/O-2172-2019	Iacobino, Angelo/0000-0002-0176-3662; SCALFARO, CONCETTA/0000-0001-8626-7563; FRANCIOSA, GIOVANNA/0000-0003-1520-4826; Iacobino, Angelo/0000-0002-0176-3662	Istituto Superiore di Sanita [11US/P2]	Istituto Superiore di Sanita	This work was supported by the Istituto Superiore di Sanita through grant 11US/P2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anniballi F, 2002, J FOOD PROTECT, V65, P1267, DOI 10.4315/0362-028X-65.8.1267; AURELI P, 1986, J INFECT DIS, V154, P207, DOI 10.1093/infdis/154.2.207; Bendich AJ, 2001, BIOCHIMIE, V83, P177, DOI 10.1016/S0300-9084(00)01209-8; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Biswas A, 2013, RNA BIOL, V10, P817, DOI 10.4161/rna.24046; Connan C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041848; Fenicia L, 2002, EUR J CLIN MICROBIOL, V21, P736, DOI 10.1007/s10096-002-0816-z; Fenicia L, 1999, CLIN INFECT DIS, V29, P1381, DOI 10.1086/313497; Franciosa G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021706; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; HALL JD, 1985, J CLIN MICROBIOL, V21, P654, DOI 10.1128/JCM.21.4.654-655.1985; Hatheway C. L., 1992, CLOSTRIDIUM BOTULINU, P3; Hill KK, 2013, CURR TOP MICROBIOL, V364, P1, DOI 10.1007/978-3-642-33570-9_1; Hill KK, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-66; Horvath P, 2009, INT J FOOD MICROBIOL, V131, P62, DOI 10.1016/j.ijfoodmicro.2008.05.030; Hunter SB, 2005, J CLIN MICROBIOL, V43, P1045, DOI 10.1128/JCM.43.3.1045-1050.2005; Johnson EA, 2005, PHAGES THEIR ROLE BA, P280; Lima-Mendez G, 2008, BIOINFORMATICS, V24, P863, DOI 10.1093/bioinformatics/btn043; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Schunder E, 2013, INT J MED MICROBIOL, V303, P51, DOI 10.1016/j.ijmm.2012.11.004; Stern A, 2012, GENOME RES, V22, P1985, DOI 10.1101/gr.138297.112; SUEN JC, 1988, INT J SYST BACTERIOL, V38, P375, DOI 10.1099/00207713-38-4-375; WILSON GG, 1991, ANNU REV GENET, V25, P585, DOI 10.1146/annurev.ge.25.120191.003101	24	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71324	10.1371/journal.pone.0071324	http://dx.doi.org/10.1371/journal.pone.0071324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967192	Green Submitted, gold, Green Published			2022-12-25	WOS:000323378000040
J	Van Loy, T; Thys, K; Tritsmans, L; Stuyver, LJ				Van Loy, Tom; Thys, Kim; Tritsmans, Luc; Stuyver, Lieven J.			Quasispecies Analysis of JC Virus DNA Present in Urine of Healthy Subjects	PLOS ONE			English	Article							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; POLYOMAVIRUS-BK; TRANSPLANT RECIPIENTS; CEREBROSPINAL-FLUID; T' PROTEINS; REPLICATION; REGION; SEQUENCES; PATHOGENESIS; INDIVIDUALS	JC virus is a human polyomavirus that infects the majority of people without apparent symptoms in healthy subjects and it is the causative agent of progressive multifocal leucoencephalopathy (PML), a disorder following lytic infection of oligodendrocytes that mainly manifests itself under immunosuppressive conditions. A hallmark for JC virus isolated from PML-brain is the presence of rearrangements in the non-coding control region (NCCR) interspersed between the early and late genes on the viral genome. Such rearrangements are believed to originate from the archetype JC virus which is shed in urine by healthy subjects and PML patients. We applied next generation sequencing to explore the non-coding control region variability in urine of healthy subjects in search for JC virus quasispecies and rearrangements reminiscent of PML. For 61 viral shedders (out of a total of 254 healthy subjects) non-coding control region DNA and VP1 (major capsid protein) coding sequences were initially obtained by Sanger sequencing. Deletions between 1 and 28 nucleotides long appeared in similar to 24.5% of the NCCR sequences while insertions were only detected in similar to 3.3% of the samples. 454 pyrosequencing was applied on a subset of 54 urine samples demonstrating the existence of JC virus quasispecies in four subjects (similar to 7.4%). Hence, our results indicate that JC virus DNA in urine is not always restricted to one unique virus variant, but can be a mixture of naturally occurring variants (quasispecies) reflecting the susceptibility of the non-coding control region for genomic rearrangements in healthy individuals. Our findings pave the way to explore the presence of viral quasispecies and the altered viral tropism that might go along with it as a potential risk factor for opportunistic secondary infections such as PML.	[Van Loy, Tom; Stuyver, Lieven J.] Janssen Diagnost, Beerse, Belgium; [Thys, Kim] Janssen Infect Dis Community Res Excellence & Adv, Beerse, Belgium; [Tritsmans, Luc] Janssen Neurosci Dev, Beerse, Belgium		Van Loy, T (corresponding author), Janssen Diagnost, Beerse, Belgium.	tvanloy@its.jnj.com	Van Loy, Tom/E-2374-2018	Van Loy, Tom/0000-0003-2524-7264	Agentschap voor Innovatie door Wetenschap en Technologie [120480]	Agentschap voor Innovatie door Wetenschap en Technologie	This work was funded in part by the 'Agentschap voor Innovatie door Wetenschap en Technologie'; http://www.iwt.be/; IWT-project nr 120480. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Agostini HT, 2001, J GEN VIROL, V82, P1221, DOI 10.1099/0022-1317-82-5-1221; Agostini HT, 1996, J CLIN MICROBIOL, V34, P159, DOI 10.1128/JCM.34.1.159-164.1996; Ault GS, 1997, J GEN VIROL, V78, P163, DOI 10.1099/0022-1317-78-1-163; Barcena-Panero A, 2012, J CELL PHYSIOL, V227, P136, DOI 10.1002/jcp.22711; Bennett SM, 2012, MICROBES INFECT, V14, P672, DOI 10.1016/j.micinf.2012.02.002; Berger JR, 2006, CLIN INFECT DIS, V43, pE9, DOI 10.1086/504947; Daniel AM, 1996, VIROLOGY, V216, P90, DOI 10.1006/viro.1996.0037; Drachenberg CB, 2007, TRANSPLANTATION, V84, P323, DOI 10.1097/01.tp.0000269706.59977.a5; Egli A, 2009, J INFECT DIS, V199, P837, DOI 10.1086/597126; Ferenczy MW, 2012, CLIN MICROBIOL REV, V25, P471, DOI 10.1128/CMR.05031-11; Frisque RJ, 2001, J NEUROVIROL, V7, P293, DOI 10.1080/13550280152537120; FRISQUE RJ, 1984, J VIROL, V51, P458, DOI 10.1128/JVI.51.2.458-469.1984; Gosert R, 2008, J EXP MED, V205, P841, DOI 10.1084/jem.20072097; Gosert R, 2010, J VIROL, V84, P10448, DOI 10.1128/JVI.00614-10; Jensen PN, 2001, J NEUROVIROL, V7, P280; Johnson EM, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/197807; Kazory A, 2003, TRANSPLANTATION, V76, P1653, DOI 10.1097/01.TP.0000090749.42791.14; Keene DL, 2011, CAN J NEUROL SCI, V38, P565, DOI 10.1017/S0317167100012105; Langer-Gould A, 2005, NEW ENGL J MED, V353, P375, DOI 10.1056/NEJMoa051847; Major EO, 2010, ANNU REV MED, V61, P35, DOI 10.1146/annurev.med.080708.082655; Marshall LJ, 2010, J GEN VIROL, V91, P3042, DOI 10.1099/vir.0.023184-0; Marshall LJ, 2010, J NEUROIMMUNE PHARM, V5, P404, DOI 10.1007/s11481-010-9203-1; Olsen GH, 2009, J MED VIROL, V81, P1959, DOI 10.1002/jmv.21605; Prins C, 2001, J NEUROVIROL, V7, P250; Reid CE, 2011, J INFECT DIS, V204, P237, DOI 10.1093/infdis/jir256; Ryschkewitsch C, 2004, J VIROL METHODS, V121, P217, DOI 10.1016/j.jviromet.2004.06.021; Ryschkewitsch CF, 2000, MICROBES INFECT, V2, P987, DOI 10.1016/S1286-4579(00)01252-1; Schowalter RM, 2010, CELL HOST MICROBE, V7, P509, DOI 10.1016/j.chom.2010.05.006; van der Meijden E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001024; White MK, 2011, J INFECT DIS, V203, P578, DOI 10.1093/infdis/jiq097; Wu KN, 2010, INT J SURG PATHOL, V18, P342, DOI 10.1177/1066896910371638; YOGO Y, 1990, J VIROL, V64, P3139, DOI 10.1128/JVI.64.6.3139-3143.1990; Yogo Y, 2008, VIROLOGY, V380, P118, DOI 10.1016/j.virol.2008.07.016	33	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e70950	10.1371/journal.pone.0070950	http://dx.doi.org/10.1371/journal.pone.0070950			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967139	Green Published, gold, Green Submitted			2022-12-25	WOS:000323378000026
J	Xin, Q; Niu, HX; Li, Z; Zhang, GP; Hu, LN; Wang, BX; Li, JJ; Yu, HJ; Liu, WB; Wang, Y; Da, ZJ; Li, RY; Xian, QY; Wang, Y; Zhang, Y; Jing, T; Ma, XM; Zhu, BD				Xin, Qi; Niu, Hongxia; Li, Zhi; Zhang, Guoping; Hu, Lina; Wang, Bingxiang; Li, Jingjing; Yu, Hongjuan; Liu, Wanbo; Wang, Yue; Da, Zejiao; Li, Ruiying; Xian, Qiaoyang; Wang, Yong; Zhang, Ying; Jing, Tao; Ma, Xingming; Zhu, Bingdong			Subunit Vaccine Consisting of Multi-Stage Antigens Has High Protective Efficacy against Mycobacterium tuberculosis Infection in Mice	PLOS ONE			English	Article							T-CELL RESPONSES; EFFICIENT PROTECTION; CALMETTE-GUERIN; BCG VACCINATION; BOVIS BCG; IMMUNOGENICITY; IMMUNITY; IL-17; METAANALYSIS; PREVENTION	To search for more effective tuberculosis (TB) subunit vaccines, antigens expressed in different growth stages of Mycobacterium tuberculosis (M. tuberculosis), such as RpfE (Rv2450c) produced in the stage of resuscitation, Mtb10.4 (Rv0288), Mtb8.4 (Rv1174c), ESAT6 (Rv3875), Ag85B (Rv1886c) mainly secreted by replicating bacilli, and HspX (Rv2031c) highly expressed in dormant bacilli, were selected to construct six fusion proteins: ESAT6-Ag85B-MPT64(190-198)-Mtb8.4 (EAMM), Mtb10.4-HspX (MH), ESAT6-Mtb8.4, Mtb10.4-Ag85B, ESAT6-Ag85B, and ESAT6-RpfE. The six fusion proteins were separately emulsified in an adjuvant composed of N, N'-dimethyl-N, N'-dioctadecylammonium bromide (DDA), polyribocytidylic acid (poly I:C) and gelatin to construct subunit vaccines, and their protective effects against M. tuberculosis infection were evaluated in C57BL/6 mice. Furthermore, the boosting effects of EAMM and MH in the adjuvant of DDA plus trehalose 6,6'-dimycolate (TDM) on BCG-induced immunity were also evaluated. It was found that the six proteins were stably produced in E. coli and successfully purified by chromatography. Among them, EAMM presented the most effective protection against M. tuberculosis. Interestingly, the mice that received EAMM+MH had significantly lower bacterial counts in the lungs and spleens than the single protein vaccinated groups, and had the same effect as those that received BCG. In addition, EAMM and MH could improve BCG-primed protective efficacy against M. tuberculosis infection in mice. In conclusion, the combination of EAMM and MH containing antigens from both replicating and dormant stages of the bacilli could induce robust immunity against M. tuberculosis infection in mice and may serve as promising subunit vaccine candidate.	[Xin, Qi; Niu, Hongxia; Li, Zhi; Zhang, Guoping; Li, Jingjing; Yu, Hongjuan; Liu, Wanbo; Wang, Yue; Da, Zejiao; Li, Ruiying; Jing, Tao; Ma, Xingming; Zhu, Bingdong] Lanzhou Univ, Lanzhou Ctr TB Res, Lanzhou 730000, Peoples R China; [Xin, Qi; Niu, Hongxia; Li, Zhi; Zhang, Guoping; Li, Jingjing; Yu, Hongjuan; Liu, Wanbo; Wang, Yue; Da, Zejiao; Li, Ruiying; Jing, Tao; Ma, Xingming; Zhu, Bingdong] Lanzhou Univ, Inst Pathogen Biol, Sch Basic Med Sci, Lanzhou 730000, Peoples R China; [Hu, Lina; Wang, Bingxiang] Lanzhou Inst Biol Prod, Lanzhou, Peoples R China; [Xian, Qiaoyang; Wang, Yong] Wuhan Univ, ABSL Lab 3, Lanzhou, Peoples R China; [Zhang, Ying] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA	Lanzhou University; Lanzhou University; Wuhan University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Zhu, BD (corresponding author), Lanzhou Univ, Lanzhou Ctr TB Res, Lanzhou 730000, Peoples R China.	bdzhu@lzu.edu.cn			National Major Science and Technology Projects [2012ZX10003-008-006, 2008ZX-10003-01305]; NSFC of China [81072499]	National Major Science and Technology Projects; NSFC of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Major Science and Technology Projects (2012ZX10003-008-006, 2008ZX-10003-01305; http://www.nmp.gov.cn/) and NSFC of China (81072499; http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; *AER, 2012, VACC DEV PROC; Altare F, 1998, SCIENCE, V280, P1432, DOI 10.1126/science.280.5368.1432; Andersen P, 2007, TRENDS MICROBIOL, V15, P7, DOI 10.1016/j.tim.2006.11.008; Bertholet S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001094; Brandt L, 2004, INFECT IMMUN, V72, P6622, DOI 10.1128/IAI.72.11.6622-6632.2004; Calmette A, 1931, Proc R Soc Med, V24, P1481; Cardona PJ, 2005, VACCINE, V23, P1393, DOI 10.1016/j.vaccine.2004.09.008; Cohen-Gonsaud M, 2004, TRENDS BIOCHEM SCI, V29, P7, DOI 10.1016/j.tibs.2003.10.009; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Coler RN, 1998, J IMMUNOL, V161, P2356; Dietrich J, 2005, J IMMUNOL, V174, P6332, DOI 10.4049/jimmunol.174.10.6332; Downing KJ, 2005, INFECT IMMUN, V73, P3038, DOI 10.1128/IAI.73.5.3038-3043.2005; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Ghebreyesus TA, 2010, LANCET, V375, P1757, DOI 10.1016/S0140-6736(10)60595-8; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Hawkridge T, 2008, J INFECT DIS, V198, P544, DOI 10.1086/590185; HORWITZ MA, 1995, P NATL ACAD SCI USA, V92, P1530, DOI 10.1073/pnas.92.5.1530; Huygen K, 1996, NAT MED, V2, P893, DOI 10.1038/nm0896-893; Kana BD, 2008, MOL MICROBIOL, V67, P672, DOI 10.1111/j.1365-2958.2007.06078.x; Kaufmann SHE, 2012, CURR OPIN BIOTECH, V23, P900, DOI 10.1016/j.copbio.2012.03.007; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; KOCHI A, 1991, TUBERCLE, V72, P1, DOI 10.1016/0041-3879(91)90017-M; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Li Q, 2012, EUR REV MED PHARMACO, V16, P2029; Li Q, 2011, SCAND J IMMUNOL, V73, P568, DOI 10.1111/j.1365-3083.2011.02531.x; Lozes E, 1997, VACCINE, V15, P830, DOI 10.1016/S0264-410X(96)00274-5; Luo Y, 2009, VACCINE, V27, P6179, DOI 10.1016/j.vaccine.2009.08.018; Niu HX, 2011, VACCINE, V29, P9451, DOI 10.1016/j.vaccine.2011.10.032; Pollock JM, 1996, IMMUNOLOGY, V87, P236, DOI 10.1046/j.1365-2567.1996.457538.x; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; SILVER RF, 1995, J IMMUNOL, V154, P4665; Skjot RLV, 2000, INFECT IMMUN, V68, P214, DOI 10.1128/IAI.68.1.214-220.2000; Sweeney KA, 2011, NAT MED, V17, P1261, DOI 10.1038/nm.2420; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Ulrichs T, 1998, EUR J IMMUNOL, V28, P3949, DOI 10.1002/(SICI)1521-4141(199812)28:12<3949::AID-IMMU3949>3.0.CO;2-4; van Dissel JT, 2010, VACCINE, V28, P3571, DOI 10.1016/j.vaccine.2010.02.094; von Reyn CF, 2010, AIDS, V24, P675, DOI 10.1097/QAD.0b013e3283350f1b; Wang CC, 2013, RESPIROLOGY, V18, P412, DOI 10.1111/resp.12052; Welsh MD, 2005, IMMUNOLOGY, V114, P101, DOI 10.1111/j.1365-2567.2004.02003.x; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7; Hu XB, 2008, RESPIROLOGY, V13, P781, DOI 10.1111/j.1440-1843.2008.01347.x; Xing Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005856; Zhang Y, 2007, CLIN PHARMACOL THER, V82, P595, DOI 10.1038/sj.clpt.6100362; ZHU B, 2011, ZHU B, pN2011; ZHU B, 2010, Patent No. 2010106133206	49	48	54	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e72745	10.1371/journal.pone.0072745	http://dx.doi.org/10.1371/journal.pone.0072745			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967337	Green Published, Green Submitted, gold			2022-12-25	WOS:000323378000111
J	George, AE; Chapman, DC				George, Amy E.; Chapman, Duane C.			Aspects of Embryonic and Larval Development in Bighead Carp Hypophthalmichthys nobilis and Silver Carp Hypophthalmichthys molitrix	PLOS ONE			English	Article							BURST-SWIMMING PERFORMANCE; CATOSTOMUS-COMMERSONI; HATCHING SUCCESS; WATER HARDNESS; EGG DIAMETER; STRIPED BASS; WHITE SUCKER; LAKE-ERIE; TEMPERATURE; FISH	As bighead carp Hypophthalmichthys nobilis and silver carp H. molitrix (the bigheaded carps) are poised to enter the Laurentian Great Lakes and potentially damage the region's economically important fishery, information on developmental rates and behaviors of carps is critical to assessing their ability to establish sustainable populations within the Great Lakes basin. In laboratory experiments, the embryonic and larval developmental rates, size, and behaviors of bigheaded carp were tracked at two temperature treatments, one "cold" and one "warm". Developmental rates were computed using previously described stages of development and the cumulative thermal unit method. Both species have similar thermal requirements, with a minimum developmental temperature for embryonic stages of 12.1 degrees C for silver carp and 12.9 degrees C for bighead carp, and 13.3 degrees C for silver carp larval stages and 13.4 degrees C for bighead carp larval stages. Egg size differed among species and temperature treatments, as egg size was larger in bighead carp, and "warm" temperature treatments. The larvae started robust upwards vertical swimming immediately after hatching, interspersed with intervals of sinking. Vertical swimming tubes were used to measure water column distribution, and ascent and descent rates of vertically swimming fish. Water column distribution and ascent and descent rates changed with ontogeny. Water column distribution also showed some diel periodicity. Developmental rates, size, and behaviors contribute to the drift distance needed to fulfill the early life history requirements of bigheaded carps and can be used in conjunction with transport information to assess invasibility of a river.	[George, Amy E.; Chapman, Duane C.] US Geol Survey, Columbia Environm Res Ctr, Columbia, MO USA	United States Department of the Interior; United States Geological Survey	George, AE (corresponding author), US Geol Survey, Columbia Environm Res Ctr, Columbia, MO USA.	ageorge@usgs.gov		Chapman, Duane/0000-0002-1086-8853	Great Lakes Restoration Initiative	Great Lakes Restoration Initiative	Funding was provided by the Great Lakes Restoration Initiative (http://greatlakesrestoration.us/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdusamadov AS., 1987, J ICHTHYOL, V26, P41; Alderdice DF, 1978, J FISH RES BOARD CAN, V35, P65; Associates Southwick Inc., 2008, OD ANGL, P206; BATTY RS, 1992, J EXP BIOL, V170, P187; BATTY RS, 1993, MAR BIOL, V115, P523, DOI 10.1007/BF00349358; BERVEN KA, 1982, OECOLOGIA, V52, P360, DOI 10.1007/BF00367960; BETTOLI PW, 1985, J FISH BIOL, V27, P239, DOI 10.1111/j.1095-8649.1985.tb04024.x; BLAXTER JHS, 1992, NETH J ZOOL, V42, P336, DOI 10.1163/156854291X00379; Breder CM., 1966, MODES REPROD FISHES; Burt JM, 2011, REV FISH BIOL FISHER, V21, P377, DOI 10.1007/s11160-010-9179-1; Chang YF, 1966, CHINESE FISH CULTURE; CHAPMAN DC, 1988, PROG FISH CULT, V50, P23, DOI 10.1577/1548-8640(1988)050<0023:IOATAA>2.3.CO;2; Chapman DC, 2011, SIR115076 US GEOL SU, P11; Chapman DC, 2006, US GEOLOGICAL SURVEY, V239, P51; Chapman DC, 2009, T AM FISH SOC, V138, P1226, DOI 10.1577/T09-004.1; Cudmore B, 2012, BINATIONAL ECOLOGICA, P57; Dahi Hassan F., 2009, Egyptian Academic Journal of Biological Sciences A Entomology, V2, P117; DAOULAS C, 1986, J FISH BIOL, V28, P449, DOI 10.1111/j.1095-8649.1986.tb05182.x; Deters JE, 2013, ENVIRON BIOL FISH, V96, P617, DOI 10.1007/s10641-012-0052-z; Dudley RK, 1999, J FRESHWATER ECOL, V14, P423, DOI 10.1080/02705060.1999.9663700; ELLIOTT JM, 1987, ARCH HYDROBIOL, V109, P257; FUIMAN LA, 1980, COPEIA, P699, DOI 10.2307/1444446; FUIMAN LA, 1986, T AM FISH SOC, V115, P143, DOI 10.1577/1548-8659(1986)115<143:BPOLZD>2.0.CO;2; Garcia T, 2013, ECOL MODEL, V263, P211, DOI 10.1016/j.ecolmodel.2013.05.005; Geffen AJ, 2012, FISH RES, V117, P48, DOI 10.1016/j.fishres.2011.01.002; GUMAA SA, 1978, FRESHWATER BIOL, V8, P221, DOI 10.1111/j.1365-2427.1978.tb01443.x; Hamel P, 1997, CAN J FISH AQUAT SCI, V54, P2040, DOI 10.1139/f97-103; Hamel P, 1997, CAN J FISH AQUAT SCI, V54, P190, DOI 10.1139/cjfas-54-1-190; HERDENDORF CE, 1990, ESTUARIES, V13, P493, DOI 10.2307/1351795; HERZIG A, 1986, J FISH BIOL, V28, P171, DOI 10.1111/j.1095-8649.1986.tb05155.x; Huet M, 1970, TXB FISH CULTURE BRE; Jatteau P, 2008, J FISH BIOL, V72, P742, DOI 10.1111/j.1095-8649.2007.01718.x; Jennings DP, 1988, BIGHEAD CARP HYPOPHT, P35; Jhingran V., 1985, HATCHERY MANUAL COMM; Kaushal DK, 2007, INDIAN J ANIM SCI, V77, P926; Knighton D., 1998, FLUVIAL FORMS PROCES; Kocovsky PM, 2012, J GREAT LAKES RES, V38, P159, DOI 10.1016/j.jglr.2011.11.015; KOLAR CS, 2007, BIGHEADED CARPS BIOL; Konstantinov A. S., 1986, J ICHTHYOL+, V26, P65; Krykhtin ML, 1981, J ICHTHYOL+, V21, P109; Landsman SJ, 2011, J FISH BIOL, V78, P1200, DOI 10.1111/j.1095-8649.2011.02927.x; McDowall RM, 2009, REV FISH BIOL FISHER, V19, P1, DOI 10.1007/s11160-008-9085-y; Morrison BJ, 2004, FISHERIES, V29, P6; Murphy EA., 2013, SCI INVESTIGATIONS R; Murty D.S., 1990, Journal of the Inland Fisheries Society of India, V18, P4; Nico LG, 2005, POTENTIAL GEOGRAPHIC, P197; OPUSZYNSKI K, 1989, Aquaculture and Fisheries Management, V20, P287, DOI 10.1111/j.1365-2109.1989.tb00354.x; Piper R.G., 1982, FISH HATCHERY MANAGE, V1st ed.; Rach JJ, 2010, N AM J FISH MANAGE, V30, P230, DOI 10.1577/M09-067.1; Schludermann E, 2012, CAN J FISH AQUAT SCI, V69, P1302, DOI 10.1139/F2012-061; Soin SG, 1972, J ICHTHYOL, V12, P67; Spade S, 1999, N AM J AQUACULT, V61, P263, DOI 10.1577/1548-8454(1999)061<0263:EOIWHO>2.0.CO;2; Wu H, 2000, INLAND WATER FISHERI, V3, P7; Yi B, 1988, GEZHOUBA WATER CONTR, P69; Zigler Steven J., 1995, North American Journal of Fisheries Management, V15, P651, DOI 10.1577/1548-8675(1995)015<0651:MBPOLA>2.3.CO;2	55	39	39	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e73829	10.1371/journal.pone.0073829	http://dx.doi.org/10.1371/journal.pone.0073829			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967350	Green Published, Green Submitted, gold			2022-12-25	WOS:000323221500149
J	Lustig, A; Ketter-Katz, H; Katzir, G				Lustig, Avichai; Ketter-Katz, Hadas; Katzir, Gadi			Relating Lateralization of Eye Use to Body Motion in the Avoidance Behavior of the Chameleon (Chamaeleo chameleon)	PLOS ONE			English	Article							SOCIAL-STIMULI; HEAD MOVEMENTS; TELEOST FISH; BRAIN; PREFERENCES; FOOT; ACCOMMODATION; INSPECTION; DOMINANCE; RESPONSES	Lateralization is mostly analyzed for single traits, but seldom for two or more traits while performing a given task (e. g. object manipulation). We examined lateralization in eye use and in body motion that co-occur during avoidance behaviour of the common chameleon, Chamaeleo chameleon. A chameleon facing a moving threat smoothly repositions its body on the side of its perch distal to the threat, to minimize its visual exposure. We previously demonstrated that during the response (i) eye use and body motion were, each, lateralized at the tested group level (N = 26), (ii) in body motion, we observed two similarsized sub-groups, one exhibiting a greater reduction in body exposure to threat approaching from the left and one - to threat approaching from the right (left-and right-biased subgroups), (iii) the left-biased sub-group exhibited weak lateralization of body exposure under binocular threat viewing and none under monocular viewing while the right-biased sub-group exhibited strong lateralization under both monocular and binocular threat viewing. In avoidance, how is eye use related to body motion at the entire group and at the sub-group levels? We demonstrate that (i) in the left-biased subgroup, eye use is not lateralized, (ii) in the right-biased sub-group, eye use is lateralized under binocular, but not monocular viewing of the threat, (iii) the dominance of the right-biased sub-group determines the lateralization of the entire group tested. We conclude that in chameleons, patterns of lateralization of visual function and body motion are inter-related at a subtle level. Presently, the patterns cannot be compared with humans' or related to the unique visual system of chameleons, with highly independent eye movements, complete optic nerve decussation and relatively few interhemispheric commissures. We present a model to explain the possible inter-hemispheric differences in dominance in chameleons' visual control of body motion during avoidance.	[Lustig, Avichai; Ketter-Katz, Hadas] Univ Haifa, Dept Neurobiol & Ethol, IL-31999 Haifa, Israel; [Katzir, Gadi] Univ Haifa, Dept Environm & Evolutionary Biol, IL-31999 Haifa, Israel; [Katzir, Gadi] Univ Haifa, Dept Marine Biol, IL-31999 Haifa, Israel; [Katzir, Gadi] Univ Haifa, Dept Biol, Tivon, Israel	University of Haifa; University of Haifa; University of Haifa; University of Haifa	Lustig, A (corresponding author), Univ Haifa, Dept Neurobiol & Ethol, IL-31999 Haifa, Israel.	Lustigavi@gmail.com			Israel Academy of Sciences and Humanities - Israel Science Foundation [20978009]	Israel Academy of Sciences and Humanities - Israel Science Foundation	The research was funded by the Israel Academy of Sciences and Humanities - Israel Science Foundation (#20978009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avni O, 2010, MACH VISION APPL, P1; Baciadonna L, 2010, BEHAV PROCESS, V83, P130, DOI 10.1016/j.beproc.2009.09.004; BENNIS M, 1994, BRAIN BEHAV EVOLUT, V43, P173, DOI 10.1159/000113633; Bisazza A, 1997, BEHAV BRAIN RES, V89, P237, DOI 10.1016/S0166-4328(97)00061-2; Bisazza A, 1998, BEHAV BRAIN RES, V91, P157, DOI 10.1016/S0166-4328(97)00114-9; Bisazza A, 2001, PHYSIOL BEHAV, V72, P575, DOI 10.1016/S0031-9384(01)00417-6; Bisazza A, 1997, BRAIN COGNITION, V2, P49; Bonati B, 2008, BEHAV PROCESS, V79, P171, DOI 10.1016/j.beproc.2008.07.007; Bourassa D C, 1996, Laterality, V1, P5, DOI 10.1080/713754206; Csermely D, 2010, LATERALITY, V15, P535, DOI 10.1080/13576500903051619; Dadda M, 2010, BIOL LETTERS, V6, P414, DOI 10.1098/rsbl.2009.0904; Dawkins MS, 2002, ANIM BEHAV, V63, P991, DOI [10.1006/anbe.2002.1999, 10.1006/anbe.2002.999]; De Santi A, 2001, ANIM BEHAV, V61, P305, DOI 10.1006/anbe.2000.1566; Deckel AW, 1997, J EXP ZOOL, V278, P9, DOI 10.1002/(SICI)1097-010X(19970501)278:1<9::AID-JEZ2>3.0.CO;2-T; HARKNESS L, 1977, NATURE, V267, P346, DOI 10.1038/267346a0; Hews DK, 2004, ANIM BEHAV, V68, P1201, DOI 10.1016/j.anbehav.2003.11.024; Izawa EI, 2005, BEHAV PROCESS, V69, P357, DOI 10.1016/j.beproc.2005.02.001; Lustig A, 2012, ANIM COGN, V15, P609, DOI 10.1007/s10071-012-0489-7; Lustig A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037875; Malashichev YB, 2004, BIOESSAYS, V26, P512, DOI 10.1002/bies.20036; Malashichev YB, 2006, J COMP PSYCHOL, V120, P401, DOI 10.1037/0735-7036.120.4.401; McGavin Sharon, 2009, Notornis, V56, P139; NACHSHON I, 1983, INT J NEUROSCI, V18, P1, DOI 10.3109/00207458308985872; Nedellec-Bienvenue D, 2005, FOLIA PRIMATOL, V76, P234, DOI 10.1159/000086026; Ott M, 2006, J COMP PHYSIOL A, V192, P97, DOI 10.1007/s00359-005-0049-6; Ott M, 2001, EXP BRAIN RES, V139, P173, DOI 10.1007/s002210100774; PORAC C, 1975, PERCEPT MOTOR SKILL, V40, P763, DOI 10.2466/pms.1975.40.3.763; PRATT DW, 1982, J EXP BIOL, V97, P217; Prior H, 2004, BEHAV BRAIN RES, V154, P301, DOI 10.1016/j.bbr.2004.02.018; Randler C, 2011, LATERALITY, V16, P201, DOI 10.1080/13576500903513188; Reddon AR, 2010, BEHAV PROCESS, V85, P68, DOI 10.1016/j.beproc.2010.06.008; Robins A, 1998, ANIM BEHAV, V56, P875, DOI 10.1006/anbe.1998.0877; Sovrano VA, 1999, BEHAV BRAIN RES, V106, P175, DOI 10.1016/S0166-4328(99)00105-9; Sovrano VA, 2001, PHYSIOL BEHAV, V74, P237, DOI 10.1016/S0031-9384(01)00552-2; Vallortigara G, 2000, BRAIN LANG, V73, P189, DOI 10.1006/brln.2000.2303; Vallortigara G, 2005, BEHAV BRAIN SCI, V28, P575, DOI 10.1017/S0140525X05000105; Vallortigara G, 2006, DEV PSYCHOBIOL, V48, P418, DOI 10.1002/dev.20166; Vallortigara G, 2011, WIRES COGN SCI, V2, P146, DOI 10.1002/wcs.100; Zucca P, 2008, CORTEX, V44, P13, DOI 10.1016/j.cortex.2006.01.002	39	6	6	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e70761	10.1371/journal.pone.0070761	http://dx.doi.org/10.1371/journal.pone.0070761			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967099	gold, Green Published, Green Submitted			2022-12-25	WOS:000323221500026
J	Rihani, A; Van Maerken, T; Pattyn, F; Van Peer, G; Beckers, A; De Brouwer, S; Kumps, C; Mets, E; Van der Meulen, J; Rondou, P; Leonelli, C; Mestdagh, P; Speleman, F; Vandesompele, J				Rihani, Ali; Van Maerken, Tom; Pattyn, Filip; Van Peer, Gert; Beckers, Anneleen; De Brouwer, Sara; Kumps, Candy; Mets, Evelien; Van der Meulen, Joni; Rondou, Pieter; Leonelli, Carina; Mestdagh, Pieter; Speleman, Frank; Vandesompele, Jo			Effective Alu Repeat Based RT-Qpcr Normalization in Cancer Cell Perturbation Experiments	PLOS ONE			English	Article							REAL-TIME PCR; GENE-EXPRESSION; NEUROBLASTOMA-CELLS; RIBOSOMAL-RNA; INAPPROPRIATE; INHIBITOR; MESSENGER; TISSUE; TUMORS	Background: Measuring messenger RNA (mRNA) levels using the reverse transcription quantitative polymerase chain reaction (RT-qPCR) is common practice in many laboratories. A specific set of mRNAs as internal control reference genes is considered as the preferred strategy to normalize RT-qPCR data. Proper selection of reference genes is a critical issue, especially in cancer cells that are subjected to different in vitro manipulations. These manipulations may result in dramatic alterations in gene expression levels, even of assumed reference genes. In this study, we evaluated the expression levels of 11 commonly used reference genes as internal controls for normalization of 19 experiments that include neuroblastoma, TALL, melanoma, breast cancer, non small cell lung cancer (NSCL), acute myeloid leukemia (AML), prostate cancer, colorectal cancer, and cervical cancer cell lines subjected to various perturbations. Results: The geNorm algorithm in the software package qbase+ was used to rank the candidate reference genes according to their expression stability. We observed that the stability of most of the candidate reference genes varies greatly in perturbation experiments. Expressed Alu repeats show relatively stable expression regardless of experimental condition. These Alu repeats are ranked among the best reference assays in all perturbation experiments and display acceptable average expression stability values (M<0.5). Conclusions: We propose the use of Alu repeats as a reference assay when performing cancer cell perturbation experiments.	[Rihani, Ali; Van Maerken, Tom; Pattyn, Filip; Van Peer, Gert; Beckers, Anneleen; De Brouwer, Sara; Kumps, Candy; Mets, Evelien; Van der Meulen, Joni; Rondou, Pieter; Leonelli, Carina; Mestdagh, Pieter; Speleman, Frank; Vandesompele, Jo] Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium	Ghent University; Ghent University Hospital	Vandesompele, J (corresponding author), Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium.	Joke.Vandesompele@UGent.be	Pattyn, Filip/A-4164-2015; Van Peer, Gert/AAV-6861-2020; speleman, frank/AAR-5184-2020; Van der Meulen, Joni/AFS-1616-2022; Pattyn, Filip/Q-4003-2019; Vandesompele, Jo/W-3411-2018; Rihani, Ali/R-6608-2019	Pattyn, Filip/0000-0003-0858-6651; speleman, frank/0000-0002-6628-8559; Van der Meulen, Joni/0000-0002-1916-2769; Pattyn, Filip/0000-0003-0858-6651; Vandesompele, Jo/0000-0001-6274-0184; Rihani, Ali/0000-0002-6176-0519; Mestdagh, Pieter/0000-0001-7821-9684; Van Peer, Gert/0000-0001-7597-5521; van der Meulen, Jan/0000-0002-9451-2335	Ghent University research fund (BOF) [01D02210]; Research Foundation - Flanders (FWO) [1116412N, 3G020209]; Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT) [101506]; FWO; Ghent University (GOA UGENT) [01G01910]	Ghent University research fund (BOF)(Ghent University); Research Foundation - Flanders (FWO)(FWO); Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); FWO(FWO); Ghent University (GOA UGENT)	Ali Rihani is supported by a PhD fellowship from the Ghent University research fund (BOF; 01D02210). Joni Van der Meulen and Evelien Mets are supported by a PhD fellowship from the Research Foundation - Flanders (FWO; 1116412N and 3G020209, respectively). Anneleen Beckers is supported by a PhD fellowship from the Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT; 101506). Tom Van Maerken, Pieter Mestdagh and Pieter Rondou are supported by postdoctoral fellowships from the FWO. SDB is supported by a postdoctoral fellowship from Ghent University (GOA UGENT; 01G01910). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arikawa E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-328; Bargagna-Mohan P, 2007, CHEM BIOL, V14, P623, DOI 10.1016/j.chembiol.2007.04.010; Bieche I, 1999, CANCER RES, V59, P2759; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cernaianu G, 2008, J PEDIATR SURG, V43, P1284, DOI 10.1016/j.jpedsurg.2008.01.007; Chlapek P, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-45; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Futami H, 2010, CANCER LETT, V297, P220, DOI 10.1016/j.canlet.2010.05.014; Galkin AV, 2007, P NATL ACAD SCI USA, V104, P270, DOI 10.1073/pnas.0609412103; Goossens K, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-27; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Kim BS, 2004, GENOMICS, V84, P441, DOI 10.1016/j.ygeno.2004.02.015; Lefever S, 2009, NUCLEIC ACIDS RES, V37, pD942, DOI 10.1093/nar/gkn777; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Mavrakis KJ, 2011, NAT GENET, V43, P673, DOI 10.1038/ng.858; Miano JM, 2000, CIRC RES, V87, P355; Pfaffl MW, 2005, P 2 INT QPCR S; Pihur V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-62; Schonherr C, 2011, TRANSL ONCOL, V4, P248, DOI 10.1593/tlo.11139; Sledz CA, 2004, BIOCHEM SOC T, V32, P952, DOI 10.1042/BST0320952; Solanas M, 2001, ANAL BIOCHEM, V288, P99, DOI 10.1006/abio.2000.4889; SUPOWIT SC, 1980, BIOCHEMISTRY-US, V19, P3452, DOI 10.1021/bi00556a008; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; Van Maerken T, 2009, CELL DEATH DIFFER, V16, P1563, DOI 10.1038/cdd.2009.138; Van Maerken T, 2011, MOL CANCER THER, V10, P983, DOI 10.1158/1535-7163.MCT-10-1090; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034	27	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71776	10.1371/journal.pone.0071776	http://dx.doi.org/10.1371/journal.pone.0071776			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23977142	Green Published, gold, Green Submitted			2022-12-25	WOS:000323221500104
J	Sawides, L; Dorronsoro, C; Haun, AM; Peli, E; Marcos, S				Sawides, Lucie; Dorronsoro, Carlos; Haun, Andrew M.; Peli, Eli; Marcos, Susana			Using Pattern Classification to Measure Adaptation to the Orientation of High Order Aberrations	PLOS ONE			English	Article							VISUAL PERFORMANCE; NEURAL COMPENSATION; FEATURES; VISION; ACUITY; MYOPIA	Background: The image formed by the eye's optics is blurred by the ocular aberrations, specific to each eye. Recent studies demonstrated that the eye is adapted to the level of blur produced by the high order aberrations (HOA). We examined whether visual coding is also adapted to the orientation of the natural HOA of the eye. Methods and Findings: Judgments of perceived blur were measured in 5 subjects in a psychophysical procedure inspired by the "Classification Images" technique. Subjects were presented 500 pairs of images, artificially blurred with HOA from 100 real eyes (i.e. different orientations), with total blur level adjusted to match the subject's natural blur. Subjects selected the image that appeared best focused in each random pair, in a 6-choice ranked response. Images were presented through Adaptive Optics correction of the subject's aberrations. The images selected as best focused were identified as positive, the other as negative responses. The highest classified positive responses correlated more with the subject's Point Spread Function, PSF, (r = 0.47 on average) than the negative (r = 0.34) and the difference was significant for all subjects (p<0.02). Using the orientation of the best fitting ellipse of angularly averaged integrated PSF intensities (weighted by the subject's responses) we found that in 4 subjects the positive PSF response was close to the subject's natural PSF orientation (within 21 degrees on average) whereas the negative PSF response was almost perpendicularly oriented to the natural PSF (at 76 degrees on average). Conclusions: The Classification-Images inspired method is very powerful in identifying the internally coded blur of subjects. The consistent bias of the Positive PSFs towards the natural PSF in most subjects indicates that the internal code of blur appears rather specific to each subject's high order aberrations and reveals that the calibration mechanisms for normalizing blur also operate using orientation cues.	[Sawides, Lucie; Dorronsoro, Carlos; Marcos, Susana] CSIC, Inst Opt, E-28006 Madrid, Spain; [Haun, Andrew M.; Peli, Eli] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Schepens Eye Res Inst, Boston, MA USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Optica (Daza de Valdes); Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute	Sawides, L (corresponding author), CSIC, Inst Opt, Serrano 121, E-28006 Madrid, Spain.	lucie@io.cfmac.csic.es	Dorronsoro, Carlos/A-2297-2011; Dorronsoro, Carlos/AAC-8003-2019; Haun, Andrew/I-4956-2012; Sawides, Lucie/O-1431-2016	Dorronsoro, Carlos/0000-0001-5968-1128; Dorronsoro, Carlos/0000-0001-5968-1128; Haun, Andrew/0000-0001-9458-8957; Sawides, Lucie/0000-0002-8918-8753; Peli, Eli/0000-0002-1340-9257	Spanish Government [FIS2011-25637]; European Research Council [ERC-AdG-294099]; US National Institutes of Health [EY05957]; NATIONAL EYE INSTITUTE [R01EY005957] Funding Source: NIH RePORTER	Spanish Government(Spanish GovernmentEuropean Commission); European Research Council(European Research Council (ERC)European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors acknoweldge funding from Spanish Government grant FIS2011-25637 (to SM), European Research Council Advanced Grant ERC-AdG-294099 (to SM), and US National Institutes of Health EY05957 (to EP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbey CK, 2007, J OPT SOC AM A, V24, pB110, DOI 10.1364/JOSAA.24.00B110; AHUMADA A, 1971, J ACOUST SOC AM, V49, P1751, DOI 10.1121/1.1912577; AHUMADA A, 1975, J ACOUST SOC AM, V57, P385, DOI 10.1121/1.380453; Ahumada AJ, 1996, PERCEPTION, V25, P18; AHUMADA AJ, 1999, INVEST OPHTH VIS SCI, V40, P3015; APPELLE S, 1972, PSYCHOL BULL, V78, P266, DOI 10.1037/h0033117; Artal P, 2004, J VISION, V4, P281, DOI 10.1167/4.4.4; Beard BL, 1998, P SOC PHOTO-OPT INS, V3299, P79, DOI 10.1117/12.320099; CAMPBELL FW, 1966, J PHYSIOL-LONDON, V187, P427, DOI 10.1113/jphysiol.1966.sp008100; Conrey B, 2009, J OPT SOC AM A, V26, pB94, DOI 10.1364/JOSAA.26.000B94; de Gracia P, 2011, J VIS, V11; Eckstein M. P., 2002, J VISION, V2; Goodman J. W., 1996, INTRO FOURIER OPTICS; Haun AM, 2011, SID 11, P302; Kompaniez E, 2013, J VISION, V13, DOI 10.1167/13.6.19; Marcos S, 2005, J REFRACT SURG, V21, P223; Marcos S, 2001, INVEST OPHTH VIS SCI, V42, P3349; Marcos S, 2008, J VISION, V8, DOI 10.1167/8.13.1; McMahon MJ, 2003, J VISION, V3, P230, DOI 10.1167/3.3.4; Mon-Williams M, 1998, P ROY SOC B-BIOL SCI, V265, P71, DOI 10.1098/rspb.1998.0266; Murray IJ, 2010, J VISION, V10, DOI 10.1167/10.11.10; Murray RF, 2005, J VISION, V5, P139, DOI 10.1167/5.2.5; Pesudovs K, 2005, J REFRACT SURG, V21, P144; Rossi EA, 2007, J VISION, V7, DOI 10.1167/7.8.14; Sawides L, 2012, J VISION, V12, DOI 10.1167/12.8.4; Sawides L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027031; Sawides L, 2011, J VISION, V11, DOI 10.1167/11.7.21; Sawides L, 2010, J VISION, V10, DOI 10.1167/10.12.22; Sawides L, 2010, J VISION, V10, DOI 10.1167/10.5.19; SOLOMON JA, 1994, NATURE, V369, P395, DOI 10.1038/369395a0; Villegas EA, 2006, INVESTIGATIVE OPHTHA, V47; Vinas M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046361; Watson Andrew B., 1997, Investigative Ophthalmology and Visual Science, V38, pS1; Webster MA, 2002, NAT NEUROSCI, V5, P839, DOI 10.1038/nn906; Yoon GY, 2002, J OPT SOC AM A, V19, P266, DOI 10.1364/JOSAA.19.000266	35	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e70856	10.1371/journal.pone.0070856	http://dx.doi.org/10.1371/journal.pone.0070856			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967123	gold, Green Published, Green Submitted			2022-12-25	WOS:000323221500041
J	McGowan, J; Hines, E; Elliott, M; Howar, J; Dransfield, A; Nur, N; Jahncke, J				McGowan, Jennifer; Hines, Ellen; Elliott, Meredith; Howar, Julie; Dransfield, Andrea; Nur, Nadav; Jahncke, Jaime			Using Seabird Habitat Modeling to Inform Marine Spatial Planning in Central California's National Marine Sanctuaries	PLOS ONE			English	Article							ECOSYSTEM-BASED MANAGEMENT; SPECIES DISTRIBUTION MODELS; NORTHERN CALIFORNIA; ECOLOGICAL CRITERIA; TROPHIC TRANSFER; WIND FARMS; HOTSPOTS; CONSERVATION; BIODIVERSITY; PREDICTION	Understanding seabird habitat preferences is critical to future wildlife conservation and threat mitigation in California. The objective of this study was to investigate drivers of seabird habitat selection within the Gulf of the Farallones and Cordell Bank National Marine Sanctuaries to identify areas for targeted conservation planning. We used seabird abundance data collected by the Applied California Current Ecosystem Studies Program (ACCESS) from 2004-2011. We used zero-inflated negative binomial regression to model species abundance and distribution as a function of near surface ocean water properties, distances to geographic features and oceanographic climate indices to identify patterns in foraging habitat selection. We evaluated seasonal, inter-annual and species-specific variability of at-sea distributions for the five most abundant seabirds nesting on the Farallon Islands: western gull (Larus occidentalis), common murre (Uria aalge), Cassin's auklet (Ptychorampus aleuticus), rhinoceros auklet (Cerorhinca monocerata) and Brandt's cormorant (Phalacrocorax penicillatus). The waters in the vicinity of Cordell Bank and the continental shelf east of the Farallon Islands emerged as persistent and highly selected foraging areas across all species. Further, we conducted a spatial prioritization exercise to optimize seabird conservation areas with and without considering impacts of current human activities. We explored three conservation scenarios where 10, 30 and 50 percent of highly selected, species-specific foraging areas would be conserved. We compared and contrasted results in relation to existing marine protected areas (MPAs) and the future alternative energy footprint identified by the California Ocean Uses Atlas. Our results show that the majority of highly selected seabird habitat lies outside of state MPAs where threats from shipping, oil spills, and offshore energy development remain. This analysis accentuates the need for innovative marine spatial planning efforts and provides a foundation on which to build more comprehensive zoning and management in California's National Marine Sanctuaries.	[McGowan, Jennifer; Hines, Ellen; Dransfield, Andrea] San Francisco State Univ, Dept Geog, San Francisco, CA 94132 USA; [McGowan, Jennifer; Elliott, Meredith; Howar, Julie; Dransfield, Andrea; Nur, Nadav; Jahncke, Jaime] Point Blue Conservat Sci, Petaluma, CA USA	California State University System; San Francisco State University	Jahncke, J (corresponding author), Point Blue Conservat Sci, Petaluma, CA USA.	jjahncke@pointblue.org	McGowan, Jennifer/A-7752-2014		Applied California Current Ecosystem Studies (ACCESS); California State University COAST	Applied California Current Ecosystem Studies (ACCESS); California State University COAST	This work was supported in part by the Applied California Current Ecosystem Studies (ACCESS, www.accessoceans.org) Partnership, an ongoing collaboration between PRBO Conservation Science, Cordell Bank and Gulf of the Farallones National Marine Sanctuaries, to support marine wildlife conservation and healthy ecosystems in northern and central California. The authors want to acknowledge contributions from the PRBO Board of Directors, individual donors, Dix and Didi Boring, Faucett Catalyst Fund, Hellman Family Foundation, McCaw Family Foundation, Moore Family Foundation, National Fish and Wildlife Foundation, and the Resources Legacy Fund. Additional financial support came from California State University COAST. This is PRBO Conservation Science publication number 1908. The funders had no role to play in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley DG, 2010, PROG OCEANOGR, V84, P242, DOI 10.1016/j.pocean.2009.10.001; AINLEY DG, 1995, MAR ECOL PROG SER, V118, P69, DOI 10.3354/meps118069; Airame S, 2003, ECOL APPL, V13, pS170; [Anonymous], 2004, APPL LINEAR STAT MOD; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Bakun A, 1973, SSRF671 NOAA NMFS; Ball I., 2000, MARXAN V1 8 2 MARINE; Barry SC, 2002, ECOL MODEL, V157, P179, DOI 10.1016/S0304-3800(02)00194-1; Becker E. A., 2012, Endangered Species Research, V16, P97, DOI 10.3354/esr00390; Burke CM, 2009, J ZOOL, V278, P354, DOI 10.1111/j.1469-7998.2009.00584.x; CAIRNS D K, 1987, Biological Oceanography, V5, P261; Crowder L, 2008, MAR POLICY, V32, P772, DOI 10.1016/j.marpol.2008.03.012; Di Lorenzo E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032838; Drewitt AL, 2006, IBIS, V148, P29, DOI 10.1111/j.1474-919X.2006.00516.x; Ehler C., 2009, IOC MANUAL GUIDES, V53, P1; Elith J, 2002, ECOL MODEL, V157, P313, DOI 10.1016/S0304-3800(02)00202-8; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fauchald P, 2002, J APPL ECOL, V39, P349, DOI 10.1046/j.1365-2664.2002.00717.x; Fitzpatrick MC, 2009, BIODIVERS CONSERV, V18, P2255, DOI 10.1007/s10531-009-9584-8; Franklin J, 2009, MAPPING SPECIES DIST; Furness RW, 1997, ICES J MAR SCI, V54, P726, DOI 10.1006/jmsc.1997.0243; Gilliland PM, 2008, MAR POLICY, V32, P787, DOI 10.1016/j.marpol.2008.03.022; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Halpern BS, 2008, OCEAN COAST MANAGE, V51, P203, DOI 10.1016/j.ocecoaman.2007.08.002; Halpern BS, 2007, CONSERV BIOL, V21, P1301, DOI 10.1111/j.1523-1739.2007.00752.x; Halpern BS, 2012, MAR POLICY, V36, P198, DOI 10.1016/j.marpol.2011.05.004; Hickey B. M., 1979, Progress in Oceanography, V8, P191, DOI 10.1016/0079-6611(79)90002-8; Hooker SK, 2004, BIOSCIENCE, V54, P27, DOI 10.1641/0006-3568(2004)054[0027:MRAATF]2.0.CO;2; Hunt G.L. Jr, 1987, P7; Hunt GL, 1998, MAR ECOL PROG SER, V167, P241, DOI 10.3354/meps167241; Hyrenbach KD, 2003, DEEP-SEA RES PT II, V50, P2537, DOI 10.1016/S0967-0645(03)00123-1; Hyrenbach KD, 2000, AQUAT CONSERV, V10, P437, DOI 10.1002/1099-0755(200011/12)10:6<437::AID-AQC425>3.3.CO;2-H; Jahncke J, 2008, PROG OCEANOGR, V77, P182, DOI 10.1016/j.pocean.2008.03.010; Johnston K., 2001, USING ARCGIS GEOSTAT; Klein CJ, 2008, CONSERV BIOL, V22, P691, DOI 10.1111/j.1523-1739.2008.00896.x; Klein CJ, 2010, FRONT ECOL ENVIRON, V8, P349, DOI 10.1890/090047; Kohavi R., 1995, INT JOINT C ART INT, V14, P1137, DOI DOI 10.1067/MOD.2000.109031; Largier JL, 2006, DEEP-SEA RES PT II, V53, P2833, DOI 10.1016/j.dsr2.2006.08.018; Lascelles BG, 2012, BIOL CONSERV, V156, P5, DOI 10.1016/j.biocon.2011.12.008; Lee DE, 2007, J ANIM ECOL, V76, P337, DOI 10.1111/j.1365-2656.2007.01198.x; Lehmann A, 2002, BIODIVERS CONSERV, V11, P2085, DOI 10.1023/A:1021354914494; Leslie HM, 2005, CONSERV BIOL, V19, P1701, DOI 10.1111/j.1523-1739.2005.00268.x; Mantua NJ, 2002, J OCEANOGR, V58, P35, DOI 10.1023/A:1015820616384; Martin TG, 2005, ECOL LETT, V8, P1235, DOI 10.1111/j.1461-0248.2005.00826.x; Masden EA, 2010, MAR POLLUT BULL, V60, P1085, DOI 10.1016/j.marpolbul.2010.01.016; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nur N, 2011, ECOL APPL, V21, P2241, DOI 10.1890/10-1460.1; Obama B, 2010, EXECUTIVE ORDER 1354; Office of National Marine Sanctuaries, 2010, GULF FAR NAT MAR SAN; Office of National Marine Sanctuaries, 2009, CORD BANK NAT MAR SA; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Piatt JF, 2006, DEEP-SEA RES PT II, V53, P387, DOI 10.1016/j.dsr2.2006.01.008; Possingham Hugh, 2000, P291, DOI 10.1007/0-387-22648-6_17; Redfern JV, 2006, MAR ECOL PROG SER, V310, P271, DOI 10.3354/meps310271; Reese DC, 2006, DEEP-SEA RES PT II, V53, P291, DOI 10.1016/j.dsr2.2006.01.014; Roberts CM, 2003, ECOL APPL, V13, pS215; Santora JA, 2011, PROG OCEANOGR, V91, P397, DOI 10.1016/j.pocean.2011.04.002; Scholz AJ, 2011, CONSERV BIOL, V25, P485, DOI 10.1111/j.1523-1739.2010.01626.x; Sydeman WJ, 2006, DEEP-SEA RES PT II, V53, P247, DOI 10.1016/j.dsr2.2006.03.001; TASKER ML, 1984, AUK, V101, P567, DOI 10.1093/auk/101.3.567; Tchou J, 2009, SAN FRANCISCO OFFSHO; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; TRENBERTH KE, 1984, MON WEATHER REV, V112, P326, DOI 10.1175/1520-0493(1984)112<0326:SVNITS>2.0.CO;2; Tyler WB, 1993, STATUS ECOLOGY CONSE; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Watts ME, 2009, ENVIRON MODELL SOFTW, V24, P1513, DOI 10.1016/j.envsoft.2009.06.005; Wenger SJ, 2008, ECOLOGY, V89, P2953, DOI 10.1890/07-1127.1; Yen PPW, 2006, DEEP-SEA RES PT II, V53, P399, DOI 10.1016/j.dsr2.2006.01.013; Yen PPW, 2004, J MARINE SYST, V50, P79, DOI 10.1016/j.jmarsys.2003.09.015; Zacharias MA, 2001, AQUAT CONSERV, V11, P59, DOI 10.1002/aqc.429; Zuur A.F, 2012, ZERO INFLATED MODELS; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; Zuur Alain F., 2009, P1	78	38	40	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71406	10.1371/journal.pone.0071406	http://dx.doi.org/10.1371/journal.pone.0071406			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	201BN	23967206	Green Published, gold, Green Submitted			2022-12-25	WOS:000323115800057
J	Mizumoto, J; Kikuchi, Y; Nakanishi, YH; Mouri, N; Cai, A; Ohta, T; Haruyama, T; Kato-Yamada, Y				Mizumoto, Junya; Kikuchi, Yuka; Nakanishi, Yo-Hei; Mouri, Naoto; Cai, Anrong; Ohta, Tokushiro; Haruyama, Takamitsu; Kato-Yamada, Yasuyuki			epsilon Subunit of Bacillus subtilis F-1-ATPase Relieves MgADP Inhibition	PLOS ONE			English	Article							NUCLEOTIDE-BINDING SITES; MITOCHONDRIAL ADENOSINE-TRIPHOSPHATASE; ESCHERICHIA-COLI F1-ATPASE; PROTON MOTIVE FORCE; F1F0 ATP SYNTHASE; ALPHA(3)BETA(3)GAMMA COMPLEX; THERMOPHILIC F-1-ATPASE; NONCATALYTIC SITES; KINETIC MECHANISM; CATALYTIC SITE	MgADP inhibition, which is considered as a part of the regulatory system of ATP synthase, is a well-known process common to all F-1-ATPases, a soluble component of ATP synthase. The entrapment of inhibitory MgADP at catalytic sites terminates catalysis. Regulation by the epsilon subunit is a common mechanism among F-1-ATPases from bacteria and plants. The relationship between these two forms of regulatory mechanisms is obscure because it is difficult to distinguish which is active at a particular moment. Here, using F-1-ATPase from Bacillus subtilis (BF1), which is strongly affected by MgADP inhibition, we can distinguish MgADP inhibition from regulation by the epsilon subunit. The epsilon subunit did not inhibit but activated BF1. We conclude that the epsilon subunit relieves BF1 from MgADP inhibition.	[Mizumoto, Junya; Kikuchi, Yuka; Nakanishi, Yo-Hei; Mouri, Naoto; Cai, Anrong; Ohta, Tokushiro; Haruyama, Takamitsu; Kato-Yamada, Yasuyuki] Rikkyo Univ, Dept Life Sci, Tokyo 171, Japan; [Kato-Yamada, Yasuyuki] Rikkyo Univ, Res Ctr Life Sci, Tokyo 171, Japan	Rikkyo University; Rikkyo University	Mizumoto, J (corresponding author), Rikkyo Univ, Dept Life Sci, Tokyo 171, Japan.	katoyama@rikkyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23770157]; Strategic Research Foundation from the Ministry of Education, Culture, Sports, Science and Technology of Japan [S1201003]; Rikkyo University	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Strategic Research Foundation from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Rikkyo University(Rikkyo University)	This work was supported in parts by Grants-in-Aid for Scientific Research for Young Scientists (B) (No. 23770157), the Strategic Research Foundation Grant-aided Project for Private Universities (No. S1201003) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Rikkyo University Special Fund for Research fro Rikkyo University (to Y. K.-Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bald D, 1998, J BIOL CHEM, V273, P865, DOI 10.1074/jbc.273.2.865; Bald D, 1999, EUR J BIOCHEM, V262, P563, DOI 10.1046/j.1432-1327.1999.00410.x; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Feniouk BA, 2007, J BIOL CHEM, V282, P764, DOI 10.1074/jbc.M606321200; Feniouk BA, 2010, BIOPHYS J, V98, P434, DOI 10.1016/j.bpj.2009.10.023; Haruyama Takamitsu, 2010, Biophysics (Nagoya-shi), V6, P59, DOI 10.2142/biophysics.6.59; HICKS DB, 1994, J BACTERIOL, V176, P4192, DOI 10.1128/JB.176.13.4192-4195.1994; HICKS DB, 1987, J BACTERIOL, V169, P4743, DOI 10.1128/jb.169.10.4743-4749.1987; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; HISABORI T, 1992, J BIOL CHEM, V267, P4551; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HYNDMAN DJ, 1994, J BIOL CHEM, V269, P28871; Iino R, 2005, J BIOL CHEM, V280, P40130, DOI 10.1074/jbc.M506160200; Jault JM, 1996, J BIOL CHEM, V271, P28818, DOI 10.1074/jbc.271.46.28818; Jault JM, 1995, BIOCHEMISTRY-US, V34, P16412, DOI 10.1021/bi00050a023; Kadoya F, 2011, BIOCHEM J, V437, P135, DOI 10.1042/BJ20110443; Kato S, 2007, J BIOL CHEM, V282, P37618, DOI 10.1074/jbc.M707509200; Kato Y, 1997, J BIOL CHEM, V272, P24906, DOI 10.1074/jbc.272.40.24906; KATO Y, 1995, BBA-BIOENERGETICS, V1231, P275, DOI 10.1016/0005-2728(95)00087-Y; Kato-Yamada Y, 2003, J BIOL CHEM, V278, P36013, DOI 10.1074/jbc.M306140200; Kinosita K Jr, 2000, Essays Biochem, V35, P3; Konno H, 2006, EMBO J, V25, P4596, DOI 10.1038/sj.emboj.7601348; Konno H, 2011, J BIOL CHEM, V286, P13423, DOI 10.1074/jbc.M110.155986; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAGET PP, 1979, ARCH BIOCHEM BIOPHYS, V197, P83, DOI 10.1016/0003-9861(79)90222-4; MATSUI T, 1995, BBA-BIOENERGETICS, V1231, P139, DOI 10.1016/0005-2728(95)00070-Y; Matsui T, 1997, J BIOL CHEM, V272, P8215, DOI 10.1074/jbc.272.13.8215; MILGROM YM, 1993, J BIOL CHEM, V268, P23179; MILGROM YM, 1991, J BIOL CHEM, V266, P11551; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; ORT DR, 1992, ANNU REV PLANT PHYS, V43, P269, DOI 10.1146/annurev.pp.43.060192.001413; Rodgers AJW, 2000, NAT STRUCT BIOL, V7, P1051; SANTANA M, 1994, J BACTERIOL, V176, P6802, DOI 10.1128/JB.176.22.6802-6811.1994; Sekiya M, 2010, J BIOL CHEM, V285, P42058, DOI 10.1074/jbc.M110.176701; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; SMITH JB, 1975, J SUPRAMOL STR CELL, V3, P248, DOI 10.1002/jss.400030307; Stiggall D L, 1979, Methods Enzymol, V55, P308; Suzuki T, 2003, J BIOL CHEM, V278, P46840, DOI 10.1074/jbc.M307165200; Tsumuraya M, 2009, FEBS LETT, V583, P1121, DOI 10.1016/j.febslet.2009.02.038; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P6560, DOI 10.1073/pnas.111128098; VASILYEVA EA, 1982, BIOCHEM J, V202, P15, DOI 10.1042/bj2020015; VASILYEVA EA, 1982, BIOCHEM J, V202, P9, DOI 10.1042/bj2020009; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Yasuno T, 2009, BIOCHEM BIOPH RES CO, V390, P230, DOI 10.1016/j.bbrc.2009.09.092; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; ZHOU JM, 1988, BIOCHEMISTRY-US, V27, P5129, DOI 10.1021/bi00414a027	49	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e73888	10.1371/journal.pone.0073888	http://dx.doi.org/10.1371/journal.pone.0073888			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967352	gold, Green Submitted, Green Published			2022-12-25	WOS:000323115800126
J	Schemmer, J; Arauzo-Bravo, MJ; Haas, N; Schafer, S; Weber, SN; Becker, A; Eckert, D; Zimmer, A; Nettersheim, D; Schorle, H				Schemmer, Jana; Arauzo-Bravo, Marcos J.; Haas, Natalie; Schafer, Sabine; Weber, Susanne N.; Becker, Astrid; Eckert, Dawid; Zimmer, Andreas; Nettersheim, Daniel; Schorle, Hubert			Transcription Factor TFAP2C Regulates Major Programs Required for Murine Fetal Germ Cell Maintenance and Haploinsufficiency Predisposes to Teratomas in Male Mice	PLOS ONE			English	Article								Maintenance and maturation of primordial germ cells is controlled by complex genetic and epigenetic cascades, and disturbances in this network lead to either infertility or malignant aberration. Transcription factor TFAP2C has been described to be essential for primordial germ cell maintenance and to be upregulated in several human germ cell cancers. Using global gene expression profiling, we identified genes deregulated upon loss of Tfap2c in embryonic stem cells and primordial germ cell-like cells. We show that loss of Tfap2c affects many aspects of the genetic network regulating germ cell biology, such as downregulation of maturation markers and induction of markers indicative for somatic differentiation, cell cycle, epigenetic remodeling and pluripotency. Chromatin-immunoprecipitation analyses demonstrated binding of TFAP2C to regulatory regions of deregulated genes (Sfrp1, Dmrt1, Nanos3, c-Kit, Cdk6, Cdkn1a, Fgf4, Klf4, Dnmt3b and Dnmt3l) suggesting that these genes are direct transcriptional targets of TFAP2C in primordial germ cells. Since Tfap2c deficient primordial germ cell-like cells display cancer related deregulations in epigenetic remodeling, cell cycle and pluripotency control, the Tfap2c-knockout allele was bred onto 129S2/Sv genetic background. There, mice heterozygous for Tfap2c develop with high incidence germ cell cancer resembling human pediatric germ cell tumors. Precursor lesions can be observed as early as E16.5 in developing testes displaying persisting expression of pluripotency markers. We further demonstrate that mice with a heterozygous deletion of the TFAP2C target gene Nanos3 are also prone to develop teratomas. These data highlight TFAP2C as a critical and dose-sensitive regulator of germ cell fate.	[Schemmer, Jana; Haas, Natalie; Schafer, Sabine; Weber, Susanne N.; Eckert, Dawid; Nettersheim, Daniel; Schorle, Hubert] Univ Bonn, Sch Med, Inst Pathol, Dept Dev Pathol, Bonn, Germany; [Arauzo-Bravo, Marcos J.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany; [Becker, Astrid; Zimmer, Andreas] Univ Bonn, Sch Med, Inst Reconstruct Neurobiol, Life & Brain Ctr, Bonn, Germany	University of Bonn; Max Planck Society; University of Bonn	Schorle, H (corresponding author), Univ Bonn, Sch Med, Inst Pathol, Dept Dev Pathol, Bonn, Germany.	Hubert.Schorle@ukb.uni-bonn.de	Zimmer, Andreas/B-8357-2009; Schorle, Hubert/M-5001-2016; Nettersheim, Daniel/M-9249-2013; Schorle, Hubert/S-1713-2019; Marcos, Arauzo-Bravo/A-1706-2011	Schorle, Hubert/0000-0001-8272-0076; Nettersheim, Daniel/0000-0002-4483-845X; Marcos, Arauzo-Bravo/0000-0002-3264-464X	DFG [Scho-503/9]; Deutsche Krebshilfe [108249]	DFG(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by DFG Grant Scho-503/9 to HS, and Deutsche Krebshilfe #108249 to HS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almstrup K, 2005, BRIT J CANCER, V92, P1934, DOI 10.1038/sj.bjc.6602560; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beumer TL, 2000, BIOL REPROD, V63, P1893, DOI 10.1095/biolreprod63.6.1893; Biermann Katharina, 2007, Cancer Genomics & Proteomics, V4, P359; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Cook MS, 2009, DEV BIOL, V328, P377, DOI 10.1016/j.ydbio.2009.01.041; Deng C, 1995, GL CHECKPOINT CONTRO, V82, P875; Deshpande A, 2005, ONCOGENE, V24, P2909, DOI 10.1038/sj.onc.1208618; Eckert D, 2008, CELL TISSUE RES, V331, P529, DOI 10.1007/s00441-007-0527-y; Eckert D, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-246; Filipczyk AA, 2007, STEM CELL RES, V1, P45, DOI 10.1016/j.scr.2007.09.002; Fraser MM, 2008, NEUROSCIENCE, V151, P476, DOI 10.1016/j.neuroscience.2007.10.048; Hackett JA, 2012, TRENDS GENET, V28, P164, DOI 10.1016/j.tig.2012.01.005; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Heaney JD, 2012, DEVELOPMENT, V139, P1577, DOI 10.1242/dev.076851; Helt C, 2001, TOXICOLOGICAL, V222, P214; Hoei-Hansen CE, 2004, CLIN CANCER RES, V10, P8521, DOI 10.1158/1078-0432.CCR-04-1285; Iii ABN, 1998, EFFECTS P21 CIPL WAF; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Javelaud D, 2000, ONCOGENE, V19, P61, DOI 10.1038/sj.onc.1203246; Kato Y, 2007, HUM MOL GENET, V16, P2272, DOI 10.1093/hmg/ddm179; Kimura T, 2003, DEVELOPMENT, V130, P1691, DOI 10.1242/dev.00392; Krentz AD, 2013, DEV BIOL, P1; Krentz AD, 2009, P NATL ACAD SCI USA, V106, P22323, DOI 10.1073/pnas.0905431106; Kuckenberg P, 2010, MOL CELL BIOL, V30, P3310, DOI 10.1128/MCB.01215-09; Kurimoto K, 2008, CELL CYCLE, V7, P3514, DOI 10.4161/cc.7.22.6979; Kurimoto K, 2008, GENE DEV, V22, P1617, DOI 10.1101/gad.1649908; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Liao HF, 2012, BIOL CELL, V104, P571, DOI 10.1111/boc.201100109; Lim S, 2010, CARCINOGENESIS, V31, P512, DOI 10.1093/carcin/bgp324; Misra K, 2010, DEV BIOL, V337, P74, DOI 10.1016/j.ydbio.2009.10.015; Motzer RJ, 1998, J UROLOGY, V159, P133, DOI 10.1016/S0022-5347(01)64035-7; MUSGROVE EA, 1994, P NATL ACAD SCI USA, V91, P8022, DOI 10.1073/pnas.91.17.8022; Nettersheim D, 2011, GENE CHROMOSOME CANC, V50, P1033, DOI 10.1002/gcc.20918; NOGUCHI T, 1985, JNCI-J NATL CANCER I, V75, P385; Ogryzko V V, 1997, WAF1 RETARDS S PHASE, P17; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Ohinata Y, 2008, REPRODUCTION, V136, P503, DOI 10.1530/REP-08-0053; Oosterhuis JW, 2005, NAT REV CANCER, V5, P210, DOI 10.1038/nrc1568; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Pauls K, 2005, INT J CANCER, V115, P470, DOI 10.1002/ijc.20913; Payer B, 2006, GENESIS, V44, P75, DOI 10.1002/gene.20187; PIERCE GB, 1967, J NATL CANCER I, V39, P755; RIVERS EN, 1986, AM J PATHOL, V124, P263; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Schafer S, 2011, INT J ANDROL, V34, pE152, DOI 10.1111/j.1365-2605.2011.01167.x; Schneider DT, 2004, PEDIATR BLOOD CANCER, V42, P169, DOI 10.1002/pbc.10321; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Seki Y, 2007, DEVELOPMENT, V134, P2627, DOI 10.1242/dev.005611; Seligman J, 1998, BIOCHEM BIOPH RES CO, V245, P878, DOI 10.1006/bbrc.1998.8530; Sharov AA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-269; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; Skotheim RI, 2005, CANCER RES, V65, P5588, DOI 10.1158/0008-5472.CAN-05-0153; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; STEVENS LC, 1964, P NATL ACAD SCI USA, V52, P654, DOI 10.1073/pnas.52.3.654; STEVENS LC, 1967, J NATL CANCER I, V38, P549; Suzuki H, 2008, DEV BIOL, V318, P133, DOI 10.1016/j.ydbio.2008.03.020; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; Ulbright TM, 2005, MODERN PATHOL, V18, pS61, DOI 10.1038/modpathol.3800310; Weber S, 2010, BIOL REPROD, V82, P214, DOI 10.1095/biolreprod.109.078717; Werling Uwe, 2002, Genesis The Journal of Genetics and Development, V32, P127, DOI 10.1002/gene.10057; Western PS, 2008, STEM CELLS, V26, P339, DOI 10.1634/stemcells.2007-0622; Williams CMJ, 2009, EMBO J, V28, P3591, DOI 10.1038/emboj.2009.290; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Ying Y, 2000, MOL ENDOCRINOL, V14, P1053, DOI 10.1210/me.14.7.1053; Ying Y, 2001, DEV BIOL, V232, P484, DOI 10.1006/dbio.2001.0173; Young JC, 2010, BIOL REPROD, V82, P390, DOI 10.1095/biolreprod.109.078493; Youngren KK, 2005, NATURE, V435, P360, DOI 10.1038/nature03595	70	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71113	10.1371/journal.pone.0071113	http://dx.doi.org/10.1371/journal.pone.0071113			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967156	Green Published, gold, Green Submitted			2022-12-25	WOS:000323115800036
J	Wanders, D; Graff, EC; White, BD; Judd, RL				Wanders, Desiree; Graff, Emily C.; White, B. Douglas; Judd, Robert L.			Niacin Increases Adiponectin and Decreases Adipose Tissue Inflammation in High Fat Diet-Fed Mice	PLOS ONE			English	Article							EXTENDED-RELEASE NIACIN; PPAR-GAMMA EXPRESSION; NECROSIS-FACTOR-ALPHA; NICOTINIC-ACID; OXIDATIVE STRESS; MACROPHAGE POLARIZATION; VASCULAR INFLAMMATION; CHOLESTEROL EFFLUX; BINDING-PROTEIN; GENE-EXPRESSION	Aims: To determine the effects of niacin on adiponectin and markers of adipose tissue inflammation in a mouse model of obesity. Materials and Methods: Male C57BL/6 mice were placed on a control or high-fat diet (HFD) and were maintained on such diets for the duration of the study. After 6 weeks on the control or high fat diets, vehicle or niacin treatments were initiated and maintained for 5 weeks. Identical studies were conducted concurrently in HCA(2)(-/-) (niacin receptor(-/-)) mice. Results: Niacin increased serum concentrations of the anti-inflammatory adipokine, adiponectin by 21% in HFD-fed wildtype mice, but had no effect on lean wild-type or lean or HFD-fed HCA(2)(-/-) mice. Niacin increased adiponectin gene and protein expression in the HFD-fed wild-type mice only. The increases in adiponectin serum concentrations, gene and protein expression occurred independently of changes in expression of PPAR gamma C/EBP alpha or SREBP-1c (key transcription factors known to positively regulate adiponectin gene transcription) in the adipose tissue. Further, niacin had no effect on adipose tissue expression of ERp44, Ero1-L alpha, or DsbA-L (key ER chaperones involved in adiponectin production and secretion). However, niacin treatment attenuated HFD-induced increases in adipose tissue gene expression of MCP-1 and IL-1 beta in the wild-type HFD-fed mice. Niacin also reduced the expression of the pro-inflammatory M1 macrophage marker CD11c in HFD-fed wild-type mice. Conclusions: Niacin treatment attenuates obesity-induced adipose tissue inflammation through increased adiponectin and anti-inflammatory cytokine expression and reduced pro-inflammatory cytokine expression in a niacin receptor-dependent manner.	[Wanders, Desiree; Graff, Emily C.; Judd, Robert L.] Auburn Univ, Coll Vet Med, Dept Anat Physiol & Pharmacol, Auburn, AL 36849 USA; [Graff, Emily C.] Auburn Univ, Coll Vet Med, Dept Pathobiol, Auburn, AL 36849 USA; [White, B. Douglas] Auburn Univ, Coll Human Sci, Dept Nutr Dietet & Hospitality Management, Auburn, AL 36849 USA	Auburn University System; Auburn University; Auburn University System; Auburn University; Auburn University System; Auburn University	Judd, RL (corresponding author), Auburn Univ, Coll Vet Med, Dept Anat Physiol & Pharmacol, Auburn, AL 36849 USA.	juddrob@auburn.edu		Wanders, Desiree/0000-0003-2638-3954	Diabetes Action Research and Education Foundation [317]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T35OD010991] Funding Source: NIH RePORTER	Diabetes Action Research and Education Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was financially supported by the Diabetes Action Research and Education Foundation (317;http://www.diabetesaction.org/site/PageServer?pagename = index. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuwon KM, 2005, AM J PHYSIOL-REG I, V288, pR1220, DOI 10.1152/ajpregu.00397.2004; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Bruun JM, 2003, AM J PHYSIOL-ENDOC M, V285, pE527, DOI 10.1152/ajpendo.00110.2003; Canner PL, 2006, AM J CARDIOL, V97, P477, DOI 10.1016/j.amjcard.2005.08.070; CARLSON LA, 1962, ACTA MED SCAND, V172, P641; CARLSON LA, 1963, ACTA MED SCAND, V173, P719; Cho KH, 2009, AM J PHYSIOL-RENAL, V297, pF106, DOI 10.1152/ajprenal.00126.2009; Delporte ML, 2002, BIOCHEM J, V367, P677, DOI 10.1042/BJ20020610; Deng YF, 2010, ANN NY ACAD SCI, V1212, pE1, DOI 10.1111/j.1749-6632.2010.05875.x; Digby JE, 2012, ARTERIOSCL THROM VAS, V32, P669, DOI 10.1161/ATVBAHA.111.241836; Digby JE, 2010, ATHEROSCLEROSIS, V209, P89, DOI 10.1016/j.atherosclerosis.2009.08.045; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gambhir D, 2012, INVEST OPHTH VIS SCI, V53, P2208, DOI 10.1167/iovs.11-8447; Ganji SH, 2009, ATHEROSCLEROSIS, V202, P68, DOI 10.1016/j.atherosclerosis.2008.04.044; Grundy SM, 1997, CIRCULATION, V95, P1, DOI 10.1161/01.CIR.95.1.1; Halleux CM, 2001, BIOCHEM BIOPH RES CO, V288, P1102, DOI 10.1006/bbrc.2001.5904; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Iwaki M, 2003, DIABETES, V52, P1655, DOI 10.2337/diabetes.52.7.1655; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Kamanna VS, 2008, AM J CARDIOL, V101, p20B, DOI 10.1016/j.amjcard.2008.02.029; Knowles HJ, 2006, BIOCHEM PHARMACOL, V71, P646, DOI 10.1016/j.bcp.2005.11.019; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Kwon WY, 2011, CRIT CARE MED, V39, P328, DOI 10.1097/CCM.0b013e3181feeae4; Lauring B, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003877; Lavigne PM, 2013, J AM COLL CARDIOL, V61, P440, DOI 10.1016/j.jacc.2012.10.030; Lee JMS, 2009, J AM COLL CARDIOL, V54, P1787, DOI 10.1016/j.jacc.2009.06.036; Li ZS, 2012, BIOCHEM PHARMACOL, V84, P821, DOI 10.1016/j.bcp.2012.06.020; Linke A, 2009, ATHEROSCLEROSIS, V205, P207, DOI 10.1016/j.atherosclerosis.2008.11.026; Liu ML, 2010, BIOCHEM J, V425, P41, DOI 10.1042/BJ20091045; Liu M, 2008, P NATL ACAD SCI USA, V105, P18302, DOI 10.1073/pnas.0806341105; Long QQ, 2010, ENDOCRINOLOGY, V151, P3195, DOI 10.1210/en.2009-1501; Lukasova M, 2011, J CLIN INVEST, V121, P1163, DOI 10.1172/JCI41651; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; Park SK, 2004, DIABETES, V53, P2757, DOI 10.2337/diabetes.53.11.2757; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Phan BAP, 2013, AM J CARDIOL, V111, P352, DOI 10.1016/j.amjcard.2012.09.034; Plaisance EP, 2008, METABOLISM, V57, P404, DOI 10.1016/j.metabol.2007.10.018; Plaisance EP, 2009, AM J PHYSIOL-ENDOC M, V296, pE549, DOI 10.1152/ajpendo.91004.2008; Qiang L, 2007, MOL CELL BIOL, V27, P4698, DOI 10.1128/MCB.02279-06; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Schaub A, 2001, EUR J IMMUNOL, V31, P3714, DOI 10.1002/1521-4141(200112)31:12<3714::AID-IMMU3714>3.0.CO;2-1; Seo JB, 2004, J BIOL CHEM, V279, P22108, DOI 10.1074/jbc.M400238200; Shaul ME, 2010, DIABETES, V59, P1171, DOI 10.2337/db09-1402; Suganami T, 2010, J LEUKOCYTE BIOL, V88, P33, DOI 10.1189/jlb.0210072; Thoenes M, 2007, INT J CLIN PRACT, V61, P1942, DOI 10.1111/j.1742-1241.2007.01597.x; Titos E, 2011, J IMMUNOL, V187, P5408, DOI 10.4049/jimmunol.1100225; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; Wang ZV, 2007, MOL CELL BIOL, V27, P3716, DOI 10.1128/MCB.00931-06; Warnholtz A, 2009, ATHEROSCLEROSIS, V204, P216, DOI 10.1016/j.atherosclerosis.2008.08.003; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Westphal S, 2007, ATHEROSCLEROSIS, V193, P361, DOI 10.1016/j.atherosclerosis.2006.06.028; Westphal S, 2006, METABOLISM, V55, P1283, DOI 10.1016/j.metabol.2006.07.002; Wu BJ, 2012, CIRCULATION, V125, P150, DOI 10.1161/CIRCULATIONAHA.111.053108; Wu BJ, 2010, ARTERIOSCL THROM VAS, V30, P968, DOI 10.1161/ATVBAHA.109.201129; Wu ZH, 2009, PHARMACOLOGY, V84, P282, DOI 10.1159/000242999; Zhao SP, 2008, INT J CARDIOL, V124, P172, DOI 10.1016/j.ijcard.2006.12.032	61	46	47	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71285	10.1371/journal.pone.0071285	http://dx.doi.org/10.1371/journal.pone.0071285			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967184	Green Submitted, gold, Green Published			2022-12-25	WOS:000323115800047
J	Chen, J; Xiong, DY; Wang, WH; Hu, WJ; Simon, M; Xiao, Q; Chen, J; Liu, TW; Liu, X; Zheng, HL				Chen, Juan; Xiong, Duan-Ye; Wang, Wen-Hua; Hu, Wen-Jun; Simon, Martin; Xiao, Qiang; Chen, Juan; Liu, Ting-Wu; Liu, Xiang; Zheng, Hai-Lei			Nitric Oxide Mediates Root K+/Na+ Balance in a Mangrove Plant, Kandelia obovata, by Enhancing the Expression of AKT1-Type K+ Channel and Na+/H+ Antiporter under High Salinity	PLOS ONE			English	Article							SALT TOLERANCE; PLASMA-MEMBRANE; PUCCINELLIA TENUIFLORA; FUNCTIONAL-ANALYSIS; ION HOMEOSTASIS; NACL; TRANSPORT; FLUXES; GENE; H+	It is well known that nitric oxide (NO) enhances salt tolerance of glycophytes. However, the effect of NO on modulating ionic balance in halophytes is not very clear. This study focuses on the role of NO in mediating K+/Na+ balance in a mangrove species, Kandelia obovata Sheue, Liu and Yong. We first analyzed the effects of sodium nitroprusside (SNP), an NO donor, on ion content and ion flux in the roots of K. obovata under high salinity. The results showed that 100 mu M SNP significantly increased K+ content and Na+ efflux, but decreased Na+ content and K+ efflux. These effects of NO were reversed by specific NO synthesis inhibitor and scavenger, which confirmed the role of NO in retaining K+ and reducing Na+ in K. obovata roots. Using western-blot analysis, we found that NO increased the protein expression of plasma membrane (PM) H+-ATPase and vacuolar Na+/H+ antiporter, which were crucial proteins for ionic balance. To further clarify the molecular mechanism of NO-modulated K+/Na+ balance, partial cDNA fragments of inward-rectifying K+ channel, PM Na+/H+ antiporter, PM H+-ATPase, vacuolar Na+/H+ antiporter and vacuolar H+-ATPase subunit c were isolated. Results of quantitative real-time PCR showed that NO increased the relative expression levels of these genes, while this increase was blocked by NO synthesis inhibitors and scavenger. Above results indicate that NO greatly contribute to K+/Na+ balance in high salinity-treated K. obovata roots, by activating AKT1-type K+ channel and Na+/H+ antiporter, which are the critical components in K+/Na+ transport system.	[Chen, Juan; Xiong, Duan-Ye; Wang, Wen-Hua; Hu, Wen-Jun; Simon, Martin; Chen, Juan; Liu, Xiang; Zheng, Hai-Lei] Xiamen Univ, Coll Environm & Ecol, Key Lab Subtrop Wetland Ecosyst Res MOE, Xiamen, Fujian, Peoples R China; [Xiao, Qiang] Hubei Inst Nationalities, Lab Biol Resources Protect & Utilizat Hubei Prov, Enshi, Hubei, Peoples R China; [Liu, Ting-Wu] Huaiyin Normal Univ, Dept Biol, Huaian, Jiangsu, Peoples R China	Xiamen University; Hubei Minzu University; Huaiyin Normal University	Zheng, HL (corresponding author), Xiamen Univ, Coll Environm & Ecol, Key Lab Subtrop Wetland Ecosyst Res MOE, Xiamen, Fujian, Peoples R China.	zhenghl@xmu.edu.cn	Zheng, Hai-Lei/G-3432-2010	Zheng, Hai-Lei/0000-0001-8588-1529	Natural Science Foundation of China (NSFC) [30930076, 31260057, 30770192, 30670317]; China Postdoctoral Science Foundation [2012M521278]; Scholarship Award for Excellent Doctoral Student; Chinese Ministry of Education	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Scholarship Award for Excellent Doctoral Student; Chinese Ministry of Education(Ministry of Education, China)	This study was financially supported by the Natural Science Foundation of China (NSFC) (30930076, 31260057, 30770192, 30670317), China Postdoctoral Science Foundation (2012M521278), and the Scholarship Award for Excellent Doctoral Student granted by the Chinese Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman F, 2011, PLANT CELL PHYSIOL, V52, P1603, DOI 10.1093/pcp/pcr096; Arasimowicz M, 2007, PLANT SCI, V172, P876, DOI 10.1016/j.plantsci.2007.02.005; Ardie SW, 2010, PLANT CELL REP, V29, P865, DOI 10.1007/s00299-010-0872-2; Berthomieu P, 2003, EMBO J, V22, P2004, DOI 10.1093/emboj/cdg207; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buschmann PH, 2000, PLANT PHYSIOL, V122, P1387, DOI 10.1104/pp.122.4.1387; Carden DE, 2003, PLANT PHYSIOL, V131, P676, DOI 10.1104/pp.011445; Chen JA, 2010, TREE PHYSIOL, V30, P1570, DOI 10.1093/treephys/tpq086; Chen S, 2010, PLANT BIOLOGY, V12, P317, DOI 10.1111/j.1438-8677.2009.00301.x; Chen Z, 2005, PLANT CELL ENVIRON, V28, P1230, DOI 10.1111/j.1365-3040.2005.01364.x; Chen ZH, 2007, PLANT PHYSIOL, V145, P1714, DOI 10.1104/pp.107.110262; FRITZ E, 1989, SCANNING MICROSCOPY, V3, P517; Fuchs I, 2005, PLANTA, V221, P212, DOI 10.1007/s00425-004-1437-9; Fukuda A, 2011, PLANTA, V233, P175, DOI 10.1007/s00425-010-1289-4; Golldack D, 2003, PLANT MOL BIOL, V51, P71, DOI 10.1023/A:1020763218045; Hariadi Y, 2011, J EXP BOT, V62, P185, DOI 10.1093/jxb/erq257; Kaddour R, 2009, CR BIOL, V332, P784, DOI 10.1016/j.crvi.2009.05.003; Kao WY, 2001, J PLANT PHYSIOL, V158, P841, DOI 10.1078/0176-1617-00248; Leigh RA, 2001, J PLANT NUTR SOIL SC, V164, P193, DOI 10.1002/1522-2624(200104)164:2<193::AID-JPLN193>3.0.CO;2-7; Li NY, 2008, AQUAT BOT, V88, P303, DOI 10.1016/j.aquabot.2007.12.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu YJ, 2013, TREE PHYSIOL, V33, P81, DOI 10.1093/treephys/tps119; Maathuis FJM, 2006, J EXP BOT, V57, P1137, DOI 10.1093/jxb/erj001; Martinez-Cordero MA, 2005, J EXP BOT, V56, P1553, DOI 10.1093/jxb/eri150; NIU XM, 1995, PLANT PHYSIOL, V109, P735, DOI 10.1104/pp.109.3.735; Parida AK, 2010, TREES-STRUCT FUNCT, V24, P199, DOI 10.1007/s00468-010-0417-x; Qi Z, 2004, PLANT PHYSIOL, V136, P2548, DOI 10.1104/pp.104.049213; Qiu QS, 2003, PLANT PHYSIOL, V132, P1041, DOI 10.1104/pp.102.010421; SCHOLANDER PF, 1968, PHYSIOL PLANTARUM, V21, P251, DOI 10.1111/j.1399-3054.1968.tb07248.x; SENTENAC H, 1992, SCIENCE, V256, P663, DOI 10.1126/science.1585180; Serrano R, 2002, EMBO REP, V3, P116, DOI 10.1093/embo-reports/kvf030; Shabala S, 2008, PHYSIOL PLANTARUM, V133, P651, DOI 10.1111/j.1399-3054.2007.01008.x; Sheue CR, 2003, TAXON, V52, P287, DOI 10.2307/3647398; Shi HZ, 2003, NAT BIOTECHNOL, V21, P81, DOI 10.1038/nbt766; Silva P, 2010, J PLANT GROWTH REGUL, V29, P23, DOI 10.1007/s00344-009-9110-y; Sun J, 2010, PLANT CELL ENVIRON, V33, P943, DOI 10.1111/j.1365-3040.2010.02118.x; Sun J, 2009, TREE PHYSIOL, V29, P1175, DOI 10.1093/treephys/tpp048; Sun J, 2009, PLANT PHYSIOL, V149, P1141, DOI 10.1104/pp.108.129494; Tester M, 2003, ANN BOT-LONDON, V91, P503, DOI 10.1093/aob/mcg058; Vazquez MD, 1999, PLANT PHYSIOL, V119, P435, DOI 10.1104/pp.119.2.435; Wang CM, 2009, PLANT CELL ENVIRON, V32, P486, DOI 10.1111/j.1365-3040.2009.01942.x; Wendehenne D, 2004, CURR OPIN PLANT BIOL, V7, P449, DOI 10.1016/j.pbi.2004.04.002; Wilson ID, 2008, PLANT CELL ENVIRON, V31, P622, DOI 10.1111/j.1365-3040.2007.01761.x; Wu C, 2009, PLANT MOL BIOL REP, V27, P1, DOI 10.1007/s11105-008-0048-1; Xu RR, 2011, FEBS J, V278, P2296, DOI 10.1111/j.1742-4658.2011.08147.x; Xu Y, 2006, J INTEGR PLANT BIOL, V48, P823, DOI 10.1111/j.1744-7909.2006.00281.x; Zhang YY, 2006, PLANTA, V224, P545, DOI 10.1007/s00425-006-0242-z; Zhao LQ, 2004, PLANT PHYSIOL, V134, P849, DOI 10.1104/pp.103.030023; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2	49	30	31	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71543	10.1371/journal.pone.0071543	http://dx.doi.org/10.1371/journal.pone.0071543			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977070	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700067
J	Morris, EP; Flecha, S; Figuerola, J; Costas, E; Navarro, G; Ruiz, J; Rodriguez, P; Huertas, E				Morris, Edward P.; Flecha, Susana; Figuerola, Jordi; Costas, Eduardo; Navarro, Gabriel; Ruiz, Javier; Rodriguez, Pablo; Huertas, Emma			Contribution of Donana Wetlands to Carbon Sequestration	PLOS ONE			English	Article							ORGANIC-CARBON; NATIONAL-PARK; SIZE-DISTRIBUTION; CLIMATE-CHANGE; COASTAL OCEAN; GAS-EXCHANGE; DIOXIDE; WATER; LAKES; FLUXES	Inland and transitional aquatic systems play an important role in global carbon (C) cycling. Yet, the C dynamics of wetlands and floodplains are poorly defined and field data is scarce. Air-water CO2 fluxes in the wetlands of Donana Natural Area (SW Spain) were examined by measuring alkalinity, pH and other physiochemical parameters in a range of water bodies during 2010-2011. Areal fluxes were calculated and, using remote sensing, an estimate of the contribution of aquatic habitats to gaseous CO2 transport was derived. Semi-permanent ponds adjacent to the large Guadalquivir estuary acted as mild sinks, whilst temporal wetlands were strong sources of CO2 (-0.8 and 36.3 mmol(CO2) m(-2) d(-1)). Fluxes in semi-permanent streams and ponds changed seasonally; acting as sources in spring-winter and mild sinks in autumn (16.7 and -1.2 mmol(CO2) m(-2) d(-1)). Overall, Donana's water bodies were a net annual source of CO2 (5.2 mol(C) m(-2) y(-1)). Up-scaling clarified the overwhelming contribution of seasonal flooding and allochthonous organic matter inputs in determining regional air-water gaseous CO2 transport (13.1 Gg(C) y(-1)). Nevertheless, this estimate is about 6 times < local marsh net primary production, suggesting the system acts as an annual net CO2 sink. Initial indications suggest longer hydroperiods may favour autochthonous C capture by phytoplankton. Direct anthropogenic impacts have reduced the hydroperiod in Donana and this maybe exacerbated by climate change (less rainfall and more evaporation), suggesting potential for the modification of C sequestration.	[Morris, Edward P.; Flecha, Susana; Navarro, Gabriel; Ruiz, Javier; Huertas, Emma] CSIC, Inst Ciencias Marinas Andaluci ICMAN CSIC, Dept Ecol & Coastal Management, Puerto Real, Spain; [Figuerola, Jordi] CSIC, Estn Biol Donana, E-41080 Seville, Spain; [Costas, Eduardo] Univ Complutense Madrid, Madrid, Spain; [Rodriguez, Pablo] Univ Murcia, Murcia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias Marinas de Andalucia (ICMAN); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Complutense University of Madrid; University of Murcia	Morris, EP (corresponding author), CSIC, Inst Ciencias Marinas Andaluci ICMAN CSIC, Dept Ecol & Coastal Management, Puerto Real, Spain.	edward.morris@csic.es	Ruiz, Javier/G-3184-2016; HUERTAS, EMMA/ABH-9719-2020; Morris, Edward/C-2359-2008; Figuerola, Jordi/B-7917-2008; HUERTAS, EMMA/A-9739-2010; Navarro, Gabriel/AAA-9528-2020	Ruiz, Javier/0000-0002-3375-2327; HUERTAS, EMMA/0000-0003-1033-7937; Morris, Edward/0000-0002-5011-6744; Figuerola, Jordi/0000-0002-4664-9011; HUERTAS, EMMA/0000-0003-1033-7937; Navarro, Gabriel/0000-0002-8919-0060; Flecha, Susana/0000-0003-2826-5820; Rodriguez-Ros, Pablo/0000-0003-0411-0197	Regional Government of Andalucia; Spanish Ministry for Agriculture, Food and Environment; JAE DOCTORES; JAE PREDOCTORAL scholarship; European Union (European Social Fund); Spanish Ministry for Economy and Competitiveness;  [P09-RNM-4744];  [049/2010]	Regional Government of Andalucia(Junta de Andalucia); Spanish Ministry for Agriculture, Food and Environment; JAE DOCTORES; JAE PREDOCTORAL scholarship; European Union (European Social Fund)(European Social Fund (ESF)European Commission); Spanish Ministry for Economy and Competitiveness(Spanish Government); ; 	This research was supported by the projects P09-RNM-4744 and 049/2010 funded by the Regional Government of Andalucia and the Spanish Ministry for Agriculture, Food and Environment, respectively. EPM and SF are supported by a JAE DOCTORES 2010 contract and JAE PREDOCTORAL scholarship, respectively, part-funded by the European Union (European Social Fund, ESF2007-2013) and the Spanish Ministry for Economy and Competitiveness. Landsat data available from the U.S. Geological Survey. DEIMOS1 data provided by DEIMOS-Imaging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldaya MM, 2010, RETHINKING WATER FOO, P193; Alin SR, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002881; Alvarez S, 2000, SOIL BIOL BIOCHEM, V32, P1941, DOI 10.1016/S0038-0717(00)00170-X; Balmer MB, 2011, INLAND WATERS, V1, P125, DOI 10.5268/IW-1.2.366; Battin TJ, 2008, NAT GEOSCI, V1, P95, DOI 10.1038/ngeo101; Battin TJ, 2009, NAT GEOSCI, V2, P598, DOI 10.1038/ngeo618; Bianchi TS, 2011, P NATL ACAD SCI USA, V108, P19473, DOI 10.1073/pnas.1017982108; Borges AV, 2011, TREATISE ON ESTUARINE AND COASTAL SCIENCE, VOL 5: BIOGEOCHEMISTRY, P119; Borges AV, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001673; Borges AV, 2011, OCEANS AND THE ATMOSPHERIC CARBON CONTENT, P47, DOI 10.1007/978-90-481-9821-4_3; Borges AV, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023053; Borges AV, 2005, ESTUARIES, V28, P3, DOI 10.1007/BF02732750; Cai WJ, 1998, LIMNOL OCEANOGR, V43, P657, DOI 10.4319/lo.1998.43.4.0657; Cao MK, 1996, J GEOPHYS RES-ATMOS, V101, P14399, DOI 10.1029/96JD00219; CARLSON RE, 1977, LIMNOL OCEANOGR, V22, P361, DOI 10.4319/lo.1977.22.2.0361; Chen CTA, 2009, DEEP-SEA RES PT II, V56, P578, DOI 10.1016/j.dsr2.2009.01.001; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Cole JJ, 1998, LIMNOL OCEANOGR, V43, P647, DOI 10.4319/lo.1998.43.4.0647; Cole JJ, 2001, MAR FRESHWATER RES, V52, P101, DOI 10.1071/MF00084; Curco A, 2002, ESTUARIES, V25, P309, DOI 10.1007/BF02695976; de la Paz M, 2007, J MARINE SYST, V68, P265, DOI 10.1016/j.jmarsys.2006.11.011; de la Paz M, 2008, MAR CHEM, V110, P195, DOI 10.1016/j.marchem.2008.03.002; Dean WE, 1998, GEOLOGY, V26, P535, DOI 10.1130/0091-7613(1998)026<0535:MASOCB>2.3.CO;2; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; Downing JA, 2006, LIMNOL OCEANOGR, V51, P2388, DOI 10.4319/lo.2006.51.5.2388; Downing JA, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2006GB002854; Downing JA, 2010, LIMNETICA, V29, P9; Downing JA, 2009, INT VER THEOR ANGEW, V30, P1149; Duarte C, 1990, LIMNETICA, V6, P1; Duarte CM, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000637; Espinar JL, 2009, AQUAT ECOL, V43, P323, DOI 10.1007/s10452-007-9162-7; Esser G, 1998, NPP MULTIBIOME GLOBA; Fernandez N, 2010, REMOTE SENS ENVIRON, V114, P211, DOI 10.1016/j.rse.2009.09.001; Flanagan LB, 2011, GLOBAL CHANGE BIOL, V17; Frankignoulle M, 1998, SCIENCE, V282, P434, DOI 10.1126/science.282.5388.434; Frankignoulle M, 2001, AQUAT GEOCHEM, V7, P267, DOI 10.1023/A:1015251010481; Garcia-Murillo P., 2006, LIMNETICA, V25, P71; Geertz-Hansen O, 2011, BIOGEOSCIENCES, V8, P963, DOI 10.5194/bg-8-963-2011; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Giraudoux P, 2012, CRAN R PROJECT ORG P; Gomez-Rodriguez C, 2010, REMOTE SENS-BASEL, V2, P1439, DOI 10.3390/rs2061439; Grasshoff K, 1983, METHODS SEAWATER ANA, V2, DOI DOI 10.1002/9783527613984.FMATTER/SUMMARY; Hooijer A, 2010, BIOGEOSCIENCES, V7, P1505, DOI 10.5194/bg-7-1505-2010; Huertas IE, 2006, DEEP-SEA RES PT II, V53, P1344, DOI 10.1016/j.dsr2.2006.03.010; Husson F, 2012, FACTOMINER MULTIVARI; Johnson M.T., 2010, OCEAN SCI DISCUSS, V7, P251, DOI DOI 10.5194/OSD-7-251-2010; Kayranli B, 2010, WETLANDS, V30, P111, DOI 10.1007/s13157-009-0003-4; Kloskowski J, 2009, AQUAT CONSERV, V19, P815, DOI 10.1002/aqc.1027; Kone YJM, 2009, ESTUAR COAST, V32, P246, DOI 10.1007/s12237-008-9121-0; Kremer JN, 2003, ESTUARIES, V26, P829, DOI 10.1007/BF02803341; Kuzyakov Y, 2010, SOIL BIOL BIOCHEM, V42, P1363, DOI 10.1016/j.soilbio.2010.04.003; Lazzarino JK, 2009, HYDROBIOLOGIA, V627, P169, DOI 10.1007/s10750-009-9723-y; Lopez-Archilla AI, 2004, EXTREMOPHILES, V8, P109, DOI 10.1007/s00792-003-0369-9; Melton JR, 2013, BIOGEOSCIENCES, V10, P753, DOI 10.5194/bg-10-753-2013; Menendez M, 2008, AQUAT BOT, V89, P365, DOI 10.1016/j.aquabot.2008.04.006; MERINO O, 1990, ACTA OECOL, V11, P103; Mintrop L, 2000, CIENC MAR, V26, P23; Mitra S, 2005, CURR SCI INDIA, V88, P25; Moss B, 2011, INLAND WATERS, V1, P101, DOI 10.5268/IW-1.2.359; Olias M, 2008, ENVIRON GEOL, V55, P1555, DOI 10.1007/s00254-007-1106-y; Palomo L, 2009, AQUAT BOT, V91, P130, DOI 10.1016/j.aquabot.2009.04.002; Pierrot D, 2006, MS EXCEL PROGRAM DEV, DOI [10.3334/CDIAC/otgCO2-SYS_XLS_CDIAC105a., DOI 10.3334/CDIAC/0TGC02-SYS_]; R Core Team, 2012, R LANG ENV STAT COMP; Rendon MA, 2008, BIOL CONSERV, V141, P1371, DOI 10.1016/j.biocon.2008.03.006; Richey JE, 2002, NATURE, V416, P617, DOI 10.1038/416617a; Rocha AV, 2009, AGR FOREST METEOROL, V149, P159, DOI 10.1016/j.agrformet.2008.07.010; Rudorff CM, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001699; Sahagian D., 1998, 46 IGBP, V46; Seekell DA, 2011, LIMNOL OCEANOGR, V56, P350, DOI 10.4319/lo.2011.56.1.0350; Serrano L., 2006, LIMNETICA, V25, P11, DOI DOI 10.1016/S1001-6058(15)60453-X; Serrano Laura, 2008, LIMNETICA, V27, P65; SMITH SD, 1988, J GEOPHYS RES-OCEANS, V93, P15467, DOI 10.1029/JC093iC12p15467; St Louis VL, 2000, BIOSCIENCE, V50, P766, DOI 10.1641/0006-3568(2000)050[0766:RSASOG]2.0.CO;2; Tortosa G, 2011, ECOL ENG, V37, P539, DOI 10.1016/j.ecoleng.2010.06.029; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298; van Nugteren P, 2009, MAR BIOL, V156, P2277, DOI 10.1007/s00227-009-1255-5; Wanninkhof R, 2009, ANNU REV MAR SCI, V1, P213, DOI 10.1146/annurev.marine.010908.163742; Weiss R, 1974, MAR CHEM, V2; Whiting GJ, 2001, TELLUS B, V53, P521, DOI 10.1034/j.1600-0889.2001.530501.x; Yvon-Durocher G, 2010, PHILOS T R SOC B, V365, P2117, DOI 10.1098/rstb.2010.0038	80	13	14	5	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71456	10.1371/journal.pone.0071456	http://dx.doi.org/10.1371/journal.pone.0071456			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977044	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700053
J	VandeVrede, L; Abdelhamid, R; Qin, ZH; Choi, J; Piyankarage, S; Luo, J; Larson, J; Bennett, BM; Thatcher, GRJ				VandeVrede, Lawren; Abdelhamid, Ramy; Qin, Zhihui; Choi, Jaewoo; Piyankarage, Sujeewa; Luo, Jia; Larson, John; Bennett, Brian M.; Thatcher, Gregory R. J.			An NO Donor Approach to Neuroprotective and Procognitive Estrogen Therapy Overcomes Loss of NO Synthase Function and Potentially Thrombotic Risk	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; HORMONE REPLACEMENT THERAPY; CEREBRAL-BLOOD-FLOW; POSTMENOPAUSAL WOMEN; RECEPTOR MODULATORS; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; DEPENDENT VASODILATION; SYNAPTIC-TRANSMISSION; CARDIOVASCULAR EVENTS	Selective estrogen receptor modulators (SERMs) are effective therapeutics that preserve favorable actions of estrogens on bone and act as antiestrogens in breast tissue, decreasing the risk of vertebral fractures and breast cancer, but their potential in neuroprotective and procognitive therapy is limited by: 1) an increased lifetime risk of thrombotic events; and 2) an attenuated response to estrogens with age, sometimes linked to endothelial nitric oxide synthase (eNOS) dysfunction. Herein, three 3rd generation SERMs with similar high affinity for estrogen receptors (ER alpha, ER beta) were studied: desmethylarzoxifene (DMA), FDMA, and a novel NO-donating SERM (NO-DMA). Neuroprotection was studied in primary rat neurons exposed to oxygen glucose deprivation; reversal of cholinergic cognitive deficit was studied in mice in a behavioral model of memory; long term potentiation (LTP), underlying cognition, was measured in hippocampal slices from older 3xTg Alzheimer's transgenic mice; vasodilation was measured in rat aortic strips; and anticoagulant activity was compared. Pharmacologic blockade of GPR30 and NOS; denudation of endothelium; measurement of NO; and genetic knockout of eNOS were used to probe mechanism. Comparison of the three chemical probes indicates key roles for GPR30 and eNOS in mediating therapeutic activity. Procognitive, vasodilator and anticoagulant activities of DMA were found to be eNOS dependent, while neuroprotection and restoration of LTP were both shown to be dependent upon GPR30, a G-protein coupled receptor mediating estrogenic function. Finally, the observation that an NO-SERM shows enhanced vasodilation and anticoagulant activity, while retaining the positive attributes of SERMs even in the presence of NOS dysfunction, indicates a potential therapeutic approach without the increased risk of thrombotic events.	[VandeVrede, Lawren; Abdelhamid, Ramy; Qin, Zhihui; Choi, Jaewoo; Piyankarage, Sujeewa; Luo, Jia; Thatcher, Gregory R. J.] Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, Chicago, IL 60680 USA; [Larson, John] Univ Illinois, Inst Neuropsychiat, Dept Psychiat, Chicago, IL USA; [Bennett, Brian M.] Queens Univ, Fac Hlth Sci, Dept Biomed & Mol Sci, Kingston, ON, Canada	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Queens University - Canada	Thatcher, GRJ (corresponding author), Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, Chicago, IL 60680 USA.	thatcher@uic.edu		Piyankarage, Sujeewa/0000-0002-9548-3839	National Institutes of Health (NIH) [CA102590]; NATIONAL CANCER INSTITUTE [R01CA102590] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health (NIH) grant CA102590. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abdelhamid R, 2011, ACS CHEM NEUROSCI, V2, P256, DOI 10.1021/cn100106a; Abdul-Hay S, 2011, ACS MED CHEM LETT, V2, P656, DOI 10.1021/ml2000033; Abdul-Hay SO, 2009, J NEUROCHEM, V111, P766, DOI 10.1111/j.1471-4159.2009.06353.x; Agnusdei D., 2000, Journal of Musculoskeletal & Neuronal Interactions, V1, P127; Antonicelli R, 2008, INT J CARDIOL, V130, P140, DOI 10.1016/j.ijcard.2008.03.051; Arlt S, 2012, J ALZHEIMERS DIS, V31, P751, DOI 10.3233/JAD-2012-112138; Barrett-Connor E, 2006, NEW ENGL J MED, V355, P125, DOI 10.1056/NEJMoa062462; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Bennett BM, 2007, NEUROPSYCHOPHARMACOL, V32, P505, DOI 10.1038/sj.npp.1301054; Brinton RD, 2008, TRENDS NEUROSCI, V31, P529, DOI 10.1016/j.tins.2008.07.003; Buccafusco JJ, 2009, FRONT NEUROSCI, P1; Cantara S, 2007, FEBS LETT, V581, P702, DOI 10.1016/j.febslet.2007.01.037; Carlson LE, 1998, PSYCHONEUROENDOCRINO, V23, P583; Chan YC, 2012, PHARMACOL RES, V65, P182, DOI 10.1016/j.phrs.2011.09.010; Ciriza I, 2004, J NEUROBIOL, V61, P209, DOI 10.1002/neu.20043; Cohen FJ, 2000, OBSTET GYNECOL, V95, P104, DOI 10.1016/S0029-7844(99)00554-2; Colton CA, 2006, P NATL ACAD SCI USA, V103, P12867, DOI 10.1073/pnas.0601075103; Delmas PD, 1997, NEW ENGL J MED, V337, P1641, DOI 10.1056/NEJM199712043372301; Dennis MK, 2009, NAT CHEM BIOL, V5, P421, DOI 10.1038/nchembio.168; Dubal DB, 1999, J NEUROSCI, V19, P6385; Fan L, 2008, J NEUROSCI RES, V86, P3655, DOI 10.1002/jnr.21801; Ferlazzo N, 2011, NEUROMOL MED, V13, P167, DOI 10.1007/s12017-011-8148-8; Figtree GA, 1999, CIRCULATION, V100, P1095, DOI 10.1161/01.CIR.100.10.1095; Foxton RH, 2007, NEUROCHEM RES, V32, P751, DOI 10.1007/s11064-006-9201-0; Galea LAM, 2008, BRAIN RES REV, V57, P332, DOI 10.1016/j.brainresrev.2007.05.008; Garthwaite G, 2006, J NEUROSCI, V26, P7730, DOI 10.1523/JNEUROSCI.1528-06.2006; Gibbs RB, 2000, NEUROBIOL AGING, V21, P107, DOI 10.1016/S0197-4580(00)00103-2; Gibbs RB, 2004, PSYCHONEUROENDOCRINO, V29, P741, DOI 10.1016/S0306-4530(03)00118-5; Gibbs RB, 2010, ENDOCR REV, V31, P224, DOI 10.1210/er.2009-0036; Gkaliagkousi E, 2011, FRONT BIOSCI-LANDMRK, V16, P1873, DOI 10.2741/3828; Goekoop R, 2005, NEUROIMAGE, V25, P63, DOI 10.1016/j.neuroimage.2004.11.012; Goekoop R, 2006, NEUROPSYCHOPHARMACOL, V31, P1508, DOI 10.1038/sj.npp.1300956; Grohe C, 2004, NEUROREPORT, V15, P89, DOI 10.1097/01.wnr.0000103270.91211.a1; Hammond R, 2011, BRAIN RES, V1379, P53, DOI 10.1016/j.brainres.2010.11.098; Hochner-Celnikier D, 1999, EUR J OBSTET GYN R B, V85, P23, DOI 10.1016/S0301-2115(98)00278-4; Hopper RA, 2006, J NEUROSCI, V26, P11513, DOI 10.1523/JNEUROSCI.2259-06.2006; Jacobsen DE, 2010, MENOPAUSE, V17, P309, DOI 10.1097/gme.0b013e3181bd54df; Jans D. M., 2006, Cardiovascular & Hematological Disorders - Drug Targets, V6, P21; Jeynes B, 2009, NEUROSCI LETT, V463, P244, DOI 10.1016/j.neulet.2009.07.091; Khorram O, 1999, J CLIN ENDOCR METAB, V84, P2226, DOI 10.1210/jc.84.6.2226; Kramar EA, 2009, J NEUROSCI, V29, P12982, DOI 10.1523/JNEUROSCI.3059-09.2009; Larson J, 1999, BRAIN RES, V840, P23, DOI 10.1016/S0006-8993(99)01698-4; LARSON J, 1988, BRAIN RES, V441, P111, DOI 10.1016/0006-8993(88)91388-1; LeBlanc ES, 2001, JAMA-J AM MED ASSOC, V285, P1489, DOI 10.1001/jama.285.11.1489; Li ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038787; Liu H, 2005, CHEM RES TOXICOL, V18, P162, DOI 10.1021/tx049776u; Liu H, 2006, CHEM RES TOXICOL, V19, P779, DOI 10.1021/tx050326r; Luiking YC, 2012, AM J PHYSIOL-ENDOC M, V303, pE1177, DOI 10.1152/ajpendo.00284.2012; Maki PM, 2013, MENOPAUSE, V20, P695, DOI [10.1097/gme.0b013e3182960cf8, 10.1097/GME.0b013e3182960cf8]; Maki PM, 2009, HUM REPROD UPDATE, V15, P667, DOI 10.1093/humupd/dmp022; Maki PM, 2006, NEUROSCIENCE, V138, P1027, DOI 10.1016/j.neuroscience.2006.01.001; Maki PM, 2000, NEUROBIOL AGING, V21, P373, DOI 10.1016/S0197-4580(00)00123-8; Meyer MR, 2012, HYPERTENSION, V59, P507, DOI 10.1161/HYPERTENSIONAHA.111.184606; Mufson EJ, 2012, ACTA NEUROPATHOL, V123, P13, DOI 10.1007/s00401-011-0884-1; Nilsen J, 2002, BRAIN RES, V930, P216, DOI 10.1016/S0006-8993(02)02254-0; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Olga NK, 2006, BEHAV BRAIN RES, V170, P233, DOI 10.1016/j.bbr.2006.02.026; Overk CR, 2007, CHEMMEDCHEM, V2, P1520, DOI 10.1002/cmdc.200700104; Palkowitz AD, 1997, J MED CHEM, V40, P1407, DOI 10.1021/jm970167b; Peng KW, 2009, ACS CHEM BIOL, V4, P1039, DOI 10.1021/cb9001848; Prossnitz ER, 2011, NAT REV ENDOCRINOL, V7, P715, DOI 10.1038/nrendo.2011.122; Qin ZH, 2007, J MED CHEM, V50, P2682, DOI 10.1021/jm070079j; Qjn ZH, 2012, J MED CHEM, V55, P6784, DOI 10.1021/jm300353r; Resnick SM, 1998, HORM BEHAV, V34, P171, DOI 10.1006/hbeh.1998.1476; Resnick SM, 1997, NEUROLOGY, V49, P1491, DOI 10.1212/WNL.49.6.1491; Ridnour LA, 2012, J NEUROCHEM, V123, P736, DOI 10.1111/jnc.12028; Rocca WA, 2010, NEURODEGENER DIS, V7, P163, DOI 10.1159/000289229; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Saitta A, 2001, ARTERIOSCL THROM VAS, V21, P1512, DOI 10.1161/hq0901.095565; Sato M, 1998, J PHARMACOL EXP THER, V287, P1; Schiefer IT, 2012, J MED CHEM, V55, P3076, DOI 10.1021/jm201504s; Selley ML, 2004, J AFFECT DISORDERS, V80, P249, DOI 10.1016/S0165-0327(03)00135-6; Sherwin BB, 2009, NAT REV ENDOCRINOL, V5, P620, DOI 10.1038/nrendo.2009.193; Shumaker SA, 1998, CONTROL CLIN TRIALS, V19, P604, DOI 10.1016/S0197-2456(98)00038-5; Simoncini T, 2002, CIRCULATION, V105, P1368, DOI 10.1161/hc1102.105267; Siris E, 2002, OSTEOPOROSIS INT, V13, P907, DOI 10.1007/s001980200125; Smith AR, 2006, AGING CELL, V5, P391, DOI 10.1111/j.1474-9726.2006.00232.x; Smith S, 2000, NEUROREPORT, V11, P3883, DOI 10.1097/00001756-200011270-00055; Steenland K, 2009, ALZ DIS ASSOC DIS, V23, P165, DOI 10.1097/WAD.0b013e3181902c3e; Sterniczuk R, 2010, BRAIN RES, V1348, P149, DOI 10.1016/j.brainres.2010.06.011; Stirone C, 2005, MOL PHARMACOL, V67, P105, DOI 10.1124/mol.104.004465; Suh N, 2001, CANCER RES, V61, P8412; Taddei S, 1996, HYPERTENSION, V28, P576, DOI 10.1161/01.HYP.28.4.576; Tanapat P, 1999, J NEUROSCI, V19, P5792, DOI 10.1523/JNEUROSCI.19-14-05792.1999; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074; Wegesin DJ, 2007, AGING NEUROPSYCHOL C, V14, P301, DOI 10.1080/13825580600802893; Wu TW, 2005, NEUROSCIENCE, V135, P59, DOI 10.1016/j.neuroscience.2004.12.027; Wu X, 1999, BRAIN RES, V847, P98, DOI 10.1016/S0006-8993(99)02062-4; Wyckoff MH, 2001, J BIOL CHEM, V276, P27071, DOI 10.1074/jbc.M100312200; Yaffe K, 1998, JAMA-J AM MED ASSOC, V279, P688, DOI 10.1001/jama.279.9.688; Yaffe K, 2005, AM J PSYCHIAT, V162, P683, DOI 10.1176/appi.ajp.162.4.683; Yaffe K, 2001, NEW ENGL J MED, V344, P1207, DOI 10.1056/NEJM200104193441604; Yu BL, 2007, MOL CANCER THER, V6, P2418, DOI 10.1158/1535-7163.MCT-07-0268; Zhang QG, 2011, P NATL ACAD SCI USA, V108, pE617, DOI 10.1073/pnas.1104391108; Zhou J, 2005, NEUROENDOCRINOLOGY, V81, P294, DOI 10.1159/000088448	95	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e70740	10.1371/journal.pone.0070740	http://dx.doi.org/10.1371/journal.pone.0070740			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23976955	Green Published, Green Submitted, gold			2022-12-25	WOS:000323570200007
J	Hu, FL; Shi, LJ; Mu, R; Zhu, JX; Li, YN; Ma, XX; Li, C; Jia, RL; Yang, DY; Li, Y; Li, ZG				Hu, Fanlei; Shi, Lianjie; Mu, Rong; Zhu, Jiaxin; Li, Yingni; Ma, Xiaoxu; Li, Chun; Jia, Rulin; Yang, Dongyue; Li, Yun; Li, Zhanguo			Hypoxia-Inducible Factor-1 alpha and Interleukin 33 Form a Regulatory Circuit to Perpetuate the Inflammation in Rheumatoid Arthritis	PLOS ONE			English	Article							TNF-ALPHA; IL-33; CYTOKINE; EXPRESSION; RECEPTOR; ST2; CHROMATIN; SYNOVIUM; PROTEIN	Hyperplasia of synovial fibroblasts, infiltration with inflammatory cytokines, and tissue hypoxia are the major characteristics of rheumatoid arthritis (RA). Interleukin 33 (IL-33) is a newly identified inflammatory cytokine exacerbating the disease severity of RA. Hypoxia-inducible factor-1 alpha (HIF-1 alpha) showed increased expression in RA synovium and could regulate a number of inflammatory cytokine productions. Nevertheless, its correlation with IL-33 remains largely unknown. Here, we showed that elevated levels of IL-33 were demonstrated in RA patient synovial fluids, with upregulated expression of HIF-1 alpha and IL-33 in the synovial fibroblasts. Knocking down HIF-1 alpha compromised IL-33 expression in rheumatoid arthritis synovial fibroblasts (RASF), while enforcing HIF-1 alpha expression in RASF substantially upregulated IL-33 levels. HIF-1 alpha promoted the activation of the signalling pathways controlling IL-33 production, particularly the p38 and ERK pathways. Moreover, we showed for the first time that IL-33 in turn could induce more HIF-1 alpha expression in RASF, thus forming a HIF-1 alpha/IL-33 regulatory circuit that would perpetuate the inflammatory process in RA. Targeting this pathological pathway and HIF-1 alpha may provide new therapeutic strategies for overcoming the persistent and chronic inflammatory disease.	[Hu, Fanlei; Shi, Lianjie; Mu, Rong; Zhu, Jiaxin; Li, Yingni; Ma, Xiaoxu; Li, Chun; Jia, Rulin; Yang, Dongyue; Li, Yun; Li, Zhanguo] Peking Univ, Peoples Hosp, Dept Rheumatol & Immunol, Beijing 100871, Peoples R China	Peking University	Li, ZG (corresponding author), Peking Univ, Peoples Hosp, Dept Rheumatol & Immunol, Beijing 100871, Peoples R China.	li99@bjmu.edu.cn			973 program of China [2010CB529100]; Natural Science Foundation of China [81120108020, 81030057, 81072401]; Peking University People's Hospital Research and Development Funds [RDB2012-04]	973 program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Peking University People's Hospital Research and Development Funds	This work was supported by grants from 973 program of China (2010CB529100)1/4CEand the Natural Science Foundation of China (81120108020, 81030057, and 81072401), as well as by Peking University People's Hospital Research and Development Funds (RDB2012-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JK, 2008, RHEUMATOLOGY, V47, P834, DOI 10.1093/rheumatology/ken086; Biniecka M, 2011, ARTHRITIS RHEUM-US, V63, P2172, DOI 10.1002/art.30395; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chackerian AA, 2007, J IMMUNOL, V179, P2551, DOI 10.4049/jimmunol.179.4.2551; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Haraldsen G, 2009, TRENDS IMMUNOL, V30, P227, DOI 10.1016/j.it.2009.03.003; Hollander AP, 2001, ARTHRITIS RHEUM-US, V44, P1540, DOI 10.1002/1529-0131(200107)44:7<1540::AID-ART277>3.0.CO;2-7; Hot A, 2012, ANN RHEUM DIS, V71, P1393, DOI 10.1136/annrheumdis-2011-200867; Hu FL, 2014, ANN RHEUM DIS, V73, P928, DOI 10.1136/annrheumdis-2012-202444; Kunisch E, 2012, INT J MOL MED, V29, P530, DOI 10.3892/ijmm.2012.883; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; LUNDOLESEN K, 1970, ARTHRITIS RHEUM-US, V13, P769, DOI 10.1002/art.1780130606; Millar NL, 2012, ANN RHEUM DIS, V71, P302, DOI 10.1136/ard.2011.154229; Mu R, 2010, J RHEUMATOL, V37, P2006, DOI 10.3899/jrheum.100184; Mun SH, 2010, CELL MOL LIFE SCI, V67, P3883, DOI 10.1007/s00018-010-0410-y; NAUGHTON DP, 1993, FEBS LETT, V332, P221, DOI 10.1016/0014-5793(93)80636-9; Ng CT, 2010, ANN RHEUM DIS, V69, P1389, DOI 10.1136/ard.2009.119776; Palmer G, 2009, ARTHRITIS RHEUM-US, V60, P738, DOI 10.1002/art.24305; Peters CL, 2004, ARTHRITIS RHEUM-US, V50, P291, DOI 10.1002/art.11473; Roussel L, 2008, EMBO REP, V9, P1006, DOI 10.1038/embor.2008.145; Samson M, 2012, ARTHRITIS RHEUM; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Sokka T, 2003, CLIN EXP RHEUMATOL, V21, pS71; Thornton RD, 2000, BIOCHEM J, V350, P307, DOI 10.1042/0264-6021:3500307; ULFGREN AK, 1995, ANN RHEUM DIS, V54, P654, DOI 10.1136/ard.54.8.654; van Oosterhout M, 2005, ANN RHEUM DIS, V64, P537, DOI 10.1136/ard.2004.024927; Westra J, 2007, ANN NY ACAD SCI, V1108, P340, DOI 10.1196/annals.1422.035; Xu D, 2008, P NATL ACAD SCI USA, V105, P10913, DOI 10.1073/pnas.0801898105	29	44	52	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e72650	10.1371/journal.pone.0072650	http://dx.doi.org/10.1371/journal.pone.0072650			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967327	Green Submitted, Green Published, gold			2022-12-25	WOS:000323378000109
J	Chien, YH; Han, DS; Hwu, WL; Thurberg, BL; Yang, WS				Chien, Yin-Hsiu; Han, Der-Sheng; Hwu, Wuh-Liang; Thurberg, Beth L.; Yang, Wei-Shiung			Myostatin and Insulin-Like Growth Factor I: Potential Therapeutic Biomarkers for Pompe Disease	PLOS ONE			English	Article							ENZYME REPLACEMENT THERAPY; SKELETAL-MUSCLE MASS; ALGLUCOSIDASE ALPHA; IGF-I; FOLLISTATIN; EXPRESSION; INFANTS; MICE; GLUCOSIDASE; PATHOLOGY	Objective: Myostatin and insulin-like growth factor 1 (IGF-1) are serum markers for muscle growth and regeneration. However, their value in the clinical monitoring of Pompe disease - a muscle glycogen storage disease - is not known. In order to evaluate their possible utility for disease monitoring, we assessed the levels of these serum markers in Pompe disease patients receiving enzyme replacement therapy (ERT). Design: A case-control study that included 10 patients with Pompe disease and 10 gender-and age-matched non-Pompe disease control subjects was performed in a referral medical center. Average follow-up duration after ERT for Pompe disease patients was 11.7 months (range: 6-23 months). Measurements of serum myostatin, IGF-1, and creatine kinase levels were obtained, and examinations of muscle pathology were undertaken before and after ERT in the patient group. Results: Compared with control subjects, Pompe disease patients prior to undergoing ERT had significantly lower serum IGF-1 levels (98.6 ng/ml vs. 307.9 ng/ml, p = 0.010) and lower myostatin levels that bordered on significance (1.38 ng/ml vs. 3.32 ng/ml, p = 0.075). After ERT, respective myostatin and IGF-1 levels in Pompe disease patients increased significantly by 129% (from 1.38 ng/ml to 3.16 ng/ml, p = 0.047) and 74% (from 98.6 ng/ml to 171.1 ng/ml, p = 0.013); these values fall within age-matched normal ranges. In contrast, myostatin and IGF-1 serum markers did not increase in age-matched controls. Follistatin, a control marker unrelated to muscle, increased in both Pompe disease patients and control subjects. At the same time, the percentage of muscle fibers containing intracytoplasmic vacuoles decreased from 80.0 +/- 26.4% to 31.6 +/- 45.3%. Conclusion: The increase in myostatin and IGF-1 levels in Pompe disease patients may reflect muscle regeneration after ERT. The role of these molecules as potential therapeutic biomarkers in Pompe disease and other neuromuscular diseases warrants further study.	[Chien, Yin-Hsiu; Hwu, Wuh-Liang] Natl Taiwan Univ Hosp, Dept Med Genet, Taipei 100, Taiwan; [Han, Der-Sheng] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei 100, Taiwan; [Yang, Wei-Shiung] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Han, Der-Sheng] Natl Taiwan Univ Hosp, BeiHu Branch, Dept Phys Med & Rehabil, Taipei 100, Taiwan; [Han, Der-Sheng; Yang, Wei-Shiung] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Yang, Wei-Shiung] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10764, Taiwan; [Thurberg, Beth L.] Genzyme, Dept Pathol, Framingham, MA USA	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; Sanofi-Aventis; Genzyme Corporation	Yang, WS (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	wsyang@ntu.edu.tw	Chien, Yin-Hsiu/I-2348-2019	Chien, Yin-Hsiu/0000-0001-8802-5728; HWU, WUH-LIANG/0000-0001-6690-4879; YANG, WEI-SHIUNG/0000-0001-5087-373X; HAN, DER-SHENG/0000-0001-7642-8060	National Taiwan University Hospital [NTUH 99-M1401]; National Science Council of Taiwan [97-2314-B-002-014-MY3, 100-2314-B-002-083-]	National Taiwan University Hospital(National Taiwan University); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	The study is sponsored by grants from National Taiwan University Hospital (NTUH 99-M1401), and National Science Council (97-2314-B-002-014-MY3, 100-2314-B-002-083-) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton ER, 2002, J CELL BIOL, V157, P137, DOI 10.1083/jcb.200108071; Chien YH, 2009, PEDIATRICS, V124, pE1116, DOI 10.1542/peds.2008-3667; Dobrowolny G, 2005, J CELL BIOL, V168, P193, DOI 10.1083/jcb.200407021; Flanagan JN, 2009, J CLIN ENDOCR METAB, V94, P3003, DOI 10.1210/jc.2008-2005; Foley JW, 2010, MOL THER, V18, P1584, DOI 10.1038/mt.2010.110; Gajos-Michniewicz A, 2010, BIOMARKERS, V15, P563, DOI 10.3109/1354750X.2010.495786; Gaussin V, 2005, CARDIOVASC RES, V68, P347, DOI 10.1016/j.cardiores.2005.09.007; Grimberg A, 2000, J CELL PHYSIOL, V183, P1, DOI 10.1002/(SICI)1097-4652(200004)183:1<1::AID-JCP1>3.0.CO;2-J; Gucev Z, 2012, HORM RES PAEDIAT, V77, P1, DOI 10.1159/000334643; Guernec A, 2004, DOMEST ANIM ENDOCRIN, V26, P143, DOI 10.1016/j.domaniend.2003.10.001; Haidet AM, 2008, P NATL ACAD SCI USA, V105, P4318, DOI 10.1073/pnas.0709144105; Han DS, 2011, CLIN ENDOCRINOL, V75, P857, DOI 10.1111/j.1365-2265.2011.04120.x; JONES G, 1994, J IMMUNOL METHODS, V177, P1, DOI 10.1016/0022-1759(94)90136-8; Kishnani PS, 2007, NEUROLOGY, V68, P99, DOI 10.1212/01.wnl.0000251268.41188.04; Kishnani PS, 2006, GENET MED, V8, P267, DOI 10.1097/01.gim.0000218152.87434.f3; Kouanda S, 2008, GROWTH HORM IGF RES, V18, P345, DOI 10.1016/j.ghir.2008.01.008; LINEHAM JD, 1986, EARLY HUM DEV, V13, P37, DOI 10.1016/0378-3782(86)90096-4; Liu Y, 2008, BRIT J SPORT MED, V42, P989, DOI 10.1136/bjsm.2007.045518; Lynch CM, 2005, J HISTOCHEM CYTOCHEM, V53, P63, DOI 10.1369/jhc.4A6365.2005; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Nicolino M, 2009, GENET MED, V11, P210, DOI 10.1097/GIM.0b013e31819d0996; Pelosi L, 2007, FASEB J, V21, P1393, DOI 10.1096/fj.06-7690com; Sebastiani G, 2012, PEDIATR OBES, V7, P39, DOI 10.1111/j.2047-6310.2011.00004.x; Shyu KG, 2005, CARDIOVASC RES, V68, P405, DOI 10.1016/j.cardiores.2005.06.028; Thurberg BL, 2006, LAB INVEST, V86, P1208, DOI 10.1038/labinvest.3700484; UENO N, 1987, P NATL ACAD SCI USA, V84, P8282, DOI 10.1073/pnas.84.23.8282; Van den Hout JMP, 2004, PEDIATRICS, V113, pE448, DOI 10.1542/peds.113.5.e448; van der Ploeg AT, 2010, NEW ENGL J MED, V362, P1396, DOI 10.1056/NEJMoa0909859; Wintgens KF, 2012, CLIN CHIM ACTA, V413, P1288, DOI 10.1016/j.cca.2012.04.023; Young SP, 2009, GENET MED, V11, P536, DOI 10.1097/GIM.0b013e3181a87867; Yuksel B, 2011, J CLIN RES PEDIATR E, V3, P84, DOI 10.4274/jcrpe.v3i2.17	31	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71900	10.1371/journal.pone.0071900	http://dx.doi.org/10.1371/journal.pone.0071900			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967261	gold, Green Published, Green Submitted			2022-12-25	WOS:000323221500112
J	Du, DS; Chen, J; Liu, M; Zhu, MX; Jing, HJ; Fang, J; Shen, LL; Zhu, DN; Yu, J; Wang, J				Du, Dongshu; Chen, Jun; Liu, Min; Zhu, Minxia; Jing, Haojia; Fang, Jie; Shen, Linlin; Zhu, Danian; Yu, Jerry; Wang, Jin			The Effects of Angiotensin II and Angiotensin-(1-7) in the Rostral Ventrolateral Medulla of Rats on Stress-Induced Hypertension	PLOS ONE			English	Article							SYMPATHETIC AFFERENT REFLEX; CONVERTING ENZYME; BLOOD-PRESSURE; SUBFORNICAL ORGAN; NERVE ACTIVITY; ACID RELEASE; RECEPTOR; EXPRESSION; BRAIN; OVEREXPRESSION	We have shown that angiotensin II (Ang II) and angiotensin-(1-7) [Ang-(1-7)] increased arterial blood pressure (BP) via glutamate release when microinjected into the rostral ventrolateral medulla (RVLM) in normotensive rats (control). In the present study, we tested the hypothesis that Ang II and Ang-(1-7) in the RVLM are differentially activated in stress-induced hypertension (SIH) by comparing the effects of microinjection of Ang II, Ang-(1-7), and their receptor antagonists on BP and amino acid release in SIH and control rats. We found that Ang II had greater pressor effect, and more excitatory (glutamate) and less inhibitory (taurine and gamma-aminobutyric acid) amino acid release in SIH than in control animals. Losartan, a selective AT(1) receptor (AT(1)R) antagonist, decreased mean BP in SIH but not in control rats. PD123319, a selective AT(2) receptor (AT(2)R) antagonist, increased mean BP in control but not in SIH rats. However, Ang-(1-7) and its selective Mas receptor antagonist Ang779 evoked similar effects on BP and amino acid release in both SIH and control rats. Furthermore, we found that in the RVLM, AT(1)R, ACE protein expression (western blot) and ACE mRNA (real-time PCR) were significantly higher, whereas AT(2)R protein, ACE2 mRNA and protein expression were significantly lower in SIH than in control rats. Mas receptor expression was similar in the two groups. The results support our hypothesis and demonstrate that upregulation of Ang II by AT(1)R, not Ang( 1-7), system in the RVLM causes hypertension in SIH rats by increasing excitatory and suppressing inhibitory amino acid release.	[Du, Dongshu; Chen, Jun; Liu, Min; Zhu, Minxia; Jing, Haojia; Fang, Jie; Shen, Linlin; Zhu, Danian; Yu, Jerry; Wang, Jin] Fudan Univ, Dept Physiol & Pathophysiol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Du, Dongshu] Shanghai Univ, Dept Neurobiol, Sch Life Sci, Shanghai, Peoples R China; [Chen, Jun] Second Mil Med Univ, Changzheng Hosp, Dept Pathol, Shanghai, Peoples R China; [Yu, Jerry] Univ Louisville, Dept Pulm Med, Louisville, KY 40292 USA	Fudan University; Shanghai University; Naval Medical University; University of Louisville	Wang, J (corresponding author), Fudan Univ, Dept Physiol & Pathophysiol, Shanghai Med Coll, Shanghai 200433, Peoples R China.	wangjin@shmu.edu.cn		Du, Dongshu/0000-0003-1198-1089; Zhu, Minxia/0000-0001-8775-1226	Shanghai Natural Science Foundation [10ZR 1402500]; National Natural Science Foundation of China [J1210041, 31100838, 31271215]; Fudan University [MDJH2012001]	Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fudan University	This work was sponsored by the Shanghai Natural Science Foundation (number 10ZR 1402500); the National Natural Science Foundation of China (numbers J1210041, 31100838, 31271215) (http://www.nsfc.gov.cn); Mingdao Program of Fudan University (MDJH2012001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Ghatrif M, 2011, ANN EPIDEMIOL, V21, P15, DOI 10.1016/j.annepidem.2010.06.002; CHAPPELL MC, 1989, J BIOL CHEM, V264, P16518; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Dobruch J, 2003, J PHYSIOL PHARMACOL, V54, P371; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Dupont AG, 2010, J HYPERTENS, V28, P1599, DOI 10.1097/HJH.0b013e32833af3b2; Feng YM, 2008, CIRC RES, V102, P729, DOI 10.1161/CIRCRESAHA.107.169110; Ferreira AJ, 2009, AM J RESP CRIT CARE, V179, P1048, DOI 10.1164/rccm.200811-1678OC; Gao L, 2008, HYPERTENSION, V51, P521, DOI 10.1161/HYPERTENSIONAHA.107.101717; Gwathmey TM, 2010, HYPERTENSION, V55, P166, DOI 10.1161/HYPERTENSIONAHA.109.141622; Hirooka Y, 1997, BRAIN RES, V772, P107, DOI 10.1016/S0006-8993(97)00861-5; Hu L, 2002, J APPL PHYSIOL, V92, P2153, DOI 10.1152/japplphysiol.00261.2001; Ito S, 2003, HYPERTENSION, V41, P744, DOI 10.1161/01.HYP.0000052944.54349.7B; Ito S, 2002, HYPERTENSION, V40, P552, DOI 10.1161/01.HYP.0000033812.99089.92; Kumagai H, 2012, HYPERTENS RES, V35, P132, DOI 10.1038/hr.2011.208; Li P, 2013, HYPERTENSION, V61, P820, DOI 10.1161/HYPERTENSIONAHA.111.00191; Mayorov DN, 2003, HYPERTENSION, V41, P1168, DOI 10.1161/01.HYP.0000064574.29317.45; McMullan S, 2012, BRAIN RES, V1439, P34, DOI 10.1016/j.brainres.2011.12.058; Nakagaki T, 2011, CLIN EXP HYPERTENS, V33, P223, DOI 10.3109/10641963.2011.583967; Nunes FC, 2011, J RENIN-ANGIO-ALDO S, V12, P440, DOI 10.1177/1470320310394891; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Phillips MI, 2008, J MOL MED, V86, P715, DOI 10.1007/s00109-008-0331-5; Phillips MI, 1998, REGUL PEPTIDES, V78, P1, DOI 10.1016/S0167-0115(98)00122-0; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Sartorio CL, 2007, HYPERTENSION, V50, P919, DOI 10.1161/HYPERTENSIONAHA.107.093450; Schmieder RE, 2007, LANCET, V369, P1208, DOI 10.1016/S0140-6736(07)60242-6; Shinohara K, 2012, CIRC J, V76, P2814, DOI 10.1253/circj.CJ-12-0399; Stornetta RL, 2002, J COMP NEUROL, V444, P207, DOI 10.1002/cne.10142; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; Vickers C, 2002, J BIOL CHEM, V277, P14838, DOI 10.1074/jbc.M200581200; Wang J, 2005, REGUL PEPTIDES, V129, P1, DOI 10.1016/j.regpep.2004.12.031; Wang J, 2003, ACUPUNCTURE ELECTRO, V28, P25, DOI 10.3727/036012903815901679; Xia CM, 2008, CLIN EXP PHARMACOL P, V35, P1258, DOI 10.1111/j.1440-1681.2008.05000.x; Xiao F, 2013, NEUROPHARMACOLOGY, V67, P16, DOI 10.1016/j.neuropharm.2012.10.021; Xu Y, 2002, J 4 MIL MED U, V23, P596; Yang Gang, 1993, Biological Signals, V2, P166; Zhou LM, 2010, PFLUG ARCH EUR J PHY, V459, P681, DOI 10.1007/s00424-010-0793-5; Zhou W, 2007, AM J PHYSIOL-HEART C, V292, pH1868, DOI 10.1152/ajpheart.00875.2006	38	25	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e70976	10.1371/journal.pone.0070976	http://dx.doi.org/10.1371/journal.pone.0070976			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967142	Green Published, Green Submitted, gold			2022-12-25	WOS:000323221500048
J	Wang, PH; Wan, DH; Gu, ZH; Qiu, W; Chen, YG; Weng, SP; Yu, XQ; He, JG				Wang, Pei-Hui; Wan, Ding-Hui; Gu, Zhi-Hua; Qiu, Wei; Chen, Yong-Gui; Weng, Shao-Ping; Yu, Xiao-Qiang; He, Jian-Guo			Analysis of Expression, Cellular Localization, and Function of Three Inhibitors of Apoptosis (IAPs) from Litopenaeus vannamei during WSSV Infection and in Regulation of Antimicrobial Peptide Genes (AMPs)	PLOS ONE			English	Article							NF-KAPPA-B; INNATE IMMUNITY; PENAEUS-MONODON; TIGER SHRIMP; ANTILIPOPOLYSACCHARIDE FACTOR; DROSOPHILA INHIBITOR; PROTEIN; CASPASE; FAMILY; ACTIVATION	Inhibitors of apoptosis (IAPs) play important roles in apoptosis and NF-kappa B activation. In this study, we cloned and characterized three IAPs (LvIAP1-3) from the Pacific white shrimp, Litopenaeus vannamei. LvIAP1-3 proteins shared signature domains and exhibited significant similarities with other IAP family proteins. The tissue distributions of LvIAP1-3 were studied. The expression of LvIAP1-3 was induced in the muscle after white spot syndrome virus (WSSV) infection. LvIAP1 expression in the gill, hemocytes, hepatopancreas, and intestine was responsive to WSSV and Vibrio alginolyticus infections. LvIAP2 expression in the gill, hemocytes, and hepatopancreas was also responsive to WSSV infection. The expression of LvIAP3 in the gill, hemocytes, and intestine was reduced after V. alginolyticus infection. When overexpressed in Drosophila S2 cells, GFP labeled-LvIAP2 was distributed in the cytoplasm and appeared as speck-like aggregates in the nucleus. Both LvIAP1 and LvIAP3 were widely distributed throughout the cytoplasm and nucleus. The expression of LvIAP1, LvIAP2, and LvIAP3 was significantly knocked down by dsRNA-mediated gene silencing. In the gill of LvIAP1- or LvIAP3-silenced shrimp, the expression of WSSV VP28 was significantly higher than that of the dsGFP control group, suggesting that LvIAP1 and LvIAP3 may play protective roles in host defense against WSSV infection. Intriguingly, the LvIAP2-silenced shrimp all died within 48 hours after dsLvIAP2 injection. In the hemocytes of LvIAP2-silenced shrimps, the expression of antimicrobial peptide genes (AMPs), including Penaeidins, lysozyme, crustins, Vibrio penaeicidae-induced cysteine and proline-rich peptides (VICPs), was significantly downregulated, while the expression of anti-lipopolysaccharide factors (ALFs) was upregulated. Moreover, LvIAP2 activated the promoters of the NF-kappa B pathway-controlled AMPs, such as shrimp Penaeidins and Drosophila drosomycin and attacin A, in Drosophila S2 cells. Taken together, these results reveal that LvIAP1 and LvIAP3 might participate in the host defense against WSSV infection, and LvIAP2 might be involved in the regulation of shrimp AMPs.	[Wang, Pei-Hui; Wan, Ding-Hui; Gu, Zhi-Hua; Weng, Shao-Ping; He, Jian-Guo] Sun Yat Sen Univ, Sch Life Sci, MOE Key Lab Aquat Prod Safety, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Qiu, Wei; Chen, Yong-Gui; He, Jian-Guo] Sun Yat Sen Univ, Sch Marine Sci, Guangzhou 510275, Guangdong, Peoples R China; [Yu, Xiao-Qiang] Univ Missouri, Div Cell Biol & Biophys, Sch Biol Sci, Kansas City, MO 64110 USA	Sun Yat Sen University; Sun Yat Sen University; University of Missouri System; University of Missouri Kansas City	Wang, PH (corresponding author), Sun Yat Sen Univ, Sch Life Sci, MOE Key Lab Aquat Prod Safety, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	wph326@gmail.com; lsshjg@mail.sysu.edu.cn	YU, XIAO-QIANG/AAL-1797-2021; Wang, Pei-Hui/F-7682-2014; YU, XiaoQiang/GRJ-1077-2022	YU, XIAO-QIANG/0000-0003-1419-9009; Wang, Pei-Hui/0000-0001-6853-2423; 	National Natural Science Foundation of China [U1131002]; National High Technology Research and Development Program of China (973 Program) [2012CB114401]; Technology Planning Project of Guangdong Province [2011A020102002]; China Agriculture Research System [CARS-47]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (973 Program)(National Basic Research Program of ChinaNational High Technology Research and Development Program of China); Technology Planning Project of Guangdong Province; China Agriculture Research System	This research was supported by National Natural Science Foundation of China under grant No. U1131002; the National High Technology Research and Development Program of China (973 Program) 2012CB114401; Technology Planning Project of Guangdong Province under number 2011A020102002, and China Agriculture Research System CARS-47. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Best SM, 2008, ANNU REV MICROBIOL, V62, P171, DOI 10.1146/annurev.micro.62.081307.163009; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Falschlehner C, 2012, EMBO J, V31, P2750, DOI 10.1038/emboj.2012.148; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; Galluzzi L, 2012, EMBO REP, V13, P322, DOI 10.1038/embor.2012.19; Gesellchen V, 2005, EMBO REP, V6, P979, DOI 10.1038/sj.embor.7400530; Gyrd-Hansen M, 2008, NAT CELL BIOL, V10, P1309, DOI 10.1038/ncb1789; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Hameed A.S. Sahul, 2006, Aquaculture, V256, P111, DOI 10.1016/j.aquaculture.2006.02.054; Hardwick JM, 2001, CELL DEATH DIFFER, V8, P109, DOI 10.1038/sj.cdd.4400820; He F, 2006, J VIROL, V80, P3884, DOI 10.1128/JVI.80.8.3884-3892.2006; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Ho SH, 2009, FISH SHELLFISH IMMUN, V27, P73, DOI 10.1016/j.fsi.2009.05.001; Huang XD, 2010, DEV COMP IMMUNOL, V34, P107, DOI 10.1016/j.dci.2009.08.009; Huh JR, 2007, J BIOL CHEM, V282, P2056, DOI 10.1074/jbc.M608051200; Kemp C, 2009, CURR OPIN IMMUNOL, V21, P3, DOI 10.1016/j.coi.2009.01.007; Kleino A, 2005, EMBO J, V24, P3423, DOI 10.1038/sj.emboj.7600807; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leu JH, 2008, DEV COMP IMMUNOL, V32, P476, DOI 10.1016/j.dci.2007.08.006; Leu JH, 2008, DEV COMP IMMUNOL, V32, P121, DOI 10.1016/j.dci.2007.05.005; Leu JH, 2013, FISH SHELLFISH IMMUN, V34, P1011, DOI 10.1016/j.fsi.2012.05.030; Leu JH, 2012, DEV COMP IMMUNOL, V38, P78, DOI 10.1016/j.dci.2012.04.006; Leu JH, 2010, DEV COMP IMMUNOL, V34, P1068, DOI 10.1016/j.dci.2010.05.010; Leulier F, 2006, MOL CELL BIOL, V26, P7821, DOI 10.1128/MCB.00548-06; Li FH, 2010, DEV COMP IMMUNOL, V34, P874, DOI 10.1016/j.dci.2010.03.008; Liu HP, 2006, J VIROL, V80, P10365, DOI 10.1128/JVI.01101-06; Liu HP, 2009, FISH SHELLFISH IMMUN, V27, P79, DOI 10.1016/j.fsi.2009.02.009; Lopez J, 2010, CURR OPIN CELL BIOL, V22, P872, DOI 10.1016/j.ceb.2010.08.025; Meinander A, 2012, EMBO J, V31, P2770, DOI 10.1038/emboj.2012.121; Nupan B, 2011, DEV COMP IMMUNOL, V35, P469, DOI 10.1016/j.dci.2010.11.016; O'Leary NA, 2006, GENE, V371, P75, DOI 10.1016/j.gene.2005.11.028; Rolland JL, 2010, MOL IMMUNOL, V47, P1269, DOI 10.1016/j.molimm.2009.12.007; Roulston A, 1999, ANNU REV MICROBIOL, V53, P577, DOI 10.1146/annurev.micro.53.1.577; Rumble JM, 2008, J CELL SCI, V121, P3505, DOI 10.1242/jcs.040303; Sabin LR, 2010, CURR OPIN IMMUNOL, V22, P4, DOI 10.1016/j.coi.2010.01.007; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; SILKE J, 2013, COLD SPRING HARB PER, V5; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Tassanakajon A, 2010, MAR BIOTECHNOL, V12, P487, DOI [10.1007/s10126-010-9288-9, 10.1007/s10126-011-9381-8]; Tharntada S, 2009, J GEN VIROL, V90, P1491, DOI 10.1099/vir.0.009621-0; Tonganunt M, 2008, FISH SHELLFISH IMMUN, V25, P633, DOI 10.1016/j.fsi.2008.08.006; Tschopp J, 1998, CURR OPIN GENET DEV, V8, P82, DOI 10.1016/S0959-437X(98)80066-X; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Wang DD, 2013, DEV COMP IMMUNOL, V39, P352, DOI 10.1016/j.dci.2012.12.005; Wang KCHC, 2010, FISH SHELLFISH IMMUN, V29, P94, DOI 10.1016/j.fsi.2010.02.020; Wang L, 2008, DEV COMP IMMUNOL, V32, P706, DOI 10.1016/j.dci.2007.10.010; Wang PH, 2013, DEV COMP IMMUNOL, V40, P266, DOI 10.1016/j.dci.2013.02.011; Wang PH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052088, 10.1371/journal.pone.0057020]; Wang PH, 2012, DEV COMP IMMUNOL, V36, P359, DOI 10.1016/j.dci.2011.07.007; Wang PH, 2012, DEV COMP IMMUNOL, V36, P39, DOI 10.1016/j.dci.2011.06.002; Wang PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024773; Wang PH, 2011, DEV COMP IMMUNOL, V35, P105, DOI 10.1016/j.dci.2010.08.013; Wang PH, 2009, MOL IMMUNOL, V46, P1897, DOI 10.1016/j.molimm.2009.01.005; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; Wang W, 2008, FISH SHELLFISH IMMUN, V25, P522, DOI 10.1016/j.fsi.2008.07.016; Wang ZM, 2004, BIOCHEM BIOPH RES CO, V325, P899, DOI 10.1016/j.bbrc.2004.09.224; Woramongkolchai N, 2011, DEV COMP IMMUNOL, V35, P530, DOI 10.1016/j.dci.2010.12.016; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhi B, 2011, MAR BIOTECHNOL, V13, P575, DOI 10.1007/s10126-010-9328-5	62	34	36	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e72592	10.1371/journal.pone.0072592	http://dx.doi.org/10.1371/journal.pone.0072592			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967321	Green Published, gold, Green Submitted			2022-12-25	WOS:000323221500139
J	Lindberg, BG; Merritt, EA; Rayl, M; Liu, CX; Parmryd, I; Olofsson, B; Faye, I				Lindberg, Bo G.; Merritt, Eleanor A.; Rayl, Melanie; Liu, Chenxiao; Parmryd, Ingela; Olofsson, Berit; Faye, Ingrid			Immunogenic and Antioxidant Effects of a Pathogen-Associated Prenyl Pyrophosphate in Anopheles gambiae	PLOS ONE			English	Article							DELTA T-CELLS; NITRIC-OXIDE SYNTHASE; PLASMODIUM-FALCIPARUM; NONPEPTIDE ANTIGENS; OOKINETE INVASION; DUAL OXIDASE; MALARIA; RECOGNITION; RESPONSES; STEPHENSI	Despite efficient vector transmission, Plasmodium parasites suffer great bottlenecks during their developmental stages within Anopheles mosquitoes. The outcome depends on a complex three-way interaction between host, parasite and gut bacteria. Although considerable progress has been made recently in deciphering Anopheles effector responses, little is currently known regarding the underlying microbial immune elicitors. An interesting candidate in this sense is the pathogen-derived prenyl pyrophosphate and designated phosphoantigen (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate (HMBPP), found in Plasmodium and most eubacteria but not in higher eukaryotes. HMBPP is the most potent stimulant known of human V gamma 9V delta 2 T cells, a unique lymphocyte subset that expands during several infections including malaria. In this study, we show that V(Y)9V delta 2 T cells proliferate when stimulated with supernatants from intraerythrocytic stages of Plasmodium falciparum cultures, suggesting that biologically relevant doses of phosphoantigens are excreted by the parasite. Next, we used Anopheles gambiae to investigate the immune-and redox-stimulating effects of HMBPP. We demonstrate a potent activation in vitro of all but one of the signaling pathways earlier implicated in the human V(Y)9V delta 2 T cell response, as p38, JNK and PI3K/Akt but not ERK were activated in the A. gambiae 4a3B cell line. Additionally, both HMBPP and the downstream endogenous metabolite isopentenyl pyrophosphate displayed antioxidant effects by promoting cellular tolerance to hydrogen peroxide challenge. When provided in the mosquito blood meal, HMBPP induced temporal changes in the expression of several immune genes. In contrast to meso-diaminopimelic acid containing peptidoglycan, HMBPP induced expression of dual oxidase and nitric oxide synthase, two key determinants of Plasmodium infection. Furthermore, temporal fluctuations in midgut bacterial numbers were observed. The multifaceted effects observed in this study indicates that HMBPP is an important elicitor in common for both Plasmodium and gut bacteria in the mosquito.	[Lindberg, Bo G.; Rayl, Melanie; Faye, Ingrid] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden; [Merritt, Eleanor A.] Royal Soc Chem, Cambridge, England; [Liu, Chenxiao; Parmryd, Ingela] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden; [Olofsson, Berit] Stockholm Univ, Dept Organ Chem, Arrhenius Lab, S-10691 Stockholm, Sweden	Stockholm University; Uppsala University; Stockholm University	Faye, I (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden.	ingrid.faye@su.se	Olofsson, Berit/A-9577-2009	Olofsson, Berit/0000-0001-7975-4582; Parmryd, Ingela/0000-0003-4834-3611	EU [228421]; Wenner-Gren Foundations	EU(European Commission); Wenner-Gren Foundations	This project was supported by the EU research infrastructures project INFRAVEC (FP7; 228421) and Wenner-Gren Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akman-Anderson L, 2007, INFECT IMMUN, V75, P4012, DOI 10.1128/IAI.00645-07; Arrighi RBG, 2009, DEV COMP IMMUNOL, V33, P216, DOI 10.1016/j.dci.2008.08.009; Baton LA, 2005, TRENDS PARASITOL, V21, P573, DOI 10.1016/j.pt.2005.09.012; Baton LA, 2004, PARASITOLOGY, V129, P663, DOI 10.1017/S0031182004005979; Behr C, 1996, INFECT IMMUN, V64, P2892, DOI 10.1128/IAI.64.8.2892-2896.1996; BUKOWSKI JF, 1995, J IMMUNOL, V154, P998; Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618; Correia DV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005657; Davey MS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002040; Dimopoulos G, 1998, EMBO J, V17, P6115, DOI 10.1093/emboj/17.21.6115; Dimopoulos G, 2002, P NATL ACAD SCI USA, V99, P8814, DOI 10.1073/pnas.092274999; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; GOERLICH R, 1991, EUR J IMMUNOL, V21, P2613, DOI 10.1002/eji.1830211045; GOODIER M, 1992, INT IMMUNOL, V4, P33, DOI 10.1093/intimm/4.1.33; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2009, NAT IMMUNOL, V10, P949, DOI 10.1038/ni.1765; Ha EM, 2009, DEV CELL, V16, P386, DOI 10.1016/j.devcel.2008.12.015; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; Hecht S, 2002, TETRAHEDRON LETT, V43, P8929, DOI 10.1016/S0040-4039(02)02195-0; Herrera-Ortiz A, 2011, DEV COMP IMMUNOL, V35, P44, DOI 10.1016/j.dci.2010.08.004; Horton AA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-574; Hurd H, 2005, EVOLUTION, V59, P2560, DOI 10.1111/j.0014-3820.2005.tb00969.x; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jaramillo-Gutierrez G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011168; Kambris Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001143; Kumar S, 2003, P NATL ACAD SCI USA, V100, P14139, DOI 10.1073/pnas.2036262100; Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008; Lim JH, 2005, INFECT IMMUN, V73, P2778, DOI 10.1128/IAI.73.5.2778-2789.2005; Ling S, 2004, MUTAT RES-FUND MOL M, V554, P33, DOI 10.1016/j.mrfmmm.2004.02.015; Meister S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000542; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; Morita CT, 2007, IMMUNOL REV, V215, P59, DOI 10.1111/j.1600-065X.2006.00479.x; Morita CT, 2000, SPRINGER SEMIN IMMUN, V22, P191, DOI 10.1007/s002810000042; Muller HM, 1999, J BIOL CHEM, V274, P11727, DOI 10.1074/jbc.274.17.11727; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Puan KJ, 2007, INT IMMUNOL, V19, P657, DOI 10.1093/intimm/dxm031; Pumpuni CB, 1996, AM J TROP MED HYG, V54, P214, DOI 10.4269/ajtmh.1996.54.214; Surachetpong W, 2011, ANTIOXID REDOX SIGN, V14, P943, DOI 10.1089/ars.2010.3401; Surachetpong W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000366; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Vantourout P, 2009, J IMMUNOL, V183, P3848, DOI 10.4049/jimmunol.0901085; Vlachou D, 2005, CURR BIOL, V15, P1185, DOI 10.1016/j.cub.2005.06.044; Wang H, 2010, J IMMUNOL, V184, P6209, DOI 10.4049/jimmunol.1000231; WHO, 2012, WORLD MALARIA REPORT 2012, P1	45	11	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e73868	10.1371/journal.pone.0073868	http://dx.doi.org/10.1371/journal.pone.0073868			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967351	Green Published, gold, Green Submitted			2022-12-25	WOS:000323115800125
J	Nguyen, GD; Molero, AE; Gokhan, S; Mehler, MF				Nguyen, Giang D.; Molero, Aldrin E.; Gokhan, Solen; Mehler, Mark F.			Functions of Huntingtin in Germ Layer Specification and Organogenesis	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; INTERACTING PROTEIN-1; SUBTYPE SPECIFICATION; DIABETES-MELLITUS; DISEASE; DIFFERENTIATION; PROMOTES; NOTCH; EXPRESSION; NEURONS	Huntington's disease (HD) is a neurodegenerative disease caused by abnormal polyglutamine expansion in the huntingtin protein (Htt). Although both Htt and the HD pathogenic mutation (mHtt) are implicated in early developmental events, their individual involvement has not been adequately explored. In order to better define the developmental functions and pathological consequences of the normal and mutant proteins, respectively, we employed embryonic stem cell (ESC) expansion, differentiation and induction experiments using huntingtin knock-out (KO) and mutant huntingtin knock-in (Q111) mouse ESC lines. In KO ESCs, we observed impairments in the spontaneous specification and survival of ectodermal and mesodermal lineages during embryoid body formation and under inductive conditions using retinoic acid and Wnt3A, respectively. Ablation of BAX improves cell survival, but failed to correct defects in germ layer specification. In addition, we observed ensuing impairments in the specification and maturation of neural, hepatic, pancreatic and cardiomyocyte lineages. These developmental deficits occurred in concert with alterations in Notch, Hes1 and STAT3 signaling pathways. Moreover, in Q111 ESCs, we observed differential developmental stage-specific alterations in lineage specification and maturation. We also observed changes in Notch/STAT3 expression and activation. Our observations underscore essential roles of Htt in the specification of ectoderm, endoderm and mesoderm, in the specification of neural and non-neural organ-specific lineages, as well as cell survival during early embryogenesis. Remarkably, these developmental events are differentially deregulated by mHtt, raising the possibility that HD-associated early developmental impairments may contribute not only to region-specific neurodegeneration, but also to non-neural co-morbidities.	[Nguyen, Giang D.; Molero, Aldrin E.; Gokhan, Solen; Mehler, Mark F.] Albert Einstein Coll Med, Roslyn & Leslie Goldstein Lab Stem Cell Biol & Re, Bronx, NY 10467 USA; [Nguyen, Giang D.; Molero, Aldrin E.; Gokhan, Solen; Mehler, Mark F.] Albert Einstein Coll Med, Inst Brain Disorders & Neural Regenerat, Bronx, NY 10467 USA; [Molero, Aldrin E.; Gokhan, Solen; Mehler, Mark F.] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; [Nguyen, Giang D.; Mehler, Mark F.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA; [Mehler, Mark F.] Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Bronx, NY 10467 USA; [Nguyen, Giang D.; Molero, Aldrin E.; Gokhan, Solen; Mehler, Mark F.] Albert Einstein Coll Med, Rose F Kennedy Ctr Res Intellectual & Dev Disabil, Bronx, NY 10467 USA; [Mehler, Mark F.] Albert Einstein Coll Med, Einstein Canc Ctr, Bronx, NY 10467 USA; [Mehler, Mark F.] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell Biol &, Bronx, NY 10467 USA; [Mehler, Mark F.] Albert Einstein Coll Med, Ctr Epigen, Bronx, NY 10467 USA; [Mehler, Mark F.] Albert Einstein Coll Med, Inst Aging Res, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Mehler, MF (corresponding author), Albert Einstein Coll Med, Roslyn & Leslie Goldstein Lab Stem Cell Biol & Re, Bronx, NY 10467 USA.	mark.mehler@einstein.yu.edu	Molero, Aldrin/AAN-5240-2020	Molero, Aldrin/0000-0001-8250-1236	NIH [NS071571, HD071593, MH66290, NS073758]; Roslyn and Leslie Goldstein Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD071593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073758, R01NS071571] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roslyn and Leslie Goldstein Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants to M.F.M. (NS071571 Funding institution NINDS, HD071593 Funding institution NICHD, MH66290 Funding institution NIMH) and to A.E.M. (NS073758 Funding institution NINDS), as well as by the F.M. Kirby, Alpern Family, Harold and Isabel Feld and Roslyn and Leslie Goldstein Foundations (M.F.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrajano JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007936; Abrajano JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007665; Almeida S, 2008, BIOCHEM BIOPH RES CO, V374, P599, DOI 10.1016/j.bbrc.2008.07.009; An MC, 2012, CELL STEM CELL, V11, P253, DOI 10.1016/j.stem.2012.04.026; Andreassen OA, 2002, NEUROBIOL DIS, V11, P410, DOI 10.1006/nbdi.2002.0562; Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Camnasio S, 2012, NEUROBIOL DIS, V46, P41, DOI 10.1016/j.nbd.2011.12.042; Carter RL, 2012, J GENET GENOMICS, V39, P253, DOI 10.1016/j.jgg.2012.04.006; Castiglioni V, 2012, NEUROBIOL DIS, V46, P30, DOI 10.1016/j.nbd.2011.12.032; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Chiba S, 2006, STEM CELLS, V24, P2437, DOI 10.1634/stemcells.2005-0661; Ciarmiello A, 2006, J NUCL MED, V47, P215; Conforti P, 2013, NEUROBIOL DIS, V50, P160, DOI 10.1016/j.nbd.2012.10.015; CONSORTIUM HD, 2012, CELL STEM CELL, V11, P264, DOI DOI 10.1016/J.STEM.2012.04.027.PUBMED:22748968; Dogan I, 2013, NEURODEGENER DIS, V12, P23, DOI 10.1159/000339528; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; FARRER LA, 1985, CLIN GENET, V27, P62; Fassler R, 1996, J CELL SCI, V109, P2989; Gao AJ, 2013, NEUROSCIENCE, V228, P47, DOI 10.1016/j.neuroscience.2012.09.076; Gervais FG, 2002, NAT CELL BIOL, V4, P95, DOI 10.1038/ncb735; Gil JM, 2008, EUR J NEUROSCI, V27, P2803, DOI 10.1111/j.1460-9568.2008.06310.x; Godin JD, 2010, NEURON, V67, P392, DOI 10.1016/j.neuron.2010.06.027; Godin JD, 2010, EMBO J, V29, P2433, DOI 10.1038/emboj.2010.117; Guan K, 1999, CYTOTECHNOLOGY, V30, P211, DOI 10.1023/A:1008041420166; Gunaseeli I, 2010, CURR MED CHEM, V17, P759, DOI 10.2174/092986710790514480; Hackam AS, 2000, J BIOL CHEM, V275, P41299, DOI 10.1074/jbc.M008408200; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Hamazaki T, 2001, FEBS LETT, V497, P15, DOI 10.1016/S0014-5793(01)02423-1; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Hirai H, 2011, BIOCHEM J, V438, P11, DOI 10.1042/BJ20102152; Jeon I, 2012, STEM CELLS, V30, P2054, DOI 10.1002/stem.1135; Josefsen K, 2008, J NEUROENDOCRINOL, V20, P165, DOI 10.1111/j.1365-2826.2007.01629.x; Juopperi TA, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-17; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Kassubek J, 2004, NEUROLOGY, V62, P523, DOI 10.1212/WNL.62.3.523-a; Kurosawa H, 2007, J BIOSCI BIOENG, V103, P389, DOI 10.1263/jbb.103.389; LANSKA DJ, 1988, ARCH NEUROL-CHICAGO, V45, P878, DOI 10.1001/archneur.1988.00520320068017; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo Sardo V, 2012, NAT NEUROSCI, V15, P713, DOI 10.1038/nn.3080; de la Pompa JL, 2012, DEV CELL, V22, P244, DOI 10.1016/j.devcel.2012.01.014; Luo SQ, 2009, J CELL SCI, V122, P875, DOI 10.1242/jcs.050013; MacDonald ME, 1996, COLD SPRING HARB SYM, V61, P627; Marder K, 2012, NEUROLOGY, V79, P621, DOI 10.1212/WNL.0b013e3182648bfe; Mihm MJ, 2007, NEUROBIOL DIS, V25, P297, DOI 10.1016/j.nbd.2006.09.016; Molero AE, 2009, P NATL ACAD SCI USA, V106, P21900, DOI 10.1073/pnas.0912171106; Moores JN, 2008, EUR J NEUROSCI, V28, P599, DOI 10.1111/j.1460-9568.2008.06359.x; MYERS RH, 1991, J NEUROPATH EXP NEUR, V50, P729, DOI 10.1097/00005072-199111000-00005; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; Nguyen GD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064368; Ninov N, 2012, DEVELOPMENT, V139, P1557, DOI 10.1242/dev.076000; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Pattison JS, 2008, CIRCULATION, V117, P2743, DOI 10.1161/CIRCULATIONAHA.107.750232; Paulsen JS, 2010, BRAIN RES BULL, V82, P201, DOI 10.1016/j.brainresbull.2010.04.003; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfendler KC, 2005, STEM CELLS DEV, V14, P162, DOI 10.1089/scd.2005.14.162; Reiner A, 2001, J NEUROSCI, V21, P7608, DOI 10.1523/JNEUROSCI.21-19-07608.2001; Rigamonti D, 2001, J BIOL CHEM, V276, P14545, DOI 10.1074/jbc.C100044200; Ritch JJ, 2012, MOL CELL NEUROSCI, V50, P70, DOI 10.1016/j.mcn.2012.03.011; Rosas HD, 2003, NEUROLOGY, V60, P1615, DOI 10.1212/01.WNL.0000065888.88988.6E; Schroeder IS, 2006, NAT PROTOC, V1, P495, DOI 10.1038/nprot.2006.71; Shimojo H, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00078; Sohn YD, 2012, PROG MOL BIOL TRANSL, V111, P1, DOI 10.1016/B978-0-12-398459-3.00001-0; Sun N, 2009, NAT PROTOC, V4, P1192, DOI 10.1038/nprot.2009.100; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Wang T, 2012, DEV GROWTH DIFFER, V54, P605, DOI 10.1111/j.1440-169X.2012.01363.x; Wheeler VC, 1999, HUM MOL GENET, V8, P115, DOI 10.1093/hmg/8.1.115; Woda JM, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-17; Yamada Y, 2010, CELL STEM CELL, V6, P10, DOI 10.1016/j.stem.2009.12.003; Yeo JC, 2013, CELL RES, V23, P20, DOI 10.1038/cr.2012.172; Younes L., 2012, HUM BRAIN MAPP; Yung SY, 2002, P NATL ACAD SCI USA, V99, P16273, DOI 10.1073/pnas.232586699; Zaret KS, 2001, CURR OPIN GENET DEV, V11, P568, DOI 10.1016/S0959-437X(00)00234-3; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155; ZHANG N, 2010, PLOS CURR, V2, P37797, DOI DOI 10.1371/CURRENTS.RRN1193]; Zhang Y, 2006, EMBO J, V25, P5896, DOI 10.1038/sj.emboj.7601445; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	80	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e72698	10.1371/journal.pone.0072698	http://dx.doi.org/10.1371/journal.pone.0072698			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967334	Green Submitted, Green Published, gold			2022-12-25	WOS:000323115800116
J	Raja, Z; Andre, S; Piesse, C; Sereno, D; Nicolas, P; Foulon, T; Oury, B; Ladram, A				Raja, Zahid; Andre, Sonia; Piesse, Christophe; Sereno, Denis; Nicolas, Pierre; Foulon, Thierry; Oury, Bruno; Ladram, Ali			Structure, Antimicrobial Activities and Mode of Interaction with Membranes of Bovel Phylloseptins from the Painted-Belly Leaf Frog, Phyllomedusa sauvagii	PLOS ONE			English	Article							BIOLOGICAL-ACTIVITY; MOLECULAR-CLONING; HYDROPHOBIC CORE; HELIX STRUCTURE; DERMASEPTIN B2; SKIN SECRETION; PEPTIDES; ANTIBACTERIAL; MECHANISM; EVOLUTION	Transcriptomic and peptidomic analysis of skin secretions from the Painted-belly leaf frog Phyllomedusa sauvagii led to the identification of 5 novel phylloseptins (PLS-S2 to -S6) and also of phylloseptin-1 (PSN-1, here renamed PLS-S1), the only member of this family previously isolated in this frog. Synthesis and characterization of these phylloseptins revealed differences in their antimicrobial activities. PLS-S1, -S2, and -S4 (79-95% amino acid sequence identity; net charge = +2) were highly potent and cidal against Gram-positive bacteria, including multidrug resistant S. aureus strains, and killed the promastigote stage of Leishmania infantum, L. braziliensis and L. major. By contrast, PLS-S3 (95% amino acid identity with PLS-S2; net charge = +1) and -S5 (net charge = +2) were found to be almost inactive against bacteria and protozoa. PLS-S6 was not studied as this peptide was closely related to PLS-S1. Differential scanning calorimetry on anionic and zwitterionic multilamellar vesicles combined with circular dichroism spectroscopy and membrane permeabilization assays on bacterial cells indicated that PLS-S1, -S2, and -S4 are structured in an amphipathic a-helix that disrupts the acyl chain packing of anionic lipid bilayers. As a result, regions of two coexisting phases could be formed, one phase rich in peptide and the other lipid-rich. After reaching a threshold peptide concentration, the disruption of lipid packing within the bilayer may lead to local cracks and disintegration of the microbial membrane. Differences in the net charge, a-helical folding propensity, and/or degree of amphipathicity between PLS-S1, -S2 and -S4, and between PLS-S3 and -S5 appear to be responsible for their marked differences in their antimicrobial activities. In addition to the detailed characterization of novel phylloseptins from P. sauvagii, our study provides additional data on the previously isolated PLS-S1 and on the mechanism of action of phylloseptins.	[Raja, Zahid; Andre, Sonia; Nicolas, Pierre; Foulon, Thierry; Ladram, Ali] Univ Paris 06, Biogenese Signaux Peptid BIOSIPE ER3, Paris, France; [Sereno, Denis; Oury, Bruno] Univ Montpellier 1&2, CNRS 5290, Unite Mixte Rech IRD 224, IRD, Montpellier, France; [Piesse, Christophe] Univ Paris 06, IFR Plate Forme Ingn Prot & Synth Peptid 83, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; UDICE-French Research Universities; Sorbonne Universite	Ladram, A (corresponding author), Univ Paris 06, Biogenese Signaux Peptid BIOSIPE ER3, Paris, France.	ali.ladram@upmc.fr	Nicolas, Pierre/C-7908-2009; denis, Sereno/I-7242-2019	denis, Sereno/0000-0002-0034-9291	UPMC; Agence Nationale pour la Recherche (ANR-Prob DOM); DVS/AIRD (Direction de la Valorisation au Sud/Agence Inter-etablissements de Recherche pour le Developpement); French Ministere de l'Enseignement Superieur et de la Recherche	UPMC; Agence Nationale pour la Recherche (ANR-Prob DOM)(French National Research Agency (ANR)); DVS/AIRD (Direction de la Valorisation au Sud/Agence Inter-etablissements de Recherche pour le Developpement); French Ministere de l'Enseignement Superieur et de la Recherche	The present work was supported by the UPMC, the Agence Nationale pour la Recherche (ANR-Prob DOM) and the DVS/AIRD (Direction de la Valorisation au Sud/Agence Inter-etablissements de Recherche pour le Developpement; AAP Leishmed 2010). Zahid Raja and Sonia Andre are PhD students at UPMC supported by a fellowship from the French Ministere de l'Enseignement Superieur et de la Recherche, allocated by the Ecole Doctorale iViv (ED 387, UPMC, Paris, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbassi F, 2008, PEPTIDES, V29, P1526, DOI 10.1016/j.peptides.2008.05.008; Abbassi F, 2008, BIOCHEMISTRY-US, V47, P10513, DOI 10.1021/bi8006884; Abbassi F, 2013, BIOCHIMIE, V95, P388, DOI 10.1016/j.biochi.2012.10.015; Abbassi F, 2010, J BIOL CHEM, V285, P16880, DOI 10.1074/jbc.M109.097204; Abdel-Wahab YHA, 2008, PEPTIDES, V29, P2136, DOI 10.1016/j.peptides.2008.09.006; Amiche M, 2008, PEPTIDES, V29, P2074, DOI 10.1016/j.peptides.2008.06.017; ARMSTRONG KM, 1993, P NATL ACAD SCI USA, V90, P11337, DOI 10.1073/pnas.90.23.11337; Chen TB, 2006, PEPTIDES, V27, P2129, DOI 10.1016/j.peptides.2006.04.006; Conceicao K, 2006, PEPTIDES, V27, P3092, DOI 10.1016/j.peptides.2006.08.005; Conlon JM, 2007, TOXICON, V50, P498, DOI 10.1016/j.toxicon.2007.04.017; Duda TF, 2002, MOL BIOL EVOL, V19, P858, DOI 10.1093/oxfordjournals.molbev.a004143; Galanth C, 2009, BIOCHEMISTRY-US, V48, P313, DOI 10.1021/bi802025a; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Henzler-Wildman KA, 2004, BIOCHEMISTRY-US, V43, P8459, DOI 10.1021/bi036284s; Jiang ZQ, 2008, BIOPOLYMERS, V90, P369, DOI 10.1002/bip.20911; Konig E, 2012, PEPTIDES, V38, P371, DOI 10.1016/j.peptides.2012.09.010; Kuckelhaus SAS, 2009, EXP PARASITOL, V123, P11, DOI 10.1016/j.exppara.2009.05.002; Leite JRSA, 2005, PEPTIDES, V26, P565, DOI 10.1016/j.peptides.2004.11.002; Lequin O, 2006, BIOCHEMISTRY-US, V45, P468, DOI 10.1021/bi051711i; Lequin O, 2003, BIOCHEMISTRY-US, V42, P10311, DOI 10.1021/bi034401d; Lohner K, 1999, BBA-BIOMEMBRANES, V1462, P141, DOI 10.1016/S0005-2736(99)00204-7; Luplertlop N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001252; MCELHANEY RN, 1986, BIOCHIM BIOPHYS ACTA, V864, P361, DOI 10.1016/0304-4157(86)90004-3; Nicolas P, 2003, PEPTIDES, V24, P1669, DOI 10.1016/j.peptides.2003.08.017; Nicolas P., 2013, HDB BIOL ACTIVE PEPT, P350; Nicolas P, 2009, FEBS J, V276, P6483, DOI 10.1111/j.1742-4658.2009.07359.x; Nicolas P, 2009, BBA-BIOMEMBRANES, V1788, P1537, DOI 10.1016/j.bbamem.2008.09.006; Pandit KR, 2012, BBA-BIOMEMBRANES, V1818, P1205, DOI 10.1016/j.bbamem.2012.01.009; Resende JM, 2008, PEPTIDES, V29, P1633, DOI 10.1016/j.peptides.2008.06.022; Roy G, 2000, MOL BIOCHEM PARASIT, V110, P195, DOI 10.1016/S0166-6851(00)00270-X; Sapay N, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-255; Seto GWJ, 2007, BBA-BIOMEMBRANES, V1768, P2787, DOI 10.1016/j.bbamem.2007.07.018; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shi ZS, 2001, BIOPOLYMERS, V60, P366, DOI 10.1002/1097-0282(2001)60:5<366::AID-BIP10177>3.0.CO;2-5; TOUKAN K, 1985, PHYS REV B, V31, P2643, DOI 10.1103/PhysRevB.31.2643; Vanhoye D, 2004, BIOCHEMISTRY-US, V43, P8391, DOI 10.1021/bi0493158; Vanhoye D, 2003, EUR J BIOCHEM, V270, P2068, DOI 10.1046/j.1432-1033.2003.03584.x; Wieprecht T, 1999, J MOL BIOL, V294, P785, DOI 10.1006/jmbi.1999.3268; Zhang RW, 2010, MOL IMMUNOL, V47, P2030, DOI 10.1016/j.molimm.2010.04.010; Zhang YP, 1997, BIOPHYS J, V72, P779, DOI 10.1016/S0006-3495(97)78712-5	40	26	33	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e70782	10.1371/journal.pone.0070782	http://dx.doi.org/10.1371/journal.pone.0070782			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967105	Green Published, Green Submitted, gold			2022-12-25	WOS:000323115800021
J	Steven, B; Lionard, M; Kuske, CR; Vincent, WF				Steven, Blaire; Lionard, Marie; Kuske, Cheryl R.; Vincent, Warwick F.			High Bacterial Diversity of Biological Soil Crusts in Water Tracks over Permafrost in the High Arctic Polar Desert	PLOS ONE			English	Article							MCMURDO DRY VALLEYS; MICROBIAL DIVERSITY; COMMUNITY STRUCTURE; ARCHAEAL DIVERSITY; TUNDRA; LAKE; MATS; METAGENOMICS; RHIZOSPHERE; RESOURCE	In this study we report the bacterial diversity of biological soil crusts (biocrusts) inhabiting polar desert soils at the northern land limit of the Arctic polar region (83 degrees 05 N). Employing pyrosequencing of bacterial 16S rRNA genes this study demonstrated that these biocrusts harbor diverse bacterial communities, often as diverse as temperate latitude communities. The effect of wetting pulses on the composition of communities was also determined by collecting samples from soils outside and inside of permafrost water tracks, hill slope flow paths that drain permafrost-affected soils. The intermittent flow regime in the water tracks was correlated with altered relative abundance of phylum level taxonomic bins in the bacterial communities, but the alterations varied between individual sampling sites. Bacteria related to the Cyanobacteria and Acidobacteria demonstrated shifts in relative abundance based on their location either inside or outside of the water tracks. Among cyanobacterial sequences, the proportion of sequences belonging to the family Oscillatoriales consistently increased in relative abundance in the samples from inside the water tracks compared to those outside. Acidobacteria showed responses to wetting pulses in the water tracks, increasing in abundance at one site and decreasing at the other two sites. Subdivision 4 acidobacterial sequences tended to follow the trends in the total Acidobacteria relative abundance, suggesting these organisms were largely responsible for the changes observed in the Acidobacteria. Taken together, these data suggest that the bacterial communities of these high latitude polar biocrusts are diverse but do not show a consensus response to intermittent flow in water tracks over high Arctic permafrost.	[Steven, Blaire; Kuske, Cheryl R.] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA; [Lionard, Marie; Vincent, Warwick F.] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; [Lionard, Marie; Vincent, Warwick F.] Univ Laval, Ctr Etud Nord, Quebec City, PQ G1K 7P4, Canada	United States Department of Energy (DOE); Los Alamos National Laboratory; Laval University; Laval University	Vincent, WF (corresponding author), Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada.	warwick.vincent@bio.ulaval.ca	Steven, Blaire/E-5295-2012; Vincent, Warwick/AAH-6152-2019	Steven, Blaire/0000-0001-5940-2432; Vincent, Warwick/0000-0001-9055-1938	National Science and Engineering Research Council; ArcticNet; Centre d'etudes Norqiques (CEN); Polar Continental Shelf Project; Los Alamos National Laboratory LDRD program	National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); ArcticNet; Centre d'etudes Norqiques (CEN); Polar Continental Shelf Project(Natural Resources Canada); Los Alamos National Laboratory LDRD program(United States Department of Energy (DOE)Los Alamos National Laboratory)	Field work was supported by the National Science and Engineering Research Council, ArcticNet, Centre d'etudes Norqiques (CEN) and the Polar Continental Shelf Project. Sequence analysis for this study was supported through a grant to CK from the Los Alamos National Laboratory LDRD program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed RMM, 2012, FEMS MICROBIOL ECOL, V80, P294, DOI 10.1111/j.1574-6941.2011.01289.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Austin AT, 2004, OECOLOGIA, V141, P221, DOI 10.1007/s00442-004-1519-1; Belnap J, 2008, J ARID ENVIRON, V72, P1257, DOI 10.1016/j.jaridenv.2008.02.019; Bockheim JG, 2008, GEODERMA, V144, P43, DOI 10.1016/j.geoderma.2007.10.015; Bolhuis H, 2011, ISME J, V5, P1701, DOI [10.1038/Ismej.2011.52, 10.1038/ismej.2011.52]; Bottos EM, 2008, ENVIRON MICROBIOL, V10, P950, DOI 10.1111/j.1462-2920.2007.01516.x; Brockett BFT, 2012, SOIL BIOL BIOCHEM, V44, P9, DOI 10.1016/j.soilbio.2011.09.003; CHAPIN FS, 1988, ECOLOGY, V69, P693; Charvet S, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00422; Chu HY, 2010, ENVIRON MICROBIOL, V12, P2998, DOI 10.1111/j.1462-2920.2010.02277.x; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Comeau AM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00604; Dickson JL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01424; Dunbar J, 1999, APPL ENVIRON MICROB, V65, P1662; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Garcia-Pichel F, 2001, NATURE, V413, P380, DOI 10.1038/35096640; GOLD WG, 1995, ECOLOGY, V76, P1558, DOI 10.2307/1938157; Gooseff MN, 2013, HYDROGEOL J, V21, P171, DOI 10.1007/s10040-012-0926-3; Harding T, 2011, APPL ENVIRON MICROB, V77, P3234, DOI 10.1128/AEM.02611-10; Hodkinson ID, 1999, GLOB CHANGE BIOL, V5, P359, DOI 10.1046/j.1365-2486.1999.00229.x; Jangid K, 2011, SOIL BIOL BIOCHEM, V43, P2184, DOI 10.1016/j.soilbio.2011.06.022; Juck DF, 2005, APPL ENVIRON MICROB, V71, P1035, DOI 10.1128/AEM.71.2.1035-1041.2005; Jungblut AD, 2010, ISME J, V4, P191, DOI 10.1038/ismej.2009.113; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Levy JS, 2011, GEOL SOC AM B, V123; Lionard M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00140; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mobberley JM, 2012, ENVIRON MICROBIOL, V14, P82, DOI 10.1111/j.1462-2920.2011.02509.x; Neufeld JD, 2005, APPL ENVIRON MICROB, V71, P5710, DOI 10.1128/AEM.71.10.5710-5718.2005; Neufeld JD, 2007, NAT PROTOC, V2, P860, DOI 10.1038/nprot.2007.109; OBERBAUER SF, 1992, OECOLOGIA, V92, P568, DOI 10.1007/BF00317851; Pearce DA, 2007, ANTARCT SCI, V19, P245, DOI 10.1017/S0954102007000326; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Schloss PD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-34; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Smith JJ, 2006, MICROB ECOL, V51, P413, DOI 10.1007/s00248-006-9022-3; Steven B, 2007, FEMS MICROBIOL ECOL, V59, P513, DOI 10.1111/j.1574-6941.2006.00247.x; Steven B, 2006, EXTREMOPHILES, V10, P259, DOI 10.1007/s00792-006-0506-3; Steven B, 2013, FEMS MICROBIOL ECOL, V86, P101, DOI 10.1111/1574-6941.12143; Steven B, 2012, ENVIRON MICROBIOL, V14, P3247, DOI 10.1111/1462-2920.12011; Steven B, 2012, ENV MICROBIOL REP, V4, P248, DOI 10.1111/j.1758-2229.2012.00328.x; Steven Blaire, 2009, V16, P59; Suleiman AK, 2013, SYST APPL MICROBIOL; Teixeira LCRS, 2010, ISME J, V4, P989, DOI 10.1038/ismej.2010.35; Uroz S, 2010, ENV MICROBIOL REP, V2, P281, DOI 10.1111/j.1758-2229.2009.00117.x; Vincent WF, 2011, ECOSCIENCE, V18, P236, DOI 10.2980/18-3-3448; Wessa P., 2013, FREE STAT SOFTWARE; Will C, 2010, APPL ENVIRON MICROB, V76, P6751, DOI 10.1128/AEM.01063-10; Yergeau E, 2009, ISME J, V3, P340, DOI 10.1038/ismej.2008.111; Yergeau E, 2007, ENVIRON MICROBIOL, V9, P2670, DOI 10.1111/j.1462-2920.2007.01379.x; Yergeau E, 2010, ISME J, V4, P1206, DOI 10.1038/ismej.2010.41; Zeglin LH, 2011, MICROB ECOL, V61, P543, DOI 10.1007/s00248-010-9782-7	59	41	44	7	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71489	10.1371/journal.pone.0071489	http://dx.doi.org/10.1371/journal.pone.0071489			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967218	Green Published, Green Submitted, gold			2022-12-25	WOS:000323115800063
J	Terasaki, M; Nagashima, M; Nohtomi, K; Kohashi, K; Tomoyasu, M; Sinmura, K; Nogi, Y; Katayama, Y; Sato, K; Itoh, F; Watanabe, T; Hirano, T				Terasaki, Michishige; Nagashima, Masaharu; Nohtomi, Kyoko; Kohashi, Kyoko; Tomoyasu, Masako; Sinmura, Kyoko; Nogi, Yukinori; Katayama, Yuki; Sato, Kengo; Itoh, Fumiko; Watanabe, Takuya; Hirano, Tsutomu			Preventive Effect of Dipeptidyl Peptidase-4 Inhibitor on Atherosclerosis Is Mainly Attributable to Incretin's Actions in Nondiabetic and Diabetic Apolipoprotein E-Null Mice	PLOS ONE			English	Article								Aim: Several recent reports have revealed that dipeptidyl peptidase (DPP)-4 inhibitors have suppressive effects on atherosclerosis in apolipoprotein E-null (Apoe(-/-)) mice. It remains to be seen, however, whether this effect stems from increased levels of the two active incretins, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Methods: Nontreated Apoe(-/-) mice, streptozotocin-induced diabetic Apoe(-/-) mice, and db/db diabetic mice were administered the DPP-4 inhibitor vildagliptin in drinking water and co-infused with either saline, the GLP-1 receptor blocker, exendin(9-39), the GIP receptor blocker, (Pro(3))GIP, or both via osmotic minipumps for 4 weeks. Aortic atherosclerosis and oxidized low-density lipoprotein-induced foam cell formation in exudate peritoneal macrophages were determined. Results: Vildagliptin increased plasma GLP-1 and GIP levels without affecting food intake, body weight, blood pressure, or plasma lipid profile in any of the animals tested, though it reduced HbA1c in the diabetic mice. Diabetic Apoe(-/-) mice exhibited further-progressed atherosclerotic lesions and foam cell formation compared with nondiabetic counterparts. Nondiabetic and diabetic Apoe(-/-) mice showed a comparable response to vildagliptin, namely, remarkable suppression of atherosclerotic lesions with macrophage accumulation and foam cell formation in peritoneal macrophages. Exendin(9-39) or (Pro(3))GIP partially attenuated the vildagliptin-induced suppression of atherosclerosis. The two blockers in combination abolished the anti-atherosclerotic effect of vildagliptin in nondiabetic mice but only partly attenuated it in diabetic mice. Vildagliptin suppressed macrophage foam cell formation in nondiabetic and diabetic mice, and this suppressive effect was abolished by infusions with exendin(9-39)+(Pro(3))GIP. Incubation of DPP-4 or vildagliptin in vitro had no effect on macrophage foam cell formation. Conclusions: Vildagliptin confers a substantial anti-atherosclerotic effect in both nondiabetic and diabetic mice, mainly via the action of the two incretins. However, the partial attenuation of atherosclerotic lesions by the dual incretin receptor antagonists in diabetic mice implies that vildagliptin confers a partial anti-atherogenic effect beyond that from the incretins.	[Terasaki, Michishige; Nagashima, Masaharu; Nohtomi, Kyoko; Kohashi, Kyoko; Tomoyasu, Masako; Sinmura, Kyoko; Nogi, Yukinori; Hirano, Tsutomu] Showa Univ, Sch Med, Dept Med, Div Diabet Metab & Endocrinol,Shinagawa Ku, Tokyo 142, Japan; [Katayama, Yuki; Sato, Kengo; Itoh, Fumiko; Watanabe, Takuya] Tokyo Univ Pharm & Life Sci, Lab Cardiovasc Med, Hachioji, Tokyo 19203, Japan	Showa University; Tokyo University of Pharmacy & Life Sciences	Hirano, T (corresponding author), Showa Univ, Sch Med, Dept Med, Div Diabet Metab & Endocrinol,Shinagawa Ku, Tokyo 142, Japan.	hirano@med.showa-u.ac.jp	Terasaki, Michishige/I-1659-2016	Terasaki, Michishige/0000-0002-7405-7419; Itoh, Fumiko/0000-0002-6134-5331	Novartis Pharma (Tokyo, Japan)	Novartis Pharma (Tokyo, Japan)	This study was sponsored in part by Novartis Pharma (Tokyo, Japan). The funders had no role in the study design, data collection or analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ahren B, 2005, EUR J PHARMACOL, V521, P164, DOI 10.1016/j.ejphar.2005.08.019; Chang SY, 2013, J CELL BIOCHEM, V114, P844, DOI 10.1002/jcb.24425; Deacon CF, 2012, EXPERT REV CARDIOVAS, V10, P337, DOI [10.1586/erc.12.5, 10.1586/ERC.12.5]; Duffy NA, 2007, EUR J PHARMACOL, V568, P278, DOI 10.1016/j.ejphar.2007.05.010; Fadini GP, 2011, VASC PHARMACOL, V55, P10, DOI 10.1016/j.vph.2011.05.001; Hansotia T, 2004, DIABETES, V53, P1326, DOI 10.2337/diabetes.53.5.1326; Lynn FC, 2001, DIABETES, V50, P1004, DOI 10.2337/diabetes.50.5.1004; Matsubara J, 2012, J AM COLL CARDIOL, V59, P265, DOI 10.1016/j.jacc.2011.07.053; Nagashima M, 2011, DIABETOLOGIA, V54, P2649, DOI 10.1007/s00125-011-2241-2; NAUCK MA, 1993, J CLIN INVEST, V91, P301, DOI 10.1172/JCI116186; Nogi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035683; Panjwani N, 2013, ENDOCRINOLOGY, V154, P127, DOI 10.1210/en.2012-1937; Preitner F, 2004, J CLIN INVEST, V113, P635, DOI 10.1172/JCI200420518; Shah Z, 2011, CIRCULATION, V124, P2339, DOI 10.1161/CIRCULATIONAHA.111.041418; Shiraishi D, 2012, BIOCHEM BIOPH RES CO, V425, P304, DOI 10.1016/j.bbrc.2012.07.086; Ta NN, 2011, J CARDIOVASC PHARM, V58, P157, DOI 10.1097/FJC.0b013e31821e5626; Takeda Y, 2012, DIABETOLOGIA, V55, P404, DOI 10.1007/s00125-011-2365-4; Terasaki M, 2012, METABOLISM, V61, P974, DOI 10.1016/j.metabol.2011.11.011; Ussher JR, 2012, ENDOCR REV, V33, P187, DOI 10.1210/er.2011-1052; Watanabe T, 2008, CIRCULATION, V117, P638, DOI 10.1161/CIRCULATIONAHA.107.712539; Xu G, 2009, CIRC RES, V105, P500, DOI 10.1161/CIRCRESAHA.109.193870; Zhong JX, 2013, ATHEROSCLEROSIS, V226, P305, DOI 10.1016/j.atherosclerosis.2012.09.012; Zhou J, 2007, AM J PHYSIOL-ENDOC M, V293, pE538, DOI 10.1152/ajpendo.00070.2007	23	64	67	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e70933	10.1371/journal.pone.0070933	http://dx.doi.org/10.1371/journal.pone.0070933			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967137	Green Submitted, Green Published, gold			2022-12-25	WOS:000323115800029
J	Nolan, M; Bouldin, SD; Bock, PE				Nolan, Miranda; Bouldin, Samantha D.; Bock, Paul E.			Full Time Course Kinetics of the Streptokinase-Plasminogen Activation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCI; ACTIVE-SITE; M-PROTEIN; CONFORMATIONAL ACTIVATION; AFFINITY-CHROMATOGRAPHY; CATALYZED ACTIVATION; ZYMOGEN ACTIVATION; COMPLEX-FORMATION; HUMAN-FIBRINOGEN; HUMAN-PLASMA	Our previously hypothesized mechanism for the pathway of plasminogen (Pg) activation by streptokinase (SK) was tested by the use of full time course kinetics. Three discontinuous chromogenic substrate initial rate assays were developed with different quenching conditions that enabled quantitation of the time courses of Pg depletion, plasmin (Pm) formation, transient formation of the conformationally activated SK.Pg* catalytic complex intermediate, formation of the SK.Pm catalytic complex, and the free concentrations of Pg, Pm, and SK. Analysis of full time courses of Pg activation by five concentrations of SK along with activity-based titrations of SK.Pg* and SK.Pm formation yielded rate and dissociation constants within 2-fold of those determined previously by continuous measurement of parabolic chromogenic substrate hydrolysis and fluorescence-based equilibrium binding. The results obtained with orthogonal assays provide independent support for a mechanism in which the conformationally activated SK.Pg* complex catalyzes an initial cycle of Pg proteolytic conversion to Pm that acts as a trigger. Higher affinity binding of the formed Pm to SK outcompetes Pg binding, terminating the trigger cycle and initiating the bullet catalytic cycle by the SK.Pm complex that converts the residual Pg into Pm. The new assays can be adapted to quantitate SK-Pg activation in the context of SK-or Pg-directed inhibitors, effectors, and SK allelic variants. To support this, we show for the first time with an assay specific for SK.Pg* that fibrinogen forms a ternary SK.Pg*.fibrinogen complex, which assembles with 200-fold enhanced SK.Pg* affinity, signaled by a perturbation of the SK.Pg* active site.	[Nolan, Miranda; Bouldin, Samantha D.; Bock, Paul E.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA	Vanderbilt University	Bock, PE (corresponding author), Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, C3321A Med Ctr North, Nashville, TN 37232 USA.	paul.bock@vanderbilt.edu			National Institutes of Health, NLHBI [RO1 HL056181]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056181] Funding Source: NIH RePORTER	National Institutes of Health, NLHBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health, NLHBI, Grant RO1 HL056181 (to P.E.B.).	ALKJAERSIG N, 1959, J BIOL CHEM, V234, P832; BERGE A, 1993, J BIOL CHEM, V268, P25417; Bock PE, 1996, J BIOL CHEM, V271, P1072, DOI 10.1074/jbc.271.2.1072; BODE W, 1976, FEBS LETT, V68, P231, DOI 10.1016/0014-5793(76)80443-7; Boxrud PD, 2000, J BIOL CHEM, V275, P14579, DOI 10.1074/jbc.275.19.14579; Boxrud PD, 2000, BIOCHEMISTRY-US, V39, P13974, DOI 10.1021/bi000594i; Boxrud PD, 2004, J BIOL CHEM, V279, P36633, DOI 10.1074/jbc.M405264200; Boxrud PD, 2004, J BIOL CHEM, V279, P36642, DOI 10.1074/jbc.M405265200; Boxrud PD, 2001, J BIOL CHEM, V276, P26084, DOI 10.1074/jbc.M101966200; Boyle MDP, 1997, THROMB HAEMOSTASIS, V77, P1; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; CASTELLINO FJ, 1981, METHOD ENZYMOL, V80, P365; CEDERHOLMWILLIAMS SA, 1979, EUR J BIOCHEM, V100, P125, DOI 10.1111/j.1432-1033.1979.tb02040.x; Chaudhary A, 1999, PROTEIN SCI, V8, P2791; CHIBBER BAK, 1985, BIOCHEMISTRY-US, V24, P3429, DOI 10.1021/bi00335a006; Cook SM, 2012, MOL MICROBIOL, V86, P1052, DOI 10.1111/mmi.12037; DAMASCHUN G, 1992, EUR BIOPHYS J BIOPHY, V20, P355; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; Dhar J, 2002, J BIOL CHEM, V277, P13257, DOI 10.1074/jbc.M108422200; Dharmawardana KR, 1998, BIOCHEMISTRY-US, V37, P13143, DOI 10.1021/bi9812165; ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102; Friedrich R, 2003, NATURE, V425, P535, DOI 10.1038/nature01962; Hess JL, 2006, PROTEOMICS, V6, P375, DOI 10.1002/pmic.200500189; HOGG PJ, 1990, J BIOL CHEM, V265, P241; JACKSON KW, 1982, BIOCHEMISTRY-US, V21, P6620, DOI 10.1021/bi00269a001; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Joshi KK, 2012, BBA-PROTEINS PROTEOM, V1824, P326, DOI 10.1016/j.bbapap.2011.10.010; Kalia A, 2004, J BACTERIOL, V186, P110, DOI 10.1128/JB.186.1.110-121.2004; LIJNEN HR, 1991, J BIOL CHEM, V266, P11826; Lin LF, 2000, BIOCHEMISTRY-US, V39, P4740, DOI 10.1021/bi992028x; LOTTENBERG R, 1983, BIOCHIM BIOPHYS ACTA, V742, P558, DOI 10.1016/0167-4838(83)90273-X; LOTTENBERG R, 1983, BIOCHIM BIOPHYS ACTA, V742, P539, DOI 10.1016/0167-4838(83)90272-8; Macheboeuf P, 2011, NATURE, V472, P64, DOI 10.1038/nature09967; McNamara C, 2008, SCIENCE, V319, P1405, DOI 10.1126/science.1154470; MOROI M, 1976, J BIOL CHEM, V251, P5956; NASKI MC, 1991, J BIOL CHEM, V266, P13003; NIEUWENHUIZEN W, 1989, THROMB HAEMOSTASIS, V61, P208; Panizzi P, 2006, J BIOL CHEM, V281, P26774, DOI 10.1074/jbc.C600171200; PHILLIPS GN, 1981, P NATL ACAD SCI-BIOL, V78, P4689, DOI 10.1073/pnas.78.8.4689; Sanderson-Smith ML, 2008, FASEB J, V22, P2715, DOI 10.1096/fj.07-105643; Sanderson-Smith ML, 2006, J BIOL CHEM, V281, P25965, DOI 10.1074/jbc.M603846200; SJOHOLM I, 1973, EUR J BIOCHEM, V39, P471, DOI 10.1111/j.1432-1033.1973.tb03146.x; STRICKLAND DK, 1982, BIOCHEMISTRY-US, V21, P721, DOI 10.1021/bi00533a021; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Sun HM, 2006, PHYSIOLOGY, V21, P281, DOI 10.1152/physiol.00059.2005; TAKADA A, 1985, THROMB RES, V37, P465, DOI 10.1016/0049-3848(85)90075-1; TAKADA Y, 1989, THROMB RES, V53, P409, DOI 10.1016/0049-3848(89)90320-4; Tharp AC, 2009, J BIOL CHEM, V284, P19511, DOI 10.1074/jbc.M109.005512; Timoney JF, 2004, VET RES, V35, P397, DOI 10.1051/vetres:2004025; Verhamme IM, 2008, J BIOL CHEM, V283, P26137, DOI 10.1074/jbc.M804038200; VIOLAND BN, 1976, J BIOL CHEM, V251, P3906; Walker MJ, 2005, TRENDS MICROBIOL, V13, P308, DOI 10.1016/j.tim.2005.05.006; WANG H, 1995, MICROB PATHOGENESIS, V18, P153, DOI 10.1016/S0882-4010(95)90013-6; Wang SG, 1999, BIOCHEMISTRY-US, V38, P5232, DOI 10.1021/bi981915h; Wang SG, 2000, EUR J BIOCHEM, V267, P3994, DOI 10.1046/j.1432-1327.2000.01434.x; Wang XQ, 1998, SCIENCE, V281, P1662, DOI 10.1126/science.281.5383.1662; Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X; WIMAN B, 1977, EUR J BIOCHEM, V78, P19, DOI 10.1111/j.1432-1033.1977.tb11709.x; WOHL RC, 1980, J BIOL CHEM, V255, P2005; WOHL RC, 1978, J BIOL CHEM, V253, P1402; Zhang YL, 2012, J BIOL CHEM, V287, P42093, DOI 10.1074/jbc.M112.417808	62	9	9	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29482	29493		10.1074/jbc.M113.477935	http://dx.doi.org/10.1074/jbc.M113.477935			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23970549	Green Published, hybrid			2022-12-25	WOS:000330615300025
J	Shabnam, N; Pardha-Saradhi, P				Shabnam, Nisha; Pardha-Saradhi, P.			Photosynthetic Electron Transport System Promotes Synthesis of Au-Nanoparticles	PLOS ONE			English	Article							GOLD NANOPARTICLES; FILAMENTOUS CYANOBACTERIA; REDUCTION; PLANTS; BIOSYNTHESIS; METABOLISM; STRESS; ACID	In this communication, a novel, green, efficient and economically viable light mediated protocol for generation of Au-nanoparticles using most vital organelle, chloroplasts, of the plant system is portrayed. Thylakoids/chloroplasts isolated from Potamogeton nodosus (an aquatic plant) and Spinacia oleracea (a terrestrial plant) turned Au3+ solutions purple in presence of light of 600 mu mol m(-2) s(-1) photon flux density (PFD) and the purple coloration intensified with time. UV-Vis spectra of these purple colored solutions showed absorption peak at similar to 545 nm which is known to arise due to surface plasmon oscillations specific to Au-nanoparticles. However, thylakoids/chloroplasts did not alter color of Au3+ solutions in dark. These results clearly demonstrated that photosynthetic electron transport can reduce Au3+ to Au-0 which nucleate to form Au-nanoparticles in presence of light. Transmission electron microscopic studies revealed that Au-nanoparticles generated by light driven photosynthetic electron transport system of thylakoids/chloroplasts were in range of 5-20 nm. Selected area electron diffraction and powder X-ray diffraction indicated crystalline nature of these nanoparticles. Energy dispersive X-ray confirmed that these nanoparticles were composed of Au. To confirm the potential of light driven photosynthetic electron transport in generation of Au-nanoparticles, thylakoids/ chloroplasts were tested for their efficacy to generate Au-nanoparticles in presence of light of PFD ranging from 60 to 600 mu mol m(-2) s(-1). The capacity of thylakoids/ chloroplasts to generate Au-nanoparticles increased remarkably with increase in PFD, which further clearly demonstrated potential of light driven photosynthetic electron transport in reduction of Au3+ to Au-0 to form nanoparticles. The light driven donation of electrons to metal ions by thylakoids/ chloroplasts can be exploited for large scale production of nanoparticles.	[Shabnam, Nisha; Pardha-Saradhi, P.] Univ Delhi, Dept Environm Studies, Delhi 110007, India	University of Delhi	Pardha-Saradhi, P (corresponding author), Univ Delhi, Dept Environm Studies, Delhi 110007, India.	ppsaradhi@gmail.com	Shabnam, Nisha/J-7470-2019	Shabnam, Nisha/0000-0002-1855-8497	University Grants Commission (Government of India); University of Delhi	University Grants Commission (Government of India)(University Grants Commission, India); University of Delhi(University of Delhi)	Ms. NS is receiving a Fellowship from University Grants Commission (Government of India) as she qualified Nationwide Examination held for selecting suitable candidates for Doctoral Research (i.e. this fellowship is provided for Ph.D. programme). Prof. PPS was provided with financial support by University of Delhi to take care of general research activities of his research team. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIA, 1991, BIOCHEM BIOPH RES CO, V181, P1238, DOI 10.1016/0006-291X(91)92071-Q; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; ASAHI T, 1964, BIOCHIM BIOPHYS ACTA, V82, P58, DOI 10.1016/0304-4165(64)90007-8; Badwaik VD, 2011, LANGMUIR, V27, P5549, DOI 10.1021/la105041d; Bali R, 2010, IND ENG CHEM RES, V49, P12762, DOI 10.1021/ie101600m; Beattie IR, 2011, METALLOMICS, V3, P628, DOI 10.1039/c1mt00044f; Bhargava SK, 2005, LANGMUIR, V21, P5949, DOI 10.1021/la050283e; Brayner R, 2007, J NANOSCI NANOTECHNO, V7, P2696, DOI 10.1166/jnn.2007.600; Brayner R, 2009, LANGMUIR, V25, P10062, DOI 10.1021/la9010345; Cheng YC, 2009, ANNU REV PHYS CHEM, V60, P241, DOI 10.1146/annurev.physchem.040808.090259; Dahoumane SA, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0883-8; Dahoumane SA, 2012, BIOTECHNOL BIOENG, V109, P284, DOI 10.1002/bit.23276; Duncan DB, 1955, BIOMETRICS, V39, P205; Engelbrekt C, 2009, J MATER CHEM, V19, P7839, DOI 10.1039/b911111e; Eustis S, 2006, CHEM SOC REV, V35, P209, DOI 10.1039/b514191e; FRENS G, 1973, NATURE-PHYS SCI, V241, P20, DOI 10.1038/physci241020a0; He SY, 2007, MATER LETT, V61, P3984, DOI 10.1016/j.matlet.2007.01.018; Huang XH, 2007, NANOMEDICINE-UK, V2, P681, DOI 10.2217/17435889.2.5.681; Lengke MF, 2006, ENVIRON SCI TECHNOL, V40, P6304, DOI 10.1021/es061040r; Lengke MF, 2006, LANGMUIR, V22, P2780, DOI 10.1021/la052652c; Li C, 2012, INT J NANOMED, V7, P5995, DOI 10.2147/IJN.S38043; Mandal S, 2002, P INDIAN AS-CHEM SCI, V114, P513, DOI 10.1007/BF02704195; Mukherjee P, 2002, CHEMBIOCHEM, V3, P461, DOI 10.1002/1439-7633(20020503)3:5<461::AID-CBIC461>3.0.CO;2-X; Nair B, 2002, CRYST GROWTH DES, V2, P293, DOI 10.1021/cg0255164; Noctor G, 1998, J EXP BOT, V49, P1895, DOI 10.1093/jexbot/49.329.1895; Nugent JHA, 1996, EUR J BIOCHEM, V237, P519, DOI 10.1111/j.1432-1033.1996.00519.x; Rai M, 2012, APPL MICROBIOL BIOT, V94, P287, DOI 10.1007/s00253-012-3969-4; Raymond J, 2008, COORDIN CHEM REV, V252, P377, DOI 10.1016/j.ccr.2007.08.026; Shankar SS, 2004, NAT MATER, V3, P482, DOI 10.1038/nmat1152; Sharmila P, 2009, PLANT PHYSIOL BIOCH, V47, P391, DOI 10.1016/j.plaphy.2009.01.001; Sicard C, 2010, J MATER CHEM, V20, P9342, DOI 10.1039/c0jm01735c; Sumner JB, 1924, J BIOL CHEM, V62, P287; Vani B, 2001, INDIAN J BIOCHEM BIO, V38, P220; Wang WX, 2007, COLLOID SURFACE A, V301, P73, DOI 10.1016/j.colsurfa.2006.12.037; Wen L, 2009, J NANOPART RES, V11, P279, DOI 10.1007/s11051-008-9378-z; Wiechers JW, 2010, J BIOMED NANOTECHNOL, V6, P408, DOI 10.1166/jbn.2010.1143; Yamal G, 2013, PROCESS BIOCHEM, V48, P532, DOI 10.1016/j.procbio.2013.02.011; Yamal G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061750; Yeh YC, 2012, NANOSCALE, V4, P1871, DOI 10.1039/c1nr11188d	40	32	32	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71123	10.1371/journal.pone.0071123	http://dx.doi.org/10.1371/journal.pone.0071123			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23976990	gold, Green Published, Green Submitted			2022-12-25	WOS:000324527300005
J	Alo, D; Correa, C; Arias, C; Cardenas, L				Alo, Dominique; Correa, Cristian; Arias, Carlos; Cardenas, Leyla			Diversity of Aplochiton Fishes (Galaxiidea) and the Taxonomic Resurrection of A. marinus	PLOS ONE			English	Article							SPECIES DELIMITATION; ZEBRA TELEOSTEI; GLACIAL CYCLES; DNA; POPULATION; SALMONIDS; PATAGONIA; PISCES; PLATEI; DIVERSIFICATION	Aplochiton is a small genus of galaxiid fishes endemic to Patagonia and the Falkland Islands whose taxonomy is insufficiently resolved. Recent genetic analyses confirmed the existence of only two closely related species, Aplochiton taeniatus and Aplochiton zebra, while a third controversial species, Aplochiton marinus, remained lost to synonymy with A. taeniatus. Using an integrative taxonomy framework, we studied original samples and published sequences from a broad range in western Patagonia and the Falkland Islands, and generated robust species hypotheses based on single-locus (Cytochrome Oxidase subunit I; COI) species-delineation methods and known diagnostic morphological characters analyzed in a multivariate context. Results revealed three distinct evolutionary lineages that morphologically resemble, in important respects, existing nominal species descriptions. Interestingly, the lineage associated with A. marinus was unambiguously identifiable (100% accuracy) both from the genetic and morphological viewpoints. In contrast, the morphology of A. taeniatus and A. zebra overlapped substantially, mainly due to the high variability of A. taeniatus. Discriminant function analysis aided the identification of these species with 83.9% accuracy. Hence, for their unambiguous identification, genetic screening is needed. A. marinus has seldom been documented, and when recorded, it has always been found in sites with clear marine influence. It is possible that only A. marinus preserves a life cycle related to the sea akin to the hypothesized ancestral galaxiid. We did not find evidence of claimed diadromy in A. taeniatus or A. zebra, and, therefore, these should be regarded as freshwater species. Finally, a lack of phylogeographic patterns and overrepresentation of uncommon haplotypes suggested demographic expansions in recent evolutionary time, especially of A. zebra, in line with the hypothesis of large-scale range expansion and lineage spread in western Patagonia.	[Alo, Dominique] Univ Austral Chile, Fac Ciencias Forestales & Recursos Nat, Inst Conservac Biodiversidad & Terr, Valdivia, Chile; [Correa, Cristian; Arias, Carlos] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Correa, Cristian; Arias, Carlos] McGill Univ, Redpath Museum, Montreal, PQ H3A 2K6, Canada; [Arias, Carlos] Smithsonian Trop Res Inst, Panama City, Panama; [Cardenas, Leyla] Univ Austral Chile, Fac Ciencias, Inst Ciencias Ambientales & Evolut, Valdivia, Chile	Universidad Austral de Chile; McGill University; McGill University; Smithsonian Institution; Smithsonian Tropical Research Institute; Universidad Austral de Chile	Alo, D (corresponding author), Univ Austral Chile, Fac Ciencias Forestales & Recursos Nat, Inst Conservac Biodiversidad & Terr, Valdivia, Chile.	dominiquealo@gmail.com; cristiancorrea@gmail.com	Alò, Dominique/AAC-9127-2019; Cardenas, Leyla/AAY-5671-2020; Correa, Cristian/AAE-5961-2020; Arias, Carlos Francisco/G-2881-2016	Alò, Dominique/0000-0003-0579-4156; Cardenas, Leyla/0000-0003-0676-6704; Correa, Cristian/0000-0002-8608-6858; Arias, Carlos Francisco/0000-0002-1546-5156; Arias, Carlos Francisco/0000-0001-5925-0985	National Geographic Society (CRE grant) [8624-09]; International Development Research Centre (LACREG grant); Fondo de Investigacion Cientifica y Tecnica (FONDECYT) [11080068]; McGill School of Environment; Mejoramento Calidad y Equidad de la Educacion Superior (MECESUP) [AUS0703]; Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT); STRI; Biology department of McGill University	National Geographic Society (CRE grant)(National Geographic Society); International Development Research Centre (LACREG grant); Fondo de Investigacion Cientifica y Tecnica (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); McGill School of Environment; Mejoramento Calidad y Equidad de la Educacion Superior (MECESUP); Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); STRI(Smithsonian InstitutionSmithsonian Tropical Research Institute); Biology department of McGill University	This research was possible thanks to the financial support from National Geographic Society (CRE grant No. 8624-09), International Development Research Centre (LACREG grant), Fondo de Investigacion Cientifica y Tecnica (FONDECYT No. 11080068), and McGill School of Environment. During the course of this study, DA received a doctoral fellowship from Mejoramento Calidad y Equidad de la Educacion Superior (MECESUP, Project AUS0703), CC held a scholarship from Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT), and CA received fellowships from STRI and the Biology department of McGill University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigo J, 2008, REV FISH BIOL FISHER, V18, P387, DOI 10.1007/s11160-007-9080-8; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; April J, 2013, MOL ECOL, V22, P409, DOI 10.1111/mec.12116; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Barriga JP, 2002, NEW ZEAL J MAR FRESH, V36, P345, DOI 10.1080/00288330.2002.9517092; Bernatchez L, 1998, MOL ECOL, V7, P431, DOI 10.1046/j.1365-294x.1998.00319.x; BERNATCHEZ L, 1995, CAN J FISH AQUAT SCI, V52, P179, DOI 10.1139/f95-018; Burget L., 2004, P 8 INT C SPOK LANG, P2549; Burridge CP, 2012, J BIOGEOGR, V39, P306, DOI 10.1111/j.1365-2699.2011.02600.x; Campos H, 1969, B MUSEO NACL HIST NA, V29, P207; Chapman WM, 1944, J MORPHOL, V75, P149, DOI 10.1002/jmor.1050750107; Clare EL, 2007, MOL ECOL NOTES, V7, P184, DOI 10.1111/j.1471-8286.2006.01657.x; Correa C, 2012, ECOL APPL, V22, P828, DOI 10.1890/11-1174.1; Crook DA, 2008, MAR FRESHWATER RES, V59, P638, DOI 10.1071/MF07238; Cussac V, 2004, J BIOGEOGR, V31, P103, DOI 10.1046/j.0305-0270.2003.01000.x; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dyer Brian S., 2000, Estudios Oceanologicos, V19, P77; EIGENMANN CARL H., 1928, MEM NATION ACAD SCI U S A, V22, P1; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ezard T. H. G., 2009, SPLITS SPECIES LIMIT; Ponce JF, 2011, BIOL J LINN SOC, V103, P363, DOI 10.1111/j.1095-8312.2011.01653.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fu YX, 1997, GENETICS, V147, P915; Glasser NF, 2008, QUATERNARY SCI REV, V27, P365, DOI 10.1016/j.quascirev.2007.11.011; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; Habit E, 2012, DIVERS DISTRIB, V18, P1153, DOI 10.1111/j.1472-4642.2012.00906.x; Habit E, 2010, GLOBAL ECOL BIOGEOGR, V19, P697, DOI 10.1111/j.1466-8238.2010.00541.x; Hall T.A., 2011, GERF B BIOSCI, V2, P60, DOI DOI 10.1002/PROT.24632; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ishiguro NB, 2003, MOL PHYLOGENET EVOL, V27, P476, DOI 10.1016/S1055-7903(02)00418-9; Jenyns L, 1842, ZOOLOGY VOYAGE HMS B; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kuhn M, 2012, CARET CLASSIFICATION; Lattuca ME, 2008, ECOL FRESHW FISH, V17, P394, DOI 10.1111/j.1600-0633.2008.00292.x; Lattuca ME, 2007, J APPL ICHTHYOL, V23, P25, DOI 10.1111/j.1439-0426.2006.00789.x; Mace GM, 2004, PHILOS T R SOC B, V359, P711, DOI 10.1098/rstb.2003.1454; Maddison W, 1997, MACCLADE ANAL PHYLOG; McDowall RM, 2006, REV FISH BIOL FISHER, V16, P233, DOI 10.1007/s11160-006-9017-7; McDowall RM, 2001, FISH FISH, V2, P278, DOI 10.1046/j.1467-2960.2001.00050.x; McDowall RM, 2010, FISH FISH SER, V32, P169, DOI 10.1007/978-90-481-9271-7_8; MCDOWALL RM, 1971, J ROY SOC NEW ZEAL, V1, P31, DOI 10.1080/03036758.1971.10419354; McDowall RM, 2005, NEW ZEAL J ZOOL, V32, P17, DOI 10.1080/03014223.2005.9518393; McDowall RM, 2005, NEW ZEAL J ZOOL, V32, P23, DOI 10.1080/03014223.2005.9518394; MCDOWALL RM, 1988, COPEIA, P233, DOI 10.2307/1445940; MCDOWALL RM, 1987, JPN J ICHTHYOL, V34, P377; McDowall Robert M., 2011, Zoosystematics and Evolution, V87, P7, DOI 10.1002/zoos.201000020; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Millette KL, 2011, LIMNOL OCEANOGR, V56, P1725, DOI 10.4319/lo.2011.56.5.1725; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Niklitschek EJ, 2013, REV AQUACULT, V5, P172, DOI 10.1111/raq.12012; Ortubay Silvia, 1991, Medio Ambiente, V11, P84; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Puillandre N, 2012, MOL ECOL, V21, P2671, DOI 10.1111/j.1365-294X.2012.05559.x; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Reid NM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-196; Rubinoff D, 2005, SYST BIOL, V54, P952, DOI 10.1080/10635150500234674; Ruzzante DE, 2008, MOL ECOL, V17, P2234, DOI 10.1111/j.1365-294X.2008.03738.x; Ruzzante DE, 2011, BIOL J LINN SOC, V103, P221, DOI 10.1111/j.1095-8312.2011.01693.x; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; Szepannek G, 2012, HDA HETEROSCEDASTIC; TAJIMA F, 1989, GENETICS, V123, P585; Vanhaecke D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032939; Vince G, 2010, SCIENCE, V329, P382, DOI 10.1126/science.329.5990.382; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Xu JW, 2009, MOL ECOL, V18, P904, DOI 10.1111/j.1365-294X.2008.04070.x; Young KA, 2010, ANIM CONSERV, V13, P399, DOI 10.1111/j.1469-1795.2010.00354.x; Young KA, 2009, BIOL INVASIONS, V11, P1955, DOI 10.1007/s10530-008-9372-5; Zama A, 1984, INTRO AYSEN CHILE PA; Zemlak TS, 2011, MOL ECOL, V20, P5280, DOI 10.1111/j.1365-294X.2011.05352.x; Zemlak TS, 2008, MOL ECOL, V17, P5049, DOI 10.1111/j.1365-294X.2008.03987.x	82	15	16	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71577	10.1371/journal.pone.0071577	http://dx.doi.org/10.1371/journal.pone.0071577			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977079	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700071
J	Gomez, F; Phillips, C; Soddu, A; Boly, M; Boveroux, P; Vanhaudenhuyse, A; Bruno, MA; Gosseries, O; Bonhomme, V; Laureys, S; Noirhomme, Q				Gomez, Francisco; Phillips, Christophe; Soddu, Andrea; Boly, Melanie; Boveroux, Pierre; Vanhaudenhuyse, Audrey; Bruno, Marie-Aurelie; Gosseries, Olivia; Bonhomme, Vincent; Laureys, Steven; Noirhomme, Quentin			Changes in Effective Connectivity by Propofol Sedation	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; GENERAL-ANESTHESIA; DEFAULT-MODE; IN-VIVO; BRAIN; HUMANS; FMRI; CONSCIOUSNESS; MECHANISMS; STATE	Mechanisms of propofol-induced loss of consciousness remain poorly understood. Recent fMRI studies have shown decreases in functional connectivity during unconsciousness induced by this anesthetic agent. Functional connectivity does not provide information of directional changes in the dynamics observed during unconsciousness. The aim of the present study was to investigate, in healthy humans during an auditory task, the changes in effective connectivity resulting from propofol induced loss of consciousness. We used Dynamic Causal Modeling for fMRI (fMRI-DCM) to assess how causal connectivity is influenced by the anesthetic agent in the auditory system. Our results suggest that the dynamic observed in the auditory system during unconsciousness induced by propofol, can result in a mixture of two effects: a local inhibitory connectivity increase and a decrease in the effective connectivity in sensory cortices.	[Gomez, Francisco; Soddu, Andrea; Boly, Melanie; Boveroux, Pierre; Vanhaudenhuyse, Audrey; Bruno, Marie-Aurelie; Gosseries, Olivia; Laureys, Steven; Noirhomme, Quentin] Univ Liege, Coma Sci Grp, Cyclotron Res Ctr, Liege, Belgium; [Gomez, Francisco; Soddu, Andrea; Boly, Melanie; Boveroux, Pierre; Vanhaudenhuyse, Audrey; Bruno, Marie-Aurelie; Gosseries, Olivia; Laureys, Steven; Noirhomme, Quentin] Univ Liege, Dept Neurol, Liege, Belgium; [Gomez, Francisco; Soddu, Andrea; Boly, Melanie; Boveroux, Pierre; Vanhaudenhuyse, Audrey; Bruno, Marie-Aurelie; Gosseries, Olivia; Laureys, Steven; Noirhomme, Quentin] Univ Hosp Liege, Liege, Belgium; [Phillips, Christophe] Univ Liege, Cyclotron Res Ctr, Liege, Belgium; [Phillips, Christophe] Univ Liege, Dept Elect Engn & Comp Sci, Liege, Belgium; [Boveroux, Pierre; Bonhomme, Vincent] Univ Hosp Liege, Dept Anesthesiol & Reanimat, Liege, Belgium	University of Liege; University of Liege; University of Liege; University of Liege; University of Liege; University of Liege	Gomez, F (corresponding author), Univ Liege, Coma Sci Grp, Cyclotron Res Ctr, Liege, Belgium.	fagomezj@gmail.com	Gosseries, Olivia/AAB-6469-2020; Soddu, Andrea/K-7087-2014; Bonhomme, Vincent/J-7144-2019; Vanhaudenhuyse, Audrey/AAP-2455-2020; Laureys, Steven/A-3349-2011; Laureys, Steven/AAN-2097-2021; Phillips, Christophe/M-3025-2017	Gosseries, Olivia/0000-0001-9011-7496; Soddu, Andrea/0000-0001-6833-745X; Bonhomme, Vincent/0000-0001-6356-547X; Laureys, Steven/0000-0002-3096-3807; Boly, Melanie/0000-0001-9584-0907; Noirhomme, Quentin/0000-0001-8247-4493; Phillips, Christophe/0000-0002-4990-425X	European Commission (European ICT Programme Projects) [FP7-247919 DECODER]; Belgian National Funds for Scientific Research (FNRS); FEDER structural fund [RADIOMED-930549]; Fonds Leon Fredericq; James McDonnell Foundation; French Speaking Community Concerted Research Action; University and University Hospital of Liege;  [FNRS 9.4501.12]	European Commission (European ICT Programme Projects); Belgian National Funds for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); FEDER structural fund; Fonds Leon Fredericq; James McDonnell Foundation; French Speaking Community Concerted Research Action; University and University Hospital of Liege; 	This research was supported by the European Commission (European ICT Programme Projects FP7-247919 DECODER), the Belgian National Funds for Scientific Research (FNRS), the Tinnitus Prize 2011 (FNRS 9.4501.12), FEDER structural fund RADIOMED-930549, Fonds Leon Fredericq, the James McDonnell Foundation, the French Speaking Community Concerted Research Action and the University and University Hospital of Liege. The funding sources are not liable for any use that may be made of the information contained therein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Alkire MT, 2001, BRIT J ANAESTH, V86, P618, DOI 10.1093/bja/86.5.618; ALKIRE MT, 1995, ANESTHESIOLOGY, V82, P393, DOI 10.1097/00000542-199502000-00010; Antkowiak B, 2002, BRIT J ANAESTH, V89, P102, DOI 10.1093/bja/aef154; Baars BJ, 2003, TRENDS NEUROSCI, V26, P671, DOI 10.1016/j.tins.2003.09.015; Bali M, 2004, MOL PHARMACOL, V65, P68, DOI 10.1124/mol.65.1.68; Barrett AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029072; BINDER JR, 1994, ANN NEUROL, V35, P662, DOI 10.1002/ana.410350606; Boly M, 2004, ARCH NEUROL-CHICAGO, V61, P233, DOI 10.1001/archneur.61.2.233; Boly M, 2012, BRAIN CONNECT, V2, P1, DOI 10.1089/brain.2011.0049; Boly M, 2011, SCIENCE, V332, P858, DOI 10.1126/science.1202043; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; Breakspear M, 2012, NEUROIMAGE; Brown EN, 2010, NEW ENGL J MED, V363, P2638, DOI 10.1056/NEJMra0808281; Daunizeau J, 2012, NEUROIMAGE, V62, P464, DOI 10.1016/j.neuroimage.2012.04.061; Daunizeau J, 2009, PHYSICA D, V238, P2089, DOI 10.1016/j.physd.2009.08.002; Daunizeau J, 2012, NEUROIMAGE; Demertzi A, 2011, PROG BRAIN RES, V193, P309, DOI 10.1016/B978-0-444-53839-0.00020-X; Destexhe A, 2006, SCIENCE, V314, P85, DOI 10.1126/science.1127241; Dueck M, ACTA ANAESTHESIOLOGI, V49; Durston S, 2003, NEUROIMAGE, V20, P2135, DOI 10.1016/j.neuroimage.2003.08.004; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fiset P, 1999, J NEUROSCI, V19, P5506; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Friston KJ, 2008, NEUROIMAGE, V41, P849, DOI 10.1016/j.neuroimage.2008.02.054; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Friston KJ, 2010, MATH PROBL ENG, V2010, DOI 10.1155/2010/621670; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Greicius MD, 2008, HUM BRAIN MAPP, V29, P839, DOI 10.1002/hbm.20537; Hudetz AG, 2012, BRAIN CONNECT, V2, P291, DOI 10.1089/brain.2012.0107; Hunter MD, 2006, P NATL ACAD SCI USA, V103, P189, DOI 10.1073/pnas.0506268103; Hutt A, 2010, COGN NEURODYNAMICS, V4, P37, DOI 10.1007/s11571-009-9092-2; Kaisti KK, 2003, ANESTHESIOLOGY, V99, P603, DOI 10.1097/00000542-200309000-00015; Kotani Y, 2008, CNS NEUROSCI THER, V14, P95, DOI 10.1111/j.1527-3458.2008.00043.x; Krasowski M, 2001, J PHARMACOL EXP THER, V297, P33851; Kumar S, 2007, PLOS COMPUT BIOL, V3, P977, DOI 10.1371/journal.pcbi.0030100; Laitio RM, 2007, ANESTHESIOLOGY, V106, P1128, DOI 10.1097/01.anes.0000267596.57497.92; Laureys S, 2009, NEUROLOGY OF CONSCIOUSNESS: COGNITIVE NEUROSCIENCE AND NEUROPATHOLOGY, P1; Laureys S, 2000, BRAIN, V123, P1589, DOI 10.1093/brain/123.8.1589; Laureys S, 2012, NEUROIMAGE, V61, P478, DOI 10.1016/j.neuroimage.2011.12.041; Lauro LJR, 2008, CEREB CORTEX, V18, P162, DOI 10.1093/cercor/bhm042; Lee JH, 2010, NATURE, V465, P788, DOI 10.1038/nature09108; Lee U, 2009, CONSCIOUS COGN, V18, P1069, DOI 10.1016/j.concog.2009.04.004; Li BJ, 2011, NEUROIMAGE, V58, P442, DOI 10.1016/j.neuroimage.2011.01.085; Liu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013492; Marreiros AC, 2008, NEUROIMAGE, V39, P269, DOI 10.1016/j.neuroimage.2007.08.019; MARSH B, 1991, BRIT J ANAESTH, V67, P41, DOI 10.1093/bja/67.1.41; Martuzzi R, 2010, NEUROIMAGE, V49, P823, DOI 10.1016/j.neuroimage.2009.07.028; Mashour GA, 2005, SCIENCE, V310, P1768; Mhuircheartaigh RN, 2010, J NEUROSCI, V30, P9095, DOI 10.1523/JNEUROSCI.5516-09.2010; Moran RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022790; Noirhomme Q, 2010, FRONTIERS SYSTEMS NE, V4; Northoff G, 2011, SCHIZOPHR RES, V127, P202, DOI 10.1016/j.schres.2010.11.009; Penny WD, 2004, NEUROIMAGE, V22, P1157, DOI 10.1016/j.neuroimage.2004.03.026; Penny WD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000709; Plourde G, 2006, ANESTHESIOLOGY, V104, P448, DOI 10.1097/00000542-200603000-00011; Qiu ML, 2008, HUM BRAIN MAPP, V29, P1390, DOI 10.1002/hbm.20472; Ramsay M, 1974, BRIT MED J, V2; Schrouff J, 2011, NEUROIMAGE, V57, P198, DOI 10.1016/j.neuroimage.2011.04.020; Seghier ML, 2011, CEREB CORTEX, V21, P1519, DOI 10.1093/cercor/bhq203; Seghier ML, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.001422007, 10.3389/fnsys.2010.00142]; Stamatakis EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014224; Stephan KE, 2007, NEUROIMAGE, V38, P387, DOI 10.1016/j.neuroimage.2007.07.040; Stephan KE, 2009, NEUROIMAGE, V46, P1004, DOI 10.1016/j.neuroimage.2009.03.025; Tacikowski P, 2011, SOC NEUROSCI-UK, V6, P98, DOI 10.1080/17470919.2010.490665; Valdes-Sosa PA, 2011, NEUROIMAGE, V58, P339, DOI 10.1016/j.neuroimage.2011.03.058; Wachtel RE, 2011, CAN J ANESTH, V58, P714, DOI 10.1007/s12630-011-9519-1; Waldorp L, 2011, NEUROIMAGE, V54, P2695, DOI 10.1016/j.neuroimage.2010.10.054; White NS, 2003, NEUROIMAGE, V19, P402, DOI 10.1016/S1053-8119(03)00103-4; Zhang H, 2010, ANATOMICAL RECORD AD, V293	72	21	21	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71370	10.1371/journal.pone.0071370	http://dx.doi.org/10.1371/journal.pone.0071370			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977030	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700042
J	Kumar, JM; Idris, MM; Srinivas, G; Kumar, PV; Meghah, V; Kavitha, M; Reddy, CR; Mainkar, PS; Pal, B; Chandrasekar, S; Nagesh, N				Kumar, Jerald Mahesh; Idris, Mohammed M.; Srinivas, Gunda; Kumar, Pallerla Vinay; Meghah, Vuppalapaty; Kavitha, Mitta; Reddy, Chada Raji; Mainkar, Prathama S.; Pal, Biswajit; Chandrasekar, Srivari; Nagesh, Narayana			Phenyl 1,2,3-Triazole-Thymidine Ligands Stabilize G-Quadruplex DNA, Inhibit DNA Synthesis and Potentially Reduce Tumor Cell Proliferation over 3 '-Azido Deoxythymidine	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; MICROWAVE-ASSISTED SYNTHESIS; POLYMERASE STOP ASSAY; TELOMERASE ACTIVITY; CLICK CHEMISTRY; BIOLOGICAL-ACTIVITY; INTERACTIVE AGENTS; DERIVATIVES; SEQUENCE; 1,2,4-TRIAZOLES	Triazoles are known for their non-toxicity, higher stability and therapeutic activity. Few nucleoside (L1, L2 and L3) and non-nucleoside 1,2,3-triazoles (L4-L14) were synthesised using click chemistry and they were screened for tumor cell cytotoxicity and proliferation. Among these triazole ligands studied, nucleoside ligands exhibited higher potential than non-nucleoside ligands. The nucleoside triazole analogues, 3'-Phenyl-1,2,3-triazole-thymidine (L2) and 3'-4-Chlorophenyl-1,2,3-triazole-thymidine (L3), demonstrated higher cytotoxicity in tumor cells than in normal cells. The IC50 value for L3 was lowest (50 mu M) among the ligands studied. L3 terminated cell cycle at S, G2/M phases and enhanced sub-G1 populations, manifesting induction of apoptosis in tumor cells. Confocal studies indicated that nucleoside triazole ligands (L2/L3) cause higher DNA fragmentation than other ligands. Preclinical experiments with tumor-induced mice showed greater reduction in tumor size with L3. In vitro DNA synthesis reaction with L3 exhibited higher DNA synthesis inhibition with quadruplex forming DNA (QF DNA) than non quadruplex forming DNA (NQF DNA). T-m of quadruplex DNA increased in the presence of L3, indicating its ability to enhance stability of quadruplex DNA at elevated temperature and the results indicate that it had higher affinity towards quadruplex DNA than the other forms of DNA (like dsDNA and ssDNA). From western blot experiment, it was noticed that telomerase expression levels in the tissues of tumor-induced mice were found to be reduced on L3 treatment. Microcalorimetry results emphasise that two nucleoside triazole ligands (L2/L3) interact with quadruplex DNA with significantly higher affinity (K-d approximate to 10(-7) M). Interestingly the addition of an electronegative moiety to the phenyl group of L2 enhanced its anti-proliferative activity. Though IC50 values are not significantly low with L3, the studies on series of synthetic 1,2,3-triazole ligands are useful for improving and building potential pro-apoptotic ligands.	[Kumar, Jerald Mahesh; Idris, Mohammed M.; Srinivas, Gunda; Kumar, Pallerla Vinay; Meghah, Vuppalapaty; Pal, Biswajit; Nagesh, Narayana] CSIR Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India; [Kavitha, Mitta; Reddy, Chada Raji; Mainkar, Prathama S.; Chandrasekar, Srivari] CSIR Indian Inst Chem Technol, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT)	Nagesh, N (corresponding author), CSIR Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India.	nagesh@ccmb.res.in	srivari, chandrasekhar/A-6833-2010; Chada, Raji/C-1545-2009	srivari, chandrasekhar/0000-0003-3695-4343; Chada, Raji/0000-0003-1491-7381; Gunda, Srinivas/0000-0003-2053-2330; Nagesh, Narayana/0000-0002-8998-8013	Indo Swiss Joint Research Programme (ISJRP) [CH: 138844]	Indo Swiss Joint Research Programme (ISJRP)	Part of the work was partly supported by Indo Swiss Joint Research Programme (ISJRP) with grant number CH: 138844. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalave SG, 2011, CHEM-ASIAN J, V6, P2696, DOI 10.1002/asia.201100432; Andersen NK, 2011, J ORG CHEM, V76, P6177, DOI 10.1021/jo200919y; BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082; Burger AM, 2005, CANCER RES, V65, P1489, DOI 10.1158/0008-5472.CAN-04-2910; Caterina ML, 2010, CHEM COMMUN, V46, P9116; Cheng MK, 2008, J MED CHEM, V51, P963, DOI 10.1021/jm070587t; Clemons M, 2004, CANCER TREAT REV, V30, P325, DOI 10.1016/j.ctrv.2004.03.004; COUNTER CM, 1995, BLOOD, V85, P2315, DOI 10.1182/blood.V85.9.2315.bloodjournal8592315; Dash J, 2011, CHEM-EUR J, V17, P4571, DOI 10.1002/chem.201003157; Demirbas N, 2004, EUR J MED CHEM, V39, P793, DOI 10.1016/j.ejmech.2004.06.007; Fasman GD., 1975, HDB BIOCH MOL BIOL N, V1, P589; Gonzalez JM, 2005, EXTREMOPHILES, V9, P75, DOI 10.1007/s00792-004-0417-0; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Han HY, 1999, NUCLEIC ACIDS RES, V27, P537, DOI 10.1093/nar/27.2.537; Harrison RJ, 2003, J MED CHEM, V46, P4463, DOI 10.1021/jm0308693; HASSNER A, 1990, J ORG CHEM, V55, P2304, DOI 10.1021/jo00295a014; HASSNER A, 1986, ANGEW CHEM INT EDIT, V25, P478, DOI 10.1002/anie.198604781; Hirpara HM, 2003, INDIAN J CHEM B, V42, P1756; Holla BS, 2002, EUR J MED CHEM, V37, P511; HORWITZ JP, 1964, J ORG CHEM, V29, P2076, DOI 10.1021/jo01030a546; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Isloor AM, 2009, EUR J MED CHEM, V44, P3784, DOI 10.1016/j.ejmech.2009.04.038; Kaiser M, 2006, ORG BIOMOL CHEM, V4, P1049, DOI 10.1039/b516378a; Kamotra P, 2007, INDIAN J CHEM B, V46, P980; Kaval N, 2005, J COMB CHEM, V7, P490, DOI 10.1021/cc0498377; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kumari S, 2008, BIOCHEMISTRY-US, V47, P12664, DOI 10.1021/bi8010797; Ladbury JE, 1996, CHEM BIOL, V3, P791, DOI 10.1016/S1074-5521(96)90063-0; Li XL, 2011, TETRAHEDRON, V67, P2299, DOI 10.1016/j.tet.2011.01.063; Lin JZ, 2010, CHINESE J CHEM ENG, V18, P1, DOI 10.1016/S1004-9541(08)60315-8; Luedtke NW, 2009, CHIMIA, V63, P134, DOI 10.2533/chimia.2009.134; Marinescu L, 2003, J ORG CHEM, V68, P9453, DOI 10.1021/jo035163v; Mathew V, 2007, EUR J MED CHEM, V42, P823, DOI 10.1016/j.ejmech.2006.12.010; Michael HC, 2003, DRUG METAB DISPOS, V31, P1125; Moorhouse AD, 2008, MOL BIOSYST, V4, P629, DOI 10.1039/b801822g; Moses JE, 2010, ORG BIOMOL CHEM, V8, P2926, DOI 10.1039/c005055e; Nagesh N, 2003, J BIOCHEM BIOPH METH, V57, P65, DOI 10.1016/S0165-022X(03)00081-2; NAGESH N, 1995, J BIOCHEM BIOPH METH, V30, P1, DOI 10.1016/0165-022X(94)00057-K; Nagesh N, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/146418; Nagesh N, 2010, BIOPHYS J, V98, P2628, DOI 10.1016/j.bpj.2010.02.050; Olomola TO, 2010, TETRAHEDRON LETT, V51, P6325, DOI 10.1016/j.tetlet.2010.09.121; Paul A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039467; PLUM GE, 2000, CURRENT PROTOCOLS NU; Poecke S. V., 2010, J MED CHEM, V53, P2902; Poecke SV, 2011, BIOORGAN MED CHEM, V19, P7603; Priego EM, 2012, CURR PHARM DESIGN, V18, P2981, DOI 10.2174/138161212800672787; Provse KR, 1995, P NATL ACAD SCI USA, V92, P4818; Raju G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035920; Raymond E, 1996, CURR OPIN BIOTECH, V7, P583, DOI 10.1016/S0958-1669(96)80068-1; Rha SY, 2000, CLIN CANCER RES, V6, P987; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Shi DF, 2001, J MED CHEM, V44, P4509, DOI 10.1021/jm010246u; Strahan GD, 1998, BIOPHYS J, V75, P968, DOI 10.1016/S0006-3495(98)77585-X; Strahl C, 1996, MOL CELL BIOL, V16, P53; Sun D, 2010, METHODS MOL BIOL, V608, P65, DOI 10.1007/978-1-59745-363-9_5; Swamy SN, 2006, EUR J MED CHEM, V41, P531, DOI 10.1016/j.ejmech.2005.12.009; Tauchi T, 2006, ONCOGENE, V25, P5719, DOI 10.1038/sj.onc.1209577; Tomita K, 2002, J MED CHEM, V45, P5564, DOI 10.1021/jm010057b; Tsukuda T, 1998, BIOORG MED CHEM LETT, V8, P1819, DOI 10.1016/S0960-894X(98)00316-3; Udupi RH, 1999, J INDIAN CHEM SOC, V76, P461; WANG Z, 1996, MOLECULES, V1, P68; WILSON JK, 1990, BRIT J CANCER, V62, P189, DOI 10.1038/bjc.1990.258; Xu H, 2010, ACS APPL MATER INTER, V2, P3211, DOI 10.1021/am1006854	64	23	25	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e70798	10.1371/journal.pone.0070798	http://dx.doi.org/10.1371/journal.pone.0070798			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23976957	Green Published, gold, Green Submitted			2022-12-25	WOS:000323425700009
J	El Khassawna, T; Bocker, W; Govindarajan, P; Schliefke, N; Hurter, B; Kampschulte, M; Schlewitz, G; Alt, V; Lips, KS; Faulenbach, M; Mollmann, H; Zahner, D; Durselen, L; Ignatius, A; Bauer, N; Wenisch, S; Langheinrich, AC; Schnettler, R; Heiss, C				El Khassawna, Thaqif; Boecker, Wolfgang; Govindarajan, Parameswari; Schliefke, Nathalie; Huerter, Britta; Kampschulte, Marian; Schlewitz, Gudrun; Alt, Volker; Lips, Katrin Susanne; Faulenbach, Miriam; Moellmann, Henriette; Zahner, Daniel; Duerselen, Lutz; Ignatius, Anita; Bauer, Natali; Wenisch, Sabine; Langheinrich, Alexander Claus; Schnettler, Reinhard; Heiss, Christian			Effects of Multi-Deficiencies-Diet on Bone Parameters of Peripheral Bone in Ovariectomized Mature Rat	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; CALORIC RESTRICTION; TRABECULAR BONE; ANIMAL-MODELS; FEMALE RATS; PARATHYROID-HORMONE; BODY-WEIGHT; OSTEOPOROSIS; MARROW; FRACTURE	Many postmenopausal women have vitamin D and calcium deficiency. Therefore, vitamin D and calcium supplementation is recommended for all patients with osteopenia and osteoporosis. We used an experimental rat model to test the hypothesis that induction of osteoporosis is more efficiently achieved in peripheral bone through combining ovariectomy with a unique multi-deficiencies diet (vitamin D depletion and deficient calcium, vitamin K and phosphorus). 14-week-old Sprague-Dawley rats served as controls to examine the initial bone status. 11 rats were bilaterally ovariectomized (OVX) and fed with multi-deficiencies diet. Three months later the treated group and the Sham group (n = 8) were euthanized. Bone biomechanical competence of the diaphyseal bone was examined on both, tibia and femur. Image analysis was performed on tibia via mu CT, and on femur via histological analysis. Lower torsional stiffness indicated inferior mechanical competence of the tibia in 3 month OVX+Diet. Proximal metaphyseal region of the tibia showed a diminished bone tissue portion to total tissue in the mu CT despite the increased total area as evaluated in both mu CT and histology. Cortical bone showed higher porosity and smaller cross sectional thickness of the tibial diaphysis in the OVX+Diet rats. A lower ALP positive area and elevated serum level of RANKL exhibited the unbalanced cellular interaction in bone remodeling in the OVX+Diet rat after 3 month of treatment. Interestingly, more adipose tissue area in bone marrow indicated an effect of bone loss similar to that observed in osteoporotic patients. Nonetheless, the presence of osteoid and elevated serum level of PTH, BGP and Opn suggest the development of osteomalacia rather than an osteoporosis. As the treatment and fracture management of both osteoporotic and osteomalacia patients are clinically overlapping, this study provides a preclinical animal model to be utilized in local supplementation of minerals, drugs and growth factors in future fracture healing studies.	[El Khassawna, Thaqif; Boecker, Wolfgang; Govindarajan, Parameswari; Alt, Volker; Lips, Katrin Susanne; Schnettler, Reinhard; Heiss, Christian] Univ Giessen, Lab Expt Trauma Surg, D-35390 Giessen, Germany; [Boecker, Wolfgang; Schliefke, Nathalie; Huerter, Britta; Schlewitz, Gudrun; Alt, Volker; Schnettler, Reinhard; Heiss, Christian] Univ Hosp Giessen Marburg, Dept Trauma Surg, Giessen, Germany; [Kampschulte, Marian; Faulenbach, Miriam; Moellmann, Henriette] Univ Hosp Giessen Marburg, Dept Radiol, Giessen, Germany; [Zahner, Daniel] Univ Giessen, Anim Lab, D-35390 Giessen, Germany; [Duerselen, Lutz; Ignatius, Anita] Univ Ulm, Ctr Musculoskeletal Res, Inst Orthoped Res & Biomech, D-89069 Ulm, Germany; [Langheinrich, Alexander Claus] BG Trauma Hosp Frankfurt Main, Dept Diagnost & Intervent Radiol, Frankfurt, Germany; [Bauer, Natali] Univ Giessen, Dept Vet Clin Sci Clin Pathol & Clin Pathophysiol, D-35390 Giessen, Germany; [Wenisch, Sabine] Univ Giessen, Dept Vet Anat, D-35390 Giessen, Germany	Justus Liebig University Giessen; University Hospital of Giessen & Marburg; University Hospital of Giessen & Marburg; Justus Liebig University Giessen; Ulm University; Justus Liebig University Giessen; Justus Liebig University Giessen	Heiss, C (corresponding author), Univ Giessen, Lab Expt Trauma Surg, D-35390 Giessen, Germany.	christian.heiss@chiru.med.uni-giessen.de	khassawna, Thaqif El/J-9748-2013; Ignatius, Anita/M-6012-2013; Dürselen, Lutz/B-9447-2012	khassawna, Thaqif El/0000-0002-1187-8578; Ignatius, Anita/0000-0002-4782-1979; Dürselen, Lutz/0000-0002-5470-5423; Mollmann, Henriette Louise/0000-0002-1040-8814	Deutsche Forschungsgemeinschaft (DFG) [SFB/Transregio 79]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (DFG) within the SFB/Transregio 79. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt V., 2013, ACTA BIOMATER; Asawa Y, 2004, BONE, V35, P870, DOI 10.1016/j.bone.2004.06.007; AUFDEMORTE TB, 1993, J BONE MINER RES, V8, pS529; Barbier A, 1999, J BONE MINER METAB, V17, P37, DOI 10.1007/s007740050061; BISBALLE S, 1991, GUT, V32, P1303, DOI 10.1136/gut.32.11.1303; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; Chen CC, 2007, CHINESE J PHYSIOL, V50, P308; Claes L, 2009, ARCH ORTHOP TRAUM SU, V129, P923, DOI 10.1007/s00402-008-0692-9; Costa GP, 2011, MED ORAL PATOL ORAL, V16, pE497, DOI 10.4317/medoral.16.e497; DANIELSEN CC, 1993, CALCIFIED TISSUE INT, V52, P26, DOI 10.1007/BF00675623; Devlin MJ, 2010, J BONE MINER RES, V25, P2078, DOI 10.1002/jbmr.82; El Khassawna T, 2012, BONE, V51, P651, DOI 10.1016/j.bone.2012.07.011; FARRUGIA W, 1986, CALCIFIED TISSUE INT, V39, P234, DOI 10.1007/BF02555210; Francisco JI, 2011, J ORTHOP RES, V29, P189, DOI 10.1002/jor.21217; French DL, 2008, PHYTOMEDICINE, V15, P1069, DOI 10.1016/j.phymed.2008.06.007; Gambacciani M, 1997, J CLIN ENDOCR METAB, V82, P414, DOI 10.1210/jc.82.2.414; Gerstenfeld LC, 2005, J BONE MINER RES, V20, P1715, DOI 10.1359/JBMR.050702; Gundberg CM, 2012, ADV NUTR, V3, P149, DOI 10.3945/an.112.001834; Guo HY, 2009, J NUTR, V139, P958, DOI 10.3945/jn.108.100586; Hamrick MW, 2008, J BONE MINER RES, V23, P870, DOI [10.1359/jbmr.080213, 10.1359/JBMR.080213]; Harvey N, 2009, PRIMER METABOLIC BON, P197; Heim M, 2004, ENDOCRINOLOGY, V145, P848, DOI 10.1210/en.2003-1014; Heiss C, 2012, MED SCI MONITOR, V18, pBR199, DOI 10.12659/MSM.882895; Ito M, 2002, BONE, V30, P594, DOI 10.1016/S8756-3282(02)00684-1; Jamsa T, 1998, BONE, V23, P155, DOI 10.1016/S8756-3282(98)00076-3; Justesen J, 2001, BIOGERONTOLOGY, V2, P165, DOI 10.1023/A:1011513223894; KALU DN, 1984, ENDOCRINOLOGY, V115, P1239, DOI 10.1210/endo-115-4-1239; KALU DN, 1991, BONE MINER, V15, P175, DOI 10.1016/0169-6009(91)90124-I; Kawai M, 2012, J INTERN MED, V272, P317, DOI 10.1111/j.1365-2796.2012.02564.x; KENNER GH, 1982, STAIN TECHNOL, V57, P121, DOI 10.3109/10520298209066540; Khosla S, 2005, ENDOCRIN METAB CLIN, V34, P1015, DOI 10.1016/j.ecl.2005.07.009; KIEBZAK GM, 1988, J BONE MINER RES, V3, P439; KIEBZAK GM, 1988, J BONE MINER RES, V3, P37; LeBoff MS, 1999, JAMA-J AM MED ASSOC, V281, P1505, DOI 10.1001/jama.281.16.1505; Lill CA, 2003, J ORTHOPAED RES, V21, P836, DOI 10.1016/S0736-0266(02)00266-8; Lillie RD, 1965, HISTOPATHOLOGIC TECH, Vxii; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; Matsumoto Y, 2009, OSTEOPOROSIS INT, V20, P1863, DOI 10.1007/s00198-009-0888-z; Melhus G, 2007, ACTA ORTHOP, V78, P393, DOI 10.1080/17453670710013988; Mohamed N, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/817814; Nazarian A, 2009, J ORTHOP RES, V27, P1667, DOI 10.1002/jor.20931; OMI N, 1995, BONE, V17, pS163, DOI 10.1016/8756-3282(95)00329-C; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pearson DA, 2007, NUTR CLIN PRACT, V22, P517, DOI 10.1177/0115426507022005517; Pino AM, 2006, J ENDOCRINOL, V191, P715, DOI 10.1677/joe.1.07026; Poole KES, 2005, CURR OPIN PHARMACOL, V5, P612, DOI 10.1016/j.coph.2005.07.004; Reddy PN, 2003, PHARMACOL RES, V48, P593, DOI 10.1016/S1043-6618(03)00224-X; RODGERS JB, 1993, BONE, V14, P369, DOI 10.1016/8756-3282(93)90166-8; Sakai A, 2001, J BONE MINER METAB, V19, P277, DOI 10.1007/s007740170011; Sanderson JP, 1997, J GERONTOL A-BIOL, V52, pB20, DOI 10.1093/gerona/52A.1.B20; Saraiva GL, 2005, OSTEOPOROSIS INT, V16, P1649, DOI 10.1007/s00198-005-1895-3; Scholz-Ahrens KE, 2002, BRIT J NUTR, V88, P365, DOI 10.1079/BJN2002661; Sella S, 2008, CLIN CASES MINER BON, V5, P118; Shevde NK, 2002, P NATL ACAD SCI USA, V99, P13487, DOI 10.1073/pnas.202471299; Shibata T, 2002, J BONE MINER RES, V17, P622, DOI 10.1359/jbmr.2002.17.4.622; Sims NA, 1996, CALCIFIED TISSUE INT, V59, P121, DOI 10.1007/s002239900098; Standal T, 2004, EXP ONCOL, V26, P179; Sunyecz John A, 2008, Ther Clin Risk Manag, V4, P827; TAKANOYAMAMOTO T, 1990, P NATL ACAD SCI USA, V87, P2172, DOI 10.1073/pnas.87.6.2172; THOMPSON DD, 1995, BONE, V17, pS125, DOI 10.1016/8756-3282(95)00285-L; Wang L, 2001, BONE, V29, P141, DOI 10.1016/S8756-3282(01)00483-5; Washimi Y, 2007, BONE, V41, P786, DOI 10.1016/j.bone.2007.06.019; Wood RJ, 2008, NUTR REV, V66, P40, DOI 10.1111/j.1753-4887.2007.00004.x; WRONSKI TJ, 1985, CALCIFIED TISSUE INT, V37, P324, DOI 10.1007/BF02554882; YAMAUCHI H, 1995, J BONE MINER RES, V10, P1033; Yamazaki M, 1999, J BONE JOINT SURG BR, V81B, P508, DOI 10.1302/0301-620X.81B3.9398	66	34	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e71665	10.1371/journal.pone.0071665	http://dx.doi.org/10.1371/journal.pone.0071665			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977109	Green Submitted, Green Published, gold			2022-12-25	WOS:000323570200042
J	Fernandez, C; Sandin, M; Sampaio, JL; Almgren, P; Narkiewicz, K; Hoffmann, M; Hedner, T; Wahlstrand, B; Simons, K; Shevchenko, A; James, P; Melander, O				Fernandez, Celine; Sandin, Marianne; Sampaio, Julio L.; Almgren, Peter; Narkiewicz, Krzysztof; Hoffmann, Michal; Hedner, Thomas; Wahlstrand, Bjorn; Simons, Kai; Shevchenko, Andrej; James, Peter; Melander, Olle			Plasma Lipid Composition and Risk of Developing Cardiovascular Disease	PLOS ONE			English	Article							SHOTGUN LIPIDOMICS; BLOOD-PLASMA; CORONARY; EVENTS; PREDICTION; POLYMORPHISMS; ASSOCIATION; CHOLESTEROL; BIOMARKERS; ETHER	Aims: We tested whether characteristic changes of the plasma lipidome in individuals with comparable total lipids level associate with future cardiovascular disease (CVD) outcome and whether 23 validated gene variants associated with coronary artery disease (CAD) affect CVD associated lipid species. Methods and Results: Screening of the fasted plasma lipidome was performed by top-down shotgun analysis and lipidome compositions compared between incident CVD cases (n = 211) and controls (n = 216) from the prospective population-based MDC study using logistic regression adjusting for Framingham risk factors. Associations with incident CVD were seen for eight lipid species (0.21 <= q <= 0.23). Each standard deviation unit higher baseline levels of two lysophosphatidylcholine species (LPC), LPC16:0 and LPC20:4, was associated with a decreased risk for CVD (P=0.024-0.028). Sphingomyelin (SM) 38: 2 was associated with increased odds of CVD (P=0.057). Five triglyceride (TAG) species were associated with protection (P=0.031-0.049). LPC16:0 was negatively correlated with the carotid intima-media thickness (P=0.010) and with HbA1c (P=0.012) whereas SM38:2 was positively correlated with LDL-cholesterol (P=0.0*10(-6)) and the q-values were good (q <= 0.03). The risk allele of 8 CAD-associated gene variants showed significant association with the plasma level of several lipid species. However, the q-values were high for many of the associations (0.015 <= q <= 0.75). Risk allele carriers of 3 CAD-loci had reduced level of LPC16:0 and/or LPC 20:4 (P <= 0.056). Conclusion: Our study suggests that CVD development is preceded by reduced levels of LPC16: 0, LPC20: 4 and some specific TAG species and by increased levels of SM38:2. It also indicates that certain lipid species are intermediate phenotypes between genetic susceptibility and overt CVD. But it is a preliminary study that awaits replication in a larger population because statistical significance was lost for the associations between lipid species and future cardiovascular events when correcting for multiple testing.	[Fernandez, Celine; Almgren, Peter; Melander, Olle] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Sandin, Marianne; James, Peter] Lund Univ, Dept Immunotechnol, Lund, Sweden; [Sampaio, Julio L.; Simons, Kai; Shevchenko, Andrej] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Narkiewicz, Krzysztof; Hoffmann, Michal] Med Univ Gdansk, Dept Hypertens & Diabetol, Gdansk, Poland; [Hedner, Thomas; Wahlstrand, Bjorn] Univ Gothenburg, Sahlgrenska Acad, Dept Med, Gothenburg, Sweden	Lund University; Lund University; Max Planck Society; Fahrenheit Universities; Medical University Gdansk; University of Gothenburg	Fernandez, C (corresponding author), Lund Univ, Dept Clin Sci, Malmo, Sweden.	Celine.Fernandez@med.lu.se; Olle.Melander@med.lu.se	Fernandez, Celine/ABH-9332-2020; Sampaio, Julio/S-3810-2019	Fernandez, Celine/0000-0003-1290-4982; Simons, Kai/0000-0002-9231-9996; Melander, Olle/0000-0002-2581-484X; Narkiewicz, Krzysztof/0000-0001-5949-5018; Sampaio, Julio/0000-0002-2881-7827	Royal Physiographic Society in Lund; European Research Council [StG-282255]; Swedish Medical Research Council; Swedish Heart and Lung Foundation; Medical Faculty of Lund University; Malmo University Hospital; Albert Pahlsson Research Foundation; Crafoord Foundation; Ernhold Lundstroms Research Foundation; Region Skane; Hulda and Conrad Mossfelt Foundation; King Gustaf V and Queen Victoria Foundation; Lennart Hansson's Memorial Fund; Wallenberg Foundation; Polish-Norwegian Research Fund; CareNorth consortium; Deutsche Forschungsgemeinschaft [TRR 83]; Virtual Liver grant Bundesministerium f. Bildung u. Forschung [0315757]; European Society of Hypertension fellowship; Novo Nordisk Fonden [NNF13OC0005339] Funding Source: researchfish	Royal Physiographic Society in Lund; European Research Council(European Research Council (ERC)European Commission); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Medical Faculty of Lund University; Malmo University Hospital; Albert Pahlsson Research Foundation; Crafoord Foundation; Ernhold Lundstroms Research Foundation; Region Skane; Hulda and Conrad Mossfelt Foundation; King Gustaf V and Queen Victoria Foundation; Lennart Hansson's Memorial Fund; Wallenberg Foundation(European Commission); Polish-Norwegian Research Fund; CareNorth consortium; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Virtual Liver grant Bundesministerium f. Bildung u. Forschung; European Society of Hypertension fellowship; Novo Nordisk Fonden(Novo Nordisk Foundation)	Dr Fernandez is the holder of an European Society of Hypertension fellowship and was supported by the Royal Physiographic Society in Lund. Prof Melander was supported by grants from the European Research Council (StG-282255), the Swedish Medical Research Council, the Swedish Heart and Lung Foundation, the Medical Faculty of Lund University, Malmo University Hospital, the Albert Pahlsson Research Foundation, the Crafoord Foundation, the Ernhold Lundstroms Research Foundation, the Region Skane, the Hulda and Conrad Mossfelt Foundation, the King Gustaf V and Queen Victoria Foundation, the Lennart Hansson's Memorial Fund, the Wallenberg Foundation, the Polish-Norwegian Research Fund and the CareNorth consortium. Dr Shevchenko is supported by TRR 83 grant from Deutsche Forschungsgemeinschaft and Virtual Liver grant (Code/0315757) from Bundesministerium f. Bildung u. Forschung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGLUND G, 1993, J INTERN MED, V233, P45, DOI 10.1111/j.1365-2796.1993.tb00647.x; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Erdmann J, 2009, NAT GENET, V41, P280, DOI 10.1038/ng.307; Fernandez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021603; Graessler J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006261; Greenland P, 2003, JAMA-J AM MED ASSOC, V290, P891, DOI 10.1001/jama.290.7.891; Griffiths WJ, 2011, J INHERIT METAB DIS, V34, P583, DOI 10.1007/s10545-010-9274-4; Gross RW, 2011, CHEM BIOL, V18, P284, DOI 10.1016/j.chembiol.2011.01.014; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; Herzog R, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r8; Kai M, 1997, J BIOL CHEM, V272, P24572, DOI 10.1074/jbc.272.39.24572; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Meikle PJ, 2011, ARTERIOSCL THROM VAS, V31, P2723, DOI 10.1161/ATVBAHA.111.234096; Melander O, 2009, JAMA-J AM MED ASSOC, V302, P49, DOI 10.1001/jama.2009.943; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Musunuru K, 2009, ARTERIOSCL THROM VAS, V29, P1975, DOI 10.1161/ATVBAHA.109.190405; Persson M, 2007, ARTERIOSCL THROM VAS, V27, P1411, DOI 10.1161/ATVBAHA.107.142679; QUINN MT, 1988, P NATL ACAD SCI USA, V85, P2805, DOI 10.1073/pnas.85.8.2805; Rhee EP, 2011, J CLIN INVEST, V121, P1402, DOI 10.1172/JCI44442; Ripatti S, 2010, LANCET, V376, P1393, DOI 10.1016/S0140-6736(10)61267-6; Rosvall M, 2005, J INTERN MED, V257, P430, DOI 10.1111/j.1365-2796.2005.01485.x; Sandra K, 2010, J CHROMATOGR A, V1217, P4087, DOI 10.1016/j.chroma.2010.02.039; Schmitz G, 2010, ATHEROSCLEROSIS, V208, P10, DOI 10.1016/j.atherosclerosis.2009.05.029; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Walkey CJ, 1997, P NATL ACAD SCI USA, V94, P12880, DOI 10.1073/pnas.94.24.12880; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373	30	83	85	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71846	10.1371/journal.pone.0071846	http://dx.doi.org/10.1371/journal.pone.0071846			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967253	Green Published, Green Submitted, gold			2022-12-25	WOS:000323378000070
J	Saez, PJ; Orellana, JA; Vega-Riveros, N; Figueroa, VA; Hernandez, DE; Castro, JF; Klein, AD; Jiang, JX; Zanlungo, S; Saez, JC				Saez, Pablo J.; Orellana, Juan A.; Vega-Riveros, Natalia; Figueroa, Vania A.; Hernandez, Diego E.; Castro, Juan F.; Klein, Andres D.; Jiang, Jean X.; Zanlungo, Silvana; Saez, Juan C.			Disruption in Connexin-Based Communication Is Associated with Intracellular Ca2+ Signal Alterations in Astrocytes from Niemann-Pick Type C Mice	PLOS ONE			English	Article							DISEASE TYPE-C; LIPOPROTEIN-DERIVED CHOLESTEROL; GAP JUNCTIONAL COMMUNICATION; OXIDATIVE STRESS; MURINE MODEL; CORTICAL ASTROCYTES; ALZHEIMERS-DISEASE; LYSOSOMAL CALCIUM; DEFICIENT CELLS; MOUSE BRAINS	Reduced astrocytic gap junctional communication and enhanced hemichannel activity were recently shown to increase astroglial and neuronal vulnerability to neuroinflammation. Moreover, increasing evidence suggests that neuroinflammation plays a pivotal role in the development of Niemann-Pick type C (NPC) disease, an autosomal lethal neurodegenerative disorder that is mainly caused by mutations in the NPC1 gene. Therefore, we investigated whether the lack of NPC1 expression in murine astrocytes affects the functional state of gap junction channels and hemichannels. Cultured cortical astrocytes of NPC1 knock-out mice (Npc1(-/-)) showed reduced intercellular communication via gap junctions and increased hemichannel activity. Similarly, astrocytes of newborn Npc1(-/-) hippocampal slices presented high hemichannel activity, which was completely abrogated by connexin 43 hemichannel blockers and was resistant to inhibitors of pannexin 1 hemichannels. Npc1(-/-) astrocytes also showed more intracellular Ca2+ signal oscillations mediated by functional connexin 43 hemichannels and P2Y1 receptors. Therefore, Npc1(-/-) astrocytes present features of connexin based channels compatible with those of reactive astrocytes and hemichannels might be a novel therapeutic target to reduce neuroinflammation in NPC disease.	[Saez, Pablo J.; Vega-Riveros, Natalia; Figueroa, Vania A.; Hernandez, Diego E.; Saez, Juan C.] Pontificia Univ Catolica Chile, Dept Fisiol, Santiago, Chile; [Orellana, Juan A.] Pontificia Univ Catolica Chile, Dept Neurol, Fac Med, Santiago, Chile; [Figueroa, Vania A.; Saez, Juan C.] Ctr Interdisciplinario Neurociencias Valparaiso, Inst Milenio, Valparaiso, Chile; [Castro, Juan F.; Klein, Andres D.; Zanlungo, Silvana] Pontificia Univ Catolica Chile, Fac Med, Dept Gastroenterol, Santiago, Chile; [Jiang, Jean X.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Zanlungo, Silvana] FONDAP Ctr Genome Regulat CGR, Santiago, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; University of Texas System; University of Texas Health San Antonio	Saez, PJ (corresponding author), Pontificia Univ Catolica Chile, Dept Fisiol, Alameda 340, Santiago, Chile.	pjsaez@uc.cl; silvana@med.puc.cl; jsaez@bio.puc.cl	Orellana, Juan A./F-6148-2012; Sáez, Pablo J./AAB-4458-2019	Sáez, Pablo J./0000-0003-0521-9426; Orellana, Juan Andres/0000-0003-4076-207X; Zanlungo, Silvana/0000-0001-8383-9829; Jiang, Jean/0000-0002-2185-5716; Figueroa Ipinza, Vania A./0000-0002-2953-9507; KLEIN, ANDRES/0000-0002-9951-2174	CONICYT [24100062]; Welch Foundation [AQ-1507]; National Institutes of Health (NIH) [EY012085]; FONDECYT [1110310, 1111033]; Fondo Nacional de Desarrollo de Areas Prioritarias (FONDAP) [15090007, DO7I1086]; Center for Genome Regulation (CGR); ANILLO ACT-71; NATIONAL EYE INSTITUTE [R01EY012085] Funding Source: NIH RePORTER	CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Welch Foundation(The Welch Foundation); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fondo Nacional de Desarrollo de Areas Prioritarias (FONDAP)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); Center for Genome Regulation (CGR); ANILLO ACT-71(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/ANILLOS); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was partially supported by the CONICYT 24100062 (to PJS); Welch Foundation grant AQ-1507 and National Institutes of Health (NIH) EY012085 (to JXJ); FONDECYT 1110310 and Fondo Nacional de Desarrollo de Areas Prioritarias (FONDAP) 15090007, Center for Genome Regulation (CGR) (to SZ); FONDECYT 1111033, FONDEF DO7I1086 and ANILLO ACT-71 (to JCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez AR, 2008, FASEB J, V22, P3617, DOI 10.1096/fj.07-102715; Amigo L, 2002, HEPATOLOGY, V36, P819, DOI 10.1053/jhep.2002.35617; Baroja-Mazo A, 2012, BIOCH BIOPHYS ACTA; Baudry M, 2003, EXP NEUROL, V184, P887, DOI 10.1016/S0014-4886(03)00345-5; Borbon I, 2012, J ALZHEIMERS DIS, V30, P875, DOI 10.3233/JAD-2012-120199; Borbon IA, 2011, J APPL GENET, V52, P213, DOI 10.1007/s13353-010-0021-1; Byun K, 2011, J CHEM NEUROANAT, V42, P39, DOI 10.1016/j.jchemneu.2011.04.003; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; Cotrina ML, 1998, P NATL ACAD SCI USA, V95, P15735, DOI 10.1073/pnas.95.26.15735; DERMIETZEL R, 1989, P NATL ACAD SCI USA, V86, P10148, DOI 10.1073/pnas.86.24.10148; Di Castro MA, 2011, NAT NEUROSCI, V14, P1276, DOI 10.1038/nn.2929; Elrick MJ, 2012, HUM MOL GENET, V21, P4876, DOI 10.1093/hmg/dds324; Elrick MJ, 2010, HUM MOL GENET, V19, P837, DOI 10.1093/hmg/ddp552; Falk MM, 2009, MOL BIOL CELL, V20, P3342, DOI 10.1091/mbc.E09-04-0288; Fu R, 2010, MOL GENET METAB, V101, P214, DOI 10.1016/j.ymgme.2010.06.018; Morales MG, 2010, LIVER INT, V30, P887, DOI 10.1111/j.1478-3231.2010.02230.x; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Gandhi GK, 2010, ASN NEURO, V2, DOI 10.1042/AN20090048; Garver VS, 1997, BBA-MOL BASIS DIS, V1361, P272, DOI 10.1016/S0925-4439(97)00047-1; Garver WS, 1997, BIOCHEM BIOPH RES CO, V236, P189, DOI 10.1006/bbrc.1997.6929; Garver WS, 2002, J LIPID RES, V43, P579; GIAUME C, 1991, NEURON, V6, P133, DOI 10.1016/0896-6273(91)90128-M; Giaume C, 2010, NAT REV NEUROSCI, V11, P87, DOI 10.1038/nrn2757; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Hui C, 2006, CELL SIGNAL, V18, P1844, DOI 10.1016/j.cellsig.2006.04.006; Iftakhar-E-Khuda I, 2009, CLIN EXP IMMUNOL, V155, P552, DOI 10.1111/j.1365-2249.2008.03779.x; Iglesias R, 2009, J NEUROSCI, V29, P7092, DOI 10.1523/JNEUROSCI.6062-08.2009; Jelinek D, 2010, OBESITY, V18, P1457, DOI 10.1038/oby.2009.415; Kang J, 2008, J NEUROSCI, V28, P4702, DOI 10.1523/JNEUROSCI.5048-07.2008; Karpuk N, 2011, J NEUROSCI, V31, P414, DOI 10.1523/JNEUROSCI.5247-10.2011; Klein A, 2011, NEUROBIOL DIS, V41, P209, DOI 10.1016/j.nbd.2010.09.008; Ko DC, 2005, PLOS GENET, V1, P81, DOI 10.1371/journal.pgen.0010007; Kodam A, 2010, GLIA, V58, P1267, DOI 10.1002/glia.21001; Koizumi S, 2010, FEBS J, V277, P286, DOI 10.1111/j.1742-4658.2009.07438.x; Koulakoff A, 2011, BIOCH BIOPHYS ACTA; LANGE Y, 1994, J BIOL CHEM, V269, P29371; Langlois S, 2008, MOL BIOL CELL, V19, P912, DOI 10.1091/mbc.E07-06-0596; Liao CK, 2010, INT J BIOCHEM CELL B, V42, P762, DOI 10.1016/j.biocel.2010.01.016; LISCUM L, 1989, J CELL BIOL, V108, P1625, DOI 10.1083/jcb.108.5.1625; LISCUM L, 1989, J BIOL CHEM, V264, P11796; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Lopez ME, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-216; Lopez ME, 2012, HUM MOL GENET, V21, P2946, DOI 10.1093/hmg/dds126; Lopez ME, 2011, J NEUROSCI, V31, P4367, DOI 10.1523/JNEUROSCI.5981-10.2011; Marambaud P, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-20; Martinez AD, 2000, BRAIN RES REV, V32, P250, DOI 10.1016/S0165-0173(99)00086-7; Meme W, 2006, FASEB J, V20, P494, DOI 10.1096/fj.05-4297fje; Nedergaard M, 2010, CELL CALCIUM, V47, P140, DOI 10.1016/j.ceca.2009.11.010; Ordonez MP, 2012, HUM MOL GENET, V21, P2651, DOI 10.1093/hmg/dds090; Orellana J.A., 2011, J NEUROCHEM; Orellana JA, 2012, REV NEUROSCIENCE, V23, P163, DOI 10.1515/revneuro-2011-0065; Orellana JA, 2012, GLIA, V60, P53, DOI 10.1002/glia.21246; Orellana JA, 2011, J NEUROSCI, V31, P4962, DOI 10.1523/JNEUROSCI.6417-10.2011; Orellana JA, 2010, GLIA, V58, P329, DOI 10.1002/glia.20926; Orellana JA, 2009, ANTIOXID REDOX SIGN, V11, P369, DOI 10.1089/ars.2008.2130; Pacheco CD, 2007, HUM MOL GENET, V16, P1495, DOI 10.1093/hmg/ddm100; Patel SC, 1999, P NATL ACAD SCI USA, V96, P1657, DOI 10.1073/pnas.96.4.1657; Peake KB, 2012, J BIOL CHEM, V287, P9290, DOI 10.1074/jbc.M111.326405; Peake KB, 2010, FEBS LETT, V584, P2731, DOI 10.1016/j.febslet.2010.04.047; Pressey SNR, 2012, NEUROBIOL DIS, V45, P1086, DOI 10.1016/j.nbd.2011.12.027; Retamal MA, 2007, J NEUROSCI, V27, P13781, DOI 10.1523/JNEUROSCI.2042-07.2007; Retamal MA, 2007, P NATL ACAD SCI USA, V104, P8322, DOI 10.1073/pnas.0702456104; Rosenbaum AI, 2011, J NEUROCHEM, V116, P789, DOI 10.1111/j.1471-4159.2010.06976.x; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Scemes E, 2008, GLIA, V56, P145, DOI 10.1002/glia.20598; Schalper KA, 2008, CELL COMMUN ADHES, V15, P207, DOI 10.1080/15419060802014198; Schalper KA, 2010, AM J PHYSIOL-CELL PH, V299, pC1504, DOI 10.1152/ajpcell.00015.2010; Shen DB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1735; Siller-Jackson AJ, 2008, J BIOL CHEM, V283, P26374, DOI 10.1074/jbc.M803136200; Skaper SD, 2010, FASEB J, V24, P337, DOI 10.1096/fj.09-138883; Smith D, 2009, NEUROBIOL DIS, V36, P242, DOI 10.1016/j.nbd.2009.07.010; Suadicani SO, 2012, GLIA, V60, P1106, DOI 10.1002/glia.22338; Suzuki H, 2003, PEDIATR INT, V45, P1, DOI 10.1046/j.1442-200X.2003.01651.x; Vazquez MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028777; Walkley SU, 2004, BBA-MOL CELL BIOL L, V1685, P48, DOI 10.1016/j.bbalip.2004.08.011; Xu S, 2010, NEUROSCIENCE, V167, P608, DOI 10.1016/j.neuroscience.2010.02.033; Xu SJ, 2011, NEUROSCI LETT, V496, P54, DOI 10.1016/j.neulet.2011.03.097; Yu T, 2011, HUM MOL GENET, V20, P4440, DOI 10.1093/hmg/ddr372; Yu WX, 2005, J BIOL CHEM, V280, P11731, DOI 10.1074/jbc.M412898200; Zaaraoui W, 2011, MOL GENET METAB, V103, P138, DOI 10.1016/j.ymgme.2011.02.013; Zampieri S, 2009, J CELL MOL MED, V13, P3786, DOI 10.1111/j.1582-4934.2008.00493.x; Zhan HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039489; Zhang M, 2008, J NEUROSCI RES, V86, P2848, DOI 10.1002/jnr.21730; ZWIJSEN RML, 1992, EUR J PHARM-ENVIRON, V228, P115, DOI 10.1016/0926-6917(92)90020-D	87	25	25	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71361	10.1371/journal.pone.0071361	http://dx.doi.org/10.1371/journal.pone.0071361			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977027	gold, Green Submitted, Green Published			2022-12-25	WOS:000323378000047
J	Sandeman, EM; Hernandez, MDV; Morris, Z; Bastin, ME; Murray, C; Gow, AJ; Corley, J; Henderson, R; Deary, IJ; Starr, JM; Wardlaw, JM				Sandeman, Elaine M.; Hernandez, Maria del Carmen Valdes; Morris, Zoe; Bastin, Mark E.; Murray, Catherine; Gow, Alan J.; Corley, Janie; Henderson, Ross; Deary, Ian J.; Starr, John M.; Wardlaw, Joanna M.			Incidental Findings on Brain MR Imaging in Older Community-Dwelling Subjects Are Common but Serious Medical Consequences Are Rare: A Cohort Study	PLOS ONE			English	Article							NEUROIMAGING RESEARCH; ABNORMALITIES; VOLUNTEERS	Objectives: Incidental findings in neuroimaging occur in 3% of volunteers. Most data come from young subjects. Data on their occurrence in older subjects and their medical, lifestyle and financial consequences are lacking. We determined the prevalence and medical consequences of incidental findings found in community-dwelling older subjects on brain magnetic resonance imaging. Design: Prospective cohort observational study. Setting: Single centre study with input from secondary care. Participants: Lothian Birth Cohort 1936, a study of cognitive ageing. Main Outcome Measures: Incidental findings identified by two consultant neuroradiologists on structural brain magnetic resonance imaging at age 73 years; resulting medical referrals and interventions. Primary and Secondary Outcome Measures: Prevalence of incidental findings by individual categories: neoplasms, cysts, vascular lesions, developmental, ear, nose or throat anomalies, by intra- and extracranial location; visual rating of white matter hyperintensities and brain atrophy. Results: There were 281 incidental findings in 223 (32%) of 700 subjects, including 14 intra-or extracranial neoplasms (2%), 15 intracranial vascular anomalies (2%), and 137 infarcts or haemorrhages (20%). Additionally, 153 had moderate/severe deep white matter hyperintensities (22%) and 176 had cerebral atrophy at, or above, the upper limit of normal (25%) compared with a normative population template. The incidental findings were unrelated to white matter hyperintensities or atrophy; about a third of subjects had both incidental findings and moderate or severe WMH and a quarter had incidental findings and atrophy. The incidental findings resulted in one urgent and nine non-urgent referrals for further medical assessment, but ultimately in no new treatments. Conclusions: In community-dwelling older subjects, incidental findings, including white matter hyperintensities and atrophy, were common. However, many findings were not of medical importance and, in this age group, most did not result in further assessment and none in change of treatment.	[Sandeman, Elaine M.; Hernandez, Maria del Carmen Valdes; Morris, Zoe; Bastin, Mark E.; Wardlaw, Joanna M.] Univ Edinburgh, Brain Res Imaging Ctr, Div Clin Neurosci, Edinburgh, Midlothian, Scotland; [Hernandez, Maria del Carmen Valdes; Bastin, Mark E.; Gow, Alan J.; Deary, Ian J.; Starr, John M.; Wardlaw, Joanna M.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Hernandez, Maria del Carmen Valdes; Morris, Zoe; Bastin, Mark E.; Wardlaw, Joanna M.] Univ Edinburgh, Dept Clin Neurosci, SINAPSE Collaborat, Edinburgh, Midlothian, Scotland; [Murray, Catherine; Gow, Alan J.; Corley, Janie; Henderson, Ross; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Starr, John M.] Western Gen Hosp, Dept Med Elderly, Edinburgh EH4 2XU, Midlothian, Scotland; [Starr, John M.] Univ Edinburgh, Alzheimer Scotland Dementia Res Ctr, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh	Wardlaw, JM (corresponding author), Univ Edinburgh, Brain Res Imaging Ctr, Div Clin Neurosci, Edinburgh, Midlothian, Scotland.	joanna.wardlaw@ed.ac.uk	Deary, Ian J/C-6297-2009; Gow, Alan J/A-6070-2009; Hernandez, María/GYU-3543-2022; Wardlaw, Joanna M/Y-3456-2019	Deary, Ian J/0000-0002-1733-263X; Gow, Alan J/0000-0002-3320-4531; Wardlaw, Joanna M/0000-0002-9812-6642; Bastin, Mark/0000-0002-0490-0845	Research Into Ageing programme grant; Age UK; Medical Research Council; Scottish Funding Council through the SINAPSE Collaboration; Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council; Economic and Social Research Council; Medical Research Council [G0700704, G1001245, MR/K026992/1] Funding Source: researchfish; MRC [G1001245, G0700704] Funding Source: UKRI	Research Into Ageing programme grant; Age UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Scottish Funding Council through the SINAPSE Collaboration; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Research Into Ageing programme grant (to IJD and JMS) and the Age UK-funded Disconnected Mind project (http://www.disconnectedmind.ed.ac.uk; to IJD, JMS and JMW), with additional funding from the Medical Research Council (to IJD, JMS, JMW and MEB). JMW is supported by the Scottish Funding Council through the SINAPSE Collaboration (http://www.sinapse.ac.uk). The imaging was performed at the Brain Research Imaging Centre, University of Edinburgh (http://www.bric.ed.ac.uk), a centre in the SINAPSE Collaboration. This work was performed in collaboration with The University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology (http://www.ccace.ed.ac.uk), part of the cross council Lifelong Health and Wellbeing Initiative (G0700704/84698). Funding from the Biotechnology and Biological Sciences Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council, and the Medical Research Council is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, Nature, V434, P17; Booth TC, 2012, BRIT J RADIOL, V85, P11, DOI 10.1259/bjr/73283917; Deary Ian J, 2007, BMC Geriatr, V7, P28, DOI 10.1186/1471-2318-7-28; Farrell C, 2009, EUR RADIOL, V19, P177, DOI 10.1007/s00330-008-1119-2; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hartwigsen G, 2010, J COMPUT ASSIST TOMO, V34, P596, DOI 10.1097/RCT.0b013e3181d9c2bb; Hayward R, 2003, BRIT MED J, V326, P1273, DOI 10.1136/bmj.326.7401.1273; Illes J, 2006, SCIENCE, V311, P783, DOI 10.1126/science.1124665; Illes J, 2004, J MAGN RESON IMAGING, V20, P743, DOI 10.1002/jmri.20180; Katzman GL, 1999, JAMA-J AM MED ASSOC, V282, P36, DOI 10.1001/jama.282.1.36; Kirkwood TB., 2008, FORESIGHT MENTAL CAP; Kirschen MP, 2006, J MAGN RESON IMAGING, V23, P205, DOI 10.1002/jmri.20499; Lumbreras B, 2010, BRIT J RADIOL, V83, P276, DOI 10.1259/bjr/98067945; Morris Z, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3016; Nuffield Council of Bioethics, 2010, MED PROF ONL MED ETH; Stone JH, 2006, NEW ENGL J MED, V354, P2748, DOI 10.1056/NEJMp058264; The Royal College of Radiologists, 2011, MAN INC FIND DET RES; UK Biobank Ethics and Governance Council, 2009, INV PUBL BIOB RES GO; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Wardlaw JM, 2011, INT J STROKE, V6, P547, DOI 10.1111/j.1747-4949.2011.00683.x; Warlow C, 2009, BRIT MED J, V338, P1274; Wellcome Trust Medical Research Council Opinion Leader, 2012, ASS PUBL ATT HLTH RE; Wolf SM, 2008, J LAW MED ETHICS, V36, P219, DOI 10.1111/j.1748-720X.2008.00266.x; Yue NC, 1997, RADIOLOGY, V202, P41, DOI 10.1148/radiology.202.1.8988190	25	41	41	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71467	10.1371/journal.pone.0071467	http://dx.doi.org/10.1371/journal.pone.0071467			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967214	Green Published, gold, Green Submitted			2022-12-25	WOS:000323378000052
J	Demirbas, D; Wyman, AR; Shimizu-Albergine, M; Cakici, O; Beavo, JA; Hoffman, CS				Demirbas, Didem; Wyman, Arlene R.; Shimizu-Albergine, Masami; Cakici, Ozgur; Beavo, Joseph A.; Hoffman, Charles S.			A Yeast-Based Chemical Screen Identifies a PDE Inhibitor That Elevates Steroidogenesis in Mouse Leydig Cells via PDE8 and PDE4 Inhibition	PLOS ONE			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; HIGH-THROUGHPUT SCREEN; SCHIZOSACCHAROMYCES-POMBE; MOLECULAR-CLONING; T-LYMPHOCYTES; GENE; EXPRESSION; 8A; MACROPHAGES; SELECTIVITY	A cell-based high-throughput screen (HTS) was developed to detect phosphodiesterase 8 (PDE8) and PDE4/8 combination inhibitors. By replacing the Schizosaccharomyces pombe PDE gene with the murine PDE8A1 gene in strains lacking adenylyl cyclase, we generated strains whose protein kinase A (PKA)-stimulated growth in 5-fluoro orotic acid (5FOA) medium reflects PDE8 activity. From our previously-identified PDE4 and PDE7 inhibitors, we identified a PDE4/8 inhibitor that allowed us to optimize screening conditions. Of 222,711 compounds screened, similar to 0.2% displayed composite Z scores of >20. Additional yeast-based assays using the most effective 367 compounds identified 30 candidates for further characterization. Among these, compound BC8-15 displayed the lowest IC50 value for both PDE4 and PDE8 inhibition in in vitro enzyme assays. This compound also displays significant activity against PDE10A and PDE11A. BC8-15 elevates steroidogenesis in mouse Leydig cells as a single pharmacological agent. Assays using BC8-15 and two structural derivatives support a model in which PDE8 is a primary regulator of testosterone production by Leydig cells, with an additional role for PDE4 in this process. BC8-15, BC8-15A, and BC8-15C, which are commercially available compounds, display distinct patterns of activity against PDE4, PDE8, PDE10A, and PDE11A, representing a chemical toolkit that could be used to examine the biological roles of these enzymes in cell culture systems.	[Demirbas, Didem; Wyman, Arlene R.; Cakici, Ozgur; Hoffman, Charles S.] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA; [Shimizu-Albergine, Masami; Beavo, Joseph A.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	Boston College; University of Washington; University of Washington Seattle	Hoffman, CS (corresponding author), Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA.	hoffmacs@bc.edu		Demirbas, Didem/0000-0003-2865-2708; Hoffman, Charles/0000-0001-8700-1863	Peter Rieser Lectureship Fund; Boston College; National Institutes of Health (NIH) [R21GM079662, R01GM083926-05]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083926, R21GM079662] Funding Source: NIH RePORTER	Peter Rieser Lectureship Fund; Boston College; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Peter Rieser Lectureship Fund, a grant from Boston College and by National Institutes of Health (NIH) grant R21GM079662 (C. S. H.) and by NIH grant R01GM083926-05 (J.A.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaamery MA, 2010, J BIOMOL SCREEN, V15, P359, DOI 10.1177/1087057110362100; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Bol SM, 2011, VIROLOGY, V420, P32, DOI 10.1016/j.virol.2011.08.013; Ceyhan O, 2012, CHEM BIOL, V19, P155, DOI 10.1016/j.chembiol.2011.12.010; D'Andrea MR, 2005, J HISTOCHEM CYTOCHEM, V53, P895, DOI 10.1369/jhc.5A6625.2005; Demirbas D, 2011, HANDB EXP PHARMACOL, V204, P135, DOI 10.1007/978-3-642-17969-3_5; Demirbas D, 2011, CELL SIGNAL, V23, P594, DOI 10.1016/j.cellsig.2010.11.013; DeNinno MP, 2011, BIOORG MED CHEM LETT, V21, P3095, DOI 10.1016/j.bmcl.2011.03.022; Dong HL, 2006, BIOCHEM BIOPH RES CO, V345, P713, DOI 10.1016/j.bbrc.2006.04.143; Fawcett L, 2000, P NATL ACAD SCI USA, V97, P3702, DOI 10.1073/pnas.050585197; Glavas NA, 2001, P NATL ACAD SCI USA, V98, P6319, DOI 10.1073/pnas.101131098; Gutz H, 1974, HDB GENETICS, P395, DOI 10.1007/978-1-4899-1710-2_25; Haider SG, 2007, ENDOCRINOLOGY, V148, P2581, DOI 10.1210/en.2007-0330; Hayashi M, 1998, BIOCHEM BIOPH RES CO, V250, P751, DOI 10.1006/bbrc.1998.9379; Hoffman CS, 2005, BIOCHEM SOC T, V33, P257, DOI 10.1042/BST0330257; HOFFMAN CS, 1990, GENETICS, V124, P807; Horvath A, 2008, EUR J HUM GENET, V16, P1245, DOI 10.1038/ejhg.2008.85; Iacob RE, 2009, P NATL ACAD SCI USA, V106, P1386, DOI 10.1073/pnas.0811912106; Ivey FD, 2008, J BIOMOL SCREEN, V13, P62, DOI 10.1177/1087057107312127; Ivey FD, 2010, EUKARYOT CELL, V9, P626, DOI 10.1128/EC.00010-10; Kadoshima-Yamaoka K, 2009, IMMUNOL LETT, V122, P193, DOI 10.1016/j.imlet.2009.01.004; MELLON SH, 1989, P NATL ACAD SCI USA, V86, P7775, DOI 10.1073/pnas.86.20.7775; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Patrucco E, 2010, J MOL CELL CARDIOL, V49, P330, DOI 10.1016/j.yjmcc.2010.03.016; Seiler KP, 2008, NUCLEIC ACIDS RES, V36, pD351, DOI 10.1093/nar/gkm843; Shimizu-Albergine M, 2012, MOL PHARMACOL, V81, P556, DOI 10.1124/mol.111.076125; Smith SJ, 2004, MOL PHARMACOL, V66, P1679, DOI 10.1124/mol.104.002246; Soderling SH, 1998, P NATL ACAD SCI USA, V95, P8991, DOI 10.1073/pnas.95.15.8991; Tsai LCL, 2011, MOL PHARMACOL, V79, P639, DOI 10.1124/mol.110.069104; Vang AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012011; Vasta V, 2006, P NATL ACAD SCI USA, V103, P19925, DOI 10.1073/pnas.0609483103; Wang HC, 2005, J BIOL CHEM, V280, P30949, DOI 10.1074/jbc.M504398200; Wang HC, 2008, BIOCHEMISTRY-US, V47, P12760, DOI 10.1021/bi801487x; Wang LL, 2005, GENETICS, V171, P1523, DOI 10.1534/genetics.105.047233; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	35	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71279	10.1371/journal.pone.0071279	http://dx.doi.org/10.1371/journal.pone.0071279			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967182	Green Submitted, Green Published, gold			2022-12-25	WOS:000323221500069
J	Liu, LF; Shen, WJ; Ueno, M; Patel, S; Azhar, S; Kraemer, FB				Liu, Li-Fen; Shen, Wen-Jun; Ueno, Masami; Patel, Shailja; Azhar, Salman; Kraemer, Fredric B.			Age-Related Modulation of the Effects of Obesity on Gene Expression Profiles of Mouse Bone Marrow and Epididymal Adipocytes	PLOS ONE			English	Article							HIGH-FAT DIET; SUBCUTANEOUS ADIPOSE-TISSUE; INSULIN-RESISTANCE; ENERGY-METABOLISM; MICE; MECHANISMS; MICROARRAY; DEPOT; PATTERNS; IMPACT	This study aimed to characterize and compare the effects of obesity on gene expression profiles in two distinct adipose depots, epididymal and bone marrow, at two different ages in mice. Alterations in gene expression were analyzed in adipocytes isolated from diet-induced obese (DIO) C57BL/6J male mice at 6 and 14 months of age and from leptin deficient mice (ob/ob) at 6 months of age using microarrays. DIO affected gene expression in both depots at 6 and 14 months, but more genes were altered in epididymal than bone marrow adipocytes at each age and younger mice displayed more changes than older animals. In epididymal adipocytes a total of 2789 (9.6%) genes were differentially expressed at 6-months with DIO, whereas 952 (3.3%) were affected at 14-months. In bone marrow adipocytes, 347 (1.2%) genes were differentially expressed at 6-months with DIO, whereas only 189 (0.66%) were changed at 14-months. 133 genes were altered by DIO in both fat depots at 6-months, and 37 genes at 14-months. Only four genes were altered in both depots at both ages with DIO. Bone marrow adipocytes are less responsive to DIO than epididymal adipocytes and the response of both depots to DIO declines with age. This loss of responsiveness with age is likely due to age-associated changes in expression of genes related to adipogenesis, inflammation and mitochondrial function that are similar to and obscure the changes commonly associated with DIO. Patterns of gene expression were generally similar in epididymal adipocytes from ob/ob and DIO mice; however, several genes were differentially expressed in bone marrow adipocytes from ob/ob and DIO mice, perhaps reflecting the importance of leptin signaling for bone metabolism. In conclusion, obesity affects age-associated alterations in gene expression in both epididymal and bone marrow adipocytes regardless of diet or genetic background.	[Liu, Li-Fen; Shen, Wen-Jun; Ueno, Masami; Patel, Shailja; Kraemer, Fredric B.] Stanford Univ, Div Endocrinol, Stanford, CA 94305 USA; [Liu, Li-Fen; Shen, Wen-Jun; Ueno, Masami; Patel, Shailja; Azhar, Salman; Kraemer, Fredric B.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Kraemer, FB (corresponding author), Stanford Univ, Div Endocrinol, Stanford, CA 94305 USA.	fbk@stanford.edu	Kraemer, Fredric/AAC-3633-2019	Shen, Wen-Jun/0000-0001-5150-1698; Kraemer, Fredric/0000-0003-2468-7807	Department of Veterans Affairs (Office of Research and Development, Medical Research Service); National Institutes of Health [R01 AG028098]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033881] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000398] Funding Source: NIH RePORTER	Department of Veterans Affairs (Office of Research and Development, Medical Research Service)(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by the Department of Veterans Affairs (Office of Research and Development, Medical Research Service) and by grant R01 AG028098 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caesar R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011525; Cartwright MJ, 2007, EXP GERONTOL, V42, P463, DOI 10.1016/j.exger.2007.03.003; Chen JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013704; Deng T, 2013, CELL METAB, V17, P411, DOI 10.1016/j.cmet.2013.02.009; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Fazeli PK, 2013, J CLIN ENDOCR METAB, V98, P935, DOI 10.1210/jc.2012-3634; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Frayn KN, 2000, BRIT J NUTR, V83, pS71, DOI 10.1017/S0007114500000982; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; Gomez-Ambrosi J, 2004, FASEB J, V18, P215, DOI 10.1096/fj.03-0591fje; Graham LS, 2010, J BONE MINER RES, V25, P2460, DOI 10.1002/jbmr.148; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Halade GV, 2010, J NUTR BIOCHEM, V21, P1162, DOI 10.1016/j.jnutbio.2009.10.002; Kabir M, 2005, AM J PHYSIOL-ENDOC M, V288, pE454, DOI 10.1152/ajpendo.00203.2004; Karsenty G, 2010, J CLIN ENDOCR METAB, V95, P4795, DOI 10.1210/jc.2010-1030; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kleemann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008817; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; KROTKIEWSKI M, 1983, J CLIN INVEST, V72, P1150, DOI 10.1172/JCI111040; Kursawe R, 2010, DIABETES, V59, P2288, DOI 10.2337/db10-0113; Lee MJ, 2011, AM J PHYSIOL-ENDOC M, V300, pE571, DOI 10.1152/ajpendo.00231.2010; Liu LF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-212; Majka SM, 2010, P NATL ACAD SCI USA, V107, P14781, DOI 10.1073/pnas.1003512107; Moraes RC, 2003, ENDOCRINOLOGY, V144, P4773, DOI 10.1210/en.2003-0456; Nadler ST, 2000, P NATL ACAD SCI USA, V97, P11371, DOI 10.1073/pnas.97.21.11371; Parhami F, 2001, J BONE MINER RES, V16, P182, DOI 10.1359/jbmr.2001.16.1.182; Patsch JM, 2011, METABOLISM, V60, P243, DOI 10.1016/j.metabol.2009.11.023; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; Rodriguez-Acebes S, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-61; Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135; Shen WJ, 2007, BBA-MOL CELL BIOL L, V1771, P177, DOI 10.1016/j.bbalip.2006.11.009; Soukas A, 2000, GENE DEV, V14, P963; Tchkonia T, 2002, AM J PHYSIOL-REG I, V282, pR1286, DOI 10.1152/ajpregu.00653.2001; Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x; Tchoukalova YD, 2010, P NATL ACAD SCI USA, V107, P18226, DOI 10.1073/pnas.1005259107; Van Schothorst EM, 2005, OBES RES, V13, P1031, DOI 10.1038/oby.2005.121	37	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e72367	10.1371/journal.pone.0072367	http://dx.doi.org/10.1371/journal.pone.0072367			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967297	Green Published, gold, Green Submitted			2022-12-25	WOS:000323221500129
J	Pogosova-Agadjanyan, EL; Kopecky, KJ; Ostronoff, F; Appelbaum, FR; Godwin, J; Lee, H; List, AF; May, JJ; Oehler, VG; Petersdorf, S; Pogosov, GL; Radich, JP; Willman, CL; Meshinchi, S; Stirewalt, DL				Pogosova-Agadjanyan, Era L.; Kopecky, Kenneth J.; Ostronoff, Fabiana; Appelbaum, Frederick R.; Godwin, John; Lee, Hana; List, Alan F.; May, Jennifer J.; Oehler, Vivian G.; Petersdorf, Steve; Pogosov, Galina L.; Radich, Jerald P.; Willman, Cheryl L.; Meshinchi, Soheil; Stirewalt, Derek L.			The Prognostic Significance of IRF8 Transcripts in Adult Patients with Acute Myeloid Leukemia	PLOS ONE			English	Article							SEQUENCE-BINDING-PROTEIN; SOUTHWEST-ONCOLOGY-GROUP; PROGENITOR CELLS; REGULATORY FACTOR-8; ELDERLY-PATIENTS; EXPRESSION; GENE; IDENTIFICATION; MACROPHAGES; ICSBP/IRF-8	Interferon regulatory factor 8 (IRF8) is a transcription factor that plays a critical role in normal hematopoiesis, such that disruption of IRF8 activity promotes leukemogenesis. We and others have identified aberrant expression of IRF8 transcripts, including novel splice variants, in acute myeloid leukemia (AML), but studies have not investigated the prognostic significance of these transcripts. Therefore, we developed and optimized quantitative expression assays for both, the wild type, or the reference sequence (WT-IRF8) and novel splice variants (SV-IRF8). These assays were used to quantify IRF8 transcript levels in 194 adult patients with AML, and multivariate analyses investigated the prognostic significance of these expression levels. After adjusting for known prognostic factors, expression levels of WT- or SV-IRF8 transcripts were not significantly associated with complete responses or overall survival. However, increased expression of WT-IRF8 was associated with decreased relapse-free survival (RFS) in both univariate (P = 0.010) and multivariate (P = 0.019) analyses. Similarly, increased expression of SV-IRF8 was associated with a decreased RFS (univariate, P = 0.026 and multivariate, P = 0.021). These studies show for the first time that WT-IRF8 and SV-IRF8 are independent adverse prognostic factors for patients with AML. Additional studies are planned to examine the prognostic significance of IRF8 transcripts in other populations of AML patients.	[Pogosova-Agadjanyan, Era L.; Ostronoff, Fabiana; Appelbaum, Frederick R.; Lee, Hana; May, Jennifer J.; Oehler, Vivian G.; Pogosov, Galina L.; Radich, Jerald P.; Meshinchi, Soheil; Stirewalt, Derek L.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Kopecky, Kenneth J.] Fred Hutchinson Canc Res Ctr, Southwest Oncol Grp Stat Ctr, Seattle, WA 98104 USA; [Ostronoff, Fabiana; Appelbaum, Frederick R.; Oehler, Vivian G.; Radich, Jerald P.; Stirewalt, Derek L.] Univ Washington, Dept Oncol, Seattle, WA 98195 USA; [Godwin, John] Earle A Chiles Res Inst, Providence Canc Ctr Grp, Portland, OR USA; [List, Alan F.] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA; [Petersdorf, Steve] Seattle Genet Inc, Bothell, WA USA; [Willman, Cheryl L.] Univ New Mexico, Canc Res & Treatment Ctr, Albuquerque, NM 87131 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Southwest Oncology Group; University of Washington; University of Washington Seattle; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Seattle Genetics; University of New Mexico	Stirewalt, DL (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	dstirewa@fhcrc.org		LIST, ALAN/0000-0002-1647-2972; Godwin, John/0000-0003-3876-2505	National Institute of Health [CA114563, CA160872, CA139256]; National Cancer Institute [DHHS: CA32102, CA38926]; NATIONAL CANCER INSTITUTE [R01CA160872, R01CA114563, U10CA032102, U10CA038926, R21CA139256] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by National Institute of Health grant numbers CA114563 (DLS), CA160872 (DLS), CA139256 (SM), and by the following PHS Cooperative Agreement grant numbers awarded by the National Cancer Institute, DHHS: CA32102 and CA38926. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JE, 2002, BLOOD, V100, P3869, DOI 10.1182/blood-2001-12-0354; Becker AM, 2012, BLOOD, V119, P2003, DOI 10.1182/blood-2011-06-364976; Diaz-Blanco E, 2007, LEUKEMIA, V21, P494, DOI 10.1038/sj.leu.2404549; Godwin JE, 1998, BLOOD, V91, P3607, DOI 10.1182/blood.V91.10.3607.3607_3607_3615; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Lee KY, 2008, ONCOGENE; List AF, 2001, BLOOD, V98, P3212, DOI 10.1182/blood.V98.12.3212; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucioni M, 2011, BLOOD, V118, P4591, DOI 10.1182/blood-2011-03-337501; Ostronoff F, 2012, LEUKEMIA; Petersdorf SH, 2007, AM J HEMATOL, V82, P1056, DOI 10.1002/ajh.20994; Qian ZJ, 2002, P NATL ACAD SCI USA, V99, P14925, DOI 10.1073/pnas.222491799; Scheller M, 1999, BLOOD, V94, P3764, DOI 10.1182/blood.V94.11.3764.423k03_3764_3771; Schmidt M, 2004, BLOOD, V103, P4142, DOI 10.1182/blood-2003-01-0285; Schmidt M, 1998, BLOOD, V91, P22, DOI 10.1182/blood.V91.1.22.22_22_29; Schmidt M, 2001, BLOOD, V97, P3648, DOI 10.1182/blood.V97.11.3648; Schwieger M, 2002, J EXP MED, V196, P1227, DOI 10.1084/jem.20020824; Silva FPG, 2009, BLOOD, V114, P3001, DOI 10.1182/blood-2009-03-211334; Stirewalt DL, 2009, LEUKEMIA, V23, P391, DOI 10.1038/leu.2008.176; Stirewalt DL, 2008, GENE CHROMOSOME CANC, V47, P8, DOI 10.1002/gcc.20500; Stirewalt DL, 2006, BLOOD, V107, P3724, DOI 10.1182/blood-2005-08-3453; Stirewalt DL, 2001, BLOOD, V97, P3589, DOI 10.1182/blood.V97.11.3589; Tamura T, 2000, IMMUNITY, V13, P155, DOI 10.1016/S1074-7613(00)00016-9; Tamura T, 2005, BLOOD, V106, P1938, DOI 10.1182/blood-2005-01-0080; Tsujimura H, 2003, BLOOD, V101, P961, DOI 10.1182/blood-2002-05-1327; Tsujimura H, 2002, J IMMUNOL, V169, P1261, DOI 10.4049/jimmunol.169.3.1261; Turcotte K, 2005, J EXP MED, V201, P881, DOI 10.1084/jem.20042170; Yang DF, 2007, CANCER RES, V67, P3301, DOI 10.1158/0008-5472.CAN-06-4068; Zhu CL, 2004, J BIOL CHEM, V279, P50874, DOI 10.1074/jbc.M405736200	29	12	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e70812	10.1371/journal.pone.0070812	http://dx.doi.org/10.1371/journal.pone.0070812			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967110	gold, Green Submitted, Green Published			2022-12-25	WOS:000323221500034
J	Zanchi, C; Locatelli, M; Benigni, A; Corna, D; Tomasoni, S; Rottoli, D; Gaspari, F; Remuzzi, G; Zoja, C				Zanchi, Cristina; Locatelli, Monica; Benigni, Ariela; Corna, Daniela; Tomasoni, Susanna; Rottoli, Daniela; Gaspari, Flavio; Remuzzi, Giuseppe; Zoja, Carlamaria			Renal Expression of FGF23 in Progressive Renal Disease of Diabetes and the Effect of Ace Inhibitor	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GROWTH-FACTOR 23; RAT MODEL; KLOTHO; RECEPTOR; FGF-23; GENE; HYPERTROPHY; ENZYME	Fibroblast growth factor 23 (FGF23) is a phosphaturic hormone mainly produced by bone that acts in the kidney through FGF receptors and Klotho. Here we investigated whether the kidney was an additional source of FGF23 during renal disease using a model of type 2 diabetic nephropathy. Renal expression of FGF23 and Klotho was assessed in Zucker diabetic fatty (ZDF) and control lean rats at 2, 4, 6, 8 months of age. To evaluate whether the renoprotective effect of angiotensin converting enzyme (ACE) inhibitor in this model was associated with changes in FGF23 and Klotho, ZDF rats received ramipril from 4, when proteinuric, to 8 months of age. FGF23 mRNA was not detectable in the kidney of lean rats, nor of ZDF rats at 2 months of age. FGF23 became measurable in the kidney of diabetic rats at 4 months and significantly increased thereafter. FGF23 protein localized in proximal and distal tubules. Renal Klotho mRNA and protein decreased during time in ZDF rats. As renal disease progressed, serum phosphate levels increased in parallel with decline of fractional phosphorus excretion. Ramipril limited proteinuria and renal injury, attenuated renal FGF23 upregulation and ameliorated Klotho expression. Ramipril normalized serum phosphate levels and tended to increase fractional phosphorus excretion. These data indicate that during progressive renal disease the kidney is a site of FGF23 production which is limited by ACE inhibition. Interfering pharmacologically with the delicate balance of FGF23 and phosphorus in diabetes may have implications in clinics.	[Zanchi, Cristina; Locatelli, Monica; Benigni, Ariela; Corna, Daniela; Tomasoni, Susanna; Rottoli, Daniela; Remuzzi, Giuseppe; Zoja, Carlamaria] IRCCS Ist Ric Farmacol Mario Negri, Ctr Anna Maria Astori, Bergamo, Italy; [Gaspari, Flavio; Remuzzi, Giuseppe] IRCCS Ist Ric Farmacol Mario Negri, Clin Res Ctr Rare Dis Aldo & Cele Dacco, Bergamo, Italy; [Remuzzi, Giuseppe] Azienda Osped Papa Giovanni XXIII, Unit Nephrol & Dialysis, Bergamo, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; ASST Papa Giovanni XXIII	Zoja, C (corresponding author), IRCCS Ist Ric Farmacol Mario Negri, Ctr Anna Maria Astori, Sci & Technol Pk Kilometro Rosso, Bergamo, Italy.	carlamaria.zoja@marionegri.it	Zanchi, Cristina/ABF-4548-2020; Corna, Daniela/ABF-4496-2020; Rottoli, Daniela/ABF-4290-2020; zoja, carlamaria/ABF-5896-2020; Ariela, Benigni/ABH-3492-2020; Tomasoni, Susanna/ABF-5747-2020; Remuzzi, Giuseppe/V-9766-2017	Zanchi, Cristina/0000-0002-1386-1868; Corna, Daniela/0000-0002-7907-3047; Rottoli, Daniela/0000-0002-2282-871X; zoja, carlamaria/0000-0003-2507-8894; Ariela, Benigni/0000-0002-4721-5485; Tomasoni, Susanna/0000-0002-7212-2512; Remuzzi, Giuseppe/0000-0002-6194-3446; Locatelli, Monica/0000-0002-1395-3172	European Community [241544]	European Community(European Commission)	The research leading to these results has received funding from the European Community's Seventh Framework Programme under the grant agreement no 241544 (SysKid). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baylis C, 2003, J PHARMACOL EXP THER, V307, P854, DOI 10.1124/jpet.103.055616; de Borst MH, 2011, J AM SOC NEPHROL, V22, P1603, DOI 10.1681/ASN.2010121251; Farrow EG, 2009, J AM SOC NEPHROL, V20, P955, DOI 10.1681/ASN.2008070783; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Forster IC, 2006, KIDNEY INT, V70, P1548, DOI 10.1038/sj.ki.5001813; Fredersdorf S, 2004, CARDIOVASC PATHOL, V13, P11, DOI 10.1016/S1054-8807(03)00109-1; Gattineni J, 2009, AM J PHYSIOL-RENAL, V297, pF282, DOI 10.1152/ajprenal.90742.2008; Gutierrez OM, 2009, CIRCULATION, V119, P2545, DOI 10.1161/CIRCULATIONAHA.108.844506; Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765; Juppner H, 2011, KIDNEY INT, V79, pS24, DOI 10.1038/ki.2011.27; Koh N, 2001, BIOCHEM BIOPH RES CO, V280, P1015, DOI 10.1006/bbrc.2000.4226; Kuro-O M, 2012, CURR OPIN NEPHROL HY, V21, P362, DOI 10.1097/MNH.0b013e32835422ad; Kuro-o M, 2010, PEDIATR NEPHROL, V25, P583, DOI 10.1007/s00467-009-1260-4; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Liu SG, 2003, J BIOL CHEM, V278, P37419, DOI 10.1074/jbc.M304544200; Liu SG, 2006, J AM SOC NEPHROL, V17, P1305, DOI 10.1681/ASN.2005111185; Mendoza FA, 2012, CLIN J AM SOC NEPHRO, V7, P1155, DOI 10.2215/CJN.13281211; Mirams M, 2004, BONE, V35, P1192, DOI 10.1016/j.bone.2004.06.014; Mitani H, 2002, HYPERTENSION, V39, P838, DOI 10.1161/01.HYP.0000013734.33441.EA; Saji F, 2009, NEPHRON PHYSIOL, V111, P59, DOI 10.1159/000210389; Schafer S, 2003, CARDIOVASC RES, V60, P447, DOI 10.1016/S0008-6363(03)00544-3; Seiler S, 2009, KIDNEY INT, V76, pS34, DOI 10.1038/ki.2009.405; Shalhoub V, 2012, J CLIN INVEST, V122, P2543, DOI 10.1172/JCI61405; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Sugiura H, 2012, AM J PHYSIOL-RENAL, V302, pF1252, DOI 10.1152/ajprenal.00294.2011; Tang WJ, 2010, CALCIFIED TISSUE INT, V86, P404, DOI 10.1007/s00223-010-9355-2; Titan SM, 2011, CLIN J AM SOC NEPHRO, V6, P241, DOI 10.2215/CJN.04250510; Toblli JE, 2009, NEPHROL DIAL TRANSPL, V24, P2384, DOI 10.1093/ndt/gfp103; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Vervloet MG, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-20; Wolf M, 2010, J AM SOC NEPHROL, V21, P1427, DOI 10.1681/ASN.2009121293; Yilmaz MI, 2010, KIDNEY INT, V78, P679, DOI 10.1038/ki.2010.194; Yoon HE, 2011, NEPHROL DIAL TRANSPL, V26, P800, DOI 10.1093/ndt/gfq537; Yoshiko Y, 2007, BONE, V40, P1565, DOI 10.1016/j.bone.2007.01.017; Zhao YH, 2011, DIABETES, V60, P1907, DOI 10.2337/db10-1262; Zoja C, 2011, AM J PHYSIOL-RENAL, V301, pF1114, DOI 10.1152/ajprenal.00122.2011	36	70	76	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e70775	10.1371/journal.pone.0070775	http://dx.doi.org/10.1371/journal.pone.0070775			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967103	Green Submitted, Green Published, gold			2022-12-25	WOS:000323221500029
J	Floc'h, N; Kolodziejski, J; Akkari, L; Simonin, Y; Ansieau, S; Puisieux, A; Hibner, U; Lassus, P				Floc'h, Nicolas; Kolodziejski, Jakub; Akkari, Leila; Simonin, Yannick; Ansieau, Stephane; Puisieux, Alain; Hibner, Urszula; Lassus, Patrice			Modulation of Oxidative Stress by Twist Oncoproteins	PLOS ONE			English	Article								Expression of developmental genes Twist1 and Twist2 is reactivated in many human tumors. Among their oncogenic activities, induction of epithelial to mesenchymal transition is believed to increase cell motility and invasiveness and may be related to acquisition of cancer stem cell phenotype. In addition, Twist proteins promote malignant conversion by overriding two oncogene-induced failsafe programs: senescence and apoptosis. Reactive oxygen species (ROS) are also important mediators of apoptosis, senescence and motility and are tightly linked to disease, notably to cancer. We report here that Twist factors and ROS are functionally linked. In wild type cells both Twist1 and Twist2 exhibit antioxidant properties. We show that Twist-driven modulation of oncogene-induced apoptosis is linked to its effects on oxidative stress. Finally, we identify several targets that mediate Twist antioxidant activity. These findings unveil a new function of Twist factors that could be important in explaining their pleiotropic role during carcinogenesis.	[Floc'h, Nicolas; Kolodziejski, Jakub; Akkari, Leila; Simonin, Yannick; Hibner, Urszula; Lassus, Patrice] Inst Genet Mol Montpellier, CNRS, UMR 5535, Montpellier, France; [Floc'h, Nicolas; Kolodziejski, Jakub; Akkari, Leila; Simonin, Yannick; Hibner, Urszula; Lassus, Patrice] Univ Montpellier I, Montpellier, France; [Floc'h, Nicolas; Kolodziejski, Jakub; Akkari, Leila; Simonin, Yannick; Hibner, Urszula; Lassus, Patrice] Univ Montpellier 2, Montpellier, France; [Ansieau, Stephane; Puisieux, Alain] INSERM, UMR S1052, Ctr Rech Cancerol Lyon, F-69008 Lyon, France; [Ansieau, Stephane; Puisieux, Alain] CNRS, UMR 5286, Ctr Rech Cancerol Lyon, Lyon, France; [Ansieau, Stephane; Puisieux, Alain] Univ Unite Mixte Rech UMR 1052, Ctr Rech Cancerol Lyon, Lyon, France; [Ansieau, Stephane; Puisieux, Alain] Univ Lyon, Lyon, France; [Puisieux, Alain] Ctr Leon Berard, F-69373 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UNICANCER; Centre Leon Berard; UNICANCER; Centre Leon Berard; UNICANCER; Centre Leon Berard	Lassus, P (corresponding author), Inst Genet Mol Montpellier, CNRS, UMR 5535, Montpellier, France.	patrice.lassus@igmm.cnrs.fr	Ansieau, Stephane/I-6195-2016	Hibner, Urszula/0000-0002-5520-7311; PUISIEUX, Alain/0000-0002-9938-3798; Akkari, Leila/0000-0001-5479-641X; simonin, yannick/0000-0002-3475-1369; ANSIEAU, Stephane/0000-0003-0989-2108; Lassus, Patrice/0000-0002-2785-7843	Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National de la Recherche Scientifique (CNRS)	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM) and the Centre National de la Recherche Scientifique (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkari L, 2010, J CELL PHYSIOL, V225, P186, DOI 10.1002/jcp.22219; Ansieau S, 2010, ONCOGENE, V29, P3173, DOI 10.1038/onc.2010.92; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; ARUOMA OI, 1988, BIOCHEM J, V256, P251, DOI 10.1042/bj2560251; Barnes RM, 2009, INT J DEV BIOL, V53, P909, DOI 10.1387/ijdb.082747rb; Charrier-Savournin FB, 2004, MOL BIOL CELL, V15, P3965, DOI 10.1091/mbc.E03-12-0871; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; Dong CF, 2013, CANCER CELL, V23, P316, DOI 10.1016/j.ccr.2013.01.022; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Hu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043362; Isenmann S, 2009, STEM CELLS, V27, P2457, DOI 10.1002/stem.181; Jakobsson PJ, 1997, J BIOL CHEM, V272, P22934, DOI 10.1074/jbc.272.36.22934; Kwok WK, 2005, CANCER RES, V65, P5153, DOI 10.1158/0008-5472.CAN-04-3785; LEDENEV AN, 1986, BIOCHEM INT, V13, P391; LEPTIN M, 1991, GENE DEV, V5, P1568, DOI 10.1101/gad.5.9.1568; Lu X, 2008, ENDOCRINOLOGY, V149, P3267, DOI 10.1210/en.2008-0024; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martin-Montalvo A, 2011, ONCOGENE, V30, P505, DOI 10.1038/onc.2010.492; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Muffat J, 2008, P NATL ACAD SCI USA, V105, P7088, DOI 10.1073/pnas.0800896105; Neumeier M, 2006, BIOCHEM BIOPH RES CO, V350, P731, DOI 10.1016/j.bbrc.2006.09.101; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Pham CG, 2007, MOL CELL BIOL, V27, P3920, DOI 10.1128/MCB.01219-06; Puisieux A, 2006, BRIT J CANCER, V94, P13, DOI 10.1038/sj.bjc.6602876; Sagun KC, 2006, MUTAT RES-FUND MOL M, V593, P64, DOI 10.1016/j.mrfmmm.2005.06.015; Sharabi AB, 2008, PLOS BIOL, V6, P2786, DOI 10.1371/journal.pbio.0060316; Sosic D, 2003, CELL, V112, P169, DOI 10.1016/S0092-8674(03)00002-3; Tanaka H, 2002, MOL CELL, V9, P1017, DOI 10.1016/S1097-2765(02)00522-1; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Valsesia-Wittmann S, 2004, CANCER CELL, V6, P625, DOI 10.1016/j.ccr.2004.09.033; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Vesuna F, 2009, NEOPLASIA, V11, P1318, DOI 10.1593/neo.91084; Yang J, 2006, CANCER RES, V66, P4549, DOI 10.1158/0008-5472.CAN-05-3850	36	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e72490	10.1371/journal.pone.0072490	http://dx.doi.org/10.1371/journal.pone.0072490			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967308	Green Submitted, Green Published, gold			2022-12-25	WOS:000323115800102
J	Haorah, J; Rump, TJ; Xiong, HG				Haorah, James; Rump, Travis J.; Xiong, Huangui			Reduction of Brain Mitochondrial beta-Oxidation Impairs Complex I and V in Chronic Alcohol Intake: The Underlying Mechanism for Neurodegeneration	PLOS ONE			English	Article							ACETYL-L-CARNITINE; ETHANOL; STRESS; DYSFUNCTION; DAMAGE; BLOOD; RATS; CONSUMPTION; EXPRESSION; SECRETION	Neuropathy and neurocognitive deficits are common among chronic alcohol users, which are believed to be associated with mitochondrial dysfunction in the brain. The specific type of brain mitochondrial respiratory chain complexes (mRCC) that are adversely affected by alcohol abuse has not been studied. Thus, we examined the alterations of mRCC in freshly isolated mitochondria from mice brain that were pair-fed the ethanol (4% v/v) and control liquid diets for 7-8 weeks. We observed that alcohol intake severely reduced the levels of complex I and V. A reduction in complex I was associated with a decrease in carnitine palmitoyltransferase 1 (cPT1) and cPT2 levels. The mitochondrial outer (cPT1) and inner (cPT2) membrane transporter enzymes are specialized in acylation of fatty acid from outer to inner membrane of mitochondria for ATP production. Thus, our results showed that alterations of cPT1 and cPT2 paralleled a decrease beta-oxidation of palmitate and ATP production, suggesting that impairment of substrate entry step (complex I function) can cause a negative impact on ATP production (complex V function). Disruption of cPT1/cPT2 was accompanied by an increase in cytochrome C leakage, while reduction of complex I and V paralleled a decrease in depolarization of mitochondrial membrane potential (DY, monitored by JC-1 fluorescence) and ATP production in alcohol intake. We noted that acetyl-L-carnitine (ALC, a cofactor of cPT1 and cPT2) prevented the adverse effects of alcohol while coenzyme Q10 (CoQ10) was not very effective against alcohol insults. These results suggest that understanding the molecular, biochemical, and signaling mechanisms of the CNS mitochondrial beta-oxidation such as ALC can mitigate alcohol related neurological disorders.	[Haorah, James; Rump, Travis J.; Xiong, Huangui] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Neurovasc Oxidat Injury Lab, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center	Haorah, J (corresponding author), Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Neurovasc Oxidat Injury Lab, Omaha, NE USA.	jhaorah@unmc.edu			National Institutes of Health [AA020370-01A1, AA017398]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017398, R21AA020370] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health grants (AA020370-01A1 and AA017398 to James Haorah). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul Muneer P M, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P48; Bailey SM, 1999, FREE RADICAL BIO MED, V27, P891, DOI 10.1016/S0891-5849(99)00138-0; Cahill A, 1999, HEPATOLOGY, V30, P881, DOI 10.1002/hep.510300434; Cahill A, 2002, ALCOHOL CLIN EXP RES, V26, P907, DOI 10.1097/00000374-200206000-00022; Choksi KB, 2008, FREE RADICAL BIO MED, V45, P826, DOI 10.1016/j.freeradbiomed.2008.06.006; CULLEN KM, 1995, METAB BRAIN DIS, V10, P81, DOI 10.1007/BF01991785; Deutch SR, 2004, EUR J EMERG MED, V11, P318, DOI 10.1097/00063110-200412000-00004; Dey A, 2006, HEPATOLOGY, V43, pS63, DOI 10.1002/hep.20957; Drew B, 2003, AM J PHYSIOL-REG I, V285, pR1259, DOI 10.1152/ajpregu.00264.2003; Floreani NA, 2010, J NEUROIMMUNE PHARM, V5, P533, DOI 10.1007/s11481-010-9213-z; Frier BC, 2011, AM J PHYSIOL-REG I, V300, pR212, DOI 10.1152/ajpregu.00367.2010; Fukumoto K, 2004, BBA-MOL CELL BIOL L, V1683, P1, DOI 10.1016/j.bbalip.2004.03.006; Gyamfi D, 2012, FREE RADICAL BIO MED, V53, P2131, DOI 10.1016/j.freeradbiomed.2012.09.024; Hagen TM, 1998, P NATL ACAD SCI USA, V95, P9562, DOI 10.1073/pnas.95.16.9562; Haorah J, 2005, J LEUKOCYTE BIOL, V78, P1223, DOI 10.1189/jlb.0605340; Haorah J, 2007, J NEUROCHEM, V100, P324, DOI 10.1111/j.1471-4159.2006.04245.x; Haorah J, 2008, FREE RADICAL BIO MED, V45, P1542, DOI 10.1016/j.freeradbiomed.2008.08.030; Jin M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.78; Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006; Kessova IG, 2007, FREE RADICAL BIO MED, V42, P1470, DOI 10.1016/j.freeradbiomed.2007.01.044; Lamarche F, 2013, CHEM RES TOXICOL; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lolic MM, 1997, ANN EMERG MED, V29, P758, DOI 10.1016/S0196-0644(97)70197-5; Maracchioni A, 2007, J NEUROCHEM, V100, P142, DOI 10.1111/j.1471-4159.2006.04204.x; Martinez SE, 2001, EUR J BIOCHEM, V268, P5045; Muneer PMA, 2011, PSYCHOPHARMACOLOGY, V214, P707, DOI 10.1007/s00213-010-2076-4; Murray J, 2003, J BIOL CHEM, V278, P37223, DOI 10.1074/jbc.M305694200; Pastorino JG, 1999, BIOCHEM BIOPH RES CO, V265, P405, DOI 10.1006/bbrc.1999.1696; PETTEGREW JW, 1995, NEUROBIOL AGING, V16, P1, DOI 10.1016/0197-4580(95)80001-8; Pettegrew JW, 2000, MOL PSYCHIATR, V5, P616, DOI 10.1038/sj.mp.4000805; PIOVESAN P, 1995, INT J DEV NEUROSCI, V13, P13, DOI 10.1016/0736-5748(94)00070-J; Rump TJ, 2010, FREE RADICAL BIO MED, V49, P1494, DOI 10.1016/j.freeradbiomed.2010.08.011; Schuler AM, 2005, MOL GENET METAB, V85, P7, DOI 10.1016/j.ymgme.2004.09.006; Taub DD, 2013, FASEB J, V27, P342, DOI 10.1096/fj.12-217620; Vidyashankar S, 2012, TOXICOLOGY, V302, P34, DOI 10.1016/j.tox.2012.07.009; Wolfgang MJ, 2006, P NATL ACAD SCI USA, V103, P7282, DOI 10.1073/pnas.0602205103; Zimatkin SM, 1996, ALCOHOL ALCOHOLISM, V31, P167; Zuba D, 2002, ALCOHOL, V26, P17, DOI 10.1016/S0741-8329(01)00186-0	38	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e70833	10.1371/journal.pone.0070833	http://dx.doi.org/10.1371/journal.pone.0070833			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967116	Green Published, Green Submitted, gold			2022-12-25	WOS:000323115800023
J	Quiros, M; Martinez-Moreno, R; Albiol, J; Morales, P; Vazquez-Lima, F; Barreiro-Vazquez, A; Ferrer, P; Gonzalez, R				Quiros, Manuel; Martinez-Moreno, Ruben; Albiol, Joan; Morales, Pilar; Vazquez-Lima, Felicitas; Barreiro-Vazquez, Antonio; Ferrer, Pau; Gonzalez, Ramon			Metabolic Flux Analysis during the Exponential Growth Phase of Saccharomyces cerevisiae in Wine Fermentations	PLOS ONE			English	Article							LOW-TEMPERATURE; ALCOHOLIC FERMENTATION; EXPRESSION ANALYSIS; ANAEROBIC GROWTH; AROMA COMPOUNDS; CLIMATE-CHANGE; YEAST; RESPONSES; BALANCES; GLYCEROL	As a consequence of the increase in global average temperature, grapes with the adequate phenolic and aromatic maturity tend to be overripe by the time of harvest, resulting in increased sugar concentrations and imbalanced C/N ratios in fermenting musts. This fact sets obvious additional hurdles in the challenge of obtaining wines with reduced alcohols levels, a new trend in consumer demands. It would therefore be interesting to understand Saccharomyces cerevisiae physiology during the fermentation of must with these altered characteristics. The present study aims to determine the distribution of metabolic fluxes during the yeast exponential growth phase, when both carbon and nitrogen sources are in excess, using continuous cultures. Two different sugar concentrations were studied under two different winemaking temperature conditions. Although consumption and production rates for key metabolites were severely affected by the different experimental conditions studied, the general distribution of fluxes in central carbon metabolism was basically conserved in all cases. It was also observed that temperature and sugar concentration exerted a higher effect on the pentose phosphate pathway and glycerol formation than on glycolysis and ethanol production. Additionally, nitrogen uptake, both quantitatively and qualitatively, was strongly influenced by environmental conditions. This work provides the most complete stoichiometric model used for Metabolic Flux Analysis of S. cerevisiae in wine fermentations employed so far, including the synthesis and release of relevant aroma compounds and could be used in the design of optimal nitrogen supplementation of wine fermentations.	[Quiros, Manuel; Martinez-Moreno, Ruben; Morales, Pilar; Gonzalez, Ramon] Univ La Rioja, Consejo Super Invest Cient, Inst Ciencias Vid & Vino, Gobierno La Rioja, Logrono, Spain; [Albiol, Joan; Vazquez-Lima, Felicitas; Barreiro-Vazquez, Antonio; Ferrer, Pau] Univ Autonoma Barcelona, Dept Chem Engn, E-08193 Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-CAR-UR - Instituto de Ciencias de la Vid y del Vino (ICVV); Universidad de La Rioja; Autonomous University of Barcelona	Quiros, M (corresponding author), Univ La Rioja, Consejo Super Invest Cient, Inst Ciencias Vid & Vino, Gobierno La Rioja, Logrono, Spain.	mquiros@icvv.es	Morales, Pilar/H-5289-2015; Vázquez, Felícitas/AGI-4362-2022; Albiol, Joan/Z-5173-2019; Sala, Joan Albiol/A-8280-2008; Ferrer, Pau/A-4147-2009; González, Ramón/G-9281-2011; Gonzalez, Ramon/Y-5961-2019	Morales, Pilar/0000-0002-0130-6111; Albiol, Joan/0000-0001-5626-429X; Sala, Joan Albiol/0000-0001-5626-429X; Ferrer, Pau/0000-0002-5287-4127; González, Ramón/0000-0001-7388-1660; Gonzalez, Ramon/0000-0001-7388-1660	CDTI (Spanish Center for Technological Industrial Development) through the Ingenio-CENIT Program; Spanish Ministry of Science and Innovation [AGL 2009-07327]; CSIC; European Social Fund of the EU	CDTI (Spanish Center for Technological Industrial Development) through the Ingenio-CENIT Program; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CSIC; European Social Fund of the EU(European Social Fund (ESF))	This work was funded by the CDTI (Spanish Center for Technological Industrial Development) through the Ingenio 2010-CENIT Program and project AGL 2009-07327 of the Spanish Ministry of Science and Innovation. M.Q. and R.M.-M. are recipients of a CSIC training JAE-Doc contract and a CSIC JAE-pre grant respectively, both co-funded by the European Social Fund of the EU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers E, 1996, APPL ENVIRON MICROB, V62, P3187, DOI 10.1128/AEM.62.9.3187-3195.1996; Albers E, 1998, MICROBIOL-UK, V144, P1683, DOI 10.1099/00221287-144-6-1683; Bakker BM, 2001, FEMS MICROBIOL REV, V25, P15, DOI 10.1016/S0168-6445(00)00039-5; BARREIROVAZQUEZ A, 2010, 4 C PHYS YEAST FIL F; Beltran G, 2005, J AGR FOOD CHEM, V53, P996, DOI 10.1021/jf0487001; Beltran G, 2004, FEMS YEAST RES, V4, P625, DOI 10.1016/j.femsyr.2003.12.004; Beltran G, 2007, WORLD J MICROB BIOT, V23, P809, DOI 10.1007/s11274-006-9302-6; Beltran G, 2006, FEMS YEAST RES, V6, P1167, DOI 10.1111/j.1567-1364.2006.00106.x; BELY M, 1990, J FERMENT BIOENG, V70, P246, DOI 10.1016/0922-338X(90)90057-4; Boender LGM, 2009, APPL ENVIRON MICROB, V75, P5607, DOI 10.1128/AEM.00429-09; Cadiere A, 2011, METAB ENG, V13, P263, DOI 10.1016/j.ymben.2011.01.008; Carnicer M, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-65; Charnomordic B, 2010, MATH COMP MODEL DYN, V16, P535, DOI 10.1080/13873954.2010.514701; Clement T, 2011, INT J FOOD MICROBIOL, V150, P42, DOI 10.1016/j.ijfoodmicro.2011.07.016; CREPIN L, 2012, THESIS U MONTPELLIER; Crepin L, 2012, APPL ENVIRON MICROB, V78, P8102, DOI 10.1128/AEM.02294-12; de Orduna RM, 2010, FOOD RES INT, V43, P1844, DOI 10.1016/j.foodres.2010.05.001; Erasmus DJ, 2004, AM J ENOL VITICULT, V55, P371; Gamero A, 2013, J APPL MICROBIOL, V114, P1405, DOI 10.1111/jam.12126; Godard P, 2007, MOL CELL BIOL, V27, P3065, DOI 10.1128/MCB.01084-06; Gomez-Alonso S, 2007, J AGR FOOD CHEM, V55, P608, DOI 10.1021/jf062820m; Grassl H, 2011, SURV GEOPHYS, V32, P319, DOI 10.1007/s10712-011-9129-z; Hoskisson PA, 2005, MICROBIOL-SGM, V151, P3153, DOI 10.1099/mic.0.27924-0; INGLEDEW WM, 1987, AM J ENOL VITICULT, V38, P246; Jain VK, 2012, APPL MICROBIOL BIOT, V93, P131, DOI 10.1007/s00253-011-3431-z; Jones GV, 2005, CLIMATIC CHANGE, V73, P319, DOI 10.1007/s10584-005-4704-2; Klamt S, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-2; KOCKOVAKRATOCHV.A, 1990, YEAST YEAST LIKE ORG; Lange HC, 2001, BIOTECHNOL BIOENG, V75, P334, DOI 10.1002/bit.10054; Martinez-Moreno R, 2012, FEMS YEAST RES, V12, P477, DOI 10.1111/j.1567-1364.2012.00802.x; Murata Y, 2006, EXTREMOPHILES, V10, P117, DOI 10.1007/s00792-005-0480-1; Nissen TL, 1997, MICROBIOL-UK, V143, P203, DOI 10.1099/00221287-143-1-203; OVERKAMP K, 2002, THESIS DELFT U TECHN; Pigeau GM, 2005, J APPL MICROBIOL, V99, P112, DOI 10.1111/j.1365-2672.2005.02577.x; Pizarro FJ, 2008, APPL ENVIRON MICROB, V74, P6358, DOI 10.1128/AEM.00602-08; Pozo-Bayon MA, 2001, J CHROMATOGR A, V922, P267, DOI 10.1016/S0021-9673(01)00966-9; Pronk JT, 1996, YEAST, V12, P1607, DOI 10.1002/(SICI)1097-0061(199612)12:16<1607::AID-YEA70>3.0.CO;2-4; Quiros M, 2010, INT J FOOD MICROBIOL, V139, P9, DOI 10.1016/j.ijfoodmicro.2010.02.014; Regenberg B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r107; REIJENGA K, 2002, DYNAMIC CONTROL YEAS; Ribereau-Gayon P., 2004, TRAITE OENOLOGIE; Rodrigues F, 2006, BIODIVERSITY AND ECOPHYSIOLOGY OF YEASTS, P101, DOI 10.1007/3-540-30985-3_6; Sahara T, 2002, J BIOL CHEM, V277, P50015, DOI 10.1074/jbc.M209258200; Schade B, 2004, MOL BIOL CELL, V15, P5492, DOI 10.1091/mbc.E04-03-0167; Schulze U, 1996, MICROBIOL-UK, V142, P2299, DOI 10.1099/13500872-142-8-2299; Segarra I, 1995, AM J ENOL VITICULT, V46, P564; Swiegers JH, 2005, AUST J GRAPE WINE R, V11, P139, DOI 10.1111/j.1755-0238.2005.tb00285.x; Tai SL, 2007, MOL BIOL CELL, V18, P5100, DOI 10.1091/mbc.E07-02-0131; Varela C, 2004, APPL ENVIRON MICROB, V70, P3392, DOI 10.1128/AEM.70.6.3392-3400.2004; Vargas FA, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-75; Villadsen J, 2011, BIOREACTION ENGINEERING PRINCIPLES, THIRD EDITION, P7, DOI 10.1007/978-1-4419-9688-6_2; WANG NS, 1983, BIOTECHNOL BIOENG, V25, P2177, DOI 10.1002/bit.260250906; Yu ZM, 2012, APPL BIOCHEM BIOTECH, V168, P1938, DOI 10.1007/s12010-012-9909-z	53	29	31	3	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71909	10.1371/journal.pone.0071909	http://dx.doi.org/10.1371/journal.pone.0071909			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967264	Green Submitted, Green Published, gold			2022-12-25	WOS:000323115800092
J	Burkitt, MD; Williams, JM; Duckworth, CA; O'Hara, A; Hanedi, A; Varro, A; Caamano, JH; Pritchard, DM				Burkitt, M. D.; Williams, J. M.; Duckworth, C. A.; O'Hara, A.; Hanedi, A.; Varro, A.; Caamano, J. H.; Pritchard, D. M.			Signaling mediated by the NF-kappa B sub-units NF-kappa B1, NF-kappa B2 and c-Rel differentially regulate Helicobacter felis-induced gastric carcinogenesis in C57BL/6 mice	ONCOGENE			English	Article						Helicobacter felis infection; NF-kappa B; MALT lymphoma; gastric cancer	MOUSE MODEL; CELL PROLIFERATION; INFECTION; PYLORI; INFLAMMATION; LACKING; CANCER; APOPTOSIS; DEFECTS; FAMILY	The classical nuclear factor-kappaB (NF-kappa B) signaling pathway has been shown to be important in a number of models of inflammation-associated cancer. In a mouse model of Helicobacter-induced gastric cancer, impairment of classical NF-kappa B signaling in the gastric epithelium led to the development of increased preneoplastic pathology, however the role of specific NF-kappa B proteins in Helicobacter-associated gastric cancer development remains poorly understood. To investigate this C57BL/6, Nfkb1(-/-), Nfkb2(-/-) and c-Rel(-/-) mice were infected with Helicobacter felis for 6 weeks or 12 months. Bacterial colonization, gastric atrophy and preneoplastic changes were assessed histologically and cytokine expression was assessed by qPCR. Nfkb1(-/-) mice developed spontaneous gastric atrophy when maintained for 12 months in conventional animal house conditions. They also developed more pronounced gastric atrophy after short-term H. felis colonization with a similar extent of preneoplasia to wild-type (WT) mice after 12 months. c-Rel(-/-) mice developed a similar degree of gastric atrophy to WT mice; 3 of 6 of these animals also developed lymphoproliferative lesions after 12 months of infection. Nfkb2(-/-) mice developed minimal gastric epithelial pathology even 12 months after H. felis infection. These findings demonstrate that NF-kappa B1- and NF-kappa B2-mediated signaling pathways differentially regulate the epithelial consequences of H. felis infection in the stomach, while c-Rel-mediated signaling also appears to modulate the risk of lymphomagenesis in gastric mucosa-associated lymphoid tissue.	[Burkitt, M. D.; Williams, J. M.; Duckworth, C. A.; O'Hara, A.; Hanedi, A.; Pritchard, D. M.] Univ Liverpool, Dept Gastroenterol, Henry Wellcome Labs, Inst Translat Med, Liverpool L69 3GE, Merseyside, England; [Varro, A.] Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Liverpool L69 3GE, Merseyside, England; [Caamano, J. H.] Univ Birmingham, Coll Med & Dent Sci, IBR Sch Immun & Infect, Birmingham, W Midlands, England	University of Liverpool; University of Liverpool; University of Birmingham	Pritchard, DM (corresponding author), Univ Liverpool, Dept Gastroenterol, Henry Wellcome Labs, Inst Translat Med, 1st Floor,Nuffield Bldg,Ashton St, Liverpool L69 3GE, Merseyside, England.	mark.pritchard@liverpool.ac.uk	Duckworth, Carrie/AAC-8361-2020; Duckworth, Carrie A/K-7302-2014; O'Hara, Adrian/ABE-7987-2020; Varro, Andras/M-2647-2016; Burkitt, Michael/AAU-9506-2021; Caamano, Jorge/I-6778-2012; Caamano, Jorge/O-7530-2019	Duckworth, Carrie/0000-0001-9992-7540; Duckworth, Carrie A/0000-0001-9992-7540; O'Hara, Adrian/0000-0003-1837-680X; Burkitt, Michael/0000-0002-5055-6408; Caamano, Jorge/0000-0003-3530-7056; Caamano, Jorge/0000-0003-3530-7056; Pritchard, David Mark/0000-0001-7971-3561; Williams, Jonathan/0000-0002-6617-0323	Wellcome Trust Research Training Fellowship; North West Cancer Research project grant; EU FP7 integrated project INFLACARE; College of Medical and Dental Sciences-University of Birmingham; BBSRC [BB/K009400/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K009400/1] Funding Source: researchfish; National Institute for Health Research [CL-2011-07-501] Funding Source: researchfish; North West Cancer Research [CR930] Funding Source: researchfish	Wellcome Trust Research Training Fellowship(Wellcome Trust); North West Cancer Research project grant; EU FP7 integrated project INFLACARE; College of Medical and Dental Sciences-University of Birmingham; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); North West Cancer Research	This work was supported by a Wellcome Trust Research Training Fellowship awarded to MDB, and a North West Cancer Research project grant. JC was supported by the EU FP7 integrated project INFLACARE and the College of Medical and Dental Sciences-University of Birmingham.	Artis D, 2002, J IMMUNOL, V169, P4481, DOI 10.4049/jimmunol.169.8.4481; Burkitt MD, 2009, WORLD J GASTROENTERO, V15, P1, DOI 10.3748/wjg.15.1; Caamano JH, 1998, J EXP MED, V187, P185, DOI 10.1084/jem.187.2.185; Court M, 2003, J PATHOL, V201, P303, DOI 10.1002/path.1422; Curry Choladda V, 2009, J Hematop, V2, P20, DOI 10.1007/s12308-009-0021-4; Duckworth CA, 2012, AM J PHYSIOL-GASTR L, V303, pG915, DOI 10.1152/ajpgi.00068.2012; ENNO A, 1995, AM J PATHOL, V147, P217; Erdman SE, 2001, J IMMUNOL, V166, P1443, DOI 10.4049/jimmunol.166.3.1443; Ferreira BI, 2008, HAEMATOLOGICA, V93, P670, DOI 10.3324/haematol.12221; Ferrero RL, 2000, J PATHOL, V191, P333; Fox JG, CANC RES, V62, P696; Gilmore TD, 2004, ONCOGENE, V23, P2275, DOI 10.1038/sj.onc.1207410; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Ishikawa H, 1998, J EXP MED, V187, P985, DOI 10.1084/jem.187.7.985; Ishikawa H, 1997, J EXP MED, V186, P999, DOI 10.1084/jem.186.7.999; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Mantovani A, 2009, NATURE, V457, P36, DOI 10.1038/457036b; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Ohmae T, 2005, J IMMUNOL, V175, P7162, DOI 10.4049/jimmunol.175.11.7162; Persson C, 2011, AM J EPIDEMIOL, V173, P259, DOI 10.1093/aje/kwq370; Pritchard DM, 2004, ALIMENT PHARM THER, V19, P841, DOI 10.1111/j.1365-2036.2004.01911.x; Rogers AB, 2005, CANCER RES, V65, P10709, DOI 10.1158/0008-5472.CAN-05-1846; Rogers Arlin B, 2012, Methods Mol Biol, V921, P189; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Shibata W, 2010, GASTROENTEROLOGY, V138, P1022, DOI 10.1053/j.gastro.2009.11.054; Smale ST, 2012, IMMUNOL REV, V246, P193, DOI 10.1111/j.1600-065X.2011.01091.x; Starczynowski DT, 2007, ONCOGENE, V26, P2685, DOI 10.1038/sj.onc.1210089; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Tu SP, 2011, CANCER RES, V71, P4247, DOI 10.1158/0008-5472.CAN-10-4009; Tu S, 2008, CANCER CELL, V14, P408, DOI 10.1016/j.ccr.2008.10.011; Wang TC, 2000, GASTROENTEROLOGY, V118, P36, DOI 10.1016/S0016-5085(00)70412-4; Yang LY, 1998, J EXP MED, V188, P1739, DOI 10.1084/jem.188.9.1739	34	29	30	0	13	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 12	2013	32	50					5563	5573		10.1038/onc.2013.334	http://dx.doi.org/10.1038/onc.2013.334			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	272LF	23975431	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000328461400001
J	Wittmann, A; Autenrieth, IB; Frick, JS				Wittmann, Alexandra; Autenrieth, Ingo B.; Frick, Julia-Stefanie			Plasmacytoid Dendritic Cells Are Crucial in Bifidobacterium adolescentis- Mediated Inhibition of Yersinia enterocolitica Infection	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; REGULATORY T-CELLS; GUT MICROBIOTA; HOST; PROBIOTICS; INFLAMMATION; SALMONELLA; RECEPTOR; BACTERIA; COLITIS	In industrialized countries bacterial intestinal infections are commonly caused by enteropathogenic Enterobacteriaceae. The interaction of the microbiota with the host immune system determines the adequacy of an appropriate response against pathogens. In this study we addressed whether the probiotic Bifidobacterium adolescentis is protective during intestinal Yersinia enterocolitica infection. Female C57BL/6 mice were fed with B. adolescentis, infected with Yersinia enterocolitica, or B. adolescentis fed and subsequently infected with Yersinia enterocolitica. B. adolescentis fed and Yersinia infected mice were protected from Yersinia infection as indicated by a significantly reduced weight loss and splenic Yersinia load when compared to Yersinia infected mice. Moreover, protection from infection was associated with increased intestinal plasmacytoid dendritic cell and regulatory T-cell frequencies. Plasmacytoid dendritic cell function was investigated using depletion experiments by injecting B. adolescentis fed, Yersinia infected C57BL/6 mice with anti-mouse PDCA-1 antibody, to deplete plasmacytoid dendritic cells, or respective isotype control. The B. adolescentis-mediated protection from Yersinia dissemination to the spleen was abrogated after plasmacytoid dendritic cell depletion indicating a crucial function for pDC in control of intestinal Yersinia infection. We suggest that feeding of B. adolescentis modulates the intestinal immune system in terms of increased plasmacytoid dendritic cell and regulatory T-cell frequencies, which might account for the B. adolescentis-mediated protection from Yersinia enterocolitica infection.	[Wittmann, Alexandra; Autenrieth, Ingo B.; Frick, Julia-Stefanie] Univ Tubingen Hosp, Inst Med Microbiol & Hyg, Tubingen, Germany; [Wittmann, Alexandra; Autenrieth, Ingo B.; Frick, Julia-Stefanie] Univ Tubingen, German Ctr Infect Res, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; German Center for Infection Research	Frick, JS (corresponding author), Univ Tubingen Hosp, Inst Med Microbiol & Hyg, Tubingen, Germany.	julia-stefanie.frick@med.uni-tuebingen.de		Frick, Julia-Stefanie/0000-0002-7662-7956	ZEM (Zentrum fur Ernahrungsmedizin); BMBF (Bundesministerium fur Bildung und Forschung	ZEM (Zentrum fur Ernahrungsmedizin); BMBF (Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by the ZEM (Zentrum fur Ernahrungsmedizin) and the BMBF (Bundesministerium fur Bildung und Forschung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; AUTENRIETH IB, 1994, INFECT IMMUN, V62, P2590, DOI 10.1128/IAI.62.6.2590-2599.1994; Bansal T, 2010, P NATL ACAD SCI USA, V107, P228, DOI 10.1073/pnas.0906112107; Barnes PD, 2006, J EXP MED, V203, P1591, DOI 10.1084/jem.20060905; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Baumgart DC, 2011, CLIN EXP IMMUNOL, V166, P46, DOI 10.1111/j.1365-2249.2011.04439.x; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Bottone EJ, 1999, MICROBES INFECT, V1, P323, DOI 10.1016/S1286-4579(99)80028-8; Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Canani RB, 2007, BMJ-BRIT MED J, V335, P340, DOI 10.1136/bmj.39272.581736.55; Cario E, 2004, GASTROENTEROLOGY, V127, P224, DOI 10.1053/j.gastro.2004.04.015; Contractor N, 2007, J IMMUNOL, V179, P2690, DOI 10.4049/jimmunol.179.5.2690; Cornelis G R, 1994, Curr Top Microbiol Immunol, V192, P243; COVER TL, 1989, NEW ENGL J MED, V321, P16, DOI 10.1056/NEJM198907063210104; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; De La Cochetiere MF, 2008, MICROB ECOL, V56, P395, DOI 10.1007/s00248-007-9356-5; del Rio ML, 2010, IMMUNOL REV, V234, P268, DOI 10.1111/j.0105-2896.2009.00874.x; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Diana J, 2009, IMMUNITY, V30, P289, DOI 10.1016/j.immuni.2008.12.017; Farache J, 2013, IMMUNITY, V38, P581, DOI 10.1016/j.immuni.2013.01.009; Frick JS, 2012, CURR TOP MICROBIOL I; Frick JS, 2007, INFECTIMMUN; Fujiwara D, 2008, J IMMUNOL, V180, P5843, DOI 10.4049/jimmunol.180.9.5843; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Gionchetti P, 2000, J GASTROEN HEPATOL, V15, P489, DOI 10.1046/j.1440-1746.2000.02162.x; Gradel KO, 2009, FOODBORNE PATHOG DIS, V6, P251, DOI 10.1089/fpd.2008.0148; Hadeiba H, 2008, NAT IMMUNOL, V9, P1253, DOI 10.1038/ni.1658; Hall AO, 2012, IMMUNITY, V37, P511, DOI 10.1016/j.immuni.2012.06.014; Ito T, 2007, J EXP MED, V204, P105, DOI 10.1084/jem.20061660; Iwasaki A, 2007, ANNU REV IMMUNOL, V25, P381, DOI 10.1146/annurev.immunol.25.022106.141634; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996; Kim Y, 2008, J MICROBIOL BIOTECHN, V18, P1278; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Kraehenbuhl JP, 2000, ANNU REV CELL DEV BI, V16, P301, DOI 10.1146/annurev.cellbio.16.1.301; Lawley TD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002995; Lofmark S, 2006, J ANTIMICROB CHEMOTH, V58, P1160, DOI 10.1093/jac/dkl420; Lupp C, 2007, CELL HOST MICROBE, V2, P204, DOI 10.1016/j.chom.2007.08.002; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Matta BM, 2010, EUR J IMMUNOL, V40, P2667, DOI 10.1002/eji.201040839; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McFarland AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016967; Moseman EA, 2004, J IMMUNOL, V173, P4433, DOI 10.4049/jimmunol.173.7.4433; Muller A, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-25; Murphy EF, 2013, GUT, V62, P220, DOI 10.1136/gutjnl-2011-300705; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Nomoto K, 2005, J BIOSCI BIOENG, V100, P583, DOI 10.1263/jbb.100.583; Otte JM, 2004, AM J PHYSIOL-GASTR L, V286, pG613, DOI 10.1152/ajpgi.00341.2003; Ranatunga DC, 2012, J IMMUNOL, V189, P1243, DOI 10.4049/jimmunol.1103421; Schindler MKH, 2012, J IMMUNOL, V189, P4900, DOI 10.4049/jimmunol.1201383; Schlitzer A, 2012, BLOOD, V119, P6063, DOI 10.1182/blood-2012-03-418400; Sekirov I, 2008, INFECT IMMUN, V76, P4726, DOI 10.1128/IAI.00319-08; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Senok AC, 2005, CLIN MICROBIOL INFEC, V11, P958, DOI 10.1111/j.1469-0691.2005.01228.x; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Turner JD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001269; Villadangos JA, 2008, IMMUNITY, V29, P352, DOI 10.1016/j.immuni.2008.09.002; Wehkamp J, 2004, INFECT IMMUN, V72, P5750, DOI 10.1128/IAI.72.10.5750-5758.2004; Weichert S, 2012, PEDIATR INFECT DIS J, V31, P859, DOI 10.1097/INF.0b013e3182620e52; Wendland M, 2007, P NATL ACAD SCI USA, V104, P6347, DOI 10.1073/pnas.0609180104; Yan F, 2007, GASTROENTEROLOGY, V132, P562, DOI 10.1053/j.gastro.2006.11.022; Yap IKS, 2008, J PROTEOME RES, V7, P3718, DOI 10.1021/pr700864x; Yen JH, 2010, J IMMUNOL, V184, P3478, DOI 10.4049/jimmunol.0902542	65	10	10	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71338	10.1371/journal.pone.0071338	http://dx.doi.org/10.1371/journal.pone.0071338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977019	gold, Green Published, Green Submitted			2022-12-25	WOS:000324527300011
J	Yanguez, E; Castro-Sanz, AB; Fernandez-Bautista, N; Oliveros, JC; Castellano, MM				Yangueez, Emilio; Castro-Sanz, Ana B.; Fernandez-Bautista, Nuria; Oliveros, Juan C.; Castellano, M. Mar			Analysis of Genome-Wide Changes in the Translatome of Arabidopsis Seedlings Subjected to Heat Stress	PLOS ONE			English	Article							MESSENGER-RNA TRANSLATION; SHOCK PROTEINS; HIGH-SALINITY; ELEVATED-TEMPERATURE; ENRICHMENT ANALYSIS; INITIATION; RESPONSES; PHOSPHORYLATION; TRANSCRIPTION; DROUGHT	Heat stress is one of the most prominent and deleterious environmental threats affecting plant growth and development. Upon high temperatures, plants launch specialized gene expression programs that promote stress protection and survival. These programs involve global and specific changes at the transcriptional and translational levels. However, the coordination of these processes and their specific role in the establishment of the heat stress response is not fully elucidated. We have carried out a genome-wide analysis to monitor the changes in the translation efficiency of individual mRNAs of Arabidopsis thaliana seedlings after the exposure to a heat shock stress. Our results demonstrate that translation exerts a wide but dual regulation of gene expression. For the majority of mRNAs, translation is severely repressed, causing a decreased of 50% in the association of the bulk of mRNAs to polysomes. However, some relevant mRNAs involved in different aspects of homeostasis maintenance follow a differential pattern of translation. Sequence analyses of the differentially translated mRNAs unravels that some features, such as the 59UTR G+C content and the cDNA length, may take part in the discrimination mechanisms for mRNA polysome loading. Among the differentially translated genes, master regulators of the stress response stand out, highlighting the main role of translation in the early establishment of the physiological response of plants to elevated temperatures.	[Yangueez, Emilio; Castro-Sanz, Ana B.; Fernandez-Bautista, Nuria; Castellano, M. Mar] INIA UPM, Ctr Biotecnol & Genom Plantas, Madrid, Spain; [Oliveros, Juan C.] CSIC, Ctr Nacl Biotecnol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Castellano, MM (corresponding author), INIA UPM, Ctr Biotecnol & Genom Plantas, Madrid, Spain.	castellano.mar@inia.es	castellano, mar m/L-2063-2014	castellano, mar m/0000-0003-0339-4247; Yanguez, Emilio/0000-0003-4271-2690	ERC [260468]; Spanish Ministry of Science and Innovation [BIO2010-1551]; FPI-INIA fellowship	ERC(European Research Council (ERC)European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FPI-INIA fellowship	This work was supported by the ERC (http://erc.europa.eu/) through the Starting Grant 260468 to M. Mar Castellano and by the Spanish Ministry of Science and Innovation (http://www.idi.mineco.gob.es/). In addition, this work is partially supported by the Spanish Ministry of Science and Innovation (http://www.idi.mineco.gob.es/) through the grant BIO2010-1551. ABC-S is recipient of a 2011 FPI-INIA fellowship. Institutional support form INIA and form UPM is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken CE, 2012, NAT STRUCT MOL BIOL, V19, P568, DOI 10.1038/nsmb.2303; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Branco-Price C, 2005, ANN BOT-LONDON, V96, P647, DOI 10.1093/aob/mci217; Branco-Price C, 2008, PLANT J, V56, P743, DOI 10.1111/j.1365-313X.2008.03642.x; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Clemens MJ, 2001, PROG MOLEC, V27, P57; Clemens MJ, 2001, J CELL MOL MED, V5, P221, DOI 10.1111/j.1582-4934.2001.tb00157.x; Del Prete MJ, 2007, RNA, V13, P414, DOI 10.1261/rna.79407; Dhaubhadel S, 2002, PLANT J, V29, P681, DOI 10.1046/j.1365-313X.2002.01257.x; Floris M, 2009, INT J MOL SCI, V10, P3168, DOI 10.3390/ijms10073168; Gallie DR, 1997, J BIOL CHEM, V272, P1046, DOI 10.1074/jbc.272.2.1046; Gallie DR, 2001, J BIOL CHEM, V276, P36951, DOI 10.1074/jbc.M103869200; Gallie DR, 2001, CROP RESPONSES ADAPT, P219; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Hirayama T, 2010, PLANT J, V61, P1041, DOI 10.1111/j.1365-313X.2010.04124.x; Huang GT, 2012, MOL BIOL REP, V39, P969, DOI 10.1007/s11033-011-0823-1; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Juntawong P, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00066; Kawaguchi R, 2005, NUCLEIC ACIDS RES, V33, P955, DOI 10.1093/nar/gki240; Kawaguchi R, 2004, PLANT J, V38, P823, DOI 10.1111/j.1365-313X.2004.02090.x; KEY JL, 1981, P NATL ACAD SCI-BIOL, V78, P3526, DOI 10.1073/pnas.78.6.3526; Klueva NY, 2001, CROP RESPONSES ADAPT, P177; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Larkindale J, 2008, PLANT PHYSIOL, V146, P748, DOI 10.1104/pp.107.112060; Lee H, 2002, EMBO J, V21, P2692, DOI 10.1093/emboj/21.11.2692; Liberek K, 2008, EMBO J, V27, P328, DOI 10.1038/sj.emboj.7601970; Liu JX, 2010, PLANT CELL, V22, P2930, DOI 10.1105/tpc.110.078154; Liu MJ, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.97; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Matsuura H, 2013, PLANT CELL PHYSIOL, V54, P474, DOI 10.1093/pcp/pcs189; Matsuura H, 2010, BIOSCI BIOTECH BIOCH, V74, P2110, DOI 10.1271/bbb.100330; Matsuura H, 2010, PLANT CELL PHYSIOL, V51, P448, DOI 10.1093/pcp/pcq010; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Mittler R, 2006, FEBS LETT, V580, P6537, DOI 10.1016/j.febslet.2006.11.002; Morimoto RI, 1998, NAT BIOTECHNOL, V16, P833, DOI 10.1038/nbt0998-833; Munoz A, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/406357; Mustroph A, 2009, P NATL ACAD SCI USA, V106, P18843, DOI 10.1073/pnas.0906131106; Nakashima K, 2000, PLANT MOL BIOL, V42, P657, DOI 10.1023/A:1006321900483; Nicolai M, 2006, PLANT PHYSIOL, V141, P663, DOI 10.1104/pp.106.079418; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; NOVER L, 1989, MOL CELL BIOL, V9, P1298, DOI 10.1128/MCB.9.3.1298; Oliveros JC, 2007, INTERACTIVE SERVER A; Oshino T, 2007, MOL GENET GENOMICS, V278, P31, DOI 10.1007/s00438-007-0229-x; Pesole G, 1997, GENE, V205, P95, DOI 10.1016/S0378-1119(97)00407-1; Pesole G, 2000, Brief Bioinform, V1, P236, DOI 10.1093/bib/1.3.236; Piques M, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.68; Qin DD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-432; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Sakamoto H, 2004, PLANT PHYSIOL, V136, P2734, DOI 10.1104/pp.104.046599; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sormani R, 2011, PLANT CELL PHYSIOL, V52, P436, DOI 10.1093/pcp/pcr001; Stone P., 2001, CROP RESPONSES ADAPT, P243; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Ueda K, 2012, PLANT CELL PHYSIOL, V53, P1481, DOI 10.1093/pcp/pcs092; Ventoso I, 2012, PLOS ONE, P7; VIERLING E, 1991, ANNU REV PLANT PHYS, V42, P579, DOI 10.1146/annurev.pp.42.060191.003051; Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wheeler TR, 2000, AGR ECOSYST ENVIRON, V82, P159, DOI 10.1016/S0167-8809(00)00224-3; Zhang YH, 2008, J EXP BOT, V59, P3131, DOI 10.1093/jxb/ern169	67	69	72	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71425	10.1371/journal.pone.0071425	http://dx.doi.org/10.1371/journal.pone.0071425			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977042	Green Submitted, Green Published, gold			2022-12-25	WOS:000323425700051
J	Ali, MB; Karray, A; Gargouri, Y; Ben Ali, Y				Ali, Madiha Bou; Karray, Aida; Gargouri, Youssef; Ben Ali, Yassine			N-Terminal Domain of Turkey Pancreatic Lipase is Active on Long Chain Triacylglycerols and Stabilized by Colipase	PLOS ONE			English	Article							INTERFACIAL ACTIVATION; PICHIA-PASTORIS; PROCOLIPASE COMPLEX; LIMITED PROTEOLYSIS; LIPOPROTEIN-LIPASE; HEPATIC LIPASE; EXPRESSION; BINDING; PROTEINS; CLEAVAGE	The gene encoding the TPL N-terminal domain (N-TPL), fused with a His6-tag, was cloned and expressed in Pichia pastoris, under the control of the glyceraldehyde-3-phosphate dehydrogenase (GAP) constitutive promoter. The recombinant protein was successfully expressed and secreted with an expression level of 5 mg/l of culture medium after 2 days of culture. The N-TPL was purified through a one-step Ni-NTA affinity column with a purification factor of approximately 23-fold. The purified N-TPL, with a molecular mass of 35 kDa, had a specific activity of 70 U/mg on tributyrin. Surprisingly, this domain was able to hydrolyse long chain TG with a specific activity of 11 U/mg using olive oil as substrate. This result was confirmed by TLC analysis showing that the N-TPL was able to hydrolyse insoluble substrates as olive oil. N-TPL was unstable at temperatures over 37 degrees C and lost 70% of its activity at acid pH, after 5 min of incubation. The N-TPL exhibited non linear kinetics, indicating its rapid denaturation at the tributyrin-water interface. Colipase increased the N-TPL stability at the lipid-water interface, so the TPL N-terminal domain probably formed functional interactions with colipase despite the absence of the C-terminal domain.	[Ali, Madiha Bou; Karray, Aida; Gargouri, Youssef; Ben Ali, Yassine] Univ Sfax, Natl Engn Sch Sfax ENIS, Biochem Lab, Sfax, Tunisia	Universite de Sfax; Ecole Nationale dIngenieurs de Sfax (ENIS)	Ben Ali, Y (corresponding author), Univ Sfax, Natl Engn Sch Sfax ENIS, Biochem Lab, Sfax, Tunisia.	yassine_marseille@yahoo.fr			Ministere de l'enseignement superieur et de la recherche scientifique; Laboratoire de Biochimie et de Genie Enzymatique des Lipases	Ministere de l'enseignement superieur et de la recherche scientifique; Laboratoire de Biochimie et de Genie Enzymatique des Lipases	This work received financial support from "Ministere de l'enseignement superieur et de la recherche scientifique" granted to the "Laboratoire de Biochimie et de Genie Enzymatique des Lipases". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUSALHAM A, 1992, PROTEIN ENG, V5, P105, DOI 10.1093/protein/5.1.105; Ali MB, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-24; Ben Bacha A, 2007, PANCREAS, V35, pE55; Bezzine S, 1998, BIOCHEMISTRY-US, V37, P11846, DOI 10.1021/bi973136r; BOUSSETRISSO M, 1985, FEBS LETT, V182, P323, DOI 10.1016/0014-5793(85)80325-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brzozowski AM, 2000, BIOCHEMISTRY-US, V39, P15071, DOI 10.1021/bi0013905; Chahinian H, 2002, BIOCHEMISTRY-US, V41, P13725, DOI 10.1021/bi0257944; CREGG JM, 1993, BIO-TECHNOL, V11, P905, DOI 10.1038/nbt0893-905; Cregg JM, 1998, METH MOL B, V103, P27; Daly R, 2005, J MOL RECOGNIT, V18, P119, DOI 10.1002/jmr.687; DAVIS RC, 1992, J BIOL CHEM, V267, P21499; DICHEK HL, 1993, J LIPID RES, V34, P1393; EGLOFF MP, 1995, PROTEIN SCI, V4, P44; Fendri A, 2006, BIOCHIMIE, V88, P1401, DOI 10.1016/j.biochi.2006.05.022; Fendri A, 2005, CHIRALITY, V17, P57, DOI 10.1002/chir.20097; Ferrato F, 1997, METHOD ENZYMOL, V286, P327; Gellissen G, 2000, APPL MICROBIOL BIOT, V54, P741, DOI 10.1007/s002530000464; Horchani H, 2010, J COLLOID INTERF SCI, V350, P586, DOI 10.1016/j.jcis.2010.07.021; JENNENS ML, 1995, J LIPID RES, V36, P1029; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Ranaldi S, 2010, BIOCHEMISTRY-US, V49, P2140, DOI 10.1021/bi901918f; ROMANOS MA, 1992, YEAST, V8, P423, DOI 10.1002/yea.320080602; Sambrook J., 2002, MOL CLONING LAB MANU; SARDA L, 1958, BIOCHIM BIOPHYS ACTA, V30, P513, DOI 10.1016/0006-3002(58)90097-0; Sayari A, 2000, BIOCHIMIE, V82, P153, DOI 10.1016/S0300-9084(00)00379-5; Sias B, 2004, BIOCHEMISTRY-US, V43, P10138, DOI 10.1021/bi049818d; VANTILBEURGH H, 1993, NATURE, V362, P814, DOI 10.1038/362814a0; VANTILBEURGH H, 1992, NATURE, V359, P159, DOI 10.1038/359159a0; WINKLER FK, 1990, NATURE, V343, P771, DOI 10.1038/343771a0	31	1	1	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e71605	10.1371/journal.pone.0071605	http://dx.doi.org/10.1371/journal.pone.0071605			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977086	gold, Green Submitted, Green Published			2022-12-25	WOS:000323570200035
J	Broker, MEE; Lalmahomed, ZS; Roest, HP; van Huizen, NA; Dekker, LJM; Calame, W; Verhoef, C; IJzermans, JNM; Luider, TM				Broker, Mirelle E. E.; Lalmahomed, Zarina S.; Roest, Henk P.; van Huizen, Nick A.; Dekker, Lennard J. M.; Calame, Wim; Verhoef, Cornelis; IJzermans, Jan N. M.; Luider, Theo M.			Collagen Peptides in Urine: A New Promising Biomarker for the Detection of Colorectal Liver Metastases	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; CANCER; TUMOR; ACCURACY; PROTEINS	Introduction: For both patients and the outpatient clinic the frequent follow-up visits after a resection of colorectal cancer (CRC) are time consuming and due to large patient numbers expensive. Therefore it is important to develop an effective non-invasive test for the detection of colorectal liver metastasis (CRLM) which could be used outside the hospital. The urine proteome is known to provide detailed information for monitoring changes in the physiology of humans. Urine collection is non-invasive and urine naturally occurring peptides (NOPs) have the advantage of being easily accessible without labour-intensive sample preparation. These advantages make it potentially useful for a quick and reliable application in clinical settings. In this study, we will focus on the identification and validation of urine NOPs to discriminate patients with CRLM from healthy controls. Materials and Methods: Urine samples were collected from 24 patients with CRLM and 25 healthy controls. In the first part of the study, samples were measured with a nano liquid chromatography (LC) system (Thermo Fisher Scientific, Germaring, Germany) coupled on-line to a hybrid linear ion trap/Orbitrap mass spectrometer (LTQ-Orbitrap-XL, Thermo Fisher Scientific, Bremen, Germany). A discovery set was used to construct the model and consecutively the validation set, being independent from the discovery set, to check the acquired model. From the peptides which were selected, multiple reaction monitoring (MRM's) were developed on a UPLC-MS/MS system. Results: Seven peptides were selected and applied in a discriminant analysis a sensitivity of 84.6% and a specificity of 92.3% were established (Canonical correlation: 0.797, Eigenvalue: 1.744, F: 4.49, p: 0.005). The peptides AGPP(-OH)GEAGKP(-OH)GEQGVP(-OH)GDLGA P(-OH)GP and KGNSGEP(-OH)GAPGSKGDTGAKGEP(-OH)GPVG were selected for further quantitative analysis which showed a sensitivity of 88% and a specificity of 88%. Conclusion: Urine proteomic analysis revealed two very promising peptides, both part from collagen type 1, AGPP(OH) GEAGKP(-OH) GEQGVP(-OH) GDLGAP(-OH)GP and KGNSGEP(-OH)GAPGSKGDTGAKGEP(-OH)GPVG which could detect CRLM in a non-invasive manner.	[Broker, Mirelle E. E.; Lalmahomed, Zarina S.; Roest, Henk P.; van Huizen, Nick A.; Verhoef, Cornelis; IJzermans, Jan N. M.] Erasmus Univ, Med Ctr, Dept Surg, Div Transplantat & Hepatobiliary Surg, Rotterdam, Netherlands; [Calame, Wim] Stat BV, Wassenaar, Netherlands; [van Huizen, Nick A.; Dekker, Lennard J. M.; Luider, Theo M.] Erasmus Univ, Med Ctr, Dept Neurol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Luider, TM (corresponding author), Erasmus Univ, Med Ctr, Dept Neurol, Rotterdam, Netherlands.	t.luider@erasmusmc.nl	Verhoef, Cornelis/ABD-3648-2020	Verhoef, Cornelis/0000-0001-9980-8613; van Huizen, Nick/0000-0002-5475-3433				Afifi A., 2003, COMPUTER AIDED MULTI; Bosman FT, 2003, J PATHOL, V200, P423, DOI 10.1002/path.1437; Giannitrapani L, 2006, ANN NY ACAD SCI, V1089, P228, DOI 10.1196/annals.1386.044; Hansen LK, 2006, CURR TOP DEV BIOL, V72, P205, DOI 10.1016/S0070-2153(05)72004-4; Hara M, 2008, DIS COLON RECTUM, V51, P1675, DOI 10.1007/s10350-008-9406-1; Haubitz M, 2009, MOL CELL PROTEOMICS, V8, P2296, DOI 10.1074/mcp.M800529-MCP200; Loenarz C, 2011, TRENDS BIOCHEM SCI, V36, P7, DOI 10.1016/j.tibs.2010.07.002; MARTINEZHERNANDEZ A, 1991, LAB INVEST, V64, P157; MARTINEZHERNANDEZ A, 1984, LAB INVEST, V51, P57; Metzger J, 2012, GUT; Meyerhardt JA, 2003, SEMIN ONCOL, V30, P349, DOI 10.1016/S0093-7754(03)00095-2; Mischak H, 2007, PROTEOM CLIN APPL, V1, P792, DOI 10.1002/prca.200700043; Mischak H, 2011, PROTEOM CLIN APPL, V5, P211, DOI 10.1002/prca.201190031; Mustafa DAN, 2007, MOL CELL PROTEOMICS, V6, P1147, DOI 10.1074/mcp.M600295-MCP200; Nystrom H, 2012, ANTICANCER RES, V32, P5183; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Rowe RG, 2009, ANNU REV CELL DEV BI, V25, P567, DOI 10.1146/annurev.cellbio.24.110707.175315; STANGL R, 1994, LANCET, V343, P1405, DOI 10.1016/S0140-6736(94)92529-1; VANEYKEN P, 1990, J HEPATOL, V11, P43, DOI 10.1016/0168-8278(90)90270-2; Wulfkuhle JD, 2003, NAT REV CANCER, V3, P267, DOI 10.1038/nrc1043	20	24	26	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e70918	10.1371/journal.pone.0070918	http://dx.doi.org/10.1371/journal.pone.0070918			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23976965	Green Published, Green Submitted, gold			2022-12-25	WOS:000323570200010
J	Gruber, L; Kisling, S; Lichti, P; Martin, FP; May, S; Klingenspor, M; Lichtenegger, M; Rychlik, M; Haller, D				Gruber, Lisa; Kisling, Sigrid; Lichti, Pia; Martin, Francois-Pierre; May, Stephanie; Klingenspor, Martin; Lichtenegger, Martina; Rychlik, Michael; Haller, Dirk			High Fat Diet Accelerates Pathogenesis of Murine Crohn's Disease-Like Ileitis Independently of Obesity	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; INTESTINAL EPITHELIAL-CELLS; BODY-MASS INDEX; CLINICAL-COURSE; MOUSE MODEL; MICE; COLITIS; EXPRESSION; PERMEABILITY; ADIPOCYTES	Background: Obesity has been associated with a more severe disease course in inflammatory bowel disease (IBD) and epidemiological data identified dietary fats but not obesity as risk factors for the development of IBD. Crohn's disease is one of the two major IBD phenotypes and mostly affects the terminal ileum. Despite recent observations that high fat diets (HFD) impair intestinal barrier functions and drive pathobiont selection relevant for chronic inflammation in the colon, mechanisms of high fat diets in the pathogenesis of Crohn's disease are not known. The aim of this study was to characterize the effect of HFD on the development of chronic ileal inflammation in a murine model of Crohn's disease-like ileitis. Methods: TNF Delta ARE/WT mice and wildtype C57BL/6 littermates were fed a HFD compared to control diet for different durations. Intestinal pathology and metabolic parameters (glucose tolerance, mesenteric tissue characteristics) were assessed. Intestinal barrier integrity was characterized at different levels including polyethylene glycol (PEG) translocation, endotoxin in portal vein plasma and cellular markers of barrier function. Inflammatory activation of epithelial cells as well as immune cell infiltration into ileal tissue were determined and related to luminal factors. Results: HFD aggravated ileal inflammation but did not induce significant overweight or typical metabolic disorders in TNF Delta ARE/WT. Expression of the tight junction protein Occludin was markedly reduced in the ileal epithelium of HFD mice independently of inflammation, and translocation of endotoxin was increased. Epithelial cells showed enhanced expression of inflammation-related activation markers, along with enhanced luminal factors-driven recruitment of dendritic cells and Th17-biased lymphocyte infiltration into the lamina propria. Conclusions: HFD feeding, independently of obesity, accelerated disease onset of small intestinal inflammation in Crohn's disease-relevant mouse model through mechanisms that involve increased intestinal permeability and altered luminal factors, leading to enhanced dendritic cell recruitment and promoted Th17 immune responses.	[Gruber, Lisa; Kisling, Sigrid; Lichti, Pia; May, Stephanie; Haller, Dirk] Tech Univ Munich, Chair Nutr & Immunol, Freising Weihenstephan, Germany; [Gruber, Lisa; Haller, Dirk] Tech Univ Munich, ZIEL Res Ctr Nutr & Food Sci, Biofunct Unit, Freising Weihenstephan, Germany; [Martin, Francois-Pierre] Nestec Ltd, Nestle Res Ctr, CH-1000 Lausanne, Switzerland; [Martin, Francois-Pierre] Nestle Inst Hlth Sci SA, Lausanne, Switzerland; [May, Stephanie; Klingenspor, Martin] Tech Univ Munich, ZIEL Res Ctr Nutr & Food Sci, Nutr Med Unit, Freising Weihenstephan, Germany; [Klingenspor, Martin] Tech Univ Munich, EKFZ Else Kroner Fresenius Ctr Nutr Med, Chair Mol Nutr Med, Freising Weihenstephan, Germany; [Lichtenegger, Martina; Rychlik, Michael] Tech Univ Munich, Chair Analyt Food Chem, Freising Weihenstephan, Germany; [Rychlik, Michael] Tech Univ Munich, ZIEL Res Ctr Nutr & Food Sci, BIOANALYT Weihenstephan, Freising Weihenstephan, Germany	Technical University of Munich; Technical University of Munich; Nestle SA; Nestle SA; Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich	Haller, D (corresponding author), Tech Univ Munich, Chair Nutr & Immunol, Freising Weihenstephan, Germany.	dirk.haller@tum.de	Klingenspor, Martin/K-5033-2019; Richter, Lisa/AAJ-8014-2021; Klingenspor, Martin/D-6930-2011; Richter, Lisa/O-3091-2015; Rychlik, Michael/G-6064-2015	Richter, Lisa/0000-0002-0769-619X; Klingenspor, Martin/0000-0002-4502-6664; Richter, Lisa/0000-0002-0769-619X; Rychlik, Michael/0000-0002-5826-6288; Martin, Francois-Pierre/0000-0003-1373-5367; Haller, Dirk/0000-0002-6977-4085	Deutsche Forschungsgemeinschaft [Ha 3148/3-1]; Bundesministerium fur Bildung und Forschung [0315674]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was funded by Deutsche Forschungsgemeinschaft (www.dfg.de; grant number Ha 3148/3-1) and Bundesministerium fur Bildung und Forschung (www.bmbf.de; grant number 0315674). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolaki M, 2008, GASTROENTEROLOGY, V134, P2025, DOI 10.1053/j.gastro.2008.02.085; Baur P, 2011, J PROTEOME RES, V10, P5523, DOI 10.1021/pr2007973; Blain A, 2002, CLIN NUTR, V21, P51, DOI 10.1054/clnu.2001.0503; Brun P, 2007, AM J PHYSIOL-GASTR L, V292, pG518, DOI 10.1152/ajpgi.00024.2006; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cayatte C, 2012, CLIN TRANSL GASTROEN, V3, DOI 10.1038/ctg.2012.2; Chan SSM, 2013, AM J GASTROENTEROL, V108, P575, DOI 10.1038/ajg.2012.453; Chang JS, 2012, J IMMUNOL, V189, P1510, DOI 10.4049/jimmunol.1200166; COOPER HS, 1993, LAB INVEST, V69, P238; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Dieu-Nosjean MC, 2000, J EXP MED, V192, P705, DOI 10.1084/jem.192.5.705; Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191; DOERRLER W, 1994, CYTOKINE, V6, P478, DOI 10.1016/1043-4666(94)90074-4; GREEN A, 1994, ENDOCRINOLOGY, V134, P2581, DOI 10.1210/en.134.6.2581; Hass DJ, 2006, CLIN GASTROENTEROL H, V4, P482, DOI 10.1016/j.cgh.2005.12.015; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hou JK, 2011, AM J GASTROENTEROL, V106, P563, DOI 10.1038/ajg.2011.44; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; KAISERLIAN D, 1993, IMMUNOL TODAY, V14, P144, DOI 10.1016/0167-5699(93)90222-7; Kaser A, 2004, J CLIN IMMUNOL, V24, P74, DOI 10.1023/B:JOCI.0000018066.46279.6b; Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996; Katchar K, 2007, AM J PHYSIOL-GASTR L, V292, pG1263, DOI 10.1152/ajpgi.00409.2006; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Lam YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034233; Long MD, 2011, INFLAMM BOWEL DIS, V17, P2162, DOI 10.1002/ibd.21585; Puleston J, 2005, ALIMENT PHARM THER, V21, P109, DOI 10.1111/j.1365-2036.2004.02262.x; Ruiz PA, 2006, ANN NY ACAD SCI, V1072, P389, DOI 10.1196/annals.1326.023; Stenman LK, 2013, BR J NUTR, P1; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Suzuki T, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-19; Van Assche G, 2010, J CROHNS COLITIS, V4, P7, DOI 10.1016/j.crohns.2009.12.003; VIDAL K, 1993, J IMMUNOL METHODS, V166, P63, DOI 10.1016/0022-1759(93)90329-6; Wang C, 2009, MUCOSAL IMMUNOL, V2, P173, DOI 10.1038/mi.2008.84; Winer S, 2009, EUR J IMMUNOL, V39, P2629, DOI 10.1002/eji.200838893	34	76	76	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e71661	10.1371/journal.pone.0071661	http://dx.doi.org/10.1371/journal.pone.0071661			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977107	Green Published, gold, Green Submitted			2022-12-25	WOS:000323570200040
J	Kistler, JO; Booth, V; Bradshaw, DJ; Wade, WG				Kistler, James O.; Booth, Veronica; Bradshaw, David J.; Wade, William G.			Bacterial Community Development in Experimental Gingivitis	PLOS ONE			English	Article							CHRONIC PERIODONTITIS; ORAL MICROFLORA; DENTAL PLAQUE; DIVERSITY; MICROBIOME; HEALTH; INDIVIDUALS; POPULATION; DISEASE; CAVITY	Current knowledge of the microbial composition of dental plaque in early gingivitis is based largely on microscopy and cultural methods, which do not provide a comprehensive description of oral microbial communities. This study used 454-pyrosequencing of the V1-V3 region of 16S rRNA genes (approximately 500 bp), and bacterial culture, to characterize the composition of plaque during the transition from periodontal health to gingivitis. A total of 20 healthy volunteers abstained from oral hygiene for two weeks, allowing plaque to accumulate and gingivitis to develop. Plaque samples were analyzed at baseline, and after one and two weeks. In addition, plaque samples from 20 chronic periodontitis patients were analyzed for cross-sectional comparison to the experimental gingivitis cohort. All of the healthy volunteers developed gingivitis after two weeks. Pyrosequencing yielded a final total of 344 267 sequences after filtering, with a mean length of 354 bases, that were clustered into an average of 299 species-level Operational Taxonomic Units (OTUs) per sample. Principal coordinates analysis (PCoA) plots revealed significant shifts in the bacterial community structure of plaque as gingivitis was induced, and community diversity increased significantly after two weeks. Changes in the relative abundance of OTUs during the transition from health to gingivitis were correlated to bleeding on probing (BoP) scores and resulted in the identification of new health-and gingivitis-associated taxa. Comparison of the healthy volunteers to the periodontitis patients also confirmed the association of a number of putative periodontal pathogens with chronic periodontitis. Taxa associated with gingivitis included Fusobacterium nucleatum subsp. polymorphum, Lachnospiraceae [G-2] sp. HOT100, Lautropia sp. HOTA94, and Prevotella oulorum, whilst Rothia dentocariosa was associated with periodontal health. Further study of these taxa is warranted and may lead to new therapeutic approaches to prevent periodontal disease.	[Kistler, James O.; Wade, William G.] Kings Coll London, Microbiol Unit, Inst Dent, London, England; [Booth, Veronica] Kings Coll London, Dept Periodontol, Inst Dent, London, England; [Bradshaw, David J.] GlaxoSmithKline Consumer Healthcare, Weybridge, Surrey, England	University of London; King's College London; University of London; King's College London; GlaxoSmithKline	Wade, WG (corresponding author), Kings Coll London, Microbiol Unit, Inst Dent, London, England.	william.wade@kcl.ac.uk		Wade, William/0000-0003-2685-826X	BBSRC [BB/G01714X/1]; GlaxoSmithKline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); GlaxoSmithKline(GlaxoSmithKline)	This study was supported by a BBSRC Industrial Case Studentship ref no. BB/G01714X/1 in collaboration with GlaxoSmithKline. The BBSRC had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. GlaxoSmithKline participated in the planning of the research and the preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Abusleme L, 2013, ISME J, V7, P1016, DOI 10.1038/ismej.2012.174; Armitage G C, 1996, Ann Periodontol, V1, P37, DOI 10.1902/annals.1996.1.1.37; Belda-Ferre P, 2012, ISME J, V6, P46, DOI 10.1038/ismej.2011.85; Bik EM, 2010, ISME J, V4, P962, DOI 10.1038/ismej.2010.30; Bunge J, 2011, BIOCOMPUT-PAC SYM, P121; Caglar E, 2005, ORAL DIS, V11, P131, DOI 10.1111/j.1601-0825.2005.01109.x; CHAO A, 1984, SCAND J STAT, V11, P265; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; de Lillo A, 2006, ORAL MICROBIOL IMMUN, V21, P61, DOI 10.1111/j.1399-302X.2005.00255.x; Diaz PI, 2012, MOL ORAL MICROBIOL, V27, P182, DOI 10.1111/j.2041-1014.2012.00642.x; Diaz PI, 2006, APPL ENVIRON MICROB, V72, P2837, DOI 10.1128/AEM.72.4.2837-2848.2006; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Evans J, 2006, J MOL EVOL, V62, P785, DOI 10.1007/s00239-005-0176-2; EXCOFFIER L, 1992, GENETICS, V131, P479; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; He X, 2009, Adv Dent Res, V21, P53, DOI 10.1177/0895937409335626; Huang S, 2011, BMC ORAL HEALTH, V11, DOI 10.1186/1472-6831-11-33; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Kroes I, 1999, P NATL ACAD SCI USA, V96, P14547, DOI 10.1073/pnas.96.25.14547; Kumar PS, 2003, J DENT RES, V82, P338, DOI 10.1177/154405910308200503; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Lazarevic V, 2009, J MICROBIOL METH, V79, P266, DOI 10.1016/j.mimet.2009.09.012; Leys EJ, 2002, J CLIN MICROBIOL, V40, P821, DOI 10.1128/JCM.40.3.821-825.2002; Li L, 2010, J DENT RES, V89, P980, DOI 10.1177/0022034510370026; LOE H, 1965, J PERIODONTOL, V36, P177, DOI 10.1902/jop.1965.36.3.177; LOESCHE WJ, 1978, INFECT IMMUN, V21, P830, DOI 10.1128/IAI.21.3.830-839.1978; Lozupone CA, 2008, FEMS MICROBIOL REV, V32, P557, DOI 10.1111/j.1574-6976.2008.00111.x; Moazzez R, 2011, EUR J ORAL SCI, V119, P441, DOI 10.1111/j.1600-0722.2011.00886.x; Moore W E, 1994, Periodontol 2000, V5, P66, DOI 10.1111/j.1600-0757.1994.tb00019.x; MOORE WEC, 1982, INFECT IMMUN, V38, P651, DOI 10.1128/IAI.38.2.651-667.1982; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Paster BJ, 2006, PERIODONTOL 2000, V42, P80, DOI 10.1111/j.1600-0757.2006.00174.x; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2011, BMC BIOINFORMATICS, V12, P38; RITZ HL, 1967, ARCH ORAL BIOL, V12, P1561, DOI 10.1016/0003-9969(67)90190-2; Rothberg JM, 2008, NAT BIOTECHNOL, V26, P1117, DOI 10.1038/nbt1485; Schatzle M, 2003, J CLIN PERIODONTOL, V30, P887, DOI 10.1034/j.1600-051X.2003.00414.x; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Scholz CFP, 2012, J CLIN MICROBIOL, V50, P1968, DOI 10.1128/JCM.00365-12; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; SILNESS J, 1964, Acta Odontol Scand, V22, P121, DOI 10.3109/00016356408993968; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; SLATKIN M, 1990, GENETICS, V126, P249; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Teles R, 2013, PERIODONTOL 2000, V62, P95, DOI 10.1111/prd.12010; THEILADE ELSE, 1966, J PERIODONTAL RES, V1, P1, DOI 10.1111/j.1600-0765.1966.tb01842.x; Wade WG, 2010, J DENT, V38, pS21, DOI 10.1016/S0300-5712(10)70007-5; Wade WG, 2004, ADV APPL MICROBIOL, V54, P93, DOI 10.1016/S0065-2164(04)54003-0; WU CC, 1992, INT J SYST BACTERIOL, V42, P536, DOI 10.1099/00207713-42-4-536; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; Zee KY, 1996, ARCH ORAL BIOL, V41, P647, DOI 10.1016/S0003-9969(96)00065-9; Zuger J, 2007, MICROBIOL-SGM, V153, P3809, DOI 10.1099/mic.0.2007/010926-0	58	124	133	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71227	10.1371/journal.pone.0071227	http://dx.doi.org/10.1371/journal.pone.0071227			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967169	Green Published, gold, Green Submitted			2022-12-25	WOS:000323221500059
J	Liu, T; Yi, WJ; Feng, BY; Zhou, Z; Xiao, GF				Liu, Ting; Yi, Wenjing; Feng, Boya; Zhou, Zheng; Xiao, Gengfu			IGF-1-Induced Enhancement of PRNP Expression Depends on the Negative Regulation of Transcription Factor FOXO3a	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; CELLULAR PRION PROTEIN; GROWTH-FACTOR; FACTOR-I; GENE-EXPRESSION; OXIDATIVE STRESS; POSTNATAL-DEVELOPMENT; PC12 CELLS; INSULIN; SCRAPIE	The conformational conversion of the cellular prion protein (PrPC) into its beta-sheet-rich scrapie isoform (PrPSc) causes fatal prion diseases, which are also called transmissible spongiform encephalopathies (TSEs). Recent studies suggest that the expression of PrPC by the PRNP gene is crucial for the development of TSEs. Therefore, the identification of the exogenous and endogenous stimulating factors that regulate PRNP expression would help to understand the pathogenesis of TSEs. Here, we demonstrate that forkhead box O3a (FOXO3a) negatively regulates PRNP expression by binding to the PRNP promoter, which is negatively regulated by insulin-like growth factor 1 (IGF-1). Our results show that the IGF-1-induced enhancement of PRNP mRNA and protein levels is due to the activation of the PI3K-Akt signaling pathway. The activation of Akt then induces the phosphorylation of FOXO3a, leading to its translocation from the nucleus to the cytoplasm and preventing its binding to the PRNP promoter. Treatment with the PI3K-Akt inhibitor LY294002 induces the nuclear retention of FOXO3a, which leads to a decrease in PRNP expression. We present a new IGF-1-PI3K-Akt-FOXO3a pathway, which influences PRNP expression. The results of this work are vital for understanding the function of PrPC and for future therapeutic approaches to human TSEs.	[Liu, Ting; Yi, Wenjing; Feng, Boya; Zhou, Zheng; Xiao, Gengfu] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Zhou, Z (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China.	Zhouzheng@wh.iov.cn; xiaogf@wh.iov.cn	Zhou, Zheng/AAK-2669-2021	Zhou, Zheng/0000-0002-3124-6041	Natural Science Foundation of China [31170156, 30970150]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (Project No. 31170156 and No. 30970150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhani M, 2005, J BIOL CHEM, V280, P12096, DOI 10.1074/jbc.M412171200; Anderson MJ, 1998, GENOMICS, V47, P187, DOI 10.1006/geno.1997.5122; Bellingham SA, 2009, J BIOL CHEM, V284, P1291, DOI 10.1074/jbc.M804755200; Biggs WH, 2001, MAMM GENOME, V12, P416, DOI 10.1007/s003350020002; Brown DR, 1998, BIOCHEM J, V334, P423, DOI 10.1042/bj3340423; Brown DR, 2002, MOL BIOTECHNOL, V22, P165, DOI 10.1385/MB:22:2:165; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Burgess STG, 2009, J BIOL CHEM, V284, P6716, DOI 10.1074/jbc.M807065200; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Caruso P, 2009, VIROLOGY, V385, P343, DOI 10.1016/j.virol.2008.12.005; CASTELNAU P, 1994, EXP NEUROL, V130, P407, DOI 10.1006/exnr.1994.1220; Chiarini LB, 2002, EMBO J, V21, P3317, DOI 10.1093/emboj/cdf324; Chiribau CB, 2008, J BIOL CHEM, V283, P8211, DOI 10.1074/jbc.M710610200; D'Ercole AJ, 2002, NEUROPEPTIDES, V36, P209, DOI 10.1054/npep.2002.0893; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; DErcole AJ, 1996, HORM RES, V45, P5, DOI 10.1159/000184816; DErcole AJ, 1996, MOL NEUROBIOL, V13, P227, DOI 10.1007/BF02740625; Droge W, 2008, ANTIOXID REDOX SIGN, V10, P661, DOI 10.1089/ars.2007.1953; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Finkel T, 2005, NAT REV MOL CELL BIO, V6, P971, DOI 10.1038/nrm1763; Folli F, 1996, MOL NEUROBIOL, V13, P155, DOI 10.1007/BF02740639; Gasparini L, 2003, TRENDS NEUROSCI, V26, P404, DOI 10.1016/S0166-2236(03)00163-2; Goto T, 2008, BRIT J CANCER, V98, P1068, DOI 10.1038/sj.bjc.6604279; Hasegawa K, 2007, CANCER SCI, V98, P838, DOI 10.1111/j.1349-7006.2007.00460.x; HAVRANKOVA J, 1978, NATURE, V272, P827, DOI 10.1038/272827a0; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Jacobs FMJ, 2003, J BIOL CHEM, V278, P35959, DOI 10.1074/jbc.M302804200; Katic M, 2005, CELL MOL LIFE SCI, V62, P320, DOI 10.1007/s00018-004-4297-y; Klamt F, 2001, FREE RADICAL BIO MED, V30, P1137; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; KRETZSCHMAR HA, 1986, AM J PATHOL, V122, P1; Landis JN, 2010, DEV DYNAM, V239, P1405, DOI 10.1002/dvdy.22244; LASMEZAS C, 1993, BIOCHEM BIOPH RES CO, V196, P1163, DOI 10.1006/bbrc.1993.2373; Lee KS, 2009, J BIOL CHEM, V284, P29454, DOI 10.1074/jbc.M109.028027; MANSON JC, 1994, NEURODEGENERATION, V3, P331; Martins VR, 2002, FEBS LETT, V512, P25, DOI 10.1016/S0014-5793(02)02291-3; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; MOSER M, 1995, NEURON, V14, P509, DOI 10.1016/0896-6273(95)90307-0; Nasrin N, 2000, P NATL ACAD SCI USA, V97, P10412, DOI 10.1073/pnas.190326997; O'Kusky JR, 2000, J NEUROSCI, V20, P8435, DOI 10.1523/JNEUROSCI.20-22-08435.2000; Park YG, 2012, INT J MOL MED, V30, P1069, DOI 10.3892/ijmm.2012.1087; Popken GJ, 2004, EUR J NEUROSCI, V19, P2056, DOI 10.1111/j.0953-816X.2004.03320.x; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Qin KF, 2009, J BIOL CHEM, V284, P4582, DOI 10.1074/jbc.M808410200; Schon EA, 2000, TRENDS BIOCHEM SCI, V25, P555, DOI 10.1016/S0968-0004(00)01688-1; Shyu WC, 2005, J NEUROSCI RES, V80, P887, DOI 10.1002/jnr.20509; Shyu WC, 2004, CELL MOL NEUROBIOL, V24, P257, DOI 10.1023/B:CEMN.0000018620.41913.d2; Shyu WC, 2002, MOL NEUROBIOL, V26, P1, DOI 10.1385/MN:26:1:001; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; van der Vos KE, 2011, ANTIOXID REDOX SIGN, V14, P579, DOI 10.1089/ars.2010.3419; Wang VC, 2005, BIOCHEM BIOPH RES CO, V333, P95, DOI 10.1016/j.bbrc.2005.05.091; White AR, 1999, AM J PATHOL, V155, P1723, DOI 10.1016/S0002-9440(10)65487-9; Wright JA, 2009, CELL MOL LIFE SCI, V66, P3809, DOI 10.1007/s00018-009-0154-8; Xuan ZY, 2005, MECH AGEING DEV, V126, P209, DOI 10.1016/j.mad.2004.09.021; Ye P, 1996, DEV BRAIN RES, V95, P44; Zawlik I, 2006, NEUROSCI LETT, V400, P58, DOI 10.1016/j.neulet.2006.02.021	59	10	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71896	10.1371/journal.pone.0071896	http://dx.doi.org/10.1371/journal.pone.0071896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967259	gold, Green Submitted, Green Published			2022-12-25	WOS:000323221500110
J	Muthukumar, S; Rajesh, D; Saibaba, G; Alagesan, A; Rengarajan, RL; Archunan, G				Muthukumar, Subramanian; Rajesh, Durairaj; Saibaba, Ganesan; Alagesan, Alagersamy; Rengarajan, Rengasamy Lakhsminarayanan; Archunan, Govindaraju			Urinary Lipocalin Protein in a Female Rodent with Correlation to Phases in the Estrous Cycle: An Experimental Study Accompanied by In Silico Analysis	PLOS ONE			English	Article							HOUSE MOUSE; STRUCTURE PREDICTION; PUTATIVE PHEROMONES; BINDING-PROTEIN; IDENTIFICATION; MICE; ALPHA(2U)-GLOBULIN; PURIFICATION; BIOACTIVITY; REFINEMENT	Male urinary lipocalin family proteins, practically odorant-binding proteins but also could be pheromones by themselves, in rodents act as a shuttle for chemosignal communication and facilitate delivery of the signals for access to congeners. However, presence of this protein in urine of female rodents has not yet been reported. Therefore, the present investigation was carried out to find if lipocalin family protein is present in the urine of female house rat and, if so, to find whether its expression differs between the phases in the estrous cycle. The rat urinary protein was separated in single dimensional gel electrophoresis. A 14.5 kDa lipocalin protein appeared in the urine prominently during the estrus and metestrus phases compared to proestrus and diestrus phases. The expression of this protein in the urine was very low in ovariectomized rats. MALDI-TOF/MS analysis affirmed the 14.5 kDa protein as a lipocalin family protein. Analysis adopting bio-informatics tools further proved the protein as a lipocalin family member. Thus, this study for the first time demonstrated the presence of a lipocalin family protein in the urine of a female rodent and it was highly expressed during estrus phase. This lipocalin protein in female rat urine may facilitate a chemosignal function independently of a pheromone or in association with a specific pheromone.	[Muthukumar, Subramanian; Rajesh, Durairaj; Saibaba, Ganesan; Alagesan, Alagersamy; Rengarajan, Rengasamy Lakhsminarayanan; Archunan, Govindaraju] Bharathidasan Univ, Sch Life Sci, Dept Anim Sci, Ctr Pheromone Technol, Tiruchirappalli, Tamil Nadu, India; [Muthukumar, Subramanian] Univ Hong Kong, Swire Inst Marine Sci, Hong Kong, Hong Kong, Peoples R China; [Muthukumar, Subramanian] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China	Bharathidasan University; University of Hong Kong; University of Hong Kong	Archunan, G (corresponding author), Bharathidasan Univ, Sch Life Sci, Dept Anim Sci, Ctr Pheromone Technol, Tiruchirappalli, Tamil Nadu, India.	archunan@bdu.ac.in	GOVINDARAJU, ARCHUNAN/A-9072-2019; Durairaj, Rajesh/N-9013-2018; Ganesan, Saibaba/AAO-9521-2020	GOVINDARAJU, ARCHUNAN/0000-0002-7094-0351; Durairaj, Rajesh/0000-0002-3807-4174; Muthukumar, Subramanian/0000-0002-4317-8621; Ganesan, Saibaba/0000-0002-6347-142X	Council for Scientific and Industrial Research (CSIR), New Delhi	Council for Scientific and Industrial Research (CSIR), New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	We thank Prof. M.A. Akbarsha, Director & Chair, Mahatma Gandhi - Doerenkamp Centre, Bharathidasan University, Tiruchirappalli, India for the critical reading of the manuscript, and Prof. Dipankar Chatterje, Molecular Biophysics Unit and Proteomics Facility Center, Indian Institute of Science, Bangalore, for help in MALDI-TOF/MS analysis. The facility availed through UGC-SAP and DST-PURSE is acknowledged. SM thanks Council for Scientific and Industrial Research (CSIR), New Delhi, for the award of Senior Research Fellowship.	Achiraman S., 2002, Indian Journal of Experimental Biology, V40, P1077; Achiraman S, 2006, THERIOGENOLOGY, V66, P1913, DOI 10.1016/j.theriogenology.2006.05.010; ARCHUNAN G, 1990, EXP CLIN ENDOCRINOL, V96, P30, DOI 10.1055/s-0029-1210985; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Beynon RJ, 2004, PEPTIDES, V25, P1553, DOI 10.1016/j.peptides.2003.12.025; Beynon RJ, 2003, BIOCHEM SOC T, V31, P142, DOI 10.1042/bst0310142; BOCSKEI Z, 1992, NATURE, V360, P186, DOI 10.1038/360186a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breer Heinz, 1994, Seminars in Cell Biology, V5, P25, DOI 10.1006/scel.1994.1004; Brennan PA, 2004, CURR BIOL, V14, pR81, DOI 10.1016/j.cub.2003.12.052; Briand L, 2004, PEPTIDES, V25, P1545, DOI 10.1016/j.peptides.2003.10.026; Brownlow S, 1997, STRUCTURE, V5, P481, DOI 10.1016/S0969-2126(97)00205-0; Byers SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035538; Cavaggioni A, 2000, BBA-PROTEIN STRUCT M, V1482, P218, DOI 10.1016/S0167-4838(00)00149-7; Chen CC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-366; COWAN SW, 1990, PROTEINS, V8, P44, DOI 10.1002/prot.340080108; DEHNHARD M, 1991, THERIOGENOLOGY, V35, P645, DOI 10.1016/0093-691X(91)90460-U; Estrada-Camarena E, 2003, NEUROPSYCHOPHARMACOL, V28, P830, DOI 10.1038/sj.npp.1300097; FLOWER DR, 1991, BIOCHEM BIOPH RES CO, V180, P69, DOI 10.1016/S0006-291X(05)81256-2; Flower DR, 1996, BIOCHEM J, V318, P1; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; HUBER R, 1987, J MOL BIOL, V198, P499, DOI 10.1016/0022-2836(87)90296-8; Hurst JL, 1998, ANIM BEHAV, V55, P1289, DOI 10.1006/anbe.1997.0650; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Ma WD, 1999, J CHEM ECOL, V25, P417, DOI 10.1023/A:1020937400480; MARCHLEWSKAKOJ A, 1977, BIOL REPROD, V17, P729, DOI 10.1095/biolreprod17.5.729; Martinez-Garcia F, 2009, BEHAV BRAIN RES, V200, P277, DOI 10.1016/j.bbr.2008.10.002; MUCIGNATCARETTA C, 1995, J PHYSIOL-LONDON, V486, P517, DOI 10.1113/jphysiol.1995.sp020830; NOVOTNY M, 1990, CHEM SIGNAL, V5, P1; Novotny MV, 1999, P ROY SOC B-BIOL SCI, V266, P2017, DOI 10.1098/rspb.1999.0880; Pugalenthi G, 2005, NUCLEIC ACIDS RES, V33, pW130, DOI 10.1093/nar/gki427; Rajanarayanan S, 2004, THERIOGENOLOGY, V61, P861, DOI 10.1016/j.theriogenology.2003.07.004; Rajanarayanan S, 2011, RES VET SCI, V91, P301, DOI 10.1016/j.rvsc.2010.12.005; Rajkumar R, 2010, RAPID COMMUN MASS SP, V24, P721, DOI 10.1002/rcm.4437; Rajkumar R, 2009, INDIAN J BIOCHEM BIO, V46, P319; Rasmussen LEL, 1997, CHEM SENSES, V22, P417, DOI 10.1093/chemse/22.4.417; Roberts SA, 2012, SCIENCE, V338, P1462, DOI 10.1126/science.1225638; Roberts SA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-75; Robertson DHL, 1996, BIOCHEM J, V316, P265, DOI 10.1042/bj3160265; ROBERTSON DHL, 1993, J CHEM ECOL, V19, P1405, DOI 10.1007/BF00984885; Sankar R, 2008, ANIM REPROD SCI, V103, P149, DOI 10.1016/j.anireprosci.2007.04.014; Selvaraj R, 2002, ZOOL STUD, V41, P127; Sharrow SD, 2003, BIOCHEMISTRY-US, V42, P6302, DOI 10.1021/bi026423q; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SINGER AG, 1986, J BIOL CHEM, V261, P3323; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; YANDRAPALLI N, 2012, ASIAN J SCI RES, V5, P228, DOI DOI 10.3923/ajsr.2012.228.237	49	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71357	10.1371/journal.pone.0071357	http://dx.doi.org/10.1371/journal.pone.0071357			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967199	Green Submitted, Green Published, gold			2022-12-25	WOS:000323221500079
J	Nie, Y; Fang, H; Li, Y; Chi, CQ; Tang, YQ; Wu, XL				Nie, Yong; Fang, Hui; Li, Yan; Chi, Chang-Qiao; Tang, Yue-Qin; Wu, Xiao-Lei			The Genome of the Moderate Halophile Amycolicicoccus subflavus DQS3-9A1(T) Reveals Four Alkane Hydroxylation Systems and Provides Some Clues on the Genetic Basis for Its Adaptation to a Petroleum Environment	PLOS ONE			English	Article							CRUDE-OIL; CORYNEBACTERIUM-GLUTAMICUM; 2-COMPONENT SYSTEM; NA+/H+ ANTIPORTER; SOLUBLE METHANE; GEN. NOV.; DEGRADATION; EXPRESSION; SEQUENCE; IDENTIFICATION	The moderate halophile Amycolicicoccus subflavus DQS3-9A1(T) is the type strain of a novel species in the recently described novel genus Amycolicicoccus, which was isolated from oil mud precipitated from oil produced water. The complete genome of A. subflavus DQS3-9A1(T) has been sequenced and is characteristic of harboring the genes for adaption to the harsh petroleum environment with salinity, high osmotic pressure, and poor nutrient levels. Firstly, it characteristically contains four types of alkane hydroxylases, including the integral-membrane non-heme iron monooxygenase (AlkB) and cytochrome P450 CYP153, a long-chain alkane monooxygenase (LadA) and propane monooxygenase. It also accommodates complete pathways for the response to osmotic pressure. Physiological tests proved that the strain could grow on n-alkanes ranging from C10 to C36 and propane as the sole carbon sources, with the differential induction of four kinds of alkane hydroxylase coding genes. In addition, the strain could grow in 1-12% NaCl with the putative genes responsible for osmotic stresses induced as expected. These results reveal the effective adaptation of the strain DQS3-9A1(T) to harsh oil environment and provide a genome platform to investigate the global regulation of different alkane metabolisms in bacteria that are crucially important for petroleum degradation. To our knowledge, this is the first report to describe the co-existence of such four types of alkane hydroxylases in a bacterial strain.	[Nie, Yong; Fang, Hui; Li, Yan; Chi, Chang-Qiao; Tang, Yue-Qin; Wu, Xiao-Lei] Peking Univ, Dept Energy & Resources Engn, Coll Engn, Beijing 100871, Peoples R China; [Nie, Yong; Chi, Chang-Qiao; Wu, Xiao-Lei] Peking Univ, Inst Engn Baotou, Coll Engn, Baotou, Peoples R China	Peking University; Peking University	Wu, XL (corresponding author), Peking Univ, Dept Energy & Resources Engn, Coll Engn, Beijing 100871, Peoples R China.	xiaolei_wu@pku.edu.cn	Wu, Xiao-Lei/G-6882-2011	Wu, Xiao-Lei/0000-0002-9897-6903	National Natural Science Foundation of China [31070107, 31225001]; National High Technology Research and Development Program ("863" Program) [2012AA02A703]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program ("863" Program)(National High Technology Research and Development Program of China)	This study was supported by the National Natural Science Foundation of China (31070107, 31225001) and the National High Technology Research and Development Program ("863" Program: 2012AA02A703). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; BONNEFOY V, 1994, ANTON LEEUW INT J G, V66, P47, DOI 10.1007/BF00871632; Brown LR, 2010, CURR OPIN MICROBIOL, V13, P316, DOI 10.1016/j.mib.2010.01.011; Cai M, 2011, J BACTERIOL, V193, P4538, DOI 10.1128/JB.05388-11; Cai M, 2011, SYST APPL MICROBIOL, V34, P321, DOI 10.1016/j.syapm.2011.03.004; CURCIC R, 1994, MOL MICROBIOL, V13, P1057, DOI 10.1111/j.1365-2958.1994.tb00496.x; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Epstein W, 2003, PROG NUCLEIC ACID RE, V75, P293, DOI 10.1016/S0079-6603(03)75008-9; Feng L, 2007, P NATL ACAD SCI USA, V104, P5602, DOI 10.1073/pnas.0609650104; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Heermann R, 2004, CURR OPIN MICROBIOL, V7, P168, DOI 10.1016/j.mib.2004.02.008; Heermann R, 2010, FEMS MICROBIOL LETT, V304, P97, DOI 10.1111/j.1574-6968.2010.01906.x; Hiramatsu T, 1998, J BACTERIOL, V180, P6642, DOI 10.1128/JB.180.24.6642-6648.1998; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; KOK M, 1989, J BIOL CHEM, V264, P5435; Kopp DA, 2002, CURR OPIN CHEM BIOL, V6, P568, DOI 10.1016/S1367-5931(02)00366-6; Kramer R, 2009, AMINO ACIDS, V37, P487, DOI 10.1007/s00726-009-0271-6; Kramer R, 2004, BBA-BIOENERGETICS, V1658, P31, DOI 10.1016/j.bbabio.2004.05.006; Kryachko Y, 2012, ANTON LEEUW INT J G, V101, P493, DOI 10.1007/s10482-011-9658-y; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Langille MGI, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-329; LEAHY JG, 1990, MICROBIOL REV, V54, P305, DOI 10.1128/MMBR.54.3.305-315.1990; Li H, 2007, FEMS MICROBIOL ECOL, V60, P74, DOI 10.1111/j.1574-6941.2006.00266.x; Liu CL, 2011, ENVIRON MICROBIOL, V13, P1168, DOI 10.1111/j.1462-2920.2010.02416.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUQUE I, 1993, PLANT MOL BIOL, V21, P1201, DOI 10.1007/BF00023618; Maier T, 2001, BIOCHEM BIOPH RES CO, V286, P652, DOI 10.1006/bbrc.2001.5449; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Markowitz VM, 2010, NUCLEIC ACIDS RES, V38, pD382, DOI 10.1093/nar/gkp887; McLeod MP, 2006, P NATL ACAD SCI USA, V103, P15582, DOI 10.1073/pnas.0607048103; Merkx M, 2001, ANGEW CHEM INT EDIT, V40, P2782, DOI 10.1002/1521-3773(20010803)40:15<2782::AID-ANIE2782>3.0.CO;2-P; Moker N, 2004, MOL MICROBIOL, V54, P420, DOI 10.1111/j.1365-2958.2004.04249.x; Nie Y, 2013, APPL MICROB IN PRESS, DOI [10.1007/s00253-00013-04821-00251, DOI 10.1007/S00253-00013-04821-00251]; Nie Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031261; Nie Y, 2011, APPL ENVIRON MICROB, V77, P7279, DOI 10.1128/AEM.00203-11; OGAWA KI, 1995, J BACTERIOL, V177, P1409, DOI 10.1128/jb.177.5.1409-1413.1995; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Rojo F, 2009, ENVIRON MICROBIOL, V11, P2477, DOI 10.1111/j.1462-2920.2009.01948.x; SAKIA RM, 1992, J ROY STAT SOC D-STA, V41, P169, DOI 10.2307/2348250; Schneiker S, 2006, NAT BIOTECHNOL, V24, P997, DOI 10.1038/nbt1232; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Throne-Holst M, 2007, APPL ENVIRON MICROB, V73, P3327, DOI 10.1128/AEM.00064-07; van Beilen JB, 2007, APPL MICROBIOL BIOT, V74, P13, DOI 10.1007/s00253-006-0748-0; Wang WP, 2012, APPL MICROBIOL BIOT, V94, P437, DOI 10.1007/s00253-011-3818-x; Wang XB, 2013, APPL ENVIRON MICROB, V79, P400, DOI 10.1128/AEM.02497-12; Wang XB, 2011, BIORESOURCE TECHNOL, V102, P7755, DOI 10.1016/j.biortech.2011.06.009; Wang YN, 2010, INT J SYST EVOL MICR, V60, P638, DOI 10.1099/ijs.0.010546-0; Wentzel A, 2007, APPL MICROBIOL BIOT, V76, P1209, DOI 10.1007/s00253-007-1119-1; Whyte LG, 2002, APPL ENVIRON MICROB, V68, P5933, DOI 10.1128/AEM.68.12.5933-5942.2002; Wood JM, 1999, MICROBIOL MOL BIOL R, V63, P230, DOI 10.1128/MMBR.63.1.230-262.1999; Yamada T, 2011, NUCLEIC ACIDS RES, V39, pW412, DOI 10.1093/nar/gkr313; Zoltan B, 2011, FEMS MICROBIOL LETT, V316, P100, DOI 10.1111/j.1574-6968.2010.02198.x	52	23	25	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e70986	10.1371/journal.pone.0070986	http://dx.doi.org/10.1371/journal.pone.0070986			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967144	gold, Green Published, Green Submitted			2022-12-25	WOS:000323221500050
J	Soletti, RC; Rodrigues, NALV; Biasoli, D; Luiz, RR; de Souza, HSP; Borges, HL				Soletti, Rossana Colla; Lins Vidal Rodrigues, Nathassya Accioly; Biasoli, Deborah; Luiz, Ronir Raggio; Pereira de Souza, Heitor Siffert; Borges, Helena Lobo			Immunohistochemical Analysis of Retinoblastoma and beta-Catenin as an Assistant Tool in the Differential Diagnosis between Crohn's Disease and Ulcerative Colitis	PLOS ONE			English	Article							ANTI-SACCHAROMYCES-CEREVISIAE; INFLAMMATORY-BOWEL-DISEASE; GENE-EXPRESSION; INDETERMINATE COLITIS; COLON-CANCER; ANTIBODIES; ACTIVATION; PATHWAY; ASCA; AUTOANTIBODIES	In about 10-15% of patients with inflammatory bowel diseases (IBD) there is no clear definitive differential diagnosis between Crohn's disease (CD) and ulcerative colitis (UC) and the disease is classified as indeterminate colitis. Since pharmacological and surgical treatments differ in CD and UC, establishing a correct diagnosis is critical. The aim of this work was to access the expression profile of proteins involved in colonic inflammation and cancer in samples from CD and UC. For that, colon samples from 24 CD, 21 UC and 10 control patients were processed for immunohistochemistry using anti-phosphorylated RB at Ser(807/811) and anti-beta-catenin. Crypts were blinded, analyzed and counted for phosphorylated RB-positive (phospho-RB) cells or scored for positive beta-catenin staining. Western blot was used for confirming immuhistochemical results: RB phosphorylation was significantly greater in colon samples from patients with CD compared with UC (p<0.005). In contrast, the expression of beta-catenin was significantly increased in UC compared with CD (p<0.005) samples. Phospho-RB and beta-catenin are negatively correlated (CC: -0.573; p = 0.001). A positive phospho-RB test yielded high levels of sensitivity, specificity, negative and positive predictive values, and accuracy for the diagnosis of CD against UC. This work indicates that RB phosphorylation and beta-catenin nuclear translocation are differently expressed in CD and UC, and provide novel insights into the pathogenic mechanisms of IBD. In particular, rates of phospho-RB-positive cells in mucosal samples emerge as a promising tool for the differential diagnosis of patients with IBD.	[Soletti, Rossana Colla; Lins Vidal Rodrigues, Nathassya Accioly; Biasoli, Deborah; Borges, Helena Lobo] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, RJ, Brazil; [Luiz, Ronir Raggio] Univ Fed Rio de Janeiro, IESC, Rio De Janeiro, RJ, Brazil; [Pereira de Souza, Heitor Siffert] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Dept Clin Med, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Borges, HL (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, RJ, Brazil.	hborges@icb.ufrj.br	de Souza, Heitor Siffert Pereira/G-3297-2012; Borges, Helena L/E-5044-2013; Luiz, Ronir Raggio/ABE-2684-2021; Luiz, Ronir R/C-3372-2013; Borges, Helena/W-7533-2019; Borges, Helena/AAG-3701-2020	de Souza, Heitor Siffert Pereira/0000-0002-3647-7324; Borges, Helena L/0000-0003-2866-4223; Luiz, Ronir Raggio/0000-0002-7784-9905; Luiz, Ronir R/0000-0002-7784-9905; Borges, Helena/0000-0003-2866-4223; 	National Council for Scientific and Technological Development (CNPq); Carlos Chagas Filho Research Support Foundation (FAPERJ)	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Carlos Chagas Filho Research Support Foundation (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was financially supported by the following Brazilian Agencies: National Council for Scientific and Technological Development (CNPq) and the Carlos Chagas Filho Research Support Foundation (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Blumberg RS, 2008, JAMA-J AM MED ASSOC, V300, P439, DOI 10.1001/jama.300.4.439; Borges HL, 2005, P NATL ACAD SCI USA, V102, P15587, DOI 10.1073/pnas.0503925102; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown JB, 2010, GASTROENTEROLOGY, V138, P595, DOI 10.1053/j.gastro.2009.10.038; Chau BN, 2002, NAT CELL BIOL, V4, P757, DOI 10.1038/ncb853; Christophi GP, 2012, INFLAMM BOWEL DIS, V29; Cicchillitti L, 2003, J BIOL CHEM, V278, P19509, DOI 10.1074/jbc.M300511200; Cohen RD, 2003, INFLAMMATORY BOWEL D, V1; Condino AA, 2005, J PEDIATR GASTR NUTR, V41, P23, DOI 10.1097/01.mpg.0000166801.61708.60; Costello CM, 2005, PLOS MED, V2, P771, DOI 10.1371/journal.pmed.0020199; Desplat-Jego S, 2007, WORLD J GASTROENTERO, V13, P2312, DOI 10.3748/wjg.v13.i16.2312; Dieckgraefe BK, 2000, PHYSIOL GENOMICS, V4, P1; Gavert N, 2007, J CELL BIOCHEM, V102, P820, DOI 10.1002/jcb.21505; Gotoh Y, 2002, CELL PROLIFERAT, V35, P221, DOI 10.1046/j.1365-2184.2002.00241.x; Han JB, 2013, MOL CANCER RES, V11, P207, DOI 10.1158/1541-7786.MCR-12-0670; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; HARVEY RF, 1980, LANCET, V1, P514; Huang XD, 2007, J BIOL CHEM, V282, P29401, DOI 10.1074/jbc.M702261200; Iskandar HN, 2012, TRANSL RES, V159, P313, DOI 10.1016/j.trsl.2012.01.001; Israeli E, 2005, GUT, V54, P1232, DOI 10.1136/gut.2004.060228; Iwamoto M, 2000, CARCINOGENESIS, V21, P1935, DOI 10.1093/carcin/21.11.1935; Joossens S, 2002, GASTROENTEROLOGY, V122, P1242, DOI 10.1053/gast.2002.32980; Kinzler K.W., 2002, GENETIC BASIS HUMAN, V2, P583; KIRSNER JB, 1988, J CLIN GASTROENTEROL, V10, P286, DOI 10.1097/00004836-198806000-00012; Kirsner JB, 2006, INFLAMM BOWEL DIS, V1, P2; Knudsen ES, 2006, EXP BIOL MED, V231, P1271; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Krause I, 2002, CLIN EXP RHEUMATOL, V20, pS21; Lakatos PL, 2006, WORLD J GASTROENTERO, V12, P6102, DOI 10.3748/wjg.v12.i38.6102; Lawrance IC, 2001, HUM MOL GENET, V10, P445, DOI 10.1093/hmg/10.5.445; Lee G, 2010, GASTROENTEROLOGY, V139, P869, DOI 10.1053/j.gastro.2010.05.037; Mokrowiecka A, 2007, HEPATO-GASTROENTEROL, V54, P1443; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nikolaus S, 2007, GASTROENTEROLOGY, V133, P1670, DOI 10.1053/j.gastro.2007.09.001; Nirmalan NJ, 2009, J PATHOL, V217, P497, DOI 10.1002/path.2504; Pallone Francesco, 2003, Curr Gastroenterol Rep, V5, P487, DOI 10.1007/s11894-003-0038-2; Quinton JF, 1998, GUT, V42, P788, DOI 10.1136/gut.42.6.788; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Sturm A, 2004, GUT, V53, P1624, DOI 10.1136/gut.2003.033613; Telakis E, 2008, ANN GASTROENTEROL, V21, P173; Torok HP, 2004, DIGESTION, V70, P49, DOI 10.1159/000080081; TRUELOVE SC, 1955, BRIT MED J, V2, P1041, DOI 10.1136/bmj.2.4947.1041; Uthoff SMS, 2001, INT J ONCOL, V19, P803; Van Assche G, 2005, CURR OPIN GASTROEN, V21, P443; van Assche G, 2010, CURR DRUG TARGETS, V11, P227; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van Dekken H, 2007, ACTA HISTOCHEM, V109, P266, DOI 10.1016/j.acthis.2007.02.007; Ying L, 2005, CANCER RES, V65, P9132, DOI 10.1158/0008-5472.CAN-05-1358; Ying L, 2007, CANCER RES, V67, P9286, DOI 10.1158/0008-5472.CAN-07-2238	51	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e70786	10.1371/journal.pone.0070786	http://dx.doi.org/10.1371/journal.pone.0070786			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967107	Green Published, gold, Green Submitted			2022-12-25	WOS:000323221500031
J	Zhang, K; Tian, L; Liu, L; Feng, Y; Dong, YB; Li, B; Shang, DS; Fang, WG; Cao, YP; Chen, YH				Zhang, Ke; Tian, Li; Liu, Li; Feng, Yu; Dong, Yan-Bin; Li, Bo; Shang, De-Shu; Fang, Wen-Gang; Cao, Yun-Peng; Chen, Yu-Hua			CXCL1 Contributes to beta-Amyloid-Induced Transendothelial Migration of Monocytes in Alzheimer's Disease	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MARROW-DERIVED MICROGLIA; HEMATOPOIETIC-CELLS; SCAVENGER RECEPTOR; PLAQUE-FORMATION; IN-VITRO; BRAIN; CHEMOKINE; MACROPHAGES; PROTEIN	Background: Bone marrow-derived microglia that originates in part from hematopoietic cells, and more particularly from monocytes preferentially attach to amyloid deposition in brains of Alzheimer's disease (AD). However, the mechanism of monocytes recruited into the amyloid plaques with an accelerated process in AD is unclear. Methodology/Principal Findings: Here we reported that monocytes from AD patients express significantly higher chemokine (C-X-C motif) ligand 1 (CXCL1) compared to age-matched controls. AD patient's monocytes or CXCL1-overexpressing THP-1 cells had enhanced ability of beta-amyloid (A beta)-induced transendothelial migration and A beta-induced transendothelial migration for AD patient's monocytes or CXCL1-overexpressing THP-1 cells was almost abrogated by anti-CXCL1 antibody. Furthermore, monocytes derived from a transgenic mouse model of AD also expressed significantly higher CXCL1. CD11b(+)CD45(hi) population of cells that were recruited from the peripheral blood were markedly bolcked in APP mouse brain by anti-CXCL1 antibody. Accordingly, in response to A beta, human brain microvascular endothelial cells (HBMEC) significantly up-regulated CXC chemokine receptor 2 (CXCR2) expression, which was the only identified receptor for CXCL1. In addition, a high level expression of CXCR2 in HBMEC significantly promoted the CXCL1-overexpressing THP-1 cells transendothelial migration, which could be was abrogated by anti-CXCR2 antibody. Further examination of possible mechanisms found that CXCL1-overexpressing THP-1 cells induced transendothelial electrical resistance decrease, horseradish peroxidase flux increase, ZO-1 discontinuous and occludin re-distribution from insoluble to soluble fraction through interacting with CXCR2. ROCK inhibitor, Y27632, could block CXCL1-overexpressing THP-1 cells transendothelial migration, whereas other inhibitors had no effects. Conclusions/Significance: The present data indicate that monocytes derived from AD patients overexpressing CXCL1, which is a determinant for A beta-induced transendothelial migration. CXCL1 expressed by monocytes and CXCR2 on HBMEC is involved in monocytes migrating from blood to brain in AD patients.	[Zhang, Ke; Tian, Li; Dong, Yan-Bin; Li, Bo; Shang, De-Shu; Fang, Wen-Gang; Chen, Yu-Hua] China Med Univ, Dept Dev Cell Biol, Key Lab Med Cell Biol, Key Lab Cell Biol,Minist Publ Hlth,Minist Educ, Shenyang, Peoples R China; [Liu, Li; Feng, Yu; Cao, Yun-Peng] China Med Univ, Affiliated Hosp 1, Dept Neurol, Shenyang, Peoples R China	China Medical University; China Medical University	Chen, YH (corresponding author), China Med Univ, Dept Dev Cell Biol, Key Lab Med Cell Biol, Key Lab Cell Biol,Minist Publ Hlth,Minist Educ, Shenyang, Peoples R China.	yhchen@mail.cmu.edu.cn		, Ke/0000-0003-3133-759X	National Natural Science Foundation of China [81101225]; National Basic Research Program of China (973 Program) [2013CB531000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (81101225) and the National Basic Research Program of China (973 Program, 2013CB531000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt C, 2002, EUR J IMMUNOL, V32, P2133, DOI 10.1002/1521-4141(200208)32:8<2133::AID-IMMU2133>3.0.CO;2-W; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Belperio JA, 2002, J CLIN INVEST, V110, P1703, DOI 10.1172/JCI200215849; Bennett JL, 2003, J NEUROVIROL, V9, P623, DOI 10.1080/714044484; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Coraci IS, 2002, AM J PATHOL, V160, P101, DOI 10.1016/S0002-9440(10)64354-4; Dickson DW, 1999, AM J PATHOL, V154, P1627, DOI 10.1016/S0002-9440(10)65416-8; Djukic M, 2006, BRAIN, V129, P2394, DOI 10.1093/brain/awl206; Dyall J, 2001, BLOOD, V97, P114, DOI 10.1182/blood.V97.1.114; El Khoury J, 1998, NEUROBIOL AGING, V19, pS81, DOI 10.1016/S0197-4580(98)00036-0; El Khoury JB, 2003, J EXP MED, V197, P1657, DOI 10.1084/jem.20021546; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; El Khoury J, 2008, TRENDS PHARMACOL SCI, V29, P626, DOI 10.1016/j.tips.2008.08.004; ElKhoury J, 1996, NATURE, V382, P716; Fiala M, 2005, J ALZHEIMERS DIS, V7, P221, DOI 10.3233/jad-2005-7304; Fiala M, 2002, EUR J CLIN INVEST, V32, P360, DOI 10.1046/j.1365-2362.2002.00994.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Giri R, 2000, AM J PHYSIOL-CELL PH, V279, pC1772, DOI 10.1152/ajpcell.2000.279.6.C1772; Grab DJ, 2004, J PARASITOL, V90, P970, DOI 10.1645/GE-287R; HASKILL S, 1990, P NATL ACAD SCI USA, V87, P7732, DOI 10.1073/pnas.87.19.7732; Huo YQ, 2001, J CLIN INVEST, V108, P1307, DOI 10.1172/JCI12877; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; KAUR C, 1987, J ANAT, V154, P215; Kokovay E, 2005, NEUROBIOL DIS, V19, P471, DOI 10.1016/j.nbd.2005.01.023; LAWSON LJ, 1992, NEUROSCIENCE, V48, P405, DOI 10.1016/0306-4522(92)90500-2; Lee JS, 2004, J BIOL CHEM, V279, P9379, DOI 10.1074/jbc.M310638200; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Li B, 2006, FEBS LETT, V580, P4252, DOI 10.1016/j.febslet.2006.06.056; LING EA, 1979, J ANAT, V128, P847; Liu YJ, 2010, NEUROBIOL AGING, V31, P175, DOI 10.1016/j.neurobiolaging.2008.03.024; MaatSchieman MLC, 1997, J NEUROPATH EXP NEUR, V56, P273, DOI 10.1097/00005072-199703000-00006; Malm TM, 2005, NEUROBIOL DIS, V18, P134, DOI 10.1016/j.nbd.2004.09.009; Man SM, 2007, NEUROBIOL AGING, V28, P485, DOI 10.1016/j.neurobiolaging.2006.02.013; Massengale M, 2005, J EXP MED, V201, P1579, DOI 10.1084/jem.20050030; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; Otto VI, 2000, J NEUROSCI RES, V60, P733, DOI 10.1002/1097-4547(20000615)60:6<733::AID-JNR5>3.0.CO;2-X; PERRY VH, 1988, TRENDS NEUROSCI, V11, P273, DOI 10.1016/0166-2236(88)90110-5; Pino PA, 2011, JOVE-J VIS EXP, DOI 10.3791/2348; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Sakakibara A, 1997, J CELL BIOL, V137, P1393, DOI 10.1083/jcb.137.6.1393; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Simard AR, 2004, FASEB J, V18, P998, DOI 10.1096/fj.04-1517fje; Soulet D, 2008, CURR OPIN PHARMACOL, V8, P508, DOI 10.1016/j.coph.2008.04.002; Stalder AK, 2005, J NEUROSCI, V25, P11125, DOI 10.1523/JNEUROSCI.2545-05.2005; Stalder M, 1999, AM J PATHOL, V154, P1673, DOI 10.1016/S0002-9440(10)65423-5; Tamura Y, 2005, NEUROSCI LETT, V379, P149, DOI 10.1016/j.neulet.2004.12.056; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Vallieres L, 2003, J NEUROSCI, V23, P5197; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Weiner HL, 2006, NAT REV IMMUNOL, V6, P404, DOI 10.1038/nri1843; Xia MQ, 2002, J NEUROIMMUNOL, V122, P55, DOI 10.1016/S0165-5728(01)00463-5; Xia MQ, 1997, AM J PATHOL, V150, P1267; Yan P, 2006, J BIOL CHEM, V281, P24566, DOI 10.1074/jbc.M602440200; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0	59	43	43	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e72744	10.1371/journal.pone.0072744	http://dx.doi.org/10.1371/journal.pone.0072744			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967336	Green Published, gold, Green Submitted			2022-12-25	WOS:000323221500144
J	Kondo, K; Ikeda, M; Kajio, Y; Saito, T; Iwayama, Y; Aleksic, B; Yamada, K; Toyota, T; Hattori, E; Ujike, H; Inada, T; Kunugi, H; Kato, T; Yoshikawa, T; Ozaki, N; Iwata, N				Kondo, Kenji; Ikeda, Masashi; Kajio, Yusuke; Saito, Takeo; Iwayama, Yoshimi; Aleksic, Branko; Yamada, Kazuo; Toyota, Tomoko; Hattori, Eiji; Ujike, Hiroshi; Inada, Toshiya; Kunugi, Hiroshi; Kato, Tadafumi; Yoshikawa, Takeo; Ozaki, Norio; Iwata, Nakao			Genetic Variants on 3q21 and in the Sp8 Transcription Factor Gene (SP8) as Susceptibility Loci for Psychotic Disorders: A Genetic Association Study	PLOS ONE			English	Article								Background: Recent genome-wide association studies (GWASs) investigating bipolar disorder (BD) have detected a number of susceptibility genes. These studies have also provided novel insight into shared genetic components between BD and schizophrenia (SCZ), two major psychotic disorders. To examine the replication of the risk variants for BD and the pleiotropic effect of the variants associated with BD, we conducted a genetic association study of single nucleotide polymorphisms (SNPs) that were selected based upon previous BD GWASs, which targeted psychotic disorders (BD and SCZ) in the Japanese population. Methods: Forty-eight SNPs were selected based upon previous GWASs. A two-stage analysis was conducted using first-set screening (for all SNPs: BD = 1,012, SCZ = 1,032 and control = 993) and second-set replication samples (for significant SNPs in the screening analysis: BD = 821, SCZ = 1,808 and control = 2,149). We assessed allelic association between BD, SCZ, psychosis (BD+SCZ) and the SNPs selected for the analysis. Results: Eight SNPs revealed nominal association signals for all comparisons (P-uncorrected<0.05). Among these SNPs, the top two SNPs (associated with psychosis: P-corrected = 0.048 and 0.037 for rs2251219 and rs2709722, respectively) were further assessed in the second-set samples, and we replicated the signals from the initial screening analysis (associated with psychosis: P-corrected = 0.0070 and 0.033 for rs2251219 and rs2709722, respectively). The meta-analysis between the current and previous GWAS results showed that rs2251219 in Polybromo1 (PBRM1) was significant on genome-wide association level (P = 5x10(-8)) only for BD (P = 9.4x10(-9)) and psychosis (P = 2.0x10(-10)). Although the association of rs2709722 in Sp8 transcription factor (SP8) was suggestive in the Asian population (P = 2.1x10(-7) for psychosis), this signal weakened when the samples size was increased by including data from a Caucasian population (P = 4.3x10(-3)). Conclusions: We found 3p21.1 (including PBRM1, strong linkage disequilibrium made it difficult to pinpoint the risk genes) and SP8 as risk loci for BD, SCZ and psychosis. Further replication studies will be required for conclusive results.	[Kondo, Kenji; Ikeda, Masashi; Kajio, Yusuke; Saito, Takeo; Iwata, Nakao] Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 47011, Japan; [Iwayama, Yoshimi; Yamada, Kazuo; Toyota, Tomoko; Hattori, Eiji; Yoshikawa, Takeo] RIKEN, Brain Sci Inst, Lab Mol Psychiat, Wako, Saitama, Japan; [Aleksic, Branko; Ozaki, Norio] Nagoya Univ, Grad Sch Med, Dept Psychiat, Nagoya, Aichi 4648601, Japan; [Ujike, Hiroshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neuropsychiat, Okayama, Japan; [Inada, Toshiya] Seiwa Hosp, Inst Neuropsychiat, Dept Psychiat, Shinjuku Ku, Tokyo, Japan; [Kunugi, Hiroshi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Disorder Res, Kodaira, Tokyo 1870031, Japan; [Kato, Tadafumi] RIKEN, Brain Sci Inst, Lab Mol Dynam Mental Disorders, Wako, Saitama, Japan	Fujita Health University; RIKEN; Nagoya University; Okayama University; National Center for Neurology & Psychiatry - Japan; RIKEN	Ikeda, M (corresponding author), Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 47011, Japan.	ikeda-ma@fujita-hu.ac.jp	Ozaki, Norio/M-8908-2014; Kato, Tadafumi/J-3583-2014; Aleksic, Branko/G-1540-2011; Yoshikawa, Takeo/F-9599-2019; Aleksic, Branko/L-7851-2019; Kunugi, Hiroshi/ABC-5260-2021	Ozaki, Norio/0000-0002-7360-4898; Kato, Tadafumi/0000-0001-7856-3952; Aleksic, Branko/0000-0001-8982-4580; Aleksic, Branko/0000-0001-8982-4580; IWATA, Nakao/0000-0003-3189-6076; Kunugi, Hiroshi/0000-0002-7209-3790; Inada, Toshiya/0000-0002-8427-5639	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Ministry of Health, Labor and Welfare of Japan; Academic Frontier Project for Private Universities, Comparative Cognitive Science Institutes; Uehara Memorial Foundation; SEISHIN Medical Research Foundation; Takeda Science Foundation; Strategic Research Program for Brain Sciences of the MEXT of Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Academic Frontier Project for Private Universities, Comparative Cognitive Science Institutes(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); SEISHIN Medical Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Strategic Research Program for Brain Sciences of the MEXT of Japan	This work was supported by research grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, the Ministry of Health, Labor and Welfare of Japan, the Academic Frontier Project for Private Universities, Comparative Cognitive Science Institutes, the Uehara Memorial Foundation, the SEISHIN Medical Research Foundation, the Takeda Science Foundation and the Strategic Research Program for Brain Sciences of the MEXT of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cichon S, 2011, AM J HUM GENET, V88, P396, DOI [10.1016/j.ajhg.2011.01.017, 10.1016/j.ajhg.2011.03.001]; Craddock N, 2010, BRIT J PSYCHIAT, V196, P92, DOI 10.1192/bjp.bp.109.073429; Craddock N, 2009, TRENDS GENET, V25, P99, DOI 10.1016/j.tig.2008.12.002; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Hamshere ML, 2013, MOL PSYCHIAT; Lee MTM, 2011, MOL PSYCHIATR, V16, P548, DOI 10.1038/mp.2010.43; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Matsunaga S, 2012, NEUROSCI LETT, V529, P66, DOI 10.1016/j.neulet.2012.08.070; McMahon FJ, 2010, NAT GENET, V42, P128, DOI 10.1038/ng.523; Merikangas KR, 2011, ARCH GEN PSYCHIAT, V68, P241, DOI 10.1001/archgenpsychiatry.2011.12; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Sahara S, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-10; Scott LJ, 2009, P NATL ACAD SCI USA, V106, P7501, DOI 10.1073/pnas.0813386106; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Smoller JW, 2003, AM J MED GENET C, V123C, P48, DOI 10.1002/ajmg.c.20013; Williams HJ, 2011, HUM MOL GENET, V20, P387, DOI 10.1093/hmg/ddq471	25	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e70964	10.1371/journal.pone.0070964	http://dx.doi.org/10.1371/journal.pone.0070964			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967141	Green Submitted, gold, Green Published			2022-12-25	WOS:000323115800031
J	Stallings, NR; Puttaparthi, K; Dowling, KJ; Luther, CM; Burns, DK; Davis, K; Elliott, JL				Stallings, Nancy R.; Puttaparthi, Krishna; Dowling, Katherine J.; Luther, Christina M.; Burns, Dennis K.; Davis, Kathryn; Elliott, Jeffrey L.			TDP-43, an ALS Linked Protein, Regulates Fat Deposition and Glucose Homeostasis	PLOS ONE			English	Article								The identification of proteins which determine fat and lean body mass composition is critical to better understanding and treating human obesity. TDP-43 is a well-conserved RNA-binding protein known to regulate alternative splicing and recently implicated in the pathogenesis of amyotrophic lateral sclerosis (ALS). While TDP-43 knockout mice show early embryonic lethality, post-natal conditional knockout mice show weight loss, fat depletion, and rapid death, suggesting an important role for TDP-43 in regulating energy metabolism. Here we report, that over-expression of TDP-43 in transgenic mice can result in a phenotype characterized by increased fat deposition and adipocyte hypertrophy. In addition, TDP-43 over-expression in skeletal muscle results in increased steady state levels of Tbc1d1, a RAB-GTPase activating protein involved in Glucose 4 transporter (Glut4) translocation. Skeletal muscle fibers isolated from TDP-43 transgenic mice show altered Glut4 translocation in response to insulin and impaired insulin mediated glucose uptake. These results indicate that levels of TDP-43 regulate body fat composition and glucose homeostasis in vivo.	[Stallings, Nancy R.; Puttaparthi, Krishna; Dowling, Katherine J.; Luther, Christina M.; Elliott, Jeffrey L.] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Burns, Dennis K.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Davis, Kathryn] Univ Texas SW Med Ctr Dallas, Dept Plast Surg, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Elliott, JL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA.	jeffrey.elliott@utsouthwestern.edu		Stallings, Nancy/0000-0001-6132-1586	Muscular Dystrophy Association (MDA); UT ALS Research Fund; Hewett Family Research Fund	Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association); UT ALS Research Fund; Hewett Family Research Fund	This work was funded in part by support from the Muscular Dystrophy Association (MDA), UT ALS Research Fund and the Hewett Family Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Bingham NC, 2008, ENDOCRINOLOGY, V149, P2138, DOI 10.1210/en.2007-1200; Bose JK, 2008, J BIOL CHEM, V283, P28852, DOI 10.1074/jbc.M805376200; Bouteloup C, 2009, J NEUROL, V256, P1236, DOI 10.1007/s00415-009-5100-z; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; CARLSEN RC, 1985, CAN J PHYSIOL PHARM, V63, P958, DOI 10.1139/y85-158; Chadt A, 2008, NAT GENET, V40, P1354, DOI 10.1038/ng.244; Chen SA, 2011, CELL METAB, V13, P68, DOI 10.1016/j.cmet.2010.12.005; Chiang PM, 2010, P NATL ACAD SCI USA, V107, P16320, DOI 10.1073/pnas.1002176107; Dupuis L, 2011, LANCET NEUROL, V10, P75, DOI 10.1016/S1474-4422(10)70224-6; Fulcher FK, 2008, EXP CELL RES, V314, P3264, DOI 10.1016/j.yexcr.2008.08.007; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kasarskis EJ, 1996, AM J CLIN NUTR, V63, P130, DOI 10.1093/ajcn/63.1.130; Kawahara Y, 2012, P NATL ACAD SCI USA; Kraemer BC, 2010, ACTA NEUROPATHOL, V119, P409, DOI 10.1007/s00401-010-0659-0; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; Lanner JT, 2006, DIABETES, V55, P2077, DOI 10.2337/db05-1613; Lansey MN, 2012, AM J PHYSIOL-ENDOC M, V303, pE1273, DOI 10.1152/ajpendo.00316.2012; Malide D, 1997, J HISTOCHEM CYTOCHEM, V45, P1083, DOI 10.1177/002215549704500806; Marin B, 2011, J NEUROL NEUROSUR PS, V82, P628, DOI 10.1136/jnnp.2010.211474; Meyre D, 2008, HUM MOL GENET, V17, P1798, DOI 10.1093/hmg/ddn070; NAU KL, 1995, J NEUROL SCI, V129, P47, DOI 10.1016/0022-510X(95)00061-6; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Pradat PF, 2010, AMYOTROPH LATERAL SC, V11, P166, DOI 10.3109/17482960902822960; Puttaparthi K, 2005, EXP NEUROL, V196, P441, DOI 10.1016/j.expneurol.2005.08.027; Puttaparthi K, 2002, J NEUROSCI, V22, P8790; REYES ET, 1984, J NEUROL SCI, V63, P317, DOI 10.1016/0022-510X(84)90154-0; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Sakamoto K, 2008, AM J PHYSIOL-ENDOC M, V295, pE29, DOI 10.1152/ajpendo.90331.2008; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Stallings NR, 2010, NEUROBIOL DIS, V40, P404, DOI 10.1016/j.nbd.2010.06.017; Stone S, 2006, HUM MOL GENET, V15, P2709, DOI 10.1093/hmg/ddl204; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Wang HY, 2012, BIOCHEM J, V449, P479; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584	42	58	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71793	10.1371/journal.pone.0071793	http://dx.doi.org/10.1371/journal.pone.0071793			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967244	Green Published, Green Submitted, gold			2022-12-25	WOS:000323115800079
J	Huang, Y; Yu, P; Li, W; Ren, G; Roberts, AI; Cao, W; Zhang, X; Su, J; Chen, X; Chen, Q; Shou, P; Xu, C; Du, L; Lin, L; Xie, N; Zhang, L; Wang, Y; Shi, Y				Huang, Y.; Yu, P.; Li, W.; Ren, G.; Roberts, A. I.; Cao, W.; Zhang, X.; Su, J.; Chen, X.; Chen, Q.; Shou, P.; Xu, C.; Du, L.; Lin, L.; Xie, N.; Zhang, L.; Wang, Y.; Shi, Y.			p53 regulates mesenchymal stem cell-mediated tumor suppression in a tumor microenvironment through immune modulation	ONCOGENE			English	Article						mesenchymal stem cells; p53; immunomodulation; iNOS	NITRIC-OXIDE; INFILTRATING LYMPHOCYTES; GENETIC ALTERATIONS; STROMAL CELLS; MUTANT P53; T-CELLS; CANCER; MUTATIONS; CARCINOMA; EXPRESSION	p53 is one of the most studied genes in cancer biology, and mutations in this gene may be predictive for the development of many types of cancer in humans and in animals. However, whether p53 mutations in non-tumor stromal cells can affect tumor development has received very little attention. In this study, we show that B16F0 melanoma cells form much larger tumors in p53-deficient mice than in wild-type mice, indicating a potential role of p53 deficiency in non-tumor cells of the microenvironment. As mesenchymal stem cells (MSCs) are attracted to tumors and form a major component of the tumor microenvironment, we examined the potential role of p53 status in MSCs in tumor development. We found that larger tumors resulted when B16F0 melanoma cells were co-injected with bone marrow MSCs derived from p53-deficient mice rather than MSCs from wild-type mice. Interestingly, this tumor-promoting effect by p53-deficient MSCs was not observed in non-obese diabetic/severe combined immunodeficiency mice, indicating the immune response has a critical role. Indeed, in the presence of inflammatory cytokines, p53-deficient MSCs expressed more inducible nitric oxide synthase (iNOS) and exhibited greater immunosuppressive capacity. Importantly, tumor promotion by p53-deficient MSCs was abolished by administration of S-methylisothiourea, an iNOS inhibitor. Therefore, our data demonstrate that p53 status in tumor stromal cells has a key role in tumor development by modulating immune responses.	[Huang, Y.; Yu, P.; Li, W.; Cao, W.; Zhang, X.; Su, J.; Chen, X.; Chen, Q.; Shou, P.; Xu, C.; Du, L.; Lin, L.; Xie, N.; Wang, Y.; Shi, Y.] Shanghai Jiao Tong Univ, Chinese Acad Sci, Sch Med,Shanghai Inst Biol Sci, Inst Hlth Sci,Key Lab Stem Cell Biol, Shanghai 200025, Peoples R China; [Ren, G.; Roberts, A. I.; Zhang, L.; Shi, Y.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Child Hlth Inst New Jersey, New Brunswick, NJ USA; [Ren, G.; Roberts, A. I.; Zhang, L.; Shi, Y.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, New Brunswick, NJ USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Wang, Y (corresponding author), Shanghai Jiao Tong Univ, Chinese Acad Sci, Sch Med,Shanghai Inst Biol Sci, Inst Hlth Sci,Key Lab Stem Cell Biol, 225 S Chongqing Rd,1 Bldg, Shanghai 200025, Peoples R China.	yingwang@sibs.ac.cn; yufangshi@sibs.ac.cn	Yu, Pengfei/AHC-3497-2022; Li, Wenzhao/H-4235-2016; Xu, Chunliang/R-7065-2018; Shi, Yufang/AAE-4431-2020; Su, Juanjuan/C-4040-2018; Shou, Peishun/J-7985-2014; HUANG, YIN/AAH-6871-2020; Du, Liming/M-8227-2019	Yu, Pengfei/0000-0002-3894-5697; Li, Wenzhao/0000-0002-3878-3333; Shi, Yufang/0000-0001-8964-319X; Su, Juanjuan/0000-0002-6159-1954; Shou, Peishun/0000-0001-7685-7471; HUANG, YIN/0000-0001-5602-9871; Chen, Qing/0000-0002-2088-0370; wang, ying/0000-0002-2571-9367; Du, Liming/0000-0002-0527-3556	Ministry of Science and Technology of China [2010CB945600, 2011DFA30630]; Chinese Academy of Sciences [XDA01040107, KSCX1-YW-22-04]; NSFC [31010103908]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Ministry of Science and Technology of China (2010CB945600 and 2011DFA30630), Scientific Innovation Project of the Chinese Academy of Sciences (XDA01040107 and KSCX1-YW-22-04) and International Cooperation and Exchanges NSFC (31010103908). We are also grateful to Yikun Yao (IHS, CAS) for his assistance and suggestions.	Addadi Y, 2010, CANCER RES, V70, P9650, DOI 10.1158/0008-5472.CAN-10-1146; Andersen MH, 2009, J CLIN INVEST, V119, P2245, DOI 10.1172/JCI38739; Armesilla-Diaz A, 2009, EXP CELL RES, V315, P3598, DOI 10.1016/j.yexcr.2009.08.004; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bergfeld SA, 2010, CANCER METAST REV, V29, P249, DOI 10.1007/s10555-010-9222-7; Bingisser RM, 1998, J IMMUNOL, V160, P5729; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Brito C, 1999, J IMMUNOL, V162, P3356; Brown GC, 1997, BIOCHEM SOC T, V25, P901, DOI 10.1042/bst0250901; Cassina A, 1996, ARCH BIOCHEM BIOPHYS, V328, P309, DOI 10.1006/abbi.1996.0178; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Donia M, 2012, ONCOIMMUNOLOGY, V1, P1476, DOI 10.4161/onci.21940; Donia M, 2012, ONCOIMMUNOLOGY, V1, P1297, DOI 10.4161/onci.21659; Dougan M, 2009, ANNU REV IMMUNOL, V27, P83, DOI 10.1146/annurev.immunol.021908.132544; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Forrester K, 1996, P NATL ACAD SCI USA, V93, P2442, DOI 10.1073/pnas.93.6.2442; Giono LE, 2006, J CELL PHYSIOL, V209, P13, DOI 10.1002/jcp.20689; Gooden MJM, 2011, BRIT J CANCER, V105, P93, DOI 10.1038/bjc.2011.189; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HARVEY M, 1995, NAT GENET, V9, P305, DOI 10.1038/ng0395-305; Hill R, 2005, CELL, V123, P1001, DOI 10.1016/j.cell.2005.09.030; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hussain SP, 2008, CANCER RES, V68, P7130, DOI 10.1158/0008-5472.CAN-08-0410; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kidd S, 2009, STEM CELLS, V27, P2614, DOI 10.1002/stem.187; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Kurose K, 2002, NAT GENET, V32, P355, DOI 10.1038/ng1013; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; LAVIGUEUR A, 1989, MOL CELL BIOL, V9, P3982, DOI 10.1128/MCB.9.9.3982; LEPOIVRE M, 1991, BIOCHEM BIOPH RES CO, V179, P442, DOI 10.1016/0006-291X(91)91390-X; Levine AJ, 2011, NAT REV MOL CELL BIO, V12, P259, DOI 10.1038/nrm3086; Li W, 2012, CELL DEATH DIFFER, V19, P1505, DOI 10.1038/cdd.2012.26; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Maffini MV, 2004, J CELL SCI, V117, P1495, DOI 10.1242/jcs.01000; Matsumoto N, 2003, BRIT J CANCER, V89, P707, DOI 10.1038/sj.bjc.6601141; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Moinfar F, 2000, CANCER RES, V60, P2562; Moskovits N, 2006, CANCER RES, V66, P10671, DOI 10.1158/0008-5472.CAN-06-2323; Murray-Zmijewski F, 2008, NAT REV MOL CELL BIO, V9, P702, DOI 10.1038/nrm2451; Nakano O, 2001, CANCER RES, V61, P5132; NGUYEN T, 1992, P NATL ACAD SCI USA, V89, P3030, DOI 10.1073/pnas.89.7.3030; Nishida N, 2012, CLIN CANCER RES, V18, P3054, DOI 10.1158/1078-0432.CCR-11-1078; Paterson RF, 2003, CANCER, V98, P1830, DOI 10.1002/cncr.11747; Patocs A, 2007, NEW ENGL J MED, V357, P2543, DOI 10.1056/NEJMoa071825; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ren GW, 2012, CELL STEM CELL, V11, P812, DOI 10.1016/j.stem.2012.08.013; Rodriguez R, 2009, NEOPLASIA, V11, P397, DOI 10.1593/neo.81620; Roninson IB, 2003, CANCER RES, V63, P2705; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Sharma MD, 2009, BLOOD, V113, P6102, DOI 10.1182/blood-2008-12-195354; Sharma P, 2007, P NATL ACAD SCI USA, V104, P3967, DOI 10.1073/pnas.0611618104; Simelyte E, 2005, ARTHRITIS RHEUM-US, V52, P1876, DOI 10.1002/ART.21099; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; STRETCH JR, 1991, CANCER RES, V51, P5976; Studeny M, 2002, CANCER RES, V62, P3603; Suzuki YJ, 2010, ANTIOXID REDOX SIGN, V12, P323, DOI 10.1089/ars.2009.2887; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Tuhkanen H, 2004, INT J CANCER, V109, P247, DOI 10.1002/ijc.11733; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; VOGELSTEIN B, 1992, CELL, V70, P523, DOI 10.1016/0092-8674(92)90421-8; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2423, DOI 10.1172/JCI28941; XIE KP, 1995, J EXP MED, V181, P1333, DOI 10.1084/jem.181.4.1333; Xu WM, 2002, CELL RES, V12, P311, DOI 10.1038/sj.cr.7290133; Yamanishi Y, 2002, P NATL ACAD SCI USA, V99, P10025, DOI 10.1073/pnas.152333199; Zhu H, 2010, NAT PROTOC, V5, P550, DOI 10.1038/nprot.2009.238; Zilfou JT, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001883; Zou WB, 2012, CANCER RES, V72, P2980, DOI 10.1158/0008-5472.CAN-11-4216	77	50	54	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 17	2014	33	29					3830	3838		10.1038/onc.2013.355	http://dx.doi.org/10.1038/onc.2013.355			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AL8MU	23975435				2022-12-25	WOS:000339394100009
J	Conti, L; Lanzardo, S; Arigoni, M; Antonazzo, R; Radaelli, E; Cantarella, D; Calogero, RA; Cavallo, F				Conti, Laura; Lanzardo, Stefania; Arigoni, Maddalena; Antonazzo, Roberta; Radaelli, Enrico; Cantarella, Daniela; Calogero, Raffaele A.; Cavallo, Federica			The noninflammatory role of high mobility group box 1/toll-like receptor 2 axis in the self-renewal of mammary cancer stem cells	FASEB JOURNAL			English	Article						endogenous TLR2 ligands; transcriptome; NF kappa B; MyD88; BOXA; breast carcinoma	BREAST-CANCER; TLR2; INFLAMMATION; EXPRESSION; REPAIR	Cancer stem cells (CSCs) are responsible for tumor progression, metastases, resistance to therapy, and tumor recurrence. Therefore, the identification of molecules involved in CSC self-renewal is a necessary step toward more effective therapies. To this aim, through the transcription profiling of the murine ErbB2(+) tumor cell line TUBO vs. derived CSC-enriched mammospheres, Toll-like receptor 2 (TLR2) was identified as 2-fold overexpressed in CSCs, as confirmed by qPCR and cytofluorimetric analysis. TLR2 signaling inhibition impaired in vitro mammosphere generation in murine TUBO (60%) and 4T1 (30%) and human MDA-MB-231 (50%), HCC1806 (60%), and MCF7 (50%) cells. In CSC, TLR2 was activated by endogenous high-mobility-group box 1 (HMGB1), inducing I kappa B alpha phosphorylation, IL-6 and TGF beta secretion, and, consequently, STAT3 and Smad3 activation. In vivo TLR2 inhibition blocked TUBO tumor takes in 9/14 mice and induced a 2-fold reduction in lung metastases development by decreasing cell proliferation and vascularization and increasing apoptosis. Collectively, these results demonstrate that murine and human mammary CSCs express TLR2 and its ligand HMGB1; this autocrine loop plays a pivotal role in CSC self-renewal, tumorigenesis, and metastatic ability. These findings, while providing evidence against the controversial use of TLR2 agonists in antitumor therapy, lay out new paths toward the design of anticancer treatments.	[Conti, Laura; Lanzardo, Stefania; Arigoni, Maddalena; Antonazzo, Roberta; Calogero, Raffaele A.; Cavallo, Federica] Univ Turin, Ctr Mol Biotechnol, Turin, Italy; [Radaelli, Enrico] Fdn Filarete, Mouse & Anim Pathol Lab, Milan, Italy; [Radaelli, Enrico] Univ Milan, Dept Anim Pathol, Milan, Italy; [Cantarella, Daniela] IRCC, Candiolo, Italy	University of Turin; University of Milan; IRCCS Fondazione del Piemonte per l'Oncologia	Cavallo, F (corresponding author), Ctr Mol Biotechnol, Via Nizza 52, I-10126 Turin, Italy.	federica.cavallo@unito.it	Calogero, Raffaele/K-9428-2019; CONTI, LAURA/A-9005-2017; Conti, Laura/AAL-8272-2020; Cavallo, Federica/C-5666-2011	Calogero, Raffaele/0000-0002-2848-628X; CONTI, LAURA/0000-0003-1780-098X; CANTARELLA, DANIELA/0000-0001-6135-2032; Cavallo, Federica/0000-0003-4571-1060; Arigoni, Maddalena/0000-0003-4629-3841	Italian Association for Cancer Research [IG 11675]; Fondazione Ricerca Molinette Onlus; University of Turin; Compagnia di San Paolo (Progetti di Ricerca Ateneo/CSP)	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Fondazione Ricerca Molinette Onlus; University of Turin; Compagnia di San Paolo (Progetti di Ricerca Ateneo/CSP)(Compagnia di San Paolo)	This work was supported by grants from the Italian Association for Cancer Research (IG 11675), Fondazione Ricerca Molinette Onlus, the University of Turin, and the Compagnia di San Paolo (Progetti di Ricerca Ateneo/CSP). The authors thank Dr. Roberto Ruiu for his technical assistance and Dr. Dale Lawson for his revision and editing of the manuscript. The authors declare no conflicts of interest.	Boggio K, 1998, J EXP MED, V188, P589, DOI 10.1084/jem.188.3.589; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Campana L, 2008, CURR OPIN IMMUNOL, V20, P518, DOI 10.1016/j.coi.2008.04.012; Carotenuto P, 2010, CRIT REV EUKAR GENE, V20, P17, DOI 10.1615/CritRevEukarGeneExpr.v20.i1.20; Chang ZL, 2010, INFLAMM RES, V59, P791, DOI 10.1007/s00011-010-0208-2; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chefetz I, 2013, CELL CYCLE, V12, P511, DOI 10.4161/cc.23406; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Fan Jie, 2010, Open Crit Care Med J, V2, P1; Frank NY, 2010, J CLIN INVEST, V120, P41, DOI 10.1172/JCI41004; Grange C, 2008, NEOPLASIA, V10, P1433, DOI 10.1593/neo.08902; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038890; Jeter CR, 2011, ONCOGENE, V30, P3833, DOI 10.1038/onc.2011.114; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kim S, 2011, ANN NY ACAD SCI, V1217, P191, DOI 10.1111/j.1749-6632.2010.05882.x; Korkaya H, 2011, CLIN CANCER RES, V17, P6125, DOI 10.1158/1078-0432.CCR-10-2743; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Morrison R, 2011, J ONCOL, V2011, DOI 10.1155/2011/941876; Nogueira-Machado JA, 2012, RECENT PATENTS ENDOC, V6, P201, DOI 10.2174/187221412802481784; Noh KH, 2012, CANCER RES, V72, P1717, DOI 10.1158/0008-5472.CAN-11-3758; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; Parmigiani G, 2004, CLIN CANCER RES, V10, P2922, DOI 10.1158/1078-0432.CCR-03-0490; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Rovero S, 2001, GENE THER, V8, P447, DOI 10.1038/sj.gt.3301416; Sallustio F, 2010, FASEB J, V24, P514, DOI 10.1096/fj.09-136481; Sanges R, 2007, BIOINFORMATICS, V23, P3406, DOI 10.1093/bioinformatics/btm469; Shaykhiev R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001393; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Taylor T, 2010, STEM CELLS DEV, V19, P1333, DOI 10.1089/scd.2009.0484; Tye H, 2012, CANCER CELL, V22, P466, DOI 10.1016/j.ccr.2012.08.010; Wang L, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt96; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Xie WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010850; Xie WJ, 2009, BIOCHEM BIOPH RES CO, V379, P1027, DOI 10.1016/j.bbrc.2009.01.009; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Yang HZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006520	40	65	68	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2013	27	12					4731	4744		10.1096/fj.13-230201	http://dx.doi.org/10.1096/fj.13-230201			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	293UK	23970797				2022-12-25	WOS:000329999000009
J	Harrison, GLA; Pryor, J; Malani, J; Supuri, M; Masta, A; Teriboriki, B; Toatu, T; Penny, D; Allain, JP; Barnes, E; Pybus, OG; Klenerman, P				Harrison, G. L. Abby; Pryor, Jan; Malani, Joji; Supuri, Mathias; Masta, Andrew; Teriboriki, Burentau; Toatu, Tebuka; Penny, David; Allain, Jean-Pierre; Barnes, Eleanor; Pybus, Oliver G.; Klenerman, Paul			Infection Frequency of Hepatitis C Virus and IL28B Haplotypes in Papua New Guinea, Fiji, and Kiribati	PLOS ONE			English	Article							TO-CUTOFF RATIO; GENETIC-VARIATION; BLOOD-DONORS; SPONTANEOUS CLEARANCE; EPIDEMIOLOGY; DIVERSITY; HISTORY; SEROPREVALENCE; IMPLEMENTATION; TRANSMISSION	It has been estimated that there are more than 60 million Hepatitis C virus (HCV) carriers in the World Health Organisation's Western Pacific region (WHO-WPR), where liver cancer is among the top three causes of cancer death. WHO and the US Centres for Disease Control and Prevention report the prevalence of HCV in the South Pacific islands (countries within the WHO-WPR) to be high (5-10% and >2% respectively). However, since HCV is not tested for in many of these countries, there is sparse data available to support this assertion. We screened similar to 2000 apparently healthy individuals from Papua New Guinea, Fiji and Kiribati and found a sero-prevalence of 2.0%, 0.1% and 0%, respectively. All sero-positive samples tested negative for HCV RNA. Curious as to why all the sero-positive individuals were negative for HCV-RNA, we also screened them for the HCV protective IL28B SNP markers rs12979860 and rs8099917. All antibody-positive participants bar one had HCV protective haplotypes. Our results suggest that HCV is present in these Pacific island countries, albeit at a prevalence lower than previous estimates. As none of our participants had undergone antiviral treatment, and therefore must have cleared infection naturally, we hypothesise that genotypes 1 and/or 4 are circulating in South Pacific Island people and that these peoples are genetically predisposed to be more likely to spontaneous resolve HCV infection than to become chronic carriers.	[Harrison, G. L. Abby; Klenerman, Paul] Univ Oxford, Nuffield Dept Med, Oxford, England; [Harrison, G. L. Abby] Walter Eliza Hall Inst Med Res, Melbourne, Vic, Australia; [Pryor, Jan; Malani, Joji] Fiji Natl Univ, Dept Med Sci, Suva, Fiji; [Supuri, Mathias] Pacific Int Hosp, Port Moresby, National Capita, Papua N Guinea; [Masta, Andrew] Univ Papua New Guinea, Sch Med & Hlth Sci, Port Moresby, National Capita, Papua N Guinea; [Teriboriki, Burentau] Kiribati Minist Hlth, Tabiteuea Hosp, Tabiteuea, Kiribati; [Toatu, Tebuka] Secretariat Pacific Community, Dis Surveillance Control & Unit, Suva, Fiji; [Penny, David] Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand; [Allain, Jean-Pierre] Univ Cambridge, East Anglia Blood Ctr, Natl Blood Serv, Cambridge, England; [Allain, Jean-Pierre] Univ Cambridge, Dept Haematol, Div Transfus Med, Cambridge, England; [Barnes, Eleanor] Univ Oxford, Oxford Natl Inst Hlth Res, Biomed Res Ctr, Nuffield Dept Med, Oxford, England; [Barnes, Eleanor] Univ Oxford, Oxford Martin Sch, Oxford, England; [Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford; Walter & Eliza Hall Institute; Fiji National University (FNU); University of Papua New Guinea; Massey University; University of Cambridge; University of Cambridge; University of Oxford; University of Oxford; University of Oxford	Harrison, GLA (corresponding author), Univ Oxford, Nuffield Dept Med, Peter Medawar Bldg Pathogen Res, Oxford, England.	a.g.l.harrison@gmail.com	Pybus, Oliver G/B-2640-2012	Pybus, Oliver G/0000-0002-8797-2667; klenerman, paul/0000-0003-4307-9161; Barnes, Eleanor/0000-0002-0860-0831	Wellcome Trust [WT091663MA]; NIHR (National Institute for Health Research) Biomedical Research Centre, Oxford; NIH NIAID (National Institutes of Health, National Institute of Allergy and Infectious Diseases) [1U19AI082630-01]; James Martin School for 21st Century, Oxford; MRC [MR/K010239/1] Funding Source: UKRI; Medical Research Council [MR/K010239/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10204] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082630] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NIHR (National Institute for Health Research) Biomedical Research Centre, Oxford; NIH NIAID (National Institutes of Health, National Institute of Allergy and Infectious Diseases); James Martin School for 21st Century, Oxford; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the Wellcome Trust, http://www.wellcome.ac.uk/, (WT091663MA), the NIHR (National Institute for Health Research) Biomedical Research Centre, Oxford, http://www.nihr.ac.uk/infrastructure/Pages/infrastructure_biomedical_research_centres.aspx, the NIH NIAID (National Institutes of Health, National Institute of Allergy and Infectious Diseases) (1U19AI082630-01), http://www.niaid.nih.gov/Pages/default.aspx, and the James Martin School for 21st Century, Oxford, http://www.oxfordmartin.ox.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain JP, 2005, LANCET, V365, P276, DOI 10.1016/S0140-6736(05)17801-5; Allain JP, 1998, TRANSFUS MED REV, V12, P46, DOI 10.1016/S0887-7963(98)80089-8; Alter MJ, 2003, MMWR RECOMM REP, V52, P12; Armstrong GL, 2006, AM J TROP MED HYG, V74, P261, DOI 10.4269/ajtmh.2006.74.261; Candotti D, 2003, J VIROL, V77, P7914, DOI 10.1128/JVI.77.14.7914-7923.2003; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; CHOO QL, 1991, P NATL ACAD SCI USA, V88, P2451, DOI 10.1073/pnas.88.6.2451; Ponde RAD, 2011, MED MICROBIOL IMMUN, V200, P7, DOI 10.1007/s00430-010-0159-9; Delieu E, 2002, 20027 MDA; Furusyo N, 1999, AM J TROP MED HYG, V61, P85, DOI 10.4269/ajtmh.1999.61.85; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Jimenez-Sousa MA, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-6; Kelly Angela, 2012, EMERGING HIV RISK PA; Kim Hyon-Suk, 2009, Korean J Intern Med, V24, P299, DOI 10.3904/kjim.2009.24.4.299; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Lucas Richard E., 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P542; Magiorkinis G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000198; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; MCFARLANE IG, 1990, LANCET, V335, P754, DOI 10.1016/0140-6736(90)90870-B; Murphy DG, 2007, J CLIN MICROBIOL, V45, P1102, DOI 10.1128/JCM.02366-06; Nakano T, 2006, J GEN VIROL, V87, P73, DOI 10.1099/vir.0.81360-0; Nakano T, 2004, J INFECT DIS, V190, P1098, DOI 10.1086/422606; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Owusu-Ofori S, 2005, TRANSFUSION, V45, P133, DOI 10.1111/j.1537-2995.2004.04279.x; Perry KR, 2001, 01001 MDA; Pybus OG, 2003, MOL BIOL EVOL, V20, P381, DOI 10.1093/molbev/msg043; Pybus OG, 2009, J VIROL, V83, P1071, DOI 10.1128/JVI.01501-08; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Rezza G, 2001, EMERG INFECT DIS, V7, P893; Seo Yeon Seok, 2009, Korean Journal of Internal Medicine, V24, P302, DOI 10.3904/kjim.2009.24.4.302; Shebl FM, 2011, J INFECT DIS, V204, P1843, DOI 10.1093/infdis/jir647; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; SIMMONDS P, 1993, J GEN VIROL, V74, P2391, DOI 10.1099/0022-1317-74-11-2391; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; TIBBS CJ, 1991, J MED VIROL, V34, P143, DOI 10.1002/jmv.1890340302; Tobler LH, 2010, TRANSFUSION, V50, P1513, DOI 10.1111/j.1537-2995.2010.02634.x; Tobler LH, 2000, TRANSFUSION, V40, P15, DOI 10.1046/j.1537-2995.2000.40010015.x; Utama A, 2008, INTERVIROLOGY, V51, P410, DOI 10.1159/000205515; VANDERPOEL CL, 1991, LANCET, V337, P317, DOI 10.1016/0140-6736(91)90942-I; WHO, 2010, VIR HEP GLOB POL; WHO Regional Committee for the Western Pacific, 1999, WPRRC509 WHO; World Health Organization, 2001, 1 WHO; YAMAGUCHI K, 1993, JPN J CANCER RES, V84, P715, DOI 10.1111/j.1349-7006.1993.tb02034.x	43	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e66749	10.1371/journal.pone.0066749	http://dx.doi.org/10.1371/journal.pone.0066749			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23976941	Green Published, gold			2022-12-25	WOS:000324527300003
J	Ohyama, T; Jovanic, T; Denisov, G; Dang, TC; Hoffmann, D; Kerr, RA; Zlatic, M				Ohyama, Tomoko; Jovanic, Tihana; Denisov, Gennady; Dang, Tam C.; Hoffmann, Dominik; Kerr, Rex A.; Zlatic, Marta			High-Throughput Analysis of Stimulus-Evoked Behaviors in Drosophila Larva Reveals Multiple Modality-Specific Escape Strategies	PLOS ONE			English	Article							MECHANOSENSORY TRANSDUCTION; GENETIC DISSECTION; DECISION-MAKING; LOCOMOTION; NEURONS; LIGHT; EXPRESSION; MELANOGASTER; CIRCUITS; CHANNEL	All organisms react to noxious and mechanical stimuli but we still lack a complete understanding of cellular and molecular mechanisms by which somatosensory information is transformed into appropriate motor outputs. The small number of neurons and excellent genetic tools make Drosophila larva an especially tractable model system in which to address this problem. We developed high throughput assays with which we can simultaneously expose more than 1,000 larvae per man-hour to precisely timed noxious heat, vibration, air current, or optogenetic stimuli. Using this hardware in combination with custom software we characterized larval reactions to somatosensory stimuli in far greater detail than possible previously. Each stimulus evoked a distinctive escape strategy that consisted of multiple actions. The escape strategy was context-dependent. Using our system we confirmed that the nociceptive class IV multidendritic neurons were involved in the reactions to noxious heat. Chordotonal (ch) neurons were necessary for normal modulation of head casting, crawling and hunching, in response to mechanical stimuli. Consistent with this we observed increases in calcium transients in response to vibration in ch neurons. Optogenetic activation of ch neurons was sufficient to evoke head casting and crawling. These studies significantly increase our understanding of the functional roles of larval ch neurons. More generally, our system and the detailed description of wild type reactions to somatosensory stimuli provide a basis for systematic identification of neurons and genes underlying these behaviors.	[Ohyama, Tomoko; Jovanic, Tihana; Denisov, Gennady; Dang, Tam C.; Hoffmann, Dominik; Kerr, Rex A.; Zlatic, Marta] Howard Hughes Med Inst, Ashburn, VA USA	Howard Hughes Medical Institute	Kerr, RA (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA USA.	kerrr@janelia.hhmi.org; zlaticm@janelia.hhmi.org		Zlatic, Marta/0000-0002-3149-2250; Ohyama, Tomoko/0000-0003-1697-1138	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This study was funded by Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsley JA, 2003, CURR BIOL, V13, P1557, DOI 10.1016/S0960-9822(03)00596-7; Babcock M, 2004, J NEUROSCI, V24, P3964, DOI 10.1523/JNEUROSCI.5259-03.2004; Berni J, 2012, CURR BIOL, V22, P1861, DOI 10.1016/j.cub.2012.07.048; BERRIGAN D, 1995, J INSECT PHYSIOL, V41, P329, DOI 10.1016/0022-1910(94)00113-U; Bharadwaj R, 2013, DEVELOPMENT, V140, P627, DOI 10.1242/dev.085100; BOYAN GS, 1993, PROG NEUROBIOL, V41, P657, DOI 10.1016/0301-0082(93)90030-V; BRAND AH, 1994, METHOD CELL BIOL, V44, P635, DOI 10.1016/S0091-679X(08)60936-X; Busto M, 1999, J NEUROSCI, V19, P3337; Caldwell JC, 2003, P NATL ACAD SCI USA, V100, P16053, DOI 10.1073/pnas.2535546100; Cheng LE, 2010, NEURON, V67, P373, DOI 10.1016/j.neuron.2010.07.004; Cohen EH, 2008, J VISION, V8, DOI 10.1167/8.7.6; Fushiki A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062199; Gershow M, 2012, NAT METHODS, V9, P290, DOI [10.1038/NMETH.1853, 10.1038/nmeth.1853]; Gomez-Marin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041642; Gomez-Marin A, 2012, CURR OPIN NEUROBIOL, V22, P208, DOI 10.1016/j.conb.2011.11.008; Gomez-Marin A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1455; Grillner S, 2009, CURR OPIN NEUROBIOL, V19, P572, DOI 10.1016/j.conb.2009.10.011; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Heckscher ES, 2012, J NEUROSCI, V32, P12460, DOI 10.1523/JNEUROSCI.0222-12.2012; Honjo K, 2012, NAT PROTOC, V7, P1470, DOI 10.1038/nprot.2012.079; Hughes CL, 2007, MOL CELL NEUROSCI, V35, P383, DOI 10.1016/j.mcn.2007.04.001; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Inada K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029019; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Kabra M, 2013, NAT METHODS, V10, P64, DOI [10.1038/NMETH.2281, 10.1038/nmeth.2281]; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Kwon Y, 2010, J NEUROSCI, V30, P10465, DOI 10.1523/JNEUROSCI.1631-10.2010; Ladle DR, 2007, NEURON, V56, P270, DOI 10.1016/j.neuron.2007.09.026; Luo LJ, 2010, J NEUROSCI, V30, P4261, DOI 10.1523/JNEUROSCI.4090-09.2010; Mazzoni EO, 2005, NEURON, V45, P293, DOI 10.1016/j.neuron.2004.12.038; MURPHEY RK, 1989, J COMP NEUROL, V290, P185, DOI 10.1002/cne.902900203; Oswald M, 2011, FLY, V5, P304, DOI 10.4161/fly.5.4.17810; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Press W. H., 2007, ART SCI COMPUTING; Robie AA, 2010, J EXP BIOL, V213, P2494, DOI 10.1242/jeb.041749; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Song W, 2007, P NATL ACAD SCI USA, V104, P5199, DOI 10.1073/pnas.0700895104; Swierczek NA, 2011, NAT METHODS, V8, P592, DOI [10.1038/NMETH.1625, 10.1038/nmeth.1625]; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Wu ZH, 2011, NEURON, V70, P281, DOI 10.1016/j.neuron.2011.02.050; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Yorozu S, 2009, NATURE, V458, P201, DOI 10.1038/nature07843; Yuan Q, 2011, SCIENCE, V333, P1458, DOI 10.1126/science.1207121; Zhong LX, 2010, CURR BIOL, V20, P429, DOI 10.1016/j.cub.2009.12.057; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2; Zlatic M, 2003, NEURON, V37, P41, DOI 10.1016/S0896-6273(02)01131-5	51	63	63	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71706	10.1371/journal.pone.0071706	http://dx.doi.org/10.1371/journal.pone.0071706			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977118	gold, Green Published, Green Submitted			2022-12-25	WOS:000324527300031
J	Reist, M; Geser, N; Hachler, H; Scharrer, S; Stephan, R				Reist, Martin; Geser, Nadine; Haechler, Herbert; Schaerrer, Sara; Stephan, Roger			ESBL-Producing Enterobacteriaceae: Occurrence, Risk Factors for Fecal Carriage and Strain Traits in the Swiss Slaughter Cattle Population Younger than 2 Years Sampled at Abattoir Level	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASES; FOOD-PRODUCING ANIMALS; EXTENDED-SPECTRUM; ESCHERICHIA-COLI; CTX-M; MEAT; EPIDEMIOLOGY; PREVALENCE; FARMS; SWINE	During the past decade extended-spectrum beta-lactamase (ESBL) producing Enterobacteriaceae have become a matter of great concern in human and veterinary medicine. In this cross-sectional study fecal swabs of a geographically representative number of Swiss cattle at slaughterhouse level were sampled i) to determine the occurrence of ESBL producing Enterobacteriaceae in the Swiss slaughter cattle population younger than 2 years, and ii) to assess risk factors for shedding ESBL producing Enterobacteriaceae. In total, 48 (8.4%; 95% C.I. 6.3-11.1%) independent ESBL producing Enterobacteriaceae were detected among the 571 tested animals. Species identification revealed 46 E. coli strains, one Enterobacter cloacae and one Citrobacter youngae. In view of beta-lactam antibiotics, all 48 isolates were resistant to ampicillin, cephalothin and cefpodoxime. Forty-five (93.8%) isolates were resistant cefuroxime; one (2.1%) isolate to cefoxitin, 28 (58.3%) isolates to cefotaxime, 2 (4.2%) isolates to ceftazidime, and 2 (4.2%) isolates to cefepime. Risk factors for shedding ESBL producing Enterobacteriaceae were (i) age (OR 0.19 and 0.12 in age category 181 d to 1y and 1y to 2 y compared to <= 180 d), (ii) primary production type, meaning dairy compared to beef on farm of origin (OR 5.95), and (iii) more than 1 compared to less than 1 animal movement per d per 100 animals on farm of origin (OR 2.37).	[Reist, Martin; Schaerrer, Sara] Univ Bern, Vetsuisse Fac, Vet Publ Hlth Inst, Bern, Switzerland; [Geser, Nadine; Haechler, Herbert; Stephan, Roger] Univ Zurich, Vetsuisse Fac, Inst Food Safety & Hyg, Zurich, Switzerland	University of Bern; University of Zurich	Stephan, R (corresponding author), Univ Zurich, Vetsuisse Fac, Inst Food Safety & Hyg, Zurich, Switzerland.	stephanr@fsafety.uzh.ch	Stephan, Roger/AAP-8501-2020		Swiss Federal Veterinary Office (FVO)	Swiss Federal Veterinary Office (FVO)	This study was funded by the Swiss Federal Veterinary Office (FVO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous ARCH-VET, 2011, SWISS ANN REPORT USA; Ben Sallem R, 2012, FOODBORNE PATHOG DIS, V9, P1137, DOI 10.1089/fpd.2012.1267; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Canton R, 2006, CURR OPIN MICROBIOL, V9, P466, DOI 10.1016/j.mib.2006.08.011; CLSI. Clinical and Laboratory Standards Institute, 2008, M100S18 CLSI; Coque T M, 2008, Euro Surveill, V13; Doi Y, 2010, CLIN MICROBIOL INFEC, V16, P33, DOI 10.1111/j.1469-0691.2009.03001.x; Geser N, 2011, J FOOD PROTECT, V74, P446, DOI 10.4315/0362-028X.JFP-10-372; Geser N, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-21; Geser N, 2012, ANTIMICROB AGENTS CH, V56, P1609, DOI 10.1128/AAC.05539-11; Gniadkowski M, 2001, CLIN MICROBIOL INFEC, V7, P597, DOI 10.1046/j.1198-743x.2001.00330.x; Hammad AM, 2008, J VET MED SCI, V70, P1269, DOI 10.1292/jvms.70.1269; Hartmann A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00083; HOSMER DW, 1989, APPL LOGISTIC REGRES; Jensen LB, 2006, J ANTIMICROB CHEMOTH, V57, P793, DOI 10.1093/jac/dkl048; KNOTHE H, 1983, INFECTION, V11, P315, DOI 10.1007/BF01641355; Mesa RJ, 2006, J ANTIMICROB CHEMOTH, V58, P211, DOI 10.1093/jac/dkl211; Meunier D, 2006, INT J ANTIMICROB AG, V28, P402, DOI 10.1016/j.ijantimicag.2006.08.016; Snow LC, 2012, PREV VET MED, V106, P225, DOI 10.1016/j.prevetmed.2012.03.009; Tamang MD, 2013, FOODBORNE PATHOG DIS, V10, P13, DOI 10.1089/fpd.2012.1245; Wittum TE, 2010, FOODBORNE PATHOG DIS, V7, P1575, DOI 10.1089/fpd.2010.0615	21	32	33	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71725	10.1371/journal.pone.0071725	http://dx.doi.org/10.1371/journal.pone.0071725			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977126	Green Accepted, gold, Green Published			2022-12-25	WOS:000324527300033
J	Cuntz, H; Forstner, F; Schnell, B; Ammer, G; Raghu, SV; Borst, A				Cuntz, Hermann; Forstner, Friedrich; Schnell, Bettina; Ammer, Georg; Raghu, Shamprasad Varija; Borst, Alexander			Preserving Neural Function under Extreme Scaling	PLOS ONE			English	Article							INTRINSIC ELECTROPHYSIOLOGICAL CHARACTERISTICS; PLATE TANGENTIAL CELLS; MOTION-SENSITIVE INTERNEURONS; LOBULA PLATE; VISUAL INTERNEURONS; MEMBRANE-PROPERTIES; RESPONSE PROPERTIES; DENDRITIC STRUCTURE; FLY; DROSOPHILA	Important brain functions need to be conserved throughout organisms of extremely varying sizes. Here we study the scaling properties of an essential component of computation in the brain: the single neuron. We compare morphology and signal propagation of a uniquely identifiable interneuron, the HS cell, in the blowfly (Calliphora) with its exact counterpart in the fruit fly (Drosophila) which is about four times smaller in each dimension. Anatomical features of the HS cell scale isometrically and minimise wiring costs but, by themselves, do not scale to preserve the electrotonic behaviour. However, the membrane properties are set to conserve dendritic as well as axonal delays and attenuation as well as dendritic integration of visual information. In conclusion, the electrotonic structure of a neuron, the HS cell in this case, is surprisingly stable over a wide range of morphological scales.	[Cuntz, Hermann; Forstner, Friedrich; Schnell, Bettina; Ammer, Georg; Raghu, Shamprasad Varija; Borst, Alexander] Max Planck Inst Neurobiol, Dept Syst & Computat Neurobiol, D-82152 Martinsried, Germany; [Cuntz, Hermann] Goethe Univ Frankfurt, Inst Clin Neuroanat, D-60054 Frankfurt, Germany; [Cuntz, Hermann] Ernst Strungmann Inst Neurosci Cooperat Max Planc, Frankfurt, Germany; [Schnell, Bettina] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Raghu, Shamprasad Varija] Neurosci Res Partnership, Biopolis, Singapore	Max Planck Society; Goethe University Frankfurt; University of Washington; University of Washington Seattle	Cuntz, H (corresponding author), Max Planck Inst Neurobiol, Dept Syst & Computat Neurobiol, D-82152 Martinsried, Germany.	hermann.neuro@gmail.com	Cuntz, Hermann/E-7057-2012; Raghu, Shamprasad Varija/AAV-3044-2020	Cuntz, Hermann/0000-0001-5445-0507; Schnell, Bettina/0000-0001-7700-2600				Bakken TE, 2011, J COMP NEUROL, V153, P142; BEKKERS JM, 1990, PROG BRAIN RES, V83, P37; BORST A, 1992, P NATL ACAD SCI USA, V89, P4139, DOI 10.1073/pnas.89.9.4139; Borst A, 1996, J COMPUT NEUROSCI, V3, P313, DOI 10.1007/BF00161091; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; Borst A, 2008, FRONT NEUROSCI-SWITZ, V2, P4, DOI 10.3389/neuro.01.016.2008; BRAITENBERG V, 1970, KYBERNETIK, V7, P235; Bucher D, 2005, J NEUROSCI, V25, P1611, DOI 10.1523/JNEUROSCI.3679-04.2005; Cajal S. R, 1995, HISTOLOGIE SYSTEME N; Cherniak C, 1999, PHYS REV E, V59, P6001, DOI 10.1103/PhysRevE.59.6001; CHERNIAK C, 1992, BIOL CYBERN, V66, P503, DOI 10.1007/BF00204115; Cuntz H, 2003, P NATL ACAD SCI USA, V100, P11082, DOI 10.1073/pnas.1830705100; Cuntz H, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-21; Cuntz H, 2007, P NATL ACAD SCI USA, V104, P10229, DOI 10.1073/pnas.0703697104; Cuntz H, 2012, P NATL ACAD SCI USA, V109, P11014, DOI 10.1073/pnas.1200430109; Cuntz H, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00002; Cuntz H, 2011, NEUROINFORMATICS, V9, P91, DOI 10.1007/s12021-010-9093-7; Cuntz H, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000877; Cuntz H, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000251; EGELHAAF M, 1994, NEUROREPORT, V6, P205, DOI 10.1097/00001756-199412300-00052; Elyada YM, 2009, NAT NEUROSCI, V12, P327, DOI 10.1038/nn.2269; FISCHBACH KF, 1984, J EXP BIOL, V112, P65; GOTZ KG, 1968, KYBERNETIK, V4, P199, DOI 10.1007/BF00272517; Gouwens NW, 2009, J NEUROSCI, V29, P6239, DOI 10.1523/JNEUROSCI.0764-09.2009; Haag J, 2004, NAT NEUROSCI, V7, P628, DOI 10.1038/nn1245; Haag J, 1997, J COMPUT NEUROSCI, V4, P349, DOI 10.1023/A:1008804117334; Haag J, 1999, J COMPUT NEUROSCI, V7, P213, DOI 10.1023/A:1008950515719; Haag J, 2002, J NEUROSCI, V22, P3227, DOI 10.1523/JNEUROSCI.22-08-03227.2002; HAUSEN K, 1982, BIOL CYBERN, V45, P143, DOI 10.1007/BF00335241; HENGSTENBERG R, 1982, J COMP PHYSIOL, V149, P163, DOI 10.1007/BF00619211; Herculano-Houzel S, 2007, P NATL ACAD SCI USA, V104, P3562, DOI 10.1073/pnas.0611396104; Herculano-Houzel S, 2006, P NATL ACAD SCI USA, V103, P12138, DOI 10.1073/pnas.0604911103; Hill A A, 1994, J Comput Neurosci, V1, P239, DOI 10.1007/BF00961736; Howarth C, 2012, J CEREBR BLOOD F MET, V32, P1222, DOI 10.1038/jcbfm.2012.35; Huxley J., 1932, PROBLEMS RELATIVE GR; Joesch M, 2008, CURR BIOL, V18, P368, DOI 10.1016/j.cub.2008.02.022; KAMPER G, 1994, COMP BIOCHEM PHYS A, V109, P23, DOI 10.1016/0300-9629(94)90308-5; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Maimon G, 2010, NAT NEUROSCI, V13, P393, DOI 10.1038/nn.2492; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Niven JE, 2007, PLOS BIOL, V5, P828, DOI 10.1371/journal.pbio.0050116; Niven JE, 2012, CURR BIOL, V22, pR323, DOI 10.1016/j.cub.2012.04.002; Otsuna H, 2006, J COMP NEUROL, V497, P928, DOI 10.1002/cne.21015; PURVES D, 1985, SCIENCE, V228, P298, DOI 10.1126/science.3983631; Schnell B, 2010, J NEUROPHYSIOL, V103, P1646, DOI 10.1152/jn.00950.2009; Scholvinck ML, 2008, NEUROIMAGE, V40, P1460, DOI 10.1016/j.neuroimage.2008.01.032; Scott EK, 2002, J COMP NEUROL, V454, P470, DOI 10.1002/cne.10467; Single S, 1998, SCIENCE, V281, P1848, DOI 10.1126/science.281.5384.1848; STALEY KJ, 1992, J NEUROPHYSIOL, V67, P1346, DOI 10.1152/jn.1992.67.5.1346; Sukontason KL, 2008, PARASITOL RES, V103, P123, DOI 10.1007/s00436-008-0939-y; Thompson D.W, 1917, GROWTH FORM; TOWER DB, 1954, J COMP NEUROL, V101, P19, DOI 10.1002/cne.901010103; Wen Q, 2008, J NEUROPHYSIOL, V99, P2320, DOI 10.1152/jn.00280.2007; Wen Q, 2009, P NATL ACAD SCI USA, V106, P12536, DOI 10.1073/pnas.0901530106; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; ZADOR AM, 1995, J NEUROSCI, V15, P1669, DOI 10.1523/JNEUROSCI.15-03-01669.1995	58	18	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71540	10.1371/journal.pone.0071540	http://dx.doi.org/10.1371/journal.pone.0071540			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977069	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700066
J	Lee, SH; Wray, NR				Lee, Sang Hong; Wray, Naomi R.			Novel Genetic Analysis for Case-Control Genome-Wide Association Studies: Quantification of Power and Genomic Prediction Accuracy	PLOS ONE			English	Article							TRAITS; RISK; LOCI; DISEASES; LINKAGE	Genome-wide association studies (GWAS) are routinely conducted for both quantitative and binary (disease) traits. We present two analytical tools for use in the experimental design of GWAS. Firstly, we present power calculations quantifying power in a unified framework for a range of scenarios. In this context we consider the utility of quantitative scores (e.g. endophenotypes) that may be available on cases only or both cases and controls. Secondly, we consider, the accuracy of prediction of genetic risk from genome-wide SNPs and derive an expression for genomic prediction accuracy using a liability threshold model for disease traits in a case-control design. The expected values based on our derived equations for both power and prediction accuracy agree well with observed estimates from simulations.	[Lee, Sang Hong; Wray, Naomi R.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	University of Queensland	Lee, SH (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	Hong.Lee@uq.edu.au	Wray, Naomi/C-8639-2015; Lee, Sang Hong/A-2569-2011	Wray, Naomi/0000-0001-7421-3357; Lee, Sang Hong/0000-0001-9701-2718	Australian Research Council [FT0991360, DE130100614]; National Health and Medical Research Council [1011506]	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by Australian Research Council (FT0991360, DE130100614), National Health and Medical Research Council (1011506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Chatterjee N, 2013, NAT GENET, V45, P400, DOI 10.1038/ng.2579; Daetwyler HD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003395; DEMPSTER ER, 1950, GENETICS, V35, P212; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; Ehret GB, 2012, AM J HUM GENET, V91, P863, DOI 10.1016/j.ajhg.2012.09.013; Falconer D. S, 1996, INTRO QUANTITATIVE G; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Janssens ACJW, 2006, GENET MED, V8, P395, DOI 10.1097/01.gim.0000229689.18263.f4; Lee PH, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.95; Lee SH, 2012, GENET EPIDEMIOL, V36, P214, DOI 10.1002/gepi.21614; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Logsdon BA, 2012, BIOINFORMATICS, V28, P1738, DOI 10.1093/bioinformatics/bts261; Ma L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015006; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Sham P., 1998, STAT HUMAN GENETICS; Sham PC, 2000, AM J HUM GENET, V66, P1616, DOI 10.1086/302891; So HC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001230; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; van der Sluis S, 2013, MOL PSYCHIATR, V18, P2, DOI 10.1038/mp.2012.65; Visscher PM, 2012, MOL PSYCHIATR, V17, P474, DOI 10.1038/mp.2011.65; Wray NR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000864; Yang J, 2010, GENET EPIDEMIOL, V34, P254, DOI 10.1002/gepi.20456	25	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71494	10.1371/journal.pone.0071494	http://dx.doi.org/10.1371/journal.pone.0071494			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977056	gold, Green Published, Green Submitted			2022-12-25	WOS:000323425700059
J	Wang, J; Lu, KY; Liang, F; Li, XY; Wang, L; Yang, CH; Yan, Z; Zhang, SL; Liu, HR				Wang, Jie; Lu, Keyi; Liang, Feng; Li, Xiaoyu; Wang, Li; Yang, Caihong; Yan, Zi; Zhang, Suli; Liu, Huirong			Decreased Autophagy Contributes to Myocardial Dysfunction in Rats Subjected to Nonlethal Mechanical Trauma	PLOS ONE			English	Article							TC-99M SESTAMIBI; GENE-TRANSFER; INFARCT SIZE; CELL-DEATH; HEART; APOPTOSIS; INJURY; LC3; FAILURE; DISEASE	Autophagy is important in cells for removing damaged organelles, such as mitochondria. Insufficient autophagy plays a critical role in tissue injury and organ dysfunction under a variety of pathological conditions. However, the role of autophagy in nonlethal traumatic cardiac damage remains unclear. The aims of the present study were to investigate whether nonlethal mechanical trauma may result in the change of cardiomyocyte autophagy, and if so, to determine whether the changed myocardial autophagy may contribute to delayed cardiac dysfunction. Male adult rats were subjected to nonlethal traumatic injury, and cardiomyocyte autophagy, cardiac mitochondrial function, and cardiac function in isolated perfused hearts were detected. Direct mechanical traumatic injury was not observed in the heart within 24 h after trauma. However, cardiomyocyte autophagy gradually decreased and reached a minimal level 6 h after trauma. Cardiac mitochondrial dysfunction was observed by cardiac radionuclide imaging 6 h after trauma, and cardiac dysfunction was observed 24 h after trauma in the isolated perfused heart. These were reversed when autophagy was induced by administration of the autophagy inducer rapamycin 30 min before trauma. Our present study demonstrated for the first time that nonlethal traumatic injury caused decreased autophagy, and decreased autophagy may contribute to post-traumatic organ dysfunction. Though our study has some limitations, it strongly suggests that cardiac damage induced by nonlethal mechanical trauma can be detected by noninvasive radionuclide imaging, and induction of autophagy may be a novel strategy for reducing posttrauma multiple organ failure.	[Wang, Jie; Li, Xiaoyu; Wang, Li; Yan, Zi; Liu, Huirong] Shanxi Med Univ, Dept Physiol, Taiyuan, Shanxi, Peoples R China; [Wang, Jie] Shanxi Med Univ, Dept Neurol, Hosp 1, Taiyuan, Shanxi, Peoples R China; [Lu, Keyi] Shanxi Med Univ, Dept Nucl Med, Hosp 1, Taiyuan, Shanxi, Peoples R China; [Liang, Feng] Steel Gen Hosp Taiyuan, Taiyuan, Shanxi, Peoples R China; [Li, Xiaoyu] Shanxi Tumor Hosp, Mol Biol Lab, Taiyuan, Shanxi, Peoples R China; [Yang, Caihong] Shanxi Med Univ, Dept Pharmacol, Taiyuan, Shanxi, Peoples R China; [Zhang, Suli; Liu, Huirong] Capital Med Univ, Dept Pathophysiol, Sch Basic Med Sci, Beijing, Peoples R China; [Liu, Huirong] Capital Med Univ, Key Lab Remodeling Related Cardiovasc Dis, Minist Educ, Beijing, Peoples R China	Shanxi Medical University; Shanxi Medical University; Shanxi Medical University; Shanxi Medical University; Capital Medical University; Capital Medical University	Liu, HR (corresponding author), Capital Med Univ, Dept Pathophysiol, Sch Basic Med Sci, Beijing, Peoples R China.	liuhr2000@126.com			National Science Foundation of China [30872680]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the National Science Foundation of China (No. 30872680). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate A, 2002, J CELL PHYSIOL, V193, P145, DOI 10.1002/jcp.10174; Cao Y, 2007, CELL RES, V17, P839, DOI 10.1038/cr.2007.78; Chatterjee S, 2003, J THORAC CARDIOV SUR, V125, P1461, DOI 10.1016/S0022-5223(02)73229-7; Doria A, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMc1303158, 10.1056/NEJMra1205406]; Gustafsson AB, 2009, CIRC RES, V104, P150, DOI 10.1161/CIRCRESAHA.108.187427; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Hein S, 2003, CIRCULATION, V107, P984, DOI 10.1161/01.CIR.0000051865.66123.B7; Huang H, 2013, AUTOPHAGY, V9, P175, DOI 10.4161/auto.22791; Ismailov RM, 2005, INT J CARDIOL, V105, P141, DOI 10.1016/j.ijcard.2004.11.025; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liu ZL, 2001, J NUCL CARDIOL, V8, P677, DOI 10.1067/mnc.2001.117687; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Matsuo S, 2007, J NUCL CARDIOL, V14, P215, DOI 10.1016/j.nuclcard.2006.10.022; Miao WF, 2000, J MOL CELL CARDIOL, V32, P2397, DOI 10.1006/jmcc.2000.1283; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mocanu MM, 2000, BRIT J PHARMACOL, V130, P197, DOI 10.1038/sj.bjp.0703336; Phillips J, 2008, REPAIR RECOVERY, P1; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Regueira T, 2009, MED INTENSIVA, V33, P385, DOI 10.1016/j.medin.2008.10.002; Sala-Mercado JA, 2010, CIRCULATION, V122, pS179, DOI 10.1161/CIRCULATIONAHA.109.928242; Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104; Shin IW, 2010, KOREAN J ANESTHESIOL, V58, P378, DOI 10.4097/kjae.2010.58.4.378; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Sinha Ajay Kumar, 2002, Indian Heart J, V54, P713; Sou Y, 2006, J BIOL CHEM, V281, P3017, DOI 10.1074/jbc.M505888200; Takemura G, 2006, AUTOPHAGY, V2, P212, DOI 10.4161/auto.2608; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Tao L, 2005, AM J PHYSIOL-HEART C, V288, pH2811, DOI 10.1152/ajpheart.01252.2004; Tekirdag KA, 2013, AUTOPHAGY, V9, P374, DOI 10.4161/auto.23117; Vasudevan AR, 2003, LANCET, V362, P370, DOI 10.1016/S0140-6736(03)14024-X; Wang LT, 2008, J TRAUMA, V64, P824, DOI 10.1097/01.ta.0000224924.67776.af; Wei TM, 2002, HEART VESSELS, V17, P77, DOI 10.1007/s003800200048; Wu LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063799; Yan L, 2005, P NATL ACAD SCI USA, V102, P13807, DOI 10.1073/pnas.0506843102; Yoon Young Won, 2007, J Trauma, V63, pE73, DOI 10.1097/01.ta.0000246896.89156.70	39	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71400	10.1371/journal.pone.0071400	http://dx.doi.org/10.1371/journal.pone.0071400			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977036	Green Submitted, gold, Green Published			2022-12-25	WOS:000323425700048
J	Liao, ZY; Zhang, R; Barclay, GF; Feng, YL				Liao, Zhi-Yong; Zhang, Ru; Barclay, Gregor F.; Feng, Yu-Long			Differences in Competitive Ability between Plants from Nonnative and Native Populations of a Tropical Invader Relates to Adaptive Responses in Abiotic and Biotic Environments	PLOS ONE			English	Article							BIOMASS ALLOCATION; INVASIVE PLANT; CHROMOLAENA-ODORATA; ENEMY RELEASE; RANGE POPULATIONS; EVOLUTION; PHOTOSYNTHESIS; GROWTH; PERFORMANCE; HYPOTHESIS	The evolution of competitive ability of invasive plant species is generally studied in the context of adaptive responses to novel biotic environments (enemy release) in introduced ranges. However, invasive plants may also respond to novel abiotic environments. Here we studied differences in competitive ability between Chromolaena odorata plants of populations from nonnative versus native ranges, considering biogeographical differences in both biotic and abiotic environments. An intraspecific competition experiment was conducted at two nutrient levels in a common garden. In both low and high nutrient treatments, C. odorata plants from nonnative ranges showed consistently lower root to shoot ratios than did plants from native ranges grown in both monoculture and competition. In the low nutrient treatment, C. odorata plants from nonnative ranges showed significantly lower competitive ability (competition-driven decreases in plant height and biomass were more), which was associated with their lower root to shoot ratios and higher total leaf phenolic content (defense trait). In the high nutrient treatment, C. odorata plants from nonnative ranges showed lower leaf toughness and cellulosic contents (defense traits) but similar competitive ability compared with plants from native ranges, which was also associated with their lower root to shoot ratios. Our results indicate that genetically based shifts in biomass allocation (responses to abiotic environments) also influence competitive abilities of invasive plants, and provide a first potential mechanism for the interaction between range and environment (environment-dependent difference between ranges).	[Liao, Zhi-Yong; Zhang, Ru] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Kunming, Yunnan Province, Peoples R China; [Liao, Zhi-Yong; Zhang, Ru] Univ Chinese Acad Sci, Beijing, Peoples R China; [Barclay, Gregor F.] Univ W Indies, Dept Life Sci, St Augustine, Trinidad Tobago; [Feng, Yu-Long] Shenyang Agr Univ, Coll Biosci & Biotechnol, Shenyang 110161, Liaoning Provin, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University West Indies Mona Jamaica; University West Indies Saint Augustine; Shenyang Agricultural University	Feng, YL (corresponding author), Shenyang Agr Univ, Coll Biosci & Biotechnol, Shenyang 110161, Liaoning Provin, Peoples R China.	fyl@xtbg.ac.cn	Feng, Yulong/B-7416-2012		National Natural Science Foundation of China [30830027, 31270582]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Project of the National Natural Science Foundation of China (30830027, 31270582). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambika S, 1990, CHROMOLAENA ODORATA, V3, P1; Blair AC, 2004, ECOLOGY, V85, P3035, DOI 10.1890/04-0341; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Bossdorf O, 2004, ECOL LETT, V7, P346, DOI 10.1111/j.1461-0248.2004.00583.x; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Cano L, 2009, OECOLOGIA, V159, P95, DOI 10.1007/s00442-008-1182-z; Colautti RI, 2009, EVOL APPL, V2, P187, DOI 10.1111/j.1752-4571.2008.00053.x; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; DeWalt SJ, 2004, ECOLOGY, V85, P471, DOI 10.1890/02-0728; Feng YL, 2007, PHOTOSYNTHETICA, V45, P245, DOI 10.1007/s11099-007-0040-2; Feng YL, 2011, J ECOL, V99, P1116, DOI 10.1111/j.1365-2745.2011.01843.x; Feng YL, 2009, P NATL ACAD SCI USA, V106, P1853, DOI 10.1073/pnas.0808434106; Feng YL, 2007, ACTA OECOL, V31, P40, DOI 10.1016/j.actao.2006.03.009; Flory SL, 2011, ECOLOGY, V92, P2248, DOI 10.1890/11-0363.1; Flory SL, 2011, BASIC APPL ECOL, V12, P350, DOI 10.1016/j.baae.2011.02.013; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Hierro JL, 2005, J ECOL, V93, P5, DOI 10.1111/j.0022-0477.2004.00953.x; Holdredge C, 2010, OIKOS, V119, P1776, DOI 10.1111/j.1600-0706.2010.18647.x; Joshi J, 2005, ECOL LETT, V8, P704, DOI 10.1111/j.1461-0248.2005.00769.x; Kanmegne J, 1999, AGROFOREST SYST, V46, P239, DOI 10.1023/A:1005902823936; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Koutika LS, 2004, PLANT SOIL, V266, P315; Kriticos DJ, 2005, WEED RES, V45, P246, DOI 10.1111/j.1365-3180.2005.00458.x; Leger EA, 2003, ECOL LETT, V6, P257, DOI 10.1046/j.1461-0248.2003.00423.x; Liang G, 2012, PLOS ONE, V7; McConnaughay KDM, 1999, ECOLOGY, V80, P2581, DOI 10.1890/0012-9658(1999)080[2581:BAIPOO]2.0.CO;2; McDonald S, 2001, FOOD CHEM, V73, P73, DOI 10.1016/S0308-8146(00)00288-0; MCFADYEN REC, 1988, CHROMOLAENA ODORATA, V2, P5; Meyer G, 2005, OECOLOGIA, V144, P299, DOI 10.1007/s00442-005-0046-z; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Muller-Scharer H, 2004, TRENDS ECOL EVOL, V19, P417, DOI 10.1016/j.tree.2004.05.010; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Qin RM, 2013, NEW PHYTOL, V197, P979, DOI 10.1111/nph.12071; Reinhart KO, 2010, NEW PHYTOL, V186, P484, DOI 10.1111/j.1469-8137.2009.03159.x; Ridenour WM, 2008, ECOL MONOGR, V78, P369, DOI 10.1890/06-1926.1; Siemann E, 2001, ECOL LETT, V4, P514, DOI 10.1046/j.1461-0248.2001.00274.x; te Beest M, 2012, BIOL INVASIONS, V14, P607, DOI 10.1007/s10530-011-0102-z; te Beest M, 2009, J ECOL, V97, P1281, DOI 10.1111/j.1365-2745.2009.01574.x; Wang Man-Lian, 2005, Zhiwu Shengtai Xuebao, V29, P697; Wang Y.W., 1987, MICROBIOLOGY, V2, P81; WITKOWSKI ETF, 1991, FUNCT ECOL, V5, P101, DOI 10.2307/2389560; Wolfe LM, 2002, AM NAT, V160, P705, DOI 10.1086/343872; Wolfe LM, 2004, ECOL LETT, V7, P813, DOI 10.1111/j.1461-0248.2004.00649.x; Xiong SM., 2005, CEREAL FEED IND, V8, P40, DOI DOI 10.3969/J.ISSN.1003-6202.2005.08.018; Zhang LiHua, 2007, Chinese Journal of Biological Control, V23, P83; Zheng YL, 2009, PLANT ECOL, V203, P263, DOI 10.1007/s11258-008-9544-5; Zou J, 2007, FUNCT ECOL, V21, P721, DOI 10.1111/j.1365-2435.2007.01298.x; Zou JW, 2008, BIOL INVASIONS, V10, P291, DOI 10.1007/s10530-007-9130-0	49	21	22	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e71767	10.1371/journal.pone.0071767	http://dx.doi.org/10.1371/journal.pone.0071767			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977140	Green Submitted, gold, Green Published			2022-12-25	WOS:000323570200047
J	Wang, Y; Li, X; Wang, XL; Lau, W; Wang, YJ; Xing, Y; Zhang, X; Ma, XL; Gao, F				Wang, Yang; Li, Xu; Wang, Xiaoliang; Lau, Waynebond; Wang, Yajing; Xing, Yuan; Zhang, Xing; Ma, Xinliang; Gao, Feng			Ginsenoside Rd Attenuates Myocardial Ischemia/Reperfusion Injury via Akt/GSK-3 beta Signaling and Inhibition of the Mitochondria-Dependent Apoptotic Pathway	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; OXIDATIVE STRESS; FREE-RADICALS; PROTECTS; SURVIVAL; CELLS; AKT; PREVENTS; MYOCYTES; INSULIN	Evidence suggests Ginsenoside Rd (GSRd), a biologically active extract from the medical plant Panax Ginseng, exerts antioxidant effect, decreasing reactive oxygen species (ROS) formation. Current study determined the effect of GSRd on myocardial ischemia/reperfusion (MI/R) injury (a pathological condition where ROS production is significantly increased) and investigated the underlying mechanisms. The current study utilized an in vivo rat model of MI/R injury and an in vitro neonatal rat cardiomyocyte (NRC) model of simulated ischemia/reperfusion (SI/R) injury. Infarct size was measured by Evans blue/TTC double staining. NRC injury was determined by MTT and lactate dehydrogenase (LDH) leakage assay. ROS accumulation and apoptosis were assessed by flow cytometry. Mitochondrial membrane potential (MMP) was determined by 5, 5', 6, 6'-tetrachloro-1, 1', 3, 3'-tetrathylbenzimidazol carbocyanine iodide (JC-1). Cytosolic translocation of mitochondrial cytochrome c and expression of caspase-9, caspase-3, Bcl-2 family proteins, and phosphorylated Akt and GSK-3 beta were determined by western blot. Pretreatment with GSRd (50 mg/kg) significantly augmented rat cardiac function, as evidenced by increased left ventricular ejection fraction (LVEF) and +/- dP/dt. GSRd reduced myocardial infarct size, apoptotic cell death, and blood creatine kinase/lactate dehydrogenase levels after MI/R. In NRCs, GSRd (10 mu M) inhibited SI/R-induced ROS generation (P<0.01), decreased cellular apoptosis, stabilized the mitochondrial membrane potential (MMP), and attenuated cytosolic translocation of mitochondrial cytochrome c. GSRd inhibited activation of caspase-9 and caspase-3, increased the phosphorylated Akt and GSK-3 beta, and increased the Bcl-2/Bax ratio. Together, these data demonstrate GSRd mediated cardioprotective effect against MI/R-induced apoptosis via a mitochondrial-dependent apoptotic pathway.	[Wang, Yang; Li, Xu; Xing, Yuan; Zhang, Xing; Gao, Feng] Fourth Mil Med Univ, Dept Physiol, Xian 710032, Peoples R China; [Wang, Xiaoliang; Lau, Waynebond; Wang, Yajing; Ma, Xinliang] Thomas Jefferson Univ, Dept Emergency Med, Philadelphia, PA 19107 USA	Air Force Military Medical University; Jefferson University	Ma, XL (corresponding author), Thomas Jefferson Univ, Dept Emergency Med, Philadelphia, PA 19107 USA.	xin.ma@jefferson.edu; fgao@fmmu.edu.cn	Zhang, Xing/ACQ-5035-2022; Gao, Feng/X-4385-2019	Lau, Wayne Bond/0000-0002-8064-8290	National Basic Research Program of China [2013CB531204]; State Key Program of National Natural Science Foundation of China [81030005]; National Natural Science Foundation of China [81270301]	National Basic Research Program of China(National Basic Research Program of China); State Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Basic Research Program of China (No. 2013CB531204), the State Key Program of National Natural Science Foundation of China (No. 81030005), and the National Natural Science Foundation of China (No. 81270301).	Attele AS, 1999, BIOCHEM PHARMACOL, V58, P1685, DOI 10.1016/S0006-2952(99)00212-9; Chen SX, 2011, J ETHNOPHARMACOL, V137, P263, DOI 10.1016/j.jep.2011.05.011; Cook SA, 1999, CIRC RES, V85, P940; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Gottlieb RA, 2003, BASIC RES CARDIOL, V98, P242, DOI 10.1007/s00395-003-0404-0; Guan YY, 2006, EUR J PHARMACOL, V548, P129, DOI 10.1016/j.ejphar.2006.08.001; Haubner BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009350; Hausenloy DJ, 2006, CARDIOVASC RES, V70, P240, DOI 10.1016/j.cardiores.2006.01.017; Hausenloy DJ, 2004, CARDIOVASC RES, V61, P448, DOI 10.1016/j.cardiores.2003.09.024; Jezek P, 2005, INT J BIOCHEM CELL B, V37, P2478, DOI 10.1016/j.biocel.2005.05.013; Ji LL, 2010, AM J PHYSIOL-ENDOC M, V298, pE871, DOI 10.1152/ajpendo.00623.2009; Jonassen AK, 2001, CIRC RES, V89, P1191, DOI 10.1161/hh2401.101385; Kannan, 2000, Pathophysiology, V7, P153, DOI 10.1016/S0928-4680(00)00053-5; Korge P, 2008, CIRC RES, V103, P873, DOI 10.1161/CIRCRESAHA.108.180869; Kumar D, 2003, J LAB CLIN MED, V142, P288, DOI 10.1016/S0022-2143(03)00148-3; Lee JH, 2002, NEUROSCI LETT, V325, P129, DOI 10.1016/S0304-3940(02)00256-2; Leung KW, 2007, BRIT J PHARMACOL, V152, P207, DOI 10.1038/sj.bjp.0707359; Li SY, 2012, APOPTOSIS, V17, P113, DOI 10.1007/s10495-011-0671-4; Li WJ, 2009, LIFE SCI, V85, P634, DOI 10.1016/j.lfs.2009.09.001; Li XY, 2010, CLIN EXP PHARMACOL P, V37, P199, DOI 10.1111/j.1440-1681.2009.05286.x; Miyamoto S, 2009, J BIOENERG BIOMEMBR, V41, P169, DOI 10.1007/s10863-009-9205-y; Masahiro N, 2007, J MOL CELL CARDIOL, V43, P564, DOI 10.1016/j.yjmcc.2007.08.010; Park SS, 2006, J MOL CELL CARDIOL, V40, P708, DOI 10.1016/j.yjmcc.2006.01.024; Peng L, 2012, CARDIOVASC THER, V30, pe183, DOI 10.1111/j.1755-5922.2011.00271.x; Scott GI, 2001, BRIT J PHARMACOL, V134, P1159, DOI 10.1038/sj.bjp.0704377; Shi YH, 2011, PHARM BIOL, V49, P900, DOI 10.3109/13880209.2011.554845; Siddall HK, 2008, BASIC RES CARDIOL, V103, P560, DOI 10.1007/s00395-008-0735-y; Sun D, 2012, PHYTOMEDICINE, V19, P369, DOI 10.1016/j.phymed.2011.08.061; Takahashi A, 2004, BRAIN RES BULL, V62, P497, DOI 10.1016/j.brainresbull.2003.07.009; Tamura T, 2008, FOOD CHEM TOXICOL, V46, P3080, DOI 10.1016/j.fct.2008.06.011; Uchiyama T, 2004, CIRCULATION, V109, P3042, DOI 10.1161/01.CIR.0000130647.29030.90; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Wang Z, 2008, CARDIOVASC DRUG THER, V22, P443, DOI 10.1007/s10557-008-6129-4; Xia R, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/767930; Yao K, 2008, MOL VIS, V14, P217; Yasmin W, 1997, CARDIOVASC RES, V33, P422, DOI 10.1016/S0008-6363(96)00254-4; Ye R, 2011, NEUROSCIENCE, V178, P169, DOI 10.1016/j.neuroscience.2011.01.007; Ye RD, 2008, BIOL PHARM BULL, V31, P1923, DOI 10.1248/bpb.31.1923; Ye RD, 2009, NEUROSCI RES, V64, P306, DOI 10.1016/j.neures.2009.03.016; Zhai PY, 2011, CIRC RES, V109, P502, DOI 10.1161/CIRCRESAHA.111.249532; Zhang Y, 2010, DIABETES OBES METAB, V12, P316, DOI 10.1111/j.1463-1326.2009.01166.x	43	81	88	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e70956	10.1371/journal.pone.0070956	http://dx.doi.org/10.1371/journal.pone.0070956			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23976968	Green Submitted, Green Published, gold			2022-12-25	WOS:000323570200011
J	Bardelli, M; Alleri, L; Angiolini, F; Buricchi, F; Tavarini, S; Sammicheli, C; Nuti, S; Degl'Innocenti, E; Isnardi, I; Fragapane, E; Del Giudice, G; Castellino, F; Galli, G				Bardelli, Monia; Alleri, Liliana; Angiolini, Francesca; Buricchi, Francesca; Tavarini, Simona; Sammicheli, Chiara; Nuti, Sandra; Degl'Innocenti, Elena; Isnardi, Isabelle; Fragapane, Elena; Del Giudice, Giuseppe; Castellino, Flora; Galli, Grazia			Ex Vivo Analysis of Human Memory B Lymphocytes Specific for A and B Influenza Hemagglutinin by Polychromatic Flow-Cytometry	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; SIALIC ACIDS; CELLS	Understanding the impact that human memory B-cells (MBC), primed by previous infections or vaccination, exert on neutralizing antibody responses against drifted influenza hemagglutinin (HA) is key to design best protective vaccines. A major obstacle to these studies is the lack of practical tools to analyze HA-specific MBCs in human PBMCs ex vivo. We report here an efficient method to identify MBCs carrying HA-specific BCR in frozen PBMC samples. By using fluorochrome-tagged recombinant HA baits, and vaccine antigens from mismatched influenza strains to block BCR-independent binding, we developed a protocol suitable for quantitative, functional and molecular analysis of single MBCs specific for HA from up to two different influenza strains in the same tube. This approach will permit to identify the naive and MBC precursors of plasmablasts and novel MBCs appearing in the blood following infection or vaccination, thus clarifying the actual contribution of pre-existing MBCs in antibody responses against novel influenza viruses. Finally, this protocol can allow applying high throughput deep sequencing to analyze changes in the repertoire of HA(+) B-cells in longitudinal samples from large cohorts of vaccinees and infected subjects with the ultimate goal of understanding the in vivo B-cell dynamics driving the evolution of broadly cross-protective antibody responses.	[Bardelli, Monia; Alleri, Liliana; Angiolini, Francesca; Buricchi, Francesca; Tavarini, Simona; Sammicheli, Chiara; Nuti, Sandra; Fragapane, Elena; Del Giudice, Giuseppe; Castellino, Flora; Galli, Grazia] Novartis Vaccines & Diagnost Srl, Siena, Italy; [Degl'Innocenti, Elena; Isnardi, Isabelle] Novartis Inst Biomed Res, Basel, Switzerland	Novartis; Novartis	Galli, G (corresponding author), Novartis Vaccines & Diagnost Srl, Siena, Italy.	graziagalli@gmail.com			Novartis Vaccines and Diagnostics srl (Siena Italy); European Union [280873 ADITEC]	Novartis Vaccines and Diagnostics srl (Siena Italy); European Union(European Commission)	This work was funded by Novartis Vaccines and Diagnostics srl (Siena Italy) and partially supported by the European Union's Seventh Framework Programme [FP7/2007 2013] under Grant Agreement No: 280873 ADITEC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Berkowska MA, 2011, BLOOD, V118, P2150, DOI 10.1182/blood-2011-04-345579; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015; Dormitzer PR, 2011, IMMUNOL REV, V239, P167, DOI 10.1111/j.1600-065X.2010.00974.x; Doucett VP, 2005, J IMMUNOL METHODS, V303, P40, DOI 10.1016/j.jim.2005.05.014; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Ellebedy AH, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00053; Faenzi E, 2012, VACCINE, V30, P4086, DOI 10.1016/j.vaccine.2012.04.020; Feshchenko E, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-77; Galli G, 2009, P NATL ACAD SCI USA, V106, P3877, DOI 10.1073/pnas.0813390106; He XS, 2013, J INFECT DIS, V207, P288, DOI 10.1093/infdis/jis664; Hu WB, 2013, VIROLOGY, V435, P320, DOI 10.1016/j.virol.2012.09.034; KAMERLING JP, 1982, BIOCHIM BIOPHYS ACTA, V714, P351, DOI 10.1016/0304-4165(82)90344-0; KRYSTAL M, 1982, P NATL ACAD SCI-BIOL, V79, P4800, DOI 10.1073/pnas.79.15.4800; Li GM, 2012, P NATL ACAD SCI USA, V109, P9047, DOI 10.1073/pnas.1118979109; Moody MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025797; Naito Y, 2007, MOL CELL BIOL, V27, P3008, DOI 10.1128/MCB.02047-06; Pinna D, 2009, EUR J IMMUNOL, V39, P1260, DOI 10.1002/eji.200839129; Sasaki S, 2007, J VIROL, V81, P215, DOI 10.1128/JVI.01957-06; Schild GC, 1975, INFLUENZA VIRUSES IN, P315; SHIBUYA N, 1987, J BIOL CHEM, V262, P1596; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Viswanathan K, 2010, GLYCOCONJUGATE J, V27, P561, DOI 10.1007/s10719-010-9303-4; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Yu XC, 2008, NATURE, V455, P532, DOI 10.1038/nature07231; ZIMMER G, 1994, GLYCOBIOLOGY, V4, P343, DOI 10.1093/glycob/4.3.343	29	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e70620	10.1371/journal.pone.0070620	http://dx.doi.org/10.1371/journal.pone.0070620			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23976947	gold, Green Published, Green Submitted			2022-12-25	WOS:000323378000009
J	Kristoffersen, US; Lebech, AM; Wiinberg, N; Petersen, CL; Hasbak, P; Gutte, H; Jensen, GB; Hag, AMF; Ripa, RS; Kjaer, A				Kristoffersen, Ulrik S.; Lebech, Anne-Mette; Wiinberg, Niels; Petersen, Claus L.; Hasbak, Philip; Gutte, Henrik; Jensen, Gorm B.; Hag, Anne Mette F.; Ripa, Rasmus S.; Kjaer, Andreas			Silent Ischemic Heart Disease and Pericardial Fat Volume in HIV-Infected Patients: A Case-Control Myocardial Perfusion Scintigraphy Study	PLOS ONE			English	Article							EPICARDIAL ADIPOSE-TISSUE; ARTERY CALCIUM SCORE; ACTIVE ANTIRETROVIRAL THERAPY; INTIMA-MEDIA THICKNESS; RISK-FACTORS; CARDIOVASCULAR RISK; COMPUTED-TOMOGRAPHY; METABOLIC SYNDROME; PROGNOSTIC VALUE; CORONARY	Objectives: to determine the prevalence of asymptomatic ischemic heart disease (IHD) in HIV patients by myocardial perfusion scintigraphy (MPS) and to determine the value of coronary artery calcium score (CACS), carotid intima-media thickness (cIMT) and pericardial fat volume as screening tools for detection of IHD in subjects with HIV. Background: Patients with HIV seem prone to early development of IHD. Methods: 105 consecutive HIV patients (mean age 47.4 years; mean duration of HIV 12.3 years; mean CD4+ cell count 636x10(6)/L; all receiving antiretroviral therapy) and 105 controls matched for age, gender and smoking status, without history of IHD were recruited. MPS, CACS, cIMT, pericardial fat volume, and cardiovascular risk scores were measured. Results: HIV patients demonstrated higher prevalence of perfusion defects than controls (18% vs. 0%; p<0.001) despite similar risk scores. Of HIV patients with perfusion defects, 42% had a CACS = 0. CACS and cIMT were similar in HIV patients and controls. HIV patients on average had 35% increased pericardial fat volume and increased concentration of biomarkers of atherosclerosis in the blood. HIV patients with myocardial perfusion defects had increased pericardial fat volume compared with HIV patients without perfusion defects (314 +/- 43 vs. 189 +/- 12 mL; p<0.001). Conclusions: HIV patients had an increased prevalence of silent IHD compared to controls as demonstrated by MPS. The finding was strongly associated with pericardial fat volume, whereas cardiovascular risk scores, cIMT and CACS seem less useful as screening tools for detection of myocardial perfusion defects in HIV patients.	[Kristoffersen, Ulrik S.; Hasbak, Philip; Gutte, Henrik; Ripa, Rasmus S.; Kjaer, Andreas] Rigshosp, Dept Clin Physiol Nucl Med & PET, DK-2100 Copenhagen, Denmark; [Kristoffersen, Ulrik S.; Gutte, Henrik; Hag, Anne Mette F.; Kjaer, Andreas] Univ Copenhagen, Cluster Mol Imaging, Copenhagen, Denmark; [Lebech, Anne-Mette] Hvidovre Univ Hosp, Dept Infect Dis, Copenhagen, Denmark; [Wiinberg, Niels; Petersen, Claus L.; Ripa, Rasmus S.] Frederiksberg Univ Hosp, Dept Clin Physiol & Nucl Med, DK-2000 Copenhagen, Denmark; [Jensen, Gorm B.] Hvidovre Univ Hosp, Dept Cardiol, Copenhagen, Denmark; [Jensen, Gorm B.] Univ Copenhagen, Copenhagen City Heart Study, Bispebjerg Hosp, Dept Occupat Med, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital	Kjaer, A (corresponding author), Rigshosp, Dept Clin Physiol Nucl Med & PET, DK-2100 Copenhagen, Denmark.	akjaer@sund.ku.dk	, Rasmus Ripa/GSN-2844-2022; Wiinberg, Niels/AAK-9205-2020; Kjaer, Andreas/E-8932-2015	, Rasmus Ripa/0000-0003-2035-2321; Wiinberg, Niels/0000-0002-1983-6129; Hag, Anne Mette F/0000-0001-9492-3663; Gutte, Henrik/0000-0001-5494-5323; Lebech, Anne-Mette/0000-0002-0943-3289; Kjaer, Andreas/0000-0002-2706-5547	John and Birthe Meyer Foundation; A.P. Moller Foundation; Danish Medical Research Council; AIDS Foundation; Danish Heart Foundation; Research Council of Rigshospitalet; Research Foundation of the Capital Region	John and Birthe Meyer Foundation; A.P. Moller Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AIDS Foundation; Danish Heart Foundation; Research Council of Rigshospitalet; Research Foundation of the Capital Region	This work was supported by the John and Birthe Meyer Foundation, the A.P. Moller Foundation, the Danish Medical Research Council, the AIDS Foundation, the Danish Heart Foundation, the Research Council of Rigshospitalet and the Research Foundation of the Capital Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Alexopoulos N, 2010, ATHEROSCLEROSIS, V210, P150, DOI 10.1016/j.atherosclerosis.2009.11.020; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Crum-Cianflone N, 2012, AIDS; Currier JS, 2007, AIDS, V21, P1137, DOI 10.1097/QAD.0b013e32811ebf79; de Vos AM, 2008, EUR HEART J, V29, P777, DOI 10.1093/eurheartj/ehm564; Engelen L, 2012, EUR HEART J IN PRESS; Fitch KV, 2010, JAIDS-J ACQ IMM DEF, V55, P495, DOI 10.1097/QAI.0b013e3181edab0b; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Friis-Moller N, 2010, EUR J CARDIOV PREV R, V17, P491, DOI 10.1097/HJR.0b013e328336a150; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Grunfeld C, 2009, AIDS, V23, P1841, DOI 10.1097/QAD.0b013e32832d3b85; Guaraldi G, 2011, AIDS, V25, P1199, DOI 10.1097/QAD.0b013e3283474b9f; Hachamovitch R, 1998, CIRCULATION, V97, P535; Kablak-Ziembicka A, 2004, HEART, V90, P1286, DOI 10.1136/hrt.2003.025080; Kaplan RC, 2008, AIDS, V22, P1615, DOI 10.1097/QAD.0b013e328300581d; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Konishi M, 2010, ATHEROSCLEROSIS, V209, P573, DOI 10.1016/j.atherosclerosis.2009.10.008; Kristoffersen US, 2009, HIV MED, V10, P627, DOI 10.1111/j.1468-1293.2009.00733.x; Kristoffersen US, 2009, HIV MED, V10, P79, DOI 10.1111/j.1468-1293.2008.00661.x; Lang S, 2010, AIDS, V24, P1228, DOI 10.1097/QAD.0b013e328339192f; Lebech AM, 2007, CLIN PHYSIOL FUNCT I, V27, P173, DOI 10.1111/j.1475-097X.2007.00737.x; Lo J, 2010, AIDS, V24, P243, DOI 10.1097/QAD.0b013e328333ea9e; Lorenz MW, 2008, ATHEROSCLEROSIS, V196, P720, DOI 10.1016/j.atherosclerosis.2006.12.022; NYBOE J, 1989, EUR HEART J, V10, P910, DOI 10.1093/oxfordjournals.eurheartj.a059401; Obel N, 2007, CLIN INFECT DIS, V44, P1625, DOI 10.1086/518285; Obel N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022698; Pletcher MJ, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-31; Sackoff JE, 2006, ANN INTERN MED, V145, P397, DOI 10.7326/0003-4819-145-6-200609190-00003; Sacks HS, 2007, AM HEART J, V153, P907, DOI 10.1016/j.ahj.2007.03.019; Sangiorgi G, 1998, J AM COLL CARDIOL, V31, P126, DOI 10.1016/S0735-1097(97)00443-9; Shaw LJ, 2004, J NUCL CARDIOL, V11, P171, DOI 10.1016/j.nuclcard.2003.12.004; Taguchi R, 2001, ATHEROSCLEROSIS, V157, P203, DOI 10.1016/S0021-9150(00)00709-7; Thiebaut F, 2005, AIDS, V19, P729, DOI 10.1097/01.aids.0000166097.46940.35; Zimmet P, 2005, J ATHEROSCLER THROMB, V12, P295, DOI 10.5551/jat.12.295	35	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e72066	10.1371/journal.pone.0072066	http://dx.doi.org/10.1371/journal.pone.0072066			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967275	Green Published, gold, Green Submitted			2022-12-25	WOS:000323221500118
J	Mayega, RW; Guwatudde, D; Makumbi, F; Nakwagala, FN; Peterson, S; Tomson, G; Ostenson, CG				Mayega, Roy William; Guwatudde, David; Makumbi, Fredrick; Nakwagala, Frederick Nelson; Peterson, Stefan; Tomson, Goran; Ostenson, Claes-Goran			Diabetes and Pre-Diabetes among Persons Aged 35 to 60 Years in Eastern Uganda: Prevalence and Associated Factors	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; CHRONIC DISEASE; RISK-FACTORS; LOW-INCOME; GLUCOSE-TOLERANCE; PREVENTION; COUNTRIES; DIET; HYPERGLYCEMIA; HYPERTENSION	Background: Our aim was to estimate the prevalence of abnormal glucose regulation (AGR) (i.e. diabetes and prediabetes) and its associated factors among people aged 35-60 years so as to clarify the relevance of targeted screening in rural Africa. Methods: A population-based survey of 1,497 people (786 women and 711 men) aged 35-60 years was conducted in a predominantly rural Demographic Surveillance Site in eastern Uganda. Participants responded to a lifestyle questionnaire, following which their Body Mass Index (BMI) and Blood Pressure (BP) were measured. Fasting plasma glucose (FPG) was measured from capillary blood using On-Call (R) Plus (Acon) rapid glucose meters, following overnight fasting. AGR was defined as FPG >= 6.1 mmol L-1 (World Health Organization (WHO) criteria or >= 5.6mmol L-1 (American Diabetes Association (ADA) criteria. Diabetes was defined as FPG >6.9mmol L-1, or being on diabetes treatment. Results: The mean age of participants was 45 years for men and 44 for women. Prevalence of diabetes was 7.4% (95% CI 6.1-8.8), while prevalence of pre-diabetes was 8.6% (95% CI 7.3-10.2) using WHO criteria and 20.2% (95% CI 17.5-22.9) with ADA criteria. Using WHO cut-offs, the prevalence of AGR was 2 times higher among obese persons compared with normal BMI persons (Adjusted Prevalence Rate Ratio (APRR) 1.9, 95% CI 1.3-2.8). Occupation as a mechanic, achieving the WHO recommended physical activity threshold, and higher dietary diversity were associated with lower likelihood of AGR (APRR 0.6, 95% CI 0.4-0.9; APRR 0.6, 95% CI 0.4-0.8; APRR 0.5, 95% CI 0.3-0.9 respectively). The direct medical cost of detecting one person with AGR was two US dollars with ADA and three point seven dollars with WHO cut-offs. Conclusions: There is a high prevalence of AGR among people aged 35-60 years in this setting. Screening for high risk persons and targeted health education to address obesity, insufficient physical activity and non-diverse diets are necessary.	[Mayega, Roy William; Peterson, Stefan; Tomson, Goran] Karolinska Inst, Dept Publ Hlth Sci, Div Global Hlth IHCAR, Stockholm, Sweden; [Mayega, Roy William; Guwatudde, David; Makumbi, Fredrick] Makerere Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda; [Nakwagala, Frederick Nelson] Mulago Natl Referral Hosp, Dept Internal Med, Kampala, Uganda; [Peterson, Stefan] Uppsala Univ, Int Maternal & Child Hlth Unit, Uppsala, Sweden; [Tomson, Goran] Karolinska Inst, Dept Learning Informat Management & Eth LIME, Div Med Management Ctr MMC, Stockholm, Sweden; [Ostenson, Claes-Goran] Karolinska Inst, Dept Mol Med & Surg, Endocrine & Diabet Unit, Stockholm, Sweden; [Peterson, Stefan] Makerere Univ, Sch Publ Hlth, Dept Hlth Policy Planning & Management, Kampala, Uganda	Karolinska Institutet; Makerere University; Mulago National Referral Hospital; Uppsala University; Karolinska Institutet; Karolinska Institutet; Makerere University	Mayega, RW (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Div Global Hlth IHCAR, Stockholm, Sweden.	wromay2000@yahoo.co.uk		Tomson, Goran/0000-0001-9222-3604	Swedish International Development Agency; Swedish International Development Agency (SIDA); African Population and Health Research Centre (APHRC); International Development Research Centre (IDRC)	Swedish International Development Agency; Swedish International Development Agency (SIDA); African Population and Health Research Centre (APHRC); International Development Research Centre (IDRC)	This work was primarily funded by the Swedish International Development Agency. This work was funded by the Swedish International Development Agency (SIDA) through its support to Makerere University in Uganda. The grant covered the costs of field work, including training of research assistants, data collection and entry (http://www.sida.se/English/Countries-and-regions/Africa/Uganda/Our-work-in-Uganda/). The African Population and Health Research Centre (APHRC) (http://www.aphrc.org/) in partnership with the International Development Research Centre (IDRC) are also duly acknowledged for their additional financial support through the African Doctoral Dissertation Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Abrahams Z, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-801; Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Allotey P, 2011, LANCET, V377, P450, DOI 10.1016/S0140-6736(10)61856-9; Ambady R, 2008, REV ENDOCR METAB DIS, V9, P193, DOI 10.1007/s11154-008-9079-z; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; Bull FC, 2009, J PHYS ACT HEALTH, V6, P790, DOI 10.1123/jpah.6.6.790; *BUR UG STAT, 2007, PROJ DEM TRENDS UG, P2007; *BUR UG STAT MARC, 2007, UG DEM HLTH SURV 200, P19; Chen KT, 2003, DIABETES RES CLIN PR, V60, P177, DOI 10.1016/S0168-8227(03)00037-8; Coronado-Malagon M, 2009, GAC MED MEX, V145, P269; Dalal S, 2011, INT J EPIDEMIOL, V40, P885, DOI 10.1093/ije/dyr050; Edelman D, 2004, J GEN INTERN MED, V19, P1175, DOI 10.1111/j.1525-1497.2004.40178.x; Gill G, 2009, DIABETOLOGIA, V52, P8, DOI 10.1007/s00125-008-1167-9; Guthold R, 2011, AM J PREV MED, V41, P52, DOI 10.1016/j.amepre.2011.03.008; Hall V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-564; Hilding A, 2006, DIABETOLOGIA, V49, P2589, DOI 10.1007/s00125-006-0402-5; Janssens B, 2007, B WORLD HEALTH ORGAN, V85, P880, DOI 10.2471/BLT.06.036574; Lasky D, 2002, NUTRITION, V18, P417, DOI 10.1016/S0899-9007(01)00726-2; Lee J, 2009, ANN ACAD MED SINGAP, V38, P714; Lindstrom J, 2003, DIABETES CARE, V26, P3230, DOI 10.2337/diacare.26.12.3230; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Lyon AW, 2004, CAN MED ASSOC J, V171, P1067, DOI 10.1503/cmaj.1040138; MAHER D, 2010, B WORLD HEALTH ORGAN, V88, P2010, DOI DOI 10.2471/BLT.10.077891.PUBMED:21124720; Maher D, 2011, INT J EPIDEMIOL, V40, P160, DOI 10.1093/ije/dyq156; Maher D, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-5; Mayega RW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047632; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; Meigs JB, 2003, DIABETES, V52, P1475, DOI 10.2337/diabetes.52.6.1475; Mendis S, 2004, J HYPERTENS, V22, P59, DOI 10.1097/00004872-200401000-00013; Mutebi E, 2012, AFR J DIABETES MED, V20, P20; Newcombe DAL, 2005, DRUG ALCOHOL REV, V24, P217, DOI 10.1080/09595230500170266; Oladapo OO, 2010, CARDIOVASC J AFR, V21, P26; Oyeyemi AL, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-156; Papathanasiou George, 2009, Hellenic J Cardiol, V50, P283; Rahman Md Mafuzar, 2007, Bangladesh Med Res Counc Bull, V33, P48; Ruel Marie T., 2003, Food and Nutrition Bulletin, V24, P231; Savy M, 2005, EUR J CLIN NUTR, V59, P703, DOI 10.1038/sj.ejcn.1602135; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Shibata K, 2005, J CLIN EPIDEMIOL, V58, P1052, DOI 10.1016/j.jclinepi.2005.01.019; SICREE R, 2012, LOBAL BURDEN DIABETE, V4, P15; Sodjinou R, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-84; Swindale A., 2005, MEASURING HOUSEHOLD; Thompson ML, 1998, OCCUP ENVIRON MED, V55, P272, DOI 10.1136/oem.55.4.272; TURYATEMBA J, 2011, STUDIES; Ustun B, 1998, DRUG ALCOHOL DEPEN, V50, P185; Waijers PMCM, 2007, BRIT J NUTR, V97, P219, DOI 10.1017/S0007114507250421; *WHO, 2009, WORLD HLTH STAT HLTH; WHO, 2011, STEPS MAN STEPS INST; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; WHO IDF, 2006, DEF DIAGN DIAB MELL; Wood Jamie R, 2012, J Diabetes Sci Technol, V6, P380; World Health Organization, 2011, GUID OPT FEED LOW BI, P16; World Health Organization, 1995, PHYS STAT US INT ANT	56	58	58	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e72554	10.1371/journal.pone.0072554	http://dx.doi.org/10.1371/journal.pone.0072554			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967317	gold, Green Published, Green Submitted			2022-12-25	WOS:000323221500137
J	Polimeni, M; Valente, E; Ulliers, D; Opdenakker, G; Van den Steen, PE; Giribaldi, G; Prato, M				Polimeni, Manuela; Valente, Elena; Ulliers, Daniela; Opdenakker, Ghislain; Van den Steen, Philippe E.; Giribaldi, Giuliana; Prato, Mauro			Natural Haemozoin Induces Expression and Release of Human Monocyte Tissue Inhibitor of Metalloproteinase-1	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; FALCIPARUM-INFECTED ERYTHROCYTES; HUMAN ADHERENT MONOCYTES; BLOOD MONONUCLEAR-CELLS; P38 MAP KINASE; MATRIX METALLOPROTEINASES; GENE-EXPRESSION; IN-VITRO; MALARIAL PIGMENT; TNF-ALPHA	Recently matrix metalloproteinase-9 (MMP-9) and its endogenous inhibitor (tissue inhibitor of metalloproteinase-1, TIMP-1) have been implicated in complicated malaria. In vivo, mice with cerebral malaria (CM) display high levels of both MMP-9 and TIMP-1, and in human patients TIMP-1 serum levels directly correlate with disease severity. In vitro, natural haemozoin (nHZ, malarial pigment) enhances monocyte MMP-9 expression and release. The present study analyses the effects of nHZ on TIMP-1 regulation in human adherent monocytes. nHZ induced TIMP-1 mRNA expression and protein release, and promoted TNF-alpha, IL-1 beta, and MIP-1 alpha/CCL3 production. Blocking antibodies or recombinant cytokines abrogated or mimicked nHZ effects on TIMP-1, respectively. p38 MAPK and NF-kappa B inhibitors blocked all nHZ effects on TIMP-1 and pro-inflammatory molecules. Still, total gelatinolytic activity was enhanced by nHZ despite TIMP-1 induction. Collectively, these data indicate that nHZ induces inflammation-mediated expression and release of human monocyte TIMP-1 through p38 MAPK- and NF-kappa B-dependent mechanisms. However, TIMP-1 induction is not sufficient to counterbalance nHZ-dependent MMP-9 enhancement. Future investigation on proteinase-independent functions of TIMP-1 (i.e. cell survival promotion and growth/differentiation inhibition) is needed to clarify the role of TIMP-1 in malaria pathogenesis.	[Polimeni, Manuela; Valente, Elena; Ulliers, Daniela; Giribaldi, Giuliana; Prato, Mauro] Univ Turin, Dipartimento Oncol, Turin, Italy; [Opdenakker, Ghislain; Van den Steen, Philippe E.] Catholic Univ Louvain, Rega Inst, Immunobiol Lab, B-3000 Louvain, Belgium; [Prato, Mauro] Univ Turin, Dipartimento Neurosci, Turin, Italy	University of Turin; KU Leuven; Universite Catholique Louvain; University of Turin	Prato, M (corresponding author), Univ Turin, Dipartimento Oncol, Turin, Italy.	mauro.prato@unito.it	Opdenakker, Ghislain/V-8562-2019; Opdenakker, Ghislain/Q-3130-2017; Van den Steen, Philippe E/K-5132-2012; Giribaldi, Giuliana/I-8115-2018	Opdenakker, Ghislain/0000-0003-1714-2294; Opdenakker, Ghislain/0000-0003-1714-2294; Van den Steen, Philippe E/0000-0002-7334-9145; Giribaldi, Giuliana/0000-0003-1374-1919	Universita di Torino; Societa Italiana di Biochimica (SIB); Fund for Scientific Research (FWO-Vlaanderen); Research Fund of the KULeuven [GOA/2012/017]; Azienda Sanitaria Locale-19 (ASL-19)	Universita di Torino; Societa Italiana di Biochimica (SIB); Fund for Scientific Research (FWO-Vlaanderen)(FWO); Research Fund of the KULeuven; Azienda Sanitaria Locale-19 (ASL-19)	This work was financed by intramural funds from Universita di Torino to G. Giribaldi, by funds from Mrs. Franca Squazza and from Societa Italiana di Biochimica (SIB) to M. Prato, and by Fund for Scientific Research (FWO-Vlaanderen) and Research Fund of the KULeuven (GOA/2012/017) to G. Opdenakker and P. Van den Steen. M. Prato holds a professorship granted by Universita di Torino and Azienda Sanitaria Locale-19 (ASL-19). P. Van den Steen holds a research professorship of the KULeuven. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldieri E, 2003, FEBS LETT, V552, P141, DOI 10.1016/S0014-5793(03)00905-0; Amina K, 2010, ASIAN PAC J TROP MED, V3, P412, DOI 10.1016/S1995-7645(10)60101-0; Bar-Or A, 2003, BRAIN, V126, P2738, DOI 10.1093/brain/awg285; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Burrows JN, 2011, CURR TOP MED CHEM, V11, P1226; Cambos M, 2010, INT J PARASITOL, V40, P1003, DOI 10.1016/j.ijpara.2010.02.007; Cauwe B, 2007, CRIT REV BIOCHEM MOL, V42, P113, DOI 10.1080/10409230701340019; Chirco R, 2006, CANCER METAST REV, V25, P99, DOI 10.1007/s10555-006-7893-x; D' Alessandro S, 2013, ASIAN PAC J TROP MED, V6, P195, DOI 10.1016/S1995-7645(13)60022-X; Dell'Agli M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-208; Deroost K, 2013, AM J RESP CELL MOL, V48, P589, DOI 10.1165/rcmb.2012-0450OC; Dietmann A, 2008, J INFECT DIS, V197, P1614, DOI 10.1086/587943; Egea V, 2012, P NATL ACAD SCI USA, V109, pE309, DOI 10.1073/pnas.1115083109; Garcia-Pineres AJ, 2001, J BIOL CHEM, V276, P39713, DOI 10.1074/jbc.M101985200; Geurts N, 2008, BIOCHEMISTRY-US, V47, P2689, DOI 10.1021/bi702260q; Geurts N, 2012, PHARMACOL THERAPEUT, V133, P257, DOI 10.1016/j.pharmthera.2011.11.008; Giribaldi G, 2004, HAEMATOLOGICA, V89, P492; Giribaldi G, 2011, ASIAN PAC J TROP MED, V4, P925, DOI 10.1016/S1995-7645(11)60220-4; Giribaldi G, 2010, INFECT IMMUN, V78, P4912, DOI 10.1128/IAI.00455-10; Griffith JW, 2009, J IMMUNOL, V183, P5208, DOI 10.4049/jimmunol.0713552; Guedez L, 1998, J CLIN INVEST, V102, P2002, DOI 10.1172/JCI2881; HANEMAAIJER R, 1993, BIOCHEM J, V296, P803, DOI 10.1042/bj2960803; Higgins SJ, 2011, EXPERT REV ANTI-INFE, V9, P803, DOI [10.1586/eri.11.96, 10.1586/ERI.11.96]; Jaramillo M, 2005, J IMMUNOL, V174, P475, DOI 10.4049/jimmunol.174.1.475; Jaramillo M, 2003, J IMMUNOL, V171, P4243, DOI 10.4049/jimmunol.171.8.4243; Johnatty RN, 1997, J IMMUNOL, V158, P2327; Jovanovic DV, 2001, J RHEUMATOL, V28, P712; Jung KK, 2006, EMBO J, V25, P3934, DOI 10.1038/sj.emboj.7601281; Khadjavi A, 2014, CELL BIOCHEM FUNCT, V32, P5, DOI 10.1002/cbf.2963; KHALID SA, 1986, J ETHNOPHARMACOL, V15, P201, DOI 10.1016/0378-8741(86)90156-X; Lee JC, 2000, IMMUNOPHARMACOLOGY, V47, P185, DOI 10.1016/S0162-3109(00)00206-X; Li GY, 1999, CANCER RES, V59, P6267; Lu ZY, 2006, J IMMUNOL, V177, P6344, DOI 10.4049/jimmunol.177.9.6344; Lucchi NW, 2011, PLACENTA, V32, P579, DOI 10.1016/j.placenta.2011.05.003; Lucchi NW, 2011, DIS MARKERS, V31, P327, DOI [10.1155/2011/345706, 10.3233/DMA-2011-0854]; Lucchi NW, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-42; Moreno A, 2013, INFECT IMMUN, V81, P1889, DOI 10.1128/IAI.00027-13; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nair MP, 2006, CLIN VACCINE IMMUNOL, V13, P319, DOI 10.1128/CVI.13.3.319-328.2006; Nguyen J, 2006, IMMUNOL LETT, V106, P34, DOI 10.1016/j.imlet.2006.04.003; Ockenhouse CF, 2006, INFECT IMMUN, V74, P5561, DOI 10.1128/IAI.00408-06; OPDENAKKER G, 1991, LYMPHOKINE CYTOK RES, V10, P317; OPDENAKKER G, 1991, FEBS LETT, V284, P73, DOI 10.1016/0014-5793(91)80765-U; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Polimeni M, 2013, BIOFACTORS, V39, P304, DOI 10.1002/biof.1071; Polimeni M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039497; Pols MS, 2009, EXP CELL RES, V315, P1584, DOI 10.1016/j.yexcr.2008.09.020; Prato M, 2005, J IMMUNOL, V175, P6436, DOI 10.4049/jimmunol.175.10.6436; Prato M, 2011, J TROP MED-US, V2011, DOI 10.1155/2011/628435; Prato M, 2011, ASIAN PAC J TROP MED, V4, P756, DOI 10.1016/S1995-7645(11)60187-9; Prato M, 2011, CELL MICROBIOL, V13, P1275, DOI 10.1111/j.1462-5822.2011.01620.x; Prato M, 2010, ASIAN PAC J TROP MED, V3, P934, DOI 10.1016/S1995-7645(11)60003-5; Prato M, 2010, CELL MICROBIOL, V12, P1780, DOI 10.1111/j.1462-5822.2010.01508.x; Prato M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-157; Punsawad C, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-191; Schrimpe AC, 2009, CHEM RES TOXICOL, V22, P433, DOI 10.1021/tx8002752; SCHWARZER E, 1992, J EXP MED, V176, P1033, DOI 10.1084/jem.176.4.1033; Schwarzer E, 2003, BLOOD, V101, P722, DOI 10.1182/blood-2002-03-0979; Seo JH, 2012, CURR PHARM DESIGN, V18, P3645; Serghides L, 2009, J INFECT DIS, V199, P1536, DOI 10.1086/598222; Singla DK, 2007, AM J PHYSIOL-HEART C, V293, pH1590, DOI 10.1152/ajpheart.00431.2007; Stetler-Stevenson WG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127re6; Szklarczyk A, 2007, J NEUROVIROL, V13, P2, DOI 10.1080/13550280701258084; Urban Britta C, 2006, J Biol, V5, P4, DOI 10.1186/jbiol37; Van den Steen PE, 2006, LAB INVEST, V86, P873, DOI 10.1038/labinvest.3700454; Van den Steen PE, 2006, J BIOL CHEM, V281, P18626, DOI 10.1074/jbc.M512308200; Vandooren Jennifer, 2011, World J Biol Chem, V2, P14, DOI 10.4331/wjbc.v2.i1.14; Were T, 2009, MICROBES INFECT, V11, P811, DOI 10.1016/j.micinf.2009.04.021; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Yamamoto T, 2000, J IMMUNOL, V164, P6174, DOI 10.4049/jimmunol.164.12.6174; Zhang YH, 1998, J IMMUNOL, V161, P3071; Zhu JZ, 2009, J BIOL CHEM, V284, P15750, DOI 10.1074/jbc.M901111200	73	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71468	10.1371/journal.pone.0071468	http://dx.doi.org/10.1371/journal.pone.0071468			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967215	Green Published, gold, Green Submitted			2022-12-25	WOS:000323221500084
J	Gagne, AL; Stevens, KE; Cassone, M; Pujari, A; Abiola, OE; Chang, DJ; Sebert, ME				Gagne, Alyssa L.; Stevens, Kathleen E.; Cassone, Marco; Pujari, Amit; Abiola, Olufunke E.; Chang, Diana J.; Sebert, Michael E.			Competence in Streptococcus pneumoniae Is a Response to an Increasing Mutational Burden	PLOS ONE			English	Article							NATURAL GENETIC-TRANSFORMATION; ALTERNATIVE SIGMA-FACTOR; ESCHERICHIA-COLI MUTT; MISMATCH REPAIR; SALMONELLA-TYPHIMURIUM; NUCLEOTIDE-SEQUENCE; CATALYTIC DOMAIN; RNA-POLYMERASE; HTRA PROTEASE; STRAIN R6	Competence for genetic transformation in Streptococcus pneumoniae has previously been described as a quorum-sensing trait regulated by a secreted peptide pheromone. Recently we demonstrated that competence is also activated by reduction in the accuracy of protein biosynthesis. We have now investigated whether errors upstream of translation in the form of random genomic mutations can provide a similar stimulus. Here we show that generation of a mutator phenotype in S. pneumoniae through deletions of mutX, hexA or hexB enhanced the expression of competence. Similarly, chemical mutagenesis with the nucleotide analog dPTP promoted development of competence. To investigate the relationship between mutational load and the activation of competence, replicate lineages of the mutX strain were serially passaged under conditions of relaxed selection allowing random accumulation of secondary mutations. Competence increased with propagation in these lineages but not in control lineages having wild-type mutX. Resequencing of these derived strains revealed between 1 and 9 single nucleotide polymorphisms (SNPs) per lineage, which were broadly distributed across the genome and did not involve known regulators of competence. Notably, the frequency of competence development among the sequenced strains correlated significantly with the number of nonsynonymous mutations that had been acquired. Together, these observations provide support for the hypothesis that competence in S. pneumoniae is regulated in response to the accumulated burden of coding mutations in the bacterial genome. In contrast to previously described DNA damage response systems that are activated by physical lesions in the chromosome, this pneumococcal pathway may represent a unique stress response system that monitors the coding integrity of the genome.	[Gagne, Alyssa L.; Stevens, Kathleen E.; Cassone, Marco; Sebert, Michael E.] Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA; [Pujari, Amit; Abiola, Olufunke E.] Univ Penn, Sch Engn & Appl Sci, Philadelphia, PA 19104 USA; [Chang, Diana J.] Univ Penn, Sch Arts & Sci, Philadelphia, PA 19104 USA; [Sebert, Michael E.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Sebert, ME (corresponding author), Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA.	sebert@email.chop.edu		Stevens, Kathleen/0000-0003-1410-5471	Public Health Service from the National Institute of Allergy and Infectious Diseases [AI075194]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075194] Funding Source: NIH RePORTER	Public Health Service from the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grant AI075194 from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlawat S, 2009, J BACTERIOL, V191, P2894, DOI 10.1128/JB.01715-08; BLANK A, 1986, BIOCHEMISTRY-US, V25, P5920, DOI 10.1021/bi00368a013; Brugger SD, 2009, J CLIN MICROBIOL, V47, P1750, DOI 10.1128/JCM.01877-08; BULLIONS LC, 1994, J BIOL CHEM, V269, P12339; Cassone M, 2012, J BIOL CHEM, V287, P38449, DOI 10.1074/jbc.M112.391482; Charpentier X, 2011, J BACTERIOL, V193, P1114, DOI 10.1128/JB.01146-10; Chastanet A, 2001, J BACTERIOL, V183, P7295, DOI 10.1128/JB.183.24.7295-7307.2001; Claverys JP, 2007, MOL MICROBIOL, V64, P1423, DOI 10.1111/j.1365-2958.2007.05757.x; Claverys JP, 2006, ANNU REV MICROBIOL, V60, P451, DOI 10.1146/annurev.micro.60.080805.142139; Croucher NJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002745; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Dorer MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001026; Drlica K, 1997, MICROBIOL MOL BIOL R, V61, P377, DOI 10.1128/.61.3.377-392.1997; Dubnau D, 1999, ANNU REV MICROBIOL, V53, P217, DOI 10.1146/annurev.micro.53.1.217; Feil EJ, 2000, GENETICS, V154, P1439; GASC AM, 1989, GENETICS, V121, P29; GRAY BM, 1980, J INFECT DIS, V142, P923, DOI 10.1093/infdis/142.6.923; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Jeong C, 2011, NAT STRUCT MOL BIOL, V18, P379, DOI 10.1038/nsmb.2009; Johnsborg O, 2009, FEMS MICROBIOL REV, V33, P627, DOI 10.1111/j.1574-6976.2009.00167.x; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kibota TT, 1996, NATURE, V381, P694, DOI 10.1038/381694a0; LACKS S, 1960, BIOCHIM BIOPHYS ACTA, V39, P508, DOI 10.1016/0006-3002(60)90205-5; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; Lau PCY, 2002, J MICROBIOL METH, V49, P193, DOI 10.1016/S0167-7012(01)00369-4; LORENZ MG, 1994, MICROBIOL REV, V58, P563, DOI 10.1128/MMBR.58.3.563-602.1994; Luo P, 2003, J BACTERIOL, V185, P349, DOI 10.1128/JB.185.1.349-358.2003; McCluskey J, 2004, MOL MICROBIOL, V51, P1661, DOI 10.1111/j.1365-2958.2003.03917.x; MEJEAN V, 1994, MOL MICROBIOL, V11, P323, DOI 10.1111/j.1365-2958.1994.tb00312.x; Meltzer M, 2009, RES MICROBIOL, V160, P660, DOI 10.1016/j.resmic.2009.07.012; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Negishi K, 1997, NUCLEIC ACIDS RES, V25, P1548, DOI 10.1093/nar/25.8.1548; Peterson SN, 2004, MOL MICROBIOL, V51, P1051, DOI 10.1046/j.1365-2958.2003.03907.x; Plumptre CD, 2012, TRENDS MICROBIOL, V20, P485, DOI 10.1016/j.tim.2012.06.004; PRIEBE SD, 1988, J BACTERIOL, V170, P190, DOI 10.1128/jb.170.1.190-196.1988; PRUDHOMME M, 1989, J BACTERIOL, V171, P5332, DOI 10.1128/jb.171.10.5332-5338.1989; Prudhomme M, 2006, SCIENCE, V313, P89, DOI 10.1126/science.1127912; Redfield RJ, 1997, GENETICS, V146, P27; REDFIELD RJ, 1993, GENETICS, V133, P755; Sebert ME, 2005, J BACTERIOL, V187, P3969, DOI 10.1128/JB.187.12.3969-3979.2005; SIBOLD C, 1994, MOL MICROBIOL, V12, P1013, DOI 10.1111/j.1365-2958.1994.tb01089.x; Stevens KE, 2011, MBIO, V2, DOI 10.1128/mBio.00071-11; Stevens KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002232; Sung CK, 2005, J BACTERIOL, V187, P3052, DOI 10.1128/JB.187.9.3052-3061.2005; Sung CK, 2001, APPL ENVIRON MICROB, V67, P5190, DOI 10.1128/AEM.67.11.5190-5196.2001; Taddei F, 1997, SCIENCE, V278, P128, DOI 10.1126/science.278.5335.128; TAJIRI T, 1995, MUTAT RES-DNA REPAIR, V336, P257, DOI 10.1016/0921-8777(94)00062-B; TIRABY JG, 1973, P NATL ACAD SCI USA, V70, P3541, DOI 10.1073/pnas.70.12.3541; Trindade S, 2010, PHILOS T R SOC B, V365, P1177, DOI 10.1098/rstb.2009.0287; Tsui HCT, 2011, MBIO, V2, DOI 10.1128/mBio.00202-11	50	14	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e72613	10.1371/journal.pone.0072613	http://dx.doi.org/10.1371/journal.pone.0072613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967325	gold, Green Published, Green Submitted			2022-12-25	WOS:000323115800111
J	Guo, W; Bao, SL; Lin, W; Wu, GH; Zhang, W; Hladik, W; Abdul-Quader, A; Bulterys, M; Fuller, S; Wang, L				Guo, Wei; Bao, Shuilian; Lin, Wen; Wu, Guohui; Zhang, Wei; Hladik, Wolfgang; Abdul-Quader, Abu; Bulterys, Marc; Fuller, Serena; Wang, Lu			Estimating the Size of HIV Key Affected Populations in Chongqing, China, Using the Network Scale-Up Method	PLOS ONE			English	Article								Objectives: To estimate the average social network size in the general population and the size of HIV key affected populations (KAPs) in Chongqing municipality using the network scale-up method (NSUM). Methods: A general population survey was conducted in 2011 through a multistage random sampling method. Participants aged between 18 and 60 years were recruited. The average social network size (c) was estimated and adjusted by known population method. The size of HIV KAP in Chongqing municipality was estimated using the adjusted c value with adjustment for the transmission effect using the scaled respect factor. Results: 3,026 inhabitants of Chongqing agreed to the survey, and 2,957 (97.7%) completed the questionnaire. The adjusted c value was 310. The estimated size of KAP was 28,418(95% Confidence Interval (CI): 26,636 similar to 30,201) for female sex workers (FSW), 163,199(95% CI: 156,490 similar to 169,908) for clients of FSW, 37,959(95% CI: 34,888 similar to 41,030) for drug users (DU), 14,975(95% CI: 13,047 similar to 16,904) for injecting drug users (IDU) and 16,767(95% CI: 14,602 similar to 18,932) for men who have sex with men (MSM). The ratio of clients to FSW was 5.74: 1, and IDU accounted for 39.5% of the DU population. The estimates suggest that FSW account for 0.37% of the female population aged 15-49 years in Chongqing, and clients of FSW and MSM represent 2.09% and 0.21% of the male population aged 15-49 years in the city, respectively. Conclusion: NSUM provides reasonable population size estimates for FSW, their clients, DU and IDU in Chongqing. However, it is likely to underestimate the population size of MSM even after adjusting for the transmission effect.	[Guo, Wei; Bao, Shuilian; Wang, Lu] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Lin, Wen; Bulterys, Marc; Fuller, Serena] US Ctr Dis Control & Prevent, Global AIDS Program, Beijing Off, Beijing, Peoples R China; [Wu, Guohui; Zhang, Wei] Chongqing Ctr Dis Control & Prevent, Inst AIDS STD Control & Prevent, Chongqing, Peoples R China; [Hladik, Wolfgang; Abdul-Quader, Abu] US Ctr Dis Control & Prevent, Div Global HIV AIDS, Ctr Global Hlth, Atlanta, GA USA	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Nokia Corporation; Pfizer; Centers for Disease Control & Prevention - USA	Wang, L (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	wanglu64@chinaaids.cn			Young Scholar Scientific Research Foundation of China CDC [2011A104]; President's Emergency Plan for AIDS Relief from the HHS/Centers for Disease Control and Prevention (US CDC) [3U2GPS001188]; Global AIDS Program	Young Scholar Scientific Research Foundation of China CDC; President's Emergency Plan for AIDS Relief from the HHS/Centers for Disease Control and Prevention (US CDC); Global AIDS Program	This publication was made possible by support from the Young Scholar Scientific Research Foundation of China CDC (2011A104 to WG, http://www.chinacdc.cn/) and the President's Emergency Plan for AIDS Relief through cooperative agreement (3U2GPS001188) from the HHS/Centers for Disease Control and Prevention (US CDC), Global AIDS Program (http://www.pepfar.gov and http://www.cdc.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011 EST HIV AIDS EP; Bernard HR, 2010, SEX TRANSM INFECT, V86, pI11, DOI 10.1136/sti.2010.044446; Carael M, 2006, SEX TRANSM INFECT, V82, pIII26, DOI 10.1136/sti.2006.021196; China Ministry of Health, 2007, JOINT ASS HIV AIDS P; China Ministry of Health UNAIDS World Health Organization (WHO), 2010, 2009 EST HIV AIDS EP; Chongqing Statistic Bureau, 2011, CHONGQ STAT YB 2011; Ezoe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031184; Feng LG, 2009, JAIDS-J ACQ IMM DEF, V52, P79, DOI 10.1097/QAI.0b013e3181a4f53e; Guo Wei, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P666; Kadushin C, 2006, J DRUG ISSUES, V36, P417, DOI 10.1177/002204260603600209; Killworth PD, 1998, EVALUATION REV, V22, P289, DOI 10.1177/0193841X9802200205; McCarty C, 2001, HUM ORGAN, V60, P28, DOI 10.17730/humo.60.1.efx5t9gjtgmga73y; Moldova UNAIDS Country Office, 2010, SIZ EST HIGH RISK GR; National Center for AIDS/STD Control and Prevention, 2011, GUID 2011 HIV EP EST; Ning Zhen, 2007, Zhonghua Liu Xing Bing Xue Za Zhi, V28, P848; Paniotto V, 2009, ESTIMATING SIZE POPU; Salganik MJ, 2011, AM J EPIDEMIOL, V174, P1190, DOI 10.1093/aje/kwr246; Salganik MJ, 2011, SOC NETWORKS, V33, P70, DOI 10.1016/j.socnet.2010.10.006; Shokoohi M, 2012, INT J PREVENTIVE MED, V3, P471; Snidero S, 2007, SOC NETWORKS, V29, P527, DOI 10.1016/j.socnet.2007.03.003; Vadivoo S, 2008, AIDS, V22, pS137, DOI 10.1097/01.aids.0000343772.82647.2d; Vandepitte J, 2006, SEX TRANSM INFECT, V82, pIII18, DOI 10.1136/sti.2006.020081; Wang Liyan, 2006, S CHINA J PREV MED, V32, P9; Yang JZ, 2009, ZHENGJIANGPREV MED, V21, P13; Zhang Yan-hui, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P969	25	22	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71796	10.1371/journal.pone.0071796	http://dx.doi.org/10.1371/journal.pone.0071796			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	201BN	23967246	Green Published, gold			2022-12-25	WOS:000323115800081
J	Guo, Y; Meng, XK; Wang, Q; Wang, YA; Shang, H				Guo, Yi; Meng, Xiangkai; Wang, Qian; Wang, Yanan; Shang, Hong			The ING4 Binding with p53 and Induced p53 Acetylation were Attenuated by Human Papillomavirus 16 E6	PLOS ONE			English	Article							TYPE-16 E6; UBIQUITIN LIGASE; PROTEIN; DEGRADATION; ONCOPROTEIN; CANCER; ACTIVATION; GROWTH; LOCALIZATION; INHIBITION	High risk subtype HPV16 early oncoprotein E6 contributes host cell immortalization and transformation through interacting with a number of cellular factors. ING4 is one member of the inhibitor of growth (ING) family of type II tumor suppressors and it has been shown to be involved in regulating p53 function. However, the effect and mechanism of HPV16 E6 on ING4 function remain elusive. In this study, we report HPV16 E6 combines with ING4 in vivo and in vitro. The ING4 induced p53 acetylation and its combining with p53 were attenuated by HPV16 E6 independent of p53 degradation. The enhancing function of ING4 on p53 mediated apoptosis was diminished when HPV16 E6 existed. These findings reveal that ING4 may be a common target of oncogenic viruses for driving host cell carcinogenesis.	[Guo, Yi; Meng, Xiangkai] China Med Univ, Affiliated Hosp 1, Dept Gynecol, Shenyang, Peoples R China; [Wang, Qian; Wang, Yanan; Shang, Hong] China Med Univ, Affiliated Hosp 1, Dept Lab Med, Key Lab AIDS Immunol,Minist Hlth, Shenyang, Peoples R China	China Medical University; China Medical University	Shang, H (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Lab Med, Key Lab AIDS Immunol,Minist Hlth, Shenyang, Peoples R China.	shanghongyj@hotmail.com		Wang, Yanan/0000-0001-7401-047X	National Natural Science Foundation of China [81171649]; Natural Science Foundation of Liaoning Province [201102267]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Liaoning Province(Natural Science Foundation of Liaoning Province)	This research was supported by grants from the National Natural Science Foundation of China (81171649) and Natural Science Foundation of Liaoning Province (201102267). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	CHEN JJ, 1995, SCIENCE, V269, P529, DOI 10.1126/science.7624774; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Gao QS, 2002, CANCER RES, V62, P3315; Garkavtsev I, 2004, NATURE, V428, P328, DOI 10.1038/nature02329; Gross-Mesilaty S, 1998, P NATL ACAD SCI USA, V95, P8058, DOI 10.1073/pnas.95.14.8058; Hebner C, 2007, J VIROL, V81, P12740, DOI 10.1128/JVI.00987-07; Hengstermann A, 2001, P NATL ACAD SCI USA, V98, P1218, DOI 10.1073/pnas.031470698; Kuhne C, 1998, J BIOL CHEM, V273, P34302, DOI 10.1074/jbc.273.51.34302; Le SS, 1997, P NATL ACAD SCI USA, V94, P6670, DOI 10.1073/pnas.94.13.6670; Li J, 2008, CARCINOGENESIS, V29, P1373, DOI 10.1093/carcin/bgn086; Liu XF, 2005, J BIOL CHEM, V280, P10807, DOI 10.1074/jbc.M410343200; Liu XF, 2009, P NATL ACAD SCI USA, V106, P18780, DOI 10.1073/pnas.0906357106; Mantovani F, 2001, ONCOGENE, V20, P7874, DOI 10.1038/sj.onc.1204869; Nakagawa S, 2000, MOL CELL BIOL, V20, P8244, DOI 10.1128/MCB.20.21.8244-8253.2000; NAKAGAWA S, 1995, VIROLOGY, V212, P535, DOI 10.1006/viro.1995.1511; Ozer A, 2005, P NATL ACAD SCI USA, V102, P7481, DOI 10.1073/pnas.0502716102; Ronco LV, 1998, GENE DEV, V12, P2061, DOI 10.1101/gad.12.13.2061; Russell M, 2006, EXP CELL RES, V312, P951, DOI 10.1016/j.yexcr.2006.01.020; Saha A, 2011, J VIROL, V85, P2079, DOI 10.1128/JVI.02279-10; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Sekaric P, 2008, J VIROL, V82, P71, DOI 10.1128/JVI.01776-07; Shal A, 2007, ONCOGENE, V26, P3321, DOI 10.1038/sj.onc.1210130; Shiseki M, 2003, CANCER RES, V63, P2373; Soliman MA, 2007, TRENDS BIOCHEM SCI, P32509; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Thomas MC, 2005, MOL CELL, V17, P251, DOI 10.1016/j.molcel.2004.12.016; Tsai KW, 2008, EXP CELL RES, V314, P3130, DOI 10.1016/j.yexcr.2008.08.002; Underbrink MP, 2008, J VIROL, V82, P10408, DOI 10.1128/JVI.00902-08; Unoki M, 2009, CANCER SCI, V100, P1173, DOI 10.1111/j.1349-7006.2009.01183.x; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang HB, 2010, J BIOL CHEM, V285, P13201, DOI 10.1074/jbc.M109.058669; Xu SQ, 2011, J CARDIOVASC PHARM, V58, P263, DOI 10.1097/FJC.0b013e3182239eb7; Zhang X, 2005, BIOCHEM BIOPH RES CO, V331, P1032, DOI 10.1016/j.bbrc.2005.04.023; Zimmermann H, 1999, J VIROL, V73, P6209, DOI 10.1128/JVI.73.8.6209-6219.1999; Zuna RE, 2004, MODERN PATHOL, V17, P1314, DOI 10.1038/modpathol.3800223; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798; zur Hausen H, 2000, JNCI-J NATL CANCER I, V92, P690, DOI 10.1093/jnci/92.9.690	38	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71453	10.1371/journal.pone.0071453	http://dx.doi.org/10.1371/journal.pone.0071453			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967213	Green Submitted, Green Published, gold			2022-12-25	WOS:000323115800062
J	Huang, YA; Kao, JW; Tseng, DTH; Chen, WS; Chiang, MH; Hwang, E				Huang, Yung-An; Kao, Jun-Wei; Tseng, Dion Tzu-Huan; Chen, Wen-Shin; Chiang, Ming-Han; Hwang, Eric			Microtubule-Associated Type II Protein Kinase A Is Important for Neurite Elongation	PLOS ONE			English	Article								Neuritogenesis is a process through which neurons generate their widespread axon and dendrites. The microtubule cytoskeleton plays crucial roles throughout neuritogenesis. Our previous study indicated that the amount of type II protein kinase A (PKA) on microtubules significantly increased upon neuronal differentiation and neuritogenesis. While the overall pool of PKA has been shown to participate in various neuronal processes, the function of microtubule-associated PKA during neuritogenesis remains largely unknown. First, we showed that PKA localized to microtubule-based region in different neurons. Since PKA is essential for various cellular functions, globally inhibiting PKA activity will causes a wide variety of phenotypes in neurons. To examine the function of microtubule-associated PKA without changing the total PKA level, we utilized the neuron-specific PKA anchoring protein MAP2. Overexpressing the dominant negative MAP2 construct that binds to type II PKA but cannot bind to the microtubule cytoskeleton in dissociated hippocampal neurons removed PKA from microtubules and resulted in compromised neurite elongation. In addition, we demonstrated that the association of PKA with microtubules can also enhance cell protrusion using the non-neuronal P19 cells. Overexpressing a MAP2 deletion construct which does not target PKA to the microtubule cytoskeleton caused non-neuronal cells to generate shorter cell protrusions than control cells overexpressing wild-type MAP2 that anchors PKA to microtubules. Finally, we demonstrated that the ability of microtubule-associated PKA to promote protrusion elongation was independent of MAP2 phosphorylation. This suggests other proteins in close proximity to the microtubule cytoskeleton are involved in this process.	[Huang, Yung-An; Hwang, Eric] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Huang, Yung-An; Chen, Wen-Shin; Hwang, Eric] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Kao, Jun-Wei; Tseng, Dion Tzu-Huan; Chiang, Ming-Han; Hwang, Eric] Natl Chiao Tung Univ, Inst Mol Med & Bioengn, Hsinchu, Taiwan; [Chen, Wen-Shin; Hwang, Eric] Natl Chiao Tung Univ, Ctr Bioinformat Res, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Hwang, E (corresponding author), Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan.	hwangeric@mail.nctu.edu.tw		Hwang, Eric/0000-0002-5188-581X	National Science Council of Taiwan [NSC 101-2627-B-009-008]; Ministry of Education Aim for the Top University Plan	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education Aim for the Top University Plan(Ministry of Education, Taiwan)	This work was supported by the National Science Council of Taiwan NSC 101-2627-B-009-008 and the Ministry of Education Aim for the Top University Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Bradshaw NJ, 2011, J NEUROSCI, V31, P9043, DOI 10.1523/JNEUROSCI.5410-10.2011; Bradshaw NJ, 2008, BIOCHEM BIOPH RES CO, V377, P1091, DOI 10.1016/j.bbrc.2008.10.120; Brandon EP, 1997, CURR OPIN NEUROBIOL, V7, P397, DOI 10.1016/S0959-4388(97)80069-4; BUXTON ILO, 1983, J BIOL CHEM, V258, P233; Chen WS, 2011, NEUROSCI RES; Chetkovich DM, 2002, J NEUROSCI, V22, P5791; Choi J, 2002, J BIOL CHEM, V277, P12359, DOI 10.1074/jbc.M200528200; Dehmelt L, 2003, J NEUROSCI, V23, P9479; EDSON K, 1993, DEVELOPMENT, V117, P689; Feng YY, 2004, NEURON, V44, P279, DOI 10.1016/j.neuron.2004.09.023; FRANCIS SH, 1994, ANNU REV PHYSIOL, V56, P237, DOI 10.1146/annurev.ph.56.030194.001321; Han JZ, 2007, J CELL BIOL, V176, P101, DOI 10.1083/jcb.200607128; Harada A, 2002, J CELL BIOL, V158, P541, DOI 10.1083/jcb.200110134; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; Kao HT, 2002, NAT NEUROSCI, V5, P431, DOI 10.1038/nn840; Khuchua Z, 2003, NEUROSCIENCE, V119, P101, DOI 10.1016/S0306-4522(03)00094-0; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; Lee HS, 2010, MOL BIOL CELL, V21, P2661, DOI 10.1091/mbc.E09-12-1036; LETOURNEAU PC, 1989, DEVELOPMENT, V105, P505; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461; Meiri D, 2009, MOL CELL BIOL, V29, P5963, DOI 10.1128/MCB.01268-08; Neukirchen D, 2011, J NEUROSCI, V31, P1528, DOI 10.1523/JNEUROSCI.3983-10.2011; Ozer RS, 2000, MOL BIOL CELL, V11, P3573, DOI 10.1091/mbc.11.10.3573; Pawlisz AS, 2008, HUM MOL GENET, V17, P2441, DOI 10.1093/hmg/ddn144; Ren Y, 1998, J BIOL CHEM, V273, P34954, DOI 10.1074/jbc.273.52.34954; Roger B, 2004, CURR BIOL, V14, P363, DOI 10.1016/j.cub.2004.01.058; Ryan XZP, 2005, NEURON, V47, P85, DOI 10.1016/j.neuron.2005.05.013; Sasaki S, 2005, MOL CELL BIOL, V25, P7812, DOI 10.1128/MCB.25.17.7812-7827.2005; SCOTT JD, 1991, PHARMACOL THERAPEUT, V50, P123, DOI 10.1016/0163-7258(91)90075-W; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Shelly M, 2011, NEURON, V71, P433, DOI 10.1016/j.neuron.2011.06.041; STEIN JC, 1987, J BIOL CHEM, V262, P3002; TANAKA Y, 1992, BRAIN RES, V596, P269, DOI 10.1016/0006-8993(92)91557-U; Thomas MJ, 2003, PHILOS T ROY SOC B, V358, P815, DOI 10.1098/rstb.2002.1236; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Zhong HN, 2009, NEURON, V62, P363, DOI 10.1016/j.neuron.2009.03.013	38	177	179	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e73890	10.1371/journal.pone.0073890	http://dx.doi.org/10.1371/journal.pone.0073890			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967353	Green Published, Green Submitted, gold			2022-12-25	WOS:000323115800127
J	Mukadi, P; Gillet, P; Lukuka, A; Mbatshi, J; Otshudiema, J; Muyembe, JJ; Buyze, J; Jacobs, J; Lejon, V				Mukadi, Pierre; Gillet, Philippe; Lukuka, Albert; Mbatshi, Joel; Otshudiema, John; Muyembe, Jean-Jacques; Buyze, Jozefien; Jacobs, Jan; Lejon, Veerle			External Quality Assessment of Reading and Interpretation of Malaria Rapid Diagnostic Tests among 1849 End-Users in the Democratic Republic of the Congo through Short Message Service (SMS)	PLOS ONE			English	Article								Background: Although malaria rapid diagnostic tests (RDT) are simple to perform, they remain subject to errors, mainly related to the post-analytical phase. We organized the first large scale SMS based external quality assessment (EQA) on correct reading and interpretation of photographs of a three-band malaria RDT among laboratory health workers in the Democratic Republic of the Congo (DR Congo). Methods and Findings: High resolution EQA photographs of 10 RDT results together with a questionnaire were distributed to health facilities in 9 out of 11 provinces in DR Congo. Each laboratory health worker answered the EQA by Short Message Service (SMS). Filled-in questionnaires from each health facility were sent back to Kinshasa. A total of 1849 laboratory health workers in 1014 health facilities participated. Most frequent errors in RDT reading were i) failure to recognize invalid (13.2-2.5%) or negative test results (9.8-12.8%), (ii) overlooking faint test lines (4.1-31.2%) and (iii) incorrect identification of the malaria species (12.1-17.4%). No uniform strategy for diagnosis of malaria at the health facility was present. Stock outs of RDTs occurred frequently. Half of the health facilities had not received an RDT training. Only two thirds used the RDT recommended by the National Malaria Control Program. Performance of RDT reading was positively associated with training and the technical level of health facility. Facilities with RDT positivity rates >50% and located in Eastern DR Congo performed worse. Conclusions: Our study confirmed that errors in reading and interpretation of malaria RDTs are widespread and highlighted the problem of stock outs of RDTs. Adequate training of end-users in the application of malaria RDTs associated with regular EQAs is recommended.	[Mukadi, Pierre; Lukuka, Albert; Muyembe, Jean-Jacques] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Mukadi, Pierre] Univ Pedagog Natl, Kinshasa, DEM REP CONGO; [Gillet, Philippe; Buyze, Jozefien; Jacobs, Jan; Lejon, Veerle] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Lukuka, Albert] Programme Natl Lutte Paludisme, Lab Natl Reference Paludisme, Kinshasa, DEM REP CONGO; [Mbatshi, Joel] Programme Natl Lutte Tuberculose, Kinshasa, DEM REP CONGO; [Otshudiema, John] US Presidents Malaria Initiat, Integrated Hlth Project, Kinshasa, DEM REP CONGO; [Muyembe, Jean-Jacques] Univ Kinshasa, Kinshasa, DEM REP CONGO; [Lejon, Veerle] CIRAD INTERTRYP, IRD, UMR 177, Montpellier, France	Institute Nacional de Recherche Biomedical; Institute of Tropical Medicine (ITM); Universite de Kinshasa; CIRAD; Institut de Recherche pour le Developpement (IRD)	Lejon, V (corresponding author), Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium.	veerle.lejon@ird.fr	Buyze, Jozefien/B-8550-2014; Lejon, Veerle/AAG-5024-2020; Lejon, Veerle/AAG-4213-2020; Jacobs, Jan/GRX-7316-2022	Buyze, Jozefien/0000-0001-6780-380X; Lejon, Veerle/0000-0002-6795-0962; gillet, philippe/0000-0001-5878-6446	Directorate General of Development Cooperation of the Belgian Government through Institutional Collaboration INRB-ITM (Network Program on Laboratory Quality Management [3.21]	Directorate General of Development Cooperation of the Belgian Government through Institutional Collaboration INRB-ITM (Network Program on Laboratory Quality Management	This study was funded by Directorate General of Development Cooperation of the Belgian Government through Institutional Collaboration INRB-ITM (Network Program on Laboratory Quality Management; Project 3.21). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asiimwe C, 2011, AM J TROP MED HYG, V85, P26, DOI 10.4269/ajtmh.2011.10-0528; Barrington J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-298; Chiu YHC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018294; Counihan H, 2012, AM J TROP MED HYG, V87, P57, DOI 10.4269/ajtmh.2012.11-0800; Culleton RL, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-174; Deglise C, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1823; Gillet P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-359; Harvey SA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-160; Jian WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044462; Kettelhut MM, 2003, J CLIN PATHOL, V56, P927, DOI 10.1136/jcp.56.12.927; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Maltha J, 2013, CLIN MICROBIOL INFEC, V19, P399, DOI 10.1111/1469-0691.12151; Masanja IM, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-322; Moonasar D, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-74; Mukadi P, 2012, B WORLD HEALTH ORGAN; Mukadi P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-308; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; Rennie W, 2007, T ROY SOC TROP MED H, V101, P9, DOI 10.1016/j.trstmh.2006.03.011; Seidahmed OME, 2008, TROP MED INT HEALTH, V13, P406, DOI 10.1111/j.1365-3156.2008.02015.x; Seidenberg P, 2012, B WORLD HEALTH ORGAN, V90, P348, DOI 10.2471/BLT.11.100032; World Health Organization, 2003, MAN BAS TECHN HLTH L; World Health Organization Regional Office for the Western Pacific, 2013, MAL RAP DIAGN TESTS; Zurovac D, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001176	23	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71442	10.1371/journal.pone.0071442	http://dx.doi.org/10.1371/journal.pone.0071442			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967211	Green Published, gold, Green Submitted			2022-12-25	WOS:000323115800060
J	Neuhaus, V; Schwarz, K; Klee, A; Seehase, S; Forster, C; Pfennig, O; Jonigk, D; Fieguth, HG; Koch, W; Warnecke, G; Yusibov, V; Sewald, K; Braun, A				Neuhaus, Vanessa; Schwarz, Katharina; Klee, Anna; Seehase, Sophie; Foerster, Christine; Pfennig, Olaf; Jonigk, Danny; Fieguth, Hans-Gerd; Koch, Wolfgang; Warnecke, Gregor; Yusibov, Vidadi; Sewald, Katherina; Braun, Armin			Functional Testing of an Inhalable Nanoparticle Based Influenza Vaccine Using a Human Precision Cut Lung Slice Technique	PLOS ONE			English	Article							AMORPHOUS SILICA; ANTIBODY-PRODUCTION; RAPID PRODUCTION; VIRUS; MUCOSAL; CELLS; RESPONSES; DELIVERY; PROTECTION; MEMORY	Annual outbreaks of influenza infections, caused by new influenza virus subtypes and high incidences of zoonosis, make seasonal influenza one of the most unpredictable and serious health threats worldwide. Currently available vaccines, though the main prevention strategy, can neither efficiently be adapted to new circulating virus subtypes nor provide high amounts to meet the global demand fast enough. New influenza vaccines quickly adapted to current virus strains are needed. In the present study we investigated the local toxicity and capacity of a new inhalable influenza vaccine to induce an antigen-specific recall response at the site of virus entry in human precision-cut lung slices (PCLS). This new vaccine combines recombinant H1N1 influenza hemagglutinin (HAC1), produced in tobacco plants, and a silica nanoparticle (NP)-based drug delivery system. We found no local cellular toxicity of the vaccine within applicable concentrations. However higher concentrations of NP (>= 10(3) mu g/ml) dose-dependently decreased viability of human PCLS. Furthermore NP, not the protein, provoked a dose-dependent induction of TNF-alpha and IL-1 beta, indicating adjuvant properties of silica. In contrast, we found an antigen-specific induction of the T cell proliferation and differentiation cytokine, IL-2, compared to baseline level (152 +/- 49 pg/mg vs. 22 +/- 5 pg/mg), which could not be seen for the NP alone. Additionally, treatment with 10 mu g/ml HAC1 caused a 6-times higher secretion of IFN-gamma compared to baseline (602 +/- 307 pg/mg vs. 97 +/- 51 pg/mg). This antigen-induced IFN-gamma secretion was further boosted by the adjuvant effect of silica NP for the formulated vaccine to a 12-fold increase (97 +/- 51 pg/mg vs. 1226 +/- 535 pg/mg). Thus we were able to show that the plant-produced vaccine induced an adequate innate immune response and re-activated an established antigen-specific T cell response within a non-toxic range in human PCLS at the site of virus entry.	[Neuhaus, Vanessa; Schwarz, Katharina; Klee, Anna; Koch, Wolfgang; Sewald, Katherina; Braun, Armin] Fraunhofer Inst Toxicol & Expt Med, Hannover, Germany; [Seehase, Sophie] ARCN, Leibniz Ctr Med & Biosci, Res Ctr Borstel, Borstel, Germany; [Foerster, Christine; Pfennig, Olaf; Fieguth, Hans-Gerd] KRH Klinikum Oststadt Heidehaus, Hannover, Germany; [Jonigk, Danny] Hannover Med Sch, Inst Pathol, Hannover, Germany; [Warnecke, Gregor] Hannover Med Sch, Div Cardiac Thorac Transplantat & Vasc Surg, Hannover, Germany; [Yusibov, Vidadi] Fraunhofer USA Ctr Mol Biotechnol, Newark, DE USA; [Braun, Armin] Hannover Med Sch, Inst Immunol, Hannover, Germany; [Neuhaus, Vanessa; Schwarz, Katharina; Klee, Anna; Jonigk, Danny; Koch, Wolfgang; Warnecke, Gregor; Sewald, Katherina; Braun, Armin] Biomed Res Endstage & Obstruct Lung Dis Hannover, Hannover, Germany; [Seehase, Sophie] German Ctr Lung Res DZL, Hannover, Germany	Fraunhofer Gesellschaft; Forschungszentrum Borstel; Hannover Medical School; Hannover Medical School; Hannover Medical School	Braun, A (corresponding author), Fraunhofer Inst Toxicol & Expt Med, Hannover, Germany.	armin.braun@item.fraunhofer.de	Braun, Armin/B-8750-2009; Yusibov, Vidadi/AAA-7408-2019	Braun, Armin/0000-0002-1142-1463; Fieguth, Hans G./0000-0003-1559-158X	Fraunhofer Society; Deutsche Forschungsgemeinschaft (DFG) [Graduiertenkolleg 1441]; Deutsche Forschungsgemeinschaft (DFG); Integriertes Forschungs- und Behandlungszentrum of Hannover Medical school;  [JO 743/2-1]	Fraunhofer Society; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Integriertes Forschungs- und Behandlungszentrum of Hannover Medical school; 	The work was funded by the Fraunhofer Society. The Fraunhofer ITEM is a public non-profit research organisation doing contract research for e. g. pharmaceutical and biotech industry. www.fraunhofer.de. VN has received a PhD grant from the Graduiertenkolleg 1441 from the Deutsche Forschungsgemeinschaft (DFG); http://www.dfg.de. DJ has received a research grant from the Deutsche Forschungsgemeinschaft (DFG); grant ID JO 743/2-1; http://www.dfg.de. DJ is sponsored by the Integriertes Forschungs- und Behandlungszentrum of Hannover Medical school (IFB-Tx, MHH; Project 09- fibrotic remodelling in lung allografts). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amidi M, 2007, VACCINE, V25, P144, DOI 10.1016/j.vaccine.2006.06.086; [Anonymous], 1980, B WORLD HEALTH ORGAN, V58, P585; Baldwin SL, 2009, VACCINE, V27, P5956, DOI 10.1016/j.vaccine.2009.07.081; Barnard DL, 2009, ANTIVIR RES, V82, pA110, DOI 10.1016/j.antiviral.2008.12.014; Carvalho LV, 2010, VACCINE, V28, P7829, DOI 10.1016/j.vaccine.2010.09.087; Centers for Disease Control and Prevention, 2009, MMWR-MORBID MORTAL W, V58, P1241; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chichester JA, 2007, HUM VACCINES, V3, P146, DOI 10.4161/hv.3.4.4148; Christensen D, 2010, INT J PHARMACEUT, V390, P19, DOI 10.1016/j.ijpharm.2009.10.043; Claas ECJ, 2000, VET MICROBIOL, V74, P133, DOI 10.1016/S0378-1135(00)00173-5; Doherty PC, 1997, IMMUNOL REV, V159, P105, DOI 10.1111/j.1600-065X.1997.tb01010.x; Gamblin SJ, 2010, J BIOL CHEM, V285, P28403, DOI 10.1074/jbc.R110.129809; Gupta V, 2006, VACCINE, V24, P3881, DOI 10.1016/j.vaccine.2006.01.010; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Holmgren J, 2012, CURR OPIN IMMUNOL, V24, P343, DOI 10.1016/j.coi.2012.03.014; Jiang WL, 2005, ADV DRUG DELIVER REV, V57, P391, DOI 10.1016/j.addr.2004.09.003; Jul-Larsen A, 2012, HUM VACCIN IMMUNOTHE, V8; Juno J, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/797180; Koutsonanos DG, 2011, J INFECT DIS, V204, P582, DOI 10.1093/infdis/jir094; Madhun AS, 2011, VACCINE, V29, P4973, DOI 10.1016/j.vaccine.2011.04.094; MANCINO D, 1977, INT ARCH ALLER A IMM, V53, P97, DOI 10.1159/000231738; MANCINO D, 1980, INT ARCH ALLER A IMM, V61, P253, DOI 10.1159/000232443; Mortimer E, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-14; Pedersen GK, 2012, J INFECT DIS, V206, P158, DOI 10.1093/infdis/jis330; PEREIRA HG, 1967, B WORLD HEALTH ORGAN, V37, P553; Purwar R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016245; RAZ E, 1994, P NATL ACAD SCI USA, V91, P9519, DOI 10.1073/pnas.91.20.9519; Riberdy JM, 2000, J VIROL, V74, P9762, DOI 10.1128/JVI.74.20.9762-9765.2000; Richert LE, 2012, VACCINE, V30, P3653, DOI 10.1016/j.vaccine.2012.03.035; Shoji Y, 2008, VACCINE, V26, P2930, DOI 10.1016/j.vaccine.2008.03.045; Shoji Y, 2012, INFLUENZA OTHER RESP, V6, P204, DOI 10.1111/j.1750-2659.2011.00295.x; Shoji Y, 2011, HUM VACCINES, V7, P41, DOI 10.4161/hv.7.0.14561; Soppimath KS, 2001, J CONTROL RELEASE, V70, P1, DOI 10.1016/s0168-3659(00)00339-4; Switalla S, 2010, TOXICOL APPL PHARM, V246, P107, DOI 10.1016/j.taap.2010.04.010; Teijaro JR, 2011, J IMMUNOL, V187, P5510, DOI 10.4049/jimmunol.1102243; Teijaro JR, 2010, J VIROL, V84, P9217, DOI 10.1128/JVI.01069-10; Thangavel RR, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-180; Topham DJ, 1997, J IMMUNOL, V159, P5197; Tumpey TM, 2001, J VIROL, V75, P5141, DOI 10.1128/JVI.75.11.5141-5150.2001; Ulmer JB, 2006, NAT BIOTECHNOL, V24, P1377, DOI 10.1038/nbt1261; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; Wee JLK, 2008, MUCOSAL IMMUNOL, V1, P489, DOI 10.1038/mi.2008.59; Winter M, 2011, NANOTOXICOLOGY, V5, P326, DOI 10.3109/17435390.2010.506957; Wohlsen A, 2003, EUR RESPIR J, V21, P1024, DOI 10.1183/09031936.03.00027502; Wu WX, 2010, VIROLOGY, V396, P178, DOI 10.1016/j.virol.2009.10.016; Yazdi AS, 2010, P NATL ACAD SCI USA, V107, P19449, DOI 10.1073/pnas.1008155107; Zhu JF, 2010, CELL RES, V20, P4, DOI 10.1038/cr.2009.138	47	30	31	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71728	10.1371/journal.pone.0071728	http://dx.doi.org/10.1371/journal.pone.0071728			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967238	Green Published, Green Submitted, gold			2022-12-25	WOS:000323115800076
J	Quistgaard, EM; Low, C; Moberg, P; Guettou, F; Maddi, K; Nordlund, P				Quistgaard, Esben M.; Low, Christian; Moberg, Per; Guettou, Fatma; Maddi, Karthik; Nordlund, Par			Structural and Biophysical Characterization of the Cytoplasmic Domains of Human BAP29 and BAP31	PLOS ONE			English	Article							SECONDARY STRUCTURE ANALYSES; CLASS-I MOLECULES; ENDOPLASMIC-RETICULUM; COILED-COILS; CRYSTAL-STRUCTURE; PROTEIN; PREDICTION; STABILITY; SPECIFICITY; EXPRESSION	Two members of the B-cell associated 31 (BAP31) family are found in humans; BAP29 and BAP31. These are ubiquitously expressed receptors residing in the endoplasmic reticulum. BAP31 functions in sorting of membrane proteins and in caspase-8 mediated apoptosis, while BAP29 appears to mainly corroborate with BAP31 in sorting. The N-terminal half of these proteins is membrane-bound while the C-terminal half is cytoplasmic. The latter include the so called variant of death effector domain (vDED), which shares weak sequence homology with DED domains. Here we present two structures of BAP31 vDED determined from a single and a twinned crystal, grown at pH 8.0 and pH 4.2, respectively. These structures show that BAP31 vDED forms a dimeric parallel coiled coil with no structural similarity to DED domains. Solution studies support this conclusion and strongly suggest that an additional a-helical domain is present in the C-terminal cytoplasmic region, probably forming a second coiled coil. The thermal stability of BAP31 vDED is quite modest at neutral pH, suggesting that it may assemble in a dynamic fashion in vivo. Surprisingly, BAP29 vDED is partially unfolded at pH 7, while a coiled coil is formed at pH 4.2 in vitro. It is however likely that folding of the domain is triggered by other factors than low pH in vivo. We found no evidence for direct interaction of the cytoplasmic domains of BAP29 and BAP31.	[Quistgaard, Esben M.; Low, Christian; Moberg, Per; Guettou, Fatma; Maddi, Karthik; Nordlund, Par] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Nordlund, Par] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore	Karolinska Institutet; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Quistgaard, EM (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.	esben.quistgard@ki.se; par.nordlund@ki.se		Guettou, Fatma/0000-0003-0523-4079; Maddi, karthik/0000-0001-9233-2288; Quistgaard, Esben/0000-0002-1381-3364; Loew, Christian/0000-0003-0764-7483	Danish Council for Independent Research (Medical Sciences) [271-09-0187]; European Molecular Biology Organization (EMBO); European Community under BioStruct-X [783]; Swedish Research council; Swedish Cancer Society; Singapore National Research Foundation [NRF2008NRFCRP002-067]	Danish Council for Independent Research (Medical Sciences)(Det Frie Forskningsrad (DFF)); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); European Community under BioStruct-X; Swedish Research council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Singapore National Research Foundation(National Research Foundation, Singapore)	E.M.Q. was supported by The Danish Council for Independent Research (Medical Sciences; grant 271-09-0187). C. L. was supported by a European Molecular Biology Organization (EMBO) postdoctoral fellowship. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under BioStruct-X (grant agreement No783). This research was also supported by grants from the Swedish Research council, the Swedish Cancer Society and a Singapore National Research Foundation Competitive Research Programme grant (NRF2008NRFCRP002-067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe F, 2009, J IMMUNOL, V182, P4776, DOI 10.4049/jimmunol.0800242; Adachi T, 1996, EMBO J, V15, P1534, DOI 10.1002/j.1460-2075.1996.tb00497.x; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akey DL, 2001, BIOCHEMISTRY-US, V40, P6352, DOI 10.1021/bi002829w; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Annaert WG, 1997, J CELL BIOL, V139, P1397, DOI 10.1083/jcb.139.6.1397; Bartee E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015132; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; COOPER TM, 1990, BIOPOLYMERS, V30, P657, DOI 10.1002/bip.360300703; Cowtan K, 2000, ACTA CRYSTALLOGR D, V56, P1612, DOI 10.1107/S0907444900013263; Delano W. L., 2003, PYMOL MOL GENETICS G; Ducret A, 2003, EUR J BIOCHEM, V270, P342, DOI 10.1046/j.1432-1033.2003.03395.x; Dutta K, 2001, PROTEIN SCI, V10, P2531, DOI 10.1110/ps.ps.28801; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Iwasawa R, 2011, EMBO J, V30, P556, DOI 10.1038/emboj.2010.346; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KIM KM, 1994, EMBO J, V13, P3793, DOI 10.1002/j.1460-2075.1994.tb06690.x; Knappenberger JA, 2002, J MOL BIOL, V321, P1, DOI 10.1016/S0022-2836(02)00592-2; Ladasky JJ, 2006, J IMMUNOL, V177, P6172, DOI 10.4049/jimmunol.177.9.6172; Lambert G, 2001, J BIOL CHEM, V276, P20340, DOI 10.1074/jbc.M011209200; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LAU SYM, 1984, J BIOL CHEM, V259, P3253; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lupas A, 1996, METHOD ENZYMOL, V266, P513; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Matsuyama S, 2000, CELL DEATH DIFFER, V7, P1155, DOI 10.1038/sj.cdd.4400779; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; MOSSER J, 1994, GENOMICS, V22, P469, DOI 10.1006/geno.1994.1413; Mukasa T, 2007, ACTA CRYSTALLOGR F, V63, P297, DOI 10.1107/S1744309107008925; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ng FWH, 1997, J CELL BIOL, V139, P327, DOI 10.1083/jcb.139.2.327; Niu Q, 2008, J MOL BIOL, V375, P1197, DOI 10.1016/j.jmb.2007.11.036; Nugent T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-159; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Paquet ME, 2004, J IMMUNOL, V172, P7548, DOI 10.4049/jimmunol.172.12.7548; Read RJ, 2011, ACTA CRYSTALLOGR D, V67, P338, DOI 10.1107/S0907444910051371; Reed J. C., 2004, SCI STKE, V2004, pre9, DOI DOI 10.1126/STKE.2392004RE9; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schamel WWA, 2003, P NATL ACAD SCI USA, V100, P9861, DOI 10.1073/pnas.1633363100; Spiliotis ET, 2000, IMMUNITY, V13, P841, DOI 10.1016/S1074-7613(00)00081-9; Steinkellner G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-32; Stojanovic M, 2005, J BIOL CHEM, V280, P30018, DOI 10.1074/jbc.M501306200; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Wakana Y, 2008, MOL BIOL CELL, V19, P1825, DOI 10.1091/mbc.E07-08-0781; Wang B, 2008, CELL, V133, P1080, DOI 10.1016/j.cell.2008.04.042; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wilson JD, 2010, J BIOL CHEM, V285, P18252, DOI 10.1074/jbc.M109.080382; Woestenenk Esmeralda A., 2004, Journal of Structural and Functional Genomics, V5, P217, DOI 10.1023/B:jsfg.0000031965.37625.0e; Xu QF, 2008, J MOL BIOL, V381, P487, DOI 10.1016/j.jmb.2008.06.002; Yu YB, 2002, ADV DRUG DELIVER REV, V54, P1113, DOI 10.1016/S0169-409X(02)00058-3; Yu YH, 1996, BIOPHYS CHEM, V59, P299, DOI 10.1016/0301-4622(95)00131-X; Zen K, 2004, J BIOL CHEM, V279, P44924, DOI 10.1074/jbc.M402115200; ZHOU NE, 1992, BIOCHEMISTRY-US, V31, P5739, DOI 10.1021/bi00140a008; Zhu H, 2000, J MOL BIOL, V300, P1377, DOI 10.1006/jmbi.2000.3936	60	14	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71111	10.1371/journal.pone.0071111	http://dx.doi.org/10.1371/journal.pone.0071111			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967155	Green Published, gold			2022-12-25	WOS:000323115800035
J	Shang, Q; Xiang, JF; Zhang, H; Li, Q; Tang, YL				Shang, Qian; Xiang, Junfeng; Zhang, Hong; Li, Qian; Tang, Yalin			The Effect of Polyhydroxylated Alkaloids on Maltase-Glucoamylase	PLOS ONE			English	Article							TYPE-1 DIABETES-MELLITUS; INSULIN; GLUCOSE; PYRROLIDINE; INHIBITION; PREVENTION; ACARBOSE; EXTRACT; DRUGS; NMR	One of the most important carbohydrate-splitting enzymes is themaltase-glucoamylase which catalyzes the hydrolysis of alpha-glucosidic linkages. Maltase-glucoamylase inhibitors during the last few years have aroused medical interests in the treatment of diabetes. They contribute to a better understanding of the mechanism of maltase-glucoamylase. At present there are many different classes of maltase-glucoamylase inhibitors. This paper focuses on alkaloidal inhibitors of maltase-glucoamylase and structure-activity relationship (SAR) studies between them in order to discover some drugs with better efficiency and lower toxicity for treating diabetes.	[Shang, Qian; Xiang, Junfeng; Zhang, Hong; Li, Qian; Tang, Yalin] Chinese Acad Sci, Inst Chem, State Key Lab Struct Chem Unstable & Stable Speci, Beijing Natl Lab Mol Sci,Ctr Mol Sci, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Chemistry, CAS	Tang, YL (corresponding author), Chinese Acad Sci, Inst Chem, State Key Lab Struct Chem Unstable & Stable Speci, Beijing Natl Lab Mol Sci,Ctr Mol Sci, Beijing 100080, Peoples R China.	tangyl@iccas.ac.cn			Chinese Academy of Sciences [KJCX2-EW-N06-01]; National Natural Science Foundation of China [91027033, 81072576]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Key Program of the Chinese Academy of Sciences (Grant No. KJCX2-EW-N06-01), the Major Research Program of the National Natural Science Foundation of China (Grant No. 91027033) and the General Program of the National Natural Science Foundation of China (Grant No. 81072576). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano N, 2001, J AGR FOOD CHEM, V49, P4208, DOI 10.1021/jf010567e; Asano N, 2003, GLYCOBIOLOGY, V13, p93R, DOI 10.1093/glycob/cwg090; Asano N, 2000, MECH AGEING DEV, V116, P155, DOI 10.1016/S0047-6374(00)00143-3; Bougneres P, 2008, J EXP MED, V205, P2953, DOI 10.1084/jem.20082622; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Chao ML, 2009, ENDOCRINE, V36, P268, DOI 10.1007/s12020-009-9222-y; Cooke DW, 2008, PEDIATR REV, V29, P374, DOI 10.1542/pir.29-11-374; Hoa NK, 2004, EXP CLIN ENDOCR DIAB, V112, P520, DOI 10.1055/s-2004-821309; Holman RR, 1999, DIABETES CARE, V22, P960, DOI 10.2337/diacare.22.6.960; INOUYE S, 1966, J ANTIBIOT, V19, P288; KAISER N, 1993, DIABETES, V42, P80, DOI 10.2337/diabetes.42.1.80; Kim IS, 2011, HETEROCYCLES, V83, P2489, DOI 10.3987/REV-11-712; Krentz AJ, 2005, DRUGS, V65, P385, DOI 10.2165/00003495-200565030-00005; KUBO M, 1994, BIOL PHARM BULL, V17, P458, DOI 10.1248/bpb.17.458; LENNON AJ, 1994, BIOPHYS J, V67, P2096, DOI 10.1016/S0006-3495(94)80693-9; Luo RS, 1999, SPECTROCHIM ACTA A, V55, P1897, DOI 10.1016/S1386-1425(99)00052-9; Maki KC, 2004, AM J CARDIOL, V93, p12C, DOI 10.1016/j.amjcard.2004.02.001; Maki KC, 2007, DIABETES CARE, V30, P1039, DOI 10.2337/dc06-2344; Matsui T, 2006, MINI-REV MED CHEM, V6, P349, DOI 10.2174/138955706776073484; Mooradian AD, 1999, DRUGS, V57, P19, DOI 10.2165/00003495-199957010-00003; PULS W, 1977, NATURWISSENSCHAFTEN, V64, P536, DOI 10.1007/BF00483562; PULS W, 1973, DIABETOLOGIA, V9, P97, DOI 10.1007/BF01230687; REAVEN GM, 1990, DIABETES CARE, V13, P32, DOI 10.2337/diacare.13.3.32; Scheen AJ, 2003, DRUGS, V63, P933, DOI 10.2165/00003495-200363100-00002; Shibano M, 2008, J NAT MED-TOKYO, V62, P349, DOI 10.1007/s11418-008-0244-1; Sim L, 2008, J MOL BIOL, V375, P782, DOI 10.1016/j.jmb.2007.10.069; Sim L, 2010, BIOCHEMISTRY-US, V49, P443, DOI 10.1021/bi9016457; STOUT RW, 1990, DIABETES CARE, V13, P631, DOI 10.2337/diacare.13.6.631; Tsou EL, 2008, BIOORGAN MED CHEM, V16, P10198, DOI 10.1016/j.bmc.2008.10.063; Vrzal R, 2012, FOOD CHEM, V133, P1671, DOI 10.1016/j.foodchem.2012.02.024; Yamashita T, 2002, J NAT PROD, V65, P1875, DOI 10.1021/np020296h	31	7	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e70841	10.1371/journal.pone.0070841	http://dx.doi.org/10.1371/journal.pone.0070841			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967118	gold, Green Published, Green Submitted			2022-12-25	WOS:000323115800025
J	Wu, Q; Gardiner, GJ; Berry, E; Wagner, SR; Lu, T; Clay, BS; Moore, TV; Ferreira, CM; Williams, JW; Luster, AD; Medoff, BD; Cannon, JL; Sperling, AI; Shilling, RA				Wu, Qiang; Gardiner, Gail J.; Berry, Elizabeth; Wagner, Sarah R.; Lu, Tiffany; Clay, Bryan S.; Moore, Tamson V.; Ferreira, Caroline M.; Williams, Jesse W.; Luster, Andrew D.; Medoff, Benjamin D.; Cannon, Judy L.; Sperling, Anne I.; Shilling, Rebecca A.			ICOS-Expressing Lymphocytes Promote Resolution of CD8-Mediated Lung Injury in a Mouse Model of Lung Rejection	PLOS ONE			English	Article								Acute rejection, a common complication of lung transplantation, may promote obliterative bronchiolitis leading to graft failure in lung transplant recipients. During acute rejection episodes, CD8(+) T cells can contribute to lung epithelial injury but the mechanisms promoting and controlling CD8-mediated injury in the lung are not well understood. To study the mechanisms regulating CD8(+) T cell-mediated lung rejection, we used a transgenic model in which adoptively transferred ovalbumin (OVA)-specific cytotoxic T lymphocytes (CTL) induce lung injury in mice expressing an ovalbumin transgene in the small airway epithelium of the lungs (CC10-OVA mice). The lung pathology is similar to findings in humans with acute lung transplant. In the presence of an intact immune response the inflammation resolves by day 30. Using CC10-OVA. RAG(-/-) mice, we found that CD4(+) T cells and ICOS+/+ T cells were required for protection against lethal lung injury, while neutrophil depletion was not protective. In addition, CD4(+) Foxp3 (+) ICOS+ T cells were enriched in the lungs of animals surviving lung injury and ICOS+/+ Tregs promoted survival in animals that received ICOS-/- T cells. Direct comparison of ICOS-/- Tregs to ICOS+/+ Tregs found defects in vitro but no differences in the ability of ICOS-/- Tregs to protect from lethal lung injury. These data suggest that ICOS affects Treg development but is not necessarily required for Treg effector function.	[Wu, Qiang; Gardiner, Gail J.; Wagner, Sarah R.; Shilling, Rebecca A.] Indiana Univ Sch Med, Dept Med, Div Pulm & Crit Care Med, Ctr Immunobiol, Indianapolis, IN 46202 USA; [Wu, Qiang; Gardiner, Gail J.; Wagner, Sarah R.; Shilling, Rebecca A.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Berry, Elizabeth; Lu, Tiffany; Clay, Bryan S.; Moore, Tamson V.; Ferreira, Caroline M.; Williams, Jesse W.; Cannon, Judy L.; Sperling, Anne I.] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Berry, Elizabeth; Lu, Tiffany; Clay, Bryan S.; Moore, Tamson V.; Ferreira, Caroline M.; Williams, Jesse W.; Cannon, Judy L.; Sperling, Anne I.] Univ Chicago, Dept Med, Pulm & Crit Care Med Sect, Chicago, IL 60637 USA; [Luster, Andrew D.] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Ctr Immunol & Inflammatory Dis, Charlestown, MA USA; [Luster, Andrew D.] Harvard Univ, Sch Med, Charlestown, MA USA; [Medoff, Benjamin D.] Massachusetts Gen Hosp, Pulm & Crit Care Unit, Boston, MA 02114 USA; [Medoff, Benjamin D.] Harvard Univ, Sch Med, Boston, MA USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Chicago; University of Chicago; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Shilling, RA (corresponding author), Indiana Univ Sch Med, Dept Med, Div Pulm & Crit Care Med, Ctr Immunobiol, Indianapolis, IN 46202 USA.	shilling@uic.edu	Luster, Andrew/ABE-6504-2020; Sperling, Anne/ACZ-2351-2022; Ferreira, Caroline M/D-3949-2012	Luster, Andrew/0000-0001-9679-7912; Wagner, Sarah/0000-0002-0257-0889; Cannon, Judy/0000-0003-0069-8106; Williams, Jesse/0000-0003-3815-0891; Medoff, Benjamin/0000-0002-2558-0449; Sperling, Anne I./0000-0002-4265-9212	NIH/NIAID [K08AI059105, R01AI67697]; American Society of Transplantation/Wyeth; Blowitz-Ridgeway Foundation; American Cancer Society-Illinois Division; Irvington Institute Fellowship Program of the Cancer Research Institute; Scientist Development Grant, American Heart Association; Roche Organ Transplantation Research Foundation; NIH [R01CA069212]; NATIONAL CANCER INSTITUTE [R01CA069212] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067697, K08AI059105] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Society of Transplantation/Wyeth; Blowitz-Ridgeway Foundation; American Cancer Society-Illinois Division(American Cancer Society); Irvington Institute Fellowship Program of the Cancer Research Institute; Scientist Development Grant, American Heart Association; Roche Organ Transplantation Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH/NIAID K08AI059105 (RAS), American Society of Transplantation/Wyeth (RAS), NIH/NIAID R01AI67697 (AIS), Blowitz-Ridgeway Foundation (AIS), American Cancer Society-Illinois Division (J.L.C.), Irvington Institute Fellowship Program of the Cancer Research Institute (J.L.C.), Scientist Development Grant, American Heart Association (J.L.C), Roche Organ Transplantation Research Foundation (BDM and ADL) and NIH R01CA069212 (ADL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhorade SM, 2010, TRANSPLANTATION, V90, P540, DOI 10.1097/TP.0b013e3181e8dabe; Bonhagen K, 2003, EUR J IMMUNOL, V33, P392, DOI 10.1002/immu.200310013; Boros P, 2009, AM J TRANSPLANT, V9, P1719, DOI 10.1111/j.1600-6143.2009.02704.x; Bour-Jordan H, 2009, IMMUNOL REV, V229, P41, DOI 10.1111/j.1600-065X.2009.00775.x; Burmeister Y, 2008, J IMMUNOL, V180, P774, DOI 10.4049/jimmunol.180.2.774; Bystry RS, 2001, NAT IMMUNOL, V2, P1126, DOI 10.1038/ni735; Chen Y, 2012, J IMMUNOL, V188, P1698, DOI 10.4049/jimmunol.1102448; Clay BS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007525; CLELLAND C, 1993, AM REV RESPIR DIS, V147, P1386, DOI 10.1164/ajrccm/147.6_Pt_1.1386; Crim C, 1996, AM J RESP CRIT CARE, V153, P1041, DOI 10.1164/ajrccm.153.3.8630543; D'Alessio FR, 2009, J CLIN INVEST, V119, P2898, DOI 10.1172/JCI36498; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Dummer W, 2001, J IMMUNOL, V166, P2460, DOI 10.4049/jimmunol.166.4.2460; Dunay IR, 2010, INFECT IMMUN, V78, P1564, DOI 10.1128/IAI.00472-09; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fulton RB, 2010, J IMMUNOL, V185, P2382, DOI 10.4049/jimmunol.1000423; Gelman AE, 2008, J IMMUNOL, V180, P4754, DOI 10.4049/jimmunol.180.7.4754; Grabie N, 2003, J CLIN INVEST, V111, P671, DOI 10.1172/JCI200316867; Gregson AL, 2008, TRANSPLANTATION, V85, P1056, DOI 10.1097/TP.0b013e318169bd85; Hodge G, 2010, CLIN EXP IMMUNOL, V161, P584, DOI 10.1111/j.1365-2249.2010.04186.x; Hodge G, 2007, TRANSPLANTATION, V84, P1452, DOI 10.1097/01.tp.0000290679.94163.e1; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Ito T, 2008, IMMUNITY, V28, P870, DOI 10.1016/j.immuni.2008.03.018; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kingsley CI, 2002, J IMMUNOL, V168, P1080, DOI 10.4049/jimmunol.168.3.1080; Kornete M, 2012, J IMMUNOL, V188, P1064, DOI 10.4049/jimmunol.1101303; Lohning M, 2003, J EXP MED, V197, P181, DOI 10.1084/jem.20020632; Malek TR, 2001, J IMMUNOL, V166, P1675, DOI 10.4049/jimmunol.166.3.1675; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI13296; Martinu T, 2010, SEMIN RESP CRIT CARE, V31, P179, DOI 10.1055/s-0030-1249113; Medoff BD, 2005, J EXP MED, V202, P97, DOI 10.1084/jem.20042481; Miyamoto K, 2005, J IMMUNOL, V175, P7341, DOI 10.4049/jimmunol.175.11.7341; Moore TV, 2011, AM J RESP CELL MOL, V45, P843, DOI 10.1165/rcmb.2010-0466OC; Muthukumar T, 2005, NEW ENGL J MED, V353, P2342, DOI 10.1056/NEJMoa051907; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Redpath SA, 2013, EUR J IMMUNOL, V43, P705, DOI 10.1002/eji.201242794; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Salomon B, 2001, ANNU REV IMMUNOL, V19, P225, DOI 10.1146/annurev.immunol.19.1.225; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Sanchez-Fueyo A, 2002, J IMMUNOL, V168, P2274, DOI 10.4049/jimmunol.168.5.2274; Seung E, 2011, J IMMUNOL, V186, P6830, DOI 10.4049/jimmunol.1001049; Shi C, 2011, J IMMUNOL, V187, P5293, DOI 10.4049/jimmunol.1101721; Shilling RA, 2009, CELL IMMUNOL, V259, P177, DOI 10.1016/j.cellimm.2009.06.013; Small BA, 2001, J EXP MED, V194, P1835, DOI 10.1084/jem.194.12.1835; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Thornton AM, 2004, EUR J IMMUNOL, V34, P366, DOI 10.1002/eji.200324455; Trulock EP, 2006, J HEART LUNG TRANSPL, V25, P880, DOI 10.1016/j.healun.2006.06.001; Vocanson M, 2010, J ALLERGY CLIN IMMUN, V126, P280, DOI 10.1016/j.jaci.2010.05.022; WHITEHEAD BF, 1995, RESP MED, V89, P27, DOI 10.1016/0954-6111(95)90067-5; Whitehead GS, 2012, J ALLERGY CLIN IMMUN, V129, P207, DOI 10.1016/j.jaci.2011.08.009; Wilkes DS, 2005, AM J RESP CRIT CARE, V172, P944, DOI 10.1164/rccm.200501-098WS; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027	54	5	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e72955	10.1371/journal.pone.0072955	http://dx.doi.org/10.1371/journal.pone.0072955			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967339	Green Published, gold, Green Submitted			2022-12-25	WOS:000323115800118
J	Yang, YJ; Tao-Cheng, JH; Bayer, KU; Reese, TS; Dosemeci, A				Yang, Yijung; Tao-Cheng, Jung-Hwa; Bayer, K. Ulrich; Reese, Thomas S.; Dosemeci, Ayse			Camkii-Mediated Phosphorylation Regulates Distributions of Syngap-alpha 1 and -alpha 2 at the Postsynaptic Density	PLOS ONE			English	Article								SynGAP, a protein abundant at the postsynaptic density (PSD) of glutamatergic neurons, is known to modulate synaptic strength by regulating the incorporation of AMPA receptors at the synapse. Two isoforms of SynGAP, alpha 1 and alpha 2, which differ in their C-termini, have opposing effects on synaptic strength. In the present study, antibodies specific for SynGAP-alpha 1 and SynGAP-alpha 2 are used to compare the distribution patterns of the two isoforms at the postsynaptic density (PSD) under basal and excitatory conditions. Western immunoblotting shows enrichment of both isoforms in PSD fractions isolated from adult rat brain. Immunogold electron microscopy of rat hippocampal neuronal cultures shows similar distribution of both isoforms at the PSD, with a high density of immunolabel within the PSD core under basal conditions. Application of NMDA promotes movement of SynGAP-alpha 1 as well as SynGAP-alpha 2 out of the PSD core. In isolated PSDs both isoforms of SynGAP can be phosphorylated upon activation of the endogenous CaMKII. Application of tatCN21, a cell-penetrating inhibitor of CaMKII, to hippocampal neuronal cultures blocks NMDA-induced redistribution of SynGAP-alpha 1 and SynGAP-alpha 2. Thus CaMKII activation promotes the removal of two distinct C-terminal SynGAP variants from the PSD.	[Yang, Yijung; Reese, Thomas S.; Dosemeci, Ayse] NINDS, Neurobiol Lab, NIH, Bethesda, MD 20892 USA; [Tao-Cheng, Jung-Hwa] NINDS, EM Facil, NIH, Bethesda, MD 20892 USA; [Bayer, K. Ulrich] Univ Colorado, Denver Sch Med, Dept Pharmacol, Aurora, CO USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Colorado System; University of Colorado Anschutz Medical Campus	Dosemeci, A (corresponding author), NINDS, Neurobiol Lab, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	dosemeca@mail.nih.gov			NINDS, National Institutes of Health (NIH); NIH [R01 NS081248]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081248, ZIANS003113] Funding Source: NIH RePORTER	NINDS, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the Intramural Research Program NINDS, National Institutes of Health (NIH) and NIH grant R01 NS081248 (to KUB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki Y, 2012, 2012 NEUR M PLANN; Barnett MW, 2006, J NEUROSCI, V26, P1355, DOI 10.1523/JNEUROSCI.3164-05.2006; Buard I, 2010, J NEUROSCI, V30, P8214, DOI 10.1523/JNEUROSCI.1469-10.2010; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Clement JP, 2012, CELL, V151, P709, DOI 10.1016/j.cell.2012.08.045; Coultrap SJ, 2012, TRENDS NEUROSCI, V35, P607, DOI 10.1016/j.tins.2012.05.003; Dosemeci A, 2000, J NEUROSCI, V20, P3076, DOI 10.1523/JNEUROSCI.20-09-03076.2000; Dosemeci A, 2002, J NEUROCYTOL, V31, P605, DOI 10.1023/A:1025735410738; Dosemeci A, 2010, BIOCHEM BIOPH RES CO, V391, P78, DOI 10.1016/j.bbrc.2009.10.167; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUDEK SM, 1993, J NEUROSCI, V13, P2910; Guo XC, 2009, NEUROPSYCHOPHARMACOL, V34, P1659, DOI 10.1038/npp.2008.223; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Lu ZM, 1998, MOL CELL NEUROSCI, V12, P363, DOI 10.1006/mcne.1998.0723; Luscher C., 2012, COLD SPRING HARB PER, V4; McMahon AC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1900; Muhia M, 2012, LEARN MEMORY, V19, P268, DOI 10.1101/lm.026351.112; Muhia M, 2010, EUR J NEUROSCI, V31, P529, DOI 10.1111/j.1460-9568.2010.07079.x; Oh JS, 2004, J BIOL CHEM, V279, P17980, DOI 10.1074/jbc.M314109200; Petralia RS, 2005, MOL CELL NEUROSCI, V29, P436, DOI 10.1016/j.mcn.2005.03.013; Rumbaugh G, 2006, P NATL ACAD SCI USA, V103, P4344, DOI 10.1073/pnas.0600084103; Vazquez LE, 2004, J NEUROSCI, V24, P8862, DOI 10.1523/JNEUROSCI.3213-04.2004; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Vest RS, 2010, J BIOL CHEM, V285, P20675, DOI 10.1074/jbc.M109.088617; Yang Y, 2011, NEUROSCIENCE, V192, P132, DOI 10.1016/j.neuroscience.2011.06.061	29	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71795	10.1371/journal.pone.0071795	http://dx.doi.org/10.1371/journal.pone.0071795			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967245	Green Published, gold, Green Submitted			2022-12-25	WOS:000323115800080
J	Charvet, CD; Saadane, A; Wang, MY; Salomon, RG; Brunengraber, H; Turko, IV; Pikuleva, IA				Charvet, Casey D.; Saadane, Aicha; Wang, Meiyao; Salomon, Robert G.; Brunengraber, Henri; Turko, Illarion V.; Pikuleva, Irina A.			Pretreatment with Pyridoxamine Mitigates Isolevuglandin-associated Retinal Effects in Mice Exposed to Bright Light	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED PHOTORECEPTOR DEGENERATION; 4-HYDROXYNONENAL PROTEIN ADDUCTS; LIPID-PEROXIDATION; GAMMA-KETOALDEHYDES; ISOPROSTANE PATHWAY; LIPOXIDATION REACTIONS; MOLECULAR-MECHANISMS; PIGMENT EPITHELIUM; ADVANCED GLYCATION; OXIDATIVE DAMAGE	The benefits of antioxidant therapy for treating age-related macular degeneration, a devastating retinal disease, are limited. Perhaps species other than reactive oxygen intermediates should be considered as therapeutic targets. These could be lipid peroxidation products, including isolevuglandins (isoLGs), prototypical and extraordinarily reactive gamma-ketoaldehydes that avidly bind to proteins, phospholipids, and DNA and modulate the properties of these biomolecules. We found isoLG adducts in aged human retina but not in the retina of mice kept under dim lighting. Hence, to test whether scavenging of isoLGs could complement or supplant antioxidant therapy, we exposed mice to bright light and found that this insult leads to retinal isoLG-adduct formation. We then pretreated mice with pyridoxamine, a B-6 vitamer and efficient scavenger of gamma-ketoaldehydes, and found that the levels of retinal isoLG adducts are decreased, and morphological changes in photoreceptor mitochondria are not as pronounced as in untreated animals. Our study demonstrates that preventing the damage to biomolecules by lipid peroxidation products, a novel concept in vision research, is a viable strategy to combat oxidative stress in the retina.	[Charvet, Casey D.; Saadane, Aicha; Pikuleva, Irina A.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Salomon, Robert G.] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA; [Brunengraber, Henri] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA; [Wang, Meiyao; Turko, Illarion V.] Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA; [Wang, Meiyao; Turko, Illarion V.] NIST, Div Analyt Chem, Gaithersburg, MD 20899 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; National Institute of Standards & Technology (NIST) - USA	Pikuleva, IA (corresponding author), Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, 2085 Adelbert Rd,Rm 303, Cleveland, OH 44106 USA.	iap8@case.edu		Salomon, Robert/0000-0001-9456-3557; Pikuleva, Irina/0000-0001-9742-6232; Saadane, Aicha/0000-0001-9985-2147	National Institutes of Health [EY018383, GM21249, R33DK070291, T32-EY007157]; Visual Sciences Research Center [P30 EY11373]; Jules and Doris Stein Research Professorship from Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY018383, R01EY016813, P30EY011373, T32EY007157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R33DK070291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021249] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Visual Sciences Research Center; Jules and Doris Stein Research Professorship from Research to Prevent Blindness; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY018383 (to I.A.P.), GM21249 (to R.G.S.), and R33DK070291 (to H.B.), and Visual Sciences Research Center Core Grant P30 EY11373. This work was also supported by the Jules and Doris Stein Research Professorship from Research to Prevent Blindness (to I.A.P.).; Recipient of a fellowship from the National Institutes of Health (Training Grant T32-EY007157).	Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Bacot S, 2003, J LIPID RES, V44, P917, DOI 10.1194/jlr.M200450-JLR200; BASU AK, 1984, MUTAT RES, V129, P39, DOI 10.1016/0027-5107(84)90121-0; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Ben-Shabat S, 2002, J BIOL CHEM, V277, P7183, DOI 10.1074/jbc.M108981200; Brame CJ, 1999, J BIOL CHEM, V274, P13139, DOI 10.1074/jbc.274.19.13139; Caldes C, 2011, CHEM BIODIVERS, V8, P1318, DOI 10.1002/cbdv.201000296; Charvet C, 2011, J BIOL CHEM, V286, P20413, DOI 10.1074/jbc.M111.232546; Charvet CD, 2013, J LIPID RES, V54, P1421, DOI 10.1194/jlr.M035790; Chen L, 2004, EXP EYE RES, V79, P239, DOI 10.1016/j.exer.2004.05.002; Chew EY, 2009, ARCH OPHTHALMOL-CHIC, V127, P1678, DOI 10.1001/archophthalmol.2009.312; Clayton PT, 2006, J INHERIT METAB DIS, V29, P317, DOI 10.1007/s10545-005-0243-2; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; Davies SS, 2006, BIOCHEMISTRY-US, V45, P15756, DOI 10.1021/bi061860g; Davies SS, 2011, J ALZHEIMERS DIS, V27, P49, DOI 10.3233/JAD-2011-102118; Davies SS, 2004, CHEM PHYS LIPIDS, V128, P85, DOI 10.1016/j.chemphyslip.2003.10.007; Degenhardt TP, 2002, KIDNEY INT, V61, P939, DOI 10.1046/j.1523-1755.2002.00207.x; DEXTER DT, 1989, J NEUROCHEM, V52, P381, DOI 10.1111/j.1471-4159.1989.tb09133.x; DIFRANCO E, 1995, CHEM RES TOXICOL, V8, P61, DOI 10.1021/tx00043a008; Donovan M, 2001, J BIOL CHEM, V276, P23000, DOI 10.1074/jbc.M005359200; Ebrahem Q, 2006, P NATL ACAD SCI USA, V103, P13480, DOI 10.1073/pnas.0601552103; EDER E, 1990, ENVIRON HEALTH PERSP, V88, P99, DOI 10.2307/3431058; ELDRED GE, 1993, NATURE, V364, P396; ESTERBAUER H, 1993, AM J CLIN NUTR, V57, P779, DOI 10.1093/ajcn/57.5.779S; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Feher J, 2006, NEUROBIOL AGING, V27, P983, DOI 10.1016/j.neurobiolaging.2005.05.012; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; Fukuda K, 2005, CIRC RES, V97, P1262, DOI 10.1161/01.RES.0000195844.31466.e9; Galluzzi L, 2013, ONCOGENE, V32, P4995, DOI 10.1038/onc.2012.623; Govindarajan B, 2008, BIOCHEMISTRY-US, V47, P817, DOI 10.1021/bi701517m; Govindarajan B, 2009, MOL VIS, V15, P1079; Gu XR, 2003, J BIOL CHEM, V278, P42027, DOI 10.1074/jbc.M305460200; GULCAN HG, 1993, INVEST OPHTH VIS SCI, V34, P3187; HABERLAND ME, 1988, SCIENCE, V241, P215, DOI 10.1126/science.2455346; Hahn P, 2004, MOL VIS, V10, P598; HENNIG B, 1988, FREE RADICAL BIO MED, V4, P99, DOI 10.1016/0891-5849(88)90070-6; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Hoang QV, 2002, VISUAL NEUROSCI, V19, P395, DOI 10.1017/S0952523802194028; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; HOUGLUM K, 1990, J CLIN INVEST, V86, P1991, DOI 10.1172/JCI114934; HUNT RC, 1992, J CELL PHYSIOL, V152, P102, DOI 10.1002/jcp.1041520114; Imanishi Y, 2008, J BIOL CHEM, V283, P25091, DOI 10.1074/jbc.M802981200; Jump DB, 2012, J LIPID RES, V53, P2525, DOI 10.1194/jlr.R027904; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Kaur K, 1997, CHEM RES TOXICOL, V10, P1387, DOI 10.1021/tx970112c; Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006; Kris-Etherton PM, 2004, CIRCULATION, V110, P637, DOI 10.1161/01.CIR.0000137822.39831.F1; Krishnadev N, 2010, CURR OPIN OPHTHALMOL, V21, P184, DOI 10.1097/ICU.0b013e32833866ee; Lambert AJ, 2009, METHODS MOL BIOL, V554, P165, DOI 10.1007/978-1-59745-521-3_11; LAVAIL MM, 1987, CURR EYE RES, V6, P825, DOI 10.3109/02713688709034850; Levin L. A., 2011, ADLERS PHYSL EYE CLI, P243; Lewis EJ, 2012, J AM SOC NEPHROL, V23, P131, DOI 10.1681/ASN.2011030272; Li W, 2009, FREE RADICAL BIO MED, V47, P1539, DOI 10.1016/j.freeradbiomed.2009.09.003; Liao WL, 2008, ANAL BIOCHEM, V377, P55, DOI 10.1016/j.ab.2008.03.016; Liton PB, 2008, INVEST OPHTH VIS SCI, V49, P3961, DOI 10.1167/iovs.08-1915; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2012, NAT CHEM BIOL, V8, P170, DOI 10.1038/nchembio.759; Malek G, 2003, AM J PATHOL, V162, P413, DOI 10.1016/S0002-9440(10)63836-9; Marchette LD, 2010, FREE RADICAL BIO MED, V48, P16, DOI 10.1016/j.freeradbiomed.2009.08.005; Markesbery WR, 1998, NEUROBIOL AGING, V19, P33, DOI 10.1016/S0197-4580(98)00009-8; Metz TO, 2003, ARCH BIOCHEM BIOPHYS, V419, P41, DOI 10.1016/j.abb.2003.08.021; Morris MC, 2002, JAMA-J AM MED ASSOC, V287, P3230, DOI 10.1001/jama.287.24.3230; Noell W K, 1966, Invest Ophthalmol, V5, P450; Ohishi K, 2005, FREE RADICAL RES, V39, P875, DOI 10.1080/10715760500177807; Ohishi K, 2006, FREE RADICAL RES, V40, P799, DOI 10.1080/10715760600555027; Omarova S, 2012, J CLIN INVEST, V122, P3012, DOI 10.1172/JCI63816; Onorato JM, 2000, J BIOL CHEM, V275, P21177, DOI 10.1074/jbc.M003263200; Ortega-Castro J, 2012, J PHYS CHEM A, V116, P2961, DOI 10.1021/jp210188w; Pascolini D, 2004, OPHTHAL EPIDEMIOL, V11, P67, DOI 10.1076/opep.11.2.67.28158; Poliakov E, 2003, FASEB J, V17, P2209, DOI 10.1096/fj.03-0086com; RIMINGTON C, 1965, LANCET, V1, P624; Roca A, 2004, NEUROSCIENCE, V129, P779, DOI 10.1016/j.neuroscience.2004.08.021; Rodriguez IR, 2009, PHOTOCHEM PHOTOBIOL, V85, P1116, DOI 10.1111/j.1751-1097.2009.00568.x; Sakai N, 1996, J AM CHEM SOC, V118, P1559, DOI 10.1021/ja953480g; Salomon R G, 1985, Adv Prostaglandin Thromboxane Leukot Res, V15, P323; Salomon RG, 1999, J BIOL CHEM, V274, P20271, DOI 10.1074/jbc.274.29.20271; Salomon RG, 2000, TRENDS CARDIOVAS MED, V10, P53, DOI 10.1016/S1050-1738(00)00040-2; Salomon RG, 1997, CHEM RES TOXICOL, V10, P750, DOI 10.1021/tx970016b; Sayre LM, 1997, J NEUROCHEM, V68, P2092; Sha W, 2000, J ORG CHEM, V65, P5315, DOI 10.1021/jo000537v; Siems WG, 1996, FREE RADICAL BIO MED, V20, P215, DOI 10.1016/0891-5849(95)02041-1; Smith RS, 2002, RES METH MUT M SER, P25; Song DL, 2012, FREE RADICAL BIO MED, V53, P64, DOI 10.1016/j.freeradbiomed.2012.04.020; Stavrovskaya IG, 2010, FREE RADICAL BIO MED, V49, P567, DOI 10.1016/j.freeradbiomed.2010.04.037; Stitt A, 2002, DIABETES, V51, P2826, DOI 10.2337/diabetes.51.9.2826; Stone J, 2008, BRAIN RES, V1189, P58, DOI 10.1016/j.brainres.2007.10.083; Subbanagounder G, 1997, J ORG CHEM, V62, P7658, DOI 10.1021/jo970858f; Sullivan CB, 2010, J LIPID RES, V51, P999, DOI 10.1194/jlr.M001040; TANDLER B, 1972, ANAT REC, V173, P309, DOI 10.1002/ar.1091730306; Tanito M, 2005, INVEST OPHTH VIS SCI, V46, P3859, DOI 10.1167/iovs.05-0672; van der Ham M, 2012, ANAL CHIM ACTA, V712, P108, DOI 10.1016/j.aca.2011.11.018; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; Williams ME, 2007, AM J NEPHROL, V27, P605, DOI 10.1159/000108104; Xu LB, 2009, J AM CHEM SOC, V131, P13037, DOI 10.1021/ja9029076; Yefimova MG, 2000, INVEST OPHTH VIS SCI, V41, P2343; Yoritaka A, 1996, P NATL ACAD SCI USA, V93, P2696, DOI 10.1073/pnas.93.7.2696; Yu DY, 2001, PROG RETIN EYE RES, V20, P175, DOI 10.1016/S1350-9462(00)00027-6; Zagol-Ikapitte I, 2005, J NEUROCHEM, V94, P1140, DOI 10.1111/j.1471-4159.2005.03264.x	100	21	21	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29267	29280		10.1074/jbc.M113.498832	http://dx.doi.org/10.1074/jbc.M113.498832			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23970548	hybrid, Green Published			2022-12-25	WOS:000330615300007
J	Keyamura, K; Sakaguchi, C; Kubota, Y; Niki, H; Hishida, T				Keyamura, Kenji; Sakaguchi, Chikako; Kubota, Yoshino; Niki, Hironori; Hishida, Takashi			RecA Protein Recruits Structural Maintenance of Chromosomes (SMC)-like RecN Protein to DNA Double-strand Breaks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STALLED REPLICATION FORKS; BACILLUS-SUBTILIS RECN; ESCHERICHIA-COLI; HOMOLOGOUS RECOMBINATION; HOLLIDAY JUNCTION; CRYSTAL-STRUCTURE; RECBCD ENZYME; GENE-PRODUCT; SMC PROTEINS; REPAIR	Escherichia coli RecN is an SMC (structural maintenance of chromosomes) family protein that is required for DNA double-strand break (DSB) repair. Previous studies show that GFP-RecN forms nucleoid-associated foci in response to DNA damage, but the mechanism by which RecN is recruited to the nucleoid is unknown. Here, we show that the assembly of GFP-RecN foci on the nucleoid in response to DNA damage involves a functional interaction between RecN and RecA. A novel RecA allele identified in this work, recA(Q300R), is proficient in SOS induction and repair of UV-induced DNA damage, but is deficient in repair of mitomycin C (MMC)-induced DNA damage. Cells carrying recA(Q300R) fail to recruit RecN to DSBs and accumulate fragmented chromosomes after exposure to MMC. The ATPase-deficient RecN(K35A) binds and forms foci at MMC-induced DSBs, but is not released from the MMC-induced DNA lesions, resulting in a defect in homologous recombination-dependent DSB repair. These data suggest that RecN plays a crucial role in homologous recombination-dependent DSB repair and that it is required upstream of RecA-mediated strand exchange.	[Keyamura, Kenji; Hishida, Takashi] Gakushuin Univ, Grad Sch Sci, Dept Life Sci, Tokyo 1718588, Japan; [Sakaguchi, Chikako; Kubota, Yoshino; Hishida, Takashi] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Niki, Hironori] Natl Inst Genet, Genet Strains Res Ctr, Microbial Genet Lab, Mishima, Shizuoka 4118540, Japan	Gakushuin University; Osaka University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Hishida, T (corresponding author), Gakushuin Univ, Grad Sch Sci, Dept Life Sci, Tokyo 1718588, Japan.	takashi.hishida@gakushuin.ac.jp		Hishida, Takashi/0000-0002-9752-6599; Niki, Hironori/0000-0002-5391-6595	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [24114516, 24570010] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for scientific research on priority areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to T.H.).	Amundsen SK, 2003, CELL, V112, P741, DOI 10.1016/S0092-8674(03)00197-1; Au N, 2005, J BACTERIOL, V187, P7655, DOI 10.1128/JB.187.22.7655-7666.2005; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bentchikou E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000774; Cao Z, 2010, DNA REPAIR, V9, P66, DOI 10.1016/j.dnarep.2009.10.009; Courcelle J, 2001, GENETICS, V158, P41; Cox MM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000815; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Cox MM, 2001, P NATL ACAD SCI USA, V98, P8173, DOI 10.1073/pnas.131004998; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; FINCH PW, 1985, J BACTERIOL, V164, P653, DOI 10.1128/JB.164.2.653-658.1985; Friedberg EC, 2006, DNA REPAIR, V5, P986, DOI 10.1016/j.dnarep.2006.05.005; Graumann PL, 2001, BIOCHIMIE, V83, P53, DOI 10.1016/S0300-9084(00)01218-9; Grove JI, 2009, DNA REPAIR, V8, P1434, DOI 10.1016/j.dnarep.2009.09.015; Hatano T, 2007, MOL MICROBIOL, V64, P1198, DOI 10.1111/j.1365-2958.2007.05728.x; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Hishida T, 2004, GENE DEV, V18, P1886, DOI 10.1101/gad.1223804; Humayun MZ, 1998, MOL MICROBIOL, V30, P905, DOI 10.1046/j.1365-2958.1998.01120.x; Ishioka K, 1998, GENES CELLS, V3, P209, DOI 10.1046/j.1365-2443.1998.00185.x; Kosa JL, 2004, MUTAT RES-FUND MOL M, V554, P149, DOI 10.1016/j.mrfmmm.2004.04.011; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Kuzminov A, 2001, P NATL ACAD SCI USA, V98, P8461, DOI 10.1073/pnas.151260698; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; LITTLE JW, 1991, BIOCHIMIE, V73, P411, DOI 10.1016/0300-9084(91)90108-D; LITTLE JW, 1982, CELL, V29, P11, DOI 10.1016/0092-8674(82)90085-X; LITTLE JW, 1979, P NATL ACAD SCI USA, V76, P6147, DOI 10.1073/pnas.76.12.6147; LLOYD RG, 1993, EMBO J, V12, P17, DOI 10.1002/j.1460-2075.1993.tb05627.x; LLOYD RG, 1983, MOL GEN GENET, V190, P162, DOI 10.1007/BF00330340; LLOYD RG, 1987, J GEN MICROBIOL, V133, P2531; LLOYD RG, 1996, ESCHERICHIA COLI SAL, P2236; Luo Y, 2001, CELL, V106, P585, DOI 10.1016/S0092-8674(01)00479-2; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; Lusetti SL, 2003, J BIOL CHEM, V278, P16372, DOI 10.1074/jbc.M212917200; Meddows TR, 2004, MOL MICROBIOL, V52, P119, DOI 10.1111/j.1365-2958.2003.03970.x; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Nagashima K, 2006, J BIOL CHEM, V281, P30941, DOI 10.1074/jbc.M606566200; Nozaki S, 2009, J BACTERIOL, V191, P4807, DOI 10.1128/JB.00435-09; Pellegrino S, 2012, STRUCTURE, V20, P2076, DOI 10.1016/j.str.2012.09.010; PICKSLEY SM, 1984, MOL GEN GENET, V195, P267, DOI 10.1007/BF00332758; Ponder RG, 2005, MOL CELL, V19, P791, DOI 10.1016/j.molcel.2005.07.025; Reyes ED, 2010, J BIOL CHEM, V285, P16521, DOI 10.1074/jbc.M110.119164; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; ROSTAS K, 1987, NUCLEIC ACIDS RES, V15, P5041, DOI 10.1093/nar/15.13.5041; Sambrook J., 2002, MOL CLONING LAB MANU; Sanchez H, 2005, NUCLEIC ACIDS RES, V33, P2343, DOI 10.1093/nar/gki533; Sanchez H, 2006, J BACTERIOL, V188, P353, DOI 10.1128/JB.188.2.353-360.2006; SARGENTINI NJ, 1983, RADIAT RES, V93, P461, DOI 10.2307/3576026; Sharples GJ, 1999, J BACTERIOL, V181, P5543, DOI 10.1128/JB.181.18.5543-5550.1999; Shibata T, 2005, GENES CELLS, V10, P181, DOI 10.1111/j.1365-2443.2005.00831.x; Shinagawa H, 1996, TRENDS BIOCHEM SCI, V21, P107, DOI 10.1016/0968-0004(96)10014-1; Simmons LA, 2009, J BACTERIOL, V191, P1152, DOI 10.1128/JB.01292-08; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; WANG TCV, 1988, J BACTERIOL, V170, P2555, DOI 10.1128/jb.170.6.2555-2559.1988	55	28	28	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29229	29237		10.1074/jbc.M113.485474	http://dx.doi.org/10.1074/jbc.M113.485474			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23974212	Green Published, hybrid			2022-12-25	WOS:000330615300002
J	Khar, KR; Goldschmidt, L; Karanicolas, J				Khar, Karen R.; Goldschmidt, Lukasz; Karanicolas, John			Fast Docking on Graphics Processing Units via Ray-Casting	PLOS ONE			English	Article							RECEPTOR FLEXIBILITY; DRUG DISCOVERY; LIGAND DOCKING; BINDING-SITES; CONFORMER GENERATION; PROTEIN DOCKING; OPTIMIZATION; COMPUTATION; SIMULATION; ALGORITHM	Docking Approach using Ray Casting (DARC) is structure-based computational method for carrying out virtual screening by docking small-molecules into protein surface pockets. In a complementary study we find that DARC can be used to identify known inhibitors from large sets of decoy compounds, and can identify new compounds that are active in biochemical assays. Here, we describe our adaptation of DARC for use on Graphics Processing Units (GPUs), leading to a speedup of approximately 27-fold in typical-use cases over the corresponding calculations carried out using a CPU alone. This dramatic speedup of DARC will enable screening larger compound libraries, screening with more conformations of each compound, and including multiple receptor conformations when screening. We anticipate that all three of these enhanced approaches, which now become tractable, will lead to improved screening results.	[Khar, Karen R.; Karanicolas, John] Univ Kansas, Ctr Bioinformat, Lawrence, KS 66045 USA; [Goldschmidt, Lukasz] Univ Calif Los Angeles, UCLA DOE Inst Genom & Prote, Los Angeles, CA USA; [Karanicolas, John] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	University of Kansas; United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of Kansas	Karanicolas, J (corresponding author), Univ Kansas, Ctr Bioinformat, Lawrence, KS 66045 USA.	johnk@ku.edu			National Institute of General Medical Sciences [1R01GM099959, 5R01GM095847]; National Institute on Aging [2R01AG029430, 5P50AG016570]; National Institute of Allergy and Infectious Diseases [5T32AI070089]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI070089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099959, R01GM095847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG016570, R01AG029430] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institute of General Medical Sciences (1R01GM099959, 5R01GM095847), the National Institute on Aging (2R01AG029430 and 5P50AG016570), and the National Institute of Allergy and Infectious Diseases (5T32AI070089). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bottegoni G, 2009, J MED CHEM, V52, P397, DOI 10.1021/jm8009958; Brown SP, 2006, CHEMMEDCHEM, V1, P70, DOI 10.1002/cmdc.200500013; Call ST, 2007, J COMPUT CHEM, V28, P1177, DOI 10.1002/jcc.20621; Cavasotto CN, 2005, J AM CHEM SOC, V127, P9632, DOI 10.1021/ja042260c; Cheng TJ, 2012, AAPS J, V14, P133, DOI 10.1208/s12248-012-9322-0; Daga M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S5-S4; Davis IW, 2009, J MOL BIOL, V385, P381, DOI 10.1016/j.jmb.2008.11.010; Eyrisch S, 2007, J MED CHEM, V50, P3457, DOI 10.1021/jm070095g; Fan H, 2009, J CHEM INF MODEL, V49, P2512, DOI 10.1021/ci9003706; Friedrichs MS, 2009, J COMPUT CHEM, V30, P864, DOI 10.1002/jcc.21209; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Fuller JC, 2009, DRUG DISCOV TODAY, V14, P155, DOI 10.1016/j.drudis.2008.10.009; Hawkins PCD, 2012, J CHEM INF MODEL, V52, P2919, DOI 10.1021/ci300314k; Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x; Heinzerling L, 2012, J COMPUT CHEM, V33, P2554, DOI 10.1002/jcc.23094; Hofinger S, 2012, J COMPUT CHEM, V33, P2351, DOI 10.1002/jcc.23082; Huang BD, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-19; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Johnson DK, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002951; Kannan S, 2010, WCCI 2010 IEEE WORLD, P3815; Kaufmann KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050769; Koes D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032839; Komarov I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037370; Korb O, 2011, J CHEM INF MODEL, V51, P865, DOI 10.1021/ci100459b; Lang PT, 2009, RNA, V15, P1219, DOI 10.1261/rna.1563609; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lee HS, 2012, PROTEINS, V80, P93, DOI 10.1002/prot.23165; Leis S, 2011, J COMPUT CHEM, V32, P3433, DOI 10.1002/jcc.21923; Lorber DM, 1998, PROTEIN SCI, V7, P938; McGann M, 2011, J CHEM INF MODEL, V51, P578, DOI 10.1021/ci100436p; Meiler J, 2006, PROTEINS, V65, P538, DOI 10.1002/prot.21086; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Neves MAC, 2012, J COMPUT AID MOL DES, V26, P675, DOI 10.1007/s10822-012-9547-0; OpenEye, OMEGA VERS 2 4 3; OpenEye, FRED VERS 3 0 0; Osguthorpe DJ, 2012, CHEM BIOL DRUG DES, V80, P182, DOI 10.1111/j.1747-0285.2012.01396.x; Perez-Sanchez H, 2011, CURR COMPUT-AID DRUG, V7, P44, DOI 10.2174/157340911793743565; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Ritchie DW, 2010, BIOINFORMATICS, V26, P2398, DOI 10.1093/bioinformatics/btq444; Sanchez-Linares I, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S14-S13; Sauton N, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-184; Simonsen M, 2011, P 13 ANN C GEN EV CO, P1803, DOI DOI 10.1145/2001576.2001818; Stone JE, 2007, J COMPUT CHEM, V28, P2618, DOI 10.1002/jcc.20829; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Vorobjev YN, 2010, J COMPUT CHEM, V31, P1080, DOI 10.1002/jcc.21394; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Yang HL, 2010, ADV EXP MED BIOL, V680, P497, DOI 10.1007/978-1-4419-5913-3_56; Zhou HY, 2013, J CHEM INF MODEL, V53, P230, DOI 10.1021/ci300510n; Zhou ZY, 2007, J CHEM INF MODEL, V47, P1599, DOI 10.1021/ci7000346; Zhu T, 2013, J CHEM INF MODEL, V53, P560, DOI 10.1021/ci300502h	51	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e70661	10.1371/journal.pone.0070661	http://dx.doi.org/10.1371/journal.pone.0070661			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23976948	Green Published, Green Submitted, gold			2022-12-25	WOS:000323570200005
J	Mokube, MN; Atashili, J; Halle-Ekane, GE; Ikomey, GM; Ndumbe, PM				Mokube, Morike Ngoe; Atashili, Julius; Halle-Ekane, Gregory Edie; Ikomey, George M.; Ndumbe, Peter M.			Bacteriuria amongst Pregnant Women in the Buea Health District, Cameroon: Prevalence, Predictors, Antibiotic Susceptibility Patterns and Diagnosis	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; DETECT ASYMPTOMATIC BACTERIURIA; ANTIMICROBIAL SUSCEPTIBILITY; SCREENING-TESTS; SENSITIVITY; UNIVERSITY; ETIOLOGY; PROFILE; CARE	Background: Bacteriuria is associated with significant maternal and foetal risks. However, its prevalence is not known in our community. Objectives: This study was carried out to determine the prevalence and predictors of bacteriuria in pregnant women of the Buea Health District (BHD) as well as the antibiotic sensitivity patterns of bacterial isolates. It also sought to determine the diagnostic performance of the nitrite and leucocyte esterase tests in detecting bacteriuria in these women. Methods: An observational analytic cross-sectional study was carried out amongst pregnant women attending selected antenatal care centres in Buea. We recruited 102 consenting pregnant women for the study. Demographic and clinical data were collected using structured questionnaires. Clean catch midstream urine was collected from each participant in sterile leak proof containers. Samples were examined biochemically, microscopically and by culture. Significant bacteriuria was defined as the presence of >= 10(8) bacteria/L of cultured urine. Identification and susceptibility of isolates was performed using API 20E and ATB UR EU (08) (BioMerieux, Marcy l'Etoile, France). Results: Significant bacteriuria was found in the urine of 24 of the 102 women tested giving a bacteriuria prevalence of 23.5% in pregnant women of the BHD. Asymptomatic bacteriuria was detected in 8(7.8%) of the women. There was no statistically significant predictor of bacteriuria. Escherichia coli were the most isolated (33%) uropathogens and were 100% sensitive to cefixime, cefoxitin and cephalothin. The nitrite and leucocyte esterase tests for determining bacteriuria had sensitivities of 8%, 20.8% and specificities of 98.7% and 80.8% respectively. Conclusion: Bacteriuria is frequent in pregnant women in the BHD suggesting the need for routine screening by urine culture. Empiric treatment with cefixime should be instituted until results of urine culture and sensitivity are available. Nitrite and leucocyte esterase tests were not sensitive enough to replace urine culture as screening tests.	[Mokube, Morike Ngoe; Atashili, Julius; Halle-Ekane, Gregory Edie; Ikomey, George M.; Ndumbe, Peter M.] Univ Buea, Fac Hlth Sci, Buea, South West Regi, Cameroon		Atashili, J (corresponding author), Univ Buea, Fac Hlth Sci, Buea, South West Regi, Cameroon.	atashili@yahoo.ie	ekane, Dean and Professor Gregory Edie Halle/I-1292-2019	ekane, Dean and Professor Gregory Edie Halle/0000-0003-4304-9210	European and Developing Countries Trial Partnership (EDCTP)	European and Developing Countries Trial Partnership (EDCTP)	Dr. JA and Professor PMN's work was partially supported by a grant from the European and Developing Countries Trial Partnership (EDCTP) to the Central African Network against Tuberculosis AIDS and Malaria (CANTAM). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam T, 2005, BMJ-BRIT MED J, V331, P1107, DOI 10.1136/bmj.331.7525.1107; Akoachere Jane-Francis Tatah Kihla, 2012, BMC Res Notes, V5, P219, DOI 10.1186/1756-0500-5-219; Al SibianiSA., 2010, JKAU MED SCI, V17, P29, DOI 10.4197/med.17-1.4; Alemu Agersew, 2012, BMC Res Notes, V5, P197, DOI 10.1186/1756-0500-5-197; Amadi E. S., 2007, Journal of Medical Sciences (Pakistan), V7, P698; Andabati G, 2010, AFR HEALTH SCI, V10, P349; Aseel MT, 2009, WORLD FAM MED, V7, P10; Assefa Addisu, 2008, Ethiop Med J, V46, P227; Awolude OA, 2010, VIRULENCE, V1, P130, DOI 10.4161/viru.1.3.11384; Bahadin J, 2011, SINGAP MED J, V52, P415; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Celen S, 2011, ISRN OBSTET GYNECOL, V2011, P1; Cheesbrough M, 2006, DISTRICT LAB PRACTIC, V2nd; Enayat K, 2008, INT BRAZ J UROL, V34, P699, DOI 10.1590/S1677-55382008000600004; Goddard J, 2006, DAVIDSONS PRINCIPLES, P455; Hamdan HZ, 2011, ANN CLIN MICROB ANTI, V10, DOI 10.1186/1476-0711-10-2; Hooton TM, 2010, UPTODATE; Imade PE, 2010, N AM J MED SCI, V2, P263, DOI 10.4297/najms.2010.2263; Jayalakshmi J, 2008, INDIAN J PATHOL MICR, V51, P379, DOI 10.4103/0377-4929.42516; Kacmaz B, 2006, JPN J INFECT DIS, V59, P261; Kehinde Aderemi O, 2011, Trop Med Health, V39, P73, DOI 10.2149/tmh.2011-02; Kirkham C, 2005, AM FAM PHYSICIAN, V71, P1555; Mehhorn AJ, 2007, ANN PHARMACOTHER, V41, P1859, DOI 10.1345/aph.1K347; Moges A F, 2002, East Afr Med J, V79, P140; Nicolle LE, 2005, CLIN INFECT DIS, V40, P643, DOI 10.1086/427507; Nicolle LE, 2003, INFECT DIS CLIN N AM, V17, P367, DOI 10.1016/S0891-5520(03)00008-4; Njunda L, 2009, INTERNET J INFECT DI, V7, P2; Nys S, 2006, J ANTIMICROB CHEMOTH, V57, P955, DOI 10.1093/jac/dkl082; Okonko I. O., 2009, Middle East Journal of Scientific Research, V4, P105; Okonko IO, 2009, AFR J BIOTECHNOL, V8, P6649; Oli AN, 2010, NIGER J CLIN PRACT, V13, P409; SCHIEVE LA, 1994, AM J PUBLIC HEALTH, V84, P405, DOI 10.2105/AJPH.84.3.405; Sheiner E, 2009, J MATERN-FETAL NEO M, V22, P423, DOI 10.1080/14767050802360783; Stamm W. E., 2008, HARRISONS PRINCIPLES, P1820; Turpin Ca, 2007, Ghana Med J, V41, P26	35	14	15	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e71086	10.1371/journal.pone.0071086	http://dx.doi.org/10.1371/journal.pone.0071086			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23976983	gold, Green Published, Green Submitted			2022-12-25	WOS:000323570200024
J	Bibi, N; Parveen, Z; Rashid, S				Bibi, Nousheen; Parveen, Zahida; Rashid, Sajid			Identification of Potential Plk1 Targets in a Cell-Cycle Specific Proteome through Structural Dynamics of Kinase and Polo Box-Mediated Interactions	PLOS ONE			English	Article							KINESIN-LIKE PROTEIN; M-PHASE; DNA-DAMAGE; PHOSPHORYLATION; DOMAIN; PREDICTION; POLO-LIKE-KINASE-1; ORGANIZATION; DROSOPHILA; REGULATOR	Polo like kinase 1 (Plk1) is a key player in orchestrating the wide variety of cell-cycle events ranging from centrosome maturation, mitotic entry, checkpoint recovery, transcriptional control, spindle assembly, mitotic progression, cytokinesis and DNA damage checkpoints recovery. Due to its versatile nature, Plk1 is considered an imperative regulator to tightly control the diverse aspects of the cell cycle network. Interactions among Plk1 polo box domain (PBD) and its putative binding proteins are crucial for the activation of Plk1 kinase domain (KD). To date, only a few substrate candidates have been characterized through the inclusion of both polo box and kinase domain-mediated interactions. Thus it became compelling to explore precise and specific Plk1 substrates through reassessment and extension of the structure-function paradigm. To narrow this apparently wide gap in knowledge, here we employed a thorough sequence search of Plk1 phosphorylation signature containing proteins and explored their structure-based features like conceptual PBD-binding capabilities and subsequent recruitment of KD directed phosphorylation to dissect novel targets of Plk1. Collectively, we identified 4,521 phosphodependent proteins sharing similarity to the consensus phosphorylation and PBD recognition motifs. Subsequent application of filters including similarity index, Gene Ontology enrichment and protein localization resulted in stringent pre-filtering of irrelevant candidates and isolated unique targets with well-defined roles in cell-cycle machinery and carcinogenesis. These candidates were further refined structurally using molecular docking and dynamic simulation assays. Overall, our screening approach enables the identification of several undefined cell-cycle associated functions of Plk1 by uncovering novel phosphorylation targets.	[Bibi, Nousheen; Parveen, Zahida; Rashid, Sajid] Quaid I Azam Univ, Natl Ctr Bioinformat, Islamabad, Pakistan	Quaid I Azam University	Rashid, S (corresponding author), Quaid I Azam Univ, Natl Ctr Bioinformat, Islamabad, Pakistan.	sajidrwp@yahoo.co.uk	Rashid, Sajid/K-8640-2019		Higher Education Commission, Pakistan [20-1493/RD/09]	Higher Education Commission, Pakistan(Higher Education Commission of Pakistan)	This research was supported by Higher Education Commission, Pakistan (Grant No. 20-1493/R&D/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Archambault V, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-203; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Brennan IM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000409; Casenghi M, 2003, DEV CELL, V5, P113, DOI 10.1016/S1534-5807(03)00193-X; Cheng KY, 2003, EMBO J, V22, P5757, DOI 10.1093/emboj/cdg558; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Diella F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Donaldson MM, 2001, J CELL SCI, V114, P2357; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Dulla K, 2010, MOL CELL PROTEOMICS, V9, P1167, DOI 10.1074/mcp.M900335-MCP200; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Glover DM, 1998, GENE DEV, V12, P3777, DOI 10.1101/gad.12.24.3777; Glover DM, 2005, ONCOGENE, V24, P230, DOI 10.1038/sj.onc.1208279; Guarguaglini G, 2005, MOL BIOL CELL, V16, P1095, DOI 10.1091/mbc.E04-10-0939; HAMANAKA R, 1995, J BIOL CHEM, V270, P21086, DOI 10.1074/jbc.270.36.21086; Higgins JMG, 2010, CHROMOSOMA, V119, P137, DOI 10.1007/s00412-009-0250-4; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ivankov DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006476; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Jang YJ, 2002, J BIOL CHEM, V277, P44115, DOI 10.1074/jbc.M202172200; Jang YJ, 2002, P NATL ACAD SCI USA, V99, P1984, DOI 10.1073/pnas.042689299; Kang YH, 2006, MOL CELL, V24, P409, DOI 10.1016/j.molcel.2006.10.016; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEE KS, 1995, MOL CELL BIOL, V15, P7143; Lin CY, 2000, P NATL ACAD SCI USA, V97, P12589, DOI 10.1073/pnas.220423497; Lin HR, 2003, J BIOL CHEM, V278, P35979, DOI 10.1074/jbc.M210659200; Liu XS, 2010, PROTEIN CELL, V1, P999, DOI 10.1007/s13238-010-0131-x; Liu XQ, 2004, J CELL SCI, V117, P3233, DOI 10.1242/jcs.01173; LLAMAZARES S, 1991, GENE DEV, V5, P2153, DOI 10.1101/gad.5.12a.2153; Lowery DM, 2005, ONCOGENE, V24, P248, DOI 10.1038/sj.onc.1208280; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; Lu K P, 1995, Prog Cell Cycle Res, V1, P187; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Meng EC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-339; Milenkovic T, 2008, CANCER INFORM, V6, P257; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Motose H, 2011, PLANT J, V67, P993, DOI 10.1111/j.1365-313X.2011.04652.x; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Neef R, 2003, J CELL BIOL, V162, P863, DOI 10.1083/jcb.200306009; Nigg EA, 1998, CURR OPIN CELL BIOL, V10, P776, DOI 10.1016/S0955-0674(98)80121-X; Park JE, 2010, CELL MOL LIFE SCI, V67, P1957, DOI 10.1007/s00018-010-0279-9; Pellegrino R, 2010, HEPATOLOGY, V51, P857, DOI 10.1002/hep.23467; Rizkallah R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015928; Sakchaisri K, 2004, P NATL ACAD SCI USA, V101, P4124, DOI 10.1073/pnas.0400641101; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Santamaria A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004457; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Snead JL, 2007, CHEM BIOL, V14, P1261, DOI 10.1016/j.chembiol.2007.09.011; Song B, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-3; SUNKEL CE, 1988, J CELL SCI, V89, P25; Sutterlin C, 2001, P NATL ACAD SCI USA, V98, P9128, DOI 10.1073/pnas.161283998; Takaki T, 2008, CURR OPIN CELL BIOL, V20, P650, DOI 10.1016/j.ceb.2008.10.005; Torchala M, 2013, BIOINFORMATICS, V29, P807, DOI 10.1093/bioinformatics/btt038; Toyoshima-Morimoto F, 2001, NATURE, V410, P215, DOI 10.1038/35065617; van de Weerdt BCM, 2006, CELL CYCLE, V5, P853, DOI 10.4161/cc.5.8.2692; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Wu ST, 2008, PROTEINS, V72, P547, DOI 10.1002/prot.21945; Wykes SM, 2003, J BIOL CHEM, V278, P29471, DOI 10.1074/jbc.M304545200; Yarm FR, 2002, MOL CELL BIOL, V22, P6209, DOI 10.1128/MCB.22.17.6209-6221.2002; Yim HS, 2009, MOL CELL BIOL, V29, P2609, DOI 10.1128/MCB.01277-08; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhou FF, 2004, BIOCHEM BIOPH RES CO, V325, P1443, DOI 10.1016/j.bbrc.2004.11.001; Zhou T, 2003, DEV CELL, V5, P127, DOI 10.1016/S1534-5807(03)00186-2; Zlenko D. V., 2012, Biofizika, V57, P197	77	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e70843	10.1371/journal.pone.0070843	http://dx.doi.org/10.1371/journal.pone.0070843			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967120	Green Published, gold, Green Submitted			2022-12-25	WOS:000323378000016
J	Kohler, SJ; Kothawala, D; Futter, MN; Liungman, O; Tranvik, L				Kohler, Stephan J.; Kothawala, Dolly; Futter, Martyn N.; Liungman, Olof; Tranvik, Lars			In-Lake Processes Offset Increased Terrestrial Inputs of Dissolved Organic Carbon and Color to Lakes	PLOS ONE			English	Article							SMALL FOREST LAKES; FLUORESCENCE SPECTROSCOPY; ULTRAVIOLET ABSORBENCY; IRON CONCENTRATIONS; MATTER; CLIMATE; EXPORT; WATER; FRACTIONATION; ABSORPTION	Increased color in surface waters, or browning, can alter lake ecological function, lake thermal stratification and pose difficulties for drinking water treatment. Mechanisms suggested to cause browning include increased dissolved organic carbon (DOC) and iron concentrations, as well as a shift to more colored DOC. While browning of surface waters is widespread and well documented, little is known about why some lakes resist it. Here, we present a comprehensive study of Malaren, the third largest lake in Sweden. In Malaren, the vast majority of water and DOC enters a western lake basin, and after approximately 2.8 years, drains from an eastern basin. Despite 40 years of increased terrestrial inputs of colored substances to western lake basins, the eastern basin has resisted browning over this time period. Here we find the half-life of iron was far shorter (0.6 years) than colored organic matter (A(420); 1.7 years) and DOC as a whole (6.1 years). We found changes in filtered iron concentrations relate strongly to the observed loss of color in the western basins. In addition, we observed a substantial shift from colored DOC of terrestrial origin, to less colored autochthonous sources, with a substantial decrease in aromaticity (-17%) across the lake. We suggest that rapid losses of iron and colored DOC caused the limited browning observed in eastern lake basins. Across a wider dataset of 69 Swedish lakes, we observed greatest browning in acidic lakes with shorter retention times (< 1.5 years). These findings suggest that water residence time, along with iron, pH and colored DOC may be of central importance when modeling and projecting changes in brownification on broader spatial scales.	[Kohler, Stephan J.; Futter, Martyn N.] SLU Dept Aquat Sci & Assessment, Uppsala, Sweden; [Kothawala, Dolly; Tranvik, Lars] Evolutionary Biol Ctr, Dept Limnol, Uppsala, Sweden; [Liungman, Olof] DHI Water & Environm Pty Ltd, Sydney, NSW, Australia	Swedish University of Agricultural Sciences	Kohler, SJ (corresponding author), SLU Dept Aquat Sci & Assessment, Uppsala, Sweden.	stephan.kohler@slu.se	Futter, Martyn N/G-6238-2011; Kothawala, Dolly/J-1867-2015; Köhler, Stephan J/H-4267-2011	Futter, Martyn N/0000-0002-9789-7138; Kothawala, Dolly/0000-0002-6106-6893; Köhler, Stephan J/0000-0001-9707-9023; Tranvik, Lars J./0000-0003-3509-8266	Swedish Research Council for Environment Agricultural Sciences and Spatial Planning (FORMAS); MISTRA FutureForests program	Swedish Research Council for Environment Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); MISTRA FutureForests program	The authors thank the Swedish Research Council for Environment Agricultural Sciences and Spatial Planning (FORMAS) for funding the strong research environments project, The Color of Water. MNF was funded by the MISTRA FutureForests program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algesten G, 2004, GLOBAL CHANGE BIOL, V10, P141, DOI 10.1111/j.1365-2486.2003.00721.x; Amon RMW, 1996, GEOCHIM COSMOCHIM AC, V60, P1783, DOI 10.1016/0016-7037(96)00055-5; Angeler DG, 2010, OECOLOGIA, V164, P231, DOI 10.1007/s00442-010-1640-2; Battin TJ, 2008, NAT GEOSCI, V1, P95, DOI 10.1038/ngeo101; Battin TJ, 2009, NAT GEOSCI, V2, P598, DOI 10.1038/ngeo618; Brown A, 2004, MAR CHEM, V89, P327, DOI 10.1016/j.marchem.2004.02.016; Coble PG, 1996, MAR CHEM, V51, P325, DOI 10.1016/0304-4203(95)00062-3; Cory RM, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000343; Cory RM, 2010, LIMNOL OCEANOGR-METH, V8, P67; Doane TA, 2010, CHEMOSPHERE, V78, P1409, DOI 10.1016/j.chemosphere.2009.12.062; Erlandsson M, 2012, J ENVIRON MONITOR, V14, P2643, DOI 10.1039/c2em30266g; Freeman C, 2001, NATURE, V412, P785, DOI 10.1038/35090628; Graneli W, 1996, LIMNOL OCEANOGR, V41, P698, DOI 10.4319/lo.1996.41.4.0698; Haaland S, 2010, ENVIRON SCI TECHNOL, V44, P2975, DOI 10.1021/es903179j; Hanson PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021884; HEIKKINEN K, 1990, EARTH SURF PROCESSES, V15, P583, DOI 10.1002/esp.3290150702; Jansen B, 2003, ANAL CHIM ACTA, V498, P105, DOI 10.1016/j.aca.2003.08.054; Johansson L, 2010, AMBIO, V39, P116, DOI 10.1007/s13280-010-0019-2; Johnson RK, 1999, ENVIRON MANAGE, V23, P115, DOI 10.1007/s002679900172; Jones R, 2002, HYDROBIOLOGIA, V229, P73; Karlsson J, 2009, NATURE, V460, P506, DOI 10.1038/nature08179; Kernan M, 2010, 141 ECRC; Kopacek J, 2005, ENVIRON SCI TECHNOL, V39, P3656, DOI 10.1021/es048101a; Kothawala DN, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004441; Kritzberg ES, 2012, BIOGEOSCIENCES, V9, P1465, DOI 10.5194/bg-9-1465-2012; Laudon H, 2004, AQUAT SCI, V66, P223, DOI 10.1007/s00027-004-0700-2; Lepisto A, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003175; Liungman O, 2010, HYDRODYNAMISK MODELL, P51; Lofts S, 2008, AQUAT GEOCHEM, V14, P337, DOI 10.1007/s10498-008-9040-5; Lyven B, 2003, GEOCHIM COSMOCHIM AC, V67, P3791, DOI 10.1016/S0016-7037(03)00087-5; Maloney KO, 2005, BIOGEOCHEMISTRY, V75, P393, DOI 10.1007/s10533-005-1675-3; McKnight D.M., 1998, AQUATIC HUMIC SUBSTA, P9, DOI DOI 10.1007/978-3-662-03736-2_; McKnight DM, 2001, LIMNOL OCEANOGR, V46, P38, DOI 10.4319/lo.2001.46.1.0038; MEILI M, 1992, HYDROBIOLOGIA, V229, P23, DOI 10.1007/BF00006988; Molot LA, 1997, CAN J FISH AQUAT SCI, V54, P2789, DOI 10.1139/cjfas-54-12-2789; Monteith DT, 2007, NATURE, V450, P537, DOI 10.1038/nature06316; Neal C, 2008, AQUAT GEOCHEM, V14, P263, DOI 10.1007/s10498-008-9036-1; Parlanti E, 2000, ORG GEOCHEM, V31, P1765, DOI 10.1016/S0146-6380(00)00124-8; Pernitsky DJ, 2006, J WATER SUPPLY RES T, V55, P121; Pokrovsky OS, 2006, GEOCHIM COSMOCHIM AC, V70, P3239, DOI 10.1016/j.gca.2006.04.008; Pullin MJ, 2007, ENVIRON ENG SCI, V24, P987, DOI 10.1089/ees.2006.0040; Richardson SD, 2007, MUTAT RES-REV MUTAT, V636, P178, DOI 10.1016/j.mrrev.2007.09.001; Roulet N, 2006, NATURE, V444, P283, DOI 10.1038/444283a; SanClements MD, 2012, ENVIRON SCI TECHNOL, V46, P3212, DOI 10.1021/es204321x; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; Sjostedt CS, 2010, ENVIRON SCI TECHNOL, V44, P8587, DOI 10.1021/es102415r; SLU, 2012, WAT CHEM PHYS AN; Sobek S, 2003, GLOBAL CHANGE BIOL, V9, P630, DOI 10.1046/j.1365-2486.2003.00619.x; Tanentzap AJ, 2008, LIMNOL OCEANOGR, V53, P404, DOI 10.4319/lo.2008.53.1.0404; TRANVIK LJ, 1990, APPL ENVIRON MICROB, V56, P1672, DOI 10.1128/AEM.56.6.1672-1677.1990; Tranvik LJ, 2002, NATURE, V415, P861, DOI 10.1038/415861b; Vattenvardsforbund, 2013, DESCR JOINT WAT AUTH; von Einem J, 2010, LIMNOL OCEANOGR, V55, P920, DOI 10.4319/lo.2009.55.2.0920; von Wachenfeldt E, 2008, ECOSYSTEMS, V11, P803, DOI 10.1007/s10021-008-9162-z; Vuorenmaa J, 2006, SCI TOTAL ENVIRON, V365, P47, DOI 10.1016/j.scitotenv.2006.02.038; Wallin M, 2000, ALAREN MILJOTILLSTAN; Weishaar JL, 2003, ENVIRON SCI TECHNOL, V37, P4702, DOI 10.1021/es030360x; Zsolnay A, 1999, CHEMOSPHERE, V38, P45, DOI 10.1016/S0045-6535(98)00166-0	58	103	103	7	167	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e70598	10.1371/journal.pone.0070598	http://dx.doi.org/10.1371/journal.pone.0070598			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23976946	Green Published, Green Submitted, gold			2022-12-25	WOS:000323378000008
J	Greiner, JT; McGlathery, KJ; Gunnell, J; McKee, BA				Greiner, Jill T.; McGlathery, Karen J.; Gunnell, John; McKee, Brent A.			Seagrass Restoration Enhances "Blue Carbon" Sequestration in Coastal Waters	PLOS ONE			English	Article							SEDIMENT RETENTION; DEPOSITION; RECOVERY; PO-210; BAY	Seagrass meadows are highly productive habitats that provide important ecosystem services in the coastal zone, including carbon and nutrient sequestration. Organic carbon in seagrass sediment, known as "blue carbon," accumulates from both in situ production and sedimentation of particulate carbon from the water column. Using a large-scale restoration (>1700 ha) in the Virginia coastal bays as a model system, we evaluated the role of seagrass, Zostera marina, restoration in carbon storage in sediments of shallow coastal ecosystems. Sediments of replicate seagrass meadows representing different age treatments (as time since seeding: 0, 4, and 10 years), were analyzed for % carbon, % nitrogen, bulk density, organic matter content, and Pb-210 for dating at 1-cm increments to a depth of 10 cm. Sediment nutrient and organic content, and carbon accumulation rates were higher in 10-year seagrass meadows relative to 4-year and bare sediment. These differences were consistent with higher shoot density in the older meadow. Carbon accumulation rates determined for the 10-year restored seagrass meadows were 36.68 g C m(-2) yr(-1). Within 12 years of seeding, the restored seagrass meadows are expected to accumulate carbon at a rate that is comparable to measured ranges in natural seagrass meadows. This the first study to provide evidence of the potential of seagrass habitat restoration to enhance carbon sequestration in the coastal zone.	[Greiner, Jill T.; McGlathery, Karen J.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA; [Gunnell, John; McKee, Brent A.] Univ N Carolina, Dept Marine Sci, Chapel Hill, NC USA	University of Virginia; University of North Carolina; University of North Carolina Chapel Hill	Greiner, JT (corresponding author), Univ Virginia, Dept Environm Sci, Clark Hall, Charlottesville, VA 22903 USA.	jtg3pm@virginia.edu			National Science Foundation [DEB-0621014, DEB-1237733]; Department of Environmental Sciences at the University of Virginia; University of Virginia Library Open Access Fund; Direct For Biological Sciences [1237733] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Department of Environmental Sciences at the University of Virginia; University of Virginia Library Open Access Fund; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for this study was provided by the National Science Foundation grant DEB-0621014 and DEB-1237733 to the Virginia Coast Reserve LTER project and from the Department of Environmental Sciences at the University of Virginia. This article was published in part thanks to funds provided by the University of Virginia Library Open Access Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agawin NSR, 2002, ESTUARIES, V25, P1205, DOI 10.1007/BF02692217; Appleby PG, 2002, DEV PALEOENVIRON RES, V1, P171; Cottam C, 1934, RHODORA, V33, P261; de Vleeschouwer F, 2010, GEOCHRONOMETRIA, V36, P1, DOI 10.2478/v10003-010-0013-5; Duarte CM, 2005, BIOGEOSCIENCES, V2, P1, DOI 10.5194/bg-2-1-2005; Duarte CM, 2010, GLOBAL BIOGEOCHEM CY, V42; ELDAOUSHY F, 1991, HYDROBIOLOGIA, V214, P43, DOI 10.1007/BF00050930; Fourqurean JW, 2012, NAT GEOSCI, V5, P505, DOI 10.1038/ngeo1477; Gacia E, 2002, LIMNOL OCEANOGR, V47, P23, DOI 10.4319/lo.2002.47.1.0023; Gacia E, 2001, ESTUAR COAST SHELF S, V52, P505, DOI 10.1006/ecss.2000.0753; Gacia E, 1999, AQUAT BOT, V65, P255, DOI 10.1016/S0304-3770(99)00044-3; Hakanson L, 2008, OCEAN COAST MANAGE, V51, P671, DOI 10.1016/j.ocecoaman.2008.07.003; Hansen JCR, 2013, ESTUAR COAST, V36, P1099, DOI 10.1007/s12237-013-9620-5; Hansen JCR, 2012, MAR ECOL PROG SER, V448, P271, DOI 10.3354/meps09225; Hemminga M.A., 2000, SEAGRASS ECOLOGY, DOI [10.1017/CBO9780511525551, DOI 10.1017/CBO9780511525551]; Kennedy H, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003848; Kolker AS, 2009, ESTUAR COAST SHELF S, V84, P493, DOI 10.1016/j.ecss.2009.06.030; Mateo MA, 1997, ESTUAR COAST SHELF S, V44, P103, DOI 10.1006/ecss.1996.0116; Mateo MA, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P159; Matthews KM, 2007, APPL RADIAT ISOTOPES, V65, P267, DOI 10.1016/j.apradiso.2006.09.005; McGlathery KJ, 2012, MAR ECOL PROG SER, V448, P209, DOI 10.3354/meps09574; McGlathery KJ, 2001, MAR ECOL PROG SER, V216, P1, DOI 10.3354/meps216001; Mckee KL, 2007, GLOBAL ECOL BIOGEOGR, V16, P545, DOI 10.1111/j.1466-8238.2007.00317.x; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; Nellemann C, 2009, BLUE CARBON ROLE HLT; Orem WH, 1999, J COASTAL RES, V15, P1055; Orth RJ, 2006, AQUAT BOT, V84, P26, DOI 10.1016/j.aquabot.2005.07.007; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Orth RJ, 2012, MAR ECOL PROG SER, V448, P177, DOI 10.3354/meps09522; Pendleton L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043542; RASMUSSEN E, 1977, SEAGRASS ECOSYSTEMS, P00001; Schlesinger WH, 2001, NATURE, V411, P466, DOI 10.1038/35078060; Townsend EC, 1998, MAR ECOL PROG SER, V169, P123, DOI 10.3354/meps169123; United States Government, 2010, TECHN SUPP DOC SOC C, P12866; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106	35	157	166	14	219	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e72469	10.1371/journal.pone.0072469	http://dx.doi.org/10.1371/journal.pone.0072469			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967303	Green Published, gold			2022-12-25	WOS:000323221500133
J	Moncunill, G; Mayor, A; Bardaji, A; Puyol, L; Nhabomba, A; Barrios, D; Aguilar, R; Pinazo, MJ; Almirall, M; Soler, C; Munoz, J; Gascon, J; Dobano, C				Moncunill, Gemma; Mayor, Alfredo; Bardaji, Azucena; Puyol, Laura; Nhabomba, Augusto; Barrios, Diana; Aguilar, Ruth; Pinazo, Maria-Jesus; Almirall, Merce; Soler, Cristina; Munoz, Jose; Gascon, Joaquim; Dobano, Carlota			Cytokine Profiling in Immigrants with Clinical Malaria after Extended Periods of Interrupted Exposure to Plasmodium falciparum	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; IMMUNE-RESPONSES; IMPORTED MALARIA; ENDEMIC AREAS; CHILDREN; TRANSMISSION; ANTIBODIES; ADULTS; GLYCOSYLPHOSPHATIDYLINOSITOLS; ASSOCIATION	Immunity to malaria is believed to wane with time in the absence of exposure to Plasmodium falciparum infection, but immunoepidemiological data on longevity of immunity remain controversial. We quantified serum cytokines and chemokines by suspension array technology as potential biomarkers for durability of immunity in immigrants with clinical malaria after years without parasite exposure. These were compared to serum/plasma profiles in naive adults (travelers) and semi-immune adults under continuous exposure, with malaria, along with immigrant and traveler patients without malaria. Immigrants had higher levels of IL-2, IL-5 and IL-8 compared to semi-immune adults with malaria (P <= 0.0200). Time since immigration correlated with increased IL-2 (rho=0.2738P=0.0495) and IFN-gamma (rho=0.3044P=0.0282). However, immigrants did not show as high IFN-gamma concentrations as travelers during a first malaria episode (P<0.0001). Immigrants and travelers with malaria had higher levels of IFN-gamma, IL-6, and IL-10 (P<0.0100) than patients with other diseases, and IL-8 and IL-1 beta were elevated in immigrants with malaria (P<0.0500). Therefore, malaria patients had a characteristic strong pro-inflammatory/Th1 signature. Upon loss of exposure, control of pro-inflammatory responses and tolerance to P. falciparum appeared to be reduced. Understanding the mechanisms to maintain non-pathogenic effector responses is important to develop new malaria control strategies.	[Moncunill, Gemma; Mayor, Alfredo; Bardaji, Azucena; Puyol, Laura; Barrios, Diana; Aguilar, Ruth; Pinazo, Maria-Jesus; Munoz, Jose; Gascon, Joaquim; Dobano, Carlota] Univ Barcelona, Hosp Clin, CRESIB, Barcelona Ctr Int Hlth Res, Barcelona, Catalonia, Spain; [Mayor, Alfredo; Nhabomba, Augusto; Aguilar, Ruth; Dobano, Carlota] Ctr Invest Saude Manhica, Maputo, Mozambique; [Almirall, Merce] Hosp Arnau Vilanova, Lleida, Catalonia, Spain; [Soler, Cristina] Hosp Santa Caterina de Salt, Girona, Catalonia, Spain	ISGlobal; CRESIB; University of Barcelona; Centro de Investigacao em Saude de Manhica; University Hospital Arnau de Vilanova	Moncunill, G (corresponding author), Univ Barcelona, Hosp Clin, CRESIB, Barcelona Ctr Int Hlth Res, Barcelona, Catalonia, Spain.	gemma.moncunill@cresib.cat	Aguilar, Ruth/D-2147-2018; Barrios-Rodríguez, Diana/D-3910-2018; Mayor, Alfredo/H-7488-2017; Gutiérrez, José/GSJ-1846-2022; Bardají, Azucena/AAE-9145-2019; Alonso, Azucena Bardají/V-5978-2018; Dobaño, Carlota/N-4119-2014; Delgado, Maria Jesús Pinazo/X-6093-2018; Gascon, Joaquim/M-3598-2015; Moncunill, Gemma/B-7989-2011; Gutierrez, Jose Muñoz/AAH-6954-2020; Gutiérrez, Jose Muñoz/X-5917-2018	Aguilar, Ruth/0000-0003-3277-3107; Barrios-Rodríguez, Diana/0000-0001-9929-5707; Mayor, Alfredo/0000-0003-3890-2897; Alonso, Azucena Bardají/0000-0002-5135-0540; Dobaño, Carlota/0000-0002-6751-4060; Delgado, Maria Jesús Pinazo/0000-0002-4237-1075; Gascon, Joaquim/0000-0002-5045-1585; Moncunill, Gemma/0000-0001-5105-9836; Gutierrez, Jose Muñoz/0000-0002-0945-1735; Gutiérrez, Jose Muñoz/0000-0002-0945-1735; Fernandez, Ivette/0000-0001-5179-0477; Puyol, Laura/0000-0003-2840-7753	Ministerio de Ciencia e Innovacion [SAF2008-00743, RYC-2008-02631]; Agencia de Gestio d'Ajuts Universitaris i de Recerca [2009SGR934, 2009SGR385]; Instituto de Salud Carlos III [PI050275, PS0901113, CD10/00156, CP-4/00220]; Fundacion Ramon Areces	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Agencia de Gestio d'Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacion Ramon Areces	The study received financial support from the Ministerio de Ciencia e Innovacion (SAF2008-00743, salary support RYC-2008-02631 to C. D.); the Agencia de Gestio d'Ajuts Universitaris i de Recerca (2009SGR934, 2009SGR385); the Instituto de Salud Carlos III (PI050275, PS0901113, salary support CD10/00156 to G. M., CP-4/00220 to A. M.), and the Fundacion Ramon Areces. The Centro de Investigacao em Sa de de Manhica receives core support from the Spanish Agency for International Cooperation and Development (AECID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthoud TK, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-115; Bouchaud O, 2005, AM J TROP MED HYG, V72, P21, DOI 10.4269/ajtmh.2005.72.21; Boutlis CS, 2006, TRENDS PARASITOL, V22, P371, DOI 10.1016/j.pt.2006.06.002; Boutlis CS, 2002, INFECT IMMUN, V70, P5052, DOI 10.1128/IAI.70.9.5052-5057.2002; Clark IA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-85; Day NPJ, 1999, J INFECT DIS, V180, P1288, DOI 10.1086/315016; de Jager W, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-52; de Souza JB, 2002, INFECT IMMUN, V70, P5045, DOI 10.1128/IAI.70.9.5045-5051.2002; DELORON P, 1992, PARASITOL TODAY, V8, P375, DOI 10.1016/0169-4758(92)90174-Z; Dodoo D, 2002, J INFECT DIS, V185, P971, DOI 10.1086/339408; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Jelinek T, 2002, CLIN INFECT DIS, V34, P572, DOI 10.1086/338235; Jennings RM, 2006, AM J TROP MED HYG, V75, P1195, DOI 10.4269/ajtmh.2006.75.1195; Kleinschmidt I, 2001, TROP MED INT HEALTH, V6, P986, DOI 10.1046/j.1365-3156.2001.00817.x; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Luxemburger C, 1997, T ROY SOC TROP MED H, V91, P256, DOI 10.1016/S0035-9203(97)90066-3; Lyke KE, 2004, INFECT IMMUN, V72, P5630, DOI 10.1128/IAI.72.10.5630-5637.2004; MacMullin G, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-148; MANTOVANI A, 1992, FASEB J, V6, P2591, DOI 10.1096/fasebj.6.8.1592209; Mascarello M, 2008, J TRAVEL MED, V15, P229, DOI 10.1111/j.1708-8305.2008.00204.x; Matteelli A, 1999, TROP MED INT HEALTH, V4, P653, DOI 10.1046/j.1365-3156.1999.00468.x; Mayor A, 2009, INFECT IMMUN, V77, P3857, DOI 10.1128/IAI.00049-09; McCall MBB, 2010, J LEUKOCYTE BIOL, V88, P1131, DOI 10.1189/jlb.0310137; Migot F, 1995, CLIN EXP IMMUNOL, V102, P529; MIGOT F, 1993, AM J TROP MED HYG, V48, P432, DOI 10.4269/ajtmh.1993.48.432; Moncunill G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073624; Moncunill G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055756; Monge-Maillo B, 2012, EMERG INFECT DIS, V18, P356, DOI [10.3201/eid1802.111283, 10.3201/eid1801.111283]; Netea MG, 2000, CLIN INFECT DIS, V31, pS178, DOI 10.1086/317513; Prakash D, 2006, J INFECT DIS, V194, P198, DOI 10.1086/504720; Robinson LJ, 2009, INFECT IMMUN, V77, P3033, DOI 10.1128/IAI.00211-09; Rovira-Vallbona E, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-181; Salvado E, 2008, ENFERM INFEC MICR CL, V26, P282, DOI 10.1157/13120415; Skogstrand K, 2012, METHODS, V56, P204, DOI 10.1016/j.ymeth.2011.09.025; Spence PJ, 2012, CURR TOP MICROBIOL I, V355, P3; Teirlinck AC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002389; Torre D, 2002, CLIN DIAGN LAB IMMUN, V9, P348, DOI 10.1128/CDLI.9.2.348-351.2002; Walther M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000364; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Wipasa J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001281; Wipasa J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000770	41	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e73360	10.1371/journal.pone.0073360	http://dx.doi.org/10.1371/journal.pone.0073360			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967342	Green Published, Green Submitted, gold			2022-12-25	WOS:000323221500146
J	Munro, TA; Huang, XP; Inglese, C; Perrone, MG; Van't Veer, A; Carroll, FI; Beguin, C; Carlezon, WA; Colabufo, NA; Cohen, BM; Roth, BL				Munro, Thomas A.; Huang, Xi-Ping; Inglese, Carmela; Perrone, Maria Grazia; Van't Veer, Ashlee; Carroll, F. Ivy; Beguin, Cecile; Carlezon, William A., Jr.; Colabufo, Nicola A.; Cohen, Bruce M.; Roth, Bryan L.			Selective kappa Opioid Antagonists nor-BNI, GNTI and JDTic Have Low Affinities for Non-Opioid Receptors and Transporters	PLOS ONE			English	Article							NOCICEPTIN/ORPHANIN FQ RECEPTOR; ALLOSTERIC MODULATION; P-GLYCOPROTEIN; SPINAL-CORD; IN-VITRO; MICE; LIGANDS; SITE; BINALTORPHIMINE; AGONISTS	Background: Nor-BNI, GNTI and JDTic induce selective kappa opioid antagonism that is delayed and extremely prolonged, but some other effects are of rapid onset and brief duration. The transient effects of these compounds differ, suggesting that some of them may be mediated by other targets. Results: In binding assays, the three antagonists showed no detectable affinity (K-i >= 10 mu M) for most non-opioid receptors and transporters (26 of 43 tested). There was no non-opioid target for which all three compounds shared detectable affinity, or for which any two shared sub-micromolar affinity. All three compounds showed low nanomolar affinity for kappa opioid receptors, with moderate selectivity over mu and delta (3 to 44-fold). Nor-BNI bound weakly to the alpha(2C)-adrenoceptor (K-i = 630 nM). GNTI enhanced calcium mobilization by noradrenaline at the alpha(1A)-adrenoceptor (EC50 = 41 nM), but did not activate the receptor, displace radioligands, or enhance PI hydrolysis. This suggests that it is a functionally-selective allosteric enhancer. GNTI was also a weak M-1 receptor antagonist (K-B = 3.7 mu M). JDTic bound to the noradrenaline transporter (K-i = 54 nM), but only weakly inhibited transport (IC50 = 1.1 mu M). JDTic also bound to the opioid-like receptor NOP (K-i = 12 nM), but gave little antagonism even at 30 mu M. All three compounds exhibited rapid permeation and active efflux across Caco-2 cell monolayers. Conclusions: Across 43 non-opioid CNS targets, only GNTI exhibited a potent functional effect (allosteric enhancement of alpha(1A)-adrenoceptors). This may contribute to GNTI's severe transient effects. Plasma concentrations of nor-BNI and GNTI may be high enough to affect some peripheral non-opioid targets. Nonetheless, kappa opioid antagonism persists for weeks or months after these transient effects dissipate. With an adequate pre-administration interval, our results therefore strengthen the evidence that nor-BNI, GNTI and JDTic are highly selective kappa opioid antagonists.	[Munro, Thomas A.; Van't Veer, Ashlee; Beguin, Cecile; Carlezon, William A., Jr.; Cohen, Bruce M.] McLean Hosp, Belmont, MA 02178 USA; [Munro, Thomas A.; Van't Veer, Ashlee; Beguin, Cecile; Carlezon, William A., Jr.; Cohen, Bruce M.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Munro, Thomas A.] Univ Melbourne, Sch Chem, Parkville, Vic 3052, Australia; [Munro, Thomas A.] Univ Melbourne, Inst Bio21, Parkville, Vic 3052, Australia; [Huang, Xi-Ping; Roth, Bryan L.] Univ N Carolina, Sch Med, Natl Inst Mental Hlth Psychoact Drug Screening Pr, Chapel Hill, NC USA; [Huang, Xi-Ping; Roth, Bryan L.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC USA; [Inglese, Carmela; Perrone, Maria Grazia; Colabufo, Nicola A.] Univ Bari, Dipartimento Farm Sci Farmaco, Bari, Italy; [Carroll, F. Ivy] Res Triangle Inst, Ctr Organ & Med Chem, Res Triangle Pk, NC 27709 USA	Harvard University; McLean Hospital; Harvard University; Harvard Medical School; University of Melbourne; University of Melbourne; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Universita degli Studi di Bari Aldo Moro; Research Triangle Institute	Munro, TA (corresponding author), McLean Hosp, 115 Mill St, Belmont, MA 02178 USA.	thomas@munro.com	Van't Veer, Ashlee/GOV-5648-2022; Munro, Thomas Anthony/B-2712-2009; Roth, Bryan/ABE-7032-2020; Roth, Bryan L/F-3928-2010; Cohen, Bruce M./AAZ-4986-2020	Van't Veer, Ashlee/0000-0003-4920-447X; Munro, Thomas Anthony/0000-0002-3366-7149; Roth, Bryan/0000-0002-0561-6520; Huang, Xi-Ping/0000-0002-2585-653X; /0000-0002-4162-3947; Perrone, Maria Grazia/0000-0003-4195-5228	National Institute of Mental Health; National Institute of Drug Abuse [DA09045, DA030586]; Department of Defense (National Defense Science and Engineering Graduate Fellowship); Ministero dell'Istruzione, dell'Universita e della Ricerca, Italy (MIUR) [PRIN 20097FJHPZ-001]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020017, R01MH063266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA009045, R03DA030586] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Department of Defense (National Defense Science and Engineering Graduate Fellowship)(United States Department of Defense); Ministero dell'Istruzione, dell'Universita e della Ricerca, Italy (MIUR); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding was provided by: the National Institute of Mental Health (Psychoactive Drug Screening Program, administered by BLR); National Institute of Drug Abuse (DA09045 to FIC and DA030586 to WAC); Department of Defense (National Defense Science and Engineering Graduate Fellowship to AVV); and Ministero dell'Istruzione, dell'Universita e della Ricerca, Italy (MIUR, PRIN 20097FJHPZ-001 to NAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artursson P, 2001, ADV DRUG DELIVER REV, V46, P27, DOI 10.1016/S0169-409X(00)00128-9; Beguin Cecile, 2009, P99, DOI 10.1007/978-1-59745-197-0_6; Besnard J, 2012, NATURE, V492, P215, DOI 10.1038/nature11691; BRAUDE M C, 1976, National Institute on Drug Abuse Research Monograph, V9, P16; Bruchas MR, 2007, J BIOL CHEM, V282, P29803, DOI 10.1074/jbc.M705540200; Carlezon WA, 2009, PHARMACOL THERAPEUT, V123, P334, DOI 10.1016/j.pharmthera.2009.05.008; Casal-Dominguez JJ, 2013, J PSYCHOPHARMACOL, V27, P192, DOI 10.1177/0269881112464828; Colabufo NA, 2010, J MED CHEM, V53, P1883, DOI 10.1021/jm900743c; Copik AJ, 2009, MOL PHARMACOL, V75, P713, DOI 10.1124/mol.108.050765; Cowan Alan, 2009, P541, DOI 10.1007/978-1-59745-197-0_28; Doan KMM, 2002, J PHARMACOL EXP THER, V303, P1029, DOI 10.1124/jpet.102.039255; Docherty JR, 2010, CELL MOL LIFE SCI, V67, P405, DOI 10.1007/s00018-009-0174-4; ENDOH T, 1992, ARCH INT PHARMACOD T, V316, P30; Evans BA, 2011, MOL PHARMACOL, V79, P298, DOI 10.1124/mol.110.067454; Evans SJ, 2000, ENDOCRINOLOGY, V141, P2294, DOI 10.1210/en.141.7.2294; Figueroa KW, 2009, J PHARMACOL EXP THER, V328, P331, DOI 10.1124/jpet.108.145219; Gotoh Y, 2011, NEUROPHARMACOLOGY, V61, P825, DOI 10.1016/j.neuropharm.2011.05.030; Heusinkveld HJ, 2011, TOXICOL APPL PHARM, V255, P1, DOI 10.1016/j.taap.2011.05.020; Hidalgo Ismael J., 2001, Current Topics in Medicinal Chemistry, V1, P385, DOI 10.2174/1568026013395010; HORAN P, 1992, J PHARMACOL EXP THER, V260, P1237; Inan S, 2009, NEUROSCIENCE, V163, P23, DOI 10.1016/j.neuroscience.2009.06.016; Inan S, 2010, THESIS TEMPLE U PHIL; Inan S, 2011, PEPTIDES, V32, P286, DOI 10.1016/j.peptides.2010.11.022; Inan S, 2009, EUR J PHARMACOL, V616, P141, DOI 10.1016/j.ejphar.2009.06.026; Jewett DC, 2001, BRAIN RES, V909, P75, DOI 10.1016/S0006-8993(01)02624-5; Jorgensen S, 2008, J NEUROSCI METH, V169, P168, DOI 10.1016/j.jneumeth.2007.12.004; Kamei J, 2001, EUR J PHARMACOL, V418, P141, DOI 10.1016/S0014-2999(01)00941-4; Kanaan M, 2009, FUND CLIN PHARMACOL, V23, P543, DOI 10.1111/j.1472-8206.2009.00724.x; Kimple AJ, 2009, J BIOL CHEM, V284, P19402, DOI 10.1074/jbc.M109.024711; Knoll AT, 2010, BRAIN RES, V1314, P56, DOI 10.1016/j.brainres.2009.09.074; Kusaka T, 2001, BIOL PHARM BULL, V24, P902, DOI 10.1248/bpb.24.902; Leppik RA, 2000, MOL PHARMACOL, V57, P436, DOI 10.1124/mol.57.3.436; Leventhal L, 1996, PHYSIOL BEHAV, V60, P833, DOI 10.1016/0031-9384(96)00103-5; LEVINE AS, 1990, BRAIN RES, V534, P60, DOI 10.1016/0006-8993(90)90112-O; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; Melief EJ, 2011, MOL PHARMACOL, V80, P920, DOI 10.1124/mol.111.074195; Meng F, 1996, J BIOL CHEM, V271, P32016, DOI 10.1074/jbc.271.50.32016; Metcalf MD, 2005, AAPS J, V7, pE704, DOI 10.1208/aapsj070371; Munro Thomas A., 2012, BMC Pharmacology, V12, P5, DOI 10.1186/1471-2210-12-5; National Institute of Mental Health, 2008, NIMH PSYCH DRUG SCRE; Need A, 2008, THESIS INDIANA U IND; Negus SS, 2002, PSYCHOPHARMACOLOGY, V163, P412, DOI 10.1007/s00213-002-1038-x; Perez DM, 2007, BIOCHEM PHARMACOL, V73, P1051, DOI 10.1016/j.bcp.2006.09.010; Plenge P, 1997, PHARMACOL TOXICOL, V80, P197, DOI 10.1111/j.1600-0773.1997.tb00396.x; Potter DN, 2011, BIOL PSYCHIAT, V70, P744, DOI 10.1016/j.biopsych.2011.05.021; Qi CT, 2006, ACTA PHARMACOL SIN, V27, P1401, DOI 10.1111/j.1745-7254.2006.00448.x; RAFFA RB, 1987, LIFE SCI, V41, P1831, DOI 10.1016/0024-3205(87)90702-8; Ragnarsson L, 2013, J BIOL CHEM, V288, P1814, DOI 10.1074/jbc.M112.430785; Schank JR, 2012, ADDICT BIOL, V17, P634, DOI 10.1111/j.1369-1600.2012.00455.x; SCOTT RW, 1987, PHARMACOL BIOCHEM BE, V26, P327, DOI 10.1016/0091-3057(87)90126-2; SHUKLA VK, 1993, EUR J PHARMACOL, V231, P293, DOI 10.1016/0014-2999(93)90463-R; Smith NJ, 2010, PHARMACOL REV, V62, P701, DOI 10.1124/pr.110.002667; Spagnolo B, 2007, J PHARMACOL EXP THER, V321, P961, DOI 10.1124/jpet.106.116764; SUKUL NC, 1988, PHARMACOL BIOCHEM BE, V31, P87, DOI 10.1016/0091-3057(88)90316-4; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; Voorn P, 2007, NEUROSCI LETT, V415, P55, DOI 10.1016/j.neulet.2006.12.041; Wakimoto T, 2009, BIOORG MED CHEM LETT, V19, P5905, DOI 10.1016/j.bmcl.2009.08.068; Waugh DJJ, 1999, J PHARMACOL EXP THER, V291, P1164; Wellman PJ, 2000, NUTRITION, V16, P837, DOI 10.1016/S0899-9007(00)00415-9; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939	60	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e70701	10.1371/journal.pone.0070701	http://dx.doi.org/10.1371/journal.pone.0070701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23976952	Green Submitted, Green Published, gold			2022-12-25	WOS:000323221500024
J	Saito, K; Inagaki, K; Kamimoto, T; Ito, Y; Sugita, T; Nakajo, S; Hirasawa, A; Iwamaru, A; Ishikura, T; Hanaoka, H; Okubo, K; Onozaki, T; Zama, T				Saito, Koichiro; Inagaki, Koji; Kamimoto, Takahiro; Ito, Yoko; Sugita, Toshiaki; Nakajo, Satoko; Hirasawa, Akira; Iwamaru, Arifumi; Ishikura, Takashi; Hanaoka, Hideki; Okubo, Keisuke; Onozaki, Tokio; Zama, Takeru			MicroRNA-196a Is a Putative Diagnostic Biomarker and Therapeutic Target for Laryngeal Cancer	PLOS ONE			English	Article							DOWN-REGULATION; COLORECTAL-CANCER; MESSENGER-RNAS; EXPRESSION; GENES; SIGNATURES; GROWTH; DEREGULATION; BIOGENESIS; MECHANISM	Background: MicroRNA (miRNA) is an emerging subclass of small non-coding RNAs that regulates gene expression and has a pivotal role for many physiological processes including cancer development. Recent reports revealed the role of miRNAs as ideal biomarkers and therapeutic targets due to their tissue-or disease-specific nature. Head and neck cancer (HNC) is a major cause of cancer-related mortality and morbidity, and laryngeal cancer has the highest incidence in it. However, the molecular mechanisms involved in laryngeal cancer development remain to be known and highly sensitive biomarkers and novel promising therapy is necessary. Methodology/Principal Findings: To explore laryngeal cancer-specific miRNAs, RNA from 5 laryngeal surgical specimens including cancer and non-cancer tissues were hybridized to microarray carrying 723 human miRNAs. The resultant differentially expressed miRNAs were further tested by using quantitative real time PCR (qRT-PCR) on 43 laryngeal tissue samples including cancers, noncancerous counterparts, benign diseases and precancerous dysplasias. Significant expressional differences between matched pairs were reproduced in miR-133b, miR-455-5p, and miR-196a, among which miR-196a being the most promising cancer biomarker as validated by qRT-PCR analyses on additional 84 tissue samples. Deep sequencing analysis revealed both quantitative and qualitative deviation of miR-196a isomiR expression in laryngeal cancer. In situ hybridization confirmed laryngeal cancer-specific expression of miR-196a in both cancer and cancer stroma cells. Finally, inhibition of miR-196a counteracted cancer cell proliferation in both laryngeal cancer-derived cells and mouse xenograft model. Conclusions/Significance: Our study provided the possibilities that miR-196a might be very useful in diagnosing and treating laryngeal cancer.	[Saito, Koichiro; Inagaki, Koji; Kamimoto, Takahiro; Iwamaru, Arifumi; Zama, Takeru] Keio Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Tokyo, Japan; [Ito, Yoko; Sugita, Toshiaki; Nakajo, Satoko] SRL Inc, Ctr Genet & Chromosomal Anal, Genet Testing Sect, Tokyo, Japan; [Hirasawa, Akira] Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 160, Japan; [Iwamaru, Arifumi] Federat Natl Publ Serv Personnel Mutual Aid Assoc, Dept Surg, Tokyo, Japan; [Ishikura, Takashi; Hanaoka, Hideki; Onozaki, Tokio] Life Technol Japan, Tokyo, Japan; [Okubo, Keisuke] Sano Kousei Gen Hosp, Dept Otolaryngol, Sano, Tochigi, Japan	Keio University; SRL Inc.; Keio University; Thermo Fisher Scientific	Zama, T (corresponding author), Keio Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Tokyo, Japan.	tzama-kei@umin.ac.jp		Saito, Koichiro/0000-0002-8107-2967	New Energy and Industrial Technology Development Organization (NEDO)	New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO))	A part of this work was supported by a Grant for Industrial Technology Research of the New Energy and Industrial Technology Development Organization (NEDO; http://www.nedo.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abella V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052568; Akao Y, 2007, CANCER SCI, V98, P1914, DOI 10.1111/j.1349-7006.2007.00618.x; Akao Y, 2007, DNA CELL BIOL, V26, P311, DOI 10.1089/dna.2006.0550; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Bandres E, 2007, DNA CELL BIOL, V26, P273, DOI 10.1089/dna.2006.0544; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Burmistrova OA, 2007, BIOCHEMISTRY-MOSCOW+, V72, P578, DOI 10.1134/S0006297907050161; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cao PY, 2013, HEAD NECK-J SCI SPEC, V35, P720, DOI 10.1002/hed.23011; Carvalho AL, 2005, INT J CANCER, V114, P806, DOI 10.1002/ijc.20740; Chang SS, 2008, INT J CANCER, V123, P2791, DOI 10.1002/ijc.23831; Chang TC, 2007, ANNU REV GENOM HUM G, V8, P215, DOI 10.1146/annurev.genom.8.080706.092351; Chen HC, 2009, BRIT J CANCER, V100, P1002, DOI 10.1038/sj.bjc.6604948; Chen KN, 2005, CLIN CANCER RES, V11, P1044; Coskun E, LEUK RES; de Carcer G, 2007, CURR MED CHEM, V14, P969, DOI 10.2174/092986707780362925; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fish JE, 2009, SCI SIGNAL, V1, DOI 10.1126/scisignal.252pe1; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Gregersen LH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008836; Guled M, 2009, GENE CHROMOSOME CANC, V48, P615, DOI 10.1002/gcc.20669; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Hiroki E, 2009, CANC SCI; Hiyoshi Y, 2009, CLIN CANCER RES, V15, P1915, DOI 10.1158/1078-0432.CCR-08-2545; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Hui ABY, 2009, LAB INVEST, V89, P597, DOI 10.1038/labinvest.2009.12; Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559; Ichimi T, 2009, INT J CANCER, V125, P345, DOI 10.1002/ijc.24390; Iekushi K, 2012, CIRCULATION, V125, P1765, DOI 10.1161/CIRCULATIONAHA.111.079699; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Isenberg JS, 2008, ANN OTO RHINOL LARYN, V117, P74, DOI 10.1177/000348940811700114; Izzotti A, 2009, FASEB J, V23, P806, DOI 10.1096/fj.08-121384; Jemal A, 2002, CA-CANCER J CLIN, V52, P23, DOI 10.3322/canjclin.52.1.23; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; KANO M, INT J CANC; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kim YJ, 2009, J BONE MINER RES, V24, P816, DOI 10.1359/JBMR.081230; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Li C, 2009, AAPS J; Li JH, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-36; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu X, 2009, CLIN CANCER RES, V15, P1177, DOI 10.1158/1078-0432.CCR-08-1355; Liu X, 2008, BRAIN PATHOL, V18, P113, DOI 10.1111/j.1750-3639.2007.00121.x; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luthra R, 2008, ONCOGENE, V27, P6667, DOI 10.1038/onc.2008.256; Mercatelli N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004029; MILLS GB, 1992, J BIOL CHEM, V267, P16000; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Ng EKO, 2009, BRIT J CANCER, V101, P699, DOI 10.1038/sj.bjc.6605195; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Schimanski CC, 2009, WORLD J GASTROENTERO, V15, P2089, DOI 10.3748/wjg.15.2089; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Suda T, 2007, CANC SCI; Szafranska AE, 2007, ONCOGENE, V26, P4442, DOI 10.1038/sj.onc.1210228; Takagi T, 2009, ONCOLOGY-BASEL, V77, P12, DOI 10.1159/000218166; Takahashi O, 2007, ONCOL REP, V17, P753; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Tie J, PLOS GEN, V6; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vermeulen A, 2007, RNA, V13, P723, DOI 10.1261/rna.448107; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang H, 2007, RNA, V13, P151, DOI 10.1261/rna.234507; Wang YF, 2009, J BIOL CHEM, V284, P23094, DOI 10.1074/jbc.M109.012617; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Wu H, 2009, EXPERT OPIN THER TAR; Wynter CVA, 2006, MED HYPOTHESES, V66, P612, DOI 10.1016/j.mehy.2005.10.024; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yuan BB, 2006, CLIN CANCER RES, V12, P405, DOI 10.1158/1078-0432.CCR-05-0903; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang BH, 2007, J CELL PHYSIOL, V210, P279, DOI 10.1002/jcp.20869; Zorn KK, 2003, CLIN CANCER RES, V9, P4811	81	66	68	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71480	10.1371/journal.pone.0071480	http://dx.doi.org/10.1371/journal.pone.0071480			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967217	gold, Green Published, Green Submitted			2022-12-25	WOS:000323221500087
J	Starke, RM; Ali, MS; Jabbour, PM; Tjoumakaris, SI; Gonzalez, F; Hasan, DM; Rosenwasser, RH; Owens, GK; Koch, WJ; Dumont, AS				Starke, Robert M.; Ali, Muhammad S.; Jabbour, Pascal M.; Tjoumakaris, Stavropoula I.; Gonzalez, Fernando; Hasan, David M.; Rosenwasser, Robert H.; Owens, Gary K.; Koch, Walter J.; Dumont, Aaron S.			Cigarette Smoke Modulates Vascular Smooth Muscle Phenotype: Implications for Carotid and Cerebrovascular Disease	PLOS ONE			English	Article							CELL DIFFERENTIATION; PASSIVE SMOKING; ISCHEMIC-STROKE; TOBACCO-SMOKE; RISK-FACTORS; EXPRESSION; ATHEROSCLEROSIS; INFLAMMATION; CORONARY; EXPOSURE	Background: The role of smooth muscle cell (SMC) phenotypic modulation in the cerebral circulation and pathogenesis of stroke has not been determined. Cigarette smoke is a major risk factor for atherosclerosis, but potential mechanisms are unclear, and its role in SMC phenotypic modulation has not been established. Methods and Results: In cultured cerebral vascular SMCs, exposure to cigarette smoke extract (CSE) resulted in decreased promoter activity and mRNA expression of key SMC contractile genes (SM-alpha-actin, SM-22 alpha, SM-MHC) and the transcription factor myocardin in a dose-dependent manner. CSE also induced pro-inflammatory/matrix remodeling genes (MCP-1, MMPs, TNF-alpha, IL-1 beta, NF-kappa B). CSE increased expression of KLF4, a known regulator of SMC differentiation, and siKLF4 inhibited CSE induced suppression of SMC contractile genes and myocardin and activation of inflammatory genes. These mechanisms were confirmed in vivo following exposure of rat carotid arteries to CSE. Chromatin immune-precipitation assays in vivo and in vitro demonstrated that CSE promotes epigenetic changes with binding of KLF4 to the promoter regions of myocardin and SMC marker genes and alterations in promoter acetylation and methylation. Conclusion: CSE exposure results in phenotypic modulation of cerebral SMC through myocardin and KLF4 dependent mechanisms. These results provides a mechanism by which cigarette smoke induces a pro-inflammatory/matrix remodeling phenotype in SMC and an important pathway for cigarette smoke to contribute to atherosclerosis and stroke.	[Starke, Robert M.; Ali, Muhammad S.; Jabbour, Pascal M.; Tjoumakaris, Stavropoula I.; Gonzalez, Fernando; Rosenwasser, Robert H.; Dumont, Aaron S.] Univ Virginia, Div Neurovasc & Endovasc Surg, Dept Neurol Surg, Joseph & Marie Field Cerebrovasc Res Lab, Charlottesville, VA USA; [Starke, Robert M.] Univ Virginia, Dept Neurol Surg, Charlottesville, VA USA; [Hasan, David M.] Univ Iowa, Dept Neurosurg, Iowa City, IA USA; [Owens, Gary K.] Robert M Berne Cardiovasc Res Ctr, Dept Mol Physiol & Biophys, Charlottesville, VA USA; [Koch, Walter J.] Temple Univ, Ctr Translat Med, Philadelphia, PA 19122 USA; [Koch, Walter J.] Temple Univ, Dept Pharmacol, Philadelphia, PA 19122 USA	University of Virginia; University of Virginia; University of Iowa; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Dumont, AS (corresponding author), Univ Virginia, Div Neurovasc & Endovasc Surg, Dept Neurol Surg, Joseph & Marie Field Cerebrovasc Res Lab, Charlottesville, VA USA.	aaron.dumont@jefferson.edu	ROSENWASSER, ROBERT H/L-2482-2014	hasan, david/0000-0002-8335-5442	National Institutes of Health [K08NS067072]; NIH [R01 HL57353, R01 HL098538, R01 HL087867, P01 HL091799, P01 HL07544]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098538, R01HL087867, R01HL121008, R01HL057353, P01HL091799, T32HL007284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS067072] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants K08NS067072 to ASD, NIH grants R01 HL57353 (GKO), R01 HL098538 (GKO), and R01 HL087867 to GKO, and NIH P01 HL091799 and P01 HL07544 Project 2 to WJK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2011, ARTERIOSCL THROM VAS, V31, P969, DOI 10.1161/ATVBAHA.110.207415; Alexander MR, 2012, PHYSIOL GENOMICS, V44, P417, DOI 10.1152/physiolgenomics.00160.2011; Alexander MR, 2012, ANNU REV PHYSIOL, V74, P13, DOI 10.1146/annurev-physiol-012110-142315; Alexander MR, 2012, J CLIN INVEST, V122, P70, DOI 10.1172/JCI43713; Ali MS, 2012, STROKE, pA110; Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Andersen KK, 2009, STROKE, V40, P2068, DOI 10.1161/STROKEAHA.108.540112; Arnson Y, 2010, J AUTOIMMUN, V34, pJ258, DOI 10.1016/j.jaut.2009.12.003; Bhaskar V, 2011, ATHEROSCLEROSIS, V216, P313, DOI 10.1016/j.atherosclerosis.2011.02.026; CELERMAJER DS, 1993, CIRCULATION, V88, P2149, DOI 10.1161/01.CIR.88.5.2149; Celermajer DS, 1996, NEW ENGL J MED, V334, P150, DOI 10.1056/NEJM199601183340303; Chalouhi N, J CEREB BLOOD FLOW M; Chalouhi N, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/271582; Chalouhi N, 2012, J CEREBR BLOOD F MET, V32, P1659, DOI 10.1038/jcbfm.2012.84; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chen QW, 2010, THESCIENTIFICWORLDJO, V10, P2139, DOI 10.1100/tsw.2010.201; Creemers EE, 2006, DEVELOPMENT, V133, P4245, DOI 10.1242/dev.02610; Csiszar A, 2008, AM J PHYSIOL-HEART C, V294, pH2721, DOI 10.1152/ajpheart.00235.2008; Di Luozzo G, 2005, ATHEROSCLEROSIS, V178, P271, DOI 10.1016/j.atherosclerosis.2004.09.017; DIEZROUX AV, 1995, PREV MED, V24, P48, DOI 10.1006/pmed.1995.1007; Feinberg MW, 2005, J BIOL CHEM, V280, P38247, DOI 10.1074/jbc.M509378200; Furnkranz A, 2005, ARTERIOSCL THROM VAS, V25, P633, DOI 10.1161/01.ATV.0000153106.03644.a0; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Gunning P, 1997, ANAT EMBRYOL, V195, P311, DOI 10.1007/s004290050050; He J, 1999, NEW ENGL J MED, V340, P920, DOI 10.1056/NEJM199903253401204; Hossain M, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-92; INOUE T, 1995, CARDIOLOGY, V86, P374, DOI 10.1159/000176904; Isakson BE, 2006, ARTERIOSCL THROM VAS, V26, P2216, DOI 10.1161/01.ATV.0000237608.19055.53; Jha P, 2013, NEW ENGL J MED, V368, P341, DOI 10.1056/NEJMsa1211128; Kawai-Kowase K, 2007, AM J PHYSIOL-CELL PH, V292, pC59, DOI 10.1152/ajpcell.00394.2006; Lee J, 2012, J DENT RES, V91, P142, DOI 10.1177/0022034511421200; Legein B, 2013, CELL MOL LIFE SCI; Li JM, 2004, ARTERIOSCL THROM VAS, V24, P80, DOI 10.1161/01.ATV.0000104007.17365.1c; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Madsen CS, 1997, J BIOL CHEM, V272, P6332, DOI 10.1074/jbc.272.10.6332; Mazzone P, 2010, INT J ENV RES PUB HE, V7, P4111, DOI 10.3390/ijerph7124111; McDonald OG, 2006, J CLIN INVEST, V116, P36, DOI 10.1172/JCI26505; McDonald OG, 2007, CIRC RES, V100, P1428, DOI 10.1161/01.RES.0000266448.30370.a0; Mendall MA, 1997, HEART, V78, P273, DOI 10.1136/hrt.78.3.273; Orosz Z, 2007, AM J PHYSIOL-HEART C, V292, pH130, DOI 10.1152/ajpheart.00599.2006; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; OWENS GK, 1995, PHYSIOL REV, V75, P487; Perlstein TS, 2006, ARTERIOSCL THROM VAS, V26, P250, DOI 10.1161/01.ATV.0000199268.27395.4f; Pidkovka NA, 2007, CIRC RES, V101, P792, DOI 10.1161/CIRCRESAHA.107.152736; Regan CP, 2000, J CLIN INVEST, V106, P1139, DOI 10.1172/JCI10522; Rosenberg GA, 2002, GLIA, V39, P279, DOI 10.1002/glia.10108; Sacco RL, 2006, STROKE, V37, P577, DOI 10.1161/01.STR.0000199147.30016.74; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwartz Joel, 1994, Annals of Epidemiology, V4, P236, DOI 10.1016/1047-2797(94)90102-3; Snasel J, 1996, FOLIA BIOL-PRAGUE, V42, P227; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Stein JJ, 2011, AM J SURG, V202, P545, DOI 10.1016/j.amjsurg.2011.06.016; Stoll G, 2006, STROKE, V37, P1923, DOI 10.1161/01.STR.0000226901.34927.10; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Talhout R, 2011, INT J ENV RES PUB HE, V8, P613, DOI 10.3390/ijerph8020613; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Tracy RP, 1997, ARTERIOSCL THROM VAS, V17, P2167, DOI 10.1161/01.ATV.17.10.2167; Trojer P, 2006, CELL, V125, P213, DOI 10.1016/j.cell.2006.04.003; Wamhoff BR, 2004, CIRC RES, V95, P981, DOI 10.1161/01.RES.0000147961.09840.fb; Wang C, 2008, J BIOCHEM, V144, P313, DOI 10.1093/jb/mvn068; WANG XK, 1995, ATHEROSCLEROSIS, V115, P89, DOI 10.1016/0021-9150(94)05503-B; Yoshida T, 2005, CIRC RES, V96, P280, DOI 10.1161/01.RES.0000155951.62152.2e; You RX, 1999, AM J PUBLIC HEALTH, V89, P572, DOI 10.2105/AJPH.89.4.572	63	43	44	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71954	10.1371/journal.pone.0071954	http://dx.doi.org/10.1371/journal.pone.0071954			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967268	Green Submitted, gold, Green Published			2022-12-25	WOS:000323221500117
J	Suyemoto, MM; Hamrick, TS; Spears, PA; Horton, JR; Washington, IM; Havell, EA; Borst, LB; Orndorff, PE				Suyemoto, M. Mitsu; Hamrick, Terri S.; Spears, Patricia A.; Horton, John R.; Washington, Ida M.; Havell, Edward A.; Borst, Luke B.; Orndorff, Paul E.			Extrauterine Listeriosis in the Gravid Mouse Influences Embryonic Growth and Development	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MURINE LISTERIOSIS; FACTOR-ALPHA; CELL-LINE; MONOCYTOGENES; MICE; PATHOGENESIS; INFECTION; PREGNANCY; HOST	Gravid mice and other rodents inoculated with Listeria monocytogenes typically fail to clear an intrauterine infection and either succumb or expel their intrauterine contents. We took advantage of this property to investigate the effects of an extrauterine infection on parameters of pregnancy success. Pregnant mice were selected for our study if they showed no clinical signs of listeriosis following oral inoculation at 7.5 gestational days (gd), and had no detectable intrauterine colony forming units (cfu) at near term (18.5 gd). The range of oral doses employed was 10(6)-10(8) cfu per mouse for two listerial serotype strains (4nonb and 1/2a). At all doses, inoculation resulted in a decrease in average near-term (18.5 gd) fetal weight per litter compared to sham inoculated controls. Additionally, embryonic death (indicated by intrauterine resorptions) was exhibited by some inoculated mice but was absent in all sham inoculated animals. In parallel experiments designed to detect possible loss of placental function, gravid uteruses were examined histopathologically and microbiologically 96 h after oral inoculation. Placental lesions were associated with high (> 10(6)), but not low (< 10(2)) or absent intrauterine cfu. In vitro, mouse embryonic trophoblasts were indistinguishable from mouse enterocytes in terms of their sensitivity to listerial exposure. A model consistent with our observations is one in which products (host or bacterial) generated during an acute infection enter embryos transplacentally and influences embryonic survival and slows normal growth in utero.	[Suyemoto, M. Mitsu; Hamrick, Terri S.; Spears, Patricia A.; Horton, John R.; Havell, Edward A.; Borst, Luke B.; Orndorff, Paul E.] N Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC 27695 USA; [Washington, Ida M.] N Carolina State Univ, Coll Vet Med, Dept Biomed Sci, Raleigh, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Orndorff, PE (corresponding author), N Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC 27695 USA.	paul_orndorff@ncsu.edu		Breitschwerdt, Edward/0000-0002-3506-0279; Borst, Luke/0000-0002-2736-1960; Hamrick, Terri/0000-0003-0388-1256	National Institutes of Health [R03AI064217, R21AI064333, 1R21AI083838]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI064333, R21AI083838, R03AI064217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Grants R03AI064217, R21AI064333 and 1R21AI083838 from the National Institutes of Health funded the research contained in this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakardjiev AI, 2005, J INFECT DIS, V191, P1889, DOI 10.1086/430090; Bakardjiev AI, 2006, PLOS PATHOG, V2, P623, DOI 10.1371/journal.ppat.0020066; Bobetsis YA, 2010, J REPROD IMMUNOL, V85, P140, DOI 10.1016/j.jri.2010.04.001; Bowen JA, 1999, BIOL REPROD, V60, P428, DOI 10.1095/biolreprod60.2.428; Brown S, 2008, SEMIN REPROD MED, V26, P391, DOI 10.1055/s-0028-1087105; CHERNOFF N, 1982, J TOXICOL ENV HEALTH, V10, P541, DOI 10.1080/15287398209530275; Conlan JW, 1997, J MED MICROBIOL, V46, P239, DOI 10.1099/00222615-46-3-239; FARBER JM, 1991, MICROBIOL REV, V55, P476, DOI 10.1128/MMBR.55.3.476-511.1991; GENDRON RL, 1990, J REPROD FERTIL, V90, P395, DOI 10.1530/jrf.0.0900395; Hamrick TS, 2003, INFECT IMMUN, V71, P5202, DOI 10.1128/IAI.71.9.5202-5209.2003; HAVELL EA, 1987, J IMMUNOL, V139, P4225; Lecuit M, 2001, SCIENCE, V292, P1722, DOI 10.1126/science.1059852; Melton-Witt JA, 2012, INFECT IMMUN, V80, P720, DOI 10.1128/IAI.05958-11; Orndorff PE, 2006, VET MICROBIOL, V114, P1, DOI 10.1016/j.vetmic.2005.12.003; OSULLIVAN AM, 1988, J MED MICROBIOL, V25, P7, DOI 10.1099/00222615-25-1-7; Papaioannou VE, 2012, VET PATHOL, V49, P64, DOI 10.1177/0300985810395725; PINE L, 1990, INFECT IMMUN, V58, P2940, DOI 10.1128/IAI.58.9.2940-2945.1990; Poulsen KP, 2011, MICROB PATHOGENESIS, V50, P360, DOI 10.1016/j.micpath.2011.02.003; REDLINE RW, 1987, J CLIN INVEST, V79, P1234, DOI 10.1172/JCI112942; Robbins JR, 2012, CURR OPIN MICROBIOL, V15, P36, DOI 10.1016/j.mib.2011.11.006; Rowe JH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002873; Sharma RK, 1998, IN VIVO, V12, P431; Spears PA, 2008, INFECT IMMUN, V76, P4046, DOI 10.1128/IAI.00283-08; Spears PA, 2011, INFECT IMMUN, V79, P5001, DOI 10.1128/IAI.05700-11; Suyemoto MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013000; VIDAL K, 1993, J IMMUNOL METHODS, V166, P63, DOI 10.1016/0022-1759(93)90329-6; Wollert T, 2007, CELL, V129, P891, DOI 10.1016/j.cell.2007.03.049; Zeldovich VB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002005; Zinaman MJ, 1996, FERTIL STERIL, V65, P503, DOI 10.1016/S0015-0282(16)58144-8	29	0	0	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e72601	10.1371/journal.pone.0072601	http://dx.doi.org/10.1371/journal.pone.0072601			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967322	gold, Green Published, Green Submitted			2022-12-25	WOS:000323221500140
J	Wang, Q; Jia, PL; Cuenco, KT; Zeng, Z; Feingold, E; Marazita, ML; Wang, L; Zhao, ZM				Wang, Quan; Jia, Peilin; Cuenco, Karen T.; Zeng, Zhen; Feingold, Eleanor; Marazita, Mary L.; Wang, Lily; Zhao, Zhongming			Association Signals Unveiled by a Comprehensive Gene Set Enrichment Analysis of Dental Caries Genome-Wide Association Studies	PLOS ONE			English	Article							PATHWAY ANALYSIS; SUSCEPTIBILITY; SCHIZOPHRENIA; POLYMORPHISM; EXPRESSION; DISCOVERY; DISEASES; INSULIN; SLIT1; RISK	Gene set-based analysis of genome-wide association study (GWAS) data has recently emerged as a useful approach to examine the joint effects of multiple risk loci in complex human diseases or phenotypes. Dental caries is a common, chronic, and complex disease leading to a decrease in quality of life worldwide. In this study, we applied the approaches of gene set enrichment analysis to a major dental caries GWAS dataset, which consists of 537 cases and 605 controls. Using four complementary gene set analysis methods, we analyzed 1331 Gene Ontology (GO) terms collected from the Molecular Signatures Database (MSigDB). Setting false discovery rate (FDR) threshold as 0.05, we identified 13 significantly associated GO terms. Additionally, 17 terms were further included as marginally associated because they were top ranked by each method, although their FDR is higher than 0.05. In total, we identified 30 promising GO terms, including 'Sphingoid metabolic process,' 'Ubiquitin protein ligase activity,' 'Regulation of cytokine secretion,' and 'Ceramide metabolic process.' These GO terms encompass broad functions that potentially interact and contribute to the oral immune response related to caries development, which have not been reported in the standard single marker based analysis. Collectively, our gene set enrichment analysis provided complementary insights into the molecular mechanisms and polygenic interactions in dental caries, revealing promising association signals that could not be detected through single marker analysis of GWAS data.	[Wang, Quan; Jia, Peilin; Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Cuenco, Karen T.; Feingold, Eleanor; Marazita, Mary L.] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA; [Cuenco, Karen T.; Marazita, Mary L.] Univ Pittsburgh, Sch Dent Med, Dept Oral Biol, Ctr Craniofacial & Dent Genet, Pittsburgh, PA USA; [Zeng, Zhen; Feingold, Eleanor] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA; [Wang, Lily] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Wang, Lily; Zhao, Zhongming] Vanderbilt Univ, Med Ctr, Ctr Quantitat Sci, Nashville, TN 37212 USA; [Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37212 USA; [Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA	Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Wang, L (corresponding author), Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA.	lily.wang@vanderbilt.edu; zhongming.zhao@vanderbilt.edu	Wang, Quan/K-4540-2017; Zeng, Zhen/R-6292-2016	Wang, Quan/0000-0002-7056-0519; Feingold, Eleanor/0000-0003-2898-6484	National Institute of Dental and Craniofacial Research, National Institutes of Health [R03DE022093, R01DE014899, U01DE018903]; NIH GWAS Data Repository [phs000095.v1.p1]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014899, R03DE022093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [U01DE018903] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH GWAS Data Repository(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grants from National Institute of Dental and Craniofacial Research, National Institutes of Health (R03DE022093, R01DE014899, and U01DE018903). Dental caries GWAS dataset use was granted through the NIH GWAS Data Repository (dbGaP, accession number phs000095.v1.p1) Data Access Committee [request #7562-2] to ZZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Azevedo LF, 2010, J APPL ORAL SCI, V18, P166, DOI 10.1590/S1678-77572010000200011; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen LS, 2010, AM J HUM GENET, V86, P860, DOI 10.1016/j.ajhg.2010.04.014; Chen X, 2010, GENET EPIDEMIOL, V34, P716, DOI 10.1002/gepi.20532; Chino T, 2009, ORAL MICROBIOL IMMUN, V24, P96, DOI 10.1111/j.1399-302X.2008.00478.x; Cho KW, 2008, GENE EXPR PATTERNS, V8, P284, DOI 10.1016/j.gep.2007.12.001; Elbers CC, 2009, GENET EPIDEMIOL, V33, P419, DOI 10.1002/gepi.20395; Fehringer G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031816; Fischer CL, 2012, ANTIMICROB AGENTS CH, V56, P1157, DOI 10.1128/AAC.05151-11; Fuchs SY, 2012, GROWTH FACTORS, V30, P141, DOI 10.3109/08977194.2012.669382; Grant MM, 2010, J CLIN PERIODONTOL, V37, P1039, DOI 10.1111/j.1600-051X.2010.01622.x; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Jia PL, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002587; Jia PL, 2011, INT J NEUROPSYCHOPH, V14, P567, DOI 10.1017/S1461145710001446; Jia PL, 2010, SCHIZOPHR RES, V122, P38, DOI 10.1016/j.schres.2010.07.001; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kang SW, 2011, ORAL DIS, V17, P399, DOI 10.1111/j.1601-0825.2010.01766.x; Kao CF, 2012, INT J NEUROPSYCHOPH, V15, P1401, DOI 10.1017/S1461145711001891; Lawrence DW, 2012, CELL IMMUNOL, V279, P46, DOI 10.1016/j.cellimm.2012.09.004; Li DH, 2012, CARCINOGENESIS, V33, P1384, DOI 10.1093/carcin/bgs151; Loes S, 2001, MECH DEVELOP, V107, P155, DOI 10.1016/S0925-4773(01)00454-3; Maddika S, 2011, NAT CELL BIOL, V13, P728, DOI 10.1038/ncb2240; MARTINEAUDOIZE B, 1986, ANAT REC, V214, P130, DOI 10.1002/ar.1092140205; Menashe I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029396; Menashe I, 2010, CANCER RES, V70, P4453, DOI 10.1158/0008-5472.CAN-09-4502; Mozaffari MS, 2011, J ORAL PATHOL MED, V40, P194, DOI 10.1111/j.1600-0714.2010.00965.x; Nguyen-Ba-Charvet KT, 2002, J NEUROSCI, V22, P5473; Nixon GF, 2009, BRIT J PHARMACOL, V158, P982, DOI 10.1111/j.1476-5381.2009.00281.x; O'Dushlaine C, 2009, BIOINFORMATICS, V25, P2762, DOI 10.1093/bioinformatics/btp448; Perry JRB, 2009, DIABETES, V58, P1463, DOI 10.2337/db08-1378; Peyyala R, 2012, CYTOKINE, V58, P65, DOI 10.1016/j.cyto.2011.12.016; POURDEIHIMI B, 1980, J PERIODONTOL, V51, P199, DOI 10.1902/jop.1980.51.4.199; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Shaffer JR, 2013, J DENT RES, V92, P38, DOI 10.1177/0022034512463579; Shaffer JR, 2011, J DENT RES, V90, P1457, DOI 10.1177/0022034511422910; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun JC, 2009, BIOINFORMATICS, V25, P2595, DOI 10.1093/bioinformatics/btp428; Tannure PN, 2012, CARIES RES, V46, P401, DOI 10.1159/000339379; Torres PU, 2009, J RENAL NUTR, V19, P50, DOI 10.1053/j.jrn.2008.10.018; Valarini N, 2012, CARIES RES, V46, P530, DOI 10.1159/000341188; Vieira AR, 2008, GENET MED, V10, P668, DOI [10.1097/GIM.0b013e3181833793, 10.1097GIM.0b013e3181833793]; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wang LL, 2011, GENOMICS, V98, P1, DOI 10.1016/j.ygeno.2011.04.006; Wang L, 2011, BIOINFORMATICS, V27, P686, DOI 10.1093/bioinformatics/btq728; Wendell S, 2010, J DENT RES, V89, P1198, DOI 10.1177/0022034510381502; Werneck RI, 2010, ORAL DIS, V16, P613, DOI 10.1111/j.1601-0825.2010.01675.x; Wilson M, 1998, INFECT IMMUN, V66, P2401, DOI 10.1128/IAI.66.6.2401-2409.1998; Zeng Z, 2013, J DENT RES, V92, P432, DOI 10.1177/0022034513481976; Zhang SH, 2012, NUCLEIC ACIDS RES, V40, P9379, DOI 10.1093/nar/gks725; Zhao ZM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S16; Zhong H, 2010, AM J HUM GENET, V86, P581, DOI 10.1016/j.ajhg.2010.02.020	54	9	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e72653	10.1371/journal.pone.0072653	http://dx.doi.org/10.1371/journal.pone.0072653			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967329	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000323221500143
J	Lahr, EC; Krokene, P				Lahr, Eleanor C.; Krokene, Paal			Conifer Stored Resources and Resistance to a Fungus Associated with the Spruce Bark Beetle Ips typographus	PLOS ONE			English	Article							MOUNTAIN PINE-BEETLE; BLUE-STAIN FUNGI; NORWAY SPRUCE; TERPENOID ACCUMULATION; ARMILLARIA-OSTOYAE; DEFENSE RESPONSES; SYMBIOTIC FUNGI; LODGEPOLE PINE; PICEA-ABIES; GROWTH	Bark beetles and associated fungi are among the greatest natural threats to conifers worldwide. Conifers have potent defenses, but resistance to beetles and fungal pathogens may be reduced if tree stored resources are consumed by fungi rather than used for tree defense. Here, we assessed the relationship between tree stored resources and resistance to Ceratocystis polonica, a phytopathogenic fungus vectored by the spruce bark beetle Ips typographus. We measured phloem and sapwood nitrogen, non-structural carbohydrates (NSC), and lipids before and after trees were attacked by I. typographus (vectoring C. polonica) or artificially inoculated with C. polonica alone. Tree resistance was assessed by measuring phloem lesions and the proportion of necrotic phloem around the tree's circumference following attack or inoculation. While initial resource concentrations were unrelated to tree resistance to C. polonica, over time, phloem NSC and sapwood lipids declined in the trees inoculated with C. polonica. Greater resource declines correlated with less resistant trees (trees with larger lesions or more necrotic phloem), suggesting that resource depletion may be caused by fungal consumption rather than tree resistance. Ips typographus may then benefit indirectly from reduced tree defenses caused by fungal resource uptake. Our research on tree stored resources represents a novel way of understanding bark beetle-fungal-conifer interactions.	[Lahr, Eleanor C.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Krokene, Paal] Norwegian Forest & Landscape Inst, As, Norway	University of Montana System; University of Montana; The Norwegian Forest & Landscape Institute	Lahr, EC (corresponding author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.	eleanorlahr@gmail.com	Krokene, Paal/A-1835-2008	Krokene, Paal/0000-0002-7205-0715	NSF graduate research fellowship; NSF Nordic Research Opportunity fellowship; Norwegian Forest and Landscape Institute; Montana Institute on Ecosystems NSF EPSCoR program [EPS-1101342]	NSF graduate research fellowship(National Science Foundation (NSF)); NSF Nordic Research Opportunity fellowship; Norwegian Forest and Landscape Institute; Montana Institute on Ecosystems NSF EPSCoR program	E.C.L. was supported by a NSF graduate research fellowship, a NSF Nordic Research Opportunity fellowship, the Norwegian Forest and Landscape Institute, and the Montana Institute on Ecosystems NSF EPSCoR program grant EPS-1101342. Any opinions, findings and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the Montana Institute on Ecosystems or the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres MP, 2000, ECOLOGY, V81, P2198, DOI 10.1890/0012-9658(2000)081[2198:NBOPFB]2.0.CO;2; BAKKE A, 1989, Holarctic Ecology, V12, P515; BALLARD RG, 1984, CAN J BOT, V62, P1724, DOI 10.1139/b84-233; BARRAS SJ, 1973, CAN ENTOMOL, V105, P1295, DOI 10.4039/Ent1051295-10; Bentz BJ, 2006, ANN ENTOMOL SOC AM, V99, P189, DOI 10.1603/0013-8746(2006)099[0189:ECOFAW]2.0.CO;2; BERRYMAN AA, 1972, BIOSCIENCE, V22, P598, DOI 10.2307/1296206; Bleiker KP, 2007, ENVIRON ENTOMOL, V36, P1384, DOI 10.1603/0046-225X(2007)36[1384:DBOFAT]2.0.CO;2; Boege K, 2005, TRENDS ECOL EVOL, V20, P441, DOI 10.1016/j.tree.2005.05.001; Bohlmann Jorg, 1999, P132; Boone CK, 2011, CAN J FOREST RES, V41, P1174, DOI [10.1139/X11-041, 10.1139/x11-041]; CHRISTIANSEN E, 1985, EUR J FOREST PATHOL, V15, P160; Christiansen E., 1988, P479; CRAIGHEAD F. C., 1928, JOUR FOREST, V26, P886; Croise L, 2001, TREE PHYSIOL, V21, P427, DOI 10.1093/treephys/21.7.427; DUNN JP, 1992, FOREST ECOL MANAG, V50, P317, DOI 10.1016/0378-1127(92)90345-A; ENTRY JA, 1991, PHYTOPATHOLOGY, V81, P682, DOI 10.1094/Phyto-81-682; ENTRY JA, 1992, PHYTOPATHOLOGY, V82, P393, DOI 10.1094/Phyto-82-393; Erbilgin N, 2006, OECOLOGIA, V148, P426, DOI 10.1007/s00442-006-0394-3; Franceschi VR, 2005, NEW PHYTOL, V167, P353, DOI 10.1111/j.1469-8137.2005.01436.x; Franceschi VR, 2000, AM J BOT, V87, P314, DOI 10.2307/2656627; GERSHENZON J, 1994, J CHEM ECOL, V20, P1281, DOI 10.1007/BF02059810; Hoch G, 2002, OIKOS, V98, P361, DOI 10.1034/j.1600-0706.2002.980301.x; Hoch G, 1999, ARCH BIOCHEM BIOPHYS, V366, P75, DOI 10.1006/abbi.1999.1212; Hofstetter RW, 2007, COMMUNITY ECOL, V8, P47, DOI 10.1556/ComEc.8.2007.1.7; Keeling CI, 2006, NEW PHYTOL, V170, P657, DOI 10.1111/j.1469-8137.2006.01716.x; Klepzig KD, 2004, MYCOL RES, V108, P183, DOI 10.1017/S0953756203009055; Krokene P, 1996, CAN J FOREST RES, V26, P2115, DOI 10.1139/x26-240; Krokene P, 1998, PHYTOPATHOLOGY, V88, P39, DOI 10.1094/PHYTO.1998.88.1.39; Krokene P, 2003, TREE PHYSIOL, V23, P191, DOI 10.1093/treephys/23.3.191; Krokene P, 1999, PLANT PHYSIOL, V121, P565, DOI 10.1104/pp.121.2.565; Krokene P, 2013, CBS BIODIVE IN PRESS, V12; Krokene Paal, 2008, P147, DOI 10.1007/978-1-4020-8182-8_7; Kuroda K, 2001, J WOOD SCI, V47, P425, DOI 10.1007/BF00767893; Lieutier F, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009066; Martin D, 2002, PLANT PHYSIOL, V129, P1003, DOI 10.1104/pp.011001; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Nagy NE, 2000, AM J BOT, V87, P302, DOI 10.2307/2656626; Paine TD, 1997, ANNU REV ENTOMOL, V42, P179, DOI 10.1146/annurev.ento.42.1.179; RAFFA KF, 1982, ENVIRON ENTOMOL, V11, P486, DOI 10.1093/ee/11.2.486; RAFFA KF, 1983, ECOL MONOGR, V53, P27, DOI 10.2307/1942586; Scott JJ, 2008, SCIENCE, V322, P63, DOI 10.1126/science.1160423; SIMONICH SL, 1995, ENVIRON SCI TECHNOL, V29, P2905, DOI 10.1021/es00012a004; Six DL, 2007, MICROB ECOL, V54, P112, DOI 10.1007/s00248-006-9178-x; Six DL, 2011, ANNU REV ENTOMOL, V56, P255, DOI 10.1146/annurev-ento-120709-144839; Six DL, 2004, SYMBIOSIS, V37, P207; Six DL, 2003, CONT T ENT, P97; Solheim H, 1998, CAN J BOT, V76, P561, DOI 10.1139/cjb-76-4-561; Solheim H, 1991, CAN J BOT, V70, P1; VonSchrenk H, 1903, US BUR PLANT IND B, V36, P1; Wainhouse D, 1998, FUNCT ECOL, V12, P561, DOI 10.1046/j.1365-2435.1998.00232.x; Wermelinger B, 2004, FOREST ECOL MANAG, V202, P67, DOI 10.1016/j.foreco.2004.07.018; White T. C. R., 1993, INADEQUATE ENV NITRO; YAMAOKA Y, 1990, CAN J FOREST RES, V20, P31, DOI 10.1139/x90-005; Zhao T, 2010, PHYTOCHEMISTRY, V71, P1332, DOI 10.1016/j.phytochem.2010.05.017	54	25	26	7	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e72405	10.1371/journal.pone.0072405	http://dx.doi.org/10.1371/journal.pone.0072405			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967298	Green Published, Green Submitted, gold			2022-12-25	WOS:000323115800098
J	Magherini, F; Gamberi, T; Pietrovito, L; Fiaschi, T; Bini, L; Esposito, F; Marini, M; Abruzzo, PM; Gulisano, M; Modesti, A				Magherini, Francesca; Gamberi, Tania; Pietrovito, Laura; Fiaschi, Tania; Bini, Luca; Esposito, Fabio; Marini, Marina; Abruzzo, Provvidenza Maria; Gulisano, Massimo; Modesti, Alessandra			Proteomic and Carbonylation Profile Analysis of Rat Skeletal Muscles following Acute Swimming Exercise	PLOS ONE			English	Article							ACUTE PHYSICAL-EXERCISE; AMINO-ACID-RESIDUES; PROTEIN CARBONYLATION; POLYACRYLAMIDE-GELS; OXIDATIVE DAMAGE; REDOX REGULATION; AGGREGATION; RESPONSES; KINASE	Previous studies by us and other groups characterized protein expression variation following long-term moderate training, whereas the effects of single bursts of exercise are less known. Making use of a proteomic approach, we investigated the effects of acute swimming exercise (ASE) on protein expression and carbonylation patterns in two hind limb muscles: the Extensor Digitorum Longus (EDL) and the Soleus, mostly composed of fast-twitch and slow-twitch fibres, respectively. Carbonylation is one of the most common oxidative modifications of proteins and a marker of oxidative stress. In fact, several studies suggest that physical activity and the consequent increase in oxygen consumption can lead to increase in reactive oxygen and nitrogen species (RONS) production, hence the interest in examining the impact of RONS on skeletal muscle proteins following ASE. Results indicate that protein expression is unaffected by ASE in both muscle types. Unexpectedly, the protein carbonylation level was reduced following ASE. In particular, the analysis found 31 and 5 spots, in Soleus and EDL muscles respectively, whose carbonylation is reduced after ASE. Lipid peroxidation levels in Soleus were markedly reduced as well. Most of the decarbonylated proteins are involved either in the regulation of muscle contractions or in the regulation of energy metabolism. A number of hypotheses may be advanced to account for such results, which will be addressed in future studies.	[Magherini, Francesca; Gamberi, Tania; Pietrovito, Laura; Fiaschi, Tania; Modesti, Alessandra] Univ Florence, Dept Expt & Clin Biomed Sci, Florence, Italy; [Bini, Luca] Univ Siena, Dept Life Sci, I-53100 Siena, Italy; [Esposito, Fabio] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Marini, Marina; Abruzzo, Provvidenza Maria] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy; [Marini, Marina; Abruzzo, Provvidenza Maria] Don Carlo Gnocchi Fdn ONLUS, Milan, Italy; [Gulisano, Massimo] Univ Florence, Dept Expt & Clin Med, Florence, Italy	University of Florence; University of Siena; University of Milan; University of Bologna; IRCCS Fondazione Don Carlo Gnocchi Onlus; University of Florence	Magherini, F (corresponding author), Univ Florence, Dept Expt & Clin Biomed Sci, Florence, Italy.	francesca.magherini@unifi.it	gamberi, tania/A-8269-2014; Modesti, Alessandra/L-3276-2017; Marini, Marina/Y-6191-2019; Esposito, Fabio/E-9340-2011; Abruzzo, Provvidenza Maria/G-7009-2015; magherini, francesca/A-2991-2014; Marini, Marina/B-1490-2012	gamberi, tania/0000-0003-1489-8934; Modesti, Alessandra/0000-0002-1290-2285; Marini, Marina/0000-0003-1932-7380; Esposito, Fabio/0000-0002-4420-2611; Abruzzo, Provvidenza Maria/0000-0001-5242-9448; magherini, francesca/0000-0001-8388-0952; Marini, Marina/0000-0003-1932-7380; Bini, Luca/0000-0001-8951-2106				Abruzzo PM, 2013, INT J SPORTS MED, V34, P676, DOI 10.1055/s-0032-1323782; Agostini F, 2010, J PHYSIOL-LONDON, V588, P5089, DOI 10.1113/jphysiol.2010.198283; AMICI A, 1989, J BIOL CHEM, V264, P3341; Barreiro E, 2010, ANTIOXID REDOX SIGN, V12, P417, DOI 10.1089/ars.2009.2808; Brandes N, 2009, ANTIOXID REDOX SIGN, V11, P997, DOI 10.1089/ARS.2008.2285; Burniston JG, 2008, BBA-PROTEINS PROTEOM, V1784, P1077, DOI 10.1016/j.bbapap.2008.04.007; Burniston JG, 2011, EXPERT REV PROTEOMIC, V8, P361, DOI [10.1586/EPR.11.17, 10.1586/epr.11.17]; Caselli A, 2007, BIOCHEMISTRY-US, V46, P6383, DOI 10.1021/bi0620858; Chandel NS, 2007, FREE RADICAL BIO MED, V42, P165, DOI 10.1016/j.freeradbiomed.2006.10.048; Chaudhuri AR, 2006, MECH AGEING DEV, V127, P849, DOI 10.1016/j.mad.2006.08.006; Dalle-Donne I, 2002, FREE RADICAL BIO MED, V32, P927, DOI 10.1016/S0891-5849(02)00799-2; Dalle-Donne I, 2006, J CELL MOL MED, V10, P389, DOI 10.1111/j.1582-4934.2006.tb00407.x; Faraone-Mennella MR, 2010, J BIOL REG HOMEOS AG, V24, P325; Fedorova M, 2010, J PROTEOME RES, V9, P2516, DOI 10.1021/pr901182r; Feng J, 2008, J GERONTOL A-BIOL, V63, P1137, DOI 10.1093/gerona/63.11.1137; Fiaschi T, 2006, J BIOL CHEM, V281, P22983, DOI 10.1074/jbc.M603040200; Fiaschi Tania, 2012, J Signal Transduct, V2012, P754964, DOI 10.1155/2012/754964; Fisher-Wellman Kelsey, 2009, Dyn Med, V8, P1, DOI 10.1186/1476-5918-8-1; Fluck M, 2006, J EXP BIOL, V209, P2239, DOI 10.1242/jeb.02149; Gandra PG, 2012, SCAND J MED SCI SPOR, V22, P207, DOI 10.1111/j.1600-0838.2010.01235.x; Goto S, 1999, MECH AGEING DEV, V107, P245, DOI 10.1016/S0047-6374(98)00133-X; Guelfi KJ, 2006, CLIN EXP PHARMACOL P, V33, P952, DOI 10.1111/j.1440-1681.2006.04470.x; Guidi F, 2011, MOL BIOSYST, V7, P640, DOI 10.1039/c0mb00106f; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; HOCHSTRASSER DF, 1988, ANAL BIOCHEM, V173, P412, DOI 10.1016/0003-2697(88)90208-4; Inashima S, 2003, EUR J APPL PHYSIOL, V89, P142, DOI 10.1007/s00421-002-0763-5; Jackson MJ, 2008, IUBMB LIFE, V60, P497, DOI 10.1002/iub.72; Lamb GD, 2009, APPL PHYSIOL NUTR ME, V34, P368, DOI 10.1139/H09-032; Madian AG, 2010, J PROTEOME RES, V9, P1330, DOI 10.1021/pr900890k; Magherini F, 2009, CELL MOL LIFE SCI, V66, P933, DOI 10.1007/s00018-009-8574-z; Magherini F, 2012, J PROTEOMICS, V75, P978, DOI 10.1016/j.jprot.2011.10.017; Margonato V, 2000, INT J SPORTS MED, V21, P163, DOI 10.1055/s-2000-8876; Marin-Corral J, 2010, ANTIOXID REDOX SIGN, V12, P365, DOI 10.1089/ars.2009.2818; McArdle F, 2004, J PHYSIOL-LONDON, V561, P233, DOI 10.1113/jphysiol.2004.069914; Mirzaei H, 2008, J CHROMATOGR B, V873, P8, DOI 10.1016/j.jchromb.2008.04.025; Molloy MP, 2003, PROTEOMICS, V3, P1912, DOI 10.1002/pmic.200300534; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Nuss JE, 2009, AGING-US, V1, P557, DOI 10.18632/aging.100055; Pauli JR, 2008, J PHYSIOL-LONDON, V586, P659, DOI 10.1113/jphysiol.2007.142414; Phaneuf S, 2001, MED SCI SPORT EXER, V33, P393, DOI 10.1097/00005768-200103000-00010; Prigol M, 2009, CELL BIOCHEM FUNCT, V27, P216, DOI 10.1002/cbf.1559; Radak Z, 1999, FREE RADICAL BIO MED, V27, P69, DOI 10.1016/S0891-5849(99)00038-6; RILEY DA, 1982, J HISTOCHEM CYTOCHEM, V30, P1275, DOI 10.1177/30.12.6218195; Romani R, 2009, J LIPID RES, V50, P2036, DOI 10.1194/jlr.M800493-JLR200; Silva LA, 2009, EUR J APPL PHYSIOL, V105, P861, DOI 10.1007/s00421-008-0971-8; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Staron RS, 1999, HISTOCHEM CELL BIOL, V111, P117, DOI 10.1007/s004180050341; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wong CM, 2008, CIRC RES, V102, P310, DOI 10.1161/CIRCRESAHA.107.159814; Wong CM, 2010, ANTIOXID REDOX SIGN, V12, P393, DOI 10.1089/ars.2009.2805	50	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71839	10.1371/journal.pone.0071839	http://dx.doi.org/10.1371/journal.pone.0071839			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967250	Green Published, gold			2022-12-25	WOS:000323115800085
J	Miloslavich, P; Cruz-Motta, JJ; Klein, E; Iken, K; Weinberger, V; Konar, B; Trott, T; Pohle, G; Bigatti, G; Benedetti-Cecchi, L; Shirayama, Y; Mead, A; Palomo, G; Ortiz, M; Gobin, J; Sardi, A; Diaz, JM; Knowlton, A; Wong, M; Peralta, AC				Miloslavich, Patricia; Jose Cruz-Motta, Juan; Klein, Eduardo; Iken, Katrin; Weinberger, Vanessa; Konar, Brenda; Trott, Tom; Pohle, Gerhard; Bigatti, Gregorio; Benedetti-Cecchi, Lisandro; Shirayama, Yoshihisa; Mead, Angela; Palomo, Gabriela; Ortiz, Manuel; Gobin, Judith; Sardi, Adriana; Manuel Diaz, Juan; Knowlton, Ann; Wong, Melisa; Peralta, Ana C.			Large-Scale Spatial Distribution Patterns of Gastropod Assemblages in Rocky Shores	PLOS ONE			English	Article							LATITUDINAL DIVERSITY GRADIENTS; SPECIES-DIVERSITY; SOUTH-AFRICA; LITTORININAE GASTROPODA; SOUTHEASTERN PACIFIC; MOLECULAR PHYLOGENY; GLOBAL PATTERNS; MARINE; COMMUNITY; BIODIVERSITY	Gastropod assemblages from nearshore rocky habitats were studied over large spatial scales to (1) describe broad-scale patterns in assemblage composition, including patterns by feeding modes, (2) identify latitudinal pattern of biodiversity, i.e., richness and abundance of gastropods and/or regional hotspots, and (3) identify potential environmental and anthropogenic drivers of these assemblages. Gastropods were sampled from 45 sites distributed within 12 Large Marine Ecosystem regions (LME) following the NaGISA (Natural Geography in Shore Areas) standard protocol (www.nagisa.coml.org). A total of 393 gastropod taxa from 87 families were collected. Eight of these families (9.2%) appeared in four or more different LMEs. Among these, the Littorinidae was the most widely distributed (8 LMEs) followed by the Trochidae and the Columbellidae (6 LMEs). In all regions, assemblages were dominated by few species, the most diverse and abundant of which were herbivores. No latitudinal gradients were evident in relation to species richness or densities among sampling sites. Highest diversity was found in the Mediterranean and in the Gulf of Alaska, while highest densities were found at different latitudes and represented by few species within one genus (e.g. Afrolittorina in the Agulhas Current, Littorina in the Scotian Shelf, and Lacuna in the Gulf of Alaska). No significant correlation was found between species composition and environmental variables (r <= 0.355, p>0.05). Contributing variables to this low correlation included invasive species, inorganic pollution, SST anomalies, and chlorophyll-a anomalies. Despite data limitations in this study which restrict conclusions in a global context, this work represents the first effort to sample gastropod biodiversity on rocky shores using a standardized protocol across a wide scale. Our results will generate more work to build global databases allowing for large-scale diversity comparisons of rocky intertidal assemblages.	[Miloslavich, Patricia; Jose Cruz-Motta, Juan; Klein, Eduardo; Sardi, Adriana; Peralta, Ana C.] Univ Simon Bolivar, Dept Estudios Ambientales, Caracas, Miranda, Venezuela; [Miloslavich, Patricia; Jose Cruz-Motta, Juan; Klein, Eduardo; Sardi, Adriana; Peralta, Ana C.] Univ Simon Bolivar, Ctr Biodiversidad Marina, Caracas, Miranda, Venezuela; [Iken, Katrin; Konar, Brenda; Knowlton, Ann] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK USA; [Weinberger, Vanessa] Pontificia Univ Catolica Chile, Dept Ecol, Santiago, Chile; [Trott, Tom] Suffolk Univ, Boston, MA 02114 USA; [Pohle, Gerhard] Huntsman Marine Sci Ctr, St Andrews, NB, Canada; [Bigatti, Gregorio] Ctr Nacl Patagon, Puerto Madryn, Chubut, Argentina; [Benedetti-Cecchi, Lisandro] Univ Pisa, Dipartimento Biol, Pisa, Italy; [Shirayama, Yoshihisa] Kyoto Univ, Field Sci Educ & Res Ctr, Seto Marine Biol Lab, Wakayama, Japan; [Mead, Angela] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Palomo, Gabriela] Museo Argentino Ciencias Nat Bernardino Rivadavia, Lab Ecosistemas Costeros, Buenos Aires, DF, Argentina; [Ortiz, Manuel] Univ La Habana, Ctr Invest Marinas, Havana, Cuba; [Gobin, Judith] Univ W Indies, Dept Life Sci, St Augustine, Trinidad Tobago; [Manuel Diaz, Juan] Univ Nacl Colombia, Bogota, Colombia; [Wong, Melisa] Fisheries & Oceans Canada, Bedford Inst Oceanog, Dartmouth, NS B2Y 4A2, Canada	Simon Bolivar University; Simon Bolivar University; University of Alaska System; University of Alaska Fairbanks; Pontificia Universidad Catolica de Chile; Suffolk University; Centro Nacional Patagonico (CENPAT); University of Pisa; Kyoto University; University of Cape Town; Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); Universidad de la Habana; University West Indies Mona Jamaica; University West Indies Saint Augustine; Universidad Nacional de Colombia; Bedford Institute of Oceanography; Fisheries & Oceans Canada	Miloslavich, P (corresponding author), Univ Simon Bolivar, Dept Estudios Ambientales, Caracas, Miranda, Venezuela.	pmilos@usb.ve	Trott, Thomas J/N-4660-2018; Brichtova, Ana Carolina Peralta/AAX-3669-2020; Benedetti-Cecchi, Lisandro/J-8225-2019	Trott, Thomas J/0000-0002-1851-5243; Benedetti-Cecchi, Lisandro/0000-0001-5244-5202; Klein, Eduardo/0000-0003-2935-7065; Sardi, Adriana E./0000-0001-5323-2006; Miloslavich, Patricia/0000-0001-5409-1401; Palomo, Maria Gabriela/0000-0002-9102-1282; BIGATTI, GREGORIO/0000-0001-7053-6802; Cruz Motta, Juan Jose/0000-0001-6117-9014	Alfred P. Sloan Foundation through the NaGISA project; History of the Near Shore (HNS) program; History of Marine Populations (HMAP); Fisheries and Oceans Canada (DFO); Suffolk University; Gulf of Maine (GoMA) project; Decanato de Investigacion y Desarrollo - Universidad Simon Bolivar; Exxon Valdez Oil Spill Trustee Council - Gulf Ecosystem Monitoring; SAEON (South African Environmental Observation Network); SANCOR Seachange Program; Centre for Invasion Biology (CIB); Chevron-Venezuela	Alfred P. Sloan Foundation through the NaGISA project(Alfred P. Sloan Foundation); History of the Near Shore (HNS) program; History of Marine Populations (HMAP); Fisheries and Oceans Canada (DFO); Suffolk University; Gulf of Maine (GoMA) project; Decanato de Investigacion y Desarrollo - Universidad Simon Bolivar; Exxon Valdez Oil Spill Trustee Council - Gulf Ecosystem Monitoring(Exxon Mobil Corporation); SAEON (South African Environmental Observation Network); SANCOR Seachange Program; Centre for Invasion Biology (CIB); Chevron-Venezuela	Funding was provided by multiple sources, including the Alfred P. Sloan Foundation through the NaGISA project, the History of the Near Shore (HNS) program, the History of Marine Populations (HMAP), Fisheries and Oceans Canada (DFO), Suffolk University, the Gulf of Maine (GoMA) project, Chevron-Venezuela, Decanato de Investigacion y Desarrollo - Universidad Simon Bolivar, Exxon Valdez Oil Spill Trustee Council - Gulf Ecosystem Monitoring, SAEON (South African Environmental Observation Network), and SANCOR Seachange Program and the Centre for Invasion Biology (CIB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2007, FRONT ECOL ENVIRON, V5, P145, DOI 10.1890/1540-9295(2007)5[145:FKGIPA]2.0.CO;2; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2008, PERMANOVA PRIMER GUI; Archambault P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012182; Avila SP, 2012, SCI WORLD J, DOI 10.1100/2012/164890; Barnes R. S. K., 2010, Marine Biodiversity, V40, P95, DOI 10.1007/s12526-010-0036-1; Beck MW, 1998, MAR ECOL PROG SER, V169, P165, DOI 10.3354/meps169165; Benedetti-Cecchi L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012946; Blakeslee AMH, 2008, MOL ECOL, V17, P3684, DOI 10.1111/j.1365-294X.2008.03865.x; Blanchette CA, 2009, PROG OCEANOGR, V83, P107, DOI 10.1016/j.pocean.2009.07.038; BOLTON JJ, 1994, BOT MAR, V37, P241, DOI 10.1515/botm.1994.37.3.241; BOUCHET P, 2006, EXPLORATION MARINE B, P32; Broitman BR, 2001, MAR ECOL PROG SER, V224, P21, DOI 10.3354/meps224021; BUSTAMANTE RH, 1995, OECOLOGIA, V102, P189, DOI 10.1007/BF00333251; Butler AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011831; Camargo JA, 2006, ENVIRON INT, V32, P831, DOI 10.1016/j.envint.2006.05.002; Chave J, 2002, AM NAT, V159, P1, DOI 10.1086/324112; Clarke A, 2000, J ANIM ECOL, V69, P799, DOI 10.1046/j.1365-2656.2000.00440.x; CLARKE A, 1992, TRENDS ECOL EVOL, V7, P286, DOI 10.1016/0169-5347(92)90222-W; Clarke A, 1997, MARINE BIODIVERSITY-BOOK, P122, DOI 10.1017/CBO9780511752360.007; Clarke K. R., 2001, CHANGES MARINE COMMU; Clarke KR, 2008, J EXP MAR BIOL ECOL, V366, P56, DOI 10.1016/j.jembe.2008.07.009; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR, 1998, J APPL ECOL, V35, P523, DOI 10.1046/j.1365-2664.1998.3540523.x; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; Crame JA, 2000, PALEOBIOLOGY, V26, P188; Donald K, 2004, 16 ANN C SPAT INF RE; Fujikura K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011836; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gofas S., 2001, EUROPEAN REGISTER MA, VVolume 50, P180; Gorostiaga JM, 1996, MAR ECOL PROG SER, V130, P157, DOI 10.3354/meps130157; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hawkins SJ, 2008, CLIM RES, V37, P123, DOI 10.3354/cr00768; Hickman C. S., 1990, SCI SERIES NATURAL H, V35, P1, DOI DOI 10.1016/0006-8993(78)90452-3; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; HOCKEY PAR, 1992, T ROY SOC S AFR, V48, P123, DOI 10.1080/00359199209520258; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Hubbell Stephen P., 2001, V32, pi; Iken K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013845; Cruz-Motta JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014354; Kennedy TA, 2002, NATURE, V417, P636, DOI 10.1038/nature00776; Kerr Jeremy, 2001, Trends in Ecology and Evolution, V16, P424, DOI 10.1016/S0169-5347(01)02226-1; Konar B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013195; Krebs C. J., 1999, ECOLOGICAL METHODOLO; Kruger AC, 2004, INT J CLIMATOL, V24, P1929, DOI 10.1002/joc.1096; LAVIE B, 1987, ENVIRON MANAGE, V11, P345, DOI 10.1007/BF01867162; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; LEIGH EG, 1987, P NATL ACAD SCI USA, V84, P1314, DOI 10.1073/pnas.84.5.1314; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Little C., 1996, BIOL ROCKY SHORES; Loreau M, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P79; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; LUBCHENCO J, 1978, AM NAT, V112, P23, DOI 10.1086/283250; LUBCHENCO J, 1983, ECOLOGY, V64, P1116, DOI 10.2307/1937822; LUBCHENCO J, 1981, ANNU REV ECOL SYST, V12, P405, DOI 10.1146/annurev.es.12.110181.002201; Macpherson E, 2002, P ROY SOC B-BIOL SCI, V269, P1715, DOI 10.1098/rspb.2002.2091; May R, 1999, PHILOS T R SOC B, V354, P1951, DOI 10.1098/rstb.1999.0534; May R. M., 1973, STABILITY COMPLEXITY; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; McGill BJ, 2003, NATURE, V422, P881, DOI 10.1038/nature01583; Mead A, 2011, J NAT HIST, V45, P2463, DOI 10.1080/00222933.2011.595836; Mead A, 2011, BIOL INVASIONS, V13, P1991, DOI 10.1007/s10530-011-0016-9; Mead A, 2010, CLIMATE BIOINVASIVES; Meeus JH., 1991, ASTRONOMICAL ALGORIT; Menge BA, 1997, P NATL ACAD SCI USA, V94, P14530, DOI 10.1073/pnas.94.26.14530; Miloslavich P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014631; Miloslavich P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011916; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Nakano T, 2004, J MOLLUS STUD, V70, P31, DOI 10.1093/mollus/70.1.31; Nakano T, 2007, J MOLLUS STUD, V73, P79, DOI 10.1093/mollus/eym001; NEVO E, 1986, BIOL J LINN SOC, V29, P139, DOI 10.1111/j.1095-8312.1986.tb01828.x; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; Pohle G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018606; Ponder WF, 1997, ZOOL J LINN SOC-LOND, V119, P83, DOI 10.1111/j.1096-3642.1997.tb00137.x; PRENDERGAST JR, 1993, NATURE, V365, P335, DOI 10.1038/365335a0; Ramakrishnan B, 2010, CRIT REV ENV SCI TEC, V40, P699, DOI 10.1080/10643380802471068; Reid DG, 2012, ZOOL SCR, V41, P125, DOI 10.1111/j.1463-6409.2011.00505.x; Reid DG, 2004, REC AUST MUS, V56, P75, DOI 10.3853/j.0067-1975.56.2004.1393; Renema W, 2008, SCIENCE, V321, P654, DOI 10.1126/science.1155674; Rex MA, 2005, ECOLOGY, V86, P2288, DOI 10.1890/04-1056; Rigby PR, 2007, SAMPLING BIODIVERSIT; Robinson TB, 2005, AFR J MAR SCI, V27, P297, DOI 10.2989/18142320509504088; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rouault M, 2010, AFR J MAR SCI, V32, P237, DOI 10.2989/1814232X.2010.501563; Rouault M, 2009, AFR J MAR SCI, V31, P63, DOI 10.2989/AJMS.2009.31.1.5.776; Rouault M, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037987; Roy K, 1998, P NATL ACAD SCI USA, V95, P3699, DOI 10.1073/pnas.95.7.3699; Roy K, 2000, P ROY SOC B-BIOL SCI, V267, P293, DOI 10.1098/rspb.2000.0999; Sagarin RD, 1999, ECOL MONOGR, V69, P465, DOI 10.1890/0012-9615(1999)069[0465:CRCIAI]2.0.CO;2; Sherman K, 2007, NMFSNE208 NOAA US DE; Solan M, 2004, SCIENCE, V306, P1177, DOI 10.1126/science.1103960; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; TAYLOR JD, 1977, J BIOGEOGR, V4, P73, DOI 10.2307/3038130; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Ugland KI, 2003, J ANIM ECOL, V72, P888, DOI 10.1046/j.1365-2656.2003.00748.x; Valdovinos C, 2003, ECOGRAPHY, V26, P139, DOI 10.1034/j.1600-0587.2003.03349.x; Valentine JW, 2010, PALAEONTOLOGY, V53, P1203, DOI 10.1111/j.1475-4983.2010.01005.x; VALENTINE JW, 1966, LIMNOL OCEANOGR, V11, P198, DOI 10.4319/lo.1966.11.2.0198; Veliz D, 2000, REV CHIL HIST NAT, V73, P757; VERMEIJ GJ, 1991, SCIENCE, V253, P1099, DOI 10.1126/science.253.5024.1099; Weingartner T, 2009, J BIOGEOGR, V36, P387, DOI 10.1111/j.1365-2699.2008.01994.x; Williams ST, 2003, MOL PHYLOGENET EVOL, V28, P60, DOI 10.1016/S1055-7903(03)00038-1; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; YAMADA SB, 1977, MAR BIOL, V39, P61; YODZIS P, 1981, NATURE, V289, P674, DOI 10.1038/289674a0	112	18	19	2	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71396	10.1371/journal.pone.0071396	http://dx.doi.org/10.1371/journal.pone.0071396			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967204	Green Published, Green Submitted, gold			2022-12-25	WOS:000323115800056
J	Ghareeb, K; Awad, WA; Soodoi, C; Sasgary, S; Strasser, A; Bohm, J				Ghareeb, Khaled; Awad, Wageha A.; Soodoi, Chimidtseren; Sasgary, Soleman; Strasser, Alois; Boehm, Josef			Effects of Feed Contaminant Deoxynivalenol on Plasma Cytokines and mRNA Expression of Immune Genes in the Intestine of Broiler Chickens	PLOS ONE			English	Article							BORNE FUSARIUM MYCOTOXINS; NF-KAPPA-B; VOMITOXIN DEOXYNIVALENOL; SIGNAL-TRANSDUCTION; EPITHELIAL-CELLS; LAYING HENS; PERFORMANCE; LIPOPOLYSACCHARIDE; PARAMETERS; INHIBITORS	An experiment was conducted to investigate the individual and combined effects of dietary deoxynivalenol (DON) and a microbial feed additive on plasma cytokine level and on the expression of immune relevant genes in jejunal tissues of broilers. A total of 40 broiler chicks were obtained from a commercial hatchery and divided randomly into four groups (10 birds per group). Birds were reared in battery cages from one day old for 5 weeks. The dietary groups were 1) control birds fed basal diet; 2) DON group fed basal diet contaminated with 10 mg DON/ kg feed; 3) DON + Mycofix group fed basal diet contaminated with 10 mg DON/ kg feed and supplemented with a commercial feed additive, Mycofix (R) Select (MS) (2.5 kg/ton of feed); 4) Mycofix group fed basal diet supplemented with MS (2.5 kg/ton of feed). At 35 days, the plasma levels of tumor necrosis factor alpha (TNF-alpha) and interleukin 8 (IL-8) were quantified by ELISA test kits. Furthermore, the mRNA expression of TNF-alpha, IL-8, IL-1 beta, interferon gamma (IFN gamma), transforming growth factor beta receptor I (TGFBR1) and nuclear factor kappa-light-chain-enhancer of activated B cells 1 (NF-kappa beta 1) in jejunum were quantified by qRT-PCR. The results showed that the plasma TNF-alpha decreased in response to DON, while in combination with MS, the effect of DON was reduced. DON down-regulated the relative gene expression of IL-1 beta, TGFBR1 and IFN-gamma, and addition of MS to the DON contaminated diet compensates these effects on IL-1 beta, TGFBR1 but not for IFN-gamma. Furthermore, supplementation of MS to either DON contaminated or control diet up-regulated the mRNA expression of NF-kappa beta 1. In conclusion, DON has the potential to provoke and modulate immunological reactions of broilers and subsequently could increase their susceptibility to disease. The additive seemed to have almost as much of an effect as DON, albeit on different genes.	[Ghareeb, Khaled; Boehm, Josef] Univ Vet Med, Inst Anim Nutr & Funct Plant Cpds, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria; [Ghareeb, Khaled] South Valley Univ, Dept Anim Hyg Behav & Management, Fac Vet Med, Qena, Egypt; [Awad, Wageha A.] Univ Vet Med, Dept Farm Anim & Vet Publ Hlth, Clin Avian Reptile & Fish Med, Vienna, Austria; [Soodoi, Chimidtseren; Sasgary, Soleman; Strasser, Alois] Univ Vet Med, Inst Physiol Pathophysiol & Biophys, Dept Biomed Sci, Vienna, Austria	University of Veterinary Medicine Vienna; Egyptian Knowledge Bank (EKB); South Valley University Egypt; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Ghareeb, K (corresponding author), Univ Vet Med, Inst Anim Nutr & Funct Plant Cpds, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria.	Khaled.Ghareeb@vetmeduni.ac.at	Awad, Wageha/R-1705-2016	Awad, Wageha/0000-0003-0843-2089; Ghareeb, Khaled/0000-0001-6191-6344	Biomin GTI GmbH, Herzogenburg, Austria	Biomin GTI GmbH, Herzogenburg, Austria	This work received the financial support from Biomin GTI GmbH, Herzogenburg, Austria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2002, J BIOL CHEM, V277, P20431, DOI 10.1074/jbc.M110333200; Awad WA, 2012, POULTRY SCI, V91, P550, DOI 10.3382/ps.2011-01742; Awad WA, 2005, POULTRY SCI, V84, P928, DOI 10.1093/ps/84.6.928; Becker Christiane, 2011, Mycotoxin Res, V27, P287, DOI 10.1007/s12550-011-0106-7; Bondy GS, 2000, J TOXICOL ENV HEAL B, V3, P109, DOI 10.1080/109374000281113; Bouhet S, 2004, TOXICOL SCI, V77, P165, DOI 10.1093/toxsci/kfh006; Cario E, 2000, J IMMUNOL, V164, P966, DOI 10.4049/jimmunol.164.2.966; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Cheng YH, 2006, ANIM RES, V55, P579, DOI 10.1051/animres:2006032; Chowdhury SR, 2005, POULTRY SCI, V84, P1841, DOI 10.1093/ps/84.12.1841; Danicke S, 2002, POULTRY SCI, V81, P1671, DOI 10.1093/ps/81.11.1671; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; EFRAT S, 1984, BIOCHEM BIOPH RES CO, V123, P842, DOI 10.1016/0006-291X(84)90307-3; Elewaut D, 1999, J IMMUNOL, V163, P1457; FINCO TS, 1995, IMMUNITY, V3, P263, DOI 10.1016/1074-7613(95)90112-4; Ghareeb K, 2012, POULTRY SCI, V91, P800, DOI 10.3382/ps.2011-01741; Girgis GN, 2008, EXP BIOL MED, V233, P1411, DOI 10.3181/0805-RM-173; Gutsmann T, 2007, INT J MED MICROBIOL, V297, P341, DOI 10.1016/j.ijmm.2007.03.004; Halawa A, 2012, THESIS U VET MED HAN; Hardin J, 2000, GUT, V47, P184, DOI 10.1136/gut.47.2.184; HARVEY RB, 1991, B ENVIRON CONTAM TOX, V46, P410, DOI 10.1007/BF01688940; Hodgson JC, 2006, J COMP PATHOL, V135, P157, DOI 10.1016/j.jcpa.2006.09.001; HOLT PS, 1988, TOXICON, V26, P549, DOI 10.1016/0041-0101(88)90235-8; Hughes R.J., 2005, ASIA PAC J CLIN NUTR, V14, pS27; Li Z, 2012, POULTRY SCI, V91, P2487, DOI 10.3382/ps.2012-02437; LIZGRANA M, 2001, ALLERGOL IMMUNOL CLI, V16, P140; Ouyang YL, 1996, TOXICOL APPL PHARM, V140, P328, DOI 10.1006/taap.1996.0228; Pestka JJ, 2003, TOXICOL LETT, V140, P287, DOI 10.1016/S0378-4274(03)00024-9; Pestka JJ, 2005, J TOXICOL ENV HEAL B, V8, P39, DOI 10.1080/10937400590889458; Pestka JJ, 2004, TOXICOL LETT, V153, P61, DOI 10.1016/j.toxlet.2004.04.023; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prescott LM, 2002, MICROBIOLOGY, P720; Richard J. L, 2000, ROMER LABS GUIDE MYC, V1, P1; Rosenwasser L. J., 2003, MIDDLETONS ALLERGY P, P135; Rotter BA, 1996, J TOXICOL ENV HEALTH, V48, P1, DOI 10.1080/009841096161447; Scheidereit C, 1998, NATURE, V395, P225, DOI 10.1038/26121; Tayal V, 2008, EUR J PHARMACOL, V579, P1, DOI 10.1016/j.ejphar.2007.10.049; VALENTA H, 2002, VDLUFA SCHRIFTENREIH, V158, P680; Van De WJ, 2008, TOXICOL LETT, V177, P205, DOI DOI 10.1016/j.toxlet.2008.01.018; Xu L, 2011, POULTRY SCI, V90, P2766, DOI 10.3382/ps.2011-01654; Yunus AW, 2012, POULTRY SCI, V91, P844, DOI 10.3382/ps.2011-01873; Zhou HR, 1997, TOXICOL APPL PHARM, V144, P294, DOI 10.1006/taap.1997.8132; ZINCK R, 1995, MOL CELL BIOL, V15, P4930	43	50	50	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71492	10.1371/journal.pone.0071492	http://dx.doi.org/10.1371/journal.pone.0071492			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977054	Green Submitted, Green Published, gold			2022-12-25	WOS:000324527300018
J	Peiffer, J; Cosnier, F; Grova, N; Nunge, H; Salquebre, G; Decret, MJ; Cossec, B; Rychen, G; Appenzeller, BMR; Schroeder, H				Peiffer, Julie; Cosnier, Frederic; Grova, Nathalie; Nunge, Herve; Salquebre, Guillaume; Decret, Marie-Josephe; Cossec, Benoit; Rychen, Guido; Appenzeller, Brice M. R.; Schroeder, Henri			Neurobehavioral Toxicity of a Repeated Exposure (14 Days) to the Airborne Polycyclic Aromatic Hydrocarbon Fluorene in Adult Wistar Male Rats	PLOS ONE			English	Article							ANXIETY-RELATED BEHAVIOR; OPEN-FIELD; RESTRAINT STRESS; ENVIRONMENTAL EXPOSURE; GAS-CHROMATOGRAPHY; BRAIN; MICE; MODULATION; EXPRESSION; CHEMICALS	Fluorene is one of the most abundant polycyclic aromatic hydrocarbons in air and may contribute to the neurobehavioral alterations induced by the environmental exposure of humans to PAHs. Since no data are available on fluorene neurotoxicity, this study was conducted in adult rats to assess the behavioral toxicity of repeated fluorene inhalation exposure. Male rats (n = 18/group) were exposed nose-only to 1.5 or 150 ppb of fluorene 6 hours/day for 14 consecutive days, whereas the control animals were exposed to non-contaminated air. At the end of the exposure, animals were tested for activity and anxiety in an open-field and in an elevated-plus maze, for short-term memory in a Y-maze, and for spatial learning in an eight-arm maze. The results showed that the locomotor activity and the learning performances of the animals were unaffected by fluorene. In parallel, the fluorene-exposed rats showed a lower level of anxiety than controls in the open-field, but not in the elevated-plus maze, which is probably due to a possible difference in the aversive feature of the two mazes. In the same animals, increasing blood and brain levels of fluorene monohydroxylated metabolites (especially the 2-OH fluorene) were detected at both concentrations (1.5 and 150 ppb), demonstrating the exposure of the animals to the pollutant and showing the ability of this compound to be metabolized and to reach the cerebral compartment. The present study highlights the possibility for a 14-day fluorene exposure to induce some specific anxiety-related behavioral disturbances, and argues in favor of the susceptibility of the adult brain when exposed to volatile fluorene.	[Peiffer, Julie; Rychen, Guido; Schroeder, Henri] Univ Lorraine, INRA UC340, Unite Rech Anim & Fonctionnalites Prod Anim, Vandoeuvre Les Nancy, France; [Cosnier, Frederic; Nunge, Herve; Decret, Marie-Josephe; Cossec, Benoit] Inst Natl Rech & Secur, Dept Polluants & Sante, Unite Serv Interlabs, Vandoeuvre Les Nancy, France; [Grova, Nathalie; Salquebre, Guillaume; Appenzeller, Brice M. R.] CRP Sante, Lab Analyt Human Biomonitoring, Luxembourg Ville, Luxembourg	INRAE; Universite de Lorraine; Luxembourg Institute of Health	Schroeder, H (corresponding author), Univ Lorraine, INRA UC340, Unite Rech Anim & Fonctionnalites Prod Anim, Vandoeuvre Les Nancy, France.	henri.schroeder@univ-lorraine.fr	Schroeder, Henri/GQZ-2571-2022; COSNIER, Frédéric/X-6122-2019	COSNIER, Frédéric/0000-0002-8596-927X; Appenzeller, Brice/0000-0001-9021-929X; Grova, Nathalie/0000-0002-7042-164X	French Environment and Energy Management Agency (ADEME); Lorraine regional council	French Environment and Energy Management Agency (ADEME); Lorraine regional council(Region Grand-Est)	This work was supported by specific grants from the French Environment and Energy Management Agency (ADEME, http://www2.ademe.fr) and from the Lorraine regional council (http://www.lorraine.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera G, 1998, TRENDS ENDOCRIN MET, V9, P329, DOI 10.1016/S1043-2760(98)00079-4; Amorim LCA, 2009, J CHROMATOGR A, V1216, P2900, DOI 10.1016/j.chroma.2008.11.012; Blaise SA, 2009, EXP NEUROL, V216, P231, DOI 10.1016/j.expneurol.2008.11.020; Boffetta P, 1997, CANCER CAUSE CONTROL, V8, P444, DOI 10.1023/A:1018465507029; Bowman RE, 2002, NEUROSCIENCE, V113, P401, DOI 10.1016/S0306-4522(02)00156-2; Carola V, 2002, BEHAV BRAIN RES, V134, P49, DOI 10.1016/S0166-4328(01)00452-1; DAYAL H, 1995, ARCH ENVIRON HEALTH, V50, P108, DOI 10.1080/00039896.1995.9940887; Dubovicky M, 2004, ANN NY ACAD SCI, V1018, P199, DOI 10.1196/annals.1296.023; Gmeiner G, 1997, J CHROMATOGR A, V767, P163, DOI 10.1016/S0021-9673(96)01092-8; Gould TD, 2009, NEUROMETHODS, V42, P1, DOI 10.1007/978-1-60761-303-9_1; Grandjean P, 2006, LANCET, V368, P2167, DOI 10.1016/S0140-6736(06)69665-7; Gregus A, 2005, BEHAV BRAIN RES, V156, P105, DOI 10.1016/j.bbr.2004.05.013; Grova N, 2008, CHEMOSPHERE, V73, pS295, DOI 10.1016/j.chemosphere.2007.12.037; Grova N, 2007, NEUROTOXICOLOGY, V28, P630, DOI 10.1016/j.neuro.2007.01.010; Grova N, 2011, CHEM RES TOXICOL, V24, P1653, DOI 10.1021/tx2003596; Hugue RN, 2004, NEUROSCI BIOBEHAV R, V28, P497; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010, IARC Monogr Eval Carcinog Risks Hum, V92, P1; KILBURN KH, 1995, NEUROTOXICOL TERATOL, V17, P89, DOI 10.1016/0892-0362(94)00057-K; Konstandi M, 1997, PHARMACOL BIOCHEM BE, V56, P637, DOI 10.1016/S0091-3057(96)00407-8; Kot-Wasik A, 2004, ANAL CHIM ACTA, V505, P289, DOI 10.1016/j.aca.2003.10.068; Li Z, 2010, J ENVIRON MONITOR, V12, P1110, DOI 10.1039/c000689k; Ling S, 2003, J PHARM PHARM SCI, V6, P246; MAJCHRZAK R, 1990, Medycyna Pracy, V41, P108; Narciso SP, 2003, INHAL TOXICOL, V15, P1133, DOI 10.1080/08958370390228592; Niu QA, 2010, OCCUP ENVIRON MED, V67, P444, DOI 10.1136/oem.2009.047969; OECD, 2009, GUID TEST CHEM; Ramirez N, 2011, ENVIRON HEALTH PERSP, V119, P1110, DOI 10.1289/ehp.1002855; Ravindranath V, 1995, TOXICOL LETT, V82-3, P633, DOI 10.1016/0378-4274(95)03508-7; Santodonato J, 1997, CHEMOSPHERE, V34, P835, DOI 10.1016/S0045-6535(97)00012-X; Saunders CR, 2003, INT J TOXICOL, V22, P263, DOI 10.1080/10915810305114; Saunders CR, 2002, TOXICOL LETT, V129, P33, DOI 10.1016/S0378-4274(01)00467-2; Schroeder H, 2011, CRIT REV ENV SCI TEC, V41, P2026, DOI 10.1080/10643389.2010.495644; Shimada T, 2006, DRUG METAB PHARMACOK, V21, P257, DOI 10.2133/dmpk.21.257; Srogi K, 2007, ENVIRON CHEM LETT, V5, P169, DOI 10.1007/s10311-007-0095-0; U.S. Environmental Protection Agency, 2002, LAT FIND NAT AIR QUA; Unwin J, 2006, ANN OCCUP HYG, V50, P395, DOI [10.1093/annhyg/mel010, 10.1093/annhyg/mei010]; Violle N, 2009, BEHAV BRAIN RES, V203, P35, DOI 10.1016/j.bbr.2009.04.015; Wormley DD, 2004, CELL MOL BIOL, V50, P715; Xia YK, 2009, ENVIRON SCI TECHNOL, V43, P4567, DOI 10.1021/es9000642	39	22	22	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71413	10.1371/journal.pone.0071413	http://dx.doi.org/10.1371/journal.pone.0071413			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977039	Green Published, gold, Green Submitted			2022-12-25	WOS:000324527300014
J	Du, WL; Wang, J; Wang, LM; Zhang, J; Chen, XH; Zhao, JX; Yang, QH; Wu, J				Du, Wanli; Wang, Jing; Wang, Liangming; Zhang, Jun; Chen, Xinhong; Zhao, Jixin; Yang, Qunhui; Wu, Jun			Development and Characterization of a Psathyrostachys huashanica Keng 7Ns Chromosome Addition Line with Leaf Rust Resistance	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; EST-SSR MARKERS; MOLECULAR CYTOGENETIC CHARACTERIZATION; SECALE-CEREALE L.; HORDEUM-CHILENSE; GENETIC-ANALYSIS; COMMON WHEAT; TRANSLOCATION; LOCATION; RYE	The aim of this study was to characterize a Triticum aestivum-Psathyrostachys huashanica Keng (2n = 2x = 14, NsNs) disomic addition line 2-1-6-3. Individual line 2-1-6-3 plants were analyzed using cytological, genomic in situ hybridization (GISH), EST-SSR, and EST-STS techniques. The alien addition line 2-1-6-3 was shown to have two P. huashanica chromosomes, with a meiotic configuration of 2n = 44 = 22 II. We tested 55 EST-SSR and 336 EST-STS primer pairs that mapped onto seven different wheat chromosomes using DNA from parents and the P. huashanica addition line. One EST-SSR and nine EST-STS primer pairs indicated that the additional chromosome of P. huashanica belonged to homoeologous group 7, the diagnostic fragments of five EST-STS markers (BE404955, BE591127, BE637663, BF482781 and CD452422) were cloned, sequenced and compared. The results showed that the amplified polymorphic bands of P. huashanica and disomic addition line 2-1-6-3 shared 100% sequence identity, which was designated as the 7Ns disomic addition line. Disomic addition line 2-1-6-3 was evaluated to test the leaf rust resistance of adult stages in the field. We found that one pair of the 7Ns genome chromosomes carried new leaf rust resistance gene(s). Moreover, wheat line 2-1-6-3 had a superior numbers of florets and grains per spike, which were associated with the introgression of the paired P. huashanica chromosomes. These high levels of disease resistance and stable, excellent agronomic traits suggest that this line could be utilized as a novel donor in wheat breeding programs.	[Du, Wanli; Wang, Jing; Wang, Liangming; Zhang, Jun; Chen, Xinhong; Zhao, Jixin; Yang, Qunhui; Wu, Jun] Northwest A&F Univ, Coll Agron, Shaanxi Key Lab Genet Engn Plant Breeding, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Wu, J (corresponding author), Northwest A&F Univ, Coll Agron, Shaanxi Key Lab Genet Engn Plant Breeding, Yangling, Shaanxi, Peoples R China.	13572016162@163.com	WANG, JINGYI/GSJ-1241-2022		Ministry of Science and Technology of the People's Republic of China [2011AA10010203]; Northwest AF University [Z109021002, A212020716]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Northwest AF University	Financial support was provided by the Ministry of Science and Technology of the People's Republic of China (No. 2011AA10010203) and Northwest A&F University (No. Z109021002, A212020716). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Able JA, 2007, TRENDS PLANT SCI, V12, P71, DOI 10.1016/j.tplants.2006.12.002; Azhaguvel P, 2012, THEOR APPL GENET, V124, P555, DOI 10.1007/s00122-011-1728-z; BADEN C, 1991, NORD J BOT, V11, P3, DOI 10.1111/j.1756-1051.1991.tb01790.x; Bansal UK, 2008, J APPL GENET, V49, P141, DOI 10.1007/BF03195607; Chen GL, 2012, J BIOSCIENCES, V37, P149, DOI 10.1007/s12038-011-9175-1; Chen HM, 2005, CHINESE SCI BULL, V50, P2328, DOI 10.1360/982005-379; CHEN S, 1991, Acta Genetica Sinica, V18, P508; Chen SY., 1996, ACTA GENET SIN, V23, P447; Cifuentes M, 2009, THEOR APPL GENET, V119, P805, DOI 10.1007/s00122-009-1090-6; Cota-Sanchez JH, 2006, PLANT MOL BIOL REP, V24, P161, DOI 10.1007/BF02914055; Gennaro A, 2009, FUNCT INTEGR GENOMIC, V9, P325, DOI 10.1007/s10142-009-0115-1; Hu LJ, 2012, GENES GENOM, V34, P67, DOI 10.1007/s13258-011-0153-7; Huerta-Espino J, 2011, EUPHYTICA, V179, P143, DOI 10.1007/s10681-011-0361-x; Kang HY, 2009, PLANT BREEDING, V128, P36, DOI 10.1111/j.1439-0523.2008.01542.x; Kang HY, 2010, GENET RESOUR CROP EV, V57, P111, DOI 10.1007/s10722-009-9455-x; Kang HY, 2012, GENOME, V55, P383, DOI [10.1139/G2012-025, 10.1139/g2012-025]; Kang HY, 2012, GENET RESOUR CROP EV, V59, P445, DOI 10.1007/s10722-011-9694-5; Kang HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021802; Konig J, 2012, MOL BREEDING, V30, P1253, DOI 10.1007/s11032-012-9712-0; Kuo P. C., 1987, FLORA REIPUBLICAE PO, P51; LARKIN PJ, 1995, GENOME, V38, P385, DOI 10.1139/g95-050; Lu BR, 1995, CHINESE BIODIVERSITY, V3, P63; McIntosh R A, 2010, CATALOGUE GENE SYM S; McIntosh RA, 1995, WHEAT RUSTS ATLAS RE, P29; Mebrate SA, 2008, EUPHYTICA, V162, P457, DOI 10.1007/s10681-007-9615-z; Molnar-Lang M, 2000, EUPHYTICA, V112, P117, DOI 10.1023/A:1003840200744; Monneveux P, 2003, PLANT BREEDING, V122, P379, DOI 10.1046/j.1439-0523.2003.00856.x; Peng J. H., 2005, Functional & Integrative Genomics, V5, P80, DOI 10.1007/s10142-004-0128-8; Qi LL, 2011, THEOR APPL GENET, V123, P159, DOI 10.1007/s00122-011-1574-z; Roux SR, 2004, THEOR APPL GENET, V110, P192, DOI 10.1007/s00122-004-1807-5; Rubiales D, 1999, EUPHYTICA, V109, P157, DOI 10.1023/A:1003796807036; Rubiales D, 2001, EUPHYTICA, V122, P369, DOI 10.1023/A:1012952819255; Said M, 2009, EUPHYTICA, V167, P253, DOI 10.1007/s10681-009-9895-6; Schneider A, 2008, EUPHYTICA, V163, P1, DOI 10.1007/s10681-007-9624-y; Sepsi A, 2008, THEOR APPL GENET, V116, P825, DOI 10.1007/s00122-008-0716-4; Sim SC, 2009, GENOME, V52, P431, DOI [10.1139/G09-019, 10.1139/g09-019]; Singh A, 2012, J APPL GENET, V53, P19, DOI 10.1007/s13353-011-0070-0; Singh RP, 1998, CROP SCI, V38, P27, DOI 10.2135/cropsci1998.0011183X003800010005x; Varshney RK, 2005, PLANT SCI, V168, P195, DOI 10.1016/j.plantsci.2004.08.001; Walling JG, 2005, METHOD ENZYMOL, V395, P443, DOI 10.1016/S0076-6879(05)95024-6; Wang CM, 2009, CEREAL RES COMMUN, V37, P13, DOI 10.1556/CRC.37.2009.1.2; Wang RRC, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: CEREALS, P77, DOI 10.1007/978-3-642-14228-4_2; Wang Y, 2011, AFR J BIOTECHNOL, V10, P2201; Wang Y, 2011, BIOTECHNOL LETT, V33, P1233, DOI 10.1007/s10529-011-0537-4; Wehling P, 2003, THEOR APPL GENET, V107, P432, DOI 10.1007/s00122-003-1263-7; Yu JK, 2004, MOL GENET GENOMICS, V271, P742, DOI 10.1007/s00438-004-1027-3; Zhang WJ, 2005, THEOR APPL GENET, V111, P573, DOI 10.1007/s00122-005-2048-y; Zhang XL, 2011, THEOR APPL GENET, V122, P263, DOI 10.1007/s00122-010-1441-3; Zhao JX, 2010, GENET RESOUR CROP EV, V57, P387, DOI 10.1007/s10722-009-9477-4	49	23	35	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e70879	10.1371/journal.pone.0070879	http://dx.doi.org/10.1371/journal.pone.0070879			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23976963	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700011
J	Burgos, JR; Iresjo, BM; Smedh, U				Burgos, Jonathan R.; Iresjo, Britt-Marie; Smedh, Ulrika			Pituitary Adenylate Cyclase-Activating Polypeptide 6-38 Blocks Cocaine- and Amphetamine-Regulated Transcript Peptide-Induced Hypophagia in Rats	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; DORSAL VAGAL COMPLEX; CART PEPTIDE; FOOD-INTAKE; NUCLEUS-ACCUMBENS; GLP-1 RECEPTORS; FOS EXPRESSION; REDUCES FOOD; BINDING; INJECTION	Cocaine- and amphetamine-regulated transcript peptides (CARTp) suppress nutritional intake after administration into the fourth intracerebral ventricle. Recent in vitro studies have shown that PACAP 6-38, a pituitary adenylate cyclase-activating polypeptide (PACAP) fragment, could act as a competitive antagonist against CARTp 55-102 on a common CARTp-sensitive receptor structure. Here, we show for the first time in vivo that the reduction in solid food intake induced by exogenous CARTp 55-102 (0.3 nmol: 1.5 mu g) administered fourth i.c.v. is blocked by pretreatment with PACAP 6-38 (3 nmol). The PACAP 6-38 fragment had no effect by itself either when given into the fourth ventricle or subcutaneously. Although effective to block the CARTp-effect on feeding and short-term body weight, PACAP 6-38 failed to attenuate CARTp-associated gross motor behavioral changes suggesting at least two CARTp-sensitive receptor subtypes. In conclusion, PACAP 6-38 acts as a functional CARTp antagonist in vivo and blocks its effects on feeding and short term weight gain.	[Burgos, Jonathan R.; Iresjo, Britt-Marie; Smedh, Ulrika] Sahlgrens Univ Hosp, Sahlgrenska Acad, Inst Clin Sci, Dept Surg, Gothenburg, Sweden	Sahlgrenska University Hospital; University of Gothenburg	Smedh, U (corresponding author), Sahlgrens Univ Hosp, Sahlgrenska Acad, Inst Clin Sci, Dept Surg, Gothenburg, Sweden.	ulrika.smedh@gu.se		Iresjo, Britt-Marie/0000-0002-7724-0243; Burgos, Jonathan/0000-0001-8056-1729	Byggmastare Olle Engkvists Foundation; Assar Gabrielssons Foundation	Byggmastare Olle Engkvists Foundation; Assar Gabrielssons Foundation	The study was supported by Byggmastare Olle Engkvists Foundation and the Assar Gabrielssons Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aja S, 2006, PEPTIDES, V27, P157, DOI 10.1016/j.peptides.2005.07.003; Aja S, 2002, BEHAV NEUROSCI, V116, P918, DOI 10.1037/0735-7044.116.5.918; Aja S, 2001, AM J PHYSIOL-REG I, V281, pR1862, DOI 10.1152/ajpregu.2001.281.6.R1862; Aja S, 2001, AM J PHYSIOL-REG I, V280, pR1613, DOI 10.1152/ajpregu.2001.280.6.R1613; De Lartigue G, 2010, GASTROENTEROLOGY, V138, P1479, DOI 10.1053/j.gastro.2009.10.034; Dylag T, 2006, PEPTIDES, V27, P1926, DOI 10.1016/j.peptides.2005.10.025; FLYNN FW, 1985, BRAIN RES, V341, P331, DOI 10.1016/0006-8993(85)91072-8; Jones DC, 2008, SYNAPSE, V62, P122, DOI 10.1002/syn.20476; Keller PA, 2006, PEPTIDES, V27, P1328, DOI 10.1016/j.peptides.2005.10.016; Kimmel HL, 2000, J PHARMACOL EXP THER, V294, P784; Koylu EO, 1998, J COMP NEUROL, V391, P115; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; Lambert PD, 1998, SYNAPSE, V29, P293, DOI 10.1002/(SICI)1098-2396(199808)29:4<293::AID-SYN1>3.0.CO;2-0; Lin YM, 2011, NEUROPEPTIDES, V45, P351, DOI 10.1016/j.npep.2011.07.006; Maixnerova J, 2007, PEPTIDES, V28, P1945, DOI 10.1016/j.peptides.2007.07.022; Maletinska L, 2007, EUR J PHARMACOL, V559, P109, DOI 10.1016/j.ejphar.2006.12.014; Matsumura K, 2001, HYPERTENSION, V38, P1096, DOI 10.1161/hy1101.092968; Nakhate KT, 2011, INT J OBESITY, V35, P773, DOI 10.1038/ijo.2010.231; Okumura T, 2000, ENDOCRINOLOGY, V141, P2854, DOI 10.1210/en.141.8.2854; Resch JM, 2011, AM J PHYSIOL-REG I, V301, pR1625, DOI 10.1152/ajpregu.00334.2011; Sarkar S, 2004, BRAIN RES, V999, P181, DOI 10.1016/j.brainres.2003.11.062; Sen A, 2007, ENDOCRINOLOGY, V148, P4400, DOI 10.1210/en.2007-0332; Skibicka KP, 2009, J NEUROSCI, V29, P6973, DOI 10.1523/JNEUROSCI.6144-08.2009; Smedh U, 1995, AM J PHYSIOL-GASTR L, V269, pG1000, DOI 10.1152/ajpgi.1995.269.6.G1000; Smedh U, 2006, AM J PHYSIOL-REG I, V291, pR124, DOI 10.1152/ajpregu.00234.2004; Smedh U, 2003, AM J PHYSIOL-REG I, V284, pR1418, DOI 10.1152/ajpregu.00665.2002; Stanley SA, 2001, BRAIN RES, V893, P186, DOI 10.1016/S0006-8993(00)03312-6; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Yang SC, 2005, NEUROSCIENCE, V133, P841, DOI 10.1016/j.neuroscience.2005.03.023; Yermolaieva O, 2001, J NEUROSCI, V21, P7474, DOI 10.1523/JNEUROSCI.21-19-07474.2001; Zheng HY, 2002, BRAIN RES, V957, P298, DOI 10.1016/S0006-8993(02)03640-5; Zheng HY, 2001, BRAIN RES, V896, P153, DOI 10.1016/S0006-8993(00)03256-X	32	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e72347	10.1371/journal.pone.0072347	http://dx.doi.org/10.1371/journal.pone.0072347			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967296	Green Submitted, gold, Green Published			2022-12-25	WOS:000323378000094
J	Cabrera, M; Pewe, LL; Harty, JT; Frevert, U				Cabrera, Mynthia; Pewe, Lecia L.; Harty, John T.; Frevert, Ute			In vivo CD8+T Cell Dynamics in the Liver of Plasmodium yoelii Immunized and Infected Mice	PLOS ONE			English	Article							CD8(+) T-CELLS; MALARIA CIRCUMSPOROZOITE PROTEIN; X-IRRADIATED SPOROZOITES; NITRIC-OXIDE SYNTHASE; PROTECTIVE IMMUNITY; BERGHEI SPOROZOITES; INTERFERON-GAMMA; KUPFFER-CELLS; PROTRACTED PROTECTION; ANTIGEN PRESENTATION	Plasmodium falciparum malaria remains one of the most serious health problems globally and a protective malaria vaccine is desperately needed. Vaccination with attenuated parasites elicits multiple cellular effector mechanisms that lead to Plasmodium liver stage elimination. While granule-mediated cytotoxicity requires contact between CD8+ effector T cells and infected hepatocytes, cytokine secretion should allow parasite killing over longer distances. To better understand the mechanism of parasite elimination in vivo, we monitored the dynamics of CD8+ T cells in the livers of naive, immunized and sporozoite-infected mice by intravital microscopy. We found that immunization of BALB/c mice with attenuated P. yoelii 17XNL sporozoites significantly increases the velocity of CD8+ T cells patrolling the hepatic microvasculature from 2.69 +/- 0.34 mu m/min in naive mice to 5.74 +/- 0.66 mu m/min, 9.26 +/- 0.92 mu m/min, and 7.11 +/- 0.73 mu m/min in mice immunized with irradiated, early genetically attenuated (Pyuis4-deficient), and late genetically attenuated (Pyfabb/f-deficient) parasites, respectively. Sporozoite infection of immunized mice revealed a 97% and 63% reduction in liver stage density and volume, respectively, compared to naive controls. To examine cellular mechanisms of immunity in situ, naive mice were passively immunized with hepatic or splenic CD8+ T cells. Unexpectedly, adoptive transfer rendered the motile CD8+ T cells from immunized mice immotile in the liver of P. yoelii infected mice. Similarly, when mice were simultaneously inoculated with viable sporozoites and CD8+ T cells, velocities 18 h later were also significantly reduced to 0.68 +/- 0.10 mu m/min, 1.53 +/- 0.22 mu m/min, and 1.06 +/- 0.26 mu m/min for CD8+ T cells from mice immunized with irradiated wild type sporozoites, Pyfabb/f-deficient parasites, and P. yoelii CS280-288 peptide, respectively. Because immobilized CD8+ T cells are unable to make contact with infected hepatocytes, soluble mediators could potentially play a key role in parasite elimination under these experimental conditions.	[Cabrera, Mynthia; Frevert, Ute] NYU, Sch Med, Dept Microbiol, Div Med Parasitol, New York, NY 10016 USA; [Pewe, Lecia L.; Harty, John T.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA	New York University; University of Iowa	Frevert, U (corresponding author), NYU, Sch Med, Dept Microbiol, Div Med Parasitol, New York, NY 10016 USA.	ute.frevert@nyumc.org		Harty, John/0000-0001-7266-2802; Frevert, Ute/0000-0001-9556-7330	National Institutes of Health [RO1 AI070894, S10 RR019288, AI85515, AI95178, AI1000527]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070894, R01AI100527, R01AI085515, R01AI095178] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by National Institutes of Health grants RO1 AI070894 and S10 RR019288 to UF and AI85515, AI95178 and AI1000527 to JTH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amino R, 2006, NAT MED, V12, P220, DOI 10.1038/nm1350; Baer K, 2007, PLOS PATHOG, V3, P1651, DOI 10.1371/journal.ppat.0030171; Baer K, 2007, CELL MICROBIOL, V9, P397, DOI 10.1111/j.1462-5822.2006.00798.x; Bajenoff M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011524; Belnoue E, 2004, J IMMUNOL, V172, P2487, DOI 10.4049/jimmunol.172.4.2487; Belnoue E, 2008, J IMMUNOL, V181, P8552, DOI 10.4049/jimmunol.181.12.8552; Berenzon D, 2003, J IMMUNOL, V171, P2024, DOI 10.4049/jimmunol.171.4.2024; Berg RE, 2005, J IMMUNOL, V175, P1751, DOI 10.4049/jimmunol.175.3.1751; Bertolino P, 2002, IMMUNOL CELL BIOL, V80, P84, DOI 10.1046/j.0818-9641.2001.01048.x; Bongfen SE, 2007, J IMMUNOL, V178, P7054, DOI 10.4049/jimmunol.178.11.7054; Butler NS, 2012, TRENDS IMMUNOL, V33, P247, DOI 10.1016/j.it.2012.02.001; Butler NS, 2011, CELL HOST MICROBE, V9, P451, DOI 10.1016/j.chom.2011.05.008; Butler NS, 2010, J IMMUNOL, V184, P2528, DOI 10.4049/jimmunol.0903529; Cabrera M., 2012, INTRAVITAL, V1, P107, DOI DOI 10.4161/INTV.23423; Chakravarty S, 2008, INFECT IMMUN, V76, P3628, DOI 10.1128/IAI.00471-08; Chakravarty S, 2007, NAT MED, V13, P1035, DOI 10.1038/nm1628; Clark IA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-85; CLYDE DF, 1990, B WORLD HEALTH ORGAN, V68, P9; CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; Cockburn IA, 2008, J IMMUNOL, V180, P64, DOI 10.4049/jimmunol.180.1.64; Cohen J, 2010, HUM VACCINES, V6, P90, DOI 10.4161/hv.6.1.9677; Conteh S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008947; Crispe I Nicholas, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0321s22; Crispe IN, 2011, J HEPATOL, V54, P357, DOI 10.1016/j.jhep.2010.10.005; Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629; DANFORTH HD, 1980, J PROTOZOOL, V27, P193, DOI 10.1111/j.1550-7408.1980.tb04680.x; Doolan DL, 2000, J IMMUNOL, V165, P1453, DOI 10.4049/jimmunol.165.3.1453; Doolan DL, 1999, J IMMUNOL, V163, P884; Doolan DL, 2006, CURR MOL MED, V6, P169, DOI 10.2174/156652406776055249; Douradinha B, 2008, INFECT IMMUN, V76, P873, DOI 10.1128/IAI.00431-07; Douradinha B, 2007, INT J PARASITOL, V37, P1511, DOI 10.1016/j.ijpara.2007.05.005; EGAN JE, 1993, AM J TROP MED HYG, V49, P166, DOI 10.4269/ajtmh.1993.49.166; Egen JG, 2011, IMMUNITY, V34, P807, DOI 10.1016/j.immuni.2011.03.022; Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548; FERREIRA A, 1986, SCIENCE, V232, P881, DOI 10.1126/science.3085218; Frevert U, 2005, PLOS BIOL, V3, P1034, DOI 10.1371/journal.pbio.0030192; Frevert U, 2013, PARASITE IMMUNOL, V35, P267, DOI 10.1111/pim.12039; Frevert U, 1998, EMBO J, V17, P3816, DOI 10.1093/emboj/17.14.3816; Frevert U, 2009, INT J PARASITOL, V39, P119, DOI 10.1016/j.ijpara.2008.06.014; Frevert U, 2008, CELL MICROBIOL, V10, P1956, DOI 10.1111/j.1462-5822.2008.01211.x; Friedl P, 2008, NAT IMMUNOL, V9, P960, DOI 10.1038/ni.f.212; GREENWAY CV, 1970, CIRC RES, V26, P697, DOI 10.1161/01.RES.26.6.697; Guebre-Xabier M, 1999, EUR J IMMUNOL, V29, P3978, DOI 10.1002/(SICI)1521-4141(199912)29:12&lt;3978::AID-IMMU3978&gt;3.0.CO;2-0; HENRIKSEN JH, 1984, LIVER, V4, P221; HERRINGTON DA, 1990, B WORLD HEALTH ORGAN, V68, P33; HOFFMAN SL, 1990, B WORLD HEALTH ORGAN, V68, P132; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; HOFFMAN SL, 1989, SCIENCE, V244, P1078, DOI 10.1126/science.2524877; Hugel FU, 1996, MOL BIOCHEM PARASIT, V81, P151, DOI 10.1016/0166-6851(96)02701-6; Jobe O, 2007, J INFECT DIS, V196, P599, DOI 10.1086/519743; Jobe O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005075; John B, 2004, J IMMUNOL, V172, P5222, DOI 10.4049/jimmunol.172.9.5222; Klein I, 2007, BLOOD, V110, P4077, DOI 10.1182/blood-2007-02-073841; Klotz C, 2008, INT J PARASITOL, V38, P1639, DOI 10.1016/j.ijpara.2008.05.018; KLOTZ FW, 1995, J IMMUNOL, V154, P3391; Knolle PA, 2001, TRENDS IMMUNOL, V22, P432, DOI 10.1016/S1471-4906(01)01957-3; Krzych U, 2005, CURR TOP MICROBIOL, V297, P1; Krzych U, 2000, IMMUNOL REV, V174, P123, DOI 10.1034/j.1600-0528.2002.00013h.x; Krzych U, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00370; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; Kumar KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004480; Labaied M, 2007, INFECT IMMUN, V75, P3758, DOI 10.1128/IAI.00225-07; LAINE GA, 1979, CIRC RES, V45, P317, DOI 10.1161/01.RES.45.3.317; Mackay IR, 2002, IMMUNOL CELL BIOL, V80, P36, DOI 10.1046/j.1440-1711.2002.01063.x; MAGARI S, 1990, J GASTROEN HEPATOL, V5, P82, DOI 10.1111/j.1440-1746.1990.tb01769.x; MAZIER D, 1986, SCIENCE, V231, P156, DOI 10.1126/science.3510455; McCall MBB, 2010, J LEUKOCYTE BIOL, V88, P1131, DOI 10.1189/jlb.0310137; McDonald B, 2008, J EXP MED, V205, P915, DOI 10.1084/jem.20071765; MELLOUK S, 1991, J IMMUNOL, V146, P3971; MELLOUK S, 1987, J IMMUNOL, V139, P4192; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Morrot A, 2006, INFECT IMMUN, V74, P2495, DOI 10.1128/IAI.74.4.2495-2497.2006; Morrot A, 2004, IMMUNOL REV, V201, P291, DOI 10.1111/j.0105-2896.2004.00175.x; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; Motoike T, 2000, GENESIS, V28, P75, DOI 10.1002/1526-968X(200010)28:2<75::AID-GENE50>3.0.CO;2-S; Muller AJ, 2012, IMMUNITY, V37, P147, DOI 10.1016/j.immuni.2012.05.015; Mueller AK, 2007, AM J PATHOL, V171, P107, DOI 10.2353/ajpath.2007.060792; Nganou-Makamdop K, 2012, PARASITE IMMUNOL; Nganou-Makamdop K, 2013, TRENDS PARASITOL, V29, P304, DOI 10.1016/j.pt.2013.03.008; NUDELMAN S, 1989, J IMMUNOL, V143, P996; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; NUSSENZWEIG RS, 1969, NATURE, V222, P488, DOI 10.1038/222488a0; NUSSENZWEIG RS, 1972, AM J TROP MED HYG, V21, P722, DOI 10.4269/ajtmh.1972.21.722; NUSSENZWEIG V, 1989, ADV IMMUNOL, V45, P283, DOI 10.1016/S0065-2776(08)60695-1; NUSSLER AK, 1993, EUR J IMMUNOL, V23, P882, DOI 10.1002/eji.1830230417; Ohtani O, 2008, ANAT REC, V291, P643, DOI 10.1002/ar.20681; Overstreet MG, 2008, IMMUNOL REV, V225, P272, DOI 10.1111/j.1600-065X.2008.00671.x; Park S, 2002, IMMUNOL CELL BIOL, V80, P74, DOI 10.1046/j.1440-1711.2002.01065.x; Pradel G, 2001, HEPATOLOGY, V33, P1154, DOI 10.1053/jhep.2001.24237; Purcell LA, 2008, VACCINE, V26, P4880, DOI 10.1016/j.vaccine.2008.07.017; Racanelli V, 2006, HEPATOLOGY, V43, pS54, DOI 10.1002/hep.21060; Renggli J, 1997, PARASITE IMMUNOL, V19, P145, DOI 10.1046/j.1365-3024.1997.d01-190.x; RENIA L, 1991, P NATL ACAD SCI USA, V88, P7963, DOI 10.1073/pnas.88.18.7963; RODRIGUES M, 1992, J EXP MED, V175, P895, DOI 10.1084/jem.175.4.895; RODRIGUES MM, 1991, INT IMMUNOL, V3, P579, DOI 10.1093/intimm/3.6.579; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; Sano G, 2001, J EXP MED, V194, P173, DOI 10.1084/jem.194.2.173; Schmidt NW, 2008, P NATL ACAD SCI USA, V105, P14017, DOI 10.1073/pnas.0805452105; Schmidt NW, 2011, J IMMUNOL, V186, P5873, DOI 10.4049/jimmunol.1100194; Schmidt NW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000998; SCHOFIELD L, 1987, J IMMUNOL, V139, P2020; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Sedegah M, 2007, PARASITE IMMUNOL, V29, P559, DOI 10.1111/j.1365-3024.2007.00976.x; SEGUIN MC, 1994, J EXP MED, V180, P353, DOI 10.1084/jem.180.1.353; SEGUIN MC, 1989, J IMMUNOL, V143, P1716; Sheth K, 2001, Curr Opin Crit Care, V7, P99, DOI 10.1097/00075198-200104000-00008; SINA BJ, 1993, EXP PARASITOL, V77, P129, DOI 10.1006/expr.1993.1069; Spaccapelo R, 1997, LANCET, V350, P335, DOI 10.1016/S0140-6736(97)24031-6; Steers N, 2005, EUR J IMMUNOL, V35, P2335, DOI 10.1002/eji.200425680; Steers N, 2005, EUR J IMMUN IN PRESS; STEWART MJ, 1988, J PROTOZOOL, V35, P389, DOI 10.1111/j.1550-7408.1988.tb04115.x; STEWART MJ, 1991, J PROTOZOOL, V38, P411, DOI 10.1111/j.1550-7408.1991.tb01379.x; Stoyanov CT, 2010, VACCINE, V28, P4644, DOI 10.1016/j.vaccine.2010.04.071; Sun PF, 2003, J IMMUNOL, V171, P6961, DOI 10.4049/jimmunol.171.12.6961; Tarun AS, 2007, J INFECT DIS, V196, P608, DOI 10.1086/519742; Tarun AS, 2006, INT J PARASITOL, V36, P1283, DOI 10.1016/j.ijpara.2006.06.009; Tavares J, 2013, J EXP MED, V210, P905, DOI 10.1084/jem.20121130; Trimnell A, 2009, J IMMUNOL, V183, P5870, DOI 10.4049/jimmunol.0900302; TRUTMANN M, 1994, ANAT EMBRYOL, V190, P201; TSUJI M, 1995, J IMMUNOL, V154, P5338; Tsuji M, 2010, EXP PARASITOL, V126, P421, DOI 10.1016/j.exppara.2009.11.009; Usynin I, 2007, CELL MICROBIOL, V9, P2610, DOI 10.1111/j.1462-5822.2007.00982.x; VanBuskirk KM, 2009, P NATL ACAD SCI USA, V106, P13004, DOI 10.1073/pnas.0906387106; Vanderberg JP, 2004, INT J PARASITOL, V34, P991, DOI 10.1016/j.ijpara.2004.05.005; VANDERBERG JP, 1968, J PARASITOL, V54, P1175, DOI 10.2307/3276987; Vaughan Ashley M, 2013, Methods Mol Biol, V923, P549; Vaughan AM, 2009, CELL MICROBIOL, V11, P506, DOI 10.1111/j.1462-5822.2008.01270.x; WEISS WR, 1992, J IMMUNOL, V149, P2103; WEISS WR, 1988, P NATL ACAD SCI USA, V85, P573, DOI 10.1073/pnas.85.2.573; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WISSE E, 1983, SCAN ELECTRON MICROS, P1441; Zarling S, 2013, J IMMUNOL, V190, P5128, DOI 10.4049/jimmunol.1203396	132	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e70842	10.1371/journal.pone.0070842	http://dx.doi.org/10.1371/journal.pone.0070842			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967119	Green Published, Green Submitted, gold			2022-12-25	WOS:000323221500039
J	Cobley, MJ; Rayfield, EJ; Barrett, PM				Cobley, Matthew J.; Rayfield, Emily J.; Barrett, Paul M.			Inter-Vertebral Flexibility of the Ostrich Neck: Implications for Estimating Sauropod Neck Flexibility	PLOS ONE			English	Article							ANTERIOR PRESACRAL REGION; LONG NECKS; POSTURE; DINOSAURS; HOMOLOGIES; ECOLOGY; MUSCLES; SYSTEM	The flexibility and posture of the neck in sauropod dinosaurs has long been contentious. Improved constraints on sauropod neck function will have major implications for what we know of their foraging strategies, ecology and overall biology. Several hypotheses have been proposed, based primarily on osteological data, suggesting different degrees of neck flexibility. This study attempts to assess the effects of reconstructed soft tissues on sauropod neck flexibility through systematic removal of muscle groups and measures of flexibility of the neck in a living analogue, the ostrich (Struthio camelus). The possible effect of cartilage on flexibility is also examined, as this was previously overlooked in osteological estimates of sauropod neck function. These comparisons show that soft tissues are likely to have limited the flexibility of the neck beyond the limits suggested by osteology alone. In addition, the inferred presence of cartilage, and varying the intervertebral spacing within the synovial capsule, also affect neck flexibility. One hypothesis proposed that flexibility is constrained by requiring a minimum overlap between successive zygapophyses equivalent to 50% of zygapophyseal articular surface length (ONP50). This assumption is tested by comparing the maximum flexibility of the articulated cervical column in ONP50 and the flexibility of the complete neck with all tissues intact. It is found that this model does not adequately convey the pattern of flexibility in the ostrich neck, suggesting that the ONP50 model may not be useful in determining neck function if considered in isolation from myological and other soft tissue data.	[Cobley, Matthew J.; Rayfield, Emily J.] Univ Bristol, Sch Earth Sci, Bristol, Avon, England; [Barrett, Paul M.] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England	University of Bristol; Natural History Museum London	Cobley, MJ (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	cobley.mj@gmail.com	Rayfield, Emily/F-5038-2010; Barrett, Paul M/A-2648-2010	Rayfield, Emily/0000-0002-2618-750X; Barrett, Paul M/0000-0003-0412-3000				ALEXANDER RM, 1985, ZOOL J LINN SOC-LOND, V83, P1, DOI 10.1111/j.1096-3642.1985.tb00871.x; BAKKER RT, 1971, NATURE, V229, P172, DOI 10.1038/229172a0; Barrett Paul M., 1995, P107; Barrett Paul M., 1994, Gaia, V10, P195; Baumel J.J, 1993, HDB AVIAN ANATOMY NO; BRYANT HN, 1992, PHILOS T ROY SOC B, V337, P405, DOI 10.1098/rstb.1992.0117; Calvo Jorge O., 1994, Gaia, V10, P183; Chin Karen, 1997, P371; Christian A, 1996, PALAEONTOLOGY, V39, P801; Christian Andreas, 1998, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V1, P73; Christian Andreas, 2002, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V5, P271; Christian Andreas, 2007, Fossil Record, V10, P38; Christian Andreas, 2011, P251; Christian A, 2010, BIOL LETTERS, V6, P823, DOI 10.1098/rsbl.2010.0359; Christiansen Per, 2000, Historical Biology, V14, P137; Dzemski G, 2007, J MORPHOL, V268, P701, DOI 10.1002/jmor.10542; Fiorillo Anthony R., 1998, Historical Biology, V13, P1; Gee Carole T., 2011, P34; Holtz TR., 2007, DINOSAURS MOST COMPL; Hummel J, 2008, P ROY SOC B-BIOL SCI, V275, P1015, DOI 10.1098/rspb.2007.1728; Klein N, 2012, BIOL LETTERS, V8, P1032, DOI 10.1098/rsbl.2012.0778; Martin J, 1987, 4 S MES TERR EC, P154; Martin John, 1998, Oryctos, V1, P113; Paul GS, 1987, DINOSAURS PAST PRESE, P5; Perry Steven F., 2011, P83; Perry SF, 2009, J EXP ZOOL PART A, V311A, P600, DOI 10.1002/jez.517; Preuschoft H, 1976, AUFSATZE REDEN SENCK, V28, P98; Ruxton GD, 2011, BIOL LETTERS, V7, P779, DOI 10.1098/rsbl.2011.0116; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Senter P, 2007, J ZOOL, V271, P45, DOI 10.1111/j.1469-7998.2006.00197.x; Seymour RS, 2009, BIOL LETTERS, V5, P317, DOI 10.1098/rsbl.2009.0096; Seymour RS, 2009, SCIENCE, V323, P1671, DOI 10.1126/science.323.5922.1671; Stevens KA, 1999, SCIENCE, V284, P798, DOI 10.1126/science.284.5415.798; Stevens KA, 2005, LIFE O PAST, P212; Stevens KA, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P178; Stevens Kent A., 2002, Senckenbergiana Lethaea, V82, P23; Taylor MP, 2011, J ZOOL, V285, P150, DOI 10.1111/j.1469-7998.2011.00824.x; Taylor MP, 2013, PEERJ, V1, DOI 10.7717/peerj.36; Taylor MP, 2009, ACTA PALAEONTOL POL, V54, P213, DOI 10.4202/app.2009.0007; Tsuihiji T, 2005, J MORPHOL, V263, P151, DOI 10.1002/jmor.10294; Tsuihiji T, 2007, J MORPHOL, V268, P986, DOI 10.1002/jmor.10565; Upchurch P., 2000, SCIENCE, V287, P547, DOI [10.1126/science.287.5453.547b, DOI 10.1126/SCIENCE.287.5453.547B]; Upchurch Paul, 2000, P79, DOI 10.1017/CBO9780511549717.005; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; Van der Leeuw AHJ, 2001, NETH J ZOOL, V51, P243, DOI 10.1163/156854201750385172; Wedel Mathew J., 2002, Paleobios, V22, P1; Whitlock JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018304; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; Young MT, 2012, NATURWISSENSCHAFTEN, V99, P637, DOI 10.1007/s00114-012-0944-y	49	45	46	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e72187	10.1371/journal.pone.0072187	http://dx.doi.org/10.1371/journal.pone.0072187			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967284	Green Submitted, Green Published, gold			2022-12-25	WOS:000323221500122
J	Kenny, EF; Quinn, SR; Doyle, SL; Vink, PM; van Eenennaam, H; O'Neill, LAJ				Kenny, Elaine F.; Quinn, Susan R.; Doyle, Sarah L.; Vink, Paul M.; van Eenennaam, Hans; O'Neill, Luke A. J.			Bruton's Tyrosine Kinase Mediates the Synergistic Signalling between TLR9 and the B Cell Receptor by Regulating Calcium and Calmodulin	PLOS ONE			English	Article							ANTIGEN PRESENTATION; AUTOANTIBODY PRODUCTION; PROTEIN UNC93B; MURINE MODEL; ACTIVATION; BTK; DNA; MUTATION; DISEASE; INITIATION	B cells signal through both the B cell receptor (BCR) which binds antigens and Toll-like receptors (TLRs) including TLR9 which recognises CpG DNA. Activation of TLR9 synergises with BCR signalling when the BCR and TLR9 co-localise within an auto-phagosome-like compartment. Here we report that Bruton's tyrosine kinase (BTK) is required for synergistic IL6 production and up-regulation of surface expression of MHC-class-II, CD69 and CD86 in primary murine and human B cells. We show that BTK is essential for co-localisation of the BCR and TLR9 within a potential auto-phagosome-like compartment in the Namalwa human B cell line. Downstream of BTK we find that calcium acting via calmodulin is required for this process. These data provide new insights into the role of BTK, an important target for autoimmune diseases, in B cell activation.	[Kenny, Elaine F.; Doyle, Sarah L.; O'Neill, Luke A. J.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Immunol Res Ctr, Dublin, Ireland; [Quinn, Susan R.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin, Ireland; [Vink, Paul M.] Janssen Infect Dis BVBA, Beerse, Belgium; [van Eenennaam, Hans] BioNov BV, Oss, Netherlands	Trinity College Dublin; Trinity College Dublin	Kenny, EF (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Immunol Res Ctr, Dublin, Ireland.	kennyef@tcd.ie	Doyle, Sarah/C-1453-2014	Doyle, Sarah/0000-0002-6294-9380; O'Neill, Luke/0000-0002-4333-2748	Science Foundation Ireland [SFI 07/SRC/B1144-O'Neill]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was funded by a grant (SFI 07/SRC/B1144-O'Neill) from Science Foundation Ireland (www.sfi.ie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani R, 2012, J CLIN ONCOL, V30; Allman D, 2008, CURR OPIN IMMUNOL, V20, P149, DOI 10.1016/j.coi.2008.03.014; Baba Y, 2011, TRENDS IMMUNOL, V32, P589, DOI 10.1016/j.it.2011.09.004; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; BRADLEY LAD, 1994, HUM MOL GENET, V3, P79, DOI 10.1093/hmg/3.1.79; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Celhar T, 2012, IMMUNOL RES, V53, P58, DOI 10.1007/s12026-012-8270-1; Chaturvedi A, 2008, IMMUNITY, V28, P799, DOI 10.1016/j.immuni.2008.03.019; Chaturvedi A, 2011, NAT IMMUNOL, V12, P1119, DOI 10.1038/ni.2116; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Christensen SR, 2005, J EXP MED, V202, P321, DOI 10.1084/jem.20050338; Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008; Doyle SL, 2007, J BIOL CHEM, V282, P36953, DOI 10.1074/jbc.M707682200; Doyle SL, 2005, J BIOL CHEM, V280, P23496, DOI 10.1074/jbc.C500053200; Gray P, 2006, J BIOL CHEM, V281, P10489, DOI 10.1074/jbc.M508892200; Herman SEM, 2011, BLOOD, V117, P6287, DOI 10.1182/blood-2011-01-328484; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Hutcheson J, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4086; Jefferies CA, 2004, IMMUNOL LETT, V92, P15, DOI 10.1016/j.imlet.2003.11.017; Jefferies CA, 2003, J BIOL CHEM, V278, P26258, DOI 10.1074/jbc.M301484200; Kil LP, 2012, BLOOD, V119, P3744, DOI 10.1182/blood-2011-12-397919; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Lawe DC, 2003, MOL BIOL CELL, V14, P2935, DOI 10.1091/mbc.E02-09-0591; Lee KG, 2008, J BIOL CHEM, V283, P11189, DOI 10.1074/jbc.M708516200; Leifer CA, 2004, J IMMUNOL, V173, P1179, DOI 10.4049/jimmunol.173.2.1179; Lenert PS, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1888; Liu WL, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002295; Luzio JP, 2007, BIOCHEM SOC T, V35, P1088, DOI 10.1042/BST0351088; Lyubchenko T, 2010, THESCIENTIFICWORLDJO, V10, P2254, DOI 10.1100/tsw.2010.219; MACARDLE PJ, 1995, IMMUNOL CELL BIOL, V73, P165, DOI 10.1038/icb.1995.26; MacGlashan D, 2011, INT IMMUNOPHARMACOL, V11, P475, DOI 10.1016/j.intimp.2010.12.018; Malhotra S, 2009, J BIOL CHEM, V284, P24088, DOI 10.1074/jbc.M109.014209; Mills IG, 2001, J CELL SCI, V114, P1959; Nakano S, 2010, RHEUMATOLOGY, V49, P876, DOI 10.1093/rheumatology/keq001; Nickerson KM, 2010, J IMMUNOL, V184, P1840, DOI 10.4049/jimmunol.0902592; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Pierce SK, 2010, NAT REV IMMUNOL, V10, P767, DOI 10.1038/nri2853; Ploegh HL, 2007, J IMMUNOL, V179, P7193, DOI 10.4049/jimmunol.179.11.7193; Rawlings DJ, 2012, NAT REV IMMUNOL, V12, P282, DOI 10.1038/nri3190; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; Robak T, 2012, EXPERT OPIN INV DRUG, V21, P921, DOI 10.1517/13543784.2012.685650; ROCK KL, 1984, J EXP MED, V160, P1102, DOI 10.1084/jem.160.4.1102; Schaub MC, 2008, BIOCHEM BIOPH RES CO, V369, P247, DOI 10.1016/j.bbrc.2007.10.082; Stoddart A, 2005, MOL BIOL CELL, V16, P2339, DOI 10.1091/mbc.e05-01-0025; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Tao K, 2007, ANN RHEUM DIS, V66, P905, DOI 10.1136/ard.2006.065961; Vig M, 2009, NAT IMMUNOL, V10, P21, DOI 10.1038/ni.f.220; Zhang M, 2012, STRUCTURE, V20, P911, DOI 10.1016/j.str.2012.03.019	50	40	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e74103	10.1371/journal.pone.0074103	http://dx.doi.org/10.1371/journal.pone.0074103			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967355	Green Published, Green Submitted, gold			2022-12-25	WOS:000323221500150
J	Nottage, KA; Hankins, JS; Smeltzer, M; Mzayek, F; Wang, WC; Aygun, B; Gurney, JG				Nottage, Kerri A.; Hankins, Jane S.; Smeltzer, Matthew; Mzayek, Fawaz; Wang, Winfred C.; Aygun, Banu; Gurney, James G.			Hydroxyurea Use and Hospitalization Trends in a Comprehensive Pediatric Sickle Cell Program	PLOS ONE			English	Article							HEALTH-CARE; DISEASE; CHILDREN; ANEMIA; COSTS; EXPENDITURES; FREQUENCY; PATTERNS; BARRIERS; ADULTS	Background: A decline in hospitalizations and pain episodes among those with sickle cell disease (SCD) who take hydroxyurea (HU) has been shown when compared to pre-HU patterns but paradoxically, when compared to those who have never been treated, HU recipients often have more frequent hospitalizations. This analysis evaluates the impact of increasing usage of HU on trends in hospitalizations and blood transfusions within a large SCD treatment program. Methods: Eligibility was restricted to patients with Hb SS or Hb S beta(0)-thalassemia who were 2-18 years old between 2006-2010 and received care at St. Jude Children's Research Hospital (N = 508). Hospitalizations and blood transfusions were calculated for each of the years under study for those exposed and never exposed to HU. Differences in number of hospitalizations before and after HU initiation were compared. Results: The proportion of patients receiving HU increased by 4% per year on average. In the HU exposed group, a modest decline in mean per-patient hospitalizations and per-patient hospital days occurred, while those never exposed to HU trended toward a slight increase over time. Rates of blood transfusions declined among those on HU but not in patients never exposed to HU. Patients on HU had a median of one fewer hospital admission in the year after initiation of HU, compared to the year prior. Two deaths occurred in the patient population, both of whom were not exposed to HU. Conclusions: Increasing usage of HU was concurrent with decreased hospitalization rates and blood transfusions. Our results support the utility of HU on decreasing hospitalizations and transfusions for patients with SCD outside of the clinical trial setting.	[Nottage, Kerri A.; Hankins, Jane S.; Wang, Winfred C.] St Jude Childrens Res Hosp, Dept Hematol, Memphis, TN 38105 USA; [Smeltzer, Matthew] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Mzayek, Fawaz; Gurney, James G.] Univ Memphis, Sch Publ Hlth, Div Epidemiol & Biostat, Memphis, TN 38152 USA; [Aygun, Banu] Steven & Alexandra Cohen Childrens Med Ctr New Yo, Div Pediat Hematol Oncol & Stem Cell Transplantat, New Hyde Pk, NY USA; [Gurney, James G.] St Jude Childrens Res Hosp, Dept Epidemiol & Canc Control, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Memphis; Northwell Health; North Shore University Hospital; Steven & Alexandra Cohen Children's Medical Center of New York; St Jude Children's Research Hospital	Nottage, KA (corresponding author), St Jude Childrens Res Hosp, Dept Hematol, 332 N Lauderdale St, Memphis, TN 38105 USA.	kerri.nottage@stjude.org	Hankins, Jane/N-3362-2018	Smeltzer, Matthew/0000-0003-1366-9267	American Lebanese Syrian Associated Charities (ALSAC)	American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC))	This work was supported by the American Lebanese Syrian Associated Charities (ALSAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendah DD, 2010, AM J PREV MED, V38, pS550, DOI 10.1016/j.amepre.2010.01.004; Brandow AM, 2010, AM J HEMATOL, V85, P611, DOI 10.1002/ajh.21749; Brawley OW, 2008, ANN INTERN MED, V148, P932, DOI 10.7326/0003-4819-148-12-200806170-00220; Chambers J. M., 1983, GRAPHICAL METHODS DA, P395; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; Heeney MM, 2008, PEDIATR CLIN N AM, V55, P483, DOI 10.1016/j.pcl.2008.02.003; Heeney MM, 2010, HEMATOL ONCOL CLIN N, V24, P199, DOI 10.1016/j.hoc.2009.11.002; Kauf TL, 2009, AM J HEMATOL, V84, P323, DOI 10.1002/ajh.21408; Kinney TR, 1999, BLOOD, V94, P1550; Lanzkron S, 2008, J NATL MED ASSOC, V100, P968; Lanzkron S, 2006, AM J HEMATOL, V81, P927, DOI 10.1002/ajh.20703; Lanzkron S, 2010, J HEALTH CARE POOR U, V21, P277, DOI 10.1353/hpu.0.0272; Mvundura M, 2009, PEDIATR BLOOD CANCER, V53, P642, DOI 10.1002/pbc.22069; Nietert PJ, 1999, J PEDIAT HEMATOL ONC, V21, P389, DOI 10.1097/00043426-199909000-00010; Raphael JL, 2012, PEDIATR BLOOD CANCER, V58, P584, DOI 10.1002/pbc.23181; Stallworth JR, 2010, AM J HEMATOL, V85, P795, DOI 10.1002/ajh.21772; Wang WC, 2011, LANCET, V377, P1663, DOI 10.1016/S0140-6736(11)60355-3; Woods K, 1997, PUBLIC HEALTH REP, V112, P44; YANG YM, 1995, PUBLIC HEALTH REP, V110, P80; Zimmerman SA, 2004, BLOOD, V103, P2039, DOI 10.1182/blood-2003-07-2475; Zumberg MS, 2005, AM J HEMATOL, V79, P107, DOI 10.1002/ajh.20353	21	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e72077	10.1371/journal.pone.0072077	http://dx.doi.org/10.1371/journal.pone.0072077			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967276	Green Published, Green Submitted, gold			2022-12-25	WOS:000323221500119
J	Schroeder, FA; Lewis, MC; Fass, DM; Wagner, FF; Zhang, YL; Hennig, KM; Gale, J; Zhao, WN; Reis, S; Barker, DD; Berry-Scott, E; Kim, SW; Clore, EL; Hooker, JM; Holson, EB; Haggarty, SJ; Petryshen, TL				Schroeder, Frederick A.; Lewis, Michael C.; Fass, Daniel M.; Wagner, Florence F.; Zhang, Yan-Ling; Hennig, Krista M.; Gale, Jennifer; Zhao, Wen-Ning; Reis, Surya; Barker, Douglas D.; Berry-Scott, Erin; Kim, Sung Won; Clore, Elizabeth L.; Hooker, Jacob M.; Holson, Edward B.; Haggarty, Stephen J.; Petryshen, Tracey L.			A Selective HDAC 1/2 Inhibitor Modulates Chromatin and Gene Expression in Brain and Alters Mouse Behavior in Two Mood-Related Tests	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; VALPROIC ACID; STRAIN DIFFERENCES; NUCLEUS-ACCUMBENS; PROTEIN-KINASE; MESSENGER-RNA; LITHIUM; MICE; ACETYLATION; HIPPOCAMPUS	Psychiatric diseases, including schizophrenia, bipolar disorder and major depression, are projected to lead global disease burden within the next decade. Pharmacotherapy, the primary - albeit often ineffective - treatment method, has remained largely unchanged over the past 50 years, highlighting the need for novel target discovery and improved mechanism-based treatments. Here, we examined in wild type mice the impact of chronic, systemic treatment with Compound 60 (Cpd-60), a slow-binding, benzamide-based inhibitor of the class I histone deacetylase (HDAC) family members, HDAC1 and HDAC2, in mood-related behavioral assays responsive to clinically effective drugs. Cpd-60 treatment for one week was associated with attenuated locomotor activity following acute amphetamine challenge. Further, treated mice demonstrated decreased immobility in the forced swim test. These changes are consistent with established effects of clinical mood stabilizers and antidepressants, respectively. Whole-genome expression profiling of specific brain regions (prefrontal cortex, nucleus accumbens, hippocampus) from mice treated with Cpd-60 identified gene expression changes, including a small subset of transcripts that significantly overlapped those previously reported in lithium-treated mice. HDAC inhibition in brain was confirmed by increased histone acetylation both globally and, using chromatin immunoprecipitation, at the promoter regions of upregulated transcripts, a finding consistent with in vivo engagement of HDAC targets. In contrast, treatment with suberoylanilide hydroxamic acid (SAHA), a non-selective fast-binding, hydroxamic acid HDAC 1/2/3/ 6 inhibitor, was sufficient to increase histone acetylation in brain, but did not alter mood-related behaviors and had dissimilar transcriptional regulatory effects compared to Cpd-60. These results provide evidence that selective inhibition of HDAC1 and HDAC2 in brain may provide an epigenetic-based target for developing improved treatments for mood disorders and other brain disorders with altered chromatin-mediated neuroplasticity.	[Schroeder, Frederick A.; Fass, Daniel M.; Hennig, Krista M.; Zhao, Wen-Ning; Reis, Surya; Haggarty, Stephen J.; Petryshen, Tracey L.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Schroeder, Frederick A.; Haggarty, Stephen J.; Petryshen, Tracey L.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Schroeder, Frederick A.; Hooker, Jacob M.; Haggarty, Stephen J.; Petryshen, Tracey L.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Haggarty, Stephen J.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Hooker, Jacob M.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Schroeder, Frederick A.; Hooker, Jacob M.] Harvard Univ, Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Sch Med,Dept Radiol, Charlestown, MA USA; [Lewis, Michael C.; Fass, Daniel M.; Wagner, Florence F.; Zhang, Yan-Ling; Hennig, Krista M.; Gale, Jennifer; Barker, Douglas D.; Berry-Scott, Erin; Clore, Elizabeth L.; Hooker, Jacob M.; Holson, Edward B.; Haggarty, Stephen J.; Petryshen, Tracey L.] Broad Inst Harvard & MIT, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Kim, Sung Won] Brookhaven Natl Lab, Dept Med, Upton, NY 11973 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; United States Department of Energy (DOE); Brookhaven National Laboratory	Haggarty, SJ (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	haggarty@chgr.mgh.harvard.edu; petryshen@chgr.mgh.harvard.edu	Petryshen, Tracey/X-5850-2019; Haggarty, Stephen J/M-9495-2016; Hooker, Jacob M/P-5716-2018	Petryshen, Tracey/0000-0002-7972-4612; Haggarty, Stephen J/0000-0002-7872-168X; Hooker, Jacob M/0000-0002-9394-7708	Stanley Medical Research Institute; NIH [R01DA028301, R01DA030321]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030321, R01DA028301] Funding Source: NIH RePORTER	Stanley Medical Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Stanley Medical Research Institute (T. L. P. and S.J.H.) and the NIH (R01DA028301 to S.J.H. and R01DA030321 to S.J.H. and J.M.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arent CO, 2011, MOL NEUROBIOL, V43, P207, DOI 10.1007/s12035-011-8178-0; Arnett MG, 2011, MOL CELL ENDOCRINOL, V336, P2, DOI 10.1016/j.mce.2010.11.011; Baltan S, 2011, J NEUROSCI, V31, P3990, DOI 10.1523/JNEUROSCI.5379-10.2011; Benes FM, 2007, P NATL ACAD SCI USA, V104, P10164, DOI 10.1073/pnas.0703806104; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertran-Gonzalez J, 2009, NEUROPSYCHOPHARMACOL, V34, P1710, DOI 10.1038/npp.2008.228; Breslow RU, 1995, NOVEL POTENT INDUCER; Chou CJ, 2008, J BIOL CHEM, V283, P35402, DOI 10.1074/jbc.M807045200; Conti M, 2007, REV MAL RESPIR, V24, P107, DOI 10.1016/S0761-8425(07)91035-9; Covington HE, 2011, NEUROSCI LETT, V493, P122, DOI 10.1016/j.neulet.2011.02.022; Covington HE, 2009, J NEUROSCI, V29, P11451, DOI 10.1523/JNEUROSCI.1758-09.2009; Del Signore SJ, 2009, AMYOTROPH LATERAL SC, V10, P85, DOI 10.1080/17482960802226148; Espallergues J, 2012, J NEUROSCI, V32, P4400, DOI 10.1523/JNEUROSCI.5634-11.2012; Fang HL, 2003, DRUG METAB DISPOS, V31, P1378, DOI 10.1124/dmd.31.11.1378; Fass DM, 2013, NEUROPHARMACOLOGY, V64, P81, DOI 10.1016/j.neuropharm.2012.06.043; Feng HL, 2008, NEUROSCIENCE, V155, P567, DOI 10.1016/j.neuroscience.2008.06.040; Fukada M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030924; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gould TD, 2007, NEUROPSYCHOPHARMACOL, V32, P1321, DOI 10.1038/sj.npp.1301254; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Hobara T, 2010, J PSYCHIATR RES, V44, P263, DOI 10.1016/j.jpsychires.2009.08.015; Hodes GE, 2012, NEUROSCIENCE, V222, P269, DOI 10.1016/j.neuroscience.2012.06.017; Hooker JM, 2010, ACS CHEM NEUROSCI, V1, P65, DOI 10.1021/cn9000268; Hu Y, 2011, P NATL ACAD SCI USA, V108, P17141, DOI 10.1073/pnas.1104409108; Huang HS, 2006, J NEUROSCI METH, V156, P284, DOI 10.1016/j.jneumeth.2006.02.018; Katragadda M, 2006, J MED CHEM, V49, P4616, DOI 10.1021/jm0603419; Kilgore M, 2010, NEUROPSYCHOPHARMACOL, V35, P870, DOI 10.1038/npp.2009.197; Kilts CD, 2000, J CLIN PSYCHIAT, V61, P41; Kim WY, 2008, NEUROSCI LETT, V432, P54, DOI 10.1016/j.neulet.2007.12.005; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; Kurita M, 2012, NAT NEUROSCI, V15, P1245, DOI 10.1038/nn.3181; Leng Y, 2008, J NEUROSCI, V28, P2576, DOI 10.1523/JNEUROSCI.5467-07.2008; Li JH, 2004, J NEUROCHEM, V90, P1117, DOI 10.1111/j.1471-4159.2004.02569.x; MacDonald JL, 2008, DEV DYNAM, V237, P2256, DOI 10.1002/dvdy.21626; Malvaez M, 2013, P NATL ACAD SCI USA, V110, P2647, DOI 10.1073/pnas.1213364110; McQuillin A, 2007, PHARMACOGENET GENOM, V17, P605, DOI 10.1097/FPC.0b013e328011b5b2; Methot JL, 2008, BIOORG MED CHEM LETT, V18, P973, DOI 10.1016/j.bmcl.2007.12.031; Moradei OM, 2007, J MED CHEM, V50, P5543, DOI 10.1021/jm701079h; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Nestler EJ, 2009, BIOL PSYCHIAT, V65, P189, DOI 10.1016/j.biopsych.2008.10.030; Obradovic T, 1996, NEUROSCIENCE, V74, P469, DOI 10.1016/0306-4522(96)00135-2; Pan JQ, 2011, NEUROPSYCHOPHARMACOL, V36, P1397, DOI 10.1038/npp.2011.24; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; PORSOLT RD, 1979, EUR J PHARMACOL, V57, P431, DOI 10.1016/0014-2999(79)90507-7; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Rane P, 2012, NEUROPHARMACOLOGY, V62, P2409, DOI 10.1016/j.neuropharm.2012.01.026; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; Robbins MJ, 2008, J PSYCHOPHARMACOL, V22, P536, DOI 10.1177/0269881107081521; Sakoda H, 2003, J BIOL CHEM, V278, P25802, DOI 10.1074/jbc.M301127200; Schroeder FA, 2007, BIOL PSYCHIAT, V62, P55, DOI 10.1016/j.biopsych.2006.06.036; Solomon MB, 2012, NEUROSCIENCE, V203, P135, DOI 10.1016/j.neuroscience.2011.12.014; Stowell John C., 1995, Journal of Medicinal Chemistry, V38, P1411; Thompson C, 2002, HUM PSYCHOPHARM CLIN, V17, pS27, DOI 10.1002/hup.386; Tsankova NM, 2004, J NEUROSCI, V24, P5603, DOI 10.1523/JNEUROSCI.0589-04.2004; Verdone L, 2005, BIOCHEM CELL BIOL, V83, P344, DOI 10.1139/o05-041; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weeks KR, 2011, J NEUROSCI RES, V89, P1658, DOI 10.1002/jnr.22705	58	98	104	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71323	10.1371/journal.pone.0071323	http://dx.doi.org/10.1371/journal.pone.0071323			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967191	gold, Green Published, Green Submitted			2022-12-25	WOS:000323221500074
J	Kaewprag, J; Umnajvijit, W; Ngamkham, J; Ponglikitmongkol, M				Kaewprag, Jittranan; Umnajvijit, Wareerat; Ngamkham, Jarunya; Ponglikitmongkol, Mathurose			HPV16 Oncoproteins Promote Cervical Cancer Invasiveness by Upregulating Specific Matrix Metalloproteinases	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; HIGH-RISK; EXPRESSION; E6; INVASION; MT1-MMP; PROTEIN; MMP-2; DEGRADATION; ACTIVATION	Production of matrix metalloproteinases (MMPs) for degradation of extracellular matrix is a vital step in cancer metastasis. We investigated the effects of HPV16 oncoproteins (16E6, 16E6*I and 16E7), either individually or combined, on the transcription of 7 MMPs implicated in cervical cancer invasiveness. The levels of 7 MMPs reported to be increased in cervical cancer were determined in C33A stably expressing different HPV16 oncoproteins using quantitative RT-PCR and compared with invasion ability of cell lines using in vitro invasion and wound healing assays. Overexpression of MMP-2 and MT1-MMP was detected in HPV16E6E7 expressing cells which correlated with increased cell invasion. Combination of HPV oncoproteins always showed greater effects than its individual form. Inhibition of cell invasion using a specific MMP-2 inhibitor, OA-Hy, and anti-MT1-MMP antibody confirmed that invasion in these cells was dependent on both MMP-2 and MT1-MMP expression. Depletion of HPV16E6E7 by shRNA-mediated knock-down experiments resulted in decreased MMP-2 and MT1-MMP expression levels as well as reduced invasion ability which strongly suggested specific effects of HPV oncoproteins on both MMPs and on cell invasion. Immunohistochemistry study in invasive cervical cancers confirmed the enhanced in vivo expression of these two MMPs in HPV16-infected cells. In addition, possible sites required by HPV16E6E7 on the MMP-2 and MT1-MMP promoters were investigated and PEA3 (at -552/-540 for MMP-2, 2303 for MT1-MMP) and Sp1 (at -91 for MMP-2, -102 for MT1-MMP) binding sites were shown to be essential for mediating their transactivation activity. In conclusion, our study demonstrated that HPV16E6 and E7 oncoproteins cooperate in promoting cervical cancer invasiveness by specifically upregulating MMP-2 and MT1-MMP transcription in a similar manner.	[Kaewprag, Jittranan] Mahidol Univ, Fac Sci, Mol Med Grad Program, Bangkok 10400, Thailand; [Ngamkham, Jarunya] Natl Canc Inst, Bangkok, Thailand; [Kaewprag, Jittranan; Umnajvijit, Wareerat; Ponglikitmongkol, Mathurose] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand	Mahidol University; National Cancer Institute - Thailand; Mahidol University	Ponglikitmongkol, M (corresponding author), Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand.	mathurose.pon@mahidol.ac.th		Umnajvijit, Wareerat/0000-0001-8598-8940	Faculty of Science; Medical Scholars Program, Mahidol University, Thailand; National Research Council of Thailand	Faculty of Science; Medical Scholars Program, Mahidol University, Thailand; National Research Council of Thailand(National Research Council of Thailand (NRCT))	This research work was supported by Faculty of Science and the Medical Scholars Program, Mahidol University, Thailand and National Research Council of Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano T, 2008, J SURG RES, V146, P32, DOI 10.1016/j.jss.2007.02.011; Boyer SN, 1996, CANCER RES, V56, P4620; Branca M, 2006, ANTICANCER RES, V26, P1543; Clark IA, 2008, INT J BIOCHEM CELL B, V40, P1362, DOI 10.1016/j.biocel.2007.12.006; Cardeal LBD, 2006, BIOCHEM CELL BIOL, V84, P713, DOI 10.1139/O06-084; Cardeal LBD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033585; Dahl KDC, 2007, MOL CANCER RES, V5, P413, DOI 10.1158/1541-7786.MCR-07-0019; Dey A, 1997, VIROLOGY, V228, P190, DOI 10.1006/viro.1996.8363; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Eisenach PA, 2010, J CELL SCI, V123, P4182, DOI 10.1242/jcs.062711; Gilles C, 1996, INT J CANCER, V65, P209; Kato Y, 2002, ONCOL REP, V9, P565; Lara-Pezzi E, 2002, J CLIN INVEST, V110, P1831, DOI 10.1172/JCI200215887; Lohi J, 2000, GENE, V242, P75, DOI 10.1016/S0378-1119(99)00549-1; Lopez-Ocejo O, 2000, ONCOGENE, V19, P4611, DOI 10.1038/sj.onc.1203817; Mitra Aparna, 2003, Journal of Environmental Pathology Toxicology and Oncology, V22, P93; Munger K, 2001, ONCOGENE, V20, P7888, DOI 10.1038/sj.onc.1204860; MUNGER K, 1989, J VIROL, V63, P4417; Nair SA, 2003, J CANCER RES CLIN, V129, P123, DOI 10.1007/s00432-002-0411-9; Nakada M, 2001, CANCER RES, V61, P8896; Oh ST, 2001, J VIROL, V75, P5559, DOI 10.1128/JVI.75.12.5559-5566.2001; Pesta M, 2005, ANTICANCER RES, V25, P3387; Pim D, 2010, APMIS, V118, P471, DOI 10.1111/j.1600-0463.2010.02618.x; Pim D, 2009, J VIROL, V83, P9863, DOI 10.1128/JVI.00539-09; Pongcharoen P, 2011, CLIN EXP METASTAS, V28, P827, DOI 10.1007/s10585-011-9414-8; Qin HW, 1999, J BIOL CHEM, V274, P29130, DOI 10.1074/jbc.274.41.29130; Qin L, 2008, MOL CELL BIOL, V28, P5937, DOI 10.1128/MCB.00579-08; Rampias T, 2009, JNCI-J NATL CANCER I, V101, P412, DOI 10.1093/jnci/djp017; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Shen BC, 2003, CANCER RES, V63, P6537; Shirvaikar N, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/685267; Smola-Hess S, 2005, J GEN VIROL, V86, P1291, DOI 10.1099/vir.0.80551-0; Sukvirach S, 2003, J INFECT DIS, V187, P1246, DOI 10.1086/373901; Takahashi A, 2007, BIOCHEM BIOPH RES CO, V355, P438, DOI 10.1016/j.bbrc.2007.01.165; Thathiah A, 2004, BIOCHEM J, V382, P363, DOI 10.1042/BJ20040513; Uekita T, 2004, J BIOL CHEM, V279, P12734, DOI 10.1074/jbc.M309957200; Vazquez-Ortiz G, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-68; Venturoli S, 1998, J CLIN PATHOL, V51, P143, DOI 10.1136/jcp.51.2.143; Wanichwatanadecha P, 2012, J GEN VIROL, V93, P1081, DOI 10.1099/vir.0.038265-0; Wise-Draper TM, 2005, J VIROL, V79, P14309, DOI 10.1128/JVI.79.22.14309-14317.2005; Yamaguchi H, 1999, BIOCHEM BIOPH RES CO, V254, P542, DOI 10.1006/bbrc.1998.0102; Zhai YL, 2005, CANCER RES, V65, P6543, DOI 10.1158/0008-5472.CAN-05-0231; Zhang ZF, 2009, INT J GYNECOL CANCER, V19, P998, DOI 10.1111/IGC.0b013e3181a83749; zurHausen H, 1996, BBA-REV CANCER, V1288, pF55	45	25	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71611	10.1371/journal.pone.0071611	http://dx.doi.org/10.1371/journal.pone.0071611			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967226	Green Published, Green Submitted, gold			2022-12-25	WOS:000323115800068
J	Turner, KM; Frederickson, ME				Turner, Kyle M.; Frederickson, Megan E.			Signals Can Trump Rewards in Attracting Seed-Dispersing Ants	PLOS ONE			English	Article							GEOGRAPHIC VARIATIONS; MYRMICA-RUBRA; SEX-RATIOS; ELAIOSOMES; PLANT; BEHAVIOR; EVOLUTION; MUTUALISM; REMOVAL; ACID	Both rewards and signals are important in mutualisms. In myrmecochory, or seed dispersal by ants, the benefits to plants are relatively well studied, but less is known about why ants pick up and move seeds. We examined seed dispersal by the ant Aphaenogaster rudis of four co-occurring species of plants, and tested whether morphology, chemical signaling, or the nutritional quality of fatty seed appendages called elaiosomes influenced dispersal rates. In removal trials, ants quickly collected diaspores (seeds plus elaiosomes) of Asarum canadense, Trillium grandiflorum, and Sanguinaria canadensis, but largely neglected those of T. erectum. This discrepancy was not explained by differences in the bulk cost-benefit ratio, as assessed by the ratio of seed to elaiosome mass. We also provisioned colonies with diaspores from one of these four plant species or no diaspores as a control. Colonies performed best when fed S. canadensis diaspores, worst when fed T. grandiflorum, and intermediately when fed A. canadense, T. erectum, or no diaspores. Thus, the nutritional rewards in elaiosomes affected colony performance, but did not completely predict seed removal. Instead, high levels of oleic acid in T. grandiflorum elaiosomes may explain why ants disperse these diaspores even though they reduce ant colony performance. We show for the first time that different elaiosome-bearing plants provide rewards of different quality to ant colonies, but also that ants appear unable to accurately assess reward quality when encountering seeds. Instead, we suggest that signals can trump rewards as attractants of ants to seeds.	[Turner, Kyle M.; Frederickson, Megan E.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada	University of Toronto	Turner, KM (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada.	kyle.turner@mail.utoronto.ca		Turner, Kyle/0000-0002-7990-1842; Frederickson, Megan/0000-0002-9058-7137	Canadian Foundation for Innovation; University of Toronto; NSERC Discovery Grant; NSERC Undergraduate Student Research Award	Canadian Foundation for Innovation(Canada Foundation for Innovation); University of Toronto(University of Toronto); NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Undergraduate Student Research Award(Natural Sciences and Engineering Research Council of Canada (NSERC))	Chemical analysis was conducted at the Centre for the Study of Complex Childhood Diseases (CSCCD) at the Hospital for Sick Children, which was supported by the Canadian Foundation for Innovation (CFI;www.innovation.ca/). The University of Toronto and an NSERC Discovery Grant (www.nserc-crsng.gc.ca/) to MEF financed this research; KMT was supported by an NSERC Undergraduate Student Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benitez-Vieyra S, 2010, J EVOLUTION BIOL, V23, P2760, DOI 10.1111/j.1420-9101.2010.02132.x; Bono JM, 2002, INSECT SOC, V49, P320, DOI 10.1007/PL00012655; BOUCHER DH, 1982, ANNU REV ECOL SYST, V13, P315, DOI 10.1146/annurev.es.13.110182.001531; Boulay R, 2007, NATURWISSENSCHAFTEN, V94, P242, DOI 10.1007/s00114-006-0185-z; Boulay R, 2006, CHEMOECOLOGY, V16, P1, DOI 10.1007/s00049-005-0322-8; BREW CR, 1989, OECOLOGIA, V80, P490, DOI 10.1007/BF00380071; BRONSTEIN JL, 1994, Q REV BIOL, V69, P31, DOI 10.1086/418432; Byk J, 2011, POPUL ECOL, V53, P327, DOI 10.1007/s10144-010-0240-7; Cook SC, 2012, INSECT SOC, V59, P93, DOI 10.1007/s00040-011-0193-7; CULVER DC, 1980, AM J BOT, V67, P710, DOI 10.2307/2442664; Dussutour A, 2008, INSECT SOC, V55, P329, DOI 10.1007/s00040-008-1008-3; Dussutour A, 2009, CURR BIOL, V19, P740, DOI 10.1016/j.cub.2009.03.015; Edwards DP, 2007, BEHAV ECOL SOCIOBIOL, V61, P1321, DOI 10.1007/s00265-007-0369-3; Edwards W, 2006, J ECOL, V94, P687, DOI 10.1111/j.1365-2745.2006.01116.x; Engqvist L, 2005, ANIM BEHAV, V70, P967, DOI 10.1016/j.anbehav.2005.01.016; Fischer RC, 2005, INSECT SOC, V52, P55, DOI 10.1007/s00040-004-0773-x; Fischer RC, 2008, OECOLOGIA, V155, P539, DOI 10.1007/s00442-007-0931-8; Fokuhl G, 2007, ECOL RES, V22, P845, DOI 10.1007/s11284-006-0331-2; Fokuhl G, 2012, ACTA OECOL, V38, P71, DOI 10.1016/j.actao.2011.09.007; Gammans N, 2005, OECOLOGIA, V146, P43, DOI 10.1007/s00442-005-0154-9; Gammans N, 2006, J CHEM ECOL, V32, P1935, DOI 10.1007/s10886-006-9119-7; Giladi I, 2006, OIKOS, V112, P481, DOI 10.1111/j.0030-1299.2006.14258.x; GORDON DM, 1983, J CHEM ECOL, V9, P105, DOI 10.1007/BF00987774; GREGGERS U, 1993, BEHAV ECOL SOCIOBIOL, V32, P17, DOI 10.1007/BF00172219; Gumbert A, 2001, BIOL J LINN SOC, V72, P419, DOI [10.1111/j.1095-8312.2001.tb01328.x, 10.1006/bijl.2000.0510]; GUNTHER RW, 1989, AM MIDL NAT, V122, P321, DOI 10.2307/2425919; Heil M, 2011, TRENDS PLANT SCI, V16, P191, DOI 10.1016/j.tplants.2011.01.003; Heiling AM, 2004, ANN ZOOL FENN, V41, P421; HIGASHI S, 1989, OIKOS, V54, P389, DOI 10.2307/3565300; Holldobler B., 1990, pi; HUGHES L, 1994, FUNCT ECOL, V8, P358, DOI 10.2307/2389829; HUGHES L, 1992, ECOLOGY, V73, P1300, DOI 10.2307/1940677; Kay A, 2004, BEHAV ECOL, V15, P63, DOI 10.1093/beheco/arg106; Kunze J, 2001, BEHAV ECOL, V12, P447, DOI 10.1093/beheco/12.4.447; KUSMENOGLU S, 1989, PHYTOCHEMISTRY, V28, P2601, DOI 10.1016/S0031-9422(00)98048-8; LANZA J, 1992, J CHEM ECOL, V18, P209, DOI 10.1007/BF00993754; Lengyel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005480; Lisci M, 1996, FLORA, V191, P131; Lisci M, 1997, ACTA SOC BOT POL, V66, P379; Mark S, 1996, OECOLOGIA, V107, P95, DOI 10.1007/BF00582239; Morales MA, 1998, ECOLOGY, V79, P734, DOI 10.1890/0012-9658(1998)079[0734:FFSDMS]2.0.CO;2; Ness JH, 2009, OIKOS, V118, P1793, DOI 10.1111/j.1600-0706.2009.17430.x; ODOWD DJ, 1980, ECOLOGY, V61, P531, DOI 10.2307/1937419; OHARA M, 1994, OECOLOGIA, V98, P25, DOI 10.1007/BF00326086; Ohkawara K, 1996, OECOLOGIA, V106, P500, DOI 10.1007/BF00329708; PACINI E, 1990, ACTA BOT NEERL, V39, P253, DOI 10.1111/j.1438-8677.1990.tb01395.x; Pfeiffer M, 2010, FUNCT ECOL, V24, P545, DOI 10.1111/j.1365-2435.2009.01661.x; Reifenrath K, 2012, J CHEM ECOL, V38, P1093, DOI 10.1007/s10886-012-0174-y; Schaefer HM, 2009, TRENDS ECOL EVOL, V24, P676, DOI 10.1016/j.tree.2009.06.006; Schaefer HM, 2004, TRENDS ECOL EVOL, V19, P577, DOI 10.1016/j.tree.2004.08.003; Servigne P, 2008, INSECT SOC, V55, P220, DOI 10.1007/s00040-008-0991-8; Sheridan SL, 1996, J INSECT PHYSIOL, V42, P149, DOI 10.1016/0022-1910(95)00087-9; Stanton ML, 2003, AM NAT, V162, pS10, DOI 10.1086/378646; THOMPSON SN, 1973, COMP BIOCHEM PHYSIOL, V45, P467, DOI 10.1016/0305-0491(73)90078-3; Turke M, 2010, OECOLOGIA, V163, P681, DOI 10.1007/s00442-010-1612-6; Wilder SM, 2011, ECOLOGY, V92, P325, DOI 10.1890/10-0623.1; Zettler JA, 2001, AM MIDL NAT, V146, P444, DOI 10.1674/0003-0031(2001)146[0444:YJVSDT]2.0.CO;2	57	26	26	0	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71871	10.1371/journal.pone.0071871	http://dx.doi.org/10.1371/journal.pone.0071871			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967257	gold, Green Submitted, Green Published			2022-12-25	WOS:000323115800090
J	Wang, Y; Wang, YJ; Qain, YS; Zhang, J; Tang, XF; Sun, JL; Zhu, DL				Wang, Yan; Wang, Yajuan; Qain, Yuesheng; Zhang, Jin; Tang, Xiaofeng; Sun, Junlei; Zhu, Dingliang			Association of Body Mass Index with Cause Specific Deaths in Chinese Elderly Hypertensive Patients: Minhang Community Study	PLOS ONE			English	Article							PROSPECTIVE COHORT; MORTALITY; OVERWEIGHT; OBESITY; RISK; MEN; AGE; BMI; EPIDEMIOLOGY; UNDERWEIGHT	Background: Most studies have suggested that elevated body mass index (BMI) was associated with the risk of death from all cause and from specific causes. However, there was little evidence illustrating the effect of BMI on the mortality in elderly hypertensive patients in Chinese population. Methods: The information of 10,957 hypertensive patients at baseline not less than 60 years were from Xinzhuang, a town in Minhang district of Shanghai, was extracted from the Electronic Health Record (EHR) system. All study participants were divided into eight categories of baseline BMI (with cut-points at 18, 20, 22, 24, 26, 28 and 30 kg/m(2)). Relative hazard ratio of death from all cause, cardiovascular and non-cardiovascular cause by baseline BMI groups were calculated, standardized for sex, age, smoking, drinking, physical activity, systolic blood pressure, history of cardiovascular disorders, serum lipid disturbance, diabetes mellitus and antihypertensive drug treatment. Results: During follow up (median: 3.7 years), 561 deaths occurred. Underweight (BMI<18 kg/m(2)) was associated with significantly increased mortality from all cause mortality (OR: 2.00; 95% CI: 1.43-2.79) and non cardiovascular mortality (OR: 2.76; 95% CI: 1.87-4.07), but not with cardiovascular mortality. For the cause specific analysis, the underweight was associated significantly with neoplasms (OR: 2.15; 95% CI: 1.16-4.00) and respiratory disorders (OR: 3.41; 95% CI: 1.64-7.06). The results for total mortality and specific cause mortality were not influenced by sex, age and smoking status. Conclusion: Our study revealed an association between underweight and increased mortality from non-cardiovascular disorders in elderly hypertensive patients in Chinese community. Overweight and obesity were not associated with all cause or cause specific death.	[Wang, Yan; Qain, Yuesheng; Zhang, Jin; Tang, Xiaofeng; Zhu, Dingliang] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China; [Wang, Yan; Qain, Yuesheng; Zhang, Jin; Tang, Xiaofeng; Zhu, Dingliang] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Hypertens, Res Ctr Hypertens Management & Prevent Community, Shanghai 200030, Peoples R China; [Wang, Yajuan; Sun, Junlei] Xinzhuang Community Hlth Serv Ctr, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Sun, JL (corresponding author), Xinzhuang Community Hlth Serv Ctr, Shanghai, Peoples R China.	sunjunlei_0408@163.com; zhudingliang@sibs.ac.cn			National Key Program for Basic Research [2009CB521905]; National Natural Science Foundation of China [81000037]; Natural Science Foundation of Shanghai [10ZR1425100]; National High Technology Research and Development Program [2006AA02Z179]; Shanghai Hospital Development Center Foundation [SHDC12012304]	National Key Program for Basic Research(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); National High Technology Research and Development Program(National High Technology Research and Development Program of China); Shanghai Hospital Development Center Foundation	This project was supported by grants from the National Key Program for Basic Research (2009CB521905), National Natural Science Foundation of China (81000037), Natural Science Foundation of Shanghai (10ZR1425100), National High Technology Research and Development Program (2006AA02Z179) and Shanghai Hospital Development Center Foundation (SHDC12012304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Akinnusi ME, 2008, CRIT CARE MED, V36, P151, DOI 10.1097/01.CCM.0000297885.60037.6E; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bender R, 1999, JAMA-J AM MED ASSOC, V281, P1498, DOI 10.1001/jama.281.16.1498; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Chen Qiuwen ZJZW, 2009, J CLIN CARDIOL CHINA, V25, P125; Fillenbaum GG, 2010, J GERONTOL A-BIOL, V65, P1123, DOI 10.1093/gerona/glq096; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Gavi S, 2009, GERIATRICS-US, V64, P12; Gu DF, 2006, JAMA-J AM MED ASSOC, V295, P776, DOI 10.1001/jama.295.7.776; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Janssen I, 2007, OBESITY, V15, P1827, DOI 10.1038/oby.2007.217; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Ji CY, 2008, INT J CARDIOL, V131, P1, DOI 10.1016/j.ijcard.2008.05.078; Kalantar-Zadeh K, 2004, J AM COLL CARDIOL, V43, P1439, DOI 10.1016/j.jacc.2003.11.039; Kumanyika SK, 2008, CIRCULATION, V118, P428, DOI 10.1161/CIRCULATIONAHA.108.189702; Lopez-Jimenez F, 2009, LANCET, V373, P1055, DOI 10.1016/S0140-6736(09)60628-0; Matsuo T, 2008, OBESITY, V16, P2348, DOI 10.1038/oby.2008.342; MENOTTI A, 1988, CARDIOLOGY, V75, P448, DOI 10.1159/000174416; Nagai M, 2010, J EPIDEMIOL, V20, P398, DOI 10.2188/jea.JE20090204; Oreopoulos A, 2008, AM HEART J, V156, P13, DOI 10.1016/j.ahj.2008.02.014; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; Sen K, 2000, LANCET, V356, P577, DOI 10.1016/S0140-6736(00)02590-3; STAMLER R, 1991, HYPERTENSION, V17, P553, DOI 10.1161/01.HYP.17.4.553; Stevens J, 1998, NEW ENGL J MED, V338, P1, DOI 10.1056/NEJM199801013380101; Volpe M, 2009, J HYPERTENS, V27, pS3, DOI 10.1097/01.hjh.0000356766.86388.e5; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Zhang YX, 2008, ANN HUM BIOL, V35, P547, DOI 10.1080/03014460802334239	30	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71223	10.1371/journal.pone.0071223	http://dx.doi.org/10.1371/journal.pone.0071223			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967168	gold, Green Published, Green Submitted			2022-12-25	WOS:000323115800043
J	Oshima, H; Ishikawa, T; Yoshida, GJ; Naoi, K; Maeda, Y; Naka, K; Ju, X; Yamada, Y; Minamoto, T; Mukaida, N; Saya, H; Oshima, M				Oshima, H.; Ishikawa, T.; Yoshida, G. J.; Naoi, K.; Maeda, Y.; Naka, K.; Ju, X.; Yamada, Y.; Minamoto, T.; Mukaida, N.; Saya, H.; Oshima, M.			TNF-alpha/TNFR1 signaling promotes gastric tumorigenesis through induction of Noxo1 and Gna14 in tumor cells	ONCOGENE			English	Article						gastric cancer; inflammation; TNF-alpha; mouse model	NECROSIS-FACTOR-ALPHA; PROSTAGLANDIN E-2; TNF-ALPHA; PATHWAY ACTIVATION; GENE-EXPRESSION; INCREASED RISK; CANCER; WNT; INFLAMMATION; RECEPTOR	Helicobacter pylori infection induces chronic inflammation that contributes to gastric tumorigenesis. Tumor necrosis factor (TNF-alpha) is a proinflammatory cytokine, and polymorphism in the TNF-alpha gene increases the risk of gastric cancer. We herein investigated the role of TNF-alpha in gastric tumorigenesis using Gan mouse model, which recapitulates human gastric cancer development. We crossed Gan mice with TNF-alpha (Tnf) or TNF-alpha receptor TNFR1 (Tnfrsf1a) knockout mice to generate Tnf -/- Gan and Tnfrsf1a -/- Gan mice, respectively, and examined their tumor phenotypes. Notably, both Tnf -/- Gan mice and Tnfrsf1a -/- Gan mice showed similar, significant suppression of gastric tumor growth compared with control Tnf +/+ or Tnfrsf1a +/+ Gan mice. These results indicate that TNF-alpha signaling through TNFR1 is important for gastric tumor development. Bone marrow (BM) transplantation experiments showed that TNF-alpha expressed by BM-derived cells (BMDCs) stimulates the TNFR1 on BMDCs by an autocrine or paracrine manner, which is important for gastric tumor promotion. Moreover, the microarray analysis and colony formation assay indicated that NADPH oxidase organizer 1 (Noxo1) and Gna14 are induced in tumor epithelial cells in a TNF-alpha-dependent manner, and have an important role in tumorigenicity and tumor-initiating cell property of gastric cancer cells. Accordingly, it is possible that the activation of TNF-alpha/TNFR1 signaling in the tumor microenvironment promotes gastric tumor development through induction of Noxo1 and Gna14, which contribute to maintaining the tumor cells in an undifferentiated state. The present results indicate that targeting the TNF-alpha/TNFR1 pathway may be an effective preventive or therapeutic strategy for gastric cancer.	[Oshima, H.; Ishikawa, T.; Naoi, K.; Maeda, Y.; Ju, X.; Oshima, M.] Kanazawa Univ, Canc Res Inst, Div Genet, Kanazawa, Ishikawa 9201192, Japan; [Yoshida, G. J.; Maeda, Y.; Saya, H.] Keio Univ, Inst Adv Med Res, Div Gene Regulat, Tokyo, Japan; [Naka, K.] Kanazawa Univ, Canc Res Inst, Canc & Stem Cell Res Program, Kanazawa, Ishikawa 9201192, Japan; [Yamada, Y.] Kanazawa Univ, Inst Sci & Engn, Fac Elect & Comp Engn, Kanazawa, Ishikawa 9201192, Japan; [Minamoto, T.] Kanazawa Univ, Canc Res Inst, Div Translat & Clin Oncol, Kanazawa, Ishikawa 9201192, Japan; [Mukaida, N.] Kanazawa Univ, Canc Res Inst, Div Mol Bioregulat, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University; Keio University; Kanazawa University; Kanazawa University; Kanazawa University; Kanazawa University	Oshima, M (corresponding author), Kanazawa Univ, Canc Res Inst, Div Genet, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	oshimam@staff.kanazawa-u.ac.jp	Oshima, Masanobu/F-9958-2014; Mukaida, Naofumi/D-7623-2011; Naka, Kazuhito/X-3756-2019; Saya, Hideyuki/J-4325-2013	Oshima, Masanobu/0000-0002-3304-0004; Mukaida, Naofumi/0000-0002-4193-1851; Naka, Kazuhito/0000-0001-6646-6004; Oshima, Hiroko/0000-0001-6855-4008; Yoshida, Go/0000-0002-1472-892X; Saya, Hideyuki/0000-0001-6610-1902	Ministry of Education, Culture, Sports, Science and Technology of Japan [22114005]; CREST; Japan Science and Technology Agency, Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency, Japan(Japan Science & Technology Agency (JST))	We thank Manami Watanabe and Ayako Tsuda for their excellent technical assistance. This work was supported by Grants-in-Aid for Scientific Research on Innovative Areas (no. 22114005) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and CREST, the Japan Science and Technology Agency, Japan.	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Adachi Y, 2008, ONCOGENE, V27, P4921, DOI 10.1038/onc.2008.133; Arnott CH, 2004, ONCOGENE, V23, P1902, DOI 10.1038/sj.onc.1207317; Balkwill F, 2006, CANCER METAST REV, V25, P409, DOI 10.1007/s10555-006-9005-3; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Block K, 2012, NAT REV CANCER, V12, P627, DOI 10.1038/nrc3339; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Clements WM, 2002, CANCER RES, V62, P3503; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; El-Omar EM, 2003, GASTROENTEROLOGY, V124, P1193, DOI 10.1016/S0016-5085(03)00157-4; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; El-Omar EM, 2006, BEST PRACT RES CL GA, V20, P675, DOI 10.1016/j.bpg.2006.04.006; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Ishimoto T, 2010, CANCER SCI, V101, P673, DOI 10.1111/j.1349-7006.2009.01430.x; Itadani H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-615; Itzkovitz S, 2012, NAT CELL BIOL, V14, P106, DOI 10.1038/ncb2384; Juhasz A, 2009, FREE RADICAL RES, V43, P523, DOI 10.1080/10715760902918683; Kong D, 2012, ONCOGENE, V31, P3949, DOI 10.1038/onc.2011.558; Kostenis E, 2005, TRENDS PHARMACOL SCI, V26, P595, DOI 10.1016/j.tips.2005.09.007; Kulbe H, 2012, CANCER RES, V72, P66, DOI 10.1158/0008-5472.CAN-11-2178; Lee MMK, 2009, J LEUKOCYTE BIOL, V86, P1319, DOI 10.1189/jlb.0209052; Liu AMF, 2005, J BIOL CHEM, V280, P34617, DOI 10.1074/jbc.M504264200; Machado JC, 2003, GASTROENTEROLOGY, V125, P364, DOI 10.1016/S0016-5085(03)00899-0; Mitsushita J, 2004, CANCER RES, V64, P3580, DOI 10.1158/0008-5472.CAN-03-3909; Moore RJ, 1999, NAT MED, V5, P828, DOI 10.1038/10552; Oguma K, 2008, EMBO J, V27, P1671, DOI 10.1038/emboj.2008.105; Oshima H, 2006, GASTROENTEROLOGY, V131, P1086, DOI 10.1053/j.gastro.2006.07.014; Oshima H, 2011, GASTROENTEROLOGY, V140, P596, DOI 10.1053/j.gastro.2010.11.007; Oshima H, 2009, CANCER SCI, V100, P1779, DOI 10.1111/j.1349-7006.2009.01258.x; Parkin DM, 2005, CA CANC J CLIN, V55, P74; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Seno H, 2002, CANCER RES, V62, P506; Tebbutt NC, 2002, NAT MED, V8, P1089, DOI 10.1038/nm763; Tu S, 2008, CANCER CELL, V14, P408, DOI 10.1016/j.ccr.2008.10.011; Tye H, 2012, CANCER CELL, V22, P466, DOI 10.1016/j.ccr.2012.08.010; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	44	87	93	0	14	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 17	2014	33	29					3820	3829		10.1038/onc.2013.356	http://dx.doi.org/10.1038/onc.2013.356			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AL8MU	23975421	hybrid			2022-12-25	WOS:000339394100008
J	Shah, T; Engmann, J; Dale, C; Shah, S; White, J; Giambartolomei, C; McLachlan, S; Zabaneh, D; Cavadino, A; Finan, C; Wong, A; Amuzu, A; Ong, K; Gaunt, T; Holmes, MV; Warren, H; Davies, TL; Drenos, F; Cooper, J; Sofat, R; Caulfield, M; Ebrahim, S; Lawlor, DA; Talmud, PJ; Humphries, SE; Power, C; Hypponen, E; Richards, M; Hardy, R; Kuh, D; Wareham, N; Ben-Shlomo, Y; Day, IN; Whincup, P; Morris, R; Strachan, MWJ; Price, J; Kumari, M; Kivimaki, M; Plagnol, V; Dudbridge, F; Whittaker, JC; Casas, JP; Hingorani, AD				Shah, Tina; Engmann, Jorgen; Dale, Caroline; Shah, Sonia; White, Jon; Giambartolomei, Claudia; McLachlan, Stela; Zabaneh, Delilah; Cavadino, Alana; Finan, Chris; Wong, Andrew; Amuzu, Antoinette; Ong, Ken; Gaunt, Tom; Holmes, Michael V.; Warren, Helen; Davies, Teri-Louise; Drenos, Fotios; Cooper, Jackie; Sofat, Reecha; Caulfield, Mark; Ebrahim, Shah; Lawlor, Debbie A.; Talmud, Philippa J.; Humphries, Steve E.; Power, Christine; Hypponen, Elina; Richards, Marcus; Hardy, Rebecca; Kuh, Diana; Wareham, Nicholas; Ben-Shlomo, Yoav; Day, Ian N.; Whincup, Peter; Morris, Richard; Strachan, Mark W. J.; Price, Jacqueline; Kumari, Meena; Kivimaki, Mika; Plagnol, Vincent; Dudbridge, Frank; Whittaker, John C.; Casas, Juan P.; Hingorani, Aroon D.		UCLEB Consortium	Population Genomics of Cardiometabolic Traits: Design of the University College London-London School of Hygiene and Tropical Medicine-Edinburgh-Bristol (UCLEB) Consortium	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; WIDE ASSOCIATION; GENOMEWIDE ASSOCIATION; CHROMOSOME 9P21.3; COMMON VARIANTS; COHORT PROFILE; AGING RESEARCH; GENETIC-LOCI; METAANALYSIS; HEART	Substantial advances have been made in identifying common genetic variants influencing cardiometabolic traits and disease outcomes through genome wide association studies. Nevertheless, gaps in knowledge remain and new questions have arisen regarding the population relevance, mechanisms, and applications for healthcare. Using a new high-resolution custom single nucleotide polymorphism (SNP) array (Metabochip) incorporating dense coverage of genomic regions linked to cardiometabolic disease, the University College-London School-Edinburgh-Bristol (UCLEB) consortium of highly-phenotyped population-based prospective studies, aims to: (1) fine map functionally relevant SNPs; (2) precisely estimate individual absolute and population attributable risks based on individual SNPs and their combination; (3) investigate mechanisms leading to altered risk factor profiles and CVD events; and (4) use Mendelian randomisation to undertake studies of the causal role in CVD of a range of cardiovascular biomarkers to inform public health policy and help develop new preventative therapies.	[Shah, Tina; Engmann, Jorgen; Finan, Chris; Holmes, Michael V.; Kumari, Meena; Kivimaki, Mika; Casas, Juan P.; Hingorani, Aroon D.] UCL, UCL Inst Epidemiol & Hlth Care, Dept Epidemiol & Publ Hlth, London, England; [Dale, Caroline; Amuzu, Antoinette; Warren, Helen; Ebrahim, Shah; Dudbridge, Frank; Casas, Juan P.] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1, England; [Shah, Sonia; White, Jon; Giambartolomei, Claudia; Zabaneh, Delilah; Plagnol, Vincent] UCL, Genet Inst, Dept Genet Environm & Evolut, London, England; [McLachlan, Stela; Price, Jacqueline] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Cavadino, Alana; Power, Christine; Hypponen, Elina] UCL, UCL Inst Child Hlth, Dept Populat Hlth Sci, MRC Ctr Epidemiol Child Hlth, London, England; [Wong, Andrew; Ong, Ken; Richards, Marcus; Hardy, Rebecca; Kuh, Diana] MRC Unit Lifelong Hlth & Ageing, London, England; [Ong, Ken; Wareham, Nicholas] Addenbrookes Hosp, Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England; [Gaunt, Tom; Davies, Teri-Louise; Lawlor, Debbie A.; Day, Ian N.] Univ Bristol, Sch Social & Community Med, MRC Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England; [Drenos, Fotios; Cooper, Jackie; Talmud, Philippa J.; Humphries, Steve E.] Royal Free & Univ Coll Med Sch, British Heart Fdn Labs, Dept Med, Ctr Cardiovasc Genet, London WC1E 6BT, England; [Sofat, Reecha; Hingorani, Aroon D.] UCL, Ctr Clin Pharmacol, London, England; [Caulfield, Mark] Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, London, England; [Ben-Shlomo, Yoav] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Whincup, Peter] Univ London, Div Populat Hlth Sci & Educ, London, England; [Morris, Richard] UCL, Dept Primary Care & Populat Hlth, London, England; [Strachan, Mark W. J.] Western Gen Hosp, Metab Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Whittaker, John C.] GlaxoSmithKline, Div Genet, Harlow, Essex, England	University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of Edinburgh; University of London; University College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Bristol; University of London; University College London; University of London; University College London; University of London; Queen Mary University London; University of Bristol; University of London; University of London; University College London; University of Edinburgh; GlaxoSmithKline	Shah, T (corresponding author), UCL, UCL Inst Epidemiol & Hlth Care, Dept Epidemiol & Publ Hlth, London, England.	t.shah@ucl.ac.uk	Wong, Andrew/M-8899-2016; Gaunt, Tom R/O-3918-2014; Kuh, Diana/L-6019-2014; Langenberg, Claudia/ABG-9067-2021; Hypponen, Elina/B-2596-2014; Wong, Andrew/AAE-6995-2019; Cavadino, Alana/CAG-8915-2022; Hardy, Rebecca/AFR-1989-2022; Ben-Shlomo, Yoav/ABD-2004-2021; Shah, Sonia/N-7547-2013; Whittaker, John C/B-8609-2012; Kivimaki, Mika/B-3607-2012; Hemingway, Harry/C-1219-2009	Wong, Andrew/0000-0003-2079-4779; Gaunt, Tom R/0000-0003-0924-3247; Kuh, Diana/0000-0001-7386-2857; Langenberg, Claudia/0000-0002-5017-7344; Hypponen, Elina/0000-0003-3670-9399; Wong, Andrew/0000-0003-2079-4779; Cavadino, Alana/0000-0002-5709-367X; Ben-Shlomo, Yoav/0000-0001-6648-3007; Shah, Sonia/0000-0001-5860-4526; Whittaker, John C/0000-0002-3529-2379; Kivimaki, Mika/0000-0002-4699-5627; Whincup, Peter/0000-0002-5589-4107; Finan, Chris/0000-0002-3319-1937; Plagnol, Vincent/0000-0002-5597-9215; Kumari, Meena/0000-0001-9716-1035; Engmann, Jorgen/0000-0001-7015-7773; Dale, Caroline/0000-0002-3889-8974; Sofat, Reecha/0000-0002-0242-6115; Morris, Richard/0000-0001-7240-4563; Richards, Marcus/0000-0001-9191-2192; Drenos, Fotios/0000-0003-2469-5516; Lawlor, Debbie A/0000-0002-6793-2262; Hemingway, Harry/0000-0003-2279-0624; Swerdlow, Daniel/0000-0002-7946-3459; Hardy, Rebecca/0000-0001-9949-0799; Caulfield, Mark/0000-0001-9295-3594; Humphries, Stephen E/0000-0002-8221-6547; Talmud, Philippa/0000-0002-5560-1933; Hingorani, Aroon/0000-0001-8365-0081; Shah, Tina/0000-0001-7724-7210	UK Medical Research Council; United States National Institutes of Health [NHLBI 33014]; Du Pont Pharma, Wilmington, USA; British Heart Foundation [RG/04/003, RG/07/008/23674, RG/97006]; Medical Research Council [G0902037, G0500877]; Stroke Association; National Institute on Aging [5RO1AG13196]; Agency for Health Care Policy Research [HS06516]; John D. and Catherine T. MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health; National Institute on Ageing (NIA); UK Medical Research Council [G0000934]; Wellcome Trust [068545/Z/02, 057762]; European Commission Framework Programme 6 [018996]; French Ministry of Research; Department of Health Policy Research Programme (England); Chief Scientist Office of Scotland [K/OPR/2/2/D320]; Chest Heart and Stroke Scotland [Res03/A75]; Bayer plc; Chief Scientist Office of Scottish [CZQ/1/38, CZB/4/672]; Pfizer plc; Diabetes UK [10/0003985]; MRC project grant; National Heart Lung and Blood Institute [5RO1 HL036310];  [AG1764406S1]; ESRC [ES/J023299/1] Funding Source: UKRI; MRC [G9521010, MC_UU_12015/2, G0000934, MC_U123092721, G0500877, G0802432, MC_UU_12015/1, MC_U123092720, G0902037, MC_UU_12013/5, G1000718, MR/K013351/1, G0801414, MC_U106179472, G0600237] Funding Source: UKRI; British Heart Foundation [RG/08/008/25291, RG/13/2/30098, PG/13/66/30442, RG/10/12/28456, RG/08/013/25942] Funding Source: researchfish; Economic and Social Research Council [ES/J023299/1] Funding Source: researchfish; Medical Research Council [1170444, MC_UU_12015/2, G0600237, MC_UU_12015/1, MR/K013351/1, G9521010, G0801414, MC_U106179472, G0000934, G0802432, MR/K006584/1, MC_U123092721, MC_U123092720, MC_UU_12013/5, G1000718] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10113] Funding Source: researchfish; Chief Scientist Office [CZB/4/672] Funding Source: researchfish; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS006516] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL033014, R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013196, R01AG017644] Funding Source: NIH RePORTER	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Du Pont Pharma, Wilmington, USA; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Stroke Association; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Agency for Health Care Policy Research(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); John D. and Catherine T. MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health; National Institute on Ageing (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); European Commission Framework Programme 6(European Commission); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Department of Health Policy Research Programme (England); Chief Scientist Office of Scotland; Chest Heart and Stroke Scotland; Bayer plc(Bayer AG); Chief Scientist Office of Scottish; Pfizer plc(Pfizer); Diabetes UK(Diabetes UK); MRC project grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	NPHS-II is supported by the UK Medical Research Council, the United States National Institutes of Health (grant NHLBI 33014) and Du Pont Pharma, Wilmington, USA. BRHS is a British Heart Foundation Research Group and is supported by British Heart Foundation (RG/04/003). The WHII study is supported by grants from the Medical Research Council (G0902037), British Heart Foundation (RG/07/008/23674), Stroke Association, National Heart Lung and Blood Institute (5RO1 HL036310), National Institute on Aging (5RO1AG13196) Agency for Health Care Policy Research (HS06516); and the John D. and Catherine T. MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health. Samples from the ELSA DNA Repository (EDNAR), received support under a grant (AG1764406S1) awarded by the National Institute on Ageing (NIA). ELSA was developed by a team of researchers based at the National Centre for Social Research, University College London and the Institute of Fiscal Studies. The data were collected by the National Centre for Social Research. MRC NSHD is funded by the UK Medical Research Council. DNA collection of the 1958BC was funded by the UK Medical Research Council (G0000934) and the Wellcome Trust (Grant 068545/Z/02). Genotyping was supported by a contract from the European Commission Framework Programme 6 (018996) and grants from the French Ministry of Research. BWHHS is supported by funding from the British Heart Foundation and the Department of Health Policy Research Programme (England). EAS is funded by the British Heart Foundation (Programme Grant RG/98002), with Metabochip genotyping funded by a project grant from the Chief Scientist Office of Scotland (Project Grant CZB/4/672). AAAT was funded by the British Heart Foundation (Programme Grant RG/97006), the Wellcome Trust (Project Grant 057762), the Chief Scientist Office of Scotland (Project Grant K/OPR/2/2/D320), Chest Heart and Stroke Scotland (Project Grant Res03/A75) and Bayer plc (Unrestricted Investigator Led Grant). Research clinics were held at the Wellcome Trust Clinical Research Facility in Edinburgh. ET2DS is funded by the Medical Research Council (Project Grant G0500877), the Chief Scientist Office of Scottish (Programme Support Grant CZQ/1/38), Pfizer plc (Unrestricted Investigator Led Grant) and Diabetes UK (Clinical Research Fellowship 10/0003985). Research clinics were held at the Wellcome Trust Clinical Research Facility and Princess Alexandra Eye Pavilion in Edinburgh. EHDPS was funded by the Medical Research Council and by the Chief Scientist Office of Scotland (Project Grant CZB/4/672). DNA standardisation was conducted at the Genetics Core of the Wellcome Trust Clinical Research Facility in Edinburgh. CaPS was funded by the Medical Research Council and undertaken by the former MRC Epidemiology Unit (South Wales). The DNA bank was established with funding from a MRC project grant. The data archive is maintained by the University of Bristol. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amouyel P, 2009, ARTERIOSCL THROM VAS, V29, P774, DOI 10.1161/ATVBAHA.108.181388; Asselbergs FW, 2012, AM J HUM GENET, V91, P823, DOI 10.1016/j.ajhg.2012.08.032; BAINTON D, 1992, BRIT HEART J, V68, P60; Bottolo L, 2011, BIOINFORMATICS, V27, P587, DOI 10.1093/bioinformatics/btq684; Bown MJ, 2008, CIRC-CARDIOVASC GENE, V1, P39, DOI 10.1161/CIRCGENETICS.108.789727; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Erdmann J, 2009, NAT GENET, V41, P280, DOI 10.1038/ng.307; FOWKES FGR, 1991, INT J EPIDEMIOL, V20, P384, DOI 10.1093/ije/20.2.384; Gaal EI, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002563; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; Gschwendtner A, 2009, ANN NEUROL, V65, P531, DOI 10.1002/ana.21590; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; Hindorff LA, 2011, CATALOG PUBLISHED GE; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Ingelsson E, 2010, DIABETES, V59, P1266, DOI [10.2337/DB09-1568, 10.2337/db09-1568]; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Kuh Diana, 2011, Int J Epidemiol, V40, pe1, DOI 10.1093/ije/dyq231; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lanktree MB, 2011, AM J HUM GENET, V88, P6, DOI 10.1016/j.ajhg.2010.11.007; Lawlor DA, 2003, J EPIDEMIOL COMMUN H, V57, P134, DOI 10.1136/jech.57.2.134; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Manolio TA, 2009, ANNU REV MED, V60, P443, DOI 10.1146/annurev.med.60.061907.093117; Manolio TA, 2009, NAT GENET, V41, P5, DOI 10.1038/ng0109-5; Marmot M, 2003, HLTH WEALTH LIFESTYL; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; MILLER GJ, 1995, THROMB HAEMOSTASIS, V73, P82; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Musunuru K, 2010, CIRC-CARDIOVASC GENE, V3, P267, DOI 10.1161/CIRCGENETICS.109.882696; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; O'Reilly PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034861; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Preuss M, 2010, CIRC-CARDIOVASC GENE, V3, P475, DOI 10.1161/CIRCGENETICS.109.899443; Price J, 2008, BMJ, V337; Price Jackie F, 2008, BMC Endocr Disord, V8, P18, DOI 10.1186/1472-6823-8-18; Price WH, 1991, DNA POLYM DIS MARKER; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reiner AP, 2008, AM J HUM GENET, V82, P1193, DOI 10.1016/j.ajhg.2008.03.017; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Shaper AG, 1981, BMJ, V283; Smith NL, 2010, CIRCULATION, V121, P1382, DOI 10.1161/CIRCULATIONAHA.109.869156; Talmud PJ, 2009, AM J HUM GENET, V85, P628, DOI 10.1016/j.ajhg.2009.10.014; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tobin MD, 2005, STAT MED, V24, P2911, DOI 10.1002/sim.2165; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Wadsworth M, 2006, INT J EPIDEMIOL, V35, P49, DOI 10.1093/ije/dyi201; Wong MY, 2003, INT J EPIDEMIOL, V32, P51, DOI 10.1093/ije/dyg002; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	56	29	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71345	10.1371/journal.pone.0071345	http://dx.doi.org/10.1371/journal.pone.0071345			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977022	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000324527300012
J	Huang, JW; Lien, YC; Yang, CY; Liu, KL; Fang, CC; Wu, CK; Lee, JK; Wu, HY; Chiang, CK; Cheng, HT; Yen, CJ; Hung, KY				Huang, Jenq-Wen; Lien, Yu-Chung; Yang, Chung-Yi; Liu, Kao-Lang; Fang, Cheng-Chung; Wu, Cho-Kai; Lee, Jen-Kuang; Wu, Hon-Yen; Chiang, Chih-Kang; Cheng, Hui-Teng; Yen, Chung-Jen; Hung, Kuan-Yu			High Peritoneal KT/V and Peritonitis Rates Are Associated with Peritoneal Calcification	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; MATRIX GLA PROTEIN; FETUIN-A; VASCULAR CALCIFICATION; MESOTHELIAL CELLS; DIALYSIS; OSTEOPROTEGERIN; PATIENT; SERUM; HYPERPARATHYROIDISM	Background: Peritoneal calcification (PC) is a specific finding in patients undergoing peritoneal dialysis (PD), but its prevalence, risk factors, and impacts in PD patients remain unclear. The present study investigated these issues and provided information useful for the management of PC. Methods: The study included 183 PD patients. The severity of PC was determined using abdominal computed tomography (CT), and we summed up all scores from slices obtained from the diaphragm to the pelvic floor normalized to body surface area. We analyzed the associations between PC and demographic and clinical characteristics, and between PC and levels of biomarkers, including C-reactive protein (CRP), osteoprotegrin and fetuin-A. The determinants of PC were examined using multiple regression analysis. Results: Patients were categorized into group 1 (without PC, n = 133) and group 2 (with PC, n = 50). Group 2 patients showed different degrees of PC with a mean of 160 +/- 769 mm(2)/m(2). Group 1 patients had higher fetuin-A levels than group 2 patients (861 +/- 309 vs. 760 +/- 210 mu g/mL; p = 0.021). The independent risk factors for the presence of PC included male gender, previous peritonitis, and PD adequacy (KT/V). Further analysis performed in group 2 patients showed that the dosage of vitamin D, serum levels of CRP, and dialysate calcium load were the independent determinants of PC. However, the presence of PC did not affect patients' technique survival, peritonitis incidence, or mortality in the mean follow up period of 28 +/- 12 months. Conclusions: The presence and severity of PC were associated with inflammation, peritoneal KT/V, and mineral metabolism. The impact of PC on the outcomes of PD patients requires further study with a longer follow-up.	[Huang, Jenq-Wen; Fang, Cheng-Chung; Wu, Cho-Kai; Wu, Hon-Yen; Chiang, Chih-Kang; Yen, Chung-Jen; Hung, Kuan-Yu] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan; [Huang, Jenq-Wen; Yang, Chung-Yi; Liu, Kao-Lang; Fang, Cheng-Chung; Wu, Cho-Kai; Wu, Hon-Yen; Chiang, Chih-Kang; Yen, Chung-Jen; Hung, Kuan-Yu] Hosp Taipei, Taipei, Taiwan; [Yang, Chung-Yi; Liu, Kao-Lang] Natl Taiwan Univ, Coll Med, Dept Med Imaging, Taipei 10764, Taiwan; [Chiang, Chih-Kang] Natl Taiwan Univ, Coll Med, Dept Integrated Diagnost & Therapeut, Taipei 10764, Taiwan; [Lien, Yu-Chung] Buddhist Tzu Chi Gen Hosp, Taipei Branch, Dept Internal Med, New Taipei City, Taiwan; [Wu, Hon-Yen] Far Eastern Mem Hosp, New Taipei City, Taiwan; [Cheng, Hui-Teng] Natl Taiwan Univ Hosp, Hsin Chu Branch, Hsin Chu City, Taiwan; [Lee, Jen-Kuang] Far Eastern Mem Hosp, Cardiovasc Ctr, New Taipei City, Taiwan; [Lee, Jen-Kuang] Far Eastern Mem Hosp, Dept Clin Pathol, New Taipei City, Taiwan	National Taiwan University; Taipei Medical University Hospital; National Taiwan University; National Taiwan University; Buddhist Tzu Chi General Hospital; Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University Hospital; Far Eastern Memorial Hospital; Far Eastern Memorial Hospital	Yen, CJ (corresponding author), Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan.	ycjycj@ntu.edu.tw; kyhung@ntu.edu.tw	CHENG, HUI-TENG/AAD-9899-2020	CHENG, HUI-TENG/0000-0003-1544-7473; CHIANG, CHIH-KANG/0000-0001-9021-4616; HUNG, KUAN-YU/0000-0003-3472-5512; WU, CHO-KAI/0000-0002-3867-150X; FANG, CHENG-CHUNG/0000-0001-5386-6674; HUANG, JENQ-WEN/0000-0001-8011-2317; LIU, KAO-LANG/0000-0003-4100-8909; YEN, CHUNG-JEN/0000-0001-5372-3657				Agarwal A, 2004, AM J ROENTGENOL, V182, P441, DOI 10.2214/ajr.182.2.1820441; Chen HY, AM J KIDNEY DIS, V56, P720; Clatworthy MR, 2008, LANCET, V371, P1452, DOI 10.1016/S0140-6736(08)60625-X; Dejima K, 2008, THER APHER DIAL, V12, P413, DOI 10.1111/j.1744-9987.2008.00620.x; Deuell KA, 2012, J VASC RES, V49, P510, DOI 10.1159/000341216; Di Paolo N, 2004, PERITON DIALYSIS INT, V24, P471; FLETCHER S, 1995, NEPHROL DIAL TRANSPL, V10, P277; Honda K, 2005, PERITON DIALYSIS INT, V25, pS19; Hsu YH, 2010, AM J KIDNEY DIS, V55, P198, DOI 10.1053/j.ajkd.2009.06.043; Hung KY, 2008, NEPHROL DIAL TRANSPL, V23, P3831, DOI 10.1093/ndt/gfn369; Hung KY, 2003, NEPHROL DIAL TRANSPL, V18, P670, DOI 10.1093/ndt/gfg141; Inoshita H, 2008, CLIN NEPHROL, V69, P58; Kaden JJ, 2004, J MOL CELL CARDIOL, V36, P57, DOI 10.1016/j.yjmcc.2003.09.015; Ketteler M, 2003, LANCET, V361, P827, DOI 10.1016/S0140-6736(03)12710-9; Ketteler M, 2011, NAT REV NEPHROL, V7, P509, DOI 10.1038/nrneph.2011.91; Kidney Disease: Improving Global Outcomes, 2009, KIDNEY INT S, pS1, DOI DOI 10.1038/KI.2009.188; Kitoh C, 1999, CLIN NEPHROL, V52, P329; KLEMM G, 1989, NEPHRON, V51, P124, DOI 10.1159/000185268; Miller FH, 1996, AM J ROENTGENOL, V166, P541, DOI 10.2214/ajr.166.3.8623624; Moe SM, 2008, J AM SOC NEPHROL, V19, P213, DOI 10.1681/ASN.2007080854; Nitta K, 2004, NEPHROL DIAL TRANSPL, V19, P1886, DOI 10.1093/ndt/gfh263; Shroff RC, 2008, NEPHROL DIAL TRANSPL, V23, P3263, DOI 10.1093/ndt/gfn226; Ubara Y, 2000, AM J KIDNEY DIS, V35, P761, DOI 10.1016/S0272-6386(00)70027-8; Vlijm A, 2011, NEPHROL DIAL TRANSPL, V26, P304, DOI 10.1093/ndt/gfq374; Wang AYM, 2005, NEPHROL DIAL TRANSPL, V20, P1676, DOI 10.1093/ndt/gfh891; Wu HY, 2008, AM J NEPHROL, V28, P765, DOI 10.1159/000128608; Wu HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030337; Wu HY, 2010, PERITON DIALYSIS INT, V30, P448, DOI 10.3747/pdi.2009.00063; Yasuda G, 2004, PERITON DIALYSIS INT, V24, P596; Zhai YH, 2010, NEPHROL DIAL TRANSPL, V25, P3213, DOI 10.1093/ndt/gfq190	30	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71636	10.1371/journal.pone.0071636	http://dx.doi.org/10.1371/journal.pone.0071636			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977097	gold, Green Submitted, Green Published			2022-12-25	WOS:000323425700076
J	Deleglise, B; Lassus, B; Soubeyre, V; Alleaume-Butaux, A; Hjorth, JJ; Vignes, M; Schneider, B; Brugg, B; Viovy, JL; Peyrin, JM				Deleglise, Berangere; Lassus, Benjamin; Soubeyre, Vaneyssa; Alleaume-Butaux, Aurelie; Hjorth, Johannes J.; Vignes, Maeva; Schneider, Benoit; Brugg, Bernard; Viovy, Jean-Louis; Peyrin, Jean-Michel			Synapto-Protective Drugs Evaluation in Reconstructed Neuronal Network	PLOS ONE			English	Article							LONG-TERM DEPRESSION; NEUROFIBRILLARY PATHOLOGY; WALLERIAN DEGENERATION; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; RHO; NEURODEGENERATION; DYSFUNCTION; KINASE; MICE	Chronic neurodegenerative syndromes such as Alzheimer's and Parkinson's diseases, or acute syndromes such as ischemic stroke or traumatic brain injuries are characterized by early synaptic collapse which precedes axonal and neuronal cell body degeneration and promotes early cognitive impairment in patients. Until now, neuroprotective strategies have failed to impede the progression of neurodegenerative syndromes. Drugs preventing the loss of cell body do not prevent the cognitive decline, probably because they lack synapto-protective effects. The absence of physiologically realistic neuronal network models which can be easily handled has hindered the development of synapto-protective drugs suitable for therapies. Here we describe a new microfluidic platform which makes it possible to study the consequences of axonal trauma of reconstructed oriented mouse neuronal networks. Each neuronal population and sub-compartment can be chemically addressed individually. The somatic, mid axon, presynaptic and postsynaptic effects of local pathological stresses or putative protective molecules can thus be evaluated with the help of this versatile "brain on chip" platform. We show that presynaptic loss is the earliest event observed following axotomy of cortical fibers, before any sign of axonal fragmentation or post-synaptic spine alteration. This platform can be used to screen and evaluate the synapto-protective potential of several drugs. For instance, NAD(+) and the Rho-kinase inhibitor Y27632 can efficiently prevent synaptic disconnection, whereas the broad-spectrum caspase inhibitor zVAD-fmk and the stilbenoid resveratrol do not prevent presynaptic degeneration. Hence, this platform is a promising tool for fundamental research in the field of developmental and neurodegenerative neurosciences, and also offers the opportunity to set up pharmacological screening of axon-protective and synapto-protective drugs.	[Deleglise, Berangere; Lassus, Benjamin; Soubeyre, Vaneyssa; Brugg, Bernard; Peyrin, Jean-Michel] CNRS, UMR7102, Paris, France; [Deleglise, Berangere; Lassus, Benjamin; Soubeyre, Vaneyssa; Brugg, Bernard; Peyrin, Jean-Michel] Univ Paris 06, Paris, France; [Alleaume-Butaux, Aurelie; Schneider, Benoit] INSERM, UMR S 747, Paris, France; [Alleaume-Butaux, Aurelie; Schneider, Benoit] Univ Paris 05, Sorbonne Paris Cite, UMR S 747, Paris, France; [Vignes, Maeva; Viovy, Jean-Louis] Inst Curie, CNRS, UMR168, F-75231 Paris, France; [Hjorth, Johannes J.] Vrije Univ Amsterdam, CNCR, Amsterdam, Netherlands	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Vrije Universiteit Amsterdam	Peyrin, JM (corresponding author), CNRS, UMR7102, Paris, France.	jean-michel.peyrin@upmc.fr	Maeva, VIGNES L/Q-9495-2016; Hjorth, Johannes/A-2043-2009; Schneider, Benoit/AAF-3850-2019	Maeva, VIGNES L/0000-0002-4768-9648; Hjorth, Johannes/0000-0002-9302-0750; Peyrin, Jean-Michel/0000-0002-0108-1266; Schneider, Benoit/0000-0002-1377-2670; ALLEAUME-BUTAUX, Aurelie/0000-0002-1134-4269; Viovy, Jean-Louis/0000-0002-8223-4040; Peyrin, Jean-Michel/0000-0002-8705-8672	French Research National Agency "Agence Nationale de la Recherche"; ANR RPIB "Neuroscreen"; ANR "PrionsensiTNF"; French 'Ministere de la Recherche'	French Research National Agency "Agence Nationale de la Recherche"(French National Research Agency (ANR)); ANR RPIB "Neuroscreen"(French National Research Agency (ANR)); ANR "PrionsensiTNF"(French National Research Agency (ANR)); French 'Ministere de la Recherche'(Ministry of Research, France)	This work was supported by the French Research National Agency "Agence Nationale de la Recherche," ANR RPIB "Neuroscreen" and ANR "PrionsensiTNF." BD was supported by a PhD grant from the French 'Ministere de la Recherche.' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alafuzoff I, 2008, BRAIN PATHOL, V18, P484, DOI 10.1111/j.1750-3639.2008.00147.x; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Arendt T, 2009, ACTA NEUROPATHOL, V118, P167, DOI 10.1007/s00401-009-0536-x; Beirowski B, 2009, J NEUROSCI, V29, P653, DOI 10.1523/JNEUROSCI.3814-08.2009; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Duyckaerts C, 2009, ACTA NEUROPATHOL, V118, P5, DOI 10.1007/s00401-009-0532-1; Fainzilber M, 2006, NEURON, V50, P819, DOI 10.1016/j.neuron.2006.05.023; Finn JT, 2000, J NEUROSCI, V20, P1333; Garland P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047552; Gillingwater TH, 2003, J ANAT, V203, P265, DOI 10.1046/j.1469-7580.2003.00214.x; Gillingwater TH, 2001, J PHYSIOL-LONDON, V534, P627, DOI 10.1111/j.1469-7793.2001.00627.x; Gillingwater TH, 2006, BRAIN, V129, P1546, DOI 10.1093/brain/awl101; Gonzalez-Forero D, 2012, J NEUROSCI, V32, P68, DOI 10.1523/JNEUROSCI.3215-11.2012; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Jagust W, 2013, NEURON, V77, P219, DOI 10.1016/j.neuron.2013.01.002; Jiao S, 2011, NEURON, V70, P758, DOI 10.1016/j.neuron.2011.04.004; Kilinc D, 2011, NEUROTOX RES, V19, P149, DOI 10.1007/s12640-010-9152-8; Li Z, 2010, CELL, V141, P859, DOI 10.1016/j.cell.2010.03.053; Marcello E, 2012, ADV EXP MED BIOL, V970, P573, DOI 10.1007/978-3-7091-0932-8_25; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Millet Larry J., 2012, Yale Journal of Biology and Medicine, V85, P501; Millet LJ, 2012, TRENDS NEUROSCI; Peyrin JM, 2011, LAB CHIP, V11, P3663, DOI 10.1039/c1lc20014c; Picconi B, 2012, ADV EXP MED BIOL, V970, P553, DOI 10.1007/978-3-7091-0932-8_24; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Raj A, 2012, NEURON, V73, P1204, DOI 10.1016/j.neuron.2011.12.040; Schmandke A, 2007, NEUROSCIENTIST, V13, P454, DOI 10.1177/1073858407303611; Schmitz SK, 2011, J NEUROSCI METH, V195, P185, DOI 10.1016/j.jneumeth.2010.12.011; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Taylor AM, 2010, NEURON, V66, P57, DOI 10.1016/j.neuron.2010.03.022; Timofeev I, 2010, NEUROSCIENTIST, V16, P19, DOI 10.1177/1073858409333545; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; To KCW, 2008, NEUROSCIENCE, V153, P645, DOI 10.1016/j.neuroscience.2008.02.043; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; WATSON DF, 1993, J NEUROSCI, V13, P4354; Whitmore AV, 2003, CELL DEATH DIFFER, V10, P260, DOI 10.1038/sj.cdd.4401147; Wishart TM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002936; Yin DM, 2012, ADV EXP MED BIOL, V970, P493, DOI 10.1007/978-3-7091-0932-8_22; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739	44	35	35	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e71103	10.1371/journal.pone.0071103	http://dx.doi.org/10.1371/journal.pone.0071103			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23976987	Green Submitted, Green Published, gold			2022-12-25	WOS:000323570200027
J	Hiong, KC; Ip, YK; Wong, WP; Chew, SF				Hiong, Kum C.; Ip, Yuen K.; Wong, Wai P.; Chew, Shit F.			Differential Gene Expression in the Brain of the African Lungfish, Protopterus annectens, after Six Days or Six Months of Aestivation in Air	PLOS ONE			English	Article							GLUTAMINE-SYNTHETASE GENES; INCREASED UREA SYNTHESIS; PROTHYMOSIN-ALPHA-GENE; SUPEROXIDE-DISMUTASE; GROWTH-HORMONE; RNA-BINDING; FRESH-WATER; NITROGEN-METABOLISM; AMMONIA PRODUCTION; RAINBOW-TROUT	The African lungfish, Protopterus annectens, can undergo aestivation during drought. Aestivation has three phases: induction, maintenance and arousal. The objective of this study was to examine the differential gene expression in the brain of P. annectens during the induction (6 days) and maintenance (6 months) phases of aestivation as compared with the freshwater control using suppression subtractive hybridization. During the induction phase of aestivation, the mRNA expression of prolactin (prl) and growth hormone were up-regulated in the brain of P. annectens, which indicate for the first time the possible induction role of these two hormones in aestivation. Also, the up-regulation of mRNA expression of tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein c polypeptide and the down-regulation of phosphatidylethanolamine binding protein, suggest that there could be a reduction in biological and neuronal activities in the brain. The mRNA expression of cold inducible RNA-binding protein and glucose regulated protein 58 were also up-regulated in the brain, probably to enhance their cytoprotective effects. Furthermore, the down-regulation of prothymosin a expression suggests that there could be a suppression of transcription and cell proliferation in preparation for the maintenance phase. In general, the induction phase appeared to be characterized by reduction in glycolytic capacity and metabolic activity, suppression of protein synthesis and degradation, and an increase in defense against ammonia toxicity. In contrast, there was a down-regulation in the mRNA expression of prl in the brain of P. annectens during the maintenance phase of aestivation. In addition, there could be an increase in oxidative defense capacity, and up-regulation of transcription, translation, and glycolytic capacities in preparation for arousal. Overall, our results signify the importance of reconstruction of protein structures and regulation of energy expenditure during the induction phase, and the needs to suppress protein degradation and conserve metabolic fuel stores during the maintenance phase of aestivation.	[Hiong, Kum C.; Chew, Shit F.] Nanyang Technol Univ, Natl Inst Educ, Singapore 639798, Singapore; [Ip, Yuen K.; Wong, Wai P.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Institute of Education (NIE) Singapore; National University of Singapore	Chew, SF (corresponding author), Nanyang Technol Univ, Natl Inst Educ, Singapore 639798, Singapore.	sfun.chew@nie.edu.sg	Chew, Shit Fun/I-2248-2012; Ip, Yuen Kwong/H-8041-2012	Chew, Shit Fun/0000-0003-4599-5817; Ip, Yuen Kwong/0000-0001-9124-7911	Ministry of Education of the Republic of Singapore [R-154-000-429-112, R154-000-470-112, RI 9/08 CSF, RI 4/12 CSF]	Ministry of Education of the Republic of Singapore(Ministry of Education, Singapore)	This project was supported by the Ministry of Education of the Republic of Singapore through grants, (R-154-000-429-112 and R154-000-470-112) and (RI 9/08 CSF and RI 4/12 CSF), administered to Y. K. Ip and S. F. Chew, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alberts B., 2010, MOL BIOL CELL; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AYSON FG, 1993, GEN COMP ENDOCR, V89, P138, DOI 10.1006/gcen.1993.1017; Ballantyne James S., 2011, P305; BELKIN DA, 1968, RESP PHYSIOL, V4, P1, DOI 10.1016/0034-5687(68)90002-9; Berg D, 2003, NAT REV NEUROSCI, V4, P752, DOI 10.1038/nrn1197; BERGERON D, 1993, BIOCHIM BIOPHYS ACTA, V1216, P123, DOI 10.1016/0167-4781(93)90047-H; CHAKRAVORTY J, 1989, BIOCHEM INT, V19, P519; Chew SF, 2004, J EXP BIOL, V207, P777, DOI 10.1242/jeb.00813; Chichiarelli S, 2007, J CELL PHYSIOL, V210, P343, DOI 10.1002/jcp.20824; Christian SL, 2008, J CEREBR BLOOD F MET, V28, P1307, DOI 10.1038/jcbfm.2008.20; CLINTON M, 1991, P NATL ACAD SCI USA, V88, P6608, DOI 10.1073/pnas.88.15.6608; Dave KR, 2006, STROKE, V37, P1261, DOI 10.1161/01.STR.0000217409.60731.38; DELANEY RG, 1974, J EXP BIOL, V61, P111; DOMINGUEZ F, 1993, EUR J CANCER, V29A, P893, DOI 10.1016/S0959-8049(05)80433-2; Erickson RR, 2005, BIOCHEM BIOPH RES CO, V332, P50, DOI 10.1016/j.bbrc.2005.04.090; ESCHENFELDT WH, 1986, P NATL ACAD SCI USA, V83, P9403, DOI 10.1073/pnas.83.24.9403; Evstafieva AG, 2003, EXP CELL RES, V284, P211, DOI 10.1016/S0014-4827(02)00047-2; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; FISHMAN AP, 1986, J MORPHOL, P237; FISHMAN AP, 1992, P AM PHILOS SOC, V136, P61; Fong NM, 2000, J BIOL CHEM, V275, P35034, DOI 10.1074/jbc.M005541200; Giusi G, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-39; Giusi G, 2011, J NEUROSCI RES, V89, P418, DOI 10.1002/jnr.22553; GOMEZMARQUEZ J, 1989, J BIOL CHEM, V264, P8451; GREENWOOD PH, 1986, J MORPHOL, P163; GURLEY LR, 1978, EUR J BIOCHEM, V84, P1, DOI 10.1111/j.1432-1033.1978.tb12135.x; Hailey A, 1997, CAN J ZOOL, V75, P1328, DOI 10.1139/z97-757; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; HOLL RW, 1991, J CLIN ENDOCR METAB, V72, P854, DOI 10.1210/jcem-72-4-854; Icardo JM, 2008, J ANAT, V213, P106, DOI 10.1111/j.1469-7580.2008.00901.x; Icardo JM, 2012, ANAT REC, V295, P60, DOI 10.1002/ar.21476; Ip Y.K., 2001, Fish Physiology, V20, P109; Ip YK, 2010, PROG MOL SUBCELL BIO, V49, P63, DOI 10.1007/978-3-642-02421-4_4; Ip YK, 2005, J EXP ZOOL PART A, V303A, P1054, DOI 10.1002/jez.a.237; Jang YC, 2009, J GERONTOL A-BIOL, V64, P1114, DOI 10.1093/gerona/glp100; Jiang XJ, 2003, SCIENCE, V299, P223, DOI 10.1126/science.1076807; JOHNELS ALF G., 1954, ARKIV ZOOL, V7, P131; Karetsou Z, 2002, EMBO REP, V3, P361, DOI 10.1093/embo-reports/kvf071; Korsgaard B., 1995, NITROGEN METABOLISM, P259; Krishnan S, 2011, CHEMBIOCHEM, V12, P254, DOI 10.1002/cbic.201000545; Lindell SL, 2005, AM J PHYSIOL-GASTR L, V288, pG473, DOI 10.1152/ajpgi.00223.2004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lomholt Jens Peter, 1993, Advances in Fish Research, V1, P17; Loong AM, 2012, J COMP PHYSIOL B, V182, P367, DOI 10.1007/s00360-011-0626-7; Loong AM, 2012, J COMP PHYSIOL B, V182, P231, DOI 10.1007/s00360-011-0613-z; Loong AM, 2008, J COMP PHYSIOL B, V178, P351, DOI 10.1007/s00360-007-0228-6; Loong AM, 2005, J EXP ZOOL PART A, V303A, P354, DOI 10.1002/jez.a.147; Luo Y, 2009, J BIOL CHEM, V284, P34901, DOI 10.1074/jbc.M109.038356; MANROW RE, 1991, J BIOL CHEM, V266, P3916; Martini PGV, 2000, MOL CELL BIOL, V20, P6224, DOI 10.1128/MCB.20.17.6224-6232.2000; Mathews MB, 2000, COLD SPRING HARBOR M, V39, P1; Monti JM, 2008, PROG BRAIN RES, V172, P625, DOI 10.1016/S0079-6123(08)00929-1; Murakami K, 1997, STROKE, V28, P1797, DOI 10.1161/01.STR.28.9.1797; Murillo-Rodriguez E, 2009, CNS NEUROL DISORD-DR, V8, P245, DOI 10.2174/187152709788921654; Murray BW, 2003, J EXP BIOL, V206, P1511, DOI 10.1242/jeb.00283; Nurnberger F, 1997, CELL TISSUE RES, V288, P441, DOI 10.1007/s004410050831; Ojeda JL, 2008, ANAT REC, V291, P1156, DOI 10.1002/ar.20729; Ojika K, 2000, PROG NEUROBIOL, V60, P37, DOI 10.1016/S0301-0082(99)00021-0; Page MM, 2010, J COMP PHYSIOL B, V180, P361, DOI 10.1007/s00360-009-0416-7; Pan F, 2004, BIOCHIMIE, V86, P451, DOI 10.1016/j.biochi.2004.06.006; Peng KW, 1998, FISH PHYSIOL BIOCHEM, V19, P59, DOI 10.1023/A:1007745003948; Perry SF, 2008, RESP PHYSIOL NEUROBI, V160, P8, DOI 10.1016/j.resp.2007.06.015; PFEFFER SR, 1987, ANNU REV BIOCHEM, V56, P829, DOI 10.1146/annurev.biochem.56.1.829; PRYER NK, 1992, ANNU REV BIOCHEM, V61, P471; Rand-Weaver Mariann, 1993, Biochemistry and Molecular Biology of Fishes, V2, P39; Rodriguez P, 1999, CELL DEATH DIFFER, V6, P3, DOI 10.1038/sj.cdd.4400450; Rodriguez P, 1998, BIOCHEM J, V331, P753, DOI 10.1042/bj3310753; Rostovtseva T, 1996, J BIOL CHEM, V271, P28006, DOI 10.1074/jbc.271.45.28006; ROTHMAN JE, 1992, NATURE, V355, P409, DOI 10.1038/355409a0; Rudra D, 2004, GENE DEV, V18, P2431, DOI 10.1101/gad.1256704; Saito K, 2010, BRAIN RES, V1358, P20, DOI 10.1016/j.brainres.2010.08.048; Sakamoto T, 2002, FISHERIES SCI, V68, P757, DOI 10.2331/fishsci.68.sup1_757; Sakurai T, 2006, BBA-MOL CELL RES, V1763, P290, DOI 10.1016/j.bbamcr.2006.02.007; SBURLATI AR, 1991, P NATL ACAD SCI USA, V88, P253, DOI 10.1073/pnas.88.1.253; SEIDEL ME, 1978, COMP BIOCHEM PHYS A, V61, P1, DOI 10.1016/0300-9629(78)90265-7; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; SERAFINI T, 1991, NATURE, V349, P214, DOI 10.1038/349215a0; SEUFERT W, 1995, NATURE, V373, P78, DOI 10.1038/373078a0; Shan XY, 2007, NEUROBIOL DIS, V28, P206, DOI 10.1016/j.nbd.2007.07.013; SIEVERT LM, 1988, COMP BIOCHEM PHYS A, V90, P157, DOI 10.1016/0300-9629(88)91022-5; Smith HW, 1930, J BIOL CHEM, V88, P97; Smith HW, 1931, ECOLOGY, V12, P164, DOI 10.2307/1932938; Smith MM, 1991, CURR OPIN CELL BIOL, V3, P429, DOI 10.1016/0955-0674(91)90070-F; Storey KB, 2002, COMP BIOCHEM PHYS A, V133, P733, DOI 10.1016/S1095-6433(02)00206-4; Storey KB, 2010, PROG MOL SUBCELL BIO, V49, P25, DOI 10.1007/978-3-642-02421-4_2; Tisdale EJ, 2007, TRAFFIC, V8, P733, DOI 10.1111/j.1600-0854.2007.00569.x; Tournebize R, 1997, EMBO J, V16, P5537, DOI 10.1093/emboj/16.18.5537; TSITSILONI OE, 1993, P NATL ACAD SCI USA, V90, P9504, DOI 10.1073/pnas.90.20.9504; Vareli K, 2000, EXP CELL RES, V257, P152, DOI 10.1006/excr.2000.4857; Wang YX, 2000, AQUAT TOXICOL, V50, P205, DOI 10.1016/S0166-445X(99)00101-0; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; WEBB JT, 1976, COMP BIOCHEM PHYS B, V54, P171, DOI 10.1016/0305-0491(76)90077-8; Wei Y, 1998, P NATL ACAD SCI USA, V95, P7480, DOI 10.1073/pnas.95.13.7480; Whitehead A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r13; Wright PA, 2007, J EXP BIOL, V210, P2905, DOI 10.1242/jeb.003905; Wu CL, 1997, LIFE SCI, V61, P2091, DOI 10.1016/S0024-3205(97)00882-5; Zemlyak I, 2009, NEUROSCI LETT, V453, P182, DOI 10.1016/j.neulet.2009.02.020; Zeng LC, 2008, EXPERT OPIN THER TAR, V12, P1275, DOI [10.1517/14728222.12.10.1275, 10.1517/14728222.12.10.1275 ]; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	102	12	12	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e71205	10.1371/journal.pone.0071205	http://dx.doi.org/10.1371/journal.pone.0071205			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23976998	gold, Green Published, Green Submitted			2022-12-25	WOS:000323570200029
J	Zhu, F; Yan, CX; Wen, YC; Wang, JY; Bi, JB; Zhao, YL; Wei, L; Gao, CG; Jia, W; Li, SB				Zhu, Feng; Yan, Chun-xia; Wen, Yi-chong; Wang, Jiayin; Bi, Jinbo; Zhao, Ya-ling; Wei, Lai; Gao, Cheng-ge; Jia, Wei; Li, Sheng-bin			Dopamine D1 Receptor Gene Variation Modulates Opioid Dependence Risk by Affecting Transition to Addiction	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS DOPAMINE; DELTA-FOSB; DRUG-ABUSE; MORPHINE; SENSITIZATION; COCAINE; HEROIN; REWARD; DRD1; D-1	Dopamine D1 receptor (DRD1) modulates opioid reinforcement, reward, and opioid-induced neuroadaptation. We propose that DRD1 polymorphism affects susceptibility to opioid dependence (OD), the efficiency of transition to OD, and opioid-induced pleasure response. We analyzed potential association between seven DRD1 polymorphisms with the following traits: duration of transition from the first use to dependence (DTFUD), subjective pleasure responses to opioid on first use and post-dependence use, and OD risk in 425 Chinese with OD and 514 healthy controls. DTFUD and level of pleasure responses were examined using a semi-structured interview. The DTFUD of opioid addicts ranged from 5 days to 11 years. Most addicts (64.0%) reported non-comfortable response upon first opioid use, while after dependence, most addicts (53.0%) felt strong opioid-induced pleasure. Survival analysis revealed a correlation of prolonged DTFUD with the minor allele-carrying genotypes of DRD1 rs4532 (hazard ratios (HR) = 0.694; p = 0.001) and rs686 (HR = 0.681, p = 0.0003). Binary logistic regression indicated that rs10063995 GT genotype (vs. GG+TT, OR = 0.261) could predict decreased pleasure response to first-time use and the minor alleles of rs686 (OR = 0.535) and rs4532 (OR = 0.537) could predict decreased post-dependence pleasure. Moreover, rs686 minor allele was associated with a decreased risk for rapid transition from initial use to dependence (DTFUD <= 30 days; OR = 0.603) or post-dependence euphoria (OR = 0.603) relative to major allele. In conclusion, DRD1 rs686 minor allele decreases the OD risk by prolonging the transition to dependence and attenuating opioid-induced pleasure in Chinese.	[Zhu, Feng; Yan, Chun-xia; Wen, Yi-chong; Wei, Lai; Li, Sheng-bin] Xi An Jiao Tong Univ, Hlth Sci Ctr, Coll Med & Forens, Xian 710049, Shaanxi, Peoples R China; [Zhu, Feng; Yan, Chun-xia; Wen, Yi-chong; Wei, Lai; Li, Sheng-bin] Xi An Jiao Tong Univ, Key Lab Hlth Minist Forens Sci, Xian 710049, Shaanxi, Peoples R China; [Zhu, Feng; Yan, Chun-xia; Wen, Yi-chong; Zhao, Ya-ling; Wei, Lai; Li, Sheng-bin] Key Lab Educ Minist Environm & Genes Related Dis, Xian, Shaanxi, Peoples R China; [Wang, Jiayin; Bi, Jinbo] Washington Univ, Genome Inst, St Louis, MO USA; [Bi, Jinbo] Univ Connecticut, Ctr Hlth, Sch Med, Dept Community Med & Hlth Care, Farmington, CT USA; [Zhao, Ya-ling] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Publ Hlth, Xian 710049, Shaanxi, Peoples R China; [Gao, Cheng-ge] Xi An Jiao Tong Univ, Hlth Sci Ctr, Affiliated Hosp 1, Dept Psychiat, Xian 710049, Shaanxi, Peoples R China; [Jia, Wei] Xian Mental Hlth Ctr, Methadone Maintenance Therapy Clin, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Washington University (WUSTL); University of Connecticut; Xi'an Jiaotong University; Xi'an Jiaotong University	Yan, CX (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Coll Med & Forens, Xian 710049, Shaanxi, Peoples R China.	yanchunxia@mail.xjtu.edu.cn; shbinlee@mail.xjtu.edu.cn	Wang, Jiayin/C-5047-2015; Zhu, Feng/CAH-0203-2022	Wang, Jiayin/0000-0002-3862-6557; Zhu, Feng/0000-0003-3986-8803	National Science Foundation of China [81172903]; Fundamental Research Funds for the Central Universities; Scientific Research Foundation of Education Ministry; HR Ministry of China for the Returned Overseas Scholars	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Scientific Research Foundation of Education Ministry; HR Ministry of China for the Returned Overseas Scholars	This work was supported by grants from the National Science Foundation of China (No. 81172903), the Fundamental Research Funds for the Central Universities (2010), the Scientific Research Foundation of Education Ministry and HR Ministry of China for the Returned Overseas Scholars for C-XY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahi A, 2012, PSYCHOPHARMACOLOGY, V222, P141, DOI 10.1007/s00213-011-2630-8; Barrett JC, 2009, COLD SPRING HARB PRO; Bie B, 2012, NEUROPSYCHOPHARMACOL; Bierut LJ, 2011, NEURON, V69, P618, DOI 10.1016/j.neuron.2011.02.015; Borgkvist A, 2008, NEUROPHARMACOLOGY, V55, P230, DOI 10.1016/j.neuropharm.2008.05.028; Caine SB, 2007, J NEUROSCI, V27, P13140, DOI 10.1523/JNEUROSCI.2284-07.2007; Chan G, 2011, ADDICTION, V106, P1146, DOI 10.1111/j.1360-0443.2011.03390.x; da Silva Lobo DS, 2007, J GAMBL STUD, V23, P421, DOI 10.1007/s10899-007-9060-x; Depue RA, 1999, BEHAV BRAIN SCI, V22, P491; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Dudman JT, 2003, J NEUROCHEM, V87, P922, DOI 10.1046/j.1471-4159.2003.02067.x; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Gelernter J, 2006, AM J HUM GENET, V78, P759, DOI 10.1086/503631; GERRITS MAFM, 1994, PSYCHOPHARMACOLOGY, V114, P486, DOI 10.1007/BF02249340; GLICK SD, 1975, RES COMMUN CHEM PATH, V12, P17; Hettinger JA, 2008, AM J MED GENET B, V147B, P628, DOI 10.1002/ajmg.b.30655; Hilario MRF, 2012, NEUROPSYCHOPHARMACOL, V37, P2661, DOI 10.1038/npp.2012.130; Huang W, 2008, HUM GENET, V123, P133, DOI 10.1007/s00439-007-0453-9; Huang WH, 2009, BIOL PSYCHIAT, V65, P702, DOI 10.1016/j.biopsych.2008.11.024; Jacobs MM, 2012, MOL PSYCHIAT; Jurinke Christian, 2002, Methods Mol Biol, V187, P179; Kasanetz F, 2010, SCIENCE, V328, P1709, DOI 10.1126/science.1187801; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kim DJ, 2007, BIOCHEM BIOPH RES CO, V357, P1135, DOI 10.1016/j.bbrc.2007.04.074; Koob George F, 2008, Drug Discov Today Dis Models, V5, P207; Koob GF, 2001, NEUROPSYCHOPHARMACOL, V24, P97, DOI 10.1016/S0893-133X(00)00195-0; Kourrich S, 2012, J NEUROSCI, V32, P6578, DOI 10.1523/JNEUROSCI.6391-11.2012; Kreek MJ, 2005, NAT NEUROSCI, V8, P1450, DOI 10.1038/nn1583; LETT BT, 1989, PSYCHOPHARMACOLOGY, V98, P357, DOI 10.1007/BF00451687; Lintas A, 2011, J NEUROSCI, V31, P11172, DOI 10.1523/JNEUROSCI.1781-11.2011; LIU JL, 1994, P NATL ACAD SCI USA, V91, P8537, DOI 10.1073/pnas.91.18.8537; Lopez-Quintero C, 2011, DRUG ALCOHOL DEPEN, V115, P120, DOI 10.1016/j.drugalcdep.2010.11.004; Manzanedo C, 2005, NEUROREPORT, V16, P201, DOI 10.1097/00001756-200502080-00028; Muller DL, 2005, J PHARMACOL EXP THER, V314, P148, DOI 10.1124/jpet.105.083410; Nestler EJ, 2004, NEUROPHARMACOLOGY, V47, P24, DOI 10.1016/j.neuropharm.2004.06.031; Piazza PV, 2000, J NEUROSCI, V20, P4226; Ridenour TA, 2005, DRUG ALCOHOL DEPEN, V80, P1, DOI 10.1016/j.drugalcdep.2005.02.005; Rowlett JK, 2007, J PHARMACOL EXP THER, V321, P1135, DOI 10.1124/jpet.107.120766; Sun JW, 2012, ADDICT BEHAV, V37, P1138, DOI 10.1016/j.addbeh.2012.05.010; Tsuang MT, 1996, AM J MED GENET, V67, P473, DOI 10.1002/(SICI)1096-8628(19960920)67:5<473::AID-AJMG6>3.3.CO;2-D; Vink J, 2005, BEHAV GENET, V35, P397, DOI 10.1007/s10519-004-1327-8; Wagner FA, 2002, NEUROPSYCHOPHARMACOL, V26, P479, DOI 10.1016/S0893-133X(01)00367-0; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203; WISE RA, 1995, SYNAPSE, V21, P140, DOI 10.1002/syn.890210207; Wise Roy A., 2000, Neuron, V26, P27, DOI 10.1016/S0896-6273(00)81134-4; Yacubian J, 2009, NEUROSCIENCE, V164, P55, DOI 10.1016/j.neuroscience.2009.05.015; Zachariou V, 2006, NAT NEUROSCI, V9, P205, DOI 10.1038/nn1636; Zhang DD, 2007, BIOL PSYCHIAT, V61, P1244, DOI 10.1016/j.biopsych.2006.07.012; Zhang J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S6-S6; Zhu F, 2011, BRAIN RES, V1420, P106, DOI 10.1016/j.brainres.2011.08.069	50	26	27	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e70805	10.1371/journal.pone.0070805	http://dx.doi.org/10.1371/journal.pone.0070805			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23976958	Green Published, gold, Green Submitted			2022-12-25	WOS:000323570200008
J	Lao, XQ; Yu, ITS; Au, DKK; Chiu, YL; Wong, CCY; Wong, TW				Lao, Xiang Qian; Yu, Ignatius Tak Sun; Au, Dennis Kin Kwok; Chiu, Yuk Lan; Wong, Claudie Chiu Yi; Wong, Tze Wai			Noise Exposure and Hearing Impairment among Chinese Restaurant Workers and Entertainment Employees in Hong Kong	PLOS ONE			English	Article							OCCUPATIONAL NOISE; RISK-FACTORS; SMOKING; POPULATION; WORKING; PREVALENCE; THRESHOLD; ADULTS; AGE	Background: Noise-induced hearing loss (NIHL) is a major concern in the non-manufacturing industries. This study aimed to investigate the occupational noise exposure and the NIHL among Chinese restaurant workers and entertainment employees working in the service industry in Hong Kong. Methods: This cross-sectional survey involved a total of 1,670 participants. Among them, 937 were randomly selected from the workers of Chinese restaurants and 733 were selected from workers in three entertainment sectors: radio and television stations; cultural performance halls or auditoria of the Leisure and Cultural Services Department (LCSD); and karaoke bars. Noise exposure levels were measured in the sampled restaurants and entertainment sectors. Each participant received an audiometric screening test. Those who were found to have abnormalities were required to take another diagnostic test in the health center. The "Klockhoff digit" method was used to classify NIHL in the present study. Results: The main source of noise inside restaurants was the stoves. The mean hearing thresholds showed a typical dip at 3 to 6 KHz and a substantial proportion (23.7%) of the workers fulfilled the criteria for presumptive NIHL. For entertainment sectors, employees in radio and television stations generally had higher exposure levels than those in the halls or auditoria of the LCSD and karaoke bars. The mean hearing thresholds showed a typical dip at 6 KHz and a substantial proportion of the employees fulfilled the criteria for presumptive NIHL (38.6%, 95%CI: 35.1-42.1%). Being male, older, and having longer service and daily alcohol consumption were associated with noise-induced hearing impairment both in restaurant workers and entertainment employees. Conclusion: Excessive noise exposure is common in the Chinese restaurant and entertainment industries and a substantial proportion of restaurant workers and entertainment employees suffer from NIHL. Comprehensive hearing conservation programs should be introduced to the service industry in Hong Kong.	[Lao, Xiang Qian; Yu, Ignatius Tak Sun; Chiu, Yuk Lan; Wong, Claudie Chiu Yi; Wong, Tze Wai] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Au, Dennis Kin Kwok] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; University of Hong Kong	Yu, ITS (corresponding author), Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China.	iyu@cuhk.edu.hk	Yu, Ignatius Tak Sun/A-9936-2008; Lao, Xiang Qian/M-5817-2017; Wong, Tze Wai/K-5344-2013	Lao, Xiang Qian/0000-0002-2645-0128; 	Health Services Research Committee/Health Care and Promotion Fund of Hong Kong [621016]	Health Services Research Committee/Health Care and Promotion Fund of Hong Kong	This study was supported by Health Services Research Committee/Health Care and Promotion Fund of Hong Kong (621016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal Y, 2008, ARCH INTERN MED, V168, P1522, DOI 10.1001/archinte.168.14.1522; ALLEYNE BC, 1985, CAN J PUBLIC HEALTH, V76, P266; ATHERLEY G, 1985, AM J IND MED, V8, P101, DOI 10.1002/ajim.4700080205; *BRIT SOC AUD, 1985, BRIT J AUDIOL, V19, P281; BRUHL P, 1994, SCAND AUDIOL, V23, P123, DOI 10.3109/01050399409047496; Coles RRA, 2000, CLIN OTOLARYNGOL, V25, P264, DOI 10.1046/j.1365-2273.2000.00368.x; Cruickshanks KJ, 1998, JAMA-J AM MED ASSOC, V279, P1715, DOI 10.1001/jama.279.21.1715; Daniel WW, 1999, BIOSTATISTICS FDN AN, V7th; El Dib RP, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-151; Ferrite S, 2005, OCCUP MED-OXFORD, V55, P48, DOI 10.1093/occmed/kqi002; Fransen E, 2008, JARO-J ASSOC RES OTO, V9, P264, DOI 10.1007/s10162-008-0123-1; GATES GA, 1993, ARCH OTOLARYNGOL, V119, P156; Gunderson E, 1997, AM J IND MED, V31, P75; Hodgetts WE, 2007, EAR HEARING, V28, P290, DOI 10.1097/AUD.0b013e3180479399; Kim MG, 2009, YONSEI MED J, V50, P771, DOI 10.3349/ymj.2009.50.6.771; KLOCKHOFF I, 1974, AUDIOLOGY, V13, P326; Kurmis Andrew P., 2007, International Journal of Occupational Medicine and Environmental Health, V20, P127, DOI 10.2478/v10001-007-0016-2; LEBO CP, 1994, WESTERN J MED, V161, P45; Liu XZ, 2007, J PATHOL, V211, P188, DOI 10.1002/path.2102; May JJ, 2000, AM J IND MED, V37, P112, DOI 10.1002/(SICI)1097-0274(200001)37:1<112::AID-AJIM9>3.3.CO;2-R; Naing L, 2006, ARCH OROFAC SCI, V1, P9; Nelson DI, 2005, AM J IND MED, V48, P446, DOI 10.1002/ajim.20223; Nomura K, 2005, INT ARCH OCC ENV HEA, V78, P178, DOI 10.1007/s00420-005-0604-z; Rabinowitz PM, 2006, EAR HEARING, V27, P742, DOI 10.1097/01.aud.0000240544.79254.bc; ROSENHALL U, 1993, AUDIOLOGY, V32, P234; Sadhra S, 2002, ANN OCCUP HYG, V46, P455, DOI 10.1093/annhyg/mef051; Uchida Y, 2005, INT J AUDIOL, V44, P86, DOI 10.1080/14992020500031256; Verbeek JH, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006396.pub2; Williams W, 2005, INT J AUDIOL, V44, P231, DOI 10.1080/14992020500057673; Zhao F, 2010, INT J AUDIOL, V49, P54, DOI 10.3109/14992020903202520	30	17	17	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e70674	10.1371/journal.pone.0070674	http://dx.doi.org/10.1371/journal.pone.0070674			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23976950	Green Published, Green Submitted, gold			2022-12-25	WOS:000323378000010
J	Wang, HL; Li, YQ; Yin, LT; Meng, XL; Guo, M; Zhang, JH; Liu, HL; Liu, JJ; Yin, GR				Wang, Hai-Long; Li, Ya-Qing; Yin, Li-Tian; Meng, Xiao-Li; Guo, Min; Zhang, Jian-Hong; Liu, Hong-Li; Liu, Juan-Juan; Yin, Guo-Rong			Toxoplasma gondii Protein Disulfide Isomerase (TgPDI) Is a Novel Vaccine Candidate against Toxoplasmosis	PLOS ONE			English	Article							PROTECTIVE IMMUNITY; NEOSPORA-CANINUM; DNA VACCINE; 2-DIMENSIONAL ELECTROPHORESIS; IGA ANTIBODIES; BALB/C MICE; INFECTION; RESPONSES; PROTEOMICS; HUMANS	Toxoplasma gondii is a ubiquitous protozoan parasite that can infect all warm-blooded animals, including both mammals and birds. Protein disulfide isomerase (PDI) localises to the surface of T. gondii tachyzoites and modulates the interactions between parasite and host cells. In this study, the protective efficacy of recombinant T. gondii PDI (rTgPDI) as a vaccine candidate against T. gondii infection in BALB/c mice was evaluated. rTgPDI was expressed and purified from Escherichia coli. Five groups of animals (10 animals/group) were immunised with 10, 20, 30, 40 mu g of rTgPDI per mouse or with PBS as a control group. All immunisations were performed via the nasal route at 1, 14 and 21 days. Two weeks after the last immunisation, the immune responses were evaluated by lymphoproliferative assays and by cytokine and antibody measurements. The immunised mice were challenged with tachyzoites of the virulent T. gondii RH strain on the 14th day after the last immunisation. Following the challenge, the tachyzoite loads in tissues were assessed, and animal survival time was recorded. Our results showed that the group immunised with 30 mu g rTgPDI showed significantly higher levels of specific antibodies against the recombinant protein, a strong lymphoproliferative response and significantly higher levels of IgG2a, IFN-gamma (IFN-gamma), IL-2 and IL-4 production compared with other doses and control groups. While no changes in IL-10 levels were detected. After being challenged with T. gondii tachyzoites, the numbers of tachyzoites in brain and liver tissues from the rTgPDI group were significantly reduced compared with those of the control group, and the survival time of the mice in the rTgPDI group was longer than that of mice in the control group. Our results showed that immunisation with rTgPDI elicited a protective immune reaction and suggested that rTgPDI might represent a promising vaccine candidate for combating toxoplasmosis.	[Wang, Hai-Long; Li, Ya-Qing; Meng, Xiao-Li; Zhang, Jian-Hong; Liu, Hong-Li; Liu, Juan-Juan; Yin, Guo-Rong] Shanxi Med Univ, Res Inst Med Parasitol, Taiyuan, Shanxi, Peoples R China; [Yin, Li-Tian] Shanxi Med Univ, Dept Physiol, Key Lab Cellular Physiol Coconstructed Prov, Taiyuan, Shanxi, Peoples R China; [Yin, Li-Tian] Shanxi Med Univ, Minist Educ, Taiyuan, Shanxi, Peoples R China; [Guo, Min] Shanxi Med Univ, Ctr Lab Anim, Taiyuan, Shanxi, Peoples R China	Shanxi Medical University; Shanxi Medical University; Shanxi Medical University; Shanxi Medical University	Yin, GR (corresponding author), Shanxi Med Univ, Res Inst Med Parasitol, Taiyuan, Shanxi, Peoples R China.	guorongyin@163.com			National Natural Science Foundation of China [81071374]; 331 Early Career Researcher Grant of Shanxi Medical University [201202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 331 Early Career Researcher Grant of Shanxi Medical University	This work was supported by the National Natural Science Foundation of China (No. 81071374) and the 331 Early Career Researcher Grant of Shanxi Medical University (No. 201202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliberti J, 2005, NAT REV IMMUNOL, V5, P162, DOI 10.1038/nri1547; Bai Y, 2012, EXP PARASITOL, V132, P458, DOI 10.1016/j.exppara.2012.09.015; Rodriguez JB, 2012, EXPERT OPIN THER PAT, V22, P311, DOI 10.1517/13543776.2012.668886; Ben Achour Y, 2002, INFECT IMMUN, V70, P3576, DOI 10.1128/IAI.70.7.3576-3585.2002; Blake DP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001279; Blunt DS, 1996, GENE, V181, P221, DOI 10.1016/S0378-1119(96)00460-X; BRABIN L, 1992, ADV PARASIT, V31, P1, DOI 10.1016/S0065-308X(08)60020-2; BUXTON D, 1995, PARASITOLOGY, V110, pS11, DOI 10.1017/S003118200000144X; Cohen AM, 2002, INT J PARASITOL, V32, P39, DOI 10.1016/S0020-7519(01)00308-3; Dziadek B, 2011, VACCINE, V29, P821, DOI 10.1016/j.vaccine.2010.11.002; Dziadek B, 2009, EXP PARASITOL, V123, P81, DOI 10.1016/j.exppara.2009.06.002; Fang R, 2009, VET PARASITOL, V164, P134, DOI 10.1016/j.vetpar.2009.06.012; Florenta I, 2000, FEBS LETT, V484, P246, DOI 10.1016/S0014-5793(00)02170-0; Frand AR, 2000, TRENDS CELL BIOL, V10, P203, DOI 10.1016/S0962-8924(00)01745-1; Golkar M, 2007, VACCINE, V25, P4301, DOI 10.1016/j.vaccine.2007.02.057; Grigg ME, 2001, SCIENCE, V294, P161, DOI 10.1126/science.1061888; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; Huang XS, 2012, EXP PARASITOL, V130, P218, DOI 10.1016/j.exppara.2012.01.001; Johnson LL, 2004, VACCINE, V22, P4054, DOI 10.1016/j.vaccine.2004.03.056; Jones JL, 2012, CLIN INFECT DIS, V55, P845, DOI 10.1093/cid/cis508; Jongert E, 2008, VACCINE, V26, P1025, DOI 10.1016/j.vaccine.2007.11.058; Jongert E, 2007, PARASITE IMMUNOL, V29, P445, DOI 10.1111/j.1365-3024.2007.00961.x; Jongert E, 2010, VACCINE, V28, P2556, DOI 10.1016/j.vaccine.2010.01.031; Kur J, 2009, EXPERT REV VACCINES, V8, P791, DOI [10.1586/erv.09.27, 10.1586/ERV.09.27]; Lau YL, 2008, EXP PARASITOL, V119, P373, DOI 10.1016/j.exppara.2008.03.016; Laurindo FRM, 2012, FREE RADICAL BIO MED, V52, P1954, DOI 10.1016/j.freeradbiomed.2012.02.037; Lee EG, 2005, J CHROMATOGR B, V815, P305, DOI 10.1016/j.jchromb.2004.08.048; Lee EG, 2003, PROTEOMICS, V3, P2339, DOI 10.1002/pmic.200300617; Liesenfeld O, 2001, J PARASITOL, V87, P1491, DOI 10.1645/0022-3395(2001)087[1491:IOGASH]2.0.CO;2; Liu QA, 2010, RES VET SCI, V89, P93, DOI 10.1016/j.rvsc.2010.01.007; Lourenco EV, 2006, MICROBES INFECT, V8, P1244, DOI 10.1016/j.micinf.2005.11.013; Ma GY, 2009, EXP PARASITOL, V122, P41, DOI 10.1016/j.exppara.2009.01.011; Martin JE, 2006, CLIN VACCINE IMMUNOL, V13, P1267, DOI 10.1128/CVI.00162-06; Meek B, 2002, FEBS LETT, V522, P104, DOI 10.1016/S0014-5793(02)02911-3; Meek B, 2002, INT IMMUNOL, V14, P1291, DOI 10.1093/intimm/dxf091; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Mosmann TR, 1997, CIBA F SYMP, V204, P148; Munoz M, 2011, IMMUNOL REV, V240, P269, DOI 10.1111/j.1600-065X.2010.00992.x; Naguleswaran A, 2005, INT J PARASITOL, V35, P1459, DOI 10.1016/j.ijpara.2005.06.006; Padilla A, 2003, J BIOL CHEM, V278, P1872, DOI 10.1074/jbc.M210322200; Pulendran B, 2004, IMMUNOL RES, V29, P187, DOI 10.1385/IR:29:1-3:187; ROBERTS CW, 1995, INFECT IMMUN, V63, P2549, DOI 10.1128/IAI.63.7.2549-2555.1995; Robinson HL, 1999, INT J MOL MED, V4, P549; Sanchez VR, 2011, EXP PARASITOL, V128, P448, DOI 10.1016/j.exppara.2011.04.004; Schulthess J, 2008, PARASITE, V15, P389, DOI 10.1051/parasite/2008153389; Serranti D, 2011, EUR REV MED PHARMACO, V15, P193; Sibley LD, 2008, ANNU REV MICROBIOL, V62, P329, DOI 10.1146/annurev.micro.62.081307.162925; Su C, 2003, SCIENCE, V299, P414, DOI 10.1126/science.1078035; Tan F, 2011, VACCINE, V29, P2742, DOI 10.1016/j.vaccine.2011.01.089; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Xiao RY, 2004, J BIOL CHEM, V279, P49780, DOI 10.1074/jbc.M409210200; Yuan ZG, 2011, VACCINE, V29, P6614, DOI 10.1016/j.vaccine.2011.06.110; Zhang J, 2007, PARASITOL RES, V101, P331, DOI 10.1007/s00436-007-0465-3	55	23	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e70884	10.1371/journal.pone.0070884	http://dx.doi.org/10.1371/journal.pone.0070884			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967128	Green Submitted, gold, Green Published			2022-12-25	WOS:000323378000019
J	Kim, TE; Seo, JS; Yang, JW; Kim, MW; Kausar, R; Joe, E; Kim, BY; Lee, MA				Kim, Tae Eun; Seo, Ji Sun; Yang, Jae Won; Kim, Min Woong; Kausar, Rukhsana; Joe, Eunhye; Kim, Bo Yeon; Lee, Myung Ae			Nurr1 Represses Tyrosine Hydroxylase Expression via SIRT1 in Human Neural Stem Cells	PLOS ONE			English	Article							ORPHAN NUCLEAR RECEPTOR; MIDBRAIN DOPAMINERGIC-NEURONS; HISTONE DEACETYLASE SIRT1; TRANSCRIPTIONAL REPRESSION; PROGENITOR CELLS; GENE-EXPRESSION; MEDIATED TRANSCRIPTION; PARKINSONS-DISEASE; NGFI-B; DIFFERENTIATION	Nurr1 is an orphan nuclear receptor best known for its essential role in the development and maintenance of midbrain dopaminergic (DA) neurons. During DA neurogenesis, Nurr1 directly targets human tyrosine hydroxylase (hTH). Here we investigated this targeting to identify the molecular mechanisms by which Nurr1 regulates DA neurogenesis. We previously cloned the hTH promoter and found three consensus elements for Nurr1 binding: NBRE-A, -B, and -C. In the present study, gel retardation and luciferase assays using hTH constructs showed that Nurr1 preferentially bound to NBRE-A, through which it mediated transcriptional activity. Furthermore, Nurr1 displayed dual-function transcriptional activities depending on the cell type. In DA-like SH-SY5Y cells, Nurr1 dose-dependently stimulated hTH-3174 promoter activity by 7- to 11-fold. However, in the human neural stem cell (hNSC) line HB1.F3, Nurr1 strongly repressed transcription from the same promoter. This repression was relieved by mutation of only the NBRE-A element and by nicotinamide [an inhibitor of class III histone deacetylases (HDACs), such as SIRT1], but not by trichostatin A (an inhibitor of class I and II HDACs). SIRT1 was strongly expressed in the nucleus of HB1.F3 cells, while it was localized in the cytoplasm in SH-SY5Y cells. ChIP assays of HB1.F3 cells showed that Nurr1 overexpression significantly increased the SIRT1 occupancy of the NBRE-A hTH promoter region, while low SIRT1 levels were observed in control cells. In contrast, no significant SIRT1 recruitment was observed in SH-SY5Y cells. These results indicate that differential SIRT1 localization may be involved in hTH gene regulation. Overall, our findings suggest that Nurr1 exists in dual transcriptional complexes, including co-repressor complexes that can be remodeled to become co-activators and can fine-tune hTH gene transcription during human DA neurogenesis.	[Kim, Tae Eun; Seo, Ji Sun; Yang, Jae Won; Kim, Min Woong; Kausar, Rukhsana; Lee, Myung Ae] Ajou Univ, Sch Med, Brain Dis Res Ctr, Suwon 441749, South Korea; [Kim, Tae Eun; Seo, Ji Sun; Yang, Jae Won; Kim, Min Woong; Kausar, Rukhsana; Lee, Myung Ae] Ajou Univ, Sch Med, Grad Sch Biomed Sci, Suwon 441749, South Korea; [Joe, Eunhye] Ajou Univ, Sch Med, Dept Pharmacol, Suwon 441749, South Korea; [Kim, Bo Yeon] KRIBB, Chem Biol Res Ctr, Ochang, South Korea; [Kim, Bo Yeon] KRIBB, World Class Inst, Ochang, South Korea	Ajou University; Ajou University; Ajou University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Lee, MA (corresponding author), Ajou Univ, Sch Med, Brain Dis Res Ctr, Suwon 441749, South Korea.	lma52347@ajou.ac.kr			National Research Foundation of Korea; Ministry of Education, Science and Technology [2010-0025006]; Ministry of Health & Welfare, Republic of Korea [1120100]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology(2010-0025006), and by a grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (1120100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson EKI, 2007, EXP CELL RES, V313, P1172, DOI 10.1016/j.yexcr.2006.12.014; Arredondo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055035; Castro DS, 1999, J BIOL CHEM, V274, P37483, DOI 10.1074/jbc.274.52.37483; Castro DS, 2001, J BIOL CHEM, V276, P43277, DOI 10.1074/jbc.M107013200; Chanda D, 2010, NUCLEIC ACIDS RES, V38, P4607, DOI 10.1093/nar/gkq227; Cho T, 2002, NEUROREPORT, V13, P1447, DOI 10.1097/00001756-200208070-00020; Chung CY, 2005, HUM MOL GENET, V14, P1709, DOI 10.1093/hmg/ddi178; Chung S, 2009, CELL STEM CELL, V5, P646, DOI 10.1016/j.stem.2009.09.015; Codina A, 2004, J BIOL CHEM, V279, P53338, DOI 10.1074/jbc.M409096200; Dai Y, 2007, MOL ENDOCRINOL, V21, P1807, DOI 10.1210/me.2006-0467; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; Donaldson AE, 2009, STEM CELLS DEV, V18, P1003, DOI 10.1089/scd.2008.0300; Freedman SB, 2001, J MOL CELL CARDIOL, V33, P379, DOI 10.1006/jmcc.2000.1329; Galleguillos D, 2004, J BIOL CHEM, V279, P2005, DOI 10.1074/jbc.M308113200; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Hedlund E, 2008, STEM CELLS, V26, P1526, DOI 10.1634/stemcells.2007-0996; Hisahara S, 2008, P NATL ACAD SCI USA, V105, P15599, DOI 10.1073/pnas.0800612105; Ichinose H, 1999, GENE, V230, P233, DOI 10.1016/S0378-1119(99)00065-7; Jacobs FMJ, 2009, DEVELOPMENT, V136, P531, DOI 10.1242/dev.029769; Jin H, 2006, J CELL PHYSIOL, V207, P49, DOI 10.1002/jcp.20534; Garcia-Yague AJ, 2013, J BIOL CHEM, V288, P5506, DOI 10.1074/jbc.M112.439190; Kim HS, 2003, BIOCHEM BIOPH RES CO, V312, P950, DOI 10.1016/j.bbrc.2003.11.012; Kim JY, 2003, J NEUROCHEM, V85, P1443, DOI 10.1046/j.1471-4159.2003.01780.x; Kim KS, 2003, J NEUROCHEM, V85, P622, DOI 10.1046/j.1471-4159.2003.01671.x; Kim Seung U, 2002, Methods Mol Biol, V198, P55; Kim SU, 2004, NEUROPATHOLOGY, V24, P159, DOI 10.1111/j.1440-1789.2004.00552.x; Kim TE, 2003, BIOCHEM BIOPH RES CO, V312, P1123, DOI 10.1016/j.bbrc.2003.11.029; Kim TE, 2003, BIOCHEM BIOPH RES CO, V305, P1040, DOI 10.1016/S0006-291X(03)00879-9; Kirn SM, 2006, BIOCHEM BIOPH RES CO, V346, P426, DOI 10.1016/j.bbrc.2006.05.142; Kitagawa H, 2007, MOL CELL BIOL, V27, P7486, DOI 10.1128/MCB.00409-07; Lammi J, 2007, BIOCHEM BIOPH RES CO, V359, P391, DOI 10.1016/j.bbrc.2007.05.122; Le WD, 2003, NAT GENET, V33, P85, DOI 10.1038/ng1066; Lee HS, 2010, STEM CELLS, V28, P501, DOI 10.1002/stem.294; Martinat C, 2006, P NATL ACAD SCI USA, V103, P2874, DOI 10.1073/pnas.0511153103; Michelhaugh SK, 2005, J NEUROCHEM, V95, P1342, DOI 10.1111/j.1471-4159.2005.03458.x; Mix KS, 2007, J BIOL CHEM, V282, P9492, DOI 10.1074/jbc.M608327200; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; PAHLMAN S, 1981, INT J CANCER, V28, P583, DOI 10.1002/ijc.2910280509; Park KC, 2005, MOL ENDOCRINOL, V19, P12, DOI 10.1210/me.2004-0107; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; PERLMANN T, 1995, GENE DEV, V9, P769, DOI 10.1101/gad.9.7.769; Romano G, 2005, J CELL PHYSIOL, V204, P666, DOI 10.1002/jcp.20319; Ryu JK, 2003, J NEUROSCI RES, V72, P352, DOI 10.1002/jnr.10507; Sacchetti P, 2001, J NEUROCHEM, V76, P1565, DOI 10.1046/j.1471-4159.2001.00181.x; Sakurada K, 1999, DEVELOPMENT, V126, P4017; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Senawong T, 2003, J BIOL CHEM, V278, P43041, DOI 10.1074/jbc.M307477200; Smidt MP, 2007, NAT REV NEUROSCI, V8, P21, DOI 10.1038/nrn2039; Tucholski J, 2003, J BIOL CHEM, V278, P26838, DOI 10.1074/jbc.M303683200; Wu YM, 2005, ENDOCRINOLOGY, V146, P237, DOI 10.1210/en.2004-0889; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248; Zhang YX, 2005, NUCLEIC ACIDS RES, V33, P6024, DOI 10.1093/nar/gki903; Zhu P, 2006, CELL, V124, P615, DOI 10.1016/j.cell.2005.12.032	54	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71469	10.1371/journal.pone.0071469	http://dx.doi.org/10.1371/journal.pone.0071469			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23977047	Green Published, gold, Green Submitted			2022-12-25	WOS:000323221500085
J	Platonov, A; Goossens, J				Platonov, Artem; Goossens, Jeroen			Influence of Contrast and Coherence on the Temporal Dynamics of Binocular Motion Rivalry	PLOS ONE			English	Article							MUTUAL INHIBITION; VISUAL-MOTION; MODEL; ALTERNATIONS; RESPONSES; NEURONS; MECHANISMS; STIMULI; REVEALS; CHOICE	Levelt's four propositions (L1-L4), which characterize the relation between changes in "stimulus strength" in the two eyes and percept alternations, are considered benchmark for binocular rivalry models. It was recently demonstrated that adaptation mutual-inhibition models of binocular rivalry capture L4 only in a limited range of input strengths, predicting an increase rather than a decrease in dominance durations with increasing stimulus strength for weak stimuli. This observation challenges the validity of those models, but possibly L4 itself is invalid. So far, L1-L4 have been tested mainly by varying the contrast of static stimuli, but since binocular rivalry breaks down at low contrasts, it has been difficult to study L4. To circumvent this problem, and to test if the recent revision of L2 has more general validity, we studied changes in binocular rivalry evoked by manipulating coherence of oppositely-moving random-dot stimuli in the two eyes, and compared them against the effects of stimulus contrast. Thirteen human observers participated. Both contrast and coherence manipulations in one eye produced robust changes in both eyes; dominance durations of the eye receiving the stronger stimulus increased while those of the other eye decreased, albeit less steeply. This is inconsistent with L2 but supports its revision. When coherence was augmented in both eyes simultaneously, dominance durations first increased at low coherence, and then decreased for further increases in coherence. The same held true for the alternation periods. The initial increase in dominance durations was absent in the contrast experiments, but with coherence manipulations, rivalry could be tested at much lower stimulus strengths. Thus, we found that L4, like L2, is only valid in a limited range of stimulus strengths. Outside that range, the opposite is true. Apparent discrepancies between contrast and coherence experiments could be fully reconciled with adaptation mutual-inhibition models using a simple input transfer-function.	[Platonov, Artem; Goossens, Jeroen] Radboud Univ Nijmegen, Med Ctr Nijmegen, Biophys Sect, Dept Cognit Neurosci,Donders Inst Brain Cognit &, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Goossens, J (corresponding author), Radboud Univ Nijmegen, Med Ctr Nijmegen, Biophys Sect, Dept Cognit Neurosci,Donders Inst Brain Cognit &, NL-6525 ED Nijmegen, Netherlands.	J.Goossens@donders.ru.nl	Goossens, Jeroen/D-7311-2010	Goossens, Jeroen/0000-0001-5522-3437	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) [864.06.005]; Radboud University Nijmegen Medical Centre	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO)); Radboud University Nijmegen Medical Centre	This work is supported by Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) Grant 864.06.005 (ALW VIDI) and the Radboud University Nijmegen Medical Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2010, CURR BIOL, V20, P1362, DOI 10.1016/j.cub.2010.06.015; ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; Andrews TJ, 1999, NAT NEUROSCI, V2, P405, DOI 10.1038/8068; Ashwin P, 2010, PHYSICA D, V239, P529, DOI 10.1016/j.physd.2009.06.018; BLAKE R, 1989, PSYCHOL REV, V96, P145, DOI 10.1037/0033-295X.96.1.145; Blake R, 2003, NEURON, V39, P869, DOI 10.1016/S0896-6273(03)00495-1; BLAKE R, 1977, J EXP PSYCHOL HUMAN, V3, P251, DOI 10.1037/0096-1523.3.2.251; BOSSINK CJH, 1993, VISION RES, V33, P1413, DOI 10.1016/0042-6989(93)90047-Z; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brascamp JW, 2006, J VISION, V6, P1244, DOI 10.1167/6.11.8; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Burke D, 1999, PERCEPTION, V28, P73, DOI 10.1068/p2694; Carter O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000343; Curtu R, 2008, SIAM J APPL DYN SYST, V7, P609, DOI 10.1137/070705842; FOX R, 1969, PERCEPT PSYCHOPHYS, V5, P215, DOI 10.3758/BF03210542; Freeman AW, 2005, J NEUROPHYSIOL, V94, P4412, DOI 10.1152/jn.00557.2005; Gold JI, 2002, NEURON, V36, P299, DOI 10.1016/S0896-6273(02)00971-6; Hohwy J, 2008, COGNITION, V108, P687, DOI 10.1016/j.cognition.2008.05.010; Jazayeri M, 2006, NAT NEUROSCI, V9, P690, DOI 10.1038/nn1691; Kang MS, 2010, ATTEN PERCEPT PSYCHO, V72, P179, DOI 10.3758/APP.72.1.179; Klink PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003473; Laing CR, 2002, J COMPUT NEUROSCI, V12, P39, DOI 10.1023/A:1014942129705; Lankheet MJM, 2006, J VISION, V6, P304, DOI 10.1167/6.4.1; LEHKY SR, 1988, PERCEPTION, V17, P215, DOI 10.1068/p170215; LEVELT WJM, 1966, BRIT J PSYCHOL, V57, P225, DOI 10.1111/j.2044-8295.1966.tb01023.x; Levelt WJM, 1965, THESIS LEIDEN; LIU L, 1992, VISION RES, V32, P1471, DOI 10.1016/0042-6989(92)90203-U; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Moreno-Bote R, 2007, J NEUROPHYSIOL, V98, P1125, DOI 10.1152/jn.00116.2007; Moreno-Bote R, 2010, J VISION, V10, DOI 10.1167/10.11.1; MUELLER TJ, 1989, BIOL CYBERN, V61, P223, DOI 10.1007/BF00198769; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Noest AJ, 2007, J VISION, V7, DOI 10.1167/7.8.10; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Platonov A, 2010, FENS FOR, V139, P17; Roitman JD, 2002, J NEUROSCI, V22, P9475; SCLAR G, 1990, VISION RES, V30, P1, DOI 10.1016/0042-6989(90)90123-3; Seely J, 2011, J NEUROPHYSIOL, V106, P2136, DOI 10.1152/jn.00228.2011; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Shpiro A, 2007, J NEUROPHYSIOL, V97, P462, DOI 10.1152/jn.00604.2006; Sundareswara R, 2008, J VISION, V8, DOI 10.1167/8.5.12; van Ee R, 2011, J VISION, V11, DOI 10.1167/11.2.13; Wilson HR, 2003, P NATL ACAD SCI USA, V100, P14499, DOI 10.1073/pnas.2333622100; Wilson HR, 2007, VISION RES, V47, P2741, DOI 10.1016/j.visres.2007.07.007	47	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71931	10.1371/journal.pone.0071931	http://dx.doi.org/10.1371/journal.pone.0071931			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	202MQ	23967265	Green Published, gold, Green Submitted			2022-12-25	WOS:000323221500115
J	Bayly, MJ; Holmes, GD; Forster, PI; Cantrill, DJ; Ladiges, PY				Bayly, Michael J.; Holmes, Gareth D.; Forster, Paul I.; Cantrill, David J.; Ladiges, Pauline Y.			Major Clades of Australasian Rutoideae (Rutaceae) Based on rbcL and atpB Sequences	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; PHYLOGENETIC-RELATIONSHIPS; NEW-CALEDONIA; CLADISTIC-ANALYSIS; HISTORICAL BIOGEOGRAPHY; MOLECULAR PHYLOGENY; DIVERGENCE TIMES; DNA-SEQUENCES; NEW-WORLD; REVISION	Background: Rutaceae subfamily Rutoideae (46 genera, c. 660 species) is diverse in both rainforests and sclerophyll vegetation of Australasia. Australia and New Caledonia are centres of endemism with a number of genera and species distributed disjunctly between the two regions. Our aim was to generate a high-level molecular phylogeny for the Australasian Rutoideae and identify major clades as a framework for assessing morphological and biogeographic patterns and taxonomy. Methodology/Principal Findings: Phylogenetic analyses were based on chloroplast genes, rbcL and atpB, for 108 samples (78 new here), including 38 of 46 Australasian genera. Results were integrated with those from other molecular studies to produce a supertree for Rutaceae worldwide, including 115 of 154 genera. Australasian clades are poorly matched with existing tribal classifications, and genera Philotheca and Boronia are not monophyletic. Major sclerophyll lineages in Australia belong to two separate clades, each with an early divergence between rainforest and sclerophyll taxa. Dehiscent fruits with seeds ejected at maturity (often associated with myrmecochory) are inferred as ancestral; derived states include woody capsules with winged seeds, samaras, fleshy drupes, and retention and display of seeds in dehisced fruits (the last two states adaptations to bird dispersal, with multiple origins among rainforest genera). Patterns of relationship and levels of sequence divergence in some taxa, mostly species, with bird-dispersed (Acronychia, Sarcomelicope, Halfordia and Melicope) or winged (Flindersia) seeds are consistent with recent long-distance dispersal between Australia and New Caledonia. Other deeper Australian/New Caledonian divergences, some involving ant-dispersed taxa (e.g., Neoschmidia), suggest older vicariance. Conclusions/Significance: This comprehensive molecular phylogeny of the Australasian Rutoideae gives a broad overview of the group's evolutionary and biogeographic history. Deficiencies of infrafamilial classifications of Rutoideae have long been recognised, and our results provide a basis for taxonomic revision and a necessary framework for more focused studies of genera and species.	[Bayly, Michael J.; Holmes, Gareth D.; Ladiges, Pauline Y.] Univ Melbourne, Sch Bot, Parkville, Vic 3052, Australia; [Forster, Paul I.] Brisbane Bot Gardens, Dept Sci Informat Technol Innovat & Arts, Queensland Herbarium, Toowong, Qld, Australia; [Cantrill, David J.] Royal Bot Gardens Melbourne, Natl Herbarium Victoria, South Yarra, Vic, Australia	University of Melbourne	Bayly, MJ (corresponding author), Univ Melbourne, Sch Bot, Parkville, Vic 3052, Australia.	mbayly@unimelb.edu.au	Cantrill, David/R-1415-2019	Cantrill, David/0000-0002-1185-4015; Bayly, Michael/0000-0001-6836-5493	Australian Research Council [LP0776737]; Australian Biological Resources Study [PD208-02]	Australian Research Council(Australian Research Council); Australian Biological Resources Study	This study was funded by grants from: Australian Research Council, grant LP0776737, url http://www.arc.gov.au/. Australian Biological Resources Study, grant PD208-02, url http://www.environment.gov.au/biodiversity/abrs/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITCHISON JC, 1995, GEOLOGY, V23, P161, DOI 10.1130/0091-7613(1995)023<0161:EACCIN>2.3.CO;2; Appelhans MS, 2011, ANN BOT-LONDON, V107, P1259, DOI 10.1093/aob/mcr076; Appelhans MS, 2012, J BIOGEOGR, V39, P1235, DOI 10.1111/j.1365-2699.2012.02686.x; Armstrong J, 1991, THESIS; ARMSTRONG J A, 1980, Telopea, V1, P399; Armstrong JA, 2002, AUST SYST BOT, V15, P277, DOI 10.1071/SB00040; Bache F, 2012, EARTH PLANET SC LETT, V321, P41, DOI 10.1016/j.epsl.2011.12.041; Bansal MS, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-18; Barker NP, 2007, J BIOGEOGR, V34, P2012, DOI 10.1111/j.1365-2699.2007.01749.x; Bartish IV, 2005, AM J BOT, V92, P667, DOI 10.3732/ajb.92.4.667; Bauer Aaron M., 2006, Proceedings of the California Academy of Sciences, V57, P503; Bayer RJ, 2009, AM J BOT, V96, P668, DOI 10.3732/ajb.0800341; Bayly Michael J., 1998, Muelleria, V11, P113; Bayly MJ, 1998, AUST SYST BOT, V11, P13, DOI 10.1071/SB96010; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; BERG RY, 1975, AUST J BOT, V23, P475, DOI 10.1071/BT9750475; Bininda-Emonds ORP, 2002, ANNU REV ECOL SYST, V33, P265, DOI 10.1146/annurev.ecolsys.33.010802.150511; Broadhurst L, 2000, AUST SYST BOT, V13, P479, DOI 10.1071/SB99009; Broadhurst LM, 2001, AUST J BOT, V49, P451, DOI 10.1071/BT00071; Brophy JJ, 2005, J ESSENT OIL RES, V17, P169, DOI 10.1080/10412905.2005.9698866; But PPH, 2009, J SYST EVOL, V47, P144, DOI 10.1111/j.1759-6831.2009.00013.x; Butler DW, 2007, J BIOGEOGR, V34, P1736, DOI 10.1111/j.1365-2699.2007.01734.x; Byrne M, 2011, J BIOGEOGR, V38, P1635, DOI 10.1111/j.1365-2699.2011.02535.x; CHAH, 2011, AUSTR PLANT CENS IBI; Chase MW, 1999, AM J BOT, V86, P1191, DOI 10.2307/2656983; Cook LG, 2005, P ROY SOC B-BIOL SCI, V272, P2535, DOI 10.1098/rspb.2005.3219; Cracraft J, 2001, P ROY SOC B-BIOL SCI, V268, P459, DOI 10.1098/rspb.2000.1368; Crisp M, 2004, PHILOS T R SOC B, V359, P1551, DOI 10.1098/rstb.2004.1528; Crisp MD, 2007, MOL PHYLOGENET EVOL, V43, P1106, DOI 10.1016/j.ympev.2007.02.030; DA SILVA MFGF, 1988, PLANT SYST EVOL, V161, P97; De Beuque SV, 1998, COMPTES RENDUS AC 2A, V326, P663; Dong JR, 2009, SYST BIOL, V58, P360, DOI 10.1093/sysbio/syp032; DOYLE JA, 1992, CRETACEOUS RES, V13, P337, DOI 10.1016/0195-6671(92)90039-S; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Duretto Marco F., 2008, Austrobaileya, V7, P681; Duretto Marco F., 2007, Austrobaileya, V7, P473; Engler A., 1896, NATURLICHEN PFLANZEN, P95; Engler H.G.A., 1931, NATURLICHEN PFLANZEN, P187; Exon NF, 2006, AUST J EARTH SCI, V53, P541, DOI 10.1080/08120090600632300; Forster Paul I., 2005, Austrobaileya, V7, P175; Forster PI, 2004, AUST SYST BOT, V17, P571, DOI 10.1071/SB04019; Gebert WA, 2008, TELOPEA, V12, P193, DOI 10.7751/telopea20085810; Grandcolas P, 2008, PHILOS T R SOC B, V363, P3309, DOI 10.1098/rstb.2008.0122; GREENE DF, 1995, CAN J BOT, V73, P1036, DOI 10.1139/b95-113; GREGOR HJ, 1989, PLANT SYST EVOL, V162, P251, DOI 10.1007/BF00936920; Groppo M, 2008, AM J BOT, V95, P985, DOI 10.3732/ajb.2007313; Hackney R, 2012, GEOPHYS J INT, V189, P1293, DOI 10.1111/j.1365-246X.2012.05441.x; Harbaugh DT, 2009, J BIOGEOGR, V36, P230, DOI 10.1111/j.1365-2699.2008.02008.x; Harden G.J., 2006, RAINFOREST TREES SHR; Hartley T, 2000, ALLERTONIA, V8, P1; Hartley T, 1986, B MUS NATN HIST PA B, V2, P183; Hartley T, 1984, B MUSEE HIST NAT 6 B, V6, P29; HARTLEY T G, 1991, Australian Systematic Botany, V4, P445, DOI 10.1071/SB9910445; HARTLEY T G, 1982, Reinwardtia, V10, P93; HARTLEY T G, 1982, Austrobaileya, V1, P451; HARTLEY T G, 1983, Brunonia, V6, P251, DOI 10.1071/BRU9830251; Hartley T. G., 1995, Bulletin du Museum National d'Histoire Naturelle Section B Adansonia Botanique Phytochimie, V17, P107; HARTLEY T G, 1983, Bulletin du Museum National d'Histoire Naturelle Section B Adansonia Botanique Phytochimie, V5, P391; HARTLEY T G, 1982, Brunonia, V5, P109, DOI 10.1071/BRU9820109; Hartley T. G., 2001, Malayan Nature Journal, V55, P197; Hartley T. G., 1981, Gardens' Bulletin, V34, P91; HARTLEY TG, 1979, J ARNOLD ARBORETUM, V60, P127, DOI 10.5962/bhl.part.12825; HARTLEY TG, 1977, J ARNOLD ARBORETUM, V58, P416; HARTLEY TG, 1975, J ARNOLD ARBORETUM, V56, P243; HARTLEY TG, 1969, J ARNOLD ARBORETUM, V50, P481; HARTLEY TG, 1985, AUST J BOT, V33, P27, DOI 10.1071/BT9850027; HARTLEY TG, 1982, AUST J BOT, V30, P359, DOI 10.1071/BT9820359; HARTLEY TG, 1974, J ARNOLD ARBORETUM, V55, P469; HARTLEY TG, 1977, J ARNOLD ARBORETUM, V58, P171; Hartley Thomas G., 2003, Adansonia (Paris), V25, P7; Hartley Thomas G., 1997, Adansonia (Paris), V19, P189; Hartley Thomas G., 2003, Adansonia (Paris), V25, P251; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Heads M, 2008, J BIOGEOGR, V35, P2153, DOI 10.1111/j.1365-2699.2008.01977.x; Hill R. S, 1999, FLORA AUSTR, P251; HOOT SB, 1995, ANN MO BOT GARD, V82, P194, DOI 10.2307/2399877; Hopper SD, 2004, ANNU REV ECOL EVOL S, V35, P623, DOI 10.1146/annurev.ecolsys.35.112202.130201; Horn HS, 2001, ECOL RES, V16, P877, DOI 10.1046/j.1440-1703.2001.00456.x; HUGHES L, 1992, ECOLOGY, V73, P1285, DOI 10.2307/1940676; HUGHES NF, 1990, REV PALAEOBOT PALYNO, V65, P145, DOI 10.1016/0034-6667(90)90065-Q; Hyland B. P. M., 2010, AUSTR TROPICAL RAINF; Kallunki Jacquelyn A., 1998, Kew Bulletin, V53, P257, DOI 10.2307/4114501; Kershaw AP., 1994, HIST AUSTR VEGETATIO, P299; Kirkbride JH, 2006, FAMILY GUIDE FRUITS; Kubitzki K., 2011, V10, P276; Labat J.-N., 2005, MONOGRAPHS SYSTEMATI, V104, P361; Ladiges PY, 2007, AUST SYST BOT, V20, P383, DOI 10.1071/SB07018; Ladiges PY, 2012, SYST BIOL, V61, P703, DOI 10.1093/sysbio/sys005; Ladiges PY, 2010, SPEC SYST, V3, P267; Ladiges PY, 2003, J BIOGEOGR, V30, P989, DOI 10.1046/j.1365-2699.2003.00881.x; LAFOY Y, 1994, CR ACAD SCI II, V319, P1063; Ling Ka-Ho, 2009, Taiwania, V54, P338; Lowry PP, 1998, ACAD SINICA MONOGRAP, P181; MADDISON D. R., 2005, MACCLADE 4 ANAL PHYL; McLoughlin S, 2001, AUST J BOT, V49, P271, DOI 10.1071/BT00023; McNeill J., 2006, V146, P1; Meissner R.A., 2007, NUYTSIA, V17, P273; Mole BJ, 2004, PLANT SYST EVOL, V249, P197, DOI 10.1007/s00606-004-0218-z; Mollemans F. H., 1993, Nuytsia, V9, P95; Morat P, 1984, BIOGEOGRAPHY TROPICA, P71; Mortimer N, 2004, GONDWANA RES, V7, P261, DOI 10.1016/S1342-937X(05)70324-5; MORTON CM, 1993, BRITTONIA, V45, P286, DOI 10.2307/2807604; Muellner AN, 2007, PLANT SYST EVOL, V266, P233, DOI 10.1007/s00606-007-0546-x; Nattier R, 2011, J BIOGEOGR, V38, P2195, DOI 10.1111/j.1365-2699.2011.02563.x; NELSON G, 1974, SYST ZOOL, V23, P555, DOI 10.2307/2412475; NG KM, 1987, BIOCHEM SYST ECOL, V15, P587, DOI 10.1016/0305-1978(87)90110-4; Nylander J. A. A., 2004, MRMODELTEST V2; Othman RNA, 2010, PLANT SYST EVOL, V288, P127, DOI 10.1007/s00606-010-0315-0; Pelletier B., 2006, COMPENDIUM MARINE SP, VII, P19; Pfeil BE, 2008, AM J BOT, V95, P1621, DOI 10.3732/ajb.0800214; Poon WS, 2007, SYST BOT, V32, P837, DOI 10.1600/036364407783390692; Rambaut A, 2002, SE AL SEQUENCE ALIGN; Rambaut A, 2007, TRACER V1 5; Ridley HN, 1922, FLORA MALAY PENINSUL; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rossetto M, 2005, BIOL CONSERV, V121, P35, DOI 10.1016/j.biocon.2004.04.007; Rozefelds AC., 2001, MUELLERIA, V15, P19; Rozefelds AC., 2001, MUELLERIA, V15, P15; Salvo G, 2008, MOL PHYLOGENET EVOL, V49, P736, DOI 10.1016/j.ympev.2008.09.004; Salvo G, 2010, SYST BIOL, V59, P705, DOI 10.1093/sysbio/syq046; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; Sauquet H, 2012, SYST BIOL, V61, P289, DOI 10.1093/sysbio/syr116; Scott KD, 2000, PLANT SYST EVOL, V223, P15, DOI 10.1007/BF00985324; SMITH-WHITE S., 1954, AUSTRALIAN JOUR BOT, V2, P287, DOI 10.1071/BT9540287; Soltis PS, 1999, NATURE, V402, P402, DOI 10.1038/46528; STACE HM, 1993, PLANT SYST EVOL, V187, P1, DOI 10.1007/BF00994089; Steel M, 2008, SYSTEMATIC BIOL, V57, P243, DOI 10.1080/10635150802033014; Sutherland R, 2010, TECTONICS, V29, DOI 10.1029/2009TC002476; Swofford DL, 2001, PAUP PHYLOGENETIC AN; Sytsma KJ, 2004, INT J PLANT SCI, V165, pS85, DOI 10.1086/421066; Telford Ian R. H., 2006, Telopea, V11, P105; Thiv M, 2011, AM J BOT, V98, P76, DOI 10.3732/ajb.1000339; Thorne RF, 2000, BOT REV, V66, P441, DOI 10.1007/BF02869011; Thorne RF, 2007, BOT REV, V73, P67, DOI 10.1663/0006-8101(2007)73[67:AUCOTC]2.0.CO;2; Trinder-Smith TH, 2007, SYST BOT, V32, P847, DOI 10.1600/036364407783390890; Walsh Neville G., 2004, Telopea, V10, P805; WATERMAN PG, 1990, PLANT SYST EVOL, V173, P39, DOI 10.1007/BF00937761; Waterman PG, 1983, CHEM CHEM TAXONOMY R; Webb L. J., 1994, AUSTR VEGETATION, P87; WESTOBY M, 1990, ECOLOGY, V71, P1307, DOI 10.2307/1938268; WESTON PH, 1984, AUST J BOT, V32, P187, DOI 10.1071/BT9840187; WILLSON MF, 1990, J VEG SCI, V1, P547, DOI 10.2307/3235789; Wilson P, 1998, NUYTSIA, V12, P83; Wilson P, 1971, NUYTSIA, V1, P197; Wilson Paul G., 1997, Nuytsia, V11, P429; Wilson Paul G., 1998, Nuytsia, V12, P107; Wilson Paul G., 1998, Nuytsia, V12, P267; Wilson Paul G., 1998, Nuytsia, V12, P239; Wilson Paul G., 1998, Nuytsia, V12, P89; Wilson PG., 1970, NUYTSIA, V1, P3; Woo VL, 2011, INT J PLANT SCI, V172, P434, DOI 10.1086/658183	151	34	35	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e72493	10.1371/journal.pone.0072493	http://dx.doi.org/10.1371/journal.pone.0072493			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967311	Green Published, Green Submitted, gold			2022-12-25	WOS:000323115800105
J	Hang, NTL; Maeda, S; Lien, LT; Thuong, PH; Hung, NV; Thuy, TB; Nanri, A; Mizoue, T; Hoang, NP; Cuong, VC; Ngoc, KTT; Sakurada, S; Endo, H; Keicho, N				Nguyen Thi Le Hang; Maeda, Shinji; Luu Thi Lien; Pham Huu Thuong; Nguyen Van Hung; Tran Bich Thuy; Nanri, Akiko; Mizoue, Tetsuya; Nguyen Phuong Hoang; Vu Cao Cuong; Khieu Thi Thuy Ngoc; Sakurada, Shinsaku; Endo, Hiroyoshi; Keicho, Naoto			Primary Drug-Resistant Tuberculosis in Hanoi, Viet Nam: Present Status and Risk Factors	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; NUMBER TANDEM REPEATS; MYCOBACTERIUM-TUBERCULOSIS; BEIJING GENOTYPE; PYRAZINAMIDE; STRAINS; EPIDEMIOLOGY; POPULATION; PREVALENCE; MECHANISMS	Introduction: Resistance of Mycobacterium tuberculosis (MTB) to anti-tuberculosis (TB) drugs presents a serious challenge to TB control worldwide. We investigated the status of drug resistance, including multidrug-resistant (MDR) TB, and possible risk factors among newly diagnosed TB patients in Hanoi, the capital of Viet Nam. Methods: Clinical and epidemiological information was collected from 506 newly diagnosed patients with sputum smear- and culture-positive TB, and 489 (96.6%) MTB isolates were subjected to conventional drug susceptibility testing, spoligotyping, and 15-locus variable numbers of tandem repeats typing. Adjusted odds ratios (aORs) were calculated to analyze the risk factors for primary drug resistance. Results: Of 489 isolates, 298 (60.9%) were sensitive to all drugs tested. Resistance to isoniazid, rifampicin, streptomycin, ethambutol, and MDR accounted for 28.2%, 4.9%, 28.2%, 2.9%, and 4.5%, respectively. Of 24 isolates with rifampicin resistance, 22 (91.7%) were MDR and also resistant to streptomycin, except one case. Factors associated with isoniazid resistance included living in old urban areas, presence of the Beijing genotype, and clustered strains [aOR = 2.23, 95% confidence interval (CI) 1.15-4.35; 1.91, 1.18-3.10; and 1.69, 1.06-2.69, respectively). The Beijing genotype was also associated with streptomycin resistance (aOR = 2.10, 95% CI 1.29-3.40). Human immunodeficiency virus (HIV) coinfection was associated with rifampicin resistance and MDR (aOR = 5.42, 95% CI 2.07-14.14; 6.23, 2.34-16.58, respectively). Conclusion: Isoniazid and streptomycin resistance was observed in more than a quarter of TB patients without treatment history in Hanoi. Transmission of isoniazid-resistant TB among younger people should be carefully monitored in urban areas, where Beijing strains and HIV coinfection are prevalent. Choosing an optimal treatment regimen on the basis of the results of drug susceptibility tests and monitoring of treatment adherence would minimize further development of drug resistance strains.	[Nguyen Thi Le Hang] NCGM BMH Med Collaborat Ctr, Hanoi, Vietnam; [Maeda, Shinji] Res Inst TB JATA, Dept Mycobacterium Reference & Res, Tokyo, Japan; [Luu Thi Lien] Hanoi Dept Hlth, Hanoi, Vietnam; [Pham Huu Thuong; Vu Cao Cuong] Hanoi Lung Hosp, Hanoi, Vietnam; [Nguyen Van Hung; Tran Bich Thuy; Khieu Thi Thuy Ngoc] Natl Lung Hosp, Dept Microbiol, Hanoi, Vietnam; [Nanri, Akiko; Mizoue, Tetsuya] Natl Ctr Global Hlth & Med, Dept Epidemiol & Prevent, Clin Res Ctr, Tokyo, Japan; [Nguyen Phuong Hoang] Hanoi Lung Hosp, Dept Microbiol, Hanoi, Vietnam; [Sakurada, Shinsaku] Natl Ctr Global Hlth & Med, Bur Int Med Cooperat, Tokyo, Japan; [Endo, Hiroyoshi] Tokyo Womens Med Univ, Dept Int Affairs & Trop Med, Tokyo, Japan; [Keicho, Naoto] Res Inst TB JATA, Dept Pathophysiol & Host Def, Tokyo, Japan; [Keicho, Naoto] Natl Ctr Global Hlth & Med, Tokyo, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; Tokyo Women's Medical University; National Center for Global Health & Medicine - Japan	Keicho, N (corresponding author), Res Inst TB JATA, Dept Pathophysiol & Host Def, Tokyo, Japan.	nkeicho-tky@umin.ac.jp	Keicho, Naoto/GQZ-0301-2022	Keicho, Naoto/0000-0001-8232-9448	Program of Japan Initiative for Global Research Network on Infectious Diseases (J-GRID), MEXT, Japan	Program of Japan Initiative for Global Research Network on Infectious Diseases (J-GRID), MEXT, Japan	This work was supported by a grant from the Program of Japan Initiative for Global Research Network on Infectious Diseases (J-GRID), MEXT, Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, GLOBAL TUBERCULOSIS, P1; [Anonymous], 2008, EP FACT SHEET HIV AI; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Buu TN, 2009, INT J TUBERC LUNG D, V13, P900; BUU TN, 2010, PLOS ONE, V2012, P42323; Caminero JA, 2010, INT J TUBERC LUNG D, V14, P382; Chang KC, 2011, ANTIMICROB AGENTS CH, V55, P4499, DOI 10.1128/AAC.00630-11; Chuang PC, 2010, J CLIN MICROBIOL, V48, P4245, DOI 10.1128/JCM.00970-10; Cohn JA, 2002, INFECT DIS CLIN N AM, V16, P745, DOI 10.1016/S0891-5520(02)00012-0; Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; GOBLE M, 1993, NEW ENGL J MED, V328, P527, DOI 10.1056/NEJM199302253280802; Huong NT, 2006, J INFECT DIS, V194, P1226, DOI 10.1086/507906; Huong NT, 2005, INT J TUBERC LUNG D, V9, P151; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Khan FA, 2012, CLIN INFECT DIS, V55, P1154, DOI 10.1093/cid/cis630; Khue PM, 2008, INT J TUBERC LUNG D, V12, P763; Lew W, 2008, ANN INTERN MED, V149, P123, DOI 10.7326/0003-4819-149-2-200807150-00008; Liang LB, 2012, THORAX, V67, P632, DOI 10.1136/thoraxjnl-2011-200018; Luo T, 2012, J CLIN MICROBIOL, V50, P633, DOI 10.1128/JCM.05539-11; McIlleron H, 2006, ANTIMICROB AGENTS CH, V50, P1170, DOI 10.1128/AAC.50.4.1170-1177.2006; Menzies D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000150, 10.1371/journal.pmed.1000146]; *MIN HLTH, 2006, NAT TUB PROGR 20 YEA; Mulenga C, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-177; Nabyonga Lydia, 2011, BMC Res Notes, V4, P280, DOI 10.1186/1756-0500-4-280; NGUYEN VA, 2010, PLOS ONE, V7, P45553; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Phyu S, 2009, J CLIN MICROBIOL, V47, P335, DOI 10.1128/JCM.01812-08; Quy HT, 2006, INT J TUBERC LUNG D, V10, P160; Sandman L, 1999, AM J RESP CRIT CARE, V159, P468, DOI 10.1164/ajrccm.159.2.9805097; Savine E, 2002, J CLIN MICROBIOL, V40, P4561, DOI 10.1128/JCM.40.12.4561-4566.2002; Shanmugam S, 2011, INFECT GENET EVOL, V11, P980, DOI 10.1016/j.meegid.2011.03.011; Sharma B, 2010, INDIAN J MED RES, V132, P72; Slam K, 2007, INT J TUBERC LUNG D, V11, P1049; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Suchindran S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005561; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; *WHO, 2003, WHOCDSTB2003320; *WHO, 2008, WHOHTMTB2008394; Yang CG, 2012, CLIN INFECT DIS, V55, P1179, DOI 10.1093/cid/cis670; Zhang Y, 2009, INT J TUBERC LUNG D, V13, P1320; Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789; 2006, EMERG INFECT DIS, V12, P736, DOI DOI 10.3201/EID1205.050400.PUBMED:16704829	43	20	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71867	10.1371/journal.pone.0071867	http://dx.doi.org/10.1371/journal.pone.0071867			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967255	gold, Green Published, Green Submitted			2022-12-25	WOS:000323115800088
J	Than, BLN; Goos, JACM; Sarver, AL; O'Sullivan, MG; Rod, A; Starr, TK; Fijneman, RJA; Meijer, GA; Zhao, L; Zhang, Y; Largaespada, DA; Scott, PM; Cormier, RT				Than, B. L. N.; Goos, J. A. C. M.; Sarver, A. L.; O'Sullivan, M. G.; Rod, A.; Starr, T. K.; Fijneman, R. J. A.; Meijer, G. A.; Zhao, L.; Zhang, Y.; Largaespada, D. A.; Scott, P. M.; Cormier, R. T.			The role of KCNQ1 in mouse and human gastrointestinal cancers	ONCOGENE			English	Article						colorectal cancer; KCNQ1; tumor suppressor	GATED POTASSIUM CHANNELS; CYSTIC-FIBROSIS MOUSE; INTESTINAL TUMORIGENESIS; COLORECTAL-CANCER; TARGETED DISRUPTION; PHENOTYPIC ANALYSIS; MICE; SUSCEPTIBILITY; EXPRESSION; GENES	Kcnq1, which encodes for the pore-forming alpha-subunit of a voltage-gated potassium channel, was identified as a gastrointestinal (GI) tract cancer susceptibility gene in multiple Sleeping Beauty DNA transposon-based forward genetic screens in mice. To confirm that Kcnq1 has a functional role in GI tract cancer, we created Apc(Min) mice that carried a targeted deletion mutation in Kcnq1. Results demonstrated that Kcnq1 is a tumor suppressor gene as Kcnq1 mutant mice developed significantly more intestinal tumors, especially in the proximal small intestine and colon, and some of these tumors progressed to become aggressive adenocarcinomas. Gross tissue abnormalities were also observed in the rectum, pancreas and stomach. Colon organoid formation was significantly increased in organoids created from Kcnq1 mutant mice compared with wild-type littermate controls, suggesting a role for Kcnq1 in the regulation of the intestinal crypt stem cell compartment. To identify gene expression changes due to loss of Kcnq1, we carried out microarray studies in the colon and proximal small intestine. We identified altered genes involved in innate immune responses, goblet and Paneth cell function, ion channels, intestinal stem cells, epidermal growth factor receptor and other growth regulatory signaling pathways. We also found genes implicated in inflammation and in cellular detoxification. Pathway analysis using Ingenuity Pathway Analysis and Gene Set Enrichment Analysis confirmed the importance of these gene clusters and further identified significant overlap with genes regulated by MUC2 and CFTR, two important regulators of intestinal homeostasis. To investigate the role of KCNQ1 in human colorectal cancer (CRC), we measured protein levels of KCNQ1 by immunohistochemistry in tissue microarrays containing samples from CRC patients with liver metastases who had undergone hepatic resection. Results showed that low expression of KCNQ1 expression was significantly associated with poor overall survival.	[Than, B. L. N.; Rod, A.; Zhao, L.; Scott, P. M.; Cormier, R. T.] Univ Minnesota, Sch Med, Dept Biomed Sci, Duluth, MN 55812 USA; [Than, B. L. N.] Univ Minnesota, Toxicol Grad Program, Duluth, MN 55812 USA; [Goos, J. A. C. M.; Fijneman, R. J. A.; Meijer, G. A.] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Sarver, A. L.] Univ Minnesota, Mason Canc Ctr, Dept Biostat & Informat, Minneapolis, MN USA; [O'Sullivan, M. G.] Univ Minnesota, Coll Vet Med, St Paul, MN 55108 USA; [Starr, T. K.] Univ Minnesota, Mason Canc Ctr, Ctr Genome Engn, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [Starr, T. K.; Largaespada, D. A.] Univ Minnesota, Mason Canc Ctr, Dept Obstet Gynecol & Womens Hlth, Duluth, MN 55812 USA; [Zhang, Y.] Univ Minnesota, Supercomp Inst, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Duluth; University of Minnesota System; University of Minnesota Duluth; Vrije Universiteit Amsterdam; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Duluth; University of Minnesota System; University of Minnesota Twin Cities	Cormier, RT (corresponding author), Univ Minnesota, Sch Med, Dept Biomed Sci, 1035 Univ Dr,247 Med, Duluth, MN 55812 USA.	rcormier@d.umn.edu	Starr, Tim/AAX-9342-2021; Fijneman, Remond/X-4199-2019; goos, jeroen/AAL-8405-2020	Fijneman, Remond/0000-0003-2076-5521; Starr, Timothy/0000-0002-6308-3451; Meijer, Gerrit/0000-0003-0330-3130; Goos, Jeroen/0000-0003-2010-7377	Center for Translational Molecular Medicine, DeCoDe project grant [03O-101];  [NCI R01 CA134759-01A1];  [NCI R00 4R00CA151672-02]; NATIONAL CANCER INSTITUTE [P30CA077598, R01CA134759, R00CA151672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK027651] Funding Source: NIH RePORTER	Center for Translational Molecular Medicine, DeCoDe project grant; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr Karl Pfeifer at the NIH for generously providing Kcnq1 mutant mice and reviewing the manuscript. Research was supported by a grant to RC and DL (NCI R01 CA134759-01A1) and to JG and RF (Center for Translational Molecular Medicine, DeCoDe project grant 03O-101) and to TKS (NCI R00 4R00CA151672-02).	Belt EJT, 2011, EUR J CANCER, V47, P1837, DOI 10.1016/j.ejca.2011.04.025; Burger-van Paassen N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038798; Casimiro MC, 2004, GENOMICS, V84, P555, DOI 10.1016/j.ygeno.2004.06.007; Casimiro MC, 2001, P NATL ACAD SCI USA, V98, P2526, DOI 10.1073/pnas.041398998; De Lisle RC, 2011, J PEDIATR GASTR NUTR, V53, P371, DOI 10.1097/MPG.0b013e318219c397; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Dedek K, 2001, PFLUG ARCH EUR J PHY, V442, P896, DOI 10.1007/s004240100609; Demolombe S, 2001, AM J PHYSIOL-CELL PH, V280, pC359, DOI 10.1152/ajpcell.2001.280.2.C359; Duerkop BA, 2009, IMMUNITY, V31, P368, DOI 10.1016/j.immuni.2009.08.009; Dziarski R, 2010, INNATE IMMUN-LONDON, V16, P168, DOI 10.1177/1753425910366059; Elso CM, 2004, HUM MOL GENET, V13, P2813, DOI 10.1093/hmg/ddh307; Fijneman RJA, 2012, CANCER SCI, V103, P593, DOI 10.1111/j.1349-7006.2011.02189.x; Fong Y, 1999, ANN SURG, V230, P309, DOI 10.1097/00000658-199909000-00004; Grahammer F, 2001, GASTROENTEROLOGY, V120, P1363, DOI 10.1053/gast.2001.24053; Hashimoto T, 2012, NATURE, V487, P477, DOI 10.1038/nature11228; Kang SJ, 2012, J IMMUNOL, V188, P1108, DOI 10.4049/jimmunol.1102084; Knobloch M, 2013, NATURE, V493, P226, DOI 10.1038/nature11689; Lang F, 2013, FASEB J, V27, P3, DOI 10.1096/fj.12-218230; Lee MP, 2000, J CLIN INVEST, V106, P1447, DOI 10.1172/JCI10897; Maisonneuve P, 2003, JNCI-J NATL CANCER I, V95, P381, DOI 10.1093/jnci/95.5.381; Mann KM, 2012, P NATL ACAD SCI USA, V109, P5934, DOI 10.1073/pnas.1202490109; March HN, 2011, NAT GENET, V43, P1202, DOI 10.1038/ng.990; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Nikou GC, 2011, INT J SURG, V9, P248, DOI 10.1016/j.ijsu.2010.12.003; Norkina O, 2004, AM J PHYSIOL-GASTR L, V286, pG1032, DOI 10.1152/ajpgi.00473.2003; Perez-Mancera PA, 2012, NATURE, V486, P266, DOI 10.1038/nature11114; Peroz D, 2008, J PHYSIOL-LONDON, V586, P1785, DOI 10.1113/jphysiol.2007.148254; Preston P, 2010, J BIOL CHEM, V285, P7165, DOI 10.1074/jbc.M109.047829; Rice KS, 2011, HEART RHYTHM, V8, P551, DOI 10.1016/j.hrthm.2010.11.039; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Shalapour S, 2010, EUR J IMMUNOL, V40, P2391, DOI 10.1002/eji.201040441; Simon R, 2004, BIOTECHNIQUES, V36, P98, DOI 10.2144/04361RV01; Starr TK, 2011, P NATL ACAD SCI USA, V108, P5765, DOI 10.1073/pnas.1018012108; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takagi T, 2007, EXP ANIM TOKYO, V56, P295, DOI 10.1538/expanim.56.295; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Vallon V, 2005, P NATL ACAD SCI USA, V102, P17864, DOI 10.1073/pnas.0505860102; Warth R, 2002, PFLUG ARCH EUR J PHY, V443, P822, DOI 10.1007/s00424-001-0751-3; Winbo A, 2012, CARDIOL YOUNG, V18, P1; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Xiong QJ, 2008, TRENDS PHARMACOL SCI, V29, P99, DOI 10.1016/j.tips.2007.11.010; Yang K, 2008, CANCER RES, V68, P7313, DOI 10.1158/0008-5472.CAN-08-0598; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zlobec I, 2007, J CLIN PATHOL, V60, P1112, DOI 10.1136/jcp.2006.044537	47	67	69	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 17	2014	33	29					3861	3868		10.1038/onc.2013.350	http://dx.doi.org/10.1038/onc.2013.350			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AL8MU	23975432	Green Accepted			2022-12-25	WOS:000339394100012
J	Ibrahim, AS; Zaghloul, H; Badria, FA				Ibrahim, Ahmed S.; Zaghloul, Hosam; Badria, Farid A.			Case Report Evidence of Relationships between Hepatocellular Carcinoma and Ochratoxicosis	PLOS ONE			English	Article							BALKAN ENDEMIC NEPHROPATHY; OXIDATIVE DNA-DAMAGE; LIVER; MYCOTOXINS; EXPOSURE; METABOLISM; AFLATOXIN; KIDNEY; RISK; RAT	Purpose: The incidence of Hepatocellular carcinoma (HCC) is on the rise, but what is causing that trend has remained a mystery. Mycotoxins are almost entirely ignored health problems, and sometimes actually naively belittled in advanced medical care. Ochratoxin A (OTA) is one of the most abundant food contaminating mycotoxins worldwide that is carcinogenic, but no studies have evaluated its levels in HCC patients. Therefore, this study was designed to monitor the presence of OTA in the serum of HCC patients and to quantify the strength of the association between OTA and HCC. Methods: We conducted a case control-based study on 61 participants. Thirty-nine were HCC cases identified between 2010 and 2012 and individually matched by age, sex, residence and date of recruitment to 22 healthy controls. Serum OTA and alpha-fetoprotein levels were measured by using high-performance liquid chromatography (HPLC) and enzyme-linked immunosorbent assay, respectively. Results: HPLC analysis of 61 serum samples indicated that the highest incidence of elevated OTA was found in the HCC group and was 5-fold higher than in the control group. The concentration of OTA in the HCC group ranged between 0.129 and 10.93 ng/mL with a mean value +/- SD of 1.1 +/- 0.3 ng/mL, while in the normal group it ranged between 0.005 and 0.50 ng/mL with a mean value +/- SD of 0.201 +/- 0.02 ng/mL. The odds ratio for HCC patients presenting OTA levels above the cut-off of 0.207 (calculated by the receiver operating characteristic curve) was 9.78 (95% confidence interval = 2.9095-32.9816, P = 0.0002) with respect to normal controls, suggesting that HCC is 9.8 times as frequent in the exposed group to OTA. Conclusion: Our results reveal a strong association between the presence of OTA and HCC, which may offer a coherent explanation for much of the descriptive epidemiology of HCC and suggest new avenues for analytical research.	[Ibrahim, Ahmed S.] Mansoura Univ, Dept Biochem, Fac Pharm, Mansoura, Egypt; [Zaghloul, Hosam] Mansoura Univ, Dept Clin Pathol, Fac Med, Mansoura, Egypt; [Badria, Farid A.] Mansoura Univ, Dept Pharmacognosy, Fac Pharm, Mansoura, Egypt	Egyptian Knowledge Bank (EKB); Mansoura University; Egyptian Knowledge Bank (EKB); Mansoura University; Egyptian Knowledge Bank (EKB); Mansoura University	Ibrahim, AS (corresponding author), Mansoura Univ, Dept Biochem, Fac Pharm, Mansoura, Egypt.	ahmedsalahibrahim@yahoo.com; faridbadria@gmail.com	Badria, Farid/M-8609-2018; Ibrahim, Ahmed/D-5241-2017	Ibrahim, Ahmed/0000-0001-8480-6252; Zaghloul, Hosam/0000-0002-7201-1812				Abd Alla el-S A, 1996, Mycotoxin Res, V12, P41, DOI 10.1007/BF03192079; ABDELHAMID AM, 1990, ARCH TIERERNAHR, V40, P647, DOI 10.1080/17450399009428413; Abid S, 2003, HUM EXP TOXICOL, V22, P77, DOI 10.1191/0960327103ht328oa; Abou-Zeid A., 1997, Egyptian Journal of Microbiology, V32, P83; [Anonymous], 1993, IARC Monogr Eval Carcinog Risks Hum, V56, P445; [Anonymous], 1983, IARC Monogr Eval Carcinog Risk Chem Hum, V31, P1; ANWAR WA, 1994, MUTAT RES, V312, P61, DOI 10.1016/0165-1161(94)90009-4; Atalla MM, 2003, NAHRUNG, V47, P6, DOI 10.1002/food.200390017; Badria FA, 1996, J TOXICOL-TOXIN REV, V15, P273, DOI 10.3109/15569549609016448; BOORMAN GA, 1992, TOXICOL PATHOL, V20, P236, DOI 10.1177/019262339202000210; Bryden WL, 2007, ASIA PAC J CLIN NUTR, V16, P95; BURDON RH, 1995, FREE RADICAL BIO MED, V18, P775, DOI 10.1016/0891-5849(94)00198-S; Dong CH, 2011, J STUD ALCOHOL DRUGS, V72, P892, DOI 10.15288/jsad.2011.72.892; Duarte SC, 2011, CRIT REV TOXICOL, V41, P187, DOI 10.3109/10408444.2010.529103; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Gross-Steinmeyer K, 2002, J AGR FOOD CHEM, V50, P938, DOI 10.1021/jf0111817; HANSEN CE, 1982, APPL ENVIRON MICROB, V43, P1267, DOI 10.1128/AEM.43.6.1267-1271.1982; Hassan AM, 2006, PEDIATR NEPHROL, V21, P102, DOI 10.1007/s00467-005-2033-3; Hassan MM, 2009, J HEPATOL, V50, P334, DOI 10.1016/j.jhep.2008.08.016; HIETANEN E, 1986, DRUG METAB DISPOS, V14, P118; Hope JH, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/835059; Horvath A, 2002, TOXICON, V40, P273, DOI 10.1016/S0041-0101(01)00219-7; HUFF JE, 1991, IARC SCI PUBL, V115, P229; IARC, 1987, IARC MON EV CARC RIS, P271; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kamp HG, 2005, TOXICOLOGY, V206, P413, DOI 10.1016/j.tox.2004.08.004; Kamp HG, 2005, MOL NUTR FOOD RES, V49, P1160, DOI 10.1002/mnfr.200500124; Kojima K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1345; KROGH P, 1977, ACTA PATH MICRO IM B, V85, P238; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; MAAROUFI K, 1995, ARCH TOXICOL, V69, P552, DOI 10.1007/s002040050211; Mally A, 2005, CHEM RES TOXICOL, V18, P1253, DOI 10.1021/tx049650x; Marin-Kuan M, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/645361; MARQUARDT RR, 1992, J ANIM SCI, V70, P3968, DOI 10.2527/1992.70123968x; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; PAVLOVIC M, 1979, ACTA PATH MICRO IM B, V87, P243; Pei YF, 2009, ACTA BIOCH BIOPH SIN, V41, P1, DOI 10.1093/abbs/gmn001; Pfohl-Leszkowicz Anne, 1994, Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales, V188, P335; Pfohl-Leszkowicz A, 2007, MOL NUTR FOOD RES, V51, P61, DOI 10.1002/mnfr.200600137; Pfohl-Leszkowicz A, 2009, ARH HIG RADA TOKSIKO, V60, P465, DOI 10.2478/10004-1254-60-2009-2000; Pineau P, 2008, MUTAT RES-GEN TOX EN, V653, P6, DOI 10.1016/j.mrgentox.2008.01.012; Poirier MC, 2004, NAT REV CANCER, V4, P630, DOI 10.1038/nrc1410; Rafai P, 2000, FOOD ADDIT CONTAM A, V17, P799, DOI 10.1080/026520300415354; Reddy L, 2010, TOXINS, V2, P771, DOI 10.3390/toxins2040771; Sanyal AJ, 2010, ONCOLOGIST, V15, P14, DOI 10.1634/theoncologist.2010-S4-14; Scott PM, 2005, FOOD ADDIT CONTAM A, V22, P99, DOI 10.1080/02652030500410315; Simon P, 1996, NEPHROL DIAL TRANSPL, V11, P2389, DOI 10.1093/oxfordjournals.ndt.a027198; Srivatanakul Petcharin, 2004, Asian Pac J Cancer Prev, V5, P118; STORMER FC, 1981, APPL ENVIRON MICROB, V42, P1051; Taketa K, 2002, ACTA MED OKAYAMA, V56, P317; Tatu CA, 1998, ENVIRON HEALTH PERSP, V106, P689, DOI 10.2307/3434257; Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05; Wafa EW, 1998, HUM EXP TOXICOL, V17, P124, DOI 10.1191/096032798678908369; Walker R, 2005, FOOD ADDIT CONTAM A, V22, P6, DOI 10.1080/02652030500309343; Wang LY, 1996, INT J CANCER, V67, P620, DOI 10.1002/(SICI)1097-0215(19960904)67:5&lt;620::AID-IJC5&gt;3.0.CO;2-W; Wild CP, 2010, CARCINOGENESIS, V31, P71, DOI 10.1093/carcin/bgp264; Zinedine A, 2010, TOXINS, V2, P1121, DOI 10.3390/toxins2051121	57	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71423	10.1371/journal.pone.0071423	http://dx.doi.org/10.1371/journal.pone.0071423			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977041	Green Published, gold			2022-12-25	WOS:000324527300016
J	Reigh, SY; Winkler, RG; Gompper, G				Reigh, Shang Yik; Winkler, Roland G.; Gompper, Gerhard			Synchronization, Slippage, and Unbundling of Driven Helical Flagella	PLOS ONE			English	Article							MULTIPARTICLE COLLISION DYNAMICS; BACTERIAL FLAGELLA; ROTATION; MODEL; HYDRODYNAMICS; CHEMOTAXIS; SIMULATION; SWIMS; MOTOR	Peritrichous bacteria exploit bundles of helical flagella for propulsion and chemotaxis. Here, changes in the swimming direction (tumbling) are induced by a change of the rotational frequency of some flagella. Employing coarse-grained modeling and simulations, we investigate the dynamical properties of helical flagella bundles driven by mismatched motor torques. Over a broad range of distances between the flagella anchors and applied torque differences, we find a stable bundled state, which is important for a robust directional motion of a bacterium. With increasing torque difference, a phase lag in the flagellar rotations develops, followed by slippage and ultimately unbundling, which sensitively depends on the anchoring distance of neighboring flagella. In the slippage and drift states, the different rotation frequencies of the flagella generate a tilting torque on the bacterial body, which implies a change of the swimming direction as observed experimentally.	[Winkler, Roland G.] Forschungszentrum Julich, Inst Complex Syst, D-52425 Julich, Germany; Forschungszentrum Julich, Inst Adv Simulat, D-52425 Julich, Germany	Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich	Winkler, RG (corresponding author), Forschungszentrum Julich, Inst Complex Syst, D-52425 Julich, Germany.	r.winkler@fz-juelich.de	Reigh, Shang Yik/O-7598-2018; Winkler, Roland/G-4059-2013; Gompper, Gerhard/I-4886-2012	Reigh, Shang Yik/0000-0003-2574-763X; Winkler, Roland/0000-0002-7513-0796; Gompper, Gerhard/0000-0002-8904-0986	VW Foundation (VolkswagenStiftung)	VW Foundation (VolkswagenStiftung)	Financial support by the VW Foundation (VolkswagenStiftung) within the program Computer Simulation of Molecular and Cellular Bio-Systems, as well as Complex Soft Matter, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFZELIUS B A, 1976, Science (Washington D C), V193, P317; Allen MP., 1989, COMPUTER SIMULATION; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; BERG HC, 1973, NATURE, V245, P380, DOI 10.1038/245380a0; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; BERG HC, 2004, BIOL MED PHYS BIOMED, P1; Berry RM, 1997, P NATL ACAD SCI USA, V94, P14433, DOI 10.1073/pnas.94.26.14433; CALLADINE CR, 1978, J MOL BIOL, V118, P457, DOI 10.1016/0022-2836(78)90285-1; CALLADINE CR, 1975, NATURE, V255, P121, DOI 10.1038/255121a0; Cartwright JHE, 2004, P NATL ACAD SCI USA, V101, P7234, DOI 10.1073/pnas.0402001101; Darnton NC, 2007, BIOPHYS J, V92, P2230, DOI 10.1529/biophysj.106.094037; Darnton NC, 2007, J BACTERIOL, V189, P1756, DOI 10.1128/JB.01501-06; Di Leonardo R, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.034104; Doi M., 1986, THEORY POLYM DYNAMIC, V1st ed.; Elfring GJ, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.088101; Elgeti J, 2013, P NATL ACAD SCI USA, V110, P4470, DOI 10.1073/pnas.1218869110; Flores H, 2005, B MATH BIOL, V67, P137, DOI 10.1016/j.bulm.2004.06.006; Friedrich BM, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.138102; Goldstein RE, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.168103; Golestanian R, 2011, SOFT MATTER, V7, P3074, DOI 10.1039/c0sm01121e; Gompper G, 2009, ADV POLYM SCI, V221, P1, DOI 10.1007/12_2008_5; GOTZ R, 1987, J BACTERIOL, V169, P3146; Huang CC, 2010, J COMPUT PHYS, V229, P168, DOI 10.1016/j.jcp.2009.09.024; Huang CC, 2010, MACROMOLECULES, V43, P10107, DOI 10.1021/ma101836x; Janssen PJA, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.011910; Kapral R, 2008, ADV CHEM PHYS, V140, P89, DOI 10.1002/9780470371572.ch2; Kim M, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.061910; Kim M, 2003, P NATL ACAD SCI USA, V100, P15481, DOI 10.1073/pnas.2633596100; Kim YW, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.158101; Kotar J, 2010, P NATL ACAD SCI USA, V107, P7669, DOI 10.1073/pnas.0912455107; Liu Y, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3548885; MACNAB RM, 1977, J MOL BIOL, V112, P1, DOI 10.1016/S0022-2836(77)80153-8; MACNAB RM, 1977, P NATL ACAD SCI USA, V74, P221, DOI 10.1073/pnas.74.1.221; Malevanets A, 1999, J CHEM PHYS, V110, P8605, DOI 10.1063/1.478857; Mussawisade K, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2041527; Platzer J, 1997, J BACTERIOL, V179, P6391, DOI 10.1128/jb.179.20.6391-6399.1997; Polin M, 2009, SCIENCE, V325, P487, DOI 10.1126/science.1172667; Qian B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.061919; Reichert M, 2005, EUR PHYS J E, V17, P493, DOI 10.1140/epje/i2004-10152-7; Reid SW, 2006, P NATL ACAD SCI USA, V103, P8066, DOI 10.1073/pnas.0509932103; Reigh SY, 2012, SOFT MATTER, V8, P4363, DOI 10.1039/c2sm07378a; Ripoll M, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.016701; Scharf B, 2002, J BACTERIOL, V184, P5979, DOI 10.1128/JB.184.21.5979-5986.2002; Schmitt R, 2002, MICROBIOL-SGM, V148, P627, DOI 10.1099/00221287-148-3-627; Stocker R, 2009, SCIENCE, V325, P400, DOI 10.1126/science.1177269; TAYLOR G, 1951, PROC R SOC LON SER-A, V209, P447, DOI 10.1098/rspa.1951.0218; Turner L, 2000, J BACTERIOL, V182, P2793, DOI 10.1128/JB.182.10.2793-2801.2000; Uchida N, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.058104; Uchida N, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.178103; Wada H, 2008, EPL-EUROPHYS LETT, V82, DOI 10.1209/0295-5075/82/28001; Wang Q, 2006, CELL, V125, P549, DOI 10.1016/j.cell.2006.02.044; Watari N, 2010, BIOPHYS J, V98, P12, DOI 10.1016/j.bpj.2009.09.044; Xie L, 2011, P NATL ACAD SCI USA, V108, P2246, DOI 10.1073/pnas.1011953108; YANG YZ, 2008, PHYS REV E 1, V78, DOI DOI 10.1103/PhysRevE.78.061903	54	33	33	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e70868	10.1371/journal.pone.0070868	http://dx.doi.org/10.1371/journal.pone.0070868			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23976961	Green Published, gold			2022-12-25	WOS:000323425700010
J	Cesaratto, L; Codarin, E; Vascotto, C; Leonardi, A; Kelley, MR; Tiribelli, C; Tell, G				Cesaratto, Laura; Codarin, Erika; Vascotto, Carlo; Leonardi, Antonio; Kelley, Mark R.; Tiribelli, Claudio; Tell, Gianluca			Specific Inhibition of the Redox Activity of Ape1/Ref-1 by E3330 Blocks Tnf-A-Induced Activation of Il-8 Production in Liver Cancer Cell Lines	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; FACTOR-KAPPA-B; SMALL-MOLECULE INHIBITOR; NONALCOHOLIC STEATOHEPATITIS; DNA-REPAIR; INTERLEUKIN-8 GENE; ACID; PROTEIN; REVEAL; GROWTH	APE1/Ref-1 is a main regulator of cellular response to oxidative stress via DNA-repair function and co-activating activity on the NF-kappa B transcription factor. APE1 is central in controlling the oxidative stress-based inflammatory processes through modulation of cytokines expression and its overexpression is responsible for the onset of chemoresistance in different tumors including hepatic cancer. We examined the functional role of APE1 overexpression during hepatic cell damage related to fatty acid accumulation and the role of the redox function of APE1 in the inflammatory process. HepG2 cells were stably transfected with functional and non-functional APE1 encoding plasmids and the protective effect of APE1 overexpression toward genotoxic compounds or FAs accumulation, was tested. JHH6 cells were stimulated with TNF-alpha in the presence or absence of E3330, an APE1 redox inhibitor. IL-8 promoter activity was assessed by a luciferase reporter assay, gene expression by Real-Time PCR and cytokines (IL-6, IL-8, IL-12) levels measured by ELISA. APE1 over-expression did not prevent cytotoxicity induced by lipid accumulation. E3330 treatment prevented the functional activation of NF-kappa B via the alteration of APE1 subcellular trafficking and reduced IL-6 and IL-8 expression induced by TNF-alpha and FAs accumulation through blockage of the redox-mediated activation of NF-kappa B. APE1 overexpression observed in hepatic cancer cells may reflect an adaptive response to cell damage and may be responsible for further cell resistance to chemotherapy and for the onset of inflammatory response. The efficacy of the inhibition of APE1 redox activity in blocking TNF-alpha and FAs induced inflammatory response opens new perspectives for treatment of inflammatory-based liver diseases.	[Cesaratto, Laura; Codarin, Erika; Vascotto, Carlo; Tell, Gianluca] Univ Udine, Dipartimento Sci Med & Biol, I-33100 Udine, Italy; [Cesaratto, Laura; Tiribelli, Claudio] Fdn Italiana Fegato, Trieste, Italy; [Leonardi, Antonio] Univ Naples Federico II, Dipartimento Patol Cellulare & Mol L Califano, Naples, Italy; [Kelley, Mark R.] Indiana Univ, Dept Pediat, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46204 USA; [Tiribelli, Claudio] Univ Trieste, Dipartimento Sci Clin, Trieste, Italy	University of Udine; University of Naples Federico II; Indiana University System; Indiana University-Purdue University Indianapolis; University of Trieste	Tell, G (corresponding author), Univ Udine, Dipartimento Sci Med & Biol, I-33100 Udine, Italy.	gianluca.tell@uniud.it	Cesaratto, Laura/AAA-7577-2019; leonardi, antonio/A-2887-2009; Tiribelli, Claudio/A-4716-2014	Cesaratto, Laura/0000-0002-7815-2544; leonardi, antonio/0000-0001-8636-9623; Kelley, Mark/0000-0002-6120-9532; Tell, Gianluca/0000-0001-8845-6448; Tiribelli, Claudio/0000-0001-6596-7595; vascotto, carlo/0000-0003-4431-029X	European Union [Health-F2-2009-241762]; Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG10269]; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) [FIRB_RBRN07BMCT]; National Institutes of Health [NCICA121168, CA114571]; Riley Children's Foundation; NATIONAL CANCER INSTITUTE [R01CA167291] Funding Source: NIH RePORTER	European Union(European Commission); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Riley Children's Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors declare that the research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement Health-F2-2009-241762, for the project FLIP and by grants from Associazione Italiana per la Ricerca sul Cancro (AIRC) (IG10269) and Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) (FIRB_RBRN07BMCT) to GT. Financial support for this work was provided by the National Institutes of Health NCICA121168, CA114571 and the Riley Children's Foundation to MRK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0; Araya J, 2004, CLIN SCI, V106, P635, DOI 10.1042/CS20030326; Bahcecioglu IH, 2005, HEPATO-GASTROENTEROL, V52, P1549; Bapat A, 2010, J PHARMACOL EXP THER, V334, P988, DOI 10.1124/jpet.110.169128; Bapat A, 2009, ANTIOXID REDOX SIGN, V11, P651, DOI [10.1089/ars.2008.2218, 10.1089/ARS.2008.2218]; Barrett KE, 2006, PHYSL GASTROINTESTIN, V1; Bhakat KK, 2009, ANTIOXID REDOX SIGN, V11, P621, DOI [10.1089/ars.2008.2198, 10.1089/ARS.2008.2198]; Boden G, 2005, DIABETES, V54, P3458, DOI 10.2337/diabetes.54.12.3458; Cardoso AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047462; Chavez-Tapia NC, 2011, CURR MED CHEM, V18, P1079; Chavez-Tapia NC, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-20; Crespo J, 2001, HEPATOLOGY, V34, P1158, DOI 10.1053/jhep.2001.29628; Dela Pena A, 2005, GASTROENTEROLOGY, V129, P1663, DOI 10.1053/j.gastro.2005.09.004; Di Maso V, 2007, MOL MED, V13, P89, DOI 10.2119/2006-00084.DiMaso; Fishel ML, 2007, MOL ASPECTS MED, V28, P375, DOI 10.1016/j.mam.2007.04.005; Fishel ML, 2011, MOL CANCER THER, V10, P1698, DOI 10.1158/1535-7163.MCT-11-0107; Fishel ML, 2010, EXP HEMATOL, V38, P1178, DOI 10.1016/j.exphem.2010.08.011; FUJISE K, 1990, HEPATO-GASTROENTEROL, V37, P457; Fung H, 2005, MOL CELL, V17, P463, DOI 10.1016/j.molcel.2004.12.029; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; He TR, 2003, AM J PHYSIOL-HEART C, V285, pH804, DOI 10.1152/ajpheart.01080.2002; Hiramoto M, 2002, METHOD ENZYMOL, V353, P81; Jackson EB, 2005, NUCLEIC ACIDS RES, V33, P3303, DOI 10.1093/nar/gki641; Jaeschke Hartmut, 2002, Hepatology, V35, P964, DOI 10.1053/jhep.2002.0350964; Jedinak A, 2011, ANTICANCER RES, V31, P379; Jiang YL, 2009, DNA REPAIR, V8, P1273, DOI 10.1016/j.dnarep.2009.08.003; Joshi-Barve S, 2007, HEPATOLOGY, V46, P823, DOI 10.1002/hep.21752; Kaina B, 2001, PROG NUCLEIC ACID RE, V68, P41; Kelley Mark R, 2012, Curr Mol Pharmacol, V5, P36; Kelley MR, 2011, ANTIOXID REDOX SIGN, V14, P1387, DOI 10.1089/ars.2010.3410; Li MX, 2012, FREE RADICAL BIO MED, V53, P237, DOI 10.1016/j.freeradbiomed.2012.04.002; Li ZP, 2003, HEPATOLOGY, V37, P343, DOI 10.1053/jhep.2003.50048; Lirussi L, 2012, MOL BIOL CELL, V23, P4079, DOI 10.1091/mbc.E12-04-0299; Lowndes NF, 2005, CURR BIOL, V15, pR99, DOI 10.1016/j.cub.2005.01.029; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Manvilla BA, 2011, BIOCHEMISTRY-US, V50, P10540, DOI 10.1021/bi201071g; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; McNeill DR, 2007, MOL CARCINOGEN, V46, P91, DOI 10.1002/mc.20196; McNeill DR, 2007, MOL CANCER RES, V5, P61, DOI 10.1158/1541-7786.MCR-06-0329; MUKAIDA N, 1990, J BIOL CHEM, V265, P21128; NAGAKAWA JI, 1992, J PHARMACOL EXP THER, V262, P145; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; NANJI AA, 1993, J PHARMACOL EXP THER, V266, P1085; O'Hara AM, 2006, J IMMUNOL, V177, P7990, DOI 10.4049/jimmunol.177.11.7990; O'Hara AM, 2009, CYTOKINE, V46, P359, DOI 10.1016/j.cyto.2009.03.010; Pascale A, 2010, J GASTROINTEST LIVER, V19, P415; Remick DG, 2005, CRIT CARE MED, V33, pS466, DOI 10.1097/01.CCM.0000186783.34908.18; Roebuck KA, 1999, J INTERF CYTOK RES, V19, P429, DOI 10.1089/107999099313866; Rubio A, 2007, J HEPATOL, V46, P708, DOI 10.1016/j.jhep.2006.10.021; Saitou Y, 2005, WORLD J GASTROENTERO, V11, P6258, DOI 10.3748/wjg.v11.i40.6258; Schwabe RF, 2007, GASTROENTEROLOGY, V132, P2601, DOI 10.1053/j.gastro.2007.04.058; Smart DJ, 2008, MUTAT RES-FUND MOL M, V641, P43, DOI 10.1016/j.mrfmmm.2008.03.005; Su DA, 2011, BIOCHEMISTRY-US, V50, P82, DOI 10.1021/bi101248s; Tell G, 2005, ANTIOXID REDOX SIGN, V7, P367, DOI 10.1089/ars.2005.7.367; Tell G, 2010, CELL MOL LIFE SCI, V67, P3589, DOI 10.1007/s00018-010-0486-4; Tell G, 2010, CELL MOL LIFE SCI, V67, P3569, DOI 10.1007/s00018-010-0484-6; Tell G, 2009, ANTIOXID REDOX SIGN, V11, P601, DOI 10.1089/ars.2008.2194; TWENTYMAN PR, 1987, BRIT J CANCER, V56, P279, DOI 10.1038/bjc.1987.190; Vascotto C, 2011, MOL BIOL CELL, V22, P3887, DOI 10.1091/mbc.E11-05-0391; Vascotto C, 2009, PROTEOMICS, V9, P1058, DOI 10.1002/pmic.200800638; Vascotto C, 2009, MOL CELL BIOL, V29, P1834, DOI 10.1128/MCB.01337-08; Xu ZR, 2005, P NATL ACAD SCI USA, V102, P4120, DOI 10.1073/pnas.0500660102; Zou GM, 2008, MOL CANCER THER, V7, P2012, DOI 10.1158/1535-7163.MCT-08-0113	63	40	42	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e70909	10.1371/journal.pone.0070909	http://dx.doi.org/10.1371/journal.pone.0070909			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967134	Green Submitted, gold, Green Published			2022-12-25	WOS:000323378000022
J	Linossier, J; Rybak, F; Aubin, T; Geberzahn, N				Linossier, Juliette; Rybak, Fanny; Aubin, Thierry; Geberzahn, Nicole			Flight Phases in the Song of Skylarks: Impact on Acoustic Parameters and Coding Strategy	PLOS ONE			English	Article							BIRD SONG; ALAUDA-ARVENSIS; PERFORMANCE; RECOGNITION; INFORMATION; COMPLEXITY; SIGNATURE; EVOLUTION	Skylarks inhabit open fields and perform an aerial song display which serves as a territorial signal. The particularly long and elaborate structure of this song flight raises questions about the impact of physical and energetic constraints acting on a communication signal. Song produced during the three distinct phases of the flight - ascending, level and descending phase could be subject to different constraints, serve different functions and encode different types of information. We compared song parameters during the ascending and the level phases. We found that the structure of the song varied with the phase of the flight. In particular, song had a higher tempo when skylarks were ascending which might be related to higher oxygen and energetic demands. We also explored which phase of the song flight might encode individuality. Earlier studies reported that skylarks reduced their territorial response to established neighbours if the neighbour song was broadcasted from the correct adjacent boundary, but reacted aggressively if the neighbour songs were broadcasted from an incorrect boundary (mimicking a displaced neighbour). Such differential response provides some evidence for individual recognition. Here, we exposed subjects to playback stimuli of neighbour song in which we had replaced either the song produced during the level or the ascending phase by the relevant song of the neighbour from the incorrect border. Singing response was higher towards stimuli in which the 'level phase song' was replaced, indicating that skylarks could be able to recognise their neighbours based on song of this phase. Thus, individuality seems to be primarily coded in the level phase of the flight song.	[Linossier, Juliette; Rybak, Fanny; Aubin, Thierry; Geberzahn, Nicole] Univ Paris 11, Ctr Neurosci Paris Sud, UMR 8195, Orsay, France; [Linossier, Juliette; Rybak, Fanny; Aubin, Thierry; Geberzahn, Nicole] CNRS, F-91405 Orsay, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet; Centre National de la Recherche Scientifique (CNRS)	Linossier, J (corresponding author), Univ Paris 11, Ctr Neurosci Paris Sud, UMR 8195, Orsay, France.	juliette.linossier1@u-psud.fr			European Research Network in Neurosciences CNRS-MPG (GDRE CNRS - MPG Neurosciences)	European Research Network in Neurosciences CNRS-MPG (GDRE CNRS - MPG Neurosciences)	Financial support was provided by the European Research Network in Neurosciences CNRS-MPG (GDRE CNRS - MPG Neurosciences) to NG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUBIN T, 1983, Z TIERPSYCHOL, V61, P141; BERGER M, 1970, Z VERGL PHYSIOL, V66, P190, DOI 10.1007/BF00297778; Berger M, 1970, J COMP PHYSIOL A, V214, P201; Boggs DF, 1997, J EXP BIOL, V200, P1413; Briefer E, 2008, J EXP BIOL, V211, P317, DOI 10.1242/jeb.013359; Briefer E, 2010, J THEOR BIOL, V262, P151, DOI 10.1016/j.jtbi.2009.09.020; Briefer E, 2009, NATURWISSENSCHAFTEN, V96, P1067, DOI 10.1007/s00114-009-0567-0; BRUDERER B, 1972, Ornithologische Beobachter, V69, P189; BUTLER PJ, 1977, J EXP BIOL, V71, P7; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; DELIUS JD, 1963, Z TIERPSYCHOL, V20, P297; EMLEN ST, 1972, BEHAVIOUR, V41, P130, DOI 10.1163/156853972X00248; Geberzahn N, 2013, BEHAV ECOL IN PRESS; Geberzahn N, 2010, BEHAV ECOL, V21, P1147, DOI 10.1093/beheco/arq122; Geberzahn N, 2009, BEHAV ECOL SOCIOBIOL, V64, P193, DOI 10.1007/s00265-009-0836-0; Hedenstrom A, 1995, J AVIAN BIOL, V26, P337, DOI 10.2307/3677050; Held J, 2005, BEHAV RES METHODS, V37, P155, DOI 10.3758/BF03206410; HULTSCH H, 1981, BEHAV ECOL SOCIOBIOL, V8, P183, DOI 10.1007/BF00299828; LAMBRECHTS M, 1988, ANIM BEHAV, V36, P327, DOI 10.1016/S0003-3472(88)80002-2; Lehongre K, 2008, ETHOLOGY, V114, P425, DOI 10.1111/j.1439-0310.2008.01486.x; MARDEN JH, 1987, J EXP BIOL, V130, P235; Mathevon N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001580; MOLLER AP, 1991, BEHAV ECOL SOCIOBIOL, V28, P309; Mundry R, 1999, ANIM BEHAV, V58, P1143, DOI 10.1006/anbe.1999.1246; Mundry R, 2007, ANIM BEHAV, V74, P965, DOI 10.1016/j.anbehav.2006.12.028; NOWICKI S, 1991, CONDOR, V93, P1, DOI 10.2307/1368599; Petruskova T, 2008, ANN ZOOL FENN, V45, P135, DOI 10.5735/086.045.0205; Podos J, 2004, ANNU REV ECOL EVOL S, V35, P55, DOI 10.1146/annurev.ecolsys.35.021103.105719; Podos J, 1997, EVOLUTION, V51, P537, DOI 10.1111/j.1558-5646.1997.tb02441.x; Riede T, 2010, BRAIN LANG, V115, P69, DOI 10.1016/j.bandl.2009.11.003; RITCHISON G, 1991, CONDOR, V93, P12, DOI 10.2307/1368600; Searcy WA, 2009, ANIM BEHAV, V78, P1281, DOI 10.1016/j.anbehav.2009.08.011; Sokal RR, 1995, BIOMETRY	33	4	5	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e72768	10.1371/journal.pone.0072768	http://dx.doi.org/10.1371/journal.pone.0072768			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967338	Green Published, Green Submitted, gold			2022-12-25	WOS:000323378000113
J	Grasmeijer, F; Hagedoorn, P; Frijlink, HW; de Boer, AH				Grasmeijer, Floris; Hagedoorn, Paul; Frijlink, Henderik W.; de Boer, Anne H.			Drug Content Effects on the Dispersion Performance of Adhesive Mixtures for Inhalation	PLOS ONE			English	Article							DRY POWDER INHALATION; CLASSIFIER-BASED INHALER; IN-VITRO EVALUATION; PARTICLE DETACHMENT; AIR CLASSIFIER; CARRIER CRYSTALS; LACTOSE; FORMULATIONS; COMPRESSION; RELEVANT	The drug content in adhesive mixtures for inhalation is known to influence their dispersion performance, but the direction and magnitude of this influence depends on other variables. In the past decades several mechanisms have been postulated to explain this finding and a number of possible interacting variables have been identified. Still, the role of drug content in the formulation of adhesive mixtures for inhalation, which includes its significance as an interacting variable to other parameters, is poorly understood. Therefore, the results from a series of drug detachment experiments are presented in which the effect of drug content and its dependence on flow rate, the mixing time and the type of drug is studied. Furthermore, it is investigated whether the effect depends on the range within which the drug content is changed. Quantitative and qualitative multiple order interactions are observed between these variables, which may be explained by a shifting balance between three different mechanisms. The results therefore demonstrate that accounting for (multiple order) interactions between variables has to be part of quality by design activities and the rational design of future experiments.	[Grasmeijer, Floris; Hagedoorn, Paul; Frijlink, Henderik W.; de Boer, Anne H.] Univ Groningen, Dept Pharmaceut Technol & Biopharm, Groningen, Netherlands	University of Groningen	Grasmeijer, F (corresponding author), Univ Groningen, Dept Pharmaceut Technol & Biopharm, Groningen, Netherlands.	F.Grasmeijer@rug.nl	Frijlink, Henderik Willem/AAD-7382-2020	Frijlink, Henderik Willem/0000-0001-7901-8198	Department of Pharmaceutical Technology and Biopharmacy of the University of Groningen	Department of Pharmaceutical Technology and Biopharmacy of the University of Groningen	The work was funded by the Department of Pharmaceutical Technology and Biopharmacy of the University of Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRYAN L, 1979, POWDER TECHNOL, V22, P147, DOI 10.1016/0032-5910(79)80020-0; de Boer AH, 2012, ADV DRUG DELIVER REV, V64, P257, DOI 10.1016/j.addr.2011.04.004; de Boer AH, 2004, PHARM RES-DORDR, V21, P2158, DOI 10.1007/s11095-004-7668-4; de Boer AH, 2004, PHARM RES-DORDR, V21, P2167, DOI 10.1007/s11095-004-5171-6; de Boer AH, 2003, INT J PHARMACEUT, V260, P187, DOI 10.1016/S0378-5173(03)00250-3; de Boer AH, 2005, INT J PHARMACEUT, V294, P173, DOI 10.1016/j.ijpharm.2005.01.035; de Koning JP, 2001, DRY POWDER INHALATIO; Dickhoff B.H.J., 2006, ADHESIVE MIXTURES PO; Dickhoff BHJ, 2003, EUR J PHARM BIOPHARM, V56, P291, DOI 10.1016/S0939-6411(03)00109-7; HERSEY JA, 1975, POWDER TECHNOL, V11, P41, DOI 10.1016/0032-5910(75)80021-0; Hooton JC, 2006, J PHARM SCI-US, V95, P1288, DOI 10.1002/jps.20618; Jones MD, 2008, PHARM RES-DORDR, V25, P337, DOI 10.1007/s11095-007-9467-1; Jones MD, 2008, EUR J PHARM BIOPHARM, V69, P496, DOI 10.1016/j.ejpb.2007.11.019; KULVANICH P, 1987, J PHARM PHARMACOL, V39, P673, DOI 10.1111/j.2042-7158.1987.tb06968.x; LAM KK, 1991, POWDER TECHNOL, V65, P167, DOI 10.1016/0032-5910(91)80179-M; Le VNP, 2012, INT J PHARMACEUT, V424, P44, DOI 10.1016/j.ijpharm.2011.12.020; Louey MD, 2002, PHARM RES-DORDR, V19, P1524, DOI 10.1023/A:1020464801786; Price R, 2010, C LACT CARR INH PROD; STANIFORTH JN, 1987, J PHARM PHARMACOL, V39, P329, DOI 10.1111/j.2042-7158.1987.tb03393.x; Staniforth JN., 1981, INT J PHARM TECH PRO, V2, P7; Steckel H, 2004, EUR J PHARM BIOPHARM, V57, P495, DOI 10.1016/j.ejpb.2003.12.003; Steckel H, 1997, INT J PHARM, V154, P31, DOI 10.1016/S0378-5173(97)00115-4; TIMSINA MP, 1994, INT J PHARM, V101, P1, DOI 10.1016/0378-5173(94)90070-1; Young PA, 2005, INT J PHARMACEUT, V296, P26, DOI 10.1016/j.ijpharm.2005.02.004	24	25	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71339	10.1371/journal.pone.0071339	http://dx.doi.org/10.1371/journal.pone.0071339			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967195	Green Submitted, Green Published, gold			2022-12-25	WOS:000323221500077
J	Hu, ZQ; Xiong, Y; Han, XF; Geng, CY; Jiang, BB; Huo, YQ; Luo, JC				Hu, Zhenqian; Xiong, Yan; Han, Xiaofan; Geng, Chenyang; Jiang, Beibei; Huo, Yingqing; Luo, Jincai			Acute Mechanical Stretch Promotes eNOS Activation in Venous Endothelial Cells Mainly via PKA and Akt Pathways	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; FLUID SHEAR-STRESS; PROTEIN-KINASE-A; WEIBEL-PALADE BODIES; NO SYNTHASE; PHOSPHORYLATION; GAB1; PROLIFERATION; ANGIOGENESIS; RECEPTOR-2	In the vasculature, physiological levels of nitric oxide (NO) protect against various stressors, including mechanical stretch. While endothelial NO production in response to various stimuli has been studied extensively, the precise mechanism underlying stretch-induced NO production in venous endothelial cells remains incompletely understood. Using a model of continuous cellular stretch, we found that stretch promoted phosphorylation of endothelial NO synthase (eNOS) at Ser(1177), Ser(633) and Ser(615) and NO production in human umbilical vein endothelial cells. Although stretch activated the kinases AMPK alpha, PKA, Akt, and ERK1/2, stretch-induced eNOS activation was only inhibited by kinase-specific inhibitors of PKA and PI3K/Akt, but not of AMPK alpha and Erk1/2. Similar results were obtained with knockdown by shRNAs targeting the PKA and Akt genes. Furthermore, inhibition of PKA preferentially attenuated eNOS activation in the early phase, while inhibition of the PI3K/Akt pathway reduced eNOS activation in the late phase, suggesting that the PKA and PI3K/Akt pathways play distinct roles in a time-dependent manner. Finally, we investigated the role of these pathways in stretch-induced endothelial exocytosis and leukocyte adhesion. Interestingly, we found that inhibition of the PI3K/Akt pathway increased stretch-induced Weibel-Palade body exocytosis and leukocyte adhesion, while inhibition of the PKA pathway had the opposite effects, suggesting that the exocytosis-promoting effect of PKA overwhelms the inhibitory effect of PKA-mediated NO production. Taken together, the results suggest that PKA and Akt are important regulators of eNOS activation in venous endothelial cells under mechanical stretch, while playing different roles in the regulation of stretch-induced endothelial exocytosis and leukocyte adhesion.	[Hu, Zhenqian; Xiong, Yan; Han, Xiaofan; Geng, Chenyang; Jiang, Beibei; Huo, Yingqing; Luo, Jincai] Peking Univ, Inst Mol Med, Lab Vasc Biol, Beijing Key Lab Cardiometab Mol Med, Beijing 100871, Peoples R China	Peking University	Luo, JC (corresponding author), Peking Univ, Inst Mol Med, Lab Vasc Biol, Beijing Key Lab Cardiometab Mol Med, Beijing 100871, Peoples R China.	jincailuo@pku.edu.cn		, Yan/0000-0003-2339-130X	Major State Basic Research Development Program of China [2012CB945100]; National Science Funds [81170098, 81070115, 31221002]	Major State Basic Research Development Program of China(National Basic Research Program of China); National Science Funds	Jincai Luo is supported by research grants from the Major State Basic Research Development Program of China (No. 2012CB945100) and the National Science Funds (No. 81170098, No. 81070115 and Project 31221002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MH, 2004, AM J PHYSIOL-LUNG C, V287, pL486, DOI 10.1152/ajplung.00389.2003; Bernier SG, 2000, J BIOL CHEM, V275, P30707, DOI 10.1074/jbc.M005116200; Boo YC, 2002, AM J PHYSIOL-HEART C, V283, pH1819, DOI 10.1152/ajpheart.00214.2002; Boo YC, 2002, J BIOL CHEM, V277, P3388, DOI 10.1074/jbc.M108789200; Brouet A, 2001, J BIOL CHEM, V276, P32663, DOI 10.1074/jbc.M101371200; Butt E, 2000, J BIOL CHEM, V275, P5179, DOI 10.1074/jbc.275.7.5179; Chachisvilis M, 2006, P NATL ACAD SCI USA, V103, P15463, DOI 10.1073/pnas.0607224103; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Cheng JZ, 2007, ARTERIOSCL THROM VAS, V27, P1744, DOI 10.1161/ATVBAHA.107.147371; Colombo PP, 2009, RIV PSICHIATR, V44, P15; Dimmeler S, 1999, ARTERIOSCL THROM VAS, V19, P656, DOI 10.1161/01.ATV.19.3.656; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dixit M, 2005, CIRC RES, V97, P1236, DOI 10.1161/01.RES.0000195611.59811.ab; Eriksson EE, 2005, ARTERIOSCL THROM VAS, V25, P723, DOI 10.1161/01.ATV.0000157578.51417.6f; Feliers D, 2005, KIDNEY INT, V68, P1648, DOI 10.1111/j.1523-1755.2005.00575.x; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Gelinas DS, 2002, BRIT J PHARMACOL, V137, P1021, DOI 10.1038/sj.bjp.0704956; Gudi SRP, 1996, CIRC RES, V79, P834, DOI 10.1161/01.RES.79.4.834; Jin ZG, 2005, J BIOL CHEM, V280, P12305, DOI 10.1074/jbc.M500294200; Jin ZG, 2003, CIRC RES, V93, P354, DOI 10.1161/01.RES.0000089257.94002.96; JOANNIDES R, 1995, CIRCULATION, V91, P1314, DOI 10.1161/01.CIR.91.5.1314; Kawai M, 2002, J HEPATOL, V37, P240, DOI 10.1016/S0168-8278(02)00171-X; Kobayashi S, 2003, BIOCHEM BIOPH RES CO, V308, P306, DOI 10.1016/S0006-291X(03)01362-7; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; Kuebler WM, 2003, AM J RESP CRIT CARE, V168, P1391, DOI 10.1164/rccm.200304-562OC; Lauer T, 2003, BASIC RES CARDIOL, V98, P84, DOI 10.1007/s003950300000; Liao XD, 2004, CELL RES, V14, P16, DOI 10.1038/sj.cr.7290198; Liu J, 2010, J IMMUNOL, V185, P1215, DOI 10.4049/jimmunol.0903660; Lowenstein CJ, 2005, TRENDS CARDIOVAS MED, V15, P302, DOI 10.1016/j.tcm.2005.09.005; Lu Y, 2011, P NATL ACAD SCI USA, V108, P2957, DOI 10.1073/pnas.1009395108; Matsushita K, 2005, BLOOD, V105, P207, DOI 10.1182/blood-2004-04-1519; Meng XP, 1999, EXP MOL PATHOL, V66, P227, DOI 10.1006/exmp.1999.2260; Michell BJ, 2002, J BIOL CHEM, V277, P42344, DOI 10.1074/jbc.M205144200; Motley ED, 2007, HYPERTENSION, V49, P577, DOI 10.1161/01.HYP.0000255954.80025.34; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Pawlak R, 1998, THROMB HAEMOSTASIS, V79, P1208; REICH KM, 1990, J CELL PHYSIOL, V143, P100, DOI 10.1002/jcp.1041430113; Rondaij MG, 2008, BLOOD, V112, P56, DOI 10.1182/blood-2007-07-099309; Sartoretto JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044627; Sartoretto JL, 2011, P NATL ACAD SCI USA, V108, P15792, DOI 10.1073/pnas.1111331108; Thors B, 2008, BBA-MOL CELL RES, V1783, P1893, DOI 10.1016/j.bbamcr.2008.07.003; Valentijn KM, 2010, BLOOD, V116, P1807, DOI 10.1182/blood-2010-03-274209; Wang GR, 1998, P NATL ACAD SCI USA, V95, P4888, DOI 10.1073/pnas.95.9.4888; Wu JX, 2011, J VASC RES, V48, P141, DOI 10.1159/000316968; Xiong Y, 2013, CELL RES, DOI [10.1038/cr.2013.56, DOI 10.1038/CR.2013.56.[]; Xiong Y, 2009, J BIOL CHEM, V284, P23217, DOI 10.1074/jbc.M109.019679; Zhang YJ, 2006, ARTERIOSCL THROM VAS, V26, P1281, DOI 10.1161/01.ATV.0000221230.08596.98	47	24	25	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71359	10.1371/journal.pone.0071359	http://dx.doi.org/10.1371/journal.pone.0071359			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23977025	Green Submitted, Green Published, gold			2022-12-25	WOS:000323221500080
J	Moncunill, G; Mayor, A; Jimenez, A; Nhabomba, A; Casas-Vila, N; Puyol, L; Campo, JJ; Manaca, MN; Aguilar, R; Pinazo, MJ; Almirall, M; Soler, C; Munoz, J; Bardaji, A; Angov, E; Dutta, S; Chitnis, CE; Alonso, PL; Gascon, J; Dobano, C				Moncunill, Gemma; Mayor, Alfredo; Jimenez, Alfons; Nhabomba, Augusto; Casas-Vila, Nuria; Puyol, Laura; Campo, Joseph J.; Manaca, Maria Nelia; Aguilar, Ruth; Pinazo, Maria-Jesus; Almirall, Merce; Soler, Cristina; Munoz, Jose; Bardaji, Azucena; Angov, Evelina; Dutta, Sheetij; Chitnis, Chetan E.; Alonso, Pedro L.; Gascon, Joaquim; Dobano, Carlota			High Antibody Responses against Plasmodium falciparum in Immigrants after Extended Periods of Interrupted Exposure to Malaria	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; INTERMITTENT PREVENTIVE TREATMENT; ERYTHROCYTE-MEMBRANE PROTEIN-1; MOZAMBICAN CHILDREN; ACQUIRED-IMMUNITY; IMPORTED MALARIA; SULFADOXINE-PYRIMETHAMINE; INHIBITORY ANTIBODIES; GHANAIAN CHILDREN; CLINICAL MALARIA	Background: Malaria immunity is commonly believed to wane in the absence of Plasmodium falciparum exposure, based on limited epidemiological data and short-lived antibody responses in some longitudinal studies in endemic areas. Methods: A cross-sectional study was conducted among sub-Saharan African adults residing in Spain for 1 up to 38 years (immigrants) with clinical malaria (n=55) or without malaria (n=37), naive adults (travelers) with a first clinical malaria episode (n=20) and life-long malaria exposed adults from Mozambique (semi-immune adults) without malaria (n=27) or with clinical malaria (n=50). Blood samples were collected and IgG levels against the erythrocytic antigens AMA-1 and MSP-1(42) (3D7 and FVO strains), EBA-175 and DBL-alpha were determined by Luminex. IgG levels against antigens on the surface of infected erythrocytes (IEs) were measured by flow cytometry. Results: Immigrants without malaria had lower IgG levels than healthy semi-immune adults regardless of the antigen tested (P <= 0.026), but no correlation was found between IgG levels and time since migration. Upon reinfection, immigrants with malaria had higher levels of IgG against all antigens than immigrants without malaria. However, the magnitude of the response compared to semi-immune adults with malaria depended on the antigen tested. Thus, immigrants had higher IgG levels against AMA-1 and MSP-1(42) (P <= 0.015), similar levels against EBA-175 and DBL-alpha, and lower levels against IEs (P <= 0.016). Immigrants had higher IgG levels against all antigens tested compared to travelers (P <= 0.001), both with malaria. Conclusions: Upon cessation of malaria exposure, IgG responses to malaria-specific antigens were maintained to a large extent, although the conservation and the magnitude of the recall response depended on the nature of the antigen. Studies on immigrant populations can shed light on the factors that determine the duration of malaria specific antibody responses and its effect on protection, with important implications for future vaccine design and public health control measures.	[Moncunill, Gemma; Mayor, Alfredo; Jimenez, Alfons; Casas-Vila, Nuria; Puyol, Laura; Campo, Joseph J.; Aguilar, Ruth; Pinazo, Maria-Jesus; Munoz, Jose; Bardaji, Azucena; Alonso, Pedro L.; Gascon, Joaquim; Dobano, Carlota] Univ Barcelona, Hosp Clin, CRESIB, Barcelona Ctr Int Hlth Res, Barcelona, Catalonia, Spain; [Mayor, Alfredo; Nhabomba, Augusto; Manaca, Maria Nelia; Aguilar, Ruth; Alonso, Pedro L.; Dobano, Carlota] Ctr Invest Saude Manhica, Maputo, Mozambique; [Almirall, Merce] Hosp Arnau Vilanova, Lleida, Catalonia, Spain; [Soler, Cristina] Hosp Santa Caterina de Salt, Girona, Catalonia, Spain; [Angov, Evelina; Dutta, Sheetij] Walter Reed Army Inst Res, Silver Spring, MD USA; [Chitnis, Chetan E.] Int Ctr Genet Engn & Biotechnol ICGEB, New Delhi, India	ISGlobal; CRESIB; University of Barcelona; Centro de Investigacao em Saude de Manhica; University Hospital Arnau de Vilanova; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Moncunill, G (corresponding author), Univ Barcelona, Hosp Clin, CRESIB, Barcelona Ctr Int Hlth Res, Barcelona, Catalonia, Spain.	gemma.moncunill@cresib.cat	Bardají, Azucena/AAE-9145-2019; Moncunill, Gemma/B-7989-2011; Gutiérrez, Jose Muñoz/X-5917-2018; JIMENEZ, ALFONS/L-2106-2019; Alonso, Pedro L/AAZ-3645-2020; Delgado, Maria Jesús Pinazo/X-6093-2018; Vila, Núria Casas/AAB-2093-2021; Aguilar, Ruth/D-2147-2018; Alonso, Azucena Bardají/V-5978-2018; Mayor, Alfredo/H-7488-2017; Dobaño, Carlota/N-4119-2014; Gutierrez, Jose Muñoz/AAH-6954-2020; Gutiérrez, José/GSJ-1846-2022; Gascon, Joaquim/M-3598-2015	Moncunill, Gemma/0000-0001-5105-9836; Gutiérrez, Jose Muñoz/0000-0002-0945-1735; JIMENEZ, ALFONS/0000-0003-0301-3344; Alonso, Pedro L/0000-0003-3292-3443; Delgado, Maria Jesús Pinazo/0000-0002-4237-1075; Aguilar, Ruth/0000-0003-3277-3107; Alonso, Azucena Bardají/0000-0002-5135-0540; Mayor, Alfredo/0000-0003-3890-2897; Dobaño, Carlota/0000-0002-6751-4060; Gutierrez, Jose Muñoz/0000-0002-0945-1735; Gascon, Joaquim/0000-0002-5045-1585; Casas Vila, Nuria/0000-0003-4233-0529; Fernandez, Ivette/0000-0001-5179-0477; Chitnis, Chetan/0000-0002-8773-9865; Puyol, Laura/0000-0003-2840-7753	Ministerio de Ciencia e Innovacion [SAF2008-00743, RYC-2008-02631]; Instituto de Salud Carlos III [PI050275, PS0901113, CD10/00156, CP-4/00220]; Agencia de Gestio d'Ajuts Universitaris i de Recerca [2009SGR934, 2009SGR385, 2010FI_B 00168]; Fundacion Ramon Areces	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Agencia de Gestio d'Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Fundacion Ramon Areces	The study received financial support from the Ministerio de Ciencia e Innovacion (SAF2008-00743, salary support RYC-2008-02631 to C. D.); the Instituto de Salud Carlos III (PI050275, PS0901113, salary support CD10/00156 to G. M. and CP-4/00220 to A. M.); the Agencia de Gestio d'Ajuts Universitaris i de Recerca (2009SGR934, 2009SGR385, salary support 2010FI_B 00168 to J.C.); and the Fundacion Ramon Areces. The Centro de Investigacao em Sa de de Manhica receives core support from the Spanish Agency for International Cooperation and Development (AECID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja A, 2008, P NATL ACAD SCI USA, V105, P4802, DOI 10.1073/pnas.0800555105; Akpogheneta OJ, 2008, INFECT IMMUN, V76, P1748, DOI 10.1128/IAI.01333-07; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Angov E, 2003, MOL BIOCHEM PARASIT, V128, P195, DOI 10.1016/S0166-6851(03)00077-X; Angov E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002189; Bouchaud O, 2005, AM J TROP MED HYG, V72, P21, DOI 10.4269/ajtmh.2005.72.21; Boutlis CS, 2006, TRENDS PARASITOL, V22, P371, DOI 10.1016/j.pt.2006.06.002; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Bull PC, 2005, PLOS PATHOG, V1, P202, DOI 10.1371/journal.ppat.0010026; Campo JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025779; Cavanagh DR, 1998, J IMMUNOL, V161, P347; Cham GKK, 2009, J IMMUNOL, V183, P3356, DOI 10.4049/jimmunol.0901331; CHOUGNET C, 1990, AM J TROP MED HYG, V43, P234, DOI 10.4269/ajtmh.1990.43.234; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Conway DJ, 2000, NAT MED, V6, P689, DOI 10.1038/76272; DELORON P, 1992, PARASITOL TODAY, V8, P375, DOI 10.1016/0169-4758(92)90174-Z; Dobano C, 2012, CLIN VACCINE IMMUNOL, V19, P157, DOI 10.1128/CVI.05523-11; Dodoo D, 1999, INFECT IMMUN, V67, P2131, DOI 10.1128/IAI.67.5.2131-2137.1999; Dodoo D, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-142; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Dorfman JR, 2005, J INFECT DIS, V191, P1623, DOI 10.1086/429671; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; FRUH K, 1991, INFECT IMMUN, V59, P1319; Giha HA, 1999, INFECT IMMUN, V67, P4092, DOI 10.1128/IAI.67.8.4092-4098.1999; Gonzalez A, 2009, AM J TROP MED HYG, V81, P595, DOI 10.4269/ajtmh.2009.08-0637; JAKOBSEN PH, 1993, IMMUNOLOGY, V79, P653; Jelinek T, 2002, CLIN INFECT DIS, V34, P572, DOI 10.1086/338235; Kinyanjui SM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-82; Kleinschmidt I, 2001, TROP MED INT HEALTH, V6, P986, DOI 10.1046/j.1365-3156.2001.00817.x; Kocken CHM, 2002, INFECT IMMUN, V70, P4471, DOI 10.1128/IAI.70.8.4471-4476.2002; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Luxemburger C, 1997, T ROY SOC TROP MED H, V91, P256, DOI 10.1016/S0035-9203(97)90066-3; MacMullin G, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-148; Mascarello M, 2008, J TRAVEL MED, V15, P229, DOI 10.1111/j.1708-8305.2008.00204.x; Matteelli A, 1999, TROP MED INT HEALTH, V4, P653, DOI 10.1046/j.1365-3156.1999.00468.x; Mayor A, 2009, INFECT IMMUN, V77, P3857, DOI 10.1128/IAI.00049-09; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; MIGOT F, 1993, AM J TROP MED HYG, V48, P432, DOI 10.4269/ajtmh.1993.48.432; Moncunill G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073360; Moncunill G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055756; Monge-Maillo B, 2012, EMERG INFECT DIS, V18, P356, DOI [10.3201/eid1802.111283, 10.3201/eid1801.111283]; Ndungu FM, 2012, P NATL ACAD SCI USA, V109, P8247, DOI 10.1073/pnas.1200472109; Nogaro SI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025582; Pandey KC, 2002, MOL BIOCHEM PARASIT, V123, P23, DOI 10.1016/S0166-6851(02)00122-6; Perraut R, 2000, AM J TROP MED HYG, V62, P746, DOI 10.4269/ajtmh.2000.62.746; Polley SD, 2004, VACCINE, V23, P718, DOI 10.1016/j.vaccine.2004.05.031; Quelhas D, 2008, CLIN VACCINE IMMUNOL, V15, P1282, DOI 10.1128/CVI.00044-08; Quelhas D, 2011, IMMUNOBIOLOGY, V216, P793, DOI 10.1016/j.imbio.2010.12.010; RAMASAMY R, 1994, AM J TROP MED HYG, V50, P537, DOI 10.4269/ajtmh.1994.50.537; Richards JS, 2010, CLIN INFECT DIS, V51, pE50, DOI 10.1086/656413; Rovira-Vallbona E, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-181; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Salvado E, 2008, ENFERM INFEC MICR CL, V26, P282, DOI 10.1157/13120415; Serra-Casas E, 2010, J INFECT DIS, V201, P123, DOI 10.1086/648595; Spence PJ, 2012, CURR TOP MICROBIOL I, V355, P3; TANABE K, 1987, J MOL BIOL, V195, P273, DOI 10.1016/0022-2836(87)90649-8; Torres KJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-173; Udhayakumar V, 2001, AM J TROP MED HYG, V65, P100, DOI 10.4269/ajtmh.2001.65.100; VANDEWAA JA, 1984, INFECT IMMUN, V45, P505, DOI 10.1128/IAI.45.2.505-510.1984; Weiss GE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000912; Wipasa J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000770	61	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e73624	10.1371/journal.pone.0073624	http://dx.doi.org/10.1371/journal.pone.0073624			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967347	Green Submitted, Green Published, gold			2022-12-25	WOS:000323221500148
J	Kuusisto, KM; Akinrinade, O; Vihinen, M; Kankuri-Tammilehto, M; Laasanen, SL; Schleutker, J				Kuusisto, Kirsi M.; Akinrinade, Oyediran; Vihinen, Mauno; Kankuri-Tammilehto, Minna; Laasanen, Satu-Leena; Schleutker, Johanna			Copy Number Variation Analysis in Familial BRCA1/2-Negative Finnish Breast and Ovarian Cancer	PLOS ONE			English	Article								Background: Inherited factors predisposing individuals to breast and ovarian cancer are largely unidentified in a majority of families with hereditary breast and ovarian cancer (HBOC). We aimed to identify germline copy number variations (CNVs) contributing to HBOC susceptibility in the Finnish population. Methods: A cohort of 84 HBOC individuals (negative for BRCA1/2-founder mutations and pre-screened for the most common breast cancer genes) and 36 healthy controls were analysed with a genome-wide SNP array. CNV-affecting genes were further studied by Gene Ontology term enrichment, pathway analyses, and database searches to reveal genes with potential for breast and ovarian cancer predisposition. CNVs that were considered to be important were validated and genotyped in 20 additional HBOC individuals (6 CNVs) and in additional healthy controls (5 CNVs) by qPCR. Results: An intronic deletion in the EPHA3 receptor tyrosine kinase was enriched in HBOC individuals (12 of 101, 11.9%) compared with controls (27 of 432, 6.3%) (OR = 1.96; P = 0.055). EPHA3 was identified in several enriched molecular functions including receptor activity. Both a novel intronic deletion in the CSMD1 tumor suppressor gene and a homozygous intergenic deletion at 5q15 were identified in 1 of 101 (1.0%) HBOC individuals but were very rare (1 of 436, 0.2% and 1 of 899, 0.1%, respectively) in healthy controls suggesting that these variants confer disease susceptibility. Conclusion: This study reveals new information regarding the germline CNVs that likely contribute to HBOC susceptibility in Finland. This information may be used to facilitate the genetic counselling of HBOC individuals but the preliminary results warrant additional studies of a larger study group.	[Kuusisto, Kirsi M.; Akinrinade, Oyediran; Schleutker, Johanna] Univ Tampere, Inst Biomed Technol BioMediTech, FIN-33101 Tampere, Finland; [Kuusisto, Kirsi M.; Akinrinade, Oyediran; Schleutker, Johanna] Fimlab Labs, Tampere, Finland; [Vihinen, Mauno] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Kankuri-Tammilehto, Minna] Turku Univ Hosp, Dept Clin Genet, FIN-20520 Turku, Finland; [Laasanen, Satu-Leena] Genet Outpatient Clin, Dept Pediat, Tampere, Finland; [Laasanen, Satu-Leena] Tampere Univ Hosp, Dept Dermatol, Tampere, Finland; [Schleutker, Johanna] Univ Turku, Inst Biomed, Dept Med Biochem & Genet, Turku, Finland	Tampere University; Lund University; University of Turku; Tampere University; Tampere University Hospital; University of Turku	Schleutker, J (corresponding author), Univ Tampere, Inst Biomed Technol BioMediTech, FIN-33101 Tampere, Finland.	Johanna.Schleutker@utu.fi	Vihinen, Mauno/A-8452-2012; Akinrinade, Oyediran/AAX-3795-2020; Kankuri-Tammilehto, Minna/GRJ-3909-2022	Vihinen, Mauno/0000-0002-9614-7976; Akinrinade, Oyediran/0000-0002-6797-6353; Schleutker, Johanna/0000-0002-1863-0305	Academy of Finland [251074]; Tampere University Hospital [9M094]; The Finnish Cultural Foundation	Academy of Finland(Academy of Finland); Tampere University Hospital; The Finnish Cultural Foundation(Finnish Cultural Foundation)	This research was funded in part by the Academy of Finland (grant 251074) and the Competitive Research Funding of the Tampere University Hospital (grant 9M094). The Finnish Cultural Foundation has supported author KMK as well. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Diskin SJ, 2009, NATURE, V459, P987, DOI 10.1038/nature08035; Erkko H, 2007, NATURE, V446, P316, DOI 10.1038/nature05609; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Gad Sophie, 2003, Hum Mutat, V21, P654, DOI 10.1002/humu.9148; Garcia-Casado Z, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-134; Guan M, 2011, CL LYMPH MYELOM LEUK, V11, P50, DOI 10.3816/CLML.2011.n.006; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jain AN, 2001, P NATL ACAD SCI USA, V98, P7952, DOI 10.1073/pnas.151241198; Kamal M, 2010, BREAST CANCER RES TR, V121, P555, DOI 10.1007/s10549-009-0500-4; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Krepischi ACV, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3109; Kuusisto KM, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2832; Li J, 2011, ANTICANCER RES, V31, P1703; Liu WN, 2009, CANCER RES, V69, P2176, DOI 10.1158/0008-5472.CAN-08-3151; Ma CQ, 2009, CANCER BIOL THER, V8, P907, DOI 10.4161/cbt.8.10.8132; Meyer D., 2012, VCD VISUALIZING CATE; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Nexo BA, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-56; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Pelttari LM, 2011, HUM MOL GENET, V20, P3278, DOI 10.1093/hmg/ddr229; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Pylkas K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002734; Pylkas K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-146; Ruprecht K, 2008, CELL MOL LIFE SCI, V65, P3366, DOI 10.1007/s00018-008-8496-1; Solyom S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003223; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Sundvall M, 2008, J MAMMARY GLAND BIOL, V13, P259, DOI 10.1007/s10911-008-9079-3; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Vahteristo P, 2002, AM J HUM GENET, V71, P432, DOI 10.1086/341943; Vehmanen P, 1997, HUM MOL GENET, V6, P2309, DOI 10.1093/hmg/6.13.2309; Venkatachalam R, 2011, INT J CANCER, V129, P1635, DOI 10.1002/ijc.25821; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Woodward AM, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.027961; Xi HQ, 2011, J CLIN PATHOL, V64, P498, DOI 10.1136/jcp.2010.087213; Xi HQ, 2012, J GASTROENTEROL; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	41	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71802	10.1371/journal.pone.0071802	http://dx.doi.org/10.1371/journal.pone.0071802			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967248	Green Published, gold, Green Submitted			2022-12-25	WOS:000323115800083
J	Oaks, AW; Marsh-Armstrong, N; Jones, JM; Credle, JJ; Sidhu, A				Oaks, Adam W.; Marsh-Armstrong, Nicholas; Jones, Jessica M.; Credle, Joel J.; Sidhu, Anita			Synucleins Antagonize Endoplasmic Reticulum Function to Modulate Dopamine Transporter Trafficking	PLOS ONE			English	Article							ALPHA-SYNUCLEIN; GAMMA-SYNUCLEIN; MICE LACKING; BETA-SYNUCLEIN; NOREPINEPHRINE TRANSPORTER; SEROTONIN TRANSPORTER; PARKINSONS-DISEASE; KNOCKOUT MICE; PROTEIN; MODEL	Synaptic re-uptake of dopamine is dependent on the dopamine transporter (DAT), which is regulated by its distribution to the cell surface. DAT trafficking is modulated by the Parkinson's disease-linked protein alpha-synuclein, but the contribution of synuclein family members beta-synuclein and gamma-synuclein to DAT trafficking is not known. Here we use SH-SY5Y cells as a model of DAT trafficking to demonstrate that all three synucleins negatively regulate cell surface distribution of DAT. Under these conditions the synucleins limit export of DAT from the endoplasmic reticulum (ER) by impairment of the ER-Golgi transition, leading to accumulation of DAT in this compartment. This mechanism for regulating DAT export indirectly through effects on ER and Golgi function represents a previously unappreciated role for the extended synuclein family that is likely applicable to trafficking of the many proteins that rely on the secretory pathway.	[Oaks, Adam W.; Jones, Jessica M.; Credle, Joel J.; Sidhu, Anita] Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cellular Biol, Lab Mol Neurochem, Washington, DC 20007 USA; [Marsh-Armstrong, Nicholas] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA; [Marsh-Armstrong, Nicholas] Hugo W Moser Res Inst Kennedy Krieger, Baltimore, MD USA	Georgetown University; Johns Hopkins University	Sidhu, A (corresponding author), Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cellular Biol, Lab Mol Neurochem, Washington, DC 20007 USA.	sidhua@georgetown.edu			NIH from the National Institute of Mental Health [R01MH075020]; National Institute on Aging [R01AG28108]; National Institute of Neurological Disorders and Stroke [R01NS060041]; National Eye Institute [RO1EY019960]; NIH National Cancer Institute [P30CA051008]; NATIONAL CANCER INSTITUTE [P30CA051008] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028108] Funding Source: NIH RePORTER	NIH from the National Institute of Mental Health; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported primarily by NIH grants to Anita Sidhu from the National Institute of Mental Health (R01MH075020), the National Institute on Aging (R01AG28108), and the National Institute of Neurological Disorders and Stroke (R01NS060041). Additional grant support to Nicholas Marsh-Armstrong came from the National Eye Institute (RO1EY019960). The Lombardi Comprehensive Cancer Center Microscopy and Imaging Shared Resource was funded in part by a grant from the NIH National Cancer Institute (P30CA051008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Adamczyk A, 2006, NEUROCHEM INT, V49, P407, DOI 10.1016/j.neuint.2006.01.025; Adkins EM, 2007, BIOCHEMISTRY-US, V46, P10484, DOI 10.1021/bi700429z; Ahmad M, 2007, FASEB J, V21, P3419, DOI 10.1096/fj.07-8379rev; Al-Wandi A, 2010, NEUROBIOL AGING, V31, P796, DOI 10.1016/j.neurobiolaging.2008.11.001; Anwar S, 2011, J NEUROSCI, V31, P7264, DOI 10.1523/JNEUROSCI.6194-10.2011; Bellucci A, 2011, J NEUROCHEM, V116, P588, DOI 10.1111/j.1471-4159.2010.07143.x; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Boyer F, 2007, EUR J NEUROSCI, V26, P2764, DOI 10.1111/j.1460-9568.2007.05878.x; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Cabin DE, 2002, J NEUROSCI, V22, P8797; Cervinski MA, 2010, NEUROSCIENCE, V170, P408, DOI 10.1016/j.neuroscience.2010.07.025; Chadchankar H, 2011, BRAIN RES; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; Colla E, 2012, J NEUROSCI, V32, P3301, DOI 10.1523/JNEUROSCI.5368-11.2012; Colla E, 2012, J NEUROSCI, V32, P3306, DOI 10.1523/JNEUROSCI.5367-11.2012; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599; Diaz-Corrales FJ, 2012, NEUROBIOL AGING, V33, P2462, DOI 10.1016/j.neurobiolaging.2011.11.014; Duka T, 2006, FASEB J, V20, P2302, DOI 10.1096/fj.06-6092com; Eriksen J, 2010, J NEUROCHEM, V113, P27, DOI 10.1111/j.1471-4159.2010.06599.x; Fountaine TM, 2007, J NEUROSCI RES, V85, P351, DOI 10.1002/jnr.21125; Galvin JE, 1999, P NATL ACAD SCI USA, V96, P13450, DOI 10.1073/pnas.96.23.13450; Garcia-Reitbock P, 2010, BRAIN, V133, P2032, DOI 10.1093/brain/awq132; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Gonzalez MI, 2007, J NEUROCHEM, V103, P1917, DOI 10.1111/j.1471-4159.2007.04881.x; Gonzalez MI, 2004, CURR OPIN PHARMACOL, V4, P30, DOI 10.1016/j.coph.2003.09.004; Gorbatyuk MS, 2012, MOL THER, V20, P1327, DOI 10.1038/mt.2012.28; Gosavi N, 2002, J BIOL CHEM, V277, P48984, DOI 10.1074/jbc.M208194200; Greten-Harrison B, 2010, P NATL ACAD SCI USA, V107, P19573, DOI 10.1073/pnas.1005005107; Holden Paul, 2009, BMC Res Notes, V2, P243, DOI 10.1186/1756-0500-2-243; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Jeannotte AM, 2008, J NEUROCHEM, V105, P1668, DOI 10.1111/j.1471-4159.2008.05258.x; Jeannotte AM, 2007, EUR J NEUROSCI, V26, P1509, DOI 10.1111/j.1460-9568.2007.05757.x; Jeannotte AM, 2009, NEUROPSYCHOPHARMACOL, V34, P987, DOI 10.1038/npp.2008.146; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kurz A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011464; Lashuel HA, 2006, ACS CHEM BIOL, V1, P420, DOI 10.1021/cb600331e; Lee FJS, 2001, FASEB J, V15, P916, DOI 10.1096/fj.00-0334com; Li JY, 2002, NEUROSCIENCE, V113, P463, DOI 10.1016/S0306-4522(02)00143-4; Li LB, 2004, J BIOL CHEM, V279, P21012, DOI 10.1074/jbc.M311972200; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lippincott-Schwartz J, 2000, ANNU REV CELL DEV BI, V16, P557, DOI 10.1146/annurev.cellbio.16.1.557; Matthies HJG, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-65; Melikian HE, 1999, J NEUROSCI, V19, P7699; Nehls S, 2000, NAT CELL BIOL, V2, P288, DOI 10.1038/35010558; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Nguyen JV, 2011, P NATL ACAD SCI USA, V108, P1176, DOI 10.1073/pnas.1013965108; Oaks AW, 2011, FEBS LETT, V585, P1001, DOI 10.1016/j.febslet.2011.03.009; Pena-Oliver Y, 2010, BEHAV BRAIN RES, V209, P234, DOI 10.1016/j.bbr.2010.01.049; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Reits EAJ, 2001, NAT CELL BIOL, V3, pE145, DOI 10.1038/35078615; Ross OA, 2008, ANN NEUROL, V63, P743, DOI 10.1002/ana.21380; Senior SL, 2008, EUR J NEUROSCI, V27, P947, DOI 10.1111/j.1460-9568.2008.06055.x; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Snyder H, 2005, J BIOL CHEM, V280, P7562, DOI 10.1074/jbc.M412887200; Snyder H, 2003, J BIOL CHEM, V278, P11753, DOI 10.1074/jbc.M208641200; Souza JM, 2000, FEBS LETT, V474, P116, DOI 10.1016/S0014-5793(00)01563-5; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sung YH, 2006, PROTEIN SCI, V15, P1162, DOI 10.1110/ps.051803606; Surgucheva I, 2002, J NEUROSCI RES, V68, P97, DOI 10.1002/jnr.10198; Thayanidhi N, 2010, MOL BIOL CELL, V21, P1850, DOI 10.1091/mbc.E09-09-0801; Verhaar R, 2012, NEUROBIOL DIS, V45, P839, DOI 10.1016/j.nbd.2011.10.012; Wersinger C, 2003, NEUROSCI LETT, V340, P189, DOI 10.1016/S0304-3940(03)00097-1; Wersinger C, 2005, BIOCHEMISTRY-US, V44, P13612, DOI 10.1021/bi050402p; Wersinger C, 2004, BIOCHEMISTRY-US, V43, P1242, DOI 10.1021/bi035308s; Wersinger C, 2003, FASEB J, V17, P2151, DOI 10.1096/fj.03-0152fje; Wersinger C, 2003, MOL CELL NEUROSCI, V24, P91, DOI 10.1016/S1044-7431(03)00124-6; Wersinger C, 2006, EUR J NEUROSCI, V24, P55, DOI 10.1111/j.1460-9568.2006.04900.x; Wersinger C, 2009, NEUROSCI LETT, V453, P157, DOI 10.1016/j.neulet.2009.02.033; Wills J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030745; Yavich L, 2004, J NEUROSCI, V24, P11165, DOI 10.1523/JNEUROSCI.2559-04.2004; Yavich L, 2006, J NEUROCHEM, V99, P724, DOI 10.1111/j.1471-4159.2006.04098.x; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	75	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e70872	10.1371/journal.pone.0070872	http://dx.doi.org/10.1371/journal.pone.0070872			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967127	Green Submitted, Green Published, gold			2022-12-25	WOS:000323115800028
J	Shikiya, Y; Tomita, S; Arakawa, T; Shiraki, K				Shikiya, Yui; Tomita, Shunsuke; Arakawa, Tsutomu; Shiraki, Kentaro			Arginine Inhibits Adsorption of Proteins on Polystyrene Surface	PLOS ONE			English	Article								Nonspecific adsorption of protein on solid surfaces causes a reduction of concentration as well as enzyme inactivation during purification and storage. However, there are no versatile inhibitors of the adsorption between proteins and solid surfaces at low concentrations. Therefore, we examined additives for the prevention of protein adsorption on polystyrene particles (PS particles) as a commonly-used material for vessels such as disposable test tubes and microtubes. A protein solution was mixed with PS particles, and then adsorption of protein was monitored by the concentration and activity of protein in the supernatant after centrifugation. Five different proteins bound to PS particles through electrostatic, hydrophobic, and aromatic interactions, causing a decrease in protein concentration and loss of enzyme activity in the supernatant. Among the additives, including arginine hydrochloride (Arg), lysine hydrochloride, guanidine hydrochloride, NaCl, glycine, and glucose, Arg was most effective in preventing the binding of proteins to PS particles as well as activity loss. Moreover, even after the mixing of protein and PS particles, the addition of Arg caused desorption of the bound protein from PS particles. This study demonstrated a new function of Arg, which expands the potential for application of Arg to proteins.	[Shikiya, Yui; Shiraki, Kentaro] Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba, Ibaraki, Japan; [Tomita, Shunsuke] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan; [Arakawa, Tsutomu] Alliance Prot Labs, San Diego, CA USA	University of Tsukuba; University of Tokyo	Shiraki, K (corresponding author), Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba, Ibaraki, Japan.	shiraki@bk.tsukuba.ac.jp	Tomita, Shunsuke/I-1464-2015	Tomita, Shunsuke/0000-0002-0586-6976	JSPS KAKENHI [23246063, 23550189]; Grants-in-Aid for Scientific Research [12J08921] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by JSPS KAKENHI Grant Numbers 23246063, 23550189 (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa T, 2007, AMINO ACIDS, V33, P587, DOI 10.1007/s00726-007-0506-3; Arakawa T, 2004, PROTEIN EXPRES PURIF, V36, P244, DOI 10.1016/j.pep.2004.04.009; ARAKAWA T, 1982, BIOCHEMISTRY-US, V21, P6545, DOI 10.1021/bi00268a034; Arakawa T, 2008, INT J PHARM, V355, P220, DOI 10.1016/j.ijpharm.2007.12.009; Arakawa T, 2007, PROTEIN EXPRES PURIF, V54, P110, DOI 10.1016/j.pep.2007.02.010; Arakawa T, 2007, PROTEIN EXPRES PURIF, V52, P410, DOI 10.1016/j.pep.2006.10.005; Arakawa T, 2007, J BIOCHEM BIOPH METH, V70, P493, DOI 10.1016/j.jbbm.2006.12.001; Arakawa T, 2007, BIOPHYS CHEM, V127, P1, DOI 10.1016/j.bpc.2006.12.007; Arakawa T, 2010, PROTEIN EXPRES PURIF, V71, P168, DOI 10.1016/j.pep.2009.11.004; Arakawa T, 2009, PROTEIN EXPRES PURIF, V63, P158, DOI 10.1016/j.pep.2008.09.011; Ariki R, 2012, J BIOCHEM, V151, P27, DOI 10.1093/jb/mvr117; Ariki R, 2011, J BIOCHEM, V149, P389, DOI 10.1093/jb/mvr004; Asano R, 2002, FEBS LETT, V528, P70, DOI 10.1016/S0014-5793(02)03254-4; Bee JS, 2010, BIOTECHNOL BIOENG, V105, P121, DOI 10.1002/bit.22525; BRESLOW R, 1990, P NATL ACAD SCI USA, V87, P167, DOI 10.1073/pnas.87.1.167; BUCHNER J, 1991, BIO-TECHNOL, V9, P157, DOI 10.1038/nbt0291-157; Ejima D, 2005, J CHROMATOGR A, V1094, P49, DOI 10.1016/j.chroma.2005.07.086; Ejima D, 2005, ANAL BIOCHEM, V345, P250, DOI 10.1016/j.ab.2005.07.004; Evers F, 2011, LANGMUIR, V27, P6995, DOI 10.1021/la2010908; Evers F, 2009, J PHYS CHEM B, V113, P8462, DOI 10.1021/jp904065w; Fujimoto A, 2010, PROTEIN J, V29, P161, DOI 10.1007/s10930-010-9235-7; Hirano A, 2008, J BIOCHEM, V144, P363, DOI 10.1093/jb/mvn078; Hirano A, 2010, J PHYS CHEM B, V114, P13455, DOI 10.1021/jp101909a; Husecken AK, 2010, LANGMUIR, V26, P13429, DOI 10.1021/la102222z; Ito L, 2011, PROTEIN ENG DES SEL, V24, P269, DOI 10.1093/protein/gzq101; KATO A, 1980, BIOCHIM BIOPHYS ACTA, V624, P13, DOI 10.1016/0005-2795(80)90220-2; KITA Y, 1994, BIOCHEMISTRY-US, V33, P15178, DOI 10.1021/bi00254a029; Koo J, 2008, J PHYS CHEM B, V112, P6292, DOI 10.1021/jp801981t; Lange C, 2009, CURR PHARM BIOTECHNO, V10, P408, DOI 10.2174/138920109788488851; LIN WJ, 1993, PROTEIN EXPRES PURIF, V4, P256, DOI 10.1006/prep.1993.1033; Matsuoka T, 2009, BIOTECHNOL PROGR, V25, P1515, DOI 10.1002/btpr.245; Shang W, 2007, NANO LETT, V7, P1991, DOI 10.1021/nl070777r; Shiraki K, 2002, J BIOCHEM, V132, P591, DOI 10.1093/oxfordjournals.jbchem.a003261; STOYAN T, 1993, EUR J BIOCHEM, V216, P239, DOI 10.1111/j.1432-1033.1993.tb18138.x; Tomita S, 2011, BIOPOLYMERS, V95, P695, DOI 10.1002/bip.21637; Tsumoto K, 2004, BIOTECHNOL PROGR, V20, P1301, DOI 10.1021/bp0498793; Tsumoto K, 1998, J IMMUNOL METHODS, V219, P119, DOI 10.1016/S0022-1759(98)00127-6; Tsumoto K, 2007, J PHARM SCI-US, V96, P1677, DOI 10.1002/jps.20821; Umetsu M, 2003, J BIOL CHEM, V278, P8979, DOI 10.1074/jbc.M212247200; Vermeer AWP, 2000, J COLLOID INTERF SCI, V225, P394, DOI 10.1006/jcis.2000.6769; Vertegel AA, 2004, LANGMUIR, V20, P6800, DOI 10.1021/la0497200	41	25	25	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e70762	10.1371/journal.pone.0070762	http://dx.doi.org/10.1371/journal.pone.0070762			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967100	gold, Green Published, Green Submitted			2022-12-25	WOS:000323115800020
J	Ramanujam, R; Ramanujam, S; Hillert, J				Ramanujam, Ryan; Ramanujam, S.; Hillert, Jan			Considerations for Subgroups and Phenocopies in Complex Disease Genetics	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; RHEUMATOID-ARTHRITIS; MYASTHENIA-GRAVIS; HERITABILITY; RISK	The number of identified genetic variants associated to complex disease cannot fully explain heritability. This may be partially due to more complicated patterns of predisposition than previously suspected. Diseases such as multiple sclerosis (MS) may consist of multiple disease causing mechanisms, each comprised of several elements. We describe how the effect of subgroups can be calculated using the standard association measurement odds ratio, which is then manipulated to provide a formula for the true underlying association present within the subgroup. This is sensitive to the initial minor allele frequencies present in both cases and the subgroup of patients. The methodology is then extended to the chi(2) statistic, for two related scenarios. First, to determine the true chi(2) when phenocopies or disease subtypes reduce association and are reclassified as controls when calculating statistics. Here, the chi(2) is given by [GRAPHICS] , or 1 vertical bar sigma/1 - sigma for equal numbers of cases and controls. Second, when subgroups corresponding to heterogeneity mask the true effect size, but no reclassification is made. Here, the proportion increase in total sample size required to attain the same chi(2) statistic as the subgroup is given as [GRAPHICS] , and a python script to calculate and plot this value is provided at kirc. se. Practical examples show how in a study of modest size (1000 cases and 1000 controls), a non-significant SNP may exceed genome-wide significance when corresponding to a subgroup of 20% of cases, and may occur in heterozygous form in all cases. This methodology may explain the modest association found in diseases such as MS wherein heterogeneity confounds straightforward measurement of association.	[Ramanujam, Ryan; Hillert, Jan] Karolinska Univ Hosp Solna, Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Ramanujam, S.] St Johns Univ, Peter J Tobin Coll Business, New York, NY USA	Karolinska Institutet; Karolinska University Hospital; Saint John's University	Ramanujam, R (corresponding author), Karolinska Univ Hosp Solna, Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	ryan.ramanujam@ki.se	Ramanujam, Ryan/ABE-2426-2020	Ramanujam, Ryan/0000-0001-7360-1497	Karolinska Institutets stiftelse; Swedish Research Council	Karolinska Institutets stiftelse; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by grants from the Karolinska Institutets stiftelse and the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdahl C, 2007, ARCH NEUROL-CHICAGO, V64, P1729, DOI 10.1001/archneur.64.12.1729; Bergen SE, 2010, EUROPEAN J HUMAN GEN; Brynedal B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000664; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Gilhus NE, 2009, EXPERT REV NEUROTHER, V9, P351, DOI 10.1586/14737175.9.3.351; Kastbom A, 2004, ANN RHEUM DIS, V63, P1085, DOI 10.1136/ard.2003.016808; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Masterman T, 2000, ANN NEUROL, V48, P211, DOI 10.1002/1531-8249(200008)48:2<211::AID-ANA11>3.3.CO;2-I; Morris DL, 2012, CURR OPIN RHEUMATOL, V24, P482, DOI 10.1097/BOR.0b013e3283562282; ONO A, 1985, Seminars in Surgical Oncology, V1, P139, DOI 10.1002/ssu.2980010305; Padyukov L, 2011, ANN RHEUM DIS, V70, P259, DOI 10.1136/ard.2009.126821; Ramanujam R, 2011, TWIN RES HUM GENET, V14, P129, DOI 10.1375/twin.14.2.129; Rothman KJ, 2005, AM J PUBLIC HEALTH, V95, pS144, DOI 10.2105/AJPH.2004.059204; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schork NJ, 1997, AM J RESP CRIT CARE, V156, pS103, DOI 10.1164/ajrccm.156.4.12-tac-5; So HC, 2011, GENET EPIDEMIOL, V35, P310, DOI 10.1002/gepi.20579; Watson CT, 2012, SCI REPORTS, V2, P8, DOI DOI 10.1038/SREP00770.ACCESSED	17	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71614	10.1371/journal.pone.0071614	http://dx.doi.org/10.1371/journal.pone.0071614			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977088	Green Submitted, gold, Green Published			2022-12-25	WOS:000324527300026
J	Grundy, S; Plumb, J; Lea, S; Kaur, M; Ray, D; Singh, D				Grundy, Seamus; Plumb, Jonathan; Lea, Simon; Kaur, Manminder; Ray, David; Singh, Dave			Down Regulation of T Cell Receptor Expression in COPD Pulmonary CD8 Cells	PLOS ONE			English	Article							CYTOKINE PRODUCTION; DISEASE; LYMPHOCYTES; LCK; AUTOIMMUNITY; EMPHYSEMA; SMOKERS; INFLAMMATION; STIMULATION; ACTIVATION	CD8 cells may contribute towards an autoimmune process in COPD. Down regulation of T cell receptor (TCR) signalling molecules occurs in autoimmune diseases with consequent T cell dysfunction. We hypothesise that TCR signalling is abnormal in COPD pulmonary CD8 cells. Micro-array gene expression analysis of blood and pulmonary COPD CD8 samples was performed and compared to pulmonary CD8 cells from smoker controls (S). We focused on the TCR signalling pathway, with validation of key findings using polymerase chain reaction and immunofluorescence. TCR signalling molecules in COPD pulmonary CD8 cells were down regulated compared to blood CD8 cells (CD247: fold change (FC) -2.43, Q = 0.001; LCK: FC -2.25, Q = 0.01). Micro-array analysis revealed no significant differences between COPD and S pulmonary CD8 cells. However, PCR revealed significantly lower gene expression levels of CD247 (FC -1.79, p = 0.04) and LCK (FC -1.77, p = 0.01) in COPD compared to S pulmonary CD8 cells. CD247 down regulation in COPD CD8 cells was confirmed by immunofluorescent staining of bronchoalveolar lavage cells: Significantly fewer COPD CD8 cells co-expressed CD247 compared to healthy non-smoker CD8 cells (mean 88.9 vs 75.2%, p < 0.05) There is down regulation of TCR signalling molecules in COPD pulmonary CD8 cells. This may cause T cell dysfunction.	[Grundy, Seamus; Plumb, Jonathan; Lea, Simon; Kaur, Manminder; Singh, Dave] Univ Manchester, Manchester Acad Hlth Sci Ctr, Univ Hosp South Manchester Fdn Trust, Manchester, Lancs, England; [Ray, David] Univ Manchester, Sch Med, Manchester, Lancs, England; [Ray, David] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England	University of Manchester; Wythenshawe Hospital NHS Foundation Trust; University of Manchester; University of Manchester	Grundy, S (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Univ Hosp South Manchester Fdn Trust, Manchester, Lancs, England.	seamus.grundy@manchester.ac.uk	Singh, Dave/AAH-4342-2020; Lea, Simon/U-3590-2019	Singh, Dave/0000-0001-8918-7075; Ray, David/0000-0002-4739-6773; Plumb, Jonathan/0000-0002-7877-8053	Wellcome Trust [WT092281MA]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust [Grant number WT092281MA]. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Baniyash M, 2004, NAT REV IMMUNOL, V4, P675, DOI 10.1038/nri1434; Barnes Peter J, 2004, COPD, V1, P59, DOI 10.1081/COPD-120028701; Cosio MG, 2012, EUR RESPIR J, V39, P1298, DOI 10.1183/09031936.00135711; Cosio MG, 2009, NEW ENGL J MED, V360, P2445, DOI 10.1056/NEJMra0804752; Curtis Jeffrey L, 2007, Proc Am Thorac Soc, V4, P512, DOI 10.1513/pats.200701-002FM; FINKELSTEIN R, 1995, AM J RESP CRIT CARE, V152, P1666, DOI 10.1164/ajrccm.152.5.7582312; Frank S J, 1991, Semin Immunol, V3, P299; Freeman CM, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-13; Freeman CM, 2010, J IMMUNOL, V184, P6504, DOI 10.4049/jimmunol.1000006; Global Initiative for Chronic Obstructive Lung Disease, GLOB STRAT DIAGN MAN; Hodge G, 2007, CLIN EXP IMMUNOL, V150, P22, DOI 10.1111/j.1365-2249.2007.03451.x; Hodge Sandra, 2006, COPD, V3, P179, DOI 10.1080/15412550600976868; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Isakov N, 2000, EUR J BIOCHEM, V267, P3413, DOI 10.1046/j.1432-1327.2000.01412.x; JANOFF A, 1985, AM REV RESPIR DIS, V132, P417; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jury EC, 2003, ARTHRITIS RHEUM-US, V48, P1343, DOI 10.1002/art.10978; Kabelitz D, 2007, CURR OPIN IMMUNOL, V19, P39, DOI 10.1016/j.coi.2006.11.007; Kaur M, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-20; Lee SH, 2007, NAT MED, V13, P567, DOI 10.1038/nm1583; Lin J, 2001, J CELL SCI, V114, P243; Lowenberg M, 2005, BLOOD, V106, P1703, DOI 10.1182/blood-2004-12-4790; Lowenberg M, 2006, EMBO REP, V7, P1023, DOI 10.1038/sj.embor.7400775; Maurice MM, 1997, J IMMUNOL, V159, P2973; MIZOGUCHI H, 1992, SCIENCE, V258, P1795, DOI 10.1126/science.1465616; Nadigel J, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-149; OShaughnessy TC, 1997, AM J RESP CRIT CARE, V155, P852, DOI 10.1164/ajrccm.155.3.9117016; Pitcher LA, 2003, IMMUNOL REV, V191, P47, DOI 10.1034/j.1600-065X.2003.00003.x; Saetta M, 1998, AM J RESP CRIT CARE, V157, P822, DOI 10.1164/ajrccm.157.3.9709027; Santamaria P, 2003, REV ENDOCR METAB DIS, V4, P271, DOI 10.1023/A:1025156413404; Serafini P, 2004, CANCER IMMUNOL IMMUN, V53, P64, DOI 10.1007/s00262-003-0443-2; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; UNUTMAZ D, 1994, J EXP MED, V180, P1159, DOI 10.1084/jem.180.3.1159; Valitutti S, 1997, J EXP MED, V185, P1859, DOI 10.1084/jem.185.10.1859; Walter U, 2005, CURR OPIN IMMUNOL, V17, P624, DOI 10.1016/j.coi.2005.09.014; Zhu XH, 2009, J IMMUNOL, V182, P3270, DOI 10.4049/jimmunol.0802622	39	23	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71629	10.1371/journal.pone.0071629	http://dx.doi.org/10.1371/journal.pone.0071629			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977094	Green Published, gold, Green Submitted			2022-12-25	WOS:000323425700075
J	Provencal, N; Suderman, MJ; Caramaschi, D; Wang, DS; Hallett, M; Vitaro, F; Tremblay, RE; Szyf, M				Provencal, Nadine; Suderman, Matthew J.; Caramaschi, Doretta; Wang, Dongsha; Hallett, Michael; Vitaro, Frank; Tremblay, Richard E.; Szyf, Moshe			Differential DNA Methylation Regions in Cytokine and Transcription Factor Genomic Loci Associate with Childhood Physical Aggression	PLOS ONE			English	Article							GLUCOCORTICOID-RECEPTOR; SALIVARY CORTISOL; EPIGENETIC REGULATION; CELL DIFFERENTIATION; HISTONE ACETYLATION; PRENATAL EXPOSURE; BEHAVIOR PROBLEMS; MAJOR DEPRESSION; GENE-EXPRESSION; STRESS	Background: Animal and human studies suggest that inflammation is associated with behavioral disorders including aggression. We have recently shown that physical aggression of boys during childhood is strongly associated with reduced plasma levels of cytokines IL-1 alpha, IL-4, IL-6, IL-8 and IL-10, later in early adulthood. This study tests the hypothesis that there is an association between differential DNA methylation regions in cytokine genes in T cells and monocytes DNA in adult subjects and a trajectory of physical aggression from childhood to adolescence. Methodology/Principal Findings: We compared the methylation profiles of the entire genomic loci encompassing the IL-1 alpha, IL-6, IL-4, IL-10 and IL-8 and three of their regulatory transcription factors (TF) NF kappa B1, NFAT5 and STAT6 genes in adult males on a chronic physical aggression trajectory (CPA) and males with the same background who followed a normal physical aggression trajectory (control group) from childhood to adolescence. We used the method of methylated DNA immunoprecipitation with comprehensive cytokine gene loci and TF loci microarray hybridization, statistical analysis and false discovery rate correction. We found differentially methylated regions to associate with CPA in both the cytokine loci as well as in their transcription factors loci analyzed. Some of these differentially methylated regions were located in known regulatory regions whereas others, to our knowledge, were previously unknown as regulatory areas. However, using the ENCODE database, we were able to identify key regulatory elements in many of these regions that indicate that they might be involved in the regulation of cytokine expression. Conclusions: We provide here the first evidence for an association between differential DNA methylation in cytokines and their regulators in T cells and monocytes and male physical aggression.	[Provencal, Nadine; Suderman, Matthew J.; Wang, Dongsha; Szyf, Moshe] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Provencal, Nadine; Caramaschi, Doretta; Wang, Dongsha; Vitaro, Frank; Tremblay, Richard E.] Univ Montreal, Res Unit Childrens Psychosocial Maladjustment, Montreal, PQ, Canada; [Provencal, Nadine; Caramaschi, Doretta; Wang, Dongsha; Vitaro, Frank; Tremblay, Richard E.] Univ Montreal, Ste Justine Hosp Res Ctr, Montreal, PQ, Canada; [Tremblay, Richard E.] McGill Univ, Sackler Program Epigenet & Psychobiol, Montreal, PQ, Canada; [Tremblay, Richard E.] Univ Montreal, Dept Psychol & Pediat, Montreal, PQ, Canada; [Tremblay, Richard E.] Univ Coll Dublin, Sch Publ Hlth & Populat Sci, Dublin 2, Ireland; [Suderman, Matthew J.; Hallett, Michael] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ, Canada; [Vitaro, Frank] Univ Montreal, Sch Psychoeduc, Montreal, PQ, Canada	McGill University; Universite de Montreal; Universite de Montreal; McGill University; Universite de Montreal; University College Dublin; McGill University; Universite de Montreal	Tremblay, RE (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada.	richard.tremblay@ucd.ie; moshe.szyf@mcgill.ca	Tremblay, Richard E./O-1360-2014	Provencal, Nadine/0000-0002-2079-8393; Suderman, Matthew/0000-0002-2715-9930; Hallett, Michael/0000-0001-6738-6786; Caramaschi, Doretta/0000-0002-9740-871X	Genes, Environment and Health Training Program from CIHR; Canadian Institutes of Health Research; Social Sciences Humanities Research Council of Canada; Quebec Health Research Fund (FRSQ); Quebec Social Science and Culture Fund (FQRSC); Sackler Program in Psychobiology and Epigenetics at McGill University; Canadian Institute for Advanced Research	Genes, Environment and Health Training Program from CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Social Sciences Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Quebec Health Research Fund (FRSQ)(Fonds de la Recherche en Sante du Quebec); Quebec Social Science and Culture Fund (FQRSC); Sackler Program in Psychobiology and Epigenetics at McGill University; Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR))	This work was supported by a fellowship from the Genes, Environment and Health Training Program from CIHR to NP, grants from the Canadian Institutes of Health Research, the Social Sciences Humanities Research Council of Canada, the Quebec Health Research Fund (FRSQ) and the Quebec Social Science and Culture Fund (FQRSC) to RET, grants from the Canadian Institutes of Health Research, the Sackler Program in Psychobiology and Epigenetics at McGill University and from the Canadian Institute for Advanced Research to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alesci S, 2005, J CLIN ENDOCR METAB, V90, P2522, DOI 10.1210/jc.2004-1667; Alink LRA, 2006, CHILD DEV, V77, P954, DOI 10.1111/j.1467-8624.2006.00912.x; Alleva E, 1998, EUR J NEUROSCI, V10, P3664, DOI 10.1046/j.1460-9568.1998.00377.x; Andia DC, 2010, J PERIODONTOL, V81, P1336, DOI 10.1902/jop.2010.100082; Ando T, 2000, LEUKEMIA, V14, P1915, DOI 10.1038/sj.leu.2401914; Anower AKMM, 2012, EUR J PHARMACOL, V688, P76, DOI 10.1016/j.ejphar.2012.05.007; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Armario A, 1998, J NEUROIMMUNOL, V92, P160, DOI 10.1016/S0165-5728(98)00199-4; Arsenio WF, 2004, MONOGR SOC RES CHILD, P1, DOI [DOI 10.1111/J.0037-976X.2004.00312.X, 10.1111/j.0037-976X.2004.00312.x]; Avni O, 2000, CURR OPIN IMMUNOL, V12, P654, DOI 10.1016/S0952-7915(00)00158-8; Barker ED, 2008, ARCH GEN PSYCHIAT, V65, P1185, DOI 10.1001/archpsyc.65.10.1185; Barker ED, 2007, ARCH GEN PSYCHIAT, V64, P592, DOI 10.1001/archpsyc.64.5.592; Bartolomei MS, 2009, GENE DEV, V23, P2124, DOI 10.1101/gad.1841409; Bauer ME, 2010, NEUROIMMUNOMODULAT, V17, P192, DOI 10.1159/000258721; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bogdanovic O, 2012, GENOME RES; Borghol N, 2006, GENOMICS, V87, P417, DOI 10.1016/j.ygeno.2005.10.008; Borghol N, 2012, INT J EPIDEMIOL, V41, P62, DOI 10.1093/ije/dyr147; Broidy LM, 2003, DEV PSYCHOL, V39, P222, DOI 10.1037/0012-1649.39.2.222; Campbell SB, 2006, J CHILD PSYCHOL PSYC, V47, P791, DOI 10.1111/j.1469-7610.2006.01636.x; Campbell SB, 2010, DEV PSYCHOPATHOL, V22, P133, DOI 10.1017/S0954579409990319; Carotta S, 2010, IMMUNOL REV, V238, P63, DOI 10.1111/j.1600-065X.2010.00955.x; Carpenter LL, 2010, NEUROPSYCHOPHARMACOL, V35, P2617, DOI 10.1038/npp.2010.159; Chapoval S, 2010, J LEUKOCYTE BIOL, V87, P1011, DOI 10.1189/jlb.1209772; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Cote SM, 2007, ARCH GEN PSYCHIAT, V64, P1305, DOI 10.1001/archpsyc.64.11.1305; Cote SM, 2006, J ABNORM CHILD PSYCH, V34, P71, DOI 10.1007/s10802-005-9001-z; Dalski A, 2001, CYTOGENET CELL GENET, V93, P239, DOI 10.1159/000056990; Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Essex MJ, 2011, CHILD DEV; Fields PE, 2002, J IMMUNOL, V169, P647, DOI 10.4049/jimmunol.169.2.647; Groer MW, 2007, PSYCHONEUROENDOCRINO, V32, P133, DOI 10.1016/j.psyneuen.2006.11.007; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hoge EA, 2009, DEPRESS ANXIETY, V26, P447, DOI 10.1002/da.20564; Janelidze S, 2011, BRAIN BEHAV IMMUN, V25, P335, DOI 10.1016/j.bbi.2010.10.010; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Jones EA, 2005, J IMMUNOL, V175, P7437, DOI 10.4049/jimmunol.175.11.7437; Kawamura A, 2001, JPN CIRC J, V65, P858, DOI 10.1253/jcj.65.858; Ke X, 2006, PHYSIOL GENOMICS, V25, P16, DOI 10.1152/physiolgenomics.00093.2005; Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719; Kim EG, 2010, CLIN EXP MED, V10, P143, DOI 10.1007/s10238-009-0083-8; Kinnally EL, 2011, BRAIN BEHAV IMMUN; Klengel T, 2013, NAT NEUROSCI, V16, P33, DOI 10.1038/nn.3275; Kokko K, 2000, DEV PSYCHOL, V36, P463, DOI 10.1037/0012-1649.36.4.463; Koo JW, 2008, P NATL ACAD SCI USA, V105, P751, DOI 10.1073/pnas.0708092105; Krug EG, 2002, LANCET, V360, P1083, DOI 10.1016/S0140-6736(02)11133-0; Larsson L, 2012, EUR J ORAL SCI, V120, P14, DOI 10.1111/j.1600-0722.2011.00917.x; Lee DU, 2004, P NATL ACAD SCI USA, V101, P16010, DOI 10.1073/pnas.0407031101; Lee DU, 2002, IMMUNITY, V16, P649, DOI 10.1016/S1074-7613(02)00314-X; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Li J, 2010, ANTIVIR RES, V85, P463, DOI 10.1016/j.antiviral.2009.10.011; Loney BR, 2006, J CHILD PSYCHOL PSYC, V47, P30, DOI 10.1111/j.1469-7610.2005.01444.x; MacLennan NK, 2004, PHYSIOL GENOMICS, V18, P43, DOI 10.1152/physiolgenomics.00042.2004; McGowan PO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014739; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Misener VL, 2008, NEUROPSYCHOBIOLOGY, V58, P71, DOI 10.1159/000159775; Nagin D, 1999, CHILD DEV, V70, P1181, DOI 10.1111/1467-8624.00086; Nagin DS, 2001, ARCH GEN PSYCHIAT, V58, P389, DOI 10.1001/archpsyc.58.4.389; Naumova OY, 2012, DEV PSYCHOPATHOL, V24, P143, DOI 10.1017/S0954579411000605; Nelson RJ, 2001, TRENDS NEUROSCI, V24, P713, DOI 10.1016/S0166-2236(00)01996-2; Nile CJ, 2008, ARTHRITIS RHEUM, V58, P2686, DOI 10.1002/art.23758; O'Brien SM, 2004, HUM PSYCHOPHARM CLIN, V19, P397, DOI 10.1002/hup.609; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; Pace TWW, 2007, BRAIN BEHAV IMMUN, V21, P9, DOI 10.1016/j.bbi.2006.08.009; Pekowska A, 2011, EMBO J, V30, P4198, DOI 10.1038/emboj.2011.295; Pingault JB, 2011, AM J PSYCHIAT; Platje E, 2013, BIOL PSYCHOL, V93, P132, DOI 10.1016/j.biopsycho.2013.01.002; Popma A, 2007, BIOL PSYCHIAT, V61, P405, DOI 10.1016/j.biopsych.2006.06.006; Provencal N, 2013, J NEUROSCI IN PRESS; Provencal N, 2013, PLOS ONE IN PRESS; R Development Core Tea, 2007, BIOINFORMATICS; RAZIN A, 1984, BIOCHIM BIOPHYS ACTA, V782, P331, DOI 10.1016/0167-4781(84)90043-5; Romano E, 2001, J CHILD PSYCHOL PSYC, V42, P451, DOI 10.1111/1469-7610.00739; Samuel JM, 2008, CYTOKINE, V42, P256, DOI 10.1016/j.cyto.2008.02.008; SEGUIN JR, 1995, J ABNORM PSYCHOL, V104, P614, DOI 10.1037/0021-843X.104.4.614; Shirtcliff EA, 2005, DEV PSYCHOPATHOL, V17, P167, DOI 10.1017/S0954579405050091; Siegel A, 2007, CURR NEUROPHARMACOL, V5, P135, DOI 10.2174/157015907780866929; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Smith AK, 2011, AM J MED GENET B, V156B, P700, DOI 10.1002/ajmg.b.31212; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; SORIC B, 1989, J AM STAT ASSOC, V84, P608, DOI 10.2307/2289950; Steptoe A, 2007, BRAIN BEHAV IMMUN, V21, P901, DOI 10.1016/j.bbi.2007.03.011; Suarez EC, 2002, BRAIN BEHAV IMMUN, V16, P675, DOI 10.1016/S0889-1591(02)00019-3; Szyf M, 2011, EPIGENETICS-US, V6, P971, DOI 10.4161/epi.6.8.16793; Tarullo AR, 2006, HORM BEHAV, V50, P632, DOI 10.1016/j.yhbeh.2006.06.010; Terry MB, 2008, CANCER EPIDEM BIOMAR, V17, P2306, DOI 10.1158/1055-9965.EPI-08-0312; TREMBLAY RE, 1991, J ABNORM CHILD PSYCH, V19, P285, DOI 10.1007/BF00911232; Tremblay RE, 2004, PEDIATRICS, V114, pE43, DOI 10.1542/peds.114.1.e43; Tremblay RE, 2010, J CHILD PSYCHOL PSYC, V51, P341, DOI 10.1111/j.1469-7610.2010.02211.x; Uddin M, 2011, PSYCHOL MED, V41, P997, DOI 10.1017/S0033291710001674; Uddin M, 2011, DIS MARKERS, V30, P111, DOI [10.1155/2011/513659, 10.3233/DMA-2011-0750]; Uddin M, 2010, P NATL ACAD SCI USA, V107, P9470, DOI 10.1073/pnas.0910794107; van Bokhoven I, 2005, J NEURAL TRANSM, V112, P1083, DOI 10.1007/s00702-004-0253-5; van Rietschoten JGI, 2008, GENES IMMUN, V9, P582, DOI 10.1038/gene.2008.53; Veenema AH, 2009, FRONT NEUROENDOCRIN, V30, P497, DOI 10.1016/j.yfrne.2009.03.003; von Kanel R, 2007, J PSYCHIATR RES, V41, P744, DOI 10.1016/j.jpsychires.2006.06.009; Wang DX, 2012, AQUAT ECOSYST HEALTH, V15, P4, DOI 10.1080/14634988.2012.663631; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Weaver ICG, 2004, ANN NY ACAD SCI, V1024, P182, DOI 10.1196/annals.1321.099; WIDOM CS, 1989, AM J ORTHOPSYCHIAT, V59, P355, DOI 10.1111/j.1939-0025.1989.tb01671.x; Zalcman SS, 2006, BRAIN BEHAV IMMUN, V20, P507, DOI 10.1016/j.bbi.2006.05.002	103	52	53	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71691	10.1371/journal.pone.0071691	http://dx.doi.org/10.1371/journal.pone.0071691			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977113	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700085
J	Lumen, AA; Li, LB; Li, JB; Ahmed, Z; Meng, Z; Owen, A; Ellens, H; Hidalgo, IJ; Bentz, J				Lumen, Annie Albin; Li, Libin; Li, Jiben; Ahmed, Zeba; Meng, Zhou; Owen, Albert; Ellens, Harma; Hidalgo, Ismael J.; Bentz, Joe			Transport Inhibition of Digoxin Using Several Common P-gp Expressing Cell Lines Is Not Necessarily Reporting Only on Inhibitor Binding to P-gp	PLOS ONE			English	Article							IN-VITRO; CONFLUENT MONOLAYER; CACO-2 CELLS; MEMBRANE TRANSPORTERS; PHARMACEUTICAL DRUGS; MDCKII-HMDR1 CELLS; GLYCOPROTEIN; EFFLUX; IDENTIFICATION; CANDIDATES	We have reported that the P-gp substrate digoxin required basolateral and apical uptake transport in excess of that allowed by digoxin passive permeability (as measured in the presence of GF120918) to achieve the observed efflux kinetics across MDCK-MDR1-NKI (The Netherlands Cancer Institute) confluent cell monolayers. That is, GF120918 inhibitable uptake transport was kinetically required. Therefore, IC50 measurements using digoxin as a probe substrate in this cell line could be due to inhibition of P-gp, of digoxin uptake transport, or both. This kinetic analysis is now extended to include three additional cell lines: MDCK-MDR1-NIH (National Institute of Health), Caco-2 and CPT-B2 (Caco-2 cells with BCRP knockdown). These cells similarly exhibit GF120918 inhibitable uptake transport of digoxin. We demonstrate that inhibition of digoxin transport across these cell lines by GF120918, cyclosporine, ketoconazole and verapamil is greater than can be explained by inhibition of P-gp alone. We examined three hypotheses for this non-P-gp inhibition. The inhibitors can: (1) bind to a basolateral digoxin uptake transporter, thereby inhibiting digoxin's cellular uptake; (2) partition into the basolateral membrane and directly reduce membrane permeability; (3) aggregate with digoxin in the donor chamber, thereby reducing the free concentration of digoxin, with concomitant reduction in digoxin uptake. Data and simulations show that hypothesis 1 was found to be uniformly acceptable. Hypothesis 2 was found to be uniformly unlikely. Hypothesis 3 was unlikely for GF120918 and cyclosporine, but further studies are needed to completely adjudicate whether hetero-dimerization contributes to the non-P-gp inhibition for ketoconazole and verapamil. We also find that P-gp substrates with relatively low passive permeability such as digoxin, loperamide and vinblastine kinetically require basolateral uptake transport over that allowed by +GF120918 passive permeability, while highly permeable P-gp substrates such as amprenavir, quinidine, ketoconazole and verapamil do not, regardless of whether they actually use the basolateral transporter.	[Lumen, Annie Albin; Ahmed, Zeba; Meng, Zhou; Bentz, Joe] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Lumen, Annie Albin; Ahmed, Zeba; Meng, Zhou; Ellens, Harma] GlaxoSmithKline, Preclin Drug Metab & Pharmacokinet, King Of Prussia, PA USA; [Li, Libin; Li, Jiben; Owen, Albert; Hidalgo, Ismael J.] Absorpt Syst LLC, Exton, PA USA	Drexel University; GlaxoSmithKline	Ellens, H (corresponding author), GlaxoSmithKline, Preclin Drug Metab & Pharmacokinet, King Of Prussia, PA USA.	Harma.M.Ellens@gsk.com; ihidalgo@absorption.com; bentzj@drexel.edu			Absorption Systems; GSK	Absorption Systems; GSK(GlaxoSmithKline)	Reagents were provided by GSK and by Absorption Systems, who also supported the execution of the experiments. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya P, 2008, DRUG METAB DISPOS, V36, P452, DOI 10.1124/dmd.107.017301; Acharya P, 2006, BIOCHEMISTRY-US, V45, P15505, DOI 10.1021/bi060593b; Agnani D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025086; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Anderle P, 1998, J PHARM SCI, V87, P757, DOI 10.1021/js970372e; BURTON PS, 1993, BIOCHEM BIOPH RES CO, V190, P760, DOI 10.1006/bbrc.1993.1114; Chen Y, 2009, J PHARMACOL EXP THER, V330, P956, DOI 10.1124/jpet.109.154781; Chen Z, 1997, BIOPHYS J, V73, P267, DOI 10.1016/S0006-3495(97)78067-6; Cook JA, 2010, MOL PHARMACEUT, V7, P398, DOI 10.1021/mp900174z; Di L, 2012, DRUG DISCOV TODAY, V17, P905, DOI 10.1016/j.drudis.2012.03.015; Dobson PD, 2008, NAT REV DRUG DISCOV, V7, P205, DOI 10.1038/nrd2438; Evers R, 2000, BRIT J CANCER, V83, P366, DOI 10.1054/bjoc.2000.1260; Gao JN, 2001, PHARMACEUT RES, V18, P171, DOI 10.1023/A:1011076217118; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Hill WG, 2000, J BIOL CHEM, V275, P30176, DOI 10.1074/jbc.M003494200; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Kell DB, 2013, DRUG DISCOV TODAY, V18, P218, DOI 10.1016/j.drudis.2012.11.008; Kimoto E, 2011, DRUG METAB DISPOS, V39, P47, DOI 10.1124/dmd.110.034298; Lee KH, 2002, J PHARMACOL EXP THER, V303, P574, DOI 10.1124/jpet.102.038521; Loo TW, 2005, J MEMBRANE BIOL, V206, P173, DOI 10.1007/s00232-005-0792-1; Lugo MR, 2005, BIOCHEMISTRY-US, V44, P643, DOI 10.1021/bi0485326; Lumen AA, 2010, DRUG METAB DISPOS, V38, P260, DOI 10.1124/dmd.109.029843; Owen SC, 2012, ACS CHEM BIOL, V7, P1429, DOI 10.1021/cb300189b; Polli JW, 2001, J PHARMACOL EXP THER, V299, P620; Rautio J, 2006, DRUG METAB DISPOS, V34, P786, DOI 10.1124/dmd.105.008615; Seidler J, 2003, J MED CHEM, V46, P4477, DOI 10.1021/jm030191r; Shoichet BK, 2006, DRUG DISCOV TODAY, V11, P607, DOI 10.1016/j.drudis.2006.05.014; Sugano K, 2010, NAT REV DRUG DISCOV, V9, P597, DOI 10.1038/nrd3187; Sugimoto H, 2011, J PHARM SCI-US, V100, P4013, DOI 10.1002/jps.22652; Tang FX, 2002, PHARMACEUT RES, V19, P765, DOI 10.1023/A:1016140429238; Taub ME, 2011, DRUG METAB DISPOS, V39, P2093, DOI 10.1124/dmd.111.040816; Tran TT, 2005, BIOPHYS J, V88, P715, DOI 10.1529/biophysj.104.045633; Troutman MD, 2003, PHARMACEUT RES, V20, P1192, DOI 10.1023/A:1025096930604; Zong J, 2003, J PHARMACOL EXP THER, V306, P556, DOI 10.1124/jpet.103.049452	34	27	27	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e69394	10.1371/journal.pone.0069394	http://dx.doi.org/10.1371/journal.pone.0069394			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23976943	gold, Green Published, Green Submitted			2022-12-25	WOS:000323570200002
J	Ortega-Prieto, AM; Sheldon, J; Grande-Perez, A; Tejero, H; Gregori, J; Quer, J; Esteban, JI; Domingo, E; Perales, C				Ortega-Prieto, Ana M.; Sheldon, Julie; Grande-Perez, Ana; Tejero, Hector; Gregori, Josep; Quer, Josep; Esteban, Juan I.; Domingo, Esteban; Perales, Celia			Extinction of Hepatitis C Virus by Ribavirin in Hepatoma Cells Involves Lethal Mutagenesis	PLOS ONE			English	Article							MOUTH-DISEASE VIRUS; ERROR-PRONE REPLICATION; ANTIVIRAL ACTIVITY; MYCOPHENOLIC-ACID; GENE-EXPRESSION; IN-VITRO; PHOSPHORYLATED RIBAVIRIN; COMBINATION THERAPY; PLUS RIBAVIRIN; MUTATION-RATE	Lethal mutagenesis, or virus extinction produced by enhanced mutation rates, is under investigation as an antiviral strategy that aims at counteracting the adaptive capacity of viral quasispecies, and avoiding selection of antiviral-escape mutants. To explore lethal mutagenesis of hepatitis C virus (HCV), it is important to establish whether ribavirin, the purine nucleoside analogue used in anti-HCV therapy, acts as a mutagenic agent during virus replication in cell culture. Here we report the effect of ribavirin during serial passages of HCV in human hepatoma Huh-7.5 cells, regarding viral progeny production and complexity of mutant spectra. Ribavirin produced an increase of mutant spectrum complexity and of the transition types associated with ribavirin mutagenesis, resulting in HCV extinction. Ribavirin-mediated depletion of intracellular GTP was not the major contributory factor to mutagenesis since mycophenolic acid evoked a similar decrease in GTP without an increase in mutant spectrum complexity. The intracellular concentration of the other nucleoside-triphosphates was elevated as a result of ribavirin treatment. Mycophenolic acid extinguished HCV without an intervening mutagenic activity. Ribavirin-mediated, but not mycophenolic acid-mediated, extinction of HCV occurred via a decrease of specific infectivity, a feature typical of lethal mutagenesis. We discuss some possibilities to explain disparate results on ribavirin mutagenesis of HCV.	[Ortega-Prieto, Ana M.; Sheldon, Julie; Tejero, Hector; Domingo, Esteban; Perales, Celia] CSIC, Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain; [Sheldon, Julie] Univ Malaga, Dept Biol Celular Genet & Fisiol, Inst Hortofruticultura Subtrop & Mediterranea La, E-29071 Malaga, Spain; [Tejero, Hector] Univ Complutense Madrid, Dept Bioquim Biol Mol 1, Madrid, Spain; [Quer, Josep; Esteban, Juan I.; Domingo, Esteban; Perales, Celia] Ctr Invest Biomed Red Enfermedades Hepat & Diges, Barcelona, Spain; [Gregori, Josep; Quer, Josep; Esteban, Juan I.] Vall Hebron Inst Recerca Hosp VHIR HUVH, Internal Med Lab Malalties Hepatiques, Liver Unit, Barcelona, Spain; [Quer, Josep; Esteban, Juan I.] Univ Autonoma Barcelona, E-08193 Barcelona, Spain; [Gregori, Josep] Roche Diagnost SL, Sant Cugat Del Valles, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM); Complutense University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Roche Holding	Domingo, E (corresponding author), CSIC, Ctr Biol Mol Severo Ochoa CSIC UAM, Campus Cantoblanco, Madrid, Spain.	edomingo@cbm.uam.es; cperales@cbm.uam.es	Quer, Josep/A-6741-2012; Ortega-Prieto, Ana Maria/M-6431-2019; Ortega-Prieto, Ana Maria/AFN-6270-2022; Grande-Pérez, Ana/D-3757-2012; Gregori, Josep/J-2586-2015; Domingo, Esteban/K-3937-2014; Tejero, Hector/M-1045-2014	Quer, Josep/0000-0003-0014-084X; Ortega-Prieto, Ana Maria/0000-0002-9023-0103; Grande-Pérez, Ana/0000-0002-2821-062X; Gregori, Josep/0000-0002-4253-8015; Domingo, Esteban/0000-0002-0573-1676; Perales Viejo, Celia Belen/0000-0003-1618-1937; Tejero, Hector/0000-0002-4940-700X; Sheldon, Julie/0000-0002-8240-0010	Ministerio de Ciencia e Innovacion [BFU 2011-23604, SAF2009-10403, PI 10/01505, IDI-20110115 CDTI]; Junta de Andalucia [P09-CVI-5428, P10-CVI-6561]; Fundacion Ramon Areces; Instituto de Salud Carlos III; MINECO; CSIC	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Andalucia(Junta de Andalucia); Fundacion Ramon Areces; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); MINECO(Spanish Government); CSIC	This work was supported by grants BFU 2011-23604, SAF2009-10403, PI 10/01505 and ref. IDI-20110115 CDTI (Centro para el Desarrollo Tecnologico Industrial) from Ministerio de Ciencia e Innovacion, P09-CVI-5428 and P10-CVI-6561 from Junta de Andalucia, and Fundacion Ramon Areces. CIBERehd (Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas) is funded at the Instituto de Salud Carlos III. A.M.O. is supported by an FPI contract from MINECO, and J.S. by a Juan de la Cierva contract from CSIC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudo R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001072; Airaksinen A, 2003, VIROLOGY, V311, P339, DOI 10.1016/S0042-6822(03)00144-2; Alves D, 1998, PHYS REV E, V57, P7008, DOI 10.1103/PhysRevE.57.7008; Anderson JF, 2002, EMERG INFECT DIS, V8, P107, DOI 10.3201/eid0801.010252; Anderson JP, 2004, ANNU REV MICROBIOL, V58, P183, DOI 10.1146/annurev.micro.58.030603.123649; Ando T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002561; Asahina Y, 2005, J HEPATOL, V43, P623, DOI 10.1016/j.jhep.2005.05.032; Baranovich T, 2013, J VIROL, V87, P3741, DOI 10.1128/JVI.02346-12; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Bougie I, 2003, J BIOL CHEM, V278, P52471, DOI 10.1074/jbc.M308917200; Brochot E, 2007, ANTIVIR THER, V12, P805; Bull JJ, 2008, ORIGIN AND EVOLUTION OF VIRUSES, 2ND EDITION, P207, DOI 10.1016/B978-0-12-374153-0.00009-6; Chen PQ, 2009, GENETICS, V183, P639, DOI 10.1534/genetics.109.106492; Chevaliez S, 2007, ADV DRUG DELIVER REV, V59, P1222, DOI 10.1016/j.addr.2007.07.002; Chevaliez S, 2007, J VIROL, V81, P7732, DOI 10.1128/JVI.00382-07; CONNOR E, 1993, ANTIMICROB AGENTS CH, V37, P532, DOI 10.1128/AAC.37.3.532; Contreras AM, 2002, J VIROL, V76, P8505, DOI 10.1128/JVI.76.17.8505-8517.2002; Crotty S, 2000, NAT MED, V6, P1375, DOI 10.1038/82191; Crotty S, 2002, J MOL MED, V80, P86, DOI 10.1007/s00109-001-0308-0; Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598; CRUMPACKER C, 1986, LANCET, V2, P45; Cubero M, 2008, VIROLOGY, V370, P237, DOI 10.1016/j.virol.2007.10.006; Cuevas JM, 2009, J VIROL, V83, P5760, DOI 10.1128/JVI.00201-09; Dapp MJ, 2013, TRENDS MICROBIOL, V21, P56, DOI 10.1016/j.tim.2012.10.006; Dapp MJ, 2009, J VIROL, V83, P11950, DOI 10.1128/JVI.01406-09; Day CW, 2005, ANTIVIR RES, V67, P38, DOI 10.1016/j.antiviral.2005.04.002; Deuffic-Burban S, 2007, J VIRAL HEPATITIS, V14, P107, DOI 10.1111/j.1365-2893.2006.00785.x; Dietz J, 2013, J VIROL, V87, P6172, DOI 10.1128/JVI.02778-12; Dixit NM, 2004, NATURE, V432, P922, DOI 10.1038/nature03153; Domingo E, 2005, VIRUS RES, V107, P115, DOI 10.1016/j.virusres.2004.11.001; Domingo E, 2003, PROG DRUG RES, V60, P133; Domingo E, 2001, QUASISPECIES RNA VIR; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; Eigen M, 2002, P NATL ACAD SCI USA, V99, P13374, DOI 10.1073/pnas.212514799; ERIKSSON B, 1977, ANTIMICROB AGENTS CH, V11, P946, DOI 10.1128/AAC.11.6.946; Farci P, 2011, SEMIN LIVER DIS, V31, P356, DOI 10.1055/s-0031-1297925; Feld JJ, 2007, HEPATOLOGY, V46, P1548, DOI 10.1002/hep.21853; Feld JJ, 2012, GASTROENTEROLOGY, V142, P1356, DOI 10.1053/j.gastro.2011.12.064; Feld JJ, 2010, GASTROENTEROLOGY, V139, P154, DOI 10.1053/j.gastro.2010.03.037; Feng DF, 1996, METHOD ENZYMOL, V266, P368; FERNANDEZLARSSON R, 1989, ANTIMICROB AGENTS CH, V33, P1668, DOI 10.1128/AAC.33.10.1668; Fox EJ, 2010, SEMIN CANCER BIOL, V20, P353, DOI 10.1016/j.semcancer.2010.10.005; FRANKLIN TJ, 1969, BIOCHEM J, V113, P515, DOI 10.1042/bj1130515; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gelman MA, 2011, TRENDS MOL MED, V17, P34, DOI 10.1016/j.molmed.2010.10.005; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerotto M, 1999, J VIROL, V73, P7241, DOI 10.1128/JVI.73.9.7241-7247.1999; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; GILBERT BE, 1986, ANTIMICROB AGENTS CH, V30, P201, DOI 10.1128/AAC.30.2.201; Gonzalez-Lopez Claudia, 2005, Infection Genetics and Evolution, V5, P366, DOI 10.1016/j.meegid.2005.05.001; GOSWAMI BB, 1979, BIOCHEM BIOPH RES CO, V89, P830, DOI 10.1016/0006-291X(79)91853-9; Graci JD, 2008, FUTURE VIROL, V3, P553, DOI 10.2217/17460794.3.6.553; Graci JD, 2007, J VIROL, V81, P11256, DOI 10.1128/JVI.01028-07; Graci JD, 2002, VIROLOGY, V298, P175, DOI 10.1006/viro.2002.1487; Grande-Perez A, 2005, J VIROL, V79, P10451, DOI 10.1128/JVI.79.16.10451-10459.2005; Grande-Perez A, 2005, P NATL ACAD SCI USA, V102, P4448, DOI 10.1073/pnas.0408871102; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hofmann WP, 2007, GASTROENTEROLOGY, V132, P921, DOI 10.1053/j.gastro.2006.12.005; Holland JJ, 1990, DEFECTIVE VIRAL GENO, P151; Homs M, 2011, NUCLEIC ACIDS RES, V39, P8457, DOI 10.1093/nar/gkr451; Hultgren C, 1998, J GEN VIROL, V79, P2381, DOI 10.1099/0022-1317-79-10-2381; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Iranzo J, 2011, P NATL ACAD SCI USA, V108, P16008, DOI 10.1073/pnas.1110489108; Jones CT, 2010, NAT BIOTECHNOL, V28, P167, DOI 10.1038/nbt.1604; Jordan I, 2000, J INFECT DIS, V182, P1214, DOI 10.1086/315847; Kanda T, 2004, J VIRAL HEPATITIS, V11, P479, DOI 10.1111/j.1365-2893.2004.00531.x; Kato T, 2005, J CLIN MICROBIOL, V43, P5679, DOI 10.1128/JCM.43.11.5679-5684.2005; KERR SJ, 1987, MOL CELL BIOCHEM, V77, P187; Kim MG, 2012, BIOCHEM BIOPH RES CO, V421, P112, DOI 10.1016/j.bbrc.2012.03.126; Kim Y, 2013, VIRUS RES, V171, P44, DOI 10.1016/j.virusres.2012.10.018; Kuntzen T, 2008, HEPATOLOGY, V48, P1769, DOI 10.1002/hep.22549; Kwong AD, 2011, GASTROENTEROLOGY; Lanford RE, 2001, J VIROL, V75, P8074, DOI 10.1128/JVI.75.17.8074-8081.2001; Lange CM, 2010, ALIMENT PHARM THER, V32, P14, DOI 10.1111/j.1365-2036.2010.04317.x; Lee CH, 1997, J VIROL, V71, P3636, DOI 10.1128/JVI.71.5.3636-3640.1997; LEE HJ, 1985, CANCER RES, V45, P5512; Lehmann KA, 2000, BIOCHEMISTRY-US, V39, P12875, DOI 10.1021/bi001383g; Leyssen P, 2006, MOL PHARMACOL, V69, P1461, DOI 10.1124/mol.105.020057; Leyssen P, 2005, J VIROL, V79, P1943, DOI 10.1128/JVI.79.3.1943-1947.2005; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lindenbach Brett D, 2003, Hepatology, V38, P769; Lindenbach Brett D., 2009, V510, P329, DOI 10.1007/978-1-59745-394-3_24; Loeb LA, 1999, P NATL ACAD SCI USA, V96, P1492, DOI 10.1073/pnas.96.4.1492; Loeb LA, 2011, NAT REV CANCER, V11, P450, DOI 10.1038/nrc3063; LOWE JK, 1977, CANCER RES, V37, P736; Lutchman G, 2007, GASTROENTEROLOGY, V132, P1757, DOI 10.1053/j.gastro.2007.03.035; Maag D, 2001, J BIOL CHEM, V276, P46094, DOI 10.1074/jbc.C100349200; Margeridon-Thermet S, 2010, VIRUSES-BASEL, V2, P2696, DOI 10.3390/v2122696; MARTELL M, 1992, J VIROL, V66, P3225, DOI 10.1128/JVI.66.5.3225-3229.1992; Mas A, 2010, J MOL BIOL, V397, P865, DOI 10.1016/j.jmb.2010.02.005; Maylin S, 2008, GASTROENTEROLOGY, V135, P821, DOI 10.1053/j.gastro.2008.05.044; Moreno H, 2012, VIRUSES-BASEL, V4, P2786, DOI 10.3390/v4112786; Moreno H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032550; Moreno H, 2011, J VIROL, V85, P7246, DOI 10.1128/JVI.00614-11; Mori K, 2011, VIRUS RES, V157, P61, DOI 10.1016/j.virusres.2011.02.005; Mullins JI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015135; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Ning Q, 1998, J IMMUNOL, V160, P3487; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Ochoa G, 2006, EVOL COMPUT, V14, P157, DOI 10.1162/evco.2006.14.2.157; OGLE JW, 1989, J INFECT DIS, V159, P748, DOI 10.1093/infdis/159.4.748; Ojosnegros S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-207; Pages H, 2012, R PACKAGE VERSION 2; Pan QW, 2012, HEPATOLOGY, V55, P1673, DOI 10.1002/hep.25562; Pariente N, 2001, J VIROL, V75, P9723, DOI 10.1128/JVI.75.20.9723-9730.2001; Parker WB, 2005, VIRUS RES, V107, P165, DOI 10.1016/j.virusres.2004.11.006; Pawlotsky JM, 2006, CURR TOP MICROBIOL, V299, P261; Perales C, 2013, J VIROL, V87, P7593, DOI 10.1128/JVI.02824-12; Perales C, 2012, TRENDS MICROBIOL, V20, P595, DOI 10.1016/j.tim.2012.08.010; Perales C, 2011, J VIROL, V85, P12227, DOI 10.1128/JVI.00716-11; Perales C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000658; Perales C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005554; Perelson AS, 2007, GASTROENTEROLOGY, V132, P2050, DOI 10.1053/j.gastro.2007.03.077; Pfeiffer JK, 2005, J VIROL, V79, P2346, DOI 10.1128/JVI.79.4.2346-2355.2005; Pham TNQ, 2010, LIVER INT, V30, P502, DOI 10.1111/j.1478-3231.2009.02193.x; Ploss A, 2012, GUT, V61, P25, DOI 10.1136/gutjnl-2012-302048; POGOLOTTI AL, 1982, ANAL BIOCHEM, V126, P335, DOI 10.1016/0003-2697(82)90524-3; Quer J, 2008, ORIGIN AND EVOLUTION OF VIRUSES, 2ND EDITION, P303, DOI 10.1016/B978-0-12-374153-0.00015-1; Querenghi F, 2001, J VIRAL HEPATITIS, V8, P120, DOI 10.1046/j.1365-2893.2001.00265.x; Ramirez C, 2013, ANTIVIR RES, V98, P273, DOI 10.1016/j.antiviral.2013.03.007; RANKIN JT, 1989, VIROLOGY, V168, P147, DOI 10.1016/0042-6822(89)90413-3; Richman D.D, 1996, ANTIVIRAL DRUG RESIS; Ruiz-Jarabo CM, 2003, VIROLOGY, V308, P37, DOI 10.1016/S0042-6822(02)00046-6; Sanchez G, 2003, VIROLOGY, V315, P34, DOI 10.1016/S0042-6822(03)00483-5; Sanchez-Jimenez C, 2012, VIROLOGY, V424, P147, DOI 10.1016/j.virol.2011.12.016; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; Schuster P, 2008, ORIGIN AND EVOLUTION OF VIRUSES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-374153-0.00001-1; Schuster P, 2011, COMPLEXITY, V17, P5, DOI 10.1002/cplx.20399; Severson WE, 2003, J VIROL, V77, P481, DOI 10.1128/JVI.77.1.481-488.2003; Sierra M, 2007, J VIROL, V81, P2012, DOI 10.1128/JVI.01606-06; Sierra S, 2000, J VIROL, V74, P8316, DOI 10.1128/JVI.74.18.8316-8323.2000; Sintchak MD, 1996, CELL, V85, P921, DOI 10.1016/S0092-8674(00)81275-1; Slavenburg S, 2011, THER DRUG MONIT, V33, P40, DOI 10.1097/FTD.0b013e318205f892; Snell N J, 2001, Expert Opin Pharmacother, V2, P1317, DOI 10.1517/14656566.2.8.1317; Sole RV, 2004, J THEOR BIOL, V228, P47, DOI 10.1016/j.jtbi.2003.08.018; Sookoian S, 2001, DIGEST DIS SCI, V46, P1067, DOI 10.1023/A:1010718213584; STREETER DG, 1973, P NATL ACAD SCI USA, V70, P1174, DOI 10.1073/pnas.70.4.1174; Suzuki A, 2013, BIOCHEM J, V449, P231, DOI 10.1042/BJ20121286; Takeuchi N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-15; Tapia N, 2005, VIROLOGY, V338, P1, DOI 10.1016/j.virol.2005.05.008; Team RC, 2012, R LANG ENV STAT COMP; Thomas Emmanuel, 2012, Antiviral Chemistry & Chemotherapy, V23, P1, DOI 10.3851/IMP2125; TOLTZIS P, 1988, ANTIMICROB AGENTS CH, V32, P492, DOI 10.1128/AAC.32.4.492; Vandamme A, 2000, EVALUATING CLIN ISOL; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Welker MW, 2009, HEPATOLOGY, V49, P665, DOI 10.1002/hep.22706; Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347; WRAY SK, 1985, ANTIVIR RES, V5, P39, DOI 10.1016/0166-3542(85)90013-0; Wyhe CS, 2012, PLOS COMPUT BIOL, V8; Ye L, 2012, VIRUS RES, V168, P33, DOI 10.1016/j.virusres.2012.06.009; Zagordi O, 2010, NUCLEIC ACIDS RES, V38, P7400, DOI 10.1093/nar/gkq655; Zhang YH, 2003, J VIROL, V77, P5933, DOI 10.1128/JVI.77.10.5933-5947.2003; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhou SF, 2003, VIROLOGY, V310, P333, DOI 10.1016/S0042-6822(03)00152-1; ZIMMERMAN TP, 1978, BIOCHEM PHARMACOL, V27, P709, DOI 10.1016/0006-2952(78)90508-7	155	48	50	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e71039	10.1371/journal.pone.0071039	http://dx.doi.org/10.1371/journal.pone.0071039			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23976977	gold, Green Published			2022-12-25	WOS:000323570200019
J	Leroy, MC; Perroud, J; Darbellay, B; Bernheim, L; Konig, S				Leroy, Marina C.; Perroud, Julie; Darbellay, Basile; Bernheim, Laurent; Konig, Stephane			Epidermal Growth Factor Receptor Down-Regulation Triggers Human Myoblast Differentiation	PLOS ONE			English	Article							RECTIFYING KIR2.1 CHANNELS; SKELETAL-MUSCLE; TERMINAL DIFFERENTIATION; POTASSIUM CURRENT; K+ CHANNELS; STEM-CELLS; GENISTEIN; ACTIVATION; EGFR; HYPERPOLARIZATION	Initiation of human myoblast differentiation requires a negative shift (hyperpolarization) of the resting potential of myoblasts that depends on the activation of Kir2.1 potassium channels. These channels are regulated by a tyrosine phosphorylation. Using human primary myoblast culture, we investigated a possible role of various receptor tyrosine kinases in the induction of the differentiation process. We found that Epidermal Growth Factor Receptor (EGFR) is a key regulator of myoblast differentiation. EGFR activity is down-regulated during early human myoblast differentiation, and this event is required for normal differentiation to take place. Furthermore, EGFR silencing in proliferation conditions was able to trigger the differentiation program. This occurs through an increase of Kir2.1 channel activity that, via a rise of store-operated Ca2+ entry, leads to the expression of myogenic transcription factors and muscle specific proteins (Myogenin, Myocyte Enhancer Factor 2 (MEF2), Myosin Heavy Chain (MyHC)). Finally, blocking myoblast cell cycle in proliferation conditions using a cdk4 inhibitor greatly decreased myoblast proliferation but was not able, on its own, to promote myoblast differentiation. Taken together, these results show that EGFR down-regulation is an early event that is required for the induction of myoblast differentiation.	[Leroy, Marina C.; Perroud, Julie; Bernheim, Laurent; Konig, Stephane] Ctr Med Univ Geneva, Dept Basic Neurosci, Geneva, Switzerland; [Darbellay, Basile] Univ Hosp Geneva, Dept Clin Neurosci, Geneva, Switzerland	University of Geneva; University of Geneva	Konig, S (corresponding author), Ctr Med Univ Geneva, Dept Basic Neurosci, Geneva, Switzerland.	Stephane.Konig@unige.ch	Darbellay, Basile/B-1708-2018	Koenig, Stephane/0000-0002-0801-279X	Fonds National Suisse de la Recherche Scientifique [310030-124910, 310030-141113]; Fondation Suisse de Recherche sur les Maladies Musculaires; Fondation Hans Wilsdorf; Fondation Marcel Levaillant	Fonds National Suisse de la Recherche Scientifique; Fondation Suisse de Recherche sur les Maladies Musculaires; Fondation Hans Wilsdorf; Fondation Marcel Levaillant	This work was supported by grants from the Fonds National Suisse de la Recherche Scientifique (310030-124910 and 310030-141113), Fondation Suisse de Recherche sur les Maladies Musculaires, Fondation Hans Wilsdorf, and Fondation Marcel Levaillant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2003, J BIOL CHEM, V278, P38360, DOI 10.1074/jbc.M306785200; ALLEN RE, 1989, J CELL PHYSIOL, V138, P311, DOI 10.1002/jcp.1041380213; Arnaudeau S, 2006, J CELL PHYSIOL, V208, P435, DOI 10.1002/jcp.20679; BAROFFIO A, 1993, MUSCLE NERVE, V16, P498, DOI 10.1002/mus.880160511; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Chiang CE, 2002, J BIOMED SCI, V9, P321, DOI 10.1007/BF02256587; CLEGG CH, 1987, J CELL BIOL, V105, P949, DOI 10.1083/jcb.105.2.949; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; Darbellay B, 2009, J BIOL CHEM, V284, P5370, DOI 10.1074/jbc.M806726200; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; Dorman CM, 1999, ONCOGENE, V18, P5167, DOI 10.1038/sj.onc.1202907; Fischer-Lougheed J, 2001, J CELL BIOL, V153, P677, DOI 10.1083/jcb.153.4.677; Gao Z, 2004, CELL SIGNAL, V16, P333, DOI 10.1016/j.cellsig.2003.08.003; Ge X, 2013, MOL CELL ENDOCRINOL; Golding JP, 2007, EXP CELL RES, V313, P341, DOI 10.1016/j.yexcr.2006.10.019; Grass B, 2009, HISTOPATHOLOGY, V54, P873, DOI 10.1111/j.1365-2559.2009.03303.x; Gredinger E, 1998, J BIOL CHEM, V273, P10436, DOI 10.1074/jbc.273.17.10436; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; Hinard V, 2008, DEVELOPMENT, V135, P859, DOI 10.1242/dev.011387; Horikawa M, 1999, FEBS LETT, V459, P100, DOI 10.1016/S0014-5793(99)01213-2; Hung LY, 2008, NUCLEIC ACIDS RES, V36, P4337, DOI 10.1093/nar/gkn417; Karalaki M, 2009, IN VIVO, V23, P779; Kleiman LB, 2011, MOL CELL, V43, P723, DOI 10.1016/j.molcel.2011.07.014; Konig S, 2004, J BIOL CHEM, V279, P28187, DOI 10.1074/jbc.M313932200; Leloup L, 2007, INT J BIOCHEM CELL B, V39, P1177, DOI 10.1016/j.biocel.2007.03.003; Li J, 2006, BIOCHEM BIOPH RES CO, V345, P1425, DOI 10.1016/j.bbrc.2006.05.051; Liu JH, 1998, J PHYSIOL-LONDON, V510, P467, DOI 10.1111/j.1469-7793.1998.467bk.x; Liu P, 2007, BIOPHYS J, V93, P684, DOI 10.1529/biophysj.106.102087; LUETTEKE NC, 1993, CELL GROWTH DIFFER, V4, P203; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; NADALGINARD B, 1978, CELL, V15, P855, DOI 10.1016/0092-8674(78)90270-2; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Okamoto F, 2001, JPN J PHYSIOL, V51, P501, DOI 10.2170/jjphysiol.51.501; OLWIN BB, 1988, J CELL BIOL, V107, P761, DOI 10.1083/jcb.107.2.761; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Schneider MR, 2009, J CELL PHYSIOL, V218, P460, DOI 10.1002/jcp.21635; Sun Y, 2007, AM J PHYSIOL-CELL PH, V292, pC106, DOI 10.1152/ajpcell.00209.2006; Sweeney C, 2004, BRIT J CANCER, V90, P289, DOI 10.1038/sj.bjc.6601500; Wachtel M, 2006, J CLIN ONCOL, V24, P816, DOI 10.1200/JCO.2005.03.4934; Wells A, 1999, INT J BIOCHEM CELL B, V31, P637, DOI 10.1016/S1357-2725(99)00015-1; Wischmeyer E, 1998, J BIOL CHEM, V273, P34063, DOI 10.1074/jbc.273.51.34063; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; Zhang DY, 2011, BBA-BIOMEMBRANES, V1808, P1993, DOI 10.1016/j.bbamem.2011.04.015; Zhao ZY, 2008, PFLUG ARCH EUR J PHY, V456, P413, DOI 10.1007/s00424-007-0391-3	45	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71770	10.1371/journal.pone.0071770	http://dx.doi.org/10.1371/journal.pone.0071770			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967242	Green Published, Green Submitted, gold			2022-12-25	WOS:000323378000068
J	Zhao, BX; Sun, YB; Wang, SQ; Duan, L; Huo, QL; Ren, F; Li, GF				Zhao, Bo-xin; Sun, Ya-bin; Wang, Sheng-qi; Duan, Lian; Huo, Qi-lu; Ren, Fei; Li, Guo-feng			Grape Seed Procyanidin Reversal of P-glycoprotein Associated Multi-Drug Resistance via Down-regulation of NF-kappa B and MAPK/ERK Mediated YB-1 Activity in A2780/T Cells	PLOS ONE			English	Article							MDR1 GENE-EXPRESSION; PHOSPHOINOSITIDE 3-KINASE; NUCLEAR EXPRESSION; DRUG-RESISTANCE; CANCER; INDUCTION; 2-ACETYLAMINOFLUORENE; INHIBITION; ACTIVATION; MODULATORS	The expression and function of P-glycoprotein (P-gp) is associated with the phenotype of multi-drug resistance (MDR), leading chemotherapy failure of patients suffered with cancer. Grape seed procyanidin(GSP) is a natural polyphenol supplement with anti-inflammatory effect. Present study assessed a new use of GSP on the MDR reversal activity and its possible molecular mechanisms in MDR1-overpressing paclitaxel resistant ovarian cancer cells. Our results showed GSP significantly enhanced the cytotoxicity of paclitaxel and adriamycin in paclitaxel resistant A2780/T cells but its parental A2780 cells. Furthermore, GSP strongly inhibited P-gp expression by blocking MDR1 gene transcription, as well as, increased the intracellular accumulation of the P-gp substrate rhodamine-123 in A2780/T cells. Nuclear factor-kappa B(NF-kappa B) activity, I kappa B degradation level and NF-kappa B/p65 nuclear translocation induced by lipopolysaccharide (LPS) and receptor activator for nuclear factor-kappa B ligand (RANKL) were markedly inhibited by pre-treatment with GSP. Meanwhile, GSP inhibited MAPK/ERK pathway by decreasing the phosphorylation of ERK1/2, resulting in reduced the Y-box binding protein 1 (YB-1) activation with blocking its nuclear translocation. Moreover, the up-regulation of P-gp expression, the activation of AKT/NF-kappa B and MAPK/ERK pathway induced by LPS was attenuated by GSP administration. Compared with PDTC and U1026, inhibitor of NF-kappa B and MAPK/ERK respectively, GSP showed the same tendency of down-regulating NF-kappa B and MAPK/ERK mediated YB-1 activities. Thus, GSP reverses P-gp associated MDR by inhibiting the function and expression of P-gp through down-regulation of NF-kappa B activity and MAPK/ERK pathway mediated YB-1 nuclear translocation, offering insight into the mechanism of reversing MDR by natural polyphenol supplement compounds. GSP could be a new potential MDR reversal agent used for combination therapy with chemotherapeutics in clinic.	[Zhao, Bo-xin; Wang, Sheng-qi; Duan, Lian; Huo, Qi-lu; Ren, Fei; Li, Guo-feng] Southern Med Univ, Nanfang Hosp, Dept Pharm, Guangzhou, Guangdong, Peoples R China; [Sun, Ya-bin] Southern Med Univ, Nanfang Hosp, GCP Off, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Li, GF (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Pharm, Guangzhou, Guangdong, Peoples R China.	liguofeng_2010@126.com			NSFC [81073061]; Science and Technology Planning Project of Guangdong Province [2010B0370700014]; Presidential Foundation of Nanfang Hospital [2012B012, 2012C028]	NSFC(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province; Presidential Foundation of Nanfang Hospital	This work was supported by the Grants from NSFC (No. 81073061), Science and Technology Planning Project of Guangdong Province (No. 2010B0370700014) and the Presidential Foundation of Nanfang Hospital (No. 2012B012 and 2012C028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aini H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037728; Ashkenazi A, 1998, ONCOGENE, V281, P1305; Cai Q, 2011, BIOSCI BIOTECH BIOCH, V75, P1692, DOI 10.1271/bbb.110194; Chan KF, 2009, CHEMMEDCHEM, V4, P594, DOI 10.1002/cmdc.200800413; Chattopadhyay R, 2008, MOL CELL BIOL, V28, P7066, DOI 10.1128/MCB.00244-08; Chen YK, 2012, BIOCHEM PHARMACOL, V83, P1112, DOI 10.1016/j.bcp.2012.01.030; Coles LS, 2005, FEBS LETT, V579, P5372, DOI 10.1016/j.febslet.2005.08.075; D'Andrea G, 2010, FITOTERAPIA, V81, P724, DOI 10.1016/j.fitote.2010.06.011; Deng L, 2001, J BIOL CHEM, V276, P413, DOI 10.1074/jbc.M004551200; Fantappie O, 2002, HEPATOLOGY, V35, P843, DOI 10.1053/jhep.2002.32469; Gimenez-Bonafe P, 2004, PROSTATE, V59, P337, DOI 10.1002/pros.20023; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; He L, 2009, PHYTOTHER RES, V23, P933, DOI 10.1002/ptr.2781; Huang X, 2004, GYNECOL ONCOL, V93, P287, DOI 10.1016/j.ygyno.2004.01.040; Johnstone RW, 2000, TRENDS BIOCHEM SCI, V25, P1, DOI 10.1016/S0968-0004(99)01493-0; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Kanagasabai R, 2011, J BIOL CHEM, V286, P33289, DOI 10.1074/jbc.M111.249102; Kelly RJ, 2011, CLIN CANCER RES, V17, P569, DOI 10.1158/1078-0432.CCR-10-1725; Krishna R, 2000, EUR J PHARM SCI, V11, P265, DOI 10.1016/S0928-0987(00)00114-7; Kuo MT, 2002, ONCOGENE, V21, P1945, DOI 10.1038/sj.onc.1205117; Lamba J, 2006, CLIN PHARMACOL THER, V79, P325, DOI 10.1016/j.clpt.2005.11.013; Li ZM, 2010, GYNECOL ONCOL, V119, P125, DOI 10.1016/j.ygyno.2010.06.004; Maimoona A, 2011, J ETHNOPHARMACOL, V133, P261, DOI 10.1016/j.jep.2010.10.041; Misra S, 2005, J BIOL CHEM, V280, P20310, DOI 10.1074/jbc.M500737200; Molnar J, 2010, CURR TOP MED CHEM, V10, P1757; O'Neill AJ, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-126; Oda Y, 1998, CLIN CANCER RES, V4, P2273; Perez-Tomas R, 2006, CURR MED CHEM, V13, P1859, DOI 10.2174/092986706777585077; Ramos S, 2011, TOXICOL IN VITRO, V25, P1771, DOI 10.1016/j.tiv.2011.09.007; Ren F, 2011, PHARM RES-DORDR, V28, P897, DOI 10.1007/s11095-010-0346-9; Saji H, 2003, CANCER LETT, V190, P191, DOI 10.1016/S0304-3835(02)00590-6; Sarver JG, 2002, J BIOMOL SCREEN, V7, P29, DOI 10.1089/108705702753520314; Shen HL, 2011, EXP HEMATOL, V39, P558, DOI 10.1016/j.exphem.2011.01.013; Shi Z, 2006, CANCER BIOL THER, V5, P39, DOI 10.4161/cbt.5.1.2236; TOFFOLI G, 1995, BIOCHEM PHARMACOL, V50, P1245, DOI 10.1016/0006-2952(95)02003-U; TWENTYMAN PR, 1988, BRIT J CANCER, V57, P254, DOI 10.1038/bjc.1988.55; Vayalil PK, 2004, CARCINOGENESIS, V25, P987, DOI 10.1093/carcin/bgh095; Yang HY, 2012, MOL CARCINOGEN, V51, P185, DOI 10.1002/mc.20789; Yang JM, 2003, MOL CANCER RES, V1, P420; Yang JM, 2011, MOL PHARM, V60, P674; Zhang HY, 2012, J CANCER RES THER, V8, P226, DOI 10.4103/0973-1482.98975; Zhou G, 1997, J BIOL CHEM, V272, P15174, DOI 10.1074/jbc.272.24.15174	43	69	79	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71071	10.1371/journal.pone.0071071	http://dx.doi.org/10.1371/journal.pone.0071071			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967153	gold, Green Published, Green Submitted			2022-12-25	WOS:000323378000030
J	Bhullar, J; Natarajan, K; Shukla, S; Mathias, TJ; Sadowska, M; Ambudkar, SV; Baer, MR				Bhullar, Jasjeet; Natarajan, Karthika; Shukla, Suneet; Mathias, Trevor J.; Sadowska, Mariola; Ambudkar, Suresh V.; Baer, Maria R.			The FLT3 Inhibitor Quizartinib Inhibits ABCG2 at Pharmacologically Relevant Concentrations, with Implications for Both Chemosensitization and Adverse Drug Interactions	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; CANCER RESISTANCE PROTEIN; TYROSINE KINASE INHIBITORS; HUMAN P-GLYCOPROTEIN; CATALYTIC CYCLE; ATP HYDROLYSIS; GROUP-B; TRANSPORTER; CELLS; MITOXANTRONE	The oral second-generation bis-aryl urea fms-like tyrosine kinase 3 (FLT3) inhibitor quizartinib (AC220) has favorable kinase selectivity and pharmacokinetics. It inhibits mutant and wild-type FLT3 in vivo at 0.1 and 0.5 mu M, respectively, and has shown favorable activity and tolerability in phase I and II trials in acute myeloid leukemia, with QT prolongation as the dose-limiting toxicity. Co-administration with chemotherapy is planned. We characterized interactions of quizartinib with the ATP-binding cassette (ABC) proteins ABCB1 (P-glycoprotein) and ABCG2 (breast cancer resistance protein). Its effects on uptake of fluorescent substrates and apoptosis were measured by flow cytometry, binding to ABCB1 and ABCG2 drug-binding sites by effects on [I-125] iodoarylazidoprazosin ([I-125]-IAAP) photolabeling and ATPase activity, and cell viability by the WST-1 colorimetric assay. Quizartinib inhibited transport of fluorescent ABCG2 and ABCB1 substrates in ABCG2- and ABCB1-overexpressing cells in a concentration-dependent manner, from 0.1 to 5 mu M and from 0.5 to 10 mu M, respectively, and inhibited [I-125]-IAAP photolabeling of ABCG2 and ABCB1 with IC50 values of 0.07 and 3.3 mu M, respectively. Quizartinib at higher concentrations decreased ABCG2, but not ABCB1, ATPase activity. Co-incubation with quizartinib at 0.1 to 1 mu M sensitized ABCG2-overexpressing K562/ABCG2 and 8226/MR20 cells to ABCG2 substrate chemotherapy drugs in a concentration-dependent manner in cell viability and apoptosis assays. Additionally, quizartinib increased cellular uptake of the ABCG2 substrate fluoroquinolone antibiotic ciprofloxacin, which also prolongs the QT interval, in a concentration-dependent manner, predicting altered ciprofloxacin pharmacokinetics and pharmacodynamics when co-administered with quizartinib. Thus quizartinib inhibits ABCG2 at pharmacologically relevant concentrations, with implications for both chemosensitization and adverse drug interactions. These interactions should be considered in the design of treatment regimens combining quizartinib and chemotherapy drugs and in choice of concomitant medications to be administered with quizartinib.	[Bhullar, Jasjeet; Natarajan, Karthika; Mathias, Trevor J.; Sadowska, Mariola; Baer, Maria R.] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Shukla, Suneet; Ambudkar, Suresh V.] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Baer, Maria R.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland Baltimore	Baer, MR (corresponding author), Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA.	mbaer@umm.edu	Ambudkar, Suresh V/L-1317-2016; Natarajan, Karthika/G-7206-2012	Natarajan, Karthika/0000-0001-7435-1477	Leukemia and Lymphoma Society Translational Research Award; University of Maryland, Baltimore UMMG Cancer Research Grant [CH 649 CRF]; State of Maryland Department of Health and Mental Hygiene (DHMH) under the Cigarette Restitution Fund Program; NCI Cancer Center Support Grant [P30 CA134274]; NIH, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [P30CA134274] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society Translational Research Award(Leukemia and Lymphoma Society); University of Maryland, Baltimore UMMG Cancer Research Grant; State of Maryland Department of Health and Mental Hygiene (DHMH) under the Cigarette Restitution Fund Program; NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Leukemia and Lymphoma Society Translational Research Award (MRB), University of Maryland, Baltimore UMMG Cancer Research Grant #CH 649 CRF issued by the State of Maryland Department of Health and Mental Hygiene (DHMH) under the Cigarette Restitution Fund Program, NCI Cancer Center Support Grant P30 CA134274, and the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research (SS, SVA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Ambudkar SV, 1998, METHOD ENZYMOL, V292, P504; Baer MR, 2002, BLOOD, V100, P1224, DOI 10.1182/blood.V100.4.1224.h81602001224_1224_1232; Benderra Z, 2004, CLIN CANCER RES, V10, P7896, DOI 10.1158/1078-0432.CCR-04-0795; Brozik A, 2011, EXPERT OPIN DRUG MET, V7, P623, DOI 10.1517/17425255.2011.562892; Burnett AK, 2010, J CLIN ONCOL, V28, P2389, DOI 10.1200/JCO.2009.26.4242; Carow CE, 1996, BLOOD, V87, P1089, DOI 10.1182/blood.V87.3.1089.bloodjournal8731089; Cripe LD, 2010, BLOOD, V116, P4077, DOI 10.1182/blood-2010-04-277269; Damiani D, 2006, HAEMATOLOGICA, V91, P825; de Wolf C, 2008, MOL CANCER THER, V7, P3092, DOI 10.1158/1535-7163.MCT-08-0427; Deininger MW, 2012, BLOOD, V120, DOI 10.1182/blood.V120.21.3743.3743; Dietrich CG, 2003, GUT, V52, P1788, DOI 10.1136/gut.52.12.1788; Fathi AT, 2011, ONCOLOGIST, V16, P1162, DOI 10.1634/theoncologist.2011-0084; Frohling S, 2002, BLOOD, V100, P4372, DOI 10.1182/blood-2002-05-1440; Greenberg PL, 2004, J CLIN ONCOL, V22, P1078, DOI 10.1200/JCO.2004.07.048; Hafkemeyer P, 2000, HUM GENE THER, V11, P555, DOI 10.1089/10430340050015743; Hazlehurst LA, 1999, CANCER RES, V59, P1021; Hegedus C, 2009, BRIT J PHARMACOL, V158, P1153, DOI 10.1111/j.1476-5381.2009.00383.x; Holowiecki J, 2012, J CLIN ONCOL, V30, P2441, DOI 10.1200/JCO.2011.37.1286; Hunter HM, 2004, BRIT J HAEMATOL, V127, P26, DOI 10.1111/j.1365-2141.2004.05145.x; James J, 2008, BLOOD, V112, P912; Karp JE, 2012, HAEMATOL-HEMATOL J, V97, P1736, DOI 10.3324/haematol.2012.062539; Kerr KM, 2001, J BIOL CHEM, V276, P8657, DOI 10.1074/jbc.M010044200; Kolitz JE, 2010, BLOOD, V116, P1413, DOI 10.1182/blood-2009-07-229492; Kottaridis PD, 2001, BLOOD, V98, P1752, DOI 10.1182/blood.V98.6.1752; Lagas JS, 2010, MOL CANCER THER, V9, P319, DOI 10.1158/1535-7163.MCT-09-0663; Levis M, 2011, BLOOD, V117, P3294, DOI 10.1182/blood-2010-08-301796; Loo KC, 1997, J LEUKOCYTE BIOL, V61, P619, DOI 10.1002/jlb.61.5.619; Mahadevan D, 2004, BLOOD, V104, P1940, DOI 10.1182/blood-2003-07-2490; Merino G, 2006, DRUG METAB DISPOS, V34, P690, DOI 10.1124/dmd.105.008219; Minderman H, 2004, CLIN CANCER RES, V10, P1826, DOI 10.1158/1078-0432.CCR-0914-3; Natarajan K, 2012, BIOCHEM PHARMACOL, V83, P1084, DOI 10.1016/j.bcp.2012.01.002; Ogretmen B, 2000, BIOCHEMISTRY-US, V39, P194, DOI 10.1021/bi991943f; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Pemmaraju N, 2012, BLOOD, V120, DOI 10.1182/blood.V120.21.2845.2845; Pluchino KM, 2012, DRUG RESIST UPDATE, V15, P98, DOI 10.1016/j.drup.2012.03.002; Pratz KW, 2010, CURR DRUG TARGETS, V11, P781; Prebet T, 2012, LEUKEMIA LYMPHOMA, V53, P2186, DOI 10.3109/10428194.2012.685733; Price SL, 2011, LEUKEMIA RES, V35, P301, DOI 10.1016/j.leukres.2010.09.002; Qadir M, 2005, CLIN CANCER RES, V11, P2320, DOI 10.1158/1078-0432.CCR-04-1725; Raaijmakers MHGP, 2006, CLIN CANCER RES, V12, P3452, DOI 10.1158/1078-0432.CCR-05-1945; Raaijmakers MHGP, 2005, CLIN CANCER RES, V11, P2436, DOI 10.1158/1078-0432.CCR-04-0212; Ramachandra M, 1998, BIOCHEMISTRY-US, V37, P5010, DOI 10.1021/bi973045u; Ravandi F, 2012, BLOOD, V120; Robey RW, 2007, MOL CANCER THER, V6, P1877, DOI 10.1158/1535-7163.MCT-06-0811; Robey RW, 2001, CLIN CANCER RES, V7, P145; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; Rosnet O, 1996, LEUKEMIA, V10, P238; Sarkadi B, 2006, PHYSIOL REV, V86, P1179, DOI 10.1152/physrev.00037.2005; Sauna ZE, 2000, P NATL ACAD SCI USA, V97, P2515, DOI 10.1073/pnas.97.6.2515; Scheffer GL, 2000, CANCER RES, V60, P2589; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Schnittger S, 2002, BLOOD, V100, P59, DOI 10.1182/blood.V100.1.59; Sen R, 2012, MOL CANCER THER, V11, P2033, DOI 10.1158/1535-7163.MCT-12-0302; Shukla S, 2006, BIOCHEMISTRY-US, V45, P8940, DOI 10.1021/bi060552f; Shukla S, 2012, DRUG RESIST UPDATE, V15, P70, DOI 10.1016/j.drup.2012.01.005; Shukla S, 2009, DRUG METAB DISPOS, V37, P359, DOI 10.1124/dmd.108.024612; Suvannasankha A, 2004, LEUKEMIA, V18, P1252, DOI 10.1038/sj.leu.2403395; Swords R, 2012, LEUKEMIA, V26, P2176, DOI 10.1038/leu.2012.114; Tiribelli M, 2011, CANCER-AM CANCER SOC, V117, P2156, DOI 10.1002/cncr.25753; van der Holt B, 2005, BLOOD, V106, P2646, DOI 10.1182/blood-2005-04-1395; Woodward OM, 2009, P NATL ACAD SCI USA, V106, P10338, DOI 10.1073/pnas.0901249106; Wu CP, 2007, MOL CANCER THER, V6, P3287, DOI 10.1158/1535-7163.MCT-07-2005; Yanase K, 2004, MOL CANCER THER, V3, P1119; Yang Johnny J, 2010, Drug Metab Lett, V4, P201; YOUNG IT, 1977, J HISTOCHEM CYTOCHEM, V25, P935, DOI 10.1177/25.7.894009; Zarrinkar PP, 2009, BLOOD, V114, P2984, DOI 10.1182/blood-2009-05-222034; Zheng R, 2004, BLOOD, V103, P267, DOI 10.1182/blood-2003-06-1969; Zhou SF, 2008, XENOBIOTICA, V38, P802, DOI 10.1080/00498250701867889 	69	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71266	10.1371/journal.pone.0071266	http://dx.doi.org/10.1371/journal.pone.0071266			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967177	Green Submitted, Green Published, gold			2022-12-25	WOS:000323221500065
J	Burns, JHR; Gregg, TM; Takabayashi, M				Burns, John Henrik Robert; Gregg, Toni Makani; Takabayashi, Misaki			Does Coral Disease Affect Symbiodinium? Investigating the Impacts of Growth Anomaly on Symbiont Photophysiology	PLOS ONE			English	Article							CHLOROPHYLL FLUORESCENCE; SPATIAL HETEROGENEITY; THERMAL TOLERANCE; LIGHT-ABSORPTION; REEF CORALS; DIVERSITY; ZOOXANTHELLAE; MORPHOLOGY; SCATTERING; EFFICIENCY	Growth anomaly (GA) is a commonly observed coral disease that impairs biological functions of the affected tissue. GA is prevalent at Wai 'opae tide pools, southeast Hawai 'i Island. Here two distinct forms of this disease, Type A and Type B, affect the coral, Montipora capitata. While the effects of GA on biology and ecology of the coral host are beginning to be understood, the impact of this disease on the photophysiology of the dinoflagellate symbiont, Symbiodinium spp., has not been investigated. The GA clearly alters coral tissue structure and skeletal morphology and density. These tissue and skeletal changes are likely to modify not only the light micro-environment of the coral tissue, which has a direct impact on the photosynthetic potential of Symbiodinium spp., but also the physiological interactions within the symbiosis. This study utilized Pulse amplitude modulation fluorometry (PAM) to characterize the photophysiology of healthy and GA-affected M. capitata tissue. Overall, endosymbionts within GA-affected tissue exhibit reduced photochemical efficiency. Values of both F-v/F-m and Delta F/F-m' were significantly lower (p<0.01) in GA tissue compared to healthy and unaffected tissues. Tracking the photophysiology of symbionts over a diurnal time period enabled a comparison of symbiont responses to photosynthetically available radiation (PAR) among tissue conditions. Symbionts within GA tissue exhibited the lowest values of Delta F/F-m' as well as the highest pressure over photosystem II (p<0.01). This study provides evidence that the symbionts within GA-affected tissue are photochemically compromised compared to those residing in healthy tissue.	[Burns, John Henrik Robert; Gregg, Toni Makani] Univ Hawaii, Hilo, HI 96720 USA; [Takabayashi, Misaki] Univ Hawaii, Dept Marine Sci, Hilo, HI 96720 USA	University of Hawaii System; University Hawaii Hilo; University of Hawaii System; University Hawaii Hilo	Burns, JHR (corresponding author), Univ Hawaii, Hilo, HI 96720 USA.	johnhr@hawaii.edu			National Oceanic and Atmospheric Administration [R/HE-4]; University of Hawaii Sea Grant College Program, SOEST from NOAA Office of Sea Grant, Department of Commerce [NA09OAR4170060]; National Science Foundation Center for Research Excellence in Science and Technology [0833211]	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); University of Hawaii Sea Grant College Program, SOEST from NOAA Office of Sea Grant, Department of Commerce; National Science Foundation Center for Research Excellence in Science and Technology	This research was funded, in part, by a grant from the National Oceanic and Atmospheric Administration, Project R/HE-4, which is sponsored by the University of Hawaii Sea Grant College Program, SOEST, under Institutional Grant No. NA09OAR4170060 from NOAA Office of Sea Grant, Department of Commerce. The views expressed herein are those of the author(s) and do not necessarily reflect the views of NOAA or any of its subagencies, UNIHI-SEAGRANT-JC-08-35. This research was also funded, in part, by National Science Foundation Center for Research Excellence in Science and Technology Grant No. 0833211 to MT for the Center in Tropical Ecology and Evolution in Marine and Terrestrial Environments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeby GS, 2004, S 2 4 NOV; [Anonymous], 2005, STATE CORAL REEF ECO; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Beer S, 1998, MAR BIOL, V131, P607, DOI 10.1007/s002270050352; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Bruno JF, 2003, ECOL LETT, V6, P1056, DOI 10.1046/j.1461-0248.2003.00544.x; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Burns JHR, 2011, CORAL REEFS, V30, P819, DOI 10.1007/s00338-011-0761-3; Burns JHR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028854; Cervino JM, 2004, SYMBIOSIS, V37, P63; Domart-Coulon IJ, 2006, CORAL REEFS, V25, P531, DOI 10.1007/s00338-006-0133-6; Dorland WAN, 2006, DORLANDS ILLUSTRATED; Edmunds PJ, 2004, BIOL BULL-US, V206, P61, DOI 10.2307/1543536; Enriquez S, 2005, MAR ECOL PROG SER, V289, P141, DOI 10.3354/meps289141; Enriquez S, 2005, LIMNOL OCEANOGR, V50, P1025, DOI 10.4319/lo.2005.50.4.1025; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; Gateno D, 2003, MAR ECOL PROG SER, V258, P97, DOI 10.3354/meps258097; Goreau TJ, 1998, REV BIOL TROP, V46, P157; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell CD, 2007, OCEANOGRAPHY, V20, P58; HATCHER BG, 1988, TRENDS ECOL EVOL, V3, P106, DOI 10.1016/0169-5347(88)90117-6; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Iglesias-Prieto R, 2004, P ROY SOC B-BIOL SCI, V271, P1757, DOI 10.1098/rspb.2004.2757; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; Jones R, 2004, BEE WORLD, V85, P63; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Jones RJ, 2000, MAR FRESHWATER RES, V51, P63, DOI 10.1071/MF99100; Kaczmarsky L, 2007, J INVERTEBR PATHOL, V94, P218, DOI 10.1016/j.jip.2006.11.007; Kaczmarsky LT, 2006, DIS AQUAT ORGAN, V69, P9, DOI 10.3354/dao069009; Knowlton N, 2003, AM NAT, V162, pS51, DOI 10.1086/378684; Kuntz NM, 2005, MAR ECOL PROG SER, V294, P173, DOI 10.3354/meps294173; Marcelino LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061492; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; MUSCATINE L, 1977, BIOSCIENCE, V27, P454, DOI 10.2307/1297526; Olson ND, 2009, J EXP MAR BIOL ECOL, V371, P140, DOI 10.1016/j.jembe.2009.01.012; PETERS EC, 1986, JNCI-J NATL CANCER I, V76, P895; Peters EC, 1997, DIS CORAL REEF ORGAN, P114; Ralph PJ, 2002, MAR BIOL, V141, P639, DOI 10.1007/s00227-002-0866-x; Richardson LL, 1998, TRENDS ECOL EVOL, V13, P438, DOI 10.1016/S0169-5347(98)01460-8; Roff G, 2008, CORAL REEFS, V27, P373, DOI 10.1007/s00338-007-0339-2; Roff G, 2008, J PHYCOL, V44, P526, DOI 10.1111/j.1529-8817.2008.00480.x; Rohwer F, 2001, CORAL REEFS, V20, P85; Rosenberg E, 2002, ENVIRON MICROBIOL, V4, P318, DOI 10.1046/j.1462-2920.2002.00302.x; Stat M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015854; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Takabayashi M, 2012, CORAL REEFS, V31, P157, DOI 10.1007/s00338-011-0832-5; Takabayashi M., 2010, P 11 INT COR REEF S, V18, P820; Teran E, 2010, APPL OPTICS, V49, P5032, DOI 10.1364/AO.49.005032; TRENCH RK, 1993, ENDOCYTOBIOSIS CELL, V9, P135; Weil E, 2006, DIS AQUAT ORGAN, V69, P1, DOI 10.3354/dao069001; Willis BL, 2004, CORAL HEALTH AND DISEASE, P69; Work TM, 2008, DIS AQUAT ORGAN, V78, P255, DOI 10.3354/dao01881; Work TM, 2006, DIS AQUAT ORGAN, V70, P155, DOI 10.3354/dao070155; Work TM, 2002, AM SAMOA REEF HLTH S; Yamashiro H, 2001, J EXP MAR BIOL ECOL, V265, P171, DOI 10.1016/S0022-0981(01)00333-1	56	20	21	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e72466	10.1371/journal.pone.0072466	http://dx.doi.org/10.1371/journal.pone.0072466			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967301	Green Published, Green Submitted, gold			2022-12-25	WOS:000323221500131
J	Vitzel, KF; Bikopoulos, G; Hung, S; Curi, R; Ceddia, RB				Vitzel, Kaio F.; Bikopoulos, George; Hung, Steven; Curi, Rui; Ceddia, Rolando B.			Loss of the Anorexic Response to Systemic 5-Aminoimidazole-4-Carboxamide-1-beta-D-Ribofuranoside Administration Despite Reducing Hypothalamic AMP-Activated Protein Kinase Phosphorylation in Insulin-Deficient Rats	PLOS ONE			English	Article							DIET-INDUCED OBESITY; ENHANCED LEPTIN SENSITIVITY; FOOD-INTAKE; ENERGY HOMEOSTASIS; SKELETAL-MUSCLE; MALONYL-COA; RESISTANCE; MECHANISMS; SOCS3; METABOLISM	This study tested whether chronic systemic administration of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR) could attenuate hyperphagia, reduce lean and fat mass losses, and improve whole-body energy homeostasis in insulin-deficient rats. Male Wistar rats were first rendered diabetic through streptozotocin (STZ) administration and then intraperitoneally injected with AICAR for 7 consecutive days. Food and water intake, ambulatory activity, and energy expenditure were assessed at the end of the AICAR-treatment period. Blood was collected for circulating leptin measurement and the hypothalami were extracted for the determination of suppressor of cytokine signaling 3 (SOCS3) content, as well as the content and phosphorylation of AMP-kinase (AMPK), acetyl-CoA carboxylase (ACC), and the signal transducer and activator of transcription 3 (STAT3). Rats were thoroughly dissected for adiposity and lean body mass (LBM) determinations. In non-diabetic rats, despite reducing adiposity, AICAR increased (similar to 1.7-fold) circulating leptin and reduced hypothalamic SOCS3 content and food intake by 67% and 25%, respectively. The anorexic effect of AICAR was lost in diabetic rats, even though hypothalamic AMPK and ACC phosphorylation markedly decreased in these animals. Importantly, hypothalamic SOCS3 and STAT3 levels remained elevated and reduced, respectively, after treatment of insulin-deficient rats with AICAR. Diabetic rats were lethargic and displayed marked losses of fat and LBM. AICAR treatment increased ambulatory activity and whole-body energy expenditure while also attenuating diabetes-induced fat and LBM losses. In conclusion, AICAR did not reverse hyperphagia, but it promoted anti-catabolic effects on skeletal muscle and fat, enhanced spontaneous physical activity, and improved the ability of rats to cope with the diabetes-induced dysfunctional alterations in glucose metabolism and whole-body energy homeostasis.	[Bikopoulos, George; Hung, Steven; Ceddia, Rolando B.] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada; [Vitzel, Kaio F.; Curi, Rui] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, SP, Brazil	York University - Canada; Universidade de Sao Paulo	Ceddia, RB (corresponding author), York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada.	roceddia@yorku.ca	Curi, Rui/C-9351-2012		Natural Science and Engineering Research Council of Canada (NSERC); Canada Foundation for Innovation (CFI); Ontario Research Fund (ORF); Canadian Institutes of Health Research (CIHR); Ontario Ministry of Research and Innovation; Brazilian National Research Funding Institution CAPES/PDE	Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Ontario Research Fund (ORF); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Brazilian National Research Funding Institution CAPES/PDE	This research was funded by a Discovery Grant from the Natural Science and Engineering Research Council of Canada (NSERC) and by infrastructure grants from the Canada Foundation for Innovation (CFI) and the Ontario Research Fund (ORF) awarded to RBC. RBC is also a recipient of the Canadian Institutes of Health Research (CIHR) New Investigator Award and the Early Research Award from the Ontario Ministry of Research and Innovation. KFV was supported by a Doctoral Student Research Award from the Brazilian National Research Funding Institution CAPES/PDE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo RL, 2010, ENDOCRINOLOGY, V151, P3460, DOI 10.1210/en.2010-0026; ARIANO MA, 1973, J HISTOCHEM CYTOCHEM, V21, P51, DOI 10.1177/21.1.51; Aschenbach WG, 2002, DIABETES, V51, P567, DOI 10.2337/diabetes.51.3.567; Buhl ES, 2002, DIABETES, V51, P2199, DOI 10.2337/diabetes.51.7.2199; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Frayn K., 2003, METABOLIC REGULATION; Gaidhu MP, 2011, J LIPID RES, V52, P1702, DOI 10.1194/jlr.M015354; Gan MJ, 2012, CURR PROB PEDIATR AD, V42, P269, DOI 10.1016/j.cppeds.2012.07.002; Gao S, 2007, P NATL ACAD SCI USA, V104, P17358, DOI 10.1073/pnas.0708385104; Goodman CA, 2011, CELL SIGNAL, V23, P1896, DOI 10.1016/j.cellsig.2011.07.013; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Holmes BF, 1999, J APPL PHYSIOL, V87, P1990, DOI 10.1152/jappl.1999.87.5.1990; Howard JK, 2004, NAT MED, V10, P734, DOI 10.1038/nm1072; Hu ZY, 2005, J BIOL CHEM, V280, P39681, DOI 10.1074/jbc.C500398200; Hu ZY, 2003, P NATL ACAD SCI USA, V100, P12624, DOI 10.1073/pnas.1834402100; Hunter RW, 2011, DIABETES, V60, P766, DOI 10.2337/db10-1148; Kievit P, 2006, CELL METAB, V4, P123, DOI 10.1016/j.cmet.2006.06.010; Kohno D, 2011, NEUROSCI LETT, V499, P194, DOI 10.1016/j.neulet.2011.05.060; Levin BE, 1997, AM J PHYSIOL-REG I, V273, pR725, DOI 10.1152/ajpregu.1997.273.2.R725; Matarazzo V, 2012, J NEUROSCI, V32, P17097, DOI 10.1523/JNEUROSCI.1669-12.2012; Mehanna A, 2013, FUTURE MED CHEM, V5, P411, DOI [10.4155/FMC.13.13, 10.4155/fmc.13.13]; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071; NESHER R, 1980, AM J PHYSIOL, V239, pE454, DOI 10.1152/ajpendo.1980.239.6.E454; Pimentel GD, 2013, METABOLISM, V62, P171, DOI 10.1016/j.metabol.2012.07.001; Pold R, 2005, DIABETES, V54, P928, DOI 10.2337/diabetes.54.4.928; Reed AS, 2010, DIABETES, V59, P894, DOI 10.2337/db09-1024; Sanchez AMJ, 2012, AM J PHYSIOL-CELL PH, V303, pC475, DOI 10.1152/ajpcell.00125.2012; Stevanovic D, 2012, NEUROENDOCRINOLOGY, V96, P24, DOI 10.1159/000333963; Stojilkovic SS, 2009, TRENDS ENDOCRIN MET, V20, P460, DOI 10.1016/j.tem.2009.05.005; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Szkudelski T, 2001, PHYSIOL RES, V50, P537; Vitzel KF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062190; WALTER GA, 1989, NEUROCHEM INT, V15, P485, DOI 10.1016/0197-0186(89)90167-8; Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219	37	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71944	10.1371/journal.pone.0071944	http://dx.doi.org/10.1371/journal.pone.0071944			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967267	Green Published, gold, Green Submitted			2022-12-25	WOS:000323221500116
J	Yang, T; Liang, Y; Zhang, Y; Gu, Q; Chen, G; Ni, XH; Lv, XZ; Liu, ZH; Xiong, CM; He, JG				Yang, Tao; Liang, Yu; Zhang, Yan; Gu, Qing; Chen, Guo; Ni, Xin-Hai; Lv, Xiu-Zhang; Liu, Zhi-Hong; Xiong, Chang-Ming; He, Jian-Guo			Echocardiographic Parameters in Patients with Pulmonary Arterial Hypertension: Correlations with Right Ventricular Ejection Fraction Derived from Cardiac Magnetic Resonance and Hemodynamics	PLOS ONE			English	Article							TISSUE DOPPLER; TEI-INDEX; SYSTOLIC FUNCTION; PROGNOSTIC VALUE; DYSFUNCTION; ACCELERATION; VALIDATION; GUIDELINES; ACCURACY; VELOCITY	Background: Echocardiography is the most convenient method used to evaluate right ventricular function, and several echocardiographic parameters were studied in previous studies. But the value of these parameters to assess the right ventricular function in patients with pulmonary arterial hypertension (PAH) has not been well defined. Methods: Patients with PAH were observed prospectively. Right heart catheterization, echocardiography and cardiac magnetic resonance (CMR) were performed within 1 week interval. The correlations between echocardiographic parameters and right ventricular ejection fraction (RVEF) derived from CMR as well as hemodynamics were analyzed. Results: Thirty patients were enrolled including 24 with idiopathic PAH, 5 with PAH associated with connective tissue diseases and 1 with hereditary PAH. All echocardiographic parameters except right ventricular myocardial performance index (RVMPI) correlated significantly with RVEF (tricuspid annual plane systolic excursion [TAPSE], r = 0.440, P = 0.015; tricuspid annular systolic excursion velocity [S'], r = 0.444, P = 0.016; isovolumic acceleration [IVA], r = 0.600, P = 0.001; right ventricular fraction area change [RVFAC], r = 0.416, P = 0.022; ratio of right ventricular transverse diameter to left ventricular transverse diameter [RVETD/LVETD], r = -0.649, P<0.001; RVMPI, r = -0.027, P = 0.888). After adjusted for mean right atrial pressure, mean pulmonary arterial pressure and pulmonary vascular resistance (PVR), only IVA and RVETD/LVETD could independently predict RVEF. Four echocardiographic parameters displayed significant correlations with PVR (TAPSE, r = -0.615, P<0.001; S', r = -0.557, P = 0.002; RVFAC, r = -0.454, P = 0.012; RVETD/LVETD, r = 0.543, P = 0.002). Conclusions: The echocardiographic parameters IVA and RVETD/LVETD can reflect RVEF independently regardless of hemodynamics in patients with PAH. In addition, TAPSE, S', RVFAC and RVETD/LVETD can also reflect PVR in PAH patients.	[Yang, Tao; Liang, Yu; Zhang, Yan; Gu, Qing; Chen, Guo; Ni, Xin-Hai; Liu, Zhi-Hong; Xiong, Chang-Ming; He, Jian-Guo] Chinese Acad Med Sci, Fuwai Hosp, State Key Lab Cardiovasc Dis, Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China; [Yang, Tao; Liang, Yu; Zhang, Yan; Gu, Qing; Chen, Guo; Ni, Xin-Hai; Liu, Zhi-Hong; Xiong, Chang-Ming; He, Jian-Guo] Peking Union Med Coll, Beijing 100021, Peoples R China; [Lv, Xiu-Zhang] Capital Med Univ, Beijing Chaoyang Hosp, Dept Cardiol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Medical University	Xiong, CM (corresponding author), Chinese Acad Med Sci, Fuwai Hosp, State Key Lab Cardiovasc Dis, Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China.	xiongcm2000@yahoo.com.cn; hejianguofw@gmail.com			National Key Technology R&D Program, China [2011BAI11B15]; Science and Technology Project of Bejing, China [Z099597017709032]; Capital Medical Scientific Development Fund, Beijing, China [2009-1003]	National Key Technology R&D Program, China(National Key Technology R&D Program); Science and Technology Project of Bejing, China; Capital Medical Scientific Development Fund, Beijing, China	This study was supported by National Key Technology R&D Program, China (Project Number: 2011BAI11B15), http://kjzc.jhgl.org/; Science and Technology Project of Bejing, China (Project Number: Z099597017709032) and Capital Medical Scientific Development Fund, Beijing, China (Project Number: 2009-1003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradlow WM, 2010, J MAGN RESON IMAGING, V31, P117, DOI 10.1002/jmri.22011; Cabrita IZ, 2010, EUR J ECHOCARDIOGR, V11, P719, DOI 10.1093/ejechocard/jeq051; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Dalsgaard M, 2007, ECHOCARDIOGR-J CARD, V24, P572, DOI 10.1111/j.1540-8175.2007.00454.x; De Castro S, 2008, ECHOCARDIOGR-J CARD, V25, P289, DOI 10.1111/j.1540-8175.2007.00587.x; Fremont B, 2008, CHEST, V133, P358, DOI 10.1378/chest.07-1231; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Grapsa J, 2012, AM J CARDIOL, V109, P906, DOI 10.1016/j.amjcard.2011.10.054; Grignola JC, 2006, INT J CARDIOL, V113, P25, DOI 10.1016/j.ijcard.2005.10.012; KAUL S, 1984, AM HEART J, V107, P526, DOI 10.1016/0002-8703(84)90095-4; Kind T, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-35; Mooij CF, 2008, J MAGN RESON IMAGING, V28, P67, DOI 10.1002/jmri.21407; Sade LE, 2009, J AM SOC ECHOCARDIOG, V22, P361, DOI 10.1016/j.echo.2009.01.018; Sato T, 2012, J AM SOC ECHOCARDIOG, V25, P280, DOI 10.1016/j.echo.2011.12.012; Schattke S, 2010, CARDIOVASC ULTRASOUN, V8, DOI 10.1186/1476-7120-8-3; Schiller NB, 2009, JACC-CARDIOVASC IMAG, V2, P150, DOI 10.1016/j.jcmg.2008.11.006; Tei C, 1996, J Am Soc Echocardiogr, V9, P838, DOI 10.1016/S0894-7317(96)90476-9; Tugcu A, 2010, CIRC J, V74, P312, DOI 10.1253/circj.CJ-09-0562; Ueti OM, 2002, HEART, V88, P244, DOI 10.1136/heart.88.3.244; van de Veerdonk MC, 2011, J AM COLL CARDIOL, V58, P2511, DOI 10.1016/j.jacc.2011.06.068; van Wolferen SA, 2007, EUR HEART J, V28, P1250, DOI 10.1093/eurheartj/ehl477; Vogel M, 2002, CIRCULATION, V105, P1693, DOI 10.1161/01.CIR.0000013773.67850.BA; Vonk MC, 2007, EUR J ECHOCARDIOGR, V8, P317, DOI 10.1016/j.euje.2006.06.002; Wahl A, 2011, INT J CARDIOL, V151, P58, DOI 10.1016/j.ijcard.2010.04.089; Wang J, 2007, J AM SOC ECHOCARDIOG, V20, P1058, DOI 10.1016/j.echo.2007.01.038; Zeng WJ, 2011, CHINESE MED J-PEKING, V124, P1672, DOI 10.3760/cma.j.issn.0366-6999.2011.11.013	26	33	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71276	10.1371/journal.pone.0071276	http://dx.doi.org/10.1371/journal.pone.0071276			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967181	gold, Green Published, Green Submitted			2022-12-25	WOS:000323221500068
J	Deschuyteneer, A; Boeckstaens, M; De Mees, C; Van Vooren, P; Wintjens, R; Marini, AM				Deschuyteneer, Aude; Boeckstaens, Melanie; De Mees, Christelle; Van Vooren, Pascale; Wintjens, Rene; Marini, Anna Maria			SNPs Altering Ammonium Transport Activity of Human Rhesus Factors Characterized by a Yeast-Based Functional Assay	PLOS ONE			English	Article								Proteins of the conserved Mep-Amt-Rh family, including mammalian Rhesus factors, mediate transmembrane ammonium transport. Ammonium is an important nitrogen source for the biosynthesis of amino acids but is also a metabolic waste product. Its disposal in urine plays a critical role in the regulation of the acid/base homeostasis, especially with an acid diet, a trait of Western countries. Ammonium accumulation above a certain concentration is however pathologic, the cytotoxicity causing fatal cerebral paralysis in acute cases. Alteration in ammonium transport via human Rh proteins could have clinical outcomes. We used a yeast-based expression assay to characterize human Rh variants resulting from non synonymous single nucleotide polymorphisms (nsSNPs) with known or unknown clinical phenotypes and assessed their ammonium transport efficiency, protein level, localization and potential trans-dominant impact. The HsRhAG variants (I61R, F65S) associated to overhydrated hereditary stomatocytosis (OHSt), a disease affecting erythrocytes, proved affected in intrinsic bidirectional ammonium transport. Moreover, this study reveals that the R202C variant of HsRhCG, the orthologue of mouse MmRhcg required for optimal urinary ammonium excretion and blood pH control, shows an impaired inherent ammonium transport activity. Urinary ammonium excretion was RHcg gene-dose dependent in mouse, highlighting MmRhcg as a limiting factor. HsRhCG(R202C) may confer susceptibility to disorders leading to metabolic acidosis for instance. Finally, the analogous R211C mutation in the yeast ScMep2 homologue also impaired intrinsic activity consistent with a conserved functional role of the preserved arginine residue. The yeast expression assay used here constitutes an inexpensive, fast and easy tool to screen nsSNPs reported by high throughput sequencing or individual cases for functional alterations in Rh factors revealing potential causal variants.	[Deschuyteneer, Aude; Boeckstaens, Melanie; De Mees, Christelle; Van Vooren, Pascale; Marini, Anna Maria] Univ Libre Brussels, Gosselies, Belgium; [Wintjens, Rene] Univ Libre Brussels, Lab Biopolymeres & Nanomat Supramol, Brussels, Belgium	Universite Libre de Bruxelles	Marini, AM (corresponding author), Univ Libre Brussels, Gosselies, Belgium.	amarini@ulb.ac.be		Boeckstaens, Melanie/0000-0003-1629-7403	'Fonds de la Recherche Scientifique Medicale' grant of the F.R.S.-FNRS [3.4633.09]; 'Mandat d'Impulsion Scientifique' grant of the F.R.S.-FNRS [F.4.521.10.F]; 'Actions de Recherche Concertee' grant of the Communaute Francaise de Belgique [AUWB-2012-12/17]; Fonds Jean Brachet; Fonds David et Alice Van Buuren	'Fonds de la Recherche Scientifique Medicale' grant of the F.R.S.-FNRS(Fonds de la Recherche Scientifique - FNRS); 'Mandat d'Impulsion Scientifique' grant of the F.R.S.-FNRS; 'Actions de Recherche Concertee' grant of the Communaute Francaise de Belgique; Fonds Jean Brachet; Fonds David et Alice Van Buuren	This work was supported by a 'Fonds de la Recherche Scientifique Medicale' (3.4633.09) grant and a 'Mandat d'Impulsion Scientifique' (F.4.521.10.F) grant of the F.R.S.-FNRS (http://www.frs-fnrs.be/), an 'Actions de Recherche Concertee' grant of the Communaute Francaise de Belgique (AUWB-2012-12/17), and by the Fonds Jean Brachet and the Fonds David et Alice Van Buuren. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Accardi A, 2010, BBA-BIOMEMBRANES, V1798, P1457, DOI 10.1016/j.bbamem.2010.02.022; Adeva MM, 2011, CLIN NUTR, V30, P416, DOI 10.1016/j.clnu.2011.03.008; ANDERSON JA, 1992, P NATL ACAD SCI USA, V89, P3736, DOI 10.1073/pnas.89.9.3736; Andrade SLA, 2005, P NATL ACAD SCI USA, V102, P14994, DOI 10.1073/pnas.0506254102; Auron A, 2012, PEDIATR NEPHROL, V27, P207, DOI 10.1007/s00467-011-1838-5; Barneaud-Rocca D, 2011, INT J CELL BIOL, V2011; BECHET J, 1970, EUR J BIOCHEM, V12, P31, DOI 10.1111/j.1432-1033.1970.tb00817.x; Bishop JM, 2010, AM J PHYSIOL-RENAL, V299, pF1065, DOI 10.1152/ajprenal.00277.2010; Biver S, 2008, NATURE, V456, P339, DOI 10.1038/nature07518; Boeckstaens M, 2008, J BIOL CHEM, V283, P21362, DOI 10.1074/jbc.M801467200; Boeckstaens M, 2007, MOL MICROBIOL, V64, P534, DOI 10.1111/j.1365-2958.2007.05681.x; Brown ACN, 2009, AM J PHYSIOL-RENAL, V296, pF1279, DOI 10.1152/ajprenal.00013.2009; Bruce LJ, 2009, BLOOD, V113, P1350, DOI 10.1182/blood-2008-07-171140; Bruce LJ, 2003, BLOOD, V101, P4180, DOI 10.1182/blood-2002-09-2824; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; Darghouth D, 2011, HAEMATOL-HEMATOL J, V96, P1861, DOI 10.3324/haematol.2011.045179; De Craene JO, 2001, J BIOL CHEM, V276, P43939, DOI 10.1074/jbc.M102944200; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Duran C, 2010, ANNU REV PHYSIOL, V72, P95, DOI 10.1146/annurev-physiol-021909-135811; Eladari D, 2002, J AM SOC NEPHROL, V13, P1999, DOI 10.1097/01.ASN.0000025280.02386.9D; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EYERS SAC, 1994, J BIOL CHEM, V269, P6417; Flatt JF, 2011, BLOOD, V118, P5267, DOI 10.1182/blood-2010-12-326645; Genetet S, 2012, AM J PHYSIOL-CELL PH, V302, pC419, DOI 10.1152/ajpcell.00092.2011; GRENSON M, 1966, BIOCHIM BIOPHYS ACTA, V127, P325, DOI 10.1016/0304-4165(66)90387-4; Gruswitz F, 2007, P NATL ACAD SCI USA, V104, P42, DOI 10.1073/pnas.0609796104; Gruswitz F, 2010, P NATL ACAD SCI USA, V107, P9638, DOI 10.1073/pnas.1003587107; HUIZENGA JR, 1994, ANN CLIN BIOCHEM, V31, P529, DOI 10.1177/000456329403100602; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JACOBS P, 1980, J MOL BIOL, V139, P691, DOI 10.1016/0022-2836(80)90055-8; Jiang WH, 2006, BIOCHEM BIOPH RES CO, V339, P1255, DOI 10.1016/j.bbrc.2005.11.138; Josic D, 2008, CURR OPIN MOL THER, V10, P116; Karet FE, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000023433.08833.88; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kraut JA, 2010, NAT REV NEPHROL, V6, P274, DOI 10.1038/nrneph.2010.33; Li X, 2007, P NATL ACAD SCI USA, V104, P19279, DOI 10.1073/pnas.0709710104; Liu Z, 2000, J BIOL CHEM, V275, P25641, DOI 10.1074/jbc.M003353200; Lluis MW, 2013, PROTEIN ENG DES SEL, V26, P91, DOI 10.1093/protein/gzs079; Loque D, 2007, NATURE, V446, P195, DOI 10.1038/nature05579; Ludewig U, 2004, J PHYSIOL-LONDON, V559, P751, DOI 10.1113/jphysiol.2004.067728; Ludewig U, 2003, J BIOL CHEM, V278, P45603, DOI 10.1074/jbc.M307424200; Lupo D, 2007, P NATL ACAD SCI USA, V104, P19303, DOI 10.1073/pnas.0706563104; Marini AM, 2000, MOL MICROBIOL, V38, P552, DOI 10.1046/j.1365-2958.2000.02151.x; Marini AM, 2000, MOL MICROBIOL, V35, P378, DOI 10.1046/j.1365-2958.2000.01704.x; MARINI AM, 1994, EMBO J, V13, P3456, DOI 10.1002/j.1460-2075.1994.tb06651.x; Marini AM, 1997, TRENDS BIOCHEM SCI, V22, P460, DOI 10.1016/S0968-0004(97)01132-8; Marini AM, 2000, NAT GENET, V26, P341, DOI 10.1038/81656; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; Marini AM, 2006, CURR GENET, V49, P364, DOI 10.1007/s00294-006-0062-5; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Monahan BJ, 2002, FUNGAL GENET BIOL, V36, P35, DOI 10.1016/S1087-1845(02)00004-X; MORTIMER RK, 1986, GENETICS, V113, P35; Mouro-Chanteloup I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008921; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Neuhauser B, 2007, PLANT PHYSIOL, V143, P1651, DOI 10.1104/pp.106.094243; NINNEMANN O, 1994, EMBO J, V13, P3464, DOI 10.1002/j.1460-2075.1994.tb06652.x; PITTS RF, 1948, J CLIN INVEST, V27, P48, DOI 10.1172/JCI101923; Ripoche P, 2004, P NATL ACAD SCI USA, V101, P17222, DOI 10.1073/pnas.0403704101; Rucevic M, 2011, ELECTROPHORESIS, V32, P1549, DOI 10.1002/elps.201100212; Stewart AK, 2011, AM J PHYSIOL-CELL PH, V301, pC1325, DOI 10.1152/ajpcell.00054.2011; Turner EJH, 2003, BRIT J HAEMATOL, V120, P894, DOI 10.1046/j.1365-2141.2003.04175.x; Verlander JW, 2003, AM J PHYSIOL-RENAL, V284, pF323, DOI 10.1152/ajprenal.00050.2002; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Weiner ID, 2011, AM J PHYSIOL-RENAL, V300, pF11, DOI 10.1152/ajprenal.00554.2010; Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101; Zidi-Yahiaoui N, 2009, AM J PHYSIOL-CELL PH, V297, pC537, DOI 10.1152/ajpcell.00137.2009	68	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71092	10.1371/journal.pone.0071092	http://dx.doi.org/10.1371/journal.pone.0071092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967154	gold, Green Published, Green Submitted			2022-12-25	WOS:000323115800034
J	Pinkernelle, J; Fansa, H; Ebmeyer, U; Keilhoff, G				Pinkernelle, Josephine; Fansa, Hisham; Ebmeyer, Uwe; Keilhoff, Gerburg			Prolonged Minocycline Treatment Impairs Motor Neuronal Survival and Glial Function in Organotypic Rat Spinal Cord Cultures	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; CELL-DEATH; AXONAL REGENERATION; REACTIVE ASTROCYTES; GAP-JUNCTIONS; SCHWANN-CELL; EXPRESSION; MICROGLIA; RECOVERY; NEUROPROTECTION	Background: Minocycline, a second-generation tetracycline antibiotic, exhibits anti-inflammatory and neuroprotective effects in various experimental models of neurological diseases, such as stroke, Alzheimer's disease, amyotrophic lateral sclerosis and spinal cord injury. However, conflicting results have prompted a debate regarding the beneficial effects of minocycline. Methods: In this study, we analyzed minocycline treatment in organotypic spinal cord cultures of neonatal rats as a model of motor neuron survival and regeneration after injury. Minocycline was administered in 2 different concentrations (10 and 100 mu M) at various time points in culture and fixed after 1 week. Results: Prolonged minocycline administration decreased the survival of motor neurons in the organotypic cultures. This effect was strongly enhanced with higher concentrations of minocycline. High concentrations of minocycline reduced the number of DAPI-positive cell nuclei in organotypic cultures and simultaneously inhibited microglial activation. Astrocytes, which covered the surface of the control organotypic cultures, revealed a peripheral distribution after early minocycline treatment. Thus, we further analyzed the effects of 100 mu M minocycline on the viability and migration ability of dispersed primary glial cell cultures. We found that minocycline reduced cell viability, delayed wound closure in a scratch migration assay and increased connexin 43 protein levels in these cultures. Conclusions: The administration of high doses of minocycline was deleterious for motor neuron survival. In addition, it inhibited microglial activation and impaired glial viability and migration. These data suggest that especially high doses of minocycline might have undesired affects in treatment of spinal cord injury. Further experiments are required to determine the conditions for the safe clinical administration of minocycline in spinal cord injured patients.	[Pinkernelle, Josephine; Keilhoff, Gerburg] Univ Magdeburg, Inst Biochem & Cell Biol, D-39106 Magdeburg, Germany; [Fansa, Hisham] Klinikum Bielefeld, Dept Plast Reconstruct & Aesthet Surg, Bielefeld, Germany; [Ebmeyer, Uwe] Univ Magdeburg, Anesthesiol Clin, D-39106 Magdeburg, Germany	Otto von Guericke University; Otto von Guericke University	Pinkernelle, J (corresponding author), Univ Magdeburg, Inst Biochem & Cell Biol, D-39106 Magdeburg, Germany.	josephine.pinkernelle@med.ovgu.de		Fansa, Hisham/0000-0003-4532-8408	NanoscieE+2008 for the MARVENE project; DFG [KE 488/15-1]	NanoscieE+2008 for the MARVENE project; DFG(German Research Foundation (DFG))	This work was supported by grants from NanoscieE+2008 for the MARVENE project (magnetic nanoparticles for nerve regeneration) and the DFG (KE 488/15-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht PJ, 2002, EXP NEUROL, V173, P46, DOI 10.1006/exnr.2001.7834; Almazin SM, 2009, J PERIODONTOL, V80, P999, DOI 10.1902/jop.2009.080574; Bastos LFS, 2007, EUR J PHARMACOL, V576, P171, DOI 10.1016/j.ejphar.2007.07.049; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Carlstedt T, 2000, J NEUROSURG, V93, P237, DOI 10.3171/spi.2000.93.2.0237; Casha S, 2012, BRAIN, V135, P1224, DOI 10.1093/brain/aws072; Chechneva O, 2006, NEUROBIOL DIS, V23, P247, DOI 10.1016/j.nbd.2006.02.015; Chen YM, 2001, J NEUROCHEM, V77, P1601, DOI 10.1046/j.1471-4159.2001.00374.x; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; Chen-Roetling J, 2009, BIOCHEM BIOPH RES CO, V386, P322, DOI 10.1016/j.bbrc.2009.06.026; Chew SSL, 2010, EXP NEUROL, V225, P250, DOI 10.1016/j.expneurol.2010.07.014; Cho DC, 2011, J KOREAN NEUROSURG S, V49, P83, DOI 10.3340/jkns.2011.49.2.83; Coutts M, 2008, EXP NEUROL, V209, P368, DOI 10.1016/j.expneurol.2007.09.002; Cronin M, 2008, MOL CELL NEUROSCI, V39, P152, DOI 10.1016/j.mcn.2008.06.005; Cui W, 2001, GLIA, V34, P272, DOI 10.1002/glia.1061; Cui Y, 2008, BRAIN BEHAV IMMUN, V22, P114, DOI 10.1016/j.bbi.2007.07.014; Diguet E, 2004, EUR J NEUROSCI, V19, P3266, DOI 10.1111/j.0953-816X.2004.03372.x; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Eggers R, 2010, EXP NEUROL, V223, P207, DOI 10.1016/j.expneurol.2009.07.021; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Faustmann PM, 2003, GLIA, V42, P101, DOI 10.1002/glia.10141; Fortun J, 2009, NEUROSCI LETT, V456, P124, DOI 10.1016/j.neulet.2008.08.092; Gieseler A, 2009, BIOCHEM PHARMACOL, V77, P888, DOI 10.1016/j.bcp.2008.11.003; Gomes PS, 2007, ARCH ORAL BIOL, V52, P251, DOI 10.1016/j.archoralbio.2006.10.005; Gu HY, 2004, EUR J NEUROSCI, V19, P2123, DOI 10.1111/j.0953-816X.2004.03295.x; Guo G, 2007, NEUROCHEM RES, V32, P2160, DOI 10.1007/s11064-007-9408-8; Haninec P, 2004, EXP BRAIN RES, V159, P425, DOI 10.1007/s00221-004-1969-z; HANSSON E, 1986, NEUROCHEM RES, V11, P759, DOI 10.1007/BF00965202; Haroon MF, 2007, NEUROBIOL DIS, V28, P237, DOI 10.1016/j.nbd.2007.07.021; Hayon T, 2003, LEUKEMIA LYMPHOMA, V44, P1957, DOI 10.1080/1042819031000116607; Homkajorn B, 2010, NEUROSCI LETT, V486, P197, DOI 10.1016/j.neulet.2010.09.051; Iannotti C, 2003, EXP NEUROL, V183, P379, DOI 10.1016/S0014-4886(03)00188-2; KASHIHARA Y, 1987, J PHYSIOL-LONDON, V386, P135, DOI 10.1113/jphysiol.1987.sp016526; Keilhoff G, 2008, EXP NEUROL, V212, P189, DOI 10.1016/j.expneurol.2008.03.028; Keilhoff G, 2007, DEV NEUROBIOL, V67, P1382, DOI 10.1002/dneu.20384; Keller AF, 2011, EXP NEUROL, V228, P69, DOI 10.1016/j.expneurol.2010.12.010; Kielian T, 2008, J NEUROCHEM, V106, P1000, DOI 10.1111/j.1471-4159.2008.05405.x; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kim HS, 2009, BEHAV BRAIN RES, V196, P168, DOI 10.1016/j.bbr.2008.09.040; KIMELBERG HK, 1983, CELL MOL NEUROBIOL, V3, P1, DOI 10.1007/BF00734994; Kupsch K, 2009, FEBS J, V276, P1729, DOI 10.1111/j.1742-4658.2009.06904.x; Kwon BK, 2011, J NEUROTRAUM, V28, P1545, DOI 10.1089/neu.2009.1149; Kwon BK, 2010, SPINE, V35, pS263, DOI 10.1097/BRS.0b013e3181f3286d; Lee SM, 2003, J NEUROTRAUM, V20, P1017, DOI 10.1089/089771503770195867; LI LX, 1994, J NEUROBIOL, V25, P759, DOI 10.1002/neu.480250702; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Machado LS, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-56; Garcia-Martinez EM, 2010, BIOCHEM PHARMACOL, V79, P239, DOI 10.1016/j.bcp.2009.07.028; Matsukawa N, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-126; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; McDonough WS, 1999, INT J DEV NEUROSCI, V17, P601, DOI 10.1016/S0736-5748(99)00024-6; Nagy JI, 2000, BRAIN RES REV, V32, P29, DOI 10.1016/S0165-0173(99)00066-1; Neumann J, 2006, FASEB J, V20, P714, DOI 10.1096/fj.05-4882fje; Nikodemova M, 2007, J BIOL CHEM, V282, P15208, DOI 10.1074/jbc.M611907200; Novikov LN, 2002, BIOMATERIALS, V23, P3369, DOI 10.1016/S0142-9612(02)00037-6; Nutile-McMenemy N, 2007, J NEUROCHEM, V103, P2035, DOI 10.1111/j.1471-4159.2007.04889.x; Orellana JA, 2012, REV NEUROSCIENCE, V23, P163, DOI 10.1515/revneuro-2011-0065; Pi RB, 2004, J NEUROCHEM, V91, P1219, DOI 10.1111/j.1471-4159.2004.02796.x; Pinkernelle J, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-32; Plane JM, 2010, ARCH NEUROL-CHICAGO, V67, P1442, DOI 10.1001/archneurol.2010.191; Qin LY, 2002, J NEUROCHEM, V83, P973, DOI 10.1046/j.1471-4159.2002.01210.x; Rakowicz WP, 2002, J NEUROSCI, V22, P3953, DOI 10.1523/JNEUROSCI.22-10-03953.2002; Retamal MA, 2007, J NEUROSCI, V27, P13781, DOI 10.1523/JNEUROSCI.2042-07.2007; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Rossiter JP, 1996, EXP NEUROL, V138, P33, DOI 10.1006/exnr.1996.0044; Rouach N, 2002, EUR J NEUROSCI, V15, P403, DOI 10.1046/j.0953-816x.2001.01868.x; Saadoun S, 2005, J CELL SCI, V118, P5691, DOI 10.1242/jcs.02680; Saez JC, 2010, EXP CELL RES, V316, P2377, DOI 10.1016/j.yexcr.2010.05.026; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; SCHWARTZ JP, 1994, BRAIN RES BULL, V35, P403, DOI 10.1016/0361-9230(94)90151-1; Bastos LFS, 2011, IMMUNOPHARM IMMUNOT, V33, P576, DOI 10.3109/08923973.2010.544659; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Stavridis S, 2005, HISTOCHEM CELL BIOL, V123, P377, DOI 10.1007/s00418-004-0743-4; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Sumantran VN, 2011, METHODS MOL BIOL, V731, P219, DOI 10.1007/978-1-61779-080-5_19; Takami T, 2002, J NEUROSCI, V22, P6670; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Tohda C, 2011, PHARMACOL THERAPEUT, V132, P57, DOI 10.1016/j.pharmthera.2011.05.006; Toku K, 1998, J NEUROSCI RES, V53, P415, DOI 10.1002/(SICI)1097-4547(19980815)53:4<415::AID-JNR3>3.0.CO;2-9; Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354; Vyas A, 2010, EXP NEUROL, V223, P112, DOI 10.1016/j.expneurol.2009.05.022; Watson C, 2009, SPINAL CORD: A CHRISTOPHER AND DANA REEVE FOUNDATION TEXT AND ATLAS, P1; Wells JEA, 2003, BRAIN, V126, P1628, DOI 10.1093/brain/awg178; White RE, 2008, RESTOR NEUROL NEUROS, V26, P197; Yang LC, 2003, J NEUROSCI RES, V74, P278, DOI 10.1002/jnr.10709; Yao JHS, 2007, NEUROCHEM INT, V50, P524, DOI 10.1016/j.neuint.2006.10.008; Yong VW, 2004, LANCET NEUROL, V3, P744, DOI 10.1016/S1474-4422(04)00937-8	89	30	33	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e73422	10.1371/journal.pone.0073422	http://dx.doi.org/10.1371/journal.pone.0073422			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967343	Green Submitted, Green Published, gold			2022-12-25	WOS:000323115800120
J	Tielen, P; Rosin, N; Meyer, AK; Dohnt, K; Haddad, I; Jansch, L; Klein, J; Narten, M; Pommerenke, C; Scheer, M; Schobert, M; Schomburg, D; Thielen, B; Jahn, D				Tielen, Petra; Rosin, Nathalie; Meyer, Ann-Kathrin; Dohnt, Katrin; Haddad, Isam; Jaensch, Lothar; Klein, Johannes; Narten, Maike; Pommerenke, Claudia; Scheer, Maurice; Schobert, Max; Schomburg, Dietmar; Thielen, Bernhard; Jahn, Dieter			Regulatory and Metabolic Networks for the Adaptation of Pseudomonas aeruginosa Biofilms to Urinary Tract-Like Conditions	PLOS ONE			English	Article							VIRULENCE FACTOR EXPRESSION; QUINOLONE SIGNAL SYNTHESIS; QUORUM-SENSING SYSTEMS; HEME-BINDING PROTEIN; ESCHERICHIA-COLI; MASS-SPECTROMETRY; FE(III)-PYOCHELIN RECEPTOR; TRANSCRIPTIONAL REGULATOR; PYOVERDINE BIOSYNTHESIS; NOSOCOMIAL INFECTIONS	Biofilms of the Gram-negative bacterium Pseudomonas aeruginosa are one of the major causes of complicated urinary tract infections with detrimental outcome. To develop novel therapeutic strategies the molecular adaption strategies of P. aeruginosa biofilms to the conditions of the urinary tract were investigated thoroughly at the systems level using transcriptome, proteome, metabolome and enzyme activity analyses. For this purpose biofilms were grown anaerobically in artificial urine medium (AUM). Obtained data were integrated bioinformatically into gene regulatory and metabolic networks. The dominating response at the transcriptome and proteome level was the adaptation to iron limitation via the broad Fur regulon including 19 sigma factors and up to 80 regulated target genes or operons. In agreement, reduction of the iron cofactor-dependent nitrate respiratory metabolism was detected. An adaptation of the central metabolism to lactate, citrate and amino acid as carbon sources with the induction of the glyoxylate bypass was observed, while other components of AUM like urea and creatinine were not used. Amino acid utilization pathways were found induced, while fatty acid biosynthesis was reduced. The high amounts of phosphate found in AUM explain the reduction of phosphate assimilation systems. Increased quorum sensing activity with the parallel reduction of chemotaxis and flagellum assembly underscored the importance of the biofilm life style. However, reduced formation of the extracellular polysaccharide alginate, typical for P. aeruginosa biofilms in lungs, indicated a different biofilm type for urinary tract infections. Furthermore, the obtained quorum sensing response results in an increased production of virulence factors like the extracellular lipase LipA and protease LasB and AprA explaining the harmful cause of these infections.	[Tielen, Petra; Rosin, Nathalie; Meyer, Ann-Kathrin; Haddad, Isam; Klein, Johannes; Narten, Maike; Pommerenke, Claudia; Schobert, Max; Jahn, Dieter] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany; [Dohnt, Katrin] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Engn, D-38106 Braunschweig, Germany; [Jaensch, Lothar] Helmholtz Ctr Infect Res, Res Grp Cellular Prote, Braunschweig, Germany; [Scheer, Maurice; Schomburg, Dietmar; Thielen, Bernhard] Tech Univ Carolo Wilhelmina Braunschweig, Inst Bioinformat & Biochem, D-38106 Braunschweig, Germany	Braunschweig University of Technology; Braunschweig University of Technology; Helmholtz Association; Helmholtz-Center for Infection Research; Braunschweig University of Technology	Tielen, P (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany.	p.tielen@tu-bs.de		Jahn, Dieter/0000-0002-4064-9205; Schomburg, Dietmar/0000-0002-3354-822X	BMBF GenoMik-Plus [Fkz: 0313801H]	BMBF GenoMik-Plus(Federal Ministry of Education & Research (BMBF))	This work was funded by the BMBF GenoMik-Plus (Fkz: 0313801H). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen L, 2005, J IMMUNOL, V174, P3643, DOI 10.4049/jimmunol.174.6.3643; ANKENBAUER RG, 1994, J BACTERIOL, V176, P307, DOI 10.1128/JB.176.2.307-319.1994; ANKENBAUER RG, 1992, J BACTERIOL, V174, P4401, DOI 10.1128/JB.174.13.4401-4409.1992; ARAI H, 1995, FEBS LETT, V371, P73, DOI 10.1016/0014-5793(95)00885-D; Arevalo-Ferro C, 2003, ENVIRON MICROBIOL, V5, P1350, DOI 10.1046/j.1462-2920.2003.00532.x; Bjarnsholt T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010115; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; Boes N, 2006, J BACTERIOL, V188, P6529, DOI 10.1128/JB.00308-06; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borriello G, 2006, ANTIMICROB AGENTS CH, V50, P382, DOI 10.1128/AAC.50.1.382-384.2006; Borriello G, 2004, ANTIMICROB AGENTS CH, V48, P2659, DOI 10.1128/AAC.48.7.2659-2664.2004; Brooks T, 1997, LETT APPL MICROBIOL, V24, P203, DOI 10.1046/j.1472-765X.1997.00378.x; BROWN MRW, 1984, FEMS MICROBIOL LETT, V21, P113, DOI 10.1016/0378-1097(84)90188-5; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caldwell CC, 2009, AM J PATHOL, V175, P2473, DOI 10.2353/ajpath.2009.090166; Calfee MW, 2001, P NATL ACAD SCI USA, V98, P11633, DOI 10.1073/pnas.201328498; Cha C, 1998, MOL PLANT MICROBE IN, V11, P1119, DOI 10.1094/MPMI.1998.11.11.1119; Chang A, 2009, NUCLEIC ACIDS RES, V37, pD588, DOI 10.1093/nar/gkn820; Choi C, 2007, NUCLEIC ACIDS RES, V35, pD533, DOI 10.1093/nar/gkl823; Cornelis P, 2009, BIOMETALS, V22, P15, DOI 10.1007/s10534-008-9193-0; CUNLIFFE HE, 1995, J BACTERIOL, V177, P2744, DOI 10.1128/jb.177.10.2744-2750.1995; DOIG P, 1987, INFECT IMMUN, V55, P1517, DOI 10.1128/IAI.55.6.1517-1522.1987; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Dornbluth O, 2002, PSCHYREMBEL KLIN WOR, P656; ENTNER N, 1952, J BIOL CHEM, V196, P853; Erickson DL, 2002, INFECT IMMUN, V70, P1783, DOI 10.1128/IAI.70.4.1783-1790.2002; Eschbach M, 2004, J BACTERIOL, V186, P4596, DOI 10.1128/JB.186.14.4596-4604.2004; Farrow JM, 2007, J BACTERIOL, V189, P3425, DOI 10.1128/JB.00209-07; FILLOUX A, 1988, MOL GEN GENET, V212, P510, DOI 10.1007/BF00330857; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Friedman L, 2004, J BACTERIOL, V186, P4457, DOI 10.1128/JB.186.14.4457-4465.2004; Frimmersdorf E, 2010, ENVIRON MICROBIOL, V12, P1734, DOI 10.1111/j.1462-2920.2010.02253.x; Fung C, 2010, J MED MICROBIOL, V59, P1089, DOI 10.1099/jmm.0.019984-0; Gallagher LA, 2002, J BACTERIOL, V184, P6472, DOI 10.1128/JB.184.23.6472-6480.2002; GALLOWAY DR, 1991, MOL MICROBIOL, V5, P2315, DOI 10.1111/j.1365-2958.1991.tb02076.x; Gastmeier P, 2008, DEUT MED WOCHENSCHR, V133, P1111, DOI 10.1055/s-2008-1077224; Gastmeier P, 1998, J HOSP INFECT, V38, P37, DOI 10.1016/S0195-6701(98)90173-6; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghafoor A, 2011, APPL ENVIRON MICROB, V77, P5238, DOI 10.1128/AEM.00637-11; Giannakopoulos X., 1997, International Urology and Nephrology, V29, P393, DOI 10.1007/BF02551103; Giardina G, 2008, J MOL BIOL, V378, P1002, DOI 10.1016/j.jmb.2008.03.013; Haddad Isam, 2009, In Silico Biology, V9, P163, DOI 10.3233/ISB-2009-0396; Halket JM, 1999, RAPID COMMUN MASS SP, V13, P279, DOI 10.1002/(SICI)1097-0231(19990228)13:4<279::AID-RCM478>3.0.CO;2-I; Hamood AN, 1996, J SURG RES, V61, P425, DOI 10.1006/jsre.1996.0140; Hanna SL, 2000, MICROBIOL-UK, V146, P2495, DOI 10.1099/00221287-146-10-2495; Hassett DJ, 1997, J BACTERIOL, V179, P1452, DOI 10.1128/jb.179.5.1452-1459.1997; Hatt JK, 2008, CURR TOP MICROBIOL, V322, P163; HEINRICHS DE, 1993, J BACTERIOL, V175, P5882, DOI 10.1128/JB.175.18.5882-5889.1993; Hentzer M, 2001, J BACTERIOL, V183, P5395, DOI 10.1128/JB.183.18.5395-5401.2001; Heurlier K, 2006, INT J MED MICROBIOL, V296, P93, DOI 10.1016/j.ijmm.2006.01.043; HOLLOWAY BW, 1979, MICROBIOL REV, V43, P73, DOI 10.1128/MMBR.43.1.73-102.1979; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Irizarry RA., 2003, STAT APPL GENET MOL, V2, pArticl; Jacobsen SM, 2008, CLIN MICROBIOL REV, V21, P26, DOI 10.1128/CMR.00019-07; Jain S, 2004, PSEUDOMONAS, VOL 3: BIOSYNTHESIS OF MACROMOLECULES AND MOLECULAR METABOLISM, P53; JARVIS WR, 1992, J ANTIMICROB CHEMOTH, V29, P19, DOI 10.1093/jac/29.suppl_A.19; JENNINGS MP, 1990, J BACTERIOL, V172, P1491, DOI 10.1128/jb.172.3.1491-1498.1990; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kaur AP, 2009, J BIOL CHEM, V284, P56, DOI 10.1074/jbc.M806068200; Klein J, 2008, NUCLEIC ACIDS RES, V36, pW460, DOI 10.1093/nar/gkn217; Kohler T, 2009, P NATL ACAD SCI USA, V106, P6339, DOI 10.1073/pnas.0811741106; Konig B, 1996, INFECT IMMUN, V64, P3252; Lau GW, 2004, TRENDS MOL MED, V10, P599, DOI 10.1016/j.molmed.2004.10.002; Letoffe S, 1998, MOL MICROBIOL, V28, P1223, DOI 10.1046/j.1365-2958.1998.00885.x; Lizewski SE, 2004, J BACTERIOL, V186, P5672, DOI 10.1128/JB.186.17.5672-5684.2004; Llamas MA, 2008, MOL MICROBIOL, V67, P458; Mathee K, 1999, MICROBIOL-SGM, V145, P1349, DOI 10.1099/13500872-145-6-1349; MCAVOY MJ, 1989, J MED MICROBIOL, V28, P183, DOI 10.1099/00222615-28-3-183; McKnight SL, 2000, J BACTERIOL, V182, P2702, DOI 10.1128/JB.182.10.2702-2708.2000; McPhee JB, 2006, J BACTERIOL, V188, P3995, DOI 10.1128/JB.00053-06; Meyer JM, 1997, MICROBIOL-UK, V143, P35, DOI 10.1099/00221287-143-1-35; Mittal R, 2008, J BIOMED SCI, V15, P731, DOI 10.1007/s11373-008-9274-7; Monds RD, 2001, MOL MICROBIOL, V42, P415, DOI 10.1046/j.1365-2958.2001.02641.x; Moore KN, 2002, J CLIN NURS, V11, P568, DOI 10.1046/j.1365-2702.2002.00629.x; Munch R, 2003, NUCLEIC ACIDS RES, V31, P266, DOI 10.1093/nar/gkg037; NG FMW, 1973, BIOCHEM J, V132, P129, DOI 10.1042/bj1320129; OBERNESSER HJ, 1981, ZBL BAKT-INT J MED M, V249, P76, DOI 10.1016/S0174-3031(81)80044-3; Ochsner UA, 2002, MOL MICROBIOL, V45, P1277, DOI 10.1046/j.1365-2958.2002.03084.x; Ochsner UA, 2000, MICROBIOL-UK, V146, P185, DOI 10.1099/00221287-146-1-185; Oglesby AG, 2008, J BIOL CHEM, V283, P15558, DOI 10.1074/jbc.M707840200; OHMAN DE, 1981, INFECT IMMUN, V33, P142, DOI 10.1128/IAI.33.1.142-148.1981; Palma M, 2004, J BACTERIOL, V186, P248, DOI 10.1128/JB.186.1.248-252.2004; Palma M, 2003, ARCH MICROBIOL, V180, P374, DOI 10.1007/s00203-003-0602-z; Pearson JP, 1997, J BACTERIOL, V179, P5756, DOI 10.1128/jb.179.18.5756-5767.1997; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pesci EC, 1997, J BACTERIOL, V179, P3127, DOI 10.1128/jb.179.10.3127-3132.1997; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Petrova OE, 2012, MOL MICROBIOL; Pollack M., 2000, PRINCIPLES PRACTICE; Poole K, 2003, FRONT BIOSCI-LANDMRK, V8, pD661, DOI 10.2741/1051; Potvin E, 2008, FEMS MICROBIOL REV, V32, P38, DOI 10.1111/j.1574-6976.2007.00092.x; Quinones B, 2005, MOL PLANT MICROBE IN, V18, P682, DOI 10.1094/MPMI-18-0682; Rabilloud T, 2001, PROTEOMICS, V1, P699, DOI 10.1002/1615-9861(200104)1:5<699::AID-PROT699>3.3.CO;2-3; Ronald A, 2003, DM-DIS MON, V49, P71, DOI 10.1067/mda.2003.8; Rumbaugh KP, 1999, J HOSP INFECT, V43, P211, DOI 10.1053/jhin.1999.0252; Schobert M, 2010, FUTURE MICROBIOL, V5, P603, DOI 10.2217/FMB.10.16; Schreiber K, 2006, J BACTERIOL, V188, P659, DOI 10.1128/JB.188.2.659-668.2006; Schurr MJ, 1996, J BACTERIOL, V178, P4997, DOI 10.1128/jb.178.16.4997-5004.1996; SHAND GH, 1985, INFECT IMMUN, V48, P35, DOI 10.1128/IAI.48.1.35-39.1985; Shen JS, 2002, J BACTERIOL, V184, P3268, DOI 10.1128/JB.184.12.3268-3275.2002; Shevchenko A, 2000, METH MOL B, V146, P1, DOI 10.1385/1-59259-045-4:1; Shigemura K, 2006, INT J UROL, V13, P538, DOI 10.1111/j.1442-2042.2006.01359.x; SHORTRIDGE VD, 1992, MOL MICROBIOL, V6, P863, DOI 10.1111/j.1365-2958.1992.tb01537.x; Snyder JA, 2004, INFECT IMMUN, V72, P6373, DOI 10.1128/IAI.72.11.6373-6381.2004; Sriramulu DD, 2005, PROTEOMICS, V5, P3712, DOI 10.1002/pmic.200401227; Sriramulu DD, 2005, J MED MICROBIOL, V54, P667, DOI 10.1099/jmm.0.45969-0; STANIER RY, 1966, J GEN MICROBIOL, V43, P159, DOI 10.1099/00221287-43-2-159; Steinberger RE, 2002, MICROBIAL ECOL, V43, P416, DOI 10.1007/s00248-001-1063-z; Stintzi A, 1998, FEMS MICROBIOL LETT, V166, P341, DOI 10.1111/j.1574-6968.1998.tb13910.x; Strelkov S, 2004, BIOL CHEM, V385, P853, DOI 10.1515/BC.2004.111; Tang HB, 1996, INFECT IMMUN, V64, P37, DOI 10.1128/IAI.64.1.37-43.1996; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Tenke P, 2006, WORLD J UROL, V24, P13, DOI 10.1007/s00345-005-0050-2; Tielen P, 2005, MICROBIOL RES, V160, P165, DOI 10.1016/j.micres.2004.11.003; Tielen P, 2011, INT J MED MICROBIOL, V301, P282, DOI 10.1016/j.ijmm.2010.10.005; Tielen P, 2010, MICROBIOL-SGM, V156, P2239, DOI 10.1099/mic.0.037036-0; Trunk K, 2010, ENVIRON MICROBIOL, V12, P1719, DOI 10.1111/j.1462-2920.2010.02252.x; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; van Delden C, 2004, PSEUDOMONAS, VOL 2: VIRULENCE AND GENE REGULATION, P3; VANDERWAUVEN C, 1984, J BACTERIOL, V160, P928, DOI 10.1128/JB.160.3.928-934.1984; Vasil ML, 2007, BIOMETALS, V20, P587, DOI 10.1007/s10534-006-9067-2; Vasil ML, 1999, MOL MICROBIOL, V34, P399, DOI 10.1046/j.1365-2958.1999.01586.x; Visca P, 2002, MOL MICROBIOL, V45, P1177, DOI 10.1046/j.1365-2958.2002.03088.x; Wade DS, 2005, J BACTERIOL, V187, P4372, DOI 10.1128/JB.187.13.4372-4380.2005; Wagenlehner FME, 2006, CLIN MICROBIOL INFEC, V12, P67, DOI 10.1111/j.1469-0691.2006.01398.x; Wagner VE, 2003, J BACTERIOL, V185, P2080, DOI 10.1128/JB.185.7.2080-2095.2003; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Whiteley M, 1999, P NATL ACAD SCI USA, V96, P13904, DOI 10.1073/pnas.96.24.13904; Wingender J, 2001, METHOD ENZYMOL, V336, P302, DOI 10.1016/S0076-6879(01)36597-7; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Xiao GP, 2006, MICROBIOL-SGM, V152, P1679, DOI 10.1099/mic.0.28605-0; Yang L, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-184; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	134	24	26	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71845	10.1371/journal.pone.0071845	http://dx.doi.org/10.1371/journal.pone.0071845			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967252	Green Published, gold, Green Submitted			2022-12-25	WOS:000323115800087
J	Sone, M; Oyama, K; Mohri, Y; Hayashi, R; Clevers, H; Nishimori, K				Sone, Mizuki; Oyama, Kazunori; Mohri, Yasuaki; Hayashi, Ryotaro; Clevers, Hans; Nishimori, Katsuhiko			LGR4 expressed in uterine epithelium is necessary for uterine gland development and contributes to decidualization in mice	FASEB JOURNAL			English	Article						Lif; Foxa2; Wnt signaling	LEUKEMIA INHIBITORY FACTOR; BLASTOCYST IMPLANTATION; WNT/BETA-CATENIN; INDIAN HEDGEHOG; MOUSE UTERUS; MESENCHYMAL INTERACTIONS; POSTNATAL-DEVELOPMENT; SIGNALING PATHWAY; STEM-CELLS; PROGESTERONE	In previous work we generated mice with a tissue specific ablation of a leucine-rich repeat containing G-protein-coupled receptor 4 (Lgr4) using the Keratin-5 (K5) Cre transgenic mouse strain (Lgr4(K5 KO)). Interestingly, the Lgr4(K5 KO) female mice were subfertile, and their embryos had impaired development. Notably, the contributions of uterine development to the subfertility phenotype were not elucidated in the previous report. In a readdress, the following study explores uterine aberration in Lgr4(K5 KO) female mice. Histological analysis revealed that the uteri of Lgr4(K5 KO) mice displayed altered epithelial differentiation characterized by a reduction in the number of uterine glands. Furthermore, Lgr4 deletion led to the reduced expression of morphoregulatory genes related to the Wnt signaling pathway. Additionally, the uteri of the Lgr4(K5 KO) mice lost the ability to undergo induced decidualization. Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) analysis and administration of recombinant leukemia inhibitory factor (LIF) demonstrated that the impaired decidualization in Lgr4(K5 KO) mice resulted from the decreased secretion of LIF concurrent with a reduction in uterine gland count. Thus, we propose that LGR4 contributes to uterine gland development, which supports decidualization during pregnancy.	[Sone, Mizuki; Oyama, Kazunori; Mohri, Yasuaki; Hayashi, Ryotaro; Nishimori, Katsuhiko] Tohoku Univ, Grad Sch Agr Sci, Mol Biol Lab, Sendai, Miyagi 9818555, Japan; [Clevers, Hans] Univ Med Ctr Utrecht, Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands	Tohoku University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Nishimori, K (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Mol Biol Lab, Aoba Ku, 1-1 Tsutsumidori Amamiyamachi, Sendai, Miyagi 9818555, Japan.	knishimori@m.tohoku.ac.jp			Japan Society for the Promotion of Science for Young Scientists [24112502]; Grants-in-Aid for Scientific Research [24112502] Funding Source: KAKEN	Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid for Scientific Research on Innovative Areas (24112502) and Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists (to Y.M. and K.O).	Aoki M, 2007, DEV BIOL, V301, P218, DOI 10.1016/j.ydbio.2006.08.018; BRANHAM WS, 1985, ENDOCRINOLOGY, V117, P2229, DOI 10.1210/endo-117-5-2229; Cadigan KM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007906; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Chassot AA, 2008, HUM MOL GENET, V17, P1264, DOI 10.1093/hmg/ddn016; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chen JR, 2000, ENDOCRINOLOGY, V141, P4365, DOI 10.1210/en.141.12.4365; Chen W, 2010, CELL TISSUE RES, V341, P441, DOI 10.1007/s00441-010-1013-5; Cooke PS, 2013, MOL HUM REPROD, V19, P547, DOI 10.1093/molehr/gat031; Daikoku T, 2011, DEV CELL, V21, P1014, DOI 10.1016/j.devcel.2011.09.010; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Dunlap KA, 2011, BIOL REPROD, V85, P386, DOI 10.1095/biolreprod.111.091769; Filant J, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.107631; FINN CA, 1972, BIOL REPROD, V7, P82, DOI 10.1093/biolreprod/7.1.82; Franco HL, 2011, FASEB J, V25, P1176, DOI 10.1096/fj.10-175349; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Gray CA, 2001, BIOL REPROD, V65, P1311, DOI 10.1095/biolreprod65.5.1311; Hayashi K, 2011, BIOL REPROD, V84, P308, DOI 10.1095/biolreprod.110.088161; Hoshii T, 2007, BIOL REPROD, V76, P303, DOI 10.1095/biolreprod.106.054619; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Jamin SP, 2002, NAT GENET, V32, P408, DOI 10.1038/ng1003; Jeong JW, 2009, ONCOGENE, V28, P31, DOI 10.1038/onc.2008.363; Jeong JW, 2010, BIOL REPROD, V83, P396, DOI 10.1095/biolreprod.109.083154; Kato S, 2007, FEBS LETT, V581, P4685, DOI 10.1016/j.febslet.2007.08.064; Kato S, 2006, NEPHRON EXP NEPHROL, V104, pE63, DOI 10.1159/000093999; Kubota K, 2010, CELL TISSUE RES, V340, P389, DOI 10.1007/s00441-010-0945-0; Lee K, 2006, NAT GENET, V38, P1204, DOI 10.1038/ng1874; Lee KY, 2007, TRENDS ENDOCRIN MET, V18, P234, DOI 10.1016/j.tem.2007.06.002; Lee KY, 2007, MOL CELL BIOL, V27, P5468, DOI 10.1128/MCB.00342-07; Lee KY, 2004, REPRODUCTION, V128, P679, DOI 10.1530/rep.1.00340; Li QX, 2007, J BIOL CHEM, V282, P31725, DOI 10.1074/jbc.M704723200; Li QX, 2013, ENDOCRINOLOGY, V154, P446, DOI 10.1210/en.2012-1585; Li XY, 2010, DEVELOPMENT, V137, P151, DOI 10.1242/dev.040659; Liu SJ, 2013, J BIOL CHEM, V288, P8794, DOI 10.1074/jbc.M112.436204; MARTIN L, 1973, J ENDOCRINOL, V57, P549, DOI 10.1677/joe.0.0570549; Matsumoto H, 2002, DEV BIOL, V245, P280, DOI 10.1006/dbio.2002.0645; Mendive F, 2006, DEV BIOL, V290, P421, DOI 10.1016/j.ydbio.2005.11.043; Mericskay M, 2004, DEVELOPMENT, V131, P2061, DOI 10.1242/dev.01090; Miller C, 1998, DEVELOPMENT, V125, P3201; Mohri Y, 2012, BIOSCI BIOTECH BIOCH, V76, P888, DOI 10.1271/bbb.110834; Mohri Y, 2011, DEV DYNAM, V240, P1626, DOI 10.1002/dvdy.22651; Mohri Y, 2010, FERTIL STERIL, V94, P2878, DOI 10.1016/j.fertnstert.2010.05.050; Mustata RC, 2011, EMBO REP, V12, P558, DOI 10.1038/embor.2011.52; Nallasamy S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002500; Nam JS, 2007, DEV BIOL, V311, P124, DOI 10.1016/j.ydbio.2007.08.023; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Oyama K, 2011, SEX DEV, V5, P205, DOI 10.1159/000329476; Qian Y, 2013, DEVELOPMENT, V140, P1751, DOI 10.1242/dev.093641; Ramathal CY, 2010, SEMIN REPROD MED, V28, P17, DOI 10.1055/s-0029-1242989; RIDER V, 1985, J ENDOCRINOL, V104, P153, DOI 10.1677/joe.0.1040153; Shelton DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040312; Song H, 2006, REPRODUCTION, V131, P341, DOI 10.1530/rep.1.00956; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Takamoto N, 2005, MOL ENDOCRINOL, V19, P2299, DOI 10.1210/me.2005-0019; Takamoto N, 2002, MOL ENDOCRINOL, V16, P2338, DOI 10.1210/me.2001-0154; Tarutani M, 1997, P NATL ACAD SCI USA, V94, P7400, DOI 10.1073/pnas.94.14.7400; Thie M, 1996, INT J DEV BIOL, V40, P389; Tomizuka K, 2008, HUM MOL GENET, V17, P1278, DOI 10.1093/hmg/ddn036; Villacorte M, 2013, ONCOGENE, V32, P3477, DOI 10.1038/onc.2012.376; Wang Y, 2013, STEM CELLS, V31, P1921, DOI 10.1002/stem.1438	63	23	25	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2013	27	12					4917	4928		10.1096/fj.13-232215	http://dx.doi.org/10.1096/fj.13-232215			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	293UK	23975934				2022-12-25	WOS:000329999000026
J	Nunez-Iglesias, J; Kennedy, R; Parag, T; Shi, J; Chklovskii, DB				Nunez-Iglesias, Juan; Kennedy, Ryan; Parag, Toufiq; Shi, Jianbo; Chklovskii, Dmitri B.			Machine Learning of Hierarchical Clustering to Segment 2D and 3D Images	PLOS ONE			English	Article							ELECTRON-MICROSCOPY; TISSUE; LOBE	We aim to improve segmentation through the use of machine learning tools during region agglomeration. We propose an active learning approach for performing hierarchical agglomerative segmentation from superpixels. Our method combines multiple features at all scales of the agglomerative process, works for data with an arbitrary number of dimensions, and scales to very large datasets. We advocate the use of variation of information to measure segmentation accuracy, particularly in 3D electron microscopy (EM) images of neural tissue, and using this metric demonstrate an improvement over competing algorithms in EM and natural images.	[Nunez-Iglesias, Juan; Parag, Toufiq; Chklovskii, Dmitri B.] Howard Hughes Med Inst, Ashburn, VA USA; [Kennedy, Ryan; Shi, Jianbo] Univ Penn, Dept Comp & Informat Sci, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania	Nunez-Iglesias, J (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA USA.	jni@janelia.hhmi.org		Nunez-Iglesias, Juan/0000-0002-7239-5828	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	Funding was provided by the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JR, 2009, PLOS BIOL, V7, P493, DOI 10.1371/journal.pbio.1000074; Andres B, 2008, LECT NOTES COMPUT SC, V5096, P142, DOI 10.1007/978-3-540-69321-5_15; Andres B, 2012, LECT NOTES COMPUT SC, V7574, P778, DOI 10.1007/978-3-642-33712-3_56; Andres B, 2012, MED IMAGE ANAL, V16, P796, DOI 10.1016/j.media.2011.11.004; Andres B, 2011, IEEE I CONF COMP VIS, P2611, DOI 10.1109/ICCV.2011.6126550; Arbelaez P, 2011, IEEE T PATTERN ANAL, V33, P898, DOI 10.1109/TPAMI.2010.161; Brendel W, 2010, NEURAL INFORM PROCES, V4, P5; Cheng B, 2011, ICCV, V2; Chklovskii DB, 2010, CURR OPIN NEUROBIOL, V20, P667, DOI 10.1016/j.conb.2010.08.002; Ciresan D, 2012, NIPS, V2012, P2852; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Dollar P., 2006, P IEEE COMP SOC C CO, V2, P1964, DOI DOI 10.1109/CVPR.2006.298; Funke J, 2012, PROC CVPR IEEE, P1004, DOI 10.1109/CVPR.2012.6247777; Grundmann M, 2010, PROC CVPR IEEE, P2141, DOI 10.1109/CVPR.2010.5539893; Harris KM, 2006, J NEUROSCI, V26, P12101, DOI 10.1523/JNEUROSCI.3994-06.2006; Hayworth K., 2006, MICROSCOPY MICROA S2, V12, P86, DOI [10.1017/s1431927606066268, DOI 10.1017/S1431927606066268]; Jain V, 2011, ADV NEURAL INFORM PR, V24, p[8, 11]; Jain V, 2010, PROC CVPR IEEE, P2488, DOI 10.1109/CVPR.2010.5539950; Jurrus E, 2013, NEUROINFORMATICS, V11, P5, DOI 10.1007/s12021-012-9149-y; Jurrus E, 2010, MED IMAGE ANAL, V14, P770, DOI 10.1016/j.media.2010.06.002; Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008; Kreshuk A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024899; Laissue PP, 1999, J COMP NEUROL, V405, P543; Laptev D, 2012, LECT NOTES COMPUT SC, V7510, P323, DOI 10.1007/978-3-642-33415-3_40; Lichtman JW, 2011, SCIENCE, V334, P618, DOI 10.1126/science.1209168; Liu T, 2012, PATTERN RECOGN, V2, p[133, 11]; Malewicz G., 2010, P 2010 ACM SIGMOD IN, P135, DOI [DOI 10.1145/1807167.1807184, 10.1145/1807167.1807184]; Martin DR, 2004, IEEE T PATTERN ANAL, V26, P530, DOI 10.1109/TPAMI.2004.1273918; Meila M., 2003, P 16 ANN C COMP LEAR; Plaza SM, 2012, PLOS ONE IN PRESS; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Ren XF, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P10; Sommer C, 2011, 8 IEEE INT S BIOM IM, V5; Takemura SY, 2008, J COMP NEUROL, V509, P493, DOI 10.1002/cne.21757; Turaga S, 2009, ADV NEURAL INFO P SY, V22, P6; Varma M, 2005, INT J COMPUT VISION, V62, P61, DOI 10.1007/s11263-005-4635-4; Vazquez-Reina A., 2011, ICCV; VINCENT L, 1991, IEEE T PATTERN ANAL, V13, P583, DOI 10.1109/34.87344; Vinh NX, 2010, J MACHINE LEARNING R, V9999; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	40	79	81	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71715	10.1371/journal.pone.0071715	http://dx.doi.org/10.1371/journal.pone.0071715			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977123	Green Submitted, Green Published, gold			2022-12-25	WOS:000324527300032
J	Ryu, J; Zhang, R; Hong, BH; Yang, EJ; Kang, KA; Choi, M; Kim, KC; Noh, SJ; Kim, HS; Lee, NH; Hyun, JW; Kim, HS				Ryu, Junghwa; Zhang, Rui; Hong, Bo-Hyun; Yang, Eun-Jung; Kang, Kyoung Ah; Choi, Moonseok; Kim, Ki Cheon; Noh, Su-Jin; Kim, Hee Soo; Lee, Nam-Ho; Hyun, Jin Won; Kim, Hye-Sun			Phloroglucinol Attenuates Motor Functional Deficits in an Animal Model of Parkinson's Disease by Enhancing Nrf2 Activity	PLOS ONE			English	Article							ANTIOXIDANT RESPONSE ELEMENT; INDUCED CELL-DAMAGE; OXIDATIVE STRESS; BASAL GANGLIA; SPINY NEURONS; PHOSPHORYLATION; PATHOGENESIS; EXPRESSION; DEPRESSION; APOPTOSIS	In this study, we investigated whether phloroglucinol (1, 3, 5 - trihydroxybenzene) has therapeutic effects in cellular and animal model of Parkinson's disease (PD). PD is the second most common, chronic and progressive neurodegenerative disease, and is clinically characterized with motor dysfunctions such as bradykinesia, rigidity, postural instability, gait impairment, and resting tremor. In the brains of PD patients, dopaminergic neuronal loss is observed in the Substantia nigra. Although the exact mechanisms underlying PD are largely unknown, mitochondrial dysfunction and oxidative stress are thought to be critical factors that induce the onset of the disease. Here, phloroglucinol administration was shown to attenuate motor functional deficits evaluated with rota-rod and apomorphine-induced rotation tests in 6-hydroxydopamine (6-OHDA)-induced PD animal models. Moreover, phloroglucinol ameliorated the loss of synapses as assessed with protein levels and immunoreactivity against synaptophysin in the midbrain region of the 6-OHDA-lesioned rats. In addition, in SH-SY5Y cultures, the cytotoxicity of 6-OHDA was reduced by pre-treatment with phloroglucinol. The increase in the reactive oxygen species, lipid peroxidation, protein carbonyl formation and 8-hydroxyguanine caused by treatment with 6-OHDA was attenuated by phloroglucinol in SH-SY5Y cells. Furthermore, phloroglucinol treatment rescued the reduced levels of nuclear Nrf2, antioxidant enzymes, i.e., catalase and glutathione peroxidase, in 6-OHDA-treated cells. Taken together, phloroglucinol has a therapeutic potential for treatment of PD.	[Ryu, Junghwa; Hong, Bo-Hyun; Yang, Eun-Jung; Choi, Moonseok; Noh, Su-Jin; Kim, Hye-Sun] Seoul Natl Univ, Coll Med, Dept Pharmacol & Biomed Sci, Seoul, South Korea; [Zhang, Rui; Kang, Kyoung Ah; Kim, Ki Cheon; Hyun, Jin Won] Jeju Natl Univ, Sch Med, Cheju, South Korea; [Zhang, Rui; Kang, Kyoung Ah; Kim, Ki Cheon; Hyun, Jin Won] Jeju Natl Univ, Inst Nucl Sci & Technol, Cheju, South Korea; [Kim, Hee Soo] Konkuk Univ, Sch Anim Biosci & Technol, Seoul, South Korea; [Lee, Nam-Ho] Jeju Natl Univ, Dept Chem, Coll Nat Sci, Cheju, South Korea; [Kim, Hye-Sun] Seoul Natl Univ, Bundang Hosp, Songnam, South Korea; [Kim, Hye-Sun] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea	Seoul National University (SNU); Jeju National University; Jeju National University; Konkuk University; Jeju National University; Seoul National University (SNU); Seoul National University (SNU)	Hyun, JW (corresponding author), Jeju Natl Univ, Sch Med, Cheju, South Korea.	jinwonh@jejunu.ac.kr; hyisun@snu.ac.kr	Ryu, Junghwa/K-4034-2015; Noh, Su-Jin/D-8362-2012; Kim, Ki Cheon/AAD-4474-2019	Choi, Moonseok/0000-0002-2816-239X	Seoul National University Hospital Research Fund [880-20110051]; Seoul National University College of Medicine [800-20110052]; National Research Foundation of Korea [2008-314-E00179]; Korea Healthcare Technology Research & Development Project by Ministry for Health, Welfare and Family Affairs, Republic of Korea [A111230]	Seoul National University Hospital Research Fund; Seoul National University College of Medicine; National Research Foundation of Korea(National Research Foundation of Korea); Korea Healthcare Technology Research & Development Project by Ministry for Health, Welfare and Family Affairs, Republic of Korea	This work was supported by grant No 880-20110051 from the Seoul National University Hospital Research Fund &800-20110052 from the Seoul National University College of Medicine, by grants from National Research Foundation of Korea Grants 2008-314-E00179 and from Korea Healthcare Technology Research & Development Project (A111230) by Ministry for Health, Welfare and Family Affairs, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ayadi EA, 2011, PLOS ONE, V6; Bagetta V, 2011, J NEUROSCI, V31, P12513, DOI 10.1523/JNEUROSCI.2236-11.2011; Beauchamp MC, 2002, J LIPID RES, V43, P215; Bove Jordi, 2005, NeuroRx, V2, P484, DOI 10.1602/neurorx.2.3.484; CARMICHAEL J, 1987, CANCER RES, V47, P936; Chan KM, 1999, P NATL ACAD SCI USA, V96, P12731, DOI 10.1073/pnas.96.22.12731; D'Errico M, 2008, MUTAT RES-REV MUTAT, V659, P4, DOI 10.1016/j.mrrev.2007.10.003; Deumens R, 2002, EXP NEUROL, V175, P303, DOI 10.1006/exnr.2002.7891; Dinkova-Kostova AT, 2005, BIOCHEMISTRY-US, V44, P6889, DOI 10.1021/bi047434h; FAHN S, 1992, ANN NEUROL, V32, P804, DOI 10.1002/ana.410320616; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; Hauser RA, 2009, MOVEMENT DISORD, V24, P564, DOI 10.1002/mds.22402; Huang HC, 2000, P NATL ACAD SCI USA, V97, P12475, DOI 10.1073/pnas.220418997; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Hwang CK, 2012, BIOSCI BIOTECH BIOCH, V76, P536, DOI 10.1271/bbb.110842; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Jenner P, 1996, NEUROLOGY, V47, pS161, DOI 10.1212/WNL.47.6_Suppl_3.161S; Kang KA, 2006, J CELL BIOCHEM, V97, P609, DOI 10.1002/jcb.20668; Kang KA, 2010, CHEM-BIOL INTERACT, V185, P215, DOI 10.1016/j.cbi.2010.02.031; Kostrzewa RM, 2007, NEUROTOX RES, V11, P261, DOI 10.1007/BF03033571; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Li J, 2012, PHARMAZIE, V67, P718, DOI 10.1691/ph.2012.2515; Li MH, 2006, FREE RADICAL BIO MED, V41, P1079, DOI 10.1016/j.freeradbiomed.2006.06.010; Moon C, 2008, PHYTOTHER RES, V22, P238, DOI 10.1002/ptr.2298; Piao MJ, 2012, PHOTOCHEM PHOTOBIOL, V88, P381, DOI 10.1111/j.1751-1097.2012.01074.x; Pulido R, 2000, J AGR FOOD CHEM, V48, P3396, DOI 10.1021/jf9913458; ROSENKRANZ AR, 1992, J IMMUNOL METHODS, V156, P39, DOI 10.1016/0022-1759(92)90008-H; Sauer T, 2013, AMINO ACIDS, V44, P1427, DOI 10.1007/s00726-012-1222-1; Schapira AH, 2011, MOVEMENT DISORD, V26, P1049, DOI 10.1002/mds.23732; Schober A, 2004, CELL TISSUE RES, V318, P215, DOI 10.1007/s00441-004-0938-y; Shulman JM, 2011, ANNU REV PATHOL-MECH, V6, P193, DOI 10.1146/annurev-pathol-011110-130242; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Sinha D, 2013, ARCH TOXICOL, V87, P383, DOI 10.1007/s00204-012-0920-5; Thrornton E, 2012, PLOS ONE, V7; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; Vomhof-DeKrey EE, 2012, J NUTR BIOCHEM, V23, P1201, DOI 10.1016/j.jnutbio.2012.03.005; Wang ZF, 2006, NEURON, V50, P443, DOI 10.1016/j.neuron.2006.04.010; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Yuan Hong, 2007, Neurosci Bull, V23, P125, DOI 10.1007/s12264-007-0018-x	41	41	42	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71178	10.1371/journal.pone.0071178	http://dx.doi.org/10.1371/journal.pone.0071178			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23976995	Green Published, Green Submitted, gold			2022-12-25	WOS:000324527300006
J	Dollive, S; Chen, YY; Grunberg, S; Bittinger, K; Hoffmann, C; Vandivier, L; Cuff, C; Lewis, JD; Wu, GD; Bushman, FD				Dollive, Serena; Chen, Ying-Yu; Grunberg, Stephanie; Bittinger, Kyle; Hoffmann, Christian; Vandivier, Lee; Cuff, Christopher; Lewis, James D.; Wu, Gary D.; Bushman, Frederic D.			Fungi of the Murine Gut: Episodic Variation and Proliferation during Antibiotic Treatment	PLOS ONE			English	Article							BROAD-SPECTRUM ANTIBIOTICS; RIBOSOMAL-RNA SEQUENCES; BACTERIAL MICROBIOTA; CANDIDA-ALBICANS; COLONIZATION; INFECTION; THERAPY; FLUCONAZOLE; RESISTANCE; DISEASE	Antibiotic use in humans has been associated with outgrowth of fungi. Here we used a murine model to investigate the gut microbiome over 76 days of treatment with vancomycin, ampicillin, neomycin, and metronidazole and subsequent recovery. Mouse stool was studied as a surrogate for the microbiota of the lower gastrointestinal tract. The abundance of fungi and bacteria was measured using quantitative PCR, and the proportional composition of the communities quantified using 454/Roche pyrosequencing of rRNA gene tags. Prior to treatment, bacteria outnumbered fungi >3orders of magnitude. Upon antibiotic treatment, bacteria dropped in abundance >3 orders of magnitude, so that the predominant 16S sequences detected became transients derived from food. Upon cessation of treatment, bacterial communities mostly returned to their previous numbers and types after 8 weeks, though communities remained detectably different from untreated controls. Fungal communities varied substantially over time, even in the untreated controls. Separate cages within the same treatment group showed radical differences, but mice within a cage generally behaved similarly. Fungi increased,40-fold in abundance upon antibiotic treatment but declined back to their original abundance after cessation of treatment. At the last time point, Candida remained more abundant than prior to treatment. These data show that 1) gut fungal populations change radically during normal mouse husbandry, 2) fungi grow out in the gut upon suppression of bacterial communities with antibiotics, and 3) perturbations due to antibiotics persist long term in both the fungal and bacterial microbiota.	[Dollive, Serena; Chen, Ying-Yu; Grunberg, Stephanie; Bittinger, Kyle; Hoffmann, Christian; Vandivier, Lee; Cuff, Christopher; Lewis, James D.; Wu, Gary D.; Bushman, Frederic D.] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA	University of Pennsylvania	Wu, GD (corresponding author), Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.	gdwu@mail.med.upenn.edu; bushman@mail.med.upenn.edu	Bittinger, Kyle/ABG-2342-2020; chen, ying/HHS-8254-2022; Hoffmann, Christian/C-1298-2015	Hoffmann, Christian/0000-0003-1736-8007; Bushman, Frederic/0000-0003-4740-4056	Penn Genome Frontiers Institute [UH2DK083981]; National Institutes of Health (NIH) [AI39368]; Penn Digestive Disease Center [P30 DK050306]; Joint Penn-CHOP Center for Digestive, Liver, and Pancreatic Medicine [S10RR024525, UL1RR024134, K24-DK078228]; University of Pennsylvania Center for AIDS Research (CFAR); NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024525, UL1RR024134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UH2DK083981, K24DK078228, P30DK050306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007229] Funding Source: NIH RePORTER	Penn Genome Frontiers Institute; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Penn Digestive Disease Center; Joint Penn-CHOP Center for Digestive, Liver, and Pancreatic Medicine; University of Pennsylvania Center for AIDS Research (CFAR); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Project UH2DK083981, the Penn Genome Frontiers Institute; National Institutes of Health (NIH) AI39368 (GDW); Penn Digestive Disease Center (P30 DK050306); The Joint Penn-CHOP Center for Digestive, Liver, and Pancreatic Medicine; S10RR024525; UL1RR024134, and K24-DK078228; and the University of Pennsylvania Center for AIDS Research (CFAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT J, 1995, ANN EMERG MED, V25, P587, DOI 10.1016/S0196-0644(95)70168-0; Acinas SG, 2004, J BACTERIOL, V186, P2629, DOI 10.1128/JB.186.9.2629-2635.2004; Ampel NM, 1996, EMERG INFECT DIS, V2, P109, DOI 10.3201/eid0202.960205; Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; Arikan-Akdagli S, 2012, ANN NY ACAD SCI, V1272, P9, DOI 10.1111/j.1749-6632.2012.06815.x; Ben-Ami R, 2012, ANTIMICROB AGENTS CH, V56, P2518, DOI 10.1128/AAC.05947-11; BOW EJ, 1987, CAN MED ASSOC J, V137, P397; Burgel PR, 2012, ANTIMICROB AGENTS CH, V56, P869, DOI 10.1128/AAC.05077-11; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chamilos G, 2006, HAEMATOL-HEMATOL J, V91, P986; Chang CF, 2012, ANTON LEEUW INT J G, V102, P9, DOI 10.1007/s10482-012-9708-0; Charlson ES, 2012, AM J RESP CRIT CARE, V186, P536, DOI 10.1164/rccm.201204-0693OC; Chen KY, 2001, CHEST, V120, P177, DOI 10.1378/chest.120.1.177; Cheong JW, 2012, FLUCONAZOLE RESISTAN; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dollive S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r60; GALLIS HA, 1975, ARCH INTERN MED, V135, P1163, DOI 10.1001/archinte.135.9.1163; Herrera ML, 2009, J CLIN MICROBIOL, V47, P1325, DOI 10.1128/JCM.02073-08; Hill DA, 2010, MUCOSAL IMMUNOL, V3, P148, DOI 10.1038/mi.2009.132; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kamada N, 2012, SCIENCE, V336, P1325, DOI 10.1126/science.1222195; Karchmer A W, 1995, Trans Am Clin Climatol Assoc, V106, P38; Ko KS, 2002, MOL PHYLOGENET EVOL, V23, P112, DOI 10.1016/S1055-7903(02)00009-X; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Koo S, 2012, TRANSPLANTATION, V94, P281, DOI 10.1097/TP.0b013e318255f864; Kurtzman CP, 2008, FEMS YEAST RES, V8, P939, DOI 10.1111/j.1567-1364.2008.00419.x; Kurtzman CP, 2011, ANTON LEEUW INT J G, V99, P13, DOI 10.1007/s10482-010-9505-6; Lee CM, 2008, FEMS MICROBIOL LETT, V287, P136, DOI 10.1111/j.1574-6968.2008.01305.x; LEYDEN JJ, 1973, ARCH DERMATOL, V107, P208, DOI 10.1001/archderm.107.2.208; Lionakis MS, 2003, LANCET, V362, P1828, DOI 10.1016/S0140-6736(03)14904-5; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2008, FEMS MICROBIOL REV, V32, P557, DOI 10.1111/j.1574-6976.2008.00111.x; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Mason KL, 2012, INFECT IMMUN, V80, P3371, DOI 10.1128/IAI.00449-12; Mason KL, 2012, INFECT IMMUN, V80, P150, DOI 10.1128/IAI.05162-11; Metwally L, 2008, J MED MICROBIOL, V57, P296, DOI 10.1099/jmm.0.47617-0; Moris DV, 2012, J MED MICROBIOL, V61, P1758, DOI 10.1099/jmm.0.045112-0; MULLIGAN ME, 1982, ANTIMICROB AGENTS CH, V22, P226, DOI 10.1128/AAC.22.2.226; Noverr MC, 2005, INFECT IMMUN, V73, P30, DOI 10.1128/IAI.73.1.30-38.2005; OKSALA E, 1990, ACTA ODONTOL SCAND, V48, P71, DOI 10.3109/00016359009012736; Perfect JR, 1999, DRUG RESIST UPDATE, V2, P259, DOI 10.1054/drup.1999.0090; Peterfreund GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046966; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rohel E, 1997, MYCOL RES, V101, P573, DOI 10.1017/S0953756296002961; SAMONIS G, 1993, ANTIMICROB AGENTS CH, V37, P51, DOI 10.1128/AAC.37.1.51; SAMONIS G, 1994, ANTIMICROB AGENTS CH, V38, P602, DOI 10.1128/AAC.38.3.602; Samuel BS, 2007, P NATL ACAD SCI USA, V104, P10643, DOI 10.1073/pnas.0704189104; Sasse C, 2012, MOL MICROBIOL, V86, P539, DOI 10.1111/j.1365-2958.2012.08210.x; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Schloss PD, 2012, GUT MICROBES, V3, P383, DOI 10.4161/gmic.21008; Schoch C. L., 2012, P NATL ACAD SCI US; Scupham AJ, 2006, APPL ENVIRON MICROB, V72, P793, DOI 10.1128/AEM.72.1.793-801.2006; Trenschel R, 2000, BONE MARROW TRANSPL, V26, P993, DOI 10.1038/sj.bmt.1702655; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Valente P, 1997, J GEN APPL MICROBIOL, V43, P179, DOI 10.2323/jgam.43.179; Viscoli C, 1999, CLIN INFECT DIS, V28, P1071, DOI 10.1086/514731; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206	62	140	147	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71806	10.1371/journal.pone.0071806	http://dx.doi.org/10.1371/journal.pone.0071806			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977147	gold, Green Submitted, Green Published			2022-12-25	WOS:000323425700103
J	Zhang, P; Maruyama, T; Konkel, JE; Abbatiello, B; Zamarron, B; Wang, ZQ; Chen, WJ				Zhang, Pin; Maruyama, Takashi; Konkel, Joanne E.; Abbatiello, Brittany; Zamarron, Brian; Wang, Zhao-qi; Chen, WanJun			PARP-1 Controls Immunosuppressive Function of Regulatory T Cells by Destabilizing Foxp3	PLOS ONE			English	Article							POLY(ADP-RIBOSE) POLYMERASE GENE; IMMUNOLOGICAL SELF-TOLERANCE; TRANSCRIPTION FACTOR FOXP3; MICE LACKING; ANTIGEN 4; TGF-BETA; ACTIVATION; RESISTANT; PLAYS	Poly (ADP-ribose) polymerase-1 (PARP-1) is a nuclear enzyme and transcription factor that is involved in inflammatory response, but its role in T cell response remains largely unknown. We show here that PARP-1 regulates the suppressive function of CD4(+)CD25(+)Foxp3(+) regulatory T cells (Tregs). Specifically, Tregs in mice with a null mutation of the PARP-1 gene (PARP-1(-/-)) showed significantly stronger suppressive activity than did wild-type Tregs in culture. We elucidate that this enhanced suppressive function is attributed to sustained higher expression of Foxp3 and CD25 in PARP-1(-/-) Tregs. Furthermore, in PARP-1(-/-) Tregs, Foxp3 protein shows substantially higher levels of binding to the conserved non-coding DNA sequence 2 (CNS2) at the foxp3 gene, a region important in maintaining Foxp3 gene expression in Tregs. Thus, our data reveal a role for PARP-1 in controlling the function of Tregs through modulation of the stable expression of Foxp3.	[Zhang, Pin; Maruyama, Takashi; Konkel, Joanne E.; Abbatiello, Brittany; Zamarron, Brian; Chen, WanJun] Natl Inst Dent & Craniofacial Res, Mucosal Immunol Unit, OIIB, NIH, Bethesda, MD USA; [Wang, Zhao-qi] Fritz Lipmann Inst eV, Leibniz Inst Age Res, D-07745 Jena, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Chen, WJ (corresponding author), Natl Inst Dent & Craniofacial Res, Mucosal Immunol Unit, OIIB, NIH, Bethesda, MD USA.	wchen@dir.nidcr.nih.gov	MaruYama, Takashi/N-5994-2014	MaruYama, Takashi/0000-0003-0820-3219; Zamarron, Brian/0000-0001-6549-4230	Intramural Research Program of the National Institute of Dental and Craniofacial Research of the National Institutes of Health; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000101] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Dental and Craniofacial Research of the National Institutes of Health; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by the Intramural Research Program of the National Institute of Dental and Craniofacial Research of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson J, 2010, CELL, V140, P123, DOI 10.1016/j.cell.2009.12.030; Belkaid Y, 2009, IMMUNITY, V30, P322, DOI 10.1016/j.immuni.2009.03.004; Bluestone JA, 2009, NAT REV IMMUNOL, V9, P811, DOI 10.1038/nri2654; Burkart V, 1999, NAT MED, V5, P314, DOI 10.1038/6535; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen WJ, 2003, CYTOKINE GROWTH F R, V14, P85, DOI 10.1016/S1359-6101(03)00003-0; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; Farez MF, 2009, NAT IMMUNOL, V10, P958, DOI 10.1038/ni.1775; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; Nakamura K, 2004, J IMMUNOL, V172, P834, DOI 10.4049/jimmunol.172.2.834; Nasta F, 2010, J IMMUNOL, V184, P3470, DOI 10.4049/jimmunol.0901568; Petrilli V, 2004, J CLIN INVEST, V114, P1072, DOI 10.1172/JCI200421854; Powrie F, 2003, SCIENCE, V299, P1030, DOI 10.1126/science.1082031; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Shevach EM, 2001, J EXP MED, V193, pF41, DOI 10.1084/jem.193.11.F41; Soriano FG, 2001, NAT MED, V7, P108, DOI 10.1038/83241; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Waldmann H, 2008, J CLIN IMMUNOL, V28, P716, DOI 10.1007/s10875-008-9249-5; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Zheng Y, 2010, NATURE	32	24	25	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71590	10.1371/journal.pone.0071590	http://dx.doi.org/10.1371/journal.pone.0071590			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977081	Green Published, gold, Green Submitted			2022-12-25	WOS:000323425700072
J	Wang, LL; Zheng, WS; Chen, SH; Fang, XQ				Wang, Lu-Lu; Zheng, Wen-Sheng; Chen, Shao-Hua; Fang, Xia-Qin			Development of In Situ Gelling and Bio Adhesive 5-Fluorouracil Enema	PLOS ONE			English	Article							ACETAMINOPHEN LIQUID SUPPOSITORY; SURFACE-ENERGY ANALYSIS; RADIATION-THERAPY; DRUG-DELIVERY; PREOPERATIVE IRRADIATION; SODIUM-CHLORIDE; POLOXAMER GELS; RECTAL-CANCER; CARCINOMA; RELEASE	In this study, a novel 5-Fluorouracil (5-FU) enema with good bio adhesion and temperature sensitivity was developed using in situ gelling technology. The preparation was formulated as a free-flowing liquid before use, while a layer of gel film was quickly formed when administered in the rectum, with a large contact surface area. It also demonstrated good biocompatibility, appropriate gel strength and bio adhesive force with excellent adhesion to rectal mucosa and prolonged action time, allowing more effective drug absorption and diffusion to surrounding tissues. Poloxamer 407 and poloxamer 188 were applied to adjust the gelling temperature. With the addition of carbopol and polycarbophil (bio adhesive substances), the solubility of 5-FU and gel strength increased, the temperature of gelation and the surface area of drug contact on mucous epithelium decreased. Decreased adhesive force between the preparation and the mucous membrane of the rectum was demonstrated with improving carbopol and polycarbophil's concentration. In vitro release demonstrated that 5-FU in situ gelling enema with different bases had a rapid and almost complete drug release. We used an optimized formulation of P407/P188/polycarbophil/5-FU (17/2.5/0.2/1.0) for animal experiments. The result showed that the drug evenly covered the surface of the rectum and there was no leakage in 6 hours. The in situ gelling enema showed significantly higher rectal tissue levels of 5-FU compared with suppository and intravenous administration, indicating that 5-FU could be well absorbed due to the enlarged releasing area, longer retention time and larger amount of dissolved active ingredients. Systemically, 5-FU levels in the enema group were similar to those in the suppository group and significantly lower than the intravenous group. The enema was not associated with morphological damage to rectal tissue. These results suggest that the bio adhesive and in situ gelling enema could be a more effective rectal delivery system of 5-FU.	[Zheng, Wen-Sheng] Chinese Acad Med Sci, Inst Mat Med, Beijing 100050, Peoples R China; Peking Union Med Coll, Beijing City Key Lab Drug Delivery Technol & Nove, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zheng, WS (corresponding author), Chinese Acad Med Sci, Inst Mat Med, Beijing 100050, Peoples R China.	zhengwensheng@imm.ac.cn						Anderson BC, 2001, J CONTROL RELEASE, V70, P157, DOI 10.1016/S0168-3659(00)00341-2; ANDERSON JH, 1992, BRIT J CANCER, V65, P133, DOI 10.1038/bjc.1992.26; Barakat NS, 2009, AAPS PHARMSCITECH, V10, P724, DOI 10.1208/s12249-009-9261-y; BOUBLIL JL, 1985, BRIT J CANCER, V52, P15, DOI 10.1038/bjc.1985.142; Charrueau C, 2001, DRUG DEV IND PHARM, V27, P351, DOI 10.1081/DDC-100103735; Chen MJ, 2012, INT J COLORECTAL DIS, V27, P869, DOI 10.1007/s00384-011-1393-3; Choi HG, 1998, INT J PHARM, V165, P33, DOI 10.1016/S0378-5173(97)00386-4; Choi HG, 1998, INT J PHARM, V165, P23, DOI 10.1016/S0378-5173(97)00385-2; DUCHENE D, 1988, DRUG DEV IND PHARM, V14, P283, DOI 10.3109/03639048809151972; El-Kamel A, 2006, DRUG DELIV, V13, P143, DOI 10.1080/10717540500316003; ESPOSITO P, 1994, BIOMATERIALS, V15, P177, DOI 10.1016/0142-9612(94)90064-7; FRAILE RJ, 1980, CANCER RES, V40, P2223; Galandiuk S, 1996, ANN SURG ONCOL, V3, P270, DOI 10.1007/BF02306282; Ganguly S, 2004, INT J PHARMACEUT, V276, P83, DOI 10.1016/j.ijpharm.2004.02.014; GU JM, 1988, CRC CR REV THER DRUG, V5, P21; Havaldar, 2009, INT J CHEM TECH RES, V1, P953; Hearan SJun HW, 1996, INT J PHARM, V129, P13; Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3; JUNGINGER HE, 1991, PHARM IND, V53, P1056; Keny R.V., 2010, INT J PHARM BIO SCI, V1, P1; Kim CK, 1998, INT J PHARM, V174, P201, DOI 10.1016/S0378-5173(98)00258-0; Koffi AA, 2008, EUR J PHARM BIOPHARM, V69, P167, DOI 10.1016/j.ejpb.2007.09.017; Krishnaiah YSR, 2002, EUR J PHARM SCI, V16, P185, DOI 10.1016/S0928-0987(02)00081-7; L MA, 1994, CHINESE J PHARM, P433; LANDRY JC, 1993, RADIOLOGY, V188, P423, DOI 10.1148/radiology.188.2.8327689; LEHR CM, 1992, PHARMACEUT RES, V9, P70, DOI 10.1023/A:1018931811189; LEHR CM, 1993, EUR J PHARM SCI, V1, P19, DOI 10.1016/0928-0987(93)90014-2; Leung SS, 1990, POLYM NEWS, V15, P333; Lu GW, 1998, INT J PHARM, V160, P1, DOI 10.1016/S0378-5173(97)00187-7; Mayol L, 2011, BIOMACROMOLECULES, V12, P28, DOI 10.1021/bm1008958; MINSKY BD, 1993, INT J RADIAT ONCOL, V25, P821, DOI 10.1016/0360-3016(93)90311-I; Nieto NL, 2010, EUR J PHARM SCI, V80, P585; NISHIOKA B, 1980, Japanese Journal of Surgery, V10, P110, DOI 10.1007/BF02468674; Pandit NK, 1998, INT J PHARM, V167, P183, DOI 10.1016/S0378-5173(98)00074-X; Park YJ, 2003, INT J PHARM, V263, P105, DOI 10.1016/S0378-5173(03)00362-4; PEPPAS N A, 1985, Journal of Controlled Release, V2, P257, DOI 10.1016/0168-3659(85)90050-1; Percarpio B, 1992, Conn Med, V56, P7; PHILLIPS TA, 1980, J PHARM SCI, V69, P1428, DOI 10.1002/jps.2600691220; Reanmongkol W, 2011, ASIAN BIOMED, V5, P269, DOI 10.5372/1905-7415.0502.037; RICH TA, 1985, J CLIN ONCOL, V3, P402, DOI 10.1200/JCO.1985.3.3.402; ROBERT C, 1988, ACTA PHARM TECHNOL, V34, P95; Rougler P, 1993, ANN ONCOL, V4, P821; Ryu JM, 1999, J CONTROL RELEASE, V59, P163, DOI 10.1016/S0168-3659(98)00189-8; Sanders NN, 2000, J PHARM SCI-US, V89, P835, DOI 10.1002/1520-6017(200007)89:7<835::AID-JPS1>3.0.CO;2-6; Schmoll HJ, 1999, SEMIN ONCOL, V26, P589; Shulka HS, 1977, AM J SURG, V133, P346; SHUMATE CR, 1993, CANCER-AM CANCER SOC, V71, P3690, DOI 10.1002/1097-0142(19930601)71:11<3690::AID-CNCR2820711136>3.0.CO;2-H; SMART JD, 1984, J PHARM PHARMACOL, V36, P295, DOI 10.1111/j.2042-7158.1984.tb04377.x; TAKAHASHI T, 1982, AM J SURG, V143, P183, DOI 10.1016/0002-9610(82)90062-9; TAKAHASHI T, 1988, AM J SURG, V156, P58, DOI 10.1016/S0002-9610(88)80173-9; Theodore M, 2000, J CONTROL RELEASE, V67, P191; Watanabe S, 1980, JPN J SURG, V10, P17; Yong CS, 2004, EUR J PHARM SCI, V23, P347, DOI 10.1016/j.ejps.2004.08.008; Yong CS, 2001, INT J PHARM, V226, P195, DOI 10.1016/S0378-5173(01)00809-2; Yuan Y, 2012, INT J PHARMACEUT, V430, P114, DOI 10.1016/j.ijpharm.2012.03.054; Yun MO, 1999, INT J PHARM, V189, P137, DOI 10.1016/S0378-5173(99)00227-6	56	6	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e71037	10.1371/journal.pone.0071037	http://dx.doi.org/10.1371/journal.pone.0071037			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23976976	gold, Green Published, Green Submitted			2022-12-25	WOS:000323570200018
J	Marathe, BM; Leveque, V; Klumpp, K; Webster, RG; Govorkova, EA				Marathe, Bindumadhav M.; Leveque, Vincent; Klumpp, Klaus; Webster, Robert G.; Govorkova, Elena A.			Determination of Neuraminidase Kinetic Constants Using Whole Influenza Virus Preparations and Correction for Spectroscopic Interference by a Fluorogenic Substrate	PLOS ONE			English	Article							IN-VITRO; SIMULTANEOUS QUANTIFICATION; FUNCTIONAL BALANCE; A VIRUS; HEMAGGLUTININ; OSELTAMIVIR; RESISTANT; SUSCEPTIBILITY; INHIBITORS; ASSAY	The influenza neuraminidase (NA) enzyme cleaves terminal sialic acid residues from cellular receptors, a process required for the release of newly synthesized virions. A balance of NA activity with sialic acid binding affinity of hemagglutinin (HA) is important for optimal virus replication. NA sequence evolution through genetic shift and drift contributes to the continuous modulation of influenza virus fitness and pathogenicity. A simple and reliable method for the determination of kinetic parameters of NA activity could add significant value to global influenza surveillance and provide parameters for the projection of fitness and pathogenicity of emerging virus variants. The use of fluorogenic substrate 2'-(4-methylumbelliferyl)-alpha-D-N-acetylneuraminic acid (MUNANA) and cell- or egg-grown whole influenza virus preparations have been attractive components of NA enzyme activity investigations. We describe important criteria to be addressed when determining K-m and V-max kinetic parameters using this method: (1) determination of the dynamic range of MUNANA and 4-methylumbelliferone product (4-MU) fluorescence for the instrument used; (2) adjustment of reaction conditions to approximate initial rate conditions, i.e. <= 15% of substrate converted during the reaction, with signal-to-noise ratio >= 10; (3) correction for optical interference and inner filter effect caused by increasing concentrations of MUNANA substrate. The results indicate a significant interference of MUNANA with 4-MU fluorescence determination. The criteria proposed enable an improved rapid estimation of NA kinetic parameters and facilitate comparison of data between laboratories.	[Marathe, Bindumadhav M.; Webster, Robert G.; Govorkova, Elena A.] St Jude Childrens Res Hosp, Div Virol, Dept Infect Dis, Memphis, TN 38105 USA; [Leveque, Vincent; Klumpp, Klaus] Hoffmann La Roche Inc, Virol Discovery, Nutley, NJ 07110 USA; [Webster, Robert G.] Univ Tennessee, Dept Pathol, Memphis, TN USA	St Jude Children's Research Hospital; Roche Holding; University of Tennessee System; University of Tennessee Health Science Center	Govorkova, EA (corresponding author), St Jude Childrens Res Hosp, Div Virol, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.	elena.govorkova@stjude.org		Govorkova, Elena/0000-0001-9067-5682	National Institute of Allergy and Infectious Diseases and Cancer Center Support (CORE) [HHSN266200700005C]; National Cancer Institute, National Institutes of Health [P30 CA 21765]; American Lebanese Syrian Associated Charities (ALSAC); F. Hoffmann La-Roche Ltd.; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases and Cancer Center Support (CORE); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); F. Hoffmann La-Roche Ltd.(Hoffmann-La Roche); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Contract HHSN266200700005C from the National Institute of Allergy and Infectious Diseases and Cancer Center Support (CORE) grant P30 CA 21765 from the National Cancer Institute, National Institutes of Health; the American Lebanese Syrian Associated Charities (ALSAC); and F. Hoffmann La-Roche Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aymard M, 2002, VACCINE, V20, pS59, DOI 10.1016/S0264-410X(02)00133-0; BUCHER DJ, 1972, J VIROL, V10, P60, DOI 10.1128/JVI.10.1.60-66.1972; Buxton RC, 2000, ANAL BIOCHEM, V280, P291, DOI 10.1006/abio.2000.4517; Colacino JM, 1997, VIROLOGY, V236, P66, DOI 10.1006/viro.1997.8709; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; Creskey MC, 2012, VACCINE, V30, P4762, DOI 10.1016/j.vaccine.2012.05.036; Gerentes L, 1999, Dev Biol Stand, V98, P189; Gerentes L, 1998, J VIROL METHODS, V73, P185, DOI 10.1016/S0166-0934(98)00056-1; Getie-Kebtie M, 2013, INFLUENZA OTHER RESP, V7, P521, DOI 10.1111/irv.12001; Ghate AA, 1998, EUR J BIOCHEM, V258, P320, DOI 10.1046/j.1432-1327.1998.2580320.x; Govorkova EA, 2010, J VIROL, V84, P8042, DOI 10.1128/JVI.00689-10; Govorkova EA, 2009, ANTIMICROB AGENTS CH, V53, P3088, DOI 10.1128/AAC.01667-08; Hurt A, 2011, EURO SURVEILL, V16; Hurt AC, 2012, LANCET INFECT DIS, V12, P240, DOI 10.1016/S1473-3099(11)70318-8; Ilyushina NA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000933; Kaverin NV, 2000, VIRUS RES, V66, P123, DOI 10.1016/S0168-1702(99)00131-8; Liu YY, 1999, ANAL BIOCHEM, V267, P331, DOI 10.1006/abio.1998.3014; Matrosovich MN, 2004, J VIROL, V78, P12665, DOI 10.1128/JVI.78.22.12665-12667.2004; Monto AS, 2006, ANTIMICROB AGENTS CH, V50, P2395, DOI 10.1128/AAC.01339-05; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; Rameix-Welti MA, 2006, ANTIMICROB AGENTS CH, V50, P3809, DOI 10.1128/AAC.00645-06; Rameix-Welti MA, 2008, PLOS, V4; Rameix-Welti MA, 2011, ANTIVIR THER, V16, P597, DOI 10.3851/IMP1804; SCHULMAN JL, 1977, J VIROL, V24, P170, DOI 10.1128/JVI.24.1.170-176.1977; Sheu TG, 2008, ANTIMICROB AGENTS CH, V52, P3284, DOI 10.1128/AAC.00555-08; Su B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008495; Tai CY, 1998, ANTIMICROB AGENTS CH, V42, P3234, DOI 10.1128/AAC.42.12.3234; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; von Itzstein M, 2007, NAT REV DRUG DISCOV, V6, P967, DOI 10.1038/nrd2400; Wagner R, 2002, REV MED VIROL, V12, P159, DOI 10.1002/rmv.352; Wang MZ, 2002, ANTIMICROB AGENTS CH, V46, P3809, DOI 10.1128/AAC.46.12.3809-3816.2002; Wetherall NT, 2003, J CLIN MICROBIOL, V41, P742, DOI 10.1128/JCM.41.2.742-750.2003; Williams TL, 2012, VACCINE, V30, P2475, DOI 10.1016/j.vaccine.2011.12.056; Xu R, 2012, J VIROL, V86, P9221, DOI 10.1128/JVI.00697-12; Yen HL, 2005, ANTIMICROB AGENTS CH, V49, P4075, DOI 10.1128/AAC.49.10.4075-4084.2005; Yen HL, 2007, J VIROL, V81, P12418, DOI 10.1128/JVI.01067-07; Yen HL, 2011, P NATL ACAD SCI USA, V108, P14264, DOI 10.1073/pnas.1111000108; Zhu XY, 2012, J VIROL, V86, P13371, DOI 10.1128/JVI.01426-12	38	40	41	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71401	10.1371/journal.pone.0071401	http://dx.doi.org/10.1371/journal.pone.0071401			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977037	Green Published, Green Submitted, gold			2022-12-25	WOS:000323378000050
J	Herrera, VL; Ponce, LR; Ruiz-Opazo, N				Herrera, Victoria L.; Ponce, Lorenz R.; Ruiz-Opazo, Nelson			Multiple Susceptibility Loci for Radiation-Induced Mammary Tumorigenesis in F2[Dahl S x R]-Intercross Rats	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; ATOMIC-BOMB SURVIVORS; BREAST-CANCER; GENETIC IDENTIFICATION; ESTROGEN; CARCINOMA; OVARIAN; TUMORS; RECEPTOR; POLYMORPHISMS	Although two major breast cancer susceptibility genes, BRCA1 and BRCA2, have been identified accounting for 20% of breast cancer genetic risk, identification of other susceptibility genes accounting for 80% risk remains a challenge due to the complex, multi-factorial nature of breast cancer. Complexity derives from multiple genetic determinants, permutations of gene-environment interactions, along with presumptive low-penetrance of breast cancer predisposing genes, and genetic heterogeneity of human populations. As with other complex diseases, dissection of genetic determinants in animal models provides key insight since genetic heterogeneity and environmental factors can be experimentally controlled, thus facilitating the detection of quantitative trait loci (QTL). We therefore, performed the first genome-wide scan for loci contributing to radiation-induced mammary tumorigenesis in female F2-(Dahl S x R)-intercross rats. Tumorigenesis was measured as tumor burden index (TBI) after induction of rat mammary tumors at forty days of age via 127 Cs-radiation. We observed a spectrum of tumor latency, size-progression, and pathology from poorly differentiated ductal adenocarcinoma to fibroadenoma, indicating major effects of gene-environment interactions. We identified two mammary tumorigenesis susceptibility quantitative trait loci (Mts-QTLs) with significant linkage: Mts-1 on chromosome-9 (LOD-2.98) and Mts-2 on chromosome-1 (LOD-2.61), as well as two Mts-QTLs with suggestive linkage: Mts-3 on chromosome-5 (LOD-1.93) and Mts-4 on chromosome-18 (LOD-1.54). Interestingly, Chr9-Mts-1, Chr5-Mts-3 and Chr18-Mts-4 QTLs are unique to irradiation-induced mammary tumorigenesis, while Chr1-Mts-2 QTL overlaps with a mammary cancer susceptibility QTL (Mcs 3) reported for 7,12-dimethylbenz-[alpha]antracene (DMBA)-induced mammary tumorigenesis in F2[COP x Wistar-Furth]-intercross rats. Altogether, our results suggest at least three distinct susceptibility QTLs for irradiation-induced mammary tumorigenesis not detected in genetic studies of chemically-induced and hormone-induced mammary tumorigenesis. While more study is needed to identify the specific Mts-gene variants, elucidation of specific variant(s) could establish causal gene pathways involved in mammary tumorigenesis in humans, and hence novel pathways for therapy.	[Herrera, Victoria L.; Ponce, Lorenz R.; Ruiz-Opazo, Nelson] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	Boston University	Ruiz-Opazo, N (corresponding author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.	nruizo@bu.edu		Ruiz-Opazo, Nelson/0000-0001-8234-1332; Herrera, Victoria/0000-0001-8991-2134	NIH [HL58136]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058136] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by grant HL58136 from the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo VD, 2007, CANCER CELL, V12, P559, DOI 10.1016/j.ccr.2007.11.004; Al-Lamki RS, 2010, AM J PATHOL, V177, P943, DOI 10.2353/ajpath.2010.091218; Bardella C, 2011, BBA-BIOENERGETICS, V1807, P1432, DOI 10.1016/j.bbabio.2011.07.003; Bernichtein S, 2010, J ENDOCRINOL, V206, P1, DOI 10.1677/JOE-10-0069; Bray F, 2004, BREAST CANCER RES, V6, P229, DOI 10.1186/bcr932; Broberg K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-140; Bui TD, 1997, BRIT J CANCER, V75, P1131, DOI 10.1038/bjc.1997.195; Cecchin E, 2004, ONCOL REP, V12, P457; CRONKITE EP, 1960, RADIAT RES, V12, P81, DOI 10.2307/3570826; DAHL LK, 1962, J EXP MED, V115, P1173, DOI 10.1084/jem.115.6.1173; Damiano JS, 2013, CLIN CANCER RES, V19, P1644, DOI 10.1158/1078-0432.CCR-12-0138; Deming SL, 2008, CANCER EPIDEM BIOMAR, V17, P563, DOI 10.1158/1055-9965.EPI-07-0752; Ding SL, 2009, CARCINOGENESIS, V30, P43, DOI 10.1093/carcin/bgn233; Dowdy SC, 2005, GYNECOL ONCOL, V96, P368, DOI 10.1016/j.ygyno.2004.10.006; Easton D F, 1999, Breast Cancer Res, V1, P14, DOI 10.1186/bcr6; Gould KA, 2004, GENETICS, V168, P2113, DOI 10.1534/genetics.104.033878; GRAGTMANS NJ, 1984, RADIAT RES, V99, P636, DOI 10.2307/3576337; Grimshaw MJ, 2005, CANCER LETT, V222, P129, DOI 10.1016/j.canlet.2004.08.029; GULLINO PM, 1975, J NATL CANCER I, V54, P401; Harvell DME, 2001, J NUTR, V131, p3087S, DOI 10.1093/jn/131.11.3087S; Horie-Inoue K, 2006, SEMIN CANCER BIOL, V16, P235, DOI 10.1016/j.semcancer.2006.03.006; HUGGINS C, 1961, NATURE, V189, P204, DOI 10.1038/189204a0; Imamura Y, 2005, ANTICANCER RES, V25, P2627; Imaoka T, 2007, INT J RADIAT ONCOL, V69, P194, DOI 10.1016/j.ijrobp.2007.05.026; Inano H, 1999, CANCER LETT, V138, P93, DOI 10.1016/S0304-3835(98)00378-4; ITO N, 1991, CARCINOGENESIS, V12, P1503, DOI 10.1093/carcin/12.8.1503; JACROT M, 1979, CANCER LETT, V8, P147, DOI 10.1016/0304-3835(79)90008-9; LEMON HM, 1989, CANCER-AM CANCER SOC, V63, P1685; Lin ZH, 2009, CLIN CANCER RES, V15, P570, DOI 10.1158/1078-0432.CCR-08-1813; Lv ZD, 2013, ONCOL REP, V29, P219, DOI 10.3892/or.2012.2111; MANDYBUR TI, 1985, RADIAT RES, V101, P460, DOI 10.2307/3576505; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Nakayama H, 2005, PATHOL INT, V55, P707, DOI 10.1111/j.1440-1827.2005.01900.x; Nevadunsky NS, 2009, GYNECOL ONCOL, V112, P325, DOI 10.1016/j.ygyno.2008.09.006; Ockenga J, 2003, GASTROENTEROLOGY, V124, P1802, DOI 10.1016/S0016-5085(03)00294-4; Papageorgis P, 2010, CANCER RES, V70, P968, DOI 10.1158/0008-5472.CAN-09-1872; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Petersen M, 2010, ONCOGENE, V29, P1351, DOI 10.1038/onc.2009.426; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; Preston DL, 2002, RADIAT RES, V158, P220, DOI 10.1667/0033-7587(2002)158[0220:REOBCR]2.0.CO;2; Quan XJ, 2006, MAMM GENOME, V17, P310, DOI 10.1007/s00335-005-0125-9; Razvi MH, 2007, GENE CHROMOSOME CANC, V46, P914, DOI 10.1002/gcc.20479; Rocchi P, 2001, CANCER RES, V61, P1196; Ronckers CM, 2005, BREAST CANCER RES, V7, P21, DOI 10.1186/bcr970; Sakamoto Y, 2001, ONCOL REP, V8, P477; Sassi A, 2013, PATHOL ONCOL RES, V19, P451, DOI 10.1007/s12253-013-9602-8; Schaffer BS, 2006, CANCER RES, V66, P7793, DOI 10.1158/0008-5472.CAN-06-0143; Schmid MH, 1999, ARCH DERMATOL, V135, P1204, DOI 10.1001/archderm.135.10.1204; SHELLABARGER CJ, 1957, RADIAT RES, V6, P501, DOI 10.2307/3570517; SHELLABARGER CJ, 1978, JNCI-J NATL CANCER I, V61, P1505; Shepel LA, 1998, GENETICS, V149, P289; Shull James D, 2007, Breast Dis, V28, P69; Smith SC, 2007, CLIN CANCER RES, V13, P3803, DOI 10.1158/1078-0432.CCR-06-2419; Smith-Bindman R, 2012, ARCH INTERN MED, V172, P1023, DOI 10.1001/archinternmed.2012.2329; Smollich M, 2007, BREAST CANCER RES TR, V106, P361, DOI 10.1007/s10549-007-9516-9; Sorensen KD, 2013, BRIT J CANCER, V108, P420, DOI 10.1038/bjc.2012.549; Stavnes HT, 2013, VIRCHOWS ARCH, V462, P163, DOI 10.1007/s00428-012-1347-3; Subramaniam MM, 2009, BREAST CANCER RES TR, V113, P113, DOI 10.1007/s10549-008-9917-4; Szpirer C, 2007, MAMM GENOME, V18, P817, DOI 10.1007/s00335-007-9073-x; Takakura S, 1999, GENE CHROMOSOME CANC, V24, P264, DOI 10.1002/(SICI)1098-2264(199903)24:3<264::AID-GCC12>3.0.CO;2-Y; THOMPSON DE, 1994, RADIAT RES, V137, pS17, DOI 10.2307/3578892; Tran TH, 2010, CANCER RES, V70, P1711, DOI 10.1158/0008-5472.CAN-09-2314; Valladares A, 2006, CANCER GENET CYTOGEN, V170, P147, DOI 10.1016/j.cancergencyto.2006.06.002; VOGEL HH, 1982, RADIAT RES, V89, P264, DOI 10.2307/3575772; Weichert W, 2008, NEOPLASIA, V10, P1021, DOI 10.1593/neo.08474; WELSCH CW, 1981, EUR J CANCER CLIN ON, V17, P1255, DOI 10.1016/0014-2964(81)90004-9; Wiese AH, 2007, CANCER DETECT PREV, V31, P282, DOI 10.1016/j.cdp.2007.07.003; Zhang ZH, 2005, BREAST CANCER RES TR, V94, P11, DOI 10.1007/s10549-005-6001-1; Zhou Y, 1999, MOL CARCINOGEN, V25, P64, DOI 10.1002/(SICI)1098-2744(199905)25:1<64::AID-MC8>3.0.CO;2-Z	69	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e72143	10.1371/journal.pone.0072143	http://dx.doi.org/10.1371/journal.pone.0072143			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967281	Green Submitted, Green Published, gold			2022-12-25	WOS:000323221500121
J	Chou, J; Hao, J; Hatoyama, H; Ben-Nissan, B; Milthorpe, B; Otsuka, M				Chou, Joshua; Hao, Jia; Hatoyama, Hirokazu; Ben-Nissan, Besim; Milthorpe, Bruce; Otsuka, Makoto			The Therapeutic Effect on Bone Mineral Formation from Biomimetic Zinc Containing Tricalcium Phosphate (ZnTCP) in Zinc-Deficient Osteoporotic Mice	PLOS ONE			English	Article								The aim of this study was to evaluate the therapeutic efficacy of biomimetic zinc-containing tricalcium phosphate (ZnTCP) produced by hydrothermally converting calcium carbonate exoskeletons from foraminifera, in the treatment of osteoporotic mice. X-Ray powder diffraction showed crystallographic structures matching JCPDS profile for tricalcium phosphate. Mass spectroscopy used to calculate total composition amount showed similar amount of calcium (5x10(4) mu g/g) and phosphate (4x10(4) ppm) after conversion and the presence of zinc (5.18x10(3) mu g/g). In vitro zinc release showed no release in PBS buffer and <1% zinc release in 7 days. In vivo evaluation was done in ovariectomized mice by implanting the ZnTCP samples in the soft tissues near the right femur bone for four weeks. Thirty ddY mice (5 weeks old, average weight of 21 g) were divided into six experimental groups (normal, sham, OVX, beta-TCP, ZnTCP and direct injection of zinc). CT images were taken every two weeks where the bone mineral density (BMD) and bone mineral content (BMC) were calculated by software based on CT images. The ZnTCP group exhibits cortical and cancellous bone growth of 45% and 20% respectively. While sham, OVX and beta-TCP suffered from bone loss. A correlation was made between the significant body weight increase in ZnTCP with the significant increase in plasma zinc level compared with OVX. The presented results indicate that biomimetic ZnTCP were effective in preventing and treating bone loss in osteoporotic mice model.	[Chou, Joshua; Hatoyama, Hirokazu; Otsuka, Makoto] Musashino Univ, Pharmaceut Sci Res Inst, Fac Pharm, Nishi Tokyo, Japan; [Hao, Jia] Tokyo Med & Dent Univ, Tokyo, Japan; [Ben-Nissan, Besim; Milthorpe, Bruce] Univ Technol Sydney, Adv Tissue Regenerat & Drug Delivery Grp, Fac Sci, Sydney, NSW 2007, Australia	Tokyo Medical & Dental University (TMDU); University of Technology Sydney	Chou, J (corresponding author), Musashino Univ, Pharmaceut Sci Res Inst, Fac Pharm, Nishi Tokyo, Japan.	Joshua.chou@uts.edu.au	Milthorpe, Bruce K/A-7014-2008; Milthorpe, Bruce/Z-1153-2019; Ben-Nissan, Besim/AAR-4445-2020	Milthorpe, Bruce/0000-0002-0867-9586; Ben-Nissan, Besim/0000-0003-0433-3593	Japan Society for the Promotion of Science (JSPS) foundation; University of Technology Sydney, Australia; Grants-in-Aid for Scientific Research [12F02814] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) foundation(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); University of Technology Sydney, Australia; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors are grateful and acknowledge the support from the Japan Society for the Promotion of Science (JSPS) foundation and University of Technology Sydney, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay A, 2007, MAT SCI ENG C-BIO S, V27, P14, DOI 10.1016/j.msec.2005.11.004; Bonnelye E, 2008, BONE, V42, P129, DOI 10.1016/j.bone.2007.08.043; Chou J, 2013, NANOMEDICIN IN PRESS; Chou J, 2013, BONEKEY IN PRESS; Chou J., 2007, J AUSTRALAS CERAM SO, V43, P44; Chou J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054676; Chou JH, 2011, ADV ENG MATER, V13, P93, DOI 10.1002/adem.201000208; Gentleman E, 2010, BIOMATERIALS, V31, P3949, DOI 10.1016/j.biomaterials.2010.01.121; HASHIZUME M, 1993, MOL CELL BIOCHEM, V122, P59, DOI 10.1007/BF00925737; Hyun TH, 2004, AM J CLIN NUTR, V80, P715; Kawamura H, 2000, J BIOMED MATER RES, V50, P184, DOI 10.1002/(SICI)1097-4636(200005)50:2<184::AID-JBM13>3.0.CO;2-3; KISHI S, 1994, BIOCHEM PHARMACOL, V48, P1225, DOI 10.1016/0006-2952(94)90160-0; LEGEROS RZ, 1981, PROG CRYST GROWTH CH, V4, P1; Li X, 2009, ACTA BIOMATER, V5, P508, DOI 10.1016/j.actbio.2008.06.010; Otsuka M, 2004, J BIOMED MATER RES A, V69A, P552, DOI 10.1002/jbm.a.30040; Otsuka M, 2003, BIO-MED MATER ENG, V13, P103; Otsuka M, 2000, J BIOMED MATER RES, V52, P819, DOI 10.1002/1097-4636(20001215)52:4<819::AID-JBM27>3.0.CO;2-O; ROY DM, 1974, NATURE, V247, P220, DOI 10.1038/247220a0; Tokudome Y, 2011, BIOL PHARM BULL, V34, P1215, DOI 10.1248/bpb.34.1215; WILLIAMS RJP, 1984, ENDEAVOUR, V8, P65, DOI 10.1016/0160-9327(84)90040-1	20	19	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71821	10.1371/journal.pone.0071821	http://dx.doi.org/10.1371/journal.pone.0071821			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967249	Green Published, Green Submitted, gold			2022-12-25	WOS:000323115800084
J	Gouaze, A; Brenachot, X; Rigault, C; Krezymon, A; Rauch, C; Nedelec, E; Lemoine, A; Gascuel, J; Bauer, S; Penicaud, L; Benani, A				Gouaze, Alexandra; Brenachot, Xavier; Rigault, Caroline; Krezymon, Alice; Rauch, Camille; Nedelec, Emmanuelle; Lemoine, Aleth; Gascuel, Jean; Bauer, Sylvian; Penicaud, Luc; Benani, Alexandre			Cerebral Cell Renewal in Adult Mice Controls the Onset of Obesity	PLOS ONE			English	Article								The hypothalamus plays a crucial role in the control of the energy balance and also retains neurogenic potential into adulthood. Recent studies have reported the severe alteration of the cell turn-over in the hypothalamus of obese animals and it has been proposed that a neurogenic deficiency in the hypothalamus could be involved in the development of obesity. To explore this possibility, we examined hypothalamic cell renewal during the homeostatic response to dietary fat in mice, i.e., at the onset of diet-induced obesity. We found that switching to high-fat diet (HFD) accelerated cell renewal in the hypothalamus through a local, rapid and transient increase in cell proliferation, peaking three days after introducing the HFD. Blocking HFD-induced cell proliferation by central delivery of an antimitotic drug prevented the food intake normalization observed after HFD introduction and accelerated the onset of obesity. This result showed that HFD-induced dividing brain cells supported an adaptive anorectic function. In addition, we found that the percentage of newly generated neurons adopting a POMC-phenotype in the arcuate nucleus was increased by HFD. This observation suggested that the maturation of neurons in feeding circuits was nutritionally regulated to adjust future energy intake. Taken together, these results showed that adult cerebral cell renewal was remarkably responsive to nutritional conditions. This constituted a physiological trait required to prevent severe weight gain under HFD. Hence this report highlighted the amazing plasticity of feeding circuits and brought new insights into our understanding of the nutritional regulation of the energy balance.	[Gouaze, Alexandra; Brenachot, Xavier; Rigault, Caroline; Krezymon, Alice; Rauch, Camille; Nedelec, Emmanuelle; Lemoine, Aleth; Gascuel, Jean; Penicaud, Luc; Benani, Alexandre] Univ Bourgogne, CNRS, Inst Natl Rech Agron, Ctr Sci Gout & Alimentat, Dijon, France; [Bauer, Sylvian] INSERM, Inst Neurobiol Mediterranee, F-13258 Marseille, France	INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Benani, A (corresponding author), Univ Bourgogne, CNRS, Inst Natl Rech Agron, Ctr Sci Gout & Alimentat, Dijon, France.	alexandre.benani@u-bourgogne.fr	; Benani, Alexandre/F-4002-2012	Sylvian, Bauer/0000-0002-0667-3412; Benani, Alexandre/0000-0003-2046-0162; Brenachot, Xavier/0000-0002-3279-6440	CNRS; INRA; Burgundy county [FABER-2009-9201-AAO036S00635]; Burgundy county (PARI); Societe Francaise de Nutrition	CNRS(Centre National de la Recherche Scientifique (CNRS)); INRA; Burgundy county; Burgundy county (PARI); Societe Francaise de Nutrition	This work was funded by CNRS, INRA, the Burgundy county (FABER-2009-9201-AAO036S00635 and PARI to LP and AB), and the Societe Francaise de Nutrition (to AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Alonso G, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-20; Bauer S, 2005, NEUROSCIENCE, V130, P75, DOI 10.1016/j.neuroscience.2004.08.047; Bauer S, 2009, ANN NY ACAD SCI, V1153, P48, DOI 10.1111/j.1749-6632.2009.03986.x; Benani A, 2012, J NEUROSCI, V32, P11970, DOI 10.1523/JNEUROSCI.0624-12.2012; Butler AA, 2006, PEPTIDES, V27, P281, DOI 10.1016/j.peptides.2005.02.029; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Caruso C, 2012, MOL CELL ENDOCRINOL, V348, P47, DOI 10.1016/j.mce.2011.07.036; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Ekdahl CT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00041; Erlandsson A, 2006, CANCER RES, V66, P8042, DOI 10.1158/0008-5472.CAN-06-0900; Fernandez AM, 2012, NAT REV NEUROSCI, V13, P225, DOI 10.1038/nrn3209; Franklin K., 2007, MOUSE BRAIN STEREOTA; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Huang LY, 1998, J NEUROBIOL, V36, P410, DOI 10.1002/(SICI)1097-4695(19980905)36:3<410::AID-NEU8>3.0.CO;2-Z; Kempermann G, 2011, EUR J NEUROSCI, V33, P1018, DOI 10.1111/j.1460-9568.2011.07599.x; Kokoeva MV, 2007, J COMP NEUROL, V505, P209, DOI 10.1002/cne.21492; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Lee DA, 2012, NAT NEUROSCI, V15, P700, DOI 10.1038/nn.3079; Li JX, 2012, NAT CELL BIOL, V14, P999, DOI 10.1038/ncb2562; Lin JHC, 2007, DEV BIOL, V302, P356, DOI 10.1016/j.ydbio.2006.09.017; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Mathieu P, 2010, J NEUROCHEM, V112, P1368, DOI 10.1111/j.1471-4159.2009.06548.x; Matsuzaki K, 2009, PFLUG ARCH EUR J PHY, V458, P661, DOI 10.1007/s00424-009-0654-2; McNay DEG, 2012, J CLIN INVEST, V122, P142, DOI 10.1172/JCI43134; Migaud M, 2011, J BIOL RHYTHM, V26, P486, DOI 10.1177/0748730411420062; Migaud M, 2010, EUR J NEUROSCI, V32, P2042, DOI 10.1111/j.1460-9568.2010.07521.x; Morrens J, 2012, GLIA, V60, P159, DOI 10.1002/glia.21247; Moyse E, 2006, AUTON NEUROSCI-BASIC, V126, P50, DOI 10.1016/j.autneu.2006.03.006; Nishimoto M, 2007, GLIA, V55, P317, DOI 10.1002/glia.20461; Noble EE, 2011, AM J PHYSIOL-REG I, V300, pR1053, DOI 10.1152/ajpregu.00776.2010; Pencea V, 2001, J NEUROSCI, V21, P6706, DOI 10.1523/JNEUROSCI.21-17-06706.2001; Perez-Martin M, 2010, EUR J NEUROSCI, V31, P1533, DOI 10.1111/j.1460-9568.2010.07220.x; Pierce AA, 2010, J NEUROSCI, V30, P723, DOI 10.1523/JNEUROSCI.2479-09.2010; Plata-Salaman C, 2001, INT J OBESITY, V25, pS48, DOI 10.1038/sj.ijo.0801911; Rankin SL, 2004, BRAIN RES PROTOC, V13, P69, DOI 10.1016/j.brainresprot.2004.01.002; Simmons AM, 2008, BRAIN BEHAV EVOLUT, V71, P41, DOI 10.1159/000108610; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; Weigel A, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3083439; Weiss S, 1996, J NEUROSCI, V16, P7599; Werner L, 2012, ENDOCRINOLOGY, V153, P2655, DOI 10.1210/en.2011-1760; Xu Y, 2005, EXP NEUROL, V192, P251, DOI 10.1016/j.expneurol.2004.12.021; Yamaguchi M, 2005, P NATL ACAD SCI USA, V102, P9697, DOI 10.1073/pnas.0406082102; Zhang J, 2007, AM J PHYSIOL-REG I, V292, pR868, DOI 10.1152/ajpregu.00213.2006; Ziotopoulou M, 2000, AM J PHYSIOL-ENDOC M, V279, pE838, DOI 10.1152/ajpendo.2000.279.4.E838	47	40	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e72029	10.1371/journal.pone.0072029	http://dx.doi.org/10.1371/journal.pone.0072029			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967273	Green Published, gold			2022-12-25	WOS:000323115800095
J	Li, SM; Wang, B; Xu, PF; Lin, QX; Gong, GL; Peng, XL; Fan, YY; He, Y; Huang, RW				Li, Shumei; Wang, Bin; Xu, Pengfei; Lin, Qixiang; Gong, Gaolang; Peng, Xiaoling; Fan, Yuanyuan; He, Yong; Huang, Ruiwang			Increased Global and Local Efficiency of Human Brain Anatomical Networks Detected with FLAIR-DTI Compared to Non-FLAIR-DTI	PLOS ONE			English	Article								Diffusion-weighted MRI (DW-MRI), the only non-invasive technique for probing human brain white matter structures in vivo, has been widely used in both fundamental studies and clinical applications. Many studies have utilized diffusion tensor imaging (DTI) and tractography approaches to explore the topological properties of human brain anatomical networks by using the single tensor model, the basic model to quantify DTI indices and tractography. However, the conventional DTI technique does not take into account contamination by the cerebrospinal fluid (CSF), which has been known to affect the estimated DTI measures and tractography in the single tensor model. Previous studies have shown that the Fluid-Attenuated Inversion Recovery (FLAIR) technique can suppress the contribution of the CSF to the DW-MRI signal. We acquired DTI datasets from twenty-two subjects using both FLAIR-DTI and conventional DTI (non-FLAIR-DTI) techniques, constructed brain anatomical networks using deterministic tractography, and compared the topological properties of the anatomical networks derived from the two types of DTI techniques. Although the brain anatomical networks derived from both types of DTI datasets showed small-world properties, we found that the brain anatomical networks derived from the FLAIR-DTI showed significantly increased global and local network efficiency compared with those derived from the conventional DTI. The increases in the network regional topological properties derived from the FLAIR-DTI technique were observed in CSF-filled regions, including the postcentral gyrus, periventricular regions, inferior frontal and temporal gyri, and regions in the visual cortex. Because brain anatomical networks derived from conventional DTI datasets with tractography have been widely used in many studies, our findings may have important implications for studying human brain anatomical networks derived from DW-MRI data and tractography.	[Li, Shumei; Wang, Bin; Peng, Xiaoling; Fan, Yuanyuan; Huang, Ruiwang] S China Normal Univ, Sch Psychol, Key Lab Mental Hlth & Cognit Sci Guangdong Prov, Ctr Study Appl Psychol, Guangzhou, Guangdong, Peoples R China; [Xu, Pengfei; Lin, Qixiang; Gong, Gaolang; He, Yong] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	South China Normal University; Beijing Normal University	Huang, RW (corresponding author), S China Normal Univ, Sch Psychol, Key Lab Mental Hlth & Cognit Sci Guangdong Prov, Ctr Study Appl Psychol, Guangzhou, Guangdong, Peoples R China.	ruiwang.huang@gmail.com	He, Yong/C-2161-2009; He, Yong/Q-5756-2018; Wang, Bin/AAX-2956-2020; Lin, Qixiang/GXG-3598-2022	Wang, Bin/0000-0001-9388-6119; Lin, Qixiang/0000-0002-1718-6855; He, Yong/0000-0002-7039-2850	National Natural Science Foundation of China [81071149, 81271548, 81030028, 31000499]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This study was supported by National Natural Science Foundation of China (Grant Nos: 81071149, 81271548, 81030028, and 31000499), and Scientific Research Foundation for the Returned Overseas Chinese Scholars (RH), State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Akkerman EM, 2010, J MAGN RESON, V206, P11, DOI 10.1016/j.jmr.2010.05.016; Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; Alexander DC, 2002, MAGN RESON MED, V48, P331, DOI 10.1002/mrm.10209; Asato MR, 2010, CEREB CORTEX, V20, P2122, DOI 10.1093/cercor/bhp282; Assaf Y, 2005, NEUROIMAGE, V27, P48, DOI 10.1016/j.neuroimage.2005.03.042; Basser PJ, 2000, MAGNET RESON MED, V44, P41, DOI 10.1002/1522-2594(200007)44:1<41::AID-MRM8>3.0.CO;2-O; Bassett DS, 2011, NEUROIMAGE, V54, P1262, DOI 10.1016/j.neuroimage.2010.09.006; Bastiani M, 2012, NEUROIMAGE, V62, P1732, DOI 10.1016/j.neuroimage.2012.06.002; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhagat YA, 2004, J MAGN RESON IMAGING, V20, P216, DOI 10.1002/jmri.20102; Canales-Rodriguez EJ, 2010, NEUROIMAGE, V49, P1326, DOI 10.1016/j.neuroimage.2009.09.067; Cheng YW, 2011, EUR J RADIOL, V79, P113, DOI 10.1016/j.ejrad.2009.12.032; Chou MC, 2005, AM J NEURORADIOL, V26, P591; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Concha L, 2005, ANN NEUROL, V57, P188, DOI 10.1002/ana.20334; De Santis S., 2013, MAGN RESON MED; Dietrich O, 2007, J MAGN RESON IMAGING, V26, P375, DOI 10.1002/jmri.20969; Fan Y, 2011, NEUROIMAGE, V54, P1862, DOI 10.1016/j.neuroimage.2010.07.025; Farrell JAD, 2007, J MAGN RESON IMAGING, V26, P756, DOI 10.1002/jmri.21053; Frank LR, 2001, MAGN RESON MED, V45, P935, DOI 10.1002/mrm.1125; Fritzsche KH, 2010, NEUROIMAGE, V51, P242, DOI 10.1016/j.neuroimage.2010.02.007; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Hagmann P, 2006, RADIOGRAPHICS, V26, pS205, DOI 10.1148/rg.26si065510; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Hirsch JG, 1999, MAGN RESON IMAGING, V17, P705, DOI 10.1016/S0730-725X(98)00217-3; Hosey T, 2005, MAGN RESON MED, V54, P1480, DOI 10.1002/mrm.20723; Iturria-Medina Y, 2007, NEUROIMAGE, V36, P645, DOI 10.1016/j.neuroimage.2007.02.012; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Jansons KM, 2003, INVERSE PROBL, V19, P1031, DOI 10.1088/0266-5611/19/5/303; Jeurissen B, 2011, HUM BRAIN MAPP, V32, P461, DOI 10.1002/hbm.21032; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Jones D.K., 2010, IMAGING MED, V2, P341, DOI [10.2217/iim.10.21, DOI 10.2217/IIM.10.21]; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Jones DK, 2003, MAGN RESON MED, V49, P7, DOI 10.1002/mrm.10331; Koo BB, 2009, NEUROIMAGE, V44, P136, DOI 10.1016/j.neuroimage.2008.07.064; KWONG KK, 1991, MAGNET RESON MED, V21, P157, DOI 10.1002/mrm.1910210120; Latour LL, 2002, MAGNET RESON MED, V48, P478, DOI 10.1002/mrm.10238; Li YH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000395; Liu CL, 2004, MAGN RESON MED, V51, P924, DOI 10.1002/mrm.20071; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; Ma XY, 2004, MAGN RESON MED, V51, P423, DOI 10.1002/mrm.10703; Malykhin N, 2008, PSYCHIAT RES-NEUROIM, V164, P132, DOI 10.1016/j.pscychresns.2007.11.007; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Metzler-Baddeley C, 2012, NEUROIMAGE, V59, P1394, DOI 10.1016/j.neuroimage.2011.08.043; Oouchi H, 2007, AM J NEURORADIOL, V28, P1102, DOI 10.3174/ajnr.A0488; Ozarslan E, 2003, MAGN RESON MED, V50, P955, DOI 10.1002/mrm.10596; Ozarslan E, 2006, NEUROIMAGE, V31, P1086, DOI 10.1016/j.neuroimage.2006.01.024; Papadakis NG, 2002, MAGNET RESON MED, V48, P394, DOI 10.1002/mrm.10204; Parker GD, 2013, NEUROIMAGE, V65, P433, DOI 10.1016/j.neuroimage.2012.10.022; Parker GJM, 2005, PHILOS T R SOC B, V360, P893, DOI 10.1098/rstb.2005.1639; Pasternak O, 2009, MAGN RESON MED, V62, P717, DOI 10.1002/mrm.22055; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Shu N, 2011, CEREB CORTEX, V21, P2565, DOI 10.1093/cercor/bhr039; Shu N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007228; Thomalla G, 2009, BRAIN, V132, P765, DOI 10.1093/brain/awn339; Tournier JD, 2008, NEUROIMAGE, V42, P617, DOI 10.1016/j.neuroimage.2008.05.002; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vaessen MJ, 2010, NEUROIMAGE, V51, P1106, DOI 10.1016/j.neuroimage.2010.03.011; Wang B, 2012, ANN M ORG HUMAN BRAI, V18, P5404; Wang B, 2013, NEUROIMAGE, V65, P476, DOI 10.1016/j.neuroimage.2012.10.007; Wang JH, 2013, BIOL PSYCHIAT, V73, P472, DOI 10.1016/j.biopsych.2012.03.026; Wang L, 2010, BRAIN, V133, P1224, DOI 10.1093/brain/awq043; Wang QF, 2012, NEUROIMAGE, V59, P1085, DOI 10.1016/j.neuroimage.2011.09.035; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Wedeen VJ, 2012, SCIENCE, V335, P1628, DOI 10.1126/science.1215280; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Wen W, 2011, J NEUROSCI, V31, P1204, DOI 10.1523/JNEUROSCI.4085-10.2011; Yan CG, 2011, CEREB CORTEX, V21, P449, DOI 10.1093/cercor/bhq111; Yoshida S, 2010, DEV MED CHILD NEUROL, V52, P935, DOI 10.1111/j.1469-8749.2010.03669.x; Yoshiura T, 2009, HUM BRAIN MAPP, V30, P3142, DOI 10.1002/hbm.20738; Zalesky A, 2011, BIOL PSYCHIAT, V69, P80, DOI 10.1016/j.biopsych.2010.08.022; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027	83	6	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71229	10.1371/journal.pone.0071229	http://dx.doi.org/10.1371/journal.pone.0071229			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967170	Green Submitted, gold, Green Published			2022-12-25	WOS:000323115800044
J	Michal, M; Wiltink, J; Kirschner, Y; Wild, PS; Munzel, T; Ojeda, FM; Zeller, T; Schnabel, RB; Lackner, K; Blettner, M; Zwiener, I; Beutel, ME				Michal, Matthias; Wiltink, Joerg; Kirschner, Yvonne; Wild, Philipp S.; Muenzel, Thomas; Ojeda, Francisco M.; Zeller, Tanja; Schnabel, Renate B.; Lackner, Karl; Blettner, Maria; Zwiener, Isabella; Beutel, Manfred E.			Differential Associations of Depressive Symptom Dimensions with Cardio-Vascular Disease in the Community: Results from the Gutenberg Health Study	PLOS ONE			English	Article								A current model suggested that the somatic symptom dimension accounts for the adverse effect of depression in patients with coronary heart disease (CHD). In order to test this model we sought to determine in a large population-based sample how symptom dimensions of depression are associated with CHD, biomarkers and traditional risk factors. The associations of cognitive and somatic symptom dimensions of depression with CHD, risk factors, endothelial function, and biomarkers of inflammation and myocardial stress were analyzed cross-sectionally in a sample of n = 5000 Mid-Europeans aged 35-74 years from the Gutenberg Health Study (GHS). Only the somatic symptom dimension of depression was associated with CHD, biomarkers (inflammation, vascular function) and cardio-vascular risk factors. When multivariable adjustment was applied by demographic and cardiovascular risk factors, the weak associations of the somatic symptom dimension with the biomarkers disappeared. However, the associations of the somatic symptom dimension with CHD, myocardial infarction, obesity, dyslipidemia and family history of myocardial infarction remained. Both dimensions of depression were independently associated with a previous diagnosis of depression and distressed personality (type D). Thus, our results partly confirm current models: Somatic, but not cognitive-affective symptom dimensions are responsible for the association between depression and CHD, inflammation, vascular function and cardiovascular risk factors in the general population. However, our findings challenge the assumptions that somatic depression might be due to inflammation or vascular dysfunction as consequence of progressed atherosclerotic disease. They rather emphasize a close interplay with life-style factors and with a family history of MI.	[Michal, Matthias; Wiltink, Joerg; Kirschner, Yvonne; Beutel, Manfred E.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Psychosomat Med & Psychotherapy, D-55122 Mainz, Germany; [Kirschner, Yvonne; Wild, Philipp S.; Muenzel, Thomas] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med 2, D-55122 Mainz, Germany; [Ojeda, Francisco M.; Zeller, Tanja; Schnabel, Renate B.] Univ Med Ctr Hamburg Eppendorf, Dept Gen & Intervent Cardiol, Hamburg, Germany; [Lackner, Karl] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Clin Chem & Lab Med, D-55122 Mainz, Germany; [Blettner, Maria; Zwiener, Isabella] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Med Biostat Epidemiol & Informat, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Hamburg; University Medical Center Hamburg-Eppendorf; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Michal, M (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Psychosomat Med & Psychotherapy, D-55122 Mainz, Germany.	michal@uni-mainz.de	Wild, Philipp S./M-2106-2019; Schnabel, Renate B/ABE-6668-2021; Munzel, Thomas/A-2912-2014; Schnabel, Renate B/F-6527-2014	Schnabel, Renate B/0000-0001-7170-9509; Munzel, Thomas/0000-0001-5503-4150; Ojeda, Francisco/0000-0003-4037-144X; Zeller, Tanja/0000-0003-3379-2641; Wild, Philipp/0000-0003-4413-9752	government of Rheinland-Pfalz ("Stiftung Rheinland Pfalz fur Innovation") [AZ 961-386261/733]; research program "Wissen schafft Zukunft" of the Johannes Gutenberg-University of Mainz; research program "Schwerpunkt Vaskulare Pravention" of the Johannes Gutenberg-University of Mainz; Boehringer Ingelheim; PHILIPS Medical Systems	government of Rheinland-Pfalz ("Stiftung Rheinland Pfalz fur Innovation"); research program "Wissen schafft Zukunft" of the Johannes Gutenberg-University of Mainz; research program "Schwerpunkt Vaskulare Pravention" of the Johannes Gutenberg-University of Mainz; Boehringer Ingelheim(Boehringer Ingelheim); PHILIPS Medical Systems	This work/the Gutenberg Health Study is funded through the government of Rheinland-Pfalz ("Stiftung Rheinland Pfalz fur Innovation", contract number AZ 961-386261/733), the research programs "Wissen schafft Zukunft" and "Schwerpunkt Vaskulare Pravention" of the Johannes Gutenberg-University of Mainz and its contract with Boehringer Ingelheim and PHILIPS Medical Systems including an unrestricted grant for the Gutenberg Health Study. The analysis presents clinical data of a large-scale population-based cohort with ongoing follow-up examinations. This project constitutes a major scientific effort with high methodological standards and detailed guidelines for analysis and publication to ensure scientific analyses on highest level. Therefore, data are not made available for the scientific community beyond the established workflows and algorithms. To meet the general idea of verification and reproducibility of scientific findings, we offer access to data at the local database in accordance with the ethics vote upon request at any time. Funders were involved in the development of the study design as scientific consultants. However, they played no role in data collection, analysis, decision to publish, or preparation of the manuscript.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Beutel ME, 2012, PSYCHOTHER PSYCHOSOM, V81, P108, DOI 10.1159/000331776; Broadley AJM, 2002, HEART, V88, P521, DOI 10.1136/heart.88.5.521; Bus BAA, 2011, PSYCHOL MED, V41, P1419, DOI 10.1017/S0033291710002151; Carney RM, 2012, PSYCHOSOM MED, V74, P33, DOI 10.1097/PSY.0b013e3182405ac4; de Jonge P, 2006, AM J PSYCHIAT, V163, P138, DOI 10.1176/appi.ajp.163.1.138; De Jonge P, 2007, PSYCHOSOM MED, V69, P735, DOI 10.1097/PSY.0b013e31815743ca; de Wit L, 2010, PSYCHIAT RES, V178, P230, DOI 10.1016/j.psychres.2009.04.015; Denollet J, 2005, PSYCHOSOM MED, V67, P89, DOI 10.1097/01.psy.0000149256.81953.49; Denollet J, 2010, CIRC-CARDIOVASC QUAL, V3, P546, DOI 10.1161/CIRCOUTCOMES.109.934406; Dong MX, 2004, CIRCULATION, V110, P1761, DOI 10.1161/01.CIR.0000143074.54995.7F; Frasure-Smith N, 2009, HEART, V96, P173; Grande G, 2004, PSYCHOTHER PSYCH MED, V54, P413, DOI 10.1055/s-2004-828376; Grandner MA, 2012, J SLEEP RES, V21, P427, DOI 10.1111/j.1365-2869.2011.00990.x; Hoen PW, 2010, J AM COLL CARDIOL, V56, P838, DOI 10.1016/j.jacc.2010.03.080; Kendler KS, 2009, ARCH GEN PSYCHIAT, V66, P857, DOI 10.1001/archgenpsychiatry.2009.94; Kim JH, 2010, INT J CARDIOL, V143, P154, DOI 10.1016/j.ijcard.2009.02.004; Kuper H, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4265; Lavoie KL, 2010, PSYCHOSOM MED, V72, P20, DOI 10.1097/PSY.0b013e3181c2d6b8; Linke SE, 2009, ARCH GEN PSYCHIAT, V66, P499, DOI 10.1001/archgenpsychiatry.2009.27; Lowe B, 2004, PSYCHOTHER PSYCHOSOM, V73, P386, DOI 10.1159/000080393; Marijnissen RM, 2011, J AM GERIATR SOC, V59, P67, DOI 10.1111/j.1532-5415.2010.03228.x; Martens EJ, 2010, PSYCHOL MED, V40, P807, DOI 10.1017/S0033291709990997; McCaffery JM, 2009, AM J MED GENET B, V150B, P381, DOI 10.1002/ajmg.b.30824; McCaffery JM, 2006, PSYCHOSOM MED, V68, P187, DOI 10.1097/01.psy.0000208630.79271.a0; Nicholson A, 2006, EUR HEART J, V27, P2763, DOI 10.1093/eurheartj/ehl338; Ormel J, 2011, PSYCHOTHER PSYCHOSOM, V80, P264, DOI 10.1159/000323165; Paranthaman R, 2010, BIOL PSYCHIAT, V68, P133, DOI 10.1016/j.biopsych.2010.04.017; Pizzi C, 2009, CLIN PHARMACOL THER, V86, P527, DOI 10.1038/clpt.2009.121; Pizzi C, 2008, EUR HEART J, V29, P1110, DOI 10.1093/eurheartj/ehn137; Poole L, 2011, J PSYCHOSOM RES, V71, P61, DOI 10.1016/j.jpsychores.2010.12.009; Richter M, 2009, MESSUNG SOZIOOKONOMI, P309; Rozanski A, 2005, J AM COLL CARDIOL, V45, P637, DOI 10.1016/j.jacc.2004.12.005; Scheffold T, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-9; Schnabel RB, 2011, CIRC-CARDIOVASC IMAG, V4, P371, DOI 10.1161/CIRCIMAGING.110.961557; Sinning C, 2011, AM J CARDIOL, V107, P1841, DOI 10.1016/j.amjcard.2011.02.318; Smolderen KG, 2012, BIOL PSYCHIAT, V71, P22, DOI 10.1016/j.biopsych.2011.07.029; Smolderen KG, 2009, CIRC-CARDIOVASC QUAL, V2, P328, DOI 10.1161/CIRCOUTCOMES.109.868588; Tomfohr LM, 2008, J BEHAV MED, V31, P137, DOI 10.1007/s10865-007-9141-4; Verbeek DEP, 2011, HEART FAIL CLIN, V7, P89, DOI 10.1016/j.hfc.2010.08.006; Wagner J, 2009, J DIABETES COMPLICAT, V23, P18, DOI 10.1016/j.jdiacomp.2007.11.007; Wendel-Vos GCW, 2003, J CLIN EPIDEMIOL, V56, P1163, DOI 10.1016/S0895-4356(03)00220-8; Whooley MA, 2008, JAMA-J AM MED ASSOC, V300, P2379, DOI 10.1001/jama.2008.711; Whooley MA, 2007, BIOL PSYCHIAT, V62, P314, DOI 10.1016/j.biopsych.2006.10.016; Wiltink J, 2011, J AFFECT DISORDERS, V130, P429, DOI 10.1016/j.jad.2010.10.041	45	37	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e72014	10.1371/journal.pone.0072014	http://dx.doi.org/10.1371/journal.pone.0072014			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	201BN	23967272	Green Submitted, Green Published, gold			2022-12-25	WOS:000323115800094
J	Mourier, J; Buray, N; Schultz, JK; Clua, E; Planes, S				Mourier, Johann; Buray, Nicolas; Schultz, Jennifer K.; Clua, Eric; Planes, Serge			Genetic Network and Breeding Patterns of a Sicklefin Lemon Shark (Negaprion acutidens) Population in the Society Islands, French Polynesia	PLOS ONE			English	Article							CARCHARHINUS-MELANOPTERUS; INBREEDING AVOIDANCE; SITE-FIDELITY; MARINE FISH; REEF SHARK; RELATEDNESS; EXTINCTION; POLYANDRY; COLLAPSE; CONSERVATION	Human pressures have put many top predator populations at risk of extinction. Recent years have seen alarming declines in sharks worldwide, while their resilience remains poorly understood. Studying the ecology of small populations of marine predators is a priority to better understand their ability to withstand anthropogenic and environmental stressors. In the present study, we monitored a naturally small island population of 40 adult sicklefin lemon sharks in Moorea, French Polynesia over 5 years. We reconstructed the genetic relationships among individuals and determined the population's mating system. The genetic network illustrates that all individuals, except one, are interconnected at least through one first order genetic relationship. While this species developed a clear inbreeding avoidance strategy involving dispersal and migration, the small population size, low number of breeders, and the fragmented environment characterizing these tropical islands, limits its complete effectiveness.	[Mourier, Johann; Buray, Nicolas; Planes, Serge] Ctr Rech Insulaire & Observ Environm, LabEx CORAIL USR CNRS EPHE 3278, Papetoai, Moorea, France; [Schultz, Jennifer K.] Natl Marine Fisheries Serv, Silver Spring, MD USA; [Clua, Eric] Haut Commissariat Republ Francaise, Delegat Reg Rech & Technol, Papeete, Tahiti, France; [Clua, Eric] Minist Agr & Peche, Paris, France	National Oceanic Atmospheric Admin (NOAA) - USA	Mourier, J (corresponding author), Ctr Rech Insulaire & Observ Environm, LabEx CORAIL USR CNRS EPHE 3278, Papetoai, Moorea, France.	johann.mourier@gmail.com	Clua, Eric EG/D-7820-2013; PLANES, Serge/ABF-1360-2021; Johann, Mourier/B-4881-2012	Clua, Eric EG/0000-0001-7629-2685; Johann, Mourier/0000-0001-9019-1717	Direction a l'Environnement (DIREN) of French Polynesia	Direction a l'Environnement (DIREN) of French Polynesia	This study benefited from the financial support of the Direction a l'Environnement (DIREN) of French Polynesia and the scientific support of Coordination Unit of the Coral Reef Initiatives for the Pacific (CRISP Programme), based in New Caledonia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Berger J, 1999, P ROY SOC B-BIOL SCI, V266, P2261, DOI 10.1098/rspb.1999.0917; Borgatti S.P., 2002, NETDRAW NETWORK VISU; Buray N, 2009, CYBIUM, V33, P21; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Chapman DD, 2011, J HERED, V102, P643, DOI 10.1093/jhered/esr098; Chapman DD, 2009, MOL ECOL, V18, P3500, DOI 10.1111/j.1365-294X.2009.04289.x; Chin A, 2013, AQUAT CONSERV, V23, P468, DOI 10.1002/aqc.2349; Clarke SC, 2013, CONSERV BIOL, V27, P197, DOI 10.1111/j.1523-1739.2012.01943.x; Clua E, 2011, MAR FRESHWATER RES, V62, P764, DOI 10.1071/MF10163; Clua E, 2010, MAR ECOL PROG SER, V414, P257, DOI 10.3354/meps08746; Compagno L.J.V., 2005, SHARKS WORLD; Daly-Engel TS, 2007, CAN J FISH AQUAT SCI, V64, P198, DOI 10.1139/F07-005; Dibattista JD, 2008, MOL ECOL, V17, P3337, DOI 10.1111/j.1365-294X.2008.03833.x; Dibattista JD, 2008, MOL ECOL, V17, P783, DOI 10.1111/j.1365-294X.2007.03623.x; Feldheim KA, 2004, EVOLUTION, V58, P2332, DOI 10.1111/j.0014-3820.2004.tb01607.x; FELDHEIM KA, 2002, P ROYAL SOC B, V269, P1471; Field IC, 2009, ADV MAR BIOL, V56, P275, DOI 10.1016/S0065-2881(09)56004-X; Filmalter JD, 2013, MAR BIOL, V160, P2425, DOI 10.1007/s00227-013-2237-1; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Frasier TR, 2008, MOL ECOL RESOUR, V8, P1263, DOI 10.1111/j.1755-0998.2008.02358.x; Frere CH, 2010, P ROY SOC B-BIOL SCI, V277, P2667, DOI 10.1098/rspb.2010.0039; Harrison HB, 2013, MOL ECOL, V22, P1158, DOI 10.1111/mec.12138; Hutchings JA, 2004, BIOSCIENCE, V54, P297, DOI 10.1641/0006-3568(2004)054[0297:MFPCCF]2.0.CO;2; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Krause J, 2007, BEHAV ECOL SOCIOBIOL, V62, P15, DOI 10.1007/s00265-007-0445-8; Larson SR, 2010, CONSERV GENET, V11, P57, DOI 10.1007/s10592-009-0002-2; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Mourier J, 2013, J FISH BIOL, V82, P979, DOI 10.1111/jfb.12039; Mourier J, 2013, MOL ECOL, V22, P201, DOI 10.1111/mec.12103; Mourier J, 2012, ANIM BEHAV, V83, P389, DOI 10.1016/j.anbehav.2011.11.008; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Nadon MO, 2012, CONSERV BIOL, V26, P493, DOI 10.1111/j.1523-1739.2012.01835.x; Olson LE, 2012, MOL ECOL, V21, P562, DOI 10.1111/j.1365-294X.2011.05389.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Porcher IF, 2005, MAR BIOL, V146, P1207, DOI 10.1007/s00227-004-1518-0; Pratt HL, 2001, ENVIRON BIOL FISH, V60, P157; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Rollins LA, 2012, MOL ECOL, V21, P1727, DOI 10.1111/j.1365-294X.2012.05492.x; Schultz JK, 2008, MOL ECOL, V17, P5336, DOI 10.1111/j.1365-294X.2008.04000.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Verissimo A, 2011, J HERED, V102, P88, DOI 10.1093/jhered/esq084; Vignaud T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061067; Ward-Paige CA, 2012, J FISH BIOL, V80, P1844, DOI 10.1111/j.1095-8649.2012.03246.x; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y; Willi Y, 2006, ANNU REV ECOL EVOL S, V37, P433, DOI 10.1146/annurev.ecolsys.37.091305.110145; Worm B, 2013, MAR POLICY, V40, P194, DOI 10.1016/j.marpol.2012.12.034	51	22	23	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e73899	10.1371/journal.pone.0073899	http://dx.doi.org/10.1371/journal.pone.0073899			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967354	Green Published, Green Submitted, gold			2022-12-25	WOS:000323115800128
J	van der Slegt, J; van der Laan, L; Veen, EJ; Hendriks, Y; Romme, J; Kluytmans, J				van der Slegt, Jasper; van der Laan, Lijckle; Veen, Eelco J.; Hendriks, Yvonne; Romme, Jannie; Kluytmans, Jan			Implementation of a Bundle of Care to Reduce Surgical Site Infections in Patients Undergoing Vascular Surgery	PLOS ONE			English	Article							INTERVENTION	Background: Surgical site infections (SSI's) are associated with severe morbidity, mortality and increased health care costs in vascular surgery. Objective: To implement a bundle of care in vascular surgery and measure the effects on the overall and deep-SSI's rates. Design: Prospective, quasi-experimental, cohort study. Methods: A prospective surveillance for SSI's after vascular surgery was performed in the Amphia hospital in Breda, from 2009 through 2011. A bundle developed by the Dutch hospital patient safety program (DHPSP) was introduced in 2009. The elements of the bundle were (1) perioperative normothermia, (2) hair removal before surgery, (3) the use of perioperative antibiotic prophylaxis and (4) discipline in the operating room. Bundle compliance was measured every 3 months in a random sample of surgical procedures and this was used for feedback. Results: Bundle compliance improved significantly from an average of 10% in 2009 to 60% in 2011. In total, 720 vascular procedures were performed during the study period and 75 (10.4%) SSI were observed. Deep SSI occurred in 25 (3.5%) patients. Patients with SSI's (28,5 +/- 29.3 vs 10.8 +/- 11.3, p<0.001) and deep-SSI's (48.3 +/- 39.4 vs 11.4 +/- 11.8, p<0.001) had a significantly longer length of hospital stay after surgery than patients without an infection. A significantly higher mortality was observed in patients who developed a deep SSI (Adjusted OR: 2.96, 95% confidence interval 1.32-6.63). Multivariate analysis showed a significant and independent decrease of the SSI-rate over time that paralleled the introduction of the bundle. The SSI-rate was 51% lower in 2011 compared to 2009. Conclusion: The implementation of the bundle was associated with improved compliance over time and a 51% reduction of the SSI-rate in vascular procedures. The bundle did not require expensive or potentially harmful interventions and is therefore an important tool to improve patient safety and reduce SSI's in patients undergoing vascular surgery.	[van der Slegt, Jasper; van der Laan, Lijckle; Veen, Eelco J.] Amphia Hosp, Dept Surg, Breda, Netherlands; [Hendriks, Yvonne; Romme, Jannie; Kluytmans, Jan] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands; [Kluytmans, Jan] Vrije Univ Amsterdam, Dept Med Microbiol & Infect Control, Med Ctr, Amsterdam, Netherlands	Amphia Hospital; Amphia Hospital; Vrije Universiteit Amsterdam	van der Slegt, J (corresponding author), Amphia Hosp, Dept Surg, Breda, Netherlands.	jvanderslegt@gmail.com		van der laan, lijckle/0000-0001-5631-594X				Anthony T, 2011, ARCH SURG-CHICAGO, V146, P263, DOI 10.1001/archsurg.2010.249; Bandyk DF, 2008, SEMIN VASC SURG, V21, P119, DOI 10.1053/j.semvascsurg.2008.05.008; Berenholtz SM, 2011, INFECT CONT HOSP EP, V32, P305, DOI 10.1086/658938; Bull A, 2011, J HOSP INFECT, V78, P297, DOI 10.1016/j.jhin.2011.03.029; Crolla RMPH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044599; de Vries EN, 2010, NEW ENGL J MED, V363, P1928, DOI 10.1056/NEJMsa0911535; HORAN TC, 1992, INFECT CONT HOSP EP, V13, P606; Perencevich EN, 2003, EMERG INFECT DIS, V9, P196; Prakken F.J., 2011, NED TIJDSCHR GENEES, V155, pA3269; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Tatterton MR, 2011, INJURY, V42, pS35, DOI 10.1016/S0020-1383(11)70131-0; van Rijen MML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043065; Wick EC, 2012, J AM COLL SURGEONS, V215, P193, DOI 10.1016/j.jamcollsurg.2012.03.017; Zegers M, 2009, QUAL SAF HEALTH CARE, V18, P297, DOI 10.1136/qshc.2007.025924	14	50	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71566	10.1371/journal.pone.0071566	http://dx.doi.org/10.1371/journal.pone.0071566			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967222	Green Published, gold, Green Submitted			2022-12-25	WOS:000323115800065
J	Zhang, Y; Chen, MJ; Wu, ZG; Chen, J; Yu, SY; Fang, YR; Zhang, C				Zhang, Yi; Chen, Meijuan; Wu, Zhiguo; Chen, Jun; Yu, Shunying; Fang, Yiru; Zhang, Chen			Association Study of Val66Met Polymorphism in Brain-Derived Neurotrophic Factor Gene with Clozapine-Induced Metabolic Syndrome: Preliminary Results	PLOS ONE			English	Article							FACTOR BDNF; SCHIZOPHRENIC-PATIENTS; ADHESION MOLECULES; INSULIN-RESISTANCE; WEIGHT-GAIN; OBESITY; VARIANTS; RISK; HYPERPHAGIA; DEFICIENT	The prevalence of the metabolic syndrome (MetS) is higher among patients receiving atypical antipsychotics (AAPs) treatment, and even among AAPs, treatment with clozapine has been shown to be associated with a higher long-term incidence rate of MetS. Likewise, brain-derived neurotrophic factor (BDNF) deficiency has been reported to result in metabolic traits, such as increased food intake, hyperphagia and obesity, etc. In this study, we hypothesized that a functional polymorphism (Val66Met) in the BDNF gene may confer susceptibility to clozapine-induced MetS, potentially in a sex-specific manner, since an interaction between Val66Met polymorphism and sex was observed in our previous studies. A total of 199 schizophrenia patients being treated with clozapine were divided into two groups, MetS and non-MetS, based on the diagnostic criteria of the National Cholesterol Education Program's Adult Treatment Panel III. We genotyped the Val66Met polymorphism, and measured the serum levels of fasting glucose (GLU), triglyceride (TG) and high density lipoprotein cholesterol (HDL). There was a trend indicating a significant association between the homozygous Met/Met genotype and MetS in male patients (OR = 2.39; 95% CI: 1.05-5.41; p = 0.039; corrected p = 0.078). Among the six risk factors listed in the ATPIII criteria, we found a significant association between fasting GLU levels and Val66Met polymorphism in males (p = 0.005; corrected p = 0.03), but not in females (p = 0.65). Post-hoc analysis in males revealed that the Met/Met carriers had significant higher levels of fasting GLU than those with Val/Val or Val/Met genotypes (p = 0.007; corrected p = 0.042 and p = 0.002; corrected p = 0.012, respectively). In conclusion, we observed a weak association between the Val66Met polymorphism and clozapine-induced MetS in a sex-specific manner. While preliminary, such findings prompt further, large-scale longitudinal studies to replicate these findings.	[Zhang, Yi; Chen, Meijuan; Zhang, Chen] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Schizophrenia Program, Shanghai 200030, Peoples R China; [Wu, Zhiguo; Chen, Jun; Fang, Yiru] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Div Mood Disorders, Shanghai 200030, Peoples R China; [Yu, Shunying] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Dept Genet, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, C (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Schizophrenia Program, Shanghai 200030, Peoples R China.	zhangchen645@gmail.com	吴, 志国/AAT-5332-2020; Chen, Jun/AAJ-1972-2020		National Natural Science Foundation of China [81000581]; Shanghai Science & Technology Development Foundation [12140904200]; China Postdoctoral Science Foundation [2013M530410]; National Key Clinical Disciplines at Shanghai Mental Health Center (OMA-MH) [2011-873]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science & Technology Development Foundation; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Key Clinical Disciplines at Shanghai Mental Health Center (OMA-MH)	This work was supported by the National Natural Science Foundation of China (81000581), the Shanghai Science & Technology Development Foundation (12140904200), the China Postdoctoral Science Foundation (2013M530410) and the National Key Clinical Disciplines at Shanghai Mental Health Center (OMA-MH, 2011-873). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Lobos CA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006633.pub2; Bao YQ, 2008, ATHEROSCLEROSIS, V201, P378, DOI 10.1016/j.atherosclerosis.2008.03.001; Blankenberg S, 2001, CIRCULATION, V104, P1336, DOI 10.1161/hc3701.095949; Burghardt KJ, 2012, CTS-CLIN TRANSL SCI, V5, P486, DOI 10.1111/cts.12001; Cai J, 2013, PSYCHOPHARMACOLOGY, V230, P49, DOI 10.1007/s00213-013-3137-2; Cai J, 2013, MED HYPOTHESES, V80, P486, DOI 10.1016/j.mehy.2013.01.012; Chaldakov G N, 2001, Arch Physiol Biochem, V109, P357, DOI 10.1076/apab.109.3.357.9353; Chaldakov GN, 2009, RIV PSICHIATR, V44, P79; Coppola V, 2004, NEUROREPORT, V15, P2665, DOI 10.1097/00001756-200412030-00022; D Kuipers S, 2006, CURR OPIN DRUG DISC, V9, P580; De Hert M, 2008, SCHIZOPHR RES, V101, P295, DOI 10.1016/j.schres.2008.01.028; Duan WZ, 2003, ENDOCRINOLOGY, V144, P2446, DOI 10.1210/en.2002-0113; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Fox EA, 2004, AM J PHYSIOL-REG I, V286, pR994, DOI 10.1152/ajpregu.00727.2003; Friedel S, 2005, AM J MED GENET B, V132B, P96, DOI 10.1002/ajmg.b.30090; Frisardi V, 2010, J ALZHEIMERS DIS, V21, P57, DOI 10.3233/JAD-2010-100015; Gray J, 2006, DANCING TIMES, V96, P55; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hill RA, 2011, BRAIN RES, V1384, P51, DOI 10.1016/j.brainres.2011.01.060; Krabbe KS, 2007, DIABETOLOGIA, V50, P431, DOI 10.1007/s00125-006-0537-4; Lee IT, 2012, CLIN CHIM ACTA, V413, P944, DOI 10.1016/j.cca.2012.02.013; Levin BE, 2007, AM J PHYSIOL-REG I, V293, pR988, DOI 10.1152/ajpregu.00434.2007; Levinger I, 2008, MED SCI SPORT EXER, V40, P535, DOI [10.1249/MSS.0b013e31815dd057, 10.1249/mss.0b013e31815dd057]; Lu WH, 2012, J MOL NEUROSCI, V47, P505, DOI 10.1007/s12031-012-9750-4; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; Ma XY, 2012, J OBES, V2012, DOI 10.1155/2012/102942; Malik I, 2001, LANCET, V358, P971, DOI 10.1016/S0140-6736(01)06104-9; McEvoy JP, 2006, AM J PSYCHIAT, V163, P600, DOI 10.1176/appi.ajp.163.4.600; Mitchell AJ, 2013, SCHIZOPHRENIA BULL, V39, P306, DOI 10.1093/schbul/sbr148; Nicholson JR, 2007, J NEUROENDOCRINOL, V19, P974, DOI 10.1111/j.1365-2826.2007.01610.x; Ono M, 2000, METABOLISM, V49, P129, DOI 10.1016/S0026-0495(00)90988-0; PELLEYMOUNTER MA, 1995, EXP NEUROL, V131, P229, DOI 10.1016/0014-4886(95)90045-4; Pramyothin P, 2010, CURR OPIN ENDOCRINOL, V17, P460, DOI 10.1097/MED.0b013e32833de61c; Raz N, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.012.2008; Ribases M, 2005, EUR J HUM GENET, V13, P428, DOI 10.1038/sj.ejhg.5201351; Ryu S, 2011, AM J MED GENET B, V156B, P949, DOI 10.1002/ajmg.b.31242; Shi YY, 2006, CELL RES, V16, P851, DOI 10.1038/sj.cr.7310101; Travaglia A, 2012, CHEM-EUR J, V18, P15618, DOI 10.1002/chem.201202775; Tsai A, 2011, NEUROMOL MED, V13, P328, DOI 10.1007/s12017-011-8159-5; Wu LJ, 2010, DIABETES, V59, P3085, DOI 10.2337/db10-0273; Yamanaka M, 2008, BIOMED RES-TOKYO, V29, P147, DOI 10.2220/biomedres.29.147; Yi ZH, 2011, BRAIN RES, V1417, P146, DOI 10.1016/j.brainres.2011.08.037; Zai GCM, 2012, PROG NEURO-PSYCHOPH, V39, P96, DOI 10.1016/j.pnpbp.2012.05.014; Zhang JP, 2013, SCHIZOPHR RES, V146, P285, DOI 10.1016/j.schres.2013.01.020; Zhang W, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-75; Zhang XY, 2008, NEUROPSYCHOPHARMACOL, V33, P2200, DOI 10.1038/sj.npp.1301619; Zhang XY, 2007, J PSYCHIATR RES, V41, P997, DOI 10.1016/j.jpsychires.2006.08.007; Zhou H, 2010, DIABETES RES CLIN PR, V90, P319, DOI 10.1016/j.diabres.2010.09.001	48	37	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e72652	10.1371/journal.pone.0072652	http://dx.doi.org/10.1371/journal.pone.0072652			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967328	Green Published, gold, Green Submitted			2022-12-25	WOS:000323115800112
J	Bruyere, P; Baudot, A; Joly, T; Commin, L; Pillet, E; Guerin, P; Louis, G; Josson-Schramme, A; Buff, S				Bruyere, Pierre; Baudot, Anne; Joly, Thierry; Commin, Loris; Pillet, Elodie; Guerin, Pierre; Louis, Gerard; Josson-Schramme, Anne; Buff, Samuel			A Chemically Defined Medium for Rabbit Embryo Cryopreservation	PLOS ONE			English	Article							POLYVINYL-ALCOHOL; BOVINE EMBRYOS; ICE NUCLEATION; PRION DISEASES; COOLING RATES; VITRIFICATION; CULTURE; MOUSE; SERUM; CRYOPROTECTANT	This study evaluates a new synthetic substitute (CRYO3, Ref. 5617, Stem Alpha, France) for animal-based products in rabbit embryo cryopreservation solutions. This evaluation was performed using two approaches: a thermodynamic approach using differential scanning calorimetry and a biological approach using rabbit embryo slow-freezing. During the experiment, foetal calf serum (FCS) was used as a reference. Because FCS varies widely by supplier, three different FCS were selected for the thermodynamic approach. The rabbit embryo slow-freezing solutions were made from Dulbecco's phosphate buffer saline containing 1.5 M Dimethyl Sulfoxide and 18% (v.v(-1)) of CRYO3 or 18% (v.v(-1)) of FCS. These solutions were evaluated using four characteristics: the end of melting temperature, the enthalpy of crystallisation (thermodynamic approach) and the embryo survival rates after culture and embryo transfer (biological approach). In the thermodynamic approach, the solutions containing one of the three different FCS had similar mean thermodynamic characteristics but had different variabilities in the overall data with aberrant values. The solution containing CRYO3 had similar thermodynamic properties when compared to those containing FCS. Moreover, no aberrant value was measured in the solution containing CRYO3. This solution appears to be more stable than the solutions containing a FCS. In the biological approach, the in vitro embryo survival rates obtained with the solution containing CRYO3 (73.7% and 81.3%) and with the solution containing a FCS (77.6% and 71.9%) were similar (p = 0.7). Nevertheless, during the in vivo evaluation, the implantation rate (21.8%) and the live-foetuses rate (18.8%) of the CRYO3 group were significantly higher than the implantation rate (7.1%, p = 0.0002) and the live-foetuses rate (5.3%, p = 0.0002) of the FCS group. The pregnancy rate was also higher in the CRYO3 group compared to the FCS group (81.3% and 43.8%, respectively, p = 0.066). We conclude that CRYO3 can be used as a chemically defined substitute for animal-based products in rabbit embryo cryopreservation solutions.	[Bruyere, Pierre; Joly, Thierry; Commin, Loris; Pillet, Elodie; Guerin, Pierre; Josson-Schramme, Anne; Buff, Samuel] Univ Lyon, VetAgro Sup, ICE, UPSP 2011 03 10, Marcy Letoile, France; [Baudot, Anne; Louis, Gerard] Univ Paris 05, INSERM U698, PRES Sorbonne Paris Cite, Paris, France; [Joly, Thierry] ISARA Lyon, Dept Anim Prod, Lyon, France	VetAgro Sup; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; ISARA	Bruyere, P (corresponding author), Univ Lyon, VetAgro Sup, ICE, UPSP 2011 03 10, Marcy Letoile, France.	pierre.bruyere@vetagro-sup.fr	Bruyère, Pierre/B-6891-2019; Pillet, Elodie/G-3370-2019; BUFF, Samuel/E-4494-2010	Pillet, Elodie/0000-0002-2314-8548; BUFF, Samuel/0000-0002-4007-4624; JOLY, Thierry/0000-0002-4002-7748; Bruyere, Pierre/0000-0001-6581-525X				[Anonymous], [No title captured]; Barcelo-Fimbers M, 2007, MOL REPROD DEV, V74, P1395, DOI 10.1002/mrd.20699; Baudot A, 2000, CRYOBIOLOGY, V40, P151, DOI 10.1006/cryo.2000.2234; Bielanski A, 2009, THERIOGENOLOGY, V71, P499, DOI 10.1016/j.theriogenology.2008.08.015; Bielanski A, 2009, THERIOGENOLOGY, V72, P919, DOI 10.1016/j.theriogenology.2009.06.010; BOUTRON P, 1984, CRYOBIOLOGY, V21, P183, DOI 10.1016/0011-2240(84)90210-4; Saenz-de-Juano MD, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100677; ERICKSON GA, 1991, DEV BIOLOGICALS, V75, P173; George F, 2008, THERIOGENOLOGY, V69, P612, DOI 10.1016/j.theriogenology.2007.11.008; Givens MD, 2008, THERIOGENOLOGY, V69, P129, DOI 10.1016/j.theriogenology.2007.09.009; Gosden RG, 2010, HUM REPROD, V25, P470, DOI 10.1093/humrep/dep395; Guerin B, 1997, THERIOGENOLOGY, V47, P33, DOI 10.1016/S0093-691X(96)00337-8; Guerin B, 2000, LIVEST PROD SCI, V62, P271, DOI 10.1016/S0301-6226(99)00162-1; Houe H, 2003, BIOLOGICALS, V31, P137, DOI 10.1016/S1045-1056(03)00030-7; Houston F, 2008, BLOOD, V112, P4739, DOI 10.1182/blood-2008-04-152520; Issartel J, 2006, J EXP BIOL, V209, P3469, DOI 10.1242/jeb.02387; JOLY T, 1992, THERIOGENOLOGY, V37, P473, DOI 10.1016/0093-691X(92)90204-5; JOLY T, 1994, GENET SEL EVOL, V26, pS267, DOI 10.1051/gse:19940718; Joly T, 2010, CRYO 2010 1 CRYO C 2, pA11; Joly T, 1998, GENET SEL EVOL, V30, pS259, DOI 10.1051/gse:19980715; Joly T, 2012, CURRENT FRONTIERS IN CRYOPRESERVATION, P179; Kleinhans FW, 2007, CRYOBIOLOGY, V54, P212, DOI 10.1016/j.cryobiol.2007.01.007; Kleinhans FW, 2006, CRYOBIOLOGY, V52, P128, DOI 10.1016/j.cryobiol.2005.10.008; Kuleshova LL, 2001, CRYOBIOLOGY, V43, P21, DOI 10.1006/cryo.2001.2335; Le Tallec B, 2001, 17 M ETEA 07 08 SEPT; Leoni G, 2002, CRYOBIOLOGY, V45, P204, DOI 10.1016/S0011-2240(02)00139-6; LEVINGS RL, 1991, DEV BIOLOGICALS, V75, P177; Li G, 2006, MOL REPROD DEV, V73, P1600, DOI 10.1002/mrd.20541; Liu XH, 2001, J EXP ZOOL, V290, P299, DOI 10.1002/jez.1060; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Lopez-Bejar M, 2002, THERIOGENOLOGY, V58, P1541, DOI 10.1016/S0093-691X(02)01045-2; Martinez D, 1998, THERMOCHIM ACTA, V317, P91, DOI 10.1016/S0040-6031(98)00359-1; MENEZO Y, 1986, LIFE SCI, V39, P1751, DOI 10.1016/0024-3205(86)90094-9; Meryman HT, 1966, CRYOPRESERVATION PLA, P13; Naik BR, 2005, ANIM REPROD SCI, V86, P329, DOI 10.1016/j.anireprosci.2004.07.008; Naitana S, 1997, ANIM REPROD SCI, V48, P247, DOI 10.1016/S0378-4320(97)00043-2; Neto V, 2012, CURRENT FRONTIERS IN CRYOPRESERVATION, P205; Nowshari MA, 2000, THERIOGENOLOGY, V53, P1157, DOI 10.1016/S0093-691X(00)00260-0; Palasz AT, 2000, CRYOBIOLOGY, V41, P35, DOI 10.1006/cryo.2000.2262; PALASZ AT, 1995, THERIOGENOLOGY, V44, P705, DOI 10.1016/0093-691X(95)00250-C; R Development Core Team, 2011, R LANG ENV STAT COMP; ROSSI CR, 1980, AM J VET RES, V41, P1680; Salvetti P, 2007, THERIOGENOLOGY, V67, P1185, DOI 10.1016/j.theriogenology.2007.01.013; Salvetti P, 2006, CRYOBIOLOGY, V53, P268, DOI 10.1016/j.cryobiol.2006.07.002; Searles JA, 2001, J PHARM SCI, V90, P860, DOI 10.1002/jps.1039; SEIDEL G E JR, 1990, Theriogenology, V33, P322, DOI 10.1016/0093-691X(90)90746-G; Seki S, 2009, CRYOBIOLOGY, V58, P157, DOI 10.1016/j.cryobiol.2008.11.011; Skyba M, 2011, THERMOCHIM ACTA, V514, P22, DOI 10.1016/j.tca.2010.11.027; Stroud B, 2011, YEAR 2010 WORLDWIDE; Taylor DM, 2000, VET J, V159, P10, DOI 10.1053/tvjl.1999.0406; Thibier M, 2006, REPROD DOMEST ANIM, V41, P260, DOI 10.1111/j.1439-0531.2006.00721.x; Thirumala S, 2006, THERIOGENOLOGY, V66, P964, DOI 10.1016/j.theriogenology.2006.02.035; VICENTE JS, 1994, THERIOGENOLOGY, V42, P1205, DOI 10.1016/0093-691X(94)90869-9; Wrathall AE, 2008, THERIOGENOLOGY, V70, P725, DOI 10.1016/j.theriogenology.2008.05.049	54	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71547	10.1371/journal.pone.0071547	http://dx.doi.org/10.1371/journal.pone.0071547			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977074	Green Submitted, Green Published, gold			2022-12-25	WOS:000324527300021
J	Hortemo, KH; Munkvik, M; Lunde, PK; Sejersted, OM				Hortemo, Kristin Halvorsen; Munkvik, Morten; Lunde, Per Kristian; Sejersted, Ole M.			Multiple Causes of Fatigue during Shortening Contractions in Rat Slow Twitch Skeletal Muscle	PLOS ONE			English	Article							LIGHT-CHAIN PHOSPHORYLATION; SARCOPLASMIC-RETICULUM FUNCTION; INTENSITY EXERCISE; RYANODINE RECEPTOR; CALCIUM-RELEASE; MYOSIN; KINETICS; FIBERS; RELAXATION; MECHANISM	Fatigue in muscles that shorten might have other causes than fatigue during isometric contractions, since both cross-bridge cycling and energy demand are different in the two exercise modes. While isometric contractions are extensively studied, the causes of fatigue in shortening contractions are poorly mapped. Here, we investigate fatigue mechanisms during shortening contractions in slow twitch skeletal muscle in near physiological conditions. Fatigue was induced in rat soleus muscles with maintained blood supply by in situ shortening contractions at 37 degrees C. Muscles were stimulated repeatedly (1 s on/off at 30 Hz) for 15 min against a constant load, allowing the muscle to shorten and perform work. Fatigue and subsequent recovery was examined at 20 s, 100 s and 15 min exercise. The effects of prior exercise were investigated in a second exercise bout. Fatigue developed in three distinct phases. During the first 20 s the regulatory protein Myosin Light Chain-2 (slow isoform, MLC-2s) was rapidly dephosphorylated in parallel with reduced rate of force development and reduced shortening. In the second phase there was degradation of high-energy phosphates and accumulation of lactate, and these changes were related to slowing of muscle relengthening and relaxation, culminating at 100 s exercise. Slowing of relaxation was also associated with increased leak of calcium from the SR. During the third phase of exercise there was restoration of high-energy phosphates and elimination of lactate, and the slowing of relaxation disappeared, whereas dephosphorylation of MLC-2s and reduced shortening prevailed. Prior exercise improved relaxation parameters in a subsequent exercise bout, and we propose that this effect is a result of less accumulation of lactate due to more rapid onset of oxidative metabolism. The correlation between dephosphorylation of MLC-2s and reduced shortening was confirmed in various experimental settings, and we suggest MLC-2s as an important regulator of muscle shortening.	[Hortemo, Kristin Halvorsen; Munkvik, Morten; Lunde, Per Kristian; Sejersted, Ole M.] Oslo Univ Hosp, Expt Med Res Inst, Oslo, Norway; [Hortemo, Kristin Halvorsen; Munkvik, Morten; Lunde, Per Kristian; Sejersted, Ole M.] Univ Oslo, Oslo, Norway; [Hortemo, Kristin Halvorsen; Munkvik, Morten; Lunde, Per Kristian; Sejersted, Ole M.] Univ Oslo, KG Jebsen Cardiac Res Ctr, Oslo, Norway; [Hortemo, Kristin Halvorsen; Munkvik, Morten; Lunde, Per Kristian; Sejersted, Ole M.] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo	Sejersted, OM (corresponding author), Oslo Univ Hosp, Expt Med Res Inst, Oslo, Norway.	o.m.sejersted@medisin.uio.no			Anders Jahre's Fund for the Promotion of Science; South-Eastern Norway Regional Health Authority	Anders Jahre's Fund for the Promotion of Science; South-Eastern Norway Regional Health Authority	The study was supported by Anders Jahre's Fund for the Promotion of Science and South-Eastern Norway Regional Health Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; Allen DG, 2008, J APPL PHYSIOL, V104, P296, DOI 10.1152/japplphysiol.00908.2007; ALLEN DG, 1995, EXP PHYSIOL, V80, P497, DOI 10.1113/expphysiol.1995.sp003864; AMEREDES BT, 1992, J APPL PHYSIOL, V73, P2105, DOI 10.1152/jappl.1992.73.5.2105; BAKER AJ, 1993, AM J PHYSIOL, V264, pC577, DOI 10.1152/ajpcell.1993.264.3.C577; Bellinger AM, 2008, P NATL ACAD SCI USA, V105, P2198, DOI 10.1073/pnas.0711074105; BRENNER B, 1988, P NATL ACAD SCI USA, V85, P3265, DOI 10.1073/pnas.85.9.3265; Bruton JD, 1998, J APPL PHYSIOL, V85, P478, DOI 10.1152/jappl.1998.85.2.478; Bruton JD, 2008, J PHYSIOL-LONDON, V586, P175, DOI 10.1113/jphysiol.2007.147470; CADY EB, 1989, J PHYSIOL-LONDON, V418, P327, DOI 10.1113/jphysiol.1989.sp017843; Campbell-O'Sullivan SP, 2002, J PHYSIOL-LONDON, V538, P931, DOI 10.1113/jphysiol.2001.013238; COOKE R, 1985, BIOPHYS J, V48, P789, DOI 10.1016/S0006-3495(85)83837-6; Cooke R, 2007, MUSCLE NERVE, V36, P756, DOI 10.1002/mus.20891; Danieli-Betto D, 2000, J APPL PHYSIOL, V89, P891, DOI 10.1152/jappl.2000.89.3.891; EDWARDS RHT, 1977, J PHYSIOL-LONDON, V272, P769, DOI 10.1113/jphysiol.1977.sp012072; Fenn WO, 1924, J PHYSIOL-LONDON, V58, P0373, DOI 10.1113/jphysiol.1924.sp002141; Fitts RH, 2008, J APPL PHYSIOL, V104, P551, DOI 10.1152/japplphysiol.01200.2007; GIBSON H, 1985, SPORTS MED, V2, P120, DOI 10.2165/00007256-198502020-00004; Gray SC, 2002, MED SCI SPORTS EXERC, V34; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gurd BJ, 2005, J APPL PHYSIOL, V98, P1371, DOI 10.1152/japplphysiol.01028.2004; Hernandez A, 2010, J APPL PHYSIOL, V108, P1169, DOI 10.1152/japplphysiol.01318.2009; Inashima S, 2003, EUR J APPL PHYSIOL, V89, P142, DOI 10.1007/s00421-002-0763-5; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; LIONNE C, 1995, FEBS LETT, V364, P59, DOI 10.1016/0014-5793(95)00356-E; Lowry OH, 1972, FLEXIBLE SYSTEM ENZY, P174; MOORE RL, 1984, AM J PHYSIOL, V247, pC462, DOI 10.1152/ajpcell.1984.247.5.C462; Munkvik M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022695; Munkvik M, 2009, AM J PHYSIOL-REG I, V297, pR900, DOI 10.1152/ajpregu.91043.2008; Nyitrai M, 2006, J MOL BIOL, V355, P432, DOI 10.1016/j.jmb.2005.10.063; OBRIEN PJ, 1990, MOL CELL BIOCHEM, V94, P113, DOI 10.1007/BF00214118; Ortenblad N, 2000, J APPL PHYSIOL, V89, P210; Reiken S, 2003, J CELL BIOL, V160, P919, DOI 10.1083/jcb.200211012; Roots H, 2009, J APPL PHYSIOL, V106, P378, DOI 10.1152/japplphysiol.90883.2008; RUELL PA, 1995, ANAL BIOCHEM, V228, P194, DOI 10.1006/abio.1995.1339; Sanbe A, 1999, J BIOL CHEM, V274, P21085, DOI 10.1074/jbc.274.30.21085; SEOW CY, 1988, J APPL PHYSIOL, V64, P2388, DOI 10.1152/jappl.1988.64.6.2388; SIMONIDES WS, 1990, ANAL BIOCHEM, V191, P321, DOI 10.1016/0003-2697(90)90226-Y; Stull JT, 2011, ARCH BIOCHEM BIOPHYS, V510, P120, DOI 10.1016/j.abb.2011.01.017; Sweeney HL, 2004, PHILOS T R SOC B, V359, P1829, DOI 10.1098/rstb.2004.1576; SWEENEY HL, 1986, AM J PHYSIOL, V250, pC657, DOI 10.1152/ajpcell.1986.250.4.C657; SWEENEY HL, 1990, P NATL ACAD SCI USA, V87, P414, DOI 10.1073/pnas.87.1.414; Toepfer C, 2013, J BIOL CHEM, V288, P13446, DOI 10.1074/jbc.M113.455444; Tschakovsky ME, 1999, J APPL PHYSIOL, V86, P1101, DOI 10.1152/jappl.1999.86.4.1101; Vedsted P, 2003, ACTA PHYSIOL SCAND, V178, P175, DOI 10.1046/j.1365-201X.2003.01123.x; Voelkel T, 2011, PFLUG ARCH EUR J PHY, V462, P143, DOI 10.1007/s00424-011-0938-1; Westerblad H, 1997, J GEN PHYSIOL, V109, P385, DOI 10.1085/jgp.109.3.385	47	6	7	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e71700	10.1371/journal.pone.0071700	http://dx.doi.org/10.1371/journal.pone.0071700			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977116	Green Submitted, gold, Green Published			2022-12-25	WOS:000323570200046
J	Kiso, WK; Selvaraj, V; Nagashima, J; Asano, A; Brown, JL; Schmitt, DL; Leszyk, J; Travis, AJ; Pukazhenthi, BS				Kiso, Wendy K.; Selvaraj, Vimal; Nagashima, Jennifer; Asano, Atsushi; Brown, Janine L.; Schmitt, Dennis L.; Leszyk, John; Travis, Alexander J.; Pukazhenthi, Budhan S.			Lactotransferrin in Asian Elephant (Elephas maximus) Seminal Plasma Correlates with Semen Quality	PLOS ONE			English	Article							FERTILITY-ASSOCIATED PROTEIN; ALKALINE-PHOSPHATASE; SPERM MOTILITY; STALLION SEMEN; LACTOFERRIN; PARAMETERS; IDENTIFICATION; COLLECTION; CALCIUM; URINE	Asian elephants (Elephas maximus) have highly variable ejaculate quality within individuals, greatly reducing the efficacy of artificial insemination and making it difficult to devise a sperm cryopreservation protocol for this endangered species. Because seminal plasma influences sperm function and physiology, including sperm motility, the objectives of this study were to characterize the chemistry and protein profiles of Asian elephant seminal plasma and to determine the relationships between seminal plasma components and semen quality. Ejaculates exhibiting good sperm motility (>= 65%) expressed higher percentages of spermatozoa with normal morphology (80.3 +/- 13.0 vs. 44.9 +/- 30.8%) and positive Spermac staining (51.9 +/- 14.5 vs. 7.5 +/- 14.4%), in addition to higher total volume (135.1 +/- 89.6 vs. 88.8 +/- 73.1 ml) and lower sperm concentration (473.0 +/- 511.2 vs. 1313.8 +/- 764.7x10(6) cells ml(-1)) compared to ejaculates exhibiting poor sperm motility (<= 10%; P<0.05). Comparison of seminal plasma from ejaculates with good versus poor sperm motility revealed significant differences in concentrations of creatine phosphokinase, alanine aminotransferase, phosphorus, sodium, chloride, magnesium, and glucose. These observations suggest seminal plasma influences semen quality in elephants. One-and two-dimensional (2D) gel electrophoresis revealed largely similar compositional profiles of seminal plasma proteins between good and poor motility ejaculates. However, a protein of similar to 80 kDa was abundant in 85% of ejaculates with good motility, and was absent in 90% of poor motility ejaculates (P<0.05). We used mass spectrometry to identify this protein as lactotransferrin, and immunoblot analysis to confirm this identification. Together, these findings lay a functional foundation for understanding the contributions of seminal plasma in the regulation of Asian elephant sperm motility, and for improving semen collection and storage in this endangered species.	[Kiso, Wendy K.] Smithsonian Conservat Biol Inst, Ctr Species Survival, Washington, DC USA; [Kiso, Wendy K.] George Mason Univ, Dept Environm Sci & Policy, Fairfax, VA 22030 USA; [Selvaraj, Vimal] Cornell Univ, Dept Anim Sci, Ithaca, NY 14853 USA; [Nagashima, Jennifer; Asano, Atsushi; Travis, Alexander J.] Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, Ithaca, NY 14853 USA; [Nagashima, Jennifer; Brown, Janine L.; Pukazhenthi, Budhan S.] Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA USA; [Schmitt, Dennis L.] Missouri State Univ, William H Darr Sch Agr, Springfield, MO USA; [Schmitt, Dennis L.] Ringling Bros Ctr Elephant Conservat, Polk City, FL USA; [Leszyk, John] Univ Massachusetts, Sch Med, Prote & Mass Spectrometry Facil, Shrewsbury, MA USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; George Mason University; Cornell University; Cornell University; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Missouri State University; University of Massachusetts System	Kiso, WK (corresponding author), Smithsonian Conservat Biol Inst, Ctr Species Survival, Natl Zool Pk, Washington, DC USA.	wkiso@feldinc.com	Selvaraj, Vimal/AAC-2853-2022		Feld Entertainment Inc.; International Elephant Foundation; Friends of the National Zoo; Baker Institute for Animal Health	Feld Entertainment Inc.; International Elephant Foundation; Friends of the National Zoo(Smithsonian InstitutionSmithsonian National Zoological Park & Conservation Biology Institute); Baker Institute for Animal Health	Funding for this study was generously provided by Feld Entertainment Inc., International Elephant Foundation, Friends of the National Zoo, and the Baker Institute for Animal Health. Wendy Kiso was supported by a grant from Feld Entertainment, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN RJ, 1993, J REPROD FERTIL, V98, P257; ANAND SR, 1973, J REPROD FERTIL, V32, P97, DOI 10.1530/jrf.0.0320097; ANDERSON RA, 1979, CLIN CHEM, V25, P1780; BARONOS S, 1971, J REPROD FERTIL, V24, P303, DOI 10.1530/jrf.0.0240303; BESSMAN SP, 1985, ANNU REV BIOCHEM, V54, P831, DOI 10.1146/annurev.bi.54.070185.004151; Brandon CI, 1999, THERIOGENOLOGY, V52, P863, DOI 10.1016/S0093-691X(99)00178-8; BRANDT H, 1978, BIOL REPROD, V19, P830, DOI 10.1095/biolreprod19.4.830; Brock JH, 2002, BIOCHEM CELL BIOL, V80, P1, DOI 10.1139/o01-212; Cancel AM, 1997, BIOL REPROD, V57, P1293, DOI 10.1095/biolreprod57.6.1293; CARR DW, 1985, BIOL REPROD, V33, P588, DOI 10.1095/biolreprod33.3.588; Cevik M, 2007, TURK J VET ANIM SCI, V31, P381; Darszon A, 2007, Soc Reprod Fertil Suppl, V65, P229; Darszon A, 1999, PHYSIOL REV, V79, P481, DOI 10.1152/physrev.1999.79.2.481; de Lamirande E, 1997, Rev Reprod, V2, P48, DOI 10.1530/revreprod/2.1.48; Eddy EM, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P3; FAKIH H, 1986, FERTIL STERIL, V46, P938; Farnaud S, 2003, MOL IMMUNOL, V40, P395, DOI 10.1016/S0161-5890(03)00152-4; Favareto A, 2008, REPROD DOMEST ANIM, V45, P323; Fouchecourt S, 2000, BIOL REPROD, V62, P1790, DOI 10.1095/biolreprod62.6.1790; FRENETTE G, 1986, ARCH ANDROLOGY, V16, P235, DOI 10.3109/01485018608986946; Gamboa S, 2011, J EQUINE VET SCI, V31, P109, DOI 10.1016/j.jevs.2010.12.011; Gerena RL, 1998, BIOL REPROD, V58, P826, DOI 10.1095/biolreprod58.3.826; Griggers S, 2001, THERIOGENOLOGY, V56, P613, DOI 10.1016/S0093-691X(01)00593-3; Gundogan M, 2005, TURK J VET ANIM SCI, V29, P595; Gusani P H, 1992, Acta Eur Fertil, V23, P39; Hermes R, 2009, ANIM REPROD SCI, V112, P390, DOI 10.1016/j.anireprosci.2008.05.007; HOWARD JG, 1984, J REPROD FERTIL, V72, P187, DOI 10.1530/jrf.0.0720187; Howards S., 1979, The spermatozoon. Maturation, motility, surface properties and comparative aspects. Proceedings of the Third International Symposium on the Spermatozoon, held at the American Academy of Arts and Sciences, Boston, and the Swope Conference Center, Marine Biological Laboratories, Woods Hole, Massachusetts, May 2-5, 1978., P35; JAINUDEEN MR, 1972, J REPROD FERTIL, V29, P99, DOI 10.1530/jrf.0.0290099; JAINUDEEN MR, 1971, J REPROD FERTIL, V24, P213, DOI 10.1530/jrf.0.0240213; Kawano N, 2008, BIOL REPROD, V79, P1153, DOI 10.1095/biolreprod.108.069054; Kikuchi M, 2003, J VET MED SCI, V65, P1273, DOI 10.1292/jvms.65.1273; KILLIAN GJ, 1993, BIOL REPROD, V49, P1202, DOI 10.1095/biolreprod49.6.1202; Kiso WK, 2011, J ANDROL, V32, P420, DOI 10.2164/jandrol.110.011460; Kiso WK, 2012, REPROD FERTIL; Kitiyanant Y, 2000, THERIOGENOLOGY, V53, P887, DOI 10.1016/S0093-691X(00)00237-5; Kozdrowski R, 2004, ANIM REPROD SCI, V80, P281, DOI 10.1016/j.anireprosci.2003.08.006; Kutzler MA, 2003, THERIOGENOLOGY, V60, P299, DOI 10.1016/S0093-691X(02)01366-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVAY PF, 1995, HAEMATOLOGICA, V80, P252; Luconi M, 2003, CELL MOL BIOL, V49, P357; MAKLER A, 1981, FERTIL STERIL, V36, P507; Mann T., 1964, BIOCH SEMEN MALE REP, DOI 10.5694/j.1326-5377.1965.tb72030.x; Mann T, 1981, MALE REPROD FUNCTION; MASSON PL, 1971, COMP BIOCHEM PHYSIOL, V39, P119, DOI 10.1016/0305-0491(71)90258-6; Minelli A, 2001, J EXP ZOOL, V290, P279, DOI 10.1002/jez.1058; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; Mosaferi S, 2005, THERIOGENOLOGY, V63, P92, DOI 10.1016/j.theriogenology.2004.03.021; Moura AA, 2006, J ANDROL, V27, P201, DOI 10.2164/jandrol.05089; Novak S, 2010, J ANDROL, V31, P188, DOI 10.2164/jandrol.109.007583; O'Briena JK, 2008, REPROD FERT DEVELOP, V20, P770, DOI 10.1071/RD08031; O'Donnell L, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1017; Oliva R, 2008, SYST BIOL REPROD MED, V54, P23, DOI 10.1080/19396360701879595; Pearl CA, 2008, DOMEST ANIM ENDOCRIN, V34, P153, DOI 10.1016/j.domaniend.2007.01.001; Pesch S, 2006, THERIOGENOLOGY, V66, P307, DOI 10.1016/j.theriogenology.2005.11.015; Portas TJ, 2007, AUST VET J, V85, P425, DOI 10.1111/j.1751-0813.2007.00207.x; Pukazhenthi BS, 2004, REPROD FERT DEVELOP, V16, P33, DOI 10.1071/RD03076; Rajeev SK, 2004, HUM REPROD, V19, P234, DOI 10.1093/humrep/deh066; Roth TL, 2010, THERIOGENOLOGY, V74, P1701, DOI 10.1016/j.theriogenology.2010.05.021; Sanocka Dorota, 2004, Reprod Biol Endocrinol, V2, P12, DOI 10.1186/1477-7827-2-12; Schmitt Dennis, 2006, P347, DOI 10.1002/9780470344484.ch26; Schmitt DL, 1998, ANIM REPROD SCI, V53, P309, DOI 10.1016/S0378-4320(98)00120-1; Singh MP, 1996, THERIOGENOLOGY, V45, P405, DOI 10.1016/0093-691X(95)00377-K; Sivilaikul S, 2010, THAI J VET MED, V40, P251; Stornelli A, 2003, REPROD DOMEST ANIM, V38, P1, DOI 10.1046/j.1439-0531.2003.00369.x; THALER CJ, 1990, BIOL REPROD, V43, P712, DOI 10.1095/biolreprod43.4.712; Thongtip N, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-9; Travis AJ, 1998, MOL BIOL CELL, V9, P263, DOI 10.1091/mbc.9.2.263; Truta Z, 2010, ROM BIOTECH LETT, V15, P5764; Turner RMO, 2003, THERIOGENOLOGY, V60, P1, DOI 10.1016/S0093-691X(02)00956-1; Weissgerber P, 2011, SCI; WICHMANN L, 1989, INT J ANDROL, V12, P179, DOI 10.1111/j.1365-2605.1989.tb01302.x; Wiese RJ, 2000, ZOO BIOL, V19, P299, DOI 10.1002/1098-2361(2000)19:5<299::AID-ZOO2>3.0.CO;2-Z; Williams AC, 2001, J ANDROL, V22, P680; Wirtu G, 2008, ANIM REPROD SCI, V103, P392, DOI 10.1016/j.anireprosci.2007.06.016; Wong WY, 2001, REPROD TOXICOL, V15, P131, DOI 10.1016/S0890-6238(01)00113-7; Yousef MI, 2003, ANIM REPROD SCI, V76, P99, DOI 10.1016/S0378-4320(02)00226-9; YU LC, 1993, BIOCHEM J, V296, P107, DOI 10.1042/bj2960107	78	16	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e71033	10.1371/journal.pone.0071033	http://dx.doi.org/10.1371/journal.pone.0071033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23976974	Green Published, Green Submitted, gold			2022-12-25	WOS:000323570200016
J	Ambrosi, C; Walker, AE; DePriest, AD; Cone, AC; Lu, C; Badger, J; Skerrett, M; Sosinsky, GE				Ambrosi, Cinzia; Walker, Amy E.; DePriest, Adam D.; Cone, Angela C.; Lu, Connie; Badger, John; Skerrett, Martha; Sosinsky, Gina E.			Analysis of Trafficking, Stability and Function of Human Connexin 26 Gap Junction Channels with Deafness-Causing Mutations in the Fourth Transmembrane Helix	PLOS ONE			English	Article							3-DIMENSIONAL STRUCTURE; CHILDHOOD DEAFNESS; HEARING IMPAIRMENT; GJB2 GENE; SKIN; PROTEIN; CX26; PERMEABILITY; REVEALS; DISEASE	Human Connexin26 gene mutations cause hearing loss. These hereditary mutations are the leading cause of childhood deafness worldwide. Mutations in gap junction proteins (connexins) can impair intercellular communication by eliminating protein synthesis, mis-trafficking, or inducing channels that fail to dock or have aberrant function. We previously identified a new class of mutants that form non-functional gap junction channels and hemichannels (connexons) by disrupting packing and inter-helix interactions. Here we analyzed fourteen point mutations in the fourth transmembrane helix of connexin26 (Cx26) that cause non-syndromic hearing loss. Eight mutations caused mis-trafficking (K188R, F191L, V198M, S199F, G200R, I203K, L205P, T208P). Of the remaining six that formed gap junctions in mammalian cells, M195T and A197S formed stable hemichannels after isolation with a baculovirus/Sf9 protein purification system, while C202F, I203T, L205V and N206S formed hemichannels with varying degrees of instability. The function of all six gap junction-forming mutants was further assessed through measurement of dye coupling in mammalian cells and junctional conductance in paired Xenopus oocytes. Dye coupling between cell pairs was reduced by varying degrees for all six mutants. In homotypic oocyte pairings, only A197S induced measurable conductance. In heterotypic pairings with wild-type Cx26, five of the six mutants formed functional gap junction channels, albeit with reduced efficiency. None of the mutants displayed significant alterations in sensitivity to transjunctional voltage or induced conductive hemichannels in single oocytes. Intra-hemichannel interactions between mutant and wild-type proteins were assessed in rescue experiments using baculovirus expression in Sf9 insect cells. Of the four unstable mutations (C202F, I203T, L205V, N206S) only C202F and N206S formed stable hemichannels when co-expressed with wild-type Cx26. Stable M195T hemichannels displayed an increased tendency to aggregate. Thus, mutations in TM4 cause a range of phenotypes of dysfunctional gap junction channels that are discussed within the context of the X-ray crystallographic structure.	[Ambrosi, Cinzia; Walker, Amy E.; Cone, Angela C.; Lu, Connie; Sosinsky, Gina E.] Univ Calif San Diego, Ctr Res Biol Syst, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; [Sosinsky, Gina E.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [DePriest, Adam D.; Skerrett, Martha] SUNY Buffalo, Dept Biol, Buffalo, NY 14260 USA; [Badger, John] DeltaG Technol, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Sosinsky, GE (corresponding author), Univ Calif San Diego, Ctr Res Biol Syst, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA.	gsosinsky@ucsd.edu			National Institutes of Health [GM065937, GM072881]; American Heart Association Scientist Development Grant, National Affiliate; NIH [GM103412, GM103311]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002250, P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103412, R01GM072881, R01GM065937, P41GM103311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Scientist Development Grant, National Affiliate(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Institutes of Health grants GM065937 and GM072881 (awarded to GES, http://www.nigms.nih.gov). I. Martha Skerrett was supported by an American Heart Association Scientist Development Grant, National Affiliate. Most of the work presented here was conducted at the National Center for Microscopy and Imaging Research at San Diego, which is supported by NIH Grant GM103412, awarded to Dr. Mark Ellisman. Chimera is developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by NIH GM103311). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosi C, 2010, BIOPHYS J, V98, P1809, DOI 10.1016/j.bpj.2010.01.019; Boassa D, 2010, TRAFFIC, V11, P1471, DOI 10.1111/j.1600-0854.2010.01109.x; CHALESHTORI MH, 2005, IRAN J PUBLIC HEALTH, V34, P1; Cohen M. M., 1995, HEREDITARY HEARING L, P9; Desplantez T, 2011, J MEMBRANE BIOL, V240, P139, DOI 10.1007/s00232-011-9352-z; Dror AA, 2010, NEURON, V68, P293, DOI 10.1016/j.neuron.2010.10.011; ELFGANG C, 1995, J CELL BIOL, V129, P805, DOI 10.1083/jcb.129.3.805; Evans WH, 2002, MOL MEMBR BIOL, V19, P121, DOI 10.1080/09687680210139839; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Gaietta GM, 2006, P NATL ACAD SCI USA, V103, P17777, DOI 10.1073/pnas.0608509103; Gerido DA, 2004, BBA-BIOMEMBRANES, V1662, P159, DOI 10.1016/j.bbamem.2003.10.017; Govindarajan R, 2002, J BIOL CHEM, V277, P50087, DOI 10.1074/jbc.M202652200; Hamelmann C, 2001, Hum Mutat, V18, P84, DOI 10.1002/humu.1156; Han SH, 2008, J HUM GENET, V53, P1022, DOI 10.1007/s10038-008-0342-7; Harris Andrew L., 2009, P165, DOI 10.1007/978-1-59745-489-6_7; Hashemi SB, 2012, MOL BIOL REP, V39, P10481, DOI 10.1007/s11033-012-1929-9; Hulser DF, 1997, EXP CELL RES, V233, P240, DOI 10.1006/excr.1997.3568; Johns S. J., TOPO2 TRANSMEMBRANE; Jordan K, 1999, MOL BIOL CELL, V10, P2033, DOI 10.1091/mbc.10.6.2033; Kenna MA, 2001, ARCH OTOLARYNGOL, V127, P1037, DOI 10.1001/archotol.127.9.1037; Kudo T, 2000, AM J MED GENET, V90, P141, DOI 10.1002/(SICI)1096-8628(20000117)90:2<141::AID-AJMG10>3.0.CO;2-G; Lee JR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001276; Lee JR, 2009, J INVEST DERMATOL, V129, P870, DOI 10.1038/jid.2008.335; Lentz JJ, 2013, NAT MED; Leshinsky-Silver E, 2005, HEARING RES, V202, P258, DOI 10.1016/j.heares.2004.11.003; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Martin BR, 2005, NAT BIOTECHNOL, V23, P1308, DOI 10.1038/nbt1136; McRee DE, 2004, ACTA CRYSTALLOGR D, V60, P2276, DOI 10.1107/S0907444904025491; Mese G, 2008, AM J PHYSIOL-CELL PH, V295, pC966, DOI 10.1152/ajpcell.00008.2008; Morle L, 2000, J MED GENET, V37, P368, DOI 10.1136/jmg.37.5.368; Oshima A, 2003, J BIOL CHEM, V278, P1807, DOI 10.1074/jbc.M207713200; Oshima A, 2008, CELL COMMUN ADHES, V15, P85, DOI 10.1080/15419060802013588; Oshima A, 2007, P NATL ACAD SCI USA, V104, P10034, DOI 10.1073/pnas.0703704104; Oshima A, 2011, J MOL BIOL, V405, P724, DOI 10.1016/j.jmb.2010.10.032; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfenniger A, 2011, EUR J CLIN INVEST, V41, P103, DOI 10.1111/j.1365-2362.2010.02378.x; Putcha GV, 2007, GENET MED, V9, P413, DOI 10.1097/GIM.0b013e3180a03276; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Scott CA, 2011, BIOCHEM J, V438, P245, DOI 10.1042/BJ20110278; Skerrett IM, 2001, METH MOL B, V154, P225; Snoeckx RL, 2005, AM J HUM GENET, V77, P945, DOI 10.1086/497996; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Sosinsky GE, 2005, BBA-BIOMEMBRANES, V1711, P99, DOI 10.1016/j.bbamem.2005.04.001; Tamayo ML, 2009, INT J PEDIATR OTORHI, V73, P97, DOI 10.1016/j.ijporl.2008.10.001; Unger VM, 1999, SCIENCE, V283, P1176, DOI 10.1126/science.283.5405.1176; Wang WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021473; Wu BL, 2002, GENET MED, V4, P279, DOI 10.1097/00125817-200207000-00006; Xiao ZA, 2011, ACTA OTO-LARYNGOL, V131, P59, DOI 10.3109/00016489.2010.506885; Xu J, 2013, BBA-BIOMEMBRANES, V1828, P167, DOI 10.1016/j.bbamem.2012.06.024; Yilmaz A, 2010, BIOCHEM GENET, V48, P248, DOI 10.1007/s10528-009-9314-7; Yuan Y, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-79; Yum SW, 2010, NEUROBIOL DIS, V38, P226, DOI 10.1016/j.nbd.2010.01.010; Zainal SA, 2012, INT J PEDIATR OTORHI, V76, P1175, DOI 10.1016/j.ijporl.2012.04.027; Zhang JX, 2011, MOL CELL NEUROSCI, V47, P71, DOI 10.1016/j.mcn.2010.10.002	54	19	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e70916	10.1371/journal.pone.0070916	http://dx.doi.org/10.1371/journal.pone.0070916			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967136	gold, Green Published, Green Submitted			2022-12-25	WOS:000323378000024
J	Dimicoli, S; Wei, Y; Bueso-Ramos, C; Yang, H; DiNardo, C; Jia, Y; Zheng, H; Fang, ZH; Nguyen, M; Pierce, S; Chen, R; Wang, H; Wu, CH; Garcia-Manero, G				Dimicoli, Sophie; Wei, Yue; Bueso-Ramos, Carlos; Yang, Hui; DiNardo, Courtney; Jia, Yu; Zheng, Hong; Fang, Zhihong; Martin Nguyen; Pierce, Sherry; Chen, Rui; Wang, Hui; Wu, Chenghua; Garcia-Manero, Guillermo			Overexpression of the Toll-Like Receptor (TLR) Signaling Adaptor MYD88, but Lack of Genetic Mutation, in Myelodysplastic Syndromes	PLOS ONE			English	Article							HEMATOPOIETIC PROGENITOR CELLS; NF-KAPPA-B; MYELOID-LEUKEMIA; INFLAMMATION; ACTIVATION; APOPTOSIS; LIPOPOLYSACCHARIDE; TUMORIGENESIS; TRANSCRIPTION; TRANSDUCTION	MYD88 is a key mediator of Toll-like receptor innate immunity signaling. Oncogenically active MYD88 mutations have recently been reported in lymphoid malignancies, but has not been described in MDS. To characterize MYD88 in MDS, we sequenced the coding region of the MYD88 gene in 40 MDS patients. No MYD88 mutation was detected. We next characterized MYD88 expression in bone marrow CD34+ cells (N = 64). Increased MYD88 RNA was detected in 40% of patients. Patients with higher MYD88 expression in CD34+ cells had a tendency for shorter survival compared to the ones with lower MYD88, which was significant when controlled for IPSS and age. We then evaluated effect of MYD88 blockade in the CD34+ cells of patients with lower-risk MDS. Colony formation assays indicated that MYD88 blockade using a MYD88 inhibitor resulted in increased erythroid colony formation. MYD88 blockade also negatively regulated the secretion of interleukin-8. Treatment of MDS CD34+ cells with an IL-8 antibody also increased formation of erythroid colonies. These results indicate that MYD88 plays a role in the pathobiology of MDS and may have prognostic and therapeutic value in the management of patients with this disease.	[Dimicoli, Sophie; Wei, Yue; Yang, Hui; DiNardo, Courtney; Jia, Yu; Zheng, Hong; Fang, Zhihong; Pierce, Sherry; Garcia-Manero, Guillermo] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Bueso-Ramos, Carlos; Martin Nguyen] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Chen, Rui; Wang, Hui; Wu, Chenghua] Baylor Coll Med, Dept Human Genet, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine	Wei, Y (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA.	ywei@mdanderson.org; ggarciam@mdanderson.org			Cancer Prevention & Research Institute of Texas [RP100202]; DOD/Congressionally Directed Medical Research Programs [(DOD/CDMRP)CA110791]; Ruth and Ken Arnold Fund; MD Anderson Cancer Center Leukemia SPORE [CA100632]; Evans Foundation; MD Anderson Cancer Center [CCSG CA016672]; NATIONAL CANCER INSTITUTE [P50CA100632, P30CA016672] Funding Source: NIH RePORTER	Cancer Prevention & Research Institute of Texas; DOD/Congressionally Directed Medical Research Programs; Ruth and Ken Arnold Fund; MD Anderson Cancer Center Leukemia SPORE; Evans Foundation; MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant RP100202 from the Cancer Prevention & Research Institute of Texas, the DOD/Congressionally Directed Medical Research Programs (DOD/CDMRP)CA110791, the Ruth and Ken Arnold Fund, the MD Anderson Cancer Center Leukemia SPORE grant CA100632, the Evans Foundation, and the MD Anderson Cancer Center CCSG CA016672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 1999, LEUKEMIA RES, V23, P741, DOI 10.1016/S0145-2126(99)00084-3; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bejar R, 2012, J CLIN ONCOL, V30, P3376, DOI 10.1200/JCO.2011.40.7379; da Costa SV, 2010, LEUKEMIA RES, V34, P507, DOI 10.1016/j.leukres.2009.10.012; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Esplin BL, 2011, J IMMUNOL, V186, P5367, DOI 10.4049/jimmunol.1003438; Fang J, 2012, BLOOD, V120, P858, DOI 10.1182/blood-2012-02-407999; Filippone C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009496; Galloway JL, 2005, DEV CELL, V8, P109, DOI 10.1016/j.devcel.2004.12.001; Grass JA, 2003, P NATL ACAD SCI USA, V100, P8811, DOI 10.1073/pnas.1432147100; Grosjean-Raillard J, 2009, ONCOGENE, V28, P1099, DOI 10.1038/onc.2008.457; Janssens S, 2002, TRENDS BIOCHEM SCI, V27, P474, DOI 10.1016/S0968-0004(02)02145-X; Je EM, 2012, EUR J HAEMATOL, V88, P273, DOI 10.1111/j.1600-0609.2011.01720.x; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; KOEFFLER HP, 1978, SCIENCE, V200, P1153, DOI 10.1126/science.306682; Kumar MS, 2011, BLOOD, V118, P4666, DOI 10.1182/blood-2010-12-324715; Langlet C, 2010, EUR J IMMUNOL, V40, P505, DOI 10.1002/eji.200939391; Loiarro M, 2005, J BIOL CHEM, V280, P15809, DOI 10.1074/jbc.C400613200; Maratheftis CI, 2007, CLIN CANCER RES, V13, P1154, DOI 10.1158/1078-0432.CCR-06-2108; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; O'Connell CM, 2006, J BIOL CHEM, V281, P1652, DOI 10.1074/jbc.M510182200; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Sato T, 2000, J CLIN INVEST, V106, P263, DOI 10.1172/JCI9361; Starczynowski DT, 2010, HEMATOL ONCOL CLIN N, V24, P343, DOI 10.1016/j.hoc.2010.02.008; Starczynowski DT, 2010, NAT MED, V16, P49, DOI 10.1038/nm.2054; Swann JB, 2008, P NATL ACAD SCI USA, V105, P652, DOI 10.1073/pnas.0708594105; Szajnik M, 2009, ONCOGENE, V28, P4353, DOI 10.1038/onc.2009.289; Tefferi A, 2009, NEW ENGL J MED, V361, P1872, DOI 10.1056/NEJMra0902908; Toshchakov VU, 2005, J IMMUNOL, V175, P494, DOI 10.4049/jimmunol.175.1.494; Treon SP, 2012, NEW ENGL J MED, V367, P826, DOI 10.1056/NEJMoa1200710; Tye H, 2012, CANCER CELL, V22, P466, DOI 10.1016/j.ccr.2012.08.010; Wang QL, 2001, INFECT IMMUN, V69, P2270, DOI 10.1128/IAI.69.4.2270-2276.2001; Wei Y, 2013, LEUKEMIA; Wei Y, 2013, TOLL LIKE RECEPTOR A; WEISS MJ, 1995, P NATL ACAD SCI USA, V92, P9623, DOI 10.1073/pnas.92.21.9623	37	51	56	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71120	10.1371/journal.pone.0071120	http://dx.doi.org/10.1371/journal.pone.0071120			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23976989	Green Published, Green Submitted, gold			2022-12-25	WOS:000323378000034
J	Deng, CL; Bai, LL; Fu, SL; Yin, WB; Zhang, YX; Chen, YH; Wang, RRC; Zhang, XQ; Han, FP; Hu, ZM				Deng, Chuanliang; Bai, Lili; Fu, Shulan; Yin, Weibo; Zhang, Yingxin; Chen, Yuhong; Wang, Richard R. -C.; Zhang, Xiangqi; Han, Fangpu; Hu, Zanmin			Microdissection and Chromosome Painting of the Alien Chromosome in an Addition Line of Wheat - Thinopyrum intermedium	PLOS ONE			English	Article							MOLECULAR CYTOGENETIC CHARACTERIZATION; GENOME ANALYSIS; RESISTANCE; COMMON; REARRANGEMENTS; GENERATION; EVOLUTION; TRITICEAE; SEQUENCE; PROBES	In this study, chromosome painting was developed and used to identify alien chromosomes in TAi-27, a wheat - Thinopyrum intermedium addition line, and the chromosomes of the three different genomes of Th. Intermedium. The smallest alien chromosome of TAi-27 was microdissected and its DNA amplified by DOP-PCR was used as a probe to hybridize with metaphase chromosomes of TAi-27 and Th. intermedium. Results showed that hybridization signals were observed in all regions of a pair of the smallest alien chromosomes and the pericentromeric area of another pair of alien chromosomes in TAi-27, indicating that the probe from microdissected chromosome is species specific. In Th. intermedium, 14 chromosomes had wide and strong hybridization signals distributed mainly on the pericentromere area and 9 chromosomes with narrow and weak signals on the pericentromere area. The remaining chromosomes displayed a very weak or no signal. Sequential FISH/GISH on Th. intermedium chromosomes using the DNAs of microdissected chromosome, Pseudoroegneria spicata (St genome) and pDbH12 (a J(s) genome specific probe) as the probes indicated that the microdissected chromosome belonged to the St genome, three genomes (J(s), J and St) in Th. intermedium could be distinguished, in which there is no hybridization signal on J genome that is similar to the genome of Th. bessarabicum. Our results showed that the smallest alien chromosomes may represent a truncated chromosome and the repetitive sequence distribution might be similar in different chromosomes within the St genome. However, the repetitive sequence distributions are different within the J(s) genome, within a single chromosome, and among different genomes in Th. intermedium. Our results suggested that chromosome painting could be feasible in some plants and useful in detecting chromosome variation and repetitive sequence distribution in different genomes of polyploidy plants, which is helpful for understanding the evolution of different genomes in polyploid plants.	[Deng, Chuanliang; Bai, Lili; Fu, Shulan; Yin, Weibo; Zhang, Yingxin; Chen, Yuhong; Zhang, Xiangqi; Han, Fangpu; Hu, Zanmin] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing, Peoples R China; [Deng, Chuanliang] Henan Normal Univ, Xinxiang, Henan, Peoples R China; [Bai, Lili; Zhang, Yingxin] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Wang, Richard R. -C.] Utah State Univ, Dept Agr, ARS, FRRL, Logan, UT 84322 USA	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Henan Normal University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Utah System of Higher Education; Utah State University	Han, FP (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Beijing, Peoples R China.	fphan@genetics.ac.cn; zmhu@genetics.ac.cn	Wang, Richard Ruey-Chyi/S-3053-2018	Wang, Richard Ruey-Chyi/0000-0003-3622-2572	National Natural Science Foundation of China [31170209]; Ministry of Science and Technology of China [2011AA100101]; ARS [ARS-0424214] Funding Source: Federal RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by the National Natural Science Foundation of China (31170209) (http://www.nsfc.gov.cn/Portal0/default152.htm) and the Ministry of Science and Technology of China (2011AA100101)(http://www.most.gov.cn/eng/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Q, 1998, THEOR APPL GENET, V96, P1, DOI 10.1007/s001220050701; Chen Q, 1998, GENOME, V41, P580, DOI 10.1139/gen-41-4-580; Fedak G, 2000, GENOME, V43, P712, DOI 10.1139/gen-43-4-712; Fedak G, 1999, GENOME, V42, P584, DOI 10.1139/gen-42-4-584; Fuchs J, 1996, CHROMOSOMA, V104, P315, DOI 10.1007/s004120050121; GUAN XY, 1994, GENOMICS, V22, P101, DOI 10.1006/geno.1994.1350; Han FP, 2009, PLANT CELL, V21, P1929, DOI 10.1105/tpc.109.066662; Han FP, 2006, P NATL ACAD SCI USA, V103, P3238, DOI 10.1073/pnas.0509650103; Han FP, 2003, GENOME, V46, P490, DOI [10.1139/g03-032, 10.1139/G03-032]; HAN FP, 1998, SCI CHINA SER C, V28, P362; HE MY, 1989, SCI CHINA SER B, V32, P695; Hobza R, 2004, CHROMOSOME RES, V12, P245, DOI 10.1023/B:CHRO.0000021929.97208.1c; Houben A, 1996, CHROMOSOMA, V105, P97, DOI 10.1007/BF02509519; Houben A, 1997, CHROMOSOMA, V106, P513, DOI 10.1007/s004120050273; JI WQ, 2001, ACTA BOT BOREALI-OCC, V21, P401; Jiang SM, 2009, GENOME, V52, P68, DOI 10.1139/G08-108; KIDWELL KK, 1992, METHODS GENETIC PHYS, P1; Kishii M., 2005, Czech Journal of Genetics and Plant Breeding, V41, P92; LARKIN PJ, 1995, GENOME, V38, P385, DOI 10.1139/g95-050; Liu C, 2009, CEREAL RES COMMUN, V37, P363, DOI 10.1556/CRC.37.2009.3.5; LIU ZW, 1993, GENOME, V36, P102, DOI 10.1139/g93-014; Mahelka V, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-127; Nie W, 2012, HEREDITY, V108, P17, DOI 10.1038/hdy.2011.107; Nie WH, 2009, CHROMOSOME RES, V17, P321, DOI 10.1007/s10577-009-9027-0; Pauciullo A, 2012, THERIOGENOLOGY, V77, P675, DOI 10.1016/j.theriogenology.2011.09.016; Peng Kun-Jing, 2010, Zoological Research, V31, P113, DOI 10.3724/SP.J.1141.2010.02113; Ried T, 1998, HUM MOL GENET, V7, P1619, DOI 10.1093/hmg/7.10.1619; Schubert Ingo, 2001, Methods in Cell Science, V23, P57, DOI 10.1023/A:1013137415093; Shibata F, 1999, CHROMOSOMA, V108, P266, DOI 10.1007/s004120050377; TELENIUS H, 1992, GENE CHROMOSOME CANC, V4, P257, DOI 10.1002/gcc.2870040311; Thalhammer S, 2004, CHROMOSOME RES, V12, P337, DOI 10.1023/B:CHRO.0000034132.77192.5f; Tian C, 2000, SCI CHINA SER C, V43, P105, DOI 10.1007/BF02881724; VEGA JM, 1994, P NATL ACAD SCI USA, V91, P12041, DOI 10.1073/pnas.91.25.12041; Wang RRC, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: CEREALS, P77, DOI 10.1007/978-3-642-14228-4_2; YU JW, 1992, GENOMICS, V14, P769, DOI 10.1016/S0888-7543(05)80183-1; ZHANG X, 1991, Acta Genetica Sinica, V18, P344; Zhang XY., 1997, CHIN AGR SCI, V1997, P71; Zhang Y, 2005, SILVAE GENET, V54, P211, DOI 10.1515/sg-2005-0031; Zhang ZY, 2001, GENOME, V44, P1129, DOI 10.1139/gen-44-6-1129	39	19	24	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e72564	10.1371/journal.pone.0072564	http://dx.doi.org/10.1371/journal.pone.0072564			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967319	Green Published, gold, Green Submitted			2022-12-25	WOS:000323221500138
J	Ma, CJ; Li, GY; Cheng, YQ; Wang, JM; Ying, RS; Shi, L; Wu, XY; Niki, T; Hirashima, M; Li, CF; Moorman, JP; Yao, ZQ				Ma, Cheng J.; Li, Guang Y.; Cheng, Yong Q.; Wang, Jia M.; Ying, Ruo S.; Shi, Lei; Wu, Xiao Y.; Niki, Toshiro; Hirashima, Mitsumi; Li, Chuan F.; Moorman, Jonathan P.; Yao, Zhi Q.			Cis Association of Galectin-9 with Tim-3 Differentially Regulates IL-12/IL-23 Expressions in Monocytes via TLR Signaling	PLOS ONE			English	Article							T-CELLS; BIOLOGICAL-ACTIVITIES; ELEVATED FREQUENCIES; IN-VITRO; TH1; RESPONSES; RECEPTOR; CONTRIBUTES; MODULATION; AUTOIMMUNE	Human monocytes/macrophages (M/M.) of the innate immunity sense and respond to microbial products via specific receptor coupling with stimulatory (such as TLR) and inhibitory (such as Tim-3) receptors. Current models imply that Tim-3 expression on M/MO can deliver negative signaling to TLR-mediated IL-12 expression through trans association with its ligand Galectin-9 (Gal-9) presented by other cells. However, Gal-9 is also expressed within M/MO, and the effect of intracellular Gal-9 on Tim-3 activities and inflammatory responses in the same M/MO remains unknown. In this study, our data suggest that Tim-3 and IL-12/IL-23 gene transcriptions are regulated by enhanced or silenced Gal-9 expression within monocytes through synergizing with TLR signaling. Additionally, TLR activation facilitates Gal-9/Tim-3 cis association within the same M/M-empty set to differentially regulate IL-12/IL-23 expressions through STAT-3 phosphorylation. These results reveal a ligand (Gal-9) compartment-dependent regulatory effect on receptor (Tim-3) activities and inflammatory responses via TLR pathways-a novel mechanism underlying cellular responses to external or internal cues.	[Moorman, Jonathan P.; Yao, Zhi Q.] James H Quillen Vet Affairs Med Ctr, Dept Vet Affairs, Hepatitis HCV HIV Program, Johnson City, TN USA; [Ma, Cheng J.; Li, Guang Y.; Cheng, Yong Q.; Wang, Jia M.; Ying, Ruo S.; Shi, Lei; Wu, Xiao Y.; Moorman, Jonathan P.; Yao, Zhi Q.] E Tennessee State Univ, Quillen Coll Med, Div Infect Dis, Dept Internal Med, Johnson City, TN 37614 USA; [Cheng, Yong Q.] 302 Hosp, Int Ctr Diag & Treatment Liver Dis, Beijing, Peoples R China; [Wang, Jia M.] Soochow Univ, Sch Med, Dept Biochem & Mol Biol, Suzhou, Peoples R China; [Ying, Ruo S.] Guangzhou 8 Peoples Hosp, Dept Hepatol, Guangzhou, Guangdong, Peoples R China; [Shi, Lei] Xi An Jiao Tong Univ, Coll Med, Dept Infect Dis, Xian 710049, Peoples R China; [Niki, Toshiro; Hirashima, Mitsumi] Kagawa Univ, Dept Immunol & Immunopathol, Fac Med, Kagawa, Japan; [Niki, Toshiro; Hirashima, Mitsumi] GalPharma, Kagawa, Japan; [Li, Chuan F.] E Tennessee State Univ, Quillen Coll Med, Dept Surg, Johnson City, TN 37614 USA	East Tennessee State University; Fifth Medical Center of Chinese PLA General Hospital; Soochow University - China; Xi'an Jiaotong University; Kagawa University; East Tennessee State University	Yao, ZQ (corresponding author), James H Quillen Vet Affairs Med Ctr, Dept Vet Affairs, Hepatitis HCV HIV Program, Johnson City, TN USA.	Yao@etsu.edu			National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases [R15A1084057]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [R01DK093526]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093526] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by an National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases grant to ZQY/JPM (R15A1084057) and an NIH National Institute of Diabetes and Digestive and Kidney Diseases grant to ZQY/JPM (R01DK093526). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Anderson AC, 2010, EUR J IMMUNOL, V40, P859, DOI 10.1002/eji.200939842; Bohnenkamp HR, 2007, CELL IMMUNOL, V247, P72, DOI 10.1016/j.cellimm.2007.07.008; Chalifour A, 2009, IMMUNITY, V30, P337, DOI 10.1016/j.immuni.2008.12.019; Dai SY, 2005, J IMMUNOL, V175, P2974, DOI 10.4049/jimmunol.175.5.2974; de Weyer PSV, 2006, BIOCHEM BIOPH RES CO, V351, P571, DOI 10.1016/j.bbrc.2006.10.079; Doucey MA, 2004, NAT IMMUNOL, V5, P328, DOI 10.1038/ni1043; Duvallet E, 2011, ANN MED, V43, P503, DOI 10.3109/07853890.2011.577093; Feili-Hariri M, 2005, J LEUKOCYTE BIOL, V78, P656, DOI 10.1189/jlb.1104631; Frisancho-Kiss S, 2006, J IMMUNOL, V176, P6411, DOI 10.4049/jimmunol.176.11.6411; Frisancho-Kiss S, 2009, BRAIN BEHAV IMMUN, V23, P649, DOI 10.1016/j.bbi.2008.12.002; Hafler DA, 2008, J EXP MED, V205, P2699, DOI 10.1084/jem.20082429; Hastings WD, 2009, EUR J IMMUNOL, V39, P2492, DOI 10.1002/eji.200939274; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; Ji XJ, 2013, EUR J IMMUNOL, V43, P458, DOI 10.1002/eji.201242768; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Kasamatsu A, 2005, INT J BIOCHEM CELL B, V37, P397, DOI 10.1016/j.biocel.2004.07.014; Khademi M, 2004, J IMMUNOL, V172, P7169, DOI 10.4049/jimmunol.172.11.7169; Koguchi K, 2006, J EXP MED, V203, P1413, DOI 10.1084/jem.20060210; Kuchroo VK, 2003, NAT REV IMMUNOL, V3, P454, DOI 10.1038/nri1111; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Matsumoto R, 2002, J IMMUNOL, V168, P1961, DOI 10.4049/jimmunol.168.4.1961; Matsuura A, 2009, GENES CELLS, V14, P511, DOI 10.1111/j.1365-2443.2009.01287.x; Mazurek N, 2005, CANCER RES, V65, P10767, DOI 10.1158/0008-5472.CAN-04-3333; McMahan RH, 2010, J CLIN INVEST, V120, P4546, DOI 10.1172/JCI43127; Mengshol JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009504; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Moorman JP, 2012, J IMMUNOL, V189, P755, DOI 10.4049/jimmunol.1200162; Nakayama M, 2009, BLOOD, V113, P3821, DOI 10.1182/blood-2008-10-185884; Oomizu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048574; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Saitoh H, 2012, TOHOKU J EXP MED, V228, P157, DOI 10.1620/tjem.228.157; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; Sato S, 2012, ANN NY ACAD SCI, V1253, P133, DOI 10.1111/j.1749-6632.2012.06475.x; Vali B, 2010, EUR J IMMUNOL, V40, P2493, DOI 10.1002/eji.201040340; Vasconcellos R, 2011, J IMMUNOL, V187, P3402, DOI 10.4049/jimmunol.1100224; Wang JM, 2013, VACCINE, V31, P2238, DOI 10.1016/j.vaccine.2013.03.003; Wang JM, 2013, J VIROL, V87, P4372, DOI 10.1128/JVI.03376-12; Wei Q, 2007, J BIOL CHEM, V277, P11802; Wenink MH, 2009, J IMMUNOL, V183, P6960, DOI 10.4049/jimmunol.0900713; Yawata M, 2006, J EXP MED, V203, P633, DOI 10.1084/jem.20051884; Zhang Y, 2012, J LEUKOCYTE BIOL, V91, P189, DOI 10.1189/jlb.1010591; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019664; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	47	25	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e72488	10.1371/journal.pone.0072488	http://dx.doi.org/10.1371/journal.pone.0072488			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967307	Green Published, gold, Green Submitted			2022-12-25	WOS:000323221500135
J	Murrell, W; Palmero, E; Bianco, J; Stangeland, B; Joel, M; Paulson, L; Thiede, B; Grieg, Z; Ramsnes, I; Skjellegrind, HK; Nygard, S; Brandal, P; Sandberg, C; Vik-Mo, E; Palmero, S; Langmoen, IA				Murrell, Wayne; Palmero, Emily; Bianco, John; Stangeland, Biljana; Joel, Mrinal; Paulson, Linda; Thiede, Bernd; Grieg, Zanina; Ramsnes, Ingunn; Skjellegrind, Havard K.; Nygard, Stale; Brandal, Petter; Sandberg, Cecilie; Vik-Mo, Einar; Palmero, Sheryl; Langmoen, Iver A.			Expansion of Multipotent Stem Cells from the Adult Human Brain	PLOS ONE			English	Article							PROGENITOR CELLS; GENE-EXPRESSION; CHROMOSOME-ABNORMALITIES; NEURAL PROGENITORS; IPS CELLS; TRANSPLANTATION; NEURONS; DIFFERENTIATION; DISEASE; DEVELOP	The discovery of stem cells in the adult human brain has revealed new possible scenarios for treatment of the sick or injured brain. Both clinical use of and preclinical research on human adult neural stem cells have, however, been seriously hampered by the fact that it has been impossible to passage these cells more than a very few times and with little expansion of cell numbers. Having explored a number of alternative culturing conditions we here present an efficient method for the establishment and propagation of human brain stem cells from whatever brain tissue samples we have tried. We describe virtually unlimited expansion of an authentic stem cell phenotype. Pluripotency proteins Sox2 and Oct4 are expressed without artificial induction. For the first time multipotency of adult human brain-derived stem cells is demonstrated beyond tissue boundaries. We characterize these cells in detail in vitro including microarray and proteomic approaches. Whilst clarification of these cells' behavior is ongoing, results so far portend well for the future repair of tissues by transplantation of an adult patient's own-derived stem cells.	[Murrell, Wayne; Palmero, Emily; Bianco, John; Stangeland, Biljana; Joel, Mrinal; Paulson, Linda; Grieg, Zanina; Ramsnes, Ingunn; Skjellegrind, Havard K.; Sandberg, Cecilie; Vik-Mo, Einar; Palmero, Sheryl; Langmoen, Iver A.] Oslo Univ Hosp, Inst Surg Res, Vilhelm Magnus Lab Neurosurg Res, Oslo, Norway; [Thiede, Bernd] Univ Oslo, Biotechnol Ctr Oslo, Oslo, Norway; [Nygard, Stale] Univ Oslo, Res Grp Biomed Informat, Oslo, Norway; [Brandal, Petter] Norwegian Radium Hosp, Ctr Canc Biomed, Oslo, Norway; [Langmoen, Iver A.] Oslo Univ Hosp, Dept Neurosurg, Oslo, Norway; [Murrell, Wayne; Langmoen, Iver A.] Oslo Univ Hosp, Norwegian Ctr Stem Cell Res, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Murrell, W (corresponding author), Oslo Univ Hosp, Inst Surg Res, Vilhelm Magnus Lab Neurosurg Res, Oslo, Norway.	wayne.murrell@rr-research.no	Bianco, John I/F-3448-2012; Stangeland, Biljana/W-4912-2019; Nygård, Ståle/AGU-4330-2022	Bianco, John I/0000-0001-5717-5125; Stangeland, Biljana/0000-0002-1723-9742; Nygard, Stale/0000-0002-5263-4748; Vik-Mo, Einar Osland/0000-0001-8303-4123	Department of Neurosurgery, Oslo University Hopital, Ulleval; Norwegian Stem Cell Center	Department of Neurosurgery, Oslo University Hopital, Ulleval; Norwegian Stem Cell Center	This work has been funded by The Department of Neurosurgery, Oslo University Hopital, Ulleval and the Norwegian Stem Cell Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Y, 2001, EXP NEUROL, V167, P27, DOI 10.1006/exnr.2000.7539; [Anonymous], 2012, STEM CELL INFORM; Badylak SF, 2012, LANCET, V379, P943, DOI 10.1016/S0140-6736(12)60073-7; Bjerknes M, 2002, AM J PHYSIOL-GASTR L, V283, pG767, DOI 10.1152/ajpgi.00415.2001; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Buhler L, 2000, TRANSPLANTATION, V69, P2296; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Chabry L., 1887, J ANAT PHYSIOL, V23, P167; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cozar-Castellano I, 2005, P NATL ACAD SCI USA, V102, P7781, DOI 10.1073/pnas.0503261102; Deasy BM, 2001, BLOOD CELL MOL DIS, V27, P924, DOI 10.1006/bcmd.2001.0463; DULBECCO R, 1952, P NATL ACAD SCI USA, V38, P747, DOI 10.1073/pnas.38.8.747; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Efron B, 2007, ANN STAT, V35, P1351, DOI 10.1214/009053606000001460; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fossdal G, 2012, SCI WORLD J, DOI 10.1100/2012/915176; Fresney R, 2005, CULTURE ANIMAL CELLS; GEY GO, 1952, CANCER RES, V12, P264; Gilbert S.F., 2000, DEV BIOL, V6th ed.; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Gritti A, 1996, J NEUROSCI, V16, P1091; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; HEIM S, 1986, CLIN HAEMATOL, V15, P1003; Johansson CB, 1999, EXP CELL RES, V253, P733, DOI 10.1006/excr.1999.4678; Kamimura J, 1997, J INVEST DERMATOL, V109, P534, DOI 10.1111/1523-1747.ep12336704; Koehler CJ, 2009, J PROTEOME RES, V8, P4333, DOI 10.1021/pr900425n; Kook H, 1997, CLIN DIAGN LAB IMMUN, V4, P96, DOI 10.1128/CDLI.4.1.96-103.1997; Kumar G, 2012, CYTOTHERAPY, V14, P494, DOI 10.3109/14653249.2011.651529; Kurakin A, 2005, DEV GENES EVOL, V215, P46, DOI 10.1007/s00427-004-0448-7; Liu SV, 2008, STEM CELLS DEV, V17, P391, DOI 10.1089/scd.2008.0062; Mandahl N, 1992, HUMAN CYTOGENETICS P, V11; Matigian N, 2010, DIS MODEL MECH, V3, P785, DOI 10.1242/dmm.005447; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mina M, 2004, CELLS TISSUES ORGANS, V176, P120, DOI 10.1159/000075033; Moe MC, 2005, BRAIN, V128, P2189, DOI 10.1093/brain/awh574; Moe MC, 2005, NEUROSURGERY, V56, P1182, DOI 10.1227/01.NEU.0000159881.09663.6D; Mori H, 2006, J NEUROSCI RES, V84, P1682, DOI 10.1002/jnr.21082; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Munne S, 1998, FERTIL STERIL, V69, P904, DOI 10.1016/S0015-0282(98)00039-9; Murrell W, 2005, DEV DYNAM, V233, P496, DOI 10.1002/dvdy.20360; Murrell W, 2008, STEM CELLS, V26, P2183, DOI 10.1634/stemcells.2008-0074; Novella S, 2012, YOUR DAILY FIX NEURO; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Olstorn H, 2011, NEUROSURGERY, V68, P213, DOI 10.1227/NEU.0b013e3181fd2c11; Paletta JR, 2012, EUR CELLS MATER, V21, P384; Palmer TD, 2001, NATURE, V411, P42, DOI 10.1038/35075141; Patterson M, 2012, CELL RES, V22, P178, DOI 10.1038/cr.2011.133; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; Rous P, 1916, J EXP MED, V23, P549, DOI 10.1084/jem.23.4.549; Sandberg CJ, 2013, EXP CELL RES, VS0014-4827; Sareen D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007630; Schaffer LG SM, 2009, ISCN 2009 INT SYSTEM, V1; Shahdadfar A, 2005, STEM CELLS, V23, P1357, DOI 10.1634/stemcells.2005-0094; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Taylor CJ, 2011, PHILOS T R SOC B, V366, P2312, DOI 10.1098/rstb.2011.0030; Thomas DE, 2000, WORLD J SURG, V24, P815; Varghese M, 2009, STEM CELLS DEV, V18, P603, DOI 10.1089/scd.2008.0144; Vik-Mo EO, 2011, EXP CELL RES, V317, P1049, DOI 10.1016/j.yexcr.2010.12.022; Vik-Mo EO, 2010, NEURO-ONCOLOGY, V12, P1220, DOI 10.1093/neuonc/noq102; Walton NM, 2006, DEVELOPMENT, V133, P3671, DOI 10.1242/dev.02541; Westerlund U, 2005, NEUROSURGERY, V57, P779, DOI 10.1227/01.NEU.0000176402.78462.cd; Westerlund U, 2003, EXP CELL RES, V289, P378, DOI 10.1016/S0014-4827(03)00291-X; Wetzig A, 2011, CHARACTERIZATION OLF; Windrem MS, 2002, J NEUROSCI RES, V69, P966, DOI 10.1002/jnr.10397; Winkler C, 2005, TRENDS NEUROSCI, V28, P86, DOI 10.1016/j.tins.2004.12.006; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Yi Eun Sang, 2012, Korean J Pediatr, V55, P93, DOI 10.3345/kjp.2012.55.3.93; Zhang HY, 2005, NEUROSCI RES, V51, P157, DOI 10.1016/j.neures.2004.10.010; Zhu JH, 2006, NEW ENGL J MED, V355, P2376, DOI 10.1056/NEJMc055304; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	77	35	37	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71334	10.1371/journal.pone.0071334	http://dx.doi.org/10.1371/journal.pone.0071334			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967194	Green Submitted, Green Published, gold			2022-12-25	WOS:000323221500076
J	Tomizawa, M; Shinozaki, F; Sugiyama, T; Yamamoto, S; Sueishi, M; Yoshida, T				Tomizawa, Minoru; Shinozaki, Fuminobu; Sugiyama, Takao; Yamamoto, Shigenori; Sueishi, Makoto; Yoshida, Takanobu			Survival of Primary Human Hepatocytes and Death of Induced Pluripotent Stem Cells in Media Lacking Glucose and Arginine	PLOS ONE			English	Article							HUMAN FIBROBLASTS; EMBRYOID BODIES; AMINO-ACID; MOUSE; GENERATION; GLYCOLYSIS; PRECURSORS; INDUCTION; APOPTOSIS; GLYCEROL	Background: Tumorigenicity is an associated risk for transplantation of hepatocytes differentiated from human induced pluripotent stem (hiPS) cells. Hepatocytes express the enzymes galactokinase and ornithine transcarbamylase (OTC) to aid in their own survival. However, hiPS cells do not express these enzymes, and therefore, are not be expected to survive in a medium containing galactose and ornithine and lacking glucose and arginine. Materials and Methods: Real-time quantitative polymerase chain reaction (PCR) was performed to analyze the expression of galactokinase 1 (GALK1)1 and GALK2, ornithine carbamyltransferase, and phenylalanine hydroxylase (PAH). The hiPS cell line 201B7 was cultured in hepatocyte selection medium (HSM), which lacks glucose and arginine but contains galactose and ornithine. Furthermore, microscopic analysis of the cultured cells was performed after hematoxylin and eosin (H&E) staining, terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick end labeling (TUNEL). The hiPS cells were immunostained to assess their pluripotency in HSM. In addition, the primary human hepatocytes were cultured with or without hiPS cells in HSM. Results: The expression levels of GALK1, GALK2, OTC, and PAH in 201B7 were 22.2 +/- 5.0 (average +/- standard deviation), 14.2% +/- 1.1%, 1.2% +/- 0.2%, and 8.4% +/- 0.7% respectively, compared with those in the adult liver. The hiPS cell population diminished when cultured in HSM and completely disappeared after 3 days. The cultured cells showed condensation or fragmentation of their nuclei, thereby suggesting apoptosis. TUNEL staining confirmed that the cells had undergone apoptosis. The 201B7 cells were positive for Nanog, SSEA-4, and TRA-1-60. The primary human hepatocytes survived when cultured alone in HSM and when co-cultured with hiPS cells. Conclusion: Therefore, HSM is and ideal medium for eliminating hiPS cells and purifying hepatocytes without inducing any damage.	[Tomizawa, Minoru] Shimoshizu Hosp, Natl Hosp Org, Dept Gastroenterol, Yotsukaido City, Chiba, Japan; [Shinozaki, Fuminobu] Shimoshizu Hosp, Natl Hosp Org, Dept Radiol, Yotsukaido City, Chiba, Japan; [Sugiyama, Takao; Sueishi, Makoto] Shimoshizu Hosp, Natl Hosp Org, Dept Rheumatol, Yotsukaido City, Chiba, Japan; [Yamamoto, Shigenori] Shimoshizu Hosp, Natl Hosp Org, Dept Pediat, Yotsukaido City, Chiba, Japan; [Yoshida, Takanobu] Shimoshizu Hosp, Natl Hosp Org, Dept Internal Med, Yotsukaido City, Chiba, Japan		Tomizawa, M (corresponding author), Shimoshizu Hosp, Natl Hosp Org, Dept Gastroenterol, Yotsukaido City, Chiba, Japan.	nihminor-cib@umin.ac.jp			Japan Society for the Promotion of Science (JSPS) [23591002]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Research Grant-in-Aid for Scientific Research (C), No. 23591002, from the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1996, EXP CELL RES, V229, P27, DOI 10.1006/excr.1996.0340; AI YJ, 1995, GENOME RES, V5, P53, DOI 10.1101/gr.5.1.53; Alekseenko LL, 2012, CELL CYCLE, V11, P3260, DOI 10.4161/cc.21595; Bieberich E, 2004, J CELL BIOL, V167, P723, DOI 10.1083/jcb.200405144; Cheng FY, 2012, BIOMATERIALS, V33, P3195, DOI 10.1016/j.biomaterials.2012.01.023; Conesa C, 2012, STEM CELL REV REP, V8, P116, DOI 10.1007/s12015-011-9248-4; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Kooreman NG, 2010, J R SOC INTERFACE, V7, pS753, DOI 10.1098/rsif.2010.0353.focus; LEFFERT HL, 1972, J CELL BIOL, V52, P559, DOI 10.1083/jcb.52.3.559; Lin Shi-Lung, 2013, Methods Mol Biol, V936, P295; MATSUMOTO K, 1994, NEUROL RES, V16, P460; MCGEE MM, 1972, BIOCHEM J, V127, P669, DOI 10.1042/bj1270669; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; NAKAMURA T, 1984, BIOCHEM BIOPH RES CO, V122, P884, DOI 10.1016/0006-291X(84)91173-2; NIWA A, 1980, IN VITRO CELL DEV B, V16, P987; Ohira RH, 2005, BIOCHEM BIOPH RES CO, V331, P239, DOI 10.1016/j.bbrc.2005.03.143; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Phillips JW, 2002, EUR J BIOCHEM, V269, P792, DOI 10.1046/j.0014-2956.2001.02687.x; PIERCE GB, 1960, LAB INVEST, V9, P583; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Strom SC, 1999, SEMIN LIVER DIS, V19, P39, DOI 10.1055/s-2007-1007096; Sumida KD, 2002, METABOLISM, V51, P876, DOI 10.1053/meta.2002.33342; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takayama K, 2012, J HEPATOL; Tanaka M, 2009, MECH DEVELOP, V126, P665, DOI 10.1016/j.mod.2009.06.939; Tomizawa M, 2008, CELL TISSUE RES, V333, P17, DOI 10.1007/s00441-008-0618-4; Wheatley DN, 2000, CELL PHYSIOL BIOCHEM, V10, P37, DOI 10.1159/000016333; Yakubov E, 2010, BIOCHEM BIOPH RES CO, V394, P189, DOI 10.1016/j.bbrc.2010.02.150; Yamamoto H, 2003, HEPATOLOGY, V37, P983, DOI 10.1053/jhep.2003.50202; Yanai H, 2010, J BIOCHEM, V148, P85, DOI 10.1093/jb/mvq034	33	17	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71897	10.1371/journal.pone.0071897	http://dx.doi.org/10.1371/journal.pone.0071897			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967260	gold, Green Published, Green Submitted			2022-12-25	WOS:000323221500111
J	Woodhall, DM; Wiegand, RE; Wellman, M; Matey, E; Abudho, B; Karanja, DMS; Mwinzi, PMN; Montgomery, SP; Secor, WE				Woodhall, Dana M.; Wiegand, Ryan E.; Wellman, Michael; Matey, Elizabeth; Abudho, Bernard; Karanja, Diana M. S.; Mwinzi, Pauline M. N.; Montgomery, Susan P.; Secor, W. Evan			Use of Geospatial Modeling to Predict Schistosoma mansoni Prevalence in Nyanza Province, Kenya	PLOS ONE			English	Article							EPIDEMIOLOGY; INFECTION; SNAILS	Background: Schistosomiasis, a parasitic disease that affects over 200 million people, can lead to significant morbidity and mortality; distribution of single dose preventative chemotherapy significantly reduces disease burden. Implementation of control programs is dictated by disease prevalence rates, which are determined by costly and labor intensive screening of stool samples. Because ecological and human factors are known to contribute to the focal distribution of schistosomiasis, we sought to determine if specific environmental and geographic factors could be used to accurately predict Schistosoma mansoni prevalence in Nyanza Province, Kenya. Methodology/Principal Findings: A spatial mixed model was fit to assess associations with S. mansoni prevalence in schools. Data on S. mansoni prevalence and GPS location of the school were obtained from 457 primary schools. Environmental and geographic data layers were obtained from publicly available sources. Spatial models were constructed using ArcGIS 10 and R 2.13.0. Lower S. mansoni prevalence was associated with further distance (km) to Lake Victoria, higher day land surface temperature (LST), and higher monthly rainfall totals. Altitude, night LST, human influence index, normalized difference vegetation index, soil pH, soil texture, soil bulk density, soil water capacity, population, and land use variables were not significantly associated with S. mansoni prevalence. Conclusions: Our model suggests that there are specific environmental and geographic factors that influence S. mansoni prevalence rates in Nyanza Province, Kenya. Validation and use of schistosomiasis prevalence maps will allow control programs to plan and prioritize efficient control campaigns to decrease schistosomiasis burden.	[Woodhall, Dana M.; Wiegand, Ryan E.; Montgomery, Susan P.; Secor, W. Evan] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Atlanta, GA 30333 USA; [Wellman, Michael] Ctr Dis Control & Prevent, Geospatial Res Anal & Serv Program, Atlanta, GA USA; [Matey, Elizabeth; Abudho, Bernard; Karanja, Diana M. S.; Mwinzi, Pauline M. N.] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Kenya Medical Research Institute	Woodhall, DM (corresponding author), Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Atlanta, GA 30333 USA.	dqw6@cdc.gov		Wiegand, Ryan/0000-0002-9486-1850	Bill and Meilinda Gates grant	Bill and Meilinda Gates grant	This project was funded through a Bill and Meilinda Gates grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, PREV CHEM HUM HELM C; Barton K., 2012, MUMIN MULTIMODEL INF; Brooker S, 2001, ANN TROP MED PARASIT, V95, P343, DOI 10.1080/00034980120063437; Brooker S, 2001, TROP MED INT HEALTH, V6, P998, DOI 10.1046/j.1365-3156.2001.00798.x; Calcagno V, 2010, J STAT SOFTW, V34, P1; Centers for Disease Control and Prevention, DPDX LAB ID PAR PUBL; Clements ACA, 2006, PARASITOLOGY, V133, P711, DOI 10.1017/S0031182006001181; Gutman J, 2009, ANN TROP MED PARASIT, V103, P501, DOI 10.1179/136485909X451843; Handzel T, 2003, AM J TROP MED HYG, V69, P318, DOI 10.4269/ajtmh.2003.69.318; JOUBERT PH, 1984, S AFR J ZOOL, V19, P314; Kabatereine NB, 2004, TROP MED INT HEALTH, V9, P372, DOI 10.1046/j.1365-3156.2003.01176.x; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Mengistu M, 2011, ETHIOP J HEALTH SCI, V21, P111; Oak Ridge National Laboratory LandScan Data Availability, GEOGR INF SCI TECHN; Opisa S, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-226; PFLUGER W, 1980, Z PARASITENKD, V63, P159, DOI 10.1007/BF00927532; R Development Core Team, 2011, R LANG ENV STAT COMP; Rollinson D, 2011, BIOMPHALARIA SNAILS AND LARVAL TREMATODES, P57, DOI 10.1007/978-1-4419-7028-2_3; Schur N, 2011, ACTA TROP IN PRESS; Schur N, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001194; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shane HL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000951; Speich B, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-71; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; STURROCK BM, 1966, ANN TROP MED PARASIT, V60, P187, DOI 10.1080/00034983.1966.11686405; Sturrock Robert F., 1993, P33; Utzinger J, 2009, PARASITOLOGY, V136, P1859, DOI 10.1017/S0031182009991600; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; WCS/CIESIN, 2005, LAST WILD DAT VERS 2; WEDDERBURN RWM, 1974, BIOMETRIKA, V61, P439, DOI 10.2307/2334725	30	26	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71635	10.1371/journal.pone.0071635	http://dx.doi.org/10.1371/journal.pone.0071635			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23977096	Green Submitted, gold, Green Published			2022-12-25	WOS:000323221500093
J	Kim, JH; Cheong, HS; Park, JS; Jang, AS; Uh, ST; Kim, YH; Kim, MK; Choi, IS; Cho, SH; Choi, BW; Bae, JS; Park, CS; Shin, HD				Kim, Jeong-Hyun; Cheong, Hyun Sub; Park, Jong Sook; Jang, An-Soo; Uh, Soo-Taek; Kim, Yong-Hoon; Kim, Mi-Kyeong; Choi, Inseon S.; Cho, Sang Heon; Choi, Byoung Whui; Bae, Joon Seol; Park, Choon-Sik; Shin, Hyoung Doo			A Genome-Wide Association Study of Total Serum and Mite-Specific IgEs in Asthma Patients	PLOS ONE			English	Article							GENETIC-VARIATION; CHILDHOOD ASTHMA; ALLERGENS; VARIANTS; CHILDREN; CELL; SUSCEPTIBILITY; REPLICATION; RECEPTOR; TRAITS	Immunoglobulin E (IgE) is one of the central players in asthma and allergic diseases. Although the serum IgE level, a useful endophenotype, is generally increased in patients with asthma, genetic factors influencing IgE regulation in asthma are still not fully understood. To identify the genetic variations associated with total serum and mite-specific IgEs in asthmatics, a genome-wide association study (GWAS) of 657,366 single nucleotide polymorphisms (SNPs) was performed in 877 Korean asthmatics. This study found that several new genes might be associated with total IgE in asthmatics, such as CRIM1 (rs848512, P = 1.18 x 10(-6); rs711254, P = 6.73 x 10(-6)), ZNF71 (rs10404342, P = 7.60 x 10(-6)), TLN1 (rs4879926, P = 7.74 x 10(-6)), and SYNPO2 (rs1472066, P = 8.36 x 10(-6); rs1038770, P = 8.66 x 10(-6)). Regarding the association of specific IgE to house dust mites, it was observed that intergenic SNPs nearby to OPRK1 and LOC730217 might be associated with Dermatophagoides pteronyssinus (D.p.) and Dermatophagoides farinae (D.f.) in asthmatics, respectively. In further pathway analysis, the phosphatidylinositol signaling system and adherens junction pathways were estimated to play a role in the regulation of total IgE levels in asthma. Although functional evaluations and replications of these results in other populations are needed, this GWAS of serum IgE in asthmatics could facilitate improved understanding of the role of the newly identified genetic variants in asthma and its related phenotypes.	[Kim, Jeong-Hyun; Bae, Joon Seol; Shin, Hyoung Doo] Sogang Univ, Dept Life Sci, Seoul, South Korea; [Cheong, Hyun Sub; Shin, Hyoung Doo] SNP Genet Inc, Dept Genet Epidemiol, Seoul, South Korea; [Park, Jong Sook; Jang, An-Soo; Uh, Soo-Taek; Park, Choon-Sik] Soonchunhyang Univ, Div Allergy & Resp Med, Bucheon Hosp, Puchon, South Korea; [Kim, Yong-Hoon] Soonchunhyang Univ, Div Allergy & Resp Dis, Cheonan Hosp, Cheonan, South Korea; [Kim, Mi-Kyeong] Chungbuk Natl Univ, Div Internal Med, Cheongju, South Korea; [Choi, Inseon S.] Chonnam Natl Univ, Dept Allergy, Kwangju, South Korea; [Cho, Sang Heon] Seoul Natl Univ, Dept Internal Med, Seoul, South Korea; [Cho, Sang Heon] Seoul Natl Univ, Inst Allergy & Clin Immunol, Seoul, South Korea; [Choi, Byoung Whui] Chung Ang Univ, Dept Internal Med, Yongsan Hosp, Seoul 156756, South Korea; [Kim, Jeong-Hyun; Shin, Hyoung Doo] Sogang Univ, Res Inst Basic Sci, Seoul, South Korea	Sogang University; SNP Genetics; Soonchunhyang University; Soonchunhyang University; Chungbuk National University; Chonnam National University; Seoul National University (SNU); Seoul National University (SNU); Chung Ang University; Sogang University	Park, CS (corresponding author), Soonchunhyang Univ, Div Allergy & Resp Med, Bucheon Hosp, Puchon, South Korea.	schalr@schmc.ac.kr; hdshin@sogang.ac.kr		Park, Choon-Sik/0000-0003-2977-0255	Korea Health 21 RD Project [A010249, A090548]; National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2009-0080157, 2012-0006690]	Korea Health 21 RD Project; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a grant from the Korea Health 21 R&D Project (A010249 & A090548) and by a grant from the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2009-0080157 & 2012-0006690). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila PC, 2007, ANNU REV MED, V58, P185, DOI 10.1146/annurev.med.58.061705.145252; Balaci L, 2007, AM J HUM GENET, V80, P1103, DOI 10.1086/518259; Bottema RWB, 2010, EUR RESPIR J, V35, P54, DOI 10.1183/09031936.00018909; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Doi T, 2008, INT IMMUNOL, V20, P499, DOI 10.1093/intimm/dxn009; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Gaffin JM, 2009, CURR OPIN ALLERGY CL, V9, P128, DOI 10.1097/ACI.0b013e32832678b0; Gao JM, 2010, RESPIRATION, V79, P17, DOI 10.1159/000235545; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Granada M, 2012, J ALLERGY CLIN IMMUN, V129, P840, DOI 10.1016/j.jaci.2011.09.029; Helm R, 1996, J ALLERGY CLIN IMMUN, V98, P172, DOI 10.1016/S0091-6749(96)70240-3; Holgate ST, 2008, NAT REV IMMUNOL, V8, P218, DOI 10.1038/nri2262; Howard TD, 2002, J ALLERGY CLIN IMMUN, V110, P743, DOI 10.1067/mai.2002.128723; Kabesch M, 2006, J ALLERGY CLIN IMMUN, V117, P269, DOI 10.1016/j.jaci.2005.10.024; Kelly LA, 2012, CURR OPIN PULM MED, V18, P29, DOI 10.1097/MCP.0b013e32834db10d; KING CL, 1989, P NATL ACAD SCI USA, V86, P10085, DOI 10.1073/pnas.86.24.10085; Kovac K, 2007, ARCH MED RES, V38, P99, DOI 10.1016/j.arcmed.2006.07.007; Laitinen T, 2004, SCIENCE, V304, P300, DOI 10.1126/science.1090010; Lee SH, 2011, ALLERGY ASTHMA IMMUN, V3, P236, DOI 10.4168/aair.2011.3.4.236; Levin AM, 2013, J ALLERGY C IN PRESS; Li XN, 2012, J ALLERGY CLIN IMMUN, V129, P575, DOI 10.1016/j.jaci.2011.09.040; Liu X, 2004, J ALLERGY CLIN IMMUN, V113, P489, DOI 10.1016/j.jaci.2003.12.037; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; PASTORELLO EA, 1991, ANN ALLERGY, V67, P365; Pino-Yanes M, 2012, J ALLERGY CLIN IMMUN, V129, P573, DOI 10.1016/j.jaci.2011.10.001; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rogers AJ, 2009, AM J RESP CRIT CARE, V179, P1084, DOI 10.1164/rccm.200812-1860OC; SEARS MR, 1991, NEW ENGL J MED, V325, P1067, DOI 10.1056/NEJM199110103251504; Sengler C, 2001, RESP RES, V3; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Sunyer J, 1996, EUR RESPIR J, V9, P1880, DOI 10.1183/09031936.96.09091880; Tsai HJ, 2009, CLIN EXP ALLERGY, V39, P101, DOI 10.1111/j.1365-2222.2008.03111.x; van de Pol MA, 2012, ALLERGY, V67, P67, DOI 10.1111/j.1398-9995.2011.02722.x; Vergara C, 2009, CLIN EXP ALLERGY, V39, P1558, DOI 10.1111/j.1365-2222.2009.03311.x; Weidinger S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000166; Wong CK, 2005, CLIN EXP IMMUNOL, V141, P122, DOI 10.1111/j.1365-2249.2005.02815.x; Wu H, 2008, GENES IMMUN, V9, P224, DOI 10.1038/gene.2008.8; Xu JF, 2000, AM J HUM GENET, V67, P1163, DOI 10.1086/321190; Yick CY, 2013, AM J RESP C IN PRESS	42	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71958	10.1371/journal.pone.0071958	http://dx.doi.org/10.1371/journal.pone.0071958			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967269	gold, Green Published, Green Submitted			2022-12-25	WOS:000323115800093
J	Matsha, TE; Kengne, AP; Yako, YY; Hon, GM; Hassan, MS; Erasmus, RT				Matsha, Tandi E.; Kengne, Andre-Pascal; Yako, Yandiswa Y.; Hon, Gloudina M.; Hassan, Mogamat S.; Erasmus, Rajiv T.			Optimal Waist-to-Height Ratio Values for Cardiometabolic Risk Screening in an Ethnically Diverse Sample of South African Urban and Rural School Boys and Girls	PLOS ONE			English	Article							METABOLIC SYNDROME; DISEASE RISK; CARDIOVASCULAR RISK; VISCERAL FAT; MASS INDEX; CHILDREN; ADOLESCENTS; ADIPOSITY; OBESITY; OVERWEIGHT	Background: The proposed waist-to-height ratio (WHtR) cut-off of 0.5 is less optimal for cardiometabolic risk screening in children in many settings. The purpose of this study was to determine the optimal WHtR for children from South Africa, and investigate variations by gender, ethnicity and residence in the achieved value. Methods: Metabolic syndrome (MetS) components were measured in 1272 randomly selected learners, aged 10-16 years, comprising of 446 black Africans, 696 mixed-ancestry and 130 Caucasians. The Youden's index and the closest-top-left (CTL) point approaches were used to derive WHtR cut-offs for diagnosing any two MetS components, excluding the waist circumference. Results: The two approaches yielded similar cut-off in girls, 0.465 (sensitivity 50.0, specificity 69.5), but two different values in boys, 0.455 (42.9, 88.4) and 0.425 (60.3, 67.7) based on the Youden's index and the CTL point, respectively. Furthermore, WHtR cut-off values derived differed substantially amongst the regions and ethnic groups investigated, whereby the highest cut-off was observed in semi-rural and white children, respectively, Youden's index0.505 (31.6, 87.1) and CTL point 0.475 (44.4, 75.9). Conclusion: The WHtR cut-off of 0.5 is less accurate for screening cardiovascular risk in South African children. The optimal value in this setting is likely gender and ethnicity-specific and sensitive to urbanization.	[Matsha, Tandi E.; Yako, Yandiswa Y.; Hon, Gloudina M.; Hassan, Mogamat S.] Cape Peninsula Univ Technol, Fac Hlth & Wellness Sci, Dept Biomed Technol, Cape Town, South Africa; [Kengne, Andre-Pascal] S African Med Council, NCRP Cardiovasc & Metab Dis, Cape Town, South Africa; [Kengne, Andre-Pascal] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Erasmus, Rajiv T.] Univ Stellenbosch, Fac Hlth Sci, Div Chem Pathol, Cape Town, South Africa	Cape Peninsula University of Technology; University of Cape Town; Stellenbosch University	Matsha, TE (corresponding author), Cape Peninsula Univ Technol, Fac Hlth & Wellness Sci, Dept Biomed Technol, Cape Town, South Africa.	matshat@cput.ac.za	Kengne, Andre Pascal/ABB-3696-2020	Matsha, Tandi/0000-0001-5251-030X; Kengne, Andre Pascal/0000-0002-5183-131X	University Research Fund of the Cape Peninsula University of Technology, South Africa	University Research Fund of the Cape Peninsula University of Technology, South Africa	Funding provided by University Research Fund of the Cape Peninsula University of Technology, South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwell M, 2005, INT J FOOD SCI NUTR, V56, P303, DOI 10.1080/09637480500195066; Chalmers J, 1999, J HYPERTENS, V17, P151; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Cook S, 2003, ARCH PEDIAT ADOL MED, V157, P821, DOI 10.1001/archpedi.157.8.821; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Freedman DS, 2007, AM J CLIN NUTR, V86, P33, DOI 10.1093/ajcn/86.1.33; Goran MI, 1999, AM J CLIN NUTR, V70, p149S; Guntsche Z, 2010, J PEDIATR ENDOCR MET, V23, P245; Hara Mitsuhiko, 2002, J Atheroscler Thromb, V9, P127; Hsieh SD, 2005, PREV MED, V40, P216, DOI 10.1016/j.ypmed.2004.05.025; Juonala M, 2011, NEW ENGL J MED, V365, P1876, DOI 10.1056/NEJMoa1010112; Kahn HS, 2005, J PEDIATR-US, V146, P482, DOI 10.1016/j.jpeds.2004.12.028; Katzmarzyk PT, 2012, PEDIATR OBES, V7, pE42, DOI 10.1111/j.2047-6310.2012.00073.x; Krakauer NY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039504; Lee KK, 2012, YONSEI MED J, V53, P99, DOI 10.3349/ymj.2012.53.1.99; Maffeis C, 2008, J PEDIATR-US, V152, P207, DOI 10.1016/j.jpeds.2007.09.021; Matsha T, 2009, ATHEROSCLEROSIS, V205, P363, DOI 10.1016/j.atherosclerosis.2009.01.030; McCarthy HD, 2006, INT J OBESITY, V30, P988, DOI 10.1038/sj.ijo.0803226; Motswagole BS, 2011, CARDIOVASC J AFR, V22, P208, DOI 10.5830/CVJA-2010-062; Nambiar S, 2009, ACTA PAEDIATR, V98, P148, DOI 10.1111/j.1651-2227.2008.01050.x; Nambiar S, 2010, PUBLIC HEALTH NUTR, V13, P1566, DOI 10.1017/S1368980009993053; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Reddy SP, 2012, AM J PUBLIC HEALTH, V102, P262, DOI 10.2105/AJPH.2011.300222; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Savva SC, 2000, INT J OBESITY, V24, P1453, DOI 10.1038/sj.ijo.0801401; Srinivasan SR, 2009, AM J CARDIOL, V104, P721, DOI 10.1016/j.amjcard.2009.04.037; Taylor RW, 2011, OBESITY, V19, P1062, DOI 10.1038/oby.2010.217; Tybor DJ, 2008, INT J PEDIATR OBES, V3, P148, DOI 10.1080/17477160802068957; Wells JCK, 2012, OBES REV, V13, P14, DOI 10.1111/j.1467-789X.2012.01034.x; Yan WL, 2007, OBESITY, V15, P748, DOI 10.1038/oby.2007.601; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zimmet P, 2007, PEDIATR DIABETES, V8, P299, DOI 10.1111/j.1399-5448.2007.00271.x	32	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71133	10.1371/journal.pone.0071133	http://dx.doi.org/10.1371/journal.pone.0071133			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967160	Green Submitted, Green Published, gold			2022-12-25	WOS:000323115800040
J	Price, EP; Sarovich, DS; Webb, JR; Ginther, JL; Mayo, M; Cook, JM; Seymour, ML; Kaestli, M; Theobald, V; Hall, CM; Busch, JD; Foster, JT; Keim, P; Wagner, DM; Tuanyok, A; Pearson, T; Currie, BJ				Price, Erin P.; Sarovich, Derek S.; Webb, Jessica R.; Ginther, Jennifer L.; Mayo, Mark; Cook, James M.; Seymour, Meagan L.; Kaestli, Mirjam; Theobald, Vanessa; Hall, Carina M.; Busch, Joseph D.; Foster, Jeffrey T.; Keim, Paul; Wagner, David M.; Tuanyok, Apichai; Pearson, Talima; Currie, Bart J.			Accurate and Rapid Identification of the Burkholderia pseudomallei Near-Neighbour, Burkholderia ubonensis, Using Real-Time PCR	PLOS ONE			English	Article								Burkholderia ubonensis is an environmental bacterium belonging to the Burkholderia cepacia complex (Bcc), a group of genetically related organisms that are associated with opportunistic but generally nonfatal infections in healthy individuals. In contrast, the near-neighbour species Burkholderia pseudomallei causes melioidosis, a disease that can be fatal in up to 95% of cases if left untreated. B. ubonensis is frequently misidentified as B. pseudomallei from soil samples using selective culturing on Ashdown's medium, reflecting both the shared environmental niche and morphological similarities of these species. Additionally, B. ubonensis shows potential as an important biocontrol agent in B. pseudomallei-endemic regions as certain strains possess antagonistic properties towards B. pseudomallei. Current methods for characterising B. ubonensis are laborious, time-consuming and costly, and as such this bacterium remains poorly studied. The aim of our study was to develop a rapid and inexpensive real-time PCR-based assay specific for B. ubonensis. We demonstrate that a novel B. ubonensis-specific assay, Bu550, accurately differentiates B. ubonensis from B. pseudomallei and other species that grow on selective Ashdown's agar. We anticipate that Bu550 will catalyse research on B. ubonensis by enabling rapid identification of this organism from Ashdown's-positive colonies that are not B. pseudomallei.	[Price, Erin P.; Sarovich, Derek S.; Webb, Jessica R.; Mayo, Mark; Kaestli, Mirjam; Theobald, Vanessa; Currie, Bart J.] Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia; [Ginther, Jennifer L.; Cook, James M.; Seymour, Meagan L.; Hall, Carina M.; Busch, Joseph D.; Foster, Jeffrey T.; Keim, Paul; Wagner, David M.; Tuanyok, Apichai; Pearson, Talima] No Arizona Univ, Ctr Microbial Genet & Genom, Flagstaff, AZ 86011 USA	Charles Darwin University; Menzies School of Health Research; Northern Arizona University	Price, EP (corresponding author), Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia.	erin.price@menzies.edu.au	Sarovich, Derek/H-5587-2019; Price, Erin/N-2336-2013; Pearson, Talima/O-7840-2019	Sarovich, Derek/0000-0002-6944-3980; Price, Erin/0000-0002-1079-4882; Pearson, Talima/0000-0003-3696-041X; Wagner, David/0000-0003-2684-6007; Foster, Jeffrey/0000-0001-8235-8564; , Mirjam/0000-0002-6053-5141	Menzies School of Health Research grant; US Department of Homeland Security Science and Technology Directorate [HSHQDC-10-C-00139]; Defense Threat Reduction Agency [HDTRA1-12-C-0066]	Menzies School of Health Research grant; US Department of Homeland Security Science and Technology Directorate(United States Department of Homeland Security (DHS)); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	The authors thank the Edgewood Chemical Biological Center (ECBC) for their contribution to genome sequencing efforts. This work was funded by a Menzies School of Health Research grant, by the US Department of Homeland Security Science and Technology Directorate through award HSHQDC-10-C-00139 and by the Defense Threat Reduction Agency award HDTRA1-12-C-0066. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHDOWN LR, 1979, PATHOLOGY, V11, P293, DOI 10.3109/00313027909061954; Baldwin A, 2005, J CLIN MICROBIOL, V43, P4665, DOI 10.1128/JCM.43.9.4665-4673.2005; Chantratita N, 2007, J BACTERIOL, V189, P807, DOI 10.1128/JB.01258-06; Coenye T, 2003, ENVIRON MICROBIOL, V5, P719, DOI 10.1046/j.1462-2920.2003.00471.x; Currie Bart J, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS1, DOI 10.1016/S0035-9203(08)70002-6; Currie BJ, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-68; Dance DAB, 2005, EMERG INF DIS 21ST C, P99; Gee JE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-54; GILLIS M, 1995, INT J SYST BACTERIOL, V45, P274, DOI 10.1099/00207713-45-2-274; Glass MB, 2009, AM J TROP MED HYG, V80, P1023, DOI 10.4269/ajtmh.2009.80.1023; Godoy D, 2003, J CLIN MICROBIOL, V41, P2068, DOI 10.1128/JCM.41.5.2068-2079.2003; Kman NE, 2012, ADV PREV MED; Levy A, 2008, AM J TROP MED HYG, V78, P599, DOI 10.4269/ajtmh.2008.78.599; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Limmathurotsakul D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002105; Lowe P, 2002, J CLIN MICROBIOL, V40, P4625, DOI 10.1128/JCM.40.12.4625-4627.2002; Marshall K, 2010, SE ASIAN J TROP MED, V41, P904; Mayo M, 2011, EMERG INFECT DIS, V17, P1283, DOI 10.3201/eid1707.100614; Novak RT, 2006, J CLIN MICROBIOL, V44, P85, DOI 10.1128/JCM.44.1.85-90.2006; Payne GW, 2005, APPL ENVIRON MICROB, V71, P3917, DOI 10.1128/AEM.71.7.3917-3927.2005; Peacock SJ, 2005, J CLIN MICROBIOL, V43, P5359, DOI 10.1128/JCM.43.10.5359-5361.2005; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Sowers B, 2004, CAL FLUOR DYES MULTI; Vanlaere E, 2008, INT J SYST EVOL MICR, V58, P1580, DOI 10.1099/ijs.0.65634-0; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; WUTHIEKANUN V, 1995, T ROY SOC TROP MED H, V89, P41, DOI 10.1016/0035-9203(95)90651-7; Yabuuchi E, 2000, MICROBIOL IMMUNOL, V44, P307, DOI 10.1111/j.1348-0421.2000.tb02500.x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	28	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71647	10.1371/journal.pone.0071647	http://dx.doi.org/10.1371/journal.pone.0071647			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967229	Green Published, gold, Green Submitted			2022-12-25	WOS:000323115800070
J	Roy, R; Kumar, D; Chakraborty, B; Chowdhury, C; Das, P				Roy, Rajneeta; Kumar, Deepak; Chakraborty, Biswajit; Chowdhury, Chinmay; Das, Padma			Apoptotic and Autophagic Effects of Sesbania grandiflora Flowers in Human Leukemic Cells	PLOS ONE			English	Article								Background: Identification of cytotoxic compounds that induce apoptosis has been the mainstay of anti-cancer therapeutics for several decades. In recent years, focus has shifted to inducing multiple modes of cell death coupled with reduced systemic toxicity. The plant Sesbania grandiflora is widely used in Indian traditional medicine for the treatment of a broad spectrum of diseases. This encouraged us to investigate into the anti-proliferative effect of a fraction (F2) isolated from S. grandiflora flowers in cancer cells and delineate the underlying involvement of apoptotic and autophagic pathways. Principal Findings: Using MTT based cell viability assay, we evaluated the cytotoxic potential of fraction F2. It was the most effective on U937 cells (IC50:18.6 mu g/ml). Inhibition of growth involved enhancement of Annexin V positivity. This was associated with elevated reactive oxygen species generation, measured by flow cytometry and reduced oxygen consumption - both effects being abrogated by anti-oxidant NAC. This caused stimulation of pro-apoptotic proteins and concomitant inhibition of anti-apoptotic protein expressions inducing mitochondrial depolarization, as measured by flow cytometry and release of cytochrome c. Interestingly, even with these molecular features of apoptosis, F2 was able to alter Atg protein levels and induce LC3 processing. This was accompanied by formation of autophagic vacuoles as revealed by fluorescence and transmission electron microscopy - confirming the occurrence of autophagy. Eventually, F2 triggered caspase cascade - executioners of programmed cell death and AIF translocation to nuclei. This culminated in cleavage of the DNA repair enzyme, poly (ADP-ribose) polymerase that caused DNA damage as proved by staining with Hoechst 33258 leading to cell death. Conclusions: The findings suggest fraction F2 triggers pro-oxidant activity and mediates its cytotoxicity in leukemic cells via apoptosis and autophagy. Thus, it merits consideration and further investigation as a therapeutic option for the treatment of leukemia.	[Roy, Rajneeta; Kumar, Deepak; Das, Padma] CSIR Indian Inst Chem Biol, Canc Biol & Inflammatory Disorder Div, Kolkata, W Bengal, India; [Chakraborty, Biswajit; Chowdhury, Chinmay] CSIR Indian Inst Chem Biol, Div Chem, Kolkata, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Das, P (corresponding author), CSIR Indian Inst Chem Biol, Canc Biol & Inflammatory Disorder Div, Kolkata, W Bengal, India.	padmadas2005@yahoo.co.in	Kumar, Deepak/J-4347-2016		Department of Science and Technology, Govt. of India [SR/S1/OC-42/2009]; Department of Biotechnology, Govt. of India [BT/PR13444/PBD/17/670/2009]; Council of Scientific and Industrial Research, Govt. of India [IAP0001]; Council of Scientific and Industrial Research, Govt. of India	Department of Science and Technology, Govt. of India(Department of Science & Technology (India)); Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Govt. of India(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research, Govt. of India(Council of Scientific & Industrial Research (CSIR) - India)	This study was supported by grants from Department of Science and Technology (SR/S1/OC-42/2009), Govt. of India; Department of Biotechnology (BT/PR13444/PBD/17/670/2009), Govt. of India and Council of Scientific and Industrial Research (IAP0001), Govt. of India. RR and DK received Senior Research fellowships from Council of Scientific and Industrial Research, Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Omar SY, 2012, INT IMMUNOL, V24, P409, DOI 10.1093/intimm/dxr122; Ballot C, 2010, APOPTOSIS, V15, P769, DOI 10.1007/s10495-010-0471-2; Bhattacharya K, 2010, BIOCHEM PHARMACOL, V79, P361, DOI 10.1016/j.bcp.2009.09.007; Bieda R, 2011, BIOMETALS, V24, P645, DOI 10.1007/s10534-011-9414-9; Brodska B, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/253529; Bursch W, 2000, J CELL SCI, V113, P1189; Chen YJ, 2009, AUTOPHAGY, V5, P173, DOI 10.4161/auto.5.2.7360; Chiu HW, 2011, J MOL MED, V89, P927, DOI 10.1007/s00109-011-0763-1; Chiu HW, 2010, AUTOPHAGY, V6, P353, DOI 10.4161/auto.6.3.11229; Daido S, 2004, CANCER RES, V64, P4286, DOI 10.1158/0008-5472.CAN-03-3084; Das B, 2010, BIOORG MED CHEM LETT, V20, P6947, DOI 10.1016/j.bmcl.2010.09.126; Daugas E, 2000, FEBS LETT, V476, P118, DOI 10.1016/S0014-5793(00)01731-2; Deeb D, 2010, BIOCHEM PHARMACOL, V79, P350, DOI 10.1016/j.bcp.2009.09.006; Doddola S, 2008, J NAT MED-TOKYO, V62, P300, DOI 10.1007/s11418-008-0235-2; Ferantinos L, 1990, PERENNIAL SESBANIA S, P105; Fong MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042265; Galluzzi L, 2010, MOL ASPECTS MED, V31, P1, DOI 10.1016/j.mam.2009.08.002; Gibellini Lara, 2010, Cancers (Basel), V2, P1288, DOI 10.3390/cancers2021288; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hail N, 2001, J BIOL CHEM, V276, P45614, DOI 10.1074/jbc.M106559200; Hail N, 2010, NEOPLASIA, V12, P464, DOI 10.1593/neo.10168; Harris MH, 2000, CELL DEATH DIFFER, V7, P1182, DOI 10.1038/sj.cdd.4400781; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Jia YL, 2009, J ASIAN NAT PROD RES, V11, P918, DOI 10.1080/10286020903264077; Joshi SG, 2000, LEGUMINOCEAE TXB MED; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaczanowski S, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-44; Kasture VS, 2002, PHYTOTHER RES, V16, P455, DOI 10.1002/ptr.971; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kondo Y, 2006, AUTOPHAGY, V2, P85, DOI 10.4161/auto.2.2.2463; Krishna S, 2011, BIOCHEM J, V435, P545, DOI 10.1042/BJ20101996; Laladhas KP, 2010, J CELL MOL MED, V14, P636, DOI 10.1111/j.1582-4934.2008.00648.x; Lavieu G, 2006, J BIOL CHEM, V281, P8518, DOI 10.1074/jbc.M506182200; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Levine B, 2010, NATURE, V466, P38, DOI 10.1038/466038a; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mandal C, 2008, APOPTOSIS, V13, P1450, DOI 10.1007/s10495-008-0271-0; Manna A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036938; McDonnell TJ, 1996, EXPERIENTIA, V52, P1008, DOI 10.1007/BF01920110; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Mondal S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-239; Nag TC, 2009, ANN ANAT, V191, P556, DOI 10.1016/j.aanat.2009.08.004; Ohsumi Y, 2004, SEMIN CELL DEV BIOL, V15, P231, DOI 10.1016/j.semcdb.2003.12.004; Okada H, 2004, NAT REV CANCER, V4, P592, DOI 10.1038/nrc1412; Paglin S, 2001, CANCER RES, V61, P439; Pari L, 2003, THERAPIE, V58, P439, DOI 10.2515/therapie:2003071; Pattingre S, 2006, CANCER RES, V66, P2885, DOI 10.1158/0008-5472.CAN-05-4412; Pelicano H, 2003, J BIOL CHEM, V278, P37832, DOI 10.1074/jbc.M301546200; PRICE P, 1990, CANCER RES, V50, P1392; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Ramesh T, 2008, J CARDIOVASC PHARM, V52, P338, DOI 10.1097/FJC.0b013e3181888383; Rodriguez-Enriquez S, 2004, INT J BIOCHEM CELL B, V36, P2463, DOI 10.1016/j.biocel.2004.04.009; Sinha S, 2008, ONCOGENE, V27, pS137, DOI 10.1038/onc.2009.51; Sreelatha S, 2011, J ETHNOPHARMACOL, V134, P984, DOI 10.1016/j.jep.2011.01.012; Sun QM, 2009, AUTOPHAGY, V5, P713, DOI 10.4161/auto.5.5.8524; Tamboli S, 1996, IND DRUG, V33, P504; Tamboli SA, 2000, IND DRUG, V37, P95; Thayyullathil F, 2008, FREE RADICAL BIO MED, V45, P1403, DOI 10.1016/j.freeradbiomed.2008.08.014; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Turrens JF, 1997, BIOSCIENCE REP, V17, P3, DOI 10.1023/A:1027374931887; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Wang N, 2010, J CELL BIOCHEM, V111, P1426, DOI 10.1002/jcb.22869; Wei YJ, 2008, AUTOPHAGY, V4, P949, DOI 10.4161/auto.6788; Wuilleme-Toumi S, 2005, LEUKEMIA, V19, P1248, DOI 10.1038/sj.leu.2403784; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zou H, 2003, J BIOL CHEM, V278, P8091, DOI 10.1074/jbc.M204783200	68	20	21	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71672	10.1371/journal.pone.0071672	http://dx.doi.org/10.1371/journal.pone.0071672			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967233	gold, Green Submitted, Green Published			2022-12-25	WOS:000323115800073
J	Sun, M; Gomes, S; Chen, P; Frankenberger, CA; Sankarasharma, D; Chung, CH; Chada, KK; Rosner, MR				Sun, M.; Gomes, S.; Chen, P.; Frankenberger, C. A.; Sankarasharma, D.; Chung, C. H.; Chada, K. K.; Rosner, M. R.			RKIP and HMGA2 regulate breast tumor survival and metastasis through lysyl oxidase and syndecan-2	ONCOGENE			English	Article						RKIP; HMGA2; LOX; SDC2; breast; metastasis	INHIBITOR PROTEIN EXPRESSION; CANCER METASTASIS; MESENCHYMAL TRANSITION; COLORECTAL-CANCER; SIGNALING PATHWAY; PROSTATE-CANCER; MIR-200 FAMILY; GENES; PROGRESSION; LET-7	Elucidating targets of physiological tumor metastasis suppressors can highlight key signaling pathways leading to invasion and metastasis. To identify downstream targets of the metastasis suppressor Raf-1 kinase inhibitory protein (RKIP/PEBP1), we utilized an integrated approach based upon statistical analysis of tumor gene expression data combined with experimental validation. Previous studies from our laboratory identified the architectural transcription factor and oncogene, high mobility group AT-hook 2 (HMGA2), as a target of inhibition by RKIP. Here we identify two signaling pathways that promote HMGA2-driven metastasis. Using both human breast tumor cells and an MMTV-Wnt mouse breast tumor model, we show that RKIP induces and HMGA2 inhibits expression of miR-200b; miR-200b directly inhibits expression of lysyl oxidase (LOX), leading to decreased invasion. RKIP also inhibits syndecan-2 (SDC2), which is aberrantly expressed in breast cancer, via downregulation of HMGA2; but this mechanism is independent of miR-200. Depletion of SDC2 induces apoptosis and suppresses breast tumor growth and metastasis in mouse xenografts. RKIP, LOX and SDC2 are coordinately regulated and collectively encompass a prognostic signature for metastasis-free survival in ER-negative breast cancer patients. Taken together, our findings reveal two novel signaling pathways targeted by the metastasis suppressor RKIP that regulate remodeling of the extracellular matrix and tumor survival.	[Sun, M.; Gomes, S.; Frankenberger, C. A.; Rosner, M. R.] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Sun, M.; Rosner, M. R.] Univ Chicago, Comm Genet Genom & Syst Biol, Chicago, IL 60637 USA; [Chen, P.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Sankarasharma, D.; Chada, K. K.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ USA; [Chung, C. H.] Vanderbilt Univ, Sch Med, Dept Med & Canc Biol, Div Hematol Oncol, Nashville, TN 37212 USA	University of Chicago; University of Chicago; University of Chicago; Rutgers State University New Brunswick; Rutgers State University Medical Center; Vanderbilt University	Rosner, MR (corresponding author), Univ Chicago, Ben May Dept Canc Res, GCIS W421C,929 E 57th St, Chicago, IL 60637 USA.	m-rosner@uchicago.edu			NIH [GM087630]; DOD Predoctoral Traineeship Award [W81XWH-10-1-0396]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087630] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD Predoctoral Traineeship Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM087630 to MRR and DOD Predoctoral Traineeship Award W81XWH-10-1-0396 to MS. We also thank Eva Eves for technical support and helpful discussion.	Al-Mulla F, 2006, J CLIN ONCOL, V24, P5672, DOI 10.1200/JCO.2006.07.5499; Barbareschi M, 2003, CANCER-AM CANCER SOC, V98, P474, DOI 10.1002/cncr.11515; Berger JA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-194; Corbit KC, 2003, J BIOL CHEM, V278, P13061, DOI 10.1074/jbc.M210015200; Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; De Oliveira T, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-19; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Enerly E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016915; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Fu Z, 2003, J NATL CANCER I, V95, P878, DOI 10.1093/jnci/95.12.878; Fu Z, 2006, PROSTATE, V66, P248, DOI 10.1002/pros.20319; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hagan S, 2005, CLIN CANCER RES, V11, P7392, DOI 10.1158/1078-0432.CCR-05-0283; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jiang X, 2012, CANCER CELL, V22, P524, DOI 10.1016/j.ccr.2012.08.028; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lambaerts K, 2009, CURR OPIN CELL BIOL, V21, P662, DOI 10.1016/j.ceb.2009.05.002; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Li ZJ, 2008, P NATL ACAD SCI USA, V105, P15535, DOI 10.1073/pnas.0808266105; Loussouarn D, 2008, BRIT J CANCER, V98, P1993, DOI 10.1038/sj.bjc.6604400; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Marion A, 2012, INT J CANCER, V130, P2514, DOI 10.1002/ijc.26246; Massague J, 2007, NEW ENGL J MED, V356, P294, DOI 10.1056/NEJMe068292; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Minn AJ, 2012, CELL CYCLE, V11, P2452, DOI 10.4161/cc.20624; Minoo P, 2007, AM J CLIN PATHOL, V127, P820, DOI 10.1309/5D7MM22DAVGDT1R8; Morishita A, 2013, CANCER RES, V73, P4289, DOI 10.1158/0008-5472.CAN-12-3848; Nikolova V, 2009, CARCINOGENESIS, V30, P397, DOI 10.1093/carcin/bgp001; Park H, 2002, J BIOL CHEM, V277, P29730, DOI 10.1074/jbc.M202435200; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Popovic A, 2010, PROSTATE CANCER P D, V13, P78, DOI 10.1038/pcan.2009.43; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Schuetz CS, 2006, CANCER RES, V66, P5278, DOI 10.1158/0008-5472.CAN-05-4610; Smith SC, 2009, NAT REV CANCER, V9, P253, DOI 10.1038/nrc2594; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Sun M, 2013, P NATL ACAD SCI USA, V110, P9920, DOI 10.1073/pnas.1305172110; Team RDC, 2009, R LANG ENV STAT COMP; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Xu YF, 2010, J HEPATOL, V53, P872, DOI 10.1016/j.jhep.2010.05.019; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686; Yun JU, 2011, EMBO J, V30, P4500, DOI 10.1038/emboj.2011.312	55	64	68	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 3	2014	33	27					3528	3537		10.1038/onc.2013.328	http://dx.doi.org/10.1038/onc.2013.328			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AL2FK	23975428	Green Accepted			2022-12-25	WOS:000338941100005
J	Qian, X; Anzovino, A; Kim, S; Suyama, K; Yao, J; Hulit, J; Agiostratidou, G; Chandiramani, N; McDaid, HM; Nagi, C; Cohen, HW; Phillips, GR; Norton, L; Hazan, RB				Qian, X.; Anzovino, A.; Kim, S.; Suyama, K.; Yao, J.; Hulit, J.; Agiostratidou, G.; Chandiramani, N.; McDaid, H. M.; Nagi, C.; Cohen, H. W.; Phillips, G. R.; Norton, L.; Hazan, R. B.			N-cadherin/FGFR promotes metastasis through epithelial-to-mesenchymal transition and stem/progenitor cell-like properties	ONCOGENE			English	Article						ErbB2; N-cadherin; FGFR; mammospheres; metastasis	BREAST-CANCER; STEM-CELLS; GROWTH; MIGRATION; FGF; POPULATION; INVASION; SUBPOPULATIONS; PROLIFERATION; ESTABLISHMENT	N-cadherin and HER2/neu were found to be co-expressed in invasive breast carcinomas. To test the contribution of N-cadherin and HER2 in mammary tumor metastasis, we targeted N-cadherin expression in the mammary epithelium of the MMTV-Neu mouse. In the context of ErbB2/Neu, N-cadherin stimulated carcinoma cell invasion, proliferation and metastasis. N-cadherin caused fibroblast growth factor receptor (FGFR) upmodulation, resulting in epithelial-to-mesenchymal transition (EMT) and stem/progenitor like properties, involving Snail and Slug upregulation, mammosphere formation and aldehyde dehydrogenase activity. N-cadherin potentiation of the FGFR stimulated extracellular signal regulated kinase (ERK) and protein kinase B (AKT) phosphorylation resulting in differential effects on metastasis. Although ERK inhibition suppressed cyclin D1 expression, cell proliferation and stem/progenitor cell properties, it did not affect invasion or EMT. Conversely, AKT inhibition suppressed invasion through Akt 2 attenuation, and EMT through Snail inhibition, but had no effect on cyclin D1 expression, cell proliferation or mammosphere formation. These findings suggest N-cadherin/FGFR has a pivotal role in promoting metastasis through differential regulation of ERK and AKT, and underscore the potential for targeting the FGFR in advanced ErbB2-amplified breast tumors.	[Qian, X.; Anzovino, A.; Kim, S.; Suyama, K.; Yao, J.; Agiostratidou, G.; Chandiramani, N.; Hazan, R. B.] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; [Hulit, J.] Univ Manchester, Manchester Breast Ctr, Manchester, Lancs, England; [Hulit, J.] Univ Manchester, Paterson Inst Canc Res, Breakthrough Breast Canc Res Unit, Manchester, Lancs, England; [McDaid, H. M.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Nagi, C.] Mt Sinai Sch Med, Dept Pathol, New York, NY USA; [Cohen, H. W.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA; [Phillips, G. R.] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Norton, L.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA	Yeshiva University; Albert Einstein College of Medicine; University of Manchester; Paterson Institute for Cancer Research; University of Manchester; Yeshiva University; Albert Einstein College of Medicine; Icahn School of Medicine at Mount Sinai; Yeshiva University; Albert Einstein College of Medicine; Icahn School of Medicine at Mount Sinai; Memorial Sloan Kettering Cancer Center	Hazan, RB (corresponding author), Albert Einstein Coll Med, Dept Pathol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	Rachel.hazan@einstein.yu.edu		Emmanuel, Natasha/0000-0003-0130-1094; Cohen, Hillel/0000-0002-4524-0898; Norton, Larry/0000-0003-3701-9250	Breast Cancer Research Foundation; National Cancer Institute [1R01 CA135061-01A1]; CTSA from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [UL1RR025750, KL2RR025749, TL1RR025748]; NIH roadmap for Medical Research; NATIONAL CANCER INSTITUTE [R01CA077263, P30CA013330, R01CA135061] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001073] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR025748, KL2RR025749, UL1RR025750] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CTSA from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Dr Jeffrey Segall for providing the wild-type MMTV-ErbB2 mouse. We thank Dr Peng Guo for expert assistance in confocal imaging and the imaging facility at Albert Einstein College of Medicine. This work was supported by grants from the Breast Cancer Research Foundation (RB Hazan and Larry Norton) and the National Cancer Institute grant (1R01 CA135061-01A1; RB Hazan). This publication was also supported in part by the CTSA Grant UL1RR025750, KL2RR025749 and TL1RR025748 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) and NIH roadmap for Medical Research.	BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Chin YR, 2009, CELL SIGNAL, V21, P470, DOI 10.1016/j.cellsig.2008.11.015; Chung S, 2013, ONCOGENE, V32, P422, DOI 10.1038/onc.2012.65; Debnath J, 2003, J CELL BIOL, V163, P315, DOI 10.1083/jcb.200304159; Dontu G, 2003, CELL PROLIFERAT, V36, P59, DOI 10.1046/j.1365-2184.36.s.1.6.x; Eceles SA, 2001, J MAMMARY GLAND BIOL, V6, P393, DOI 10.1023/A:1014730829872; Eirew P, 2012, STEM CELLS, V30, P344, DOI 10.1002/stem.1001; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Giordano A, 2012, MOL CANCER THER, V11, P2526, DOI 10.1158/1535-7163.MCT-12-0460; Gotoh N, 2009, CURR STEM CELL RES T, V4, P9, DOI 10.2174/157488809787169048; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Hulit J, 2007, CANCER RES, V67, P3106, DOI 10.1158/0008-5472.CAN-06-3401; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Issa A, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3379; Knudsen KA, 2005, J CELL BIOCHEM, V95, P1093, DOI 10.1002/jcb.20469; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Koziczak M, 2004, J BIOL CHEM, V279, P50004, DOI 10.1074/jbc.M404252200; Koziczak M, 2004, ONCOGENE, V23, P3501, DOI 10.1038/sj.onc.1207331; Larocca D, 1998, HYBRIDOMA, V17, P21, DOI 10.1089/hyb.1998.17.21; Lelievre EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033206; Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493; Lim E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2560; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Nagi C, 2005, BREAST CANCER RES TR, V94, P225, DOI 10.1007/s10549-005-7727-5; Nahta R, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1612; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; Qian X, 2013, ONCOGENE, V32, P2292, DOI 10.1038/onc.2012.249; Shapiro IM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002218; Sharpe R, 2011, CLIN CANCER RES, V17, P5275, DOI 10.1158/1078-0432.CCR-10-2727; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Smalley MJ, 2012, J MAMMARY GLAND BIOL, V17, P91, DOI 10.1007/s10911-012-9257-1; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Toker A, 2006, CANCER RES, V66, P3963, DOI 10.1158/0008-5472.CAN-06-0743; Tomaskovic-Crook E, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2416; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Walsh MM, 2001, HUM PATHOL, V32, P583, DOI 10.1053/hupa.2001.24988; Warzecha CC, 2009, RNA BIOL, V6, P546, DOI 10.4161/rna.6.5.9606; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Xue GD, 2013, JNCI-J NATL CANCER I, V105, P393, DOI 10.1093/jnci/djs648; Yoeli-Lerner M, 2005, MOL CELL, V20, P539, DOI 10.1016/j.molcel.2005.10.033	47	83	92	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 26	2014	33	26					3411	3421		10.1038/onc.2013.310	http://dx.doi.org/10.1038/onc.2013.310			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AK9WM	23975425	Green Accepted			2022-12-25	WOS:000338779300008
J	Fuchs, HL; Reidenbach, MA				Fuchs, Heidi L.; Reidenbach, Matthew A.			Biophysical Constraints on Optimal Patch Lengths for Settlement of a Reef-Building Bivalve	PLOS ONE			English	Article							OYSTER CRASSOSTREA-VIRGINICA; CHESAPEAKE BAY; LARVAL SETTLEMENT; INTERTIDAL REEF; CORAL-REEFS; WATER-FLOW; RESTORATION; HABITAT; SCALE; RECRUITMENT	Reef-building species form discrete patches atop soft sediments, and reef restoration often involves depositing solid material as a substrate for larval settlement and growth. There have been few theoretical efforts to optimize the physical characteristics of a restored reef patch to achieve high recruitment rates. The delivery of competent larvae to a reef patch is influenced by larval behavior and by physical habitat characteristics such as substrate roughness, patch length, current speed, and water depth. We used a spatial model, the "hitting-distance" model, to identify habitat characteristics that will jointly maximize both the settlement probability and the density of recruits on an oyster reef (Crassostrea virginica). Modeled larval behaviors were based on laboratory observations and included turbulence-induced diving, turbulence-induced passive sinking, and neutral buoyancy. Profiles of currents and turbulence were based on velocity profiles measured in coastal Virginia over four different substrates: natural oyster reefs, mud, and deposited oyster and whelk shell. Settlement probabilities were higher on larger patches, whereas average settler densities were higher on smaller patches. Larvae settled most successfully and had the smallest optimal patch length when diving over rough substrates in shallow water. Water depth was the greatest source of variability, followed by larval behavior, substrate roughness, and tidal current speed. This result suggests that the best way to maximize settlement on restored reefs is to construct patches of optimal length for the water depth, whereas substrate type is less important than expected. Although physical patch characteristics are easy to measure, uncertainty about larval behavior remains an obstacle for predicting settlement patterns. The mechanistic approach presented here could be combined with a spatially explicit metapopulation model to optimize the arrangement of reef patches in an estuary or region for greater sustainability of restored habitats.	[Fuchs, Heidi L.] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08903 USA; [Reidenbach, Matthew A.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA	Rutgers State University New Brunswick; University of Virginia	Fuchs, HL (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08903 USA.	hfuchs@marine.rutgers.edu			National Science 425 Foundation [OCE-1060622, DEB-0621014]; Division Of Environmental Biology [1237733] Funding Source: National Science Foundation; Division Of Ocean Sciences [1060622] Funding Source: National Science Foundation	National Science 425 Foundation; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was facilitated by funding from the National Science 425 Foundation (OCE-1060622 and DEB-0621014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartol IK, 1997, B MAR SCI, V61, P881; Beck MW, 2011, BIOSCIENCE, V61, P107, DOI 10.1525/bio.2011.61.2.5; Brumbaugh RD, 2009, J SHELLFISH RES, V28, P147, DOI 10.2983/035.028.0105; BUTMAN CA, 1994, LIMNOL OCEANOGR, V39, P1755, DOI 10.4319/lo.1994.39.7.1755; Coen LD, 2000, ECOL ENG, V15, P323, DOI 10.1016/S0925-8574(00)00084-7; Crimaldi JP, 2002, LIMNOL OCEANOGR, V47, P1137, DOI 10.4319/lo.2002.47.4.1137; Crimaldi JP, 2001, EXP FLUIDS, V31, P90, DOI 10.1007/s003480000263; ECKMAN JE, 1990, LIMNOL OCEANOGR, V35, P887, DOI 10.4319/lo.1990.35.4.0887; Eggleston David B., 1999, P213; Ermgassen PSEZ, 2012, P ROY SOC B-BIOL SCI, V279, P3393, DOI 10.1098/rspb.2012.0313; Fuchs H.L., 2011, LIMNOL OCEANOGR FLUI, V1, P120, DOI DOI 10.1215/21573698-1444613; Fuchs HL, 2007, LIMNOL OCEANOGR, V52, P1156, DOI 10.4319/lo.2007.52.3.1156; Fuchs HL, 2013, J EXP BIOL, V216, P1458, DOI 10.1242/jeb.079855; Fuchs HL, 2010, J MAR RES, V68, P153, DOI 10.1357/002224010793079013; Green MO, 1998, J MAR RES, V56, P613, DOI 10.1357/002224098765213603; Guo XY, 2007, CONT SHELF RES, V27, P20, DOI 10.1016/j.csr.2006.08.009; Hadfield MG, 2004, BIOL BULL-US, V207, P28, DOI 10.2307/1543626; HIDU H, 1978, ESTUARIES, V1, P252, DOI 10.2307/1351527; Kennedy Victor S., 1999, P25; Kim CK, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006115; Koehl MAR, 2007, EXP FLUIDS, V43, P755, DOI 10.1007/S00348-007-0371-6; Koehl MAR, 2004, J MARINE SYST, V49, P75, DOI 10.1016/j.jmarsys.2003.06.003; Lenihan HS, 1999, ECOL MONOGR, V69, P251, DOI 10.1890/0012-9615(1999)069[0251:PBCOOR]2.0.CO;2; Lenihan HS, 1998, ECOL APPL, V8, P128, DOI 10.2307/2641316; Lipcius RN, 2008, REV FISH SCI, V16, P101, DOI 10.1080/10641260701812574; MANN R, 1991, MAR ECOL PROG SER, V68, P257; Mann R, 2007, J SHELLFISH RES, V26, P905, DOI 10.2983/0730-8000(2007)26[905:WORGIT]2.0.CO;2; McCormick-Ray J, 2005, ESTUAR COAST SHELF S, V64, P119, DOI 10.1016/j.ecss.2005.02.011; McNair JN, 2001, J THEOR BIOL, V209, P351, DOI 10.1006/jtbi.2001.2273; MICHENER WK, 1991, J EXP MAR BIOL ECOL, V154, P97, DOI 10.1016/0022-0981(91)90077-A; Nestlerode JA, 2007, RESTOR ECOL, V15, P273, DOI 10.1111/j.1526-100X.2007.00210.x; North EW, 2008, MAR ECOL PROG SER, V359, P99, DOI 10.3354/meps07317; North EW, 2010, ECOL APPL, V20, P851, DOI 10.1890/08-1733.1; Powell EN, 2007, J SHELLFISH RES, V26, P181, DOI 10.2983/0730-8000(2007)26[181:IOSASE]2.0.CO;2; Powell EN, 2006, ESTUAR COAST SHELF S, V69, P531, DOI 10.1016/j.ecss.2006.05.014; Powers SP, 2009, MAR ECOL PROG SER, V389, P159, DOI 10.3354/meps08164; Reidenbach MA, 2009, LIMNOL OCEANOGR, V54, P318, DOI 10.4319/lo.2009.54.1.0318; Schulte DM, 2009, SCIENCE, V325, P1124, DOI 10.1126/science.1176516; Soniat TM, 2004, J EXP MAR BIOL ECOL, V310, P163, DOI 10.1016/j.jembe.2004.04.007; TURNER EJ, 1994, LIMNOL OCEANOGR, V39, P1579, DOI 10.4319/lo.1994.39.7.1579; van de Koppel J, 2005, AM NAT, V165, pE66; van de Koppel J, 2012, J EXP BIOL, V215, P962, DOI 10.1242/jeb.060467; van der Zee EM, 2012, ECOSYSTEMS, V15, P664, DOI 10.1007/s10021-012-9538-y; Walker RL, 2001, TECHNICAL REPORT; Whitman ER, 2012, MAR ECOL PROG SER, V463, P177, DOI 10.3354/meps09882; WITMAN JD, 1984, MAR ECOL PROG SER, V16, P259, DOI 10.3354/meps016259; Young Craig M., 1995, P249; ZARILLO GA, 1985, MAR GEOL, V67, P13, DOI 10.1016/0025-3227(85)90146-X; ZIMMERFAUST RK, 1994, LIMNOL OCEANOGR, V39, P1075, DOI 10.4319/lo.1994.39.5.1075	49	18	19	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71506	10.1371/journal.pone.0071506	http://dx.doi.org/10.1371/journal.pone.0071506			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977059	Green Published, gold			2022-12-25	WOS:000323425700061
J	McPherson, NO; Bakos, HW; Owens, JA; Setchell, BP; Lane, M				McPherson, Nicole O.; Bakos, Hassan W.; Owens, Julie A.; Setchell, Brian P.; Lane, Michelle			Improving Metabolic Health in Obese Male Mice via Diet and Exercise Restores Embryo Development and Fetal Growth	PLOS ONE			English	Article							BODY-MASS INDEX; ASSISTED REPRODUCTIVE TECHNOLOGY; HIGH-FAT DIET; HUMAN SPERMATOZOA; DNA-DAMAGE; OXIDATIVE STRESS; MALE-INFERTILITY; SPERM FUNCTION; MOUSE EMBRYO; WEIGHT-LOSS	Paternal obesity is now clearly associated with or causal of impaired embryo and fetal development and reduced pregnancy rates in humans and rodents. This appears to be a result of reduced blastocyst potential. Whether these adverse embryo and fetal outcomes can be ameliorated by interventions to reduce paternal obesity has not been established. Here, male mice fed a high fat diet (HFD) to induce obesity were used, to determine if early embryo and fetal development is improved by interventions of diet (CD) and/or exercise to reduce adiposity and improve metabolism. Exercise and to a lesser extent CD in obese males improved embryo development rates, with increased cell to cell contacts in the compacting embryo measured by E-cadherin in exercise interventions and subsequently, increased blastocyst trophectoderm (TE), inner cell mass (ICM) and epiblast cell numbers. Implantation rates and fetal development from resulting blastocysts were also improved by exercise in obese males. Additionally, all interventions to obese males increased fetal weight, with CD alone and exercise alone, also increasing fetal crown-rump length. Measures of embryo and fetal development correlated with paternal measures of glycaemia, insulin action and serum lipids regardless of paternal adiposity or intervention, suggesting a link between paternal metabolic health and subsequent embryo and fetal development. This is the first study to show that improvements to metabolic health of obese males through diet and exercise can improve embryo and fetal development, suggesting such interventions are likely to improve offspring health.	[McPherson, Nicole O.; Owens, Julie A.; Lane, Michelle] Univ Adelaide, Discipline Obstet & Gynaecol, Sch Paediat & Reprod Hlth, Adelaide, SA 5005, Australia; [Bakos, Hassan W.] Univ Adelaide, Discipline Med, Sch Med, Adelaide, SA 5005, Australia; [Setchell, Brian P.] Univ Adelaide, Discipline Anat, Sch Med Sci, Adelaide, SA 5005, Australia; [Bakos, Hassan W.; Lane, Michelle] Repromed, Dulwich, SA, Australia	University of Adelaide; University of Adelaide; University of Adelaide	McPherson, NO (corresponding author), Univ Adelaide, Discipline Obstet & Gynaecol, Sch Paediat & Reprod Hlth, Adelaide, SA 5005, Australia.	nicole.palmer@adelaide.edu.au	Owens, Julie A/C-9744-2009	Owens, Julie A/0000-0002-7498-1353; McPherson, Nicole/0000-0002-3492-9403	NHMRC [44109262]; Prospective Lodge Freemason Medical Scholarship; Australian Postgraduate award	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Prospective Lodge Freemason Medical Scholarship; Australian Postgraduate award(Australian Government)	This work was supported by NHMRC project grant 44109262 awarded to ML and JAO. ML is the recipient of an NHMRC Senior Research Fellowship. NOP is the recipient of an Australian Postgraduate award and a Prospective Lodge Freemason Medical Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RJ, 2010, HUM REPROD, V25, P2415, DOI 10.1093/humrep/deq214; Aitken RJ, 2002, INT J ANDROL, V25, P191, DOI 10.1046/j.1365-2605.2002.03521.x; Aitken RJ, 2011, ANTIOXID REDOX SIGN, V14, P367, DOI 10.1089/ars.2010.3186; ALVAREZ JG, 1995, MOL REPROD DEV, V42, P334, DOI 10.1002/mrd.1080420311; Andreazzi AE, 2009, J ENDOCRINOL, V201, P351, DOI 10.1677/JOE-08-0312; Bakos HW, 2011, INT J ANDROL, V34, P402, DOI 10.1111/j.1365-2605.2010.01092.x; Bakos HW, 2008, INT J ANDROL, V31, P518, DOI 10.1111/j.1365-2605.2007.00803.x; Bakos HW, 2011, FERTIL STERIL, V95, P1700, DOI 10.1016/j.fertnstert.2010.11.044; Bakos HW, 2010, INT J ANDROL; Barker DJP, 2004, ACTA PAEDIATR, V93, P26, DOI 10.1080/08035320410022730; Bastounis EA, 1998, EUR SURG RES, V30, P43, DOI 10.1159/000008556; Binder NK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052304; Binder NK, 2012, REPROD FERT DEVELOP, V24, P804, DOI 10.1071/RD11256; Brake DK, 2006, AM J PHYSIOL-CELL PH, V291, pC1232, DOI 10.1152/ajpcell.00008.2006; Campbell JM, 2012, STEM CELLS DEV, V21, P2430, DOI 10.1089/scd.2011.0598; Chen LY, 2010, CELL RES, V20, P982, DOI 10.1038/cr.2010.106; Dada R, 2010, INDIAN J MED RES, V132, P728; Dal Canto M, 2012, REPROD BIOMED ONLINE, V25, P474, DOI 10.1016/j.rbmo.2012.07.016; Dard N, 2008, MOL CELL ENDOCRINOL, V282, P70, DOI 10.1016/j.mce.2007.11.004; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; Du Plessis SS, 2010, NAT REV UROL, V7, P153, DOI 10.1038/nrurol.2010.6; El Hajj N, 2011, SEX DEV, V5, P60, DOI 10.1159/000323806; Esteghamati A, 2010, METABOLISM, V59, P1730, DOI 10.1016/j.metabol.2010.04.016; Fernandez CDB, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-32; Filkowski JN, 2010, CARCINOGENESIS, V31, P1110, DOI 10.1093/carcin/bgp300; Fleming TP, 2001, FRONT BIOSCI-LANDMRK, V6, pD1000, DOI 10.2741/Fleming; Fullston T, 2012, HUM REPROD, V27, P1391, DOI 10.1093/humrep/des030; Fullston T, 2013, FASEB J IN PRESS; Gardner DK, 2004, LAB GUIDE MAMMALIAN; Ghanayem BI, 2010, BIOL REPROD, V82, P96, DOI 10.1095/biolreprod.109.078915; Gharagozloo P, 2011, HUM REPROD; Haidl G, 1997, HUM REPROD, V12, P2720, DOI 10.1093/humrep/12.12.2720; Hakonsen LB, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-24; Hammoud A, 2009, J CLIN ENDOCR METAB, V94, P1329, DOI 10.1210/jc.2008-1598; Hammoud AO, 2008, FERTIL STERIL, V90, P897, DOI 10.1016/j.fertnstert.2008.08.026; Harrouk W, 2000, BIOL REPROD, V63, P74, DOI 10.1095/biolreprod63.1.74; Hinz S, 2010, UROLOGY, V76, P851, DOI 10.1016/j.urology.2010.01.055; Hwang K, 2011, NAT REV UROL, V8, P86, DOI 10.1038/nrurol.2010.230; Ivy JL, 1997, SPORTS MED, V24, P323; JOHNSON MH, 2000, ESSENTIAL REPROD; Johnson RC, 2011, AM J PUBLIC HEALTH, V101, P2317, DOI 10.2105/AJPH.2011.300252; Jones R, 1998, J REPROD FERTIL, P73; Kamjoo M, 2002, MOL REPROD DEV, V61, P67, DOI 10.1002/mrd.1132; Kan NG, 2007, DEVELOPMENT, V134, P31, DOI 10.1242/dev.02722; Kasturi SS, 2008, J ANDROL, V29, P251, DOI 10.2164/jandrol.107.003731; Kaukua J, 2003, OBES RES, V11, P689, DOI 10.1038/oby.2003.98; Keltz J, 2010, J ASSIST REPROD GEN, V27, P539, DOI 10.1007/s10815-010-9439-y; Koppers AJ, 2010, FREE RADICAL BIO MED, V48, P112, DOI 10.1016/j.freeradbiomed.2009.10.033; Kriegel TM, 2009, REPROD BIOMED ONLINE, V19, P660, DOI 10.1016/j.rbmo.2009.07.001; Kumar K, 2012, J ASSIST REPROD GENE; Lane M, 1997, J REPROD FERTIL, V109, P153, DOI 10.1530/jrf.0.1090153; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Lea RG, 1996, DIABETES, V45, P1463, DOI 10.2337/diabetes.45.11.1463; MacDonald AA, 2010, HUM REPROD UPDATE, V16, P293, DOI 10.1093/humupd/dmp047; Marquard KL, 2011, FERTIL STERIL, V95, P2146, DOI 10.1016/j.fertnstert.2010.10.026; Minor A, 2011, REPRODUCTION; Mitchell M, 2011, FERTIL STERIL, V95, P1349, DOI 10.1016/j.fertnstert.2010.09.038; Nagy A, 2003, LAB MANUAL, ppp399; Nanassy L, 2011, ASIAN J ANDROL, V13, P342, DOI 10.1038/aja.2010.160; Napoli C, 2004, P NATL ACAD SCI USA, V101, P8797, DOI 10.1073/pnas.0402734101; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Nguyen RHN, 2007, HUM REPROD, V22, P2488, DOI 10.1093/humrep/dem139; Ortega FJ, 2013, CLIN CHEM; Palmer NO, 2012, AM J PHYSIOL-ENDOC M, V302, pE768, DOI 10.1152/ajpendo.00401.2011; Palmer NO, 2011, REPROD FERT DEVELOP, V23, P929, DOI 10.1071/RD10326; Palmer NO, 2011, REPROD FERTILITY DEV; Pey R, 1998, P NATL ACAD SCI USA, V95, P12977, DOI 10.1073/pnas.95.22.12977; Pinborg A, 2011, REPROD BIOMED ONLINE, V23, P490, DOI 10.1016/j.rbmo.2011.06.010; Ramlau-Hansen CH, 2007, HUM REPROD, V22, P1634, DOI 10.1093/humrep/dem035; Reis LO, 2012, REPROD SCI, V19, P1057, DOI 10.1177/1933719112440747; Saez F, 2011, ASIAN J ANDROL, V13, P11, DOI 10.1038/aja.2010.64; Lancellotti TES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013457; Shea KM, 1997, AM J IND MED, V31, P738, DOI 10.1002/(SICI)1097-0274(199706)31:6<738::AID-AJIM11>3.0.CO;2-Z; Shea KM, 1997, AM J EPIDEMIOL, V145, P546, DOI 10.1093/oxfordjournals.aje.a009143; STRAIN GW, 1988, J CLIN ENDOCR METAB, V66, P1019, DOI 10.1210/jcem-66-5-1019; Tunc O, 2010, INT J ANDROL, V33, P13, DOI 10.1111/j.1365-2605.2008.00941.x; Tunc O, 2009, J ASSIST REPROD GEN, V26, P537, DOI 10.1007/s10815-009-9346-2; Veleva Z, 2008, HUM REPROD, V23, P878, DOI 10.1093/humrep/den017; Villareal DT, 2011, NEW ENGL J MED, V364, P1218, DOI 10.1056/NEJMoa1008234; World Health Organization, 2012, WORLD HLTH STAT 2012; Yan W, 2008, BIOL REPROD, V78, P896, DOI 10.1095/biolreprod.107.067033; Youngson NA, 2011, ASIAN J ANDROL, V13, P195, DOI 10.1038/aja.2010.163; Zribi N, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-47	83	51	51	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71459	10.1371/journal.pone.0071459	http://dx.doi.org/10.1371/journal.pone.0071459			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977045	Green Submitted, Green Published, gold			2022-12-25	WOS:000323425700054
J	Vaccarella, S; Soderlund-Strand, A; Franceschi, S; Plummer, M; Dillner, J				Vaccarella, Salvatore; Soderlund-Strand, Anna; Franceschi, Silvia; Plummer, Martyn; Dillner, Joakim			Patterns of Human Papillomavirus Types in Multiple Infections: An Analysis in Women and Men of the High Throughput Human Papillomavirus Monitoring Study	PLOS ONE			English	Article							HPV TYPES; CERVICAL COINFECTION; GLOBAL PROFICIENCY; PREVALENCE SURVEYS; POOLED ANALYSIS; ACQUISITION; PERSISTENCE; CONCURRENT; CANCER; DETERMINANTS	Background: To evaluate the pattern of co-infection of human papillomavirus (HPV) types in both sexes in Sweden. Methods: Cell samples from genital swabs, first-void urine, and genital swabs immersed in first-void urine were collected in the present cross-sectional High Throughput HPV Monitoring study. Overall, 31,717 samples from women and 9,949 from men (mean age 25) were tested for 16 HPV types using mass spectrometry. Multilevel logistic regression was used to estimate the expected number of multiple infections with specific HPV types, adjusted for age, type of sample, and accounting for correlations between HPV types due to unobserved risk factors using sample-level random effects. Bonferroni correction was used to allow for multiple comparisons (120). Results: Observed-to-expected ratio for any multiple infections was slightly above unity in both sexes, but, for most 2-type combinations, there was no evidence of significant departure from expected numbers. HPV6/18 was found more often and HPV51/68 and 6/68 less often than expected. However, HPV68 tended to be generally underrepresented in co-infections, suggesting a sub-optimal performance of our testing method for this HPV type. Conclusions: We found no evidence for positive or negative clustering between HPV types included in the current prophylactic vaccines and other untargeted oncogenic types, in either sex.	[Vaccarella, Salvatore; Franceschi, Silvia; Plummer, Martyn; Dillner, Joakim] Int Agcy Res Canc, F-69372 Lyon, France; [Soderlund-Strand, Anna; Dillner, Joakim] Skane Univ Hosp, Dept Clin Microbiol, Malmo, Sweden; [Dillner, Joakim] Karolinska Inst, Dept Lab Med, Stockholm, Sweden; [Dillner, Joakim] Karolinska Inst, Dept Med Epidemiol, Stockholm, Sweden; [Dillner, Joakim] Karolinska Inst, Dept Biostat, Stockholm, Sweden; [Dillner, Joakim] Karolinska Hosp, S-10401 Stockholm, Sweden	World Health Organization; International Agency for Research on Cancer (IARC); Lund University; Skane University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Vaccarella, S (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon, France.	vaccarella@iarc.fr	franceschi, silvia/M-2452-2014	franceschi, silvia/0000-0003-4181-8071; Plummer, Martyn/0000-0001-5130-6497	Osterlund Foundation; Region Skane Clinical Research Funds; Bill & Melinda Gates Foundation [OPP1053353]; Sanofi Pasteur MSD	Osterlund Foundation; Region Skane Clinical Research Funds; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Sanofi Pasteur MSD	This work was supported by research grants from Osterlund Foundation; Region Skane Clinical Research Funds; and by a grant from the Bill & Melinda Gates Foundation [grant number OPP1053353]. The HT-HPV study was supported by Sanofi Pasteur MSD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, MON EV CARC RISKS HU; Bissett SL, 2011, J MED VIROL, V83, P1744, DOI 10.1002/jmv.22167; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Carozzi F, 2012, EUR J CANCER, V48, P1633, DOI 10.1016/j.ejca.2011.10.010; Chaturvedi AK, 2005, CANCER EPIDEM BIOMAR, V14, P2439, DOI 10.1158/1055-9965.EPI-05-0465; Chaturvedi AK, 2011, J INFECT DIS, V203, P910, DOI 10.1093/infdis/jiq139; Cuschieri K, 2011, J MED VIROL, V83, P1983, DOI 10.1002/jmv.22183; Eklund C, 2012, J CLIN MICROBIOL, V50, P2289, DOI 10.1128/JCM.00840-12; Eklund C, 2010, J CLIN MICROBIOL, V48, P4147, DOI 10.1128/JCM.00918-10; Franco EL, 1999, J INFECT DIS, V180, P1415, DOI 10.1086/315086; Gelman A., 2004, BAYESIAN DATA ANAL; Goldman B, 2013, VACCINE, V31, P1604, DOI 10.1016/j.vaccine.2012.12.084; Lajous M, 2005, CANCER EPIDEM BIOMAR, V14, P1710, DOI 10.1158/1055-9965.EPI-04-0926; Liaw KL, 2001, J INFECT DIS, V183, P8, DOI 10.1086/317638; Mendez F, 2005, J INFECT DIS, V192, P1158, DOI 10.1086/444391; Nielson CM, 2009, CANCER EPIDEM BIOMAR, V18, P1077, DOI 10.1158/1055-9965.EPI-08-0447; Rositch AF, 2012, J INFECT DIS, V205, P72, DOI 10.1093/infdis/jir709; Rousseau MC, 2001, J INFECT DIS, V184, P1508, DOI 10.1086/324579; Soderlund-Strand A, 2013, CANCER EPIDEM BIOMAR, V22, P242, DOI 10.1158/1055-9965.EPI-12-1003; Soederlund-Strand A, 2009, J CLIN MICROBIOL, V47, P541, DOI 10.1128/JCM.02007-08; Thomas KK, 2000, J INFECT DIS, V182, P1097, DOI 10.1086/315805; Vaccarella S, 2006, CANCER EPIDEM BIOMAR, V15, P326, DOI 10.1158/1055-9965.EPI-05-0577; Vaccarella S, 2006, INT J CANCER, V119, P1934, DOI 10.1002/ijc.21992; Vaccarella S, 2011, J INFECT DIS, V204, P1500, DOI 10.1093/infdis/jir595; Vaccarella S, 2011, J INFECT DIS, V204, P385, DOI 10.1093/infdis/jir286; Vaccarella S, 2010, CANCER EPIDEM BIOMAR, V19, P503, DOI 10.1158/1055-9965.EPI-09-0983; Vorsters A, 2012, EUR J CLIN MICROBIOL, V31, P627, DOI 10.1007/s10096-011-1358-z; Wheeler CM, 2012, LANCET ONCOL, V13, P100, DOI 10.1016/S1470-2045(11)70287-X	28	15	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71617	10.1371/journal.pone.0071617	http://dx.doi.org/10.1371/journal.pone.0071617			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977090	Green Published, gold, Green Submitted			2022-12-25	WOS:000323425700074
J	Li, DL; Fu, ZK; Chen, S; Yuan, WG; Liu, YH; Li, LQ; Pang, D; Li, DJ				Li, Dalin; Fu, Zhenkun; Chen, Shuang; Yuan, Weiguang; Liu, Yanhong; Li, Liqun; Pang, Da; Li, Dianjun			HVEM Gene Polymorphisms Are Associated with Sporadic Breast Cancer in Chinese Women	PLOS ONE			English	Article							HERPESVIRUS ENTRY MEDIATOR; T-CELLS; CO-STIMULATION; SIMPLEX-VIRUS; B-LYMPHOCYTE; EXPRESSION; BTLA; ACTIVATION; TUMOR; SURVIVAL	As a costimulatory molecule, Herpesvirus entry mediator (HVEM) can bind with several costimulatory members, thus HVEM plays different roles in T cell immunity. HVEM and its ligands have been involved in the pathogenesis of various autoimmune, inflammatory diseases and tumors. In the current study, we conducted a case-control study comparing polymorphisms of HVEM and breast cancer. Subjects included 575 females with breast cancer and 604 age-matched healthy controls. Six HVEM SNPs (rs2281852, rs1886730, rs2234163, rs11573979, rs2234165, and rs2234167) were genotyped by PCR-RFLP. The results showed significant differences in genotypes and alleles between rs1886730 and rs2234167 (P<0.05). One haplotype (CTGCGG) that was associated with breast cancer was found via haplotype analysis. Our research also indicated an association between polymorphisms of HVEM and clinicopathologic features, including lymph node metastasis, estrogen receptor, progesterone receptor and P53. Our results primarily indicate that polymorphisms of the HVEM gene were associated with the risk of sporadic breast cancer in northeast Chinese females.	[Li, Dalin; Pang, Da] Harbin Med Univ, Affiliated Hosp 3, Dept Breast Surg, Harbin, Peoples R China; [Li, Dalin; Fu, Zhenkun; Chen, Shuang; Yuan, Weiguang; Li, Liqun; Li, Dianjun] Harbin Med Univ, Dept Immunol, Harbin, Peoples R China; [Li, Dalin; Fu, Zhenkun; Chen, Shuang; Yuan, Weiguang; Li, Liqun; Li, Dianjun] Harbin Med Univ, Heilongjiang Prov Key Lab Infect & Immun, Harbin, Peoples R China; [Yuan, Weiguang; Li, Dianjun] Harbin Med Univ, Inst Canc Prevent & Treatment, Harbin, Peoples R China; [Liu, Yanhong] Harbin Med Univ, Hosp 2, Dept Lab Med, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University	Pang, D (corresponding author), Harbin Med Univ, Affiliated Hosp 3, Dept Breast Surg, Harbin, Peoples R China.	pangdasir@163.com; dianjunli@163.com			National Natural Science Foundation of China [31070780]; China Postdoctoral Science Foundation [2012M520036]; Postdoctoral Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This research was supported by the National Natural Science Foundation of China (No. 31070780), China Postdoctoral Science Foundation funded project (2012M520036) and Postdoctoral Science Foundation funded project of Heilongjiang Province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baralle D, 2005, J MED GENET, V42, P737, DOI 10.1136/jmg.2004.029538; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Cai GF, 2009, IMMUNOL REV, V229, P244, DOI 10.1111/j.1600-065X.2009.00783.x; Carfi A, 2001, MOL CELL, V8, P169, DOI 10.1016/S1097-2765(01)00298-2; Chemnitz JM, 2006, J IMMUNOL, V176, P6603, DOI 10.4049/jimmunol.176.11.6603; Cheung TC, 2009, P NATL ACAD SCI USA, V106, P6244, DOI 10.1073/pnas.0902115106; Cohavy O, 2004, J IMMUNOL, V173, P251, DOI 10.4049/jimmunol.173.1.251; Deanne MC, 2005, J BIOL CHEM, V280, P39553; del Rio ML, 2010, J LEUKOCYTE BIOL, V87, P223, DOI 10.1189/jlb.0809590; Fu ZK, 2010, BREAST CANCER RES TR, V120, P195, DOI 10.1007/s10549-009-0462-6; JONSSON JJ, 1992, NUCLEIC ACIDS RES, V20, P3191, DOI 10.1093/nar/20.12.3191; Kim HJ, 2011, BREAST CANCER RES TR, V130, P499, DOI 10.1007/s10549-011-1736-3; Kroczek RA, 2004, CURR OPIN IMMUNOL, V16, P321, DOI 10.1016/j.coi.2004.03.002; Kwon BS, 1997, J BIOL CHEM, V272, P14272, DOI 10.1074/jbc.272.22.14272; Logullo AF, 2007, ONCOL REP, V18, P121; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; Murphy KM, 2006, NAT REV IMMUNOL, V6, P671, DOI 10.1038/nri1917; Murphy TL, 2010, ANNU REV IMMUNOL, V28, P389, DOI 10.1146/annurev-immunol-030409-101202; Perez EA, 2010, BREAST CANCER RES TR, V121, P261, DOI 10.1007/s10549-010-0824-0; Rudolph P, 2001, HUM PATHOL, V32, P311, DOI 10.1053/hupa.2001.22748; Spear PG, 2004, CELL MICROBIOL, V6, P401, DOI 10.1111/j.1462-5822.2004.00389.x; Stendahl M, 2006, CLIN CANCER RES, V12, P4614, DOI 10.1158/1078-0432.CCR-06-0248; Struyf F, 2002, J INFECT DIS, V185, P36, DOI 10.1086/338116; Tamada K, 2000, NAT MED, V6, P283; Tao R, 2008, J IMMUNOL, V180, P6649, DOI 10.4049/jimmunol.180.10.6649; Wang JB, 2012, CURR DRUG METAB, V13, P978, DOI 10.2174/138920012802138552	26	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e71040	10.1371/journal.pone.0071040	http://dx.doi.org/10.1371/journal.pone.0071040			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23976978	Green Published, Green Submitted, gold			2022-12-25	WOS:000323570200020
J	Qu, YY; Hu, SL; Xu, XY; Wang, RZ; Yu, HY; Xu, JY; Chen, L; Dong, GL				Qu, Yuan-yuan; Hu, Song-liu; Xu, Xiang-ying; Wang, Rui-zhi; Yu, Hong-yang; Xu, Jian-yu; Chen, Lin; Dong, Guang-lu			Nimotuzumab Enhances the Radiosensitivity of Cancer Cells In Vitro by Inhibiting Radiation-Induced DNA Damage Repair	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; METASTATIC COLORECTAL-CANCER; LUNG-CANCER; IONIZING-RADIATION; 1ST-LINE TREATMENT; NUCLEAR IMPORT; PLUS CETUXIMAB; HEAD; NECK; ANTIBODY	Background: Nimotuzumab is a humanized IgG1 monoclonal antibody specifically targeting EGFR. In this study, we aimed to investigate the molecular mechanisms of nimotuzumab in its effects of enhancing cancer cell radiosensitivity. Principal Finding: Lung cancer A549 cells and breast cancer MCF-7 cells were pretreated with or without nimotuzumab for 24 h before radiation to perform the clonogenic survival assay and to analyze the cell apoptosis by flow ctyometry. gamma-H2AX foci were detected by confocal microscopy to assess the effect of nimotuzumab on radiation induced DNA repair. EGFR activation was examined and the levels of DNA damage repair related proteins in A549 cells at different time point and at varying doses exposure after nimotuzumab and radiation treatment were examined by Western blot. Pretreatment with nimotuzumab reduced clonogenic survival after radiation, inhibited radiation-induced EGFR activation and increased the radiation-induced apoptosis in both A549 cells and MCF-7 cells. The foci of gamma-H2AX 24 h after radiation significantly increased in nimotuzumab pretreated cells with different doses. The phosphorylation of AKT and DNA-PKcs were remarkably inhibited in the combination group at each dose point as well as time point. Conclusions: Our results revealed that the possible mechanism of nimotuzumab enhancing the cancer radiosensitivity is that nimotuzumab inhibited the radiation-induced activation of DNA-PKcs through blocking the PI3K/AKT pathway, which ultimately affected the DNA DSBs repair.	[Qu, Yuan-yuan; Hu, Song-liu; Xu, Xiang-ying; Wang, Rui-zhi; Xu, Jian-yu; Chen, Lin] Harbin Med Univ, Affiliated Hosp 3, Dept Radiat Oncol, Harbin, Heilongjiang, Peoples R China; [Xu, Xiang-ying] Heilongjiang Prov Inst Canc Res, Harbin, Heilongjiang, Peoples R China; [Yu, Hong-yang; Dong, Guang-lu] Harbin Med Univ, Affiliated Hosp 2, Dept Radiat Oncol, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University	Xu, XY (corresponding author), Harbin Med Univ, Affiliated Hosp 3, Dept Radiat Oncol, Harbin, Heilongjiang, Peoples R China.	xuxxyy@sohu.com						Akashi Y, 2008, BRIT J CANCER, V98, P749, DOI 10.1038/sj.bjc.6604222; Basavaraj C, 2010, CANCER BIOL THER, V10, P673, DOI 10.4161/cbt.10.7.12793; Blumenschein GR, 2011, J CLIN ONCOL, V29, P2312, DOI 10.1200/JCO.2010.31.7875; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Boland W, 2010, BIOL-TARGETS THER, V4, P289, DOI 10.2147/BTT.S8617; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Burtness B, 2005, J CLIN ONCOL, V23, P8646, DOI 10.1200/JCO.2005.02.4646; Chen DJ, 2007, CLIN CANCER RES, V13, P6555, DOI 10.1158/1078-0432.CCR-07-1610; Chinnaiyan P, 2005, CANCER RES, V65, P3328, DOI 10.1158/0008-5472.CAN-04-3547; Crombet-Ramos T, 2002, INT J CANCER, V101, P567, DOI 10.1002/ijc.10647; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; Dittmann K, 2005, RADIOTHER ONCOL, V76, P157, DOI 10.1016/j.radonc.2005.06.022; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Garrido G, 2011, CANCER BIOL THER, V11, P373, DOI 10.4161/cbt.11.4.14097; Jensen AD, 2011, CANCER-AM CANCER SOC, V117, P2986, DOI 10.1002/cncr.25888; Miqueli AD, 2009, BRIT J CANCER, V100, P950, DOI 10.1038/sj.bjc.6604943; Rodriguez MO, 2010, CANCER BIOL THER, V9, P343, DOI 10.4161/cbt.9.5.10981; Raben D, 2005, CLIN CANCER RES, V11, P795; Ramakrishnan MS, 2009, MABS-AUSTIN, V1, P41, DOI 10.4161/mabs.1.1.7509; Reade CA, 2009, BIOL-TARGETS THER, V3, P215; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Tanaka T, 2008, CLIN CANCER RES, V14, P1266, DOI 10.1158/1078-0432.CCR-07-1606; Toulany M, 2006, CLIN CANCER RES, V12, P4119, DOI 10.1158/1078-0432.CCR-05-2454; Verheij M, 2010, DRUG RESIST UPDATE, V13, P29, DOI 10.1016/j.drup.2010.01.002; Zhuang HQ, 2009, CANCER SCI, V100, P1520, DOI 10.1111/j.1349-7006.2009.01190.x	25	40	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e70727	10.1371/journal.pone.0070727	http://dx.doi.org/10.1371/journal.pone.0070727			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23976954	Green Published, Green Submitted, gold			2022-12-25	WOS:000323570200006
J	Fernandez-Alvira, JM; te Velde, SJ; Jimenez-Pavon, D; Manios, Y; Singh, A; Moreno, LA; Brug, J				Fernandez-Alvira, Juan Miguel; te Velde, Saskia J.; Jimenez-Pavon, David; Manios, Yannis; Singh, Amika; Moreno, Luis A.; Brug, Johannes			Can Ethnic Background Differences in Children's Body Composition Be Explained by Differences in Energy Balance-Related Behaviors? A Mediation Analysis within the Energy-Project	PLOS ONE			English	Article							SUGAR-SWEETENED BEVERAGES; TEST-RETEST RELIABILITY; SHORT-SLEEP DURATION; PHYSICAL-ACTIVITY; CHILDHOOD OBESITY; WEIGHT STATUS; SOCIOECONOMIC-STATUS; PRESCHOOL-CHILDREN; CONSTRUCT-VALIDITY; PARENTAL EDUCATION	Background: In affluent countries, children from non-native ethnicity have in general less favourable body composition indicators and energy balance-related behaviors (EBRBs) than children from native ethnicity. However, differences between countries have been reported. Methodology/Principal Findings: A school-based survey among 10-12 years old children was conducted in seven European countries with a standardized protocol. Weight, height and waist circumference were measured; engagement in EBRBs was self-reported. For those countries with significant ethnic differences in body composition (Greece and the Netherlands), multilevel mediation analyses were conducted, to test the mediating effect of the EBRBs in the association between ethnic background and body composition indicators. Analyses were adjusted for gender and age, and for parental education in a later step. Partial mediation was found for sugared drinks intake and sleep duration in the Greek sample, and breakfast in the Dutch sample. A suppression effect was found for engagement in sports activites in the Greek sample. Conclusions/Significance: Ethnic differences in children's body composition were partially mediated by differences in breakfast skipping in the Netherlands and sugared drinks intake, sports participation and sleep duration in Greece.	[Fernandez-Alvira, Juan Miguel; te Velde, Saskia J.; Singh, Amika; Brug, Johannes] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Fernandez-Alvira, Juan Miguel; Jimenez-Pavon, David; Moreno, Luis A.] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Fernandez-Alvira, Juan Miguel; Jimenez-Pavon, David; Moreno, Luis A.] Univ Zaragoza, Fac Hlth Sci, GENUD Growth Exercise Nutr & Development Res Grp, Zaragoza, Spain; [Manios, Yannis] Harokopio Univ, Dept Nutr & Dietet, Athens, Greece	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Zaragoza; Harokopio University Athens	Fernandez-Alvira, JM (corresponding author), Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.	juanfdez@unizar.es	Jiménez-Pavón, David/AAA-2970-2020; Moreno, Luis/S-1780-2019; Manios, Yannis/AAM-8953-2021; Fernández-Alvira, Juan Miguel/O-9665-2019; Jiménez-Pavón, David/M-9005-2015; Brug, Johannes/A-8242-2018	Jiménez-Pavón, David/0000-0002-8977-4744; Moreno, Luis/0000-0003-0454-653X; Manios, Yannis/0000-0001-6486-114X; Jiménez-Pavón, David/0000-0002-8977-4744; Brug, Johannes/0000-0002-1904-7349; Fernandez-Alvira, Juan Miguel/0000-0002-4145-5103; te Velde, Saskia/0000-0002-4674-8052	Seventh Framework Programme (CORDIS FP7) of the European Commision, HEALTH [FP7-HEALTH-2007-B]; Spanish Ministry of Science and Innovation [JCI-2010-07055]	Seventh Framework Programme (CORDIS FP7) of the European Commision, HEALTH; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The ENERGY-project is funded by the Seventh Framework Programme (CORDIS FP7) of the European Commision, HEALTH (FP7-HEALTH-2007-B). The content of this article reflects only the authors' views and the European Community is not liable for any use that may be made of the information contained therein. This analysis was also supported by a grant in the Spanish Ministry of Science and Innovation (JCI-2010-07055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SE, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-366; Brug J, 2012, PEDIATR OBES, V7, P399, DOI 10.1111/j.2047-6310.2012.00067.x; Brug J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034742; Brug J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-276; Caperchione CM, 2009, SPORTS MED, V39, P167, DOI 10.2165/00007256-200939030-00001; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Caprio S, 2008, OBESITY, V16, P2566, DOI 10.1038/oby.2008.398; Cattaneo A, 2010, OBES REV, V11, P389, DOI 10.1111/j.1467-789X.2009.00639.x; Cerin E, 2009, PUBLIC HEALTH NUTR, V12, P1182, DOI 10.1017/S1368980008003649; de Ruyter JC, 2012, NEW ENGL J MED, V367, P1397, DOI 10.1056/NEJMoa1203034; de Wilde JA, 2009, ARCH DIS CHILD, V94, P795, DOI 10.1136/adc.2009.163709; Delva J, 2006, J ADOLESCENT HEALTH, V39, P536, DOI 10.1016/j.jadohealth.2006.02.013; Douthwaite W, 2012, IDENTIFYING MOST IMP; Fredriks AM, 2005, ACTA PAEDIATR, V94, P496, DOI [10.1080/08035250410024240, 10.1111/j.1651-2227.2005.tb01923.x]; Garaulet M, 2011, INT J OBESITY, V35, P1308, DOI 10.1038/ijo.2011.149; Harding S, 2008, INT J EPIDEMIOL, V37, P162, DOI 10.1093/ije/dym252; Brodersen NH, 2007, BRIT J SPORT MED, V41, P140, DOI 10.1136/bjsm.2006.031138; Hense S, 2011, SLEEP, V34, P633, DOI 10.1093/sleep/34.5.633; Jansen W, 2010, J HUM NUTR DIET, V23, P85, DOI 10.1111/j.1365-277X.2009.01027.x; Jimenez-Pavon D, 2012, PREV MED, V55, P310, DOI 10.1016/j.ypmed.2012.07.011; Lamerz A, 2005, INT J OBESITY, V29, P373, DOI 10.1038/sj.ijo.0802914; Livingstone MBE, 2004, BRIT J NUTR, V92, pS213, DOI 10.1079/BJN20041169; Lobstein T, 2003, Obes Rev, V4, P195, DOI 10.1046/j.1467-789X.2003.00116.x; MacKinnon D.P., 2012, INTRO STAT MEDIATION; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Malik VS, 2006, AM J CLIN NUTR, V84, P274; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Mont Giorgia, 2011, Acta Biomed, V82, P132; Muthen L. K., 2011, MPLUS USERS GUIDE; Saxena S, 2004, ARCH DIS CHILD, V89, P30; Schokker DF, 2007, OBES REV, V8, P101, DOI 10.1111/j.1467-789X.2006.00273.x; Sichert-Hellert W, 2011, PUBLIC HEALTH NUTR, V14, P2083, DOI 10.1017/S1368980011001352; Singh Amika S, 2012, BMC Res Notes, V5, P434, DOI 10.1186/1756-0500-5-434; Singh AS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-136; Singh GK, 2010, ANN EPIDEMIOL, V20, P40, DOI 10.1016/j.annepidem.2009.09.008; Singh R, 2009, AM J CLIN NUTR, V89, P1744, DOI 10.3945/ajcn.2008.26752; Szajewska H, 2010, CRIT REV FOOD SCI, V50, P113, DOI 10.1080/10408390903467514; Taveras EM, 2010, PEDIATRICS, V125, P686, DOI 10.1542/peds.2009-2100; van der Horst K, 2009, INT J PEDIATR OBES, V4, P371, DOI 10.3109/17477160902953066; van Stralen MM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-65; Wang YF, 2001, INT J EPIDEMIOL, V30, P1129, DOI 10.1093/ije/30.5.1129; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Whitaker RC, 2006, ARCH PEDIAT ADOL MED, V160, P578, DOI 10.1001/archpedi.160.6.578	43	4	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71848	10.1371/journal.pone.0071848	http://dx.doi.org/10.1371/journal.pone.0071848			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967254	Green Published, Green Submitted, gold			2022-12-25	WOS:000323378000071
J	Kondeti, V; Duah, E; Al-Azzam, N; Thodeti, CK; Boyce, JA; Paruchuri, S				Kondeti, Vinay; Duah, Ernest; Al-Azzam, Nosayba; Thodeti, Charles K.; Boyce, Joshua A.; Paruchuri, Sailaja			Differential Regulation of Cysteinyl Leukotriene Receptor Signaling by Protein Kinase C in Human Mast Cells	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; ASTHMATIC SUBJECTS; PULMONARY INFLAMMATION; EXPRESSION; RESPONSES; ACTIVATION; HYPERRESPONSIVENESS; DESENSITIZATION; PROLIFERATION; ANTAGONIST	Cysteinyl leukotrienes (cys-LTs) are a group of lipid mediators that are potent bronchoconstrictors, powerful inducers of vascular leakage and potentiators of airway hyperresponsiveness. Cys-LTs play an essential role in asthma and are synthesized as well as activated in mast cells (MCs). Cys-LTs relay their effects mainly through two known GPCRs, CysLT(1)R and CysLT(2)R. Although protein kinase C (PKC) isoforms are implicated in the regulation of CysLT(1)R function, neither the role of PKCs in cys-LT-dependent MC inflammatory signaling nor the involvement of specific isoforms in MC function are known. Here, we show that PKC inhibition augmented LTD4 and LTE4-induced calcium influx through CysLT(1)R in MCs. In contrast, inhibition of PKCs suppressed c-fos expression as well MIP1 beta generation by cys-LTs. Interestingly, cys-LTs activated both PKC alpha and PKC epsilon isoforms in MC. However, knockdown of PKC alpha augmented cys-LT mediated calcium flux, while knockdown of PKC epsilon attenuated cys-LT induced c-fos expression and MIP1 beta generation. Taken together, these results demonstrate for the first time that cys-LT signaling downstream of CysLT(1)R in MCs is differentially regulated by two distinct PKCs which modulate inflammatory signals that have significant pathobiologic implications in allergic reactions and asthma pathology.	[Kondeti, Vinay; Duah, Ernest; Al-Azzam, Nosayba; Paruchuri, Sailaja] Univ Akron, Dept Chem, Akron, OH 44325 USA; [Thodeti, Charles K.] Northeast Ohio Med Univ, Dept Integrat Med Sci, Rootstown, OH USA; [Boyce, Joshua A.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Boyce, Joshua A.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Boyce, Joshua A.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Jeff & Penny Vinik Ctr Allerg Dis Res, Boston, MA 02115 USA	University System of Ohio; University of Akron; Northeast Ohio Medical University (NEOMED); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Paruchuri, S (corresponding author), Univ Akron, Dept Chem, Akron, OH 44325 USA.	sp97@uakron.edu	Duah, Ernest/I-5985-2019; kondeti, vinay kumar/C-3171-2012	Duah, Ernest/0000-0002-5125-0830; 	National Institutes of Health [HL098953, AI-52353]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL098953, R01HL117945, K99HL098953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI052353, R37AI052353, R01AI052353] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by National Institutes of Health Grants HL098953 and AI-52353, and by James Foght Assistant Professor support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman LC, 1998, J ALLERGY CLIN IMMUN, V102, P50, DOI 10.1016/S0091-6749(98)70054-5; Austen KF, 2009, J ALLERGY CLIN IMMUN, V124, P406, DOI 10.1016/j.jaci.2009.05.046; Bandeira-Melo C, 2002, J EXP MED, V196, P841, DOI 10.1084/jem.20020516; Beller TC, 2004, J BIOL CHEM, V279, P46129, DOI 10.1074/jbc.M407057200; Beller TC, 2004, P NATL ACAD SCI USA, V101, P3047, DOI 10.1073/pnas.0400235101; Boyce JA, 2003, J ALLERGY CLIN IMMUN, V111, P24, DOI 10.1067/mai.2003.60; CHRISTIE PE, 1992, AM REV RESPIR DIS, V146, P1506, DOI 10.1164/ajrccm/146.6.1506; DAVIDSON AB, 1987, AM REV RESPIR DIS, V135, P333; Deshpande DA, 2007, FASEB J, V21, P2335, DOI 10.1096/fj.06-8060com; DRAZEN JM, 1992, AM REV RESPIR DIS, V146, P104, DOI 10.1164/ajrccm/146.1.104; DRAZEN JM, 1987, AM REV RESPIR DIS, V136, P985, DOI 10.1164/ajrccm/136.4.985; Gurish MF, 2006, J ALLERGY CLIN IMMUN, V117, P1285, DOI 10.1016/j.jaci.2006.04.017; Hamilton A, 1998, J ALLERGY CLIN IMMUN, V102, P177, DOI 10.1016/S0091-6749(98)70083-1; Heise CE, 2000, J BIOL CHEM, V275, P30531, DOI 10.1074/jbc.M003490200; Israel E, 1996, JAMA-J AM MED ASSOC, V275, P931, DOI 10.1001/jama.275.12.931; Jaken S, 2000, BIOESSAYS, V22, P245, DOI 10.1002/(SICI)1521-1878(200003)22:3<245::AID-BIES6>3.0.CO;2-X; Jiang YF, 2006, J IMMUNOL, V177, P2755, DOI 10.4049/jimmunol.177.5.2755; Kanaoka Y, 2004, J IMMUNOL, V173, P1503, DOI 10.4049/jimmunol.173.3.1503; Kim DC, 2006, J IMMUNOL, V176, P4440, DOI 10.4049/jimmunol.176.7.4440; Kirshenbaum AS, 2003, LEUKEMIA RES, V27, P677, DOI 10.1016/S0145-2126(02)00343-0; Laidlaw TM, 2012, CLIN EXP ALLERGY, V42, P1313, DOI 10.1111/j.1365-2222.2012.03982.x; Lynch KR, 1999, NATURE, V399, P789; Maekawa A, 2008, P NATL ACAD SCI USA, V105, P16695, DOI 10.1073/pnas.0808993105; Mellor EA, 2003, P NATL ACAD SCI USA, V100, P11589, DOI 10.1073/pnas.2034927100; Mellor EA, 2002, J EXP MED, V195, P583, DOI 10.1084/jem.20020044; Mellor EA, 2001, P NATL ACAD SCI USA, V98, P7964, DOI 10.1073/pnas.141221498; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Naik S, 2005, J BIOL CHEM, V280, P8722, DOI 10.1074/jbc.M413014200; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; Ng SW, 2012, NATURE, V482, P111, DOI 10.1038/nature10731; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Ochi H, 1999, J EXP MED, V190, P267, DOI 10.1084/jem.190.2.267; Paruchuri S, 2003, J BIOL CHEM, V278, P45577, DOI 10.1074/jbc.M302881200; Paruchuri S, 2002, J CELL SCI, V115, P1883; Paruchuri S, 2008, J BIOL CHEM, V283, P16477, DOI 10.1074/jbc.M705822200; Paruchuri S, 2009, J EXP MED, V206, P2543, DOI 10.1084/jem.20091240; Rius M, 2008, J PHARMACOL EXP THER, V324, P86, DOI 10.1124/jpet.107.131342; Thodeti CK, 2001, EXP CELL RES, V262, P95, DOI 10.1006/excr.2000.5077; Thompson C, 2006, AM J RESP CELL MOL, V35, P697, DOI 10.1165/rcmb.2005-0407OC; VEGESNA RVK, 1988, MOL PHARMACOL, V33, P537; VEGESNA RVK, 1988, EUR J PHARMACOL, V147, P387, DOI 10.1016/0014-2999(88)90173-2; Wedemeyer J, 2000, CURR OPIN IMMUNOL, V12, P624, DOI 10.1016/S0952-7915(00)00154-0; WENZEL SE, 1990, AM REV RESPIR DIS, V142, P112, DOI 10.1164/ajrccm/142.1.112; WINKLER JD, 1990, CELL SIGNAL, V2, P427, DOI 10.1016/0898-6568(90)90039-D	44	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71536	10.1371/journal.pone.0071536	http://dx.doi.org/10.1371/journal.pone.0071536			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977066	Green Submitted, Green Published, gold			2022-12-25	WOS:000323378000056
J	Li, DK; Tisdale, S; Espinoza-Derout, J; Saieva, L; Lotti, F; Pellizzoni, L				Li, Darrick K.; Tisdale, Sarah; Espinoza-Derout, Jorge; Saieva, Luciano; Lotti, Francesco; Pellizzoni, Livio			A Cell System for Phenotypic Screening of Modifiers of SMN2 Gene Expression and Function	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; MOTOR-NEURON PROTEIN; VALPROIC ACID INCREASES; MOUSE MODEL; LENTIVIRUS VECTOR; SURVIVAL; IDENTIFICATION; DEFICIENCY; COMPLEX; POMBE	Spinal muscular atrophy (SMA) is an inherited neurodegenerative disease caused by homozygous inactivation of the SMN1 gene and reduced levels of the survival motor neuron (SMN) protein. Since higher copy numbers of the nearly identical SMN2 gene reduce disease severity, to date most efforts to develop a therapy for SMA have focused on enhancing SMN expression. Identification of alternative therapeutic approaches has partly been hindered by limited knowledge of potential targets and the lack of cell-based screening assays that serve as readouts of SMN function. Here, we established a cell system in which proliferation of cultured mouse fibroblasts is dependent on functional SMN produced from the SMN2 gene. To do so, we introduced the entire human SMN2 gene into NIH3T3 cell lines in which regulated knockdown of endogenous mouse Smn severely decreases cell proliferation. We found that low SMN2 copy number has modest effects on the cell proliferation phenotype induced by Smn depletion, while high SMN2 copy number is strongly protective. Additionally, cell proliferation correlates with the level of SMN activity in small nuclear ribonucleoprotein assembly. Following miniaturization into a high-throughput format, our cell-based phenotypic assay accurately measures the beneficial effects of both pharmacological and genetic treatments leading to SMN upregulation. This cell model provides a novel platform for phenotypic screening of modifiers of SMN2 gene expression and function that act through multiple mechanisms, and a powerful new tool for studies of SMN biology and SMA therapeutic development.	[Li, Darrick K.; Tisdale, Sarah; Espinoza-Derout, Jorge; Saieva, Luciano; Lotti, Francesco; Pellizzoni, Livio] Columbia Univ, Ctr Motor Neuron Biol & Dis, New York, NY 10027 USA; [Li, Darrick K.; Tisdale, Sarah; Espinoza-Derout, Jorge; Saieva, Luciano; Lotti, Francesco; Pellizzoni, Livio] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA	Columbia University; Columbia University	Pellizzoni, L (corresponding author), Columbia Univ, Ctr Motor Neuron Biol & Dis, New York, NY 10027 USA.	lp2284@columbia.edu	Lotti, Francesco/AAC-3186-2019	Pellizzoni, Livio/0000-0002-9168-5628	NIH-NINDS [R01NS069601, R21NS071092]; DoD [W81XWH-10-1-0126]; SMA Foundation; Ruth L. Kirschstein National Research Service Award [F31NS079002]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069601, F31NS079002, R21NS071092] Funding Source: NIH RePORTER	NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DoD(United States Department of Defense); SMA Foundation; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from NIH-NINDS R01NS069601 and R21NS071092 (LP), DoD W81XWH-10-1-0126 (LP) and SMA Foundation (LP). ST is the recipient of a Ruth L. Kirschstein National Research Service Award for Individual Predoctoral Fellows (F31NS079002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann B, 2013, HUM MOL GENET, V22, P1328, DOI 10.1093/hmg/dds540; Akten B, 2011, P NATL ACAD SCI USA, V108, P10337, DOI 10.1073/pnas.1104928108; Avila AM, 2007, J CLIN INVEST, V117, P659, DOI 10.1172/JCI29562; Battle DJ, 2006, COLD SPRING HARB SYM, V71, P313, DOI 10.1101/sqb.2006.71.001; Bowerman M, 2010, HUM MOL GENET, V19, P1468, DOI 10.1093/hmg/ddq021; Brichta L, 2003, HUM MOL GENET, V12, P2481, DOI 10.1093/hmg/ddg256; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Burnett BG, 2009, MOL CELL BIOL, V29, P1107, DOI 10.1128/MCB.01262-08; Butchbach MER, 2010, HUM MOL GENET, V19, P454, DOI 10.1093/hmg/ddp510; Carissimi C, 2005, FEBS LETT, V579, P2348, DOI 10.1016/j.febslet.2005.03.034; Carissimi C, 2006, J BIOL CHEM, V281, P37009, DOI 10.1074/jbc.M607505200; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Cherry JJ, 2012, J BIOMOL SCREEN, V17, P481, DOI 10.1177/1087057111431605; Cho SC, 2010, GENE DEV, V24, P438, DOI 10.1101/gad.1884910; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; Dominguez E, 2011, HUM MOL GENET, V20, P681, DOI 10.1093/hmg/ddq514; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Foust KD, 2010, NAT BIOTECHNOL, V28, P271, DOI 10.1038/nbt.1610; Gabanella F, 2005, HUM MOL GENET, V14, P3629, DOI 10.1093/hmg/ddi390; Gabanella F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000921; Gogliotti RG, 2013, HUM MOL GENET; Grimmler M, 2005, EMBO REP, V6, P70, DOI 10.1038/sj.embor.7400301; Hannus S, 2000, HUM MOL GENET, V9, P663, DOI 10.1093/hmg/9.5.663; Hao LT, 2012, J NEUROSCI, V32, P5074, DOI 10.1523/JNEUROSCI.5808-11.2012; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Imlach WL, 2012, CELL, V151, P427, DOI 10.1016/j.cell.2012.09.011; Jarecki J, 2005, HUM MOL GENET, V14, P2003, DOI 10.1093/hmg/ddi205; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lorson CL, 2000, HUM MOL GENET, V9, P259, DOI 10.1093/hmg/9.2.259; Lorson MA, 2012, FUTURE MED CHEM, V4, P2067, DOI [10.4155/FMC.12.131, 10.4155/fmc.12.131]; Lotti F, 2012, CELL, V151, P440, DOI 10.1016/j.cell.2012.09.012; Lunn MR, 2008, LANCET, V371, P2120, DOI 10.1016/S0140-6736(08)60921-6; Lunn MR, 2004, CHEM BIOL, V11, P1489, DOI 10.1016/j.chembiol.2004.08.024; Makhortova NR, 2011, NAT CHEM BIOL, V7, P544, DOI [10.1038/NCHEMBIO.595, 10.1038/nchembio.595]; McAndrew PE, 1997, AM J HUM GENET, V60, P1411, DOI 10.1086/515465; Meister G, 2002, TRENDS CELL BIOL, V12, P472, DOI 10.1016/S0962-8924(02)02371-1; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Monani UR, 2005, NEURON, V48, P885, DOI 10.1016/j.neuron.2005.12.001; Neuenkirchen N, 2008, FEBS LETT, V582, P1997, DOI 10.1016/j.febslet.2008.03.009; Owen N, 2000, HUM MOL GENET, V9, P675, DOI 10.1093/hmg/9.5.675; Passini MA, 2011, TRENDS MOL MED, V17, P259, DOI 10.1016/j.molmed.2011.01.002; Passini MA, 2010, J CLIN INVEST, V120, P1253, DOI 10.1172/JCI41615; Paushkin S, 2000, J BIOL CHEM, V275, P23841, DOI 10.1074/jbc.M001441200; Pedrotti S, 2010, EMBO J, V29, P1235, DOI 10.1038/emboj.2010.19; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Pellizzoni L, 2007, EMBO REP, V8, P340, DOI 10.1038/sj.embor.7400941; Porensky PN, 2012, HUM MOL GENET, V21, P1625, DOI 10.1093/hmg/ddr600; Riessland M, 2010, HUM MOL GENET, V19, P1492, DOI 10.1093/hmg/ddq023; Rigo F, 2012, J CELL BIOL, V199, P21, DOI 10.1083/jcb.201207087; Ruggiu M, 2012, MOL CELL BIOL, V32, P126, DOI 10.1128/MCB.06077-11; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Singh J, 2008, ACS CHEM BIOL, V3, P711, DOI 10.1021/cb800120t; Sumner CJ, 2003, ANN NEUROL, V54, P647, DOI 10.1002/ana.10743; Tsai LK, 2008, J MOL MED, V86, P1243, DOI 10.1007/s00109-008-0388-1; Valori CF, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000830; Van Meerbeke JP, 2011, DISCOV MED, V12, P291; Van Meerbeke JP, 2013, HUM MOL GENET; Wang J, 2001, J BIOL CHEM, V276, P9599, DOI 10.1074/jbc.M009162200; Winkler C, 2005, GENE DEV, V19, P2320, DOI 10.1101/gad.342005; Wishart TM, 2010, HUM MOL GENET, V19, P4216, DOI 10.1093/hmg/ddq340; Workman E, 2009, HUM MOL GENET, V18, P2215, DOI 10.1093/hmg/ddp157; Xiao JB, 2011, J MED CHEM, V54, P6215, DOI 10.1021/jm200497t; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	69	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71965	10.1371/journal.pone.0071965	http://dx.doi.org/10.1371/journal.pone.0071965			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967270	gold, Green Published, Green Submitted			2022-12-25	WOS:000323378000075
J	Pan, WC; Kile, ML; Seow, WJ; Lin, XH; Quamruzzaman, Q; Rahman, M; Mahiuddin, G; Mostofa, G; Lu, Q; Christiani, DC				Pan, Wen-Chi; Kile, Molly L.; Seow, Wei Jie; Lin, Xihong; Quamruzzaman, Quazi; Rahman, Mahmuder; Mahiuddin, Golam; Mostofa, Golam; Lu, Quan; Christiani, David C.			Genetic Susceptible Locus in NOTCH2 Interacts with Arsenic in Drinking Water on Risk of Type 2 Diabetes	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; STIMULATED INSULIN-SECRETION; SKIN-LESIONS; TRIVALENT ARSENICALS; GLUCOSE-UPTAKE; MEAT INTAKE; EXPOSURE; PREVALENCE; MELLITUS; POLYMORPHISMS	Background: Chronic exposure to arsenic in drinking water is associated with increased risk of type 2 diabetes mellitus (T2DM) but the underlying molecular mechanism remains unclear. Objectives: This study evaluated the interaction between single nucleotide polymorphisms (SNPs) in genes associated with diabetes and arsenic exposure in drinking water on the risk of developing T2DM. Methods: In 2009-2011, we conducted a follow up study of 957 Bangladeshi adults who participated in a case-control study of arsenic-induced skin lesions in 2001-2003. Logistic regression models were used to evaluate the association between 38 SNPs in 18 genes and risk of T2DM measured at follow up. T2DM was defined as having a blood hemoglobin A1C level greater than or equal to 6.5% at follow-up. Arsenic exposure was characterized by drinking water samples collected from participants' tubewells. False discovery rates were applied in the analysis to control for multiple comparisons. Results: Median arsenic levels in 2001-2003 were higher among diabetic participants compared with non-diabetic ones (71.6 mu g/L vs. 12.5 mu g/L, p-value <0.001). Three SNPs in ADAMTS9 were nominally associated with increased risk of T2DM (rs17070905, Odds Ratio (OR) = 2.30, 95% confidence interval (CI) 1.17-4.50; rs17070967, OR = 2.02, 95% CI 1.00-4.06; rs6766801, OR = 2.33, 95% CI 1.18-4.60), but these associations did not reach the statistical significance after adjusting for multiple comparisons. A significant interaction between arsenic and NOTCH2 (rs699780) was observed which significantly increased the risk of T2DM (p for interaction = 0.003; q-value = 0.021). Further restricted analysis among participants exposed to water arsenic of less than 148 mu g/L showed consistent results for interaction between the NOTCH2 variant and arsenic exposure on T2DM (p for interaction = 0.048; q-value = 0.004). Conclusions: These findings suggest that genetic variation in NOTCH2 increased susceptibility to T2DM among people exposed to inorganic arsenic. Additionally, genetic variants in ADAMTS9 may increase the risk of T2DM.	[Pan, Wen-Chi; Seow, Wei Jie; Lu, Quan; Christiani, David C.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Kile, Molly L.] Oregon State Univ, Dept Publ Hlth, Coll Publ Hlth & Human Sci, Corvallis, OR 97331 USA; [Lin, Xihong] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Quamruzzaman, Quazi; Rahman, Mahmuder; Mahiuddin, Golam; Mostofa, Golam] Dhaka Community Hosp, Dept Environm Res, Dhaka, Bangladesh; [Lu, Quan] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Oregon State University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Christiani, DC (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.	dchris@hsph.harvard.edu		Pan, Wen-Chi/0000-0002-0588-8083	Harvard School of Public Health (Gene and Environment Initiative grant); U.S.A. National Institute of Environmental Health Sciences [P42ES016454, K01ES017800, RO1ES011622, R01ES022230, P30ES000002]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES022230, P42ES016454, R01ES011622, K01ES017800, P30ES000002] Funding Source: NIH RePORTER	Harvard School of Public Health (Gene and Environment Initiative grant); U.S.A. National Institute of Environmental Health Sciences; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Harvard School of Public Health (Gene and Environment Initiative grant) and U.S.A. National Institute of Environmental Health Sciences (P42ES016454, K01ES017800, RO1ES011622, R01ES022230, and P30ES000002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, Diabetes Care, V33 Suppl 1, pS4, DOI 10.2337/dc10-S004; [Anonymous], 2012, PHENOTYPE GENOTYPEIN; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Breton CV, 2007, CARCINOGENESIS, V28, P1520, DOI 10.1093/carcin/bgm063; CDC, 2011, 2011 NAT DIS FACT SH; Diaz-Villasenor A, 2008, TOXICOL APPL PHARM, V231, P291, DOI 10.1016/j.taap.2008.05.018; Diaz-Villasenor A, 2006, TOXICOL APPL PHARM, V214, P30, DOI 10.1016/j.taap.2005.11.015; Douillet C, 2013, TOXICOL APPL PHARM, V267, P11, DOI 10.1016/j.taap.2012.12.007; Focazio M.J., 2000, USGS NUMBERED SERIES, V99-4279; Fu JQ, 2010, ENVIRON HEALTH PERSP, V118, P864, DOI 10.1289/ehp.0901608; Fung TT, 2004, ARCH INTERN MED, V164, P2235, DOI 10.1001/archinte.164.20.2235; Gamble MV, 2005, AM J CLIN NUTR, V81, P1372; Gribble MO, 2012, AM J EPIDEMIOL, V176, P865, DOI 10.1093/aje/kws153; Grontved A, 2011, JAMA-J AM MED ASSOC, V305, P2448, DOI 10.1001/jama.2011.812; Islam MR, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-38; James KA, 2013, ENVIRON RES, V123, P33, DOI 10.1016/j.envres.2013.02.005; Kim Y, 2011, SCI TOTAL ENVIRON, V409, P4054, DOI 10.1016/j.scitotenv.2011.06.003; Kozul CD, 2009, ENVIRON HEALTH PERSP, V117, P1108, DOI 10.1289/ehp.0800199; LAI MS, 1994, AM J EPIDEMIOL, V139, P484, DOI 10.1093/oxfordjournals.aje.a117031; Lindstrom E, 2011, ACTA OBSTET GYN SCAN, V90, P47, DOI 10.1111/j.1600-0412.2010.01014.x; McCarty KM, 2007, ENVIRON HEALTH PERSP, V115, P341, DOI 10.1289/ehp.9152; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Navas-Acien A, 2008, JAMA-J AM MED ASSOC, V300, P814, DOI 10.1001/jama.300.7.814; Navas-Acien A, 2009, EPIDEMIOLOGY, V20, P816, DOI 10.1097/EDE.0b013e3181afef88; Ogden CL, 2012, PREVALENCE OBESITY U; Oh RS, 2012, J BIOL CHEM, V287, P6025, DOI 10.1074/jbc.M111.311217; Paul DS, 2007, ENVIRON HEALTH PERSP, V115, P734, DOI 10.1289/ehp.9867; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rahman M, 1999, OCCUP ENVIRON MED, V56, P277, DOI 10.1136/oem.56.4.277; Rahman M, 1998, AM J EPIDEMIOL, V148, P198, DOI 10.1093/oxfordjournals.aje.a009624; Ravenscroft P., 2007, PREDICTION GLOBAL EX; Sakata-Yanagimoto M, 2012, CURR TOP MICROBIOL, V360, P151, DOI 10.1007/82_2012_235; Shamsabadi A., 2013, P 7 NAT SEISM C BRID, P1; Tseng CH, 2000, ENVIRON HEALTH PERSP, V108, P847, DOI 10.2307/3434992; van Dam RM, 2002, DIABETES CARE, V25, P417, DOI 10.2337/diacare.25.3.417; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Walton FS, 2004, TOXICOL APPL PHARM, V198, P424, DOI 10.1016/j.taap.2003.10.026; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002; Wu MM, 2003, ENVIRON HEALTH PERSP, V111, P1429, DOI 10.1289/ehp.6396; Xue P, 2011, BIOCHEM BIOPH RES CO, V407, P360, DOI 10.1016/j.bbrc.2011.03.024; Zhang Q, 2011, J BIOL CHEM	43	11	12	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e70792	10.1371/journal.pone.0070792	http://dx.doi.org/10.1371/journal.pone.0070792			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967108	gold, Green Submitted, Green Published			2022-12-25	WOS:000323221500032
J	Achanta, S; Jaju, J; Kumar, AMV; Nagaraja, SB; Shamrao, SRM; Bandi, SK; Kumar, A; Satyanarayana, S; Harries, AD; Nair, SA; Dewan, PK				Achanta, Shanta; Jaju, Jyoti; Kumar, Ajay M. V.; Nagaraja, Sharath Burugina; Shamrao, Srinivas Rao Motta; Bandi, Sasidhar Kumar; Kumar, Ashok; Satyanarayana, Srinath; Harries, Anthony David; Nair, Sreenivas Achutan; Dewan, Puneet K.			Tuberculosis Management Practices by Private Practitioners in Andhra Pradesh, India	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS	Setting: Private medical practitioners in Visakhapatnam district, Andhra Pradesh, India. Objectives: To evaluate self-reported TB diagnostic and treatment practices amongst private medical practitioners against benchmark practices articulated in the International Standards of Tuberculosis Care (ISTC), and factors associated with compliance with ISTC. Design: Cross-sectional survey using semi-structured interviews. Results: Of 296 randomly selected private practitioners, 201 (68%) were assessed for compliance to ISTC diagnostic and treatment standards in TB management. Only 11 (6%) followed a combination of 6 diagnostic standards together and only 1 followed a combination of all seven treatment standards together. There were 28 (14%) private practitioners who complied with a combination of three core ISTC (cough for tuberculosis suspects, sputum smear examination and use of standardized treatment). Higher ISTC compliance was associated with caring for more than 20 TB patients annually, prior sensitization to TB control guidelines, and practice of alternate systems of medicine. Conclusion: Few private practitioners in Visakhapatnam, India reported TB diagnostic and treatment practices that met ISTC. Better engagement of the private sector is urgently required to improve TB management practices and to prevent diagnostic delay and drug resistance.	[Achanta, Shanta; Jaju, Jyoti; Nagaraja, Sharath Burugina; Nair, Sreenivas Achutan; Dewan, Puneet K.] WHO, Country Off India, New Delhi, India; [Kumar, Ajay M. V.; Nagaraja, Sharath Burugina; Kumar, Ashok] Govt India, Minist Hlth & Family Welf, Directorate Gen Hlth Serv, Cent TB Div, New Delhi, India; [Shamrao, Srinivas Rao Motta] Govt Andhra Pradesh, Minist Hlth & Family Welf, Directorate Gen Hlth Serv, State TB Cell, Hyderabad, Andhra Pradesh, India; [Bandi, Sasidhar Kumar] Govt Andhra Pradesh, Minist Hlth & Family Welf, Directorate Gen Hlth Serv, Dist TB Ctr, Visakhapatnam, Andhra Pradesh, India; [Satyanarayana, Srinath] Int Union TB & Lung Dis Union, South East Asia Reg Off, New Delhi, India; [Harries, Anthony David] Int Union TB & Lung Dis Union, Paris, France	World Health Organization	Achanta, S (corresponding author), WHO, Country Off India, New Delhi, India.	AchantaS@rntcp.org	Nagaraja, Sharath Burugina/ABD-7748-2021; Nagaraja, Sharath Burugina/ABD-7238-2021	Nagaraja, Sharath Burugina/0000-0002-6599-5753; Nagaraja, Sharath Burugina/0000-0002-6599-5753; Nair, Sreenivas/0000-0002-2586-6797; Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531; Satyanarayana, Srinath/0000-0002-5420-2551	Union from Global Fund Round 9 India TB Project funds; WHO-India from USAID funds	Union from Global Fund Round 9 India TB Project funds; WHO-India from USAID funds(United States Agency for International Development (USAID)World Health Organization)	Funding support was provided in part by the Union from Global Fund Round 9 India TB Project funds and the rest by WHO-India from USAID funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljunid S, 1995, HEALTH POLICY PLANN, V10, P333, DOI 10.1093/heapol/10.4.333; [Anonymous], 2003, AM J RESP CRIT CARE, V167, P603; [Anonymous], 2011, WORLD HLTH ORG REP G, V2, P11; [Anonymous], 2003, ADHERENCE LONG TERM; Central TB, 2008, REV SCHEM NGOS PRIV; Chaulk CP, 1998, JAMA-J AM MED ASSOC, V279, P943, DOI 10.1001/jama.279.12.943; Das J, 2012, HEALTH AFFAIR, V31, P2774, DOI 10.1377/hlthaff.2011.1356; Datta Kisalay, 2010, Indian J Tuberc, V57, P199; Enarson D.A., 2000, MANAGEMENT TUBERCULO; Frieden TR, 2002, INT J EPIDEMIOL, V31, P894, DOI 10.1093/ije/31.5.894; HARRIES A, 2004, TOMANS TUBERCULOSIS, P61; Hazarika I, 2011, J GLOB INFECT DIS, V3, P19, DOI 10.4103/0974-777X.77291; IIPS and Macro International, 2007, NATL FAMILY HLTH SUR, V1; Koppaka R, 2004, TOMANS TUBERCULOSIS, P51; Leonard KL, 2007, HEALTH AFFAIR, V26, pW380, DOI 10.1377/hlthaff.26.3.w380; Luelmo F., 2004, TOMANS TUBERCULOSIS, P7; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Nagpaul DR, 1974, P 9 E REG TUB C 29 N; Pai M, 2008, PLOS MED, V5, P1043, DOI 10.1371/journal.pmed.0050156; Pope DS, 2003, INT J TUBERC LUNG D, V7, P611; Prasad R, 2003, INT J TUBERC LUNG D, V7, P52; Santha T, 2005, INT J TUBERC LUNG D, V9, P61; Santha T, 2004, TOMANS TUBERCULOSIS, P250; Satyanarayana S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024160; Singh AA, 2004, INT J TUBERC LUNG D, V8, P1255; Singla N, 1998, INT J TUBERC LUNG D, V2, P1005; Steingart KR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001062; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Suarez PG, 2001, J INFECT DIS, V184, P473, DOI 10.1086/322777; Swan M, 1997, PRIVATE PRACTITIONER; Tang SL, 2005, HEALTH POLICY, V72, P93, DOI 10.1016/j.healthpol.2004.06.009; Thakur J. S., 2006, Indian Journal of Tuberculosis, V53, P149; Tuberculosis Coalition for Technical Assistance, 2009, INT STAND TUB CAR IS; Udwadia ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012023; Uplekar M, 1998, INT J TUBERC LUNG D, V2, P324; UPLEKAR MW, 1991, TUBERCLE, V72, P284, DOI 10.1016/0041-3879(91)90055-W; Wells WA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018964; World Health Organization, 2000, MAN CHILD SER INF SE; World Health Organization, 2008, WHOHTMTB2008402; World Health Organization, 2003, HOCDSTB2003313; World Health Organization (WHO), 2009, WHOHTMTB2009420	41	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71119	10.1371/journal.pone.0071119	http://dx.doi.org/10.1371/journal.pone.0071119			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	201BN	23967158	Green Published, Green Submitted, gold			2022-12-25	WOS:000323115800038
J	Fox, A; Hung, TM; Wertheim, H; Hoa, LNM; Vincent, A; Lang, B; Waters, P; Ha, NH; Trung, NV; Farrar, J; Van Kinh, N; Horby, P				Fox, Annette; Than Manh Hung; Wertheim, Heiman; Le Nguyen Minh Hoa; Vincent, Angela; Lang, Bethan; Waters, Patrick; Nguyen Hong Ha; Nguyen Vu Trung; Farrar, Jeremy; Nguyen Van Kinh; Horby, Peter			Acute Measles Encephalitis in Partially Vaccinated Adults	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ACUTE DISSEMINATED ENCEPHALOMYELITIS; REGULATORY T-CELLS; VIRUS INFECTION; MESSENGER-RNA; AUTOANTIBODIES; ANTIBODY; PROTEIN; CNS; EPIDEMIOLOGY	Background: The pathogenesis of acute measles encephalitis (AME) is poorly understood. Treatment with immune-modulators is based on theories that post-infectious autoimmune responses cause demyelination. The clinical course and immunological parameters of AME were examined during an outbreak in Vietnam. Methods and Findings: Fifteen measles IgM-positive patients with confusion or Glasgow Coma Scale (GCS) score below 13, and thirteen with uncomplicated measles were enrolled from 2008-2010. Standardized clinical exams were performed and blood collected for lymphocyte and measles-and auto-antibody analysis. The median age of AME patients was 21 years, similar to controls. Eleven reported receiving measles vaccination when aged one year. Confusion developed a median of 4 days after rash. Six patients had GCS <8 and four required mechanical ventilation. CSF showed pleocytosis (64%) and proteinorrhachia (71%) but measles virus RNA was not detected. MRI revealed bilateral lesions in the cerebellum and brain stem in some patients. Most received dexamethasone +/- IVIG within 4 days of admission but symptoms persisted for >= 3 weeks in five. The concentration of voltage gated calcium channel-complex-reactive antibodies was 900 pM in one patient, and declined to 609 pM similar to 3 months later. Measles-reactive IgG antibody avidity was high in AME patients born after vaccine coverage exceeded 50% (similar to 25 years earlier). AME patients had low CD4 (218/mu l, p = 0.029) and CD8 (200/mu l, p = 0.012) T-cell counts compared to controls. Conclusion: Young adults presenting with AME in Vietnam reported a history of one prior measles immunization, and those aged <25 years had high measles-reactive IgG avidity indicative of prior vaccination. This suggests that one-dose measles immunization is not sufficient to prevent AME in young adults and reinforces the importance of maintaining high coverage with a two-dose measles immunization schedule. Treatment with corticosteroids and IVIG is common practice, and should be assessed in randomized clinical trials.	[Fox, Annette; Wertheim, Heiman; Le Nguyen Minh Hoa; Farrar, Jeremy; Horby, Peter] Univ Oxford, Wellcome Trust Major Overseas Programme, Clin Res Unit, Ho Chi Minh City, Vietnam; [Fox, Annette; Wertheim, Heiman; Le Nguyen Minh Hoa; Farrar, Jeremy; Horby, Peter] Univ Oxford, Wellcome Trust Major Overseas Programme, Clin Res Unit, Hanoi, Vietnam; [Fox, Annette; Wertheim, Heiman; Farrar, Jeremy; Horby, Peter] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Than Manh Hung; Nguyen Hong Ha; Nguyen Vu Trung; Nguyen Van Kinh] Natl Hosp Trop Dis, Hanoi, Vietnam; [Vincent, Angela; Lang, Bethan; Waters, Patrick] Univ Oxford, John Radcliffe Hosp, Dept Clin Neurol, Neurosci Grp, Oxford OX3 9DU, England	University of Oxford; University of Oxford; University of Oxford; National Hospital of Tropical Diseases; University of Oxford	Fox, A (corresponding author), Univ Oxford, Wellcome Trust Major Overseas Programme, Clin Res Unit, Ho Chi Minh City, Vietnam.	afox@oucru.org	Farrar, Jeremy J./HGA-7610-2022; Waters, Patrick/AAF-2658-2019; Waters, Patrick/Y-3753-2019; Vincent, Angela/AAE-7310-2019; Wertheim, Heiman FL/F-3338-2016	Waters, Patrick/0000-0003-4142-2667; Waters, Patrick/0000-0003-4142-2667; Wertheim, Heiman FL/0000-0002-5003-5565; Fox, Annette/0000-0002-0565-7146; Horby, Peter/0000-0002-9822-1586; Farrar, Jeremy/0000-0002-2700-623X	South East Asian Infectious Diseases Clinical Research Network [69]; Wellcome Trust of Great Britain; European Union [223498]; Epilepsy Research UK [P1201] Funding Source: researchfish	South East Asian Infectious Diseases Clinical Research Network; Wellcome Trust of Great Britain(Wellcome Trust); European Union(European Commission); Epilepsy Research UK	This work was funded by the South East Asian Infectious Diseases Clinical Research Network (Jl Diponegoro no 69, Jakarta, Indonesia, 10430) and the Wellcome Trust of Great Britain. AF was supported by the European Union FP7 project "European Management Platform for Emerging and Re-emerging Infectious Disease Entities (EMPERIE)" (no. 223498). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JE, 1957, PEDIATRICS, V20, P87; Bellini WJ, 2005, J INFECT DIS, V192, P1686, DOI 10.1086/497169; BOE J, 1965, BRIT MED J, V1, P1094, DOI 10.1136/bmj.1.5442.1094; CHEN RT, 1990, J INFECT DIS, V162, P1036, DOI 10.1093/infdis/162.5.1036; El Mubarak HS, 2005, J CLIN VIROL, V32, P313, DOI 10.1016/j.jcv.2004.08.017; Feasby T, 2007, TRANSFUS MED REV, V21, pS57, DOI 10.1016/j.tmrv.2007.01.002; FORTHAL DN, 1992, J INFECT DIS, V166, P421, DOI 10.1093/infdis/166.2.421; Fox A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031535; FUJINAMI RS, 1985, SCIENCE, V230, P1043, DOI 10.1126/science.2414848; GENDELMAN HE, 1984, ANN NEUROL, V15, P353, DOI 10.1002/ana.410150409; GRIFFIN DE, 1994, J INFECT DIS, V170, pS24, DOI 10.1093/infdis/170.Supplement_1.S24; HANNINEN P, 1980, J CLIN MICROBIOL, V11, P610; Hansen KE, 1998, SEMIN ARTHRITIS RHEU, V27, P263, DOI 10.1016/S0049-0172(98)80047-4; Hickey WF, 2001, GLIA, V36, P118, DOI 10.1002/glia.1101; Hickman CJ, 2011, J INFECT DIS, V204, pS549, DOI 10.1093/infdis/jir106; HIRSCH RL, 1984, CLIN IMMUNOL IMMUNOP, V31, P1, DOI 10.1016/0090-1229(84)90184-3; Irani SR, 2011, ANN NEUROL, V69, P892, DOI 10.1002/ana.22307; Irani SR, 2010, BRAIN, V133, P2734, DOI 10.1093/brain/awq213; Irani SR, 2010, BRAIN, V133, P1655, DOI 10.1093/brain/awq113; JOHNSON RT, 1984, NEW ENGL J MED, V310, P137, DOI 10.1056/NEJM198401193100301; JOHNSON RT, 1987, J INFECT DIS, V155, P359, DOI 10.1093/infdis/155.3.359; Kastrup Oliver, 2005, NeuroRx, V2, P324, DOI 10.1602/neurorx.2.2.324; Katayama Y, 1998, J CLIN MICROBIOL, V36, P299, DOI 10.1128/JCM.36.1.299-301.1998; KATAYAMA Y, 1995, J GEN VIROL, V76, P3201, DOI 10.1099/0022-1317-76-12-3201; Khurana DS, 2005, PEDIATRICS, V116, P431, DOI 10.1542/peds.2004-2038; Lawrence DMP, 1999, J VIROL, V73, P1795, DOI 10.1128/JVI.73.3.1795-1801.1999; Lu ZQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022766; Marleau AM, 2005, J LEUKOCYTE BIOL, V78, P575, DOI 10.1189/jlb.0105050; Mayer MC, 2012, THER ADV NEUROL DISO, V5, P147, DOI 10.1177/1756285611433772; McKnight K, 2005, NEUROLOGY, V65, P1730, DOI 10.1212/01.wnl.0000187129.66353.13; Menge T, 2007, CURR OPIN NEUROL, V20, P247, DOI 10.1097/WCO.0b013e3280f31b45; MOENCH TR, 1988, J INFECT DIS, V158, P433, DOI 10.1093/infdis/158.2.433; Nakajima M, 2008, CLIN INFECT DIS, V47, P148, DOI 10.1086/588851; Narita M, 1996, CLIN DIAGN LAB IMMUN, V3, P211, DOI 10.1128/CDLI.3.2.211-215.1996; Nmor JC, 2011, INT J BIOL SCI, V7, P138, DOI 10.7150/ijbs.7.138; O'Connor KC, 2007, NAT MED, V13, P211, DOI 10.1038/nm1488; ODESSKY L, 1953, J PEDIATR-US, V43, P536, DOI 10.1016/S0022-3476(53)80330-6; Oglesbee M, 2011, FUTURE VIROL, V6, P85, DOI 10.2217/FVL.10.70; Perry Robert T., 2004, Journal of Infectious Diseases, V189, pS4, DOI 10.1086/377712; Pohl D, 2008, CURR OPIN NEUROL, V21, P366, DOI 10.1097/WCO.0b013e3282fd172b; Riddell MA, 2001, J CLIN MICROBIOL, V39, P375, DOI 10.1128/JCM.39.1.375-376.2001; RUCKLE G, 1957, J IMMUNOL, V78, P341; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Schneider-Schaulies J, 1999, J NEUROVIROL, V5, P613, DOI 10.3109/13550289909021290; Schutte CM, 1998, J INFECTION, V37, P112, DOI 10.1016/S0163-4453(98)80163-1; Sellin CI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004948; Shahar E, 2002, J CHILD NEUROL, V17, P810, DOI 10.1177/08830738020170111001; Sniadack DH, 2011, J INFECT DIS, V204, pS476, DOI 10.1093/infdis/jir092; Tunkel AR, 2008, CLIN INFECT DIS, V47, P303, DOI 10.1086/589747; Vincent A, 2011, LANCET NEUROL, V10, P759, DOI 10.1016/S1474-4422(11)70096-5; WARD BJ, 1991, CLIN IMMUNOL IMMUNOP, V61, P236, DOI 10.1016/S0090-1229(05)80027-3; Wolfson LJ, 2007, LANCET, V369, P191, DOI 10.1016/S0140-6736(07)60107-X; Young VA, 2009, CURR TOP MICROBIOL, V330, P3; Yu XL, 2008, J IMMUNOL, V181, P7356, DOI 10.4049/jimmunol.181.10.7356	54	12	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71671	10.1371/journal.pone.0071671	http://dx.doi.org/10.1371/journal.pone.0071671			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967232	gold, Green Published			2022-12-25	WOS:000323115800072
J	Miyagawa, M; Naito, T; Nishio, S; Kamatani, N; Usami, S				Miyagawa, Maiko; Naito, Takehiko; Nishio, Shin-ya; Kamatani, Naoyuki; Usami, Shin-ichi			Targeted Exon Sequencing Successfully Discovers Rare Causative Genes and Clarifies the Molecular Epidemiology of Japanese Deafness Patients	PLOS ONE			English	Article								Target exon resequencing using Massively Parallel DNA Sequencing (MPS) is a new powerful strategy to discover causative genes in rare Mendelian disorders such as deafness. We attempted to identify genomic variations responsible for deafness by massive sequencing of the exons of 112 target candidate genes. By the analysis of 216randomly selected Japanese deafness patients (120 early-onset and 96 late-detected), who had already been evaluated for common genes/mutations by Invader assay and of which 48 had already been diagnosed, we efficiently identified causative mutations and/or mutation candidates in 57 genes. Approximately 86.6% (187/216) of the patients had at least one mutation. Of the 187 patients, in 69 the etiology of the hearing loss was completely explained. To determine which genes have the greatest impact on deafness etiology, the number of mutations was counted, showing that those in GJB2 were exceptionally higher, followed by mutations in SLC26A4, USH2A, GPR98, MYO15A, COL4A5 and CDH23. The present data suggested that targeted exon sequencing of selected genes using the MPS technology followed by the appropriate filtering algorithm will be able to identify rare responsible genes including new candidate genes for individual patients with deafness, and improve molecular diagnosis. In addition, using a large number of patients, the present study clarified the molecular epidemiology of deafness in Japanese. GJB2 is the most prevalent causative gene, and the major (commonly found) gene mutations cause 30-40% of deafness while the remainder of hearing loss is the result of various rare genes/mutations that have been difficult to diagnose by the conventional one-by-one approach. In conclusion, target exon resequencing using MPS technology is a suitable method to discover common and rare causative genes for a highly heterogeneous monogenic disease like hearing loss.	[Miyagawa, Maiko; Naito, Takehiko; Nishio, Shin-ya; Usami, Shin-ichi] Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Asahi Ku, Matsumoto, Nagano 390, Japan; [Kamatani, Naoyuki] RIKEN, Lab Stat Anal, Kanagawa, Japan	Shinshu University; RIKEN	Usami, S (corresponding author), Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Asahi Ku, Matsumoto, Nagano 390, Japan.	usami@shinshu-u.ac.jp		Nishio, Shin-ya/0000-0001-6640-2297	Ministry of Education, Science and Culture of Japan; Ministry of Health, Labour and Welfare of Japan; Acute Profound Deafness Research Committee of the Ministry of Health, Labour and Welfare of Japan	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Acute Profound Deafness Research Committee of the Ministry of Health, Labour and Welfare of Japan	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan (http://www.mext.go.jp/english/) (SU), a Health and Labour Sciences Research Grant for Comprehensive Research on Disability Health and Welfare from the Ministry of Health, Labour and Welfare of Japan (SU), and by the Acute Profound Deafness Research Committee of the Ministry of Health, Labour and Welfare of Japan (SU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2003, AM J HUM GENET, V72, P73, DOI 10.1086/345398; Abe S, 2007, GENET TEST, V11, P333, DOI 10.1089/gte.2007.0002; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altmann A, 2011, BIOINFORMATICS, V27, pI77, DOI 10.1093/bioinformatics/btr205; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bonnet C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-21; Brownstein Z, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r89; De Keulenaer S, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-17; Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002; Kothiyal P, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-10; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin X, 2012, HEARING RES, V288, P67, DOI 10.1016/j.heares.2012.01.004; Majewski J, 2011, J MED GENET, V48, P580, DOI 10.1136/jmedgenet-2011-100223; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Reed R, 2000, CURR OPIN CELL BIOL, V12, P340, DOI 10.1016/S0955-0674(00)00097-1; Rehman AU, 2010, AM J HUM GENET, V86, P378, DOI 10.1016/j.ajhg.2010.01.030; Robinson PN, 2011, CLIN GENET, V80, P127, DOI 10.1111/j.1399-0004.2011.01713.x; Rodriguez-Paris J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011804; Schraders M, 2011, AM J HUM GENET, V88, P628, DOI 10.1016/j.ajhg.2011.04.012; Shearer AE, 2010, P NATL ACAD SCI USA, V107, P21104, DOI 10.1073/pnas.1012989107; Sheth N, 2006, NUCLEIC ACIDS RES, V34, P3955, DOI 10.1093/nar/gkl556; Tang WX, 2012, GENET TEST MOL BIOMA, V16, P536, DOI 10.1089/gtmb.2011.0187; Tsukada K, 2010, CLIN GENET, V78, P464, DOI 10.1111/j.1399-0004.2010.01407.x; Usami S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031276; Walsh T, 2010, AM J HUM GENET, V87, P90, DOI 10.1016/j.ajhg.2010.05.010	26	78	85	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71381	10.1371/journal.pone.0071381	http://dx.doi.org/10.1371/journal.pone.0071381			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967202	Green Published, Green Submitted, gold			2022-12-25	WOS:000323115800054
J	Tallet, A; Nault, JC; Renier, A; Hysi, I; Galateau-Salle, F; Cazes, A; Copin, MC; Hofman, P; Andujar, P; Le Pimpec-Barthes, F; Zucman-Rossi, J; Jaurand, MC; Jean, D				Tallet, A.; Nault, J-C; Renier, A.; Hysi, I.; Galateau-Salle, F.; Cazes, A.; Copin, M-C; Hofman, P.; Andujar, P.; Le Pimpec-Barthes, F.; Zucman-Rossi, J.; Jaurand, M-C; Jean, D.			Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma	ONCOGENE			English	Article						thoracic neoplasm; mesothelioma; asbestos; telomere; telomerase reverse transcriptase; mutation	INDUCED MURINE; TELOMERASE; SUPPRESSION; MECHANISMS; EXPRESSION; PROFILES; SUBUNIT; CELLS; BAP1	Malignant pleural mesothelioma (MPM) is a very aggressive tumor with no known curative treatment. Better knowledge of the molecular mechanisms of mesothelial carcinogenesis is required to develop new therapeutic strategies. MPM, like all cancer cells, needs to maintain telomere length to prevent senescence. Previous studies suggested that the telomere lengthening mechanism in MPM is based mainly on telomerase activity. For this reason, we focused on the key catalytic enzyme, TERT (telomerase reverse transcriptase), by analyzing its gene expression in MPM and by studying the mechanism underlying its upregulation. We used our large collection of MPM composed of 61 MPM in culture and 71 frozen MPM tumor samples. Evaluation of TERT mRNA expression by quantitative RT-PCR showed overexpression in MPM in culture compared with normal mesothelial cells, and in MPM tumor samples compared with normal pleura. We identified a 'hot spot' of mutations in the TERT gene core promoter in both MPM in culture and in MPM tumor samples with an overall frequency of 15%. Furthermore, data clearly identified mutation in the TERT promoter as a mechanism of TERT mRNA upregulation in MPM. In contrast, gene copy number amplification was not associated with TERT overexpression. Then, we analyzed the clinicopathological, etiological and genetic characteristics of MPM with mutations in the TERT promoter. TERT promoter mutations were more frequent in MPM with sarcomatoid histologic subtype (P<0.01), and they were frequently associated with CDKN2A gene inactivation (P = 0.03). In conclusion, a subgroup of MPM presents TERT promoter mutations, which lead to TERT mRNA upregulation. This is the first recurrent gain-of-function oncogenic mutations identified in MPM.	[Tallet, A.; Nault, J-C; Renier, A.; Le Pimpec-Barthes, F.; Zucman-Rossi, J.; Jaurand, M-C; Jean, D.] INSERM, UMR 674, IUH, F-75010 Paris, France; [Tallet, A.; Nault, J-C; Renier, A.; Le Pimpec-Barthes, F.; Zucman-Rossi, J.; Jaurand, M-C; Jean, D.] Univ Paris 05, Labex Immunooncol, Sorbonne Paris Cite, Fac Med, Paris, France; [Hysi, I.] CHRU Lille, Serv Chirurg Card, F-59037 Lille, France; [Galateau-Salle, F.] CHU Caen, Serv Anatomopathol, F-14000 Caen, France; [Galateau-Salle, F.] INSERM, U1086, Caen, France; [Cazes, A.] Hop Europeen Georges Pompidou, AP HP, GHU Ouest, Anat Pathol Lab, Paris, France; [Copin, M-C] Univ Lille 2, CHRU Lille, Inst Pathol, Ctr Biol Pathol, Lille, France; [Hofman, P.] CHU Nice, Hop Louis Pasteur, Lab Pathol Clin & LPCE & Biobanque Humaine, F-06202 Nice, France; [Andujar, P.] Ctr Hosp Intercommunal Creteil, Serv Pneumol & Pathol Profess, Creteil, France; [Andujar, P.] Hop Henri Mondor, INSERM, U955, Equipe 4, F-94010 Creteil, France; [Le Pimpec-Barthes, F.] Hop Europe Georges Pompidou, AP HP, GHU Ouest, Serv Chirurg Thorac, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; CHU de Caen NORMANDIE; Universite de Caen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; Universite de Lille; CHU Nice; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Jean, D (corresponding author), INSERM, UMR S 674, 27 Rue Juliette Dodu, F-75010 Paris, France.	didier.jean@inserm.fr	Hofman, Paul/P-7654-2018; Jean, Didier/A-1615-2009; j, zucman-rossi/AAV-3594-2021; Salle, Francoise BJ Galateau/J-1530-2015; JAURAND, MARIE-CLAUDE/S-3538-2017; Le+Pimpec-Barthes, Francoise/ABD-1300-2021; zucman-rossi, Jessica/B-5098-2009; Andujar, Pascal/A-2395-2013	Hofman, Paul/0000-0003-0431-9353; Jean, Didier/0000-0001-5823-7404; j, zucman-rossi/0000-0002-5687-0334; Salle, Francoise BJ Galateau/0000-0003-3642-0165; JAURAND, MARIE-CLAUDE/0000-0002-0915-6728; zucman-rossi, Jessica/0000-0002-5687-0334; Le Pimpec-Barthes, Francoise/0000-0001-6364-4813; nault, jean charles/0000-0002-4875-9353; Andujar, Pascal/0000-0002-9408-7033	INSERM; University of Paris-Descartes; French League against Cancer (Ligue Nationale Contre le Cancer); 'Carte d'Identite des Tumeurs' CIT1 program; 'Carte d'Identite des Tumeurs' CIT2 program; Chancellerie des Universite ' s de Paris (Legs POIX); Comite de l'Oise	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University of Paris-Descartes; French League against Cancer (Ligue Nationale Contre le Cancer); 'Carte d'Identite des Tumeurs' CIT1 program; 'Carte d'Identite des Tumeurs' CIT2 program; Chancellerie des Universite ' s de Paris (Legs POIX); Comite de l'Oise	This work was supported by funds and grants from INSERM, the University of Paris-Descartes, the French League against Cancer (Ligue Nationale Contre le Cancer, 'Carte d'Identite des Tumeurs' CIT1 and CIT2 programs and the Comite ' de l'Oise) and the Chancellerie des Universite ' s de Paris (Legs POIX).	Andujar P, 2013, MUTAGENESIS, V28, P323, DOI 10.1093/mutage/get008; Andujar P, 2010, LUNG CANCER, V67, P23, DOI 10.1016/j.lungcan.2009.03.018; Au AYM, 2011, LUNG CANCER, V73, P283, DOI 10.1016/j.lungcan.2010.12.023; Bazarov AV, 2010, AGING CELL, V9, P736, DOI 10.1111/j.1474-9726.2010.00599.x; Bott M, 2011, NAT GENET, V43, P668, DOI 10.1038/ng.855; Cao Y, 2008, CANCER SCI, V99, P1092, DOI 10.1111/j.1349-7006.2008.00815.x; Cesare AJ, 2010, NAT REV GENET, V11, P319, DOI 10.1038/nrg2763; Chretien JB J, 1985, PLEURA HLTH DIS, P23; Daniel M, 2012, GENE, V498, P135, DOI 10.1016/j.gene.2012.01.095; Dhaene K, 1998, THORAX, V53, P915, DOI 10.1136/thx.53.11.915; Ganem NJ, 2012, J CELL BIOL, V199, P871, DOI 10.1083/jcb.201210040; Gladych M, 2011, BIOCHEM CELL BIOL, V89, P359, DOI 10.1139/O11-037; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Huang SXL, 2011, J TOXICOL ENV HEAL B, V14, P179, DOI 10.1080/10937404.2011.556051; Husain AN, 2009, ARCH PATHOL LAB MED, V133, P1317, DOI 10.1043/1543-2165-133.8.1317; Jasani B, 2012, ARCH PATHOL LAB MED, V136, P262, DOI 10.5858/arpa.2011-0039-RA; Jean D, 2012, ARCH PATHOL LAB MED, V136, P277, DOI 10.5858/arpa.2011-0215-RA; Jean D, 2011, AM J PATHOL, V178, P881, DOI 10.1016/j.ajpath.2010.10.039; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Kumaki F, 2002, AM J SURG PATHOL, V26, P365, DOI 10.1097/00000478-200203000-00011; Larsson LG, 2011, SEMIN CANCER BIOL, V21, P367, DOI 10.1016/j.semcancer.2011.10.005; Lecomte C, 2005, CELL CYCLE, V4, P1862, DOI 10.4161/cc.4.12.2300; Mutsaers SE, 2002, RESPIROLOGY, V7, P171, DOI 10.1046/j.1440-1843.2002.00404.x; RAMAEL M, 1995, HISTOL HISTOPATHOL, V10, P639; Shen XH, 2013, INT IMMUNOPHARMACOL, V16, P261, DOI 10.1016/j.intimp.2013.04.003; Testa JR, 2011, NAT GENET, V43, P1022, DOI 10.1038/ng.912; Villa R, 2008, CLIN CANCER RES, V14, P4134, DOI 10.1158/1078-0432.CCR-08-0099; ZENG L, 1993, INT J CANCER, V55, P515, DOI 10.1002/ijc.2910550331	30	54	54	0	11	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 10	2014	33	28					3748	3752		10.1038/onc.2013.351	http://dx.doi.org/10.1038/onc.2013.351			5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AL2GC	23975423	Green Submitted			2022-12-25	WOS:000338942900014
J	Matz, MV; Wright, RM; Scott, JG				Matz, Mikhail V.; Wright, Rachel M.; Scott, James G.			No Control Genes Required: Bayesian Analysis of qRT-PCR Data	PLOS ONE			English	Article							TIME QUANTITATIVE PCR; RELATIVE QUANTIFICATION; MESSENGER-RNA; EXPRESSION; MODEL; FRAMEWORK; POWERFUL; STANDARD; ASSAY	Background: Model-based analysis of data from quantitative reverse-transcription PCR (qRT-PCR) is potentially more powerful and versatile than traditional methods. Yet existing model-based approaches cannot properly deal with the higher sampling variances associated with low-abundant targets, nor do they provide a natural way to incorporate assumptions about the stability of control genes directly into the model-fitting process. Results: In our method, raw qPCR data are represented as molecule counts, and described using generalized linear mixed models under Poisson-lognormal error. A Markov Chain Monte Carlo (MCMC) algorithm is used to sample from the joint posterior distribution over all model parameters, thereby estimating the effects of all experimental factors on the expression of every gene. The Poisson-based model allows for the correct specification of the mean-variance relationship of the PCR amplification process, and can also glean information from instances of no amplification (zero counts). Our method is very flexible with respect to control genes: any prior knowledge about the expected degree of their stability can be directly incorporated into the model. Yet the method provides sensible answers without such assumptions, or even in the complete absence of control genes. We also present a natural Bayesian analogue of the "classic" analysis, which uses standard data pre-processing steps (logarithmic transformation and multi-gene normalization) but estimates all gene expression changes jointly within a single model. The new methods are considerably more flexible and powerful than the standard delta-delta Ct analysis based on pairwise t-tests. Conclusions: Our methodology expands the applicability of the relative-quantification analysis protocol all the way to the lowest-abundance targets, and provides a novel opportunity to analyze qRT-PCR data without making any assumptions concerning target stability. These procedures have been implemented as the MCMC.qpcr package in R.	[Matz, Mikhail V.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Wright, Rachel M.] Univ Texas Austin, Inst Cell & Mol Biol, Austin, TX 78712 USA; [Scott, James G.] Univ Texas Austin, McCombs Sch Business, Austin, TX 78712 USA; [Scott, James G.] Univ Texas Austin, Div Stat & Sci Comp, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Matz, MV (corresponding author), Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.	matz@utexas.edu	Matz, Mikhail V/K-4392-2017	Matz, Mikhail V/0000-0001-5453-9819	National Science Foundation [DEB-1022196]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation grant DEB-1022196. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bayarri MJ, 1999, BAYESIAN STATISTICS 6, P53; Beckham JT, 2010, LASER SURG MED, V42, P752, DOI 10.1002/lsm.20983; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; CLAYTON D, 1987, BIOMETRICS, V43, P671, DOI 10.2307/2532003; Cremer FW, 1997, ANN ONCOL, V8, P633, DOI 10.1023/A:1008286803199; Elston DA, 2001, PARASITOLOGY, V122, P563, DOI 10.1017/S0031182001007740; Gelman A, 2012, J RES EDUC EFF, V5, P189, DOI 10.1080/19345747.2011.618213; Gentle A, 2001, BIOTECHNIQUES, V31, P502, DOI 10.2144/01313st03; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Johnson MR, 2000, ANAL BIOCHEM, V278, P175, DOI 10.1006/abio.1999.4461; Karge W H 3rd, 1998, Methods Mol Biol, V110, P43; Kenkel CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026914; Ling DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029788; Liu WH, 2002, ANAL BIOCHEM, V302, P52, DOI 10.1006/abio.2001.5530; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Livak KJ, 1997, USER B, P11; Lukyanov KA, 1996, NUCLEIC ACIDS RES, V24, P2194, DOI 10.1093/nar/24.11.2194; Luu-The V, 2005, BIOTECHNIQUES, V38, P287, DOI 10.2144/05382RR05; McCulloch C. E., 2008, GEN LINEAR MIXED MOD; Morrison T, 2006, NUCLEIC ACIDS RES, P34; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poletto R, 2006, BRAIN RES, V1067, P36, DOI 10.1016/j.brainres.2005.10.001; Poletto R, 2011, BRAIN RES, V1381, P11, DOI 10.1016/j.brainres.2010.11.035; R Core Team, 2022, R LANG ENV STAT COMP; Regier N, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-57; Schwartz L., 1965, Z F R WAHRSCHEINLICH, P10, DOI DOI 10.1007/BF00535479; Scott JG, 2010, ANN STAT, V38, P2587, DOI 10.1214/10-AOS792; Seneca FO, 2009, MAR BIOTECHNOL, DOI [10.1007/s10126-10009-19247-10125, DOI 10.1007/S10126-10009-19247-10125]; Spiess AN, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-221; Steibel JP, 2009, GENOMICS, V94, P146, DOI 10.1016/j.ygeno.2009.04.008; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tichopad A, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng122; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85	39	103	104	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71448	10.1371/journal.pone.0071448	http://dx.doi.org/10.1371/journal.pone.0071448			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977043	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700052
J	Bergmann-Leitner, ES; Chaudhury, S; Steers, NJ; Sabato, M; Delvecchio, V; Wallqvist, AS; Ockenhouse, CF; Angov, E				Bergmann-Leitner, Elke S.; Chaudhury, Sidhartha; Steers, Nicholas J.; Sabato, Mark; Delvecchio, Vito; Wallqvist, Anders S.; Ockenhouse, Christian F.; Angov, Evelina			Computational and Experimental Validation of B and T-Cell Epitopes of the In Vivo Immune Response to a Novel Malarial Antigen	PLOS ONE			English	Article							STRUCTURE PREDICTION; PROTEIN ANTIGENS; BINDING; CELTOS; SERVER; PROTECTION; PROFILES; VACCINES; ROSETTA; REGIONS	Vaccine development efforts will be guided by algorithms that predict immunogenic epitopes. Such prediction methods rely on classification-based algorithms that are trained against curated data sets of known B and T cell epitopes. It is unclear whether this empirical approach can be applied prospectively to predict epitopes associated with protective immunity for novel antigens. We present a comprehensive comparison of in silico B and T cell epitope predictions with in vivo validation using an previously uncharacterized malaria antigen, CelTOS. CelTOS has no known conserved structural elements with any known proteins, and thus is not represented in any epitope databases used to train prediction algorithms. This analysis represents a blind assessment of this approach in the context of a novel, immunologically relevant antigen. The limited accuracy of the tested algorithms to predict the in vivo immune responses emphasizes the need to improve their predictive capabilities for use as tools in vaccine design.	[Bergmann-Leitner, Elke S.; Ockenhouse, Christian F.; Angov, Evelina] Walter Reed Army Inst Res, Malaria Vaccine Branch, US Mil Malaria Vaccine Program, Silver Spring, MD USA; [Steers, Nicholas J.] US Mil HIV Res Program, Div Retrovirol, Silver Spring, MD USA; [Chaudhury, Sidhartha; Wallqvist, Anders S.] US Army Med Res & Mat Command, DoD Biotechnol High Performance Comp Software App, Telemed & Adv Technol Res Ctr, Ft Detrick, MD USA; [Sabato, Mark; Delvecchio, Vito] Vital Probes Inc, Mayfield, PA USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army	Bergmann-Leitner, ES (corresponding author), Walter Reed Army Inst Res, Malaria Vaccine Branch, US Mil Malaria Vaccine Program, Silver Spring, MD USA.	Elke.S.BergmannLeitner.ctr@mail.mil	Bergmann-Leitner, Elke S./B-3548-2011; Bergmann-Leitner, Elke/I-5431-2019; wallqvist, anders/W-2584-2019	Bergmann-Leitner, Elke S./0000-0002-8571-8956; Bergmann-Leitner, Elke/0000-0002-8571-8956; wallqvist, anders/0000-0002-9775-7469	U.S. Agency for International Development [936-3118, GHA-T-00-08-00007-01]; United States Army Medical Research and Materiel Command	U.S. Agency for International Development(United States Agency for International Development (USAID)); United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	This work was supported by the U.S. Agency for International Development under project number 936-3118, award number GHA-T-00-08-00007-01, and by the United States Army Medical Research and Materiel Command. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906; Ansari Hifzur Rahman, 2010, Immunome Res, V6, P6, DOI 10.1186/1745-7580-6-6; Bergmann-Leitner ES, 2011, VACCINE, V29, P5940, DOI 10.1016/j.vaccine.2011.06.053; Bergmann-Leitner ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012294; Bradley P, 2005, PROTEINS, V61, P128, DOI 10.1002/prot.20729; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Greenbaum JA, 2007, J MOL RECOGNIT, V20, P75, DOI 10.1002/jmr.815; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kang Y, 1998, J IMMUNOL, V161, P4211; Kariu T, 2006, MOL MICROBIOL, V59, P1369, DOI 10.1111/j.1365-2958.2005.05024.x; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Lee MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006254; Leitner WW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-145; Liang SD, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-381; Ockenhouse EB, 2009, AM J TROP MED HYG, V81, P260; Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514; Reche PA, 2004, IMMUNOGENETICS, V56, P405, DOI 10.1007/s00251-004-0709-7; Reche PA, 2002, HUM IMMUNOL, V63, P701, DOI 10.1016/S0198-8859(02)00432-9; Reche Pedro A., 2007, V409, P185, DOI 10.1007/978-1-60327-118-9_13; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; Scheiblhofer S, 2001, EUR J IMMUNOL, V31, P692, DOI 10.1002/1521-4141(200103)31:3&lt;692::AID-IMMU692&gt;3.0.CO;2-Y; Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017; Steers NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042579; Steers NJ, 2011, J VIROL, V85, P1541, DOI 10.1128/JVI.01790-10; Steers NJ, 2009, J VIROL, V83, P7049, DOI 10.1128/JVI.00327-09; Sun J, 2009, NUCLEIC ACIDS RES, V37, pW612, DOI 10.1093/nar/gkp417; Sweredoski MJ, 2008, BIOINFORMATICS, V24, P1459, DOI 10.1093/bioinformatics/btn199; Sweredoski MJ, 2009, PROTEIN ENG DES SEL, V22, P113, DOI 10.1093/protein/gzn075; Tomar N, 2010, IMMUNOLOGY, V131, P153, DOI 10.1111/j.1365-2567.2010.03330.x; van Beers MMC, 2012, BIOTECHNOL J, V7, P1473, DOI 10.1002/biot.201200065; Vulliet R, 1996, BIOTECHNIQUES, V20, P797; Wee LJK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S21; Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065; Yao B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062249; Zhang Y, 2005, PROTEINS, V61, P91, DOI 10.1002/prot.20724; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002	39	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e71610	10.1371/journal.pone.0071610	http://dx.doi.org/10.1371/journal.pone.0071610			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977087	Green Published, gold, Green Submitted			2022-12-25	WOS:000323570200036
J	Mai, H; Jin, M; Guo, XL; Liu, J; Liu, N; Cong, X; Gao, Y; Wei, L				Mai, Huan; Jin, Miao; Guo, XiaoLin; Liu, Jian; Liu, Ning; Cong, Xu; Gao, Yan; Wei, Lai			Clinical and Epidemiologic Characteristics of Norovirus GII.4 Sydney during Winter 2012-13 in Beijing, China following Its Global Emergence	PLOS ONE			English	Article							SPORADIC GASTROENTERITIS; VARIANT	Background: Limited information is available on the molecular epidemiology of GII.4 Sydney-associated diarrhea in China in the winter of 2012-13 during the global epidemic associated with the emergence of GII.4 Sydney. Methods: Fecal specimens collected from 171 diarrhea outpatients (one from each) between late October 2012 and the middle of March 2013 were examined for NoV by reverse transcription-polymerase chain reaction and sequences corresponding to both the NoV partial polymerase and partial capsid regions were analyzed phylogenetically. Clinical characteristics of GII.4 Sydney cases versus other NoV-positive cases detected in a previous study were compared statistically. Results: Twenty-six (15.2%, 26/171) outpatients with diarrhea were infected with NoV. Twenty-two of the 26 (84.6%) identified NoV strains clustered into GII.4 Sydney. There was a significant difference in symptoms of fever (chi(2), P < 0.05), abdominal pain (chi(2), P<0.05) and diarrhea frequency (Mann-Whitney U test, P<0.05) between the GII.4 Sydney case group and other NoV-positive case group. Conclusions: The new NoV variant, GII.4 Sydney, has been circulating in Beijing, China and became the predominant strain in the winter of 2012-13. GII.4 Sydney causes severe fever, abdominal pain and higher diarrhea frequency clinically compared to other NoV infections.	[Mai, Huan; Guo, XiaoLin; Gao, Yan] Peking Univ, Peking Univ Peoples Hosp, Inst Hepatol, Dept Infect Dis, Beijing 100871, Peoples R China; [Jin, Miao] Natl Inst Viral Dis Control & Prevent, Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Liu, Jian; Liu, Ning] Peking Univ Peoples Hosp, Dept Clin Lab, Beijing, Peoples R China; [Cong, Xu; Wei, Lai] Peking Univ, Peking Univ Peoples Hosp, Inst Hepatol, Beijing 100871, Peoples R China	Peking University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Peking University; Peking University	Gao, Y (corresponding author), Peking Univ, Peking Univ Peoples Hosp, Inst Hepatol, Dept Infect Dis, Beijing 100871, Peoples R China.	gaoyan6384@163.com			Key Project of Science and Technology, People's Republic of China [2012ZX10004215];  [81000727]	Key Project of Science and Technology, People's Republic of China; 	This study was funded by Foundation of China (grant number 81000727) and The Key Project of Science and Technology (grant number 2012ZX10004215), People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2013, LANCET INFECT DIS, V13, P97, DOI 10.1016/S1473-3099(13)70016-1; Atmar RL, 2010, FOOD ENVIRON VIROL, V2, P117, DOI 10.1007/s12560-010-9038-1; Bennett S, 2013, EURO SURVEILL, V18; Bok K, 2012, NEW ENGL J MED, V367, P2126, DOI 10.1056/NEJMra1207742; Bull RA, 2006, J CLIN MICROBIOL, V44, P327, DOI 10.1128/JCM.44.2.327-333.2006; Bull RA, 2007, J GEN VIROL, V88, P3347, DOI 10.1099/vir.0.83321-0; Bull RA, 2011, TRENDS MICROBIOL, V19, P233, DOI 10.1016/j.tim.2011.01.002; Bull RA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000831; Centers for Disease Control and Prevention (CDC), 2013, MMWR Morb Mortal Wkly Rep, V62, P55; Fonager J, 2013, EURO SURVEILL, V18; Gao Y, 2011, J MED VIROL, V83, P1078, DOI 10.1002/jmv.22077; Guo L, 2009, J CLIN VIROL, V44, P94, DOI 10.1016/j.jcv.2008.10.002; Han TH, 2011, ARCH VIROL, V156, P323, DOI 10.1007/s00705-010-0844-4; Health Protection Agency (HPA), 2013, UPD SEAS NOR ACT; Jin M, 2008, J MED VIROL, V80, P1997, DOI 10.1002/jmv.21308; Li Xiao-Le, 2012, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V26, P14; Lindesmith LC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002705; Lopman B, 2008, PLOS MED, V5, P187, DOI 10.1371/journal.pmed.0050042; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; VANBEEK J, 2013, EURO SURVEILL, V18; Walker CLF, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000768; Yang Y, 2010, J VIROL, V84, P9595, DOI 10.1128/JVI.02614-09; Zeng M, 2012, J MED VIROL, V84, P145, DOI 10.1002/jmv.22248; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	24	20	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e71483	10.1371/journal.pone.0071483	http://dx.doi.org/10.1371/journal.pone.0071483			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977050	Green Published, gold, Green Submitted			2022-12-25	WOS:000323570200032
J	Wallace, JA; Li, F; Balakrishnan, S; Cantemir-Stone, CZ; Pecot, T; Martin, C; Kladney, RD; Sharma, SM; Trimboli, AJ; Fernandez, SA; Yu, LB; Rosol, TJ; Stromberg, PC; Lesurf, R; Hallett, M; Park, M; Leone, G; Ostrowski, MC				Wallace, Julie A.; Li, Fu; Balakrishnan, Subhasree; Cantemir-Stone, Carmen Z.; Pecot, Thierry; Martin, Chelsea; Kladney, Raleigh D.; Sharma, Sudarshana M.; Trimboli, Anthony J.; Fernandez, Soledad A.; Yu, Lianbo; Rosol, Thomas J.; Stromberg, Paul C.; Lesurf, Robert; Hallett, Michael; Park, Morag; Leone, Gustavo; Ostrowski, Michael C.			Ets2 in Tumor Fibroblasts Promotes Angiogenesis in Breast Cancer	PLOS ONE			English	Article							MOUSE MAMMARY-TUMORS; EXTRACELLULAR-MATRIX; STROMAL FIBROBLASTS; ENRICHMENT ANALYSIS; ADJUVANT THERAPY; EXPRESSION; ARCHITECTURE; PROGRESSION; TARGET; MODELS	Tumor fibroblasts are active partners in tumor progression, but the genes and pathways that mediate this collaboration are ill-defined. Previous work demonstrates that Ets2 function in stromal cells significantly contributes to breast tumor progression. Conditional mouse models were used to study the function of Ets2 in both mammary stromal fibroblasts and epithelial cells. Conditional inactivation of Ets2 in stromal fibroblasts in PyMT and ErbB2 driven tumors significantly reduced tumor growth, however deletion of Ets2 in epithelial cells in the PyMT model had no significant effect. Analysis of gene expression in fibroblasts revealed a tumor-and Ets2-dependent gene signature that was enriched in genes important for ECM remodeling, cell migration, and angiogenesis in both PyMT and ErbB2 driven-tumors. Consistent with these results, PyMT and ErbB2 tumors lacking Ets2 in fibroblasts had fewer functional blood vessels, and Ets2 in fibroblasts elicited changes in gene expression in tumor endothelial cells consistent with this phenotype. An in vivo angiogenesis assay revealed the ability of Ets2 in fibroblasts to promote blood vessel formation in the absence of tumor cells. Importantly, the Ets2-dependent gene expression signatures from both mouse models were able to distinguish human breast tumor stroma from normal stroma, and correlated with patient outcomes in two whole tumor breast cancer data sets. The data reveals a key function for Ets2 in tumor fibroblasts in signaling to endothelial cells to promote tumor angiogenesis. The results highlight the collaborative networks that orchestrate communication between stromal cells and tumor cells, and suggest that targeting tumor fibroblasts may be an effective strategy for developing novel anti-angiogenic therapies.	[Wallace, Julie A.; Li, Fu; Balakrishnan, Subhasree; Cantemir-Stone, Carmen Z.; Martin, Chelsea; Sharma, Sudarshana M.; Ostrowski, Michael C.] Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Li, Fu; Pecot, Thierry; Trimboli, Anthony J.; Leone, Gustavo] Ohio State Univ, Coll Biol Sci, Dept Mol Genet, Columbus, OH 43210 USA; [Pecot, Thierry; Kladney, Raleigh D.; Trimboli, Anthony J.; Leone, Gustavo] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Pecot, Thierry] Ohio State Univ, Ohio State Univ Biomed Informat, Ohio State Univ Comp Sci & Engn, Columbus, OH 43210 USA; [Fernandez, Soledad A.; Yu, Lianbo] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [Rosol, Thomas J.; Stromberg, Paul C.] Ohio State Univ, Coll Vet Med, Dept Vet Biosci, Columbus, OH 43210 USA; [Lesurf, Robert; Hallett, Michael; Park, Morag] McGill Univ, Rosalind & Morris Goodman Canc Ctr, Dept Biochem, Quebec City, PQ, Canada; [Hallett, Michael] McGill Univ, McGill Ctr Bioinformat, Quebec City, PQ, Canada; [Park, Morag] McGill Univ, Dept Oncol, Quebec City, PQ, Canada; [Leone, Gustavo; Ostrowski, Michael C.] Ohio State Univ, Ctr Comprehens Canc, Tumor Microenvironm Program, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; McGill University; McGill University; McGill University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Ostrowski, MC (corresponding author), Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA.	michael.ostrowski@osumc.edu	yu, lianbo/B-3472-2010; Sharma, Sudarshana Mangalore/AAI-2475-2019; Rosol, Thomas/G-9585-2011; Ostrowski, Michael/H-3108-2011	Rosol, Thomas/0000-0003-3737-1190; Hallett, Michael/0000-0001-6738-6786; Lesurf, Robert/0000-0001-7095-1491; Sharma, Sudarshana/0000-0002-9745-0061; Pecot, Thierry/0000-0003-0772-9753; Ostrowski, Michael/0000-0003-2948-6297	Susan Komen Foundation; Evelyn Simmers Foundation; Department of Defense [GRANT00410570, GRANT10578047];  [NIHPO1CA097189];  [RO1CA053271]; NATIONAL CANCER INSTITUTE [P01CA097189, P30CA016058, R01CA053271] Funding Source: NIH RePORTER	Susan Komen Foundation(Susan G. Komen Breast Cancer Foundation); Evelyn Simmers Foundation; Department of Defense(United States Department of Defense); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIHPO1CA097189 (http://nih.gov/), RO1CA053271, Susan Komen Foundation (http://ww5.komen.org/), the Evelyn Simmers Foundation and Department of Defense Pre-Doctoral Fellowships GRANT00410570 and GRANT10578047. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; Auer H, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-111; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Buggy Y, 2006, EUR J CANCER, V42, P485, DOI 10.1016/j.ejca.2005.10.018; Chantrain CF, 2004, CANCER RES, V64, P1675, DOI 10.1158/0008-5472.CAN-03-0160; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Crawford Y, 2009, CANCER CELL, V15, P21, DOI 10.1016/j.ccr.2008.12.004; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Fowles LF, 1998, MOL CELL BIOL, V18, P5148, DOI 10.1128/MCB.18.9.5148; Goeman JJ, 2010, BIOMETRICAL J, V52, P70, DOI 10.1002/bimj.200900028; Gonda TA, 2010, SEMIN CELL DEV BIOL, V21, P2, DOI 10.1016/j.semcdb.2009.10.001; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Hsu T, 2004, J CELL BIOCHEM, V91, P896, DOI 10.1002/jcb.20012; Inai T, 2004, AM J PATHOL, V165, P35, DOI 10.1016/S0002-9440(10)63273-7; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Man AK, 2003, MOL CELL BIOL, V23, P8614, DOI 10.1128/MCB.23.23.8614-8625.2003; Mook ORF, 2003, J HISTOCHEM CYTOCHEM, V51, P821, DOI 10.1177/002215540305100613; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Munera J, 2011, STEM CELLS, V29, P430, DOI 10.1002/stem.599; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Norrby K, 2006, J CELL MOL MED, V10, P588, DOI 10.1111/j.1582-4934.2006.tb00423.x; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sharma SM, 2007, J BIOL CHEM, V282, P15921, DOI 10.1074/jbc.M609723200; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SOULE HD, 1986, IN VITRO CELL DEV B, V22, P6, DOI 10.1007/BF02623435; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sussan TE, 2008, NATURE, V451, P73, DOI 10.1038/nature06446; Trimboli AJ, 2008, CANCER RES, V68, P937, DOI 10.1158/0008-5472.CAN-07-2148; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Tynan JA, 2005, ONCOGENE, V24, P6870, DOI 10.1038/sj.onc.1208856; van de Vijver M, 2005, ONCOLOGIST, V10, P30, DOI 10.1634/theoncologist.10-90002-30; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Wei G, 2009, BLOOD, V114, P1123, DOI 10.1182/blood-2009-03-211391; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Yamamoto H, 1998, GENE DEV, V12, P1315, DOI 10.1101/gad.12.9.1315; Zabuawala T, 2010, CANCER RES, V70, P1323, DOI 10.1158/0008-5472.CAN-09-1474	42	28	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e71533	10.1371/journal.pone.0071533	http://dx.doi.org/10.1371/journal.pone.0071533			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977064	Green Published, Green Submitted, gold			2022-12-25	WOS:000323570200033
J	Duguma, D; Rugman-Jones, P; Kaufman, MG; Hall, MW; Neufeld, JD; Stouthamer, R; Walton, WE				Duguma, Dagne; Rugman-Jones, Paul; Kaufman, Michael G.; Hall, Michael W.; Neufeld, Josh D.; Stouthamer, Richard; Walton, William E.			Bacterial Communities Associated with Culex Mosquito Larvae and Two Emergent Aquatic Plants of Bioremediation Importance	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; THORSELLIA-ANOPHELIS; AEDES-TRISERIATUS; MACROPHYTES; IDENTIFICATION; WATER	Microbes are important for mosquito nutrition, growth, reproduction and control. In this study, we examined bacterial communities associated with larval mosquitoes and their habitats. Specifically, we characterized bacterial communities associated with late larval instars of the western encephalitis mosquito (Culex tarsalis), the submerged portions of two emergent macrophytes (California bulrush, Schoenoplectus californicus and alkali bulrush, Schoenoplectus maritimus), and the associated water columns to investigate potential differential use of resources by mosquitoes in different wetland habitats. Using next-generation sequence data from 16S rRNA gene hypervariable regions, the alpha diversity of mosquito gut microbial communities did not differ between pond mesocosms containing distinct monotypic plants. Proteobacteria, dominated by the genus Thorsellia (Enterobacteriaceae), was the most abundant phylum recovered from C. tarsalis larvae. Approximately 49% of bacterial OTUs found in larval mosquitoes were identical to OTUs recovered from the water column and submerged portions of the two bulrushes. Plant and water samples were similar to one another, both being dominated by Actinobacteria, Bacteroidetes, Cyanobacteria, Proteobacteria and Verrucomicrobia phyla. Overall, the bacterial communities within C. tarsalis larvae were conserved and did not change across sampling dates and between two distinct plant habitats. Although Thorsellia spp. dominated mosquito gut communities, overlap of mosquito gut, plant and water-column OTUs likely reveal the effects of larval feeding. Future research will investigate the role of the key indicator groups of bacteria across the different developmental stages of this mosquito species.	[Duguma, Dagne; Rugman-Jones, Paul; Stouthamer, Richard; Walton, William E.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Kaufman, Michael G.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [Hall, Michael W.; Neufeld, Josh D.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	University of California System; University of California Riverside; Michigan State University; University of Waterloo	Duguma, D (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.	ddemi002@student.ucr.edu		Duguma, Dagne/0000-0003-1941-7095	Agricultural Experiment Station at University of California Riverside; Ian and Helen Moore Scholarship; Graduate Division Research Mentorship Program of University of California Riverside; Natural Sciences and Engineering Research Council of Canada; National Institutes of Health [R37 A121884]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI021884] Funding Source: NIH RePORTER	Agricultural Experiment Station at University of California Riverside; Ian and Helen Moore Scholarship; Graduate Division Research Mentorship Program of University of California Riverside; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	WEW acknowledges funding from the Agricultural Experiment Station at University of California Riverside. DD was supported by an Ian and Helen Moore Scholarship and the Graduate Division Research Mentorship Program of University of California Riverside. MWH and JDN acknowledge funding from a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada. MGK acknowledges National Institutes of Health award R37 A121884. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Bengtsson J, 2011, ANTON LEEUW INT J G, V100, P471, DOI 10.1007/s10482-011-9598-6; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Boissiere Anne, 2012, PLoS Pathog, V8, pe1002742, DOI 10.1371/journal.ppat.1002742; Borchardt JR, 2008, J MED PLANTS RES, V2, P98; Briones AM, 2008, ISME J, V2, P74, DOI 10.1038/ismej.2007.95; Brix H, 1997, WATER SCI TECHNOL, V35, P11, DOI 10.1016/S0273-1223(97)00047-4; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; CHAO JOWETT, 1959, JOUR INSECT PATHOL, V1, P311; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Gupta AK, 2012, FEMS MICROBIOL ECOL, V79, P581, DOI 10.1111/j.1574-6941.2011.01248.x; Hansen JP, 2011, AQUAT ECOL, V45, P11, DOI 10.1007/s10452-010-9319-7; Hempel M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-58; Kadlec RH., 2008, TREATMENT WETLANDS, DOI [10.1201/9781420012514, DOI 10.1201/9781420012514]; Kampfer P, 2006, INT J SYST EVOL MICR, V56, P335, DOI 10.1099/ijs.0.63999-0; KANTRUD HA, 1996, 6 NAT BIOL SERV NO P; Kaufman MG, 1999, APPL ENVIRON MICROB, V65, P2661; Kaufman MG, 2001, J MED ENTOMOL, V38, P711, DOI 10.1603/0022-2585-38.5.711; Kirchman DL., 1993, HDB METHODS AQUATIC; Kroger R, 2007, ENVIRON POLLUT, V146, P114, DOI 10.1016/j.envpol.2006.06.005; Laird M., 1988, NATURAL HIST LARVAL, P555; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lindh JM, 2005, APPL ENVIRON MICROB, V71, P7217, DOI 10.1128/AEM.71.11.7217-7223.2005; Lynch MDJ, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-3; MERRITT RW, 1992, ANNU REV ENTOMOL, V37, P349, DOI 10.1146/annurev.en.37.010192.002025; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nawrocki EP, 2009, STRUCTURAL RNA HOMOL; Okafor N, 2011, ENVIRONMENTAL MICROBIOLOGY OF AQUATIC AND WASTE SYSTEMS, P111, DOI 10.1007/978-94-007-1460-1_5; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Orr BK, 1991, THESIS U CALIFORNIA; Martinez-Falcon AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027443; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pelz-Stelinski K, 2011, MICROB ECOL, V62, P690, DOI 10.1007/s00248-011-9872-1; Ponnusamy L, 2008, P NATL ACAD SCI USA, V105, P9262, DOI 10.1073/pnas.0802505105; Ponnusamy L, 2010, MICROB ECOL, V59, P158, DOI 10.1007/s00248-009-9565-1; Rani A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-96; Ricci I, 2011, J APPL ENTOMOL, V135, P487, DOI 10.1111/j.1439-0418.2011.01613.x; Roberts D.W., 2010, LABDSV ORDINATION MU; Sas J, 2010, JMP SOFTWARE RELEASE; Serandour J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003350; Su C, 2012, APPL MICROBIOL BIOT, V93, P993, DOI 10.1007/s00253-011-3800-7; Tanaka Y, 2009, MICROBES ENVIRON, V27, P149; Walton WE, 2005, J AM MOSQUITO CONTR, V21, P22, DOI 10.2987/8756-971X(2005)21[22:VMTSDI]2.0.CO;2; Walton WE, 2003, U CALIFORNIA PUBLICA, V8117; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024767; WISTREICH GEORGE A., 1960, JOUR INSECT PATHOL, V2, P30	51	57	59	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e72522	10.1371/journal.pone.0072522	http://dx.doi.org/10.1371/journal.pone.0072522			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967314	Green Published, Green Submitted, gold			2022-12-25	WOS:000323378000100
J	Walker, CM; Lee, J; Ramirez, MS; Schellingerhout, D; Millward, S; Bankson, JA				Walker, Christopher M.; Lee, Jaehyuk; Ramirez, Marc S.; Schellingerhout, Dawid; Millward, Steven; Bankson, James A.			A Catalyzing Phantom for Reproducible Dynamic Conversion of Hyperpolarized [1-C-13]-Pyruvate	PLOS ONE			English	Article							TUMOR RESPONSE; IN-VIVO; C-13; PYRUVATE; LACTATE; METABOLISM; EXCHANGE; PROSTATE; MODELS; BREAST	In vivo real time spectroscopic imaging of hyperpolarized C-13 labeled metabolites shows substantial promise for the assessment of physiological processes that were previously inaccessible. However, reliable and reproducible methods of measurement are necessary to maximize the effectiveness of imaging biomarkers that may one day guide personalized care for diseases such as cancer. Animal models of human disease serve as poor reference standards due to the complexity, heterogeneity, and transient nature of advancing disease. In this study, we describe the reproducible conversion of hyperpolarized [1-C-13]-pyruvate to [1-C-13]-lactate using a novel synthetic enzyme phantom system. The rate of reaction can be controlled and tuned to mimic normal or pathologic conditions of varying degree. Variations observed in the use of this phantom compare favorably against within-group variations observed in recent animal studies. This novel phantom system provides crucial capabilities as a reference standard for the optimization, comparison, and certification of quantitative imaging strategies for hyperpolarized tracers.	[Walker, Christopher M.; Lee, Jaehyuk; Ramirez, Marc S.; Bankson, James A.] Univ Texas MD Anderson Canc Ctr, Dept Imaging Phys, Houston, TX 77030 USA; [Schellingerhout, Dawid; Millward, Steven] Univ Texas MD Anderson Canc Ctr, Dept Canc Syst Imaging, Houston, TX 77030 USA; [Schellingerhout, Dawid] Univ Texas MD Anderson Canc Ctr, Dept Diagnost Radiol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Bankson, JA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Imaging Phys, Houston, TX 77030 USA.	jbankson@mdanderson.org	Walker, Chris/AAV-1539-2021; Bankson, James A./J-9798-2014	Bankson, James A./0000-0002-8574-154X; Walker, Christopher/0000-0002-6381-8737	Cancer Prevention and Research Institute of Texas [RP101243-P5, RP101502]; National Institutes of Health [P30-CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Cancer Prevention and Research Institute of Texas (RP101243-P5, RP101502) and the National Institutes of Health (P30-CA016672). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAGAM A, 1978, REP PROG PHYS, V41, P395, DOI 10.1088/0034-4885/41/3/002; Albers MJ, 2008, CANCER RES, V68, P8607, DOI 10.1158/0008-5472.CAN-08-0749; Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; Arunachalam A, 2009, NMR BIOMED, V22, P867, DOI 10.1002/nbm.1401; Bergmeyer H. U., 1983, METHODS ENZYMATIC AN; Bohndiek SE, 2012, CANCER RES, V72, P854, DOI 10.1158/0008-5472.CAN-11-2795; Bohndiek SE, 2010, MOL CANCER THER, V9, P3278, DOI 10.1158/1535-7163.MCT-10-0706; BRINDLE KM, 1988, PROG NUCL MAG RES SP, V20, P257, DOI 10.1016/0079-6565(88)80003-7; Buckler AJ, 2011, RADIOLOGY, V259, P875, DOI 10.1148/radiol.10100800; Clatworthy MR, 2012, P NATL ACAD SCI USA, V109, P13374, DOI 10.1073/pnas.1205539109; Cunningham CH, 2007, J MAGN RESON, V187, P357, DOI 10.1016/j.jmr.2007.05.014; Day SE, 2007, NAT MED, V13, P1382, DOI 10.1038/nm1650; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Harris T, 2009, P NATL ACAD SCI USA, V106, P18131, DOI 10.1073/pnas.0909049106; Harrison C, 2012, NMR BIOMED, V25, P1286, DOI 10.1002/nbm.2801; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hu S, 2008, J MAGN RESON, V192, P258, DOI 10.1016/j.jmr.2008.03.003; Hu S, 2010, MAGN RESON MED, V63, P312, DOI 10.1002/mrm.22233; Kazan SM, 2012, MAGN RESON IN PRESS; Kurhanewicz J, 2011, NEOPLASIA, V13, P81, DOI 10.1593/neo.101102; Larson PEZ, 2011, MAGN RESON MED, V65, P610, DOI 10.1002/mrm.22650; Larson PEZ, 2010, MAGN RESON MED, V63, P582, DOI 10.1002/mrm.22264; Lau AZ, 2013, MAGN RESON MED, V69, P1063, DOI 10.1002/mrm.24342; Laustsen C, 2013, DIABETES-METAB RES, V29, P125, DOI 10.1002/dmrr.2370; Lei Zhao, 1996, Journal of Magnetic Resonance, Series B, V113, P179, DOI 10.1006/jmrb.1996.0173; Levin YS, 2007, MAGN RESON MED, V58, P245, DOI 10.1002/mrm.21327; Lodi A, 2013, NMR BIOMED, V26, P299, DOI 10.1002/nbm.2848; Matsumoto S, 2013, MAGN RESON MED, V69, P1443, DOI 10.1002/mrm.24355; Mayer D, 2009, MAGN RESON MED, V62, P557, DOI 10.1002/mrm.22041; Morse DL, 2010, BIOCHEM PHARMACOL, V80, P731, DOI 10.1016/j.bcp.2010.04.011; Ohliger MA, 2013, J MAGN RESON IMAGING, V38, P701, DOI 10.1002/jmri.23989; Park I, 2011, J MAGN RESON IMAGING, V33, P1284, DOI 10.1002/jmri.22563; Reynolds S, 2012, APPL MAGN RESON, V43, P263, DOI 10.1007/s00723-012-0333-x; Sandulache VC, 2012, MOL CANCER THER, V11, P1373, DOI 10.1158/1535-7163.MCT-12-0041; Sun FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034525; Thind K, 2012, MAGN RESON IN PRESS; Ward CS, 2010, CANCER RES, V70, P1296, DOI 10.1158/0008-5472.CAN-09-2251; Witney TH, 2011, J BIOL CHEM, V286, P24572, DOI 10.1074/jbc.M111.237727; YAGIL G, 1969, BIOCHEMISTRY-US, V8, P352, DOI 10.1021/bi00829a049; ZEWE V, 1962, J BIOL CHEM, V237, P1668; ZEWE V, 1965, BIOCHEMISTRY-US, V4, P782, DOI 10.1021/bi00880a024	41	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71274	10.1371/journal.pone.0071274	http://dx.doi.org/10.1371/journal.pone.0071274			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977006	gold, Green Published, Green Submitted			2022-12-25	WOS:000323378000037
J	Nogueira, RC; Bor-Seng-Shu, E; Santos, MR; Negrao, CE; Teixeira, MJ; Panerai, RB				Nogueira, Ricardo C.; Bor-Seng-Shu, Edson; Santos, Marcelo R.; Negrao, Carlos E.; Teixeira, Manoel J.; Panerai, Ronney B.			Dynamic Cerebral Autoregulation Changes during Sub-Maximal Handgrip Maneuver	PLOS ONE			English	Article							CRITICAL CLOSING PRESSURE; ARTERIAL-BLOOD-PRESSURE; RHYTHMIC HANDGRIP; TRANSCRANIAL DOPPLER; FLOW VELOCITY; HUMANS; EXERCISE; CIRCULATION; ISCHEMIA; SYNCOPE	Purpose: We investigated the effect of handgrip (HG) maneuver on time-varying estimates of dynamic cerebral autoregulation (CA) using the autoregressive moving average technique. Methods: Twelve healthy subjects were recruited to perform HG maneuver during 3 minutes with 30% of maximum contraction force. Cerebral blood flow velocity, end-tidal CO2 pressure (PETCO2), and noninvasive arterial blood pressure (ABP) were continuously recorded during baseline, HG and recovery. Critical closing pressure (CrCP), resistance area-product (RAP), and time-varying autoregulation index (ARI) were obtained. Results: PETCO2 did not show significant changes during HG maneuver. Whilst ABP increased continuously during the maneuver, to 27% above its baseline value, CBFV raised to a plateau approximately 15% above baseline. This was sustained by a parallel increase in RAP, suggestive of myogenic vasoconstriction, and a reduction in CrCP that could be associated with metabolic vasodilation. The time-varying ARI index dropped at the beginning and end of the maneuver (p<0.005), which could be related to corresponding alert reactions or to different time constants of the myogenic, metabolic and/or neurogenic mechanisms. Conclusion: Changes in dynamic CA during HG suggest a complex interplay of regulatory mechanisms during static exercise that should be considered when assessing the determinants of cerebral blood flow and metabolism.	[Nogueira, Ricardo C.] Univ Sao Paulo, Sch Med, Hosp Clin, Dept Neurol, Sao Paulo, Brazil; [Bor-Seng-Shu, Edson; Teixeira, Manoel J.] Univ Sao Paulo, Sch Med, Hosp Clin, Dept Neurosurg, Sao Paulo, Brazil; [Santos, Marcelo R.; Negrao, Carlos E.] Univ Sao Paulo, Sch Med, Heart Inst InCor, Sao Paulo, Brazil; [Santos, Marcelo R.; Negrao, Carlos E.] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil; [Panerai, Ronney B.] Univ Leicester, Leicester Royal Infirm, Dept Cardiovas Sci, Med Phys Grp, Leicester, Leics, England; [Panerai, Ronney B.] Glenfield Hosp, Biomed Res Unit Cardiovasc Sci, Leicester, Leics, England	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital	Panerai, RB (corresponding author), Univ Leicester, Leicester Royal Infirm, Dept Cardiovas Sci, Med Phys Grp, Leicester, Leics, England.	rp9@le.ac.uk	Negrao, Carlos E/C-4281-2012; BOR-SENG-SHU, EDSON/AAC-9762-2019; de Carvalho Nogueira, Ricardo/V-3482-2019	BOR-SENG-SHU, EDSON/0000-0002-6713-8974; de Carvalho Nogueira, Ricardo/0000-0003-3309-3760; Negrao, Carlos Eduardo/0000-0003-4652-1226	CAPES/Brazilian Ministry of Education	CAPES/Brazilian Ministry of Education(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	RC Nogueira was supported by a travelling scholarship from CAPES/Brazilian Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainslie PN, 2011, J PHYSIOL-LONDON, V589, P2917, DOI 10.1113/jphysiol.2011.211292; Aoi MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046794; Azevedo E, 2011, CLIN AUTON RES, V21, P395, DOI 10.1007/s10286-011-0129-3; Carey BJ, 2001, CLIN SCI, V101, P351, DOI 10.1042/CS20010021; Dawson SL, 2000, CEREBROVASC DIS, V10, P126, DOI 10.1159/000016041; Dineen NE, 2010, J APPL PHYSIOL, V108, P604, DOI 10.1152/japplphysiol.01157.2009; Eames PJ, 2003, AM J HYPERTENS, V16, P746, DOI 10.1016/S0895-7061(03)00947-6; Edwards MR, 2003, CLIN AUTON RES, V13, P306, DOI 10.1007/s10286-003-0136-0; Giller CA, 2000, J APPL PHYSIOL, V88, P2205, DOI 10.1152/jappl.2000.88.6.2205; JORGENSEN LG, 1992, J APPL PHYSIOL, V72, P1123, DOI 10.1152/jappl.1992.72.3.1123; Kim YS, 2007, AM J PHYSIOL-HEART C, V293, pH467, DOI 10.1152/ajpheart.00045.2007; Kleinfeld David, 2011, Front Neuroenergetics, V3, P1, DOI 10.3389/fnene.2011.00001; Krzemijski K, 2012, EUR J APPL PHYSL, P1315; Nakagawa K, 2009, STROKE, V40, P2062, DOI 10.1161/STROKEAHA.108.545285; Nowak M, 2005, HUM BRAIN MAPP, V25, P259, DOI 10.1002/hbm.20097; Ogoh S, 2011, EXP PHYSIOL, V96, P417, DOI 10.1113/expphysiol.2010.055871; Ogoh S, 2010, J APPL PHYSIOL, V108, P1701, DOI 10.1152/japplphysiol.01031.2009; Ogoh S, 2010, EXP PHYSIOL, V95, P678, DOI 10.1113/expphysiol.2010.052340; Ogoh S, 2009, J APPL PHYSIOL, V107, P1370, DOI 10.1152/japplphysiol.00573.2009; Panerai RB, 2008, PHYSIOL MEAS, V29, P497, DOI 10.1088/0967-3334/29/4/006; Panerai RB, 2011, PHYSIOL MEAS, V32, P467, DOI 10.1088/0967-3334/32/4/007; Panerai RB, 2010, J APPL PHYSIOL, V109, P1860, DOI 10.1152/japplphysiol.00857.2010; Panerai RB, 2003, MED ENG PHYS, V25, P621, DOI 10.1016/S1350-4533(03)00027-4; Panerai RB, 2001, AM J PHYSIOL-HEART C, V280, pH2162, DOI 10.1152/ajpheart.2001.280.5.H2162; Panerai RB, 2012, AM J PHYSIOL-REG I, V303, pR395, DOI 10.1152/ajpregu.00161.2012; Panerai RB, 2009, CLIN AUTON RES, V19, P197, DOI 10.1007/s10286-009-0011-8; Paulson OB, 2010, J CEREBR BLOOD F MET, V30, P2, DOI 10.1038/jcbfm.2009.188; Rasmussen P, 2006, J APPL PHYSIOL, V101, P1406, DOI 10.1152/japplphysiol.00423.2006; Ravits JM, 1997, MUSCLE NERVE, V20, P919, DOI 10.1002/(SICI)1097-4598(199708)20:8<919::AID-MUS1>3.0.CO;2-9; Sander M, 2010, J APPL PHYSIOL, V108, P1691, DOI 10.1152/japplphysiol.91539.2008; Serrador JM, 2000, STROKE, V31, P1672, DOI 10.1161/01.STR.31.7.1672; Stanimirovic DB, 2012, J CEREBR BLOOD F MET, V32, P1207, DOI 10.1038/jcbfm.2012.25; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014	33	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e70821	10.1371/journal.pone.0070821	http://dx.doi.org/10.1371/journal.pone.0070821			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967113	Green Published, gold, Green Submitted			2022-12-25	WOS:000323221500036
J	O'Rourke, RW; Meyer, KA; Gaston, G; White, AE; Lumeng, CN; Marks, DL				O'Rourke, Robert W.; Meyer, Kevin A.; Gaston, Garen; White, Ashley E.; Lumeng, Carey N.; Marks, Daniel L.			Hexosamine Biosynthesis is a Possible Mechanism Underlying Hypoxia's Effects on Lipid Metabolism in Human Adipocytes	PLOS ONE			English	Article							ADIPOSE-TISSUE HYPOXIA; FATTY-ACID OXIDATION; INSULIN-RESISTANCE; OBESITY; GLUCOSE; ACTIVATION; EXPRESSION; REDUCTION; INCREASES; PATHWAY	Introduction: Hypoxia regulates adipocyte metabolism. Hexosamine biosynthesis is implicated in murine 3T3L1 adipocyte differentiation and is a possible underlying mechanism for hypoxia's effects on adipocyte metabolism. Methods: Lipid metabolism was studied in human visceral and subcutaneous adipocytes in in vitro hypoxic culture with adipophilic staining, glycerol release, and palmitate oxidation assays. Gene expression and hexosamine biosynthesis activation was studied with QRTPCR, immunofluorescence microscopy, and Western blotting. Results: Hypoxia inhibits lipogenesis and induces basal lipolysis in visceral and subcutaneous human adipocytes. Hypoxia induces fatty acid oxidation in visceral adipocytes but had no effect on fatty acid oxidation in subcutaneous adipocytes. Hypoxia inhibits hexosamine biosynthesis in adipocytes. Inhibition of hexosamine biosynthesis with azaserine attenuates lipogenesis and induces lipolysis in adipocytes in normoxic conditions, while promotion of hexosamine biosynthesis with glucosamine in hypoxic conditions slightly increases lipogenesis. Conclusions: Hypoxia's net effect on human adipocyte lipid metabolism would be expected to impair adipocyte buffering capacity and contribute to systemic lipotoxicity. Our data suggest that hypoxia may mediate its effects on lipogenesis and lipolysis through inhibition of hexosamine biosynthesis. Hexosamine biosynthesis represents a target for manipulation of adipocyte metabolism.	[O'Rourke, Robert W.; Meyer, Kevin A.; Gaston, Garen; White, Ashley E.] Oregon Hlth & Sci Univ, Dept Surg, Portland, OR 97201 USA; [Lumeng, Carey N.] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Marks, Daniel L.] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA	Oregon Health & Science University; University of Michigan System; University of Michigan; Oregon Health & Science University	O'Rourke, RW (corresponding author), Oregon Hlth & Sci Univ, Dept Surg, Portland, OR 97201 USA.	orourkro@ohsu.edu	Marks, Daniel/C-3712-2009	Lumeng, Carey/0000-0003-0303-6204; O'Rourke, Robert/0000-0002-4038-4198	National Institutes of Health [K08DK074397, R03DK095050, R01DK097449, R01DK090262, R01DK070333]; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R01DK070333, R03DK095050, R01DK097449, K08DK074397, R01DK090262] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by National Institutes of Health Grants K08DK074397 (RWO), R03DK095050 (RWO), R01DK097449 (RWO), R01DK090262 (CNL), R01DK070333 (DLM), and the Burroughs Wellcome Fund (DLM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Bhonagiri P, 2011, ENDOCRINOLOGY, V152, P3373, DOI 10.1210/en.2011-1295; de Heredia FP, 2010, PFLUG ARCH EUR J PHY, V459, P509, DOI 10.1007/s00424-009-0750-3; Einstein FH, 2008, FASEB J, V22, P3450, DOI 10.1096/fj.08-109041; Fleischmann E, 2005, OBES SURG, V15, P813, DOI 10.1381/0960892054222867; Gentil C, 2006, LIPIDS HEALTH DIS, V5, DOI 10.1186/1476-511X-5-27; Hazel M, 2004, ENDOCRINOLOGY, V145, P2118, DOI 10.1210/en.2003-0812; Hebert LF, 1996, J CLIN INVEST, V98, P930, DOI 10.1172/JCI118876; Hertzel AV, 2006, AM J PHYSIOL-ENDOC M, V290, pE814, DOI 10.1152/ajpendo.00465.2005; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Hsieh TJ, 2012, J CELL PHYSIOL, V227, P108, DOI 10.1002/jcp.22707; Jaworski K, 2009, NAT MED, V15, P159, DOI 10.1038/nm.1904; Jones JR, 2005, P NATL ACAD SCI USA, V102, P6207, DOI 10.1073/pnas.0306743102; Jun JC, 2012, AM J PHYSIOL-ENDOC M, V303, pE377, DOI 10.1152/ajpendo.00641.2011; Kabon B, 2004, ANESTHESIOLOGY, V100, P274, DOI 10.1097/00000542-200402000-00015; Kim KH, 2005, BIOCHEM BIOPH RES CO, V333, P1178, DOI 10.1016/j.bbrc.2005.06.023; Large V, 1999, J LIPID RES, V40, P2059; Luo B, 2007, J BIOL CHEM, V282, P7172, DOI 10.1074/jbc.M607362200; Macauley MS, 2008, J BIOL CHEM, V283, P34687, DOI 10.1074/jbc.M804525200; McClain DA, 2005, AM J PHYSIOL-ENDOC M, V288, pE973, DOI 10.1152/ajpendo.00549.2004; O'Rourke RW, 2011, DIABETOLOGIA, V54, P1480, DOI 10.1007/s00125-011-2103-y; Oh WK, 2005, P NATL ACAD SCI USA, V102, P1384, DOI 10.1073/pnas.0409451102; Park YK, 2010, J BIOL CHEM, V285, P3289, DOI 10.1074/jbc.M109.059212; Pasarica M, 2010, J CLIN ENDOCR METAB, V95, P4052, DOI 10.1210/jc.2009-2377; Pouwels MJJ, 2004, J CLIN ENDOCR METAB, V89, P5132, DOI 10.1210/jc.2004-0291; Regazzetti C, 2009, DIABETES, V58, P95, DOI 10.2337/db08-0457; REYNISDOTTIR S, 1995, CLIN SCI, V89, P421, DOI 10.1042/cs0890421; Robinson KA, 2007, AM J PHYSIOL-ENDOC M, V292, pE884, DOI 10.1152/ajpendo.00569.2006; Swiersz LM, 2004, METHOD ENZYMOL, V381, P387; Tchkonia T, 2006, DIABETES, V55, P2571, DOI 10.2337/db06-0540; Trayhurn P, 2008, BRIT J NUTR, V100, P227, DOI 10.1017/S0007114508971282; Valorani MG, 2012, CELL PROLIFERAT, V45, P225, DOI 10.1111/j.1365-2184.2012.00817.x; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Wang B, 2008, BIOCHEM BIOPH RES CO, V368, P88, DOI 10.1016/j.bbrc.2008.01.036; Wood IS, 2007, BIOCHEM BIOPH RES CO, V361, P468, DOI 10.1016/j.bbrc.2007.07.032; Ye J, 2009, INT J OBESITY, V33, P54, DOI 10.1038/ijo.2008.229; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007; Yin J, 2009, AM J PHYSIOL-ENDOC M, V296, pE333, DOI 10.1152/ajpendo.90760.2008; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4	39	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71165	10.1371/journal.pone.0071165	http://dx.doi.org/10.1371/journal.pone.0071165			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967162	Green Published, Green Submitted, gold			2022-12-25	WOS:000323221500055
J	Renier, L; Cuevas, I; Grandin, CB; Dricot, L; Plaza, P; Lerens, E; Rombaux, P; De Volder, AG				Renier, Laurent; Cuevas, Isabel; Grandin, Cecile B.; Dricot, Laurence; Plaza, Paula; Lerens, Elodie; Rombaux, Philippe; De Volder, Anne G.			Right Occipital Cortex Activation Correlates with Superior Odor Processing Performance in the Early Blind	PLOS ONE			English	Article							CROSS-MODAL PLASTICITY; EVENT-RELATED POTENTIALS; CONGENITALLY BLIND; VISUAL-CORTEX; SENSORY SUBSTITUTION; SIGHTED INDIVIDUALS; BRAILLE READERS; AUDITORY MOTION; CEREBRAL-CORTEX; WORKING-MEMORY	Using functional magnetic resonance imaging (fMRI) in ten early blind humans, we found robust occipital activation during two odor-processing tasks (discrimination or categorization of fruit and flower odors), as well as during control auditory-verbal conditions (discrimination or categorization of fruit and flower names). We also found evidence for reorganization and specialization of the ventral part of the occipital cortex, with dissociation according to stimulus modality: the right fusiform gyrus was most activated during olfactory conditions while part of the left ventral lateral occipital complex showed a preference for auditory-verbal processing. Only little occipital activation was found in sighted subjects, but the same right-olfactory/left-auditory-verbal hemispheric lateralization was found overall in their brain. This difference between the groups was mirrored by superior performance of the blind in various odor-processing tasks. Moreover, the level of right fusiform gyrus activation during the olfactory conditions was highly correlated with individual scores in a variety of odor recognition tests, indicating that the additional occipital activation may play a functional role in odor processing.	[Renier, Laurent; Cuevas, Isabel; Grandin, Cecile B.; Dricot, Laurence; Plaza, Paula; Lerens, Elodie; Rombaux, Philippe; De Volder, Anne G.] Catholic Univ Louvain, Inst Neurosci IoNS, B-1200 Brussels, Belgium; [Cuevas, Isabel] Pontificia Univ Catolica Valparaiso, Escuela Kinesiol, Valparaiso, Chile; [Grandin, Cecile B.] Clin Univ St Luc, Dept Radiol, B-1200 Brussels, Belgium; [Rombaux, Philippe] Clin Univ St Luc, Dept Otorhinolaryngol, B-1200 Brussels, Belgium	Universite Catholique Louvain; Pontificia Universidad Catolica de Valparaiso; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Renier, L (corresponding author), Catholic Univ Louvain, Inst Neurosci IoNS, B-1200 Brussels, Belgium.	laurent.renier@uclouvain.be; anne.de.volder@uclouvain.be			"Fonds special de Cooperation Universitaire au Developpement" of the Universite catholique de Louvain (Belgium); Brussels Institute for Research and Innovation (INNOVIRIS, Belgium); FRSM grant (Belgium) [3.4502.08]	"Fonds special de Cooperation Universitaire au Developpement" of the Universite catholique de Louvain (Belgium); Brussels Institute for Research and Innovation (INNOVIRIS, Belgium)(Innoviris); FRSM grant (Belgium)(Fonds de la Recherche Scientifique - FNRS)	The "Fonds special de Cooperation Universitaire au Developpement" of the Universite catholique de Louvain (Belgium) supported Isabel Cuevas and Paula Plaza. Anne G. De Volder is Senior Research Associate and Elodie Lerens is Research Fellow at the Belgian National Funds for Scientific Research (FNRS, http://www.frs-fnrs.be/, Belgium). Laurent Renier is a Postdoctoral Researcher supported by the Brussels Institute for Research and Innovation (INNOVIRIS, http://www.innoviris.be/site/, Belgium). This study was supported by FRSM grant #3.4502.08 (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amedi A, 2003, NAT NEUROSCI, V6, P758, DOI 10.1038/nn1072; Amedi A, 2007, NAT NEUROSCI, V10, P687, DOI 10.1038/nn1912; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Beaulieu-Lefebvre M, 2011, BRAIN RES BULL, V84, P206, DOI 10.1016/j.brainresbull.2010.12.014; Bedny M, 2011, P NATL ACAD SCI USA, V108, P4429, DOI 10.1073/pnas.1014818108; Bedny M, 2010, CURR BIOL, V20, P1900, DOI 10.1016/j.cub.2010.09.044; Bensafi M, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P259; Bonino D, 2008, ARCH ITAL BIOL, V146, P133; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brand G, 2001, NEUROSCI BIOBEHAV R, V25, P159, DOI 10.1016/S0149-7634(01)00005-7; Buchel C, 1998, BRAIN, V121, P409, DOI 10.1093/brain/121.3.409; Burton H, 2006, HUM BRAIN MAPP, V27, P325, DOI 10.1002/hbm.20188; Burton H, 2002, J NEUROPHYSIOL, V87, P589, DOI 10.1152/jn.00285.2001; Burton H, 2010, HUM BRAIN MAPP, V31, P1686, DOI 10.1002/hbm.20966; Cohen LG, 1997, NATURE, V389, P180, DOI 10.1038/38278; Cuevas I, 2011, B-ENT, V7, P11; Cuevas I, 2010, J VIS IMP BLINDNESS, V104, P169; Cuevas I, 2010, BEHAV RES METHODS, V42, P1072, DOI 10.3758/BRM.42.4.1072; Cuevas I, 2009, NEUROPSYCHOLOGIA, V47, P3079, DOI 10.1016/j.neuropsychologia.2009.07.004; De Volder AG, 2001, NEUROIMAGE, V14, P129, DOI 10.1006/nimg.2001.0782; Fiehler K, 2010, RESTOR NEUROL NEUROS, V28, P193, DOI 10.3233/RNN-2010-0500; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Friston K.J., 1994, HUM BRAIN MAPP, V1, P153, DOI DOI 10.1002/HBM.460010207; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; GEFFEN G, 1976, CORTEX, V12, P337, DOI 10.1016/S0010-9452(76)80037-8; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Gougoux F, 2005, PLOS BIOL, V3, P324, DOI 10.1371/journal.pbio.0030027; Gougoux F, 2004, NATURE, V430, P309, DOI 10.1038/430309a; Grant AC, 2000, PERCEPT PSYCHOPHYS, V62, P301, DOI 10.3758/BF03205550; Grill-Spector K, 2004, ANNU REV NEUROSCI, V27, P649, DOI 10.1146/annurev.neuro.27.070203.144220; HAXBY JV, 1991, P NATL ACAD SCI USA, V88, P1621, DOI 10.1073/pnas.88.5.1621; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; KUJALA T, 1992, ELECTROEN CLIN NEURO, V84, P469, DOI 10.1016/0168-5597(92)90034-9; Kujala T, 2000, TRENDS NEUROSCI, V23, P115, DOI 10.1016/S0166-2236(99)01504-0; Kupers R, 2011, NEUROPSYCHOLOGIA, V49, P2037, DOI 10.1016/j.neuropsychologia.2011.03.033; Kupers R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00019; Kupers R, 2010, P NATL ACAD SCI USA, V107, P12716, DOI 10.1073/pnas.1006199107; Lange N., 1996, APPL STAT, V46, P1; Lessard N, 1998, NATURE, V395, P278, DOI 10.1038/26228; Lewis LB, 2010, J NEUROPHYSIOL, V104, P2995, DOI 10.1152/jn.00983.2009; Liegeois F, 2004, BRAIN, V127, P1229, DOI 10.1093/brain/awh159; Lomber SG, 2010, NAT NEUROSCI, V13, P1421, DOI 10.1038/nn.2653; Mahon BZ, 2009, NEURON, V63, P397, DOI 10.1016/j.neuron.2009.07.012; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Merabet LB, 2010, NAT REV NEUROSCI, V11, P44, DOI 10.1038/nrn2758; Meredith MA, 2011, P NATL ACAD SCI USA, V108, P8856, DOI 10.1073/pnas.1018519108; MORRELL LK, 1971, SCIENCE, V174, P164, DOI 10.1126/science.174.4005.164; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; PASCUALLEONE A, 1993, BRAIN, V116, P39, DOI 10.1093/brain/116.1.39; Pietrini P, 2004, P NATL ACAD SCI USA, V101, P5658, DOI 10.1073/pnas.0400707101; Poirier C, 2006, NEUROIMAGE, V31, P279, DOI 10.1016/j.neuroimage.2005.11.036; Ptito M, 2005, BRAIN, V128, P606, DOI 10.1093/brain/awh380; Ptito M, 2009, NEUROREPORT, V20, P543, DOI 10.1097/WNR.0b013e3283279909; RAUSCHECKER JP, 1993, J NEUROSCI, V13, P4538; RAUSCHECKER JP, 1995, TRENDS NEUROSCI, V18, P36, DOI 10.1016/0166-2236(95)93948-W; Reich L, 2011, CURR BIOL, V21, P363, DOI 10.1016/j.cub.2011.01.040; Renier LA, 2013, NEUROS IN PRESS 0220, DOI [10.1016/j.neubiorev.2013.01.025, DOI 10.1016/J.NEUBI0REV.2013.01.025.[]; Renier LA, 2010, NEURON, V68, P138, DOI 10.1016/j.neuron.2010.09.021; Ricciardi E, 2007, CEREB CORTEX, V17, P2933, DOI 10.1093/cercor/bhm018; Roder B, 1999, NATURE, V400, P162, DOI 10.1038/22106; Roder B, 2002, EUR J NEUROSCI, V16, P930, DOI 10.1046/j.1460-9568.2002.02147.x; Roder B, 1996, COGNITIVE BRAIN RES, V4, P77, DOI 10.1016/0926-6410(96)00024-9; Rombaux P, 2010, NEUROREPORT, V21, P1069, DOI 10.1097/WNR.0b013e32833fcb8a; Royet JP, 2004, CHEM SENSES, V29, P731, DOI 10.1093/chemse/bjh067; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Saenz M, 2008, J NEUROSCI, V28, P5141, DOI 10.1523/JNEUROSCI.0803-08.2008; Savic I, 2000, NEURON, V26, P735, DOI 10.1016/S0896-6273(00)81209-X; Small DM, 2005, NEURON, V47, P593, DOI 10.1016/j.neuron.2005.07.022; Springer JA, 1999, BRAIN, V122, P2033, DOI 10.1093/brain/122.11.2033; Stevens AA, 2007, J NEUROSCI, V27, P10734, DOI 10.1523/JNEUROSCI.1669-07.2007; Stilla R, 2008, J VISION, V8, DOI 10.1167/8.10.13; Striem-Amit E, 2012, NEURON, V76, P640, DOI 10.1016/j.neuron.2012.08.026; Talairach J., 1988, COPLANAR STEREOTAXIC; Vanlierde A, 2003, NEUROIMAGE, V19, P698, DOI 10.1016/S1053-8119(03)00153-8; Voss P, 2004, CURR BIOL, V14, P1734, DOI 10.1016/j.cub.2004.09.051; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Weaver KE, 2007, J COGNITIVE NEUROSCI, V19, P315, DOI 10.1162/jocn.2007.19.2.315; Weeks R, 2000, J NEUROSCI, V20, P2664; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; ZATORRE RJ, 1992, NATURE, V360, P339, DOI 10.1038/360339a0	80	30	30	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71907	10.1371/journal.pone.0071907	http://dx.doi.org/10.1371/journal.pone.0071907			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967263	Green Published, Green Submitted, gold			2022-12-25	WOS:000323221500114
J	Cui, XY; Lu, X; Hiura, M; Oda, M; Miyazaki, W; Katoh, T				Cui, Xiaoyi; Lu, Xi; Hiura, Mizue; Oda, Masako; Miyazaki, Wataru; Katoh, Takahiko			Evaluation of Genetic Polymorphisms in Patients with Multiple Chemical Sensitivity	PLOS ONE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; S-TRANSFERASE M1; ENVIRONMENTAL EXPOSURE; SUSCEPTIBILITY; GENOTYPES; JAPANESE; VARIANTS; CYP2E1; CANCER; ASSOCIATION	Objective: Multiple chemical sensitivity (MCS) is a chronic medical condition characterized by symptoms that the affect an individual's response to low-level chemical exposure. In this study, we identified a chemical sensitive population (CSP) and investigated the effect of genetic polymorphisms on their risk of chemical sensitivity. Methods: A quick environment exposure sensitivity (QEESI) questionnaire was used to survey 324 Japanese male workers whose DNA samples had been collected and stored. The following genes, which encode enzymes affecting the metabolic activation of a large number of xenobiotic compounds, were selected and analyzed in order to determine their influence on genetic predisposition to CSP: cytochrome P450 (CYP) 2E1, N-acetyl transferase (NAT) 2, glutathione S-transferase (GST) M1, GSTT1, GSTP1, low Km aldehyde dehydrogenase (ALDH2), and superoxide dismutase (SOD) 2. Results: Significant case-control distributed differences were observed in SOD2 polymorphisms and allele frequency distribution in high chemical sensitive subjects. Both the significant adjusted OR of 4.30 (95% CI, 1.23-15.03) and 4.53 (95% CI, 1.52-13.51) were observed in SOD2 Ala/Ala and Val/Ala compared to Val/Val and in SOD2 Ala/Ala compared to Val/Ala compared to Val/Val genetic analysis in the high chemical sensitivity case-control study. Conclusions: We observed that high chemical sensitive individuals diagnosed by using Japanese criteria as MCS patients were more significantly associated with SOD2 polymorphisms.	[Cui, Xiaoyi; Lu, Xi; Hiura, Mizue; Oda, Masako; Miyazaki, Wataru; Katoh, Takahiko] Kumamoto Univ, Fac Life Sci, Dept Publ Hlth, Kumamoto, Japan	Kumamoto University	Cui, XY (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Publ Hlth, Kumamoto, Japan.	bjcxy860508@hotmail.com		Hiura, Mizue/0000-0001-9195-5547	Ministry of Health, Labor and Welfare of Japan [H24-Kenki-jpan]; Graduate School of Medical Sciences, Kumamoto University, Japan	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Graduate School of Medical Sciences, Kumamoto University, Japan	This work was supported in part by Grants-in-Aid for Research on Health Security Control (H24-Kenki-jpan) from the Ministry of Health, Labor and Welfare of Japan (http://www.mhlw.go.jp/) and was supported in part by the scholarship of the Graduate School of Medical Sciences, Kumamoto University, Japan (http://www.kumamoto-u.ac.jp/). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkerwi A, 2009, ATHEROSCLEROSIS, V204, P624, DOI 10.1016/j.atherosclerosis.2008.10.036; Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; Bag A, 2008, CANCER EPIDEM BIOMAR, V17, P3298, DOI 10.1158/1055-9965.EPI-08-0235; Bell IR, 1996, ARCH ENVIRON HEALTH, V51, P9, DOI 10.1080/00039896.1996.9935987; Berg ND, 2010, INT J HYG ENVIR HEAL, V213, P131, DOI 10.1016/j.ijheh.2010.02.001; Betteridge DJ, 2000, METABOLISM, V49, P3, DOI 10.1016/S0026-0495(00)80077-3; Caress SM, 2003, ENVIRON HEALTH PERSP, V111, P1490, DOI 10.1289/ehp.5940; Fiedler N, 1997, ENVIRON HEALTH PERSP, V105, P409; Gilliland FD, 2004, LANCET, V363, P119, DOI 10.1016/S0140-6736(03)15262-2; Graveling RA, 1999, OCCUP ENVIRON MED, V56, P73, DOI 10.1136/oem.56.2.73; HAYASHI S, 1991, J BIOCHEM-TOKYO, V110, P559, DOI 10.1093/oxfordjournals.jbchem.a123619; HEIN DW, 1988, BIOCHIM BIOPHYS ACTA, V948, P37, DOI 10.1016/0304-419X(88)90004-2; Hojo Sachiko, 2009, Environmental Health and Preventive Medicine, V14, P267, DOI 10.1007/s12199-009-0095-8; Inatomi H, 1999, INT J UROL, V6, P446, DOI 10.1046/j.1442-2042.1999.00096.x; Ishikawa S, 1999, ALLERGOLOGY IMMUNOLO, V6, P990; Katoh T, 1996, CARCINOGENESIS, V17, P1855, DOI 10.1093/carcin/17.9.1855; Katoh T, 1999, PHARMACOGENETICS, V9, P165; KAWAMOTO T, 1994, ARCH ENVIRON HEALTH, V49, P332, DOI 10.1080/00039896.1994.9954983; Lacour M, 2005, INT J HYG ENVIR HEAL, V208, P141, DOI 10.1016/j.ijheh.2005.01.017; Lu Y, 2008, FREE RADICAL BIO MED, V44, P723, DOI 10.1016/j.freeradbiomed.2007.11.004; Malle E, 2007, BRIT J PHARMACOL, V152, P838, DOI 10.1038/sj.bjp.0707358; Mapp CE, 2002, J ALLERGY CLIN IMMUN, V109, P867, DOI 10.1067/mai.2002.123234; McKeown-Eyssen G, 2004, INT J EPIDEMIOL, V33, P971, DOI 10.1093/ije/dyh251; Miller CS, 1999, TOXICOL IND HEALTH, V15, P370, DOI 10.1177/074823379901500311; Nakamura K, 2006, HUM GENET, V120, P243, DOI 10.1007/s00439-006-0189-y; Saito M, 2005, PSYCHOSOM MED, V67, P318, DOI 10.1097/01.psy.0000155676.69030.28; Schnakenberg E, 2007, ENVIRON HEALTH-GLOB, V6, DOI 10.1186/1476-069X-6-6; ShimodaMatsubayashi S, 1997, NEUROLOGY, V49, P1257, DOI 10.1212/WNL.49.5.1257; Sutton A, 2003, PHARMACOGENETICS, V13, P145, DOI 10.1097/00008571-200303000-00004; TAKESHITA T, 1994, HUM GENET, V94, P217; Takeuchi F, 2011, CIRC J, V75, P911, DOI 10.1253/circj.CJ-10-0774; Tsukino H, 2002, INT J CANCER, V100, P425, DOI 10.1002/ijc.10492; Usui S, 2011, FREE RADICAL BIO MED, V51, P1347, DOI 10.1016/j.freeradbiomed.2011.06.010; VINEIS P, 1994, NATURE, V369, P154, DOI 10.1038/369154a0; WATANABE J, 1994, J BIOCHEM-TOKYO, V116, P321, DOI 10.1093/oxfordjournals.jbchem.a124526; Watson MA, 1998, CARCINOGENESIS, V19, P275, DOI 10.1093/carcin/19.2.275; Wiesmuller GA, 2008, J TOXICOL ENV HEAL A, V71, P786, DOI 10.1080/15287390801985620; Xu Z, 2012, CANCER-AM CANCER SOC, V118, P5489, DOI 10.1002/cncr.27599; Yokoyama M, 2005, ALCOHOL CLIN EXP RES, V29, P1165, DOI 10.1097/01.ALC.0000172457.62535.EE	39	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e73708	10.1371/journal.pone.0073708	http://dx.doi.org/10.1371/journal.pone.0073708			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967348	gold, Green Submitted, Green Published			2022-12-25	WOS:000323115800123
J	Kisiel, M; Klar, AS; Martino, MM; Ventura, M; Hilborn, J				Kisiel, Marta; Klar, Agnieszka S.; Martino, Mikael M.; Ventura, Manuela; Hilborn, Jons			Evaluation of Injectable Constructs for Bone Repair with a Subperiosteal Cranial Model in the Rat	PLOS ONE			English	Article								While testing regenerative medicine strategies, the use of animal models that match the research questions and that are related to clinical translation is crucial. During the initial stage of evaluating new strategies for bone repair, the main goal is to state whether the strategies efficiently induce the formation of new bone tissue at an orthotopic site. Here, we present a subperiosteal model in rat calvaria that allow the evaluation of a broad range of approaches including bone augmentation, replacement and regeneration. The model is a fast to perform, minimally invasive, and has clearly defined control groups. The procedure enables to evaluate the outcomes quantitatively using micro-computed tomography and qualitatively by histology and immunohistochemistry. We established this new model, using bone morphogenetic protein-2 as an osteoinductive factor and hyaluronic acid hydrogel as injectable biomaterial. We showed that this subperiosteal cranial model offers a minimally invasive and promising solution for a rapid initial evaluation of injectables for bone repair. We believe that this approach could be a powerful platform for orthopedic research and regenerative medicine.	[Kisiel, Marta; Hilborn, Jons] Uppsala Univ, Div Polymer Chem, Dept Chem Angstrom, Sci Life Lab, Uppsala, Sweden; [Kisiel, Marta] Univ Hosp Akademiska, Fac Med, Uppsala, Sweden; [Klar, Agnieszka S.] Univ Childrens Hosp, Dept Surg, Tissue Biol Res Unit, Zurich, Switzerland; [Martino, Mikael M.] Osaka Univ, Host Def Lab, WPI Immunol Frontier Res Ctr IFReC, Osaka, Japan; [Ventura, Manuela] Radboud Univ Nijmegen, Nijmegen Med Ctr, NL-6525 ED Nijmegen, Netherlands	Uppsala University; University Children's Hospital Zurich; Osaka University; Radboud University Nijmegen	Hilborn, J (corresponding author), Uppsala Univ, Div Polymer Chem, Dept Chem Angstrom, Sci Life Lab, Uppsala, Sweden.	jons.hilborn@kemi.uu.se	Martino, Mikaël M/N-9345-2013; Kisiel, Marta/AAB-1312-2022; Hilborn, Jons/W-2864-2018	Martino, Mikaël M/0000-0002-5012-4605; Kisiel, Marta Alina/0000-0002-0410-1509; Hilborn, Jons/0000-0001-6947-9601; Klar, Agnes S./0000-0003-3521-8010	Marie Curie ITN	Marie Curie ITN(European Commission)	The study was supported by Marie Curie ITN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer JA, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-72; Barger-Lux M Janet, 2002, Top Magn Reson Imaging, V13, P297; Bergman K, 2009, J BIOMED MATER RES A, V91A, P1111, DOI 10.1002/jbm.a.32289; Boden SD, 2000, TISSUE ENG, V6, P383, DOI 10.1089/107632700418092; Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Docherty-Skogh AC, 2010, PLAST RECONSTR SURG, V125, P1383, DOI 10.1097/PRS.0b013e3181d629dc; Drosse I, 2008, TISSUE ENG PART C-ME, V14, P79, DOI 10.1089/tec.2007.0234; Einhorn TA, 1999, CLIN ORTHOP RELAT R, pS59, DOI 10.1097/00003086-199910001-00007; ELLENDER G, 1988, J ANAT, V158, P173; Emans PJ, 2005, TISSUE ENG, V11, P369, DOI 10.1089/ten.2005.11.369; Eryilmaz T, 2011, J CRANIOFAC SURG, V22, P1888, DOI 10.1097/SCS.0b013e31822e86a3; Fujimoto R, 1999, J BONE MINER METAB, V17, P11, DOI 10.1007/s007740050057; Gomes PS, 2011, LAB ANIM-UK, V45, P14, DOI 10.1258/la.2010.010085; Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123, DOI 10.2106/00004623-200212000-00001; Histing T, 2011, BONE, V49, P591, DOI 10.1016/j.bone.2011.07.007; Hulsart-Billstrom G, 2012, J TISSUE ENG REGEN M; Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08; Kisiel M, 2012, J CONTROL RELEASE; Kisiel M, 2013, BIOMATERIALS, V34, P704, DOI 10.1016/j.biomaterials.2012.10.015; Kisiel M, 2012, J CONTROL RELEASE, V162, P646, DOI 10.1016/j.jconrel.2012.08.004; Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542; Mahomed AA, 2007, J LAPAROENDOSC ADV S, V17, P375, DOI 10.1089/lap.2006.0077; Manes S, 2000, IUBMB LIFE, V49, P89; Martinez-Sanz E, 2012, J TISSUE ENG REGEN M; Muschler GF, 2010, TISSUE ENG PART B-RE, V16, P123, DOI [10.1089/ten.teb.2009.0658, 10.1089/ten.TEB.2009.0658]; Neyt J G, 1998, Iowa Orthop J, V18, P118; Perilli E, 2007, J MICROSC-OXFORD, V225, P192, DOI 10.1111/j.1365-2818.2007.01731.x; Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449; Rosen V, 2009, CYTOKINE GROWTH F R, V20, P475, DOI 10.1016/j.cytogfr.2009.10.018; Rowan A N, 1980, Dev Biol Stand, V45, P175; Russell AJ, 2005, TISSUE ENG, V11, pVII, DOI 10.1089/ten.2005.11.vii; Ryzewicz M, 2009, J BONE JOINT SURG BR, V91B, P522, DOI 10.1302/0301-620X.91B4.21399; Santos MI, 2010, MACROMOL BIOSCI, V10, P12, DOI 10.1002/mabi.200900107; SCHIMANDLE JH, 1994, SPINE, V19, P1998, DOI 10.1097/00007632-199409000-00023; SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299, DOI 10.1097/00003086-198604000-00036; Scott MA, 2012, STEM CELLS DEV, V21, P655, DOI 10.1089/scd.2011.0517; Sen MK, 2007, INJURY, V38, pS75, DOI 10.1016/j.injury.2007.02.012; Stevens MM, 2005, P NATL ACAD SCI USA, V102, P11450, DOI 10.1073/pnas.0504705102; Thomas MV, 2011, J DENT RES, V90, P1052, DOI 10.1177/0022034510393967; Viateau V, 2007, J ORTHOP RES, V25, P741, DOI 10.1002/jor.20352; WILLIAMS D F, 1992, Clinical Materials, V10, P9, DOI 10.1016/0267-6605(92)90078-8; Yamada Y, 2008, TISSUE ENG PT A, V14, P1699, DOI 10.1089/ten.tea.2007.0189; Zhu SJ, 2006, ORAL SURG ORAL MED O, V101, P166, DOI 10.1016/j.tripleo.2005.04.006	44	20	20	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71683	10.1371/journal.pone.0071683	http://dx.doi.org/10.1371/journal.pone.0071683			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967235	Green Published, gold, Green Submitted			2022-12-25	WOS:000323115800075
J	Kook, SH; Jeon, YM; Lim, SS; Jang, MJ; Cho, ES; Lee, SY; Choi, KC; Kim, JG; Lee, JC				Kook, Sung-Ho; Jeon, Young-Mi; Lim, Shin-Saeng; Jang, Moon-Ju; Cho, Eui-Sic; Lee, Seung-Yeop; Choi, Ki-Choon; Kim, Jong-Ghee; Lee, Jeong-Chae			Fibroblast Growth Factor-4 Enhances Proliferation of Mouse Embryonic Stem Cells via Activation of c-Jun Signaling	PLOS ONE			English	Article								Fibroblast growth factor-4 (FGF4) is expressed in embryonic stages and in adult tissues, where it plays critical roles in modulating multiple cellular functions. However, the exact roles of FGF4 on proliferation and differentiation of embryonic stem cells (ESCs) are not completely understood. Exogenous addition of FGF4 stimulated proliferation of mouse ESCs (mESCs), as proven by the increases in DNA synthesis and cell cycle regulatory protein induction. These increases were almost completely inhibited by pre-treating cells with anti-FGF4 antibody. FGF4 also activated c-Jun N-terminal kinase (JNK) and extracellular-signal regulated kinase (ERK) signaling, but not p38 kinase. Blockage of JNK signaling by SP600125 or by transfection with its specific siRNA significantly inhibited FGF4-stimulated cell proliferation through the suppression of c-Jun induction and activator protein-1 (AP-1) activity. However, ERK or p38 kinase inhibitor did not affect FGF4-stimulated proliferation in mESCs. FGF4 suppressed osteogenic differentiation of mESCs by inhibiting expression of transcription factors involved in bone formation. Further, exogenous FGF4 addition stimulated proliferation of human periodontal ligament stem cells (hPDLSCs) and bone marrow mesenchymal stem cells (BMMSCs) via activation of ERK signaling. FGF4 also augmented mineralization of hPDLSCs, but not of BMMSCs. Collectively, it is suggested that FGF4 triggers proliferation of stem cells by activating MAPK-mediated signaling, while it affects differently osteogenic differentiation according to the origins of stem cells.	[Kook, Sung-Ho; Jeon, Young-Mi; Jang, Moon-Ju; Cho, Eui-Sic; Lee, Seung-Yeop; Kim, Jong-Ghee; Lee, Jeong-Chae] Chonbuk Natl Univ, Inst Oral Biosci, Cluster Craniofacial Dev & Regenerat Res, Jeonju, South Korea; [Kook, Sung-Ho; Jeon, Young-Mi; Jang, Moon-Ju; Cho, Eui-Sic; Lee, Seung-Yeop; Kim, Jong-Ghee; Lee, Jeong-Chae] Chonbuk Natl Univ, Sch Dent, Jeonju, South Korea; [Lim, Shin-Saeng; Lee, Jeong-Chae] Chonbuk Natl Univ, Res Ctr Bioact Mat, Jeonju, South Korea; [Choi, Ki-Choon] Natl Inst Anim Sci, Grassland & Forages Res Ctr, Cheonan, South Korea	Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; National Institute of Animal Science, Republic of Korea	Lee, JC (corresponding author), Chonbuk Natl Univ, Inst Oral Biosci, Cluster Craniofacial Dev & Regenerat Res, Jeonju, South Korea.	leejc88@jbnu.ac.kr			National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0009123]; Chonbuk National University	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Chonbuk National University	This research was supported by Basic Science Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0009123). This paper was in part supported by research funds of Chonbuk National University in 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2009, FEBS LETT, V583, P2922, DOI 10.1016/j.febslet.2009.07.056; Baek WY, 2009, J BONE MINER RES, V24, P1055, DOI [10.1359/JBMR.081248, 10.1359/jbmr.081248]; Bakiri L, 2000, EMBO J, V19, P2056, DOI 10.1093/emboj/19.9.2056; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Bobick BE, 2007, J CELL PHYSIOL, V211, P233, DOI 10.1002/jcp.20923; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen Y, 2000, J INFRARED MILLIM W, V19, P19; Choi JY, 1996, J CELL BIOCHEM, V61, P609, DOI 10.1002/(SICI)1097-4644(19960616)61:4<609::AID-JCB15>3.3.CO;2-Q; Choi SC, 2008, STEM CELLS DEV, V17, P725, DOI 10.1089/scd.2007.0230; D'Andrea LD, 2009, CURR PHARM DESIGN, V15, P2414, DOI 10.2174/138161209788682235; Ding M, 1999, J BIOL CHEM, V274, P30611, DOI 10.1074/jbc.274.43.30611; Eiselleova L, 2009, STEM CELLS, V27, P1847, DOI 10.1002/stem.128; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Florin L, 2005, J CELL SCI, V118, P1981, DOI 10.1242/jcs.02303; Geest CR, 2009, J LEUKOCYTE BIOL, V86, P237, DOI 10.1189/jlb.0209097; Gron B, 2002, APMIS, V110, P892, DOI 10.1034/j.1600-0463.2002.1101208.x; HEATH JK, 1985, CIBA F SYMP, V116, P3; Ito T, 2008, CYTOTECHNOLOGY, V56, P1, DOI 10.1007/s10616-007-9092-1; Jacobs-Helber SM, 1998, MOL CELL BIOL, V18, P3699, DOI 10.1128/MCB.18.7.3699; Jeon YM, 2009, MOL CELL BIOCHEM, V320, P45, DOI 10.1007/s11010-008-9897-z; Jeong JH, 2011, BMB REP, V44, P613, DOI 10.5483/BMBRep.2011.44.10.613; Kim SY, 2012, MOL CELLS, V33, P343, DOI 10.1007/s10059-012-2172-x; Kook SH, 2009, J CELL BIOCHEM, V106, P1060, DOI 10.1002/jcb.22085; Kosaka N, 2006, FASEB J, V20, P1484, DOI 10.1096/fj.05-5293fje; Kosaka N, 2009, DEV DYNAM, V238, P265, DOI 10.1002/dvdy.21699; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Kuntzen C, 2005, CANCER RES, V65, P6780, DOI 10.1158/0008-5472.CAN-04-2618; Lapidot T, 2002, EXP HEMATOL, V30, P973, DOI 10.1016/S0301-472X(02)00883-4; Liedert A, 2006, BIOCHEM BIOPH RES CO, V349, P1, DOI 10.1016/j.bbrc.2006.07.214; Maulik N, 1998, FEBS LETT, V429, P365, DOI 10.1016/S0014-5793(98)00632-2; McFarland DC, 2008, COMP BIOCHEM PHYS B, V149, P463, DOI 10.1016/j.cbpb.2007.11.013; Miller K, 1996, CELL GROWTH DIFFER, V7, P203; Moore MAS, 2002, J CELL BIOCHEM, P29, DOI 10.1002/jcb.10105; Quarto N, 2008, BONE, V42, P1040, DOI 10.1016/j.bone.2008.01.026; Quito FL, 1996, BLOOD, V87, P1282, DOI 10.1182/blood.V87.4.1282.bloodjournal8741282; Rose LC, 2013, J TISSUE ENG REGEN M, V7, P371, DOI 10.1002/term.532; SANDBERG MM, 1993, CLIN ORTHOP RELAT R, P292; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Sinha KM, 2013, J CELL BIOCHEM, V114, P975, DOI 10.1002/jcb.24439; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Visco V, 2009, J CELL PHYSIOL, V220, P204, DOI 10.1002/jcp.21752; Yang WT, 2006, DEV CELL, V10, P317, DOI 10.1016/j.devcel.2006.01.002; Zaragosi LE, 2006, STEM CELLS, V24, P2412, DOI 10.1634/stemcells.2006-0006	46	16	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71641	10.1371/journal.pone.0071641	http://dx.doi.org/10.1371/journal.pone.0071641			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967228	Green Submitted, Green Published, gold			2022-12-25	WOS:000323115800069
J	Pei, Y; Chen, X; Aboutouk, D; Fuller, MT; Dadoo, O; Yu, P; White, EJ; Igdoura, SA; Trigatti, BL				Pei, Ying; Chen, Xing; Aboutouk, Dina; Fuller, Mark T.; Dadoo, Omid; Yu, Pei; White, Elizabeth J.; Igdoura, Suleiman A.; Trigatti, Bernardo L.			SR-BI in Bone Marrow Derived Cells Protects Mice from Diet Induced Coronary Artery Atherosclerosis and Myocardial Infarction	PLOS ONE			English	Article								SR-BI deficient mice that are also hypomorphic for apolipoprotein E expression develop diet induced occlusive coronary artery atherosclerosis, myocardial infarction and early death. To test the role of SR-BI in bone marrow derived cells, we used bone marrow transplantation to generate SR-BI-null; apoE-hypomorphic mice in which SR-BI expression was restored solely in bone marrow derived cells. SR-BI-null; apoE-hypomorphic mice were transplanted with SR-BI+/+ apoE-hypomorphic, or control, autologous SR-BI-null; apoE-hypomorphic bone marrow. Four weeks later, mice were fed a high-fat, high-cholesterol, cholate-containing diet to induce coronary artery atherosclerosis. Mice transplanted with autologous bone marrow developed extensive aortic atherosclerosis and severe occlusive coronary artery atherosclerosis after 4 weeks of feeding. This was accompanied by myocardial fibrosis and increased heart weights. In contrast, restoration of SR-BI expression in bone marrow derived-cells reduced diet induced aortic and coronary artery atherosclerosis, myocardial fibrosis and the increase in heart weights in SR-BI-null; apoE-hypomorphic mice. Restoration of SR-BI in bone marrow derived cells did not, however, affect steady state lipoprotein cholesterol levels, but did reduce plasma levels of IL-6. Monocytes from SR-BI-null mice exhibited a greater capacity to bind to VCAM-1 and ICAM-1 than those from SR-BI+/+ mice. Furthermore, restoration of SR-BI expression in bone marrow derived cells attenuated monocyte recruitment into atherosclerotic plaques in mice fed high fat, high cholesterol cholate containing diet. These data demonstrate directly that SR-BI in bone marrow-derived cells protects against both aortic and CA atherosclerosis.	[Pei, Ying; Chen, Xing; Aboutouk, Dina; Fuller, Mark T.; Dadoo, Omid; Yu, Pei; Trigatti, Bernardo L.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Pei, Ying; Chen, Xing; Aboutouk, Dina; Fuller, Mark T.; Dadoo, Omid; Yu, Pei; Trigatti, Bernardo L.] McMaster Univ, Thrombosis & Atherosclerosis Res Inst, Hamilton, ON L8N 3Z5, Canada; [White, Elizabeth J.; Igdoura, Suleiman A.] McMaster Univ, Dept Biol & Pathol & Mol Med, Hamilton, ON L8N 3Z5, Canada	McMaster University; McMaster University; McMaster University	Trigatti, BL (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada.	trigatt@mcmaster.ca		Trigatti, Bernardo (Dino) L./0000-0002-4556-119X	Canadian Institutions of Health Research [MOP74753]; Heart and Stroke Foundation of Ontario Program [PRG 6502]; Heart and Stroke Foundation of Canada; Canadian Institutes of Health Research; Chinese Scholarship Council; Natural Sciences and Engineering Research Council of Canada; Institution of Genetics	Canadian Institutions of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario Program; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Chinese Scholarship Council(China Scholarship Council); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Institution of Genetics	This research was supported by a grant (MOP74753) from the Canadian Institutions of Health Research, Institution of Genetics and the Heart and Stroke Foundation of Ontario Program Grant (PRG 6502). BLT has been a New Investigator of the Heart and Stroke Foundation of Canada. MF is supported by scholarships from the Heart and Stroke Foundation of Canada and the Canadian Institutes of Health Research. PY is the recipient of a graduate scholarship from the Chinese Scholarship Council. DA was supported by an Undergraduate Summer Research Award from the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Jarallah A, 2010, BBA-MOL CELL BIOL L, V1801, P1239, DOI 10.1016/j.bbalip.2010.08.006; Arai T, 1999, J BIOL CHEM, V274, P2366, DOI 10.1074/jbc.274.4.2366; Barth H, 2008, J VIROL, V82, P3466, DOI 10.1128/JVI.02478-07; BOISVERT WA, 1995, J CLIN INVEST, V96, P1118, DOI 10.1172/JCI118098; Braun A, 2003, P NATL ACAD SCI USA, V100, P7283, DOI 10.1073/pnas.1237725100; Braun A, 2002, CIRC RES, V90, P270, DOI 10.1161/hh0302.104462; Brundert M, 2005, ARTERIOSCL THROM VAS, V25, P143, DOI 10.1161/01.ATV.0000149381.16166.c6; Roque-Cuellar MC, 2012, J MED VIROL, V84, P1727, DOI 10.1002/jmv.23345; Covey SD, 2003, ARTERIOSCL THROM VAS, V23, P1589, DOI 10.1161/01.ATV.0000083343.19940.A0; Feng CG, 2011, J LEUKOCYTE BIOL, V90, P313, DOI 10.1189/jlb.1210708; Feng H, 2011, ARTERIOSCL THROM VAS, V31, P2543, DOI 10.1161/ATVBAHA.111.234716; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; Getz GS, 2006, ARTERIOSCL THROM VAS, V26, P242, DOI 10.1161/01.ATV.0000201071.49029.17; Hatzopoulos AK, 1998, J LIPID RES, V39, P495; Hirano K, 1999, CIRC RES, V85, P108; Huber SA, 1999, ARTERIOSCL THROM VAS, V19, P2364, DOI 10.1161/01.ATV.19.10.2364; Huszar D, 2000, ARTERIOSCL THROM VAS, V20, P1068, DOI 10.1161/01.ATV.20.4.1068; Imachi H, 2003, ARTERIOSCL THROM VAS, V23, P898, DOI 10.1161/01.ATV.0000067429.46333.7B; Imachi H, 2001, HORM METAB RES, V33, P389, DOI 10.1055/s-2001-16237; Kaplanski G, 2003, TRENDS IMMUNOL, V24, P25, DOI 10.1016/S1471-4906(02)00013-3; Karackattu SL, 2006, ARTERIOSCL THROM VAS, V26, P548, DOI 10.1161/01.ATV.0000202662.63876.02; Karackattu SL, 2005, ARTERIOSCLER THROMB; Kozarsky KF, 2000, ARTERIOSCL THROM VAS, V20, P721, DOI 10.1161/01.ATV.20.3.721; Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0; Landschulz KT, 1996, J CLIN INVEST, V98, P984, DOI 10.1172/JCI118883; Lawrie A, 2011, AM J PATHOL, V179, P1693, DOI 10.1016/j.ajpath.2011.06.037; Lichterfeld M, 2000, BRIT J HAEMATOL, V110, P71, DOI 10.1046/j.1365-2141.2000.02130.x; Mardones P, 2001, J LIPID RES, V42, P170; Murphy AJ, 2008, ARTERIOSCL THROM VAS, V28, P2071, DOI 10.1161/ATVBAHA.108.168690; Out R, 2004, J LIPID RES, V45, P2088, DOI 10.1194/jlr.M400191-JLR200; Raffai RL, 2002, J BIOL CHEM, V277, P11064, DOI 10.1074/jbc.M111222200; Raffai RL, 2001, P NATL ACAD SCI USA, V98, P11587, DOI 10.1073/pnas.201279298; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Rose DM, 2000, BLOOD, V95, P602, DOI 10.1182/blood.V95.2.602; Smythies LE, 2010, AM J PHYSIOL-CELL PH, V298, pC1538, DOI 10.1152/ajpcell.00467.2009; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; Ueda Y, 2000, J BIOL CHEM, V275, P20368, DOI 10.1074/jbc.M000730200; Ueda Y, 1999, J BIOL CHEM, V274, P7165, DOI 10.1074/jbc.274.11.7165; Van Eck M, 2004, AM J PATHOL, V165, P785, DOI 10.1016/S0002-9440(10)63341-X; Van Eck M, 2003, J BIOL CHEM, V278, P23699, DOI 10.1074/jbc.M211233200; VanEck M, 1997, ARTERIOSCL THROM VAS, V17, P3117, DOI 10.1161/01.ATV.17.11.3117; Varban ML, 1998, P NATL ACAD SCI USA, V95, P4619, DOI 10.1073/pnas.95.8.4619; Wang N, 1998, J BIOL CHEM, V273, P32920, DOI 10.1074/jbc.273.49.32920; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228; Yancey PG, 2003, ARTERIOSCL THROM VAS, V23, P712, DOI 10.1161/01.ATV.0000057572.97137.DD; Yu H, 2006, ARTERIOSCL THROM VAS, V26, P150, DOI 10.1161/01.ATV.0000194096.89476.73; Yuhanna IS, 2001, NAT MED, V7, P853, DOI 10.1038/89986; Zannis VI, 2006, J MOL MED, V84, P276, DOI 10.1007/s00109-005-0030-4; Zhang SW, 2005, CIRCULATION, V111, P3457, DOI 10.1161/CIRCULATIONAHA.104.523563; Zhang WW, 2003, CIRCULATION, V108, P2258, DOI 10.1161/01.CIR.0000093189.97429.9D; Zhang Y, 2007, J LIPID RES, V48, P405, DOI 10.1194/jlr.M600326-JLR200; Zhang YZ, 2005, J CLIN INVEST, V115, P2870, DOI 10.1172/JCI25327	55	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e72492	10.1371/journal.pone.0072492	http://dx.doi.org/10.1371/journal.pone.0072492			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967310	Green Published, gold, Green Submitted			2022-12-25	WOS:000323115800104
J	Pitt, KA; Duarte, CM; Lucas, CH; Sutherland, KR; Condon, RH; Mianzan, H; Purcell, JE; Robinson, KL; Uye, SI				Pitt, Kylie A.; Duarte, Carlos M.; Lucas, Cathy H.; Sutherland, Kelly R.; Condon, Robert H.; Mianzan, Hermes; Purcell, Jennifer E.; Robinson, Kelly L.; Uye, Shin-Ichi			Jellyfish Body Plans Provide Allometric Advantages beyond Low Carbon Content	PLOS ONE			English	Article								Jellyfish form spectacular blooms throughout the world's oceans. Jellyfish body plans are characterised by high water and low carbon contents which enables them to grow much larger than non-gelatinous animals of equivalent carbon content and to deviate from non-gelatinous pelagic animals when incorporated into allometric relationships. Jellyfish have, however, been argued to conform to allometric relationships when carbon content is used as the metric for comparison. Here we test the hypothesis that differences in allometric relationships for several key functional parameters remain for jellyfish even after their body sizes are scaled to their carbon content. Data on carbon and nitrogen contents, rates of respiration, excretion, growth, longevity and swimming velocity of jellyfish and other pelagic animals were assembled. Allometric relationships between each variable and the equivalent spherical diameters of jellyfish and other pelagic animals were compared before and after sizes of jellyfish were standardised for their carbon content. Before standardisation, the slopes of the allometric relationships for respiration, excretion and growth were the same for jellyfish and other pelagic taxa but the intercepts differed. After standardisation, slopes and intercepts for respiration were similar but excretion rates of jellyfish were 10x slower, and growth rates 2x faster than those of other pelagic animals. Longevity of jellyfish was independent of size. The slope of the allometric relationship of swimming velocity of jellyfish differed from that of other pelagic animals but because they are larger jellyfish operate at Reynolds numbers approximately 10x greater than those of other pelagic animals of comparable carbon content. We conclude that low carbon and high water contents alone do not explain the differences in the intercepts or slopes of the allometric relationships of jellyfish and other pelagic animals and that the evolutionary longevity of jellyfish and their propensity to form blooms is facilitated by their unique body plans.	[Pitt, Kylie A.] Griffith Univ, Australian Rivers Inst Coasts & Estuaries, Gold Coast, Qld, Australia; [Pitt, Kylie A.] Griffith Univ, Griffith Sch Environm, Gold Coast, Qld, Australia; [Duarte, Carlos M.] Univ Western Australia, UWA Oceans Inst, Perth, WA 6009, Australia; [Duarte, Carlos M.] Univ Illes Balears, Consejo Super Invest Cient, Inst Mediterraneo Estudios Avanzados, Dept Global Change Res, Esporles, Spain; [Duarte, Carlos M.] King Abdulaziz Univ, Fac Marine Sci, Jeddah 21413, Saudi Arabia; [Lucas, Cathy H.] Univ Southampton, Natl Oceanog Ctr Southampton, Southampton, Hants, England; [Sutherland, Kelly R.] Univ Oregon, Oregon Inst Marine Biol, Eugene, OR 97403 USA; [Sutherland, Kelly R.] Univ Oregon, Inst Ecol & Evolut, Eugene, OR 97403 USA; [Condon, Robert H.] Dauphin Isl Sea Lab, Dauphin Isl, AL USA; [Mianzan, Hermes] Inst Nacl Invest & Desarrollo Pesquero, Mar Del Plata, Buenos Aires, Argentina; [Purcell, Jennifer E.] Western Washington Univ, Shannon Point Marine Ctr, Anacortes, WA USA; [Robinson, Kelly L.] Univ So Mississippi, Dept Marine Sci, Stennis, MS USA; [Uye, Shin-Ichi] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima 724, Japan	Griffith University; Griffith University; University of Western Australia; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; King Abdulaziz University; NERC National Oceanography Centre; University of Southampton; University of Oregon; University of Oregon; Dauphin Island Sea Lab; National Fisheries Research & Development Institute (INIDEP); Western Washington University; University of Southern Mississippi; Hiroshima University	Pitt, KA (corresponding author), Griffith Univ, Australian Rivers Inst Coasts & Estuaries, Gold Coast, Qld, Australia.	K.Pitt@griffith.edu.au	Pitt, Kylie A/N-7421-2014; Duarte, Carlos M/A-7670-2013; Duarte Quesada, Carlos Manuel/ABD-6208-2021; Lucas, Cathy H/N-1230-2013; Robinson, Kelly/ABA-1902-2021	Pitt, Kylie A/0000-0002-2292-2052; Duarte, Carlos M/0000-0002-1213-1361; Lucas, Cathy H/0000-0002-5929-7481; Robinson, Kelly/0000-0002-5241-1675; Sutherland, Kelly/0000-0001-6832-6515	National Science Foundation [DEB-94-21535]; University of California at Santa Barbara; State of California	National Science Foundation(National Science Foundation (NSF)); University of California at Santa Barbara; State of California	The authors are members of the Jellyfish Working Group (JWG), convened by the National Center for Ecological Analysis and Synthesis (NCEAS). Funding for NCEAS and the JWG comes from National Science Foundation Grant no. DEB-94-21535, from the University of California at Santa Barbara, and from the State of California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna JL, 2001, AM NAT, V158, P100, DOI 10.1086/320864; Braefield AE, 1982, ANIMAL ENERGETICS; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; CHILDRESS JJ, 1995, TRENDS ECOL EVOL, V10, P30, DOI 10.1016/S0169-5347(00)88957-0; CLARKE A, 1985, J MAR BIOL ASSOC UK, V65, P983, DOI 10.1017/S0025315400019457; Colin SP, 2002, J EXP BIOL, V205, P427; Condon R.H., 2011, ECOLOGY, V92, P1704, DOI [10.1890/11-0302.1, DOI 10.1890/11-0302.1]; Condon RH, 2011, P NATL ACAD SCI USA, V108, P10225, DOI 10.1073/pnas.1015782108; COSTELLO J, 1991, MAR BIOL, V108, P119, DOI 10.1007/BF01313479; Costello JH, 2008, INVERTEBR BIOL, V127, P265, DOI 10.1111/j.1744-7410.2008.00126.x; CRAIG CL, 1990, EVOL ECOL, V4, P115, DOI 10.1007/BF02270909; Dabiri JO, 2007, J EXP BIOL, V210, P1868, DOI 10.1242/jeb.003772; Decker MB, 2007, MAR ECOL PROG SER, V329, P99, DOI 10.3354/meps329099; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; DONALDSON S, 1980, CAN J ZOOL, V58, P549, DOI 10.1139/z80-076; DONNELLY J, 1994, POLAR BIOL, V14, P171; Fawcett D., 1994, TXB HISTOLOGY; Ford MD, 2000, SCI MAR, V64, P47; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; GOLDMAN JC, 1987, LIMNOL OCEANOGR, V32, P1239, DOI 10.4319/lo.1987.32.6.1239; HAMNER WM, 1974, AM ZOOL, V14, P833; Hansen PJ, 1997, LIMNOL OCEANOGR, V42, P687, DOI 10.4319/lo.1997.42.4.0687; HARBISON GR, 1992, OCEANUS, V35, P18; Hirst AG, 2003, ADV MAR BIOL, V44, P1, DOI 10.1016/S0065-2881(03)44002-9; Hulbert AJ, 2007, PHYSIOL REV, V87, P1175, DOI 10.1152/physrev.00047.2006; Humphries S, 2009, P NATL ACAD SCI USA, V106, P7882, DOI 10.1073/pnas.0809063106; KIKINGER R, 1992, MAR ECOL-P S Z N I, V13, P333, DOI 10.1111/j.1439-0485.1992.tb00359.x; Kiorboe T, 2011, BIOL REV, V86, P311, DOI 10.1111/j.1469-185X.2010.00148.x; LARSON RJ, 1987, CAN J ZOOL, V65, P2690, DOI 10.1139/z87-408; LOTAN A, 1992, MAR BIOL, V112, P237, DOI 10.1007/BF00702467; Acuna JL, 2011, SCIENCE, V333, P1627, DOI 10.1126/science.1205134; MADIN LP, 1988, B MAR SCI, V43, P413; Mccoy MW, 2008, ECOL LETT, V11, P710, DOI 10.1111/j.1461-0248.2008.01190.x; Miglietta MP, 2008, J PLANKTON RES, V30, P783, DOI 10.1093/plankt/fbn038; MILLS CE, 1993, B MAR SCI, V53, P194; Moller LF, 2007, MAR ECOL PROG SER, V346, P167, DOI 10.3354/meps06959; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Okubo A., 1987, Lecture Notes in Biomathematics, V71, P32; Pitt KA, 2009, HYDROBIOLOGIA, V616, P133, DOI 10.1007/s10750-008-9584-9; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Riisgard HU, 1998, ECOL LETT, V1, P71; Ruppert EE, 2004, INVERTEBRATE ZOOLOGY; SCHNEIDER G, 1992, HELGOLANDER MEERESUN, V46, P377, DOI 10.1007/BF02367205; SCHNEIDER G, 1988, KIELER MEERESFORSCH, V6, P295; Seibel BA, 2007, PHILOS T R SOC B, V362, P2061, DOI 10.1098/rstb.2007.2101; Thuesen EV, 2005, J EXP BIOL, V208, P2475, DOI 10.1242/jeb.01655; THUESEN EV, 1994, BIOL BULL-US, V187, P84, DOI 10.2307/1542168; TORRES JJ, 1994, MAR ECOL PROG SER, V113, P221, DOI 10.3354/meps113221; Uye Siain-Icth, 2008, Plankton & Benthos Research, V3, P125, DOI 10.3800/pbr.3.125; Ventura M, 2006, MAR ECOL PROG SER, V327, P233, DOI 10.3354/meps327233; Verde EA, 1998, MAR ECOL PROG SER, V168, P147, DOI 10.3354/meps168147; Zahn VM., 1981, ZOOL BEITR, V27, P491	52	58	58	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e72683	10.1371/journal.pone.0072683	http://dx.doi.org/10.1371/journal.pone.0072683			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967331	Green Published, gold, Green Accepted			2022-12-25	WOS:000323115800114
J	Takahashi, K; Matsumoto, Y; Zhulanqiqige, DE; Kanazawa, M; Satoh, K; Shimizu, T; Sato, A; Fukumoto, Y; Shimokawa, H				Takahashi, Kikuyo; Matsumoto, Yasuharu; Zhulanqiqige, Do E.; Kanazawa, Masanori; Satoh, Kimio; Shimizu, Takuya; Sato, Akira; Fukumoto, Yoshihiro; Shimokawa, Hiroaki			Combination Therapy with Atorvastatin and Amlodipine Suppresses Angiotensin II-Induced Aortic Aneurysm Formation	PLOS ONE			English	Article							HMG-COA REDUCTASE; RHO-KINASE; INHIBITOR; PATHWAY; GROWTH; PHARMACOKINETICS; ATHEROSCLEROSIS; PATHOGENESIS; CYCLOPHILIN; PROGRESSION	Background: Abdominal aortic aneurysm (AAA) is a life-threatening vascular disease. It is controversial whether statin and calcium channel blockers (CCBs) has an inhibitory effect on the expansion of AAA. Some studies reported that CCBs have an inhibitory effect on Rho-kinase activity. Rho-kinase plays an important role in the pathogenesis of various cardiovascular diseases. However, there is no study reporting of the association between Rho-kinase and human AAAs. Methods and Results: Experimental AAA was induced in Apolipoprotein E-deficient (ApoE(-/-)) mice infused with angiotensin II (AngII) for 28 days. They were randomly divided into the following 5 groups; saline infusion alone (sham), AngII infusion alone, AngII infusion plus atorvastatin (10 mg/kg/day), AngII infusion plus amlodipine (1 mg/kg/day), and AngII infusion plus combination therapy with atorvastatin (10 mg/kg/day) and amlodipine (1 mg/kg/day). The combination therapy significantly suppressed AngII-induced increase in maximal aortic diameter as compared with sham, whereas each monotherapy had no inhibitory effects. The combination therapy significantly reduced AngII-induced apoptosis and elastin degradation at the AAA lesion, whereas each monotherapy did not. Moreover, Rho-kinase activity, as evaluated by the extent of phosphorylation of myosin-binding subunit (a substrate of Rho-kinase) and matrix metalloproteinase activity were significantly increased in the AngII-induced AAA lesion as compared with sham, both of which were again significantly suppressed by the combination therapy. In human aortic samples, immunohistochemistory revealed that the activity and expression of Rho-kinase was up-regulated in AAA lesion as compared with abdominal aorta from control subjects. Conclusions: Rho-kinase is up-regulated in the aortic wall of human AAA. The combination therapy with amlodipine and Atorvastatin, but not each monotherapy, suppresses AngII-induced AAA formation in mice in vivo, for which Rho-kinase inhibition may be involved.	[Takahashi, Kikuyo; Matsumoto, Yasuharu; Zhulanqiqige, Do E.; Kanazawa, Masanori; Satoh, Kimio; Fukumoto, Yoshihiro; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 980, Japan; [Shimizu, Takuya; Sato, Akira] Tohoku Univ, Grad Sch Med, Dept Transplantat Reconstruct & Endoscop Surg, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University	Matsumoto, Y (corresponding author), Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 980, Japan.	matsumoto@cardio.med.tohoku.ac.jp	Satoh, Kimio/O-7794-2019	Shimokawa, Hiroaki/0000-0001-7534-4826	Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan	Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the Grant-in-Aid for Scientific Research on Innovative Areas (Signaling Functions of Reactive Oxygen Species), the Grant-in-Aid for Tohoku University Global COE for Conquest of Signal Transduction Diseases with Network Medicine, and the Grants-in-Aid for Scientific Research, all of which are from the Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins GB, 2007, CIRC RES, V100, P1686, DOI 10.1161/01.RES.0000267856.00713.0a; Bailey MA, 2012, J VASC SURG, V55, P1593, DOI 10.1016/j.jvs.2011.12.075; Baxter BT, 2008, CIRCULATION, V117, P1883, DOI 10.1161/CIRCULATIONAHA.107.735274; Black AE, 1998, DRUG METAB DISPOS, V26, P755; Bruemmer D, 2003, J CLIN INVEST, V112, P1318, DOI 10.1172/JCI200318141; Cafueri G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035312; Cassis LA, 2009, AM J PHYSIOL-HEART C, V296, pH1660, DOI 10.1152/ajpheart.00028.2009; Cilla DD, 1996, CLIN PHARMACOL THER, V60, P687, DOI 10.1016/S0009-9236(96)90218-0; Das R, 2009, CIRC RES, V105, P167, DOI 10.1161/CIRCRESAHA.109.200311; Do E Z, 2009, CIRC J, V73, P1731, DOI 10.1253/circj.CJ-09-0135; Dua MM, 2010, VASC PHARMACOL, V53, P11, DOI 10.1016/j.vph.2010.03.004; Feeney JM, 2009, J AM COLL SURGEONS, V209, P41, DOI 10.1016/j.jamcollsurg.2009.03.005; Ghoshal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044369; Golledge J, 2011, ATHEROSCLEROSIS, V217, P57, DOI 10.1016/j.atherosclerosis.2011.03.006; Hagita S, 2011, HYPERTENS RES, V34, P450, DOI 10.1038/hr.2010.254; Hata T, 2011, J HYPERTENS, V29, P373, DOI 10.1097/HJH.0b013e328340902d; Hellenthal FAMVI, 2009, NAT REV CARDIOL, V6, P543, DOI 10.1038/nrcardio.2009.102; Kaneko H, 2011, CARDIOVASC RES, V91, P358, DOI 10.1093/cvr/cvr080; Kanematsu Y, 2010, HYPERTENSION, V55, P1267, DOI 10.1161/HYPERTENSIONAHA.109.140558; Kawai H, 2011, BRAIN RES, V1382, P308, DOI 10.1016/j.brainres.2011.01.062; Matsumoto Y, 2010, CIRCULATION, V121, P759, DOI 10.1161/CIRCULATIONAHA.109.892224; Matsumoto Y, 2009, EUR HEART J, V30, P346, DOI 10.1093/eurheartj/ehn501; Michel JB, 2011, CARDIOVASC RES, V90, P18, DOI 10.1093/cvr/cvq337; Miyake T, 2009, CARDIOVASC RES, V83, P436, DOI 10.1093/cvr/cvp155; Mukai Y, 2003, J CARDIOVASC PHARM, V42, P118, DOI 10.1097/00005344-200307000-00018; Nordon IM, 2011, NAT REV CARDIOL, V8, P92, DOI 10.1038/nrcardio.2010.180; Rashid M, 2009, CIRC J, V73, P361, DOI 10.1253/circj.CJ-08-0817; Satoh K, 2011, AM J PHYSIOL-HEART C, V301, pH287, DOI 10.1152/ajpheart.00327.2011; Satoh K, 2009, NAT MED, V15, P649, DOI 10.1038/nm.1958; Schweitzer M, 2010, VASC ENDOVASC SURG, V44, P116, DOI 10.1177/1538574409348352; Shimokawa H, 2005, ARTERIOSCL THROM VAS, V25, P1767, DOI 10.1161/01.ATV.0000176193.83629.c8; STOPHER DA, 1988, J CARDIOVASC PHARM, V12, pS55, DOI 10.1097/00005344-198812007-00012; Sukhija R, 2006, AM J CARDIOL, V97, P279, DOI 10.1016/j.amjcard.2005.08.033; Suzuki J, 2006, CIRC RES, V98, P811, DOI 10.1161/01.RES.0000216405.85080.a6; Sweeting MJ, 2010, J VASC SURG, V52, P1, DOI 10.1016/j.jvs.2010.02.264; Tada T, 2008, CARDIOVASC RES, V80, P346, DOI 10.1093/cvr/cvn211; Thompson A, 2010, J VASC SURG, V52, P55, DOI 10.1016/j.jvs.2010.02.012; Tsuruda T, 2008, CIRC RES, V102, P1368, DOI 10.1161/CIRCRESAHA.108.173682; Twine CP, 2011, BRIT J SURG, V98, P346, DOI 10.1002/bjs.7343; Wang JA, 2011, ATHEROSCLEROSIS, V217, P90, DOI 10.1016/j.atherosclerosis.2011.03.005; Wang Y, 2010, J CLIN INVEST, V120, P422, DOI 10.1172/JCI38136; Wang YX, 2005, CIRCULATION, V111, P2219, DOI 10.1161/01.CIR.0000163544.17221.BE; Yagi S, 2010, HYPERTENSION, V55, P918, DOI 10.1161/HYPERTENSIONAHA.109.146076; Zhou Q, 2010, CIRC J, V74, P818, DOI 10.1253/circj.CJ-10-0110	44	25	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e72558	10.1371/journal.pone.0072558	http://dx.doi.org/10.1371/journal.pone.0072558			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967318	Green Submitted, Green Published, gold			2022-12-25	WOS:000323115800109
J	Zhao, MM; Zhang, G; Zhang, DW; Hsiao, YY; Guo, SX				Zhao, Ming-Ming; Zhang, Gang; Zhang, Da-Wei; Hsiao, Yu-Yun; Guo, Shun-Xing			ESTs Analysis Reveals Putative Genes Involved in Symbiotic Seed Germination in Dendrobium officinale	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; MYCORRHIZAL FUNGUS; ORCHID; EXPRESSION; ROOTS; IDENTIFICATION; FAMILY; CELLS; PINE; RICE	Dendrobium officinale (Orchidaceae) is one of the world's most endangered plants with great medicinal value. In nature, D. officinale seeds must establish symbiotic relationships with fungi to germinate. However, the molecular events involved in the interaction between fungus and plant during this process are poorly understood. To isolate the genes involved in symbiotic germination, a suppression subtractive hybridization (SSH) cDNA library of symbiotically germinated D. officinale seeds was constructed. From this library, 1437 expressed sequence tags (ESTs) were clustered to 1074 Unigenes (including 902 singletons and 172 contigs), which were searched against the NCBI non-redundant (NR) protein database (E-value cutoff, e(-5)). Based on sequence similarity with known proteins, 579 differentially expressed genes in D. officinale were identified and classified into different functional categories by Gene Ontology (GO), Clusters of orthologous Groups of proteins (COGs) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. The expression levels of 15 selected genes emblematic of symbiotic germination were confirmed via real-time quantitative PCR. These genes were classified into various categories, including defense and stress response, metabolism, transcriptional regulation, transport process and signal transduction pathways. All transcripts were upregulated in the symbiotically germinated seeds (SGS). The functions of these genes in symbiotic germination were predicted. Furthermore, two fungus-induced calcium-dependent protein kinases (CDPKs), which were upregulated 6.76- and 26.69-fold in SGS compared with un-germinated seeds (UGS), were cloned from D. officinale and characterized for the first time. This study provides the first global overview of genes putatively involved in D. officinale symbiotic seed germination and provides a foundation for further functional research regarding symbiotic relationships in orchids.	[Zhao, Ming-Ming; Zhang, Gang; Zhang, Da-Wei; Guo, Shun-Xing] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China; [Zhao, Ming-Ming; Zhang, Gang; Zhang, Da-Wei; Guo, Shun-Xing] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhao, Ming-Ming] Beihua Univ, Med Lab Coll, Jilin, Peoples R China; [Hsiao, Yu-Yun] Natl Cheng Kung Univ, Orchid Res Ctr, Dept Life Sci, Tainan 70101, Taiwan	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Beihua University; National Cheng Kung University	Guo, SX (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China.	sxguo2006@yahoo.com.cn			National Nature Science Foundation of China [31070300, 31170016]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation of China (No. 31070300, 31170016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ MR, 1968, AM J BOT, V55, P1036, DOI 10.2307/2440469; Amian Awah Anna, 2011, GM Crops, V2, P104, DOI 10.4161/gmcr.2.2.16125; Aparicio S, 2011, J MICROSC-OXFORD, V89, P139; Arditti J, 2000, NEW PHYTOL, V146, P569; Asano T, 2005, PLANT CELL PHYSIOL, V46, P356, DOI 10.1093/pcp/pci035; Berardini TZ, 2004, PLANT PHYSIOL, V135, P745, DOI 10.1104/pp.104.040071; BEYRLE HF, 1995, CAN J BOT, V73, P1128, DOI 10.1139/b95-123; Burgeff H, 1932, JENA G FISCHER, V249; Cai XY, 2011, SCI HORTIC-AMSTERDAM, V129, P877, DOI 10.1016/j.scienta.2011.06.001; Campos-Soriano L, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-90; Capoen W, 2009, PLANT CELL, V21, P1526, DOI 10.1105/tpc.109.066233; Choi HI, 2005, PLANT PHYSIOL, V139, P1750, DOI 10.1104/pp.105.069757; Chutima R, 2011, SYMBIOSIS, V53, P149, DOI 10.1007/s13199-011-0120-8; Dixon KW, 2003, ORCHID CONSERVATION; Efrose RC, 2008, PLANTA, V228, P37, DOI 10.1007/s00425-008-0717-1; ElGhachtouli N, 1996, FEBS LETT, V385, P189, DOI 10.1016/0014-5793(96)00379-1; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Gargantini PR, 2006, PLANT J, V48, P843, DOI 10.1111/j.1365-313X.2006.02910.x; Hou XQ, 2009, J INTEGR PLANT BIOL, V51, P374, DOI 10.1111/j.1744-7909.2008.00777.x; Hrabak EM, 1996, PLANT MOL BIOL, V31, P405, DOI 10.1007/BF00021802; Hsiao YY, 2011, PLANT CELL PHYSIOL, V52, P1467, DOI 10.1093/pcp/pcr100; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Kristiansen KA, 2004, MOL PHYLOGENET EVOL, V33, P251, DOI 10.1016/j.ympev.2004.05.015; Kytoviita MM, 1997, MYCORRHIZA, V7, P107, DOI 10.1007/s005720050170; Leake Jonathan R., 2005, Mycologist, V19, P113, DOI 10.1017/S0269915X05003046; Lee H, 2008, J PLANT BIOL, V51, P291, DOI 10.1007/BF03036129; Liu B, 2010, MOL BIOL REP, V37, P1045, DOI 10.1007/s11033-009-9823-9; Merckx V, 2013, MYCOHETEROTROPHY BIO; Mikes V, 1997, FEBS LETT, V416, P190, DOI 10.1016/S0014-5793(97)01193-9; Niemi K, 2002, TREE PHYSIOL, V22, P373, DOI 10.1093/treephys/22.6.373; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oldroyd GED, 2009, SCIENCE, V324, P753, DOI 10.1126/science.1171644; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rasmussen HN, 2009, OIKOS, V118, P334, DOI 10.1111/j.1600-0706.2008.17116.x; Reddy SM, 2003, PLANT CELL ENVIRON, V26, P681, DOI 10.1046/j.1365-3040.2003.01003.x; Reinhardt D, 2007, CURR OPIN PLANT BIOL, V10, P98, DOI 10.1016/j.pbi.2006.11.001; Requena N, 2003, PLANT PHYSIOL, V132, P1540, DOI 10.1104/pp.102.019042; Romeis T, 2001, CURR OPIN PLANT BIOL, V4, P407, DOI 10.1016/S1369-5266(00)00193-X; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Spaink HP, 2002, NATURE, V417, P910, DOI 10.1038/417910a; Stewart Scott L., 2003, Selbyana, V24, P64; Stewart SL, 2002, AQUAT BOT, V72, P25, DOI 10.1016/S0304-3770(01)00214-5; Wang H, 2011, WORLD J MICROB BIOT, V27, P2051, DOI 10.1007/s11274-011-0667-9; WARCUP JH, 1981, NEW PHYTOL, V87, P371, DOI 10.1111/j.1469-8137.1981.tb03208.x; Watkinson JI, 2003, ACTA HORTIC, P463, DOI 10.17660/ActaHortic.2003.624.64; WILLIAMSON B, 1970, PLANTA, V92, P347, DOI 10.1007/BF00385100; Yu XC, 2007, PLANT MOL BIOL, V64, P531, DOI 10.1007/s11103-007-9172-9; Zhang G, 2012, BIOLOGIA, V67, P360, DOI 10.2478/s11756-012-0016-y	48	40	63	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e72705	10.1371/journal.pone.0072705	http://dx.doi.org/10.1371/journal.pone.0072705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967335	Green Submitted, gold, Green Published			2022-12-25	WOS:000323115800117
J	Mei, Y; Zhang, P; Zuo, H; Clark, D; Xia, R; Li, J; Liu, Z; Mao, L				Mei, Y.; Zhang, P.; Zuo, H.; Clark, D.; Xia, R.; Li, J.; Liu, Z.; Mao, L.			Ebp1 activates podoplanin expression and contributes to oral tumorigenesis	ONCOGENE			English	Article						EBP1; podoplanin; oral; tumorigenesis	BINDING-PROTEIN EBP1; ECTOPIC EXPRESSION; CANCER; ERBB3; LYMPHANGIOGENESIS; PROGRESSION; METASTASIS; CARCINOMAS; INVASION; ANTIGEN	Podoplanin is highly expressed in human cancers. However, mechanisms regulating podoplanin expression remain elusive. Here we show that podoplanin promotes tumorigenesis of oral squamous cell carcinoma (OSCC) and precancerous cells both in vitro and in vivo, and the ErbB3-binding protein-1 (Ebp1) can be activated in oral tumorigenesis and can serve as a transcriptional activator to drive podoplanin expression in the malignant progression. Most of the OSCC cell lines have no detectable podoplanin protein in low-density cultures. However, the protein becomes detectable in high-density cultures and is required for in-vivo tumor formation of OSCC and oral premalignancies. In a high-density culture condition, podoplanin expression can be triggered at both mRNA and protein levels. In this condition, we showed that Ebp1 is upregulated, translocated from the cytoplasm to the nucleus and binds to the podoplanin promoter to result in a dramatic increase of podoplanin mRNA and protein. Ebp1 downregulation significantly reduced podoplanin expression levels in OSCC cells with a decreased anchorage-dependent growth, invasion and wound healing. Conversely, Ebp1 overexpression enhanced these malignant features through podoplanin upregulation both in vitro and in vivo. In 81 patients with oral premalignant lesions, we found that Ebp1 expression is strongly related to OSCC development. We conclude that Ebp1 has a key role in the upregulation of podoplanin and may contribute to oral tumorigenesis.	[Mei, Y.; Zuo, H.; Clark, D.; Mao, L.] Univ Maryland, Sch Dent, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA; [Zhang, P.; Xia, R.; Li, J.] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9,Sch Stomatoloty, Dept Oral & Maxillofacial Surg,Shanghai Key Lab S, Shanghai, Peoples R China; [Zhang, P.; Xia, R.; Li, J.] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9,Sch Stomatoloty, Dept Oral & Maxillofacial Surg,Shanghai Res Inst, Shanghai, Peoples R China; [Liu, Z.; Mao, L.] Univ Maryland, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; Shanghai Jiao Tong University; Shanghai Jiao Tong University; University System of Maryland; University of Maryland Baltimore	Mao, L (corresponding author), Univ Maryland, Sch Dent, Dept Oncol & Diagnost Sci, 650 W Baltimore St,Room 7259, Baltimore, MD 21201 USA.	lmao@umaryland.edu		Clark, David/0000-0003-0527-8469				Cortez MA, 2010, GENE CHROMOSOME CANC, V49, P981, DOI 10.1002/gcc.20808; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; de Sousa SF, 2012, APPL IMMUNOHISTO M M, V20, P588, DOI 10.1097/PAI.0b013e31824bb3ea; Funayama A, 2011, PATHOBIOLOGY, V78, P171, DOI 10.1159/000324926; Hamburger AW, 2008, J MAMMARY GLAND BIOL, V13, P225, DOI 10.1007/s10911-008-9077-5; Hantusch B, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-20; Honma M, 2012, J DERMATOL SCI, V65, P134, DOI 10.1016/j.jdermsci.2011.11.011; Huber GF, 2011, INT J CANCER, V129, P1404, DOI 10.1002/ijc.25795; Hwang YS, 2012, CARCINOGENESIS, V33, P2135, DOI 10.1093/carcin/bgs258; Inoue H, 2012, TUMOR BIOL, V33, P183, DOI 10.1007/s13277-011-0261-7; Kawaguchi H, 2008, J CLIN ONCOL, V26, P354, DOI 10.1200/JCO.2007.13.4072; Kim CK, 2010, CANCER RES, V70, P9730, DOI 10.1158/0008-5472.CAN-10-1882; Kreppel M, 2012, ORAL DIS, V18, P692, DOI 10.1111/j.1601-0825.2012.01927.x; Kunita A, 2011, AM J PATHOL, V179, P1041, DOI 10.1016/j.ajpath.2011.04.027; Lessor TJ, 2000, J CELL PHYSIOL, V183, P321, DOI 10.1002/(SICI)1097-4652(200006)183:3<321::AID-JCP4>3.0.CO;2-O; Martin-Villar E, 2009, INT J BIOCHEM CELL B, V41, P1421, DOI 10.1016/j.biocel.2008.12.010; Mashhadiabbas F, 2012, OR SURG OR MED OR PA, V114, P240, DOI 10.1016/j.oooo.2012.04.009; Mei Y, 2008, NEUROSCIENCE, V151, P771, DOI 10.1016/j.neuroscience.2007.10.057; Mei YP, 2012, ONCOGENE, V31, P2794, DOI 10.1038/onc.2011.449; Monie TP, 2007, EMBO J, V26, P3936, DOI 10.1038/sj.emboj.7601817; Neph S, 2012, CELL, V150, P1274, DOI 10.1016/j.cell.2012.04.040; Ohta M, 2013, ORAL ONCOL, V49, P20, DOI 10.1016/j.oraloncology.2012.06.017; Peterziel H, 2012, NEURO-ONCOLOGY, V14, P426, DOI 10.1093/neuonc/nos055; Raica M, 2008, ANTICANCER RES, V28, P2997; Scholl FG, 2000, LAB INVEST, V80, P1749, DOI 10.1038/labinvest.3780185; Shen YQ, 2010, J BIOL CHEM, V285, P9649, DOI 10.1074/jbc.M109.047696; Shimamura Y, 2011, ACTA HISTOCHEM CYTOC, V44, P239, DOI 10.1267/ahc.11032; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Wicki A, 2007, BRIT J CANCER, V96, P1, DOI 10.1038/sj.bjc.6603518; Yuan P, 2006, CANCER, V107, P563, DOI 10.1002/cncr.22061; Zhang YX, 2010, CANCER RES, V70, P240, DOI 10.1158/0008-5472.CAN-09-2904; Zhang YX, 2005, NUCLEIC ACIDS RES, V33, P6024, DOI 10.1093/nar/gki903; Zhou X, 2010, J CANCER RES CLIN, V136, P891, DOI 10.1007/s00432-009-0730-1	34	31	33	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 17	2014	33	29					3839	3850		10.1038/onc.2013.354	http://dx.doi.org/10.1038/onc.2013.354			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AL8MU	23975429				2022-12-25	WOS:000339394100010
J	Zhang, Z; Yang, M; Chen, R; Su, W; Li, P; Chen, S; Chen, Z; Chen, A; Li, S; Hu, C				Zhang, Z.; Yang, M.; Chen, R.; Su, W.; Li, P.; Chen, S.; Chen, Z.; Chen, A.; Li, S.; Hu, C.			IBP regulates epithelial-to-mesenchymal transition and the motility of breast cancer cells via Rac1, RhoA and Cdc42 signaling pathways	ONCOGENE			English	Article						IBP; EMT; breast cancer; migration; invasion	PROTEIN; EMT; EXPRESSION; GTPASES; DEF6; PROLIFERATION; CYTOSKELETON; ACTIVATOR; SYSTEM; GENE	Epithelial-to-mesenchymal transition (EMT) is a crucial process for the invasion and metastasis of epithelial tumors. However, the molecular mechanisms underlying this transition are poorly understood. In this study, we demonstrate that interferon regulatory factor 4 binding protein (IBP) regulates EMT and the motility of breast cancer cells through Rac1, RhoA and Cdc42 signaling pathways. We found that increased expression of IBP was associated with the progression of breast cancer and that IBP protein levels were significantly elevated in matched distant metastases. High IBP levels also predict shorter overall survival of breast cancer patients. Furthermore, the forced expression of IBP decreased the expression of the epithelial marker E-cadherin but increased the mesenchymal markers in breast cancer cells. In contrast, silencing IBP in metastatic breast tumor cells promoted a shift toward an epithelial morphology concomitant with increased expression of E-cadherin and decreased expression of mesenchymal markers. IBP silencing also reduced the expression of EMT-inducing transcription factors (Snail, Slug, ZEB1 and ZEB2). Moreover, we identified a role for IBP in endogenous EMT induced by epidermal growth factor (EGF) and deletion of IBP attenuated EGF receptor (EGFR) signaling in breast cancer cells. Furthermore, IBP regulates the migration, invasion and matrix metalloprotease production in breast cancer cells as well as actin cytoskeleton rearrangement and the activation of GTP-Rac1, GTP-RhoA and GTP-Cdc42. Taken together, our findings demonstrate an oncogenic property for IBP in promoting the metastatic potential of breast cancer cells.	[Zhang, Z.; Yang, M.; Li, P.; Chen, S.; Chen, Z.; Chen, A.; Li, S.; Hu, C.] Third Mil Med Univ, Southwest Hosp, Fac Med Lab Sci, Dept Clin Biochem, Chongqing 400038, Peoples R China; [Chen, R.] Third Mil Med Univ, Xinqiao Hosp, Dept Pathol, Chongqing 400038, Peoples R China; [Su, W.] Beibei Maternal & Child Hlth Hosp, Dept Lab Med, Chongqing, Peoples R China	Army Medical University; Army Medical University	Hu, C (corresponding author), Third Mil Med Univ, Southwest Hosp, Fac Med Lab Sci, Dept Clin Biochem, 30 Gaotanyan Ctr St, Chongqing 400038, Peoples R China.	chuminhu@163.com			National Natural Science Foundation of China [81201952, 81172538, 81072154]; SRF for ROCS, SEM	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); SRF for ROCS, SEM(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	We thank Wei Sun and Liting Wang (Central Laboratories, TMMU, China) for their help with laser scanning confocal microscopy work. This project was supported by the National Natural Science Foundation of China (no. 81201952, 81172538 and 81072154) and SRF for ROCS, SEM.	ALLRED DC, 1993, J NATL CANCER I, V85, P200, DOI 10.1093/jnci/85.3.200; Barr S, 2008, CLIN EXP METASTAS, V25, P685, DOI 10.1007/s10585-007-9121-7; Becart S, 2008, IMMUNITY, V29, P704, DOI 10.1016/j.immuni.2008.08.015; Becart S, 2007, J CLIN INVEST, V117, P2164, DOI 10.1172/JCI31640; Bendris Nawal, 2012, Small GTPases, V3, P225, DOI 10.4161/sgtp.20791; Byles V, 2012, ONCOGENE, V31, P4619, DOI 10.1038/onc.2011.612; Canonigo-Balancio AJ, 2009, J IMMUNOL, V183, P7259, DOI 10.4049/jimmunol.0902573; Fanzo JC, 2006, J CLIN INVEST, V116, P703, DOI 10.1172/JCI24096; Gupta S, 2003, HUM IMMUNOL, V64, P389, DOI 10.1016/S0198-8859(03)00024-7; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hardy KM, 2010, J MAMMARY GLAND BIOL, V15, P191, DOI 10.1007/s10911-010-9172-2; Hey F, 2012, J BIOL CHEM, V287, P31073, DOI 10.1074/jbc.M112.346767; Hotfilder M, 1999, BRIT J HAEMATOL, V106, P335, DOI 10.1046/j.1365-2141.1999.01551.x; Hugo HJ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-235; Jian CX, 2012, CANCER INVEST, V30, P748, DOI 10.3109/07357907.2012.734355; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Li P, 2009, INT IMMUNOPHARMACOL, V9, P1002, DOI 10.1016/j.intimp.2009.04.008; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Mavrakis KJ, 2004, EXP CELL RES, V294, P335, DOI 10.1016/j.yexcr.2003.12.004; Mimeault M, 2007, ANN ONCOL, V18, P1605, DOI 10.1093/annonc/mdm070; Moreno-Bueno G, 2008, ONCOGENE, V27, P6958, DOI 10.1038/onc.2008.346; Oka T, 2007, J BIOL CHEM, V282, P2011, DOI 10.1074/jbc.M605153200; Samson T, 2007, J BIOL CHEM, V282, P15730, DOI 10.1074/jbc.M611197200; Tanaka Y, 2003, IMMUNITY, V18, P403, DOI 10.1016/S1074-7613(03)00054-2; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Yang MZ, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-54; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Zhang ZJ, 2009, CANCER EPIDEMIOL, V33, P130, DOI 10.1016/j.canep.2009.05.004	29	39	43	4	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 26	2014	33	26					3374	3382		10.1038/onc.2013.337	http://dx.doi.org/10.1038/onc.2013.337			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AK9WM	23975422	hybrid, Green Published			2022-12-25	WOS:000338779300004
J	Kaneti, G; Sarig, H; Marjieh, I; Fadia, Z; Mor, A				Kaneti, Galoz; Sarig, Hadar; Marjieh, Ibrahim; Fadia, Zaknoon; Mor, Amram			Simultaneous breakdown of multiple antibiotic resistance mechanisms in S. aureus	FASEB JOURNAL			English	Article						host defense peptides; peptidomimetics; OAK; oxacillin; membrane potential; synergy	OLIGO-ACYL-LYSYL; STAPHYLOCOCCUS-AUREUS; CAPSULE POLYSACCHARIDE; BETA-LACTAMS; DAPTOMYCIN; OXACILLIN; RESPONSES; SUSCEPTIBILITY; COMBINATIONS; INHIBITORS	In previous studies, the oligo-acyl-lysyl (OAK) C12(omega 7)K-beta(12) added to cultures of gram-positive bacteria exerted a bacteriostatic activity that was associated with membrane depolarization, even at high concentrations. Here, we report that multidrug-resistant Staphylococcus aureus strains, unlike other gram-positive species, have reverted to the sensitive phenotype when exposed to subminimal inhibitory concentrations (sub-MICs) of the OAK, thereby increasing antibiotics potency by up to 3 orders of magnitude. Such chemosensitization was achieved using either cytoplasm or cell-wall targeting antibiotics. Moreover, eventual emergence of resistance to antibiotics was significantly delayed. Using the mouse peritonitis-sepsis model, we show that on single-dose administration of oxacillin and OAK combinations, death induced by a lethal staphylococcal infection was prevented in a synergistic manner, thereby supporting the likelihood for synergism to persist under in vivo conditions. Toward illuminating the molecular basis for these observations, we present data arguing that sub-MIC OAK interactions with the plasma membrane can inhibit proton-dependent signal transduction responsible for expression and export of resistance factors, as demonstrated for beta-lactamase and PBP2a. Collectively, the data reveal a potentially useful approach for overcoming antibiotic resistance and for preventing resistance from emerging as readily as when bacteria are exposed to an antibiotic alone.	[Kaneti, Galoz; Sarig, Hadar; Marjieh, Ibrahim; Fadia, Zaknoon; Mor, Amram] Technion Israel Inst Technol, Dept Food Engn & Biotechnol, IL-32000 Haifa, Israel	Technion Israel Institute of Technology	Mor, A (corresponding author), Technion Israel Inst Technol, Dept Food Engn & Biotechnol, IL-32000 Haifa, Israel.	amor@tx.technion.ac.il			Israel Science Foundation [909/12]; Russell Berrie Nanotechnology Institute (Technion)	Israel Science Foundation(Israel Science Foundation); Russell Berrie Nanotechnology Institute (Technion)	This work was supported by the Israel Science Foundation (grant 909/12) and by the Russell Berrie Nanotechnology Institute (Technion).	ANTHONY E. E., 1931, SCIENCE, V73, P319, DOI 10.1126/science.73.1890.319; Arede P, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002816; BELLOMO G, 1991, CELL CALCIUM, V12, P335, DOI 10.1016/0143-4160(91)90049-K; Campos MA, 2004, INFECT IMMUN, V72, P7107, DOI 10.1128/IAI.72.12.7107-7114.2004; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Dhand A, 2011, CLIN INFECT DIS, V53, P158, DOI 10.1093/cid/cir340; Ejim L, 2011, NAT CHEM BIOL, V7, P348, DOI [10.1038/NCHEMBIO.559, 10.1038/nchembio.559]; Epand RF, 2009, BIOPHYS J, V97, P2250, DOI 10.1016/j.bpj.2009.08.006; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Fournier B, 2005, CLIN MICROBIOL REV, V18, P521, DOI 10.1128/CMR.18.3.521-540.2005; Gao W, 2013, J INFECT DIS, V207, P929, DOI 10.1093/infdis/jis772; Garrigos C, 2012, ANTIMICROB AGENTS CH, V56, P3806, DOI 10.1128/AAC.00127-12; Goldberg K, 2013, FASEB J, V27, P3818, DOI 10.1096/fj.13-227942; Held-Kuznetsov V, 2009, FASEB J, V23, P4299, DOI 10.1096/fj.09-136358; Jana S, 2006, APPL MICROBIOL BIOT, V70, P140, DOI 10.1007/s00253-005-0279-0; Jenkins RE, 2012, J ANTIMICROB CHEMOTH, V67, P1405, DOI 10.1093/jac/dks071; Klitgaard JK, 2008, J ANTIMICROB CHEMOTH, V62, P1215, DOI 10.1093/jac/dkn417; Kobayashi SD, 2011, NAT MED, V17, P168, DOI 10.1038/nm0211-168; Kwon DH, 2007, ANTIMICROB AGENTS CH, V51, P2070, DOI 10.1128/AAC.01472-06; Leonard SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042103; Lin GR, 2010, ANTIMICROB AGENTS CH, V54, P2201, DOI 10.1128/AAC.01143-09; Livne L, 2010, FASEB J, V24, P5092, DOI 10.1096/fj.10-167809; Llobet E, 2008, MICROBIOL-SGM, V154, P3877, DOI 10.1099/mic.0.2008/022301-0; Makobongo MO, 2012, ANTIMICROB AGENTS CH, V56, P378, DOI 10.1128/AAC.00689-11; Mayer ML, 2010, ADV M C M, P195, DOI 10.1079/9781845936570.0195; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Mor A, 2010, ADV M C M, P100, DOI 10.1079/9781845936570.0100; NIEMINEN AL, 1990, BIOCHEM BIOPH RES CO, V167, P600, DOI 10.1016/0006-291X(90)92067-A; OCALLAGHAN CH, 1972, ANTIMICROB AGENTS CH, V1, P283, DOI 10.1128/AAC.1.4.283; Oliveira DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023287; Patel D, 2010, ANTIMICROB AGENTS CH, V54, P5070, DOI 10.1128/AAC.01058-10; Perez-Vazquez M, 2009, J ANTIMICROB CHEMOTH, V63, P21, DOI 10.1093/jac/dkn430; Pietiainen M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-429; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Radzishevsky IS, 2008, CHEM BIOL, V15, P354, DOI 10.1016/j.chembiol.2008.03.006; Rand KH, 2004, ANTIMICROB AGENTS CH, V48, P2871, DOI 10.1128/AAC.48.8.2871-2875.2004; Rotem S, 2008, FASEB J, V22, P2652, DOI 10.1096/fj.07-105015; Rotem S, 2009, BBA-BIOMEMBRANES, V1788, P1582, DOI 10.1016/j.bbamem.2008.10.020; Morones-Ramirez JR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006276; Sarig H, 2011, FASEB J, V25, P3336, DOI 10.1096/fj.11-183764; Sarig H, 2011, ANTIMICROB AGENTS CH, V55, P688, DOI 10.1128/AAC.00666-10; Sarig H, 2010, FASEB J, V24, P1904, DOI 10.1096/fj.09-149427; Stavri M, 2007, J ANTIMICROB CHEMOTH, V59, P1247, DOI 10.1093/jac/dkl460; Strahl H, 2010, P NATL ACAD SCI USA, V107, P12281, DOI 10.1073/pnas.1005485107; Szweda P, 2012, APPL MICROBIOL BIOT, V96, P1157, DOI 10.1007/s00253-012-4484-3; Therien AG, 2012, ANTIMICROB AGENTS CH, V56, P4662, DOI 10.1128/AAC.00726-12; Weigel LM, 2003, SCIENCE, V302, P1569, DOI 10.1126/science.1090956; Wilke MS, 2004, J BIOL CHEM, V279, P47278, DOI 10.1074/jbc.M407054200; Yang SJ, 2010, ANTIMICROB AGENTS CH, V54, P3161, DOI 10.1128/AAC.00487-10; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yuan J, 2011, J MOL BIOL, V406, P730, DOI 10.1016/j.jmb.2011.01.014; Zaknoon F, 2012, ANTIMICROB AGENTS CH, V56, P4827, DOI 10.1128/AAC.00511-12; Zaknoon F, 2011, ANTIMICROB AGENTS CH, V55, P3803, DOI 10.1128/AAC.00129-11	53	15	15	1	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2013	27	12					4834	4843		10.1096/fj.13-237610	http://dx.doi.org/10.1096/fj.13-237610			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	293UK	23970798				2022-12-25	WOS:000329999000018
J	Bonney, S; Kominsky, D; Brodsky, K; Eltzschig, H; Walker, L; Eckle, T				Bonney, Stephanie; Kominsky, Doug; Brodsky, Kelley; Eltzschig, Holger; Walker, Lori; Eckle, Tobias			Cardiac Per2 Functions as Novel Link between Fatty Acid Metabolism and Myocardial Inflammation during Ischemia and Reperfusion Injury of the Heart	PLOS ONE			English	Article							NF-KAPPA-B; CIRCADIAN CLOCK; CARDIOVASCULAR-DISEASE; SHIFT WORK; RISK-FACTORS; COMPONENT; MICE; ACTIVATION; HYPOXIA; INNATE	Disruption of peripheral circadian rhyme pathways dominantly leads to metabolic disorders. Studies on circadian rhythm proteins in the heart indicated a role for Clock or Per2 in cardiac metabolism. In contrast to Clock(-/-), Per2(-/-) mice have larger infarct sizes with deficient lactate production during myocardial ischemia. To test the hypothesis that cardiac Per2 represents an important regulator of cardiac metabolism during myocardial ischemia, we measured lactate during reperfusion in Per1(-/-), Per2(-/-) or wildtype mice. As lactate measurements in whole blood indicated an exclusive role of Per2 in controlling lactate production during myocardial ischemia, we next performed gene array studies using various ischemia-reperfusion protocols comparing wildtype and Per2(-/-) mice. Surprisingly, high-throughput gene array analysis revealed dominantly lipid metabolism as the differentially regulated pathway in wildtype mice when compared to Per2(-/-). In all ischemia-reperfusion protocols used, the enzyme enoyl-CoA hydratase, which is essential in fatty acid beta-oxidation, was regulated in wildtype animals only. Studies using nuclear magnet resonance imaging (NMRI) confirmed altered fatty acid populations with higher mono-unsaturated fatty acid levels in hearts from Per2(-/-) mice. Unexpectedly, studies on gene regulation during reperfusion revealed solely pro inflammatory genes as differentially regulated 'Per2-genes'. Subsequent studies on inflammatory markers showed increasing IL-6 or TNF alpha levels during reperfusion in Per2(-/-) mice. In summary, these studies reveal an important role of cardiac Per2 for fatty acid metabolism and inflammation during myocardial ischemia and reperfusion, respectively.	[Bonney, Stephanie; Kominsky, Doug; Brodsky, Kelley; Eltzschig, Holger; Eckle, Tobias] Univ Colorado Denver, Dept Anesthesiol, Aurora, CO USA; [Bonney, Stephanie; Kominsky, Doug; Brodsky, Kelley; Eltzschig, Holger; Eckle, Tobias] Univ Colorado Denver, Mucosal Inflammat Program, Aurora, CO USA; [Walker, Lori] Univ Colorado Denver, Div Cardiol, Dept Med, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Eckle, T (corresponding author), Univ Colorado Denver, Dept Anesthesiol, Aurora, CO USA.	tobias.eckle@ucdenver.edu	Eckle, Tobias/AAE-6705-2020	Eckle, Tobias/0000-0002-6065-4669	National Heart, Lung, and Blood Institute [R01-HL0921, R01-HL098294 1]; National Institute of Diabetes and Digestive and Kidney Disease [R01-DK083385, R01DK097075-01, K08-HL102267]; Crohn's and Colitis Foundation of America; Genomics Shared Resource of Colorado's NIH/NCI Cancer Center Support Grant [P30CA046934]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL102267, R01HL098294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083385, R01DK097075] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Crohn's and Colitis Foundation of America; Genomics Shared Resource of Colorado's NIH/NCI Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The present research work is supported by National Heart, Lung, and Blood Institute Grant R01-HL0921, and R01-HL098294 1, by the National Institute of Diabetes and Digestive and Kidney Disease Grant R01-DK083385 and R01DK097075-01 to HKE, K08-HL102267 to TE, and a Crohn's and Colitis Foundation of America grant to HKE and supported in part by the Genomics Shared Resource of Colorado's NIH/NCI Cancer Center Support Grant P30CA046934. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERSTEDT T, 1984, SCAND J WORK ENV HEA, V10, P409, DOI 10.5271/sjweh.2302; Akerstedt T, 1997, SCAND J WORK ENV HEA, V23, P241, DOI 10.5271/sjweh.216; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Boggild H, 1999, SCAND J WORK ENV HEA, V25, P85, DOI 10.5271/sjweh.410; Bonney S, 2013, INT J BIOCHEM CELL B, V45, P667, DOI 10.1016/j.biocel.2012.12.022; Bray MS, 2008, AM J PHYSIOL-HEART C, V294, pH1036, DOI 10.1152/ajpheart.01291.2007; Curtis AM, 2007, P NATL ACAD SCI USA, V104, P3450, DOI 10.1073/pnas.0611680104; Doi M, 2010, NAT MED, V16, P67, DOI 10.1038/nm.2061; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Eckle T, 2006, AM J PHYSIOL-HEART C, V291, pH2533, DOI 10.1152/ajpheart.00472.2006; Eckle T, 2012, NAT MED, V18, P774, DOI 10.1038/nm.2728; Eckle T, 2011, ANESTHESIOLOGY, V114, P490, DOI 10.1097/ALN.0b013e31820a4d78; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; Gomez-Abellan P, 2008, INT J OBESITY, V32, P121, DOI 10.1038/sj.ijo.0803689; Grimaldi B, 2010, CELL METAB, V12, P509, DOI 10.1016/j.cmet.2010.10.005; Haffner SM, 2006, AM J CARDIOL, V97, p3A, DOI 10.1016/j.amjcard.2005.11.010; Harma M, 2001, SCAND J WORK ENV HEA, V27, P85; Jaswal JS, 2011, BBA-MOL CELL RES, V1813, P1333, DOI 10.1016/j.bbamcr.2011.01.015; JENNINGS RB, 1991, ANNU REV MED, V42, P225, DOI 10.1146/annurev.med.42.1.225; Kim MY, 2010, CARDIOVASC RES, V87, P119, DOI 10.1093/cvr/cvq048; Kivimaki M, 2006, SCAND J WORK ENV HEA, V32, P204, DOI 10.5271/sjweh.1000; Kohler D, 2007, CIRCULATION, V116, P1784, DOI 10.1161/CIRCULATIONAHA.107.690180; Koeppen M, 2012, ANESTHESIOLOGY, V116, P1245, DOI 10.1097/ALN.0b013e318255793c; Koeppen M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006784; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Ladilov Y, 2002, AM J PHYSIOL-HEART C, V283, pH1092, DOI 10.1152/ajpheart.00318.2001; Laxton RC, 2009, CIRC RES, V105, P921, DOI 10.1161/CIRCRESAHA.109.200279; Logan RW, 2012, J IMMUNOL, V188, P2583, DOI 10.4049/jimmunol.1102715; LOPASCHUK GD, 1989, MOL CELL BIOCHEM, V88, P175; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; Luo XL, 2011, DIABETES, V60, P1435, DOI 10.2337/db10-1663; MALIK M, 1990, AM J CARDIOL, V66, P1049, DOI 10.1016/0002-9149(90)90503-S; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Mishra A, 2007, AM J PHYSIOL-LUNG C, V293, pL305, DOI 10.1152/ajplung.00147.2007; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Narasimamurthy R, 2012, P NATL ACAD SCI USA, V109, P12662, DOI 10.1073/pnas.1209965109; Pando MP, 2002, CELL, V110, P107, DOI 10.1016/S0092-8674(02)00803-6; PANZA JA, 1991, NEW ENGL J MED, V325, P986, DOI 10.1056/NEJM199110033251402; Paschos GK, 2012, NAT MED, V18, P1768, DOI 10.1038/nm.2979; Petrzilka S, 2009, J BIOL RHYTHM, V24, P283, DOI 10.1177/0748730409336579; Redel A, 2008, EXP BIOL MED, V233, P84, DOI 10.3181/0612-RM-308; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Richards J, 2012, FASEB J, V26, P3602, DOI 10.1096/fj.12-203554; Schmutz I, 2010, GENE DEV, V24, P345, DOI 10.1101/gad.564110; Serkova N, 2005, KIDNEY INT, V67, P1142, DOI 10.1111/j.1523-1755.2005.00181.x; Silver AC, 2012, IMMUNITY, V36, P251, DOI 10.1016/j.immuni.2011.12.017; Staels B, 2006, NAT MED, V12, P54, DOI 10.1038/nm0106-54; Timmers L, 2012, CARDIOVASC RES, V94, P276, DOI 10.1093/cvr/cvs018; TOFLER GH, 1987, NEW ENGL J MED, V316, P1514, DOI 10.1056/NEJM198706113162405; Tsai JY, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.077800; Tuchsen F, 2006, OCCUP ENVIRON MED, V63, P451, DOI 10.1136/oem.2006.026716; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; van Amelsvoort LGPM, 2004, J OCCUP ENVIRON MED, V46, P699, DOI 10.1097/01.jom.0000131794.83723.45; Volz HC, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0250-z; Wang CY, 2008, CIRCULATION, V118, P2166, DOI 10.1161/CIRCULATIONAHA.108.790469; Warth A, 2007, CARDIOLOGY, V107, P402, DOI 10.1159/000099060; Wisorl JP, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-20; Wu YS, 2007, AM J PHYSIOL-ENDOC M, V292, pE469, DOI 10.1152/ajpendo.00486.2006; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	63	58	62	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71493	10.1371/journal.pone.0071493	http://dx.doi.org/10.1371/journal.pone.0071493			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977055	Green Submitted, gold, Green Published			2022-12-25	WOS:000324527300019
J	Nakamura, MJ; Hotta, K; Oka, K				Nakamura, Mitsuru J.; Hotta, Kohji; Oka, Kotaro			Raman Spectroscopic Imaging of the Whole Ciona intestinalis Embryo during Development	PLOS ONE			English	Article							CELL LINEAGE ANALYSIS; INTRACELLULAR INJECTION; ASCIDIAN EMBRYOS; TRACER ENZYME; SCATTERING; ENDODERM; POLARITY; PATTERN; TISSUES; STORAGE	Intracellular composition and the distribution of bio-molecules play central roles in the specification of cell fates and morphogenesis during embryogenesis. Consequently, investigation of changes in the expression and distribution of bio-molecules, especially mRNAs and proteins, is an important challenge in developmental biology. Raman spectroscopic imaging, a non-invasive and label-free technique, allows simultaneous imaging of the intracellular composition and distribution of multiple bio-molecules. In this study, we explored the application of Raman spectroscopic imaging in the whole Ciona intestinalis embryo during development. Analysis of Raman spectra scattered from C. intestinalis embryos revealed a number of localized patterns of high Raman intensity within the embryo. Based on the observed distribution of bio-molecules, we succeeded in identifying the location and structure of differentiated muscle and endoderm within the whole embryo, up to the tailbud stage, in a label-free manner. Furthermore, during cell differentiation, we detected significant differences in cell state between muscle/endoderm daughter cells and daughter cells with other fates that had divided from the same mother cells; this was achieved by focusing on the Raman intensity of single Raman bands at 1002 or 1526 cm(-1), respectively. This study reports the first application of Raman spectroscopic imaging to the study of identifying and characterizing differentiating tissues in a whole chordate embryo. Our results suggest that Raman spectroscopic imaging is a feasible label-free technique for investigating the developmental process of the whole embryo of C. intestinalis.	[Nakamura, Mitsuru J.; Hotta, Kohji; Oka, Kotaro] Keio Univ, Fac Sci & Technol, Dept Biosci & Informat, Kohoku Ku, Yokohama, Kanagawa 223, Japan	Keio University	Hotta, K (corresponding author), Keio Univ, Fac Sci & Technol, Dept Biosci & Informat, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 223, Japan.	khotta@bio.keio.ac.jp	Oka, Kotaro/C-4918-2014; Hotta, Kohji/D-1162-2014	Hotta, Kohji/0000-0003-4614-7473	Kyoto University [12844617, 12903189]; University of Tokyo [12844617, 12903189]; National Bio-Resource Project of the MEXT, Japan; Grants-in-Aid for Scientific Research [24657164, 24112522] Funding Source: KAKEN	Kyoto University; University of Tokyo; National Bio-Resource Project of the MEXT, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Challenging Exploratory Research, Grant Number 12844617; Grant-in-Aid for Scientific Research on Innovative Areas, Grant Number 12903189; and Keio Gijuku Academic Development Funds B. Ciona intestinalis was provided by Kyoto University and University of Tokyo with support by the National Bio-Resource Project of the MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASASHIMA M, 1994, DEV GROWTH DIFFER, V36, P343; BATES WR, 1988, DEV BIOL, V129, P241, DOI 10.1016/0012-1606(88)90178-9; Chien CH, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3528642; Conklin E, 1905, BIOL BULL-US, V8, P205, DOI 10.2307/1535879; Das RS, 2011, VIB SPECTROSC, V57, P163, DOI 10.1016/j.vibspec.2011.08.003; de Oliveira VE, 2010, J RAMAN SPECTROSC, V41, P642, DOI 10.1002/jrs.2493; Dou W, 2012, BIOPHYS J, V102, P1666, DOI 10.1016/j.bpj.2012.01.057; Downes A, 2011, J RAMAN SPECTROSC, V42, P1864, DOI 10.1002/jrs.2975; Downes A, 2010, SENSORS-BASEL, V10, P1871, DOI 10.3390/s100301871; El-Hagrasy MA, 2012, ANAL BIOANAL CHEM, V402, P1073, DOI 10.1007/s00216-011-5554-6; Hotta K, 2007, DEV DYNAM, V236, P1790, DOI 10.1002/dvdy.21188; Huang CK, 2012, ANAL CHEM, V84, P5661, DOI 10.1021/ac300834f; Huang YS, 2005, BIOCHEMISTRY-US, V44, P10009, DOI 10.1021/bi050179w; Irie T, 2004, COMP BIOCHEM PHYS B, V139, P597, DOI 10.1016/j.cbpc.2004.07.014; Irie T, 2003, COMP BIOCHEM PHYS B, V134, P221, DOI 10.1016/S1096-4959(02)00251-8; KARNOVSKY MJ, 1964, J HISTOCHEM CYTOCHEM, V12, P219, DOI 10.1177/12.3.219; Kim GJ, 2000, DEVELOPMENT, V127, P2853; Krafft C, 2006, ANAL CHEM, V78, P4424, DOI 10.1021/ac060205b; Lau K, 2012, VIB SPECTROSC, V60, P34, DOI 10.1016/j.vibspec.2012.01.009; Lemaire P, 2011, DEVELOPMENT, V138, P2143, DOI 10.1242/dev.048975; Lemaire P, 2009, DEV BIOL, V332, P48, DOI 10.1016/j.ydbio.2009.05.540; Levi L, 2008, BIOL REPROD, V79, P570, DOI 10.1095/biolreprod.107.066548; Matthaus C, 2007, BIOPHYS J, V93, P668, DOI 10.1529/biophysj.106.102061; McNay G, 2011, APPL SPECTROSC, V65, P825, DOI 10.1366/11-06365; Morjani H, 1998, BIOSPECTROSCOPY, V4, P297, DOI 10.1002/(SICI)1520-6343(1998)4:5<297::AID-BSPY1>3.3.CO;2-Y; Nakamura MJ, 2012, DEV BIOL, V372, P274, DOI 10.1016/j.ydbio.2012.09.007; NISHIDA H, 1985, DEV BIOL, V110, P440, DOI 10.1016/0012-1606(85)90102-2; Nishida H, 2005, DEV DYNAM, V233, P1177, DOI 10.1002/dvdy.20469; NISHIDA H, 1987, DEV BIOL, V121, P526, DOI 10.1016/0012-1606(87)90188-6; NISHIDA H, 1983, DEV BIOL, V99, P382, DOI 10.1016/0012-1606(83)90288-9; Patalano S, 2006, J CELL SCI, V119, P1592, DOI 10.1242/jcs.02873; PEZOLET M, 1978, BIOCHIM BIOPHYS ACTA, V533, P263, DOI 10.1016/0005-2795(78)90570-6; Prodon F, 2007, DEV DYNAM, V236, P1698, DOI 10.1002/dvdy.21109; REVERBERI G, 1956, EXPERIENTIA, V12, P55, DOI 10.1007/BF02164674; RIMAI L, 1971, J AM CHEM SOC, V93, P1353, DOI 10.1021/ja00735a006; RIMAI L, 1970, J AM CHEM SOC, V92, P3824, DOI 10.1021/ja00715a066; Sathuluri RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022802; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Surai PF, 1998, J SCI FOOD AGR, V76, P593, DOI 10.1002/(SICI)1097-0010(199804)76:4&lt;593::AID-JSFA993&gt;3.0.CO;2-R; Swalla BJ, 2004, METHOD CELL BIOL, V74, P115; Weiss SL, 2011, J ANIM ECOL, V80, P519, DOI 10.1111/j.1365-2656.2010.01801.x	41	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71739	10.1371/journal.pone.0071739	http://dx.doi.org/10.1371/journal.pone.0071739			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977129	Green Submitted, gold, Green Published			2022-12-25	WOS:000324527300034
J	Gericke, J; Ittensohn, J; Mihaly, J; Dubrac, S; Ruhl, R				Gericke, Janine; Ittensohn, Jan; Mihaly, Johanna; Dubrac, Sandrine; Ruehl, Ralph			Allergen-Induced Dermatitis Causes Alterations in Cutaneous Retinoid-Mediated Signaling in Mice	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; ATOPIC-DERMATITIS; VITAMIN-A; PPAR-BETA/DELTA; SKIN; ACID; EXPRESSION; KERATINOCYTES; BARRIER; DISEASE	Nuclear receptor-mediated signaling via RARs and PPAR delta is involved in the regulation of skin homeostasis. Moreover, activation of both RAR and PPAR delta was shown to alter skin inflammation. Endogenous all-trans retinoic acid (ATRA) can activate both receptors depending on specific transport proteins: Fabp5 initiates PPAR delta signaling whereas Crabp2 promotes RAR signaling. Repetitive topical applications of ovalbumin (OVA) in combination with intraperitoneal injections of OVA or only intraperitoneal OVA applications were used to induce allergic dermatitis. In our mouse model, expression of IL-4, and Hbegf increased whereas expression of involucrin, Abca12 and Spink5 decreased in inflamed skin, demonstrating altered immune response and epidermal barrier homeostasis. Comprehensive gene expression analysis showed alterations of the cutaneous retinoid metabolism and retinoid-mediated signaling in allergic skin immune response. Notably, ATRA synthesis was increased as indicated by the elevated expression of retinaldehyde dehydrogenases and increased levels of ATRA. Consequently, the expression pattern of genes downstream to RAR was altered. Furthermore, the increased ratio of Fabp5 vs. Crabp2 may indicate an up-regulation of the PPAR delta pathway in allergen-induced dermatitis in addition to the altered RAR signaling. Thus, our findings suggest that ATRA levels, RAR-mediated signaling and signaling involved in PPAR delta pathways are mainly increased in allergen-induced dermatitis and may contribute to the development and/or maintenance of allergic skin diseases.	[Gericke, Janine; Ittensohn, Jan; Mihaly, Johanna; Ruehl, Ralph] Univ Debrecen, Dept Biochem & Mol Biol, Lab Nutr Bioactivat & Bioanal, Debrecen, Hungary; [Mihaly, Johanna; Ruehl, Ralph] Paprika Bioanalyt BT, Debrecen, Hungary; [Dubrac, Sandrine] Med Univ Innsbruck, Dept Dermatol, Epidermal Biol Lab, A-6020 Innsbruck, Austria; [Ruehl, Ralph] Hungarian Acad Sci, Apoptosis & Genom Res Grp, Debrecen, Hungary	University of Debrecen; Medical University of Innsbruck; Hungarian Academy of Sciences	Ruhl, R (corresponding author), Univ Debrecen, Dept Biochem & Mol Biol, Lab Nutr Bioactivat & Bioanal, Debrecen, Hungary.	ralphruehl@web.de		Dubrac, Sandrine/0000-0002-2936-8488	European Social fun; Austrian Science Fund (FWF) [P 21449] Funding Source: researchfish	European Social fun; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The project is implemented through the New Hungary Development Plan, co-financed by the European Social fund. RR and SD are members of the COST action BM0903 "SkinBAD-skin barrier and atopic diseases". RR is also a member of the COST action BM1007 "Mast Cells and Basophils - Targets for Innovative Therapies". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry DC, 2009, MOL CELL BIOL, V29, P3286, DOI 10.1128/MCB.01742-08; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Bieber T, 2009, CURR ALLERGY ASTHM R, V9, P291, DOI 10.1007/s11882-009-0041-2; Borland MG, 2011, CELL SIGNAL, V23, P2039, DOI 10.1016/j.cellsig.2011.07.020; Calleja C, 2006, GENE DEV, V20, P1525, DOI 10.1101/gad.368706; Collins CA, 2008, DEV BIOL, V324, P55, DOI 10.1016/j.ydbio.2008.08.034; Cork MJ, 2009, J INVEST DERMATOL, V129, P1892, DOI 10.1038/jid.2009.133; Dahten A, 2008, J INVEST DERMATOL, V128, P2211, DOI 10.1038/jid.2008.84; ELIAS P M, 1987, Dermatologica (Basel), V175, P28; Elias PM, 2008, J ALLERGY CLIN IMMUN, V121, P1337, DOI 10.1016/j.jaci.2008.01.022; ELIAS PM, 1981, LAB INVEST, V44, P531; FISHER GJ, 1994, J BIOL CHEM, V269, P20629; Grewe M, 1998, IMMUNOL TODAY, V19, P359, DOI 10.1016/S0167-5699(98)01285-7; Horikawa T, 2002, INT IMMUNOL, V14, P767, DOI 10.1093/intimm/dxf044; Ito Y, 2011, ALLERGY, V66, P1107, DOI 10.1111/j.1398-9995.2011.02570.x; Jiang YJ, 2009, J BIOL CHEM, V284, P18942, DOI 10.1074/jbc.M109.006973; LEUNG DYM, 1995, J ALLERGY CLIN IMMUN, V96, P302, DOI 10.1016/S0091-6749(95)70049-8; Leung DYM, 2003, LANCET, V361, P151, DOI 10.1016/S0140-6736(03)12193-9; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Marsella R, 2009, VET DERMATOL, V20, P533, DOI 10.1111/j.1365-3164.2009.00809.x; Mevorah B, 1996, J AM ACAD DERMATOL, V34, P379, DOI 10.1016/S0190-9622(07)80013-2; Michalik L, 2007, BBA-MOL CELL BIOL L, V1771, P991, DOI 10.1016/j.bbalip.2007.02.004; Mihaly J, 2011, EXP DERMATOL, V20, P326, DOI 10.1111/j.1600-0625.2010.01225.x; Ogawa E, 2011, J INVEST DERMATOL, V131, P604, DOI 10.1038/jid.2010.342; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Rieck M, 2008, MOL PHARMACOL, V74, P1269, DOI 10.1124/mol.108.050625; Romanowska M, 2008, J INVEST DERMATOL, V128, P110, DOI 10.1038/sj.jid.5700943; Romanowska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009701; Roos TC, 1998, PHARMACOL REV, V50, P315; Ruhl R, 2007, P NUTR SOC, V66, P458, DOI 10.1017/S002966510600509X; Ruhl R, 2007, MOL NUTR FOOD RES, V51, P1173, DOI 10.1002/mnfr.200600277; Ruhl R, 2004, INT J VITAM NUTR RES, V74, P279, DOI 10.1024/0300-9831.74.4.279; Ruhl R, 2006, RAPID COMMUN MASS SP, V20, P2497, DOI 10.1002/rcm.2621; Saurat JH, 1999, J AM ACAD DERMATOL, V41, pS2, DOI 10.1016/S0190-9622(99)70358-0; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Schuster GU, 2008, J IMMUNOL, V180, P1834, DOI 10.4049/jimmunol.180.3.1834; Shaw N, 2003, J BIOL CHEM, V278, P41589, DOI 10.1074/jbc.C300368200; Spiegl N, 2008, BLOOD, V112, P3762, DOI 10.1182/blood-2008-01-135251; Stephensen CB, 2001, ANNU REV NUTR, V21, P167, DOI 10.1146/annurev.nutr.21.1.167; Stephensen CB, 2007, IMMUNOLOGY, V121, P484, DOI 10.1111/j.1365-2567.2007.02595.x; Weise C, 2011, EXP DERMATOL, V20, P805, DOI 10.1111/j.1600-0625.2011.01326.x; Werfel T, 1996, J INVEST DERMATOL, V107, P871, DOI 10.1111/1523-1747.ep12331164; Westergaard M, 2003, J INVEST DERMATOL, V121, P1104, DOI 10.1046/j.1523-1747.2003.12536.x; Zhou GX, 2010, MEAT SCI, V86, P440, DOI 10.1016/j.meatsci.2010.05.031	44	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71244	10.1371/journal.pone.0071244	http://dx.doi.org/10.1371/journal.pone.0071244			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977003	Green Published, gold, Green Submitted			2022-12-25	WOS:000323378000035
J	Kolisek, M; Sponder, G; Mastrototaro, L; Smorodchenko, A; Launay, P; Vormann, J; Schweigel-Rontgen, M				Kolisek, Martin; Sponder, Gerhard; Mastrototaro, Lucia; Smorodchenko, Alina; Launay, Pierre; Vormann, Juergen; Schweigel-Roentgen, Monika			Substitution p.A350V in Na+/Mg2+ Exchanger SLC41A1, Potentially Associated with Parkinson's Disease, Is a Gain-of-Function Mutation	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MAGNETIC-RESONANCE-SPECTROSCOPY; RUMINAL EPITHELIAL-CELLS; MGTE MG2+ TRANSPORTERS; MAGNESIUM-DEFICIENCY; ALPHA-SYNUCLEIN; MITOCHONDRIAL DYSFUNCTION; ALZHEIMERS-DISEASE; DEMENTIA COMPLEX; DIETARY-INTAKE	Parkinson's disease (PD) is a complex multifactorial ailment predetermined by the interplay of various environmental and genetic factors. Systemic and intracellular magnesium (Mg) deficiency has long been suspected to contribute to the development and progress of PD and other neurodegenerative diseases. However, the molecular background is unknown. Interestingly, gene SLC41A1 located in the novel PD locus PARK16 has recently been identified as being a Na+/Mg2+ exchanger (NME, Mg2+ efflux system), a key component of cellular magnesium homeostasis. Here, we demonstrate that the substitution p.A350V potentially associated with PD is a gain-of-function mutation that enhances a core function of SLC41A1, namely Na+-dependent Mg2+ efflux by 69 +/- 10% under our experimental conditions (10-minute incubation in high-Na+ (145 mM) and completely Mg2+-free medium). The increased efflux capacity is accompanied by an insensitivity of mutant NME to cAMP stimulation suggesting disturbed hormonal regulation and leads to a reduced proliferation rate in p.A350V compared with wt cells. We hypothesize that enhanced Mg2+-efflux conducted by SLC41A1 variant p.A350V might result, in the long-term, in chronic intracellular Mg2+-deficiency, a condition that is found in various brain regions of PD patients and that exacerbates processes triggering neuronal damage.	[Kolisek, Martin; Sponder, Gerhard; Mastrototaro, Lucia] Free Univ Berlin, Inst Vet Physiol, Berlin, Germany; [Smorodchenko, Alina] Univ Vet Med, Inst Physiol Pathophysiol & Biophys, Vienna, Austria; [Launay, Pierre] INSERM, U699, Paris, France; [Vormann, Juergen] Inst Prevent & Nutr, Ismaning, Germany; [Schweigel-Roentgen, Monika] Leibniz Inst Farm Anim Biol, Inst Nutr Physiol Oskar Kellner, Dummerstorf, Germany	Free University of Berlin; University of Veterinary Medicine Vienna; Institut National de la Sante et de la Recherche Medicale (Inserm); Forschungsinstitut fur Nutztierbiologie (FBN)	Kolisek, M (corresponding author), Free Univ Berlin, Inst Vet Physiol, Berlin, Germany.	martink@zedat.fu-berlin.de; roentgen@fbn-dummerstorf.de	Smorodchenko, Alina/ABB-2411-2020; Launay, Pierre/AAH-7076-2019; Smorodchenko, Alina/AAU-2854-2020; Smorodchenko, Alina/D-1880-2010; Vormann, Jürgen/F-5055-2016	Vormann, Jürgen/0000-0002-5954-5799; Smorodchenko, Alina/0000-0003-1415-1531	German Research Foundation (DFG) [KO-3586/3-1, KO-3586/3-2]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by a research grant from the German Research Foundation (DFG), KO-3586/3-1 and KO-3586/3-2 to MK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Aden E, 2011, NUTR NEUROSCI, V14, P25, DOI 10.1179/174313211X12966635733312; AGUS ZS, 1991, ANNU REV PHYSIOL, V53, P299, DOI 10.1146/annurev.physiol.53.1.299; Andre C, 2005, ELECTROPHORESIS, V26, P3256, DOI 10.1002/elps.200500169; Barbagallo M, 2011, MAGNESIUM RES, V24, pS115, DOI 10.1684/mrh.2011.0287; Barbiroli B, 1999, MOVEMENT DISORD, V14, P430, DOI 10.1002/1531-8257(199905)14:3<430::AID-MDS1007>3.0.CO;2-S; Bekris LM, 2010, J GERIATR PSYCH NEUR, V23, P228, DOI 10.1177/0891988710383572; Bocca B, 2006, J NEUROL SCI, V248, P23, DOI 10.1016/j.jns.2006.05.007; Bussiere FI, 2002, BRIT J NUTR, V87, P107, DOI 10.1079/BJN2001498; Buttner S, 1998, MAGNESIUM-B, V20, P101; Cannon JR, 2011, TOXICOL SCI, V124, P225, DOI 10.1093/toxsci/kfr239; Covacci V, 1998, J CELL BIOCHEM, V70, P313, DOI 10.1002/(SICI)1097-4644(19980901)70:3<313::AID-JCB4>3.0.CO;2-Q; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Dolder M, 2003, J BIOL CHEM, V278, P17760, DOI 10.1074/jbc.M208705200; Fatholahi M, 2000, ARCH BIOCHEM BIOPHYS, V374, P395, DOI 10.1006/abbi.1999.1619; GARRUTO RM, 1985, NEUROLOGY, V35, P193, DOI 10.1212/WNL.35.2.193; Gerdin A., 2010, ACTA OPHTHALMOL, DOI [10.1111/j.1755-3768.2010.4142.x, DOI 10.1111/J.1755-3768.2010.4142.X]; GESSNER W, 1985, FEBS LETT, V183, P345, DOI 10.1016/0014-5793(85)80807-3; Golts N, 2002, J BIOL CHEM, V277, P16116, DOI 10.1074/jbc.M107866200; Goytain A, 2005, PHYSIOL GENOMICS, V21, P337, DOI 10.1152/physiolgenomics.00261.2004; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUNTHER T, 1984, BIOCHEM BIOPH RES CO, V119, P124, DOI 10.1016/0006-291X(84)91627-9; GUNTHER T, 1985, BIOCHEM BIOPH RES CO, V130, P540, DOI 10.1016/0006-291X(85)90450-4; GUNTHER T, 1992, FEBS LETT, V297, P132, DOI 10.1016/0014-5793(92)80343-F; Hartwig A, 2001, MUTAT RES-FUND MOL M, V475, P113, DOI 10.1016/S0027-5107(01)00074-4; Hashimoto T, 2008, BRAIN RES, V1197, P143, DOI 10.1016/j.brainres.2007.12.033; Hattingen E, 2009, BRAIN, V132, P3285, DOI 10.1093/brain/awp293; He Y, 2005, CIRC RES, V96, P207, DOI 10.1161/01.RES.0000152967.88472.3e; Hurd TW, 2013, J AM SOC NEPHROL; Hutchinson M, 2000, AM J NEURORADIOL, V21, P697; Jantaratnotai N, 2012, BRAIN RES, V1442, P1, DOI 10.1016/j.brainres.2012.01.004; Johnson S, 2001, MED HYPOTHESES, V56, P163, DOI 10.1054/mehy.2000.1133; Kolisek M, 2013, HYPERTENS PREGNANCY; Kolisek M, 2008, J BIOL CHEM, V283, P16235, DOI 10.1074/jbc.M707276200; Kolisek M, 2012, AM J PHYSIOL-CELL PH, V302, pC318, DOI 10.1152/ajpcell.00289.2011; Lodi R, 2001, BRAIN RES BULL, V54, P437, DOI 10.1016/S0361-9230(01)00440-3; Lovitt B, 2010, BIOCHEMISTRY-US, V49, P3092, DOI 10.1021/bi901726c; Malpuech-Brugere C, 2000, BBA-MOL BASIS DIS, V1501, P91, DOI 10.1016/S0925-4439(00)00018-1; Mandt T, 2011, BIOCHEM J, V439, P129, DOI 10.1042/BJ20110807; McCoy MK, 2012, ANTIOXID REDOX SIGN, V16, P869, DOI [10.1089/ars.2011.4019, 10.1089/ars.2011.4074]; Miyake Y, 2011, J NEUROL SCI, V306, P98, DOI 10.1016/j.jns.2011.03.035; Mousain-Bosc M, 2004, J AM COLL NUTR, V23, p545S, DOI 10.1080/07315724.2004.10719400; Nie ZL, 2012, NUTR METAB CARDIOVAS; Nussbaum RL, 2003, NEW ENGL J MED, V348, P1356, DOI 10.1056/NEJM2003ra020003; Oyanagi K, 2006, NEUROPATHOLOGY, V26, P115, DOI 10.1111/j.1440-1789.2006.00672.x; Oyanagi K, 2005, PARKINSONISM RELAT D, V11, pS17, DOI 10.1016/j.parkreldis.2005.02.010; Pham DH, 2008, BIOTECHNIQUES, V45, P155, DOI 10.2144/000112896; Puschmann A, 2013, PARKINSONISM RELAT D, V19, P407, DOI 10.1016/j.parkreldis.2013.01.020; Regan RF, 1998, J NEUROCHEM, V70, P77; REIKOFSKI J, 1992, BIOTECHNOL ADV, V10, P535, DOI 10.1016/0734-9750(92)91451-J; Sartori SB, 2012, NEUROPHARMACOLOGY, V62, P304, DOI 10.1016/j.neuropharm.2011.07.027; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schweigel M, 2006, AM J PHYSIOL-GASTR L, V290, pG56, DOI 10.1152/ajpgi.00014.2005; Schweigel M, 2000, AM J PHYSIOL-GASTR L, V278, pG400, DOI 10.1152/ajpgi.2000.278.3.G400; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Stout AK, 1996, J PHYSIOL-LONDON, V492, P641, DOI 10.1113/jphysiol.1996.sp021334; Tucci A, 2010, EUR J HUM GENET, V18, P1356, DOI 10.1038/ejhg.2010.125; UITTI RJ, 1989, CAN J NEUROL SCI, V16, P310, DOI 10.1017/S0317167100029140; VORMANN J, 1995, J NUTR BIOCHEM, V6, P681, DOI 10.1016/0955-2863(95)00143-3; Wabakken T, 2003, BIOCHEM BIOPH RES CO, V306, P718, DOI 10.1016/S0006-291X(03)01030-1; Wakabayashi K, 2007, NEUROPATHOLOGY, V27, P494, DOI 10.1111/j.1440-1789.2007.00803.x; Wolf FI, 2009, NUTR CANCER, V61, P131, DOI 10.1080/01635580802376360; WOLF FI, 1994, BIOCHEM BIOPH RES CO, V202, P1209, DOI 10.1006/bbrc.1994.2059; Xi Biao, 2008, Biotechnology Journal, V3, P484, DOI 10.1002/biot.200800020; Yamaguchi S, 2008, BIOCHEM BIOPH RES CO, V376, P100, DOI 10.1016/j.bbrc.2008.08.104; Yan YP, 2011, INT J NEUROSCI, V121, P632, DOI 10.3109/00207454.2011.598983	67	53	53	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71096	10.1371/journal.pone.0071096	http://dx.doi.org/10.1371/journal.pone.0071096			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23976986	gold, Green Published, Green Submitted			2022-12-25	WOS:000323378000033
J	Lukjanenko, L; Brachat, S; Pierrel, E; Lach-Trifilieff, E; Feige, JN				Lukjanenko, Laura; Brachat, Sophie; Pierrel, Eliane; Lach-Trifilieff, Estelle; Feige, Jerome N.			Genomic Profiling Reveals That Transient Adipogenic Activation Is a Hallmark of Mouse Models of Skeletal Muscle Regeneration	PLOS ONE			English	Article							IN-VIVO; FIBRO/ADIPOGENIC PROGENITORS; MYOBLAST DIFFERENTIATION; INSULIN-RESISTANCE; PROTEIN-SYNTHESIS; SATELLITE CELLS; ADIPOSE-TISSUE; FAT; MECHANISMS; MYOGENESIS	The marbling of skeletal muscle by ectopic adipose tissue is a hallmark of many muscle diseases, including sarcopenia and muscular dystrophies, and generally associates with impaired muscle regeneration. Although the etiology and the molecular mechanisms of ectopic adipogenesis are poorly understood, fatty regeneration can be modeled in mice using glycerol-induced muscle damage. Using comprehensive molecular and histological profiling, we compared glycerol-induced fatty regeneration to the classical cardiotoxin (CTX)-induced regeneration model previously believed to lack an adipogenic response in muscle. Surprisingly, ectopic adipogenesis was detected in both models, but was stronger and more persistent in response to glycerol. Importantly, extensive differential transcriptomic profiling demonstrated that glycerol induces a stronger inflammatory response and promotes adipogenic regulatory networks while reducing fatty acid beta-oxidation. Altogether, these results provide a comprehensive mapping of gene expression changes during the time course of two muscle regeneration models, and strongly suggest that adipogenic commitment is a hallmark of muscle regeneration, which can lead to ectopic adipocyte accumulation in response to specific physio-pathological challenges.	[Lukjanenko, Laura; Brachat, Sophie; Pierrel, Eliane; Lach-Trifilieff, Estelle; Feige, Jerome N.] Novartis Inst Biomed Res, MusculoSkeletal Dis Grp, Basel, Switzerland	Novartis	Feige, JN (corresponding author), Nestle Inst Hlth Sci, EPFL Campus, Lausanne, Switzerland.	jerome.feige@rd.nestle.com		Lemire-Brachat, Sophie/0000-0002-3398-8225	Novartis Pharma AG	Novartis Pharma AG	All research was funded by Novartis Pharma AG. All authors were employees of Novartis Pharma AG at the time the experiments were performed. The authors independently designed the study, collected and analyzed the data, decided to publish, and prepared the manuscript.	Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Arsic N, 2004, MOL THER, V10, P844, DOI 10.1016/j.ymthe.2004.08.007; Berry R, 2013, NAT CELL BIOL, V15, P302, DOI 10.1038/ncb2696; Biressi S, 2010, SEMIN CELL DEV BIOL, V21, P845, DOI 10.1016/j.semcdb.2010.09.003; Carosio S, 2011, AGEING RES REV, V10, P35, DOI 10.1016/j.arr.2009.08.001; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Deponti D, 2007, J CELL BIOL, V179, P305, DOI 10.1083/jcb.200701027; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; Gaeta M, 2012, SKELETAL RADIOL, V41, P955, DOI 10.1007/s00256-011-1301-5; Gharaibeh B, 2012, BIRTH DEFECTS RES C, V96, P82, DOI 10.1002/bdrc.21005; Goodpaster BH, 2001, J APPL PHYSIOL, V90, P2157, DOI 10.1152/jappl.2001.90.6.2157; Hansen JB, 2006, BIOCHEM J, V398, P153, DOI 10.1042/BJ20060402; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Huard J, 2002, J BONE JOINT SURG AM, V84A, P822, DOI 10.2106/00004623-200205000-00022; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Lee CH, 2003, ENDOCRINOLOGY, V144, P2201, DOI 10.1210/en.2003-0288; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Liu WY, 2012, DEV BIOL, V361, P27, DOI 10.1016/j.ydbio.2011.10.011; Lowe CE, 2011, J CELL SCI, V124, P2681, DOI 10.1242/jcs.079699; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Minetti GC, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002038; Mitchell KJ, 2010, NAT CELL BIOL, V12, P257, DOI 10.1038/ncb2025; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002; Oishi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056641; Okazaki S, 1996, CELL PROLIFERAT, V29, P173; OWNBY CL, 1993, TOXICON, V31, P697, DOI 10.1016/0041-0101(93)90376-T; Phillips BE, 2012, CURR OPIN CLIN NUTR, V15, P58, DOI 10.1097/MCO.0b013e32834d19bc; Pisani DF, 2010, BIOCHEM BIOPH RES CO, V396, P767, DOI 10.1016/j.bbrc.2010.05.021; Pisani DF, 2010, STEM CELLS, V28, P753, DOI 10.1002/stem.317; Rodeheffer MS, 2010, NAT CELL BIOL, V12, P102, DOI 10.1038/ncb0210-102; Rosen ED, 2000, GENE DEV, V14, P1293; Segawa M, 2008, EXP CELL RES, V314, P3232, DOI 10.1016/j.yexcr.2008.08.008; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Song MY, 2004, AM J CLIN NUTR, V79, P874; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Uezumi A, 2011, J CELL SCI, V124, P3654, DOI 10.1242/jcs.086629; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; van Iersel MP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-399; Vettor R, 2009, AM J PHYSIOL-ENDOC M, V297, pE987, DOI 10.1152/ajpendo.00229.2009; Wagatsuma A, 2007, MOL CELL BIOCHEM, V304, P25, DOI 10.1007/s11010-007-9482-x; Wallace GQ, 2009, ANNU REV PHYSIOL, V71, P37, DOI 10.1146/annurev.physiol.010908.163216; Weigl LG, 2012, CURR OPIN PHARMACOL, V12, P377, DOI 10.1016/j.coph.2012.02.017; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475	48	44	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71084	10.1371/journal.pone.0071084	http://dx.doi.org/10.1371/journal.pone.0071084			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23976982	Green Published, Green Submitted, gold			2022-12-25	WOS:000323378000032
J	Van Goethem, D; De Smedt, S; Valcke, R; Potters, G; Samson, R				Van Goethem, Davina; De Smedt, Sebastiaan; Valcke, Roland; Potters, Geert; Samson, Roeland			Seasonal, Diurnal and Vertical Variation of Chlorophyll Fluorescence on Phyllostachys humilis in Ireland	PLOS ONE			English	Article							PINE PINUS-SYLVESTRIS; PHOTOSYSTEM-II; A FLUORESCENCE; SCOTS PINE; PHOTOCHEMICAL EFFICIENCY; COLD-ACCLIMATION; PHOTOSYNTHESIS; LIGHT; STRESS; WINTER	In recent years, temperate bamboo species have been introduced in Europe not only as an ornamental plant, but also as a new biomass crop. To measure adaptation stress of bamboo to the climate of Western Europe, chlorophyll fluorescence was measured on a diurnal and seasonal basis in Ballyboughal, Co. Dublin, Ireland. Measurements were attained on the leaves of each node of Phyllostachys humilis. The most frequently used parameter in chlorophyll fluorescence is the photosynthetic efficiency (Fv/Fm). A seasonal dip - as well as a larger variation - of Fv/Fm in spring compared to the rest of the year was observed. Over the year, the upper leaves of the plant perform better than the bottom leaves. These findings were linked to environmental factors such as light intensity, air temperature and precipitation, as increased light intensities, decreasing air temperatures and their interactions, also with precipitation levels have an effect on the photosynthetic efficiency (Fv/Fm) in these plants.	[Van Goethem, Davina; De Smedt, Sebastiaan; Potters, Geert; Samson, Roeland] Univ Antwerp, Dept Biosci Engn, B-2020 Antwerp, Belgium; [Valcke, Roland] Hasselt Univ, Lab Mol & Phys Plant Physiol, Hasselt, Belgium; [Potters, Geert] Antwerp Maritime Acad, Antwerp, Belgium	University of Antwerp; Hasselt University	Van Goethem, D (corresponding author), Univ Antwerp, Dept Biosci Engn, B-2020 Antwerp, Belgium.	davina.vangoethem@ua.ac.be	Potters, Geert/HDM-3489-2022; Samson, Roeland/L-2109-2018	Potters, Geert/0000-0002-8924-3169; Samson, Roeland/0000-0001-7582-1450	Special Research Fund (BOF)	Special Research Fund (BOF)	The Special Research Fund (BOF) partly funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ADAMS WW, 1995, PLANT CELL ENVIRON, V18, P117, DOI 10.1111/j.1365-3040.1995.tb00345.x; ADAMS WW, 1994, PHYSIOL PLANTARUM, V92, P451, DOI 10.1111/j.1399-3054.1994.tb08835.x; ADAMS WW, 1995, AUST J PLANT PHYSIOL, V22, P261, DOI 10.1071/PP9950261; Ain-Lhout F, 2004, PHOTOSYNTHETICA, V42, P399, DOI 10.1023/B:PHOT.0000046159.96228.49; [Anonymous], 2006, ORNAMENTAL BAMBOOS; BAKER N.R., 1987, PHOTOINHIBITION, V9, P145; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Binder WD, 1996, NEW FOREST, V11, P233; BOLHARNORDENKAMPE HR, 1989, FUNCT ECOL, V3, P497, DOI 10.2307/2389624; Chen JM, 1997, J GEOPHYS RES-ATMOS, V102, P29429, DOI 10.1029/97JD01107; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; El Bassam N, 1998, ENERGY PLANT SPECIES, DOI DOI 10.4324/9781315073699; Ensminger I, 2004, GLOBAL CHANGE BIOL, V10, P995, DOI 10.1111/j.1365-2486.2004.00781.x; Fernandez-Baco L, 1998, PHOTOSYNTHETICA, V35, P535, DOI 10.1023/A:1006926923293; Figueroa ME, 1997, J VEG SCI, V8, P881, DOI 10.2307/3237033; Fracheboud Y, 1999, J EXP BOT, V50, P1533, DOI 10.1093/jexbot/50.338.1533; FRANKLIN JF, 1979, ECOL MONOGR, V49, P311, DOI 10.2307/1942487; GUISSE B, 1995, ARCH SCI, V48, P147; Haubrich R, 1980, J AM BAMBOO SOC, V1, P48; Haughton D, 1990, J STAT COMPUT SIM, V35, P187, DOI [10.1080/00949659008811243, DOI 10.1080/00949659008811243]; Huner NPA, 1996, PHYSIOL PLANTARUM, V98, P358, DOI 10.1034/j.1399-3054.1996.980218.x; Huner NPA, 1998, TRENDS PLANT SCI, V3, P224, DOI 10.1016/S1360-1385(98)01248-5; Imre V, 2011, PHYSIOL PLANTARUM, V142, P6, DOI 10.1111/j.1399-3054.2011.01454.x; ISAGI Y, 1993, ECOL RES, V8, P123, DOI 10.1007/BF02348524; Judziewicz EJ, 1999, AM BAMBOOS; Karavatas S, 1999, PHOTOSYNTHETICA, V36, P41, DOI 10.1023/A:1007010502269; KARPINSKI S, 1994, PHYSIOL PLANTARUM, V90, P358, DOI 10.1111/j.1399-3054.1994.tb00400.x; Kruger GHJ, 1997, PHYSIOL PLANTARUM, V101, P265, DOI 10.1034/j.1399-3054.1997.1010203.x; Kwong M, 2002, TRACING RAD ARCHITEC, P1; Kyle D.J., 1987, PHOTOINHIBITION, P197; Langvall O, 2001, CAN J FOREST RES, V31, P155, DOI 10.1139/cjfr-31-1-155; Lichtenthaler Hartmut K., 1999, Bulgarian Journal of Plant Physiology, V25, P3; Logan BA, 1998, OECOLOGIA, V116, P9, DOI 10.1007/PL00013823; LONG SP, 1994, ANNU REV PLANT PHYS, V45, P633, DOI 10.1146/annurev.pp.45.060194.003221; Montti L, 2011, FOREST ECOL MANAG, V262, P1360, DOI 10.1016/j.foreco.2011.06.029; Nippert JB, 2004, FUNCT ECOL, V18, P876, DOI 10.1111/j.0269-8463.2004.00909.x; OBERHUBER W, 1991, PLANTA, V185, P545, DOI 10.1007/BF00202965; Ogaya R, 2011, ENVIRON EXP BOT, V73, P89, DOI 10.1016/j.envexpbot.2011.08.004; Olejnik S, 2003, PSYCHOL METHODS, V8, P434, DOI 10.1037/1082-989X.8.4.434; OQUIST G, 1986, CAN J BOT, V64, P748, DOI 10.1139/b86-096; OQUIST G, 1991, FUNCT ECOL, V5, P91, DOI 10.2307/2389559; OTTANDER C, 1991, PLANT CELL ENVIRON, V14, P345, DOI 10.1111/j.1365-3040.1991.tb01511.x; OTTANDER C, 1995, PLANTA, V197, P176, DOI 10.1007/BF00239954; Ouzounidou G, 1997, AUST J PLANT PHYSIOL, V24, P81, DOI 10.1071/PP96028; Papadopoulos A. N., 2004, Holz als Roh- und Werkstoff, V62, P36, DOI 10.1007/s00107-003-0447-9; Papageaorgiou GC, 2005, ADV PHOTOSYNTHESIS R; Pinheiro J., 2011, NLME LINEAR NONLINEA; Pinheiro J, 2001, MIXED EFFECTS MODELS; Porcar-Castell A, 2008, TREE PHYSIOL, V28, P1475, DOI 10.1093/treephys/28.10.1475; Potters G, ACTA HORTICULTURA; Potters G, 2009, P 8 WORLD BAMB C, P22; Qiu GX, 1992, PRIMARY PRODUCTIVITY, P159; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rakesh Kumar, 2002, Journal of Bamboo and Rattan, V1, P341, DOI 10.1163/15691590260470447; Scurlock JMO, 2000, BIOMASS BIOENERG, V19, P229, DOI 10.1016/S0961-9534(00)00038-6; Srivastava A, 1996, J PLANT PHYSIOL, V148, P445, DOI 10.1016/S0176-1617(96)80278-1; Srivastava A, 1997, BBA-BIOENERGETICS, V1320, P95, DOI 10.1016/S0005-2728(97)00017-0; STRAND M, 1985, PHYSIOL PLANTARUM, V65, P117, DOI 10.1111/j.1399-3054.1985.tb02369.x; Strand M, 1987, TREE PHYSIOL, V3, P211, DOI 10.1093/treephys/3.3.211; STRAND M, 1995, TREE PHYSIOL, V15, P151, DOI 10.1093/treephys/15.3.151; Strasser BJ, 1997, PHOTOSYNTH RES, V52, P147, DOI 10.1023/A:1005896029778; Strasser R.J., 2000, PROBING PHOTOSYNTH M, P443; Sveshnikov D, 2006, TREE PHYSIOL, V26, P325, DOI 10.1093/treephys/26.3.325; TAYLOR AH, 1988, J ECOL, V76, P1204, DOI 10.2307/2260643; Tomimatsu H, 2011, PLANT SPEC BIOL, V26, P3, DOI 10.1111/j.1442-1984.2010.00310.x; TsimilliMichael M, 1995, PHOTOSYNTHESIS: FROM LIGHT TO BIOSPHERE, VOL 5, P981; Van Acker J, 2000, IUFRO M KUAL LUMP MA; Van Goethem D, ACTA HORTICULTURA; Van Goethem D, 2012, 9 WORLD BAMB C, P298; Van Hoyweghen L, 2010, J NAT PROD, V73, P1573, DOI 10.1021/np100220g; vanRensburg L, 1996, S AFR J BOT, V62, P337, DOI 10.1016/S0254-6299(15)30676-1; VEBLEN TT, 1982, B TORREY BOT CLUB, V109, P474, DOI 10.2307/2996488; Wang TJ, 2009, PHOTOGRAMM ENG REM S, V75, P37, DOI 10.14358/PERS.75.1.37; Whittaker P, 2005, HARDY BAMBOOS TAMING; Yang DD, 1988, Q J CHINESE FORESTRY, V14, P1	75	16	16	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e72145	10.1371/journal.pone.0072145	http://dx.doi.org/10.1371/journal.pone.0072145			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967282	Green Published, gold			2022-12-25	WOS:000323378000083
J	Zhang, RY; Peng, ZG; Li, GG; Zhang, CF; Tang, YT; Gan, XN; He, SP; Zhao, K				Zhang, Renyi; Peng, Zuogang; Li, Guogang; Zhang, Cunfang; Tang, Yongtao; Gan, Xiaoni; He, Shunping; Zhao, Kai			Ongoing Speciation in the Tibetan Plateau Gymnocypris Species Complex	PLOS ONE			English	Article							LOCAL ADAPTATION; EUROPEAN POPULATIONS; PARALLEL EVOLUTION; POISON FROGS; TELEOSTEI; CYPRINIDAE; LAKE; BIOGEOGRAPHY; COMPETITION; DIVERGENCE	Local adaptation towards divergent ecological conditions often results in genetic differentiation and adaptive phenotypic divergence. To illuminate the ecological distinctiveness of the schizothoracine fish, we studied a Gymnocypris species complex consisting of three morphs distributed across four bodies of water (the Yellow River, Lake Qinghai, the Ganzi River and Lake Keluke) in the Northeast Tibetan Plateau. We used a combination of mitochondrial (16S rRNA and Cyt b) and nuclear (RAG-2) genetic sequences to investigate the phylogeography of these morphs based on a sample of 277 specimens. Analysis of gill rakers allowed for mapping of phenotypic trajectories along the phylogeny. The phylogenetic and morphological analyses showed that the three sparsely rakered morphs were present at two extremes of the phylogenetic tree: the Yellow River morphs were located at the basal phylogenetic split, and the Lake Keluke and Ganzi River morphs at the peak, with the densely rakered Lake Qinghai morphs located between these two extremes. Age estimation further indicated that the sparsely rakered morphs constituted the oldest and youngest lineages, whereas the densely rakered morph was assigned to an intermediate-age lineage. These results are most compatible with the process of evolutionary convergence or reversal. Disruptive natural selection due to divergent habitats and dietary preferences is likely the driving force behind the formation of new morphs, and the similarities between their phenotypes may be attributable to the similarities between their forms of niche tracking associated with food acquisition. This study provides the first genetic evidence for the occurrence of convergence or reversal in the schizothoracine fish of the Tibetan Plateau at small temporal scales.	[Zhang, Renyi; Li, Guogang; Zhang, Cunfang; Tang, Yongtao; Zhao, Kai] Chinese Acad Sci, Northwest Inst Plateau Biol, Key Lab Adaptat & Evolut Plateau Biota, Xining, Qinghai, Peoples R China; [Zhang, Renyi; Li, Guogang] Univ Chinese Acad Sci, Beijing, Peoples R China; [Peng, Zuogang; Gan, Xiaoni; He, Shunping] Chinese Acad Sci, Inst Hydrobiol, Lab Fish Phylogenet & Biogeog, Wuhan, Hubei, Peoples R China; [Peng, Zuogang] Minist Educ, Key Lab Freshwater Fish Reprod & Dev, Chongqing, Peoples R China; [Peng, Zuogang] Southwest Univ Sch Life Sci, Chongqing, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Zhao, K (corresponding author), Chinese Acad Sci, Northwest Inst Plateau Biol, Key Lab Adaptat & Evolut Plateau Biota, Xining, Qinghai, Peoples R China.	zhaokai@nwipb.cas.cn	Li, Guogang/AAK-7427-2020; Zhang, Renyi/K-6900-2015; Peng, Zuogang/D-4448-2011	Li, Guogang/0000-0003-0981-0328; Zhang, Renyi/0000-0002-3647-1416; Peng, Zuogang/0000-0001-8810-2025	Chinese Academy of Sciences [KSCX2-YW-N-101, KSCX2-1W-N-004]; National Natural Science Foundation of China [30970341, 31172070, 31071903]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was partially supported by grants from the Chinese Academy of Sciences (Key Innovation Plan: KSCX2-YW-N-101 and KSCX2-1W-N-004) and from the National Natural Science Foundation of China (30970341, 31172070, 31071903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundsen PA, 2004, ANN ZOOL FENN, V41, P301; Amundsen PA, 2004, ANN ZOOL FENN, V41, P291; Antoniazza S, 2010, EVOLUTION, V64, P1944, DOI 10.1111/j.1558-5646.2010.00969.x; Baird HP, 2011, MOL ECOL, V20, P3439, DOI 10.1111/j.1365-294X.2011.05173.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BERGSTRAND E, 1982, REP I FRESHWATER RES, V60, P5; Bolnick DI, 2004, EVOLUTION, V58, P608, DOI 10.1111/j.0014-3820.2004.tb01683.x; Chen Y., 2000, FAUNA SINICA OSTEICH, P273; Chen ZM, 1988, P 3 CHIN OC LIMN SCI, P244; Chiari Y, 2004, MOL ECOL, V13, P3763, DOI 10.1111/j.1365-294X.2004.02367.x; Collin H, 2011, MOL ECOL, V20, P4490, DOI 10.1111/j.1365-294X.2011.05284.x; Dieckmann U., 2004, ADAPTIVE SPECIATION; Duan ZY, 2009, MOL PHYLOGENET EVOL, V53, P1025, DOI 10.1016/j.ympev.2009.03.034; Edwards SV, 2000, EVOLUTION, V54, P1839; Endler J.A., 1986, Monographs in Population Biology, pviii; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fu YX, 1997, GENETICS, V147, P915; Grant Taran, 1997, American Museum Novitates, V3212, P1; He DK, 2006, J BIOGEOGR, V33, P1448, DOI 10.1111/j.1365-2699.2006.01510.x; Huang S, 2007, MOL PHYLOGENET EVOL, V44, P942, DOI 10.1016/j.ympev.2007.05.019; Jijun L., 2001, QUAT SCI, V21, P381, DOI DOI 10.3321/J.ISSN:1001-7410.2001.05.001; Jin YT, 2008, MOL ECOL, V17, P3033, DOI 10.1111/j.1365-294X.2008.03810.x; Kahilainen K, 2006, J FISH BIOL, V68, P63, DOI 10.1111/j.0022-1112.2006.00876.x; Kaukoranta M., 2000, ATLAS FINNISH FISHES; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kirkpatrick M, 2006, GENETICS, V173, P419, DOI 10.1534/genetics.105.047985; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Leinonen PH, 2009, AM J BOT, V96, P1129, DOI 10.3732/ajb.0800080; Li JJ, 1996, SCI CHINA SER D, V39, P380; Li JB, 2008, MOL PHYLOGENET EVOL, V47, P472, DOI 10.1016/j.ympev.2007.09.012; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; LOSOS JB, 1992, SYST BIOL, V41, P403, DOI 10.2307/2992583; Lovejoy NR, 2001, COPEIA, P324, DOI 10.1643/0045-8511(2001)001[0324:PRONWN]2.0.CO;2; MAYR E, 1947, EVOLUTION, V1, P263, DOI 10.2307/2405327; NEI M, 1981, GENETICS, V97, P145; Nei M., 1987, MOL EVOLUTIONARY GEN; Ostbye K, 2006, MOL ECOL, V15, P3983, DOI 10.1111/j.1365-294X.2006.03062.x; Ostbye K, 2005, MOL ECOL, V14, P4371, DOI 10.1111/j.1365-294X.2005.02737.x; Pan B., 1994, ARID LAND GEOGRAPHY, V7, P43; Pan BT, 2001, CHINESE SCI BULL, V46, P509, DOI 10.1007/BF03187270; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Qi DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034070; Qin GX, 2001, HEILONGJIANG J ANIMA, V12, P7; REYNOLDS J, 1983, GENETICS, V105, P767; Rice WR, 1987, EVOL ECOL, V1, P301, DOI 10.1007/BF02071555; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rowe KC, 2011, SYST BIOL, V60, P188, DOI 10.1093/sysbio/syq092; Ruber L, 2001, J EVOLUTION BIOL, V14, P325, DOI 10.1046/j.1420-9101.2001.00269.x; Ruber L, 1999, P NATL ACAD SCI USA, V96, P10230, DOI 10.1073/pnas.96.18.10230; Saether SA, 2007, J EVOLUTION BIOL, V20, P1563, DOI 10.1111/j.1420-9101.2007.01328.x; Sanbrook J., 1989, MOL CLONING LAB MANU; SCHLUTER D, 1994, SCIENCE, V266, P798, DOI 10.1126/science.266.5186.798; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; SLATKIN M, 1995, GENETICS, V139, P457; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Syme AE, 2012, SYST BIOL, V61, P314, DOI 10.1093/sysbio/syr085; Taylor EB, 2006, MOL ECOL, V15, P343, DOI 10.1111/j.1365-294X.2005.02794.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsao WX, 1962, ACTA HYDROBIOL, V2, P79; Vences M, 2003, ORG DIVERS EVOL, V3, P215, DOI 10.1078/1439-6092-00076; Wang JL, 1975, ICHTHYOFAUNA LAKE QI, P27; Wu Y, 1992, FISHES QINGHAI XIZAN; Xiao WH, 2001, MOL PHYLOGENET EVOL, V18, P163, DOI 10.1006/mpev.2000.0879; [张智勇 Zhang Zhiyong], 2003, [地球科学, Earth science], V28, P621; Zhao K, 2005, CHINESE SCI BULL, V50, P1325, DOI 10.1360/982005-223; Zhao K, 2007, PROG NAT SCI-MATER, V17, P520; Zhao K, 2011, MOL PHYLOGENET EVOL, V59, P303, DOI 10.1016/j.ympev.2011.02.001; Zhao K, 2009, MOL ECOL, V18, P3616, DOI 10.1111/j.1365-294X.2009.04274.x; Zhao Lihua, 1990, Journal of Fisheries of China, V14, P286; Zhu S.-Q., 1981, STUDIES PERIOD AMPLI, P118; Zhu SQ, 1975, ICHTHYOFAUNA LAKE QI, P9	72	19	19	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71331	10.1371/journal.pone.0071331	http://dx.doi.org/10.1371/journal.pone.0071331			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977018	Green Published, gold, Green Submitted			2022-12-25	WOS:000323378000042
J	Hussen, J; Duvel, A; Sandra, O; Smith, D; Sheldon, IM; Zieger, P; Schuberth, HJ				Hussen, Jamal; Duevel, Anna; Sandra, Olivier; Smith, David; Sheldon, Iain Martin; Zieger, Peter; Schuberth, Hans-Joachim			Phenotypic and Functional Heterogeneity of Bovine Blood Monocytes	PLOS ONE			English	Article							DENDRITIC CELLS; PERIPHERAL-BLOOD; GENE-EXPRESSION; INTERFERON; IDENTIFICATION; POPULATION; INFECTION	Murine and human peripheral blood monocytes are heterogeneous in size, granularity, nuclear morphology, phenotype and function. Whether and how bovine blood monocytes follow this pattern was analyzed in this study. Flow cytometrically, classical monocytes (cM) CD14(+) CD16(-), intermediate monocytes (intM) CD14(+) CD16(+) and nonclassical monocytes (ncM) CD14+ CD16+ were identified, with cM being the predominant subset (89%). cM showed a significant lower expression of CD172a, intM expressed the highest level of MHC class II molecules, and ncM were low positive for CD163. Compared to cM and intM, ncM showed a significantly reduced phagocytosis capacity, a significantly reduced generation of reactive oxygen species, and reduced mRNA expression of CXCL8, CXCL1 and IL-1 beta after LPS stimulation. Based on IL-1 beta secretion after LPS/ATP stimulation, the inflammasome could be activated in cM and intM, but not in ncM. IFN gamma increased the expression of CD16 selectively on cM and induced a shift from cM into intM in vitro. In summary, bovine CD172a-positive mononuclear cells define three monocyte subsets with distinct phenotypic and functional differences. Bovine cM and intM share homologies with their human counterparts, whereas bovine ncM are not inflammatory monocytes.	[Hussen, Jamal; Duevel, Anna; Schuberth, Hans-Joachim] Univ Vet Med, Immunol Unit, Hannover, Germany; [Sandra, Olivier] INRA, Biol Dev & Reprod UMR1198, Jouy En Josas, France; [Sandra, Olivier] Ecole Natl Vet Alfort, Maisons Alfort, France; [Smith, David] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Sheldon, Iain Martin] Swansea Univ, Sch Med, Inst Life Sci, Swansea, W Glam, Wales; [Zieger, Peter] Zoetis, Paris, France	University of Veterinary Medicine Hannover, Foundation; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Ecole Nationale Veterinaire d'Alfort (ENVA); University of Glasgow; Swansea University; Zoetis	Schuberth, HJ (corresponding author), Univ Vet Med, Immunol Unit, Hannover, Germany.	hans-joachim.schuberth@tiho-hannover.de	Sheldon, I Martin/E-1567-2013; Hussen, Jamal/ABC-5809-2020; Hussen, Jamal/M-4389-2016; Smith, David/N-9743-2018; Schuberth, Hans-Joachim/AAE-4845-2020	Sheldon, I Martin/0000-0001-7902-5558; Hussen, Jamal/0000-0001-8942-005X; Hussen, Jamal/0000-0001-8942-005X; Smith, David/0000-0002-2484-2603; 	Bundesministerium fur Bildung und Forschung [FKZ 0315861]; Biotechnology and Biological Sciences Research Council [BB/I017283/1] Funding Source: researchfish; BBSRC [BB/I017283/1] Funding Source: UKRI	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funded by Bundesministerium fur Bildung und Forschung, www.bmbf.de, Grant: FKZ 0315861, Project 'EMIDA-Era-Net: iPUD- integrierter systemischer Ansatz zur Verhinderung uteriner Erkrankungen beim Rind'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancuta P, 2003, J EXP MED, V197, P1701, DOI 10.1084/jem.20022156; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Chamorro S, 2005, IMMUNOLOGY, V114, P63, DOI 10.1111/j.1365-2567.2004.01994.x; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Duvel A, INNATE IMMUN; Frankenberger M, 1996, BLOOD, V87, P373; Frankenberger M, 2012, IMMUNOBIOLOGY; Gibson A, 2012, DEV COMP IMMUNOL, V36, P332, DOI 10.1016/j.dci.2011.05.002; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Heine GH, 2012, NAT REV NEPHROL; Hume DA, 2002, J LEUKOCYTE BIOL, V72, P621; Hussen J, 2012, DEV COMP IMMUNOL, V38, P312, DOI 10.1016/j.dci.2012.06.004; MacHugh DE, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-25; Magee DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032034; Magil AB, 2006, NEPHROL DIAL TRANSPL, V21, P1382, DOI 10.1093/ndt/gfk028; Mirkovitch J, 2006, VET IMMUNOL IMMUNOP, V114, P1, DOI 10.1016/j.vetimm.2006.06.004; Moreno S, 2010, VET RES, V41, DOI 10.1051/vetres/2010048; Neuvians TP, 2004, BIOL REPROD, V70, P473, DOI 10.1095/biolreprod.103.016154; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Rogacev KS, 2010, NEPHROL THER, V6, P219, DOI 10.1016/j.nephro.2010.01.008; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Summerfield A, 2003, IMMUNOLOGY, V110, P440, DOI 10.1111/j.1365-2567.2003.01755.x; Taraktsoglou M, 2011, VET IMMUNOL IMMUNOP, V140, P130, DOI 10.1016/j.vetimm.2010.12.002; Taubert A, 2008, VET RES COMMUN, V32, P35, DOI 10.1007/s11259-007-9001-2; van Beek EM, 2005, J IMMUNOL, V175, P7781, DOI 10.4049/jimmunol.175.12.7781; WEINER LM, 1994, CANCER RES, V54, P4084; Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355; Yang W, 2008, MOL IMMUNOL, V45, P1385, DOI 10.1016/j.molimm.2007.09.004; Zawada AM, 2011, BLOOD, V118, pE50, DOI 10.1182/blood-2011-01-326827; Zawada AM, 2012, IMMUNOBIOLOGY; Ziegler-Heitbrock HWL, 2000, J LEUKOCYTE BIOL, V67, P603, DOI 10.1002/jlb.67.5.603; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	35	64	64	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71502	10.1371/journal.pone.0071502	http://dx.doi.org/10.1371/journal.pone.0071502			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967219	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000323221500088
J	Ono, M; Inkson, CA; Sonn, R; Kilts, TM; de Castro, LF; Maeda, A; Fisher, LW; Robey, PG; Berendsen, AD; Li, L; McCartney-Francis, N; Brown, AC; Crawford, NPS; Molinolo, A; Jain, A; Fedarko, NS; Young, MF				Ono, Mitsuaki; Inkson, Colette A.; Sonn, Robert; Kilts, Tina M.; de Castro, Luis F.; Maeda, Azusa; Fisher, Larry W.; Robey, Pamela G.; Berendsen, Agnes D.; Li, Li; McCartney-Francis, Nancy; Brown, Aaron C.; Crawford, Nigel P. S.; Molinolo, Alfredo; Jain, Alka; Fedarko, Neal S.; Young, Marian F.			WISP1/CCN4: A Potential Target for Inhibiting Prostate Cancer Growth and Spread to Bone	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; FACTOR CTGF/CCN2; TUMOR-GROWTH; WISP-1; METASTASIS; CYR61; BREAST; MECHANISMS; REGULATOR; GENES	Prostate cancer (PC) is a leading cause of death in men however the factors that regulate its progression and eventual metastasis to bone remain unclear. Here we show that WISP1/CCN4 expression in prostate cancer tissues was up-regulated in early stages of the disease and, further, that it correlated with increased circulating levels of WISP1 in the sera of patients at early stages of the disease. WISP1 was also elevated in the mouse prostate cancer model TRAMP in the hypoplastic diseased tissue that develops prior to advanced carcinoma formation. When the ability of anti-WISP1 antibodies to reduce the spread of PC3-Luc cells to distant sites was tested it showed that twice weekly injections of anti-WISP1 antibodies reduced the number and overall size of distant tumors developed after intracardiac (IC) injection of PC3-Luc cells in mice. The ability of antibodies against WISP1 to inhibit growth of PC3-Luc cancer cells in mice was also evaluated and showed that twice weekly injections of anti-WISP1 antibodies reduced local tumor growth when examined in xenografts. To better understand the mechanism of action, the migration of PC3-Luc cells through membranes with or without a Matrigel (TM) barrier showed the cells were attracted to WISP1, and that this attraction was inhibited by treatment with anti-WISP1 antibodies. We also show the expression of WISP1 at the bone-tumor interface and in the stroma of early grade cancers suggested WISP1 expression is well placed to play roles in both fostering growth of the cancer and its spread to bone. In summary, the up-regulation of WISP1 in the early stages of cancer development coupled with its ability to inhibit spread and growth of prostate cancer cells makes it both a potential target and an accessible diagnostic marker for prostate cancer.	[Ono, Mitsuaki; Inkson, Colette A.; Sonn, Robert; Kilts, Tina M.; de Castro, Luis F.; Maeda, Azusa; Fisher, Larry W.; Robey, Pamela G.; Berendsen, Agnes D.; Li, Li; McCartney-Francis, Nancy; Brown, Aaron C.; Young, Marian F.] NIDCR, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD USA; [Molinolo, Alfredo] NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD USA; [Crawford, Nigel P. S.] NHGRI, Metastasis Genet Sect, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; [Jain, Alka; Fedarko, Neal S.] Johns Hopkins Sch Med, Div Geriatr Med & Gerontol, Baltimore, MD USA; [Ono, Mitsuaki] Okayama Univ, Dept Oral Rehabil & Regenerat Med, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Inkson, Colette A.] Univ Manchester, Fac Life Sci, Manchester Immunol Grp, Manchester, Lancs, England	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Johns Hopkins University; Johns Hopkins Medicine; Okayama University; University of Manchester	Young, MF (corresponding author), NIDCR, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD USA.	myoung@dir.nicdr.nih.gov	Robey, Pamela Gehron/H-1429-2011; de Castro, Luis Fernandez/AAV-1858-2021	Robey, Pamela Gehron/0000-0002-5316-5576; de Castro, Luis Fernandez/0000-0003-3194-9780; Fedarko, Neal/0000-0001-6055-6279; Inkson, Colette/0000-0003-1215-312X; Young, Marian F/0000-0003-0929-8854	Division of Intramural Research, NIDCR of the Intramural Research Program, NIH, DHHS; Department of Defense [W81XWH-11-1-0239]; Howard Hughes Scholarship; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000379, ZIADE000380] Funding Source: NIH RePORTER	Division of Intramural Research, NIDCR of the Intramural Research Program, NIH, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Department of Defense(United States Department of Defense); Howard Hughes Scholarship; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by the Division of Intramural Research, NIDCR of the Intramural Research Program, NIH, DHHS (MO, CAI, TMK, LFCD, AM (Maeda), LWF, PGR, ADB, LL NM-F, ACB, NPSC, AM (Molinolo) and MFY), by a grant from the Department of Defense W81XWH-11-1-0239 (AJ and NSF) and by a Howard Hughes Scholarship (RS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barqawi A, 2012, ADV UROL, V2012, DOI 10.1155/2012/862639; Barry MJ, 2001, NEW ENGL J MED, V344, P1373, DOI 10.1056/NEJM200105033441806; Bauer M, 2010, ONCOGENE, V29, P1732, DOI 10.1038/onc.2009.463; Bennewith KL, 2009, CANCER RES, V69, P775, DOI 10.1158/0008-5472.CAN-08-0987; Buijs JT, 2007, AM J PATHOL, V171, P1047, DOI 10.2353/ajpath.2007.070168; Center MM, 2012, EUR UROL, V61, P1079, DOI 10.1016/j.eururo.2012.02.054; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Chirgwin JM, 2000, CRIT REV EUKAR GENE, V10, P159; Chung LWK, 2005, J UROLOGY, V173, P10, DOI 10.1097/01.ju.0000141582.15218.10; Dornhofer N, 2006, CANCER RES, V66, P5816, DOI 10.1158/0008-5472.CAN-06-0081; Feeley BT, 2006, BONE, V38, P154, DOI 10.1016/j.bone.2005.07.015; French DM, 2004, AM J PATHOL, V165, P855, DOI 10.1016/S0002-9440(10)63348-2; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Gururajan M, 2012, TRANSL ANDROL UROL, V1, P19, DOI 10.3978/j.issn.2223-4683.2012.01.03; Hashimoto Y, 1998, J EXP MED, V187, P289, DOI 10.1084/jem.187.3.289; Hou CH, 2011, BIOCHEM PHARMACOL, V81, P1286, DOI 10.1016/j.bcp.2011.03.016; Inkson CA, 2008, J CELL BIOCHEM, V104, P1865, DOI 10.1002/jcb.21754; Inkson CA, 2009, CELLS TISSUES ORGANS, V189, P153, DOI 10.1159/000151377; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kapinas K, 2012, MATRIX BIOL, V31, P299, DOI 10.1016/j.matbio.2012.03.002; Khor TO, 2006, INT J COLORECTAL DIS, V21, P291, DOI 10.1007/s00384-005-0002-8; Kleer CG, 2007, CELLS TISSUES ORGANS, V185, P95, DOI 10.1159/000101308; Kobayashi A, 2011, J EXP MED, V208, P2641, DOI 10.1084/jem.20110840; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Langley RR, 2011, INT J CANCER, V128, P2527, DOI 10.1002/ijc.26031; Lv HZ, 2009, J CELL BIOCHEM, V106, P738, DOI 10.1002/jcb.22075; Maillard M, 2001, J CLIN PATHOL-MOL PA, V54, P275, DOI 10.1136/mp.54.4.275; Margalit O, 2003, BRIT J CANCER, V89, P314, DOI 10.1038/sj.bjc.6600977; Nagai Y, 2011, ANTICANCER RES, V31, P991; Ono M, 2011, J BONE MINER RES, V26, P193, DOI 10.1002/jbmr.205; Parisi MS, 2006, BONE, V38, P671, DOI 10.1016/j.bone.2005.10.005; Pasmant E, 2010, J NEUROPATH EXP NEUR, V69, P60, DOI 10.1097/NEN.0b013e3181c79bff; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; Roodman GD, 2012, CANC METASTASIS REV; Sabile AA, 2011, J BONE MINER RES; Schneider A, 2005, ENDOCRINOLOGY, V146, P1727, DOI 10.1210/en.2004-1211; Shimo T, 2006, J BONE MINER RES, V21, P1045, DOI 10.1359/JBMR.060416; Sun YX, 2005, J BONE MINER RES, V20, P318, DOI 10.1359/JBMR.041109; Suva LJ, 2011, NAT REV ENDOCRINOL, V7, P208, DOI 10.1038/nrendo.2010.227; Tan TW, 2009, CARCINOGENESIS, V30, P258, DOI 10.1093/carcin/bgn284; Tanaka S, 2001, ONCOGENE, V20, P5525, DOI 10.1038/sj.onc.1204723; Tang QL, 2011, J OBSTET GYNAECOL RE, V37, P606, DOI 10.1111/j.1447-0756.2011.01631.x; Terada N, 2012, PROSTATE, V72, P966, DOI 10.1002/pros.21501; Terada N, 2012, ASIAN J ANDROL, V14, P405, DOI 10.1038/aja.2011.149; Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055; Xie D, 2001, CANCER RES, V61, P8917; Xu LF, 2000, GENE DEV, V14, P585	48	54	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71709	10.1371/journal.pone.0071709	http://dx.doi.org/10.1371/journal.pone.0071709			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23977121	Green Submitted, Green Published, gold			2022-12-25	WOS:000323221500098
J	Yamaguchi, T; Turhan, A; Harris, DL; Hu, K; Pruss, H; von Andrian, U; Hamrah, P				Yamaguchi, Takefumi; Turhan, Aslihan; Harris, Deshea L.; Hu, Kai; Pruess, Harald; von Andrian, Ulrich; Hamrah, Pedram			Bilateral Nerve Alterations in a Unilateral Experimental Neurotrophic Keratopathy Model: A Lateral Conjunctival Approach for Trigeminal Axotomy	PLOS ONE			English	Article							VIVO-CONFOCAL-MICROSCOPY; RAT SPINAL-CORD; SUBSTANCE-P; INTRAOCULAR-PRESSURE; CORNEAL INNERVATION; SENSORY DENERVATION; SUBBASAL NERVES; OCULAR SURFACE; CAPSAICIN; KERATITIS	To study bilateral nerve changes in a newly developed novel mouse model for neurotrophic keratopathy by approaching the trigeminal nerve from the lateral fornix. Surgical axotomy of the ciliary nerve of the trigeminal nerve was performed in adult BALB/c mice at the posterior sclera. Axotomized, contralateral, and sham-treated corneas were excised on post-operative days 1, 3, 5, 7 and 14 and immunofluorescence histochemistry was performed with anti-beta-tubulin antibody to evaluate corneal nerve density. Blink reflex was evaluated using a nylon thread. The survival rate was 100% with minimal bleeding during axotomy and a surgical time of 8 +/- 0.5 minutes. The blink reflex was diminished at day 1 after axotomy, but remained intact in the contralateral eyes in all mice. The central and peripheral subbasal nerves were not detectable in the axotomized cornea at day 1 (p<0.001), compared to normal eyes (101.3 +/- 14.8 and 69.7 +/- 12.0 mm/mm(2) centrally and peripherally). Interestingly, the subbasal nerve density in the contralateral non-surgical eyes also decreased significantly to 62.4 +/- 2.8 mm/mm(2) in the center from day 1 (p<0.001), but did not change in the periphery (77.3 +/- 11.7 mm/mm(2), P = 0.819). Our novel trigeminal axotomy mouse model is highly effective, less invasive, rapid, and has a high survival rate, demonstrating immediate loss of subbasal nerves in axotomized eyes and decreased subbasal nerves in contralateral eyes after unilateral axotomy. This model will allow investigating the effects of corneal nerve damage and serves as a new model for neurotrophic keratopathy.	[Yamaguchi, Takefumi; Turhan, Aslihan; Harris, Deshea L.; Hu, Kai; Hamrah, Pedram] Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst, Boston, MA 02114 USA; [Yamaguchi, Takefumi; Turhan, Aslihan; Harris, Deshea L.; Hamrah, Pedram] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Cornea Serv,Dept Ophthalmol, Boston, MA USA; [Pruess, Harald] Charite, Dept Neurol, D-13353 Berlin, Germany; [von Andrian, Ulrich; Hamrah, Pedram] Harvard Univ, Sch Med, Immune Dis Inst, Program Cellular & Mol Med,Childrens Hosp Boston, Boston, MA USA	Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Hamrah, P (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst, Boston, MA 02114 USA.	pedram_hamrah@meei.harvard.edu	YAMAGUCHI, Takefumi/AAY-6964-2020; Yamaguchi, Takefumi/AEV-4169-2022	Harris, Deshea/0000-0002-8194-1827	National Institutes of Health (NIH) [K08-EY020575, K12-EY016335]; Research to Prevent Blindness Career Development Award; Bausch Lomb Ocular Surface Research Award; NATIONAL EYE INSTITUTE [K08EY020575, K12EY016335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069259] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Career Development Award(Research to Prevent Blindness (RPB)); Bausch Lomb Ocular Surface Research Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institutes of Health (NIH) K08-EY020575 (PH), NIH K12-EY016335 (PH), Research to Prevent Blindness Career Development Award (PH), and Bausch Lomb Ocular Surface Research Award (TY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaratnasingam C, 2011, NEUROSCIENCE, V177, P269, DOI 10.1016/j.neuroscience.2010.12.053; Bekar A, 2004, NEUROSURGERY, V55, P1434, DOI 10.1227/01.NEU.0000143372.60209.09; BELMONTE C, 1981, J PHYSIOL-LONDON, V321, P355, DOI 10.1113/jphysiol.1981.sp013989; Belmonte C, 2004, EXP EYE RES, V78, P513, DOI 10.1016/j.exer.2003.09.023; BERARDELLI A, 1983, J NEUROL NEUROSUR PS, V46, P837, DOI 10.1136/jnnp.46.9.837; BEUERMAN RW, 1980, EXP NEUROL, V69, P196, DOI 10.1016/0014-4886(80)90154-5; Bezerra P, 2009, MUSCLE NERVE, V40, P430, DOI 10.1002/mus.21329; BILEVICIUTE I, 1993, NEUROSCI LETT, V153, P37, DOI 10.1016/0304-3940(93)90071-R; Bonini S, 2003, EYE, V17, P989, DOI 10.1038/sj.eye.6700616; Celebisoy N, 2000, Electromyogr Clin Neurophysiol, V40, P95; Chang PY, 2006, AM J OPHTHALMOL, V142, P488, DOI 10.1016/j.ajo.2006.04.033; Cruzat A, 2011, INVEST OPHTH VIS SCI, V52, P5136, DOI 10.1167/iovs.10-7048; CULBERSON JL, 1979, EXP NEUROL, V64, P83, DOI 10.1016/0014-4886(79)90007-4; Darwish T, 2007, J CATARACT REFR SURG, V33, P1515, DOI 10.1016/j.jcrs.2007.05.023; De Cilla S, 2009, INVEST OPHTH VIS SCI, V50, P5155, DOI 10.1167/iovs.09-3384; Decaris E, 1999, ARTHRITIS RHEUM-US, V42, P1951, DOI 10.1002/1529-0131(199909)42:9<1951::AID-ANR22>3.3.CO;2-4; Dinn RB, 2007, OPHTHALMOLOGY, V114, P915, DOI 10.1016/j.ophtha.2007.01.018; EPSTEIN DL, 1968, NEW ENGL J MED, V279, P396, DOI 10.1056/NEJM196808222790802; Ferrari G, 2011, INVEST OPHTH VIS SCI, V52, P2532, DOI 10.1167/iovs.10-5688; GALLAR J, 1990, INVEST OPHTH VIS SCI, V31, P1968; Gallar J, 2010, INVEST OPHTH VIS SCI, V51, P4516, DOI 10.1167/iovs.10-5225; GARCIAHIRSCHFELD J, 1994, EXP EYE RES, V59, P597, DOI 10.1006/exer.1994.1145; GONZALEZ GG, 1993, INVEST OPHTH VIS SCI, V34, P3329; Hamrah P, 2013, OPHTHALMOLOGY, V120, P40, DOI 10.1016/j.ophtha.2012.07.036; Hamrah P, 2010, OPHTHALMOLOGY, V117, P1930, DOI 10.1016/j.ophtha.2010.07.010; Hamrah P, 2009, TRANSPLANTATION, V88, P180, DOI 10.1097/TP.0b013e3181ac11ea; HOFFMAN PN, 1992, J CELL BIOL, V119, P595, DOI 10.1083/jcb.119.3.595; Jancalek R, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-11; Kaufman SC, 2008, OPHTHALMOLOGY, V115, pS24, DOI 10.1016/j.ophtha.2007.10.010; KEEN P, 1982, NEUROSCI LETT, V29, P231, DOI 10.1016/0304-3940(82)90322-6; Keijser S, 2002, INVEST OPHTH VIS SCI, V43, P87; Kleinschnitz C, 2005, MOL BRAIN RES, V136, P23, DOI 10.1016/j.molbrainres.2004.12.015; Kobayashi A, 2012, AM J OPHTHALMOL, V153, P445, DOI 10.1016/j.ajo.2011.07.026; Koh SWM, 2009, J NEUROCHEM, V109, P792, DOI 10.1111/j.1471-4159.2009.06012.x; Koh SW, 2012, INVEST OPHTH VIS SCI, V52, P5632; Koltzenburg M, 1999, TRENDS NEUROSCI, V22, P122, DOI 10.1016/S0166-2236(98)01302-2; Kurbanyan K, 2012, EYE, V26, P126, DOI 10.1038/eye.2011.270; KUWAYAMA Y, 1987, EXP EYE RES, V44, P907, DOI 10.1016/S0014-4835(87)80053-2; Lambiase A, 2000, INVEST OPHTH VIS SCI, V41, P1063; Lambiase A, 1999, Curr Opin Ophthalmol, V10, P270, DOI 10.1097/00055735-199908000-00009; Lee M, 2009, CLIN NEUROPHYSIOL, V120, P802, DOI 10.1016/j.clinph.2009.01.002; Marfurt CF, 1998, EXP EYE RES, V66, P437, DOI 10.1006/exer.1997.0445; MARFURT CF, 1991, J COMP NEUROL, V303, P489, DOI 10.1002/cne.903030313; MARFURT CF, 1993, J COMP NEUROL, V336, P517, DOI 10.1002/cne.903360405; MORITANI T, 1979, AM J PHYS MED REHAB, V58, P115; Muller L, 1996, INVEST OPHTH VIS SCI, V37, P476; Nagano T, 2003, INVEST OPHTH VIS SCI, V44, P3810, DOI 10.1167/iovs.03-0189; Niederer RL, 2007, INVEST OPHTH VIS SCI, V48, P621, DOI 10.1167/iovs.06-0538; Oaklander AL, 2004, ANN NEUROL, V55, P639, DOI 10.1002/ana.20048; Oaklander AL, 1998, ANN NEUROL, V44, P789, DOI 10.1002/ana.410440513; Ongerboer de Visser B W, 1983, Adv Neurol, V39, P757; Patel SV, 2007, ARCH OPHTHALMOL-CHIC, V125, P1693, DOI 10.1001/archopht.125.12.1693; PFALLER K, 1988, J COMP NEUROL, V268, P91, DOI 10.1002/cne.902680110; PORRO CA, 1991, NEUROSCIENCE, V41, P655, DOI 10.1016/0306-4522(91)90357-T; Realini T, 2002, OPHTHALMOLOGY, V109, P1367, DOI 10.1016/S0161-6420(02)01073-4; ROBERSON MD, 1992, J NEUROSCI RES, V33, P156, DOI 10.1002/jnr.490330120; Rosenberg ME, 2002, CORNEA, V21, P265, DOI 10.1097/00003226-200204000-00006; Schadrack J, 1999, NEUROSCIENCE, V94, P595, DOI 10.1016/S0306-4522(99)00186-4; SCHIMMELPFENNIG B, 1982, GRAEF ARCH CLIN EXP, V218, P287, DOI 10.1007/BF02150440; Shenker N, 2003, RHEUMATOLOGY, V42, P1279, DOI 10.1093/rheumatology/keg397; Shenker NG, 2008, RHEUMATOLOGY, V47, P1417, DOI 10.1093/rheumatology/ken251; SIGELMAN S, 1954, AMA ARCH OPHTHALMOL, V52, P751, DOI 10.1001/archopht.1954.00920050757010; Simard-Lebrun A, 2010, CORNEA, V29, P1291, DOI 10.1097/ICO.0b013e3181cbf9f5; SJOSTRAND J, 1965, Z ZELLFORSCH MIK ANA, V68, P481, DOI 10.1007/BF00347712; Song YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052230; Stern ME, 1998, CORNEA, V17, P584, DOI 10.1097/00003226-199811000-00002; Tuominen ISJ, 2003, INVEST OPHTH VIS SCI, V44, P2545, DOI 10.1167/iovs.02-1260; Twining CM, 2004, PAIN, V110, P299, DOI 10.1016/j.pain.2004.04.008; Ueno H, 2012, INVEST OPHTH VIS SCI, V53, P867, DOI 10.1167/iovs.11-8438; Urban MO, 1999, P NATL ACAD SCI USA, V96, P7687, DOI 10.1073/pnas.96.14.7687; Villani E, 2007, INVEST OPHTH VIS SCI, V48, P2017, DOI 10.1167/iovs.06-1129; Walker HK, 1990, CLIN METHODS HIST PH; WILLIAMS S, 1990, NEUROSCIENCE, V36, P73, DOI 10.1016/0306-4522(90)90352-5; Wong EK, 2004, EXP EYE RES, V79, P297, DOI 10.1016/j.exer.2004.05.010; You LT, 2001, INVEST OPHTH VIS SCI, V42, P2496; You LT, 2000, INVEST OPHTH VIS SCI, V41, P692; Zhang M, 2005, CORNEA, V24, P818, DOI 10.1097/01.ico.0000154402.01710.95	77	36	38	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e70908	10.1371/journal.pone.0070908	http://dx.doi.org/10.1371/journal.pone.0070908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967133	gold, Green Published, Green Submitted			2022-12-25	WOS:000323221500046
J	Zeng, WQ; Zhang, JQ; Li, Y; Yang, K; Chen, YP; Liu, ZJ				Zeng, Wei-qun; Zhang, Ji-qin; Li, Yue; Yang, Kang; Chen, Yu-pei; Liu, Zuo-Jin			A New Method to Isolate and Culture Rat Kupffer Cells	PLOS ONE			English	Article							ALTERNATIVELY ACTIVATED MACROPHAGES; HEPATIC STELLATE CELLS; LIVER-DISEASE; PROLIFERATION; LIPOPOLYSACCHARIDE; PATHOGENESIS; HEPATOCYTES; FIBROSIS	Background: Previous methods for Kupffer cells (KCs) isolation require sophisticated skills and tedious procedures. Few studies have attempted to explore the self-renewal capacity of KCs in vitro. Therefore, the aim of this study was to establish a simple method for rat KCs isolation and further investigate the mitotic potential of KCs in vitro. Methods: KCs were obtained by performing one-step perfusion, enzymatic tissue treatment, differential centrifugation and selective adherence. The proliferation ability of cultured KCs was determined by MTT assay and Propidium Iodide FACS analysis. Phagocytic assay and ED-1, ED-2 immunofluorescence were used to identify cell phenotype. After stimulation with LPS, the expression of surface antigens (MHCII, CD40, CD80, and CD86) and the production of cytokines (NF-kappa B, TNF-alpha, IL-6 and IL-10) were measured for cell function identification. Results: KCs were isolated with certain numbers and reasonable purities. The KCs were able to survive until at least passage 5 (P5), and at P3 showed equally strong phagocytic activity as primary KCs (P0). After stimulation with LPS, the change in the expression of surface antigens and the production of cytokines for P3 cells was similar to that for P0 cells. Conclusions: Our study provides a simple and efficient method for KCs isolation, and reveals that self-renewing KCs have the same phagocytic activity and functions as primary KCs.	[Zeng, Wei-qun; Li, Yue; Yang, Kang; Liu, Zuo-Jin] Chongqing Med Univ, Affiliated Hosp 2, Hepatobiliary Surg Dept, Chongqing, Peoples R China; [Zhang, Ji-qin; Chen, Yu-pei] Chongqing Med Univ, Affiliated Hosp 2, Dept Anesthesia, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Liu, ZJ (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Hepatobiliary Surg Dept, Chongqing, Peoples R China.	Liuzuojin66@163.com			National Natural Science Foundation of China [81170442, 30972888]; Ministry of Education [211153]; Natural Science Foundation of Chongqing [CSTC2012JJA10090]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education; Natural Science Foundation of Chongqing(Natural Science Foundation of Chongqing)	This study was supported by grants from the National Natural Science Foundation of China (No. 81170442, No. 30972888), the Important Scientific Research Project of the Ministry of Education (No. 211153), and the Natural Science Foundation of Chongqing (No. CSTC2012JJA10090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alric L, 2000, INFLAMM RES, V49, P700, DOI 10.1007/s000110050649; Anthony BJ, 2012, TRENDS PARASITOL, V28, P572, DOI 10.1016/j.pt.2012.09.005; BOUWENS L, 1984, HEPATOLOGY, V4, P213, DOI 10.1002/hep.1840040208; Choi SS, 2009, HEPATOLOGY, V50, P2007, DOI 10.1002/hep.23196; Diehl AM, 2002, AM J PHYSIOL-GASTR L, V282, pG1, DOI 10.1152/ajpgi.00384.2001; Fan JH, 2012, HEPATOL RES, V42, P696, DOI 10.1111/j.1872-034X.2012.00972.x; Fukada H, 2012, HEPATOL RES, V42, P1112, DOI 10.1111/j.1872-034X.2012.01024.x; Golbar HM, 2012, EXP TOXICOL PATHOL, V64, P1, DOI 10.1016/j.etp.2010.05.011; Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238; Ikejima K, 1999, AM J PHYSIOL-GASTR L, V276, pG591, DOI 10.1152/ajpgi.1999.276.3.G591; Iwaisako K, 2012, P NATL ACAD SCI USA, V109, pE1369, DOI 10.1073/pnas.1202464109; Kang Liang-I, 2012, Cells, V1, P1261, DOI 10.3390/cells1041261; Kitani H, 2011, JOVE-J VIS EXP, DOI 10.3791/2757; Klein I, 2007, BLOOD, V110, P4077, DOI 10.1182/blood-2007-02-073841; Kolios G, 2006, WORLD J GASTROENTERO, V12, P7413, DOI 10.3748/wjg.v12.i46.7413; Kong XN, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00069; Liaskou E, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/949157; Mandal P, 2011, J BIOL CHEM, V286, P13460, DOI 10.1074/jbc.M110.204644; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Naylor AJ, 2012, ARTHRITIS RHEUM-US, V64, P3334, DOI 10.1002/art.34556; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Papackova Z, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-22; Parker GA, 2012, TOXICOL PATHOL, V40, P237, DOI 10.1177/0192623311428475; Reyes JL, 2007, PARASITE IMMUNOL, V29, P609, DOI 10.1111/j.1365-3024.2007.00973.x; Su LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053988; Tadbir AA, 2012, ASIAN PAC J CANCER P, V13, P5155, DOI 10.7314/APJCP.2012.13.10.5155; Valatas V, 2003, CELL BIOL INT, V27, P67, DOI 10.1016/S1065-6995(02)00249-4; Watanabe A, 2012, DIGEST DIS SCI, V57, P2371, DOI 10.1007/s10620-012-2183-7; Wen JW, 2012, JOVE-J VIS EXP, DOI 10.3791/3669; WIDMANN JJ, 1975, AM J PATHOL, V80, P349; Wojtalla A, 2012, AM J PHYSIOL-GASTR L, V302, pG873, DOI 10.1152/ajpgi.00241.2011; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Xie GH, 2013, GUT, V62, P299, DOI 10.1136/gutjnl-2011-301494; Ye QY, 2013, HEPATOL RES, V43, P1115, DOI 10.1111/hepr.12063; Zimmermann HW, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00056	35	40	46	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e70832	10.1371/journal.pone.0070832	http://dx.doi.org/10.1371/journal.pone.0070832			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967115	Green Published, gold, Green Submitted			2022-12-25	WOS:000323221500038
J	Garcia, O; Carraro, G; Turcatel, G; Hall, M; Sedrakyan, S; Roche, T; Buckley, S; Driscoll, B; Perin, L; Warburton, D				Garcia, Orquidea; Carraro, Gianni; Turcatel, Gianluca; Hall, Marisa; Sedrakyan, Sargis; Roche, Tyler; Buckley, Sue; Driscoll, Barbara; Perin, Laura; Warburton, David			Amniotic Fluid Stem Cells Inhibit the Progression of Bleomycin-Induced Pulmonary Fibrosis via CCL2 Modulation in Bronchoalveolar Lavage	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; RELEASE NEUTROPHIL; PROGENITOR CELLS; GENE-EXPRESSION; GROWTH-FACTOR; LUNG; REPAIR; CHEMOKINES; MCP-1; TRANSPLANTATION	The potential for amniotic fluid stem cell (AFSC) treatment to inhibit the progression of fibrotic lung injury has not been described. We have previously demonstrated that AFSC can attenuate both acute and chronic-fibrotic kidney injury through modification of the cytokine environment. Fibrotic lung injury, such as in Idiopathic Pulmonary Fibrosis (IPF), is mediated through pro-fibrotic and pro-inflammatory cytokine activity. Thus, we hypothesized that AFSC treatment might inhibit the progression of bleomycin-induced pulmonary fibrosis through cytokine modulation. In particular, we aimed to investigate the effect of AFSC treatment on the modulation of the pro-fibrotic cytokine CCL2, which is increased in human IPF patients and is correlated with poor prognoses, advanced disease states and worse fibrotic outcomes. The impacts of intravenous murine AFSC given at acute (day 0) or chronic (day 14) intervention time-points after bleomycin injury were analyzed at either day 3 or day 28 post-injury. Murine AFSC treatment at either day 0 or day 14 post-bleomycin injury significantly inhibited collagen deposition and preserved pulmonary function. CCL2 expression increased in bleomycin-injured bronchoalveolar lavage (BAL), but significantly decreased following AFSC treatment at either day 0 or at day 14. AFSC were observed to localize within fibrotic lesions in the lung, showing preferential targeting of AFSC to the area of fibrosis. We also observed that MMP-2 was transiently increased in BAL following AFSC treatment. Increased MMP-2 activity was further associated with cleavage of CCL2, rendering it a putative antagonist for CCL2/CCR2 signaling, which we surmise is a potential mechanism for CCL2 reduction in BAL following AFSC treatment. Based on this data, we concluded that AFSC have the potential to inhibit the development or progression of fibrosis in a bleomycin injury model during both acute and chronic remodeling events.	[Garcia, Orquidea; Carraro, Gianni; Turcatel, Gianluca; Hall, Marisa; Roche, Tyler; Buckley, Sue; Driscoll, Barbara; Perin, Laura; Warburton, David] Childrens Hosp Los Angeles, Saban Res Inst, Dev Biol & Regenerat Med Program, Los Angeles, CA 90027 USA; [Garcia, Orquidea; Driscoll, Barbara; Warburton, David] Univ So Calif, Keck Sch Med, Integrat Biol Dis Grad Program, Los Angeles, CA 90033 USA; [Sedrakyan, Sargis; Perin, Laura] Childrens Hosp Los Angeles, Saban Res Inst, Div Urol, Los Angeles, CA 90027 USA	Children's Hospital Los Angeles; University of Southern California; Children's Hospital Los Angeles	Warburton, D (corresponding author), Childrens Hosp Los Angeles, Saban Res Inst, Dev Biol & Regenerat Med Program, Los Angeles, CA 90027 USA.	dwarburton@chla.usc.edu	Warburton, David/AAD-5709-2020	Carraro, Gianni/0000-0003-0824-7692; Roche, Tyler/0000-0003-1206-3239	NIH grants: NIDCR University of Southern California [1T90DE021982-01 HL44060, HL065352]; California Institute for Regenerative Medicine Training Grant [TG2 01168]; Garland Foundation; Webb Foundation; Pasadena Guild Endowment of Children's Hospital Los Angeles; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065352, R01HL044060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021982] Funding Source: NIH RePORTER	NIH grants: NIDCR University of Southern California; California Institute for Regenerative Medicine Training Grant; Garland Foundation; Webb Foundation; Pasadena Guild Endowment of Children's Hospital Los Angeles; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Research funded by NIH grants: NIDCR University of Southern California, Predoctoral Training Grant 1T90DE021982-01 HL44060 and HL065352, California Institute for Regenerative Medicine Training Grant TG2 01168, the Garland and Webb Foundations; and the Pasadena Guild Endowment of Children's Hospital Los Angeles. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2004, AM J RESP CRIT CARE, V170, P1158, DOI 10.1164/rccm.200307-908OC; Agostini Carlo, 2006, Proc Am Thorac Soc, V3, P357, DOI 10.1513/pats.200601-010TK; Aguilar S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008013; ANTONIADES HN, 1992, P NATL ACAD SCI USA, V89, P5371, DOI 10.1073/pnas.89.12.5371; Antoniou KM, 2010, RESP MED, V104, P1535, DOI 10.1016/j.rmed.2010.04.015; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Baran CP, 2007, AM J RESP CRIT CARE, V176, P78, DOI 10.1164/rccm.200609-1279OC; Buckley S, 2011, AM J RESP CELL MOL, V45, P1212, DOI 10.1165/rcmb.2010-0325OC; CAR BD, 1994, AM J RESP CRIT CARE, V149, P655, DOI 10.1164/ajrccm.149.3.8118632; Cardona AE, 2008, BLOOD, V112, P256, DOI 10.1182/blood-2007-10-118497; Cargnoni A, 2012, CYTOTHERAPY, V14, P153, DOI 10.3109/14653249.2011.613930; Cargnoni A, 2009, CELL TRANSPLANT, V18, P405, DOI 10.3727/096368909788809857; Carraro G, 2008, STEM CELLS, V26, P2902, DOI 10.1634/stemcells.2008-0090; Dancer RCA, 2011, EUR RESPIR J, V38, P1461, DOI 10.1183/09031936.00024711; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Dean RA, 2008, BLOOD, V112, P3455, DOI 10.1182/blood-2007-12-129080; Denney H, 2009, BIOCHEM BIOPH RES CO, V382, P341, DOI 10.1016/j.bbrc.2009.02.164; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Ekert JE, 2011, BIOMED CENTRAL FIBRO, V4; Garcia-de-Alba C, 2010, AM J RESP CRIT CARE, V182, P1144, DOI 10.1164/rccm.201001-0028OC; Gharaee-Kermani M, 2003, CYTOKINE, V24, P266, DOI 10.1016/j.cyto.2003.08.003; GharaeeKermani M, 1996, J BIOL CHEM, V271, P17779, DOI 10.1074/jbc.271.30.17779; Harris R Scott, 2005, Respir Care, V50, P78; Inoshima I, 2004, AM J PHYSIOL-LUNG C, V286, pL1038, DOI 10.1152/ajplung.00167.2003; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Lee J, 2005, AM J PHYSIOL-LUNG C, V290, P684; Liu XD, 2007, AM J RESP CELL MOL, V37, P121, DOI 10.1165/rcmb.2005-0253OC; Maguire CT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053372; Manali ED, 2011, BIOMED CENTRAL PULMO, V11; McNulty Katrina, 2012, Proc Am Thorac Soc, V9, P164, DOI 10.1513/pats.201201-010AW; McQuibban GA, 2002, BLOOD, V100, P1160, DOI 10.1182/blood.V100.4.1160.h81602001160_1160_1167; Mercer PF, 2009, AM J RESP CRIT CARE, V179, P414, DOI 10.1164/rccm.200712-1827OC; Miyamoto K, 2009, BIOCHEM BIOPH RES CO, V383, P373, DOI 10.1016/j.bbrc.2009.04.020; Moodley Y, 2010, AM J RESP CRIT CARE, V182, P643, DOI 10.1164/rccm.201001-0014OC; Moodley Y, 2009, AM J PATHOL, V175, P303, DOI 10.2353/ajpath.2009.080629; Moore BB, 2005, AM J PATHOL, V166, P675, DOI 10.1016/S0002-9440(10)62289-4; Moore BB, 2001, J IMMUNOL, V167, P4368, DOI 10.4049/jimmunol.167.8.4368; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Moschidou D, 2012, MOL THER, V20, P1953, DOI 10.1038/mt.2012.117; Murphy S, 2011, CELL TRANSPLANT, V20, P909, DOI 10.3727/096368910X543385; Neuringer IP, 2004, BIOMED CENTRAL RESP, V5; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Perin L, 2007, CELL PROLIFERAT, V40, P936, DOI 10.1111/j.1365-2184.2007.00478.x; Perin L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009357; Prasse A, 2009, RESPIROLOGY, V14, P788, DOI 10.1111/j.1440-1843.2009.01600.x; Raghu G, 2006, AM J RESP CRIT CARE, V174, P810, DOI 10.1164/rccm.200602-163OC; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rojas M, 2005, AM J RESP CELL MOL, V33, P145, DOI 10.1165/rcmb.2004-0330OC; Rull A, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/326580; Sato E, 1999, AM J PHYSIOL-LUNG C, V276, pL941, DOI 10.1152/ajplung.1999.276.6.L941; Sedrakyan S, 2012, J AM SOC NEPHROL, V23, P661, DOI 10.1681/ASN.2011030243; Serrano-Mollar A, 2007, AM J RESP CRIT CARE, V176, P1261, DOI 10.1164/rccm.200610-1491OC; Shinoda H, 2009, RESPIRATION, V78, P285, DOI 10.1159/000207617; Sisson TH, 2010, AM J RESP CRIT CARE, V181, P254, DOI 10.1164/rccm.200810-1615OC; Smith RE, 1996, AM J RESP CELL MOL, V15, P693, DOI 10.1165/ajrcmb.15.6.8969262; Suga M, 1999, EUR RESPIR J, V14, P376, DOI 10.1034/j.1399-3003.1999.14b23.x; Sun L, 2011, AM J PHYSIOL-LUNG C, V300, pL341, DOI 10.1152/ajplung.00122.2010; Takamizawa A, 1999, J IMMUNOL, V162, P6200; Toonkel RL, 2013, AM J RESP CRITICAL C; Vasakova M, 2009, SCAND J IMMUNOL, V69, P268, DOI 10.1111/j.1365-3083.2008.02222.x; Vosdoganes P, 2012, CELL TRANSPLANT; Walker N, 2011, AM J PATHOL, V178, P2461, DOI 10.1016/j.ajpath.2011.01.058; Warburton David, 2008, Proc Am Thorac Soc, V5, P703, DOI 10.1513/pats.200801-012AW; Weiss Daniel J, 2011, Proc Am Thorac Soc, V8, P223, DOI 10.1513/pats.201012-071DW; WESSELIUS LJ, 1984, AM REV RESPIR DIS, V129, P485; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yamada M, 2004, J IMMUNOL, V172, P1266, DOI 10.4049/jimmunol.172.2.1266; ZHANG K, 1994, J IMMUNOL, V153, P4733; Ziegenhagen MW, 1998, J INVEST MED, V46, P223	70	41	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71679	10.1371/journal.pone.0071679	http://dx.doi.org/10.1371/journal.pone.0071679			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967234	gold, Green Published, Green Submitted			2022-12-25	WOS:000323115800074
J	Leunissen, EHP; Nair, AV; Bull, C; Lefeber, DJ; van Delft, FL; Bindels, RJM; Hoenderop, JGJ				Leunissen, Elizabeth H. P.; Nair, Anil V.; Bull, Christian; Lefeber, Dirk J.; van Delft, Floris L.; Bindels, Ren J. M.; Hoenderop, Joost G. J.			The Epithelial Calcium Channel TRPV5 Is Regulated Differentially by Klotho and Sialidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ CHANNEL; N-GLYCANS; GALECTIN-1; EXPRESSION; BINDING; CELLS; PROTEIN; FAMILY	The transient receptor potential vanilloid type 5 (TRPV5) Ca2+ channel facilitates transcellular Ca2+ transport in the distal convoluted tubule (DCT) of the kidney. The channel is glycosylated with a complex type N-glycan and it has been postulated that hydrolysis of the terminal sialic acid(s) stimulate TRPV5 activity. The present study delineates the role of the N-glycan in TRPV5 activity using biochemical assays in Human Embryonic Kidney 293 cells expressing TRPV5, isoelectric focusing and total internal reflection fluorescent microscopy. The anti-aging hormone klotho and other glycosidases stimulate TRPV5-dependent Ca2+ uptake. Klotho was found to increase the plasma membrane stability of TRPV5, via the TRPV5 N-glycan. Sialidase mimicked this stimulatory action. However, this effect was independent of the N-glycosylation state of TRPV5, since the N-glycosylation mutant (TRPV5N358Q) was activated to the same extent. We showed that the increased TRPV5 activity after sialidase treatment is caused by inhibition of lipid raft-mediated internalization. In addition, sialidase modified the N-glycan of transferrin, a model glycoprotein, differently from klotho. Previous studies showed that after klotho treatment, galectin-1 binds the TRPV5 N-glycan and thereby increases TRPV5 activity. However, galectin-3, but not galectin-1, was expressed in the DCT. Furthermore, an increase in TRPV5-mediated Ca2 + uptake was detected after galectin-3 treatment. In conclusion, two distinct TRPV5 stimulatory mechanisms were demonstrated; a klotho-mediated effect that is dependent on the N-glycan of TRPV5 and a sialidase-mediated stimulation that is lipid raft-dependent and independent of the N-glycan of TRPV5.	[Leunissen, Elizabeth H. P.; Nair, Anil V.; Bull, Christian; Bindels, Ren J. M.; Hoenderop, Joost G. J.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Physiol, NL-6500 HB Nijmegen, Netherlands; [Lefeber, Dirk J.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Lab Med, NL-6500 HB Nijmegen, Netherlands; [van Delft, Floris L.] Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 AJ Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Hoenderop, JGJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands.	J.Hoenderop@fysiol.umcn.nl	Bindels, René JM/B-9824-2013; Lefeber, Dirk DJ/A-2146-2014; Hoenderop, Joost G.J./H-8047-2014; Büll, Christian/AAN-1946-2021; Büll, Christian/L-9417-2013	Bindels, René JM/0000-0003-1167-1339; Hoenderop, Joost G.J./0000-0002-1816-8544; Büll, Christian/0000-0001-7785-2920; Büll, Christian/0000-0001-7785-2920	Nijmegen Centre for Molecular membrane; Dutch Kidney Foundation [C06.2170, CP10.11]; Netherlands Organization for Scientific Research [NWO-CW 700.55.302]; European Union [305608]; Life Sciences (NCMLS)	Nijmegen Centre for Molecular membrane; Dutch Kidney Foundation; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Union(European Commission); Life Sciences (NCMLS)	This work was supported by grants from the Nijmegen Centre for Molecular membrane and therefore, the Ca<SUP>2+</SUP> reabsorption. Life Sciences (NCMLS) (to J.G.H.), the Dutch Kidney Foundation (C06.2170, CP10.11), the Netherlands Organization for Scientific Research (NWO-CW 700.55.302), and EURenOmics funding from the European Union Seventh Framework Programme (FP7/2007-2013, agreement no 305608).	Burger A, 1996, KIDNEY INT, V50, P754, DOI 10.1038/ki.1996.373; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Chen X, 2010, ACS CHEM BIOL, V5, P163, DOI 10.1021/cb900266r; CHO MJ, 1995, J BIOL CHEM, V270, P5198, DOI 10.1074/jbc.270.10.5198; Coddeville B, 2000, BBA-GEN SUBJECTS, V1475, P321, DOI 10.1016/S0304-4165(00)00083-0; Cohen DM, 2006, SEMIN CELL DEV BIOL, V17, P630, DOI 10.1016/j.semcdb.2006.11.007; de Groot T, 2009, J AM SOC NEPHROL, V20, P1693, DOI 10.1681/ASN.2008080873; Dimke H, 2011, J AM SOC NEPHROL, V22, P508, DOI 10.1681/ASN.2010060606; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Hoenderop JGJ, 2000, AM J PHYSIOL-RENAL, V278, pF352, DOI 10.1152/ajprenal.2000.278.3.F352; Hoenderop JGJ, 2001, J PHYSIOL-LONDON, V537, P747; Hoenderop JGJ, 1999, J BIOL CHEM, V274, P8375, DOI 10.1074/jbc.274.13.8375; Hoenderop JGJ, 2008, PHYSIOLOGY, V23, P32, DOI 10.1152/physiol.00039.2007; Huang CL, 2011, PFLUG ARCH EUR J PHY, V462, P185, DOI 10.1007/s00424-011-0950-5; Kawamura S, 2012, CELL DEATH DIFFER, V19, P170, DOI 10.1038/cdd.2011.83; Kikuchi Y, 2004, NEPHROL DIAL TRANSPL, V19, P602, DOI 10.1093/ndt/gfg603; Kohno T, 2002, FASEB J, V16, P983, DOI 10.1096/fj.01-0809com; Lu P, 2008, NEPHROL DIAL TRANSPL, V23, P3397, DOI 10.1093/ndt/gfn291; Meyer AH, 2002, J NEUROSCI, V22, P7055; Miller RL, 2006, AM J PHYSIOL-RENAL, V291, pF236, DOI 10.1152/ajprenal.00273.2005; Miyagi T, 2012, GLYCOBIOLOGY, V22, P880, DOI 10.1093/glycob/cws057; Moen A, 2011, GLYCOBIOLOGY, V21, P1416, DOI 10.1093/glycob/cwr069; Patnaik SK, 2006, GLYCOBIOLOGY, V16, P305, DOI 10.1093/glycob/cwj063; Singh RD, 2010, TRAFFIC, V11, P348, DOI 10.1111/j.1600-0854.2009.01022.x; SPIK G, 1985, FEBS LETT, V183, P65, DOI 10.1016/0014-5793(85)80955-8; Suzuki T, 2002, FASEB J, V16, DOI 10.1096/fj.01-0889rev; Suzuki Y, 2008, ANNU REV PHYSIOL, V70, P257, DOI 10.1146/annurev.physiol.69.031905.161003; Takahashi M, 2008, BBA-GEN SUBJECTS, V1780, P520, DOI 10.1016/j.bbagen.2007.10.019; Tohyama O, 2004, J BIOL CHEM, V279, P9777, DOI 10.1074/jbc.M312392200; Toomre D, 2010, ANNU REV CELL DEV BI, V26, P285, DOI 10.1146/annurev-cellbio-100109-104048; van de Graaf SFJ, 2007, REV PHYSIOL BIOCH P, V158, P77, DOI 10.1007/11220060607; Van de Graaf SFJ, 2003, EMBO J, V22, P1478, DOI 10.1093/emboj/cdg162; VANEIJK HG, 1992, ELECTROPHORESIS, V13, P354, DOI 10.1002/elps.1150130173; Varki A., 2009, ESSENTIALS GLYCOBIOL; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Winyard PJD, 1997, J AM SOC NEPHROL, V8, P1647; Zhuo Y, 2011, J BIOL CHEM, V286, P5935, DOI 10.1074/jbc.R110.191429	38	33	35	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29238	29246		10.1074/jbc.M113.473520	http://dx.doi.org/10.1074/jbc.M113.473520			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23970553	Green Published, hybrid			2022-12-25	WOS:000330615300003
J	Ali, T; Kokotos, G; Magrioti, V; Bone, RN; Mobley, JA; Hancock, W; Ramanadham, S				Ali, Tomader; Kokotos, George; Magrioti, Victoria; Bone, Robert N.; Mobley, James A.; Hancock, William; Ramanadham, Sasanka			Characterization of FKGK18 as Inhibitor of Group VIA Ca2+-Independent Phospholipase A(2) (iPLA(2)beta): Candidate Drug for Preventing Beta-Cell Apoptosis and Diabetes	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; MECHANISM-BASED DISCRIMINATION; STIMULATED PANCREATIC-ISLETS; ARACHIDONIC-ACID RELEASE; SMOOTH-MUSCLE-CELLS; BROMOENOL LACTONE; INSULIN-SECRETION; CERAMIDE GENERATION; HALOENOL LACTONES; EXPRESS GROUP	Ongoing studies suggest an important role for iPLA(2)beta in a multitude of biological processes and it has been implicated in neurodegenerative, skeletal and vascular smooth muscle disorders, bone formation, and cardiac arrhythmias. Thus, identifying an iPLA(2)beta inhibitor that can be reliably and safely used in vivo is warranted. Currently, the mechanism-based inhibitor bromoenol lactone (BEL) is the most widely used to discern the role of iPLA(2)beta in biological processes. While BEL is recognized as a more potent inhibitor of iPLA(2) than of cPLA(2) or sPLA(2), leading to its designation as a "specific" inhibitor of iPLA(2), it has been shown to also inhibit non-PLA(2) enzymes. A potential complication of its use is that while the S and R enantiomers of BEL exhibit preference for cytosol-associated iPLA(2)beta and membrane-associated iPLA(2)gamma, respectively, the selectivity is only 10-fold for both. In addition, BEL is unstable in solution, promotes irreversible inhibition, and may be cytotoxic, making BEL not amenable for in vivo use. Recently, a fluoroketone (FK)-based compound (FKGK18) was described as a potent inhibitor of iPLA(2)beta. Here we characterized its inhibitory profile in beta-cells and find that FKGK18: (a) inhibits iPLA(2)beta with a greater potency (100-fold) than iPLA(2)gamma, (b) inhibition of iPLA(2)beta is reversible, (c) is an ineffective inhibitor of alpha-chymotrypsin, and (d) inhibits previously described outcomes of iPLA(2)beta activation including (i) glucose-stimulated insulin secretion, (ii) arachidonic acid hydrolysis; as reflected by PGE2 release from human islets, (iii) ER stress-induced neutral sphingomyelinase 2 expression, and (iv) ER stress-induced beta-cell apoptosis. These findings suggest that FKGK18 is similar to BEL in its ability to inhibit iPLA(2)beta. Because, in contrast to BEL, it is reversible and not a non-specific inhibitor of proteases, it is suggested that FKGK18 is more ideal for ex vivo and in vivo assessments of iPLA(2)beta role in biological functions.	[Ali, Tomader; Hancock, William; Ramanadham, Sasanka] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA; [Kokotos, George; Magrioti, Victoria] Univ Athens, Dept Chem, Organ Chem Lab, GR-10680 Athens, Greece; [Bone, Robert N.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Mobley, James A.] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; National & Kapodistrian University of Athens; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Ramanadham, S (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA.	sramvem@uab.edu	Magrioti, Victoria/A-6245-2009	Magrioti, Victoria/0000-0001-5441-9219; Bone, Robert/0000-0003-3222-8918	National Institutes of Health (NIH) [R01-DK69455]; NIH/National Cancer Institute [P30CA13148-38]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069455] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the National Institutes of Health (NIH) (R01-DK69455) and the NIH/National Cancer Institute (P30CA13148-38). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMANN EJ, 1995, J BIOL CHEM, V270, P445, DOI 10.1074/jbc.270.1.445; ACKERMANN EJ, 1994, J BIOL CHEM, V269, P9227; Ayilavarapu S, 2010, J IMMUNOL, V184, P1507, DOI 10.4049/jimmunol.0901219; BAEK DJ, 1990, BIOCHEMISTRY-US, V29, P4305, DOI 10.1021/bi00470a007; Balboa MA, 1997, J BIOL CHEM, V272, P8576, DOI 10.1074/jbc.272.13.8576; Balsinde J, 2005, CELL SIGNAL, V17, P1052, DOI 10.1016/j.cellsig.2005.03.002; Balsinde J, 1996, J BIOL CHEM, V271, P31937, DOI 10.1074/jbc.271.50.31937; Bao S, 2008, AM J PHYSIOL-ENDOC M, V294, pE217, DOI 10.1152/ajpendo.00474.2007; Bao SZ, 2006, J BIOL CHEM, V281, P20958, DOI 10.1074/jbc.M600075200; Bao SZ, 2004, J BIOL CHEM, V279, P38194, DOI 10.1074/jbc.M406489200; CHAKRAVARTY PK, 1982, J BIOL CHEM, V257, P610; DANIELS SB, 1983, J BIOL CHEM, V258, P5046; DANIELS SB, 1986, BIOCHEMISTRY-US, V25, P1436, DOI 10.1021/bi00354a037; Delatte SJ, 2001, J PEDIATR SURG, V36, P43, DOI 10.1053/jpsu.2001.20002; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Fuentes L, 2003, J BIOL CHEM, V278, P44683, DOI 10.1074/jbc.M307209200; Gijon MA, 1997, SEMIN CELL DEV BIOL, V8, P297, DOI 10.1006/scdb.1997.0151; GROSS RW, 1993, BIOCHEMISTRY-US, V32, P327, DOI 10.1021/bi00052a041; HAZEN SL, 1991, J BIOL CHEM, V266, P7227; Hooks SB, 2008, BIOCHEM PHARMACOL, V76, P1059, DOI 10.1016/j.bcp.2008.07.044; Hsu YH, 2013, J AM CHEM SOC, V135, P1330, DOI 10.1021/ja306490g; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Jenkins CM, 2002, J BIOL CHEM, V277, P32807, DOI 10.1074/jbc.M202568200; Kalyvas A, 2009, BRAIN, V132, P1221, DOI 10.1093/brain/awp002; Kokotos G, 2010, J MED CHEM, V53, P3602, DOI 10.1021/jm901872v; Lei X, 2010, DIABETES OBES METAB, V12, P93, DOI 10.1111/j.1463-1326.2010.01270.x; Lei XY, 2007, BIOCHEMISTRY-US, V46, P10170, DOI 10.1021/bi700017z; Lei XY, 2013, ISLETS, V5, P29, DOI 10.4161/isl.23758; Lei XY, 2012, AM J PHYSIOL-ENDOC M, V303, pE1386, DOI 10.1152/ajpendo.00234.2012; Lei XY, 2010, BIOCHIMIE, V92, P627, DOI 10.1016/j.biochi.2010.01.005; Lei XY, 2010, J BIOL CHEM, V285, P6693, DOI 10.1074/jbc.M109.084293; Lei XY, 2008, J BIOL CHEM, V283, P34819, DOI 10.1074/jbc.M807409200; Ma ZM, 1998, BBA-LIPID LIPID MET, V1391, P384, DOI 10.1016/S0005-2760(98)00027-7; Ma ZM, 2002, AM J PHYSIOL-ENDOC M, V282, pE820, DOI 10.1152/ajpendo.00165.2001; Ma ZM, 1999, J BIOL CHEM, V274, P9607, DOI 10.1074/jbc.274.14.9607; Ma ZM, 1997, J BIOL CHEM, V272, P11118; Magrioti V, 2013, EXPERT OPIN THER PAT, V23, P333, DOI 10.1517/13543776.2013.754425; Mancuso DJ, 2000, J BIOL CHEM, V275, P9937, DOI 10.1074/jbc.275.14.9937; Rahnema P, 2011, AM J PHYSIOL-HEART C, V300, pH326, DOI 10.1152/ajpheart.00743.2010; RAMANADHAM S, 1993, BIOCHEMISTRY-US, V32, P5339, DOI 10.1021/bi00071a009; RAMANADHAM S, 1993, BIOCHEMISTRY-US, V32, P13499, DOI 10.1021/bi00212a015; RAMANADHAM S, 1993, BIOCHEMISTRY-US, V32, P337, DOI 10.1021/bi00052a042; Ramanadham S, 2004, BIOCHEMISTRY-US, V43, P918, DOI 10.1021/bi035536m; Ramanadham S, 1999, J BIOL CHEM, V274, P13915, DOI 10.1074/jbc.274.20.13915; Schaeffer EL, 2005, PSYCHOPHARMACOLOGY, V181, P392, DOI 10.1007/s00213-005-2256-9; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Song HW, 2006, BIOCHEMISTRY-US, V45, P6392, DOI 10.1021/bi060502a; Song HW, 2006, BIOCHEMISTRY-US, V45, P1061, DOI 10.1021/bi052065q; Stephens D, 2006, J MED CHEM, V49, P2821, DOI 10.1021/jm050993h; TURK J, 1993, DIABETES, V42, P367, DOI 10.2337/diabetes.42.3.367; TURK J, 1992, BIOCHIM BIOPHYS ACTA, V1125, P280, DOI 10.1016/0005-2760(92)90057-3; van Tienhoven M, 2002, J BIOL CHEM, V277, P20942, DOI 10.1074/jbc.M200330200; Wilkins WP, 2008, CURR DRUG TARGETS, V9, P683, DOI 10.2174/138945008785132385; WOLF BA, 1991, BIOCHEMISTRY-US, V30, P6372, DOI 10.1021/bi00240a004; Xie ZW, 2010, J BIOL CHEM, V285, P8628, DOI 10.1074/jbc.M109.057711	55	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71748	10.1371/journal.pone.0071748	http://dx.doi.org/10.1371/journal.pone.0071748			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977134	Green Submitted, Green Published, gold			2022-12-25	WOS:000324527300035
J	Koester, KA; Collins, SP; Fuller, SM; Galindo, GR; Gibson, S; Steward, WT				Koester, Kimberly A.; Collins, Shane P.; Fuller, Shannon M.; Galindo, Gabriel R.; Gibson, Steven; Steward, Wayne T.			Sexual Healthcare Preferences among Gay and Bisexual Men: A Qualitative Study in San Francisco, California	PLOS ONE			English	Article							HIV PREVENTION; SURVEILLANCE DATA; UNITED-STATES; TOBACCO USE; YOUNG MEN; RISK; CANCER; IMPLEMENTATION; DISPARITIES; POPULATION	Background: Research on gay and other men who have sex with men's (G/MSM) preferences for sexual healthcare services focuses largely on HIV testing and to some extent on sexually transmitted infections (STI). This research illustrates the frequency and location of where G/MSM interface with the healthcare system, but it does not speak to why men seek care in those locations. As HIV and STI prevention strategies evolve, evidence about G/MSM's motivations and decision-making can inform future plans to optimize models of HIV/STI prevention and primary care. Methods: We conducted a phenomenological study of gay men's sexual health seeking experiences, which included 32 in-depth interviews with gay and bisexual men. Interviews were transcribed verbatim and entered into Atlas.ti. We conducted a Framework Analysis. Findings: We identified a continuum of sexual healthcare seeking practices and their associated drivers. Men differed in their preferences for separating sexual healthcare from other forms of healthcare ("fragmentation") versus combining all care into one location ("consolidation"). Fragmentation drivers included: fear of being monitored by insurance companies, a desire to seek non-judgmental providers with expertise in sexual health, a desire for rapid HIV testing, perceiving sexual health services as more convenient than primary care services, and a lack of healthcare coverage. Consolidation drivers included: a comfortable and trusting relationship with a provider, a desire for one provider to oversee overall health and those with access to public or private health insurance. Conclusions: Men in this study were likely to separate sexual healthcare from primary care. Based on this finding, we recommend placing new combination HIV/STI prevention interventions within sexual health clinics. Furthermore, given the evolution of the financing and delivery of healthcare services and in HIV prevention, policymakers and clinicians should consider including more primary care services within sexual healthcare settings.	[Koester, Kimberly A.; Collins, Shane P.; Fuller, Shannon M.; Galindo, Gabriel R.; Steward, Wayne T.] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA; [Gibson, Steven] San Francisco AIDS Fdn, San Francisco, CA USA	University of California System; University of California San Francisco	Koester, KA (corresponding author), Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA.	Kimberly.Koester@ucsf.edu		Fuller, Shannon/0000-0001-6070-8172	California HIV/AIDS Research Program (CHRP);  [CR08-SF-403];  [CR08-SFAF-402]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246, T32MH019105] Funding Source: NIH RePORTER	California HIV/AIDS Research Program (CHRP); ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The study was funded by two awards from the California HIV/AIDS Research Program (CHRP). CR08-SF-403, awarded to UCSF (PI: W. Steward), and CR08-SFAF-402, awarded to the San Francisco AIDS Foundation (PI: S. Gibson). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg JA, 2009, CLIN INFECT DIS, V49, P651, DOI 10.1086/605292; Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P845; Asencio M, 2009, SEX RES SOC POLICY, V6, P38, DOI 10.1525/srsp.2009.6.4.38; Berg MB, 2008, J HOMOSEXUAL, V54, P293, DOI 10.1080/00918360801982215; Bostwick WB, 2010, AM J PUBLIC HEALTH, V100, P468, DOI 10.2105/AJPH.2008.152942; Bowen DJ, 2007, CANCER CAUSE CONTROL, V18, P343, DOI 10.1007/s10552-007-0115-1; Buchbinder SP, 2011, AIDS BEHAV, V15, pS72, DOI 10.1007/s10461-011-9894-1; Burgess D, 2008, J LGBT HLTH RES, V4, P43; Centers for Disease Control and Prevention, 2010, SUBST AB GAY BIS MEN; Centers for Disease Control and Prevention, 2012, HIV SURV REP 2010, V22, P1; Centers for Disease Control and Prevention, 2010, VIR HEP GAY BIS MENS; Chang LW, 2013, LANCET INFECT DIS, V13, P65, DOI 10.1016/S1473-3099(12)70273-6; Chin-Hong PV, 2005, JNCI-J NATL CANCER I, V97, P896, DOI 10.1093/jnci/dji163; Cochran SD, 2007, J CONSULT CLIN PSYCH, V75, P785, DOI 10.1037/0022-006X.75.5.785; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; Creswell J W, 1995, RES DESIGN QUALITATI; Deputy NP, 2010, PREV MED, V51, P129, DOI 10.1016/j.ypmed.2010.05.010; Gee R, 2006, J AM ACAD NURSE PRAC, V18, P144, DOI 10.1111/j.1745-7599.2006.00117.x; Gilman SE, 2001, AM J PUBLIC HEALTH, V91, P933, DOI 10.2105/AJPH.91.6.933; Goffman E., 1963, BEHAV PUBLIC PLACES; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Greenwood GL, 2005, AM J PUBLIC HEALTH, V95, P145, DOI 10.2105/AJPH.2003.021451; Gruskin EP, 2007, AM J PUBLIC HEALTH, V97, P1496, DOI 10.2105/AJPH.2006.090258; Halkitis PN, 2009, AIDS BEHAV, V13, P783, DOI 10.1007/s10461-008-9432-y; Herek GM, 2009, J INTERPERS VIOLENCE, V24, P54, DOI 10.1177/0886260508316477; Heslin KC, 2008, MED CARE, V46, P1240, DOI 10.1097/MLR.0b013e31817d697f; HIV Modelling Consortium Treatment, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001259; Hood JE, 2011, SEX HEALTH, V8, P159, DOI 10.1071/SH10070; Houston E, 2007, J URBAN HEALTH, V84, P681, DOI 10.1007/s11524-007-9188-0; Hu YYW, 2012, AIDS PATIENT CARE ST, V26, P471, DOI 10.1089/apc.2011.0371; Irwin TW, 2006, AIDS BEHAV, V10, P299, DOI 10.1007/s10461-005-9045-7; Johnson CV, 2009, AM J PUBLIC HEALTH, V99, pS187, DOI 10.2105/AJPH.2007.127464; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kurth Ann E, 2011, Curr HIV/AIDS Rep, V8, P62, DOI 10.1007/s11904-010-0063-3; Lanier Y, 2013, AM J PUBLIC HEALTH, V103, P262, DOI 10.2105/AJPH.2012.300921; Lauby JL, 2009, AM J MENS HEALTH, V3, P50, DOI 10.1177/1557988307313465; Lee JGL, 2009, TOB CONTROL, V18, P275, DOI 10.1136/tc.2008.028241; Mayer KH, 2008, AM J PUBLIC HEALTH, V98, P989, DOI 10.2105/AJPH.2007.127811; Mayer KH, 2010, AM J PUBLIC HEALTH, V100, P1867, DOI 10.2105/AJPH.2009.184796; McCreary DR, 2007, AM J MENS HEALTH, V1, P307, DOI 10.1177/1557988306309408; McRee AL, 2010, CANCER EPIDEM BIOMAR, V19, P1937, DOI 10.1158/1055-9965.EPI-09-1287; Merson MH, 2008, LANCET, V372, P475, DOI 10.1016/S0140-6736(08)60884-3; Mimiaga MJ, 2007, SEX TRANSM DIS, V34, P113, DOI 10.1097/01.olq.0000225327.13214.bf; Moustakas Clark, 1994, PHENOMENOLOGICAL RES; Muhr T., 1997, ATLAS TI 5 KNOWLEDGE; Ostrow DG, 2008, UNEQUAL OPPORTUNITY, P121; Padian NS, 2011, LANCET, V378, P269, DOI 10.1016/S0140-6736(11)60877-5; Padilla YC, 2010, SOC WORK, V55, P265, DOI 10.1093/sw/55.3.265; Parcesepe AM, 2012, ADM POLICY MENT HLTH; Purcell David W, 2012, Open AIDS J, V6, P98, DOI 10.2174/1874613601206010098; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Richie J, 1994, ANAL QUALITATIVE DAT, P173, DOI DOI 10.4324/9780203413081_CHAPTER_9; Riley ED, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035207; Roll JM, 2013, PSYCHIAT SERV, V64, P80, DOI 10.1176/appi.ps.201200071; Saag MS, 2009, AIDS READ, V19, P166; Siconolfi D., 2009, International Journal of Men's Health, V8, P254, DOI 10.3149/jmh.0803.254; Stall R, 2001, ADDICTION, V96, P1589, DOI 10.1046/j.1360-0443.2001.961115896.x; The Henry J. Kaiser Family Foundation, 2013, FACT SHEET RYAN WHIT; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; U.S. Department of Health and Human Services, 2010, PREV SERV COV AFF CA; U.S. Department of Health & Human Services, 2010, PREEX COND INS PLAN; Ulett KB, 2009, AIDS PATIENT CARE ST, V23, P41, DOI 10.1089/apc.2008.0132; Underhill Kristen, 2010, Curr HIV/AIDS Rep, V7, P210, DOI 10.1007/s11904-010-0062-4; Underhill K, 2010, JAIDS-J ACQ IMM DEF, V55, P8, DOI 10.1097/QAI.0b013e3181e8efe4; Vermund S, 2013, CURR HIV AIDS REP; Wall Kristin M, 2010, J Int Assoc Physicians AIDS Care (Chic), V9, P284, DOI 10.1177/1545109710379051; Weiser Sheri D, 2004, Curr Infect Dis Rep, V6, P404, DOI 10.1007/s11908-004-0041-2; Willis Danny G, 2004, Issues Ment Health Nurs, V25, P115, DOI 10.1080/01612840490268090; Wilson D, 2008, LANCET, V372, P423, DOI 10.1016/S0140-6736(08)60883-1; Wolitski RJ, 2011, AIDS BEHAV, V15, pS9, DOI 10.1007/s10461-011-9901-6; Wong CF, 2008, ADDICT BEHAV, V33, P1012, DOI 10.1016/j.addbeh.2008.03.008; World Heart Federation, 2012, CARD DIS RISK FACT	73	24	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71546	10.1371/journal.pone.0071546	http://dx.doi.org/10.1371/journal.pone.0071546			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	205ER	23977073	Green Submitted, Green Published, gold			2022-12-25	WOS:000323425700069
J	Martin, CH; Wainwright, PC				Martin, Christopher H.; Wainwright, Peter C.			On the Measurement of Ecological Novelty: Scale-Eating Pupfish Are Separated by 168 my from Other Scale-Eating Fishes	PLOS ONE			English	Article							RED-BILLED OXPECKERS; ADAPTIVE RADIATION; CICHLID FISH; MORPHOLOGICAL DIVERSIFICATION; DIVERGENCE TIMES; FRESH-WATER; ECOMORPHOLOGICAL DIVERSIFICATION; FUNCTIONAL-MORPHOLOGY; COMMUNITY ECOLOGY; SQUAMATE REPTILES	The colonization of new adaptive zones is widely recognized as one of the hallmarks of adaptive radiation. However, the adoption of novel resources during this process is rarely distinguished from phenotypic change because morphology is a common proxy for ecology. How can we quantify ecological novelty independent of phenotype? Our study is split into two parts: we first document a remarkable example of ecological novelty, scale-eating (lepidophagy), within a rapidly-evolving adaptive radiation of Cyprinodon pupfishes on San Salvador Island, Bahamas. This specialized predatory niche is known in several other fish groups, but is not found elsewhere among the 1,500 species of atherinomorphs. Second, we quantify this ecological novelty by measuring the time-calibrated phylogenetic distance in years to the most closely-related species with convergent ecology. We find that scale-eating pupfish are separated by 168 million years of evolution from the nearest scale-eating fish. We apply this approach to a variety of examples and highlight the frequent decoupling of ecological novelty from phenotypic divergence. We observe that novel ecology is not always tightly correlated with rates of phenotypic or species diversification, particularly within recent adaptive radiations, necessitating the use of additional measures of ecological novelty independent of phenotype.	[Martin, Christopher H.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Martin, CH (corresponding author), Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA.	chmartin@ucdavis.edu	NAME, NO/AAA-3691-2021	Martin, Christopher/0000-0001-7989-9124	NSF [DEB-1061981]; UC Davis Dissertation Year fellowship; Northern California ARCS Foundation; Center for Population Biology; Gerace Research Centre	NSF(National Science Foundation (NSF)); UC Davis Dissertation Year fellowship; Northern California ARCS Foundation; Center for Population Biology; Gerace Research Centre	Funding was provided by an NSF Graduate Research Fellowship, an NSF doctoral dissertation improvement grant, a UC Davis Dissertation Year fellowship, the Northern California ARCS Foundation, the Center for Population Biology, student grants from the Gerace Research Centre (2008, 2011), and NSF grant DEB-1061981 to PCW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly D, 2009, P NATL ACAD SCI USA, V106, P19699, DOI 10.1073/pnas.0901635106; Adams DC, 2009, P ROY SOC B-BIOL SCI, V276, P2729, DOI 10.1098/rspb.2009.0543; Alexandrou MA, 2011, NATURE, V469, P84, DOI 10.1038/nature09660; Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; AMADON DEAN, 1950, BULL AMER MUS NAT HIST, V95, P151; Arbogast BS, 2006, EVOLUTION, V60, P370, DOI 10.1111/j.0014-3820.2006.tb01113.x; Baldwin Bruce G., 1997, P103; Blankers T, 2012, J EVOLUTION BIOL, V25, P634, DOI 10.1111/j.1420-9101.2012.02458.x; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Brandley MC, 2008, EVOLUTION, V62, P2042, DOI 10.1111/j.1558-5646.2008.00430.x; Britz R, 2009, P ROY SOC B-BIOL SCI, V276, P2179, DOI 10.1098/rspb.2009.0141; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Burns KJ, 2002, EVOLUTION, V56, P1240; Carlquist S, 1965, ISLAND LIFE NATURAL; Castillo P, 1988, B GEO SOC AM, V9, P1400; Cooper VS, 2002, QUANTIFYING FUNDAMEN, V9, P1; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Estes R., 1984, Journal of Vertebrate Paleontology, V4, P96; FitzJohn RG, 2009, SYST BIOL, V58, P595, DOI 10.1093/sysbio/syp067; FREED LA, 1987, TRENDS ECOL EVOL, V2, P196, DOI 10.1016/0169-5347(87)90020-6; Frimpong EA, 2009, FISHERIES, V34, P487, DOI 10.1577/1548-8446-34.10.487; Fryer G., 1972, CICHLID FISHES GREAT; Gillespie R, 2004, SCIENCE, V303, P356, DOI 10.1126/science.1091875; GILLESPIE RG, 1994, P NATL ACAD SCI USA, V91, P2290, DOI 10.1073/pnas.91.6.2290; Givnish T.J., 1997, MOL EVOLUTION ADAPTI; Givnish TJ, 2011, AM J BOT, V98, P872, DOI 10.3732/ajb.1000059; GORLICK DL, 1980, COPEIA, P863; Gottfried MD, 1997, J VERTEBR PALEONTOL, V17, P750, DOI 10.1080/02724634.1997.10011022; Grant P. R., 2008, WHY SPECIES MULTIPLY; Grant PR, 2009, P NATL ACAD SCI USA, V106, P20141, DOI 10.1073/pnas.0911761106; Grubh AR, 2004, COPEIA, P903; Hallstrom BM, 2009, MOL BIOL EVOL, V26, P463, DOI 10.1093/molbev/msn271; HARDY DE, 1965, INSECTS HAWAII, V12; Hata H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029349; Heath TA, 2012, SYST BIOL, V61, P793, DOI 10.1093/sysbio/sys032; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Heed WB, 1968, ECOLOGY HAWAIIAN DRO, V6818; Herrel A, 2008, ZOOLOGY, V111, P467, DOI 10.1016/j.zool.2008.01.002; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Holt RD, 2009, P NATL ACAD SCI USA, V106, P19659, DOI 10.1073/pnas.0905137106; Holtmeier CL, 2001, EVOLUTION, V55, P330; HOLTMEIER CL, 2000, THESIS CORNELL U; HORI M, 1993, SCIENCE, V260, P216, DOI 10.1126/science.260.5105.216; Hrbek T, 2003, J EVOLUTION BIOL, V16, P17, DOI 10.1046/j.1420-9101.2003.00475.x; Huelsenbeck JP, 2003, SYST BIOL, V52, P131, DOI 10.1080/10635150309342; Huelsenbeck JP, 2000, SCIENCE, V288, P2349, DOI 10.1126/science.288.5475.2349; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Janovetz J, 2005, J EXP BIOL, V208, P4757, DOI 10.1242/jeb.01938; Joyce DA, 2005, NATURE, V435, P90, DOI 10.1038/nature03489; KAMBYSELLIS MP, 1997, MOL EVOLUTION ADAPTI; Koblmueller Stephan, 2007, Molecular Phylogenetics and Evolution, V44, P1295, DOI 10.1016/j.ympev.2007.02.010; Kontula T, 2003, MOL PHYLOGENET EVOL, V27, P143, DOI 10.1016/S1055-7903(02)00376-7; Kusche H, 2012, P ROY SOC B-BIOL SCI, V279, P4715, DOI 10.1098/rspb.2012.2082; Langerhans RB, 2004, AM NAT, V164, P335, DOI 10.1086/422857; Lee HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044670; Lefebvre L, 2004, BRAIN BEHAV EVOLUT, V63, P233, DOI 10.1159/000076784; Leibold MA, 2006, ECOLOGY, V87, P1399, DOI 10.1890/0012-9658(2006)87[1399:COTNAN]2.0.CO;2; Lemmon AR, 2012, SYST BIOL, V61, P727, DOI 10.1093/sysbio/sys049; Li GL, 2008, SYST BIOL, V57, P647, DOI 10.1080/10635150802203898; Losos JB, 2009, ORGANISM ENVIRON, V10, P1; Lovette IJ, 2002, P ROY SOC B-BIOL SCI, V269, P37, DOI 10.1098/rspb.2001.1789; Macdonald KS, 2005, MOL PHYLOGENET EVOL, V35, P323, DOI 10.1016/j.ympev.2005.01.013; Maddison WP, 2007, SYST BIOL, V56, P701, DOI 10.1080/10635150701607033; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; Magurran A.E, 2003, MEASURING BIOL DIVER; Martin CH, 2013, SCIENCE, V339, P208, DOI 10.1126/science.1227710; Martin CH, 2012, AM NAT, V180, pE90, DOI 10.1086/667586; Martin CH, 2011, EVOLUTION, V65, P2197, DOI 10.1111/j.1558-5646.2011.01294.x; Martin CH, 2009, CAN J FISH AQUAT SCI, V66, P579, DOI 10.1139/F09-023; McCandlish DM, 2013, EVOLUTION IN PRESS; McCune Amy R., 1997, P585; McElligott AG, 2004, ZOO BIOL, V23, P347, DOI 10.1002/zoo.20013; Meehan CJ, 2009, CURR BIOL, V19, pR892, DOI 10.1016/j.cub.2009.08.049; Moczek AP, 2008, BIOESSAYS, V30, P432, DOI 10.1002/bies.20754; MULLER GB, 1991, ANNU REV ECOL SYST, V22, P229, DOI 10.1146/annurev.es.22.110191.001305; Nakae M, 2002, ICHTHYOL RES, V49, P7, DOI 10.1007/s102280200001; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; Near TJ, 2004, PHIL T ROY SOC, V75; Nitecki NH, 1990, EVOLUTIONARY INNOVAT; Noonan BP, 2010, AM NAT, V175, P61, DOI 10.1086/648607; NORRIS S. M., 2005, FRESHWATER FISHES ME; NSHOMBO M, 1985, JPN J ICHTHYOL, V32, P66; O'Meara BC, 2006, EVOLUTION, V60, P922; PARENTI L, 1984, B AM MUS NAT HIST, V178, P107; Peterson AT, 2011, ECOLOGICAL NICHES GE; Poschmann M, 2005, J PALEONTOL, V79, P110, DOI 10.1666/0022-3360(2005)079<0110:CAITOP>2.0.CO;2; Price SA, 2011, ECOL LETT, V14, P462, DOI 10.1111/j.1461-0248.2011.01607.x; Price SA, 2012, P NATL ACAD SCI USA, V109, P7008, DOI 10.1073/pnas.1117133109; Reichenbacher B, 2009, PALAEOGEOGR PALAEOCL, V281, P43, DOI 10.1016/j.palaeo.2009.07.008; Roderick GK, 1998, MOL ECOL, V7, P519, DOI 10.1046/j.1365-294x.1998.00309.x; ROUGHGARDEN J, 1972, AM NAT, V106, P683, DOI 10.1086/282807; Rubinoff D, 2010, P NATL ACAD SCI USA, V107, P5903, DOI 10.1073/pnas.0912501107; SAZIMA I, 1983, ENVIRON BIOL FISH, V9, P87, DOI 10.1007/BF00690855; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schoener T.W., 1989, P79; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Seegers L, 2000, KILLIFISHES WORLD NE; Seehausen O, 2006, P ROY SOC B-BIOL SCI, V273, P1987, DOI 10.1098/rspb.2006.3539; Setiamarga DHE, 2008, MOL PHYLOGENET EVOL, V49, P598, DOI 10.1016/j.ympev.2008.08.008; Sideleva VG, 2003, ENDEMIC FISHES LAKE; Simpson G.G., 1944, TEMPO MODE EVOLUTION, DOI DOI 10.1073/pnas.1821292116; Takahashi R, 2007, J FISH BIOL, V70, P1458, DOI 10.1111/j.1095-8649.2007.01423.x; Turner BJ, 2008, BIOL J LINN SOC, V95, P566, DOI 10.1111/j.1095-8312.2008.01079.x; Uyeda JC, 2011, P NATL ACAD SCI USA, V108, P15908, DOI 10.1073/pnas.1014503108; Vainola R, 2008, HYDROBIOLOGIA, V595, P241, DOI 10.1007/s10750-007-9020-6; Van Dooren TJM, 2010, EVOLUTION, V64, P2159, DOI 10.1111/j.1558-5646.2010.00977.x; VAUX P, 1988, BIOTROPICA, V20, P220, DOI 10.2307/2388237; Wagner CE, 2012, NATURE, V487, P366, DOI 10.1038/nature11144; Wainwright PC, 2012, SYST BIOL, V61, P1001, DOI 10.1093/sysbio/sys060; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; WEBB JK, 1994, COPEIA, P390; Weeks P, 2000, BEHAV ECOL, V11, P154, DOI 10.1093/beheco/11.2.154; Wiens JJ, 2006, EVOLUTION, V60, P123, DOI 10.1111/j.0014-3820.2006.tb01088.x; Wiens JJ, 2011, EVOLUTION, V65, P1283, DOI 10.1111/j.1558-5646.2011.01221.x; Wildekamp Rudolf H., 1999, Turkish Journal of Zoology, V23, P23; WINEMILLER KO, 1989, COPEIA, P511, DOI 10.2307/1445457; WINEMILLER KO, 1991, ECOL MONOGR, V61, P343, DOI 10.2307/2937046; WINEMILLER KO, 1995, ENVIRON BIOL FISH, V44, P235, DOI 10.1007/BF00005919; Wueringer BE, 2009, REV FISH BIOL FISHER, V19, P445, DOI 10.1007/s11160-009-9112-7; Zuccon D, 2006, MOL PHYLOGENET EVOL, V41, P333, DOI 10.1016/j.ympev.2006.05.007	121	31	31	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71164	10.1371/journal.pone.0071164	http://dx.doi.org/10.1371/journal.pone.0071164			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23976994	Green Published, gold, Green Submitted			2022-12-25	WOS:000323425700026
J	Svartstrom, O; Mushtaq, M; Pringle, M; Segerman, B				Svartstrom, Olov; Mushtaq, Memoona; Pringle, Marit; Segerman, Bo			Genome-Wide Relatedness of Treponema pedis, from Gingiva and Necrotic Skin Lesions of Pigs, with the Human Oral Pathogen Treponema denticola	PLOS ONE			English	Article							DIGITAL DERMATITIS; MICROBIAL COMMUNITIES; VIRULENCE FACTORS; IDENTIFICATION; GENE; SEQUENCE; HOMOLOG; TONSILS; PROTEIN; NOV.	Treponema pedis and T. denticola are two genetically related species with different origins of isolation. Treponema denticola is part of the human oral microbiota and is associated with periodontitis while T. pedis has been isolated from skin lesions in animals, e.g., digital dermatitis in cattle and necrotic ulcers in pigs. Although multiple Treponema phylotypes may exist in ulcerative lesions in pigs, T. pedis appears to be a predominant spirochete in these lesions. Treponema pedis can also be present in pig gingiva. In this study, we determined the complete genome sequence of T. pedis strain T A4, isolated from a porcine necrotic ear lesion, and compared its genome with that of T. denticola. Most genes in T. pedis were homologous to those in T. denticola and the two species were similar in general genomic features such as size, G+C content, and number of genes. In addition, many homologues of specific virulence-related genes in T. denticola were found in T. pedis. Comparing a selected pair of strains will usually not give a complete picture of the relatedness between two species. We therefore complemented the analysis with draft genomes from six T. pedis isolates, originating from gingiva and necrotic ulcers in pigs, and from twelve T. denticola strains. Each strain carried a considerable amount of accessory genetic material, of which a large part was strain specific. There was also extensive sequence variability in putative virulence-related genes between strains belonging to the same species. Signs of lateral gene-transfer events from bacteria known to colonize oral environments were found. This suggests that the oral cavity is an important habitat for T. pedis. In summary, we found extensive genomic similarities between T. pedis and T. denticola but also large variability within each species.	[Svartstrom, Olov] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden; [Mushtaq, Memoona] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden; [Pringle, Marit] Natl Vet Inst, Dept Anim Hlth & Antimicrobial Strategies, S-75007 Uppsala, Sweden; [Segerman, Bo] Natl Vet Inst, Dept Bacteriol, S-75007 Uppsala, Sweden	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; National Veterinary Institute SVA; National Veterinary Institute SVA	Svartstrom, O (corresponding author), Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden.	olov.svartstrom@slu.se			Swedish Research Council Formas	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	This study was funded by The Swedish Research Council Formas. http://www.formas.se/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039107; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Chevreux B, 1999, GERMAN C BIOINFORMAT, V99, P45, DOI DOI 10.1.1.23/7465; Dashper SG, 2011, J DENT RES, V90, P691, DOI 10.1177/0022034510385242; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Evans NJ, 2009, INT J SYST EVOL MICR, V59, P987, DOI 10.1099/ijs.0.002287-0; Fenno JC, 1997, J BACTERIOL, V179, P1082, DOI 10.1128/jb.179.4.1082-1089.1997; Fenno JC, 2000, INFECT IMMUN, V68, P1884, DOI 10.1128/IAI.68.4.1884-1892.2000; Fenno JC, 2001, INFECT IMMUN, V69, P6193, DOI 10.1128/IAI.69.10.6193-6200.2001; Gaibani P, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-345; Godovikova V, 2010, J BACTERIOL, V192, P3337, DOI 10.1128/JB.00274-10; Gordon D, 2003, CURR PROTOC BIOINFOR; Ishihara K, 1996, INFECT IMMUN, V64, P5178, DOI 10.1128/IAI.64.12.5178-5186.1996; Ishihara K, 2010, BIOL CHEM, V391, P1047, DOI 10.1515/BC.2010.113; Ishihara K, 2010, PERIODONTOL 2000, V54, P117, DOI 10.1111/j.1600-0757.2009.00345.x; Karlsson F, 2013, VET MICROBIOL; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lowe BA, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-20; Lowe BA, 2011, VET MICROBIOL, V147, P346, DOI 10.1016/j.vetmic.2010.06.025; McDowell JV, 2011, MOL ORAL MICROBIOL, V26, P140, DOI 10.1111/j.2041-1014.2010.00598.x; McDowell JV, 2005, INFECT IMMUN, V73, P7126, DOI 10.1128/IAI.73.11.7126-7132.2005; Moore LJ, 2005, VET MICROBIOL, V111, P199, DOI 10.1016/j.vetmic.2005.10.016; Myers GSA, 2007, NAT BIOTECHNOL, V25, P569, DOI 10.1038/nbt1302; Neumann E.J., 2012, DIS SWINE, V10th ed., P141; Pringle M, 2010, VET MICROBIOL, V142, P461, DOI 10.1016/j.vetmic.2009.10.027; Pringle M, 2009, VET MICROBIOL, V139, P279, DOI 10.1016/j.vetmic.2009.05.018; Rasmussen M, 2012, VET MICROBIOL, V160, P151, DOI 10.1016/j.vetmic.2012.05.018; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schlafer S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-66; Schrank K, 1999, INT J SYST BACTERIOL, V49, P43, DOI 10.1099/00207713-49-1-43; Seshadri G, 2004, P NATL ACAD SCI USA, V101, P5646, DOI 10.1073/pnas.0307639101; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Walker RL, 1995, VET MICROBIOL, V47, P343, DOI 10.1016/0378-1135(95)00114-X	36	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71281	10.1371/journal.pone.0071281	http://dx.doi.org/10.1371/journal.pone.0071281			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977007	Green Submitted, Green Published, gold			2022-12-25	WOS:000323425700033
J	Miernikiewicz, P; Dabrowska, K; Piotrowicz, A; Owczarek, B; Wojas-Turek, J; Kicielinska, J; Rossowska, J; Pajtasz-Piasecka, E; Hodyra, K; Macegoniuk, K; Rzewucka, K; Kopciuch, A; Majka, T; Letarov, A; Kulikov, E; Maciejewski, H; Gorski, A				Miernikiewicz, Paulina; Dabrowska, Krystyna; Piotrowicz, Agnieszka; Owczarek, Barbara; Wojas-Turek, Justyna; Kicielinska, Jagoda; Rossowska, Joanna; Pajtasz-Piasecka, Elzbieta; Hodyra, Katarzyna; Macegoniuk, Katarzyna; Rzewucka, Kamila; Kopciuch, Agnieszka; Majka, Tomasz; Letarov, Andrey; Kulikov, Eugene; Maciejewski, Henryk; Gorski, Andrzej			T4 Phage and Its Head Surface Proteins Do Not Stimulate Inflammatory Mediator Production	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS; BACTERIOPHAGES; INFECTION; THERAPY	Viruses are potent activators of the signal pathways leading to increased cytokine or ROS production. The effects exerted on the immune system are usually mediated by viral proteins. Complementary to the progress in phage therapy practice, advancement of knowledge about the influence of bacteriophages on mammalian immunity is necessary. Particularly, the potential ability of phage proteins to act like other viral stimulators of the immune system may have strong practical implications for the safety and efficacy of bacteriophage therapy. Here we present studies on the effect of T4 phage and its head proteins on production of inflammatory mediators and inflammation-related factors: IL-1 alpha, IL-1 beta, IL-2, IL-6, IL-10, IL-12 p40/p70, IFN-gamma, TNF-alpha, MCP-1, MIG, RANTES, GCSF, GM-CSF and reactive oxygen species (ROS). Plasma cytokine profiles in an in vivo mouse model and in human blood cells treated with gp23*, gp24*, Hoc and Soc were evaluated by cytokine antibody arrays. Cytokine production and expression of CD40, CD80, CD86 and MHC class II molecules were also investigated in mouse bone marrow-derived dendritic cells treated with whole T4 phage particle or the same capsid proteins. The influence of T4 and gp23*, gp24*, Hoc and Soc on reactive oxygen species generation was examined in blood cells using luminol-dependent chemiluminescence assay. In all performed assays, the T4 bacteriophage and its capsid proteins gp23*, gp24*, Hoc and Soc did not affect production of inflammatory-related cytokines or ROS. These observations are of importance for any medical or veterinary application of bacteriophages.	[Miernikiewicz, Paulina; Dabrowska, Krystyna; Piotrowicz, Agnieszka; Owczarek, Barbara; Wojas-Turek, Justyna; Kicielinska, Jagoda; Rossowska, Joanna; Pajtasz-Piasecka, Elzbieta; Hodyra, Katarzyna; Macegoniuk, Katarzyna; Rzewucka, Kamila; Kopciuch, Agnieszka; Majka, Tomasz; Gorski, Andrzej] Polish Acad Sci, Inst Immunol & Expt Therapy, PL-53114 Wroclaw, Poland; [Letarov, Andrey; Kulikov, Eugene] Russian Acad Sci, Winogradsky Inst Microbiol, Moscow, Russia; [Maciejewski, Henryk] Wroclaw Univ Technol, Inst Comp Engn Control & Robot, PL-50370 Wroclaw, Poland; [Gorski, Andrzej] Med Univ Warsaw, Inst Transplantat, Dept Clin Immunol, Warsaw, Poland	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Research Center of Biotechnology RAS; Russian Academy of Sciences; Wroclaw University of Science & Technology; Medical University of Warsaw	Miernikiewicz, P (corresponding author), Polish Acad Sci, Inst Immunol & Expt Therapy, PL-53114 Wroclaw, Poland.	pola@iitd.pan.wroc.pl	Rossowska, Joanna/Y-6164-2019; Letarov, Andrey V./AAD-1731-2022; Rossowska, Joanna/E-9159-2015; Maciejewski, Henryk/B-1836-2008	Rossowska, Joanna/0000-0002-3682-7160; Gorski, Andrzej/0000-0002-0863-6041; Pajtasz-Piasecka, Elzbieta/0000-0002-0253-970X; Dabrowska, Krystyna/0000-0002-1518-3183; Owczarek, Barbara/0000-0001-5658-1455; Kulikov, Eugene/0000-0002-9101-1543; Mierzejewska, Jagoda/0000-0001-7233-442X; Miernikiewicz, Paulina/0000-0003-4592-3741	Polish Ministry of Science [N N401 417236, 13-0089-06/2010, 0588/R/P01/2009/06]; EU	Polish Ministry of Science(Ministry of Science and Higher Education, Poland); EU(European Commission)	This work was supported by the Polish Ministry of Science (grants no. N N401 417236 and 13-0089-06/2010 decision no. 0588/R/P01/2009/06) and EU Structural Funds (Operational Programme Innovative Economy "Optimization of characteristics and preparation of bacteriophage preparations for therapeutic purposes"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MH, 1959, BACTERIOPHAGES; ALLEN RC, 1986, METHOD ENZYMOL, V133, P449; Black Lindsay W., 1994, P218; Boratynski J, 2004, CELL MOL BIOL LETT, V9, P253; Bruttin A, 2005, ANTIMICROB AGENTS CH, V49, P2874, DOI 10.1128/AAC.49.7.2874-2878.2005; Capparelli R, 2007, ANTIMICROB AGENTS CH, V51, P2765, DOI 10.1128/AAC.01513-06; Clark Jason R, 2004, Expert Rev Vaccines, V3, P463, DOI 10.1586/14760584.3.4.463; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Debarbieux L, 2010, J INFECT DIS, V201, P1096, DOI 10.1086/651135; Fokine A, 2005, P NATL ACAD SCI USA, V102, P7163, DOI 10.1073/pnas.0502164102; Gorski A, 2006, TRANSPL P, V38, P331, DOI 10.1016/j.transproceed.2005.12.073; Gorski A, 2005, CELL MOL LIFE SCI, V62, P511, DOI 10.1007/s00018-004-4403-6; Gorski A, 2012, ADV VIRUS RES, V83, P41, DOI 10.1016/B978-0-12-394438-2.00002-5; Jiang J, 1997, INFECT IMMUN, V65, P4770, DOI 10.1128/IAI.65.11.4770-4777.1997; Korenaga M, 2005, J BIOL CHEM, V280, P37481, DOI 10.1074/jbc.M506412200; Krisch HM, 2008, RES MICROBIOL, V159, P314, DOI 10.1016/j.resmic.2008.04.014; Lam WY, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-554; Letarov A, 2009, J APPL MICROBIOL, V107, P1, DOI 10.1111/j.1365-2672.2009.04143.x; Li YC, 2007, FASEB J, V21, P2474, DOI 10.1096/fj.06-7345com; Lukasiewicz Jolanta, 2003, Postepy Hig Med Dosw, V57, P33; Mann NH, 2008, RES MICROBIOL, V159, P400, DOI 10.1016/j.resmic.2008.04.003; Matsuzaki S, 2003, J INFECT DIS, V187, P613, DOI 10.1086/374001; Maura D, 2011, APPL MICROBIOL BIOT, V90, P851, DOI 10.1007/s00253-011-3227-1; Miedzybrodzki R, 2012, ADV VIRUS RES, V83, P73, DOI 10.1016/B978-0-12-394438-2.00003-7; Miller ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003; Mogensen TH, 2001, MICROBIOL MOL BIOL R, V65, P131, DOI 10.1128/MMBR.65.1.131-150.2001; Przerwa A, 2006, MED MICROBIOL IMMUN, V195, P143, DOI 10.1007/s00430-006-0011-4; Rao VB, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-356; Ren SX, 2011, VACCINE, V29, P5802, DOI 10.1016/j.vaccine.2011.03.051; Sathaliyawala T, 2006, J VIROL, V80, P7688, DOI 10.1128/JVI.00235-06; Schwarz KB, 1996, FREE RADICAL BIO MED, V21, P641, DOI 10.1016/0891-5849(96)00131-1; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; van Crevel R, 1999, J IMMUNOL METHODS, V222, P145, DOI 10.1016/S0022-1759(98)00192-6; Watanabe R, 2007, ANTIMICROB AGENTS CH, V51, P446, DOI 10.1128/AAC.00635-06; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030	35	55	56	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e71036	10.1371/journal.pone.0071036	http://dx.doi.org/10.1371/journal.pone.0071036			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23976975	Green Published, gold, Green Submitted			2022-12-25	WOS:000323570200017
J	Dozmorov, I; Dominguez, N; Sestak, AL; Robertson, JM; Harley, JB; James, JA; Guthridge, JM				Dozmorov, Igor; Dominguez, Nicolas; Sestak, Andrea L.; Robertson, Julie M.; Harley, John B.; James, Judith A.; Guthridge, Joel M.			Evidence of Dynamically Dysregulated Gene Expression Pathways in Hyperresponsive B Cells from African American Lupus Patients	PLOS ONE			English	Article							STANDARD-BASED ANALYSIS; REGULATORY NETWORKS; GERMINAL-CENTERS; ERYTHEMATOSUS; ALPHA; PROLIFERATION; NORMALIZATION; ASSOCIATIONS; LYMPHOCYTES; RESISTANCE	Recent application of gene expression profiling to the immune system has shown a great potential for characterization of complex regulatory processes. It is becoming increasingly important to characterize functional systems through multigene interactions to provide valuable insights into differences between healthy controls and autoimmune patients. Here we apply an original systematic approach to the analysis of changes in regulatory gene interconnections between in Epstein-Barr virus transformed hyperresponsive B cells from SLE patients and normal control B cells. Both traditional analysis of differential gene expression and analysis of the dynamics of gene expression variations were performed in combination to establish model networks of functional gene expression. This Pathway Dysregulation Analysis identified known transcription factors and transcriptional regulators activated uniquely in stimulated B cells from SLE patients.	[Dozmorov, Igor] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Dominguez, Nicolas; Robertson, Julie M.; James, Judith A.; Guthridge, Joel M.] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; [Sestak, Andrea L.; James, Judith A.] Univ Oklahoma Hlth Sci Ctr, Oklahoma City, OK USA; [Harley, John B.] US Dept Vet Affairs Med Ctr, Cincinnati, OH USA; [Harley, John B.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; Cincinnati Children's Hospital Medical Center	Guthridge, JM (corresponding author), Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA.	Joel-Guthridge@omrf.org		Guthridge, Joel/0000-0002-9308-237X	National Institutes of Health; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Allergy and Infectious Diseases; National Institute of General Medical Sciences [RR016478-10, AR058959-02, AI039824-15, AI058150, R01A1045050-10, RR020143, RR015577, RR015577-10S1, GM103510, N01AI000026, AI082714, AI101934, NO1AR062277, AI031584, AR053483, AR048940, AR049084, AR042460, AR012253, AR062277, AI024717, DEO15223, HR08-037]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015577, P20RR020143, P20RR016478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082714, N01AI000026, P01AI039824, R01AI024717, R37AI024717, R01AI058150, R01AI031584, U01AI101934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR053483, N01AR012253, P50AR048940, P01AR049084, RC2AR058959, R01AR042460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103510] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001834] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This project was supported by National Institutes of Health, including the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences [through grant numbers: RR016478-10, AR058959-02, AI039824-15, AI058150, and R01A1045050-10 to ID, RR020143 to JMG, ID, and JBH, RR015577 to JMG, JBH, and JAJ, RR015577-10S1 to JMG, GM103510 to JMG and JAJ, N01AI000026 to JMG and JAJ, AI082714 to JAJ, AI101934 to JAJ, NO1AR062277 to JBH, AI031584 to JBH, JMG, and JAJ, AR053483 to JMG and JAJ, AR048940 to JBH and JAJ, AR049084 to JBH, AR042460 to JBH, AR012253 to JBH, AR062277 to JBH, AI024717 to JBH, DEO15223 to JBH; Alliance for Lupus Research to JBH; the United States Department of Veterans Affairs to JBH; and OHRS award number HR08-037 from the Oklahoma Center for the Advancement of Science and Technology to JMG]. Additionally, this study was supported by the Lou Kerr Chair in Biomedical Research. This study is also made possible by the Kirkland Scholar Award Program at the Hospital for Special Surgery in New York City and is funded exclusively by Rheuminations, Inc., a non-profit foundation dedicated to supporting research leading to the treatment and cure of lupus to JBH and JAJ. The contents of this study are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health or the National Institute of Arthritis and Musculoskeletal and Skin Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Basso K, 2010, ADV IMMUNOL, V105, P193, DOI 10.1016/S0065-2776(10)05007-8; Blair PA, 2010, IMMUNITY, V32, P129; Braga-Neto UM, 2006, PLOS COMPUT BIOL, V2, P651, DOI 10.1371/journal.pcbi.0020081; Caldwell RG, 1998, IMMUNITY, V9, P405, DOI 10.1016/S1074-7613(00)80623-8; Carter KL, 2002, J VIROL, V76, P10427, DOI 10.1128/JVI.76.20.10427-10436.2002; Chiang D Y, 2001, Bioinformatics, V17 Suppl 1, pS49; de la Fuente A, 2004, BIOINFORMATICS, V20, P3565, DOI 10.1093/bioinformatics/bth445; Dorner T, 2011, J IMMUNOL METHODS, V363, P187, DOI 10.1016/j.jim.2010.06.009; Dozmorov I, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh146; Dozmorov I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-53; Dozmorov I, 2003, PHYSIOL GENOMICS, V15, P209, DOI 10.1152/physiolgenomics.00130.2003; Dozmorov I, 2003, BIOINFORMATICS, V19, P204, DOI 10.1093/bioinformatics/19.2.204; Dozmorov I, 2003, PHYSIOL GENOMICS, V12, P239, DOI 10.1152/physiolgenomics.00141.2002; Dozmorov I, 2009, NUCLEIC ACIDS RES, V37, P6323, DOI 10.1093/nar/gkp706; Dozmorov IM, 2011, NUCLEIC ACIDS RES, V39, P7881, DOI 10.1093/nar/gkr503; Dozmorov MG, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-12; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Griffin DO, 2011, J EXP MED, V208, P2591, DOI 10.1084/jem.20110978; Harley JB, 2002, J NATL MED ASSOC, V94, P670; Jarvis JN, 2004, ARTHRITIS RES THER, V6, pR15, DOI 10.1186/ar1018; Jenks SA, 2009, AUTOIMMUN REV, V8, P209, DOI 10.1016/j.autrev.2008.07.047; Kerbauy DB, 2007, EXP HEMATOL, V35, P1739, DOI 10.1016/j.exphem.2007.09.007; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Lawrence Shelley, 2007, J Inflamm (Lond), V4, P4, DOI 10.1186/1476-9255-4-4; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Lim WK, 2007, BIOINFORMATICS, V23, pI282, DOI 10.1093/bioinformatics/btm201; Liossis SNC, 1996, J CLIN INVEST, V98, P2549, DOI 10.1172/JCI119073; Madar Aviv, 2009, V541, P181, DOI 10.1007/978-1-59745-243-4_9; Mandel M, 2006, LUPUS, V15, P451, DOI 10.1191/0961203306lu2332oa; Mani KM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.2; Margolin AA, 2006, NAT PROTOC, V1, P663, DOI 10.1038/nprot.2006.106; McShane LM, 2002, BIOINFORMATICS, V18, P1462, DOI 10.1093/bioinformatics/18.11.1462; Nicholas MIW, 2008, CLIN IMMUNOL, V126, P189, DOI 10.1016/j.clim.2007.10.004; Niewold TB, 2011, J INTERF CYTOK RES, V31, P887, DOI 10.1089/jir.2011.0071; Park CH, 2004, J CELL BIOCHEM, V91, P777, DOI 10.1002/jcb.10776; Rovedo M, 2008, J VIROL, V82, P8520, DOI 10.1128/JVI.00843-08; Slonim N, 2005, P NATL ACAD SCI USA, V102, P18297, DOI 10.1073/pnas.0507432102; Suarez-Fueyo A, 2011, J IMMUNOL, V187, P2376, DOI 10.4049/jimmunol.1101602; Szodoray P, 2005, CLIN IMMUNOL, V117, P168, DOI 10.1016/j.clim.2005.06.016; Taher TE, 2010, ARTHRITIS RHEUM-US, V62, P2412, DOI 10.1002/art.27505; Vadigepalli Rajanikanth, 2003, OMICS A Journal of Integrative Biology, V7, P235, DOI 10.1089/153623103322452378; Vossenkamper A, 2012, CLIN EXP IMMUNOL, V167, P7, DOI 10.1111/j.1365-2249.2011.04460.x; Wakeland EK, 2001, IMMUNITY, V15, P397, DOI 10.1016/S1074-7613(01)00201-1; Weckerle CE, 2012, ARTHRITIS RHEUM-US, V64, P2947, DOI 10.1002/art.34483; Wu TF, 2007, J CLIN INVEST, V117, P2186, DOI 10.1172/JCI30398; Zhu LJ, 2010, J RHEUMATOL, V37, P1658, DOI 10.3899/jrheum.091123; Zimmerman RA, 2004, PROSTATE CANCER P D, V7, P364, DOI 10.1038/sj.pcan.4500761; Ziv E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.046117	50	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71397	10.1371/journal.pone.0071397	http://dx.doi.org/10.1371/journal.pone.0071397			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977035	Green Published, Green Submitted, gold			2022-12-25	WOS:000323378000049
J	Poisbleau, M; Dehnhard, N; Demongin, L; Parenteau, C; Quillfeldt, P; Eens, M				Poisbleau, Maud; Dehnhard, Nina; Demongin, Laurent; Parenteau, Charline; Quillfeldt, Petra; Eens, Marcel			Females Paired with New and Heavy Mates Reduce Intra-Clutch Differences in Resource Allocation	PLOS ONE			English	Article							EGG-SIZE VARIATION; HATCHING ASYNCHRONY; ROCKHOPPER PENGUINS; MALE ATTRACTIVENESS; BROOD REDUCTION; YOLK ANDROGENS; REPRODUCTIVE SUCCESS; EUROPEAN STARLINGS; MATERNAL HORMONES; PARENTAL QUALITY	Reproductive investment affects both offspring and parental fitness and influences the evolution of life histories. Females may vary their overall primary reproductive effort in relation to the phenotypic characteristics of their mate. However, the effects of male quality on differential resource allocation within clutches have been largely neglected despite the potential implications for mate choice and population dynamics, especially in species exhibiting biparental care and brood reduction. Female southern rockhopper penguins Eudyptes chrysocome paired with heavy mates reduced intra-clutch variation in egg and albumen masses. Females paired with new mates also reduced intra-clutch variation in yolk androgen levels. Since both an increased mass and increased androgen concentrations positively influence chick survival under sibling competition, the chances of fledging the whole clutch are likely to be higher for newly formed pairs with heavy males than for previously formed pairs with light males. Interestingly, total clutch provisioning did not vary with male quality. We show for the first time that females vary intra-clutch variation in resource allocation according to male quality. In species with brood reduction, it may be more adaptive for females to modulate the distribution of resources within the clutch according to breeding conditions, than to change their total clutch provisioning.	[Poisbleau, Maud; Demongin, Laurent; Eens, Marcel] Univ Antwerp, Dept Biol Ethol, Antwerp, Belgium; [Poisbleau, Maud; Dehnhard, Nina; Quillfeldt, Petra] Max Planck Inst Ornithol, Vogelwarte Radolfzell, Radolfzell, Germany; [Parenteau, Charline] CNRS, Ctr Etud Biol Chize, Villiers En Bois, France; [Quillfeldt, Petra] Univ Giessen, Behav Ecol & Ecophysiol Grp, D-35390 Giessen, Germany	University of Antwerp; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); Justus Liebig University Giessen	Poisbleau, M (corresponding author), Univ Antwerp, Dept Biol Ethol, Antwerp, Belgium.	maud.poisbleau@ua.ac.be	Quillfeldt, Petra/A-9549-2009; Poisbleau, Maud/B-9968-2014; Dehnhard, Nina/H-6160-2016; Eens, Marcel/AAC-8466-2020	Quillfeldt, Petra/0000-0002-4450-8688; Poisbleau, Maud/0000-0002-0729-3251; Dehnhard, Nina/0000-0002-4182-2698; 	University of Antwerp; FWO-Flanders [1.2.619.10.N.00, 1.5.020.11.N.00]; Deutsche Forschungsgemeinschaft [DFG Qu 148/1-ff]; Overseas Territories Environment Programme [OTEP FAL 603]; Falkland Islands Government	University of Antwerp; FWO-Flanders(FWO); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Overseas Territories Environment Programme; Falkland Islands Government	The study was funded by grants provided by the University of Antwerp and FWO-Flanders (Application numbers 1.2.619.10.N.00 and 1.5.020.11.N.00) to ME and MP. Financial supports for the gateway system were provided by the Deutsche Forschungsgemeinschaft (DFG Qu 148/1-ff), the Overseas Territories Environment Programme (OTEP FAL 603), and an Environmental Studies Budget grant from the Falkland Islands Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison B, 2008, GEN COMP ENDOCR, V158, P5, DOI 10.1016/j.ygcen.2008.05.020; Balzer AL, 1998, BEHAVIOUR, V135, P297, DOI 10.1163/156853998793066230; Black J.M., 1996, PARTNERSHIPS BIRDS S; Bonisoli-Alquati A, 2008, ECOLOGY, V89, P2315, DOI 10.1890/07-1066.1; BRADLEY JS, 1990, J ANIM ECOL, V59, P487, DOI 10.2307/4876; BURLEY N, 1986, AM NAT, V127, P415, DOI 10.1086/284493; BURLEY N, 1988, AM NAT, V132, P611, DOI 10.1086/284877; Catry P, 1997, ANIM BEHAV, V54, P1475, DOI 10.1006/anbe.1997.0552; Charlesworth B., 1994, EVOLUTION AGE STRUCT, DOI [10.1017/CBO9780511525711, DOI 10.1017/CBO9780511525711]; Christians JK, 2002, BIOL REV, V77, P1, DOI 10.1017/S1464793101005784; CLARK AB, 1981, Q REV BIOL, V56, P253, DOI 10.1086/412316; Crawford RJM, 2008, AFR J MAR SCI, V30, P185, DOI 10.2989/AJMS.2008.30.1.19.469; Crawford RJM, 2006, CCAMLR SCI, V13, P175; Cunningham EJA, 2000, NATURE, V404, P74, DOI 10.1038/35003565; Deeming DC, 2002, OX ORN SER, V13, P43; Demongin L, 2010, POLAR BIOL, V33, P469, DOI 10.1007/s00300-009-0722-2; Eising CM, 2008, BEHAVIOUR, V145, P51, DOI 10.1163/156853908782687232; Ens Bruno J., 1996, Oxford Ornithology Series, V6, P344; Ferrari RP, 2006, J EVOLUTION BIOL, V19, P981, DOI 10.1111/j.1420-9101.2005.01030.x; FOWLER GS, 1995, AM ZOOL, V35, P318; Gauthier-Clerc M, 2001, ANIM BEHAV, V62, P661, DOI 10.1006/anbe.2001.1803; Gilbert L, 2012, P ROY SOC B-BIOL SCI, V279, P523, DOI 10.1098/rspb.2011.0962; Groothuis TGG, 2005, ANN NY ACAD SCI, V1046, P168, DOI 10.1196/annals.1343.014; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Hackl R, 2003, J COMP PHYSIOL B, V173, P327, DOI 10.1007/s00360-003-0339-7; Hargitai R, 2006, FUNCT ECOL, V20, P829, DOI 10.1111/j.1365-2435.2006.01171.x; Hegyi G, 2011, BEHAV ECOL, V22, P29, DOI 10.1093/beheco/arq165; Horvathova T, 2012, P ROY SOC B-BIOL SCI, V279, P163, DOI 10.1098/rspb.2011.0663; HOWE HF, 1978, ECOLOGY, V59, P1109, DOI 10.2307/1938226; HUTCHINGS JA, 1991, EVOLUTION, V45, P1162, DOI 10.1111/j.1558-5646.1991.tb04382.x; Kolm N, 2001, P ROY SOC B-BIOL SCI, V268, P2229, DOI 10.1098/rspb.2001.1792; Lamey T.C., 1990, P399; Lipar JL, 1999, GEN COMP ENDOCR, V115, P220, DOI 10.1006/gcen.1999.7296; Massaro M, 2004, BEHAV ECOL SOCIOBIOL, V56, P426, DOI 10.1007/s00265-004-0803-8; Muller W, 2010, BEHAV ECOL, V21, P493, DOI 10.1093/beheco/arq010; Numata M, 2000, NEW ZEAL J ZOOL, V27, P277, DOI 10.1080/03014223.2000.9518236; OCONNOR RJ, 1978, ANIM BEHAV, V26, P79, DOI 10.1016/0003-3472(78)90008-8; Paitz RT, 2011, P ROY SOC B-BIOL SCI, V278, P99, DOI 10.1098/rspb.2010.0813; Penney R. L., 1968, Antarctic Research Series Washington, V12, P83; Pilz KM, 2004, FUNCT ECOL, V18, P58, DOI 10.1111/j.1365-2435.2004.00811.x; Poisbleau M, 2011, GEN COMP ENDOCR, V170, P622, DOI 10.1016/j.ygcen.2010.11.027; Poisbleau M, 2008, POLAR BIOL, V31, P925, DOI 10.1007/s00300-008-0431-2; Poisbleau M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042174; Poisbleau M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027765; Poisbleau M, 2011, BIOL LETTERS, V7, P605, DOI 10.1098/rsbl.2010.1134; Poisbleau M, 2010, ARDEA, V98, P217, DOI 10.5253/078.098.0212; Poisbleau M, 2009, HORM BEHAV, V55, P500, DOI 10.1016/j.yhbeh.2009.02.002; Rafferty NE, 2005, CONDOR, V107, P921, DOI 10.1650/7688.1; REID WV, 1990, EVOLUTION, V44, P1780, DOI 10.1111/j.1558-5646.1990.tb05248.x; Reyer HU, 1999, P ROY SOC B-BIOL SCI, V266, P2101, DOI 10.1098/rspb.1999.0894; Roff Derek, 2002, pi; Rowley I., 1983, P331; Royle NJ, 2001, BEHAV ECOL, V12, P381, DOI 10.1093/beheco/12.4.381; Saino N, 2002, P ROY SOC B-BIOL SCI, V269, P1005, DOI 10.1098/rspb.2002.1992; Saino N, 2010, BEHAV ECOL SOCIOBIOL, V64, P1813, DOI 10.1007/s00265-010-0993-1; Sandell MI, 2007, J AVIAN BIOL, V38, P284, DOI 10.1111/j.2007.0908-8857.03640.x; Schamber JL, 2009, J AVIAN BIOL, V40, P49, DOI 10.1111/j.1600-048X.2008.04462.x; Schwabl H, 1997, NATURE, V386, P231, DOI 10.1038/386231a0; Sheldon BC, 2000, TRENDS ECOL EVOL, V15, P397, DOI 10.1016/S0169-5347(00)01953-4; Sheldon BC, 1999, CURR BIOL, V9, pR487, DOI 10.1016/S0960-9822(99)80303-0; SINERVO B, 1990, EVOLUTION, V44, P279, DOI 10.1111/j.1558-5646.1990.tb05198.x; SLAGSVOLD T, 1984, AUK, V101, P685, DOI 10.2307/4086895; Sockman KW, 2000, P ROY SOC B-BIOL SCI, V267, P1451, DOI 10.1098/rspb.2000.1163; Sonneveld E, 2006, TOXICOL SCI, V89, P173, DOI 10.1093/toxsci/kfj009; SOTHERLAND PR, 1987, CONDOR, V89, P48, DOI 10.2307/1368759; St Clair CC, 1998, AUK, V115, P478, DOI 10.2307/4089208; St Clair CC, 1996, J ANIM ECOL, V65, P485; St. Clair Colleen Cassady, 1999, Marine Ornithology, V27, P37; Stearns S.C., 1992, pi; STOKLAND JN, 1988, AUK, V105, P308, DOI 10.2307/4087495; Styrsky JD, 1999, P ROY SOC B-BIOL SCI, V266, P1253, DOI 10.1098/rspb.1999.0771; Uller T, 2005, BEHAV ECOL SOCIOBIOL, V57, P584, DOI 10.1007/s00265-004-0886-2; Vinuela J, 1997, J ANIM ECOL, V66, P781, DOI 10.2307/5995; Williams T.D., 1995, PENGUINS; WILLIAMS TD, 1992, CONDOR, V94, P636, DOI 10.2307/1369249; WILLIAMS TD, 1990, OIKOS, V59, P349, DOI 10.2307/3545145; WILLIAMS TD, 1994, BIOL REV, V69, P35, DOI 10.1111/j.1469-185X.1994.tb01485.x; YORIO P, 1994, CONDOR, V96, P1076, DOI 10.2307/1369116	78	9	9	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e72136	10.1371/journal.pone.0072136	http://dx.doi.org/10.1371/journal.pone.0072136			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967280	Green Published, gold			2022-12-25	WOS:000323378000082
J	Tehrani, FR; Noroozzadeh, M; Zahediasl, S; Ghasemi, A; Piryaei, A; Azizi, F				Tehrani, Fahimeh Ramezani; Noroozzadeh, Mahsa; Zahediasl, Saleh; Ghasemi, Asghar; Piryaei, Abbas; Azizi, Fereidoun			Prenatal Testosterone Exposure Worsen the Reproductive Performance of Male Rat at Adulthood	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; CONGENITAL ADRENAL-HYPERPLASIA; FOLLICLE-STIMULATING-HORMONE; SPRAGUE-DAWLEY RATS; SERTOLI-CELL NUMBER; 21-HYDROXYLASE DEFICIENCY; PROGRAMMING WINDOW; ANDROGEN; RECEPTOR; MICE	The reproductive system is extremely susceptible to environmental insults, for example exogenous steroids during gestational development and differentiation. Experimental induction of androgen excess during prenatal life in female animal models reprograms their reproductive physiology, however the fetal programming of the male reproductive system by androgen excess has not been well studied. We aimed to determine the effect of prenatal exposure of two different doses of testosterone on different gestational days, on the male reproductive system using a rat model. Sixteen pregnant rats were randomly divided into two experimental groups and two control groups. Experimental group. were subcutaneously injected with 3 mg free testosterone on gestational days 16-19 and its controls received solvent for that time; experimental group. were subcutaneously injected with 20 mg free testosterone on day 20 of gestational period and its controls received solvent at the same time. The reproductive system morphology and function of 32 male offspring of these study groups were compared at days 6-30-60 of age and after puberty. The anogenital distance of the male offspring of both experimental groups had no significant differences on the different days of measurement, compared with controls. In the offspring of experimental group., the testes weight, number of Sertoli, Spermatocyte and Spermatid cells, sperm count and motility and the serum concentration of testosterone after puberty were significantly decreased; except for reduction of sperm motility (p<0.01), the other effects were not observed in the offspring of experimental group II. In summary, our data show that prenatal exposure of male rat fetuses to excess testosterone disrupted reproductive function, an effect highly dependent on the time, duration and level of exposure. It seems that the reproductive system in individuals exposed to high levels of androgens during fetal life should be evaluated at puberty and likely to be treated.	[Tehrani, Fahimeh Ramezani; Noroozzadeh, Mahsa] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Reprod Endocrinol Res Ctr, Tehran, Iran; [Zahediasl, Saleh; Ghasemi, Asghar] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Endocrine Physiol Res Ctr, Tehran, Iran; [Piryaei, Abbas] Shahid Beheshti Univ Med Sci, Dept Biol & Anat Sci, Fac Med, Tehran, Iran; [Azizi, Fereidoun] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Endocrine Res Ctr, Tehran, Iran	Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences	Zahediasl, S (corresponding author), Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Endocrine Physiol Res Ctr, Tehran, Iran.	zahedi@endocrine.ac.ir	Tehrani, Fahimeh Ramezani/H-6133-2017; Noroozzadeh, Mahsa/K-4765-2017; Ghasemi, Asghar/O-4145-2017; Piryaei, Abbas/O-5903-2017; Azizi, Fereidoun/ABD-4136-2021	Tehrani, Fahimeh Ramezani/0000-0002-4609-065X; Ghasemi, Asghar/0000-0001-6867-2151; Piryaei, Abbas/0000-0002-3182-6214; Azizi, Fereidoun/0000-0002-6470-2517	Research Institute for Endocrine Sciences, Shahid Beheshti University Of Medical Sciences, Tehran, Iran	Research Institute for Endocrine Sciences, Shahid Beheshti University Of Medical Sciences, Tehran, Iran	This research was supported by Research Institute for Endocrine Sciences, Shahid Beheshti University Of Medical Sciences, Tehran, Iran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DH, 2005, HUM REPROD UPDATE, V11, P357, DOI 10.1093/humupd/dmi013; Amalfi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037658; Baker PJ, 2003, ENDOCRINOLOGY, V144, P138, DOI 10.1210/en.2002-220637; Bormann CL, 2011, REPRODUCTION, V142, P167, DOI 10.1530/REP-10-0210; Cooper CS, 1998, J UROLOGY, V159, P441, DOI 10.1016/S0022-5347(01)63944-2; Creasy DM, 1997, TOXICOL PATHOL, V25, P119, DOI 10.1177/019262339702500201; Dela Cruz C, 2012, J PHYSIOL SCI, V62, P123, DOI 10.1007/s12576-011-0190-7; Giribabu N, 2012, ENV TOXICOL; Handelsman DJ, 1999, ENDOCRINOLOGY, V140, P3938, DOI 10.1210/en.140.9.3938; Hotchkiss AK, 2007, TOXICOL SCI, V96, P335, DOI 10.1093/toxsci/kfm002; Johnston H, 2004, ENDOCRINOLOGY, V145, P318, DOI 10.1210/en.2003-1055; LYON MF, 1970, NATURE, V227, P1217, DOI 10.1038/2271217a0; Manneras L, 2007, ENDOCRINOLOGY, V148, P3781, DOI 10.1210/en.2007-0168; McLachlan JA, 2001, ENDOCR REV, V22, P319, DOI 10.1210/er.22.3.319; McLaren A, 2000, MOL CELL ENDOCRINOL, V163, P3, DOI 10.1016/S0303-7207(99)00234-8; Mussig K, 2006, EXP CLIN ENDOCR DIAB, V114, P208, DOI 10.1055/s-2006-924072; ORTH JM, 1988, ENDOCRINOLOGY, V122, P787, DOI 10.1210/endo-122-3-787; Peper JS, 2009, EUR J ENDOCRINOL, V160, P739, DOI 10.1530/EJE-08-0915; Recabarren SE, 2008, J CLIN ENDOCR METAB, V93, P3318, DOI 10.1210/jc.2008-0255; Recabarren SE, 2007, BIOL RES, V40, P329, DOI [/S0716-97602007000400007, 10.4067/S0716-97602007000400007]; Recabarren SE, 2008, ENDOCRINOLOGY, V149, P6444, DOI 10.1210/en.2008-0785; Rojas-Garcia PP, 2010, AM J PHYSIOL-ENDOC M, V299, pE998, DOI 10.1152/ajpendo.00032.2010; Russell LD, 2001, BIOL REPROD, V65, P318, DOI 10.1095/biolreprod65.1.318; Scott HM, 2008, ENDOCRINOLOGY, V149, P5280, DOI 10.1210/en.2008-0413; Scott HM, 2007, ENDOCRINOLOGY, V148, P2027, DOI 10.1210/en.2006-1622; Sir-Petermann T, 2002, HUM REPROD, V17, P2573, DOI 10.1093/humrep/17.10.2573; Sugino Y, 2006, J ASSIST REPROD GEN, V23, P377, DOI 10.1007/s10815-006-9062-0; Tan KAL, 2005, ENDOCRINOLOGY, V146, P2674, DOI 10.1210/en.2004-1630; Toledo FC, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-94; Welsh M, 2008, J CLIN INVEST, V118, P1479, DOI 10.1172/JCI34241; Wu XY, 2010, ENDOCR J, V57, P201, DOI 10.1507/endocrj.K09E-205	31	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71705	10.1371/journal.pone.0071705	http://dx.doi.org/10.1371/journal.pone.0071705			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967236	Green Published, gold, Green Submitted			2022-12-25	WOS:000323378000065
J	Stab, V; Nitsche, S; Niezold, T; Bonsmann, MSG; Wiechers, A; Tippler, B; Hannaman, D; Ehrhardt, C; Uberla, K; Grunwald, T; Tenbusch, M				Stab, Viktoria; Nitsche, Sandra; Niezold, Thomas; Bonsmann, Michael Storcksdieck Genannt; Wiechers, Andrea; Tippler, Bettina; Hannaman, Drew; Ehrhardt, Christina; Ueberla, Klaus; Grunwald, Thomas; Tenbusch, Matthias			Protective Efficacy and Immunogenicity of a Combinatory DNA Vaccine against Influenza A Virus and the Respiratory Syncytial Virus	PLOS ONE			English	Article							T-CELL RESPONSES; HETEROSUBTYPIC IMMUNITY; F-PROTEIN; MICE; INFECTION; ELECTROPORATION; IMMUNIZATION; IMMUNODOMINANCE; EXPRESSION; CHALLENGE	The Respiratory Syncytial Virus (RSV) and Influenza A Virus (IAV) are both two major causative agents of severe respiratory tract infections in humans leading to hospitalization and thousands of deaths each year. In this study, we evaluated the immunogenicity and efficacy of a combinatory DNA vaccine in comparison to the single component vaccines against both diseases in a mouse model. Intramuscular electroporation with plasmids expressing the hemagglutinin (HA) of IAV and the F protein of RSV induced strong humoral immune responses regardless if they were delivered in combination or alone. In consequence, high neutralizing antibody titers were detected, which conferred protection against a lethal challenge with IAV. Furthermore, the viral load in the lungs after a RSV infection could be dramatically reduced in vaccinated mice. Concurrently, substantial amounts of antigen-specific, polyfunctional CD8(+) T-cells were measured after vaccination. Interestingly, the cellular response to the hemagglutinin was significantly reduced in the presence of the RSV-F encoding plasmid, but not vice versa. Although these results indicate a suppressive effect of the RSV-F protein, the protective efficacy of the combinatory vaccine was comparable to the efficacy of both single-component vaccines. In conclusion, the novel combinatory vaccine against RSV and IAV may have great potential to reduce the rate of severe respiratory tract infections in humans without increasing the number of necessary vaccinations.	[Stab, Viktoria; Nitsche, Sandra; Niezold, Thomas; Bonsmann, Michael Storcksdieck Genannt; Wiechers, Andrea; Tippler, Bettina; Ueberla, Klaus; Grunwald, Thomas; Tenbusch, Matthias] Ruhr Univ Bochum, Dept Mol & Med Virol, Bochum, Germany; [Hannaman, Drew] Ichor Med Syst, San Diego, CA USA; [Ehrhardt, Christina] Univ Munster, Ctr Mol Biol Inflammat, Inst Mol Virol, D-48149 Munster, Germany	Ruhr University Bochum; University of Munster	Tenbusch, M (corresponding author), Ruhr Univ Bochum, Dept Mol & Med Virol, Bochum, Germany.	matthias.tenbusch@rub.de	Grunwald, Thomas/J-7728-2015	Tripp, Ralph/0000-0002-2924-9956	German Research Foundation [GK1045/3]; Heinrich and Alma Vogelsang-Stiftung; Mercator Research Center Ruhr [St-2010-0004]	German Research Foundation(German Research Foundation (DFG)); Heinrich and Alma Vogelsang-Stiftung; Mercator Research Center Ruhr	This work was supported by grants from the German Research Foundation (GK1045/3), the Heinrich and Alma Vogelsang-Stiftung and the Mercator Research Center Ruhr (St-2010-0004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht MT, 2012, VACCINE, V30, P4872, DOI 10.1016/j.vaccine.2012.04.078; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Belshe RB, 2000, J INFECT DIS, V181, P1133, DOI 10.1086/315323; Benton KA, 2001, J IMMUNOL, V166, P7437, DOI 10.4049/jimmunol.166.12.7437; Bridges C, 2000, JAMA-J AM MED ASSOC, V284, P12; Chen WS, 2000, IMMUNITY, V12, P83, DOI 10.1016/S1074-7613(00)80161-2; CONNORS M, 1994, J VIROL, V68, P5321, DOI 10.1128/JVI.68.8.5321-5325.1994; Dabbagh K, 2002, J IMMUNOL, V168, P4524, DOI 10.4049/jimmunol.168.9.4524; De Baets S, 2013, J VIROL, V87, P3314, DOI 10.1128/JVI.03019-12; Ferraro B, 2011, CLIN INFECT DIS, V53, P296, DOI 10.1093/cid/cir334; Fouchier RAM, 2000, J CLIN MICROBIOL, V38, P4096, DOI 10.1128/JCM.38.11.4096-4101.2000; Frankild S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001831; Frey S, 1999, J INFECT DIS, V180, P2018, DOI 10.1086/315119; GRAHAM BS, 1991, J CLIN INVEST, V88, P1026, DOI 10.1172/JCI115362; GRAHAM BS, 1993, J IMMUNOL, V151, P2032; Kohlmann R, 2009, J VIROL, V83, P12601, DOI 10.1128/JVI.01036-09; Kreijtz JHCM, 2011, VIRUS RES, V162, P19, DOI 10.1016/j.virusres.2011.09.022; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Kutzler MA, 2008, NAT REV GENET, V9, P776, DOI 10.1038/nrg2432; Ledgerwood JE, 2009, HUM VACCINES, V5, P623, DOI 10.4161/hv.8627; Li XM, 1998, J EXP MED, V188, P681, DOI 10.1084/jem.188.4.681; Livingston BD, 2010, VACCINE, V28, P1056, DOI 10.1016/j.vaccine.2009.10.111; Lo CY, 2008, VACCINE, V26, P2062, DOI 10.1016/j.vaccine.2008.02.047; Mok H, 2008, VACCINE, V26, P4775, DOI 10.1016/j.vaccine.2008.07.012; Ostler T, 2002, EUR J IMMUNOL, V32, P2117, DOI 10.1002/1521-4141(200208)32:8<2117::AID-IMMU2117>3.0.CO;2-C; Park SH, 2008, J IMMUNOL METHODS, V331, P27, DOI 10.1016/j.jim.2007.10.012; Patel A, 2012, VACCINE, V30, P626, DOI 10.1016/j.vaccine.2011.11.017; Perrin-Cocon L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002260; Potthoff A, 2009, VACCINE, V27, P2768, DOI 10.1016/j.vaccine.2009.03.001; Schlender J, 2002, J VIROL, V76, P1163, DOI 10.1128/JVI.76.3.1163-1170.2002; Schotsaert M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/863985; Talaat AM, 2001, VACCINE, V20, P538, DOI 10.1016/S0264-410X(01)00352-8; Tenbusch M, 2010, VACCINE, V28, P3273, DOI 10.1016/j.vaccine.2010.02.090; Tenbusch M, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-13; Ternette N, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-51; Ternette N, 2007, VACCINE, V25, P7271, DOI 10.1016/j.vaccine.2007.07.025; Weinfurter JT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002381; Wiesener N, 2011, VIRAL IMMUNOL, V24, P321, DOI 10.1089/vim.2011.0001; Xu K, 2011, VIRAL IMMUNOL, V24, P45, DOI 10.1089/vim.2010.0056; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Zhou Y, 2008, INTERVIROLOGY, V51, P241, DOI 10.1159/000156483	41	17	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e72217	10.1371/journal.pone.0072217	http://dx.doi.org/10.1371/journal.pone.0072217			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967287	Green Published, gold, Green Submitted			2022-12-25	WOS:000323221500123
J	Haldiman, T; Kim, C; Cohen, Y; Chen, W; Blevins, J; Qing, LT; Cohen, ML; Langeveld, J; Telling, GC; Kong, QZ; Safar, JG				Haldiman, Tracy; Kim, Chae; Cohen, Yvonne; Chen, Wei; Blevins, Janis; Qing, Liuting; Cohen, Mark L.; Langeveld, Jan; Telling, Glenn C.; Kong, Qingzhong; Safar, Jiri G.			Co-existence of Distinct Prion Types Enables Conformational Evolution of Human PrPSc by Competitive Selection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREUTZFELDT-JAKOB-DISEASE; TRANSMISSIBLE MINK ENCEPHALOPATHY; CHRONIC WASTING DISEASE; STRAIN VARIATION; MOLECULAR-BASIS; PROTEIN; MICE; CLASSIFICATION; INTERFERENCE; COOCCURRENCE	The unique phenotypic characteristics of mammalian prions are thought to be encoded in the conformation of pathogenic prion proteins (PrPSc). The molecular mechanism responsible for the adaptation, mutation, and evolution of prions observed in cloned cells and upon crossing the species barrier remains unsolved. Using biophysical techniques and conformation-dependent immunoassays in tandem, we isolated two distinct populations of PrPSc particles with different conformational stabilities and aggregate sizes, which frequently co-exist in the most common human prion disease, sporadic Creutzfeldt-Jakob disease. The protein misfolding cyclic amplification replicates each of the PrPSc particle types independently and leads to the competitive selection of those with lower initial conformational stability. In serial propagation with a nonglycosylated mutant PrPC substrate, the dominant PrPSc conformers are subject to further evolution by natural selection of the subpopulation with the highest replication rate due to its lowest stability. Cumulatively, the data show that sporadic Creutzfeldt-Jakob disease PrPSc is not a single conformational entity but a dynamic collection of two distinct populations of particles. This implies the co-existence of different prions, whose adaptation and evolution are governed by the selection of progressively less stable, faster replicating PrPSc conformers.	[Haldiman, Tracy; Kim, Chae; Cohen, Yvonne; Chen, Wei; Blevins, Janis; Qing, Liuting; Cohen, Mark L.; Kong, Qingzhong; Safar, Jiri G.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Kong, Qingzhong; Safar, Jiri G.] Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA; [Cohen, Yvonne; Chen, Wei; Blevins, Janis; Cohen, Mark L.; Safar, Jiri G.] Case Western Reserve Univ, Sch Med, Natl Prion Dis Pathol Surveillance Ctr, Cleveland, OH 44106 USA; [Langeveld, Jan] Cent Vet Inst Wageningen UR, NL-8200 AB Lelystad, Netherlands; [Telling, Glenn C.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Wageningen University & Research; Colorado State University	Safar, JG (corresponding author), Case Western Reserve Univ, Dept Pathol, 2085 Adelbert Rd, Cleveland, OH 44106 USA.	jiri.safar@case.edu	Telling, Glenn C/G-1217-2019	Telling, Glenn C/0000-0002-6294-1805	National Institutes of Health [NS074317]; Centers for Disease Control and Prevention [UR8/CCU515004]; Charles S. Britton Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040334, R01NS074317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Charles S. Britton Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS074317. This work was also supported by Centers for Disease Control and Prevention Grant UR8/CCU515004 and the Charles S. Britton Fund.	Bartz JC, 2007, J VIROL, V81, P689, DOI 10.1128/JVI.01751-06; Bellon A, 2003, J GEN VIROL, V84, P1921, DOI 10.1099/vir.0.18996-0; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BESSEN RA, 1992, J GEN VIROL, V73, P329, DOI 10.1099/0022-1317-73-2-329; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; Bishop MT, 2010, P NATL ACAD SCI USA, V107, P12005, DOI 10.1073/pnas.1004688107; Bruce M E, 1991, Curr Top Microbiol Immunol, V172, P125; BRUCE ME, 1993, BRIT MED BULL, V49, P822, DOI 10.1093/oxfordjournals.bmb.a072649; Cali I, 2009, BRAIN, V132, P2643, DOI 10.1093/brain/awp196; Castilla J, 2008, EMBO J, V27, P2557, DOI 10.1038/emboj.2008.181; Choi EM, 2009, LAB INVEST, V89, P624, DOI 10.1038/labinvest.2009.30; Choi YP, 2011, J GEN VIROL, V92, P727, DOI 10.1099/vir.0.026948-0; Colby DW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000736; Collins SJ, 2006, BRAIN, V129, P2278, DOI 10.1093/brain/awl159; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Gambetti P, 2003, BRIT MED BULL, V66, P213, DOI 10.1093/bmb/66.1.213; Geschwind MD, 2008, ANN NEUROL, V64, P97, DOI 10.1002/ana.21430; Ghaemmaghami S, 2013, AM J PATHOL, V182, P866, DOI 10.1016/j.ajpath.2012.11.038; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kim C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002835; Kim C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002242; KIMBERLIN RH, 1978, J GEN VIROL, V39, P487, DOI 10.1099/0022-1317-39-3-487; Kobayashi A, 2011, AM J PATHOL, V178, P1309, DOI 10.1016/j.ajpath.2010.11.069; Kong QZ, 2005, J NEUROSCI, V25, P7944, DOI 10.1523/JNEUROSCI.2467-05.2005; Korth C, 2003, P NATL ACAD SCI USA, V100, P4784, DOI 10.1073/pnas.2627989100; Langeveld Jan P M, 2006, BMC Vet Res, V2, P19, DOI 10.1186/1746-6148-2-19; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Makarava N, 2013, J BIOL CHEM, V288, P33, DOI 10.1074/jbc.M112.419531; Manuelidis L, 2003, P NATL ACAD SCI USA, V100, P5360, DOI 10.1073/pnas.0931192100; McCutcheon S, 2005, J IMMUNOL METHODS, V298, P119, DOI 10.1016/j.jim.2005.01.012; Notari S, 2007, LAB INVEST, V87, P1103, DOI 10.1038/labinvest.3700676; Oelschlegel AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003158; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Parchi P, 1996, ANN NEUROL, V39, P767, DOI 10.1002/ana.410390613; Piro JR, 2009, J VIROL, V83, P5321, DOI 10.1128/JVI.02502-08; Pocchiari M, 2004, BRAIN, V127, P2348, DOI 10.1093/brain/awh249; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Puoti G, 2012, LANCET NEUROL, V11, P618, DOI 10.1016/S1474-4422(12)70063-7; SAFAR J, 1993, J BIOL CHEM, V268, P20276; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Safar J. G., 2012, PRIONS DIS, P161; Safar JG, 2005, P NATL ACAD SCI USA, V102, P3501, DOI 10.1073/pnas.0409651102; Safar JG, 2002, NAT BIOTECHNOL, V20, P1147, DOI 10.1038/nbt748; Safar JG, 2008, J INFECT DIS, V198, P81, DOI 10.1086/588193; Safar JG, 2006, P NATL ACAD SCI USA, V103, P11312, DOI 10.1073/pnas.0604021103; Safar JG, 2012, PRION, V6, P108, DOI 10.4161/pri.18666; Safer J, 1998, PROG BRAIN RES, V117, P421; Schoch G, 2006, PLOS MED, V3, P236, DOI 10.1371/journal.pmed.0030014; Scott Michael, 2004, VVolume 41, P435; Scott MR, 2005, J VIROL, V79, P5259, DOI 10.1128/JVI.79.9.5259-5271.2005; Shikiya RA, 2010, J VIROL, V84, P5706, DOI 10.1128/JVI.00243-10; Steensgaard J., 1992, PREPARATIVE CENTRIFU, P187; Swietnicki W, 2000, BIOCHEMISTRY-US, V39, P424, DOI 10.1021/bi991967m; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Thackray AM, 2007, BIOCHEM J, V401, P475, DOI 10.1042/BJ20061264; Uro-Coste E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000029; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; WHO, 1999, WHO LAB MAN EX HUM S, P1; Yuan J, 2006, J BIOL CHEM, V281, P34848, DOI 10.1074/jbc.M602238200; Yull HM, 2006, AM J PATHOL, V168, P151, DOI 10.2353/ajpath.2006.050766; Zanusso G, 1998, P NATL ACAD SCI USA, V95, P8812, DOI 10.1073/pnas.95.15.8812	65	37	37	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29846	29861		10.1074/jbc.M113.500108	http://dx.doi.org/10.1074/jbc.M113.500108			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23974118	Green Published, hybrid			2022-12-25	WOS:000330615300058
J	Suzuki, N; Kunishima, S; Ikejiri, M; Maruyama, S; Sone, M; Takagi, A; Ikawa, M; Okabe, M; Kojima, T; Saito, H; Naoe, T; Matsushita, T				Suzuki, Nobuaki; Kunishima, Shinji; Ikejiri, Makoto; Maruyama, Shoichi; Sone, Michihiko; Takagi, Akira; Ikawa, Masahito; Okabe, Masaru; Kojima, Tetsuhito; Saito, Hidehiko; Naoe, Tomoki; Matsushita, Tadashi			Establishment of Mouse Model of MYH9 Disorders: Heterozygous R702C Mutation Provokes Macrothrombocytopenia with Leukocyte Inclusion Bodies, Renal Glomerulosclerosis and Hearing Disability	PLOS ONE			English	Article							MYOSIN HEAVY-CHAIN; PROPLATELET FORMATION; MYH9-RELATED DISEASE; FECHTNER SYNDROMES; II-A; MICE; EXPRESSION; EPSTEIN; PATHWAY	Nonmuscle myosin heavy chain IIA (NMMHCIIA) encoded by MYH9 is associated with autosomal dominantly inherited diseases called MYH9 disorders. MYH9 disorders are characterized by macrothrombocytopenia and very characteristic inclusion bodies in granulocytes. MYH9 disorders frequently cause nephritis, sensorineural hearing disability and cataracts. One of the most common and deleterious mutations causing these disorders is the R702C missense mutation. We generated knock-in mice expressing the Myh9 R702C mutation. R702C knock-in hetero mice (R702C+/- mice) showed macrothrombocytopenia. We studied megakaryopoiesis of cultured fetal liver cells of R702C+/- mice and found that proplatelet formation was impaired: the number of proplatelet tips was decreased, proplatelet size was increased, and proplatelet shafts were short and enlarged. Although granulocyte inclusion bodies were not visible by May-Grunwald Giemsa staining, immunofluorescence analysis indicated that NMMHCIIA proteins aggregated and accumulated in the granulocyte cytoplasm. In other organs, R702C+/- mice displayed albuminuria which increased with age. Renal pathology examination revealed glomerulosclerosis. Sensory hearing loss was indicated by lowered auditory brainstem response. These findings indicate that Myh9 R702C knock-in mice mirror features of human MYH9 disorders arising from the R702C mutation.	[Suzuki, Nobuaki; Naoe, Tomoki] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Showa Ku, Nagoya, Aichi 4648601, Japan; [Kunishima, Shinji] Natl Hosp Org, Nagoya Med Ctr, Clin Res Ctr, Dept Adv Diag,Naka Ku, Nagoya, Aichi, Japan; [Ikejiri, Makoto; Takagi, Akira; Kojima, Tetsuhito] Nagoya Univ, Sch Hlth Sci, Dept Med Technol, Higashi Ku, Nagoya, Aichi 4648601, Japan; [Maruyama, Shoichi] Nagoya Univ, Grad Sch Med, Dept Nephrol, Showa Ku, Nagoya, Aichi 4648601, Japan; [Sone, Michihiko] Nagoya Univ, Grad Sch Med, Dept Otorhinolaryngol, Showa Ku, Nagoya, Aichi 4648601, Japan; [Ikawa, Masahito; Okabe, Masaru] Osaka Univ, Genome Informat Res Ctr, Dept Expt Genome Res, Suita, Osaka, Japan; [Saito, Hidehiko] Natl Hosp Org, Nagoya Med Ctr, Naka Ku, Nagoya, Aichi, Japan; [Matsushita, Tadashi] Nagoya Univ Hosp, Dept Transfus Med, Showa Ku, Nagoya, Aichi, Japan	Nagoya University; Nagoya Medical Center; Nagoya University; Nagoya University; Nagoya University; Osaka University; Nagoya Medical Center; Nagoya University	Matsushita, T (corresponding author), Nagoya Univ Hosp, Dept Transfus Med, Showa Ku, Nagoya, Aichi, Japan.	tmatsu@med.nagoya-u.ac.jp	ikawa, masahito/A-5315-2009; Matsushita, Tadadshi/I-7349-2014; Naoe, Tomoki/I-1888-2012; Kojima, Tetsuhito/I-6271-2014; Okabe, Masaru/B-6917-2015	ikawa, masahito/0000-0001-9859-6217; Kojima, Tetsuhito/0000-0002-1905-1065; Okabe, Masaru/0000-0002-0803-9044	Japan Society for the Promotion of Science [16390283, 18591094, 20591161]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in Aid for Scientific Research from Japan Society for the Promotion of Science grant numbers 16390283, 18591094, 20591161. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrondel C, 2002, J AM SOC NEPHROL, V13, P65, DOI 10.1681/ASN.V13165; Balduini CL, 2011, BRIT J HAEMATOL, V154, P161, DOI 10.1111/j.1365-2141.2011.08716.x; Chang Y, 2007, BLOOD, V109, P4229, DOI 10.1182/blood-2006-04-020024; Chen Z, 2007, BLOOD, V110, P171, DOI 10.1182/blood-2007-02-071589; Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200; Hirahashi J, 2009, CIRCULATION, V120, P1255, DOI 10.1161/CIRCULATIONAHA.109.873695; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; Iwai S, 2006, J BIOL CHEM, V281, P30736, DOI 10.1074/jbc.M605365200; Johnstone DB, 2011, MOL CELL BIOL, V31, P2162, DOI 10.1128/MCB.05234-11; Kelley MJ, 2000, NAT GENET, V26, P106, DOI 10.1038/79069; Kunishima S, 2003, LAB INVEST, V83, P115, DOI 10.1097/01.LAB.0000050960.48774.17; Kunishima S, 2001, BLOOD, V97, P1147, DOI 10.1182/blood.V97.4.1147; Kunishima S, 2008, BLOOD, V111, P3015, DOI 10.1182/blood-2007-10-116194; Kunishima S, 2007, EUR J HAEMATOL, V78, P220, DOI 10.1111/j.1600-0609.2006.00806.x; Kunishima S, 2011, BLOOD, V117, P5479, DOI 10.1182/blood-2010-12-323691; Kunishima S, 2010, CURR OPIN HEMATOL, V17, P405, DOI 10.1097/MOH.0b013e32833c069c; Leon C, 2007, BLOOD, V110, P3183, DOI 10.1182/blood-2007-03-080184; Matsushita T, 2004, BIOCHEM BIOPH RES CO, V325, P1163, DOI 10.1016/j.bbrc.2004.10.147; Pecci A, 2008, HUM MUTAT, V29, P409, DOI 10.1002/humu.20661; Schell C, 2012, NEPHROL DIAL TRANSPL, V27, P3406, DOI 10.1093/ndt/gfs273; Sekine T, 2010, KIDNEY INT, V78, P207, DOI 10.1038/ki.2010.21; Seri M, 2000, NAT GENET, V26, P103; Zhang YF, 2012, BLOOD, V119, P238, DOI 10.1182/blood-2011-06-358853	23	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71187	10.1371/journal.pone.0071187	http://dx.doi.org/10.1371/journal.pone.0071187			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23976996	gold, Green Published, Green Submitted			2022-12-25	WOS:000324527300007
J	Yang, MX; Liu, B; Zhao, MM; Li, F; Wang, GQ; Zhou, FF				Yang, Meixue; Liu, Bin; Zhao, Miaomiao; Li, Fan; Wang, Guoqing; Zhou, Fengfeng			Normalizing Electrocardiograms of Both Healthy Persons and Cardiovascular Disease Patients for Biometric Authentication	PLOS ONE			English	Article							TIME; DATABASE	Although electrocardiogram (ECG) fluctuates over time and physical activity, some of its intrinsic measurements serve well as biometric features. Considering its constant availability and difficulty in being faked, the ECG signal is becoming a promising factor for biometric authentication. The majority of the currently available algorithms only work well on healthy participants. A novel normalization and interpolation algorithm is proposed to convert an ECG signal into multiple template cycles, which are comparable between any two ECGs, no matter the sampling rates or health status. The overall accuracies reach 100% and 90.11% for healthy participants and cardiovascular disease (CVD) patients, respectively.	[Yang, Meixue; Zhao, Miaomiao; Zhou, Fengfeng] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Guangdong, Peoples R China; [Yang, Meixue; Zhao, Miaomiao; Zhou, Fengfeng] Chinese Acad Sci, Key Lab Hlth Informat, Shenzhen, Guangdong, Peoples R China; [Li, Fan; Wang, Guoqing] Jilin Univ, Norman Bethune Coll Med, Minist Educ, Key Lab Zoonosis, Changchun 130023, Jilin, Peoples R China; [Liu, Bin] Jilin Univ, Hosp 1, Changchun 130023, Jilin, Peoples R China	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese Academy of Sciences; Jilin University; Jilin University	Zhou, FF (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Guangdong, Peoples R China.	FengfengZhou@gmail.com	Zhou, Fengfeng/A-8932-2008	Zhou, Fengfeng/0000-0002-8108-6007	Shenzhen Research Grant [ZDSY20120617113021359]; China 973 program [2011CB512003, 2010CB732606-6]; NSFC [31000447]	Shenzhen Research Grant; China 973 program(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC))	It was supported in part by the Shenzhen Research Grant ZDSY20120617113021359, China 973 program (2011CB512003 and 2010CB732606-6) and NSFC 31000447. Computing resources were partly provided by the Dawning supercomputing clusters at Shenzhen Institute of Advanced Integration Technology, Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biel L, 2001, IEEE T INSTRUM MEAS, V50, P808, DOI 10.1109/19.930458; Butterworth S., 1930, WIRELESS ENG, V7, P536; Can Y, 2010, 27 29 SEPT 2010 BTAS, P1; Chen Y, 2008, GENETICS, V179, P2291, DOI 10.1534/genetics.108.089995; Chiu CC, 2009, INT J WAVELETS MULTI, V7, P341, DOI 10.1142/S0219691309002957; Dai HH, 2013, COMPUT BIOL MED, V43, P176, DOI 10.1016/j.compbiomed.2012.12.005; DANIELSSON PE, 1980, COMPUT VISION GRAPH, V14, P227, DOI 10.1016/0146-664X(80)90054-4; de Wit T, 2010, MOL CELL BIOL, V30, P68, DOI 10.1128/MCB.00913-09; Di Crescenzo G, 2005, APPROXIMATE MESSAGE, P578; Gloria L, 2009, PATENT APPL FULL TEX; He CG, 2013, IEEE T BIO-MED ENG, V60, P230, DOI 10.1109/TBME.2012.2222404; Ma QL, 2013, INT J MED SCI, V10, P624, DOI 10.7150/ijms.5779; Min CH, 2006, BIOMETRICS SYSTEM ME; Moody GB, 2011, IEEE ENG MED BIO, P8327, DOI 10.1109/IEMBS.2011.6092053; Odinaka I, 2012, IEEE T INF FOREN SEC, V7, P1812, DOI 10.1109/TIFS.2012.2215324; Plataniotis Konstantinos N., 2006, 2006 BIOMETRICS S SP, P1; Poh N, 2001, LECT NOTES COMPUT SC, V2091, P348; Sandhu R, 1996, ACM COMPUT SURV, V28, P241, DOI 10.1145/234313.234412; SCHECHTMAN VL, 1991, J DEV PHYSIOL, V16, P349; Sidek K., 2010, 2010 IEEE EMBS Conference on Biomedical Engineering and Sciences (IECBES 2010), P330, DOI 10.1109/IECBES.2010.5742255; Sidek KA, 2012, COMPUT CARDIOL CONF, V39, P97; Sidek KA, 2011, IEEE ENG MED BIO, P3772, DOI 10.1109/IEMBS.2011.6090644; Snelick R, 2005, IEEE T PATTERN ANAL, V27, P450, DOI 10.1109/TPAMI.2005.57; So HH, 1997, P ANN INT IEEE EMBS, V19, P289, DOI 10.1109/IEMBS.1997.754529; Sun HJ, 2011, BIOMETRICS INFORM ME; TADDEI A, 1992, EUR HEART J, V13, P1164, DOI 10.1093/oxfordjournals.eurheartj.a060332; Wang YJ, 2008, EURASIP J ADV SIG PR, DOI 10.1155/2008/148658	28	9	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71523	10.1371/journal.pone.0071523	http://dx.doi.org/10.1371/journal.pone.0071523			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977063	Green Submitted, Green Published, gold			2022-12-25	WOS:000324527300020
J	Palacios, M; Arias-Rodriguez, L; Plath, M; Eifert, C; Lerp, H; Lamboj, A; Voelker, G; Tobler, M				Palacios, Maura; Arias-Rodriguez, Lenin; Plath, Martin; Eifert, Constanze; Lerp, Hannes; Lamboj, Anton; Voelker, Gary; Tobler, Michael			The Rediscovery of a Long Described Species Reveals Additional Complexity in Speciation Patterns of Poeciliid Fishes in Sulfide Springs	PLOS ONE			English	Article							IMMIGRANTS MAINTAINS DIFFERENTIATION; MOLECULAR PHYLOGENETIC-RELATIONSHIPS; AQUATIC SURFACE RESPIRATION; DERMAL LIP PROTUBERANCES; GENETIC-DIVERGENCE; HYDROGEN-SULFIDE; SEXUAL SELECTION; EVOLUTION; ACTINOPTERYGII; POPULATION	The process of ecological speciation drives the evolution of locally adapted and reproductively isolated populations in response to divergent natural selection. In Southern Mexico, several lineages of the freshwater fish species of the genus Poecilia have independently colonized toxic, hydrogen sulfide-rich springs. Even though ecological speciation processes are increasingly well understood in this system, aligning the taxonomy of these fish with evolutionary processes has lagged behind. While some sulfide spring populations are classified as ecotypes of Poecilia mexicana, others, like P. sulphuraria, have been described as highly endemic species. Our study particularly focused on elucidating the taxonomy of the long described sulfide spring endemic, Poecilia thermalis Steindachner 1863, and investigates if similar evolutionary patterns of phenotypic trait divergence and reproductive isolation are present as observed in other sulfidic species of Poecilia. We applied a geometric morphometric approach to assess body shape similarity to other sulfidic and non-sulfidic fish of the genus Poecilia. We also conducted phylogenetic and population genetic analyses to establish the phylogenetic relationships of P. thermalis and used a population genetic approach to determine levels of gene flow among Poecilia from sulfidic and non-sulfidic sites. Our results indicate that P. thermalis' body shape has evolved in convergence with other sulfide spring populations in the genus. Phylogenetic analyses placed P. thermalis as most closely related to one population of P. sulphuraria, and population genetic analyses demonstrated that P. thermalis is genetically isolated from both P. mexicana ecotypes and P. sulphuraria. Based on these findings, we make taxonomic recommendations for P. thermalis. Overall, our study verifies the role of hydrogen sulfide as a main factor shaping convergent, phenotypic evolution and the emergence of reproductive isolation between Poecilia populations residing in adjacent sulfidic and non-sulfidic environments.	[Palacios, Maura; Voelker, Gary] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Arias-Rodriguez, Lenin] Univ Juarez Autonoma Tabasco, Div Acad Ciencias Biol, Villahermosa, Tabasco, Mexico; [Plath, Martin; Eifert, Constanze; Lerp, Hannes] Goethe Univ Frankfurt, Evolutionary Ecol Grp, D-60054 Frankfurt, Hessen, Germany; [Lamboj, Anton] Univ Vienna, Dept Integrat Zool, Vienna, Austria; [Tobler, Michael] Oklahoma State Univ, Dept Zool, Stillwater, OK 74078 USA	Texas A&M University System; Texas A&M University College Station; Universidad Juarez Autonoma de Tabasco; Goethe University Frankfurt; University of Vienna; Oklahoma State University System; Oklahoma State University - Stillwater	Palacios, M (corresponding author), Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA.	mepalacios@tamu.edu	Arias Rodriguez, Lenin/AAE-5577-2022	Tobler, Michael/0000-0002-0326-0890; ARIAS RODRIGUEZ, LENIN/0000-0002-8025-5569	NSF-IOS [IOS-1121832]; LOEWE - Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz" of Hesse's Ministry of Higher Education, Research, and the Arts [Bik-F Projektbereich C2]; Direct For Biological Sciences [1121832] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [1463720] Funding Source: National Science Foundation	NSF-IOS(National Science Foundation (NSF)); LOEWE - Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz" of Hesse's Ministry of Higher Education, Research, and the Arts; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by NSF-IOS (Grant number: IOS-1121832, http://www.nsf.gov/div/index.jsp?div=ios); and LOEWE - Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz" of Hesse's Ministry of Higher Education, Research, and the Arts (Grant number: Bik-F Projektbereich C2, http://verwaltung.hessen.de/irj/HMWK_Internet?uid=fa560c0b-ed11-9311-1010-43bf5aa60dfa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alda F, 2013, MOL PHYLOGENET EVOL, V66, P1011, DOI 10.1016/j.ympev.2012.12.012; Alvarez del Villar J, 1947, AN ESC NAC CIENC BIO, V5, P275; ARMIENTA MA, 1995, APPL GEOCHEM, V10, P215, DOI 10.1016/0883-2927(94)00044-7; Bose E., 1905, RESENA ACERCA GEOLOG, V20; Broughton RE, 2000, COPEIA, P1; Darwin C, 1859, ORIGINS SPECIES MEAN; Dobzhansky T., 1937; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; GASTON KJ, 1993, P ROY SOC B-BIOL SCI, V251, P139, DOI 10.1098/rspb.1993.0020; GORDON MALCOLM S., 1962, COPEIA, V2, P360; GRANT BR, 1989, AM NAT, V133, P377, DOI 10.1086/284924; Gunther A, 1866, COLLECTION BRIT MUSE; Hausdorf B, 2011, EVOLUTION, V65, P923, DOI 10.1111/j.1558-5646.2011.01231.x; Heller KB, 1853, REISEN MEXICO JAHREN; Hendry AP, 2007, FUNCT ECOL, V21, P455, DOI 10.1111/j.1365-2435.2007.01240.x; Hey J, 2003, TRENDS ECOL EVOL, V18, P597, DOI 10.1016/j.tree.2003.08.014; Hubbs CL, 1926, MISCELLANEOUS PUBLIC, V16, P1; IUCN, 2022, IUCN RED LIST THREAT; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kittell Michele M., 2005, Hidrobiológica, V15, P131; Kocher TD, 1995, MOL PHYLOGENET EVOL, V4, P420, DOI 10.1006/mpev.1995.1039; Langerhans RB, 2009, J EVOLUTION BIOL, V22, P1057, DOI 10.1111/j.1420-9101.2009.01716.x; Langerhans RB, 2004, AM NAT, V164, P335, DOI 10.1086/422857; Langerhans RB, 2004, EVOLUTION, V58, P2305, DOI 10.1111/j.0014-3820.2004.tb01605.x; LOSOS JB, 1992, SYST BIOL, V41, P403, DOI 10.2307/2992583; Lu GQ, 1999, EVOLUTION, V53, P1491, DOI 10.1111/j.1558-5646.1999.tb05413.x; Magurran AE, 1998, PHILOS T R SOC B, V353, P275, DOI 10.1098/rstb.1998.0209; MAYR E., 1942, Systematics and the origin of species from the viewpoint of a zoologist.; Meredith RW, 2011, MOL PHYLOGENET EVOL, V59, P148, DOI 10.1016/j.ympev.2011.01.014; Meredith RW, 2010, MOL PHYLOGENET EVOL, V55, P631, DOI 10.1016/j.ympev.2009.11.006; MILLER RR, 1983, COPEIA, P817; Nosil P, 2008, MOL ECOL, V17, P2103, DOI 10.1111/j.1365-294X.2008.03715.x; Nylander J, 2004, MR MODELTEST V2 PROG; Olvido AE, 2012, ENCY LIFE SCI, DOI [10.1002/9780470015902.a0001736.pub3, DOI 10.1002/9780470015902.A0001736.PUB3]; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; PARZEFALL J, 1989, ETHOLOGY, V82, P101; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pfennig DW, 2010, TRENDS ECOL EVOL, V25, P459, DOI 10.1016/j.tree.2010.05.006; Pfenninger M, 2009, PARALLEL EVOLUTION C; Plath M, 2007, MOL ECOL, V16, P967, DOI 10.1111/j.1365-294X.2006.03212.x; Plath M, 2005, BEHAV ECOL SOCIOBIOL, V58, P144, DOI 10.1007/s00265-005-0918-6; Plath M, 2013, EVOLUTION IN PRESS; Plath M, 2007, NATURWISSENSCHAFTEN, V94, P991, DOI 10.1007/s00114-007-0279-2; Plath M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-256; Plath M, 2010, NATURWISSENSCHAFTEN, V97, P769, DOI 10.1007/s00114-010-0691-x; Poeser F, 2003, THESIS AMSTERDAM U A; Poeser FN, 2003, P BIOL SOC WASH, V116, P356; Poeser FN, 2011, COPEIA, P418, DOI 10.1643/CI-09-111; Pritchard JK, 2000, GENETICS, V155, P945; PSUTY NP, 1965, ANN ASSOC AM GEOGR, V55, P112, DOI 10.1111/j.1467-8306.1965.tb00509.x; Rambaut A, 2007, TRACER 1 4; Regan C. T., 1907, Annals & Magazine of Natural History, V19; REGAN CT, 1913, P ZOOL SOC LOND, V11, P977; Reis R. E., 2003, CHECKLIST FRESHWATER; Roach KA, 2011, ECOLOGY, V92, P2056, DOI 10.1890/11-0276.1; Rohlf, 2010, TPSDIG2 VERSION 216; Rohlf FJ, 2005, TPSREGR VERSION 1 38; ROHLF FJ, 2007, TPSRELW VERSION 1 45; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rosales Lagarde L., 2006, ASS MEXICAN CAVE STU, V19, P177; Rosales Lagarde L, 2012, THESIS NEW MEXICO I; Rosen D. E., 1963, Bulletin of the American Museum of Natural History, V126, P1; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; RYDER OA, 1986, TRENDS ECOL EVOL, V1, P9, DOI 10.1016/0169-5347(86)90059-5; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scarabotti PA, 2011, ENVIRON BIOL FISH, V92, P391, DOI 10.1007/s10641-011-9850-y; Scarabotti PA, 2009, NEOTROP ICHTHYOL, V7, P459, DOI 10.1590/S1679-62252009000300013; SCHLUTER D, 1992, AM NAT, V140, P85, DOI 10.1086/285404; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schluter D, 2009, P NATL ACAD SCI USA, V106, P9955, DOI 10.1073/pnas.0901264106; Schmidt TR, 1998, COPEIA, P14, DOI 10.2307/1447697; Seda JB, 2010, THESIS CLEMSON U CLE; SEMARNAT (Secretaria de Medio Ambiente y Recursos Naturales), 2010, DIARIO OFICIAL FEDER, V12, P1; Slattery P, 2012, CONSERV GENET RESOUR, P1; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steindachner F., 1863, SITZUNGSBERICHTE MN, V48, P162; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tiedemann R, 2005, MOL ECOL NOTES, V5, P586, DOI 10.1111/j.1471-8286.2005.00993.x; Tobler M, 2009, J EVOLUTION BIOL, V22, P2298, DOI 10.1111/j.1420-9101.2009.01844.x; Tobler M, 2008, BIOL J LINN SOC, V95, P517, DOI 10.1111/j.1095-8312.2008.01063.x; Tobler M, 2008, EVOLUTION, V62, P2643, DOI 10.1111/j.1558-5646.2008.00466.x; Tobler M, 2006, EXTREMOPHILES, V10, P577, DOI 10.1007/s00792-006-0531-2; Tobler M, 2011, EVOL BIOL, V38, P412, DOI 10.1007/s11692-011-9129-4; Tobler M, 2011, EVOLUTION, V65, P2213, DOI 10.1111/j.1558-5646.2011.01298.x; Tobler M, 2009, EVOL ECOL RES, V11, P935; Tobler M, 2009, ENVIRON BIOL FISH, V85, P333, DOI 10.1007/s10641-009-9506-3; Vamosi SM, 2004, EVOLUTION, V58, P376, DOI 10.1111/j.0014-3820.2004.tb01653.x; West R. C., 1969, TABASCO LOWLANDS SE; WINEMILLER KO, 1989, COPEIA, P382; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1; Zuniga-Vega JJ, 2011, J FISH BIOL, V79, P1029, DOI 10.1111/j.1095-8649.2011.03081.x; Zwickl D., 2006, GARLI GENETIC ALGORI	99	35	35	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e71069	10.1371/journal.pone.0071069	http://dx.doi.org/10.1371/journal.pone.0071069			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23976979	Green Published, Green Submitted, gold			2022-12-25	WOS:000323570200022
J	Hamaguchi, M; Kamikubo, H; Suzuki, KN; Hagihara, Y; Yanagihara, I; Sakata, I; Kataoka, M; Hamada, D				Hamaguchi, Mitsuhide; Kamikubo, Hironari; Suzuki, Kayo N.; Hagihara, Yoshihisa; Yanagihara, Itaru; Sakata, Ikuhiro; Kataoka, Mikio; Hamada, Daizo			Structural Basis of alpha-Catenin Recognition by EspB from Enterohaemorrhagic E. coli Based on Hybrid Strategy Using Low-Resolution Structural and Protein Dissection	PLOS ONE			English	Article							MOLTEN-GLOBULE STATE; ENTEROPATHOGENIC ESCHERICHIA-COLI; RAY SOLUTION SCATTERING; SMALL-ANGLE SCATTERING; FOLDING PROBLEM; EMPIRICAL PARAMETERS; BIOLOGICAL MACROMOLECULES; SECONDARY STRUCTURE; BINDING; PREDICTION	Enterohaemorrhagic E. coli (EHEC) induces actin reorganization of host cells by injecting various effectors into host cytosol through type III secretion systems. EspB is the natively partially folded EHEC effector which binds to host alpha-catenin to promote the actin bundling. However, its structural basis is poorly understood. Here, we characterize the overall structural properties of EspB based on low-resolution structural data in conjunction with protein dissection strategy. EspB showed a unique thermal response involving cold denaturation in the presence of denaturant according to far-UV circular dichroism (CD). Small angle X-ray scattering revealed the formation of a highly extended structure of EspB comparable to the ideal random coil. Various disorder predictions as well as CD spectra of EspB fragments identified the presence of alpha-helical structures around G41 to Q70. The fragment corresponding to this region indicated the thermal response similar to EspB. Moreover, this fragment showed a high affinity to C-terminal vinculin homology domain of alpha-catenin. The results clarified the importance of preformed alpha-helix of EspB for recognition of alpha-catenin.	[Hamaguchi, Mitsuhide; Sakata, Ikuhiro] Kinki Univ, Sch Med, Dept Emergency Crit Care Med, Osaka 589, Japan; [Hamaguchi, Mitsuhide; Suzuki, Kayo N.; Yanagihara, Itaru] Osaka Med Ctr Maternal & Child Hlth, Res Inst, Izumi, Japan; [Kamikubo, Hironari; Kataoka, Mikio] Nara Inst Sci & Technol NAIST, Lab Bioenerget & Biophys, Nara, Japan; [Hagihara, Yoshihisa] Natl Inst Adv Ind Sci & Technol, Ikeda, Osaka, Japan; [Hamada, Daizo] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Struct Biol,Chuo Ku, Kobe, Hyogo 657, Japan	Kindai University (Kinki University); Nara Institute of Science & Technology; National Institute of Advanced Industrial Science & Technology (AIST); Kobe University	Hamada, D (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Struct Biol,Chuo Ku, Kobe, Hyogo 657, Japan.	daizo@med.kobe-u.ac.jp	Hamada, Daizo/N-1118-2016; HAGIHARA, Yoshihisa/K-4996-2016; Kataoka, Mikio/H-4402-2011	Hamada, Daizo/0000-0002-1799-5476; HAGIHARA, Yoshihisa/0000-0002-5980-1764; 	Global COE program from MEXT, Japan [A08]; MEXT, Japan; JSPS; Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care	Global COE program from MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care	This work was supported in part by Grants-in-Aids for the Global COE program A08 (DH), for Scientific Research on Innovative Area "Molecular Science of Fluctuations toward Biological Functions (DH & MK) from MEXT, Japan and for Scientific Research (C) (DH) from JSPS, and the research grants from The Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care (DH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benning MM, 2000, J BIOL CHEM, V275, P30556, DOI 10.1074/jbc.M003852200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chaffotte AF, 1997, J PROTEIN CHEM, V16, P433, DOI 10.1023/A:1026397008011; Chatterjee S, 2013, BIOCHEMISTRY-US, V52, P2508, DOI 10.1021/bi400160a; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Doniach S, 2001, CHEM REV, V101, P1763, DOI 10.1021/cr990071k; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Eliezer D, 2009, CURR OPIN STRUC BIOL, V19, P23, DOI 10.1016/j.sbi.2008.12.004; Geierhaas CD, 2007, PROTEIN SCI, V16, P125, DOI 10.1110/ps.062383807; Hamada D, 2005, FEBS J, V272, P756, DOI 10.1111/j.1742-4658.2004.04513.x; Hamada D, 1996, J MOL BIOL, V256, P172, DOI 10.1006/jmbi.1996.0075; Hamada D, 2010, FEBS J, V277, P2409, DOI 10.1111/j.1742-4658.2010.07655.x; Hamaguchi M, 2008, FEBS J, V275, P6260, DOI 10.1111/j.1742-4658.2008.06750.x; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; Hartland EL, 2000, MOL MICROBIOL, V35, P1483, DOI 10.1046/j.1365-2958.2000.01814.x; Hirose S, 2007, BIOINFORMATICS, V23, P2046, DOI 10.1093/bioinformatics/btm302; Ide T, 2001, CELL MICROBIOL, V3, P669, DOI 10.1046/j.1462-5822.2001.00146.x; Iizumi Y, 2007, CELL HOST MICROBE, V2, P383, DOI 10.1016/j.chom.2007.09.012; Kataoka M, 1996, FOLD DES, V1, pR107, DOI 10.1016/S1359-0278(96)00047-8; Kiefhaber T, 2012, CURR OPIN STRUC BIOL, V22, P21, DOI 10.1016/j.sbi.2011.09.010; Knappstein S, 2004, INFECT IMMUN, V72, P4344, DOI 10.1128/IAI.72.8.4344-4350.2004; Koch MHJ, 2003, Q REV BIOPHYS, V36, P147, DOI 10.1017/S0033583503003871; Kodama T, 2002, CELL MICROBIOL, V4, P213, DOI 10.1046/j.1462-5822.2002.00176.x; Kohn JE, 2004, P NATL ACAD SCI USA, V101, P12491, DOI 10.1073/pnas.0403643101; KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202; Kuwajima K, 1996, FASEB J, V10, P102, DOI 10.1096/fasebj.10.1.8566530; Lacroix E, 1998, J MOL BIOL, V284, P173, DOI 10.1006/jmbi.1998.2145; LAU SYM, 1984, J BIOL CHEM, V259, P3253; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Munoz V, 1997, BIOPOLYMERS, V41, P495, DOI 10.1002/(SICI)1097-0282(19970415)41:5<495::AID-BIP2>3.3.CO;2-6; MUNOZ V, 1995, J MOL BIOL, V245, P297, DOI 10.1006/jmbi.1994.0024; MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399; MUNOZ V, 1995, J MOL BIOL, V245, P275, DOI 10.1006/jmbi.1994.0023; OHGUSHI M, 1983, FEBS LETT, V164, P21, DOI 10.1016/0014-5793(83)80010-6; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Onitsuka M, 2008, PROTEINS, V72, P837, DOI 10.1002/prot.21978; Romero, 1997, Genome Inform Ser Workshop Genome Inform, V8, P110; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Taylor KA, 1999, INFECT IMMUN, V67, P120, DOI 10.1128/IAI.67.1.120-125.1999; Uversky VN, 1996, J MOL BIOL, V255, P215, DOI 10.1006/jmbi.1996.0018; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Xue B, 2010, PROTEIN PEPTIDE LETT, V17, P932, DOI 10.2174/092986610791498984; Yu QF, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078318, 10.1371/journal.pone.0059627]; YUTANI K, 1992, J MOL BIOL, V228, P347, DOI 10.1016/0022-2836(92)90824-4	49	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71618	10.1371/journal.pone.0071618	http://dx.doi.org/10.1371/journal.pone.0071618			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967227	Green Published, Green Submitted, gold			2022-12-25	WOS:000323221500090
J	Blacklaws, BA; Gajda, AM; Tippelt, S; Jepson, PD; Deaville, R; Van Bressem, MF; Pearce, GP				Blacklaws, Barbara A.; Gajda, Anna M.; Tippelt, Sabine; Jepson, Paul D.; Deaville, Rob; Van Bressem, Marie-Francoise; Pearce, Gareth P.			Molecular Characterization of Poxviruses Associated with Tattoo Skin Lesions in UK Cetaceans	PLOS ONE			English	Article								There is increasing concern for the well-being of cetacean populations around the UK. Tattoo skin disease (characterised by irregular, grey, black or yellowish, stippled cutaneous lesions) caused by poxvirus infection is a potential health indicatora potential health indicator for cetaceans. Limited sequence data indicates that cetacean poxviruses (CPVs) belong to an unassigned genus of the Chordopoxvirinae. To obtain further insight into the phylogenetic relationships between CPV and other Chordopoxvirinae members we partially characterized viral DNA originating from tattoo lesions collected in Delphinidae and Phocoenidae stranded along the UK coastline in 1998-2008. We also evaluated the presence of CPV in skin lesions other than tattoos to examine specificity and sensitivity of visual diagnosis. After DNA extraction, regions of the DNA polymerase and DNA topoisomerase I genes were amplified by PCR, sequenced and compared with other isolates. The presence of CPV DNA was demonstrated in tattoos from one striped dolphin (Stenella coeruleoalba), eight harbour porpoises (Phocoena phocoena) and one short-beaked common dolphin (Delphinus delphis) and in one 'dubious tattoo' lesion detected in one other porpoise. Seventeen of the 18 PCR positive skin lesions had been visually identified as tattoos and one as a dubious tattoo. None of the other skin lesions were PCR positive. Thus, visual identification had a 94.4% sensitivity and 100% specificity. The DNA polymerase PCR was most effective in detecting CPV DNA. Limited sequence phylogeny grouped the UK samples within the odontocete poxviruses (CPV group 1) and indicated that two different poxvirus lineages infect the Phocoenidae and the Delphinidae. The phylogenetic tree had three major branches: one with the UK Phocoenidae viruses, one with the Delphinidae isolates and one for the mysticete poxvirus (CPV group 2). This implies a radiation of poxviruses according to the host suborder and the families within these suborders.	[Blacklaws, Barbara A.; Pearce, Gareth P.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Gajda, Anna M.] Warsaw Univ Life Sci, Dept Pathol & Vet Diagnost, Lab Bee Dis, Fac Vet Med, Warsaw, Poland; [Tippelt, Sabine] Univ Vet Med Hannover, Dept Pharmacol Toxicol & Pharm, Hannover, Germany; [Jepson, Paul D.; Deaville, Rob] Zool Soc London, Inst Zool, London NW1 4RY, England; [Van Bressem, Marie-Francoise] Peruvian Ctr Cetacean Res CEPEC, Cetacean Conservat Med Grp, Berlin, Germany	University of Cambridge; Warsaw University of Life Sciences; University of Veterinary Medicine Hannover, Foundation; Zoological Society of London	Blacklaws, BA (corresponding author), Univ Cambridge, Dept Vet Med, Cambridge, England.	bab2@cam.ac.uk	Pearce, Gareth P/D-1044-2013; Blacklaws, Barbara A/AAF-6360-2019; Gajda, Anna/AAB-8107-2022	Blacklaws, Barbara A/0000-0001-5454-6496; Gajda, Anna/0000-0003-3900-7368; Pearce, Gareth/0000-0002-0656-6553	Wellcome Trust Fundamentals of Veterinary Science Summer School, University of Cambridge	Wellcome Trust Fundamentals of Veterinary Science Summer School, University of Cambridge	AG and ST were supported by the Wellcome Trust Fundamentals of Veterinary Science Summer School, University of Cambridge, Ref. 075871/Z/04/Z (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILAR A, 1994, SCI TOTAL ENVIRON, V154, P237, DOI 10.1016/0048-9697(94)90091-4; Becher P, 2002, ARCH VIROL, V147, P1133, DOI 10.1007/s00705-002-0804-8; Bossart Gregory D., 2006, Oceanography, V19, P134; Bracht AJ, 2006, ARCH VIROL, V151, P423, DOI 10.1007/s00705-005-0679-6; BULLER RML, 1991, MICROBIOL REV, V55, P80, DOI 10.1128/MMBR.55.1.80-122.1991; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; GERACI JR, 1979, CAN J COMP MED, V43, P399; Hall AJ, 2006, ENVIRON HEALTH PERSP, V114, P704, DOI 10.1289/ehp.8222; Harkonen T, 2006, DIS AQUAT ORGAN, V68, P115, DOI 10.3354/dao068115; Jepson PD, 2005, ENVIRON TOXICOL CHEM, V24, P238, DOI 10.1897/03-663.1; King A.M., 2012, VIRUS TAXONOMY, V9; Moss B., 2007, FIELDS VIROLOGY, V2, P2905; Nitsche A, 2006, CLIN CHEM, V52, P316, DOI 10.1373/clinchem.2005.060335; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Upton C, 2003, J VIROL, V77, P7590, DOI 10.1128/JVI.77.13.7590-7600.2003; Van Bressem M.-F., 2006, Latin American Journal of Aquatic Mammals, V5, P49; Van Bressem MF, 2007, J GEN VIROL, V88, P1928, DOI 10.1099/vir.0.82694-0; Van Bressem MF, 2009, DIS AQUAT ORGAN, V86, P143, DOI 10.3354/dao02101; Van Bressem MF, 2009, DIS AQUAT ORGAN, V85, P225, DOI 10.3354/dao02080; Van Bressem MF, 2003, DIS AQUAT ORGAN, V56, P171, DOI 10.3354/dao056171; VanBressem MF, 1996, MAR MAMMAL SCI, V12, P371; VANBRESSEM MF, 1993, J WILDLIFE DIS, V29, P109, DOI 10.7589/0090-3558-29.1.109; Wilson B, 2000, MAR ECOL PROG SER, V205, P283, DOI 10.3354/meps205283	23	19	21	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71734	10.1371/journal.pone.0071734	http://dx.doi.org/10.1371/journal.pone.0071734			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967239	Green Published, Green Submitted, gold			2022-12-25	WOS:000323115800077
J	Fukuda, A; Shimada, M; Nakadai, T; Nishimura, K; Hisatake, K				Fukuda, Aya; Shimada, Miho; Nakadai, Tomoyoshi; Nishimura, Ken; Hisatake, Koji			Heterogeneous Nuclear Ribonucleoprotein R Cooperates with Mediator to Facilitate Transcription Reinitiation on the c-Fos Gene	PLOS ONE			English	Article								The c-fos gene responds to extracellular stimuli and undergoes robust but transient transcriptional activation. Here we show that heterogeneous nuclear ribonucleoprotein R (hnRNP R) facilitates transcription reinitiation of the c-fos promoter in vitro in cooperation with Mediator. Consistently, hnRNP R interacts with the Scaffold components (Mediator, TBP, and TFIIH) as well as TFIIB, which recruits RNA polymerase II (Pol II) and TFIIF to Scaffold. The cooperative action of hnRNP R and Mediator is diminished by the cyclin-dependent kinase 8 (CDK8) module, which is comprised of CDK8, Cyclin C, MED12 and MED13 of the Mediator subunits. Interestingly, we find that the length of the G-free cassettes, and thereby their transcripts, influences the hnRNP R-mediated facilitation of reinitiation. Indeed, indicative of a possible role of the transcript in facilitating transcription reinitiation, the RNA transcript produced from the G-free cassette interacts with hnRNP R through its RNA recognition motifs (RRMs) and arginine-glycine-glycine (RGG) domain. Mutational analyses of hnRNP R indicate that facilitation of initiation and reinitiation requires distinct domains of hnRNP R. Knockdown of hnRNP R in mouse cells compromised rapid induction of the c-fos gene but did not affect transcription of constitutive genes. Together, these results suggest an important role for hnRNP R in regulating robust response of the c-fos gene.	[Fukuda, Aya; Nishimura, Ken; Hisatake, Koji] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan; [Shimada, Miho; Nakadai, Tomoyoshi] Rockefeller Univ, Lab Biochem & Mol Biol, New York, NY 10021 USA	University of Tsukuba; Rockefeller University	Fukuda, A (corresponding author), Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan.	fukudaa@md.tsukuba.ac.jp	Nishimura, KEN/HGC-6147-2022	Nishimura, Ken/0000-0002-0716-4142; Hisatake, Koji/0000-0002-5795-3115	JSPS KAKENHI [23770200, 25460354]; Grants-in-Aid for Scientific Research [25460354, 24700474] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Numbers 23770200 (AF) and 25460354 (KH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoulitchev S, 2000, NATURE, V407, P102, DOI 10.1038/35024111; Auboeuf D, 2004, MOL CELL BIOL, V24, P442, DOI 10.1128/MCB.24.1.442-453.2004; Auboeuf D, 2007, TRENDS ENDOCRIN MET, V18, P122, DOI 10.1016/j.tem.2007.02.003; Baek HJ, 2006, J BIOL CHEM, V281, P15172, DOI 10.1074/jbc.M601983200; Belakavadi M, 2010, MOL CELL BIOL, V30, P2437, DOI 10.1128/MCB.01541-09; BIRNEY E, 1993, NUCLEIC ACIDS RES, V21, P5803, DOI 10.1093/nar/21.25.5803; Bourbon HM, 2004, MOL CELL, V14, P553, DOI 10.1016/j.molcel.2004.05.011; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; Deng WS, 2007, CHROMOSOMA, V116, P417, DOI 10.1007/s00412-007-0113-9; Dieci G, 2003, TRENDS BIOCHEM SCI, V28, P202, DOI 10.1016/S0968-0004(03)00054-9; Donner AJ, 2010, NAT STRUCT MOL BIOL, V17, P194, DOI 10.1038/nsmb.1752; Elmlund H, 2006, P NATL ACAD SCI USA, V103, P15788, DOI 10.1073/pnas.0607483103; Fukuda A, 2004, MOL CELL BIOL, V24, P6525, DOI 10.1128/MCB.24.14.6525-6535.2004; Fukuda A, 2001, GENES CELLS, V6, P707, DOI 10.1046/j.1365-2443.2001.00456.x; Fukuda A, 2009, J BIOL CHEM, V284, P23472, DOI 10.1074/jbc.M109.013656; Furumoto T, 2007, GENES CELLS, V12, P119, DOI 10.1111/j.1365-2443.2007.01036.x; HAWLEY DK, 1985, J BIOL CHEM, V260, P8163; Hengartner CJ, 1998, MOL CELL, V2, P43, DOI 10.1016/S1097-2765(00)80112-4; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; Huang J, 2008, CELL MOL BIOL LETT, V13, P303, DOI 10.2478/s11658-008-0002-0; Iyer V, 1996, P NATL ACAD SCI USA, V93, P5208, DOI 10.1073/pnas.93.11.5208; Jackson DA, 2000, FASEB J, V14, P242, DOI 10.1096/fasebj.14.2.242; Jackson DA, 1998, MOL BIOL CELL, V9, P1523, DOI 10.1091/mbc.9.6.1523; JANKNECHT R, 1995, CARCINOGENESIS, V16, P443, DOI 10.1093/carcin/16.3.443; JIANG Y, 1993, MOL CELL BIOL, V13, P4572, DOI 10.1128/MCB.13.8.4572; Kimura H, 2002, J CELL BIOL, V159, P777, DOI 10.1083/jcb.200206019; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Liu Y, 2004, MOL CELL BIOL, V24, P1721, DOI 10.1128/MCB.24.4.1721-1735.2004; Malik S, 2005, MOL CELL BIOL, V25, P2117, DOI 10.1128/MCB.25.6.2117-2129.2005; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; OBRIEN T, 1993, MOL CELL BIOL, V13, P3456, DOI 10.1128/MCB.13.6.3456; OBRIEN T, 1991, MOL CELL BIOL, V11, P5285, DOI 10.1128/MCB.11.10.5285; OSHEIM YN, 1989, METHOD ENZYMOL, V180, P481; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; Price DH, 2008, MOL CELL, V30, P7, DOI 10.1016/j.molcel.2008.03.001; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; SZENTIRMAY MN, 1994, NUCLEIC ACIDS RES, V22, P5341, DOI 10.1093/nar/22.24.5341; SZENTIRMAY MN, 1993, EMBO J, V12, P4677, DOI 10.1002/j.1460-2075.1993.tb06156.x; SZENTIRMAY MN, 1991, P NATL ACAD SCI USA, V88, P10691, DOI 10.1073/pnas.88.23.10691; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; Yudkovsky N, 2000, NATURE, V408, P225, DOI 10.1038/35041603	50	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e72496	10.1371/journal.pone.0072496	http://dx.doi.org/10.1371/journal.pone.0072496			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967313	gold, Green Published, Green Submitted			2022-12-25	WOS:000323115800106
J	Kang, HJ; Chun, SM; Kim, KR; Sohn, I; Sung, CO				Kang, Hyo Jeong; Chun, Sung-Min; Kim, Kyu-Rae; Sohn, Insuk; Sung, Chang Ohk			Clinical Relevance of Gain-Of-Function Mutations of p53 in High-Grade Serous Ovarian Carcinoma	PLOS ONE			English	Article							MOUSE MODEL; MUTANTS; PHENOTYPE; COMPLEX; TP53; PTEN	Purpose: Inactivation of TP53, which occurs predominantly by missense mutations in exons 4-9, is a major genetic alteration in a subset of human cancer. In spite of growing evidence that gain-of-function (GOF) mutations of p53 also have oncogenic activity, little is known about the clinical relevance of these mutations. Methods: The clinicopathological features of high-grade serous ovarian carcinoma (HGS-OvCa) patients with GOF p53 mutations were evaluated according to a comprehensive somatic mutation profile comprised of whole exome sequencing, mRNA expression, and protein expression profiles obtained from the Cancer Genome Atlas (TCGA). Results: Patients with a mutant p53 protein (mutp53) with a GOF mutation showed higher p53 mRNA and protein expression levels than patients with p53 mutation with no evidence of GOF (NE-GOF). GOF mutations were more likely to occur within mutational hotspots, and at CpG sites, and resulted in mutp53 with higher functional severity (FS) scores. Clinically, patients with GOF mutations showed a higher frequency of platinum resistance (22/58, 37.9%) than patients with NE-GOF mutations (12/56, 21.4%) (p=0.054). Furthermore, patients with GOF mutations were more likely to develop distant metastasis (36/55, 65.5%) than local recurrence (19/55, 34.5%), whereas patients with NE-GOF mutations showed a higher frequency of locoregional recurrence (26/47, 55.3%) than distant metastasis (21/47, 44.7%) (p=0.035). There were no differences in overall or progression-free survival between patients with GOF or NE-GOF mutp53. Conclusion: This study demonstrates that patient with GOF mutp53 is characterized by a greater likelihood of platinum treatment resistance and distant metastatic properties in HGS-OvCa.	[Kang, Hyo Jeong; Chun, Sung-Min; Kim, Kyu-Rae; Sung, Chang Ohk] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea; [Chun, Sung-Min] Univ Ulsan, Coll Med, Asan Med Ctr, ASAN Ctr Canc Genome Discovery, Seoul, South Korea; [Sohn, Insuk] Samsung Canc Res Inst, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Sung, CO (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea.	co.sung@amc.seoul.kr		Sung, Chang Ohk/0000-0002-8567-456X; Chun, Sung-Min/0000-0002-3357-1382	Asan Institute for Life Sciences, Seoul, Korea [2013-550]	Asan Institute for Life Sciences, Seoul, Korea	This study was supported by a grant (2013-550) from the Asan Institute for Life Sciences, Seoul, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Ahmed AA, 2010, J PATHOL, V221, P49, DOI 10.1002/path.2696; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Blandino G, 1999, ONCOGENE, V18, P477, DOI 10.1038/sj.onc.1202314; Bookman MA, 2003, J CLIN ONCOL, V21, P283, DOI 10.1200/JCO.2003.10.104; Bowtell DDL, 2010, NAT REV CANCER, V10, P803, DOI 10.1038/nrc2946; Carlsson J, 2009, FEBS J, V276, P4142, DOI 10.1111/j.1742-4658.2009.07124.x; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Doyle B, 2010, J PATHOL, V222, P129, DOI 10.1002/path.2748; Heinlein C, 2008, INT J CANCER, V122, P1701, DOI 10.1002/ijc.23317; Kogan-Sakin I, 2011, CELL DEATH DIFFER, V18, P271, DOI 10.1038/cdd.2010.94; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Li YQ, 2008, CANCER RES, V68, P1723, DOI 10.1158/0008-5472.CAN-07-1963; Liu G, 2000, P NATL ACAD SCI USA, V97, P4174, DOI 10.1073/pnas.97.8.4174; Miller DS, 2009, J CLIN ONCOL, V27, P2686, DOI 10.1200/JCO.2008.19.2963; Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107; Muench P, 2010, CANCER RES, V70, P6913, DOI 10.1158/0008-5472.CAN-10-1307; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Muller PAJ, 2011, J CELL BIOL, V192, P209, DOI 10.1083/jcb.201009059; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Persad S, 2001, J CELL BIOL, V153, P1161, DOI 10.1083/jcb.153.6.1161; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Rivlin Noa, 2011, Genes Cancer, V2, P466, DOI 10.1177/1947601911408889; Sabatier R, 2009, CRIT REV ONCOL HEMAT, V72, P98, DOI 10.1016/j.critrevonc.2009.01.007; Simon R, 2007, CANCER INFORM, V3, P11; Sohn I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054089; Sohn I, 2012, GYNECOL ONCOL, V126, P103, DOI 10.1016/j.ygyno.2012.03.050; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang SP, 2009, NAT CELL BIOL, V11, P694, DOI 10.1038/ncb1875; Wojnarowicz PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045484	32	48	51	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e72609	10.1371/journal.pone.0072609	http://dx.doi.org/10.1371/journal.pone.0072609			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967324	gold, Green Published, Green Submitted			2022-12-25	WOS:000323115800110
J	Manzano-Winkler, B; McGaugh, SE; Noor, MAF				Manzano-Winkler, Brenda; McGaugh, Suzanne E.; Noor, Mohamed A. F.			How Hot Are Drosophila Hotspots? Examining Recombination Rate Variation and Associations with Nucleotide Diversity, Divergence, and Maternal Age in Drosophila pseudoobscura	PLOS ONE			English	Article							MEIOTIC RECOMBINATION; CROSSOVER RATE; ROSY LOCUS; SCALE; GENOME; MAP; TEMPERATURE; LINKAGE; GENE; HETEROGENEITY	Fine scale meiotic recombination maps have uncovered a large amount of variation in crossover rate across the genomes of many species, and such variation in mammalian and yeast genomes is concentrated to <5 kb regions of highly elevated recombination rates (10-100x the background rate) called "hotspots." Drosophila exhibit substantial recombination rate heterogeneity across their genome, but evidence for these highly-localized hotspots is lacking. We assayed recombination across a 40 Kb region of Drosophila pseudoobscura chromosome 2, with one 20 kb interval assayed every 5 Kb and the adjacent 20 kb interval bisected into 10 kb pieces. We found that recombination events across the 40 kb stretch were relatively evenly distributed across each of the 5 kb and 10 kb intervals, rather than concentrated in a single 5 kb region. This, in combination with other recent work, indicates that the recombination landscape of Drosophila may differ from the punctate recombination pattern observed in many mammals and yeast. Additionally, we found no correlation of average pairwise nucleotide diversity and divergence with recombination rate across the 20 kb intervals, nor any effect of maternal age in weeks on recombination rate in our sample.	[Manzano-Winkler, Brenda; McGaugh, Suzanne E.; Noor, Mohamed A. F.] Duke Univ, Dept Biol, Durham, NC 27706 USA; [McGaugh, Suzanne E.] Washington Univ, Genome Inst, St Louis, MO USA	Duke University; Washington University (WUSTL)	Noor, MAF (corresponding author), Duke Univ, Dept Biol, Durham, NC 27706 USA.	noor@duke.edu		Noor, Mohamed/0000-0002-5400-4408	National Institutes of Health (NIH) [GM076051, GM086445, GM092501]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076051, RC2GM092501, R01GM086445] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this research was provided by National Institutes of Health (NIH) grants GM076051, GM086445 and GM092501. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquadro CF, 2001, CURR OPIN GENET DEV, V11, P627, DOI 10.1016/S0959-437X(00)00245-8; Auton A, 2012, SCIENCE, V336, P193, DOI 10.1126/science.1216872; Axelsson E, 2012, GENOME RES, V22, P51, DOI 10.1101/gr.124123.111; Backstrom N, 2010, GENOME RES, V20, P485, DOI 10.1101/gr.101410.109; Bessoltane N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036229; Bridges C. B., 1929, CARNEGIE I WASH PUBL, V399, P63; Brunschwig H, 2012, GENETICS, V191, P757, DOI 10.1534/genetics.112.141036; Chan AH, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003090; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Cirulli ET, 2007, J MOL EVOL, V64, P129, DOI 10.1007/s00239-006-0142-7; CLARK SH, 1988, GENETICS, V118, P261; Comeron JM, 1999, GENETICS, V151, P239; Comeron JM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002905; Coop G, 2007, NAT REV GENET, V8, P23, DOI 10.1038/nrg1947; D'Avila MF, 2010, GENETICA, V138, P907, DOI 10.1007/s10709-010-9473-9; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Giraut L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002354; Gloor G. B., 1992, DROSOPHILA INFORMATI, V71, P148; Groenen MAM, 2009, GENOME RES, V19, P510, DOI 10.1101/gr.086538.108; Heil CSS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045055; Hey J, 2004, PLOS BIOL, V2, P730, DOI 10.1371/journal.pbio.0020190; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; HILLIKER AJ, 1991, GENETICS, V129, P779; Hussin J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002251; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Langley CH, 2000, GENETICS, V156, P1837; Lichten M, 1995, ANNU REV GENET, V29, P423, DOI 10.1146/annurev.ge.29.120195.002231; Lim JGY, 2008, GENETICS, V180, P715, DOI 10.1534/genetics.108.090142; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Marhold J, 2004, INSECT MOL BIOL, V13, P117, DOI 10.1111/j.0962-1075.2004.00466.x; McGaugh SE, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001422; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Nachman MW, 2002, CURR OPIN GENET DEV, V12, P657, DOI 10.1016/S0959-437X(02)00358-1; Niehuis O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008597; Noor MAF, 2009, HEREDITY, V103, P439, DOI 10.1038/hdy.2009.151; Noor MAF, 2001, GENETICS, V159, P581; Ortiz-Barrientos D, 2006, GENET RES, V87, P23, DOI 10.1017/S0016672306007932; Paape T, 2012, GENOME BIOL EVOL, V4, P726, DOI 10.1093/gbe/evs046; Paigen K, 2010, NAT REV GENET, V11, P221, DOI 10.1038/nrg2712; Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; Radford SJ, 2007, GENETICS, V176, P53, DOI 10.1534/genetics.107.070367; REDFIELD H, 1966, GENETICS, V53, P593; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roesti M, 2013, MOL ECOL, V22, P3014, DOI 10.1111/mec.12322; ROSE AM, 1979, GENETICS, V92, P409; Sandor C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002854; Singh ND, 2013, GENETICS, V194, P375, DOI 10.1534/genetics.112.146746; Singh ND, 2009, J MOL EVOL, V69, P42, DOI 10.1007/s00239-009-9250-5; Smukowski CS, 2011, HEREDITY, V107, P496, DOI 10.1038/hdy.2011.44; Spencer CCA, 2006, PLOS GENET, V2, P1375, DOI 10.1371/journal.pgen.0020148; Stern C, 1926, P NATL ACAD SCI USA, V12, P530, DOI 10.1073/pnas.12.8.530; Stevison LS, 2010, J MOL EVOL, V71, P332, DOI 10.1007/s00239-010-9388-1; Tedman-Aucoin K, 2012, EVOLUTION, V66, P575, DOI 10.1111/j.1558-5646.2011.01450.x; Tortereau F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-586; Tsai IJ, 2010, P NATL ACAD SCI USA, V107, P7847, DOI 10.1073/pnas.0908774107; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322	62	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71582	10.1371/journal.pone.0071582	http://dx.doi.org/10.1371/journal.pone.0071582			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967224	Green Published, gold, Green Submitted			2022-12-25	WOS:000323115800067
J	Oguz, I; Yaxley, R; Budin, F; Hoogstoel, M; Lee, J; Maltbie, E; Liu, W; Crews, FT				Oguz, Ipek; Yaxley, Richard; Budin, Francois; Hoogstoel, Marion; Lee, Joohwi; Maltbie, Eric; Liu, Wen; Crews, Fulton T.			Comparison of Magnetic Resonance Imaging in Live vs. Post Mortem Rat Brains	PLOS ONE			English	Article								Magnetic Resonance Imaging (MRI) is an increasingly popular technique for examining neurobiology in rodents because it is both noninvasive and nondestructive. MRI scans can be acquired from either live or post mortem specimens. In vivo scans have a key advantage in that subjects can be scanned at multiple time-points in longitudinal studies. However, repeated exposure to anesthesia and stress may confound studies. In contrast, post mortem scans offer improved image quality and increased signal-to-noise ratio (SNR) due to several key advantages: First, the images are not disrupted by motion and pulsation artifacts. Second, they allow the brain tissue to be perfused with contrast agents, enhancing tissue contrast. Third, they allow longer image acquisition times, yielding higher resolution and/or improved SNR. Fourth, they allow assessment of groups of animals at the same age without scheduling complications. Despite these advantages, researchers are often skeptical of post mortem MRI scans because of uncertainty about whether the fixation process alters the MRI measurements. To address these concerns, we present a thorough comparative study of in vivo and post mortem MRI scans in healthy male Wistar rats at three age points throughout adolescence (postnatal days 28 through 80). For each subject, an in vivo scan was acquired, followed by perfusion and two post mortem scans at two different MRI facilities. The goal was to assess robustness of measurements, to detect any changes in volumetric measurements after fixation, and to investigate any differential bias that may exist between image acquisition techniques. We present this volumetric analysis for comparison of 22 anatomical structures between in vivo and post mortem scans. No significant changes in volumetric measurements were detected; however, as hypothesized, the image quality is dramatically improved in post mortem scans. These findings illustrate the validity and utility of using post mortem scans in volumetric neurobiological studies.	[Oguz, Ipek; Yaxley, Richard; Budin, Francois; Hoogstoel, Marion; Maltbie, Eric] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27515 USA; [Oguz, Ipek; Lee, Joohwi] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC USA; [Liu, Wen; Crews, Fulton T.] Univ N Carolina, Bowles Ctr Alcohol Studies, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Oguz, I (corresponding author), Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27515 USA.	ipek@cs.unc.edu	Crews, Fulton/T-1181-2019	Crews, Fulton/0000-0003-2393-4976; Maltbie, Eric/0000-0003-2489-9674; Yaxley, Richard/0000-0002-8894-4852	NADIA Consortium (Neurobiology of Adolescent Drinking in Adulthood) [U01-AA020022, U01-AA020023, U01-AA020024]; UNC Bowles Alcohol Center; UNC IDDRC Core [P30-HD03110];  [R41-NS059095];  [RC1-AA019211]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R41NS059095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U24AA020022, U24AA020024, P60AA011605, U01AA020023, RC1AA019211] Funding Source: NIH RePORTER	NADIA Consortium (Neurobiology of Adolescent Drinking in Adulthood); UNC Bowles Alcohol Center; UNC IDDRC Core; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work is funded by NADIA Consortium (Neurobiology of Adolescent Drinking in Adulthood, U01-AA020022, U01-AA020023, U01-AA020024), UNC Bowles Alcohol Center, UNC IDDRC Core (P30-HD03110), R41-NS059095 and RC1-AA019211. The higher resolution (50 micron) ex vivo images (site 2) were acquired at the Duke Center for In Vivo Microscopy, an NIBIB Biomedical Technology Resource Center (NIBIB 8P41EB015897-23). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bissette G, 2009, J ALZHEIMERS DIS, V18, P371, DOI 10.3233/JAD-2009-1171; Buynitsky T, 2009, NEUROSCI BIOBEHAV R, V33, P1089, DOI 10.1016/j.neubiorev.2009.05.004; Firbank MJ, 1999, PHYS MED BIOL, V44, pN261, DOI 10.1088/0031-9155/44/12/403; Isgor C, 2004, HIPPOCAMPUS, V14, P636, DOI 10.1002/hipo.10207; Johnson GA, 2002, RADIOLOGY, V222, P789, DOI 10.1148/radiol.2223010531; Joshi S, 2004, NEUROIMAGE, V23, pS151, DOI 10.1016/j.neuroimage.2004.07.068; Kim JH, 2007, NMR BIOMED, V20, P352, DOI 10.1002/nbm.1138; Lee J, 2009, P SOC PHOTO-OPT INS, V7259; LEE J, 2011, PROC SPIE, V7962, DOI DOI 10.1117/12.878305; Lee T, 2009, NEUROREPORT, V20, P1554, DOI 10.1097/WNR.0b013e328332bb09; Lerch JP, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00006; Ma Y, 2008, FRONT NEUROANAT, V2, DOI 10.3389/neuro.05.001.2008; Oguz I, 2011, P SOC PHOTO-OPT INST, V7962; Petiet A, 2010, METHODS MOL BIOL, V611, P141, DOI 10.1007/978-1-60327-345-9_11; Scheuer DA, 2010, EXP PHYSIOL, V95, P26, DOI 10.1113/expphysiol.2008.045971; Schulz G, 2011, J NEUROSCI METH, V202, P17, DOI 10.1016/j.jneumeth.2011.08.031; Shalev U, 2010, BRAIN RES, V1314, P15, DOI 10.1016/j.brainres.2009.07.028; Sun SW, 2009, NEUROIMAGE, V44, P611, DOI 10.1016/j.neuroimage.2008.10.032; Sun SW, 2003, MAGN RESON MED, V50, P743, DOI 10.1002/mrm.10605; Vestergaard-Poulsen P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020653	20	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71027	10.1371/journal.pone.0071027	http://dx.doi.org/10.1371/journal.pone.0071027			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967148	gold, Green Published, Green Submitted			2022-12-25	WOS:000323115800032
J	Staubach, F; Baines, JF; Kunzel, S; Bik, EM; Petrov, DA				Staubach, Fabian; Baines, John F.; Kuenzel, Sven; Bik, Elisabeth M.; Petrov, Dmitri A.			Host Species and Environmental Effects on Bacterial Communities Associated with Drosophila in the Laboratory and in the Natural Environment	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; GUT; MELANOGASTER; HOMEOSTASIS; SYMBIONTS; COLONIZATION; PROVIDENCIA; RESISTANCE; DIVERSITY; EVOLUTION	The fruit fly Drosophila is a classic model organism to study adaptation as well as the relationship between genetic variation and phenotypes. Although associated bacterial communities might be important for many aspects of Drosophila biology, knowledge about their diversity, composition, and factors shaping them is limited. We used 454-based sequencing of a variable region of the bacterial 16S ribosomal RNA gene to characterize the bacterial communities associated with wild and laboratory Drosophila isolates. In order to specifically investigate effects of food source and host species on bacterial communities, we analyzed samples from wild Drosophila melanogaster and D. simulans collected from a variety of natural substrates, as well as from adults and larvae of nine laboratory-reared Drosophila species. We find no evidence for host species effects in lab-reared flies; instead, lab of origin and stochastic effects, which could influence studies of Drosophila phenotypes, are pronounced. In contrast, the natural Drosophila-associated microbiota appears to be predominantly shaped by food substrate with an additional but smaller effect of host species identity. We identify a core member of this natural microbiota that belongs to the genus Gluconobacter and is common to all wild-caught flies in this study, but absent from the laboratory. This makes it a strong candidate for being part of what could be a natural D. melanogaster and D. simulans core microbiome. Furthermore, we were able to identify candidate pathogens in natural fly isolates.	[Staubach, Fabian; Petrov, Dmitri A.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Baines, John F.; Kuenzel, Sven] Max Planck Inst Evolutionary Biol, Plon, Germany; [Bik, Elisabeth M.] Stanford Sch Med, Dept Microbiol & Immunol, Stanford, CA USA	Stanford University; Max Planck Society; Stanford University	Staubach, F (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	fabians@stanford.edu	Bik, Elisabeth M/A-1204-2007; Baines, John F/B-3580-2010	Bik, Elisabeth M/0000-0001-5477-0324; Baines, John F/0000-0002-8132-4909; Petrov, Dmitri/0000-0002-3664-9130	DFG Forschungsstipedium [STA 1154/1-1]; NIH [RO1GM100366, RO1GM097415]; Excellence Cluster Inflammation at Interfaces; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100366, R01GM097415] Funding Source: NIH RePORTER	DFG Forschungsstipedium(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Excellence Cluster Inflammation at Interfaces; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a DFG Forschungsstipedium to FS (STA 1154/1-1). NIH grants RO1GM100366 and RO1GM097415 to DAP; and the Excellence Cluster Inflammation at Interfaces(JFB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Auld RR, 2013, J MICROBIOL METH, V93, P108, DOI 10.1016/j.mimet.2013.01.023; BAKULA M, 1969, J INVERTEBR PATHOL, V14, P365, DOI 10.1016/0022-2011(69)90163-3; Barata A, 2012, MICROB ECOL, V64, P416, DOI 10.1007/s00248-012-0041-y; Broderick NA, 2012, GUT MICROBES, V3, P307, DOI 10.4161/gmic.19896; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Corby-Harris V, 2007, APPL ENVIRON MICROB, V73, P3470, DOI 10.1128/AEM.02120-06; Cox CR, 2007, INFECT IMMUN, V75, P1565, DOI 10.1128/IAI.01496-06; Crotti E, 2010, APPL ENVIRON MICROB, V76, P6963, DOI 10.1128/AEM.01336-10; DABBAH R, 1970, APPL MICROBIOL, V19, P27, DOI 10.1128/AEM.19.1.27-31.1970; Deppenmeier U, 2002, APPL MICROBIOL BIOT, V60, P233, DOI 10.1007/s00253-002-1114-5; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Erkosar B, 2013, CELL HOST MICROBE, V13, P8, DOI 10.1016/j.chom.2012.12.004; Ferrari J, 2011, PHILOS T R SOC B, V366, P1389, DOI 10.1098/rstb.2010.0226; Fraune S, 2009, ENVIRON MICROBIOL, V11, P2361, DOI 10.1111/j.1462-2920.2009.01963.x; Galac MR, 2011, MICROBES INFECT, V13, P673, DOI 10.1016/j.micinf.2011.02.005; Hubbell Stephen P., 2001, V32, pi; Hurst GDD, 2000, GENETICS, V156, P699; Juneja P, 2009, INT J SYST EVOL MICR, V59, P1108, DOI 10.1099/ijs.0.000117-0; Kaiser W, 2010, P ROY SOC B-BIOL SCI, V277, P2311, DOI 10.1098/rspb.2010.0214; Kaltenpoth M, 2005, CURR BIOL, V15, P475, DOI 10.1016/j.cub.2004.12.084; Krause DO, 2003, FEMS MICROBIOL REV, V27, P663, DOI 10.1016/S0168-6445(03)00072-X; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lazzaro BP, 2004, SCIENCE, V303, P1873, DOI 10.1126/science.1092447; Lazzaro BP, 2006, GENETICS, V174, P1539, DOI 10.1534/genetics.105.054593; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lhocine N, 2008, CELL HOST MICROBE, V4, P147, DOI 10.1016/j.chom.2008.07.004; Linderman JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041907; McFall-Ngai M, 2012, SEMIN IMMUNOL, V24, P3, DOI 10.1016/j.smim.2011.11.006; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Nunney L, 1996, OECOLOGIA, V108, P552, DOI 10.1007/BF00333733; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Ochman H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000546; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Peay KG, 2012, P ROY SOC B-BIOL SCI, V279, P749, DOI 10.1098/rspb.2011.1230; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rao RS, 2008, LETT APPL MICROBIOL, V47, P19, DOI 10.1111/j.1472-765X.2008.02380.x; Ravussin Y, 2011, OBESITY SILVER SPRIN, V20, P738, DOI 10.1038/oby.2011.111; Ren C, 2007, CELL METAB, V6, P144, DOI 10.1016/j.cmet.2007.06.006; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sharon G, 2010, P NATL ACAD SCI USA, V107, P20051, DOI 10.1073/pnas.1009906107; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Staubach F, 2012, ISME J, V6, P1345, DOI 10.1038/ismej.2011.204; Stensmyr MC, 2012, CELL, V151, P1345, DOI 10.1016/j.cell.2012.09.046; Storelli G, 2011, CELL METAB, V14, P403, DOI 10.1016/j.cmet.2011.07.012; TSIROPOULOS GJ, 1983, Z ANGEW ENTOMOL, V96, P337; Vellend M, 2010, Q REV BIOL, V85, P183, DOI 10.1086/652373; Vos P., 2009, BERGEYS MANUAL SYSTE; Wong CNA, 2011, ENVIRON MICROBIOL, V13, P1889, DOI 10.1111/j.1462-2920.2011.02511.x; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Young TP, 2001, ECOL RESTOR, V19, P5, DOI [10.3368/er.19.1.5, DOI 10.3368/ER.19.1.5]	59	145	154	3	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e70749	10.1371/journal.pone.0070749	http://dx.doi.org/10.1371/journal.pone.0070749			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967097	Green Submitted, gold, Green Published			2022-12-25	WOS:000323115800019
J	Heidari, B; Nemie-Feyissa, D; Kangasjarvi, S; Lillo, C				Heidari, Behzad; Nemie-Feyissa, Dugassa; Kangasjarvi, Saijaliisa; Lillo, Cathrine			Antagonistic Regulation of Flowering Time through Distinct Regulatory Subunits of Protein Phosphatase 2A	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; FLORAL-INDUCTION; GIBBERELLIN; PATHWAYS; LIGHT; TRANSCRIPTION; GENE; PHOSPHORYLATION; REDUCTASE; INTERACT	Protein phosphatase 2A (PP2A) consists of three types of subunits: a catalytic (C), a scaffolding (A), and a regulatory (B) subunit. In Arabidopsis thaliana and other organisms the regulatory B subunits are divided into at least three non-related groups, B55, B' and B ''. Flowering time in plants mutated in B55 or B' genes were investigated in this work. The PP2A-b55 alpha and PP2A-b55 beta (knockout) lines showed earlier flowering than WT, whereas a PP2A-b'gamma (knockdown) line showed late flowering. Average advancements of flowering in PP2A-b55 mutants were 3.4 days in continuous light, 6.6 days in 12 h days, and 8.2 days in 8 h days. Average delays in the PP2A-b'gamma mutant line were 7.1 days in 16 h days and 4.7 days in 8 h days. Expression of marker genes of genetically distinct flowering pathways (CO, FLC, MYB33, SPL3), and the floral integrator (FT, SOC1) were tested in WT, pp2a mutants, and two known flowering time mutants elf6 and edm2. The results are compatible with B55 acting at and/or downstream of the floral integrator, in a non-identified pathway. B'. was involved in repression of FLC, the main flowering repressor gene. For B'gamma the results are consistent with the subunit being a component in the major autonomous flowering pathway. In conclusion PP2A is both a positive and negative regulator of flowering time, depending on the type of regulatory subunit involved.	[Heidari, Behzad; Nemie-Feyissa, Dugassa; Lillo, Cathrine] Univ Stavanger, Ctr Organelle Res, Fac Sci & Technol, Stavanger, Norway; [Kangasjarvi, Saijaliisa] Univ Turku, Dept Biochem & Food Chem, FIN-20014 Turku, Finland	Universitetet i Stavanger; University of Turku	Lillo, C (corresponding author), Univ Stavanger, Ctr Organelle Res, Fac Sci & Technol, Stavanger, Norway.	Cathrine.lillo@uis.no	Ahootapeh, Behzad Heidari/R-3074-2018; Kangasjärvi, Saijaliisa/H-9013-2013	Kangasjärvi, Saijaliisa/0000-0002-7605-8546; Lillo, Cathrine/0000-0002-8470-8983; Nemie-Feyissa, Dugassa/0000-0002-9281-7119	Norwegian Research Council (NFR) [213853/F20]	Norwegian Research Council (NFR)(Research Council of Norway)	This work was supported by the Norwegian Research Council (NFR) grant 213853/F20 to CL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2004, DEVELOPMENT, V131, P3357, DOI 10.1242/dev.01206; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; Andersen CH, 2004, TRENDS PLANT SCI, V9, P105, DOI 10.1016/j.tplants.2004.01.002; Camilleri C, 2002, PLANT CELL, V14, P833, DOI 10.1105/tpc.010402; Corbesier L, 2006, J EXP BOT, V57, P3395, DOI 10.1093/jxb/erl095; de Boer AH, 2012, PROTOPLASMA; Farkas I, 2007, TRENDS PLANT SCI, V12, P169, DOI 10.1016/j.tplants.2007.03.003; Feyissa DN, 2009, PLANTA, V230, P747, DOI 10.1007/s00425-009-0978-3; Fornara F, 2010, CELL, V141, DOI 10.1016/j.cell.2010.04.024; Glover B.J., 2007, UNDERSTANDING FLOWER; Gocal GFW, 2001, PLANT PHYSIOL, V127, P1682, DOI 10.1104/pp.010442; Heidari B, 2011, PLANT PHYSIOL, V156, P165, DOI 10.1104/pp.111.172734; Higgins JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010065; Izawa T, 2003, CURR OPIN PLANT BIOL, V6, P113, DOI 10.1016/S1369-5266(03)00014-1; Jeong JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008033; Jonassen EM, 2011, PLANT SIGNAL BEHAV, V6, P1216, DOI 10.4161/psb.6.8.16180; Kerk D, 2008, PLANT PHYSIOL, V146, P351, DOI 10.1104/pp.107.111393; Kim DH, 2002, PLANT CELL, V14, P3043, DOI 10.1105/tpc.005306; Kusakina J, 2012, TRENDS PLANT SCI, V17, P575, DOI 10.1016/j.tplants.2012.06.008; Leivar P, 2011, PLANT CELL, V23, P1494, DOI 10.1105/tpc.110.074278; Li JH, 2010, J EXP BOT, V61, P4221, DOI 10.1093/jxb/erq241; Marin IC, 2011, PLANTA, V233, P539, DOI 10.1007/s00425-010-1316-5; Matre P, 2009, PLANTA, V230, P935, DOI 10.1007/s00425-009-0998-z; Moorhead GBG, 2009, BIOCHEM J, V417, P401, DOI 10.1042/BJ20081986; Mulekar JJ, 2012, PLANT J, V69, P343, DOI 10.1111/j.1365-313X.2011.04794.x; Mutasa-Gottgens E, 2009, J EXP BOT, V60, P1979, DOI 10.1093/jxb/erp040; Noh B, 2004, PLANT CELL, V16, P2601, DOI 10.1105/tpc.104.025353; Robertson M, 2008, PLANT CELL PHYSIOL, V49, P1859, DOI 10.1093/pcp/pcn167; Salome PA, 2011, GENETICS, V188, P421, DOI 10.1534/genetics.111.126607; Sents W, 2013, FEBS J, V280, P644, DOI 10.1111/j.1742-4658.2012.08579.x; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Shalitin D, 2003, PLANT CELL, V15, P2421, DOI 10.1105/tpc.013011; Tang WQ, 2011, NAT CELL BIOL, V13, P124, DOI 10.1038/ncb2151; Taoka K, 2011, NATURE, V476, P332, DOI 10.1038/nature10272; Tran HT, 2012, PLANT J, V71, P263, DOI 10.1111/j.1365-313X.2012.04984.x; Trotta A, 2011, PLANT SIGNAL BEHAV, V6, P1665, DOI 10.4161/psb.6.11.17829; Trotta A, 2011, PLANT PHYSIOL, V156, P1464, DOI 10.1104/pp.111.178442; Tsai AYL, 2012, PLANT J, V69, P809, DOI 10.1111/j.1365-313X.2011.04832.x; Tsuchiya T, 2010, PLANT J, V62, P518, DOI 10.1111/j.1365-313X.2010.04169.x; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Yang L, 2011, DEVELOPMENT, V138, P245, DOI 10.1242/dev.058578	42	20	23	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e67987	10.1371/journal.pone.0067987	http://dx.doi.org/10.1371/journal.pone.0067987			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23976921	Green Published, gold, Green Submitted			2022-12-25	WOS:000322838900006
J	Tao, RY; Xiong, XW; DePinho, RA; Deng, CX; Dong, XC				Tao, Rongya; Xiong, Xiwen; DePinho, Ronald A.; Deng, Chu-Xia; Dong, X. Charlie			FoxO3 Transcription Factor and Sirt6 Deacetylase Regulate Low Density Lipoprotein (LDL)-cholesterol Homeostasis via Control of the Proprotein Convertase Subtilisin/Kexin Type 9 (Pcsk9) Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA; MONOCLONAL-ANTIBODY; HUMAN LONGEVITY; CHOLESTEROL-BIOSYNTHESIS; RECEPTOR EXPRESSION; RANDOMIZED-TRIAL; LDL CHOLESTEROL; HEPATIC PCSK9; DOUBLE-BLIND; HEPG2 CELLS	Elevated LDL-cholesterol is a risk factor for the development of cardiovascular disease. Thus, proper control of LDL-cholesterol homeostasis is critical for organismal health. Genetic analysis has identified PCSK9 (proprotein convertase subtilisin/kexin type 9) as a crucial gene in the regulation of LDL-cholesterol via control of LDL receptor degradation. Although biochemical characteristics and clinical implications of PCSK9 have been extensively investigated, epigenetic regulation of this gene is largely unknown. In this work we have discovered that Sirt6, an NAD(+)-dependent histone deacetylase, plays a critical role in the regulation of the Pcsk9 gene expression in mice. Hepatic Sirt6 deficiency leads to elevated Pcsk9 gene expression and LDL-cholesterol as well. Mechanistically, we have demonstrated that Sirt6 can be recruited by forkhead transcription factor FoxO3 to the proximal promoter region of the Pcsk9 gene and deacetylates histone H3 at lysines 9 and 56, thereby suppressing the gene expression. Also remarkably, overexpression of Sirt6 in high fat diet-fed mice lowers LDL-cholesterol. Overall, our data suggest that FoxO3 and Sirt6, two longevity genes, can reduce LDL-cholesterol levels through regulation of the Pcsk9 gene.	[Tao, Rongya; Xiong, Xiwen; Dong, X. Charlie] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [DePinho, Ronald A.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Deng, Chu-Xia] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA	Indiana University System; Indiana University Bloomington; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Dong, XC (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr,MS1021D, Indianapolis, IN 46202 USA.	xcdong@iu.edu	deng, chuxia/N-6713-2016; tao, rongya/B-8042-2014; Xiong, Xiwen/GSN-0686-2022	tao, rongya/0000-0002-3316-5587; DePinho, Ronald/0000-0002-5625-577X	National Institutes of Health (NIDDK) [R00DK077505, R01DK091592]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091592, R00DK077505] Funding Source: NIH RePORTER	National Institutes of Health (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R00DK077505 and R01DK091592 (NIDDK; to X.C.D.).	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Ai D, 2012, J CLIN INVEST, V122, P1262, DOI 10.1172/JCI61919; Anselmi CV, 2009, REJUV RES, V12, P95, DOI 10.1089/rej.2008.0827; Browning JD, 2010, J LIPID RES, V51, P3359, DOI 10.1194/jlr.P009860; Bulbulia R, 2012, CURR OPIN LIPIDOL, V23, P265, DOI 10.1097/MOL.0b013e3283556c1b; Cameron J, 2008, ATHEROSCLEROSIS, V201, P266, DOI 10.1016/j.atherosclerosis.2008.02.004; Cao AQ, 2011, J LIPID RES, V52, P518, DOI 10.1194/jlr.M010603; Costet P, 2006, J BIOL CHEM, V281, P6211, DOI 10.1074/jbc.M508582200; Denis M, 2012, CIRCULATION, V125, P894, DOI 10.1161/CIRCULATIONAHA.111.057406; Dias CS, 2012, J AM COLL CARDIOL, V60, P1888, DOI 10.1016/j.jacc.2012.08.986; Dominy JE, 2012, MOL CELL, V48, P900, DOI 10.1016/j.molcel.2012.09.030; Dong B, 2010, J LIPID RES, V51, P1486, DOI 10.1194/jlr.M003566; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Duan YJ, 2012, J BIOL CHEM, V287, P23667, DOI 10.1074/jbc.M112.350181; Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106; Giugliano RP, 2012, LANCET, V380, P2007, DOI 10.1016/S0140-6736(12)61770-X; Jeong HJ, 2008, J LIPID RES, V49, P399, DOI 10.1194/jlr.M700443-JLR200; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Kanfi Y, 2010, AGING CELL, V9, P162, DOI 10.1111/j.1474-9726.2009.00544.x; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Koren MJ, 2012, LANCET, V380, P1995, DOI 10.1016/S0140-6736(12)61771-1; Kourimate S, 2008, J BIOL CHEM, V283, P9666, DOI 10.1074/jbc.M705831200; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Lalanne F, 2005, J LIPID RES, V46, P1312, DOI 10.1194/jlr.M400396-JLR200; Lambert G, 2012, J LIPID RES, V53, P2515, DOI 10.1194/jlr.R026658; Langhi C, 2008, FEBS LETT, V582, P949, DOI 10.1016/j.febslet.2008.02.038; Li H, 2012, BIOCHEM J, V443, P757, DOI 10.1042/BJ20111645; Li H, 2009, J BIOL CHEM, V284, P28885, DOI 10.1074/jbc.M109.052407; Luo Y, 2009, J LIPID RES, V50, P1581, DOI 10.1194/jlr.M800542-JLR200; Marais DA, 2012, CURR OPIN LIPIDOL, V23, P511, DOI 10.1097/MOL.0b013e3283587563; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Maxwell KN, 2003, J LIPID RES, V44, P2109, DOI 10.1194/jlr.M300203-JLR200; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Michishita E, 2009, CELL CYCLE, V8, P2664, DOI 10.4161/cc.8.16.9367; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Niesen M, 2008, ARCH BIOCHEM BIOPHYS, V470, P111, DOI 10.1016/j.abb.2007.11.009; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Persson L, 2010, ARTERIOSCL THROM VAS, V30, P2666, DOI 10.1161/ATVBAHA.110.214130; Persson L, 2009, ENDOCRINOLOGY, V150, P1140, DOI 10.1210/en.2008-1281; Raal F, 2012, CIRCULATION, V126, P2408, DOI 10.1161/CIRCULATIONAHA.112.144055; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Roth EM, 2012, NEW ENGL J MED, V367, P1891, DOI 10.1056/NEJMoa1201832; Schmidt RJ, 2008, BIOCHEM BIOPH RES CO, V370, P634, DOI 10.1016/j.bbrc.2008.04.004; Soerensen M, 2010, AGING CELL, V9, P1010, DOI 10.1111/j.1474-9726.2010.00627.x; Stein EA, 2012, LANCET, V380, P29, DOI 10.1016/S0140-6736(12)60771-5; Stein EA, 2012, NEW ENGL J MED, V366, P1108, DOI 10.1056/NEJMoa1105803; Sullivan D, 2012, JAMA-J AM MED ASSOC, V308, P2497, DOI 10.1001/jama.2012.25790; Tao RY, 2013, J LIPID RES, V54, P2745, DOI 10.1194/jlr.M039339; Tao RY, 2011, J BIOL CHEM, V286, P14681, DOI 10.1074/jbc.M110.201061; van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22; van der Wulp MYM, 2013, MOL CELL ENDOCRINOL, V368, P1, DOI 10.1016/j.mce.2012.06.007; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Wu MH, 2012, ATHEROSCLEROSIS, V224, P401, DOI 10.1016/j.atherosclerosis.2012.08.012; Yang B, 2009, CELL CYCLE, V8, P2662, DOI 10.4161/cc.8.16.9329; Zhang KB, 2012, ENDOCRINOLOGY, V153, P631, DOI 10.1210/en.2011-1527; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	59	116	123	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29252	29259		10.1074/jbc.M113.481473	http://dx.doi.org/10.1074/jbc.M113.481473			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23974119	Green Published, hybrid			2022-12-25	WOS:000330615300005
J	Simoes, TC; Codeco, CT; Nobre, AA; Eiras, AE				Simoes, Taynana C.; Codeco, Claudia T.; Nobre, Aline A.; Eiras, Alvaro E.			Modeling the Non-Stationary Climate Dependent Temporal Dynamics of Aedes aegypti	PLOS ONE			English	Article							DENGUE; TEMPERATURE; TRANSMISSION; VARIABILITY; HUMIDITY; VECTOR	Background: Temperature and humidity strongly affect the physiology, longevity, fecundity and dispersal behavior of Aedes aegypti, vector of dengue fever. Contrastingly, the statistical associations measured between time series of mosquito abundance and meteorological variables are often weak and contradictory. Here, we investigated the significance of these relationships at different time scales. Methods and Findings: A time series of the adult mosquito abundance from a medium-sized city in Brazil, lasting 109 weeks was analyzed. Meteorological variables included temperature, precipitation, wind velocity and humidity. As analytical tools, generalized linear models (GLM) with time lags and interaction terms were used to identify average effects while the wavelet analysis was complementarily used to identify transient associations. The fitted GLM showed that mosquito abundance is significantly affected by the interaction between lagged temperature and humidity, and also by the mosquito abundance a week earlier. Extreme meteorological variables were the best predictors, and the mosquito population tended to increase at values above 18 degrees C and 54% humidity. The wavelet analysis identified non-stationary local effects of these meteorological variables on abundance throughout the study period, with peaks in the spring-summer period. The wavelet detected weak but significant effects for precipitation and wind velocity. Conclusion: Our results support the presence of transient relationships between meteorological variables and mosquito abundance. Such transient association may be explained by the ability of Ae. aegypti to buffer part of its response to climate, for example, by choosing sites with proper microclimate. We also observed enough coupling between the abundance and meteorological variables to develop a model with good predictive power. Extreme values of meteorological variables with time lags, interaction terms and previous mosquito abundance are strong predictors and should be considered when understanding the climate effect on mosquito abundance and population growth.	[Simoes, Taynana C.] Fiocruz MS, Dept Epidemiol & Quantitat Methods Hlth DEMQS ENS, BR-21045900 Rio De Janeiro, RJ, Brazil; [Codeco, Claudia T.] Fiocruz MS, Sci Comp Program PROCC, BR-21045900 Rio De Janeiro, RJ, Brazil; [Nobre, Aline A.] Fiocruz MS, Sci Computat Program PROCC, BR-21045900 Rio De Janeiro, RJ, Brazil; [Eiras, Alvaro E.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Parasitol, Belo Horizonte, MG, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais	Simoes, TC (corresponding author), Fiocruz MS, Dept Epidemiol & Quantitat Methods Hlth DEMQS ENS, BR-21045900 Rio De Janeiro, RJ, Brazil.	taynanasimoes@ensp.fiocruz.br	Simões, Taynãna César/ABE-8964-2021; Eiras, Alvaro/Z-6023-2019	Eiras, Alvaro/0000-0002-3045-0673	CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; FAPERJ - Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (PRONEX Dengue - Programa de Apoio a Nucleos de Excelencia - Dengue)	CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ - Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (PRONEX Dengue - Programa de Apoio a Nucleos de Excelencia - Dengue)	This study was partially funded by CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico and FAPERJ - Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (PRONEX Dengue - Programa de Apoio a Nucleos de Excelencia - Dengue). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2004, WIK FREE ENC; Azil AH, 2010, TROP MED INT HEALTH, V15, P1190, DOI 10.1111/j.1365-3156.2010.02592.x; Calado Daniéla C., 2002, Rev. Bras. entomol., V46, P93, DOI 10.1590/S0085-56262002000100011; Castellan NJ, 1988, NONPARAMETRIC STAT B; Cazelles B, 2005, PLOS MED, V2, P313, DOI 10.1371/journal.pmed.0020106; Cazelles B, 2006, PLOS MED, V3, P1212, DOI 10.1371/journal.pmed.0030328; Cazelles B, 2007, J R SOC INTERFACE, V4, P625, DOI 10.1098/rsif.2007.0212; Chaves LF, 2010, B ENTOMOL RES, P1; Chaves LF, 2012, GLOBAL CHANGE BIOL, V18, P457, DOI 10.1111/j.1365-2486.2011.02522.x; Chen SC, 2010, SCI TOTAL ENVIRON, V408, P4069, DOI 10.1016/j.scitotenv.2010.05.021; Christophers, 1960, AEDES AEGYPTI L YELL; Clements AN., 1999, SENSORY RECEPTION BE; Colossimo EA, 2001, SURVIVAL ANAL; Cummings DAT, 2004, NATURE, V427, P344, DOI 10.1038/nature02225; Eiras AE, 2009, CAD SAUDE PUBLICA, V25, pS45, DOI 10.1590/S0102-311X2009001300005; Estallo EL, 2008, J AM MOSQUITO CONTR, V24, P368, DOI 10.2987/5705.1; Favier C, 2006, TROP MED INT HEALTH, V11, P1104, DOI 10.1111/j.1365-3156.2006.01653.x; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Honorio NA, 2009, J MED ENTOMOL, V46, P1001, DOI 10.1603/033.046.0505; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Johansson MA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000168; Kuno G, 1995, EPIDEMIOL REV, V17, P321, DOI 10.1093/oxfordjournals.epirev.a036196; LANSDOWNE C, 1975, J MED ENTOMOL, V11, P723, DOI 10.1093/jmedent/11.6.723; McCullagh P, 1989, GEN LINEAR MODELS; Nagao Y, 2008, P NATL ACAD SCI USA, V105, P2238, DOI 10.1073/pnas.0709029105; Costa EAPD, 2010, REV BRAS ENTOMOL, V54, P488, DOI 10.1590/S0085-56262010000300021; Pepin KM, 2013, EMERG INFECT DIS, V19, P542, DOI 10.3201/eid1904.120117; R Development Core Team, 2010, R LANG ENV STAT COMP; Tauil P L, 2001, Cad Saude Publica, V17 Suppl, P99, DOI 10.1590/S0102-311X2001000700018; Thai KTD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000747; Torrence C, 1998, PRACTICAL GUIDE WAVL; Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000920; World Health Organization, 2002, DENG FEV DENG HEM FE	34	21	21	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e64773	10.1371/journal.pone.0064773	http://dx.doi.org/10.1371/journal.pone.0064773			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23976939	Green Published, Green Submitted, gold			2022-12-25	WOS:000324527300001
J	Smits, SL; Raj, VS; Oduber, MD; Schapendonk, CME; Bodewes, R; Provacia, L; Stittelaar, KJ; Osterhaus, ADME; Haagmans, BL				Smits, Saskia L.; Raj, V. Stalin; Oduber, Minoushka D.; Schapendonk, Claudia M. E.; Bodewes, Rogier; Provacia, Lisette; Stittelaar, Koert J.; Osterhaus, Albert D. M. E.; Haagmans, Bart L.			Metagenomic Analysis of the Ferret Fecal Viral Flora	PLOS ONE			English	Article							HEPATITIS-E VIRUS; HUMAN PARECHOVIRUS-3; INFLUENZA; INFECTION; CLASSIFICATION; IDENTIFICATION; PICORNAVIRIDAE; EPIDEMIOLOGY; KOBUVIRUSES; CORONAVIRUS	Ferrets are widely used as a small animal model for a number of viral infections, including influenza A virus and SARS coronavirus. To further analyze the microbiological status of ferrets, their fecal viral flora was studied using a metagenomics approach. Novel viruses from the families Picorna-, Papilloma-, and Anelloviridae as well as known viruses from the families Astro-, Corona-, Parvo-, and Hepeviridae were identified in different ferret cohorts. Ferret kobu- and hepatitis E virus were mainly present in human household ferrets, whereas coronaviruses were found both in household as well as farm ferrets. Our studies illuminate the viral diversity found in ferrets and provide tools to prescreen for newly identified viruses that potentially could influence disease outcome of experimental virus infections in ferrets.	[Smits, Saskia L.; Raj, V. Stalin; Oduber, Minoushka D.; Schapendonk, Claudia M. E.; Bodewes, Rogier; Provacia, Lisette; Osterhaus, Albert D. M. E.; Haagmans, Bart L.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Smits, Saskia L.; Stittelaar, Koert J.; Osterhaus, Albert D. M. E.] Viroclin Biosci BV, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Smits, SL (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.	s.smits@erasmusmc.nl	Haagmans, Bart/E-9791-2015; Smits, Saskia/A-2953-2014; Raj, Victor Stalin/E-9670-2016	Haagmans, Bart/0000-0001-6221-2015; Raj, Victor Stalin/0000-0003-2250-8481; Bodewes, Rogier/0000-0002-0689-7889; Osterhaus, Albert/0000-0002-6074-1172	European Community's Seventh Framework Programme (FP7) under the project "European Management Platform for Emerging and Re-emerging Infectious disease Entities'' (EMPERIE) EC [223498]; Virgo consortium	European Community's Seventh Framework Programme (FP7) under the project "European Management Platform for Emerging and Re-emerging Infectious disease Entities'' (EMPERIE) EC; Virgo consortium	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under the project "European Management Platform for Emerging and Re-emerging Infectious disease Entities'' (EMPERIE) EC grant agreement number 223498 and the Virgo consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2005, J PARASITOL, V91, P179, DOI 10.1645/GE-3405RN; Aggarwal R, 2011, HEPATOLOGY, V54, P2218, DOI 10.1002/hep.24674; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/pnas.211424698; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Biagini P, 2009, CURR TOP MICROBIOL, V331, P21; Boivin G, 2005, EMERG INFECT DIS, V11, P103, DOI 10.3201/eid1101.040606; Bossart KN, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000642; Campagnolo ER, 2013, ZOONOSES PUBLIC HLTH, V60, P117, DOI 10.1111/j.1863-2378.2012.01503.x; CHOMEL BB, 1992, PEDIATR INFECT DIS J, V11, P479, DOI 10.1097/00006454-199206000-00011; Dalton HR, 2008, LANCET INFECT DIS, V8, P698, DOI 10.1016/S1473-3099(08)70255-X; Day JM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-313; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Farkas T, 2012, VIRUS GENES, V45, P518, DOI 10.1007/s11262-012-0803-0; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; Ge XY, 2012, J VIROL, V86, P4620, DOI 10.1128/JVI.06671-11; Hankenson FC, 2003, COMPARATIVE MED, V53, P579; Harvala H, 2008, J CLIN MICROBIOL, V46, P3446, DOI 10.1128/JCM.01207-08; Harvala H, 2009, J CLIN VIROL, V45, P1, DOI 10.1016/j.jcv.2009.03.009; HIRSCH VM, 1989, NATURE, V339, P389, DOI 10.1038/339389a0; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Johansson S, 2002, J VIROL, V76, P8920, DOI 10.1128/JVI.76.17.8920-8930.2002; Kapoor A, 2011, J VIROL, V85, P11520, DOI 10.1128/JVI.05317-11; Knowles NJ, 2012, VIRUS TAXONOMY CLASS, P855, DOI DOI 10.1016/B978-0-12-384684-6.00074-4; Kuiken T, 2005, SCIENCE, V309, P1680, DOI 10.1126/science.1113310; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levorson RE, 2009, PEDIATR INFECT DIS J, V28, P545, DOI 10.1097/INF.0b013e318194596a; Li LL, 2011, J GEN VIROL, V92, P2534, DOI 10.1099/vir.0.034611-0; Li LL, 2011, EMERG INFECT DIS, V17, P1876, DOI 10.3201/eid1710.110233; Li LL, 2011, J VIROL, V85, P9909, DOI 10.1128/JVI.05026-11; Li LL, 2010, J VIROL, V84, P6955, DOI 10.1128/JVI.00501-10; Li LL, 2010, J VIROL, V84, P1674, DOI 10.1128/JVI.02109-09; Lipkin WI, 2010, MICROBIOL MOL BIOL R, V74, P363, DOI 10.1128/MMBR.00007-10; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Losada L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019054; Maggi F, 2010, REV MED VIROL, V20, P392, DOI 10.1002/rmv.668; MARINI RP, 1989, J AM VET MED ASSOC, V195, P990; Martina BEE, 2003, NATURE, V425, P915, DOI 10.1038/425915a; Meng XJ, 2010, VET MICROBIOL, V140, P256, DOI 10.1016/j.vetmic.2009.03.017; Mokili JL, 2012, CURR OPIN VIROL, V2, P63, DOI 10.1016/j.coviro.2011.12.004; Ng TFF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020579; Ng TFF, 2011, J GEN VIROL, V92, P1318, DOI 10.1099/vir.0.029678-0; Ng TFF, 2009, J VIROL, V83, P2500, DOI 10.1128/JVI.01946-08; Osterhaus A, 2001, PHILOS T ROY SOC B, V356, P791, DOI 10.1098/rstb.2001.0856; Osterholm MT, 2012, MBIO, V3, DOI 10.1128/mBio.00045-12; Phan TG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002218; Provacia LBV, 2011, EMERG INFECT DIS, V17, P1570, DOI 10.3201/eid1708.110115; Raj VS, 2012, EMERG INFECT DIS, V18, P1369, DOI 10.3201/eid1808.111659; Reuter G, 2009, ARCH VIROL, V154, P101, DOI 10.1007/s00705-008-0288-2; Reuter G, 2011, REV MED VIROL, V21, P32, DOI 10.1002/rmv.677; Reuter G, 2010, EMERG INFECT DIS, V16, P869, DOI 10.3201/eid1605.091934; Shan TL, 2011, J VIROL, V85, P11697, DOI 10.1128/JVI.05217-11; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; SMITH H, 1988, REV INFECT DIS, V10, P56; Smits SL, 2011, EMERG INFECT DIS, V17, P2328, DOI 10.3201/eid1712.110934; Smits SL, 2010, J GEN VIROL, V91, P2719, DOI 10.1099/vir.0.024067-0; Song HD, 2005, P NATL ACAD SCI USA, V102, P2430, DOI 10.1073/pnas.0409608102; Svitek N, 2007, VIROLOGY, V362, P404, DOI 10.1016/j.virol.2007.01.002; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang XC, 2006, J VIROL, V80, P7481, DOI 10.1128/JVI.00697-06; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; van den Brand JMA, 2012, J VIROL, V86, P2360, DOI 10.1128/JVI.06373-11; van der Vries E, 2013, PLOS PATHOG IN PRESS; van Leeuwen M, 2010, J CLIN MICROBIOL, V48, P1787, DOI 10.1128/JCM.02452-09; Verboon-Maciolek MA, 2008, ANN NEUROL, V64, P266, DOI 10.1002/ana.21445; Woolhouse MEJ, 2005, TRENDS ECOL EVOL, V20, P238, DOI 10.1016/j.tree.2005.02.009; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997; Yamashita T, 1998, J VIROL, V72, P8408, DOI 10.1128/JVI.72.10.8408-8412.1998; Yamashita T, 2003, J GEN VIROL, V84, P3069, DOI 10.1099/vir.0.19266-0; Yokoyama CC, 2012, J VIROL, V86, P12262, DOI 10.1128/JVI.02018-12; Zitzow LA, 2002, J VIROL, V76, P4420, DOI 10.1128/JVI.76.9.4420-4429.2002	73	56	59	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71595	10.1371/journal.pone.0071595	http://dx.doi.org/10.1371/journal.pone.0071595			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977082	Green Published, gold, Green Submitted			2022-12-25	WOS:000324527300023
J	Pattnaik, BR; Tokarz, S; Asuma, MP; Schroeder, T; Sharma, A; Mitchell, JC; Edwards, AO; Pillers, DAM				Pattnaik, Bikash R.; Tokarz, Sara; Asuma, Matti P.; Schroeder, Tyler; Sharma, Anil; Mitchell, Julie C.; Edwards, Albert O.; Pillers, De-Ann M.			Snowflake Vitreoretinal Degeneration (SVD) Mutation R162W Provides New Insights into Kir7.1 Ion Channel Structure and Function	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; RECTIFIER K+ CHANNEL; POTASSIUM CHANNEL; PERMEATION PROPERTIES; RECESSIVE MUTATIONS; EXPRESSION; CELLS; PIP2; LOCALIZATION; MEMBRANE	Snowflake Vitreoretinal Degeneration (SVD) is associated with the R162W mutation of the Kir7.1 inwardly-rectifying potassium channel. Kir7.1 is found at the apical membrane of Retinal Pigment Epithelial (RPE) cells, adjacent to the photoreceptor neurons. The SVD phenotype ranges from RPE degeneration to an abnormal b-wave to a liquid vitreous. We sought to determine how this mutation alters the structure and function of the human Kir7.1 channel. In this study, we expressed a Kir7.1 construct with the R162W mutation in CHO cells to evaluate function of the ion channel. Compared to the wild-type protein, the mutant protein exhibited a non-functional Kir channel that resulted in depolarization of the resting membrane potential. Upon co-expression with wild-type Kir7.1, R162W mutant showed a reduction of I-Kir7.1 and positive shift in '0' current potential. Homology modeling based on the structure of a bacterial Kir channel protein suggested that the effect of R162W mutation is a result of loss of hydrogen bonding by the regulatory lipid binding domain of the cytoplasmic structure.	[Pattnaik, Bikash R.; Tokarz, Sara; Asuma, Matti P.; Schroeder, Tyler; Pillers, De-Ann M.] Univ Wisconsin, Dept Pediat, Madison, WI 53706 USA; [Pattnaik, Bikash R.] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI USA; [Pattnaik, Bikash R.; Pillers, De-Ann M.] Univ Wisconsin, McPherson Eye Res Inst, Madison, WI USA; [Mitchell, Julie C.] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA; [Sharma, Anil] Mayo Clin, Dept Expt Pathol, Rochester, MN USA; [Edwards, Albert O.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Edwards, Albert O.] Oregon Retina, Eugene, OR USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Mayo Clinic; University of Oregon	Pattnaik, BR (corresponding author), Univ Wisconsin, Dept Pediat, Madison, WI 53706 USA.	bikashp@pediatrics.wisc.edu	Mitchell, Julie C/D-6436-2018	Sharma, Anil/0000-0002-4471-7172; Pattnaik, Bikash/0000-0002-5385-358X	University of Wisconsin-Madison Department of Pediatrics; Graduate School; School of Medicine and Public Health; Rebecca Meyer Brown Professorship of the UW-Eye Research Institute; Retina Research Foundation; Mirus Research Award; National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program [NCRR-1UL1RR025011, NCATS-9U54TR000021]; UW-Stem Cell & Regenerative Medicine Center (BRP); Foundation Fighting Blindness (AOE); Fight for Sight; Sigma Xi;  [NCRR-P51 RR000167];  [NIH-EY014467]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000167, UL1RR025011] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014467] Funding Source: NIH RePORTER	University of Wisconsin-Madison Department of Pediatrics; Graduate School; School of Medicine and Public Health; Rebecca Meyer Brown Professorship of the UW-Eye Research Institute; Retina Research Foundation; Mirus Research Award; National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); UW-Stem Cell & Regenerative Medicine Center (BRP); Foundation Fighting Blindness (AOE); Fight for Sight; Sigma Xi; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the University of Wisconsin-Madison Department of Pediatrics (DMP, BRP), the Graduate School (DMP), the School of Medicine and Public Health (DMP, BRP), and by the Rebecca Meyer Brown Professorship (BRP) of the UW-Eye Research Institute which is funded by the Retina Research Foundation. Transfection reagents were kindly provided by Mirus Bio LLC (Madison, WI) through a Mirus Research Award to BRP. The project was also supported in part by the National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program (NCRR-1UL1RR025011, and NCATS-9U54TR000021), and the UW-Stem Cell & Regenerative Medicine Center (BRP). Funding was provided by NCRR-P51 RR000167 to the Wisconsin National Primate Research Center (WNPRC) at the University of Wisconsin-Madison, the Foundation Fighting Blindness (AOE), and NIH-EY014467 (AOE). This research was conducted in part at a facility constructed with support from Meriter Hospital (DMP). TS received a summer student fellowship from Fight for Sight and a Grant-in-Aid of Research from Sigma Xi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Booij Judith C, 2010, PLoS One, V5, pe9341, DOI 10.1371/journal.pone.0009341; Clarke OB, 2010, CELL, V141, P1018, DOI 10.1016/j.cell.2010.05.003; Crewther DP, 2000, PROG RETIN EYE RES, V19, P421, DOI 10.1016/S1350-9462(00)00004-5; Crewther SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002839; Derst C, 1998, GENOMICS, V54, P560, DOI 10.1006/geno.1998.5598; Derst C, 2001, KIDNEY INT, V59, P2197; Doring F, 1998, J NEUROSCI, V18, P8625; Edwards AO, 2008, EYE, V22, P1233, DOI 10.1038/eye.2008.38; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; GALLEMORE R, 1998, RETINAL PIGMENT EPIT; Gamper Nikita, 2005, Journal of Pharmacological and Toxicological Methods, V51, P177, DOI 10.1016/j.vascn.2004.08.008; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hejtmancik JF, 2008, AM J HUM GENET, V82, P174, DOI 10.1016/j.ajhg.2007.08.002; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Hofherr A, 2005, J CELL SCI, V118, P1935, DOI 10.1242/jcs.02322; Hughes B.A., 1998, TRANSPORT MECH RETIN; Hughes BA, 1998, AM J PHYSIOL-CELL PH, V275, pC1372, DOI 10.1152/ajpcell.1998.275.5.C1372; HUGHES BA, 1995, AM J PHYSIOL-CELL PH, V268, pC1164, DOI 10.1152/ajpcell.1995.268.5.C1164; Hughes BA, 1996, INVEST OPHTH VIS SCI, V37, P1125; Kofuji P, 2004, NEUROSCIENCE, V129, P1045, DOI 10.1016/j.neurscience.2004.06.008; Krapivinsky G, 1998, NEURON, V20, P995, DOI 10.1016/S0896-6273(00)80480-8; Kusaka S, 2001, J PHYSIOL-LONDON, V531, P27, DOI 10.1111/j.1469-7793.2001.0027j.x; Leduc-Nadeau A, 2010, J PHYSIOL-LONDON, V588, P2205, DOI 10.1113/jphysiol.2010.187674; Lee MM, 2003, OPHTHALMOLOGY, V110, P2418, DOI 10.1016/S0161-6420(03)00828-5; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P83, DOI 10.1007/s00424-007-0276-5; Logothetis DE, 2007, J PHYSIOL-LONDON, V582, P953, DOI 10.1113/jphysiol.2007.133157; Marmor MFaW, 1998, TRANSPORT MECH RETIN, P103; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Nakamura N, 1999, BIOCHEM J, V342, P329, DOI 10.1042/0264-6021:3420329; Ookata K, 2000, J AM SOC NEPHROL, V11, P1987, DOI 10.1681/ASN.V11111987; Pattnaik BR, 2012, MOL GENET METAB, V105, P64, DOI 10.1016/j.ymgme.2011.10.004; Pattnaik BR, 2009, AM J PHYSIOL-CELL PH, V297, pC1001, DOI 10.1152/ajpcell.00250.2009; Sackin H, 2010, CHANNELS, V4, P203, DOI 10.4161/chan.4.3.11982; Sanchez KM, 2011, BIOPHYS J, V100, P2121, DOI 10.1016/j.bpj.2011.03.018; Schittenhelm J, 2012, AM J CLIN PATHOL, V138, P85, DOI 10.1309/AJCPPRKNNL09JTLP; Sergouniotis PI, 2011, AM J HUM GENET, V89, P183, DOI 10.1016/j.ajhg.2011.06.002; Shimura M, 2001, J PHYSIOL-LONDON, V531, P329, DOI 10.1111/j.1469-7793.2001.0329i.x; Stansfeld PJ, 2009, BIOCHEMISTRY-US, V48, P10926, DOI 10.1021/bi9013193; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Strauss O, 2009, OPHTHALMOLOGE, V106, P299, DOI 10.1007/s00347-008-1869-x; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Tateno T, 2006, CELL BIOL INT, V30, P270, DOI 10.1016/j.cellbi.2005.11.007; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Wang FE, 2010, FASEB J, V24, P1552, DOI 10.1096/fj.08-125856; Wimmers S, 2007, PROG RETIN EYE RES, V26, P263, DOI 10.1016/j.preteyeres.2006.12.002; Xie LH, 2008, J PHYSIOL-LONDON, V586, P1833, DOI 10.1113/jphysiol.2007.147868; Yang DL, 2003, INVEST OPHTH VIS SCI, V44, P3178, DOI 10.1167/iovs.02-1189; Yang DL, 2008, EXP EYE RES, V86, P81, DOI 10.1016/j.exer.2007.09.011; Yang DL, 2008, EXP EYE RES, V87, P176, DOI 10.1016/j.exer.2008.05.010; Zhang W, 2013, AM J PHYSIOL-CELL PH, V304, pC440, DOI 10.1152/ajpcell.00363.2012; Zhang WY, 2003, J BIOL CHEM, V278, P21459, DOI 10.1074/jbc.M301652200	51	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71744	10.1371/journal.pone.0071744	http://dx.doi.org/10.1371/journal.pone.0071744			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977131	Green Published, gold, Green Submitted			2022-12-25	WOS:000323425700093
J	Shi, XG; Zhang, H; Lin, SJ				Shi, Xinguo; Zhang, Huan; Lin, Senjie			Tandem Repeats, High Copy Number and Remarkable Diel Expression Rhythm of Form II RuBisCO in Prorocentrum donghaiense (Dinophyceae)	PLOS ONE			English	Article							RIBULOSE 1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; MITOCHONDRIAL CYTOCHROME-B; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; CARBON FIXATION; DINOFLAGELLATE GONYAULAX; PHYLOGENETIC TREES; GENE-EXPRESSION; BREFELDIN-A; PROTEIN; CHLOROPLASTS	Gene structure and expression regulation of form II RuBisCO (rbcII) in dinoflagellates are still poorly understood. Here we isolated this gene (Pdrbc) and investigated its diel expression pattern in a harmful algal bloom forming dinoflagellate Prorocentrum donghaiense. We obtained cDNA sequences with triple tandem repeats of the coding unit (CU); the 5' region has the sequence of a typical dinoflagellate plastid gene, encoding an N-terminus with two transmembrane regions separated by a plastid transit peptide. The CUs (1,455 bp except 1464 bp in last CU) are connected through a 63 bp spacer. Phylogenetic analysis showed that rbcII CUs within species formed monophyletic clusters, indicative of intraspecific gene duplication or purifying evolution. Using quantitative PCR (qPCR) we estimated 117 +/- 40 CUs of Pdrbc in the P. donghaiense genome. Although it is commonly believed that most dinoflagellate genes lack transcriptional regulation, our RT-qPCR analysis on synchronized cultures revealed remarkable diel rhythm of Pdrbc expression, showing significant correlations of transcript abundance with the timing of the dark-to-light transition and cell cycle G2M-phase. When the cultures were shifted to continuous light, Pdrbc expression remained significantly correlated with the G2M-phase. Under continuous darkness the cell cycle was arrested at the G1 phase, and the rhythm of Pdrbc transcription disappeared. Our results suggest that dinoflagellate rbcII 1) undergoes duplication or sequence purification within species, 2) is organized in tandem arrays in most species probably to facilitate efficient translation and import of the encoded enzyme, and 3) is regulated transcriptionally in a cell cycle-dependent fashion at least in some dinoflagellates.	[Shi, Xinguo; Lin, Senjie] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China; [Shi, Xinguo; Lin, Senjie] Xiamen Univ, Coll Ocean & Earth Sci, Xiamen, Fujian, Peoples R China; [Zhang, Huan; Lin, Senjie] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Shi, Xinguo] Xiamen Univ, Coll Environm & Ecol, Xiamen, Fujian, Peoples R China; [Zhang, Huan] Ocean Univ China, Dept Environm Sci, Qingdao, Shandong, Peoples R China	Xiamen University; Xiamen University; University of Connecticut; Xiamen University; Ocean University of China	Lin, SJ (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China.	senjie.lin@uconn.edu	Lin, Senjie/A-7466-2011; Guo, chentao/G-7320-2016; zhang, yaqun/J-8478-2014		Xiamen University; State Key Laboratory of Marine Environmental Science grant [MELRI1203]; Chinese National Science Foundation [41176091]	Xiamen University(Xiamen University); State Key Laboratory of Marine Environmental Science grant; Chinese National Science Foundation(National Natural Science Foundation of China (NSFC))	The work was supported by Xiamen University, a State Key Laboratory of Marine Environmental Science grant for exploratory research (MELRI1203), and the Chinese National Science Foundation grant 41176091. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen GF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025527; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Finn MW, 2003, J BACTERIOL, V185, P3049, DOI 10.1128/JB.185.10.3049-3059.2003; GIBBS SP, 1979, J CELL SCI, V35, P253; Hanson TE, 2001, P NATL ACAD SCI USA, V98, P4397, DOI 10.1073/pnas.081610398; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; Hou YB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009545; Hou YB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006978; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hwang S, 1996, P NATL ACAD SCI USA, V93, P996, DOI 10.1073/pnas.93.3.996; Jensen SI, 2011, ISME J, V5, P317, DOI 10.1038/ismej.2010.131; John DE, 2007, ISME J, V1, P517, DOI 10.1038/ismej.2007.70; JORDAN DB, 1981, PLANT PHYSIOL, V67, P237, DOI 10.1104/pp.67.2.237; Kuo RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060826; LaJeunesse TC, 2005, J PHYCOL, V41, P880, DOI 10.1111/j.0022-3646.2005.04231.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEE DH, 1993, J BIOL CHEM, V268, P8842; Leggat W, 1999, PLANT PHYSIOL, V121, P1247, DOI 10.1104/pp.121.4.1247; Lin SJ, 2006, J PHYCOL, V42, P646, DOI 10.1111/j.1529-8817.2006.00229.x; Lin SJ, 2011, RES MICROBIOL, V162, P551, DOI 10.1016/j.resmic.2011.04.006; Lin SJ, 2010, P NATL ACAD SCI USA, V107, P20033, DOI 10.1073/pnas.1007246107; Lu DD, 2005, HARMFUL ALGAE, V4, P493, DOI 10.1016/j.hal.2004.08.015; MORSE D, 1995, SCIENCE, V268, P1622, DOI 10.1126/science.7777861; Nassoury N, 2005, TRAFFIC, V6, P548, DOI 10.1111/j.1600-0854.2005.00296.x; Nassoury N, 2005, BBA-MOL CELL RES, V1743, P5, DOI 10.1016/j.bbamcr.2004.09.017; Nassoury N, 2003, J CELL SCI, V116, P2867, DOI 10.1242/jcs.00517; Nassoury N, 2001, PLANT CELL, V13, P923; Orr RJS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050004; Patron NJ, 2005, J MOL BIOL, V348, P1015, DOI 10.1016/j.jmb.2005.03.030; Paul JH, 2000, MAR BIOTECHNOL, V2, P429; Rowan R, 1996, PLANT CELL, V8, P539, DOI 10.1105/tpc.8.3.539; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Savage DF, 2010, SCIENCE, V327, P1258, DOI 10.1126/science.1186090; Tabita FR, 2008, PHILOS T R SOC B, V363, P2629, DOI 10.1098/rstb.2008.0023; Tabita FR, 2007, MICROBIOL MOL BIOL R, V71, P576, DOI 10.1128/MMBR.00015-07; Thommen Q, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000990; van Dooren GG, 2001, BBA-MOL CELL RES, V1541, P34, DOI 10.1016/S0167-4889(01)00154-9; Wyman M, 1999, APPL ENVIRON MICROB, V65, P3651; Wyman M, 2005, APPL ENVIRON MICROB, V71, P1659, DOI 10.1128/AEM.71.3.1659-1661.2005; Zhang H, 2006, J EUKARYOT MICROBIOL, V53, P142, DOI 10.1111/j.1550-7408.2005.00085.x; Zhang H, 2005, J PHYCOL, V41, P411, DOI 10.1111/j.1529-8817.2005.04168.x; Zhang H, 2003, J PHYCOL, V39, P1160, DOI 10.1111/j.0022-3646.2003.03-055.x; Zhang H, 2007, P NATL ACAD SCI USA, V104, P4618, DOI 10.1073/pnas.0700258104; Zhang H, 2009, MOL BIOL EVOL, V26, P1757, DOI 10.1093/molbev/msp083; Zhuang YY, 2013, HARMFUL ALGAE, V26, P71, DOI 10.1016/j.hal.2013.04.002	45	36	37	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71232	10.1371/journal.pone.0071232	http://dx.doi.org/10.1371/journal.pone.0071232			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23976999	gold, Green Published, Green Submitted			2022-12-25	WOS:000323425700029
J	Wright, CM; Kirschner, MB; Cheng, YY; O'Byrne, KJ; Gray, SG; Schelch, K; Hoda, MA; Klebe, S; McCaughan, B; van Zandwijk, N; Reid, G				Wright, Casey M.; Kirschner, Michaela B.; Cheng, Yuen Yee; O'Byrne, Kenneth J.; Gray, Steven G.; Schelch, Karin; Hoda, Mir Alireza; Klebe, Sonja; McCaughan, Brian; van Zandwijk, Nico; Reid, Glen			Long Non Coding RNAs (lncRNAs) Are Dysregulated in Malignant Pleural Mesothelioma (MPM)	PLOS ONE			English	Article							CELL LUNG-CANCER; NONCODING RNA; POOR-PROGNOSIS; MESSENGER-RNAS; OVARIAN-CANCER; GENE; EXPRESSION; METASTASIS; CARCINOMA; MALAT-1	Malignant Pleural Mesothelioma (MPM) is an aggressive cancer that is often diagnosed at an advanced stage and is characterized by a long latency period (20-40 years between initial exposure and diagnosis) and prior exposure to asbestos. Currently accurate diagnosis of MPM is difficult due to the lack of sensitive biomarkers and despite minor improvements in treatment, median survival rates do not exceed 12 months. Accumulating evidence suggests that aberrant expression of long non-coding RNAs (lncRNAs) play an important functional role in cancer biology. LncRNAs are a class of recently discovered non-protein coding RNAs >200 nucleotides in length with a role in regulating transcription. Here we used NCode long noncoding microarrays to identify differentially expressed lncRNAs potentially involved in MPM pathogenesis. High priority candidate lncRNAs were selected on the basis of statistical (P<0.05) and biological significance (>3-fold difference). Expression levels of 9 candidate lncRNAs were technically validated using RT-qPCR, and biologically validated in three independent test sets: (1) 57 archived MPM tissues obtained from extrapleural pneumonectomy patients, (2) 15 cryopreserved MPM and 3 benign pleura, and (3) an extended panel of 10 MPM cell lines. RT-qPCR analysis demonstrated consistent up-regulation of these lncRNAs in independent datasets. ROC curve analysis showed that two candidates were able to separate benign pleura and MPM with high sensitivity and specificity, and were associated with nodal metastases and survival following induction chemotherapy. These results suggest that lncRNAs have potential to serve as biomarkers in MPM.	[Wright, Casey M.; Kirschner, Michaela B.; Cheng, Yuen Yee; van Zandwijk, Nico; Reid, Glen] Univ Sydney, Asbestos Dis Res Inst, Concord, NSW, Australia; [O'Byrne, Kenneth J.; Gray, Steven G.] Trinity Coll Dublin, Dublin, Ireland; [Klebe, Sonja] Flinders Med Ctr, Adelaide, SA, Australia; [McCaughan, Brian] Royal Prince Alfred Hosp, Dept Cardiothorac Surg, Sydney, NSW, Australia; [McCaughan, Brian] Royal N Shore Hosp, Dept Med Oncol, Sydney, NSW, Australia; [Schelch, Karin; Hoda, Mir Alireza] Med Univ Vienna, Ctr Comprehens Canc, Inst Canc Res, Vienna, Austria; [Schelch, Karin; Hoda, Mir Alireza] Med Univ Vienna, Ctr Comprehens Canc, Div Thorac Surg, Vienna, Austria	University of Sydney; Trinity College Dublin; Flinders Medical Centre; University of Sydney; Royal North Shore Hospital; University of Sydney; Medical University of Vienna; Medical University of Vienna	Wright, CM (corresponding author), Univ Sydney, Asbestos Dis Res Inst, Concord, NSW, Australia.	casey.wright@sydney.edu.au	Cheng, Yuen Yee/G-4406-2016; Wright, Casey M/J-9693-2014; Gray, Steven G./I-3081-2019; Dodds, Casey/HGC-6866-2022; Wright, Casey/G-1078-2011; van Zandwijk, Nico/E-4177-2012; Kirschner, Michaela/D-2214-2015; Cheng, Yuen/AAU-2402-2020	Cheng, Yuen Yee/0000-0001-7060-0624; Wright, Casey M/0000-0001-9214-5749; Gray, Steven G./0000-0002-5850-6392; van Zandwijk, Nico/0000-0002-8405-9688; Kirschner, Michaela/0000-0001-7444-9829; O'Byrne, Kenneth/0000-0002-6754-5633; Klebe, Sonja/0000-0002-8976-4714; Reid, Glen/0000-0001-6465-5223	Biaggio Signorelli Fellowship	Biaggio Signorelli Fellowship	This work has been supported by a Biaggio Signorelli Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bowman RV, 2009, EXPERT OPIN THER TAR, V13, P625, DOI [10.1517/14728220902926119, 10.1517/14728220902926119 ]; Braconi C, 2011, ONCOGENE, V30, P4750, DOI 10.1038/onc.2011.193; Brunner AH, 2011, INT J GYNECOL PATHOL, V30, P569, DOI 10.1097/PGP.0b013e31821ac6c3; Camargo MC, 2011, ENVIRON HEALTH PERSP, V119, P1211, DOI 10.1289/ehp.1003283; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Chisholm KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047998; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Crispi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007016; Cui Z, 2012, UROL ONCOL; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; Engstrom PG, 2006, PLOS GENET, V2, P564, DOI 10.1371/journal.pgen.0020047; Fischer JR, 2006, LUNG CANCER, V54, P109, DOI 10.1016/j.lungcan.2006.06.017; Gordon GJ, 2005, LUNG CANCER, V49, pS99, DOI 10.1016/j.lungcan.2005.03.018; Gordon GJ, 2005, AM J PATHOL, V166, P1827, DOI 10.1016/S0002-9440(10)62492-3; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Henderson DW, 2004, PATHOLOGY, V36, P517, DOI 10.1080/00313020400010955; Hoda MA, 2012, BRIT J CANCER, V107, P1978, DOI 10.1038/bjc.2012.519; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iadevaia V, 2012, NUCLEIC ACIDS RES, V40, P2527, DOI 10.1093/nar/gkr1040; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Kao SCH, 2011, PATHOLOGY, V43, P128, DOI 10.1097/PAT.0b013e328342016c; Kau TR, 2004, NAT REV CANCER, V4, P106, DOI 10.1038/nrc1274; Kettunen E, 2001, INT J CANCER, V91, P492, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1094>3.0.CO;2-M; Khaitan D, 2011, CANCER RES, V71, P3852, DOI 10.1158/0008-5472.CAN-10-4460; Kimura T, 2012, CELL MOL LIFE SCI; Klebe S, 2009, PATHOLOGY, V41, P140, DOI 10.1080/00313020802579250; Kogo R, 2011, CANCER RES, V71, P6320, DOI 10.1158/0008-5472.CAN-11-1021; Kryeziu K, 2013, MOL CANC THER; Laury AR, 2010, AM J SURG PATHOL, V34, P627, DOI 10.1097/PAS.0b013e3181da7687; Li DD, 2013, AM J PATHOL, V182, P64, DOI 10.1016/j.ajpath.2012.08.042; Mahmoudi S, 2009, MOL CELL, V33, P462, DOI 10.1016/j.molcel.2009.01.028; Melotti A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-54; Mironov O, 2011, J GYNECOL ONCOL, V22, P260, DOI 10.3802/jgo.2011.22.4.260; Nie Y, 2013, CANC SCI; Panzitt K, 2007, GASTROENTEROLOGY, V132, P330, DOI 10.1053/j.gastro.2006.08.026; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Relan V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058132; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Schmidt LH, 2011, J THORAC ONCOL, V6, P1984, DOI 10.1097/JTO.0b013e3182307eac; Shappell Scott B, 2008, Rev Urol, V10, P44; Simon R, 2007, CANCER INFORM, V3, P11; SMYTHE WR, 1994, ANN THORAC SURG, V57, P1395, DOI 10.1016/0003-4975(94)90090-6; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Sun XJ, 2005, J PATHOL, V207, P91, DOI 10.1002/path.1810; Tano K, 2010, FEBS LETT, V584, P4575, DOI 10.1016/j.febslet.2010.10.008; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Tsang WP, 2007, RNA, V13, P890, DOI 10.1261/rna.359007; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Weder W, 2007, ANN ONCOL, V18, P1196, DOI 10.1093/annonc/mdm093; Yang Z, 2011, ANN SURG ONCOL, V18, P1243, DOI 10.1245/s10434-011-1581-y	53	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e70940	10.1371/journal.pone.0070940	http://dx.doi.org/10.1371/journal.pone.0070940			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23976967	Green Published, gold, Green Submitted			2022-12-25	WOS:000323425700013
J	Kim, JT; Park, MS; Chang, J; Lee, JS; Choi, KH; Cho, KH				Kim, Joon-Tae; Park, Man-Seok; Chang, Jane; Lee, Ji Sung; Choi, Kang-Ho; Cho, Ki-Hyun			Proximal Arterial Occlusion in Acute Ischemic Stroke with Low NIHSS Scores Should Not Be Considered as Mild Stroke	PLOS ONE			English	Article							EARLY NEUROLOGICAL DETERIORATION; TISSUE-PLASMINOGEN ACTIVATOR; RAPIDLY IMPROVING SYMPTOMS; MINOR STROKE; ADMISSION HYPERGLYCEMIA; SCALE SCORE; THROMBOLYSIS; OUTCOMES; ATTACK; RISK	Background: Untreated acute mild stroke patients have substantial 90-day disability rates and worse outcomes than those who are treated with thrombolysis. There is little information regarding which patients with acute mild stroke will benefit from thrombolysis. We sought to investigate factors that are associated with early neurological deterioration (END) and poor prognosis in patients with acute mild stroke. Methods: This was a retrospective study of consecutively registered patients with acute mild stroke (NIHSS <= 3) at our tertiary stroke center between October 2008 and December 2011. END was defined as an increase in NIHSS >= 2 points between hospital days 0 and 5. Modified Rankin Scale (mRS) scores of 0-1 at 90 days post-stroke were defined as favorable outcomes. Results: A total of 378 (mean age, 65.9 +/- 13.0 years) patients were included in this study. END occurred in 55 patients (14.6%). IV-thrombolysis was performed in only 9 patients. Symptomatic arterial occlusion on the initial MRA was independently associated with END (OR, 2.206; 95% CI, 1.219-3.994; p = 0.009) by multivariate logistic regression. Of the 119 patients with symptomatic arterial occlusion, ICA occlusion was independently associated with END (OR, 8.606; 95% CI, 2.312-32.043; p = 0.001). Conclusions: This study demonstrates that symptomatic arterial occlusion may be an important predictor of END in patients with acute mild stroke. It may therefore be important to consider that acute ischemic stroke with symptomatic arterial occlusion and low NIHSS scores may not represent mild stroke in acute periods.	[Kim, Joon-Tae; Park, Man-Seok; Chang, Jane; Choi, Kang-Ho; Cho, Ki-Hyun] Chonnam Natl Univ Hosp, Cerebrovasc Ctr, Dept Neurol, Kwangju, South Korea; [Kim, Joon-Tae] Chonnam Natl Univ, Sch Med, Res Inst Med Sci, Kwangju, South Korea; [Lee, Ji Sung] Soonchunhyang Univ, Med Ctr, Biostat Consulting Unit, Seoul, South Korea	Chonnam National University; Chonnam National University Hospital; Chonnam National University; Soonchunhyang University	Kim, JT (corresponding author), Chonnam Natl Univ Hosp, Cerebrovasc Ctr, Dept Neurol, Kwangju, South Korea.	alldelight2@hanmail.net; mspark@jnu.ac.kr			Research Institute of Medical Sciences, Chonnam National University [2011-CURIMS-DR002]; Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A102065]	Research Institute of Medical Sciences, Chonnam National University; Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This work was supported by a research grant from the Research Institute of Medical Sciences, Chonnam National University (2011-CURIMS-DR002). This study also was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A102065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Alvarez-Sabin J, 2004, STROKE, V35, P2493, DOI 10.1161/01.STR.0000143728.45516.c6; Alvarez-Sabin J, 2003, STROKE, V34, P1235, DOI 10.1161/01.STR.0000068406.30514.31; Coutts SB, 2008, STROKE, V39, P2461, DOI 10.1161/STROKEAHA.107.513234; DeGraba TJ, 1999, STROKE, V30, P1208, DOI 10.1161/01.STR.30.6.1208; Dengler R, 2010, LANCET NEUROL, V9, P159, DOI 10.1016/S1474-4422(09)70361-8; Ferrari J, 2010, NEUROLOGY, V74, P136, DOI 10.1212/WNL.0b013e3181c9188b; Fischer U, 2010, STROKE, V41, P661, DOI 10.1161/STROKEAHA.109.572883; Kennedy J, 2007, LANCET NEUROL, V6, P961, DOI 10.1016/S1474-4422(07)70250-8; Khatri P, 2012, STROKE, V43, P560, DOI 10.1161/STROKEAHA.110.593897; Kohrmann M, 2009, CEREBROVASC DIS, V27, P160, DOI 10.1159/000185607; Kruetzelmann A, 2009, J NEUROL NEUROSUR PS, V80, P1156, DOI 10.1136/jnnp.2008.157313; Kwan J, 2006, QJM-INT J MED, V99, P625, DOI 10.1093/qjmed/hcl082; Lee DK, 2005, STROKE, V36, P2583, DOI 10.1161/01.STR.0000189999.19948.14; Leigh R, 2004, STROKE, V35, P1903, DOI 10.1161/01.STR.0000132571.77987.4c; Liebeskind DS, 2010, STROKE, V41, P3005, DOI 10.1161/STROKEAHA.110.596023; Maas MB, 2009, STROKE, V40, P2988, DOI 10.1161/STROKEAHA.109.555664; Martin-Schild S, 2011, ANN EMERG MED, V57, P42, DOI 10.1016/j.annemergmed.2010.06.564; Mori M, 2012, CEREBROVASC DIS, V34, P140, DOI 10.1159/000339759; Nedeltchev K, 2007, STROKE, V38, P2531, DOI 10.1161/STROKEAHA.107.482554; Ois A, 2008, CEREBROVASC DIS, V25, P151, DOI 10.1159/000113732; Rajajee V, 2006, NEUROLOGY, V67, P980, DOI 10.1212/01.wnl.0000237520.88777.71; Selim MH, 2010, STROKE, V41, P3007, DOI 10.1161/STROKEAHA.110.597427; Siegler JE, 2012, J STROKE CEREBROVASC; Smith EE, 2005, STROKE, V36, P2497, DOI 10.1161/01.STR.0000185798.78817.f3; Willey JZ, 2012, INT J STROKE, V7, P202, DOI 10.1111/j.1747-4949.2011.00696.x; Wong KSL, 2010, LANCET NEUROL, V9, P489, DOI 10.1016/S1474-4422(10)70060-0; Yong SW, 2006, STROKE, V37, P841, DOI 10.1161/01.STR.0000202590.75972.39	28	73	84	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e70996	10.1371/journal.pone.0070996	http://dx.doi.org/10.1371/journal.pone.0070996			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23976971	gold, Green Published, Green Submitted			2022-12-25	WOS:000323570200013
J	Takakuma, K; Ogo, N; Uehara, Y; Takahashi, S; Miyoshi, N; Asai, A				Takakuma, Kazuyuki; Ogo, Naohisa; Uehara, Yutaka; Takahashi, Susumu; Miyoshi, Nao; Asai, Akira			Novel Multiplexed Assay for Identifying SH2 Domain Antagonists of STAT Family Proteins	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITOR; HIGH-THROUGHPUT SCREEN; SIGNAL TRANSDUCERS; KINASE INHIBITOR; FLUORESCENCE POLARIZATION; IDENTIFICATION; TRANSCRIPTION; ACTIVATION; CANCER; TRANSFORMATION	Some of the signal transducer and activator of transcription (STAT) family members are constitutively activated in a wide variety of human tumors. The activity of STAT depends on their Src homology 2 (SH2) domain-mediated binding to sequences containing phosphorylated tyrosine. Thus, antagonizing this binding is a feasible approach to inhibiting STAT activation. We have developed a novel multiplexed assay for STAT3- and STAT5b-SH2 binding, based on amplified luminescent proximity homogeneous assay (Alpha) technology. AlphaLISA and AlphaScreen beads were combined in a single-well assay, which allowed the binding of STAT3- and STAT5b-SH2 to phosphotyrosine peptides to be simultaneously monitored. Biotin-labeled recombinant human STAT proteins were obtained as N- and C-terminal deletion mutants. The spacer length of the DIG-labeled peptide, the reaction time, and the concentration of sodium chloride were optimized to establish a HTS system with Z' values of greater than 0.6 for both STAT3- and STAT5b-SH2 binding. We performed a HTS campaign for chemical libraries using this multiplexed assay and identified hit compounds. A 2-chloro-1,4-naphthalenedione derivative, Compound 1, preferentially inhibited STAT3-SH2 binding in vitro, and the nuclear translocation of STAT3 in HeLa cells. Initial structure activity relationship (SAR) studies using the multiplexed assay showed the 3-substituent effect on both the activity and selectivity of STAT3 and STAT5b inhibition. Therefore, this multiplexed assay is useful for not only searching for potential lead compounds but also obtaining SAR data for developing new STAT3/STAT5b inhibitors.	[Takakuma, Kazuyuki; Ogo, Naohisa; Uehara, Yutaka; Takahashi, Susumu; Miyoshi, Nao; Asai, Akira] Univ Shizuoka, Ctr Drug Discovery, Grad Sch Pharmaceut Sci, Suruga Ku, Shizuoka 4228526, Japan	University of Shizuoka	Asai, A (corresponding author), Univ Shizuoka, Ctr Drug Discovery, Grad Sch Pharmaceut Sci, Suruga Ku, Shizuoka 4228526, Japan.	aasai@u-shizuoka-ken.ac.jp			National Institute of Biomedical Innovation (NIBO) [06-02]; JSPS KAKENHI [23510281]; Pharma Valley Center (PVC) Shizuoka, Japan	National Institute of Biomedical Innovation (NIBO); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Pharma Valley Center (PVC) Shizuoka, Japan	This work was supported by National Institute of Biomedical Innovation (NIBO) grant number 06-02, JSPS KAKENHI Grant Number 23510281, and Pharma Valley Center (PVC) Shizuoka, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcand M, 2010, BIOCHEMISTRY-US, V49, P3213, DOI 10.1021/bi100253p; Athavankar S, 2003, CHEM BIOL, V10, P1245, DOI 10.1016/j.chembiol.2003.11.007; Buettner R, 2002, CLIN CANCER RES, V8, P945; Cunningham L, 2012, P NATL ACAD SCI USA, V109, P14592, DOI 10.1073/pnas.1200037109; Desrivieres S, 2006, J MAMMARY GLAND BIOL, V11, P75, DOI 10.1007/s10911-006-9014-4; Fletcher S, 2011, CHEMMEDCHEM, V6, P1459, DOI 10.1002/cmdc.201100194; Grover GS, 2003, J BIOMOL SCREEN, V8, P239, DOI 10.1177/1087057103008003001; Haura EB, 2005, NAT CLIN PRACT ONCOL, V2, P315, DOI 10.1038/ncponc0195; Kadkhodayan S, 2007, ASSAY DRUG DEV TECHN, V5, P501, DOI 10.1089/adt.2007.070; Kazansky AV, 2003, CANCER RES, V63, P8757; Kazansky AV, 2001, CELL GROWTH DIFFER, V12, P1; Klampfer L, 2006, CURR CANCER DRUG TAR, V6, P107, DOI 10.2174/156800906776056491; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; Leong PL, 2002, ONCOGENE, V21, P2846, DOI 10.1038/sj.onc.1205385; Levine RL, 2007, NAT REV CANCER, V7, P673, DOI 10.1038/nrc2210; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Liu K, 2010, ASSAY DRUG DEV TECHN, V8, P367, DOI 10.1089/adt.2009.0245; May P, 1996, FEBS LETT, V394, P221, DOI 10.1016/0014-5793(96)00955-6; Miyoshi K, 2011, J INVEST DERMATOL, V131, P108, DOI 10.1038/jid.2010.255; Muller J, 2008, CHEMBIOCHEM, V9, P723, DOI 10.1002/cbic.200700701; Muller J, 2008, ANAL BIOCHEM, V375, P249, DOI 10.1016/j.ab.2008.01.017; Oikawa T, 2010, BIOCHEM BIOPH RES CO, V393, P253, DOI 10.1016/j.bbrc.2010.01.113; Pan YB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054565; Pedranzini L, 2006, CANCER RES, V66, P9714, DOI 10.1158/0008-5472.CAN-05-4280; Potz O, 2012, METHODS MOL BIOL, V795, P191, DOI 10.1007/978-1-61779-337-0_13; Quelle FW, 1996, MOL CELL BIOL, V16, P1622; Quintas-Cardama A, 2013, CLIN CANCER RES, V19, P1933, DOI 10.1158/1078-0432.CCR-12-0284; Ren ZY, 2003, BIOORG MED CHEM LETT, V13, P633, DOI 10.1016/S0960-894X(02)01050-8; Schust J, 2004, ANAL BIOCHEM, V330, P114, DOI 10.1016/j.ab.2004.03.024; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Sehr P, 2007, J BIOMOL SCREEN, V12, P560, DOI 10.1177/1087057107301246; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Siddiquee KAZ, 2007, ACS CHEM BIOL, V2, P787, DOI 10.1021/cb7001973; Surviladze Z, 2012, METHODS MOL BIOL, V827, P253, DOI 10.1007/978-1-61779-442-1_17; Thompson JE, 2002, BIOORG MED CHEM LETT, V12, P1219, DOI 10.1016/S0960-894X(02)00106-3; Turkson J, 2001, J BIOL CHEM, V276, P45443, DOI 10.1074/jbc.M107527200; Uehara Y, 2009, BIOCHEM BIOPH RES CO, V380, P627, DOI 10.1016/j.bbrc.2009.01.137; Wittig Ilka, 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P449, DOI 10.2174/156800805774912999; Xi SC, 2003, CANCER RES, V63, P6763; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	40	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e71646	10.1371/journal.pone.0071646	http://dx.doi.org/10.1371/journal.pone.0071646			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977103	Green Published, Green Submitted, gold			2022-12-25	WOS:000323570200039
J	Gothe, E; Angeler, DG; Gottschalk, S; Lofgren, S; Sandin, L				Gothe, Emma; Angeler, David G.; Gottschalk, Steffi; Lofgren, Stefan; Sandin, Leonard			The Influence of Environmental, Biotic and Spatial Factors on Diatom Metacommunity Structure in Swedish Headwater Streams	PLOS ONE			English	Article							DISPERSAL LIMITATION; COMMUNITY STRUCTURE; BENTHIC DIATOM; TROPHIC INTERACTIONS; REGIONAL OCCUPANCY; NETWORK STRUCTURE; ECOLOGICAL DATA; BOREAL STREAMS; SPECIES TRAITS; PATCH DYNAMICS	Stream assemblages are structured by a combination of local (environmental filtering and biotic interactions) and regional factors (e. g., dispersal related processes). The relative importance of environmental and spatial (i.e., regional) factors structuring stream assemblages has been frequently assessed in previous large-scale studies, but biotic predictors (potentially reflecting local biotic interactions) have rarely been included. Diatoms may be useful for studying the effect of trophic interactions on community structure since: (1) a majority of experimental studies shows significant grazing effects on diatom species composition, and (2) assemblages can be divided into guilds that have different susceptibility to grazing. We used a dataset from boreal headwater streams in south-central Sweden (covering a spatial extent of similar to 14000 km(2)), which included information about diatom taxonomic composition, abundance of invertebrate grazers (biotic factor), environmental (physicochemical) and spatial factors (obtained through spatial eigenfunction analyses). We assessed the relative importance of environmental, biotic, and spatial factors structuring diatom assemblages, and performed separate analyses on different diatom guilds. Our results showed that the diatom assemblages were mainly structured by environmental factors. However, unique spatial and biological gradients, specific to different guilds and unrelated to each other, were also evident. We conclude that biological predictors, in combination with environmental and spatial variables, can reveal a more complete picture of the local vs. regional control of species assemblages in lotic environments. Biotic factors should therefore not be overlooked in applied research since they can capture additional local control and therefore increase accuracy and performance of predictive models. The inclusion of biotic predictors did, however, not significantly influence the unique fraction explained by spatial factors, which suggests low bias in previous assessments of unique regional control of stream assemblages.	[Gothe, Emma; Angeler, David G.; Gottschalk, Steffi; Lofgren, Stefan] Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, Uppsala, Sweden; [Sandin, Leonard] Aarhus Univ, Dept Biosci, Silkeborg, Denmark	Swedish University of Agricultural Sciences; Aarhus University	Gothe, E (corresponding author), Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, Uppsala, Sweden.	emma.gothe@gmail.com	Löfgren, Stefan/C-1825-2012; Sandin, Leonard/HHY-7292-2022; Sandin, Leonard/K-4475-2012; Göthe, Emma/A-6310-2016	Löfgren, Stefan/0000-0001-7892-2708; Sandin, Leonard/0000-0003-1685-5305; Göthe, Emma/0000-0002-7387-6770	Marie Curie Actions of the European Commission [273215]	Marie Curie Actions of the European Commission(European Commission)	The project was funded by various projects administrated by Leonard Sandin. No specific funding was granted for this project. At the time of submission of the manuscript Leonard Sandin was funded by the Marie Curie Actions of the European Commission (FP7-2010- PEOPLE-IEF) through the FRESHCLIM project (project nr 273215) (http://ec.europa.eu/research/mariecurieactions/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astorga A, 2012, GLOBAL ECOL BIOGEOGR, V21, P365, DOI 10.1111/j.1466-8238.2011.00681.x; Baas Becking L.G.M., 1934, GEOBIOLOGIE INLEIDIN; Battarbee R. W., 2010, The diatoms: applications for the environmental and earth sciences, P98; Bengtsson Janne, 2010, P115; Blanchet FG, 2008, ECOL MODEL, V215, P325, DOI 10.1016/j.ecolmodel.2008.04.001; Blanchet FG, 2011, OECOLOGIA, V166, P357, DOI 10.1007/s00442-010-1867-y; Bohonak AJ, 2003, ECOL LETT, V6, P783, DOI 10.1046/j.1461-0248.2003.00486.x; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; Brown BL, 2010, J ANIM ECOL, V79, P571, DOI 10.1111/j.1365-2656.2010.01668.x; Brown BL, 2011, J N AM BENTHOL SOC, V30, P310, DOI 10.1899/10-129.1; De Bie T, 2012, ECOL LETT, V15, P740, DOI 10.1111/j.1461-0248.2012.01794.x; Dray S., 2009, PACKFOR FORWARD SELE; ERIKSSON MOG, 1980, AMBIO, V9, P248; Feminella JW, 1995, J N AM BENTHOL SOC, V14, P465, DOI 10.2307/1467536; Finlay BJ, 2002, PROTIST, V153, P261, DOI 10.1078/1434-4610-00103; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Finlay BJ, 1999, NATURE, V400, P828, DOI 10.1038/23616; Gothe E, 2013, J ANIM ECOL, V82, P449, DOI 10.1111/1365-2656.12004; Gray DK, 2012, FRESHWATER BIOL, V57, P741, DOI 10.1111/j.1365-2427.2012.02739.x; Heino J, 2006, FRESHWATER BIOL, V51, P672, DOI 10.1111/j.1365-2427.2006.01520.x; Heino J, 2012, BIOL REV; Heino J, 2012, OIKOS, V121, P537, DOI 10.1111/j.1600-0706.2011.19715.x; Heino J, 2010, OIKOS, V119, P129, DOI 10.1111/j.1600-0706.2009.17778.x; HEMPHILL N, 1983, OECOLOGIA, V58, P378, DOI 10.1007/BF00385239; HILDREW AG, 1984, FRESHWATER BIOL, V14, P297, DOI 10.1111/j.1365-2427.1984.tb00042.x; Hill BH, 2001, J N AM BENTHOL SOC, V20, P299, DOI 10.2307/1468324; HILL WR, 1988, LIMNOL OCEANOGR, V33, P15, DOI 10.4319/lo.1988.33.1.0015; HILL WR, 1987, ECOLOGY, V68, P1955, DOI 10.2307/1939886; Hoopes MF, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P35; Johnson RK, 2007, FRESHWATER BIOL, V52, P939, DOI 10.1111/j.1365-2427.2006.01692.x; Johnson RK, 2010, ECOL APPL, V20, P978, DOI 10.1890/08-1153.1; JUNGER M, 1993, HYDROBIOLOGIA, V262, P97, DOI 10.1007/BF00007510; Kristiansen J, 1996, HYDROBIOLOGIA, V336, P151, DOI 10.1007/BF00010829; Lange K, 2011, FRESHWATER BIOL, V56, P264, DOI 10.1111/j.1365-2427.2010.02492.x; Layer K, 2010, ADV ECOL RES, V42, P265, DOI 10.1016/S0065-2504(10)42005-X; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P., 1998, DEV ENV MODELLING, V20; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lofgren S, 2011, 52 SMED; Lofgren S, 2011, AMBIO, V40, P836, DOI 10.1007/s13280-011-0207-8; MCAULIFFE JR, 1984, ECOLOGY, V65, P894, DOI 10.2307/1938063; MERRITT R. W., 1996, INTRO AQUATIC INSECT; Moog O., 1995, P1; Mouquet N, 2003, AM NAT, V162, P544, DOI 10.1086/378857; Mouquet N, 2002, AM NAT, V159, P420, DOI 10.1086/338996; MULHOLLAND PJ, 1986, CAN J FISH AQUAT SCI, V43, P1846, DOI 10.1139/f86-229; Mykra H, 2007, GLOBAL ECOL BIOGEOGR, V16, P149, DOI 10.1111/j.1466-8238.2006.00272.x; Oksanen J., 2011, VEGAN COMMUNITY ECOL; Ormerod SJ, 2009, J APPL ECOL, V46, P164, DOI 10.1111/j.1365-2664.2008.01587.x; Pappas JL, 1996, J PHYCOL, V32, P693, DOI 10.1111/j.0022-3646.1996.00693.x; Passy SI, 2007, AQUAT BOT, V86, P171, DOI 10.1016/j.aquabot.2006.09.018; Poff NL, 1997, J N AM BENTHOL SOC, V16, P391, DOI 10.2307/1468026; Potapova MG, 2002, J BIOGEOGR, V29, P167, DOI 10.1046/j.1365-2699.2002.00668.x; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; R Core Team, 2016, R FDN STAT COMP; Sandin L, 2004, LANDSCAPE ECOL, V19, P501, DOI 10.1023/B:LAND.0000036116.44231.1c; SCHOFIELD K, 1988, FRESHWATER BIOL, V20, P85, DOI 10.1111/j.1365-2427.1988.tb01720.x; Shurin JB, 2009, OECOLOGIA, V159, P151, DOI 10.1007/s00442-008-1174-z; Smucker NJ, 2011, ECOL INDIC, V11, P1191, DOI 10.1016/j.ecolind.2010.12.022; Soininen J, 2005, J BIOGEOGR, V32, P1971, DOI 10.1111/j.1365-2699.2005.01342.x; Soininen J, 2004, INT REV HYDROBIOL, V89, P139, DOI 10.1002/iroh.200310714; Soininen J, 2004, ECOGRAPHY, V27, P330, DOI 10.1111/j.0906-7590.2004.03749.x; STATZNER B, 1986, FRESHWATER BIOL, V16, P127, DOI 10.1111/j.1365-2427.1986.tb00954.x; Thompson R, 2006, J ANIM ECOL, V75, P476, DOI 10.1111/j.1365-2656.2006.01068.x; Thompson RM, 2012, FRESHWATER BIOL, V57, P1329, DOI 10.1111/j.1365-2427.2012.02808.x; TOWNSEND CR, 1989, J N AM BENTHOL SOC, V8, P36, DOI 10.2307/1467400; TUCHMAN NC, 1991, J N AM BENTHOL SOC, V10, P430, DOI 10.2307/1467668; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Verleyen E, 2009, OIKOS, V118, P1239, DOI 10.1111/j.1600-0706.2009.17575.x; Verreydt D, 2012, ECOL LETT, V15, P218, DOI 10.1111/j.1461-0248.2011.01728.x; Vinson MR, 1998, ANNU REV ENTOMOL, V43, P271, DOI 10.1146/annurev.ento.43.1.271; WHITTAKER RH, 1970, COMMUNITIES ECOSYSTE; Winemiller KO, 2010, J N AM BENTHOL SOC, V29, P84, DOI 10.1899/08-048.1	74	63	65	4	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e72237	10.1371/journal.pone.0072237	http://dx.doi.org/10.1371/journal.pone.0072237			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967290	Green Published, Green Submitted, gold			2022-12-25	WOS:000323378000087
J	Li, CT; Chou, KH; Su, TP; Huang, CC; Chen, MH; Bai, YM; Lin, CP				Li, Cheng-Ta; Chou, Kun-Hsien; Su, Tung-Ping; Huang, Chu-Chung; Chen, Mu-Hong; Bai, Ya-Mei; Lin, Ching-Po			Gray Matter Abnormalities in Schizophrenia Patients with Tardive Dyskinesia: A Magnetic Resonance Imaging Voxel-Based Morphometry Study	PLOS ONE			English	Article							OUTPATIENT HEALTH OUTCOMES; FRONTAL-LOBE DYSFUNCTION; BASAL GANGLIA; ASSOCIATION ANALYSIS; MOVEMENT-DISORDERS; GENETIC-VARIATIONS; DOUBLE-BLIND; NEGATIVE SYMPTOMS; RELAXATION-TIMES; LEGAL ISSUES	Objective: The pathophysiological mechanism of TD remains unknown. All previous studies, using the region-of-interest method, focused on basal ganglion areas, were with inconsistent results. This whole-brain voxel-based morphometry (VBM) study investigate the grey matter abnormality of TD and its correlates with clinical ratings. Method: High resolution T1-weighted brain volumetric MRI from 25 schizophrenia patients with TD (TD group), 25 age-, gender-, and handedness-matched schizophrenia patients without TD (non-TD group), and 25 matched healthy subjects (NC group) were analyzed using a VBM approach. Clinical ratings included the Positive and Negative Symptom Scale (PANSS), Abnormal Involuntary Movement Scale (AIMS), and the Simpson-Angus Scale (SAS). Results: The TD group had significantly smaller total gray matter volumes than the NC group (p = 0.05). Compared to the non-TD group, the TD group had significantly higher PANSS negative (p<0.001), SAS (p<0.001), and AIMS (p<0.001) scores; and smaller bilateral inferior frontal gyrus, which correlated negatively with the PANSS negative scores (r = -0.366, p<0.05); and smaller right superior frontal gyrus, which correlated negatively with AIMS scores (r = -0.399, p<0.001), and PANSS general score (r = -0.338, p<0.05). Limitations: The cross-section design can't separate the gray matter change to TD from the context of the illness of schizophrenia, although TD with more severe clinical psychopathology could be a phenotype. Conclusions: The schizophrenia patients with TD had significantly reduced gray matter, mostly at the bilateral inferior frontal gyrus and the right superior frontal gyrus, which correlated with severity of clinical symptoms and involuntary movement, respectively.	[Chou, Kun-Hsien; Lin, Ching-Po] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan; [Li, Cheng-Ta; Su, Tung-Ping; Chen, Mu-Hong; Bai, Ya-Mei] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Li, Cheng-Ta; Su, Tung-Ping] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Li, Cheng-Ta; Su, Tung-Ping; Bai, Ya-Mei] Natl Yang Ming Univ, Fac Med, Div Psychiat, Taipei 112, Taiwan; [Huang, Chu-Chung] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Bai, YM (corresponding author), Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan.	ymbi@mail2000.com.tw	Chen, MuHong/ACJ-6131-2022; Li, Cheng-Ta/AAI-5759-2021	Chen, MuHong/0000-0001-6516-1073; Li, Cheng-Ta/0000-0002-0670-1153; Huang, Chu-Chung/0000-0002-9096-9610	Taiwan National Science Council [NSC 99-2628-B-075 -004 -MY3]; Taipei Veterans General Hospital, Taiwan [V100C-057]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital, Taiwan(Taipei Veterans General Hospital)	This study was supported by Taiwan National Science Council (NSC 99-2628-B-075 -004 -MY3), and Taipei Veterans General Hospital, Taiwan (V100C-057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Ascher-Svanum H, 2008, J CLIN PSYCHIAT, pe1; Bai YM, 2009, SCHIZOPHR RES, V109, P167, DOI 10.1016/j.schres.2009.02.003; Bai YM, 2005, INT CLIN PSYCHOPHARM, V20, P79, DOI 10.1097/00004850-200503000-00003; Bai YM, 2003, J CLIN PSYCHIAT, V64, P1342, DOI 10.4088/JCP.v64n1110; BARTZOKIS G, 1990, BIOL PSYCHIAT, V28, P1027, DOI 10.1016/0006-3223(90)90603-Y; Bengtsson SL, 2004, EUR J NEUROSCI, V19, P2591, DOI 10.1111/j.0953-816X.2004.03269.x; Berry K, 2007, AM J GERIAT PSYCHIAT, V15, P800, DOI 10.1097/JGP.0b013e31806841ae; BUCKLEY P, 1995, PSYCHIAT RES-NEUROIM, V61, P95, DOI 10.1016/0925-4927(95)02591-K; Casey DE, 2004, J CLIN PSYCHIAT, V65, P25; Cerasa A, 2011, MOVEMENT DISORD, V26, P807, DOI 10.1002/mds.23660; Chen JY, 2001, AM J PSYCHIAT, V158, P1931, DOI 10.1176/appi.ajp.158.11.1931; Chouinard G, 2006, J PSYCHIATR NEUROSCI, V31, P177; Correll CU, 2008, CURR OPIN PSYCHIATR, V21, P151, DOI 10.1097/YCO.0b013e3282f53132; Cuadra MB, 2005, IEEE T MED IMAGING, V24, P1548, DOI 10.1109/TMI.2005.857652; Eberhard J, 2006, INT CLIN PSYCHOPHARM, V21, P35, DOI 10.1097/01.yic.0000182120.51672.7d; ELKASHEF AM, 1994, AM J PSYCHIAT, V151, P752; Gebhardt S, 2008, EUR CHILD ADOLES PSY, V17, P44, DOI 10.1007/s00787-007-0633-0; GOLDMANRAKIC PS, 1992, J NEURAL TRANSM-GEN, P163; GRANHOLM E, 1993, PSYCHIAT RES-NEUROIM, V50, P33; Gupta S, 2002, PSYCHIAT ANN, V32, P245, DOI 10.3928/0048-5713-20020401-09; HARVEY I, 1991, PSYCHOL MED, V21, P587, DOI 10.1017/S0033291700022224; Lai IC, 2011, WORLD J BIOL PSYCHIA, V12, P143, DOI 10.3109/15622975.2010.496870; Lai IC, 2011, EUR J CLIN PHARMACOL, V67, P383, DOI 10.1007/s00228-010-0967-2; Lai IC, 2005, J NEURAL TRANSM, V112, P1107, DOI 10.1007/s00702-004-0252-6; Lai IC, 2002, NEUROPSYCHOBIOLOGY, V46, P173, DOI 10.1159/000067808; Leitman DI, 2011, BIOL PSYCHIAT, V70, P611, DOI 10.1016/j.biopsych.2011.05.032; Lerner V, 2007, J CLIN PSYCHIAT, V68, P1648, DOI 10.4088/JCP.v68n1103; Leung HC, 2007, J NEUROSCI, V27, P9893, DOI 10.1523/JNEUROSCI.2837-07.2007; Li R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031877; Liang PP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022153; Libov I, 2007, J CLIN PSYCHIAT, V68, P1031, DOI 10.4088/JCP.v68n0709; Lin CC, 2008, PROG NEURO-PSYCHOPH, V32, P599, DOI 10.1016/j.pnpbp.2007.09.009; Liou YJ, 2008, EUR J NEUROL, V15, P1406, DOI 10.1111/j.1468-1331.2008.02316.x; Liou YJ, 2007, PSYCHIAT RES, V153, P271, DOI 10.1016/j.psychres.2006.08.007; Liou YJ, 2006, PHARMACOGENET GENOM, V16, P151; Liou YJ, 2006, SCHIZOPHR RES, V86, P323, DOI 10.1016/j.schres.2006.04.008; Liou YJ, 2009, AM J MED GENET B, V150B, P439, DOI 10.1002/ajmg.b.30795; Liou YJ, 2009, AM J MED GENET B, V150B, P239, DOI 10.1002/ajmg.b.30796; Liou YJ, 2005, INT J NEUROPSYCHOPH, V8, P483, DOI 10.1017/S1461145705005262; Liou YJ, 2004, NEUROMOL MED, V5, P243, DOI 10.1385/NMM:5:3:243; Liou YJ, 2004, NEUROPSYCHOBIOLOGY, V49, P167, DOI 10.1159/000077360; Miller DD, 2005, SCHIZOPHR RES, V80, P33, DOI 10.1016/j.schres.2005.07.034; MION CC, 1991, PSYCHIAT RES-NEUROIM, V40, P157, DOI 10.1016/0165-1781(91)90155-I; Mo GH, 2007, SCHIZOPHR RES, V97, P302, DOI 10.1016/j.schres.2007.06.026; Park IH, 2009, PSYCHIAT RES-NEUROIM, V171, P155, DOI 10.1016/j.pscychresns.2008.03.010; Pena MS, 2011, MOVEMENT DISORD, V26, P147, DOI 10.1002/mds.23402; Rajapakse JC, 1997, IEEE T MED IMAGING, V16, P176, DOI 10.1109/42.563663; REY M, 1988, NEUROPSYCHOLOGIA, V26, P167, DOI 10.1016/0028-3932(88)90040-1; Sachdev P, 1996, ACTA PSYCHIAT SCAND, V93, P451, DOI 10.1111/j.1600-0447.1996.tb10677.x; Sarro S, 2012, BR J PSYCHIAT; SCHOOLER NR, 1982, ARCH GEN PSYCHIAT, V39, P486; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Semkovska M, 2001, ENCEPHALE, V27, P405; SIMPSON GM, 1979, PSYCHOPHARMACOLOGY, V64, P171, DOI 10.1007/BF00496058; Slovenko R, 2000, J CLIN PSYCHIAT, V61, P45; Telfer S, 2011, ACTA PSYCHIAT SCAND, V124, P357, DOI 10.1111/j.1600-0447.2011.01751.x; Tenback DE, 2007, COMPR PSYCHIAT, V48, P436, DOI 10.1016/j.comppsych.2007.05.003; Tenback DE, 2006, AM J PSYCHIAT, V163, P1438, DOI 10.1176/appi.ajp.163.8.1438; Tian L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028794; Tohka J, 2004, NEUROIMAGE, V23, P84, DOI 10.1016/j.neuroimage.2004.05.007; WADDINGTON JL, 1995, BRIT J PSYCHIAT, V167, P41, DOI 10.1192/bjp.167.1.41; Wang YC, 2004, J NEURAL TRANSM, V111, P623, DOI 10.1007/s00702-004-0118-y; Wang YC, 2008, NEUROPSYCHOBIOLOGY, V57, P200, DOI 10.1159/000149818; Wang ZG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039701; Woods SW, 2010, J CLIN PSYCHIAT, V71, P463, DOI 10.4088/JCP.07m03890yel; Zhang XY, 2007, J CLIN PSYCHIAT, V68, P754, DOI 10.4088/JCP.v68n0513	68	21	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71034	10.1371/journal.pone.0071034	http://dx.doi.org/10.1371/journal.pone.0071034			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967150	Green Submitted, Green Published, gold			2022-12-25	WOS:000323378000028
J	Muehlhan, M; Lueken, U; Siegert, J; Wittchen, HU; Smolka, MN; Kirschbaum, C				Muehlhan, Markus; Lueken, Ulrike; Siegert, Jens; Wittchen, Hans-Ulrich; Smolka, Michael N.; Kirschbaum, Clemens			Enhanced Sympathetic Arousal in Response to fMRI Scanning Correlates with Task Induced Activations and Deactivations	PLOS ONE			English	Article							SALIVARY ALPHA-AMYLASE; SKIN-CONDUCTANCE; BRAIN-FUNCTION; DEFAULT-MODE; RESTING-STATE; RESONANCE; ANXIETY; STRESS; MODULATION; ATTENTION	It has been repeatedly shown that functional magnetic resonance imaging (fMRI) triggers distress and neuroendocrine response systems. Prior studies have revealed that sympathetic arousal increases, particularly at the beginning of the examination. Against this background it appears likely that those stress reactions during the scanning procedure may influence task performance and neural correlates. However, the question how sympathetic arousal elicited by the scanning procedure itself may act as a potential confounder of fMRI data remains unresolved today. Thirty-seven scanner naive healthy subjects performed a simple cued target detection task. Levels of salivary alpha amylase (sAA), as a biomarker for sympathetic activity, were assessed in samples obtained at several time points during the lab visit. SAA increased two times, immediately prior to scanning and at the end of the scanning procedure. Neural activation related to motor preparation and timing as well as task performance was positively correlated with the first increase. Furthermore, the first sAA increase was associated with task induced deactivation (TID) in frontal and parietal regions. However, these effects were restricted to the first part of the experiment. Consequently, this bias of scanner related sympathetic activation should be considered in future fMRI investigations. It is of particular importance for pharmacological investigations studying adrenergic agents and the comparison of groups with different stress vulnerabilities like patients and controls or adolescents and adults.	[Muehlhan, Markus; Lueken, Ulrike; Siegert, Jens; Wittchen, Hans-Ulrich] Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, Dept Psychol, D-01062 Dresden, Germany; [Muehlhan, Markus; Kirschbaum, Clemens] Tech Univ Dresden, Chair Biopsychol, Dept Psychol, D-01062 Dresden, Germany; [Smolka, Michael N.] Tech Univ Dresden, Sect Syst Neurosci, Dept Psychiat & Psychotherapy, D-01062 Dresden, Germany; [Muehlhan, Markus; Lueken, Ulrike; Smolka, Michael N.] Tech Univ Dresden, Dept Psychol, Neuroimaging Ctr, D-01062 Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden	Muehlhan, M (corresponding author), Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, Dept Psychol, D-01062 Dresden, Germany.	muehlhan@klipsy.tu-dresden.de	Muehlhan, Markus/K-2389-2019; Wittchen, Hans-Ulrich/A-8507-2014; Wittchen, Hans-Ulrich/ABA-8901-2020; Kirschbaum, Clemens/AAB-1752-2020; Lueken, Ulrike/A-8109-2014; Smolka, Michael/B-4865-2011	Muehlhan, Markus/0000-0002-8855-8724; Wittchen, Hans-Ulrich/0000-0002-6311-7711; Lueken, Ulrike/0000-0003-1564-4012; Smolka, Michael/0000-0001-5398-5569	Department of Psychology, TU Dresden; german research foundation (DFG); TU Dresden	Department of Psychology, TU Dresden; german research foundation (DFG)(German Research Foundation (DFG)); TU Dresden(European Commission)	This study was partly supported by an intramural research funding from the Department of Psychology, TU Dresden to M. Muehlhan. The authors further acknowledge support by the Open Access Publication Funds of the german research foundation (DFG) and the TU Dresden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JK, 2007, J COGNITIVE NEUROSCI, V19, P468, DOI 10.1162/jocn.2007.19.3.468; Bennett CM, 2010, ANN NY ACAD SCI, V1191, P133, DOI 10.1111/j.1749-6632.2010.05446.x; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; BRENNAN SC, 1988, LANCET, V2, P512; Chapman HA, 2010, PSYCHIAT RES-NEUROIM, V182, P160, DOI 10.1016/j.pscychresns.2010.01.005; Coull JT, 2000, NEUROPSYCHOLOGIA, V38, P808, DOI 10.1016/S0028-3932(99)00132-3; Coull JT, 2004, NEUROIMAGE, V22, P315, DOI 10.1016/j.neuroimage.2003.12.022; Courtier JL, 2011, J PEDIAT GASTROENTER; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Critchley HD, 2009, INT J PSYCHOPHYSIOL, V73, P88, DOI 10.1016/j.ijpsycho.2009.01.012; Dantendorfer K, 1997, MAGN RESON IMAGING, V15, P301, DOI 10.1016/S0730-725X(96)00385-2; Duncan NW, 2013, J PSYCHIATR NEUROSCI, V38, P84, DOI 10.1503/jpn.120059; Eatough EM, 2009, PSYCHONEUROENDOCRINO, V34, P1242, DOI 10.1016/j.psyneuen.2009.03.006; Elling L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018009; Esposito F, 2006, BRAIN RES BULL, V70, P263, DOI 10.1016/j.brainresbull.2006.06.012; Farrow TFD, 2013, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00349; Fechir M, 2010, NEUROIMAGE, V50, P847, DOI 10.1016/j.neuroimage.2009.12.004; FOOTE SL, 1987, ANNU REV NEUROSCI, V10, P67, DOI 10.1146/annurev.ne.10.030187.000435; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Friston KJ, 2005, NEUROIMAGE, V25, P661, DOI 10.1016/j.neuroimage.2005.01.013; Gamer M, 2007, HUM BRAIN MAPP, V28, P1287, DOI 10.1002/hbm.20343; Glascher J, 2009, NEUROINFORMATICS, V7, P73, DOI 10.1007/s12021-008-9042-x; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Jantzen KJ, 2007, NEUROPSYCHOLOGIA, V45, P673, DOI 10.1016/j.neuropsychologia.2006.07.020; Josephs O, 1999, PHILOS T R SOC B, V354, P1215, DOI 10.1098/rstb.1999.0475; KATZ RC, 1994, J BEHAV THER EXP PSY, V25, P131, DOI 10.1016/0005-7916(94)90005-1; Kern S, 2008, PSYCHONEUROENDOCRINO, V33, P517, DOI 10.1016/j.psyneuen.2008.01.010; King SO, 2009, LEARN MEMORY, V16, P625, DOI 10.1101/lm.1513109; Kvetnansky R, 2009, PHYSIOL REV, V89, P535, DOI 10.1152/physrev.00042.2006; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Loubinoux I, 2001, J CEREBR BLOOD F MET, V21, P592, DOI 10.1097/00004647-200105000-00014; Lueken U, 2012, PSYCHONEUROENDOCRINO; Lueken U, 2011, EUR NEUROPSYCHOPHARM, V21, P516, DOI 10.1016/j.euroneuro.2010.12.002; MACKENZIE R, 1995, CLIN RADIOL, V50, P137, DOI 10.1016/S0009-9260(05)83042-9; Maihofner C, 2011, NEUROIMAGE, V55, P216, DOI 10.1016/j.neuroimage.2010.11.061; Marshall J, 2007, CAN J NEUROL SCI, V34, P11, DOI 10.1017/S0317167100005734; MELENDEZ JC, 1993, JAMA-J AM MED ASSOC, V270, P745, DOI 10.1001/jama.270.6.745; Muehlhan M, 2011, INT J PSYCHOPHYSIOL, V79, P118, DOI 10.1016/j.ijpsycho.2010.09.009; Nater UM, 2009, PSYCHONEUROENDOCRINO, V34, P486, DOI 10.1016/j.psyneuen.2009.01.014; Piche M, 2010, PAIN, V149, P453, DOI 10.1016/j.pain.2010.01.005; Pacheco-Unguetti AP, 2010, PSYCHOL SCI, V21, P298, DOI 10.1177/0956797609359624; Qin SZ, 2009, BIOL PSYCHIAT, V66, P25, DOI 10.1016/j.biopsych.2009.03.006; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Raz A, 2005, NEUROIMAGE, V25, P1, DOI 10.1016/j.neuroimage.2004.11.015; Schwarze U, 2012, J NEUROSCI, V32, P1481, DOI 10.1523/JNEUROSCI.4497-11.2012; Skosnik PD, 2000, INT J PSYCHOPHYSIOL, V36, P59, DOI 10.1016/S0167-8760(99)00100-2; Smeets T, 2008, PSYCHONEUROENDOCRINO, V33, P1378, DOI 10.1016/j.psyneuen.2008.07.009; Smith A, 1996, NATURE, V380, P291, DOI 10.1038/380291a0; Specht K, 2003, J MAGN RESON IMAGING, V17, P463, DOI 10.1002/jmri.10277; Tessner KD, 2006, HUM BRAIN MAPP, V27, P889, DOI 10.1002/hbm.20229; Uddin LQ, 2010, CEREB CORTEX, V20, P2636, DOI 10.1093/cercor/bhq011; van Stegeren A, 2006, PSYCHONEUROENDOCRINO, V31, P137, DOI 10.1016/j.psyneuen.2005.05.012; Williams LM, 2001, NEUROIMAGE, V14, P1070, DOI 10.1006/nimg.2001.0904; Zandbelt BB, 2008, NEUROIMAGE, V42, P196, DOI 10.1016/j.neuroimage.2008.04.183; Zhang S, 2012, NEUROIMAGE, V62, P1489, DOI 10.1016/j.neuroimage.2012.05.036	55	21	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e72576	10.1371/journal.pone.0072576	http://dx.doi.org/10.1371/journal.pone.0072576			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967320	Green Published, gold, Green Submitted			2022-12-25	WOS:000323378000104
J	Campion, CG; Labrie, M; Lavoie, G; St-Pierre, Y				Campion, Carole G.; Labrie, Marilyne; Lavoie, Genevieve; St-Pierre, Yves			Expression of Galectin-7 Is Induced in Breast Cancer Cells by Mutant p53	PLOS ONE			English	Article							FACTOR-KAPPA-B; TUMOR PROGRESSION; MARKER; IDENTIFICATION; ACTIVATION; CARCINOMA; OVEREXPRESSION; METASTASIS; MUTATIONS; BIOMARKER	Galectin-7 was initially described as a marker of epithelial differentiation expressed in the stratified epithelium of various tissues. Like other members of the galectin family, its expression level is often significantly altered in cancer cells. In breast cancer, its expression is significantly augmented in aggressive molecular subtypes, most notably in estrogen receptor-negative tumors and in cell lines with a basal-like phenotype. Studies using experimental mouse models have further shown high expression of galectin-7 was sufficient to increase the metastatic behavior of poorly metastatic breast cancer cells, rendering them more resistant to apoptosis. This expression pattern in breast cancer cells is unexpected because galectin-7 was originally identified as a p53-induced gene. To address this paradox, we have examined the molecular mechanisms regulating galectin-7 in breast cancer cells. Our results showed that transfection of breast cancer cells with expression vectors encoding mutant p53 was sufficient to induce galectin-7 at both mRNA and protein levels. Doxorubicin treatment of breast cancer cells harboring a mutant p53 also induced galectin-7. This induction was specific since knockdown of endogenous mutant p53 inhibited doxorubicin-induced galectin-7 expression. The p53-induced galectin-7 expression in breast cancer cells correlated with increased NF-kappa B activity and was inhibited by NF-kappa B inhibitors, indicating that the ability of mutant p53 to induce galectin-7 was dependent on NF-kappa B activity. The implication of NF-kappa B was further supported by data showing that NF-kappa B bound to the endogenous galectin-7 promoter and that TNF alpha-induced galectin-7 expression was abolished by NF-kappa B inhibitors. Taken together, our data provide an explanation to the observed high galectin-7 expression levels in cancer cells and suggest that galectin-7 could be part of a common pathway used by mutant p53 to promote cancer progression.	[Campion, Carole G.; Labrie, Marilyne; Lavoie, Genevieve; St-Pierre, Yves] Univ Quebec, Inst Armand Frappier, Inst Natl Rech Sci, Laval, PQ, Canada	University of Quebec; Institut national de la recherche scientifique (INRS)	St-Pierre, Y (corresponding author), Univ Quebec, Inst Armand Frappier, Inst Natl Rech Sci, Laval, PQ, Canada.	yves.st-pierre@iaf.inrs.ca		St-Pierre, Yves/0000-0002-1948-2041; Labrie, Marilyne/0000-0003-3957-5533	Canadian Institutes for Health Research [MOP-89697]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by the Canadian Institutes for Health Research (Grant No. MOP-89697). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; Bektas S, 2010, PATHOL ONCOL RES, V16, P569, DOI 10.1007/s12253-010-9248-8; Bernerd F, 1999, P NATL ACAD SCI USA, V96, P11329, DOI 10.1073/pnas.96.20.11329; Bidard FC, 2007, ANN ONCOL, V18, P1285, DOI 10.1093/annonc/mdm360; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bullock AN, 2000, ONCOGENE, V19, P1245, DOI 10.1038/sj.onc.1203434; Cho SY, 2003, MOL CELL BIOCHEM, V243, P153, DOI 10.1023/A:1021624520740; Demers M, 2010, AM J PATHOL, V176, P3023, DOI 10.2353/ajpath.2010.090876; Gendronneau G, 2008, MOL BIOL CELL, V19, P5541, DOI 10.1091/mbc.E08-02-0166; Gomez-Brouchet A, 2010, HUM PATHOL, V41, P1220, DOI 10.1016/j.humpath.2009.10.028; Hainaut P, 2000, ADV CANCER RES, V77, P81; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Jung EJ, 2007, INT J CANCER, V120, P2331, DOI 10.1002/ijc.22434; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kuwabara I, 2002, J BIOL CHEM, V277, P3487, DOI 10.1074/jbc.M109360200; LEHMAN TA, 1993, CARCINOGENESIS, V14, P833, DOI 10.1093/carcin/14.5.833; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Magnaldo T, 1998, DIFFERENTIATION, V63, P159, DOI 10.1046/j.1432-0436.1998.6330159.x; Mayoral MA, 2008, CANCER INVEST, V26, P615, DOI 10.1080/07357900701837051; Mourskaia AA, 2009, ONCOGENE, V28, P1005, DOI 10.1038/onc.2008.454; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; Oka N, 2004, J CELL BIOCHEM, V91, P118, DOI 10.1002/jcb.10663; Orlandi F, 1998, CANCER RES, V58, P3015; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Saussez S, 2008, HISTOPATHOLOGY, V52, P483, DOI 10.1111/j.1365-2559.2008.02973.x; Saussez S, 2006, CELL MOL LIFE SCI, V63, P686, DOI 10.1007/s00018-005-5458-8; Schneider G, 2010, ONCOGENE, V29, P2795, DOI 10.1038/onc.2010.46; Scian MJ, 2005, MOL CELL BIOL, V25, P10097, DOI 10.1128/MCB.25.22.10097-10110.2005; St-Pierre Y, 2012, FRONT BIOSCI-LANDMRK, V17, P438, DOI 10.2741/3937; Takata T, 2012, ONCOL REP, V28, P1968, DOI 10.3892/or.2012.2020; Tang CE, 2010, ONCOL REP, V24, P495, DOI 10.3892/or_00000884; Villeneuve C, 2011, MOL BIOL CELL, V22, P999, DOI 10.1091/mbc.E10-06-0534; Weisz L, 2007, CANCER RES, V67, P2396, DOI 10.1158/0008-5472.CAN-06-2425; Zhu X, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-290	36	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e72468	10.1371/journal.pone.0072468	http://dx.doi.org/10.1371/journal.pone.0072468			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967302	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000323221500132
J	Forwood, SE; Ahern, A; Hollands, GJ; Fletcher, PC; Marteau, TM				Forwood, Suzanna E.; Ahern, Amy; Hollands, Gareth J.; Fletcher, Paul C.; Marteau, Theresa M.			Underestimating Calorie Content When Healthy Foods Are Present: An Averaging Effect or a Reference-Dependent Anchoring Effect?	PLOS ONE			English	Article							PSYCHOLOGY; NUTRITION; VICES	Objective: Previous studies have shown that estimations of the calorie content of an unhealthy main meal food tend to be lower when the food is shown alongside a healthy item (e. g. fruit or vegetables) than when shown alone. This effect has been called the negative calorie illusion and has been attributed to averaging the unhealthy (vice) and healthy (virtue) foods leading to increased perceived healthiness and reduced calorie estimates. The current study aimed to replicate and extend these findings to test the hypothesized mediating effect of ratings of healthiness of foods on calorie estimates. Methods: In three online studies, participants were invited to make calorie estimates of combinations of foods. Healthiness ratings of the food were also assessed. Results: The first two studies failed to replicate the negative calorie illusion. In a final study, the use of a reference food, closely following a procedure from a previously published study, did elicit a negative calorie illusion. No evidence was found for a mediating role of healthiness estimates. Conclusion: The negative calorie illusion appears to be a function of the contrast between a food being judged and a reference, supporting the hypothesis that the negative calorie illusion arises from the use of a reference-dependent anchoring and adjustment heuristic and not from an 'averaging' effect, as initially proposed. This finding is consistent with existing data on sequential calorie estimates, and highlights a significant impact of the order in which foods are viewed on how foods are evaluated.	[Forwood, Suzanna E.; Hollands, Gareth J.; Marteau, Theresa M.] Univ Cambridge, Dept Publ Hlth & Primary Care, Behav & Hlth Res Unit, Cambridge, England; [Ahern, Amy] Med Res Council Human Nutr Res, Cambridge, England; [Fletcher, Paul C.] Univ Cambridge, Dept Psychiat, Cambridge, England	University of Cambridge; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; University of Cambridge; University of Cambridge	Forwood, SE (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Behav & Hlth Res Unit, Cambridge, England.	Sef26@cam.ac.uk	Forwood, Suzanna/A-5376-2008; Fletcher, Paul/F-5380-2011	Forwood, Suzanna/0000-0002-8406-5121; Marteau, Theresa/0000-0003-3025-1129; Fletcher, Paul/0000-0001-8257-1517; Hollands, Gareth/0000-0002-0492-3924; Ahern, Amy/0000-0001-5069-4758	Department of Health, UK; MRC [MC_U105960389] Funding Source: UKRI; Medical Research Council [MC_U105960389] Funding Source: researchfish	Department of Health, UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Department of Health, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2011, BRIT J NUTR, V105, P810, DOI 10.1017/S0007114510004435; Bargh JA, 1996, J PERS SOC PSYCHOL, V71, P230, DOI 10.1037/0022-3514.71.2.230; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Bem DJ, 2011, J PERS SOC PSYCHOL, V100, P407, DOI 10.1037/a0021524; Chandon P, 2007, J CONSUM RES, V34, P301, DOI 10.1086/519499; Chernev A, 2011, J CONSUM PSYCHOL, V21, P178, DOI 10.1016/j.jcps.2010.08.002; Chernev A, 2011, J CONSUM RES, V37, P761, DOI 10.1086/656731; Chernev A, 2010, J MARKETING RES, V47, P738, DOI 10.1509/jmkr.47.4.738; Doyen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029081; Horton J., 2011, EXP ECON, V14, P1; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Karlsson J, 2000, INT J OBESITY, V24, P1715, DOI 10.1038/sj.ijo.0801442; Makel MC, 2012, PERSPECT PSYCHOL SCI, V7, P537, DOI 10.1177/1745691612460688; Pashler H, 2012, PERSPECT PSYCHOL SCI, V7, P528, DOI 10.1177/1745691612465253; Ritchie SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033423; Rozin P, 1996, HEALTH PSYCHOL, V15, P438, DOI 10.1037//0278-6133.15.6.438; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Wansink B, 2006, J MARKETING RES, V43, P605, DOI 10.1509/jmkr.43.4.605	19	7	7	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71475	10.1371/journal.pone.0071475	http://dx.doi.org/10.1371/journal.pone.0071475			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	202MQ	23967216	Green Published, gold, Green Submitted			2022-12-25	WOS:000323221500086
J	Marazioti, A; Kairi, CA; Spella, M; Giannou, AD; Magkouta, S; Giopanou, I; Papaleonidopoulos, V; Kalomenidis, I; Snyder, LA; Kardamakis, D; Stathopoulos, GT				Marazioti, Antonia; Kairi, Chrysoula A.; Spella, Magda; Giannou, Anastasios D.; Magkouta, Sophia; Giopanou, Ioanna; Papaleonidopoulos, Vassilios; Kalomenidis, Ioannis; Snyder, Linda A.; Kardamakis, Dimitrios; Stathopoulos, Georgios T.			Beneficial Impact of CCL2 and CCL12 Neutralization on Experimental Malignant Pleural Effusion	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; LUNG-CANCER; TALC PLEURODESIS; GROWTH; PERMEABILITY; EXPRESSION; INVASION; CELLS	Using genetic interventions, we previously determined that C-C motif chemokine ligand 2 (CCL2) promotes malignant pleural effusion (MPE) formation in mice. Here we conducted preclinical studies aimed at assessing the specific therapeutic potential of antibody-mediated CCL2 blockade against MPE. For this, murine MPEs or skin tumors were generated in C57BL/6 mice by intrapleural or subcutaneous delivery of lung (LLC) or colon (MC38) adenocarcinoma cells. Human lung adenocarcinoma cells (A549) were used to induce MPEs in severe combined immunodeficient mice. Intraperitoneal antibodies neutralizing mouse CCL2 and/or CCL12, a murine CCL2 ortholog, were administered at 10 or 50 mg/kg every three days. We found that high doses of CCL2/12 neutralizing antibody treatment (50 mg/kg) were required to limit MPE formation by LLC cells. CCL2 and CCL12 blockade were equally potent inhibitors of MPE development by LLC cells. Combined CCL2 and CCL12 neutralization was also effective against MC38-induced MPE and prolonged the survival of mice in both syngeneic models. Mouse-specific CCL2-blockade limited A549-caused xenogeneic MPE, indicating that host-derived CCL2 also contributes to MPE precipitation in mice. The impact of CCL2/12 antagonism was associated with inhibition of immune and vascular MPE-related phenomena, such as inflammation, new blood vessel assembly and plasma extravasation into the pleural space. We conclude that CCL2 and CCL12 blockade are effective against experimental MPE induced by murine and human adenocarcinoma in mice. These results suggest that CCL2-targeted therapies may hold promise for future use against human MPE.	[Marazioti, Antonia; Spella, Magda; Giannou, Anastasios D.; Giopanou, Ioanna; Papaleonidopoulos, Vassilios; Stathopoulos, Georgios T.] Univ Patras, Lab Mol Resp Carcinogenesis, Dept Physiol, Fac Med, Rion, Achaia, Greece; [Kairi, Chrysoula A.; Magkouta, Sophia; Kalomenidis, Ioannis; Stathopoulos, Georgios T.] Univ Athens, Sch Med, Dept Crit Care & Pulm Med 1, Gen Hosp Evangelismos, GR-11527 Athens, Attica, Greece; [Snyder, Linda A.] Janssen R&D LLC, Oncol Discovery Res, Spring House, PA USA; [Kardamakis, Dimitrios] Univ Patras, Dept Radiat Oncol & Stereotact Radiotherapy, Fac Med, Rion, Achaia, Greece	University of Patras; Athens Medical School; National & Kapodistrian University of Athens; Johnson & Johnson; Janssen Pharmaceuticals; University of Patras	Stathopoulos, GT (corresponding author), Univ Patras, Lab Mol Resp Carcinogenesis, Dept Physiol, Fac Med, Rion, Achaia, Greece.	gstathop@upatras.gr	Stathopoulos, Georgios/D-6576-2013; Stathopoulos, Georgios/AAE-6884-2020; Kalomenidis, Ioannis/AAD-7521-2019	Stathopoulos, Georgios/0000-0002-9215-6461; Giopanou, Ioanna/0000-0003-4393-7517; MARAZIOTI, ANTONIA/0000-0002-1978-1121	European Research Council under the European Community's Seventh Framework Program [FP7-IDEAS-ERC-StG-2010-260524-KRASHIMPE]; 'Thorax' Foundation, Athens, Greece	European Research Council under the European Community's Seventh Framework Program(European Research Council (ERC)); 'Thorax' Foundation, Athens, Greece	This work was supported in part by a European Research Council (http://erc.europa.eu/) Starting Independent Investigator Grant (http://erc.europa.eu/ starting-grants) under the European Community's Seventh Framework Program (FP7-IDEAS-ERC-StG-2010-260524-KRASHIMPE to GTS; http://cordis.europa.eu/search/index.cfm?fuseaction = proj.document&PJ_LANG = EN&PJ_RCN = 11789622&pid = 0&q = 61222D4F193AC74A3C679CD344AD41B0&type = sim) and by the 'Thorax' Foundation, Athens, Greece (to CAK, SM, IK, and GTS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broermann A, 2011, J EXP MED, V208, P2393, DOI 10.1084/jem.20110525; Burgers JA, 2008, EUR RESPIR J, V32, P1321, DOI 10.1183/09031936.00165607; Cao YA, 2005, TRANSPLANTATION, V80, P134, DOI 10.1097/01.TP.0000164347.50559.A3; Davies HE, 2012, JAMA-J AM MED ASSOC, V307, P2383, DOI 10.1001/jama.2012.5535; Fridlender ZG, 2011, AM J RESP CELL MOL, V44, P230, DOI 10.1165/rcmb.2010-0080OC; Fridlender ZG, 2010, CANCER RES, V70, P109, DOI 10.1158/0008-5472.CAN-09-2326; Froudarakis ME, 2012, RESPIRATION, V83, P367, DOI 10.1159/000338169; GOOD JT, 1985, AM REV RESPIR DIS, V131, P737; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang B, 2007, CANCER LETT, V252, P86, DOI 10.1016/j.canlet.2006.12.012; Kalomenidis I, 2011, RESPIROLOGY, V16, P1020, DOI 10.1111/j.1440-1843.2011.02023.x; Koller FL, 2010, CARCINOGENESIS, V31, P1010, DOI 10.1093/carcin/bgq044; Lee YCG, 2008, AM J RESP CRIT CARE, V178, P3, DOI 10.1164/rccm.200804-616ED; Light RW, 1997, EUR RESPIR J, V10, P476, DOI 10.1183/09031936.97.10020476; Magkouta S, 2009, NUTR CANCER, V61, P640, DOI 10.1080/01635580902825647; Maker AV, 2005, ANN THORAC SURG, V80, P1941, DOI 10.1016/j.athoracsur.2003.11.065; Maskell NA, 2012, JAMA-J AM MED ASSOC, V307, P2432, DOI 10.1001/jama.2012.5543; Moschos C, 2011, LUNG CANCER, V73, P171, DOI 10.1016/j.lungcan.2010.12.005; Moschos C, 2009, NEOPLASIA, V11, P298, DOI 10.1593/neo.81480; Muller WA, 2001, J EXP MED, V194, pF47, DOI 10.1084/jem.194.9.f47; Munson JM, 2013, CANCER RES, V73, P1536, DOI 10.1158/0008-5472.CAN-12-2838; Pages F, 2010, ONCOGENE, V29, P1093, DOI 10.1038/onc.2009.416; Pichelmayer O, 2006, Ann Oncol, V17, P1853, DOI 10.1093/annonc/mdl143; Pienta KJ, 2013, INVEST NEW DRUG, V31, P760, DOI 10.1007/s10637-012-9869-8; Psallidas I, 2013, ONCOGENE, V32, P528, DOI 10.1038/onc.2012.57; Psallidas I, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-56; Puri V, 2012, ANN THORAC SURG, V94, P374, DOI 10.1016/j.athoracsur.2012.02.100; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; Sarafi MN, 1997, J EXP MED, V185, P99, DOI 10.1084/jem.185.1.99; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stathopoulos GT, 2008, JNCI-J NATL CANCER I, V100, P1464, DOI 10.1093/jnci/djn325; Stathopoulos GT, 2008, AM J RESP CRIT CARE, V178, P50, DOI 10.1164/rccm.200710-1513OC; Stathopoulos GT, 2007, CANCER RES, V67, P9825, DOI 10.1158/0008-5472.CAN-07-1064; Stathopoulos GT, 2012, AM J RESP CRIT CARE, V186, P487, DOI 10.1164/rccm.201203-0465PP; Stathopoulos GT, 2011, RESPIROLOGY, V16, P53, DOI 10.1111/j.1440-1843.2010.01890.x; Stathopoulos GT, 2010, AM J RESP CRIT CARE, V182, P1273, DOI 10.1164/rccm.201001-0001OC; Stathopoulos GT, 2006, AM J RESP CELL MOL, V34, P142, DOI 10.1165/rcmb.2005-0130OC; Tsui Ping, 2007, Human Antibodies, V16, P117; Wu SG, 2012, EUR RESP J IN PRESS; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Yano S, 2000, AM J PATHOL, V157, P1893, DOI 10.1016/S0002-9440(10)64828-6; Zaynagetdinov R, 2013, AM J RESP C IN PRESS; Zebrowski BK, 1999, CLIN CANCER RES, V5, P3364; Zhang J, 2010, CYTOKINE GROWTH F R, V21, P41, DOI 10.1016/j.cytogfr.2009.11.009	45	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71207	10.1371/journal.pone.0071207	http://dx.doi.org/10.1371/journal.pone.0071207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967166	gold, Green Published, Green Submitted			2022-12-25	WOS:000323221500058
J	Holtgrieve, GW; Arias, ME; Irvine, KN; Lamberts, D; Ward, EJ; Kummu, M; Koponen, J; Sarkkula, J; Richey, JE				Holtgrieve, Gordon W.; Arias, Mauricio E.; Irvine, Kim N.; Lamberts, Dirk; Ward, Eric J.; Kummu, Matti; Koponen, Jorma; Sarkkula, Juha; Richey, Jeffrey E.			Patterns of Ecosystem Metabolism in the Tonle Sap Lake, Cambodia with Links to Capture Fisheries	PLOS ONE			English	Article							CLIMATE-CHANGE; MEKONG; VARIABILITY; OXYGEN; IMPACT	The Tonle Sap Lake in Cambodia is a dynamic flood-pulsed ecosystem that annually increases its surface area from roughly 2,500 km(2) to over 12,500 km(2) driven by seasonal flooding from the Mekong River. This flooding is thought to structure many of the critical ecological processes, including aquatic primary and secondary productivity. The lake also has a large fishery that supports the livelihoods of nearly 2 million people. We used a state-space oxygen mass balance model and continuous dissolved oxygen measurements from four locations to provide the first estimates of gross primary productivity (GPP) and ecosystem respiration (ER) for the Tonle Sap. GPP averaged 4.1 +/- 2.3 g O-2 m(-3) d(-1) with minimal differences among sites. There was a negative correlation between monthly GPP and lake level (r = 0.45) and positive correlation with turbidity (r = 0.65). ER averaged 24.9 +/- 20.0 g O-2 m(-3) d(-1) but had greater than six-fold variation among sites and minimal seasonal change. Repeated hypoxia was observed at most sampling sites along with persistent net heterotrophy (GPP < ER), indicating significant bacterial metabolism of organic matter that is likely incorporated into the larger food web. Using our measurements of GPP, we calibrated a hydrodynamic-productivity model and predicted aquatic net primary production (aNPP) of 2.0 +/- 0.2 g C m(-2) d(-1) (2.4 +/- 0.2 million tonnes C y(-1)). Considering a range of plausible values for the total fisheries catch, we estimate that fisheries harvest is an equivalent of 7-69% of total aNPP, which is substantially larger than global average for marine and freshwater systems. This is likely due to relatively efficient carbon transfer through the food web and support of fish production from terrestrial NPP. These analyses are an important first-step in quantifying the resource pathways that support this important ecosystem.	[Holtgrieve, Gordon W.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Arias, Mauricio E.] Univ Canterbury, Dept Civil & Nat Resources Engn, Christchurch 1, New Zealand; [Irvine, Kim N.] SUNY Buffalo, Dept Geog Planning, Buffalo, NY 14260 USA; [Irvine, Kim N.] SUNY Buffalo, Ctr Southeast Asia Environm & Sustainable Dev, Buffalo, NY 14260 USA; [Lamberts, Dirk] Katholieke Univ Leuven, Lab Aquat Ecol Evolut & Conservat, Louvain, Belgium; [Ward, Eric J.] NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Conservat Biol Div, Seattle, WA 98112 USA; [Kummu, Matti] Aalto Univ, Water & Dev Res Grp, Espoo, Finland; [Koponen, Jorma] Environm Impact Assessment Ctr Finland Ltd, Espoo, Finland; [Sarkkula, Juha] Finnish Environm Inst, Helsinki, Finland; [Richey, Jeffrey E.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Canterbury; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; KU Leuven; National Oceanic Atmospheric Admin (NOAA) - USA; Aalto University; Finnish Environment Institute; University of Washington; University of Washington Seattle	Holtgrieve, GW (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	gholt@uw.edu	Arias, Mauricio/H-5667-2013; Kummu, Matti/C-4797-2011; Holtgrieve, Gordon/C-5371-2009	Arias, Mauricio/0000-0002-8805-6353; Kummu, Matti/0000-0001-5096-0163; Holtgrieve, Gordon/0000-0002-4451-3567	University of Washington School of Aquatic and Fishery Sciences; John D. and Catherine T. MacArthur Foundation; Gordon and Betty Moore Foundation; NASA IDS [NNX07AL78G]; SUNY Research Foundation	University of Washington School of Aquatic and Fishery Sciences(University of Washington); John D. and Catherine T. MacArthur Foundation; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NASA IDS; SUNY Research Foundation	GWH was supported by the University of Washington School of Aquatic and Fishery Sciences, John D. and Catherine T. MacArthur Foundation, and the Gordon and Betty Moore Foundation. This paper was completed while KNI was on sabbatical at the National Institute of Education, Nanyang Technological University, Singapore. Research was funded in part by NASA IDS NNX07AL78G and the SUNY Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alin SR, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002881; Arias ME, 2012, J ENVIRON MANAGE, V112, P53, DOI 10.1016/j.jenvman.2012.07.003; Batt RD, 2012, LIMNOL OCEANOGR-METH, V10, P20, DOI 10.4319/lom.2012.10.20; Deap L, 1998, CATCH STAT CAMBODIAN; Denwood M.J., 2011, RUNJAGS RUN BAYESIAN; Francis RICC, 1997, CAN J FISH AQUAT SCI, V54, P1699, DOI 10.1139/cjfas-54-8-1699; Froese R., 2003, FISHBASE; GW Holtgrieve, UNPUB; Hand RT, 2002, THESIS U MARYLAND; HECKY RE, 1981, T AM FISH SOC, V110, P336, DOI 10.1577/1548-8659(1981)110<336:RBPPAF>2.0.CO;2; Hilborn Ray, 1997, V28; Ho DT, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006854; Holtgrieve GW, 2010, LIMNOL OCEANOGR, V55, P1047, DOI 10.4319/lo.2010.55.3.1047; Hortle K.G., 2007, MRC TECH PAP; Irvine KN, 2011, INT J RIVER BASIN MA, V9, P151, DOI 10.1080/15715124.2011.621430; Johnston R, 2012, WATER RESOUR MANAG, V26, P429, DOI 10.1007/s11269-011-9925-8; JUNK W J, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P110; Junk W. J., 1997, CENTRAL AMAZON FLOOD; Koponen J, 2010, DETAILED MODELLING S; Kummu M, 2010, GEOMORPHOLOGY, V119, P181, DOI 10.1016/j.geomorph.2010.03.018; Kummu M, 2008, AMBIO, V37, P185, DOI 10.1579/0044-7447(2008)37[185:IOTMRF]2.0.CO;2; Kummu M, 2008, AMBIO, V37, P158, DOI 10.1579/0044-7447(2008)37[158:SCOBFT]2.0.CO;2; Lamberts D., 2001, TONLE SAP FISHERIES; Lamberts D, 2006, INT J WATER RESOUR D, V22, P481, DOI 10.1080/07900620500482592; Larnberts D, 2008, AMBIO, V37, P178, DOI 10.1579/0044-7447(2008)37[178:FPAAPO]2.0.CO;2; Lauri H, 2012, HYDROL EARTH SYST SC, V16, P4603, DOI 10.5194/hess-16-4603-2012; Likens GE., 1975, PRIMARY PRODUCTIVITY, P185, DOI [10.1007/978-3-642-80913-2_9, DOI 10.1007/978-3-642-80913-2_9]; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; McCann K., COMMUNICATION; MELACK JM, 1976, T AM FISH SOC, V105, P575, DOI 10.1577/1548-8659(1976)105<575:PPAFYI>2.0.CO;2; MRC, 2008, ANN REP 2008; ODUM HT, 1956, LIMNOL OCEANOGR, V1, P102, DOI 10.4319/lo.1956.1.2.0102; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; RICH PH, 1978, AM NAT, V112, P57, DOI 10.1086/283252; Sanseverino AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042723; Sarkkula J, 2003, MODELLING T IN PRESS; Schindler DE, 2002, OIKOS, V98, P177, DOI 10.1034/j.1600-0706.2002.980201.x; Solomon CT, 2013, LIMNOL OCEANOGR, V58, P849, DOI 10.4319/lo.2013.58.3.0849; Staehr PA, 2012, AQUAT SCI, V74, P15, DOI 10.1007/s00027-011-0199-2; Stone R, 2011, SCIENCE, V333, P814, DOI 10.1126/science.333.6044.814; Su Y.-S., 2012, R2JAGS PACKAGE RUNNI; Van de Bogert MC, 2007, LIMNOL OCEANOGR-METH, V5, P145, DOI 10.4319/lom.2007.5.145; van Zalinge NP, 2002, CATCH CULTURE, P1; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; WANNINKHOF R, 1992, J GEOPHYS RES-OCEANS, V97, P7373, DOI 10.1029/92JC00188; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER, DOI DOI 10.1046/J.1529-8817.2001.37602.X; Ziv G, 2012, P NATL ACAD SCI USA, V109, P5609, DOI 10.1073/pnas.1201423109	47	36	37	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71395	10.1371/journal.pone.0071395	http://dx.doi.org/10.1371/journal.pone.0071395			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967203	gold, Green Published, Green Submitted			2022-12-25	WOS:000323115800055
J	Nguyen, NP; Ceizyk, M; Vock, J; Vos, P; Chi, A; Vincent, VH; Pugh, J; Khan, R; Truong, C; Albala, G; Locke, A; Karlsson, U; Gelumbauskas, S; Smith-Raymond, L				Nguyen, Nam P.; Ceizyk, Misty; Vock, Jacqueline; Vos, Paul; Chi, Alexander; Vincent Vinh-Hung; Pugh, Judy; Khan, Rihan; Christina Truong; Albala, Gabby; Locke, Angela; Karlsson, Ulf; Gelumbauskas, Steve; Smith-Raymond, Lexie			Feasibility of Image-Guided Radiotherapy for Elderly Patients with Locally Advanced Rectal Cancer	PLOS ONE			English	Article							INTENSITY-MODULATED RADIOTHERAPY; PREOPERATIVE HELICAL TOMOTHERAPY; PHASE-III TRIAL; RADIATION-THERAPY; POSTOPERATIVE CHEMORADIOTHERAPY; CAPECITABINE; RADIOCHEMOTHERAPY; OXALIPLATIN; TOXICITY; BOOST	Purpose: The study aims to assess the tolerance of elderly patients (70 years or older) with locally advanced rectal cancers to image-guided radiotherapy (IGRT). A retrospective review of 13 elderly patients with locally advanced rectal cancer who underwent preoperative chemoradiation using IGRT was performed. Grade 3-4 acute toxicities, survival, and long-term complications were compared to 17 younger patients (<70 years) with the same disease stage. Results: Grade 3-4 hematologic toxicities occurred in 7.6% and 0% (p = 0.4) and gastrointestinal toxicities, and, in 15.2% and 5% (p = 0.5), of elderly and younger patients, respectively. Surgery was aborted in three patients, two in the elderly group and one in the younger group. One patient in the elderly group died after surgery from cardiac arrhythmia. After a median follow-up of 34 months, five patients had died, two in the elderly and three in the younger group. The 3-year survival was 90.9% and 87.5% (p = 0.7) for the elderly and younger group respectively. Two patients in the younger group developed ischemic colitis and fecal incontinence. There was no statistically significant difference in acute and late toxicities as well as survival between the two groups. Conclusions and Clinical Relevance: Elderly patients with locally advanced rectal cancers may tolerate preoperative chemoradiation with IGRT as well as younger patients. Further prospective studies should be performed to investigate the potential of IGRT for possible cure in elderly patients with locally advanced rectal cancer.	[Nguyen, Nam P.; Ceizyk, Misty; Christina Truong; Albala, Gabby; Locke, Angela; Gelumbauskas, Steve; Smith-Raymond, Lexie] Univ Arizona, Dept Radiat Oncol, Tucson, AZ 85721 USA; [Vock, Jacqueline] Lindenhofspital, Dept Radiat Oncol, Bern, Switzerland; [Vos, Paul] E Carolina Univ, Dept Biostat, Greenville, NC USA; [Chi, Alexander] W Virginia Univ, Dept Radiat Oncol, Morgantown, WV 26506 USA; [Vincent Vinh-Hung] Univ Hosp Geneva, Dept Radiat Oncol, Geneva, Switzerland; [Pugh, Judy] Univ Arizona, Dept Pathol, Tucson, AZ 85721 USA; [Khan, Rihan] Univ Arizona, Dept Radiol, Tucson, AZ 85721 USA; [Karlsson, Ulf] Marshfield Clin Fdn Med Res & Educ, Dept Radiat Oncol, Marshfield, WI USA	University of Arizona; University of North Carolina; East Carolina University; West Virginia University; University of Geneva; University of Arizona; University of Arizona; Marshfield Clinic	Nguyen, NP (corresponding author), Univ Arizona, Dept Radiat Oncol, Tucson, AZ 85721 USA.	NamPhong.Nguyen@yahoo.com	Vinh-Hung, Vincent/A-5762-2008	Vinh-Hung, Vincent/0000-0002-6403-6120				Aparicio T, 2009, CRIT REV ONCOL HEMAT, V71, P249, DOI 10.1016/j.critrevonc.2008.11.006; Arbea L, 2012, INT J RADIAT ONCOL, V83, P587, DOI 10.1016/j.ijrobp.2011.06.2008; Arbea L, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-17; Ballonoff A, 2008, AM J CLIN ONCOL-CANC, V31, P264, DOI 10.1097/COC.0b013e318161dbd3; Beavis AW, 2004, BRIT J RADIOL, V77, P285, DOI 10.1259/bjr/22666727; Chang GJ, 2007, ANN SURG, V246, P215, DOI 10.1097/SLA.0b013e318070838f; Chen RC, 2012, INT J RADIAT ONCOL, V83, pE513, DOI 10.1016/j.ijrobp.2012.01.013; Chi A, 2012, TECHNOL CANCER RES T, V11, P353, DOI 10.7785/tcrt.2012.500283; Dale David C, 2003, J Support Oncol, V1, P11; Engels B, 2012, INT J RADIAT ONCOL, V83, P142, DOI 10.1016/j.ijrobp.2011.05.068; Engels B, 2009, INT J RADIAT ONCOL, V74, P1476, DOI 10.1016/j.ijrobp.2008.10.017; Hofheinz RD, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70116-X; Ippolito E, 2008, ACTA ONCOL, V47, P1317, DOI 10.1080/02841860802256459; Jabbour SK, 2012, INT J SURG ONCOL, V2012, DOI 10.1155/2012/891067; Kalofonos HP, 2008, EUR J CANCER, V44, P1693, DOI 10.1016/j.ejca.2008.05.025; Kiran RP, 2007, DIS COLON RECTUM, V50, P604, DOI 10.1007/s10350-006-0802-0; Li JL, 2012, RADIOTHER ONCOL, V102, P4, DOI 10.1016/j.radonc.2011.07.030; Margalit DN, 2011, INT J RADIAT ONCOL, V81, pE735, DOI 10.1016/j.ijrobp.2010.12.056; Nguyen NP, 2011, ANN SURG ONCOL, V18, P380, DOI 10.1245/s10434-010-1329-0; Samuelian JM, 2012, INT J RADIAT ONCOL, V82, P1981, DOI 10.1016/j.ijrobp.2011.01.051; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Sauer R, 2012, J CLIN ONCOL, V30, P1926, DOI 10.1200/JCO.2011.40.1836; Winkler J, 2012, STRAHLENTHER ONKOL, V188, P377, DOI 10.1007/s00066-012-0073-8	23	3	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71250	10.1371/journal.pone.0071250	http://dx.doi.org/10.1371/journal.pone.0071250			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967173	Green Published, Green Submitted, gold			2022-12-25	WOS:000323115800045
J	Samaran, F; Stafford, KM; Branch, TA; Gedamke, J; Royer, JY; Dziak, RP; Guinet, C				Samaran, Flore; Stafford, Kathleen M.; Branch, Trevor A.; Gedamke, Jason; Royer, Jean-Yves; Dziak, Robert P.; Guinet, Christophe			Seasonal and Geographic Variation of Southern Blue Whale Subspecies in the Indian Ocean	PLOS ONE			English	Article								Understanding the seasonal movements and distribution patterns of migratory species over ocean basin scales is vital for appropriate conservation and management measures. However, assessing populations over remote regions is challenging, particularly if they are rare. Blue whales (Balaenoptera musculus spp) are an endangered species found in the Southern and Indian Oceans. Here two recognized subspecies of blue whales and, based on passive acoustic monitoring, four "acoustic populations" occur. Three of these are pygmy blue whale (B. m. brevicauda) populations while the fourth is the Antarctic blue whale (B. m. intermedia). Past whaling catches have dramatically reduced their numbers but recent acoustic recordings show that these oceans are still important habitat for blue whales. Presently little is known about the seasonal movements and degree of overlap of these four populations, particularly in the central Indian Ocean. We examined the geographic and seasonal occurrence of different blue whale acoustic populations using one year of passive acoustic recording from three sites located at different latitudes in the Indian Ocean. The vocalizations of the different blue whale subspecies and acoustic populations were recorded seasonally in different regions. For some call types and locations, there was spatial and temporal overlap, particularly between Antarctic and different pygmy blue whale acoustic populations. Except on the southernmost hydrophone, all three pygmy blue whale acoustic populations were found at different sites or during different seasons, which further suggests that these populations are generally geographically distinct. This unusual blue whale diversity in sub-Antarctic and sub-tropical waters indicates the importance of the area for blue whales in these former whaling grounds.	[Samaran, Flore; Guinet, Christophe] Univ La Rochelle, Observ PELAGIS, CNRS, UMS 3462, La Rochelle, France; [Stafford, Kathleen M.] Univ Washington, Appl Phys Lab, Seattle, WA 98105 USA; [Branch, Trevor A.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Gedamke, Jason] NOAA, Ocean Acoust Program, Off Sci & Technol, Natl Marine Fisheries Serv, Silver Spring, MD USA; [Royer, Jean-Yves] Univ Brest, CNRS, Lab Domaines Ocean, UMR 6538, Plouzane, France; [Dziak, Robert P.] NOAA, Pacific Marine Environm Lab, Newport, OR USA; [Samaran, Flore; Guinet, Christophe] CNRS, Ctr Etud Biol Chize, UPR 1934, Villiers En Bois, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Bretagne Occidentale; National Oceanic Atmospheric Admin (NOAA) - USA; Centre National de la Recherche Scientifique (CNRS)	Samaran, F (corresponding author), Univ La Rochelle, Observ PELAGIS, CNRS, UMS 3462, La Rochelle, France.	fsamaran@univ-lr.fr	Guinet, Christophe/AAR-8457-2020; Royer, Jean-Yves/B-4312-2010; Dziak, Robert/AAC-6107-2020	Royer, Jean-Yves/0000-0002-7653-7715; Stafford, Kathleen/0000-0003-0039-5025	Conseil Regional de Bretagne; Institut National des Sciences de l'Univers (a department of the Centre National de la Recherche Scientifique, France); Institut Paul Emile Victor; Total Foundation; NOAA's Ocean Exploration and Research program; French Minister of Ecology; Terres Australes et Antarctiques Francaises; University of La Rochelle	Conseil Regional de Bretagne(Region Bretagne); Institut National des Sciences de l'Univers (a department of the Centre National de la Recherche Scientifique, France); Institut Paul Emile Victor; Total Foundation(Total SA); NOAA's Ocean Exploration and Research program; French Minister of Ecology; Terres Australes et Antarctiques Francaises; University of La Rochelle	Funding for deployment and recovery for the hydrophone array in the Indian Ocean was provided by the Conseil Regional de Bretagne, the Institut National des Sciences de l'Univers (a department of the Centre National de la Recherche Scientifique, France), Institut Paul Emile Victor, Total Foundation and the NOAA's Ocean Exploration and Research program that provided support to the Pacific Marine Environmental Laboratory to build the hydrophones and moorings for the DEFLO experiment. Analysis and writing were supported by French Minister of Ecology, Terres Australes et Antarctiques Francaises, University of La Rochelle. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alling A, 1991, UNEP MARINE MAMMAL T, V3, P247; Anderson R. Charles, 2012, Journal of Cetacean Research and Management, V12, P203; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Attard CRM, 2010, CONSERV GENET, V11, P2437, DOI 10.1007/s10592-010-0121-9; Ballance Lisa T., 2001, Journal of Cetacean Research and Management, V3, P213; Best Peter B., 2003, Journal of Cetacean Research and Management, V5, P253; Branch T.A., 2007, Journal of Cetacean Research and Management, V9, P253; Branch TA, 2007, MAR MAMMAL SCI, V23, P803, DOI 10.1111/j.1748-7692.2007.00137.x; Branch TA, 2007, MAMMAL REV, V37, P116, DOI 10.1111/j.1365-2907.2007.00106.x; Branch TA, 2009, MAR MAMMAL SCI, V25, P833, DOI 10.1111/j.1748-7692.2009.00292.x; Branch TA, 2004, MAR MAMMAL SCI, V20, P726, DOI 10.1111/j.1748-7692.2004.tb01190.x; Brown S. G., 1954, Discovery Reports, V26, P355; Croll DA, 1998, DEEP-SEA RES PT II, V45, P1353, DOI 10.1016/S0967-0645(98)00031-9; Currie R.I., 1973, BIOL INDIAN OCEAN, V3, P37, DOI DOI 10.1007/978-3-642-65468-8_4; Dziak RP, 2008, T AM GEOPH UN FALL M; Fiedler PC, 1998, DEEP-SEA RES PT II, V45, P1781, DOI 10.1016/S0967-0645(98)80017-9; Gales N, 2010, SCI COMM INT WHAL CO; Galletti Vernazzani Barbara, 2012, Journal of Cetacean Research and Management, V12, P353; Gavrilov AN, 2011, J ACOUST SOC AM, V130, P3651, DOI 10.1121/1.3651817; Gedamke J, 2007, SCI COMM INT WHAL CO; Gedamke J, 2010, DEEP-SEA RES PT II, V57, P968, DOI 10.1016/j.dsr2.2008.10.042; Gill Peter C., 2002, Journal of Cetacean Research and Management, V4, P179; Hinton MAC, 1915, REPORT INTER DEPARTM, P69; Hucke-Gaete R, 2004, BIOL LETT, V271, P170; Ichihara T., 1963, Norsk Hvalfangsttidende Sandefjord, V52, P128; Ichihara T., 1961, Norsk Hvalfangsttidende Sandefjord, V50, P1; Ichihara T., 1966, WHALES DOLPHINS PORP, P79, DOI 10.1525/9780520321373-008; Kato H, 1995, REPORTS INT WHALING, V45, P273; LEDUC RG, 2007, J CETACEAN RES MANAG, V97, P3; Ljungblad Donald K., 1998, Report of the International Whaling Commission, V48, P439; Mackintosh N. A., 1929, Discovery Reports Cambridge, V1, P257; Mackintosh NA., 1966, WHALES DOLPHINS PORP, P125; McCauley R, 2004, R200429 CURT U TECHN; Mellinger DK, 2007, OCEANOGRAPHY, V20, P36, DOI 10.5670/oceanog.2007.03; Mellinger DK, 2000, J ACOUST SOC AM, V107, P3518, DOI 10.1121/1.429434; Mikhalev Y.A., 2000, SOVIET WHALING DATA, P141; Moore JK, 2000, J GEOPHYS RES-OCEANS, V105, P28709, DOI 10.1029/1999JC000043; Oleson EM, 2007, MAR ECOL PROG SER, V330, P269, DOI 10.3354/meps330269; PAKHOMOV EA, 1994, MAR ECOL PROG SER, V111, P155, DOI 10.3354/meps111155; Rankin Shannon, 2005, Journal of Cetacean Research and Management, V7, P13; Reilly SB, 2008, IUCN 2012 IUCN RED L; Rennie S, 2009, J MARINE SYST, V77, P21, DOI 10.1016/j.jmarsys.2008.11.008; RICE DW, 1998, MARINE MAMMALS WORLD; Risting S., 1928, Rapport Conseil Exploration Mer Copenhague, V50, P1; Royer J-Y, 2008, T AM GEOPH UN FALL M; Samaran F, 2010, APPL ACOUST, V71, P1099, DOI 10.1016/j.apacoust.2010.05.014; Samaran Flore, 2010, Endangered Species Research, V12, P157, DOI 10.3354/esr00302; Samaran F, 2010, J ACOUST SOC AM, V127, P3800, DOI 10.1121/1.3409479; Schott FA, 2002, PROG OCEANOGR, V53, P57, DOI 10.1016/S0079-6611(02)00039-3; Sirovic A, 2004, DEEP-SEA RES PT II, V51, P2327, DOI 10.1016/j.dsr2.2004.08.005; Sirovic A, 2009, MAR MAMMAL SCI, V25, P125, DOI 10.1111/j.1748-7692.2008.00239.x; Stafford KM, 2011, MAR MAMMAL SCI, V27, P828, DOI 10.1111/j.1748-7692.2010.00437.x; Stafford KM, 2004, DEEP-SEA RES PT I, V51, P1337, DOI 10.1016/j.dsr.2004.05.007; Stafford KM, 1999, J ACOUST SOC AM, V106, P3687, DOI 10.1121/1.428220; Thompson PO, 1996, MAR MAMMAL SCI, V12, P288, DOI 10.1111/j.1748-7692.1996.tb00578.x; Williams R, 2011, CONSERV BIOL, V25, P526, DOI 10.1111/j.1523-1739.2011.01656.x; Wyrtki K., 1973, ECOL STUD, V3, P18, DOI [10.1007/978-3-642-65468-8_3, DOI 10.1007/978-3-642-65468-8_3]; Zemskij V.A., 1982, P53	58	72	84	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71561	10.1371/journal.pone.0071561	http://dx.doi.org/10.1371/journal.pone.0071561			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967221	Green Submitted, gold, Green Published			2022-12-25	WOS:000323115800064
J	Su, AP; He, SR; Tian, BL; Hu, WM; Zhang, ZD				Su, Anping; He, Sirong; Tian, Bole; Hu, Weiming; Zhang, Zhaoda			MicroRNA-221 Mediates the Effects of PDGF-BB on Migration, Proliferation, and the Epithelial-Mesenchymal Transition in Pancreatic Cancer Cells	PLOS ONE			English	Article								The platelet-derived growth factor (PDGF) signaling pathway has been found to play important roles in the development and progression of human cancers by regulating the processes of cell proliferation, apoptosis, migration, invasion, metastasis, and the acquisition of the epithelial-mesenchymal transition (EMT) phenotype. Moreover, PDGF signaling has also been found to alter the expression profile of miRNAs, leading to the reversal of EMT phenotype. Although the role of miRNAs in cancer has been documented, there are very few studies documenting the cellular consequences of targeted re-expression of specific miRNAs. Therefore, we investigated whether the treatment of human pancreatic cancer cells with PDGF could alter the expression profile of miRNAs, and we also assessed the cellular consequences. Our study demonstrates that miR-221 is essential for the PDGF-mediated EMT phenotype, migration, and growth of pancreatic cancer cells. Downregulation of TRPS1 by miR-221 is critical for PDGF-mediated acquisition of the EMT phenotype. Additionally, the PDGF-dependent increase in cell proliferation appears to be mediated by inhibition of a specific target of miR-221 and down-regulation of p27Kip1.	[Su, Anping; Tian, Bole; Hu, Weiming; Zhang, Zhaoda] Sichuan Univ, West China Hosp, Dept Hepatobiliopancreat Surg, Chengdu 610064, Peoples R China; [He, Sirong] Sichaun Univ, West China Hosp, Regenerat Med Res Ctr, Chengdu, Peoples R China	Sichuan University	Zhang, ZD (corresponding author), Sichuan Univ, West China Hosp, Dept Hepatobiliopancreat Surg, Chengdu 610064, Peoples R China.	zhangzhaoda2013@163.com						Ali S, 2010, CANCER RES, V70, P3606, DOI 10.1158/0008-5472.CAN-09-4598; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Besson A, 2004, NAT REV CANCER, V4, P948, DOI 10.1038/nrc1501; Cano A, 2008, TRENDS CELL BIOL, V18, P357, DOI 10.1016/j.tcb.2008.05.005; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Davis BN, 2009, J BIOL CHEM, V284, P3728, DOI 10.1074/jbc.M808788200; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; EBERT M, 1995, INT J CANCER, V62, P529, DOI 10.1002/ijc.2910620507; Fornari F, 2008, ONCOGENE, V27, P5651, DOI 10.1038/onc.2008.178; Fuchs BC, 2008, CANCER RES, V68, P2391, DOI 10.1158/0008-5472.CAN-07-2460; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Goff LA, 2008, EXP HEMATOL, V36, P1354, DOI 10.1016/j.exphem.2008.05.004; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Jechlinger M, 2006, J CLIN INVEST, V116, P1561, DOI 10.1172/JCI24652; Kawaguchi T, 2013, BRIT J CANCER, V108, P361, DOI 10.1038/bjc.2012.546; Kawahira K, 1999, ARCH DERMATOL RES, V291, P413, DOI 10.1007/s004030050431; Keese CR, 2004, P NATL ACAD SCI USA, V101, P1554, DOI 10.1073/pnas.0307588100; Kong Dejuan, 2011, Cancers (Basel), V3, P716, DOI 10.3390/cancers30100716; Kong DJ, 2009, STEM CELLS, V27, P1712, DOI 10.1002/stem.101; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Le XF, 2010, CANCER MICROENVIRON, V3, P137, DOI 10.1007/s12307-010-0037-4; Lloyd RV, 1999, AM J PATHOL, V154, P313, DOI 10.1016/S0002-9440(10)65277-7; Malik TH, 2002, MOL CELL BIOL, V22, P8592, DOI 10.1128/MCB.22.24.8592-8600.2002; Nikiforova MN, 2008, J CLIN ENDOCR METAB, V93, P1600, DOI 10.1210/jc.2007-2696; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Sabbah M, 2008, DRUG RESIST UPDATE, V11, P123, DOI 10.1016/j.drup.2008.07.001; Shao MH, 2011, NUCLEIC ACIDS RES, V39, P4035, DOI 10.1093/nar/gkq1305; Stinson S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001538; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Wang Z, 2010, BBA-REV CANCER, V1806, P122, DOI 10.1016/j.bbcan.2010.04.003	32	60	60	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71309	10.1371/journal.pone.0071309	http://dx.doi.org/10.1371/journal.pone.0071309			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967190	gold, Green Published, Green Submitted			2022-12-25	WOS:000323115800049
J	Thomsen, C; Grundevik, P; Elias, P; Stahlberg, A; Aman, P				Thomsen, Christer; Grundevik, Pernilla; Elias, Per; Stahlberg, Anders; Aman, Pierre			A conserved N-terminal motif is required for complex formation between FUS, EWSR1, TAF15 and their oncogenic fusion proteins	FASEB JOURNAL			English	Article						neurodegenerative diseases; tumor biology; neuropathology	AMYOTROPHIC-LATERAL-SCLEROSIS; EWINGS-SARCOMA PROTEIN; B-LYMPHOCYTE DEVELOPMENT; CELL-FREE FORMATION; MYXOID LIPOSARCOMA; BINDING PROTEIN; ARGININE METHYLATION; FAMILY ONCOPROTEINS; NUCLEAR IMPORT; DNA-DAMAGE	The three FET (FUS, EWSR1, and TAF15) family RNA binding proteins are expressed in all tissues and almost all cell types. The disordered N-terminal parts are always present in FET fusion oncoproteins of sarcomas and leukemia. Mutations in FUS and TAF15 cause aggregation of FET proteins in neurological disorders. Here we used recombinant proteins in pulldown experiments and mass spectrometry to identify major interaction partners of the FET N-terminal parts. We report that FUS, EWSR1, and TAF15 form homo-and heterocomplexes as major binding partners and identify an evolutionarily conserved N-terminal motif (FETBM1) that is required for this interaction. The binding is RNA and DNA independent and robust up to 1 M of NaCl. The localization of FETBM1 and its target sequences supports a simple model for FET protein aggregation as reported in neurological disorders such as amyotrophic lateral sclerosis, frontotemporal dementia, and essential tremor. The FETBM1 localization also explains the binding of normal full-length FET proteins to their oncogenic fusion proteins.	[Thomsen, Christer; Grundevik, Pernilla; Stahlberg, Anders; Aman, Pierre] Univ Gothenburg, Sahlgrenska Acad, Dept Pathol, Sahlgrenska Canc Ctr,Inst Biomed, S-40530 Gothenburg, Sweden; [Elias, Per] Univ Gothenburg, Sahlgrenska Acad, Dept Med Biochem & Cell Biol, Inst Biomed, S-40530 Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Aman, P (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Pathol, Sahlgrenska Canc Ctr,Inst Biomed, Box 425, S-40530 Gothenburg, Sweden.	pierre.aman@llcr.med.gu.se		Stahlberg, Anders/0000-0003-4243-0191; Aman, Pierre/0000-0002-1482-8875	Swedish Cancer Society; Assar Gabrielssons Research Foundation; Johan Jansson Foundation for Cancer Research; Social-styrelsen; Swedish Society for Medical Research; Swedish Children's Cancer Society; BioCARE National Strategic Research Program at University of Gothenburg; Wilhelm and Martina Lundgren Foundation for Scientific Research; Swedish Research Council [2367]; Swedish Foundation for Strategic Research	Swedish Cancer Society(Swedish Cancer Society); Assar Gabrielssons Research Foundation; Johan Jansson Foundation for Cancer Research; Social-styrelsen; Swedish Society for Medical Research; Swedish Children's Cancer Society; BioCARE National Strategic Research Program at University of Gothenburg; Wilhelm and Martina Lundgren Foundation for Scientific Research; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	This work was supported by grants from the Swedish Cancer Society, Assar Gabrielssons Research Foundation, Johan Jansson Foundation for Cancer Research, Social-styrelsen, Swedish Society for Medical Research, Swedish Children's Cancer Society, BioCARE National Strategic Research Program at University of Gothenburg, Wilhelm and Martina Lundgren Foundation for Scientific Research, the Swedish Research Council (2367), and the Swedish Foundation for Strategic Research. The protein interactions from this publication have been submitted to the International Molecular Exchange (IMEx) Consortium (http://www.imexconsortium.org) through IntAct [pmid: 22121220] and assigned the identifier IM-21252.	AMAN P, 1992, GENE CHROMOSOME CANC, V5, P278, DOI 10.1002/gcc.2870050403; Andersson MK, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-37; Araya N, 2003, J BIOL CHEM, V278, P5427, DOI 10.1074/jbc.M210234200; Belyanskaya LL, 2003, EXP CELL RES, V288, P374, DOI 10.1016/S0014-4827(03)00221-0; Belyanskaya LL, 2001, J BIOL CHEM, V276, P18681, DOI 10.1074/jbc.M011446200; Bento C, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-89; Bertolotti A, 1996, EMBO J, V15, P5022, DOI 10.1002/j.1460-2075.1996.tb00882.x; Bertolotti A, 1999, ONCOGENE, V18, P8000, DOI 10.1038/sj.onc.1203207; Blechingberg J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046251; Couthouis J, 2012, HUM MOL GENET, V21, P2899, DOI 10.1093/hmg/dds116; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Dormann D, 2012, EMBO J, V31, P4258, DOI 10.1038/emboj.2012.261; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Embree LJ, 2009, CANCER RES, V69, P4363, DOI 10.1158/0008-5472.CAN-08-3229; Fujii R, 2005, J CELL SCI, V118, P5755, DOI 10.1242/jcs.02692; Gardiner M, 2008, BIOCHEM J, V415, P297, DOI 10.1042/BJ20081135; Goransson M, 2002, EXP CELL RES, V278, P125, DOI 10.1006/excr.2002.5566; Goransson M, 2009, ONCOGENE, V28, P270, DOI 10.1038/onc.2008.378; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Hicks GG, 2000, NAT GENET, V24, P175, DOI 10.1038/72842; Hoell JI, 2011, NAT STRUCT MOL BIOL, V18, P1428, DOI 10.1038/nsmb.2163; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Klevernic IV, 2009, BIOCHEM J, V418, P625, DOI 10.1042/BJ20082097; Kuroda M, 2000, EMBO J, V19, P453, DOI 10.1093/emboj/19.3.453; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagier-Tourenne C, 2012, NAT NEUROSCI, V15, P1488, DOI 10.1038/nn.3230; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Law Warren J., 2006, Briefings in Functional Genomics & Proteomics, V5, P8, DOI 10.1093/bfgp/ell015; Lee JW, 2005, STEM CELLS, V23, P738, DOI 10.1634/stemcells.2004-0375; Lee KAW, 2007, CELL RES, V17, P286, DOI 10.1038/cr.2007.22; Li HJ, 2007, J CLIN INVEST, V117, P1314, DOI 10.1172/JCI31222; Mitchell JC, 2013, ACTA NEUROPATHOL, V125, P273, DOI 10.1007/s00401-012-1043-z; Morlando M, 2012, EMBO J, V31, P4502, DOI 10.1038/emboj.2012.319; Munoz DG, 2009, ACTA NEUROPATHOL, V118, P617, DOI 10.1007/s00401-009-0598-9; Neumann M, 2011, BRAIN, V134, P2595, DOI 10.1093/brain/awr201; Ng KP, 2007, P NATL ACAD SCI USA, V104, P479, DOI 10.1073/pnas.0607007104; Pahlich S, 2009, J PROTEOME RES, V8, P4455, DOI 10.1021/pr900235t; Paronetto MP, 2011, MOL CELL, V43, P353, DOI 10.1016/j.molcel.2011.05.035; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; RABBITTS TH, 1993, NAT GENET, V4, P175, DOI 10.1038/ng0693-175; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Riggi N, 2007, J PATHOL, V213, P4, DOI 10.1002/path.2209; Spahn L, 2003, ONCOGENE, V22, P6819, DOI 10.1038/sj.onc.1206810; Tan AY, 2012, P NATL ACAD SCI USA, V109, P6030, DOI 10.1073/pnas.1203028109; Tan AY, 2009, J MOL CELL BIOL, V1, P82, DOI 10.1093/jmcb/mjp025; Thelin-Jarnum S, 2002, INT J CANCER, V97, P446, DOI 10.1002/ijc.1632; Thomas GR, 2002, CANCER BIOL THER, V1, P428, DOI 10.4161/cbt.1.4.23; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Woulfe J, 2010, BRAIN PATHOL, V20, P589, DOI 10.1111/j.1750-3639.2009.00337.x; Yang L, 1998, J BIOL CHEM, V273, P27761, DOI 10.1074/jbc.273.43.27761; Zinszner H, 1997, J CELL SCI, V110, P1741	55	19	19	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2013	27	12					4965	4974		10.1096/fj.13-234435	http://dx.doi.org/10.1096/fj.13-234435			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	293UK	23975937				2022-12-25	WOS:000329999000030
J	Demers-Giroux, PO; Bourdin, B; Sauve, R; Parent, L				Demers-Giroux, Pierre-Olivier; Bourdin, Benoite; Sauve, Remy; Parent, Lucie			Cooperative Activation of the T-type Ca(V)3.2 Channel INTERACTION BETWEEN DOMAINS II AND III	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED SODIUM-CHANNEL; CALCIUM-CHANNELS; CRYSTAL-STRUCTURE; STRUCTURAL DETERMINANTS; CA2+ CHANNELS; MOLECULAR DETERMINANTS; VOLTAGE SENSORS; S4-S5 LINKER; INACTIVATION; MUTATIONS	T-type Ca(V)3 channels are important mediators of Ca2+ entry near the resting membrane potential. Little is known about the molecular mechanisms responsible for channel activation. Homology models based upon the high-resolution structure of bacterial Na-V channels predict interaction between the S4-S5 helix of Domain II (IIS4-S5) and the distal S6 pore region of Domain II (IIS6) and Domain III (IIIS6). Functional intra-and inter-domain interactions were investigated with a double mutant cycle analysis. Activation gating and channel kinetics were measured for 47 single mutants and 20 pairs of mutants. Significant coupling energies (Delta Delta G(interact) >= 1.5 kcal mol(-1)) were measured for 4 specific pairs of mutants introduced between IIS4-S5 and IIS6 and between IIS4-S5 and IIIS6. In agreement with the computer based models, Thr-911 in IIS4-S5 was functionally coupled with Ile-1013 in IIS6 during channel activation. The interaction energy was, however, found to be stronger between Val-907 in IIS4-S5 and Ile-1013 in IIS6. In addition Val-907 was significantly coupled with Asn-1548 in IIIS6 but not with Asn-1853 in IVS6. Altogether, our results demonstrate that the S4-S5 and S6 helices from adjacent domains are energetically coupled during the activation of a low voltage-gated T-type Ca(V)3 channel.	[Demers-Giroux, Pierre-Olivier; Bourdin, Benoite; Sauve, Remy; Parent, Lucie] Univ Montreal, Dept Physiol, Membrane Prot Res Grp, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Parent, L (corresponding author), POB 6128, Montreal, PQ H3C 3J7, Canada.	lucie.parent@umontreal.ca						Amaral C, 2012, P NATL ACAD SCI USA, V109, P21336, DOI 10.1073/pnas.1218087109; Arias-Olguin II, 2008, J BIOL CHEM, V283, P8136, DOI 10.1074/jbc.M708761200; Autret L, 2005, J PHYSIOL-LONDON, V567, P67, DOI 10.1113/jphysiol.2005.089342; Batulan Z, 2010, J BIOL CHEM, V285, P14005, DOI 10.1074/jbc.M109.097717; Baumgart JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002976; Berrou L, 2005, J BIOL CHEM, V280, P494, DOI 10.1074/jbc.M410859200; Berrou L, 2001, BIOPHYS J, V80, P215, DOI 10.1016/S0006-3495(01)76008-0; Beyl S, 2012, PFLUG ARCH EUR J PHY, V464, P391, DOI 10.1007/s00424-012-1144-5; BIRNBAUMER L, 1994, NEURON, V13, P505, DOI 10.1016/0896-6273(94)90021-3; Blunck R, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00166; Bourdin B, 2010, J BIOL CHEM, V285, P22851, DOI 10.1074/jbc.M110.111062; Cao YQ, 2005, P NATL ACAD SCI USA, V102, P2590, DOI 10.1073/pnas.0409896102; Carbone E, 2006, CELL CALCIUM, V40, P147, DOI 10.1016/j.ceca.2006.04.019; CARBONE E, 1984, NATURE, V310, P501, DOI 10.1038/310501a0; CARL SL, 1995, J CELL BIOL, V129, P673, DOI 10.1083/jcb.129.3.673; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2010, NEURON, V67, P915, DOI 10.1016/j.neuron.2010.08.021; Cribbs LL, 1998, CIRC RES, V83, P103, DOI 10.1161/01.RES.83.1.103; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; Dolphin AC, 2009, CURR OPIN NEUROBIOL, V19, P237, DOI 10.1016/j.conb.2009.06.006; Gao TY, 1997, J BIOL CHEM, V272, P19401, DOI 10.1074/jbc.272.31.19401; Hans M, 1999, J NEUROSCI, V19, P1610; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hohaus A, 2005, J BIOL CHEM, V280, P38471, DOI 10.1074/jbc.M507013200; Horovitz A, 1996, FOLD DES, V1, pR121, DOI 10.1016/S1359-0278(96)00056-9; Islas LD, 1999, J GEN PHYSIOL, V114, P723, DOI 10.1085/jgp.114.5.723; Karmazinova M, 2011, PFLUG ARCH EUR J PHY, V461, P461, DOI 10.1007/s00424-011-0937-2; Karmazinova M, 2010, PFLUG ARCH EUR J PHY, V460, P1015, DOI 10.1007/s00424-010-0874-5; Khosravani H, 2006, PHYSIOL REV, V86, P941, DOI 10.1152/physrev.00002.2006; Klockner U, 1999, EUR J NEUROSCI, V11, P4171, DOI 10.1046/j.1460-9568.1999.00849.x; Kraus RL, 1998, J BIOL CHEM, V273, P5586, DOI 10.1074/jbc.273.10.5586; Kurejova M, 2007, PFLUG ARCH EUR J PHY, V455, P527, DOI 10.1007/s00424-007-0302-7; Kusch J, 2010, BIOPHYS J, V99, P2488, DOI 10.1016/j.bpj.2010.07.041; Labro AJ, 2011, J BIOL CHEM, V286, P717, DOI 10.1074/jbc.M110.146977; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Ledwell JL, 1999, J GEN PHYSIOL, V113, P389, DOI 10.1085/jgp.113.3.389; Lee SY, 2009, PLOS BIOL, V7, P676, DOI 10.1371/journal.pbio.1000047; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Marksteiner R, 2001, J PHYSIOL-LONDON, V537, P27, DOI 10.1111/j.1469-7793.2001.0027k.x; McCusker EC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2077; Nelson MT, 2006, CURR PHARM DESIGN, V12, P2189, DOI 10.2174/138161206777585184; Nilius B, 2006, CELL CALCIUM, V40, P81, DOI 10.1016/j.ceca.2006.04.011; Olcese R, 1996, J PHYSIOL-LONDON, V497, P675, DOI 10.1113/jphysiol.1996.sp021799; Payandeh J, 2012, NATURE, V486, P135, DOI 10.1038/nature11077; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Perez-Reyes E, 1998, NATURE, V391, P896, DOI 10.1038/36110; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Randall A, 1999, MOL CELL NEUROSCI, V14, P255, DOI 10.1006/mcne.1999.0795; Ranganathan R, 1996, NEURON, V16, P131, DOI 10.1016/S0896-6273(00)80030-6; Raybaud A, 2007, J BIOL CHEM, V282, P27944, DOI 10.1074/jbc.M703895200; Raybaud A, 2006, J BIOL CHEM, V281, P39424, DOI 10.1074/jbc.M607405200; Shakeri B, 2012, J BIOL CHEM, V287, P32835, DOI 10.1074/jbc.M112.387233; Singh Baljinder, 2007, Hum Mutat, V28, P524, DOI 10.1002/humu.9491; Siwek M, 2012, ADV EXP MED BIOL, V740, P1219, DOI 10.1007/978-94-007-2888-2_55; Snutch T P, 1992, Curr Opin Neurobiol, V2, P247, DOI 10.1016/0959-4388(92)90111-W; Staes M, 2001, J PHYSIOL-LONDON, V530, P35, DOI 10.1111/j.1469-7793.2001.0035m.x; Stefani E, 1998, METHOD ENZYMOL, V293, P300; Talavera K, 2006, PFLUG ARCH EUR J PHY, V453, P189, DOI 10.1007/s00424-006-0129-7; Tottene A, 2002, P NATL ACAD SCI USA, V99, P13284, DOI 10.1073/pnas.192242399; Vitko I, 2007, J NEUROSCI, V27, P322, DOI 10.1523/JNEUROSCI.1817-06.2007; Wall-Lacelle S, 2011, J BIOL CHEM, V286, P27197, DOI 10.1074/jbc.M111.237412; Yang Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2184; ZHANG JF, 1993, NEUROPHARMACOLOGY, V32, P1075, DOI 10.1016/0028-3908(93)90003-L; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054	66	9	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29281	29293		10.1074/jbc.M113.500975	http://dx.doi.org/10.1074/jbc.M113.500975			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23970551	hybrid, Green Published			2022-12-25	WOS:000330615300008
J	Li, PC; Gu, JB; Yang, X; Cai, HZ; Tao, J; Yang, XJ; Lu, Q; Wang, ZJ; Yin, CJ; Gu, M				Li, Pengchao; Gu, Jinbao; Yang, Xiao; Cai, Hongzhou; Tao, Jun; Yang, Xuejian; Lu, Qiang; Wang, Zengjun; Yin, Changjun; Gu, Min			Functional Promoter-94 ins/del ATTG Polymorphism in NFKB1 Gene Is Associated with Bladder Cancer Risk in a Chinese Population	PLOS ONE			English	Article							NF-KAPPA-B; TRANSCRIPTION FACTOR; INSERTION/DELETION POLYMORPHISM; MAP KINASE; TNF-ALPHA; MATRIX; ACTIVATION; EXPRESSION; CELLS; P50	Background: A functional -94 insertion/deletion polymorphism (rs28362491) in the promoter of the NFKB1 gene was reported to influence NFKB1 expression and confer susceptibility to different types of cancer. This study aims to determine whether the polymorphism is associated with risk of bladder cancer. Materials and methods: TaqMan assay was used to determine genotype among 609 cases and 640 controls in a Chinese population. Logistic regression was used to assess the association between the polymorphism and bladder cancer risk, and quantitative real-time polymerase chain reaction was used to determine NFKB1 mRNA expression. Results: Compared with the ins/ins/ins/del genotypes, the del/del genotype was associated with a significantly increased risk of bladder cancer [adjusted odd ratio (OR) = 1.92, 95% confidence interval (CI) = 1.42-2.59]. The increased risk was more prominent among subjects over 65 years old (OR = 2.37, 95% CI = 1.52-3.70), male subjects (OR = 1.97, 95% CI = 1.40-2.79) and subjects with self-reported family history of cancer (OR = 3.59, 95% CI = 1.19-10.9). Furthermore, the polymorphism was associated with a higher risk of developing non-muscle invasive bladder cancer (OR = 2.07, 95% CI = 1.51-2.85), grade 1 bladder cancer (OR = 2.40, 95% CI = 1.68-3.43), single tumor bladder cancer (OR = 2.04, 95% CI = 1.48-2.82) and smaller tumor size bladder cancer (OR = 2.10, 95% CI = 1.51-2.92). The expression of NFKB1 mRNA in bladder cancer tissues with homozygous insertion genotype was higher than that with deletion allele. Conclusions: In conclusion, the -94 ins/del ATTG polymorphism in NFKB1 promoter may contribute to the etiology of bladder cancer in the Chinese population.	[Li, Pengchao; Gu, Jinbao; Yang, Xiao; Cai, Hongzhou; Tao, Jun; Yang, Xuejian; Lu, Qiang; Wang, Zengjun; Yin, Changjun; Gu, Min] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Yin, CJ (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China.	drcjyin@gmail.com; Lancetgu@yahoo.com.cn		Cai, Hongzhou/0000-0001-6915-564X; Yang, Xiao/0000-0002-5429-9162	Program for Development of Innovative Research Team of the First Affiliated Hospital of Nanjing Medical University; Provincial Initiative Program for Excellency Disciplines of Jiangsu Province; National Natural Science Foundation of China [81272832, 81201997]; Natural Science Foundation of Jiangsu Province [BK2011848]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Program for Development of Innovative Research Team of the First Affiliated Hospital of Nanjing Medical University; Provincial Initiative Program for Excellency Disciplines of Jiangsu Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the Program for Development of Innovative Research Team of the First Affiliated Hospital of Nanjing Medical University, the Provincial Initiative Program for Excellency Disciplines of Jiangsu Province, the National Natural Science Foundation of China (grants No. 81272832 and 81201997), the Natural Science Foundation of Jiangsu Province (grant No. BK2011848) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib-Conquy M, 2000, AM J RESP CRIT CARE, V162, P1877, DOI 10.1164/ajrccm.162.5.2003058; Bhat-Nakshatri P, 2002, ONCOGENE, V21, P2066, DOI 10.1038/sj.onc.1205243; BOURS V, 1994, BIOCHEM PHARMACOL, V47, P145, DOI 10.1016/0006-2952(94)90448-0; Catto JWF, 2007, J UROLOGY, V177, P1715, DOI 10.1016/j.juro.2007.01.030; Chen F, 1999, CLIN CHEM, V45, P7; Danese S, 2010, ONCOGENE, V29, P3313, DOI 10.1038/onc.2010.109; DAVIES B, 1993, CANCER RES, V53, P5365; Dudziec E, 2011, EPIGENOMICS-UK, V3, P35, DOI 10.2217/EPI.10.71; Erdman SE, 2001, J IMMUNOL, V166, P1443, DOI 10.4049/jimmunol.166.3.1443; Fan YX, 2011, DNA CELL BIOL, V30, P241, DOI 10.1089/dna.2010.1107; Gerwins P, 1997, J BIOL CHEM, V272, P8288, DOI 10.1074/jbc.272.13.8288; Inan MS, 2000, GASTROENTEROLOGY, V118, P724, DOI 10.1016/S0016-5085(00)70142-9; Inan MS, 2000, AM J PHYSIOL-GASTR L, V279, pG1282, DOI 10.1152/ajpgi.2000.279.6.G1282; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Karban AS, 2004, HUM MOL GENET, V13, P35, DOI 10.1093/hmg/ddh008; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kaufman DS, 2009, LANCET, V374, P239, DOI 10.1016/S0140-6736(09)60491-8; Kiriluk KJ, 2012, UROL ONCOL-SEMIN ORI, V30, P199, DOI 10.1016/j.urolonc.2011.10.010; Kovalsky O, 2001, J BIOL CHEM, V276, P39330, DOI 10.1074/jbc.M105115200; Lee SJ, 2008, ONCOL REP, V19, P1007; Lee SJ, 2008, INT IMMUNOPHARMACOL, V8, P1821, DOI 10.1016/j.intimp.2008.08.018; Lin SC, 2006, CANCER LETT, V243, P47, DOI 10.1016/j.canlet.2005.11.019; LIOTTA LA, 1986, CANCER RES, V46, P1; Lo SS, 2009, SURGERY, V145, P280, DOI 10.1016/j.surg.2008.11.001; MATRISIAN LM, 1990, TRENDS GENET, V6, P121, DOI 10.1016/0168-9525(90)90126-Q; MUKHOPADHYAY T, 1995, ONCOGENE, V11, P999; Murta-Nascimento C, 2007, CANCER EPIDEM BIOMAR, V16, P1595, DOI 10.1158/1055-9965.EPI-06-0743; Murta-Nascimento C, 2007, WORLD J UROL, V25, P285, DOI 10.1007/s00345-007-0168-5; Nutt JE, 2003, BJU INT, V91, P99, DOI 10.1046/j.1464-410X.2003.04020.x; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Place RF, 2003, J CELL PHYSIOL, V195, P470, DOI 10.1002/jcp.10262; Riemann K, 2007, INT J CLIN PHARM TH, V45, P423; Saitoh Y, 2010, LUNG CANCER, V70, P263, DOI 10.1016/j.lungcan.2010.03.001; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; Shariat SF, 2010, BJU INT, V105, P300, DOI 10.1111/j.1464-410X.2009.09076.x; Shariat SF, 2009, UROL ONCOL-SEMIN ORI, V27, P653, DOI 10.1016/j.urolonc.2009.07.020; Shin KY, 2000, CANCER LETT, V159, P127, DOI 10.1016/S0304-3835(00)00522-X; Song L, 2006, J CELL BIOL, V175, P607, DOI 10.1083/jcb.200602149; Stein JP, 2001, J CLIN ONCOL, V19, P666, DOI 10.1200/JCO.2001.19.3.666; Sumitomo M, 1999, HUM GENE THER, V10, P37, DOI 10.1089/10430349950019174; Tang TL, 2010, DNA CELL BIOL, V29, P9, DOI 10.1089/dna.2009.0937; Tong X, 2004, MOL CELL BIOCHEM, V265, P171, DOI 10.1023/B:MCBI.0000044394.66951.4d; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Wang WX, 1999, CLIN CANCER RES, V5, P119; Yu YH, 2009, CURR CANCER DRUG TAR, V9, P566, DOI 10.2174/156800909788486759; Zeegers MPA, 2004, WORLD J UROL, V21, P392, DOI 10.1007/s00345-003-0382-8; Zhang P, 2009, CANCER GENET CYTOGEN, V191, P73, DOI 10.1016/j.cancergencyto.2009.01.017; Ziegler-Heitbrock L, 2001, J ENDOTOXIN RES, V7, P219, DOI 10.1177/09680519010070030401; ZIEGLERHEITBROCK HWL, 1995, IMMUNOBIOLOGY, V193, P217	49	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71604	10.1371/journal.pone.0071604	http://dx.doi.org/10.1371/journal.pone.0071604			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977085	Green Published, gold, Green Submitted			2022-12-25	WOS:000324527300025
J	Li, S; Mo, CJ; Peng, QL; Kang, XN; Sun, C; Jiang, K; Huang, L; Lu, Y; Sui, JZ; Qin, X; Liu, YK				Li, Shan; Mo, Cuiju; Peng, Qiliu; Kang, Xiaonan; Sun, Chun; Jiang, Kai; Huang, Li; Lu, Yu; Sui, Jingzhe; Qin, Xue; Liu, Yinkun			Cell Surface Glycan Alterations in Epithelial Mesenchymal Transition Process of Huh7 Hepatocellular Carcinoma Cell	PLOS ONE			English	Article							N-ACETYLGLUCOSAMINYLTRANSFERASE-III; ALPHA-FETOPROTEIN; LECTIN AFFINITY; CANCER-CELLS; PROGRESSION; METASTASIS; MICROARRAY; ANTIGENS; IDENTIFICATION; FIBRONECTIN	Background and Objective: Due to recurrence and metastasis, the mortality of Hepatocellular carcinoma (HCC) is high. It is well known that the epithelial mesenchymal transition (EMT) and glycan of cell surface glycoproteins play pivotal roles in tumor metastasis. The goal of this study was to identify HCC metastasis related differential glycan pattern and their enzymatic basis using a HGF induced EMT model. Methodology: HGF was used to induce HCC EMT model. Lectin microarray was used to detect the expression of cell surface glycan and the difference was validated by lectin blot and fluorescence cell lectin-immunochemistry. The mRNA expression levels of glycotransferases were determined by qRT-PCR. Results: After HGF treatment, the Huh7 cell lost epithelial characteristics and obtained mesenchymal markers. These changes demonstrated that HGF could induce a typical cell model of EMT. Lectin microarray analysis identified a decreased affinity in seven lectins ACL, BPL, JAC, MPL, PHA-E, SNA, and SBA to the glycan of cell surface glycoproteins. This implied that glycan containing T/Tn-antigen, NA2 and bisecting GlcNAc, Sia alpha 2-6Gal/GalNAc, terminal alpha or beta GalNAc structures were reduced. The binding ability of thirteen lectins, AAL, LCA, LTL, ConA, NML, NPL, DBA, HAL, PTL II, WFL, ECL, GSL II and PHA-L to glycan were elevated, and a definite indication that glycan containing terminal alpha Fuc and +/- Sia-Le, core fucose, alpha-man, gal-beta(alpha) GalNAc, beta 1,6 GlcNAc branching and tetraantennary complex oligosaccharides structures were increased. These results were further validated by lectin blot and fluorescence cell lectin-immunochemistry. Furthermore, the mRNA expression level of Mgat3 decreased while that of Mgat5, FucT8 and beta 3GalT5 increased. Therefore, cell surface glycan alterations in the EMT process may coincide with the expression of glycosyltransferase. Conclusions: The findings of this study systematically clarify the alterations of cell surface glycan in cancer EMT, and may provide novel insight for HCC metastasis.	[Li, Shan; Mo, Cuiju; Peng, Qiliu; Huang, Li; Lu, Yu; Sui, Jingzhe; Qin, Xue] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China; [Kang, Xiaonan; Sun, Chun; Jiang, Kai; Liu, Yinkun] Fudan Univ, Inst Biomed Sci, Canc Res Ctr, Shanghai 200433, Peoples R China; [Sun, Chun; Jiang, Kai; Liu, Yinkun] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai 200433, Peoples R China	Guangxi Medical University; Fudan University; Fudan University	Qin, X (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China.	qinxue919@126.com; liu.yinkun@zs-hospital.sh.cn			National Research Program of China (973 Program) [2011CB910604, 2013CB910501]; National Research Program of China (863 program) [2011AA020204]; China National Key Projects for Infectious Diseases [2012ZX 10002-012, 2008ZX10002-009]; National Natural Science Foundation of China [81060199, 81260302]	National Research Program of China (973 Program)(National Basic Research Program of China); National Research Program of China (863 program)(National High Technology Research and Development Program of China); China National Key Projects for Infectious Diseases; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by National Research Program of China (973 Program: 2011CB910604, 2013CB910501; 863 program: 2011AA020204), China National Key Projects for Infectious Diseases (2012ZX 10002-012 and 2008ZX10002-009), National Natural Science Foundation of China (No. 81060199 and No. 81260302). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aoyagi Y, 1998, CANCER, V83, P2076, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2076::AID-CNCR5>3.0.CO;2-L; Chammas R, 2010, PLOS ONE, V5; Chen P, 2008, J CANCER RES CLIN, V134, P851, DOI 10.1007/s00432-008-0357-7; Chen Qiao-pei, 2011, Fudan Xuebao (Yixueban), V38, P389, DOI 10.3969/j.issn.1672-8467.2011.05.003; Comunale MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012419; Dai Z, 2006, PROTEOMICS, V6, P5857, DOI 10.1002/pmic.200500707; Debruyne EN, 2010, CLIN CHEM, V56, P823, DOI 10.1373/clinchem.2009.139295; DENNIS J, 1982, NATURE, V300, P274, DOI 10.1038/300274a0; DENNIS JW, 1987, SCIENCE, V236, P582, DOI 10.1126/science.2953071; Freire-De-Lima L, 2011, P NATL ACAD SCI USA, V108, P17690, DOI 10.1073/pnas.1115191108; FURMANSKI P, 1972, P SOC EXP BIOL MED, V140, P216; Gu JG, 2004, GLYCOCONJUGATE J, V21, P9, DOI 10.1023/B:GLYC.0000043741.47559.30; Guan F, 2009, P NATL ACAD SCI USA, V106, P7461, DOI 10.1073/pnas.0902368106; Guarino M, 2007, INT J BIOCHEM CELL B, V39, P2153, DOI 10.1016/j.biocel.2007.07.011; ITZKOWITZ SH, 1989, CANCER RES, V49, P197; Kang X, 2011, EXPT THERAPEUTIC MED, V3, P415; Konska G, 2006, ONCOL REP, V15, P305; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Monzavi-Karbassi B, 2002, HYBRIDOMA HYBRIDOM, V21, P103, DOI 10.1089/153685902317401690; Nagai T, 2011, MOL CANCER THER, V10, P169, DOI 10.1158/1535-7163.MCT-10-0544; Park C, 1999, ARCH BIOCHEM BIOPHYS, V367, P281, DOI 10.1006/abbi.1999.1252; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pinho SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033191; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Sun Hai-yan, 2011, Zhonghua Gan Zang Bing Za Zhi, V19, P904, DOI 10.3760/cma.j.issn.1007-3418.2011.12.006; TAKADA A, 1993, CANCER RES, V53, P354; Taniguchi N, 1999, BBA-MOL BASIS DIS, V1455, P287, DOI 10.1016/S0925-4439(99)00066-6; Tateno H, 2007, GLYCOBIOLOGY, V17, P1138, DOI 10.1093/glycob/cwm084; Terao M, 2011, J BIOL CHEM, V286, P28303, DOI 10.1074/jbc.M111.220376; Turley EA, 2008, NAT CLIN PRACT ONCOL, V5, P280, DOI 10.1038/ncponc1089; Wang N, 2009, PROG BIOCHEM BIOPHYS, V36, P1348, DOI 10.3724/SP.J.1206.2009.00120; Wang SS, 1996, J HEPATOL, V25, P166, DOI 10.1016/S0168-8278(96)80069-9; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Xu QS, 2012, J BIOL CHEM, V287, P16563, DOI 10.1074/jbc.M111.262154; Yang MH, 2009, HEPATOLOGY, V50, P1464, DOI 10.1002/hep.23221; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhao YY, 2006, J BIOL CHEM, V281, P32122, DOI 10.1074/jbc.M607274200	38	13	14	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71273	10.1371/journal.pone.0071273	http://dx.doi.org/10.1371/journal.pone.0071273			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977005	Green Published, gold, Green Submitted			2022-12-25	WOS:000324527300009
J	Ahlin, S; Olsson, M; Olsson, B; Svensson, PA; Sjoholm, K				Ahlin, Sofie; Olsson, Maja; Olsson, Bob; Svensson, Per-Arne; Sjoholm, Kajsa			No Evidence for a Role of Adipose Tissue-Derived Serum Amyloid A in the Development of Insulin Resistance or Obesity-Related Inflammation in hSAA1(+/)- Transgenic Mice	PLOS ONE			English	Article							C-REACTIVE PROTEIN; MACROPHAGE CHOLESTEROL; WEIGHT-LOSS; INTERLEUKIN-6; COMPLICATIONS; INFILTRATION; ASSOCIATION; ADIPOCYTES; OVERWEIGHT; LEUKOCYTES	Obesity is associated with a low-grade inflammation including moderately increased serum levels of the acute phase protein serum amyloid A (SAA). In obesity, SAA is mainly produced from adipose tissue and serum levels of SAA are associated with insulin resistance. SAA has been described as a chemoattractant for inflammatory cells and adipose tissue from obese individuals contains increased numbers of macrophages. However, whether adipose tissue-derived SAA can have a direct impact on macrophage infiltration in adipose tissue or the development of insulin resistance is unknown. The aim of this study was to investigate the effects of adipose tissue-derived SAA1 on the development of insulin resistance and obesity-related inflammation. We have previously established a transgenic mouse model expressing human SAA1 in the adipose tissue. For this report, hSAA1(+/-) transgenic mice and wild type mice were fed with a high fat diet or normal chow. Effects of hSAA1 on glucose metabolism were assessed using an oral glucose tolerance test. Real-time PCR was used to measure the mRNA levels of macrophage markers and genes related to insulin sensitivity in adipose tissue. Cytokines during inflammation were analyzed using a Proinflammatory 7-plex Assay. We found similar insulin and glucose levels in hSAA1 mice and wt controls during an oral glucose tolerance test and no decrease in mRNA levels of genes related to insulin sensitivity in adipose tissue in neither male nor female hSAA1 animals. Furthermore, serum levels of proinflammatory cytokines and mRNA levels of macrophage markers in adipose tissue were not increased in hSAA1 mice. Hence, in this model we find no evidence that adipose tissue-derived hSAA1 influences the development of insulin resistance or obesity-related inflammation.	[Ahlin, Sofie; Olsson, Maja; Svensson, Per-Arne; Sjoholm, Kajsa] Univ Gothenburg, Inst Med, Dept Mol & Clin Med, Sahlgrenska Acad, Gothenburg, Sweden; [Olsson, Bob] Univ Gothenburg, Dept Neurochem & Psychiat, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Sjoholm, K (corresponding author), Univ Gothenburg, Inst Med, Dept Mol & Clin Med, Sahlgrenska Acad, Gothenburg, Sweden.	kajsa.sjoholm@medic.gu.se	Svensson, Per-Arne/R-4626-2019	Sjoholm, Kajsa/0000-0003-0146-8193; Svensson, Per-Arne/0000-0002-6731-806X; Olsson, Bob/0000-0002-6368-6172; Ahlin, Sofie/0000-0003-0619-2683	Swedish Research Council [K2008-65X-20753-01-4]; Swedish federal government under the LUA/ALF; Swedish Foundation for Strategic Research; Ake Wiberg Foundation; Foundation of the National Board of Health; Foundations of the National Board of Welfare; Emelle Foundation; Swedish Knowledge Foundation through the Industrial PhD program in Medical Bioinformatics at Corporate Alliances, Karolinska Institutet; Jeansson Foundations; Magnus Bergvall Foundation; Royal Physiographic Society (Nilsson-Ehle Foundation); Tore Nilsson Foundation; Arosenius Foundation; Clas Groschinsky Foundation; Torsten and Ragnar Soderberg Foundation; VINNOVA-VINNMER program; Sahlgrenska University Hospital Foundation; Langmanska foundation; Wilhelm and Martina Lundgren foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish federal government under the LUA/ALF; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Ake Wiberg Foundation; Foundation of the National Board of Health; Foundations of the National Board of Welfare; Emelle Foundation; Swedish Knowledge Foundation through the Industrial PhD program in Medical Bioinformatics at Corporate Alliances, Karolinska Institutet; Jeansson Foundations; Magnus Bergvall Foundation; Royal Physiographic Society (Nilsson-Ehle Foundation); Tore Nilsson Foundation; Arosenius Foundation; Clas Groschinsky Foundation; Torsten and Ragnar Soderberg Foundation; VINNOVA-VINNMER program(Vinnova); Sahlgrenska University Hospital Foundation; Langmanska foundation; Wilhelm and Martina Lundgren foundation	The work was funded by the Swedish Research Council (K2008-65X-20753-01-4), the Swedish federal government under the LUA/ALF agreement, the Swedish Foundation for Strategic Research to Sahlgrenska Center for Cardiovascular and Metabolic Research, the Ake Wiberg Foundation, the Foundations of the National Board of Health and Welfare, the Emelle Foundation and the Swedish Knowledge Foundation through the Industrial PhD program in Medical Bioinformatics at Corporate Alliances, Karolinska Institutet, the Jeansson Foundations, the Magnus Bergvall Foundation, the Royal Physiographic Society (Nilsson-Ehle Foundation), the Tore Nilsson Foundation, the Arosenius Foundation, the Clas Groschinsky Foundation, the Torsten and Ragnar Soderberg Foundation, the VINNOVA-VINNMER program, the Sahlgrenska University Hospital Foundation, the Langmanska foundation, and the Wilhelm and Martina Lundgren foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADOLATO R, 1994, J EXP MED, V180, P203, DOI 10.1084/jem.180.1.203; Bastard JP, 2000, J CLIN ENDOCR METAB, V85, P3338, DOI 10.1210/jc.85.9.3338; BENDITT EP, 1982, ANN NY ACAD SCI, V389, P183, DOI 10.1111/j.1749-6632.1982.tb22136.x; Bjorkman L, 2010, ARTHRITIS RHEUM-US, V62, P1660, DOI 10.1002/art.27440; Christenson K, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00092; COETZEE GA, 1986, J BIOL CHEM, V261, P9644; Dandona P, 1998, J CLIN ENDOCR METAB, V83, P2907, DOI 10.1210/jc.83.8.2907; Dong Z, 2011, MOL MED, V17, P1357, DOI 10.2119/molmed.2011.00186; Ebeling P, 1999, DIABETOLOGIA, V42, P1433, DOI 10.1007/s001250051315; Faty A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034031; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hatanaka E, 2007, IMMUNOL LETT, V108, P160, DOI 10.1016/j.imlet.2006.12.005; JIANG SL, 1995, J IMMUNOL, V154, P825; Jylhava J, 2009, J INTERN MED, V266, P286, DOI 10.1111/j.1365-2796.2009.02120.x; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kindy MS, 2000, ARTERIOSCL THROM VAS, V20, P1543, DOI 10.1161/01.ATV.20.6.1543; Kisilevsky R, 2003, J LIPID RES, V44, P2257, DOI 10.1194/jlr.M300133-JLR200; KISILEVSKY R, 1992, LAB INVEST, V66, P778; Kisilevsky R, 2012, AMYLOID, V19, P5, DOI 10.3109/13506129.2011.654294; KUMON Y, 1994, CLIN BIOCHEM, V27, P469, DOI 10.1016/0009-9120(94)00044-V; Lindhorst E, 1997, BBA-PROTEIN STRUCT M, V1339, P143, DOI 10.1016/S0167-4838(96)00227-0; MCADAM KPWJ, 1978, J CLIN INVEST, V61, P390, DOI 10.1172/JCI108949; Muller S, 2002, DIABETOLOGIA, V45, P805, DOI 10.1007/s00125-002-0829-2; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; O'Brien Kevin D, 2006, Curr Atheroscler Rep, V8, P62, DOI 10.1007/s11883-006-0066-0; Olsson M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019609; Pickup JC, 1997, DIABETOLOGIA, V40, P1286, DOI 10.1007/s001250050822; Poitou C, 2005, DIABETOLOGIA, V48, P519, DOI 10.1007/s00125-004-1654-6; Scheja L, 2008, EXP DIABETES RES, DOI 10.1155/2008/230837; Shah C, 2006, BLOOD, V108, P1751, DOI 10.1182/blood-2005-11-011932; Sjoholm K, 2005, J CLIN ENDOCR METAB, V90, P2233, DOI 10.1210/jc.2004-1830; Sjoholm K, 2009, CYTOKINE, V48, P260, DOI 10.1016/j.cyto.2009.08.005; Song CJ, 2009, ATHEROSCLEROSIS, V207, P374, DOI 10.1016/j.atherosclerosis.2009.05.007; Su SB, 1999, J EXP MED, V189, P395, DOI 10.1084/jem.189.2.395; Tam SP, 2002, J LIPID RES, V43, P1410, DOI 10.1194/jlr.M100388-JLR200; van den Brand B, 2013, ARTHRITIS RHEUM-US, V65, P283, DOI 10.1002/art.37737; van der Westhuyzen DR, 2007, CURR OPIN LIPIDOL, V18, P147, DOI 10.1097/MOL.0b013e328051b4fe; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Webb NR, 1997, J LIPID RES, V38, P1583; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang RZ, 2006, PLOS MED, V3, P884, DOI 10.1371/journal.pmed.0030287; Ye XY, 2009, J ENDOCRINOL INVEST, V32, P568, DOI [10.1007/BF03346510, 10.3275/6111]; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972	44	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e72204	10.1371/journal.pone.0072204	http://dx.doi.org/10.1371/journal.pone.0072204			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967285	Green Published, Green Submitted, gold			2022-12-25	WOS:000323378000085
J	Ang, J; Sheng, JH; Lai, KR; Wei, SS; Gao, XW				Ang, Jian; Sheng, Jinghao; Lai, Kairan; Wei, Saisai; Gao, Xiangwei			Identification of Estrogen Receptor-Related Receptor Gamma as a Direct Transcriptional Target of Angiogenin	PLOS ONE			English	Article							CELL-PROLIFERATION; ENDOTHELIAL-CELLS; CHROMATIN IMMUNOPRECIPITATION; THERAPEUTIC TARGET; GENE-EXPRESSION; PROSTATE-CANCER; DNA; NUCLEUS; PROTEIN	Nuclear translocation of angiogenin (ANG) is essential for the proliferation of its target cells. ANG promotes rRNA synthesis, while whether it regulates mRNA transcription remains unknown. Using the chromatin immunoprecipitation method, we have identified 12 ANG-binding sequences. One of these sequences lies in the estrogen receptor-related receptor gamma (ERR gamma) gene which we designated as ANG-Binding Sequence within ERR gamma (ABSE). ABSE exhibited ANG-dependent repressor activity in the luciferase reporter system. Down-regulation of ANG increased ERR gamma expression, and active gene marker level at the ABSE region. The expression levels of ERR gamma targets genes, p21(WAF/CIP) and p27(KIP1), and the occupation of ERR gamma on their promoter regions were increased in ANG-deficient cells accordingly. Furthermore, knockdown of ERR gamma promoted the proliferation rate in ANG-deficient breast cancer cells. Finally, immunohistochemistry staining showed negative correlation between ANG and ERR gamma in breast cancer tissue. Altogether, our study provides evidence that nuclear ANG directly binds to the ABSE of ERR gamma gene and inhibits ERR gamma transcription to promote breast cancer cell proliferation.	[Ang, Jian; Sheng, Jinghao; Lai, Kairan; Wei, Saisai; Gao, Xiangwei] Zhejiang Univ, Sch Med, Inst Environm Med, Hangzhou 310003, Zhejiang, Peoples R China; [Sheng, Jinghao; Gao, Xiangwei] Zhejiang Univ, Sch Med, Program Mol Cell Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Lai, Kairan] Zhejiang Univ, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China; [Ang, Jian] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Gao, XW (corresponding author), Zhejiang Univ, Sch Med, Inst Environm Med, Hangzhou 310003, Zhejiang, Peoples R China.	xiangweigao@gmail.com	Gao, Xiangwei/J-3026-2015	Gao, Xiangwei/0000-0002-8358-6320	National Natural Science Foundation of China [30770470, 30900235, 31170721]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants from National Natural Science Foundation of China (No. 30770470, 30900235, and 31170721). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariazi EA, 2002, CANCER RES, V62, P6510; FETT JW, 1985, BIOCHEMISTRY-US, V24, P5480, DOI 10.1021/bi00341a030; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Hu GF, 2000, J CELL BIOCHEM, V76, P452, DOI 10.1002/(SICI)1097-4644(20000301)76:3<452::AID-JCB12>3.0.CO;2-Z; Hu GF, 1998, P NATL ACAD SCI USA, V95, P9791, DOI 10.1073/pnas.95.17.9791; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; MOROIANU J, 1994, P NATL ACAD SCI USA, V91, P1677, DOI 10.1073/pnas.91.5.1677; O'Sullivan AC, 2002, MOL CELL BIOL, V22, P657, DOI 10.1128/MCB.22.2.657-668.2002; Riordan JF, 2001, METHOD ENZYMOL, V341, P263, DOI 10.1016/S0076-6879(01)41157-8; Tiraby C, 2011, CANCER RES, V71, P2518, DOI 10.1158/0008-5472.CAN-10-1315; Tsuji T, 2005, CANCER RES, V65, P1352, DOI 10.1158/0008-5472.CAN-04-2058; Wei SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028797; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; Winter N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018837; Xu ZP, 2003, BIOCHEMISTRY-US, V42, P121, DOI 10.1021/bi020465x; Xu ZP, 2002, BIOCHEM BIOPH RES CO, V294, P287, DOI 10.1016/S0006-291X(02)00479-5; Xu ZP, 2001, BIOCHEM BIOPH RES CO, V285, P909, DOI 10.1006/bbrc.2001.5255; Yoshioka N, 2006, P NATL ACAD SCI USA, V103, P14519, DOI 10.1073/pnas.0606708103; Yu SA, 2007, CANCER RES, V67, P4904, DOI 10.1158/0008-5472.CAN-06-3855	23	8	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71487	10.1371/journal.pone.0071487	http://dx.doi.org/10.1371/journal.pone.0071487			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977052	Green Published, gold, Green Submitted			2022-12-25	WOS:000323378000053
J	Iwamori, N; Iwamori, T; Matzuk, MM				Iwamori, Naoki; Iwamori, Tokuko; Matzuk, Martin M.			H3K27 Demethylase, JMJD3, Regulates Fragmentation of Spermatogonial Cysts	PLOS ONE			English	Article							HISTONE H3 LYSINE-27; MALE GERM-CELLS; STEM-CELLS; DIFFERENTIATION; PLZF; UTX; PROLIFERATION; CONTRIBUTES; MAINTENANCE; METHYLATION	The spermatogonial stem cell (SSC) compartment is maintained by self-renewal of stem cells as well as fragmentation of differentiating spermatogonia through abscission of intercellular bridges in a random and stochastic manner. The molecular mechanisms that regulate this reversible developmental lineage remain to be elucidated. Here, we show that histone H3K27 demethylase, JMJD3 (KDM6B), regulates the fragmentation of spermatogonial cysts. Down-regulation of Jmjd3 in SSCs promotes an increase in undifferentiated spermatogonia but does not affect their differentiation. Germ cell-specific Jmjd3 null male mice have larger testes and sire offspring for a longer period compared to controls, likely secondary to increased and prolonged maintenance of the spermatogonial compartment. Moreover, JMJD3 deficiency induces frequent fragmentation of spermatogonial cysts by abscission of intercellular bridges. These results suggest that JMJD3 controls the spermatogonial compartment through the regulation of fragmentation of spermatogonial cysts and this mechanism may be involved in maintenance of diverse stem cell niches.	[Iwamori, Naoki; Iwamori, Tokuko; Matzuk, Martin M.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Iwamori, Naoki; Iwamori, Tokuko; Matzuk, Martin M.] Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; [Iwamori, Naoki; Matzuk, Martin M.] Baylor Coll Med, Ctr Reprod Med, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Ctr Drug Discovery, Houston, TX 77030 USA; [Iwamori, Naoki; Iwamori, Tokuko] Kyushu Univ, Grad Sch Med Sci, Res Ctr Human Dis Modeling, Ctr Biomed Res, Fukuoka 812, Japan; [Iwamori, Naoki; Iwamori, Tokuko] Kyushu Univ, Lab Biomed, Div Pathobiol, Dept Basic Med,Fac Med, Fukuoka 812, Japan; [Iwamori, Tokuko] Kyushu Univ, Med Inst Bioregulat, Div Organogenesis & Regenerat, Fukuoka 812, Japan	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Kyushu University; Kyushu University; Kyushu University	Iwamori, N (corresponding author), Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA.	iwamori@anim.med.kyushu-u.ac.jp			National Institutes of Health [U01HD060496]; Kyushu University Interdisciplinary Programs in Education and Projects in Research Development (PP)	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kyushu University Interdisciplinary Programs in Education and Projects in Research Development (PP)	This study was supported by National Institutes of Health grant U01HD060496 (to MMM) and Kyushu University Interdisciplinary Programs in Education and Projects in Research Development (P&P). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109; Barroca V, 2009, NAT CELL BIOL, V11, P190, DOI 10.1038/ncb1826; Blais A, 2007, J CELL BIOL, V179, P1399, DOI 10.1083/jcb.200705051; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Burgold T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003034; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; de Rooij DG, 2001, REPRODUCTION, V121, P347, DOI 10.1530/rep.0.1210347; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Ehmcke J, 2006, HUM REPROD UPDATE, V12, P275, DOI 10.1093/humupd/dmk001; He ZP, 2007, BIOL REPROD, V77, P723, DOI 10.1095/biolreprod.107.062513; Iwamori N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038914; Iwamori N, 2011, BIOL REPROD, V84, P1225, DOI 10.1095/biolreprod.110.088955; Iwamori T, 2010, MOL CELL BIOL, V30, P2280, DOI 10.1128/MCB.01392-09; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023663; Klein AM, 2010, CELL STEM CELL, V7, P214, DOI 10.1016/j.stem.2010.05.017; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Lambrot R, 2012, J ANDROL, V33, P1058, DOI 10.2164/jandrol.111.013870; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; Nakagawa T, 2010, SCIENCE, V328, P62, DOI 10.1126/science.1182868; Naughton CK, 2006, BIOL REPROD, V74, P314, DOI 10.1095/biolreprod.105.047365; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Payne C, 2006, DEV BIOL, V293, P461, DOI 10.1016/j.ydbio.2006.02.013; Sada A, 2009, SCIENCE, V325, P1394, DOI 10.1126/science.1172645; Sadate-Ngatchou PI, 2008, GENESIS, V46, P738, DOI 10.1002/dvg.20437; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Seenundun S, 2010, EMBO J, V29, P1401, DOI 10.1038/emboj.2010.37; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Tokuda M, 2007, BIOL REPROD, V76, P130, DOI 10.1095/biolreprod.106.053181; Waheeb R, 2011, INT J ANDROL, V34, pE296, DOI 10.1111/j.1365-2605.2011.01199.x; Yoshida S, 2012, REPRODUCTION, V144, P293, DOI 10.1530/REP-11-0320; Yoshida S, 2010, DEV GROWTH DIFFER, V52, P311, DOI 10.1111/j.1440-169X.2010.01174.x	43	26	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e72689	10.1371/journal.pone.0072689	http://dx.doi.org/10.1371/journal.pone.0072689			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967333	Green Published, Green Submitted, gold			2022-12-25	WOS:000323378000110
J	Pirracchio, R; Parenica, J; Rigon, MR; Chevret, S; Spinar, J; Jarkovsky, J; Zannad, F; Alla, F; Mebazaa, A				Pirracchio, Romain; Parenica, Jiri; Rigon, Matthieu Resche; Chevret, Sylvie; Spinar, Jindrich; Jarkovsky, Jiri; Zannad, Faiez; Alla, Francois; Mebazaa, Alexandre		GREAT Network	The Effectiveness of Inodilators in Reducing Short Term Mortality among Patient with Severe Cardiogenic Shock: A Propensity-Based Analysis	PLOS ONE			English	Article							MICROCIRCULATORY BLOOD-FLOW; CHRONIC HEART-FAILURE; NOREPINEPHRINE; DOBUTAMINE; NITROGLYCERIN; EPINEPHRINE; GUIDELINES; MANAGEMENT; MILRINONE; DIAGNOSIS	Background: The best catecholamine regimen for cardiogenic shock has been poorly evaluated. When a vasopressor is required to treat patients with the most severe form of cardiogenic shock, whether inodilators should be added or whether inopressors can be used alone has not been established. The purpose of this study was to compare the impact of these two strategies on short-term mortality in patients with severe cardiogenic shocks. Methods and Results: Three observational cohorts of patients with decompensated heart failure were pooled to comprise a total of 1,272 patients with cardiogenic shocks. Of these 1,272 patients, 988 were considered to be severe because they required a vasopressor during the first 24 hours. We developed a propensity-score (PS) model to predict the individual probability of receiving one of the two regimens (inopressors alone or a combination) conditionally on baseline-measured covariates. The benefit of the treatment regimen on the mortality rate was estimated by fitting a weighted Cox regression model. A total of 643 patients (65.1%) died within the first 30 days (inopressors alone: 293 (72.0%); inopressors and inodilators: 350 (60.0%)). After PS weighting, we observed that the use of an inopressor plus an inodilator was associated with an improved short-term mortality (HR: 0.66 [0.55-0.80]) compared to inopressors alone. Conclusions: In the most severe forms of cardiogenic shock where a vasopressor is immediately required, adding an inodilator may improve short-term mortality. This result should be confirmed in a randomized, controlled trial.	[Pirracchio, Romain] Hop Europeen Georges Pompidou, Dept Anesthesiol & Crit Care Med, Paris, France; [Rigon, Matthieu Resche; Chevret, Sylvie] Hop St Louis, INSERM, Dept Biostat, UMR S717, Paris, France; [Parenica, Jiri; Spinar, Jindrich; Jarkovsky, Jiri] ICRC, Internal Cardiol Dept, Fac Hosp Brno, Brno, Czech Republic; [Parenica, Jiri; Spinar, Jindrich; Jarkovsky, Jiri] Masaryk Univ, Fac Med, Brno, Czech Republic; [Mebazaa, Alexandre] Hop Lariboisiere, INSERM, UMR S942, Dept Anesthesiol & Crit Care Med, F-75475 Paris, France; [Zannad, Faiez] Univ Hosp Nancy, Dept Cardiol, Nancy, France; [Alla, Francois] Univ Hosp Nancy, Dept Epidemiol, Nancy, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; St Anne's University Hospital Brno (FNUSA-ICRC); University Hospital Brno; Masaryk University Brno; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU de Nancy; Universite de Lorraine; CHU de Nancy; Universite de Lorraine	Pirracchio, R (corresponding author), Hop Europeen Georges Pompidou, Dept Anesthesiol & Crit Care Med, Paris, France.	romainpirracchio@yahoo.fr	Zannad, Faiez/K-4649-2019; Resche-Rigon, Matthieu/ABA-5374-2021; alla, francois/D-2295-2014; Jarkovsky, Jiri/G-5494-2017	Mebazaa, Alexandre/0000-0001-8715-7753; alla, francois/0000-0002-5793-7190; resche-rigon, matthieu/0000-0003-2220-5085; chevret, sylvie/0000-0001-6449-4730				Adams KF, 2005, AM HEART J, V149, P209, DOI 10.1016/j.ahj.2004.08.005; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Bayram M, 2005, AM J CARDIOL, V96, p47G, DOI 10.1016/j.amjcard.2005.07.021; Boerma EC, 2010, CRIT CARE MED, V38, P93, DOI 10.1097/CCM.0b013e3181b02fc1; Capomolla S, 1997, AM HEART J, V134, P1089, DOI 10.1016/S0002-8703(97)70030-9; Cuffe MS, 2002, JAMA-J AM MED ASSOC, V287, P1541, DOI 10.1001/jama.287.12.1541; De Backer D, 2004, AM HEART J, V147, P91, DOI 10.1016/j.ahj.2003.07.006; De Backer D, 2010, NEW ENGL J MED, V362, P779, DOI 10.1056/NEJMoa0907118; den Uil CA, 2009, EUR J HEART FAIL, V11, P386, DOI 10.1093/eurjhf/hfp021; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; HEUSCH G, 1990, CIRCULATION, V81, P1, DOI 10.1161/01.CIR.81.1.1; Hochman JS, 2003, CIRCULATION, V107, P2998, DOI 10.1161/01.CIR.0000075927.67673.F2; How OJ, 2010, TRANSL RES, V156, P273, DOI 10.1016/j.trsl.2010.07.011; Jung C, 2009, CLIN RES CARDIOL, V98, P469, DOI 10.1007/s00392-009-0018-0; Krejci V, 2006, CRIT CARE MED, V34, P1456, DOI 10.1097/01.CCM.0000215834.48023.57; Krenn L, 2011, CRIT CARE MED, V39, P583, DOI 10.1097/CCM.0b013e318208e381; Levy B, 2011, CRIT CARE MED, V39, P450, DOI 10.1097/CCM.0b013e3181ffe0eb; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Mebazaa A, 2011, INTENS CARE MED, V37, P290, DOI 10.1007/s00134-010-2073-4; Nieminen MS, 2005, EUR HEART J, V26, P384; Nikolaidis LA, 2002, CARDIOVASC RES, V53, P392, DOI 10.1016/S0008-6363(01)00490-4; Palizas F, 2009, CRIT CARE, V13, DOI 10.1186/cc7767; Reynolds HR, 2008, CIRCULATION, V117, P686, DOI 10.1161/CIRCULATIONAHA.106.613596; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rubin DB, 1996, J AM STAT ASSOC, V91, P473, DOI 10.1080/01621459.1996.10476908; Spinar J, 2011, CRIT CARE, V15, DOI 10.1186/cc10584; Thompson RB, 2003, EUR J HEART FAIL, V5, P741, DOI 10.1016/S1388-9842(03)00152-1; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; White IR, 2011, STAT MED, V30, P3192, DOI 10.1002/sim.4360; White IR, 2009, STAT MED, V28, P1982, DOI 10.1002/sim.3618; Zannad F, 2006, EUR J HEART FAIL, V8, P697, DOI 10.1016/j.ejheart.2006.01.001	31	34	35	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71659	10.1371/journal.pone.0071659	http://dx.doi.org/10.1371/journal.pone.0071659			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977106	Green Published, Green Submitted, gold			2022-12-25	WOS:000323378000063
J	Edmunds, KL; Hunter, PR; Few, R; Bell, DJ				Edmunds, Kelly L.; Hunter, Paul R.; Few, Roger; Bell, Diana J.			Hazard Analysis of Critical Control Points Assessment as a Tool to Respond to Emerging Infectious Disease Outbreaks	PLOS ONE			English	Article							INFLUENZA-A H5N1; AVIAN INFLUENZA; RISK-FACTORS; WILDLIFE TRADE; ANIMAL ORIGINS; HONG-KONG; POULTRY; HEALTH	Highly pathogenic avian influenza virus (HPAI) strain H5N1 has had direct and indirect economic impacts arising from direct mortality and control programmes in over 50 countries reporting poultry outbreaks. HPAI H5N1 is now reported as the most widespread and expensive zoonotic disease recorded and continues to pose a global health threat. The aim of this research was to assess the potential of utilising Hazard Analysis of Critical Control Points (HACCP) assessments in providing a framework for a rapid response to emerging infectious disease outbreaks. This novel approach applies a scientific process, widely used in food production systems, to assess risks related to a specific emerging health threat within a known zoonotic disease hotspot. We conducted a HACCP assessment for HPAI viruses within Vietnam's domestic poultry trade and relate our findings to the existing literature. Our HACCP assessment identified poultry flock isolation, transportation, slaughter, preparation and consumption as critical control points for Vietnam's domestic poultry trade. Introduction of the preventative measures highlighted through this HACCP evaluation would reduce the risks posed by HPAI viruses and pressure on the national economy. We conclude that this HACCP assessment provides compelling evidence for the future potential that HACCP analyses could play in initiating a rapid response to emerging infectious diseases.	[Edmunds, Kelly L.; Bell, Diana J.] Univ E Anglia, Sch Biol Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England; [Hunter, Paul R.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Few, Roger] Univ E Anglia, Sch Int Dev, Norwich NR4 7TJ, Norfolk, England	University of East Anglia; University of East Anglia; University of East Anglia	Bell, DJ (corresponding author), Univ E Anglia, Sch Biol Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England.	d.bell@uea.ac.uk	Edmunds, Kelly/J-2892-2015; Few, Roger/AAT-3914-2021; Hunter, Paul/A-7172-2008; Hunter, Paul/N-9021-2019	Edmunds, Kelly/0000-0001-5351-3721; Few, Roger/0000-0001-6653-1400; Hunter, Paul/0000-0002-5608-6144; Hunter, Paul/0000-0002-5608-6144	UK Economic and Social Research Council (ESRC); Natural Environment Research Council (NERC); ESRC/NERC [ES/F009925/1]	UK Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ESRC/NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)Economic & Social Research Council (ESRC))	The research was supported by the UK Economic and Social Research Council (ESRC) and the Natural Environment Research Council (NERC) (http://www.nerc.ac.uk). KE was funded by ESRC/NERC studentship ES/F009925/1. The funders provided the latter and had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Areechokchai Darin, 2006, MMWR Suppl, V55, P3; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Bell D, 2004, PHILOS T R SOC B, V359, P1107, DOI 10.1098/rstb.2004.1492; Binder S, 1999, SCIENCE, V284, P1311, DOI 10.1126/science.284.5418.1311; Bogich TL, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0127; Bridges CB, 2002, J INFECT DIS, V185, P1005, DOI 10.1086/340044; Chomel BB, 2007, EMERG INFECT DIS, V13, P6, DOI 10.3201/eid1301.060480; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; Dinh PN, 2006, EMERG INFECT DIS, V12, P1841; Eagles D, 2009, REV SCI TECH OIE, V28, P341, DOI 10.20506/rst.28.1.1864; Edmunds KL, 2011, THESIS U E ANGLIA UK; Edmunds KL, 2011, THESIS U E ANGLIA NO; Grenier M, 2007, BERL MUNCH TIERARZTL, V2/4, P98; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kandun IN, 2010, ZOONOSES PUBLIC HLTH, V57, P285, DOI 10.1111/j.1863-2378.2009.01246.x; Karesh WB, 2005, EMERG INFECT DIS, V11, P1000; Kung NY, 2003, AVIAN DIS, V47, P1037, DOI 10.1637/0005-2086-47.s3.1037; Liao QY, 2009, J PUBLIC HEALTH-UK, V31, P573, DOI 10.1093/pubmed/fdp043; MacLehose L, 2003, INFEKTIONSEPIDEMIOLO, P119; Mounts AW, 1999, J INFECT DIS, V180, P505, DOI 10.1086/314903; OIE, WORLD ORG AN HLTH UP; Roberton SI, 2006, P ROY SOC B-BIOL SCI, V273, P1729, DOI 10.1098/rspb.2006.3549; Savill NJ, 2006, NATURE, V442, P757, DOI 10.1038/442757a; Swift L, 2007, ECOHEALTH, V4, P25, DOI 10.1007/s10393-006-0076-y; Thorson A, 2006, ARCH INTERN MED, V166, P119, DOI 10.1001/archinte.166.1.119; Tian GB, 2005, VIROLOGY, V341, P153, DOI 10.1016/j.virol.2005.07.011; Van Kerkhove MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014582; Van Kerkhove MD, 2008, INFLUENZA OTHER RESP, V2, P155, DOI 10.1111/j.1750-2659.2008.00052.x; Vong S, 2009, J INFECT DIS, V199, P1744, DOI 10.1086/599208; Webster RG, 2006, EMERG INFECT DIS, V12, P3, DOI 10.3201/eid1201.051024; Weiss RA, 2001, PHILOS T R SOC B, V356, P957, DOI 10.1098/rstb.2001.0838; WHO, 2013, CUM NUMB CONF HUM CA; World Health Organization (WHO), 2007, REV LAT AV EV POT TR	34	7	8	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e72279	10.1371/journal.pone.0072279	http://dx.doi.org/10.1371/journal.pone.0072279			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967294	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000323221500127
J	Jun, SH; Lee, JH; Kim, BR; Kim, SI; Park, TI; Lee, JC; Lee, YC				Jun, So Hyun; Lee, Jung Hwa; Kim, Bo Ra; Kim, Seung Il; Park, Tae In; Lee, Je Chul; Lee, Yoo Chul			Acinetobacter baumannii Outer Membrane Vesicles Elicit a Potent Innate Immune Response via Membrane Proteins	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; CELL; BIOGENESIS; PATHOGEN; BIOFILM; ROLES	Acinetobacter baumannii is increasingly becoming a major nosocomial pathogen. This opportunistic pathogen secretes outer membrane vesicles (OMVs) that interact with host cells. The aim of this study was to investigate the ability of A. baumannii OMVs to elicit a pro-inflammatory response in vitro and the immunopathology in response to A. baumannii OMVs in vivo. OMVs derived from A. baumannii ATCC 19606(T) induced expression of pro-inflammatory cytokine genes, interleukin (IL)-beta b and IL-6, and chemokine genes, IL-8, macrophage inflammatory protein-1 alpha, and monocyte chemoattractant protein-1, in epithelial cells in a dose-dependent manner. Disintegration of OMV membrane with ethylenediaminetetraacetic acid resulted in low expression of pro-inflammatory cytokine genes, as compared with the response to intact OMVs. In addition, proteinase K-treated A. baumannii OMVs did not induce significant increase in expression of pro-inflammatory cytokine genes above the basal level, suggesting that the surface-exposed membrane proteins in intact OMVs are responsible for pro-inflammatory response. Early inflammatory processes, such as vacuolization and detachment of epithelial cells and neutrophilic infiltration, were clearly observed in lungs of mice injected with A. baumannii OMVs. Our data demonstrate that OMVs produced by A. baumannii elicit a potent innate immune response, which may contribute to immunopathology of the infected host.	[Jun, So Hyun; Lee, Jung Hwa; Kim, Bo Ra; Lee, Je Chul; Lee, Yoo Chul] Kyungpook Natl Univ, Sch Med, Dept Microbiol, Taegu, South Korea; [Kim, Seung Il] Korea Basic Sci Inst, Div Life Sci, Taejon, South Korea; [Park, Tae In] Kyungpook Natl Univ, Sch Med, Dept Pathol, Taegu, South Korea	Kyungpook National University; Korea Basic Science Institute (KBSI); Kyungpook National University	Lee, JC (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Microbiol, Taegu, South Korea.	leejc@knu.ac.kr; yclee@knu.ac.kr			Kyungpook National University Research Fund	Kyungpook National University Research Fund	This research was supported by Kyungpook National University Research Fund, 2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaniz RC, 2007, J IMMUNOL, V179, P7692, DOI 10.4049/jimmunol.179.11.7692; Bauman SJ, 2006, MICROBES INFECT, V8, P2400, DOI 10.1016/j.micinf.2006.05.001; BergogneBerezin E, 1996, CLIN MICROBIOL REV, V9, P148, DOI 10.1128/CMR.9.2.148; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; Breslow JM, 2011, INFECT IMMUN, V79, P3317, DOI 10.1128/IAI.00069-11; Cho YJ, 2009, DIAGN MICR INFEC DIS, V64, P185, DOI 10.1016/j.diagmicrobio.2009.02.010; Choi CH, 2005, CELL MICROBIOL, V7, P1127, DOI 10.1111/j.1462-5822.2005.00538.x; Choi CH, 2008, CELL MICROBIOL, V10, P309, DOI 10.1111/j.1462-5822.2007.01041.x; Choi CH, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-216; de Breij A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030673; de Breij A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010732; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Ellis TN, 2010, INFECT IMMUN, V78, P3822, DOI 10.1128/IAI.00433-10; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Gaddy JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09; Jin JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017027; Kim CH, 2013, MICROB PATHOGENESIS, V54, P20, DOI 10.1016/j.micpath.2012.08.008; Kim SW, 2009, FEMS MICROBIOL LETT, V301, P224, DOI 10.1111/j.1574-6968.2009.01820.x; Kim SA, 2008, FEMS IMMUNOL MED MIC, V54, P45, DOI 10.1111/j.1574-695X.2008.00446.x; Knapp S, 2006, AM J RESP CRIT CARE, V173, P122, DOI 10.1164/rccm.200505-730OC; Koning RI, 2013, RES MICROBIOL, V164, P397, DOI 10.1016/j.resmic.2013.02.007; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Kwon SO, 2009, FEMS MICROBIOL LETT, V297, P150, DOI 10.1111/j.1574-6968.2009.01669.x; Lee EY, 2008, MASS SPECTROM REV, V27, P535, DOI 10.1002/mas.20175; Lee HW, 2008, CLIN MICROBIOL INFEC, V14, P49, DOI 10.1111/j.1469-0691.2007.01842.x; Lee JC, 2006, RES MICROBIOL, V157, P360, DOI 10.1016/j.resmic.2005.09.011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mashburn LM, 2005, NATURE, V437, P422, DOI 10.1038/nature03925; McBroom AJ, 2007, MOL MICROBIOL, V63, P545, DOI 10.1111/j.1365-2958.2006.05522.x; McConnell MJ, 2011, VACCINE, V29, P5705, DOI 10.1016/j.vaccine.2011.06.001; Michalopoulos A, 2010, EXPERT OPIN PHARMACO, V11, P779, DOI 10.1517/14656561003596350; Moon DC, 2012, J MICROBIOL, V50, P155, DOI 10.1007/s12275-012-1589-4; Unal CM, 2011, SEMIN IMMUNOPATHOL, V33, P395, DOI 10.1007/s00281-010-0231-y	34	73	85	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71751	10.1371/journal.pone.0071751	http://dx.doi.org/10.1371/journal.pone.0071751			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23977136	Green Submitted, Green Published, gold			2022-12-25	WOS:000323221500101
J	Kwong, RWM; Kumai, Y; Perry, SF				Kwong, Raymond W. M.; Kumai, Yusuke; Perry, Steve F.			The Role of Aquaporin and Tight Junction Proteins in the Regulation of Water Movement in Larval Zebrafish (Danio rerio)	PLOS ONE			English	Article							EEL ANGUILLA-ANGUILLA; EUROPEAN EEL; MOLECULAR CHARACTERIZATION; EPITHELIAL PERMEABILITY; SEAWATER ACCLIMATION; GLUCOSE TRANSPORTERS; EXPRESSION; CORTISOL; CHANNEL; INTESTINE	Teleost fish living in freshwater are challenged by passive water influx; however the molecular mechanisms regulating water influx in fish are not well understood. The potential involvement of aquaporins (AQP) and epithelial tight junction proteins in the regulation of transcellular and paracellular water movement was investigated in larval zebrafish (Danio rerio). We observed that the half-time for saturation of water influx (K-u) was 4.3 +/- 0.9 min, and reached equilibrium at approximately 30 min. These findings suggest a high turnover rate of water between the fish and the environment. Water influx was reduced by the putative AQP inhibitor phloretin (100 or 500 mu M). Immunohistochemistry and confocal microscopy revealed that AQP1a1 protein was expressed in cells on the yolk sac epithelium. A substantial number of these AQP1a1-positive cells were identified as ionocytes, either H+-ATPase-rich cells or Na+/K+-ATPase-rich cells. AQP1a1 appeared to be expressed predominantly on the basolateral membranes of ionocytes, suggesting its potential involvement in regulating ionocyte volume and/or water flux into the circulation. Additionally, translational gene knockdown of AQP1a1 protein reduced water influx by approximately 30%, further indicating a role for AQP1a1 in facilitating transcellular water uptake. On the other hand, incubation with the Ca2+-chelator EDTA or knockdown of the epithelial tight junction protein claudin-b significantly increased water influx. These findings indicate that the epithelial tight junctions normally act to restrict paracellular water influx. Together, the results of the present study provide direct in vivo evidence that water movement can occur through transcellular routes (via AQP); the paracellular routes may become significant when the paracellular permeability is increased.	[Kwong, Raymond W. M.; Kumai, Yusuke; Perry, Steve F.] Univ Ottawa, Dept Biol, Ottawa, ON, Canada	University of Ottawa	Kwong, RWM (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON, Canada.	wkwong@uottawa.ca	Kwong, Raymond/AAC-3368-2020	Kwong, Raymond/0000-0002-0784-9651	Natural Sciences and Engineering Research Council (NSERC)	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by Natural Sciences and Engineering Research Council (NSERC) Discovery and NSERC Research Tools and Instrumentation Grants to SFP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 1996, PFLUG ARCH EUR J PHY, V431, P408, DOI 10.1007/BF02207279; Cerda J, 2010, J EXP ZOOL PART A, V313A, P623, DOI 10.1002/jez.634; Chen LM, 2010, AM J PHYSIOL-REG I, V299, pR1163, DOI 10.1152/ajpregu.00319.2010; Conner MT, 2010, BIOCHEMISTRY-US, V49, P821, DOI 10.1021/bi902068b; Contreras RG, 1991, CALCIUM TIGHT JUNCTI; Cutler CP, 2002, J EXP BIOL, V205, P2643; Drummond IA, 1998, DEVELOPMENT, V125, P4655; Echevarria M, 1996, J BIOL CHEM, V271, P25079, DOI 10.1074/jbc.271.41.25079; Endeward V, 2006, FASEB J, V20, P1974, DOI 10.1096/fj.04-3300com; Engelund MB, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00051; Evans DH, 2008, AM J PHYSIOL-REG I, V295, pR704, DOI 10.1152/ajpregu.90337.2008; Fabra M, 2005, SCIENCE, V307, P545, DOI 10.1126/science.1106305; FISCHBARG J, 1990, P NATL ACAD SCI USA, V87, P3244, DOI 10.1073/pnas.87.8.3244; Fischbarg J, 2010, PHYSIOL REV, V90, P1271, DOI 10.1152/physrev.00025.2009; Gao JW, 2006, ANAL BIOCHEM, V350, P165, DOI 10.1016/j.ab.2006.01.003; Giffard-Mena I, 2007, COMP BIOCHEM PHYS A, V148, P430, DOI 10.1016/j.cbpa.2007.06.002; Haddoub Rose, 2009, Handb Exp Pharmacol, P385, DOI 10.1007/978-3-540-79885-9_19; Huber VJ, 2007, BIOORG MED CHEM LETT, V17, P1270, DOI 10.1016/j.bmcl.2006.12.010; Hwang PP, 2010, FISH PHYSIOL, V29, P311, DOI 10.1016/S1546-5098(10)02908-0; ISAIA J, 1984, FISH PHYSIOL, V10, P1; Kawedia JD, 2008, J PHARMACOL EXP THER, V326, P829, DOI 10.1124/jpet.107.135798; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; King LS, 2001, NEW ENGL J MED, V345, P175, DOI 10.1056/NEJM200107193450304; KNEPPER MA, 1989, AM J PHYSIOL, V256, pF610, DOI 10.1152/ajprenal.1989.256.4.F610; Kramer-Zucker AG, 2005, DEV BIOL, V285, P316, DOI 10.1016/j.ydbio.2005.06.038; Kwong RWM, 2013, J ENDOCRINOL, V217, P253, DOI 10.1530/JOE-12-0574; Kwong RWM, 2013, AM J PHYSIOL-REG I, V304, pR504, DOI 10.1152/ajpregu.00385.2012; Kwong RWM, 2013, J COMP PHYSIOL B, V183, P203, DOI 10.1007/s00360-012-0700-9; Lin LY, 2000, PHYSIOL BIOCHEM ZOOL, V73, P283, DOI 10.1086/316747; LOESCHKE K, 1994, AM J PHYSIOL, V266, pG722, DOI 10.1152/ajpgi.1994.266.4.G722; Ma TH, 1998, J BIOL CHEM, V273, P4296, DOI 10.1074/jbc.273.8.4296; Madsen SS, 2011, FRONTIER PHYSL, V2; MANGORJENSEN A, 1987, FISH PHYSIOL BIOCHEM, V3, P99, DOI 10.1007/BF02183004; Martial S, 1996, AM J PHYSIOL-RENAL, V271, pF1264, DOI 10.1152/ajprenal.1996.271.6.F1264; Martinez AS, 2005, BIOL CELL, V97, P615, DOI 10.1042/BC20040111; Martinez AS, 2005, AM J PHYSIOL-REG I, V288, pR1733, DOI 10.1152/ajpregu.00747.2004; Nakhoul NL, 1998, AM J PHYSIOL-CELL PH, V274, pC543, DOI 10.1152/ajpcell.1998.274.2.C543; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rehn K, 2011, INT J DEV BIOL, V55, P613, DOI 10.1387/ijdb.103249kp; Rombough P, 2002, J EXP BIOL, V205, P1787; Schnermann J, 1998, P NATL ACAD SCI USA, V95, P9660, DOI 10.1073/pnas.95.16.9660; Sundell KS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00388; Tanimura Y, 2009, J STRUCT BIOL, V166, P16, DOI 10.1016/j.jsb.2008.11.010; Tingaud-Sequeira A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-38; Tipsmark CK, 2010, J EXP BIOL, V213, P368, DOI 10.1242/jeb.034785; Tseng YC, 2009, AM J PHYSIOL-REG I, V297, pR275, DOI 10.1152/ajpregu.00180.2009; Tsukaguchi H, 1999, AM J PHYSIOL-RENAL, V277, pF685, DOI 10.1152/ajprenal.1999.277.5.F685; Vallon V, 2000, AM J PHYSIOL-RENAL, V278, pF1030, DOI 10.1152/ajprenal.2000.278.6.F1030; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Verkman AS, 2011, J CELL SCI, V124, P2107, DOI 10.1242/jcs.079467; Watanabe S, 2005, J EXP BIOL, V208, P2673, DOI 10.1242/jeb.01684; Whittamore JM, 2012, J COMP PHYSIOL B, V182, P1, DOI 10.1007/s00360-011-0601-3; Wood CM, 2012, J EXP BIOL, V215, P508, DOI 10.1242/jeb.060004; Yang BX, 1998, J BIOL CHEM, V273, P9369, DOI 10.1074/jbc.273.16.9369; Zeuthen T, 2007, J PHYSIOL-LONDON, V579, P345, DOI 10.1113/jphysiol.2006.123380	56	19	19	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e70764	10.1371/journal.pone.0070764	http://dx.doi.org/10.1371/journal.pone.0070764			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967101	Green Published, Green Submitted, gold			2022-12-25	WOS:000323221500027
J	Mahdi, LK; Ebrahimie, E; Adelson, DL; Paton, JC; Ogunniyi, AD				Mahdi, Layla K.; Ebrahimie, Esmaeil; Adelson, David L.; Paton, James C.; Ogunniyi, Abiodun D.			A Transcription Factor Contributes to Pathogenesis and Virulence in Streptococcus pneumoniae	PLOS ONE			English	Article								To date, the role of transcription factors (TFs) in the progression of disease for many pathogens is yet to be studied in detail. This is probably due to transient, and generally low expression levels of TFs, which are the central components controlling the expression of many genes during the course of infection. However, a small change in the expression or specificity of a TF can radically alter gene expression. In this study, we combined a number of quality-based selection strategies including structural prediction of modulated genes, gene ontology and network analysis, to predict the regulatory mechanisms underlying pathogenesis of Streptococcus pneumoniae (the pneumococcus). We have identified two TFs (SP_0676 and SP_0927 [SmrC]) that might control tissue-specific gene expression during pneumococcal translocation from the nasopharynx to lungs, to blood and then to brain of mice. Targeted mutagenesis and mouse models of infection confirmed the role of SP_0927 in pathogenesis and virulence, and suggests that SP_0676 might be essential to pneumococcal viability. These findings provide fundamental new insights into virulence gene expression and regulation during pathogenesis.	[Mahdi, Layla K.; Paton, James C.; Ogunniyi, Abiodun D.] Univ Adelaide, Sch Mol & Biomed Sci, Res Ctr Infect Dis, Adelaide, SA, Australia; [Ebrahimie, Esmaeil; Adelson, David L.] Univ Adelaide, Sch Mol & Biomed Sci, Ctr Bioinformat & Computat Genet, Adelaide, SA, Australia	University of Adelaide; University of Adelaide	Ogunniyi, AD (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Res Ctr Infect Dis, Adelaide, SA, Australia.	david.ogunniyi@adelaide.edu.au	Ebrahimie, Esmaeil/AAN-2611-2020; Ebrahimi, Mansour/AAO-9096-2021; Adelson, David L/E-5506-2011	Ebrahimie, Esmaeil/0000-0002-4431-2861; Ebrahimi, Mansour/0000-0001-7011-2567; Adelson, David L/0000-0003-2404-5636; Ogunniyi, Abiodun/0000-0001-9308-5629; Mahdi, Layla/0000-0002-5878-8385	Meningitis Research Foundation (UK) [0802.0]; National Health and Medical Research Council of Australia (NHMRC) [627142]; NHMRC [565526]	Meningitis Research Foundation (UK)(Meningitis Research Foundation (MRF)); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Meningitis Research Foundation (UK) Research Grant 0802.0 to ADO, JCP and LKM, the National Health and Medical Research Council of Australia (NHMRC) Project Grant 627142 to JCP and ADO, and NHMRC Program Grant 565526 to JCP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balleza E, 2009, FEMS MICROBIOL REV, V33, P133, DOI 10.1111/j.1574-6976.2008.00145.x; Berry AM, 2000, INFECT IMMUN, V68, P133, DOI 10.1128/IAI.68.1.133-140.2000; Berthoumieux S, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.70; Bina J, 2003, P NATL ACAD SCI USA, V100, P2801, DOI 10.1073/pnas.2628026100; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Caymaris S, 2010, MOL MICROBIOL, V78, P344, DOI 10.1111/j.1365-2958.2010.07339.x; DIRITA VJ, 1992, MOL MICROBIOL, V6, P451, DOI 10.1111/j.1365-2958.1992.tb01489.x; DIRITA VJ, 1991, P NATL ACAD SCI USA, V88, P5403, DOI 10.1073/pnas.88.12.5403; DiRita VJ, 1996, P NATL ACAD SCI USA, V93, P7991, DOI 10.1073/pnas.93.15.7991; Finlay BB, 2010, SCI AM, V302, P56, DOI 10.1038/scientificamerican0210-56; Fruzangohar M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058759; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.t01-1-03106.x; Hava DL, 2003, MOL MICROBIOL, V50, P1103, DOI 10.1046/j.1365-2958.2003.03764.x; Hemsley C, 2003, J BACTERIOL, V185, P6640, DOI 10.1128/JB.185.22.6640-6647.2003; Hendriksen WT, 2009, MICROBIOL-SGM, V155, P1569, DOI 10.1099/mic.0.025072-0; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Kaufman GE, 2007, J BACTERIOL, V189, P5183, DOI 10.1128/JB.00449-07; Kloosterman TG, 2008, J BACTERIOL, V190, P5382, DOI 10.1128/JB.00307-08; Kwon HY, 2004, INFECT IMMUN, V72, P5646, DOI 10.1128/IAI.72.10.5646-5653.2004; Kwon HY, 2003, INFECT IMMUN, V71, P3757, DOI 10.1128/IAI.71.7.3757-3765.2003; Lau GW, 2001, MOL MICROBIOL, V40, P555, DOI 10.1046/j.1365-2958.2001.02335.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Mahdi LK, 2008, INFECT IMMUN, V76, P646, DOI 10.1128/IAI.01161-07; Mandi LK, 2012, J CLIN INVEST, V122, P2208, DOI 10.1172/JCI45850; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Ogunniyi AD, 2007, INFECT IMMUN, V75, P1843, DOI 10.1128/IAI.01384-06; Ogunniyi AD, 2012, INFECT IMMUN, V80, P3268, DOI 10.1128/IAI.00295-12; Ogunniyi AD, 2010, J BACTERIOL, V192, P4489, DOI 10.1128/JB.00064-10; Orihuela CJ, 2004, INFECT IMMUN, V72, P5582, DOI 10.1128/IAI.72.10.5582-5596.2004; Orihuela CJ, 2003, SCAND J INFECT DIS, V35, P647, DOI 10.1080/00365540310015854; Park CY, 2010, J MICROBIOL, V48, P229, DOI 10.1007/s12275-010-9300-0; Paterson GK, 2006, J MED MICROBIOL, V55, P355, DOI 10.1099/jmm.0.46423-0; Paton James C., 2008, P421; Robertson GT, 2002, J BACTERIOL, V184, P3508, DOI 10.1128/JB.184.13.3508-3520.2002; Schoolnik GK, 2002, MICROARRAY ANAL BACT, V46; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Solano-Collado V, 2012, J BACTERIOL, V194, P4197, DOI 10.1128/JB.00536-12; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Ulijasz AT, 2009, MOL MICROBIOL, V71, P382, DOI 10.1111/j.1365-2958.2008.06532.x; van Opijnen T, 2012, GENOME RES, V22, P2541, DOI 10.1101/gr.137430.112; WEISER JN, 1994, INFECT IMMUN, V62, P2582, DOI 10.1128/IAI.62.6.2582-2589.1994	43	13	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e70862	10.1371/journal.pone.0070862	http://dx.doi.org/10.1371/journal.pone.0070862			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967124	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000323115800027
J	Volckaert, T; Campbell, A; De Langhe, S				Volckaert, Thomas; Campbell, Alice; De Langhe, Stijn			c-Myc Regulates Proliferation and Fgf10 Expression in Airway Smooth Muscle after Airway Epithelial Injury in Mouse	PLOS ONE			English	Article							MULTIPLE MESENCHYMAL LINEAGES; STEM-CELLS; BETA-CATENIN; LUNG DEVELOPMENT; TERMINAL BRONCHIOLES; PROGENITOR CELLS; DISTAL LUNG; PLASTICITY; REPAIR; DIFFERENTIATION	During lung development, Fibroblast growth factor 10 (Fgf10), which is expressed in the distal mesenchyme and regulated by Wnt signaling, acts on the distal epithelial progenitors to maintain them and prevent them from differentiating into proximal (airway) epithelial cells. Fgf10-expressing cells in the distal mesenchyme are progenitors for parabronchial smooth muscle cells (PSMCs). After naphthalene, ozone or bleomycin-induced airway epithelial injury, surviving epithelial cells secrete Wnt7b which then activates the PSMC niche to induce Fgf10 expression. This Fgf10 secreted by the niche then acts on a subset of Clara stem cells to break quiescence, induce proliferation and initiate epithelial repair. Here we show that conditional deletion of the Wnt target gene c-Myc from the lung mesenchyme during development does not affect proper epithelial or mesenchymal differentiation. However, in the adult lung we show that after naphthalene-mediated airway epithelial injury c-Myc is important for the activation of the PSMC niche and as such induces proliferation and Fgf10 expression in PSMCs. Our data indicate that conditional deletion of c-Myc from PSMCs inhibits airway epithelial repair, whereas c-Myc ablation from Clara cells has no effect on airway epithelial regeneration. These findings may have important implications for understanding the misregulation of lung repair in asthma and COPD.	[Volckaert, Thomas; Campbell, Alice; De Langhe, Stijn] Natl Jewish Hlth, Div Cell Biol, Dept Pediat, Denver, CO USA; [Volckaert, Thomas] VIB, Unit Mol Signal Transduct Inflammat, Dept Mol Biomed Res, Ghent, Belgium; [Volckaert, Thomas] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [De Langhe, Stijn] Univ Colorado Denver, Sch Med, Dept Cellular & Dev Biol, Aurora, CO USA	National Jewish Health; Flanders Institute for Biotechnology (VIB); Ghent University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	De Langhe, S (corresponding author), Natl Jewish Hlth, Div Cell Biol, Dept Pediat, Denver, CO USA.	delanghes@njhealth.org	De Langhe, Stijn/ABH-6876-2020	De Langhe, Stijn/0000-0003-3867-4572	US National Institutes of Health (NIH) [R01 HL092967]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092967] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported by funding from the US National Institutes of Health (NIH) R01 HL092967 (to SDL, www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barroca V, 2009, NAT CELL BIOL, V11, P190, DOI 10.1038/ncb1826; Bedada FB, 2006, CELL CYCLE, V5, P223, DOI 10.4161/cc.5.3.2364; Bellusci S, 1997, DEVELOPMENT, V124, P4867; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Chen F, 2010, J CLIN INVEST, V120, P2040, DOI 10.1172/JCI40253; Chen HY, 2012, STEM CELLS, V30, P1948, DOI 10.1002/stem.1150; Cobaleda C, 2008, CURR OPIN IMMUNOL, V20, P139, DOI 10.1016/j.coi.2008.03.017; Cohen ED, 2009, J CLIN INVEST, V119, P2538, DOI 10.1172/JCI38079; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Daniely Y, 2004, AM J PHYSIOL-CELL PH, V287, pC171, DOI 10.1152/ajpcell.00226.2003; De Langhe SP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001516; De Langhe SP, 2006, DEV BIOL, V299, P52, DOI 10.1016/j.ydbio.2006.07.001; EVANS MJ, 1976, LAB INVEST, V35, P246; Giangreco A, 2002, AM J PATHOL, V161, P173, DOI 10.1016/S0002-9440(10)64169-7; Goss AM, 2011, DEV BIOL; Goss AM, 2009, DEV CELL, V17, P290, DOI 10.1016/j.devcel.2009.06.005; Hong KU, 2001, AM J RESP CELL MOL, V24, P671, DOI 10.1165/ajrcmb.24.6.4498; Izvolsky KI, 2003, DEV BIOL, V258, P185, DOI 10.1016/S0012-1606(03)00114-3; Izvolsky KI, 2003, AM J PHYSIOL-LUNG C, V285, pL838, DOI 10.1152/ajplung.00081.2003; Ji H, 2006, ONCOGENE, V25, P2105, DOI 10.1038/sj.onc.1209237; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; Kim Y, 2009, J CELL BIOL, V184, P309, DOI 10.1083/jcb.200806067; Konigshoff M, 2010, AM J RESP CELL MOL, V42, P21, DOI 10.1165/rcmb.2008-0485TR; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Konigshoff M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002142; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Mailleux AA, 2005, DEVELOPMENT, V132, P2157, DOI 10.1242/dev.01795; McKeehan WL, 1998, PROG NUCLEIC ACID RE, V59, P135; Nyeng P, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-2; Okubo T, 2005, DEVELOPMENT, V132, P1363, DOI 10.1242/dev.01678; PACK RJ, 1981, J ANAT, V132, P71; Park KS, 2006, AM J RESP CELL MOL, V34, P151, DOI 10.1165/rcmb.2005-0332OC; PLOPPER CG, 1992, LAB INVEST, V67, P553; Ramasamy SK, 2007, DEV BIOL, V307, P237, DOI 10.1016/j.ydbio.2007.04.033; Rawlins EL, 2006, DEVELOPMENT, V133, P2455, DOI 10.1242/dev.02407; Rawlins EL, 2009, DEVELOPMENT, V136, P3741, DOI 10.1242/dev.037317; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Reynolds SD, 2000, AM J PATHOL, V156, P269, DOI 10.1016/S0002-9440(10)64727-X; Rock JR, 2011, ANNU REV CELL DEV BI, V27, P493, DOI 10.1146/annurev-cellbio-100109-104040; Rock JR, 2010, DIS MODEL MECH, V3, P545, DOI 10.1242/dmm.006031; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Sala FG, 2011, DEVELOPMENT, V138, P273, DOI 10.1242/dev.051680; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Sedita J, 2004, DEV DYNAM, V231, P782, DOI 10.1002/dvdy.20173; Shimokawa K, 2011, DEV CELL, V21, P257, DOI 10.1016/j.devcel.2011.06.027; Simon Dawn M, 2006, Proc Am Thorac Soc, V3, P510; Stocum DL, 2004, ADV ANAT EMBRYOL CEL, V176, P1; Stocum DL, 2004, CURR TOP MICROBIOL, V280, P1; Stripp BR, 1995, AM J PHYSIOL-LUNG C, V269, pL791, DOI 10.1152/ajplung.1995.269.6.L791; Tiozzo C, 2009, PEDIATR RES, V66, P386, DOI 10.1203/PDR.0b013e3181b45580; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Ulsamer A, 2012, J BIOL CHEM, V287, P5164, DOI 10.1074/jbc.M111.322123; Volckaert T, 2011, J CLIN INVEST, V121, P4409, DOI 10.1172/JCI58097; Xi Y, ONCOGENE; Xin HB, 2002, PHYSIOL GENOMICS, V10, P211, DOI 10.1152/physiolgenomics.00054.2002; Yin Y, 2008, DEV BIOL, V319, P426, DOI 10.1016/j.ydbio.2008.04.009; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	61	29	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71426	10.1371/journal.pone.0071426	http://dx.doi.org/10.1371/journal.pone.0071426			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967208	Green Published, gold			2022-12-25	WOS:000323115800058
J	Kashiwase, Y; Matsumiya, K; Kuriki, I; Shioiri, S				Kashiwase, Yoshiyuki; Matsumiya, Kazumichi; Kuriki, Ichiro; Shioiri, Satoshi			Temporal Dynamics of Visual Attention Measured with Event-Related Potentials	PLOS ONE			English	Article							TIME-COURSE; SELECTIVE ATTENTION; EVOKED POTENTIALS; COVERT SHIFTS; CUED SHIFTS; PERFORMANCE; MODULATION; AMPLIFICATION; FACILITATION; SUPPRESSION	How attentional modulation on brain activities determines behavioral performance has been one of the most important issues in cognitive neuroscience. This issue has been addressed by comparing the temporal relationship between attentional modulations on neural activities and behavior. Our previous study measured the time course of attention with amplitude and phase coherence of steady-state visual evoked potential (SSVEP) and found that the modulation latency of phase coherence rather than that of amplitude was consistent with the latency of behavioral performance. In this study, as a complementary report, we compared the time course of visual attention shift measured by event-related potentials (ERPs) with that by target detection task. We developed a novel technique to compare ERPs with behavioral results and analyzed the EEG data in our previous study. Two sets of flickering stimulus at different frequencies were presented in the left and right visual hemifields, and a target or distracter pattern was presented randomly at various moments after an attention-cue presentation. The observers were asked to detect targets on the attended stimulus after the cue. We found that two ERP components, P300 and N2pc, were elicited by the target presented at the attended location. Time-course analyses revealed that attentional modulation of the P300 and N2pc amplitudes increased gradually until reaching a maximum and lasted at least 1.5 s after the cue onset, which is similar to the temporal dynamics of behavioral performance. However, attentional modulation of these ERP components started later than that of behavioral performance. Rather, the time course of attentional modulation of behavioral performance was more closely associated with that of the concurrently recorded SSVEPs analyzed. These results suggest that neural activities reflected not by either the P300 or N2pc, but by the SSVEPs, are the source of attentional modulation of behavioral performance.	[Kashiwase, Yoshiyuki; Matsumiya, Kazumichi; Kuriki, Ichiro; Shioiri, Satoshi] Tohoku Univ, Grad Sch Informat Sci, Sendai, Miyagi 980, Japan; [Matsumiya, Kazumichi; Kuriki, Ichiro; Shioiri, Satoshi] Tohoku Univ, Elect Commun Res Inst, Sendai, Miyagi 980, Japan; [Kashiwase, Yoshiyuki] Japan Soc Promot Sci, Tokyo, Japan	Tohoku University; Tohoku University; Japan Society for the Promotion of Science	Kashiwase, Y (corresponding author), Tohoku Univ, Grad Sch Informat Sci, Sendai, Miyagi 980, Japan.	yoshi.kashiwase@gmail.com	Matsumiya, Kazumichi/T-1995-2019; Kuriki, Ichiro/C-7225-2011; Shioiri, Satoshi/B-9625-2008	Matsumiya, Kazumichi/0000-0003-3744-6762; Kuriki, Ichiro/0000-0001-9981-9339; Shioiri, Satoshi/0000-0003-2149-6132	Japan Society for the Promotion of Science [A18203036, B18330153, B22330198]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partially supported by Grants-in-Aid for Scientific Research (A18203036, B18330153, and B22330198) and by a Grant-in-Aid for JSPS Fellows to Y. K. by the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SK, 2010, P NATL ACAD SCI USA, V107, P13878, DOI 10.1073/pnas.1002436107; Andersen SK, 2008, CURR BIOL, V18, P1006, DOI 10.1016/j.cub.2008.06.030; Andersen SK, 2011, J COGNITIVE NEUROSCI, V23, P238, DOI 10.1162/jocn.2009.21328; Andersen SK, 2009, J VISION, V9, DOI 10.1167/9.6.2; Attar CH, 2010, NEUROIMAGE, V53, P1326, DOI 10.1016/j.neuroimage.2010.06.074; Bendixen A, 2013, CLIN NEUROPHYSIOL, V124, P928, DOI 10.1016/j.clinph.2012.11.012; Brisson B, 2007, NEUROREPORT, V18, P1627, DOI 10.1097/WNR.0b013e3282f0b559; Di Russo F, 2007, HUM BRAIN MAPP, V28, P323, DOI 10.1002/hbm.20276; Ding J, 2006, CEREB CORTEX, V16, P1016, DOI 10.1093/cercor/bhj044; Egeth HE, 1997, ANNU REV PSYCHOL, V48, P269, DOI 10.1146/annurev.psych.48.1.269; Hayden BY, 2005, NEURON, V47, P637, DOI 10.1016/j.neuron.2005.07.020; Herrington TM, 2010, J NEUROSCI, V30, P3287, DOI 10.1523/JNEUROSCI.6025-09.2010; Hillyard SA, 1997, HUM BRAIN MAPP, V5, P287, DOI 10.1002/(SICI)1097-0193(1997)5:4<287::AID-HBM14>3.0.CO;2-B; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Hopf JM, 2000, CEREB CORTEX, V10, P1233, DOI 10.1093/cercor/10.12.1233; Hopfinger JB, 1998, PSYCHOL SCI, V9, P441, DOI 10.1111/1467-9280.00083; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; Kashiwase Y, 2012, J COGNITIVE NEUROSCI, V24, P1779, DOI 10.1162/jocn_a_00212; Khayat PS, 2006, J NEUROSCI, V26, P138, DOI 10.1523/JNEUROSCI.2784-05.2006; Kim YJ, 2007, NAT NEUROSCI, V10, P117, DOI 10.1038/nn1821; Luck S.J., 2005, INTRO EVENT RELATED; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P1000, DOI 10.1037/0096-1523.20.5.1000; LUCK SJ, 1994, PSYCHOPHYSIOLOGY, V31, P291, DOI 10.1111/j.1469-8986.1994.tb02218.x; Luck SJ, 1996, NATURE, V383, P616, DOI 10.1038/383616a0; MACMILLAN NA, 1985, PSYCHOL BULL, V98, P185, DOI 10.1037/0033-2909.98.1.185; Morgan ST, 1996, P NATL ACAD SCI USA, V93, P4770, DOI 10.1073/pnas.93.10.4770; Muller MM, 2006, P NATL ACAD SCI USA, V103, P14250, DOI 10.1073/pnas.0606668103; Muller MM, 2008, CEREB CORTEX, V18, P1892, DOI 10.1093/cercor/bhm215; Muller MM, 2008, BIOL PSYCHOL, V77, P292, DOI 10.1016/j.biopsycho.2007.11.003; Muller MM, 1998, COGNITIVE BRAIN RES, V6, P249, DOI 10.1016/S0926-6410(97)00036-0; Muller MM, 2000, CLIN NEUROPHYSIOL, V111, P1544, DOI 10.1016/S1388-2457(00)00371-0; Muller MM, 1998, NAT NEUROSCI, V1, P631, DOI 10.1038/2865; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Schack B, 2002, NEUROSCI LETT, V331, P107, DOI 10.1016/S0304-3940(02)00846-7; Sergent C, 2005, NAT NEUROSCI, V8, P1391, DOI 10.1038/nn1549; Vogel EK, 1998, J EXP PSYCHOL HUMAN, V24, P1656, DOI 10.1037/0096-1523.24.6.1656; Woodman GF, 1999, NATURE, V400, P867, DOI 10.1038/23698	41	6	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e70922	10.1371/journal.pone.0070922	http://dx.doi.org/10.1371/journal.pone.0070922			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	205ER	23976966	Green Submitted, gold, Green Published			2022-12-25	WOS:000323425700012
J	Sene, LD; Mesquita, FF; de Moraes, LN; Santos, DC; Carvalho, R; Gontijo, JAR; Boer, PA				Sene, Leticia de Barros; Mesquita, Flavia Fernandes; de Moraes, Leonardo Nazario; Santos, Daniela Carvalho; Carvalho, Robson; Rocha Gontijo, Jose Antonio; Boer, Patricia Aline			Involvement of Renal Corpuscle microRNA Expression on Epithelial-to-Mesenchymal Transition in Maternal Low Protein Diet in Adult Programmed Rats	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MIR-200 FAMILY; MESSENGER-RNA; REPRESSORS ZEB1; TARGETING ZEB1; BLOOD-PRESSURE; UNITED-STATES; PODOCYTE; FIBROSIS; DISEASE	Prior study shows that maternal protein-restricted (LP) 16-wk-old offspring have pronounced reduction of nephron number and arterial hypertension associated with unchanged glomerular filtration rate, besides enhanced glomerular area, which may be related to glomerular hyperfiltration/overflow and which accounts for the glomerular filtration barrier breakdown and early glomerulosclerosis. In the current study, LP rats showed heavy proteinuria associated with podocyte simplification and foot process effacement. TGF-beta 1 glomerular expression was significantly enhanced in LP. Isolated LP glomeruli show a reduced level of miR-200a, miR-141, miR-429 and ZEB2 mRNA and upregulated collagen 1 alpha 1/2 mRNA expression. By western blot analyzes of whole kidney tissue, we found significant reduction of both podocin and nephrin and enhanced expression of mesenchymal protein markers such as desmin, collagen type I and fibronectin. From our present knowledge, these are the first data showing renal miRNA modulation in the protein restriction model of fetal programming. The fetal-programmed adult offspring showed pronounced structural glomerular disorders with an accentuated and advanced stage of fibrosis, which led us to state that the glomerular miR-200 family would be downregulated by TGF-beta 1 action inducing ZEB 2 expression that may subsequently cause glomeruli epithelial-to-mesenchymal transition.	[Sene, Leticia de Barros; Boer, Patricia Aline] Sao Paulo State Univ, Fetal Programming Lab, Dept Morphol, Sao Paulo, Brazil; [de Moraes, Leonardo Nazario; Carvalho, Robson] Sao Paulo State Univ, Striated Muscle Lab, Dept Morphol, Sao Paulo, Brazil; [Mesquita, Flavia Fernandes; Rocha Gontijo, Jose Antonio] Univ Estadual Campinas, Renal Funct Lab, Dept Internal Med, Sao Paulo, Brazil; [Santos, Daniela Carvalho] Sao Paulo State Univ, Dept Morphol, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual de Campinas; Universidade Estadual Paulista	Boer, PA (corresponding author), Sao Paulo State Univ, Fetal Programming Lab, Dept Morphol, Sao Paulo, Brazil.	boer@ibb.unesp.br	Santos, Daniela/GZK-5367-2022; Gontijo, José Antonio Rocha Gontijo/C-5128-2012; Carvalho, Robson Francisco/AAE-4134-2020; Boer, Patricia Aline/E-2551-2013; Gontijo, José/AAW-2644-2021; Boer, Patrícia A/P-4435-2014; de Barros Sene, Leticia/L-2542-2018; Santos, Daniela Carvalho dos/E-3102-2012; de Moraes, Leonardo Nazario/F-8621-2012; Carvalho, Robson Francisco/E-1161-2012	Carvalho, Robson Francisco/0000-0002-4901-7714; Boer, Patricia Aline/0000-0002-1196-2606; de Barros Sene, Leticia/0000-0002-9777-5413; Santos, Daniela Carvalho dos/0000-0001-8062-104X; Carvalho, Robson Francisco/0000-0002-4901-7714; Moraes, Leonardo/0000-0003-4515-4137; Gontijo, Jose/0000-0002-4658-385X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [10/52696-0, 09/54141-9]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (10/52696-0 and 09/54141-9) supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel D, 2009, J AM SOC NEPHROL, V20, P333, DOI 10.1681/ASN.2008070795; BARKER DJP, 1995, MOL MED TODAY, V1, P418, DOI 10.1016/S1357-4310(95)90793-9; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; BRENNER BM, 1988, AM J HYPERTENS, V1, P335, DOI 10.1093/ajh/1.4.335; Carew RM, 2012, CELL TISSUE RES, V347, P103, DOI 10.1007/s00441-011-1227-1; Chung ACK, 2010, J AM SOC NEPHROL, V21, P1317, DOI 10.1681/ASN.2010020134; Fan Q, 2006, KIDNEY INT, V69, P1207, DOI 10.1038/sj.ki.5000245; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hsu CY, 2003, J AM SOC NEPHROL, V14, P2902, DOI 10.1097/01.ASN.0000091586.46532.B4; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kato M, 2009, CLIN J AM SOC NEPHRO, V4, P1255, DOI 10.2215/CJN.00520109; Kim JH, 2003, KIDNEY INT, V64, P1715, DOI 10.1046/j.1523-1755.2003.00288.x; Kim TS, 1999, J PATHOL, V189, P425; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kriz W, 1996, NEPHROL DIAL TRANSPL, V11, P1738, DOI 10.1093/oxfordjournals.ndt.a027660; Lackland DT, 2000, ARCH INTERN MED, V160, P1472, DOI 10.1001/archinte.160.10.1472; Lackland DT, 2002, HYPERTENSION, V39, P179, DOI 10.1161/hy0102.100545; Lee HS, 2012, CELL TISSUE RES, V347, P129, DOI 10.1007/s00441-011-1169-7; Li YJ, 2008, AM J PATHOL, V172, P299, DOI 10.2353/ajpath.2008.070057; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Mesquita FF, 2010, BRAZ J MED BIOL RES, V43, P1010, DOI [10.1590/S0100-879X2010007500113, 10.1590/S0100-879X2010001100001]; Mesquita FF, 2010, NEPHROL DIAL TRANSPL, V25, P380, DOI 10.1093/ndt/gfp505; MUNDEL P, 1995, ANAT EMBRYOL, V192, P387; Murray D, 2000, J BIOL CHEM, V275, P3610, DOI 10.1074/jbc.275.5.3610; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pippin JW, 2009, AM J PHYSIOL-RENAL, V296, pF213, DOI 10.1152/ajprenal.90421.2008; Ponticos M, 2004, MOL CELL BIOL, V24, P6151, DOI 10.1128/MCB.24.14.6151-6161.2004; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Shankland SJ, 1996, KIDNEY INT, V50, P1230, DOI 10.1038/ki.1996.432; Swetha G, 2011, J CELL MOL MED, V15, P396, DOI 10.1111/j.1582-4934.2009.00937.x; Terraz C, 2001, J BIOL CHEM, V276, P37011, DOI 10.1074/jbc.M104185200; Villar-Martini VC, 2009, J HYPERTENS, V27, pS47, DOI 10.1097/01.hjh.0000358838.71675.5e; Wahab NA, 2005, DIABETOLOGIA, V48, P2650, DOI 10.1007/s00125-005-0006-5; Wang B, 2011, DIABETES, V60, P280, DOI 10.2337/db10-0892; Wang B, 2010, DIABETES, V59, P1794, DOI 10.2337/db09-1736; Xiong MX, 2012, AM J PHYSIOL-RENAL, V302, pF369, DOI 10.1152/ajprenal.00268.2011; Yamamoto T, 2009, RENAL URINARY PROTEO; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; Zavadil J, 2007, CELLS TISSUES ORGANS, V185, P157, DOI 10.1159/000101316; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zhang J, 2012, AM J PHYSIOL-RENAL, V302, pF571, DOI 10.1152/ajprenal.00516.2011	43	23	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71310	10.1371/journal.pone.0071310	http://dx.doi.org/10.1371/journal.pone.0071310			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977013	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700037
J	Li, XH; Redus, L; Chen, C; Martinez, PA; Strong, R; Li, SL; O'Connor, JC				Li, Xiuhua; Redus, Laney; Chen, Cang; Martinez, Paul A.; Strong, Randy; Li, Senlin; O'Connor, Jason C.			Cognitive Dysfunction Precedes the Onset of Motor Symptoms in the MitoPark Mouse Model of Parkinson's Disease	PLOS ONE			English	Article							DEPRESSIVE-LIKE BEHAVIOR; NONMOTOR SYMPTOMS; TREATED PATIENTS; CALMETTE-GUERIN; MICE; IMPAIRMENT; INDUCTION; DOPAMINE; DEMENTIA; MEMORY	Parkinson's disease (PD) is a neurodegenerative disorder primarily characterized by progressive loss of dopamine neurons, leading to loss of motor coordination. However, PD is associated with a high rate of non-motor neuropsychiatric comorbities that often develop before the onset of movement symptoms. The MitoPark transgenic mouse model is the first to recapitulate the cardinal clinical features, namely progressive neurodegeneration and death of neurons, loss of motor function and therapeutic response to L-DOPA. To investigate whether MitoPark mice exhibit early onset of cognitive impairment, a non-motor neuropsychiatric comorbidity, we measured performance on a spatial learning and memory task before (similar to 8 weeks) or after (similar to 20 weeks) the onset of locomotor decline in MitoPark mice or in littermate controls. Consistent with previous studies, we established that a progressive loss of spontaneous locomotor activity began at 12 weeks of age, which was followed by progressive loss of body weight beginning at 16-20 weeks. Spatial learning and memory was measured using the Barnes Maze. By 20 weeks of age, MitoPark mice displayed a substantial reduction in overall locomotor activity that impaired their ability to perform the task. However, in the 8-week-old mice, locomotor activity was no different between genotypes, yet MitoPark mice took longer, traveled further and committed more errors than same age control mice, while learning to successfully navigate the maze. The modest between-day learning deficit of MitoPark mice was characterized by impaired within-day learning during the first two days of testing. No difference was observed between genotypes during probe trials conducted one or twelve days after the final acquisition test. Additionally, 8-week-old MitoPark mice exhibited impaired novel object recognition when compared to control mice. Together, these data establish that mild cognitive impairment precedes the loss of motor function in a novel rodent model of PD, which may provide unique opportunities for therapeutic development.	[Li, Xiuhua; Redus, Laney; Chen, Cang; Martinez, Paul A.; Strong, Randy; Li, Senlin; O'Connor, Jason C.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Li, Xiuhua; Chen, Cang; Li, Senlin] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Martinez, Paul A.; Strong, Randy; Li, Senlin; O'Connor, Jason C.] Univ Texas Hlth Sci Ctr San Antonio, Ctr Biomed Neurosci, San Antonio, TX 78229 USA; [O'Connor, Jason C.] Univ Texas Hlth Sci Ctr San Antonio, Mood Disorders Translat Res Core, San Antonio, TX 78229 USA; [Strong, Randy; Li, Senlin] South Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr, San Antonio, TX USA; [Strong, Randy; Li, Senlin] Barshop Inst Longev & Aging Studies, San Antonio, TX USA; [Li, Xiuhua] Shandong Univ, Shandong Prov Qianfoshan Hosp, Dept Neurol, Jinan 250100, Peoples R China	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Li, SL (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA.	lis1@uthscsa.edu; oconnorj@uthscsa.edu	li, xiu/GXV-1745-2022		Owen's Medical research Foundation;  [R01-MH090127];  [P30-MH089868];  [NIA-1P30-AG13319];  [VA-BX001641];  [VA-BX000737];  [NIH-UL1-TR0000149]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH089868, R01MH090127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013319] Funding Source: NIH RePORTER	Owen's Medical research Foundation; ; ; ; ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by grants R01-MH090127 and P30-MH089868 (to JO); NIA-1P30-AG13319 and VA-BX001641 (to RS); and VA-BX000737, NIH-UL1-TR0000149 Pilot Project grant and an Owen's Medical research Foundation Award (to SL). The content is the sole the responsibility of the authors and does not necessarily represent the views of the National Institutes of Health or the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggleton JP, 2012, NEUROPSYCHOLOGIA, V50, P3141, DOI 10.1016/j.neuropsychologia.2012.05.018; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Da Cunha C, 2006, BEHAV NEUROSCI, V120, P1279, DOI 10.1037/0735-7044.120.6.1279; Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103; Ekstrand MI, 2009, PARKINSONISM RELAT D, V15, pS185, DOI 10.1016/S1353-8020(09)70811-9; Galter D, 2010, GENES BRAIN BEHAV, V9, P173, DOI 10.1111/j.1601-183X.2009.00542.x; Good CH, 2011, FASEB J, V25, P1333, DOI 10.1096/fj.10-173625; Harvey BK, 2008, ACTA NEUROCHIR SUPPL, V101, P89; Kim JS, 2012, NEUROLOGY, V79, P1323, DOI 10.1212/WNL.0b013e31826c1acd; Kulisevsky J, 2000, DRUG AGING, V16, P365, DOI 10.2165/00002512-200016050-00006; Lehmann ML, 2010, BRAIN BEHAV IMMUN, V24, P1008, DOI 10.1016/j.bbi.2010.04.005; McCusker R. H., 2013, BRAIN BEHAV IMMUN; McNamara P, 2006, BEHAV NEUROL, V17, P43, DOI 10.1155/2006/138263; Moriguchi S, 2012, J NEUROCHEM, V120, P541, DOI 10.1111/j.1471-4159.2011.07608.x; O'Connor JC, 2009, J NEUROSCI, V29, P4200, DOI 10.1523/JNEUROSCI.5032-08.2009; O'Connor JC, 2009, J IMMUNOL, V182, P3202, DOI 10.4049/jimmunol.0802722; Onur OA, 2011, J COGNITIVE NEUROSCI, V23, P2797, DOI 10.1162/jocn.2011.21603; Schneider JS, 2012, MOV DISORD; Shulman LM, 2001, MOVEMENT DISORD, V16, P507, DOI 10.1002/mds.1099; Uc EY, 2009, NEUROLOGY, V73, P1469, DOI 10.1212/WNL.0b013e3181bf992f; Velseboer DC, 2013, NEUROLOGY, V80, P627, DOI 10.1212/WNL.0b013e318281cc99; Walker JM, 2011, BEHAV BRAIN RES, V222, P169, DOI 10.1016/j.bbr.2011.03.049; Ziemssen T, 2007, PARKINSONISM RELAT D, V13, P323, DOI 10.1016/j.parkreldis.2006.12.014; Zoccolella S, 2010, CURR MED CHEM, V17, P3253, DOI 10.2174/092986710792232012; Zoccolella S, 2009, MOVEMENT DISORD, V24, P1028, DOI 10.1002/mds.22511	26	45	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71341	10.1371/journal.pone.0071341	http://dx.doi.org/10.1371/journal.pone.0071341			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977020	Green Published, gold, Green Submitted			2022-12-25	WOS:000323378000043
J	Savchuk, I; Soder, O; Svechnikov, K				Savchuk, Iuliia; Soder, Olle; Svechnikov, Konstantin			Mouse Leydig Cells with Different Androgen Production Potential Are Resistant to Estrogenic Stimuli but Responsive to Bisphenol A Which Attenuates Testosterone Metabolism	PLOS ONE			English	Article							NUCLEAR RECEPTOR NUR77; LUTEINIZING-HORMONE; GENE-EXPRESSION; STEROIDOGENESIS; ALPHA; BIOSYNTHESIS; MICE; RAT; INHIBITION; SECRETION	It is well known that estrogens and estrogen-like endocrine disruptors can suppress steroidogenic gene expression, attenuate androgen production and decrease differentiation of adult Leydig cell lineage. However, there is no information about the possible link between the potency of Leydig cells to produce androgens and their sensitivity to estrogenic stimuli. Thus, the present study explored the relationship between androgen production potential of Leydig cells and their responsiveness to estrogenic compounds. To investigate this relationship we selected mouse genotypes contrasting in sex hormone levels and differing in testosterone/estradiol (T/E-2) ratio. We found that two mouse genotypes, CBA/Lac and C57BL/6j have the highest and the lowest serum T/E-2 ratio associated with increased serum LH level in C57BL/6j compared to CBA/Lac. Analysis of steroidogenic gene expression demonstrated significant upregulation of Cyp19 gene expression but coordinated suppression of LHR, StAR, 3 beta HSDI and Cyp17a1 in Leydig cells from C57BL/6j that was associated with attenuated androgen production in basal and hCG-stimulated conditions compared to CBA/Lac mice. These genotype-dependent differences in steroidogenesis were not linked to changes in the expression of estrogen receptors ER alpha and Gpr30, while ER beta expression was attenuated in Leydig cells from C57BL/6j compared to CBA/Lac. No effects of estrogenic agonists on steroidogenesis in Leydig cells from both genotypes were found. In contrast, xenoestrogen bisphenol A significantly potentiated hCG-activated androgen production by Leydig cells from C57BL/6j and CBA/Lac mice by suppressing conversion of testosterone into corresponding metabolite 5 alpha-androstane-3 alpha, 17 beta-diol. All together our data indicate that developing mouse Leydig cells with different androgen production potential are resistant to estrogenic stimuli, while xenoestrogen BPA facilitates hCG-induced steroidogenesis in mouse Leydig cells via attenuation of testosterone metabolism. This cellular event can cause premature maturation of Leydig cells that may create abnormal intratesticular paracrine milieu and disturb proper development of germ cells.	[Savchuk, Iuliia; Soder, Olle; Svechnikov, Konstantin] Karolinska Inst, Dept Womens & Childrens Hlth, Pediat Endocrinol Unit, Stockholm, Sweden	Karolinska Institutet	Svechnikov, K (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Pediat Endocrinol Unit, Stockholm, Sweden.	konstantin.svechnikov@ki.se			Karolinska Institutet; Frimurare Barnhuset in Stockholm; Stiftelsen Olle Engkvist Byggmastare; Pediatric Research Foundation; Sallskapet Barnavard; Vetenskapsradet (VR); VR/FA; Barncancerfonden	Karolinska Institutet(Karolinska Institutet); Frimurare Barnhuset in Stockholm; Stiftelsen Olle Engkvist Byggmastare(Swedish Research Council); Pediatric Research Foundation; Sallskapet Barnavard; Vetenskapsradet (VR)(Swedish Research Council); VR/FA; Barncancerfonden	Financial support was received from Karolinska Institutet, the Frimurare Barnhuset in Stockholm, Stiftelsen Olle Engkvist Byggmastare, Pediatric Research Foundation, Sallskapet Barnavard, Vetenskapsradet (VR), VR/FA and Barncancerfonden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABNEY TO, 1991, J ANDROL, V12, P295; Akingbemi BT, 2007, ENDOCRINOLOGY, V148, P4475, DOI 10.1210/en.2007-0327; Akingbemi BT, 2004, ENDOCRINOLOGY, V145, P592, DOI 10.1210/en.2003-1174; Akingbemi BT, 2003, ENDOCRINOLOGY, V144, P84, DOI 10.1210/en.2002-220292; BARTKE A, 1974, J HERED, V65, P204, DOI 10.1093/oxfordjournals.jhered.a108504; BENAHMED M, 1982, MOL CELL ENDOCRINOL, V28, P705, DOI 10.1016/0303-7207(82)90157-5; Brouillette J, 2005, CARDIOVASC RES, V65, P148, DOI 10.1016/j.cardiores.2004.09.012; Castro B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055905; Cederroth CR, 2007, ENDOCRINOLOGY, V148, P5507, DOI 10.1210/en.2007-0689; Delbes G, 2005, ENDOCRINOLOGY, V146, P2454, DOI 10.1210/en.2004-1540; Ge RS, 1998, ENDOCRINOLOGY, V139, P3787, DOI 10.1210/en.139.9.3787; Gould ML, 2007, REPRODUCTION, V134, P271, DOI 10.1530/REP-07-0025; Hiort O, 2002, BEST PRACT RES CL EN, V16, P31, DOI 10.1053/beem.2002.0178; Izzo G, 2010, J APPL TOXICOL; KALLA NR, 1980, ENDOCRINOLOGY, V106, P35, DOI 10.1210/endo-106-1-35; Kazusa K, 2004, COMPARATIVE MED, V54, P179; Lee SY, 2012, MOL CELL ENDOCRINOL, V362, P91, DOI 10.1016/j.mce.2012.05.015; Li XD, 2001, ENDOCRINOLOGY, V142, P2435, DOI 10.1210/en.142.6.2435; Mahendroo M, 2004, MOL CELL ENDOCRINOL, V222, P113, DOI 10.1016/j.mce.2004.04.009; Matthews JB, 2001, CHEM RES TOXICOL, V14, P149, DOI 10.1021/tx0001833; Mitchell RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061726; N'Tumba-Byn T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051579; ONODA M, 1981, ENDOCRINOLOGY, V109, P763, DOI 10.1210/endo-109-3-763; Osadchuk LV, 2010, B EXP BIOL MED+, V149, P739, DOI 10.1007/s10517-010-1040-y; PAYNE AH, 1980, ENDOCRINOLOGY, V106, P1424, DOI 10.1210/endo-106-5-1424; PAYNE AH, 1991, ENDOCRINOLOGY, V129, P1429, DOI 10.1210/endo-129-3-1429; Song KH, 2002, ENDOCRINOLOGY, V143, P2208, DOI 10.1210/en.143.6.2208; Stocco DM, 2001, ANNU REV PHYSIOL, V63, P193, DOI 10.1146/annurev.physiol.63.1.193; Strauss L, 2009, ENDOCRINOLOGY, V150, P2865, DOI 10.1210/en.2008-1311; Svechnikov KV, 2001, MOL CELL ENDOCRINOL, V182, P193, DOI 10.1016/S0303-7207(01)00554-8; VALLADARES LE, 1979, P NATL ACAD SCI USA, V76, P4460, DOI 10.1073/pnas.76.9.4460; VALLADARES LE, 1979, ENDOCRINOLOGY, V105, P431, DOI 10.1210/endo-105-2-431	32	18	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71722	10.1371/journal.pone.0071722	http://dx.doi.org/10.1371/journal.pone.0071722			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967237	gold, Green Submitted, Green Published			2022-12-25	WOS:000323378000066
J	Shin, J; Mashour, GA; Ku, S; Kim, S; Lee, U				Shin, Jeongkyu; Mashour, George A.; Ku, Seungwoo; Kim, Seunghwan; Lee, Uncheol			Subgraph "Backbone" Analysis of Dynamic Brain Networks during Consciousness and Anesthesia	PLOS ONE			English	Article							PROPOFOL-INDUCED LOSS; CONNECTIVITY CHANGES; UNCONSCIOUSNESS; INTEGRATION; INFORMATION; SYNCHRONY	General anesthesia significantly alters brain network connectivity. Graph-theoretical analysis has been used extensively to study static brain networks but may be limited in the study of rapidly changing brain connectivity during induction of or recovery from general anesthesia. Here we introduce a novel method to study the temporal evolution of network modules in the brain. We recorded multichannel electroencephalograms (EEG) from 18 surgical patients who underwent general anesthesia with either propofol (n = 9) or sevoflurane (n = 9). Time series data were used to reconstruct networks; each electroencephalographic channel was defined as a node and correlated activity between the channels was defined as a link. We analyzed the frequency of subgraphs in the network with a defined number of links; subgraphs with a high probability of occurrence were deemed network "backbones." We analyzed the behavior of network backbones across consciousness, anesthetic induction, anesthetic maintenance, and two points of recovery. Constitutive, variable and state-specific backbones were identified across anesthetic state transitions. Brain networks derived from neurophysiologic data can be deconstructed into network backbones that change rapidly across states of consciousness. This technique enabled a granular description of network evolution over time. The concept of network backbones may facilitate graph-theoretical analysis of dynamically changing networks.	[Shin, Jeongkyu] Pohang Univ Sci & Technol, Dept Phys, Pohang Si, Gyeongsangbuk D, South Korea; [Shin, Jeongkyu; Lee, Uncheol] Univ Michigan, Dept Anesthesiol, Sch Med, Ann Arbor, MI 48109 USA; [Mashour, George A.] Univ Michigan, Dept Anesthesiol, Sch Med, Grad Program Neurosci, Ann Arbor, MI 48109 USA; [Ku, Seungwoo] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Anesthesiol, Ulsan 680749, South Korea; [Kim, Seunghwan] Pohang Univ Sci & Technol, Dept Phys, Inst Edge Theoret Sci, Pohang Si, Gyeongsangbuk D, South Korea	Pohang University of Science & Technology (POSTECH); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Ulsan; Asan Medical Center; Pohang University of Science & Technology (POSTECH)	Kim, S (corresponding author), Pohang Univ Sci & Technol, Dept Phys, Inst Edge Theoret Sci, Pohang Si, Gyeongsangbuk D, South Korea.	swan@postech.ac.kr; uclee@med.umich.edu		KIM, Seunghwan/0000-0002-0563-3902	Original Technology Research Program for Brain Science through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0018847]; National Institutes of Health, Bethesda, MD, USA [1RO1GM098578]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098578] Funding Source: NIH RePORTER	Original Technology Research Program for Brain Science through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Institutes of Health, Bethesda, MD, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	JS was supported by the Original Technology Research Program for Brain Science through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (No. 2010-0018847). GAM and UCL are supported by the National Institutes of Health, Bethesda, MD, USA, grant 1RO1GM098578. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Boly M, 2012, J NEUROSCI, V32, P7082, DOI 10.1523/JNEUROSCI.3769-11.2012; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; Breshears JD, 2010, P NATL ACAD SCI USA, V107, P21170, DOI 10.1073/pnas.1011949107; Bressler SL, 2001, TRENDS COGN SCI, V5, P26, DOI 10.1016/S1364-6613(00)01564-3; Buzsaki G., 2006, RHYTHMS BRAIN, P448; Cantero JL, 2004, NEUROIMAGE, V22, P1271, DOI 10.1016/j.neuroimage.2004.03.014; Fingelkurts AA, 2004, INT J NEUROSCI, V114, P843, DOI 10.1080/00207450490450046; Fingelkurts AA, 2012, COGN PROCESS, V13, P111, DOI 10.1007/s10339-011-0416-x; Hudetz A., 2006, SEMIN ANESTH PERIO M, V25, P196, DOI [DOI 10.1053/j.sane.2006.09.003, 10.1053/j.sane.2006.09.003]; Imas OA, 2006, NEUROSCI LETT, V402, P216, DOI 10.1016/j.neulet.2006.04.003; John ER, 2005, ANESTHESIOLOGY, V102, P447, DOI 10.1097/00000542-200502000-00030; Jordan D, 2008, ANESTHESIOLOGY, V109, P1014, DOI 10.1097/ALN.0b013e31818d6c55; Kiviniemi VJ, 2005, MAGN RESON IMAGING, V23, P531, DOI 10.1016/j.mri.2005.02.009; Koenig T, 1999, EUR ARCH PSY CLIN N, V249, P205, DOI 10.1007/s004060050088; Ku SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025155; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lee U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046313; Lee U, 2011, ANESTHESIOLOGY, V114, P872, DOI 10.1097/ALN.0b013e31821102c9; Lee U, 2009, CONSCIOUS COGN, V18, P1069, DOI 10.1016/j.concog.2009.04.004; Lewis LD, 2012, P NATL ACAD SCI USA, V109, pE3377, DOI 10.1073/pnas.1210907109; Li D, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/046010; Mashour GA, 2006, ANESTH ANALG, V103, P975, DOI 10.1213/01.ane.0000232442.69757.4a; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; MUNGLANI R, 1993, BRIT J ANAESTH, V71, P633, DOI 10.1093/bja/71.5.633; Peltier SJ, 2005, NEUROREPORT, V16, P285, DOI 10.1097/00001756-200502280-00017; Scholvinck ML, 2010, NEUROIMAGE, V107, P10238; Schrouff J, 2011, NEUROIMAGE, V57, P198, DOI 10.1016/j.neuroimage.2011.04.020; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Stamatakis EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014224; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Tononi G, 2005, PROG BRAIN RES, V150, P109, DOI 10.1016/S0079-6123(05)50009-8; Tononi Giulio, 2004, BMC Neurosci, V5, P42, DOI 10.1186/1471-2202-5-42; Tononi G, 2008, BIOL BULL-US, V215, P216, DOI 10.2307/25470707; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758	35	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e70899	10.1371/journal.pone.0070899	http://dx.doi.org/10.1371/journal.pone.0070899			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967131	Green Published, Green Submitted, gold			2022-12-25	WOS:000323378000021
J	Fertin, M; Lemesle, G; Turkieh, A; Beseme, O; Chwastyniak, M; Amouyel, P; Bauters, C; Pinet, F				Fertin, Marie; Lemesle, Gilles; Turkieh, Annie; Beseme, Olivia; Chwastyniak, Maggy; Amouyel, Philippe; Bauters, Christophe; Pinet, Florence			Serum MMP-8: A Novel Indicator of Left Ventricular Remodeling and Cardiac Outcome in Patients after Acute Myocardial Infarction	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; NATRIURETIC PEPTIDE; MATRIX-METALLOPROTEINASE-9; DYSFUNCTION; ENLARGEMENT; PREDICTORS; CAPTOPRIL; MICE	Objective: Left ventricular (LV) remodeling following myocardial infarction (MI) is characterized by progressive alterations of structure and function, named LV remodeling. Although several risk factors such as infarct size have been identified, LV remodeling remains difficult to predict in clinical practice. Changes within the extracellular matrix, involving matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs), are an integral part of left ventricular (LV) remodeling after myocardial infarction (MI). We investigated the temporal profile of circulating MMPs and TIMPs and their relations with LV remodeling at 1 year and clinical outcome at 3 years in post-MI patients. Methods: This prospective multicentre study included 246 patients with a first anterior MI. Serial echocardiographic studies were performed at hospital discharge, 3 months, and 1 year after MI, and analysed at a core laboratory. LV remodeling was defined as the percent change in LV end-diastolic volume (EDV) from baseline to 1 year. Serum samples were obtained at hospital discharge, 1, 3, and 12 months. Multiplex technology was used for analysis of MMP-1, -2, -3, -8, -9, -13, and TIMP-1, 2, -2, -3, -4 serum levels. Results: Baseline levels of MMP-8 and MMP-9 were positively associated with changes in LVEDV (P = 0.01 and 0.02, respectively). When adjusted for major baseline characteristics, MMP-8 levels remained an independent predictor LV remodeling (P = 0.025). By univariate analysis, there were positive relations between cardiovascular death or hospitalization for heart failure during the 3-year follow-up and the baseline levels of MMP-2 (P = 0.03), MMP-8 (P = 0.002), and MMP-9 (P = 0.03). By multivariate analysis, MMP-8 was the only MMP remaining significantly associated with clinical outcome (P = 0.02). Conclusion: Baseline serum MMP-8 is a significant predictor of LV remodeling and cardiovascular outcome after MI and may help to improve risk stratification.	[Fertin, Marie; Lemesle, Gilles; Amouyel, Philippe; Bauters, Christophe; Pinet, Florence] Ctr Hosp Reg & Univ Lille, F-59037 Lille, France; [Fertin, Marie; Lemesle, Gilles; Bauters, Christophe] Fac Med Lille, F-59045 Lille, France; [Fertin, Marie; Lemesle, Gilles; Turkieh, Annie; Beseme, Olivia; Chwastyniak, Maggy; Amouyel, Philippe; Bauters, Christophe; Pinet, Florence] INSERM, U744, F-59045 Lille, France; [Fertin, Marie; Lemesle, Gilles; Turkieh, Annie; Beseme, Olivia; Chwastyniak, Maggy; Amouyel, Philippe; Bauters, Christophe; Pinet, Florence] Inst Pasteur, F-59019 Lille, France; [Fertin, Marie; Lemesle, Gilles; Turkieh, Annie; Beseme, Olivia; Amouyel, Philippe; Bauters, Christophe; Pinet, Florence] Univ Lille Nord France, Lille, France	Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille - ISITE; Universite de Lille	Pinet, F (corresponding author), Ctr Hosp Reg & Univ Lille, Pl Verdun, F-59037 Lille, France.	florence.pinet@pasteur-lille.fr	Pinet, Florence/F-2892-2013	Pinet, Florence/0000-0002-5471-1487; TURKIEH, Annie/0000-0001-6968-4517; Lemesle, Gilles/0000-0002-2917-9273; Bauters, christophe/0000-0001-8268-8467; Amouyel, Philippe/0000-0001-9088-234X	"Federation Francaise de Cardiologie/Societe Francaise de Cardiologie'' fellowship; ANR [ANR-11-EMMA-029-01]; Inserm-Transfert; E.U. [305507]	"Federation Francaise de Cardiologie/Societe Francaise de Cardiologie'' fellowship(French National Research Agency (ANR)); ANR(French National Research Agency (ANR)); Inserm-Transfert; E.U.(European Commission)	Marie Fertin was a recipient of "Federation Francaise de Cardiologie/Societe Francaise de Cardiologie'' fellowship. This work was supported by a grant from ANR (ANR-11-EMMA-029-01), from Inserm-Transfert and from E.U. FP7 (HOMAGE project 305507). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolognese L, 2002, CIRCULATION, V106, P2351, DOI 10.1161/01.CIR.0000036014.90197.FA; Creemers EEJM, 2003, AM J PHYSIOL-HEART C, V284, pH364, DOI 10.1152/ajpheart.00511.2002; Etoh T, 2001, AM J PHYSIOL-HEART C, V281, pH987, DOI 10.1152/ajpheart.2001.281.3.H987; Fertin M, 2012, AM J CARDIOL, V110, P277, DOI 10.1016/j.amjcard.2012.02.069; Fertin M, 2010, AM J CARDIOL, V106, P1410, DOI 10.1016/j.amjcard.2010.06.071; Garcia-Alvarez A, 2009, AM J CARDIOL, V104, P878, DOI 10.1016/j.amjcard.2009.05.025; Gerlach RF, 2009, CLIN CHEM LAB MED, V47, P888, DOI 10.1515/CCLM.2009.203; Kelly D, 2008, EUR J HEART FAIL, V10, P133, DOI 10.1016/j.ejheart.2007.12.009; Kelly D, 2008, EUR HEART J, V29, P2116, DOI 10.1093/eurheartj/ehn315; Kelly D, 2007, EUR HEART J, V28, P711, DOI 10.1093/eurheartj/ehm003; Lalu MM, 2005, EUR HEART J, V26, P27, DOI 10.1093/eurheratj/ehi007; Miyazaki S, 2010, CIRC J, V74, P1158, DOI 10.1253/circj.CJ-09-0412; Nilsson L, 2012, HEART, V98, P31, DOI 10.1136/heartjnl-2011-300079; Peeters W, 2011, EUR HEART J, V32, P2314, DOI 10.1093/eurheartj/ehq517; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Rohde LE, 1999, CIRCULATION, V99, P3063, DOI 10.1161/01.CIR.99.23.3063; Samnegard A, 2006, J INTERN MED, V259, P530, DOI 10.1111/j.1365-2796.2006.01632.x; Savoye C, 2006, AM J CARDIOL, V98, P1144, DOI 10.1016/j.amjcard.2006.06.011; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Squire IB, 2004, J CARD FAIL, V10, P328, DOI 10.1016/j.cardfail.2003.11.003; SUTTON MS, 1994, CIRCULATION, V89, P68, DOI 10.1161/01.CIR.89.1.68; Sutton MS, 1997, CIRCULATION, V96, P3294; Tuomainen AM, 2007, ARTERIOSCL THROM VAS, V27, P2722, DOI 10.1161/ATVBAHA.107.154831; van den Bome SWM, 2009, CARDIOVASC PATHOL, V18, P37, DOI 10.1016/j.carpath.2007.12.012; Webb CS, 2006, CIRCULATION, V114, P1020, DOI 10.1161/CIRCULATIONAHA.105.600353; Weir RAP, 2011, J CARD FAIL, V17, P465, DOI 10.1016/j.cardfail.2011.02.002; Weir RAP, 2010, J THROMB THROMBOLYS, V29, P421, DOI 10.1007/s11239-009-0383-6	27	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71280	10.1371/journal.pone.0071280	http://dx.doi.org/10.1371/journal.pone.0071280			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967183	Green Submitted, Green Published, gold			2022-12-25	WOS:000323221500070
J	Milsom, CC; Lee, CR; Hackl, C; Man, S; Kerbel, RS				Milsom, Chloe C.; Lee, Christina R.; Hackl, Christina; Man, Shan; Kerbel, Robert S.			Differential Post-Surgical Metastasis and Survival in SCID, NOD-SCID and NOD-SCID-IL-2R gamma(null) Mice with Parental and Subline Variants of Human Breast Cancer: Implications for Host Defense Mechanisms Regulating Metastasis	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; LIVER METASTASIS; MESENCHYMAL TRANSITIONS; TUMOR-FORMATION; MOUSE MODELS; COLON-CANCER; GROWTH; EXPRESSION; IMMUNITY; CYCLOPHOSPHAMIDE	We compare for the first time, the metastatic aggressiveness of the parental MDA-MB-231 breast cancer cell line and two luciferase-tagged in vivo-derived and selected pro-metastatic variants (LM2-4/luc(+) and 164/8-1B/luc(+)) in SCID, NOD-SCID and NOD-SCID-IL-2R gamma(null) (NSG) mice following orthotopic implantation and primary tumour resection. The variants are known to be more aggressively metastatic in SCID mice, compared to the parental line which has limited spontaneous metastatic competence in these mice. When 2x10(6) cells were injected into the mammary fat pad, the growth of the resultant primary tumours was identical for the various cell lines in the three strains of mice. However, metastatic spread of all three cell lines, including the MDA-MB-231 parental cell line, was strikingly more aggressive in the highly immunocompromised NSG mice compared to both NOD-SCID and SCID mice, resulting in extensive multi-organ metastases and a significant reduction in overall survival. While these studies were facilitated by monitoring post-surgical spontaneous metastases using whole body bioluminescence imaging, we observed that the luciferase-tagged parental line showed altered growth and diminished metastatic properties compared to its untagged counterpart. Our results are the first to show that host immunity can have a profound impact on the spread of spontaneous visceral metastases and survival following resection of a primary tumour in circumstances where the growth of primary tumours is not similarly affected; as such they highlight the importance of immunity in the metastatic process, and by extension, suggest certain therapeutic strategies that may have a significant impact on reducing metastasis.	[Milsom, Chloe C.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; Sunnybrook Res Inst, Toronto, ON, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Milsom, CC (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.	cmilsom@sri.utoronto.ca; Robert.Kerbel@sri.utoronto.ca			National Institutes of Health [NIH-CA-41233]; Canadian Breast Cancer Foundation; Canadian Institute of Health Research [CIHR - 5815]; Ontario Ministry of Research Innovation; CIHR; L'Oreal Canada; Canadian Commission for UNESCO; 2010 Brenda M. Williams Young Investigator Award; Deutsche Forschungsgemeinschaft (German Research Foundation); NATIONAL CANCER INSTITUTE [R01CA041233] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Research Innovation(Ministry of Research and Innovation, Ontario); CIHR(Canadian Institutes of Health Research (CIHR)); L'Oreal Canada; Canadian Commission for UNESCO; 2010 Brenda M. Williams Young Investigator Award; Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants to RSK from the National Institutes of Health (NIH-CA-41233, www.nih.gov), the Canadian Breast Cancer Foundation (CBCF, www.cbcf.org) and the Canadian Institute of Health Research (CIHR - 5815, www.cihr-irsc.gc.ca). CCM is supported by postdoctoral fellowships awards from the Ontario Ministry of Research & Innovation and CIHR. CCM is the recipient of a Research Excellence Fellowship for Women in Science (L'Oreal Canada and Canadian Commission for UNESCO) and the 2010 Brenda M. Williams Young Investigator Award. CH was supported by a postdoctoral research fellowship from the Deutsche Forschungsgemeinschaft (German Research Foundation). RSK holds a Tier I Canada Research Chair in Tumour Biology, Angiogenesis and Antiangiogenic Therapy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brutkiewicz S, 2007, LUMINESCENCE, V22, P221, DOI 10.1002/bio.953; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Carreno BM, 2009, CLIN CANCER RES, V15, P3277, DOI 10.1158/1078-0432.CCR-08-2502; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Cruz-Munoz W, 2008, CANCER RES, V68, P4500, DOI 10.1158/0008-5472.CAN-08-0041; Cruz-Munoz W, 2009, CLIN CANCER RES, V15, P4867, DOI 10.1158/1078-0432.CCR-08-3275; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Dewan MZ, 2007, BREAST CANCER RES TR, V104, P267, DOI 10.1007/s10549-006-9416-4; Dewan MZ, 2005, BIOMED PHARMACOTHER, V59, pS375, DOI 10.1016/S0753-3322(05)80082-4; Dougan M, 2009, ANNU REV IMMUNOL, V27, P83, DOI 10.1146/annurev.immunol.021908.132544; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Fidler I J, 2001, Surg Oncol Clin N Am, V10, P257; Francia G, 2011, NAT REV CANCER, V11, P135, DOI 10.1038/nrc3001; Francia G, 2009, CLIN CANCER RES, V15, P6358, DOI 10.1158/1078-0432.CCR-09-0931; Greiner DL, 1998, STEM CELLS, V16, P166, DOI 10.1002/stem.160166; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hackl C, 2013, GUT, V62, P259, DOI 10.1136/gutjnl-2011-301585; Hamada K, 2008, INT J ONCOL, V32, P153; Hashimoto K, 2010, MOL CANCER THER, V9, P996, DOI 10.1158/1535-7163.MCT-09-0960; HOLMGREN L, 1995, NAT MED, V1, P149, DOI 10.1038/nm0295-149; Hudson WA, 1998, LEUKEMIA, V12, P2029, DOI 10.1038/sj.leu.2401236; Ikoma N, 2005, ONCOL REP, V14, P633; Iorns E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047995; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kerbel RS, 2003, CANCER BIOL THER, V2, pS134; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Machida K, 2009, J TOXICOL SCI, V34, P123, DOI 10.2131/jts.34.123; Man S, 2007, CANCER METAST REV, V26, P737, DOI 10.1007/s10555-007-9087-6; Milsom CC, 2008, CANCER RES, V68, P10068, DOI 10.1158/0008-5472.CAN-08-2067; Moriyama EH, 2008, PHOTOCH PHOTOBIO SCI, V7, P675, DOI 10.1039/b719231b; Munoz R, 2006, CANCER RES, V66, P3386, DOI 10.1158/0008-5472.CAN-05-4411; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Quintana E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004599; Schnell CR, 2011, CANCER RES, V71, DOI 10.1158/1538-7445.AM2011-5317; Smyth MJ, 2006, ADV IMMUNOL, V90, P1, DOI 10.1016/S0065-2776(06)90001-7; Suemizu H, 2007, INT J ONCOL, V31, P741; Swann JB, 2007, J CLIN INVEST, V117, P1137, DOI 10.1172/JCI31405; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Weinberg RA, 2008, CARCINOGENESIS, V29, P1092, DOI 10.1093/carcin/bgn104; Zitvogel L, 2008, B ACAD NAT MED PARIS, V192, P1469, DOI 10.1016/S0001-4079(19)32694-9	43	31	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71270	10.1371/journal.pone.0071270	http://dx.doi.org/10.1371/journal.pone.0071270			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967178	Green Published, Green Submitted, gold			2022-12-25	WOS:000323221500066
J	Qiu, J; Gao, FH; Shen, GA; Li, CH; Han, XY; Zhao, Q; Zhao, DX; Hua, XJ; Pang, YZ				Qiu, Jian; Gao, Fenghua; Shen, Guoan; Li, Chonghui; Han, Xiaoyan; Zhao, Qiao; Zhao, Dexiu; Hua, Xuejun; Pang, Yongzhen			Metabolic Engineering of the Phenylpropanoid Pathway Enhances the Antioxidant Capacity of Saussurea involucrata	PLOS ONE			English	Article							MYB TRANSCRIPTION FACTOR; ARABIDOPSIS-THALIANA; MAIZE LC; BIOSYNTHESIS; PROANTHOCYANIDINS; ANTHOCYANINS; EXPRESSION; GENE; BIOCHEMISTRY; FLAVONOIDS	The rare wild species of snow lotus Saussurea involucrata is a commonly used medicinal herb with great pharmacological value for human health, resulting from its uniquely high level of phenylpropanoid compound production. To gain information on the phenylpropanid biosynthetic pathway genes in this critically important medicinal plant, global transcriptome sequencing was performed. It revealed that the phenylpropanoid pathway genes were well represented in S. involucrata. In addition, we introduced two key phenylpropanoid pathway inducing transcription factors (PAP1 and Lc) into this medicinal plant. Transgenic S. involucrata co-expressing PAP1 and Lc exhibited purple pigments due to a massive accumulation of anthocyanins. The over-expression of PAP1 and Lc largely activated most of the phenylpropanoid pathway genes, and increased accumulation of several phenylpropanoid compounds significantly, including chlorogenic acid, syringin, cyanrine and rutin. Both ABTS (2,2'-azinobis-3-ethylbenzotiazo-line-6-sulfonic acid) and FRAP (ferric reducing antioxidant power) assays revealed that the antioxidant capacity of transgenic S. involucrata lines was greatly enhanced over controls. In addition to providing a deeper understanding of the molecular basis of phenylpropanoid metabolism, our results potentially enable an alternation of bioactive compound production in S. involucrata through metabolic engineering.	[Qiu, Jian; Gao, Fenghua; Shen, Guoan; Li, Chonghui; Han, Xiaoyan; Zhao, Dexiu; Hua, Xuejun; Pang, Yongzhen] Chinese Acad Sci, Inst Bot, Beijing Bot Garden, Key Lab Plant Resources, Beijing, Peoples R China; [Qiu, Jian] Chinese Acad Trop Agr Sci, Rubber Res Inst, Key Lab Biol & Genet Resources Rubber Tree, Danzhou, Hainan, Peoples R China; [Zhao, Qiao] Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73402 USA	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Tropical Agricultural Sciences; Noble Research Institute	Hua, XJ (corresponding author), Chinese Acad Sci, Inst Bot, Beijing Bot Garden, Key Lab Plant Resources, Beijing, Peoples R China.	xjhua@ibcas.ac.cn; yzhpang@ibcas.ac.cn	han, xiao/HDN-9782-2022		National Science Foundation of China [30873452, 31200228]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Foundation of China (Grant No. 30873452 and 31200228). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan AC, 2008, TRENDS PLANT SCI, V13, P99, DOI 10.1016/j.tplants.2007.11.012; Baudry A, 2006, PLANT J, V46, P768, DOI 10.1111/j.1365-313X.2006.02733.x; Ben Zvi MM, 2012, NEW PHYTOL, V195, P335, DOI 10.1111/j.1469-8137.2012.04161.x; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Bovy A, 2002, PLANT CELL, V14, P2509, DOI 10.1105/tpc.004218; Bradley JM, 1998, PLANT J, V13, P381, DOI 10.1046/j.1365-313X.1998.00031.x; Chen F, 1999, CHINESE B BOT, P82; Chen L, 2014, J SCI FOOD AGR, V94, P180, DOI 10.1002/jsfa.6216; Chen YZ, 2005, ZHONGGUO YESHENG ZHI, V24, P1; Cui C, 2013, FOOD CHEM, V139, P1, DOI 10.1016/j.foodchem.2013.01.107; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Feller A, 2011, PLANT J, V66, P94, DOI 10.1111/j.1365-313X.2010.04459.x; Flores FP, 2013, J AGR FOOD CHEM, V61, P4441, DOI 10.1021/jf400429f; Gatica-Arias A, 2012, PLANT CELL REP, V31, P111, DOI 10.1007/s00299-011-1144-5; Goldsbrough AP, 1996, PLANT J, V9, P927, DOI 10.1046/j.1365-313X.1996.9060927.x; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; Lepiniec L, 2006, ANNU REV PLANT BIOL, V57, P405, DOI 10.1146/annurev.arplant.57.032905.105252; Li HH, 2007, PLANTA, V226, P1243, DOI 10.1007/s00425-007-0573-4; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li SJ, 2005, PLANT CELL REP, V23, P716, DOI 10.1007/s00299-004-0871-2; Li X, 2010, J AGR FOOD CHEM, V58, P1639, DOI 10.1021/jf903527y; LUDWIG SR, 1989, P NATL ACAD SCI USA, V86, P7092, DOI 10.1073/pnas.86.18.7092; Mehrtens F, 2005, PLANT PHYSIOL, V138, P1083, DOI 10.1104/pp.104.058032; Modolo LV, 2009, RECENT ADV POLYPHENO, V1, P113; Peel GJ, 2009, PLANT J, V59, P136, DOI 10.1111/j.1365-313X.2009.03885.x; Qiu JA, 2010, PLANT CELL REP, V29, P1325, DOI 10.1007/s00299-010-0919-4; Rasmussen RR, 2010, ANAL BIOANAL CHEM, V397, P765, DOI 10.1007/s00216-010-3545-7; Ray H, 2003, PLANT PHYSIOL, V132, P1448, DOI 10.1104/pp.103.025361; Sharma SB, 2005, PLANT J, V44, P62, DOI 10.1111/j.1365-313X.2005.02510.x; Shi MZ, 2010, PLANTA, V231, P1385, DOI 10.1007/s00425-010-1142-9; Tohge T, 2005, PLANT J, V42, P218, DOI 10.1111/j.1365-313X.2005.02371.x; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Way TD, 2010, J AGR FOOD CHEM, V58, P3356, DOI 10.1021/jf903793p; Xie DY, 2006, PLANT J, V45, P895, DOI 10.1111/j.1365-313X.2006.02655.x; Ye J, 2004, J FORENSIC SCI, V49, P754; Zhang YA, 2010, J AGR FOOD CHEM, V58, P12168, DOI 10.1021/jf103203e	36	41	47	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e70665	10.1371/journal.pone.0070665	http://dx.doi.org/10.1371/journal.pone.0070665			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23976949	Green Submitted, gold, Green Published			2022-12-25	WOS:000323221500021
J	Chen, W; Zhang, CK; Cheng, YM; Zhang, SW; Zhao, HY				Chen, Wei; Zhang, Clarence K.; Cheng, Yongmei; Zhang, Shaowu; Zhao, Hongyu			A Comparison of Methods for Clustering 16S rRNA Sequences into OTUs	PLOS ONE			English	Article								Recent studies of 16S rRNA sequences through next-generation sequencing have revolutionized our understanding of the microbial community composition and structure. One common approach in using these data to explore the genetic diversity in a microbial community is to cluster the 16S rRNA sequences into Operational Taxonomic Units (OTUs) based on sequence similarities. The inferred OTUs can then be used to estimate species, diversity, composition, and richness. Although a number of methods have been developed and commonly used to cluster the sequences into OTUs, relatively little guidance is available on their relative performance and the choice of key parameters for each method. In this study, we conducted a comprehensive evaluation of ten existing OTU inference methods. We found that the appropriate dissimilarity value for defining distinct OTUs is not only related with a specific method but also related with the sample complexity. For data sets with low complexity, all the algorithms need a higher dissimilarity threshold to define OTUs. Some methods, such as, CROP and SLP, are more robust to the specific choice of the threshold than other methods, especially for shorter reads. For high-complexity data sets, hierarchical cluster methods need a more strict dissimilarity threshold to define OTUs because the commonly used dissimilarity threshold of 3% often leads to an under-estimation of the number of OTUs. In general, hierarchical clustering methods perform better at lower dissimilarity thresholds. Our results show that sequence abundance plays an important role in OTU inference. We conclude that care is needed to choose both a threshold for dissimilarity and abundance for OTU inference.	[Chen, Wei; Cheng, Yongmei; Zhang, Shaowu] Northwestern Polytech Univ, Coll Automat, Xian 710072, Shaanxi, Peoples R China; [Chen, Wei; Zhao, Hongyu] Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT 06520 USA; [Zhang, Clarence K.; Zhao, Hongyu] Yale Univ, Sch Med, Keck Biotechnol Lab, New Haven, CT USA	Northwestern Polytechnical University; Yale University; Yale University	Zhao, HY (corresponding author), Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT 06520 USA.	hongyu.zhao@yale.edu			NIH [R01 GM59507, UL1 RR024139]; National Natural Science Foundation of China [61170134]; Aeronautical Science Foundation of China [20100853010]; Doctorate Foundation of Northwestern Polytechnical University [cx201017]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059507] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Aeronautical Science Foundation of China; Doctorate Foundation of Northwestern Polytechnical University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIH grants R01 GM59507 and UL1 RR024139, National Natural Science Foundation of China (No. 61170134), Aeronautical Science Foundation of China (No. 20100853010) and Doctorate Foundation of Northwestern Polytechnical University (No. cx201017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armougom F., 2009, J COMPUT SCI SYST BI, V2, P74, DOI DOI 10.4172/JCSB.1000019; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Cai YP, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr349; Duncan KE, 2009, ENVIRON SCI TECHNOL, V43, P7977, DOI 10.1021/es9013932; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ghodsi M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-271; Giongo A, 2010, ISME J, V4, P852, DOI 10.1038/ismej.2010.16; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hao XL, 2011, BIOINFORMATICS, V27, P611, DOI 10.1093/bioinformatics/btq725; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Kellenberger E, 2001, EMBO REP, V2, P5, DOI 10.1093/embo-reports/kve014; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Lysholm Fredrik, 2011, BMC Res Notes, V4, P449, DOI 10.1186/1756-0500-4-449; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Oakley BB, 2008, APPL ENVIRON MICROB, V74, P4898, DOI 10.1128/AEM.02884-07; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Reeder J, 2009, NAT METHODS, V6, P636, DOI 10.1038/nmeth0909-636; Richter DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003373; Russell DJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-601; Schloss PD, 2013, ISME J, V7, P457, DOI 10.1038/ismej.2012.102; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2004, MICROBIOL MOL BIOL R, V68, P686, DOI 10.1128/MMBR.68.4.686-691.2004; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sharpton TJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001061; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Studholme C, 1999, PATTERN RECOGN, V32, P71, DOI 10.1016/S0031-3203(98)00091-0; Sun YJ, 2012, BRIEF BIOINFORM, V13, P107, DOI 10.1093/bib/bbr009; Sun YJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq872; Sun YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp285; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Van Rijsbergen C, 1980, INFORM RETRIEVAL; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang X, 2011, ISME J; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578	45	110	113	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e70837	10.1371/journal.pone.0070837	http://dx.doi.org/10.1371/journal.pone.0070837			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967117	Green Published, gold, Green Submitted			2022-12-25	WOS:000323115800024
J	Huang, JF; Wang, XZ; Li, XX; Tian, HQ; Pan, ZK				Huang, Jingfeng; Wang, Xiuzhen; Li, Xinxing; Tian, Hanqin; Pan, Zhuokun			Remotely Sensed Rice Yield Prediction Using Multi-Temporal NDVI Data Derived from NOAA's-AVHRR	PLOS ONE			English	Article							WHEAT YIELD; CROP YIELD; TIME-SERIES; GRAIN-YIELD; WINTER-WHEAT; MODEL DEVELOPMENT; VEGETATION INDEX; MAIZE PRODUCTION; SENSING DATA; MODIS	Grain-yield prediction using remotely sensed data have been intensively studied in wheat and maize, but such information is limited in rice, barley, oats and soybeans. The present study proposes a new framework for rice-yield prediction, which eliminates the influence of the technology development, fertilizer application, and management improvement and can be used for the development and implementation of provincial rice-yield predictions. The technique requires the collection of remotely sensed data over an adequate time frame and a corresponding record of the region's crop yields. Longer normalized-difference-vegetation-index (NDVI) time series are preferable to shorter ones for the purposes of rice-yield prediction because the well-contrasted seasons in a longer time series provide the opportunity to build regression models with a wide application range. A regression analysis of the yield versus the year indicated an annual gain in the rice yield of 50 to 128 kg ha 21. Stepwise regression models for the remotely sensed rice-yield predictions have been developed for five typical rice-growing provinces in China. The prediction models for the remotely sensed rice yield indicated that the influences of the NDVIs on the rice yield were always positive. The association between the predicted and observed rice yields was highly significant without obvious outliers from 1982 to 2004. Independent validation found that the overall relative error is approximately 5.82%, and a majority of the relative errors were less than 5% in 2005 and 2006, depending on the study area. The proposed models can be used in an operational context to predict rice yields at the provincial level in China. The methodologies described in the present paper can be applied to any crop for which a sufficient time series of NDVI data and the corresponding historical yield information are available, as long as the historical yield increases significantly.	[Huang, Jingfeng; Li, Xinxing; Pan, Zhuokun] Zhejiang Univ, Inst Agr Remote Sensing & Informat Applicat, Hangzhou 310003, Zhejiang, Peoples R China; [Huang, Jingfeng; Li, Xinxing] Zhejiang Univ, China Minist Educ, Key Lab Environm Remediat & Ecol Hlth, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Xiuzhen] Hangzhou Normal Univ, Inst Remote Sensing & Earth Sci, Hangzhou, Zhejiang, Peoples R China; [Tian, Hanqin] Auburn Univ, Int Ctr Climate & Global Change Res, Auburn, AL 36849 USA; [Tian, Hanqin] Auburn Univ, Sch Forestry & Wildlife Sci, Ecosyst Dynam & Global Ecol EDGE Lab, Auburn, AL 36849 USA	Zhejiang University; Zhejiang University; Hangzhou Normal University; Auburn University System; Auburn University; Auburn University System; Auburn University	Wang, XZ (corresponding author), Hangzhou Normal Univ, Inst Remote Sensing & Earth Sci, Hangzhou, Zhejiang, Peoples R China.	wxz05160516@126.com	Tian, Hanqin/A-6484-2012	Tian, Hanqin/0000-0002-1806-4091; Huang, Jingfeng/0000-0003-4627-6021	National Key Technology R&D Program of China [2011BAD32B01]; National Natural Science Foundation of China (NSFC) [40875070, 40871158]; Zhejiang Provincial Natural Science Foundation of China [Y5100021]	National Key Technology R&D Program of China(National Key Technology R&D Program); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	The authors' work was supported from National Key Technology R&D Program of China Grant(2011BAD32B01), the National Natural Science Foundation of China (NSFC) grant (40875070 and 40871158) and Zhejiang Provincial Natural Science Foundation of China grant (Y5100021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaghi R, 2008, INT J APPL EARTH OBS, V10, P438, DOI 10.1016/j.jag.2006.12.001; Bastiaanssen WGM, 2003, AGR ECOSYST ENVIRON, V94, P321, DOI 10.1016/S0167-8809(02)00034-8; Becker-Reshef I, 2010, REMOTE SENS ENVIRON, V114, P1312, DOI 10.1016/j.rse.2010.01.010; BENEDETTI R, 1993, REMOTE SENS ENVIRON, V45, P311, DOI 10.1016/0034-4257(93)90113-C; Boken VK, 2002, INT J REMOTE SENS, V23, P4155, DOI 10.1080/014311602320567955; Bullock P.R, 1992, CAN J REMOTE SENS, V18, P23; Cheng Q, 1994, REMOTE SENSING TECHN, V9, P12; CLARKE FR, 1994, CROP SCI, V34, P1479, DOI 10.2135/cropsci1994.0011183X003400060011x; Doraiswamy P. C., 1995, CANADIAN J REMOTE SE, V21, P43, DOI [10.1080/07038992.1995.10874595, DOI 10.1080/07038992.1995.10874595]; DUBEY RP, 1994, INT J REMOTE SENS, V15, P2137, DOI 10.1080/01431169408954232; Dyson T, 1999, P NATL ACAD SCI USA, V96, P5929, DOI 10.1073/pnas.96.11.5929; Epplin FM, 1998, CAN J PLANT SCI, V78, P71, DOI 10.4141/P97-012; Esquerdo JCDM, 2011, INT J REMOTE SENS, V32, P3711, DOI 10.1080/01431161003764112; Evenson RE, 2003, SCIENCE, V300, P758, DOI 10.1126/science.1078710; Fensholt R, 2006, INT J REMOTE SENS, V27, P2719, DOI 10.1080/01431160600567761; Fensholt R, 2009, REMOTE SENS ENVIRON, V113, P1886, DOI 10.1016/j.rse.2009.04.004; Ferencz C, 2004, INT J REMOTE SENS, V25, P4113, DOI 10.1080/01431160410001698870; Foody GM, 2003, REMOTE SENS ENVIRON, V85, P463, DOI 10.1016/S0034-4257(03)00039-7; Freund J T, 2005, ESTIMATING CROP PROD, P72; Fuller DO, 1998, INT J REMOTE SENS, V19, P2013, DOI 10.1080/014311698215135; Funk C, 2009, REMOTE SENS ENVIRON, V113, P115, DOI 10.1016/j.rse.2008.08.015; Genovese G, 2001, AGRONOMIE, V21, P91, DOI 10.1051/agro:2001111; GROTEN SME, 1993, INT J REMOTE SENS, V14, P1495, DOI 10.1080/01431169308953983; GUPTA RK, 1993, ADV SPACE RES-SERIES, V13, P253, DOI 10.1016/0273-1177(93)90553-N; Hafner S, 2003, AGR ECOSYST ENVIRON, V97, P275, DOI 10.1016/S0167-8809(03)00019-7; Hayes MJ, 1996, INT J REMOTE SENS, V17, P3189, DOI 10.1080/01431169608949138; Hochheim K. P., 1998, CANADIAN J REMOTE SE, V24, P17, DOI DOI 10.1080/07038992.1998.10874687; Huang JingFeng, 1999, Journal of Zhejiang Agricultural University, V25, P519; [黄敬峰 Huang Jingfeng], 2002, [遥感技术与应用, Remote sensing Technology and Application], V17, P125; Kalubarme AH, 2003, INT J REMOTE SENS, V24, P2037, DOI 10.1080/01431160210156018; Kastens JH, 2005, REMOTE SENS ENVIRON, V99, P341, DOI 10.1016/j.rse.2005.09.010; Labus MP, 2002, INT J REMOTE SENS, V23, P4169, DOI 10.1080/01431160110107653; Lee R, 2000, FORECASTING CORN YIE, P460; Lewis JE, 1998, INT J REMOTE SENS, V19, P2609, DOI 10.1080/014311698214677; Liu WT, 2002, INT J REMOTE SENS, V23, P1161, DOI 10.1080/01431160110076126; MACDONALD RB, 1980, SCIENCE, V208, P670, DOI 10.1126/science.208.4445.670; Manjunath KR, 2002, INT J REMOTE SENS, V23, P3023, DOI 10.1080/01431160110104692; Maselli F, 2001, PHOTOGRAMM ENG REM S, V67, P593; Maselli F, 2000, INT J REMOTE SENS, V21, P3509, DOI 10.1080/014311600750037525; Mika J, 2002, ADV SPACE RES, V30, P2399, DOI 10.1016/S0273-1177(02)80288-5; Mkhabela MS, 2011, AGR FOREST METEOROL, V151, P385, DOI 10.1016/j.agrformet.2010.11.012; Mkhabela MS, 2005, AGR FOREST METEOROL, V129, P1, DOI 10.1016/j.agrformet.2004.12.006; Mo XG, 2005, ECOL MODEL, V183, P301, DOI 10.1016/j.ecolmodel.2004.07.032; Moriondo M, 2007, EUR J AGRON, V26, P266, DOI 10.1016/j.eja.2006.10.007; National Bureau of Statistics of China, 2010, CHIN STAT YB; Patel NR, 2006, INT J REMOTE SENS, V27, P4071, DOI 10.1080/01431160500377188; Peltonen-Sainio P, 2009, FIELD CROP RES, V110, P85, DOI 10.1016/j.fcr.2008.07.007; Peng S, 2000, CROP SCI, V40, P307, DOI 10.2135/cropsci2000.402307x; Pinzon J, 2004, EMD ITS APPL, V10, P285; POTDAR MB, 1993, INT J REMOTE SENS, V14, P895, DOI 10.1080/01431169308904385; Prasad AK, 2007, INT J REMOTE SENS, V28, P5207, DOI 10.1080/01431160601105843; Prasad AK, 2006, INT J APPL EARTH OBS, V8, P26, DOI 10.1016/j.jag.2005.06.002; QUARMBY NA, 1993, INT J REMOTE SENS, V14, P199, DOI 10.1080/01431169308904332; Rasmussen MS, 1997, INT J REMOTE SENS, V18, P1059, DOI 10.1080/014311697218575; Rasmussen MS, 1998, INT J REMOTE SENS, V19, P97, DOI 10.1080/014311698216459; RASMUSSEN MS, 1992, INT J REMOTE SENS, V13, P3431, DOI 10.1080/01431169208904132; Ren JQ, 2008, INT J APPL EARTH OBS, V10, P403, DOI 10.1016/j.jag.2007.11.003; Ren Jianqiang, 2006, Yingyong Shengtai Xuebao, V17, P2371; Reynolds CA, 2000, INT J REMOTE SENS, V21, P3487, DOI 10.1080/014311600750037516; Rojas O, 2007, INT J REMOTE SENS, V28, P3775, DOI 10.1080/01431160601075608; RUDORFF BFT, 1991, INT J REMOTE SENS, V12, P2477, DOI 10.1080/01431169108955281; Salazar L, 2007, INT J REMOTE SENS, V28, P3795, DOI 10.1080/01431160601050395; Schut AGT, 2009, CROP PASTURE SCI, V60, P60, DOI 10.1071/CP08182; Seiler RA, 2000, ADV SPACE RES-SERIES, V26, P1177, DOI 10.1016/S0273-1177(99)01144-8; Sirkin RMark, 2006, STAT SOCIAL SCI; SMITH RCG, 1995, AUST J AGR RES, V46, P113, DOI 10.1071/AR9950113; SRIDHAR VN, 1994, INT J REMOTE SENS, V15, P1307, DOI 10.1080/01431169408954163; Stergiou KI, 1996, FISH RES, V25, P105, DOI 10.1016/0165-7836(95)00389-4; TENNAKOON SB, 1992, INT J REMOTE SENS, V13, P427, DOI 10.1080/01431169208904047; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; TUCKER CJ, 1980, PHOTOGRAMM ENG REM S, V46, P657; Tucker CJ, 2005, INT J REMOTE SENS, V26, P4485, DOI 10.1080/01431160500168686; Unganai LS, 1998, REMOTE SENS ENVIRON, V63, P219, DOI 10.1016/S0034-4257(97)00132-6; Wall L, 2008, INT J REMOTE SENS, V29, P2211, DOI 10.1080/01431160701395252; Wang ChangYao, 2005, Transactions of the Chinese Society of Agricultural Engineering, V21, P90; Wang RC, 2002, RICE YIELD ESTIMATIO; Wang X.Z., 2010, HYPERSPECTRAL EXPT P; Wannebo A, 2003, INT J REMOTE SENS, V24, P2055, DOI 10.1080/01431160210154786; Weissteiner CJ, 2005, J AGRON CROP SCI, V191, P308, DOI 10.1111/j.1439-037X.2005.00154.x; Wendroth O, 2003, J HYDROL, V272, P250, DOI 10.1016/S0022-1694(02)00269-X; [张峰 Zhang Feng], 2004, [遥感学报, Journal of Remote Sensing], V8, P611	82	76	82	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e70816	10.1371/journal.pone.0070816	http://dx.doi.org/10.1371/journal.pone.0070816			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967112	Green Submitted, gold, Green Published			2022-12-25	WOS:000323115800022
J	Komura, N; Maeda, N; Mori, T; Kihara, S; Nakatsuji, H; Hirata, A; Tochino, Y; Funahashi, T; Shimomura, I				Komura, Noriyuki; Maeda, Norikazu; Mori, Takuya; Kihara, Shinji; Nakatsuji, Hideaki; Hirata, Ayumu; Tochino, Yoshihiro; Funahashi, Tohru; Shimomura, Iichiro			Adiponectin Protein Exists in Aortic Endothelial Cells	PLOS ONE			English	Article								Aims: Inflammation is closely associated with the development of atherosclerosis and metabolic syndrome. Adiponectin, an adipose-derived secretory protein, possesses an anti-atherosclerotic property. The present study was undertaken to elucidate the presence and significance of adiponectin in vasculature. Methods and Results: Immunofluorescence staining was performed in aorta of wild-type (WT) mice and demonstrated that adiponectin was co-stained with CD31. Thoracic aorta was cut through and then aortic intima was carefully shaved from aorta. Western blotting showed the existence of adiponectin protein in aortic intima, while there was no adiponectin mRNA expression. Adiponectin knockout (Adipo-KO) and WT mice were administered with a low-dose and short-term lipopolysaccharide (LPS) (1 mg/kg of LPS for 4 hours). The endothelium vascular adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1) were highly increased in Adipo-KO mice compared to WT mice after LPS administration. Conclusions: Adiponectin protein exists in aortic endothelium under steady state and may protect vasculature from the initiation of atherosclerosis.	[Komura, Noriyuki; Maeda, Norikazu; Mori, Takuya; Nakatsuji, Hideaki; Hirata, Ayumu; Tochino, Yoshihiro; Funahashi, Tohru; Shimomura, Iichiro] Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka, Japan; [Kihara, Shinji] Osaka Univ, Grad Sch Med, Dept Biomed Informat, Suita, Osaka, Japan; [Funahashi, Tohru] Osaka Univ, Grad Sch Med, Dept Metab & Atherosclerosis, Suita, Osaka, Japan	Osaka University; Osaka University; Osaka University	Maeda, N (corresponding author), Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka, Japan.	norikazu_maeda@endmet.med.osaka-u.ac.jp			Takeda Science Foundation;  [22590979];  [24390238];  [22126008]	Takeda Science Foundation(Takeda Science Foundation (TSF)); ; ; 	This work was supported in part by a Grants-in-Aid for Scientific Research (C) no. 22590979 (to NM), a Grants-in-Aid for Scientific Research (B) no. 24390238 (to IS), a Grants-in-Aid for Scientific Research on Innovative Areas no. 22126008 (to TF), and Takeda Science Foundation (to NM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Fujita K, 2008, ARTERIOSCL THROM VAS, V28, P863, DOI 10.1161/ATVBAHA.107.156687; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Komura N, 2010, CARDIOVASC RES, V86, P471, DOI 10.1093/cvr/cvp415; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; Lassenius MI, 2011, DIABETES CARE, V34, P1809, DOI 10.2337/dc10-2197; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Matsuzawa Y, 2004, ARTERIOSCL THROM VAS, V24, P29, DOI 10.1161/01.ATV.0000099786.99623.EF; Nakagawa Y, 2009, BIOCHEM BIOPH RES CO, V382, P183, DOI 10.1016/j.bbrc.2009.03.004; Nishimura M, 2008, CIRCULATION, V117, P216, DOI 10.1161/CIRCULATIONAHA.107.725044; Ohashi K, 2007, ARTERIOSCL THROM VAS, V27, P1910, DOI 10.1161/ATVBAHA.107.147645; Okamoto Y, 2002, CIRCULATION, V106, P2767, DOI 10.1161/01.CIR.0000042707.50032.19; Okamoto Y, 2000, HORM METAB RES, V32, P47, DOI 10.1055/s-2007-978586; Ouchi N, 2000, CIRCULATION, V102, P1296, DOI 10.1161/01.CIR.102.11.1296; Ouchi N, 2001, CIRCULATION, V103, P1057, DOI 10.1161/01.CIR.103.8.1057; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Pussinen PJ, 2007, ARTERIOSCL THROM VAS, V27, P1433, DOI 10.1161/ATVBAHA.106.138743; Pussinen PJ, 2011, DIABETES CARE, V34, P392, DOI 10.2337/dc10-1676; Ryo M, 2004, CIRC J, V68, P975, DOI 10.1253/circj.68.975; Shibata R, 2007, CARDIOVASC RES, V74, P471, DOI 10.1016/j.cardiores.2007.02.010; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Stoll LL, 2004, ARTERIOSCL THROM VAS, V24, P2227, DOI 10.1161/01.ATV.0000147534.69062.dc; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Wiedermann CJ, 1999, J AM COLL CARDIOL, V34, P1975, DOI 10.1016/S0735-1097(99)00448-9; Yamada H, 2008, ARTERIOSCL THROM VAS, V28, P2173, DOI 10.1161/ATVBAHA.108.171736; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Zhang HR, 2010, ARTERIOSCL THROM VAS, V30, P2156, DOI 10.1161/ATVBAHA.110.214700	30	36	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71271	10.1371/journal.pone.0071271	http://dx.doi.org/10.1371/journal.pone.0071271			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967179	Green Published, gold, Green Submitted			2022-12-25	WOS:000323115800046
J	Pu, JL; Mao, YF; Lei, XG; Yan, YP; Lu, XX; Tian, J; Yin, XZ; Zhao, GH; Zhang, BR				Pu, Jiali; Mao, Yanfang; Lei, Xiaoguang; Yan, Yaping; Lu, Xiaoxiong; Tian, Jun; Yin, Xinzhen; Zhao, Guohua; Zhang, Baorong			FERM Domain Containing Protein 7 Interacts with the Rho GDP Dissociation Inhibitor and Specifically Activates Rac1 Signaling	PLOS ONE			English	Article							GTP-BINDING PROTEIN; REGULATORY PROTEIN; MOLECULAR-CLONING; DENDRITIC GROWTH; EXCHANGE FACTOR; FRMD7 GENE; GTPASES; BRAIN; HOMOLOGY; IDENTIFICATION	The FERM domain containing protein 7 gene (FRMD7) associated with the X-linked disorder idiopathic congenital nystagmus (ICN) is involved in the regulation of neurite elongation during neuronal development. Members of the Rho family of small G-proteins (Rho GTPases) are key regulators of the actin cytoskeleton and are implicated in the control of neuronal morphology. The Rho GDP dissociation inhibitor alpha, RhoGDI alpha, the main regulator of Rho GTPases, can form a complex with the GDP-bound form of Rho GTPases and inhibit their activation. Here, we demonstrate that the full length of the mouse FRMD7, rather than the N-terminus or the C-terminus alone, directly interacts with RhoGDI alpha and specifically initiates Rac1 signaling in mouse neuroblastoma cell line (neuro-2a). Moreover, we show that wild-type human FRMD7 protein is able to activate Rac1 signaling by interacting with RhoGDI alpha and releasing Rac1 from Rac1-RhoGDI alpha complex. However, two missense mutations (c. 781C>G and c. 886G>C) of human FRMD7 proteins weaken the ability to interact with RhoGDI alpha and release less Rac1, that induce the activation of Rac1 to a lesser degree; while an additional mutant, c. 1003C>T, which results in a C-terminal truncated protein, almost fails to interact with RhoGDI alpha and to activate Rac1 signaling. Collectively, these results suggest that FRMD7 interacts with one of the Rho GTPase regulators, RhoGDI alpha, and activates the Rho subfamily member Rac1, which regulates reorganization of actin filaments and controls neuronal outgrowth. We predict that human mutant FRMD7 thus influences Rac1 signaling activation, which can lead to abnormal neuronal outgrowth and cause the X-linked ICN.	[Pu, Jiali; Mao, Yanfang; Lei, Xiaoguang; Yan, Yaping; Lu, Xiaoxiong; Tian, Jun; Yin, Xinzhen; Zhao, Guohua; Zhang, Baorong] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Dept Neurol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Zhang, BR (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 2, Dept Neurol, Hangzhou 310003, Zhejiang, Peoples R China.	brzhang@zju.edu.cn		Lei, Xiaoguang/0000-0002-1106-6465	Nature Science Foundation of China [81070903, 81000484]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Nature Science Foundation of China (Nos. 81070903) to B. Zhang and (Nos. 81000484) to G. Zhao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adra CN, 1997, P NATL ACAD SCI USA, V94, P4279, DOI 10.1073/pnas.94.9.4279; Akasaki T, 1999, J BIOL CHEM, V274, P18055, DOI 10.1074/jbc.274.25.18055; ARPIN M, 1994, CURR OPIN CELL BIOL, V6, P136, DOI 10.1016/0955-0674(94)90127-9; Betts-Henderson J, 2010, HUM MOL GENET, V19, P342, DOI 10.1093/hmg/ddp500; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Boulter E, 2010, NAT CELL BIOL, V12, P477, DOI 10.1038/ncb2049; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; CHUANG TH, 1995, P NATL ACAD SCI USA, V92, P10282, DOI 10.1073/pnas.92.22.10282; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; Fingert JH, 2010, OPHTHALMIC GENET, V31, P77, DOI 10.3109/13816810903584989; FUKUMOTO Y, 1990, ONCOGENE, V5, P1321; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; GARY R, 1995, MOL BIOL CELL, V6, P1061, DOI 10.1091/mbc.6.8.1061; He X, 2008, MOL VIS, V14, P56; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kim O, 2002, J BIOL CHEM, V277, P30066, DOI 10.1074/jbc.M201713200; Koyano Y, 1997, BIOCHEM BIOPH RES CO, V241, P369, DOI 10.1006/bbrc.1997.7826; Kubo T, 2002, J NEUROSCI, V22, P8504; LELIAS JM, 1993, P NATL ACAD SCI USA, V90, P1479, DOI 10.1073/pnas.90.4.1479; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; MAGENDANTZ M, 1995, J BIOL CHEM, V270, P25324, DOI 10.1074/jbc.270.43.25324; MARTIN M, 1995, J CELL BIOL, V128, P1081, DOI 10.1083/jcb.128.6.1081; Penzes P, 2000, J BIOL CHEM, V275, P6395, DOI 10.1074/jbc.275.9.6395; Pu JL, 2011, MOL VIS, V17, P591; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Richnau N, 2001, J BIOL CHEM, V276, P35060, DOI 10.1074/jbc.M103540200; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; SCHERLE P, 1993, P NATL ACAD SCI USA, V90, P7568, DOI 10.1073/pnas.90.16.7568; Schorderet Daniel F, 2007, Hum Mutat, V28, P525, DOI 10.1002/humu.9492; Takahashi K, 1997, J BIOL CHEM, V272, P23371, DOI 10.1074/jbc.272.37.23371; Tarpey P, 2006, NAT GENET, V38, P1242, DOI 10.1038/ng1893; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Toyofuku T, 2005, NAT NEUROSCI, V8, P1712, DOI 10.1038/nn1596; Tsukita S, 1997, CURR OPIN CELL BIOL, V9, P70, DOI 10.1016/S0955-0674(97)80154-8; Tsukita S, 1997, TRENDS BIOCHEM SCI, V22, P53, DOI 10.1016/S0968-0004(96)10071-2; UEDA T, 1990, J BIOL CHEM, V265, P9373; WATKINS RJ, 2013, HUM MOL GENET; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Zalcman G, 1996, J BIOL CHEM, V271, P30366, DOI 10.1074/jbc.271.48.30366; Zalcman G, 1999, Prog Mol Subcell Biol, V22, P85; Zhang BR, 2007, MOL VIS, V13, P1674; Zhuang BQ, 2009, NEURON, V61, P359, DOI 10.1016/j.neuron.2008.12.022	44	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e73108	10.1371/journal.pone.0073108	http://dx.doi.org/10.1371/journal.pone.0073108			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967341	Green Submitted, Green Published, gold			2022-12-25	WOS:000323115800119
J	Chen, C; Krishnan, V; Macon, K; Manne, K; Narayana, SVL; Schneewind, O				Chen, Chen; Krishnan, Vengadesan; Macon, Kevin; Manne, Kartik; Narayana, Sthanam V. L.; Schneewind, Olaf			Secreted Proteases Control Autolysin-mediated Biofilm Growth of Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-N-ACETYLGLUCOSAMINIDASE; BINDING PROTEIN-A; L-ALANINE AMIDASE; MUREIN HYDROLASE; BACTERIAL BIOFILMS; SERINE-PROTEASE; MOLECULAR-BASIS; REPEAT DOMAINS; NASAL CARRIAGE; CROSS-WALL	Staphylococcus epidermidis, a commensal of humans, secretes Esp protease to prevent Staphylococcus aureus biofilm formation and colonization. Blocking S. aureus colonization may reduce the incidence of invasive infectious diseases; however, the mechanism whereby Esp disrupts biofilms is unknown. We show here that Esp cleaves autolysin (Atl)-derived murein hydrolases and prevents staphylococcal release of DNA, which serves as extracellular matrix in biofilms. The three-dimensional structure of Esp was revealed by x-ray crystallography and shown to be highly similar to that of S. aureus V8 (SspA). Both atl and sspA are necessary for biofilm formation, and purified SspA cleaves Atl-derived murein hydrolases. Thus, S. aureus biofilms are formed via the controlled secretion and proteolysis of autolysin, and this developmental program appears to be perturbed by the Esp protease of S. epidermidis.	[Chen, Chen; Schneewind, Olaf] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA; [Krishnan, Vengadesan] Biotech Sci Cluster, Reg Ctr Biotechnol, Gurgaon 122016, Haryana, India; [Macon, Kevin; Manne, Kartik; Narayana, Sthanam V. L.] Univ Alabama Birmingham, Sch Optometry, Ctr Biophys Sci & Engn, Birmingham, AL 35294 USA	University of Chicago; Department of Biotechnology (DBT) India; Regional Centre for Biotechnology; University of Alabama System; University of Alabama Birmingham	Schneewind, O (corresponding author), Univ Chicago, Dept Microbiol, 920 E 58th St, Chicago, IL 60637 USA.	oschnee@bsd.uchicago.edu	Manne, Kartik/AAC-9511-2021; krishnan, vengadesan/F-8069-2011	Manne, Kartik/0000-0002-7218-4852; krishnan, vengadesan/0000-0002-8083-0121	National Institutes of Health [AI38897, AI52474]; National Institutes of Health through membership in the Region V "Great Lakes" Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium [1-U54-AI-057153]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052474, R01AI038897, U54AI057153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health through membership in the Region V "Great Lakes" Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI38897 and AI52474 (to O.S.). This work was also supported by National Institutes of Health Award 1-U54-AI-057153 through membership in the Region V "Great Lakes" Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (to O.S.).	Ahn JS, 2006, MOL MICROBIOL, V62, P1158, DOI 10.1111/j.1365-2958.2006.05433.x; Archer NK, 2011, VIRULENCE, V2, P445, DOI 10.4161/viru.2.5.17724; Baba T, 1998, EMBO J, V17, P4639, DOI 10.1093/emboj/17.16.4639; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052; Boles BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010146; Boles BR, 2011, TRENDS MICROBIOL, V19, P449, DOI 10.1016/j.tim.2011.06.004; Bose JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042244; BROWDER HP, 1965, BIOCHEM BIOPH RES CO, V19, P383, DOI 10.1016/0006-291X(65)90473-0; Burian M, 2010, J INFECT DIS, V201, P1414, DOI 10.1086/651619; Cavarelli J, 1997, STRUCTURE, V5, P813, DOI 10.1016/S0969-2126(97)00235-9; CHARNEY J, 1947, J BIOL CHEM, V171, P501; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; DRAPEAU GR, 1972, J BIOL CHEM, V247, P6720; DRAPEAU GR, 1978, J BACTERIOL, V136, P607, DOI 10.1128/JB.136.2.607-613.1978; Dubin G, 2001, BIOL CHEM, V382, P1575, DOI 10.1515/BC.2001.192; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frankel MB, 2012, J BIOL CHEM, V287, P10460, DOI 10.1074/jbc.M111.336404; Frankel MB, 2011, J BIOL CHEM, V286, P32593, DOI 10.1074/jbc.M111.258863; Geoghegan JA, 2013, J BACTERIOL, V195, P2675, DOI 10.1128/JB.02128-12; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x; Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x; HOLM L, 1994, NUCLEIC ACIDS RES, V22, P3600; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; HOUMARD J, 1972, P NATL ACAD SCI USA, V69, P3506, DOI 10.1073/pnas.69.12.3506; Houston P, 2011, INFECT IMMUN, V79, P1153, DOI 10.1128/IAI.00364-10; Iwase T, 2010, NATURE, V465, P346, DOI 10.1038/nature09074; Johnson M, 2008, INFECT IMMUN, V76, P1756, DOI 10.1128/IAI.01635-07; Kaplan JB, 2012, MBIO, V3, DOI 10.1128/mBio.00198-12; Klevens RM, 2008, CLIN INFECT DIS, V47, P927, DOI 10.1086/591698; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Krismer B, 2011, FUTURE MICROBIOL, V6, P489, DOI [10.2217/fmb.11.37, 10.2217/FMB.11.37]; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lopez D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000398; Lower SK, 2011, P NATL ACAD SCI USA, V108, P18372, DOI 10.1073/pnas.1109071108; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCGRATH ME, 1992, BIOCHEMISTRY-US, V31, P3059, DOI 10.1021/bi00127a005; Moon JL, 2001, BIOL CHEM, V382, P1095, DOI 10.1515/BC.2001.138; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nemoto TK, 2008, FEBS J, V275, P573, DOI 10.1111/j.1742-4658.2007.06224.x; Nemoto TK, 2009, BIOL CHEM, V390, P277, DOI 10.1515/BC.2009.027; Ono T, 2010, BIOL CHEM, V391, P1221, DOI 10.1515/BC.2010.116; OSHIDA T, 1995, P NATL ACAD SCI USA, V92, P285, DOI 10.1073/pnas.92.1.285; Otto M, 2012, SEMIN IMMUNOPATHOL, V34, P201, DOI 10.1007/s00281-011-0296-2; Papageorgiou AC, 2000, PROTEIN SCI, V9, P610; Park DW, 2011, BMB REP, V44, P279, DOI 10.5483/BMBRep.2011.44.4.279; PERONA JJ, 1995, BIOCHEMISTRY-US, V34, P1489, DOI 10.1021/bi00005a004; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Prasad L, 2004, ACTA CRYSTALLOGR D, V60, P256, DOI 10.1107/S090744490302599X; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Rouf SMA, 2012, INDIAN J BIOCHEM BIO, V49, P421; RUHLMANN A, 1973, J MOL BIOL, V77, P417, DOI 10.1016/0022-2836(73)90448-8; Sadykov MR, 2012, CURR OPIN MICROBIOL, V15, P211, DOI 10.1016/j.mib.2011.12.010; SCHINDLER CA, 1964, P NATL ACAD SCI USA, V51, P414, DOI 10.1073/pnas.51.3.414; Schlag M, 2010, MOL MICROBIOL, V75, P864, DOI 10.1111/j.1365-2958.2009.07007.x; Scriba TJ, 2008, INFECT IMMUN, V76, P2164, DOI 10.1128/IAI.01699-07; Shaw L, 2004, MICROBIOL-SGM, V150, P217, DOI 10.1099/mic.0.26634-0; Stec-Niemczyk J, 2009, BIOCHEM J, V419, P555, DOI 10.1042/BJ20081351; Sugai M, 1997, J BACTERIOL, V179, P2958, DOI 10.1128/jb.179.9.2958-2962.1997; SUGAI M, 1995, J BACTERIOL, V177, P1491, DOI 10.1128/jb.177.6.1491-1496.1995; Sugimoto S, 2013, J BACTERIOL, V195, P1645, DOI 10.1128/JB.01672-12; Thompson KM, 2010, FEMS MICROBIOL LETT, V305, P143, DOI 10.1111/j.1574-6968.2010.01918.x; Vengadesan K, 2013, ACTA CRYSTALLOGR F, V69, P49, DOI 10.1107/S1744309112047124; Vlamakis H, 2013, NAT REV MICROBIOL, V11, P157, DOI 10.1038/nrmicro2960; Volanakis JE, 1996, PROTEIN SCI, V5, P553; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wertheim HFL, 2004, LANCET, V364, P703, DOI 10.1016/S0140-6736(04)16897-9; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamada S, 1996, J BACTERIOL, V178, P1565, DOI 10.1128/jb.178.6.1565-1571.1996; Zoll S, 2012, J BACTERIOL, V194, P3789, DOI 10.1128/JB.00331-12	76	70	73	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29440	29452		10.1074/jbc.M113.502039	http://dx.doi.org/10.1074/jbc.M113.502039			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23970550	Green Published, hybrid			2022-12-25	WOS:000330615300022
J	Honda, K; Nakamura, Y; Nakaoka, M; Uy, WH; Fortes, MD				Honda, Kentaro; Nakamura, Yohei; Nakaoka, Masahiro; Uy, Wilfredo H.; Fortes, Miguel D.			Habitat Use by Fishes in Coral Reefs, Seagrass Beds and Mangrove Habitats in the Philippines	PLOS ONE			English	Article							MARINE RESERVES; COMMUNITY STRUCTURE; SPECIES COMPOSITION; NURSERY FUNCTION; APO ISLAND; CONNECTIVITY; CONSERVATION; ASSEMBLAGES; MANAGEMENT; ESTUARINE	Understanding the interconnectivity of organisms among different habitats is a key requirement for generating effective management plans in coastal ecosystems, particularly when determining component habitat structures in marine protected areas. To elucidate the patterns of habitat use by fishes among coral, seagrass, and mangrove habitats, and between natural and transplanted mangroves, visual censuses were conducted semiannually at two sites in the Philippines during September and March 2010-2012. In total, 265 species and 15,930 individuals were recorded. Species richness and abundance of fishes were significantly higher in coral reefs (234 species, 12,306 individuals) than in seagrass (38 species, 1,198 individuals) and mangrove (47 species, 2,426 individuals) habitats. Similarity tests revealed a highly significant difference among the three habitats. Fishes exhibited two different strategies for habitat use, inhabiting either a single (85.6% of recorded species) or several habitats (14.4%). Some fish that utilized multiple habitats, such as Lutjanus monostigma and Parupeneus barberinus, showed possible ontogenetic habitat shifts from mangroves and/or seagrass habitats to coral reefs. Moreover, over 20% of commercial fish species used multiple habitats, highlighting the importance of including different habitat types within marine protected areas to achieve efficient and effective resource management. Neither species richness nor abundance of fishes significantly differed between natural and transplanted mangroves. In addition, 14 fish species were recorded in a 20-year-old transplanted mangrove area, and over 90% of these species used multiple habitats, further demonstrating the key role of transplanted mangroves as a reef fish habitat in this region.	[Honda, Kentaro; Nakaoka, Masahiro] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Akkeshi Marine Stn, Akkeshi, Hokkaido, Japan; [Nakamura, Yohei] Kochi Univ, Grad Sch Kuroshio Sci, Nankoku, Kochi, Japan; [Uy, Wilfredo H.] Mindanao State Univ Naawan, Inst Fisheries Res & Dev, Misamis Oriental, Philippines; [Fortes, Miguel D.] Univ Philippines Diliman, CS, Inst Marine Sci, Quezon City, Philippines	Hokkaido University; Kochi University; Mindanao State University System; Mindanao State University-Naawan; University of the Philippines System; University of the Philippines Diliman	Honda, K (corresponding author), Hokkaido Univ, Field Sci Ctr Northern Biosphere, Akkeshi Marine Stn, Akkeshi, Hokkaido, Japan.	fbmods@fish.hokudai.ac.jp	Nakaoka, Masahiro/I-9237-2019; Uy, Wilfredo/AAP-6316-2021	Nakaoka, Masahiro/0000-0002-5722-3585; Honda, Kentaro/0000-0003-1967-9263; Nakamura, Yohei/0000-0002-2412-2139	Japan Science and Technology Agency/Japan International Cooperation Agency; Science and Technology Research Partnership for Sustainable Development	Japan Science and Technology Agency/Japan International Cooperation Agency(Japan Science & Technology Agency (JST)); Science and Technology Research Partnership for Sustainable Development	This study was supported by Japan Science and Technology Agency (http://www.jst.go.jp/EN/index.html)/Japan International Cooperation Agency (http://www.jica.go.jp/english/index.html), Science and Technology Research Partnership for Sustainable Development (http://www.jst.go.jp/global/english/index.html), for the project Coastal Ecosystem Conservation and Adaptive Management under Local and Global Environmental Impacts in the Philippines (CECAM, http://www.cecam-project.net/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AJ, 2006, MAR ECOL PROG SER, V318, P287, DOI 10.3354/meps318287; Alcala AC, 2005, CAN J FISH AQUAT SCI, V62, P98, DOI 10.1139/F04-176; Alcala AC, 2006, AMBIO, V35, P245, DOI 10.1579/05-A-054R1.1; Alongi DM, 2008, ESTUAR COAST SHELF S, V76, P1, DOI 10.1016/j.ecss.2007.08.024; Barnes L, 2012, MAR BIOL, V159, P211, DOI 10.1007/s00227-011-1801-9; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berkes F, 2006, SCIENCE, V311, P1557, DOI 10.1126/science.1122804; BLABER SJM, 1990, MAR BIOL, V105, P259, DOI 10.1007/BF01344295; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Carpenter KE, 2005, ENVIRON BIOL FISH, V72, P467, DOI 10.1007/s10641-004-3154-4; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Christie MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015715; Christie P, 2002, J ENVIRON MANAGE, V66, P441, DOI 10.1006/jema.2002.0595; Crona BI, 2007, ESTUAR COAST SHELF S, V74, P44, DOI 10.1016/j.ecss.2007.03.023; Dolar MLL, 1991, P WORKSH MANGR FISH, P137; Dorenbosch M, 2007, MAR ECOL PROG SER, V334, P103, DOI 10.3354/meps334103; Dorenbosch M, 2005, MAR ECOL PROG SER, V302, P63, DOI 10.3354/meps302063; Dorenbosch M, 2004, ESTUAR COAST SHELF S, V60, P37, DOI 10.1016/j.ecss.2003.11.018; EDGAR GJ, 2007, MARINE ECOLOGY; Fortes MD, 2004, DEV ECOSYSTEMS, V1, P233, DOI 10.1016/S1572-7785(04)01014-7; Fortes MD, 2008, ASIAN PACIFIC COASTS, P131; FROESE R., 2012, FISHBASE; Garces LR, 2012, OCEAN COAST MANAGE, DOI DOI 10.1016/J.0CEC0AMAN.2012.07.014.ACCESSED; Gladstone W, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P565, DOI 10.1007/978-90-481-2406-0_16; Gordon HS, 1954, J POLIT ECON, V62, P124, DOI 10.1086/257497; HANNESSON R, 1998, MARINE RESOURCE EC, V13, P159, DOI DOI 10.1086/MRE.13.3.42629231; Hughes JE, 2002, ESTUARIES, V25, P235, DOI 10.1007/BF02691311; Kimirei IA, 2013, ECOSYSTEMS, V16, P783, DOI 10.1007/s10021-013-9645-4; Kimirei IA, 2011, ESTUAR COAST SHELF S, V92, P47, DOI 10.1016/j.ecss.2010.12.016; Kirkman H, 2002, B MAR SCI, V71, P1379; Kleypas JA, 2009, OCEANOGRAPHY, V22, P108, DOI 10.5670/oceanog.2009.101; Kochzius M, 1999, PROCEEDINGS OF THE 5TH INDO-PACIFIC FISH CONFERENCE, P517; Krumme U, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P271, DOI 10.1007/978-90-481-2406-0_8; Luo JG, 2009, MAR ECOL PROG SER, V380, P255, DOI 10.3354/meps07911; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Mumby PJ, 2004, NATURE, V427, P533, DOI 10.1038/nature02286; Nagelkerken I, 2004, MAR ECOL PROG SER, V274, P153, DOI 10.3354/meps274153; Nagelkerken I, 2000, ESTUAR COAST SHELF S, V51, P31, DOI 10.1006/ecss.2000.0617; Nagelkerken I, 2002, MAR ECOL PROG SER, V244, P299, DOI 10.3354/meps244299; Nagelkerken I, 2000, MAR ECOL PROG SER, V202, P175, DOI 10.3354/meps202175; Nagelkerken I, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P357, DOI 10.1007/978-90-481-2406-0_10; Nakamura Y, 2004, FISHERIES SCI, V70, P788, DOI 10.1111/j.1444-2906.2004.00872.x; Nakamura Y, 2008, MAR ECOL PROG SER, V355, P257, DOI 10.3354/meps07234; Nakamura Y, 2008, ESTUAR COAST SHELF S, V76, P345, DOI 10.1016/j.ecss.2007.07.014; Nakamura Y, 2012, MAR BIOL, V159, P1305, DOI 10.1007/s00227-012-1911-z; Olds AD, 2012, MAR ECOL PROG SER, V462, P191, DOI 10.3354/meps09849; Olds AD, 2012, CONSERV LETT, V5, P56, DOI 10.1111/j.1755-263X.2011.00204.x; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Primavera J. H., 2008, Wetlands Ecology and Management, V16, P345, DOI 10.1007/s11273-008-9101-y; Primavera JH, 2000, ECOL ECON, V35, P91, DOI 10.1016/S0921-8009(00)00170-1; PRIMAVERA JH, 1995, HYDROBIOLOGIA, V295, P303, DOI 10.1007/BF00029137; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Russ GR, 2004, ECOL APPL, V14, P597, DOI 10.1890/03-5076; Russ GR, 2003, MAR ECOL PROG SER, V264, P15, DOI 10.3354/meps264015; Russ GR, 1996, MAR ECOL PROG SER, V132, P1, DOI 10.3354/meps132001; Shibuno T, 2008, ICHTHYOL RES, V55, P218, DOI 10.1007/s10228-007-0022-1; Spalding M. D., 2001, WORLD ATLAS CORAL RE; Thollot P, 1992, P 7 INT COR REEF S G, V2, P934; Unsworth RKF, 2008, MAR ECOL PROG SER, V353, P213, DOI 10.3354/meps07199; Unsworth RKF, 2007, J MAR BIOL ASSOC UK, V87, P1287, DOI 10.1017/S002531540705638X; Unsworth RKF, 2010, CONSERV LETT, V3, P63, DOI 10.1111/j.1755-263X.2010.00101.x; Unsworth RKF, 2009, AQUAT BIOL, V5, P85, DOI 10.3354/ab00139; Valiela I, 2001, BIOSCIENCE, V51, P807, DOI 10.1641/0006-3568(2001)051[0807:MFOOTW]2.0.CO;2; Verweij MC, 2008, LIMNOL OCEANOGR, V53, P1540, DOI 10.4319/lo.2008.53.4.1540; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Weeks R, 2010, CONSERV BIOL, V24, P531, DOI 10.1111/j.1523-1739.2009.01340.x; Wilkinston CR, 2004, STATUS CORAL REEFS W	70	75	77	3	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e65735	10.1371/journal.pone.0065735	http://dx.doi.org/10.1371/journal.pone.0065735			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23976940	Green Submitted, Green Published, gold			2022-12-25	WOS:000324527300002
J	Cifani, N; Pompili, B; Anile, M; Patella, M; Diso, D; Venuta, F; Cimino, G; Quattrucci, S; Di Domenico, EG; Ascenzioni, F; Del Porto, P				Cifani, Noemi; Pompili, Barbara; Anile, Marco; Patella, Miriam; Diso, Daniele; Venuta, Federico; Cimino, Giuseppe; Quattrucci, Serena; Di Domenico, Enea Gino; Ascenzioni, Fiorentina; Del Porto, Paola			Reactive-Oxygen-Species-Mediated P. aeruginosa Killing Is Functional in Human Cystic Fibrosis Macrophages	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; INFECTION; CFTR; ACIDIFICATION; NEUTROPHILS; DISEASE; LUNG; IDENTIFICATION; INFLAMMATION; MODELS	Pseudomonas aeruginosa is the most common pathogen for chronic lung infection in cystic fibrosis (CF) patients. About 80% of adult CF patients have chronic P. aeruginosa infection, which accounts for much of the morbidity and most of the mortality. Both bacterial genetic adaptations and defective innate immune responses contribute to the bacteria persistence. It is well accepted that CF transmembrane conductance regulator (CFTR) dysfunction impairs the airways-epithelium-mediated lung defence; however, other innate immune cells also appear to be affected, such as neutrophils and macrophages, which thus contribute to this infectious pathology in the CF lung. In macrophages, the absence of CFTR has been linked to defective P. aeruginosa killing, increased pro-inflammatory cytokine secretion, and reduced reactive oxygen species (ROS) production. To learn more about macrophage dysfunction in CF patients, we investigated the generation of the oxidative burst and its impact on bacterial killing in CF macrophages isolated from peripheral blood or lung parenchyma of CF patients, after P. aeruginosa infection. Our data demonstrate that CF macrophages show an oxidative response of similar intensity to that of non-CF macrophages. Intracellular ROS are recognized as one of the earliest microbicidal mechanisms against engulfed pathogens that are activated by macrophages. Accordingly, NADPH inhibition resulted in a significant increase in the intracellular bacteria survival in CF and non-CF macrophages, both as monocyte-derived macrophages and as lung macrophages. These data strongly suggest that the contribution of ROS to P. aeruginosa killing is not affected by CFTR mutations.	[Cifani, Noemi; Pompili, Barbara; Di Domenico, Enea Gino; Ascenzioni, Fiorentina; Del Porto, Paola] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Rome, Italy; [Anile, Marco; Patella, Miriam; Diso, Daniele; Venuta, Federico] Univ Roma La Sapienza, Dept Thorac Surg, Policlin Umberto I, Rome, Italy; [Cimino, Giuseppe; Quattrucci, Serena] Univ Roma La Sapienza, Ctr Riferimento Fibrosi Cist Reg Lazio, Dept Pediat & Infant Neuropsychiat, Rome, Italy	Sapienza University Rome; Sapienza University Rome; University Hospital Sapienza Rome; Sapienza University Rome	Ascenzioni, F (corresponding author), Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Rome, Italy.	fiorentina.ascenzioni@uniroma1.it	Del Porto, Paola/AAU-2550-2020; Di Domenico, Enea Gino/I-2542-2019; Diso, Daniele/AAI-7101-2020	Di Domenico, Enea Gino/0000-0001-6295-6006; Venuta, Federico/0000-0001-9296-877X; Del Porto, Paola/0000-0003-4802-8910	Italian Foundation for Cystic Fibrosis Research [FFC 14/2007, FFC 21/2009]; Istituto Pasteur Fondazione Cenci Bolognetti, Universita di Roma "La Sapienza'' and "Regione Lazio, fondi fibrosi cistica, quota ricerca''	Italian Foundation for Cystic Fibrosis Research; Istituto Pasteur Fondazione Cenci Bolognetti, Universita di Roma "La Sapienza'' and "Regione Lazio, fondi fibrosi cistica, quota ricerca''	This work was supported by the Italian Foundation for Cystic Fibrosis Research (grant FFC 14/2007 and FFC 21/2009 adopted by Delegazione FFC di Latina e Lega Italiana Fibrosi Cistica Onlus) to PDP and partially by the Istituto Pasteur Fondazione Cenci Bolognetti, Universita di Roma "La Sapienza'' and "Regione Lazio, fondi fibrosi cistica, quota ricerca'' to FA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auriche C, 2010, GENE THER, V17, P1341, DOI 10.1038/gt.2010.89; Bessich JL, 2013, J IMMUNOL; BIRRER P, 1994, AM J RESP CRIT CARE, V150, P207, DOI 10.1164/ajrccm.150.1.7912987; Bonfield TL, 2012, J LEUKOCYTE BIOL, V92, P1111, DOI 10.1189/jlb.0412188; Bruscia EM, 2011, J IMMUNOL, V186, P6990, DOI 10.4049/jimmunol.1100396; Cohen TS, 2012, NAT MED, V18, P509, DOI 10.1038/nm.2715; Davies JC, 2007, BMJ-BRIT MED J, V335, P1255, DOI 10.1136/bmj.39391.713229.AD; Del Porto P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019970; Deriy LV, 2009, J BIOL CHEM, V284, P35926, DOI 10.1074/jbc.M109.057372; Descamps D, 2012, P NATL ACAD SCI USA, V109, P1619, DOI 10.1073/pnas.1108464109; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Doring G, 2012, J CYST FIBROS, V11, P461, DOI 10.1016/j.jcf.2012.10.004; Folkesson A, 2012, NAT REV MICROBIOL, V10, P841, DOI 10.1038/nrmicro2907; Guglietta S, 2005, EUR J IMMUNOL, V35, P2627, DOI 10.1002/eji.200526067; Haggie PM, 2007, J BIOL CHEM, V282, P31422, DOI 10.1074/jbc.M705296200; Harrison F, 2007, MICROBIOL-SGM, V153, P917, DOI 10.1099/mic.0.2006/004077-0; Houston N, 2013, J CYST FIBROS, V12, P352, DOI 10.1016/j.jcf.2012.11.004; Keiser NW, 2011, CURR OPIN PULM MED, V17, P478, DOI 10.1097/MCP.0b013e32834b14c9; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Lezo A, 2013, J CYST FIBROS, V12, P35, DOI 10.1016/j.jcf.2012.06.002; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; McKeon DJ, 2010, EUR RESPIR J, V35, P1264, DOI 10.1183/09031936.00089709; Pirone L, 2008, ENVIRON MICROBIOL, V10, P2773, DOI 10.1111/j.1462-2920.2008.01697.x; Ratner D, 2012, AM J RESP CELL MOL, V46, P715, DOI 10.1165/rcmb.2011-0399RT; Regamey N, 2011, THORAX, V66, P624, DOI 10.1136/thx.2009.134106; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rozmahel R, 1996, NAT GENET, V12, P280, DOI 10.1038/ng0396-280; SPEERT DP, 1994, J INFECT DIS, V170, P1524, DOI 10.1093/infdis/170.6.1524; Steinberg BE, 2010, J CELL BIOL, V189, P1171, DOI 10.1083/jcb.200911083; TRIGGIANI M, 1994, J IMMUNOL, V152, P1394; Wilke M, 2011, J CYST FIBROS, V10, pS152, DOI 10.1016/S1569-1993(11)60020-9; Yuan KF, 2012, J CELL SCI, V125, P507, DOI 10.1242/jcs.094573; Zhang Y, 2011, NAT MED, V17, P341, DOI 10.1038/nm.2296; Zhang Y, 2010, J IMMUNOL, V184, P5104, DOI 10.4049/jimmunol.0902851	34	32	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71717	10.1371/journal.pone.0071717	http://dx.doi.org/10.1371/journal.pone.0071717			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977124	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700090
J	Scarsoglio, S; Laio, F; Ridolfi, L				Scarsoglio, Stefania; Laio, Francesco; Ridolfi, Luca			Climate Dynamics: A Network-Based Approach for the Analysis of Global Precipitation	PLOS ONE			English	Article							COMPLEX NETWORKS; INTERANNUAL VARIABILITY; DECADAL VARIATIONS; BAYESIAN NETWORKS; TELECONNECTIONS; ENSO; OSCILLATION; ANOMALIES	Precipitation is one of the most important meteorological variables for defining the climate dynamics, but the spatial patterns of precipitation have not been fully investigated yet. The complex network theory, which provides a robust tool to investigate the statistical interdependence of many interacting elements, is used here to analyze the spatial dynamics of annual precipitation over seventy years (1941-2010). The precipitation network is built associating a node to a geographical region, which has a temporal distribution of precipitation, and identifying possible links among nodes through the correlation function. The precipitation network reveals significant spatial variability with barely connected regions, as Eastern China and Japan, and highly connected regions, such as the African Sahel, Eastern Australia and, to a lesser extent, Northern Europe. Sahel and Eastern Australia are remarkably dry regions, where low amounts of rainfall are uniformly distributed on continental scales and small-scale extreme events are rare. As a consequence, the precipitation gradient is low, making these regions well connected on a large spatial scale. On the contrary, the Asiatic South-East is often reached by extreme events such as monsoons, tropical cyclones and heat waves, which can all contribute to reduce the correlation to the short-range scale only. Some patterns emerging between mid-latitude and tropical regions suggest a possible impact of the propagation of planetary waves on precipitation at a global scale. Other links can be qualitatively associated to the atmospheric and oceanic circulation. To analyze the sensitivity of the network to the physical closeness of the nodes, short-term connections are broken. The African Sahel, Eastern Australia and Northern Europe regions again appear as the supernodes of the network, confirming furthermore their long-range connection structure. Almost all North-American and Asian nodes vanish, revealing that extreme events can enhance high precipitation gradients, leading to a systematic absence of long-range patterns.	[Scarsoglio, Stefania] Politecn Torino, Dept Mech & Aerosp Engn, Turin, Italy; [Laio, Francesco; Ridolfi, Luca] Politecn Torino, Dept Environm Land & Infrastruct Engn, Turin, Italy	Polytechnic University of Turin; Polytechnic University of Turin	Scarsoglio, S (corresponding author), Politecn Torino, Dept Mech & Aerosp Engn, Turin, Italy.	stefania.scarsoglio@polito.it	Scarsoglio, Stefania/E-8067-2015; Scarsoglio, Stefania/ABC-4325-2020	Scarsoglio, Stefania/0000-0002-9427-6491; Scarsoglio, Stefania/0000-0002-9427-6491; RIDOLFI, Luca/0000-0003-2947-8641; Laio, Francesco/0000-0003-3931-1482	Italian Ministry of Education, Universities and Research [RBFR12BA3Y]	Italian Ministry of Education, Universities and Research(Ministry of Education, Universities and Research (MIUR))	Funding from the Italian Ministry of Education, Universities and Research (Futuro in Ricerca 2012, Project RBFR12BA3Y) is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2004, EUROPHYS LETT, V65, P581, DOI 10.1209/epl/i2003-10108-1; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Archer DR, 2004, HYDROL EARTH SYST SC, V8, P47, DOI 10.5194/hess-8-47-2004; Barros V, 2012, MANAGING RISKS EXTRE; Becker A, 2013, EARTH SYST SCI DATA, V5, P71, DOI 10.5194/essd-5-71-2013; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Boulanger JP, 2005, CLIM DYNAM, V24, DOI [10.1007/s00382-004-0514-x, DOI 10.1007/S00382-004-0514-X.)]; Bronnimann S, 2007, REV GEOPHYS, V45, DOI 10.1029/2006RG000199; Cano R, 2004, STUD FUZZ SOFT COMP, V146, P309; Chen LL, 2009, BRIT J CANCER, V101, DOI [10.1038/sj.bjc.6605214, DOI 10.1038/SJ.BJC.6605214.)]; Chen W, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005669; Chou C, 2013, NAT GEOSCI, V6, DOI [10.1038/ngeo1744., DOI 10.1038/NGE01744.)]; Cofino AS, 2002, FR ART INT, V77, P695; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Costa LD, 2011, ADV PHYS, V60, P329, DOI 10.1080/00018732.2011.572452; Davis KF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053723; Diaz HF, 2001, INT J CLIMATOL, V21, P1845, DOI 10.1002/joc.631; Donges JF, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/48007; Donges JF, 2009, EUR PHYS J-SPEC TOP, V174, P157, DOI 10.1140/epjst/e2009-01098-2; Donges JF, 2011, EUR PHYS J-SPEC TOP, V84, DOI [10.1140/epjb/e2011-10795-8, DOI 10.1140/EPJB/E2011-10795-8.)]; Fatichi S, 2012, J CLIMATE, V25, P5512, DOI 10.1175/JCLI-D-11-00356.1; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Fritsche M, 2012, J GEODYN, V59-60, DOI [10.1016/j.jog.2011.04.001, DOI 10.1016/J.J0G.2011.04.001.)]; Gessner U, 2013, GLOBAL PLANET CHANGE, V110, P74, DOI 10.1016/j.gloplacha.2012.09.007; Gozolchiani A, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/28005; Hansen J. E., 1984, WASHINGT 600 AM GEOP, V29, P368, DOI [10.1029/GM029., DOI 10.1029/GM029.)]; Heitzig J, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2011-20678-7; Hemming D, 2010, PHILOS T R SOC A, V368, P5117, DOI 10.1098/rsta.2010.0174; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Kennedy J, 2007, WEATHER, V62, DOI [10.1002/wea.119., DOI 10.1002/WEA.119.)]; Kennedy J, 2008, WEATHER, V63, P296, DOI 10.1002/wea.320; Kennedy J, 2012, WEATHER, V67, P212, DOI 10.1002/wea.1945; Kolzsch A, 2007, J ANIM ECOL, V76, P740, DOI 10.1111/j.1365-2656.2007.01246.x; Kripalani RH, 2001, INT J CLIMATOL, V21, P603, DOI 10.1002/joc.625; Malik N, 2012, CLIM DYNAM, V39, DOI [10.1007/s00382-011-1156-4, DOI 10.1007/S00382-011-1156-4.)]; McCabe GJ, 1999, INT J CLIMATOL, V19, P1399, DOI 10.1002/(SICI)1097-0088(19991115)19:13&lt;1399::AID-JOC457&gt;3.0.CO;2-A; Michaelides S, 2009, ATMOS RES, V94, DOI DOI 10.1016/J.ATM0SRES.2009.08.017.); Montroy DL, 1998, J CLIMATE, V11, P1812, DOI 10.1175/1520-0442(1998)011<1812:ONOMTB>2.0.CO;2; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nicholson SE, 1997, INT J CLIMATOL, V17, P117, DOI 10.1002/(SICI)1097-0088(199702)17:2<117::AID-JOC84>3.0.CO;2-O; Palus M, 2011, NONLINEAR PROC GEOPH, V18, P751, DOI 10.5194/npg-18-751-2011; Petoukhov V, 2013, P NATL ACAD SCI USA, V110, P5336, DOI 10.1073/pnas.1222000110; Raicich F, 2003, INT J CLIMATOL, V23, DOI [10.1002/joc.862, DOI 10.1002/J0C.862.)]; Rajagopalan B, 1998, J HYDROL, V210, P51, DOI 10.1016/S0022-1694(98)00184-X; Ryoo JM, 2013, J CLIMATE, DOI [10.1175/JCLID-12-00297.1., DOI 10.1175/JCLID-12-00297.1.)]; Saeed S, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046984; Schneider U, 2013, THEOR APPL CLIMATOL, DOI [10.1007/s00704-013-0860-x, DOI 10.1007/S00704-013-0860-X.)]; Shaman J, 2011, J CLIMATE, V24, P124, DOI 10.1175/2010JCLI3590.1; Simmons AJ, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012442; Steinhaeuser K, 2012, CLIM DYNAM, V39, DOI [10.1007/s00382-011-1135-9, DOI 10.1007/S00382-011-1135-9.)]; Trewartha G., 1980, INTRO CLIMATE, p397?403; Tsonis AA, 2011, CLIM DYNAM, V37, DOI [10.1007/s00382-010-0874-3, DOI 10.1007/S00382-010-0874-3.)]; Tsonis AA, 2008, J CLIMATE, V21, P2990, DOI 10.1175/2007JCLI1907.1; Tsonis AA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.228502; van Oldenborgh GJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023110; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yamasaki K, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.228501; Zhou TJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034881	58	51	52	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71129	10.1371/journal.pone.0071129	http://dx.doi.org/10.1371/journal.pone.0071129			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23976991	gold, Green Published, Green Submitted			2022-12-25	WOS:000323425700019
J	Wan, JP; Zhao, H; Li, T; Li, CZ; Wang, XT; Chen, ZJ				Wan, Ji-peng; Zhao, Han; Li, Tao; Li, Chang-zhong; Wang, Xie-tong; Chen, Zi-Jiang			The Common Variant rs11646213 Is Associated with Preeclampsia in Han Chinese Women	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LATE-ONSET PREECLAMPSIA; T-CADHERIN; ADIPONECTIN LEVELS; IDENTIFIES CDH13; DOWN-REGULATION; FAMILY-HISTORY; BLOOD-PRESSURE; RISK-FACTORS; HYPERTENSION	Background: Preeclampsia, characterized by hypertension and proteinuria, is a multifactorial disease caused by complex interactions between environmental and genetic factors. A recent genome-wide association study of blood pressure reported an association between hypertension and rs11646213. This study evaluated the association between preeclampsia and rs11646213. Methods: A total of 454 cases and 460 controls were recruited to participate in this study. The single nucleotide polymorphism (SNP) rs11646213 was genotyped by polymerase chain reaction (PCR) and direct sequencing. Results: The allele frequency of rs11646213 was significantly different between the preeclampsia and control groups (P = 0.017, OR = 1.36, 95% CI = 1.06-1.76). Differences were particularly significant in the severe preeclampsia subgroup (P = 0.002, OR = 1.54, 95% CI = 1.17-2.03) and the early-onset preeclampsia subgroup (P = 0.004, OR = 1.57, 95% CI = 1.16-2.13). Genotyping analysis showed that the T allele of rs11646213 could confer a risk for preeclampsia, severe preeclampsia and early-onset preeclampsia. Conclusions: Rs11646213 upstream of the CDH13 gene is associated with preeclampsia in Han Chinese women.	[Wan, Ji-peng; Li, Chang-zhong; Wang, Xie-tong] Shandong Univ, Dept Obstet & Gynecol, Prov Hosp, Jinan 250100, Peoples R China; [Zhao, Han; Li, Tao; Chen, Zi-Jiang] Shandong Univ, Ctr Reprod Med, Prov Hosp, Jinan 250100, Peoples R China; [Zhao, Han; Li, Tao; Chen, Zi-Jiang] Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Jinan, Peoples R China; [Zhao, Han; Li, Tao; Chen, Zi-Jiang] Minist Educ, Key Lab Reprod Endocrinol, Jinan, Peoples R China; [Zhao, Han; Li, Tao; Chen, Zi-Jiang] Shandong Prov Key Lab Reprod Med, Jinan, Peoples R China; [Chen, Zi-Jiang] Shanghai Jiao Tong Univ, Ctr Reprod Med, Renji Hosp, Sch Med, Shanghai 200030, Peoples R China; [Chen, Zi-Jiang] Shanghai Key Lab Assisted Reprod & Reprod Genet, Shanghai, Peoples R China	Shandong University; Shandong University; Shanghai Jiao Tong University	Wang, XT (corresponding author), Shandong Univ, Dept Obstet & Gynecol, Prov Hosp, Jinan 250100, Peoples R China.	wangxiet@gmail.com	Yan, Junhao/AAH-8310-2019; Li, Yuan/GXV-1310-2022; Chen, Zi-Jiang/GOE-6119-2022	Chen, Zi-Jiang/0000-0001-6637-6631	National Basic Research Program of China (973 Program) [2011CB944502]; National Natural Science Foundation of China [81170590]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Basic Research Program of China (973 Program) (2011CB944502) and the National Natural Science Foundation of China (81170590). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chung CM, 2011, DIABETES, V60, P2417, DOI 10.2337/db10-1321; D'Anna R, 2006, BJOG-INT J OBSTET GY, V113, P1264, DOI 10.1111/j.1471-0528.2006.01078.x; D'Anna R, 2005, OBSTET GYNECOL, V106, P340, DOI 10.1097/01.AOG.0000168441.79050.03; Denzel MS, 2010, J CLIN INVEST, V120, P4342, DOI 10.1172/JCI43464; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Fava C, 2011, AM J CARDIOL, V108, P1432, DOI 10.1016/j.amjcard.2011.06.068; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Ivanov D, 2001, HISTOCHEM CELL BIOL, V115, P231; James JL, 2010, J PATHOL, V221, P363, DOI 10.1002/path.2719; Jee SH, 2010, AM J HUM GENET, V87, P545, DOI 10.1016/j.ajhg.2010.09.004; Junus K, 2012, MOL HUM REPROD, V18, P146, DOI 10.1093/molehr/gar067; Liang JA, 2010, INT J GYNECOL OBSTET, V110, P93, DOI 10.1016/j.ijgo.2010.03.013; Ling H, 2009, OBESITY, V17, P737, DOI 10.1038/oby.2008.625; Masuyama H, 2010, BJOG-INT J OBSTET GY, V117, P314, DOI 10.1111/j.1471-0528.2009.02453.x; Morgan T, 1999, SEMIN PERINATOL, V23, P14, DOI 10.1016/S0146-0005(99)80056-1; Morisaki H, 2012, HUM MUTAT, V33, P402, DOI 10.1002/humu.21652; Odegard RA, 2000, BRIT J OBSTET GYNAEC, V107, P1410, DOI 10.1111/j.1471-0528.2000.tb11657.x; Org E, 2009, HUM MOL GENET, V18, P2288, DOI 10.1093/hmg/ddp135; Oudejans CBM, 2007, HUM GENET, V120, P607, DOI 10.1007/s00439-006-0259-1; Pfaff D, 2011, J PATHOL, V225, P512, DOI 10.1002/path.2900; Philippova M, 2012, CARDIOVASC RES, V93, P498, DOI 10.1093/cvr/cvs004; Qiu CF, 2003, HYPERTENSION, V41, P408, DOI 10.1161/01.HYP.0000056996.25503.F5; Ramsay JE, 2003, HYPERTENSION, V42, P891, DOI 10.1161/01.HYP.0000095981.92542.F6; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Rigo J, 2006, EUR J OBSTET GYN R B, V128, P148, DOI 10.1016/j.ejogrb.2006.02.019; Ros HS, 2000, AM J MED GENET, V91, P256; Thornton JG, 1999, BRIT J OBSTET GYNAEC, V106, P570, DOI 10.1111/j.1471-0528.1999.tb08326.x; Tie WW, 2009, REPROD SCI, V16, P676, DOI 10.1177/1933719109334258; Verlohren S, 2009, HYPERTENSION, V54, P439, DOI 10.1161/HYPERTENSIONAHA.108.120253; Wu Y, 2010, HUM MOL GENET, V19, P4955, DOI 10.1093/hmg/ddq423	31	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71202	10.1371/journal.pone.0071202	http://dx.doi.org/10.1371/journal.pone.0071202			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23976997	Green Published, gold, Green Submitted			2022-12-25	WOS:000323425700027
J	Isham, EA; Geng, JJ				Isham, Eve A.; Geng, Joy J.			Looking Time Predicts Choice but Not Aesthetic Value	PLOS ONE			English	Article							VISUAL FIXATIONS; DECISION-MAKING; PREFERENCE; MODEL; ACT	Although visual fixations are commonly used to index stimulus-driven or internally-determined preference, recent evidence suggests that visual fixations can also be a source of decisional bias that moves selection toward the fixated object. These contrasting results raise the question of whether visual fixations always index comparative processes during choice-based tasks, or whether they might better reflect internal preferences when the decision does not carry any economic or corporeal consequences. In two experiments, participants chose which of two objects were more aesthetically pleasing (Exp.1) or appeared more organic (Exp.2), and provided independent aesthetic ratings of the stimuli. Our results demonstrated that fixation parameters were a better index of choice in both decisional domains than of aesthetic preference. The data support models in which visual fixations are specifically related to the evolution of decision processes even when the decision has no tangible consequences.	[Isham, Eve A.; Geng, Joy J.] Univ Calif Davis, Ctr Mind & Brain, Dept Psychol, Davis, CA 95616 USA	University of California System; University of California Davis	Geng, JJ (corresponding author), Univ Calif Davis, Ctr Mind & Brain, Dept Psychol, Davis, CA 95616 USA.	jgeng@ucdavis.edu	Geng, Joy/J-6225-2019		Hellman Foundation; NSF [BCS-1230377-0]	Hellman Foundation; NSF(National Science Foundation (NSF))	This project was supported by the Hellman Foundation and NSF grant (BCS-1230377-0) awarded to JG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks WP, 2009, PSYCHOL SCI, V20, P17, DOI 10.1111/j.1467-9280.2008.02254.x; Buswell Guy Thomas, 1935, PEOPLE LOOK PICTURES; DOBSON V, 1983, BEHAV BRAIN RES, V10, P25, DOI 10.1016/0166-4328(83)90147-X; Glaholt MG, 2009, PSYCHNOLOGY J, V7, P141; Heidenreich SM, 2011, EMPIR STUD ARTS, V29, P51, DOI 10.2190/EM.29.1.d; Holmes T, 2012, I-PERCEPTION, V3, P426, DOI 10.1068/i0448aap; Isham EA, 2010, PSYCHOL AESTHET CREA, V4, P235, DOI 10.1037/a0019308; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Izuma K, 2010, P NATL ACAD SCI USA, V107, P22014, DOI 10.1073/pnas.1011879108; Krajbich I, 2011, P NATL ACAD SCI USA, V108, P13852, DOI 10.1073/pnas.1101328108; Krajbich I, 2010, NAT NEUROSCI, V13, P1292, DOI 10.1038/nn.2635; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; Locher P. J., 2006, PSYCHOL SCI, V48, P106, DOI DOI 10.1198/016214504000000683; Mather M, 2000, PSYCHOL SCI, V11, P132, DOI 10.1111/1467-9280.00228; Niwa M, 2008, J NEUROSCI, V28, P4435, DOI 10.1523/JNEUROSCI.5564-07.2008; Quiroga RQ, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00098; Ramachandran V.S., 1999, J CONSCIOUSNESS STUD, V6, P15, DOI [10.1179/174327908X392906, DOI 10.1179/174327908X392906]; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; SAMUELS CA, 1994, PERCEPTION, V23, P823, DOI 10.1068/p230823; Sharot T, 2012, PSYCHOL SCI, V23, P1123, DOI 10.1177/0956797612438733; Shimojo S, 2003, NAT NEUROSCI, V6, P1317, DOI 10.1038/nn1150; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; TELLER DY, 1979, INFANT BEHAV DEV, V2, P135, DOI 10.1016/S0163-6383(79)80016-8; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	25	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e71698	10.1371/journal.pone.0071698	http://dx.doi.org/10.1371/journal.pone.0071698			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	207BA	23977115	Green Published, Green Submitted, gold			2022-12-25	WOS:000323570200045
J	Coe, BP; Thu, KL; Aviel-Ronen, S; Vucic, EA; Gazdar, AF; Lam, S; Tsao, MS; Lam, WL				Coe, Bradley P.; Thu, Kelsie L.; Aviel-Ronen, Sarit; Vucic, Emily A.; Gazdar, Adi F.; Lam, Stephen; Tsao, Ming-Sound; Lam, Wan L.			Genomic Deregulation of the E2F/Rb Pathway Leads to Activation of the Oncogene EZH2 in Small Cell Lung Cancer	PLOS ONE			English	Article							POLYCOMB GROUP PROTEIN; DNA METHYLATION; GENE-EXPRESSION; HEPATOCELLULAR-CARCINOMA; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR; MICROARRAY ANALYSIS; DRIVER MUTATIONS; EPITHELIAL-CELLS; BREAST-CANCER	Small cell lung cancer (SCLC) is a highly aggressive lung neoplasm with extremely poor clinical outcomes and no approved targeted treatments. To elucidate the mechanisms responsible for driving the SCLC phenotype in hopes of revealing novel therapeutic targets, we studied copy number and methylation profiles of SCLC. We found disruption of the E2F/Rb pathway was a prominent feature deregulated in 96% of the SCLC samples investigated and was strongly associated with increased expression of EZH2, an oncogene and core member of the polycomb repressive complex 2 (PRC2). Through its catalytic role in the PRC2 complex, EZH2 normally functions to epigenetically silence genes during development, however, it aberrantly silences genes in human cancers. We provide evidence to support that EZH2 is functionally active in SCLC tumours, exerts pro-tumourigenic functions in vitro, and is associated with aberrant methylation profiles of PRC2 target genes indicative of a "stem-cell like'' hypermethylator profile in SCLC tumours. Furthermore, lentiviral-mediated knockdown of EZH2 demonstrated a significant reduction in the growth of SCLC cell lines, suggesting EZH2 has a key role in driving SCLC biology. In conclusion, our data confirm the role of EZH2 as a critical oncogene in SCLC, and lend support to the prioritization of EZH2 as a potential therapeutic target in clinical disease.	[Coe, Bradley P.; Thu, Kelsie L.; Vucic, Emily A.; Lam, Stephen; Lam, Wan L.] BC Canc Res Ctr, Integrat Oncol Dept, Vancouver, BC, Canada; [Aviel-Ronen, Sarit] Chaim Sheba Med Ctr, Dept Pathol, IL-52621 Tel Hashomer, Israel; [Gazdar, Adi F.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; [Gazdar, Adi F.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Tsao, Ming-Sound] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Tsao, Ming-Sound] Princess Margaret Hosp Univ Hlth Network, Dept Pathol, Toronto, ON, Canada	British Columbia Cancer Agency; Chaim Sheba Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Thu, KL (corresponding author), BC Canc Res Ctr, Integrat Oncol Dept, Vancouver, BC, Canada.	kthu@bccrc.ca	Tsao, Ming Sound/AFQ-7332-2022; Coe, Bradley/A-2878-2009; Tsao, Ming-Sound/M-3503-2017	Tsao, Ming Sound/0000-0002-9160-5405; Coe, Bradley/0000-0001-8471-4016; Thu, Kelsie/0000-0001-9262-7238; Vucic, Emily/0000-0002-2728-8708	Canadian Institutes for Health Research (CIHR); NATIONAL CANCER INSTITUTE [P50CA070907] Funding Source: NIH RePORTER	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Canadian Institutes for Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arisan S, 2005, UROL INT, V75, P252, DOI 10.1159/000087804; Arriola E, 2008, CLIN TRANSL ONCOL, V10, P189, DOI 10.1007/s12094-008-0181-1; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI 10.2217/EPI.09.14; Bondzi C, 2000, CELL GROWTH DIFFER, V11, P305; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Breuer RHJ, 2004, NEOPLASIA, V6, P736, DOI 10.1593/neo.04160; Bryant RJ, 2007, PROSTATE, V67, P547, DOI 10.1002/pros.20550; Byers LA, 2012, CANCER DISCOV, V2, P798, DOI 10.1158/2159-8290.CD-12-0112; Caputi M, 2005, J CELL PHYSIOL, V205, P319, DOI 10.1002/jcp.20424; Chari R, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-32; Chen YC, 2007, HEPATOLOGY, V46, P200, DOI 10.1002/hep.21668; Coe BP, 2006, BRIT J CANCER, V94, P1927, DOI 10.1038/sj.bjc.6603167; Coe BP, 2005, GENES CHROM IN PRESS; Cooper CS, 2006, LUNG CANCER, V54, P155, DOI 10.1016/j.lungcan.2006.07.005; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Du W, 2006, ONCOGENE, V25, P5190, DOI 10.1038/sj.onc.1209651; Easwaran H, 2012, GENOME RES, V22, P837, DOI 10.1101/gr.131169.111; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Fang F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001875; Grimaud C, 2006, CHROMOSOME RES, V14, P363, DOI 10.1007/s10577-006-1069-y; Hinz S, 2007, J CANC RES CLIN ONCO; Holm K, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2590; Hu S, 2010, CANCER BIOL THER, V10, P788, DOI 10.4161/cbt.10.8.12913; Jones MH, 2004, LANCET, V363, P775, DOI 10.1016/S0140-6736(04)15693-6; Kalari S, 2012, ONCOGENE; Kamminga LM, 2006, BLOOD, V107, P2170, DOI 10.1182/blood-2005-09-3585; Karanikolas BDW, 2010, PROSTATE, V70, P675, DOI 10.1002/pros.21112; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lally BE, 2007, ONCOLOGIST, V12, P1096, DOI 10.1634/theoncologist.12-9-1096; Lee J, 2008, CLIN CANCER RES, V14, P82, DOI 10.1158/1078-0432.CCR-07-0612; LEES JA, 1993, MOL CELL BIOL, V13, P7813, DOI 10.1128/MCB.13.12.7813; Lockwood WW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000315; Lomazzi M, 2002, NAT GENET, V31, P190, DOI 10.1038/ng891; Lonergan KM, 2006, AM J RESP CELL MOL, V35, P651, DOI 10.1165/rcmb.2006-0056OC; Ma PC, 2007, BRIT J CANCER, V97, P368, DOI 10.1038/sj.bjc.6603884; MORI N, 1990, ONCOGENE, V5, P1713; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Rossi A, 2004, CRIT REV ONCOL HEMAT, V51, P45, DOI 10.1016/j.critrevonc.2004.02.003; Rostad H, 2004, EUR J CARDIO-THORAC, V26, P782, DOI 10.1016/j.ejcts.2004.06.011; Rozengurt Enrique, 1999, Current Opinion in Oncology, V11, P116; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Sasaki M, 2008, LAB INVEST, V88, P873, DOI 10.1038/labinvest.2008.52; Sattler M, 2003, SEMIN ONCOL, V30, P57, DOI 10.1053/sonc.2003.50019; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Shan L, 2007, AM J PHYSIOL-LUNG C, V292, pL500, DOI 10.1152/ajplung.00052.2006; Simon GR, 2003, CHEST, V123, p259S, DOI 10.1378/chest.123.1_suppl.259S; Socinski MA, 2007, J CLIN ONCOL, V25, P4137, DOI 10.1200/JCO.2007.11.5303; Thu KL, 2011, J THORAC ONCOL, V6, P1521, DOI 10.1097/JTO.0b013e3182289479; Vestergaard J, 2006, LUNG CANCER, V52, P281, DOI 10.1016/j.lungcan.2005.12.014; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Walker Suzanne, 2003, Clin J Oncol Nurs, V7, P563, DOI 10.1188/03.CJON.563-568; Weinmann M, 2003, LUNG CANCER, V40, P1, DOI 10.1016/S0169-5002(02)00524-X; XU GF, 1995, P NATL ACAD SCI USA, V92, P1357, DOI 10.1073/pnas.92.5.1357; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498	60	64	69	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71670	10.1371/journal.pone.0071670	http://dx.doi.org/10.1371/journal.pone.0071670			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967231	gold, Green Submitted, Green Published			2022-12-25	WOS:000323378000064
J	Angeloni, NL; Bond, CW; McVary, KT; Podlasek, CA				Angeloni, Nicholas L.; Bond, Christopher W.; McVary, Kevin T.; Podlasek, Carol A.			Sonic Hedgehog Protein Is Decreased and Penile Morphology Is Altered in Prostatectomy and Diabetic Patients	PLOS ONE			English	Article							CAVERNOUS NERVE INJURY; ERECTILE DYSFUNCTION; SMOOTH-MUSCLE; SILDENAFIL; MODEL; RAT; REGENERATION; APOPTOSIS; RESECTION	Erectile dysfunction (ED) is a debilitating medical condition and current treatments are ineffective in patients with cavernous nerve (CN) injury, due to penile remodeling and apoptosis. A critical regulator of penile smooth muscle and apoptosis is the secreted protein sonic hedgehog (SHH). SHH protein is decreased in rat prostatectomy and diabetic ED models, SHH inhibition in the penis induces apoptosis and ED, and SHH treatment at the time of CN injury suppresses smooth muscle apoptosis and promotes regeneration of erectile function. Thus SHH treatment has significant translational potential as an ED therapy if similar mechanisms underlie ED development in patients. In this study we quantify SHH protein and morphological changes in corpora cavernosal tissue of control, prostatectomy and diabetic patients and hypothesize that decreased SHH protein is an underlying cause of ED development in prostatectomy and diabetic patients. Our results show significantly decreased SHH protein in prostatectomy and diabetic penis. Morphological remodelling of the penis, including significantly increased apoptotic index and decreased smooth muscle/collagen ratio, accompanies declining SHH. SHH signaling is active in human penis and is altered in a parallel manner to previous observations in the rat. These results suggest that SHH has significant potential to be developed as an ED therapy in prostatectomy and diabetic patients. The increased apoptotic index long after initial injury is suggestive of ongoing remodeling that may be clinically manipulatable.	[Angeloni, Nicholas L.; Bond, Christopher W.; Podlasek, Carol A.] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA; [McVary, Kevin T.] So Illinois Univ, Sch Med, Div Urol, Springfield, IL USA	Northwestern University; Feinberg School of Medicine; Southern Illinois University System; Southern Illinois University	Podlasek, CA (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA.	cap325@northwestern.edu		Angeloni, Nicholas/0000-0002-0840-0223	National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [DK079184]; Southern Illinois University Urology Endowment Fund; Havana Day Dreamers Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079184] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Southern Illinois University Urology Endowment Fund; Havana Day Dreamers Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases, Grant number: DK079184; the Southern Illinois University Urology Endowment Fund; and the Havana Day Dreamers Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeloni N, 2013, J SEX MED, V10, P1240, DOI 10.1111/j.1743-6109.2012.02930.x; Angeloni NL, 2011, BIOMATERIALS, V32, P1091, DOI 10.1016/j.biomaterials.2010.10.003; Behr-Roussel D, 2005, EUR UROL, V47, P87, DOI 10.1016/j.eururo.2004.09.005; Bond CW, 2013, J SEX MED, V10, P730, DOI 10.1111/jsm.12030; Bond CW, 2011, J SEX MED, V8, P78, DOI 10.1111/j.1743-6109.2010.02001.x; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; Gefen A, 2000, J BIOMECH, V33, P1739, DOI 10.1016/S0021-9290(00)00122-6; Heruti R, 2004, J SEX MED, V1, P284, DOI 10.1111/j.1743-6109.04041.x; Iacono F, 2008, UROL INT, V80, P249, DOI 10.1159/000127335; Kendirci Muammer, 2004, Clin Prostate Cancer, V3, P87, DOI 10.3816/CGC.2004.n.017; Kovanecz I, 2008, INT J IMPOT RES, V20, P202, DOI 10.1038/sj.ijir.3901612; Lee CH, 2011, J SEX MED, V8, P1330, DOI 10.1111/j.1743-6109.2011.02228.x; Lysiak JJ, 2008, J UROLOGY, V179, P779, DOI 10.1016/j.juro.2007.09.021; Mulhall JP, 2008, J SEX MED, V5, P1126, DOI 10.1111/j.1743-6109.2008.00794.x; Mullerad M, 2006, J SEX MED, V3, P77, DOI 10.1111/j.1743-6109.2005.00158.x; Nangle MR, 2007, EXP NEUROL, V207, P30, DOI 10.1016/j.expneurol.2007.05.011; Perimenis P, 2002, EUR UROL, V41, P387, DOI 10.1016/S0302-2838(02)00032-5; Podlasek CA, 2003, BIOL REPROD, V68, P423, DOI 10.1095/biolreprod.102.006643; Podlasek CA, 2001, J UROLOGY, V166, P746, DOI 10.1016/S0022-5347(05)66054-5; Podlasek CA, 2003, BIOL REPROD, V69, P816, DOI 10.1095/biolreprod.102.013508; Podlasek CA, 2007, BIOL REPROD, V76, P19, DOI 10.1095/biolreprod.106.053926; Schwartz EJ, 2004, J UROLOGY, V171, P771, DOI 10.1097/01.ju.0000106970.97082.61; Sheehan DC, 1980, THEORY PRACTICE HIST, P141; Steers William D, 2002, Rev Urol, V4 Suppl 3, pS17; User HM, 2003, J UROLOGY, V169, P1175, DOI 10.1097/01.ju.0000048974.47461.50	26	17	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e70985	10.1371/journal.pone.0070985	http://dx.doi.org/10.1371/journal.pone.0070985			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967143	Green Published, Green Submitted, gold			2022-12-25	WOS:000323221500049
J	Dezerald, O; Leroy, C; Corbara, B; Carrias, JF; Pelozuelo, L; Dejean, A; Cereghino, R				Dezerald, Olivier; Leroy, Celine; Corbara, Bruno; Carrias, Jean-Francois; Pelozuelo, Laurent; Dejean, Alain; Cereghino, Regis			Food-Web Structure in Relation to Environmental Gradients and Predator-Prey Ratios in Tank-Bromeliad Ecosystems	PLOS ONE			English	Article							COMMUNITY STRUCTURE; PHYTOTELM COMMUNITIES; FUNCTIONAL DIVERSITY; ANTS MEDIATE; LAND-USE; CONNECTANCE; FOREST; SIZE; METACOMMUNITIES; EVOLUTIONARY	Little is known of how linkage patterns between species change along environmental gradients. The small, spatially discrete food webs inhabiting tank-bromeliads provide an excellent opportunity to analyse patterns of community diversity and food-web topology (connectance, linkage density, nestedness) in relation to key environmental variables (habitat size, detrital resource, incident radiation) and predators: prey ratios. We sampled 365 bromeliads in a wide range of understorey environments in French Guiana and used gut contents of invertebrates to draw the corresponding 365 connectance webs. At the bromeliad scale, habitat size (water volume) determined the number of species that constitute food-web nodes, the proportion of predators, and food-web topology. The number of species as well as the proportion of predators within bromeliads declined from open to forested habitats, where the volume of water collected by bromeliads was generally lower because of rainfall interception by the canopy. A core group of microorganisms and generalist detritivores remained relatively constant across environments. This suggests that (i) a highly-connected core ensures food-web stability and key ecosystem functions across environments, and (ii) larger deviations in food-web structures can be expected following disturbance if detritivores share traits that determine responses to environmental changes. While linkage density and nestedness were lower in bromeliads in the forest than in open areas, experiments are needed to confirm a trend for lower food-web stability in the understorey of primary forests.	[Dezerald, Olivier; Dejean, Alain] CNRS, EcoFoG, Ecol Forets Guyane, UMR 8172, Kourou, France; [Leroy, Celine] IRD, AMAP, UMR 123, Montpellier, France; [Corbara, Bruno; Carrias, Jean-Francois] Univ Clermont Ferrand, CNRS, LMGE, UMR 6023, Aubiere, France; [Pelozuelo, Laurent; Dejean, Alain; Cereghino, Regis] Univ Toulouse 3, Lab Ecol Fonct & Environm, EcoLab, F-31062 Toulouse, France; [Pelozuelo, Laurent; Cereghino, Regis] CNRS, EcoLab, Lab Ecol Fonct & Environm, UMR 5245, Toulouse, France	AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse	Dezerald, O (corresponding author), CNRS, EcoFoG, Ecol Forets Guyane, UMR 8172, Kourou, France.	olivier.dezerald@gmail.com	Leroy, Celine/I-4857-2016; Carrias, Jean-François/AAT-2738-2021	Leroy, Celine/0000-0003-4859-8040; Carrias, Jean-François/0000-0002-6201-1544; CORBARA, Bruno/0000-0003-4232-8234; Cereghino, Regis/0000-0003-3981-3159; Dejean, Alain/0000-0002-3561-2248	Programme Amazonie II of the French Centre National de la Recherche Scientifique [2ID]; European Community; Agence Nationale de la Recherche (CEBA) [ANR-10-LABX-0025]; CNRS; FSE (Fond Social Europeen)	Programme Amazonie II of the French Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); European Community(European Commission); Agence Nationale de la Recherche (CEBA)(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); FSE (Fond Social Europeen)(European Social Fund (ESF))	Financial support for this study was provided by the Programme Amazonie II of the French Centre National de la Recherche Scientifique (Project 2ID), and the Programme Convergence 2007-2013 (Region Guyane) from the European Community (Project DEGA). This work has benefited from an "Investissement d'Avenir" grant managed by Agence Nationale de la Recherche (CEBA, ref. ANR-10-LABX-0025). OD's financial support was provided by a PhD fellowship from the CNRS and the FSE (Fond Social Europeen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbruster P, 2002, OIKOS, V96, P225, DOI 10.1034/j.1600-0706.2002.960204.x; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2009, SCIENCE, V325, P416, DOI 10.1126/science.1170749; BENZING DH, 2000, BROMELIACEAE PROFILE; Bongers F, 2001, DYNAMICS PLANT ANIMA; Brouard O, 2012, FRESHWATER BIOL, V57, P815, DOI 10.1111/j.1365-2427.2012.02749.x; Brouard O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020129; Carrias JF, 2012, BASIC APPL ECOL, V13, P698, DOI 10.1016/j.baae.2012.10.002; Carrias JF, 2001, J TROP ECOL, V17, P611, DOI 10.1017/S0266467401001456; Cereghino R, 2011, FUNCT ECOL, V25, P954, DOI 10.1111/j.1365-2435.2011.01863.x; Cereghino R, 2010, ECOLOGY, V91, P1549, DOI 10.1890/09-1534.1; Chase JM, 2009, ECOL LETT, V12, P1210, DOI 10.1111/j.1461-0248.2009.01362.x; Compin A, 2007, LANDSCAPE ECOL, V22, P1215, DOI 10.1007/s10980-007-9101-y; Declerck S, 2006, BIOL CONSERV, V131, P523, DOI 10.1016/j.biocon.2006.02.024; Drakare S, 2006, ECOL LETT, V9, P215, DOI 10.1111/j.1461-0248.2005.00848.x; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Fontaine C, 2011, ECOL LETT, V14, P1170, DOI 10.1111/j.1461-0248.2011.01688.x; Fontaine C, 2009, P R SOC B, V276, P3027, DOI 10.1098/rspb.2009.0635; Fox JW, 2006, OIKOS, V115, P97; Frazer G.W., 1999, GAP LIGHT ANAL GLA 2, DOI DOI 10.1038/ismej.2015.171; Gilbert AJ, 2009, ECOL INDIC, V9, P72, DOI 10.1016/j.ecolind.2008.01.010; Givnish TJ, 2011, AM J BOT, V98, P872, DOI 10.3732/ajb.1000059; Jabiol J, 2009, FOREST ECOL MANAG, V257, P351, DOI 10.1016/j.foreco.2008.09.010; Jocque M, 2010, HYDROBIOLOGIA, V649, P293, DOI 10.1007/s10750-010-0272-1; Kondoh M, 2003, SCIENCE, V299, P1388, DOI 10.1126/science.1079154; Leroy C, 2009, NEW PHYTOL, V183, P1124, DOI 10.1111/j.1469-8137.2009.02891.x; LOUNIBOS LP, 1993, OIKOS, V66, P114, DOI 10.2307/3545203; Marino NAC, 2011, HYDROBIOLOGIA, V678, P191, DOI 10.1007/s10750-011-0848-4; Morin P., 1999, COMMUNITY ECOL; Oertli B, 2002, BIOL CONSERV, V104, P59, DOI 10.1016/S0006-3207(01)00154-9; Paradise CJ, 2004, J N AM BENTHOL SOC, V23, P793, DOI 10.1899/0887-3593(2004)023<0793:ROWALL>2.0.CO;2; Post DM, 2002, TRENDS ECOL EVOL, V17, P269, DOI 10.1016/S0169-5347(02)02455-2; R Development Core Team, 2010, R LANG ENV STAT COMP; Rall BC, 2008, OIKOS, V117, P202, DOI 10.1111/j.2007.0030-1299.15491.x; Richardson BA, 2000, ECOL ENTOMOL, V25, P348, DOI 10.1046/j.1365-2311.2000.00255.x; Rodriguez-Girones MA, 2006, J BIOGEOGR, V33, P924, DOI 10.1111/j.1365-2699.2006.01444.x; Romero GQ, 2010, J ANIM ECOL, V79, P1122, DOI 10.1111/j.1365-2656.2010.01716.x; Ryberg WA, 2012, OIKOS, V121, P1995, DOI 10.1111/j.1600-0706.2012.19620.x; Srivastava DS, 2009, ECOL LETT, V12, P1016, DOI 10.1111/j.1461-0248.2009.01357.x; Strong D.R., 1984, INSECTS PLANTS COMMU; Takimoto G, 2012, ECOL RES, P1; TOWNSEND CR, 1989, J N AM BENTHOL SOC, V8, P36, DOI 10.2307/1467400; Tylianakis JM, 2010, BIOL CONSERV, V143, P2270, DOI 10.1016/j.biocon.2009.12.004; Valladares G, 2012, OIKOS, V121, P299, DOI 10.1111/j.1600-0706.2011.19671.x; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Vondracek B, 2005, ENVIRON MANAGE, V36, P775, DOI 10.1007/s00267-005-0039-z	46	41	42	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71735	10.1371/journal.pone.0071735	http://dx.doi.org/10.1371/journal.pone.0071735			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23977128	Green Published, gold, Green Submitted			2022-12-25	WOS:000323221500100
J	Li, YY; Fu, S; Wang, XP; Wang, HY; Zeng, MS; Shao, JY				Li, Yang-Yang; Fu, Sha; Wang, Xiao-Pai; Wang, Hai-Yun; Zeng, Mu-Sheng; Shao, Jian-Yong			Down-Regulation of C9orf86 in Human Breast Cancer Cells Inhibits Cell Proliferation, Invasion and Tumor Growth and Correlates with Survival of Breast Cancer Patients	PLOS ONE			English	Article							RAS SUPERFAMILY; CYCLE ARREST; RHOC GENE; EXPRESSION; GTPASE; METASTASIS; P53; OVEREXPRESSION; IDENTIFICATION; STABILIZATION	C9orf86 which is a novel subfamily within the Ras superfamily of GTPases, is overexpressed in the majority of primary breast tumors. Few functional studies have focused on the C9orf86 protein; therefore, in this study, we explored the role of C9orf86 in breast carcinogenesis. In our study, we found that silencing of C9orf86 by siRNA in MCF-7 and SK-BR-3 cells resulted in suppressed cell proliferation as well as in vitro cell invasion capabilities. Moreover, knockdown of C9orf86 inhibited tumor growth in nude mice. Cell cycle and apoptotic assays showed that the anti-proliferative effect of C9orf86-siRNA was mediated by arresting cells in the G1 phase and promoting apoptosis. In addition, we found that patients with high levels of C9orf86 expression showed a significant trend towards worse survival compared to patients with low C9orf86 expression (P = 0.002). These results provide evidence that C9orf86 represents a novel and clinically useful biomarker for BC patients and plays an important role during the progression of BC.	[Li, Yang-Yang; Fu, Sha; Wang, Xiao-Pai; Wang, Hai-Yun; Zeng, Mu-Sheng; Shao, Jian-Yong] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China; [Li, Yang-Yang; Fu, Sha; Wang, Xiao-Pai; Wang, Hai-Yun; Shao, Jian-Yong] Sun Yat Sen Univ, Ctr Canc, Dept Mol Diagnost, Guangzhou 510275, Guangdong, Peoples R China; [Zeng, Mu-Sheng; Shao, Jian-Yong] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Shao, JY (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China.	shaojy@sysucc.org.cn			National High Technology Research and Development Program of China (863 Program) [20060102A4002]; State Key Laboratory Grant (985 Project II) from Ministry of Science and Technology of P.R. China	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); State Key Laboratory Grant (985 Project II) from Ministry of Science and Technology of P.R. China	This work was supported in part by the National High Technology Research and Development Program of China (863 Program) (No. 20060102A4002), and State Key Laboratory Grant (985 Project II) from Ministry of Science and Technology of P.R. China. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen J, 2010, RADIAT PROT DOSIM, V142, P1, DOI 10.1093/rpd/ncq205; Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Day CP, 2006, CANCER GENE THER, V13, P706, DOI 10.1038/sj.cgt.7700945; Ding QQ, 2007, CANCER RES, V67, P4564, DOI 10.1158/0008-5472.CAN-06-1788; Gallagher S, 2005, CELL CYCLE, V4, P465, DOI 10.4161/cc.4.3.1526; Grady WM, 2002, ANNU REV GENOM HUM G, V3, P101, DOI 10.1146/annurev.genom.3.022502.103043; Hendrix A, 2010, JNCI-J NATL CANCER I, V102, P866, DOI 10.1093/jnci/djq153; Jaffee EM, 2002, CANCER CELL, V2, P25, DOI 10.1016/S1535-6108(02)00093-4; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kamai T, 2003, CLIN CANCER RES, V9, P2632; Korgaonkar C, 2002, MOL CELL BIOL, V22, P196, DOI 10.1128/MCB.22.1.196-206.2002; Kuo HP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000590; Lindstrom MS, 2001, ONCOGENE, V20, P2171, DOI 10.1038/sj.onc.1204303; Ma DZ, 2010, J BIOL CHEM, V285, P8621, DOI 10.1074/jbc.M109.092353; Mazieres J, 2004, CLIN CANCER RES, V10, P2742, DOI 10.1158/1078-0432.CCR-03-0149; Melo SA, 2009, NAT GENET, V41, P365, DOI 10.1038/ng.317; Mitsuuchi Y, 2002, AM J MED GENET, V115, P183, DOI 10.1002/ajmg.10692; Montalbano J, 2007, J BIOL CHEM, V282, P37640, DOI 10.1074/jbc.M704760200; Montalbano J, 2009, J BIOL CHEM, V284, P18129, DOI 10.1074/jbc.M109.009597; Rincon-Arano H, 2003, CANCER, V97, P575, DOI 10.1002/cncr.11093; Shikada Y, 2003, CLIN CANCER RES, V9, P5282; Simpson KJ, 2004, CANCER RES, V64, P8694, DOI 10.1158/0008-5472.CAN-04-2247; Singletary SE, 2003, SURG CLIN N AM, V83, P803, DOI 10.1016/S0039-6109(03)00034-3; Suwa H, 1998, BRIT J CANCER, V77, P147, DOI 10.1038/bjc.1998.23; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tompkins V, 2006, CELL CYCLE, V5, P641; van Golen KL, 2000, CANCER RES, V60, P5832; Vestey SB, 2004, BREAST CANCER RES, V6, pR571, DOI 10.1186/bcr912; Wang JS, 2008, MOL CANCER RES, V6, P372, DOI 10.1158/1541-7786.MCR-07-0162; Wang W, 2003, WORLD J GASTROENTERO, V9, P1950, DOI 10.3748/wjg.v9.i9.1950; Weber HO, 2002, ONCOGENE, V21, P3207, DOI 10.1038/sj.onc.1205429; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660	34	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71764	10.1371/journal.pone.0071764	http://dx.doi.org/10.1371/journal.pone.0071764			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23977139	Green Submitted, Green Published, gold			2022-12-25	WOS:000323221500103
J	Kuo, YC; Li, YSJ; Zhou, J; Shih, YRV; Miller, M; Broide, D; Lee, OKS; Chien, S				Kuo, Yi-Chun; Li, Yi-Shuan Julie; Zhou, Jing; Shih, Yu-Ru Vernon; Miller, Marina; Broide, David; Lee, Oscar Kuang-Sheng; Chien, Shu			Human Mesenchymal Stem Cells Suppress the Stretch-Induced Inflammatory miR-155 and Cytokines in Bronchial Epithelial Cells	PLOS ONE			English	Article							ACUTE LUNG INJURY; CYCLIC STRETCH; ASTHMA MODEL; TRANSCRIPTION FACTORS; AIRWAY INFLAMMATION; MECHANICAL STRAIN; GENE-EXPRESSION; II CELLS; MARROW; MICRORNAS	Current research in pulmonary pathology has focused on inflammatory reactions initiated by immunological responses to allergens and irritants. In addition to these biochemical stimuli, physical forces also play an important role in regulating the structure, function, and metabolism of the lung. Hyperstretch of lung tissues can contribute to the inflammatory responses in asthma, but the mechanisms of mechanically induced inflammation in the lung remain unclear. Our results demonstrate that excessive stretch increased the secretion of inflammatory cytokines by human bronchial epithelial cells (hBECs), including IL-8. This increase of IL-8 secretion was due to an elevated microRNA-155 (miR-155) expression, which caused the suppression of Src homology 2 domain-containing inositol 5-phosphatase 1 (SHIP1) production and the subsequent activation of JNK signaling. In vivo studies in our asthmatic mouse model also showed such changes in miR-155, IL-8, and SHIP1 expressions that reflect inflammatory responses. Co-culture with human mesenchymal stem cells (hMSCs) reversed the stretch-induced hBEC inflammatory responses as a result of IL-10 secretion by hMSCs to down-regulate miR-155 expression in hBECs. In summary, we have demonstrated that mechanical stretch modulates the homeostasis of the hBEC secretome involving miR-155 and that hMSCs can be used as a potential therapeutic approach to reverse bronchial epithelial inflammation in asthma.	[Kuo, Yi-Chun; Shih, Yu-Ru Vernon; Lee, Oscar Kuang-Sheng] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Kuo, Yi-Chun; Li, Yi-Shuan Julie; Zhou, Jing; Chien, Shu] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Kuo, Yi-Chun; Li, Yi-Shuan Julie; Zhou, Jing; Chien, Shu] Univ Calif San Diego, Inst Engn Med, La Jolla, CA 92093 USA; [Miller, Marina; Broide, David] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Lee, Oscar Kuang-Sheng] Taipei Vet Gen Hosp, Dept Orthopaed & Traumatol, Taipei, Taiwan; [Lee, Oscar Kuang-Sheng] Natl Yang Ming Univ, Stem Cell Res Ctr, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Lee, OKS (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan.	kslee@vghtpe.gov.tw; shuchien@ucsd.edu		Zhou, Jing/0000-0002-2211-4901; Broide, David/0000-0001-8405-9090	UST-UCSD International Center of Excellence in Advanced Bio-engineering; Taiwan National Science Council I-RiCE Program [NSC100-2911-I-009-101]; National Science Council, Taiwan [NSC100-2120-M-010-001, NSC 101-2911-I-010-503]; NIH [HL106579, HL108735, AI 38425, AI 70535, AI 72115]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106579, R01HL108735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070535, R01AI038425, R01AI072115, R37AI038425] Funding Source: NIH RePORTER	UST-UCSD International Center of Excellence in Advanced Bio-engineering; Taiwan National Science Council I-RiCE Program; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the UST-UCSD International Center of Excellence in Advanced Bio-engineering sponsored by the Taiwan National Science Council I-RiCE Program under Grant Number: NSC100-2911-I-009-101. The authors also acknowledge financial support from the National Science Council, Taiwan (NSC100-2120-M-010-001, NSC 101-2911-I-010-503). This study is, in part, supported by NIH funding (HL106579, HL108735, AI 38425, AI 70535, and AI 72115). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi R, 2008, DIABETES, V57, P1759, DOI 10.2337/db08-0180; Al-Khaldi A, 2003, GENE THER, V10, P621, DOI 10.1038/sj.gt.3301934; Ariel D, 2012, CURR OPIN ALLERGY CL, V12, P49, DOI 10.1097/ACI.0b013e32834ecb7f; Bai YY, 2011, EXP MOL PATHOL, V91, P471, DOI 10.1016/j.yexmp.2011.04.016; Bhattacharyya S, 2011, J BIOL CHEM, V286, P11604, DOI 10.1074/jbc.M110.198390; Bonfield TL, 2010, AM J PHYSIOL-LUNG C, V299, pL760, DOI 10.1152/ajplung.00182.2009; Caruso P, 2010, ARTERIOSCL THROM VAS, V30, P716, DOI 10.1161/ATVBAHA.109.202028; Cho JY, INT IMMUNOPHARMACOL, V11, P1038; Copland IB, 2007, J CELL PHYSIOL, V210, P133, DOI 10.1002/jcp.20840; Crosby LM, 2011, AM J PHYSIOL-LUNG C, V301, pL536, DOI 10.1152/ajplung.00371.2010; Curley GF, THORAX; Duan W, 2005, INT IMMUNOPHARMACOL, V5, P495, DOI 10.1016/j.intimp.2004.10.015; Elton TS, 2012, GENE; Faisy C, 2011, CRIT CARE, V15, DOI 10.1186/cc10443; Fredberg JJ, 2000, J ALLERGY CLIN IMMUN, V106, P615, DOI 10.1067/mai.2000.109429; Fulmer MT, 1998, J MATER SCI-MATER M, V9, P197, DOI 10.1023/A:1008832006277; Garbacki N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016509; Gervasio OL, 2011, J CELL SCI, V124, P3581, DOI 10.1242/jcs.084376; Gonzalez MA, 2009, GASTROENTEROLOGY, V136, P978, DOI 10.1053/j.gastro.2008.11.041; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Hammerschmidt S, 2004, AM J RESP CELL MOL, V30, P396, DOI 10.1165/rcmb.2003-0136OC; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kasper G, 2007, STEM CELLS, V25, P903, DOI 10.1634/stemcells.2006-0432; Kern HB, 2012, DNA CELL BIOL, V31, P1403, DOI 10.1089/dna.2011.1469; Ko IK, 2010, MOL THER, V18, P1365, DOI 10.1038/mt.2010.54; KOLLER EA, 1973, RESP PHYSIOL, V17, P113, DOI 10.1016/0034-5687(73)90114-X; Kumar A, 2003, FASEB J, V17, P1800, DOI 10.1096/fj.02-1148com; Kumar RK, 2008, CURR DRUG TARGETS, V9, P485, DOI 10.2174/138945008784533561; Kuo TK, 2009, CELL TRANSPLANT, V18, P1013, DOI 10.3727/096368909X471206; Lam AP, 2008, J GENE MED, V10, P668, DOI 10.1002/jgm.1187; Le Bellego F, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-68; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Lee KS, 2006, FASEB J, V20, P455, DOI 10.1096/fj.05-5045com; Li LF, 2003, AM J PHYSIOL-LUNG C, V285, pL464, DOI 10.1152/ajplung.00031.2003; Liang H, 2009, MOL BIOL EVOL, V26, P1195, DOI 10.1093/molbev/msp053; LIM TK, 1987, AM REV RESPIR DIS, V135, P591; Liu GH, 2012, BIOMATERIALS AND STEM CELLS IN REGENERATIVE MEDICINE, P419; Manning E, 2010, HUM GENE THER, V21, P713, DOI 10.1089/hum.2009.147; MANNY J, 1978, SURGERY, V84, P127; McCoy CE, 2010, J BIOL CHEM, V285, P20492, DOI 10.1074/jbc.M110.102111; Min CK, 2007, BONE MARROW TRANSPL, V39, P637, DOI 10.1038/sj.bmt.1705644; Moschos SA, 2007, BMC GENOMICS, V8; Newman Robert E., 2009, Inflammation & Allergy Drug Targets, V8, P110; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Oglesby IK, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-148; Oh JY, 2008, STEM CELLS, V26, P1047, DOI 10.1634/stemcells.2007-0737; Onyeagucha BC, 2013, EXP CELL RES; OREHEK J, 1980, AM REV RESPIR DIS, V121, P297; Pedersen IM, 2009, EMBO MOL MED, V1, P288, DOI 10.1002/emmm.200900028; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; Qiu Chen, 2006, Zhonghua Jiehe He Huxi Zazhi, V29, P688; RADELL P, 1992, UPSALA J MED SCI, V97, P127, DOI 10.3109/03009739209179289; RUSSO LA, 1989, AM J PHYSIOL, V257, pE261, DOI 10.1152/ajpendo.1989.257.2.E261; Song GB, 2007, COLLOID SURFACE B, V58, P271, DOI 10.1016/j.colsurfb.2007.04.001; Sotoudeh M, 1998, ANN BIOMED ENG, V26, P181, DOI 10.1114/1.88; Tili E, 2009, INT REV IMMUNOL, V28, P264, DOI 10.1080/08830180903093796; Tschumperlin DJ, 2006, ANNU REV PHYSIOL, V68, P563, DOI 10.1146/annurev.physiol.68.072304.113102; Uhlig S, 2002, AM J PHYSIOL-LUNG C, V282, pL892, DOI 10.1152/ajplung.00124.2001; Waterman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010088; Wehner S, 2010, AM J PHYSIOL-GASTR L, V299, pG1187, DOI 10.1152/ajpgi.00452.2009; Yehya N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-154; Yi R, 2011, J CELL SCI, V124, P1775, DOI 10.1242/jcs.069104; Zhou T, 2011, TRANSL RES, V157, P180, DOI 10.1016/j.trsl.2011.01.010; Zou XH, 2009, CELL TRANSPLANT, V18, P433, DOI 10.3727/096368909788809839	65	20	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71342	10.1371/journal.pone.0071342	http://dx.doi.org/10.1371/journal.pone.0071342			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967196	Green Submitted, Green Published, gold			2022-12-25	WOS:000323115800051
J	Pandey, RB; Kuang, ZF; Farmer, BL				Pandey, Ras B.; Kuang, Zhifeng; Farmer, Barry L.			A Hierarchical Coarse-Grained (All-Atom-to-All-Residue) Computer Simulation Approach: Self-Assembly of Peptides	PLOS ONE			English	Article							POTENTIALS; BINDING; SURFACES; PARAMETERS; PALLADIUM; GOLD	A hierarchical computational approach (all-atom residue to all-residue peptide) is introduced to study self-organizing structures of peptides as a function of temperature. A simulated residue-residue interaction involving all-atom description, analogous to knowledge-based analysis (with different input), is used as an input to a phenomenological coarse-grained interaction for large scales computer simulations. A set of short peptides P1 (H-1 S-2 S-3 Y-4 W-5 Y-6 (7)A F-8 N-9 N-10 K-11 T-12) is considered as an example to illustrate the utility. We find that peptides assemble rather fast into globular aggregates at low temperatures and disperse as random-coil at high temperatures. The specificity of the mass distribution of the self-assembly depends on the temperature and spatial lengths which are identified from the scaling of the structure factor. Analysis of energy and mobility profiles, gyration radius of peptide, and radial distribution function of the assembly provide insight into the multi-scale (intra-and inter-chain) characteristics. Thermal response of the global assembly with the simulated residue-residue interaction is consistent with that of the knowledge-based analysis despite expected quantitative differences.	[Pandey, Ras B.] Univ So Mississippi, Dept Phys & Astron, Hattiesburg, MS 39406 USA; [Kuang, Zhifeng; Farmer, Barry L.] Air Force Res Lab, Mat & Mfg Directorate, Dayton, OH USA	University of Southern Mississippi	Pandey, RB (corresponding author), Univ So Mississippi, Dept Phys & Astron, Hattiesburg, MS 39406 USA.	ras.pandey@usm.edu			Air Force Research Laboratory	Air Force Research Laboratory	This work is supported by the Air Force Research Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betancourt MR, 1999, PROTEIN SCI, V8, P361; Cui Y, 2010, NANO LETT, V10, P4559, DOI 10.1021/nl102564d; de Jong DH, 2013, J CHEM THEORY COMPUT, V9, P687, DOI 10.1021/ct300646g; ERCOLESSI F, 1994, EUROPHYS LETT, V26, P583, DOI 10.1209/0295-5075/26/8/005; Fang YN, 2009, CHEM MATER, V21, P5704, DOI 10.1021/cm9011525; Fritsche M, 2012, PLOS ONE, V7; Godzik A, 1996, STRUCTURE, V4, P363, DOI 10.1016/S0969-2126(96)00041-X; Heinz H, 2009, J AM CHEM SOC, V131, P9704, DOI 10.1021/ja900531f; Hong L, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.028104; Huang SY, 2011, PROTEINS, V79, P2648, DOI 10.1002/prot.23086; Kim SN, 2011, J AM CHEM SOC, V133, P14480, DOI 10.1021/ja2042832; Liwo A, 2008, CURR OPIN STRUC BIOL, V18, P134, DOI 10.1016/j.sbi.2007.12.001; LYUBARTSEV AP, 1995, PHYS REV E, V52, P3730, DOI 10.1103/PhysRevE.52.3730; Miao YL, 2012, J AM CHEM SOC, V134, P19576, DOI 10.1021/ja3097898; Miyazawa S, 1996, J MOL BIOL, V256, P623, DOI 10.1006/jmbi.1996.0114; MIYAZAWA S, 1985, MACROMOLECULES, V18, P534, DOI 10.1021/ma00145a039; Pandey RB, 2012, SOFT MATTER, V8, P9101, DOI 10.1039/c2sm25870f; Pandey RB, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3358340; Pandey RB, 2009, PHYS CHEM CHEM PHYS, V11, P1989, DOI 10.1039/b816187a; Pandey RB, 2013, PREPRINT; Pandey RB, 2012, PLOS ONE, V7; Pender MJ, 2006, NANO LETT, V6, P40, DOI 10.1021/nl051899r; Peng LLX, 2011, J CHEM INF MODEL, V51, P3030, DOI 10.1021/ci200214m; Reith D, 2003, J COMPUT CHEM, V24, P1624, DOI 10.1002/jcc.10307; Sakai VG, 2013, SOFT MATTER, V9, P5336, DOI 10.1039/c3sm50492a; Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964; Sorensen J, 2011, J PHYS CHEM LETT, V2, P2385, DOI 10.1021/jz2010094; TANAKA S, 1976, MACROMOLECULES, V9, P945, DOI 10.1021/ma60054a013; Tomasio SM, 2009, J PHYS CHEM C, V113, P8778, DOI 10.1021/jp8087594; van Giessen AE, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1833354; Whaley SR, 2000, NATURE, V405, P665, DOI 10.1038/35015043; Wu Z, 2011, J CHEM THEORY COMPUT, V7, P3793, DOI 10.1021/ct200593t; Zhou J, 2003, LANGMUIR, V19, P3472, DOI 10.1021/la026871z; Zhou J, 2007, BIOPHYS J, V92, P4289, DOI 10.1529/biophysj.106.094425	34	8	8	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e70847	10.1371/journal.pone.0070847	http://dx.doi.org/10.1371/journal.pone.0070847			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967121	Green Submitted, Green Published, gold			2022-12-25	WOS:000323115800026
J	Wallace, MD; Southard, TL; Schimenti, KJ; Schimenti, JC				Wallace, M. D.; Southard, T. L.; Schimenti, K. J.; Schimenti, J. C.			Role of DNA damage response pathways in preventing carcinogenesis caused by intrinsic replication stress	ONCOGENE			English	Article						DNA replication; DNA damage checkpoints; minichromosome maintenance proteins; 9-1-1; MCM2-7 helicase; replication stress	ATAXIA-TELANGIECTASIA; BREAST-CANCER; TUMOR SUSCEPTIBILITY; GENOMIC INSTABILITY; IONIZING-RADIATION; MOUSE MODEL; ATM; MICE; CHK2; PHOSPHORYLATION	Defective DNA replication can result in genomic instability, cancer and developmental defects. To understand the roles of DNA damage response (DDR) genes on carcinogenesis in mutants defective for core DNA replication components, we utilized the Mcm4Chaos3/Chaos3 ('Chaos3') mouse model that, by virtue of an amino-acid alteration in MCM4 that destabilizes the MCM2-7 DNA replicative helicase, has fewer dormant replication origins and an increased number of stalled replication forks. This leads to genomic instability and cancer in most Chaos3 mice. We found that animals doubly mutant for Chaos3 and components of the ataxia telangiectasia-mutated (ATM) double-strand break response pathway (Atm, p21/Cdkn1a and Chk2/Chek2) had decreased tumor latency and/or increased tumor susceptibility. Tumor latency and susceptibility differed between genetic backgrounds and genders, with females demonstrating an overall greater cancer susceptibility to Atm and p21 deficiency than males. Atm deficiency was semilethal in the Chaos3 background and impaired embryonic fibroblast proliferation, suggesting that ATM drug inhibitors might be useful against tumors with DNA replication defects. Hypomorphism for the 9-1-1 component Hus1 did not affect tumor latency or susceptibility in Chaos3 animals, and tumors in these mice did not exhibit impaired ATR pathway signaling. These and other data indicate that under conditions of systemic replication stress, the ATM pathway is particularly important both for cancer suppression and viability during development.	[Wallace, M. D.; Southard, T. L.; Schimenti, K. J.; Schimenti, J. C.] Cornell Univ, Dept Biomed Sci, Coll Vet Med, Ithaca, NY 14853 USA; [Wallace, M. D.; Schimenti, J. C.] Dept Mol Biol & Genet, Ithaca, NY USA; [Southard, T. L.] Sect Anat Pathol, Ithaca, NY USA; [Schimenti, J. C.] Cornell Univ, Ctr Vertebrate Genom, Ithaca, NY 14853 USA	Cornell University; Cornell University	Schimenti, JC (corresponding author), Cornell Univ, Dept Biomed Sci, Coll Vet Med, VRT 9014A, Ithaca, NY 14853 USA.	jcs92@cornell.edu		Wallace, Marsha/0000-0001-8588-9512	NIH Training [IT32HDO57854, 5T32GM007617]; Empire State Stem Cell Fund [C026442, C024174]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD057854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007617] Funding Source: NIH RePORTER	NIH Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Empire State Stem Cell Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank RS Weiss and T Mak for providing mice. We also thank RS Weiss and G Balmus for critical feedback on the manuscript. This study was supported by NIH Training Grants IT32HDO57854 and 5T32GM007617, and Empire State Stem Cell Fund Contract Numbers C026442 and C024174 to JCS.	Albertson TM, 2009, P NATL ACAD SCI USA, V106, P17101, DOI 10.1073/pnas.0907147106; Arana ME, 2010, SEMIN CANCER BIOL, V20, P304, DOI 10.1016/j.semcancer.2010.10.003; Bagley BN, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003034; Balmus G, 2012, HUM MOL GENET, V21, P3408, DOI 10.1093/hmg/dds173; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Barlow C, 1999, NAT GENET, V21, P359, DOI 10.1038/7684; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berger AH, 2011, NATURE, V476, P163, DOI 10.1038/nature10275; Bhatti S, 2011, CELL MOL LIFE SCI, V68, P2977, DOI 10.1007/s00018-011-0683-9; Cazzalini O, 2010, MUTAT RES-REV MUTAT, V704, P12, DOI 10.1016/j.mrrev.2010.01.009; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chuang CH, 2012, NUCLEIC ACIDS RES, V40, P4914, DOI 10.1093/nar/gks176; Chuang CH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001110; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Dorak M. Tevfik, 2012, Frontiers in Genetics, V3, P268, DOI 10.3389/fgene.2012.00268; El GS, 2011, PLOS GENET, V7; Elson A, 1996, P NATL ACAD SCI USA, V93, P13084, DOI 10.1073/pnas.93.23.13084; Errico A, 2012, CRIT REV BIOCHEM MOL, V47, P222, DOI 10.3109/10409238.2012.655374; Gatei M, 2003, J BIOL CHEM, V278, P14806, DOI 10.1074/jbc.M210862200; Goldsby RE, 2001, NAT MED, V7, P638, DOI 10.1038/88963; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hirao A, 2002, MOL CELL BIOL, V22, P6521, DOI 10.1128/MCB.22.18.6521-6532.2002; Honeycutt KA, 2006, ONCOGENE, V25, P4027, DOI 10.1038/sj.onc.1209435; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Jones RM, 2012, BIOCHEM J, V443, P13, DOI 10.1042/BJ20112100; Karabinis ME, 2001, CARCINOGENESIS, V22, P343, DOI 10.1093/carcin/22.2.343; Kawabata T, 2011, MAMM GENOME, V22, P506, DOI 10.1007/s00335-011-9333-7; Kawabata T, 2011, MOL CELL, V41, P543, DOI 10.1016/j.molcel.2011.02.006; Kemp M, 2009, CURR BIOL, V19, pR733, DOI 10.1016/j.cub.2009.07.026; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kunnev D, 2010, ONCOGENE, V29, P3630, DOI 10.1038/onc.2010.125; Lee JS, 2000, NATURE, V404, P201, DOI 10.1038/35004614; Levitt PS, 2007, MOL CELL BIOL, V27, P2189, DOI 10.1128/MCB.01763-06; Levitt PS, 2005, GENOMICS, V86, P212, DOI 10.1016/j.ygeno.2005.04.007; Li XCL, 2011, GENETICS, V187, P1031, DOI 10.1534/genetics.110.125450; Lieberman HB, 2011, J MOL CELL BIOL, V3, P39, DOI 10.1093/jmcb/mjq039; Lopez-Contreras AJ, 2010, DNA REPAIR, V9, P1249, DOI 10.1016/j.dnarep.2010.09.012; Lu S, 2006, CARCINOGENESIS, V27, P848, DOI 10.1093/carcin/bgi302; Mao JH, 2008, ONCOGENE, V27, P6596, DOI 10.1038/onc.2008.280; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Mokrani-Benhelli H, 2013, HUM MUTAT, V34, P374, DOI 10.1002/humu.22245; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Murga M, 2011, NAT STRUCT MOL BIOL, V18, P1331, DOI 10.1038/nsmb.2189; Murga M, 2009, NAT GENET, V41, P891, DOI 10.1038/ng.420; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Niida H, 2010, EMBO J, V29, P3558, DOI 10.1038/emboj.2010.218; Pabla N, 2008, J BIOL CHEM, V283, P6572, DOI 10.1074/jbc.M707568200; Petermann E, 2010, NAT REV MOL CELL BIO, V11, P683, DOI 10.1038/nrm2974; Preston BD, 2010, SEMIN CANCER BIOL, V20, P281, DOI 10.1016/j.semcancer.2010.10.009; Pruitt SC, 2007, STEM CELLS, V25, P3121, DOI 10.1634/stemcells.2007-0483; Reiman A, 2011, BRIT J CANCER, V105, P586, DOI 10.1038/bjc.2011.266; Schoppy DW, 2012, J CLIN INVEST, V122, P241, DOI 10.1172/JCI58928; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Shechter D, 2004, P NATL ACAD SCI USA, V101, P10845, DOI 10.1073/pnas.0404143101; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shima N, 2007, NAT GENET, V39, P93, DOI 10.1038/ng1936; Spring K, 2002, NAT GENET, V32, P185, DOI 10.1038/ng958; Stracker TH, 2008, MOL CELL, V31, P21, DOI 10.1016/j.molcel.2008.04.028; Takai H, 2002, EMBO J, V21, P5195, DOI 10.1093/emboj/cdf506; Thompson D, 2005, JNCI-J NATL CANCER I, V97, P813, DOI 10.1093/jnci/dji141; Vijayraghavan Sriram, 2012, Subcell Biochem, V62, P113, DOI 10.1007/978-94-007-4572-8_7; Wallace MD, 2012, GENETICS, V192, P385, DOI 10.1534/genetics.112.142802; Warmerdam DO, 2009, MUTAT RES, V704, P2; Weiss RS, 2000, GENE DEV, V14, P1886; Weiss RS, 2002, CURR BIOL, V12, P73, DOI 10.1016/S0960-9822(01)00626-1; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zheng YL, 2010, INT J CANCER, V126, P2199, DOI 10.1002/ijc.24771	78	16	17	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 10	2014	33	28					3688	3695		10.1038/onc.2013.339	http://dx.doi.org/10.1038/onc.2013.339			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AL2GC	23975433	Green Accepted			2022-12-25	WOS:000338942900008
J	Makgotlho, PE; Marincola, G; Schafer, D; Liu, Q; Bae, T; Geiger, T; Wasserman, E; Wolz, C; Ziebuhr, W; Sinha, B				Makgotlho, Phuti E.; Marincola, Gabriella; Schaefer, Daniel; Liu, Qian; Bae, Taeok; Geiger, Tobias; Wasserman, Elizabeth; Wolz, Christiane; Ziebuhr, Wilma; Sinha, Bhanu			SDS Interferes with SaeS Signaling of Staphylococcus aureus Independently of SaePQ	PLOS ONE			English	Article							HOST-CELL INVASION; 2-COMPONENT SYSTEM; ALLELIC REPLACEMENT; GENOME SEQUENCE; STRAIN NEWMAN; GENE; ACTIVATION; EXPRESSION; INFECTION; ADHERENCE	The Staphylococcus aureus regulatory saePQRS system controls the expression of numerous virulence factors, including extracellular adherence protein (Eap), which amongst others facilitates invasion of host cells. The saePQRS operon codes for 4 proteins: the histidine kinase SaeS, the response regulator SaeR, the lipoprotein SaeP and the transmembrane protein SaeQ. S. aureus strain Newman has a single amino acid substitution in the transmembrane domain of SaeS (L18P) which results in constitutive kinase activity. SDS was shown to be one of the signals interfering with SaeS activity leading to inhibition of the sae target gene eap in strains with SaeS(L) but causing activation in strains containing SaeS(P). Here, we analyzed the possible involvement of the SaeP protein and saePQ region in SDS-mediated sae/eap expression. We found that SaePQ is not needed for SDS-mediated SaeS signaling. Furthermore, we could show that SaeS activity is closely linked to the expression of Eap and the capacity to invade host cells in a number of clinical isolates. This suggests that SaeS activity might be directly modulated by structurally non-complex environmental signals, as SDS, which possibly altering its kinase/phosphatase activity.	[Makgotlho, Phuti E.; Schaefer, Daniel] Univ Wurzburg, Inst Hyg & Microbiol, D-97070 Wurzburg, Germany; [Marincola, Gabriella; Geiger, Tobias; Wolz, Christiane] Univ Tubingen, Inst Med Microbiol & Hyg, Tubingen, Germany; [Liu, Qian; Bae, Taeok] Indiana Univ, Sch Med Northwest, Dept Microbiol & Immunol, Gary, IN USA; [Wasserman, Elizabeth] Univ Stellenbosch, Dept Pathol, Cape Town, South Africa; [Ziebuhr, Wilma] Univ Wurzburg, Inst Mol Infect Biol, D-97070 Wurzburg, Germany; [Sinha, Bhanu] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol & Infect Prevent, NL-9713 AV Groningen, Netherlands	University of Wurzburg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Indiana University System; Indiana University Northwest; Stellenbosch University; University of Cape Town; University of Wurzburg; University of Groningen	Wolz, C (corresponding author), Univ Tubingen, Inst Med Microbiol & Hyg, Tubingen, Germany.	christiane.wolz@med.uni-tuebingen.de	Marincola, Gabriella/AAB-2969-2020	Marincola, Gabriella/0000-0001-9227-6554; Sinha, Bhanu/0000-0003-1634-0010; Bae, Taeok/0000-0002-0576-2851; Wolz, Christiane/0000-0003-3909-5281	International Research Training Group [IRTG 1522]; BMBF [FKZ 01KI1014E]; Deutsche Forschungsgemeinschaft [Wo578/7-1, TransRegio34]	International Research Training Group; BMBF(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the International Research Training Group IRTG 1522, the BMBF-funded MedVetStaph Research Network (FKZ 01KI1014E) and the Deutsche Forschungsgemeinschaft Wo578/7-1 and TransRegio34 Projects B1, B4, and C6/11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari RP, 2008, MICROBIOL-SGM, V154, P949, DOI 10.1099/mic.0.2007/012245-0; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; BALWIT JM, 1994, J INFECT DIS, V170, P1033, DOI 10.1093/infdis/170.4.1033; Blickwede M, 2005, J ANTIMICROB CHEMOTH, V56, P315, DOI 10.1093/jac/dki233; Bruckner R, 1997, FEMS MICROBIOL LETT, V151, P1; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; Foster TJ, 2004, J CLIN INVEST, V114, P1693, DOI 10.1172/JCI200423825; Geiger T, 2008, J BACTERIOL, V190, P3419, DOI 10.1128/JB.01927-07; Giraudo AT, 1999, FEMS MICROBIOL LETT, V177, P15, DOI 10.1016/S0378-1097(99)00282-7; Goerke C, 2000, INFECT IMMUN, V68, P1304, DOI 10.1128/IAI.68.3.1304-1311.2000; Grundmeier M, 2004, INFECT IMMUN, V72, P7155, DOI 10.1128/IAI.72.12.7155-7163.2004; Jeong DW, 2012, MOL MICROBIOL, V86, P331, DOI 10.1111/j.1365-2958.2012.08198.x; Jeong DW, 2011, J BACTERIOL, V193, P4672, DOI 10.1128/JB.00353-11; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Kuroda H, 2007, FEMS MICROBIOL LETT, V268, P98, DOI 10.1111/j.1574-6968.2006.00568.x; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Mainiero M, 2010, J BACTERIOL, V192, P613, DOI 10.1128/JB.01242-09; Marincola G, 2012, MOL MICROBIOL, V85, P817, DOI 10.1111/j.1365-2958.2012.08144.x; Novick RP, 2003, MICROBIOL-SGM, V149, P2709, DOI 10.1099/mic.0.26575-0; PATTEE PA, 1981, J BACTERIOL, V145, P479, DOI 10.1128/JB.145.1.479-488.1981; Que YA, 2005, J EXP MED, V201, P1627, DOI 10.1084/jem.20050125; Schafer D, 2009, J BACTERIOL, V191, P7306, DOI 10.1128/JB.00630-09; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sinha B, 2010, INT J MED MICROBIOL, V300, P170, DOI 10.1016/j.ijmm.2009.08.019; Steinhuber A, 2003, J BACTERIOL, V185, P6278, DOI 10.1128/JB.185.21.6278-6286.2003	29	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71644	10.1371/journal.pone.0071644	http://dx.doi.org/10.1371/journal.pone.0071644			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977102	Green Published, gold, Green Submitted			2022-12-25	WOS:000324527300029
J	Zhang, HL; Lai, SJ; Wang, LP; Zhao, D; Zhou, DL; Lan, YJ; Buckeridge, DL; Li, ZJ; Yang, WZ				Zhang, Honglong; Lai, Shengjie; Wang, Liping; Zhao, Dan; Zhou, Dinglun; Lan, Yajia; Buckeridge, David L.; Li, Zhongjie; Yang, Weizhong			Improving the Performance of Outbreak Detection Algorithms by Classifying the Levels of Disease Incidence	PLOS ONE			English	Article							MOUTH-DISEASE; EPIDEMIC	We evaluated a novel strategy to improve the performance of outbreak detection algorithms, namely setting the alerting threshold separately in each region according to the disease incidence in that region. By using data on hand, foot and mouth disease in Shandong province, China, we evaluated the impact of disease incidence on the performance of outbreak detection algorithms (EARS-C1, C2 and C3). Compared to applying the same algorithm and threshold to the whole region, setting the optimal threshold in each region according to the level of disease incidence (i.e., high, middle, and low) enhanced sensitivity (C1: from 94.4% to 99.1%, C2: from 93.5% to 95.4%, C3: from 91.7% to 95.4%) and reduced the number of alert signals (the percentage of reduction is C1:4.3%, C2:11.9%, C3:10.3%). Our findings illustrate a general method for improving the accuracy of detection algorithms that is potentially applicable broadly to other diseases and regions.	[Zhang, Honglong; Lai, Shengjie; Wang, Liping; Li, Zhongjie] Chinese Ctr Dis Control & Prevent, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China; [Zhao, Dan] Beijing Ctr Dis Control & Prevent, Inst Immunizat & Prevent, Beijing, Peoples R China; [Zhou, Dinglun; Lan, Yajia] Sichuan Univ, West China Sch Publ Hlth, Chengdu 610064, Peoples R China; [Buckeridge, David L.] McGill Univ, Dept Epidemiol & Biostat, Surveillance Lab, Montreal, PQ, Canada; [Yang, Weizhong] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; Sichuan University; McGill University; Chinese Center for Disease Control & Prevention	Li, ZJ (corresponding author), Chinese Ctr Dis Control & Prevent, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China.	lizj@chinacdc.cn; yangwz@chinacdc.cn	Yang, Wei/HIA-0360-2022	Lai, Shengjie/0000-0001-9781-8148	Research and Promotion of Key Technology on Health Emergency Preparation and Dispositions [201202006]; National Key Science and Technology Project on Infectious Disease Surveillance Technique Platform of China [2012ZX10004-201]; Development of Early Warning Systems for Dengue Fever Based on Socio-ecological Factors [NHMRC APP1002608]	Research and Promotion of Key Technology on Health Emergency Preparation and Dispositions; National Key Science and Technology Project on Infectious Disease Surveillance Technique Platform of China; Development of Early Warning Systems for Dengue Fever Based on Socio-ecological Factors	This work was supported by the grants from Research and Promotion of Key Technology on Health Emergency Preparation and Dispositions (201202006), the National Key Science and Technology Project on Infectious Disease Surveillance Technique Platform of China (2012ZX10004-201) and Development of Early Warning Systems for Dengue Fever Based on Socio-ecological Factors (NHMRC APP1002608). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buckeridge DL, 2005, J BIOMED INFORM, V38, P99, DOI 10.1016/j.jbi.2004.11.007; Buckeridge DL, 2003, AMIA ANN S P, P120; Burkom HS, 2003, J HOPKINS APL TECH D, V24, P335; Centers for Disease Control and Prevention, 2007, BIOSENSE REAL TIM HO; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chang Zhao-rui, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P676; Heymann DL, 2008, CONTROL COMMUNICABLE, P151; Hjalmars U, 1996, STAT MED, V15, P707, DOI 10.1002/(SICI)1097-0258(19960415)15:7/9<707::AID-SIM242>3.3.CO;2-W; Hutwagner L, 2005, AVIAT SPACE ENVIR MD, V76, P1001; Hutwagner L, 2003, J URBAN HEALTH, V80, pI89; Lai Sheng-jie, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P579; Li ZJ, 2012, J AM MED INFORM ASSN, V19, pE51, DOI 10.1136/amiajnl-2011-000126; Ministry of Health of the People's Republic of China, 2009, GUID HAND FOOT MOUTH; Ministry of Health of the People's Republic of China, 2012, NORMS HAND FOOT MOUT; Wang Xiao-li, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P159; Wang XL, 2010, J BIOMED INFORM, V43, P97, DOI 10.1016/j.jbi.2009.08.003; Watkins RE, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-37; *WHO W PAC REG, GUID CLIN MAN PUBL H; Yang Wei-Zhong, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P1039; Zhang HL, 2010, CHIN J EPIDEMIOL, V31, P1403; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002	22	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71803	10.1371/journal.pone.0071803	http://dx.doi.org/10.1371/journal.pone.0071803			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977146	Green Accepted, Green Submitted, gold, Green Published			2022-12-25	WOS:000323425700102
J	Yang, SQ; Counter, CM				Yang, Shuqun; Counter, Christopher M.			Cell Cycle Regulated Phosphorylation of the Telomere-Associated Protein TIN2	PLOS ONE			English	Article							IN-VIVO; DYSKERATOSIS-CONGENITA; LENGTH CONTROL; TRF1; MITOSIS; COMPLEX; SITE; HETEROCHROMATIN; STABILIZES; LOCALIZES	The protein TIN2 is a member of telomere-binding protein complex that serves to cap and protect mammalian chromosome ends. As a number of proteins in this complex are phosphorylated in a cell cycle-dependent manner, we investigated whether TIN2 is modified by phosphorylation as well. We performed phospho-proteomic analysis of human TIN2, and identified two phosphorylated residues, serines 295 and 330. We demonstrated that both these sites were phosphorylated during mitosis in human cells, as detected by Phos-tag reagent and phosphorylation-specific antibodies. Phosphorylation of serines 295 and 330 appeared to be mediated, at least in part, by the mitotic kinase RSK2. Specifically, phosphorylation of TIN2 at both these residues was increased upon expression of RSK2 and reduced by an inhibitor of the RSK family of kinases. Moreover, RSK2 phosphorylated TIN2 in vitro. The identification of these specifically timed post-translational events during the cell cycle suggests a potential mitotic regulation of TIN2 by phosphorylation.	[Yang, Shuqun; Counter, Christopher M.] DUMC, Dept Radiat Oncol, Dept Pharmacol & Canc Biol, Durham, NC USA	Duke University	Counter, CM (corresponding author), DUMC, Dept Radiat Oncol, Dept Pharmacol & Canc Biol, Durham, NC USA.	count004@mc.duke.edu		Counter, Christopher M/0000-0003-0748-3079	National Cancer Institute [CA094184]; NATIONAL CANCER INSTITUTE [R01CA094184] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by grant CA094184 (CMC) from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bhanot M, 2012, MOL CELL BIOL, V32, P376, DOI 10.1128/MCB.06227-11; Canudas S, 2007, EMBO J, V26, P4867, DOI 10.1038/sj.emboj.7601903; Canudas S, 2011, GENE DEV, V25, P1807, DOI 10.1101/gad.17325211; Chen LY, 2012, MOL CELL, V47, P839, DOI 10.1016/j.molcel.2012.07.002; Chen RQ, 2009, CANCER RES, V69, P2663, DOI 10.1158/0008-5472.CAN-08-3222; Cude K, 2007, J CELL BIOL, V177, P253, DOI 10.1083/jcb.200609166; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Fisher D, 2012, J CELL SCI, V125, P4703, DOI 10.1242/jcs.106351; Gorr IH, 2005, MOL CELL, V19, P135, DOI 10.1016/j.molcel.2005.05.022; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Houghtaling BR, 2004, CURR BIOL, V14, P1621, DOI 10.1016/j.cub.2004.08.052; Kaminker PG, 2009, CELL CYCLE, V8, P931, DOI 10.4161/cc.8.6.7941; Kim S, 2004, J BIOL CHEM, V279, P43799, DOI 10.1074/jbc.M408650200; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Kinoshita E, 2009, NAT PROTOC, V4, P1513, DOI 10.1038/nprot.2009.154; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; McKerlie M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1372; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; O'Hayer KM, 2006, METHOD ENZYMOL, V407, P637, DOI 10.1016/S0076-6879(05)07050-3; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Poteet-Smith CE, 1999, J BIOL CHEM, V274, P22135, DOI 10.1074/jbc.274.32.22135; Richardson Brenna McJury, 2013, J Biomol Tech, V24, P8, DOI 10.7171/jbt.13-2401-002; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Takai KK, 2011, MOL CELL, V44, P647, DOI 10.1016/j.molcel.2011.08.043; Tyler RK, 2007, CELL CYCLE, V6, P2846, DOI 10.4161/cc.6.22.4940; Vigneron S, 2010, ONCOGENE, V29, P3566, DOI 10.1038/onc.2010.105; Vik TA, 1997, BIOCHEM BIOPH RES CO, V235, P398, DOI 10.1006/bbrc.1997.6794; Walne AJ, 2008, BLOOD, V112, P3594, DOI 10.1182/blood-2008-05-153445; Yang D, 2011, J BIOL CHEM, V286, P23022, DOI 10.1074/jbc.M111.225870; Yang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011621; Ye JZS, 2004, J BIOL CHEM, V279, P47264, DOI 10.1074/jbc.M409047200; Ye JZS, 2004, NAT GENET, V36, P618, DOI 10.1038/ng1360; Yonekawa T, 2012, MOL CELL BIOL, V32, P1387, DOI 10.1128/MCB.05641-11; Zhang Y, 2013, P NATL ACAD SCI USA, V110, P5457, DOI 10.1073/pnas.1217733110	39	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e71697	10.1371/journal.pone.0071697	http://dx.doi.org/10.1371/journal.pone.0071697			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977114	Green Submitted, gold, Green Published			2022-12-25	WOS:000323570200044
J	Darwish, I; Banner, D; Mubareka, S; Kim, H; Besla, R; Kelvin, DJ; Kain, KC; Liles, WC				Darwish, Ilyse; Banner, David; Mubareka, Samira; Kim, Hani; Besla, Rickvinder; Kelvin, David J.; Kain, Kevin C.; Liles, W. Conrad			Mesenchymal Stromal (Stem) Cell Therapy Fails to Improve Outcomes in Experimental Severe Influenza	PLOS ONE			English	Article							INDUCED ACUTE LUNG; NECROSIS-FACTOR-ALPHA; TOLL-LIKE RECEPTORS; BACTERIAL CLEARANCE; STRANDED-RNA; IN-VITRO; VIRUS; INFECTION; INJURY; MICE	Rationale: Severe influenza remains a major public health threat and is responsible for thousands of deaths annually. Increasing antiviral resistance and limited effectiveness of current therapies highlight the need for new approaches to influenza treatment. Extensive pre-clinical data have shown that mesenchymal stromal (stem) cell (MSC) therapy can induce anti-inflammatory effects and enhance repair of the injured lung. We hypothesized that MSC therapy would improve survival, dampen lung inflammation and decrease acute lung injury (ALI) in a murine model of severe influenza. Methods: C57Bl/6 mice were infected with influenza A/PuertoRico/8/34 (mouse-adapted H1N1) or influenza A/Mexico/4108/2009 (swine-origin pandemic H1N1) and administered human or mouse MSCs via the tail vein, either pre- or post-infection. MSC efficacy was evaluated as both an independent and adjunctive treatment strategy in combination with the antiviral agent, oseltamivir. Weight loss and survival were monitored. Inflammatory cells, cytokine/chemokines (IFN-gamma, CXCL10, CCL2 and CCL5) and markers of ALI (total protein and IgM), were measured in bronchoalveolar lavage fluid and lung parenchyma. Results: Administration of murine MSCs or human MSCs in a prophylactic or therapeutic regimen failed to improve survival, decrease pulmonary inflammation/inflammatory cell counts or prevent ALI in influenza virus-infected mice. MSCs administered in combination with oseltamivir also failed to improve outcomes. Conclusions: Despite similarities in the clinical presentation and pathobiology of ALI and severe influenza, our findings suggest that MSC therapy may not be effective for prevention and/or treatment of acute severe influenza.	[Darwish, Ilyse; Besla, Rickvinder; Kain, Kevin C.; Liles, W. Conrad] Univ Toronto, Inst Med Sci, Fac Med, Toronto, ON, Canada; [Darwish, Ilyse; Kim, Hani; Kain, Kevin C.; Liles, W. Conrad] Univ Hlth Network, Toronto Gen Hosp, Sandra Rotman Ctr Global Hlth, Sandra A Rotman Labs, Toronto, ON, Canada; [Banner, David; Kelvin, David J.; Kain, Kevin C.; Liles, W. Conrad] Univ Hlth Network, Toronto Gen Res Inst, Div Expt Therapeut, Toronto, ON, Canada; [Mubareka, Samira] Univ Toronto, Sunnybrook Hlth Sci Ctr & Res Inst, Dept Microbiol, Toronto, ON, Canada; [Mubareka, Samira] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Kain, Kevin C.; Liles, W. Conrad] Univ Toronto, Dept Med, Div Infect Dis, Toronto, ON, Canada; [Liles, W. Conrad] Univ Washington, Dept Med, Seattle, WA USA	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Washington; University of Washington Seattle	Liles, WC (corresponding author), Univ Toronto, Inst Med Sci, Fac Med, Toronto, ON, Canada.	wcliles@medicine.washington.edu		Kain, Kevin/0000-0001-6068-1272	Canadian Institutes of Health Research (CIHR); CIHR Pandemic Preparedness Catalyst Grant; Defense Advanced Research Projects Agency Grant [DARPA-BAA-09-43]; CIHR [MOP-13721, 115160]; Canada Research Chair in Molecular Parasitology; Canada Research Chair in Infectious Diseases and Inflammation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Pandemic Preparedness Catalyst Grant(Canadian Institutes of Health Research (CIHR)); Defense Advanced Research Projects Agency Grant; CIHR(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Molecular Parasitology; Canada Research Chair in Infectious Diseases and Inflammation(Canada Research Chairs)	This work was supported by a Canadian Institutes of Health Research (CIHR) Master's Award [ID], a CIHR Pandemic Preparedness Catalyst Grant [SM], a Defense Advanced Research Projects Agency Grant (DARPA-BAA-09-43) [WCL, KCK], CIHR MOP-13721 and 115160 [KCK], a Canada Research Chair in Molecular Parasitology [KCK] and a Canada Research Chair in Infectious Diseases and Inflammation [WCL]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Aoki FY, 2003, J ANTIMICROB CHEMOTH, V51, P123, DOI 10.1093/jac/dkg007; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Bernard GR, 2005, AM J RESP CRIT CARE, V172, P798, DOI 10.1164/rccm.200504-663OE; Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413; Carey MA, 2005, J IMMUNOL, V175, P6878, DOI 10.4049/jimmunol.175.10.6878; Chan JL, 2006, BLOOD, V107, P4817, DOI 10.1182/blood-2006-01-0057; Cho HH, 2006, STEM CELLS, V24, P2744, DOI 10.1634/stemcells.2006-0189; Danchuk S, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt68; Dawson TC, 2000, AM J PATHOL, V156, P1951, DOI 10.1016/S0002-9440(10)65068-7; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Djouad F, 2005, ARTHRITIS RHEUM-US, V52, P1595, DOI 10.1002/art.21012; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; dos Santos CC, 2012, AM J PATHOL, V181, P1681, DOI 10.1016/j.ajpath.2012.08.009; Gill JR, 2010, ARCH PATHOL LAB MED, V134, P235, DOI 10.1043/1543-2165-134.2.235; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Gupta N, 2012, THORAX, V67, P533, DOI 10.1136/thoraxjnl-2011-201176; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Inoue S, 2006, TRANSPLANTATION, V81, P1589, DOI 10.1097/01.tp.0000209919.90630.7b; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Kandun IN, 2008, LANCET, V372, P744, DOI 10.1016/S0140-6736(08)61125-3; Khatri M, 2013, CELL TRANSPLANT, V22, P461, DOI 10.3727/096368912X656063; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Lee JW, 2009, P NATL ACAD SCI USA, V106, P16357, DOI 10.1073/pnas.0907996106; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Lee SMY, 2008, J INFECT DIS, V198, P525, DOI 10.1086/590499; Lin KL, 2011, J IMMUNOL, V186, P508, DOI 10.4049/jimmunol.1001002; Liotta F, 2008, STEM CELLS, V26, P279, DOI 10.1634/stemcells.2007-0454; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; Mei SHJ, 2007, PLOS MED, V4, P1525, DOI 10.1371/journal.pmed.0040269; Mei SHJ, 2010, AM J RESP CRIT CARE, V182, P1047, DOI 10.1164/rccm.201001-0010OC; Mindrescu C, 2005, BIOCHEM BIOPH RES CO, V330, P737, DOI 10.1016/j.bbrc.2005.03.040; MURPHY BR, 1973, J INFECT DIS, V128, P488, DOI 10.1093/infdis/128.4.488; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Perrone LA, 2010, J INFECT DIS, V202, P1161, DOI 10.1086/656365; Pevsner-Fischer M, 2007, BLOOD, V109, P1422, DOI 10.1182/blood-2006-06-028704; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Ren GW, 2009, STEM CELLS, V27, P1954, DOI 10.1002/stem.118; Rojas M, 2005, AM J RESP CELL MOL, V33, P145, DOI 10.1165/rcmb.2004-0330OC; Sheu TG, 2008, ANTIMICROB AGENTS CH, V52, P3284, DOI 10.1128/AAC.00555-08; Sudres M, 2006, J IMMUNOL, V176, P7761, DOI 10.4049/jimmunol.176.12.7761; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; To KF, 2001, J MED VIROL, V63, P242, DOI 10.1002/1096-9071(200103)63:3&lt;242::AID-JMV1007&gt;3.0.CO;2-N; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Xu J, 2008, J PATHOL, V214, P472, DOI 10.1002/path.2302; Xu JG, 2007, AM J PHYSIOL-LUNG C, V293, pL131, DOI 10.1152/ajplung.00431.2006; Yagi H, 2010, MOL THER, V18, P1857, DOI 10.1038/mt.2010.155	54	40	42	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71761	10.1371/journal.pone.0071761	http://dx.doi.org/10.1371/journal.pone.0071761			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967240	gold, Green Published, Green Submitted			2022-12-25	WOS:000323378000067
J	Frey, EN; Pavlovicz, RE; Wegman, CJ; Li, CL; Askwith, CC				Frey, Erin N.; Pavlovicz, Ryan E.; Wegman, Clem John; Li, Chenglong; Askwith, Candice C.			Conformational Changes in the Lower Palm Domain of ASIC1a Contribute to Desensitization and RFamide Modulation	PLOS ONE			English	Article							SENSING ION-CHANNEL; ACID-EVOKED CURRENTS; SENSORY NEURONS; EXTRACELLULAR DOMAIN; PROTEIN STRUCTURES; SODIUM-CHANNEL; GATED CURRENTS; UCSF CHIMERA; PEPTIDES; PAIN	Acid-sensing ion channel 1a (ASIC1a) is a proton-gated cation channel that contributes to fear and pain as well as neuronal damage following persistent cerebral acidosis. Neuropeptides can affect acid-induced neuronal injury by altering ASIC1a inactivation and/or steady-state desensitization. Yet, exactly how ASIC1a inactivation and desensitization occur or are modulated by peptides is not completely understood. We found that regions of the extracellular palm domain and the beta(11-12) linker are important for inactivation and steady-state desensitization of ASIC1a. The single amino acid substitutions L280C and L415C dramatically enhanced the rate of inactivation and altered the pH-dependence of steady-state desensitization. Further, the use of methanethiosulfonate (MTS) reagents suggests that the lower palm region (L280C) undergoes a conformational change when ASIC1a transitions from closed to desensitized. We determined that L280C also displays an altered response to the RFamide peptide, FRRFamide. Further, the presence of FRRFamide limited MTS modification of L280C. Together, these results indicate a potential role of the lower palm domain in peptide modulation and suggest RFamide-related peptides promote conformational changes within this region. These data provide empirical support for the idea that L280, and likely this region of the central vestibule, is intimately involved in channel inactivation and desensitization.	[Frey, Erin N.; Wegman, Clem John; Askwith, Candice C.] Ohio State Univ, Wexner Med Ctr, Dept Neurosci, Columbus, OH 43210 USA; [Frey, Erin N.] Ohio State Univ, Biomed Sci Grad Program, Columbus, OH 43210 USA; [Pavlovicz, Ryan E.; Li, Chenglong] Ohio State Univ, Biophys Grad Program, Columbus, OH 43210 USA; [Li, Chenglong] Ohio State Univ, Coll Pharm, Div Med Chem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Askwith, CC (corresponding author), Ohio State Univ, Wexner Med Ctr, Dept Neurosci, Columbus, OH 43210 USA.	askwith.1@osu.edu	Li, Chenglong/E-7182-2010	Li, Chenglong/0000-0003-3174-8719	National Institute of Health, National Institute of Neurological Disorders and Stroke [R01 NS062967]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM068412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045758, R01NS062967] Funding Source: NIH RePORTER	National Institute of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institute of Health, National Institute of Neurological Disorders and Stroke, R01 NS062967. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alijevic O, 2012, J BIOL CHEM, V287, P36059, DOI 10.1074/jbc.M112.360487; Allen NJ, 2002, J PHYSIOL-LONDON, V543, P521, DOI 10.1113/jphysiol.2002.020297; Askwith CC, 2000, NEURON, V26, P133, DOI 10.1016/S0896-6273(00)81144-7; Askwith CC, 2001, P NATL ACAD SCI USA, V98, P6459, DOI 10.1073/pnas.111155398; Babini E, 2002, J BIOL CHEM, V277, P41597, DOI 10.1074/jbc.M205877200; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Bargeton B, 2010, J BIOL CHEM, V285, P13816, DOI 10.1074/jbc.M109.086843; Behan AT, 2013, CELL DEATH DIFFER, V20, P589, DOI 10.1038/cdd.2012.158; Bohlen CJ, 2011, NATURE, V479, P410, DOI 10.1038/nature10607; Catarsi S, 2001, NEUROPHARMACOLOGY, V41, P592, DOI 10.1016/S0028-3908(01)00107-1; Chen XM, 2005, J GEN PHYSIOL, V126, P71, DOI 10.1085/jgp.200509303; Chen XM, 2006, NEUROPHARMACOLOGY, V50, P964, DOI 10.1016/j.neuropharm.2006.01.007; Coric T, 2003, J BIOL CHEM, V278, P45240, DOI 10.1074/jbc.M304441200; Coryell MW, 2007, BIOL PSYCHIAT, V62, P1140, DOI 10.1016/j.biopsych.2007.05.008; Coryell MW, 2009, J NEUROSCI, V29, P5381, DOI 10.1523/JNEUROSCI.0360-09.2009; Coryell MW, 2008, J NEUROSCI, V28, P13738, DOI 10.1523/JNEUROSCI.3907-08.2008; Cushman KA, 2007, J GEN PHYSIOL, V129, P345, DOI 10.1085/jgp.200709757; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; de la Rosa DA, 2000, ANNU REV PHYSIOL, V62, P573, DOI 10.1146/annurev.physiol.62.1.573; Della Vecchia MC, 2013, J BIOL CHEM, V288, P5487, DOI 10.1074/jbc.M112.441964; Deval E, 2003, NEUROPHARMACOLOGY, V44, P662, DOI 10.1016/S0028-3908(03)00047-9; Diochot S, 2004, EMBO J, V23, P1516, DOI 10.1038/sj.emboj.7600177; Diochot S, 2012, NATURE, V490, P552, DOI 10.1038/nature11494; Dube GR, 2009, CURR PHARM DESIGN, V15, P1750, DOI 10.2174/138161209788186263; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Grunder S, 2012, CHANNELS, V6, P409, DOI 10.4161/chan.22154; Hoagland EN, 2010, J BIOL CHEM, V285, P41852, DOI 10.1074/jbc.M110.171330; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; KNAP AK, 1989, PROTEINS, V6, P316, DOI 10.1002/prot.340060314; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li TB, 2010, J BIOL CHEM, V285, P31285, DOI 10.1074/jbc.M110.160382; Li TB, 2010, J BIOL CHEM, V285, P22706, DOI 10.1074/jbc.M110.134114; Lingueglia E, 2006, PEPTIDES, V27, P1138, DOI 10.1016/j.peptides.2005.06.037; Mazzuca M, 2007, NAT NEUROSCI, V10, P943, DOI 10.1038/nn1940; Nishimura M, 2000, HYPERTENSION, V35, P443, DOI 10.1161/01.HYP.35.1.443; Ostrovskaya O, 2004, J NEUROCHEM, V91, P252, DOI 10.1111/j.1471-4159.2004.02688.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pignataro G, 2007, BRAIN, V130, P151, DOI 10.1093/brain/awl325; ROBERTS DD, 1986, BIOCHEMISTRY-US, V25, P5595, DOI 10.1021/bi00367a038; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Sherwood TW, 2008, J BIOL CHEM, V283, P1818, DOI 10.1074/jbc.M705118200; Sherwood TW, 2009, J NEUROSCI, V29, P14371, DOI 10.1523/JNEUROSCI.2186-09.2009; Springauf A, 2011, J BIOL CHEM, V286, P24374, DOI 10.1074/jbc.M111.230797; Staniland AA, 2009, EUR J PAIN, V13, P554, DOI 10.1016/j.ejpain.2008.07.001; Vergo S, 2011, BRAIN, V134, P571, DOI 10.1093/brain/awq337; Vralsted VC, 2011, GENES BRAIN BEHAV, V10, P444, DOI 10.1111/j.1601-183X.2011.00683.x; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2004, P NATL ACAD SCI USA, V101, P3621, DOI 10.1073/pnas.0308753101; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Wemmie JA, 2013, NAT REV NEUROSCI, V14, P461, DOI 10.1038/nrn3529; Xie JH, 2003, J NEUROPHYSIOL, V89, P2459, DOI 10.1152/jn.00707.2002; Xie JH, 2002, J NEUROPHYSIOL, V87, P2835, DOI 10.1152/jn.2002.87.6.2835; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yang Z, 2012, J STRUCT BIOL, V179, P269, DOI 10.1016/j.jsb.2011.09.006; Yu Y, 2011, J BIOL CHEM, V286, P24996, DOI 10.1074/jbc.M111.239558; Yu Y, 2010, NEURON, V68, P61, DOI 10.1016/j.neuron.2010.09.001; Zhang P, 2006, J GEN PHYSIOL, V127, P109, DOI 10.1085/jgp.200509396; Ziemann AE, 2008, NAT NEUROSCI, V11, P816, DOI 10.1038/nn.2132	64	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71733	10.1371/journal.pone.0071733	http://dx.doi.org/10.1371/journal.pone.0071733			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23977127	Green Published, gold, Green Submitted			2022-12-25	WOS:000323221500099
J	Kulbrock, M; Lehner, S; Metzger, J; Ohnesorge, B; Distl, O				Kulbrock, Maike; Lehner, Stefanie; Metzger, Julia; Ohnesorge, Bernhard; Distl, Ottmar			A Genome-Wide Association Study Identifies Risk Loci to Equine Recurrent Uveitis in German Warmblood Horses	PLOS ONE			English	Article							AUTOIMMUNE-DISEASE; GENE POLYMORPHISMS; BEHCETS-DISEASE; T-CELLS; LEPTOSPIRA; EYES; IMMUNOPATHOLOGY; INTERLEUKIN-17; EXPRESSION; VITRECTOMY	Equine recurrent uveitis (ERU) is a common eye disease affecting up to 3-15% of the horse population. A genome-wide association study (GWAS) using the Illumina equine SNP50 bead chip was performed to identify loci conferring risk to ERU. The sample included a total of 144 German warmblood horses. A GWAS showed a significant single nucleotide polymorphism (SNP) on horse chromosome (ECA) 20 at 49.3 Mb, with IL-17A and IL-17F being the closest genes. This locus explained a fraction of 23% of the phenotypic variance for ERU. A GWAS taking into account the severity of ERU, revealed a SNP on ECA18 nearby to the crystalline gene cluster CRYGA-CRYGF. For both genomic regions on ECA18 and 20, significantly associated haplotypes containing the genome-wide significant SNPs could be demonstrated. In conclusion, our results are indicative for a genetic component regulating the possible critical role of IL-17A and IL-17F in the pathogenesis of ERU. The associated SNP on ECA18 may be indicative for cataract formation in the course of ERU.	[Kulbrock, Maike; Lehner, Stefanie; Metzger, Julia; Distl, Ottmar] Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany; [Kulbrock, Maike; Ohnesorge, Bernhard] Univ Vet Med Hannover, Clin Horses, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation	Distl, O (corresponding author), Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany.	ottmar.distl@tiho-hannover.de		Metzger, Julia/0000-0002-2089-8933	Mehl-Mulhens Stiftung, Koln [DI-MM/1-1]	Mehl-Mulhens Stiftung, Koln	This study was supported by the Mehl-Mulhens Stiftung, Koln (DI-MM/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams K.L., 1990, EQUINE PRACT, V12, P27; Alexander C S, 1990, Tierarztl Prax, V18, P623; ANGELOS J, 1988, ANIM GENET, V19, P417, DOI 10.1111/j.1365-2052.1988.tb00833.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Blalock EL, 2013, CYTOKINE, DOI S1043-4666; Borstel MV, 2010, PFERDEHEILKUNDE, V26, P219; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brem S, 1999, BERL MUNCH TIERARZTL, V112, P390; CARTIER M, 1992, NAT GENET, V2, P42, DOI 10.1038/ng0992-42; Chi W, 2007, J ALLERGY CLIN IMMUN, V119, P1218, DOI 10.1016/j.jaci.2007.01.010; Chu ML, 2011, INVEST OPHTH VIS SCI, V52, P7084, DOI 10.1167/iovs.11-7539; Cross RS, 1996, VET REC, V78, P8; Deeg CA, 2004, EQUINE VET J, V36, P73, DOI 10.2746/0425164044864651; Deeg CA, 2002, EXP EYE RES, V75, P127, DOI 10.1006/exer.2002.2011; Deeg CA, 2002, EUR J IMMUNOL, V32, P2598, DOI 10.1002/1521-4141(200209)32:9&lt;2598::AID-IMMU2598&gt;3.0.CO;2-#; Deeg CA, 2008, VET OPHTHALMOL, V11, P61, DOI 10.1111/j.1463-5224.2008.00625.x; Deeg CA, 2008, OPHTHAL RES, V40, P151, DOI 10.1159/000119867; Deeg CA, 2006, MOL CELL PROTEOMICS, V5, P1462, DOI 10.1074/mcp.M500352-MCP200; Deeg CA, 2009, VET IMMUNOL IMMUNOP, V128, P132, DOI 10.1016/j.vetimm.2008.10.302; Dwyer A. E., 2005, EQUINE OPHTHALMOLOGY, P285; DWYER AE, 1995, J AM VET MED ASSOC, V207, P1327; Gilger B C, 2010, Equine Vet J Suppl, P57; Gilger BC, 1999, VET IMMUNOL IMMUNOP, V71, P17, DOI 10.1016/S0165-2427(99)00082-3; Gilger BC, 2002, AM J VET RES, V63, P942, DOI 10.2460/ajvr.2002.63.942; Hartskeerl RA, 2004, J VET MED B, V51, P110, DOI 10.1111/j.1439-0450.2004.00740.x; Jang WC, 2008, RHEUMATOL INT, V29, P173, DOI 10.1007/s00296-008-0664-y; Kaese HJ, 2005, VET OPHTHALMOL, V8, P437; Kalsow CM, 1998, OCUL IMMUNOL INFLAMM, V6, P239, DOI 10.1076/ocii.6.4.239.4026; Kim ES, 2012, LIFE SCI, V90, P740, DOI 10.1016/j.lfs.2012.03.017; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lowe R C, 2010, Equine Vet J Suppl, P46; NaYoung Y, 2009, J VET CLIN, V26, P520; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Regan DP, 2012, VET OPHTHALMOL, V15, P145, DOI 10.1111/j.1463-5224.2011.00951.x; Romeike A, 1998, VET PATHOL, V35, P515, DOI 10.1177/030098589803500606; Shimizu J, 2012, CLIN EXP IMMUNOL, V168, P68, DOI 10.1111/j.1365-2249.2011.04543.x; Shu QM, 2010, HUM IMMUNOL, V71, P988, DOI 10.1016/j.humimm.2010.06.020; Spiess B M, 2010, Equine Vet J Suppl, P50; Szemes PA, 2000, PRAKT TIERARZT, V81, P408; Tomordy E, 2010, PFERDEHEILKUNDE, V26, P251; Vandenbroeck K, 2012, J INTERF CYTOK RES, V32, P139, DOI 10.1089/jir.2011.0103; Wollanke B, 1998, BERL MUNCH TIERARZTL, V111, P134; Wollanke B, 2004, PFERDEHEILKUNDE, V20, P327, DOI 10.21836/PEM20040403; Yang Y, 2012, INVEST OPHTH VIS SCI, V53, P1012, DOI 10.1167/iovs.11-8505; Zhang R, 2009, CURR EYE RES, V34, P297, DOI 10.1080/02713680902741696	47	42	43	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71619	10.1371/journal.pone.0071619	http://dx.doi.org/10.1371/journal.pone.0071619			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23977091	Green Published, gold, Green Submitted			2022-12-25	WOS:000323221500091
J	Li, J; Mansmann, UR				Li, Jian; Mansmann, Ulrich R.			Modeling of Non-Steroidal Anti-Inflammatory Drug Effect within Signaling Pathways and miRNA-Regulation Pathways	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; CYCLOOXYGENASE-2 EXPRESSION; COLORECTAL-CANCER; PROSTAGLANDIN E-2; RNA INTERFERENCE; PROSTATE-CANCER; GROWTH; RECEPTOR; CHEMOPREVENTION; PROLIFERATION	To date, it is widely recognized that Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) can exert considerable anti-tumor effects regarding many types of cancers. The prolonged use of NSAIDs is highly associated with diverse side effects. Therefore, tailoring down the NSAID application onto individual patients has become a necessary and relevant step towards personalized medicine. This study conducts the systemsbiological approach to construct a molecular model (NSAID model) containing a cyclooxygenase (COX)-pathway and its related signaling pathways. Four cancer hallmarks are integrated into the model to reflect different developmental aspects of tumorigenesis. In addition, a Flux-Comparative-Analysis (FCA) based on Petri net is developed to transfer the dynamic properties (including drug responsiveness) of individual cellular system into the model. The gene expression profiles of different tumor-types with available drug-response information are applied to validate the predictive ability of the NSAID model. Moreover, two therapeutic developmental strategies, synthetic lethality and microRNA (miRNA) biomarker discovery, are investigated based on the COX-pathway. In conclusion, the result of this study demonstrates that the NSAID model involving gene expression, gene regulation, signal transduction, protein interaction and other cellular processes, is able to predict the individual cellular responses for different therapeutic interventions (such as NS-398 and COX-2 specific siRNA inhibition). This strongly indicates that this type of model is able to reflect the physiological, developmental and pathological processes of an individual. The approach of miRNA biomarker discovery is demonstrated for identifying miRNAs with oncogenic and tumor suppressive functions for individual cell lines of breast-, colon- and lung-tumor. The achieved results are in line with different independent studies that investigated miRNA biomarker related to diagnostics of cancer treatments, therefore it might shed light on the development of biomarker discovery at individual level. Particular results of this study might contribute to step further towards personalized medicine with the systemsbiological approach.	[Li, Jian; Mansmann, Ulrich R.] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Li, Jian; Mansmann, Ulrich R.] German Canc Consortium DKTK, Heidelberg, Germany; [Li, Jian] German Canc Res Ctr, Heidelberg, Germany	University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Li, J (corresponding author), Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany.	lijian@ibe.med.uni-muenchen.de			German Cancer Research Institute (DKFZ); German Consortium for Translational Cancer Research (DKTK)	German Cancer Research Institute (DKFZ); German Consortium for Translational Cancer Research (DKTK)	This work was supported by the German Cancer Research Institute (DKFZ)(http://www.dkfz.de) and German Consortium for Translational Cancer Research (DKTK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; Arora H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023802; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Chakrabarty A, 2007, P NATL ACAD SCI USA, V104, P15144, DOI 10.1073/pnas.0705917104; Charames GS, 2006, INT J ONCOL, V28, P543; Daikoku T, 2008, CANCER RES, V68, P5619, DOI 10.1158/0008-5472.CAN-08-1274; Dannenberg AJ, 1999, SEMIN ONCOL, V26, P499; Denkert C, 2003, ONCOGENE, V22, P8653, DOI 10.1038/sj.onc.1206920; Durot M, 2009, FEMS MICROBIOL REV, V33, P164, DOI 10.1111/j.1574-6976.2008.00146.x; Ferrario A, 2005, CANCER RES, V65, P9473, DOI 10.1158/0008-5472.CAN-05-1659; Fosslien E, 2000, ANN CLIN LAB SCI, V30, P3; Frankel LB, 2011, EMBO J, V30, P4628, DOI 10.1038/emboj.2011.331; Friedman JM, 2009, CANCER RES, V69, P2623, DOI 10.1158/0008-5472.CAN-08-3114; Green DR, 1998, CELL, V94, P695, DOI 10.1016/S0092-8674(00)81728-6; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris RE, 2007, INT J BIOL SCI, V3, P328; Hidvegi T, 2010, SCIENCE, V329, P229, DOI 10.1126/science.1190354; Hiraga T, 2006, CANCER RES, V66, P2067, DOI 10.1158/0008-5472.CAN-05-2012; Husain SS, 2001, LIFE SCI, V69, P3045, DOI 10.1016/S0024-3205(01)01411-4; Iniguez MA, 2003, TRENDS MOL MED, V9, P73, DOI 10.1016/S1471-4914(02)00011-4; Jana NR, 2008, CELL MOL LIFE SCI, V65, P1295, DOI 10.1007/s00018-008-7511-x; Jayaprakash V, 2006, ARCH OTOLARYNGOL, V132, P1231, DOI 10.1001/archotol.132.11.1231; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kanaan Z, 2012, ANN SURG, V256, P544, DOI 10.1097/SLA.0b013e318265bd6f; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Leone G, 2002, HAEMATOLOGICA, V87, P1324; Li JLL, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-678; Li LC, 2000, CANCER RES, V60, P702; Lichtenberger LM, 2001, BIOCHEM PHARMACOL, V61, P631, DOI 10.1016/S0006-2952(00)00576-1; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Ma L, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2720; Mann M, 2001, GASTROENTEROLOGY, V120, P1713, DOI 10.1053/gast.2001.24844; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; Papin JA, 2005, NAT REV MOL CELL BIO, V6, P99, DOI 10.1038/nrm1570; Poligone B, 2001, J BIOL CHEM, V276, P38658, DOI 10.1074/jbc.M106599200; Preis M, 2011, CLIN CANCER RES, V17, P5812, DOI 10.1158/1078-0432.CCR-11-0695; Richards JA, 2002, J STEROID BIOCHEM, V80, P203, DOI 10.1016/S0960-0760(01)00187-X; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Shlomi T, 2005, P NATL ACAD SCI USA, V102, P7695, DOI 10.1073/pnas.0406346102; Shreedhar V, 1998, J IMMUNOL, V160, P3783; Smalley W E, 1997, Adv Pharmacol, V39, P1, DOI 10.1016/S1054-3589(08)60067-8; Stasinopoulos L, 2008, NEOPLASIA, V10, P1163, DOI 10.1593/neo.08568; Strillacci A, 2006, BRIT J CANCER, V94, P1300, DOI 10.1038/sj.bjc.6603094; Torrance CJ, 2000, NAT MED, V6, P1024, DOI 10.1038/79534; Tortora G, 2003, CLIN CANCER RES, V9, P1566; Troiani T, 2008, CRIT REV ONCOL HEMAT, V65, P200, DOI 10.1016/j.critrevonc.2007.10.003; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; Tuccillo C, 2005, CLIN CANCER RES, V11, P1268; Tuck-Muller CM, 2000, CYTOGENET CELL GENET, V89, P121, DOI 10.1159/000015590; Uefuji K, 2000, CLIN CANCER RES, V6, P135; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang DZ, 2005, GASTROENTEROLOGY, V128, P1445, DOI 10.1053/j.gastro.2004.09.080; Wang DZ, 2004, CANCER CELL, V6, P285, DOI 10.1016/j.ccr.2004.08.011; Wang R, 2008, MOL CELL BIOCHEM, V317, P179, DOI 10.1007/s11010-008-9847-9; Wei Juan, 2011, Chin J Cancer, V30, P407; Weinberg RA, 2008, CARCINOGENESIS, V29, P1092, DOI 10.1093/carcin/bgn104; Wolfe MM, 1999, NEW ENGL J MED, V340, P1888, DOI 10.1056/NEJM199906173402407; Wong BCY, 2004, GASTROENTEROLOGY, V126, P136, DOI 10.1053/j.gastro.2003.10.063; Wu HL, 2009, CELL RES, V19, P439, DOI 10.1038/cr.2009.18; Wurdinger T, 2007, PHARMACOGENOMICS J, V7, P297, DOI 10.1038/sj.tpj.6500429; Wynne S, 2010, MOL CANCER RES, V8, P1656, DOI 10.1158/1541-7786.MCR-10-0342; Yoshimoto T, 2002, ADV EXP MED BIOL, V507, P403, DOI 10.1016/B978-044450973-4/50072-X; Yu XF, 2011, WORLD J GASTROENTERO, V17, P4711, DOI 10.3748/wjg.v17.i42.4711; Yu YJ, 2012, CARCINOGENESIS, V33, P68, DOI 10.1093/carcin/bgr246; Zhang H, 2006, BIOCHEM BIOPH RES CO, V404, P273; Zhang JG, 2011, J THORAC ONCOL, V6, P671, DOI 10.1097/JTO.0b013e318208eb35	73	15	16	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e72477	10.1371/journal.pone.0072477	http://dx.doi.org/10.1371/journal.pone.0072477			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967306	Green Published, Green Submitted, gold			2022-12-25	WOS:000323221500134
J	Nguyen, GK; Hwang, BH; Zhang, YQ; Monahan, JFW; Davis, GB; Lee, YS; Ragina, NP; Wang, C; Zhou, ZY; Hong, YK; Spivak, RM; Wong, AK				Nguyen, Gerard K.; Hwang, Brian H.; Zhang, Yiqiang; Monahan, John F. W.; Davis, Gabrielle B.; Lee, Yong Suk; Ragina, Neli P.; Wang, Charles; Zhou, Zhao Y.; Hong, Young Kwon; Spivak, Ryan M.; Wong, Alex K.			Novel Biomarkers of Arterial and Venous Ischemia in Microvascular Flaps	PLOS ONE			English	Article							ISLAND SKIN FLAPS; GENE-EXPRESSION; TISSUE; TIME; OCCLUSION; TRANSPLANTATION; DYSFUNCTION; FAILURE; RATS; ISCHEMIA/REPERFUSION	The field of reconstructive microsurgery is experiencing tremendous growth, as evidenced by recent advances in face and hand transplantation, lower limb salvage after trauma, and breast reconstruction. Common to all of these procedures is the creation of a nutrient vascular supply by microsurgical anastomosis between a single artery and vein. Complications related to occluded arterial inflow and obstructed venous outflow are not uncommon, and can result in irreversible tissue injury, necrosis, and flap loss. At times, these complications are challenging to clinically determine. Since early intervention with return to the operating room to re-establish arterial inflow or venous outflow is key to flap salvage, the accurate diagnosis of early stage complications is essential. To date, there are no biochemical markers or serum assays that can predict these complications. In this study, we utilized a rat model of flap ischemia in order to identify the transcriptional signatures of venous congestion and arterial ischemia. We found that the critical ischemia time for the superficial inferior epigastric fasciocutaneus flap was four hours and therefore performed detailed analyses at this time point. Histolgical analysis confirmed significant differences between arterial and venous ischemia. The transcriptome of ischemic, congested, and control flap tissues was deciphered by performing Affymetrix microarray analysis and verified by qRT-PCR. Principal component analysis revealed that arterial ischemia and venous congestion were characterized by distinct transcriptomes. Arterial ischemia and venous congestion was characterized by 408 and 1536.2-fold differentially expressed genes, respectively. qRT-PCR was used to identify five candidate genes Prol1, Muc1, Fcnb, Il1b, and Vcsa1 to serve as biomarkers for flap failure in both arterial ischemia and venous congestion. Our data suggests that Prol1 and Vcsa1 may be specific indicators of venous congestion and allow clinicians to both diagnose and successfully treat microvascular complications before irreversible tissue damage and flap loss occurs.	[Nguyen, Gerard K.; Hwang, Brian H.; Monahan, John F. W.; Davis, Gabrielle B.; Lee, Yong Suk; Zhou, Zhao Y.; Spivak, Ryan M.; Wong, Alex K.] Univ So Calif, Keck Sch Med, Dept Surg, Div Plast & Reconstruct Surg, Los Angeles, CA 90033 USA; [Zhang, Yiqiang; Wang, Charles] Funct Genom Core, Duarte, CA USA; [Zhang, Yiqiang] Univ Washington, Dept Med, Div Cardiol, Seattle, WA USA; [Ragina, Neli P.] Univ So Calif, Keck Sch Med, Dept Surg, Div Colorectal Surg, Los Angeles, CA 90033 USA; [Hong, Young Kwon] Univ So Calif, Keck Sch Med, Dept Surg & Biochem & Mol Biol, Los Angeles, CA 90033 USA	University of Southern California; University of Washington; University of Washington Seattle; University of Southern California; University of Southern California	Wong, AK (corresponding author), Univ So Calif, Keck Sch Med, Dept Surg, Div Plast & Reconstruct Surg, Los Angeles, CA 90033 USA.	alex.wong@med.usc.edu	Zhang, Yiqiang/E-2349-2016	Zhang, Yiqiang/0000-0002-2437-925X; Wong, Alex/0000-0002-4068-5230	Robert and May Wright Foundation; SC CTSI (NIH/NCRR/NCATS) [UL1TR000130]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000130] Funding Source: NIH RePORTER	Robert and May Wright Foundation; SC CTSI (NIH/NCRR/NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funding for this work was supported in part by the Robert and May Wright Foundation (to A. K. W). This project was supported by SC CTSI (NIH/NCRR/NCATS) through Grant UL1TR000130. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amon M, 2003, FASEB J, V17, P175, DOI 10.1096/fj.02-0368com; ANGEL MF, 1990, PLAST RECONSTR SURG, V85, P789, DOI 10.1097/00006534-199005000-00021; Ashley S, 2003, SCI AM, V289, P52, DOI 10.1038/scientificamerican1003-52; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Badylak SF, 2012, LANCET, V379, P943, DOI 10.1016/S0140-6736(12)60073-7; Bachle AC, 2011, MICROVASC RES, V82, P28, DOI 10.1016/j.mvr.2011.03.010; Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498; Carrozza MC, 2006, BIOL CYBERN, V95, P629, DOI 10.1007/s00422-006-0124-2; Carrozza M C, 2002, Technol Health Care, V10, P77; Chafin B, 1999, HEAD NECK-J SCI SPEC, V21, P198, DOI 10.1002/(SICI)1097-0347(199905)21:3<198::AID-HED3>3.3.CO;2-K; Chen KT, 2007, PLAST RECONSTR SURG, V120, P187, DOI 10.1097/01.prs.0000264077.07779.50; Christ GJ, 2004, AM J PHYSIOL-HEART C, V287, pH1544, DOI 10.1152/ajpheart.00792.2003; Craelius W, 2002, SCIENCE, V295, P1018, DOI 10.1126/science.295.5557.1018; Davies KP, 2009, J SEX MED, V6, P286, DOI 10.1111/j.1743-6109.2008.01186.x; Dhillon GS, 2004, J HAND SURG-AM, V29A, P605, DOI 10.1016/j.jhsa.2004.02.006; Dorafshar A-H, 2012, PLAST RECONSTR SURG; Dubernard JM, 2007, NEW ENGL J MED, V357, P2451, DOI 10.1056/NEJMoa072828; EISENHART C, 1947, BIOMETRICS, V3, P1, DOI 10.2307/3001534; Elliott MJ, 2012, LANCET, V380, P994, DOI 10.1016/S0140-6736(12)60737-5; Filippidis A, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.8.FOCUS09167; Foroohar A, 2011, TRANSPL P, V43, P3521, DOI 10.1016/j.transproceed.2011.09.047; HARASHINA T, 1977, PLAST RECONSTR SURG, V60, P92, DOI 10.1097/00006534-197707000-00013; Harder Y, 2005, AM J PHYSIOL-HEART C, V288, pH1224, DOI 10.1152/ajpheart.00640.2004; HEDEN P, 1989, PLAST RECONSTR SURG, V84, P475, DOI 10.1097/00006534-198909000-00014; HJORTDAL VE, 1994, PLAST RECONSTR SURG, V93, P366, DOI 10.1097/00006534-199402000-00023; HJORTDAL VE, 1992, PLAST RECONSTR SURG, V89, P1083, DOI 10.1097/00006534-199206000-00014; HJORTDAL VE, 1992, PLAST RECONSTR SURG, V89, P521, DOI 10.1097/00006534-199203000-00021; Guzman-de la Garza FJ, 2009, WORLD J GASTROENTERO, V15, P3901, DOI 10.3748/wjg.15.3901; KERRIGAN CL, 1994, PLAST RECONSTR SURG, V93, P1485; Kuiken TA, 2004, PROSTHET ORTHOT INT, V28, P245; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6; MARZELLA L, 1988, PLAST RECONSTR SURG, V81, P742, DOI 10.1097/00006534-198805000-00016; MELDON JH, 1975, ACTA MED SCAND, P19; Menger MD, 1997, SHOCK, V8, P2, DOI 10.1097/00024382-199707000-00002; Mirzabeigi MN, 2012, PLAST RECONSTR SURG, V130, P579, DOI 10.1097/PRS.0b013e31825dbfb7; Mithani SK, 2009, ANN PLAS SURG, V63, P323, DOI 10.1097/SAP.0b013e318190320a; Morris KE, 2009, AM J PHYSIOL-CELL PH, V296, pC514, DOI 10.1152/ajpcell.00214.2008; Mukhopadhyay P, 2011, BBA-REV CANCER, V1815, P224, DOI 10.1016/j.bbcan.2011.01.001; Murray JI, 2004, MOL BIOL CELL, V15, P2361, DOI 10.1091/mbc.E03-11-0799; Niv Y, 2008, WORLD J GASTROENTERO, V14, P2139, DOI 10.3748/wjg.14.2139; Ozmen S, 2008, J PLAST RECONSTR AES, V61, P939, DOI 10.1016/j.bjps.2007.05.017; Pomahac B, 2012, NEW ENGL J MED, V366, P715, DOI 10.1056/NEJMoa1111432; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schmid M, 2011, IMMUNOBIOLOGY; Schneeberger S, 2012, ANN SURG; Schneeberger S, 2011, TRANSPL INT, V24, P760, DOI 10.1111/j.1432-2277.2011.01261.x; Sherman R, 2002, NEW ENGL J MED, V347, P1906, DOI 10.1056/NEJMp020150; Siemionow M, 2012, CLIN PLAST SURG, V39, P425, DOI 10.1016/j.cps.2012.07.011; SU CT, 1982, PLAST RECONSTR SURG, V70, P202, DOI 10.1097/00006534-198208000-00014; Tong Y, 2008, BJU INT, V102, P736, DOI 10.1111/j.1464-410X.2008.07631.x; Tong YH, 2007, J UROLOGY, V178, P338, DOI 10.1016/j.juro.2007.03.004; Vollmar B, 1997, LIVER, V17, P93; Waynforth H. B., 1980, Experimental and surgical technique in the rat.; Winter JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040157; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhang F, 2006, J RECONSTR MICROSURG, V22, P641, DOI 10.1055/s-2006-956238	57	1	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71628	10.1371/journal.pone.0071628	http://dx.doi.org/10.1371/journal.pone.0071628			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23977093	Green Published, gold, Green Submitted			2022-12-25	WOS:000323221500092
J	Shu, SH; Chen, B; Zhou, MC; Zhao, XM; Xia, HY; Wang, M				Shu, Shaohua; Chen, Bei; Zhou, Mengchun; Zhao, Xinmei; Xia, Haiyang; Wang, Mo			De Novo Sequencing and Transcriptome Analysis of Wolfiporia cocos to Reveal Genes Related to Biosynthesis of Triterpenoids	PLOS ONE			English	Article							RNA-SEQ DATA; PORIA-COCOS; COMPONENTS; ACIDS	Wolfiporia cocos Ryvarden et Gilbertson is a saprophytic fungus in the Basidiomycetes. Its dried sclerotium is widely used as a traditional crude drug in East Asia. Especially in China, the dried sclerotium is regarded as the silver of the Chinese traditional drugs, not only for its white color, but also its medicinal value. Furthermore, triterpenoids from W. cocos are the main active compounds with antitumor and anti-inflammatory activity. Biosynthesis of the triterpenoids has rarely been researched. In this study, the de novo sequencing of the mycelia and sclerotia of W. cocos were carried out by Illumina HiSeq 2000. A total of 3,484,996,740 bp from 38,722,186 sequence reads of mycelia, and 3,573,921,960 bp from 39,710,244 high quality sequence reads of sclerotium were obtained. These raw data were assembled into 60,354 contigs and 40,939 singletons, and 56,938 contigs and 37,220 singletons for mycelia and sclerotia, respectively. The transcriptomic data clearly showed that terpenoid biosynthesis was only via the MVA pathwayin W. cocos. The production of total triterpenoids and pachymic acid was examined in the dry mycelia and sclerotia. The content of total triterpenoids was 5.36% and 1.43% in mycelia and sclerotia, respectively, and the content of pachymic acid was 0.458% and 0.174%. Some genes involved in the triterpenoid biosynthetic pathway were chosen to be verified by qRT-PCR. The unigenes encoding diphosphomevalonate decarboxylase (Unigene 20430), farnesyl diphosphate synthase (Unigene 14106 and 21656), hydroxymethylglutaryl-CoA reductase (NADPH) (Unigene 6395_All) and lanosterol synthase (Unigene28001_All) were upregulated in the mycelia stage. It is likely that expression of these genes influences the biosynthesis of triterpenoids in the mycelia stage.	[Shu, Shaohua; Chen, Bei; Zhou, Mengchun; Zhao, Xinmei; Wang, Mo] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China; [Xia, Haiyang] Chinese Acad Sci, Shanghai Inst Plant Physiol & Ecol, Shanghai, Peoples R China	Huazhong Agricultural University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Xia, HY (corresponding author), Chinese Acad Sci, Shanghai Inst Plant Physiol & Ecol, Shanghai, Peoples R China.	hyxia@sibs.ac.cn; wangmo@hzau.edu.cn			Projects in the National Science & Technology Pillar Program [2011BAI06B03]; Fundamental Research Funds for the Central Universities [2011QC085]	Projects in the National Science & Technology Pillar Program; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This project was supported by Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (2011BAI06B03) and the Fundamental Research Funds for the Central Universities (2011QC085). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r2; Ding Gang, 2002, Zhongguo Zhongyao Zazhi, V27, P756; Fan JP, 2006, J PHARMACEUT BIOMED, V41, P950, DOI 10.1016/j.jpba.2006.01.044; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; HATTORI T, 1992, JPN J PHARMACOL, V59, P89, DOI 10.1254/jjp.59.89; Esteban CI, 2009, REV IBEROAM MICOL, V26, P103, DOI 10.1016/S1130-1406(09)70019-1; Kaminaga T, 1996, ONCOLOGY, V53, P382; Liu D, 2012, PLOS ONE, V7; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Rios JL, 2011, PLANTA MED, V77, P681, DOI 10.1055/s-0030-1270823; Wang L Y, 1993, Zhongguo Zhong Yao Za Zhi, V18, P613; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang YF, 2004, CARBOHYD RES, V339, P327, DOI 10.1016/j.carres.2003.10.006; Yang F, 2012, J BIOSCI BIOENG, V114, P228, DOI 10.1016/j.jbiosc.2012.03.009; Zheng Y, 2008, J ASIAN NAT PROD RES, V10, P640, DOI 10.1080/10286020802133597; Zheng Yan, 2008, J Asian Nat Prod Res, V10, P323, DOI 10.1080/10286020801892250	16	56	74	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71350	10.1371/journal.pone.0071350	http://dx.doi.org/10.1371/journal.pone.0071350			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967197	gold, Green Submitted, Green Published			2022-12-25	WOS:000323221500078
J	Wang, B; Suzuki, H; Aihara, K				Wang, Bing; Suzuki, Hideyuki; Aihara, Kazuyuki			Evaluating Roles of Nodes in Optimal Allocation of Vaccines with Economic Considerations	PLOS ONE			English	Article							OPTIMAL VACCINATION STRATEGIES; INFECTIOUS-DISEASES; COMPLEX NETWORKS; TABU SEARCH; EPIDEMIC; ROBUSTNESS; DYNAMICS; BEHAVIOR	Since the allocation of vaccines is often constrained by limited resources, designing an economical vaccination strategy is a fundamental goal of the epidemiological modelling. In this study, with the objective of reducing costs, we determine the optimal allocation of vaccines for a general class of infectious diseases that spread mainly via contact. We use an optimization routine to identify the roles of nodes with distinct degrees as depending on the cost of treatment to that of vaccination (relative cost of treatment). The optimal allocation drives vaccination priority to medium-degree nodes at a low relative cost of treatment or to high-degree nodes at a high relative cost of treatment. According to the presented results, we may adjust the vaccination priority in the face of an endemic situation.	[Wang, Bing; Aihara, Kazuyuki] Japan Sci & Technol Agcy, Aihara Innovat Math Modelling Project, FIRST, Meguro Ku, Tokyo, Japan; [Wang, Bing; Suzuki, Hideyuki; Aihara, Kazuyuki] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo, Japan; [Suzuki, Hideyuki] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama, Japan	Japan Science & Technology Agency (JST); University of Tokyo; Japan Science & Technology Agency (JST)	Wang, B (corresponding author), Japan Sci & Technol Agcy, Aihara Innovat Math Modelling Project, FIRST, Meguro Ku, Tokyo, Japan.	bingbignmath@gmail.com	Suzuki, Hideyuki/A-4161-2013; WANG, Bing/C-3529-2008	Suzuki, Hideyuki/0000-0002-8150-140X; WANG, Bing/0000-0002-7078-4352	Aihara Innovative Mathematical Modelling Project; Japan Society for the Promotion of Science (JSPS); Council for Science and Technology Policy (CSTP); Japan Science and Technology Agency (JST)	Aihara Innovative Mathematical Modelling Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This research is supported by the Aihara Innovative Mathematical Modelling Project, the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)," initiated by the Council for Science and Technology Policy (CSTP) (BW, HS, and KA), as well as the program by the Japan Science and Technology Agency (JST) "Precursory Research for Embryonic Science and Technology (PRESTO) program" (HS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal S, 2006, PLOS MED, V3, P1816, DOI 10.1371/journal.pmed.0030387; Bauch CT, 2005, P ROY SOC B-BIOL SCI, V272, P1669, DOI 10.1098/rspb.2005.3153; Bauch CT, 2004, P NATL ACAD SCI USA, V101, P13391, DOI 10.1073/pnas.0403823101; Becker NG, 1997, MATH BIOSCI, V139, P117, DOI 10.1016/S0025-5564(96)00139-3; Blower S., 2003, AIDS Reviews, V5, P113; Cohen R, 2001, PHYS REV LETT, V86, P3682, DOI 10.1103/PhysRevLett.86.3682; Cohen R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247901; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Forster GA, 2007, P NATL ACAD SCI USA, V104, P4984, DOI 10.1073/pnas.0607900104; Funk S, 2010, J R SOC INTERFACE, V7, P1247, DOI 10.1098/rsif.2010.0142; Gandon S, 2001, NATURE, V414, P751, DOI 10.1038/414751a; Glover F., 1989, ORSA Journal on Computing, V1, P190, DOI [10.1287/ijoc.2.1.4, 10.1287/ijoc.1.3.190]; GLOVER F, 1990, INTERFACES, V20, P74, DOI 10.1287/inte.20.4.74; Hill AN, 2003, MATH BIOSCI, V181, P85, DOI 10.1016/S0025-5564(02)00129-3; Hoffman SL, 1996, MALARIA VACCINE DEV; Huerta R, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.056115; Ji MJ, 2004, APPL MATH COMPUT, V159, P449, DOI 10.1016/j.amc.2003.10.028; Kleczkowski A, 2012, J R SOC INTERFACE, V9, P158, DOI 10.1098/rsif.2011.0216; Klepac P, 2011, P NATL ACAD SCI USA, V108, P14366, DOI 10.1073/pnas.1101694108; Latora V, 2006, J MED VIROL, V78, P724, DOI 10.1002/jmv.20614; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; Liu JM, 2011, J MED SYST, V35, P1153, DOI 10.1007/s10916-011-9734-x; Manfredi P, 2009, VACCINE, V28, P98, DOI 10.1016/j.vaccine.2009.09.109; Manski CF, 2010, P NATL ACAD SCI USA, V107, P3953, DOI 10.1073/pnas.0915009107; Medlock J, 2009, SCIENCE, V325, P1705, DOI 10.1126/science.1175570; Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906; MOLLOY M, 1995, RANDOM STRUCT ALGOR, V6, P161, DOI 10.1002/rsa.3240060204; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Pastor-Satorras R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036104; Pastor-Satorras R, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.066117; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Patel R, 2005, J THEOR BIOL, V234, P201, DOI 10.1016/j.jtbi.2004.11.032; Perisic A, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-77; Shulgin B, 1998, B MATH BIOL, V60, P1123, DOI 10.1016/S0092-8240(98)90005-2; Tanaka G, 2012, SCI REP-UK, V2, DOI 10.1038/srep00232; Tuite AR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010520; Wallinga J, 2010, P NATL ACAD SCI USA, V107, P923, DOI 10.1073/pnas.0908491107; Wang B, 2007, EUR PHYS J B, V60, P89, DOI 10.1140/epjb/e2007-00324-y; Wang B, 2006, PHYSICA A, V363, P591, DOI 10.1016/j.physa.2005.08.025; Wang B, 2012, SCI REP-UK, V2, DOI 10.1038/srep00887	40	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e70793	10.1371/journal.pone.0070793	http://dx.doi.org/10.1371/journal.pone.0070793			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967109	Green Published, gold, Green Submitted			2022-12-25	WOS:000323221500033
J	Zheng, Z; Chang, L; Nekrashevich, I; Ruchhoeft, P; Khizroev, S; Litvinov, D				Zheng, Zhen; Chang, Long; Nekrashevich, Ivan; Ruchhoeft, Paul; Khizroev, Sakhrat; Litvinov, Dmitri			Fabrication of Dense Non-Circular Nanomagnetic Device Arrays Using Self-Limiting Low-Energy Glow-Discharge Processing	PLOS ONE			English	Article							PROXIMITY EFFECT CORRECTION; ELECTRON-BEAM LITHOGRAPHY; BLOCK-COPOLYMER; ION	We describe a low-energy glow-discharge process using reactive ion etching system that enables non-circular device patterns, such as squares or hexagons, to be formed from a precursor array of uniform circular openings in polymethyl methacrylate, PMMA, defined by electron beam lithography. This technique is of a particular interest for bit-patterned magnetic recording medium fabrication, where close packed square magnetic bits may improve its recording performance. The process and results of generating close packed square patterns by self-limiting low-energy glow-discharge are investigated. Dense magnetic arrays formed by electrochemical deposition of nickel over self-limiting formed molds are demonstrated.	[Zheng, Zhen; Chang, Long; Nekrashevich, Ivan; Ruchhoeft, Paul; Litvinov, Dmitri] Univ Houston, Houston, TX 77004 USA; [Zheng, Zhen; Chang, Long; Nekrashevich, Ivan; Ruchhoeft, Paul; Litvinov, Dmitri] Univ Houston, Ctr Integrated Bio & Nano Syst, Houston, TX USA; [Khizroev, Sakhrat] Florida Int Univ, Miami, FL 33199 USA	University of Houston System; University of Houston; University of Houston System; University of Houston; State University System of Florida; Florida International University	Litvinov, D (corresponding author), Univ Houston, Houston, TX 77004 USA.	Litvinov@uh.edu			National Science Foundation [ECCS-0926027, CMMI-0927786, CBET-0933140]	National Science Foundation(National Science Foundation (NSF))	This material is based upon work supported in part by the following National Science Foundation grants: ECCS-0926027, CMMI-0927786, and CBET-0933140. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn DU, 2008, SOFT MATTER, V4, P1454, DOI 10.1039/b801515e; Bruce RL, 2009, J VAC SCI TECHNOL B, V27, P1142, DOI 10.1116/1.3136864; CHANG THP, 1975, J VAC SCI TECHNOL, V12, P1271, DOI 10.1116/1.568515; Dobisz EA, 2008, P IEEE, V96, P1836, DOI 10.1109/JPROC.2008.2007600; Koval Y, 2004, J VAC SCI TECHNOL B, V22, P843, DOI 10.1116/1.1689306; Liu CH, 2010, MODEL BASED PROXIMIT, P7637; Nagano S, 2006, LANGMUIR, V22, P5233, DOI 10.1021/la060350k; Nishihara H, 2011, CHEM MATER, V23, P3144, DOI 10.1021/cm103388y; Osawa M, 2001, J VAC SCI TECHNOL B, V19, P2483, DOI 10.1116/1.1410090; OWEN G, 1983, J APPL PHYS, V54, P3573, DOI 10.1063/1.332426; Owen G, 1993, PROXIMITY EFFECT COR, P114; Parekh VA, 2007, NANO LETT, V7, P3246, DOI 10.1021/nl071793r; Shiroishi Y, 2009, IEEE T MAGN, V45, P3816, DOI 10.1109/TMAG.2009.2024879; Tehrani S, 2000, IEEE T MAGN, V36, P2752, DOI 10.1109/20.908581; Weller D, 1999, IEEE T MAGN, V35, P4423, DOI 10.1109/20.809134; Zhou ZF, 2008, MATER LETT, V62, P3419, DOI 10.1016/j.matlet.2008.02.071	16	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e73083	10.1371/journal.pone.0073083	http://dx.doi.org/10.1371/journal.pone.0073083			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967340	Green Published, Green Submitted, gold			2022-12-25	WOS:000323221500145
J	Kono, K; Takeda, E; Tsutsui, H; Kuroishi, A; Hulme, AE; Hope, TJ; Nakayama, EE; Shioda, T				Kono, Ken; Takeda, Eri; Tsutsui, Hiromi; Kuroishi, Ayumu; Hulme, Amy E.; Hope, Thomas J.; Nakayama, Emi E.; Shioda, Tatsuo			Slower Uncoating Is Associated with Impaired Replicative Capability of Simian-Tropic HIV-1	PLOS ONE			English	Article								Human immunodeficiency virus type 1 (HIV-1) productively infects only humans and chimpanzees, but not Old World monkeys, such as rhesus and cynomolgus (CM) monkeys. To establish a monkey model of HIV-1/AIDS, several HIV-1 derivatives have been constructed. We previously generated a simian-tropic HIV-1 that replicates efficiently in CM cells. This virus encodes a capsid protein (CA) with SIVmac239-derived loops between alpha-helices 4 and 5 (L4/5) and between alpha-helices 6 and 7 (L6/7), along with the entire vif from SIVmac239 (NL-4/5S6/7SvifS). These SIVmac239-derived sequences were expected to protect the virus from HIV-1 restriction factors in monkey cells. However, the replicative capability of NL-4/5S6/7SvifS in human cells was severely impaired. By long-term cultivation of human CEM-SS cells infected with NL-4/5S6/7SvifS, we succeeded in partially rescuing the impaired replicative capability of the virus in human cells. This adapted virus encoded a G-to-E substitution at the 116th position of the CA (NL-4/5SG116E6/7SvifS). In the work described here, we explored the mechanism by which the replicative capability of NL-4/5S6/7SvifS was impaired in human cells. Quantitative analysis (by real-time PCR) of viral DNA synthesis from infected cells revealed that NL-4/5S6/7SvifS had a major defect in nuclear entry. Mutations in CA are known to affect viral core stability and result in deleterious effects in HIV-1 infection; therefore, we measured the kinetics of uncoating of these viruses. The uncoating of NL-4/5S6/7SvifS was significantly slower than that of wild type HIV-1 (WT), whereas the uncoating of NL-4/5SG116E6/7SvifS was similar to that of WT. Our results suggested that the lower replicative capability of NL-4/5S6/7SvifS in human cells was, at least in part, due to the slower uncoating of this virus.	[Kono, Ken; Takeda, Eri; Tsutsui, Hiromi; Kuroishi, Ayumu; Nakayama, Emi E.; Shioda, Tatsuo] Osaka Univ, Microbial Dis Res Inst, Dept Viral Infect, Suita, Osaka 565, Japan; [Hulme, Amy E.; Hope, Thomas J.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Osaka University; Northwestern University; Feinberg School of Medicine	Shioda, T (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Viral Infect, Suita, Osaka 565, Japan.	shioda@biken.osaka-u.ac.jp		ying mei, zhong shan/0000-0002-0477-0980	Japan Society for the Promotion of Science Excellent Young Researcher Overseas Visit Program; Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labour and Welfare, Japan; Health Science Foundation; NIH [RO1 AI47770, P50 GM082545, F32AI089359]; Grants-in-Aid for Scientific Research [23390111] Funding Source: KAKEN; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI089359, R01AI047770] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082545] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science Excellent Young Researcher Overseas Visit Program; Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Health Science Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Japan Society for the Promotion of Science Excellent Young Researcher Overseas Visit Program and grants from the Ministry of Education, Culture, Sports, Science, and Technology; the Ministry of Health, Labour and Welfare, Japan; and the Health Science Foundation. This work also was supported by NIH grants RO1 AI47770 and P50 GM082545 to TJH and F32AI089359 to AEH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao Z, 2004, J VIROL, V78, P3170, DOI 10.1128/JVI.78.6.3170-3177.2004; Ao ZJ, 2007, J BIOL CHEM, V282, P13456, DOI 10.1074/jbc.M610546200; Bouyac-Bertoia M, 2001, MOL CELL, V7, P1025, DOI 10.1016/S1097-2765(01)00240-4; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; BUKRINSKY MI, 1993, NATURE, V365, P666, DOI 10.1038/365666a0; BUKRINSKY MI, 1993, P NATL ACAD SCI USA, V90, P6125, DOI 10.1073/pnas.90.13.6125; Campbell EM, 2007, VIROLOGY, V360, P286, DOI 10.1016/j.virol.2006.10.025; Christ F, 2008, CURR BIOL, V18, P1192, DOI 10.1016/j.cub.2008.07.079; Condra JH, 1996, J VIROL, V70, P8270, DOI 10.1128/JVI.70.12.8270-8276.1996; CONDRA JH, 1995, NATURE, V374, P569, DOI 10.1038/374569a0; Croteau G, 1997, J VIROL, V71, P1089, DOI 10.1128/JVI.71.2.1089-1096.1997; Dismuke DJ, 2006, J VIROL, V80, P3712, DOI 10.1128/JVI.80.8.3712-3720.2006; Dvorin JD, 2002, J VIROL, V76, P12087, DOI 10.1128/JVI.76.23.12087-12096.2002; Fassati A, 2003, EMBO J, V22, P3675, DOI 10.1093/emboj/cdg357; Fassati A, 2001, J VIROL, V75, P3626, DOI 10.1128/JVI.75.8.3626-3635.2001; Fitzon T, 2000, VIROLOGY, V268, P294, DOI 10.1006/viro.1999.0178; Forshey BM, 2005, J VIROL, V79, P869, DOI 10.1128/JVI.79.2.869-875.2005; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Gallay P, 1997, P NATL ACAD SCI USA, V94, P9825, DOI 10.1073/pnas.94.18.9825; Hearps AC, 2006, BIOCHEM J, V398, P475, DOI 10.1042/BJ20060466; Hulme AE, 2011, P NATL ACAD SCI USA, V108, P9975, DOI 10.1073/pnas.1014522108; Julias JG, 2001, J VIROL, V75, P6537, DOI 10.1128/JVI.75.14.6537-6546.2001; Kamada K, 2006, P NATL ACAD SCI USA, V103, P16959, DOI 10.1073/pnas.0608289103; Krishnan L, 2010, J VIROL, V84, P397, DOI 10.1128/JVI.01899-09; Kuroishi A, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-58; Kuroishi A, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-70; Leschonsky B, 2007, J GEN VIROL, V88, P207, DOI 10.1099/vir.0.81894-0; Limon A, 2002, J VIROL, V76, P12078, DOI 10.1128/JVI.76.23.12078-12086.2002; Martinez-Picado J, 1999, J VIROL, V73, P3744, DOI 10.1128/JVI.73.5.3744-3752.1999; Miller MD, 1997, J VIROL, V71, P5382, DOI 10.1128/JVI.71.7.5382-5390.1997; Molla A, 1996, NAT MED, V2, P760, DOI 10.1038/nm0796-760; Myint L, 2004, ANTIMICROB AGENTS CH, V48, P444, DOI 10.1128/AAC.48.2.444-452.2004; Nijhuis M, 1999, AIDS, V13, P2349, DOI 10.1097/00002030-199912030-00006; Nomaguchi M, 2013, MICROBES INFECT, V15, P56, DOI 10.1016/j.micinf.2012.10.013; Ohishi M, 2007, VIROLOGY, V362, P131, DOI 10.1016/j.virol.2006.12.030; Popov S, 1998, EMBO J, V17, P909, DOI 10.1093/emboj/17.4.909; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; Scholz I, 2005, J VIROL, V79, P1470, DOI 10.1128/JVI.79.3.1470-1479.2005; Sebastian S, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-40; Shi J, 2006, VIROLOGY, V350, P493, DOI 10.1016/j.virol.2006.03.013; Song H, 2007, J VIROL, V81, P7280, DOI 10.1128/JVI.00406-07; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Tang SX, 2003, J VIROL, V77, P12592, DOI 10.1128/JVI.77.23.12592-12602.2003; Tang SX, 2001, J VIROL, V75, P9357, DOI 10.1128/JVI.75.19.9357-9366.2001; Vanmaele C, 2003, Bull Soc Belge Ophtalmol, P21; Wacharapornin P, 2007, VIROLOGY, V358, P48, DOI 10.1016/j.virol.2006.08.031; Woodward CL, 2009, J VIROL, V83, P6522, DOI 10.1128/JVI.02061-08; Yamashita M, 2004, J VIROL, V78, P5670, DOI 10.1128/JVI.78.11.5670-5678.2004; Yamashita M, 2007, PLOS PATHOG, V3, P1502, DOI 10.1371/journal.ppat.0030156; Zaitseva L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-11; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4; Zennou V, 1998, J VIROL, V72, P3300, DOI 10.1128/JVI.72.4.3300-3306.1998	52	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e72531	10.1371/journal.pone.0072531	http://dx.doi.org/10.1371/journal.pone.0072531			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967315	Green Published, gold, Green Submitted			2022-12-25	WOS:000323115800107
J	Liu, ML; Wilson, NO; Hibbert, JM; Stiles, JK				Liu, Mingli; Wilson, Nana O.; Hibbert, Jacqueline M.; Stiles, Jonathan K.			STAT3 Regulates MMP3 in Heme-Induced Endothelial Cell Apoptosis	PLOS ONE			English	Article								Background: We have previously reported that free Heme generated during experimental cerebral malaria (ECM) in mice, is central to the pathogenesis of fatal ECM. Heme-induced up-regulation of STAT3 and CXCL10 promotes whereas up-regulation of HO-1 prevents brain tissue damage in ECM. We have previously demonstrated that Heme is involved in the induction of apoptosis in vascular endothelial cells. In the present study, we further tested the hypothesis that Heme reduces blood-brain barrier integrity during ECM by induction of apoptosis of brain vascular endothelial cells through STAT3 and its target gene matrix metalloproteinase three (MMP3) signaling. Methods: Genes associated with the JAK/STAT3 signaling pathway induced upon stimulation by Heme treatment, were assessed using real time RT2 Profile PCR arrays. A human MMP3 promoter was cloned into a luciferase reporter plasmid, pMMP3, and its activity was examined following exposure to Heme treatment by a luciferase reporter gene assay. In order to determine whether activated nuclear protein STAT3 binds to the MMP3 promoter and regulates MMP3 gene, we conducted a ChIP analysis using Heme-treated and untreated human brain microvascular endothelial cells (HBVEC), and determined mRNA and protein expression levels of MMP3 using qRT-PCR and Western blot. Apoptosis in HBVEC treated with Heme was evaluated by MTT and TUNEL assay. Results: The results show that (1) Heme activates a variety of JAK/STAT3 downstream pathways in HBVEC. STAT3 targeted genes such as MMP3 and C/EBPb (Apoptosis-related genes), are up regulated in HBVEC treated with Heme. (2) Heme-induced HBVEC apoptosis via activation of STAT3 as well as its downstream signaling molecule MMP3 and upregulation of CXCL10 and HO-1 expressions. (3) Phosphorylated STAT3 binds to the MMP3 promoter in HBVEC cells, STAT3 transcribed MMP3 and induced MMP3 protein expression in HBVEC cells. Conclusions: Activated STAT3 binds to the MMP3 promoter region and regulates MMP3 in Heme-induced endothelial cell apoptosis.	[Liu, Mingli; Wilson, Nana O.; Hibbert, Jacqueline M.; Stiles, Jonathan K.] Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA	Morehouse School of Medicine	Liu, ML (corresponding author), Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA.	mliu@msm.edu; jstiles@msm.edu	Hibbert, Jacqueline/W-2282-2019; Stiles, Jonathan K./AFM-1940-2022	Stiles, Jonathan Kwamina/0000-0003-0829-1482	National Institutes of Health, NIH-FIC [1T90-HG004151-01]; NIH/FIC/NINDS R21; NIH-RCMI [RR033062]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R90HG004151] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	National Institutes of Health, NIH-FIC; NIH/FIC/NINDS R21; NIH-RCMI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by a grant from the National Institutes of Health, NIH-FIC (1T90-HG004151-01) for postdoctoral training in Genomics and Hemoglobinopathies, and NIH/FIC/NINDS R21 and NIH-RCMI (RR033062) to JKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; BeruBe KA, 1996, AM J RESP CELL MOL, V15, P141, DOI 10.1165/ajrcmb.15.1.8679218; Boengler K, 2008, PHARMACOL THERAPEUT, V120, P172, DOI 10.1016/j.pharmthera.2008.08.002; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Bussolati B, 2006, ANTIOXID REDOX SIGN, V8, P1153, DOI 10.1089/ars.2006.8.1153; Butt OI, 2011, AM J PATHOL, V178, P1316, DOI 10.1016/j.ajpath.2010.12.006; Chilongola J, 2009, TROP MED INT HEALTH, V14, P810, DOI 10.1111/j.1365-3156.2009.02298.x; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Combes V, 2010, PROG NEUROBIOL, V91, P140, DOI 10.1016/j.pneurobio.2010.01.007; Craig A, 2001, MOL BIOCHEM PARASIT, V115, P129, DOI 10.1016/S0166-6851(01)00275-4; D'Ombrain MC, 2007, CELL HOST MICROBE, V2, P130, DOI 10.1016/j.chom.2007.06.012; Datta D, 2010, J BIOL CHEM; Datta D, 2007, AM J PHYSIOL-RENAL, V293, pF1222, DOI 10.1152/ajprenal.00164.2007; Eguchi T, 2008, MOL CELL BIOL, V28, P2391, DOI 10.1128/MCB.01288-07; El Kasmi KC, 2006, J IMMUNOL, V177, P7880, DOI 10.4049/jimmunol.177.11.7880; Epiphanio S, PLOS PATHOG, V6; Ferreira A, 2011, CELL, V145, P398, DOI 10.1016/j.cell.2011.03.049; Fischer P, 2007, BASIC RES CARDIOL, V102, P393, DOI 10.1007/s00395-007-0674-z; Freitas MCS, 2010, LIVER TRANSPLANT, V16, P600, DOI 10.1002/lt.22036; Fujio Y, 2011, J PHARMACOL SCI, V117, P213, DOI 10.1254/jphs.11R05CR; Geuken E, 2005, AM J TRANSPLANT, V5, P1875, DOI 10.1111/j.1600-6143.2005.00960.x; Guo SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043610; Gyan B, 2009, AM J TROP MED HYG, V80, P541, DOI 10.4269/ajtmh.2009.80.541; Haghikia A, 2011, HEART FAIL REV, V16, P35, DOI 10.1007/s10741-010-9170-x; Ho M, 2000, J EXP MED, V192, P1205, DOI 10.1084/jem.192.8.1205; Hunt NH, 2007, NAT MED, V13, P667, DOI 10.1038/nm0607-667; Idro R, 2010, PEDIATR RES, V68, P267, DOI 10.1203/00006450-201011001-00524; Kacimi R, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-7; Kang SS, 2010, J NEUROIMMUNE PHARM, V5, P370, DOI 10.1007/s11481-010-9208-9; Katsu M, 2010, J CEREBR BLOOD F MET, V30, P1939, DOI 10.1038/jcbfm.2010.45; Kelly KJ, 2003, AM J PHYSIOL-CELL PH, V284, pC1309, DOI 10.1152/ajpcell.00353.2002; Lackner P, 2007, NEUROPATH APPL NEURO, V33, P560, DOI 10.1111/j.1365-2990.2007.00833.x; Lee JJ, 2013, INFECT IMMUN; Lin S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-46; Liu ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034280; Loharungsikul S, 2008, ACTA TROP, V105, P10, DOI 10.1016/j.actatropica.2007.08.002; Mendonca VRR, 2012, INFECT IMMUN, V80, P1445, DOI 10.1128/IAI.05933-11; Mockenhaupt FP, 2006, P NATL ACAD SCI USA, V103, P177, DOI 10.1073/pnas.0506803102; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Neria F, 2007, AM J PHYSIOL-CELL PH, V292, pC1123, DOI 10.1152/ajpcell.00548.2005; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Ochola LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014741; Pae HO, 2005, ENDOCRINOLOGY, V146, P2229, DOI 10.1210/en.2004-1431; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Pamplona A, 2009, INT J BIOCHEM CELL B, V41, P711, DOI 10.1016/j.biocel.2008.09.020; Pino P, 2003, J INFECT DIS, V187, P1283, DOI 10.1086/373992; Prisco M, 2004, MOL CELL BIOL, V24, P5421, DOI 10.1128/MCB.24.12.5421-5433.2004; Satriotomo I, 2006, J NEUROCHEM, V98, P1353, DOI 10.1111/j.1471-4159.2006.04051.x; SCHOFIELD L, 1993, J EXP MED, V177, P145, DOI 10.1084/jem.177.1.145; Seixas E, 2009, EUR J IMMUNOL, V39, P1850, DOI 10.1002/eji.200838403; Shi XB, 2008, CELL MOL IMMUNOL, V5, P341, DOI 10.1038/cmi.2008.42; Si-Tayeb K, 2006, AM J PATHOL, V169, P1390, DOI 10.2353/ajpath.2006.060005; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Sternlicht MD, 1999, CELL, V98, P137, DOI 10.1016/S0092-8674(00)81009-0; Stone KP, 2011, CELL PHYSIOL BIOCHEM, V28, P115, DOI 10.1159/000331720; Sukumari-Ramesh S, 2010, GLIA, V58, P1858, DOI 10.1002/glia.21055; Takiguchi M, 1998, INT J EXP PATHOL, V79, P369, DOI 10.1046/j.1365-2613.1998.00082.x; Thangaraju M, 2005, DEVELOPMENT, V132, P4675, DOI 10.1242/dev.02050; Tiffen PG, 2008, MOL ENDOCRINOL, V22, P2677, DOI 10.1210/me.2008-0097; Tripathi AK, 2006, INFECT IMMUN, V74, P3262, DOI 10.1128/IAI.01625-05; Tripathi AK, 2009, BLOOD, V114, P4243, DOI 10.1182/blood-2009-06-226415; Tsuda M, 2011, BRAIN, V134, P1127, DOI 10.1093/brain/awr025; Wang X, 2011, TOXICOLOGY, V280, P126, DOI 10.1016/j.tox.2010.12.001; Wilson NO, 2008, MOL BIOCHEM PARASIT, V162, P172, DOI 10.1016/j.molbiopara.2008.09.003; Yang B, 2010, J NEUROSCI RES, V88, P3090, DOI 10.1002/jnr.22458; Yang XS, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-54; Yao XA, 2010, BIOCHEM BIOPH RES CO, V403, P30, DOI 10.1016/j.bbrc.2010.10.101; Ying H, 2013, INFLAMMATION; Yipp BG, 2003, BLOOD, V101, P2850, DOI 10.1182/blood-2002-09-2841; Yipp BG, 2007, MICROCIRCULATION, V14, P593, DOI 10.1080/10739680701404705; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zgheib C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043313	73	22	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71366	10.1371/journal.pone.0071366	http://dx.doi.org/10.1371/journal.pone.0071366			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967200	Green Published, gold, Green Submitted			2022-12-25	WOS:000323115800052
J	Lu, C; Li, JY; Ge, Z; Zhang, L; Zhou, GP				Lu, C.; Li, J-Y; Ge, Z.; Zhang, L.; Zhou, G-P			Par-4/THAP1 complex and Notch3 competitively regulated pre-mRNA splicing of CCAR1 and affected inversely the survival of T-cell acute lymphoblastic leukemia cells	ONCOGENE			English	Article						Par-4; THAP1; CCAR1; Notch3; apoptosis; leukemia	TARGET GENE; EXPRESSION; APOPTOSIS; IDENTIFICATION; TRANSCRIPTION; GROWTH; PAR-4; THAP1; CYCLE	Although the intensification of therapy for children with T-cell acute lymphoblastic leukemia (T-ALL) has substantially improved clinical outcomes, T-ALL remains an important challenge in pediatric oncology. Here, we report that the cooperative synergy between prostate apoptosis response factor-4 (Par-4) and THAP1 induces cell cycle and apoptosis regulator 1 (CCAR1) gene expression and cellular apoptosis in human T-ALL cell line Jurkat cells, CEM cells and primary cultured neoplastic T lymphocytes from children with T-ALL. Par-4 and THAP1 collaborated to activate the promoter of CCAR1 gene. Mechanistic investigations revealed that Par-4 and THAP1 formed a protein complex by the interaction of their carboxyl termini, and THAP1 bound to CCAR1 promoter though its zinc-dependent DNA-binding domain at amino terminus. Par-4/THAP1 complex and Notch3 competitively bound to CCAR1 promoter and competitively modulated alternative pre-mRNA splicing of CCAR1, which resulted in two different transcripts and played an opposite role in T-ALL cell survival. Despite Notch3 induced a shift splicing from the full-length isoform toward a shorter form of CCAR1 mRNA by splicing factor SRp40 and SRp55, Par-4/THAP1 complex strongly antagonized this inductive effect. Our finding revealed a mechanistic rationale for Par-4/THAP1-induced apoptosis in T-ALL cells that would be of benefit to develop a new therapy strategy for T-ALL.	[Lu, C.; Zhang, L.; Zhou, G-P] Nanjing Med Univ, Affiliated Hosp 1, Dept Pediat, Nanjing 210029, Jiangsu, Peoples R China; [Li, J-Y; Ge, Z.] Nanjing Med Univ, Affiliated Hosp 1, Dept Hematol, Nanjing 210029, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Lu, C (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Pediat, Guangzhou Rd 300, Nanjing 210029, Jiangsu, Peoples R China.	luchaodoctor@163.com; gpzhou2013@163.com			National Natural Science Foundation of China [81170487]; National Major Scientific and Technological Special Project for 'Significant New Drugs Development' [2011ZX09302-003-02]; Jiangsu Province Major Scientific and Technological Special Project [BM2011017]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Scientific and Technological Special Project for 'Significant New Drugs Development'; Jiangsu Province Major Scientific and Technological Special Project; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the National Natural Science Foundation of China (81170487), the National Major Scientific and Technological Special Project for 'Significant New Drugs Development' (2011ZX09302-003-02), the Jiangsu Province Major Scientific and Technological Special Project (BM2011017) and the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Bellavia D, 2007, EMBO J, V26, P1670, DOI 10.1038/sj.emboj.7601626; Boehrer S, 2006, LEUKEMIA RES, V30, P597, DOI 10.1016/j.leukres.2005.09.003; Campagne S, 2010, NUCLEIC ACIDS RES, V38, P3466, DOI 10.1093/nar/gkq053; Cheema SK, 2003, J BIOL CHEM, V278, P19995, DOI 10.1074/jbc.M205865200; Chow KU, 2005, LEUKEMIA, V19, P1103, DOI 10.1038/sj.leu.2403739; Clouaire T, 2005, P NATL ACAD SCI USA, V102, P6907, DOI 10.1073/pnas.0406882102; Glienke W, 2006, LEUKEMIA LYMPHOMA, V47, P1629, DOI 10.1080/10428190600625398; Hebbar N, 2012, J CELL PHYSIOL, V227, P3715, DOI 10.1002/jcp.24098; Kent S, 2011, CELL CYCLE, V10; Kim JH, 2008, MOL CELL, V31, P510, DOI 10.1016/j.molcel.2008.08.001; Ling X, 2005, LUNG CANCER, V49, P353, DOI 10.1016/j.lungcan.2005.03.037; Lu CT, 2008, INT J ARTIF INTELL T, V17, P1; McFie PJ, 2006, J BIOL CHEM, V281, P18069, DOI 10.1074/jbc.M512734200; Ou CY, 2009, J BIOL CHEM, V284, P20629, DOI 10.1074/jbc.M109.014332; Park JT, 2008, CANCER RES, V68, P8852, DOI 10.1158/0008-5472.CAN-08-0517; Roussigne M, 2003, ONCOGENE, V22, P2432, DOI 10.1038/sj.onc.1206271; Schrappe M, 2012, NEW ENGL J MED, V366, P1371, DOI 10.1056/NEJMoa1110169; Tzoneva G, 2012, CURR TOP MICROBIOL, V360, P163, DOI 10.1007/82_2012_232; Van Vlierberghe P, 2012, J CLIN INVEST, V122, P3398, DOI 10.1172/JCI61269; Wei BB, 2010, J BIOMED RES, V24, P58, DOI 10.1016/S1674-8301(10)60009-7; Zhang DX, 2011, J BIOL CHEM, V286, P17746, DOI 10.1074/jbc.M110.206029; Zhang LY, 2007, MOL CANCER THER, V6, P1661, DOI 10.1158/1535-7163.MCT-06-0653	23	25	26	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 12	2013	32	50					5602	5613		10.1038/onc.2013.349	http://dx.doi.org/10.1038/onc.2013.349			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	272LF	23975424	Green Published, hybrid			2022-12-25	WOS:000328461400005
J	Hou, SW; Lee, YK; Hsu, CY; Lee, CC; Su, YC				Hou, Sheng-Wen; Lee, Yi-Kung; Hsu, Chen-Yang; Lee, Ching-Chih; Su, Yung-Cheng			Increased Risk of Acute Pancreatitis in Patients with Chronic Hemodialysis: A 4-Year Follow-Up Study	PLOS ONE			English	Article							CHRONIC DIALYSIS PATIENTS; CHRONIC-RENAL-FAILURE; PERITONEAL-DIALYSIS; SEVERITY; DISEASE; TAIWAN	Background: The risk of acute pancreatitis in patients on long-term peritoneal dialysis is higher as compared to the general population. However, the relationship between long-term hemodialysis and acute pancreatitis has never been established. Objectives: We investigated the incidence of acute pancreatitis among patients on long-term hemodialysis in Taiwan to evaluate if there is a higher risk of acute pancreatitis in comparison to the general population. Methods: We utilized a National Health Insurance (NHI) claims data sample containing one million beneficiaries. We followed all adult beneficiaries from January 1, 2007 until December 31, 2010 to see if they had been hospitalized for acute pancreatitis during this period. We further identified patients on chronic hemodialysis and compared their risk of acute pancreatitis with the general population. Results: This study included 2603 patients with long-term hemodialysis and 773,140 patients without hemodialysis. After controlling for age, gender, Charlson Comorbidity Index Score, geographic region, socioeconomic status and urbanization level, the adjusted hazard ratio was 3.44 (95% Confidence interval, 2.5-4.7). Conclusions: The risk of acute pancreatitis in patients on long-term hemodialysis is significantly higher in comparison to the general population.	[Hou, Sheng-Wen] Shin Kong Wu Ho Su Mem Hosp, Emergency Dept, Taipei, Taiwan; [Lee, Yi-Kung; Su, Yung-Cheng] Buddhist Tzu Chi Dalin Gen Hosp, Emergency Dept, Chiayi, Taiwan; [Lee, Yi-Kung; Lee, Ching-Chih; Su, Yung-Cheng] Tzu Zhi Univ, Sch Med, Hualien, Taiwan; [Hsu, Chen-Yang; Lee, Ching-Chih] Natl Taiwan Univ, Dept Publ Heath, Taipei 10764, Taiwan; [Lee, Ching-Chih] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Lee, Ching-Chih] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Dept Otolaryngol, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Ctr Canc, Chiayi, Taiwan	Shin Kong Wu Ho Su Memorial Hospital; Buddhist Tzu Chi General Hospital; National Taiwan University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital	Su, YC (corresponding author), Buddhist Tzu Chi Dalin Gen Hosp, Emergency Dept, Chiayi, Taiwan.	drsu119@gmail.com						ARAKI T, 1992, INT J PANCREATOL, V12, P263; Bruno MJ, 2000, GUT, V46, P385, DOI 10.1136/gut.46.3.385; Chang CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044325; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chiang TL, 1997, HEALTH POLICY, V39, P225, DOI 10.1016/S0168-8510(96)00877-9; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Greenberger NJ, 2012, HARRISONS PRINCIPLES; Lankisch PG, 2008, NEPHROL DIAL TRANSPL, V23, P1401, DOI 10.1093/ndt/gfm769; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Lee YK, 2013, EMERG MED J; Manga F, 2012, EUR J GASTROEN HEPAT, V24, P95, DOI 10.1097/MEG.0b013e32834d4bcc; OWYANG C, 1982, GUT, V23, P357, DOI 10.1136/gut.23.5.357; Quraishi ER, 2005, AM J GASTROENTEROL, V100, P2288, DOI 10.1111/j.1572-0241.2005.41646.x; SACHS EF, 1983, AM J GASTROENTEROL, V78, P170; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Shen HN, 2012, PANCREAS, V41, P696, DOI 10.1097/MPA.0b013e31823db941; Shen HN, 2012, DIABETES CARE, V35, P1061, DOI 10.2337/dc11-1925; SIRINEK KR, 1984, AM J SURG, V148, P732, DOI 10.1016/0002-9610(84)90426-4; VAZIRI ND, 1987, NEPHRON, V46, P347, DOI 10.1159/000184387	19	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71801	10.1371/journal.pone.0071801	http://dx.doi.org/10.1371/journal.pone.0071801			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977145	gold, Green Published, Green Submitted			2022-12-25	WOS:000324527300038
J	Chang, HH; Wang, TP; Chen, PK; Lin, YY; Liao, CH; Lin, TK; Chiang, YW; Lin, WB; Chiang, CY; Kau, JH; Huang, HH; Hsu, HL; Liao, CY; Sun, DS				Chang, Hsin-Hou; Wang, Tsung-Pao; Chen, Po-Kong; Lin, Yo-Yin; Liao, Chih-Hsien; Lin, Ting-Kai; Chiang, Ya-Wen; Lin, Wen-Bin; Chiang, Chih-Yu; Kau, Jyh-Hwa; Huang, Hsin-Hsien; Hsu, Hui-Ling; Liao, Chi-Yuan; Sun, Der-Shan			Erythropoiesis Suppression Is Associated with Anthrax Lethal Toxin-Mediated Pathogenic Progression	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; INHALATIONAL ANTHRAX; ERYTHROID-DIFFERENTIATION; RECOMBINANT ERYTHROPOIETIN; TISSUE PROTECTION; HEMOGLOBIN; ANEMIA; IDENTIFICATION; GLYCOPHORIN; ACTIVATION	Anthrax is a disease caused by the bacterium Bacillus anthracis, which results in high mortality in animals and humans. Although some of the mechanisms are already known such as asphyxia, extensive knowledge of molecular pathogenesis of this disease is deficient and remains to be further investigated. Lethal toxin (LT) is a major virulence factor of B. anthracis and a specific inhibitor/protease of mitogen-activated protein kinase kinases (MAPKKs). Anthrax LT causes lethality and induces certain anthrax-like symptoms, such as anemia and hypoxia, in experimental mice. Mitogen-activated protein kinases (MAPKs) are the downstream pathways of MAPKKs, and are important for erythropoiesis. This prompted us to hypothesize that anemia and hypoxia may in part be exacerbated by erythropoietic dysfunction. As revealed by colony-forming cell assays in this study, LT challenges significantly reduced mouse erythroid progenitor cells. In addition, in a proteolytic activity-dependent manner, LT suppressed cell survival and differentiation of cord blood CD34(+)-derived erythroblasts in vitro. Suppression of cell numbers and the percentage of erythroblasts in the bone marrow were detected in LT-challenged C57BL/6J mice. In contrast, erythropoiesis was provoked through treatments of erythropoietin, significantly ameliorating the anemia and reducing the mortality of LT-treated mice. These data suggested that suppressed erythropoiesis is part of the pathophysiology of LT-mediated intoxication. Because specific treatments to overcome LT-mediated pathogenesis are still lacking, these efforts may help the development of effective treatments against anthrax.	[Chang, Hsin-Hou; Wang, Tsung-Pao; Liao, Chih-Hsien; Lin, Ting-Kai; Chiang, Ya-Wen; Lin, Wen-Bin; Chiang, Chih-Yu; Sun, Der-Shan] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan; [Chang, Hsin-Hou; Chen, Po-Kong; Lin, Yo-Yin; Sun, Der-Shan] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Kau, Jyh-Hwa] Natl Def Med Ctr, Dept Microbiol & Immunol, Taipei, Taiwan; [Huang, Hsin-Hsien; Hsu, Hui-Ling] Natl Def Med Ctr, Inst Prevent Med, Taipei, Taiwan; [Liao, Chi-Yuan] Mennonite Christian Hosp, Dept Obstet & Gynecol, Hualien, Taiwan	Tzu Chi University; Tzu Chi University; National Defense Medical Center; National Defense Medical Center	Sun, DS (corresponding author), Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan.	dssun@mail.tcu.edu.tw	Chang, Hsin-Hou/B-6225-2012	Chang, Hsin-Hou/0000-0002-8731-3485	Tzu-Chi University [TCMRC9220]; National Science Council [NSC95-2311-B3200-06, NSC 96-2311-B-320-005-MY3, 99-2311-B-320-003-MY3]	Tzu-Chi University; National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by grants from Tzu-Chi University http://www.tcu.edu.tw/(TCMRC9220) and the National Science Council http://web1.nsc.gov.tw/mp.aspx(NSC95-2311-B3200-06, NSC 96-2311-B-320-005-MY3, and 99-2311-B-320-003-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMOVA FA, 1993, P NATL ACAD SCI USA, V90, P2291, DOI 10.1073/pnas.90.6.2291; Baek EJ, 2008, TRANSFUSION, V48, P2235, DOI 10.1111/j.1537-2995.2008.01828.x; Bakhshi T, 2008, TRANSFUSION, V48, P2638, DOI 10.1111/j.1537-2995.2008.01926.x; Bardwell AJ, 2004, BIOCHEM J, V378, P569, DOI 10.1042/BJ20031382; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Brines M, 2008, J INTERN MED, V264, P405, DOI 10.1111/j.1365-2796.2008.02024.x; Brossier F, 2001, TOXICON, V39, P1747, DOI 10.1016/S0041-0101(01)00161-1; Brown AS, 1997, ARTERIOSCL THROM VAS, V17, P802, DOI 10.1161/01.ATV.17.4.802; Chang HH, 2006, J BIOTECHNOL, V126, P277, DOI 10.1016/j.jbiotec.2006.04.038; Chateauvieux S, 2011, BIOCHEM PHARMACOL, V82, P1291, DOI 10.1016/j.bcp.2011.06.045; Chen PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059512; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Cui XZ, 2004, AM J PHYSIOL-REG I, V286, pR699, DOI 10.1152/ajpregu.00593.2003; de Francisco ALM, 2011, CONTRIB NEPHROL, V171, P248, DOI 10.1159/000327173; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Fisher JW, 2003, EXP BIOL MED, V228, P1; Freedman A, 2002, JAMA-J AM MED ASSOC, V287, P869, DOI 10.1001/jama.287.7.869; FUKUDA MN, 1989, BLOOD, V73, P84; GAHMBERG CG, 1978, BLOOD, V52, P379; GALLAGHER PG, 1993, CLIN PERINATOL, V20, P169, DOI 10.1016/S0095-5108(18)30418-4; George-Gay Beverly, 2003, J Perianesth Nurs, V18, P96, DOI 10.1053/jpan.2003.50013; Hagemann C, 2001, CELL SIGNAL, V13, P863, DOI 10.1016/S0898-6568(01)00220-0; Halupa A, 2005, BLOOD, V105, P552, DOI 10.1182/blood-2003-09-3237; Hand CC, 2011, J INVEST MED, V59, P1073, DOI 10.2310/JIM.0b013e3181ed30bf; Holty JEC, 2006, ANN INTERN MED, V144, P270, DOI 10.7326/0003-4819-144-4-200602210-00009; Huo XF, 2005, BIOCHEM BIOPH RES CO, V331, P1346, DOI 10.1016/j.bbrc.2005.04.049; Inayat MS, 2006, TRANSFUS APHER SCI, V34, P25, DOI 10.1016/j.transci.2005.09.005; Jacobs-Helber SM, 2004, BLOOD, V104, P696, DOI 10.1182/blood-2003-05-1754; Jernigan JA, 2001, EMERG INFECT DIS, V7, P933, DOI 10.3201/eid0706.010604; Kau JH, 2002, CURR MICROBIOL, V44, P106, DOI 10.1007/s00284-001-0059-8; Kina T, 2000, BRIT J HAEMATOL, V109, P280, DOI 10.1046/j.1365-2141.2000.02037.x; KLIMPEL KR, 1994, MOL MICROBIOL, V13, P1093, DOI 10.1111/j.1365-2958.1994.tb00500.x; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Li JZ, 2001, BLOOD, V98, P3241, DOI 10.1182/blood.V98.12.3241; Liu K, 2009, J CELL MOL MED, V13, P1907, DOI 10.1111/j.1582-4934.2008.00477.x; MARY JY, 1980, BLOOD CELLS, V6, P241; Mide SM, 2001, IN VIVO, V15, P125; Mina B, 2002, JAMA-J AM MED ASSOC, V287, P858, DOI 10.1001/jama.287.7.858; Moayeri M, 2004, CURR OPIN MICROBIOL, V7, P19, DOI 10.1016/j.mib.2003.12.001; Moayeri M, 2003, J CLIN INVEST, V112, P670, DOI [10.1172/JCI200317991, 10.1172/JCI17991]; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Moosavi MA, 2007, INT J BIOCHEM CELL B, V39, P1685, DOI 10.1016/j.biocel.2007.04.016; Mourez M, 2004, Rev Physiol Biochem Pharmacol, V152, P135; NAGEL RL, 1971, J BIOL CHEM, V246, P69; Rainey GJA, 2004, NAT REV MICROBIOL, V2, P721, DOI 10.1038/nrmicro977; Rameshwar P, 2012, CYTOKINE, V57, P143, DOI 10.1016/j.cyto.2011.10.013; Ratajczak MZ, 1997, BRIT J HAEMATOL, V98, P8, DOI 10.1046/j.1365-2141.1997.1802997.x; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Shafazand S, 1999, CHEST, V116, P1369, DOI 10.1378/chest.116.5.1369; Shehata N, 2008, ANN HEMATOL, V87, P961, DOI 10.1007/s00277-008-0525-5; Shoop WL, 2005, P NATL ACAD SCI USA, V102, P7958, DOI 10.1073/pnas.0502159102; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Tournier JN, 2009, EXPERT REV ANTI-INFE, V7, P219, DOI 10.1586/14787210.7.2.219; TROWBRIDGE IS, 1982, J CELL PHYSIOL, V112, P403, DOI 10.1002/jcp.1041120314; Turk BE, 2007, BIOCHEM J, V402, P405, DOI 10.1042/BJ20061891; VACHA J, 1982, EXP HEMATOL, V10, P768; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wu AG, 2003, J INFECT DIS, V188, P1138, DOI 10.1086/378516; Yao CL, 2006, STEM CELLS DEV, V15, P70, DOI 10.1089/scd.2006.15.70; Zhang J, 2004, BLOOD, V104, P1679, DOI 10.1182/blood-2004-04-1362; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479	61	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71718	10.1371/journal.pone.0071718	http://dx.doi.org/10.1371/journal.pone.0071718			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977125	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700091
J	Lee, SY; Lee, HS; Kim, EY; Ko, JJ; Yoon, TK; Lee, WS; Lee, KA				Lee, Su-Yeon; Lee, Hyun-Seo; Kim, Eun-Young; Ko, Jung-Jae; Yoon, Tae Ki; Lee, Woo-Sik; Lee, Kyung-Ah			Thioredoxin-Interacting Protein Regulates Glucose Metabolism and Affects Cytoplasmic Streaming in Mouse Oocytes	PLOS ONE			English	Article							ACTIN-FILAMENTS; GENE-EXPRESSION; MEIOTIC ARREST; MATURATION; TXNIP; CELLS; IDENTIFICATION; TRANSITION; OOGENESIS; MECHANISM	Thioredoxin-interacting protein (Txnip) regulates intracellular redox state and prompts oxidative stress by binding to and inhibiting Thioredoxin (Trx). In addition, via a Trx-independent mechanism, Txnip regulates glucose metabolism and thus maintains intracellular glucose levels. Previously, we found Txnip mRNA highly expressed in immature germinal vesicle (GV) oocytes, but currently there is no report describing the role of Txnip in oocytes. Therefore, we conducted the present study to determine the function of Txnip in mouse oocytes' maturation and meiosis by using RNA interference (RNAi) method. Upon specific depletion of Txnip, 79.5% of oocytes were arrested at metaphase I (MI) stage. Time-lapse video microscopy analysis revealed that the formation of granules in the oocyte cytoplasm increased concurrent with retarded cytoplasmic streaming after Txnip RNAi treatment. Txnip RNAi-treated oocytes had upregulated glucose uptake and lactate production. To confirm the supposition that mechanism responsible for these observed phenomena involves increased lactate in oocytes, we cultured oocytes in high lactate medium and observed the same increased granule formation and retarded cytoplasmic streaming as found by Txnip RNAi. The MI-arrested oocytes exhibited scattered microtubules and aggregated chromosomes indicating that actin networking was disturbed by Txnip RNAi. Therefore, we conclude that Txnip is a critical regulator of glucose metabolism in oocytes and is involved in maintaining cytoplasmic streaming in mouse oocytes.	[Lee, Su-Yeon; Kim, Eun-Young; Ko, Jung-Jae; Lee, Kyung-Ah] CHA Univ, Coll Life Sci, Dept Biomed Sci, Seoul, South Korea; [Lee, Hyun-Seo] Chosun Univ, DNA Repair Res Ctr, Kwangju, South Korea; [Yoon, Tae Ki; Lee, Woo-Sik; Lee, Kyung-Ah] CHA Univ, Fertil Ctr, CHA Gangnam Med Ctr, Seoul, South Korea	Pochon Cha University; Chosun University; Pochon Cha University	Lee, KA (corresponding author), CHA Univ, Coll Life Sci, Dept Biomed Sci, Seoul, South Korea.	leeka@ovary.co.kr			Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A084923]; Priority Research Centers Program through the National Resesarch Foundation of Korea (NRF); Ministry of Education, Science and Technology [2009-0093821]	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea; Priority Research Centers Program through the National Resesarch Foundation of Korea (NRF); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A084923) and by Priority Research Centers Program through the National Resesarch Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2009-0093821). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azoury J, 2008, CURR BIOL, V18, P1514, DOI 10.1016/j.cub.2008.08.044; Barnes FL, 2000, SEMIN REPROD MED, V18, P123, DOI 10.1055/s-2000-12551; Chen J, 2008, DIABETES, V57, P938, DOI 10.2337/db07-0715; Chutkow WA, 2008, J BIOL CHEM, V283, P2397, DOI 10.1074/jbc.M708169200; Davis RA, 2007, CIRC RES, V101, P1216, DOI 10.1161/CIRCRESAHA.107.165654; Donnelly KL, 2004, J NUTR, V134, P1475, DOI 10.1093/jn/134.6.1475; Goldstein RE, 2008, P NATL ACAD SCI USA, V105, P3663, DOI 10.1073/pnas.0707223105; Junn E, 2000, J IMMUNOL, V164, P6287, DOI 10.4049/jimmunol.164.12.6287; KACHAR B, 1988, J CELL BIOL, V106, P1545, DOI 10.1083/jcb.106.5.1545; Kessi E, 1996, BIOCHEM J, V315, P455, DOI 10.1042/bj3150455; Kezele P, 2002, FRONT BIOSCI-LANDMRK, V7, pD1990, DOI 10.2741/kezele; Kim KH, 2008, BIOL REPROD, V79, P1192, DOI 10.1095/biolreprod.108.068478; Kishimoto T, 2003, CURR OPIN CELL BIOL, V15, P654, DOI 10.1016/j.ceb.2003.10.010; Lee HS, 2010, FASEB J, V24, P2314, DOI 10.1096/fj.09-147314; Lenart P, 2005, NATURE, V436, P812, DOI 10.1038/nature03810; Li R, 2013, NAT REV MOL CELL BIO, V14, P141, DOI 10.1038/nrm3531; Mehlmann LM, 2005, REPRODUCTION, V130, P791, DOI 10.1530/rep.1.00793; Niimura Sueo, 2004, Reprod Med Biol, V3, P231, DOI 10.1111/j.1447-0578.2004.00075.x; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Niwayama R, 2011, P NATL ACAD SCI USA, V108, P11900, DOI 10.1073/pnas.1101853108; Oka S, 2006, FASEB J, V20, pA45, DOI 10.1096/fj.05-4439fje; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Patwari P, 2006, J BIOL CHEM, V281, P21884, DOI 10.1074/jbc.M600427200; Patwari P, 2009, J BIOL CHEM, V284, P24996, DOI 10.1074/jbc.M109.018093; Pinot M, 2012, P NATL ACAD SCI USA, V109, P11705, DOI 10.1073/pnas.1121583109; Purcell SH, 2009, TRENDS ENDOCRIN MET, V20, P483, DOI 10.1016/j.tem.2009.06.006; Sagata N, 1996, TRENDS CELL BIOL, V6, P22, DOI 10.1016/0962-8924(96)81034-8; Salhab M, 2013, MOL REPROD DEV, V80, P166, DOI 10.1002/mrd.22148; Sardet C, 2002, DEV BIOL, V241, P1, DOI 10.1006/dbio.2001.0474; Sheth SS, 2005, J LIPID RES, V46, P123, DOI 10.1194/jlr.M400341-JLR200; Starr DA, 2003, J CELL SCI, V116, P211, DOI 10.1242/jcs.00248; Su YQ, 2009, SEMIN REPROD MED, V27, P32, DOI 10.1055/s-0028-1108008; Ureta T, 2001, IUBMB LIFE, V51, P5, DOI 10.1080/15216540152034993; Wang Q, 2012, AM J PHYSIOL-ENDOC M, V302, pE1511, DOI 10.1152/ajpendo.00016.2012; Wang SF, 2010, P NATL ACAD SCI USA, V107, P17639, DOI 10.1073/pnas.1013185107; Wolke U, 2007, DEVELOPMENT, V134, P2227, DOI 10.1242/dev.004952; Yamanaka H, 2000, BIOCHEM BIOPH RES CO, V271, P796, DOI 10.1006/bbrc.2000.2699; Yi K, 2011, NAT CELL BIOL, V13, P1252, DOI 10.1038/ncb2320; Yoon SJ, 2009, BIOL REPROD, V81, P497, DOI 10.1095/biolreprod.108.073759; Yoon SJ, 2005, FERTIL STERIL, V83, P1293, DOI 10.1016/j.fertnstert.2004.09.037; Zou CH, 2005, J BIOCHEM BIOPH METH, V64, P207, DOI 10.1016/j.jbbm.2005.08.001	41	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e70708	10.1371/journal.pone.0070708	http://dx.doi.org/10.1371/journal.pone.0070708			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23976953	Green Submitted, Green Published, gold			2022-12-25	WOS:000323425700007
J	Limalanathan, S; Eritsland, J; Andersen, GO; Klow, NE; Abdelnoor, M; Hoffmann, P				Limalanathan, Shanmuganathan; Eritsland, Jan; Andersen, Geir Oystein; Klow, Nils-Einar; Abdelnoor, Michael; Hoffmann, Pavel			Myocardial Salvage is Reduced in Primary PCI-Treated STEMI Patients with Microvascular Obstruction, Demonstrated by Early and Late CMR	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; CARDIOVASCULAR MAGNETIC-RESONANCE; NO-REFLOW PHENOMENON; PROGNOSTIC-SIGNIFICANCE; FOLLOW-UP; INFARCTION; DETERMINANTS; REPERFUSION; RECOVERY; DISEASE	Objectives: This study evaluates the association between microvascular obstruction and myocardial salvage, determined by cardiac magnetic resonance performed both in the acute stage of myocardial infarction and after 4 months. Methods: In patients with acute ST-elevation myocardial infarction treated by primary percutaneous coronary intervention, myocardial salvage, infarct size, left ventricular volumes, and ejection fraction were assessed by early (1-4 days) and follow-up (4 months) cardiac magnetic resonance. These variables were related to the presence or absence of microvascular obstruction at early investigation. Myocardial salvage was determined by: (1) myocardium at risk and infarct size measured in the acute stage and (2) myocardium at risk, measured acutely, and infarct size measured after 4 months. Multivariate analyses were performed, adjusting for clinical confounders at baseline. Results: Microvascular obstruction was present in 49 of 94 included patients, (52%). Myocardial salvage was significantly reduced in patients with microvascular obstruction, compared to those without: 23% vs. 38%, measured acutely, and 39.8% vs. 65.4%, after 4 months (p<0.001). The presence of microvascular obstruction was significantly and independently associated with large infarct size, lower left ventricular ejection fraction, and larger left ventricular end-systolic volume. Conclusion: The presence of microvascular obstruction demonstrated by cardiac magnetic resonance early after infarction was associated with impaired myocardial salvage. This association was more marked when based on measurement of infarct size after 4 months compared to assessment in the acute stage.	[Limalanathan, Shanmuganathan; Eritsland, Jan; Andersen, Geir Oystein; Hoffmann, Pavel] Univ Oslo, Dept Cardiol, Ulleval Hosp, Oslo, Norway; [Klow, Nils-Einar; Hoffmann, Pavel] Univ Oslo, Dept Radiol, Ulleval Hosp, Oslo, Norway; [Abdelnoor, Michael] Univ Oslo, Unit Epidemiol & Biostat, Clin Res Ctr, Ulleval Hosp, Oslo, Norway; [Limalanathan, Shanmuganathan; Eritsland, Jan; Andersen, Geir Oystein] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway; [Andersen, Geir Oystein] Univ Oslo, Ctr Clin Heart Res, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Limalanathan, S (corresponding author), Univ Oslo, Dept Cardiol, Ulleval Hosp, Oslo, Norway.	lisq@uus.no	Andersen, Geir/AAR-3010-2020		Norwegian Health and Rehabilitation Foundation	Norwegian Health and Rehabilitation Foundation	The study is funded by The Norwegian Health and Rehabilitation Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekkers SCAM, 2010, J AM COLL CARDIOL, V55, P1649, DOI 10.1016/j.jacc.2009.12.037; Bogaert J, 2007, EUR RADIOL, V17, P2572, DOI 10.1007/s00330-007-0627-9; BRAUNWALD E, 1985, J CLIN INVEST, V76, P1713, DOI 10.1172/JCI112160; Carlsson M, 2009, JACC-CARDIOVASC IMAG, V2, P569, DOI 10.1016/j.jcmg.2008.11.018; Choi CJ, 2004, J CARDIOVASC MAGN R, V6, P917, DOI 10.1081/JCMR-20036206; de Waha S, 2010, EUR HEART J, V31, P2660, DOI 10.1093/eurheartj/ehq247; Desch S, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-204; Eitel I, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-13; Eitel I, 2010, J AM COLL CARDIOL, V55, P2470, DOI 10.1016/j.jacc.2010.01.049; Engblom H, 2009, CIRC-CARDIOVASC IMAG, V2, P47, DOI 10.1161/CIRCIMAGING.108.802199; Gurm HS, 2008, J AM COLL CARDIOL, V51, P529, DOI 10.1016/j.jacc.2007.09.053; Hombach V, 2005, EUR HEART J, V26, P549, DOI 10.1093/eurheartj/ehi147; Kleinbaum DG, 1982, EPIDEMIOLOGIC RES PR; KLONER RA, 1974, J CLIN INVEST, V54, P1496, DOI 10.1172/JCI107898; Limalanathan S, 2010, CARDIOLOGY, V116, P103, DOI 10.1159/000316965; Lonborg J, 2011, EUR HEART J CARDIOVA, V13, P433, DOI [10.1093/ejechocard/jer296, DOI 10.1093/EJECH0CARD/JER296]; Lund GK, 2007, RADIOLOGY, V245, P95, DOI 10.1148/radiol.2451061219; Masci PG, 2010, JACC-CARDIOVASC IMAG, V3, P45, DOI 10.1016/j.jcmg.2009.06.016; Nijveldt R, 2008, J AM COLL CARDIOL, V52, P181, DOI 10.1016/j.jacc.2008.04.006; Orn S, 2009, EUR HEART J, V30, P1978, DOI 10.1093/eurheartj/ehp219; Rezkalla SH, 2002, CIRCULATION, V105, P656, DOI 10.1161/hc0502.102867; Van de Werf F, 2008, EUR HEART J, V29, P2909, DOI 10.1093/eurheartj/ehn416; Vicente J, 2009, CATHETER CARDIO INTE, V74, P1000, DOI 10.1002/ccd.22157; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; Wu KC, 1998, CIRCULATION, V97, P765, DOI 10.1161/01.CIR.97.8.765; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667	26	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71780	10.1371/journal.pone.0071780	http://dx.doi.org/10.1371/journal.pone.0071780			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977143	gold, Green Published, Green Submitted			2022-12-25	WOS:000323425700097
J	Ryoo, I; Choi, SH; Kim, JH; Sohn, CH; Kim, SC; Shin, HS; Yeom, JA; Jung, SC; Lee, AL; Yun, TJ; Park, CK; Park, SH				Ryoo, Inseon; Choi, Seung Hong; Kim, Ji-Hoon; Sohn, Chul-Ho; Kim, Soo Chin; Shin, Hwa Seon; Yeom, Jeong A.; Jung, Seung Chai; Lee, A. Leum; Yun, Tae Jin; Park, Chul-Kee; Park, Sung-Hye			Cerebral Blood Volume Calculated by Dynamic Susceptibility Contrast-Enhanced Perfusion MR Imaging: Preliminary Correlation Study with Glioblastoma Genetic Profiles	PLOS ONE			English	Article							O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; PROMOTER METHYLATION; TUMOR GRADE; EXPRESSION; BRAIN; GLIOMAS; MGMT; TEMOZOLOMIDE; PARAMETERS; MULTIFORME	Purpose: To evaluate the usefulness of dynamic susceptibility contrast (DSC) enhanced perfusion MR imaging in predicting major genetic alterations in glioblastomas. Materials and Methods: Twenty-five patients (M:F = 13:12, mean age: 52.1 +/- 15.2 years) with pathologically proven glioblastoma who underwent DSC MR imaging before surgery were included. On DSC MR imaging, the normalized relative tumor blood volume (nTBV) of the enhancing solid portion of each tumor was calculated by using dedicated software (Nordic TumorEX, NordicNeuroLab, Bergen, Norway) that enabled semi-automatic segmentation for each tumor. Five major glioblastoma genetic alterations (epidermal growth factor receptor (EGFR), phosphatase and tensin homologue (PTEN), Ki-67, O6-methylguanine-DNA methyltransferase (MGMT) and p53) were confirmed by immunohistochemistry and analyzed for correlation with the nTBV of each tumor. Statistical analysis was performed using the unpaired Student t test, ROC (receiver operating characteristic) curve analysis and Pearson correlation analysis. Results: The nTBVs of the MGMT methylation-negative group (mean 9.5 +/- 7.5) were significantly higher than those of the MGMT methylation-positive group (mean 5.4 +/- 1.8) (p = .046). In the analysis of EGFR expression-positive group, the nTBVs of the subgroup with loss of PTEN gene expression (mean: 10.3 +/- 8.1) were also significantly higher than those of the subgroup without loss of PTEN gene expression (mean: 5.6 +/- 2.3) (p = .046). Ki-67 labeling index indicated significant positive correlation with the nTBV of the tumor (p = .01). Conclusion: We found that glioblastomas with aggressive genetic alterations tended to have a high nTBV in the present study. Thus, we believe that DSC-enhanced perfusion MR imaging could be helpful in predicting genetic alterations that are crucial in predicting the prognosis of and selecting tailored treatment for glioblastoma patients.	[Ryoo, Inseon; Choi, Seung Hong; Kim, Ji-Hoon; Sohn, Chul-Ho; Kim, Soo Chin; Shin, Hwa Seon; Yeom, Jeong A.; Jung, Seung Chai; Lee, A. Leum; Yun, Tae Jin] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Park, Chul-Kee] Seoul Natl Univ, Coll Med, Dept Neurosurg, Seoul, South Korea; [Park, Sung-Hye] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Choi, SH (corresponding author), Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea.	verocay@snuh.org	Park, Chul-Kee/O-7842-2019; Park, Chul-Kee/J-5499-2012; Sohn, ChulHo/AAV-4565-2021	Park, Chul-Kee/0000-0002-2350-9876; Yun, Tae Jin/0000-0001-8441-4574	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [1120300]; Korea Healthcare technology R&D Projects, Ministry for Health, Welfare Family Affairs [A112028, Cover Letter HI13C0015]; Research Center Program of IBS (Institute for Basic Science) in Korea	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korea Healthcare technology R&D Projects, Ministry for Health, Welfare Family Affairs; Research Center Program of IBS (Institute for Basic Science) in Korea	This study was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (1120300), the Korea Healthcare technology R&D Projects, Ministry for Health, Welfare& Family Affairs (A112028 and Cover Letter HI13C0015) and by the Research Center Program of IBS (Institute for Basic Science) in Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghi M, 2005, CLIN CANCER RES, V11, P8600, DOI 10.1158/1078-0432.CCR-05-0713; Bjornerud A, 2003, P HUM BRAIN MAPPING, P19; Bobola MS, 2005, CLIN CANCER RES, V11, P2747, DOI 10.1158/1078-0432.CCR-04-2045; Boxerman JL, 2006, AM J NEURORADIOL, V27, P859; Brell M, 2005, CLIN CANCER RES, V11, P5167, DOI 10.1158/1078-0432.CCR-05-0230; Burton EC, 2002, CANCER RES, V62, P6205; CAIRNCROSS JG, 1988, ANN NEUROL, V23, P360, DOI 10.1002/ana.410230408; Chawla S, 2013, AJNR AM J NEURORADIO; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; CruzSanchez FF, 1997, HISTOL HISTOPATHOL, V12, P43; Diehn M, 2008, P NATL ACAD SCI USA, V105, P5213, DOI 10.1073/pnas.0801279105; Donato V, 2007, TUMORI, V93, P248; Drabycz S, 2010, NEUROIMAGE, V49, P1398, DOI 10.1016/j.neuroimage.2009.09.049; Dunn J, 2009, BRIT J CANCER, V101, P124, DOI 10.1038/sj.bjc.6605127; Emblem KE, 2008, RADIOLOGY, V247, P808, DOI 10.1148/radiol.2473070571; Endersby R, 2008, ONCOGENE, V27, P5416, DOI 10.1038/onc.2008.239; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Habberstad AH, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-43; Hadjipanayis CG, 2010, CANCER RES, V70, P6303, DOI 10.1158/0008-5472.CAN-10-1022; Hegi ME, 2004, CLIN CANCER RES, V10, P1871, DOI 10.1158/1078-0432.CCR-03-0384; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Jackson RJ, 2001, NEURO-ONCOLOGY, V3, P193, DOI 10.1093/neuonc/3.3.193; Kapoor GS, 2009, J NEURO-ONCOL, V92, P373, DOI 10.1007/s11060-009-9880-x; KARKAVELAS G, 1995, ANTICANCER RES, V15, P531; Koul D, 2008, CANCER BIOL THER, V7, P1321, DOI 10.4161/cbt.7.9.6954; Law M, 2008, RADIOLOGY, V247, P490, DOI 10.1148/radiol.2472070898; Maia ACM, 2005, AM J NEURORADIOL, V26, P777; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Ostergaard L, 1996, MAGNET RESON MED, V36, P726, DOI 10.1002/mrm.1910360511; Park SH, 2006, RADIOLOGY, V239, P105, DOI 10.1148/radiol.2391050361; Pope WB, 2008, RADIOLOGY, V249, P268, DOI 10.1148/radiol.2491072000; Quinn JA, 2004, NEURO-ONCOLOGY, V6, P145, DOI 10.1215/S1152851703000498; ROSEN BR, 1990, MAGNET RESON MED, V14, P249, DOI 10.1002/mrm.1910140211; Sampson JH, 2008, SEMIN IMMUNOL, V20, P267, DOI 10.1016/j.smim.2008.04.001; Schmidt MC, 2002, J NEUROPATH EXP NEUR, V61, P321, DOI 10.1093/jnen/61.4.321; SILBER JR, 1993, CANCER RES, V53, P3416; Tykocinski ES, 2012, NEURO-ONCOLOGY, V14, P613, DOI 10.1093/neuonc/nos073; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Van Meter T, 2006, DIAGN MOL PATHOL, V15, P195, DOI 10.1097/01.pdm.0000213464.06387.36; Whitmore RG, 2007, J NEUROSURG, V107, P600, DOI 10.3171/JNS-07/09/0600; Yin S VME, 2009, P53 PATHWAY ALTERATI	41	40	45	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71704	10.1371/journal.pone.0071704	http://dx.doi.org/10.1371/journal.pone.0071704			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23977117	Green Submitted, Green Published, gold			2022-12-25	WOS:000323425700088
J	Topin, J; Arnaud, J; Sarkar, A; Audfray, A; Gillon, E; Perez, S; Jamet, H; Varrot, A; Imberty, A; Thomas, A				Topin, Jeremie; Arnaud, Julie; Sarkar, Anita; Audfray, Aymeric; Gillon, Emilie; Perez, Serge; Jamet, Helene; Varrot, Annabelle; Imberty, Anne; Thomas, Aline			Deciphering the Glycan Preference of Bacterial Lectins by Glycan Array and Molecular Docking with Validation by Microcalorimetry and Crystallography	PLOS ONE			English	Article							BLOOD-GROUP ANTIGENS; FUCOSE-BINDING LECTIN; LEWIS-X; PSEUDOMONAS-AERUGINOSA; CARBOHYDRATE DETERMINANTS; STRUCTURAL BASIS; PA-IIL; OLIGOSACCHARIDES; PREDICTION; SPECIFICITY	Recent advances in glycobiology revealed the essential role of lectins for deciphering the glycocode by specific recognition of carbohydrates. Integrated multiscale approaches are needed for characterizing lectin specificity: combining on one hand high-throughput analysis by glycan array experiments and systematic molecular docking of oligosaccharide libraries and on the other hand detailed analysis of the lectin/oligosaccharide interaction by x-ray crystallography, microcalorimetry and free energy calculations. The lectins LecB from Pseudomonas aeruginosa and BambL from Burkholderia ambifaria are part of the virulence factors used by the pathogenic bacteria to invade the targeted host. These two lectins are not related but both recognize fucosylated oligosaccharides such as the histo-blood group oligosaccharides of the ABH(O) and Lewis epitopes. The specificities were characterized using semi-quantitative data from glycan array and analyzed by molecular docking with the Glide software. Reliable prediction of protein/oligosaccharide structures could be obtained as validated by existing crystal structures of complexes. Additionally, the crystal structure of BambL/Lewis x was determined at 1.6 A resolution, which confirms that Lewis x has to adopt a high-energy conformation so as to bind to this lectin. Free energies of binding were calculated using a procedure combining the Glide docking protocol followed by free energy rescoring with the Prime/Molecular Mechanics Generalized Born Surface Area (MM-GBSA) method. The calculated data were in reasonable agreement with experimental free energies of binding obtained by titration microcalorimetry. The established predictive protocol is proposed to rationalize large sets of data such as glycan arrays and to help in lead discovery projects based on such high throughput technology.	[Topin, Jeremie; Arnaud, Julie; Sarkar, Anita; Audfray, Aymeric; Gillon, Emilie; Perez, Serge; Varrot, Annabelle; Imberty, Anne; Thomas, Aline] Univ Grenoble 1, CERMAV Ctr Natl Rech Sci UPR5301, F-38041 Grenoble, France; [Topin, Jeremie; Arnaud, Julie; Sarkar, Anita; Audfray, Aymeric; Gillon, Emilie; Perez, Serge; Varrot, Annabelle; Imberty, Anne; Thomas, Aline] ICMG, F-38041 Grenoble, France; [Jamet, Helene] Univ Grenoble 1, Dept Chim Mol, UMR Ctr Natl Rech Sci 5250, F-38041 Grenoble, France; [Jamet, Helene] Univ Grenoble 1, ICMG FR 2607, F-38041 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Imberty, A (corresponding author), Univ Grenoble 1, CERMAV Ctr Natl Rech Sci UPR5301, BP53, F-38041 Grenoble, France.	imberty@cermav.cnrs.fr	Imberty, Anne/P-6451-2018	Imberty, Anne/0000-0001-6825-9527; Varrot, Annabelle/0000-0001-6667-8162; Sarkar, Anita/0000-0001-5602-8406	Labex Arcane [ANR-11-LABEX-003]; Centre national de la recherche scientifique; Universite Joseph Fourier; ANR [ANR-11-BSV5-002-01, ANR-GENOM-BTV-010]; Association Vaincre la Mucoviscidose; GDR Pseudomonas	Labex Arcane; Centre national de la recherche scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Joseph Fourier; ANR(French National Research Agency (ANR)); Association Vaincre la Mucoviscidose; GDR Pseudomonas	The research was funded by Labex Arcane (ANR-11-LABEX-003) and also supported by Centre national de la recherche scientifique, Universite Joseph Fourier and ANR grant NeoLect (ANR-11-BSV5-002-01) and WallArray II (ANR-GENOM-BTV-010). The authors acknowledge the COST action BM1003 and CM1102 and the Initial Training Network "EuroGlycoArrays". Support from the Association Vaincre la Mucoviscidose and GDR Pseudomonas is appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostino M, 2009, J CHEM INF MODEL, V49, P2749, DOI 10.1021/ci900388a; Ali MMN, 2009, CARBOHYD RES, V344, P355, DOI 10.1016/j.carres.2008.11.013; Audfray A, 2012, J BIOL CHEM, V287, P4335, DOI 10.1074/jbc.M111.314831; Auzanneau FI, 2012, BIOORGAN MED CHEM, V20, P5085, DOI 10.1016/j.bmc.2012.07.017; Azurmendi HF, 2002, BIOPOLYMERS, V63, P89, DOI 10.1002/bip.10015; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bekiroglu S, 2004, CARBOHYD RES, V339, P2465, DOI 10.1016/j.carres.2004.07.002; BERGER SA, 1989, EUR J CLIN MICROBIOL, V8, P681, DOI 10.1007/BF01963752; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bohne A, 1999, BIOINFORMATICS, V15, P767, DOI 10.1093/bioinformatics/15.9.767; Du J, 2011, J COMPUT CHEM, V32, P2800, DOI 10.1002/jcc.21859; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engelsen SB, 1996, BIOPOLYMERS, V39, P417, DOI 10.1002/(SICI)1097-0282(199609)39:3<417::AID-BIP13>3.3.CO;2-R; Fadda E, 2010, DRUG DISCOV TODAY, V15, P596, DOI 10.1016/j.drudis.2010.06.001; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; GARBER N, 1987, FEMS MICROBIOL LETT, V48, P331, DOI 10.1016/0378-1097(87)90070-X; Glick MC, 2001, BIOCHIMIE, V83, P743, DOI 10.1016/S0300-9084(01)01323-2; Greenwell P, 1997, GLYCOCONJUGATE J, V14, P159, DOI 10.1023/A:1018581503164; Haider MK, 2011, J CHEM INF MODEL; Heggelund JE, 2012, BIOCHEM BIOPH RES CO, V418, P731, DOI 10.1016/j.bbrc.2012.01.089; IMBERTY A, 1995, GLYCOCONJUGATE J, V12, P331, DOI 10.1007/BF00731336; Imberty A, 1996, BIOORGAN MED CHEM, V4, P1979, DOI 10.1016/S0968-0896(96)00179-4; Imberty A, 2000, CHEM REV, V100, P4567, DOI 10.1021/cr990343j; Imberty A, 2008, CURR OPIN STRUC BIOL, V18, P567, DOI 10.1016/j.sbi.2008.08.001; Ishida T, 2010, J PHYS CHEM B, V114, P3950, DOI 10.1021/jp905872t; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Koppisetty CAK, 2010, J COMPUT AID MOL DES, V24, P423, DOI 10.1007/s10822-010-9353-5; Lamblin G, 2001, GLYCOCONJUGATE J, V18, P661, DOI 10.1023/A:1020867221861; LEMIEUX RU, 1980, CAN J CHEM, V58, P631, DOI 10.1139/v80-098; LESLIE AGW, 1992, JOINT CCP4 ESF EACMB, V26; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Lyne PD, 2006, J MED CHEM, V49, P4805, DOI 10.1021/jm060522a; Marionneau S, 2001, BIOCHIMIE, V83, P565, DOI 10.1016/S0300-9084(01)01321-9; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mishra NK, 2008, PROTEINS, V72, P382, DOI 10.1002/prot.21935; Mishra NK, 2010, CARBOHYD RES, V345, P1432, DOI 10.1016/j.carres.2010.04.021; Mishra SK, 2012, J COMPUT CHEM, V33, P2340, DOI 10.1002/jcc.23081; Mishra SK, 2012, J CHEM INF MODEL, V52, P1250, DOI 10.1021/ci200529n; Mitchell E, 2002, NAT STRUCT BIOL, V9, P918, DOI 10.1038/nsb865; Mitchell EP, 2005, PROTEINS, V58, P735, DOI 10.1002/prot.20330; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nurisso A, 2008, MOL SIMULAT, V34, P469, DOI 10.1080/08927020701697709; Perez S, 1996, GLYCOBIOLOGY, V6, P537, DOI 10.1093/glycob/6.5.537; Perret S, 2005, BIOCHEM J, V389, P325, DOI 10.1042/BJ20050079; Porter A, 2010, GLYCOBIOLOGY, V20, P369, DOI 10.1093/glycob/cwp187; Repasky Matthew P, 2007, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0812s18; Rillahan CD, 2011, ANNU REV BIOCHEM, V80, P797, DOI 10.1146/annurev-biochem-061809-152236; Rosen J, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-16; Sharon N, 1996, ADV EXP MED BIOL, V408, P1; Smith DF, 2013, MOL CELL PROTEOMICS, V12, P902, DOI 10.1074/mcp.R112.027110; Smith DF, 2010, METHOD ENZYMOL, V480, P417, DOI 10.1016/S0076-6879(10)80033-3; Springer SA, 2013, J BIOL CHEM, V288, P6904, DOI 10.1074/jbc.R112.424523; Sulak O, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002238; Sulak O, 2010, STRUCTURE, V18, P59, DOI 10.1016/j.str.2009.10.021; Van Liempt E, 2004, J BIOL CHEM, V279, P33161, DOI 10.1074/jbc.M404988200; WATKINS WM, 1952, NATURE, V169, P825, DOI 10.1038/169825a0; Wimmerova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046032; Xuan PF, 2012, GLYCOBIOLOGY, V22, P552, DOI 10.1093/glycob/cwr163; Yuriev E, 2005, IMMUNOL CELL BIOL, V83, P709, DOI 10.1111/j.1440-1711.2005.01374.x	59	23	23	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e71149	10.1371/journal.pone.0071149	http://dx.doi.org/10.1371/journal.pone.0071149			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23976992	Green Published, Green Submitted, gold			2022-12-25	WOS:000323425700022
J	Anidi, IU; Servinsky, LE; Rentsendorj, O; Stephens, RS; Scott, AL; Pearse, DB				Anidi, Ifeanyi U.; Servinsky, Laura E.; Rentsendorj, Otgonchimeg; Stephens, R. Scott; Scott, Alan L.; Pearse, David B.			CD36 and Fyn Kinase Mediate Malaria-Induced Lung Endothelial Barrier Dysfunction in Mice Infected with Plasmodium berghei	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; PARASITE SEQUESTRATION; VASCULAR-PERMEABILITY; HYDROGEN-PEROXIDE; TYROSINE KINASE; CELL-ADHESION; IN-VITRO; FALCIPARUM; INJURY; OXYGEN	Severe malaria can trigger acute lung injury characterized by pulmonary edema resulting from increased endothelial permeability. However, the mechanism through which lung fluid conductance is altered during malaria remains unclear. To define the role that the scavenger receptor CD36 may play in mediating this response, C57BL/6J (WT) and CD36-/- mice were infected with P. berghei ANKA and monitored for changes in pulmonary endothelial barrier function employing an isolated perfused lung system. WT lungs demonstrated a >10-fold increase in two measures of paracellular fluid conductance and a decrease in the albumin reflection coefficient (sigma alb) compared to control lungs indicating a loss of barrier function. In contrast, malaria-infected CD36-/- mice had near normal fluid conductance but a similar reduction in sigma alb. In WT mice, lung sequestered iRBCs demonstrated production of reactive oxygen species (ROS). To determine whether knockout of CD36 could protect against ROS-induced endothelial barrier dysfunction, mouse lung microvascular endothelial monolayers (MLMVEC) from WT and CD36-/- mice were exposed to H2O2. Unlike WT monolayers, which showed dose-dependent decreases in transendothelial electrical resistance (TER) from H2O2 indicating loss of barrier function, CD36-/- MLMVEC demonstrated dose-dependent increases in TER. The differences between responses in WT and CD36-/- endothelial cells correlated with important differences in the intracellular compartmentalization of the CD36-associated Fyn kinase. Malaria infection increased total lung Fyn levels in CD36-/- lungs compared to WT, but this increase was due to elevated production of the inactive form of Fyn further suggesting a dysregulation of Fyn-mediated signaling. The importance of Fyn in CD36-dependent endothelial signaling was confirmed using in vitro Fyn knockdown as well as Fyn-/- mice, which were also protected from H2O2- and malaria-induced lung endothelial leak, respectively. Our results demonstrate that CD36 and Fyn kinase are critical mediators of the increased lung endothelial fluid conductance caused by malaria infection.	[Anidi, Ifeanyi U.; Scott, Alan L.] Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Servinsky, Laura E.; Rentsendorj, Otgonchimeg; Stephens, R. Scott; Pearse, David B.] Johns Hopkins Med Inst, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Pearse, DB (corresponding author), Johns Hopkins Med Inst, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA.	dpearse@jhmi.edu			NIH [HL075236]; Johns Hopkins Malaria Research Institute; Johns Hopkins MD/PhD training program [T32 GM007309]; Johns Hopkins University Libraries; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins Malaria Research Institute; Johns Hopkins MD/PhD training program; Johns Hopkins University Libraries(Johns Hopkins University); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant HL075236 (DBP), a grant from the Johns Hopkins Malaria Research Institute (DBP), a predoctoral fellowship from the Johns Hopkins Malaria Research Institute (IUA) and the Johns Hopkins MD/PhD training program (T32 GM007309). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Publication of this article was funded in part by the Open Access Promotion Fund of the Johns Hopkins University Libraries.	APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; ATAMNA H, 1993, MOL BIOCHEM PARASIT, V61, P231, DOI 10.1016/0166-6851(93)90069-A; Bolcato-Bellemin AL, 2007, P NATL ACAD SCI USA, V104, P16050, DOI 10.1073/pnas.0707831104; BULL HA, 1994, FEBS LETT, V351, P41, DOI 10.1016/0014-5793(94)00814-0; Butzloff S, 2012, CYTOM PART A, V81A, P698, DOI 10.1002/cyto.a.22081; Cambos M, 2010, INT J PARASITOL, V40, P1003, DOI 10.1016/j.ijpara.2010.02.007; Chang WL, 2001, INFECT IMMUN, V69, P7341, DOI 10.1128/IAI.69.12.7341-7348.2001; Cox-Singh J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-10; Cunha-Rodrigues M, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-32; Curry FRE, 2010, CARDIOVASC RES, V87, P218, DOI 10.1093/cvr/cvq115; Davis SP, 2012, FASEB J, V26, P1119, DOI 10.1096/fj.11-196923; Deroost K, 2013, AM J RESP CELL MOL, V48, P589, DOI 10.1165/rcmb.2012-0450OC; Dodd-O JM, 2008, AM J PHYSIOL-LUNG C, V294, pL714, DOI 10.1152/ajplung.00185.2007; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Filby A, 2007, J IMMUNOL, V179, P4635, DOI 10.4049/jimmunol.179.7.4635; Fonager J, 2012, J EXP MED, V209, P93, DOI 10.1084/jem.20110762; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; Franke-Fayard B, 2005, P NATL ACAD SCI USA, V102, P11468, DOI 10.1073/pnas.0503386102; Gadue P, 1999, J EXP MED, V190, P1189, DOI 10.1084/jem.190.8.1189; Gamain B, 2007, INT J PARASITOL, V37, P273, DOI 10.1016/j.ijpara.2006.11.011; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; Gillrie MR, 2007, BLOOD, V110, P3426, DOI 10.1182/blood-2007-04-084582; Gillrie MR, 2012, AM J PATHOL, V180, P1028, DOI 10.1016/j.ajpath.2011.11.037; Graewe Stefanie, 2009, Biotechnology Journal, V4, P895, DOI 10.1002/biot.200900035; Gruring C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1169; Haldar K, 2007, ANNU REV PATHOL-MECH, V2, P217, DOI 10.1146/annurev.pathol.2.010506.091913; Han JY, 2011, J PHARMACOL EXP THER, V338, P82, DOI 10.1124/jpet.111.180620; Hu GC, 2009, MICROVASC RES, V77, P21, DOI 10.1016/j.mvr.2008.10.002; JANSE CJ, 1995, PARASITOL TODAY, V11, P138, DOI 10.1016/0169-4758(95)80133-2; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; Lovegrove FE, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000068; Michel CC, 1999, PHYSIOL REV, V79, P703, DOI 10.1152/physrev.1999.79.3.703; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Mishra Neerad C., 1994, Indian Journal of Malariology, V31, P77; Mohan Alladi, 2008, Journal of Vector Borne Diseases, V45, P179; Moldobaeva A, 2006, AM J PHYSIOL-LUNG C, V290, pL919, DOI 10.1152/ajplung.00434.2005; Moldobaeva A, 2005, AM J PHYSIOL-LUNG C, V288, pL1117, DOI 10.1152/ajplung.00370.2004; MONS B, 1985, PARASITOLOGY, V91, P423, DOI 10.1017/S0031182000062673; Mota MM, 2000, INFECT IMMUN, V68, P4135, DOI 10.1128/IAI.68.7.4135-4144.2000; Pearse DB, 2003, ENDOTHELIUM-J ENDOTH, V10, P309, DOI 10.1080/10623320390272307; Pearse DB, 2001, AM J PHYSIOL-HEART C, V280, pH918, DOI 10.1152/ajpheart.2001.280.2.H918; Pearse DB, 1996, AM J RESP CRIT CARE, V153, P196, DOI 10.1164/ajrccm.153.1.8542116; Pino P, 2003, J INFECT DIS, V187, P1283, DOI 10.1086/373992; Postma NS, 1996, PHARM WORLD SCI, V18, P121, DOI 10.1007/BF00717727; Qin Y, 2008, CELL BIOL INT, V32, P224, DOI 10.1016/j.cellbi.2007.08.028; Rentsendorj O, 2008, AM J PHYSIOL-LUNG C, V294, pL686, DOI 10.1152/ajplung.00417.2007; Rentsendorj O, 2011, AM J PHYSIOL-LUNG C, V301, pL161, DOI 10.1152/ajplung.00073.2011; SAKURADA H, 1992, ARCH DERMATOL RES, V284, P114, DOI 10.1007/BF00373382; Schmidt EP, 2012, NAT MED, V18, P1217, DOI 10.1038/nm.2843; Schmidt EP, 2008, AM J PHYSIOL-LUNG C, V295, pL1056, DOI 10.1152/ajplung.90329.2008; Seydel KB, 2006, J INFECT DIS, V194, P208, DOI 10.1086/505078; Sherman IW, 2003, MICROBES INFECT, V5, P897, DOI 10.1016/S1286-4579(03)00162-X; Siracusa MC, 2008, J LEUKOCYTE BIOL, V84, P1422, DOI 10.1189/jlb.0308199; Smith JD, 1998, MOL BIOCHEM PARASIT, V97, P133, DOI 10.1016/S0166-6851(98)00145-5; Sponaas AM, 2009, BLOOD, V114, P5522, DOI 10.1182/blood-2009-04-217489; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; Stephens RS, 2010, AM J PHYSIOL-LUNG C, V299, pL323, DOI 10.1152/ajplung.00442.2009; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; Taylor Walter R J, 2006, Treat Respir Med, V5, P419, DOI 10.2165/00151829-200605060-00007; van der Heyde HC, 2001, INFECT IMMUN, V69, P3460, DOI 10.1128/IAI.69.5.3460-3465.2001	61	17	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71010	10.1371/journal.pone.0071010	http://dx.doi.org/10.1371/journal.pone.0071010			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967147	Green Published, gold, Green Submitted			2022-12-25	WOS:000323378000027
J	Scherrer, SA; Begon, M; Leardini, A; Coillard, C; Rivard, CH; Allard, P				Scherrer, Sophie-Anne; Begon, Mickael; Leardini, Alberto; Coillard, Christine; Rivard, Charles-Hilaire; Allard, Paul			Three-Dimensional Vertebral Wedging in Mild and Moderate Adolescent Idiopathic Scoliosis	PLOS ONE			English	Article							IMAGING-SYSTEM; MORPHOMETRIC-ANALYSIS; NATURAL-HISTORY; COBB ANGLE; GROWTH; SPINE; DISC; EOS; PROGRESSION; DEFORMITY	Background: Vertebral wedging is associated with spinal deformity progression in adolescent idiopathic scoliosis. Reporting frontal and sagittal wedging separately could be misleading since these are projected values of a single three-dimensional deformation of the vertebral body. The objectives of this study were to determine if three-dimensional vertebral body wedging is present in mild scoliosis and if there are a preferential vertebral level, position and plane of deformation with increasing scoliotic severity. Methodology: Twenty-seven adolescent idiopathic scoliotic girls with mild to moderate Cobb angles (10 degrees to 50 degrees) participated in this study. All subjects had at least one set of bi-planar radiographs taken with the EOS (R) X-ray imaging system prior to any treatment. Subjects were divided into two groups, separating the mild (under 20 degrees) from the moderate (20 degrees and over) spinal scoliotic deformities. Wedging was calculated in three different geometric planes with respect to the smallest edge of the vertebral body. Results: Factorial analyses of variance revealed a main effect for the scoliosis severity but no main effect of vertebral Levels (apex and each of the three vertebrae above and below it) (F = 1.78, p = 0.101). Main effects of vertebral Positions (apex and above or below it) (F = 4.20, p = 0.015) and wedging Planes (F = 34.36, p<0.001) were also noted. Post-hoc analysis demonstrated a greater wedging in the inferior group of vertebrae (3.6 degrees) than the superior group (2.9 degrees, p = 0.019) and a significantly greater wedging (p <= 0.03) along the sagittal plane (4.3 degrees). Conclusions: Vertebral wedging was present in mild scoliosis and increased as the scoliosis progressed. The greater wedging of the inferior group of vertebrae could be important in estimating the most distal vertebral segment to be restrained by bracing or to be fused in surgery. Largest vertebral body wedging values obtained in the sagittal plane support the claim that scoliosis could be initiated through a hypokyphosis.	[Scherrer, Sophie-Anne; Begon, Mickael] Univ Montreal, Dept Kinesiol, Lab Ingn Mouvement, Montreal, PQ, Canada; [Leardini, Alberto] Ist Ortoped Rizzoli, Movement Anal Lab, Bologna, Italy; [Coillard, Christine; Rivard, Charles-Hilaire] Univ Montreal, Fac Med, Montreal, PQ H3C 3J7, Canada; [Allard, Paul] Univ Montreal, Dept Kinesiol, Montreal, PQ, Canada; [Allard, Paul] St Justine Hosp, Human Movement Lab, Res Ctr, Montreal, PQ, Canada	Universite de Montreal; IRCCS Istituto Ortopedico Rizzoli; Universite de Montreal; Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Scherrer, SA (corresponding author), Univ Montreal, Dept Kinesiol, Lab Ingn Mouvement, Montreal, PQ, Canada.	sophie-anne.scherrer@umontreal.ca	Allard, Paul/ABA-3257-2021; Leardini, Alberto/C-8189-2019; Begon, Mickaël/AAH-9887-2019; BEGON, Mickael/M-9574-2013	Leardini, Alberto/0000-0003-3547-7370; Begon, Mickaël/0000-0002-4107-9160; BEGON, Mickael/0000-0002-4107-9160	Natural Science and Engineering Research Council of Canada (NSERC)	Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this project was obtained from the Natural Science and Engineering Research Council of Canada (NSERC) http://www.nserc-crsng.gc.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLARD P, 1980, CAN J NEUROL SCI, V7, P383, DOI 10.1017/S0317167100022915; Allard P, 1994, 3 DIMENSIONAL ANAL H, P19; Aubin C E, 1998, Eur Spine J, V7, P59, DOI 10.1007/s005860050029; Beaulieu M, 2009, EUR SPINE J, V18, P38, DOI 10.1007/s00586-008-0831-6; BO X, 1994, SPINE, V19, P159, DOI 10.1097/00007632-199401001-00008; BUNNELL WP, 1986, SPINE, V11, P773, DOI 10.1097/00007632-198610000-00003; CRUICKSHANK JL, 1989, J BONE JOINT SURG BR, V71, P259, DOI 10.1302/0301-620X.71B2.2925744; Dalleau G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036755; Delorme S, 2003, IEEE T BIO-MED ENG, V50, P989, DOI 10.1109/TBME.2003.814525; Dickson R A, 1992, Acta Orthop Belg, V58 Suppl 1, P21; Dubousset Jean, 2010, Journal of Musculoskeletal Research, V13, P1, DOI 10.1142/S0218957710002430; Hasler CC, 2010, EUR SPINE J, V19, P732, DOI 10.1007/s00586-010-1320-2; Haumont T, 2011, SPINE, V36, pE847, DOI 10.1097/BRS.0b013e3181ff5837; Holt Richard T., 1997, P1537; Illes T, 2012, INT ORTHOP, V36, P1325, DOI 10.1007/s00264-012-1512-y; ISU T, 1992, CHILD NERV SYST, V8, P97, DOI 10.1007/BF00298449; Kim YJ, 2004, SPINE, V29, P2040, DOI 10.1097/01.brs.0000138268.12324.1a; Liljenqvist UR, 2000, SPINE, V25, P1247, DOI 10.1097/00007632-200005150-00008; Little DG, 2000, J BONE JOINT SURG AM, V82A, P685, DOI 10.2106/00004623-200005000-00009; LONCARDUSEK M, 1991, CLIN ORTHOP RELAT R, P278; LONSTEIN JE, 1984, J BONE JOINT SURG AM, V66A, P1061, DOI 10.2106/00004623-198466070-00013; Marks M, 2012, SPINE, V37, P826, DOI 10.1097/BRS.0b013e31823b4eab; Masharawi Y, 2008, CLIN ANAT, V21, P46, DOI 10.1002/ca.20532; Mehlman C T, 1997, Am J Orthop (Belle Mead NJ), V26, P798; Meir AR, 2007, SCOLIOSIS, V2, P1; MILNE JS, 1983, AGE AGEING, V12, P225, DOI 10.1093/ageing/12.3.225; Modi HN, 2008, SCOLIOSIS, V3, P1; MORRISSY RT, 1990, J BONE JOINT SURG AM, V72A, P320, DOI 10.2106/00004623-199072030-00002; Morvan Gerard, 2011, Eur Spine J, V20 Suppl 5, P602, DOI 10.1007/s00586-011-1927-y; Parent S, 2002, SPINE, V27, P2305, DOI 10.1097/00007632-200211010-00002; Parent S, 2004, SPINE, V29, pE455, DOI 10.1097/01.brs.0000142430.65463.3a; Simoneau M, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-68; Somoskeoy S, 2012, SPINE J, V12, P1052, DOI 10.1016/j.spinee.2012.10.002; Stokes IAF, 2001, J SPINAL DISORD, V14, P317, DOI 10.1097/00002517-200108000-00006; Stokes Ian A., 1994, European Journal of Experimental Musculoskeletal Research, V3, P51; Stokes IAF, 2007, EUR SPINE J, V16, P1621, DOI 10.1007/s00586-007-0442-7; Stokes IAF, 2009, STUD HEALTH TECHNOL, V135, P75; Stylianides GA, 2012, EUR SPINE J, V21, P725, DOI 10.1007/s00586-011-2070-5; TAYLOR JR, 1975, J ANAT, V120, P49; TAYLOR TKF, 1981, CLIN ORTHOP RELAT R, P79; Wade R, 2013, EUR SPINE J, V22, P296, DOI 10.1007/s00586-012-2469-7; Wang SF, 2012, J SPINAL DISORD TECH, V25, P277, DOI 10.1097/BSD.0b013e31821f4f10; Will RE, 2009, SPINE, V34, P2782, DOI 10.1097/BRS.0b013e3181c11853; Wong HK, 2010, INDIAN J ORTHOP, V44, P9, DOI 10.4103/0019-5413.58601	44	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71504	10.1371/journal.pone.0071504	http://dx.doi.org/10.1371/journal.pone.0071504			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23977058	Green Submitted, gold, Green Published			2022-12-25	WOS:000323378000054
J	Wang, Y; Xiong, B; Liang, B; Zhao, H; Li, H; Qian, J; Liang, HM; Feng, GS; Zheng, CS				Wang, Yong; Xiong, Bin; Liang, Bin; Zhao, Hui; Li, Hui; Qian, Jun; Liang, Hui-Min; Feng, Gan-Sheng; Zheng, Chuan-Sheng			Hepatic Parenchymal Changes following Transcatheter Embolization and Chemoembolization in a Rabbit Tumor Model	PLOS ONE			English	Article							ARTERIAL EMBOLIZATION; HEPATOCELLULAR-CARCINOMA; LIVER FIBROSIS; STELLATE CELLS; THERAPY; DAMAGE; MALIGNANCY; CIRRHOSIS; INJURIES	Objective: To compare the effects of transcatheter arterial chemoembolization (TACE) with transcatheter arterial embolization (TAE) on liver function, hepatic damage, and hepatic fibrogenesis in a rabbit tumor model. Materials and Methods: Thirty-nine New Zealand white rabbits implanted with VX2 tumors in the left liver lobes were randomly divided into three groups: TAE, TACE, and control group. In the TAE group (n = 15), polyvinyl alcohol particles (PVAs) were used for left hepatic artery embolization. In the TACE group (n = 15), the tumors were treated with left hepatic arterial infusions of a suspension of 10-hydroxycamptothecin and lipiodol, followed by embolization with PVAs. In the control group (n = 9), the animals received sham treatment with distilled water. Serum and liver samples were collected at 6 hours, 3 days and 7 days after treatment. Liver damage was measured using a liver function test and histological analyses. Liver fibrogenesis and hepatic stellate cell (HSC) activation were evaluated using Sirius Red and anti-alpha-smooth muscle actin (alpha-SMA) immunohistochemical stains. Results: TACE caused liver injury with greater increases in serum alanine aminotransferase and aspartate aminotransferase levels on day 3 (P<0.05). Histological analyses revealed increased hepatic necrosis in adjacent non-tumorous liver tissue from day 3 compared to the TAE group (Suzuki score of 2.33 +/- 1.29 versus 1.13 +/- 1.18, P = 0.001). HSC activation and proliferation were significantly increased in the TACE group compared to the control group at 3 and 7 days after treatment (0.074 +/- 0.014 vs. 0.010 +/- 0.006, and 0.088 +/- 0.023 vs. 0.017 +/- 0.009, P<0.05). Sirius Red staining demonstrated a statistically significant increase in collagen deposition in the livers in the TACE group 7 days after embolization compared to the control group (0.118 +/- 0.012 vs. 0.060 +/- 0.017, P = 0.05). Conclusion: The results of this animal study revealed that TACE induced prominent hepatocellular damage and hepatic fibrogenesis, which compromised liver function and may be responsible for chronic liver decompensation.	[Wang, Yong; Xiong, Bin; Liang, Bin; Zhao, Hui; Li, Hui; Qian, Jun; Liang, Hui-Min; Feng, Gan-Sheng; Zheng, Chuan-Sheng] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Radiol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Zheng, CS (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Radiol, Wuhan 430074, Peoples R China.	hqzcsxh@sina.com	Wang, Yong/B-6207-2015; Xiong, Bin/AGX-8289-2022	Wang, Yong/0000-0003-4707-5280; 	National Natural Sciences Foundation of China [30970804]; Hubei Provincial Key Laboratory of Molecular Imaging [02.03.2011-78]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Provincial Key Laboratory of Molecular Imaging	This study was supported by grants (30970804) from National Natural Sciences Foundation of China and grants from Hubei Provincial Key Laboratory of Molecular Imaging (No. 02.03.2011-78). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artinyan A, 2008, HPB, V10, P396, DOI 10.1080/13651820802356564; Beaussier M, 2007, LAB INVEST, V87, P292, DOI 10.1038/labinvest.3700513; Caturelli E, 2000, RADIOLOGY, V215, P123, DOI 10.1148/radiology.215.1.r00ap21123; Chan AO, 2002, CANCER-AM CANCER SOC, V94, P1747, DOI 10.1002/cncr.10407; Chung J, 2010, BRIT J RADIOL, V83, P71, DOI 10.1259/bjr/82377365; Farinati F, 1996, DIGEST DIS SCI, V41, P2332, DOI 10.1007/BF02100123; Geerts A, 2001, SEMIN LIVER DIS, V21, P311, DOI 10.1055/s-2001-17550; Itoh Y, 1999, LIVER, V19, P97, DOI 10.1111/j.1478-3231.1999.tb00017.x; KANEKO A, 1992, AM J GASTROENTEROL, V87, P1014; KHAN KN, 1991, CANCER RES, V51, P5667; KOBAYASHI S, 1994, J GASTROEN HEPATOL, V9, P45, DOI 10.1111/j.1440-1746.1994.tb01215.x; Kong J, 2002, SHI YONG FANG SHE XU, V18, P312; Li D, 1999, J GASTROEN HEPATOL, V14, P618, DOI 10.1046/j.1440-1746.1999.01928.x; Liang B, 2010, CARDIOVASC INTER RAD, V33, P806, DOI 10.1007/s00270-009-9762-9; Morimoto K, 2008, CARDIOVASC INTER RAD, V31, P981, DOI 10.1007/s00270-008-9367-8; Reeves HL, 2002, FRONT BIOSCI-LANDMRK, V7, pD808, DOI 10.2741/reeves; SUOU T, 1993, HEPATOLOGY, V18, P809, DOI 10.1002/hep.1840180410; Virmani S, 2008, J VASC INTERV RADIOL, V19, P1483, DOI 10.1016/j.jvir.2008.06.017; Wallace S, 2000, ACTA GASTRO-ENT BELG, V63, P169; Wang Y, 2011, J VASC INTERV RADIOL, V22, P1606, DOI 10.1016/j.jvir.2011.08.005; YAMASHITA Y, 1993, ABDOM IMAGING, V18, P352, DOI 10.1007/BF00201780; Yu JS, 2002, CARDIOVASC INTER RAD, V25, P270, DOI 10.1007/s00270-001-0049-z; Yu JS, 2001, RADIOLOGY, V221, P429, DOI 10.1148/radiol.2212010339; Zhang H, 2006, J BIOMED MATER RES A, V76A, P120, DOI 10.1002/jbm.a.30491	24	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e70757	10.1371/journal.pone.0070757	http://dx.doi.org/10.1371/journal.pone.0070757			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202MQ	23967098	Green Published, Green Submitted, gold			2022-12-25	WOS:000323221500025
J	Caliceti, C; Aquila, G; Pannella, M; Morelli, MB; Fortini, C; Pinton, P; Bonora, M; Hrelia, S; Pannuti, A; Miele, L; Rizzo, P; Ferrari, R				Caliceti, Cristiana; Aquila, Giorgio; Pannella, Micaela; Morelli, Marco Bruno; Fortini, Cinzia; Pinton, Paolo; Bonora, Massimo; Hrelia, Silvana; Pannuti, Antonio; Miele, Lucio; Rizzo, Paola; Ferrari, Roberto			17 beta-Estradiol Enhances Signalling Mediated by VEGF-A-Delta-Like Ligand 4-Notch1 Axis in Human Endothelial Cells	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; POSTMENOPAUSAL WOMEN; SECRETASE INHIBITOR; UP-REGULATION; TUMOR-CELLS; PHASE-I; NOTCH; ESTRADIOL; ACTIVATION; GROWTH	Estrogens play a protective role in coronary artery disease. The mechanisms of action are still poorly understood, although a role for estrogens in stimulation of angiogenesis has been suggested. In several cell types, estrogens modulate the Notch pathway, which is involved in controlling angiogenesis downstream of vascular endothelial growth factor A (VEGF-A). The goal of our study was to establish whether estrogens modulate Notch activity in endothelial cells and the possible consequences on angiogenesis. Human umbilical vein endothelial cells (HUVECs) were treated with 17 beta-estradiol (E2) and the effects on Notch signalling were evaluated. E2 increased Notch1 processing as indicated by i) decreased levels of Notch1 transmembrane subunit ii) increased amount of Notch1 in nuclei iii) unaffected level of mRNA. Similarly, E2 increased the levels of the active form of Notch4 without altering Notch4 mRNA. Conversely, protein and mRNA levels of Notch2 were both reduced suggesting transcriptional repression of Notch2 by E2. Under conditions where Notch was activated by upregulation of Delta-like ligand 4 (Dll4) following VEGF-A treatment, E2 caused a further increase of the active form of Notch1, of the number of cells with nuclear Notch1 and of Hey2 mRNA. Estrogen receptor antagonist ICI 182.780 antagonized these effects suggesting that E2 modulation of Notch1 is mediated by estrogen receptors. E2 treatment abolished the increase in endothelial cells sprouting caused by Notch inhibition in a tube formation assay on 3D Matrigel and in mouse aortic ring explants. In conclusion, E2 affects several Notch pathway components in HUVECs, leading to an activation of the VEGF-A-Dll4-Notch1 axis and to a modulation of vascular branching when Notch signalling is inhibited. These results contribute to our understanding of the molecular mechanisms of cardiovascular protection exerted by estrogens by uncovering a novel role of E2 in the Notch signalling-mediated modulation of angiogenesis.	[Caliceti, Cristiana; Aquila, Giorgio; Pannella, Micaela; Morelli, Marco Bruno; Fortini, Cinzia; Rizzo, Paola; Ferrari, Roberto] Univ Ferrara, Lab Technol Adv Therapies LTTA, Azienda Osped Univ, Dept Med Sci,Cardiovasc Sect,Arcispedale St Anna, I-44100 Ferrara, Italy; [Pinton, Paolo; Bonora, Massimo] Univ Ferrara, Dept Surg Morphol & Expt Med, Sect Gen Pathol, ICSI,Lab Technol Adv Therapies LTTA, I-44100 Ferrara, Italy; [Hrelia, Silvana] Univ Bologna, Dept Life Qual Studies, Bologna, Italy; [Pannuti, Antonio; Miele, Lucio] Univ Mississippi, Med Ctr, Inst Canc, Jackson, MS 39216 USA	University of Ferrara; Arcispedale Sant'Anna; University of Ferrara; University of Bologna; University of Mississippi; University of Mississippi Medical Center	Rizzo, P (corresponding author), Univ Ferrara, Lab Technol Adv Therapies LTTA, Azienda Osped Univ, Dept Med Sci,Cardiovasc Sect,Arcispedale St Anna, I-44100 Ferrara, Italy.	prizzo@mtagroup.net	Aquila, Giorgio/X-4412-2019; Morelli, Marco Bruno/AAD-9632-2021; Hrelia, Silvana/P-2864-2015; FERRARI, ROBERTO/ABD-5169-2020; Bonora, Massimo/AAC-3609-2022; Pinton, Paolo/J-8025-2012; caliceti, cristiana/AAW-9614-2020	Aquila, Giorgio/0000-0002-3936-8895; Morelli, Marco Bruno/0000-0001-5540-0368; Hrelia, Silvana/0000-0001-7857-4512; Bonora, Massimo/0000-0002-5752-3318; Pinton, Paolo/0000-0001-7108-6508; caliceti, cristiana/0000-0002-6740-5331; Ferrari, Roberto/0000-0003-2046-9175; Miele, Lucio/0000-0002-5853-7287; rizzo, paola/0000-0001-7174-9674	Fondazione Annamaria Sechi per il Cuore (FASC), Italy	Fondazione Annamaria Sechi per il Cuore (FASC), Italy	This work was supported by a grant from Fondazione Annamaria Sechi per il Cuore (FASC), Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar Y, 2012, ENDOCRINOLOGY, V153, P2884, DOI 10.1210/en.2011-2122; Afshar Y, 2012, FASEB J, V26, P282, DOI 10.1096/fj.11-184663; Albain KS, 2010, CANC RES S, V70, p113s; Arnal JF, 2010, ARTERIOSCL THROM VAS, V30, P1506, DOI 10.1161/ATVBAHA.109.191221; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Bender RA, 2010, CEREB CORTEX, V20, P2985, DOI 10.1093/cercor/bhq047; Benedito R, 2012, NATURE, V484, P110, DOI 10.1038/nature10908; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Borggrefe T, 2012, CELL CYCLE, V11, P264, DOI 10.4161/cc.11.2.18995; COLE SPC, 1986, CANCER CHEMOTH PHARM, V17, P259; Dubey RK, 2005, CARDIOVASC RES, V66, P295, DOI 10.1016/j.cardiores.2004.12.012; Espinoza I, 2013, PHARMACOL THERAPEUT, V139, P95, DOI 10.1016/j.pharmthera.2013.02.003; Estrach S, 2011, CIRC RES, V109, P172, DOI 10.1161/CIRCRESAHA.111.240622; Evans MJ, 2002, ENDOCRINOLOGY, V143, P3785, DOI 10.1210/en.2002-220356; Farnie G, 2007, JNCI-J NATL CANCER I, V99, P616, DOI 10.1093/jnci/djk133; Fernandez JW, 2010, FEBS LETT, V584, P4259, DOI 10.1016/j.febslet.2010.09.022; Florian M, 2008, STEROIDS, V73, P47, DOI 10.1016/j.steroids.2007.08.010; Funahashi Y, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-2; Funahashi Yasuhiro, 2010, J Angiogenes Res, V2, P3, DOI 10.1186/2040-2384-2-3; Gray S, 2003, LANCET, V362, P1332, DOI 10.1016/S0140-6736(03)14598-9; Gu JW, 2012, VASC CELL, V4, DOI 10.1186/2045-824X-4-7; Hansson EM, 2010, J CELL SCI, V123, P2931, DOI 10.1242/jcs.073239; Hao L, 2010, ONCOGENE, V29, P201, DOI 10.1038/onc.2009.323; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Huang JH, 2002, J BIOL CHEM, V277, P10760, DOI 10.1074/jbc.M110219200; Jesmin S, 2002, ARTERIOSCL THROM VAS, V22, P1591, DOI 10.1161/01.ATV.0000034929.42459.0D; Kolb EA, 2012, PEDIATR BLOOD CANCER, V58, P815, DOI 10.1002/pbc.23290; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Krop I, 2012, J CLIN ONCOL, V30, P2307, DOI 10.1200/JCO.2011.39.1540; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; MORALES DE, 1995, CIRCULATION, V91, P755, DOI 10.1161/01.CIR.91.3.755; Noseda M, 2004, MOL CELL BIOL, V24, P8813, DOI 10.1128/MCB.24.20.8813-8822.2004; Paschoalin T, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-44; Peekhaus NT, 2004, J MOL ENDOCRINOL, V32, P987, DOI 10.1677/jme.0.0320987; Quillard T, 2010, BIOCHEM PHARMACOL, V80, P2032, DOI 10.1016/j.bcp.2010.07.010; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Rizzo P, 2008, ONCOGENE, V27, P5124, DOI 10.1038/onc.2008.226; Rizzo P, 2012, EUR HEART J; Rizzo P, 2008, CANCER RES, V68, P5226, DOI 10.1158/0008-5472.CAN-07-5744; Rosati E, 2009, BLOOD, V113, P856, DOI 10.1182/blood-2008-02-139725; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Ruiz-Palmero I, 2011, J NEUROENDOCRINOL, V23, P355, DOI 10.1111/j.1365-2826.2011.02110.x; Russell KS, 2000, P NATL ACAD SCI USA, V97, P5930, DOI 10.1073/pnas.97.11.5930; Sainson RCA, 2008, ANGIOGENESIS, V11, P41, DOI 10.1007/s10456-008-9098-0; Sainson RCA, 2008, BLOOD, V111, P4997, DOI 10.1182/blood-2007-08-108597; Saltiki Katerina, 2007, Hormones (Athens), V6, P9; Schierbeck LL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6409; Soares R, 2004, MOL ENDOCRINOL, V18, P2333, DOI 10.1210/me.2003-0362; Sobrino A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008242; Spyridopoulos I, 1997, CIRCULATION, V95, P1505; Stefano GB, 2000, CIRCULATION, V101, P1594, DOI 10.1161/01.CIR.101.13.1594; Stirone C, 2005, MOL PHARMACOL, V67, P105, DOI 10.1124/mol.104.004465; Strehlow K, 2003, CIRCULATION, V107, P3059, DOI 10.1161/01.CIR.0000077911.81151.30; Sumanasekera WK, 2007, AM J PHYSIOL-CELL PH, V293, pC566, DOI 10.1152/ajpcell.00418.2006; Takeshita K, 2007, CIRC RES, V100, P70, DOI 10.1161/01.RES.0000254788.47304.6e; Tolcher AW, 2012, J CLIN ONCOL, V30, P2348, DOI 10.1200/JCO.2011.36.8282; Toth B, 2009, ACTA HISTOCHEM, V111, P508, DOI 10.1016/j.acthis.2008.05.006; Williams CK, 2006, BLOOD, V107, P931, DOI 10.1182/blood-2005-03-1000; Yamaoka-Tojo M, 2004, CIRC RES, V95, P276, DOI 10.1161/01.RES.0000136522.58649.60; Yang LT, 2005, MOL BIOL CELL, V16, P927, DOI 10.1091/mbc.e04-07-0614; Zen AA, 2010, CIRC RES, V107, P283, DOI 10.1161/CIRCRESAHA.110.221663	62	48	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71440	10.1371/journal.pone.0071440	http://dx.doi.org/10.1371/journal.pone.0071440			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967210	Green Published, Green Submitted, gold			2022-12-25	WOS:000323115800059
J	Douvaras, P; Mort, RL; Edwards, D; Ramaesh, K; Dhillon, B; Morley, SD; Hill, RE; West, JD				Douvaras, Panagiotis; Mort, Richard L.; Edwards, Dominic; Ramaesh, Kanna; Dhillon, Baljean; Morley, Steven D.; Hill, Robert E.; West, John D.			Increased Corneal Epithelial Turnover Contributes to Abnormal Homeostasis in the Pax6(+/-) Mouse Model of Aniridia	PLOS ONE			English	Article							LABEL-RETAINING CELLS; STEM-CELL; IN-VIVO; BONE-MARROW; LIMBAL; MIGRATION; PAX6; MICE; PATTERNS; IDENTIFICATION	We aimed to test previous predictions that limbal epithelial stem cells (LESCs) are quantitatively deficient or qualitatively defective in Pax6(+/-) mice and decline with age in wild-type (WT) mice. Consistent with previous studies, corneal epithelial stripe patterns coarsened with age in WT mosaics. Mosaic patterns were also coarser in Pax6(+/-) mosaics than WT at 15 weeks but not at 3 weeks, which excludes a developmental explanation and strengthens the prediction that Pax6(+/-) mice have a LESC-deficiency. To investigate how Pax6 genotype and age affected corneal homeostasis, we compared corneal epithelial cell turnover and label-retaining cells (LRCs; putative LESCs) in Pax6(+/-) and WT mice at 15 and 30 weeks. Limbal BrdU-LRC numbers were not reduced in the older WT mice, so this analysis failed to support the predicted age-related decline in slow-cycling LESC numbers in WT corneas. Similarly, limbal BrdU-LRC numbers were not reduced in Pax6(+/-) heterozygotes but BrdU-LRCs were also present in Pax6(+/-) corneas. It seems likely that Pax6(+/-) LRCs are not exclusively stem cells and some may be terminally differentiated CD31-positive blood vessel cells, which invade the Pax6(+/-) cornea. It was not, therefore, possible to use this approach to test the prediction that Pax6(+/-) corneas had fewer LESCs than WT. However, short-term BrdU labelling showed that basal to suprabasal movement (leading to cell loss) occurred more rapidly in Pax6(+/-) than WT mice. This implies that epithelial cell loss is higher in Pax6(+/-) mice. If increased corneal epithelial cell loss exceeds the cell production capacity it could cause corneal homeostasis to become unstable, resulting in progressive corneal deterioration. Although it remains unclear whether Pax6(+/-) mice have LESC-deficiency, we suggest that features of corneal deterioration, that are often taken as evidence of LESC-deficiency, might occur in the absence of stem cell deficiency if corneal homeostasis is destabilised by excessive cell loss.	[Douvaras, Panagiotis; Mort, Richard L.; Edwards, Dominic; West, John D.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [Ramaesh, Kanna] Gartnaval Gen Hosp, Tennent Inst Ophthalmol, Glasgow, Lanark, Scotland; [Dhillon, Baljean] Univ Edinburgh, Sch Clin Sci, Edinburgh, Midlothian, Scotland; [Morley, Steven D.] Univ Edinburgh, Div Hlth Sci, Edinburgh, Midlothian, Scotland; [Hill, Robert E.] Univ Edinburgh, MRC, Human Genet Unit, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh	West, JD (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland.	John.West@ed.ac.uk	Mort, Richard/X-5592-2019; Morley, Steve/AAY-9985-2020	Mort, Richard/0000-0002-3566-8217; Morley, Steven/0000-0002-7355-3349; Douvaras, Panagiotis/0000-0002-4430-997X; West, John/0000-0002-5886-0359	Fight For Sight (UK); RS MacDonald Charitable Trust; University of Edinburgh, College of Medicine & Veterinary Medicine; Ross Foundation for the Prevention of Blindness; Royal College of Surgeons of Edinburgh; Wellcome Trust [088876]; MRC [MC_U127584494, G1002033, MC_PC_U127584494] Funding Source: UKRI; Medical Research Council [MC_PC_U127584494, MC_U127584494, G1002033] Funding Source: researchfish	Fight For Sight (UK); RS MacDonald Charitable Trust; University of Edinburgh, College of Medicine & Veterinary Medicine; Ross Foundation for the Prevention of Blindness; Royal College of Surgeons of Edinburgh; Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a PhD studentship for PD from Fight For Sight (UK) and the RS MacDonald Charitable Trust, a PhD studentship for RM from the University of Edinburgh, College of Medicine & Veterinary Medicine and grants from the Ross Foundation for the Prevention of Blindness, the Royal College of Surgeons of Edinburgh and the Wellcome Trust (088876). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beebe DC, 1996, INVEST OPHTH VIS SCI, V37, P1815; BUCK RC, 1985, INVEST OPHTH VIS SCI, V26, P1296; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; CENEDELLA RJ, 1990, INVEST OPHTH VIS SCI, V31, P1957; Chan RWS, 2006, STEM CELLS, V24, P1529, DOI 10.1634/stemcells.2005-0411; Chen WS, 2003, JPN J OPHTHALMOL, V47, P119, DOI 10.1016/S0021-5155(02)00687-1; Collinson JM, 2004, INVEST OPHTH VIS SCI, V45, P1101, DOI 10.1167/iovs.03-1118; Collinson JM, 2002, DEV DYNAM, V224, P432, DOI 10.1002/dvdy.10124; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; DAVANGER M, 1971, NATURE, V229, P560, DOI 10.1038/229560a0; Davis J, 2003, J CELL SCI, V116, P2157, DOI 10.1242/jcs.00441; Douvaras P, 2012, STEM CELL RES, V8, P109, DOI 10.1016/j.scr.2011.08.007; GOODRICK CL, 1990, MECH AGEING DEV, V55, P69, DOI 10.1016/0047-6374(90)90107-Q; Haddad A, 2000, CORNEA, V19, P378, DOI 10.1097/00003226-200005000-00024; HANNA C, 1960, ARCH OPHTHALMOL-CHIC, V64, P536; HANSON IM, 1993, HUM MOL GENET, V2, P915; HASKJOLD E, 1990, VIRCHOWS ARCH B, V58, P229; HASKJOLD E, 1989, ACTA OPHTHALMOL, V67, P91; Hodson BA, 2011, J ANAT, V219, P418, DOI 10.1111/j.1469-7580.2011.01395.x; Kao WWY, 1996, INVEST OPHTH VIS SCI, V37, P2572; Kaufmann B, 1944, ANAT REC, V90, P161, DOI 10.1002/ar.1090900210; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; KINOSHITA S, 1981, INVEST OPHTH VIS SCI, V21, P434; Klein AM, 2011, DEVELOPMENT, V138, P3103, DOI 10.1242/dev.060103; Kucerova R, 2006, INVEST OPHTH VIS SCI, V47, P5276, DOI 10.1167/iovs.06-0581; LAVKER RM, 1991, INVEST OPHTH VIS SCI, V32, P1864; Lee H, 2008, ACTA OPHTHALMOL, V86, P708, DOI 10.1111/j.1755-3768.2008.01427.x; Lehrer MS, 1998, J CELL SCI, V111, P2867; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Li W, 2008, J PATHOL, V214, P114, DOI 10.1002/path.2256; LIU CY, 1993, CURR EYE RES, V12, P963, DOI 10.3109/02713689309029222; Liu JJ, 1999, EXP EYE RES, V68, P295, DOI 10.1006/exer.1998.0593; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; MACKMAN G, 1979, AM J OPHTHALMOL, V87, P497, DOI 10.1016/0002-9394(79)90238-1; Majo F, 2008, NATURE, V456, P250, DOI 10.1038/nature07406; Marinari E, 2012, NATURE, V484, P542, DOI 10.1038/nature10984; MARTHA A, 1994, AM J HUM GENET, V54, P801; Mort Richard L, 2012, Results Probl Cell Differ, V55, P357, DOI 10.1007/978-3-642-30406-4_19; Mort RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028895; Mort RL, 2009, J ANAT, V215, P698, DOI 10.1111/j.1469-7580.2009.01150.x; Mort RL, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-4; Nagasaki T, 2005, INVEST OPHTH VIS SCI, V46, P126, DOI 10.1167/iovs.04-0356; Nagasaki T, 2003, INVEST OPHTH VIS SCI, V44, P558, DOI 10.1167/iovs.02-0705; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; NELSON LB, 1984, SURV OPHTHALMOL, V28, P621, DOI 10.1016/0039-6257(84)90184-X; NISHIDA K, 1995, AM J OPHTHALMOL, V120, P368, DOI 10.1016/S0002-9394(14)72167-1; Ou J, 2008, J PATHOL, V215, P421, DOI 10.1002/path.2371; Ou JX, 2010, INVEST OPHTH VIS SCI, V51, P1415, DOI 10.1167/iovs.09-4023; Pajoohesh-Ganji A, 2005, BIOL CELL, V97, P265, DOI 10.1042/BC20040114; Pajoohesh-Ganji A, 2004, DEV DYNAM, V230, P518, DOI 10.1002/dvdy.20050; Pajoohesh-Ganji A, 2012, STEM CELLS, V30, P2032, DOI 10.1002/stem.1176; Pajooresh-Ganji A, 2006, STEM CELLS, V24, P1075, DOI 10.1634/stemcells.2005-0382; Pal-Ghosh S, 2004, INVEST OPHTH VIS SCI, V45, P1775, DOI 10.1167/iovs.03-1194; Pawelczyk E, 2008, STEM CELLS, V26, P1366, DOI 10.1634/stemcells.2007-0707; Pawelczyk E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006712; POTTEN CS, 1988, J CELL SCI, P45; PUANGSRICHARERN V, 1995, OPHTHALMOLOGY, V102, P1476; Quinn JC, 1996, GENE DEV, V10, P435, DOI 10.1101/gad.10.4.435; Ramaesh T, 2005, EXP EYE RES, V81, P224, DOI 10.1016/j.exer.2005.02.002; Ramaesh T, 2003, INVEST OPHTH VIS SCI, V44, P1871, DOI 10.1167/iovs.02-0576; Ramaesh T, 2006, INVEST OPHTH VIS SCI, V47, P1911, DOI 10.1167/iovs.05-1028; Roach SA., 1968, THEORY RANDOM CLUMPI; SCHEVING LE, 1967, J CELL BIOL, V32, P677, DOI 10.1083/jcb.32.3.677; SCHMIDT GH, 1986, J EMBRYOL EXP MORPH, V91, P197; SHARMA A, 1989, INVEST OPHTH VIS SCI, V30, P1962; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696; Shiraishi A, 1998, INVEST OPHTH VIS SCI, V39, P2554; Snippert HJ, 2011, EMBO REP, V12, P113, DOI 10.1038/embor.2010.216; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Staszkiewicz J, 2009, BIOCHEM BIOPH RES CO, V378, P539, DOI 10.1016/j.bbrc.2008.11.092; SZERENYI K, 1994, CORNEA, V13, P487; TAN SS, 1993, NAT GENET, V3, P170, DOI 10.1038/ng0293-170; THOFT RA, 1983, INVEST OPHTH VIS SCI, V24, P1442; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; Vincent MC, 2003, EUR J HUM GENET, V11, P163, DOI 10.1038/sj.ejhg.5200940; WEI ZG, 1995, INVEST OPHTH VIS SCI, V36, P236; WEST JD, 1976, J EMBRYOL EXP MORPH, V35, P445; West JD, 1997, DEV GROWTH DIFFER, V39, P305; Yoshida S, 2006, INVEST OPHTH VIS SCI, V47, P4780, DOI 10.1167/iovs.06-0574; Zhang W, 2008, MOL VIS, V14, P1929; Zhao J, 2009, J HISTOCHEM CYTOCHEM, V57, P177, DOI 10.1369/jhc.2008.952390	82	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71117	10.1371/journal.pone.0071117	http://dx.doi.org/10.1371/journal.pone.0071117			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967157	Green Published, gold, Green Submitted			2022-12-25	WOS:000323115800037
J	Sayim, B; Cavanagh, P				Sayim, Bilge; Cavanagh, Patrick			Grouping and Crowding Affect Target Appearance over Different Spatial Scales	PLOS ONE			English	Article							ECCENTRIC VISION; LATERAL MASKING; CONTRAST; COLOR; RESOLUTION; INTERFERENCE; ASSIMILATION; RECOGNITION; INTEGRATION; KINDS	Crowding is the impairment of peripheral target perception by nearby flankers. A number of recent studies have shown that crowding shares many features with grouping. Here, we investigate whether effects of crowding and grouping on target perception are related by asking whether they operate over the same spatial scale. A target letter T had two sets of flanking Ts of varying orientations. The first set was presented close to the target, yielding strong crowding. The second set was either close enough to cause crowding on their own or too far to cause crowding on their own. The Ts of the second set had the same orientation that either matched the target's orientation (Grouped condition) or not (Ungrouped condition). In Experiment 1, the Grouped flankers reduced crowding independently of their distance from the target, suggesting that grouping operated over larger distances than crowding. In Experiments 2 and 3 we found that grouping did not affect sensitivity but produced a strong bias to report that the grouped orientation was present at the target location whether or not it was. Finally, we investigated whether this bias was a response or perceptual bias, rejecting the former in favor of a perceptual grouping explanation. We suggest that the effect of grouping is to assimilate the target to the identity of surrounding flankers when they are all the same, and that this shape assimilation effect differs in its spatial scale from the integration effect of crowding.	[Sayim, Bilge; Cavanagh, Patrick] Univ Paris 05, Sorbonne Paris Cite, LabPsychol Percept, Paris, France; [Sayim, Bilge; Cavanagh, Patrick] CNRS, UMR 8158, Paris, France; [Sayim, Bilge] Univ Louvain, Expt Psychol Lab, Louvain, Belgium	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS)	Sayim, B (corresponding author), Univ Paris 05, Sorbonne Paris Cite, LabPsychol Percept, Paris, France.	bilge.sayim@ppw.kuleuven.be		Sayim, Bilge/0000-0002-7589-5385	Chaire d'Excellence grant	Chaire d'Excellence grant	This research was supported by a Chaire d'Excellence grant to Patrick Cavanagh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRIESSEN JJ, 1976, VISION RES, V16, P71, DOI 10.1016/0042-6989(76)90078-X; BANKS WP, 1984, PERCEPT PSYCHOPHYS, V36, P285, DOI 10.3758/BF03206370; BANKS WP, 1976, PERCEPT PSYCHOPHYS, V19, P361, DOI 10.3758/BF03204244; Bernard JB, 2011, J VISION, V11, DOI 10.1167/11.8.1; BOUMA H, 1970, NATURE, V226, P177, DOI 10.1038/226177a0; Bouma H., 1969, IPO ANN PROGR REPORT, V4, P95; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chung STL, 2001, VISION RES, V41, P1833, DOI 10.1016/S0042-6989(01)00071-2; COREN S, 1980, J EXP PSYCHOL HUMAN, V6, P404, DOI 10.1037/0096-1523.6.3.404; Felisberti FM, 2005, PERCEPTION, V34, P823, DOI 10.1068/p5206; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; Fuchs W, 1923, Z PSYCHOL PHYSIOL SI, V92, P249; Greenwood JA, 2010, CURR BIOL, V20, P496, DOI 10.1016/j.cub.2010.01.023; Hariharan S, 2005, VISION RES, V45, P617, DOI 10.1016/j.visres.2004.09.035; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Huckauf A, 2002, VIS COGN, V9, P889, DOI 10.1080/13506280143000548A; Intriligator J, 2001, COGNITIVE PSYCHOL, V43, P171, DOI 10.1006/cogp.2001.0755; Jordan TR, 1999, PERCEPTION, V28, P1413, DOI 10.1068/p2919; Kanai R, 2005, HEALING GRID ANNUAL; KING DL, 1988, NEW IDEAS PSYCHOL, V6, P277, DOI 10.1016/0732-118X(88)90039-6; King DL, 2001, REV GEN PSYCHOL, V5, P23; Koffka K., 1935, PRINCIPLES OF GESTAL; Kohler W, 1947, GESTALTPSYCHOLOGY; KOOI FL, 1994, SPATIAL VISION, V8, P255, DOI 10.1163/156856894X00350; Korte W, 1923, Z PSYCHOL PHYSIOL SI, V93, P17; Leat SJ, 1999, INVEST OPHTH VIS SCI, V40, P504; Levi DM, 2008, VISION RES, V48, P635, DOI 10.1016/j.visres.2007.12.009; Levi DM, 2002, J VISION, V2, P167, DOI 10.1167/2.2.3; Livne T, 2007, J VISION, V7, DOI 10.1167/7.2.4; Livne T, 2010, J VISION, V10, DOI 10.1167/10.3.1; Macmillan N. A, 2005, DETECTION THEORY A U; Malania M, 2007, J VISION, V7, DOI 10.1167/7.2.1; Manassi M, 2012, J VISION, V12, DOI 10.1167/12.10.13; May KA, 2007, J VISION, V7, DOI 10.1167/7.13.9; NAZIR TA, 1992, VISION RES, V32, P771, DOI 10.1016/0042-6989(92)90192-L; Palmer S, 2009, JOURNAL OF VISION, V9; Parkes L, 2001, NAT NEUROSCI, V4, P739, DOI 10.1038/89532; Pelli DG, 2008, NAT NEUROSCI, V11, P1129, DOI 10.1038/nn.2187; Pelli DG, 2004, J VISION, V4, P1136, DOI 10.1167/4.12.12; Poder E, 2006, J VISION, V6, P163, DOI 10.1167/6.2.7; Poder E, 2007, PSYCHOL RES-PSYCH FO, V71, P641, DOI 10.1007/s00426-006-0053-7; PRINZMETAL W, 1977, PERCEPT PSYCHOPHYS, V21, P389, DOI 10.3758/BF03199491; Saarela TP, 2010, J VISION, V10, DOI 10.1167/10.10.17; Saarela TP, 2009, J VISION, V9, DOI 10.1167/9.2.5; Sayim B, 2010, PSYCHOL SCI, V21, P641, DOI 10.1177/0956797610368811; Sayim B, 2011, J VISION, V11, DOI 10.1167/11.1.6; Sayim B, 2008, J VISION, V8, DOI 10.1167/8.8.12; Scolari M, 2007, J VISION, V7, DOI 10.1167/7.2.7; STRASBURGER H, 1991, PERCEPT PSYCHOPHYS, V49, P495, DOI 10.3758/BF03212183; Strasburger H, 2005, J VISION, V5, P1024, DOI 10.1167/5.11.8; TOET A, 1992, VISION RES, V32, P1349, DOI 10.1016/0042-6989(92)90227-A; van Lier R, 1997, ACTA PSYCHOL, V97, P37, DOI 10.1016/S0001-6918(97)00023-1; Wertheimer M, 1955, SOURCE BOOK GESTALTP; WESTHEIMER G, 1976, J OPT SOC AM, V66, P332, DOI 10.1364/JOSA.66.000332; Whitney D, 2011, TRENDS COGN SCI, V15, P160, DOI 10.1016/j.tics.2011.02.005; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wilkinson F, 1997, J OPT SOC AM A, V14, P2057, DOI 10.1364/JOSAA.14.002057; Xian SX, 2004, VISUAL NEUROSCI, V21, P383, DOI 10.1017/S0952523804213062	58	18	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71188	10.1371/journal.pone.0071188	http://dx.doi.org/10.1371/journal.pone.0071188			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	201BN	23967164	gold, Green Submitted, Green Published			2022-12-25	WOS:000323115800041
J	Sun, XR; Cai, JD; Fan, X; Han, PF; Xie, YP; Chen, JM; Xiao, Y; Kang, YJ				Sun, Xiaorong; Cai, Jindan; Fan, Xin; Han, Pengfei; Xie, Yuping; Chen, Jianmin; Xiao, Ying; Kang, Y. James			Decreases in Electrocardiographic R-Wave Amplitude and QT Interval Predict Myocardial Ischemic Infarction in Rhesus Monkeys with Left Anterior Descending Artery Ligation	PLOS ONE			English	Article								Clinical studies have demonstrated the predictive values of changes in electrocardiographic (ECG) parameters for the preexisting myocardial ischemic infarction. However, a simple and early predictor for the subsequent development of myocardial infarction during the ischemic phase is of significant value for the identification of ischemic patients at high risk. The present study was undertaken by using non-human primate model of myocardial ischemic infarction to fulfill this gap. Twenty male Rhesus monkeys at age of 2-3 years old were subjected to left anterior descending artery ligation. This ligation was performed at varying position along the artery so that it produced varying sizes of myocardial infarction at the late stage. The ECG recording was undertaken before the surgical procedure, at 2 h after the ligation, and 8 weeks after the surgery for each animal. The correlation of the changes in the ECG waves in the early or the late stage with the myocardial infarction size was analyzed. The R wave depression and the QT shortening in the early ischemic stage were found to have an inverse correlation with the myocardial infarction size. At the late stage, the R wave depression, the QT prolongation, the QRS score, and the ST segment elevation were all closely correlated with the developed infarction size. The poor R wave progression was identified at both the early ischemic and the late infarction stages. Therefore, the present study using non-human primate model of myocardial ischemic infarction identified the decreases in the R wave and the QT interval as early predictors of myocardial infarction. Validation of these parameters in clinical studies would greatly help identifying patients with myocardial ischemia at high risk for the subsequent development of myocardial infarction.	[Sun, Xiaorong; Cai, Jindan; Fan, Xin; Han, Pengfei; Xie, Yuping; Chen, Jianmin; Xiao, Ying; Kang, Y. James] Sichuan Univ, West China Hosp, Regenerat Med Res Ctr, Chengdu 610064, Sichuan, Peoples R China; [Kang, Y. James] Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA	Sichuan University; University of Louisville	Kang, YJ (corresponding author), Sichuan Univ, West China Hosp, Regenerat Med Res Ctr, Chengdu 610064, Sichuan, Peoples R China.	yjkang01@louisville.edu	xiao, ying/AAW-8845-2021		National Basic Research Program of China (973 Program) [2013CB530700]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This study was supported by the National Basic Research Program of China (973 Program, Grant No. 2013CB530700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHNVE S, 1985, EUR HEART J, V6, P85, DOI 10.1093/eurheartj/6.suppl_D.85; ALDRICH HR, 1988, AM J CARDIOL, V61, P749, DOI 10.1016/0002-9149(88)91060-0; Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Antzelevitch C, 2007, CIRCULATION, V115, P442, DOI 10.1161/CIRCULATIONAHA.106.668392; BANKA N, 1982, RES EXP MED, V181, P125, DOI 10.1007/BF01852189; de Luna AB, 2008, J ELECTROCARDIOL, V41, P413, DOI 10.1016/j.jelectrocard.2007.10.002; Bellocq C, 2004, CIRCULATION, V109, P2394, DOI 10.1161/01.CIR.0000130409.72142.FE; Birnbaum Y, 1999, AM J CARDIOL, V84, P530, DOI 10.1016/S0002-9149(99)00372-0; BIRNBAUM Y, 1993, CHEST, V103, P1681, DOI 10.1378/chest.103.6.1681; Brugada R, 2004, CIRCULATION, V109, P30, DOI 10.1161/01.CIR.0000109482.92774.3A; BUSS DD, 1982, ANAT REC, V203, P411, DOI 10.1002/ar.1092030311; CLEMMENSEN P, 1990, AM J CARDIOL, V66, P1407, DOI 10.1016/0002-9149(90)90524-5; DAVID D, 1981, CIRCULATION, V63, P1364, DOI 10.1161/01.CIR.63.6.1364; De Sutter J, 1999, HEART, V81, P533, DOI 10.1136/hrt.81.5.533; DEPACE NL, 1983, J AM COLL CARDIOL, V2, P1073, DOI 10.1016/S0735-1097(83)80332-5; FLAMENG W, 1990, BASIC RES CARDIOL, V85, P392, DOI 10.1007/BF01907131; Gaita F, 2003, CIRCULATION, V108, P965, DOI 10.1161/01.CIR.0000085071.28695.C4; Geerse DA, 2009, ANN NONINVAS ELECTRO, V14, P360, DOI 10.1111/j.1542-474X.2009.00327.x; Gussak I, 2000, CARDIOLOGY, V94, P99, DOI 10.1159/000047299; HOLLAND RP, 1975, CIRC RES, V37, P471, DOI 10.1161/01.RES.37.4.471; IDEKER RE, 1982, AM J CARDIOL, V49, P1604, DOI 10.1016/0002-9149(82)90235-1; Isobe S, 2002, J ELECTROCARDIOL, V35, P173, DOI 10.1054/jelc.2002.33761; Isobe S, 2006, CIRC J, V70, P1385, DOI 10.1253/circj.70.1385; Katsuno T, 2010, ANN NONINVAS ELECTRO, V15, P116, DOI 10.1111/j.1542-474X.2010.00351.x; Loring Z, 2011, J ELECTROCARDIOL, V44, P544, DOI 10.1016/j.jelectrocard.2011.06.008; MacKenzie Ross, 2005, J Insur Med, V37, P58; Mandelzweig L, 2006, EUR HEART J, V27, P2285, DOI 10.1093/eurheartj/ehl196; MORENO FL, 1994, CIRCULATION, V90, P94, DOI 10.1161/01.CIR.90.1.94; MOSS AJ, 1985, CIRCULATION, V71, P17, DOI 10.1161/01.CIR.71.1.17; Priori SG, 2005, CIRC RES, V96, P800, DOI 10.1161/01.RES.0000162101.76263.8c; Rijnierse MT, 2011, NETHERLANDS HEART J, V20, P326; Roe MT, 2005, ARCH INTERN MED, V165, P1630, DOI 10.1001/archinte.165.14.1630; Sadanandan S, 2003, AM HEART J, V146, P653, DOI 10.1016/S0002-8703(03)00369-7; SCHRODER R, 1995, J AM COLL CARDIOL, V26, P1657, DOI 10.1016/0735-1097(95)00372-X; SCHWARTZ PJ, 1978, CIRCULATION, V57, P1074, DOI 10.1161/01.CIR.57.6.1074; Sinno MCN, 2008, J ELECTROCARDIOL, V41, P425, DOI 10.1016/j.jelectrocard.2007.12.008; Takagawa J, 2007, J APPL PHYSIOL, V102, P2104, DOI 10.1152/japplphysiol.00033.2007; Tamura A, 1999, AM J CARDIOL, V83, P1423, DOI 10.1016/S0002-9149(99)00118-6; Teofilovski-Parapid G, 1998, LAB ANIM-UK, V32, P200, DOI 10.1258/002367798780600007; Tohno Y, 2008, BIOL TRACE ELEM RES, V125, P141, DOI 10.1007/s12011-008-8167-y; Viskin S, 2004, HEART RHYTHM, V1, P587, DOI 10.1016/j.hrthm.2004.07.010; WAGNER GS, 1982, CIRCULATION, V65, P342, DOI 10.1161/01.CIR.65.2.342; Wang K, 2003, NEW ENGL J MED, V349, P2128, DOI 10.1056/NEJMra022580; Xie YP, 2012, EXP BIOL MED, V237, P853, DOI 10.1258/ebm.2012.012070; Yang PL, 2011, CARDIOVASC TOXICOL, V11, P365, DOI 10.1007/s12012-011-9129-8	45	33	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71876	10.1371/journal.pone.0071876	http://dx.doi.org/10.1371/journal.pone.0071876			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967258	gold, Green Submitted, Green Published			2022-12-25	WOS:000323115800091
J	Fredriksson, NJ; Hermansson, M; Wilen, BM				Fredriksson, Nils Johan; Hermansson, Malte; Wilen, Britt-Marie			The Choice of PCR Primers Has Great Impact on Assessments of Bacterial Community Diversity and Dynamics in a Wastewater Treatment Plant	PLOS ONE			English	Article							ESTIMATING PROKARYOTIC DIVERSITY; RNA GENE DATABASE; WEB-BASED TOOL; ACTIVATED-SLUDGE; MICROBIAL COMMUNITIES; TREATMENT SYSTEM; 16S; LIBRARIES; QUANTIFICATION; SPECIFICITY	Assessments of bacterial community diversity and dynamics are fundamental for the understanding of microbial ecology as well as biotechnological applications. We show that the choice of PCR primers has great impact on the results of analyses of diversity and dynamics using gene libraries and DNA fingerprinting. Two universal primer pairs targeting the 16S rRNA gene, 27F&1492R and 63F&M1387R, were compared and evaluated by analyzing the bacterial community in the activated sludge of a large-scale wastewater treatment plant. The two primer pairs targeted distinct parts of the bacterial community, none encompassing the other, both with similar richness. Had only one primer pair been used, very different conclusions had been drawn regarding dominant phylogenetic and putative functional groups. With 27F&1492R, Betaproteobacteria would have been determined to be the dominating taxa while 63F&M1387R would have described Alphaproteobacteria as the most common taxa. Microscopy and fluorescence in situ hybridization analysis showed that both Alphaproteobacteria and Betaproteobacteria were abundant in the activated sludge, confirming that the two primer pairs target two different fractions of the bacterial community. Furthermore, terminal restriction fragment polymorphism analyses of a series of four activated sludge samples showed that the two primer pairs would have resulted in different conclusions about community stability and the factors contributing to changes in community composition. In conclusion, different PCR primer pairs, although considered universal, target different ranges of bacteria and will thus show the diversity and dynamics of different fractions of the bacterial community in the analyzed sample. We also show that while a database search can serve as an indicator of how universal a primer pair is, an experimental assessment is necessary to evaluate the suitability for a specific environmental sample.	[Fredriksson, Nils Johan; Wilen, Britt-Marie] Chalmers Univ Technol, Dept Civil & Environm Engn, S-41296 Gothenburg, Sweden; [Hermansson, Malte] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden	Chalmers University of Technology; University of Gothenburg	Fredriksson, NJ (corresponding author), Chalmers Univ Technol, Dept Civil & Environm Engn, S-41296 Gothenburg, Sweden.	johan.fredriksson@chalmers.se	Fredriksson, Nils Johan/AAC-8083-2020; Wilen, Britt-Marie/B-5042-2016	Fredriksson, Nils Johan/0000-0002-5763-6777; Wilen, Britt-Marie/0000-0001-6155-7759; Steensland, Pia/0000-0003-4443-5017	FORMAS, The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning	FORMAS, The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas)	This work was funded by a research grant from FORMAS, The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akarsubasi AT, 2009, ENVIRON SCI TECHNOL, V43, P2950, DOI 10.1021/es8026488; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; [Anonymous], 2003, PROGRAM SPADE SPECIE; Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Bramucci M, 2003, APPL MICROBIOL BIOT, V62, P594, DOI 10.1007/s00253-003-1372-x; Chouari R, 2005, ENVIRON MICROBIOL, V7, P1104, DOI 10.1111/j.1462-2920.2005.00795.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cole JR, 2003, NUCLEIC ACIDS RES, V31, P442, DOI 10.1093/nar/gkg039; Curtis TP, 2006, WATER SCI TECHNOL, V54, P227, DOI 10.2166/wst.2006.391; Curtis TP, 2002, P NATL ACAD SCI USA, V99, P10494, DOI 10.1073/pnas.142680199; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Daims H, 2006, TRENDS BIOTECHNOL, V24, P483, DOI 10.1016/j.tibtech.2006.09.002; Dedysh SN, 2004, MICROBIOL-SGM, V150, P1301, DOI 10.1099/mic.0.26585-0; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dunbar J, 2001, APPL ENVIRON MICROB, V67, P190, DOI 10.1128/AEM.67.1.190-197.2001; Dykhuizen DE, 1998, ANTON LEEUW INT J G, V73, P25, DOI 10.1023/A:1000665216662; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Figuerola ELM, 2007, ENVIRON MICROBIOL, V9, P1780, DOI 10.1111/j.1462-2920.2007.01298.x; Fortuna AM, 2011, APPL MICROBIOL BIOT, V91, P1193, DOI 10.1007/s00253-011-3363-7; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Hong SH, 2009, ISME J, V3, P1365, DOI 10.1038/ismej.2009.89; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Hugenholtz P, 2002, GENOME BIOL, V3; Jin DC, 2011, J ENVIRON SCI-CHINA, V23, P1880, DOI 10.1016/S1001-0742(10)60621-3; Kemp PF, 2004, LIMNOL OCEANOGR-METH, V2, P114, DOI 10.4319/lom.2004.2.114; Khan ST, 2002, APPL ENVIRON MICROB, V68, P3206, DOI 10.1128/AEM.68.7.3206-3214.2002; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kong YH, 2007, MICROBIOL-SGM, V153, P4061, DOI 10.1099/mic.0.2007/007245-0; Lane D.J., 1991, NUCL ACID TECHNIQUES, P115, DOI DOI 10.4135/9781446279281.N7; Layton AC, 2000, APPL ENVIRON MICROB, V66, P1167, DOI 10.1128/AEM.66.3.1167-1174.2000; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Lowe BA, 2011, VET MICROBIOL, V147, P346, DOI 10.1016/j.vetmic.2010.06.025; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Marchesi JR, 1998, APPL ENVIRON MICROB, V64, P795; Marzorati M, 2008, ENVIRON MICROBIOL, V10, P1571, DOI 10.1111/j.1462-2920.2008.01572.x; McMahon KD, 2007, CURR OPIN BIOTECH, V18, P287, DOI 10.1016/j.copbio.2007.04.007; Mertens B, 2005, ENVIRON MICROBIOL, V7, P660, DOI 10.1111/j.1462-2920.2005.00735.x; Morales SE, 2009, APPL ENVIRON MICROB, V75, P2677, DOI 10.1128/AEM.02166-08; Nadarajah N, 2007, WATER RES, V41, P2563, DOI 10.1016/j.watres.2007.02.002; Nielsen PH, 2010, WATER RES, V44, P5070, DOI 10.1016/j.watres.2010.07.036; Pholchan MK, 2010, WATER RES, V44, P1341, DOI 10.1016/j.watres.2009.11.005; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Saikaly PE, 2005, APPL ENVIRON MICROB, V71, P5814, DOI 10.1128/AEM.71.10.5814-5822.2005; Saikaly PE, 2004, MICROB ECOL, V48, P274, DOI 10.1007/s00248-003-1027-6; Schloss PD, 2004, MICROBIOL MOL BIOL R, V68, P686, DOI 10.1128/MMBR.68.4.686-691.2004; Shyu C, 2007, MICROB ECOL, V53, P562, DOI 10.1007/s00248-006-9106-0; Singleton DR, 2001, APPL ENVIRON MICROB, V67, P4374, DOI 10.1128/AEM.67.9.4374-4376.2001; Sipos R, 2007, FEMS MICROBIOL ECOL, V60, P341, DOI 10.1111/j.1574-6941.2007.00283.x; Sloan WT, 2006, ENVIRON MICROBIOL, V8, P732, DOI 10.1111/j.1462-2920.2005.00956.x; Smith CJ, 2005, FEMS MICROBIOL ECOL, V54, P375, DOI 10.1016/j.femsec.2005.05.002; Stackebrandt E, 2006, MICROBIOLOGY TODAY, V06, P152, DOI DOI 10.1038/MSB.2013.22; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; URAKAMI T, 1995, INT J SYST BACTERIOL, V45, P528, DOI 10.1099/00207713-45-3-528; Valentin-Vargas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042524; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wartiainen I, 2006, INT J SYST EVOL MICR, V56, P541, DOI 10.1099/ijs.0.63912-0; Wells GF, 2011, WATER RES, V45, P5476, DOI 10.1016/j.watres.2011.08.006; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wilen BM, 2010, WATER ENVIRON RES, V82, P155, DOI 10.2175/106143009X426004; Yang C, 2011, ENVIRON SCI TECHNOL, V45, P7408, DOI 10.1021/es2010545; Yuan ZG, 2002, WATER RES, V36, P482, DOI 10.1016/S0043-1354(01)00230-5; Zhang T, 2012, ISME J, V6, P1137, DOI 10.1038/ismej.2011.188	68	133	135	6	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76431	10.1371/journal.pone.0076431	http://dx.doi.org/10.1371/journal.pone.0076431			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	23977009	Green Published, gold, Green Submitted			2022-12-25	WOS:000325427100066
J	Chapman, R; Stutz, H; Jacobs, W; Shephard, E; Williamson, AL				Chapman, Rosamund; Stutz, Helen; Jacobs, William, Jr.; Shephard, Enid; Williamson, Anna-Lise			Priming with Recombinant Auxotrophic BCG Expressing HIV-1 Gag, RT and Gp120 and Boosting with Recombinant MVA Induces a Robust T Cell Response in Mice	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS BCG; TYPE-1 SUBTYPE-C; IMMUNODEFICIENCY-VIRUS TYPE-1; BACILLUS-CALMETTE-GUERIN; DNA VACCINE; LISTERIA-MONOCYTOGENES; ELITE CONTROLLERS; IMMUNE-RESPONSES; TUBERCULOSIS; INFECTION	In previous studies we have shown that a pantothenate auxotroph of Myocbacterium bovis BCG (BCG Delta panCD) expressing HIV-1 subtype C Gag induced Gag-specific immune responses in mice and Chacma baboons after prime-boost immunization in combination with matched rMVA and VLP vaccines respectively. In this study recombinant BCG (rBCG) expressing HIV-1 subtype C reverse transcriptase and a truncated envelope were constructed using both the wild type BCG Pasteur strain as a vector and the pantothenate auxotroph. Mice were primed with rBCG expressing Gag and RT and boosted with a recombinant MVA, expressing a polyprotein of Gag, RT, Tat and Nef (SAAVI MVA-C). Priming with rBCG Delta panCD expressing Gag or RT rather than the wild type rBCG expressing Gag or RT resulted in higher frequencies of total HIV-specific CD8(+) T cells and increased numbers of T cells specific to the subdominant Gag and RT epitopes. Increasing the dose of rBCG from 10(5) cfu to 10(7) cfu also led to an increase in the frequency of responses to subdominant HIV epitopes. A mix of the individual rBCG Delta panCD vaccines expressing either Gag, RT or the truncated Env primed the immune system for a boost with SAAVI MVA-C and generated five-fold higher numbers of HIV-specific IFN-gamma-spot forming cells than mice primed with rBCG Delta panCD containing an empty vector control. Priming with the individual rBCG Delta panCD vaccines or the mix and boosting with SAAVI MVA-C also resulted in the generation of HIV-specific CD4(+) and CD8(+) T cells producing IFN-gamma and TNF-alpha and CD4(+) cells producing IL-2. The rBCG vaccines tested in this study were able to prime the immune system for a boost with rMVA expressing matching antigens, inducing robust, HIV-specific T cell responses to both dominant and subdominant epitopes in the individual proteins when used as individual vaccines or in a mix.	[Chapman, Rosamund; Stutz, Helen; Shephard, Enid; Williamson, Anna-Lise] Albert Einstein Coll Med, Inst Infect Dis & Mol Med, Bronx, NY 10467 USA; [Chapman, Rosamund; Stutz, Helen; Williamson, Anna-Lise] Albert Einstein Coll Med, Dept Clin Lab Sci, Div Med Virol, Bronx, NY 10467 USA; [Jacobs, William, Jr.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Shephard, Enid] Univ Cape Town, Fac Hlth Sci, Dept Med, ZA-7925 Cape Town, South Africa; [Shephard, Enid] MRC, Cape Town, South Africa; [Williamson, Anna-Lise] Natl Hlth Lab Serv, Cape Town, South Africa	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Cape Town	Chapman, R (corresponding author), Albert Einstein Coll Med, Inst Infect Dis & Mol Med, Bronx, NY 10467 USA.	Ros.Chapman@uct.ac.za	Chapman, Rosamund/AAJ-6490-2020	Chapman, Rosamund/0000-0001-9162-2099; Waller, Karen/0000-0002-0530-3292; Williamson, Anna-Lise/0000-0002-5467-1200	South African AIDS Vaccine Initiative (SAAVI) [PIA R21/R33, 5R33AI73182-4]; National Institutes of Health (NIH USA) [PIA R21/R33, 5R33AI73182-4]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI073182, R01AI026170, R37AI026170] Funding Source: NIH RePORTER	South African AIDS Vaccine Initiative (SAAVI); National Institutes of Health (NIH USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the South African AIDS Vaccine Initiative (SAAVI) and National Institutes of Health (NIH USA) for funding from the Phased Innovation Awards (PIA R21/R33) in AIDS Vaccine Research; grant number 5R33AI73182-4. This work is also based upon research supported by the South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ami Y, 2006, J VIROL, V80, P10288, DOI 10.1128/JVI.01681-06; Burgers WA, 2006, J GEN VIROL, V87, P399, DOI 10.1099/vir.0.81379-0; Burgers WA, 2008, AIDS RES HUM RETROV, V24, P195, DOI 10.1089/aid.2007.0205; Cayabyab MJ, 2009, J VIROL, V83, P5505, DOI 10.1128/JVI.02544-08; Chapman R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032769; Chege GK, 2013, J VIROL, V87, P5151, DOI 10.1128/JVI.03178-12; Eisenhut M, 2009, VACCINE, V27, P6116, DOI 10.1016/j.vaccine.2009.08.031; Ferrando-Martinez S, 2012, J VIROL, V86, P3667, DOI 10.1128/JVI.07034-11; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hopkins R, 2011, EUR J IMMUNOL, V41, P3542, DOI 10.1002/eji.201141962; Hopkins R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020067; Im EJ, 2007, J VIROL, V81, P9408, DOI 10.1128/JVI.00707-07; Joseph J, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/357370; Letvin NL, 2006, NAT REV IMMUNOL, V6, P930, DOI 10.1038/nri1959; Mata M, 1998, J IMMUNOL, V161, P2985; Mata M, 1999, J IMMUNOL, V163, P1449; Mattapallil JJ, 2006, J MED PRIMATOL, V35, P217, DOI 10.1111/j.1600-0684.2006.00170.x; Mederle I, 2003, VACCINE, V21, P4153, DOI 10.1016/S0264-410X(03)00537-1; Ndhlovu ZM, 2012, J VIROL, V86, P6959, DOI 10.1128/JVI.00531-12; Neyrolles O, 2001, J IMMUNOL, V166, P447, DOI 10.4049/jimmunol.166.1.447; Parish T, 1998, METH MOL B, V101, P129, DOI 10.1385/0-89603-471-2:129; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rodriguez F, 2002, J VIROL, V76, P4251, DOI 10.1128/JVI.76.9.4251-4259.2002; Rosario M, 2010, J VIROL, V84, P5898, DOI 10.1128/JVI.02607-09; Roy RB, 2012, AM J RESP CRIT CARE, V186, P378, DOI 10.1164/rccm.201201-0026OC; Russell MS, 2007, J IMMUNOL, V179, P211, DOI 10.4049/jimmunol.179.1.211; Russell MS, 2009, J IMMUNOL, V183, P7710, DOI 10.4049/jimmunol.0901274; Sad S, 2008, J IMMUNOL, V180, P5853, DOI 10.4049/jimmunol.180.9.5853; Shephard E, 2008, AIDS RES HUM RETROV, V24, P207, DOI 10.1089/aid.2007.0206; Soysal A, 2005, LANCET, V366, P1443, DOI 10.1016/S0140-6736(05)67534-4; TAKAHASHI H, 1988, P NATL ACAD SCI USA, V85, P3105, DOI 10.1073/pnas.85.9.3105; Tullius MV, 2008, INFECT IMMUN, V76, P5200, DOI 10.1128/IAI.00434-08; van Faassen H, 2004, J IMMUNOL, V172, P3491, DOI 10.4049/jimmunol.172.6.3491; van Faassen H, 2005, J IMMUNOL, V174, P5341, DOI 10.4049/jimmunol.174.9.5341; van Harmelen JH, 2003, VACCINE, V21, P4380, DOI 10.1016/S0264-410X(03)00406-7; Williamson AL, 2012, SAMJ S AFR MED J, V102, P452, DOI 10.7196/SAMJ.5668; Williamson C, 2003, AIDS RES HUM RETROV, V19, P133, DOI 10.1089/088922203762688649; Zahrt TC, 2000, J BACTERIOL, V182, P3832, DOI 10.1128/JB.182.13.3832-3838.2000	38	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71601	10.1371/journal.pone.0071601	http://dx.doi.org/10.1371/journal.pone.0071601			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977084	gold, Green Submitted, Green Published			2022-12-25	WOS:000324527300024
J	Kirchner, SM; Hiltunen, L; Doring, TF; Virtanen, E; Palohuhta, JP; Valkonen, JPT				Kirchner, Sascha M.; Hiltunen, Lea; Doering, Thomas F.; Virtanen, Elina; Palohuhta, Jukka P.; Valkonen, Jari P. T.			Seasonal Phenology and Species Composition of the Aphid Fauna in a Northern Crop Production Area	PLOS ONE			English	Article							POTATO-VIRUS-Y; HEMIPTERA APHIDIDAE; RHOPALOSIPHUM-PADI; NEW-BRUNSWICK; STRAW MULCH; VECTOR; FLIGHT; EPIDEMIOLOGY; TRANSMISSION; SELECTION	Background: The species diversity of aphids and seasonal timing of their flight activity can have significant impacts on crop production, as aphid species differ in their ability to transmit plant viruses and flight timing affects virus epidemiology. The aim of the study was to characterise the species composition and phenology of aphid fauna in Finland in one of the northernmost intensive crop production areas of the world (latitude 64 degrees). Methodology/Principal Findings: Flight activity was monitored in four growing seasons (2007-010) using yellow pan traps (YPTs) placed in 4-8 seed potato fields and a Rothamsted suction trap. A total of 58,528 winged aphids were obtained, identified to 83 taxa based on morphology, and 34 species were additionally characterised by DNA barcoding. Seasonal flight activity patterns analysed based on YPT catch fell into three main phenology clusters. Monoecious taxa showed early or middle-season flight activity and belonged to species living on shrubs/trees or herbaceous plants, respectively. Heteroecious taxa occurred over the entire potato growing season (ca. 90 days). Abundance of aphids followed a clear 3-year cycle based on suction trap data covering a decade. Rhopalosiphum padi occurring at the end of the potato growing season was the most abundant species. The flight activity of Aphis fabae, the main vector of Potato virus Y in the region, and Aphis gossypii peaked in the beginning of potato growing season. Conclusions/Significance: Detailed information was obtained on phenology of a large number aphid species, of which many are agriculturally important pests acting as vectors of plant viruses. Aphis gossypii is known as a pest in greenhouses, but our study shows that it occurs also in the field, even far in the north. The novel information on aphid phenology and ecology has wide implications for prospective pest management, particularly in light of climate change.	[Kirchner, Sascha M.; Valkonen, Jari P. T.] Univ Helsinki, Dept Agr Sci, Helsinki, Finland; [Kirchner, Sascha M.; Hiltunen, Lea; Virtanen, Elina] MTT AgriFood Res Finland, Oulu, Finland; [Doering, Thomas F.] Humboldt Univ, Dept Crop & Anim Sci, D-10099 Berlin, Germany; [Palohuhta, Jukka P.] Finnish Seed Potato Ctr, Tyrnava, Finland	University of Helsinki; Natural Resources Institute Finland (Luke); Humboldt University of Berlin	Kirchner, SM (corresponding author), Univ Helsinki, Dept Agr Sci, Helsinki, Finland.	sascha.kirchner@helsinki.fi	; Wittbrodt, Joachim/D-4735-2014	Kirchmaier, Stephan/0000-0002-3870-8624; Valkonen, Jari/0000-0002-3704-9911; Lust, Katharina/0000-0002-2580-5492; Wittbrodt, Joachim/0000-0001-8550-7377; Doring, Thomas/0000-0001-9074-5978	Ministry of Agriculture and Forestry, Finland [618/502/2008, 2383/312/2009]	Ministry of Agriculture and Forestry, Finland	This work was supported by the Ministry of Agriculture and Forestry, Finland (grants 618/502/2008 and 2383/312/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht A, 2012, ATLAS APHIDS FINLAND; [Anonymous], 2015, SPRINGERPLUS, DOI DOI 10.1186/s40064-015-1263-5; BAGNALL RH, 1992, CAN J PLANT PATHOL, V14, P137, DOI 10.1080/07060669209500890; Bagnall RH, 1991, ADV DIS VECTOR RES, P53; Bale Jeffrey S., 1999, Ecological Bulletins, V47, P38; Basky Z, 2003, ANZ SCHADL-J PEST SC, V76, P83, DOI 10.1046/j.1439-0280.2003.03019.x; BEEMSTER, 1972, Virus translocation in Potato plants and mature-plant resistance., P144; Bisnieks M, 2004, ARCH VIROL, V149, P843, DOI 10.1007/s00705-003-0242-2; BLACKMAN RL, 1974, B ENTOMOL RES, V63, P595, DOI 10.1017/S0007485300047830; Blackman RL, 2000, APHIDS WORLDS CROPS, V2nd, DOI 10.1016/0261-2194(96)89825-5; Blackman RL, 2007, APHIDS AS CROP PESTS, P1, DOI 10.1079/9780851998190.0001; BOITEAU G, 1988, AM POTATO J, V65, P639, DOI 10.1007/BF02854832; Carletto J, 2009, SYST ENTOMOL, V34, P307, DOI 10.1111/j.1365-3113.2008.00458.x; CHAN CK, 1991, AGR CAN RES BRANCH T; Chittka L, 2007, PLOS BIOL, V5, P1640, DOI 10.1371/journal.pbio.0050187; Cocu N, 2005, AGR FOREST ENTOMOL, V7, P31, DOI 10.1111/j.1461-9555.2005.00245.x; Cocuzza G, 2008, B INSECTOL, V61, P125; DEGUINE JP, 1997, SERIE DEPREDATEURS C, V11; Doring TF, 2011, POTATO RES, V54, P341, DOI 10.1007/s11540-011-9195-0; Doring TF, 2009, P ROY SOC B-BIOL SCI, V276, P121, DOI 10.1098/rspb.2008.0858; Doring TF, 2004, ENTOMOL EXP APPL, V113, P53, DOI 10.1111/j.0013-8703.2004.00208.x; EASTOP VF, 1955, NATURE, V176, P936, DOI 10.1038/176936b0; Foottit RG, 2008, MOL ECOL RESOUR, V8, P1189, DOI 10.1111/j.1755-0998.2008.02297.x; GONZALEZ D, 1968, J ECON ENTOMOL, V61, P109, DOI 10.1093/jee/61.1.109; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Halkka A, 2010, SUOMEN LUONTO, V5, P8; HARDIE J, 1989, J INSECT PHYSIOL, V35, P619, DOI 10.1016/0022-1910(89)90124-8; Harrington R., 1995, P125; Heie O.E., 1980, APHIDOIDEA HEMIPTERA, V9; Heie O.E., 1995, APHIDOIDEA HEMIPTE 3; Heie OE, 1986, APHIDOIDEA HEMIPTE 1, VIII; Heie OE, 1982, APHIDOIDEA HEMIPTE 1; HEIE OE, 1994, APHIDOIDEA HEMIPTE 2; HEIE OE, 1992, APHIDOIDEA HEMIPTE 1; Holman J., 2009, HOST PLANT CATALOG A; HULLE M, 1994, J APPL ECOL, V31, P49, DOI 10.2307/2404598; Huusela-Veistola E, 2009, 8 INT S APH CAT, P167; Kindlmann P, 2007, APHIDS AS CROP PESTS, P311, DOI 10.1079/9780851998190.0311; Kirchner SM, 2011, ANN APPL BIOL, V159, P414, DOI 10.1111/j.1744-7348.2011.00501.x; KRING JB, 1972, ANNU REV ENTOMOL, V17, P461, DOI 10.1146/annurev.en.17.010172.002333; KURPPA A, 1989, ANN AGR FENN, V28, P309; KURPPA S, 1989, ANN AGR FENN, V28, P349; KURPPA S, 1986, ANN AGR FENN, V25, P199; Lambers DHR, 1955, ANN APPL BIOL, V42, P355, DOI 10.1111/j.1744-7348.1955.tb02440.x; LAMBERS DHR, 1966, ANNU REV ENTOMOL, V11, P47, DOI 10.1146/annurev.en.11.010166.000403; MACAULAY EDM, 1988, B ENTOMOL RES, V78, P121, DOI 10.1017/S0007485300016126; MOERICKE V, 1969, ENTOMOL EXP APPL, V12, P524, DOI 10.1007/BF00297083; Moericke V., 1955, Zeitschrift fuer Angewandte Entomologie, V37, P29; MOERICKE V., 1962, Zeitschrift fur Angewandte Entomologie, V50, P70; Mueller EE, 2010, J ECON ENTOMOL, V103, P1670, DOI 10.1603/EC09411; Official Statistics of Finland, 2012, CROP PROD STAT; Peltonen-Sainio P, 2009, AGR FOOD SCI, V18, P171, DOI 10.2137/145960609790059479; PERRY JN, 1983, ECOL ENTOMOL, V8, P383, DOI 10.1111/j.1365-2311.1983.tb00518.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Saucke H, 2009, ANN APPL BIOL, V154, P239, DOI 10.1111/j.1744-7348.2008.00288.x; Saucke H, 2004, ANN APPL BIOL, V144, P347, DOI 10.1111/j.1744-7348.2004.tb00350.x; SIGVALD R, 1985, POTATO RES, V28, P135, DOI 10.1007/BF02357439; SIGVALD R, 1987, POTATO RES, V30, P267, DOI 10.1007/BF02357668; Simola H, 2012, COMMUNICATION; STROYAN H.L.G., 1984, HDB IDENTIFICATION 6; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Taylor L. R., 1974, Report of the Rothamsted Experimental Station 1973, P202; Taylor L.R., 1984, HDB APHID IDENTIFICA; Thieme Th., 1994, Nachrichtenblatt des Deutschen Pflanzenschutzdienstes (Stuttgart), V46, P65; Vanninen I, 2011, AGR FOOD SCI, V20, P96, DOI 10.2137/145960611795163033; WIKTELIUS S, 1987, ANN APPL BIOL, V110, P1, DOI 10.1111/j.1744-7348.1987.tb03226.x; Williams IS, 2007, APHIDS AS CROP PESTS, P69, DOI 10.1079/9780851998190.0069; ZHOU XL, 1995, GLOB CHANGE BIOL, V1, P303, DOI 10.1111/j.1365-2486.1995.tb00029.x	68	42	43	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71030	10.1371/journal.pone.0071030	http://dx.doi.org/10.1371/journal.pone.0071030			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	24116091	Green Published, gold, Green Submitted			2022-12-25	WOS:000323115800033
J	Li, ZR; Gao, L; Tang, H; Yin, Y; Xiang, XX; Li, Y; Zhao, J; Mulholland, M; Zhang, WZ				Li, Ziru; Gao, Ling; Tang, Hong; Yin, Yue; Xiang, Xinxin; Li, Yin; Zhao, Jing; Mulholland, Michael; Zhang, Weizhen			Peripheral Effects of Nesfatin-1 on Glucose Homeostasis	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; INSULIN-SECRETION; ENERGY-BALANCE; GHRELIN; OBESITY	Aims/hypothesis: The actions of peripherally administered nesfatin-1 on glucose homeostasis remain controversial. The aim of this study was to characterize the mechanisms by which peripheral nesfatin-1 regulates glucose metabolism. Methods: The effects of nesfatin-1 on glucose metabolism were examined in mice by continuous infusion of the peptide via osmotic pumps. Changes in AKT phosphorylation and Glut4 were investigated by Western blotting and immnuofluorescent staining. Primary myocytes, adipocytes and hepatocytes were isolated from male mice. Results: Continuous peripheral infusion of nesfatin-1 altered glucose tolerance and insulin sensitivity in mice fed either normal or high fat diet, while central administration of nesfatin-1 demonstrated no effect. Nesfatin-1 increases insulin secretion in vivo, and in vitro in cultured min6 cells. In addition, nesfatin-1 up-regulates the phosphorylation of AKT in pancreas and min6 islet cells. In mice fed normal diet, peripheral nesfatin-1 significantly increased insulin-stimulated phosphorylation of AKT in skeletal muscle, adipose tissue and liver; similar effects were observed in skeletal muscle and adipose tissue in mice fed high fat diet. At basal conditions and after insulin stimulation, peripheral nesfatin-1 markedly increased GLUT4 membrane translocation in skeletal muscle and adipose tissue in mice fed either diet. In vitro studies showed that nesfatin-1 increased both basal and insulin-stimulated levels of AKT phosphorylation in cells derived from skeletal muscle, adipose tissue and liver. Conclusions: Our studies demonstrate that nesfatin-1 alters glucose metabolism by mechanisms which increase insulin secretion and insulin sensitivity via altering AKT phosphorylation and GLUT 4 membrane translocation in the skeletal muscle, adipose tissue and liver.	[Li, Ziru; Tang, Hong; Yin, Yue; Xiang, Xinxin; Li, Yin; Zhao, Jing; Zhang, Weizhen] Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Beijing 100871, Peoples R China; [Gao, Ling] Coll Binzhou Polytech, Binzhou, Shandong, Peoples R China; [Mulholland, Michael; Zhang, Weizhen] Univ Michigan, Med Ctr, Dept Surg, Ann Arbor, MI 48109 USA	Peking University; University of Michigan System; University of Michigan	Zhang, WZ (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Beijing 100871, Peoples R China.	weizhenzhang@bjmu.edu.cn	Li, Yin/P-9296-2016; zhang, weizhen/K-1484-2018; Li, Zhonghai/N-6670-2018	Li, Yin/0000-0002-4019-3391; zhang, weizhen/0000-0001-8791-2798; Li, Zhonghai/0000-0003-4735-1193; Li, Ziru/0000-0002-2755-9299	National Natural Science Foundation of China [81030012]; Major National Basic Research Program of P. R. China [2010CB912504]; American Diabetes Association [1-13-BS-225]; Visiting Scholar Project Fund for Outstanding Junior Faculties from Shandong Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major National Basic Research Program of P. R. China(National Basic Research Program of China); American Diabetes Association(American Diabetes Association); Visiting Scholar Project Fund for Outstanding Junior Faculties from Shandong Province	This work was supported by grants from the National Natural Science Foundation of China (81030012), the Major National Basic Research Program of P. R. China (No. 2010CB912504), American Diabetes Association grant #1-13-BS-225, and the Visiting Scholar Project Fund for Outstanding Junior Faculties from Shandong Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelone T, 2012, CELL MOL LIFE SCI; Atsuchi K, 2010, NEUROREPORT, V21, P1008, DOI 10.1097/WNR.0b013e32833f7b96; CAMPBELL PJ, 1993, DIABETES, V42, P405, DOI 10.2337/diabetes.42.3.405; Gonzalez R, 2011, ENDOCRINOLOGY, V152, P3628, DOI 10.1210/en.2010-1471; Grill HJ, 2006, OBESITY, V14, P216, DOI 10.1038/oby.2006.312; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; Kanzaki M, 2006, ENDOCR J, V53, P267, DOI 10.1507/endocrj.KR-65; Li QC, 2010, REGUL PEPTIDES, V159, P72, DOI 10.1016/j.regpep.2009.11.003; Li ZR, 2012, CELL PHYSIOL BIOCHEM, V29, P493, DOI 10.1159/000338503; LUDVIK B, 1995, DIABETES, V44, P1121, DOI 10.2337/diabetes.44.9.1121; Miki T, 2001, NAT NEUROSCI, V4, P507, DOI 10.1038/87455; Nakata M, 2011, ENDOCR J, V58, P305, DOI 10.1507/endocrj.K11E-056; Nedachi T, 2006, AM J PHYSIOL-ENDOC M, V291, pE817, DOI 10.1152/ajpendo.00194.2006; Oh-I S, 2006, NATURE, V443, P709, DOI 10.1038/nature05162; Pan WH, 2007, PEPTIDES, V28, P2223, DOI 10.1016/j.peptides.2007.09.005; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Price TO, 2007, PEPTIDES, V28, P2372, DOI 10.1016/j.peptides.2007.10.008; Riva M, 2011, CELL TISSUE RES, V346, P393, DOI 10.1007/s00441-011-1268-5; Stengel A, 2009, ENDOCRINOLOGY, V150, P232, DOI 10.1210/en.2008-0747; Stengel A, 2010, PEPTIDES, V31, P357, DOI 10.1016/j.peptides.2009.11.019; Su YJ, 2010, BIOCHEM BIOPH RES CO, V391, P1039, DOI 10.1016/j.bbrc.2009.12.014; Tagaya Y, 2012, PROTEIN PEPTIDE LETT, V19, P997, DOI 10.2174/092986612802084546; Xia ZF, 2012, AM J PHYSIOL-GASTR L, V303, pG570, DOI 10.1152/ajpgi.00178.2012; Xu GY, 2009, ENDOCRINOLOGY, V150, P3637, DOI 10.1210/en.2009-0372; Yamawaki H, 2012, BIOCHEM BIOPH RES CO, V418, P676, DOI 10.1016/j.bbrc.2012.01.076; Yang ML, 2012, DIABETES, V61, P1959, DOI 10.2337/db11-1755; Yosten GLC, 2012, J NEUROENDOCRINOL, V24, P1078, DOI 10.1111/j.1365-2826.2012.02304.x; Zhang Z, 2012, EXP CLIN ENDOCR DIAB, V120, P91, DOI 10.1055/s-0031-1286339	28	46	48	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e71513	10.1371/journal.pone.0071513	http://dx.doi.org/10.1371/journal.pone.0071513			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967220	Green Published, Green Submitted, gold			2022-12-25	WOS:000323378000055
J	Wu, CL; Zhang, ZF; Lu, Z; Liao, M; Zhang, YJ; Xie, YL; Guo, XF; Yu, XX; Yang, XB; Gao, Y; Tan, AH; Mo, ZN				Wu, Chunlei; Zhang, Zhifu; Lu, Zheng; Liao, Ming; Zhang, Youjie; Xie, Yuanliang; Guo, Xuefeng; Yu, Xiaoxiang; Yang, Xiaobo; Gao, Yong; Tan, Aihua; Mo, Zengnan			Prevalence of and Risk Factors for Asymptomatic Inammatory (NIH-IV) Prostatitis in Chinese Men	PLOS ONE			English	Article							FANGCHENGGANG AREA; HEALTH; SYMPTOMS; POPULATION; ASSOCIATION; PAIN	Background: While many investigators have studied symptomatic prostatitis, little research has been done with regard to asymptomatic (NIH-IV) prostatitis. Purpose: To describe the prevalence of and risk factors for NIH-IV prostatitis among a large male population. Methods: The study population was comprised of 1,868 men at the second phase recruitment of a population-based cohort in China. Asymptomatic and symptomatic men were defined by the National Institutes of Health Chronic Prostatitis (CP) Symptom Index. Meanwhile, EPS specimens and their leukocyte count were collected. Lifestyle and demographic characteristics were obtained through a questionnaire. Results: Prevalence of NIH-IV prostatitis was 21.1% among 1,868 asymptomatic men aged 19-78 years and increased with age. After adjusteing for potential confounding variables (age, smoking habits, alcohol drinking habits, education, physical activity, hypertension, dyslipidemia, obesity and diabetes), age remained a significant factor for NIH-IV prostatitis (OR = 1.35; 95% CI = 1.06-1.71; P = 0.01) and the risk of NIH-IV prostatitis was significantly higher in smokers >= 15 pack/years than nonsmokers (OR = 1.33; 95% CI = 1.01-1.75; P = 0.03). In addition, compared with non-drinkers, the OR of NIH-IV prostatitis in drinkers >= 1 drinks/week was 1.35 (95% CI = 1.03, 1.77, p = 0.02) after adjusting for the other variables above. In addition, having less than a college education may be a risk factor for NIH-IV prostatitis, although a statistically significant difference did not exist in our data (OR = 1.22; 95% CI = 0.97-1.52; P = 0.08). Conclusions: Our findings suggest that NIH-IV prostatitis is prevalent in China. Age, smoking, drinking and lower education levels were associated with an increased risk of NIH-IV prostatitis. The prevalence of NIH-IV prostatitis should be taken into account when estimating the total prevalence of CP in future studies.	[Wu, Chunlei; Zhang, Zhifu; Lu, Zheng; Liao, Ming; Zhang, Youjie; Xie, Yuanliang; Mo, Zengnan] Guangxi Med Univ, Affiliated Hosp 1, Inst Urol & Nephrol, Nanning, Guangxi Zhuang, Peoples R China; [Zhang, Zhifu; Lu, Zheng; Liao, Ming; Zhang, Youjie; Xie, Yuanliang; Guo, Xuefeng; Yu, Xiaoxiang; Gao, Yong; Tan, Aihua] Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Guangxi Zhuang, Peoples R China; [Yang, Xiaobo] Guangxi Med Univ, Sch Publ Hlth, Dept Occupat Hlth & Environm Hlth, Nanning, Guangxi Zhuang, Peoples R China; [Yu, Xiaoxiang] 303rd Hosp Chinese Peoples Liberat Army, Dept Urol, Nanning, Guangxi Zhuang, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Mo, ZN (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Inst Urol & Nephrol, Nanning, Guangxi Zhuang, Peoples R China.	zengnanmo@hotmail.com	Zhang, Youjie/F-7346-2016; Sun, Yuelian/AFF-2622-2022; Olsen, Jørn/F-8801-2015; Yang, Xiaobo/G-3854-2016	Zhang, Youjie/0000-0002-6035-8536; Sun, Yuelian/0000-0002-6905-0503; Olsen, Jørn/0000-0001-7462-5140; mo, zengnan/0000-0002-3047-3138; Miller, Jessica/0000-0002-1806-1894	National Natural Science Foundation of China [30945204]; Provincial Department of Finance, Guangxi Zhuang Autonomous Region, China [2009GJCJ150]; Provincial Department of Education, Guangxi Zhuang Autonomous Region, China [2009GJCJ150]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial Department of Finance, Guangxi Zhuang Autonomous Region, China; Provincial Department of Education, Guangxi Zhuang Autonomous Region, China	The work described in this article is supported by grants from the National Natural Science Foundation of China (grant number 30945204) and the Provincial Departments of Finance and Education, Guangxi Zhuang Autonomous Region, China (grant number 2009GJCJ150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390; Bozeman CB, 2002, J UROLOGY, V167, P1723, DOI 10.1016/S0022-5347(05)65186-5; Carver BS, 2003, J UROLOGY, V169, P589, DOI 10.1016/S0022-5347(05)63959-6; Chen Chunming, 2004, Biomed Environ Sci, V17 Suppl, P1; De Nunzio C, 2011, EUR UROL, V60, P106, DOI 10.1016/j.eururo.2011.03.055; Ejike CECC, 2008, INT J UROL, V15, P340, DOI 10.1111/j.1442-2042.2008.02003.x; Ferris JA, 2010, BJU INT, V105, P373, DOI 10.1111/j.1464-410X.2009.08708.x; Gavin JR, 1999, DIABETES CARE, V22, pS5; Korrovits P, 2008, UROLOGY, V71, P1010, DOI 10.1016/j.urology.2007.12.082; Krieger JN, 1999, JAMA-J AM MED ASSOC, V282, P236, DOI 10.1001/jama.282.3.236; Ku JH, 2005, INT J ANDROL, V28, P317, DOI 10.1111/j.1365-2605.2005.00560.x; Kunishima Y, 2006, INT J UROL, V13, P1286, DOI 10.1111/j.1442-2042.2004.01556.x; Li GZ, 2011, INT UROL NEPHROL, V43, P295, DOI 10.1007/s11255-010-9825-5; Liang CZ, 2009, J UROLOGY, V182, P558, DOI 10.1016/j.juro.2009.04.011; Litwin MS, 1999, J UROLOGY, V162, P369, DOI 10.1016/S0022-5347(05)68562-X; MEARES EM, 1991, MED CLIN N AM, V75, P405, DOI 10.1016/S0025-7125(16)30462-X; Mehik A, 2000, BJU INT, V86, P443, DOI 10.1046/j.1464-410X.2000.00836.x; Mi H, 2012, UROLOGY, V79, P403, DOI 10.1016/j.urology.2011.09.032; Muller CH, 2001, J UROLOGY, V166, P2518, DOI 10.1016/S0022-5347(05)65627-3; Nickel JC, 2003, J UROLOGY, V170, P818, DOI 10.1097/01.ju.0000082252.49374.e9; Nickel JC, 2001, J UROLOGY, V165, P842, DOI 10.1016/S0022-5347(05)66541-X; Pontari MA, 2007, J UROLOGY, V177, P2050, DOI 10.1016/j.juro.2007.01.128; Sharma RK, 2001, J ANDROL, V22, P575; Shimomura Tatsuya, 2003, Kansenshogaku Zasshi, V77, P611; Simardi LH, 2004, UROLOGY, V64, P1098, DOI 10.1016/j.urology.2004.08.060; Stancik I, 2004, EUR UROL, V46, P760, DOI 10.1016/j.eururo.2004.08.003; Tripp DA, 2009, BJU INT, V103, P1080, DOI 10.1111/j.1464-410X.2008.08157.x; Wu CL, 2011, J ANDROL, V33, P59, DOI 10.2164/jandrol.110.012542	28	24	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71298	10.1371/journal.pone.0071298	http://dx.doi.org/10.1371/journal.pone.0071298			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967188	Green Submitted, Green Published, gold			2022-12-25	WOS:000323115800048
J	Wu, XD; Satpathy, AT; Wumesh, KC; Liu, PT; Murphy, TL; Murphy, KM				Wu, Xiaodi; Satpathy, Ansuman T.; Wumesh, K. C.; Liu, Pentao; Murphy, Theresa L.; Murphy, Kenneth M.			Bcl11a Controls Flt3 Expression in Early Hematopoietic Progenitors and Is Required for pDC Development In Vivo	PLOS ONE			English	Article							DENDRITIC CELL-DEVELOPMENT; RECEPTOR-DEFICIENT MICE; INTERLEUKIN-2-RECEPTOR GAMMA-CHAIN; COMMON LYMPHOID PROGENITORS; TRANSCRIPTION FACTOR E2-2; RESCUES T-LYMPHOPOIESIS; MOUSE BONE-MARROW; FACTOR PU.1; STEM-CELLS; GM-CSF	Bcl11a is a transcription factor known to regulate lymphoid and erythroid development. Recent bioinformatic analysis of global gene expression patterns has suggested a role for Bcl11a in the development of dendritic cell (DC) lineages. We tested this hypothesis by analyzing the development of DC and other lineages in Bcl11a(-/-) mice. We found that Bcl11a was required for expression of IL-7 receptor (IL-7R) and Flt3 in early hematopoietic progenitor cells. In addition, we found severely decreased numbers of plasmacytoid dendritic cells (pDCs) in Bcl11a(-/-) fetal livers and in the bone marrow of Bcl11a(-/-) fetal liver chimeras. Moreover, Bcl11a(-/-) cells showed severely impaired in vitro development of Flt3L-derived pDCs and classical DCs (cDCs). In contrast, we found normal in vitro development of DCs from Bcl11a(-/-) fetal liver cells treated with GM-CSF. These results suggest that the persistent cDC development observed in Bcl11a(-/-) fetal liver chimeras reflects derivation from a Bcl11a- and Flt3-independent pathway in vivo.	[Wu, Xiaodi; Satpathy, Ansuman T.; Wumesh, K. C.; Murphy, Theresa L.; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Liu, Pentao] Wellcome Trust Sanger Inst, Cambridge, England; [Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Wellcome Trust Sanger Institute; Howard Hughes Medical Institute; Washington University (WUSTL)	Murphy, KM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	kmurphy@wustl.edu		Satpathy, Ansuman/0000-0002-5167-537X	Howard Hughes Medical Institute, National Institutes of Health [AI076427-02]; Department of Defense [W81XWH-09-1-0185]; American Heart Association [12PRE8610005, 12PRE1205041912]; National Cancer Institute [P30 CA91842]; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076427] Funding Source: NIH RePORTER	Howard Hughes Medical Institute, National Institutes of Health(Howard Hughes Medical InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); American Heart Association(American Heart Association); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Howard Hughes Medical Institute, National Institutes of Health (AI076427-02 to K. M. M.), and Department of Defense (W81XWH-09-1-0185 to K. M. M.); and by the American Heart Association (12PRE8610005 to A. T. S.; 12PRE1205041912 to W. K. C.). The Alvin J. Siteman Cancer Center is supported in part by the National Cancer Institute (P30 CA91842). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Allman D, 2006, BLOOD, V108, P4025, DOI 10.1182/blood-2006-03-007757; Anderson KL, 2000, J IMMUNOL, V164, P1855, DOI 10.4049/jimmunol.164.4.1855; Becker AM, 2012, BLOOD, V119, P2003, DOI 10.1182/blood-2011-06-364976; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Carotta S, 2010, IMMUNITY, V32, P628, DOI 10.1016/j.immuni.2010.05.005; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Dias S, 2005, J EXP MED, V201, P971, DOI 10.1084/jem.20042393; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; Edelson BT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025660; Franco CB, 2010, CELL STEM CELL, V6, P361, DOI 10.1016/j.stem.2010.02.013; Freeden-Jeffry U, 1997, IMMUNITY, V7, P147; Ghosh HS, 2010, IMMUNITY, V33, P905, DOI 10.1016/j.immuni.2010.11.023; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Guerriero A, 2000, BLOOD, V95, P879, DOI 10.1182/blood.V95.3.879.003k13_879_885; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kikuchi K, 2005, J EXP MED, V201, P1197, DOI 10.1084/jem.20050158; Kikuchi K, 2008, J IMMUNOL, V181, P383, DOI 10.4049/jimmunol.181.1.383; Kingston D, 2009, BLOOD, V114, P835, DOI 10.1182/blood-2009-02-206318; Kondo M, 1997, IMMUNITY, V7, P155, DOI 10.1016/S1074-7613(00)80518-X; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Laouar Y, 2003, IMMUNITY, V19, P903, DOI 10.1016/S1074-7613(03)00332-7; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Liu PT, 2003, NAT IMMUNOL, V4, P525, DOI 10.1038/ni925; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; Maraskovsky E, 1998, INT IMMUNOL, V10, P1367, DOI 10.1093/intimm/10.9.1367; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Merad M, 2009, BLOOD, V113, P3418, DOI 10.1182/blood-2008-12-180646; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Moore TA, 1996, J IMMUNOL, V157, P2366; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Nakamura T, 2000, MOL CELL BIOL, V20, P3178, DOI 10.1128/MCB.20.9.3178-3186.2000; OGAWA M, 1991, J EXP MED, V174, P63, DOI 10.1084/jem.174.1.63; Ohbo K, 1996, BLOOD, V87, P956, DOI 10.1182/blood.V87.3.956.bloodjournal873956; Onai N, 2006, J EXP MED, V203, P227, DOI 10.1084/jem.20051645; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Pelayo R, 2005, BLOOD, V105, P4407, DOI 10.1182/blood-2004-07-2529; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Pulford K, 2006, LEUKEMIA, V20, P1439, DOI 10.1038/sj.leu.2404260; Rathinam C, 2005, IMMUNITY, V22, P717, DOI 10.1016/j.immuni.2005.04.007; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Satpathy AT, 2011, SEMIN IMMUNOL, V23, P388, DOI 10.1016/j.smim.2011.08.009; Satterwhite E, 2001, BLOOD, V98, P3413, DOI 10.1182/blood.V98.12.3413; Schotte R, 2004, J EXP MED, V200, P1503, DOI 10.1084/jem.20041231; Sitnicka E, 2007, BLOOD, V110, P2955, DOI 10.1182/blood-2006-10-054726; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Sugamura K, 1996, ANNU REV IMMUNOL, V14, P179, DOI 10.1146/annurev.immunol.14.1.179; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Tsujimura H, 2003, J IMMUNOL, V170, P1131, DOI 10.4049/jimmunol.170.3.1131; Vogt TK, 2009, BLOOD, V113, P3961, DOI 10.1182/blood-2008-08-176321; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Wu L, 1998, IMMUNITY, V9, P839, DOI 10.1016/S1074-7613(00)80649-4; Wu L, 1997, IMMUNITY, V7, P483, DOI 10.1016/S1074-7613(00)80370-2; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310; Yu Y, 2012, J EXP MED, V209, P2467, DOI 10.1084/jem.20121846	61	62	65	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64800	10.1371/journal.pone.0064800	http://dx.doi.org/10.1371/journal.pone.0064800			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23741395	Green Published, gold, Green Submitted			2022-12-25	WOS:000319799900108
J	Abd El Wahed, A; El-Deeb, A; El-Tholoth, M; Abd El Kader, H; Ahmed, A; Hassan, S; Hoffmann, B; Haas, B; Shalaby, MA; Hufert, FT; Weidmann, M				Abd El Wahed, Ahmed; El-Deeb, Ayman; El-Tholoth, Mohamed; Abd El Kader, Hanaa; Ahmed, Abeer; Hassan, Sayed; Hoffmann, Bernd; Haas, Bernd; Shalaby, Mohamed A.; Hufert, Frank T.; Weidmann, Manfred			A Portable Reverse Transcription Recombinase Polymerase Amplification Assay for Rapid Detection of Foot-and-Mouth Disease Virus	PLOS ONE			English	Article							CHAIN-REACTION; SAT 2; PERFORMANCE; SEQUENCES; SEROTYPE; GENOME; EGYPT; RNA; PCR	Foot-and-mouth disease (FMD) is a trans-boundary viral disease of livestock, which causes huge economic losses and constitutes a serious infectious threat for livestock farming worldwide. Early diagnosis of FMD helps to diminish its impact by adequate outbreak management. In this study, we describe the development of a real-time reverse transcription recombinase polymerase amplification (RT-RPA) assay for the detection of FMD virus (FMDV). The FMDV RT-RPA design targeted the 3D gene of FMDV and a 260 nt molecular RNA standard was used for assay validation. The RT-RPA assay was fast (4-10 minutes) and the analytical sensitivity was determined at 1436 RNA molecules detected by probit regression analysis. The FMDV RT-RPA assay detected RNA prepared from all seven FMDV serotypes but did not detect classical swine fever virus or swine vesicular disease virus. The FMDV RT-RPA assay was used in the field during the recent FMD outbreak in Egypt. In clinical samples, reverse transcription polymerase chain reaction (RT-PCR) and RT-RPA showed a diagnostic sensitivity of 100% and 98%, respectively. In conclusion, FMDV RT-RPA was quicker and much easier to handle in the field than real-time RT-PCR. Thus RT-RPA could be easily implemented to perform diagnostics at quarantine stations or farms for rapid spot-of-infection detection.	[Abd El Wahed, Ahmed; Hufert, Frank T.; Weidmann, Manfred] Univ Med Ctr, Dept Virol, Gottingen, Germany; [Abd El Wahed, Ahmed; El-Tholoth, Mohamed] Mansoura Univ, Fac Vet Med, Dept Virol, Mansoura, Egypt; [El-Deeb, Ayman; Shalaby, Mohamed A.] Cairo Univ, Fac Vet Med, Dept Virol, Giza, Egypt; [Abd El Kader, Hanaa; Hassan, Sayed] Anim Hlth Res Inst, Giza, Egypt; [Ahmed, Abeer] Anim Hlth Res Inst, Faiyum, Egypt; [Hoffmann, Bernd; Haas, Bernd] Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany	University of Gottingen; Egyptian Knowledge Bank (EKB); Mansoura University; Egyptian Knowledge Bank (EKB); Cairo University; Animal Health Research Institute (AHRI); Animal Health Research Institute (AHRI); Friedrich Loeffler Institute	Abd El Wahed, A (corresponding author), Univ Med Ctr, Dept Virol, Gottingen, Germany.	abdelwahed@me.com	Weidmann, Manfred/G-1817-2015; El-Tholoth, Mohamed/O-2797-2018; Ahmed, Hanaa/E-4123-2013	Weidmann, Manfred/0000-0002-7063-7491; El-Tholoth, Mohamed/0000-0002-5253-5168; Ahmed, Hanaa/0000-0001-5553-5676; Abd El Wahed, Ahmed/0000-0003-3347-6075; Heidenreich, Doris/0000-0002-2010-9017	Alexander von Humboldt Foundation, Bonn, Germany [3.4 - Fokoop-DEU/1144102]	Alexander von Humboldt Foundation, Bonn, Germany(Alexander von Humboldt Foundation)	The study was funded by Alexander von Humboldt Foundation, Bonn, Germany (project ID: 3.4 - Fokoop-DEU/1144102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed HA, 2012, TRANSBOUND EMERG DIS, V59, P476, DOI 10.1111/tbed.12015; BOOTHROYD JC, 1981, NATURE, V290, P800, DOI 10.1038/290800a0; Boyle DS, 2013, MBIO, V4, DOI 10.1128/mBio.00135-13; Callahan JD, 2002, J AM VET MED ASSOC, V220, P1636, DOI 10.2460/javma.2002.220.1636; Callens M, 1997, J VIROL METHODS, V67, P35, DOI 10.1016/S0166-0934(97)00074-8; Chen HT, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-510; Chen HT, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-489; Dukes JP, 2006, ARCH VIROL, V151, P1093, DOI 10.1007/s00705-005-0708-5; Euler M, 2012, J CLIN VIROLOGY OFFI; Euler M, 2012, J CLIN MICROBIOL, V50, P2234, DOI 10.1128/JCM.06504-11; FAO, 2012, EMPRES WATCH, V25; Ferris NP, 2009, J VIROL METHODS, V155, P10, DOI 10.1016/j.jviromet.2008.09.009; Ghoneim NH, 2010, TRANSBOUND EMERG DIS, V57, P19, DOI 10.1111/j.1865-1682.2010.01126.x; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Knowles NJ, 2007, EMERG INFECT DIS, V13, P1593, DOI 10.3201/eid1310.070252; Knowles NJ, 2003, VIRUS RES, V91, P65, DOI 10.1016/S0168-1702(02)00260-5; Longjam Neeta, 2011, Vet Med Int, V2011, P905768, DOI 10.4061/2011/905768; Moniwa M, 2007, J VET DIAGN INVEST, V19, P9, DOI 10.1177/104063870701900103; Pharo HJ, 2002, NEW ZEAL VET J, V50, P46, DOI 10.1080/00480169.2002.36250; Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204; Reid SM, 1999, J VIROL METHODS, V83, P113, DOI 10.1016/S0166-0934(99)00113-5; Rodriguez LL, 2011, EXPERT REV VACCINES, V10, P377, DOI [10.1586/erv.11.4, 10.1586/ERV.11.4]; Sanson RL, 2011, VET REC, V169, P336, DOI 10.1136/vr.d4401; SantaLucia John Jr., 2007, V402, P3; Valdazo-Gonzalez B, 2012, J VIROL, V86, P8901, DOI 10.1128/JVI.01231-12; Weidmann M, 2003, J CLIN MICROBIOL, V41, P1565, DOI 10.1128/JCM.41.4.1565-1568.2003; Whiley DM, 2006, J CLIN VIROL, V35, P81, DOI 10.1016/j.jcv.2005.05.002	28	180	185	0	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71642	10.1371/journal.pone.0071642	http://dx.doi.org/10.1371/journal.pone.0071642			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977101	Green Published, gold, Green Submitted			2022-12-25	WOS:000324527300028
J	Chen, PY; Yen, JH; Kao, RH; Chen, JH				Chen, Pei-Yi; Yen, Jui-Hung; Kao, Ruey-Ho; Chen, Ji-Hshiung			Down-Regulation of the Oncogene PTTG1 via the KLF6 Tumor Suppressor during Induction of Myeloid Differentiation	PLOS ONE			English	Article							TRANSFORMING GENE PTTG; DEPENDENT PROTEIN-KINASE; KRUPPEL-LIKE FACTOR-6; BETA-CATENIN/TCF; BINDING-PROTEIN; CYCLIN D1; EXPRESSION; CELLS; GROWTH; HPTTG	The aberrant expression of proto-oncogenes is involved in processes that are responsible for cellular proliferation and the inhibition of myeloid differentiation in acute myeloid leukemia (AML). Pituitary Tumor-Transforming gene 1 (PTTG1), an oncogenic transcription factor, is abundantly expressed in various human cancers and hematopoietic malignancies. However, its expression in normal leukocytes and most normal tissues is very low or undetectable. The mechanism by which PTTG1 overexpression modifies myeloid cell development and promotes leukemogenesis remain unclear. To investigate the mechanistic links between PTTG1 overexpression and leukemia cell differentiation, we utilized phorbol 12-myristate 13-acetate (PMA), a well-known agent that triggers monocyte/macrophage differentiation, to analyze the expression patterns of PTTG1 in PMA-induced myeloid differentiation. We found that PTTG1 is down-regulated at the transcriptional level in PMA-treated HL-60 and THP1 cells. In addition, we identified a binding site for a tumor suppressor protein, Kruppel-like factor 6 (KLF6), in the PTTG1 promoter. We found that KLF6 could directly bind and repress PTTG1 expression. In HL-60 and THP1 cells, KLF6 mRNA and protein levels are up-regulated with a concordant reduction of PTTG1 expression upon treatment with PMA. Furthermore, KLF6 knockdown by shRNA abolished the suppression of PTTG1 and reduced the activation of the differentiation marker CD11b in PMA-primed cells. The protein kinase C (PKC) inhibitor and the MAPK/ERK kinase (MEK) inhibitor significantly blocked the potentiation of PMA-mediated KLF6 induction and the down-regulation of PTTG1, indicating that PTTG1 is suppressed via the activation of PKC/ERK/KLF6 pathway. Our findings suggest that drugs that increase the KLF6 inhibition of PTTG1 may have a therapeutic application in AML treatment strategies.	[Chen, Pei-Yi; Yen, Jui-Hung; Chen, Ji-Hshiung] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Chen, Pei-Yi] Buddhist Tzu Chi Gen Hosp, Ctr Med Genet, Hualien, Taiwan; [Yen, Jui-Hung; Chen, Ji-Hshiung] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan; [Kao, Ruey-Ho] Buddhist Tzu Chi Gen Hosp, Dept Hematol Oncol, Hualien, Taiwan	Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital	Chen, JH (corresponding author), Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan.	jhc@mail.tcu.edu.tw			National Health Research Institute of Taiwan [NHRI-EX101-9929BI]; Buddhist Tzu Chi General Hospital [TCRD-101-62]	National Health Research Institute of Taiwan(National Health Research Institutes - Taiwan); Buddhist Tzu Chi General Hospital	This study was supported by grant NHRI-EX101-9929BI from the National Health Research Institute of Taiwan (http://www.nhri.org.tw/), and by grant TCRD-101-62 from the Buddhist Tzu Chi General Hospital (http://www.tzuchi.com.tw/tzuchi_en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benzeno S, 2004, CANCER RES, V64, P3885, DOI 10.1158/0008-5472.CAN-03-2818; Boelaert K, 2003, J CLIN ENDOCR METAB, V88, P2341, DOI 10.1210/jc.2002-021113; Cao ZX, 2010, BLOOD, V116, P4404, DOI 10.1182/blood-2010-05-285353; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Chesnokova V, 2007, CANCER RES, V67, P10564, DOI 10.1158/0008-5472.CAN-07-0974; Clem AL, 2003, GENE, V322, P113, DOI 10.1016/j.gene.2003.08.012; Crans-Vargas HN, 2002, BLOOD, V99, P2617, DOI 10.1182/blood.V99.7.2617; Das D, 2000, FEBS LETT, V472, P50, DOI 10.1016/S0014-5793(00)01416-2; Difeo A, 2006, ONCOGENE, V25, P6026, DOI 10.1038/sj.onc.1209611; Dominguez A, 1998, ONCOGENE, V17, P2187, DOI 10.1038/sj.onc.1202140; Espina AG, 2009, MOL BIOL CELL, V20, P3353, DOI 10.1091/mbc.E08-09-0965; Filippella M, 2006, CLIN ENDOCRINOL, V65, P536, DOI 10.1111/j.1365-2265.2006.02630.x; Hamid T, 2005, J BIOL CHEM, V276, P8484; Heaney AP, 1999, NAT MED, V5, P1317, DOI 10.1038/15275; Heaney AP, 2002, J CLIN INVEST, V109, P277, DOI 10.1172/JCI200214264; Heaney AP, 2000, LANCET, V355, P716, DOI 10.1016/S0140-6736(99)10238-1; Hlubek F, 2006, BRIT J CANCER, V94, P1672, DOI 10.1038/sj.bjc.6603155; Humbert M, 2011, LEUKEMIA RES, V35, P909, DOI 10.1016/j.leukres.2011.03.010; Ishitsuka Y, 2012, J INVEST DERMATOL, V132, P1775, DOI 10.1038/jid.2012.74; Kohro Takahide, 2004, J Atheroscler Thromb, V11, P88; Lee UE, 2010, FEBS LETT, V584, P1006, DOI 10.1016/j.febslet.2010.01.049; Li D, 2005, J BIOL CHEM, V280, P26941, DOI 10.1074/jbc.M500463200; Liao YC, 2012, ONCOGENE, V31, P3086, DOI 10.1038/onc.2011.476; Matsumoto Eriko, 2006, Kobe Journal of Medical Sciences, V52, P181; Matsumoto N, 2006, BLOOD, V107, P1357, DOI 10.1182/blood-2005-05-1916; Miranda MB, 2002, LEUKEMIA, V16, P683, DOI 10.1038/sj.leu.2402400; MIYOSHI H, 1991, P NATL ACAD SCI USA, V88, P10431, DOI 10.1073/pnas.88.23.10431; Narla G, 2007, ONCOGENE, V26, P4428, DOI 10.1038/sj.onc.1210223; Narla G, 2001, SCIENCE, V294, P2563, DOI 10.1126/science.1066326; Pei L, 1997, MOL ENDOCRINOL, V11, P433, DOI 10.1210/me.11.4.433; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Ramos-Morales F, 2000, ONCOGENE, V19, P403, DOI 10.1038/sj.onc.1203320; Romero F, 2001, NUCLEIC ACIDS RES, V29, P1300, DOI 10.1093/nar/29.6.1300; ROVERA G, 1980, NATURE, V284, P69, DOI 10.1038/284069a0; Rubinek T, 2007, AM J PHYSIOL-CELL PH, V293, pC1082, DOI 10.1152/ajpcell.00145.2007; Saez C, 2002, ONCOGENE, V21, P8173, DOI 10.1038/sj.onc.1205954; Shima Y, 2011, INT J HEMATOL, V94, P134, DOI 10.1007/s12185-011-0905-9; Shivdasani RA, 1996, BLOOD, V87, P4025, DOI 10.1182/blood.V87.10.4025.bloodjournal87104025; Slavin DA, 2004, ONCOGENE, V23, P8196, DOI 10.1038/sj.onc.1208020; Tahara E, 2009, CANCER BIOL THER, V8, P801, DOI 10.4161/cbt.8.9.8186; Tfelt-Hansen J, 2004, ENDOCRINOLOGY, V145, P4222, DOI 10.1210/en.2003-1661; Thompson AD, 2005, FEBS LETT, V579, P3195, DOI 10.1016/j.febslet.2005.05.008; Tong Y, 2007, ONCOGENE, V26, P5596, DOI 10.1038/sj.onc.1210339; Tong YG, 2009, J MOL ENDOCRINOL, V43, P179, DOI 10.1677/JME-08-0176; Vlotides G, 2006, MOL ENDOCRINOL, V20, P3321, DOI 10.1210/me.2006-0280; Vlotides G, 2007, ENDOCR REV, V28, P165, DOI 10.1210/er.2006-0042; Wang ZY, 2003, P NATL ACAD SCI USA, V100, P3428, DOI 10.1073/pnas.0638052100; Wang ZY, 2001, MOL ENDOCRINOL, V15, P1870, DOI 10.1210/me.15.11.1870; White SL, 2005, LEUKEMIA RES, V29, P1141, DOI 10.1016/j.leukres.2005.02.012; Zhang X, 1999, MOL ENDOCRINOL, V13, P156, DOI 10.1210/me.13.1.156; Zhou CQ, 2005, INT J CANCER, V113, P891, DOI 10.1002/ijc.20642; Zhou YL, 2003, J BIOL CHEM, V278, P462, DOI 10.1074/jbc.M203793200; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	53	50	58	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e71282	10.1371/journal.pone.0071282	http://dx.doi.org/10.1371/journal.pone.0071282			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977008	Green Published, gold, Green Submitted			2022-12-25	WOS:000323570200030
J	Lemola, S; Ledermann, T; Friedman, EM				Lemola, Sakari; Ledermann, Thomas; Friedman, Elliot M.			Variability of Sleep Duration Is Related to Subjective Sleep Quality and Subjective Well-Being: An Actigraphy Study	PLOS ONE			English	Article							POSITIVE AFFECT; OLDER-ADULTS; LIFE; POPULATION; INSOMNIA; HEALTH; PARAMETERS; COHORT; MEN	While there is a large body of evidence that poor subjective sleep quality is related to lower subjective well-being, studies on the relation of objective sleep measures and subjective well-being are fewer in number and less consistent in their findings. Using data of the Survey of Mid-Life in the United States (MIDUS), we investigated whether duration and quality of sleep, assessed by actigraphy, were related to subjective well-being and whether this relationship was mediated by subjective sleep quality. Three hundred and thirteen mainly white American individuals from the general population and 128 urban-dwelling African American individuals between 35 and 85 years of age were studied cross-sectionally. Sleep duration, variability of sleep duration, sleep onset latency, and time awake after sleep onset were assessed by actigraphy over a period of 7 days. Subjective sleep quality was assessed with the Pittsburgh Sleep Quality Index, positive psychological well-being and symptoms of psychological distress were assessed with the Satisfaction with Life Scale and the Mood and Anxiety Symptom Questionnaire. In both white and African Americans high day-to-day variability in sleep duration was related to lower levels of subjective well-being controlling age, gender, educational and marital status, and BMI. By contrast, sleep duration, sleep onset latency, and time awake after sleep onset were not related to subjective well-being controlling covariates and other sleep variables. Moreover, the relationship between variability in sleep duration and well-being was partially mediated by subjective sleep quality. The findings show that great day-to-day variability in sleep duration - more than average sleep duration - is related to poor subjective sleep quality and poor subjective well-being.	[Lemola, Sakari; Ledermann, Thomas] Univ Basel, Dept Psychol, Basel, Switzerland; [Friedman, Elliot M.] Purdue Univ, W Lafayette, IN 47907 USA	University of Basel; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Lemola, S (corresponding author), Univ Basel, Dept Psychol, Basel, Switzerland.	sakari.lemola@unibas.ch	Lemola, Sakari/A-2659-2008; Friedman, Elliot M/AAT-2585-2020	Lemola, Sakari/0000-0002-1314-6194; 	National Institute on Aging [P01-AG020166]; John D. and Catherine T. MacArthur Foundation Research Network on Successful Midlife Development; General Clinical Research Centers Program [M01-RR023942, M01-RR00865]; Clinical and Translational Science Award (CTSA) program of the National Center for Research Resources, National Institutes of Health [1UL1RR025011]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000865, M01RR023942, UL1RR025011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG020166] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); John D. and Catherine T. MacArthur Foundation Research Network on Successful Midlife Development; General Clinical Research Centers Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Clinical and Translational Science Award (CTSA) program of the National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The longitudinal follow-up of the MIDUS investigation was supported by grant P01-AG020166 from the National Institute on Aging (www.nia.nih.gov). The original MIDUS study was supported by the John D. and Catherine T. MacArthur Foundation Research Network on Successful Midlife Development (http://midmac.med.harvard.edu). Further support comes from the following grants: M01-RR023942 (Georgetown), M01-RR00865 (UCLA) from the General Clinical Research Centers Program, and 1UL1RR025011 (UW) from the Clinical and Translational Science Award (CTSA) program of the National Center for Research Resources, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L.S., 1991, MULTIPLE REGRESSION; Arbuckle JL, 2003, AMOS 18; Baker FC, 1999, J PSYCHOSOM RES, V47, P335, DOI 10.1016/S0022-3999(99)00017-3; BILLIARD M, 1987, SLEEP, V10, P297, DOI 10.1093/sleep/10.4.297; Buysse DJ, 2010, SLEEP MED, V11, P56, DOI 10.1016/j.sleep.2009.02.010; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carvalho-Bos SS, 2007, AM J GERIAT PSYCHIAT, V15, P92, DOI 10.1097/01.JGP.0000236584.03432.dc; Chida Y, 2008, PSYCHOSOM MED, V70, P741, DOI 10.1097/PSY.0b013e31818105ba; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; Diener E, 2003, ANNU REV PSYCHOL, V54, P403, DOI 10.1146/annurev.psych.54.101601.145056; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Ertel KA, 2011, SLEEP, V34, P509, DOI 10.1093/sleep/34.4.509; Faubel R, 2009, SLEEP, V32, P1059; Fortier-Brochu E, 2010, J PSYCHOSOM RES, V69, P475, DOI 10.1016/j.jpsychores.2010.05.005; Frey W. H., 2010, NEW RACIAL SEGREGATI; Fuligni AJ, 2006, J RES ADOLESCENCE, V16, P353, DOI 10.1111/j.1532-7795.2006.00498.x; Hale L, 2007, SLEEP, V30, P1096, DOI 10.1093/sleep/30.9.1096; Harvey AG, 2002, BEHAV RES THER, V40, P869, DOI 10.1016/S0005-7967(01)00061-4; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jean-Louis G, 2000, SLEEP, V23, P1115; KLINK ME, 1992, ARCH INTERN MED, V152, P1634, DOI 10.1001/archinte.152.8.1634; Knutson KL, 2007, SLEEP, V30, P793, DOI 10.1093/sleep/30.6.793; Lauderdale DS, 2006, AM J EPIDEMIOL, V164, P5, DOI 10.1093/aje/kwj199; Lemola S, 2013, INT J BEHAV MED, V20, P567, DOI 10.1007/s12529-012-9272-z; Lemola S, 2013, J GERONTOL B-PSYCHOL, V68, P721, DOI 10.1093/geronb/gbs113; Lemola S, 2012, J ADOLESCENCE, V35, P97, DOI 10.1016/j.adolescence.2011.06.001; Love GD, 2010, J AGING HEALTH, V22, P1059, DOI 10.1177/0898264310374355; Lund HG, 2010, J ADOLESCENT HEALTH, V46, P124, DOI 10.1016/j.jadohealth.2009.06.016; MacKinnon D.P., 2012, INTRO STAT MEDIATION; Magee CA, 2011, SLEEP MED, V12, P346, DOI 10.1016/j.sleep.2010.09.013; Manber R, 1996, SLEEP, V19, P432, DOI 10.1093/sleep/19.5.432; Mezick EJ, 2009, PSYCHONEUROENDOCRINO, V34, P1346, DOI 10.1016/j.psyneuen.2009.04.005; Monk TH, 2003, CHRONOBIOL INT, V20, P97, DOI 10.1081/CBI-120017812; MORIN CM, 2005, PRINCIPLES PRACTICE, P726; MYERS DG, 1995, PSYCHOL SCI, V6, P10, DOI 10.1111/j.1467-9280.1995.tb00298.x; Oakley NR., 1997, VALIDATION POLYSOMN; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Ong AD, 2013, ANN BEHAV MED, V46, P52, DOI 10.1007/s12160-013-9484-8; Paunio T, 2009, AM J EPIDEMIOL, V169, P206, DOI 10.1093/aje/kwn305; Perlis ML, 2005, SLEEP MED REV, V9, P381, DOI 10.1016/j.smrv.2005.05.001; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Pressman SD, 2005, PSYCHOL BULL, V131, P925, DOI 10.1037/0033-2909.131.6.925; Rowe M, 2008, BEHAV SLEEP MED, V6, P127, DOI 10.1080/15402000801952872; Ryan RM, 2001, ANNU REV PSYCHOL, V52, P141, DOI 10.1146/annurev.psych.52.1.141; Ryff CD, 2004, PHILOS T R SOC B, V359, P1383, DOI 10.1098/rstb.2004.1521; Sadeh A, 2011, SLEEP MED REV, V15, P259, DOI 10.1016/j.smrv.2010.10.001; SPIELMAN AJ, 1987, PSYCHIAT CLIN N AM, V10, P541; Steptoe A, 2008, J PSYCHOSOM RES, V64, P409, DOI 10.1016/j.jpsychores.2007.11.008; Tworoger SS, 2005, J PSYCHOSOM RES, V59, P11, DOI 10.1016/j.jpsychores.2005.03.008; Vallieres A, 2005, J SLEEP RES, V14, P447, DOI 10.1111/j.1365-2869.2005.00480.x; Van Someren EJW, 2007, J SLEEP RES, V16, P269, DOI 10.1111/j.1365-2869.2007.00592.x; Vitiello MV, 2004, J PSYCHOSOM RES, V56, P503, DOI 10.1016/S0022-3999(04)00023-6; Wohlgemuth WK, 1999, PSYCHOPHYSIOLOGY, V36, P233, DOI 10.1111/1469-8986.3620233	54	192	192	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2013	8	8							e71292	10.1371/journal.pone.0071292	http://dx.doi.org/10.1371/journal.pone.0071292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	202MQ	23967186	gold, Green Submitted, Green Published			2022-12-25	WOS:000323221500072
J	Zhu, SH; Gamst, A; Lee, M; Cummins, S; Yin, L; Zoref, L				Zhu, Shu-Hong; Gamst, Anthony; Lee, Madeleine; Cummins, Sharon; Yin, Lu; Zoref, Leslie			The Use and Perception of Electronic Cigarettes and Snus among the US Population	PLOS ONE			English	Article							NICOTINE DELIVERY-SYSTEMS; DEVICE E-CIGARETTE; SMOKELESS TOBACCO; HARM REDUCTION; SMOKING-CESSATION; PUBLIC-HEALTH; INTERVAL ESTIMATION; CAMEL SNUS; AWARENESS; RISE	Background: E-cigarettes have generated controversy in the tobacco control field similar to that of Swedish snus, which came to the U. S. market six years earlier. Some argue that e-cigarettes have great potential to help smokers quit regular cigarettes while others contend they should be banned for lack of safety and efficacy data. This study examined population data from the U. S. Methods: A U. S. population survey with a national probability sample (N=10,041) was conducted (February 24 to March 8, 2012, before any major paid advertisement of e-cigarettes appeared on television). Survey respondents were asked if they had heard about e-cigarettes, where they had heard about them, whether they had used e-cigarettes or snus, how often they used them, and why they used them. Responses were weighted to represent the entire U. S. population. Findings: A high proportion, 75.4%, reported having heard about e-cigarettes. Television ranked as the number one source of information, followed by "in-person conversation" and "Internet." About 8.1% had tried e-cigarettes, and 1.4% were current users. These rates were twice those of snus (4.3% and 0.8%, respectively). Among current smokers, 32.2% had tried e-cigarettes, and 6.3% were current users. Over 80% of current e-cigarette users were non-daily users. Women were significantly more likely to have tried e-cigarettes than men. Those who had tried e-cigarettes were more likely than those who tried snus to report their products being safer than regular cigarettes (49.9% vs. 10.8%). Almost half (49.5%) of current smokers were susceptible to using e-cigarettes in the future. Conclusions: That e-cigarettes have surpassed snus in adoption rate, even before any promotion by major tobacco companies, suggests that the former have tapped into smokers' intuitive preference for potentially harm-reducing products, probably due to the product design. E-cigarette use is likely to increase in the next few years.	[Zhu, Shu-Hong; Gamst, Anthony; Lee, Madeleine; Cummins, Sharon; Yin, Lu; Zoref, Leslie] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Zhu, SH (corresponding author), Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA.	szhu@ucsd.edu	Gamst, Anthony/AAH-9440-2019; Zhu, Shu-Hong/AAF-5164-2019	Ding, Han-Fei/0000-0001-5702-3439; Zhu, Shu-Hong/0000-0002-4149-3441	National Cancer Institute [U01 CA154280]; NATIONAL CANCER INSTITUTE [U01CA154280] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the National Cancer Institute (http://www.cancer.gov), U01 CA154280. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkison SE, 2013, AM J PREV MED, V44, P207, DOI 10.1016/j.amepre.2012.10.018; Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Anderson SJ, 2008, TOB CONTROL, V17, DOI 10.1136/tc.2007.024273; [Anonymous], 2010, ORIGINAL EPUFFERS DO; [Anonymous], 2012, CONSUMER REPORTS; Ayers JW, 2011, AM J PREV MED, V40, P448, DOI 10.1016/j.amepre.2010.12.007; Biener L, 2009, NICOTINE TOB RES, V11, P1154, DOI 10.1093/ntr/ntp113; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Bullen C, 2010, TOB CONTROL, V19, P98, DOI 10.1136/tc.2009.031567; Cahn Z, 2011, J PUBLIC HEALTH POL, V32, P16, DOI 10.1057/jphp.2010.41; Callaghan R, 2011, W AUSTR PERTH HEA, P3; Caponnetto P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066317; CBS, 2012, BS NEWS REP EL CIG; Chang L, 2009, PUBLIC OPIN QUART, V73, P641, DOI 10.1093/poq/nfp075; Cobb NK, 2010, AM J PUBLIC HEALTH, V100, P2340, DOI 10.2105/AJPH.2010.199281; Cowling DW, 2010, TOB CONTROL, V19, pI37, DOI 10.1136/tc.2009.030692; Dennis J., 2010, KNOWLEDGEPANEL PROCE; Dennis JM, 2010, UMMARY KNOWLEDGEPANE; Dennis JM, 2005, 2005 ANN M AM ASS PU; DiSogra C, 2010, UPDATE ADDRESS BASED; Dockrell M, 2013, NICOTINE TOB RES, V15, P1737, DOI 10.1093/ntr/ntt057; Esterl M, 2013, E CIGARETTES FIRE IN; Etter JF, 2011, ADDICTION, V106, P2017, DOI 10.1111/j.1360-0443.2011.03505.x; Etter JF, 2011, TOB CONTROL, V20, P243, DOI 10.1136/tc.2010.042168; Etter JF, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-231; Foulds J, 2011, INT J CLIN PRACT, V65, P1037, DOI 10.1111/j.1742-1241.2011.02751.x; Foulds J, 2007, LANCET, V369, P1976, DOI 10.1016/S0140-6736(07)60679-5; Freeman B, 2011, E CIGARETTES ARENT S; Gartner CE, 2007, PLOS MED, V4, P1138, DOI 10.1371/journal.pmed.0040185; Gilljam H, 2003, ADDICTION, V98, P1183, DOI 10.1046/j.1360-0443.2003.00379.x; Grana RA, 2011, TOB CONTROL, V20, P425, DOI 10.1136/tc.2011.043778; Hatsukami DK, 2004, PREV MED, V38, P309, DOI 10.1016/j.ypmed.2003.10.006; Heavner K, 2009, 011 TOB HARM RED; Henningfield JE, 2001, TOB CONTROL, V10, P253, DOI 10.1136/tc.10.3.253; Hickman N, 2004, J BEHAV MED, V27, P413, DOI 10.1023/B:JOBM.0000042413.69425.aa; King Brian, 2011, Morbidity and Mortality Weekly Report, V60, P1207; King BA, 2013, NICOTINE TOB RES, V15, P1623, DOI 10.1093/ntr/ntt013; Kirshner Laura, 2011, Am J Law Med, V37, P194; Knowledge Networks, 2012, NOWLEDGEPANEL DES SU; Knowledge Networks, 2012, NOWLEDGEPANEL DEMOGR; KTLA News, 2012, KTLA NEWS; Lee M, 2013, 19 ANN M SOC RES NIC; Lund KE, 2011, ADDICTION, V106, P162, DOI 10.1111/j.1360-0443.2010.03122.x; McMillen R, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/989474; McQueen A, 2011, NICOTINE TOB RES, V13, P860, DOI 10.1093/ntr/ntr088; Mejia AB, 2010, TOB CONTROL, V19, P297, DOI 10.1136/tc.2009.031427; Myslin M, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2534; Noel JK, 2011, TOB CONTROL, V20, P81, DOI 10.1136/tc.2010.038562; O'Hegarty M, 2006, AM J PREV MED, V30, P467, DOI 10.1016/j.amepre.2006.01.018; Parker-Pope T, 2001, SAFER CIGARETTES HIS; Pauly J, 2007, TOB CONTROL, V16, P357, DOI 10.1136/tc.2006.019687; Pearson JL, 2012, AM J PUBLIC HEALTH, V102, P1758, DOI 10.2105/AJPH.2011.300526; Pierce JP, 2005, ADDICT BEHAV, V30, P685, DOI 10.1016/j.addbeh.2004.08.014; Polosa R, 2013, EMERGEN MED, DOI [10.1007/s11739-013-0977-z, DOI 10.1007/S11739-013-0977-Z]; Polosa R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-786; Regan AK, 2013, TOB CONTROL, V22, P19, DOI 10.1136/tobaccocontrol-2011-050044; Regan AK, 2012, AM J PREV MED, V42, P29, DOI 10.1016/j.amepre.2011.08.019; Rigik E, 2012, LAWMAKERS TARGETING; Siegel MB, 2011, AM J PREV MED, V40, P472, DOI 10.1016/j.amepre.2010.12.006; Slade J, 2002, TOB CONTROL, V11, pII64; Song AV, 2007, AM J PREV MED, V33, P396, DOI 10.1016/j.amepre.2007.07.026; Study WHO Group on Product Regulation, 2009, WHO TECH REP S, V955, P41; Tellis A, 2012, CIGARETTES VS E CIGA; The Doctors TVShow, 2009, SYNOPSIS TOP 10 HLTH; V2 Cigs, 2012, AP COUT; Vansickel AR, 2012, ADDICTION, V107, P1493, DOI 10.1111/j.1360-0443.2012.03791.x; Wackowski OA, 2011, TOB CONTROL, V20, pE1, DOI 10.1136/tc.2010.037911; Wagener TL, 2012, ADDICTION, V107, P1545, DOI 10.1111/j.1360-0443.2012.03826.x; Yeager DS, 2011, PUBLIC OPIN QUART, V75, P709, DOI 10.1093/poq/nfr020; Zhu SH, 2009, TOB CONTROL, V18, P82, DOI 10.1136/tc.2008.028209; Zhu SH, 2012, TOB CONTROL, V21, P110, DOI 10.1136/tobaccocontrol-2011-050371	71	254	260	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e79332	10.1371/journal.pone.0079332	http://dx.doi.org/10.1371/journal.pone.0079332			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	241FR	24250756	gold, Green Submitted, Green Published			2022-12-25	WOS:000326152300092
J	Zhu, SQ; Yan, XM; Xiang, ZH; Ding, HF; Cui, HJ				Zhu, Shunqin; Yan, Xiaomin; Xiang, Zhonghuai; Ding, Han-Fei; Cui, Hongjuan			Leflunomide Reduces Proliferation and Induces Apoptosis in Neuroblastoma Cells In Vitro and In Vivo	PLOS ONE			English	Article							DIHYDROOROTATE DEHYDROGENASE; CYTOMEGALOVIRUS-INFECTION; PYRIMIDINE BIOSYNTHESIS; IMMUNOMODULATORY DRUG; A77 1726; INHIBITION; TRANSPLANTATION; PATHWAY; METABOLITE; INSIGHTS	Leflunomide as an immunosuppressive drug is generally used in the treatment of rheumatoid arthritis. It inhibits DHODH (dihydroorotate dehydrogenase), which is one of the essential enzymes in the de novo pyrimidine biosynthetic pathway. Here we showed that leflunomide significantly reduced cell proliferation and self-renewal activity. Annexin V-FITC/PI staining assay revealed that leflunomide induced S-phase cell cycle arrest, and promoted cell apoptosis. In vivo xenograft study in SCID mice showed that leflunomide inhibited tumor growth and development. We also observed that DHODH was commonly expressed in neuroblastoma. When treated with leflunomide, the neuroblastoma cell lines BE(2)-C, SK-N-DZ, and SK-N-F1 showed dramatic inhibition of DHODH at mRNA and protein levels. Considering the favorable toxicity profile and the successful clinical experience with leflunomide in rheumatoid arthritis, this drug represents a potential new candidate for targeted therapy in neuroblastoma.	[Zhu, Shunqin; Yan, Xiaomin; Xiang, Zhonghuai; Cui, Hongjuan] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Zhu, Shunqin] Southwest Univ, Coll Life Sci, Chongqing, Peoples R China; [Ding, Han-Fei] Georgia Hlth Sci Univ, Ctr Canc, Augusta, GA USA; [Ding, Han-Fei] Georgia Hlth Sci Univ, Dept Pathol, Augusta, GA USA	Southwest University - China; Southwest University - China; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Cui, HJ (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	hongjuan.cui@gmail.com	Gamst, Anthony/AAH-9440-2019; Zhu, Shu-Hong/AAF-5164-2019	Ding, Han-Fei/0000-0001-5702-3439; Zhu, Shu-Hong/0000-0002-4149-3441	National Basic Research Program of China [2012cb114600]; National Natural Science Foundation of China [31172268, 31271462]; NATIONAL CANCER INSTITUTE [U01CA154280] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors are grateful for Dr. Han-fei Ding for the invaluable support. This study was supported by the National Basic Research Program of China (number 2012cb114600), the National Natural Science Foundation of China (numbers 31172268 and 31271462). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakaki TL, 2008, MOL MICROBIOL, V68, P37, DOI 10.1111/j.1365-2958.2008.06131.x; Araya CE, 2010, PEDIATR TRANSPLANT, V14, P145, DOI 10.1111/j.1399-3046.2009.01183.x; Avery RK, 2004, BONE MARROW TRANSPL, V34, P1071, DOI 10.1038/sj.bmt.1704694; Battiwalla M, 2007, TRANSPL INFECT DIS, V9, P28, DOI 10.1111/j.1399-3062.2006.00170.x; Baumann P, 2009, MOL CANCER THER, V8, P366, DOI 10.1158/1535-7163.MCT-08-0664; Beckwith J B, 1968, J Pediatr Surg, V3, P106; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Bruneau JM, 1998, BIOCHEM J, V336, P299, DOI 10.1042/bj3360299; CHEN SF, 1986, CANCER RES, V46, P5014; CHERWINSKI HM, 1995, J PHARMACOL EXP THER, V275, P1043; Couzin-Frankel J, 2011, SCIENCE, V333, P1569, DOI 10.1126/science.333.6049.1569; Cui HJ, 2006, J BIOL CHEM, V281, P34696, DOI 10.1074/jbc.M604009200; Dietrich S, 2012, CLIN CANCER RES, V18, P417, DOI 10.1158/1078-0432.CCR-11-1049; Ehlert K, 2006, KLIN PADIATR, V218, P180, DOI 10.1055/s-2006-933412; Evans DR, 2004, J BIOL CHEM, V279, P33035, DOI 10.1074/jbc.R400007200; GREENE S, 1995, BIOCHEM PHARMACOL, V50, P861, DOI 10.1016/0006-2952(95)00255-X; Hail N, 2010, NEOPLASIA, V12, P464, DOI 10.1593/neo.10168; Loffler M, 2005, TRENDS MOL MED, V11, P430, DOI 10.1016/j.molmed.2005.07.003; Nara T, 2000, GENE, V257, P209, DOI 10.1016/S0378-1119(00)00411-X; Pardo N, 1996, MED PEDIATR ONCOL, V27, P534, DOI 10.1002/(SICI)1096-911X(199612)27:6<534::AID-MPO5>3.0.CO;2-M; Ringshausen I, 2008, LEUKEMIA, V22, P635, DOI 10.1038/sj.leu.2404922; Ruckemann K, 1998, J BIOL CHEM, V273, P21682, DOI 10.1074/jbc.273.34.21682; Sawamukai N, 2007, J IMMUNOL, V179, P6479, DOI 10.4049/jimmunol.179.10.6479; Shawver LK, 1997, CLIN CANCER RES, V3, P1167; Teschner S, 2010, IMMUNOTHERAPY-UK, V2, P637, DOI [10.2217/imt.10.52, 10.2217/IMT.10.52]; van der Heijden JW, 2009, ARTHRITIS RHEUM-US, V60, P669, DOI 10.1002/art.24354; White RM, 2011, NATURE, V471, P518, DOI 10.1038/nature09882; Williams JW, 2005, NEW ENGL J MED, V352, P1157, DOI 10.1056/NEJM200503173521125; Xu XL, 1999, BIOCHEM PHARMACOL, V58, P1405, DOI 10.1016/S0006-2952(99)00228-2; Xu XL, 1996, BIOCHEM PHARMACOL, V52, P527, DOI 10.1016/0006-2952(96)00303-6; YONG VW, 1987, J NEUROSCI METH, V21, P9, DOI 10.1016/0165-0270(87)90098-7	31	254	260	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e71555	10.1371/journal.pone.0071555	http://dx.doi.org/10.1371/journal.pone.0071555			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	24250756	Green Published, Green Submitted, gold			2022-12-25	WOS:000326473200053
J	Wu, CS; Pedersen, LH; Miller, JE; Sun, YL; Streja, E; Uldall, P; Olsen, J				Wu, Chun S.; Pedersen, Lars H.; Miller, Jessica E.; Sun, Yuelian; Streja, Elani; Uldall, Peter; Olsen, Jorn			Risk of Cerebral Palsy and Childhood Epilepsy Related to Infections before or during Pregnancy	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDERS; MATERNAL GENITOURINARY INFECTION; POPULATION-BASED COHORT; INTRAUTERINE INFECTION; PRENATAL INFECTION; EXPOSURE; SCHIZOPHRENIA; INFLUENZA; WOMEN; BIRTH	Background and Aim: Maternal infections during pregnancy have been associated with several neurological disorders in the offspring. However, given the lack of specificity for both the exposures and the outcomes, other factors related to infection such as impaired maternal immune function may be involved in the causal pathway. If impaired maternal immune function plays a role, we would expect infection before pregnancy to be associated with these neurological outcomes. Methods/Principal Findings: The study population included all first-born singletons in Denmark between January 1 1982 and December 31 2004. We identified women who had hospital-recorded infections within the 5 year period before pregnancy, and women who had hospital-recorded infections during pregnancy. We grouped infections into either infections of the genitourinary system, or any other infections. Cox models were used to estimate adjusted hazard ratios (aHRs) with 95% confidence interval (CI). Maternal infection of the genitourinary system during pregnancy was associated with an increased risk of cerebral palsy (aHR = 1.63, 95% CI: 1.34-1.98) and epilepsy (aHR = 1.27, 95% CI: 1.13-1.42) in the children, compared to children of women without infections during pregnancy. Among women without hospital-recorded infections during pregnancy, maternal infection before pregnancy was associated with an increased risk of epilepsy (aHR = 1.35, 95% CI: 1.21-1.50 for infections of the genitourinary system, and HR = 1.12, 95% CI: 1.03-1.22 for any other infections) and a slightly higher risk of cerebral palsy (aHR = 1.20, 95% CI: 0.96-1.49 for infections of the genitourinary system, and HR = 1.23, 95% CI: 1.06-1.43 for any other infections) in the children, compared to children of women without infections before (and during) pregnancy. Conclusions: These findings indicate that the maternal immune system, maternal infections, or factors related to maternal immune function play a role in the observed associations between maternal infections before pregnancy and cerebral diseases in the offspring.	[Wu, Chun S.; Pedersen, Lars H.; Sun, Yuelian; Olsen, Jorn] Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark; [Pedersen, Lars H.] Aarhus Univ Hosp, Dept Obstet & Gynecol, Inst Clin Med, DK-8000 Aarhus, Denmark; [Miller, Jessica E.; Streja, Elani; Olsen, Jorn] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA; [Uldall, Peter] Univ Southern Denmark, Natl Inst Publ Hlth, Cerebral Palsy Registry Denmark, Odense, Denmark; [Uldall, Peter] Copenhagen Univ Hosp, Rigshosp, Juliane Marie Ctr, Paediat Clin, Copenhagen, Denmark	Aarhus University; Aarhus University; University of California System; University of California Los Angeles; University of Southern Denmark; Rigshospitalet; University of Copenhagen	Wu, CS (corresponding author), Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark.	cw@soci.au.dk	Zhang, Youjie/F-7346-2016; Sun, Yuelian/AFF-2622-2022; Olsen, Jørn/F-8801-2015; Yang, Xiaobo/G-3854-2016	Zhang, Youjie/0000-0002-6035-8536; Sun, Yuelian/0000-0002-6905-0503; Olsen, Jørn/0000-0001-7462-5140; mo, zengnan/0000-0002-3047-3138; Miller, Jessica/0000-0002-1806-1894	Danish Medical Research Council (FSS)	Danish Medical Research Council (FSS)(Danish Medical Research Council)	The study was supported by the Danish Medical Research Council (FSS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams VM, 2008, IMMUNOL INVEST, V37, P427, DOI 10.1080/08820130802191599; Agrawal V, 2012, SEMIN FETAL NEONAT M, V17, P12, DOI 10.1016/j.siny.2011.09.001; Andersen TF, 1999, DAN MED BULL, V46, P263; Atladottir HO, 2010, J AUTISM DEV DISORD, V40, P1423, DOI 10.1007/s10803-010-1006-y; Atladottir HO, 2009, PEDIATRICS, V124, P687, DOI 10.1542/peds.2008-2445; Atladottir HO, 2010, ARCH PEDIAT ADOL MED, V164, P470, DOI 10.1001/archpediatrics.2010.9; Boksa P, 2010, BRAIN BEHAV IMMUN, V24, P881, DOI 10.1016/j.bbi.2010.03.005; Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361; Crump C, 2011, NEUROLOGY, V77, P1376, DOI 10.1212/WNL.0b013e318231528f; DEYKIN EY, 1979, AM J EPIDEMIOL, V109, P628, DOI 10.1093/oxfordjournals.aje.a112726; Genc MR, 2011, BJOG-INT J OBSTET GY, V118, P154, DOI 10.1111/j.1471-0528.2010.02772.x; Genc MR, 2007, BEST PRACT RES CL OB, V21, P491, DOI 10.1016/j.bpobgyn.2007.01.009; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Goncalves LF, 2002, MENT RETARD DEV D R, V8, P3, DOI 10.1002/mrdd.10008; Knudsen LB, 1998, DAN MED BULL, V45, P320; Koman LA, 2004, LANCET, V363, P1619, DOI 10.1016/S0140-6736(04)16207-7; Krageloh-Mann I, 2009, BRAIN DEV-JPN, V31, P537, DOI 10.1016/j.braindev.2009.03.009; Libbey JE, 2005, J NEUROVIROL, V11, P1, DOI 10.1080/13550280590900553; Mann JR, 2009, AM J PERINAT, V26, P667, DOI 10.1055/s-0029-1220792; Mann JR, 2009, DEV MED CHILD NEUROL, V51, P282, DOI 10.1111/j.1469-8749.2008.03226.x; McDermott S, 2010, NEUROEPIDEMIOLOGY, V34, P117, DOI 10.1159/000268824; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Meyer U, 2007, NEUROSCIENTIST, V13, P241, DOI 10.1177/1073858406296401; Miller JE, 2012, PAEDIATR PERINAT EP, V26, P589, DOI 10.1111/j.1365-3016.2012.01317.x; Nelson KB, 2008, CLIN OBSTET GYNECOL, V51, P749, DOI 10.1097/GRF.0b013e318187087c; Nelson KB, 2009, DEV MED CHILD NEUROL, V51, P253, DOI 10.1111/j.1469-8749.2008.03256.x; Norgaard M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030850; Norgaard M, 2011, AM J EPIDEMIOL, V174, P945, DOI 10.1093/aje/kwr201; Patterson PH, 2011, TRENDS MOL MED, V17, P389, DOI 10.1016/j.molmed.2011.03.001; Silva MJPMD, 2011, BRAZ J INFECT DIS, V15, P533, DOI 10.1590/S1413-86702011000600006; Rasmussen SA, 2012, AM J OBSTET GYNECOL, V207, pS3, DOI 10.1016/j.ajog.2012.06.068; Schendel D E, 2001, J Am Med Womens Assoc (1972), V56, P105; Sun Y, 2008, PEDIATRICS, V121, pE1100, DOI 10.1542/peds.2007-2316; Sun YL, 2011, PAEDIATR PERINAT EP, V25, P53, DOI 10.1111/j.1365-3016.2010.01143.x; Takei N, 1996, BIOL PSYCHIAT, V40, P817, DOI 10.1016/0006-3223(95)00592-7; Uldall P, 2001, DAN MED BULL, V48, P161; VanderWeele TJ, 2012, EPIDEMIOLOGY, V23, P1, DOI 10.1097/EDE.0b013e31823aca5d; Westergaard T, 1999, ARCH GEN PSYCHIAT, V56, P993, DOI 10.1001/archpsyc.56.11.993; Wilcox AJ, 2011, AM J EPIDEMIOL, V174, P1062, DOI 10.1093/aje/kwr230; Yoon BH, 2003, BJOG-INT J OBSTET GY, V110, P124, DOI 10.1016/S1470-0328(03)00063-6; Zanardo V, 2010, OBSTET GYNECOL, V116, P1454, DOI 10.1097/AOG.0b013e3181fd343a	42	24	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57552	10.1371/journal.pone.0057552	http://dx.doi.org/10.1371/journal.pone.0057552			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23967188	gold, Green Published			2022-12-25	WOS:000315519000128
J	Suchankova, P; Steensland, P; Fredriksson, I; Engel, JA; Jerlhag, E				Suchankova, Petra; Steensland, Pia; Fredriksson, Ida; Engel, Jorgen A.; Jerlhag, Elisabet			Ghrelin Receptor (GHS-R1A) Antagonism Suppresses Both Alcohol Consumption and the Alcohol Deprivation Effect in Rats following Long-Term Voluntary Alcohol Consumption	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; STIMULATES LOCOMOTOR-ACTIVITY; CONDITIONED PLACE PREFERENCE; ACCUMBAL DOPAMINE-OVERFLOW; NUCLEUS-ACCUMBENS; ETHANOL INTAKE; SYSTEMIC GHRELIN; DRUG-ADDICTION; MESSENGER-RNA; REWARD	Alcohol dependence is a heterogeneous disorder where several signalling systems play important roles. Recent studies implicate that the gut-brain hormone ghrelin, an orexigenic peptide, is a potential mediator of alcohol related behaviours. Ghrelin increases whereas a ghrelin receptor (GHS-R1A) antagonist decreases alcohol consumption as well as operant self-administration of alcohol in rodents that have consumed alcohol for twelve weeks. In the present study we aimed at investigating the effect of acute and repeated treatment with the GHS-R1A antagonist JMV2959 on alcohol intake in a group of rats following voluntarily alcohol consumption for two, five and eight months. After approximately ten months of voluntary alcohol consumption the expression of the GHS-R1A gene (Ghsr) as well as the degree of methylation of a CpG island found in Ghsr was examined in reward related brain areas. In a separate group of rats, we examined the effect of the JMV2959 on alcohol relapse using the alcohol deprivation paradigm. Acute JMV2959 treatment was found to decrease alcohol intake and the effect was more pronounced after five, compared to two months of alcohol exposure. In addition, repeated JMV2959 treatment decreased alcohol intake without inducing tolerance or rebound increase in alcohol intake after the treatment. The GHS-R1A antagonist prevented the alcohol deprivation effect in rats. There was a significant down-regulation of the Ghsr expression in the ventral tegmental area (VTA) in high-compared to low-alcohol consuming rats after approximately ten months of voluntary alcohol consumption. Further analysis revealed a negative correlation between Ghsr expression in the VTA and alcohol intake. No differences in methylation degree were found between high-compared to low-alcohol consuming rats. These findings support previous studies showing that the ghrelin signalling system may constitute a potential target for development of novel treatment strategies for alcohol dependence.	[Suchankova, Petra; Engel, Jorgen A.; Jerlhag, Elisabet] Univ Gothenburg, Sahlgrenska Acad, Dept Pharmacol, Inst Neurosci & Physiol, Gothenburg, Sweden; [Steensland, Pia; Fredriksson, Ida] Karolinska Inst, Div Psychiat, Dept Clin Neurosci, Stockholm, Sweden	University of Gothenburg; Karolinska Institutet	Engel, JA (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Pharmacol, Inst Neurosci & Physiol, Gothenburg, Sweden.	Jorgen.engel@pharm.gu.se	Fredriksson, Nils Johan/AAC-8083-2020; Wilen, Britt-Marie/B-5042-2016	Fredriksson, Nils Johan/0000-0002-5763-6777; Wilen, Britt-Marie/0000-0001-6155-7759; Steensland, Pia/0000-0003-4443-5017	Swedish Research Council [K2006-21X-04247-33-3, 2009-2782, K2010-80X-21496-01-6]; Swedish Brain Foundation; LUA/ALF from the Sahlgrenska University Hospital [148251]; Alcohol Research Council of the Swedish Alcohol Retailing Monopoly; foundation of Adlerbertska; foundation of Fredrik and Ingrid Thuring; foundation of Tore Nilsson; foundation of Langmanska; foundation of Torsten and Ragnar Soderberg; foundation of Wilhelm and Martina Lundgren; foundation of NovoNordisk; foundation of Knut and Alice Wallenberg; foundation of Magnus Bergvall; foundation of Aners; foundation of Jeansons; foundation of AkeWiberg; Swedish Society of Medicine; Swedish Society for Medical Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Foundation; LUA/ALF from the Sahlgrenska University Hospital; Alcohol Research Council of the Swedish Alcohol Retailing Monopoly; foundation of Adlerbertska; foundation of Fredrik and Ingrid Thuring; foundation of Tore Nilsson; foundation of Langmanska; foundation of Torsten and Ragnar Soderberg; foundation of Wilhelm and Martina Lundgren; foundation of NovoNordisk; foundation of Knut and Alice Wallenberg(Knut & Alice Wallenberg Foundation); foundation of Magnus Bergvall; foundation of Aners; foundation of Jeansons; foundation of AkeWiberg; Swedish Society of Medicine; Swedish Society for Medical Research	The research was supported by grants from the Swedish Research Council (grant no. K2006-21X-04247-33-3, 2009-2782 and K2010-80X-21496-01-6), The Swedish Brain Foundation, LUA/ALF (grant no. 148251) from the Sahlgrenska University Hospital, Alcohol Research Council of the Swedish Alcohol Retailing Monopoly and the foundations of Adlerbertska, Fredrik and Ingrid Thuring, Tore Nilsson, Langmanska, Torsten and Ragnar Soderberg, Wilhelm and Martina Lundgren, NovoNordisk, Knut and Alice Wallenberg, Magnus Bergvall, Aners, Jeansons, AkeWiberg, the Swedish Society of Medicine, Swedish Society for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Addolorato G, 2006, ALCOHOL CLIN EXP RES, V30, p140A; Anton RF, 2006, JAMA-J AM MED ASSOC, V295, P2003, DOI 10.1001/jama.295.17.2003; Blednov YA, 2004, ALCOHOL CLIN EXP RES, V28, P1683, DOI 10.1097/01.ALC.0000145790.60216.C8; Blomqvist O, 1997, EUR J PHARMACOL, V334, P149, DOI 10.1016/S0014-2999(97)01220-X; Camicella S, 2009, ALCOHOL, V43, P35, DOI 10.1016/j.alcohol.2008.12.001; Davis KW, 2007, REGUL PEPTIDES, V140, P148, DOI 10.1016/j.regpep.2006.12.003; Delcuve GP, 2009, J CELL PHYSIOL, V219, P243, DOI 10.1002/jcp.21678; Egecioglu E, 2012, PSYCHONEUROENDOCRINO; Egecioglu E, 2010, ADDICT BIOL, V15, P304, DOI 10.1111/j.1369-1600.2010.00216.x; Ericson M, 2003, EUR J PHARMACOL, V467, P85, DOI 10.1016/S0014-2999(03)01564-4; Guan XM, 1997, MOL BRAIN RES, V48, P23, DOI 10.1016/S0169-328X(97)00071-5; Hansson C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050409; Heyser CJ, 2003, NEUROPSYCHOPHARMACOL, V28, P1463, DOI 10.1038/sj.npp.1300175; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; Horvath TL, 2001, ENDOCRINOLOGY, V142, P4163, DOI 10.1210/en.142.10.4163; Jerlhag E, 2008, ADDICT BIOL, V13, P358, DOI 10.1111/j.1369-1600.2008.00125.x; Jerlhag E, 2008, EUR NEUROPSYCHOPHARM, V18, P508, DOI 10.1016/j.euroneuro.2008.02.006; Jerlhag E, 2007, ADDICT BIOL, V12, P6, DOI 10.1111/j.1369-1600.2006.00041.x; Jerlhag E, 2006, ALCOHOL ALCOHOLISM, V41, P486, DOI 10.1093/alcalc/agl049; Jerlhag E, 2006, ADDICT BIOL, V11, P45, DOI 10.1111/j.1369-1600.2006.00002.x; Jerlhag E, 2011, DRUG ALCOHOL DEPEN, V117, P126, DOI 10.1016/j.drugalcdep.2011.01.010; Jerlhag E, 2011, ALCOHOL, V45, P341, DOI 10.1016/j.alcohol.2010.10.002; Jerlhag E, 2011, ADDICT BIOL, V16, P82, DOI 10.1111/j.1369-1600.2010.00231.x; Jerlhag E, 2010, PSYCHOPHARMACOLOGY, V211, P415, DOI 10.1007/s00213-010-1907-7; Jerlhag E, 2009, P NATL ACAD SCI USA, V106, P11318, DOI 10.1073/pnas.0812809106; Jiang H, 2006, MOL ENDOCRINOL, V20, P1772, DOI 10.1210/me.2005-0084; Kaur S, 2010, ALCOHOL CLIN EXP RES, V34, P1525, DOI 10.1111/j.1530-0277.2010.01237.x; Kern A, 2012, NEURON, V73, P317, DOI 10.1016/j.neuron.2011.10.038; Koob GF, 2001, NEUROPSYCHOPHARMACOL, V24, P97, DOI 10.1016/S0893-133X(00)00195-0; Koopmann A, 2012, PSYCHONEUROENDOCRINO, V37, P980, DOI 10.1016/j.psyneuen.2011.11.005; Kuzmin A, 2009, PSYCHOPHARMACOLOGY, V203, P99, DOI 10.1007/s00213-008-1375-5; Landgren S, 2008, ALCOHOL CLIN EXP RES, V32, P2054, DOI 10.1111/j.1530-0277.2008.00793.x; Landgren S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018170; Landgren S, 2011, BEHAV BRAIN RES, V221, P182, DOI 10.1016/j.bbr.2011.03.003; Landgren S, 2012, ADDICT BIOL, V17, P86, DOI 10.1111/j.1369-1600.2010.00280.x; Landgren S, 2010, ALCOHOL CLIN EXP RES, V34, P1519, DOI 10.1111/j.1530-0277.2010.01236.x; Larsson A, 2004, ALCOHOL, V34, P239, DOI 10.1016/j.alcohol.2004.10.002; Larsson A, 2004, NEUROSCI BIOBEHAV R, V27, P713, DOI 10.1016/j.neubiorev.2003.11.010; Leggio L, 2012, ADDICT BIOL, V17, P452, DOI 10.1111/j.1369-1600.2010.00308.x; Lewis MJ, 2004, ALCOHOL CLIN EXP RES, V28, P1822, DOI 10.1097/01.ALC.0000148099.12344.C8; Litten RZ, 2013, J ADDICT MED; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lof E, 2007, PSYCHOPHARMACOLOGY, V195, P333, DOI 10.1007/s00213-007-0899-4; McKee SA, 2009, BIOL PSYCHIAT, V66, P185, DOI 10.1016/j.biopsych.2009.01.029; Mitchell JM, 2012, PSYCHOPHARMACOLOGY, V223, P299, DOI 10.1007/s00213-012-2717-x; Moulin A, 2007, J MED CHEM, V50, P5790, DOI 10.1021/jm0704550; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Quarta D, 2009, NEUROCHEM INT, V54, P89, DOI 10.1016/j.neuint.2008.12.006; Rada P, 2004, ALCOHOL, V33, P91, DOI 10.1016/j.alcohol.2004.05.002; Salome N, 2009, J NEUROENDOCRINOL, V21, P777, DOI 10.1111/j.1365-2826.2009.01895.x; Simms JA, 2008, ALCOHOL CLIN EXP RES, V32, P1816, DOI 10.1111/j.1530-0277.2008.00753.x; Skibicka KP, 2011, NEUROSCIENCE, V180, P129, DOI 10.1016/j.neuroscience.2011.02.016; Skibicka KP, 2012, ADDICT BIOL, V17, P95, DOI 10.1111/j.1369-1600.2010.00294.x; Soderpalm B, 2009, PHARMACOPSYCHIATRY, V42, pS87, DOI 10.1055/s-0029-1220690; Soyka Michael, 2008, Curr Drug Abuse Rev, V1, P280; Spanagel R, 2000, ALCOHOL RES HEALTH, V24, P124; Spanagel R, 1997, TRENDS PHARMACOL SCI, V18, P54, DOI 10.1016/S0165-6147(97)89800-8; Steensland P, 2007, P NATL ACAD SCI USA, V104, P12518, DOI 10.1073/pnas.0705368104; Tessari M, 2007, ADDICT BIOL, V12, P22, DOI 10.1111/j.1369-1600.2007.00052.x; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Tupala E, 2004, PROG NEURO-PSYCHOPH, V28, P1221, DOI 10.1016/j.pnpbp.2004.06.022; Volkow ND, 2004, NAT REV NEUROSCI, V5, P963, DOI 10.1038/nrn1539; Wellman PJ, 2007, PHARMACOL BIOCHEM BE, V88, P89, DOI 10.1016/j.pbb.2007.07.008; Wellman PJ, 2011, REGUL PEPTIDES, V172, P77, DOI 10.1016/j.regpep.2011.08.014; Wellman PJ, 2005, REGUL PEPTIDES, V125, P151, DOI 10.1016/j.regpep.2004.08.013; WISE RA, 1973, PSYCHOPHARMACOLOGIA, V29, P203, DOI 10.1007/BF00414034; Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992; Wren AM, 2001, DIABETES, V50, P2540, DOI 10.2337/diabetes.50.11.2540; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823	71	133	135	6	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71284	10.1371/journal.pone.0071284	http://dx.doi.org/10.1371/journal.pone.0071284			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977009	Green Published, gold, Green Submitted			2022-12-25	WOS:000324527300010
J	Zhang, Y; Zhang, WN; Lu, K; Ji, RR; Wang, FL; Liu, T				Zhang, Yu; Zhang, Wei-Nan; Lu, Ke; Ji, Rongrong; Wang, Fanglin; Liu, Ting			Phrasal Paraphrase Based Question Reformulation for Archived Question Retrieval	PLOS ONE			English	Article								Lexical gap in cQA search, resulted by the variability of languages, has been recognized as an important and widespread phenomenon. To address the problem, this paper presents a question reformulation scheme to enhance the question retrieval model by fully exploring the intelligence of paraphrase in phrase-level. It compensates for the existing paraphrasing research in a suitable granularity, which either falls into fine-grained lexical-level or coarse-grained sentence-level. Given a question in natural language, our scheme first detects the involved key-phrases by jointly integrating the corpus-dependent knowledge and question-aware cues. Next, it automatically extracts the paraphrases for each identified key-phrase utilizing multiple online translation engines, and then selects the most relevant reformulations from a large group of question rewrites, which is formed by full permutation and combination of the generated paraphrases. Extensive evaluations on a real world data set demonstrate that our model is able to characterize the complex questions and achieves promising performance as compared to the state-of-the-art methods.	[Zhang, Yu; Zhang, Wei-Nan; Liu, Ting] Harbin Inst Technol, Res Ctr Social Comp & Informat Retrieval, Harbin, Heilongjiang, Peoples R China; [Lu, Ke] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Ji, Rongrong] Xiamen Univ, Dept Cognit Sci, Xiamen, Fujian, Peoples R China; [Wang, Fanglin] Natl Univ Singapore, Sch Comp, Singapore 117548, Singapore	Harbin Institute of Technology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Xiamen University; National University of Singapore	Ji, RR (corresponding author), Xiamen Univ, Dept Cognit Sci, Xiamen, Fujian, Peoples R China.	rrji@ee.columbia.edu; hardegg@gmail.com		zhang, longxian/0000-0002-5706-131X; ling, hong/0000-0002-1886-1242; Liu, Jun/0000-0002-0522-6733				[Anonymous], 2006, P LREC; [Anonymous], 2012, P 2012 JOINT C EMP M; Bannard Colin, 2005, P 43 ANN M ASS COMP, P597, DOI [10.3115/1219840.1219914, DOI 10.3115/1219840.1219914]; Barzilay R, 2003, HLT-NAACL 2003: HUMAN LANGUAGE TECHNOLOGY CONFERENCE OF THE NORTH AMERICAN CHAPTER OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE MAIN CONFERENCE, P16; Bendersky M, 2011, PROCEEDINGS OF THE 34TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL (SIGIR'11), P605; Bendersky M, 2012, SIGIR 2012: PROCEEDINGS OF THE 35TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P941, DOI 10.1145/2348283.2348408; Bendersky Michael, 2010, P 3 ACM INT C WEB SE, P31, DOI [10.1145/1718487.1718492, DOI 10.1145/1718487.1718492]; Bendersky Michael, 2008, P 31 ANN INT ACM SIG, P491, DOI DOI 10.1145/1390334.1390419; Buscaldi D, 2005, CROSS LANG EV FOR CL; CALLAN JP, 1995, INFORM PROCESS MANAG, V31, P327, DOI 10.1016/0306-4573(94)00050-D; Callison-Burch Chris, 2008, P C EMP METH NAT LAN, P196; Chakrabarti D., 2011, P 5 INT AAAI C WEBL, V11, P66; Dinh D, 2011, LECT NOTES COMPUT SC, V6611, P375, DOI 10.1007/978-3-642-20161-5_38; Duclaye F, 2003, P EACL WORKSH NAT LA, P35; Gao Y., 2017, ACM MULTIMEDIA, P1517; Gao Yue, 2010, P INT C MULT, P123; Gehler P, 2009, IEEE I CONF COMP VIS, P221, DOI 10.1109/ICCV.2009.5459169; Grineva Maria, 2009, P 18 INT C WORLD WID, P661, DOI DOI 10.1145/1526709.1526798; Harabagiu S, 2001, P TEXT RETR C QUEST; Harman D., 1988, 11th International Conference on Research and Development in Information Retrieval, P321; Hovy E., 2001, P 10 TEXT RETRIEVAL; Jianfeng Gao, 2004, Proceedings of Sheffield SIGIR 2004. The Twenty-Seventh Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P170; Jinxi Xu, 1996, SIGIR Forum, P4; Kai Wang, 2010, P 23 INT C COMP LING, P1155; Lam-Adesina A. M., 2001, SIGIR Forum, P1; Mihalcea R., 2004, P 2004 C EMP METH NA, P404, DOI DOI 10.3115/1219044.1219064; Ponte J. M., 1998, P 21 ANN INT ACM SIG, P275, DOI DOI 10.1145/290941.291008; Riezler S, 2007, P 45 ANN M ASS COMP, V45, P464; Robertson S, 2002, INFORM RETRIEVAL, V5, P239, DOI 10.1023/A:1015702129514; Robertson S. E., 1995, Text REtrieval Conference (TREC-3) (NIST SP 500-225), P109; Robertson SE, 1999, TREC 99, V8; Sang J., 2012, P 20 ACM INT C MULT, P19; Sang JT, 2011, ACM T MULTIM COMPUT, V7, DOI 10.1145/2037676.2037687; Song F, 1999, SIGIR'99: PROCEEDINGS OF 22ND INTERNATIONAL CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P279, DOI 10.1145/312624.312698; Srikanth M., 2002, Proceedings of SIGIR 2002. Twenty-Fifth Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P425; VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260, DOI 10.1109/TIT.1967.1054010; Wang K, 2009, PROCEEDINGS 32ND ANNUAL INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P187, DOI 10.1145/1571941.1571975; Xu J, 2011, P 20 INT C COMP WORL, P153, DOI [10.1145/1963192.1963270, DOI 10.1145/1963192.1963270]; Xue X., 2008, P 31 ANN INT ACM SIG, P475, DOI 10.1145/1390334.1390416; Yang H, 2005, PDCAT 2005: SIXTH INTERNATIONAL CONFERENCE ON PARALLEL AND DISTRIBUTED COMPUTING, APPLICATIONS AND TECHNOLOGIES, PROCEEDINGS, P40; Yonggang Qiu, 1993, SIGIR Forum, P160; Zhang ST, 2012, LECT NOTES COMPUT SC, V7573, P660, DOI 10.1007/978-3-642-33709-3_47; Zhang ST, 2012, IEEE T SYST MAN CY B, V42, P838, DOI 10.1109/TSMCB.2011.2179533; Zhao S, 2008, P ACL 08, P1021; Zhao SQ, 2007, 20TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P1795; Zhao Shiqi, 2010, P COL 2010, P1326; Zhao Shiqi, 2009, P JOINT C 47 ANN M A, V2, P834	48	100	109	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e64601	10.1371/journal.pone.0064601	http://dx.doi.org/10.1371/journal.pone.0064601			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23977002	Green Published, Green Submitted, gold			2022-12-25	WOS:000320846500006
J	Li, S; Jin, XK; Guo, XN; Yu, AQ; Wu, MH; Tan, SJ; Zhu, YT; Li, WW; Wang, Q				Li, Shuang; Jin, Xing-Kun; Guo, Xiao-Nv; Yu, Ai-Qing; Wu, Min-Hao; Tan, Shang-Jian; Zhu, You-Ting; Li, Wei-Wei; Wang, Qun			A Double WAP Domain-Containing Protein Es-DWD1 from Eriocheir sinensis Exhibits Antimicrobial and Proteinase Inhibitory Activities	PLOS ONE			English	Article							WHEY ACIDIC PROTEIN; CHINESE MITTEN CRAB; CRUSTIN-LIKE GENE; C-TYPE LECTIN; MOLECULAR-CLONING; WHITE SHRIMP; ALPHA-2-MACROGLOBULIN ALPHA-2-M; RECOMBINANT EXPRESSION; ANTIBACTERIAL PROTEINS; PEPTIDE	Whey acidic proteins (WAP) belong to a large gene family of antibacterial peptides, which are critical in the host immune response against microbial invasion. The common feature of these proteins is a single WAP domain maintained by at least one four-disulfide core (4-DSC) structure rich in cysteine residues. In this study, a double WAP domain (DWD)-containing protein, Es-DWD1, was first cloned from the Chinese mitten crab (Eriocheir sinensis). The full-length Es-DWD1cDNA was 1193 bp, including a 411 bp open reading frame (ORF) encoding 136 amino acids with a signal peptide of 22 amino acids in the N-terminus. A comparison with other reported invertebrate and vertebrate sequences revealed the presence of WAP domains characteristic of WAP superfamilies. As determined by quantitative real-time RT-PCR, Es-DWD1 transcripts were ubiquitously expressed in all tissues, but it was upregulated in hemocytes post-challenge with pathogen-associated molecular patterns (PAMPs). The mature recombinant Es-DWD1 (rEs-DWD1) protein exhibited different binding activities to bacteria and fungus. Moreover, rEs-DWD1 could exert agglutination activities against Bacillus subtilis and Pichia pastoris and demonstrated inhibitory activities against the growth of Staphylococcus aureus, Aeromonas hydrophila and P. pastoris. Furthermore, rEs-DWD1 showed a specific protease inhibitory activity in B. subtilis. Coating of rEs-DWD1 onto agarose beads enhanced encapsulation of the beads by crab hemocytes. Collectively, the results suggest that Es-DWD1 is a double WAP domain containing protein with antimicrobial and proteinase inhibitory activities, which play significant roles in the immunity of crustaceans.	[Li, Shuang; Jin, Xing-Kun; Guo, Xiao-Nv; Yu, Ai-Qing; Wu, Min-Hao; Tan, Shang-Jian; Zhu, You-Ting; Li, Wei-Wei; Wang, Qun] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China	East China Normal University	Wang, Q (corresponding author), E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China.	qwang@bio.ecnu.edu.cn	Wang, Qun/I-7778-2013; Zhang, Quanfa/H-1922-2011; LI, WEIWEI/J-3538-2013; Jin, Xingkun/H-4366-2013; Li, Siyue/DCN-3040-2022; Li, Siyue/E-8297-2012	Wang, Qun/0000-0001-7929-7692; Jin, Xingkun/0000-0003-2454-1621; Li, Siyue/0000-0002-3097-6819; Li, Siyue/0000-0002-3097-6819; li, si yue/0000-0002-4550-892X	National Natural Science Foundation of China [31172393]; National Science and Technology Support Program of China [2012BAD26B04-04]; Innovation Program of Shanghai Municipal Education Commission [13zz031]; National Research Foundation for the Doctoral Program of Higher Education of China [20110076110016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Program of China; Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); National Research Foundation for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This research was supported by grants from the National Natural Science Foundation of China (No. 31172393), the National Science and Technology Support Program of China (2012BAD26B04-04), the Innovation Program of Shanghai Municipal Education Commission (13zz031) and the National Research Foundation for the Doctoral Program of Higher Education of China (20110076110016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amparyup P, 2008, DEV COMP IMMUNOL, V32, P1497, DOI 10.1016/j.dci.2008.06.005; Amparyup P, 2008, MOL IMMUNOL, V45, P1085, DOI 10.1016/j.molimm.2007.07.031; ARAKI K, 1989, BIOCHEM BIOPH RES CO, V164, P496, DOI 10.1016/0006-291X(89)91747-6; AVIDOR Y, 1953, J BACTERIOL, V66, P1, DOI 10.1002/path.1700660103; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Chen A, 2008, FISH SHELLFISH IMMUN, V25, P775, DOI 10.1016/j.fsi.2008.02.017; CORONEL CE, 1990, J BIOL CHEM, V265, P6854; Davey GC, 2001, GENE, V263, P121, DOI 10.1016/S0378-1119(00)00587-4; DEAR TN, 1988, CANCER RES, V48, P5203; Du ZQ, 2009, COMP BIOCHEM PHYS B, V154, P203, DOI 10.1016/j.cbpb.2009.06.004; Du ZQ, 2010, FISH SHELLFISH IMMUN, V28, P134, DOI 10.1016/j.fsi.2009.10.009; DYAR MT, 1946, J BACTERIOL, V51, P149, DOI 10.1128/JB.51.2.149-167.1946; Gollas-Galvan T, 2003, COMP BIOCHEM PHYS C, V134, P431, DOI 10.1016/S1532-0456(03)00002-4; Gowda NM, 2008, J INVERTEBR PATHOL, V99, P141, DOI 10.1016/j.jip.2008.04.003; Hagiwara K, 2003, J IMMUNOL, V170, P1973, DOI 10.4049/jimmunol.170.4.1973; HALL M, 1989, FEBS LETT, V254, P111, DOI 10.1016/0014-5793(89)81019-1; Hauton C, 2006, MOL IMMUNOL, V43, P1490, DOI 10.1016/j.molimm.2005.07.029; He L, PLOS ONE, V20127; HENNIGHAUSEN LG, 1982, NUCLEIC ACIDS RES, V10, P2677, DOI 10.1093/nar/10.8.2677; Hiemstra PS, 1996, INFECT IMMUN, V64, P4520, DOI 10.1128/IAI.64.11.4520-4524.1996; Jia YP, 2008, AQUACULTURE, V284, P246, DOI 10.1016/j.aquaculture.2008.07.046; Jiang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011175; Jimenez-Vega F, 2005, DEV COMP IMMUNOL, V29, P385, DOI 10.1016/j.dci.2004.10.001; Jimenez-Vega F, 2007, FISH SHELLFISH IMMUN, V23, P1119, DOI 10.1016/j.fsi.2007.06.006; JOHANSSON MW, 1994, EUR J BIOCHEM, V223, P389, DOI 10.1111/j.1432-1033.1994.tb19005.x; Krusong K, 2012, DEV COMP IMMUNOL, V36, P208, DOI 10.1016/j.dci.2011.08.002; Li FM, 2012, DEV COMP IMMUNOL, V36, P183, DOI 10.1016/j.dci.2011.07.003; Liang ZC, 1997, P NATL ACAD SCI USA, V94, P6682, DOI 10.1073/pnas.94.13.6682; LIANG ZC, 1995, COMP BIOCHEM PHYS B, V112, P385, DOI 10.1016/0305-0491(95)00105-0; Lin YC, 2008, DEV COMP IMMUNOL, V32, P317, DOI 10.1016/j.dci.2007.07.002; Lin YC, 2007, MOL IMMUNOL, V44, P1065, DOI 10.1016/j.molimm.2006.08.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mu CK, 2011, FISH SHELLFISH IMMUN, V31, P142, DOI 10.1016/j.fsi.2011.04.013; Mu CK, 2010, DEV COMP IMMUNOL, V34, P734, DOI 10.1016/j.dci.2010.02.001; Nile CJ, 2006, MOL IMMUNOL, V43, P388, DOI 10.1016/j.molimm.2005.02.015; Pech LL, 1996, J CELL SCI, V109, P2053; Ranganathan S, 1999, J MOL GRAPH MODEL, V17, P106, DOI 10.1016/S1093-3263(99)00023-6; Rattanachai A, 2004, FISH SHELLFISH IMMUN, V16, P599, DOI 10.1016/j.fsi.2003.09.011; Ren Q, 2009, FISH SHELLFISH IMMUN, V27, P739, DOI 10.1016/j.fsi.2009.09.007; Sallenave JM, 2002, BIOCHEM SOC T, V30, P111, DOI 10.1042/BST0300111; Smith VJ, 2008, DEV COMP IMMUNOL, V32, P758, DOI 10.1016/j.dci.2007.12.002; Smith VJ, 2011, BIOCHEM SOC T, V39, P1403, DOI 10.1042/BST0391403; Smith VJ, 2001, ADV EXP MED BIOL, V484, P95; Snedecor G., 1971, STAT METHODS; SODERHALL K, 1983, DEV COMP IMMUNOL, V7, P229, DOI 10.1016/0145-305X(83)90004-6; Somprasong N, 2006, DEV COMP IMMUNOL, V30, P998, DOI 10.1016/j.dci.2006.01.004; Sperstad SV, 2009, DEV COMP IMMUNOL, V33, P583, DOI 10.1016/j.dci.2008.10.010; Supungul P, 2002, MAR BIOTECHNOL, V4, P487, DOI 10.1007/s10126-002-0043-8; Tomee JFC, 1997, J INFECT DIS, V176, P740, DOI 10.1086/514098; Van Harreveld A, 1936, P SOC EXP BIOL MED, V34, P428; Vargas-Albores F, 2004, COMP BIOCHEM PHYS B, V138, P415, DOI 10.1016/j.cbpc.2004.05.007; Wang W, 2004, RES MICROBIOL, V155, P630, DOI 10.1016/j.resmic.2004.04.010; WIEDOW O, 1990, J BIOL CHEM, V265, P14791; Wu HX, 2004, J INVERTEBR PATHOL, V86, P59, DOI 10.1016/j.jip.2004.03.010; Yang JL, 2010, DEV COMP IMMUNOL, V34, P1274, DOI 10.1016/j.dci.2010.07.004; Yang WL, 2005, CHIN J FRESHWATER FI, V35, P62; Yenugu S, 2004, BIOL REPROD, V71, P1484, DOI 10.1095/biolreprod.104.031567; Yu YH, 2007, J IMMUNOL, V179, P8425, DOI 10.4049/jimmunol.179.12.8425; Zhang JQ, 2007, J BIOTECHNOL, V127, P605, DOI 10.1016/j.jbiotec.2006.08.013; Zhang Shu-yong, 2002, Virologica Sinica, V17, P263	61	177	190	4	181	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e73563	10.1371/journal.pone.0073563	http://dx.doi.org/10.1371/journal.pone.0073563			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967346	gold, Green Published, Green Submitted			2022-12-25	WOS:000323115800122
J	Li, SY; Xia, XL; Tan, X; Zhang, QF				Li, Siyue; Xia, Xiaoling; Tan, Xiang; Zhang, Quanfa			Effects of Catchment and Riparian Landscape Setting on Water Chemistry and Seasonal Evolution of Water Quality in the Upper Han River Basin, China	PLOS ONE			English	Article							MAJOR-ELEMENT CHEMISTRY; LAND-USE; ALPINE/SUBALPINE BASINS; ION COMPOSITIONS; GEOCHEMISTRY; COVER; NITROGEN; IMPACT; FLUXES; RATES	Six-year (2005-2010) evolution of water chemistry (Cl-, NO3-, SO42-, HCO3-, Na+, K+, Ca2+ and Mg2+) and their interactions with morphological properties (i.e., slope and area), land cover, and hydrological seasonality were examined to identify controlling factors and processes governing patterns of stream water quality in the upper Han River, China. Correlation analysis and stepwise multiple regression models revealed significant correlations between ions (i.e., Cl-, SO42-, Na+ and K+) and land cover (i.e., vegetation and bare land) over the entire catchment in both high-and low-flow periods, and in the buffer zone the correlation was much more stronger in the low-flow period. Catchment with steeper slope (>15 degrees) was negatively correlated with major ions, largely due to multicollinearity of basin characteristics. Land cover within the buffer zone explained slightly less of major elements than at catchment scale in the rainy season, whereas in the dry season, land cover along the river networks in particular this within 100 m riparian zone much better explained major elements rather than this over the entire catchment. Anthropogenic land uses (i.e., urban and agriculture) however could not explain water chemical variables, albeit EC, TDS, anthropogenic markers (Cl-, NO3-, SO42), Na+, K+ and Ca2+ significantly increased during 2005-2010, which was corroborated by principal component analyses (PCA) that indicated anthropogenic inputs. Observations demonstrated much higher solute concentrations in the industrial-polluted river. Our results suggested that seasonal evolution of water quality in combined with spatial analysis at multiple scales should be a vital part of identifying the controls on spatio-temporal patterns of water quality.	[Li, Siyue; Xia, Xiaoling; Tan, Xiang; Zhang, Quanfa] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS	Li, SY (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Peoples R China.	lisiyue@wbgcas.cn; qzhang@wbgcas.cn	Wang, Qun/I-7778-2013; Zhang, Quanfa/H-1922-2011; LI, WEIWEI/J-3538-2013; Jin, Xingkun/H-4366-2013; Li, Siyue/DCN-3040-2022; Li, Siyue/E-8297-2012	Wang, Qun/0000-0001-7929-7692; Jin, Xingkun/0000-0003-2454-1621; Li, Siyue/0000-0002-3097-6819; Li, Siyue/0000-0002-3097-6819; li, si yue/0000-0002-4550-892X	National Natural Science Foundation of China [31100347, 31130010]; Youth Innovation Promotion Association; Chinese Academy of Sciences, China [Y129431C06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Innovation Promotion Association; Chinese Academy of Sciences, China(Chinese Academy of Sciences)	The research is funded by the National Natural Science Foundation of China (31100347 and 31130010) and Youth Innovation Promotion Association, the Chinese Academy of Sciences, China (Y129431C06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RB, 2000, NATURE, V403, P758, DOI 10.1038/35001562; Anshumali, 2007, APPL GEOCHEM, V22, P1736, DOI 10.1016/j.apgeochem.2007.03.045; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Chang H, 2008, WATER RES, V42, P3285, DOI 10.1016/j.watres.2008.04.006; Chen JS, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002325; Chen JS, 2002, CHEM GEOL, V187, P231, DOI 10.1016/S0009-2541(02)00032-3; Chinese Ministry of Health, 2006, GB5749 CHIN MIN HLTH; Clow DW, 2000, WATER RESOUR RES, V36, P49, DOI 10.1029/1999WR900294; Dodds WK, 1998, WATER RES, V32, P1455, DOI 10.1016/S0043-1354(97)00370-9; Gaillardet J, 1999, CHEM GEOL, V159, P3, DOI 10.1016/S0009-2541(99)00031-5; Garcia-Esteves J, 2007, APPL GEOCHEM, V22, P230, DOI 10.1016/j.apgeochem.2006.09.013; GIBBS RJ, 1970, SCIENCE, V170, P1088, DOI 10.1126/science.170.3962.1088; HU MH, 1982, NATURE, V298, P550, DOI 10.1038/298550a0; HUNSAKER CT, 1995, BIOSCIENCE, V45, P193, DOI 10.2307/1312558; Iqbal J, 2011, J HAZARD MATER, V192, P887, DOI 10.1016/j.jhazmat.2011.05.105; Johnson LB, 1997, FRESHWATER BIOL, V37, P193, DOI 10.1046/j.1365-2427.1997.d01-539.x; Li SY, 2009, J HAZARD MATER, V162, P1340, DOI 10.1016/j.jhazmat.2008.06.059; Li SY, 2008, CATENA, V75, P216, DOI 10.1016/j.catena.2008.06.005; Li SY, 2009, J HAZARD MATER, V170, P605, DOI 10.1016/j.jhazmat.2009.05.022; Li SY, 2009, CHEM GEOL, V264, P89, DOI 10.1016/j.chemgeo.2009.02.021; Li SY, 2008, APPL GEOCHEM, V23, P3535, DOI 10.1016/j.apgeochem.2008.08.012; Li SY, 2009, J HAZARD MATER, V165, P317, DOI 10.1016/j.jhazmat.2008.09.123; MEYBECK M, 1987, AM J SCI, V287, P401, DOI 10.2475/ajs.287.5.401; Meybeck M, 2005, TREATISE GEOCHEM, V5, P207; Meynendonckx J, 2006, HYDROL EARTH SYST SC, V10, P913, DOI 10.5194/hess-10-913-2006; OSBORNE LL, 1988, J ENVIRON MANAGE, V26, P9; PEIERLS BL, 1991, NATURE, V350, P386, DOI 10.1038/350386b0; Pratt B, 2012, J HAZARD MATER, V209, P48, DOI 10.1016/j.jhazmat.2011.12.068; PROSPERO JM, 1989, NATURE, V339, P687, DOI 10.1038/339687a0; Sliva L, 2001, WATER RES, V35, P3462, DOI 10.1016/S0043-1354(01)00062-8; STALLARD RF, 1983, J GEOPHYS RES-OCEANS, V88, P9671, DOI 10.1029/JC088iC14p09671; Stark JM, 1997, NATURE, V385, P61, DOI 10.1038/385061a0; Sueker JK, 2001, HYDROL PROCESS, V15, P2749, DOI 10.1002/hyp.265; Varol M, 2011, J HAZARD MATER, V195; Varol M, 2012, CATENA, V92, P11, DOI 10.1016/j.catena.2011.11.013; WHO, 2006, GUID DRINK WAT QUAL, V1; Wu WH, 2008, CHEM GEOL, V249, P307, DOI 10.1016/j.chemgeo.2008.01.025; ZHANG J, 1995, J HYDROL, V168, P173, DOI 10.1016/0022-1694(94)02635-O; Zhang LA, 2011, APPL GEOCHEM, V26, P293, DOI 10.1016/j.apgeochem.2010.12.002; Zhang SR, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000493	40	177	190	4	181	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53163	10.1371/journal.pone.0053163	http://dx.doi.org/10.1371/journal.pone.0053163			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23967346	Green Published, Green Submitted, gold			2022-12-25	WOS:000314019100016
J	Yang, Y; Wang, Q				Yang, Yong; Wang, Qi			The Earliest Fleshy Cone of Ephedra from the Early Cretaceous Yixian Formation of Northeast China	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; GNETALES; AGE; CHLOROPLAST; FOSSIL; MORPHOLOGY; ANGIOSPERM; DISPERSAL; DIVERSITY; PORTUGAL	Bracts of female cones of extant gymnosperm Ephedra (Joint fir) are either colorful and fleshy (section Ephedra), or dry-winged and membranous (section Alatae), or dry and coriaceous (section Asarca), which have played a crucial role in long-distance seed dispersal that is responsible for a wide distribution of the genus in semiarid and arid areas of Eurasia, North Africa, North America, and South America. Recent molecular systematic studies on Ephedra have suggested that the fleshy bracts in character evolution may be plesiomorphic relative to the dry, membranous and coriaceous bracts. However, little is known about when the fleshy bracts of Ephedra have made their debut in the geological past. Herein, we describe a novel, fleshy bract-bearing female cone macrofossil from the Early Cretaceous (ca. 120-125 Ma) Yixian Formation in Liaoning, northeastern China. This cone bears three ellipsoid seeds subtended by only one whorl of fleshy bracts. Each seed has a thin outer envelope and an inner integument that extends upward and passes through the opening of the outer envelope, forming a thin and straight micropylar tube. Such a syndrome shows the closest similarity to an extant triovulate species Ephedra intermedia in the section Ephedra, but the latter bears a whorl of terminal fertile bracts and more than one whorl of inferior sterile bracts, and a thick outer envelope. Hence, we establish a new fossil species Ephedra carnosa. Our discovery provides the first direct macrofossil evidence for the previous molecular systematics of Ephedra, implying that the origin of fleshy bracts in Ephedra should not have been later than that of the membranous and coriaceous bracts by at least the Early Cretaceous.	[Yang, Yong; Wang, Qi] Chinese Acad Sci, State Key Lab Systemat & Evolutionary Bot, Inst Bot, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS	Wang, Q (corresponding author), Chinese Acad Sci, State Key Lab Systemat & Evolutionary Bot, Inst Bot, Beijing, Peoples R China.	happyking@ibcas.ac.cn	Yang, Yong/S-1202-2019	Kang, Hong-Yo/0000-0003-0626-5037; Fu, Hung-Chun/0000-0002-0660-9349	National Natural Science Foundation of China [30970177, 30600035, 40830209, 40972015]; State Key Laboratory of Systematic and Evolutionary Botany, Institute of Botany, Chinese Academy of Sciences [56176G1044]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Systematic and Evolutionary Botany, Institute of Botany, Chinese Academy of Sciences(Chinese Academy of Sciences)	The study was supported by the National Natural Science Foundation of China (no. 30970177, 30600035, 40830209, 40972015), the State Key Laboratory of Systematic and Evolutionary Botany, Institute of Botany, Chinese Academy of Sciences (no. 56176G1044) to WQ and YY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 2007, STRELITZIA, V20, P1; Barrett PM, 2000, TRENDS ECOL EVOL, V15, P99, DOI 10.1016/S0169-5347(99)01782-6; Caveney S, 2001, AM J BOT, V88, P1199, DOI 10.2307/3558330; Cladera Gerardo, 2007, Revista del Museo Argentino de Ciencias Naturales, V9, P49; Duan SY, 1998, SCI CHINA SER D, V41, P14, DOI 10.1007/BF02932415; Friis E. M., 2011, EARLY FLOWERS ANGIOS; Friis EM, 2007, NATURE, V450, P549, DOI 10.1038/nature06278; Friis EM, 2009, AM J BOT, V96, P252, DOI 10.3732/ajb.0800113; Fu LK, 1999, FLORA CHINA, P97; Gifford E.M., 1989, COMP MORPHOLOGY VASC; Gradstein FM, 2004, EPISODES, V27, P83, DOI 10.18814/epiiugs/2004/v27i2/002; Guo S.X., 2000, ACTA PALAEONTOLOGICA, V39, P81; Hollander JL, 2010, EVOL ECOL, V24, P333, DOI 10.1007/s10682-009-9309-1; Hollander JL, 2009, INT J PLANT SCI, V170, P323, DOI 10.1086/596334; Huang JL, 2005, MOL PHYLOGENET EVOL, V35, P48, DOI 10.1016/j.ympev.2004.12.020; Huang JL, 2003, MOL BIOL EVOL, V20, P435, DOI 10.1093/molbev/msg049; Ickert-Bond SM, 2004, SYST BOT, V29, P834, DOI 10.1600/0363644042451143; Ickert-Bond SM, 2011, INT J PLANT SCI, V172, P36, DOI 10.1086/657299; Ickert-Bond SM, 2009, J SYST EVOL, V47, P444, DOI 10.1111/j.1759-6831.2009.00053.x; KRASSILOV V, 1982, Palaeontographica Abteilung B Palaeophytologie, V181, P1; Krassilov VA, 2009, PALEONTOL J+, V43, P1272, DOI 10.1134/S0031030109100098; KRASSILOV VA, 1986, REV PALAEOBOT PALYNO, V47, P9, DOI 10.1016/0034-6667(86)90003-5; Kubitzki K., 1990, FAMILIES GENERA VASC, V1, P378; Kunzmann L, 2009, REV PALAEOBOT PALYNO, V158, P193, DOI 10.1016/j.revpalbo.2009.09.001; Leslie AB, 2011, PALEOBIOLOGY, V37, P587, DOI 10.1666/10049.1; Liu HM, 2008, TAXON, V57, P577, DOI 10.2307/25066023; Pearson HHW, 1929, GNETALES; Price RA, 1996, INT J PLANT SCI, V157, pS40, DOI 10.1086/297402; Ridley H., 1930, J ECOL, DOI DOI 10.2307/2255951; Rydin C, 2006, PLANT SYST EVOL, V262, P239, DOI 10.1007/s00606-006-0481-2; Rydin C, 2004, P NATL ACAD SCI USA, V101, P16571, DOI 10.1073/pnas.0407588101; Rydin C, 2006, ANN BOT-LONDON, V98, P123, DOI 10.1093/aob/mcl078; Rydin C, 2010, BOT J LINN SOC, V163, P387, DOI 10.1111/j.1095-8339.2010.01066.x; Rydin C, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-183; Rydin C, 2009, INT J PLANT SCI, V170, P1031, DOI 10.1086/605116; Stapf O., 1889, MATHEMATISCH NATURWI, V56, P1; Stevenson D.W., 1993, FLORA N AM, V2, P428; Sun G, 1998, SCIENCE, V282, P1692, DOI 10.1126/science.282.5394.1692; Sun G, 2001, EARLY ANGIOSPERMS TH; Swisher CC, 2002, CHINESE SCI BULL, V47, P135; Swisher CC, 1999, NATURE, V400, P58, DOI 10.1038/21872; Yang Y, 2005, BOT BULL ACAD SINICA, V46, P363; Yang Y, 2005, AM J BOT, V92, P231, DOI 10.3732/ajb.92.2.231; Yang Y, 2004, AM J BOT, V91, P361, DOI 10.3732/ajb.91.3.361; Yang Y, 2001, ACTA BOT SIN, V43, P1011; Yang Y., 2002, CHIN ACAD SCI, P1; Yang Y, 2007, TAXON, V56, P1271, DOI 10.2307/25065920; Yang Yong, 2011, Journal of Tropical and Subtropical Botany, V19, P1; [杨永 Yang Yong], 2011, [地质论评, Geological Review], V57, P9; Yang Yong, 2010, Taiwania, V55, P346; Zhou ZH, 2002, NATURE, V418, P405, DOI 10.1038/nature00930; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420; Zhou ZG, 2006, GEOL J, V41, P377, DOI 10.1002/gj.1045; 王鑫, 2010, [科学通报, Chinese Science Bulletin], V55, P675	54	37	38	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53652	10.1371/journal.pone.0053652	http://dx.doi.org/10.1371/journal.pone.0053652			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	24244503	gold, Green Published, Green Submitted			2022-12-25	WOS:000314759400058
